Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A1BG ENSG00000121410 "Alpha-1-B glycoprotein" P04217 19 58345178-58353499 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 180 "liver: 299.6" "Cell type enriched" "Detected in many" 11 "Hepatocytes: 1227.5" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 5.1;Hep G2: 4.9;REH: 6.6;U-266/70: 4.9" "Not detected" "Not detected" "CAB016673, HPA044252" Supported "Secreted to blood" NA NA 200000000000 49000000000 "CAB016673: AB_1611892, HPA044252: AB_2678876" "unprognostic (9.95e-2)" "unprognostic (5.31e-2)" "unprognostic (3.67e-2)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-2)" "unprognostic (4.19e-5)" "unprognostic (2.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (6.72e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 299.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.1 0.0 1.0 0.7 0.0 0.7 0.1 1.3 0.0 0.3 0.6 2.0 0.0 0.0 0.0 0.2 0.0 1.8 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.9 5.1 2.6 0.0 4.9 0.0 1.0 0.4 0.2 0.4 0.0 0.0 1.2 0.0 1.5 0.8 0.0 0.0 1.8 0.9 1.7 0.3 0.2 0.4 6.6 3.2 1.3 0.0 0.0 0.0 0.4 0.7 0.2 0.8 0.0 1.1 1.1 0.0 1.8 0.3 0.0 0.0 4.9 2.2 1.6 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.4 0.5 0.5 0.6 0.0 0.3 0.0 0.0 0.0 1.6 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 13.1 48.0 2.3 7.8 2.9 0.4 17.8 14.7 14.8 21.0 2.0 0.9 6.6 0.8 0.5 9.8 0.0 0.0 7.9 7.4 27.9 11.0 16.3 1227.5 26.2 7.9 1.2 36.8 96.4 1.9 1.1 50.1 109.6 47.7 0.0 2.2 8.5 0.0 1.1 1.3 5.2 25.8 52.4 1.4 5.1 3.1 1.6 34.8 0.1 0.6 A1CF "ACF, ACF64, ACF65, APOBEC1CF, ASP" ENSG00000148584 "APOBEC1 complementation factor" Q9NQ94 10 50799409-50885675 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 32.5;liver: 99.7" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 107.0;Enterocytes: 90.6;Hepatocytes: 295.0;Intestinal endocrine cells: 111.9;Paneth cells: 71.9;Proximal tubular cells: 93.2" "Cancer enriched" "Detected in some" 6 "liver cancer: 18.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Group enriched" "Detected in some" 23 "CACO-2: 13.8;Hep G2: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037779, HPA044079" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA037779: AB_10670529, HPA044079: AB_2678800" "unprognostic (3.87e-3)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-3)" "unprognostic (2.73e-1)" "unprognostic (4.61e-3)" "unprognostic (1.71e-1)" "unprognostic (7.38e-3)" "unprognostic (1.30e-2)" "unprognostic (2.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-3)" "unprognostic (1.97e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.50e-4)" 0.1 0.1 0.1 1.7 0.1 0.0 0.1 0.1 0.1 0.1 14.4 0.0 0.0 8.7 0.1 0.6 0.1 0.1 3.0 0.1 0.1 0.1 9.5 99.7 0.1 0.0 0.1 0.0 0.1 5.6 0.0 0.1 0.0 0.1 0.1 3.8 0.0 0.1 0.0 0.1 0.1 32.5 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 1.6 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 9.1 0.0 0.0 0.4 0.4 107.0 0.0 0.0 3.5 2.0 0.0 8.3 0.8 0.0 0.0 90.6 0.0 9.5 0.0 0.0 0.0 0.0 295.0 0.0 0.0 111.9 7.4 6.4 0.0 0.0 0.0 0.0 0.0 49.6 0.0 15.6 71.9 0.0 93.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 25.9 0.1 A2M "CPAMD5, FWP007, S863-7" ENSG00000175899 Alpha-2-macroglobulin P01023 12 9067664-9116229 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 231.0;lung: 227.4" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 495.9;Hepatocytes: 596.0;Horizontal cells: 643.6;Ito cells: 555.5;Sertoli cells: 329.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4" "Group enriched" "Detected in many" 7 "dendritic cells: 1.4;T-cells: 4.4" "Group enriched" "Detected in some" 5 "AF22: 113.6;ASC diff: 33.7;Hep G2: 91.5;SK-MEL-30: 32.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002265, CAB017621" Supported "Secreted to blood" NA NA 1630000000000 220000000000 "CAB017621: AB_1118894, HPA002265: AB_1078142" "unprognostic (1.73e-2)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (2.29e-2)" "unprognostic (7.36e-2)" "unprognostic (3.91e-2)" "unprognostic (7.95e-2)" "unprognostic (3.65e-2)" "unprognostic (2.38e-1)" "unprognostic (7.19e-2)" "unprognostic (4.71e-2)" "unprognostic (2.06e-2)" "unprognostic (1.28e-2)" "unprognostic (8.04e-3)" "unprognostic (2.32e-2)" "unprognostic (8.58e-2)" "unprognostic (9.03e-3)" 77.4 20.5 12.5 14.7 16.8 0.3 39.6 6.1 16.1 41.8 27.3 25.3 10.5 15.0 54.6 28.2 39.5 30.6 49.7 68.0 12.4 10.2 50.0 231.0 227.4 14.9 16.9 8.0 40.8 13.0 20.9 20.4 48.0 20.5 77.3 35.9 47.5 20.5 26.3 26.0 10.2 23.1 57.7 20.9 42.3 25.8 26.2 13.0 4.0 29.5 17.0 8.6 68.9 59.0 0.2 1.4 0.0 0.4 0.0 4.4 0.3 0.0 0.0 113.6 0.0 33.7 2.4 0.3 13.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 91.5 0.0 0.1 0.1 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 32.9 0.5 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.4 0.0 4.4 0.2 2.6 0.2 0.5 1.2 0.3 0.0 0.1 0.7 0.0 0.0 0.0 1.4 0.0 0.3 12.5 16.8 6.1 16.1 12.4 10.2 16.9 8.0 20.5 13.0 11.9 137.3 25.5 1.9 17.3 5.4 90.3 28.1 8.1 12.5 1.8 7.9 1.9 0.0 0.1 16.7 495.9 0.0 23.3 4.5 3.0 24.6 4.2 25.6 596.0 196.9 643.6 0.0 555.5 100.3 27.1 71.7 64.0 21.9 65.9 0.0 4.7 0.2 0.0 133.0 0.0 18.6 329.8 207.9 1.8 1.1 12.3 3.4 16.7 0.0 2.2 A2ML1 "CPAMD9, FLJ25179, p170" ENSG00000166535 "Alpha-2-macroglobulin like 1" A8K2U0 12 8822472-8887001 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 131.6;lymphoid tissue: 67.9;tongue: 54.7" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 11.0;Urothelial cells: 4.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 39.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 12.3;hTCEpi: 6.2;SK-BR-3: 15.4" "HPA038847, HPA038848" Enhanced "Secreted in other tissues" NA NA 34000000 "HPA038847: AB_2676236, HPA038848: AB_10672654" "unprognostic (1.13e-2)" "unprognostic (7.64e-2)" "unprognostic (1.04e-2)" "unprognostic (9.46e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (4.59e-2)" "unprognostic (7.58e-3)" "unprognostic (2.63e-1)" "unprognostic (1.57e-1)" "unprognostic (1.15e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-9)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (5.88e-2)" "unprognostic (2.42e-2)" 0.1 0.1 0.1 0.1 0.2 0.1 1.2 0.1 0.6 31.3 0.1 0.1 0.1 0.0 0.6 0.2 131.6 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 1.3 0.1 0.2 0.1 0.1 17.3 0.1 0.1 18.1 0.1 0.1 0.1 0.1 0.1 1.3 0.1 1.2 0.1 54.7 67.9 0.3 28.7 1.0 1.2 1.8 2.0 1.5 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.0 2.7 12.3 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 15.4 0.0 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.8 0.7 0.4 0.9 1.0 0.7 0.9 0.4 0.4 0.3 1.0 0.5 0.6 1.7 1.5 2.0 1.2 0.4 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.3 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.4 0.0 11.0 0.1 0.0 0.0 4.9 A4GNT alpha4GnT ENSG00000118017 Alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3 3 138123718-138132387 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0" "Cell type enriched" "Detected in single" 9 "Cholangiocytes: 2.5" "Group enriched" "Detected in some" 6 "pancreatic cancer: 2.5;stomach cancer: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;BJ: 3.7;hTERT-RPE1: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA008017 Enhanced "Intracellular and membrane" NA NA "HPA008017: AB_1078073" "unprognostic (1.21e-1)" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (1.18e-2)" "unprognostic (1.48e-2)" "unprognostic (8.79e-2)" "unprognostic (9.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (4.03e-2)" "unprognostic (1.03e-1)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.48e-3)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 2.5 0.1 0.1 0.1 0.1 25.9 0.1 0.1 0.1 1.5 0.4 0.3 0.1 0.1 0.1 0.2 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 25.0 0.1 0.1 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AADAC "CES5A1, DAC" ENSG00000114771 "Arylacetamide deacetylase" P22760 3 151814037-151828488 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 66.2;intestine: 81.7;liver: 123.1" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 610.4" "Cancer enriched" "Detected in many" 22 "liver cancer: 153.4" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7" "Not detected" "Not detected" HPA002911 Approved NA NA "HPA002911: AB_1078074" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.11e-2)" "unprognostic (4.41e-2)" "unprognostic (9.23e-2)" "unprognostic (7.82e-2)" "unprognostic (2.15e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.58e-6)" "prognostic unfavorable (5.02e-4)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" 3.9 66.2 0.1 0.1 1.6 0.0 2.1 0.1 0.1 0.1 26.1 0.5 0.4 29.6 0.1 0.3 0.3 0.2 4.3 0.2 0.1 0.0 0.1 123.1 1.7 0.1 0.1 0.1 0.1 22.7 0.0 0.1 1.7 0.2 0.3 0.0 0.1 0.3 0.1 0.2 1.7 81.7 0.1 0.1 0.1 7.3 0.3 0.1 0.1 0.2 4.8 1.3 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 4.5 0.2 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.2 6.4 0.0 0.1 0.4 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.7 0.1 0.1 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.3 0.2 1.4 0.3 0.2 0.4 2.1 0.0 2.3 0.2 1.9 0.3 0.1 0.0 0.0 0.0 0.0 2.5 0.0 2.4 1.4 0.0 0.4 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 11.0 0.0 0.0 0.2 0.0 1.1 58.6 4.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.2 0.0 0.0 610.4 0.2 0.0 0.0 3.7 10.8 0.0 0.0 0.0 3.3 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.2 0.0 0.0 0.1 AADACL2 MGC72001 ENSG00000197953 "Arylacetamide deacetylase like 2" Q6P093 3 151733916-151761339 "Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "placenta: 8.6;skin 1: 26.1;tongue: 22.2" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "hTCEpi: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.20e-2)" "unprognostic (3.10e-3)" "unprognostic (2.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (3.00e-1)" "unprognostic (2.91e-4)" 1.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.8 0.0 0.7 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.4 0.0 0.2 26.1 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 22.2 1.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.0 AADACL3 ENSG00000188984 "Arylacetamide deacetylase like 3" Q5VUY0 1 12716115-12728759 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "placenta: 13.4;skin 1: 4.7" "Cell type enhanced" "Detected in single" 35 "Extravillous trophoblasts: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.01e-1)" "unprognostic (2.54e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AADACL4 ENSG00000204518 "Arylacetamide deacetylase like 4" Q5VUY2 1 12644547-12667086 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 2.8;epididymis: 3.5;vagina: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 2.1;REH: 1.0" "Not detected" "Not detected" NA NA "unprognostic (3.20e-1)" "unprognostic (1.89e-2)" 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.4 3.5 0.0 0.7 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.7 1.1 0.0 0.0 1.4 0.2 0.0 0.0 0.5 0.0 0.6 0.4 1.4 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 56.5" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 60.6;Hepatocytes: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favorable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 3.0 3.1 9.2 2.2 9.0 0.9 4.7 0.8 10.8 8.3 4.7 10.3 2.9 1.9 9.7 5.8 2.8 5.7 3.9 2.8 7.2 6.4 6.3 56.5 4.7 1.1 8.2 8.0 4.7 4.6 7.6 8.9 2.2 6.0 13.3 5.0 6.6 1.7 5.4 3.6 1.8 2.0 7.0 7.0 2.0 3.2 7.2 9.2 0.9 7.0 1.2 1.3 5.5 4.9 0.4 0.4 0.0 0.7 0.0 0.7 0.0 2.2 5.5 16.7 0.0 3.3 13.0 6.0 5.7 2.8 3.3 3.3 5.3 0.6 0.0 0.9 6.3 4.3 1.9 7.4 2.7 2.3 0.0 6.4 0.0 6.2 8.9 2.7 0.0 2.4 5.3 1.6 2.7 3.5 9.1 3.1 7.5 0.9 0.1 12.6 5.6 2.7 0.1 12.6 6.2 5.0 0.0 5.2 0.0 2.9 10.0 13.5 15.7 4.5 1.1 5.4 5.6 0.0 1.1 2.1 8.4 9.0 9.5 8.8 0.0 0.0 0.0 8.4 0.0 9.8 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.4 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 9.2 9.0 0.8 10.8 7.2 6.4 8.2 8.0 6.0 9.2 0.0 5.1 0.0 2.6 0.8 5.1 1.1 2.5 14.7 3.4 0.0 2.0 1.4 0.0 1.3 0.4 0.5 0.0 0.0 1.9 60.6 2.4 3.6 0.0 22.9 1.4 0.0 6.4 0.0 0.3 0.6 1.1 0.6 1.7 0.0 1.3 3.2 0.9 0.0 2.1 6.5 8.2 6.5 2.2 2.4 12.5 0.4 4.7 0.0 2.3 1.4 AAK1 "DKFZp686K16132, KIAA1048" ENSG00000115977 "AP2 associated kinase 1" Q2M2I8 2 69457997-69674349 "Enzymes, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 109.7" "Cell type enhanced" "Detected in all" 9 "Cone photoreceptor cells: 732.4;Rod photoreceptor cells: 621.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017931, HPA020289" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA No "Vesicles, Plasma membrane" Cytosol "HPA017931: AB_1844406, HPA020289: AB_1844407" "unprognostic (2.11e-3)" "unprognostic (3.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.01e-3)" "unprognostic (5.06e-2)" "unprognostic (4.04e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (4.18e-2)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.76e-3)" "unprognostic (1.18e-1)" 5.1 5.9 11.0 5.7 11.9 7.8 6.9 25.2 26.5 4.8 4.2 3.9 6.3 3.8 4.7 7.1 3.8 4.9 4.3 7.9 14.4 12.8 7.2 3.1 7.5 6.8 9.4 11.6 3.3 6.7 109.7 10.3 6.9 10.2 5.0 4.6 4.7 3.6 12.3 6.8 3.7 3.7 5.4 9.3 5.5 5.4 4.1 6.9 4.7 16.0 2.1 5.3 4.9 5.8 1.0 0.8 4.1 3.9 2.8 5.6 1.3 16.8 10.1 9.3 9.0 8.9 9.9 29.9 13.7 10.9 8.3 7.4 10.2 6.7 0.6 3.4 17.9 11.4 7.9 7.1 7.1 17.0 12.5 3.0 9.1 6.1 6.9 8.1 6.4 21.7 8.5 6.3 15.6 20.3 6.8 17.6 8.6 1.9 9.5 14.4 2.8 5.9 3.4 4.4 3.1 5.6 3.9 10.0 1.4 6.6 35.3 3.1 4.9 7.9 6.1 7.1 6.4 3.6 9.1 17.5 18.7 12.5 13.4 13.5 9.3 2.4 1.0 15.6 10.9 12.7 2.5 1.4 0.6 4.5 0.6 4.2 0.4 4.0 3.0 0.8 1.0 5.6 4.5 4.1 2.8 3.9 0.7 3.1 1.3 11.0 11.9 25.2 26.5 14.4 12.8 9.4 11.6 10.2 6.9 32.8 38.8 3.0 17.4 14.2 235.7 71.2 99.3 10.7 23.9 136.1 732.4 65.1 36.5 37.7 19.2 43.8 67.4 23.3 57.5 45.9 24.0 51.4 20.7 30.1 51.9 289.2 69.3 93.9 98.0 23.3 35.4 45.1 10.1 50.5 26.9 42.5 48.8 26.4 43.9 53.7 621.3 19.4 29.2 45.9 51.3 8.7 178.4 135.1 14.6 50.6 AAMDC "C11orf67, CK067, FLJ21035, PTD015" ENSG00000087884 "Adipogenesis associated Mth938 domain containing" Q9H7C9 11 77821109-77918432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 73.6" "Low region specificity" "Detected in all" "HPA037918, HPA037919" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037918: AB_2675737, HPA037919: AB_2675738" "unprognostic (3.10e-2)" "unprognostic (9.04e-3)" "unprognostic (6.02e-2)" "unprognostic (4.67e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-1)" "unprognostic (7.08e-2)" "unprognostic (1.90e-1)" "unprognostic (2.08e-1)" "unprognostic (1.35e-1)" "unprognostic (1.37e-1)" "unprognostic (3.84e-2)" 18.8 42.2 7.5 7.5 11.4 5.2 16.2 10.9 8.6 13.8 15.8 9.5 16.9 10.1 18.0 9.5 12.4 13.4 11.8 35.0 7.5 6.4 12.8 15.5 11.8 3.5 13.0 6.8 14.3 18.1 6.9 11.1 7.9 9.9 12.6 8.3 10.0 16.7 14.5 155.8 13.0 13.6 21.0 15.3 7.4 14.2 14.4 13.1 6.5 14.1 15.7 5.0 14.4 17.0 8.1 13.2 43.3 11.9 13.7 18.0 6.4 7.8 6.4 10.0 7.1 29.3 20.4 2.7 13.0 8.9 11.8 14.8 73.6 11.9 5.3 12.7 21.8 11.7 4.4 15.0 8.7 14.1 12.2 12.1 5.1 11.1 13.5 14.4 2.8 4.6 27.1 6.0 12.4 6.6 11.0 35.0 7.1 5.8 8.6 24.9 9.2 6.0 11.4 4.7 22.0 11.0 5.8 17.2 5.1 15.6 4.7 3.5 13.4 16.5 7.2 9.2 15.6 11.1 5.7 36.4 12.5 6.8 23.6 4.3 9.3 14.5 9.7 4.8 4.7 6.9 43.3 11.9 12.3 6.1 6.6 7.8 7.0 11.9 10.0 12.7 8.1 10.4 7.8 6.9 13.7 6.4 13.2 18.0 6.4 7.5 11.4 10.9 8.6 7.5 6.4 13.0 6.8 9.9 13.1 77.4 23.1 12.7 70.3 57.1 10.1 103.7 63.7 44.2 25.0 75.0 3.9 21.7 122.7 56.1 47.2 50.1 92.1 0.0 64.0 37.5 60.8 57.8 40.4 94.8 39.9 11.1 21.8 93.9 31.4 27.5 63.3 28.7 79.2 82.0 49.3 57.0 62.2 98.2 60.5 133.6 12.6 45.3 59.7 89.5 53.2 88.1 13.2 17.5 57.2 63.6 AANAT SNAT ENSG00000129673 "Aralkylamine N-acetyltransferase" Q16613 17 76453351-76470117 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Melatonin biosynthesis" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 27.7;testis: 8.2" "Cell type enriched" "Detected in some" 9 "Bipolar cells: 269.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.6;Daudi: 3.8;SCLC-21H: 5.7;U-266/70: 4.6;U-266/84: 4.8;U-698: 6.8" "Not detected" "Not detected" HPA054321 Supported Cytosol "Intracellular and membrane" NA NA Cytosol "HPA054321: AB_2682449" "unprognostic (7.89e-2)" "unprognostic (2.62e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-1)" "unprognostic (1.83e-2)" "unprognostic (2.03e-2)" "unprognostic (1.05e-2)" "unprognostic (3.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.61e-1)" "unprognostic (9.30e-2)" "unprognostic (4.19e-1)" "unprognostic (2.81e-7)" "unprognostic (1.04e-1)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (1.34e-2)" 0.3 0.2 1.2 3.8 0.8 2.7 0.3 1.3 1.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.8 0.4 1.8 0.3 1.2 1.5 0.3 0.3 0.3 3.3 1.7 0.7 0.4 0.3 0.0 0.9 0.3 1.9 0.3 0.0 27.7 0.3 0.3 1.8 3.3 0.7 0.3 1.2 2.2 0.2 8.2 0.3 0.3 0.8 0.3 0.3 0.9 0.3 1.3 1.3 2.2 0.1 1.8 0.2 0.0 0.9 4.6 0.7 0.5 0.0 0.1 0.5 0.0 0.4 0.3 0.1 0.1 3.3 3.8 0.5 0.0 0.7 1.2 0.0 0.0 0.3 0.0 1.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.4 0.0 2.0 0.4 0.6 0.1 0.1 1.2 1.5 0.4 0.2 0.2 2.0 0.0 0.1 5.7 0.4 0.1 0.2 1.6 0.6 2.8 0.7 0.0 0.0 1.8 0.2 0.1 4.6 4.8 6.8 1.2 0.4 0.8 2.0 0.1 2.2 0.2 0.0 0.0 0.6 0.1 0.0 0.0 1.3 0.0 0.2 0.6 1.8 0.0 1.3 0.1 0.0 1.2 0.8 1.3 0.9 1.2 1.5 1.7 0.7 1.9 0.3 0.0 0.0 0.0 0.0 0.0 269.2 0.3 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 1.2 0.0 0.0 12.3 0.3 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.3 29.7 0.0 0.0 1.7 1.0 0.0 0.1 0.0 0.0 0.0 AARD "C8orf85, LOC441376" ENSG00000205002 "Alanine and arginine rich domain containing protein" Q4LEZ3 8 116938199-116944487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 18.4;testis: 43.6" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 22.2;granulocytes: 13.9;Spermatocytes: 27.6" "Cancer enriched" "Detected in many" 8 "breast cancer: 27.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 19.8;JURKAT: 6.8;SK-BR-3: 11.2;U-2 OS: 5.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 4 "midbrain: 7.3" HPA068290 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA068290: " "unprognostic (5.81e-2)" "unprognostic (2.28e-1)" "unprognostic (1.32e-1)" "unprognostic (7.28e-8)" "unprognostic (3.42e-2)" "unprognostic (4.32e-3)" "unprognostic (4.34e-2)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (8.29e-2)" "unprognostic (8.57e-3)" "unprognostic (4.20e-1)" "unprognostic (2.23e-6)" "unprognostic (1.67e-1)" "unprognostic (9.78e-3)" "unprognostic (3.77e-2)" "unprognostic (5.27e-4)" 0.4 0.8 0.7 1.8 1.2 0.3 4.9 0.0 0.9 0.3 4.5 0.0 0.0 0.2 1.1 0.8 8.1 0.2 0.4 0.1 0.5 0.6 1.3 0.1 2.9 1.0 0.4 0.5 0.1 0.1 0.1 0.0 0.6 0.5 8.4 0.7 4.0 2.1 0.2 0.2 1.1 0.8 18.4 0.1 0.3 7.2 43.6 0.1 0.0 0.2 0.2 0.5 10.2 5.6 1.1 1.0 3.3 0.9 1.5 2.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.5 0.0 0.2 0.1 2.3 0.0 0.2 0.4 0.0 0.1 0.1 0.2 0.0 6.8 0.0 2.3 0.1 0.4 0.8 0.1 1.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 1.9 0.3 0.0 11.2 0.0 0.2 0.5 0.0 0.0 0.1 5.5 0.2 0.0 1.6 4.1 0.0 2.9 0.1 0.3 3.3 0.9 0.6 0.6 0.4 0.3 0.6 0.5 0.4 0.2 1.1 0.5 0.6 3.1 1.5 0.6 1.0 2.0 0.1 0.7 1.2 0.0 0.4 0.5 0.6 0.4 0.5 0.5 0.1 11.9 22.2 0.0 0.2 0.7 0.5 0.8 0.0 1.4 9.1 7.0 0.0 0.1 1.7 0.0 7.5 0.0 0.0 0.0 0.0 0.6 0.4 0.8 13.9 0.0 0.0 1.6 0.0 0.0 0.0 7.9 3.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 10.5 0.0 0.0 0.5 27.6 6.0 0.5 0.2 0.0 0.0 0.3 AATK "AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77" ENSG00000181409 "Apoptosis associated tyrosine kinase" Q6ZMQ8 17 81117295-81166077 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;intestine: 28.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 29.8;Alveolar cells type 2: 23.6;Bipolar cells: 43.5;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.6" "Group enriched" "Detected in some" 6 "CACO-2: 30.3;SH-SY5Y: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009073 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA009073: AB_1078076" "unprognostic (3.47e-3)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.95e-4)" "unprognostic (1.96e-1)" "unprognostic (1.94e-1)" "unprognostic (7.29e-2)" "unprognostic (9.85e-2)" "unprognostic (6.09e-2)" "unprognostic (4.27e-2)" "unprognostic (2.88e-3)" "unprognostic (2.48e-1)" "unprognostic (4.28e-6)" "unprognostic (1.58e-3)" "unprognostic (1.21e-1)" "unprognostic (1.39e-1)" "unprognostic (4.57e-2)" 2.8 4.7 14.3 3.2 16.6 3.7 0.9 19.0 29.0 1.2 3.3 16.5 0.0 28.7 1.0 1.1 1.7 1.2 2.7 2.3 23.6 13.9 1.2 1.2 9.7 1.5 20.1 13.6 1.0 17.9 3.6 6.4 2.6 11.0 2.4 1.1 4.1 5.6 3.6 1.1 1.9 20.3 1.3 35.3 5.9 4.5 1.3 9.8 0.0 1.3 0.0 1.0 1.3 1.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 1.2 1.4 1.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.1 0.5 0.3 0.1 1.3 2.5 0.2 0.0 0.0 2.9 10.4 0.2 0.0 1.5 0.1 0.3 0.8 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 14.3 16.6 19.0 22.3 23.6 13.9 20.1 13.6 11.0 9.8 29.8 23.6 0.0 0.8 0.2 43.5 2.2 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.6 0.0 1.1 6.9 0.0 1.6 0.1 0.4 1.0 5.8 0.0 2.0 20.6 1.7 0.6 4.1 0.0 1.4 0.6 5.0 0.0 4.5 8.3 1.3 4.5 2.5 0.8 4.1 0.0 0.8 0.5 0.2 0.3 1.9 0.7 7.2 0.1 ABAT GABAT ENSG00000183044 "4-aminobutyrate aminotransferase" P80404 16 8674565-8784575 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Neurotransmitter degradation" "Aminotransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 53.3;liver: 136.5;pancreas: 54.2" "Cell type enhanced" "Detected in many" 19 "Hepatocytes: 234.8;Proximal tubular cells: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 45.3;MCF7: 29.1;RH-30: 25.6;T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041528, HPA041690" Enhanced Supported Supported Mitochondria No No 1500000 Mitochondria "HPA041528: AB_10795690, HPA041690: AB_10794674" "unprognostic (1.77e-2)" "unprognostic (3.27e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-1)" "unprognostic (2.90e-1)" "unprognostic (2.05e-1)" "prognostic favorable (5.36e-5)" "prognostic favorable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "prognostic favorable (5.44e-8)" "unprognostic (2.10e-1)" "unprognostic (2.48e-2)" "unprognostic (3.80e-1)" "unprognostic (1.50e-2)" 2.1 12.6 26.1 2.7 39.3 1.7 3.2 19.9 43.3 2.2 5.2 10.9 0.1 17.5 2.1 5.0 3.0 2.8 2.7 6.2 20.4 30.9 53.3 136.5 2.8 2.8 24.5 26.1 5.3 54.2 4.0 22.1 2.3 14.3 9.9 4.2 2.6 2.6 2.5 1.4 2.1 8.4 2.1 14.1 2.5 3.9 6.3 11.8 1.0 12.7 0.4 3.3 6.4 1.1 2.2 1.9 8.8 5.8 1.6 2.5 1.8 0.2 0.0 12.1 6.9 1.9 0.7 0.5 1.4 0.8 0.7 0.2 4.5 0.3 1.4 0.5 0.8 0.4 3.1 0.8 2.8 0.9 0.8 0.6 2.0 0.0 45.3 3.1 0.4 3.1 2.5 1.3 1.2 0.5 0.3 0.2 3.9 0.3 1.0 0.2 29.1 0.7 0.2 1.0 8.5 0.1 3.5 25.6 0.6 0.4 7.2 1.9 5.8 0.7 0.4 0.0 2.5 15.9 1.2 0.2 0.2 2.0 0.9 0.0 1.1 0.1 0.3 0.3 2.1 1.4 1.1 3.1 4.1 2.5 3.6 1.1 0.8 1.7 1.7 1.9 2.2 1.1 1.8 8.8 1.6 5.8 0.3 1.6 1.8 26.1 39.3 19.9 35.1 20.4 30.9 24.5 26.1 14.3 11.8 0.0 5.8 12.2 3.3 1.3 16.6 8.9 15.3 2.7 7.9 1.8 3.9 1.2 19.9 1.2 8.3 1.4 10.3 0.0 5.5 1.2 2.1 9.6 1.1 234.8 4.3 33.4 15.0 5.5 9.1 6.0 3.4 5.4 1.7 0.0 4.9 48.7 6.3 6.5 4.2 72.0 6.0 0.0 2.5 1.5 0.9 0.5 1.1 7.2 6.8 4.2 ABCA10 EST698739 ENSG00000154263 "ATP binding cassette subfamily A member 10" Q8WWZ4 17 69147214-69244846 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.6" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 189.3;Late spermatids: 66.1;Leydig cells: 47.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 11 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "ASC diff: 1.7;HSkMC: 3.8;HUVEC TERT2: 3.7;RT4: 3.5;U-2197: 5.5" HPA014535 Uncertain NA NA "HPA014535: AB_1844426" "unprognostic (1.45e-4)" "unprognostic (3.17e-1)" "unprognostic (7.74e-2)" "unprognostic (5.18e-2)" "unprognostic (2.52e-2)" "unprognostic (1.17e-2)" "unprognostic (3.78e-2)" "unprognostic (1.40e-1)" "unprognostic (4.51e-3)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (4.91e-1)" "unprognostic (2.70e-4)" "unprognostic (5.23e-3)" "unprognostic (6.98e-2)" "unprognostic (4.37e-2)" "unprognostic (9.86e-3)" 4.6 0.5 0.0 0.0 0.2 0.0 10.4 5.0 0.4 1.6 1.7 0.6 2.7 2.4 1.1 6.3 3.1 2.7 0.1 0.2 0.5 2.7 2.5 0.1 0.1 11.6 1.3 0.1 1.3 0.0 0.8 3.8 2.6 0.2 3.5 4.1 1.4 1.7 0.2 0.3 1.0 1.6 3.1 0.3 1.3 1.9 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 3.8 0.5 0.8 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.9 7.1 2.4 0.0 4.0 0.0 0.0 23.6 0.0 0.0 0.4 189.3 1.7 2.5 0.0 0.2 0.0 3.8 0.3 0.0 1.0 0.1 0.0 4.7 0.6 0.0 66.1 47.2 0.9 1.7 2.8 2.9 3.1 0.6 0.0 11.0 0.3 7.6 0.0 1.4 7.7 2.8 0.4 0.0 0.0 0.5 0.5 ABCA12 "DKFZP434G232, ICR2B, LI2" ENSG00000144452 "ATP binding cassette subfamily A member 12" Q86UK0 2 214931542-215138428 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 23.1;tongue: 29.3" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "cerebral cortex: 1.6;hippocampal formation: 1.8" HPA078239 Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoli, Cytosol" "HPA078239: AB_2732373" "unprognostic (6.12e-2)" "unprognostic (4.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.49e-1)" "unprognostic (2.13e-1)" "unprognostic (2.09e-4)" "unprognostic (6.52e-3)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (2.50e-2)" "unprognostic (7.69e-2)" "unprognostic (5.92e-2)" "unprognostic (2.64e-2)" "unprognostic (2.36e-1)" "unprognostic (5.08e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.9 0.1 0.1 6.2 0.3 0.0 1.4 0.0 0.0 4.4 8.4 0.1 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 6.1 4.9 0.0 0.1 0.4 0.0 0.3 0.0 0.1 23.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 29.3 6.1 0.1 3.7 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.7 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 2.0 0.0 13.4 0.0 0.1 7.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 11.4 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.1 0.3 0.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.7 0.0 0.0 0.0 0.2 0.5 0.2 33.8 2.9 0.0 0.0 2.2 ABCA13 "FLJ33876, FLJ33951" ENSG00000179869 "ATP binding cassette subfamily A member 13" 7 48171458-48647496 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063601 Approved Vesicles,Centrosome,Cytosol NA NA Vesicles "Centrosome, Cytosol" "HPA063601: AB_2685057" "unprognostic (8.97e-2)" "unprognostic (5.82e-2)" "unprognostic (3.18e-1)" "unprognostic (6.48e-2)" "unprognostic (2.65e-2)" "unprognostic (5.59e-2)" "unprognostic (5.19e-2)" "unprognostic (2.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.86e-3)" "unprognostic (6.03e-3)" "unprognostic (3.26e-1)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (3.62e-2)" 0.3 0.2 0.1 0.3 1.0 35.4 0.7 0.0 1.1 1.2 0.3 0.4 0.0 0.3 0.3 1.1 10.3 1.8 0.5 3.5 1.8 0.2 1.1 0.7 15.7 0.2 0.1 0.0 0.4 1.2 0.1 8.7 1.2 0.4 0.2 0.4 0.0 1.7 0.4 0.8 1.3 0.3 0.2 0.9 1.3 0.2 4.2 0.0 4.6 7.1 5.4 14.4 0.5 0.3 0.6 0.6 3.2 0.7 1.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.9 0.6 1.2 2.1 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.8 0.0 0.3 0.0 0.1 3.7 0.0 0.0 0.1 0.1 0.0 2.1 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.0 0.6 10.4 0.4 1.5 3.1 4.2 0.0 1.3 0.4 0.4 3.2 0.7 0.6 0.3 0.4 0.3 0.4 0.2 0.2 0.1 0.6 0.4 0.4 1.6 1.0 0.3 0.6 0.1 0.2 0.1 1.0 0.0 1.1 1.8 0.2 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.0 64.3 9.1 1.8 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.2 0.0 0.0 0.0 0.3 0.1 ABCA2 ABC2 ENSG00000107331 "ATP binding cassette subfamily A member 2" Q9BZC7 9 137007227-137028922 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 84.3" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 35.0;Intestinal endocrine cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2" "Cell line enhanced" "Detected in many" "T-47d: 35.2" "Low region specificity" "Detected in all" HPA042886 Approved NA NA "HPA042886: AB_2678213" "unprognostic (1.01e-2)" "unprognostic (9.21e-3)" "unprognostic (9.59e-2)" "unprognostic (6.15e-2)" "unprognostic (1.02e-1)" "unprognostic (8.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.13e-2)" "unprognostic (5.61e-3)" "unprognostic (1.76e-1)" "unprognostic (2.93e-2)" "unprognostic (2.74e-2)" "unprognostic (6.78e-3)" "unprognostic (3.14e-3)" "unprognostic (1.37e-1)" "unprognostic (2.80e-1)" "unprognostic (1.36e-1)" 7.8 6.1 20.0 3.9 42.4 5.7 2.6 16.7 54.2 4.0 4.5 84.3 0.9 3.2 2.8 4.7 3.5 6.3 5.7 7.1 32.2 17.6 4.8 3.8 4.1 4.1 57.5 21.9 2.5 8.6 8.1 7.8 3.3 31.1 5.2 2.5 3.8 8.0 5.1 5.7 6.3 4.1 2.7 70.5 8.3 6.1 3.0 47.7 0.2 9.5 0.1 2.2 3.3 1.8 0.4 2.7 0.4 0.3 1.2 2.2 1.1 4.4 4.8 2.4 9.7 6.1 6.5 4.2 4.9 2.0 2.2 0.8 1.4 5.4 0.2 14.1 5.3 2.2 7.5 1.5 3.6 0.4 3.3 3.1 0.4 13.9 1.7 3.0 7.0 7.7 2.7 3.3 1.6 0.4 8.3 1.2 1.4 1.1 0.8 2.7 13.3 0.0 15.0 1.2 5.6 4.9 6.8 2.4 6.5 1.5 1.0 9.3 10.7 5.3 10.4 3.8 0.1 35.2 9.1 6.3 6.1 3.3 8.6 2.0 0.1 0.1 0.0 10.3 1.3 3.0 0.0 0.3 0.0 2.2 0.2 1.3 0.4 0.2 0.7 0.3 0.2 0.0 0.9 0.4 1.2 0.0 2.7 1.0 1.1 20.0 42.4 16.7 30.7 32.2 17.6 57.5 21.9 31.1 47.7 0.0 0.0 0.5 1.3 3.0 9.5 4.0 17.8 0.0 0.0 1.8 13.7 1.0 1.7 2.9 0.6 3.4 10.3 0.0 1.3 1.0 4.3 2.6 0.0 6.7 1.2 35.0 33.4 7.4 2.4 1.1 20.4 1.1 5.0 0.0 5.7 10.8 2.3 6.8 22.3 1.1 7.2 0.0 3.8 0.5 4.5 2.4 0.7 14.1 8.9 0.9 ABCA3 "ABC-C, ABC3, EST111653, LBM180" ENSG00000167972 "ATP binding cassette subfamily A member 3" Q99758 16 2275881-2340746 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;lung: 75.8" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 2: 382.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007884 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA007884: AB_1078077" "unprognostic (2.64e-1)" "unprognostic (2.19e-2)" "unprognostic (6.09e-3)" "unprognostic (2.61e-3)" "unprognostic (2.20e-1)" "unprognostic (1.35e-1)" "unprognostic (2.90e-2)" "unprognostic (1.86e-1)" "unprognostic (6.58e-3)" "unprognostic (3.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (3.32e-2)" "unprognostic (7.85e-2)" "unprognostic (2.91e-1)" "unprognostic (1.30e-1)" 6.3 6.2 12.9 3.4 15.3 1.6 7.0 21.9 30.8 3.0 3.8 13.1 1.8 2.7 3.2 4.2 3.6 4.9 3.3 5.6 14.6 13.8 3.9 1.5 75.8 3.9 11.4 13.1 3.2 9.6 14.8 6.0 4.7 18.3 5.3 2.1 4.9 8.5 5.0 5.0 4.2 2.5 5.0 11.3 3.7 3.0 7.2 6.1 5.6 16.2 0.5 6.4 3.0 1.3 0.2 0.5 0.0 0.6 2.0 1.5 0.4 0.3 9.7 1.8 15.1 0.4 0.0 0.1 2.6 0.6 1.0 1.1 1.3 1.5 0.1 3.8 1.2 0.9 0.2 8.7 0.1 0.3 15.2 5.8 1.0 1.1 0.2 1.3 0.1 1.6 0.1 0.2 0.1 0.5 6.2 14.7 0.1 10.4 0.0 0.0 12.9 0.0 1.0 2.0 2.3 4.7 2.4 0.3 1.7 8.7 0.3 21.2 15.3 1.8 10.7 0.2 0.8 34.9 0.9 4.2 0.1 0.5 4.1 4.3 2.8 1.2 0.0 2.1 5.2 0.1 0.0 0.1 0.0 1.5 0.1 0.8 0.2 0.6 1.4 0.5 0.1 0.6 1.5 0.0 2.0 0.6 0.0 0.3 0.4 12.9 15.3 21.9 30.8 14.6 13.8 11.4 13.1 18.3 6.1 65.5 382.0 0.0 0.4 0.6 16.5 5.1 2.5 4.0 17.0 17.4 11.8 0.0 0.0 4.6 7.7 4.2 0.2 0.0 3.3 0.0 1.4 1.9 27.8 0.9 0.9 17.5 5.2 2.5 2.7 2.7 1.7 1.6 1.7 2.8 0.7 6.9 2.4 0.0 3.2 1.5 9.5 6.5 3.1 1.9 14.0 1.4 0.0 2.5 0.6 0.1 ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992835-94121132 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 142.7" "Group enriched" "Detected in some" 14 "Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in some" 13 "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064420, HPA078826" Enhanced Approved Cytosol NA NA Cytosol "HPA064420: , HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.72e-4)" 0.7 0.0 0.3 0.2 0.4 0.0 1.1 0.2 0.9 0.7 0.2 3.2 0.2 3.7 0.2 12.9 0.2 0.6 0.2 0.2 2.0 0.2 6.7 1.2 0.4 0.3 0.3 0.2 0.3 0.2 0.0 0.2 0.8 25.5 0.3 0.0 142.7 0.2 2.1 0.2 3.5 4.2 0.2 0.2 0.2 0.1 2.1 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 11.2 0.5 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.7 3.5 1.2 0.6 0.0 0.0 0.5 0.0 0.5 0.0 0.2 1.0 0.0 0.0 0.2 0.0 1.4 0.5 0.0 2.0 0.0 0.0 0.2 0.3 0.3 0.5 0.5 0.0 0.0 1.0 4.2 0.2 5.1 0.4 0.0 0.2 0.3 2.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.9 2.0 0.2 0.3 0.2 25.5 0.2 0.0 0.6 0.0 0.2 0.1 14.3 0.8 0.0 2.7 0.0 7.0 424.1 0.1 0.0 0.0 8.5 0.8 0.0 0.0 0.0 1.1 0.2 1.5 0.0 0.0 0.1 9.5 0.0 0.6 0.0 15.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 455.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 ABCA5 EST90625 ENSG00000154265 "ATP binding cassette subfamily A member 5" Q8WWZ7 17 69244311-69327244 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022032, HPA062904" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022032: AB_1844427, HPA062904: AB_2732692" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (1.62e-3)" "unprognostic (7.17e-2)" "unprognostic (8.05e-4)" "unprognostic (3.05e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "prognostic favorable (9.97e-5)" "unprognostic (3.60e-2)" "unprognostic (1.09e-3)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (2.55e-1)" "unprognostic (8.52e-2)" 10.5 8.6 6.7 3.8 9.8 6.0 12.7 35.6 12.4 8.8 9.6 4.3 13.5 9.7 6.0 7.7 8.6 6.6 4.6 5.2 5.3 6.2 7.9 21.7 4.9 3.3 4.1 7.9 6.9 20.3 13.0 35.9 5.3 13.6 7.4 10.6 15.5 8.2 11.4 52.8 24.0 15.5 3.4 7.6 4.3 8.9 9.0 3.9 1.7 7.9 10.3 5.9 5.5 8.1 4.2 3.9 4.5 0.7 3.0 4.2 1.2 4.2 2.0 1.6 2.5 7.9 5.7 0.5 4.5 4.9 4.7 7.0 0.6 1.6 0.0 2.4 3.9 3.7 6.4 1.0 3.7 5.3 0.1 3.0 0.0 4.8 3.0 10.5 0.0 2.7 5.6 4.6 2.0 5.4 1.0 10.2 1.6 0.0 1.7 0.4 3.7 2.6 0.0 1.6 1.6 3.0 0.3 0.1 0.4 0.9 7.2 8.9 1.4 16.1 7.4 4.6 1.5 7.6 2.7 7.4 5.3 1.5 4.9 0.9 9.2 0.2 0.3 2.2 0.0 4.8 0.7 0.7 4.5 3.1 0.2 4.2 2.4 4.0 3.4 0.5 4.2 2.1 3.4 1.9 3.0 0.1 3.9 2.4 1.2 6.7 9.8 35.6 12.4 5.3 6.2 4.1 7.9 13.6 3.9 17.9 16.9 10.2 30.0 58.2 127.4 22.1 28.1 49.5 14.8 36.6 110.0 11.6 5.0 9.2 14.9 17.1 72.6 0.0 8.6 4.9 18.8 32.6 13.9 89.4 6.2 100.1 108.2 18.4 4.8 9.5 59.0 8.9 96.2 47.7 65.8 49.9 12.8 38.6 43.2 10.2 117.6 90.5 24.0 103.0 47.0 46.9 19.8 13.8 26.6 34.4 ABCA6 EST155051 ENSG00000154262 "ATP binding cassette subfamily A member 6" Q8N139 17 69078702-69141888 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.9" "Group enriched" "Detected in many" 4 "Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5" "Cancer enriched" "Detected in some" 7 "liver cancer: 4.8" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3" "Cell type enhanced" "Detected in some" "classical monocyte: 1.0;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA064878, HPA067180" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA064878: AB_2685380, HPA067180: AB_2685797" "unprognostic (7.76e-2)" "unprognostic (6.80e-2)" "unprognostic (2.12e-1)" "unprognostic (8.01e-2)" "unprognostic (8.47e-2)" "unprognostic (9.82e-3)" "prognostic favorable (3.29e-4)" "unprognostic (1.35e-1)" "unprognostic (6.60e-2)" "unprognostic (3.00e-2)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (7.96e-4)" "unprognostic (1.61e-4)" "unprognostic (2.10e-2)" "unprognostic (3.03e-2)" "unprognostic (1.69e-1)" 31.4 4.3 1.4 2.0 6.6 0.4 12.1 0.7 1.9 12.3 9.9 4.7 2.9 1.8 7.9 6.9 10.5 4.9 7.2 13.2 1.5 0.9 3.0 53.9 9.3 3.6 10.9 0.2 22.0 1.9 1.1 6.0 1.8 11.2 8.0 3.4 4.2 7.1 1.9 6.6 5.0 3.9 9.8 21.0 1.8 4.4 5.0 9.3 0.0 6.7 6.6 2.5 16.6 11.7 0.0 1.2 0.0 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 20.7 30.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 13.1 0.0 1.6 0.4 0.8 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.0 0.3 1.4 6.6 0.7 1.9 1.5 0.9 10.9 0.2 11.2 9.3 0.0 0.0 2.7 0.9 2.7 13.9 4.8 0.0 0.0 1.2 3.5 5.9 0.0 0.0 0.2 2.9 2.2 0.5 0.0 0.2 0.0 27.1 0.1 0.0 95.4 1.2 0.0 2.4 2.5 1.8 2.2 47.5 2.8 5.0 1.0 0.1 3.9 0.5 0.0 11.3 0.6 13.8 0.0 1.7 0.9 1.0 2.5 0.0 0.0 0.0 0.3 ABCA7 ABCX ENSG00000064687 "ATP binding cassette subfamily A member 7" Q8IZY2 19 1040101-1065572 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Phagocytosis, Transport" Translocase "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 68.5;Bipolar cells: 64.0;Cone photoreceptor cells: 164.9;Extravillous trophoblasts: 217.5;Rod photoreceptor cells: 151.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 26.7;HMC-1: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041564 Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Golgi apparatus, Plasma membrane" "Cell Junctions" "HPA041564: AB_2677550" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (7.26e-4)" "prognostic favorable (1.12e-4)" "unprognostic (8.88e-2)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (4.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "unprognostic (1.51e-3)" "unprognostic (3.68e-2)" "unprognostic (8.99e-3)" "unprognostic (2.08e-2)" "unprognostic (3.66e-1)" "unprognostic (7.88e-2)" "unprognostic (7.85e-2)" 6.0 3.5 6.2 20.2 4.8 35.2 7.6 13.6 11.1 5.0 5.8 1.9 4.7 4.9 2.1 3.9 7.5 2.8 5.5 2.3 5.3 6.5 5.3 3.6 9.5 17.7 5.2 5.1 1.0 7.0 5.6 34.5 3.1 7.7 4.9 4.2 34.7 9.9 6.5 5.5 11.1 11.1 1.8 6.7 26.6 7.9 1.6 4.3 19.8 7.0 3.9 14.5 5.1 4.9 1.5 9.9 10.8 2.5 1.9 2.6 1.2 5.7 5.4 1.1 3.4 6.7 3.0 5.6 0.8 0.8 0.3 0.6 4.1 2.2 11.2 3.8 0.8 0.4 5.7 2.3 5.1 0.3 7.4 2.1 8.6 26.7 4.1 2.6 3.2 32.2 2.8 1.8 1.5 2.9 5.5 1.9 6.1 8.7 7.0 1.0 1.4 3.1 2.3 0.6 4.2 2.5 2.9 0.6 8.0 2.8 10.8 0.7 2.2 6.3 1.9 0.6 2.5 3.7 5.2 2.8 0.6 1.4 2.9 0.8 8.1 7.9 6.1 1.4 7.7 1.3 4.3 2.5 7.0 2.6 1.7 1.6 1.0 1.5 1.8 2.8 1.5 1.4 2.1 10.8 1.9 1.6 9.9 0.6 1.2 6.2 4.8 13.6 11.1 5.3 6.5 5.2 5.1 7.7 4.3 68.5 31.1 10.2 0.6 3.0 64.0 5.6 2.5 5.3 9.1 5.2 164.9 2.4 1.7 2.7 6.0 2.9 9.0 0.0 2.1 217.5 2.8 1.4 9.3 3.2 6.9 14.3 3.4 3.1 14.8 2.9 0.0 7.0 0.0 10.0 3.8 13.0 5.9 10.5 0.0 1.3 151.3 0.0 3.1 0.7 1.9 3.0 21.5 10.2 2.9 1.7 ABCA9 EST640918 ENSG00000154258 "ATP binding cassette subfamily A member 9" Q8IUA7 17 68974488-69061064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 42.5" "Cell type enhanced" "Detected in many" 22 "Ito cells: 26.4;Leydig cells: 89.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "ASC diff: 14.5;ASC TERT1: 31.1;HSkMC: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052113, HPA054823" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA052113: AB_2732573, HPA054823: AB_2682615" "unprognostic (3.88e-2)" "unprognostic (9.86e-2)" "unprognostic (2.21e-1)" "unprognostic (9.75e-2)" "unprognostic (4.46e-1)" "unprognostic (5.64e-3)" "unprognostic (4.51e-4)" "unprognostic (1.83e-2)" "unprognostic (1.94e-3)" "unprognostic (7.86e-2)" "unprognostic (3.26e-3)" "unprognostic (3.51e-1)" "unprognostic (7.77e-6)" "unprognostic (5.32e-4)" "unprognostic (7.22e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-3)" 42.5 4.2 1.2 5.5 2.8 1.7 14.1 2.7 2.6 13.4 17.4 2.6 6.8 1.7 15.5 11.8 25.5 8.8 7.2 15.0 2.1 1.9 2.5 7.6 5.6 2.1 7.8 2.0 25.2 2.3 1.7 2.8 1.1 4.4 13.9 3.8 4.1 5.7 4.7 12.4 5.4 3.7 11.9 3.8 1.6 4.8 10.9 2.1 1.0 7.6 9.9 2.5 20.4 18.7 1.8 0.9 2.9 0.8 1.2 1.3 0.0 0.2 0.4 0.5 0.6 14.5 31.1 0.5 0.3 0.3 0.0 0.2 0.4 0.4 0.4 0.1 0.5 0.3 0.4 0.3 0.5 0.2 0.2 0.4 0.5 1.3 0.4 1.6 0.6 0.9 11.1 0.4 2.3 0.2 0.6 3.1 0.4 0.5 1.1 0.2 0.2 0.2 1.4 0.3 0.1 0.3 1.5 0.1 0.2 0.1 1.3 0.6 0.5 0.4 0.3 0.3 0.4 0.3 0.5 1.3 0.9 0.4 1.7 0.3 1.0 0.3 0.3 0.3 0.3 1.5 1.7 0.8 1.4 1.3 0.6 1.3 1.1 0.8 0.5 0.9 1.8 1.3 1.3 2.9 1.2 0.5 0.7 0.4 0.0 1.2 2.8 2.7 2.6 2.1 1.9 7.8 2.0 4.4 2.1 0.0 1.0 0.0 0.2 1.5 5.4 2.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.4 0.0 0.0 0.0 10.6 0.1 0.0 9.9 0.2 0.0 0.0 26.4 1.8 2.1 89.2 0.6 0.0 0.0 0.0 12.1 0.3 0.0 14.5 0.0 6.1 12.9 1.4 1.2 0.6 1.4 0.0 0.0 0.0 0.1 ABCB1 "ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1" ENSG00000085563 "ATP binding cassette subfamily B member 1" P08183 7 87503633-87713323 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 57.8;intestine: 49.6" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2" "Cancer enhanced" "Detected in many" "renal cancer: 14.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 19.2" "Group enriched" "Detected in many" 8 "NK-cells: 11.4;T-cells: 19.2" "Cell line enhanced" "Detected in some" "CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8" "CAB001716, HPA002199, HPA074614" Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites" "CAB001716: , HPA002199: AB_1844428, HPA074614: " "unprognostic (5.38e-3)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.06e-1)" "unprognostic (2.25e-2)" "unprognostic (9.99e-5)" "unprognostic (2.23e-3)" "unprognostic (5.65e-3)" "unprognostic (1.14e-1)" "unprognostic (5.17e-2)" "prognostic favorable (3.33e-4)" "unprognostic (5.19e-1)" "prognostic favorable (2.95e-4)" "unprognostic (2.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.83e-1)" "unprognostic (6.12e-2)" 2.6 57.8 9.4 3.2 11.5 1.2 3.4 5.1 10.5 5.5 22.7 3.8 2.0 14.4 9.4 3.5 2.0 3.2 9.0 1.8 9.2 6.6 19.1 15.6 3.8 2.2 9.4 5.7 2.2 1.5 1.7 1.3 3.1 11.1 2.7 10.7 7.6 1.5 2.1 1.1 1.3 49.6 5.7 9.0 2.4 1.7 1.3 8.6 0.1 2.4 1.4 2.2 2.6 5.9 1.9 0.0 0.1 0.0 11.4 19.2 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 9.3 16.7 1.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 11.5 0.1 0.4 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.4 3.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 7.8 0.0 19.2 0.4 2.0 4.7 0.0 1.9 1.2 4.8 0.1 11.4 0.0 0.0 0.0 1.5 9.4 11.5 5.1 10.5 9.2 6.6 9.4 5.7 11.1 8.6 0.0 4.8 5.9 0.1 0.7 0.6 2.8 104.4 1.4 1.2 47.1 0.0 5.0 5.0 10.2 21.6 23.1 174.5 23.3 1.6 0.1 0.5 0.1 3.5 32.6 0.4 0.0 0.0 3.7 1.2 2.5 0.9 0.8 0.0 0.0 8.9 0.0 11.4 77.2 0.0 44.0 0.9 0.0 0.8 0.5 0.4 0.5 8.2 27.3 1.7 0.1 ABCB11 "ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP" ENSG00000073734 "ATP binding cassette subfamily B member 11" O95342 2 168922938-169031322 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 47.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9" "Cancer enriched" "Detected in single" 87 "liver cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA019035 Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA019035: AB_1844429" "unprognostic (7.78e-2)" "unprognostic (3.92e-1)" "unprognostic (8.31e-2)" "unprognostic (2.56e-1)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.00e-2)" "unprognostic (9.71e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-2)" "unprognostic (5.64e-3)" "unprognostic (3.71e-1)" "unprognostic (5.26e-6)" "unprognostic (7.12e-2)" "unprognostic (1.82e-1)" "unprognostic (1.94e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 38.7 58.1 0.0 0.0 0.0 0.0 0.3 0.0 16.0 35.2 0.0 0.0 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.1 17.9 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 ABCB4 "GBD1, MDR2, MDR3, PFIC-3, PGY3" ENSG00000005471 "ATP binding cassette subfamily B member 4" P21439 7 87401697-87480435 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 93.2" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 235.3" "Cancer enriched" "Detected in some" 11 "liver cancer: 16.3" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.9;naive B-cell: 11.4" "Lineage enriched" "Detected in many" 8 "B-cells: 11.4" "Group enriched" "Detected in some" 5 "SH-SY5Y: 12.0;WM-115: 22.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA049395, HPA053288" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Plasma membrane, Actin filaments" "Focal adhesion sites" "HPA049395: AB_2680745, HPA053288: AB_2682102" "unprognostic (7.92e-2)" "unprognostic (8.87e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (8.95e-2)" "unprognostic (1.06e-2)" "unprognostic (2.35e-3)" "unprognostic (9.91e-2)" "unprognostic (3.53e-1)" "unprognostic (1.19e-1)" "unprognostic (2.44e-3)" "unprognostic (8.43e-2)" "unprognostic (2.83e-2)" "unprognostic (8.01e-3)" "unprognostic (7.12e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" 0.5 4.1 0.2 4.3 0.2 0.2 0.3 0.1 1.1 0.2 0.6 0.4 0.0 0.0 0.1 0.2 0.6 0.1 0.3 4.0 0.3 0.2 0.4 93.2 0.1 4.1 0.3 0.2 0.3 0.1 0.0 0.5 0.0 0.3 0.3 0.4 0.8 0.4 0.1 2.9 0.6 1.2 1.6 0.5 5.2 0.2 0.5 0.4 0.1 0.4 4.2 3.2 0.6 0.5 11.4 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 12.0 0.0 0.6 2.2 0.5 0.2 0.5 0.0 0.2 1.6 0.1 0.0 0.0 0.0 2.8 0.2 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 1.4 11.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 0.1 1.1 0.3 0.2 0.3 0.2 0.3 0.4 0.0 0.3 23.1 0.0 0.9 0.0 9.3 0.0 0.0 0.0 1.8 0.0 0.9 0.0 0.1 0.6 0.8 0.1 0.0 0.0 0.2 1.5 0.0 0.0 235.3 0.5 36.5 0.0 5.5 5.4 0.2 0.0 0.0 10.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.9 0.5 0.1 0.4 0.1 0.0 0.0 0.0 ABCB5 "ABCB5alpha, ABCB5beta, EST422562" ENSG00000004846 "ATP binding cassette subfamily B member 5" Q2M3G0 7 20615207-20777038 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 33.4;retina: 43.3" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 2.6;Early spermatids: 6.1;Melanocytes: 1.7" "Cancer enriched" "Detected in some" 9 "melanoma: 5.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "SK-MEL-30: 32.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.55e-3)" "unprognostic (1.55e-2)" "unprognostic (1.14e-2)" "unprognostic (2.98e-1)" "unprognostic (2.60e-3)" "unprognostic (1.65e-2)" "unprognostic (2.05e-1)" "unprognostic (2.63e-1)" "unprognostic (6.23e-2)" "unprognostic (5.26e-3)" "unprognostic (3.56e-3)" "unprognostic (9.30e-4)" "unprognostic (1.29e-1)" "unprognostic (1.80e-2)" "unprognostic (2.70e-2)" 10.6 0.1 0.0 0.4 0.0 0.3 8.6 0.0 0.1 4.4 3.8 0.0 5.3 0.1 1.8 33.4 0.3 0.4 2.8 0.9 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.1 2.9 0.6 43.3 0.3 0.4 1.0 2.1 0.9 1.5 0.3 0.1 0.7 2.6 0.0 0.0 0.1 0.2 0.1 1.8 1.6 0.7 0.5 2.3 0.5 0.5 0.3 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 4.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.0 0.1 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.5 0.4 0.2 0.2 0.1 0.4 0.3 0.2 0.1 0.7 0.2 0.3 0.8 0.5 0.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 2.6 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.9 0.7 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.5 0.2 0.5 0.0 0.0 0.0 0.7 ABCC11 MRP8 ENSG00000121270 "ATP binding cassette subfamily C member 11" Q96J66 16 48166910-48247568 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "breast: 37.3" "Group enriched" "Detected in some" 5 "Early spermatids: 2.7;Hepatocytes: 2.1;Late spermatids: 1.1;Spermatocytes: 3.3" "Group enriched" "Detected in some" 6 "breast cancer: 8.7;prostate cancer: 2.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.6" "Group enriched" "Detected in many" 5 "B-cells: 2.6;T-cells: 1.2" "Cell line enriched" "Detected in some" 4 "T-47d: 39.4" "Not detected" "Not detected" NA NA "unprognostic (1.35e-1)" "unprognostic (3.47e-2)" "unprognostic (3.87e-2)" "unprognostic (2.47e-1)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (1.56e-2)" "unprognostic (8.11e-2)" "unprognostic (2.39e-1)" "unprognostic (2.64e-1)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-2)" "unprognostic (1.58e-1)" "unprognostic (1.13e-2)" "unprognostic (5.54e-4)" 0.1 0.0 0.8 0.1 0.8 0.1 37.3 0.2 0.5 0.1 0.1 0.1 0.1 0.2 0.1 9.3 0.1 0.4 0.1 0.1 0.4 0.2 0.1 4.0 0.1 0.1 0.7 0.1 0.4 0.1 0.0 2.0 0.1 0.6 2.7 0.0 8.4 0.1 0.1 0.1 0.9 0.1 0.1 0.4 0.1 0.0 3.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.6 0.3 0.0 0.2 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 9.3 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 2.6 0.2 1.2 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.5 0.4 0.2 0.7 0.1 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.4 0.0 0.2 0.0 0.0 0.0 ABCC12 MRP9 ENSG00000140798 "ATP binding cassette subfamily C member 12" Q96J65 16 48082973-48156018 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 3.5;testis: 13.4" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 3.1;Late spermatids: 1.9;Spermatocytes: 1.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 4 "cerebral cortex: 3.5;hippocampal formation: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "RPMI-8226: 2.2;T-47d: 4.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA043100 Uncertain NA NA "HPA043100: AB_10794922" "unprognostic (1.53e-1)" "unprognostic (6.87e-2)" "unprognostic (2.37e-2)" "unprognostic (4.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-2)" "unprognostic (2.65e-1)" "unprognostic (7.53e-2)" "unprognostic (4.23e-1)" 0.1 0.0 0.6 0.1 0.1 0.0 1.9 0.3 3.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 13.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 3.5 2.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.0 0.0 ABCC2 "CMOAT, cMRP, DJS, MRP2" ENSG00000023839 "ATP binding cassette subfamily C member 2" Q92887 10 99782732-99852192 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 28.4;kidney: 25.6;liver: 74.3" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 52.9" "Cancer enhanced" "Detected in many" "liver cancer: 24.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.1" "Group enriched" "Detected in some" 5 "A549: 60.2;Hep G2: 60.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA071145 Enhanced NA NA "HPA071145: " "unprognostic (1.49e-3)" "unprognostic (5.92e-2)" "unprognostic (1.59e-1)" "unprognostic (3.67e-1)" "unprognostic (1.93e-2)" "unprognostic (2.33e-1)" "unprognostic (2.51e-1)" "unprognostic (7.15e-3)" "unprognostic (5.68e-2)" "unprognostic (2.01e-1)" "unprognostic (4.30e-1)" "unprognostic (1.40e-3)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.95e-1)" "unprognostic (1.26e-2)" 0.8 0.3 0.1 0.1 0.1 0.1 1.1 0.3 0.1 0.2 13.4 0.1 0.1 16.1 0.3 0.5 0.2 0.4 13.7 0.2 0.1 0.1 25.6 74.3 0.3 0.1 0.1 0.1 0.2 0.6 0.0 0.1 1.2 0.1 0.3 0.0 0.1 0.3 0.1 0.6 0.6 28.4 0.1 0.2 0.8 0.4 0.4 0.1 0.1 0.3 0.4 0.1 0.7 0.3 0.3 0.7 4.1 0.2 0.1 0.5 0.0 0.0 60.2 0.9 3.0 4.6 3.5 1.0 0.1 0.3 0.1 0.2 12.9 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.2 60.0 0.1 0.0 0.2 0.6 4.1 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.4 0.1 11.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.9 7.4 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.2 0.0 0.0 4.9 1.0 0.3 4.1 0.2 0.3 0.3 0.0 0.4 0.2 0.3 0.1 0.3 0.3 0.3 0.1 1.3 0.1 0.1 0.7 0.5 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.0 0.2 0.4 2.5 4.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.1 52.9 0.2 0.0 0.0 0.6 1.3 0.2 0.3 0.0 5.0 0.0 0.0 0.2 0.1 0.0 0.0 9.1 1.4 0.0 0.4 0.7 0.3 0.0 1.4 0.0 0.0 0.0 ABCC3 "cMOAT2, EST90757, MLP2, MOAT-D, MRP3" ENSG00000108846 "ATP binding cassette subfamily C member 3" O15438 17 50634777-50692252 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 53.5;liver: 66.2" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.2;non-classical monocyte: 7.6" "Lineage enriched" "Detected in many" 5 "monocytes: 7.6" "Cell line enhanced" "Detected in many" "A549: 31.4;CAPAN-2: 24.0;OE19: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB037136, HPA048483" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB037136: AB_477165, HPA048483: AB_2680414" "unprognostic (1.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.65e-2)" "unprognostic (9.67e-3)" "unprognostic (6.19e-3)" "unprognostic (7.44e-3)" "unprognostic (8.20e-2)" "unprognostic (3.18e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.60e-3)" "prognostic unfavorable (4.68e-6)" "unprognostic (3.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.44e-2)" "unprognostic (1.57e-3)" 3.5 36.0 0.4 17.0 0.4 0.5 7.7 0.3 0.4 1.9 23.9 0.8 14.1 10.3 1.6 4.6 5.3 1.0 53.5 0.8 0.4 0.4 13.5 66.2 9.0 10.3 0.6 0.0 1.0 22.2 1.7 0.8 3.5 1.5 5.4 7.7 0.8 4.7 23.6 0.4 4.8 37.0 2.5 4.6 4.9 12.8 1.0 0.0 0.8 4.5 7.0 7.9 7.1 3.5 0.0 1.6 1.3 7.6 0.3 0.5 7.4 2.2 31.4 0.0 0.1 1.8 2.8 0.0 4.2 5.2 0.3 0.3 1.7 24.0 0.0 3.3 8.2 5.9 5.7 0.0 0.4 0.4 0.0 0.0 0.6 13.2 9.5 7.1 0.0 0.0 3.1 2.3 1.2 2.5 3.5 0.5 0.0 0.0 0.0 3.3 7.3 0.0 0.0 0.0 34.9 4.1 0.0 0.0 0.1 13.7 13.6 0.0 0.2 7.6 1.3 0.0 0.0 1.0 0.0 6.9 0.2 1.4 0.1 3.3 0.0 0.0 0.0 3.4 0.0 0.3 0.3 2.8 0.0 0.0 6.2 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 1.3 0.3 7.6 0.2 0.5 7.4 0.4 0.4 0.3 0.4 0.4 0.4 0.6 0.0 1.5 0.0 17.9 5.6 2.4 103.4 8.4 1.2 2.5 262.4 0.0 23.9 14.0 0.0 0.3 5.0 84.3 55.0 1.4 161.4 0.0 92.3 3.0 3.5 62.4 0.0 155.5 27.5 1.6 22.7 4.9 18.2 59.8 8.3 13.8 3.3 4.6 85.5 3.7 82.4 153.0 2.8 7.9 0.1 0.0 5.2 0.7 0.6 9.3 0.8 2.5 66.2 81.6 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.5 8.0 1.3 2.4 2.5 3.3 0.3 3.6 3.7 3.3 2.8 11.1 3.4 2.5 2.4 4.9 2.4 6.2 2.0 1.8 4.1 7.5 3.1 61.8 2.5 2.2 5.1 7.0 67.7 2.5 0.8 2.3 4.8 4.7 4.2 2.8 6.4 0.1 4.4 1.4 1.3 1.1 1.5 5.5 1.9 1.9 3.7 6.6 18.2 10.3 3.3 2.4 1.2 0.2 2.5 1.5 0.0 3.8 6.9 3.5 2.2 2.9 4.3 0.0 0.0 1.0 6.6 4.0 1.7 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 8.9 28.3 3.7 6.2 3.8 0.0 3.1 5.1 6.7 11.4 22.7 21.6 0.1 0.0 5.2 3.2 11.3 1.4 0.0 2.6 0.4 3.9 38.5 53.1 0.0 3.8 0.0 0.0 2.5 1.0 1.7 6.4 6.3 1.7 19.0 3.2 0.3 4.1 9.3 1.8 32.7 0.7 0.0 3.9 0.6 9.1 6.6 0.2 2.2 7.8 3.7 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16148928-16223522 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.4" "Cell type enhanced" "Detected in many" 14 "Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8" "Cancer enhanced" "Detected in many" "liver cancer: 16.7" "Cell type enriched" "Detected in some" 5 "classical monocyte: 7.3" "Lineage enriched" "Detected in many" 5 "monocytes: 7.3" "Cell line enriched" "Detected in some" 8 "Hep G2: 38.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038105 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038105: AB_2675835" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favorable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 2.3 1.4 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.1 1.5 7.0 0.0 0.0 0.0 0.3 1.2 0.8 0.1 0.1 9.0 27.4 2.8 0.0 0.2 0.1 6.7 0.5 0.1 0.0 0.7 1.2 6.7 0.2 1.7 0.0 3.7 0.0 0.2 0.1 2.2 0.0 2.2 0.0 0.0 0.0 0.2 0.9 1.3 7.3 0.6 0.1 1.2 0.0 0.9 0.4 0.0 0.0 0.5 1.1 0.0 0.2 0.6 0.9 3.8 1.5 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.4 1.1 0.1 38.6 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.6 0.1 0.5 0.1 0.2 4.9 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 7.3 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.9 0.2 0.1 0.1 1.3 0.6 0.1 0.1 0.0 1.2 26.8 26.9 3.6 0.7 0.1 0.3 2.4 20.4 18.7 9.1 8.7 0.0 0.0 38.1 1.6 0.2 0.6 19.1 0.0 7.1 0.0 1.0 1.6 1.1 56.7 1.1 0.0 2.9 1.8 4.1 0.4 1.4 1.5 1.7 1.0 13.4 1.3 2.9 3.5 5.3 117.8 0.7 0.0 0.5 0.1 0.2 0.6 0.0 0.0 13.3 0.4 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 39.2;Intestinal endocrine cells: 21.0" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" No NA Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: AB_2677947" "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.7 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 0.0 0.0 0.0 0.0 0.0 39.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 21.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.1 ABCD1 "adrenoleukodystrophy, ALD, ALDP, AMN" ENSG00000101986 "ATP binding cassette subfamily D member 1" P33897 X 153724868-153744762 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 17.9;Syncytiotrophoblasts: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 33.1;PC-3: 23.4;SK-BR-3: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.90e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-3)" "unprognostic (5.57e-3)" "unprognostic (8.81e-3)" "unprognostic (1.54e-1)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (6.14e-3)" "unprognostic (3.40e-2)" "unprognostic (1.41e-1)" "unprognostic (6.17e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.23e-2)" 13.8 20.3 2.1 6.0 2.7 5.0 8.9 1.1 2.5 6.2 15.9 2.7 12.7 12.5 21.4 9.7 4.7 6.1 8.8 10.4 2.0 2.0 7.0 14.3 7.5 10.1 3.0 1.9 6.0 11.7 2.2 6.5 23.1 2.0 7.1 2.3 9.3 6.1 7.3 14.7 3.0 46.2 8.3 2.7 9.1 4.6 24.0 1.7 12.1 3.8 6.5 4.9 7.8 9.8 1.9 4.8 4.1 5.4 1.4 7.7 3.4 5.9 1.8 1.2 5.2 3.6 1.5 16.2 2.9 3.2 2.0 3.5 1.2 3.2 1.6 33.1 3.9 5.4 0.8 0.7 0.6 0.2 5.3 1.0 4.7 18.5 15.3 4.7 2.9 10.6 3.0 0.8 2.2 0.2 2.1 3.1 2.2 2.6 5.8 2.7 2.1 2.0 2.7 1.5 1.4 23.4 3.5 2.9 2.5 1.5 0.6 1.3 5.4 7.6 23.1 11.8 1.5 1.7 4.9 3.6 2.6 3.5 6.7 3.2 5.8 2.5 3.8 3.3 9.9 3.6 0.7 4.8 4.1 1.6 5.4 7.7 1.9 1.9 2.3 4.8 1.5 2.1 1.5 3.1 1.4 4.7 3.0 0.6 3.4 2.1 2.7 1.1 2.1 2.0 2.0 3.0 1.9 2.0 1.7 0.0 1.4 0.9 1.5 2.9 2.2 2.0 5.1 0.0 2.3 3.5 2.0 10.8 0.0 3.3 0.5 3.5 13.5 0.0 6.0 14.8 3.3 0.7 0.0 5.5 12.1 7.9 5.8 6.2 17.9 1.9 3.7 7.4 1.7 1.0 4.1 2.6 5.3 2.3 5.3 2.2 0.8 6.5 4.1 2.7 4.8 1.1 22.9 1.5 3.5 1.6 ABCD2 "ALDL1, ALDR, ALDRP" ENSG00000173208 "ATP binding cassette subfamily D member 2" Q9UBJ2 12 39550033-39619751 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 24.1;brain: 30.1" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 55.5" "Cancer enriched" "Detected in single" 7 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Group enriched" "Detected in some" 5 "ASC diff: 9.2;HDLM-2: 12.4;Karpas-707: 22.2;SH-SY5Y: 13.4;U-266/70: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (4.06e-4)" "unprognostic (9.27e-2)" "unprognostic (1.15e-2)" "unprognostic (2.06e-1)" "unprognostic (7.31e-5)" "unprognostic (3.42e-2)" "unprognostic (2.90e-2)" "unprognostic (8.06e-3)" "unprognostic (3.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-4)" "unprognostic (5.04e-2)" "unprognostic (8.04e-2)" "unprognostic (1.13e-1)" "unprognostic (6.74e-2)" 24.1 3.6 6.8 3.5 6.8 0.9 5.5 30.1 13.4 10.6 1.7 1.3 0.0 1.4 5.4 1.0 1.3 5.2 1.4 7.4 5.1 4.1 1.4 0.7 1.4 4.8 4.8 8.4 0.7 0.7 0.7 5.1 0.5 11.4 1.2 1.7 2.9 4.6 1.6 0.7 0.7 1.7 5.1 2.1 3.0 1.6 0.9 2.6 0.9 1.0 0.6 3.2 2.8 1.9 0.8 0.8 0.1 0.0 1.4 6.5 1.8 0.0 0.0 0.1 0.0 9.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.4 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.5 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 1.9 0.8 4.3 5.7 0.2 0.4 5.0 6.5 0.1 1.4 0.0 0.8 5.1 1.8 6.8 6.8 30.1 13.4 5.1 4.1 4.8 8.4 11.4 2.6 0.0 0.0 0.8 0.0 0.0 55.5 8.9 0.0 4.0 0.0 0.0 5.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.7 0.0 0.0 0.7 0.5 1.8 0.0 0.3 0.1 0.0 0.0 0.0 3.5 0.0 0.0 ABCF1 "ABC50, EST123147" ENSG00000204574 "ATP binding cassette subfamily F member 1" Q8NE71 6 30571376-30597179 "Plasma proteins, Predicted intracellular proteins" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017578 Approved Enhanced Cytosol NA NA Cytosol "HPA017578: AB_1844438" "unprognostic (5.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-3)" "unprognostic (4.31e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (9.47e-4)" "unprognostic (5.50e-2)" "unprognostic (3.45e-2)" "unprognostic (1.70e-2)" "unprognostic (2.35e-1)" "unprognostic (2.77e-1)" "unprognostic (3.50e-2)" "unprognostic (1.65e-1)" "unprognostic (3.65e-1)" "unprognostic (1.68e-3)" "unprognostic (7.16e-2)" 16.1 12.5 12.1 11.8 13.9 31.9 12.4 12.1 15.7 11.4 13.7 9.8 9.5 7.1 17.0 9.6 14.6 10.9 10.6 13.1 12.0 7.3 15.5 18.3 13.5 9.4 10.6 10.5 12.5 14.0 23.1 16.6 21.6 13.7 12.4 13.6 9.2 14.1 15.3 70.6 21.3 17.6 15.2 12.7 13.9 19.6 22.0 13.2 14.7 13.8 14.9 13.0 14.2 13.5 10.1 9.3 4.1 7.9 11.9 14.3 6.5 12.1 5.4 7.1 9.7 8.0 5.2 3.2 10.3 5.3 7.1 9.9 18.0 3.0 10.2 11.2 6.4 9.8 8.8 10.5 6.0 13.9 7.2 9.1 12.4 7.6 5.6 2.5 12.6 4.1 4.7 6.2 11.1 2.8 1.9 2.3 2.9 22.6 3.7 7.9 2.7 6.6 2.8 4.9 4.2 3.3 20.8 7.0 10.7 5.5 11.0 6.5 13.4 5.6 15.6 3.1 3.5 3.9 3.4 7.1 13.9 4.2 3.3 5.6 13.6 22.0 17.7 1.5 14.7 10.1 4.1 7.9 3.4 14.3 6.7 12.2 10.1 10.4 12.8 7.1 9.1 9.5 9.7 3.7 11.9 7.3 9.3 5.9 6.5 12.1 13.9 12.1 15.7 12.0 7.3 10.6 10.5 13.7 13.2 47.6 84.6 56.7 79.8 76.5 41.7 75.9 38.2 49.5 78.5 55.8 62.8 83.9 51.4 84.1 80.0 46.5 74.6 46.7 75.7 116.4 50.0 62.6 85.4 115.0 44.1 52.4 48.7 34.4 39.0 122.9 35.9 46.8 33.7 67.7 40.5 42.0 84.8 38.6 48.8 58.5 108.2 71.1 55.1 135.4 94.1 74.2 138.9 55.4 45.7 74.3 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.6 18.8 5.6 0.0 0.2 0.0 32.9 0.7 0.6 1.0 1.6 4.1 0.2 0.0 0.2 0.1 2.4 5.5 0.1 0.5 1.4 5.3 0.8 0.2 0.1 5.6 0.0 0.2 0.0 0.1 2.3 2.2 0.1 0.5 1.7 0.4 0.4 0.0 0.6 10.9 2.6 0.0 1.9 25.5 0.0 1.2 0.0 16.5 0.0 4.0 0.0 0.2 3.9 0.4 0.5 12.7 0.1 0.0 0.0 0.7 0.7 0.2 0.0 5.2 1.9 0.0 1.4 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 3.0 1.4 0.5 0.2 3.4 0.0 1.1 0.0 1.4 0.0 0.0 0.0 14.3 1.7 0.0 2.6 9.0 135.7 0.0 0.2 47.1 2.1 0.2 5.7 25.0 105.8 0.0 2.9 13.5 1.0 0.4 1.1 1.1 5.0 0.0 2.9 0.9 0.1 35.1 0.4 4.5 0.2 0.0 1.4 0.9 3.4 0.4 31.5 0.8 0.8 0.1 ABCG4 WHITE2 ENSG00000172350 "ATP binding cassette subfamily G member 4" Q9H172 11 119149012-119162653 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 20.7;parathyroid gland: 7.4;retina: 7.5;testis: 7.2" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 47.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HAP1: 2.9;U-2 OS: 2.8" "Low region specificity" "Detected in all" HPA057635 Enhanced NA NA "HPA057635: " "unprognostic (3.26e-2)" "unprognostic (4.75e-4)" "unprognostic (6.31e-2)" "unprognostic (1.83e-3)" "unprognostic (3.76e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (9.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (8.78e-2)" "unprognostic (2.25e-1)" "unprognostic (4.15e-4)" "unprognostic (2.26e-1)" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" 0.7 1.6 3.9 0.7 5.7 0.3 0.4 20.7 12.8 0.8 0.8 0.8 0.0 0.9 1.1 1.3 1.9 0.6 1.2 2.2 4.9 6.6 0.8 0.5 0.5 0.5 4.7 5.2 0.5 1.2 7.4 0.3 0.7 12.7 0.9 0.7 7.5 0.4 2.0 0.4 1.2 0.7 1.4 1.5 0.5 0.5 7.2 0.5 0.6 1.5 0.0 1.5 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 1.2 5.5 0.8 0.0 0.1 0.2 0.1 0.7 1.5 0.0 0.1 0.0 0.6 0.2 2.4 0.5 2.9 0.3 0.7 0.3 1.0 1.0 0.1 0.0 1.9 0.0 1.6 0.5 0.0 1.0 0.0 0.7 1.2 2.8 0.1 0.1 0.9 0.2 0.4 0.0 2.4 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.5 1.1 1.7 0.2 0.1 0.3 0.4 0.0 0.2 0.4 2.8 0.4 0.2 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.7 20.7 12.8 4.9 6.6 4.7 5.2 12.7 0.5 0.0 0.0 0.0 0.0 0.0 11.4 0.8 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 47.1 0.0 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.0 ABCG5 STSL ENSG00000138075 "ATP binding cassette subfamily G member 5" Q9H222 2 43812472-43838865 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "intestine: 54.3;liver: 40.9" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 47.3" "Cancer enriched" "Detected in some" 23 "liver cancer: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.71e-1)" "unprognostic (5.47e-2)" "unprognostic (4.01e-1)" "unprognostic (6.92e-2)" "unprognostic (2.24e-1)" "unprognostic (9.97e-2)" "prognostic favorable (2.60e-5)" "unprognostic (4.59e-2)" "unprognostic (3.10e-1)" "unprognostic (1.38e-3)" "unprognostic (3.07e-4)" "unprognostic (1.86e-1)" "unprognostic (3.07e-1)" "unprognostic (5.52e-3)" "unprognostic (8.29e-2)" "unprognostic (5.31e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 19.5 0.0 0.0 27.6 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 40.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 54.3 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 ABCG8 GBD4 ENSG00000143921 "ATP binding cassette subfamily G member 8" Q9H221 2 43831942-43882987 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "intestine: 62.4;liver: 64.4" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 24.1" "Cancer enriched" "Detected in some" 30 "liver cancer: 21.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019556 Uncertain Approved Vesicles NA NA Vesicles "HPA019556: AB_1844444" "unprognostic (1.99e-1)" "unprognostic (4.49e-1)" "unprognostic (3.22e-1)" "unprognostic (1.37e-1)" "unprognostic (3.09e-2)" "unprognostic (2.43e-1)" "unprognostic (1.99e-3)" "unprognostic (1.27e-1)" "unprognostic (6.28e-1)" "unprognostic (6.14e-3)" "unprognostic (4.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.68e-1)" "unprognostic (7.86e-3)" "unprognostic (5.03e-1)" "unprognostic (1.50e-1)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.4 0.1 21.2 0.0 0.0 24.0 0.1 0.1 0.1 0.1 1.7 0.1 0.2 0.3 0.2 64.4 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 62.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.6 2.1 0.3 0.5 0.8 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 14.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 2.1 0.3 0.4 0.7 0.3 0.5 0.5 0.6 0.5 0.1 0.7 0.8 0.7 1.7 0.5 0.3 0.6 0.3 0.2 0.2 0.3 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 1.2 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABHD1 "FLJ36128, LABH1" ENSG00000143994 "Abhydrolase domain containing 1" Q96SE0 2 27123789-27130812 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 58.4" "Group enriched" "Detected in many" 22 "Early spermatids: 249.7;Late spermatids: 777.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 3.3;T-47d: 6.8;U-266/70: 6.6;U-266/84: 5.4" "Low region specificity" "Detected in all" HPA044390 Uncertain NA NA "HPA044390: AB_10959380" "unprognostic (1.20e-3)" "unprognostic (6.07e-3)" "unprognostic (7.71e-4)" "unprognostic (1.63e-2)" "unprognostic (6.68e-2)" "unprognostic (2.70e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-3)" "unprognostic (2.75e-1)" "unprognostic (1.76e-1)" "unprognostic (9.09e-4)" "unprognostic (9.76e-2)" "unprognostic (1.70e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-2)" "unprognostic (3.09e-2)" "unprognostic (7.97e-2)" 1.3 0.9 0.9 0.2 1.4 0.0 0.7 0.3 0.8 0.3 0.2 1.2 0.5 0.1 0.4 1.4 0.2 0.3 0.3 1.6 0.5 0.4 0.5 4.4 0.2 0.8 0.6 1.0 0.5 0.3 0.6 0.4 0.0 1.0 1.0 0.0 1.1 6.4 0.3 2.2 0.2 0.2 0.5 0.8 0.3 0.3 58.4 0.2 0.0 0.5 1.5 0.1 0.2 0.2 2.3 0.3 1.9 0.8 0.0 2.7 0.7 0.2 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.2 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 1.1 0.0 0.0 3.3 0.2 0.0 0.0 0.7 0.1 0.6 0.3 0.1 6.8 0.5 0.0 0.0 0.1 0.0 0.4 6.6 5.4 0.1 0.2 0.2 0.3 0.1 0.8 1.9 2.7 0.1 0.9 2.3 1.4 1.3 0.2 0.7 1.4 0.7 1.3 0.0 0.0 0.3 0.0 0.7 0.9 1.4 0.3 0.8 0.5 0.4 0.6 1.0 1.0 0.2 0.0 0.0 0.8 2.1 0.0 4.7 2.5 0.0 1.4 0.0 0.0 7.9 0.1 0.0 0.1 249.7 0.6 0.0 23.3 0.2 0.0 0.8 3.0 1.1 2.5 0.1 0.0 0.0 2.5 0.0 777.1 6.1 0.4 0.0 0.0 0.0 8.3 0.0 0.0 5.3 2.2 5.0 0.0 0.9 23.4 3.9 0.3 0.0 0.9 0.0 2.6 ABHD12B "BEM46L3, C14orf29" ENSG00000131969 "Abhydrolase domain containing 12B" Q7Z5M8 14 50872160-50904970 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;retina: 10.0;skin 1: 21.6" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 136.7" "Cancer enriched" "Detected in many" 5 "testis cancer: 7.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.3;neutrophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9" "Region enriched" "Detected in single" 5 "thalamus: 2.3" "Low region specificity" "Detected in many" HPA002873 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA002873: AB_2220573" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (2.92e-3)" "unprognostic (1.99e-3)" "unprognostic (4.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.62e-2)" "unprognostic (2.09e-1)" "unprognostic (4.31e-2)" "unprognostic (6.27e-2)" "unprognostic (3.30e-1)" "unprognostic (3.35e-1)" "unprognostic (1.70e-3)" "unprognostic (3.16e-2)" "unprognostic (9.62e-2)" "unprognostic (3.18e-3)" "unprognostic (1.68e-1)" 1.1 0.2 2.4 0.4 10.0 2.4 2.8 0.3 5.2 0.2 1.5 5.4 0.3 0.2 0.8 0.4 0.7 2.0 0.4 0.5 1.4 1.2 0.6 0.2 0.8 0.4 2.2 2.7 0.3 1.1 1.3 0.3 0.4 2.2 0.3 2.4 10.0 0.2 0.2 0.2 21.6 0.3 0.2 0.7 0.2 0.2 1.2 3.9 0.0 0.4 0.0 0.3 0.2 0.2 0.0 0.1 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.5 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.9 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 2.4 10.0 0.3 5.2 1.4 1.2 2.2 2.7 2.2 3.9 0.0 0.0 0.0 0.0 0.3 3.3 1.4 0.0 14.7 0.0 1.8 2.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 1.1 0.0 0.0 0.0 0.9 136.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.2 1.3 0.2 0.0 1.6 0.1 ABHD17B "C9orf77, CGI-67, FAM108B1" ENSG00000107362 "Abhydrolase domain containing 17B" Q5VST6 9 71862452-71910931 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 46.2" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047862 Uncertain NA NA "HPA047862: AB_10959595" "unprognostic (7.47e-2)" "unprognostic (4.41e-2)" "unprognostic (4.03e-3)" "unprognostic (5.59e-2)" "unprognostic (5.57e-2)" "unprognostic (8.53e-3)" "unprognostic (9.44e-2)" "unprognostic (6.84e-2)" "unprognostic (5.46e-2)" "unprognostic (3.44e-2)" "unprognostic (3.49e-2)" "unprognostic (1.74e-1)" "prognostic favorable (2.59e-4)" "unprognostic (4.33e-2)" "unprognostic (2.12e-1)" "unprognostic (3.06e-3)" "unprognostic (1.34e-2)" 7.7 6.6 16.5 6.9 25.0 18.0 8.2 14.4 21.6 9.0 12.0 43.3 2.3 18.1 9.5 4.6 13.5 9.6 9.1 5.8 23.6 13.8 13.4 13.6 7.5 10.8 44.0 13.6 7.6 6.4 12.7 5.8 7.8 24.3 11.0 11.2 9.0 9.4 5.1 13.6 11.2 14.9 9.4 30.4 8.9 8.9 11.1 38.2 46.2 8.8 3.6 10.7 11.8 8.8 7.2 5.7 8.1 3.8 6.6 4.9 1.7 6.3 6.1 14.0 8.1 7.3 4.5 12.3 7.0 7.6 6.1 5.2 1.8 4.0 15.4 6.5 4.7 5.1 12.6 13.6 4.6 7.1 7.9 8.1 9.0 10.3 5.9 5.1 10.6 14.6 5.6 6.5 5.5 4.9 5.5 7.9 26.0 7.3 7.0 5.2 2.9 27.4 8.4 21.2 8.0 8.7 36.8 10.7 0.1 7.0 12.8 9.3 10.8 7.4 8.0 6.0 10.5 2.6 7.7 6.3 5.9 7.7 10.9 5.6 6.9 8.1 12.2 4.7 7.6 2.9 8.1 3.8 4.1 3.1 1.4 3.0 4.2 3.8 4.3 4.8 7.2 3.2 4.5 2.9 6.6 1.3 5.7 4.9 1.7 16.5 25.0 14.4 20.8 23.6 13.8 44.0 13.6 24.3 38.2 6.0 4.6 13.2 28.4 15.1 13.8 7.0 5.1 17.4 10.3 5.2 11.8 9.1 10.0 7.3 15.6 8.2 22.1 0.0 5.0 6.9 9.6 21.5 17.3 8.2 5.1 4.8 8.5 10.4 4.7 6.0 10.6 7.0 5.0 6.4 22.8 24.7 3.9 14.2 9.9 9.9 54.4 0.0 16.1 33.6 20.2 8.5 6.1 25.4 10.6 41.0 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 70.3" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 171.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 26.1;classical monocyte: 7.6;neutrophil: 21.0" "Group enriched" "Detected in many" 5 "granulocytes: 26.1;monocytes: 7.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 26.5 10.5 5.2 7.4 12.2 32.2 70.3 8.5 10.3 7.6 10.2 10.5 5.9 7.4 4.6 4.0 22.7 3.7 10.4 9.8 7.4 4.5 10.1 18.4 14.1 8.7 18.5 4.6 4.2 12.8 9.1 8.6 20.2 14.9 5.8 6.7 4.4 21.1 7.4 10.4 24.8 15.1 8.1 19.0 7.0 8.9 8.1 12.5 3.3 13.2 9.9 6.7 11.2 16.0 1.7 3.6 26.1 7.6 0.9 2.4 2.5 8.5 3.0 3.6 3.8 15.2 5.8 7.5 34.9 13.9 9.6 7.2 4.7 3.0 7.1 4.8 10.9 8.5 2.8 5.7 8.5 9.8 25.8 5.5 18.2 11.6 3.2 7.6 4.1 5.9 6.4 29.5 16.1 13.8 8.4 16.0 4.8 10.8 5.4 21.3 4.6 2.9 2.9 9.7 6.8 9.8 1.3 10.4 4.1 12.4 17.0 4.4 6.0 15.3 8.3 3.6 4.0 8.9 3.5 8.8 8.5 6.7 15.7 15.1 4.9 13.6 3.4 9.0 7.5 6.6 26.1 7.6 4.4 1.2 3.7 1.0 1.7 0.9 1.4 3.6 1.2 0.8 1.3 21.0 0.9 2.7 0.9 2.4 2.5 5.2 12.2 8.5 10.3 7.4 4.5 18.5 4.6 14.9 12.5 23.8 43.8 8.5 23.5 35.4 11.3 9.7 15.3 17.4 25.0 26.2 25.5 13.3 28.2 49.4 13.5 16.9 64.4 23.3 53.5 21.2 16.2 21.6 16.1 11.3 16.6 3.2 34.9 14.7 26.6 12.9 4.9 30.4 6.8 16.2 17.1 12.4 61.4 24.6 5.3 31.4 14.7 0.0 26.8 35.6 43.9 35.8 171.7 15.8 18.2 41.1 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6" Q9BV23 3 58237506-58295693 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 53.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: AB_2686583" "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favorable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 8.3 10.0 11.6 4.6 14.0 1.0 5.8 17.7 22.5 3.7 8.1 30.0 10.3 26.3 4.7 10.8 4.8 6.9 4.4 4.1 19.0 9.2 24.3 43.4 6.3 5.2 18.6 12.2 4.1 2.4 4.8 15.2 4.8 19.0 4.4 8.1 10.5 3.0 12.9 3.1 17.2 33.5 6.8 24.0 22.8 9.0 3.1 14.3 2.0 6.6 2.1 5.4 4.6 4.1 3.9 7.0 2.1 9.3 0.7 2.6 1.1 2.0 7.7 1.1 5.0 14.5 2.6 13.4 5.4 4.8 5.7 7.7 4.0 2.8 3.9 0.5 2.9 17.6 6.0 5.2 2.4 5.1 6.6 2.6 3.3 5.2 5.5 4.9 1.0 17.6 2.5 11.1 5.2 2.5 6.7 3.2 6.5 3.9 9.0 4.6 1.5 6.7 0.4 3.7 16.7 17.0 2.5 2.3 8.7 8.7 2.8 6.7 2.7 5.9 3.3 11.1 2.3 2.2 2.7 3.4 4.1 4.5 10.1 6.4 2.6 7.6 0.1 10.5 9.9 5.6 0.0 2.8 2.1 2.1 9.3 2.0 3.9 1.2 2.6 4.6 3.0 1.2 1.5 0.0 0.7 6.2 7.0 1.4 1.1 11.6 14.0 17.7 22.5 19.0 9.2 18.6 12.2 19.0 14.3 0.0 2.6 8.8 2.6 7.7 13.8 4.8 0.0 17.4 5.7 3.5 3.9 2.2 1.7 2.9 0.8 7.8 13.6 0.0 1.6 0.4 2.1 1.3 10.5 53.3 8.1 14.3 0.0 26.4 14.6 0.4 6.4 9.6 3.3 14.4 2.2 10.8 1.6 0.0 7.8 15.4 3.0 0.0 3.5 0.5 2.3 21.5 0.5 3.2 4.5 2.0 ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 114.8;Horizontal cells: 68.3;Late spermatids: 221.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 28.4;U-266/70: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: AB_2683638" "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 5.4 14.7 24.7 6.0 23.6 6.4 3.7 20.3 34.0 4.6 5.4 4.1 6.1 4.6 5.9 3.7 3.9 6.2 5.4 6.8 22.0 17.5 6.1 12.4 7.3 6.5 12.3 17.1 9.3 11.0 11.4 9.1 8.9 9.0 7.9 1.6 8.5 12.6 11.6 11.4 6.8 3.6 4.6 4.6 7.7 6.5 19.6 6.9 4.8 6.6 3.2 3.8 4.8 4.6 1.3 6.0 5.6 4.8 3.2 3.6 1.7 11.4 3.3 1.7 6.7 2.2 0.7 18.1 2.3 3.2 2.5 3.3 2.9 7.9 0.8 3.2 1.8 4.0 1.6 1.6 4.0 0.5 13.5 11.1 3.7 5.0 4.9 7.3 0.2 5.3 2.1 2.5 4.3 0.5 4.0 1.9 6.6 3.3 6.6 1.0 0.6 4.5 0.6 3.2 1.9 28.4 6.8 5.3 3.3 2.2 1.1 2.1 11.3 5.2 1.7 7.2 1.5 7.2 6.6 1.1 2.4 5.2 12.0 4.1 21.7 16.3 4.1 8.0 4.5 2.1 0.1 4.8 5.6 2.5 3.7 1.7 0.7 3.6 2.1 6.0 1.3 2.9 2.6 3.0 3.2 4.0 2.9 2.5 1.7 24.7 23.6 20.3 34.0 22.0 17.5 12.3 17.1 9.0 6.9 0.0 2.2 3.0 4.6 3.4 51.4 1.8 7.6 0.0 3.4 7.0 17.7 15.8 6.6 12.4 114.8 3.6 0.5 0.0 7.5 7.4 7.3 5.2 4.6 12.5 19.9 68.3 6.9 1.8 7.6 221.4 11.5 6.0 1.7 26.2 3.1 27.9 7.4 2.9 24.1 7.8 30.3 6.5 3.5 18.4 1.4 3.6 20.7 3.8 1.4 2.8 ABI3 "NESH, SSH3BP3" ENSG00000108798 "ABI family member 3" Q9P2A4 17 49210227-49223225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 84.6;lymphoid tissue: 50.6" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 43.1;Hofbauer cells: 46.5;Ito cells: 40.5;Kupffer cells: 104.3;Macrophages: 57.6;T-cells: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 84.4;non-classical monocyte: 84.6" "Group enriched" "Detected in all" 4 "dendritic cells: 29.5;monocytes: 84.6;T-cells: 36.5" "Cell line enhanced" "Detected in some" "Daudi: 19.4;HDLM-2: 11.2;HUVEC TERT2: 33.0;RH-30: 7.6;TIME: 23.3" "Low region specificity" "Detected in many" "HPA017345, HPA064805" Enhanced NA NA "HPA017345: AB_2669592, HPA064805: " "unprognostic (1.24e-1)" "unprognostic (1.23e-2)" "unprognostic (2.18e-2)" "prognostic favorable (7.13e-4)" "unprognostic (1.56e-1)" "unprognostic (1.16e-3)" "unprognostic (5.29e-1)" "unprognostic (8.25e-2)" "unprognostic (3.63e-2)" "unprognostic (1.48e-1)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" "unprognostic (2.28e-3)" "unprognostic (1.03e-1)" "unprognostic (9.24e-3)" "unprognostic (4.16e-2)" "unprognostic (2.40e-1)" 6.4 6.1 8.1 16.2 15.7 3.8 5.7 1.1 8.5 4.9 5.4 9.1 1.2 6.9 7.4 2.7 4.0 5.6 6.0 5.7 7.8 3.9 6.4 7.8 12.0 18.7 14.8 1.6 3.5 3.4 1.8 3.7 4.6 12.1 6.0 6.0 3.8 4.3 2.9 2.5 3.5 12.0 6.0 18.0 50.6 5.3 1.4 13.4 9.2 6.7 3.2 21.0 6.4 4.9 4.4 29.5 2.2 84.6 12.5 36.5 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 1.3 2.1 0.2 0.0 19.4 0.2 0.0 0.0 0.0 0.0 0.0 2.2 11.2 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 33.0 1.1 0.0 0.0 0.2 0.0 3.9 3.0 1.3 0.0 0.0 3.2 7.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 23.3 0.0 4.6 0.0 0.0 0.3 1.0 3.3 0.0 0.2 0.0 0.1 14.4 0.3 36.5 84.4 17.9 4.4 6.8 23.6 29.5 3.4 4.1 18.5 2.2 12.5 84.6 1.2 3.6 22.5 8.1 15.7 1.1 8.5 7.8 3.9 14.8 1.6 12.1 13.4 0.0 8.3 18.5 0.0 1.6 0.0 1.6 0.0 1.4 0.0 0.0 0.0 0.2 43.1 0.0 0.3 37.3 0.0 0.0 0.2 0.3 1.8 0.1 6.9 0.9 46.5 0.0 1.2 40.5 104.3 0.4 0.3 57.6 1.7 39.7 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 2.2 0.1 0.2 3.8 0.2 86.3 0.0 0.1 ABLIM2 KIAA1808 ENSG00000163995 "Actin binding LIM protein family member 2" Q6H8Q1 4 7965310-8158832 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0;skeletal muscle: 71.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 11.1;Intestinal endocrine cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 13.2;SiHa: 5.8;U-2197: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035808 Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA035808: AB_10601962" "unprognostic (7.57e-2)" "unprognostic (3.24e-3)" "unprognostic (7.78e-2)" "unprognostic (3.33e-1)" "unprognostic (2.86e-2)" "unprognostic (6.09e-2)" "unprognostic (1.49e-2)" "unprognostic (5.54e-2)" "unprognostic (1.46e-1)" "unprognostic (5.01e-3)" "unprognostic (2.04e-2)" "unprognostic (3.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.32e-2)" "unprognostic (5.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.45e-2)" 4.0 3.8 8.2 1.9 19.1 0.8 2.1 4.0 26.0 1.4 2.1 2.3 0.0 1.1 1.2 1.3 10.5 1.4 1.7 5.7 3.4 5.1 2.5 1.2 1.8 1.4 2.8 7.6 1.1 3.3 2.4 6.1 1.2 9.9 1.8 2.1 1.3 2.6 1.2 71.8 3.8 1.8 2.1 1.8 14.8 1.8 1.5 4.0 0.0 2.4 1.9 2.3 1.5 1.7 0.7 0.5 0.0 0.2 0.0 3.0 0.2 1.0 0.0 0.2 1.5 0.4 0.1 0.4 0.0 0.0 0.1 0.0 0.0 1.3 2.9 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.6 1.9 0.1 0.0 1.2 2.7 0.9 0.1 1.0 0.6 0.2 0.0 13.2 1.0 5.8 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.4 20.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.1 3.0 0.0 2.5 0.0 0.5 0.7 1.2 0.9 0.0 0.0 0.2 0.0 1.2 0.2 8.2 19.1 4.0 26.0 3.4 5.1 2.8 7.6 9.9 4.0 0.0 1.4 0.0 0.1 2.3 5.1 3.6 0.0 2.7 0.0 3.5 0.0 0.0 0.0 3.0 1.7 2.7 7.5 0.0 3.8 0.5 0.4 0.3 2.3 0.4 0.1 11.1 10.3 1.3 0.3 4.2 0.0 0.0 0.0 0.0 3.0 2.7 3.4 4.5 3.5 0.3 2.9 6.5 4.2 0.0 1.5 5.5 0.0 0.0 5.2 0.1 ABLIM3 KIAA0843 ENSG00000173210 "Actin binding LIM protein family member 3" O94929 5 149141483-149260542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 58.4" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 57.0;Hepatocytes: 97.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003245 Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "HPA003245: AB_1078083" "unprognostic (1.07e-1)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (1.75e-1)" "unprognostic (8.74e-2)" "unprognostic (4.19e-2)" "unprognostic (9.48e-3)" "unprognostic (4.37e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.12e-2)" "unprognostic (8.10e-2)" "unprognostic (2.45e-3)" "unprognostic (1.20e-1)" 45.9 6.0 7.9 3.5 9.8 1.2 35.0 29.7 12.5 9.1 4.7 11.6 7.0 2.9 4.9 8.9 15.6 5.8 6.1 58.4 8.5 10.2 17.0 48.1 9.1 4.8 9.9 5.9 2.6 2.4 39.3 3.1 26.1 14.3 6.5 4.7 7.7 3.0 9.9 24.3 3.5 3.7 8.7 14.0 5.0 2.7 2.3 3.3 0.1 4.2 8.9 4.5 8.8 14.6 0.0 0.6 2.2 0.3 0.0 0.0 6.8 7.2 1.5 0.0 0.0 13.1 25.1 0.0 5.1 14.3 2.9 5.1 0.0 5.1 0.0 0.8 6.4 15.6 0.1 0.0 5.9 5.8 0.0 0.0 0.0 0.3 0.1 25.7 0.0 0.0 29.6 1.6 10.5 29.6 24.8 13.1 0.0 0.0 2.3 17.0 2.8 0.0 0.0 0.0 0.4 20.1 0.0 0.0 0.0 16.4 5.0 2.0 0.0 1.0 0.3 2.7 0.4 0.4 0.0 32.8 6.2 1.4 6.4 8.6 0.0 0.0 0.0 10.8 0.0 17.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 6.8 7.9 9.8 29.7 12.5 8.5 10.2 9.9 5.9 14.3 3.3 0.0 3.0 4.7 1.0 1.3 1.1 57.0 28.1 4.0 1.2 0.0 0.0 0.1 5.0 6.8 1.8 20.2 0.0 0.0 3.0 0.6 2.1 2.2 1.1 97.0 9.3 27.0 0.0 20.3 11.9 0.0 0.3 0.8 5.0 0.0 0.0 19.7 14.9 0.0 0.7 18.3 21.8 0.0 2.3 1.7 2.3 1.4 0.3 0.0 0.0 4.9 ABO "A3GALNT, A3GALT1" ENSG00000175164 "ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase" 9 133250401-133275219 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 28.2" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 56.2;Collecting duct cells: 45.4;Enterocytes: 68.1;Mucus-secreting cells: 54.8;Paneth cells: 49.5;Undifferentiated cells: 61.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2" "Group enriched" "Detected in many" 8 "B-cells: 2.2;granulocytes: 3.0" "Group enriched" "Detected in some" 6 "K-562: 20.4;RT4: 8.0" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.78e-3)" "unprognostic (2.56e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (1.39e-1)" "unprognostic (3.10e-2)" "unprognostic (1.84e-3)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (8.51e-2)" "unprognostic (9.30e-3)" "unprognostic (7.23e-2)" "unprognostic (2.67e-2)" "unprognostic (4.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (9.04e-2)" 1.6 1.0 0.1 5.8 0.1 0.3 0.4 0.0 0.6 1.0 15.0 0.0 2.3 1.7 1.6 0.8 3.0 0.3 7.6 0.3 0.0 10.7 0.3 3.6 0.3 0.0 0.0 3.2 2.6 0.3 0.0 0.3 0.2 1.5 2.4 1.0 2.2 0.3 1.4 0.3 28.2 0.6 0.0 0.3 0.3 2.0 0.0 0.0 10.1 4.2 5.8 1.0 1.4 2.2 0.1 3.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 3.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 2.2 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.2 29.8 22.2 0.5 3.6 0.0 0.0 2.8 17.8 56.2 27.3 45.4 0.0 0.7 0.0 3.7 3.3 6.8 68.1 0.0 0.3 0.2 0.8 6.5 0.0 0.0 0.2 0.0 24.6 3.1 0.6 6.7 14.1 0.3 0.0 1.0 54.8 0.0 8.2 49.5 6.3 19.5 0.1 6.5 0.6 0.5 1.5 0.0 0.6 0.0 61.3 15.2 ABR MDB ENSG00000159842 "Active BCR-related" Q12979 17 1003518-1229021 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "basophil: 8.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.9" "Cell line enhanced" "Detected in some" "Daudi: 18.8;hTERT-RPE1: 20.2;LHCN-M2: 12.6;RPMI-8226: 10.8;TIME: 20.9;U-251 MG: 21.0;U-698: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053618, HPA054824" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053618: AB_2682208, HPA054824: AB_2682616" "unprognostic (1.69e-1)" "prognostic favorable (4.03e-4)" "unprognostic (1.58e-1)" "unprognostic (1.94e-3)" "unprognostic (1.12e-1)" "unprognostic (2.20e-2)" "unprognostic (4.99e-2)" "unprognostic (7.53e-2)" "unprognostic (1.91e-1)" "unprognostic (9.61e-2)" "unprognostic (7.20e-3)" "unprognostic (4.43e-3)" "prognostic favorable (2.21e-4)" "unprognostic (2.27e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-1)" "unprognostic (1.74e-2)" 12.9 5.8 31.8 18.0 28.7 6.0 5.8 7.0 43.6 6.6 19.9 12.0 2.3 9.4 7.9 4.0 11.0 6.1 6.7 26.6 24.0 16.9 6.8 4.0 9.3 6.9 14.1 27.0 3.9 5.0 8.3 6.0 7.2 11.3 4.6 21.6 19.4 23.7 3.4 2.9 5.9 11.9 25.1 8.1 8.1 13.6 3.8 11.3 2.9 7.0 2.3 18.0 7.2 7.4 0.3 0.7 8.9 0.8 0.0 0.8 0.0 0.5 0.6 0.2 0.0 0.9 0.1 0.5 0.1 0.1 0.0 0.0 0.4 0.0 18.8 0.3 0.1 0.8 0.0 2.0 0.0 0.4 5.8 10.2 0.0 0.2 0.0 0.4 2.3 6.7 0.2 0.0 0.1 6.7 20.2 0.0 0.0 0.0 0.0 12.6 0.7 0.0 2.5 0.1 0.4 0.1 0.1 0.0 10.8 0.1 0.2 0.2 0.3 0.0 0.0 1.0 0.0 5.9 2.9 20.9 0.1 0.2 2.1 21.0 0.0 0.2 15.4 1.0 4.1 0.4 8.9 0.3 1.0 0.2 0.8 0.4 0.1 0.3 0.0 0.7 0.3 0.0 0.3 0.9 0.0 0.4 0.0 0.8 0.0 31.8 28.7 7.0 43.6 24.0 16.9 14.1 27.0 11.3 11.3 29.8 21.1 7.8 15.2 15.1 60.3 21.8 25.5 10.7 17.0 1.8 2.0 1.9 0.0 15.6 33.8 21.5 39.3 0.0 5.5 2.5 13.4 17.6 18.5 0.8 27.7 11.1 14.5 18.4 24.0 112.5 12.7 28.3 18.6 18.0 35.9 29.4 29.8 25.9 8.9 5.8 18.0 38.8 21.7 1.9 7.5 14.8 1.8 13.8 49.9 22.6 ABRA STARS ENSG00000174429 "Actin binding Rho activating protein" Q8N0Z2 8 106759483-106770245 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Actin-binding, Activator" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "heart muscle: 21.6;skeletal muscle: 77.6;tongue: 35.0" "Group enriched" "Detected in some" 23 "Cardiomyocytes: 188.3;Early spermatids: 61.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (9.08e-3)" "unprognostic (1.61e-2)" "unprognostic (3.26e-1)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "unprognostic (2.64e-2)" "unprognostic (1.35e-2)" "unprognostic (6.84e-2)" "unprognostic (2.69e-1)" "unprognostic (2.09e-1)" "unprognostic (2.69e-1)" "unprognostic (1.15e-2)" "unprognostic (4.34e-1)" "unprognostic (6.21e-3)" 1.2 0.2 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.3 0.1 0.0 0.8 0.1 0.6 1.7 2.1 0.2 0.1 21.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.6 0.7 0.1 0.0 2.6 1.6 77.6 0.1 0.1 0.5 0.1 0.1 0.1 0.9 0.0 0.0 2.6 35.0 1.2 0.6 2.2 0.7 0.5 2.6 0.6 0.6 0.5 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.1 0.0 0.2 0.2 0.6 0.3 0.2 0.0 0.0 0.2 0.0 0.5 0.1 0.4 0.0 0.0 0.7 0.5 0.4 0.1 0.2 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.6 0.2 0.5 0.3 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.5 0.8 0.2 0.0 1.2 0.2 0.6 0.1 0.1 0.1 0.2 0.6 1.3 0.1 0.4 0.0 0.2 0.4 0.1 0.2 0.7 0.5 0.5 2.6 0.6 0.5 0.5 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 4.4 0.9 0.7 0.1 0.0 0.0 0.0 0.0 ABRACL "C6orf115, Costars, HSPC280, PRO2013" ENSG00000146386 "ABRA C-terminal like" Q9P1F3 6 139028682-139043302 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.9" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 308.6;Proximal tubular cells: 337.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 77.9;U-937: 75.7" "Low region specificity" "Detected in all" HPA030217 Enhanced Approved Nucleoplasm,Cytosol NA NA 7400000 Nucleoplasm Cytosol "HPA030217: AB_10602335" "unprognostic (1.10e-2)" "unprognostic (1.63e-1)" "unprognostic (9.30e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.72e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.21e-1)" "unprognostic (8.17e-2)" "unprognostic (2.16e-1)" "unprognostic (3.07e-3)" "unprognostic (5.90e-3)" "unprognostic (3.63e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.65e-6)" 12.2 4.2 12.0 25.5 10.1 23.1 22.1 1.8 19.0 6.5 28.4 2.4 10.6 22.6 10.3 43.8 23.5 6.0 10.9 7.9 15.1 7.1 29.0 26.8 14.0 39.0 5.5 10.3 5.1 9.5 10.3 9.3 12.9 4.8 8.2 26.9 4.3 19.9 9.7 2.3 12.8 35.5 7.1 5.1 45.6 13.7 20.1 5.0 60.2 13.2 19.2 26.0 23.0 9.0 17.1 37.2 30.5 82.9 24.6 48.8 51.8 11.2 6.0 15.5 14.4 6.2 9.7 17.0 9.0 6.4 6.8 14.0 13.4 13.2 0.0 16.4 8.8 29.4 17.1 13.6 19.4 7.9 29.9 25.1 43.9 3.4 4.6 9.0 73.2 20.2 8.7 16.4 9.1 7.5 12.3 35.5 31.0 5.5 15.4 19.4 23.6 45.6 77.9 18.5 17.6 11.8 29.5 9.5 3.5 18.2 33.4 34.7 3.8 6.1 17.2 28.0 22.9 6.8 55.0 26.4 4.3 3.7 9.0 15.9 8.4 23.8 3.0 5.5 75.7 12.8 30.5 31.7 18.9 29.8 55.8 46.1 15.3 48.8 38.1 33.8 17.1 47.7 44.3 8.6 24.6 82.9 37.2 43.5 51.8 12.0 10.1 1.8 19.0 15.1 7.1 5.5 10.3 4.8 5.0 17.9 26.9 128.7 58.7 124.0 0.2 2.8 30.6 20.1 22.7 41.8 0.0 69.4 51.4 124.4 2.6 35.9 215.0 0.0 127.3 176.9 29.2 47.3 79.5 178.9 308.6 0.0 41.3 49.1 193.8 9.4 4.4 118.3 82.7 71.3 101.8 34.9 147.3 167.5 12.0 337.1 1.3 32.3 17.4 1.4 2.1 78.7 40.6 137.1 116.5 103.7 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680920 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 107.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 107.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 20.4 13.7 11.7 17.7 20.1 42.3 14.2 43.4 27.2 15.4 14.3 13.8 12.9 12.3 15.6 10.9 9.6 13.1 17.6 20.4 10.9 8.2 11.4 8.3 15.5 22.1 9.7 15.8 15.8 11.2 7.8 15.3 12.0 11.4 13.5 4.9 12.4 15.2 14.5 25.1 11.6 13.0 13.3 7.5 41.4 11.7 5.9 12.5 17.8 10.2 9.1 10.4 14.6 17.4 2.9 3.8 107.3 8.6 3.2 5.8 5.1 3.1 7.6 0.7 1.5 7.2 6.9 5.8 5.0 8.7 3.5 4.8 0.2 6.7 1.4 9.0 3.8 4.3 1.4 0.0 3.8 0.8 14.7 2.1 2.3 13.5 1.8 5.8 0.3 7.1 8.6 4.1 3.5 0.9 11.3 3.6 5.9 0.1 10.3 3.7 5.0 3.5 9.9 0.6 3.6 8.4 2.2 4.2 9.8 5.2 2.0 7.0 4.7 3.6 4.4 18.2 1.9 1.1 2.6 6.6 3.6 3.1 6.5 1.6 8.4 2.7 0.4 8.5 2.9 5.7 4.5 8.6 20.5 2.4 6.2 2.3 2.5 2.6 2.3 3.8 2.9 2.2 1.9 107.3 3.2 5.4 2.4 5.8 5.1 11.7 20.1 43.4 27.2 10.9 8.2 9.7 15.8 11.4 12.5 17.9 18.3 15.2 14.1 10.4 9.9 6.2 10.2 4.0 2.3 7.0 17.7 6.5 13.3 12.2 0.4 13.5 12.4 0.0 15.1 20.9 14.5 11.3 14.9 8.5 19.9 3.2 23.0 23.4 52.6 1.9 31.4 20.7 10.1 45.9 16.6 16.2 19.1 23.0 21.2 17.0 30.1 64.7 31.9 0.7 6.8 8.2 13.3 46.5 11.2 8.4 ABTB2 "ABTB2A, BTBD22, DKFZP586C1619" ENSG00000166016 "Ankyrin repeat and BTB domain containing 2" Q8N961 11 34150988-34358008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 31.6" "Cell type enhanced" "Detected in many" 7 "monocytes: 16.2;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "eosinophil: 8.1;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 13 "dendritic cells: 2.8;granulocytes: 8.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020065, HPA030699" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA020065: AB_1844459, HPA030699: AB_2673576" "unprognostic (3.00e-1)" "prognostic unfavorable (5.70e-5)" "unprognostic (2.61e-1)" "unprognostic (9.09e-2)" "unprognostic (3.17e-2)" "unprognostic (2.40e-2)" "unprognostic (1.34e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-3)" "unprognostic (2.86e-1)" "prognostic favorable (3.51e-5)" "unprognostic (1.50e-1)" "unprognostic (1.42e-1)" "unprognostic (3.81e-2)" "unprognostic (6.58e-2)" 3.1 13.7 4.8 2.7 6.7 3.2 2.2 5.0 5.8 8.0 8.5 10.6 18.2 11.7 7.4 6.3 4.4 4.1 3.2 13.0 4.7 3.9 8.4 8.0 2.9 2.7 9.0 1.5 2.8 2.2 0.3 2.8 8.1 15.8 4.5 3.6 7.5 8.7 31.6 19.4 5.6 20.2 3.6 20.2 1.2 3.0 3.1 7.7 6.4 2.1 3.5 2.8 3.4 5.0 0.0 2.8 8.1 0.4 0.0 0.1 0.1 4.0 12.0 4.9 1.3 1.3 0.1 4.9 2.4 1.9 2.1 4.1 2.9 3.0 0.1 4.1 3.0 12.7 7.8 2.7 2.7 1.7 0.1 6.6 0.0 7.1 12.7 0.7 6.4 0.9 0.7 1.5 4.2 1.8 7.8 0.0 0.5 1.3 0.3 1.3 10.1 0.2 7.8 6.1 6.0 6.6 1.2 2.9 4.5 7.6 9.7 6.2 5.1 6.0 18.7 4.7 3.4 4.0 2.8 0.6 2.4 0.4 7.4 4.3 0.7 0.3 0.1 5.5 1.8 7.3 0.0 0.1 8.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.8 0.1 0.1 4.8 6.7 5.0 5.6 4.7 3.9 9.0 1.5 15.8 7.7 0.0 2.9 0.8 2.3 4.1 2.8 7.4 5.1 0.0 0.0 12.2 0.0 1.9 5.0 4.5 0.8 0.6 10.3 0.0 3.9 0.9 5.5 5.8 1.1 5.7 0.7 0.0 6.9 0.0 1.0 0.0 1.1 0.8 1.7 16.2 1.6 6.2 7.3 0.8 5.6 1.1 0.3 0.0 3.3 0.5 0.6 4.3 23.7 0.0 1.3 6.0 AC001226.2 ENSG00000283208 13 76992078-77129589 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "bone marrow: 19.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 3.4;NB-4: 3.0;U-698: 2.8" NA NA 3.9 2.7 2.0 2.7 2.3 19.2 4.8 1.8 4.2 3.6 2.4 3.0 2.9 1.7 3.0 6.6 2.7 3.1 4.2 3.5 1.7 10.4 6.0 2.9 3.3 4.1 1.0 5.8 3.4 1.9 5.7 6.1 3.4 3.1 1.8 4.3 2.8 3.8 2.6 4.6 3.2 3.4 2.6 2.9 2.0 2.6 3.2 3.2 12.5 1.0 1.9 3.1 2.6 2.3 0.9 2.8 2.4 0.6 1.3 0.2 0.8 0.5 1.1 0.0 1.7 0.8 0.7 0.1 0.5 0.4 0.2 0.1 1.0 2.1 0.2 0.0 0.5 0.3 0.2 0.0 0.2 0.1 0.1 0.3 0.5 0.0 0.5 3.4 1.1 0.0 0.0 0.4 0.2 1.0 0.0 1.1 0.0 1.6 0.3 0.0 0.7 3.0 0.1 0.5 0.0 0.7 0.0 0.3 0.0 0.6 0.9 0.5 0.5 0.9 0.2 0.3 0.3 2.6 0.0 0.2 0.2 0.2 0.6 2.0 1.2 2.8 0.4 1.9 0.4 2.8 0.7 0.7 0.4 0.5 1.1 0.7 0.9 1.0 0.1 2.3 1.1 1.3 1.4 0.6 2.4 0.9 1.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC002094.3 ENSG00000273171 17 28364288-28368012 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 82 "liver: 75.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;NTERA-2: 1.0;RT4: 1.1;U-2197: 1.1;U-266/84: 1.2" NA NA "unprognostic (2.54e-2)" 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 75.7 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 1.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC002996.1 ENSG00000257767 12 111753890-111791418 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adipose tissue: 27.0;blood: 29.9;skeletal muscle: 16.3;stomach 1: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "classical monocyte: 29.4;myeloid DC: 29.9" "Group enriched" "Detected in many" 5 "dendritic cells: 29.9;monocytes: 29.4" "Cell line enhanced" "Detected in many" "BEWO: 9.0;EFO-21: 17.7;SK-BR-3: 8.7" NA NA "unprognostic (4.89e-1)" "unprognostic (1.20e-1)" 27.0 2.5 0.7 0.8 1.3 0.0 0.4 1.3 1.3 0.6 4.8 4.4 0.2 0.0 0.5 0.3 0.0 0.5 0.6 0.4 4.0 1.6 2.1 0.0 0.5 1.0 0.6 0.0 0.4 0.0 0.3 0.0 2.4 0.5 16.3 0.9 1.7 0.0 0.8 0.4 8.0 0.0 0.3 0.0 0.8 0.6 1.1 29.9 6.2 29.4 0.3 0.2 14.8 3.4 0.0 0.0 0.9 0.0 1.4 9.0 1.0 4.3 1.6 0.8 0.0 2.0 0.0 17.7 1.9 1.6 3.1 0.0 0.7 0.1 0.5 0.4 0.0 2.6 0.0 0.0 0.3 0.0 0.0 2.0 1.9 0.0 0.0 4.4 0.0 1.5 0.2 0.7 0.0 0.0 0.6 5.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.6 4.8 0.0 8.7 0.1 0.1 6.3 3.3 0.0 0.0 2.0 0.2 0.0 1.3 1.9 4.6 2.5 0.1 0.0 0.4 29.4 6.2 0.1 13.0 0.2 1.1 0.0 0.0 29.9 0.4 0.0 0.0 1.1 0.3 3.9 8.0 0.1 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC003002.2 ENSG00000268533 19 57394183-57438457 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 8.8" NA NA "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "unprognostic (1.22e-1)" "unprognostic (3.03e-1)" "unprognostic (1.44e-1)" "unprognostic (5.96e-3)" "unprognostic (5.13e-3)" "unprognostic (1.87e-1)" "unprognostic (1.97e-1)" "unprognostic (1.33e-1)" "unprognostic (8.02e-3)" "unprognostic (1.01e-2)" "unprognostic (8.52e-4)" "unprognostic (7.89e-2)" "unprognostic (1.05e-1)" "unprognostic (5.17e-1)" "unprognostic (1.58e-3)" 0.4 1.0 1.4 0.6 2.1 3.5 0.5 3.3 1.9 0.2 0.5 1.0 0.4 1.4 0.6 0.6 1.1 0.9 1.1 1.8 1.3 0.3 0.3 1.4 1.3 1.3 2.6 0.0 0.9 0.2 0.7 0.7 0.6 0.1 0.5 7.5 1.7 0.0 0.8 1.1 1.2 2.7 3.0 0.4 0.3 0.4 4.3 3.4 4.7 2.8 5.3 3.2 0.8 1.7 0.2 5.5 5.7 2.0 0.0 1.6 0.6 0.6 0.0 2.3 0.5 2.3 2.3 1.1 1.5 3.4 1.2 0.9 0.0 1.0 1.2 3.6 1.0 8.8 0.0 0.0 2.6 7.2 0.7 0.0 0.6 0.0 4.5 0.0 3.0 0.3 2.9 1.2 2.6 1.8 3.1 1.5 0.5 1.7 1.3 1.3 1.3 0.0 6.8 7.6 0.9 0.7 1.6 1.2 3.5 2.0 2.6 0.0 2.6 2.5 2.3 1.3 2.6 2.0 1.8 1.7 2.8 1.4 0.7 2.7 1.0 2.7 1.1 3.1 1.5 2.2 1.6 1.4 4.3 3.2 2.9 4.7 5.3 2.8 3.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004080.3 ENSG00000257184 7 27163535-27180013 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 24.9;endometrium 1: 20.7;prostate: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;BJ: 4.4;BJ hTERT+ SV40 Large T+: 1.5;HEK 293: 2.9;RPTEC TERT1: 2.2;U-937: 2.2" NA NA "unprognostic (4.27e-1)" "unprognostic (4.63e-1)" "unprognostic (4.49e-1)" 1.6 0.2 0.3 1.8 0.3 0.0 0.2 0.3 0.3 24.9 6.9 0.0 1.0 0.0 20.7 2.1 0.2 0.2 0.0 0.3 0.2 0.3 4.7 0.3 0.2 0.0 0.3 0.0 0.3 0.3 0.0 0.3 4.6 0.0 12.9 1.1 0.0 0.2 1.2 6.9 0.3 0.5 6.7 0.2 0.2 0.2 1.0 0.0 0.0 0.3 0.0 0.0 7.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.2 0.2 4.4 0.8 1.5 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004223.3 ENSG00000267618 17 35011349-35121493 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 4.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.4" "Cell line enhanced" "Detected in many" "A549: 7.7;TIME: 4.7" NA NA 6.1 1.6 2.3 2.7 3.1 3.6 2.4 2.3 5.3 2.1 1.9 2.9 0.5 1.2 2.0 1.8 1.6 2.0 3.7 2.3 2.4 1.6 1.9 1.5 1.7 2.3 3.0 2.4 3.5 3.3 1.7 1.5 1.4 1.7 1.6 1.6 2.2 1.5 1.3 1.8 1.7 2.8 2.4 1.6 2.2 1.7 16.6 2.8 4.3 2.3 0.3 2.7 1.7 2.0 0.1 0.1 0.5 0.4 4.4 0.5 0.5 0.6 7.7 0.0 1.5 0.0 0.6 2.4 0.0 0.0 1.8 1.6 0.6 1.1 0.2 2.0 0.0 0.5 0.2 0.0 0.0 0.2 4.2 1.2 1.0 2.3 0.0 2.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.2 0.8 0.0 0.8 0.0 2.5 0.0 0.8 0.3 0.1 0.3 0.0 3.4 0.4 0.0 2.1 2.0 0.2 0.0 3.1 2.9 4.7 0.1 1.1 1.1 1.2 0.8 3.6 0.4 1.5 1.6 0.9 0.1 0.4 0.5 0.3 0.1 0.3 0.0 0.5 0.5 0.0 0.1 0.4 0.2 0.0 4.4 0.0 0.1 0.3 0.5 2.3 3.1 2.3 4.0 2.4 1.6 3.0 2.4 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004233.2 ENSG00000270168 16 2988256-3002016 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "skin 1: 8.9" "Cell type enriched" "Detected in single" 30 "Alveolar cells type 2: 5.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.4;HaCaT: 7.3;hTCEpi: 5.5;MCF7: 3.8;OE19: 6.0;SCLC-21H: 5.6" NA NA "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (1.04e-1)" "unprognostic (6.21e-2)" "unprognostic (7.98e-3)" "unprognostic (1.50e-1)" "unprognostic (2.72e-1)" "unprognostic (9.48e-2)" "unprognostic (2.06e-2)" "unprognostic (1.42e-1)" "unprognostic (2.30e-1)" "unprognostic (3.61e-1)" "unprognostic (1.97e-3)" "unprognostic (1.28e-1)" "unprognostic (6.73e-2)" "unprognostic (4.21e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.1 0.6 0.1 0.1 1.1 0.1 0.1 8.9 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.6 0.4 0.1 0.1 0.5 0.2 3.4 0.0 0.2 0.0 0.1 7.3 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.1 5.5 0.2 0.0 0.1 0.0 0.0 0.6 0.3 0.0 3.8 0.0 0.4 0.0 6.0 0.0 0.0 1.0 0.1 0.0 0.2 5.6 0.2 0.5 2.3 0.1 0.1 2.9 0.1 0.0 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004556.1 ENSG00000276345 Unmapped 2585-11802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.0" "Cell type enhanced" "Detected in many" 17 "Distal tubular cells: 26.6;Hofbauer cells: 22.3;Kupffer cells: 73.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 25.6;K-562: 21.5;MOLT-4: 24.1;NB-4: 46.5;PC-3: 43.4;WM-115: 31.2" HPA050406 Uncertain Supported "Nucleoli fibrillar center,Mitochondria" NA NA Mitochondria "Nucleoli fibrillar center" "HPA050406: AB_2681116" 0.9 0.0 0.9 0.0 8.3 3.7 0.0 3.8 0.0 1.3 5.9 0.0 1.5 1.7 9.3 1.6 3.0 0.0 0.0 2.4 2.0 0.0 0.0 1.5 0.0 2.2 0.0 6.1 1.4 3.6 0.0 0.9 1.2 0.0 0.3 0.0 1.4 2.8 4.7 13.0 9.6 3.2 6.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 8.4 12.0 13.0 9.4 25.6 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 14.4 0.0 8.7 13.4 21.5 11.8 0.1 0.1 24.1 46.5 0.0 0.0 43.4 0.1 7.6 0.0 12.1 7.3 0.0 0.1 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 31.2 13.0 5.6 3.1 2.8 9.6 2.4 2.5 4.5 6.0 4.1 2.8 4.5 5.2 1.0 3.2 4.0 4.7 5.9 4.0 0.0 0.0 8.7 0.1 0.0 0.0 0.0 2.5 4.0 2.3 17.4 0.0 2.8 26.6 0.0 0.9 0.0 0.0 0.0 0.3 10.9 0.0 0.0 0.0 1.1 22.3 0.0 0.0 17.2 73.1 2.8 3.7 0.2 0.0 0.0 1.1 0.0 0.1 0.2 0.4 6.9 0.0 0.0 0.0 3.5 5.9 0.0 3.3 3.8 0.4 0.1 AC004593.3 ENSG00000285162 "Beta-chimaerin isoform 3 " 7 29122340-29514667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 6.3;brain: 16.3" "Group enriched" "Detected in some" 11 "Collecting duct cells: 1.8;Early spermatids: 1.0;granulocytes: 1.1;Hepatocytes: 2.4;Late spermatids: 1.1" "Group enriched" "Detected in some" 34 "classical monocyte: 6.2;intermediate monocyte: 5.1;myeloid DC: 6.3;non-classical monocyte: 2.5" "Group enriched" "Detected in many" 59 "dendritic cells: 6.3;monocytes: 6.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.7;GAMG: 3.3;HaCaT: 3.5;HEL: 2.5;U-266/84: 4.1" HPA019026 Uncertain "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA019026: " 0.1 0.3 0.1 0.2 0.1 0.2 0.1 16.3 0.1 0.1 0.2 0.1 0.1 2.6 0.4 0.1 0.1 0.0 0.4 1.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.5 0.7 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.5 1.9 2.9 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.0 6.3 0.1 6.2 0.0 0.0 2.2 0.0 0.2 0.7 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 1.5 0.0 2.7 0.0 3.3 3.5 0.1 0.0 0.0 0.1 1.2 2.5 0.8 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 1.2 0.0 1.6 1.3 0.7 0.0 0.2 0.0 0.3 0.6 0.2 0.1 0.8 1.2 0.9 1.6 0.4 0.1 0.7 0.6 0.0 0.0 0.1 0.3 4.1 0.0 0.0 0.0 1.7 0.0 6.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 2.5 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004754.1 ENSG00000269881 16 249547-269943 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "intestine: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9" "HPA011651, HPA071871" Uncertain Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA011651: , HPA071871: AB_2732188" "unprognostic (1.22e-1)" "unprognostic (2.09e-2)" "unprognostic (2.26e-1)" "unprognostic (1.75e-2)" "unprognostic (5.40e-2)" "unprognostic (2.56e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (3.37e-2)" "unprognostic (5.06e-2)" "unprognostic (5.24e-3)" "unprognostic (4.66e-2)" "unprognostic (7.84e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-2)" 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.3 0.6 0.6 0.2 15.3 0.3 0.3 0.1 0.2 0.0 0.9 0.4 1.4 0.3 0.1 0.0 0.0 0.7 0.1 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.3 1.0 0.1 7.4 0.2 0.7 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.4 1.8 2.4 2.4 0.5 0.0 1.2 0.0 0.1 0.3 0.1 0.0 5.1 1.1 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 0.0 1.0 0.0 0.2 1.0 2.9 0.7 0.1 0.0 0.3 0.0 2.1 0.0 0.2 1.2 0.6 0.0 1.3 0.0 0.0 0.9 0.0 0.3 1.0 0.0 0.0 0.4 0.2 1.0 0.6 0.0 0.4 0.0 1.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.8 0.0 0.5 1.5 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC004832.3 ENSG00000249590 22 30409255-30428990 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "epididymis: 32.4" "Group enriched" "Detected in some" 14 "Club cells: 1.2;Distal tubular cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.9;T-reg: 2.1" "Lineage enriched" "Detected in single" 6 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 17.0;hTERT-HME1: 10.6;HUVEC TERT2: 11.6" NA NA 0.7 1.5 1.6 2.7 1.2 0.2 1.0 0.6 0.9 1.2 1.0 1.0 4.7 5.5 0.7 32.4 0.6 0.8 1.0 0.8 1.0 1.4 2.3 6.4 1.1 0.6 1.9 0.6 1.0 1.2 1.2 0.6 0.9 0.8 2.4 2.1 0.8 1.7 0.6 0.6 0.9 3.9 0.6 1.5 0.6 1.5 1.3 0.6 0.6 1.6 0.6 1.9 0.7 0.7 0.2 0.5 0.2 0.1 0.0 2.9 0.7 3.6 0.0 2.0 1.6 0.4 1.8 0.0 0.0 3.2 5.2 6.5 0.0 2.1 0.6 0.7 1.1 5.8 5.2 1.8 17.0 7.3 0.0 0.0 0.0 0.0 0.0 0.7 0.3 2.3 1.1 3.6 5.4 10.6 6.3 11.6 0.2 0.0 0.3 2.9 0.0 1.0 1.1 0.6 5.1 0.0 0.7 3.0 0.0 5.6 0.3 0.4 0.7 3.0 2.4 1.9 1.4 1.2 0.2 0.8 2.5 2.9 1.5 3.3 0.1 0.0 0.2 0.6 0.0 2.1 0.2 0.1 0.0 0.0 0.1 1.4 0.2 0.3 0.0 0.0 0.0 0.7 2.9 0.0 0.0 0.0 0.5 2.1 0.7 1.6 1.2 0.6 0.9 1.0 1.4 1.9 0.6 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC004997.1 ENSG00000248751 22 30285238-30299482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "GAMG: 2.7;HSkMC: 5.1;Karpas-707: 2.9;REH: 3.1" HPA073183 Uncertain NA NA "HPA073183: " "unprognostic (2.09e-1)" "unprognostic (1.68e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-2)" "unprognostic (3.83e-2)" "unprognostic (7.25e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (1.18e-2)" "unprognostic (2.46e-1)" "unprognostic (9.84e-2)" "unprognostic (1.92e-1)" "unprognostic (1.83e-5)" "unprognostic (7.90e-2)" "unprognostic (7.28e-2)" "unprognostic (4.96e-3)" "unprognostic (1.02e-2)" 0.4 0.5 0.2 0.0 1.1 0.0 0.4 0.5 2.9 1.2 0.1 0.0 0.1 0.0 3.2 0.0 0.3 0.3 0.2 0.2 0.7 0.0 0.5 1.1 0.2 0.4 1.0 0.6 0.5 1.6 0.4 0.0 0.5 2.2 0.0 0.8 1.2 0.7 0.0 0.3 0.2 1.8 0.4 0.0 0.3 1.8 3.7 1.3 2.2 1.2 1.4 4.1 0.6 1.2 0.0 0.0 0.2 0.8 1.0 0.0 0.9 1.4 0.9 0.7 0.0 0.3 0.0 0.7 0.0 2.7 1.9 0.3 0.0 0.1 0.6 0.0 0.0 0.0 0.1 2.6 0.0 0.7 5.1 0.3 0.4 0.0 0.0 0.7 0.0 0.0 2.9 2.2 0.0 1.3 0.0 0.0 0.8 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.9 0.9 0.8 0.4 1.7 0.0 0.0 1.3 2.1 0.1 1.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.0 1.2 2.2 1.0 0.0 1.3 1.3 1.8 1.1 1.3 3.7 4.1 3.1 0.7 1.4 0.5 0.5 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005324.3 ENSG00000251537 17 15571491-15651653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.3;tongue: 21.1;vagina: 17.9" "Group enriched" "Detected in some" 11 "Club cells: 1.2;Pancreatic endocrine cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.6;HeLa: 3.1;OE19: 2.2" "HPA023623, HPA066431" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (3.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (2.48e-1)" "unprognostic (1.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.87e-3)" "unprognostic (1.93e-1)" "unprognostic (2.98e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (6.35e-3)" "unprognostic (1.80e-11)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (5.30e-2)" "unprognostic (3.09e-1)" 7.5 2.8 0.9 1.5 1.0 1.0 7.7 0.9 1.0 5.3 2.2 1.3 0.0 2.1 0.7 1.5 23.3 0.8 4.0 2.6 0.8 0.9 0.9 1.0 2.1 1.6 3.7 0.0 0.7 1.0 0.8 0.7 12.4 2.7 1.4 0.9 0.2 2.4 1.1 2.9 4.4 1.6 2.1 1.5 1.0 2.8 1.8 1.0 1.6 1.8 21.1 17.5 3.2 17.9 0.6 0.6 0.0 0.1 0.0 0.5 0.0 0.6 3.5 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 3.1 0.1 0.1 1.0 0.0 6.6 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.4 1.0 0.0 0.0 0.6 0.4 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.3 0.9 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.9 1.0 0.8 0.9 3.7 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005551.1 ENSG00000284638 19 3482804-3483446 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "intestine: 15.0;retina: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.6;CAPAN-2: 1.1;HEL: 1.0;OE19: 2.8;PC-3: 1.5;U-937: 2.7" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.0 0.8 0.0 2.6 0.0 0.0 0.0 0.3 6.0 0.0 1.3 15.0 0.0 1.9 0.0 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 22.4 0.0 0.6 0.0 0.0 8.9 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005697.1 ENSG00000266202 17 27798806-27893365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enriched" "Detected in single" 15 "SCLC-21H: 1.5" HPA023051 Uncertain NA NA "HPA023051: AB_10602333" "unprognostic (1.92e-2)" 2.7 1.7 5.1 1.3 8.7 1.3 2.1 4.0 11.8 1.9 1.9 2.0 3.2 1.3 2.4 2.9 1.7 3.2 2.0 2.0 7.0 2.5 2.0 1.5 1.4 2.0 3.1 9.1 7.2 11.5 1.3 1.5 1.3 4.9 1.6 1.7 4.1 3.5 3.1 5.9 2.2 1.8 2.0 3.0 1.4 2.5 3.1 1.0 0.3 2.1 0.9 1.5 1.9 1.7 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 8.7 4.0 11.8 7.0 2.5 3.1 9.1 4.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005702.1 ENSG00000267318 17 59940908-59973101 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 15.6" "Group enriched" "Detected in some" 26 "Alveolar cells type 2: 1.7;Ciliated cells: 2.7;Club cells: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 8.0;U-266/84: 20.2" NA NA 4.6 2.0 0.4 0.0 0.6 0.0 2.7 0.5 0.7 0.1 1.1 0.6 0.3 5.3 0.7 0.4 0.4 4.4 0.5 0.6 2.8 7.1 0.6 0.1 0.8 0.3 1.5 0.0 0.6 0.0 0.8 1.1 1.1 0.0 15.6 1.0 0.6 0.0 0.6 0.6 0.5 3.7 0.5 0.1 0.3 0.5 2.7 1.6 3.3 6.1 3.7 7.2 1.3 0.6 1.1 0.4 2.0 1.3 0.2 2.3 0.7 0.3 1.0 1.3 0.3 7.1 0.6 4.1 0.8 1.4 0.1 1.4 1.3 1.2 4.9 1.0 3.2 0.5 0.8 1.8 0.7 6.7 1.9 0.6 1.6 1.4 0.1 0.0 0.6 0.9 2.8 0.7 8.0 0.4 0.4 0.0 4.4 0.9 1.0 2.1 0.8 0.2 0.3 0.1 0.5 1.4 1.2 2.3 0.5 4.4 3.1 0.0 1.6 2.1 1.1 1.2 6.0 20.2 4.6 1.0 2.4 0.8 0.0 0.8 3.3 1.9 1.9 5.0 2.7 3.2 2.7 1.2 0.9 2.2 3.4 0.2 3.7 6.1 1.6 7.2 1.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC005726.1 ENSG00000258472 17 28455752-28614197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.8" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.4;Ciliated cells: 10.7;Club cells: 10.3;Collecting duct cells: 3.5;granulocytes: 5.8;Proximal tubular cells: 9.0;Syncytiotrophoblasts: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.5;CACO-2: 2.1;Karpas-707: 3.5;PC-3: 3.2;THP-1: 3.5" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.26e-2)" "unprognostic (1.82e-1)" "unprognostic (6.04e-3)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (7.25e-2)" "unprognostic (5.96e-2)" "unprognostic (4.58e-2)" "unprognostic (9.22e-3)" "unprognostic (3.17e-3)" "unprognostic (1.49e-4)" "unprognostic (1.25e-1)" "unprognostic (2.65e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-4)" 0.5 0.6 6.3 0.4 16.4 1.6 0.5 3.5 16.8 2.8 0.9 0.0 0.0 1.6 1.3 0.6 1.4 2.3 2.4 1.0 5.1 3.6 0.9 1.5 3.6 0.5 1.6 6.6 0.8 3.6 0.2 3.1 0.4 6.9 1.0 0.2 3.6 0.5 0.2 0.6 0.5 0.5 0.8 1.1 0.5 1.0 0.6 2.1 0.0 2.6 0.0 1.3 3.5 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.5 0.2 0.8 0.0 0.0 0.2 0.3 0.0 0.2 0.0 2.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 3.5 0.0 0.5 0.0 1.0 0.0 0.0 3.2 0.3 0.0 0.0 0.2 1.3 0.0 0.4 0.3 0.9 0.0 0.0 0.6 3.5 0.0 0.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 6.3 16.4 3.5 16.8 5.1 3.6 1.6 6.6 6.9 2.1 8.9 10.4 0.0 0.0 0.0 0.0 0.0 0.0 10.7 10.3 3.5 0.0 1.3 1.7 1.1 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 5.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.8 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 AC005837.2 ENSG00000267168 17 76732978-76738522 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;bone marrow: 2.3;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 1.2;hTEC/SVTERT24-B: 1.6;OE19: 1.3;PC-3: 1.7;RT4: 1.4;SCLC-21H: 1.0" NA NA 0.1 0.5 0.5 0.0 0.2 2.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.4 0.1 0.0 0.0 0.0 1.2 2.2 1.9 0.6 0.5 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.1 0.0 0.6 1.2 0.0 0.5 0.5 0.0 1.1 0.4 0.0 0.5 0.2 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC006518.7 ENSG00000284826 12 10881011-10884255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 913 "salivary gland: 2376.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.2;hTCEpi: 1.4;MCF7: 1.2;RT4: 1.9;SiHa: 2.1;WM-115: 1.4" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2376.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.3 0.0 0.4 1.2 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007040.2 ENSG00000258881 2 70939318-70995336 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 2.8;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 6.9;JURKAT: 5.2;U-2 OS: 4.8" NA NA "unprognostic (1.86e-1)" "unprognostic (2.94e-1)" "unprognostic (7.99e-4)" "unprognostic (1.36e-1)" "unprognostic (9.49e-2)" "unprognostic (1.78e-3)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (2.93e-1)" "unprognostic (2.53e-9)" "unprognostic (6.54e-2)" "unprognostic (7.86e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" 0.4 0.1 0.9 0.3 0.7 1.0 0.5 1.5 0.8 0.3 0.3 0.4 0.4 0.4 0.3 0.5 0.3 0.2 0.6 0.4 0.6 0.0 0.2 0.4 0.2 0.5 0.4 0.0 0.1 0.2 0.6 0.1 1.6 0.1 0.7 2.8 0.1 0.1 0.3 0.2 0.0 2.7 0.5 0.0 0.2 0.3 0.7 0.4 1.5 0.5 1.0 1.3 0.1 2.3 0.3 0.2 1.3 0.3 0.3 0.9 0.1 0.1 0.4 0.6 0.3 0.3 3.4 0.4 0.4 6.9 0.5 1.0 0.1 0.6 2.7 2.5 2.1 0.4 0.8 0.0 0.1 0.9 0.2 0.1 0.7 0.1 0.4 1.3 5.2 0.2 0.9 0.4 0.6 0.3 0.3 0.3 0.5 0.4 2.7 0.9 0.0 0.7 0.2 0.3 0.3 0.5 0.5 1.0 0.2 0.8 0.1 1.0 2.6 4.8 0.7 2.1 0.3 0.0 0.1 2.9 1.2 2.5 0.7 0.5 1.5 0.7 0.3 0.8 0.6 0.5 0.3 0.2 0.7 1.3 0.8 1.1 1.0 0.3 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC007325.1 ENSG00000276017 Unmapped 72411-74814 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 14.0" "Cell type enriched" "Detected in single" 25 "Spermatocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;ASC TERT1: 2.8;HSkMC: 4.4" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.5 0.3 0.6 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.8 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.5 0.2 0.3 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 AC007325.2 ENSG00000277196 Unmapped 138082-161852 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 12.8;skin 1: 12.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 5.1;Distal tubular cells: 6.6" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Group enriched" "Detected in some" 13 "OE19: 84.6;RPTEC TERT1: 44.7" HPA020361 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" 0.0 0.0 0.0 0.0 0.6 6.4 0.0 0.0 11.1 0.0 0.0 2.1 0.0 0.0 2.8 4.5 1.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 12.6 12.8 0.0 0.0 0.0 0.0 1.1 1.8 0.5 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.6 1.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.1 0.0 0.0 2.4 4.5 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.1 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 84.6 0.0 0.0 0.0 0.0 44.7 0.1 0.1 0.1 0.0 1.7 0.3 4.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AC007325.4 ENSG00000278817 Unmapped 131494-137392 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 15.9;skeletal muscle: 32.8" "Group enriched" "Detected in many" 16 "Early spermatids: 161.4;Late spermatids: 532.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 14.8;AN3-CA: 9.0;HEK 293: 9.5;T-47d: 10.8" NA NA 0.3 0.8 0.0 0.0 1.5 5.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 15.9 0.1 1.7 0.1 0.0 0.0 3.6 0.0 0.0 0.3 0.0 2.7 0.0 32.8 1.3 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.0 1.0 6.3 5.0 9.6 0.8 5.0 5.6 0.6 14.8 0.3 9.0 2.4 0.0 0.5 1.4 0.0 1.7 0.1 0.7 3.1 0.0 3.8 0.0 1.5 0.1 0.7 0.8 0.1 1.3 9.5 0.1 1.7 0.0 7.0 1.6 0.0 0.6 2.3 0.0 0.1 0.0 0.8 4.4 0.8 6.6 0.1 3.0 0.0 0.5 0.3 4.9 6.6 0.6 7.4 0.1 1.8 0.0 0.1 1.6 5.0 2.5 3.8 1.8 10.8 0.8 0.0 0.2 1.1 0.1 0.2 1.5 0.1 0.0 0.9 4.0 2.2 1.9 7.6 5.0 2.1 8.8 5.0 1.0 3.8 2.4 6.3 1.0 4.9 4.2 0.4 0.8 9.6 0.5 3.5 5.6 0.0 6.4 0.0 1.7 0.0 3.0 0.0 10.2 18.7 3.4 3.5 0.0 7.2 21.6 2.3 161.4 0.5 1.3 0.0 8.0 3.7 0.0 1.5 0.0 12.3 5.2 4.8 0.0 3.1 5.3 532.6 4.4 2.1 0.0 2.8 3.3 9.6 5.0 0.6 9.6 9.0 1.0 12.9 0.0 4.9 4.1 0.0 4.1 0.0 1.0 1.7 AC007326.5 ENSG00000283809 22 18906238-18947732 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 13.7;Ciliated cells: 6.7;Club cells: 19.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 81.3;NTERA-2: 26.0;SuSa: 20.6" NA NA 3.9 4.2 7.3 3.8 11.5 5.2 4.5 9.8 10.5 1.2 1.7 4.3 0.1 7.4 3.1 7.7 1.9 2.1 2.4 16.8 7.0 6.8 4.4 3.5 5.6 5.9 9.5 3.5 2.6 1.9 2.5 3.0 9.0 2.9 2.1 3.8 5.0 2.2 38.6 8.6 7.1 1.7 4.6 6.3 3.5 6.8 6.7 1.9 6.0 14.8 2.4 1.3 0.3 8.6 8.1 18.4 14.1 6.6 10.5 6.2 3.1 3.0 2.3 3.1 1.8 2.3 13.6 2.4 0.8 0.8 1.0 2.7 6.4 2.0 4.9 1.7 3.0 2.9 81.3 1.5 1.2 7.6 2.1 1.5 6.7 2.6 1.7 2.1 2.0 2.0 2.2 1.9 0.7 2.4 0.4 3.9 2.4 3.5 0.9 3.0 3.0 2.2 26.0 2.0 2.4 3.7 1.8 3.8 2.2 2.4 3.8 2.8 2.4 2.0 9.4 20.6 3.5 1.8 2.6 3.1 3.6 2.3 1.8 3.2 1.7 2.4 4.2 2.8 1.8 6.4 14.1 6.4 10.3 12.4 7.3 5.6 7.5 7.9 8.1 8.6 8.8 10.5 18.4 6.6 8.0 3.6 5.9 6.2 17.9 13.7 0.0 0.0 0.0 0.0 0.0 0.0 6.7 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007846.2 ENSG00000285471 17 5772926-6080792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 3.0;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 29.7" NA NA 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 29.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007906.2 ENSG00000277639 16 53035690-53052873 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 29.9" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 385.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 9.3;ASC TERT1: 7.9;BEWO: 12.7;HSkMC: 7.9;RPTEC TERT1: 8.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.97e-2)" "unprognostic (8.34e-3)" "unprognostic (1.63e-1)" "unprognostic (5.38e-3)" "unprognostic (1.70e-1)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (3.34e-1)" "unprognostic (2.25e-2)" "unprognostic (1.54e-2)" "unprognostic (5.02e-2)" "unprognostic (6.07e-2)" "unprognostic (5.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.02e-2)" "unprognostic (4.46e-3)" 0.0 0.0 0.0 0.0 1.7 0.0 4.3 1.0 0.0 0.4 0.0 2.8 29.9 3.4 0.0 3.8 0.0 3.0 0.0 0.0 3.7 0.0 0.0 3.1 1.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 2.7 4.5 2.3 9.3 7.9 12.7 1.3 1.0 0.1 0.0 0.3 1.8 0.2 2.3 1.8 0.8 0.7 0.0 1.7 0.5 0.2 0.1 0.0 0.1 0.6 1.8 0.0 2.0 7.9 6.8 2.5 0.8 2.6 1.8 0.1 0.1 0.1 4.1 0.1 0.1 0.0 4.9 0.4 0.6 1.1 0.0 0.0 8.1 1.7 0.2 0.0 0.3 0.0 0.1 4.0 0.9 0.1 2.1 3.0 3.0 0.1 0.0 0.0 0.0 0.0 3.6 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 385.4 55.7 24.4 0.0 0.1 5.0 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007998.2 ENSG00000267140 18 35443871-35497940 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 24.6" "Cell type enhanced" "Detected in single" 25 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.0;MAIT T-cell: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 2.0;T-cells: 2.1" "Cell line enriched" "Detected in some" 63 "HUVEC TERT2: 77.0" NA NA "unprognostic (6.67e-3)" "unprognostic (5.32e-2)" "unprognostic (2.01e-1)" "unprognostic (3.51e-2)" "unprognostic (1.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.60e-1)" "unprognostic (7.77e-2)" "unprognostic (4.11e-2)" "unprognostic (1.04e-1)" "unprognostic (2.61e-1)" 4.9 2.0 3.6 4.2 5.4 1.3 8.4 2.4 3.1 6.7 2.9 1.6 0.5 1.4 2.2 1.1 5.7 8.2 4.3 2.8 3.0 2.0 2.9 2.7 3.8 9.7 2.0 2.4 2.1 2.1 0.2 5.8 9.1 1.9 2.2 2.3 3.3 4.0 2.0 2.2 3.3 3.4 4.2 1.9 3.2 2.8 24.6 2.0 3.2 4.7 6.3 3.7 3.6 2.9 0.4 1.5 2.0 0.3 0.0 2.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 1.2 0.1 0.7 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.2 77.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.6 0.1 0.3 0.0 0.2 0.1 2.0 0.3 0.3 2.1 0.4 0.5 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 3.6 5.4 2.4 3.1 3.0 2.0 2.0 2.4 1.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC008162.2 ENSG00000278646 X 120877496-120878924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 9.3" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008397.1 ENSG00000284797 19 18249950-18255419 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "gallbladder: 19.9;intestine: 13.8;pancreas: 12.5" "Cell type enriched" "Detected in some" 5 "Collecting duct cells: 34.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 528 "OE19: 67.7" NA NA 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.5 13.8 0.0 0.0 0.0 0.0 0.0 3.4 0.2 19.9 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.0 9.4 0.2 0.0 0.0 1.7 1.1 0.0 0.0 0.1 0.5 3.5 0.4 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008397.2 ENSG00000285188 "CAMP-specific 3',5'-cyclic phosphodiesterase 4C " Q08493 19 18207961-18255419 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.4;intestine: 15.6;pancreas: 14.2" "Group enriched" "Detected in some" 8 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;U-2197: 1.6;U-87 MG: 4.8" "HPA048975, HPA054218" Uncertain Approved "Midbody ring,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.2 1.9 15.6 0.0 0.0 1.3 1.1 3.6 4.0 1.0 22.4 0.6 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.8 0.0 0.0 1.7 0.0 2.1 1.1 3.7 0.0 8.0 0.6 0.0 0.4 7.1 0.2 0.0 0.0 0.4 0.8 4.1 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.4 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.9 0.0 0.0 0.3 0.4 0.0 0.8 0.0 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.0 0.2 1.6 0.0 0.3 0.2 0.1 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008403.1 ENSG00000268465 19 48465837-48472431 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.7;intestine: 3.6;testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.8;U-698: 5.0" HPA060662 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA060662: AB_2732652" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.5 0.1 3.6 0.0 2.7 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.1 1.6 0.0 0.2 0.1 0.5 4.7 0.1 0.0 0.0 0.0 1.0 0.5 0.7 0.4 0.0 1.0 0.0 0.0 0.0 0.0 2.9 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.6 2.3 1.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 1.9 0.3 0.0 3.6 0.0 0.0 3.8 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.9 0.9 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.2 1.0 0.3 0.4 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008687.1 ENSG00000267335 19 49022953-49036895 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "pancreas: 8.2;pituitary gland: 19.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 7.4;U-251 MG: 10.6" HPA038925 Uncertain Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038925: AB_2676272" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 19.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.9 0.2 0.1 0.2 0.0 1.9 0.0 0.0 0.1 0.3 0.1 1.2 0.0 0.3 0.0 0.3 1.1 0.0 0.0 0.6 0.2 0.9 0.0 0.9 0.1 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.0 0.2 0.5 0.2 0.0 0.0 0.1 0.2 1.2 0.2 0.0 0.0 0.0 0.7 0.2 0.1 0.4 0.1 0.5 0.0 0.2 0.4 0.0 2.7 2.3 0.7 10.6 0.5 2.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC008687.4 ENSG00000268655 19 49017496-49020523 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "pancreas: 13.7" "Cell type enriched" "Detected in single" 10 "Pancreatic endocrine cells: 2.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.7;HEK 293: 4.0;SiHa: 2.7;U-2 OS: 3.1;U-251 MG: 2.7" NA NA "unprognostic (2.06e-1)" "unprognostic (7.61e-3)" "unprognostic (7.17e-3)" "unprognostic (1.12e-2)" "unprognostic (2.93e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-2)" "unprognostic (4.91e-2)" "unprognostic (3.85e-1)" "unprognostic (7.96e-4)" "unprognostic (9.37e-3)" "unprognostic (4.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.6 0.2 0.0 0.6 0.2 0.0 0.7 0.3 0.1 0.0 0.0 0.6 1.3 0.8 0.1 0.3 0.0 0.3 0.1 0.0 0.1 2.7 4.0 0.0 0.4 0.1 0.1 0.7 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.7 1.5 0.0 0.2 0.0 0.2 0.2 0.2 0.1 1.5 0.4 1.2 0.0 0.1 0.4 0.2 2.7 0.2 0.2 0.1 0.3 0.3 0.0 0.7 3.1 0.0 2.7 1.2 2.2 1.2 0.6 1.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008763.3 ENSG00000269711 19 7678501-7682854 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 51.4;bone marrow: 17.2" "Group enriched" "Detected in some" 42 "Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 6.8;granulocytes: 2.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "basal ganglia: 2.8" "Cell type enhanced" "Detected in some" "classical monocyte: 51.4;neutrophil: 22.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "EFO-21: 9.1;HMC-1: 14.6;NB-4: 8.3;THP-1: 22.4;U-937: 16.6" NA NA 0.4 0.1 0.2 3.8 2.8 17.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 6.5 0.7 0.2 0.2 0.4 1.1 0.2 0.2 0.1 0.2 1.5 6.8 0.2 0.2 0.2 0.2 0.2 0.0 0.2 1.8 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.4 1.5 0.2 0.2 2.9 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 10.6 22.2 51.4 0.1 0.3 23.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 51.4 0.3 0.0 4.5 0.0 0.0 0.1 0.0 10.6 0.0 0.0 0.3 22.2 0.1 0.4 0.4 0.2 23.0 0.2 2.8 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008878.1 ENSG00000267952 19 7507052-7519622 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 19.5;skeletal muscle: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "AF22: 9.8;ASC diff: 11.1;fHDF/TERT166: 11.9;hTERT-RPE1: 14.2;SuSa: 11.1" NA NA "unprognostic (4.56e-1)" "unprognostic (8.56e-2)" 2.1 2.0 3.1 1.2 6.3 1.6 3.5 4.9 6.8 0.4 1.9 0.9 1.2 0.4 2.6 0.4 2.5 2.2 2.0 1.5 2.2 1.8 5.4 1.5 1.9 0.6 3.9 1.0 1.7 0.4 0.4 0.6 0.9 3.3 0.8 1.7 19.5 0.7 0.6 21.3 0.9 1.7 0.7 7.1 2.4 1.2 1.0 2.5 0.0 2.0 0.0 0.4 0.9 2.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 9.8 1.1 11.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.6 0.0 1.0 2.3 6.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 14.2 4.0 0.0 0.0 0.0 2.7 0.6 0.1 0.0 0.2 2.7 0.0 2.4 3.5 1.7 3.6 0.0 0.0 3.0 1.1 1.0 0.0 11.1 0.5 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.1 6.3 4.9 5.2 2.2 1.8 3.9 1.0 3.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008878.3 ENSG00000268861 19 7382834-7472477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6" "Cell type enhanced" "Detected in single" 40 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 18.3;HL-60: 8.3;MOLT-4: 11.7;REH: 9.6;THP-1: 13.8;U-698: 10.9;U-937: 8.6" "HPA042689, HPA071867" Supported Uncertain Cytosol NA NA Cytosol "HPA042689: AB_10794385, HPA071867: AB_2686466" "unprognostic (1.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.20e-2)" "unprognostic (3.92e-2)" "unprognostic (2.45e-4)" 0.0 1.2 4.3 7.1 0.0 0.0 0.0 0.5 0.0 0.9 0.1 1.5 0.0 2.1 0.0 0.2 0.0 1.0 8.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.3 4.9 0.0 0.0 0.7 4.8 2.4 7.4 1.4 7.7 3.3 0.1 4.2 1.4 0.0 0.2 0.5 0.0 1.3 0.3 0.0 0.0 1.1 0.0 0.3 0.0 0.0 18.3 0.0 4.5 0.0 0.0 2.5 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.4 8.3 7.3 2.8 0.1 0.1 2.2 0.0 1.0 4.7 0.0 0.0 3.7 0.0 11.7 3.0 0.0 0.9 0.0 9.6 0.1 3.7 0.2 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 13.8 0.0 0.1 0.3 0.2 0.0 0.1 0.0 10.9 0.3 8.6 0.0 0.9 1.7 7.7 2.7 1.9 1.5 7.4 3.6 1.8 1.1 6.7 4.2 1.4 4.3 0.1 3.3 1.4 1.7 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC009086.2 ENSG00000277669 16 29663279-29695144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 17.3;lymphoid tissue: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 4.0;intermediate monocyte: 4.5;myeloid DC: 5.3;non-classical monocyte: 7.2;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 9 "dendritic cells: 5.3;monocytes: 7.2" "Group enriched" "Detected in some" 5 "BEWO: 19.3;EFO-21: 51.2" HPA011887 Uncertain NA NA "HPA011887: AB_2668555" 3.4 0.4 0.3 8.5 1.3 1.9 0.4 0.0 0.5 0.4 9.5 1.2 0.0 6.8 0.4 0.4 0.7 0.4 1.4 2.2 0.1 0.4 0.5 17.3 12.5 2.0 0.0 0.4 0.5 0.4 0.0 0.4 1.0 0.4 0.4 0.5 3.1 0.4 0.4 0.4 2.5 0.4 2.7 8.3 1.5 0.4 0.7 55.9 0.4 0.6 11.7 0.4 0.0 0.0 5.3 0.0 7.2 0.1 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 3.7 0.0 0.0 2.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.7 0.0 0.4 0.0 0.0 4.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.1 7.2 2.8 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC009119.2 ENSG00000260300 16 83908132-83951445 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 6.3;liver: 3.9;pancreas: 3.9" "Cell type enhanced" "Detected in single" 20 "Proximal tubular cells: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.5" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.40e-1)" "unprognostic (1.25e-2)" "unprognostic (5.29e-3)" "unprognostic (4.02e-3)" "unprognostic (2.54e-1)" "unprognostic (2.04e-1)" "unprognostic (3.36e-6)" "unprognostic (2.06e-2)" "unprognostic (6.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.72e-2)" "unprognostic (3.15e-1)" "unprognostic (2.90e-2)" "unprognostic (1.83e-1)" "unprognostic (8.56e-2)" "unprognostic (1.52e-1)" "unprognostic (6.70e-3)" 0.8 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.6 0.1 0.5 0.0 0.0 0.0 6.3 1.3 3.9 0.1 0.1 0.5 3.9 0.0 0.0 0.0 0.7 0.1 0.9 1.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 2.5 0.6 0.0 0.2 0.1 0.9 2.5 2.2 2.1 1.5 0.0 3.5 0.9 1.1 0.7 0.5 0.0 1.8 0.0 3.1 0.7 4.3 1.1 0.8 0.7 0.8 0.1 2.4 0.6 1.0 2.9 4.5 1.4 2.0 0.0 0.8 0.3 0.1 1.4 0.7 1.2 1.1 0.2 1.3 1.4 0.2 1.9 2.0 4.0 0.0 1.8 1.3 0.5 1.1 0.0 1.1 0.1 2.8 1.8 3.8 3.0 4.1 3.8 0.0 2.6 0.4 1.0 0.0 2.3 0.5 1.6 0.7 0.2 2.7 2.5 0.2 0.7 0.1 0.6 0.0 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC009477.2 ENSG00000284479 2 131035092-131035262 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "adipose tissue: 8.5;brain: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BJ: 2.9;HaCaT: 3.5;HEK 293: 5.2" NA NA 8.5 0.9 7.3 0.9 11.6 0.9 0.9 0.0 18.5 0.9 2.0 4.0 0.0 0.9 0.9 1.2 0.9 0.9 1.2 0.9 8.1 1.1 0.9 0.9 0.9 1.3 9.7 0.9 0.9 0.9 1.0 0.9 5.5 1.2 0.9 0.5 0.9 0.9 2.2 0.9 1.7 1.9 0.8 0.9 0.9 1.1 1.8 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010255.3 ENSG00000250803 "Uncharacterized protein LOC100505841 " 5 122129622-122183949 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "testis: 59.7" "Cell type enriched" "Detected in single" 63 "Ciliated cells: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;GAMG: 1.3;HUVEC TERT2: 1.7;U-2197: 1.7;U-266/84: 1.3;U-87 MG: 1.8" "Not detected" "Not detected" NA NA "unprognostic (8.24e-2)" "unprognostic (3.81e-3)" "unprognostic (3.43e-2)" "unprognostic (1.42e-1)" "unprognostic (8.28e-2)" "unprognostic (1.76e-1)" "unprognostic (4.18e-1)" "unprognostic (5.54e-2)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.0 0.1 2.2 0.0 1.7 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.7 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 3.0 0.0 0.0 0.1 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 1.7 0.1 0.0 1.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010319.2 ENSG00000269035 19 17436611-17460804 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "retina: 41.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.3;HHSteC: 1.0;THP-1: 1.2" HPA041580 Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700" 0.9 0.2 0.4 0.1 0.5 0.1 0.3 0.1 0.5 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.3 0.5 0.4 0.1 0.1 0.3 0.1 0.2 0.0 0.7 0.1 0.1 0.3 0.1 1.2 0.1 0.1 41.6 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.5 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010325.1 ENSG00000261341 19 50776141-50793142 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 51.5" "Group enriched" "Detected in some" 5 "Club cells: 1.2;Exocrine glandular cells: 1.6;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 6.7;HEK 293: 9.0" "Low region specificity" "Detected in many" NA NA "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (2.63e-2)" "unprognostic (2.47e-1)" "unprognostic (9.62e-3)" "unprognostic (9.41e-2)" "unprognostic (1.11e-2)" "unprognostic (5.95e-3)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.52e-1)" "unprognostic (5.32e-7)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.37e-3)" "unprognostic (3.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.7 0.4 1.6 1.1 2.2 0.8 0.8 0.0 6.7 2.1 0.0 0.0 1.3 2.1 0.0 4.0 3.1 0.0 0.3 0.2 0.5 0.7 0.6 1.4 0.4 0.0 0.0 1.4 9.0 0.5 0.0 0.8 0.0 0.6 0.8 0.0 0.0 1.6 4.7 0.5 1.8 1.0 1.9 4.2 0.6 1.0 0.8 0.2 5.0 0.0 0.7 0.5 4.0 1.0 0.4 1.3 0.8 0.6 0.5 0.0 0.0 0.6 0.5 0.4 0.0 0.0 2.1 3.0 0.2 0.3 3.0 0.7 1.5 1.1 2.1 0.0 1.6 0.0 2.2 0.2 1.0 0.3 1.3 2.2 2.6 1.6 0.8 0.6 0.4 1.1 0.4 2.7 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC010531.1 ENSG00000131152 16 87302876-87334273 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 5.0;U-266/70: 6.7" HPA040850 Approved NA NA "HPA040850: AB_10794882" "unprognostic (1.44e-1)" "unprognostic (5.07e-2)" "unprognostic (3.15e-2)" "unprognostic (2.89e-1)" "unprognostic (1.69e-1)" "unprognostic (1.98e-1)" "unprognostic (4.72e-3)" "unprognostic (1.56e-1)" "unprognostic (9.65e-2)" "unprognostic (5.23e-2)" "unprognostic (1.61e-1)" "unprognostic (1.94e-1)" "unprognostic (9.21e-3)" "unprognostic (7.78e-2)" "unprognostic (2.14e-1)" "unprognostic (4.35e-2)" "unprognostic (3.72e-3)" 1.1 0.5 0.3 0.2 0.4 1.2 1.2 1.8 0.9 0.6 0.9 2.3 1.4 0.0 1.1 1.2 1.0 1.2 0.3 0.4 0.7 2.4 0.4 1.8 0.6 1.7 1.1 0.0 1.6 1.3 1.3 0.3 0.5 0.6 6.8 0.5 1.0 0.7 0.2 0.7 0.6 2.0 0.5 0.6 0.8 1.0 0.8 0.0 0.0 0.0 0.1 0.3 0.0 0.9 0.4 0.3 0.0 4.0 1.7 0.3 0.3 0.0 0.7 0.2 1.1 0.0 3.1 0.7 3.3 0.1 3.1 0.8 0.0 0.4 0.7 2.5 5.0 0.3 3.4 2.0 0.0 0.6 0.0 0.0 0.0 0.6 0.8 1.5 0.7 4.4 0.7 0.0 1.1 1.7 3.7 1.1 0.9 0.7 1.5 0.2 3.2 0.0 0.1 2.6 0.7 1.7 0.5 1.0 0.4 0.4 0.0 0.0 2.2 0.3 0.0 0.6 6.7 2.0 2.3 0.4 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010616.1 ENSG00000268041 19 41907705-41928516 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 5.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 9.8;HMC-1: 7.2;U-2 OS: 4.4;U-266/70: 3.8;U-698: 5.9;U-937: 4.2" "Low region specificity" "Detected in some" NA NA "unprognostic (1.97e-1)" "unprognostic (1.84e-3)" "unprognostic (3.88e-4)" "unprognostic (3.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.75e-2)" "unprognostic (6.71e-2)" "unprognostic (1.12e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-2)" "unprognostic (3.42e-1)" "unprognostic (1.57e-1)" "unprognostic (1.21e-14)" "unprognostic (5.11e-1)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (9.98e-3)" 0.0 0.0 2.4 1.2 0.0 0.2 0.0 0.4 0.2 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.8 0.7 0.0 2.4 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.1 0.7 0.4 0.0 0.3 0.2 0.3 0.3 0.0 0.8 9.8 0.3 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.4 7.2 0.1 0.4 0.4 0.2 0.3 0.0 1.5 0.3 0.5 0.0 1.0 0.0 0.0 0.0 0.7 0.3 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 4.4 0.2 0.0 3.8 0.2 5.9 0.2 4.2 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC010646.1 ENSG00000269095 19 17235940-17255448 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 11.6;EFO-21: 3.4" NA NA 0.3 0.4 0.7 0.0 0.3 0.0 0.3 0.3 0.3 0.2 0.9 2.0 0.2 3.0 0.5 0.4 0.0 0.3 0.2 0.5 0.3 1.2 1.1 0.0 0.6 0.2 1.3 0.7 0.3 0.9 0.3 1.0 0.2 0.2 0.3 2.5 0.6 0.8 0.2 0.3 1.9 0.3 0.5 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.7 1.1 1.1 0.6 0.0 11.6 0.4 0.6 0.3 0.0 0.6 1.5 0.2 3.4 0.5 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.3 1.1 0.0 0.3 0.6 0.5 0.7 1.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.4 0.0 0.1 0.7 0.3 0.0 0.8 0.3 1.6 0.5 1.6 0.0 0.3 1.1 1.0 1.5 0.5 0.4 0.5 0.2 0.4 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011005.1 ENSG00000230626 7 129126518-129130793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 7.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.7;MCF7: 2.3;RT4: 1.9" HPA051993 Uncertain Approved Cytosol NA NA Cytosol "HPA051993: AB_2681685" "unprognostic (2.03e-1)" "unprognostic (7.97e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-3)" "unprognostic (1.58e-1)" "unprognostic (2.67e-3)" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (3.11e-2)" "unprognostic (3.61e-1)" "unprognostic (2.60e-2)" "unprognostic (3.01e-1)" "unprognostic (1.06e-1)" "unprognostic (4.36e-5)" "unprognostic (3.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.6 0.4 0.9 0.3 0.7 0.6 0.1 0.2 0.6 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 1.7 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.5 0.0 2.3 0.4 0.1 0.2 0.1 0.5 0.2 0.0 0.0 0.0 1.9 0.3 0.1 0.0 0.0 0.8 0.1 0.0 0.7 0.0 0.2 0.0 0.9 0.3 0.2 0.1 0.3 0.4 0.0 0.0 0.5 0.3 0.9 0.3 0.3 0.5 0.4 0.3 0.6 0.4 0.6 0.4 0.4 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011043.2 ENSG00000278198 Unmapped 173872-179372 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 1.2;skin 1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 6.4;NB-4: 5.5" NA NA 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.1 1.1 0.3 0.9 0.2 0.1 1.8 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.7 0.0 6.4 0.4 1.8 2.5 0.5 0.1 1.7 0.9 0.6 0.7 1.4 2.7 0.6 0.1 0.4 0.2 1.8 2.0 1.7 0.5 1.9 1.4 2.0 1.2 1.7 2.5 0.1 2.5 2.8 0.0 0.9 0.6 1.2 0.9 0.3 1.8 0.5 2.1 0.9 0.4 0.6 5.5 1.2 0.5 0.1 0.1 0.4 0.0 0.3 0.3 0.6 0.3 0.3 0.2 1.2 1.2 0.2 1.2 0.1 1.2 0.5 0.5 1.3 0.6 0.5 0.1 0.6 1.8 1.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011195.2 ENSG00000266826 17 58660424-58692018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 48.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;BEWO: 1.0" "HPA000634, HPA001004" Uncertain Approved Microtubules NA NA Microtubules "HPA000634: AB_1079102, HPA001004: AB_1079104" "unprognostic (3.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.37e-1)" "unprognostic (8.67e-2)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 48.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.0 3.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011448.1 ENSG00000258674 19 19516227-19536076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.4" "Group enriched" "Detected in some" 137 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 14.5;Ciliated cells: 22.7;Club cells: 17.0;granulocytes: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 21.2" NA NA "unprognostic (8.39e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-3)" "unprognostic (5.40e-3)" "unprognostic (1.61e-1)" "unprognostic (2.85e-2)" "unprognostic (1.77e-2)" "unprognostic (2.46e-1)" "unprognostic (1.16e-2)" "unprognostic (1.41e-2)" "unprognostic (6.73e-5)" "unprognostic (7.15e-2)" "unprognostic (5.78e-2)" "unprognostic (1.62e-2)" "unprognostic (3.46e-1)" "unprognostic (5.89e-2)" "unprognostic (2.89e-2)" 5.9 7.9 9.7 7.4 19.9 8.7 3.8 12.4 13.5 4.1 6.0 3.6 7.8 6.7 4.5 13.8 4.8 5.6 5.9 35.1 11.0 7.0 5.8 7.2 4.6 6.0 9.6 10.9 5.0 8.3 5.3 5.3 5.6 9.7 6.0 4.9 4.3 8.7 7.3 41.4 10.4 9.7 5.5 6.2 6.9 7.1 9.8 7.6 3.1 5.2 13.9 3.8 4.8 4.5 8.8 8.1 7.2 9.4 4.7 10.0 13.3 2.6 2.6 3.0 2.2 1.9 2.2 21.2 1.5 2.1 1.8 1.9 3.5 4.9 3.2 7.1 1.3 1.3 4.0 1.4 1.4 0.5 2.4 12.0 1.4 2.3 1.1 2.1 1.4 3.3 1.6 1.4 2.1 0.5 0.7 1.1 2.9 3.7 2.8 1.0 4.6 1.5 5.8 11.9 2.1 6.7 6.6 1.5 2.0 2.0 2.5 2.2 3.9 2.0 0.9 2.1 1.1 3.5 5.4 1.2 3.6 3.9 8.0 3.3 8.4 3.7 2.6 1.8 6.0 1.9 7.2 8.9 6.7 5.9 9.4 5.1 8.8 7.7 6.3 8.1 7.8 6.7 6.8 2.8 4.7 7.6 6.7 10.0 13.3 9.7 19.9 12.4 12.4 11.0 7.0 9.6 10.9 9.7 7.6 14.9 14.5 0.0 0.0 0.0 0.0 0.0 0.0 22.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011455.2 ENSG00000269547 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;ovary: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.7;A549: 5.2;AN3-CA: 2.8;T-47d: 4.4;U-251 MG: 6.4" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 1.3 2.6 0.3 1.7 0.3 0.0 0.1 0.4 1.1 0.3 0.1 0.0 1.2 0.5 0.1 0.4 0.8 1.1 0.1 0.1 1.6 1.1 0.2 0.0 0.2 3.0 0.6 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.2 0.0 2.8 0.9 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.5 0.3 1.2 0.5 0.5 0.0 1.2 0.3 2.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.2 0.0 1.4 1.4 0.0 6.4 0.0 0.6 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011462.1 ENSG00000255730 19 41350853-41425001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.8" "Group enriched" "Detected in some" 18 "Alveolar cells type 2: 1.7;Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Region enhanced" "Detected in all" "basal ganglia: 19.9" "Cell type enhanced" "Detected in many" "classical monocyte: 24.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 9.3;SK-MEL-30: 8.3;THP-1: 14.7" "Low region specificity" "Detected in all" HPA036640 Approved NA NA "HPA036640: AB_10671964" "unprognostic (9.81e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (2.65e-1)" "unprognostic (3.39e-2)" "unprognostic (1.45e-1)" "unprognostic (3.73e-2)" "unprognostic (2.18e-8)" "unprognostic (8.91e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (2.97e-2)" 5.0 5.8 1.7 6.2 19.9 10.5 3.6 1.5 8.0 6.6 3.5 0.8 0.6 1.3 5.4 2.1 3.9 5.3 0.7 3.1 1.5 2.6 4.7 3.3 5.9 3.8 2.4 2.9 3.1 3.5 3.3 3.1 2.5 3.1 5.5 0.7 2.3 1.7 1.9 9.0 9.2 1.9 5.4 2.3 4.5 2.5 7.3 2.6 0.0 2.9 1.7 3.2 10.5 7.5 1.0 11.8 8.2 24.8 1.4 5.6 15.7 3.0 0.0 5.9 2.5 1.6 0.2 1.7 1.7 1.4 0.8 0.0 0.0 3.9 0.0 3.2 2.1 1.9 0.1 0.0 0.9 1.2 1.6 1.6 3.9 0.1 1.1 4.8 0.7 0.4 3.8 3.6 1.5 7.6 9.3 2.8 0.0 0.9 5.6 0.0 0.0 4.2 5.1 0.8 0.0 0.0 1.7 0.0 0.3 0.5 0.0 0.0 3.7 0.8 0.0 8.3 2.8 1.1 14.7 0.5 0.0 2.8 0.4 0.0 4.7 0.0 0.1 1.8 3.8 0.1 6.2 24.8 1.5 3.9 9.2 4.3 0.6 3.7 2.9 11.8 1.0 5.6 3.1 8.2 1.4 7.2 8.1 4.0 15.7 1.7 19.9 1.5 5.0 1.5 2.6 2.4 2.9 3.1 2.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011479.1 ENSG00000267748 19 38289151-38304910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 14.9;pancreas: 6.4;salivary gland: 15.1" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 5.3;Club cells: 7.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 4.5;CAPAN-2: 3.7;SK-BR-3: 8.8;U-266/84: 4.8" NA NA "unprognostic (1.48e-2)" "unprognostic (7.63e-2)" "unprognostic (8.91e-3)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-1)" "unprognostic (4.78e-2)" "unprognostic (1.12e-1)" "unprognostic (7.66e-2)" "unprognostic (2.00e-1)" "unprognostic (3.94e-2)" "unprognostic (4.41e-2)" "unprognostic (2.40e-1)" "unprognostic (3.56e-1)" 0.0 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.9 1.4 2.5 0.2 1.7 1.9 0.0 0.1 0.0 0.0 0.0 2.8 0.0 1.0 0.1 0.0 2.5 6.4 0.0 2.1 1.2 2.1 0.5 15.1 0.9 0.0 2.2 1.1 0.0 0.0 0.3 1.9 0.6 2.9 0.0 0.6 1.2 4.6 14.9 14.5 2.9 0.3 2.9 5.2 4.5 2.0 0.0 0.3 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.3 0.0 0.4 1.4 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.0 0.0 1.4 0.0 0.0 0.0 2.8 0.2 1.2 1.4 1.9 0.6 3.1 0.0 0.0 0.9 1.6 0.0 0.0 0.7 8.8 0.0 0.4 1.4 2.6 1.2 0.0 0.0 0.0 0.0 1.1 4.8 0.2 0.0 0.0 0.6 11.1 2.9 14.5 0.1 1.7 0.2 3.3 1.4 0.5 11.7 4.6 2.9 2.5 1.6 0.3 1.6 14.9 0.4 5.2 26.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.9 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 AC011530.1 ENSG00000268434 19 45779437-45785973 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 4.2;lymphoid tissue: 3.1;skeletal muscle: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.6;HBEC3-KT: 4.0;SuSa: 3.1;T-47d: 2.0;U-937: 2.8" NA NA "unprognostic (3.77e-2)" "unprognostic (2.87e-1)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" 0.1 0.8 0.0 3.1 0.1 0.0 0.0 0.1 0.5 0.3 0.9 0.0 0.8 4.2 0.0 0.4 0.0 2.4 0.0 0.0 0.2 0.2 0.9 0.3 0.0 0.2 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.0 3.4 0.0 0.2 0.0 0.1 0.0 0.4 0.8 0.0 0.7 0.3 0.2 0.1 0.3 0.0 0.0 0.0 1.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 1.0 0.8 0.4 4.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 2.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 1.4 0.3 1.7 2.8 1.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.3 0.1 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011604.2 ENSG00000257046 12 20815674-21090245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "breast: 22.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.9;A549: 2.4;CAPAN-2: 4.0;GAMG: 2.4;HeLa: 6.6;PC-3: 1.5;U-2 OS: 2.2" HPA050892 Uncertain NA NA "HPA050892: AB_2681265" "unprognostic (2.74e-1)" "unprognostic (1.39e-3)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.7 0.0 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC011841.1 ENSG00000273496 Unmapped 99351-104855 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 1.2;skin 1: 1.8" "Cell type enriched" "Detected in single" 7 "Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 6.4;NB-4: 5.5" NA NA 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.1 1.1 0.3 0.9 0.2 0.1 1.8 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.7 0.0 6.4 0.4 1.8 2.5 0.5 0.1 1.7 0.9 0.6 0.7 1.4 2.7 0.6 0.1 0.4 0.2 1.8 2.0 1.7 0.5 1.9 1.4 2.0 1.2 1.7 2.5 0.1 2.5 2.8 0.0 0.9 0.6 1.2 0.9 0.3 1.8 0.5 2.1 0.9 0.4 0.6 5.5 1.2 0.5 0.1 0.1 0.4 0.0 0.3 0.3 0.6 0.3 0.3 0.2 1.2 1.2 0.2 1.2 0.1 1.2 0.5 0.5 1.3 0.6 0.5 0.1 0.6 1.8 1.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012309.1 ENSG00000267360 19 37093019-37210512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;thyroid gland: 2.7" "Cell type enhanced" "Detected in single" 32 "Club cells: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.2;hTERT-RPE1: 2.2;LHCN-M2: 1.9;MOLT-4: 1.6;SCLC-21H: 2.5" NA NA "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (7.33e-2)" "unprognostic (1.96e-1)" "unprognostic (2.68e-1)" "unprognostic (2.08e-1)" "unprognostic (3.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.09e-4)" "unprognostic (5.94e-2)" "unprognostic (1.68e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-1)" 1.1 0.0 0.6 0.0 1.0 0.2 0.2 0.6 2.6 0.9 0.6 0.0 0.5 0.0 0.0 0.4 1.5 1.1 0.6 0.3 0.1 0.0 0.1 1.7 0.7 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.5 1.2 0.1 0.0 0.4 0.4 0.3 1.3 2.7 0.0 0.2 0.3 0.8 0.2 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 1.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012476.1 ENSG00000285396 15 40695129-40732158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 19.5;testis: 16.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039310 Approved Approved "Nucleoli rim,Cytosol" NA NA "Nucleoli rim" Cytosol "HPA039310: AB_2676434" 0.4 0.8 0.0 4.2 0.0 0.9 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.8 2.1 0.2 1.4 0.9 0.0 0.2 0.3 0.8 0.9 0.0 0.0 0.3 0.5 0.9 0.0 3.9 0.0 0.1 0.0 0.0 0.3 0.0 1.8 0.9 1.2 0.0 0.2 3.0 1.6 16.7 0.0 19.5 0.1 2.1 6.1 0.0 0.0 1.3 1.0 2.3 0.4 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.5 1.2 0.2 1.0 0.2 1.1 0.3 0.4 1.3 0.2 0.3 2.3 1.2 0.1 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC012531.3 ENSG00000273049 12 53985845-54034888 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 8.6;kidney: 24.3;skeletal muscle: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.5" "Lineage enriched" "Detected in single" 26 "T-cells: 2.5" "Cell line enhanced" "Detected in some" "AN3-CA: 13.6;fHDF/TERT166: 3.2;HDLM-2: 5.0" NA NA 8.6 0.9 0.1 0.1 0.2 0.0 1.2 0.1 0.1 1.0 0.4 0.0 0.0 0.2 2.0 4.5 0.8 2.8 0.0 0.4 0.1 0.1 24.3 0.3 0.3 1.2 0.1 0.0 3.2 0.5 0.8 0.2 1.1 0.1 0.7 0.0 0.0 0.3 0.0 10.3 0.8 1.2 1.3 0.4 0.3 0.7 1.1 0.0 0.0 0.4 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.6 0.9 0.0 13.6 1.1 0.0 0.0 0.2 0.2 0.7 0.2 0.0 1.2 0.0 0.3 3.2 0.1 1.5 0.0 0.0 0.0 5.0 0.0 0.0 0.3 0.3 0.3 0.0 0.4 0.4 0.0 0.4 0.4 0.0 0.0 0.2 0.2 0.0 1.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.7 0.1 0.3 1.3 0.3 2.5 0.1 0.0 0.8 1.9 1.3 0.3 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC013394.1 ENSG00000279765 15 92883413-92949230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 28.4;lymphoid tissue: 23.7" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.1;Ciliated cells: 6.7;Club cells: 6.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (7.26e-3)" "unprognostic (1.34e-1)" "unprognostic (1.53e-3)" "unprognostic (1.42e-1)" "unprognostic (2.84e-2)" "unprognostic (8.97e-2)" "unprognostic (4.62e-2)" "unprognostic (9.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.12e-2)" "unprognostic (2.33e-2)" "unprognostic (1.46e-6)" "unprognostic (2.74e-1)" "unprognostic (3.13e-1)" "unprognostic (2.94e-2)" "unprognostic (3.12e-2)" 2.2 2.7 2.7 1.7 4.2 28.4 6.3 3.6 7.3 3.4 3.9 3.1 0.5 1.8 3.3 3.7 2.9 2.8 2.9 5.3 5.8 3.9 2.5 4.6 3.8 2.2 6.2 4.3 6.8 3.5 4.2 3.5 4.8 3.9 3.5 2.4 3.1 3.5 4.9 2.8 4.0 2.9 1.1 23.7 2.1 20.7 3.1 1.0 7.2 2.1 3.6 2.8 0.5 11.4 4.8 8.8 1.5 2.6 4.3 0.8 10.7 8.4 32.0 20.5 9.9 13.1 23.4 10.6 19.1 17.1 12.8 8.5 25.1 11.4 10.7 13.7 12.9 16.8 13.4 10.9 17.1 0.0 13.2 20.0 16.8 8.1 20.7 10.5 13.3 13.8 16.1 6.3 32.3 24.9 16.0 15.3 20.5 33.2 18.8 11.5 12.3 16.4 27.9 23.8 7.2 17.6 16.1 24.4 24.1 20.9 17.0 19.4 22.8 16.5 38.5 31.4 38.2 24.3 11.1 12.8 9.9 9.9 23.2 24.2 28.7 24.2 9.9 20.3 14.7 8.6 1.1 3.5 3.2 0.9 2.8 11.4 3.4 3.1 1.0 5.0 4.3 3.1 8.8 2.6 1.5 4.8 3.7 0.8 6.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 6.8 1.8 0.0 1.6 3.3 0.9 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.0 3.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 AC013470.2 ENSG00000226690 7 12469621-12542222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.7;epididymis: 6.3;fallopian tube: 10.6" "Group enriched" "Detected in some" 16 "Ciliated cells: 42.8;Club cells: 13.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 4.8;hTCEpi: 3.0;Karpas-707: 2.1;U-266/70: 2.4" NA NA "unprognostic (3.89e-1)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "unprognostic (1.48e-1)" "unprognostic (8.16e-2)" "unprognostic (1.53e-4)" "unprognostic (1.14e-3)" "unprognostic (3.62e-3)" "unprognostic (7.82e-3)" "unprognostic (3.61e-1)" "unprognostic (8.04e-2)" "unprognostic (8.40e-2)" "unprognostic (1.98e-1)" "unprognostic (2.88e-2)" "unprognostic (2.67e-1)" 0.1 0.1 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.7 6.3 0.0 10.6 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 2.8 0.4 0.0 1.1 0.1 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.7 0.0 0.2 0.0 0.0 0.1 0.0 0.9 0.7 2.3 0.5 0.8 0.4 0.0 0.1 0.2 1.0 0.4 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.2 1.1 0.1 0.2 0.1 0.0 0.2 4.8 0.0 0.0 0.1 0.1 0.0 0.9 0.6 0.0 1.1 0.2 0.1 3.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.2 1.6 0.0 0.0 0.3 0.1 0.4 0.0 0.5 1.2 0.1 0.0 0.3 0.2 1.4 0.2 0.3 0.0 0.5 0.6 0.0 0.0 2.4 0.1 0.0 0.2 0.0 0.0 2.3 0.5 0.3 0.3 0.2 0.4 0.8 0.3 0.3 0.2 0.9 0.4 0.3 1.8 0.8 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.8 13.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC015802.6 ENSG00000284526 17 76563710-76570544 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 16.5;testis: 25.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 5.6;Ciliated cells: 14.7;Club cells: 7.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.7 1.7 0.7 1.3 0.7 2.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 1.2 1.0 0.7 2.3 0.1 1.0 3.3 0.7 0.7 0.7 1.4 1.1 0.7 0.7 1.4 4.6 0.0 0.7 0.8 0.7 0.7 0.0 0.9 4.4 0.7 10.2 7.3 0.7 0.7 0.7 0.9 1.8 25.2 0.7 0.7 1.7 0.7 0.7 1.5 0.7 8.2 5.0 14.2 6.1 4.9 16.5 6.1 6.7 5.4 4.4 9.6 0.0 0.0 5.9 3.0 0.0 0.0 0.0 11.5 5.3 7.2 3.7 0.0 3.4 7.2 0.0 0.3 0.0 1.8 6.2 10.1 4.3 26.4 0.0 9.4 6.6 0.0 0.5 0.0 0.0 6.4 0.0 4.3 8.4 8.3 0.0 9.3 8.1 16.5 7.6 7.7 6.8 4.8 12.0 6.7 0.1 6.4 9.4 11.8 4.1 22.0 31.9 9.4 16.0 8.1 4.7 13.0 9.0 8.8 12.9 10.6 4.2 6.0 7.6 7.4 15.7 0.8 5.8 1.5 10.1 6.1 16.5 8.2 11.0 11.0 5.0 5.8 10.2 10.4 14.2 4.9 3.5 4.9 5.5 6.1 14.9 5.6 0.0 0.0 0.0 0.0 0.0 0.0 14.7 7.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC018554.3 ENSG00000278499 "Putative UPF0607 protein ENSP00000381418 " A8MU76 16 60358455-60359480 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "skeletal muscle: 1.9;testis: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 2.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC018709.1 ENSG00000272297 4 186426546-186555328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "testis: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 6.8;OE19: 3.6;T-47d: 3.5" NA NA 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC018755.2 ENSG00000268500 19 51612091-51646889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 50.4;bone marrow: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 50.4" "Group enriched" "Detected in many" 5 "granulocytes: 50.4;monocytes: 17.5" "Group enriched" "Detected in some" 11 "HMC-1: 41.2;U-937: 16.7" HPA009085 Approved NA NA "HPA009085: AB_1079965" 1.0 0.4 0.4 5.9 0.1 20.8 0.3 0.0 0.4 0.7 0.3 0.4 0.2 0.0 0.6 1.4 0.6 0.6 0.1 0.1 0.3 0.9 1.9 2.0 0.2 0.1 0.3 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.3 0.3 0.1 0.2 0.7 3.0 0.3 0.0 0.2 0.1 1.5 0.3 0.8 6.2 50.4 17.5 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 16.7 0.0 2.6 8.9 0.2 0.0 9.1 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 50.4 0.2 17.5 1.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC019117.3 ENSG00000283321 7 17299295-17467234 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 9.9;urinary bladder: 21.3" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Club cells: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 35.1" HPA029722 Uncertain NA NA "HPA029722: AB_10599189" 2.8 0.1 0.0 1.5 0.0 0.6 1.3 0.0 2.2 9.9 0.9 0.0 0.5 0.3 1.7 0.8 1.3 2.2 1.6 0.7 0.0 1.0 1.8 2.5 4.8 0.0 0.0 1.1 4.1 0.0 0.0 3.3 0.4 1.6 0.3 0.7 0.8 3.9 0.0 0.5 0.1 4.8 1.3 1.8 1.1 0.4 0.3 0.3 0.6 2.4 1.3 21.3 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 7.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.3 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC020909.1 ENSG00000142539 19 50415799-50428409 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.3;intestine: 2.6;lymphoid tissue: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 2.5;naive B-cell: 1.3;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 21 "B-cells: 2.5;dendritic cells: 5.3" "Cell line enhanced" "Detected in some" "REH: 6.9;U-2 OS: 2.7;U-266/70: 3.8;U-698: 5.6" HPA018523 Uncertain NA NA "HPA018523: AB_1857443" 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 6.0 0.1 0.1 0.0 0.0 0.0 0.0 2.5 5.3 0.1 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 1.2 0.0 0.0 0.1 0.6 0.0 0.1 0.0 6.9 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.4 0.0 3.8 0.6 5.6 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC021072.1 ENSG00000283536 12 53241889-53245134 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "retina: 24.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 1.4;NTERA-2: 2.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC021097.2 ENSG00000285480 7 151207837-151210378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 9.2;U-266/84: 6.0" HPA043013 Uncertain NA NA "HPA043013: AB_2678269" 1.0 0.2 0.2 0.5 1.2 0.0 0.2 0.0 0.0 1.5 0.0 0.6 0.0 1.1 0.0 0.0 0.0 1.0 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 8.0 0.0 0.5 1.2 0.0 0.1 0.0 0.2 0.0 0.5 0.1 0.8 0.4 0.0 0.5 0.0 0.0 0.8 0.0 0.6 2.0 2.3 0.0 0.7 0.3 0.3 0.0 1.9 1.2 1.4 0.7 0.5 0.0 0.0 0.0 0.5 0.0 1.0 3.6 0.4 0.4 0.0 1.0 0.5 1.9 2.6 0.4 0.0 3.4 0.6 0.8 0.8 0.3 3.0 0.0 0.5 0.2 0.2 0.2 0.1 1.2 0.8 0.0 1.1 0.0 0.0 0.4 0.0 0.4 0.0 1.5 0.0 0.0 2.3 1.0 0.0 0.4 1.2 0.2 9.2 6.0 0.3 0.7 2.9 0.2 0.0 0.3 0.0 0.2 0.4 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.5 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC022167.5 ENSG00000283516 16 8881634-8885351 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.1 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 1.7 0.4 0.1 0.1 0.1 0.1 17.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.4 1.6 3.5 1.4 2.0 1.2 0.6 0.8 0.5 0.0 0.7 0.0 0.4 2.9 0.5 0.0 0.0 0.0 0.3 1.5 0.7 0.6 0.0 0.7 0.9 0.0 0.5 0.0 1.9 0.0 1.0 1.8 1.0 0.0 0.8 1.3 0.2 0.3 1.3 0.6 0.4 0.0 2.3 0.8 2.7 0.4 1.3 1.4 1.8 0.0 0.9 0.7 1.0 0.6 1.3 0.4 1.4 0.7 0.3 0.5 1.3 0.1 0.5 1.5 0.2 1.3 0.8 2.5 0.0 0.5 1.8 2.5 0.3 0.3 0.5 0.3 3.5 1.4 0.9 1.2 0.8 1.2 1.5 1.1 0.8 0.3 2.4 1.2 1.2 3.3 2.0 0.7 1.6 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC022414.1 ENSG00000284762 "High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform 11 " 5 77086732-77427124 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.2;HeLa: 12.6;SCLC-21H: 4.5;SK-BR-3: 5.3" HPA036912 Supported NA NA "HPA036912: AB_10670377" 2.9 1.1 3.8 0.8 5.3 0.0 1.5 2.1 5.6 2.6 0.2 7.2 0.9 0.1 4.0 3.9 0.2 4.8 1.0 2.9 3.8 2.0 0.4 0.7 0.0 8.9 1.6 1.6 1.7 0.3 2.0 3.2 4.5 3.6 0.4 1.5 0.9 3.2 0.0 0.0 0.0 3.7 4.3 0.0 0.6 0.6 6.6 0.6 27.1 0.0 0.3 0.1 1.2 0.0 0.8 0.0 0.4 0.6 0.6 0.0 0.2 4.2 0.5 1.4 3.2 0.0 0.0 0.0 1.6 0.5 0.6 0.3 0.3 0.0 1.0 0.0 0.1 0.0 0.6 0.0 0.2 0.0 0.7 0.2 12.6 0.1 0.2 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 1.4 0.0 0.7 0.0 1.1 0.6 0.1 0.8 0.0 0.2 1.0 0.3 0.0 0.3 0.0 4.5 0.9 2.9 5.3 0.8 0.2 2.0 0.1 0.0 0.1 0.5 0.0 0.2 0.4 0.5 0.8 0.2 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC022506.1 ENSG00000285133 12 57517712-57520480 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 4.6;neutrophil: 17.4" "Lineage enriched" "Detected in single" 19 "granulocytes: 17.4" "Cell line enriched" "Detected in some" 14 "U-266/70: 24.6" "Not detected" "Not detected" NA NA 9.9 1.6 2.5 8.2 6.0 1.6 3.8 2.6 4.8 2.2 1.8 3.5 2.4 1.6 2.2 3.0 1.7 1.6 1.6 1.6 3.1 2.4 1.6 5.5 1.6 7.1 2.4 3.9 1.6 1.6 1.9 1.6 6.5 4.2 1.6 5.3 3.6 1.6 36.7 1.6 10.9 2.3 3.6 2.4 12.0 2.2 7.3 0.0 15.0 1.6 1.6 6.0 2.7 0.4 0.0 17.4 0.5 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 24.6 0.0 0.0 0.0 1.7 0.0 4.6 0.5 0.1 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 17.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC023055.1 ENSG00000257390 12 55757275-55827546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "blood: 6.4;testis: 12.9" "Group enriched" "Detected in some" 16 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 4.6;Ciliated cells: 6.7;Club cells: 2.3;granulocytes: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 6.5" "HPA017653, HPA030902, HPA030903" Uncertain Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (8.84e-4)" "unprognostic (2.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.55e-3)" "unprognostic (1.86e-1)" "unprognostic (6.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.05e-2)" "unprognostic (2.16e-2)" "unprognostic (1.16e-5)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-3)" 0.3 0.1 0.1 0.0 0.1 0.6 0.0 0.3 0.4 0.0 0.1 0.3 0.0 0.6 0.2 0.1 0.7 0.2 0.2 0.1 0.1 0.3 0.1 0.5 0.2 0.0 0.1 0.4 0.1 0.0 0.3 0.7 0.0 0.0 0.4 0.2 0.7 0.0 0.1 0.1 0.2 12.9 0.0 0.3 0.4 0.0 6.4 4.1 5.3 5.9 5.7 5.8 4.7 0.3 0.0 2.8 4.1 3.1 0.0 3.2 1.7 1.4 0.3 1.2 1.1 0.8 3.1 0.6 2.0 1.2 1.5 2.5 3.1 1.3 0.0 2.7 2.2 0.6 0.3 1.2 2.7 2.9 0.7 0.0 1.4 0.6 0.0 0.4 1.7 1.3 0.0 0.6 0.0 1.6 2.4 4.5 3.0 0.0 2.9 3.2 1.8 1.7 0.8 4.3 1.3 0.9 4.5 6.5 1.7 1.1 1.1 0.0 0.0 0.3 0.6 0.9 0.0 2.3 1.8 0.8 0.3 0.6 2.8 2.6 5.3 5.6 3.2 3.5 6.4 4.9 4.5 4.1 3.5 3.9 5.8 1.5 5.7 5.9 2.7 5.2 4.7 6.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC023491.2 ENSG00000278633 Unmapped 10598-13001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 28.4" "Cell type enriched" "Detected in single" 40 "Spermatocytes: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HEK 293: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.1 0.1 0.7 0.1 0.2 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.7 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.6 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.2 0.0 0.0 0.0 0.0 0.0 AC025165.3 ENSG00000257921 12 57773028-57787046 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 14.2;salivary gland: 16.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "ASC diff: 3.7;fHDF/TERT166: 1.7;HMC-1: 2.0;Karpas-707: 1.8;RH-30: 4.7" NA NA "unprognostic (1.28e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.88e-1)" "unprognostic (1.38e-4)" "unprognostic (3.74e-2)" "unprognostic (6.78e-4)" "unprognostic (2.19e-2)" "unprognostic (2.05e-1)" "unprognostic (8.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.55e-1)" "unprognostic (3.46e-2)" "unprognostic (6.73e-2)" "unprognostic (1.74e-2)" 3.0 1.2 1.4 0.8 1.3 0.8 3.4 1.4 1.5 2.4 1.3 0.0 2.8 0.8 3.3 2.3 1.7 0.8 2.5 0.8 0.9 1.0 3.7 1.7 2.1 3.3 1.2 0.1 3.6 14.2 0.8 0.8 0.9 0.4 2.3 2.0 1.6 16.5 5.3 0.8 0.8 0.8 2.0 2.5 0.8 1.0 1.0 0.0 0.0 2.4 1.1 1.7 2.3 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 1.4 1.5 0.9 1.0 1.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC025283.2 ENSG00000262621 16 3382113-3397745 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.8;pancreas: 3.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 2.1;Collecting duct cells: 1.8;Distal tubular cells: 5.0;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 3.6;SK-MEL-30: 4.3;U-698: 4.7" NA NA "unprognostic (1.30e-2)" "unprognostic (9.87e-3)" "unprognostic (1.83e-2)" "unprognostic (1.07e-1)" "unprognostic (3.99e-2)" "unprognostic (4.39e-2)" "unprognostic (2.39e-1)" "unprognostic (6.17e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (2.77e-3)" "unprognostic (3.75e-3)" "unprognostic (1.05e-5)" "unprognostic (3.33e-3)" "unprognostic (1.19e-1)" "unprognostic (5.98e-2)" "unprognostic (5.58e-2)" 0.0 0.0 1.7 0.0 0.4 0.0 0.1 0.0 0.2 1.4 2.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.4 1.1 3.0 0.5 0.7 0.2 0.0 0.4 0.8 0.8 0.8 0.4 0.1 0.1 0.5 0.5 0.4 0.0 0.0 0.9 1.9 2.4 0.8 0.2 2.8 1.6 0.0 2.3 0.1 0.0 0.5 0.5 0.8 0.0 0.5 0.2 0.3 1.7 0.8 1.2 0.4 0.4 1.3 1.8 0.0 0.3 0.1 2.2 0.0 0.0 0.0 0.8 1.6 1.4 0.7 0.4 0.1 0.3 0.0 2.3 0.7 1.5 0.1 0.4 0.8 0.0 0.4 0.3 2.8 0.9 0.0 1.5 0.0 3.6 0.0 0.0 1.7 1.5 0.0 0.0 4.3 0.2 0.4 2.7 0.0 1.0 1.2 1.4 0.3 1.9 0.3 4.7 0.0 0.8 1.6 0.0 0.8 2.4 0.5 0.8 0.7 0.9 0.4 0.4 1.9 0.1 1.2 2.8 0.7 0.2 0.2 0.9 0.2 1.6 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.4 5.0 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC025287.4 ENSG00000284484 16 75660227-75677009 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.2;bone marrow: 1.2;skin 1: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.1;THP-1: 1.4" NA NA 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.3 0.9 0.0 0.1 0.1 0.0 1.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.8 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC025594.2 ENSG00000272899 7 128866308-128872044 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 45.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Lineage enriched" "Detected in single" 7 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.8;HDLM-2: 6.9;HMC-1: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.17e-2)" "unprognostic (3.00e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (8.21e-4)" "unprognostic (1.23e-1)" "unprognostic (9.98e-2)" "unprognostic (5.10e-2)" "unprognostic (1.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.20e-1)" "unprognostic (1.56e-2)" "unprognostic (1.50e-1)" "unprognostic (2.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.33e-3)" 1.1 0.0 0.4 0.2 0.2 0.0 0.2 0.2 3.6 0.2 0.2 0.2 0.2 2.4 0.2 0.5 0.2 0.0 1.6 0.8 0.2 2.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.6 1.0 5.3 0.3 0.2 0.2 0.0 45.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.0 1.0 0.0 1.4 0.5 0.5 4.9 1.4 0.7 0.2 0.4 0.6 0.6 0.4 0.4 9.8 1.7 0.6 0.2 1.3 1.5 0.5 0.2 0.4 6.9 1.0 2.5 0.3 0.1 0.8 0.3 7.9 0.6 0.4 0.3 0.4 1.0 0.2 0.9 1.2 3.6 0.5 0.6 0.5 2.3 0.2 0.4 0.5 1.0 1.7 1.4 0.2 0.4 2.6 1.1 0.4 2.5 0.5 1.8 0.7 1.1 0.2 2.6 0.6 4.6 0.4 5.3 6.1 1.2 3.3 2.6 0.8 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC026316.5 ENSG00000285218 3 170418868-170860380 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 64.6;testis: 27.4" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 2.4 3.9 6.2 3.5 30.3 9.0 3.1 2.1 18.4 1.2 1.4 64.6 0.0 2.7 3.4 4.2 2.8 1.9 4.9 2.4 9.0 2.4 1.8 2.1 3.0 44.6 12.4 7.2 1.7 2.6 0.0 2.2 27.8 4.4 1.2 0.0 3.8 2.2 3.1 6.2 2.7 2.1 27.1 2.1 1.9 27.4 35.8 0.0 2.5 0.2 1.6 1.8 1.6 1.0 0.6 2.4 0.9 0.4 1.3 0.3 1.5 2.4 2.9 2.4 0.7 0.6 2.4 1.6 1.0 0.5 0.1 0.5 2.2 2.4 3.6 1.2 1.0 3.0 0.1 0.0 0.5 2.4 2.0 3.2 3.6 2.1 0.0 2.0 3.3 0.7 0.6 0.7 0.3 0.9 0.6 2.1 1.5 2.7 0.7 0.7 0.8 3.4 4.0 2.5 3.1 1.5 0.8 1.0 1.4 2.0 5.6 1.7 1.9 1.6 0.8 2.5 1.8 0.5 2.0 1.5 2.2 5.8 0.6 1.6 2.0 1.0 1.0 2.4 1.2 0.6 0.6 0.5 0.8 0.9 1.3 0.8 1.1 1.1 0.6 1.0 1.3 1.2 2.4 0.4 0.9 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC026461.4 ENSG00000275691 16 56676132-56677763 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "blood: 1.1;intestine: 2.7;kidney: 1.0;thyroid gland: 2.7" "Group enriched" "Detected in some" 6 "Distal tubular cells: 1.7;Proximal tubular cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;naive CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.03e-1)" "unprognostic (2.92e-2)" "unprognostic (2.63e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.4 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 2.7 0.1 0.0 0.3 0.0 0.0 0.6 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.5 0.0 0.3 0.2 0.1 0.0 0.1 1.1 0.0 0.0 0.1 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC026464.3 ENSG00000260371 16 69335091-69356306 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA 1.1 1.8 0.9 0.6 0.8 0.0 0.4 1.3 1.6 1.9 2.5 0.0 1.3 0.0 1.5 1.0 0.0 0.4 0.6 0.7 0.5 1.0 0.8 0.6 0.4 2.4 4.9 0.0 0.8 0.0 0.4 0.0 0.0 1.6 3.4 1.1 1.2 0.0 0.3 1.1 1.3 1.8 0.4 1.1 1.8 0.8 2.5 1.3 1.0 2.9 5.9 2.5 1.0 1.1 9.5 2.3 4.1 0.8 7.8 0.0 0.4 4.9 5.2 5.7 2.3 3.3 0.0 1.7 0.6 2.4 1.6 3.1 3.0 3.2 0.0 1.4 0.1 4.6 5.5 3.1 0.6 1.9 0.0 0.0 1.4 3.8 2.2 1.4 0.2 0.0 3.5 8.0 1.3 4.3 0.0 4.6 3.1 0.0 2.8 1.1 1.1 4.5 0.4 1.5 1.0 0.0 2.9 0.0 3.6 3.2 7.9 0.0 3.0 0.7 0.3 3.5 2.0 3.4 5.6 4.2 0.9 3.2 0.2 1.3 1.0 2.5 1.0 0.2 2.3 1.9 2.1 1.3 2.5 2.3 1.6 1.0 5.9 2.9 0.1 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC026464.4 ENSG00000260914 16 69299682-69322700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.3" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA060092 Approved Midbody NA NA Midbody "HPA060092: AB_2684203" "unprognostic (2.95e-1)" "unprognostic (4.21e-1)" "unprognostic (7.34e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-1)" "unprognostic (3.50e-1)" "unprognostic (4.08e-2)" "unprognostic (6.51e-4)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (5.11e-2)" 5.6 3.4 1.0 2.7 2.2 2.3 4.8 15.1 6.8 5.5 4.5 3.1 9.1 0.6 5.0 7.5 2.0 5.0 1.0 1.3 3.3 1.4 7.3 2.4 1.0 6.4 5.7 7.1 3.9 3.0 3.0 2.7 3.7 3.0 19.4 6.4 4.6 3.5 1.2 4.4 3.1 1.3 5.3 3.0 4.5 5.1 17.5 19.5 24.9 19.1 15.9 28.3 21.1 22.5 20.0 23.6 22.2 18.2 19.3 13.3 28.6 19.4 30.6 20.2 25.4 12.5 21.5 30.0 22.9 15.6 17.6 22.4 19.5 19.6 13.2 10.7 17.0 11.0 12.6 23.0 21.3 18.1 16.3 26.9 25.3 28.0 17.4 25.2 18.6 21.5 10.7 24.8 29.5 21.2 10.4 19.1 14.8 9.7 32.6 13.5 28.6 14.3 14.6 24.6 13.7 38.4 12.8 16.4 15.1 18.1 15.1 26.4 28.6 20.5 24.5 21.5 37.1 26.6 50.6 28.9 8.0 34.0 11.1 17.7 24.9 23.6 14.1 22.0 17.5 21.2 28.3 19.5 15.7 21.8 21.3 12.4 15.9 19.1 13.4 19.9 21.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC026786.1 ENSG00000256825 12 133130984-133202369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "pituitary gland: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.5;BJ: 1.7;CACO-2: 3.6;TIME: 2.5" NA NA 1.4 1.5 1.5 1.3 3.3 1.3 1.3 3.9 2.7 2.1 1.4 1.9 4.5 1.3 3.7 4.4 1.9 1.6 2.7 1.6 1.5 1.4 1.4 1.9 2.0 1.3 2.1 1.3 3.2 1.5 1.3 21.5 1.3 2.1 1.8 1.3 2.3 1.4 5.3 2.4 1.8 1.3 3.6 2.2 1.5 1.4 5.3 1.9 1.4 2.4 0.8 1.3 1.4 1.4 0.3 1.8 0.0 0.7 0.0 1.3 0.2 0.4 1.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.3 0.3 0.2 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.8 0.1 0.2 1.5 3.3 3.9 2.7 1.5 1.4 2.1 1.3 2.1 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC037459.1 ENSG00000248235 8 22589274-22602084 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 35.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 3.9;U-2 OS: 3.9;U-2197: 7.7;U-87 MG: 4.1" HPA024667 Uncertain NA NA "HPA024667: AB_1845783" "unprognostic (3.72e-2)" "unprognostic (5.48e-2)" "unprognostic (2.04e-1)" "unprognostic (2.01e-1)" "unprognostic (7.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.96e-1)" "unprognostic (2.29e-2)" "unprognostic (9.64e-2)" "unprognostic (1.67e-1)" "unprognostic (4.64e-3)" "unprognostic (2.29e-1)" "unprognostic (2.55e-4)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.28e-1)" "unprognostic (8.23e-3)" 5.0 4.0 4.1 5.4 5.2 1.9 6.1 9.4 4.0 7.8 12.1 3.1 4.7 3.7 10.1 5.3 5.9 3.9 9.2 6.5 3.7 3.6 3.9 2.8 5.4 4.7 5.7 3.6 5.0 4.4 1.5 1.3 3.3 6.4 6.1 1.5 3.8 6.9 3.6 35.8 2.5 10.3 11.1 2.3 14.2 5.7 2.3 2.0 0.0 1.6 6.1 1.6 7.5 5.6 0.7 0.2 0.0 0.1 0.0 0.5 0.3 0.2 1.3 0.6 3.3 0.0 3.1 0.5 2.0 2.7 1.0 2.4 0.1 0.0 1.8 0.1 0.7 0.0 0.0 0.3 0.3 0.2 0.0 0.6 0.0 0.0 0.4 0.5 0.5 0.0 1.0 0.0 0.6 0.0 1.6 0.0 0.2 0.0 1.4 0.0 0.0 0.2 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 3.9 1.4 1.8 2.9 0.2 1.3 0.7 0.0 1.9 3.9 7.7 0.2 0.0 0.1 0.2 4.1 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 4.1 5.2 9.4 4.0 3.7 3.6 5.7 3.6 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC051649.2 ENSG00000283787 11 1888577-1891895 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.0;skeletal muscle: 18.5" "Cell type enriched" "Detected in single" 22 "Cardiomyocytes: 2.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 4.3;HDLM-2: 11.9;JURKAT: 2.7;Karpas-707: 8.1;NB-4: 3.3;U-937: 6.0" "Low region specificity" "Detected in many" NA NA 0.0 4.9 3.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 18.5 6.0 0.6 0.0 4.5 0.8 0.0 0.0 0.0 0.2 1.6 2.8 7.0 3.1 1.0 1.9 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 8.1 0.0 0.0 0.7 3.3 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 1.1 2.8 2.8 1.5 2.9 0.7 1.6 1.2 1.3 2.8 1.2 0.8 1.1 7.0 1.0 3.1 2.7 1.9 4.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC058822.1 ENSG00000282278 4 53377839-54295272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.4;fHDF/TERT166: 12.7;HDLM-2: 3.4;NTERA-2: 2.9;U-2197: 2.9" HPA058202 Supported Nucleoplasm NA NA Nucleoplasm "HPA058202: AB_2683636" 4.3 2.6 3.6 9.5 5.0 2.7 3.4 4.3 19.1 4.7 4.6 3.4 2.6 2.6 5.5 2.6 3.2 2.6 2.6 4.5 2.6 3.0 3.3 5.4 3.9 3.6 5.1 7.8 6.6 2.6 5.3 5.3 3.8 4.0 2.8 2.6 3.0 3.1 3.2 2.6 7.1 6.5 3.3 4.7 4.1 4.7 4.2 9.3 4.3 3.0 4.2 4.5 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 2.0 0.0 0.2 5.4 0.0 0.1 1.0 0.0 0.0 0.0 12.7 0.0 0.0 1.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 1.5 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.2 ENSG00000284622 2 227608784-227608927 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 20 "lymphoid tissue: 1.3;testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 45 "HeLa: 3.9;hTCEpi: 5.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.3 ENSG00000284631 2 227616998-227618655 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9;epididymis: 4.4;placenta: 8.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 18 "U-2197: 15.8" NA NA 0.0 0.0 0.9 1.4 0.0 0.5 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 8.4 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.2 1.3 2.9 0.8 0.6 0.8 0.4 0.1 0.4 0.3 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.7 0.6 0.0 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.8 0.1 0.0 0.1 0.3 0.2 0.1 0.3 0.1 0.0 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.3 0.7 0.3 0.1 15.8 0.3 0.2 0.1 0.5 0.1 0.1 0.4 2.9 0.8 0.4 0.6 0.4 0.2 0.7 0.4 0.4 0.2 1.2 0.7 0.8 2.1 0.6 0.4 1.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.4 ENSG00000284643 2 227598893-227599255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "adipose tissue: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "HeLa: 2.7" NA NA 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.5 ENSG00000284667 2 227666804-227667061 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "placenta: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.6 ENSG00000284704 2 227614538-227614840 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "placenta: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "HeLa: 3.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068533.4 ENSG00000249319 7 66087761-66152277 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (7.24e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" "unprognostic (2.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.74e-1)" "unprognostic (2.32e-1)" "unprognostic (2.50e-3)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" 1.2 1.3 1.9 1.7 2.0 1.6 2.1 3.2 2.4 2.8 4.4 2.7 1.1 1.4 1.1 1.2 0.8 0.8 1.7 2.6 3.6 10.0 1.5 0.2 1.9 2.1 1.6 5.4 1.6 0.6 1.7 3.9 1.0 1.6 0.6 0.8 1.4 1.8 2.2 1.0 2.2 0.2 1.2 1.2 0.9 1.1 6.5 2.9 6.5 7.9 4.8 6.4 2.3 2.9 0.0 3.0 2.3 5.1 6.9 0.7 3.6 4.2 1.6 2.3 1.4 3.8 2.6 3.5 8.7 7.8 4.2 0.8 2.1 6.1 0.8 2.1 0.9 2.0 1.6 3.0 1.8 3.7 4.6 4.4 7.1 11.7 7.2 2.2 1.2 2.4 1.5 2.0 1.3 2.3 2.5 2.4 12.2 2.2 1.1 1.8 4.1 5.0 1.6 2.8 5.1 2.6 14.3 0.9 7.8 5.0 0.8 5.3 2.1 2.1 3.7 4.3 2.6 3.3 1.3 10.2 5.4 2.0 5.9 3.7 4.8 6.4 4.3 6.4 6.5 2.8 4.9 2.9 5.0 4.4 5.4 6.5 4.8 7.9 2.2 4.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068580.4 ENSG00000250644 11 1734821-1763954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 84.9" "Group enriched" "Detected in some" 17 "Alveolar cells type 2: 1.7;Ciliated cells: 4.0;granulocytes: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 63.8;hTERT-RPE1: 46.3;SH-SY5Y: 14.5;U-87 MG: 17.5" HPA003001 Uncertain NA NA "HPA003001: AB_1078404" "unprognostic (5.71e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-6)" "unprognostic (1.77e-2)" "unprognostic (5.21e-2)" "unprognostic (6.20e-2)" "unprognostic (4.05e-3)" "unprognostic (1.45e-2)" "unprognostic (3.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.45e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-3)" "unprognostic (8.30e-4)" "unprognostic (7.35e-2)" "unprognostic (5.79e-5)" "unprognostic (7.47e-2)" 33.3 84.9 5.0 5.4 5.1 15.6 13.8 12.2 25.7 7.5 8.3 7.6 7.9 5.1 7.0 9.9 6.9 5.3 17.6 18.3 5.6 8.8 32.5 35.5 22.2 17.0 9.7 4.3 7.8 12.5 3.7 4.0 11.1 8.0 6.1 4.4 50.8 20.6 22.6 14.3 10.5 19.1 3.8 7.6 16.7 7.4 7.0 5.2 3.3 6.8 8.9 7.7 13.7 8.3 0.5 3.8 7.6 6.9 8.1 2.0 4.7 0.3 2.5 0.1 0.5 0.9 0.5 0.6 0.7 1.0 0.2 0.3 0.6 63.8 0.1 0.9 3.0 2.0 4.5 0.0 0.0 0.0 0.2 0.9 0.4 0.4 0.2 1.1 0.6 1.4 2.3 0.7 0.3 0.3 46.3 0.1 0.2 0.0 1.0 5.2 6.2 0.0 0.7 0.2 2.4 0.2 0.1 0.9 0.4 2.5 2.8 0.2 14.5 0.2 4.8 9.0 0.1 11.3 0.2 1.5 3.2 0.4 0.7 1.0 2.8 6.3 0.1 17.5 0.5 2.7 1.5 6.9 2.1 1.9 3.2 1.4 0.5 1.0 1.1 2.1 0.2 1.5 2.0 7.6 8.1 4.3 3.8 1.1 4.7 5.0 5.1 12.2 10.5 5.6 8.8 9.7 4.3 8.0 5.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068631.2 ENSG00000283149 3 186581995-186597103 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA010814 Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010814: AB_1078691" 1.9 1.3 3.1 6.3 2.7 1.2 0.0 4.7 2.9 1.3 8.3 0.7 0.1 1.9 0.4 1.3 5.3 0.5 1.5 0.2 2.8 0.0 1.6 0.0 2.3 0.6 0.5 0.0 0.0 1.5 0.3 2.1 1.7 0.2 2.9 1.2 0.0 9.0 17.4 9.7 8.7 10.7 11.9 6.6 12.7 10.1 12.9 16.1 10.9 5.1 4.2 24.0 6.7 9.9 6.8 35.5 6.2 8.0 29.8 16.1 15.7 9.5 13.0 9.1 13.0 6.5 0.2 8.0 18.2 37.2 13.0 15.6 5.5 5.7 5.5 11.6 20.7 8.0 6.3 3.9 4.5 31.8 4.4 28.0 8.0 5.3 4.0 32.0 0.0 5.3 12.9 11.3 10.3 23.0 1.0 1.9 10.7 22.9 7.3 15.2 15.6 20.2 3.4 6.7 8.0 5.9 22.5 13.5 27.2 22.8 10.1 12.5 13.9 7.6 6.7 9.7 11.9 8.7 8.5 9.0 7.5 10.1 10.5 5.5 4.9 9.5 1.8 10.7 7.2 17.4 8.8 6.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068775.1 ENSG00000255641 12 10412312-10436001 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 43.7;brain: 11.4;lymphoid tissue: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 43.7" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.7" "Cell line enhanced" "Detected in some" "GAMG: 4.5;HeLa: 13.3;HSkMC: 2.3;SuSa: 5.1" HPA062570 Uncertain NA NA "HPA062570: AB_2684795" "unprognostic (6.09e-2)" 0.3 0.5 7.0 0.8 4.5 3.0 0.6 1.0 11.4 0.3 1.4 2.0 0.0 0.8 1.0 0.8 0.3 0.3 0.4 0.6 6.8 4.9 0.2 1.1 1.5 1.3 5.7 2.4 0.4 0.3 0.1 0.0 0.5 3.4 0.3 1.0 0.0 1.0 0.1 0.1 0.2 1.6 0.4 3.9 9.2 1.0 0.5 1.5 2.0 0.1 0.0 1.0 1.0 0.0 0.0 0.0 0.3 0.0 43.7 7.6 2.6 0.0 0.8 0.1 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.3 0.0 0.0 0.0 0.8 13.3 0.4 0.1 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 7.6 0.3 43.7 0.0 0.0 0.0 2.6 7.0 4.5 1.0 3.3 6.8 4.9 5.7 2.4 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC068790.8 ENSG00000274874 12 123973944-124088594 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7;pancreas: 3.3" "Group enriched" "Detected in some" 9 "Alveolar cells type 2: 1.9;Ciliated cells: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.99e-1)" "unprognostic (1.18e-1)" "unprognostic (8.95e-2)" "unprognostic (3.45e-2)" "unprognostic (7.23e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "unprognostic (6.15e-2)" "unprognostic (2.45e-2)" "unprognostic (7.87e-2)" "unprognostic (6.42e-3)" "unprognostic (1.50e-1)" "unprognostic (4.26e-1)" "unprognostic (1.95e-1)" "unprognostic (1.43e-1)" "unprognostic (1.52e-1)" "unprognostic (3.15e-1)" 0.8 0.0 0.0 0.0 0.9 1.8 0.0 0.3 0.5 0.9 1.1 0.1 0.7 0.0 0.0 0.5 0.2 0.5 0.0 0.0 3.3 1.4 0.7 0.4 0.0 0.6 0.7 0.1 0.0 0.5 0.0 0.0 1.0 0.3 0.8 0.1 0.3 0.7 1.5 0.1 0.3 0.0 2.7 0.7 2.5 0.0 1.2 2.2 1.6 0.7 0.8 1.4 1.1 0.0 0.3 0.0 0.9 1.8 0.8 1.9 0.9 1.0 1.4 0.0 2.0 1.8 0.6 0.0 0.5 1.4 0.6 0.4 1.8 1.5 2.2 0.5 1.3 1.6 1.1 1.4 0.7 0.0 1.2 1.7 0.9 0.4 0.6 3.5 2.2 0.8 1.0 0.8 3.5 2.8 2.9 3.9 0.5 1.5 1.2 1.6 5.4 0.3 1.3 0.9 1.6 2.3 0.8 0.8 1.8 3.1 0.0 0.5 1.3 0.0 0.3 0.0 2.7 0.0 2.4 0.4 1.6 0.9 1.5 0.7 1.5 1.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC068987.5 ENSG00000284730 12 51813940-51814926 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.4;intestine: 1.7" "Group enriched" "Detected in some" 18 "Collecting duct cells: 1.8;Proximal tubular cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;SiHa: 1.8;SuSa: 1.2" NA NA 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.7 1.6 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC069368.1 ENSG00000249240 15 64841883-64930920 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 23.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 22.2" NA NA "unprognostic (2.49e-1)" "unprognostic (1.95e-2)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (3.28e-1)" "unprognostic (3.68e-2)" "unprognostic (4.45e-2)" "unprognostic (7.51e-2)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (4.25e-1)" "unprognostic (2.83e-1)" "unprognostic (1.97e-1)" 9.5 10.5 5.8 13.5 7.5 1.2 4.1 5.1 11.7 2.8 5.8 4.4 1.4 9.5 5.2 5.3 4.1 3.0 6.3 3.9 5.3 3.4 3.5 4.2 8.7 7.5 3.9 3.1 3.9 2.2 1.2 2.4 9.8 7.2 4.0 3.1 7.1 2.9 1.2 3.1 2.8 3.4 7.0 5.9 23.8 7.7 2.6 4.4 1.4 7.6 2.1 4.0 6.7 5.7 0.5 0.8 0.4 1.2 0.0 2.6 0.1 2.3 0.0 0.5 0.7 0.6 2.7 0.7 9.2 3.9 0.5 1.5 0.7 0.0 7.7 3.5 2.2 0.4 0.2 0.0 0.0 1.4 8.8 0.0 7.2 2.0 0.0 1.2 9.5 4.6 0.9 0.4 0.5 0.0 1.0 0.0 0.7 1.9 8.9 0.0 0.2 1.0 0.1 1.3 0.0 0.0 1.5 7.4 2.6 0.0 1.7 0.0 2.5 2.4 0.0 1.3 0.2 0.3 0.9 9.4 2.7 2.5 2.7 2.1 4.5 22.2 2.4 3.6 4.8 0.3 0.0 0.5 0.0 1.2 1.2 0.8 0.5 0.3 2.6 0.8 0.2 0.1 0.1 0.4 0.0 0.5 0.0 1.5 0.1 5.8 7.5 5.1 5.6 5.3 3.4 3.9 3.1 7.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC073111.5 ENSG00000284691 7 150400702-150412470 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 9.9" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 7.0;Distal tubular cells: 11.6;monocytes: 19.0" "Group enriched" "Detected in many" 5 "gdT-cell: 4.5;MAIT T-cell: 3.3;memory B-cell: 5.3;memory CD4 T-cell: 5.9;memory CD8 T-cell: 3.9;naive B-cell: 7.2;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.5;plasmacytoid DC: 9.9;T-reg: 4.2" "Group enriched" "Detected in many" 7 "B-cells: 7.2;dendritic cells: 9.9;T-cells: 6.7" "Cell line enhanced" "Detected in many" "HDLM-2: 9.0;MOLT-4: 16.7;NTERA-2: 7.7;RPMI-8226: 14.3;U-266/70: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 3.2 3.3 4.5 4.5 3.4 2.1 0.3 2.9 5.3 0.5 2.8 1.3 1.6 6.1 2.4 1.0 0.9 1.5 0.8 0.5 1.8 1.3 0.2 1.7 7.7 0.9 2.3 2.7 4.5 0.6 1.2 0.9 1.8 1.9 0.8 1.0 4.6 1.5 3.5 3.5 4.1 2.7 0.0 7.4 4.5 0.4 1.5 6.3 1.2 0.3 5.0 1.0 1.1 7.2 9.9 0.8 0.7 1.0 6.7 2.7 0.0 2.3 1.1 0.4 0.3 0.5 1.0 0.9 0.3 0.0 0.1 0.4 1.6 3.6 5.2 0.1 0.3 0.4 0.0 0.2 0.0 9.0 0.6 0.8 0.1 1.7 0.4 1.5 0.6 0.1 0.2 0.0 0.0 0.2 0.1 3.5 2.0 1.9 0.0 0.5 16.7 3.2 7.7 0.4 0.7 4.5 0.4 14.3 0.0 0.7 1.2 1.9 0.3 0.2 0.6 0.5 0.2 1.4 1.2 0.3 0.1 0.0 0.1 20.4 1.5 1.8 0.6 0.7 0.6 0.0 0.3 0.8 4.5 0.7 3.3 5.3 5.9 3.9 0.8 7.2 6.7 4.5 0.0 1.0 0.0 9.9 4.2 2.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 7.0 0.0 0.0 11.6 3.9 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC073610.2 ENSG00000255863 12 48921963-48939663 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.0;skeletal muscle: 1.5" "Cell type enriched" "Detected in single" 14 "Alveolar cells type 2: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.5;MOLT-4: 1.8;NB-4: 1.1" NA NA 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.7 0.8 0.3 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.4 0.0 0.6 0.5 0.7 0.3 0.7 0.0 1.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC073610.3 ENSG00000272822 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 27.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.9;hTERT-RPE1: 8.0" HPA068942 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA068942: AB_2732124" "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 6.8 3.4 10.5 2.2 20.7 3.6 4.6 7.7 27.5 6.4 4.9 6.3 2.6 2.2 9.7 7.3 5.1 4.7 7.6 7.2 8.8 7.2 5.0 4.1 5.5 5.5 5.7 13.7 6.1 7.4 2.2 5.3 3.3 10.6 5.4 4.6 3.5 4.8 4.5 3.4 4.4 4.2 10.6 4.6 4.7 4.0 8.4 4.3 3.3 5.0 2.3 4.4 4.9 3.9 0.8 1.8 1.1 1.1 1.3 3.2 2.0 1.0 0.4 3.8 2.9 4.1 1.6 0.0 1.6 7.9 2.3 1.0 0.0 1.1 1.1 2.4 1.4 2.5 0.4 1.4 0.0 2.1 5.1 0.6 1.1 0.6 0.0 2.8 0.0 1.1 0.4 2.0 0.6 1.3 8.0 1.0 1.9 0.1 1.4 1.3 0.4 0.2 0.6 0.0 2.1 1.1 2.2 0.6 0.2 0.2 0.3 1.9 0.5 0.9 0.7 0.8 0.7 0.2 0.5 4.3 0.7 0.5 0.2 0.5 2.0 0.3 0.7 1.8 1.1 0.4 0.9 1.1 0.3 2.7 0.4 3.2 0.6 0.9 1.8 0.9 0.8 2.3 2.6 1.1 1.3 0.4 1.8 0.5 2.0 10.5 20.7 7.7 27.5 8.8 7.2 5.7 13.7 10.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AC078864.2 ENSG00000284791 12 52079696-52108239 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 23.3;prostate: 18.7;testis: 15.3" "Group enriched" "Detected in some" 17 "Ciliated cells: 2.7;Distal tubular cells: 1.7" "Cell type enriched" "Detected in single" 87 "plasmacytoid DC: 8.7" "Lineage enriched" "Detected in single" 87 "dendritic cells: 8.7" "Cell line enhanced" "Detected in some" "HHSteC: 2.5;MOLT-4: 1.6;RPMI-8226: 1.9" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 1.1 1.9 0.0 0.0 0.8 0.2 0.1 3.0 0.0 1.4 2.2 0.0 0.0 0.1 23.3 0.6 0.9 0.0 4.1 0.3 0.0 0.0 0.8 0.0 18.7 1.4 0.0 0.0 0.6 0.1 0.0 1.4 4.3 0.6 9.1 1.1 15.3 0.0 0.0 0.0 0.2 2.5 4.8 1.5 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC079341.3 ENSG00000284849 4 121758930-121765185 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "brain: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "MOLT-4: 6.8" HPA077585 Approved NA NA "HPA077585: AB_2732353" 0.3 0.3 1.1 0.3 7.1 0.3 0.3 0.0 16.4 0.3 0.3 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 6.8 0.3 0.3 0.3 0.4 0.0 7.6 0.3 0.3 0.3 0.0 1.1 0.4 0.3 0.3 0.5 0.3 0.4 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC083800.1 ENSG00000251012 3 119147375-119187807 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "adipose tissue: 1.3;testis: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "HEL: 3.9" NA NA 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC083902.2 ENSG00000248713 "Homo sapiens uncharacterized LOC285556 (LOC285556), mRNA." 4 99636529-99654648 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 40.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.5;SK-BR-3: 3.6;SK-MEL-30: 2.0;WM-115: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" NA NA "unprognostic (3.91e-2)" "unprognostic (3.76e-1)" "unprognostic (4.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.76e-2)" "unprognostic (4.00e-3)" "unprognostic (2.31e-3)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (2.20e-1)" "unprognostic (2.42e-3)" "unprognostic (1.89e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.2 0.0 4.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 40.9 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.1 0.7 6.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC087498.1 ENSG00000180042 17 3385930-3386874 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 5.2;testis: 2.8" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 16 "dendritic cells: 5.2" "Cell line enriched" "Detected in single" 6 "HDLM-2: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (5.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091057.5 ENSG00000284906 "Rho GTPase-activating protein 11B " Q3KRB8 15 30624548-30685606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA064479 Uncertain Uncertain Vesicles NA Yes Vesicles "HPA064479: AB_2685272" 0.2 0.1 0.8 10.3 1.8 7.1 0.5 0.7 0.9 0.1 5.1 0.6 0.0 1.1 0.8 0.2 1.8 0.2 0.3 0.2 1.0 0.0 0.1 0.9 2.8 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.6 0.0 1.2 0.3 0.1 0.1 0.4 0.9 1.5 0.8 1.9 1.4 1.0 5.8 2.1 14.4 0.0 1.4 5.7 0.5 0.0 1.0 1.0 1.6 0.3 0.0 0.8 0.0 4.4 2.9 5.0 2.5 0.1 0.6 2.8 4.6 1.9 3.2 3.7 3.0 3.7 2.8 1.8 1.9 3.6 4.0 2.6 1.6 2.8 6.1 3.1 7.4 10.0 1.3 0.0 4.7 5.3 0.2 0.2 2.1 1.6 1.1 2.2 6.6 4.4 8.7 2.2 2.1 3.6 4.0 1.5 2.2 1.5 5.1 5.1 1.3 0.9 2.8 2.4 2.2 5.4 2.0 1.0 1.4 2.5 2.4 2.5 5.0 4.2 2.4 3.9 3.0 3.2 6.1 1.7 5.4 4.0 1.6 0.3 0.2 0.4 0.0 0.0 0.6 0.8 0.6 0.1 1.0 0.1 0.1 0.1 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091167.6 ENSG00000275674 15 90266317-90314499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 5.8;CACO-2: 3.0;U-266/84: 3.3" NA NA "unprognostic (1.02e-1)" "unprognostic (6.86e-2)" "unprognostic (7.11e-2)" "unprognostic (9.39e-2)" "unprognostic (4.70e-2)" "unprognostic (2.50e-2)" "unprognostic (6.17e-2)" "unprognostic (1.27e-1)" "unprognostic (1.23e-1)" "unprognostic (9.18e-2)" "unprognostic (4.73e-2)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" 3.0 0.6 1.4 1.0 4.2 0.8 4.0 1.3 12.0 1.3 2.6 0.3 1.1 6.8 1.4 2.3 2.6 2.0 2.1 2.8 1.6 1.3 4.1 1.5 0.6 0.9 3.0 2.8 6.6 0.6 1.2 0.7 1.5 1.7 1.1 0.0 3.5 1.9 7.7 0.6 4.2 2.2 0.7 0.7 2.8 5.6 0.8 0.9 2.6 2.4 0.9 1.9 2.8 1.1 1.5 0.0 0.6 0.0 0.9 0.9 0.9 0.9 1.0 0.7 0.0 0.0 5.8 0.5 0.0 0.4 0.4 3.0 1.0 0.0 1.2 0.0 0.0 0.0 1.4 0.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.3 0.2 0.6 0.4 1.7 0.4 0.0 0.4 0.0 0.9 0.7 0.2 0.0 0.4 0.0 0.4 0.3 0.0 1.3 0.9 0.7 0.3 0.3 1.4 3.3 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.6 0.8 0.0 0.3 0.0 0.0 1.1 0.5 0.9 0.0 0.0 0.0 1.5 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC091959.3 ENSG00000275740 5 146203550-146339251 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 21.6" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Club cells: 7.9;granulocytes: 3.5;monocytes: 5.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA035944, HPA036422" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035944: AB_10670672, HPA036422: AB_10669987" "unprognostic (6.42e-2)" "unprognostic (7.72e-4)" "unprognostic (2.05e-2)" "unprognostic (4.95e-2)" "unprognostic (1.51e-2)" "unprognostic (1.13e-2)" "unprognostic (3.24e-2)" "unprognostic (8.78e-2)" "unprognostic (1.42e-1)" "unprognostic (3.61e-2)" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.57e-1)" "unprognostic (2.31e-1)" "unprognostic (1.56e-2)" "unprognostic (2.12e-2)" 3.6 2.8 4.0 5.7 5.4 8.0 3.4 6.5 5.4 4.6 5.1 2.9 3.5 6.0 4.8 2.3 4.9 4.4 2.8 3.6 3.7 3.1 4.1 3.3 5.0 3.6 4.1 5.9 3.3 5.5 4.3 4.1 4.0 4.3 3.4 3.0 3.5 3.4 7.3 2.2 4.6 5.8 3.7 4.3 4.2 21.6 3.8 8.4 5.8 4.0 4.7 5.6 3.9 16.1 12.5 17.6 13.3 11.8 15.0 8.4 6.0 9.9 4.8 4.6 1.5 1.5 4.4 7.7 4.7 9.2 9.5 10.6 4.8 7.0 4.6 4.1 5.7 4.6 7.1 6.7 7.8 13.4 3.9 8.1 4.8 1.1 1.1 9.7 8.1 2.2 0.9 8.6 5.3 1.5 2.7 2.7 10.8 4.7 2.7 2.7 7.8 0.0 4.4 2.6 6.5 8.0 9.2 3.9 0.7 7.8 4.7 3.5 11.1 2.5 3.8 1.7 7.9 1.4 5.4 4.9 5.9 6.0 7.5 5.5 12.2 11.4 5.6 5.8 5.4 17.6 8.8 16.6 13.6 8.7 15.0 12.9 12.5 10.4 9.0 16.1 13.3 12.9 12.8 11.8 13.3 12.5 10.8 8.4 8.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.9 1.8 0.0 0.4 1.7 1.6 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC091980.2 ENSG00000275038 5 171305981-171308755 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "HeLa: 3.4;RH-30: 1.5;SH-SY5Y: 6.0" NA NA "unprognostic (5.98e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092017.3 ENSG00000283952 1 211082872-211188533 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.2;testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.7;HSkMC: 1.5;hTEC/SVTERT24-B: 1.7" NA NA 0.3 0.0 0.0 0.1 0.0 0.0 0.8 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092042.3 ENSG00000273291 3 42809446-43055871 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 29 "testis: 57.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;U-2197: 1.7" NA NA "unprognostic (2.83e-2)" "unprognostic (2.13e-1)" "unprognostic (3.09e-1)" "unprognostic (3.69e-3)" "unprognostic (1.02e-1)" "unprognostic (3.74e-2)" "unprognostic (2.04e-1)" "unprognostic (6.65e-3)" "unprognostic (4.46e-2)" "unprognostic (8.42e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-2)" "unprognostic (2.54e-2)" "unprognostic (2.15e-1)" "unprognostic (4.20e-2)" "unprognostic (2.81e-1)" 0.5 0.5 0.4 0.4 1.5 0.4 0.5 1.5 1.7 0.7 0.5 1.1 0.4 0.4 1.0 1.9 0.5 0.4 0.6 1.6 0.6 0.5 0.5 0.4 0.5 0.4 0.4 0.6 0.7 1.4 0.4 1.1 0.6 1.0 1.0 1.3 1.6 0.5 0.4 0.5 0.5 0.5 1.3 0.9 0.5 0.5 57.2 0.0 0.0 1.2 0.0 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 1.5 1.5 1.7 0.6 0.5 0.4 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092073.1 ENSG00000266953 19 34396315-34409364 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 5.4;HaCaT: 5.5;HMC-1: 4.2;MOLT-4: 4.0;U-251 MG: 4.7;U-266/84: 4.1" NA NA "unprognostic (1.18e-1)" "unprognostic (2.34e-2)" "unprognostic (3.43e-1)" "unprognostic (6.48e-3)" "unprognostic (3.25e-2)" "unprognostic (2.61e-1)" "unprognostic (6.67e-2)" 2.8 1.3 1.6 0.6 2.2 3.5 5.5 3.0 3.9 1.3 2.1 0.0 1.1 1.9 1.2 0.6 1.4 0.6 1.2 4.6 1.4 1.9 1.2 6.3 1.5 1.7 1.6 3.2 1.5 0.6 1.4 1.1 0.9 2.6 0.9 0.9 0.3 0.6 4.0 14.4 1.0 5.0 0.6 1.3 1.5 2.1 2.4 0.3 2.1 1.4 2.3 1.1 2.4 0.9 1.2 0.4 0.5 0.6 0.5 1.1 1.1 5.4 0.9 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.5 0.7 2.8 0.0 0.0 5.5 0.0 0.6 0.3 0.5 0.0 0.9 2.3 0.9 0.0 2.6 4.2 0.0 0.9 0.0 0.0 0.2 0.0 0.9 1.2 0.6 0.0 0.7 4.0 1.5 3.3 1.0 0.0 1.9 1.2 0.0 0.0 1.6 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 3.4 1.0 4.7 0.2 4.1 0.8 0.5 0.4 0.0 0.0 0.3 0.5 1.1 0.6 0.7 1.2 0.0 0.3 0.4 0.6 0.3 0.0 0.3 0.5 0.3 0.0 0.0 1.1 1.6 2.2 3.0 3.9 1.4 1.9 1.6 3.2 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092143.1 ENSG00000198211 16 89919165-89936092 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 19.0" "CAB011512, HPA043640, HPA046280" Uncertain Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.90e-4)" "unprognostic (6.87e-2)" 0.4 0.2 0.2 0.1 0.8 0.3 0.1 0.4 0.7 1.0 0.5 0.6 0.0 0.1 1.2 0.9 1.0 0.7 1.5 1.8 0.2 0.4 0.1 1.3 0.4 0.1 0.9 0.4 4.0 0.2 0.1 0.7 1.4 2.0 2.6 0.1 0.3 0.1 0.1 0.6 5.1 0.4 0.5 2.8 0.6 0.1 10.9 0.2 0.0 0.3 0.0 0.1 1.0 5.1 0.1 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.1 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.3 0.2 0.8 0.4 0.7 0.2 0.4 0.9 0.4 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092442.1 ENSG00000284684 4 6064977-6070162 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "blood: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.5;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "hypothalamus: 0.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092718.8 ENSG00000284512 16 81022316-81096284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.6" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA041368 Uncertain Approved Vesicles NA NA Vesicles "HPA041368: AB_10804001" 1.4 1.9 3.2 2.1 4.7 4.0 1.7 1.8 6.9 1.4 1.3 4.4 4.0 1.4 2.0 4.2 1.3 1.7 1.6 2.4 3.7 2.5 4.2 1.4 1.9 5.1 4.7 2.2 2.5 3.6 1.4 1.7 5.7 4.0 1.3 2.6 2.3 1.7 3.2 1.9 1.6 1.3 3.9 1.5 1.7 20.6 5.4 1.2 4.5 0.9 1.2 1.7 0.0 1.9 2.8 2.3 1.0 1.7 2.1 0.9 1.3 0.7 1.9 1.6 0.3 0.0 1.6 2.4 0.2 0.5 0.1 1.2 1.9 1.8 1.0 0.6 0.9 2.8 0.1 0.1 0.5 0.3 1.1 1.1 2.5 1.8 0.2 1.8 3.4 0.6 0.2 0.4 0.0 1.0 0.0 2.2 1.0 3.3 0.0 3.7 1.6 4.0 1.9 0.7 1.1 1.6 1.3 0.5 0.2 0.8 2.8 0.8 1.8 1.2 0.4 1.0 1.2 0.5 0.3 1.7 2.0 1.3 1.1 1.6 0.8 3.4 0.6 0.8 0.8 1.9 1.0 0.6 1.2 0.6 1.0 1.1 0.9 2.1 0.6 1.9 1.2 1.5 2.3 1.7 0.9 2.8 1.8 0.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093155.3 ENSG00000267561 1 86993009-87169204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 10.8" "Cell type enriched" "Detected in some" 4 "granulocytes: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.0;HEL: 13.2;HMC-1: 16.8;THP-1: 11.4" "HPA043069, HPA043603" Approved Uncertain Mitochondria NA NA Mitochondria "HPA043069: AB_10964127, HPA043603: AB_10963432" "unprognostic (4.41e-1)" "unprognostic (3.13e-2)" "unprognostic (2.05e-1)" "unprognostic (1.85e-2)" "unprognostic (3.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.51e-2)" "unprognostic (5.19e-3)" "unprognostic (3.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" 10.8 3.2 0.6 0.9 0.8 0.0 3.7 0.8 0.6 2.1 1.3 0.6 0.8 0.5 1.1 0.5 2.1 4.1 0.6 0.6 0.8 4.3 2.5 0.3 0.7 3.7 0.6 0.0 0.5 2.7 0.6 1.2 0.9 0.7 1.6 0.6 1.0 2.0 0.8 0.8 0.7 2.4 0.6 0.0 2.2 0.6 0.1 0.9 4.6 0.1 0.4 0.2 0.1 0.0 0.1 0.8 2.0 2.4 9.0 0.2 0.0 0.1 0.0 0.3 0.6 0.8 0.0 0.2 0.0 0.2 0.2 0.3 0.1 0.4 0.1 0.5 13.2 0.4 0.1 0.1 0.3 16.8 1.5 0.3 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.2 0.2 0.3 1.1 0.0 0.2 0.3 0.0 0.4 0.4 0.1 0.4 0.3 0.0 0.4 0.9 0.2 11.4 0.0 0.3 0.7 0.1 1.3 0.9 3.5 0.0 0.6 0.0 0.4 2.0 0.1 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 0.4 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093525.2 ENSG00000260272 16 2496032-2520218 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.5;brain: 5.4" "Group enriched" "Detected in some" 331 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 55.2;Ciliated cells: 41.5;Club cells: 31.8;granulocytes: 16.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 4.0;RPMI-8226: 3.3;SCLC-21H: 3.5;SH-SY5Y: 4.4" HPA044712 Uncertain NA NA "HPA044712: AB_10795619" "unprognostic (4.12e-1)" "unprognostic (9.64e-2)" "unprognostic (4.36e-3)" "unprognostic (1.13e-1)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (3.34e-2)" "unprognostic (2.34e-1)" "unprognostic (1.37e-1)" "unprognostic (9.77e-3)" "unprognostic (9.13e-2)" "unprognostic (9.83e-2)" "unprognostic (5.98e-3)" 0.4 0.1 1.1 0.1 1.0 4.5 0.4 5.4 1.8 0.1 0.4 0.1 0.2 0.1 0.3 0.5 0.7 0.1 1.0 0.9 3.2 0.2 1.0 0.7 0.6 0.1 0.3 0.1 1.5 0.1 0.2 0.2 0.6 0.4 1.1 0.4 0.1 0.5 0.1 0.4 0.2 0.6 0.4 0.2 0.6 0.0 0.1 1.7 0.5 0.8 0.7 0.4 0.0 0.5 0.0 0.7 1.8 0.0 0.0 0.0 0.8 1.2 0.0 0.6 0.0 0.8 0.1 0.0 1.7 0.4 0.0 0.9 0.0 0.0 0.3 4.0 0.5 0.6 0.4 1.2 1.3 0.0 0.0 0.4 0.5 0.0 0.8 0.9 0.3 0.1 0.5 0.0 2.3 0.2 1.1 0.2 0.1 1.2 0.4 0.0 3.3 0.6 0.2 3.5 4.4 0.0 0.8 0.9 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.6 1.9 0.8 0.3 0.4 0.0 0.8 0.5 0.4 0.7 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.7 0.3 1.7 0.0 0.0 20.8 55.2 0.0 0.0 0.0 0.0 0.0 0.0 41.5 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093668.1 ENSG00000270249 7 102541501-102592444 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 6.9" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.7;hTERT-RPE1: 3.4;Karpas-707: 4.0" HPA046970 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.4 0.7 0.6 0.8 0.6 0.7 0.4 3.1 1.1 1.0 1.0 2.5 0.9 2.5 0.4 0.6 0.0 0.3 0.6 0.5 1.4 0.1 0.7 0.5 0.3 0.7 1.2 6.9 2.9 0.4 0.5 0.6 1.1 0.2 5.4 1.7 1.4 0.0 0.3 1.3 1.1 0.2 0.3 0.1 0.4 0.7 4.0 3.5 1.3 1.0 0.7 5.3 1.2 0.1 0.0 1.0 0.2 0.2 3.7 0.5 1.1 0.7 0.6 0.0 0.0 2.1 2.3 0.7 1.6 0.4 0.8 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.2 0.0 4.0 0.0 0.4 2.6 1.3 0.5 2.3 1.0 1.4 0.0 0.5 0.3 0.8 1.5 1.2 0.0 0.0 0.2 1.7 0.5 0.0 0.0 0.0 0.1 0.3 0.0 1.8 1.5 0.4 0.4 1.0 0.0 0.0 0.7 0.4 2.9 0.9 4.1 4.0 3.8 2.9 1.7 3.1 5.3 3.0 1.3 0.7 1.0 3.5 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093762.1 ENSG00000284635 2 227745845-227746681 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "skin 1: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.3" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC093899.2 ENSG00000251569 2 169479480-169525922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 19.1" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.0;HSkMC: 6.4;LHCN-M2: 9.1" HPA046125 Uncertain NA NA "HPA046125: AB_2679549" 2.4 2.4 3.7 0.9 7.8 0.5 4.8 3.1 8.6 3.0 2.5 4.1 2.9 0.9 5.5 5.0 2.3 5.8 5.1 5.5 7.8 2.7 3.6 2.1 3.2 1.1 2.4 5.8 4.0 2.5 5.0 8.5 1.6 7.7 5.7 2.5 10.5 3.1 4.5 6.7 2.3 2.2 3.5 2.5 2.0 2.4 19.1 2.6 0.0 5.5 2.0 2.0 2.4 2.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 1.0 2.9 9.0 0.0 1.9 1.0 1.0 1.0 0.0 0.0 0.0 0.3 1.9 2.2 0.1 1.4 0.1 2.4 0.3 0.0 0.1 0.1 0.3 0.7 1.1 0.0 6.4 2.0 2.7 0.8 2.4 3.2 1.5 0.3 0.0 9.1 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.3 0.0 1.8 0.0 1.3 0.4 0.3 0.0 2.4 0.3 0.5 0.0 0.0 1.9 0.5 0.2 0.5 0.0 1.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 3.7 7.8 3.1 8.6 7.8 2.7 2.4 5.8 7.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC096582.3 ENSG00000283247 7 45859994-45873082 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "breast: 2.8;epididymis: 1.2;placenta: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.2" NA NA 0.1 0.0 0.1 0.1 0.1 0.0 2.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 3.3 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.3 0.1 0.3 0.6 0.0 0.1 0.1 0.1 0.7 0.8 0.1 0.8 0.4 0.4 0.5 0.0 0.3 0.4 0.4 0.4 0.1 0.3 0.5 0.0 0.1 0.5 0.1 0.1 0.3 1.2 0.6 0.0 0.3 0.2 0.0 0.5 0.2 0.5 0.2 0.0 0.2 0.4 0.3 0.4 0.1 0.8 1.0 0.4 0.2 1.0 0.4 0.2 0.7 0.6 0.0 2.2 0.4 0.2 0.5 0.1 0.7 0.1 0.2 0.3 0.1 1.4 1.3 0.2 0.7 1.3 0.2 1.2 0.2 0.3 0.0 0.1 0.2 0.3 0.0 0.3 0.5 0.3 0.6 0.0 0.4 0.3 0.4 0.3 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC097637.1 ENSG00000173366 3 52221081-52231190 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 31.7" "Lineage enriched" "Detected in many" 4 "dendritic cells: 31.7" "Group enriched" "Detected in some" 5 "Daudi: 11.6;RPMI-8226: 21.8;U-698: 10.8" NA NA "unprognostic (4.08e-2)" "unprognostic (9.63e-2)" 0.3 0.0 0.4 2.9 0.7 0.3 0.1 1.1 0.5 0.3 0.4 0.1 0.2 0.0 0.1 0.1 0.6 0.3 0.4 0.4 0.2 0.1 0.1 6.5 0.3 0.8 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.1 1.4 0.3 4.0 0.0 0.3 6.2 0.5 0.0 0.1 5.3 1.0 0.2 7.0 31.7 0.1 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.7 0.0 0.0 0.2 0.8 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 1.8 0.4 10.8 0.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 1.2 7.0 0.5 0.5 0.1 3.7 0.0 0.2 0.1 0.0 0.0 31.7 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC097662.2 ENSG00000284629 2 227387683-227387949 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.0" "Cell type enhanced" "Detected in some" 26 "Cone photoreceptor cells: 15.7;Muller glia cells: 4.2;Spermatocytes: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "PC-3: 5.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.9 0.4 0.0 0.0 0.1 0.1 AC098582.1 ENSG00000285385 4 88523810-88649847 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 4.5;RPTEC TERT1: 3.4" NA NA 1.4 0.1 2.4 2.5 3.3 2.8 2.4 2.8 6.3 0.9 0.4 3.3 1.3 0.1 1.1 3.2 0.7 2.2 0.3 0.7 1.4 1.3 0.5 1.3 0.6 0.8 3.5 1.3 0.1 0.1 8.8 1.0 4.8 1.3 2.0 2.2 2.4 1.5 3.1 0.8 0.9 1.1 3.0 2.0 0.1 1.8 1.7 0.0 3.6 0.1 0.7 0.7 0.5 0.9 0.0 0.0 0.2 0.6 2.8 0.7 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.7 0.0 1.9 0.0 1.1 0.0 0.5 1.4 1.2 0.4 0.0 0.0 0.0 0.9 0.0 1.4 0.0 0.6 0.9 0.0 0.0 0.9 1.3 0.0 4.5 1.4 1.4 0.2 1.2 0.9 0.0 0.0 1.0 0.3 0.0 0.1 0.6 1.1 0.4 0.4 3.4 0.0 0.0 1.7 0.0 0.4 0.1 1.1 0.5 0.0 0.0 0.6 0.7 0.0 1.9 2.3 0.0 0.0 2.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.4 0.3 1.4 0.3 0.0 0.9 2.8 1.5 0.0 0.6 0.2 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC099489.1 ENSG00000188897 16 11359845-11523588 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 7.2;lymphoid tissue: 9.9;skin 1: 6.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.7;Club cells: 2.3;granulocytes: 3.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 7.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.2" "Cell line enhanced" "Detected in some" "Daudi: 6.6;HDLM-2: 7.1;U-266/70: 3.7" "Not detected" "Not detected" HPA042154 Uncertain NA NA "HPA042154: AB_2677877" "unprognostic (4.69e-2)" "unprognostic (3.80e-2)" "unprognostic (7.24e-2)" "unprognostic (5.91e-2)" "unprognostic (1.21e-3)" "unprognostic (7.91e-2)" "unprognostic (9.18e-2)" "unprognostic (6.08e-2)" "unprognostic (8.04e-2)" "unprognostic (5.10e-2)" "unprognostic (1.87e-1)" "unprognostic (3.04e-1)" "unprognostic (3.72e-6)" "unprognostic (3.18e-1)" "unprognostic (1.18e-1)" "unprognostic (1.23e-1)" "unprognostic (4.33e-5)" 1.5 0.0 0.3 6.4 0.2 2.0 0.8 0.1 0.1 0.5 0.1 0.0 0.5 0.2 0.1 1.6 0.6 0.7 0.4 0.1 1.1 1.1 2.4 0.9 0.5 0.3 0.5 0.0 0.3 0.3 1.0 0.0 5.0 0.6 1.3 6.2 0.3 0.0 0.5 9.9 0.7 2.8 0.3 0.2 0.7 0.3 0.2 0.0 7.2 0.0 0.0 0.5 0.0 0.1 0.8 0.8 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.8 6.6 2.4 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.5 0.0 0.4 0.0 0.2 0.1 1.3 0.0 1.9 0.0 0.0 0.0 0.1 0.5 0.5 0.9 0.0 0.2 0.2 2.1 0.7 0.1 0.0 0.6 0.3 2.4 0.0 0.5 0.7 0.4 0.0 0.9 0.9 0.6 0.0 0.2 0.3 0.1 0.1 0.3 0.0 3.7 0.2 0.2 0.0 0.7 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.3 7.2 0.0 0.0 0.0 0.1 0.0 8.9 7.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC104389.5 ENSG00000284931 11 5248270-5254783 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 26 "placenta: 321.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 1409 "HEL: 431.1;K-562: 158.9" HPA043234 Uncertain NA NA "HPA043234: AB_2678378" 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 431.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC106774.10 ENSG00000284552 5 17486231-17486829 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 12.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 122 "neutrophil: 12.2" "Lineage enriched" "Detected in single" 122 "granulocytes: 12.2" "Cell line enriched" "Detected in single" 10 "U-937: 8.5" NA NA 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC106774.6 ENSG00000284234 5 17525235-17525831 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC106774.8 ENSG00000284373 "Putative TAF11-like protein ENSP00000332601 " A6NLC8 5 17498231-17498827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.2;testis: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in single" "U-937: 1.1" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC106782.1 ENSG00000258130 16 30204316-30209071 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 12.2;testis: 12.1" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Club cells: 1.2;Collecting duct cells: 1.8;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "A549: 6.7;CAPAN-2: 24.9;SK-BR-3: 21.0" HPA053608 Uncertain NA NA "HPA053608: AB_2682205" "unprognostic (4.44e-1)" "unprognostic (1.13e-2)" "unprognostic (5.96e-4)" "unprognostic (1.95e-1)" "unprognostic (4.32e-2)" "unprognostic (1.31e-2)" "unprognostic (4.92e-1)" "unprognostic (6.13e-2)" "unprognostic (2.68e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-3)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" "unprognostic (5.11e-2)" "unprognostic (3.19e-2)" "unprognostic (5.58e-2)" "unprognostic (1.14e-2)" 2.1 0.2 0.8 1.9 0.1 0.7 1.7 0.4 1.8 2.1 0.7 3.2 1.0 0.0 0.0 2.9 2.1 0.7 0.4 2.1 2.8 0.0 0.9 2.0 0.4 0.4 0.0 0.3 4.6 0.2 0.9 0.1 12.2 0.5 0.8 0.7 2.5 0.4 0.1 1.6 1.5 12.1 0.8 1.4 1.5 0.7 1.0 4.2 0.4 4.6 0.4 2.5 1.1 1.6 6.7 0.3 0.1 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 24.9 0.2 1.7 0.4 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.3 0.1 0.0 0.0 0.0 0.0 2.9 0.0 1.0 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.4 0.1 0.5 0.0 0.1 0.0 0.1 0.4 0.0 0.3 0.4 0.0 21.0 0.0 0.0 0.6 0.1 0.6 0.3 0.4 0.2 0.1 0.2 1.3 0.1 1.8 0.2 0.0 0.3 4.2 0.0 1.4 4.6 0.7 1.0 2.5 1.4 4.2 0.1 0.4 2.1 0.4 0.4 1.0 0.2 2.1 1.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC107959.5 ENSG00000284956 8 23084403-23115536 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "blood: 69.8" "Cell type enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell type enriched" "Detected in some" 9 "neutrophil: 69.8" "Lineage enriched" "Detected in single" 153 "granulocytes: 69.8" "Cell line enhanced" "Detected in many" "AN3-CA: 13.6;HDLM-2: 16.7" NA NA 0.3 2.0 0.0 1.5 0.0 3.1 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 2.7 0.0 0.0 3.5 0.0 0.4 0.0 0.7 0.0 0.4 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 9.7 0.5 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.1 69.8 0.4 0.0 0.0 0.1 2.6 3.8 0.7 13.6 0.0 1.7 2.8 0.0 0.5 0.2 2.1 0.4 1.2 2.8 4.1 0.9 1.0 0.1 0.5 0.5 1.9 16.7 1.6 0.0 2.1 7.6 1.6 0.5 5.8 1.7 2.1 0.7 0.7 3.5 2.5 0.4 0.7 0.0 0.6 0.0 0.0 0.7 3.5 2.8 0.5 0.1 0.9 0.3 0.9 0.1 0.2 0.1 0.3 2.0 4.9 1.3 1.8 0.3 1.3 4.8 6.8 6.9 0.8 6.4 4.8 0.2 5.3 1.3 4.0 0.6 0.4 8.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 69.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC108488.2 ENSG00000255767 2 3531984-3547957 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.4" "Group enriched" "Detected in some" 26 "Alveolar cells type 2: 1.7;Ciliated cells: 4.0;Club cells: 3.4;granulocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 1.0 1.8 2.5 0.0 2.0 0.0 2.1 1.2 1.4 2.6 1.2 0.0 4.3 5.6 1.4 2.2 2.3 11.3 2.4 2.1 2.1 3.1 1.7 1.2 3.0 6.4 1.7 0.1 1.6 1.8 1.6 2.0 1.5 3.8 3.9 1.2 1.1 5.0 2.2 1.6 6.1 2.5 1.3 1.5 2.3 0.8 3.7 14.4 0.7 3.9 4.4 5.5 2.3 2.5 15.8 4.9 3.8 6.4 7.6 7.0 2.7 2.9 7.5 4.9 10.5 4.0 1.9 9.0 8.5 6.2 3.2 4.6 5.3 6.2 0.8 5.5 11.7 3.0 19.8 4.3 2.1 2.3 5.0 4.2 3.3 3.4 6.1 13.8 6.4 8.0 0.4 6.7 2.5 0.7 3.1 2.1 2.4 8.4 0.9 11.4 1.0 5.1 3.2 1.6 1.3 1.9 2.9 5.1 3.4 1.3 12.7 5.2 6.4 3.9 3.5 4.5 3.1 4.8 0.7 6.0 5.8 3.2 0.0 3.0 0.7 0.7 3.7 0.9 2.4 0.5 1.4 3.6 3.7 3.0 5.5 0.4 4.4 3.9 14.4 0.7 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC115220.1 ENSG00000241149 7 63998874-64016130 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 10.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 19 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.4;T-47d: 1.4;U-266/70: 1.4" NA NA "unprognostic (6.95e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC116565.1 ENSG00000273238 4 573880-576300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 12.7;skin 1: 7.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.1;NB-4: 2.6;NTERA-2: 4.8;SCLC-21H: 10.5;U-2 OS: 2.6;U-251 MG: 3.2" "Low region specificity" "Detected in all" NA NA "unprognostic (4.13e-3)" "unprognostic (6.97e-3)" "unprognostic (2.65e-2)" 0.0 1.8 1.3 0.0 3.1 0.0 0.1 0.0 12.7 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.3 2.6 4.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC117457.1 ENSG00000275163 3 178419123-178843300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 1.4;Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HSkMC: 5.7" NA NA 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.1 2.9 0.0 0.0 0.0 11.8 0.0 12.2 0.3 0.2 0.3 5.2 0.2 1.5 0.0 0.0 0.0 2.6 2.9 0.0 19.9 0.0 11.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118470.1 ENSG00000239395 1 247711813-247723764 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 44 "testis: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 89 "GAMG: 8.9" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC119396.1 ENSG00000263264 I3L1I5 19 7348943-7383385 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 61.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 28.8;HL-60: 12.4;HMC-1: 7.8;MOLT-4: 11.9;REH: 11.1;THP-1: 12.0;U-698: 18.6;U-937: 9.7" HPA049151 Uncertain NA NA "HPA049151: AB_2680654" "unprognostic (7.21e-3)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (2.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.23e-5)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (2.06e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-2)" "unprognostic (9.22e-2)" "unprognostic (3.55e-2)" 0.5 2.8 0.2 26.7 0.2 13.3 0.4 0.2 0.2 0.7 6.1 0.1 0.0 0.4 6.1 0.3 1.7 0.8 1.9 0.3 0.2 0.2 0.7 0.4 2.0 28.7 0.3 0.5 0.3 0.3 0.0 0.3 0.4 0.1 0.4 0.4 0.4 7.8 0.5 0.3 0.2 9.3 4.0 0.2 21.0 2.9 0.4 0.1 61.5 0.7 0.6 25.9 1.9 0.4 12.1 1.8 15.1 3.9 0.8 4.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 12.4 7.8 0.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 11.9 1.7 0.0 0.0 0.0 11.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 18.6 0.0 9.7 0.0 1.2 2.4 15.1 2.7 3.0 2.0 7.3 3.8 2.7 1.3 12.1 4.7 3.1 9.9 0.8 3.9 1.8 3.4 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC119676.1 ENSG00000284895 1 41585306-41628816 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "blood: 1.9;lung: 3.2;smooth muscle: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.2;ASC diff: 11.5;U-266/70: 1.8;WM-115: 2.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC126283.2 ENSG00000285330 4 109713916-109801999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "kidney: 61.8;liver: 135.8" "Group enriched" "Detected in some" 60 "Alveolar cells type 2: 2.9;Club cells: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 27.6;EFO-21: 5.2;Hep G2: 9.6;RPTEC TERT1: 9.8" "HPA001143, HPA024061, HPA035909" Uncertain NA NA "HPA001143: AB_1078555, HPA024061: AB_1847129, HPA035909: AB_10672074" 2.4 2.3 0.4 2.0 0.4 0.0 1.6 0.0 1.3 2.6 2.2 0.1 1.3 3.8 2.2 7.6 2.4 1.8 2.5 2.6 0.5 61.8 135.8 4.3 1.5 0.6 0.0 6.6 6.5 0.7 2.0 2.2 1.1 2.0 0.7 4.0 0.5 0.7 1.4 0.0 3.9 0.8 1.4 4.7 1.3 1.8 0.4 0.0 3.0 0.9 0.4 2.6 1.8 0.2 0.8 0.2 0.3 0.2 0.7 1.2 0.0 0.5 0.0 0.3 0.2 0.1 0.0 0.4 1.0 0.0 0.1 0.1 27.6 0.1 5.2 0.2 0.2 0.0 0.1 0.0 0.0 4.2 0.1 0.0 0.4 9.6 3.3 0.3 0.0 3.5 0.0 0.0 0.1 0.5 1.8 0.0 0.3 1.6 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.1 9.8 0.8 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 4.2 0.1 1.2 0.2 0.3 0.0 0.3 0.0 0.4 0.1 0.5 0.3 0.7 0.2 0.7 0.5 0.0 0.2 0.2 0.8 0.5 1.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC126755.2 ENSG00000233024 "Nuclear pore complex-interacting protein family member A5 isoform 2 " 16 18358086-18379331 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.5" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Ciliated cells: 10.7;granulocytes: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.7" "Group enriched" "Detected in many" 6 "B-cells: 4.7;T-cells: 1.8" "Low cell line specificity" "Detected in all" HPA053611 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (9.10e-2)" "unprognostic (6.00e-3)" "unprognostic (1.66e-1)" "unprognostic (5.77e-2)" "unprognostic (8.31e-2)" "unprognostic (6.34e-2)" "unprognostic (6.34e-2)" "unprognostic (6.76e-2)" "unprognostic (1.30e-3)" "unprognostic (5.87e-2)" "unprognostic (5.79e-3)" "unprognostic (1.60e-2)" "unprognostic (1.25e-5)" "unprognostic (1.96e-1)" "unprognostic (1.90e-2)" "unprognostic (5.38e-2)" "unprognostic (6.45e-3)" 4.1 5.4 5.2 3.3 5.5 3.3 6.0 46.5 10.1 5.4 6.9 3.4 9.5 10.0 4.7 6.3 4.4 3.3 6.4 6.4 3.5 4.6 5.4 4.2 3.3 11.5 6.6 14.3 27.8 2.8 5.4 6.3 3.7 7.0 17.5 9.8 4.5 7.6 2.8 4.9 4.0 4.6 6.5 3.6 4.6 3.8 4.7 0.5 0.5 0.5 0.3 1.8 0.5 7.0 4.7 26.0 21.2 22.3 20.8 6.1 27.2 9.9 13.4 20.0 4.6 4.2 9.8 10.6 23.9 7.9 12.8 8.0 7.3 16.4 8.3 7.7 26.2 22.7 22.6 22.7 12.4 60.1 21.3 33.3 16.8 22.6 28.3 6.5 12.2 6.0 19.7 13.4 10.8 20.3 27.2 11.0 7.0 5.9 29.2 6.4 9.8 13.3 13.4 7.4 11.6 17.1 10.8 14.6 10.4 9.9 14.9 12.4 18.1 8.0 15.2 8.3 14.9 11.6 15.0 8.1 17.3 9.3 0.0 0.5 0.5 1.8 0.1 0.6 4.7 1.2 0.9 0.2 1.1 1.0 0.4 0.0 0.3 0.3 0.5 0.4 0.5 3.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 10.7 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC129492.3 ENSG00000263620 17 8150816-8162975 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 49.9;brain: 39.2;skeletal muscle: 55.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 23.3;HEK 293: 9.6;PC-3: 7.7;REH: 11.5" NA NA 14.0 6.0 11.2 2.6 25.6 2.6 2.7 14.6 39.2 4.9 20.3 11.0 1.3 2.6 5.9 2.6 3.4 3.3 2.6 32.0 8.5 3.0 3.6 4.4 7.5 2.9 5.3 15.7 2.6 2.6 2.6 5.4 2.6 19.9 3.3 2.6 7.6 3.1 2.6 55.4 2.6 2.6 2.6 3.7 14.9 18.7 3.0 7.0 0.7 2.6 0.6 2.6 5.2 3.1 31.4 23.7 49.9 12.9 29.2 45.5 15.5 1.6 0.2 0.2 0.0 0.0 0.0 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.3 3.9 0.0 0.0 0.0 23.3 9.6 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 7.7 11.5 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.5 0.5 0.7 0.0 2.9 0.0 2.6 3.9 5.9 2.6 0.0 0.0 3.7 18.0 9.8 36.6 37.5 11.4 33.1 31.4 38.0 42.3 8.7 28.3 45.5 39.7 49.9 29.2 12.9 23.7 27.2 15.5 11.2 25.6 14.6 39.2 8.5 3.0 5.3 15.7 19.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC131097.2 ENSG00000216921 2 241893985-241902551 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "pancreas: 27.6;tongue: 59.2" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 7.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.1;MCF7: 1.8;REH: 6.3;SCLC-21H: 4.1" HPA073342 Approved Nucleoplasm NA NA Nucleoplasm "HPA073342: " "unprognostic (9.31e-2)" "unprognostic (4.59e-2)" "unprognostic (1.61e-2)" "unprognostic (1.10e-1)" "unprognostic (7.48e-2)" "unprognostic (3.12e-1)" "unprognostic (2.93e-2)" "unprognostic (4.75e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (2.04e-2)" "unprognostic (5.12e-2)" "unprognostic (5.44e-2)" "unprognostic (8.45e-2)" "unprognostic (2.44e-1)" "unprognostic (3.29e-1)" 2.7 0.3 4.9 0.6 4.4 0.2 1.6 1.7 2.4 0.8 0.6 0.6 0.6 0.1 0.6 0.6 3.8 0.5 0.9 0.6 2.1 2.3 0.6 0.6 0.6 0.6 3.9 0.6 1.4 27.6 0.0 0.6 0.6 0.6 2.6 0.0 0.6 4.4 4.0 3.7 2.6 0.6 0.6 0.6 0.6 0.1 0.8 0.6 1.1 6.4 59.2 2.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.5 0.6 0.0 1.8 1.4 0.2 0.5 0.0 0.0 6.3 0.0 0.6 0.0 0.0 4.1 0.1 0.0 0.6 0.0 0.9 0.0 0.9 1.2 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.4 1.7 2.4 2.1 2.3 3.9 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC133551.1 ENSG00000274175 Unmapped 17234-19833 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 30 "epididymis: 11.7;testis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;EFO-21: 2.1;HEL: 1.6;HMC-1: 1.3;K-562: 2.2;RPMI-8226: 1.4;U-2 OS: 1.8;U-266/84: 3.6" "HPA047832, HPA060916" Uncertain "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.2 1.8 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC133555.3 ENSG00000258150 16 29464967-29467833 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.8" "Cell type enriched" "Detected in some" 7 "Alveolar cells type 1: 11.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.9;CAPAN-2: 22.0;SK-BR-3: 17.2" HPA053608 Uncertain NA NA "HPA053608: AB_2682205" "unprognostic (9.92e-2)" 1.5 0.2 1.1 0.2 0.3 1.5 1.3 0.1 1.6 0.7 0.8 4.2 1.1 0.0 0.7 3.0 4.1 0.8 0.4 1.0 1.3 0.0 0.8 3.1 0.5 0.5 0.2 0.2 1.6 0.0 0.5 0.3 5.1 0.3 0.9 0.6 0.7 0.2 0.3 0.5 0.3 9.8 0.5 0.3 0.3 0.6 0.6 2.5 0.9 2.5 0.2 1.7 0.8 1.4 4.9 0.2 0.1 0.8 0.5 0.6 0.1 0.4 0.4 0.6 0.0 22.0 0.7 2.2 0.4 0.0 1.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.8 0.0 0.4 0.0 0.2 0.0 0.1 0.8 0.5 0.1 0.0 0.0 0.5 0.0 0.4 0.0 0.4 2.5 0.2 0.0 0.3 0.0 17.2 0.0 0.0 0.3 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.4 0.6 1.8 0.1 1.7 1.5 0.4 0.6 1.2 0.4 2.5 0.2 0.5 1.0 0.9 0.2 2.5 0.2 0.8 0.8 11.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC134669.1 ENSG00000265118 17 31305213-31318831 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "blood: 57.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 57.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.5;HMC-1: 5.3;Karpas-707: 4.9;MOLT-4: 9.5;RPMI-8226: 7.7" HPA045033 Uncertain NA NA "HPA045033: AB_2679191" "unprognostic (5.33e-2)" "unprognostic (3.44e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (5.88e-2)" "unprognostic (2.94e-2)" "unprognostic (2.40e-2)" "unprognostic (4.63e-2)" "unprognostic (3.23e-1)" "unprognostic (5.45e-5)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (4.53e-2)" 2.4 0.3 1.4 6.6 2.1 3.0 0.5 0.5 4.5 0.3 1.1 0.5 0.2 1.2 0.5 1.1 0.8 0.7 2.0 0.4 2.6 1.5 0.6 0.7 4.9 4.0 6.8 1.8 0.6 0.3 0.1 0.4 2.0 2.1 0.7 1.2 0.5 2.2 0.6 0.6 0.4 2.6 1.1 4.4 4.5 2.4 0.8 4.3 2.2 0.7 0.2 5.9 1.7 0.5 9.3 14.7 57.6 24.1 4.7 12.3 20.3 0.1 0.0 0.0 0.0 0.0 5.5 0.1 0.4 1.0 0.6 1.2 0.0 0.0 1.0 0.0 0.4 1.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 3.5 1.8 5.3 1.2 0.1 0.0 2.3 0.6 0.0 1.9 0.0 4.9 1.8 0.0 9.5 0.8 0.0 0.0 0.0 2.9 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.1 1.9 2.2 1.0 0.2 1.1 1.2 4.7 0.0 3.6 0.3 1.6 1.1 1.7 24.1 2.0 8.6 11.0 7.9 9.3 10.0 8.9 14.7 5.6 10.1 9.1 57.6 4.7 10.9 4.8 12.3 20.3 1.4 2.1 0.5 4.5 2.6 1.5 6.8 1.8 2.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC134980.5 ENSG00000285472 15 22015233-22095857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.3" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135050.2 ENSG00000255439 16 31083439-31094956 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042720 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (6.94e-2)" "unprognostic (2.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.68e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "unprognostic (3.57e-1)" "unprognostic (2.79e-2)" "unprognostic (4.48e-3)" "unprognostic (8.49e-2)" "unprognostic (2.84e-8)" "unprognostic (4.96e-6)" "unprognostic (1.39e-1)" "unprognostic (4.81e-1)" "unprognostic (2.29e-4)" 4.5 2.6 1.6 4.8 1.7 3.0 6.4 1.9 2.6 5.4 3.9 3.3 3.2 3.3 5.1 5.9 3.7 4.0 4.9 3.7 1.8 1.8 6.9 47.1 3.6 3.7 2.4 1.1 5.6 14.1 4.6 3.1 4.8 2.3 4.8 2.2 4.4 8.3 3.8 2.0 7.8 6.0 6.3 1.8 4.3 3.5 3.6 1.5 3.0 5.7 2.4 2.6 6.5 3.9 2.3 2.6 2.9 2.7 1.4 3.8 2.0 1.2 1.2 0.0 1.2 2.7 3.6 0.3 3.7 0.9 0.0 0.5 0.6 0.7 0.7 1.9 0.3 0.0 0.5 0.0 0.4 0.0 0.4 1.7 1.5 1.2 0.5 0.0 0.0 1.5 1.0 0.6 0.6 0.0 0.6 0.0 1.1 0.0 1.5 0.3 1.2 1.0 3.1 0.3 0.1 1.6 2.9 0.2 1.1 0.0 0.8 1.0 0.9 1.8 1.0 1.9 0.0 0.0 0.4 0.0 1.2 0.0 3.2 0.9 3.6 0.8 0.0 2.9 0.9 0.4 0.8 1.6 2.9 2.7 1.6 3.5 2.3 3.4 3.8 2.3 1.8 2.1 2.8 1.5 1.4 2.7 2.6 3.4 2.0 1.6 1.7 1.9 2.6 1.8 1.8 2.4 1.1 2.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.1 ENSG00000182974 15 21637909-21638992 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "U-2 OS: 2.7" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.3 ENSG00000279408 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.7" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135586.2 ENSG00000256632 12 132688049-132714912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 29.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 2.0;REH: 3.8;THP-1: 3.6;U-698: 4.5" NA NA "unprognostic (1.17e-1)" "unprognostic (2.35e-1)" "unprognostic (1.86e-1)" "unprognostic (3.82e-3)" "unprognostic (1.47e-1)" "unprognostic (8.10e-3)" "unprognostic (1.22e-1)" "unprognostic (2.00e-2)" "unprognostic (2.76e-1)" "unprognostic (5.99e-3)" "unprognostic (6.55e-2)" "unprognostic (1.94e-1)" "unprognostic (1.87e-1)" "unprognostic (2.98e-1)" 1.3 1.3 1.5 1.7 1.4 1.3 3.4 1.3 2.2 1.2 6.8 0.5 2.1 12.6 1.2 1.7 1.3 1.6 5.0 6.0 1.4 1.2 4.6 29.6 1.3 1.3 1.4 1.5 1.6 13.0 0.9 1.2 1.0 0.8 1.4 1.2 0.9 2.8 0.9 3.1 1.3 10.2 0.9 1.2 1.3 3.3 2.3 0.9 4.9 2.3 1.4 0.9 1.2 1.3 1.0 0.0 0.2 0.3 0.0 1.3 0.4 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 1.4 1.3 0.0 0.5 0.7 3.8 0.4 0.6 0.0 0.7 0.5 1.5 0.0 0.0 0.2 0.7 1.0 3.6 0.0 0.0 0.7 0.7 0.0 0.0 0.8 4.5 0.0 0.2 0.6 0.0 0.3 0.2 0.0 0.0 0.0 1.0 0.8 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.5 1.4 1.3 2.2 1.4 1.2 1.4 1.5 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136352.3 ENSG00000277666 Unmapped 100123-101141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 2.2;U-2 OS: 1.1" HPA003342 Uncertain NA NA "HPA003342: AB_1078588" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136428.1 ENSG00000259680 16 33844784-33845229 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 3.6;naive B-cell: 4.0" "Lineage enriched" "Detected in single" 40 "B-cells: 4.0" "Not detected" "Not detected" NA NA "unprognostic (1.57e-3)" "unprognostic (1.35e-2)" "unprognostic (5.32e-2)" "prognostic favorable (6.96e-5)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-3)" "unprognostic (7.52e-2)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.58e-1)" 0.6 0.4 0.4 5.0 0.4 1.8 1.6 0.4 0.4 2.7 7.0 0.5 0.2 5.9 0.5 0.2 2.3 1.1 0.2 1.1 0.4 0.4 0.9 0.5 2.0 0.2 0.4 0.2 0.4 0.4 0.0 0.4 0.2 0.2 0.5 3.7 0.5 3.4 0.2 0.4 0.4 5.7 0.2 0.4 6.8 6.9 0.5 0.2 0.2 0.5 0.2 15.7 6.3 1.0 4.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136612.1 ENSG00000275869 "TP53 target 3 family member E " Unmapped 933862-936467 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "epididymis: 2.1;testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;HMC-1: 1.6;K-562: 2.9;U-2 OS: 2.5;U-266/84: 3.8" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.7 0.0 0.4 0.0 0.0 2.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.3 0.7 0.4 0.5 0.0 0.0 0.4 2.5 0.2 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.7 0.4 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 AC136616.1 ENSG00000273554 Unmapped 1139577-1147868 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "skin 1: 3.0;testis: 8.5" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 36.3;Late spermatids: 27.8;Spermatocytes: 20.6;Spermatogonia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AN3-CA: 18.7" NA NA 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 18.7 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 8.4 0.0 1.1 0.0 0.0 0.0 AC136616.2 ENSG00000277761 Unmapped 1167457-1257196 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.8;intestine: 15.5;stomach 1: 13.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 92 "memory B-cell: 17.8;naive B-cell: 4.7" "Lineage enriched" "Detected in single" 145 "B-cells: 17.8" "Group enriched" "Detected in some" 9 "HaCaT: 2.6;RH-30: 2.1;U-251 MG: 1.1;U-937: 2.7" NA NA 0.0 9.5 5.0 0.4 4.3 0.0 0.0 15.5 6.6 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.1 4.7 0.0 0.0 0.0 0.0 6.8 11.1 0.0 0.0 0.0 7.1 0.0 3.9 13.5 0.0 0.0 11.0 10.4 17.8 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC136616.3 ENSG00000278782 Unmapped 1157687-1240349 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 6.6;breast: 4.8;cervix, uterine: 6.8;intestine: 5.2;lymphoid tissue: 7.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "naive B-cell: 6.6" "Lineage enriched" "Detected in single" 66 "B-cells: 6.6" "Cell line enriched" "Detected in single" 16 "U-251 MG: 1.6" NA NA 0.0 0.0 0.1 0.4 4.8 0.0 6.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.6 0.0 0.0 0.0 5.2 0.0 2.0 0.0 0.0 0.0 7.7 3.6 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC138647.1 ENSG00000226490 8 141514638-141518737 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "testis: 39.4" "Group enriched" "Detected in some" 66 "Early spermatids: 146.1;Late spermatids: 40.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "SCLC-21H: 2.0" "Not detected" "Not detected" NA NA 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 2.6 0.9 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 146.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.0 0.0 AC138811.2 ENSG00000260342 16 18788063-18801519 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 51.6;testis: 43.2" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 3.5;Ciliated cells: 9.4;Club cells: 4.5;granulocytes: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 28.6;HDLM-2: 34.8" HPA045307 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045307: AB_10961042" "unprognostic (1.03e-2)" "unprognostic (8.89e-3)" "unprognostic (1.22e-1)" "unprognostic (3.59e-3)" "unprognostic (2.28e-1)" "unprognostic (6.32e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (1.46e-1)" "unprognostic (1.40e-2)" "unprognostic (3.27e-1)" "unprognostic (3.18e-4)" "unprognostic (2.92e-1)" "unprognostic (3.89e-2)" "unprognostic (2.65e-2)" "unprognostic (3.95e-2)" 5.0 5.8 7.8 7.0 12.6 4.6 4.4 9.4 17.0 3.8 13.5 6.3 2.3 1.9 4.2 3.1 5.6 3.5 3.8 4.8 6.9 4.8 6.4 12.1 4.3 4.0 6.6 10.6 4.1 9.3 10.8 3.6 4.0 17.1 3.6 4.1 9.6 4.1 4.1 12.0 4.0 5.9 5.5 7.0 6.0 14.6 43.2 4.0 7.5 4.5 1.6 4.1 4.7 3.9 29.2 51.6 29.0 25.8 37.2 49.0 48.3 11.6 2.3 2.0 12.2 0.7 0.3 0.4 12.6 0.7 1.2 1.6 8.3 14.9 3.1 28.6 2.9 3.1 13.9 4.4 1.8 3.6 34.8 1.3 3.3 5.3 2.2 0.0 15.8 8.2 0.7 0.4 4.2 0.0 1.2 0.7 1.5 6.7 12.1 1.3 0.0 5.5 0.2 1.1 0.7 0.3 21.1 4.5 1.6 0.8 7.0 6.4 0.7 16.3 4.3 1.1 1.1 7.8 0.3 13.1 5.7 8.9 5.6 13.0 3.3 16.5 7.2 8.1 1.9 13.2 29.0 25.8 15.0 43.5 18.0 34.2 29.0 34.9 41.5 24.5 29.2 29.8 32.9 20.1 37.2 22.9 51.6 49.0 48.3 7.8 12.6 9.4 17.0 6.9 4.8 6.6 10.6 17.1 4.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AC140504.1 ENSG00000261130 16 15395754-15515348 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1.3 1.3 2.2 1.3 3.5 1.3 1.3 1.7 3.2 1.3 1.3 4.5 0.0 1.3 1.3 1.3 1.5 1.3 1.9 1.3 2.8 1.6 2.4 5.3 1.4 1.3 1.5 2.2 1.5 16.2 1.3 5.1 1.3 2.3 1.3 1.3 4.1 1.3 1.3 7.3 1.3 1.9 3.9 1.3 1.6 1.3 1.3 2.6 0.0 1.3 0.0 1.3 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.5 1.7 3.2 2.8 1.6 1.5 2.2 2.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC141272.1 ENSG00000277836 Unmapped 1270984-1271271 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 15.4;intestine: 16.4;lymphoid tissue: 22.4;urinary bladder: 14.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 113 "memory B-cell: 15.4;naive B-cell: 7.0" "Lineage enriched" "Detected in single" 155 "B-cells: 15.4" "Cell line enhanced" "Detected in some" "Daudi: 1.9;K-562: 2.1;RH-30: 1.8;RPMI-8226: 6.0;SCLC-21H: 1.7" NA NA 0.0 0.0 6.5 1.5 1.0 0.0 2.9 16.2 16.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 5.2 10.9 0.0 0.0 0.0 8.3 0.0 4.3 11.6 0.0 0.0 22.4 14.5 15.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 6.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC171558.1 ENSG00000274792 Unmapped 386278-387620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "testis: 1.6" "Group enriched" "Detected in some" 5 "Early spermatids: 4.8;Late spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "NTERA-2: 1.1;U-2 OS: 1.1" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 AC171558.3 ENSG00000275249 Unmapped 372322-373405 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC187653.1 ENSG00000248767 7 290170-294422 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC213203.1 ENSG00000277475 Unmapped 31698-32528 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 10.5;pancreas: 5.8;testis: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 27 "eosinophil: 10.5" "Lineage enriched" "Detected in single" 27 "granulocytes: 10.5" "Cell line enhanced" "Detected in some" "A549: 10.6;HeLa: 3.3;HMC-1: 8.4;SCLC-21H: 7.0" NA NA 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.4 0.2 0.0 0.3 0.8 0.0 1.2 0.0 0.5 5.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.2 1.5 13.3 0.0 0.0 0.0 0.3 0.0 10.5 0.0 0.0 0.3 0.1 2.2 10.6 1.3 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.4 0.9 0.2 0.5 0.0 0.2 0.6 0.0 0.0 0.1 0.0 1.1 0.6 3.3 0.0 0.0 0.1 8.4 0.2 0.0 0.2 0.0 2.2 0.8 1.7 1.0 0.0 0.0 0.0 0.0 0.2 1.2 1.0 0.0 1.1 0.0 0.0 0.0 0.0 7.0 0.1 1.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.4 0.1 0.0 0.4 0.6 0.2 0.2 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233723.1 ENSG00000262165 17 4801159-4807013 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 4.7;pancreas: 3.4" "Cell type enriched" "Detected in some" 4 "monocytes: 13.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 4.9;SCLC-21H: 15.0" "Region enhanced" "Detected in single" "basal ganglia: 2.6" NA NA "unprognostic (3.93e-2)" "unprognostic (3.90e-2)" "unprognostic (1.87e-2)" "unprognostic (1.84e-3)" "unprognostic (3.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.23e-2)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (5.14e-3)" "unprognostic (9.42e-2)" "unprognostic (3.09e-2)" "unprognostic (1.16e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" 0.3 0.9 0.3 0.3 0.3 0.0 0.8 0.3 1.4 0.8 0.3 0.3 0.3 0.0 0.4 0.3 0.3 1.5 0.3 1.0 0.3 0.5 0.3 0.5 0.3 0.3 0.3 4.7 3.4 0.0 0.3 0.3 0.3 1.1 0.0 0.3 0.4 0.5 1.0 2.3 0.3 0.5 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.8 0.7 1.2 1.9 0.3 2.4 1.1 0.4 0.9 0.0 4.9 0.7 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.7 0.0 0.0 0.7 1.5 1.3 0.6 0.4 1.0 0.8 0.0 1.3 0.5 0.7 0.0 0.9 0.7 1.5 1.3 0.1 0.2 0.0 1.5 0.0 15.0 0.9 0.0 0.0 0.3 1.4 0.0 0.0 2.0 0.2 0.5 0.3 0.1 0.2 0.0 0.5 0.5 0.0 0.2 0.0 1.9 0.0 1.1 0.0 1.8 1.4 1.0 0.1 0.7 1.8 1.7 2.4 1.2 0.3 1.6 0.1 0.4 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 1.7 0.6 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.9 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 AC233724.12 ENSG00000250782 5 17634460-17635053 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "smooth muscle: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "U-2 OS: 4.9" NA NA 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233724.15 ENSG00000283740 5 17604177-17605377 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 4.8" NA NA 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233724.16 ENSG00000283776 5 17632088-17632684 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "urinary bladder: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "U-2 OS: 3.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233724.19 ENSG00000284356 5 17597232-17597828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233724.20 ENSG00000284465 5 17585162-17585758 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233724.6 ENSG00000249156 5 17610496-17611583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.1;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.1" "Group enriched" "Detected in some" 7 "HEK 293: 1.8;U-2 OS: 5.8" NA NA "unprognostic (2.61e-1)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233755.1 ENSG00000275063 "Immunoglobulin heavy variable 4-38-2 " P0DP08 Unmapped 41444-41876 "Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 75.1;intestine: 32.1;lymphoid tissue: 37.1;urinary bladder: 45.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 363 "memory B-cell: 75.1;naive B-cell: 42.7" "Lineage enriched" "Detected in single" 463 "B-cells: 75.1" "Cell line enriched" "Detected in some" 8 "REH: 56.1" "Secreted to blood" NA NA 0.8 0.0 14.4 2.6 2.8 0.0 10.9 32.1 24.1 0.0 0.0 4.3 0.0 1.0 0.0 0.0 0.0 0.7 5.5 0.0 0.0 0.0 0.0 0.0 11.1 11.1 0.0 0.0 0.0 6.4 0.6 9.4 11.7 0.0 0.0 37.1 45.9 75.1 0.1 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.0 7.4 0.1 0.1 0.0 0.0 56.1 0.6 1.2 0.0 0.0 0.0 3.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.1 0.0 0.0 0.0 42.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC233755.2 ENSG00000277856 Unmapped 26241-26534 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 20.4;intestine: 14.5;lymphoid tissue: 33.2;stomach 1: 13.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 180 "memory B-cell: 15.5;naive B-cell: 20.4" "Lineage enriched" "Detected in single" 205 "B-cells: 20.4" "Cell line enhanced" "Detected in some" "JURKAT: 11.2;MOLT-4: 10.4;REH: 3.3;SH-SY5Y: 3.5;TIME: 2.3" NA NA 0.3 0.0 4.2 2.9 1.1 0.0 0.7 14.5 14.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 2.4 5.5 0.0 0.0 0.0 4.2 0.0 4.7 13.5 0.0 0.0 33.2 11.3 20.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.2 0.0 0.0 0.0 10.4 0.6 0.0 0.0 0.0 3.3 1.7 0.0 0.0 0.0 0.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC243547.3 ENSG00000280778 1 145927258-145977811 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pituitary gland: 7.2;testis: 9.9" "Group enriched" "Detected in some" 13 "Alveolar cells type 2: 1.4;Ciliated cells: 1.4;granulocytes: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 5.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.2" "Group enriched" "Detected in some" 25 "U-698: 1.2;U-87 MG: 3.8" NA NA 0.7 0.7 1.8 0.7 2.2 0.7 0.7 5.9 2.6 0.7 0.7 2.3 0.7 0.7 0.7 1.2 0.7 0.7 0.7 0.7 1.2 0.9 0.7 0.7 0.8 1.9 1.1 0.7 3.5 0.7 7.2 0.7 3.0 0.7 0.7 0.8 2.1 0.7 0.7 0.7 0.7 0.7 1.6 0.7 0.7 9.9 2.2 4.2 0.7 0.3 0.7 0.7 0.0 1.0 0.0 5.2 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC243756.1 ENSG00000270339 1 146344131-146344790 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;endometrium 1: 1.0;lymphoid tissue: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 15 "THP-1: 5.3" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (1.35e-1)" "unprognostic (2.13e-3)" "unprognostic (2.34e-1)" "unprognostic (2.76e-2)" "unprognostic (2.34e-1)" "unprognostic (2.84e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.0 1.7 0.0 0.3 0.0 0.5 0.0 0.4 0.7 0.2 0.2 0.3 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.0 0.1 1.1 0.4 0.8 0.5 0.4 0.4 0.5 1.0 0.2 0.3 0.1 0.7 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC243967.1 ENSG00000267881 19 41708612-41761282 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "esophagus: 79.7;intestine: 34.3;lymphoid tissue: 77.4;tongue: 22.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;HaCaT: 1.6;MCF7: 1.6;OE19: 4.8;RT4: 3.5;U-2 OS: 1.1" HPA011041 Approved NA NA "HPA011041: AB_1078481" "unprognostic (1.55e-2)" "unprognostic (1.15e-2)" "unprognostic (9.59e-3)" 0.4 0.3 0.3 60.6 0.4 0.2 0.5 0.6 0.4 9.2 34.3 0.0 0.0 0.5 0.3 0.1 79.7 0.3 0.5 0.5 0.4 0.3 0.4 0.7 1.4 0.1 0.3 0.0 0.5 0.6 0.3 0.5 0.1 0.0 0.5 0.4 0.0 0.7 0.1 0.4 0.5 6.1 0.7 0.3 0.6 0.8 0.6 0.0 0.0 0.4 22.3 77.4 1.0 8.0 0.1 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.0 0.0 0.3 0.4 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC244197.3 ENSG00000241489 X 149482543-149533935 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "pituitary gland: 17.9" "Group enriched" "Detected in some" 34 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0;granulocytes: 4.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.57e-2)" "unprognostic (2.77e-2)" "unprognostic (5.48e-2)" "unprognostic (4.27e-2)" "unprognostic (4.81e-2)" "unprognostic (9.16e-3)" "unprognostic (4.51e-3)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.01e-3)" "unprognostic (4.33e-2)" "unprognostic (1.37e-5)" "unprognostic (1.84e-1)" "unprognostic (2.58e-1)" "unprognostic (3.90e-2)" "unprognostic (3.27e-4)" 1.6 2.6 0.3 0.9 1.0 1.1 2.6 1.1 0.9 3.4 2.8 1.5 5.2 16.4 3.1 7.5 2.1 3.8 0.5 1.0 3.3 1.7 3.6 1.4 0.4 6.4 2.9 4.2 17.9 1.3 5.6 3.3 3.3 5.0 1.0 4.1 2.2 3.0 0.7 2.2 2.2 1.8 5.3 1.9 3.2 3.6 1.5 1.8 14.0 4.3 2.6 5.5 4.3 4.6 16.2 9.3 3.5 5.5 5.3 1.6 3.0 3.9 2.6 7.1 2.2 7.6 8.5 7.6 7.0 6.8 12.8 1.6 5.7 2.6 9.1 4.6 1.5 10.8 1.1 2.3 1.9 11.9 8.6 4.7 6.8 5.2 15.9 3.3 3.9 1.2 10.6 3.5 11.9 1.7 1.3 0.7 6.7 5.1 1.8 2.3 5.0 7.5 4.6 5.3 5.3 2.1 4.0 1.0 5.7 3.3 1.5 7.0 4.9 6.2 4.8 3.4 8.2 3.5 3.3 8.0 3.8 2.4 0.2 2.7 14.0 5.5 2.6 2.9 1.5 1.9 2.7 1.8 0.8 0.9 0.9 10.4 2.6 4.3 1.7 4.9 4.3 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC244517.10 ENSG00000279983 5 141223372-141245861 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;U-87 MG: 1.7;WM-115: 2.7" NA NA 2.0 0.7 2.5 1.7 3.9 0.7 0.8 3.9 6.2 3.6 1.1 2.5 0.0 0.7 4.8 8.6 1.9 2.0 1.5 1.2 2.6 0.9 1.4 1.1 1.0 1.0 2.5 2.3 0.7 1.7 6.4 1.3 2.2 2.5 0.7 1.9 1.1 0.7 1.8 1.9 0.7 2.4 1.2 0.9 0.9 1.1 1.1 0.0 0.7 1.2 0.8 2.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.7 0.4 0.0 0.4 0.3 0.3 0.0 0.9 0.0 0.8 1.1 0.7 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.4 0.0 1.0 1.0 1.0 1.0 0.0 0.0 0.7 0.7 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.3 0.4 0.0 1.7 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC244517.6 ENSG00000279068 5 141182409-141188582 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;ASC diff: 4.6;EFO-21: 3.7;RH-30: 5.1;U-138 MG: 10.4;U-2197: 6.8" NA NA "unprognostic (2.86e-4)" "unprognostic (2.14e-2)" "unprognostic (4.28e-3)" "unprognostic (1.59e-1)" "unprognostic (4.32e-2)" "unprognostic (2.68e-2)" "unprognostic (2.53e-2)" "unprognostic (1.35e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" "unprognostic (1.04e-1)" "unprognostic (1.44e-2)" 4.0 2.0 1.5 2.0 2.1 0.4 2.4 8.2 2.4 7.0 0.9 4.3 0.0 0.4 5.2 6.2 2.6 1.9 2.9 3.6 1.3 1.8 0.9 2.5 0.7 1.2 0.1 8.2 0.6 0.4 14.9 1.8 2.7 5.1 0.8 5.9 1.0 1.0 2.9 1.1 0.6 2.6 1.9 0.9 1.9 1.7 4.1 0.0 2.4 0.0 0.7 5.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 4.6 3.0 0.0 0.0 1.6 0.3 0.2 0.0 0.0 0.1 3.7 0.2 1.9 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.1 0.0 0.0 1.6 1.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.8 0.0 2.1 0.0 0.0 10.4 0.2 6.8 0.4 0.0 0.0 0.1 2.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Group enriched" "Detected in some" 240 "Alveolar cells type 1: 29.8;Alveolar cells type 2: 42.6;Ciliated cells: 20.1;Club cells: 15.9;granulocytes: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 19.0" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: AB_2682686" "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.7 19.0 0.3 0.0 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 29.8 42.6 0.0 0.0 0.0 0.0 0.0 0.0 20.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAA1 ENSG00000060971 "Acetyl-CoA acyltransferase 1" P09110 3 38103129-38137242 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 152.1" "Cell type enhanced" "Detected in all" 9 "Hepatocytes: 651.0;Proximal tubular cells: 601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 51.9;SK-BR-3: 82.5" "Low region specificity" "Detected in all" "HPA006764, HPA007244" Enhanced Supported Peroxisomes NA NA 4300000 Peroxisomes "HPA006764: AB_1078085, HPA007244: AB_1078084" "prognostic favorable (3.00e-4)" "unprognostic (5.57e-2)" "unprognostic (4.54e-2)" "prognostic favorable (7.53e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.23e-4)" "unprognostic (9.35e-3)" "unprognostic (2.91e-2)" "unprognostic (8.11e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.90e-1)" "prognostic favorable (6.99e-9)" "unprognostic (1.72e-1)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (1.65e-2)" 9.5 12.7 11.0 5.6 11.9 9.6 10.2 8.1 14.3 6.7 16.1 12.5 10.6 23.4 4.9 13.3 12.1 4.6 16.0 17.7 10.2 8.9 48.7 152.1 8.2 5.9 14.0 9.4 5.0 19.2 7.4 5.9 6.8 11.0 13.4 12.4 7.3 11.5 9.4 9.8 6.2 23.8 4.8 12.7 10.0 8.5 4.4 10.9 5.7 9.3 10.1 10.2 9.4 7.0 9.2 47.0 32.8 45.2 17.8 19.3 18.8 8.1 8.9 3.0 9.5 13.1 7.7 10.6 7.5 10.9 8.6 8.2 11.9 9.2 4.8 5.4 12.0 4.2 5.4 8.2 12.7 4.7 7.0 8.5 6.2 7.9 33.7 8.5 14.3 14.0 14.2 9.1 7.4 5.3 5.4 11.6 11.8 5.8 5.7 9.5 10.6 13.8 10.2 3.2 51.9 10.8 3.1 5.8 8.1 24.2 24.2 2.6 4.1 7.3 82.5 5.2 4.4 8.5 11.5 8.4 5.2 5.0 10.4 10.3 7.6 4.8 3.8 8.5 12.5 8.3 15.3 29.9 32.8 13.6 40.7 11.4 9.2 13.1 13.3 47.0 8.7 13.0 12.1 20.4 17.8 45.2 27.7 19.3 18.8 11.0 11.9 8.1 14.3 10.2 8.9 14.0 9.4 11.0 10.9 38.7 31.4 45.5 55.9 29.7 37.5 2.4 109.5 17.4 19.4 62.8 13.7 77.1 140.9 89.4 3.0 25.4 292.3 23.3 69.3 52.5 32.7 64.1 18.5 651.0 74.1 7.9 52.9 34.4 86.5 6.4 33.1 68.8 55.6 86.6 63.2 33.0 78.8 122.8 31.1 601.4 14.2 32.3 25.8 17.5 11.7 31.0 83.1 42.0 60.0 69.8 ACAA2 DSAEC ENSG00000167315 "Acetyl-CoA acyltransferase 2" P42765 18 49782167-49813960 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 245.7" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 686.3;Proximal tubular cells: 536.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042303 Approved Supported Mitochondria NA NA 3200000 Mitochondria "HPA042303: AB_10794046" "unprognostic (7.94e-2)" "unprognostic (3.14e-2)" "unprognostic (2.20e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (7.63e-2)" "unprognostic (1.70e-1)" "unprognostic (7.97e-2)" "unprognostic (8.03e-3)" "unprognostic (1.72e-1)" "unprognostic (3.84e-1)" "prognostic favorable (1.36e-10)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (8.26e-3)" "unprognostic (3.41e-1)" 22.7 12.9 9.4 6.9 10.7 4.4 13.0 3.6 7.0 4.1 27.2 8.0 7.8 25.9 5.1 5.1 7.1 4.1 9.2 38.9 6.8 7.0 60.3 245.7 7.9 7.5 10.7 6.1 6.4 13.6 6.3 7.1 7.5 6.7 7.9 18.4 9.5 3.3 6.2 22.9 4.2 37.0 11.3 9.7 6.9 6.0 6.5 7.5 8.4 15.7 8.8 5.0 8.1 4.9 13.0 31.8 27.5 33.0 35.5 40.9 28.6 0.8 14.1 23.6 21.6 31.3 16.6 12.0 7.2 11.8 12.2 9.5 30.0 12.3 12.6 15.5 26.6 12.6 0.9 39.3 4.6 12.1 38.6 9.2 8.9 18.5 35.6 14.8 0.1 16.9 21.9 1.5 19.7 6.2 9.9 20.0 18.3 7.7 11.9 33.9 16.3 0.5 19.5 21.4 5.3 5.7 31.0 50.5 46.2 41.3 0.6 33.9 26.9 0.5 16.6 1.1 19.5 9.4 13.1 9.5 10.4 13.1 15.7 7.9 24.2 27.9 32.2 7.4 18.2 9.5 13.1 25.9 27.5 32.1 33.0 40.9 13.0 19.2 28.6 31.8 9.7 16.4 24.3 2.5 35.5 31.1 14.9 22.6 28.6 9.4 10.7 3.6 7.0 6.8 7.0 10.7 6.1 6.7 7.5 35.7 38.9 45.7 10.9 3.2 5.9 161.7 229.3 29.4 30.7 52.4 3.9 30.0 250.4 111.1 56.2 32.3 191.9 0.0 40.7 49.6 32.6 10.2 44.9 686.3 101.9 1.6 38.5 46.6 63.1 122.0 44.5 46.6 18.6 61.3 59.2 53.2 84.8 76.3 35.0 536.1 27.2 19.4 17.6 27.7 39.6 4.3 22.5 68.2 98.9 4.5 ACACB "ACC2, ACCB, HACC275" ENSG00000076555 "Acetyl-CoA carboxylase beta" O00763 12 109116595-109268226 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Allosteric enzyme, Ligase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 159.9;Peritubular cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.5" "Cell line enriched" "Detected in many" 18 "ASC diff: 73.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006554 Enhanced "Intracellular and membrane" NA NA "HPA006554: AB_1844495" "unprognostic (2.24e-1)" "unprognostic (4.66e-1)" "unprognostic (3.97e-2)" "unprognostic (4.54e-6)" "unprognostic (2.82e-1)" "unprognostic (1.59e-2)" "unprognostic (8.62e-3)" "unprognostic (5.81e-2)" "unprognostic (2.86e-1)" "unprognostic (1.63e-2)" "prognostic favorable (1.93e-4)" "unprognostic (6.63e-2)" "prognostic favorable (1.15e-5)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (1.21e-3)" "unprognostic (2.58e-2)" 104.5 8.2 4.3 10.6 4.0 1.6 67.4 3.3 3.5 3.5 19.3 3.2 6.2 3.8 4.6 4.3 4.9 3.9 10.5 12.1 4.5 2.0 5.4 42.0 3.1 4.0 6.4 2.7 6.8 8.5 8.9 7.1 1.3 3.7 3.6 3.9 4.0 5.8 9.0 154.2 2.8 4.8 7.5 6.5 2.5 5.6 1.6 4.9 0.4 6.2 12.5 1.7 7.3 6.3 2.5 0.2 15.5 0.4 0.1 1.7 0.1 0.2 1.8 1.1 2.2 73.2 0.5 0.8 0.3 0.4 0.3 0.2 1.2 0.3 0.9 0.5 0.3 0.8 1.5 0.9 0.5 0.2 1.1 1.7 2.0 1.8 1.3 0.3 1.7 0.5 0.8 0.4 0.7 0.2 0.5 0.1 1.5 0.2 0.1 0.2 0.5 1.2 1.6 1.2 0.1 3.9 0.6 1.5 0.4 0.6 0.6 0.7 1.7 1.8 0.9 1.1 0.5 0.8 1.8 0.1 0.7 0.4 0.8 0.6 2.8 1.5 1.2 1.7 1.4 0.5 4.1 0.4 15.5 1.1 0.1 0.6 1.7 1.0 0.3 0.2 2.5 1.7 0.9 0.6 0.1 0.2 0.2 0.6 0.1 4.3 4.0 3.3 3.5 4.5 2.0 6.4 2.7 3.7 4.9 6.0 0.6 0.0 2.5 2.1 1.3 29.0 28.1 1.4 2.3 22.7 0.0 0.4 1.7 1.0 27.5 7.1 12.9 0.0 3.6 0.4 5.4 1.4 1.1 159.9 1.6 22.3 9.8 31.3 8.6 31.3 27.0 2.2 5.0 1.0 8.8 7.5 3.5 7.0 47.4 6.5 4.7 6.5 7.6 2.7 2.5 1.4 0.1 0.0 9.7 0.7 ACAD11 FLJ12592 ENSG00000240303 "Acyl-CoA dehydrogenase family member 11" Q709F0 3 132558138-132660723 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 35.0;liver: 42.7" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Intestinal endocrine cells: 4.6;Syncytiotrophoblasts: 8.1" "Cancer enhanced" "Detected in single" "renal cancer: 1.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048317 Enhanced NA NA "HPA048317: AB_2680354" "unprognostic (5.04e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (3.31e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-4)" "unprognostic (1.20e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (5.90e-2)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (1.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.71e-2)" "unprognostic (2.93e-1)" 10.0 7.6 4.9 2.6 9.6 6.3 5.2 5.4 8.0 7.4 9.8 7.2 6.8 11.1 7.2 8.3 3.2 6.4 4.2 8.8 6.6 3.9 35.0 42.7 4.9 3.2 12.9 3.8 7.6 5.9 3.8 13.9 5.9 8.7 4.7 2.7 5.5 4.7 7.4 3.7 6.9 18.8 4.9 12.6 4.5 4.0 5.3 10.2 4.0 5.5 2.3 3.3 5.4 4.7 1.9 2.3 0.2 0.8 2.4 3.7 0.9 4.0 4.0 5.8 8.1 6.2 6.5 7.6 8.7 12.6 4.5 5.8 11.6 1.3 2.8 5.3 3.4 6.6 3.4 3.2 5.7 4.9 4.9 4.1 3.3 3.3 8.5 8.8 2.3 2.3 4.9 3.9 5.9 11.5 9.4 4.2 3.1 1.8 5.4 4.8 5.3 2.3 2.6 3.7 1.9 4.4 2.5 4.7 4.0 7.8 2.2 3.4 5.5 7.5 3.0 18.1 4.4 8.2 2.6 4.0 3.4 1.9 2.5 3.4 5.7 1.8 3.0 4.6 0.9 2.7 0.0 0.7 0.2 1.6 0.8 1.6 1.3 1.4 0.7 0.5 1.9 3.7 1.7 0.0 2.4 0.8 2.3 0.7 0.9 4.9 9.6 5.4 8.0 6.6 3.9 12.9 3.8 8.7 10.2 6.0 2.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 1.2 0.0 0.0 3.3 0.0 0.7 0.6 0.5 0.9 0.0 1.0 0.6 0.7 0.2 1.1 3.0 0.6 0.0 4.6 0.0 1.5 0.0 0.6 0.3 0.0 3.6 0.0 1.0 0.3 0.0 0.7 1.1 1.9 0.0 0.4 0.0 0.2 0.3 8.1 0.0 0.8 0.1 ACADL "ACAD4, LCAD" ENSG00000115361 "Acyl-CoA dehydrogenase long chain" P28330 2 210187939-210225491 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 29.5;thyroid gland: 29.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 49.8;Early spermatids: 59.0;Late spermatids: 54.8;Leydig cells: 43.4;Peritubular cells: 43.9" "Group enriched" "Detected in many" 8 "liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 7.0;RPTEC TERT1: 6.3;RT4: 2.4;SuSa: 6.5;U-2 OS: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011990 Enhanced Supported NA NA "HPA011990: AB_1844465" "unprognostic (6.29e-3)" "unprognostic (7.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (1.33e-2)" "unprognostic (7.66e-3)" "unprognostic (3.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" "unprognostic (1.99e-1)" "prognostic favorable (1.58e-11)" "unprognostic (4.22e-3)" "unprognostic (1.18e-4)" "unprognostic (8.81e-3)" "unprognostic (1.06e-1)" 9.6 1.1 2.0 1.0 1.8 0.0 10.7 1.4 1.8 3.2 0.8 1.5 4.5 0.1 0.7 6.8 1.3 2.3 2.1 2.2 2.4 1.0 17.3 23.0 29.5 0.0 1.6 2.3 12.2 19.3 11.6 5.8 1.2 3.4 14.5 0.2 3.2 9.9 4.8 7.0 2.2 0.3 1.5 3.1 0.0 3.3 4.2 0.9 0.7 29.7 3.7 0.0 0.7 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.3 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.4 0.0 0.0 2.3 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.6 0.0 0.0 0.0 6.3 2.4 0.1 0.9 0.0 0.1 0.0 6.5 0.0 0.0 0.0 0.0 3.5 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.8 1.4 1.8 2.4 1.0 1.6 2.3 3.4 0.9 26.8 49.8 0.0 1.1 0.6 0.2 0.8 10.2 1.4 12.5 21.0 2.0 5.8 13.3 3.4 59.0 0.0 0.0 0.0 10.5 0.4 1.3 4.7 2.3 20.7 0.5 0.0 0.0 1.3 0.3 54.8 43.4 0.8 0.0 0.0 0.0 0.0 5.3 0.0 43.9 25.4 0.1 0.0 1.0 0.6 0.5 0.9 5.3 0.0 0.0 0.6 ACADM "ACAD1, MCAD, MCADH" ENSG00000117054 "Acyl-CoA dehydrogenase medium chain" P11310 1 75724347-75787575 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7;skeletal muscle: 82.8" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 77.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006198, HPA026542" Enhanced Enhanced Mitochondria NA NA 1200000 Mitochondria "HPA006198: AB_1078087, HPA026542: AB_1844469" "unprognostic (9.04e-3)" "unprognostic (2.36e-1)" "prognostic favorable (7.30e-4)" "unprognostic (5.09e-3)" "unprognostic (1.61e-3)" "unprognostic (5.68e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-1)" "unprognostic (8.02e-2)" "unprognostic (4.95e-2)" "unprognostic (9.40e-3)" "unprognostic (3.35e-1)" "prognostic favorable (3.83e-8)" "unprognostic (1.27e-1)" "unprognostic (4.09e-2)" "unprognostic (3.56e-2)" "unprognostic (1.24e-1)" 18.1 25.0 12.3 11.3 13.0 3.9 18.0 12.0 10.8 8.4 21.6 8.3 10.1 25.1 6.7 8.6 21.9 7.6 6.7 49.7 10.5 11.2 71.1 89.7 6.3 9.4 13.0 9.2 10.5 10.3 8.1 12.0 4.2 14.3 9.2 12.1 8.0 9.0 11.7 82.8 5.6 25.1 9.8 10.7 12.3 12.0 8.5 11.0 11.0 12.2 42.1 10.0 9.5 8.1 29.7 16.7 14.1 13.8 16.8 20.0 13.2 7.0 5.6 17.7 7.8 15.3 12.6 5.0 13.3 10.9 13.0 11.0 10.5 11.3 77.6 11.8 9.5 11.2 6.6 15.1 11.3 16.3 30.0 7.4 25.4 17.3 16.2 10.7 21.7 7.1 14.5 6.5 11.4 6.8 10.1 10.2 16.9 25.9 17.5 14.0 2.6 25.4 10.2 14.3 21.5 13.6 33.2 23.4 8.1 21.6 18.7 9.6 12.1 10.8 32.1 27.7 12.8 9.5 27.5 5.5 8.9 8.8 7.6 21.7 11.4 16.3 34.5 7.5 17.7 10.1 10.7 9.6 14.1 13.2 13.8 20.0 29.7 13.8 15.9 14.3 18.0 15.8 17.6 0.8 16.8 12.7 16.7 13.8 13.2 12.3 13.0 12.0 10.8 10.5 11.2 13.0 9.2 14.3 11.0 53.6 43.4 62.8 34.2 24.3 36.0 330.8 53.5 152.6 51.2 55.8 23.6 30.2 291.8 28.7 45.7 27.1 38.4 23.3 23.5 17.3 29.9 27.0 42.8 232.4 67.1 28.6 39.0 43.6 39.4 18.0 43.4 40.9 49.0 30.7 34.0 51.0 23.3 33.6 42.8 350.1 27.0 0.0 32.5 64.2 67.3 23.6 12.8 30.5 42.5 35.5 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Centrosome,Mitochondria NA NA 15000 Mitochondria "Nucleoplasm, Centrosome" "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.2 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 1.8 3.3 4.2 1.3 0.5 10.5 5.3 5.2 2.2 11.9 6.2 0.4 23.6 10.3 2.0 1.7 0.1 1.2 3.9 13.3 4.2 0.0 1.7 4.2 7.2 12.0 1.3 6.6 3.0 5.3 2.7 1.4 7.3 11.5 0.7 4.0 6.2 0.0 9.8 0.6 5.0 8.2 4.4 0.1 3.1 3.0 0.5 10.0 5.6 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 11.9 10.7 10.2 10.2 6.0 1.1 32.5 30.6 2.7 5.7 17.4 0.0 60.7 43.1 26.8 15.8 14.2 312.7 23.3 28.4 26.2 16.9 7.1 19.5 154.5 47.4 1.6 43.8 12.9 27.2 26.3 19.8 11.1 16.9 32.5 94.5 13.0 25.9 154.3 17.0 74.9 0.7 6.5 13.0 29.1 8.3 4.0 63.2 20.3 144.6 9.0 ACADSB "ACAD7, SBCAD" ENSG00000196177 "Acyl-CoA dehydrogenase short/branched chain" P45954 10 123008979-123058311 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 28.9;liver: 114.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 481.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041458, HPA063555" Enhanced Supported Mitochondria NA NA 63000 Mitochondria "HPA041458: AB_2677491, HPA063555: " "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.91e-3)" "unprognostic (2.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.87e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-3)" "unprognostic (1.30e-1)" "unprognostic (3.67e-1)" "prognostic favorable (3.40e-4)" "unprognostic (9.37e-3)" "prognostic favorable (6.37e-12)" "unprognostic (2.69e-1)" "unprognostic (7.20e-2)" "unprognostic (1.60e-3)" "unprognostic (7.14e-2)" 4.6 9.4 6.7 2.4 9.0 1.4 8.3 10.3 8.3 3.9 5.3 5.5 6.4 16.8 4.1 3.3 4.4 4.1 3.1 13.7 8.5 4.8 28.9 114.2 4.3 2.7 5.1 8.2 5.0 5.3 8.0 4.9 1.9 7.5 7.9 5.8 4.9 5.6 6.0 12.7 4.7 5.5 5.2 4.8 2.7 4.8 2.9 5.4 3.6 4.3 7.9 3.9 5.0 4.1 6.3 6.8 13.5 5.0 9.0 11.7 6.0 9.7 7.0 5.2 9.5 7.1 8.9 4.6 6.0 12.2 6.1 6.1 6.1 3.2 10.2 4.2 5.1 3.7 4.1 8.1 4.2 10.1 6.6 8.4 5.3 2.1 35.3 5.0 7.5 5.1 6.5 4.3 3.8 3.5 9.0 5.8 8.6 5.1 7.5 7.5 4.5 7.1 6.2 3.2 5.4 4.4 8.5 10.9 3.2 8.6 10.8 1.0 6.0 9.2 2.8 9.5 5.2 8.4 3.7 6.1 3.3 3.0 7.5 7.3 8.5 9.6 5.4 5.1 7.1 2.5 13.5 5.0 12.3 10.0 5.0 11.7 5.9 9.4 8.6 6.8 6.3 8.9 9.9 3.2 9.0 3.0 4.1 7.6 6.0 6.7 9.0 10.3 8.3 8.5 4.8 5.1 8.2 7.5 5.4 26.8 40.3 7.3 7.2 8.2 17.2 64.9 43.3 17.4 29.6 10.4 9.8 17.9 39.7 6.4 6.0 7.4 6.8 0.0 4.2 2.5 7.5 26.5 3.5 481.6 6.3 20.6 11.6 15.4 11.8 7.8 12.4 7.6 6.8 8.2 13.3 12.2 4.3 5.8 10.3 116.2 7.3 19.4 11.3 9.7 2.5 12.0 25.2 13.8 15.7 10.7 ACAP1 "CENTB1, KIAA0050" ENSG00000072818 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 1" Q15027 17 7336529-7351478 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.4;bone marrow: 30.3;lymphoid tissue: 51.5" "Cell type enriched" "Detected in many" 5 "Late spermatids: 2487.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 17.5;HDLM-2: 23.1;JURKAT: 32.7;Karpas-707: 22.9;NB-4: 28.3;U-937: 18.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075570 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA075570: AB_2732295" "unprognostic (1.20e-2)" "prognostic favorable (3.66e-4)" "unprognostic (2.49e-1)" "prognostic favorable (2.97e-5)" "unprognostic (4.43e-4)" "prognostic favorable (4.17e-5)" "unprognostic (5.66e-3)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (2.48e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.14e-1)" "unprognostic (5.58e-2)" "unprognostic (2.90e-1)" "unprognostic (8.61e-3)" 2.6 0.6 0.6 31.4 1.3 30.3 1.1 1.0 1.2 1.4 4.5 0.4 0.4 3.2 0.9 1.5 3.3 2.0 3.1 1.4 0.6 0.6 2.9 2.3 7.3 29.3 2.7 0.1 1.0 0.7 0.0 0.8 0.5 1.2 1.8 1.5 1.7 9.6 1.3 0.5 1.2 19.2 0.8 1.3 44.9 3.7 1.4 0.9 51.5 2.5 1.0 33.9 3.7 1.8 17.8 13.3 22.4 5.9 23.7 29.4 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 17.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 6.6 0.1 0.0 0.0 8.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 22.9 0.0 0.0 10.6 28.3 0.3 0.0 0.0 11.3 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.1 0.0 0.0 7.1 6.0 8.0 0.1 18.7 0.0 17.0 5.9 22.4 24.6 1.8 27.5 16.6 25.8 26.1 10.5 17.8 22.7 22.4 17.7 23.7 0.2 13.3 29.4 16.1 0.6 1.3 1.0 1.2 0.6 0.6 2.7 0.1 1.2 0.9 8.9 8.5 123.3 5.5 7.3 14.8 26.2 10.2 28.1 11.4 5.2 17.7 3.1 6.6 3.5 485.0 7.1 1.3 0.0 3.0 2.2 12.2 3.7 39.3 4.9 7.7 0.0 3.5 6.7 23.4 2487.1 18.7 24.9 23.6 19.0 2.0 9.6 4.6 0.0 14.5 3.6 19.3 19.4 8.5 14.2 10.7 6.5 3.7 282.4 1.0 3.0 ACAP3 "CENTB5, KIAA1716" ENSG00000131584 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 3" Q96P50 1 1292376-1309609 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 148.4;Cone photoreceptor cells: 98.2;Rod photoreceptor cells: 208.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049317, HPA058381" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA049317: AB_2680710, HPA058381: AB_2683699" "unprognostic (5.92e-2)" "unprognostic (1.55e-1)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (7.94e-2)" "unprognostic (3.77e-3)" "unprognostic (2.98e-3)" "unprognostic (1.01e-3)" "unprognostic (1.29e-2)" "unprognostic (8.05e-2)" "unprognostic (1.56e-3)" "unprognostic (5.35e-3)" "unprognostic (3.70e-2)" "unprognostic (6.76e-3)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (6.35e-2)" 8.7 7.8 16.4 4.2 24.5 10.4 7.3 42.0 23.6 6.4 6.4 11.5 4.3 7.9 5.9 4.2 10.6 3.7 5.1 7.9 19.5 8.7 4.8 4.9 4.7 4.0 13.0 15.4 5.5 8.2 5.1 11.2 4.3 10.4 5.8 3.4 5.6 14.6 7.7 14.2 26.5 7.7 11.8 8.1 6.0 8.0 3.1 12.8 3.1 2.7 4.5 3.5 5.6 6.4 0.9 1.2 1.5 2.0 0.0 1.4 0.7 5.3 6.0 2.8 4.8 7.1 4.9 3.0 13.5 4.4 3.9 3.0 7.6 4.6 5.9 7.0 7.5 3.9 12.3 2.7 3.6 0.9 6.6 12.0 2.5 22.3 14.3 4.9 5.0 6.2 3.4 2.9 3.3 2.1 3.6 1.8 7.0 6.8 8.2 4.4 7.4 10.5 7.2 2.9 7.2 14.0 10.2 6.4 22.7 2.3 2.9 21.4 15.1 8.1 5.0 12.7 2.6 5.4 3.9 5.9 7.3 5.1 5.8 4.7 6.6 4.7 5.1 10.1 13.3 3.1 0.0 1.4 1.5 1.3 2.0 0.0 0.9 1.0 0.6 1.2 0.8 1.4 1.2 0.2 0.0 1.4 1.0 0.5 0.7 16.4 24.5 42.0 22.1 19.5 8.7 13.0 15.4 10.4 12.8 0.0 6.6 10.0 5.2 28.5 148.4 22.4 17.8 2.7 1.2 1.8 98.2 7.4 3.3 8.2 1.9 6.3 12.4 0.0 4.3 6.8 9.1 4.9 0.0 12.1 6.2 50.9 31.0 14.1 19.0 5.8 14.1 8.3 8.5 1.0 11.9 23.8 9.6 9.5 12.4 5.9 208.8 6.5 14.3 4.2 9.5 29.9 8.5 10.2 10.9 8.1 ACAT1 "ACAT, THIL" ENSG00000075239 "Acetyl-CoA acetyltransferase 1" P24752 11 108121516-108147776 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 267.1" "Cell type enhanced" "Detected in all" 10 "Distal tubular cells: 591.9;Hepatocytes: 643.6;Proximal tubular cells: 1104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 86.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004428, HPA007569" Enhanced Enhanced Mitochondria NA NA 870000 Mitochondria "HPA004428: AB_1078088, HPA007569: AB_1844482" "unprognostic (3.70e-3)" "unprognostic (2.23e-2)" "unprognostic (7.84e-3)" "unprognostic (4.65e-2)" "unprognostic (3.05e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.43e-5)" "unprognostic (3.59e-3)" "unprognostic (1.26e-1)" "unprognostic (5.20e-2)" "unprognostic (2.64e-2)" "unprognostic (1.13e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.68e-1)" "unprognostic (8.06e-2)" "unprognostic (6.62e-3)" 18.8 28.5 8.9 6.9 9.5 5.4 16.9 5.6 11.6 8.5 16.8 8.5 9.4 15.5 8.8 8.9 8.8 7.6 5.1 53.8 7.4 7.4 88.8 267.1 7.3 6.0 9.9 9.9 10.3 27.3 14.3 6.3 3.8 22.4 7.6 13.1 10.6 27.1 15.9 65.0 8.2 10.9 16.4 8.1 7.7 13.9 14.2 7.2 1.7 10.1 32.1 5.2 12.3 6.9 18.8 20.2 2.3 14.7 7.7 20.7 11.6 16.1 13.3 10.5 30.2 34.0 30.1 5.9 15.5 16.7 16.9 19.7 36.5 16.8 8.9 26.7 17.3 26.5 17.1 30.4 14.7 18.4 17.9 24.9 25.8 15.1 33.1 23.5 24.3 15.3 27.2 16.3 14.7 27.6 19.4 17.9 20.5 35.8 13.3 26.8 9.3 14.4 22.8 10.3 21.0 29.7 20.1 20.7 86.8 23.1 10.6 16.8 20.0 25.3 32.9 17.0 9.2 28.0 20.0 19.9 18.1 10.6 16.5 18.6 4.5 13.2 16.8 8.1 48.9 12.8 0.8 9.8 2.3 15.6 14.7 17.7 18.8 17.6 17.5 20.2 10.2 15.5 14.3 1.0 7.7 14.4 7.0 20.7 11.6 8.9 9.5 5.6 11.6 7.4 7.4 9.9 9.9 22.4 7.2 50.6 77.4 72.9 45.6 38.2 28.8 404.6 79.0 85.6 26.1 99.5 25.5 38.2 591.9 37.4 319.5 68.1 61.5 93.5 53.3 35.3 44.8 27.3 26.6 643.6 86.3 36.5 28.8 95.8 65.2 38.7 61.5 42.1 55.6 58.7 33.3 35.0 46.6 90.8 77.4 1104.9 23.8 64.7 64.3 159.1 28.1 42.3 21.1 42.4 83.1 20.7 ACAT2 ENSG00000120437 "Acetyl-CoA acetyltransferase 2" Q9BWD1 6 159760328-159779055 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 20.4;liver: 31.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 168.5;Exocrine glandular cells: 155.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 48.1" "Low region specificity" "Detected in all" "CAB021106, HPA025736, HPA025765, HPA025811" Enhanced Approved Nucleoplasm,Cytosol NA NA 16000000 Cytosol Nucleoplasm "CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488" "unprognostic (3.31e-1)" "unprognostic (2.44e-2)" "prognostic favorable (1.12e-4)" "prognostic unfavorable (7.25e-4)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" "unprognostic (9.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (8.56e-2)" "unprognostic (2.54e-2)" 1.6 2.6 2.7 1.5 1.7 1.6 2.2 2.2 6.3 2.1 4.3 3.2 1.4 4.8 5.7 1.0 0.7 0.7 2.9 3.6 3.0 31.0 1.8 2.5 2.9 2.1 0.7 1.3 1.2 0.9 4.2 3.9 2.3 0.5 0.1 2.4 1.6 1.4 5.1 1.1 1.7 6.6 0.9 4.2 1.1 2.6 13.3 9.5 12.3 8.4 10.0 20.4 12.2 6.7 6.3 42.7 16.3 6.1 11.3 1.4 5.9 7.1 14.1 24.4 24.5 8.6 5.6 3.0 4.7 48.1 6.5 17.7 46.2 16.7 3.3 18.1 13.1 10.2 40.6 6.1 7.6 3.5 6.1 3.4 23.3 10.0 2.1 6.9 16.0 14.1 9.6 8.5 11.9 13.0 12.1 14.3 6.7 4.6 8.1 9.6 17.4 32.9 8.7 11.4 6.5 6.9 4.5 2.4 2.0 8.5 15.1 4.3 5.2 4.5 7.3 15.2 4.6 8.4 13.8 1.5 14.9 7.8 6.1 7.1 12.3 13.9 8.4 13.7 13.3 15.9 13.8 9.5 13.3 16.0 12.3 3.2 10.0 5.6 8.7 20.4 12.2 11.9 35.5 24.6 29.0 23.2 14.0 1.2 40.8 20.1 21.6 19.2 2.0 44.4 59.7 47.3 168.5 10.9 23.5 0.0 155.7 84.2 22.6 31.4 12.7 55.7 46.8 12.7 16.4 12.9 10.5 110.0 12.7 23.1 28.7 92.8 21.4 21.8 47.0 17.5 18.0 33.8 19.6 0.0 34.0 14.7 48.7 18.3 29.4 26.6 23.3 27.6 ACBD4 FLJ13322 ENSG00000181513 "Acyl-CoA binding domain containing 4" Q8NC06 17 45132600-45144181 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 43.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051772 Approved Approved Nucleoplasm,Vesicles Yes No "Nucleoplasm, Vesicles" "HPA051772: AB_2681603" "unprognostic (1.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.59e-2)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (1.60e-2)" "prognostic favorable (4.76e-4)" "unprognostic (2.27e-2)" "unprognostic (9.06e-2)" "unprognostic (4.86e-2)" "prognostic favorable (4.64e-4)" "unprognostic (8.24e-2)" "unprognostic (2.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.53e-4)" 7.5 9.5 8.1 8.5 15.3 3.5 6.7 10.8 10.9 8.6 19.6 4.9 14.4 25.9 9.2 6.8 8.3 10.1 10.7 6.2 8.1 6.8 12.3 43.1 6.3 8.0 6.1 11.1 10.4 14.2 13.6 8.5 5.4 6.3 11.1 5.4 9.9 12.3 13.6 5.4 7.5 29.0 10.3 4.8 8.3 7.3 2.5 6.3 3.9 11.3 4.4 7.3 8.5 7.2 8.8 3.5 5.6 4.3 6.3 7.7 5.4 5.9 11.6 1.5 3.3 2.7 5.2 4.1 2.2 4.7 3.7 7.3 4.5 8.4 6.3 5.8 3.2 2.2 5.7 2.0 3.8 1.5 9.1 4.6 3.1 7.5 8.9 6.1 1.2 8.7 5.1 3.6 1.3 1.9 12.7 3.6 5.9 2.0 10.2 1.8 4.0 4.4 1.6 0.2 6.3 3.2 3.7 0.3 14.0 9.2 3.8 2.5 1.1 1.6 2.4 6.4 0.8 15.6 2.2 1.3 0.9 2.9 1.4 1.4 16.0 4.4 1.9 5.4 1.6 1.6 5.5 3.8 5.6 5.3 4.3 5.7 6.8 6.2 5.9 3.5 8.8 6.7 7.7 1.0 6.3 2.8 2.2 7.1 5.4 8.1 15.3 10.8 10.9 8.1 6.8 6.1 11.1 6.3 6.3 3.0 4.8 2.9 5.7 1.6 14.6 8.0 17.8 1.4 0.0 3.5 21.6 5.5 6.6 5.7 1.3 5.3 10.5 0.0 6.3 1.0 4.3 3.8 8.1 20.8 4.6 11.1 5.8 4.9 1.6 2.7 6.4 1.7 3.3 5.4 5.8 12.3 5.2 10.5 7.1 15.1 15.8 6.5 7.2 0.7 3.8 1.6 5.3 4.4 7.0 1.7 ACBD7 "bA455B2.2, FLJ38219" ENSG00000176244 "Acyl-CoA binding domain containing 7" Q8N6N7 10 15077523-15088776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 4.1;Intestinal endocrine cells: 1.7;Late spermatids: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 24.2;MOLT-4: 20.4;U-266/84: 15.3;U-698: 17.6" "Region enriched" "Detected in many" 5 "olfactory region: 21.6" "Low region specificity" "Detected in all" "HPA043326, HPA062478" Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043326: AB_2678429, HPA062478: AB_2684777" "unprognostic (2.15e-1)" "unprognostic (8.94e-2)" "unprognostic (7.79e-3)" "unprognostic (6.53e-3)" "unprognostic (7.30e-2)" "unprognostic (6.89e-3)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.32e-1)" "unprognostic (6.34e-2)" "unprognostic (3.59e-3)" "unprognostic (3.06e-1)" "unprognostic (2.18e-4)" "unprognostic (9.72e-2)" "unprognostic (2.95e-1)" "unprognostic (2.14e-1)" "unprognostic (6.90e-2)" 1.1 1.1 25.0 1.5 27.1 3.9 8.3 12.9 35.3 1.1 1.4 9.3 0.0 2.5 1.4 2.7 1.7 4.4 1.7 1.2 25.3 9.8 1.4 1.7 1.4 2.1 15.0 16.2 1.7 1.5 1.5 0.7 1.3 14.0 1.5 1.6 0.0 4.7 1.4 2.0 3.0 1.9 1.3 6.6 1.6 1.8 5.9 11.7 2.9 4.2 0.0 1.7 1.4 0.5 1.7 1.5 3.8 0.6 2.1 1.1 0.2 2.5 0.6 9.8 4.7 0.6 0.4 1.2 0.7 0.6 1.8 3.0 2.8 3.0 2.3 3.4 2.3 2.5 0.6 5.8 1.8 2.6 5.1 8.0 2.4 0.7 1.5 0.1 0.4 1.0 0.1 0.1 0.6 0.1 2.6 2.4 24.2 1.9 2.8 1.9 7.8 20.4 2.2 4.9 0.6 1.7 11.0 3.5 5.3 1.2 1.0 8.1 4.9 2.5 5.6 1.1 3.9 8.0 0.6 0.7 0.4 5.4 1.0 2.1 7.7 15.3 17.6 1.6 0.4 0.7 3.8 0.6 0.8 1.1 0.6 0.9 1.3 0.6 0.6 0.3 1.7 1.1 1.1 3.7 2.1 0.5 1.5 0.5 0.2 25.0 27.1 12.9 21.8 25.3 9.8 15.0 16.2 14.0 11.7 0.0 1.1 0.0 0.1 0.1 0.1 0.0 0.0 2.7 0.0 0.0 2.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.0 0.1 ACCSL ENSG00000205126 "1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like" Q4AC99 11 44047981-44059977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.6;testis: 2.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 4.1;U-266/70: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA065042 Approved Cytosol NA NA Cytosol "HPA065042: " "unprognostic (2.37e-2)" "unprognostic (2.91e-1)" "unprognostic (9.76e-5)" "unprognostic (7.42e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACE "ACE1, CD143, DCP1" ENSG00000159640 "Angiotensin I converting enzyme" P12821 17 63477061-63498380 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 205.6" "Group enriched" "Detected in many" 25 "Early spermatids: 470.5;Late spermatids: 1015.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Group enriched" "Detected in many" 23 "B-cells: 3.7;monocytes: 2.0;T-cells: 1.9" "Group enriched" "Detected in some" 4 "ASC TERT1: 36.7;HUVEC TERT2: 18.7" "CAB002426, CAB002921, HPA029298, HPA069790" Enhanced Approved Vesicles "Secreted to blood" NA NA 104000000 92000000 Vesicles "CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197" "unprognostic (4.72e-2)" "unprognostic (4.16e-1)" "unprognostic (1.93e-3)" "unprognostic (6.06e-2)" "unprognostic (2.78e-1)" "unprognostic (1.35e-2)" "unprognostic (4.37e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-2)" "unprognostic (3.13e-2)" "unprognostic (2.38e-1)" "unprognostic (7.66e-2)" "unprognostic (9.07e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (2.76e-2)" 6.8 2.0 0.5 2.4 4.2 0.0 2.9 0.5 1.1 5.3 83.2 0.7 37.7 46.4 4.5 5.1 1.7 1.5 4.4 4.7 0.6 0.7 2.6 1.4 16.3 2.2 0.4 0.7 1.4 3.0 3.6 3.6 3.6 0.8 3.4 1.4 1.7 2.5 20.1 3.6 1.3 205.6 2.4 0.6 1.4 1.9 32.6 1.3 0.5 6.9 3.1 2.2 1.7 1.6 3.7 0.1 0.0 2.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 1.5 36.7 0.4 1.3 2.7 0.0 0.0 0.5 3.2 0.7 1.1 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.7 3.5 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.6 18.7 0.0 3.1 0.0 0.0 0.6 0.0 0.8 0.3 6.3 0.4 0.1 0.2 0.5 0.0 0.0 4.6 3.2 0.0 0.0 0.0 0.7 1.6 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.9 3.7 1.9 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.5 4.2 0.5 1.1 0.6 0.7 0.4 0.7 0.8 1.3 0.0 3.5 0.0 1.5 1.3 3.1 1.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 3.4 470.5 13.5 29.6 0.0 0.4 0.1 1.0 6.0 6.9 0.0 4.4 0.0 17.3 2.5 18.5 1015.1 4.0 5.1 3.3 0.0 8.7 1.9 0.7 10.2 2.5 10.7 1.0 0.0 0.9 8.1 3.4 0.1 0.1 0.9 8.6 2.1 ACE2 ENSG00000130234 "Angiotensin I converting enzyme 2" Q9BYF1 X 15561033-15602148 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 122.0" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 61.1;Enterocytes: 38.8;Proximal tubular cells: 45.6;Sertoli cells: 19.4" "Cancer enhanced" "Detected in many" "renal cancer: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.5;NB-4: 2.2;RPMI-8226: 2.1;RT4: 2.5;SH-SY5Y: 2.8;SuSa: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028" Enhanced "Secreted to blood" NA NA 85000 "CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160" "unprognostic (1.40e-1)" "unprognostic (7.26e-2)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "unprognostic (2.51e-1)" "unprognostic (5.26e-2)" "prognostic favorable (4.21e-4)" "unprognostic (2.34e-2)" "unprognostic (6.74e-3)" "unprognostic (2.54e-3)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "prognostic favorable (2.12e-5)" "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (2.11e-1)" "unprognostic (7.10e-2)" 4.5 0.4 0.2 0.8 0.2 0.0 2.3 0.2 0.2 0.4 49.1 0.2 2.3 46.0 0.4 2.7 1.2 0.6 16.4 10.5 0.2 0.1 23.2 1.2 0.8 0.6 0.2 0.2 1.3 1.6 0.0 0.2 1.0 0.2 0.5 1.3 0.2 1.1 1.2 0.7 0.2 122.0 0.3 0.2 0.2 0.5 17.9 0.2 0.2 4.5 0.5 0.2 0.4 0.9 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.4 4.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.2 0.0 0.0 2.1 0.4 2.5 0.6 2.8 0.1 0.3 0.2 1.9 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 2.2 0.5 0.1 0.0 9.8 61.1 0.0 0.0 0.0 0.0 2.9 3.3 0.5 0.4 0.0 38.8 0.0 0.7 0.2 0.0 0.4 0.0 0.8 0.7 0.0 6.9 0.0 0.0 1.1 7.8 0.0 0.0 0.0 1.2 0.0 0.9 4.2 5.6 45.6 0.0 19.4 0.0 1.1 0.7 0.1 10.6 0.0 3.3 1.6 ACER1 ASAH3 ENSG00000167769 "Alkaline ceramidase 1" Q8TDN7 19 6306142-6333629 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "esophagus: 14.3;skin 1: 38.2;tongue: 17.3" "Cell type enhanced" "Detected in some" 23 "Melanocytes: 1.7;Spermatocytes: 1.8;Suprabasal keratinocytes: 5.1" "Group enriched" "Detected in some" 7 "head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 2.2;T-47d: 8.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-2)" "unprognostic (2.87e-4)" "unprognostic (5.04e-2)" "unprognostic (6.18e-2)" "unprognostic (8.16e-4)" "unprognostic (7.27e-4)" "unprognostic (2.17e-2)" "unprognostic (1.61e-1)" "unprognostic (1.99e-1)" "unprognostic (1.02e-4)" "unprognostic (1.02e-1)" "unprognostic (1.30e-5)" "unprognostic (2.11e-1)" "unprognostic (4.44e-2)" "unprognostic (4.22e-1)" "unprognostic (2.24e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 2.2 0.1 0.1 3.8 0.1 0.1 0.1 0.0 0.4 0.1 14.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.1 1.4 0.1 0.2 38.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 17.3 3.5 0.1 2.2 0.6 0.4 0.4 0.2 1.0 3.6 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 8.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.0 3.6 0.1 3.5 1.6 0.0 0.6 2.3 2.3 0.4 1.0 0.2 0.4 2.0 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.5 5.1 0.0 0.0 0.0 0.1 ACER2 "ALKCDase2, ASAH3L, FLJ41587" ENSG00000177076 "Alkaline ceramidase 2" Q5QJU3 9 19409059-19452020 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 2.0;Early spermatids: 2.1;Ito cells: 1.8;Late spermatids: 1.8;Syncytiotrophoblasts: 3.3" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "BEWO: 16.7;RT4: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.94e-1)" "unprognostic (2.29e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (2.03e-1)" "unprognostic (3.90e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (7.42e-2)" "unprognostic (8.46e-3)" 17.4 1.7 3.1 0.7 5.9 0.4 20.7 2.3 6.8 1.4 3.5 0.9 5.3 3.0 1.3 3.0 1.8 2.8 1.3 3.2 3.0 1.9 1.6 2.6 1.5 0.6 4.4 0.3 1.3 4.7 2.7 1.6 20.0 4.5 9.4 3.1 1.4 1.8 6.8 2.1 4.0 1.7 2.1 2.9 1.2 41.0 1.3 4.7 0.4 1.8 1.0 0.8 31.3 40.6 1.0 1.2 0.0 3.1 0.0 1.0 0.5 0.6 1.3 2.1 1.1 3.5 0.2 16.7 1.1 0.8 0.5 0.5 0.3 1.0 0.7 0.4 0.1 0.2 2.5 0.5 3.3 0.9 1.4 0.6 1.1 1.0 1.5 0.7 0.2 1.1 1.1 3.1 1.3 1.4 0.3 3.5 1.2 1.7 2.1 1.2 1.0 1.9 0.9 1.6 6.0 0.5 1.7 0.6 0.4 0.3 41.0 3.9 0.9 0.2 1.1 0.2 5.6 1.4 1.4 1.7 0.3 0.8 0.3 0.5 0.7 0.9 0.8 0.3 0.8 0.7 0.0 0.1 0.0 0.8 3.1 0.2 1.0 0.3 0.3 0.3 0.4 1.0 0.2 0.0 0.0 0.0 1.2 0.3 0.5 3.1 5.9 2.3 6.8 3.0 1.9 4.4 0.3 4.5 4.7 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.1 2.1 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.5 0.0 3.3 0.0 0.0 0.5 ACHE YT ENSG00000087085 "Acetylcholinesterase (Cartwright blood group)" P22303 7 100889994-100896974 "Blood group antigen proteins, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter degradation" "Blood group antigen, Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 43.8;skeletal muscle: 98.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 45.5;Erythroid cells: 46.7;Exocrine glandular cells: 34.7;Horizontal cells: 52.4;Paneth cells: 52.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.2;CACO-2: 12.9;K-562: 15.2;Karpas-707: 25.2;U-2 OS: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027098 Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 650000 "Golgi apparatus" Vesicles "HPA027098: AB_2672111" "unprognostic (2.23e-1)" "unprognostic (9.44e-2)" "unprognostic (2.71e-2)" "unprognostic (5.80e-3)" "prognostic unfavorable (5.27e-4)" "unprognostic (2.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.36e-2)" "unprognostic (2.48e-2)" "unprognostic (8.92e-2)" "unprognostic (2.65e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.88e-5)" "unprognostic (2.95e-1)" "unprognostic (2.59e-2)" "unprognostic (9.28e-2)" "unprognostic (8.38e-2)" 1.4 4.8 5.8 3.5 16.1 10.3 1.4 22.8 11.8 1.4 4.2 2.7 1.4 5.7 1.9 2.6 2.8 1.8 3.1 4.5 5.5 43.8 1.4 1.8 1.8 5.9 22.2 4.8 1.7 1.6 7.0 3.2 2.0 37.9 3.3 3.4 4.6 6.5 3.3 98.2 1.4 7.9 1.9 8.7 2.3 2.1 1.9 2.6 3.5 1.6 15.9 3.2 2.1 1.2 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.3 0.2 0.5 0.0 8.2 0.3 0.0 0.1 0.2 12.9 0.3 0.0 0.5 0.0 1.2 0.4 2.2 0.1 0.0 4.4 0.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.1 15.2 25.2 0.1 3.6 0.0 0.1 1.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.0 0.0 3.7 0.0 0.0 0.1 0.7 6.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 16.1 22.8 11.8 5.5 43.8 22.2 4.8 37.9 2.6 0.0 0.0 0.0 21.7 0.7 7.2 4.5 0.0 0.0 0.0 0.0 0.0 5.4 0.0 6.2 0.0 2.3 45.5 46.7 34.7 1.9 4.2 17.2 0.0 0.0 0.7 52.4 3.4 1.3 0.0 0.0 0.6 0.0 1.7 8.2 7.6 11.9 30.0 52.6 0.7 1.0 4.3 0.0 3.3 3.9 4.5 0.9 5.9 0.0 3.3 11.2 ACKR1 "CCBP1, CD234, DARC, Dfy, FY, GPD" ENSG00000213088 "Atypical chemokine receptor 1 (Duffy blood group)" Q16570 1 159203307-159206500 "Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins" "Blood group antigen, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.8" "Cell type enhanced" "Detected in many" 26 "Bipolar cells: 50.1;Endothelial cells: 278.7;Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 22.5;HSkMC: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016421, HPA017672" Enhanced NA NA "HPA016421: AB_1849219, HPA017672: AB_1849221" "unprognostic (8.74e-3)" "prognostic favorable (2.52e-5)" "unprognostic (9.73e-2)" "unprognostic (1.91e-1)" "unprognostic (2.34e-3)" "unprognostic (3.84e-3)" "prognostic favorable (1.48e-4)" "unprognostic (7.80e-2)" "unprognostic (2.22e-1)" "unprognostic (3.46e-2)" "unprognostic (1.65e-3)" "unprognostic (1.81e-1)" "unprognostic (3.82e-3)" "unprognostic (5.17e-3)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.30e-2)" 109.8 4.0 6.7 16.2 4.2 5.7 54.5 23.3 5.4 40.1 13.1 2.4 10.2 6.5 28.8 23.0 32.6 27.1 26.9 47.1 9.1 3.4 5.7 1.3 27.8 36.8 19.2 0.6 22.3 8.1 3.9 2.0 5.8 14.0 29.1 7.1 5.3 12.8 9.8 38.3 19.8 11.5 36.6 9.4 25.0 13.0 21.6 6.4 3.0 16.5 29.9 15.5 42.3 24.2 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 22.5 0.0 0.0 4.2 0.0 0.0 24.5 0.0 0.0 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.7 4.2 23.3 5.3 9.1 3.4 19.2 0.6 14.0 6.4 6.0 19.1 0.0 1.6 0.0 50.1 8.1 0.0 1.4 3.4 0.0 2.0 0.2 0.0 0.0 1.6 278.7 0.0 116.8 9.1 0.2 6.3 1.9 4.7 0.0 0.8 6.4 0.0 6.7 0.8 2.0 1.1 0.2 0.0 0.0 0.0 6.4 0.0 0.0 0.4 0.0 3.6 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.9 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Not detected" "Not detected" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.5 0.1 32.2 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.3 0.2 1.8 0.0 0.1 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.4 4.5 0.1 0.1 0.8 17.2 0.0 1.9 1.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 6.5 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.6 2.5 1.4 0.0 0.0 2.0 26.5 1.7 0.0 1.9 1.4 2.0 0.0 0.0 87.8 1.8 0.4 2.3 5.8 4.6 1.6 1.7 3.7 0.3 1.1 0.3 0.2 0.0 0.0 0.1 2.5 0.6 0.0 1.1 0.3 0.9 0.0 0.0 4.5 3.3 0.0 61.6 0.5 0.4 0.1 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597237-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.6;salivary gland: 29.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 35.7;monocytes: 11.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "basophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 88.7" "Group enriched" "Detected in some" 7 "cerebellum: 5.3;pons and medulla: 1.6" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 13.9 1.9 0.3 2.9 0.4 0.5 10.9 0.4 0.4 3.7 8.7 0.2 4.5 16.2 5.6 7.1 5.7 2.6 9.8 7.1 0.6 0.6 6.6 2.0 10.0 2.7 0.6 0.2 2.1 3.0 0.0 8.2 0.7 0.6 5.2 1.2 1.3 29.0 2.0 3.1 10.7 35.6 5.0 0.4 1.5 10.5 3.4 0.1 0.8 1.8 12.8 1.5 8.2 4.5 0.2 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.4 3.4 0.0 14.5 88.7 0.9 2.5 0.0 0.1 1.0 0.0 9.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.6 0.6 0.6 0.2 0.6 0.1 35.7 1.4 0.0 0.4 5.8 1.8 0.7 0.0 1.4 2.3 5.2 5.9 0.2 0.0 0.2 2.1 5.1 1.3 0.0 10.8 0.0 4.1 0.4 0.0 0.0 0.4 1.6 0.0 9.8 0.8 0.0 2.0 0.0 1.7 11.8 0.0 1.1 6.6 0.0 2.5 2.4 3.1 0.0 1.9 0.1 0.0 5.6 0.2 0.0 0.6 1.0 ACMSD ENSG00000153086 "Aminocarboxymuconate semialdehyde decarboxylase" Q8TDX5 2 134838547-134902034 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "kidney: 44.8;liver: 64.1" "Cell type enhanced" "Detected in some" 29 "Cholangiocytes: 58.6;Distal tubular cells: 46.4;Hepatocytes: 104.7;Proximal tubular cells: 312.9" "Group enriched" "Detected in some" 23 "liver cancer: 21.2;renal cancer: 19.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 22 "RPTEC TERT1: 24.8" "Not detected" "Not detected" "HPA010533, HPA011179" Enhanced NA NA 11000 "HPA010533: AB_1844517, HPA011179: AB_1844516" "unprognostic (1.06e-2)" "unprognostic (5.30e-2)" "unprognostic (1.40e-1)" "unprognostic (7.50e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (4.40e-3)" "unprognostic (1.15e-1)" "unprognostic (5.35e-4)" "unprognostic (7.60e-2)" "unprognostic (5.17e-2)" "unprognostic (2.44e-3)" "prognostic favorable (2.39e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (2.65e-5)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 2.5 0.0 0.0 0.0 44.8 64.1 0.1 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.4 0.9 0.6 0.2 1.7 0.5 0.3 0.1 0.4 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.3 0.6 0.2 1.1 0.1 0.5 0.1 0.5 0.2 24.8 0.3 1.0 0.3 0.1 0.2 0.4 0.7 0.2 0.6 0.8 0.0 0.3 0.2 0.7 0.2 0.1 0.4 0.2 0.3 0.6 0.0 0.6 0.9 0.9 0.5 0.4 1.5 0.9 1.3 0.9 1.1 1.7 0.9 0.4 0.2 0.5 1.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.1 58.6 0.0 0.0 8.7 0.0 0.0 46.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.7 0.0 0.0 0.0 2.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 312.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACO1 "IREB1, IREBP, IRP1" ENSG00000122729 "Aconitase 1" P21399 9 32384603-32454769 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Lyase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 174.5;Proximal tubular cells: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019371, HPA024157" Enhanced Supported Mitochondria,Cytosol NA NA 8000000 "Mitochondria, Cytosol" "HPA019371: AB_1844519, HPA024157: AB_1844520" "unprognostic (2.11e-1)" "unprognostic (5.61e-2)" "unprognostic (8.38e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-1)" "unprognostic (3.12e-2)" "unprognostic (4.25e-3)" "unprognostic (2.61e-2)" "unprognostic (1.37e-1)" "unprognostic (1.19e-1)" "unprognostic (2.55e-1)" "unprognostic (3.08e-1)" "prognostic favorable (5.73e-5)" "unprognostic (2.54e-1)" "unprognostic (6.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.23e-2)" 41.4 27.2 9.6 7.1 9.4 1.5 30.1 8.9 8.1 9.3 19.7 6.2 6.4 21.9 12.8 14.6 12.8 7.2 8.9 15.1 6.5 7.6 40.5 80.9 9.2 9.4 6.1 6.2 14.1 27.9 8.9 8.7 11.3 7.7 10.7 9.8 11.7 11.7 9.5 11.2 5.5 28.4 14.5 6.0 6.4 13.5 11.4 5.9 6.0 18.4 7.2 5.1 13.9 11.7 4.7 7.1 21.4 8.8 4.7 7.4 6.2 9.5 8.7 6.8 10.7 53.1 28.8 3.1 18.1 44.5 8.3 6.6 9.2 3.0 1.9 5.8 18.9 22.8 1.3 13.5 17.3 16.8 6.0 3.6 14.0 9.5 10.0 26.7 1.3 5.6 25.0 5.3 21.4 15.1 25.7 21.5 7.4 5.0 4.1 23.7 2.5 7.4 6.7 7.1 6.0 9.4 5.8 10.1 1.9 31.7 8.8 0.9 2.8 18.8 0.7 1.9 7.6 4.4 3.4 23.2 30.4 10.3 10.1 4.7 2.1 3.9 3.8 21.2 4.7 2.6 21.4 8.7 2.4 7.4 8.8 6.4 4.7 5.2 5.7 7.1 4.2 6.8 7.0 1.0 4.7 7.2 3.4 2.8 6.2 9.6 9.4 8.9 8.1 6.5 7.6 6.1 6.2 7.7 5.9 3.0 25.5 7.5 6.9 3.9 18.8 39.8 45.9 8.1 9.1 22.7 21.6 39.8 16.6 14.3 6.3 18.2 29.7 0.0 35.8 17.8 21.6 11.2 2.3 174.5 13.3 31.8 4.7 14.1 12.7 5.1 21.9 7.2 6.8 2.8 32.4 30.7 23.2 21.0 21.9 160.8 13.9 19.4 22.3 6.1 16.2 4.6 44.7 8.7 26.9 7.1 ACO2 ACONM ENSG00000100412 "Aconitase 2" Q99798 22 41469125-41528989 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 121.0;skeletal muscle: 157.9" "Cell type enhanced" "Detected in all" 5 "Proximal tubular cells: 244.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001097 Enhanced Approved Approved Mitochondria NA NA 4000000 Mitochondria "HPA001097: AB_1078092" "unprognostic (1.95e-1)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (3.06e-2)" "unprognostic (6.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.99e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-2)" "unprognostic (7.32e-2)" "unprognostic (1.64e-2)" "unprognostic (6.07e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.46e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.12e-2)" 22.8 18.5 41.4 11.1 38.2 9.8 12.2 21.0 43.5 12.2 25.4 27.7 12.3 45.1 9.5 9.9 17.5 15.7 11.1 121.0 33.8 24.2 37.9 22.2 10.0 11.1 27.6 32.7 8.6 17.2 48.5 7.6 9.1 24.9 12.5 20.0 14.7 20.1 15.2 157.9 9.8 46.6 12.5 28.6 10.0 21.0 9.6 23.1 9.5 16.0 42.7 12.0 12.3 8.8 22.9 28.1 7.3 36.6 15.8 16.4 19.4 13.9 16.2 16.3 33.7 28.2 18.4 22.9 12.8 16.3 21.6 20.2 23.9 18.2 32.0 21.0 19.1 18.1 32.1 30.3 23.5 11.4 21.2 21.6 15.5 22.7 25.4 24.6 41.3 23.8 32.6 18.9 22.4 23.9 16.7 21.4 17.1 20.0 35.0 17.0 26.1 21.1 14.0 11.1 79.8 32.6 28.6 11.2 44.4 27.9 27.7 11.7 10.0 31.6 37.3 23.8 14.0 21.7 22.1 15.2 18.5 20.7 16.8 14.0 20.8 25.8 22.4 29.9 18.1 19.9 4.5 21.1 7.3 14.7 31.3 14.0 22.9 12.5 15.8 28.1 20.2 14.2 14.6 5.3 15.8 36.6 11.2 16.4 19.4 41.4 38.2 21.0 43.5 33.8 24.2 27.6 32.7 24.9 23.1 23.8 35.1 48.4 42.0 16.7 52.7 8.1 53.5 38.8 18.2 57.6 76.6 84.6 111.0 47.3 10.7 21.1 193.9 23.3 37.3 50.2 22.9 31.1 40.3 50.4 81.0 50.9 51.1 16.5 27.5 6.8 22.5 35.7 33.7 87.4 92.9 56.0 39.9 87.7 26.2 244.6 62.4 58.2 31.1 23.6 36.4 14.1 161.6 34.6 88.8 55.9 ACOD1 "CAD, IRG1" ENSG00000102794 "Aconitate decarboxylase 1" A6NK06 13 76948497-76958642 "Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 3.0;lymphoid tissue: 5.8" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "PC-3: 1.1;U-87 MG: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040143 Uncertain NA NA "HPA040143: AB_10793916" "unprognostic (2.39e-1)" "unprognostic (6.42e-2)" "unprognostic (2.37e-1)" "unprognostic (3.54e-2)" "unprognostic (3.09e-1)" "unprognostic (8.30e-2)" "unprognostic (4.30e-2)" "unprognostic (1.64e-5)" "unprognostic (7.70e-2)" "unprognostic (3.68e-2)" "unprognostic (6.51e-3)" 1.4 0.1 0.0 5.8 0.0 0.6 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.1 0.0 0.0 0.3 3.0 1.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.8 0.3 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACOT1 "ACH2, CTE-1, LACH2" ENSG00000184227 "Acyl-CoA thioesterase 1" Q86TX2 14 73537114-73543794 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.6" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 18.2;T-47d: 25.1" HPA043705 Approved Approved Mitochondria NA NA Mitochondria "HPA043705: AB_2678626" "unprognostic (4.74e-3)" "unprognostic (3.81e-3)" "unprognostic (7.65e-2)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (1.29e-1)" "unprognostic (4.54e-2)" "unprognostic (1.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.73e-2)" "unprognostic (1.84e-1)" "unprognostic (4.16e-1)" "prognostic favorable (5.09e-8)" "unprognostic (1.35e-3)" "unprognostic (4.60e-2)" "unprognostic (1.75e-1)" "unprognostic (1.43e-1)" 8.5 7.2 5.1 3.7 3.9 1.0 13.7 2.0 7.7 3.0 5.8 4.1 0.9 5.3 6.8 8.8 2.7 3.4 1.8 11.3 4.3 3.6 16.4 27.6 9.0 0.9 3.2 6.0 4.5 1.4 2.9 0.9 4.1 5.6 5.5 3.4 2.4 2.7 6.1 10.7 3.8 12.9 13.0 1.9 1.0 3.4 2.7 2.4 0.9 1.8 5.0 1.9 5.6 1.7 3.8 5.7 1.0 1.7 4.2 6.3 3.1 4.2 5.0 1.9 0.1 9.9 6.1 0.1 1.3 5.4 4.5 8.2 1.9 2.1 0.0 0.0 3.6 0.0 2.5 0.0 0.9 2.2 2.3 1.6 2.7 1.2 18.2 9.6 0.1 3.0 7.9 0.4 3.6 0.0 0.1 2.0 0.0 0.0 0.0 3.5 1.6 0.3 0.5 1.9 0.6 1.9 5.1 3.9 0.1 4.4 4.7 2.3 3.8 4.2 12.4 6.8 0.4 25.1 6.2 2.2 2.5 3.2 2.3 0.0 0.0 0.0 1.3 3.6 0.0 4.0 0.1 1.3 1.0 6.0 1.7 4.9 3.8 5.5 4.7 5.7 2.6 4.8 5.3 0.2 4.2 1.5 3.2 6.3 3.1 5.1 3.9 2.0 7.7 4.3 3.6 3.2 6.0 5.6 2.4 0.0 2.7 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.4 0.0 0.0 0.0 7.2 0.2 0.3 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.4 0.8 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 ACOT12 "Cach, STARD15, THEAL" ENSG00000172497 "Acyl-CoA thioesterase 12" Q8WYK0 5 81330005-81394179 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 49.6" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 37.1" "Cancer enriched" "Detected in single" 76 "liver cancer: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA037723, HPA037724" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037723: AB_10672606, HPA037724: AB_2675631" "unprognostic (6.06e-2)" "unprognostic (1.39e-1)" "prognostic favorable (5.30e-4)" "unprognostic (7.68e-2)" "unprognostic (8.22e-2)" "unprognostic (5.68e-3)" "unprognostic (2.46e-1)" "unprognostic (6.86e-2)" "unprognostic (1.46e-2)" "unprognostic (3.07e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.2 49.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.5 0.1 0.0 0.1 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.4 0.0 0.0 0.6 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ACOT13 "HT012, THEM2" ENSG00000112304 "Acyl-CoA thioesterase 13" Q9NPJ3 6 24667035-24705065 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 41.7" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 754.9;Proximal tubular cells: 372.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019881, HPA057134" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA019881: AB_1857978, HPA057134: " "unprognostic (3.61e-1)" "unprognostic (1.62e-1)" "unprognostic (6.02e-2)" "unprognostic (1.80e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "prognostic favorable (2.53e-6)" "unprognostic (3.67e-2)" "unprognostic (1.64e-2)" "unprognostic (7.16e-2)" "unprognostic (5.97e-2)" "unprognostic (4.86e-2)" "unprognostic (1.50e-1)" "unprognostic (2.13e-2)" 10.0 9.7 13.5 7.0 14.5 4.7 7.9 8.2 13.1 5.8 12.8 5.6 5.9 9.4 5.2 6.2 5.4 5.9 9.9 24.2 11.1 11.6 26.3 41.7 7.0 7.1 13.8 10.6 6.4 9.7 8.9 12.2 6.3 12.3 9.8 11.0 4.0 7.4 6.4 15.7 8.2 8.6 5.5 10.1 6.8 8.1 19.8 8.8 10.5 8.7 8.5 5.2 6.9 4.7 12.8 8.7 11.5 10.5 7.8 12.0 8.8 4.3 5.6 5.7 10.3 8.2 10.3 3.2 3.6 4.3 2.6 4.2 7.5 5.6 8.1 12.3 4.1 14.0 4.8 5.0 7.3 4.1 12.7 4.6 7.6 5.8 5.2 4.1 4.8 3.5 5.9 7.2 3.5 7.0 6.5 6.2 8.4 12.1 4.3 5.2 4.5 8.7 9.4 3.9 8.6 4.5 7.5 5.1 10.2 8.8 4.1 11.5 4.0 4.2 14.4 10.1 7.0 9.9 4.0 7.2 4.8 2.7 1.3 3.4 8.2 20.8 8.2 5.0 17.6 14.3 6.9 10.2 6.4 8.8 10.5 12.0 12.8 9.9 10.0 8.7 8.7 11.7 10.2 11.5 7.8 9.9 7.0 9.5 8.8 13.5 14.5 8.2 13.1 11.1 11.6 13.8 10.6 12.3 8.8 62.5 32.4 18.2 21.9 15.2 15.6 80.7 43.3 40.2 25.0 29.6 15.7 46.4 134.3 36.6 754.9 21.5 50.1 0.0 35.3 23.9 19.9 21.9 13.9 199.8 79.5 4.8 52.6 21.5 21.2 100.1 18.1 27.8 25.3 112.8 85.9 34.6 30.9 101.7 22.6 372.2 30.4 25.8 15.5 41.9 20.4 20.6 33.4 16.2 62.8 21.7 ACOT2 "Mte1, ZAP128" ENSG00000119673 "Acyl-CoA thioesterase 2" P49753 14 73567620-73575658 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 60.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043705, HPA060170" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043705: AB_2678626, HPA060170: AB_2732642" "unprognostic (4.44e-3)" "unprognostic (1.68e-2)" "unprognostic (3.17e-1)" "unprognostic (8.66e-2)" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (2.78e-2)" "unprognostic (6.61e-2)" "unprognostic (4.10e-2)" "unprognostic (9.21e-2)" "unprognostic (6.42e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.66e-3)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (4.35e-1)" 41.4 16.5 5.9 6.4 5.3 2.7 13.4 3.3 8.7 7.8 11.9 4.6 4.0 12.8 13.9 10.6 9.4 8.3 8.8 35.1 4.5 4.0 25.0 60.5 6.2 4.4 4.3 5.4 6.2 8.1 6.4 2.7 7.9 4.3 8.5 6.2 6.9 7.3 6.8 50.7 3.9 12.0 16.3 3.2 4.3 7.4 5.7 3.7 5.3 7.4 11.6 3.9 11.3 4.6 9.7 13.8 1.8 4.4 9.0 19.0 8.1 11.2 11.0 2.3 9.7 10.3 4.0 0.4 6.0 14.0 9.8 13.0 7.8 7.5 0.0 4.4 3.2 5.1 6.2 0.0 0.6 5.2 14.2 13.9 6.8 4.5 26.8 6.7 0.0 19.3 9.1 0.0 3.7 0.0 9.6 4.2 0.0 0.0 0.0 8.4 4.7 1.0 7.7 3.3 1.3 16.7 16.1 9.8 0.1 3.6 4.7 10.1 12.2 14.8 11.5 12.0 1.1 27.6 5.4 7.6 8.6 21.6 5.5 5.7 0.0 0.0 4.0 7.2 0.0 8.1 1.5 3.7 1.8 14.6 4.4 10.7 9.7 13.7 11.1 13.8 7.9 12.4 13.5 0.1 9.0 3.9 8.5 19.0 8.1 5.9 5.3 3.3 8.7 4.5 4.0 4.3 5.4 4.3 3.7 0.0 5.4 1.7 1.0 1.4 0.9 43.0 7.6 4.0 1.2 7.0 9.8 4.6 11.6 18.3 1.0 3.6 16.2 0.0 29.2 2.3 3.9 0.3 13.8 25.8 13.9 1.6 15.1 3.7 4.0 0.4 5.5 2.0 5.0 30.7 15.1 3.3 19.0 5.8 7.8 16.5 4.5 6.5 4.2 0.4 4.3 0.4 6.9 5.7 19.7 0.4 ACOT4 "FLJ31235, PTE-Ib, PTE2B" ENSG00000177465 "Acyl-CoA thioesterase 4" Q8N9L9 14 73591706-73596496 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.6" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 22.2;Proximal tubular cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.3;MCF7: 5.6;SK-BR-3: 11.7;T-47d: 29.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000779 Enhanced NA NA "HPA000779: AB_1078093" "unprognostic (2.29e-3)" "unprognostic (2.53e-3)" "unprognostic (2.30e-1)" "unprognostic (2.29e-3)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "unprognostic (2.25e-2)" "unprognostic (3.10e-2)" "unprognostic (1.72e-2)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.77e-4)" "unprognostic (3.95e-1)" "prognostic favorable (8.43e-5)" "unprognostic (2.47e-1)" "unprognostic (1.92e-1)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" 6.3 2.2 2.9 1.4 3.6 0.6 4.4 1.6 5.7 3.6 2.6 1.0 1.5 3.9 1.0 2.4 2.0 0.9 3.3 2.9 2.1 2.0 13.0 15.6 3.9 1.1 1.6 2.8 0.9 2.2 1.1 0.7 4.9 2.7 1.4 3.1 1.8 3.1 3.4 0.7 0.9 7.4 2.5 0.8 1.4 1.9 2.8 0.9 0.3 1.2 0.8 1.2 1.1 1.3 1.7 0.6 5.0 0.4 4.6 10.6 3.2 4.3 1.2 0.1 0.0 0.5 0.2 0.0 0.3 0.0 0.3 0.5 0.1 7.3 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 1.6 0.0 0.8 0.0 4.1 0.3 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 5.6 0.1 0.8 0.4 1.5 1.2 0.0 0.0 0.0 0.1 2.1 0.6 0.2 2.8 11.7 0.8 0.0 29.2 4.4 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 1.0 10.6 0.4 5.5 1.6 5.2 6.0 0.2 1.7 3.2 6.5 0.3 4.6 0.2 0.6 4.8 3.2 2.9 3.6 1.6 5.7 2.1 2.0 1.6 2.8 2.7 0.9 0.0 2.4 2.2 1.0 0.2 0.2 1.2 2.5 2.7 1.2 10.4 0.0 11.8 13.3 3.6 1.6 0.3 10.3 0.0 8.3 11.5 1.1 0.5 5.7 22.2 10.2 1.6 0.0 0.0 2.7 3.8 0.3 1.7 0.0 1.8 2.7 0.5 4.8 2.9 0.4 51.8 0.5 0.0 0.9 2.7 14.3 0.3 3.8 4.4 2.8 1.1 ACOT6 C14orf42 ENSG00000205669 "Acyl-CoA thioesterase 6" Q3I5F7 14 73610945-73619888 "Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.8;liver: 6.1;skeletal muscle: 6.5" "Cell type enhanced" "Detected in some" 21 "Hepatocytes: 2.4;Proximal tubular cells: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "T-47d: 15.3" HPA058258 Uncertain NA NA "HPA058258: AB_2683656" "unprognostic (1.88e-1)" "unprognostic (1.77e-1)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.15e-2)" "unprognostic (6.52e-2)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (2.28e-1)" "unprognostic (5.04e-1)" 2.6 1.0 1.5 0.0 2.0 0.0 0.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.8 0.6 6.8 6.1 0.0 0.0 0.8 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.1 0.0 0.9 1.4 0.0 0.0 0.0 0.1 1.8 0.0 0.6 0.0 1.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 1.0 2.8 0.1 0.0 15.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.1 0.8 1.8 0.1 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ACOT7 "ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126" ENSG00000097021 "Acyl-CoA thioesterase 7" O00154 1 6264269-6394391 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Cell type enhanced" "Detected in many" 8 "granulocytes: 137.0;Late spermatids: 118.5;Proximal tubular cells: 214.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "NK-cell: 20.5;plasmacytoid DC: 19.4" "Group enriched" "Detected in many" 4 "dendritic cells: 19.4;NK-cells: 20.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025735, HPA025762" Enhanced Supported Nucleoplasm,Cytosol No No 29000 Cytosol Nucleoplasm "HPA025735: AB_1844523, HPA025762: AB_1844524" "unprognostic (3.94e-2)" "unprognostic (1.74e-1)" "unprognostic (7.09e-2)" "unprognostic (4.33e-2)" "unprognostic (4.10e-2)" "unprognostic (5.06e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.35e-2)" "unprognostic (4.05e-2)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.55e-6)" "unprognostic (2.68e-2)" "unprognostic (1.45e-1)" "unprognostic (9.06e-2)" "unprognostic (3.72e-2)" 4.7 13.3 25.8 10.8 29.8 7.7 3.9 23.9 50.0 4.4 18.3 11.3 0.5 33.2 5.1 3.8 14.3 4.4 5.3 6.3 27.8 43.9 29.4 9.1 8.6 12.3 36.0 20.7 5.3 4.0 1.9 18.5 7.4 49.9 5.6 13.5 6.6 4.1 4.9 1.5 9.4 33.2 14.3 14.2 8.9 6.2 13.1 6.9 9.0 2.3 6.5 11.6 9.1 6.6 1.0 19.4 0.4 0.6 20.5 4.4 2.8 23.7 20.7 20.4 22.0 4.7 7.8 7.7 20.5 10.6 30.4 18.2 71.4 7.7 29.1 15.1 16.6 23.5 23.5 32.9 54.7 11.4 25.5 28.7 15.3 16.4 25.3 19.3 17.9 12.7 6.9 10.5 25.1 29.8 8.1 17.0 36.5 12.4 6.3 16.0 27.7 37.3 19.0 10.2 23.9 48.0 44.6 23.5 19.7 17.1 9.1 11.2 31.7 18.4 28.3 65.2 10.5 10.1 8.4 27.5 27.7 16.2 27.4 32.3 5.3 21.6 40.9 17.5 31.3 16.8 0.0 0.1 0.1 4.1 0.6 1.0 1.0 3.4 3.6 2.9 0.4 1.2 2.3 0.4 20.5 0.5 19.4 4.4 2.8 25.8 29.8 23.9 50.0 27.8 43.9 36.0 20.7 49.9 6.9 6.0 25.5 13.7 13.3 28.2 33.6 8.1 12.7 1.4 7.9 8.7 9.8 15.1 13.3 19.1 73.6 15.6 70.9 0.0 6.2 23.1 14.2 7.0 137.0 13.4 26.8 44.5 4.6 5.5 4.0 118.5 3.4 16.9 37.1 25.2 88.8 10.6 16.5 29.1 6.7 214.2 15.6 0.0 6.2 38.2 26.7 25.7 14.4 21.4 48.7 19.5 ACOX1 PALMCOX ENSG00000161533 "Acyl-CoA oxidase 1" Q15067 17 75941507-75979363 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.6" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 185.5;Hepatocytes: 244.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 22.9;neutrophil: 38.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 38.6" "Cell line enhanced" "Detected in all" "BEWO: 35.3;RT4: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021094, HPA021192, HPA021195, HPA028759" Approved Approved Nucleoli,Peroxisomes NA NA 160000 Peroxisomes Nucleoli "CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352" "unprognostic (7.47e-2)" "unprognostic (3.69e-1)" "unprognostic (1.25e-3)" "unprognostic (1.36e-1)" "unprognostic (7.49e-2)" "unprognostic (8.14e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "prognostic favorable (5.25e-7)" "unprognostic (3.39e-1)" "unprognostic (2.41e-2)" "unprognostic (1.72e-1)" "unprognostic (4.46e-2)" 21.8 12.9 8.8 8.3 10.2 4.2 13.6 6.4 9.8 6.4 26.5 8.2 9.6 31.0 6.6 6.7 19.5 6.0 12.3 16.0 8.3 7.9 20.8 95.6 9.2 7.5 8.2 8.3 7.6 28.7 9.8 8.9 13.6 7.8 9.5 14.3 11.3 9.5 9.1 18.3 13.4 53.1 7.9 6.7 7.2 13.6 6.2 6.3 7.1 9.1 11.4 10.6 10.6 7.9 1.6 3.3 38.6 5.8 2.1 2.7 2.2 5.4 7.7 2.5 3.8 13.3 5.6 35.3 4.0 4.0 4.8 5.5 5.4 9.0 3.1 4.3 6.8 4.5 3.3 10.7 4.2 7.6 2.8 3.2 4.0 4.4 17.7 7.2 3.4 2.6 9.3 3.3 5.4 3.6 5.1 12.0 4.3 4.1 3.1 5.3 16.1 7.6 2.5 1.9 13.5 6.7 4.2 7.7 3.6 8.1 47.5 3.1 4.6 11.4 17.8 3.8 8.7 10.9 3.9 7.9 6.7 4.9 5.4 3.8 5.1 3.5 1.2 3.9 3.2 3.9 22.9 5.8 1.6 2.1 4.5 2.7 1.6 2.0 2.7 3.3 1.6 2.4 2.3 38.6 2.1 2.8 2.9 2.6 2.2 8.8 10.2 6.4 9.8 8.3 7.9 8.2 8.3 7.8 6.3 26.8 20.6 3.0 13.1 11.9 23.8 38.6 48.4 14.7 18.2 22.7 21.6 32.5 18.3 19.8 8.4 14.6 185.5 23.3 35.6 39.3 17.0 27.2 16.2 244.8 23.1 17.5 33.1 22.1 31.8 6.5 27.6 19.9 13.5 25.2 35.0 64.2 31.5 87.7 44.2 74.6 28.4 0.0 16.4 5.6 10.7 26.5 36.2 10.2 32.4 22.6 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537319 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 70.5" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 75.4;Proximal tubular cells: 33.8" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;ASC TERT1: 20.7;fHDF/TERT166: 6.7;Hep G2: 8.0;HSkMC: 13.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol No No 190000 Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 4.0 5.3 1.9 3.8 2.5 0.1 3.4 1.6 2.1 4.4 10.2 2.7 9.5 10.0 9.0 6.2 3.8 4.4 4.8 8.8 2.4 1.4 17.1 70.5 2.8 0.7 2.0 1.7 5.1 2.9 3.8 3.0 1.4 4.0 7.2 3.4 11.4 3.0 5.9 4.2 1.7 13.7 10.6 2.5 0.9 2.6 4.0 2.0 1.0 7.7 2.7 1.6 5.4 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.5 20.7 3.6 2.3 0.2 0.0 0.3 0.6 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 1.8 0.0 0.0 13.5 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.5 1.6 2.1 2.4 1.4 2.0 1.7 4.0 2.0 3.0 4.3 0.5 7.2 0.6 0.2 14.4 0.0 0.0 1.2 3.5 0.0 0.6 13.3 0.3 0.1 1.1 5.4 0.0 1.7 0.2 5.0 0.8 1.1 75.4 5.3 1.6 2.9 4.3 2.2 1.4 10.0 0.8 0.0 0.0 4.7 10.0 0.5 0.0 8.1 33.8 0.8 6.5 3.4 0.2 0.5 0.3 0.7 0.0 3.6 0.8 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732573-111118222 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 29.7;lung: 20.8;placenta: 23.8" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 27.4" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 0.3 0.3 0.2 0.5 0.4 1.6 0.3 0.2 0.4 0.4 0.4 0.2 2.3 0.0 0.3 29.7 0.2 0.5 0.4 0.3 0.2 0.2 0.6 0.2 20.8 0.6 0.2 0.2 0.2 0.4 4.9 0.7 23.8 0.4 4.1 0.1 0.2 0.5 0.2 0.3 0.4 0.3 2.6 0.2 1.3 0.4 4.6 0.2 0.6 1.5 0.2 0.9 8.5 5.2 1.0 0.6 4.1 1.1 0.7 0.6 0.3 9.1 0.0 0.2 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.2 0.2 0.1 0.2 1.0 0.0 0.0 0.0 0.2 3.2 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.3 0.0 0.4 1.4 1.4 0.1 3.3 0.7 0.4 3.1 0.1 0.4 0.1 0.2 16.5 0.0 21.3 2.0 0.4 0.1 0.4 0.1 0.7 0.2 1.0 0.3 0.2 0.4 0.2 0.1 14.4 3.7 0.5 0.1 0.2 0.2 2.2 1.1 0.5 0.4 0.7 0.2 1.0 0.4 0.6 0.2 0.8 0.5 0.4 4.1 0.7 0.4 0.6 0.4 0.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.0 27.4 0.0 0.2 0.2 0.6 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 1.2 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.3 0.9 2.2 0.3 0.0 0.0 0.0 0.7 ACP4 ACPT ENSG00000142513 "Acid phosphatase 4" Q9BZG2 19 50790415-50795224 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Hydrolase "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.2;testis: 4.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.4;Karpas-707: 2.9;U-266/84: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.41e-2)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (3.70e-3)" "unprognostic (7.62e-2)" "unprognostic (3.18e-2)" "unprognostic (3.89e-3)" "unprognostic (5.46e-2)" "unprognostic (2.47e-1)" "unprognostic (5.59e-2)" "unprognostic (3.96e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-3)" "unprognostic (2.36e-1)" "unprognostic (4.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.5 0.3 0.8 0.0 0.5 0.2 0.9 1.6 0.0 0.0 1.0 0.5 0.0 0.0 0.0 2.2 0.2 0.8 0.1 0.0 0.1 0.6 0.0 0.0 0.0 1.6 4.4 0.1 1.3 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 2.9 0.0 0.9 0.7 1.4 0.5 0.8 1.5 1.0 0.4 0.6 0.0 1.6 0.4 0.6 0.3 0.3 0.7 0.1 0.1 1.0 0.0 0.7 0.6 0.8 0.4 0.7 5.4 0.6 0.7 0.9 0.3 0.0 0.1 0.0 0.2 0.5 0.8 0.8 0.6 0.5 0.0 0.9 0.8 0.5 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACP5 "HPAP, TRAP" ENSG00000102575 "Acid phosphatase 5, tartrate resistant" P13686 19 11574660-11579008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 117.9;lung: 151.9" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 439.8;Ito cells: 434.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 51.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002584, HPA057655, HPA059463" Enhanced Uncertain Cytosol "Intracellular and membrane" NA NA 3700000 Cytosol "CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028" "unprognostic (4.27e-2)" "unprognostic (2.05e-2)" "unprognostic (2.93e-1)" "unprognostic (8.60e-3)" "unprognostic (2.96e-1)" "unprognostic (1.95e-2)" "unprognostic (5.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.13e-2)" "unprognostic (3.80e-1)" "unprognostic (3.66e-3)" "unprognostic (9.09e-2)" "unprognostic (1.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 117.9 2.8 0.9 21.1 1.1 1.4 7.7 0.7 1.0 11.9 10.2 1.2 2.1 7.7 7.7 6.5 12.1 3.5 9.1 6.8 0.9 0.4 28.0 16.3 151.9 30.8 1.0 1.0 13.2 8.7 0.2 1.6 9.2 1.2 6.4 8.7 19.1 8.6 2.8 3.0 10.4 15.6 3.3 1.9 20.7 15.0 3.5 0.7 9.2 2.2 8.2 18.4 11.4 10.1 51.4 13.9 16.8 9.4 2.6 16.0 8.1 3.3 0.4 0.0 0.0 0.2 0.0 14.6 0.4 9.8 0.0 0.0 0.0 0.1 0.5 0.6 2.9 2.4 0.1 0.0 1.5 0.0 3.7 0.3 0.1 0.0 1.8 0.6 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.7 0.3 0.5 0.3 0.1 0.3 0.1 0.7 13.9 0.0 0.1 0.2 0.3 0.0 0.0 41.4 0.4 0.0 0.1 0.3 38.9 0.4 0.7 0.1 0.2 1.8 0.2 8.0 0.0 1.2 0.0 9.4 16.8 4.1 9.1 2.1 51.4 6.4 4.7 1.7 23.5 8.3 4.7 2.6 2.6 8.7 13.9 16.0 8.1 0.9 1.1 0.7 1.0 0.9 0.4 1.0 1.0 1.2 0.7 8.9 8.5 68.7 8.2 9.2 6.0 1.1 22.9 2.7 2.3 7.0 17.7 29.7 8.3 1.6 0.1 2.9 5.9 0.0 9.9 23.7 12.1 16.2 65.4 6.4 439.8 1.6 2.9 434.6 101.6 0.0 1.7 100.7 13.5 131.7 4.5 43.7 4.7 21.0 11.3 91.3 31.7 0.0 3.2 0.0 0.1 9.7 21.9 25.4 8.3 4.3 ACP7 "FLJ16165, PAPL, PAPL1" ENSG00000183760 "Acid phosphatase 7, tartrate resistant (putative)" Q6ZNF0 19 39083913-39111493 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 21.5;U-87 MG: 28.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA042613 Uncertain "Secreted - unknown location" NA NA "HPA042613: AB_10963214" "unprognostic (6.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-3)" "unprognostic (1.92e-3)" "unprognostic (1.41e-1)" "unprognostic (3.41e-1)" "unprognostic (4.94e-3)" "unprognostic (2.66e-1)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" "unprognostic (1.51e-5)" "unprognostic (4.36e-3)" "unprognostic (5.08e-2)" "unprognostic (2.31e-2)" "unprognostic (2.42e-1)" 0.3 0.3 1.6 0.3 5.5 0.3 1.0 15.2 5.4 0.9 0.3 4.2 0.3 0.4 0.4 1.4 1.1 0.3 0.9 0.3 2.5 1.2 0.3 0.3 0.4 0.3 6.5 0.7 0.3 0.3 0.3 0.0 0.3 5.2 1.2 0.3 0.0 0.6 0.3 0.3 14.1 0.3 0.3 4.1 0.3 0.6 0.4 5.3 0.0 0.3 5.5 6.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.4 0.5 0.3 3.2 0.0 0.0 0.0 21.5 0.2 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.9 0.7 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.5 15.2 5.4 2.5 1.2 6.5 0.7 5.2 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACPP "ACP-3, ACP3, PAP" ENSG00000014257 "Acid phosphatase, prostate" P15309 3 132317367-132368298 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "prostate: 345.2" "Cell type enriched" "Detected in many" 135 "Glandular cells: 2098.0" "Cancer enriched" "Detected in many" 275 "prostate cancer: 1227.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 43.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0" "Low region specificity" "Detected in some" "CAB000071, HPA004335, HPA063916" Enhanced "Secreted to blood" NA NA 460000 9200 "CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152" "unprognostic (6.67e-2)" "unprognostic (4.70e-2)" "unprognostic (1.76e-1)" "unprognostic (7.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.58e-2)" "unprognostic (2.46e-1)" "unprognostic (7.41e-2)" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (2.14e-1)" "unprognostic (5.95e-2)" "unprognostic (9.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-1)" "unprognostic (3.91e-2)" "unprognostic (1.71e-1)" 0.4 0.6 0.4 0.7 1.6 1.4 0.8 0.3 0.7 3.9 0.4 0.2 0.0 0.4 0.3 2.5 14.7 0.6 0.2 0.9 0.3 0.3 6.2 0.3 2.0 2.7 0.6 0.8 0.4 0.8 0.5 0.3 5.3 0.7 345.2 0.7 0.8 9.1 0.2 0.3 2.5 0.4 0.4 2.2 1.0 0.5 1.0 0.6 0.2 1.3 6.6 6.8 0.5 1.5 0.2 11.2 43.1 9.7 0.9 0.0 2.9 0.2 0.0 0.0 0.0 0.1 0.6 7.0 0.1 10.2 0.0 0.0 0.2 0.2 5.7 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 1.2 0.2 0.1 0.1 4.1 0.1 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.1 0.1 0.0 7.8 0.4 12.7 1.2 0.0 0.0 32.4 3.1 3.8 0.0 2.5 0.0 1.2 0.3 1.1 0.2 3.7 0.0 0.0 0.1 1.5 0.0 0.4 0.2 9.4 9.0 7.3 0.1 0.0 9.7 43.1 0.0 8.6 0.0 0.2 0.0 0.0 11.2 0.0 0.0 0.0 8.5 0.9 7.7 0.8 0.0 2.9 0.4 1.6 0.3 0.7 0.3 0.3 0.6 0.8 0.7 0.6 0.0 10.7 0.0 13.0 0.8 0.0 0.5 0.0 0.0 4.5 7.0 0.0 9.6 0.0 1.1 0.0 0.0 1.0 0.0 1.6 1.0 0.8 2098.0 0.0 0.0 4.1 0.0 15.5 0.0 9.2 0.0 0.0 2.8 0.0 0.0 2.4 0.3 1.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 7.4 0.0 1.0 11.5 ACR ENSG00000100312 Acrosin P10323 22 50738196-50745334 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "testis: 106.3" "Cell type enriched" "Detected in some" 4 "Early spermatids: 388.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.0;Hep G2: 1.8;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA048687 Enhanced "Secreted in male reproductive system" NA NA "HPA048687: AB_2680494" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" "unprognostic (6.27e-3)" "unprognostic (3.58e-2)" "unprognostic (8.04e-2)" "unprognostic (3.30e-3)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (1.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (1.25e-1)" 0.9 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.7 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 1.2 0.0 106.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 1.5 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 388.8 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 8.6 0.0 86.9 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.5 0.0 0.0 6.5 0.0 28.8 1.7 0.0 0.0 0.0 1.5 0.1 ACRBP "CT23, OY-TES-1, SP32" ENSG00000111644 "Acrosin binding protein" Q8NEB7 12 6638075-6647460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 170.4" "Group enriched" "Detected in many" 6 "Early spermatids: 884.1;Late spermatids: 605.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 8 "dendritic cells: 11.0;monocytes: 17.6" "Cell line enhanced" "Detected in some" "HEL: 5.5;HMC-1: 7.3;U-266/70: 16.3;U-266/84: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039081, HPA039082" Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA039081: AB_10670920, HPA039082: AB_10671036" "unprognostic (7.76e-3)" "unprognostic (2.27e-1)" "unprognostic (3.41e-3)" "unprognostic (2.31e-2)" "unprognostic (3.65e-2)" "unprognostic (2.13e-2)" "unprognostic (2.42e-1)" "unprognostic (3.40e-3)" "unprognostic (2.85e-1)" "unprognostic (5.47e-3)" "unprognostic (1.17e-2)" "unprognostic (1.43e-1)" "unprognostic (9.41e-3)" "unprognostic (1.25e-1)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-4)" 0.8 0.4 0.3 0.9 0.8 2.5 0.5 1.3 0.6 0.4 1.6 0.6 0.5 2.2 0.4 4.2 0.5 0.6 1.7 1.0 0.6 0.3 0.9 0.7 0.8 3.6 0.4 0.3 0.4 1.5 0.0 0.5 0.4 0.8 0.7 0.4 0.8 0.5 0.1 0.3 0.4 3.3 0.6 0.6 2.3 0.6 170.4 0.3 0.5 3.9 0.3 0.8 0.7 0.5 1.2 11.0 1.6 17.6 0.3 0.1 6.5 0.2 0.1 0.9 2.7 1.0 1.3 1.4 0.0 0.0 0.1 0.1 0.0 1.9 0.3 0.9 0.2 0.1 0.0 0.5 0.0 0.2 0.6 0.0 5.5 0.6 0.0 2.1 0.1 7.3 0.1 3.7 1.0 0.1 0.7 0.6 1.9 3.6 0.0 0.1 0.4 0.2 1.9 1.7 4.5 0.0 0.3 0.1 0.3 0.6 0.1 1.1 0.2 0.0 0.7 1.2 1.4 0.0 2.0 0.8 0.1 0.8 0.6 0.0 16.3 10.7 0.5 0.6 2.0 0.0 0.9 7.7 0.7 0.1 9.8 0.0 0.8 0.0 0.0 11.0 1.2 0.1 0.1 1.6 0.3 17.6 2.8 0.0 6.5 0.3 0.8 1.3 0.6 0.6 0.3 0.4 0.3 0.8 0.3 0.0 2.2 0.0 0.2 0.1 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 884.1 0.5 1.2 0.0 0.4 0.2 0.4 0.0 5.8 0.0 9.0 0.0 0.0 2.5 11.7 605.9 7.5 3.9 0.0 0.0 0.9 1.0 0.2 0.9 4.2 0.8 1.5 6.5 0.1 127.7 7.2 0.0 0.1 0.0 0.9 0.1 ACRV1 "D11S4365, SP-10, SPACA2" ENSG00000134940 "Acrosomal vesicle protein 1" P26436 11 125671522-125681123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "testis: 57.2" "Group enriched" "Detected in some" 77 "Early spermatids: 687.8;Late spermatids: 204.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 6.1;HEL: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038718, HPA038719" Enhanced "Intracellular and membrane" NA NA "HPA038718: AB_2676171, HPA038719: AB_10670787" "unprognostic (3.58e-2)" "unprognostic (8.68e-3)" "unprognostic (1.46e-1)" "unprognostic (6.18e-2)" "unprognostic (4.58e-2)" "unprognostic (7.91e-3)" "unprognostic (6.73e-4)" "unprognostic (1.76e-1)" "unprognostic (2.12e-3)" "unprognostic (8.39e-2)" "unprognostic (7.09e-2)" "unprognostic (2.90e-3)" "unprognostic (1.80e-8)" "unprognostic (5.26e-3)" "unprognostic (2.52e-1)" "unprognostic (1.95e-1)" "unprognostic (3.75e-1)" 0.1 0.0 0.3 0.1 0.8 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 1.8 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 57.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.7 0.0 0.3 1.9 6.1 4.3 0.0 0.0 1.7 1.5 0.0 0.2 0.0 2.3 2.2 4.3 0.8 0.0 0.8 0.6 0.0 0.0 0.6 3.0 0.6 7.0 1.1 1.6 0.2 3.8 1.8 0.0 0.0 0.0 0.3 0.3 0.1 1.3 1.9 3.4 0.8 1.3 4.4 3.9 2.1 0.7 1.5 3.1 1.7 0.5 0.0 0.7 0.9 1.0 0.8 0.2 0.2 1.4 1.2 1.0 0.9 2.2 1.6 0.3 0.5 1.7 1.9 1.8 0.4 1.9 3.6 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 0.1 0.5 0.3 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 687.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 204.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 4.2 2.6 0.0 0.0 0.0 0.0 0.0 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.4;brain: 40.5;skin 1: 19.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 26.8;Spermatogonia: 7.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 8.1;SK-MEL-30: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles NA NA Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 1.1 11.4 16.9 1.5 26.9 4.5 3.8 6.6 27.0 1.1 1.2 10.5 0.0 1.6 1.2 2.3 1.3 5.9 1.3 1.1 16.4 8.5 1.0 1.0 1.7 1.6 21.1 13.9 1.2 1.0 0.9 0.3 1.1 32.9 2.0 1.1 0.0 1.5 1.4 1.2 19.9 1.5 1.2 40.5 1.3 1.2 5.4 19.0 0.0 1.2 0.0 1.1 1.5 0.2 0.4 3.9 1.2 0.2 0.6 0.2 1.5 0.8 0.1 1.6 2.4 0.0 0.0 0.6 0.5 0.0 0.5 0.1 0.5 0.6 0.8 0.2 0.1 0.6 0.9 0.1 0.3 0.2 0.4 1.4 0.7 1.4 0.7 0.0 0.7 1.6 0.6 0.0 0.4 0.2 0.5 0.2 1.0 0.5 1.1 0.1 0.4 0.6 1.4 8.1 0.7 0.3 0.3 1.0 0.5 0.0 1.0 0.6 0.9 0.4 1.0 3.8 1.0 0.5 0.5 1.0 0.6 0.6 0.5 0.3 0.9 0.3 0.9 0.3 0.6 1.6 0.4 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.4 0.2 0.1 1.2 0.6 0.2 3.9 0.0 1.5 16.9 26.9 6.6 17.9 16.4 8.5 21.1 13.9 32.9 19.0 0.0 1.3 0.0 0.3 1.0 2.1 2.0 0.0 26.8 4.5 0.0 3.9 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.9 0.9 7.7 0.5 0.3 0.0 0.0 0.3 ACSBG2 "BGR, DKFZp434K1635, PRTD-NY3" ENSG00000130377 "Acyl-CoA synthetase bubblegum family member 2" Q5FVE4 19 6135247-6193094 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 71.3" "Group enriched" "Detected in some" 68 "Early spermatids: 443.1;Late spermatids: 1482.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HEL: 3.4;Karpas-707: 2.6;MCF7: 1.0" "Not detected" "Not detected" "HPA043421, HPA051013" Enhanced Supported Cytosol NA NA Cytosol "HPA043421: AB_10794182, HPA051013: AB_2681311" "unprognostic (4.13e-2)" "unprognostic (1.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.27e-2)" "unprognostic (4.33e-2)" "unprognostic (1.92e-4)" "unprognostic (1.96e-2)" "unprognostic (4.17e-2)" "unprognostic (2.07e-1)" "unprognostic (2.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.13e-2)" "unprognostic (3.91e-3)" "unprognostic (2.20e-1)" "unprognostic (9.23e-2)" "unprognostic (8.78e-2)" "unprognostic (4.70e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 2.6 0.0 1.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.5 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 443.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1482.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.0 0.0 6.5 0.0 14.2 5.7 0.0 1.1 0.0 0.0 0.0 ACSF2 "ACSMW, FLJ20920" ENSG00000167107 "Acyl-CoA synthetase family member 2" Q96CM8 17 50426158-50474845 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 60.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 70.1;Proximal tubular cells: 99.5;Syncytiotrophoblasts: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024693 Enhanced Uncertain Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "HPA024693: AB_2671654" "unprognostic (1.40e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (1.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.48e-2)" "unprognostic (1.14e-2)" "unprognostic (6.49e-2)" "unprognostic (7.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (2.45e-2)" "prognostic favorable (2.41e-4)" 13.2 37.6 4.8 7.7 4.4 1.1 16.3 2.0 4.0 8.4 19.1 4.0 30.3 9.2 3.5 15.4 6.7 4.3 7.2 12.9 5.6 2.0 60.0 15.0 9.0 3.7 3.7 2.8 9.4 3.4 2.6 1.7 14.1 3.9 12.4 7.4 7.6 10.1 33.3 28.4 9.7 22.4 4.5 3.5 4.5 8.0 4.5 3.6 3.5 30.6 6.6 5.9 13.0 7.6 7.8 13.8 11.9 6.2 1.2 4.3 2.1 9.6 3.1 2.6 6.2 27.5 5.0 15.3 2.3 3.4 5.0 9.9 12.3 18.5 6.0 5.1 2.8 4.6 5.8 1.8 11.4 6.0 7.5 4.4 10.3 1.5 21.8 4.6 1.3 9.6 22.2 17.5 6.4 0.8 18.0 6.8 7.9 1.2 3.4 5.4 11.6 3.1 4.1 0.4 18.2 4.6 7.8 1.9 15.2 1.6 37.7 8.5 4.6 4.5 6.9 4.7 5.5 6.0 8.8 5.1 9.2 2.9 1.3 0.7 6.1 1.2 3.1 3.8 6.5 0.5 0.0 2.5 11.9 1.8 6.2 1.6 7.8 1.3 1.8 13.8 1.9 0.6 0.8 0.4 1.2 5.4 5.2 4.3 2.1 4.8 4.4 2.0 4.0 5.6 2.0 3.7 2.8 3.9 3.6 26.8 22.4 2.4 22.9 5.4 0.0 17.3 10.2 12.0 17.0 3.5 0.0 70.1 10.0 10.9 0.2 5.2 47.0 0.0 3.9 9.5 5.9 3.5 21.9 34.1 19.9 0.0 9.8 4.3 8.8 1.3 24.7 11.5 3.3 15.4 19.9 6.6 4.5 35.1 13.4 99.5 0.2 0.0 3.9 0.0 2.7 6.0 67.7 5.7 18.3 10.6 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Group enriched" "Detected in many" 4 "Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Cell line enhanced" "Detected in many" "ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 6.1 1.9 1.2 3.1 151.2 36.7 1.0 3.4 1.7 2.0 1.4 0.4 1.7 2.5 0.3 4.0 4.9 3.8 5.4 2.2 1.7 12.4 1.9 1.8 1.7 5.0 24.3 4.9 4.6 80.3 18.6 1.7 8.7 3.6 2.6 0.4 0.8 7.8 9.8 3.2 0.3 6.8 0.2 4.1 2.7 0.9 1.0 3.2 47.8 17.5 4.6 4.3 3.1 9.4 10.5 0.5 3.4 5.0 2.8 1.8 2.1 4.3 1.0 3.0 1.5 1.1 5.8 6.9 2.8 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 23.8 107.2 14.5 16.5 18.7 5.8 89.7 28.1 13.4 21.6 29.6 17.7 8.6 79.6 3.9 359.4 5.6 2.6 0.0 11.0 1.9 9.1 56.1 23.1 1018.8 39.4 3.2 0.0 19.0 136.2 335.5 17.8 64.1 30.4 24.4 4.2 3.3 9.0 0.9 15.6 75.0 10.3 12.9 12.0 8.1 16.7 35.9 2.9 10.0 1.7 21.4 ACSL3 "ACS3, FACL3, PRO2194" ENSG00000123983 "Acyl-CoA synthetase long chain family member 3" O95573 2 222860934-222944639 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 206.1" "Cell type enhanced" "Detected in all" 9 "Horizontal cells: 494.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 94.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011315, HPA071021" Approved Approved "Nucleoli,Nucleoli rim,Lipid droplets" NA NA "Nucleoli, Nucleoli rim" "Lipid droplets" "HPA011315: AB_1848344, HPA071021: AB_2686335" "unprognostic (1.87e-1)" "unprognostic (5.64e-2)" "unprognostic (2.36e-1)" "unprognostic (9.35e-3)" "unprognostic (7.53e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (2.75e-4)" "prognostic unfavorable (8.78e-4)" "unprognostic (3.90e-2)" "unprognostic (2.50e-1)" "unprognostic (2.64e-1)" "unprognostic (4.26e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-1)" "unprognostic (2.72e-1)" "unprognostic (2.65e-1)" "unprognostic (1.60e-1)" 14.7 17.0 22.8 9.9 26.0 16.3 51.5 19.4 45.9 15.3 16.5 16.1 11.6 12.7 10.9 18.4 28.3 9.0 11.8 22.7 20.9 22.8 17.9 22.3 15.6 10.5 19.6 21.2 11.7 10.3 206.1 8.8 19.1 24.4 44.4 16.7 14.4 34.2 15.5 19.1 11.4 12.7 12.2 22.2 9.7 28.3 13.7 14.2 13.5 17.3 11.2 8.7 14.6 15.4 15.0 22.5 21.8 16.8 16.6 20.1 16.5 10.1 17.9 27.4 29.8 12.0 29.8 7.6 12.9 33.6 15.5 32.7 16.1 26.1 4.8 7.5 12.3 33.5 29.9 5.9 28.7 20.1 8.7 11.2 11.4 14.5 17.9 26.5 7.5 5.6 15.3 40.8 25.6 44.7 11.9 16.8 8.5 21.5 18.6 21.8 21.5 14.6 8.8 13.9 23.0 9.3 8.0 23.2 8.2 22.3 41.6 14.5 10.7 7.6 20.6 94.2 22.1 10.3 18.4 11.6 10.4 16.6 8.9 9.4 6.6 3.2 16.8 11.1 7.1 31.4 16.6 14.6 21.8 20.1 16.8 19.3 11.6 12.8 14.6 15.7 15.0 18.7 16.7 21.8 16.6 15.9 22.5 9.5 16.5 22.8 26.0 19.4 45.9 20.9 22.8 19.6 21.2 24.4 14.2 32.8 58.5 16.4 65.8 41.3 91.7 51.2 40.8 37.5 44.3 34.9 72.6 32.9 6.6 28.6 31.0 38.3 33.1 23.3 27.3 8.4 36.3 113.5 26.5 47.9 33.5 494.2 20.1 36.2 50.2 18.9 24.2 42.9 45.5 32.5 32.3 205.8 32.5 38.6 33.6 12.5 51.8 45.3 51.8 50.2 49.9 42.7 50.7 27.7 46.5 102.1 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 278.7" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 266.6;Paneth cells: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.3;RT4: 44.2;U-937: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA 22000 Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 10.0 1.4 3.1 12.7 3.5 2.2 6.4 1.2 3.1 9.3 84.6 1.6 3.8 64.5 8.7 41.8 4.2 8.0 11.2 3.1 3.3 3.1 3.2 56.5 10.8 7.1 4.0 1.2 5.0 1.6 0.1 1.2 2.1 3.9 7.0 21.5 8.4 2.4 4.0 2.6 1.3 278.7 2.6 3.8 12.4 7.7 2.3 2.5 6.3 3.1 2.7 7.2 17.4 6.7 10.8 19.4 16.3 17.0 16.2 25.1 11.7 11.6 0.3 0.2 0.0 0.8 0.1 1.0 0.3 2.3 0.0 0.2 10.6 43.3 14.2 2.6 0.6 2.1 0.1 0.0 0.0 0.2 11.9 0.0 11.1 0.4 18.5 2.8 17.2 18.8 1.9 0.0 0.2 0.0 0.8 0.8 0.0 0.0 6.5 0.0 0.0 0.0 7.9 0.0 9.8 0.4 3.9 0.0 8.7 1.2 44.2 0.0 0.3 17.3 6.6 0.0 0.0 0.0 9.7 12.5 0.1 0.1 0.7 0.7 4.7 0.0 6.9 0.4 21.6 0.0 14.5 9.3 16.3 16.7 17.0 16.6 10.8 13.7 18.4 19.4 8.2 9.5 14.5 2.5 16.2 15.9 6.2 25.1 11.7 3.1 3.5 1.2 3.1 3.3 3.1 4.0 1.2 3.9 2.5 11.9 43.5 21.6 7.4 3.4 0.0 1.4 12.7 5.3 33.0 0.0 3.9 1.6 0.0 12.0 65.8 24.5 266.6 0.0 5.6 1.9 1.7 5.7 17.3 79.9 16.7 0.0 39.2 16.0 19.2 29.7 14.7 23.5 3.3 4.6 84.3 0.0 29.0 93.1 11.3 0.0 1.2 0.0 1.4 1.7 1.4 1.5 0.6 14.9 90.6 41.4 ACSL6 "ACS2, FACL6, KIAA0837, LACS2, LACS5" ENSG00000164398 "Acyl-CoA synthetase long chain family member 6" Q9UKU0 5 131949973-132012243 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0;ductus deferens: 30.1;seminal vesicle: 35.8;testis: 23.0" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 216.0;Erythroid cells: 116.8;Rod photoreceptor cells: 126.2" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 14.9;U-937: 8.7" HPA040470 Enhanced NA NA "HPA040470: AB_10794033" "unprognostic (1.99e-2)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (5.89e-2)" "unprognostic (6.97e-2)" "unprognostic (1.92e-2)" "unprognostic (8.38e-3)" "unprognostic (5.84e-2)" "unprognostic (8.69e-2)" "unprognostic (7.57e-2)" "unprognostic (9.28e-4)" "unprognostic (8.69e-2)" "unprognostic (3.22e-2)" "unprognostic (6.24e-3)" "unprognostic (1.79e-1)" "unprognostic (6.44e-3)" "unprognostic (1.70e-1)" 0.6 4.8 16.5 1.5 15.7 21.3 0.7 22.8 34.0 0.5 0.7 5.3 30.1 5.4 0.5 1.0 0.9 0.7 0.9 2.0 12.4 9.7 2.3 2.6 0.8 2.5 9.6 12.1 0.5 1.9 13.0 2.7 1.1 12.1 0.8 0.8 3.3 0.8 35.8 3.6 0.6 3.3 0.5 4.2 1.2 1.2 23.0 4.7 0.0 0.9 0.0 1.5 0.7 0.3 0.1 0.0 0.6 0.1 1.2 4.2 1.1 0.0 0.0 0.3 0.1 0.6 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.1 1.6 0.2 0.0 0.0 0.9 0.1 0.0 2.2 0.0 0.2 2.1 0.0 0.1 0.0 0.1 0.0 0.0 2.1 1.0 0.2 0.0 0.0 0.0 1.5 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 14.9 0.7 0.2 0.2 1.2 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.3 8.7 0.5 0.6 0.1 0.1 1.5 0.0 3.5 0.1 2.1 4.2 0.0 0.1 3.9 1.8 0.2 1.2 0.0 0.0 0.1 1.1 16.5 15.7 22.8 18.8 12.4 9.7 9.6 12.1 12.1 4.7 23.8 33.5 0.5 1.0 1.6 55.8 0.0 2.5 14.7 29.6 1.8 216.0 0.3 6.6 0.4 22.7 0.4 0.7 116.8 0.2 0.2 1.1 1.0 9.3 5.7 0.1 20.6 2.4 2.5 1.2 3.6 0.3 7.9 0.0 0.0 0.6 20.4 0.2 0.9 1.8 0.3 126.2 0.0 0.8 16.1 1.3 1.1 0.2 10.7 0.2 0.9 ACSM1 "BUCS1, MACS1" ENSG00000166743 "Acyl-CoA synthetase medium chain family member 1" Q08AH1 16 20623237-20698890 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "breast: 83.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 7.6;Early spermatids: 11.5;Late spermatids: 18.5" "Group enriched" "Detected in many" 8 "liver cancer: 14.7;prostate cancer: 36.7" "Cell type enhanced" "Detected in some" "eosinophil: 3.5;memory B-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 18.8" "Not detected" "Not detected" HPA046291 Uncertain NA NA "HPA046291: AB_10960704" "unprognostic (1.08e-2)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-2)" "unprognostic (5.49e-4)" "unprognostic (1.66e-1)" "unprognostic (3.50e-2)" "unprognostic (9.46e-2)" "unprognostic (3.10e-1)" "unprognostic (8.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.64e-1)" "unprognostic (8.24e-2)" "unprognostic (3.79e-2)" "unprognostic (3.01e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 0.0 0.1 0.0 0.0 0.0 1.1 83.4 0.1 0.1 1.7 0.4 0.2 2.3 0.2 0.1 2.4 0.2 0.1 0.0 0.0 1.2 3.8 0.2 0.1 0.0 2.8 1.4 0.5 0.0 0.0 3.4 0.2 1.2 0.2 0.1 2.2 0.4 0.3 0.0 0.2 2.1 4.5 0.2 0.1 1.1 1.5 3.4 0.0 3.5 0.9 1.3 0.6 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.1 18.8 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.5 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 3.5 0.1 0.2 0.1 3.4 0.6 0.0 0.0 2.9 0.5 0.2 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.6 0.0 0.3 7.6 4.0 1.2 0.0 0.0 0.1 1.7 3.0 11.5 0.7 0.4 0.0 2.0 0.1 0.0 3.1 0.0 0.8 0.2 0.0 1.2 0.6 0.0 18.5 4.0 1.8 0.0 2.8 3.7 0.0 1.5 3.5 6.7 1.2 0.0 0.0 0.0 0.5 0.0 1.4 0.1 0.0 2.2 1.2 ACSM2A "A-923A4.1, ACSM2, MGC150530" ENSG00000183747 "Acyl-CoA synthetase medium chain family member 2A" Q08AH3 16 20451461-20487667 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 90 "kidney: 63.5;liver: 82.6" "Group enriched" "Detected in some" 13 "Hepatocytes: 567.1;Proximal tubular cells: 367.9" "Group enriched" "Detected in some" 479 "liver cancer: 22.7;renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Hep G2: 6.6" HPA057699 Supported NA NA "HPA057699: AB_2683506" "unprognostic (1.17e-4)" "prognostic favorable (1.41e-5)" "unprognostic (5.25e-1)" "unprognostic (2.42e-1)" "unprognostic (9.28e-3)" "unprognostic (1.52e-1)" "unprognostic (5.10e-1)" "unprognostic (2.09e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.0 63.5 82.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 25.5 0.0 0.2 0.0 0.3 35.7 0.0 0.0 7.0 0.0 0.0 26.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 567.1 0.0 0.0 0.0 21.5 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 367.9 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.5 0.0 0.0 ACSM2B "ACSM2, HXMA, HYST1046" ENSG00000066813 "Acyl-CoA synthetase medium chain family member 2B" Q68CK6 16 20536226-20576427 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 69 "kidney: 76.1;liver: 93.4" "Group enriched" "Detected in some" 13 "Hepatocytes: 830.9;Proximal tubular cells: 347.6" "Group enriched" "Detected in some" 450 "liver cancer: 30.9;renal cancer: 17.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 5.5;Hep G2: 10.1" HPA057699 Supported NA NA "HPA057699: AB_2683506" "unprognostic (1.34e-2)" "prognostic favorable (3.31e-4)" "unprognostic (7.13e-2)" "unprognostic (2.29e-1)" "unprognostic (6.67e-2)" "unprognostic (1.24e-1)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 76.1 93.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.9 1.0 0.5 0.2 1.2 0.0 1.0 0.0 5.5 1.5 0.0 0.0 1.4 0.9 0.2 0.0 0.0 1.2 0.9 0.1 2.8 0.0 0.9 0.8 0.0 0.0 0.0 1.0 0.7 0.3 1.3 10.1 0.0 1.3 1.4 0.0 0.0 0.0 0.4 0.8 0.6 0.3 0.9 1.2 0.0 0.7 0.6 1.3 1.2 1.7 0.0 0.1 1.2 0.2 0.4 0.2 1.9 1.0 2.7 0.0 1.0 0.2 2.0 0.4 0.0 0.0 1.0 0.0 0.8 0.8 0.5 0.7 0.7 3.5 1.9 0.5 0.5 0.2 0.6 0.0 0.6 0.1 0.8 0.2 0.1 0.6 0.7 1.2 1.0 0.2 0.1 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 41.9 0.0 0.2 0.0 0.3 28.1 0.0 0.0 7.0 0.0 0.0 29.9 0.1 0.7 0.5 0.0 46.7 0.0 0.0 0.0 0.0 0.0 830.9 0.1 0.0 1.7 23.9 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 347.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ACSM3 "SA, SAH" ENSG00000005187 "Acyl-CoA synthetase medium chain family member 3" Q53FZ2 16 20610243-20797581 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6;ovary: 47.7;pancreas: 46.6" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 71.3;Ito cells: 98.8;Proximal tubular cells: 77.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 18.3" "Group enriched" "Detected in all" 4 "granulocytes: 18.3;T-cells: 7.4" "Cell line enhanced" "Detected in some" "HEL: 20.3;HMC-1: 85.9;K-562: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041013 Uncertain NA NA "HPA041013: AB_10671693" "unprognostic (1.62e-4)" "unprognostic (1.30e-2)" "unprognostic (2.12e-2)" "unprognostic (9.50e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.42e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "prognostic favorable (1.97e-4)" "unprognostic (3.56e-2)" "unprognostic (1.95e-3)" "prognostic favorable (9.88e-6)" "unprognostic (1.27e-1)" "unprognostic (6.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.84e-2)" 2.1 1.8 0.3 3.7 1.0 3.4 18.6 0.4 0.4 10.9 7.0 0.5 4.3 1.7 10.4 5.3 2.9 11.2 5.0 4.0 0.3 0.3 33.1 58.6 6.4 3.7 0.4 0.3 47.7 46.6 5.1 1.0 1.8 0.7 9.6 7.2 1.4 3.6 6.5 1.0 2.0 3.1 3.2 0.5 1.3 10.9 14.7 0.3 1.5 1.5 1.6 1.8 3.9 6.6 2.2 1.9 18.3 2.9 1.9 7.4 2.3 0.2 2.8 0.5 0.1 0.8 0.5 0.3 0.0 0.3 0.0 0.2 0.2 4.0 0.3 4.5 0.1 0.1 0.3 0.0 0.4 0.3 0.9 1.4 20.3 0.0 1.5 0.3 2.2 85.9 0.8 0.4 0.1 0.4 0.4 0.0 0.1 60.5 3.4 0.0 0.3 0.1 0.7 0.1 3.0 0.7 0.6 0.0 4.3 4.1 0.2 0.1 0.1 0.0 1.2 0.0 0.1 1.3 0.1 0.3 0.2 0.2 0.2 0.1 4.9 3.8 0.2 0.3 1.6 0.1 2.3 1.6 18.3 3.3 1.0 3.8 1.4 4.1 3.0 0.2 2.2 6.5 7.4 0.5 1.9 2.9 1.9 4.6 2.3 0.3 1.0 0.4 0.4 0.3 0.3 0.4 0.3 0.7 0.3 3.0 25.3 23.1 29.1 2.5 0.0 3.2 17.8 2.7 2.3 12.2 0.0 14.9 71.3 44.7 11.7 0.5 3.9 0.0 11.1 1.0 1.5 14.6 0.0 34.1 3.2 0.0 2.4 98.8 6.9 9.1 25.6 1.5 0.0 1.0 9.1 0.0 14.1 11.5 12.0 77.8 0.0 0.0 3.1 2.7 1.0 1.6 16.0 5.7 22.5 4.3 ACSM4 ENSG00000215009 "Acyl-CoA synthetase medium chain family member 4" P0C7M7 12 7304284-7328724 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.0;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 3.8;Karpas-707: 2.6;NB-4: 4.0;SH-SY5Y: 4.7;U-87 MG: 6.7" "Region enhanced" "Detected in single" "olfactory region: 0.6" "Not detected" "Not detected" HPA049895 Uncertain NA NA "HPA049895: AB_2680940" "unprognostic (9.50e-5)" "unprognostic (5.45e-2)" "unprognostic (4.84e-2)" "unprognostic (6.06e-4)" "unprognostic (1.77e-2)" "unprognostic (1.76e-2)" "unprognostic (2.24e-3)" "unprognostic (3.31e-3)" "unprognostic (3.85e-2)" "unprognostic (8.78e-2)" "unprognostic (3.27e-1)" "unprognostic (3.60e-1)" "unprognostic (2.45e-9)" "unprognostic (1.82e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.73e-1)" 0.2 0.5 0.1 0.7 0.1 0.0 0.1 0.1 0.6 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.3 0.0 0.1 2.0 0.1 3.6 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.5 0.4 0.3 0.0 0.0 0.7 4.7 0.7 1.1 0.0 0.0 0.0 1.5 1.0 0.5 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 ACSM5 FLJ20581 ENSG00000183549 "Acyl-CoA synthetase medium chain family member 5" Q6NUN0 16 20409534-20441336 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 94.6" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 179.6" "Group enriched" "Detected in some" 7 "liver cancer: 20.5;renal cancer: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Group enriched" "Detected in some" 5 "ASC diff: 5.8;ASC TERT1: 12.6;HSkMC: 15.0;U-87 MG: 9.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041435 Uncertain Uncertain Vesicles NA NA Vesicles "HPA041435: AB_10961121" "unprognostic (1.01e-1)" "unprognostic (1.61e-3)" "unprognostic (3.73e-2)" "unprognostic (1.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-2)" "unprognostic (1.84e-2)" "unprognostic (4.64e-3)" "unprognostic (1.64e-1)" "unprognostic (2.01e-2)" "unprognostic (2.15e-2)" "unprognostic (2.33e-1)" "unprognostic (5.11e-3)" "unprognostic (2.09e-2)" "unprognostic (3.85e-2)" "unprognostic (2.78e-2)" "unprognostic (1.57e-1)" 11.1 1.1 1.9 0.7 2.1 0.4 3.2 1.3 1.6 1.0 1.0 2.9 0.0 0.5 0.3 2.8 0.5 0.6 1.0 0.9 3.0 1.9 8.9 94.6 0.9 1.6 2.9 2.1 0.4 1.4 0.4 0.1 0.7 2.0 0.4 0.6 0.5 0.5 0.5 4.4 0.6 0.6 0.5 2.9 1.7 0.9 1.0 3.0 0.1 1.7 0.6 0.4 0.5 0.7 0.3 3.2 0.3 2.8 0.0 0.3 0.5 0.0 0.0 0.1 0.1 5.8 12.6 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 15.0 0.0 0.8 0.1 0.3 0.0 0.0 0.1 0.6 1.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 9.2 0.1 0.0 0.3 2.8 0.1 0.1 1.9 0.1 0.1 0.3 0.2 3.2 0.3 0.2 0.3 0.1 0.0 1.3 0.1 0.0 0.5 1.9 2.1 1.3 1.6 3.0 1.9 2.9 2.1 2.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 179.6 3.3 0.0 0.0 6.7 8.8 0.2 8.6 1.2 0.0 1.8 0.0 1.1 0.0 0.0 5.6 31.5 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.1 ACSM6 "bA310E22.3, C10orf129" ENSG00000173124 "Acyl-CoA synthetase medium chain family member 6" Q6P461 10 95194200-95228928 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 16.3;pancreas: 7.3;stomach 1: 6.2" "Group enriched" "Detected in some" 16 "Cone photoreceptor cells: 2.0;Early spermatids: 1.9;Rod photoreceptor cells: 4.6" "Cancer enriched" "Detected in single" 7 "urothelial cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 30 "RT4: 9.2" HPA044593 Uncertain NA NA "HPA044593: AB_10960261" "unprognostic (2.91e-2)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (5.73e-2)" "unprognostic (2.48e-2)" "unprognostic (6.34e-2)" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (3.75e-3)" "unprognostic (2.25e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.71e-4)" 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.8 0.4 0.0 6.2 0.3 0.0 16.3 0.8 0.0 0.0 2.5 1.9 0.1 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACSS1 "ACAS2L, AceCS2L, dJ568C11.3, MGC33843" ENSG00000154930 "Acyl-CoA synthetase short chain family member 1" Q9NUB1 20 25006230-25058980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.4" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 211.3;Syncytiotrophoblasts: 350.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 19.6;JURKAT: 20.6;OE19: 25.4;RPMI-8226: 29.2;U-937: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041014, HPA043228" Enhanced NA NA "HPA041014: AB_2677251, HPA043228: AB_2678372" "unprognostic (6.87e-2)" "prognostic favorable (9.37e-4)" "unprognostic (5.32e-2)" "unprognostic (1.54e-1)" "unprognostic (2.78e-1)" "unprognostic (3.03e-2)" "unprognostic (3.20e-3)" "prognostic favorable (8.33e-5)" "unprognostic (2.44e-1)" "unprognostic (2.17e-2)" "unprognostic (2.43e-1)" "unprognostic (7.72e-2)" "unprognostic (4.58e-3)" "unprognostic (5.85e-2)" "unprognostic (2.68e-1)" "unprognostic (3.69e-1)" "unprognostic (1.60e-1)" 6.1 4.8 22.8 8.6 26.6 16.3 9.1 17.1 19.6 9.0 14.0 21.8 9.7 28.1 8.5 12.3 7.5 10.8 12.4 32.4 26.3 9.2 19.5 5.5 10.8 13.4 15.1 20.4 12.3 28.8 9.3 5.7 66.4 21.3 14.8 12.5 9.9 21.8 10.2 19.5 9.3 25.9 8.0 11.1 16.1 26.9 21.6 22.9 11.9 14.9 4.8 12.2 8.7 7.1 7.2 4.4 8.7 6.3 12.6 5.5 2.7 0.0 4.7 1.4 0.0 4.5 1.7 0.1 0.5 2.0 2.0 1.4 4.7 0.6 8.2 0.8 1.9 8.8 2.4 6.9 1.0 0.4 0.0 0.6 14.1 0.1 19.6 4.6 3.3 0.1 2.9 3.5 0.2 0.0 0.0 4.4 20.6 0.7 15.8 0.1 0.5 19.0 5.6 0.1 25.4 7.6 14.9 0.4 29.2 3.0 3.7 3.4 0.1 0.9 1.9 13.1 0.1 9.1 7.5 0.6 0.0 0.0 0.0 0.2 11.0 0.7 0.0 0.2 20.3 5.2 6.3 3.7 8.7 5.5 6.3 4.5 5.2 3.7 4.8 4.4 7.2 3.2 4.9 0.8 12.6 4.1 2.8 3.2 2.7 22.8 26.6 17.1 19.6 26.3 9.2 15.1 20.4 21.3 22.9 11.9 13.7 25.6 6.7 4.6 2.4 60.2 45.9 9.4 9.1 10.4 0.0 211.3 64.6 3.4 72.5 7.1 29.0 23.3 6.7 6.5 11.6 9.5 5.7 5.0 43.5 0.0 0.0 9.2 7.5 14.5 31.9 8.1 6.8 2.8 28.5 14.3 3.0 14.0 30.4 14.0 0.7 19.4 14.4 0.9 1.1 3.8 350.8 23.5 21.3 3.0 ACSS2 "ACAS2, AceCS, ACS, ACSA, dJ1161H23.1" ENSG00000131069 "Acyl-CoA synthetase short chain family member 2" Q9NR19 20 34872146-34927962 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 98.3;Mucus-secreting cells: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Group enriched" "Detected in many" 5 "dendritic cells: 12.6;granulocytes: 17.0;monocytes: 11.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004141 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA004141: AB_1078094" "unprognostic (1.97e-2)" "unprognostic (1.33e-1)" "unprognostic (1.70e-1)" "unprognostic (2.25e-2)" "unprognostic (1.84e-2)" "unprognostic (1.86e-1)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (3.92e-2)" "unprognostic (1.66e-1)" "unprognostic (1.42e-2)" "prognostic favorable (2.04e-4)" "unprognostic (2.72e-1)" "unprognostic (2.32e-1)" "unprognostic (3.08e-1)" "unprognostic (2.54e-1)" 30.3 12.6 2.8 9.2 7.0 1.9 12.4 5.6 7.0 6.8 21.0 10.6 8.3 21.4 6.6 7.0 8.1 4.5 7.7 24.8 2.9 2.5 11.2 15.7 11.7 3.2 6.8 3.2 5.1 3.2 4.7 2.5 4.6 5.5 3.4 10.4 3.5 9.8 6.8 63.4 6.8 24.1 3.0 6.1 2.7 13.4 3.1 7.1 1.1 3.9 7.3 3.0 6.5 6.1 0.7 12.6 17.0 11.6 0.3 3.0 4.7 11.9 1.6 1.2 1.6 8.5 9.0 12.4 7.1 5.5 2.0 3.5 4.3 6.6 0.0 8.1 3.1 7.7 9.0 2.9 17.9 1.5 0.1 2.8 16.6 0.8 2.0 6.2 1.6 9.1 6.1 3.9 2.9 2.8 2.9 3.1 1.2 10.5 1.3 2.7 1.4 0.5 7.3 0.8 3.6 20.3 4.4 7.8 26.2 6.8 1.2 1.1 5.4 8.7 6.4 6.9 3.4 3.1 3.6 11.7 2.4 3.3 4.3 2.3 11.3 8.2 3.8 6.7 2.6 1.9 17.0 11.6 3.0 0.6 7.2 0.5 0.4 1.6 0.7 12.6 0.7 3.0 1.5 6.5 0.3 3.4 2.1 1.1 4.7 2.8 7.0 5.6 7.0 2.9 2.5 6.8 3.2 5.5 7.1 11.9 40.9 3.0 8.5 6.9 6.0 70.4 25.5 5.3 13.6 10.4 5.9 13.6 10.0 16.5 7.2 13.2 98.3 23.3 29.5 8.5 8.9 8.8 9.2 44.8 14.7 7.9 7.5 10.4 17.2 6.0 10.6 13.8 13.5 19.8 80.6 8.8 18.1 60.0 4.2 51.2 3.4 12.9 9.9 11.6 7.3 9.5 17.5 5.0 60.0 8.9 ACTA1 "ACTA, NEM3" ENSG00000143632 "Actin, alpha 1, skeletal muscle" P68133 1 229431245-229434098 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 1935.3;tongue: 523.6" "Cell type enriched" "Detected in some" 448 "Cardiomyocytes: 1758.3" "Group enriched" "Detected in many" 18 "head and neck cancer: 133.1;prostate cancer: 34.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 22 "BEWO: 104.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000045, HPA041264, HPA041271" Enhanced NA NA 6100000000 "CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (5.59e-2)" "unprognostic (1.60e-2)" "unprognostic (1.77e-1)" "unprognostic (3.07e-4)" "unprognostic (5.75e-3)" "unprognostic (3.84e-3)" "unprognostic (1.86e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.24e-1)" "unprognostic (2.64e-3)" "unprognostic (2.50e-1)" "unprognostic (1.56e-3)" "unprognostic (9.40e-4)" "unprognostic (2.61e-1)" "unprognostic (1.58e-2)" "unprognostic (1.01e-1)" 29.6 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.3 0.2 0.2 0.0 0.8 0.2 0.2 48.6 30.0 0.2 0.2 122.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.0 2.7 0.2 0.0 40.4 0.2 1935.3 0.5 0.2 1.2 0.4 0.2 0.2 0.2 0.0 0.0 5.3 523.6 39.9 0.2 0.1 4.4 14.7 20.5 15.5 5.1 9.7 20.8 0.0 0.0 0.0 0.0 0.0 0.0 104.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.5 0.0 0.1 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 8.9 9.3 20.5 7.6 15.5 5.7 4.4 6.4 7.4 14.7 4.3 5.0 7.7 12.1 5.1 14.0 4.7 9.7 20.8 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.7 1758.3 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.0 0.0 1.0 0.7 0.0 0.4 0.2 0.0 0.0 0.0 ACTBL2 DKFZp686D0972 ENSG00000169067 "Actin, beta like 2" Q562R1 5 57480016-57482809 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 2.4;placenta: 4.2;skin 1: 3.4" "Cell type enhanced" "Detected in some" 15 "Ductal cells: 1.3;Early spermatids: 2.3;Pancreatic endocrine cells: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;hTERT-RPE1: 3.4;RPTEC TERT1: 3.9;SiHa: 6.8;U-2 OS: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041264, HPA041271" Uncertain NA NA 2600000000 "HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (7.83e-2)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (8.66e-2)" "unprognostic (2.57e-2)" "unprognostic (2.39e-1)" "unprognostic (3.63e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-3)" "unprognostic (3.20e-1)" "unprognostic (2.48e-3)" "unprognostic (1.60e-2)" "unprognostic (2.04e-2)" "unprognostic (1.92e-2)" 0.2 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.8 0.0 0.0 1.2 0.1 0.1 3.4 0.0 0.6 0.0 0.0 0.2 1.2 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.0 6.8 0.6 0.0 0.6 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.3 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTC1 "ACTC, CMD1R" ENSG00000159251 "Actin, alpha, cardiac muscle 1" P68032 15 34788096-34796139 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Atrial septal defect, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "heart muscle: 243.9" "Cell type enriched" "Detected in some" 285 "Cardiomyocytes: 8201.7" "Group enriched" "Detected in many" 6 "head and neck cancer: 20.7;prostate cancer: 5.1;testis cancer: 6.9;urothelial cancer: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 37.2;LHCN-M2: 151.1;RH-30: 72.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB037330, HPA041264, HPA041271" Enhanced NA NA 6200000000 "CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (8.18e-3)" "unprognostic (3.74e-2)" "unprognostic (4.82e-3)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (3.26e-1)" "unprognostic (2.05e-3)" "unprognostic (2.26e-1)" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (2.10e-3)" "unprognostic (5.68e-4)" "unprognostic (8.79e-2)" "unprognostic (1.65e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (9.32e-4)" 1.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 243.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.6 12.5 8.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 72.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.5 5.9 8201.7 0.0 0.0 0.0 0.0 19.6 0.0 1.7 0.0 4.3 0.3 0.0 0.0 0.2 0.9 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 6.2 0.0 28.8 0.5 0.1 0.4 0.2 0.0 0.0 0.0 ACTG2 "ACTA3, ACTL3, ACTSG" ENSG00000163017 "Actin, gamma 2, smooth muscle, enteric" P63267 2 73892314-73919865 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 404.6;smooth muscle: 581.1;urinary bladder: 568.2" "Cell type enriched" "Detected in many" 9 "Smooth muscle cells: 243.6" "Cancer enhanced" "Detected in all" "prostate cancer: 255.0;stomach cancer: 237.2" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 9 "T-reg: 10.9" "Lineage enriched" "Detected in single" 17 "T-cells: 10.9" "Cell line enhanced" "Detected in some" "BEWO: 16.7;BJ hTERT+: 13.6;BJ hTERT+ SV40 Large T+: 54.0;HHSteC: 14.0;SuSa: 14.4;U-251 MG: 58.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA041264, HPA041271" Supported NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (5.79e-3)" "unprognostic (2.25e-1)" "unprognostic (2.36e-2)" "unprognostic (2.91e-1)" "unprognostic (4.56e-3)" "unprognostic (2.50e-1)" "unprognostic (8.05e-2)" "unprognostic (6.53e-2)" "unprognostic (4.48e-2)" "unprognostic (2.93e-1)" "unprognostic (7.23e-2)" "unprognostic (4.75e-2)" "prognostic unfavorable (3.95e-7)" "unprognostic (9.30e-3)" "unprognostic (6.84e-2)" "unprognostic (2.29e-2)" "unprognostic (7.57e-3)" 8.7 1.2 0.3 57.4 0.4 0.0 6.8 0.3 0.4 90.0 404.6 0.8 187.4 15.9 188.2 76.1 348.3 45.5 122.5 5.6 0.3 0.3 2.9 0.6 7.0 3.6 0.4 0.6 25.9 1.1 0.0 0.4 10.0 0.9 160.8 52.4 2.8 9.4 271.2 2.4 4.7 80.2 581.1 0.4 0.9 134.9 14.5 0.1 0.1 1.8 2.0 2.3 568.2 35.2 0.2 0.5 0.4 0.6 0.2 10.9 2.3 0.1 0.0 5.6 0.0 0.0 0.0 16.7 3.6 13.6 54.0 10.0 1.8 0.0 0.0 0.2 0.0 0.1 0.0 9.7 0.0 7.8 0.0 0.0 0.0 0.8 0.1 14.0 0.0 0.1 0.1 0.0 7.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.1 0.8 0.1 3.5 0.1 0.6 0.1 0.7 0.3 14.4 0.0 0.0 0.0 0.3 0.6 0.7 58.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.5 0.4 0.4 0.4 0.2 0.2 1.1 0.4 0.5 0.2 0.6 0.7 0.2 0.2 0.6 0.2 10.9 2.3 0.3 0.4 0.3 0.4 0.3 0.3 0.4 0.6 0.9 0.1 0.0 0.3 0.0 2.6 3.9 0.0 11.8 0.0 1.4 0.0 0.0 0.0 2.8 0.0 0.0 5.5 2.7 0.0 0.0 0.0 27.8 6.6 5.5 0.0 0.0 4.7 0.0 0.0 23.9 0.0 16.8 0.3 0.3 6.8 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 6.5 243.6 0.2 0.2 6.8 5.4 0.0 0.0 2.0 ACTL10 C20orf134 ENSG00000182584 "Actin like 10" Q5JWF8 20 33666498-33668525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 46.3" "Group enriched" "Detected in many" 53 "Early spermatids: 282.6;Late spermatids: 423.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 6.2;RPMI-8226: 8.0;SiHa: 5.8" "Not detected" "Not detected" NA NA "unprognostic (5.69e-3)" "unprognostic (3.62e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-1)" "unprognostic (5.91e-3)" "unprognostic (4.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.31e-2)" "unprognostic (2.35e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-3)" "unprognostic (5.90e-2)" "unprognostic (1.15e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "unprognostic (8.61e-2)" 0.3 0.3 0.3 0.4 0.4 0.1 0.4 0.2 0.9 0.6 0.9 0.4 1.2 0.9 0.5 1.9 1.0 0.6 1.7 0.4 0.6 0.2 0.8 0.2 0.3 1.1 0.1 0.2 0.9 6.4 0.4 0.5 0.3 0.2 1.3 0.4 0.3 1.6 0.7 0.2 0.8 0.7 0.1 0.1 0.8 1.9 46.3 0.4 0.9 1.0 0.2 0.9 0.7 1.3 3.6 1.3 2.4 1.8 6.0 6.5 0.7 0.1 0.0 0.1 0.1 1.2 0.7 0.3 1.1 0.5 0.3 0.6 2.5 3.4 3.4 1.8 0.8 0.0 6.2 0.0 1.2 0.0 3.0 0.0 1.3 0.6 0.0 0.5 0.0 1.8 0.5 0.7 0.3 0.3 0.5 0.7 0.0 0.1 3.1 0.0 2.7 0.1 1.4 0.3 3.4 3.4 0.0 0.2 8.0 0.9 1.2 2.3 1.4 5.8 4.6 1.0 0.0 2.1 0.5 2.1 0.3 0.1 0.3 0.0 2.0 2.4 0.4 1.3 0.6 0.1 0.0 1.1 2.4 1.3 1.0 1.3 1.0 2.5 3.4 1.3 3.6 1.7 1.9 0.0 6.0 1.8 1.0 6.5 0.7 0.3 0.4 0.2 0.9 0.6 0.2 0.1 0.2 0.2 0.4 0.0 0.3 0.0 3.4 0.5 0.4 0.3 0.0 0.0 0.0 1.8 0.0 0.3 1.7 4.1 282.6 0.4 2.6 0.0 6.7 0.4 0.7 1.9 0.0 0.5 0.8 0.0 1.2 0.6 0.6 423.5 4.9 1.8 1.7 1.8 4.9 0.8 3.9 3.5 2.8 1.3 0.0 0.0 0.4 2.8 1.2 1.1 0.1 1.5 2.6 2.5 ACTL6B "ACTL6, BAF53B" ENSG00000077080 "Actin like 6B" O94805 7 100643097-100656461 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 43.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 7.7;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 2.1" "Group enriched" "Detected in some" 11 "glioma: 3.9;pancreatic cancer: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 75 "SCLC-21H: 21.5;SH-SY5Y: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045126 Uncertain Approved "Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoli rim, Mitotic chromosome" "HPA045126: AB_10961265" "unprognostic (3.31e-2)" "unprognostic (6.89e-2)" "unprognostic (4.59e-3)" "unprognostic (4.15e-2)" "unprognostic (1.27e-3)" "unprognostic (4.81e-3)" "unprognostic (6.00e-2)" "unprognostic (8.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.72e-3)" "unprognostic (1.28e-1)" "unprognostic (3.01e-4)" "unprognostic (1.64e-1)" "unprognostic (6.84e-2)" "unprognostic (2.01e-2)" 1.1 3.8 9.4 1.1 17.4 1.1 1.0 25.9 43.6 1.0 1.2 0.8 0.0 1.3 1.0 1.0 1.0 1.0 1.0 1.0 9.7 9.9 1.1 1.0 1.1 1.0 5.3 12.2 1.0 2.2 1.0 7.0 1.0 9.4 1.0 1.1 0.3 1.0 1.0 1.0 1.1 1.2 1.1 1.6 1.0 2.0 1.7 1.9 0.0 1.1 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.4 25.9 26.8 9.7 9.9 5.3 12.2 9.4 1.9 0.0 0.0 0.0 0.0 0.0 7.7 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 2.1 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 ACTL7A ENSG00000187003 "Actin like 7A" Q9Y615 9 108862266-108863759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 145 "testis: 81.7" "Group enriched" "Detected in some" 122 "Early spermatids: 1179.4;Late spermatids: 3544.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;NB-4: 1.0;U-2197: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA021624 Enhanced NA NA "HPA021624: AB_1844549" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1179.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3544.4 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 19.4 0.0 17.9 6.4 0.0 0.0 0.0 0.0 0.0 ACTL7B Tact1 ENSG00000148156 "Actin like 7B" Q9Y614 9 108854589-108856967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 437 "testis: 43.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 1482.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021803, HPA024664" Enhanced NA NA "HPA021803: AB_1844551, HPA024664: AB_1844552" "unprognostic (7.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.09e-1)" "unprognostic (3.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1482.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 301.1 8.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 7.9 3.2 0.0 0.0 0.0 0.0 0.0 ACTL8 CT57 ENSG00000117148 "Actin like 8" Q9H568 1 17755313-17827063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "testis: 23.6" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 42.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-266/84: 72.4" HPA027176 Approved Cytosol NA NA Cytosol "HPA027176: AB_1844553" "unprognostic (1.79e-3)" "unprognostic (3.18e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (6.18e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (1.63e-3)" "unprognostic (2.33e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (3.69e-1)" "unprognostic (4.89e-1)" "unprognostic (1.43e-1)" "unprognostic (5.49e-2)" "unprognostic (4.68e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.2 0.0 0.7 0.0 0.0 2.9 1.8 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 72.4 0.0 1.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 42.7 0.0 0.0 0.0 0.6 0.0 ACTL9 MGC33407 ENSG00000181786 "Actin like 9" Q8TC94 19 8697397-8698822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 59.5" "Group enriched" "Detected in some" 137 "Early spermatids: 901.4;Late spermatids: 1703.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HMC-1: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019231, HPA026693" Uncertain NA NA "HPA019231: AB_1853883, HPA026693: AB_1853884" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 901.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1703.8 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 9.5 3.8 0.0 0.0 0.0 0.0 0.0 ACTN2 ENSG00000077522 "Actinin alpha 2" P35609 1 236686454-236764631 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4" "Cell type enriched" "Detected in some" 88 "Cardiomyocytes: 1655.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.1;HSkMC: 12.2;hTEC/SVTERT24-B: 7.6;WM-115: 2.4" "Region enhanced" "Detected in many" "basal ganglia: 59.7" "Low region specificity" "Detected in many" "HPA006035, HPA008315" Enhanced Uncertain "Actin filaments" NA NA 69000000 "Actin filaments" "HPA006035: AB_1078095, HPA008315: AB_1844543" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (2.41e-2)" "unprognostic (1.69e-3)" "unprognostic (2.91e-1)" "unprognostic (4.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.80e-1)" "unprognostic (2.97e-1)" "unprognostic (2.66e-1)" "unprognostic (2.71e-11)" "unprognostic (1.30e-2)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (1.22e-1)" 3.5 0.6 1.6 0.6 10.7 0.6 0.7 0.3 2.5 0.6 0.6 5.1 0.0 0.6 0.7 4.4 3.7 0.7 0.7 141.3 2.5 1.4 0.6 0.6 0.9 0.6 4.7 1.4 0.7 0.7 0.6 0.1 0.6 2.7 2.8 0.6 0.0 4.9 0.6 320.9 0.6 0.7 1.5 3.9 0.6 0.7 0.9 4.3 0.0 3.5 75.4 4.8 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.1 3.1 0.0 0.0 0.1 0.0 0.0 0.7 12.2 0.0 7.6 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.5 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 10.7 0.3 2.5 2.5 1.4 4.7 1.4 2.7 4.3 0.0 1.1 0.0 0.3 0.2 0.7 1655.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 1.3 0.0 18.7 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.6 1.1 0.0 1.4 1.9 2.0 0.1 0.0 0.0 0.0 0.1 ACTN3 ENSG00000248746 "Actinin alpha 3 (gene/pseudogene)" Q08043 11 66546395-66563329 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "skeletal muscle: 185.5" "Group enriched" "Detected in some" 5 "Early spermatids: 4.7;Late spermatids: 11.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "HDLM-2: 17.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA006035 Uncertain Uncertain "Actin filaments" NA NA 29000000 "Actin filaments" "HPA006035: AB_1078095" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (6.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (3.35e-4)" "unprognostic (1.40e-3)" "unprognostic (5.37e-3)" "unprognostic (5.09e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "unprognostic (6.71e-9)" "unprognostic (2.06e-1)" "unprognostic (6.98e-2)" "unprognostic (5.16e-2)" "unprognostic (2.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 185.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 7.7 1.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 11.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ACTR3B "ARP11, ARP3beta" ENSG00000133627 "ARP3 actin related protein 3 homolog B" Q9P1U1 7 152759749-152855378 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 45.5;Peritubular cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047016, HPA051683" Uncertain NA NA "HPA047016: AB_2679903, HPA051683: AB_2681573" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.06e-1)" "unprognostic (1.25e-1)" "unprognostic (1.50e-1)" "unprognostic (7.34e-3)" "unprognostic (5.89e-2)" "unprognostic (5.72e-2)" "unprognostic (9.28e-3)" "unprognostic (6.11e-3)" "unprognostic (5.62e-2)" "prognostic favorable (1.66e-4)" "prognostic favorable (4.53e-4)" "unprognostic (4.14e-2)" "unprognostic (3.04e-1)" "unprognostic (7.48e-2)" 3.3 8.2 16.4 3.8 38.1 3.9 7.5 12.7 37.3 4.6 4.0 6.2 7.8 4.4 5.2 8.8 3.3 8.6 3.2 5.1 21.9 11.2 7.1 7.0 3.5 4.5 8.1 14.1 6.8 8.7 11.7 10.9 3.9 7.9 4.4 4.5 5.3 13.6 5.4 6.6 4.4 3.6 3.7 5.1 3.3 5.0 14.8 5.8 2.6 5.7 1.8 4.8 4.2 2.7 2.7 1.9 0.4 0.8 2.5 4.7 2.7 11.9 5.8 10.9 13.6 3.3 4.2 9.1 6.3 4.0 2.6 2.6 7.0 7.1 10.2 4.9 4.1 4.9 4.4 10.0 3.0 3.2 3.7 5.3 4.1 4.0 6.5 3.5 5.6 1.7 2.1 3.7 1.5 3.9 1.8 3.3 4.2 21.3 0.2 5.6 12.5 8.2 11.0 23.6 11.8 6.5 6.7 4.2 8.0 4.3 6.7 21.6 18.2 8.0 6.3 5.3 4.2 6.5 4.5 1.9 2.6 0.6 3.4 5.4 9.1 9.9 7.0 5.3 8.1 5.5 0.0 0.8 0.0 2.1 0.5 2.7 1.7 2.2 4.3 1.9 2.7 4.7 2.7 0.4 2.5 0.3 1.0 3.0 2.7 16.4 38.1 12.7 23.9 21.9 11.2 8.1 14.1 7.9 5.8 6.0 0.6 7.6 4.5 2.4 18.0 3.6 2.5 6.7 3.4 3.5 21.6 7.4 26.6 4.8 25.5 3.5 1.3 0.0 4.9 6.3 3.4 5.7 4.6 7.4 2.7 14.3 10.4 2.5 1.8 29.5 39.7 2.7 45.5 1.8 3.6 31.9 4.4 3.5 50.9 5.1 19.9 6.5 4.7 24.4 23.4 1.4 10.4 1.8 3.7 3.4 ACTR3C ARP11 ENSG00000106526 "ARP3 actin related protein 3 homolog C" Q9C0K3 7 150243916-150323725 "Predicted intracellular proteins" Actin-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 27.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.6;RT4: 18.2;SiHa: 12.2" NA NA "unprognostic (3.41e-1)" "unprognostic (4.79e-2)" "unprognostic (9.62e-2)" "unprognostic (8.25e-2)" "unprognostic (6.07e-6)" "unprognostic (2.83e-1)" "unprognostic (6.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.10e-2)" "unprognostic (2.91e-1)" "unprognostic (9.69e-3)" "unprognostic (1.65e-2)" "unprognostic (3.27e-2)" "unprognostic (4.73e-3)" "unprognostic (1.72e-1)" "unprognostic (9.14e-2)" "unprognostic (5.53e-3)" 1.5 9.0 3.1 8.7 5.0 1.2 4.4 5.7 3.2 3.9 7.5 0.8 8.3 3.5 2.9 6.4 5.9 3.9 8.1 2.4 3.1 3.1 21.7 22.5 8.4 5.6 2.1 1.1 1.8 17.5 39.0 19.6 13.2 3.0 4.5 4.9 5.1 5.0 9.8 1.4 2.4 7.5 1.9 1.6 2.6 4.0 3.2 1.2 2.1 4.2 2.6 8.0 4.3 7.4 6.5 4.5 3.3 1.7 4.1 7.5 2.0 4.5 0.4 0.1 0.2 0.0 0.0 0.9 0.1 0.1 0.8 1.0 3.5 21.6 1.7 5.8 0.8 0.6 9.4 0.0 0.0 0.5 4.7 1.3 1.3 5.6 3.1 2.4 0.0 0.8 0.8 2.9 0.0 0.0 0.5 0.2 2.2 8.7 4.9 0.0 6.4 4.9 0.2 2.5 3.0 0.0 0.0 3.4 6.7 3.6 18.2 4.8 3.8 12.2 2.7 1.8 0.7 5.9 1.1 0.1 0.0 0.0 0.2 0.0 1.8 2.2 0.0 0.1 0.0 0.0 0.3 1.7 3.3 7.5 1.5 3.5 5.7 6.4 4.7 2.6 6.5 6.9 5.5 2.0 4.1 0.6 4.5 4.6 2.0 3.1 5.0 5.7 3.2 3.1 3.1 2.1 1.1 3.0 1.2 3.0 7.4 0.9 5.3 17.9 5.5 1.2 0.0 13.4 5.7 17.4 27.5 5.3 11.6 9.0 3.6 0.8 6.9 0.0 18.4 0.9 1.0 5.1 11.5 13.0 1.1 1.6 3.4 1.3 0.6 0.9 0.9 2.0 1.7 7.2 3.9 13.8 11.8 0.0 0.7 12.0 4.5 0.0 0.7 6.6 1.9 13.0 5.9 2.1 4.9 4.7 ACTRT1 "AIP1, ARIP1, Arp-T1, KIAA0705" ENSG00000123165 "Actin related protein T1" Q8TDG2 X 128050962-128052398 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 83 "testis: 8.2" "Group enriched" "Detected in some" 64 "Early spermatids: 21.8;Late spermatids: 68.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003119 Supported NA NA "HPA003119: AB_1078219" "unprognostic (3.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 ACTRT2 "Arp-T2, ARPM2, FLJ25424" ENSG00000169717 "Actin related protein T2" Q8TDY3 1 3021483-3022903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 139 "testis: 60.2" "Group enriched" "Detected in some" 120 "Early spermatids: 1117.5;Late spermatids: 2561.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;NTERA-2: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006480, HPA025079" Enhanced NA NA "HPA006480: AB_1845047, HPA025079: AB_1845048" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1117.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2561.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 6.5 0.0 15.3 6.6 0.0 0.0 0.0 0.0 0.0 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769895 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 57.4" "Cell type enriched" "Detected in many" 9 "Early spermatids: 728.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4" "Group enriched" "Detected in many" 4 "B-cells: 1.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;HSkMC: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA035817, HPA035818" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035817: AB_10671938, HPA035818: AB_2674801" "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.0 0.7 0.9 0.4 1.1 0.5 1.5 2.4 1.3 1.0 0.5 0.5 1.3 0.7 0.7 1.4 0.6 1.4 0.5 0.7 0.7 0.9 1.8 1.7 0.7 0.6 1.0 0.4 1.1 0.3 0.8 1.0 0.7 1.1 1.0 0.4 0.6 0.5 1.3 0.7 0.3 0.5 1.0 0.6 0.1 0.8 57.4 0.7 0.2 1.0 0.1 0.5 1.5 3.1 1.2 0.5 0.0 0.0 0.0 3.4 0.4 3.6 2.2 0.2 1.1 16.0 5.2 0.0 4.4 2.6 2.7 2.3 0.0 4.6 0.0 6.1 4.9 1.8 2.3 1.2 2.1 2.8 2.7 1.6 8.4 1.9 0.4 2.6 0.9 0.7 10.3 0.5 3.3 0.6 1.8 4.9 1.0 0.0 0.0 4.8 1.8 0.3 0.1 3.9 3.1 4.6 0.7 0.0 0.1 2.9 0.9 2.9 2.0 5.2 1.3 0.1 0.5 2.2 3.6 2.2 0.0 0.0 2.2 0.0 0.5 0.2 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.7 0.0 3.4 1.2 0.0 1.1 0.5 1.1 0.4 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.9 1.1 2.4 1.3 0.7 0.9 1.0 0.4 1.1 0.7 0.0 1.0 0.0 0.7 0.3 1.0 0.6 0.0 2.7 2.3 0.0 2.0 1.4 1.7 2.0 728.6 0.7 0.0 0.0 1.8 1.1 1.4 0.4 1.1 1.7 1.4 3.2 0.0 1.8 0.6 82.5 8.9 0.6 1.7 0.0 0.1 1.4 1.3 0.0 5.3 2.5 1.1 12.9 1.9 5.5 4.0 0.0 0.7 0.0 0.4 0.3 ACVR1C "ACVRLK7, ALK7" ENSG00000123612 "Activin A receptor type 1C" Q8NER5 2 157526767-157629005 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 36.2;breast: 15.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 11.4;Leydig cells: 29.4;Paneth cells: 10.4;Undifferentiated cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Group enriched" "Detected in some" 4 "ASC diff: 15.4;HDLM-2: 6.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 29.2;cerebral cortex: 8.1;hippocampal formation: 21.6" "HPA007982, HPA011933" Approved "Intracellular and membrane" NA NA "HPA007982: AB_1078134, HPA011933: AB_1844754" "unprognostic (1.03e-1)" "unprognostic (4.55e-2)" "unprognostic (9.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (1.00e-1)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (7.12e-3)" "unprognostic (3.62e-1)" "unprognostic (9.31e-6)" "unprognostic (7.28e-2)" "unprognostic (1.95e-1)" "unprognostic (9.74e-2)" "unprognostic (1.30e-1)" 36.2 3.7 3.9 2.7 10.3 0.7 15.3 1.6 4.4 0.9 9.4 2.7 0.0 5.5 0.7 1.0 0.8 0.8 1.8 1.0 9.2 3.1 1.1 3.3 0.8 1.2 3.7 3.1 5.1 2.4 0.5 12.0 0.7 3.5 0.9 4.4 0.0 1.5 1.0 1.3 0.7 4.4 0.8 2.8 0.8 3.4 1.1 4.0 0.0 0.9 0.5 1.0 0.6 2.9 0.6 0.0 0.0 0.0 0.0 2.8 0.4 2.0 0.0 0.0 0.2 15.4 0.5 0.3 0.4 0.4 0.1 0.5 2.3 0.2 0.0 0.2 1.2 1.0 0.0 0.1 0.0 0.3 6.8 1.0 0.0 0.0 0.5 0.0 0.0 1.2 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.0 1.4 0.1 0.7 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.3 0.0 0.3 0.0 0.8 0.2 0.0 0.2 0.8 2.4 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 1.0 0.6 1.8 1.2 0.0 0.5 2.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 3.9 10.3 1.6 4.4 9.2 3.1 3.7 3.1 3.5 4.0 0.0 0.6 0.0 0.9 0.6 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 1.1 1.0 11.4 0.0 0.2 0.3 1.2 0.8 0.0 4.7 0.1 0.0 7.5 0.0 0.0 0.4 29.4 0.0 3.3 7.2 8.4 1.0 0.4 10.4 8.5 0.7 0.0 0.0 1.0 0.0 2.0 1.3 0.2 0.0 12.1 0.4 ACVRL1 "ACVRLK1, ALK1, HHT, HHT2, ORW2" ENSG00000139567 "Activin A receptor like type 1" P37023 12 51906908-51923361 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 55.0" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 53.3;Enterocytes: 82.1;Ito cells: 40.5;Paneth cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 3.6;myeloid DC: 5.0" "Group enriched" "Detected in many" 12 "dendritic cells: 5.0;monocytes: 3.6" "Cell line enhanced" "Detected in some" "ASC diff: 18.5;ASC TERT1: 12.6;EFO-21: 16.4;HUVEC TERT2: 59.9;TIME: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007041 Approved "Intracellular and membrane" NA NA "HPA007041: AB_1078097" "unprognostic (2.50e-1)" "unprognostic (4.83e-1)" "unprognostic (3.79e-2)" "unprognostic (3.61e-2)" "unprognostic (4.98e-1)" "unprognostic (4.06e-3)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (5.80e-2)" "unprognostic (5.10e-2)" "unprognostic (4.60e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-3)" "unprognostic (1.39e-1)" "unprognostic (7.98e-3)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" 25.5 5.1 3.2 9.3 4.3 0.2 15.6 1.6 3.6 15.1 20.1 3.7 13.1 4.9 12.7 11.0 12.1 13.9 11.0 15.4 3.7 3.2 13.6 3.4 55.0 19.1 4.9 3.6 5.9 6.1 21.6 2.7 44.1 5.3 12.3 14.7 12.3 6.9 10.6 14.2 8.0 11.1 8.2 3.7 14.8 8.1 3.5 3.6 1.7 12.9 6.8 5.4 9.3 11.2 0.1 5.0 0.3 3.6 0.0 0.1 0.7 0.0 0.2 0.1 0.0 18.5 12.6 0.0 0.8 1.6 0.0 0.0 0.1 0.1 0.0 16.4 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 2.7 0.0 0.4 5.2 0.0 0.1 0.0 0.0 59.9 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 46.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 3.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.7 3.2 4.3 1.6 3.6 3.7 3.2 4.9 3.6 5.3 3.6 3.0 12.2 0.0 0.2 4.6 0.0 3.9 0.0 4.0 2.3 0.0 0.0 0.5 0.0 2.5 0.0 53.3 82.1 0.0 1.2 36.2 20.2 0.5 0.0 0.0 10.2 0.0 5.2 40.5 25.4 0.7 10.9 5.6 5.0 15.4 26.0 2.3 0.0 50.9 3.2 0.0 0.2 38.8 15.3 0.1 0.7 4.6 2.2 0.0 26.4 0.4 ACY1 ENSG00000243989 "Aminoacylase 1" Q03154 3 51983278-51989202 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "intestine: 53.3;kidney: 91.6;liver: 77.8" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 70.2;Erythroid cells: 23.3;Proximal tubular cells: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB003695, HPA036174, HPA036175" Enhanced NA NA 28000000 "CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989" "unprognostic (4.28e-2)" "unprognostic (1.89e-1)" "unprognostic (2.10e-1)" "unprognostic (2.48e-3)" "unprognostic (3.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.08e-2)" "unprognostic (2.36e-2)" "unprognostic (2.70e-2)" "prognostic favorable (2.93e-4)" "unprognostic (3.57e-1)" "unprognostic (3.75e-1)" "unprognostic (7.88e-2)" "prognostic favorable (6.77e-4)" 4.4 8.5 2.5 3.9 3.0 1.5 4.4 1.5 3.3 3.2 24.9 4.1 9.8 34.5 1.9 7.9 3.8 3.0 8.4 4.1 2.3 1.8 91.6 77.8 3.5 6.3 2.8 2.9 2.1 9.0 6.2 1.9 4.3 2.9 3.7 6.2 6.6 9.4 9.2 7.6 2.6 53.3 2.1 3.5 3.4 4.9 1.5 1.7 0.6 5.9 6.7 4.1 3.3 2.5 5.0 12.1 3.8 10.0 12.1 6.4 4.5 3.9 8.0 3.9 10.8 9.0 12.1 12.8 4.2 7.9 9.3 5.1 12.4 20.8 2.5 3.5 7.3 3.4 4.9 4.0 25.6 3.7 6.9 5.1 8.9 4.6 38.3 16.6 6.0 5.8 14.0 21.2 8.2 22.1 7.6 3.5 4.4 13.4 7.9 9.1 11.1 0.0 11.0 5.7 25.3 13.6 3.1 3.3 22.5 24.3 15.0 5.5 5.0 5.3 17.5 9.2 1.6 14.1 7.9 1.7 6.7 6.4 8.3 4.9 20.9 4.9 3.8 7.8 12.5 8.0 3.8 10.0 0.2 6.4 9.0 3.6 5.0 2.0 2.8 12.1 4.0 3.3 4.0 0.0 12.1 3.4 1.9 2.7 4.5 2.5 3.0 1.5 3.3 2.3 1.8 2.8 2.9 2.9 1.7 3.0 2.7 0.8 0.8 0.6 0.0 0.1 2.5 2.7 3.4 5.2 0.0 3.3 8.3 12.2 0.2 0.5 70.2 23.3 7.4 3.7 0.8 0.5 6.9 10.9 1.7 0.0 2.4 1.8 2.1 0.4 0.6 2.4 0.0 16.2 9.3 0.8 12.6 21.0 0.0 35.6 0.9 0.0 0.5 0.0 0.2 0.4 3.4 1.5 12.1 0.3 ACY3 "ACY-3, HCBP1, MGC9740" ENSG00000132744 "Aminoacylase 3" Q96HD9 11 67642555-67650659 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 72.2;kidney: 28.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 163.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.1" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;monocytes: 21.1" "Cell line enhanced" "Detected in some" "CACO-2: 6.1;CAPAN-2: 9.5;Daudi: 34.5;OE19: 9.6;RPMI-8226: 6.0" "Low region specificity" "Detected in all" "HPA039219, HPA048187" Enhanced NA NA "HPA039219: AB_10671872, HPA048187: AB_2680306" "unprognostic (8.37e-3)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (1.43e-1)" "unprognostic (7.37e-4)" "unprognostic (2.44e-3)" "unprognostic (1.15e-1)" "unprognostic (3.21e-1)" "unprognostic (2.63e-3)" "unprognostic (1.07e-1)" "unprognostic (8.24e-2)" "unprognostic (2.68e-2)" "unprognostic (1.48e-3)" 0.1 0.1 3.4 1.8 5.5 0.6 0.5 0.8 7.8 5.5 13.0 15.3 0.2 38.2 0.3 2.1 0.7 0.4 6.1 0.1 3.1 2.9 28.9 18.3 0.2 3.1 4.6 5.1 0.1 11.2 0.0 0.3 0.1 7.1 0.4 2.2 0.3 1.2 0.2 0.1 0.1 72.2 0.1 5.2 0.9 5.9 0.1 2.8 0.7 0.2 0.0 4.2 0.2 0.2 1.1 5.9 0.0 21.1 2.3 0.9 1.2 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.1 9.5 34.5 0.4 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 1.2 1.5 0.0 9.6 0.0 1.1 0.0 6.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.8 0.3 0.0 0.5 0.0 0.1 4.9 0.5 1.0 0.2 0.1 2.6 1.1 0.9 0.6 0.0 2.3 21.1 5.9 0.0 1.2 3.4 5.5 0.8 7.8 3.1 2.9 4.6 5.1 7.1 2.8 0.0 1.7 6.3 0.1 0.0 0.0 0.4 10.2 0.0 1.2 21.0 0.0 0.2 26.6 3.5 0.0 0.0 11.8 0.0 9.0 0.2 0.0 0.6 0.0 17.9 1.7 0.0 1.2 0.0 0.3 0.0 0.0 0.9 5.0 0.0 25.1 0.0 6.8 5.9 0.0 163.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 6.6 0.8 ACYP2 ENSG00000170634 "Acylphosphatase 2" P14621 2 53970838-54305300 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 116.4" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035301 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA035301: AB_10670291" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (3.40e-1)" "unprognostic (2.16e-1)" "unprognostic (6.90e-3)" "unprognostic (6.21e-2)" "unprognostic (2.03e-3)" "unprognostic (3.17e-1)" "unprognostic (5.22e-2)" "unprognostic (7.83e-3)" "unprognostic (3.64e-3)" "unprognostic (1.16e-1)" "unprognostic (6.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (3.24e-1)" "unprognostic (2.24e-2)" 12.9 24.0 31.0 4.6 33.9 5.6 10.1 15.5 29.3 6.7 6.2 19.4 4.4 6.2 6.7 10.5 6.6 7.1 7.3 39.6 29.1 28.4 8.8 18.7 7.2 7.5 35.7 18.2 5.7 10.3 9.1 9.7 5.9 28.1 10.4 4.8 6.3 11.5 8.4 116.4 6.6 5.6 6.9 35.7 7.8 7.5 6.5 22.7 3.5 8.2 22.9 6.4 8.2 4.1 20.9 23.7 24.1 10.2 12.6 15.9 8.9 7.7 4.3 4.6 3.8 16.8 13.3 4.2 9.3 7.0 5.8 5.1 1.0 5.6 15.1 24.7 9.2 5.8 6.6 2.5 7.8 5.4 13.0 10.3 11.6 4.7 11.5 6.9 9.7 5.6 9.6 14.6 4.1 6.9 11.8 2.6 7.8 4.8 8.1 12.2 4.9 6.0 12.0 5.2 6.1 5.4 4.8 4.4 8.5 13.6 7.1 13.3 8.8 11.3 7.1 4.2 1.8 2.6 8.9 9.3 8.2 7.9 3.6 8.6 17.1 9.4 8.4 11.9 16.6 9.0 24.1 10.2 19.8 13.4 9.0 11.9 20.9 13.4 12.7 14.7 19.7 15.9 13.4 8.5 12.6 8.8 23.7 11.6 8.9 31.0 33.9 15.5 29.3 29.1 28.4 35.7 18.2 28.1 22.7 14.9 13.2 27.4 34.8 18.2 14.8 159.9 25.5 25.4 21.6 17.4 9.8 12.0 53.0 19.2 60.2 23.2 19.1 23.3 33.4 5.0 14.9 30.3 19.6 58.0 27.9 27.0 29.4 26.4 35.8 48.4 12.4 30.9 21.9 21.6 25.3 53.2 29.4 17.5 29.0 36.5 28.8 51.8 26.4 19.2 9.7 18.6 8.6 17.0 18.0 35.7 ADA ENSG00000196839 "Adenosine deaminase" P00813 20 44619522-44652233 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Nucleotide metabolism" Hydrolase "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 90.2;Leydig cells: 39.1;monocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 64.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "JURKAT: 61.5;MOLT-4: 198.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001399, CAB004307, HPA023884" Enhanced Supported "Plasma membrane,Cytosol" No No 650000 "Plasma membrane" Cytosol "CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573" "unprognostic (4.30e-2)" "unprognostic (6.89e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.23e-7)" "unprognostic (9.33e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (6.77e-5)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (2.94e-14)" "unprognostic (2.29e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-1)" 8.1 3.2 2.5 5.4 6.5 5.3 5.1 0.9 5.0 2.8 7.4 5.0 1.8 142.2 1.7 3.4 4.6 2.4 3.0 9.2 2.7 0.8 1.3 2.1 2.8 8.9 3.6 2.3 1.2 2.4 0.8 0.3 1.8 3.9 1.8 1.5 0.7 2.6 1.3 2.0 2.8 5.0 2.1 1.3 9.5 19.7 1.6 6.1 99.0 2.8 2.1 7.6 3.6 2.6 1.3 41.6 0.5 64.0 16.9 10.3 9.6 1.4 4.0 2.0 1.4 3.9 5.5 3.3 1.4 0.8 1.4 1.0 1.8 1.5 4.0 1.7 1.9 2.7 0.2 1.4 5.9 0.8 0.3 1.8 0.8 0.7 1.4 1.6 0.6 2.2 26.2 2.5 0.5 0.9 1.3 5.4 61.5 2.0 3.3 0.6 3.4 198.0 2.9 0.5 1.8 1.4 10.7 2.8 9.9 0.2 0.0 0.0 0.9 2.1 0.4 2.5 2.7 0.4 1.9 1.7 1.0 2.0 2.2 0.2 4.3 2.7 8.3 0.3 3.3 0.9 0.0 1.8 0.2 8.7 30.7 5.7 1.3 7.3 10.3 6.8 1.0 5.7 8.1 0.5 16.9 64.0 41.6 5.3 9.6 2.5 6.5 0.9 5.0 2.7 0.8 3.6 2.3 3.9 6.1 0.0 3.4 12.7 3.0 11.4 0.0 1.9 0.0 2.7 0.0 1.8 0.0 2.3 0.0 3.7 0.1 16.2 0.5 0.0 17.9 90.2 16.7 0.9 0.0 2.9 27.6 0.0 0.0 6.7 13.4 1.5 39.1 14.4 8.5 49.5 1.4 2.9 8.2 0.0 2.5 2.1 0.0 12.9 16.1 0.4 1.3 12.2 3.1 30.5 3.3 2.4 ADA2 "ADGF, CECR1, IDGFL" ENSG00000093072 "Adenosine deaminase 2" Q9NZK5 22 17178790-17221989 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 63.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 22.1;Ciliated cells: 28.1;Club cells: 20.5;Hofbauer cells: 58.5;Macrophages: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.2;EFO-21: 11.6;HUVEC TERT2: 12.5;Karpas-707: 22.3;MOLT-4: 20.7;U-266/70: 12.8;U-937: 21.0" "Low region specificity" "Detected in all" HPA007888 Uncertain "Secreted to blood" NA NA 50000000 "HPA007888: AB_1078495" "unprognostic (1.03e-3)" "unprognostic (2.00e-3)" "unprognostic (6.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.48e-2)" "unprognostic (7.01e-3)" "unprognostic (4.48e-2)" "unprognostic (3.09e-3)" "unprognostic (3.80e-2)" "prognostic favorable (9.26e-4)" "prognostic favorable (8.91e-4)" "unprognostic (1.41e-1)" "unprognostic (1.49e-1)" "unprognostic (4.86e-3)" "unprognostic (1.96e-2)" "unprognostic (4.83e-2)" "unprognostic (2.51e-1)" 24.7 6.6 6.9 15.3 7.5 8.7 6.3 9.7 9.2 7.8 9.8 17.3 3.9 7.0 9.6 7.0 6.9 18.2 12.4 15.9 6.4 8.8 15.2 8.5 28.6 24.3 9.2 5.8 8.9 6.7 0.6 13.7 8.4 14.5 7.4 12.3 15.3 6.9 6.3 2.5 2.5 12.6 7.9 18.2 45.0 7.2 9.7 5.3 63.0 7.5 2.9 22.6 18.0 4.1 6.1 29.8 2.6 46.4 9.5 7.9 28.3 0.0 0.0 3.4 0.0 0.0 0.6 0.1 1.2 0.2 0.0 0.0 0.0 13.2 3.0 11.6 3.6 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.2 0.1 6.3 0.0 0.1 0.0 0.0 12.5 4.4 0.1 22.3 0.5 0.0 20.7 1.5 10.3 0.0 0.0 0.4 0.0 3.2 0.0 3.9 5.9 0.1 0.0 0.1 0.0 10.6 0.0 5.9 1.4 0.0 0.1 0.1 0.0 12.8 1.1 0.7 0.1 21.0 0.1 2.6 44.1 2.4 7.9 46.4 6.3 6.1 6.4 7.9 29.8 5.0 7.6 7.8 2.1 9.5 35.2 14.7 3.6 28.3 6.9 7.5 9.7 9.2 6.4 8.8 9.2 5.8 14.5 5.3 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 28.1 20.5 5.2 0.0 0.4 6.6 2.3 0.0 0.0 0.0 0.0 4.6 0.6 0.0 0.0 4.7 0.0 58.5 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 ADAD1 Tenr ENSG00000164113 "Adenosine deaminase domain containing 1" Q96M93 4 122378966-122429802 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 331 "testis: 65.5" "Group enriched" "Detected in some" 11 "Early spermatids: 815.1;Late spermatids: 770.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 815.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 770.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 69.4 16.8 0.0 0.0 0.0 0.0 0.0 ADAD2 "FLJ00337, TENRL" ENSG00000140955 "Adenosine deaminase domain containing 2" Q8NCV1 16 84191138-84197168 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "testis: 68.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 57.9;Spermatocytes: 124.2;Spermatogonia: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "myeloid DC: 1.6" "Lineage enhanced" "Detected in single" "dendritic cells: 1.6" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA079443 Enhanced NA NA "HPA079443: " "unprognostic (5.73e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-2)" "unprognostic (2.18e-2)" "unprognostic (6.72e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.82e-1)" "unprognostic (5.95e-2)" "unprognostic (3.01e-2)" "unprognostic (6.68e-2)" "unprognostic (1.69e-1)" "unprognostic (7.40e-2)" "unprognostic (3.18e-1)" "unprognostic (3.52e-1)" "unprognostic (2.47e-2)" 0.2 0.0 0.9 0.1 1.1 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 1.9 0.0 68.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 7.9 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 1.1 0.1 0.6 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 2.9 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 57.9 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.1 0.0 14.6 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 124.2 23.3 1.6 0.0 0.0 0.0 3.0 ADAM11 MDC ENSG00000073670 "ADAM metallopeptidase domain 11" O75078 17 44759031-44781846 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 42.3;heart muscle: 11.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 6.1;Cardiomyocytes: 10.8;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.7" "Cell line enriched" "Detected in some" 4 "HEK 293: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074550 Enhanced NA NA "HPA074550: AB_2732259" "unprognostic (1.79e-1)" "unprognostic (7.78e-2)" "unprognostic (1.73e-3)" "unprognostic (2.59e-3)" "unprognostic (1.75e-1)" "unprognostic (1.50e-1)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.37e-2)" "unprognostic (5.41e-2)" "unprognostic (5.46e-3)" "unprognostic (7.16e-2)" "unprognostic (9.99e-16)" "unprognostic (1.39e-1)" "unprognostic (2.51e-1)" "unprognostic (3.11e-1)" "unprognostic (3.00e-1)" 1.2 0.5 8.5 0.6 7.5 1.0 0.6 42.3 23.1 0.9 0.8 0.7 0.0 0.8 4.0 1.1 1.1 1.2 1.5 11.2 11.4 4.2 0.7 0.6 0.7 0.7 2.7 9.8 0.9 0.6 0.7 0.6 0.7 5.5 1.6 0.6 0.2 0.5 2.2 0.8 2.5 0.7 2.6 1.5 0.7 0.7 2.3 1.1 0.0 0.6 0.0 0.6 0.7 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.6 4.9 0.2 0.0 0.3 0.1 0.0 1.4 0.4 0.7 0.2 0.1 0.3 0.0 2.2 0.0 3.6 0.0 0.4 1.4 21.0 0.2 0.4 0.3 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.4 0.4 0.1 4.2 0.1 2.4 0.9 1.6 1.3 2.9 0.1 0.4 0.0 0.1 3.8 1.9 0.0 0.1 1.1 0.4 1.4 0.7 0.0 0.6 1.7 1.8 0.4 0.7 0.2 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 8.5 7.5 42.3 21.0 11.4 4.2 2.7 9.8 5.5 1.1 0.0 0.0 0.0 0.2 0.0 6.1 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 1.4 0.0 2.7 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell type enhanced" "Detected in many" 24 "Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" NA NA "Plasma membrane" "HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638" "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 5.0 0.7 2.0 0.0 6.0 12.4 0.0 13.2 1.1 4.5 11.3 0.0 0.0 0.0 0.0 47.3 9.5 0.0 0.0 0.4 4.9 0.5 0.1 0.0 8.0 0.0 0.9 0.0 10.5 15.2 0.0 29.7 0.9 8.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 1.3 0.1 13.5 0.1 9.0 1.5 0.0 0.2 0.8 0.0 0.0 0.0 16.3 5.4 29.3 26.2 0.0 0.1 0.0 22.5 0.0 10.0 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 0.0 3.4 0.0 0.4 1.3 0.8 1.4 0.0 1.4 0.0 0.0 96.2 12.1 0.0 7.6 6.3 1.1 0.4 0.0 1.0 348.4 2.0 0.6 49.5 0.0 14.2 6.4 0.0 2.5 0.3 1.1 15.5 0.7 1.7 15.4 0.2 5.5 1.9 0.0 0.7 0.0 31.5 0.0 1.2 5.1 5.5 0.5 108.0 3.1 0.7 0.5 ADAM18 "ADAM27, tMDCIII" ENSG00000168619 "ADAM metallopeptidase domain 18" Q9Y3Q7 8 39584489-39730064 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 42.7" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 41.4;Late spermatids: 19.4;Spermatocytes: 111.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.4;SuSa: 1.1" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (2.10e-4)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 111.2 2.2 0.0 2.1 0.0 0.0 0.0 ADAM19 MLTNB ENSG00000135074 "ADAM metallopeptidase domain 19" Q9H013 5 157395534-157575775 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.4;smooth muscle: 46.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 69.2;Cone photoreceptor cells: 58.9;Extravillous trophoblasts: 72.0;monocytes: 134.3;Rod photoreceptor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5" "Group enriched" "Detected in many" 5 "B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5" "Cell line enhanced" "Detected in many" "HDLM-2: 31.7;U-251 MG: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055537 Approved Vesicles NA NA Vesicles "HPA055537: AB_2797253" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (4.64e-2)" "unprognostic (1.81e-3)" "unprognostic (2.63e-1)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (2.80e-1)" "unprognostic (1.42e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.90e-12)" "unprognostic (1.44e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-2)" 3.7 2.5 1.3 49.4 1.5 4.8 2.8 6.9 2.4 4.4 15.1 1.1 3.6 3.9 8.6 5.9 4.6 5.9 14.7 18.9 1.6 1.7 1.6 4.3 9.1 19.2 1.6 1.0 3.0 0.5 0.0 1.4 33.0 3.4 5.9 4.9 5.0 6.8 4.6 3.9 0.8 14.0 46.1 2.8 16.8 7.7 1.3 0.5 5.6 3.1 3.3 29.4 17.0 3.9 15.8 18.5 37.5 3.9 0.1 4.4 2.2 11.1 1.7 3.4 0.0 0.2 0.2 22.3 13.3 4.7 8.3 6.2 5.8 9.1 5.8 0.7 6.8 1.7 9.5 0.5 0.8 7.6 31.7 0.3 0.0 0.9 0.7 2.0 0.0 0.0 1.6 0.0 6.5 1.3 9.9 9.4 0.0 1.6 0.8 17.7 0.0 0.0 0.0 3.7 0.0 5.8 0.1 19.9 4.8 0.9 0.1 1.6 1.0 0.0 4.8 0.7 14.4 0.0 0.2 14.3 9.0 9.7 2.0 60.2 3.6 0.1 20.8 2.0 0.0 4.0 32.3 3.9 37.5 0.4 0.3 1.0 14.1 4.4 1.0 1.1 15.8 0.1 0.1 20.1 0.1 0.0 18.5 4.4 2.2 1.3 1.5 6.9 2.3 1.6 1.7 1.6 1.0 3.4 0.5 6.0 1.1 69.2 0.0 1.9 32.2 3.3 0.0 0.0 1.2 3.5 58.9 0.7 0.0 0.5 3.4 3.9 0.0 0.0 1.3 72.0 4.7 0.1 0.0 8.6 1.5 14.3 0.0 6.2 14.4 1.1 5.2 6.7 1.7 134.3 0.0 2.0 1.6 0.0 7.4 0.0 47.3 6.5 5.2 0.0 1.5 1.3 7.0 10.2 0.0 0.1 ADAM2 "CT15, FTNB, PH-30b, PH30" ENSG00000104755 "ADAM metallopeptidase domain 2" Q99965 8 39743735-39838289 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 416 "testis: 50.6" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 72.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-266/70: 2.1" "Not detected" "Not detected" "CAB022390, HPA024621, HPA026581" Enhanced NA NA "CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577" "unprognostic (4.74e-2)" "unprognostic (1.67e-3)" "unprognostic (3.82e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 72.7 0.2 0.0 0.2 0.0 0.0 0.0 ADAM20 ENSG00000134007 "ADAM metallopeptidase domain 20" O43506 14 70522358-70535015 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "testis: 18.7" "Cell type enriched" "Detected in some" 9 "Early spermatids: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" HPA059377 Enhanced NA NA "HPA059377: AB_2683997" "unprognostic (4.13e-3)" "unprognostic (3.45e-2)" "unprognostic (1.14e-1)" "unprognostic (8.34e-2)" "unprognostic (2.06e-1)" "unprognostic (1.57e-2)" "unprognostic (5.61e-2)" "unprognostic (2.89e-2)" "unprognostic (1.58e-3)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-1)" "unprognostic (2.46e-3)" "unprognostic (2.64e-1)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (9.52e-3)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.7 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.6 0.0 1.0 0.0 0.3 0.3 0.4 0.2 0.0 0.0 0.3 0.2 0.1 0.3 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.5 0.4 0.2 0.0 0.0 0.3 0.6 0.6 0.2 0.5 0.3 0.0 0.2 0.0 0.1 1.1 0.6 0.4 0.7 0.3 0.4 0.9 0.4 0.2 0.0 0.3 0.5 0.6 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.7 0.4 0.0 0.1 0.2 0.0 0.5 0.3 0.4 0.1 0.1 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 4.2 0.4 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 36.8 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 2.3 0.1 0.1 0.1 0.0 0.0 0.3 ADAM21 ADAM31 ENSG00000139985 "ADAM metallopeptidase domain 21" Q9UKJ8 14 70452157-70459899 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 19.7" "Group enriched" "Detected in some" 46 "Early spermatids: 54.9;Late spermatids: 93.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-138 MG: 4.5;U-251 MG: 4.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059016 Uncertain NA NA "HPA059016: AB_2683882" "unprognostic (7.85e-2)" "unprognostic (7.67e-3)" "unprognostic (4.20e-2)" "unprognostic (1.35e-2)" "unprognostic (5.12e-1)" "unprognostic (1.48e-1)" "unprognostic (5.98e-2)" "unprognostic (2.16e-1)" "unprognostic (3.30e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (6.78e-2)" "unprognostic (1.82e-2)" "unprognostic (1.52e-1)" "unprognostic (2.08e-1)" "unprognostic (2.72e-1)" 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 19.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 1.6 0.3 0.9 0.2 0.4 0.8 1.6 1.6 0.5 0.9 0.6 0.2 0.4 0.2 1.0 0.0 0.6 0.7 0.9 0.1 0.5 1.6 1.0 0.6 0.8 0.6 0.1 0.4 0.3 0.0 0.3 1.0 0.1 0.4 0.9 2.5 0.3 1.0 0.2 0.8 2.1 0.0 2.0 0.2 0.1 0.3 0.2 1.3 1.2 0.0 0.3 0.0 0.7 0.7 0.0 0.7 1.7 0.5 0.5 1.7 0.5 4.5 0.2 0.3 4.3 0.3 2.3 0.0 2.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.2 0.0 0.8 0.8 1.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.3 0.4 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 54.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 1.6 0.9 0.0 0.1 0.0 0.0 0.0 ADAM22 MDC2 ENSG00000008277 "ADAM metallopeptidase domain 22" Q9P0K1 7 87934143-88202889 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 30.7;Cone photoreceptor cells: 21.6;Horizontal cells: 14.3;Rod photoreceptor cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 36.3;SH-SY5Y: 34.6;U-266/84: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050325, CAB079064" Supported Approved "Cell Junctions" "Intracellular and membrane" NA NA 78000 "Cell Junctions" "CAB079064: , HPA050325: AB_2681087" "unprognostic (1.20e-2)" "unprognostic (8.61e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-2)" "unprognostic (2.89e-2)" "unprognostic (3.09e-1)" "unprognostic (7.84e-3)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-1)" "unprognostic (3.71e-3)" "unprognostic (1.69e-1)" "unprognostic (3.47e-2)" "unprognostic (4.13e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-4)" "unprognostic (4.70e-2)" 2.9 11.7 10.9 1.5 15.7 1.5 2.1 46.9 36.4 8.6 2.3 6.2 1.6 1.3 6.3 11.2 1.6 3.7 3.7 3.0 14.0 10.6 5.5 0.8 2.0 2.9 8.8 14.4 5.6 1.8 4.5 3.7 0.9 17.0 14.5 2.3 2.9 1.5 7.1 3.3 1.8 1.9 5.0 8.2 2.9 1.4 2.7 5.7 2.8 4.5 0.0 1.9 2.1 2.9 0.4 1.2 1.9 0.0 0.5 1.6 0.1 1.1 0.3 2.1 2.6 0.6 0.1 1.6 0.0 0.2 0.1 0.2 2.2 3.6 3.2 0.9 0.0 1.5 0.0 3.0 0.0 0.0 8.7 4.0 2.4 2.3 0.6 0.0 2.9 0.0 0.3 0.0 0.0 0.1 2.8 0.2 3.5 0.1 36.3 0.1 2.8 3.7 0.6 5.1 0.2 1.1 2.2 8.4 4.6 0.0 1.7 11.6 34.6 1.8 0.0 0.3 1.7 1.5 0.3 0.0 2.2 1.5 0.4 1.5 8.4 13.9 2.5 1.8 6.1 3.1 1.9 0.0 0.0 1.0 0.0 0.1 0.4 0.3 1.0 0.0 0.3 1.6 1.2 0.2 0.5 0.0 1.2 0.0 0.1 10.9 15.7 46.9 21.8 14.0 10.6 8.8 14.4 17.0 5.7 0.0 1.3 0.0 1.8 0.5 30.7 2.9 0.0 1.4 1.2 1.8 21.6 0.3 1.7 0.0 5.9 0.7 0.0 0.0 0.0 0.1 1.0 0.3 0.0 0.0 0.1 14.3 1.2 0.0 0.0 1.1 2.3 0.0 1.7 0.0 0.8 1.4 0.0 1.5 2.5 0.8 10.6 0.0 0.9 0.5 1.1 0.4 0.0 0.5 1.0 0.1 ADAM23 MDC3 ENSG00000114948 "ADAM metallopeptidase domain 23" O75077 2 206443539-206621130 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 30.5;heart muscle: 19.3;parathyroid gland: 67.6" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 28.0;Cardiomyocytes: 52.9;Late spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 5.7" "Lineage enriched" "Detected in single" 14 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.8;RH-30: 21.9;RPMI-8226: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033276 Approved "Intracellular and membrane" NA NA 24000 "CAB033276: AB_2305247" "unprognostic (7.33e-2)" "unprognostic (7.80e-2)" "unprognostic (4.60e-1)" "unprognostic (5.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.59e-2)" "unprognostic (4.27e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-1)" "unprognostic (6.84e-2)" "unprognostic (1.09e-2)" "unprognostic (2.64e-2)" "unprognostic (9.75e-6)" "unprognostic (3.32e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-3)" "unprognostic (1.03e-3)" 2.0 4.7 8.5 2.5 30.5 2.3 1.7 14.2 27.4 3.4 2.4 3.4 0.3 2.0 2.5 3.8 3.8 1.2 4.0 19.3 8.7 11.4 1.5 1.4 2.0 2.3 9.8 13.5 2.4 5.7 67.6 4.8 1.0 22.4 1.8 2.6 2.4 1.5 2.8 8.1 1.6 2.4 4.2 3.9 1.4 2.0 6.5 4.0 0.8 1.3 1.6 2.7 3.2 2.4 0.4 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.3 7.6 0.0 4.1 6.1 0.3 0.8 0.9 1.1 0.2 8.9 0.1 1.0 0.0 1.2 13.6 11.4 4.9 0.2 0.1 4.3 4.2 0.0 0.6 0.1 4.0 0.0 0.5 2.2 0.0 0.0 0.0 18.8 13.3 0.4 0.0 0.0 2.8 0.1 0.1 0.0 15.0 0.1 1.5 0.0 21.9 57.1 0.0 5.5 6.0 2.4 0.0 0.0 4.2 3.9 0.0 0.0 11.5 3.8 3.6 2.0 1.7 15.5 0.0 0.0 7.3 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.5 30.5 14.2 25.6 8.7 11.4 9.8 13.5 22.4 4.0 0.0 0.0 0.0 0.7 0.3 28.0 52.9 0.0 1.4 0.0 1.8 2.0 0.0 0.0 0.0 9.9 2.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 3.2 1.7 0.0 0.0 20.6 0.6 0.0 3.3 0.0 0.0 3.5 0.1 0.0 2.8 0.0 6.0 0.0 0.4 4.5 3.6 0.4 0.1 0.0 0.0 0.1 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell type enhanced" "Detected in many" 15 "B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "CAPAN-2: 24.8;OE19: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA "Plasma membrane" Mitochondria "HPA074034: AB_2686654" "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favorable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.8 0.2 0.8 0.0 0.8 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 7.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 3.0 5.9 115.5 2.2 0.8 0.0 0.9 25.5 17.4 62.6 3.5 0.0 0.3 0.0 7.1 0.9 0.7 0.5 0.0 3.1 8.1 1.1 2.0 2.3 0.0 9.0 0.0 0.0 0.0 12.3 1.8 0.6 32.1 5.0 5.4 0.1 0.0 32.8 0.0 0.4 3.6 0.0 6.5 0.3 0.2 0.1 0.5 0.5 6.9 0.9 6.3 ADAM29 "CT73, svph1" ENSG00000168594 "ADAM metallopeptidase domain 29" Q9UKF5 4 174829668-174978180 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 38.2" "Group enriched" "Detected in some" 68 "Early spermatids: 330.7;Late spermatids: 253.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MAIT T-cell: 1.0;naive CD8 T-cell: 1.3;T-reg: 2.2" "Lineage enriched" "Detected in single" 7 "T-cells: 2.2" "Cell line enhanced" "Detected in some" "Karpas-707: 3.3;RH-30: 2.2;U-266/70: 1.7;U-698: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.40e-3)" "unprognostic (2.03e-2)" "unprognostic (4.72e-3)" "unprognostic (4.93e-2)" "unprognostic (1.16e-6)" "unprognostic (1.35e-1)" "unprognostic (1.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 330.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 253.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.3 1.6 0.0 0.0 0.0 0.0 0.0 ADAM30 svph4 ENSG00000134249 "ADAM metallopeptidase domain 30" Q9UKF2 1 119893533-119896495 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 30.0" "Cell type enriched" "Detected in some" 8 "Early spermatids: 53.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA026080 Uncertain NA NA "HPA026080: AB_1844581" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 47.0" "Cell type enhanced" "Detected in many" 27 "Early spermatids: 134.9;Late spermatids: 35.0;Spermatocytes: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: AB_2684699" "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 0.6 0.6 0.3 0.2 0.4 0.4 0.6 0.3 0.5 0.6 0.3 0.2 0.2 0.0 0.3 0.8 0.2 0.3 0.5 0.4 0.3 0.7 0.2 0.2 0.2 0.2 0.3 0.6 0.5 1.2 0.1 0.2 0.2 0.4 0.3 0.4 0.4 0.2 0.7 0.2 0.8 0.3 0.2 0.2 0.5 0.1 47.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.9 0.2 1.5 0.4 2.6 0.9 0.0 0.7 0.3 0.1 0.4 2.0 0.2 0.2 1.3 0.4 1.2 0.4 0.1 2.6 0.0 0.5 2.4 0.1 0.2 0.5 0.0 1.5 0.1 0.3 0.0 2.2 0.3 0.3 0.2 0.8 2.7 0.2 0.1 0.0 1.9 0.1 0.3 0.2 0.5 1.3 2.8 0.4 0.6 0.0 1.4 0.0 0.2 0.1 0.0 0.1 0.3 1.0 0.4 0.2 0.4 0.0 0.3 1.1 0.0 0.0 2.6 3.8 0.1 1.4 0.0 0.4 0.1 0.9 0.1 0.7 1.5 0.4 0.2 0.7 0.4 0.3 0.9 0.6 0.9 0.1 0.8 0.7 0.8 1.0 2.6 0.4 0.2 0.2 0.0 0.3 0.4 0.3 0.5 0.3 0.7 0.3 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.8 8.0 1.4 0.0 1.4 0.0 1.8 17.7 0.2 0.0 0.2 134.9 1.0 0.0 0.0 1.2 0.1 1.9 1.3 0.0 0.4 0.4 0.0 4.1 0.6 0.0 35.0 2.6 0.0 0.0 0.0 0.7 1.1 2.0 0.0 2.8 0.0 4.2 0.0 0.7 21.9 1.8 0.0 0.1 0.0 1.1 1.0 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA067152: AB_2685791, HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 40.6 0.1 13.8 23.7 4.1 8.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.9 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 0.0 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 23.2 0.2 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 21.0 0.6 3.3 0.0 0.0 3.3 0.0 0.0 9.6 0.0 0.0 6.5 15.1 0.6 0.5 2.8 0.5 0.0 0.0 0.0 ADAM7 "EAPI, GP-83" ENSG00000069206 "ADAM metallopeptidase domain 7" Q9H2U9 8 24440930-24526970 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "epididymis: 309.9" "Cell type enriched" "Detected in some" 15 "Early spermatids: 89.5" "Group enriched" "Detected in some" 16 "prostate cancer: 1.0;renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "BEWO: 4.4;NB-4: 11.0;RPMI-8226: 2.8;SH-SY5Y: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA008879 Enhanced "Intracellular and membrane" NA NA "HPA008879: AB_10601789" "unprognostic (1.03e-3)" "unprognostic (3.96e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 21.7 0.0 0.1 309.9 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 6.8 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 ADAM8 "CD156, CD156a, MS2" ENSG00000151651 "ADAM metallopeptidase domain 8" P78325 10 133262403-133276868 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 82.5;Macrophages: 42.6;monocytes: 115.4;T-cells: 46.3;Urothelial cells: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 56.8" "Cell line enhanced" "Detected in some" "A-431: 22.9;BEWO: 32.9;CAPAN-2: 27.9;HaCaT: 27.4;HDLM-2: 17.6;U-87 MG: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA064637 Approved "Intracellular and membrane" NA NA "HPA064637: AB_2685306" "unprognostic (8.24e-2)" "unprognostic (6.07e-3)" "unprognostic (1.27e-3)" "unprognostic (5.18e-2)" "unprognostic (8.26e-2)" "unprognostic (6.47e-2)" "unprognostic (5.59e-2)" "unprognostic (2.22e-1)" "unprognostic (2.57e-1)" "unprognostic (1.94e-3)" "unprognostic (3.37e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (3.99e-10)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.28e-1)" "unprognostic (9.32e-2)" 4.8 1.0 0.7 18.0 1.6 37.1 3.1 1.7 1.2 3.8 4.8 0.9 0.2 3.5 1.8 1.6 2.8 3.6 10.1 4.1 0.8 1.1 2.8 4.3 13.0 25.0 1.0 0.2 1.7 2.4 0.1 2.0 7.5 1.6 2.9 0.9 2.9 5.5 0.7 1.5 1.9 6.0 1.6 1.5 28.3 6.9 2.3 0.5 6.6 2.0 1.8 19.7 12.0 2.8 2.5 8.6 56.8 5.4 5.5 5.5 4.6 22.9 0.7 0.2 0.3 0.2 0.0 32.9 0.2 0.5 0.1 0.1 1.8 27.9 0.4 0.6 0.0 0.2 27.4 0.0 4.7 0.0 17.6 0.3 0.3 0.1 0.0 0.2 1.3 6.4 0.1 0.4 0.2 0.4 1.5 0.0 0.2 1.2 1.0 0.0 1.8 0.0 7.7 0.1 2.7 0.6 0.1 0.2 2.5 0.3 0.5 0.0 0.3 0.1 0.1 0.4 0.4 0.4 0.7 0.6 0.0 0.6 0.2 0.4 1.4 0.8 0.2 14.0 0.7 0.1 20.7 5.4 56.8 5.5 2.1 4.0 2.5 3.7 5.2 8.6 1.5 1.4 2.0 32.9 5.5 2.0 0.1 3.8 4.6 0.7 1.6 1.7 1.2 0.8 1.1 1.0 0.2 1.6 0.5 3.0 14.6 0.9 1.4 6.9 4.1 2.0 2.5 5.3 5.7 0.0 7.9 4.1 1.7 3.0 0.9 2.2 0.0 0.0 2.3 82.5 2.9 5.5 11.6 2.1 24.1 0.0 0.0 3.1 11.1 0.2 0.9 42.6 6.8 115.4 0.2 0.2 22.9 0.0 0.0 0.3 5.3 0.0 0.8 1.4 0.7 5.6 16.7 46.3 0.4 41.4 ADAMDEC1 M12.219 ENSG00000134028 "ADAM like decysin 1" O15204 8 24384285-24406013 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "intestine: 126.7;lymphoid tissue: 46.3" "Group enriched" "Detected in some" 16 "Hofbauer cells: 15.6;Kupffer cells: 10.4;Macrophages: 9.5;monocytes: 9.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.5" "Group enriched" "Detected in many" 7 "B-cells: 2.7;granulocytes: 4.5;monocytes: 2.1" "Cell line enriched" "Detected in some" 4 "U-266/70: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 22000000 "unprognostic (1.17e-2)" "unprognostic (1.80e-2)" "unprognostic (4.15e-3)" "unprognostic (3.60e-1)" "unprognostic (6.21e-2)" "unprognostic (3.84e-3)" "unprognostic (2.12e-1)" "unprognostic (2.90e-1)" "unprognostic (1.61e-1)" "unprognostic (5.99e-3)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (1.74e-2)" "unprognostic (2.06e-1)" "unprognostic (1.35e-2)" "unprognostic (3.66e-2)" "unprognostic (8.23e-2)" 0.6 0.6 0.3 46.3 0.3 0.0 0.4 0.3 0.3 0.4 57.4 0.1 0.1 30.4 0.3 0.4 0.6 0.4 0.4 0.4 0.3 0.3 0.5 0.4 1.4 30.0 0.3 0.1 0.4 0.4 0.0 0.4 0.9 0.1 0.4 52.2 0.2 0.8 0.1 0.3 0.5 126.7 1.7 0.4 5.2 0.8 0.4 0.1 1.9 0.5 0.5 5.4 5.0 0.4 2.7 0.4 4.5 2.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.6 0.0 15.6 3.6 0.0 0.0 0.0 0.0 0.0 2.0 4.5 0.0 2.1 0.0 2.7 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 10.4 0.0 0.0 9.5 0.0 9.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835747-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 112.8" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 85 "NK-cells: 9.0;T-cells: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016394, HPA031498" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 1900000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: AB_2673907" "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 70.6 13.4 8.2 18.7 14.0 0.7 29.0 6.3 9.2 22.0 18.2 9.5 4.8 3.3 27.7 25.8 30.0 45.8 62.3 40.9 7.6 4.8 15.4 22.8 25.0 10.9 12.7 3.7 112.8 9.3 6.3 7.6 56.8 13.2 23.3 16.5 7.8 5.8 8.1 25.7 6.1 16.2 46.4 10.2 7.2 16.8 12.8 11.4 0.0 14.3 18.1 2.7 32.7 45.3 0.0 0.0 0.0 0.0 9.0 8.0 1.4 0.0 0.0 1.1 0.0 62.1 15.4 3.8 72.4 25.3 12.5 8.3 0.0 0.0 0.0 5.0 22.9 0.3 1.3 0.8 3.7 22.1 0.0 23.0 0.0 7.5 0.0 11.9 2.9 0.0 17.2 0.0 49.9 45.5 3.0 5.1 0.7 1.2 0.0 37.1 0.0 0.3 0.0 4.1 0.0 2.9 0.0 28.6 0.2 42.4 4.0 0.0 5.6 3.4 0.0 0.4 2.7 0.1 0.7 5.2 17.8 0.9 27.8 10.7 0.1 0.0 0.0 14.7 0.0 5.4 0.0 0.0 0.0 8.0 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.0 1.5 0.0 9.0 0.0 0.0 0.0 1.4 8.2 14.0 6.3 9.2 7.6 4.8 12.7 3.7 13.2 11.4 6.0 31.4 0.0 31.2 107.6 0.5 151.1 7.6 5.3 14.8 54.1 0.0 44.4 1.7 29.9 1.3 165.7 0.0 0.0 18.6 211.3 148.2 23.5 2.3 1.3 14.7 0.0 0.0 124.0 6.0 2.2 100.9 4.8 50.6 1.0 0.0 31.7 24.2 0.0 39.3 2.2 2.2 207.0 366.0 0.5 1.0 36.4 45.9 5.0 0.0 13.3 ADAMTS13 "C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP" ENSG00000160323 "ADAM metallopeptidase with thrombospondin type 1 motif 13" Q76LX8 9 133414358-133459402 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 53.7" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 7.6;Early spermatids: 20.6;Ito cells: 8.0;Late spermatids: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "Cell line enhanced" "Detected in many" "SuSa: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA042014, HPA042844, HPA052077" Approved Approved Vesicles "Secreted to blood" NA NA 1300000000 38000000 Vesicles "HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: " "unprognostic (1.09e-1)" "unprognostic (1.45e-1)" "unprognostic (8.75e-4)" "unprognostic (1.49e-2)" "unprognostic (1.83e-1)" "unprognostic (3.02e-1)" "unprognostic (4.76e-2)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.88e-1)" "unprognostic (4.52e-5)" "unprognostic (1.11e-1)" "unprognostic (9.91e-2)" "unprognostic (4.78e-2)" "unprognostic (3.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.30e-3)" 1.4 1.0 3.1 1.4 3.7 0.5 1.4 6.6 4.2 1.4 1.4 1.4 1.4 4.1 1.6 4.0 1.4 2.1 1.5 1.7 3.4 2.2 1.8 53.7 4.8 1.4 2.1 1.4 2.3 1.8 2.2 4.2 1.7 1.6 1.6 1.1 1.6 2.5 2.0 2.6 2.9 4.4 1.4 2.0 1.4 5.5 3.8 1.4 1.4 1.7 1.4 1.4 1.7 1.4 0.3 0.0 2.3 0.0 0.0 0.5 0.1 0.0 1.3 3.3 4.6 2.7 2.4 1.2 1.1 0.9 0.4 0.6 0.5 3.6 0.4 1.5 0.8 1.1 0.6 0.3 0.6 0.1 1.9 3.0 0.4 1.3 0.7 1.9 0.1 1.1 6.4 1.6 0.5 1.2 2.2 0.3 2.3 0.1 1.4 0.5 5.5 0.1 1.5 3.5 1.9 2.0 0.4 0.4 1.6 1.5 1.4 2.1 6.8 2.3 1.3 1.8 7.1 5.8 0.6 0.8 2.4 1.4 1.6 0.0 2.5 0.6 0.5 2.0 0.4 2.8 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 3.7 6.6 4.2 3.4 2.2 2.1 1.4 1.6 1.4 0.0 1.3 0.0 0.1 0.2 1.4 3.6 7.6 0.0 3.4 0.0 0.0 0.1 1.7 0.6 20.6 0.3 1.0 0.0 0.3 0.2 0.8 0.4 0.0 1.5 0.2 3.2 1.2 8.0 0.0 10.2 0.9 0.0 0.0 0.0 1.3 1.9 0.3 1.4 1.4 0.7 1.7 0.0 0.4 4.7 3.8 0.4 0.1 0.0 0.6 0.3 ADAMTS14 ENSG00000138316 "ADAM metallopeptidase with thrombospondin type 1 motif 14" Q8WXS8 10 70672803-70762441 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;gallbladder: 12.3;placenta: 13.5" "Group enriched" "Detected in some" 6 "granulocytes: 4.6;Paneth cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.1" "Lineage enriched" "Detected in single" 11 "monocytes: 1.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.8;CAPAN-2: 10.4;K-562: 11.6;RH-30: 6.3;U-138 MG: 10.5" "Region enriched" "Detected in single" 5 "hippocampal formation: 0.4" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (5.98e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-3)" "unprognostic (2.40e-1)" "unprognostic (5.33e-3)" "unprognostic (2.35e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.98e-2)" "unprognostic (6.81e-2)" "unprognostic (3.84e-13)" "unprognostic (3.90e-2)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" "unprognostic (2.16e-2)" 1.7 0.5 4.6 5.4 10.7 1.1 0.6 1.0 4.7 1.3 3.3 13.4 1.0 4.1 1.4 1.0 1.8 1.1 12.3 2.8 7.2 3.0 0.7 0.5 2.7 2.0 8.1 5.7 0.7 0.5 0.2 0.4 13.5 4.0 1.1 3.6 2.6 1.6 0.4 0.4 2.5 5.7 3.9 4.6 0.8 2.6 0.9 5.9 0.5 0.4 2.3 2.3 6.7 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 4.8 0.0 1.2 3.7 0.3 2.0 0.0 10.4 0.0 0.8 1.9 0.5 0.8 0.0 0.0 0.1 4.0 0.0 0.4 0.0 0.3 0.0 0.0 2.7 0.4 0.1 0.9 0.2 1.2 0.0 0.0 11.6 0.0 1.5 0.0 0.0 1.0 0.4 0.1 0.0 0.0 6.3 0.2 0.0 0.0 4.0 0.7 0.0 0.1 0.3 0.2 0.0 0.0 0.0 10.5 0.1 0.9 0.5 1.0 0.0 0.0 0.5 1.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.6 10.7 1.0 4.7 7.2 3.0 8.1 5.7 4.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 1.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 ADAMTS15 ENSG00000166106 "ADAM metallopeptidase with thrombospondin type 1 motif 15" Q8TE58 11 130448974-130476641 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.4" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 9.6;Fibroblasts: 8.2;Leydig cells: 4.6;Melanocytes: 3.3;Smooth muscle cells: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.6;ASC TERT1: 22.1;EFO-21: 18.4;hTERT-RPE1: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA042867 Uncertain Approved Cytosol "Secreted to extracellular matrix" NA NA Cytosol "HPA042867: AB_10794535" "unprognostic (7.64e-2)" "unprognostic (1.49e-3)" "unprognostic (7.15e-2)" "unprognostic (1.34e-3)" "unprognostic (1.07e-3)" "unprognostic (7.07e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (6.18e-2)" "unprognostic (4.37e-2)" "unprognostic (2.56e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (5.95e-3)" "unprognostic (6.68e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.63e-5)" 47.4 1.1 0.2 1.7 0.3 0.1 14.5 0.1 0.8 3.4 3.8 0.8 3.0 0.6 3.7 9.8 3.8 9.3 9.1 12.6 0.4 0.3 9.1 0.4 6.6 5.6 0.8 0.2 7.0 1.6 0.9 1.0 16.4 1.3 3.7 2.1 10.9 1.0 1.3 1.6 4.1 3.1 6.9 1.4 1.9 4.9 2.4 0.6 0.7 9.8 2.5 0.8 8.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.4 36.6 22.1 0.0 1.3 2.6 0.5 0.1 0.2 0.6 0.0 18.4 0.1 1.3 3.4 0.3 0.3 0.1 0.0 0.8 0.0 1.6 0.0 0.3 0.0 0.0 7.2 0.0 0.3 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.3 0.0 5.9 0.0 0.0 2.7 1.9 0.0 0.0 0.3 4.3 3.5 1.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.7 0.4 0.3 0.8 0.2 1.3 0.6 0.0 0.0 0.0 0.1 0.5 0.0 9.6 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.5 8.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.3 0.0 0.5 0.0 0.7 0.0 0.7 0.8 0.0 0.0 3.3 0.1 0.3 0.3 0.7 0.0 2.1 0.0 ADAMTS16 ADAMTS16s ENSG00000145536 "ADAM metallopeptidase with thrombospondin type 1 motif 16" Q8TE57 5 5140330-5320304 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4;ovary: 16.3" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 7.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;cerebral cortex: 5.2" "Cell type enriched" "Detected in single" 10 "NK-cell: 3.6" "Lineage enriched" "Detected in single" 10 "NK-cells: 3.6" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA067668 Approved "Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria" "Secreted to extracellular matrix" Yes No "Nuclear membrane, Mitochondria" "Nucleoplasm, Midbody ring" "HPA067668: " "unprognostic (8.48e-2)" "unprognostic (1.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.98e-4)" "unprognostic (1.91e-2)" "unprognostic (5.04e-2)" "unprognostic (7.64e-2)" "unprognostic (7.80e-3)" "unprognostic (2.12e-2)" "unprognostic (5.44e-2)" "unprognostic (1.51e-2)" "unprognostic (2.18e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.20e-4)" "unprognostic (1.46e-1)" "unprognostic (4.59e-3)" "unprognostic (2.86e-3)" 7.4 0.4 1.8 0.5 2.8 0.6 1.0 20.4 5.2 2.6 0.9 0.1 3.7 0.6 2.3 11.0 1.9 1.1 8.8 0.9 1.7 0.5 5.4 0.6 0.9 0.2 0.5 1.9 16.3 6.3 0.0 0.5 0.2 2.2 0.7 0.4 0.0 0.4 0.8 0.5 0.5 0.6 10.4 0.6 0.4 0.6 0.8 0.0 0.0 0.8 0.0 0.1 3.4 1.5 0.2 0.1 0.3 0.0 3.6 0.2 0.0 2.5 2.7 2.7 0.1 0.2 0.6 0.2 0.1 0.1 0.6 0.9 0.1 2.4 0.1 3.3 0.0 4.7 0.2 0.0 0.0 0.8 0.1 1.6 0.1 3.8 0.0 0.0 0.3 0.1 0.0 0.0 6.1 0.2 0.7 0.0 0.3 0.8 0.4 1.1 0.1 0.1 0.3 1.7 0.1 2.5 0.5 3.2 0.1 0.1 0.0 1.1 0.1 0.1 0.1 0.2 5.6 0.1 0.2 0.1 3.2 4.8 8.9 2.1 0.5 0.2 0.1 4.6 0.1 0.4 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.3 3.6 0.0 0.0 0.0 0.0 1.8 2.8 20.4 5.2 1.7 0.5 0.5 1.9 2.2 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAMTS17 "FLJ16363, FLJ32769" ENSG00000140470 "ADAM metallopeptidase with thrombospondin type 1 motif 17" Q8TE56 15 99971589-100342005 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Deafness, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 111.4;Horizontal cells: 20.6;Late spermatids: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HEK 293: 7.4;JURKAT: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062487 Approved Nucleoplasm "Secreted to extracellular matrix" NA NA Nucleoplasm "HPA062487: AB_2684780" "unprognostic (7.73e-2)" "unprognostic (2.38e-2)" "unprognostic (1.79e-2)" "unprognostic (9.03e-3)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-3)" "unprognostic (5.03e-3)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (1.27e-1)" "unprognostic (3.35e-2)" "unprognostic (8.48e-2)" "unprognostic (1.21e-1)" "unprognostic (7.43e-3)" "unprognostic (6.43e-2)" 1.2 2.0 3.6 2.7 3.1 1.5 1.9 0.7 4.5 1.9 2.1 2.9 6.4 2.5 4.9 1.9 5.1 2.9 1.9 2.2 3.4 1.6 2.2 15.7 10.5 2.0 1.6 1.0 3.0 12.2 0.3 3.5 1.6 1.7 1.9 2.1 2.7 8.3 4.7 13.5 5.0 2.8 6.6 2.1 2.5 3.6 4.0 2.0 20.1 1.9 2.7 2.1 2.7 2.1 0.1 0.0 1.4 0.1 0.2 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.1 1.3 0.2 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 25.8 0.0 0.1 0.1 0.6 2.2 0.4 0.2 1.2 1.1 0.0 0.6 2.8 0.0 0.3 2.3 0.4 0.3 2.8 3.7 0.6 0.0 0.4 0.4 0.0 0.9 0.7 0.0 0.4 0.0 0.0 0.0 0.5 3.4 1.4 0.0 0.0 0.1 0.0 0.5 0.0 0.8 0.2 0.0 0.1 0.5 0.5 0.4 0.2 0.1 0.0 0.0 0.1 3.6 3.1 0.7 4.5 3.4 1.6 1.6 1.0 1.7 2.0 0.0 0.0 0.0 0.6 0.9 0.9 3.4 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 111.4 0.7 0.1 0.0 0.7 0.0 0.8 1.7 0.0 3.9 6.1 20.6 0.0 0.0 0.6 51.8 2.0 0.0 0.0 0.0 0.3 2.3 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 1.4 0.5 0.1 1.3 0.3 0.8 ADAMTS18 ADAMTS21 ENSG00000140873 "ADAM metallopeptidase with thrombospondin type 1 motif 18" Q8TE60 16 77247813-77435114 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.1;brain: 31.9;placenta: 27.6" "Group enriched" "Detected in some" 6 "Muller glia cells: 16.4;Rod photoreceptor cells: 8.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5" "Region enriched" "Detected in single" 5 "cerebellum: 3.7" "Not detected" "Not detected" HPA044326 Uncertain Approved "Midbody,Mitotic spindle" "Secreted to extracellular matrix" Yes NA "Midbody, Mitotic spindle" "HPA044326: AB_10961006" "unprognostic (1.10e-2)" "unprognostic (2.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.50e-1)" "unprognostic (8.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.98e-1)" "unprognostic (4.11e-2)" "unprognostic (2.20e-2)" "unprognostic (8.17e-4)" "unprognostic (1.77e-5)" "unprognostic (2.17e-1)" "unprognostic (3.41e-1)" "unprognostic (2.47e-4)" 16.1 0.6 1.1 0.8 5.1 0.4 3.2 31.9 3.3 2.2 0.4 8.2 0.0 0.5 1.6 0.4 0.5 0.7 1.1 0.4 2.0 1.3 0.5 0.3 0.5 0.5 1.8 1.4 0.5 0.8 0.4 1.4 27.6 6.4 1.0 0.4 0.2 2.1 0.5 1.0 0.4 0.4 1.2 3.7 0.3 0.3 0.7 2.4 0.0 0.4 0.0 0.3 0.8 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.5 0.0 0.5 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 5.1 31.9 3.3 2.0 1.3 1.8 1.4 6.4 2.4 0.0 0.0 0.0 0.1 0.1 0.4 0.5 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 ADAMTS19 ENSG00000145808 "ADAM metallopeptidase with thrombospondin type 1 motif 19" Q8TE59 5 129460265-129738683 "Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 15.3;Syncytiotrophoblasts: 4.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "MCF7: 12.0;SH-SY5Y: 27.6" "Region enriched" "Detected in single" 5 "olfactory region: 4.8" "Low region specificity" "Detected in all" "HPA056171, HPA058438" Uncertain Approved Vesicles,Midbody "Secreted to extracellular matrix" Yes NA "Vesicles, Midbody" "HPA056171: AB_2683054, HPA058438: AB_2683718" "unprognostic (1.14e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.10e-3)" "unprognostic (1.09e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-2)" "unprognostic (4.17e-2)" "unprognostic (5.99e-3)" "unprognostic (5.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.88e-2)" "unprognostic (3.06e-2)" 0.2 1.2 0.7 0.6 3.6 0.1 0.2 0.0 4.9 16.6 0.5 1.2 0.0 0.4 14.6 0.3 1.5 2.6 0.8 0.5 1.0 0.8 0.7 0.1 0.2 0.2 0.5 4.3 2.8 0.2 0.2 0.1 5.3 1.8 0.4 0.6 0.9 1.1 0.2 0.8 0.2 0.3 9.0 1.0 0.2 0.2 0.4 0.8 0.0 0.1 1.8 0.1 0.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 12.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 27.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.6 0.0 4.9 1.0 0.8 0.5 4.3 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 15.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 0.0 ADAMTS20 GON-1 ENSG00000173157 "ADAM metallopeptidase with thrombospondin type 1 motif 20" P59510 12 43353866-43551921 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3" "Cell type enhanced" "Detected in single" 24 "Bipolar cells: 2.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;SuSa: 4.4;U-266/70: 7.4;U-266/84: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027608, HPA027609" Uncertain "Secreted to extracellular matrix" NA NA "HPA027608: AB_10600098, HPA027609: AB_10599024" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (1.91e-2)" "unprognostic (2.04e-1)" "unprognostic (9.61e-2)" "unprognostic (3.29e-1)" "unprognostic (6.67e-2)" "unprognostic (2.26e-1)" "unprognostic (1.05e-4)" "unprognostic (7.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.81e-3)" "unprognostic (2.57e-1)" 0.2 0.0 0.7 0.1 1.4 0.1 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.2 0.0 3.6 5.1 0.0 0.0 1.5 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 2.3 1.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.6 0.2 0.0 0.0 2.9 5.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 4.4 1.4 0.0 0.0 0.0 0.7 0.0 0.0 7.4 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.2 0.3 0.7 0.6 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 ADAMTS4 "ADAMTS-2, ADMP-1, KIAA0688" ENSG00000158859 "ADAM metallopeptidase with thrombospondin type 1 motif 4" O75173 1 161184308-161199056 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 58.0" "Cell type enriched" "Detected in many" 7 "Smooth muscle cells: 356.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in many" 8 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025876, HPA051296, HPA068374" Uncertain Supported "Nuclear speckles" "Secreted to extracellular matrix" NA NA "Nuclear speckles" "CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978" "unprognostic (2.70e-2)" "unprognostic (8.10e-3)" "unprognostic (3.00e-3)" "unprognostic (2.75e-1)" "unprognostic (9.95e-3)" "unprognostic (1.19e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.20e-2)" "unprognostic (9.59e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (7.27e-7)" "unprognostic (1.10e-2)" "unprognostic (1.04e-1)" "unprognostic (1.44e-3)" "unprognostic (3.13e-2)" 58.0 9.7 2.6 18.1 20.7 1.8 14.6 1.5 10.7 7.8 6.3 33.4 0.0 1.9 5.8 2.0 7.7 14.2 16.4 19.5 3.4 2.3 3.1 11.0 15.7 2.7 28.6 3.5 35.7 10.6 4.7 4.9 4.4 20.5 5.8 3.4 0.0 1.7 1.7 7.7 1.7 3.0 12.0 15.5 1.9 8.1 1.7 15.7 0.0 7.5 1.2 1.4 8.7 4.0 0.5 8.0 1.0 0.2 0.4 0.6 0.2 0.0 0.0 0.2 0.1 6.1 3.9 0.6 4.9 0.2 0.4 2.8 0.2 0.1 0.2 4.1 1.5 0.0 0.1 0.0 0.0 1.7 0.1 0.3 0.1 0.4 1.2 0.6 0.0 0.1 4.3 0.0 10.9 0.1 0.0 13.2 0.1 0.1 0.3 0.3 0.1 0.0 0.2 4.9 0.0 0.0 0.1 4.8 0.1 0.0 0.1 0.1 7.4 0.0 0.1 0.1 0.3 0.2 0.5 11.1 6.9 0.1 0.3 9.8 0.2 0.1 0.1 2.1 0.1 0.1 0.7 0.2 0.2 0.6 0.1 0.3 0.3 0.3 0.3 0.1 0.5 0.4 0.4 1.0 0.4 0.1 8.0 0.3 0.2 2.6 20.7 1.5 10.0 3.4 2.3 28.6 3.5 20.5 15.7 0.0 5.5 0.0 2.3 27.7 2.2 2.8 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 43.0 0.0 0.0 0.0 0.2 33.3 8.7 0.0 0.8 0.8 3.2 0.0 48.5 1.5 0.0 0.3 6.0 33.7 1.8 0.0 0.3 0.0 0.0 1.1 0.0 1.0 51.8 356.4 2.3 0.6 16.7 0.3 1.5 0.0 4.4 ADAMTS5 "ADAMTS11, ADMP-2" ENSG00000154736 "ADAM metallopeptidase with thrombospondin type 1 motif 5" Q9UNA0 21 26917912-26966513 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.2;placenta: 20.9" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 51.0;Leydig cells: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "classical monocyte: 1.5" "Lineage enriched" "Detected in single" 6 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;ASC TERT1: 10.1;fHDF/TERT166: 9.5;RH-30: 25.2;U-87 MG: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA005661, CAB025996, HPA030906, HPA030908" Approved Supported Nucleoplasm "Secreted to extracellular matrix" NA NA 18000 Nucleoplasm "CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655" "unprognostic (1.97e-1)" "unprognostic (2.88e-3)" "unprognostic (2.69e-2)" "unprognostic (4.01e-2)" "unprognostic (4.67e-1)" "unprognostic (2.10e-2)" "unprognostic (4.38e-8)" "unprognostic (1.11e-3)" "unprognostic (7.66e-2)" "unprognostic (6.17e-2)" "unprognostic (8.13e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (6.69e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.15e-1)" 14.1 0.4 1.0 1.6 0.6 0.0 21.2 2.5 0.9 5.5 2.3 0.4 7.2 0.3 10.7 8.2 1.2 3.3 1.0 6.9 1.0 0.0 1.6 0.8 1.2 0.4 1.1 0.4 14.9 0.4 0.1 0.4 20.9 1.5 2.2 0.8 2.3 1.8 9.7 11.0 3.3 2.4 6.2 1.1 6.4 1.8 2.3 0.4 0.6 5.3 1.5 0.6 2.8 3.1 0.0 0.2 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.9 10.1 0.0 1.3 0.2 1.4 0.5 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.3 0.0 2.5 0.1 0.0 5.5 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.2 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.3 1.3 0.6 0.0 0.0 0.0 9.1 0.1 1.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.6 2.5 0.9 1.0 0.0 1.1 0.4 1.5 0.4 0.0 0.3 0.0 0.1 2.6 1.9 2.6 0.0 0.0 1.2 3.5 0.0 0.8 0.0 0.0 4.8 7.1 0.0 0.0 0.2 1.4 51.0 0.2 0.0 0.0 1.8 0.0 1.7 2.5 0.0 0.8 58.1 0.8 3.3 0.0 0.0 0.0 0.0 0.0 8.5 2.2 0.0 12.9 13.7 0.0 0.5 2.6 2.3 0.0 0.0 0.1 ADAMTS6 ADAM-TS6 ENSG00000049192 "ADAM metallopeptidase with thrombospondin type 1 motif 6" Q9UKP5 5 65148736-65481920 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 32.4" "Cell type enhanced" "Detected in many" 7 "B-cells: 16.4;Cytotrophoblasts: 28.3;Muller glia cells: 28.3;Peritubular cells: 17.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 4.8;naive B-cell: 3.6" "Group enriched" "Detected in many" 13 "B-cells: 4.8;T-cells: 1.4" "Cell line enhanced" "Detected in many" "BJ: 10.0;HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;hTERT-HME1: 12.2;TIME: 11.5;U-2197: 13.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043441 Enhanced "Secreted to extracellular matrix" NA Yes "HPA043441: AB_2678484" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.70e-3)" "unprognostic (4.33e-2)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (8.24e-2)" "unprognostic (1.65e-2)" "unprognostic (4.77e-2)" "unprognostic (8.04e-2)" "unprognostic (1.56e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-6)" "unprognostic (3.23e-5)" "unprognostic (2.09e-1)" "unprognostic (3.02e-4)" "unprognostic (4.18e-3)" 2.2 0.7 0.9 2.0 0.8 0.3 1.8 0.2 1.8 2.9 1.4 0.8 1.6 0.6 5.1 3.0 1.0 2.7 6.3 2.3 0.8 0.9 1.5 0.5 2.3 1.7 0.8 1.4 1.8 0.5 0.4 2.0 32.4 2.9 2.3 0.9 1.4 0.6 0.9 0.4 0.8 2.4 5.4 3.2 3.4 1.8 1.9 0.7 3.3 0.9 1.2 1.9 3.6 1.7 4.8 0.2 0.0 0.0 0.0 1.4 0.1 2.1 0.0 0.5 0.5 0.0 1.7 0.0 10.0 5.9 6.2 7.4 0.0 0.2 0.0 0.0 3.8 4.4 0.4 0.1 1.9 11.0 1.5 0.0 0.1 3.7 0.2 0.3 0.0 0.5 0.7 0.0 10.2 12.2 3.0 5.5 1.0 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.2 0.0 0.3 2.1 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 1.4 0.0 0.0 11.5 2.4 3.7 13.1 8.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.0 1.3 0.0 1.0 4.8 0.3 0.5 0.0 3.6 1.3 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.8 0.2 1.4 0.8 0.9 0.8 1.4 2.9 0.7 0.0 0.0 16.4 0.0 0.2 7.8 2.2 0.0 0.0 0.0 3.5 0.0 28.3 0.0 0.7 12.3 9.9 0.0 0.0 0.0 3.5 4.0 0.1 1.1 0.0 2.2 0.0 0.0 5.5 0.0 6.4 11.2 2.9 0.0 0.0 0.6 28.3 1.7 0.0 17.0 0.8 0.7 6.5 4.1 4.9 1.3 0.0 11.9 0.0 0.2 0.0 ADAMTS7 "ADAM-TS7, DKFZp434H204" ENSG00000136378 "ADAM metallopeptidase with thrombospondin type 1 motif 7" Q9UKP4 15 78759203-78811431 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 31.9" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 9.0;Early spermatids: 3.9;Endothelial cells: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "HMC-1: 77.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045284, HPA048453" Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA045284: AB_2679285, HPA048453: AB_2680399" "unprognostic (5.94e-3)" "unprognostic (9.94e-3)" "unprognostic (2.76e-2)" "unprognostic (7.09e-2)" "unprognostic (3.38e-1)" "unprognostic (1.93e-1)" "unprognostic (5.88e-4)" "unprognostic (3.34e-3)" "unprognostic (2.89e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-2)" "unprognostic (3.79e-1)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (8.86e-2)" 6.0 4.1 0.7 4.1 2.5 0.3 2.8 1.5 1.8 4.3 2.9 1.7 1.4 2.2 8.6 1.9 2.2 1.6 9.9 31.9 1.7 0.6 1.5 0.8 5.3 3.2 1.2 0.7 8.7 1.0 0.4 0.7 4.0 2.3 1.5 0.6 4.4 0.9 1.1 1.8 1.4 2.8 4.5 1.3 4.1 1.7 3.5 2.6 0.3 1.6 1.1 1.4 3.1 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 2.2 2.1 2.5 6.2 1.0 0.3 0.3 0.1 0.0 0.0 0.0 1.4 0.1 0.3 0.1 0.1 0.5 0.0 0.0 0.2 0.6 0.1 0.0 2.1 0.0 77.9 1.0 0.6 0.5 0.3 1.6 7.1 0.0 0.0 0.2 1.6 0.0 0.0 1.4 1.4 0.0 0.4 4.9 2.2 0.0 0.1 0.2 0.0 7.1 1.4 0.0 0.1 1.2 0.9 0.1 8.7 2.8 0.3 1.0 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.5 1.5 1.8 1.7 0.6 1.2 0.7 2.3 2.6 0.0 0.0 0.0 0.1 0.3 0.3 9.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.9 4.5 0.0 0.0 0.0 0.2 3.1 0.2 3.5 0.0 0.6 0.0 0.0 3.1 0.0 2.2 1.4 0.0 1.7 0.0 0.0 1.3 0.2 0.0 1.8 0.0 0.0 0.0 1.6 3.0 1.3 0.1 0.2 0.0 0.0 0.2 ADAMTS8 "ADAM-TS8, FLJ41712, METH2" ENSG00000134917 "ADAM metallopeptidase with thrombospondin type 1 motif 8" Q9UP79 11 130404925-130428993 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 13.0;lung: 21.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.1;Bipolar cells: 1.1;Cardiomyocytes: 2.5;Ciliated cells: 4.0;Club cells: 2.3;Fibroblasts: 2.6;granulocytes: 1.1;Melanocytes: 1.7;Peritubular cells: 1.4;Smooth muscle cells: 3.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.0;HeLa: 1.8;HMC-1: 5.8;NTERA-2: 2.9;U-2 OS: 13.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2" HPA066349 Approved "Secreted to extracellular matrix" NA NA 2200000 "HPA066349: AB_2685662" "unprognostic (4.76e-6)" "unprognostic (3.92e-2)" "unprognostic (6.13e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.41e-1)" "unprognostic (7.81e-2)" "unprognostic (3.09e-2)" "unprognostic (9.83e-2)" "unprognostic (1.09e-4)" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (4.66e-3)" "unprognostic (4.03e-3)" "unprognostic (5.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-1)" 2.1 0.1 1.5 10.2 2.5 0.0 0.5 0.6 4.4 1.3 5.3 0.5 0.2 1.1 2.6 1.5 3.1 1.7 13.0 3.9 1.6 0.6 2.1 0.2 21.0 0.2 0.7 0.2 1.0 0.7 0.0 0.8 2.7 0.9 2.9 0.5 0.7 0.3 5.7 0.4 0.1 1.6 7.4 0.8 0.9 5.6 0.2 0.4 0.2 0.4 0.2 0.4 3.8 3.4 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 2.5 0.6 3.2 1.6 0.6 0.7 0.2 0.9 0.4 0.0 1.1 0.0 0.2 0.3 1.1 2.5 0.0 4.0 2.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.4 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 3.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 51.4" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 62.4;Ductal cells: 67.2;Endothelial cells: 76.0;Glandular cells: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.4;RPTEC TERT1: 11.2;SH-SY5Y: 52.5;SuSa: 17.3;WM-115: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" No NA Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 51.4 4.7 5.6 12.0 11.5 0.5 15.2 3.9 8.0 10.4 10.4 2.8 7.2 1.6 13.9 5.6 6.8 7.7 8.2 29.6 5.7 2.7 9.0 3.1 11.5 7.7 6.8 0.3 17.4 9.9 17.2 2.4 30.5 12.4 7.4 3.2 0.7 3.5 4.3 10.8 2.6 3.2 12.2 12.6 4.4 4.6 3.1 5.9 0.0 6.4 3.7 1.6 19.6 29.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 3.6 1.0 0.0 0.0 0.2 0.0 9.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.0 0.4 0.0 0.0 1.0 0.0 11.2 0.1 0.0 52.5 0.0 0.0 0.0 17.3 0.0 0.2 2.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 11.5 3.9 8.0 5.7 2.7 6.8 0.3 12.4 5.9 3.0 4.5 0.0 62.4 15.5 0.0 5.9 5.1 0.0 4.5 36.6 2.0 0.6 0.0 67.2 0.8 76.0 0.0 0.0 2.9 0.5 35.3 51.3 0.0 0.0 5.8 0.0 1.2 23.4 0.3 0.0 2.3 3.0 25.3 0.0 1.4 0.0 27.6 0.0 2.1 6.3 0.0 0.0 38.9 0.3 0.2 11.8 1.4 0.0 0.4 26.6 ADAMTSL1 "ADAMTSR1, C9orf94, FLJ35283" ENSG00000178031 "ADAMTS like 1" Q8N6G6 9 17906563-18910950 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 50.7;retina: 39.3" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.5;Leydig cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 35.1;HSkMC: 17.8;hTEC/SVTERT24-B: 18.4;LHCN-M2: 18.1;TIME: 57.9;U-138 MG: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057437, HPA074973" Uncertain Approved Vesicles "Secreted in other tissues" NA NA 74000000 Vesicles "HPA057437: AB_2683440, HPA074973: " "unprognostic (4.64e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-2)" "unprognostic (7.21e-2)" "unprognostic (2.45e-3)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (7.77e-2)" "unprognostic (2.01e-4)" "unprognostic (3.66e-2)" "unprognostic (1.21e-1)" "unprognostic (6.41e-2)" "unprognostic (7.29e-3)" "unprognostic (2.58e-2)" "unprognostic (1.87e-1)" "unprognostic (6.59e-2)" "unprognostic (1.50e-2)" 6.3 7.6 0.5 5.9 0.8 0.0 4.4 3.9 1.5 14.3 5.2 0.6 6.5 1.6 50.7 12.0 9.0 5.2 4.4 2.9 1.6 1.0 3.4 1.0 1.9 2.2 0.4 1.2 4.9 1.3 0.1 3.9 0.8 0.9 8.4 4.6 39.3 3.1 5.6 0.5 2.0 2.7 13.3 0.7 0.9 5.0 2.3 0.0 0.0 2.0 1.7 1.5 2.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.0 5.1 35.1 0.0 1.0 4.5 4.1 9.5 0.0 0.0 0.0 0.0 12.3 1.5 0.0 1.8 0.2 12.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 17.8 0.0 18.4 0.0 15.9 7.7 0.0 0.0 0.0 18.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.9 28.2 0.7 0.7 4.1 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 3.9 1.5 1.6 1.0 0.4 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.5 0.8 1.3 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 1.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.4 1.9 0.9 0.1 0.1 0.0 0.8 0.0 ADAMTSL2 KIAA0605 ENSG00000197859 "ADAMTS like 2" Q86TH1 9 133532164-133575519 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 30.4;heart muscle: 36.4" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 5.0;Intestinal endocrine cells: 5.1;Ito cells: 8.0;Leydig cells: 4.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 5.9;RPMI-8226: 8.2;SH-SY5Y: 25.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045634, HPA053812" Approved Approved Vesicles "Secreted in other tissues" NA NA 67000000 Vesicles "HPA045634: AB_2679399, HPA053812: AB_2682271" "unprognostic (5.10e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.35e-2)" "unprognostic (1.07e-1)" "unprognostic (5.50e-2)" "unprognostic (6.78e-3)" "unprognostic (1.31e-2)" "unprognostic (5.49e-2)" "unprognostic (1.35e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.17e-2)" "unprognostic (7.37e-2)" "unprognostic (1.56e-1)" "unprognostic (3.40e-1)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" 3.6 30.4 5.5 1.8 5.4 0.7 0.9 6.4 9.3 1.6 1.6 8.8 0.9 2.4 1.9 4.9 1.8 1.8 11.0 36.4 4.7 4.0 15.1 24.8 11.3 6.8 5.7 4.9 6.9 7.9 1.4 8.6 2.6 9.9 4.3 1.1 4.5 5.4 3.8 5.5 0.9 2.6 1.8 5.1 3.5 2.3 3.2 6.8 0.0 6.5 1.3 1.3 2.2 6.0 0.3 0.2 1.0 0.2 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.4 0.0 0.9 0.6 8.2 0.0 0.0 1.2 25.7 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.8 0.4 0.0 0.2 0.0 0.3 5.5 5.4 6.4 9.3 4.7 4.0 5.7 4.9 9.9 6.8 0.0 0.3 0.0 0.1 0.1 1.8 2.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.9 0.2 0.0 5.1 8.0 0.0 0.7 4.4 0.2 0.0 0.0 0.0 0.2 0.2 0.0 2.8 0.6 0.3 6.5 1.6 0.0 0.2 0.3 0.0 0.0 0.7 0.1 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 157.1" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 47000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 14.4 2.4 0.8 8.9 1.4 2.2 13.2 0.7 1.1 11.0 8.2 1.5 3.9 2.2 9.7 8.1 19.7 11.1 6.6 10.7 1.0 0.2 3.4 14.9 13.3 2.3 1.4 0.4 14.5 1.8 0.2 1.3 157.1 3.4 9.4 2.4 19.1 5.7 2.3 21.1 5.4 6.0 17.4 2.2 3.9 8.9 3.3 1.1 0.8 3.8 15.5 4.8 19.1 15.9 0.0 0.5 2.3 3.5 0.0 0.1 0.6 6.7 0.1 0.1 1.2 6.2 30.2 63.6 6.5 5.7 3.9 2.2 0.5 2.6 0.0 1.3 4.4 0.0 3.4 0.2 0.9 1.6 0.5 0.1 1.9 0.7 2.7 5.0 0.0 0.9 14.2 0.2 0.9 2.2 3.3 0.0 0.0 20.3 0.2 0.6 0.1 0.0 0.3 1.1 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.2 2.0 5.0 0.0 3.3 1.4 3.5 1.2 0.2 1.8 2.7 0.1 0.6 0.1 1.4 0.2 1.2 0.1 0.0 1.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 3.5 0.0 0.0 0.6 0.8 1.4 0.7 1.1 1.0 0.2 1.4 0.4 3.4 1.1 0.0 1.0 0.8 2.1 2.2 1.0 2.0 7.6 1.4 0.0 0.0 0.0 113.3 0.0 1.1 0.4 3.5 0.0 0.0 0.5 39.4 15.5 1.3 2.3 9.2 28.7 0.0 0.0 1.3 22.6 0.0 27.9 16.5 3.3 25.2 0.0 2.4 7.4 0.0 3.2 0.0 2.4 0.0 1.4 0.0 0.9 2.5 83.2 0.0 0.1 1.7 ADAMTSL5 THSD6 ENSG00000185761 "ADAMTS like 5" 19 1505018-1513604 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 19.3" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 8.1;Leydig cells: 17.8;Peritubular cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044050 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA044050: AB_10962625" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (5.85e-2)" "unprognostic (2.45e-1)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" "unprognostic (1.17e-2)" "unprognostic (1.77e-2)" "unprognostic (1.89e-1)" "unprognostic (2.79e-2)" "unprognostic (2.89e-3)" "unprognostic (1.52e-1)" "unprognostic (5.03e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-3)" 1.0 1.0 1.2 1.7 1.5 0.0 1.5 1.3 1.2 19.3 5.0 0.5 2.2 7.8 14.4 6.2 7.0 2.7 2.3 13.5 1.9 0.8 0.9 2.8 1.4 0.2 0.9 0.2 1.7 0.9 0.0 1.5 5.2 1.8 4.0 0.7 8.6 4.0 3.9 10.5 1.0 10.0 9.9 0.8 0.8 1.0 3.7 0.3 0.0 1.0 8.1 5.1 1.6 7.2 0.2 0.1 0.8 1.8 0.1 4.7 1.1 6.4 2.9 0.1 0.2 3.4 2.5 3.1 11.9 8.1 4.6 6.8 16.4 3.2 0.0 3.0 9.9 1.3 5.5 2.9 3.5 3.4 6.2 0.4 1.2 8.5 3.0 3.9 0.2 8.5 1.5 3.7 1.1 2.9 6.1 0.0 2.2 3.8 8.2 0.4 6.0 0.3 0.4 0.1 1.9 1.6 0.2 0.6 1.6 3.6 0.0 0.2 0.4 2.8 0.3 3.3 1.6 7.5 2.4 0.8 0.0 4.5 9.1 0.5 5.1 3.2 0.8 0.1 0.6 2.0 0.4 0.1 0.8 3.4 1.1 2.2 0.1 3.7 2.5 0.1 0.2 4.7 3.2 0.2 0.1 1.8 0.1 1.1 1.1 1.2 1.5 1.3 1.2 1.9 0.8 0.9 0.2 1.8 0.3 0.0 0.6 0.0 2.2 0.3 0.2 8.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.5 0.0 1.7 0.0 1.5 1.9 5.4 0.7 0.0 1.6 0.2 0.0 0.0 0.0 0.0 2.2 17.8 0.2 1.7 0.0 1.0 3.4 4.3 0.8 17.0 0.3 2.0 0.0 3.5 0.5 1.4 0.4 0.6 0.5 0.6 3.0 ADAP1 "CENTA1, GCS1L" ENSG00000105963 "ArfGAP with dual PH domains 1" O75689 7 897901-955407 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;intestine: 30.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 56.4;Mucus-secreting cells: 30.1;Paneth cells: 34.3;Undifferentiated cells: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 31.2;CAPAN-2: 22.5;HMC-1: 21.6;OE19: 57.2;THP-1: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007033, HPA012049" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007033: AB_1846529, HPA012049: AB_1846527" "unprognostic (2.45e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (4.41e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (3.06e-1)" "unprognostic (9.10e-3)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-1)" "prognostic favorable (4.13e-5)" "unprognostic (5.88e-2)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-2)" 3.0 2.1 32.9 8.9 25.9 8.1 1.2 13.8 41.8 3.6 30.8 30.3 1.7 16.7 2.6 1.3 4.5 4.2 6.2 3.9 36.1 17.7 6.5 1.6 5.8 3.3 28.0 20.1 0.7 5.4 3.7 1.3 3.0 19.3 1.9 20.6 0.9 3.0 3.1 0.8 2.0 22.8 7.7 36.1 7.4 16.3 1.1 19.3 0.0 4.8 0.4 2.3 5.1 1.0 1.3 5.5 3.4 11.7 1.6 6.8 3.7 31.2 1.1 0.0 1.1 0.4 0.0 0.3 1.0 0.0 0.3 0.1 12.4 22.5 0.0 3.1 0.1 0.0 14.3 1.7 2.4 0.1 0.1 1.3 0.0 1.9 7.0 0.5 0.2 21.6 0.5 6.7 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 10.0 0.0 8.4 1.0 57.2 0.0 4.2 0.0 0.1 1.7 7.6 0.9 0.3 0.9 0.4 0.1 0.1 8.1 36.7 0.1 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 6.5 1.1 1.1 7.6 3.4 6.8 8.1 3.3 1.3 2.0 6.1 5.5 1.1 0.6 3.1 3.4 1.6 11.7 0.4 0.9 3.7 32.9 25.9 13.8 33.4 36.1 17.7 28.0 20.1 19.3 19.3 0.0 13.0 3.2 2.5 0.9 4.2 7.7 7.6 8.1 2.3 7.0 0.0 0.1 8.3 3.7 0.0 0.5 56.4 0.0 4.0 0.4 1.4 2.0 6.9 0.4 11.1 0.0 15.5 0.0 21.6 0.0 0.0 13.7 10.1 0.0 30.1 1.2 12.4 34.3 0.0 5.9 0.6 0.0 1.0 0.3 0.9 1.1 0.6 4.4 26.9 3.3 ADARB1 "ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1" ENSG00000197381 "Adenosine deaminase, RNA specific B1" P78563 21 45073853-45226560 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 59.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.9;Horizontal cells: 65.2;Muller glia cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 27.9;HHSteC: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029645 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA029645: AB_10602106" "unprognostic (2.69e-1)" "unprognostic (7.65e-2)" "prognostic unfavorable (8.16e-5)" "unprognostic (1.82e-2)" "unprognostic (1.07e-2)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (6.97e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (1.28e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.57e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-2)" "unprognostic (2.38e-2)" 12.2 5.3 7.1 10.4 8.4 4.5 8.9 33.1 11.6 11.7 17.2 2.5 5.6 2.9 13.4 6.6 14.0 8.8 11.1 6.7 7.3 8.1 4.6 4.0 19.9 11.8 7.4 8.1 5.3 4.7 19.0 3.7 12.0 13.6 14.7 5.0 11.0 4.6 8.7 11.8 10.8 5.9 59.9 3.5 10.5 11.7 3.8 4.0 3.9 3.8 4.5 8.4 34.6 20.3 6.1 2.1 4.8 0.6 0.5 2.6 0.5 3.1 0.4 2.5 2.9 3.1 2.1 3.4 2.1 3.5 6.9 4.4 5.0 0.5 1.0 5.8 10.5 3.8 0.3 3.7 8.9 7.6 0.7 3.3 6.9 27.9 3.3 32.3 4.7 3.4 11.6 3.9 2.4 7.2 2.6 7.2 9.6 1.6 0.4 20.0 2.3 3.1 4.5 4.0 1.6 4.8 0.9 2.4 3.2 1.5 1.0 14.7 3.9 17.1 0.7 5.4 4.3 1.6 3.8 7.6 2.3 2.8 9.2 8.0 3.1 1.4 0.8 2.0 11.1 12.1 1.3 0.2 4.8 1.1 0.6 1.8 2.4 2.6 1.6 0.0 6.1 1.8 1.4 0.2 0.5 0.3 2.1 1.6 0.5 7.1 8.4 33.1 11.6 7.3 8.1 7.4 8.1 13.6 4.0 0.0 0.6 3.2 2.5 9.8 52.9 17.1 0.0 0.0 2.3 0.0 11.8 0.4 0.0 1.3 2.0 13.5 0.4 0.0 0.4 0.9 11.0 4.9 8.1 5.9 6.1 65.2 0.0 14.7 3.4 1.9 3.4 2.9 5.0 7.2 0.7 34.4 1.0 0.0 5.3 2.2 15.5 0.0 18.6 4.1 11.5 6.4 0.8 6.9 1.2 2.0 ADARB2 "ADAR3, hRED2, RED2" ENSG00000185736 "Adenosine deaminase, RNA specific B2 (inactive)" Q9NS39 10 1177318-1737476 "Predicted intracellular proteins" "mRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2" "Group enriched" "Detected in some" 5 "Early spermatids: 33.9;Late spermatids: 86.6;Muller glia cells: 25.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.5" "Cell line enhanced" "Detected in some" "HDLM-2: 2.8;REH: 2.4;SH-SY5Y: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.64e-2)" "unprognostic (7.44e-3)" "unprognostic (2.12e-1)" "unprognostic (2.62e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (9.58e-2)" "unprognostic (9.28e-3)" "unprognostic (3.41e-1)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-1)" "unprognostic (3.81e-3)" 1.1 1.3 13.3 1.0 21.8 1.5 2.9 3.8 20.8 1.3 1.6 24.9 0.0 1.2 0.9 0.9 1.2 3.8 0.9 1.2 12.2 7.0 1.1 1.0 1.7 1.3 33.2 9.4 1.3 9.3 0.9 0.4 1.1 15.3 1.2 1.0 0.0 9.8 3.1 1.0 0.9 1.1 0.9 22.8 1.1 1.5 3.5 26.2 0.0 0.9 0.0 1.8 1.1 0.5 0.1 0.1 8.5 0.0 1.6 0.9 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.7 3.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.5 0.0 0.1 0.3 0.2 8.5 1.6 0.0 0.1 0.6 0.1 13.3 21.8 3.8 13.4 12.2 7.0 33.2 9.4 15.3 26.2 0.0 0.0 0.0 0.0 0.0 10.3 1.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 0.0 7.4 0.0 86.6 0.3 0.0 3.3 0.0 0.0 25.5 0.0 0.0 0.4 0.4 1.3 6.5 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 ADCY1 "AC1, DFNB44" ENSG00000164742 "Adenylate cyclase 1" Q08828 7 45574140-45723116 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, cAMP biosynthesis" "Calmodulin-binding, Lyase" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Group enriched" "Detected in many" 8 "Cone photoreceptor cells: 490.9;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 15.3;SH-SY5Y: 17.6;SK-MEL-30: 20.3;WM-115: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018364, HPA068274" Uncertain Approved Mitochondria NA NA Mitochondria "CAB018364: AB_2223098, HPA068274: " "unprognostic (9.41e-3)" "unprognostic (7.30e-4)" "unprognostic (9.31e-2)" "unprognostic (2.98e-1)" "unprognostic (4.18e-2)" "unprognostic (3.07e-3)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (1.64e-3)" "unprognostic (2.89e-1)" "unprognostic (7.73e-3)" "unprognostic (1.54e-1)" "unprognostic (4.74e-6)" "unprognostic (2.49e-1)" "unprognostic (7.65e-3)" "unprognostic (2.87e-1)" "unprognostic (2.23e-1)" 2.8 2.8 11.5 0.7 11.7 0.4 6.8 22.7 29.0 7.8 0.9 2.0 0.0 0.7 2.7 1.1 1.2 2.4 1.2 4.0 11.6 4.0 1.8 9.6 1.0 0.8 5.8 13.4 1.2 3.6 1.0 1.5 0.9 6.2 4.1 1.0 5.0 0.8 2.1 9.2 0.6 0.7 1.6 2.2 1.0 1.8 3.9 1.2 0.0 3.0 0.2 0.8 1.0 1.5 0.5 0.4 0.6 0.1 0.0 0.2 0.0 0.5 3.9 1.5 2.2 2.9 0.0 2.7 0.1 0.0 0.5 0.2 0.4 0.0 0.0 0.2 0.1 4.0 1.2 2.5 0.2 0.0 7.0 1.8 0.0 0.0 0.3 0.0 0.1 0.0 3.4 1.9 0.3 15.3 0.0 0.1 5.8 0.2 4.7 0.2 4.6 0.0 0.0 5.7 3.3 0.0 0.0 0.0 7.6 0.0 3.8 9.2 17.6 1.4 0.0 20.3 2.2 1.3 2.3 0.0 0.4 2.9 0.3 2.3 0.0 0.0 0.0 0.0 0.0 11.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 11.5 11.7 22.7 29.0 11.6 4.0 5.8 13.4 6.2 1.2 0.0 0.0 0.0 0.4 0.2 35.8 9.0 0.0 0.0 0.0 0.0 490.9 0.1 1.7 0.0 2.3 1.0 0.0 0.0 0.8 0.1 1.9 2.6 0.0 34.7 0.3 39.7 30.0 18.4 3.2 0.4 1.7 0.0 3.3 0.0 0.2 11.9 0.9 0.0 7.1 0.2 145.7 0.0 5.0 0.7 6.8 0.1 0.0 0.0 0.5 0.3 ADCY10 "HCA2, RP1-313L4.2, SAC, SACI, Sacy" ENSG00000143199 "Adenylate cyclase 10" Q96PN6 1 167809388-167914215 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "liver: 14.9;testis: 38.6" "Group enriched" "Detected in some" 11 "Early spermatids: 64.6;Late spermatids: 64.3" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Region enriched" "Detected in single" 5 "cerebellum: 1.6" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.7;T-47d: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA015243, HPA017749" Approved NA NA "HPA015243: AB_1856540, HPA017749: AB_1856541" "unprognostic (1.20e-1)" "unprognostic (2.53e-1)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.05e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (1.56e-1)" "unprognostic (1.63e-1)" "unprognostic (3.65e-1)" "unprognostic (4.43e-2)" "unprognostic (7.83e-5)" "unprognostic (5.86e-7)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "unprognostic (7.83e-2)" "unprognostic (2.59e-1)" 0.1 0.1 0.2 0.1 0.3 0.0 1.3 1.6 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.3 14.9 0.1 0.1 0.2 0.3 0.1 0.4 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 38.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.4 0.6 0.0 0.3 0.4 0.3 0.1 0.2 0.2 0.6 0.5 2.7 0.1 1.0 0.3 1.1 1.6 0.1 0.2 0.3 0.0 0.0 0.0 1.1 0.1 0.2 0.4 1.6 0.5 0.3 0.7 0.1 0.0 0.0 0.1 1.9 0.8 0.6 0.3 0.0 0.7 1.2 0.1 0.1 0.0 0.5 0.8 1.0 0.8 0.0 0.1 0.0 0.3 1.2 0.0 0.4 0.0 0.0 0.0 0.5 1.6 5.0 0.8 0.1 0.2 0.0 0.3 0.1 1.2 0.6 0.8 0.7 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.4 0.2 0.3 1.6 0.3 0.3 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 64.6 0.0 0.5 0.0 0.0 0.4 0.0 0.2 0.0 5.9 0.1 0.0 0.0 1.3 0.0 64.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 4.1 0.7 0.4 1.5 0.0 0.0 0.1 ADCY2 "AC2, HBAC2, KIAA1060" ENSG00000078295 "Adenylate cyclase 2" Q08462 5 7396208-7830081 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 35.9;skeletal muscle: 58.6" "Cell type enhanced" "Detected in many" 24 "Cone photoreceptor cells: 64.8;Horizontal cells: 190.7;Melanocytes: 38.8" "Cancer enhanced" "Detected in some" "glioma: 4.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "AF22: 9.0;NTERA-2: 6.9;SK-MEL-30: 7.5;SuSa: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031482, HPA038015, HPA038483" Approved NA NA "CAB031482: AB_630838, HPA038015: AB_10673653, HPA038483: AB_10675799" "unprognostic (6.48e-2)" "unprognostic (2.60e-2)" "unprognostic (1.49e-1)" "unprognostic (5.65e-2)" "unprognostic (3.77e-1)" "unprognostic (4.03e-4)" "unprognostic (1.94e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (7.68e-2)" "unprognostic (1.09e-5)" "unprognostic (1.05e-1)" "unprognostic (7.33e-3)" "unprognostic (4.90e-2)" "unprognostic (3.92e-3)" 1.8 3.3 16.8 1.3 14.5 1.2 2.8 6.6 35.9 4.9 1.9 6.7 0.7 1.9 3.9 1.7 4.0 4.1 2.1 1.2 14.5 9.4 1.2 1.1 1.3 1.1 12.8 10.0 5.1 1.9 1.0 5.1 1.8 11.3 6.2 1.6 2.0 1.5 5.1 58.6 6.3 1.8 4.3 12.5 1.2 2.6 3.6 5.4 0.0 1.1 5.1 1.2 1.9 2.1 0.9 0.4 1.5 0.4 0.3 0.6 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.5 6.4 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.4 0.1 0.4 0.2 0.4 0.5 0.3 0.3 0.1 0.9 0.4 0.6 1.5 0.3 0.3 0.4 0.2 0.0 16.8 14.5 6.6 22.5 14.5 9.4 12.8 10.0 11.3 5.4 3.0 2.4 0.0 0.6 5.3 28.6 1.6 0.0 9.4 4.5 0.0 64.8 0.6 0.0 0.5 2.5 1.4 0.0 0.0 0.4 0.2 2.8 7.3 1.1 0.0 0.2 190.7 12.1 0.6 0.0 2.1 4.0 2.6 38.8 0.0 0.1 1.9 2.0 0.3 1.8 0.2 4.0 0.0 1.0 1.2 0.7 4.1 0.7 0.0 0.2 0.8 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449758 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 69.9" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5" "Region enriched" "Detected in many" 5 "basal ganglia: 347.3" "Region enriched" "Detected in all" 6 "basal ganglia: 205.1" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 13.3 3.0 12.5 3.7 32.0 0.6 9.3 2.6 14.4 4.5 11.7 10.4 3.1 4.2 6.2 4.4 13.8 5.3 7.3 69.9 10.4 8.3 5.3 2.4 2.6 2.0 15.0 8.6 10.1 5.7 1.1 7.7 4.8 9.7 13.8 4.6 4.6 3.1 16.3 2.2 1.1 4.8 13.5 8.8 4.7 9.6 5.9 16.0 0.0 1.0 0.2 2.6 9.5 8.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 1.6 0.1 0.1 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.4 0.2 2.7 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 18.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 3.1 6.5 0.6 2.2 2.0 0.0 0.6 0.1 2.2 0.0 0.1 0.0 0.1 1.5 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 12.5 32.0 2.6 14.4 10.4 8.3 15.0 8.6 9.7 16.0 0.0 0.0 0.0 0.1 0.2 16.5 56.0 2.5 0.0 0.0 7.0 0.0 1.1 0.0 11.5 0.7 0.4 0.5 0.0 6.3 3.1 2.3 0.1 0.0 0.0 0.2 0.0 0.0 2.5 0.0 1.1 19.0 0.0 0.0 1.8 0.3 0.8 0.6 59.6 69.3 0.7 1.5 64.7 12.2 0.7 5.6 0.6 10.4 0.0 1.2 0.0 ADCY8 "AC8, ADCY3, HBAC1" ENSG00000155897 "Adenylate cyclase 8" P40145 8 130780301-131042426 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;epididymis: 27.8" "Cell type enhanced" "Detected in some" 22 "Cardiomyocytes: 1.0;Early spermatids: 2.5" "Group enriched" "Detected in some" 5 "glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.9;GAMG: 6.3;U-138 MG: 13.7;U-87 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018652, HPA024291" Supported NA NA "CAB018652: AB_633654, HPA024291: AB_1844597" "unprognostic (5.59e-3)" "unprognostic (3.10e-1)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "unprognostic (8.22e-3)" "unprognostic (4.91e-2)" "unprognostic (7.39e-3)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" "unprognostic (6.67e-2)" 0.2 0.2 8.2 0.2 5.1 0.2 0.9 5.3 9.6 0.8 0.2 1.2 1.4 0.2 0.3 27.8 0.2 4.8 0.2 0.3 6.4 6.2 0.5 0.2 1.6 0.2 7.8 0.6 0.3 0.2 0.2 0.0 0.2 5.7 0.2 0.2 0.0 2.8 2.0 0.2 1.5 0.2 0.9 5.0 0.2 0.3 0.7 1.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 0.3 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 5.1 5.3 5.0 6.4 6.2 7.8 0.6 5.7 1.1 0.0 1.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 ADCY9 AC9 ENSG00000162104 "Adenylate cyclase 9" O60503 16 3953387-4116185 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.4" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041328, HPA044225" Approved Approved Cytosol NA NA Cytosol "HPA041328: AB_2677414, HPA044225: AB_2678863" "unprognostic (1.78e-1)" "unprognostic (5.54e-2)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (6.62e-2)" "unprognostic (1.30e-2)" "unprognostic (2.52e-1)" "unprognostic (3.61e-2)" "unprognostic (6.93e-2)" "unprognostic (4.76e-3)" "unprognostic (5.40e-2)" "unprognostic (1.37e-1)" "prognostic favorable (5.24e-8)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (1.55e-2)" 5.2 4.8 7.1 3.2 10.9 0.9 5.4 8.5 9.6 7.0 6.4 4.1 4.4 6.5 6.5 4.4 6.8 7.7 6.5 13.3 6.2 3.0 8.0 9.6 11.1 2.5 3.0 6.2 9.4 12.5 12.3 5.8 7.8 7.7 3.6 5.5 9.0 10.1 5.0 36.4 4.4 10.9 6.3 2.2 3.2 5.5 4.4 3.4 0.7 21.8 7.7 3.0 7.9 4.8 0.1 1.0 3.2 1.5 1.0 1.9 0.9 4.9 7.6 2.3 4.3 8.3 10.2 3.5 8.8 9.2 4.9 4.0 6.3 4.4 0.0 13.5 24.0 3.0 4.8 9.1 5.4 3.4 6.1 8.8 0.2 17.4 12.1 9.1 0.6 4.0 10.8 8.5 5.7 3.0 4.1 3.3 1.6 2.7 0.0 5.0 9.1 0.0 2.6 4.2 2.1 4.1 7.8 11.1 0.2 1.8 1.3 5.3 2.3 6.8 8.1 5.9 2.7 20.5 8.9 3.0 9.8 2.7 9.5 3.8 1.9 1.1 1.0 2.1 2.7 3.8 3.2 1.5 1.0 1.9 1.5 1.7 0.0 0.6 0.6 0.1 0.1 0.1 1.1 0.3 1.0 0.0 1.0 0.0 0.9 7.1 10.9 8.5 9.6 6.2 3.0 3.0 6.2 7.7 3.4 11.9 10.9 0.5 1.0 5.7 9.3 15.1 28.1 6.7 7.9 12.2 11.8 1.4 0.0 3.8 0.6 5.2 13.6 0.0 4.6 1.7 6.9 0.6 0.0 17.4 1.4 1.6 1.2 8.0 5.9 1.5 7.8 2.6 6.8 1.0 8.4 7.5 2.8 0.0 7.1 4.7 12.8 0.0 13.8 1.1 5.2 3.3 0.8 4.3 5.2 0.9 ADCYAP1 PACAP ENSG00000141433 "Adenylate cyclase activating polypeptide 1" P18509 18 904943-912172 "Predicted secreted proteins" Neurogenesis Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;lymphoid tissue: 16.5" "Cell type enriched" "Detected in some" 12 "granulocytes: 42.7" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SCLC-21H: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065887 Supported Supported "Secreted in other tissues" NA NA "HPA065887: " "unprognostic (2.68e-1)" "unprognostic (1.83e-2)" "unprognostic (7.09e-2)" "unprognostic (4.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.87e-4)" "unprognostic (9.58e-3)" "unprognostic (1.00e-1)" "unprognostic (2.34e-1)" "unprognostic (6.86e-2)" "unprognostic (4.16e-2)" "unprognostic (9.94e-2)" "prognostic favorable (2.91e-6)" "unprognostic (2.24e-3)" "unprognostic (9.22e-2)" "unprognostic (1.74e-1)" "unprognostic (5.74e-4)" 2.1 0.5 2.5 16.5 7.7 0.1 1.6 2.1 12.5 3.4 2.6 0.8 0.0 0.1 4.0 0.1 2.2 0.5 12.3 1.0 1.2 18.4 0.6 0.3 1.7 1.6 2.8 6.2 0.2 7.7 0.1 4.5 0.3 33.8 1.4 1.4 2.5 2.2 1.0 0.3 0.9 1.3 1.5 5.9 0.2 1.8 3.6 0.2 0.1 0.3 0.0 1.4 3.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.7 2.1 12.1 1.2 18.4 2.8 6.2 33.8 0.2 3.0 1.1 0.0 0.0 0.6 0.1 0.4 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 42.7 0.0 0.1 0.0 0.0 0.6 0.0 1.0 0.3 0.3 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.0 0.0 0.0 0.1 ADCYAP1R1 "PAC1, PAC1R, PACAPR" ENSG00000078549 "ADCYAP receptor type I" P41586 7 31052461-31111479 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.2;fallopian tube: 25.1" "Group enriched" "Detected in some" 5 "Leydig cells: 10.6;Peritubular cells: 5.3" "Cancer enriched" "Detected in some" 11 "glioma: 45.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;NTERA-2: 7.3;SCLC-21H: 6.2;SH-SY5Y: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030739, HPA049877" Enhanced Enhanced Vesicles NA NA Vesicles "HPA030739: AB_2732461, HPA049877: AB_2680928" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.16e-2)" "prognostic favorable (5.78e-4)" "unprognostic (2.17e-1)" "unprognostic (8.36e-2)" "unprognostic (4.93e-2)" "unprognostic (5.75e-2)" "unprognostic (3.50e-2)" "unprognostic (3.88e-1)" "unprognostic (1.58e-1)" "unprognostic (6.67e-3)" "unprognostic (6.43e-4)" "unprognostic (1.09e-3)" "unprognostic (9.55e-2)" "unprognostic (3.85e-2)" "unprognostic (2.75e-4)" 5.4 10.6 23.6 2.7 24.2 0.9 2.9 13.7 71.2 12.8 2.7 13.4 0.0 1.6 5.4 2.3 3.3 25.1 2.0 2.8 22.1 21.6 1.0 1.1 1.6 1.0 19.0 20.2 1.9 2.2 2.9 4.4 1.0 18.7 2.1 2.0 0.0 2.6 3.7 1.9 1.8 2.0 3.9 6.5 1.3 1.6 2.2 13.3 0.0 2.3 0.9 1.6 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 11.1 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.9 1.3 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.6 24.2 13.7 17.3 22.1 21.6 19.0 20.2 18.7 13.3 0.0 0.0 0.0 0.0 0.5 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.0 1.4 0.0 1.5 0.3 0.0 0.0 0.0 0.0 ADD2 ADDB ENSG00000075340 "Adducin 2" P35612 2 70607618-70768225 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "bone marrow: 53.6;brain: 35.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 28.5;Erythroid cells: 70.0;Horizontal cells: 131.9" "Cancer enhanced" "Detected in many" "testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 4.7;non-classical monocyte: 4.4" "Group enriched" "Detected in many" 20 "B-cells: 4.7;monocytes: 4.4;T-cells: 1.9" "Cell line enhanced" "Detected in many" "HAP1: 14.3;JURKAT: 13.9;K-562: 18.7;NTERA-2: 36.9;RPMI-8226: 17.6;SCLC-21H: 18.4;U-251 MG: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009796, HPA034509, HPA034510" Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 66000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202" "unprognostic (3.58e-2)" "unprognostic (2.68e-4)" "unprognostic (3.83e-2)" "unprognostic (3.01e-4)" "unprognostic (1.94e-1)" "unprognostic (2.25e-3)" "unprognostic (1.35e-1)" "unprognostic (3.26e-1)" "unprognostic (3.49e-1)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (8.93e-2)" "unprognostic (4.47e-7)" "unprognostic (2.81e-4)" "unprognostic (1.77e-1)" "unprognostic (1.71e-3)" "unprognostic (1.31e-3)" 1.9 2.6 14.0 2.6 17.9 53.6 1.5 29.7 35.0 1.3 1.3 1.2 0.0 1.0 1.3 1.2 2.3 1.4 1.2 1.5 14.1 10.7 0.9 0.9 1.8 3.1 6.0 19.7 1.0 2.1 1.3 2.8 1.6 14.0 1.3 1.2 1.7 1.1 1.1 1.6 1.2 1.2 1.9 6.0 1.9 1.1 2.9 2.7 0.0 2.3 0.0 2.9 1.5 0.5 4.7 0.1 0.1 4.4 0.0 1.9 0.6 7.1 8.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.1 5.3 0.0 14.3 0.0 0.0 0.0 8.4 0.7 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.4 0.0 13.9 18.7 0.0 0.0 0.0 0.1 0.6 36.9 0.0 0.2 0.0 0.2 17.6 2.4 0.0 18.4 8.3 9.1 0.0 0.0 4.2 0.0 4.4 0.3 0.0 0.4 0.0 19.4 6.0 7.0 0.0 0.3 2.9 3.3 0.1 0.1 0.0 0.0 2.4 0.1 4.7 0.0 0.0 0.1 4.0 1.9 1.0 0.1 0.0 4.4 0.0 0.0 0.6 14.0 17.9 29.7 35.0 14.1 10.7 6.0 19.7 14.0 2.7 0.0 0.3 3.4 0.1 0.1 19.8 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.5 2.9 0.0 70.0 0.9 0.2 1.0 0.7 0.0 0.0 0.2 131.9 0.0 1.3 0.3 24.0 0.9 0.0 1.7 1.0 0.0 0.5 0.5 0.0 0.7 0.0 9.4 0.0 0.0 0.7 3.2 0.1 0.2 0.0 0.0 0.6 ADGB "C6orf103, CAPN16, dJ408K24.1, FLJ23121" ENSG00000118492 Androglobin Q8N7X0 6 146598965-146815462 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.9;epididymis: 13.1;testis: 30.6" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 6.6;pons and medulla: 20.9" "Cell type enriched" "Detected in single" 10 "myeloid DC: 2.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 2.6" "Cell line enriched" "Detected in single" 25 "HDLM-2: 17.9" "Low region specificity" "Detected in all" "HPA036340, HPA036341" Enhanced Uncertain Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA036340: AB_2675071, HPA036341: AB_10672241" "unprognostic (4.15e-3)" "unprognostic (1.23e-2)" "unprognostic (9.30e-3)" "unprognostic (1.09e-1)" "unprognostic (2.07e-2)" "unprognostic (3.11e-2)" "unprognostic (5.05e-1)" "unprognostic (2.34e-1)" "unprognostic (4.83e-3)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (1.77e-2)" "unprognostic (3.66e-2)" "unprognostic (2.68e-1)" 0.1 0.1 1.6 0.1 6.6 0.1 0.2 0.0 0.2 1.0 0.5 5.1 0.0 0.1 0.4 13.1 0.2 9.8 0.1 0.1 2.2 2.7 0.2 0.2 4.8 0.2 0.0 0.0 4.3 0.1 0.3 0.8 0.2 20.9 0.2 0.4 0.0 0.1 0.3 0.1 0.3 0.1 0.1 0.4 0.1 0.2 30.6 1.2 0.0 0.2 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 6.6 0.0 0.1 2.2 2.7 0.0 0.0 20.9 1.2 3.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 121.8 14.8 0.0 3.9 0.0 0.0 0.0 236.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.2 2.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.2 3.0 0.0 0.0 0.0 0.0 0.0 ADGRA1 "GPR123, KIAA1828" ENSG00000197177 "Adhesion G protein-coupled receptor A1" Q86SQ6 10 133070929-133131675 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.8;brain: 26.6" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 1.1;Cholangiocytes: 2.5;Ito cells: 6.2" "Cancer enriched" "Detected in single" 13 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "RH-30: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042773 Approved NA NA "HPA042773: AB_10794764" "unprognostic (8.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (1.09e-2)" "unprognostic (7.51e-3)" "unprognostic (2.48e-2)" "unprognostic (3.33e-1)" "unprognostic (1.66e-1)" 0.8 7.8 9.9 0.7 9.3 0.7 0.7 3.5 26.6 0.7 0.7 3.2 0.0 0.7 0.7 0.7 0.7 4.3 0.7 0.7 11.6 14.6 1.0 1.1 0.9 0.7 7.5 6.6 0.7 0.8 0.7 1.9 0.7 5.3 0.7 0.7 0.3 4.1 0.7 0.7 0.7 0.7 0.7 4.6 1.0 0.8 1.0 1.4 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 9.3 3.5 19.0 11.6 14.6 7.5 6.6 5.3 1.4 0.0 0.0 0.0 0.0 0.0 0.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 ADGRA3 "FLJ38547, GPR125, PGR21" ENSG00000152990 "Adhesion G protein-coupled receptor A3" Q8IWK6 4 22345071-22516054 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 2.9" "Lineage enriched" "Detected in single" 5 "NK-cells: 2.9" "Cell line enhanced" "Detected in many" "RH-30: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008904 Uncertain "Intracellular and membrane" NA NA 160000 "HPA008904: AB_1849258" "unprognostic (3.70e-1)" "unprognostic (9.01e-2)" "unprognostic (5.32e-3)" "unprognostic (8.27e-3)" "unprognostic (4.58e-2)" "unprognostic (1.55e-1)" "unprognostic (8.15e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (3.91e-2)" "unprognostic (8.77e-2)" "unprognostic (1.88e-1)" "unprognostic (1.78e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-3)" 5.3 6.9 15.5 3.0 14.7 1.2 7.6 5.7 11.6 8.2 11.8 12.8 5.9 5.0 10.9 7.1 3.8 15.6 5.4 7.4 17.8 8.6 7.5 51.8 3.5 2.4 13.1 8.5 6.6 14.6 9.7 5.5 6.4 14.2 8.9 12.3 6.7 5.7 10.6 11.8 3.1 4.8 10.0 12.8 1.8 6.4 4.5 11.8 3.2 17.9 4.1 1.8 4.6 3.6 0.0 0.3 0.0 0.0 2.9 0.6 0.0 8.3 6.3 16.3 13.6 13.3 6.0 14.6 10.3 11.3 7.0 3.8 7.1 16.8 1.3 5.3 4.9 9.7 9.3 10.2 14.7 10.0 0.0 7.2 0.7 4.9 15.8 4.4 7.3 0.0 5.6 18.4 4.5 7.9 13.3 10.4 5.3 7.6 0.2 11.5 3.7 6.4 0.2 18.0 7.9 6.5 30.3 33.5 2.1 8.4 8.7 12.2 14.1 4.3 0.3 7.2 11.8 4.4 6.4 0.2 10.5 7.5 4.7 9.6 1.2 0.0 0.0 5.8 5.2 8.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.9 0.0 0.3 0.0 0.0 15.5 14.7 5.7 11.6 17.8 8.6 13.1 8.5 14.2 11.8 3.0 2.6 0.0 12.1 0.0 13.6 11.5 20.4 4.0 9.1 15.7 19.6 16.6 0.0 14.9 5.8 1.0 4.3 23.3 10.0 7.2 6.6 10.4 0.0 93.3 3.0 0.0 11.7 6.2 4.7 5.5 8.9 0.6 0.0 0.0 26.0 4.8 16.8 7.0 9.2 5.7 12.3 0.0 3.2 1.2 7.7 0.0 6.1 0.7 19.7 8.8 ADGRB1 BAI1 ENSG00000181790 "Adhesion G protein-coupled receptor B1" O14514 8 142449430-142545009 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 27.4" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 119.2" "Cancer enhanced" "Detected in many" "glioma: 11.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 11.8;MCF7: 4.3;NB-4: 5.8;RPMI-8226: 16.3;U-2 OS: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (9.57e-4)" "unprognostic (1.28e-1)" "unprognostic (3.87e-3)" "unprognostic (8.50e-3)" "unprognostic (9.98e-2)" "unprognostic (5.87e-2)" "unprognostic (3.39e-1)" "unprognostic (2.14e-2)" "unprognostic (2.76e-1)" "unprognostic (2.55e-1)" "unprognostic (6.48e-2)" "unprognostic (3.43e-1)" "unprognostic (7.30e-11)" "unprognostic (6.27e-2)" "unprognostic (7.42e-2)" "unprognostic (4.52e-3)" "unprognostic (3.29e-2)" 1.0 3.4 13.6 1.4 18.1 0.9 1.1 5.4 27.4 2.0 1.0 3.1 0.1 1.4 1.8 2.3 0.9 1.4 0.9 0.9 11.0 11.9 1.1 0.8 1.2 1.6 8.7 9.2 1.6 1.1 0.9 2.7 2.5 9.1 1.3 0.9 0.9 2.6 1.9 0.7 3.1 1.4 1.0 2.3 3.7 1.5 2.1 3.2 0.0 0.9 0.0 1.0 0.9 0.4 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.9 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 5.8 1.8 0.2 0.0 0.1 0.0 16.3 0.0 0.0 3.1 3.1 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 18.1 5.4 19.5 11.0 11.9 8.7 9.2 9.1 3.2 0.0 0.0 0.0 0.2 0.0 13.1 5.3 2.5 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 119.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 3.8 0.1 0.0 12.7 0.0 0.6 6.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 ADGRB2 BAI2 ENSG00000121753 "Adhesion G protein-coupled receptor B2" O60241 1 31727117-31764893 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 52.0" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 18.3;Horizontal cells: 7.9;Late spermatids: 10.3;Muller glia cells: 10.1" "Cancer enhanced" "Detected in many" "glioma: 20.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.7;SH-SY5Y: 15.2;T-47d: 17.5;U-2 OS: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069175 Supported "Plasma membrane" NA NA 49000 "Plasma membrane" "HPA069175: " "prognostic favorable (6.46e-4)" "unprognostic (1.74e-1)" "unprognostic (7.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.90e-1)" "unprognostic (2.40e-1)" "unprognostic (8.17e-4)" "prognostic unfavorable (4.02e-5)" "unprognostic (2.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-3)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (1.75e-3)" "unprognostic (7.98e-2)" 2.2 5.4 15.9 1.3 26.8 1.1 1.4 7.9 52.0 2.4 1.4 7.3 0.0 5.2 2.4 1.2 1.6 2.2 2.1 2.8 18.9 8.0 1.4 0.9 1.3 1.3 7.4 16.5 1.8 1.4 1.3 2.7 3.8 8.4 2.4 1.1 1.3 1.4 3.1 1.1 1.5 5.0 2.4 2.9 1.8 1.8 3.2 6.3 1.5 3.2 0.0 1.1 2.0 0.5 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.6 4.4 4.2 12.0 1.2 0.7 2.0 2.8 4.5 2.8 4.9 0.2 1.3 0.0 2.8 1.2 4.6 0.4 1.8 0.2 0.4 3.1 1.9 0.0 20.7 0.0 0.1 0.0 1.6 0.7 0.3 3.8 0.0 8.8 0.4 8.8 0.4 0.1 3.1 0.4 7.9 0.1 5.2 0.1 1.3 12.1 0.4 0.4 0.0 5.7 3.2 15.2 6.5 0.4 0.5 1.5 17.5 0.0 0.1 2.1 17.0 0.3 0.7 0.0 0.0 0.4 6.7 0.0 5.1 0.0 0.0 0.0 0.9 0.0 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 15.9 26.8 7.9 37.6 18.9 8.0 7.4 16.5 8.4 6.3 0.0 0.0 0.0 0.5 0.0 18.3 4.1 0.0 0.0 0.0 0.0 5.9 0.7 0.0 0.1 2.9 0.0 0.0 0.0 0.0 1.1 0.4 0.5 0.0 0.0 0.4 7.9 1.2 0.0 0.0 10.3 1.1 0.0 0.0 0.0 0.0 10.1 0.1 0.0 1.8 1.9 4.1 0.0 0.3 0.7 4.5 0.0 0.2 0.0 0.1 0.9 ADGRB3 "BAI3, KIAA0550" ENSG00000135298 "Adhesion G protein-coupled receptor B3" O60242 6 68635367-69389511 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.0;pituitary gland: 17.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 43.5;Early spermatids: 14.7;Peritubular cells: 8.1" "Cancer enriched" "Detected in single" 10 "glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 6 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "SCLC-21H: 9.3;SH-SY5Y: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 9200 "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-3)" "unprognostic (3.27e-2)" "unprognostic (1.04e-1)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (5.08e-5)" "unprognostic (4.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-3)" "unprognostic (2.43e-1)" "unprognostic (1.01e-1)" "unprognostic (8.16e-3)" 2.7 8.0 20.0 2.8 22.5 1.5 2.1 46.9 55.0 3.1 3.4 6.2 0.0 2.2 5.2 3.1 2.7 2.4 3.0 3.2 17.6 15.2 2.4 2.4 3.6 1.6 9.0 22.7 4.3 1.9 1.8 17.1 1.8 9.6 2.6 3.6 1.2 3.2 3.9 1.9 1.9 3.2 6.7 10.1 2.4 1.9 4.4 11.1 0.0 2.1 0.0 1.6 2.9 1.8 0.0 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.0 0.0 1.2 1.0 0.0 0.0 9.3 20.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 20.0 22.5 46.9 25.1 17.6 15.2 9.0 22.7 9.6 11.1 0.0 0.0 0.0 0.1 0.0 43.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 1.6 1.0 4.6 0.0 0.0 1.8 0.0 0.8 0.1 0.0 8.1 0.0 2.6 0.0 0.0 4.6 2.1 0.0 0.0 0.0 0.0 0.0 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.1" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 29.1;Cardiomyocytes: 39.1;Fibroblasts: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 4.9" "Cell line enhanced" "Detected in some" "BJ: 5.1;fHDF/TERT166: 5.8;HeLa: 10.5;HHSteC: 6.7;HMC-1: 14.5;U-2 OS: 7.1" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "Low region specificity" "Detected in all" "HPA042395, HPA076279" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA 600000 "Plasma membrane" Nucleoplasm "HPA042395: AB_10796906, HPA076279: " "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 12.7 2.1 2.0 3.2 3.1 0.5 8.9 1.1 3.9 11.2 5.5 2.2 3.9 2.2 13.3 14.0 6.8 8.8 45.6 34.8 1.9 1.5 1.6 5.2 18.6 0.6 4.2 2.2 12.5 11.8 0.3 3.5 26.6 2.4 13.3 2.4 13.0 1.6 2.3 11.6 3.8 6.4 66.1 6.4 1.9 10.2 3.8 2.6 0.0 6.3 7.1 2.1 29.5 30.8 0.2 2.4 0.0 4.9 0.5 0.0 1.2 0.0 0.7 0.0 2.6 0.1 0.0 0.1 5.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.0 6.7 0.0 14.5 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.9 0.0 0.1 0.2 2.2 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.5 7.1 1.9 0.1 0.1 1.8 0.9 0.1 0.0 0.0 0.0 4.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.5 3.6 0.0 0.0 1.2 2.0 3.1 1.1 3.9 1.9 1.5 4.2 2.2 2.4 2.6 20.8 29.1 0.0 0.0 0.0 0.0 39.1 0.0 4.0 9.1 1.8 0.0 0.9 0.0 0.0 14.7 1.0 0.0 0.0 0.3 0.6 20.1 0.1 1.1 2.6 2.3 0.0 0.0 3.1 2.4 14.7 12.7 0.7 0.0 1.8 0.0 0.0 0.5 0.0 14.9 0.0 0.7 6.5 0.9 2.6 5.7 0.0 0.8 0.0 0.0 0.3 ADGRD2 "GPR144, PGR24" ENSG00000180264 "Adhesion G protein-coupled receptor D2" Q7Z7M1 9 124451425-124478589 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 2.8;pituitary gland: 7.2;seminal vesicle: 5.8" "Group enriched" "Detected in some" 18 "Early spermatids: 27.1;Late spermatids: 64.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 1.5" "Group enriched" "Detected in some" 4 "hypothalamus: 0.7;midbrain: 1.9;pons and medulla: 0.7" NA NA "unprognostic (7.39e-4)" "unprognostic (1.34e-2)" "unprognostic (4.21e-2)" "unprognostic (8.01e-3)" "unprognostic (6.29e-2)" "unprognostic (3.23e-6)" "unprognostic (1.15e-1)" "unprognostic (3.15e-1)" "unprognostic (5.82e-2)" "unprognostic (4.22e-2)" "unprognostic (3.63e-2)" "unprognostic (2.25e-1)" "unprognostic (3.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.41e-1)" 0.0 0.6 0.1 0.0 0.1 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.3 0.0 0.0 5.8 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.9 ADGRE1 "EMR1, TM7LN3" ENSG00000174837 "Adhesion G protein-coupled receptor E1" Q14246 19 6887566-6940459 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "blood: 64.1;lymphoid tissue: 50.0" "Cell type enriched" "Detected in some" 9 "Kupffer cells: 25.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 64.1" "Group enriched" "Detected in many" 17 "granulocytes: 64.1;monocytes: 20.2" "Cell line enhanced" "Detected in some" "A549: 5.8;BJ hTERT+: 7.9;GAMG: 8.3;HDLM-2: 19.2;HMC-1: 13.7;Karpas-707: 16.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA052809 Uncertain NA NA 9100 "HPA052809: AB_2681959" "unprognostic (2.06e-2)" "unprognostic (3.45e-1)" "unprognostic (1.32e-1)" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (6.93e-5)" "unprognostic (6.77e-2)" "unprognostic (1.18e-1)" "unprognostic (5.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-7)" "unprognostic (6.69e-2)" "unprognostic (3.33e-4)" "unprognostic (1.11e-2)" "unprognostic (1.35e-1)" 1.8 0.5 0.7 7.2 2.4 5.9 0.5 0.3 1.7 0.5 0.6 0.3 0.0 2.8 0.4 0.9 0.4 0.6 0.7 1.3 1.5 0.7 0.7 4.1 4.6 6.6 1.7 0.0 0.3 0.4 0.0 1.0 1.8 0.9 0.5 0.5 0.5 0.5 0.0 0.4 0.3 2.8 1.7 1.9 50.0 0.7 1.2 1.0 6.9 0.5 0.0 1.7 2.8 0.4 0.0 2.4 64.1 20.2 0.1 2.0 1.9 2.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 19.2 0.0 0.1 0.0 0.0 0.0 0.4 13.7 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 16.8 0.0 0.1 0.5 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.2 0.3 0.1 0.9 3.0 0.1 3.9 3.7 0.0 27.2 4.3 64.1 0.0 12.0 0.0 0.0 1.5 0.2 2.4 0.0 2.0 0.1 1.6 0.1 20.2 0.1 0.4 1.9 0.7 2.4 0.3 1.7 1.5 0.7 1.7 0.0 0.9 1.0 3.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.8 25.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.1 0.0 0.0 0.0 ADGRE2 "CD312, EMR2" ENSG00000127507 "Adhesion G protein-coupled receptor E2" Q9UHX3 19 14732393-14778541 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Cell adhesion, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;lymphoid tissue: 38.9" "Cell type enhanced" "Detected in many" 15 "granulocytes: 44.2;Kupffer cells: 60.1;Macrophages: 39.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7" "Group enriched" "Detected in many" 8 "granulocytes: 24.2;monocytes: 28.7" "Cell line enhanced" "Detected in some" "HEL: 10.3;HMC-1: 16.6;NB-4: 10.1;RPMI-8226: 7.3;U-937: 13.2" HPA055200 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055200: " "unprognostic (2.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (9.10e-2)" "unprognostic (3.58e-2)" "unprognostic (2.77e-2)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.32e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.35e-6)" "unprognostic (1.46e-1)" "unprognostic (2.45e-3)" "unprognostic (2.50e-1)" "unprognostic (1.01e-1)" 6.3 3.1 1.7 22.9 1.9 7.2 4.4 1.0 1.3 14.9 8.1 2.5 0.9 2.4 12.0 1.0 1.9 2.3 3.3 7.3 2.0 1.8 3.4 4.3 15.6 37.4 2.2 0.0 5.3 3.5 0.7 1.6 10.9 2.4 3.8 2.5 3.2 2.4 3.9 3.5 3.0 3.0 2.0 3.1 38.9 2.0 2.2 1.4 2.8 3.4 5.2 2.8 7.5 2.1 0.1 3.1 24.2 28.7 1.2 0.0 1.8 0.2 1.0 0.1 0.2 0.1 0.3 1.1 0.8 1.1 0.0 0.0 0.2 0.2 0.2 0.1 0.7 2.1 1.7 0.3 0.1 0.0 0.2 0.2 10.3 3.3 0.2 0.5 3.8 16.6 0.8 1.5 3.7 0.6 0.1 0.1 0.9 2.4 0.4 1.2 0.5 1.3 10.1 0.4 0.7 0.2 0.1 1.4 7.3 0.0 0.3 0.1 0.2 2.1 1.8 0.4 0.2 0.3 4.8 0.3 0.3 0.3 0.2 0.1 0.2 0.1 0.2 1.0 13.2 0.6 19.6 4.4 24.2 0.0 15.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 19.1 1.2 28.7 0.6 0.0 1.8 1.7 1.9 1.0 1.3 2.0 1.8 2.2 0.0 2.4 1.4 3.0 10.6 5.4 4.4 0.0 0.7 0.6 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.3 0.3 1.7 44.2 0.4 13.5 0.0 1.2 1.3 60.1 2.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.2 0.3 0.0 0.3 0.7 0.0 3.0 ADGRE3 EMR3 ENSG00000131355 "Adhesion G protein-coupled receptor E3" Q9BY15 19 14619117-14690027 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 70.7;lung: 26.3" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 3.7;Ciliated cells: 1.4;granulocytes: 2.3;Macrophages: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7" "Lineage enriched" "Detected in many" 9 "granulocytes: 70.7" "Cell line enriched" "Detected in single" 38 "HMC-1: 32.5" "Not detected" "Not detected" HPA015638 Uncertain "Secreted to blood" NA NA "HPA015638: AB_1848039" "unprognostic (2.11e-4)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (5.69e-2)" "unprognostic (5.63e-2)" "unprognostic (4.53e-2)" "unprognostic (1.14e-1)" "unprognostic (8.07e-2)" "unprognostic (9.61e-2)" "unprognostic (9.11e-4)" "unprognostic (4.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.13e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 1.7 0.2 0.3 8.5 0.8 4.0 0.3 0.2 0.7 0.2 0.4 0.3 0.1 2.1 0.2 0.7 0.4 0.6 1.2 0.6 0.3 0.3 0.4 1.1 26.3 5.9 0.4 0.1 0.5 0.3 0.0 0.3 1.7 0.7 0.6 0.5 0.7 6.2 0.1 0.9 0.2 3.2 0.7 0.6 8.1 0.4 0.8 0.3 0.8 0.5 0.9 3.4 2.6 0.4 0.0 0.7 70.7 8.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 3.2 69.6 0.0 7.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 70.7 0.0 8.0 0.0 0.0 0.9 0.3 0.8 0.2 0.7 0.3 0.3 0.4 0.1 0.7 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRE5 "CD97, TM7LN1" ENSG00000123146 "Adhesion G protein-coupled receptor E5" P48960 19 14380501-14408725 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA013707 Enhanced Approved Cytosol "Secreted to blood" NA Yes 10000000 930000 Cytosol "HPA013707: AB_1846345" "unprognostic (3.16e-1)" "unprognostic (1.80e-1)" "unprognostic (5.10e-2)" "unprognostic (2.30e-1)" "unprognostic (2.85e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.51e-2)" "unprognostic (6.06e-3)" "unprognostic (3.14e-2)" "unprognostic (1.08e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.87e-6)" "unprognostic (2.08e-2)" "unprognostic (4.14e-2)" "unprognostic (2.44e-2)" "unprognostic (6.41e-2)" 17.7 8.9 2.5 23.0 4.0 55.3 14.3 1.1 5.2 21.7 15.9 12.9 0.5 12.9 56.9 18.5 11.6 19.1 27.1 16.4 3.0 2.4 10.7 15.5 30.3 41.1 6.3 3.2 10.7 16.2 2.4 3.3 18.2 5.9 11.3 9.0 6.9 17.0 3.6 12.5 6.0 22.2 36.2 4.2 56.9 15.0 6.9 4.9 24.3 8.6 3.7 22.5 34.7 12.4 3.9 13.3 95.3 43.2 22.8 25.8 23.3 30.8 21.9 0.2 21.0 9.3 15.3 3.3 21.4 34.5 15.4 16.9 6.2 31.3 3.5 21.7 27.5 22.0 7.3 5.7 10.4 6.9 19.2 6.4 6.9 32.5 2.7 11.5 14.9 32.3 6.7 0.3 15.7 5.4 5.0 1.5 6.1 9.0 27.7 16.8 6.9 0.9 20.0 0.6 24.5 27.3 2.0 9.2 16.1 5.2 2.7 0.2 0.7 12.2 17.5 15.2 0.5 4.5 13.8 3.7 5.2 8.7 21.7 35.2 0.0 0.1 0.2 18.7 26.7 19.5 42.0 18.6 95.3 25.8 36.7 17.3 3.9 13.1 17.8 13.3 2.6 9.4 12.8 82.7 22.8 43.2 6.4 9.0 23.3 2.5 4.0 1.1 5.2 3.0 2.4 6.3 3.2 5.9 4.9 32.8 102.4 15.9 7.4 0.0 0.2 3.1 12.7 50.9 31.8 0.0 0.0 2.7 0.0 15.1 0.0 4.5 10.2 23.3 19.1 36.8 4.8 9.8 70.9 1.5 47.0 0.0 4.7 26.4 83.8 1.0 6.1 50.6 0.0 2.8 34.7 2.3 17.9 21.0 4.6 0.7 1.2 25.8 17.2 0.5 5.7 0.0 6.6 152.3 31.8 14.1 ADGRF1 "GPR110, hGPCR36, PGR19" ENSG00000153292 "Adhesion G protein-coupled receptor F1" Q5T601 6 46997703-47042363 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.4" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 102.9;Pancreatic endocrine cells: 59.1;Urothelial cells: 305.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 40.0;HaCaT: 8.9;PC-3: 13.0;RPTEC TERT1: 18.3;RT4: 45.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038438 Approved "Secreted - unknown location" NA NA "HPA038438: AB_10672645" "unprognostic (4.83e-4)" "unprognostic (1.38e-1)" "unprognostic (1.64e-1)" "unprognostic (6.71e-3)" "unprognostic (1.95e-3)" "unprognostic (3.02e-3)" "unprognostic (7.76e-2)" "unprognostic (2.63e-2)" "unprognostic (2.90e-1)" "unprognostic (4.20e-2)" "unprognostic (3.64e-3)" "unprognostic (1.99e-1)" "prognostic favorable (1.35e-5)" "unprognostic (7.41e-2)" "unprognostic (8.39e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 6.5 6.1 0.0 3.7 0.1 1.3 4.2 15.7 0.8 10.0 0.0 0.0 0.0 27.4 0.1 5.4 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.6 0.0 7.5 0.2 0.0 3.2 1.9 0.1 0.1 5.5 2.1 0.1 0.1 1.5 1.3 0.0 0.0 11.3 5.6 12.3 16.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.7 0.0 0.0 8.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 13.0 0.0 0.0 0.0 18.3 45.7 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.9 0.0 12.6 0.0 0.0 0.4 15.3 26.8 25.0 102.9 0.0 0.0 19.9 25.6 0.0 0.0 0.0 0.0 16.7 0.0 0.0 30.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 59.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.4 305.8 ADGRF2 "GPR111, hGPCR35, PGR20" ENSG00000164393 "Adhesion G protein-coupled receptor F2" Q8IZF7 6 47656436-47697797 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7" "Cell type enhanced" "Detected in single" 21 "Ciliated cells: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;U-87 MG: 3.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA035507 Uncertain NA NA "HPA035507: AB_10601809" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.74e-2)" "unprognostic (5.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (2.51e-4)" "unprognostic (3.05e-2)" "unprognostic (3.86e-2)" "unprognostic (1.20e-1)" "unprognostic (2.24e-1)" "unprognostic (7.99e-2)" 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.4 1.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 6.0 4.2 0.0 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.6 0.3 0.2 0.0 0.0 0.4 0.0 4.7 6.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.7 5.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRF3 "GPR113, hGPCR37, PGR23" ENSG00000173567 "Adhesion G protein-coupled receptor F3" Q8IZF5 2 26308173-26346817 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 7.6" "Group enriched" "Detected in some" 8 "Early spermatids: 10.2;Late spermatids: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 3.9;U-937: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA044500 Uncertain NA NA "HPA044500: AB_10794290" "unprognostic (9.58e-3)" "unprognostic (2.13e-2)" "unprognostic (4.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (6.68e-4)" "unprognostic (8.98e-3)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" "unprognostic (9.66e-4)" "unprognostic (2.29e-1)" "unprognostic (8.09e-2)" "unprognostic (3.53e-2)" "unprognostic (2.58e-1)" "unprognostic (4.08e-2)" "unprognostic (8.70e-5)" 0.4 0.5 0.4 1.1 0.9 1.4 0.5 2.1 1.2 1.0 1.2 0.1 0.1 2.0 0.8 0.1 0.8 0.5 0.5 1.3 3.3 0.3 3.4 0.7 2.6 1.8 0.3 0.1 0.8 3.2 0.0 0.8 0.7 1.5 0.6 0.4 0.1 2.7 2.6 0.4 0.8 0.7 0.1 1.5 1.4 0.8 2.8 0.7 2.0 0.9 0.1 0.5 0.7 7.6 1.3 0.0 2.0 0.8 0.5 1.5 0.0 0.5 0.2 0.4 1.5 0.1 0.3 2.1 0.2 0.2 0.0 0.3 0.7 0.0 2.4 1.7 0.2 0.0 0.9 0.0 0.0 0.0 0.5 0.5 1.0 1.7 0.2 0.0 0.9 1.0 0.3 0.0 0.1 0.0 0.0 0.6 1.4 0.1 1.0 0.1 0.1 3.9 1.1 2.8 0.0 0.0 2.3 2.2 1.0 0.2 3.1 1.9 0.9 0.0 1.0 0.0 0.1 0.1 0.2 0.4 0.1 0.5 0.9 0.3 1.8 1.4 2.7 0.1 3.5 0.4 0.0 0.0 2.0 1.1 0.8 0.8 1.3 0.5 0.6 0.0 0.3 0.7 1.5 0.1 0.5 0.3 0.0 1.5 0.0 0.4 0.9 2.1 1.2 3.3 0.3 0.3 0.1 1.5 0.7 0.0 0.0 0.0 0.1 0.0 0.8 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.2 0.0 0.1 1.1 0.4 0.0 0.1 0.0 0.0 0.0 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 8.7 0.0 13.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 3.3 0.2 0.0 0.0 0.0 3.0 9.6 0.1 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 16.0 ADGRF5 "DKFZp564O1923, GPR116, KIAA0758" ENSG00000069122 "Adhesion G protein-coupled receptor F5" Q8IZF2 6 46852512-46954943 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 54.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 271.0;Alveolar cells type 2: 421.7;Club cells: 164.9;Endothelial cells: 125.4;Ito cells: 281.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 13.5;TIME: 40.3" "Low region specificity" "Detected in all" NA NA 23000000 "unprognostic (8.45e-2)" "unprognostic (3.00e-3)" "unprognostic (1.13e-1)" "unprognostic (3.26e-1)" "unprognostic (6.51e-2)" "unprognostic (1.89e-2)" "unprognostic (5.76e-2)" "unprognostic (9.00e-3)" "unprognostic (7.80e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.56e-2)" "prognostic favorable (8.84e-5)" "unprognostic (1.43e-2)" "unprognostic (5.91e-2)" "unprognostic (2.82e-2)" "unprognostic (3.78e-2)" 32.6 11.9 5.0 3.4 7.1 0.2 27.5 2.1 5.8 6.6 5.3 4.2 7.0 2.9 10.4 8.9 5.9 6.7 8.5 34.3 6.4 4.9 33.6 8.7 54.6 6.1 7.3 4.7 6.5 3.3 7.0 5.2 25.1 5.9 5.5 3.1 7.5 3.5 5.0 19.4 3.8 4.0 11.1 6.1 26.2 3.8 3.1 3.0 0.1 16.1 8.8 1.7 8.1 13.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 7.1 2.1 5.8 6.4 4.9 7.3 4.7 5.9 3.0 271.0 421.7 5.7 0.3 0.0 0.0 8.4 12.7 88.3 164.9 1.8 0.0 0.2 10.0 0.2 8.1 125.4 0.0 0.0 0.0 1.0 0.0 0.4 11.6 1.5 0.2 0.0 0.0 281.1 20.0 3.0 2.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 97.0 1.5 0.1 0.4 0.0 0.2 0.0 0.0 0.5 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989309-19122637 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 202.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Ciliated cells: 4.0;Glandular cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 4.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.3;BEWO: 7.9;HeLa: 6.5;NTERA-2: 6.8;SH-SY5Y: 7.1;U-2197: 15.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" NA NA 7900000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 4.4 0.3 0.4 0.9 0.2 0.2 2.8 0.1 0.2 0.8 1.0 0.1 6.6 0.2 0.5 202.4 0.9 6.9 1.4 1.8 0.6 0.6 0.7 0.9 1.7 3.1 0.2 0.2 0.9 0.9 24.8 1.9 0.6 0.3 3.2 0.2 1.6 9.6 0.8 0.6 0.3 1.4 0.6 0.2 1.2 3.5 4.7 0.2 2.7 1.8 0.6 1.9 1.1 1.5 0.1 0.2 0.9 0.6 0.0 0.2 0.0 0.2 6.3 0.0 0.0 0.1 1.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.5 0.0 6.5 0.3 0.9 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 2.3 6.8 0.0 2.1 0.0 0.1 4.5 0.0 1.3 2.4 7.1 1.6 0.1 0.0 1.2 0.1 0.1 0.1 0.2 0.4 15.7 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.9 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.6 0.6 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.8 5.1 4.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 3.0 0.0 0.4 0.0 3.2 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 1.8 0.0 1.4 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 ADGRG3 "GPR97, Pb99, PGR26" ENSG00000182885 "Adhesion G protein-coupled receptor G3" Q86Y34 16 57668187-57689378 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.8;bone marrow: 62.7;lymphoid tissue: 26.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.9;Ciliated cells: 2.7;Club cells: 3.4;granulocytes: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "eosinophil: 33.3;neutrophil: 42.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 42.8" "Group enriched" "Detected in some" 6 "NB-4: 8.7;SK-MEL-30: 4.8;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040469 Uncertain NA NA "HPA040469: AB_10794032" "unprognostic (4.41e-3)" "unprognostic (3.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" "unprognostic (8.84e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-4)" "unprognostic (5.25e-3)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.67e-3)" "unprognostic (4.75e-2)" "unprognostic (3.77e-1)" "unprognostic (1.00e-1)" "unprognostic (2.90e-1)" 4.6 0.4 0.3 7.2 0.9 62.7 1.6 0.2 0.5 1.1 4.1 0.0 0.0 1.4 1.4 2.0 2.9 3.4 1.6 7.7 0.2 0.3 0.7 2.7 11.0 26.4 2.0 0.0 1.7 0.6 0.2 0.3 1.7 0.6 1.6 0.9 1.2 0.4 0.3 2.3 0.7 3.9 1.5 0.3 25.4 1.2 1.7 0.3 1.1 6.5 1.2 0.8 3.4 7.2 0.0 0.0 42.8 0.0 8.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 15.6 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.8 8.8 0.0 0.0 0.0 0.1 0.3 0.9 0.2 0.5 0.2 0.3 2.0 0.0 0.6 0.3 8.9 7.9 0.0 0.0 0.0 0.0 0.6 0.0 2.7 3.4 0.0 0.0 0.3 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.6 0.6 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.0 ADGRG4 "GPR112, PGR17, RP1-299I16" ENSG00000156920 "Adhesion G protein-coupled receptor G4" Q8IZF6 X 136300963-136416888 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "intestine: 23.6" "Cell type enriched" "Detected in some" 10 "Horizontal cells: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "TIME: 3.3" HPA035324 Uncertain NA NA "HPA035324: AB_10671512" "unprognostic (3.40e-3)" "unprognostic (7.68e-5)" "unprognostic (7.61e-2)" 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.9 0.0 0.0 7.1 0.7 1.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 23.6 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 39.7 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRG5 "GPR114, PGR27" ENSG00000159618 "Adhesion G protein-coupled receptor G5" Q8IZF4 16 57542421-57591681 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 37.7;lymphoid tissue: 25.6" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.2;Kupffer cells: 1.2;monocytes: 1.8;T-cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 37.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HMC-1: 28.1;OE19: 9.2" "Region enhanced" "Detected in single" "thalamus: 0.4" "Not detected" "Not detected" HPA007133 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" Nucleoplasm "HPA007133: AB_1849253" "unprognostic (6.11e-3)" "prognostic favorable (4.25e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (6.14e-2)" "unprognostic (1.14e-2)" "unprognostic (6.43e-2)" "unprognostic (1.42e-2)" "unprognostic (8.09e-4)" "unprognostic (3.80e-3)" "unprognostic (3.02e-3)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (7.69e-3)" "unprognostic (4.52e-1)" "unprognostic (1.62e-3)" "unprognostic (6.32e-3)" 0.7 0.6 2.4 20.2 2.7 1.4 0.8 0.6 2.1 0.6 2.1 2.5 0.0 4.3 0.5 0.2 1.7 0.8 0.8 0.5 1.6 1.1 0.5 0.6 2.9 12.1 2.6 0.9 0.5 0.4 0.2 0.8 0.0 2.9 1.2 1.7 0.5 4.6 0.8 0.4 0.7 7.5 0.3 3.5 12.8 0.5 1.2 3.5 3.4 1.1 0.2 25.6 2.8 0.9 4.0 21.9 37.7 0.0 8.8 11.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.4 2.6 9.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 37.7 11.1 0.0 5.6 4.0 1.6 6.4 0.7 2.8 0.4 4.0 0.1 8.8 0.0 21.9 0.0 2.3 2.4 2.7 0.6 2.1 1.6 1.1 2.6 0.9 2.9 3.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.7 0.4 0.0 ADGRG6 "FLJ14937, GPR126" ENSG00000112414 "Adhesion G protein-coupled receptor G6" Q86SQ4 6 142301854-142446266 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 51.9;placenta: 104.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 118.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "myeloid DC: 3.5" "Lineage enriched" "Detected in single" 13 "dendritic cells: 3.5" "Cell line enhanced" "Detected in many" "A549: 25.7;Hep G2: 24.0;hTERT-HME1: 24.4;HUVEC TERT2: 47.1;MCF7: 44.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017346 Approved NA NA 70000000 "HPA017346: AB_1849260" "unprognostic (1.04e-2)" "unprognostic (2.72e-2)" "unprognostic (7.37e-2)" "unprognostic (3.00e-2)" "unprognostic (8.64e-4)" "unprognostic (1.67e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.46e-1)" "unprognostic (6.49e-2)" "unprognostic (2.15e-1)" "unprognostic (1.36e-2)" "unprognostic (2.97e-2)" "unprognostic (4.59e-2)" 5.6 1.4 1.1 4.1 1.0 0.0 6.1 0.5 1.1 4.1 14.0 1.0 2.7 8.9 2.2 2.8 9.1 2.6 8.8 4.4 1.4 1.1 5.3 51.9 12.0 2.6 1.9 0.8 1.4 3.1 0.3 0.7 104.9 1.3 7.2 3.3 3.3 6.3 3.6 1.5 7.8 17.5 5.0 2.3 6.1 6.6 1.5 0.9 2.2 2.1 3.9 4.7 11.3 9.2 0.0 3.5 0.0 0.2 0.0 0.1 0.0 4.8 25.7 0.5 2.7 0.1 0.0 0.0 6.7 1.2 5.1 3.2 20.5 14.9 0.0 6.0 3.8 1.4 12.1 0.7 6.4 8.4 0.0 2.0 1.0 4.4 24.0 5.0 4.0 0.0 0.0 10.4 0.1 24.4 2.9 47.1 0.1 0.1 0.0 2.0 44.2 0.0 0.0 0.2 1.7 5.9 0.0 2.3 5.0 2.6 10.9 0.0 0.0 1.9 9.0 4.2 4.4 4.9 0.0 1.6 0.0 2.3 2.2 3.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 1.0 0.5 1.1 1.4 1.1 1.9 0.8 1.3 0.9 6.0 5.1 0.5 15.4 0.0 0.0 1.4 15.3 5.3 14.8 8.7 0.0 4.8 0.0 11.5 0.0 4.4 0.8 0.0 4.7 24.6 0.6 11.8 0.0 118.8 2.0 0.0 0.0 16.5 24.7 0.2 0.6 0.6 0.0 1.0 0.9 0.0 22.8 3.6 0.4 10.3 0.0 6.5 0.5 1.6 5.1 0.0 11.3 0.0 1.8 21.0 ADGRG7 "FLJ14454, GPR128" ENSG00000144820 "Adhesion G protein-coupled receptor G7" Q96K78 3 100609589-100695479 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "intestine: 58.4;liver: 26.9" "Cell type enhanced" "Detected in some" 25 "Collecting duct cells: 1.8;Enterocytes: 2.6;Hepatocytes: 10.4;Paneth cells: 4.0" "Cancer enhanced" "Detected in some" "stomach cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 2.9;CACO-2: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA056451 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056451: " "unprognostic (1.65e-1)" "unprognostic (1.10e-1)" "unprognostic (2.79e-1)" "unprognostic (8.46e-3)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-3)" "unprognostic (2.84e-5)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.77e-2)" 0.1 0.2 0.1 0.5 0.1 1.2 0.1 0.1 0.1 0.9 17.1 0.1 0.1 25.7 0.3 0.1 0.2 0.9 0.3 0.2 0.1 0.1 0.1 26.9 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.4 1.7 0.1 0.1 0.1 0.1 0.2 58.4 0.8 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 ADGRL1 "CIRL1, KIAA0821, LEC2, LPHN1" ENSG00000072071 "Adhesion G protein-coupled receptor L1" O94910 19 14147743-14206187 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 59.8;Horizontal cells: 33.4;Muller glia cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 31.8;HMC-1: 23.1;SCLC-21H: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037974 Uncertain NA NA 63000 "HPA037974: AB_10675623" "unprognostic (5.52e-2)" "unprognostic (3.89e-1)" "unprognostic (1.04e-1)" "unprognostic (5.52e-3)" "unprognostic (6.29e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" "unprognostic (5.39e-2)" "unprognostic (2.73e-1)" "unprognostic (5.68e-2)" "prognostic favorable (1.14e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.45e-4)" "unprognostic (7.65e-3)" "unprognostic (1.32e-1)" "unprognostic (3.06e-2)" "unprognostic (2.18e-1)" 10.5 4.6 12.1 3.5 18.0 1.8 3.9 27.0 30.9 7.7 6.4 12.7 4.3 6.1 9.0 4.1 6.5 10.8 4.1 5.5 12.7 9.3 3.4 0.5 5.4 2.6 8.7 9.0 4.0 5.8 12.8 9.1 3.7 11.8 5.4 3.7 9.4 9.8 8.1 1.6 9.1 5.4 8.1 8.1 4.4 5.0 5.5 6.9 2.8 9.2 2.0 1.8 4.6 3.4 0.4 1.7 1.3 1.3 4.6 1.3 0.6 10.0 3.9 8.9 31.8 2.4 0.7 3.1 0.7 1.0 1.0 0.6 3.4 3.5 0.8 10.7 1.2 2.0 0.6 10.7 3.0 0.3 1.4 9.1 1.8 1.6 0.5 5.4 0.6 23.1 1.9 2.8 0.3 0.5 1.6 0.8 10.0 8.8 0.9 0.1 16.9 0.8 0.9 13.3 5.4 7.6 4.9 1.1 11.2 1.7 3.2 24.6 6.3 1.9 12.7 4.4 3.3 12.6 4.7 1.2 8.4 12.9 2.3 2.9 2.5 2.1 13.8 2.5 11.7 3.0 0.0 1.3 0.5 1.3 1.1 0.9 0.4 0.7 0.4 0.5 0.2 1.0 0.6 1.3 4.6 1.1 1.7 0.7 0.6 12.1 18.0 27.0 27.6 12.7 9.3 8.7 9.0 11.8 6.9 0.0 5.0 0.0 2.8 0.0 59.8 7.3 2.5 0.0 3.4 7.0 9.8 0.3 0.0 3.2 0.3 4.5 3.2 0.0 2.7 0.3 3.3 3.9 4.7 0.0 0.7 33.4 7.0 9.2 2.2 2.0 8.6 0.4 0.0 1.0 3.0 32.9 2.4 7.8 15.2 0.7 22.2 19.4 0.9 0.9 22.6 0.0 0.2 1.9 6.7 1.4 ADGRL3 "KIAA0768, LEC3, LPHN3" ENSG00000150471 "Adhesion G protein-coupled receptor L3" Q9HAR2 4 61201258-62078335 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;parathyroid gland: 23.1" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 33.8;Late spermatids: 24.4;Muller glia cells: 39.3" "Cancer enriched" "Detected in some" 8 "glioma: 5.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 30.1;EFO-21: 7.9;HEK 293: 4.6;SCLC-21H: 4.6;SuSa: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015027, HPA015762, CAB022698" Uncertain NA NA "CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245" "unprognostic (2.88e-2)" "unprognostic (1.12e-1)" "unprognostic (6.43e-4)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (7.56e-2)" "unprognostic (8.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (6.81e-2)" "unprognostic (1.28e-1)" "unprognostic (1.62e-5)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (9.85e-3)" "unprognostic (4.23e-3)" 4.9 7.6 19.7 1.6 19.0 0.4 2.7 11.3 30.5 7.3 4.8 5.0 0.4 3.3 4.9 2.6 1.6 3.3 2.3 3.2 13.1 12.3 2.4 0.9 3.4 0.8 11.8 11.9 1.8 0.7 23.1 0.9 4.9 9.8 2.0 5.0 0.4 0.8 5.6 0.8 2.6 4.4 3.9 8.5 0.8 3.9 4.8 6.1 0.0 0.9 0.6 0.6 2.2 2.9 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 4.2 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.7 0.0 2.8 0.4 0.1 0.1 0.0 3.3 0.1 0.0 4.6 0.2 0.0 0.0 0.0 5.7 0.0 2.3 0.0 0.1 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 19.7 19.0 11.3 23.3 13.1 12.3 11.8 11.9 9.8 6.1 0.0 0.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.0 0.0 3.9 0.2 8.3 0.0 33.8 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.1 1.6 0.0 1.8 0.0 24.4 0.0 0.0 0.0 0.0 0.0 39.3 0.0 0.0 1.1 0.0 2.2 6.5 0.0 0.5 2.1 0.0 1.8 0.0 0.0 0.1 ADGRL4 "ELTD1, ETL" ENSG00000162618 "Adhesion G protein-coupled receptor L4" Q9HBW9 1 78889764-79006718 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 98.9" "Group enriched" "Detected in some" 7 "Endothelial cells: 232.9;Ito cells: 348.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 19.6;HUVEC TERT2: 64.3;RPTEC TERT1: 14.0;TIME: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025229 Supported NA NA 1800000 "HPA025229: AB_10602493" "unprognostic (2.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.05e-2)" "unprognostic (2.58e-1)" "unprognostic (5.32e-2)" "unprognostic (8.11e-3)" "unprognostic (2.01e-1)" "unprognostic (1.23e-1)" "unprognostic (7.52e-2)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (5.32e-3)" "unprognostic (1.48e-1)" "unprognostic (3.45e-2)" "unprognostic (3.85e-3)" 98.9 4.7 3.6 5.6 5.7 0.0 43.8 3.2 6.1 14.6 7.8 1.5 6.6 2.8 12.9 7.1 12.4 6.8 12.3 12.3 4.3 3.7 11.3 8.8 16.2 8.5 5.4 1.4 9.3 3.0 5.7 7.8 12.8 6.2 12.2 3.6 5.9 4.8 5.7 16.1 5.3 4.8 16.0 4.7 34.8 4.9 6.8 4.3 1.1 13.9 8.0 3.9 16.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 1.6 5.2 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 3.8 0.0 11.1 0.0 19.6 64.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 78.4 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 5.7 3.2 6.1 4.3 3.7 5.4 1.4 6.2 4.3 0.0 8.9 2.2 0.3 0.0 0.0 4.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 232.9 0.0 0.0 0.2 0.0 0.3 1.1 0.0 2.0 0.5 1.6 0.0 348.0 29.4 42.9 0.6 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 1.2 1.4 1.1 0.0 0.0 0.0 0.0 0.6 ADGRV1 "DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1" ENSG00000164199 "Adhesion G protein-coupled receptor V1" Q8WXG9 5 90529344-91164437 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Hydrolase, Receptor, Transducer" "Deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 95.3;pituitary gland: 35.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 90.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.2;HAP1: 18.1;NTERA-2: 9.5;SCLC-21H: 8.8;SuSa: 12.4;U-266/70: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067503 Approved Approved "Lipid droplets" NA NA "Lipid droplets" "HPA067503: AB_2685856" "unprognostic (1.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.69e-2)" "unprognostic (1.38e-1)" "unprognostic (4.01e-2)" "unprognostic (2.61e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-3)" "unprognostic (1.48e-2)" "unprognostic (1.87e-1)" "unprognostic (3.95e-3)" "unprognostic (7.50e-3)" "unprognostic (9.73e-7)" "unprognostic (1.87e-2)" "unprognostic (5.24e-2)" "unprognostic (3.48e-2)" "unprognostic (7.14e-2)" 0.5 95.3 21.9 0.6 19.8 0.8 2.2 13.9 14.7 0.7 1.0 3.1 1.2 0.7 0.6 0.9 1.0 0.6 6.3 0.6 26.5 1.5 10.6 19.4 5.5 0.5 1.1 7.0 0.6 1.3 1.1 35.4 2.4 4.9 1.1 1.0 4.9 0.7 2.4 0.6 1.5 0.7 0.6 0.4 0.7 1.0 1.1 5.3 0.0 4.2 0.0 0.7 5.4 0.4 4.1 2.2 8.4 1.7 1.7 3.4 0.4 0.4 1.6 12.2 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 1.3 0.1 0.2 0.3 0.0 0.3 0.1 18.1 0.1 0.0 0.7 3.4 3.1 1.4 1.0 0.0 0.2 0.1 0.0 3.8 0.0 0.1 0.1 0.0 0.1 7.3 2.0 0.0 1.5 0.1 0.1 9.5 2.2 3.2 0.0 0.3 1.6 0.0 0.4 8.8 2.2 2.6 1.7 0.1 12.4 4.7 0.0 0.6 0.3 1.5 0.4 0.8 10.7 3.0 0.4 0.6 0.1 0.0 4.9 1.7 4.8 2.0 1.3 3.2 2.5 2.2 2.6 0.9 4.1 3.4 1.8 8.4 1.7 1.0 2.2 2.7 0.4 21.9 19.8 13.9 14.7 26.5 1.5 1.1 7.0 4.9 5.3 23.8 17.9 0.0 4.8 0.0 26.4 2.0 5.1 13.4 10.3 5.2 249.4 2.3 1.7 1.4 35.8 0.8 0.0 0.0 3.8 1.5 1.2 2.9 0.0 12.4 0.2 9.5 7.0 0.0 0.3 38.5 0.6 0.0 0.0 1.8 0.0 8.6 2.7 0.0 0.4 12.0 90.0 0.0 0.2 1.9 2.8 0.0 3.4 0.0 0.4 8.6 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276367-99291028 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 322 "liver: 250.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 212.0" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 11.2" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" NA NA 12000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 250.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 212.0 0.0 0.0 0.0 7.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ADH1B ADH2 ENSG00000196616 "Alcohol dehydrogenase 1B (class I), beta polypeptide" P00325 4 99304964-99352760 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 253.5;liver: 466.3" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 3603.2" "Cancer enriched" "Detected in many" 31 "liver cancer: 223.1" "Group enriched" "Detected in some" 5 "midbrain: 2.3;pons and medulla: 1.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "ASC diff: 394.3" "HPA047814, HPA060902" Supported Approved "Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.13e-2)" "unprognostic (9.80e-3)" "unprognostic (6.59e-2)" "unprognostic (5.56e-2)" "unprognostic (9.49e-2)" "unprognostic (5.53e-2)" "unprognostic (1.54e-3)" "unprognostic (1.04e-2)" "unprognostic (6.51e-2)" "unprognostic (2.73e-2)" "unprognostic (7.47e-3)" "unprognostic (7.79e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (4.60e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-2)" 253.5 12.3 0.2 21.8 0.0 0.4 78.7 0.2 0.4 18.3 60.0 0.4 5.7 3.5 12.8 14.4 33.5 22.3 31.9 24.2 0.3 0.0 9.2 466.3 43.8 17.5 2.3 0.1 18.0 8.7 0.8 5.3 0.9 1.6 30.7 10.1 2.3 11.2 3.9 20.5 11.9 25.4 30.8 2.4 5.9 10.9 18.0 0.2 0.2 16.1 9.7 2.0 42.3 76.0 0.6 0.2 1.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 394.3 57.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.1 0.0 0.6 0.3 0.4 1.2 0.8 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 2.3 0.1 1.6 0.2 0.0 4.3 14.0 0.4 19.8 0.0 8.9 66.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 9.2 0.0 46.7 0.0 0.0 81.0 0.3 1.1 3603.2 0.1 0.0 0.0 93.9 77.5 0.0 51.2 1.0 27.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 43.7 0.0 0.0 11.4 0.1 12.5 0.0 0.1 ADH1C ADH3 ENSG00000248144 "Alcohol dehydrogenase 1C (class I), gamma polypeptide" P00326 4 99336492-99353027 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 47.1;liver: 149.4;stomach 1: 43.1" "Cell type enhanced" "Detected in many" 15 "Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 238.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 5.2;HSkMC: 15.4" "HPA047814, HPA060902" Supported Supported "Plasma membrane,Cytosol" NA NA 9700000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (3.98e-2)" "unprognostic (9.88e-3)" "unprognostic (7.04e-2)" "unprognostic (1.90e-1)" "unprognostic (5.14e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.55e-4)" "prognostic favorable (2.99e-4)" "unprognostic (8.25e-2)" "unprognostic (8.89e-3)" "unprognostic (7.95e-2)" "unprognostic (2.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (9.37e-2)" 4.7 0.0 0.0 18.5 0.0 0.0 1.1 0.0 0.0 1.1 37.9 0.0 1.1 43.4 0.3 1.2 1.7 0.0 12.0 2.0 0.0 8.3 149.4 1.1 0.0 0.2 0.0 1.1 11.4 0.0 0.0 0.0 0.0 2.5 13.6 0.0 1.1 0.8 6.0 0.0 47.1 0.9 0.5 0.0 43.1 1.6 0.0 0.0 0.5 2.0 0.2 1.3 0.7 0.2 0.2 0.3 0.1 0.1 0.3 0.1 0.0 2.3 0.0 0.1 1.8 5.2 1.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.1 0.5 1.4 0.3 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 1.0 0.4 0.0 0.1 0.1 0.9 2.2 0.9 0.0 0.4 1.6 0.7 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.3 0.2 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.1 3.0 5.3 1.5 3.6 0.0 0.0 0.8 50.9 80.3 45.5 27.9 0.0 0.0 0.0 141.2 2.4 0.0 51.2 23.3 606.8 0.0 0.0 1.2 0.0 378.8 0.0 0.0 20.7 12.9 12.9 0.6 9.8 0.0 0.0 3.6 36.7 0.0 99.5 63.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 355.3 2.0 ADH4 ADH-2 ENSG00000198099 "Alcohol dehydrogenase 4 (class II), pi polypeptide" P08319 4 99123657-99157792 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 345.2" "Cell type enriched" "Detected in some" 34 "Hepatocytes: 802.6" "Cancer enriched" "Detected in some" 60 "liver cancer: 230.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "Hep G2: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020525 Enhanced Uncertain Nucleoplasm,Cytosol NA NA 5300000 "Nucleoplasm, Cytosol" "HPA020525: AB_1844609" "unprognostic (2.75e-1)" "unprognostic (1.69e-2)" "unprognostic (1.85e-2)" "unprognostic (5.54e-3)" "unprognostic (2.14e-2)" "unprognostic (1.33e-2)" "prognostic favorable (7.08e-6)" "unprognostic (1.49e-1)" "unprognostic (1.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.88e-1)" "unprognostic (2.34e-2)" "unprognostic (7.16e-3)" "unprognostic (2.20e-1)" "unprognostic (5.89e-3)" 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 3.6 0.0 0.1 11.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.2 345.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.1 4.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.1 0.1 0.5 1.2 0.7 2.8 0.5 0.4 0.9 0.1 0.3 0.3 0.2 0.3 0.5 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.2 0.3 0.0 0.2 0.4 0.3 0.1 0.6 0.8 22.4 0.1 1.8 0.5 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.4 1.0 0.1 0.3 0.3 0.6 0.4 0.0 0.2 0.2 1.8 0.5 0.2 0.4 0.2 0.3 2.0 0.3 0.0 0.3 0.5 0.0 0.4 0.5 0.2 0.5 0.1 0.6 0.4 0.7 0.1 0.7 0.1 2.8 0.4 0.5 0.9 0.5 0.8 0.4 0.5 0.5 0.1 1.2 0.8 0.8 1.0 0.4 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 23.3 0.5 0.0 0.0 0.0 0.0 802.6 0.0 0.0 0.0 13.5 20.9 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 ADH6 ADH-5 ENSG00000172955 "Alcohol dehydrogenase 6 (class V)" P28332 4 99202638-99219537 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 123.3" "Group enriched" "Detected in some" 10 "Hepatocytes: 299.7;Proximal tubular cells: 76.3" "Cancer enriched" "Detected in many" 18 "liver cancer: 46.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "Hep G2: 31.3" "Not detected" "Not detected" "HPA067946, HPA069081" Enhanced NA NA 480000 "HPA067946: AB_2732776, HPA069081: AB_2732127" "unprognostic (1.38e-2)" "unprognostic (1.83e-2)" "unprognostic (5.82e-2)" "unprognostic (1.49e-3)" "unprognostic (8.49e-2)" "unprognostic (1.08e-1)" "unprognostic (5.11e-3)" "unprognostic (2.40e-1)" "unprognostic (3.60e-2)" "unprognostic (1.35e-1)" "unprognostic (9.72e-3)" "unprognostic (1.67e-1)" "unprognostic (3.66e-3)" "unprognostic (1.35e-1)" "unprognostic (2.43e-1)" "unprognostic (8.74e-3)" "unprognostic (3.86e-3)" 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 6.0 0.0 0.0 7.2 0.1 0.2 0.2 1.5 5.6 0.1 0.1 0.1 10.6 123.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.4 0.0 0.1 0.0 0.1 0.6 23.7 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.5 0.0 1.3 0.1 0.2 0.2 0.3 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 31.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 6.6 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.3 0.1 0.2 1.3 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 1.4 0.0 0.5 0.0 0.3 15.3 18.7 1.2 5.2 0.0 0.0 6.6 0.0 0.0 0.0 12.6 0.0 0.2 0.0 0.0 0.0 0.0 299.7 0.0 0.0 11.6 5.5 2.7 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 2.6 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.9 0.1 ADH7 ADH-4 ENSG00000196344 "Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide" P40394 4 99412261-99435737 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7" "Group enriched" "Detected in some" 15 "Ciliated cells: 8.1;Club cells: 10.3" "Group enriched" "Detected in some" 17 "cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC TERT1: 4.0;HaCaT: 4.5" "Not detected" "Not detected" HPA039695 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039695: AB_10795681" "unprognostic (1.02e-2)" "unprognostic (8.64e-2)" "unprognostic (4.86e-2)" "unprognostic (5.66e-3)" "unprognostic (4.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 68.7 30.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 8.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 ADHFE1 "ADHFe1, FLJ32430" ENSG00000147576 "Alcohol dehydrogenase, iron containing 1" Q8IWW8 8 66430185-66471601 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.5" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023062 Enhanced Approved Vesicles NA NA Vesicles "HPA023062: AB_1844611" "prognostic favorable (5.76e-5)" "unprognostic (8.69e-2)" "unprognostic (6.71e-2)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.90e-5)" "unprognostic (7.76e-3)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (9.43e-2)" "prognostic favorable (4.55e-5)" "unprognostic (1.37e-2)" "unprognostic (2.06e-1)" "unprognostic (4.66e-2)" "unprognostic (5.94e-3)" 12.5 3.2 10.3 2.2 9.7 1.8 4.3 2.2 10.7 5.9 3.8 10.9 4.8 2.7 4.2 8.6 3.1 5.9 5.0 34.6 6.9 5.4 11.8 44.5 3.6 2.3 8.6 7.5 5.2 8.3 11.6 9.8 3.7 6.9 7.3 3.1 10.7 6.6 10.5 35.7 2.4 2.4 6.9 4.8 2.8 8.6 3.2 7.3 0.0 4.5 12.9 2.5 6.2 1.9 1.3 0.4 3.4 1.1 2.2 2.6 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.5 0.4 0.3 0.0 0.0 1.7 0.0 0.0 0.7 0.3 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 3.0 0.0 0.2 2.7 0.0 0.0 1.3 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.9 0.0 0.5 1.2 1.4 2.0 0.0 0.0 0.3 0.2 0.0 0.0 1.2 0.1 0.1 0.8 0.0 0.3 3.4 1.1 0.0 2.6 0.0 2.4 1.3 0.5 2.2 0.4 0.8 0.7 2.2 0.1 2.2 0.0 0.3 0.0 0.6 10.3 9.7 2.2 7.8 6.9 5.4 8.6 7.5 6.9 7.3 8.9 12.4 2.7 3.8 0.9 1.4 32.1 15.3 20.1 13.6 8.7 9.8 7.1 10.0 1.1 0.3 1.6 2.0 0.0 0.6 0.8 2.7 4.3 8.1 23.7 2.1 0.0 3.5 7.4 1.0 1.0 22.2 1.4 0.0 0.0 1.5 6.7 0.8 5.8 25.5 10.9 7.6 0.0 3.3 0.2 0.2 0.9 97.4 8.7 1.8 2.0 ADI1 "APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL" ENSG00000182551 "Acireductone dioxygenase 1" Q9BV57 2 3497361-3519736 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 127.7" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035403, HPA035404" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA035403: AB_10603576, HPA035404: AB_2674611" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (2.60e-2)" "unprognostic (1.75e-1)" "unprognostic (3.65e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-3)" "unprognostic (4.23e-3)" "unprognostic (2.36e-3)" "unprognostic (4.00e-3)" "unprognostic (2.97e-2)" "unprognostic (1.50e-1)" "unprognostic (1.90e-2)" "unprognostic (1.56e-1)" "unprognostic (9.94e-2)" "unprognostic (6.76e-2)" "unprognostic (8.74e-2)" 13.5 19.1 10.8 9.0 11.5 6.4 15.1 5.2 9.2 12.5 60.6 9.3 29.9 27.3 11.7 17.8 16.3 11.4 35.5 49.5 9.0 7.9 42.6 127.7 10.8 12.4 11.3 9.4 12.8 14.7 9.2 8.4 18.7 9.6 24.5 11.8 10.7 22.7 27.0 43.1 7.9 38.9 17.3 11.7 16.6 18.3 8.0 7.9 4.9 12.9 18.9 10.4 14.7 17.9 14.2 37.8 64.7 26.5 10.1 17.7 32.2 12.0 14.7 13.3 10.6 46.7 22.8 24.9 25.2 32.6 27.4 19.9 20.9 13.8 5.7 39.9 26.7 4.6 11.0 15.7 11.8 14.1 10.2 35.1 17.6 9.5 33.8 39.1 18.2 39.5 25.2 15.7 12.8 16.0 9.7 17.2 8.4 13.1 10.0 21.5 27.1 6.1 32.1 11.6 27.4 23.0 6.5 8.5 32.4 19.0 18.0 14.9 15.0 13.9 14.7 9.6 8.2 15.6 19.3 14.3 18.9 7.7 9.2 14.1 9.9 23.9 23.4 13.9 28.3 9.9 14.2 26.5 64.7 6.3 25.2 6.8 14.2 14.9 5.9 25.6 11.2 17.7 5.9 12.3 10.1 22.0 37.8 13.8 32.2 10.8 11.5 5.2 9.2 9.0 7.9 11.3 9.4 9.6 7.9 62.5 87.9 109.0 118.8 67.5 8.0 255.0 285.3 33.5 56.9 144.8 13.7 343.4 752.7 121.5 6.7 56.4 182.2 46.7 76.6 194.2 104.6 159.8 40.5 1079.9 211.6 7.9 54.8 164.5 143.1 16.8 126.8 60.1 194.0 117.2 123.2 123.6 76.7 181.4 197.7 1041.1 13.1 161.7 119.7 4.6 8.9 67.1 319.0 55.1 135.6 117.6 ADIG "MGC39724, RP5-1100H13.2, SMAF1" ENSG00000182035 Adipogenin Q0VDE8 20 38581195-38588463 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 31.4" "Group enriched" "Detected in some" 126 "Early spermatids: 391.1;Late spermatids: 1240.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;Hep G2: 1.2;NB-4: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA041124 Uncertain NA NA "HPA041124: AB_10795534" "unprognostic (2.97e-2)" "unprognostic (7.69e-3)" "unprognostic (2.27e-1)" "unprognostic (4.52e-3)" "unprognostic (1.34e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.4 0.1 0.1 3.2 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 391.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1240.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 6.5 0.0 5.6 2.7 0.0 0.0 0.0 0.0 0.0 ADIPOQ "ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28" ENSG00000181092 "Adiponectin, C1Q and collagen domain containing" Q15848 3 186842690-186858463 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hormone "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 176.7;breast: 79.4" "Cell type enriched" "Detected in single" 12 "Distal tubular cells: 1.7" "Group enriched" "Detected in some" 8 "breast cancer: 6.5;pancreatic cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 670 "ASC diff: 86.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB046467, HPA051767" Uncertain "Secreted to blood" NA NA 8360000000 1000000000 "CAB046467: AB_1078104, HPA051767: AB_2681598" "unprognostic (1.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.20e-2)" "unprognostic (6.99e-3)" "unprognostic (1.87e-1)" 176.7 1.9 0.0 16.7 0.0 0.1 79.4 0.0 0.1 0.1 23.2 0.0 0.4 0.1 0.1 1.3 0.3 0.1 13.2 5.8 0.0 0.0 0.5 0.1 0.1 6.1 0.0 0.0 0.2 1.3 0.1 0.0 0.1 0.0 0.4 1.4 0.0 14.7 0.6 2.0 1.5 2.1 0.4 0.0 0.1 0.6 0.1 0.0 0.0 0.7 9.5 0.3 1.0 0.9 0.8 0.6 2.4 0.4 0.7 0.5 0.1 0.0 0.0 0.0 0.0 86.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.6 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.8 0.3 0.5 1.9 0.7 0.4 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADK AK ENSG00000156110 "Adenosine kinase" P55263 10 74151185-74709303 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Purine salvage" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 71.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032876, HPA038391, HPA038409, HPA075222" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 320000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032876: AB_2242229, HPA038391: AB_2675990, HPA038409: AB_10675798, HPA075222: " "unprognostic (1.55e-3)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.62e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.93e-4)" "prognostic favorable (9.91e-4)" "unprognostic (2.64e-1)" "unprognostic (2.88e-1)" "unprognostic (1.55e-1)" "unprognostic (8.15e-3)" "unprognostic (2.51e-1)" "unprognostic (1.89e-3)" "unprognostic (2.03e-1)" "unprognostic (2.88e-2)" "unprognostic (4.97e-3)" "unprognostic (2.95e-2)" 13.8 10.7 11.8 13.6 25.4 12.1 14.5 11.2 11.8 9.5 9.3 9.0 9.6 8.8 6.6 10.6 29.4 8.9 6.3 15.7 9.8 11.1 19.0 71.9 15.1 17.9 12.3 9.3 5.2 12.6 15.1 23.5 43.2 11.6 8.7 10.8 8.5 13.1 11.4 18.1 20.8 6.4 8.3 13.2 11.3 7.4 11.9 10.3 13.4 20.8 24.1 21.9 12.6 14.7 49.3 23.0 5.4 21.6 6.5 15.7 9.8 38.1 8.6 9.1 12.2 9.2 14.2 21.0 33.2 26.3 25.7 28.9 24.1 39.8 20.0 8.3 13.3 12.1 34.9 10.7 35.3 41.2 13.4 12.3 12.7 14.1 25.9 10.5 20.3 5.2 13.0 23.3 18.7 46.6 19.0 22.3 9.3 10.1 6.5 19.3 21.3 23.9 27.5 2.6 17.8 60.9 23.1 15.8 17.2 28.1 21.0 7.2 8.5 14.6 56.7 11.0 8.5 37.7 15.4 19.1 8.5 15.7 22.7 27.3 9.4 10.6 22.6 16.1 29.3 5.2 1.3 10.1 1.4 4.5 18.0 10.0 29.7 9.5 8.2 23.0 49.3 7.9 6.5 5.4 6.5 21.6 16.7 15.7 9.8 11.8 25.4 11.2 11.8 9.8 11.1 12.3 9.3 11.6 10.3 77.4 57.2 37.1 62.9 83.7 14.5 53.3 35.7 34.8 76.2 29.6 53.0 120.6 77.9 60.0 55.9 14.7 5.9 0.0 58.9 113.1 27.2 33.9 19.8 112.8 36.3 11.1 10.4 14.7 21.4 22.9 15.5 40.6 45.5 31.5 11.5 10.0 45.7 14.0 11.3 48.3 27.9 6.5 32.8 13.3 12.2 84.8 89.7 20.3 19.9 57.0 ADM AM ENSG00000148926 Adrenomedullin P35318 11 10304680-10307397 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 133.1" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 624.9;Extravillous trophoblasts: 468.6;Syncytiotrophoblasts: 907.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 19 "neutrophil: 62.3" "Lineage enriched" "Detected in many" 19 "granulocytes: 62.3" "Cell line enhanced" "Detected in many" "ASC diff: 110.1;fHDF/TERT166: 55.0;HSkMC: 67.3;U-138 MG: 58.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016075, HPA068955" Approved "Secreted to blood" NA NA 31000 46000 "CAB016075: AB_628693, HPA068955: " "unprognostic (1.67e-1)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (1.55e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.78e-3)" "unprognostic (1.06e-1)" "unprognostic (2.83e-1)" "unprognostic (8.13e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.33e-4)" "unprognostic (9.70e-3)" "unprognostic (2.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.62e-2)" 65.2 18.3 6.8 18.3 12.4 21.1 52.1 2.5 15.0 28.3 23.3 5.9 1.6 4.8 11.6 8.0 26.5 7.9 18.7 28.3 4.7 3.5 17.3 26.1 34.3 15.2 8.0 2.0 19.0 16.0 10.8 8.4 133.1 14.2 13.8 7.0 23.5 9.6 2.1 92.3 28.7 8.0 11.8 12.7 14.6 10.7 11.6 9.9 0.3 15.9 13.3 10.1 76.1 32.4 0.1 0.6 62.3 3.2 0.0 0.0 0.4 5.4 4.3 5.2 1.4 110.1 47.3 8.2 41.6 39.0 39.4 27.2 21.9 6.7 0.0 1.9 55.0 22.5 7.8 1.5 6.4 33.1 0.1 1.7 0.1 2.1 2.6 14.0 0.2 0.1 67.3 5.2 4.5 7.2 14.6 8.9 0.0 0.0 0.0 9.8 0.1 0.0 1.2 9.8 1.2 1.7 0.1 0.1 7.7 2.4 7.4 0.1 0.4 15.8 3.4 0.0 5.9 4.8 0.0 2.5 58.0 0.8 36.2 6.0 0.4 4.4 1.5 17.3 0.0 17.2 0.0 1.7 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 62.3 0.0 3.2 0.0 0.0 0.4 6.8 12.4 2.5 15.0 4.7 3.5 8.0 2.0 14.2 9.9 8.9 20.1 28.2 624.9 170.6 2.1 75.8 28.1 13.4 39.8 3.5 7.9 112.5 13.3 103.4 0.5 81.7 87.8 0.0 27.4 468.6 90.7 189.9 9.2 14.1 64.4 3.2 64.8 117.9 65.7 0.5 122.8 65.2 38.8 8.2 96.0 4.3 56.7 31.5 18.0 50.7 14.1 0.0 70.6 5.1 1.9 109.8 907.2 6.9 24.6 220.0 ADM2 "AM2, FLJ21135" ENSG00000128165 "Adrenomedullin 2" Q7Z4H4 22 50481556-50486440 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 30.2;salivary gland: 32.2" "Cell type enhanced" "Detected in some" 13 "Exocrine glandular cells: 8.8;Pancreatic endocrine cells: 8.9;Proximal tubular cells: 19.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 22.1;hTCEpi: 13.8;Karpas-707: 22.0;SK-MEL-30: 14.5;U-266/70: 16.1" "Not detected" "Not detected" "Secreted to blood" NA NA 61300 "unprognostic (1.30e-2)" "unprognostic (4.96e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-1)" "unprognostic (2.67e-1)" "unprognostic (3.15e-1)" "unprognostic (4.62e-3)" "unprognostic (7.26e-3)" "unprognostic (1.50e-1)" "unprognostic (3.44e-1)" "unprognostic (7.20e-2)" "unprognostic (9.41e-2)" "unprognostic (7.30e-3)" "unprognostic (1.17e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (1.06e-2)" 0.5 0.5 0.4 2.9 0.4 0.1 0.7 0.4 0.4 0.8 1.2 0.0 1.3 3.7 0.5 2.9 2.2 0.6 5.6 0.4 0.4 0.4 11.4 6.6 0.8 4.1 0.4 0.0 0.4 30.2 0.0 0.6 0.7 0.2 2.6 0.4 0.1 32.2 2.2 0.4 0.5 5.2 0.0 0.5 2.0 4.3 0.6 0.0 1.6 11.7 1.7 4.0 0.5 0.6 0.9 0.5 2.0 0.5 0.4 1.4 0.2 1.0 0.2 0.3 1.1 0.7 1.3 4.1 5.2 0.5 0.7 1.7 2.1 0.9 0.0 0.8 4.4 0.9 0.8 1.1 0.7 0.2 9.9 0.0 0.0 0.2 1.5 22.1 2.1 1.4 4.4 13.8 2.4 5.0 0.0 0.0 5.8 1.3 22.0 0.1 3.2 0.2 0.4 0.7 6.0 3.3 0.0 0.0 8.2 1.0 0.1 0.5 2.4 0.0 3.2 14.5 0.7 4.4 6.9 0.0 0.0 4.9 0.0 0.0 16.1 2.2 2.8 0.4 0.0 1.2 0.7 0.5 0.4 0.6 0.2 0.3 0.6 0.5 0.6 0.0 0.9 1.4 1.1 2.0 0.4 0.5 0.5 0.3 0.2 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.2 0.0 0.0 4.0 2.4 0.6 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.0 3.3 2.7 0.0 0.0 3.2 0.0 8.8 0.6 0.4 2.7 0.0 1.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.7 1.0 5.2 0.0 8.9 0.3 0.0 19.2 0.0 0.0 0.0 0.2 0.7 0.4 0.8 0.7 1.2 0.7 ADORA1 RDC7 ENSG00000163485 "Adenosine A1 receptor" P30542 1 203090654-203167405 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.7" "Group enriched" "Detected in some" 4 "granulocytes: 23.0;Muller glia cells: 40.0" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.7;MCF7: 11.9;RH-30: 32.7;RPTEC TERT1: 15.9;SK-BR-3: 17.7;U-138 MG: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044383 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044383: AB_2678921" "unprognostic (3.93e-3)" "unprognostic (8.16e-2)" "unprognostic (6.16e-2)" "unprognostic (2.38e-3)" "unprognostic (2.25e-2)" "unprognostic (2.34e-1)" "unprognostic (4.64e-2)" "unprognostic (4.17e-2)" "unprognostic (3.04e-1)" "unprognostic (4.80e-3)" "unprognostic (1.42e-1)" "unprognostic (2.98e-1)" "unprognostic (2.96e-3)" "unprognostic (1.54e-1)" "unprognostic (1.27e-1)" "unprognostic (4.13e-2)" "unprognostic (5.76e-4)" 4.5 1.0 19.7 2.6 21.7 0.8 6.1 9.7 38.7 1.1 1.6 27.4 0.0 2.0 2.0 1.6 1.6 2.0 1.8 13.8 19.8 12.1 4.2 1.0 2.8 1.4 22.8 13.4 0.8 15.5 15.5 0.9 8.9 25.0 1.2 1.6 1.8 8.9 1.3 2.0 1.9 1.8 1.3 20.7 7.4 1.6 16.3 15.9 0.0 3.2 0.0 1.4 3.4 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.3 0.1 0.1 0.8 0.1 1.0 1.5 0.4 0.2 19.7 0.3 0.0 4.5 3.6 2.4 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 3.2 0.0 3.2 0.0 0.0 3.1 11.9 0.0 0.0 5.1 0.0 0.0 0.0 32.7 1.0 15.9 0.0 0.3 0.4 2.1 17.7 0.2 1.9 1.0 0.4 0.0 10.6 5.4 0.0 5.7 0.0 0.1 0.0 5.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 19.7 21.7 9.7 25.7 19.8 12.1 22.8 13.4 25.0 15.9 0.0 0.0 0.0 0.0 0.0 0.5 2.5 5.1 0.0 0.0 3.5 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 3.0 1.0 0.7 0.0 23.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.4 1.7 0.0 0.0 40.0 0.5 0.0 0.7 1.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ADORA2A "ADORA2, RDC8" ENSG00000128271 "Adenosine A2a receptor" P29274 22 24417879-24442360 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0" "Cell type enriched" "Detected in single" 25 "monocytes: 19.0" "Not detected" "Not detected" "Region enriched" "Detected in all" 8 "basal ganglia: 43.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 15.4;Karpas-707: 21.2;RPMI-8226: 15.0;SK-BR-3: 30.4;U-266/70: 21.2;U-266/84: 27.7;U-698: 21.7" "Region enriched" "Detected in some" 10 "basal ganglia: 357.5" "Region enriched" "Detected in single" 92 "basal ganglia: 166.0" "CAB001943, HPA065566, HPA075997" Enhanced Supported NA NA "CAB001943: , HPA065566: , HPA075997: AB_2732298" "unprognostic (7.30e-2)" "unprognostic (2.42e-2)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (1.88e-3)" "unprognostic (9.85e-2)" "unprognostic (3.63e-1)" "unprognostic (2.88e-2)" "unprognostic (4.57e-3)" "unprognostic (2.15e-3)" "unprognostic (1.87e-3)" "unprognostic (6.81e-4)" "unprognostic (1.50e-1)" "unprognostic (9.78e-3)" "unprognostic (1.30e-1)" "unprognostic (7.10e-3)" 1.0 2.4 1.9 10.4 43.9 28.1 1.5 3.4 3.8 0.8 2.0 1.7 0.3 5.4 1.4 1.4 1.0 0.9 2.4 3.5 2.4 1.8 3.5 4.3 5.1 14.8 2.6 1.6 1.2 0.8 0.0 2.1 1.4 2.3 1.6 0.8 3.3 2.7 1.5 1.2 0.9 2.6 0.7 1.3 7.5 2.8 2.0 5.7 59.0 1.3 0.9 8.6 3.8 1.3 17.7 1.1 13.7 9.0 2.2 22.8 11.2 0.2 0.3 0.4 0.1 0.2 0.1 0.4 0.2 9.5 0.5 1.0 1.7 0.1 15.4 1.0 0.3 1.0 0.3 0.9 0.0 0.0 1.8 2.7 0.2 0.0 2.2 0.2 0.3 7.7 0.1 0.0 2.9 0.0 0.2 3.4 2.2 0.1 21.2 0.0 0.2 5.3 1.6 0.6 2.0 0.0 0.2 0.7 15.0 0.0 0.1 1.5 8.9 0.4 30.4 0.1 0.4 0.4 1.5 0.2 0.9 1.5 0.2 0.1 21.2 27.7 21.7 4.8 5.2 0.1 3.0 0.8 4.8 8.6 2.6 20.1 9.6 16.1 16.9 1.1 17.7 22.8 18.3 13.7 2.2 9.0 1.1 21.4 11.2 1.9 43.9 3.4 3.8 2.4 1.8 2.6 1.6 2.3 5.7 0.0 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADORA3 AD026 ENSG00000282608 "Adenosine A3 receptor" P0DMS8 1 111499429-111503760 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 88.6;brain: 25.5" "Cell type enhanced" "Detected in some" 26 "Hofbauer cells: 17.7;Kupffer cells: 53.6;Late spermatids: 12.4" "Cell type enriched" "Detected in some" 40 "eosinophil: 88.6" "Lineage enriched" "Detected in many" 40 "granulocytes: 88.6" "Cell line enriched" "Detected in some" 9 "HMC-1: 48.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 5.2 13.4 8.7 3.1 12.0 0.0 4.5 1.0 6.7 3.7 5.2 10.3 0.0 3.5 0.5 1.0 1.8 2.8 4.8 1.6 7.5 1.9 2.1 2.8 3.8 17.7 2.2 1.2 1.0 0.9 1.2 2.0 12.1 1.0 4.2 2.7 1.1 1.9 0.5 0.0 7.9 3.8 25.5 1.5 2.2 1.1 13.3 0.4 0.5 0.0 1.9 3.4 0.0 0.0 2.2 88.6 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 88.6 0.0 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.9 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 6.9 0.0 17.7 0.0 0.0 2.5 53.6 12.4 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 ADPRHL1 ARH2 ENSG00000153531 "ADP-ribosylhydrolase like 1" Q8NDY3 13 113399610-113453524 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 89.6;skeletal muscle: 68.1" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 122.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.7;T-47d: 26.4" "Region enhanced" "Detected in single" "cerebellum: 2.6" "Not detected" "Not detected" "HPA066478, HPA072123" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA066478: AB_2685673, HPA072123: " "unprognostic (3.03e-1)" "unprognostic (1.38e-2)" "unprognostic (2.31e-1)" "unprognostic (8.88e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.35e-1)" "unprognostic (2.56e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-2)" "unprognostic (1.53e-2)" "unprognostic (4.99e-3)" "unprognostic (1.02e-1)" 1.8 1.0 0.6 0.2 1.1 0.0 0.8 0.5 3.0 0.4 1.4 0.3 0.0 0.9 0.4 4.0 2.2 1.9 0.7 89.6 0.5 0.8 0.2 0.4 0.5 0.1 0.7 1.1 0.5 1.5 0.0 1.8 1.4 0.3 0.9 0.5 0.0 1.9 0.1 68.1 0.9 3.0 0.2 0.5 0.3 1.0 1.3 0.0 0.1 0.7 21.8 0.6 0.3 0.5 1.9 2.8 1.7 1.6 1.1 2.5 1.0 4.0 9.6 1.0 3.0 3.1 5.0 2.7 1.5 0.7 0.5 0.4 2.7 9.9 1.4 5.7 1.7 2.8 2.2 3.8 0.2 0.4 1.4 1.6 4.1 2.3 0.7 1.0 0.3 1.7 1.7 2.3 3.2 0.4 0.4 0.1 3.6 1.2 0.4 4.0 8.7 0.6 2.4 2.2 10.4 5.1 6.3 2.5 3.6 1.0 0.4 14.7 3.4 1.0 4.8 1.2 1.2 26.4 0.5 0.3 0.1 1.8 4.4 0.5 1.4 1.1 4.7 2.9 0.8 2.1 0.4 1.2 0.1 0.1 1.6 1.8 1.9 0.8 2.5 2.8 0.8 1.4 1.5 1.7 1.1 1.3 0.5 1.3 1.0 0.6 1.1 0.5 3.0 0.5 0.8 0.7 1.1 0.3 0.0 0.0 5.8 0.0 1.9 1.1 1.3 122.4 0.0 8.1 4.5 0.0 0.0 3.2 0.0 2.8 1.1 1.6 3.8 0.0 2.9 2.2 1.5 2.3 0.0 1.0 0.5 1.6 4.1 1.3 0.3 1.3 0.0 0.5 1.7 0.0 5.1 2.1 1.4 5.8 1.4 0.3 1.7 0.0 0.5 1.8 2.6 2.3 2.1 0.0 3.2 2.8 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 15 "Early spermatids: 50.8;Hepatocytes: 14.0;Late spermatids: 20.6" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 1.3;HAP1: 1.7;JURKAT: 2.0;NTERA-2: 2.3;U-2 OS: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679, HPA076693" Approved Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.3 0.0 20.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ADRA1B ENSG00000170214 "Adrenoceptor alpha 1B" P35368 5 159865080-159972544 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;liver: 20.3;lymphoid tissue: 17.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;HaCaT: 6.7;TIME: 11.1;U-2 OS: 9.3;U-251 MG: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074416 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074416: AB_2686688" "unprognostic (4.93e-3)" "unprognostic (2.94e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.00e-5)" "prognostic unfavorable (6.98e-4)" "unprognostic (4.08e-3)" "unprognostic (1.67e-3)" "unprognostic (1.68e-1)" "unprognostic (6.12e-2)" "prognostic favorable (2.67e-4)" "unprognostic (2.28e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.40e-6)" "unprognostic (5.24e-4)" "unprognostic (2.54e-1)" "prognostic favorable (3.19e-5)" "unprognostic (1.59e-2)" 5.3 2.9 5.3 0.9 9.0 0.4 2.3 1.3 21.6 0.9 1.2 0.7 0.8 1.2 1.5 3.6 1.1 3.6 1.3 3.3 6.2 5.8 7.4 20.3 4.7 2.3 1.2 13.9 6.2 0.8 1.0 0.8 1.1 5.2 1.6 1.1 0.9 1.0 1.9 1.6 1.3 1.7 1.2 0.9 17.4 0.9 0.8 0.5 0.0 2.0 0.0 1.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.3 0.0 2.4 0.9 0.1 0.5 0.2 0.6 0.3 0.0 4.3 0.0 13.2 3.9 5.2 6.7 0.0 0.6 0.3 0.0 0.3 0.0 1.7 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.7 0.0 4.5 0.0 0.4 0.0 0.0 0.3 0.4 2.3 0.1 0.0 11.1 0.1 9.3 0.0 7.1 0.0 0.0 0.0 3.4 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 9.0 1.3 21.6 6.2 5.8 1.2 13.9 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADRA1D "ADRA1, ADRA1A, ADRA1R" ENSG00000171873 "Adrenoceptor alpha 1D" P25100 20 4220631-4249074 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7" "Cell type enhanced" "Detected in single" 18 "Smooth muscle cells: 1.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.4;hippocampal formation: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;BJ: 12.0;CAPAN-2: 5.4;fHDF/TERT166: 7.1" "Group enriched" "Detected in many" 4 "cerebral cortex: 23.5;hippocampal formation: 31.8;olfactory region: 11.0" "Low region specificity" "Detected in many" HPA038789 Uncertain NA NA "HPA038789: AB_10673475" "unprognostic (5.37e-2)" "unprognostic (4.65e-1)" "unprognostic (8.73e-2)" "unprognostic (7.75e-11)" "unprognostic (7.83e-3)" "unprognostic (1.54e-2)" "unprognostic (7.62e-2)" "unprognostic (7.82e-4)" "unprognostic (4.41e-3)" "unprognostic (8.37e-2)" "unprognostic (6.09e-2)" "unprognostic (7.24e-3)" "unprognostic (7.71e-7)" "unprognostic (5.21e-3)" "unprognostic (2.76e-1)" "unprognostic (6.01e-3)" "unprognostic (3.32e-5)" 2.5 1.1 1.9 0.5 2.8 0.3 1.0 0.1 7.4 9.1 2.4 1.4 1.1 0.6 4.7 1.8 0.9 3.5 1.2 0.4 17.7 1.7 0.5 0.4 2.9 1.5 0.5 1.1 1.0 1.2 0.4 0.0 0.7 2.9 8.8 1.0 0.0 0.8 6.0 1.2 0.4 0.8 1.6 0.5 3.6 2.5 1.5 0.0 0.0 0.9 0.0 0.4 3.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 12.0 2.1 0.8 0.3 0.5 5.4 0.0 0.0 7.1 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.1 7.4 17.7 1.7 0.5 1.1 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 ADRA2A "ADRA2, ADRA2R, ADRAR" ENSG00000150594 "Adrenoceptor alpha 2A" P08913 10 111077163-111080907 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 84.9" "Cell type enhanced" "Detected in many" 21 "Cholangiocytes: 63.7;Paneth cells: 72.4;Smooth muscle cells: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 8.2;ASC TERT1: 10.1;HEL: 14.8;HeLa: 8.0;HSkMC: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (1.63e-2)" "unprognostic (1.38e-1)" "prognostic favorable (8.06e-4)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "unprognostic (4.78e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-1)" "unprognostic (4.64e-3)" "unprognostic (5.86e-2)" "unprognostic (5.63e-2)" "unprognostic (3.08e-6)" "unprognostic (1.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-3)" 29.9 1.3 1.4 8.0 1.8 0.2 25.4 4.3 8.1 28.2 7.5 0.7 3.0 8.5 12.4 3.9 2.1 2.6 84.9 5.6 1.7 4.0 3.8 1.1 2.8 18.8 1.5 2.3 15.5 26.2 1.5 1.7 3.4 3.8 10.4 3.5 2.2 4.8 7.4 1.5 6.8 4.9 5.7 1.1 32.2 3.5 3.5 0.0 0.0 5.9 7.1 16.6 9.8 15.9 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 8.2 10.1 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 14.8 8.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 1.4 1.8 4.3 8.1 1.7 4.0 1.5 2.3 3.8 0.0 0.0 2.2 0.0 0.4 9.2 0.0 1.4 63.7 0.0 2.3 0.0 0.0 0.1 0.0 1.1 2.6 0.6 5.4 0.0 3.1 0.1 5.2 0.7 6.9 0.0 0.1 0.0 11.9 0.6 0.3 1.0 20.8 0.0 27.0 0.0 1.2 0.0 0.3 72.4 4.6 0.3 0.0 6.5 182.3 2.7 0.1 5.4 0.1 0.0 9.2 0.6 ADRA2C "ADRA2L2, ADRA2RL2, ADRARL2" ENSG00000184160 "Adrenoceptor alpha 2C" P18825 4 3766348-3768526 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.1" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 12.2;Muller glia cells: 5.2;Smooth muscle cells: 4.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 11.1;MCF7: 18.4;NTERA-2: 6.5;OE19: 7.3;SCLC-21H: 7.1;SH-SY5Y: 8.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 41.4" HPA057688 Uncertain NA NA "HPA057688: AB_2683503" "unprognostic (1.44e-2)" "unprognostic (2.21e-3)" "unprognostic (1.23e-1)" "unprognostic (2.02e-2)" "unprognostic (4.70e-2)" "unprognostic (1.11e-1)" "unprognostic (7.12e-2)" "unprognostic (6.69e-2)" "unprognostic (1.88e-1)" "unprognostic (3.71e-1)" "unprognostic (3.24e-2)" "unprognostic (9.08e-3)" "unprognostic (1.01e-2)" "unprognostic (6.00e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (6.48e-2)" 6.5 2.4 2.1 1.0 9.8 0.4 9.2 0.5 2.6 35.1 1.5 0.6 12.8 1.0 20.3 18.0 2.1 6.4 5.5 3.0 1.2 1.0 9.2 1.3 2.0 1.2 0.7 1.6 7.6 4.1 0.5 4.2 27.6 1.1 7.3 0.6 3.6 0.8 24.6 2.6 2.1 0.9 3.0 0.7 7.5 0.7 6.2 2.0 0.2 0.8 1.9 0.5 2.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.1 0.5 0.0 0.2 0.4 0.0 0.0 0.0 2.0 1.2 0.0 2.1 0.3 0.7 0.0 0.2 0.0 0.0 0.0 5.7 0.0 0.0 11.1 0.6 0.0 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.7 18.4 0.0 0.0 6.5 7.3 0.0 0.0 6.0 0.0 0.0 0.3 7.1 8.5 2.5 0.0 0.1 1.7 6.1 0.1 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 9.8 0.5 1.4 1.2 1.0 0.7 1.6 1.1 2.0 0.0 0.0 0.0 0.1 0.0 1.4 0.9 2.5 0.0 0.0 12.2 0.0 0.8 3.3 0.4 0.0 0.5 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.3 3.2 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.2 0.2 0.0 3.5 1.8 0.0 0.0 4.1 0.0 0.7 0.0 1.4 0.0 0.0 0.1 ADRB1 ADRB1R ENSG00000043591 "Adrenoceptor beta 1" P08588 10 114044056-114046908 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.0;placenta: 41.7" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 80.0;Cytotrophoblasts: 56.3;Sertoli cells: 51.8;Syncytiotrophoblasts: 32.2" "Cancer enriched" "Detected in many" 10 "prostate cancer: 12.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;PC-3: 4.0;THP-1: 6.9;TIME: 8.9;U-937: 5.2" "Group enriched" "Detected in many" 4 "amygdala: 10.0;basal ganglia: 7.3;cerebral cortex: 17.1;hippocampal formation: 11.3;thalamus: 6.9" "Low region specificity" "Detected in many" HPA067972 Enhanced NA NA "HPA067972: AB_2685936" "unprognostic (1.45e-3)" "unprognostic (1.18e-3)" "unprognostic (1.44e-1)" "unprognostic (4.92e-2)" "unprognostic (3.22e-1)" "unprognostic (8.88e-2)" "unprognostic (9.28e-2)" "unprognostic (3.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-2)" "unprognostic (2.77e-4)" "unprognostic (1.33e-1)" "unprognostic (7.80e-3)" "unprognostic (1.53e-1)" "unprognostic (1.85e-1)" "unprognostic (1.59e-2)" "unprognostic (1.44e-1)" 4.3 1.0 6.9 1.1 14.0 1.3 5.9 1.0 10.7 0.8 3.1 0.8 0.0 1.8 0.9 0.9 1.9 0.8 0.9 48.0 5.6 2.4 1.7 2.5 18.3 0.9 3.5 4.4 0.8 2.4 0.9 1.2 41.7 2.6 6.5 1.6 4.5 10.7 0.8 3.1 0.9 2.3 0.9 1.3 1.7 1.4 1.0 2.5 0.0 1.0 0.0 1.1 1.1 0.4 1.4 1.9 0.1 1.3 0.0 0.5 0.1 2.1 1.3 0.2 1.3 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.5 1.6 0.3 0.4 0.0 0.6 0.4 0.1 0.1 0.3 10.2 0.6 0.4 0.2 0.2 0.0 0.4 0.7 0.0 1.1 0.0 2.1 0.2 0.3 1.6 0.1 0.1 0.2 1.2 1.6 1.4 0.5 0.3 4.0 0.3 0.4 0.1 0.0 1.7 0.2 0.4 0.0 0.8 0.1 0.5 0.3 6.9 8.9 0.3 0.1 0.2 0.2 0.0 0.1 0.5 0.0 5.2 0.2 0.0 1.3 0.0 0.5 0.9 0.0 0.6 0.1 0.3 1.9 1.4 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.1 6.9 14.0 1.0 10.7 5.6 2.4 3.5 4.4 2.6 2.5 17.9 8.5 0.0 4.2 0.9 4.7 80.0 5.1 12.0 13.6 0.0 0.0 56.3 1.7 0.0 0.1 0.7 0.0 0.0 0.2 2.1 3.7 7.1 0.0 0.2 3.9 12.7 0.0 0.6 2.4 0.0 0.0 0.6 1.7 0.0 3.1 0.7 0.1 0.3 0.4 0.0 1.2 51.8 0.8 0.5 0.0 0.0 32.2 1.5 0.4 3.1 ADRB2 "ADRB2R, ADRBR, B2AR, BAR" ENSG00000169252 "Adrenoceptor beta 2" P07550 5 148825245-148828687 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 104.2;Basal keratinocytes: 344.2;granulocytes: 116.5;Suprabasal keratinocytes: 214.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 24.5;hTERT-HME1: 25.4;PC-3: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003431, HPA075322" Uncertain Uncertain Cytosol NA NA Cytosol "HPA003431: AB_1845333, HPA075322: " "unprognostic (2.28e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (9.35e-3)" "unprognostic (5.54e-2)" "unprognostic (2.34e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (3.15e-9)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" "unprognostic (7.65e-2)" 11.7 0.2 0.7 0.9 0.4 4.6 13.8 0.0 0.3 6.1 0.9 0.3 0.9 0.2 6.4 1.4 1.1 2.8 0.7 0.3 0.2 6.0 8.5 1.1 0.9 0.0 0.0 0.5 0.0 4.0 3.8 0.7 3.3 0.1 4.4 15.9 1.3 1.2 1.0 3.7 2.9 0.0 0.5 2.0 2.3 5.4 4.8 6.1 14.0 10.8 7.3 34.6 9.6 7.6 0.0 0.0 0.0 0.3 0.0 0.0 1.5 4.4 2.0 2.3 0.0 3.3 0.0 2.1 0.4 7.4 6.8 0.0 9.2 2.3 0.0 0.2 0.0 1.6 0.0 0.2 0.0 3.8 0.0 24.5 0.6 25.4 1.7 0.9 0.0 0.0 2.9 5.3 0.0 0.0 4.2 0.1 0.0 10.5 2.2 1.4 4.3 1.1 1.9 0.0 0.0 1.8 0.2 0.6 0.9 0.0 2.3 4.1 0.0 1.8 2.5 1.1 0.7 0.0 0.1 0.0 5.0 0.8 3.5 4.7 14.0 34.6 7.8 25.7 4.8 8.2 20.9 5.3 3.0 1.4 12.9 7.6 7.3 10.8 6.1 0.4 9.6 104.2 33.5 11.1 31.2 344.2 0.2 12.4 0.0 8.1 33.0 0.0 0.0 0.3 0.0 1.4 0.2 17.5 0.0 0.0 0.2 0.2 6.1 16.2 116.5 11.9 14.7 0.0 2.9 6.7 12.7 0.4 0.0 16.5 28.7 1.0 1.4 3.5 5.3 0.0 0.0 0.0 4.8 0.0 3.6 0.0 0.0 214.5 0.5 35.5 0.8 48.5 ADRB3 ENSG00000188778 "Adrenoceptor beta 3" P13945 8 37962991-37966965 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 23.9;ovary: 15.7;smooth muscle: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "amygdala: 1.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 2.4;Karpas-707: 1.0;U-2 OS: 1.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA061969 Uncertain NA NA "HPA061969: AB_2732674" "unprognostic (1.70e-1)" "unprognostic (2.24e-1)" "unprognostic (6.64e-3)" "unprognostic (5.41e-1)" "unprognostic (1.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-2)" "unprognostic (2.29e-8)" "unprognostic (1.10e-3)" "unprognostic (2.81e-2)" "unprognostic (5.37e-2)" "unprognostic (6.06e-3)" 0.4 0.1 1.3 1.9 0.3 0.3 0.3 0.0 0.8 1.6 2.3 0.0 0.0 0.4 0.9 1.9 1.7 5.3 23.9 0.1 0.2 0.1 0.1 0.0 0.2 1.2 0.0 0.0 15.7 0.0 0.0 0.0 4.7 0.0 4.1 0.4 0.0 0.0 0.1 0.0 0.1 0.9 10.8 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.1 9.9 1.5 0.9 0.2 1.2 0.4 0.8 0.5 0.0 0.2 0.2 0.1 0.1 0.3 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 2.4 0.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.1 0.4 0.4 0.4 1.3 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.0 1.0 0.3 0.3 0.1 0.1 0.4 0.7 0.2 0.1 0.0 0.9 0.2 0.2 1.2 0.8 0.4 0.2 0.5 0.0 1.3 0.3 0.0 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ADSL ENSG00000239900 "Adenylosuccinate lyase" P30566 22 40346500-40390463 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Lyase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000525, CAB019285" Enhanced Enhanced Cytosol NA NA 180000 Cytosol "CAB019285: , HPA000525: AB_1078106" "unprognostic (2.80e-1)" "unprognostic (2.12e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.64e-1)" "unprognostic (1.02e-1)" "unprognostic (6.87e-3)" "prognostic unfavorable (5.81e-8)" "unprognostic (1.35e-1)" "unprognostic (1.25e-1)" "unprognostic (3.99e-1)" "unprognostic (6.28e-2)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (8.43e-2)" "unprognostic (2.70e-1)" "unprognostic (4.06e-1)" "unprognostic (1.44e-2)" 9.3 11.6 5.0 13.7 8.5 11.2 9.0 6.8 10.1 7.9 9.5 7.3 4.4 6.0 10.8 9.4 9.7 9.0 6.9 14.6 4.5 4.7 12.0 17.3 6.8 17.6 4.9 4.9 10.5 21.8 5.4 9.1 9.5 5.1 7.1 9.7 9.2 14.7 6.4 79.0 6.2 9.4 10.7 4.9 14.5 9.6 10.9 4.4 18.8 8.4 23.6 15.5 9.5 7.4 15.3 28.8 11.0 22.7 19.8 34.0 24.6 21.4 25.3 21.8 31.1 14.7 20.8 25.3 19.6 19.4 42.6 32.5 41.8 12.6 62.4 16.7 22.7 19.4 16.2 48.6 31.6 43.8 16.6 45.7 28.3 28.6 38.5 30.9 92.1 23.8 22.3 17.9 37.4 39.7 21.1 31.4 28.2 33.4 27.4 31.8 24.0 28.4 32.9 35.5 25.9 27.0 43.3 45.8 44.3 27.4 17.0 14.1 13.9 23.4 13.0 37.2 20.0 17.9 29.1 20.8 22.8 42.2 20.1 37.5 26.0 45.4 47.8 19.0 34.2 22.2 11.0 19.3 7.8 16.2 22.7 22.8 15.3 34.0 21.7 28.8 14.9 27.0 20.8 1.9 19.8 20.2 14.9 34.0 24.6 5.0 8.5 6.8 10.1 4.5 4.7 4.9 4.9 5.1 4.4 11.9 9.6 11.9 15.4 16.1 15.9 25.7 20.4 5.3 7.9 3.5 35.3 78.9 6.6 48.2 34.1 17.1 14.2 0.0 38.1 60.7 23.3 13.9 36.8 21.3 54.2 6.4 13.3 33.2 40.2 16.1 23.0 24.7 11.8 41.5 20.7 43.1 33.8 7.0 13.4 13.5 17.0 25.8 17.6 39.7 73.9 13.2 27.7 27.4 37.6 9.3 ADSSL1 FLJ38602 ENSG00000185100 "Adenylosuccinate synthase like 1" Q8N142 14 104724186-104747325 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 200.5;tongue: 53.2" "Cell type enhanced" "Detected in many" 21 "Cardiomyocytes: 119.6;Early spermatids: 397.7;Late spermatids: 83.9;Muller glia cells: 76.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 12.0;MCF7: 10.6;OE19: 17.0;SiHa: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 220000 "unprognostic (2.23e-2)" "unprognostic (3.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.14e-2)" "unprognostic (2.81e-3)" "unprognostic (3.46e-1)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (2.26e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (2.33e-1)" "unprognostic (2.35e-1)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" 2.5 1.1 0.8 0.5 1.8 0.4 0.9 0.3 1.2 0.8 0.7 3.4 0.3 0.8 0.9 3.5 3.9 1.5 2.2 27.8 1.2 1.5 2.9 7.2 0.7 0.5 3.3 0.4 0.8 1.7 1.9 2.2 1.6 2.0 1.9 0.6 4.6 3.2 1.1 200.5 1.3 0.8 1.0 2.1 0.5 1.2 3.4 2.0 0.0 1.7 53.2 2.8 6.1 3.8 0.0 0.4 1.2 2.1 0.0 0.5 0.0 0.1 2.5 1.8 5.5 1.3 0.8 0.6 0.7 1.0 0.2 0.5 0.2 1.9 0.0 12.0 0.6 0.4 1.0 0.1 0.4 0.4 0.8 0.4 0.0 5.9 0.8 1.4 0.0 4.7 2.6 1.8 0.0 2.0 2.1 0.3 0.2 2.1 0.0 0.9 10.6 0.0 0.5 1.6 17.0 1.1 0.1 0.2 0.6 0.4 1.3 1.6 3.3 17.8 0.8 2.4 1.5 5.6 1.5 0.6 0.1 0.5 1.2 0.0 3.5 2.5 0.0 1.7 0.8 1.2 0.0 0.1 1.2 0.5 2.1 0.0 0.0 0.1 0.4 0.4 0.0 0.4 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.8 1.8 0.3 1.2 1.2 1.5 3.3 0.4 2.0 2.0 3.0 0.3 0.0 5.2 4.6 3.5 119.6 2.5 14.7 2.3 3.5 0.0 2.8 6.6 2.1 397.7 3.1 3.2 0.0 4.3 1.4 4.7 3.6 0.0 12.8 3.0 4.8 9.2 7.4 2.2 83.9 8.1 2.6 10.1 1.8 2.5 76.5 2.0 3.5 17.3 14.6 2.6 12.9 3.1 35.8 21.6 5.3 1.3 1.7 1.7 7.1 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 12.4" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.5;T-reg: 9.8" "Lineage enriched" "Detected in many" 7 "T-cells: 10.5" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA048113: AB_2680268" "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.8 0.4 0.6 10.6 0.8 0.0 0.9 0.3 2.1 0.4 21.8 1.5 48.3 22.4 0.4 4.0 0.9 0.5 0.3 0.5 1.2 0.4 3.8 1.0 3.9 2.0 0.4 1.1 0.4 0.6 0.8 0.3 0.3 12.4 1.7 16.2 38.0 0.7 48.0 0.4 12.7 61.2 0.5 0.4 1.0 11.4 14.1 0.1 0.8 0.7 0.6 3.2 2.7 0.5 0.2 0.2 1.4 0.3 0.1 10.5 1.5 1.7 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.3 0.5 0.3 1.6 0.8 0.0 0.7 0.3 1.1 0.7 0.0 4.8 0.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.9 3.6 10.5 7.5 35.9 0.2 8.6 0.0 1.2 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.1 13.5 0.7 0.1 0.0 0.1 0.6 0.0 0.3 1.3 0.0 0.3 19.4 12.9 0.9 0.3 1.0 0.5 15.2 0.0 2.7 0.5 0.1 1.4 0.1 0.0 0.0 0.3 2.3 0.2 2.8 0.2 0.1 0.1 10.5 0.8 0.2 0.1 0.2 0.2 9.8 1.5 0.6 0.8 0.3 2.1 1.2 0.4 0.4 1.1 12.4 0.1 0.0 1.4 1.5 0.2 4.5 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.1 44.7 0.7 109.7 0.1 113.2 23.3 2.2 0.1 1.0 0.5 5.7 0.0 8.9 0.0 5.2 0.0 0.3 127.1 1.7 1.3 1.7 47.7 36.6 0.0 5.0 73.7 0.7 0.0 0.0 0.0 1.0 1.5 0.8 5.0 0.1 5.7 46.8 0.4 AEBP1 ACLP ENSG00000106624 "AE binding protein 1" Q8IUX7 7 44104361-44114562 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Transcription, Transcription regulation" "Calmodulin-binding, DNA-binding, Repressor" "Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009966, HPA047724, HPA063595, HPA064970" Supported Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 2300000 Vesicles "Nucleoplasm, Cytosol" "CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394" "unprognostic (1.70e-2)" "unprognostic (5.42e-2)" "unprognostic (1.66e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.13e-1)" "unprognostic (7.00e-2)" "unprognostic (8.79e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "unprognostic (1.26e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.31e-9)" "unprognostic (2.88e-3)" "unprognostic (9.58e-2)" "unprognostic (1.17e-2)" "unprognostic (6.28e-3)" 46.5 19.0 8.9 23.9 9.5 3.1 90.9 1.7 5.4 78.1 20.5 17.9 15.8 5.8 73.7 39.4 20.7 43.7 47.9 35.4 12.7 6.4 19.6 6.3 35.5 13.0 12.5 10.8 84.8 8.8 2.7 10.9 26.7 17.2 46.1 7.9 33.3 11.9 70.2 11.4 19.7 16.9 42.6 43.7 16.6 17.6 30.6 9.6 48.0 19.6 12.3 7.5 58.2 177.1 2.3 10.5 0.0 0.0 0.2 1.4 0.4 0.1 0.0 10.8 0.0 34.9 12.4 0.2 45.9 30.3 5.2 1.1 0.0 0.0 1.2 5.1 49.3 0.0 0.0 0.5 0.8 2.2 0.1 0.0 3.1 0.0 0.0 9.8 0.0 0.0 18.8 0.0 17.7 0.0 0.2 2.3 34.8 1.9 0.0 0.0 0.0 19.9 3.7 4.6 0.0 0.0 16.5 0.4 0.3 1.2 0.0 1.1 6.1 0.0 0.0 20.1 10.6 0.1 3.3 8.0 0.0 21.3 0.1 0.0 0.2 0.2 24.2 0.1 0.0 28.2 0.0 0.0 0.0 0.4 0.0 0.3 2.1 0.4 0.0 0.0 2.3 1.4 0.8 0.0 0.2 0.0 10.5 0.0 0.4 8.9 9.5 1.7 5.4 12.7 6.4 12.5 10.8 17.2 9.6 0.0 4.5 6.7 5.4 30.7 0.2 15.5 0.0 4.0 2.3 7.0 0.0 1.7 0.0 0.8 2.0 14.4 0.0 0.0 0.0 2.6 159.0 2.4 2.3 0.0 3.1 0.0 0.0 38.6 1.9 9.5 140.4 3.8 81.0 1.0 0.0 0.1 0.7 0.0 478.4 0.6 0.6 38.8 174.1 2.4 4.5 24.0 2.9 0.7 0.0 2.0 AF241726.2 ENSG00000250349 X 37349330-38687674 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 17.4;skeletal muscle: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.4;HDLM-2: 1.2;HEK 293: 1.4;JURKAT: 5.6" HPA003140 Uncertain NA NA "HPA003140: AB_1078454" 2.7 1.9 3.3 1.7 10.2 1.8 1.9 2.1 6.1 1.7 1.9 17.4 1.3 1.7 1.7 1.7 1.8 1.7 1.7 2.1 3.7 1.9 2.2 2.0 2.1 1.7 14.9 4.1 1.9 1.8 1.7 1.7 3.7 9.9 1.8 1.7 0.6 1.8 1.7 16.5 1.8 1.8 1.7 12.2 1.9 1.7 1.7 11.1 0.0 2.0 0.5 1.7 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 1.4 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 5.6 0.2 0.0 0.3 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.4 0.0 1.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.3 10.2 2.1 6.1 3.7 1.9 14.9 4.1 9.9 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AFAP1L1 FLJ36748 ENSG00000157510 "Actin filament associated protein 1 like 1" Q8TED9 5 149271871-149341802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 42.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 34.7;Early spermatids: 90.3;Endothelial cells: 50.9;Extravillous trophoblasts: 41.4;Ito cells: 41.7;Late spermatids: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 16 "NK-cells: 1.5" "Cell line enhanced" "Detected in many" "BEWO: 25.0;HUVEC TERT2: 13.2;TIME: 18.8;WM-115: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.91e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.20e-1)" "unprognostic (3.44e-1)" "unprognostic (2.61e-1)" "unprognostic (1.41e-3)" "unprognostic (5.25e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" "unprognostic (4.00e-1)" "unprognostic (9.64e-2)" "unprognostic (3.07e-3)" "unprognostic (1.52e-3)" "unprognostic (1.97e-1)" "unprognostic (1.88e-1)" "unprognostic (9.88e-2)" 32.1 2.4 1.1 5.6 1.3 0.2 42.9 1.2 3.1 4.2 4.4 1.0 3.5 1.3 8.4 6.2 5.8 9.0 4.3 24.6 1.3 1.2 3.9 4.6 15.2 9.8 1.3 0.7 6.6 1.1 15.2 2.4 15.4 2.8 5.6 1.2 6.6 3.4 5.8 28.3 5.2 2.9 5.1 2.9 8.3 2.4 5.8 0.4 2.9 6.9 13.7 1.9 7.3 16.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 4.1 1.2 0.0 0.1 7.3 1.5 25.0 0.8 3.3 3.3 5.4 0.0 2.4 0.0 2.0 1.5 9.3 0.9 0.5 3.7 2.4 0.0 1.0 0.8 0.7 0.0 3.9 0.0 0.0 5.7 0.8 2.0 9.6 3.3 13.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 3.3 0.8 0.5 0.7 3.3 0.0 8.9 1.5 0.0 0.2 18.8 1.4 5.2 0.0 0.7 0.0 0.0 0.0 0.3 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.1 1.3 1.2 3.1 1.3 1.2 1.3 0.7 2.8 0.4 0.0 2.2 0.0 1.7 1.3 0.2 34.7 2.5 5.3 3.4 0.0 0.0 11.7 0.0 0.3 90.3 50.9 0.0 0.0 0.0 41.4 4.1 1.1 1.1 0.2 2.3 0.0 0.0 41.7 4.3 39.7 8.9 1.0 6.8 0.0 0.0 0.8 0.0 0.0 14.9 0.6 4.7 12.9 3.1 0.5 2.5 1.3 5.4 0.0 0.0 1.4 AFAP1L2 "Em:AC005383.4, FLJ14564, KIAA1914, XB130" ENSG00000169129 "Actin filament associated protein 1 like 2" Q8N4X5 10 114294824-114404756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 47.9" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 38.4;Sertoli cells: 19.4;Smooth muscle cells: 17.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;T-cells: 4.0" "Cell line enhanced" "Detected in some" "A-431: 26.4;CAPAN-2: 28.5;EFO-21: 21.2;HaCaT: 36.3;RPMI-8226: 18.6;RPTEC TERT1: 22.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 169.5;olfactory region: 48.1" HPA037843 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037843: AB_10669990" "unprognostic (2.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-1)" "unprognostic (5.06e-3)" "unprognostic (4.14e-2)" "unprognostic (9.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.55e-5)" "unprognostic (1.11e-1)" "unprognostic (3.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.86e-1)" 4.5 1.7 9.0 5.9 6.3 0.3 7.1 24.7 8.8 12.9 7.1 5.3 30.5 2.4 22.3 9.7 5.9 13.8 3.6 2.9 7.8 7.1 9.1 1.2 3.2 2.4 8.0 6.7 9.3 8.2 35.1 1.8 10.6 5.5 7.9 3.2 8.1 4.2 28.4 1.8 5.7 4.0 11.1 5.7 39.9 4.1 1.5 6.5 3.4 47.9 7.5 4.3 3.7 14.0 4.0 0.3 0.4 0.0 0.8 4.0 1.4 26.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 28.5 0.0 21.2 0.2 0.4 36.3 0.1 9.9 0.0 0.5 0.0 0.0 0.2 0.0 1.1 0.0 1.0 0.0 10.8 3.0 2.7 0.1 0.1 1.0 0.0 0.0 0.0 1.1 0.6 0.0 0.2 0.7 0.2 0.3 0.3 18.6 22.4 0.2 0.1 0.1 0.8 0.6 1.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.6 3.8 2.7 2.8 0.0 4.0 0.9 2.2 0.4 0.8 0.0 0.3 4.0 1.4 9.0 6.3 24.7 8.5 7.8 7.1 8.0 6.7 5.5 6.5 0.0 0.0 0.5 8.2 11.0 0.8 1.2 0.0 0.0 2.3 38.4 0.0 0.6 0.0 0.6 1.0 9.5 2.5 0.0 12.8 0.9 5.8 3.2 0.0 0.0 0.4 1.6 0.0 4.9 0.0 2.1 2.8 0.0 5.0 1.0 1.3 2.8 14.6 1.7 1.8 0.3 0.5 19.4 17.6 0.0 0.8 5.9 0.2 3.2 1.7 3.0 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 121.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA069947: AB_2686219" "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.7 16.6 8.0 11.8 9.5 19.5 26.5 6.5 12.2 20.2 21.0 10.5 18.9 11.1 27.4 16.6 15.8 18.6 15.3 22.4 10.3 5.3 27.6 15.5 18.4 12.9 9.3 5.5 24.7 19.0 28.6 18.5 121.7 9.5 16.8 14.3 27.0 16.0 25.6 58.8 18.6 16.2 20.3 11.5 13.9 15.0 6.7 10.3 17.0 38.8 21.1 13.9 19.5 26.5 11.3 14.6 21.1 5.4 5.1 8.8 2.8 7.9 7.3 6.1 6.4 10.1 12.1 8.6 8.0 11.8 6.1 9.2 7.7 14.8 9.0 11.0 9.8 7.8 3.6 9.6 12.1 8.5 15.4 3.8 18.8 19.1 6.4 7.8 18.0 14.9 9.8 8.8 10.5 9.3 8.9 22.5 7.6 11.5 25.6 2.6 2.1 16.2 5.2 8.1 13.3 2.6 12.9 3.6 11.5 18.1 7.6 13.9 2.5 12.3 8.1 3.9 13.4 4.8 15.1 11.3 11.4 10.4 6.9 4.4 22.2 12.3 15.6 9.4 20.8 4.1 3.5 5.4 11.7 6.7 4.1 7.4 8.0 8.8 6.6 6.0 11.3 4.7 4.4 21.1 5.1 2.2 14.6 7.5 2.8 8.0 9.5 6.5 12.2 10.3 5.3 9.3 5.5 9.5 10.3 38.7 57.2 25.4 12.5 21.4 44.7 96.4 40.8 40.2 31.8 87.2 212.1 0.9 3.3 11.6 6.6 38.8 30.8 46.7 10.9 3.8 14.6 24.9 23.3 27.7 11.3 17.5 31.0 65.1 43.0 5.4 27.0 25.6 21.9 8.2 40.8 22.0 11.1 31.7 26.9 40.9 150.1 25.8 15.6 3.5 6.4 27.7 27.5 15.2 25.3 14.4 AFF2 "FMR2, FRAXE" ENSG00000155966 "AF4/FMR2 family member 2" P51816 X 148500619-149000663 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4" "Cell type enhanced" "Detected in some" 12 "Cone photoreceptor cells: 21.6;Peritubular cells: 16.6;Rod photoreceptor cells: 13.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "Daudi: 30.3;HL-60: 12.8;U-698: 44.3;U-937: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003139 Approved NA NA "HPA003139: AB_1078107" "unprognostic (5.68e-2)" "unprognostic (1.96e-1)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (1.88e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (5.00e-2)" "unprognostic (5.37e-2)" "unprognostic (1.59e-1)" "unprognostic (1.08e-2)" "unprognostic (5.31e-2)" "unprognostic (6.80e-2)" "unprognostic (9.78e-5)" "unprognostic (2.54e-2)" "unprognostic (1.23e-1)" "unprognostic (9.34e-2)" 1.9 0.6 4.2 5.3 3.7 13.6 1.1 13.6 5.9 4.8 0.4 0.2 1.2 0.2 0.8 15.1 0.5 0.6 2.9 1.3 10.7 5.2 0.7 0.3 3.6 6.3 2.3 5.9 2.0 0.5 0.2 17.4 17.4 3.9 1.0 0.3 0.2 0.8 2.1 0.4 1.3 0.5 0.3 2.4 0.8 0.4 2.8 0.0 5.5 1.1 0.0 7.3 1.0 0.7 0.1 0.0 4.5 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 30.3 0.0 1.7 0.0 0.0 4.7 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 12.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.9 0.0 1.6 3.8 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.5 1.7 0.0 0.5 0.0 1.4 0.1 0.1 44.3 0.0 9.4 0.0 1.7 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 4.2 3.7 13.6 5.9 10.7 5.2 2.3 5.9 3.9 0.0 0.0 0.0 0.0 0.0 0.3 4.6 1.5 0.0 0.0 0.0 0.0 21.6 0.1 0.0 0.3 6.4 0.0 0.0 0.0 0.0 0.1 1.0 0.2 5.7 0.0 0.1 1.6 0.0 0.0 0.0 3.6 7.2 0.0 0.0 1.0 0.0 0.9 0.0 0.0 16.6 0.3 13.4 6.5 0.4 0.2 0.2 0.0 0.2 0.0 0.0 0.0 AFF3 "LAF4, MLLT2-like" ENSG00000144218 "AF4/FMR2 family member 3" P51826 2 99545419-100142739 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 79.7;Horizontal cells: 44.5" "Cancer enhanced" "Detected in many" "breast cancer: 11.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 16.2;naive B-cell: 27.5;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 16 "B-cells: 27.5;dendritic cells: 12.8" "Cell line enhanced" "Detected in many" "Daudi: 23.7;U-698: 35.1" "Low region specificity" "Detected in all" "HPA044512, HPA053379" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044512: AB_10795984, HPA053379: AB_2682133" "unprognostic (1.05e-2)" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.88e-3)" "unprognostic (1.02e-1)" "unprognostic (4.98e-5)" "unprognostic (1.11e-3)" "unprognostic (3.04e-2)" "unprognostic (8.75e-2)" "unprognostic (3.07e-1)" "unprognostic (1.95e-3)" "unprognostic (7.57e-2)" "prognostic unfavorable (5.64e-4)" "unprognostic (6.40e-3)" "unprognostic (6.79e-2)" "unprognostic (3.69e-2)" "unprognostic (7.87e-3)" 3.2 2.4 6.0 40.2 6.1 10.3 16.6 20.5 9.9 4.2 4.2 1.8 0.8 1.2 8.9 1.7 4.1 4.1 2.3 4.9 6.3 6.2 1.8 2.4 7.6 23.3 5.4 6.8 7.5 1.1 0.3 5.2 6.9 4.4 18.9 2.3 5.5 6.6 3.3 1.0 1.0 5.9 8.6 6.6 43.6 4.8 6.0 2.5 34.7 1.7 0.7 42.0 7.4 2.7 27.5 12.8 0.2 0.2 0.9 1.2 0.4 0.1 0.0 10.0 3.5 0.0 0.4 0.0 1.4 0.3 3.0 1.0 0.0 0.0 23.7 0.1 1.5 7.6 0.1 0.2 0.0 1.8 6.0 2.9 0.0 0.1 0.0 0.2 0.1 6.8 0.6 0.0 6.2 0.1 7.7 0.0 1.3 0.1 0.0 0.0 0.1 1.9 0.3 1.3 0.0 1.6 3.2 0.0 0.1 0.0 0.0 9.9 3.5 0.1 0.1 6.4 1.3 11.9 10.9 3.9 9.5 2.6 0.3 1.5 0.2 0.0 35.1 8.8 0.8 0.8 0.2 0.2 0.0 0.0 0.2 0.2 16.2 0.1 0.0 2.9 27.5 1.2 0.0 0.1 0.9 0.2 12.8 0.0 0.4 6.0 6.1 20.5 9.9 6.3 6.2 5.4 6.8 4.4 2.5 6.0 29.7 79.7 0.4 1.5 15.0 9.6 0.0 0.0 6.8 0.0 11.8 0.2 0.0 0.0 25.7 1.2 0.0 0.0 0.0 0.1 4.7 14.7 0.0 0.8 1.4 44.5 22.0 0.6 7.0 28.0 10.0 12.9 13.5 0.0 0.3 8.9 0.0 0.0 19.8 0.8 1.4 0.0 6.9 5.1 7.0 1.1 0.1 2.2 0.0 0.1 AFM "ALB2, ALBA" ENSG00000079557 Afamin P43652 4 73481683-73504001 "Plasma proteins, Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 169.0" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 272.5" "Cancer enriched" "Detected in single" 167 "liver cancer: 62.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA017006, HPA052437" Enhanced "Secreted to blood" NA NA 54900000000 5000000000 "HPA017006: AB_1844635, HPA052437: AB_2732575" "prognostic favorable (1.80e-4)" "unprognostic (5.73e-2)" "unprognostic (4.24e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 169.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 2.5 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 272.5 0.1 0.0 0.0 4.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 AFMID "DKFZp686F03259, KF" ENSG00000183077 Arylformamidase Q63HM1 17 78187317-78207701 "Enzymes, Predicted intracellular proteins" "Tryptophan catabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.7" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 68.8;Hepatocytes: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.5" "Group enriched" "Detected in all" 5 "B-cells: 5.1;dendritic cells: 6.7;monocytes: 14.5" "Cell line enhanced" "Detected in all" "Hep G2: 62.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023861, HPA026536" Uncertain Approved Mitochondria NA NA Mitochondria "HPA023861: AB_1844636, HPA026536: AB_1844637" "unprognostic (3.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.53e-1)" "unprognostic (2.65e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.78e-1)" "unprognostic (1.83e-1)" "unprognostic (1.49e-3)" "unprognostic (1.53e-2)" "unprognostic (5.78e-2)" "unprognostic (9.59e-3)" "unprognostic (9.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.94e-1)" "unprognostic (7.79e-2)" 5.9 3.5 12.1 5.4 17.1 4.6 33.0 27.1 18.3 6.1 7.5 44.8 11.7 8.5 7.5 7.0 7.7 11.3 11.4 9.4 17.3 12.0 39.4 78.7 10.6 5.2 29.7 13.3 15.9 27.7 6.9 4.1 12.4 18.1 10.7 9.2 5.8 24.7 11.8 7.9 15.5 7.1 6.6 27.0 6.2 10.2 6.2 23.9 3.9 6.5 5.6 6.2 6.7 7.4 5.1 6.7 1.7 14.5 1.6 1.1 1.5 7.0 10.0 8.8 8.0 10.0 11.7 4.8 10.1 5.8 7.2 8.6 10.6 5.9 22.1 6.7 7.7 4.2 6.1 14.9 8.9 10.1 14.0 11.9 17.8 11.8 62.3 8.7 14.7 9.2 15.6 9.4 8.3 10.9 11.8 13.4 6.7 18.0 7.8 5.5 7.0 11.2 22.4 7.2 17.2 17.3 12.8 9.0 26.5 9.7 6.5 19.7 14.6 8.7 26.3 8.2 9.2 7.9 14.3 6.6 11.0 7.2 6.9 7.1 11.9 7.8 22.7 9.1 7.2 2.8 1.1 6.1 0.7 0.7 14.5 1.1 5.1 1.0 1.1 6.7 2.0 0.6 0.6 1.7 1.6 9.3 4.4 0.9 1.5 12.1 17.1 27.1 18.3 17.3 12.0 29.7 13.3 18.1 23.9 14.9 13.6 10.0 19.1 23.5 1.4 11.5 68.8 17.4 12.5 61.1 3.9 10.9 14.9 10.4 0.3 14.7 12.9 0.0 7.4 9.5 15.0 15.8 2.3 100.2 9.5 1.6 12.6 21.5 21.9 1.5 20.8 18.3 28.7 10.8 20.6 1.7 8.6 24.9 20.5 39.6 1.5 0.0 7.5 1.2 11.8 35.9 9.6 4.4 25.0 12.2 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "heart muscle: 4.3;liver: 9.6;lung: 2.9" "Group enriched" "Detected in some" 10 "Hepatocytes: 99.9;Proximal tubular cells: 38.7" "Group enriched" "Detected in some" 14 "liver cancer: 208.8;testis cancer: 49.4" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 190 "Hep G2: 219.7" "Region enhanced" "Detected in single" "cerebellum: 0.8" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 3010000 930000 "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.4 0.1 0.0 1.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.3 0.3 0.0 0.0 9.6 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 219.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.3 0.0 2.4 0.7 0.3 0.0 0.0 99.9 2.1 0.0 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 AGAP2 CENTG1 ENSG00000135439 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 2" Q99490 12 57723761-57742157 "Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.9;lymphoid tissue: 18.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 7.5;Horizontal cells: 7.9;Sertoli cells: 32.3;T-cells: 12.1" "Cancer enriched" "Detected in many" 12 "glioma: 20.6" "Group enriched" "Detected in many" 4 "amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 18.0;Karpas-707: 17.5;RH-30: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023474, HPA075831" Enhanced Supported "Nucleoplasm,Midbody ring,Cytosol" NA NA "Nucleoplasm, Cytosol" "Midbody ring" "HPA023474: AB_1855378, HPA075831: " "unprognostic (1.87e-1)" "unprognostic (2.46e-3)" "unprognostic (9.26e-2)" "unprognostic (5.56e-4)" "unprognostic (3.95e-1)" "unprognostic (1.14e-2)" "unprognostic (5.00e-2)" "unprognostic (2.36e-2)" "unprognostic (3.39e-1)" "unprognostic (2.80e-1)" "unprognostic (1.93e-3)" "unprognostic (4.18e-1)" "unprognostic (4.81e-9)" "unprognostic (3.30e-1)" "unprognostic (2.72e-2)" "unprognostic (3.07e-1)" "unprognostic (5.75e-2)" 3.8 1.8 34.3 11.8 40.2 8.1 0.7 48.2 55.9 0.6 2.1 1.2 0.0 2.0 1.5 0.9 1.6 0.8 2.8 4.3 37.6 8.9 1.2 0.8 2.2 13.5 6.3 3.1 1.2 2.4 1.7 1.2 1.7 2.5 1.0 1.2 0.7 4.5 0.9 8.3 2.1 2.2 0.8 2.1 10.0 2.1 0.9 0.7 18.8 0.9 1.5 16.6 2.9 0.6 1.9 1.4 6.3 1.2 2.3 6.3 1.7 3.0 4.5 8.7 2.5 0.0 0.0 5.0 2.1 0.4 0.0 0.2 0.5 2.9 7.9 0.6 0.0 1.6 1.9 0.0 0.0 0.0 8.6 1.3 8.7 0.7 1.4 0.0 8.9 18.0 0.0 0.0 0.0 0.0 3.7 0.0 9.3 0.0 17.5 0.0 5.3 15.7 5.7 1.4 0.9 4.6 6.5 43.8 5.7 0.0 2.6 2.5 9.1 1.1 1.6 1.8 0.0 1.1 6.3 4.8 2.4 4.1 4.6 1.5 7.4 4.4 3.9 4.4 5.9 4.1 6.0 0.8 1.0 4.8 1.2 5.1 1.9 4.8 5.1 1.4 1.6 2.0 3.0 6.3 2.3 0.7 1.2 6.3 1.7 34.3 40.2 48.2 35.4 37.6 8.9 6.3 3.1 2.5 0.7 3.0 0.6 4.1 0.2 0.0 7.5 2.2 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.4 0.2 2.3 0.0 1.4 7.9 0.0 0.6 0.6 0.7 0.0 1.6 0.0 3.6 0.3 0.1 0.1 0.0 0.7 0.0 1.9 32.3 1.2 0.7 0.4 0.4 0.0 12.1 0.1 0.0 AGAP3 CENTG3 ENSG00000133612 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 3" Q96P47 7 151085831-151144436 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012883 Approved NA NA "HPA012883: AB_1846533" "unprognostic (3.63e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (4.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.71e-1)" "prognostic unfavorable (6.21e-4)" "unprognostic (2.05e-2)" "unprognostic (1.55e-1)" "unprognostic (7.30e-2)" "unprognostic (2.89e-2)" "unprognostic (3.15e-3)" "prognostic unfavorable (8.58e-5)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (1.55e-2)" "unprognostic (9.50e-3)" 16.4 16.8 47.0 11.2 38.3 5.0 16.3 40.9 67.8 15.1 10.1 24.4 8.7 14.1 18.3 9.6 16.9 16.9 12.2 12.0 47.2 30.3 6.7 11.5 21.4 8.9 24.6 44.1 18.6 28.0 21.8 20.2 15.1 27.6 15.4 6.7 12.4 23.3 16.0 21.1 27.0 14.2 12.1 17.2 12.9 11.5 7.0 21.8 0.9 9.5 6.7 6.8 12.9 12.5 3.4 2.5 0.5 5.7 3.8 3.5 3.0 14.4 11.6 10.5 22.9 9.9 8.0 16.1 11.3 10.8 8.9 7.9 11.2 15.1 0.2 14.6 6.6 10.9 20.4 7.4 16.0 2.9 16.7 22.9 13.0 12.8 15.2 14.1 8.6 5.3 8.0 19.9 7.2 7.6 14.2 13.1 5.6 23.2 10.5 5.1 38.0 3.6 40.3 19.7 11.5 13.0 9.0 7.2 20.4 11.0 35.3 31.5 26.3 8.7 2.7 26.8 7.7 7.6 13.3 12.6 12.1 4.1 14.7 13.9 13.6 6.0 0.1 23.9 14.9 15.1 0.0 5.7 0.4 2.1 3.4 1.5 3.4 2.9 3.5 2.5 0.6 2.2 1.1 0.5 3.8 1.2 0.1 0.5 3.0 47.0 38.3 40.9 67.8 47.2 30.3 24.6 44.1 27.6 21.8 26.8 22.3 1.9 12.4 18.9 47.7 17.9 12.7 5.3 18.2 3.5 7.9 7.5 0.0 5.1 0.3 20.3 15.1 0.0 9.0 1.6 12.6 12.1 17.3 17.1 18.1 54.0 6.9 9.8 16.4 2.2 10.9 17.2 11.8 7.2 9.1 9.6 17.3 0.0 11.0 5.8 14.0 12.9 9.0 0.7 11.1 16.3 2.6 2.5 10.1 9.6 AGBL1 "CCP4, FLJ32310" ENSG00000273540 "ATP/GTP binding protein like 1" Q96MI9 15 86079973-87029052 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 16.7;tongue: 35.5" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.8;Early spermatids: 2.1;Late spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.5;RH-30: 1.8;SCLC-21H: 2.8" "Low region specificity" "Detected in single" NA NA "unprognostic (3.70e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.0 5.8 1.3 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.6 0.0 0.0 1.3 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 35.5 1.0 0.0 0.0 0.5 0.3 1.3 0.3 0.3 0.2 0.0 0.0 0.1 2.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 1.8 0.1 0.0 0.2 2.8 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.4 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.7 0.3 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.3 0.3 0.0 0.3 0.1 0.0 3.0 11.8 0.0 0.0 0.0 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 AGBL2 "CCP2, FLJ23598" ENSG00000165923 "ATP/GTP binding protein like 2" Q5U5Z8 11 47659591-47715389 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.0" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 107.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;T-47d: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007718 Uncertain NA NA "HPA007718: AB_1078110" "unprognostic (3.44e-5)" "unprognostic (1.16e-1)" "unprognostic (5.84e-2)" "unprognostic (5.33e-4)" "unprognostic (1.13e-1)" "unprognostic (3.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (9.83e-3)" "unprognostic (4.11e-2)" "unprognostic (5.56e-2)" "unprognostic (1.79e-1)" "unprognostic (8.24e-6)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (9.62e-2)" "unprognostic (1.17e-3)" 0.4 1.7 0.8 6.6 2.7 0.7 1.1 3.6 1.1 1.9 2.0 2.8 1.5 1.1 1.6 11.2 0.5 12.2 2.4 0.4 1.3 1.4 1.8 3.0 6.4 1.4 0.3 0.3 2.1 4.7 1.2 3.8 0.7 3.4 1.6 0.8 0.7 1.1 1.7 0.4 0.6 3.3 0.6 0.7 1.7 0.8 34.0 0.7 4.4 1.9 0.5 2.6 2.1 1.4 2.6 1.5 0.4 0.2 1.4 2.2 0.6 1.2 0.0 0.0 0.0 0.3 1.7 0.1 0.4 0.8 0.5 1.7 0.6 6.1 0.1 0.4 0.4 0.8 1.6 0.0 0.1 0.8 1.8 0.4 0.3 2.9 2.2 0.9 0.0 1.0 1.8 0.7 0.9 0.5 0.6 0.1 2.1 0.4 1.3 0.9 2.4 1.2 0.6 0.0 0.3 0.1 1.7 0.1 0.5 0.9 2.7 2.2 0.5 0.7 0.0 0.7 0.0 3.5 0.0 0.2 0.2 0.5 0.3 0.0 0.0 0.1 0.1 0.3 0.3 0.3 0.0 0.1 0.0 1.5 0.0 1.3 1.0 1.6 1.2 0.1 2.6 1.9 1.7 0.4 1.4 0.2 1.5 2.2 0.6 0.8 2.7 3.6 1.1 1.3 1.4 0.3 0.3 3.4 0.7 0.0 2.4 0.0 1.2 0.1 0.0 0.4 0.0 107.1 10.3 7.0 0.0 0.4 0.0 0.2 23.4 0.0 1.0 0.0 0.0 0.2 0.6 0.3 0.0 0.6 0.1 0.0 1.2 0.6 0.3 6.6 0.3 0.3 0.0 1.8 0.6 0.5 0.2 0.0 1.4 0.0 0.4 0.0 0.1 19.6 1.0 0.0 0.3 0.7 0.8 0.3 AGBL4 "CCP6, FLJ14442" ENSG00000186094 "ATP/GTP binding protein like 4" Q5VU57 1 48532855-50023913 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20.4;pituitary gland: 31.5" "Cell type enhanced" "Detected in some" 23 "Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 22.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.7;SCLC-21H: 5.3;SH-SY5Y: 2.0;SuSa: 1.8;U-937: 2.2" "Low region specificity" "Detected in many" HPA037994 Approved NA NA "HPA037994: AB_10673036" "unprognostic (3.06e-2)" "unprognostic (2.76e-1)" "unprognostic (2.58e-2)" "unprognostic (3.31e-4)" "unprognostic (3.42e-4)" "unprognostic (1.72e-1)" "unprognostic (3.86e-3)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (5.85e-3)" "unprognostic (3.91e-2)" "unprognostic (1.51e-4)" "unprognostic (5.95e-2)" "unprognostic (1.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.85e-1)" 1.4 4.5 7.8 0.8 13.6 1.1 1.5 1.3 20.4 1.0 0.8 3.0 0.1 0.7 1.0 4.5 0.9 7.8 1.0 3.7 7.1 7.2 10.2 4.6 1.6 0.8 3.2 11.6 1.3 2.7 3.6 31.5 2.7 6.7 1.0 0.7 4.6 0.8 1.5 0.9 1.5 0.8 0.7 1.5 1.3 1.1 10.7 1.9 0.0 3.4 0.0 0.8 0.7 0.7 0.8 0.5 2.2 0.3 0.6 1.8 0.2 0.0 0.5 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.3 0.1 0.4 3.7 0.0 0.4 0.1 0.1 0.1 0.1 0.3 5.3 2.0 0.0 0.2 0.0 1.8 0.0 0.3 0.0 0.0 1.4 0.2 0.0 0.2 0.0 0.1 0.1 2.2 0.5 2.2 0.3 0.4 0.3 0.3 1.8 0.5 0.2 0.1 0.2 0.8 0.4 0.2 1.0 0.6 0.2 0.5 0.3 0.2 7.8 13.6 1.3 20.4 7.1 7.2 3.2 11.6 6.7 1.9 0.0 0.0 0.0 0.6 0.2 2.3 1.0 0.0 9.4 1.2 3.5 80.5 0.1 1.7 0.1 9.7 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 4.8 5.8 0.6 0.0 6.5 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 3.8 22.3 0.0 0.0 13.6 3.6 0.0 0.1 0.0 0.0 0.1 AGBL5 "CCP5, FLJ21839" ENSG00000084693 "ATP/GTP binding protein like 5" Q8NDL9 2 27042364-27070622 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 91.6" "Group enriched" "Detected in many" 7 "Early spermatids: 249.1;Late spermatids: 264.5;Spermatocytes: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030981 Uncertain Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge" "Microtubules, Cytosol" "HPA030981: AB_10611673" "unprognostic (1.29e-2)" "unprognostic (8.70e-2)" "unprognostic (2.26e-1)" "unprognostic (3.13e-3)" "unprognostic (1.95e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.86e-1)" "unprognostic (4.34e-1)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (3.41e-2)" "unprognostic (5.56e-2)" "unprognostic (2.05e-1)" "unprognostic (1.69e-2)" "unprognostic (4.50e-2)" 3.8 8.1 3.9 3.5 4.8 3.8 4.2 3.1 6.6 5.0 6.8 6.6 11.7 2.8 5.4 9.3 6.3 7.2 6.6 4.1 3.4 3.9 8.2 3.0 3.6 3.2 3.5 3.4 5.9 5.9 11.2 6.2 6.3 5.4 6.8 3.8 7.7 8.2 5.9 2.6 6.8 3.9 8.6 3.4 4.6 5.4 91.6 3.5 8.4 9.9 4.9 4.4 7.8 3.5 5.7 5.4 7.1 2.3 11.2 6.3 4.6 23.0 15.0 24.5 16.3 5.2 10.5 27.4 4.7 10.3 13.7 14.2 12.9 17.7 12.8 14.9 8.1 19.3 10.6 19.6 21.4 15.2 10.7 29.0 18.7 18.7 27.8 10.6 9.0 6.3 11.0 16.2 12.0 9.9 21.0 14.3 18.7 16.0 10.4 13.2 9.1 26.2 13.6 17.3 16.8 10.3 27.1 27.7 20.0 14.1 5.9 16.4 23.5 9.3 7.3 15.2 25.1 11.0 7.0 6.8 12.8 17.6 6.1 10.1 20.8 10.9 26.2 14.2 10.4 11.4 7.1 2.3 5.7 4.5 1.3 3.4 5.7 5.7 6.3 5.4 3.0 5.1 2.8 1.4 11.2 0.9 3.0 3.6 4.6 3.9 4.8 3.1 6.6 3.4 3.9 3.5 3.4 5.4 3.5 0.0 8.5 1.9 5.9 3.0 4.9 5.0 12.7 1.4 5.7 8.7 0.0 12.8 16.6 7.0 249.1 3.6 4.6 0.0 5.2 6.0 4.1 6.6 1.1 3.4 4.4 0.0 2.4 6.2 2.7 264.5 9.8 5.3 6.8 6.4 8.7 4.4 4.8 7.0 10.6 18.1 8.7 0.0 5.8 150.8 30.0 2.4 7.0 4.1 8.4 6.8 AGER "RAGE, SCARJ1" ENSG00000204305 "Advanced glycosylation end-product specific receptor" Q15109 6 32180968-32184324 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Inflammatory response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 178.6" "Cell type enriched" "Detected in many" 18 "Alveolar cells type 1: 2224.3" "Cancer enhanced" "Detected in all" "lung cancer: 27.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB011682, HPA064436, HPA069474" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane,Cell Junctions" "Secreted in other tissues" NA NA 5360000 140000 "Plasma membrane, Cell Junctions" "Nucleoli fibrillar center" "CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: " "unprognostic (9.37e-2)" "unprognostic (3.70e-1)" "unprognostic (2.37e-2)" "unprognostic (1.14e-1)" "unprognostic (4.55e-2)" "unprognostic (1.59e-3)" "unprognostic (4.36e-2)" "unprognostic (1.00e-1)" "unprognostic (4.38e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.01e-7)" "unprognostic (3.57e-1)" "unprognostic (3.70e-2)" "unprognostic (4.44e-2)" "prognostic favorable (2.74e-6)" 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.3 0.6 0.4 0.4 0.2 0.2 0.2 0.0 0.5 0.2 178.6 0.2 0.2 0.2 0.5 0.3 0.1 0.7 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.2 22.6 0.2 0.2 0.2 0.3 0.7 0.7 1.0 0.3 0.1 0.5 0.1 0.2 0.2 0.0 0.6 0.2 1.9 2.7 0.1 0.2 0.1 0.2 0.1 0.4 0.2 2.1 0.5 0.0 2.2 0.2 1.1 0.3 0.4 4.9 1.3 0.1 0.0 0.0 0.6 2.2 0.3 0.3 0.1 0.2 0.3 0.3 8.1 0.0 0.8 0.2 4.2 0.3 1.5 0.0 0.2 0.0 0.1 0.2 0.3 5.1 0.1 0.1 0.5 0.1 0.0 1.9 0.1 1.2 0.1 0.2 0.0 1.5 1.5 0.1 6.1 3.2 2.2 2.2 0.5 0.5 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.0 0.7 0.4 0.3 1.0 0.1 0.2 0.7 0.0 0.1 0.2 0.2 0.9 0.2 0.2 0.0 0.2 0.2 0.4 0.2 2224.3 120.3 1.7 1.1 0.8 4.8 3.4 5.1 8.1 37.5 1.8 0.0 0.9 0.0 1.5 0.0 2.6 0.5 0.0 0.8 0.8 1.6 2.3 16.3 1.8 1.2 6.4 0.0 2.5 9.0 0.2 1.7 4.9 1.7 2.8 1.4 7.4 0.8 2.9 1.1 0.2 4.1 6.5 1.7 0.0 0.7 1.6 1.8 5.0 0.9 0.8 AGFG2 "HRBL, RABR" ENSG00000106351 "ArfGAP with FG repeats 2" O95081 7 100539211-100568219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "salivary gland: 154.3" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 35.8;Ito cells: 65.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019689, HPA073562" Enhanced NA NA "HPA019689: AB_1855074, HPA073562: " "unprognostic (7.67e-2)" "unprognostic (1.04e-3)" "unprognostic (7.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (6.99e-3)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "prognostic favorable (9.64e-4)" "unprognostic (3.00e-1)" "prognostic favorable (1.03e-6)" "unprognostic (7.83e-2)" "unprognostic (7.47e-2)" "unprognostic (9.90e-3)" "unprognostic (9.31e-2)" 4.8 13.6 9.2 5.5 12.5 3.8 3.7 8.8 9.6 6.6 8.7 6.6 8.5 7.0 7.1 4.5 14.3 7.7 7.9 5.1 9.1 5.1 7.1 21.4 4.7 5.6 7.2 8.6 11.3 9.7 3.4 8.4 2.7 7.7 5.9 6.9 4.0 154.3 9.5 3.8 11.7 6.5 5.7 10.0 11.7 5.5 6.8 7.5 4.0 6.5 3.7 10.9 5.2 4.7 1.4 1.0 4.5 0.4 1.1 4.5 1.1 6.3 10.3 1.3 3.1 9.5 5.0 1.8 3.0 8.3 4.9 5.1 9.0 5.8 4.1 10.2 3.6 21.5 5.3 1.5 3.1 2.2 14.1 4.1 1.2 4.7 19.4 3.8 1.3 7.2 8.2 2.4 3.9 4.4 3.0 13.2 2.7 3.7 5.6 3.9 5.6 5.1 4.7 0.9 17.8 4.3 2.5 1.5 3.6 2.8 3.3 1.9 2.3 5.9 8.6 2.7 2.2 2.4 1.8 3.3 6.1 4.1 15.1 3.2 3.5 17.7 1.5 4.6 3.8 3.4 3.6 0.1 4.5 3.8 0.4 3.3 0.7 3.8 4.5 0.2 1.4 1.3 1.7 0.9 1.1 0.1 1.0 3.0 1.1 9.2 12.5 8.8 9.6 9.1 5.1 7.2 8.6 7.7 7.5 0.0 3.8 7.0 5.7 1.8 1.3 8.4 30.6 0.0 2.3 24.4 2.0 1.3 10.0 10.5 1.3 11.4 14.7 0.0 10.1 1.4 3.3 4.4 2.3 35.8 1.3 3.2 25.4 65.7 5.7 1.8 5.2 1.7 3.3 10.8 11.2 2.7 6.4 8.6 8.5 1.9 1.4 12.9 3.3 5.7 8.5 4.6 0.7 10.1 12.0 6.4 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850084-99924023 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 23.1;skeletal muscle: 85.6;tongue: 34.4" "Cell type enhanced" "Detected in all" 6 "Muller glia cells: 151.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 16000 Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: AB_2682455" "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favorable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 5.0 4.5 2.5 4.7 3.6 2.0 4.2 5.4 6.1 3.4 4.5 2.1 5.4 3.3 4.8 4.2 9.1 4.1 2.6 8.2 2.2 2.3 5.8 23.1 4.2 5.3 2.4 4.2 3.8 3.6 8.7 4.7 4.8 2.9 5.5 4.2 3.9 5.1 8.7 85.6 3.7 4.0 5.4 2.8 4.8 4.4 2.9 1.2 7.1 4.3 34.4 3.4 6.7 3.6 3.0 2.3 3.5 1.6 6.1 4.3 2.1 12.1 3.6 4.3 7.0 7.1 6.8 14.5 3.8 5.7 3.4 6.0 13.5 4.1 15.9 7.4 6.5 3.0 6.9 25.1 7.5 6.4 8.4 7.9 9.2 12.4 7.5 4.7 8.2 5.6 8.2 4.9 4.7 3.9 4.8 5.3 5.6 15.2 1.1 3.5 3.8 9.6 2.6 6.8 5.4 4.6 0.0 1.4 0.8 10.3 16.4 10.7 7.4 11.1 10.7 6.0 8.4 7.7 5.5 5.4 4.1 5.9 5.5 3.7 4.5 3.6 18.4 7.2 2.2 2.1 0.1 1.3 3.5 4.3 1.6 4.1 3.0 3.2 2.9 2.3 2.9 3.2 3.2 1.5 6.1 0.9 2.1 3.3 2.1 2.5 3.6 5.4 6.1 2.2 2.3 2.4 4.2 2.9 1.2 20.8 23.2 15.3 15.5 9.4 36.9 94.9 20.4 29.4 29.6 15.7 51.1 77.6 19.9 11.9 1.1 10.8 15.8 23.3 11.2 17.2 13.6 9.9 10.4 84.7 15.8 49.3 16.1 16.0 16.2 1.1 9.5 9.2 15.1 10.8 18.2 151.6 14.2 10.5 20.1 16.3 47.8 6.5 14.2 8.1 11.7 8.2 24.4 15.0 17.4 16.6 AGMAT FLJ23384 ENSG00000116771 Agmatinase Q9BSE5 1 15572353-15585110 "Enzymes, Predicted intracellular proteins" "Putrescine biosynthesis, Spermidine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3;kidney: 54.7;liver: 66.1" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 278.6" "Group enriched" "Detected in all" 5 "colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.6;T-cells: 10.5" "Cell line enhanced" "Detected in many" "CACO-2: 19.0;Hep G2: 46.0;RPMI-8226: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA026443, HPA028321" Enhanced NA NA 250000 "HPA026443: AB_1844644, HPA028321: AB_10600779" "unprognostic (2.27e-2)" "unprognostic (3.45e-1)" "unprognostic (1.79e-3)" "unprognostic (3.60e-2)" "unprognostic (8.72e-2)" "unprognostic (6.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-2)" "unprognostic (2.06e-2)" "unprognostic (2.37e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.13e-4)" "unprognostic (4.43e-3)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-2)" 0.7 0.8 0.7 2.8 0.5 0.1 0.4 0.2 1.0 0.2 14.9 0.3 0.0 7.1 0.3 1.2 0.5 0.2 3.6 0.3 0.6 0.8 54.7 66.1 0.2 1.3 0.7 0.3 0.2 1.1 1.3 0.4 0.2 0.6 0.3 2.8 0.1 9.6 0.0 12.3 0.2 21.3 0.1 0.3 1.0 0.5 0.5 0.1 1.0 0.3 1.7 1.5 0.4 0.2 4.6 0.4 1.4 0.3 0.4 10.5 2.8 4.0 3.2 0.2 0.1 0.0 0.4 0.1 0.7 0.7 0.4 0.2 19.0 2.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 3.9 0.0 2.5 2.7 46.0 0.5 2.0 0.0 0.5 0.2 1.3 0.0 0.3 0.4 0.0 0.0 5.4 1.0 4.3 0.0 1.9 4.3 3.2 1.8 0.0 0.0 11.4 0.1 1.0 0.7 0.6 5.5 0.2 0.6 0.2 0.7 3.8 0.5 0.1 0.1 1.0 0.0 0.1 3.0 2.6 0.2 0.0 0.0 0.9 0.3 0.2 2.4 0.3 3.1 4.6 5.7 3.0 0.2 3.2 10.5 5.9 1.4 0.4 0.2 0.4 7.1 2.8 0.7 0.5 0.2 1.0 0.6 0.8 0.7 0.3 0.6 0.1 0.0 0.0 3.2 1.5 0.2 1.2 0.4 5.1 1.4 0.0 3.5 0.0 0.7 26.6 0.8 6.9 0.1 12.9 0.0 0.8 0.7 0.7 0.9 0.0 38.9 0.9 3.2 1.2 1.8 2.2 3.6 0.3 0.4 1.7 1.0 6.7 0.8 2.0 3.5 0.0 278.6 1.7 0.0 0.4 1.6 2.9 0.5 0.7 5.0 13.8 2.6 AGMO "FLJ16237, TMEM195" ENSG00000187546 "Alkylglycerol monooxygenase" Q6ZNB7 7 15200318-15562015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 41.9;liver: 57.9" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 79.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 15.7" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 3.6;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057900 Uncertain Vesicles NA NA Vesicles "HPA057900: " "unprognostic (2.82e-1)" "unprognostic (9.28e-2)" "unprognostic (5.60e-3)" "unprognostic (1.44e-4)" "unprognostic (7.52e-2)" "unprognostic (1.07e-2)" "unprognostic (3.61e-2)" "unprognostic (6.56e-2)" "unprognostic (3.31e-1)" "unprognostic (3.35e-1)" "unprognostic (4.18e-3)" "unprognostic (3.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (3.45e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 6.8 0.2 0.8 1.0 1.2 0.1 3.7 0.3 0.5 0.3 16.5 1.1 0.1 4.6 0.3 7.3 0.3 0.3 4.7 0.9 0.7 0.6 5.3 57.9 0.4 0.5 1.1 0.8 0.3 0.3 0.0 0.7 0.4 0.7 0.4 0.3 0.0 0.4 0.1 0.5 0.5 41.9 0.1 1.1 0.3 0.3 1.8 2.0 0.0 0.7 0.1 0.1 1.0 0.4 0.2 0.1 3.6 0.1 0.6 0.1 0.0 0.0 2.5 0.1 2.2 0.2 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.3 0.0 0.7 3.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 4.4 1.5 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 17.2 3.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.8 1.2 0.3 0.4 0.7 0.6 1.1 0.8 0.7 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.3 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.7 0.1 2.6 0.0 0.0 0.1 0.7 0.0 0.0 79.7 0.1 0.0 1.7 1.3 1.3 0.9 0.0 0.1 3.3 0.0 0.1 0.0 0.6 0.0 0.0 15.2 0.0 6.5 0.2 0.4 2.5 0.0 0.1 0.0 0.6 0.0 AGPAT2 "BSCL, LPAAT-beta" ENSG00000169692 "1-acylglycerol-3-phosphate O-acyltransferase 2" O15120 9 136673143-136687423 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 71.5;liver: 63.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 930.5;Paneth cells: 350.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019544 Uncertain Approved Centrosome NA NA Centrosome "HPA019544: AB_1844646" "unprognostic (3.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.01e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (9.30e-3)" "unprognostic (5.06e-3)" "unprognostic (8.98e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (2.17e-1)" "unprognostic (5.61e-2)" "unprognostic (2.60e-1)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" "unprognostic (2.93e-1)" 71.5 5.3 2.3 8.1 2.2 8.4 35.2 2.0 3.0 7.4 20.2 2.2 5.9 31.3 4.7 7.1 11.7 4.1 15.8 12.4 2.8 2.4 10.9 63.1 12.1 11.1 2.5 2.8 5.3 47.7 2.5 6.2 4.9 2.6 5.5 3.3 8.9 12.9 6.2 9.5 7.0 33.6 4.0 1.9 6.8 11.0 5.2 1.9 5.1 13.4 7.0 8.8 6.6 4.9 7.0 20.3 33.2 28.4 2.1 2.5 9.8 14.7 20.8 2.4 11.5 17.9 5.6 10.5 9.8 7.8 6.7 5.1 23.6 29.2 4.9 22.1 5.6 10.9 40.1 3.5 6.1 0.7 50.5 15.9 7.2 8.6 5.1 12.3 7.5 17.6 5.3 8.5 5.7 3.0 5.8 3.5 6.6 8.7 0.8 2.8 26.6 0.5 23.5 6.3 27.2 37.8 11.1 8.9 26.9 7.9 9.3 5.5 8.9 12.7 13.4 16.1 2.0 8.5 29.8 6.8 8.9 9.2 2.9 6.2 1.2 0.1 3.1 0.1 16.3 8.9 6.0 28.4 33.2 2.2 25.3 2.1 4.1 1.9 2.5 14.9 7.0 1.6 1.8 19.1 2.1 22.2 20.3 2.3 9.8 2.3 2.2 2.0 3.0 2.8 2.4 2.5 2.8 2.6 1.9 14.9 59.7 17.6 50.1 40.2 2.1 34.7 68.8 10.7 18.2 69.8 0.0 6.7 46.4 135.1 138.9 26.4 930.5 0.0 193.7 28.9 36.3 80.5 13.8 203.0 114.8 38.1 34.3 22.1 50.6 271.0 24.7 62.8 129.9 36.9 126.5 13.3 140.9 350.7 19.1 33.5 3.6 45.3 29.6 1.1 36.6 71.0 5.7 20.3 115.8 138.0 AGPAT3 LPAAT-gamma ENSG00000160216 "1-acylglycerol-3-phosphate O-acyltransferase 3" Q9NRZ7 21 43865186-43986536 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.1" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 172.8;Early spermatids: 230.1;Late spermatids: 164.7;Rod photoreceptor cells: 181.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.36e-2)" "prognostic unfavorable (8.31e-4)" "unprognostic (5.50e-2)" "unprognostic (4.56e-3)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (4.88e-2)" "unprognostic (9.72e-3)" "unprognostic (2.14e-1)" "unprognostic (3.54e-2)" "unprognostic (1.65e-1)" "unprognostic (2.84e-1)" "prognostic favorable (2.29e-4)" "unprognostic (1.50e-2)" "unprognostic (8.91e-2)" "unprognostic (1.80e-1)" "unprognostic (4.60e-2)" 12.0 10.2 21.5 11.1 23.0 5.8 12.7 14.6 22.7 6.4 20.1 18.9 8.5 27.4 5.1 10.4 13.4 8.1 8.6 11.6 19.9 15.1 33.8 30.2 9.9 9.0 21.7 11.4 5.4 12.7 17.1 7.3 7.6 13.6 7.9 7.6 10.6 24.0 8.0 59.1 10.2 34.6 5.8 25.2 10.2 11.1 11.7 11.4 7.2 14.1 15.0 7.0 9.8 6.6 1.3 4.5 2.4 10.6 0.7 3.5 2.0 26.9 15.4 3.8 10.5 7.8 8.6 3.0 12.5 15.7 15.9 9.8 15.1 19.7 9.1 9.5 14.8 14.9 10.5 6.6 13.8 4.6 43.5 17.6 4.0 9.5 20.2 13.6 14.7 9.1 10.2 11.9 14.0 5.9 14.9 11.9 3.1 22.5 15.1 5.7 11.6 0.1 9.1 1.8 10.7 10.9 15.1 4.4 24.6 12.6 26.6 13.3 9.7 15.2 17.4 11.6 1.6 12.0 16.0 17.6 10.1 0.1 15.1 12.7 12.1 18.0 5.7 13.1 29.4 9.1 0.0 4.1 2.4 1.5 8.9 1.5 1.3 2.1 2.2 4.5 1.2 1.7 1.9 1.0 0.7 10.6 1.1 3.5 2.0 21.5 23.0 14.6 22.7 19.9 15.1 21.7 11.4 13.6 11.4 11.9 23.1 7.5 7.5 7.1 36.1 31.3 20.4 32.1 22.7 24.4 172.8 13.2 8.3 23.9 230.1 11.7 47.3 0.0 25.5 0.7 8.9 14.4 4.7 59.5 16.9 62.0 13.3 15.4 24.3 164.7 7.2 22.0 1.7 27.9 21.9 27.1 23.5 20.1 5.3 42.8 181.7 6.5 7.8 9.0 2.1 9.7 10.1 9.2 19.3 12.2 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 51.8;Late spermatids: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: AB_2682101, HPA060525: AB_2684306" "unprognostic (5.69e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 9.2 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 7.1 4.6 2.3 7.3 6.8 1.8 0.0 1.0 1.6 4.7 0.0 7.5 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 8.1 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 3.0 5.6 5.2 4.6 2.9 1.0 4.0 2.5 10.7 5.7 5.2 0.0 16.0 0.0 4.3 51.8 12.2 0.0 0.0 7.0 10.7 11.3 0.8 10.5 0.4 16.7 0.0 1.7 9.8 7.6 44.8 5.5 15.4 3.3 11.8 0.0 4.0 5.9 0.0 8.1 0.3 0.9 19.4 6.2 3.6 2.9 2.3 18.5 7.4 0.0 3.2 AGR2 "AG2, HAG-2, PDIA17, XAG-2" ENSG00000106541 "Anterior gradient 2, protein disulphide isomerase family member" O95994 7 16791811-16833433 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 1045.3;Mucus-secreting cells: 2788.2;Paneth cells: 1013.4;Undifferentiated cells: 1404.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "OE19: 672.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA007912 Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 22000 "Endoplasmic reticulum" "HPA007912: AB_1844879" "unprognostic (6.19e-2)" "unprognostic (1.91e-1)" "unprognostic (9.05e-2)" "unprognostic (2.59e-2)" "unprognostic (2.23e-1)" "unprognostic (2.10e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.49e-2)" "unprognostic (1.84e-1)" "unprognostic (1.08e-2)" "unprognostic (3.24e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (8.79e-5)" "unprognostic (6.98e-2)" "unprognostic (2.38e-1)" "unprognostic (2.38e-1)" "unprognostic (3.22e-3)" 0.9 0.9 0.9 23.0 0.9 0.0 5.3 0.9 0.9 52.8 58.8 1.3 160.2 36.5 4.8 51.9 4.0 23.7 147.0 0.9 0.9 0.9 3.3 0.9 19.0 0.0 0.8 0.0 4.0 59.2 0.0 11.3 1.6 0.1 18.8 97.7 0.0 70.0 159.4 0.9 1.1 62.2 3.3 0.8 0.9 107.6 0.9 0.0 0.1 1.1 20.0 97.7 13.2 3.7 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 0.0 0.0 0.0 0.2 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 672.3 5.3 0.0 0.0 0.1 21.3 12.6 0.0 0.0 0.0 3.4 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.9 0.9 0.9 0.9 0.9 0.8 0.0 0.1 0.0 47.6 221.9 2.2 104.9 2.5 0.0 0.0 351.6 1045.3 577.8 76.8 0.0 4.6 0.0 37.7 2.8 0.1 824.5 0.0 764.4 3.5 4.2 606.7 44.8 0.6 180.1 0.0 501.7 0.0 0.6 0.0 0.3 2.7 3.3 1.8 2788.2 0.0 180.9 1013.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 2.7 0.7 1404.9 754.7 AGR3 "BCMP11, hAG-3, HAG3, PDIA18" ENSG00000173467 "Anterior gradient 3, protein disulphide isomerase family member" Q8TD06 7 16859405-16881987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 40.5;intestine: 99.1" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 1287.5;Club cells: 422.0;Enterocytes: 526.8;Mucus-secreting cells: 499.0;Paneth cells: 524.0" "Cancer enhanced" "Detected in many" "breast cancer: 104.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "OE19: 27.2;T-47d: 86.4" "Region enriched" "Detected in single" 5 "olfactory region: 5.6" HPA053942 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 31000 "Endoplasmic reticulum" Vesicles "HPA053942: AB_2682317" "unprognostic (2.18e-2)" "unprognostic (2.02e-1)" "unprognostic (2.13e-1)" "unprognostic (9.59e-2)" "unprognostic (3.32e-3)" "unprognostic (3.08e-2)" "unprognostic (1.49e-1)" "unprognostic (1.46e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.96e-1)" "unprognostic (6.66e-2)" "unprognostic (1.57e-1)" 0.6 0.0 0.6 7.5 0.7 0.0 13.1 0.7 0.6 4.4 45.8 0.6 0.6 29.2 1.2 5.4 0.9 40.5 11.8 0.6 0.6 0.3 1.5 0.6 26.3 0.6 0.6 0.6 5.1 1.9 0.0 12.9 2.8 1.9 1.1 38.9 0.6 9.4 0.6 0.6 0.3 99.1 1.2 0.8 0.6 17.1 1.0 0.6 0.6 1.4 1.9 3.9 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 27.2 0.0 0.0 0.0 0.5 2.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 86.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.7 0.6 0.6 0.3 0.6 0.6 1.9 0.6 309.7 310.7 0.0 9.4 2.4 0.0 0.0 35.7 1287.5 422.0 27.9 0.0 1.4 1.7 20.8 0.0 0.0 526.8 0.0 65.4 1.2 0.2 4.4 19.7 0.0 0.5 0.0 108.2 0.0 0.0 0.0 0.3 0.7 0.0 1.0 499.0 0.0 10.6 524.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.5 1.8 0.0 345.5 94.0 AGRP "Agrt, ART, ASIP2" ENSG00000159723 "Agouti related neuropeptide" O00253 16 67482571-67483813 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.4;epididymis: 49.8" "Group enriched" "Detected in some" 6 "Distal tubular cells: 3.3;Hofbauer cells: 9.2;Leydig cells: 2.8;Peritubular cells: 2.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 13 "hypothalamus: 19.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;CAPAN-2: 2.8;HeLa: 1.5;Hep G2: 2.2;HMC-1: 1.8" "Region enriched" "Detected in single" 16 "hypothalamus: 18.9" "Region enhanced" "Detected in many" "hypothalamus: 3.9" HPA041017 Enhanced Supported "Secreted in other tissues" NA NA 255000 "HPA041017: AB_10795498" "unprognostic (1.32e-1)" "unprognostic (6.26e-2)" "unprognostic (1.13e-1)" "unprognostic (4.16e-1)" "unprognostic (3.15e-1)" "unprognostic (1.10e-1)" "unprognostic (3.61e-1)" "unprognostic (3.34e-1)" "unprognostic (4.68e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (3.17e-1)" "unprognostic (2.80e-1)" "unprognostic (1.72e-1)" "unprognostic (5.63e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-2)" 0.1 9.6 0.1 0.1 1.4 0.0 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 49.8 0.1 0.0 0.1 0.1 0.1 19.4 0.5 0.1 2.1 0.3 0.1 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.0 0.3 0.5 0.1 0.1 0.4 0.1 0.1 0.3 0.3 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 2.1 1.4 3.8 0.3 3.2 1.0 0.1 0.0 0.4 1.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.6 2.8 0.8 0.2 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.4 1.5 2.2 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.2 0.0 1.5 0.1 1.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.2 0.0 0.1 1.0 0.5 1.0 0.0 0.4 0.3 0.0 3.8 1.4 3.2 2.3 1.6 2.2 0.8 1.1 1.5 1.9 2.1 2.2 0.6 0.3 1.2 2.1 1.3 1.0 0.1 1.4 0.1 0.2 0.1 19.4 0.1 0.3 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 AGT SERPINA8 ENSG00000135744 Angiotensinogen P01019 1 230702523-230714297 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 309.0" "Group enriched" "Detected in many" 12 "Cholangiocytes: 828.0;Hepatocytes: 2051.9" "Group enriched" "Detected in all" 10 "glioma: 275.3;liver cancer: 1163.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 111.1;THP-1: 42.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB025798 Supported "Secreted to blood" NA NA 5940000 110000000000 "CAB025798: " "unprognostic (7.77e-2)" "unprognostic (4.46e-1)" "unprognostic (2.15e-2)" "unprognostic (2.07e-2)" "unprognostic (2.67e-1)" "unprognostic (3.61e-2)" "unprognostic (5.75e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-2)" "unprognostic (4.46e-2)" "unprognostic (4.32e-3)" "unprognostic (6.70e-2)" "unprognostic (9.28e-2)" "unprognostic (4.42e-3)" "unprognostic (2.17e-1)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" 2.8 3.2 23.6 1.9 25.0 1.4 1.6 17.1 37.0 3.8 2.1 24.2 0.0 1.9 1.7 1.8 2.0 2.3 22.5 30.9 18.0 11.9 9.3 309.0 1.6 1.5 19.5 15.0 1.8 2.3 1.8 2.6 1.5 23.8 2.5 2.2 0.0 1.5 1.9 7.8 1.4 2.2 2.6 29.8 1.4 2.4 2.0 15.9 0.0 1.9 0.5 1.4 3.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 111.1 0.3 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.0 42.4 0.0 0.0 0.2 0.0 0.2 0.6 7.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 25.0 17.1 20.0 18.0 11.9 19.5 15.0 23.8 15.9 0.0 1.7 34.4 0.9 0.6 4.5 43.1 828.0 0.0 0.0 3.5 33.4 0.1 21.6 119.6 56.8 0.5 0.0 116.8 8.6 0.1 2.8 19.4 0.0 2051.9 1.8 3.2 0.0 34.4 50.3 31.9 3.7 0.0 8.5 1.0 0.0 89.3 18.7 0.0 3.2 123.3 42.2 12.9 6.4 0.4 0.4 0.0 0.6 4.5 0.0 1.3 AGTPBP1 "CCP1, KIAA1035, Nna1" ENSG00000135049 "ATP/GTP binding protein 1" Q9UPW5 9 85546539-85742029 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.2" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057208, HPA071094" Approved Approved Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA057208: AB_2683370, HPA071094: " "unprognostic (2.15e-1)" "unprognostic (3.78e-2)" "unprognostic (4.93e-3)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (8.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-1)" "unprognostic (8.26e-3)" "unprognostic (5.69e-3)" "unprognostic (6.31e-2)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (9.60e-3)" "unprognostic (1.25e-1)" 7.9 5.7 13.1 8.6 14.6 48.2 6.0 14.2 21.4 5.1 5.0 21.6 1.8 3.8 5.0 4.2 5.4 4.2 5.3 11.2 17.3 13.5 6.8 4.5 11.9 16.0 18.8 14.5 3.5 6.4 8.0 4.8 6.0 23.5 4.9 5.9 7.4 3.9 3.4 13.6 6.0 4.3 6.4 24.1 12.8 5.3 12.5 14.4 8.8 5.8 4.3 7.8 5.7 3.8 1.6 10.7 20.3 9.5 4.5 6.6 5.7 2.9 5.7 16.9 6.7 3.5 3.8 6.4 4.4 3.8 4.5 5.2 3.0 5.1 18.4 3.8 4.6 8.0 1.7 7.8 5.6 4.3 19.5 6.9 3.1 6.9 5.4 7.3 14.1 3.7 3.6 6.6 4.2 14.5 2.9 7.2 9.5 3.9 14.8 2.0 4.6 11.0 8.4 11.7 10.6 4.0 10.1 6.2 5.6 7.9 3.2 20.4 14.5 5.0 5.5 9.1 16.8 2.1 4.6 7.1 2.9 5.2 18.5 5.2 10.1 8.4 8.4 6.2 13.9 5.9 20.3 9.5 8.3 6.6 5.7 6.4 1.6 3.3 5.1 10.7 1.2 2.7 5.2 14.0 4.5 4.3 1.7 3.4 5.7 13.1 14.6 14.2 21.4 17.3 13.5 18.8 14.5 23.5 14.4 59.6 13.8 5.4 2.3 7.0 29.1 39.1 0.0 18.7 21.6 3.5 96.2 3.7 6.6 4.8 44.2 7.5 2.7 0.0 3.5 3.5 4.5 3.7 25.5 3.6 7.2 33.4 7.5 10.4 38.6 49.1 1.7 22.6 3.3 9.0 4.9 16.0 4.6 0.0 2.5 6.1 56.8 12.9 7.2 25.0 27.2 9.4 2.4 20.8 3.8 1.6 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.6;placenta: 44.9" "Group enriched" "Detected in many" 5 "Leydig cells: 134.3;Sertoli cells: 142.3" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 64.4;ASC TERT1: 9.0;BJ hTERT+ SV40 Large T+: 12.3;HBF TERT88: 19.4;HSkMC: 11.7" "Low region specificity" "Detected in many" HPA003596 Enhanced Uncertain Vesicles NA NA Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 18.8 11.6 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.8 5.5 0.0 0.6 0.5 0.5 2.2 1.6 3.1 0.0 0.1 5.7 29.6 2.6 0.0 0.9 0.8 0.6 0.6 0.8 44.9 1.3 1.0 1.0 1.0 2.9 4.4 0.7 1.1 0.0 2.3 1.7 0.2 4.1 0.0 4.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 64.4 9.0 0.0 0.0 1.3 12.3 7.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 1.1 0.6 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 3.1 0.0 5.7 5.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 6.6 0.2 13.7 1.2 0.0 26.8 0.6 0.0 22.7 29.4 0.8 0.2 134.3 0.0 1.7 0.0 0.0 4.5 0.8 0.0 7.1 0.0 0.0 142.3 15.5 0.0 0.4 1.5 0.2 0.0 0.0 0.0 AGTR2 "AT2, MRX88" ENSG00000180772 "Angiotensin II receptor type 2" P50052 X 116170722-116174972 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6" "Cell type enriched" "Detected in some" 15 "Alveolar cells type 2: 17.8" "Group enriched" "Detected in some" 12 "endometrial cancer: 3.0;lung cancer: 1.9" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HSkMC: 1.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 9 "cerebellum: 3.8" NA NA "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (3.22e-2)" "unprognostic (4.37e-2)" 0.3 1.6 0.1 0.8 0.1 0.0 0.1 1.0 0.1 5.3 0.4 0.1 0.1 0.0 20.8 3.3 0.2 3.6 0.4 1.7 0.1 0.0 0.4 0.1 26.7 0.8 0.1 0.1 1.1 1.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 13.6 0.1 0.1 0.6 0.2 0.1 0.4 0.1 1.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGTRAP ATRAP ENSG00000177674 "Angiotensin II receptor associated protein" Q6RW13 1 11736084-11754802 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 96.5" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 387.3;Kupffer cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044120 Enhanced Supported "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA044120: AB_10960748" "unprognostic (1.08e-3)" "unprognostic (2.98e-3)" "unprognostic (6.10e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (7.92e-3)" "prognostic unfavorable (6.57e-7)" "unprognostic (4.44e-2)" "unprognostic (7.96e-2)" "unprognostic (4.31e-2)" "unprognostic (1.61e-2)" "unprognostic (7.22e-2)" "unprognostic (1.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (2.33e-3)" "unprognostic (5.89e-2)" 16.5 19.2 8.7 16.6 10.8 65.5 31.0 3.1 10.0 13.0 9.7 16.7 15.6 6.5 10.3 37.0 19.6 28.4 14.5 22.0 8.9 6.9 29.7 11.0 26.4 35.6 14.2 6.6 15.0 27.2 7.9 12.2 15.2 16.5 33.2 5.6 17.1 22.2 13.5 25.3 13.2 8.4 13.4 12.9 31.0 12.3 15.3 10.7 11.4 25.5 12.6 14.6 15.2 26.0 5.2 35.2 85.3 96.5 7.7 21.7 53.1 15.0 18.7 4.7 10.3 7.9 10.1 8.7 7.9 13.7 9.8 8.6 11.9 36.7 1.6 36.2 9.6 24.7 12.8 7.8 37.7 3.1 0.8 17.1 0.4 11.3 14.1 24.7 7.4 18.3 10.0 29.9 32.0 17.0 12.1 13.1 4.8 19.7 14.9 5.5 12.4 3.6 21.9 8.4 6.5 19.1 1.2 4.2 7.5 16.0 1.4 4.1 6.2 14.6 7.4 13.5 6.6 16.8 15.8 7.4 12.6 8.9 19.8 8.4 5.5 6.5 8.8 32.2 53.7 5.8 45.4 96.5 74.3 21.7 47.6 10.8 5.2 8.2 12.9 35.2 4.0 8.8 11.7 85.3 7.7 39.8 2.9 9.6 53.1 8.7 10.8 3.1 10.0 8.9 6.9 14.2 6.6 16.5 10.7 20.8 27.2 6.9 27.5 10.3 0.3 10.1 30.6 56.2 17.0 34.9 5.9 15.2 8.3 87.9 13.0 31.8 6.4 0.0 387.3 71.9 36.4 56.1 84.5 6.6 107.2 3.2 6.9 45.4 167.4 16.3 35.1 52.2 27.0 8.2 11.0 15.6 91.8 24.6 25.5 44.0 5.5 12.9 6.6 3.3 27.5 11.8 11.0 47.5 19.1 21.8 AGXT "AGT, AGT1, AGXT1, PH1, SPAT, SPT" ENSG00000172482 "Alanine-glyoxylate aminotransferase" P21549 2 240868479-240880502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 172 "liver: 247.3" "Cell type enriched" "Detected in many" 17 "Hepatocytes: 1878.6" "Cancer enriched" "Detected in some" 425 "liver cancer: 253.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Hep G2: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035370, HPA035371" Enhanced Supported Vesicles NA NA 5200000 Vesicles "HPA035370: AB_10673218, HPA035371: AB_2674593" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (3.37e-4)" "unprognostic (1.04e-1)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "prognostic favorable (5.92e-5)" "unprognostic (8.28e-2)" "unprognostic (2.77e-1)" "unprognostic (5.39e-2)" "unprognostic (1.55e-1)" "unprognostic (7.57e-3)" "unprognostic (2.54e-1)" "unprognostic (9.22e-2)" "unprognostic (1.37e-1)" "unprognostic (3.26e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 247.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.4 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.1 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.8 28.1 0.0 0.0 7.0 0.0 0.5 19.9 0.0 0.0 0.0 2.6 46.7 1.6 22.7 0.0 0.5 0.0 1878.6 0.2 0.0 8.6 45.4 38.8 0.0 0.9 0.0 0.0 0.0 3.9 0.0 0.2 7.0 0.4 108.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 8.2 1.2 0.0 AGXT2 AGT2 ENSG00000113492 "Alanine--glyoxylate aminotransferase 2" Q9BYV1 5 34998101-35048135 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "kidney: 63.2;liver: 63.3" "Group enriched" "Detected in some" 5 "Hepatocytes: 87.7;Proximal tubular cells: 319.5" "Group enriched" "Detected in some" 112 "liver cancer: 9.2;renal cancer: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "T-47d: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037382 Enhanced NA NA 7300 "HPA037382: AB_10670851" "unprognostic (2.61e-1)" "unprognostic (1.40e-2)" "prognostic favorable (7.47e-4)" "unprognostic (8.24e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 63.2 63.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.7 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.7 0.0 0.0 0.0 1.8 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 319.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AHCYL2 KIAA0828 ENSG00000158467 "Adenosylhomocysteinase like 2" Q96HN2 7 129225023-129430211 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 72.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 75.8;Enterocytes: 114.1;Muller glia cells: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 8 "HDLM-2: 73.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053128 Uncertain Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA053128: AB_2682050" "unprognostic (1.57e-1)" "unprognostic (2.91e-1)" "unprognostic (8.52e-3)" "unprognostic (1.71e-3)" "unprognostic (7.44e-3)" "prognostic favorable (4.17e-4)" "unprognostic (8.85e-2)" "unprognostic (1.43e-1)" "unprognostic (3.35e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-1)" "unprognostic (6.79e-3)" "prognostic favorable (1.08e-7)" "unprognostic (4.70e-3)" "unprognostic (2.46e-1)" "unprognostic (7.21e-2)" "unprognostic (2.62e-1)" 4.3 6.6 12.8 5.9 20.3 1.5 4.3 7.2 16.9 7.1 61.8 13.3 5.1 23.1 6.1 3.3 5.7 4.4 22.7 3.4 16.5 9.6 11.9 3.4 26.1 4.2 10.7 14.9 5.7 5.8 9.1 12.8 5.1 19.8 5.0 72.4 24.3 15.0 3.3 20.7 9.8 15.0 5.3 11.4 2.9 16.5 8.1 9.6 4.6 24.1 4.0 4.0 5.4 4.7 0.9 1.3 2.0 2.5 3.3 5.0 0.5 2.7 4.3 8.3 4.9 2.2 3.3 1.7 2.1 3.0 2.4 2.2 2.5 1.8 1.6 2.2 2.3 5.2 1.9 4.1 3.4 2.7 73.5 5.1 3.9 4.8 2.0 1.3 2.8 5.0 3.0 4.4 1.9 3.0 4.1 4.8 3.2 1.7 9.3 3.1 2.5 4.2 3.7 4.1 2.7 3.0 2.8 2.2 4.4 4.9 3.6 3.8 2.4 4.9 2.1 2.9 7.2 2.0 2.1 2.7 2.1 1.2 5.5 2.2 3.9 4.4 2.2 5.4 3.1 3.2 0.1 1.2 2.0 0.9 2.5 1.2 0.9 1.5 0.7 1.3 0.5 1.3 0.5 0.4 3.3 1.2 0.4 5.0 0.5 12.8 20.3 7.2 16.9 16.5 9.6 10.7 14.9 19.8 9.6 56.6 75.8 3.4 4.5 13.9 9.4 4.5 17.8 5.3 19.4 5.2 5.9 8.4 10.0 3.6 61.0 3.9 114.1 0.0 4.9 2.2 3.1 6.2 5.7 4.9 3.9 4.8 8.7 4.3 8.3 20.3 3.7 5.1 23.6 7.2 29.7 87.7 4.5 30.8 6.3 15.7 5.0 6.5 1.2 4.6 2.4 8.5 12.7 3.2 32.7 13.9 AHI1 "FLJ20069, JBTS3, ORF1" ENSG00000135541 "Abelson helper integration site 1" Q8N157 6 135283532-135497776 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation" "Developmental protein" "Ciliopathy, Disease mutation, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 54.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 1056.4;Rod photoreceptor cells: 1624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031698, HPA046684" Approved Uncertain Centrosome NA NA Centrosome "HPA031698: AB_2673997, HPA046684: AB_2679752" "unprognostic (4.00e-2)" "unprognostic (2.86e-1)" "unprognostic (8.13e-2)" "unprognostic (1.02e-1)" "unprognostic (3.17e-2)" "unprognostic (2.18e-2)" "unprognostic (2.70e-3)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (4.58e-2)" "prognostic favorable (7.51e-5)" "unprognostic (2.81e-2)" "prognostic unfavorable (4.07e-9)" "unprognostic (2.49e-2)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" "unprognostic (6.19e-3)" 6.7 16.2 16.8 6.4 16.5 5.9 12.5 35.3 26.5 11.7 8.7 4.2 13.2 4.9 14.4 32.1 7.8 9.0 9.0 7.6 15.9 19.9 8.4 6.8 8.1 6.0 11.4 19.6 13.9 11.6 11.5 54.2 8.3 18.2 16.3 13.1 10.0 8.2 15.9 6.7 6.1 5.7 11.1 18.5 4.3 10.7 29.2 13.1 3.3 11.6 5.0 6.3 8.9 12.0 10.6 16.6 4.8 1.7 3.8 4.2 0.5 5.2 7.2 8.5 10.9 13.9 15.1 3.8 9.7 12.2 9.8 15.1 2.8 5.6 8.2 4.8 9.3 9.8 4.0 6.3 3.0 14.6 6.5 8.5 3.0 20.3 5.3 5.9 15.2 3.3 7.0 5.0 15.2 8.3 15.2 8.0 10.2 13.5 0.5 13.2 5.6 14.4 3.4 5.1 4.0 4.4 7.3 3.4 2.7 4.9 5.3 14.8 7.9 12.9 4.8 5.8 6.6 3.8 6.9 7.6 8.5 10.5 14.5 7.6 10.7 9.8 3.8 12.0 2.2 10.1 4.8 1.7 0.6 4.2 0.5 2.6 8.2 4.0 4.2 2.6 10.6 3.2 4.1 0.1 3.8 0.5 16.6 2.4 0.5 16.8 16.5 35.3 26.5 15.9 19.9 11.4 19.6 18.2 13.1 35.7 87.4 13.4 33.8 25.4 293.7 22.6 7.6 89.7 51.2 55.8 1056.4 21.3 11.6 24.5 265.7 46.0 7.7 0.0 38.6 16.0 36.7 32.6 56.6 15.8 12.0 311.4 97.8 16.5 4.7 272.8 62.7 18.8 30.4 11.8 34.2 96.6 20.6 37.4 61.2 9.7 1624.0 51.8 41.2 126.9 110.1 19.7 23.9 12.8 31.5 21.8 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978357 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 131.1" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 101.5;Horizontal cells: 57.2;Suprabasal keratinocytes: 143.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "ASC diff: 28.6;ASC TERT1: 32.5;HBEC3-KT: 28.6;hTCEpi: 72.0;hTERT-HME1: 30.7;TIME: 32.3" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371" "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.23e-5)" 6.9 1.8 2.9 2.0 5.6 1.0 8.5 3.0 13.7 17.2 23.0 2.9 5.7 1.7 16.3 2.9 25.8 7.1 3.2 1.5 2.4 3.1 1.1 10.8 2.3 1.0 2.7 11.6 1.8 1.2 1.2 0.7 1.8 23.3 5.7 5.1 10.1 6.0 14.6 1.6 131.1 4.8 19.9 4.8 1.1 7.1 3.2 0.8 0.0 1.2 14.4 3.0 10.0 19.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 20.0 0.0 1.4 28.6 32.5 0.0 2.4 5.1 0.9 0.4 0.0 8.9 0.0 3.4 18.8 20.0 14.5 0.0 28.6 0.4 0.0 0.1 0.0 13.3 0.1 2.6 0.0 0.9 4.1 72.0 2.8 30.7 12.3 12.5 0.0 0.0 0.0 14.4 1.6 0.0 0.0 0.0 2.1 9.9 0.0 1.3 0.0 19.6 0.0 0.1 0.1 10.6 0.0 0.5 0.6 1.3 0.0 32.3 6.9 4.3 7.9 2.2 0.0 0.0 0.0 21.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 5.6 3.0 13.7 2.4 3.1 2.7 11.6 23.3 0.8 11.9 1.4 0.0 4.0 101.5 4.7 1.0 0.0 25.4 18.2 1.8 2.0 0.0 0.0 10.2 20.6 16.7 0.0 0.0 7.7 0.2 11.4 1.9 16.2 0.5 1.0 57.2 0.0 1.8 0.3 1.6 0.6 0.7 30.4 0.0 0.0 3.0 41.0 0.0 0.4 0.3 10.5 0.0 7.2 0.4 3.8 143.9 0.1 0.7 0.0 4.9 AHR bHLHe76 ENSG00000106546 "Aryl hydrocarbon receptor" P35869 7 16916359-17346152 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Cancer-related genes, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.6" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 140.0;granulocytes: 130.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 28.0;hTERT-HME1: 29.2;RT4: 24.0" "CAB005072, HPA029722, HPA029723" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025" "unprognostic (1.29e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (7.28e-2)" "unprognostic (1.22e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-1)" "unprognostic (4.32e-2)" "unprognostic (9.98e-2)" "unprognostic (1.24e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-2)" "unprognostic (9.45e-2)" 23.1 12.2 2.5 13.2 3.5 19.8 19.1 1.6 3.5 14.6 14.0 5.7 8.7 8.5 11.9 10.1 14.2 11.2 22.2 14.8 3.2 2.2 7.3 23.9 26.4 20.0 6.5 2.5 21.3 6.8 4.5 3.8 69.6 3.7 21.4 8.9 10.9 11.1 8.5 5.2 16.6 13.7 12.1 4.8 15.6 13.3 6.8 4.0 7.1 12.4 7.9 12.3 26.7 26.6 1.1 9.3 5.6 7.6 3.1 2.9 2.0 3.0 2.5 1.0 0.0 7.7 5.3 0.4 6.3 9.1 2.9 4.3 3.0 6.8 0.0 1.9 9.2 11.6 8.4 0.6 5.7 7.7 0.1 1.4 1.8 3.2 2.7 14.3 3.0 4.5 7.2 28.0 11.1 29.2 13.3 9.7 0.0 0.2 0.0 13.2 1.5 0.0 4.8 0.8 23.0 4.0 0.0 0.0 0.1 9.3 24.0 0.9 0.0 4.7 5.1 4.6 7.7 3.6 1.0 1.6 1.2 0.0 15.9 0.0 1.3 0.0 0.0 20.4 11.7 20.0 0.7 7.6 5.6 0.7 3.6 1.1 0.8 2.6 1.4 9.3 1.1 1.5 1.1 0.8 3.1 1.3 2.2 2.9 2.0 2.5 3.5 1.6 3.5 3.2 2.2 6.5 2.5 3.7 4.0 140.0 72.8 9.4 40.0 66.9 34.6 12.9 43.3 42.8 75.1 7.0 7.9 3.1 0.0 15.8 4.8 55.4 13.6 0.0 13.4 1.2 31.0 42.7 130.4 40.0 24.3 41.3 5.2 44.2 75.1 2.4 3.4 73.2 67.4 36.9 10.6 0.5 24.6 16.9 2.5 5.6 5.7 6.5 41.1 2.4 2.3 78.0 18.0 7.5 12.6 90.1 AHRR "AHH, AHHR, bHLHe77, KIAA1234" ENSG00000063438 "Aryl-hydrocarbon receptor repressor" A9YTQ3 5 304176-438291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 44.3" "Group enriched" "Detected in some" 8 "Early spermatids: 233.3;Late spermatids: 118.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 23.8;HMC-1: 35.8;NB-4: 43.1;WM-115: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021483 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021483: AB_1855110" "unprognostic (2.06e-4)" "unprognostic (3.48e-2)" "unprognostic (8.71e-3)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.33e-4)" "unprognostic (4.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.02e-5)" "unprognostic (1.87e-1)" "unprognostic (5.07e-2)" "unprognostic (1.65e-6)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.55e-2)" 0.8 0.4 1.0 4.6 0.8 0.2 2.4 0.4 1.4 2.4 1.2 0.7 1.4 0.7 1.6 0.9 1.4 0.5 4.4 0.3 1.2 1.0 0.6 0.4 6.2 0.4 0.3 0.0 2.1 1.0 0.1 1.3 2.1 0.9 0.6 1.2 2.7 0.9 0.3 0.6 5.8 1.7 0.9 0.3 4.7 0.7 44.3 0.3 0.1 0.9 1.8 4.2 2.0 3.6 0.9 2.3 1.0 0.5 0.0 1.0 0.3 0.1 4.0 0.6 0.5 2.2 4.6 4.7 8.5 11.5 4.8 9.5 0.1 3.2 0.3 4.4 15.4 1.3 0.2 0.7 0.2 2.1 0.6 1.7 4.0 23.8 0.1 1.6 1.2 35.8 0.9 0.3 3.3 0.4 6.4 1.7 1.0 0.6 0.3 5.1 0.3 0.3 43.1 0.1 1.0 4.0 0.6 0.2 0.4 0.1 0.0 5.6 0.2 11.3 2.1 5.8 0.1 0.2 14.7 2.1 8.9 1.1 10.0 0.3 1.3 2.1 0.3 3.8 0.3 25.2 0.0 0.5 1.0 0.3 0.0 0.1 0.2 0.6 0.3 0.0 0.9 0.1 0.1 0.5 0.0 0.1 2.3 1.0 0.3 1.0 0.8 0.4 1.4 1.2 1.0 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 233.3 1.0 0.0 0.0 0.2 4.3 3.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 118.4 3.1 2.2 18.6 10.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 6.5 1.4 21.3 7.0 1.3 0.7 0.0 0.0 0.1 AHSA1 "Aha1, C14orf3, hAha1, p38" ENSG00000100591 "Activator of HSP90 ATPase activity 1" O95433 14 77457870-77469474 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 177.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000903, CAB006244" Supported Supported Cytosol NA NA 28000 Cytosol "CAB006244: AB_425858, HPA000903: AB_1078112" "unprognostic (3.91e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (3.48e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (5.04e-6)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.88e-1)" "unprognostic (2.63e-2)" "unprognostic (2.16e-2)" "unprognostic (1.33e-1)" "unprognostic (3.06e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-1)" 23.7 39.3 37.8 26.9 44.4 20.7 58.9 33.1 52.1 25.7 27.9 22.6 28.9 21.0 31.7 34.9 27.2 56.4 18.6 47.8 38.2 38.2 31.5 28.4 21.9 29.4 61.8 29.7 30.3 25.4 32.0 37.0 34.9 50.1 32.0 34.9 11.5 24.7 35.3 48.5 20.8 20.7 40.0 42.5 21.5 22.8 40.5 54.3 26.0 37.6 24.5 40.3 24.8 177.1 44.3 36.6 34.5 45.1 42.3 42.3 26.9 33.8 66.9 18.3 23.9 28.4 20.5 32.2 25.2 20.0 39.6 29.7 50.1 29.3 63.0 19.8 24.6 45.9 38.7 66.0 32.3 44.2 25.0 39.3 29.7 33.3 60.4 20.9 18.7 42.9 18.1 43.2 26.6 13.0 23.7 37.4 41.0 36.7 20.3 24.7 93.0 46.0 35.7 31.8 57.6 70.4 37.1 21.7 31.4 31.2 35.2 28.2 31.1 23.4 52.3 21.6 29.8 31.9 25.9 19.4 21.5 30.5 24.1 35.8 20.5 41.2 48.4 31.2 37.6 23.6 32.6 28.2 34.5 37.8 39.0 42.3 44.3 34.8 38.7 36.6 34.3 40.0 40.1 20.2 42.3 45.1 34.1 40.0 26.9 37.8 44.4 33.1 52.1 38.2 38.2 61.8 29.7 50.1 54.3 32.8 22.9 72.8 138.0 138.5 35.7 79.2 35.7 115.1 37.5 26.2 80.5 132.6 63.0 69.8 30.4 41.4 51.9 0.0 42.8 89.9 69.9 112.4 76.0 37.3 81.2 17.5 75.1 23.4 22.5 25.2 62.7 50.6 86.0 82.0 41.3 42.4 57.3 50.1 62.6 59.7 52.4 97.0 101.1 80.9 45.1 122.5 114.3 44.9 57.2 106.3 AHSG "A2HS, FETUA, HSGA" ENSG00000145192 "Alpha 2-HS glycoprotein" P02765 3 186612923-186621318 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Mineral balance" "Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 269 "liver: 402.0" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 986.2" "Cancer enriched" "Detected in some" 284 "liver cancer: 1231.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.4" "Lineage enhanced" "Detected in single" "NK-cells: 1.4" "Cell line enriched" "Detected in some" 77 "Hep G2: 215.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001524, HPA001525, CAB026209" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 864000000000 140000000000 "Golgi apparatus" "CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849" "unprognostic (6.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (3.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (7.47e-3)" "unprognostic (3.05e-1)" "unprognostic (5.27e-2)" "unprognostic (8.64e-2)" "unprognostic (3.99e-7)" "unprognostic (5.21e-2)" "unprognostic (5.21e-2)" "unprognostic (1.04e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 402.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 215.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 10.2 0.0 0.0 0.0 0.0 0.1 3.3 0.1 4.6 0.0 0.0 46.7 0.5 0.6 0.0 0.0 0.0 986.2 1.2 0.0 0.0 29.4 29.9 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.1 AHSP "EDRF, ERAF" ENSG00000169877 "Alpha hemoglobin stabilizing protein" Q9NZD4 16 31527864-31528803 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 189.3" "Cell type enriched" "Detected in some" 394 "Erythroid cells: 8947.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 7.7;K-562: 3.3;MOLT-4: 2.1;NTERA-2: 1.4" "Low region specificity" "Detected in all" HPA040940 Enhanced NA NA 8400000 "HPA040940: AB_10796231" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (8.44e-2)" "unprognostic (3.76e-1)" "unprognostic (1.53e-1)" "unprognostic (3.10e-1)" "unprognostic (2.16e-1)" "unprognostic (3.70e-3)" "unprognostic (2.04e-2)" "unprognostic (9.02e-2)" "unprognostic (3.25e-2)" 0.6 0.1 0.3 0.3 0.4 189.3 0.9 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.3 0.1 0.2 0.1 0.1 4.0 0.2 0.2 1.0 3.5 20.0 0.1 0.7 0.0 0.8 1.1 0.1 1.1 30.2 0.2 0.5 0.1 1.0 0.1 0.1 0.7 0.3 0.1 0.1 0.3 18.9 0.1 2.8 0.1 1.1 2.1 0.0 0.1 1.5 0.8 0.3 0.2 0.8 0.1 0.0 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 9.2 0.3 0.4 0.0 0.1 0.2 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 8947.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 18.0 0.3 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 AICDA "AID, ARP2, CDA2, HIGM2" ENSG00000111732 "Activation induced cytidine deaminase" Q9GZX7 12 8602166-8612871 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "mRNA processing" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.6;lymphoid tissue: 22.3" "Cell type enhanced" "Detected in single" 10 "Alveolar cells type 2: 1.1" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 6.6" "Group enriched" "Detected in many" 6 "B-cells: 6.6;granulocytes: 1.6" "Group enriched" "Detected in some" 6 "Daudi: 49.6;U-698: 41.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.71e-2)" "unprognostic (1.39e-2)" "unprognostic (7.76e-2)" "unprognostic (1.68e-1)" "unprognostic (8.73e-3)" "unprognostic (1.11e-1)" "unprognostic (4.05e-2)" "unprognostic (9.69e-2)" "unprognostic (1.96e-2)" "unprognostic (4.04e-6)" "unprognostic (8.82e-2)" "unprognostic (1.28e-1)" "unprognostic (4.21e-1)" "unprognostic (4.65e-1)" 1.3 0.1 0.1 22.3 0.1 0.4 0.4 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.9 0.1 0.1 0.2 0.3 0.4 0.1 0.0 0.2 0.1 0.5 15.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 1.8 0.1 1.1 0.5 3.9 0.1 0.1 1.7 0.2 0.2 0.1 0.6 0.3 0.1 12.2 0.1 0.7 6.6 0.7 1.6 0.7 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 49.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 41.4 0.0 0.1 0.0 1.0 0.7 0.4 0.4 0.3 0.2 4.3 0.4 0.2 0.4 6.6 0.4 0.4 1.6 0.5 0.4 0.7 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.3 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 AIF1 "AIF-1, Em:AF129756.17, IBA1, IRT-1" ENSG00000204472 "Allograft inflammatory factor 1" P55008 6 31615184-31617021 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.2;lymphoid tissue: 99.3" "Group enriched" "Detected in many" 19 "Hofbauer cells: 1482.8;Kupffer cells: 1886.5;Macrophages: 1383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2" "Group enriched" "Detected in many" 33 "dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2" "Cell line enhanced" "Detected in some" "HEL: 25.8;HMC-1: 37.2;JURKAT: 15.1;NB-4: 59.1;THP-1: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049234, HPA062949" Enhanced Uncertain Cytosol NA NA Cytosol "HPA049234: AB_2680685, HPA062949: AB_2732694" "unprognostic (3.20e-2)" "unprognostic (7.21e-3)" "unprognostic (6.11e-2)" "unprognostic (2.33e-2)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (6.98e-2)" "unprognostic (4.83e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.41e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.29e-1)" "unprognostic (1.02e-2)" "unprognostic (9.59e-2)" "unprognostic (4.89e-2)" 13.5 9.5 13.0 27.7 23.8 39.8 7.8 1.8 10.0 5.2 8.0 17.0 0.1 6.1 3.2 8.3 3.6 5.6 9.8 5.8 10.2 10.2 15.4 12.6 19.9 40.5 16.9 3.1 4.9 3.4 2.0 4.9 17.0 12.8 6.1 9.7 4.6 5.7 4.3 3.5 2.9 10.8 11.1 28.5 99.3 4.8 2.6 16.2 71.7 3.6 1.7 9.8 11.2 3.5 0.7 35.9 51.7 119.2 0.3 2.1 59.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 0.0 0.0 1.7 37.2 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.1 0.0 0.0 0.0 0.2 59.1 0.1 0.0 0.0 9.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.3 0.0 0.5 67.4 3.2 0.2 104.8 0.2 0.7 0.3 0.3 35.9 0.1 2.1 1.7 51.7 0.3 119.2 3.3 0.1 59.6 13.0 23.8 1.8 10.0 10.2 10.2 16.9 3.1 12.8 16.2 23.8 84.5 70.4 0.6 28.8 0.0 5.5 25.5 18.7 35.2 40.1 0.0 9.9 0.0 0.0 1.1 13.5 0.4 0.0 0.4 10.9 24.2 0.3 64.9 8.9 1482.8 0.0 1.2 43.0 1886.5 1.5 6.9 1383.0 37.1 40.5 0.0 0.0 0.1 5.8 0.7 3.1 0.0 51.8 17.6 0.3 1.5 24.7 19.0 27.4 0.4 0.0 AIF1L "C9orf58, FLJ12783, IBA2" ENSG00000126878 "Allograft inflammatory factor 1 like" Q9BQI0 9 131096476-131123152 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 128.9;lymphoid tissue: 92.1" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 338.5;Distal tubular cells: 245.4;Extravillous trophoblasts: 271.1;Proximal tubular cells: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.8" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.8" "Cell line enhanced" "Detected in many" "AF22: 35.3;MCF7: 23.2;NTERA-2: 26.5;RPTEC TERT1: 76.2;SuSa: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020522, HPA056852" Enhanced NA NA "HPA020522: AB_2670463, HPA056852: AB_2683256" "unprognostic (2.59e-2)" "unprognostic (1.83e-3)" "unprognostic (2.55e-2)" "unprognostic (2.81e-2)" "unprognostic (1.78e-2)" "unprognostic (2.01e-2)" "unprognostic (1.01e-2)" "unprognostic (2.64e-1)" "unprognostic (1.77e-1)" "unprognostic (4.39e-1)" "unprognostic (2.81e-2)" "unprognostic (2.68e-1)" "prognostic favorable (5.54e-6)" "unprognostic (2.48e-2)" "unprognostic (2.37e-1)" "unprognostic (1.38e-2)" "unprognostic (6.20e-2)" 20.5 3.1 31.4 3.3 35.4 2.2 17.4 7.7 24.9 7.6 3.6 42.9 42.1 1.9 5.5 6.1 28.2 6.3 5.1 10.4 36.9 22.4 128.9 1.9 7.0 2.0 45.3 12.4 2.9 3.4 13.2 5.5 12.4 27.3 3.4 4.0 5.9 15.2 39.4 7.4 7.4 2.6 6.1 59.9 92.1 2.8 4.2 25.4 0.0 45.0 7.7 5.2 5.8 6.9 0.1 0.0 0.0 0.0 1.8 0.4 0.2 0.1 0.5 35.3 6.1 0.0 0.0 14.7 0.0 0.0 0.0 0.0 6.3 2.7 0.0 16.0 0.0 0.7 3.3 5.2 0.3 0.2 0.0 6.8 3.5 1.8 12.5 0.0 0.0 1.8 0.3 1.6 0.1 0.1 0.1 1.6 9.6 2.3 0.0 0.0 23.2 2.1 0.4 26.5 2.1 2.4 0.0 0.4 9.7 76.2 2.0 13.4 2.2 1.8 15.0 4.9 21.9 14.2 0.2 0.2 0.9 2.6 0.1 7.2 0.1 0.1 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.2 31.4 35.4 7.7 24.9 36.9 22.4 45.3 12.4 27.3 25.4 0.0 0.0 0.0 1.8 3.7 0.0 3.9 0.0 0.0 2.3 338.5 0.0 2.9 245.4 1.6 1.1 17.3 0.0 0.0 0.7 271.1 15.3 4.2 0.0 0.0 6.2 0.0 3.5 17.8 0.3 1.7 34.8 0.8 64.1 0.0 1.9 14.5 4.7 0.0 55.5 142.6 0.0 0.0 4.1 0.3 2.3 2.0 17.6 0.0 1.1 1.4 AIFM1 "AIF, CMTX4, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130129362-130165887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 66.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 148.9;Proximal tubular cells: 209.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced Supported Mitochondria NA NA 160000 Mitochondria "CAB003764: AB_289587, HPA030611: AB_2673549" "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favorable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 9.9 28.9 7.1 11.3 8.6 5.3 7.1 7.5 8.9 10.4 14.2 8.4 10.0 19.6 9.9 11.7 8.6 13.0 11.4 34.2 7.2 7.0 66.8 50.5 5.8 9.8 8.2 7.1 7.3 14.6 16.8 7.7 6.1 8.8 6.9 14.2 12.3 13.1 9.4 35.7 5.8 23.2 8.9 6.4 8.7 14.9 14.9 7.2 19.5 7.9 16.1 9.7 8.4 6.0 10.8 22.0 9.8 18.3 15.8 12.8 8.0 16.8 31.2 12.8 32.0 14.6 10.4 16.9 10.7 9.3 16.5 13.3 22.1 12.5 36.4 37.3 9.8 19.6 16.3 39.4 13.9 17.6 13.9 24.0 23.1 23.5 30.0 18.6 20.2 24.3 12.9 13.7 17.5 15.0 9.2 13.9 27.5 19.8 16.9 11.6 40.6 20.5 31.7 9.2 34.0 24.2 18.6 14.3 42.1 37.3 17.1 16.5 9.6 12.5 28.9 27.8 15.2 14.9 18.3 10.1 7.9 7.6 21.4 20.3 9.0 14.6 17.0 10.1 33.9 11.8 2.9 14.8 9.8 9.1 18.3 9.6 10.8 9.7 11.2 22.0 8.1 9.6 9.7 2.1 15.8 15.5 10.6 12.8 8.0 7.1 8.6 7.5 8.9 7.2 7.0 8.2 7.1 8.8 7.2 14.9 15.3 20.1 8.0 7.7 17.8 148.9 20.4 21.4 15.9 38.4 21.6 48.7 77.9 21.8 1.3 10.2 33.3 0.0 18.1 22.0 13.9 6.9 10.4 83.4 33.5 14.3 9.2 14.7 15.5 3.9 16.1 14.0 10.1 17.2 17.6 12.2 17.3 17.3 16.3 209.8 36.6 6.5 9.0 3.9 32.1 5.9 33.2 13.1 32.6 8.9 AIFM2 "AMID, FLJ14497, PRG3" ENSG00000042286 "Apoptosis inducing factor, mitochondria associated 2" Q9BRQ8 10 70098223-70132934 "Predicted intracellular proteins" "DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 41.9" "Cell type enhanced" "Detected in many" 5 "monocytes: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 57.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028961, HPA042309, HPA075576" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: " "unprognostic (6.62e-2)" "unprognostic (2.73e-1)" "unprognostic (4.29e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.26e-3)" "unprognostic (2.57e-2)" "unprognostic (7.95e-3)" "unprognostic (2.80e-1)" "unprognostic (5.31e-2)" "unprognostic (8.90e-2)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (4.49e-1)" "unprognostic (4.59e-3)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.92e-4)" 32.9 7.8 3.1 6.6 5.9 1.3 41.9 5.0 3.7 3.5 9.0 2.1 22.1 7.6 4.5 9.6 9.1 4.0 7.6 19.7 2.8 4.1 10.2 18.2 8.1 4.0 2.9 2.4 7.5 3.6 3.9 3.1 5.2 3.5 6.4 5.9 9.2 5.8 15.2 9.1 2.8 9.9 7.8 3.7 5.9 6.5 3.1 2.1 1.0 10.8 6.4 7.3 11.8 15.7 3.4 0.7 1.5 1.0 7.8 3.5 1.2 8.8 15.4 0.4 4.0 9.3 3.5 0.1 3.5 8.8 7.3 8.3 11.9 17.2 1.3 9.1 4.9 9.7 9.6 4.3 1.2 2.0 17.2 0.7 0.0 9.1 57.7 20.0 0.1 2.2 4.7 2.9 11.7 2.5 4.6 3.2 0.6 6.7 7.6 3.7 11.2 0.4 0.4 1.6 7.1 5.0 0.2 1.4 4.2 3.9 6.5 1.3 0.3 6.5 5.7 10.0 0.6 0.2 2.4 4.0 0.1 9.0 5.4 10.3 5.7 10.6 2.4 4.9 0.3 4.8 1.5 0.9 1.0 3.5 0.8 3.1 3.4 1.2 3.0 0.7 2.9 1.7 2.7 1.0 7.8 1.0 0.5 2.4 1.2 3.1 5.9 5.0 3.7 2.8 4.1 2.9 2.4 3.5 2.1 6.0 13.1 2.2 11.6 2.1 5.5 11.7 10.2 9.4 10.3 17.4 0.0 12.6 3.3 35.2 19.5 2.3 32.9 0.0 19.3 2.5 6.3 12.0 11.5 20.2 10.5 1.6 11.5 2.5 1.8 33.7 4.9 3.5 8.5 59.5 6.0 4.5 31.0 17.5 4.2 11.5 1.7 19.4 13.0 3.2 3.2 1.3 15.6 5.1 9.0 14.8 AIFM3 "AIFL, FLJ30473" ENSG00000183773 "Apoptosis inducing factor, mitochondria associated 3" Q96NN9 22 20965108-20981360 "Predicted intracellular proteins" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.7;intestine: 28.0" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 42.3;Mucus-secreting cells: 33.7;Paneth cells: 29.1;Undifferentiated cells: 39.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 7.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 2.2;intermediate monocyte: 5.7;myeloid DC: 3.8;non-classical monocyte: 3.4" "Group enriched" "Detected in many" 22 "dendritic cells: 3.8;monocytes: 5.7" "Cell line enhanced" "Detected in some" "Hep G2: 8.8;HMC-1: 13.1;T-47d: 6.4;THP-1: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001271 Supported Mitochondria NA NA Mitochondria "HPA001271: AB_1078114" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (7.49e-2)" "unprognostic (9.99e-2)" "unprognostic (6.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.73e-3)" "unprognostic (3.28e-1)" "unprognostic (1.56e-1)" "unprognostic (4.13e-3)" "unprognostic (5.13e-2)" "unprognostic (7.99e-2)" "unprognostic (6.78e-2)" "unprognostic (1.47e-1)" "unprognostic (3.37e-1)" "prognostic favorable (7.13e-5)" 1.3 1.3 20.3 4.6 19.0 5.4 0.8 14.4 18.4 1.2 28.0 9.7 0.0 4.3 0.9 0.8 0.9 1.2 1.6 0.9 14.6 9.9 0.9 0.8 1.5 1.4 14.8 12.4 1.0 0.9 0.9 1.9 1.3 21.7 1.2 13.0 5.0 2.2 1.9 0.7 0.9 3.4 1.9 9.6 2.7 1.6 1.1 7.6 0.0 1.0 0.0 0.8 1.9 0.1 0.2 3.8 0.0 5.7 0.0 0.0 0.9 1.2 2.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.3 0.0 2.2 0.0 8.8 0.2 0.0 13.1 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.6 0.0 0.1 0.0 0.4 0.0 0.1 0.0 1.4 0.0 1.5 1.8 1.1 1.0 0.1 0.0 0.1 6.4 9.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 5.7 0.0 0.2 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.9 20.3 19.0 14.4 18.4 14.6 9.9 14.8 12.4 21.7 7.6 0.0 1.0 1.7 1.6 0.6 10.9 2.4 0.0 0.0 0.0 1.8 5.9 0.9 10.0 0.7 0.0 0.7 42.3 0.0 0.6 0.6 0.4 2.9 1.1 1.8 2.9 0.0 9.9 1.3 3.7 0.0 0.0 2.2 0.0 0.0 33.7 18.1 0.6 29.1 0.0 6.0 2.9 0.0 0.8 0.0 0.7 0.6 0.7 0.0 39.2 2.2 AIG1 "AIG-1, dJ95L4.1, FLJ10485" ENSG00000146416 "Androgen induced 1" Q9NVV5 6 143060496-143340304 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.7" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 202.6;Proximal tubular cells: 212.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060766 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA060766: AB_2684356" "unprognostic (2.70e-2)" "prognostic unfavorable (3.26e-6)" "unprognostic (4.27e-2)" "prognostic unfavorable (3.06e-4)" "unprognostic (5.34e-2)" "prognostic unfavorable (3.25e-7)" "unprognostic (1.91e-2)" "unprognostic (8.75e-3)" "unprognostic (2.17e-1)" "unprognostic (5.53e-2)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (9.11e-2)" "unprognostic (2.75e-1)" 18.4 14.9 20.1 5.6 18.7 13.0 16.8 15.6 22.3 8.1 15.1 26.6 7.9 22.3 7.7 18.8 14.7 16.7 14.2 21.9 21.7 26.0 51.4 115.7 8.6 5.7 23.3 15.7 17.1 14.2 9.7 19.2 6.3 25.7 12.5 9.7 21.1 11.5 12.8 10.1 8.2 25.6 8.9 28.6 9.4 8.7 10.0 14.7 1.7 23.0 11.2 11.3 14.5 10.5 6.4 19.0 8.2 18.7 6.3 10.0 5.7 9.4 7.1 6.7 18.8 9.6 8.5 2.3 8.2 18.3 8.2 20.1 10.5 27.9 6.3 11.8 18.9 12.1 13.5 8.1 27.1 20.4 18.5 17.9 1.5 11.0 43.5 14.3 13.5 0.9 10.1 27.8 10.4 44.5 29.8 3.2 8.7 1.1 22.2 21.0 12.6 4.1 3.4 12.6 10.7 8.2 6.0 18.2 10.5 32.9 21.6 23.7 13.2 10.7 10.1 4.8 12.0 10.6 31.5 1.0 7.9 8.5 7.8 10.1 29.6 23.5 0.5 19.4 3.2 8.1 5.8 3.9 5.9 4.4 16.8 10.0 6.4 8.2 6.7 19.0 4.2 8.8 6.8 8.2 6.3 18.7 1.9 5.7 5.7 20.1 18.7 15.6 22.3 21.7 26.0 23.3 15.7 25.7 14.7 14.9 23.0 21.7 44.8 22.1 63.0 65.1 76.5 57.6 35.2 48.8 23.6 56.8 44.7 47.3 9.7 28.1 17.9 23.3 27.4 6.9 41.9 39.0 36.8 202.6 29.0 50.9 37.9 31.3 26.1 5.6 29.7 27.8 52.3 23.4 25.0 69.0 25.6 26.6 36.0 212.5 31.0 32.3 36.0 3.6 12.3 40.0 90.4 20.4 28.1 43.8 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Group enriched" "Detected in some" 6 "B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Cell line enhanced" "Detected in some" "Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: AB_2676925" "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.3 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 44.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 2.9 0.0 2.8 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.1 14.8 11.1 0.3 13.7 1.2 2.3 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 0.0 0.0 18.9 0.1 0.0 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.9 24.1 0.3 1.0 3.3 1.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.1 0.0 0.4 AIMP2 "JTV-1, JTV1, p38, PRO0992" ENSG00000106305 "Aminoacyl tRNA synthetase complex interacting multifunctional protein 2" Q13155 7 6009245-6023834 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Protein biosynthesis" "Developmental protein" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.1" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019098, HPA020057" Supported Approved Cytosol NA NA 8200 Cytosol "HPA019098: AB_1852040, HPA020057: AB_1852042" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (7.30e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (9.29e-2)" "unprognostic (3.41e-2)" "unprognostic (8.75e-2)" "unprognostic (1.11e-1)" "unprognostic (5.13e-2)" "unprognostic (3.96e-1)" "prognostic favorable (1.38e-5)" "unprognostic (7.44e-2)" "unprognostic (8.97e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (3.09e-4)" 10.2 11.2 6.3 6.9 7.3 5.3 11.2 5.3 11.0 5.6 14.9 10.2 7.1 22.8 8.9 10.8 11.2 7.7 8.7 17.7 6.5 5.8 18.6 30.7 6.8 15.1 6.8 8.2 7.5 9.6 12.3 4.5 9.0 7.6 6.1 12.2 6.6 13.6 9.0 66.1 10.3 21.0 9.8 7.2 9.4 7.5 20.4 5.1 9.3 12.9 28.4 9.1 8.2 6.6 19.0 37.3 13.8 30.0 17.8 17.7 16.1 26.1 29.7 10.1 14.4 10.7 11.7 34.4 14.9 10.0 24.4 18.2 32.4 17.4 32.2 14.0 15.2 27.9 29.2 34.1 22.3 15.2 10.4 25.8 17.8 17.5 24.2 33.1 25.0 16.1 18.0 33.0 22.0 36.1 4.1 18.2 13.6 24.9 10.7 17.8 41.5 10.8 45.5 41.0 13.0 21.6 24.3 22.4 27.2 35.7 12.2 20.2 19.1 15.0 30.3 20.3 13.4 28.3 20.4 15.2 14.0 34.9 23.2 32.4 13.7 20.7 27.8 11.7 35.8 22.6 13.8 25.0 7.6 17.7 30.0 15.0 19.0 12.2 14.0 37.3 13.3 12.2 12.8 2.5 17.8 22.1 23.9 13.0 16.1 6.3 7.3 5.3 11.0 6.5 5.8 6.8 8.2 7.6 5.1 8.9 9.3 13.7 15.6 9.6 9.6 1.7 28.1 25.4 17.0 12.2 5.9 42.3 59.7 47.3 99.1 15.8 18.7 0.0 49.8 47.9 11.5 12.2 11.6 30.6 44.3 6.4 6.4 13.5 19.2 61.8 18.4 16.6 18.6 50.5 15.4 16.4 34.2 10.5 17.0 54.2 9.1 12.9 15.1 55.6 21.1 10.2 33.1 10.2 35.9 16.5 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 123.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 388.8;Rod photoreceptor cells: 1307.2" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.1;OE19: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026578: AB_2671905" "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.1 0.1 1.4 0.4 0.3 2.9 0.1 0.5 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.3 1.1 0.0 0.3 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 123.7 2.3 0.1 0.1 2.4 0.1 0.1 0.1 1.0 0.2 3.3 0.1 0.2 0.4 0.1 0.2 0.1 0.1 1.0 1.1 2.2 0.7 1.1 0.6 0.0 0.1 1.5 0.5 0.1 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.1 0.3 0.1 0.0 0.1 4.1 0.1 0.2 0.2 0.2 0.3 0.4 1.7 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.4 0.2 0.1 0.8 7.6 1.3 0.1 0.0 0.0 0.1 1.0 0.2 0.2 0.9 0.3 0.0 0.3 0.2 0.0 0.0 0.3 0.2 0.4 0.3 0.3 0.1 0.1 0.6 0.5 0.2 0.9 0.7 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.3 1.0 0.3 0.4 2.2 1.1 0.5 1.1 0.4 0.0 1.4 0.3 0.5 0.5 0.6 0.5 0.5 0.1 0.1 0.1 3.0 0.6 0.0 1.0 0.7 109.4 0.6 0.0 0.0 2.3 0.0 388.8 0.1 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 62.0 0.0 2.5 0.0 1.0 0.0 0.3 1.7 0.0 0.0 135.1 0.1 0.0 0.4 0.0 1307.2 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 2.0 AIRE "APECED, APS1, PGA1" ENSG00000160224 "Autoimmune regulator" O43918 21 44285838-44298648 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;lymphoid tissue: 8.3" "Cell type enhanced" "Detected in single" 19 "Cardiomyocytes: 2.2" "Cancer enriched" "Detected in single" 14 "testis cancer: 6.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 1.4;NTERA-2: 1.1;U-87 MG: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.24e-2)" "unprognostic (2.37e-2)" "unprognostic (1.77e-2)" "unprognostic (1.56e-1)" "unprognostic (1.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.68e-1)" "unprognostic (1.37e-2)" "unprognostic (1.43e-1)" "unprognostic (8.53e-3)" "unprognostic (3.69e-3)" "unprognostic (1.79e-1)" "unprognostic (6.29e-7)" "unprognostic (5.04e-2)" "unprognostic (3.18e-1)" "unprognostic (2.27e-1)" "unprognostic (3.57e-2)" 0.3 0.3 1.4 0.9 3.4 1.3 1.2 0.2 3.5 0.5 0.3 1.0 0.0 0.0 0.4 0.8 0.4 0.3 0.2 0.5 1.0 5.3 0.4 0.2 0.6 2.3 1.1 1.8 0.3 1.1 0.0 0.3 0.1 3.6 0.4 0.0 0.2 2.2 1.2 0.5 0.3 0.8 0.1 1.3 0.5 0.8 0.4 0.4 8.3 0.3 0.0 0.2 0.2 0.2 0.4 0.3 1.3 0.3 0.3 0.6 0.2 0.1 0.0 0.4 0.1 0.3 0.2 0.0 0.5 0.0 0.0 0.1 0.3 0.3 0.1 0.3 0.0 0.2 0.3 0.2 0.6 0.0 0.3 0.3 0.0 0.7 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.7 0.0 0.3 0.0 0.3 1.1 0.0 0.0 0.1 0.0 0.5 0.0 0.7 0.3 0.4 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.7 0.3 0.3 0.3 0.8 0.0 0.3 1.4 0.2 0.3 0.8 0.3 0.1 0.5 0.3 0.1 0.3 0.2 0.0 0.0 0.4 0.1 0.6 1.3 0.3 0.2 0.3 0.2 0.2 1.4 3.4 0.2 3.5 1.0 5.3 1.1 1.8 3.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 AJAP1 "MOT8, SHREW-1, SHREW1" ENSG00000196581 "Adherens junctions associated protein 1" Q9UKB5 1 4654732-4792534 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;ovary: 13.1" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 8.7;Early spermatids: 4.6;Peritubular cells: 5.6;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "eosinophil: 4.8;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 18 "dendritic cells: 2.1;granulocytes: 4.8" "Cell line enhanced" "Detected in some" "BEWO: 7.0;EFO-21: 6.2;hTERT-HME1: 3.6;RPTEC TERT1: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.11e-1)" "unprognostic (1.40e-1)" "unprognostic (2.35e-2)" "unprognostic (2.75e-2)" "unprognostic (7.52e-2)" "unprognostic (6.81e-2)" "unprognostic (2.57e-2)" "unprognostic (6.54e-2)" "unprognostic (1.16e-1)" "unprognostic (8.87e-2)" "unprognostic (4.04e-2)" "unprognostic (3.58e-1)" "prognostic favorable (1.89e-7)" "unprognostic (2.57e-1)" "unprognostic (1.70e-1)" "unprognostic (2.50e-1)" "unprognostic (5.49e-2)" 1.4 1.8 18.9 1.1 9.9 0.9 1.1 3.8 18.0 3.0 1.2 4.7 1.6 1.4 2.8 2.5 1.3 2.4 1.2 0.8 10.8 6.0 8.2 1.0 1.2 1.2 6.3 13.4 13.1 3.1 0.9 0.7 1.5 5.5 2.3 1.1 2.2 1.3 6.7 1.3 1.2 1.2 1.6 4.1 3.2 1.3 2.6 7.2 0.0 1.2 0.0 1.2 1.3 1.1 0.0 2.1 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 1.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.7 22.7 0.0 1.1 0.6 0.0 2.1 0.0 2.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 18.9 9.9 3.8 14.9 10.8 6.0 6.3 13.4 5.5 7.2 0.0 0.0 0.0 0.0 3.3 8.7 0.8 2.5 4.0 2.3 1.8 0.0 1.6 0.0 1.0 4.6 0.7 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.3 0.0 1.7 0.0 0.0 1.2 0.2 0.0 5.6 4.9 1.1 0.0 1.9 0.2 0.7 2.0 1.5 0.0 0.0 0.0 AJM1 "ajm-1, C9orf172" ENSG00000232434 "Apical junction component 1 homolog" C9J069 9 136844415-136848801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;testis: 15.0" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 5.2;Ductal cells: 1.4;granulocytes: 1.1;Pancreatic endocrine cells: 1.0" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.7" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 11 "dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021200 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "HPA021200: AB_10601695" "unprognostic (3.30e-3)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (9.54e-2)" "unprognostic (2.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-2)" "unprognostic (8.00e-2)" "unprognostic (6.29e-2)" "unprognostic (4.33e-1)" "unprognostic (2.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (2.71e-3)" "unprognostic (2.94e-1)" "unprognostic (6.07e-3)" "unprognostic (7.27e-2)" 1.1 1.9 4.6 1.3 6.3 1.4 1.1 22.7 7.9 1.1 4.0 1.1 1.1 3.3 1.2 1.1 1.1 0.3 1.1 1.2 4.4 3.1 1.1 1.1 1.1 1.1 2.1 1.1 1.1 7.6 1.1 5.2 1.1 1.1 2.6 1.1 1.1 2.0 2.2 3.9 1.5 4.3 1.1 1.3 3.6 2.3 15.0 1.1 1.1 1.1 1.1 1.1 2.6 1.1 0.2 3.9 0.1 1.6 0.2 1.9 0.8 3.7 3.0 0.4 1.1 0.5 0.4 4.9 3.0 0.5 0.4 0.2 1.0 2.0 2.3 2.6 0.8 1.0 4.2 0.4 1.1 0.0 5.8 2.2 0.6 5.6 0.9 1.7 1.3 4.2 0.9 1.5 0.5 0.3 2.5 0.2 1.1 3.5 1.5 0.7 4.1 0.4 4.5 1.2 3.1 3.9 2.8 0.9 7.3 0.9 0.7 7.4 2.6 1.9 7.6 4.0 0.6 6.0 2.8 3.1 5.0 3.5 1.7 1.8 6.6 4.5 0.8 8.8 4.6 1.2 0.0 1.6 0.1 1.9 1.0 0.4 0.2 0.5 0.9 1.5 0.0 0.2 0.9 0.1 0.2 1.5 3.9 0.1 0.8 4.6 6.3 22.7 6.8 4.4 3.1 2.1 1.1 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AJUBA "JUB, MGC15563" ENSG00000129474 "Ajuba LIM protein" Q96IF1 14 22971174-22982642 "Cancer-related genes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.0" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 42.2;Sertoli cells: 32.3;Suprabasal keratinocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 49.9;hTCEpi: 52.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA006171 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA006171: AB_1852044" "unprognostic (1.15e-1)" "unprognostic (2.99e-2)" "unprognostic (2.39e-1)" "unprognostic (1.24e-3)" "unprognostic (9.81e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-3)" "unprognostic (2.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.47e-1)" "unprognostic (3.19e-3)" "unprognostic (2.94e-1)" "unprognostic (2.68e-1)" "unprognostic (9.35e-3)" "unprognostic (2.07e-1)" 2.9 2.0 1.1 2.4 1.8 0.0 4.1 1.1 1.6 11.1 2.0 1.6 4.9 0.5 8.8 4.4 12.3 4.7 7.9 3.2 2.3 0.6 15.6 55.0 8.5 2.2 1.5 1.3 8.2 5.6 5.5 1.4 12.5 2.6 9.2 1.1 7.1 5.5 11.0 1.5 31.3 1.7 4.3 0.5 2.9 2.6 4.1 1.3 7.1 15.4 5.3 6.6 3.7 10.0 1.3 1.0 2.6 1.2 2.9 2.5 0.6 10.4 12.4 16.6 6.4 1.6 2.9 13.3 10.3 13.6 24.2 21.7 26.4 10.9 0.2 10.8 21.2 16.7 34.0 12.7 49.9 29.6 1.0 1.1 0.8 20.1 29.7 19.0 1.1 0.7 9.3 52.3 10.1 39.0 17.2 9.2 1.9 0.4 0.6 22.3 8.4 1.0 1.2 1.0 19.6 17.1 2.8 13.8 0.2 24.2 16.3 0.0 1.4 31.1 9.2 2.0 14.1 12.8 1.0 8.2 10.5 21.2 1.7 9.8 0.1 0.3 0.1 1.6 0.9 4.7 2.2 1.2 0.5 1.4 0.5 0.5 0.4 1.2 2.5 0.4 1.3 1.5 0.9 2.6 2.9 0.8 1.0 0.2 0.6 1.1 1.8 1.1 1.6 2.3 0.6 1.5 1.3 2.6 1.3 17.9 5.4 0.0 12.1 42.2 0.0 4.0 15.3 4.0 9.1 7.0 0.0 8.2 5.0 13.1 4.3 5.0 0.0 0.0 12.9 9.4 5.4 3.4 0.0 14.0 1.5 0.0 0.0 1.8 0.0 3.8 3.4 0.7 3.3 0.0 0.3 7.7 24.1 0.0 0.7 17.8 0.0 32.3 12.7 6.0 2.5 43.3 3.3 0.0 0.9 4.3 AK1 ENSG00000106992 "Adenylate kinase 1" P00568 9 127866480-127877743 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 84.5;skeletal muscle: 279.0" "Cell type enhanced" "Detected in all" 11 "Late spermatids: 823.7;Peritubular cells: 363.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006456, CAB009893" Enhanced Supported Cytosol NA NA 32000000 Cytosol "CAB009893: AB_2225151, HPA006456: AB_1078116" "unprognostic (6.07e-3)" "unprognostic (1.44e-2)" "unprognostic (2.36e-2)" "unprognostic (1.03e-1)" "unprognostic (3.44e-1)" "unprognostic (3.09e-1)" "unprognostic (1.52e-2)" "unprognostic (3.12e-2)" "unprognostic (2.19e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-3)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "prognostic favorable (7.31e-4)" "unprognostic (2.62e-1)" "unprognostic (8.40e-3)" "unprognostic (6.99e-3)" 7.7 9.2 19.6 3.7 18.8 6.5 3.9 9.8 17.3 10.5 8.6 18.1 12.2 5.2 3.4 17.3 9.0 84.5 12.0 60.4 17.6 18.5 6.3 10.7 18.7 2.2 16.4 15.3 12.3 4.6 5.6 7.1 2.9 17.5 5.2 10.8 7.0 13.4 15.7 279.0 3.4 2.6 6.3 11.5 5.6 5.8 9.8 11.1 0.0 10.5 61.5 4.0 4.4 4.4 1.2 3.4 2.8 0.4 1.4 1.5 1.2 15.0 6.5 8.3 11.4 20.3 41.3 7.6 10.5 10.6 18.7 11.4 4.8 9.6 0.4 11.5 21.6 12.4 21.7 0.0 11.7 7.5 2.4 7.2 2.2 18.7 8.4 11.4 0.0 0.2 31.4 22.8 13.9 10.1 10.3 25.0 0.2 8.9 0.6 21.2 14.4 0.0 0.3 3.0 37.8 20.2 0.4 8.4 3.3 12.5 1.1 13.6 8.4 27.7 16.0 8.0 4.5 12.8 9.0 20.6 13.1 5.3 46.1 10.0 1.0 0.1 0.0 16.4 0.0 9.1 0.9 0.4 0.4 1.5 0.3 1.1 0.3 0.6 1.1 0.1 1.2 0.3 1.1 2.8 1.4 0.4 3.4 0.3 1.2 19.6 18.8 9.8 17.3 17.6 18.5 16.4 15.3 17.5 11.1 38.7 148.9 3.7 16.6 23.5 48.5 42.8 30.6 46.8 19.4 7.0 15.7 6.3 14.9 97.5 229.8 49.4 94.1 93.5 54.8 37.4 51.2 15.5 1.1 69.2 46.3 46.1 102.2 47.9 3.2 823.7 209.7 11.0 79.2 2.8 66.4 290.8 46.6 58.8 363.1 6.3 55.1 25.8 50.9 14.4 15.6 24.8 11.3 7.5 73.1 20.9 AK4 "AK3, AK3L1" ENSG00000162433 "Adenylate kinase 4" P27144 1 65147549-65232145 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 89.7;liver: 50.7" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 223.0;Proximal tubular cells: 422.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;myeloid DC: 5.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "Hep G2: 59.4" "Low region specificity" "Detected in all" "HPA042753, HPA049461" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 18000 Mitochondria "HPA042753: AB_2678146, HPA049461: AB_2680776" "unprognostic (3.73e-2)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.25e-1)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.16e-3)" "unprognostic (3.89e-2)" "unprognostic (4.03e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (4.34e-5)" "unprognostic (6.71e-2)" "prognostic unfavorable (4.36e-4)" "prognostic unfavorable (4.87e-4)" "unprognostic (2.69e-1)" "unprognostic (7.07e-2)" "unprognostic (7.57e-2)" 12.4 1.6 11.7 3.7 11.2 2.7 13.4 12.0 9.9 4.0 9.5 4.0 4.7 2.7 3.9 4.4 12.3 4.2 8.6 26.0 9.3 7.1 89.7 50.7 1.6 1.4 6.3 9.1 5.8 1.8 8.2 2.6 4.5 7.2 8.9 7.7 4.4 9.4 7.3 2.2 14.0 3.5 13.6 8.1 1.2 7.8 6.0 5.0 0.4 1.9 5.7 3.2 12.4 7.4 0.5 5.3 1.6 6.1 0.6 0.5 1.4 20.6 1.4 1.6 7.0 15.6 14.9 3.5 3.5 4.4 7.6 21.2 31.0 2.5 11.1 9.2 5.4 9.5 13.4 5.5 26.1 30.6 9.3 6.3 10.8 7.0 59.4 0.7 8.3 1.3 8.2 14.7 7.4 21.9 12.6 0.2 3.5 13.4 0.2 11.6 8.8 0.3 0.3 7.2 0.3 12.4 0.0 12.1 2.0 11.2 0.9 6.1 4.5 6.2 0.4 4.9 8.0 8.7 3.7 1.2 12.7 10.9 0.9 5.9 11.7 5.2 0.6 20.5 3.1 0.7 1.6 6.1 0.0 0.2 1.4 0.4 0.5 0.2 0.5 5.3 0.4 0.2 0.2 1.0 0.6 0.2 0.8 0.1 1.4 11.7 11.2 12.0 9.9 9.3 7.1 6.3 9.1 7.2 5.0 0.0 0.3 4.9 19.8 44.2 14.7 91.5 61.1 5.3 6.8 29.6 2.0 1.2 48.0 16.1 1.6 17.5 13.5 0.0 11.0 13.9 10.3 33.2 0.0 223.0 3.3 15.9 5.2 5.5 5.6 4.2 3.7 2.7 23.6 7.2 6.7 27.4 22.8 3.5 8.9 422.4 6.2 6.5 27.4 2.1 5.1 65.0 4.1 1.0 22.9 16.6 AK5 ENSG00000154027 "Adenylate kinase 5" Q9Y6K8 1 77282051-77559969 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.5" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 137.0;Extravillous trophoblasts: 30.0;Spermatogonia: 72.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 10.9;naive CD4 T-cell: 14.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.9;T-cells: 14.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.3;BJ: 20.7;fHDF/TERT166: 23.6;LHCN-M2: 59.3;U-2 OS: 18.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019128, HPA057255" Enhanced Supported "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA019128: AB_1844682, HPA057255: AB_2683383" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (1.13e-1)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (6.04e-2)" "unprognostic (2.20e-1)" "unprognostic (2.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.91e-2)" "prognostic favorable (3.88e-4)" "unprognostic (3.56e-3)" "unprognostic (6.17e-4)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (6.76e-2)" 1.8 2.1 43.8 1.9 35.7 3.7 14.1 1.3 95.5 2.0 1.8 20.4 0.0 1.8 1.6 1.5 1.8 1.8 1.7 1.5 35.8 11.8 2.0 1.2 1.4 2.5 13.0 41.1 1.5 2.1 2.4 1.4 1.8 11.4 2.7 1.8 0.0 3.1 2.7 1.3 2.4 1.7 1.7 14.2 2.4 2.9 7.3 13.9 0.0 1.7 0.0 2.1 1.5 0.4 0.8 10.9 0.7 0.7 0.1 14.2 1.9 0.0 1.1 0.9 0.0 11.2 30.3 0.4 20.7 4.4 3.4 1.4 0.1 0.5 0.1 0.1 23.6 1.3 0.1 0.0 0.0 1.7 0.7 0.2 0.1 0.1 0.0 0.5 0.1 0.0 3.7 0.1 0.6 1.3 12.0 9.7 0.1 0.2 0.2 59.3 0.2 0.0 0.1 1.2 5.5 7.5 0.5 2.2 0.3 9.2 0.3 4.6 1.1 0.0 0.0 1.3 0.1 0.1 0.1 2.4 8.2 18.6 0.4 0.6 4.8 4.3 0.0 1.6 1.0 3.0 0.7 0.7 0.0 3.4 0.1 0.5 0.8 3.2 1.6 10.9 0.8 14.2 7.8 0.5 0.1 0.2 1.2 1.4 1.9 43.8 35.7 1.3 47.1 35.8 11.8 13.0 41.1 11.4 13.9 0.0 0.0 0.0 0.5 0.2 0.5 1.2 0.0 0.0 0.0 1.8 0.0 0.9 6.6 0.2 137.0 1.1 0.0 0.0 0.6 30.0 1.2 2.2 0.0 0.0 2.2 12.7 11.5 0.6 0.0 16.1 1.1 0.4 3.3 0.0 0.0 0.0 0.1 0.0 0.7 4.5 0.2 0.0 3.1 6.5 72.5 0.3 2.4 1.5 0.0 0.1 AK7 FLJ32864 ENSG00000140057 "Adenylate kinase 7" Q96M32 14 96392111-96489427 "Enzymes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.0" "Cell type enriched" "Detected in many" 7 "Ciliated cells: 175.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 17 "basophil: 10.6" "Lineage enriched" "Detected in single" 22 "granulocytes: 10.6" "Cell line enhanced" "Detected in some" "BEWO: 10.6;CAPAN-2: 9.2;MCF7: 29.4;REH: 20.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003543 Enhanced NA NA "HPA003543: AB_1078117" "unprognostic (4.18e-3)" "unprognostic (1.14e-1)" "unprognostic (9.40e-3)" "prognostic favorable (3.18e-4)" "unprognostic (4.98e-5)" "unprognostic (8.41e-2)" "unprognostic (9.81e-3)" "unprognostic (1.29e-1)" "unprognostic (9.02e-2)" "unprognostic (3.65e-4)" "unprognostic (8.64e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.00e-2)" "unprognostic (1.23e-2)" "unprognostic (4.01e-2)" "unprognostic (2.25e-3)" 1.5 3.4 4.0 0.9 12.6 2.0 2.1 0.7 3.1 2.7 2.8 8.4 5.1 2.5 2.8 13.1 2.4 29.0 5.0 1.2 6.7 9.2 7.6 3.0 9.2 1.4 2.3 2.6 4.9 2.9 11.7 17.5 0.9 16.7 1.4 2.2 1.5 1.6 2.9 0.5 7.5 3.1 1.6 2.7 4.3 3.5 17.6 4.2 1.1 4.8 1.3 0.8 1.1 1.5 0.4 0.1 10.6 0.3 0.3 0.4 0.2 0.1 2.9 1.2 1.0 0.5 1.8 10.6 0.2 0.3 0.2 0.1 0.3 9.2 0.2 0.2 0.1 0.2 1.1 2.9 0.1 0.1 1.3 0.2 0.2 1.4 0.1 0.5 0.1 0.2 0.1 0.4 1.5 0.0 0.5 0.1 0.9 0.1 0.2 0.2 29.4 0.2 0.2 0.5 1.3 0.6 20.9 0.3 0.3 4.6 0.2 2.0 4.2 1.1 0.4 0.0 1.2 2.5 0.1 0.0 0.3 0.1 0.3 0.1 0.4 1.3 0.1 0.1 0.0 0.4 10.6 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.4 0.1 0.4 0.2 0.2 0.6 0.3 0.3 0.1 0.1 0.2 4.0 12.6 0.7 3.1 6.7 9.2 2.3 2.6 16.7 4.2 6.0 2.6 0.5 0.7 1.5 0.0 0.3 2.5 175.3 18.2 7.0 2.0 0.7 3.3 2.4 14.5 0.9 1.1 0.0 1.0 1.5 0.4 0.4 0.0 0.6 0.2 0.0 1.2 0.6 0.3 2.2 0.0 0.6 1.7 0.0 0.4 0.9 0.3 0.0 0.0 3.0 1.5 0.0 0.2 24.1 9.4 2.6 2.4 0.0 1.3 0.4 AK8 "C9orf98, FLJ32704" ENSG00000165695 "Adenylate kinase 8" Q96MA6 9 132725578-132878777 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 12.8;fallopian tube: 17.7;testis: 15.6" "Group enriched" "Detected in many" 7 "Early spermatids: 81.9;Late spermatids: 93.2;monocytes: 85.6;Spermatocytes: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "NK-cell: 3.9" "Lineage enriched" "Detected in single" 8 "NK-cells: 3.9" "Cell line enhanced" "Detected in some" "AN3-CA: 3.1;MCF7: 5.3;RPTEC TERT1: 6.2;T-47d: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021443, HPA023894" Enhanced NA NA "HPA021443: AB_1845852, HPA023894: AB_1845854" "unprognostic (4.14e-2)" "unprognostic (1.20e-4)" "unprognostic (1.31e-2)" "unprognostic (1.70e-3)" "unprognostic (2.16e-1)" "unprognostic (2.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.18e-1)" "unprognostic (3.43e-1)" "unprognostic (1.71e-1)" "unprognostic (7.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.61e-4)" "unprognostic (9.89e-2)" "unprognostic (3.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.43e-1)" 0.5 0.7 1.3 0.5 2.2 0.0 0.5 1.6 1.3 1.6 0.5 0.5 0.5 0.0 1.1 12.8 0.5 17.7 0.7 0.5 1.3 2.0 1.4 0.5 1.1 0.5 1.2 0.5 0.9 0.5 2.5 1.7 1.5 2.3 0.5 0.0 0.9 1.0 1.8 0.5 1.1 0.5 0.5 1.7 0.5 0.3 15.6 0.5 0.5 3.1 0.5 0.5 0.5 0.5 0.1 0.0 0.0 0.0 3.9 0.5 0.0 2.0 1.0 0.6 3.1 0.4 0.8 0.6 0.3 0.2 0.2 0.0 0.4 2.2 0.0 0.7 0.3 0.8 0.5 0.3 0.0 0.1 0.1 0.7 0.0 0.2 0.0 1.3 0.0 0.0 1.9 0.9 0.3 0.6 0.6 0.2 1.8 0.1 0.0 0.5 5.3 1.5 0.4 0.2 0.9 0.6 0.0 0.0 0.0 6.2 0.0 1.1 1.2 2.6 0.0 0.4 0.6 4.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.3 2.2 1.6 1.0 1.3 2.0 1.2 0.5 2.3 0.5 3.0 1.7 0.0 0.5 0.5 0.2 0.8 0.0 10.7 2.3 3.5 0.0 0.4 0.0 1.9 81.9 0.5 0.0 0.0 0.5 0.4 0.7 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.3 93.2 5.8 0.8 1.7 85.6 0.7 0.6 1.0 0.0 3.9 4.4 1.7 0.0 0.5 23.3 5.7 1.4 0.3 0.0 0.6 0.5 AKAIN1 C18orf42 ENSG00000231824 "A-kinase anchor inhibitor 1" P0CW23 18 5145285-5197503 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 21.6;brain: 40.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 40.8" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;T-reg: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 1.0;Hep G2: 1.0;Karpas-707: 1.0;NTERA-2: 2.2;SCLC-21H: 3.9;SK-MEL-30: 2.5;U-2197: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049365 Uncertain NA NA "HPA049365: AB_2680729" "unprognostic (4.86e-1)" "unprognostic (1.49e-3)" "unprognostic (7.05e-2)" 0.2 21.6 0.4 0.1 0.8 0.1 0.1 40.8 3.1 0.1 0.3 0.4 0.0 0.2 0.1 0.1 0.1 0.2 0.3 0.1 5.4 0.6 0.4 2.3 0.1 0.2 1.1 0.9 0.3 1.2 1.1 3.1 0.1 3.7 0.2 0.3 0.6 0.1 0.6 0.1 0.5 0.2 0.3 1.3 0.1 0.3 1.3 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.8 40.8 3.1 5.4 0.6 1.1 0.9 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AKAP1 "AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17" ENSG00000121057 "A-kinase anchoring protein 1" Q92667 17 57085092-57121349 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.1;testis: 75.4" "Group enriched" "Detected in many" 9 "Early spermatids: 596.3;Late spermatids: 1760.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008620, HPA008691, CAB019286" Supported Supported Mitochondria NA NA Mitochondria "CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119" "unprognostic (5.52e-2)" "unprognostic (1.83e-1)" "unprognostic (6.96e-3)" "unprognostic (1.78e-1)" "unprognostic (1.79e-2)" "unprognostic (6.38e-2)" "unprognostic (7.19e-2)" "unprognostic (1.48e-2)" "unprognostic (8.14e-2)" "unprognostic (2.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.00e-1)" "prognostic favorable (7.86e-9)" "unprognostic (6.82e-2)" "unprognostic (2.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.38e-1)" 16.4 6.1 13.5 9.2 16.3 2.8 14.7 13.4 12.5 10.3 28.1 8.7 9.3 22.6 10.2 14.3 18.1 12.5 19.2 35.0 10.0 6.6 11.9 26.4 8.3 4.4 13.6 9.9 9.0 16.4 18.8 7.1 3.3 7.9 15.5 20.6 9.3 13.6 13.9 80.1 10.2 25.2 23.5 8.4 4.9 22.2 75.4 10.1 4.7 14.9 19.7 7.4 20.5 9.8 3.3 6.5 2.8 3.3 6.0 7.4 2.1 16.2 20.4 28.3 9.3 7.3 4.8 17.0 6.8 6.6 9.0 6.4 21.8 14.6 26.1 19.4 5.2 9.5 25.9 15.8 14.9 9.0 14.3 23.0 22.2 18.0 41.3 6.9 20.8 8.6 4.2 14.9 9.9 13.9 5.1 9.1 8.0 14.8 10.1 5.2 13.9 26.3 7.9 10.4 34.4 21.9 20.2 12.0 21.3 6.0 19.3 21.7 14.3 5.4 15.8 8.8 6.4 10.9 21.5 6.7 7.9 8.8 10.2 15.3 10.0 12.5 19.7 5.0 16.3 7.0 2.8 1.7 0.6 4.7 3.3 4.1 3.3 3.8 3.8 4.0 2.4 7.4 4.0 0.2 6.0 0.9 6.5 2.8 2.1 13.5 16.3 13.4 12.5 10.0 6.6 13.6 9.9 7.9 10.1 32.8 37.5 15.1 21.0 20.0 35.4 133.6 33.1 6.7 45.5 5.2 45.2 18.0 1.7 15.3 596.3 10.7 60.0 0.0 14.4 10.0 9.5 23.9 3.5 54.6 8.4 35.0 44.1 10.4 8.5 1760.2 18.1 7.7 6.8 6.4 85.1 6.8 10.7 43.2 13.1 5.8 71.0 45.3 45.3 13.9 10.0 17.2 5.7 6.4 92.8 11.8 AKAP14 AKAP28 ENSG00000186471 "A-kinase anchoring protein 14" Q86UN6 X 119895837-119920716 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.1;fallopian tube: 31.0;testis: 33.5" "Group enriched" "Detected in some" 5 "Early spermatids: 412.7;Late spermatids: 944.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.5" "Region enriched" "Detected in many" 7 "pons and medulla: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.3;LHCN-M2: 1.8;SCLC-21H: 6.3;SuSa: 4.2" HPA060999 Enhanced NA NA "HPA060999: AB_2684407" "unprognostic (1.36e-2)" "unprognostic (2.36e-2)" "unprognostic (2.82e-2)" "unprognostic (1.25e-3)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (4.16e-1)" "unprognostic (4.68e-2)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.73e-2)" "unprognostic (3.17e-1)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" 0.0 0.0 2.6 0.1 1.5 0.2 0.1 0.2 0.6 1.0 0.1 2.4 0.0 0.3 0.6 9.0 0.0 31.0 0.0 0.0 1.3 2.9 0.1 0.1 7.5 0.1 0.6 0.2 4.2 0.0 0.0 0.3 0.1 21.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.4 0.1 0.2 0.1 0.0 33.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.3 1.8 0.2 0.0 0.5 0.2 0.4 0.0 1.5 0.0 0.0 0.0 0.6 6.3 0.2 0.0 0.0 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 1.5 0.2 0.6 1.3 2.9 0.6 0.2 21.1 0.5 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 145.9 9.1 0.0 0.0 0.0 0.0 0.0 412.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 944.7 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.7 0.0 0.0 12.9 0.0 5.7 2.2 0.0 0.0 0.0 0.0 0.0 AKAP3 "AKAP110, CT82, FSP95, SOB1" ENSG00000111254 "A-kinase anchoring protein 3" O75969 12 4615508-4649047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 60.3" "Group enriched" "Detected in some" 23 "Early spermatids: 766.9;Late spermatids: 220.7" "Cancer enriched" "Detected in many" 6 "testis cancer: 6.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 8 "B-cells: 1.5;NK-cells: 2.0;T-cells: 2.8" "Cell line enhanced" "Detected in many" "ASC diff: 5.1;JURKAT: 6.0;NTERA-2: 7.4;SuSa: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039765 Enhanced NA NA "HPA039765: AB_10795113" "unprognostic (2.89e-2)" "unprognostic (2.89e-1)" "unprognostic (5.85e-2)" "unprognostic (2.36e-2)" "unprognostic (2.69e-1)" "unprognostic (1.66e-1)" "unprognostic (6.88e-2)" "unprognostic (7.03e-3)" "unprognostic (8.73e-3)" "unprognostic (5.81e-3)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (8.07e-6)" "unprognostic (3.22e-3)" "unprognostic (3.21e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" 0.2 0.6 1.1 0.3 1.1 0.0 0.5 0.5 1.7 0.3 0.3 2.1 0.1 0.5 0.3 1.8 0.3 1.4 0.2 2.5 0.8 0.7 1.3 0.6 0.4 0.2 1.0 0.6 0.5 1.1 0.6 1.6 0.4 1.7 0.5 0.3 0.3 0.8 0.4 0.4 0.4 0.4 0.4 1.4 0.3 0.4 60.3 1.0 0.5 0.9 0.2 0.4 0.4 0.6 1.5 0.1 0.0 0.2 2.0 2.8 0.5 0.1 0.6 1.9 0.5 5.1 0.5 1.1 0.6 0.5 0.7 1.8 0.2 3.6 0.4 0.1 1.2 3.7 0.0 2.8 0.1 0.8 2.7 3.4 0.4 0.0 0.5 0.3 0.3 0.9 1.0 0.8 1.1 1.3 0.5 0.6 6.0 1.5 3.9 1.3 0.6 0.6 0.1 7.4 0.6 0.2 1.0 0.2 0.5 2.2 0.3 0.6 0.1 0.4 0.3 1.7 5.3 0.0 0.0 0.2 0.3 0.6 1.3 0.1 1.7 2.3 0.8 1.9 0.5 1.0 0.0 0.0 0.0 0.6 0.0 0.7 0.8 0.9 1.5 0.0 1.5 2.2 2.8 0.0 2.0 0.2 0.1 0.0 0.5 1.1 1.1 0.5 1.7 0.8 0.7 1.0 0.6 1.7 1.0 0.0 0.3 0.0 0.2 0.0 0.0 10.9 0.0 2.7 0.0 0.0 0.0 0.8 0.0 0.4 766.9 0.0 0.4 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 220.7 3.4 0.0 0.0 0.0 0.6 0.8 0.1 0.0 2.1 0.8 0.3 6.5 0.0 21.2 5.0 0.0 0.2 0.0 0.3 0.1 AKAP4 "AKAP82, CT99, Fsc1, hAKAP82, HI, p82" ENSG00000147081 "A-kinase anchoring protein 4" Q5JQC9 X 50190768-50201013 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 63 "testis: 86.0" "Group enriched" "Detected in some" 98 "Early spermatids: 697.1;Late spermatids: 1788.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.3;OE19: 1.5;U-2197: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005949, HPA020046" Enhanced NA NA "HPA005949: AB_1078120, HPA020046: AB_1844693" "unprognostic (2.94e-2)" "unprognostic (1.86e-2)" "unprognostic (2.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 697.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1788.3 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 6.5 0.0 12.6 3.6 0.0 0.0 0.0 0.0 0.0 AKAP5 "AKAP75, AKAP79" ENSG00000179841 "A-kinase anchoring protein 5" P24588 14 64465499-64474503 "Plasma proteins, Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 39.1" "Group enriched" "Detected in many" 4 "granulocytes: 63.8;Mucus-secreting cells: 24.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "basophil: 5.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "CACO-2: 14.1" "Group enriched" "Detected in all" 5 "amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3" "CAB004308, HPA053891" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB004308: AB_626655, HPA053891: AB_2682294" "unprognostic (4.29e-2)" "unprognostic (5.89e-3)" "unprognostic (3.44e-4)" "unprognostic (2.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.24e-3)" "unprognostic (1.08e-1)" "unprognostic (3.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.02e-3)" "unprognostic (8.23e-2)" "unprognostic (1.42e-1)" "unprognostic (5.44e-2)" "unprognostic (4.49e-4)" "unprognostic (2.11e-1)" "unprognostic (2.42e-1)" "unprognostic (7.45e-2)" 0.7 0.8 17.3 2.2 39.1 1.0 1.1 2.9 21.8 0.7 5.9 0.2 0.0 1.1 2.3 0.6 1.0 0.8 1.6 0.6 9.9 1.4 2.4 1.2 3.0 2.9 1.3 9.2 0.7 0.5 1.5 1.3 1.8 0.9 1.0 6.1 0.0 0.7 1.0 0.6 1.0 2.4 2.2 0.7 2.0 1.1 0.7 1.3 0.1 1.1 0.0 2.5 1.4 0.7 0.7 0.4 5.7 0.3 0.9 1.0 0.2 1.7 1.4 1.7 1.0 0.6 0.1 5.7 1.3 0.6 1.6 2.1 14.1 4.4 1.3 2.7 1.0 0.2 0.6 3.7 0.3 1.6 2.6 3.1 4.3 2.6 1.2 0.1 0.5 0.6 0.6 0.1 1.1 0.0 2.9 0.6 3.2 0.5 1.0 1.0 1.0 3.4 0.3 1.3 0.2 0.7 4.2 0.8 0.3 2.6 1.6 4.4 2.0 1.5 0.1 0.4 5.5 1.3 0.3 0.8 1.9 5.8 0.2 2.2 3.0 3.3 3.2 1.3 0.5 0.3 5.7 0.3 0.2 1.0 0.1 0.2 0.5 0.3 0.9 0.2 0.7 0.4 0.5 0.7 0.9 0.1 0.4 0.1 0.2 17.3 39.1 2.9 19.9 9.9 1.4 1.3 9.2 0.9 1.3 6.0 3.7 0.5 1.3 0.8 7.0 0.9 2.5 0.0 0.0 0.0 7.9 0.5 0.0 0.5 1.6 0.8 0.9 0.0 0.2 1.4 1.5 1.0 63.8 0.8 0.4 7.9 0.0 0.6 0.8 0.5 0.0 1.3 1.7 0.0 24.0 0.5 0.6 0.0 0.0 0.7 7.9 0.0 0.4 0.5 4.3 0.6 0.6 10.2 4.6 0.7 AKAP6 "ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6" ENSG00000151320 "A-kinase anchoring protein 6" Q13023 14 32329273-32837681 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 47.0;heart muscle: 46.6;skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 44.0;Cardiomyocytes: 96.0;Cone photoreceptor cells: 47.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 7.8" "Lineage enriched" "Detected in many" 6 "B-cells: 7.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001983, HPA048741" Enhanced NA NA "CAB001983: , HPA048741: AB_2680506" "unprognostic (1.99e-1)" "unprognostic (9.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.37e-1)" "unprognostic (2.52e-1)" "unprognostic (4.33e-2)" "unprognostic (1.41e-4)" "unprognostic (1.81e-3)" "unprognostic (1.93e-2)" "unprognostic (4.49e-3)" "unprognostic (1.24e-3)" "unprognostic (3.54e-1)" "unprognostic (3.33e-16)" "unprognostic (8.57e-2)" "unprognostic (1.27e-1)" "unprognostic (5.14e-3)" "unprognostic (1.79e-3)" 2.1 5.9 17.9 2.9 28.0 1.2 4.5 32.5 34.3 2.3 4.1 28.3 0.0 2.3 4.2 5.9 5.6 3.2 4.0 46.6 16.8 13.7 3.4 2.6 2.8 1.3 27.5 22.2 3.0 1.5 5.3 3.1 4.5 47.0 2.5 2.7 2.3 2.6 1.8 37.0 1.8 2.8 7.3 16.5 1.4 2.1 5.5 29.8 0.0 5.0 6.6 1.4 3.2 1.4 7.8 0.8 1.2 0.3 0.3 1.2 0.5 0.6 0.9 1.2 1.1 0.2 2.1 0.3 1.5 4.2 0.2 0.5 1.3 1.2 1.6 1.1 17.7 0.7 0.9 1.3 1.6 0.6 1.4 1.1 1.4 1.9 1.2 0.6 0.1 0.4 2.1 1.5 0.0 0.5 0.7 0.1 2.5 0.3 4.7 1.2 0.9 0.8 0.3 0.2 1.2 1.3 0.8 5.6 0.6 0.5 1.4 6.1 4.8 1.2 0.8 3.8 0.9 3.3 0.1 0.3 0.2 0.9 0.9 0.5 3.0 2.6 0.7 1.8 0.1 6.2 0.5 0.3 0.1 0.1 0.2 0.2 0.5 0.1 0.4 0.4 7.8 0.8 1.2 1.2 0.3 0.2 0.8 0.1 0.5 17.9 28.0 32.5 34.3 16.8 13.7 27.5 22.2 47.0 29.8 6.0 2.4 0.5 2.8 2.1 44.0 96.0 0.0 14.7 7.9 1.8 47.1 0.9 0.0 0.8 18.9 1.0 1.2 0.0 0.5 0.2 9.3 0.9 1.1 2.6 1.0 25.4 1.2 1.3 0.6 9.7 13.6 1.3 6.8 1.0 0.2 2.4 0.4 0.0 31.1 1.1 20.7 19.4 13.7 9.6 1.1 1.4 0.3 0.0 0.6 0.8 AKAP7 "AKAP15, AKAP18" ENSG00000118507 "A-kinase anchoring protein 7" "O43687, Q9P0M2" 6 131135666-131283535 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 39.4;pancreas: 37.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 19.4;RPTEC TERT1: 17.0;RT4: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027172, HPA027200, HPA028327" Approved Approved Vesicles NA NA Vesicles "HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353" "unprognostic (2.83e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.45e-3)" "unprognostic (4.57e-2)" "unprognostic (1.24e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (4.41e-1)" "unprognostic (1.18e-1)" "unprognostic (3.89e-1)" "unprognostic (1.54e-1)" "unprognostic (1.32e-3)" "unprognostic (2.52e-1)" "unprognostic (6.03e-3)" "unprognostic (2.53e-1)" "prognostic favorable (2.56e-4)" 5.7 39.4 16.1 6.2 11.2 6.3 4.7 16.6 15.4 6.0 12.9 4.9 4.1 19.9 4.5 4.1 3.0 4.9 6.8 4.4 12.0 9.9 5.6 15.7 6.2 11.6 8.1 11.7 7.2 37.5 3.1 3.5 2.8 7.2 10.0 13.3 2.9 3.4 4.8 9.8 2.3 12.4 5.2 6.2 6.2 3.7 5.8 6.4 18.9 4.2 2.1 5.5 8.6 4.3 4.4 1.8 9.5 3.4 3.2 14.9 5.0 0.8 1.5 5.6 2.7 3.1 6.7 3.9 2.3 3.8 4.0 5.3 1.9 1.5 0.1 4.4 4.0 3.0 0.0 1.6 2.5 2.9 0.0 2.3 5.6 1.8 8.3 4.5 0.2 1.8 5.7 1.8 2.5 3.3 3.7 4.1 3.3 0.9 8.1 3.8 1.5 2.4 1.4 19.4 0.5 2.1 5.0 3.7 0.1 17.0 18.8 0.1 2.0 3.2 0.3 7.6 3.4 1.3 11.7 1.4 1.9 2.6 5.3 5.8 7.6 0.0 1.3 4.5 5.7 4.2 9.5 1.5 0.2 6.8 2.9 10.5 2.6 9.4 9.1 1.8 4.4 14.9 9.3 0.4 3.2 3.4 0.1 3.2 5.0 16.1 11.2 16.6 15.4 12.0 9.9 8.1 11.7 7.2 6.4 17.9 7.8 10.9 7.0 5.6 20.9 9.0 124.9 1.4 2.3 5.2 15.7 6.4 16.6 21.9 3.9 4.8 14.7 23.3 3.6 8.3 5.9 6.7 10.4 34.7 7.7 7.9 1.2 8.0 11.0 1.3 7.8 9.3 1.7 0.0 14.4 37.6 2.7 31.5 5.3 15.2 11.5 0.0 6.9 3.5 9.1 3.6 3.9 17.5 16.6 3.7 AKNA KIAA1968 ENSG00000106948 "AT-hook transcription factor" Q7Z591 9 114334156-114394405 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 71.2" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 137.4;T-cells: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 32.0;MOLT-4: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052367, HPA063993" Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA052367: AB_2681801, HPA063993: AB_2685169" "unprognostic (5.19e-3)" "prognostic favorable (1.22e-4)" "unprognostic (5.38e-3)" "prognostic favorable (2.14e-5)" "unprognostic (3.12e-1)" "prognostic favorable (1.25e-4)" "unprognostic (1.88e-1)" "unprognostic (3.28e-2)" "unprognostic (4.13e-2)" "unprognostic (6.62e-2)" "unprognostic (5.85e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.19e-2)" "unprognostic (6.61e-3)" "unprognostic (2.93e-1)" "prognostic favorable (2.29e-4)" 7.2 2.8 4.6 41.8 4.9 17.5 6.1 2.0 4.5 13.9 7.3 5.9 2.4 5.7 13.4 4.5 3.3 11.4 12.9 2.8 4.9 3.8 3.9 5.6 11.2 30.4 4.9 3.3 9.9 3.4 0.8 3.6 2.8 4.9 5.3 4.7 7.1 10.2 4.2 1.6 2.5 18.4 8.8 3.6 43.1 7.3 3.9 4.8 71.2 4.0 4.5 42.9 6.1 6.4 7.2 8.8 16.6 6.1 11.9 16.6 6.4 1.4 1.5 1.8 1.3 12.8 1.5 8.0 1.6 1.9 1.5 1.2 2.7 1.6 17.5 1.6 1.4 2.8 3.4 1.2 0.4 0.5 32.0 0.7 1.8 0.7 1.8 15.4 16.9 19.2 2.6 2.8 1.3 1.4 2.2 2.7 15.8 1.7 21.2 0.6 2.5 30.4 22.0 6.9 3.4 1.8 18.9 0.3 4.0 14.6 0.8 0.9 1.7 0.4 1.4 4.7 2.4 4.0 9.3 4.4 0.8 1.7 0.3 1.4 4.4 4.9 14.8 1.0 8.6 0.7 8.0 6.1 9.6 16.6 4.6 13.1 6.5 8.9 14.1 4.1 7.2 7.9 10.6 16.6 11.9 4.1 8.8 7.0 6.4 4.6 4.9 2.0 4.5 4.9 3.8 4.9 3.3 4.9 4.8 11.9 28.1 43.3 5.9 4.6 25.8 3.1 0.0 29.4 12.5 22.7 139.4 7.7 0.0 3.4 16.1 6.3 6.7 0.0 7.0 5.7 8.0 6.2 31.3 8.5 16.0 4.8 12.2 13.5 41.0 20.2 13.6 31.2 5.0 26.2 19.5 6.5 5.0 10.5 6.3 0.9 137.4 0.0 10.8 0.6 0.7 3.0 2.9 94.4 12.9 7.5 AKNAD1 "C1orf62, MGC26989" ENSG00000162641 "AKNA domain containing 1" Q5T1N1 1 108815898-108858228 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 12.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 58.5" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HBEC3-KT: 1.3;hTCEpi: 4.0;hTERT-HME1: 2.2;LHCN-M2: 1.2" "HPA030270, HPA030271, HPA030272" Uncertain Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA Cytosol "Microtubules, Cytokinetic bridge" "HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342" "unprognostic (4.93e-2)" "unprognostic (1.72e-1)" "unprognostic (5.52e-2)" "unprognostic (2.00e-3)" "unprognostic (7.22e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-5)" "unprognostic (8.15e-2)" "unprognostic (5.95e-2)" "unprognostic (2.83e-2)" "unprognostic (1.89e-1)" "unprognostic (2.24e-1)" "unprognostic (3.00e-8)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "unprognostic (5.75e-2)" "unprognostic (8.22e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.9 0.6 0.0 0.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 3.5 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 2.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 58.5 1.0 0.0 0.0 0.2 0.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.6 2.3 0.0 1.7 0.0 0.3 0.6 0.3 0.0 1.1 0.0 0.0 0.0 0.7 0.5 0.7 0.1 0.6 0.0 0.4 0.0 AKR1B1 "ALDR1, AR" ENSG00000085662 "Aldo-keto reductase family 1 member B" P15121 7 134442350-134459284 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adrenal gland: 302.2;seminal vesicle: 109.3" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026425, CAB027391, CAB047353, HPA052751" Enhanced Supported Nucleoplasm,Cytosol No No 1700000 Cytosol Nucleoplasm "CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935" "unprognostic (2.76e-2)" "unprognostic (2.84e-2)" "unprognostic (2.02e-2)" "unprognostic (1.37e-2)" "unprognostic (6.81e-2)" "unprognostic (2.26e-1)" "unprognostic (4.18e-2)" "unprognostic (5.09e-2)" "unprognostic (2.51e-3)" "unprognostic (2.47e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.44e-5)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.00e-4)" 5.9 302.2 7.5 4.7 13.7 2.5 9.5 6.9 10.9 4.4 3.9 8.2 50.4 2.7 4.6 6.1 4.2 4.6 5.2 24.2 7.3 8.4 17.7 2.5 6.9 10.0 9.5 9.0 8.2 7.2 9.4 8.0 24.8 11.9 5.5 4.1 5.8 4.4 109.3 37.6 2.8 4.8 5.6 7.9 6.7 5.0 5.2 5.9 7.3 6.0 10.3 7.6 7.1 3.7 31.4 34.8 22.5 26.0 26.3 42.7 47.2 13.5 122.4 13.8 19.5 59.5 16.2 36.8 13.1 224.5 19.3 25.0 5.6 12.4 0.0 6.1 21.9 85.2 5.7 15.0 13.1 15.4 4.8 13.7 6.9 18.4 16.6 85.3 0.0 0.0 15.1 9.8 27.6 7.3 18.9 27.2 13.6 0.0 4.6 21.3 0.2 20.3 9.3 22.9 0.9 0.1 21.2 8.8 10.2 106.2 66.2 10.3 22.9 91.9 0.1 9.6 9.4 0.0 10.3 21.4 19.1 8.9 1.7 14.2 12.6 13.9 34.2 101.0 0.0 11.4 22.5 26.0 1.2 37.9 17.0 34.0 31.4 32.4 36.7 34.8 28.5 42.7 41.1 2.1 26.3 8.9 4.9 22.0 47.2 7.5 13.7 6.9 10.9 7.3 8.4 9.5 9.0 11.9 5.9 11.9 23.7 50.6 46.4 18.3 34.0 127.0 30.6 24.1 23.9 615.9 7.9 969.9 139.3 102.5 3.0 53.2 0.7 0.0 35.6 1080.2 76.5 15.6 52.0 1.3 331.4 68.3 29.7 89.6 135.4 11.5 73.4 69.6 28.7 93.8 13.6 46.3 62.2 5.8 72.9 43.7 20.2 58.2 30.9 20.7 70.9 10.2 1691.2 45.4 5.0 37.4 AKR1B10 "AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI" ENSG00000198074 "Aldo-keto reductase family 1 member B10" O60218 7 134527592-134541408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.5;intestine: 99.7;stomach 1: 68.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4" "Cancer enhanced" "Detected in many" "liver cancer: 353.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 99 "A549: 217.4;Hep G2: 60.3;OE19: 227.4" "HPA020280, CAB070163, HPA073633" Enhanced Supported "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 68000000 Cytosol "Plasma membrane" "CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (1.29e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.91e-4)" "unprognostic (6.03e-2)" "unprognostic (4.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.16e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (4.80e-9)" "unprognostic (2.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" 0.6 0.8 0.6 2.2 0.6 0.0 0.6 0.6 0.6 13.1 11.5 0.6 0.6 99.7 0.6 0.9 41.5 0.0 28.9 0.6 0.6 0.0 4.0 6.3 2.0 0.6 0.6 0.6 0.6 0.6 0.0 2.5 0.6 0.6 2.0 7.3 1.3 6.1 0.6 0.6 1.0 54.1 7.1 0.6 0.6 68.6 0.8 0.6 0.9 0.7 28.6 3.6 16.3 22.9 0.4 0.1 1.8 0.2 0.4 0.2 0.1 0.0 217.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 60.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 227.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.2 1.8 0.4 0.1 0.1 0.1 0.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.0 0.0 0.5 1.9 2.5 0.0 0.4 275.2 5.3 1.2 0.0 0.0 0.2 0.0 21.5 0.3 0.0 221.4 23.3 23.1 0.1 0.1 0.3 0.0 31.6 0.0 0.0 3.4 3.7 1.6 0.4 3.1 0.0 0.0 1.0 11.7 0.0 89.4 24.6 1.8 1.4 0.0 0.0 0.9 0.0 0.0 9.2 0.2 0.0 41.3 5.2 AKR1B15 ENSG00000227471 "Aldo-keto reductase family 1 member B15" C9JRZ8 7 134549136-134579875 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 61.7;placenta: 31.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6" "HPA020280, HPA073633" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (9.74e-3)" "unprognostic (2.74e-2)" "unprognostic (2.08e-1)" "prognostic favorable (8.36e-4)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.04e-2)" "unprognostic (2.39e-1)" "unprognostic (2.75e-1)" "unprognostic (2.14e-3)" "unprognostic (1.24e-1)" "unprognostic (1.22e-7)" "unprognostic (6.88e-2)" "unprognostic (4.29e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.90e-5)" 2.7 0.1 0.1 0.1 0.1 0.0 61.7 0.1 0.2 1.6 0.6 0.2 0.1 5.6 0.1 1.5 3.8 0.0 2.2 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 31.8 0.2 0.8 0.2 0.5 2.9 0.1 11.6 1.9 1.7 0.8 0.4 0.1 5.0 0.6 0.1 0.3 0.4 16.1 1.8 1.5 3.0 0.1 0.0 1.8 0.1 0.4 0.0 0.3 0.0 15.5 0.2 0.0 0.6 0.5 1.0 0.0 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 12.3 0.1 0.1 0.2 10.8 0.0 0.2 0.5 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 3.2 0.3 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.6 5.2 0.0 0.1 0.1 0.3 0.0 0.1 0.7 0.4 0.0 0.2 0.2 0.2 6.6 0.2 0.2 1.8 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.1 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 8 "ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: AB_2685966" "unprognostic (1.54e-2)" "prognostic favorable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favorable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.5 0.1 25.7 185.8 22.4 0.0 0.8 5.7 0.3 0.2 0.4 0.0 0.0 0.3 5.7 4.4 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.1 315.1 1.8 0.1 0.0 11.4 1.6 2.6 1.6 0.0 0.6 0.1 5.4 0.0 4.4 0.1 0.0 0.0 0.0 134.5 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 62.5 27.2 1.5 11.8 18.8 2.5 2.4 239.5 96.4 128.5 59.3 0.0 0.0 11.6 33.9 14.9 17.8 9.3 70.0 290.3 0.0 13.4 11.4 4.6 511.8 0.3 0.0 1.7 26.4 14.5 8.0 140.4 3.8 101.3 8.2 1.7 47.9 184.6 0.9 138.6 40.8 4.3 0.0 14.4 1.7 0.7 17.9 0.1 0.9 2.6 140.8 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Group enriched" "Detected in some" 4 "A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: AB_2685966" "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 130.6 0.1 13.8 162.1 5.6 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 0.6 3.6 0.0 0.6 0.0 0.0 0.0 0.0 36.8 243.7 0.3 0.0 0.0 14.5 8.2 0.6 0.6 0.0 0.0 0.0 5.0 0.0 1.3 0.2 0.0 0.0 0.0 168.2 0.0 0.0 0.0 2.1 1.2 74.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.8 0.0 0.0 0.0 0.0 1.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 11.9 3.2 0.0 3.2 10.5 1.8 3.7 135.0 18.7 19.4 0.0 0.0 0.0 0.0 12.3 18.3 8.7 9.3 0.0 93.5 0.1 15.0 4.5 0.0 341.7 0.1 3.2 1.7 12.3 13.7 5.6 73.4 1.1 8.5 1.0 2.8 33.8 140.7 7.0 73.9 2.6 2.6 0.0 7.6 0.3 0.3 11.8 0.0 1.3 7.4 79.1 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.1;intestine: 52.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 50.1;gdT-cell: 26.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 11000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: AB_2685966" "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 16.6 6.6 3.2 3.2 3.9 3.5 12.8 3.2 3.9 3.2 17.3 3.2 3.2 52.3 3.2 3.2 6.0 4.5 32.2 4.8 4.4 1.0 20.1 34.4 5.5 3.2 3.2 3.2 3.2 4.2 1.8 3.2 3.2 4.2 3.2 11.4 3.2 4.4 3.2 13.0 2.6 31.1 4.2 3.2 3.2 28.6 3.2 3.2 3.2 3.2 3.2 3.2 12.3 3.2 0.1 9.6 50.1 0.7 4.6 26.7 9.7 0.0 115.0 0.0 33.6 66.2 23.8 0.0 0.0 1.6 0.0 0.1 3.4 1.9 0.0 6.2 1.5 3.4 0.9 0.1 2.3 0.0 0.2 0.0 0.2 35.6 48.3 0.3 0.0 0.0 13.2 4.7 1.5 0.0 1.9 2.2 0.2 0.7 0.0 3.0 0.2 0.7 0.1 0.0 226.4 0.3 0.2 0.7 3.4 11.3 45.4 0.0 0.2 16.5 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.3 6.9 0.2 0.0 0.0 0.0 3.8 4.5 0.3 50.1 0.7 1.1 26.7 0.2 1.7 0.0 5.0 4.8 0.5 0.1 3.2 2.4 1.9 4.6 0.3 9.6 4.9 9.7 3.2 3.9 3.2 3.9 4.4 1.0 3.2 3.2 4.2 3.2 41.7 4.0 1.5 1.1 10.6 1.7 3.6 0.0 88.3 61.4 34.9 0.0 0.1 36.5 85.3 2.9 61.2 261.7 0.0 644.1 0.0 13.8 0.7 5.7 0.0 1.6 1.6 18.4 0.0 0.0 2.1 72.5 19.0 20.3 5.4 31.0 121.7 362.8 121.1 100.4 434.1 3.6 25.8 8.0 0.3 0.7 9.4 0.0 0.0 103.0 27.3 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 437.4" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "Group enriched" "Detected in some" 4 "HDLM-2: 11.6;OE19: 5.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: AB_2679058, HPA068265: AB_2685966" "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 5.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 45.9 2.7 1.2 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 23.3 0.6 0.0 0.0 0.0 0.0 437.4 0.0 0.0 0.0 14.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 AKR1D1 SRD5B1 ENSG00000122787 "Aldo-keto reductase family 1 member D1" P51857 7 138002324-138117986 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 103.2" "Group enriched" "Detected in some" 41 "Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4" "Cancer enriched" "Detected in single" 77 "liver cancer: 20.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 20 "Hep G2: 16.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA057002 Enhanced Approved Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "HPA057002: AB_2683308" "unprognostic (2.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "prognostic favorable (9.91e-5)" "unprognostic (6.11e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (6.87e-2)" "unprognostic (2.94e-1)" "unprognostic (9.68e-3)" "unprognostic (2.90e-1)" "unprognostic (5.80e-2)" "unprognostic (3.11e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 2.7 0.5 0.7 0.7 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.8 0.3 0.2 0.1 0.0 0.6 0.3 0.0 0.0 0.2 0.3 0.1 0.4 0.3 16.9 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.2 0.1 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.4 0.3 0.2 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.3 0.3 2.7 0.5 0.6 0.4 0.4 0.3 0.6 0.4 0.4 0.3 1.1 0.5 0.7 1.8 0.7 0.5 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 50.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 96.2 0.4 0.0 0.0 1.3 1.9 85.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.1 AKR1E2 "AKR1CL2, AKRDC1, MGC10612" ENSG00000165568 "Aldo-keto reductase family 1 member E2" Q96JD6 10 4786629-4848062 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "testis: 35.0" "Group enriched" "Detected in some" 5 "Early spermatids: 126.7;Late spermatids: 125.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 3.2;myeloid DC: 1.6;naive CD4 T-cell: 1.4;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;granulocytes: 3.2;T-cells: 1.4" "Cell line enhanced" "Detected in many" "JURKAT: 11.3;RT4: 9.4;U-2197: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA037821, HPA037822" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA037821: AB_2675687, HPA037822: AB_10671722" "unprognostic (2.33e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (8.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (1.44e-1)" "unprognostic (7.42e-3)" "unprognostic (7.47e-2)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (1.53e-1)" "unprognostic (3.06e-2)" "unprognostic (2.74e-1)" "unprognostic (2.04e-2)" "unprognostic (1.62e-4)" "unprognostic (5.62e-2)" 3.3 1.6 1.8 3.2 2.6 2.4 4.2 1.4 2.5 2.6 2.3 0.7 3.4 1.8 5.0 1.7 1.9 1.4 5.0 2.7 1.5 1.5 1.8 1.1 4.4 2.8 1.4 2.1 1.5 2.7 3.7 1.2 2.6 1.9 1.7 1.7 5.0 1.9 2.6 2.3 2.0 1.7 2.9 2.1 1.5 2.1 35.0 0.9 0.8 4.5 2.0 0.6 1.7 2.9 0.1 1.8 3.2 0.4 0.0 1.4 0.3 0.4 5.1 2.0 0.9 0.0 0.0 0.1 2.0 0.1 0.1 0.0 8.0 0.8 0.0 0.0 5.2 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 1.0 5.5 1.0 0.0 0.0 5.9 11.3 4.5 0.0 0.0 4.8 0.6 0.0 2.1 7.2 3.8 0.0 0.0 0.0 1.4 9.4 0.0 4.4 7.5 2.1 4.0 2.2 4.0 2.2 3.5 0.0 1.8 17.8 0.0 2.4 0.0 0.0 0.1 0.0 1.4 3.2 0.4 0.3 0.1 0.2 0.0 0.1 0.4 0.2 1.6 0.0 1.4 0.4 0.1 0.0 0.0 1.8 0.0 0.3 1.8 2.6 1.4 2.5 1.5 1.5 1.4 2.1 1.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.1 126.7 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.1 1.6 0.0 1.8 0.6 125.1 2.6 0.5 3.3 1.0 0.0 0.3 0.1 0.0 1.4 0.3 1.1 0.0 0.9 23.0 4.7 0.1 0.0 0.0 0.0 0.1 AKR7A3 ENSG00000162482 "Aldo-keto reductase family 7 member A3" O95154 1 19282558-19289250 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5" "Cell type enhanced" "Detected in many" 19 "Cholangiocytes: 178.3;Enterocytes: 187.5;Proximal tubular cells: 542.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Group enriched" "Detected in some" 4 "OE19: 11.3;SK-BR-3: 18.4" HPA064638 Approved Cytosol NA NA 1000000 Cytosol "HPA064638: AB_2685307" "unprognostic (7.78e-2)" "unprognostic (5.07e-2)" "unprognostic (6.08e-2)" "unprognostic (1.61e-1)" "unprognostic (1.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (7.70e-3)" "unprognostic (2.72e-1)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.80e-7)" "unprognostic (4.53e-2)" "unprognostic (5.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.35e-1)" 0.7 0.4 0.7 0.7 0.7 0.0 0.7 0.7 0.9 0.7 5.1 0.7 0.7 48.5 0.7 1.3 0.7 0.0 6.9 0.7 0.7 0.2 13.4 27.4 0.7 0.7 0.7 0.7 1.0 59.0 0.0 0.7 0.7 0.7 0.7 3.0 0.7 0.7 0.7 0.7 0.2 27.0 0.7 0.7 0.7 35.5 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.3 1.9 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.6 0.4 0.4 0.2 1.8 0.1 0.1 0.2 0.1 0.4 1.4 0.2 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.8 0.1 0.1 0.3 0.3 0.2 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.5 0.4 1.4 0.3 11.3 0.6 0.7 0.1 1.4 0.0 0.3 0.9 1.4 0.3 18.4 0.4 0.1 3.3 0.4 0.3 0.3 0.2 1.0 0.3 1.3 0.3 0.3 0.5 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.7 0.7 0.9 0.7 0.2 0.7 0.7 0.7 0.7 0.0 0.0 3.5 0.6 0.7 0.4 0.8 178.3 4.0 0.0 27.9 0.0 0.4 101.2 3.8 2.7 0.2 187.5 0.0 28.4 0.2 0.0 1.1 4.6 92.4 0.3 0.0 20.0 5.5 1.9 3.1 0.3 0.3 0.0 0.0 51.4 3.5 17.3 81.8 0.4 542.3 1.1 0.0 0.4 1.1 0.9 0.5 0.5 0.0 99.7 0.3 AL022312.1 ENSG00000285025 "MIEF1 upstream open reading frame protein " L0R8F8 22 39504231-39504443 "Predicted intracellular proteins" "Ribosome biogenesis, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 66 "blood: 3.3;skeletal muscle: 9.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 3.9;MOLT-4: 11.5;REH: 2.0;U-698: 2.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 3.3 0.9 2.4 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.9 3.3 1.0 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.1 0.0 2.4 0.0 0.6 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL022318.4 ENSG00000284554 22 39014363-39033276 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "seminal vesicle: 42.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.9;HHSteC: 3.8;HSkMC: 2.1;Karpas-707: 7.6;NB-4: 1.7" HPA055116 Uncertain NA NA "HPA055116: AB_2682701" 3.8 1.2 0.0 4.7 0.0 1.1 1.1 0.0 0.7 6.9 2.9 0.3 9.2 0.6 5.7 7.7 6.2 2.7 4.0 1.9 0.0 1.1 1.9 3.2 8.6 0.0 0.0 8.8 1.8 0.6 0.0 1.7 0.0 6.6 1.8 3.7 3.2 42.5 1.3 0.6 2.3 5.3 0.1 11.0 0.6 16.1 0.0 4.9 2.1 5.2 16.1 7.1 1.0 5.4 1.9 1.5 3.2 1.1 6.1 0.1 0.0 0.9 0.0 0.0 0.9 0.8 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.5 0.1 7.6 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 1.5 4.8 3.2 2.8 5.4 4.5 6.1 0.2 5.4 2.7 3.0 0.0 1.1 3.1 1.9 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL031777.3 ENSG00000282988 6 26195595-26199293 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 184.8" "Cell type enhanced" "Detected in some" 22 "Cytotrophoblasts: 4.4;Extravillous trophoblasts: 4.1;granulocytes: 3.5;Hofbauer cells: 7.2;Syncytiotrophoblasts: 17.3" "Cell type enriched" "Detected in many" 4 "neutrophil: 18.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 18.7" "Cell line enhanced" "Detected in some" "K-562: 7.9;SiHa: 7.5;U-2 OS: 5.7;U-266/70: 9.5;U-266/84: 6.3" HPA041189 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" 1.3 1.3 0.1 10.9 0.2 13.1 4.8 0.3 0.7 3.9 3.4 0.0 2.2 0.7 1.0 2.2 7.1 1.2 1.9 4.2 0.0 1.0 1.1 3.5 12.7 0.0 0.1 2.4 1.2 0.7 0.0 3.4 0.4 2.9 0.9 0.9 1.1 3.2 0.7 0.7 3.2 1.5 2.6 8.5 1.7 4.3 0.1 184.8 0.9 3.9 11.4 4.0 0.0 2.7 1.1 18.7 1.0 0.6 1.1 0.7 0.8 0.5 0.2 0.7 0.2 0.1 0.0 0.7 0.1 1.5 0.4 0.6 0.9 0.8 2.4 0.0 0.2 1.2 0.3 0.0 0.0 2.6 0.3 0.7 2.5 1.5 0.0 0.2 0.8 1.2 0.0 0.8 0.5 0.1 0.2 0.4 7.9 1.6 0.0 1.1 2.9 1.7 0.2 2.5 2.4 0.7 0.2 4.4 0.0 0.0 0.9 0.2 7.5 0.0 0.5 0.0 4.8 0.0 0.8 0.8 5.7 0.0 0.2 9.5 6.3 0.9 0.6 2.2 0.3 4.3 0.0 1.2 0.3 0.3 0.4 0.9 0.6 0.6 0.4 2.7 0.5 0.8 18.7 0.6 1.0 1.1 1.1 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.6 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.0 3.5 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 AL032819.3 ENSG00000284395 16 1431035-1433397 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 4.1;prostate: 5.2;salivary gland: 2.5;stomach 1: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "SCLC-21H: 27.7" "Not detected" "Not detected" NA NA 0.2 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.2 0.0 0.4 2.5 0.0 0.2 0.3 2.1 1.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.7 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL034430.1 ENSG00000285508 20 10413520-10431922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "blood: 31.4" "Group enriched" "Detected in some" 12 "Ciliated cells: 1.4;Club cells: 1.2;granulocytes: 1.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 39.8" "Low region specificity" "Detected in all" NA NA 4.4 1.7 5.0 6.3 0.0 0.6 0.0 2.5 3.2 0.0 0.0 1.2 0.0 0.0 6.2 0.0 2.8 0.0 1.0 0.0 3.7 0.0 0.4 1.3 0.0 1.6 0.0 0.0 0.0 2.3 0.0 0.0 4.3 2.9 0.0 0.0 0.0 8.2 31.4 19.1 16.3 4.3 7.4 5.0 17.7 9.4 5.9 7.6 0.0 1.0 8.1 12.6 3.6 5.2 5.8 6.5 19.4 5.1 8.1 2.8 13.8 13.2 0.0 11.6 10.1 1.4 3.0 9.2 7.8 39.8 3.0 17.9 6.1 1.5 0.0 2.9 6.4 2.4 7.9 2.3 10.8 13.5 7.0 7.3 4.2 20.2 11.1 0.8 8.8 8.1 17.0 11.3 4.4 12.1 2.8 4.4 11.6 20.1 26.0 7.2 9.6 8.6 9.3 12.0 14.4 10.3 16.3 6.8 10.4 12.5 5.9 10.2 11.5 19.1 13.7 15.7 4.7 16.3 5.5 8.2 5.6 7.4 13.4 6.7 5.3 6.4 11.8 4.3 13.7 31.4 6.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL035078.4 ENSG00000285283 "Reticulocalbin-1 " Q15293 11 31812391-32104665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.2" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 63.7;RH-30: 39.5;RT4: 43.1" HPA038474 Uncertain Supported "Endoplasmic reticulum" NA NA 2300000 "Endoplasmic reticulum" "HPA038474: AB_10672595" 4.7 0.9 1.6 7.5 2.4 0.0 0.3 16.2 3.2 0.3 5.9 1.7 0.3 0.9 3.8 0.3 1.7 4.3 0.3 0.3 3.1 0.4 2.8 1.4 0.3 2.2 1.9 6.1 0.3 0.0 1.8 1.6 3.0 0.3 0.8 6.9 0.3 0.3 3.3 0.0 2.4 4.6 3.6 0.5 2.2 0.3 1.0 0.3 0.5 0.3 0.7 1.9 0.3 0.6 5.3 0.4 3.5 3.2 2.1 1.7 7.4 12.4 12.0 11.5 3.4 2.1 6.7 63.7 21.2 11.2 10.4 6.0 9.6 0.0 21.0 24.0 16.2 6.5 9.0 7.2 12.3 5.0 1.5 3.6 9.0 0.7 0.0 3.1 1.5 10.6 1.4 12.3 8.1 3.9 15.8 2.0 1.2 3.9 0.1 2.6 4.9 0.0 5.1 0.0 0.1 2.7 39.5 1.6 0.0 43.1 5.0 1.9 12.4 0.8 7.6 3.1 9.1 0.1 37.7 28.7 12.1 17.3 24.3 0.0 0.0 0.1 30.4 1.2 13.1 0.0 3.5 0.0 2.1 3.4 1.9 0.6 0.2 1.8 5.3 0.1 0.3 0.9 0.4 3.2 2.0 0.6 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL035425.2 ENSG00000260548 X 108722070-108732687 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 13.0;pituitary gland: 7.4;thyroid gland: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 19.0;NTERA-2: 2.7;RT4: 4.9;WM-115: 5.0" NA NA 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 2.9 0.0 0.0 3.9 0.9 0.0 0.5 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.5 13.0 0.9 0.0 7.4 0.0 0.1 0.0 0.0 0.7 0.0 1.1 0.0 1.5 0.1 0.0 0.4 0.0 8.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL035460.1 ENSG00000241690 20 2814968-2818066 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 44 "testis: 61.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 14.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL049629.2 ENSG00000284969 "CD59 glycoprotein " 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "placenta: 65.2" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 5.3;Ductal cells: 8.2;Exocrine glandular cells: 12.5;Pancreatic endocrine cells: 27.1" "Group enriched" "Detected in some" 6 "memory CD8 T-cell: 1.6;T-reg: 2.5" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.4;HUVEC TERT2: 24.9;TIME: 30.6;U-2197: 26.0" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 3.2 0.4 0.3 2.8 0.5 1.2 2.2 0.4 2.6 0.7 0.5 0.1 0.9 1.5 1.3 2.3 1.5 0.3 2.6 2.4 1.6 2.0 0.6 1.9 2.0 0.9 1.0 0.4 1.3 0.1 0.2 65.2 0.9 0.4 0.4 0.5 3.1 1.3 3.9 0.0 0.1 1.4 0.7 0.4 3.6 1.0 0.5 0.2 1.0 1.4 1.4 0.8 2.9 0.0 0.3 0.0 0.0 0.0 2.5 0.2 0.5 1.5 0.1 1.0 1.6 3.8 0.0 8.4 3.8 1.1 1.0 0.0 4.3 0.0 0.9 5.7 0.5 1.0 0.1 19.4 1.8 0.8 0.1 0.1 3.3 0.4 0.4 0.2 0.5 1.4 1.3 0.5 6.9 0.9 24.9 0.1 0.2 3.3 7.1 0.4 0.7 0.3 0.2 0.6 11.4 0.2 0.7 0.5 2.2 0.9 0.0 0.1 0.9 1.5 2.8 0.1 0.4 0.0 30.6 3.2 1.2 26.0 3.2 1.7 1.5 0.1 7.4 0.0 7.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.4 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL049634.2 ENSG00000260861 20 1540144-1620009 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.0;blood: 36.1;lymphoid tissue: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 22.5;neutrophil: 36.1" "Group enriched" "Detected in many" 6 "granulocytes: 36.1;monocytes: 11.3" "Cell line enhanced" "Detected in some" "HL-60: 5.3;HMC-1: 11.3;hTERT-RPE1: 2.4;NB-4: 3.7;THP-1: 4.3;U-937: 3.2" NA NA 18.0 2.4 0.9 6.0 3.8 6.4 0.8 0.7 7.5 0.8 0.8 1.1 0.0 0.6 0.9 1.0 0.8 0.7 0.9 5.2 1.4 1.1 0.8 5.4 14.7 14.8 4.7 0.1 1.0 1.0 0.0 0.7 2.5 2.4 0.8 0.3 0.9 0.9 1.0 0.9 0.8 1.5 1.4 5.2 21.9 0.8 4.6 2.6 1.5 0.8 0.0 1.8 1.6 1.0 0.0 3.8 36.1 11.3 0.0 0.2 5.9 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 11.3 0.0 0.1 0.4 0.0 2.4 0.0 0.1 0.0 0.0 0.2 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 4.3 1.4 0.0 0.0 0.3 1.7 0.1 0.0 0.1 0.1 3.2 0.1 0.2 11.1 22.5 0.2 8.2 0.1 0.0 0.0 0.1 3.8 0.0 0.0 0.0 36.1 0.0 11.3 3.4 0.0 5.9 0.9 3.8 0.7 2.0 1.4 1.1 4.7 0.1 2.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL096814.1 ENSG00000214732 6 42155426-42163439 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 183 "testis: 78.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.4;HL-60: 1.4;hTCEpi: 2.1;OE19: 1.3" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL096870.1 ENSG00000258973 14 24332310-24337382 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.1;neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "HDLM-2: 2.5;HUVEC TERT2: 1.7" NA NA "unprognostic (2.50e-1)" "unprognostic (1.97e-1)" "unprognostic (1.26e-1)" "unprognostic (1.34e-1)" "unprognostic (4.64e-1)" "unprognostic (2.53e-1)" "unprognostic (1.04e-1)" "unprognostic (3.25e-1)" "unprognostic (6.48e-2)" 2.7 0.0 0.0 0.9 0.0 1.4 2.0 0.0 0.0 0.9 0.9 1.2 0.7 0.0 0.6 0.2 0.6 0.8 0.0 0.0 0.5 0.1 1.7 0.6 0.0 0.0 0.2 0.0 0.0 1.4 0.6 0.7 0.8 0.1 0.9 1.6 1.3 0.3 0.0 1.1 1.8 0.1 1.2 0.3 0.6 1.1 0.1 0.3 4.1 0.8 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.5 0.4 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 4.1 0.8 0.1 0.1 0.3 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.1 2.5 0.2 0.1 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL109810.2 ENSG00000235710 1 231184098-231187627 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "brain: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "A549: 1.4" NA NA 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL109811.4 ENSG00000277726 1 11012662-11030528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 4.2" "Group enriched" "Detected in some" 82 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 9.9;Ciliated cells: 9.4;Club cells: 7.9;granulocytes: 4.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 7.1;hTCEpi: 2.3;MCF7: 3.5;RT4: 4.7" NA NA "unprognostic (1.86e-2)" "unprognostic (1.32e-1)" "unprognostic (5.30e-2)" "unprognostic (6.34e-3)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (9.33e-2)" "unprognostic (2.39e-1)" "unprognostic (7.80e-2)" "unprognostic (2.77e-1)" "unprognostic (3.86e-1)" "unprognostic (4.48e-2)" 0.3 0.0 0.0 2.2 0.1 0.0 0.3 0.2 0.0 0.5 4.2 0.0 0.0 0.1 0.0 0.0 0.0 2.8 1.8 0.0 0.0 1.8 0.0 0.1 2.9 2.6 1.1 1.0 1.9 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.3 1.5 1.7 1.2 1.3 0.2 2.9 0.0 0.0 0.7 0.0 0.6 1.7 1.3 0.7 1.7 0.0 0.0 0.0 0.7 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.1 1.0 0.0 0.3 1.2 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 3.5 0.6 0.4 0.0 0.0 0.2 0.0 1.3 0.0 0.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.2 0.8 0.7 2.5 0.5 2.7 1.3 1.8 2.6 0.2 1.5 1.6 2.9 0.7 0.2 1.3 1.7 1.1 0.0 8.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 9.4 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121758.1 ENSG00000270299 20 646626-675800 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.1;retina: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebral cortex: 19.1" "Group enriched" "Detected in some" 6 "naive CD8 T-cell: 1.0;neutrophil: 2.0;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 14 "granulocytes: 2.0;monocytes: 2.1;T-cells: 1.0" "Cell line enhanced" "Detected in many" "GAMG: 10.7;Hep G2: 14.3;Karpas-707: 8.4;SK-BR-3: 8.8" NA NA "unprognostic (2.38e-2)" "unprognostic (1.45e-1)" "unprognostic (3.40e-2)" "unprognostic (1.26e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (7.42e-3)" "unprognostic (4.14e-3)" "unprognostic (2.22e-1)" "unprognostic (3.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.87e-3)" "unprognostic (5.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.42e-2)" "unprognostic (5.00e-2)" "unprognostic (2.03e-2)" 0.3 2.4 0.9 0.0 0.8 0.3 0.3 3.6 19.1 0.3 0.3 0.8 0.0 0.0 2.9 0.0 2.3 0.3 0.9 4.7 1.0 0.9 0.3 0.4 0.4 0.3 0.7 0.0 0.3 0.4 0.0 0.5 0.4 3.3 0.4 0.0 6.0 2.2 0.0 0.7 0.7 0.4 0.0 0.8 0.5 0.6 2.6 0.2 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.1 2.0 2.1 0.0 1.0 0.0 0.3 4.3 0.0 1.8 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.6 0.3 0.6 0.2 0.0 10.7 0.0 0.0 0.8 0.0 0.5 0.1 6.3 0.9 14.3 0.0 1.1 3.2 0.0 0.0 0.7 0.0 0.5 0.0 5.0 0.4 8.4 0.0 0.0 0.0 0.0 3.1 5.1 0.2 0.0 2.0 2.7 0.0 0.5 1.0 2.4 1.4 8.8 1.5 2.6 1.1 2.6 5.1 0.8 1.2 0.0 1.5 0.5 4.0 0.3 0.4 0.1 3.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 2.0 0.0 2.1 0.0 0.0 0.0 0.9 0.8 3.6 19.1 1.0 0.9 0.7 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121845.2 ENSG00000273047 20 63738270-63740398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "liver: 75.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.6" "Group enriched" "Detected in many" 26 "dendritic cells: 7.6;T-cells: 5.7" "Cell line enhanced" "Detected in some" "Hep G2: 10.8;HHSteC: 2.4;JURKAT: 2.9;OE19: 3.5;U-266/70: 2.2;U-698: 4.0" NA NA "unprognostic (3.96e-2)" "unprognostic (1.60e-1)" 2.0 0.1 0.1 0.0 0.2 0.3 1.2 0.2 0.1 0.3 1.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.1 0.1 0.0 8.5 75.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 2.3 0.0 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.1 2.4 0.1 0.2 7.6 0.0 0.2 0.0 5.7 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 2.2 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 1.3 0.2 4.7 5.7 0.0 0.2 3.2 1.9 0.0 0.0 0.2 7.6 4.4 1.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL121845.3 ENSG00000273154 20 63708864-63739103 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.2;blood: 2.4;lymphoid tissue: 2.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 1.4;monocytes: 1.8" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 3.6;U-266/84: 3.7;U-698: 4.8" NA NA "unprognostic (3.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (6.29e-2)" "unprognostic (1.32e-1)" "unprognostic (2.28e-1)" "unprognostic (3.48e-1)" "unprognostic (4.29e-2)" "unprognostic (7.13e-2)" "unprognostic (2.18e-4)" "unprognostic (3.37e-4)" "unprognostic (1.84e-7)" "unprognostic (7.09e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (1.96e-3)" 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 0.0 1.0 2.0 0.0 0.5 0.8 0.0 1.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.8 2.4 0.4 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 2.3 0.1 2.3 0.0 0.3 0.9 0.5 0.6 0.0 0.7 0.0 0.0 2.4 0.0 1.8 1.2 0.3 1.3 1.5 0.8 0.0 0.0 0.4 0.4 0.0 0.6 0.0 1.2 0.0 2.4 0.4 0.0 0.0 1.6 0.0 0.0 0.0 2.1 0.7 1.9 0.0 0.0 0.2 0.0 1.4 3.6 0.0 3.4 1.3 1.3 0.7 0.4 3.7 4.8 0.0 1.3 0.3 0.0 0.0 0.1 0.9 0.1 0.6 0.0 1.1 2.4 0.0 0.0 1.0 0.7 0.0 1.8 0.0 0.6 1.5 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL132671.2 ENSG00000282218 6 117318211-117573571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "epididymis: 3.7;lung: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 37 "U-138 MG: 14.5" HPA019477 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA019477: AB_1849890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136295.3 ENSG00000259371 14 24120956-24131829 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;HMC-1: 3.0" NA NA "unprognostic (1.38e-1)" "unprognostic (4.35e-3)" "unprognostic (4.81e-2)" "unprognostic (1.87e-2)" "unprognostic (6.61e-5)" "unprognostic (5.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.29e-1)" "unprognostic (1.78e-1)" "unprognostic (5.39e-2)" "unprognostic (1.53e-2)" "unprognostic (4.52e-4)" "unprognostic (2.37e-1)" "unprognostic (9.36e-2)" "unprognostic (2.23e-1)" 0.2 0.2 0.1 0.2 0.2 1.5 0.3 1.1 0.2 0.3 0.6 1.2 0.2 0.8 0.5 0.1 0.1 0.0 0.1 0.0 0.5 3.0 0.2 0.6 0.1 0.4 0.9 0.6 0.3 0.3 0.4 0.5 0.5 0.7 0.0 1.1 1.5 0.0 0.1 1.1 1.2 1.4 0.5 0.4 0.2 0.3 0.2 0.0 0.1 0.1 0.7 0.4 0.1 0.4 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.6 0.4 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.3 0.5 0.5 1.0 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.9 0.2 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.4 0.4 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.7 0.1 0.5 1.1 0.0 0.8 0.2 0.1 0.0 0.0 0.3 0.6 0.5 0.0 0.5 1.0 0.9 0.4 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL136373.1 ENSG00000282881 "Uncharacterized protein LOC105378696 " 1 46532166-46533614 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.9;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "BEWO: 3.4" "Group enriched" "Detected in some" 5 "amygdala: 1.2;basal ganglia: 1.6;hypothalamus: 1.4" NA NA 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL138694.1 ENSG00000283384 13 108335354-108448316 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.1;brain: 7.4" "Group enriched" "Detected in some" 11 "Collecting duct cells: 5.2;monocytes: 1.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA 0.0 0.4 3.6 0.7 2.8 2.0 0.8 0.0 7.4 0.0 0.2 0.2 0.0 0.2 0.7 2.0 0.5 1.1 0.4 0.6 2.0 0.1 0.0 0.6 0.8 0.0 3.2 1.2 0.6 0.5 0.0 0.3 0.4 0.4 0.5 0.0 0.7 0.7 0.9 2.4 0.3 0.3 0.0 0.8 1.2 1.7 0.0 0.0 1.6 0.0 0.1 0.0 0.0 2.2 1.4 4.1 1.4 1.8 1.7 0.2 0.7 0.2 1.7 2.3 1.5 1.5 0.5 0.6 0.6 0.5 0.4 1.3 1.6 1.2 0.9 1.2 1.9 0.7 0.8 0.5 0.8 1.0 0.5 0.5 1.8 1.5 2.9 1.6 1.4 1.0 1.3 0.4 0.7 2.0 1.0 2.5 1.5 1.5 1.7 1.0 4.6 2.3 1.7 0.9 1.2 0.9 0.8 0.4 2.1 1.3 1.8 0.8 0.6 0.7 0.9 2.0 1.5 1.7 0.4 1.3 0.7 1.7 0.8 1.2 1.0 1.3 1.6 2.0 2.2 3.3 1.4 1.1 1.0 0.7 0.8 1.2 0.9 0.8 0.4 2.2 1.2 1.7 4.1 1.8 0.8 1.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL139260.3 ENSG00000274944 1 38864501-38881617 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.3;testis: 15.5" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 8.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA041188, HPA078331" Uncertain Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA041188: AB_10794405, HPA078331: AB_2686882" "unprognostic (8.00e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (2.00e-1)" "unprognostic (9.72e-3)" "unprognostic (4.27e-4)" "unprognostic (4.64e-7)" "unprognostic (2.59e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (9.54e-3)" "unprognostic (6.09e-6)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.32e-3)" 1.2 0.0 0.4 1.3 0.9 0.0 0.4 0.4 1.0 0.4 3.3 0.6 0.4 2.0 0.4 0.4 3.0 0.0 0.4 0.4 0.4 0.5 1.5 0.4 2.7 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.6 0.4 2.3 1.8 2.3 0.4 0.4 1.5 2.1 0.4 0.4 0.4 2.4 15.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 7.3 2.8 4.0 0.0 1.7 0.0 12.4 1.3 3.3 0.0 0.6 0.0 3.6 0.4 0.0 0.0 0.5 6.7 13.3 2.4 11.3 0.2 0.5 9.2 0.0 0.9 0.0 7.9 2.1 2.8 2.5 2.2 0.0 17.0 5.0 0.0 0.0 1.6 1.1 1.5 2.0 0.5 6.4 4.6 1.7 3.3 6.8 16.1 6.5 9.8 7.7 7.9 8.0 12.6 0.0 7.0 6.3 3.4 7.7 7.3 1.5 3.6 4.2 5.2 5.8 2.3 6.5 6.3 11.5 1.5 11.7 9.4 5.7 7.4 2.6 0.0 1.3 0.2 0.5 1.9 1.1 3.0 0.2 0.5 4.2 2.0 0.4 0.4 2.8 0.0 4.0 7.3 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 AL139300.1 ENSG00000256500 14 103562962-103685924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.2" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044617, HPA052450" Uncertain Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (1.56e-1)" 10.2 7.5 16.6 7.8 20.3 2.8 15.5 21.9 25.1 5.9 4.8 3.2 5.1 2.0 5.5 4.6 5.8 3.9 4.2 20.0 17.2 17.2 5.3 5.6 4.2 7.7 17.3 6.2 5.0 15.8 9.9 5.8 4.2 5.2 5.0 2.9 2.7 7.7 6.3 37.2 2.0 4.2 8.5 22.6 2.9 2.8 18.5 4.0 2.2 7.8 9.2 5.4 6.6 6.9 4.2 4.9 4.2 5.1 2.3 4.4 1.3 6.3 12.0 13.2 1.2 7.3 9.0 5.8 18.5 14.3 20.9 13.2 7.3 9.7 16.2 12.1 13.4 14.1 6.3 8.8 10.6 13.3 5.4 1.0 6.2 6.3 6.8 9.7 8.5 3.7 7.0 2.9 10.0 11.4 11.8 11.9 10.7 8.3 4.2 15.0 12.1 13.3 3.1 9.1 14.3 15.1 5.9 10.4 8.7 10.7 7.4 17.3 10.6 11.0 4.6 10.3 5.5 10.2 4.9 8.4 9.2 7.3 14.7 8.7 5.4 6.3 18.5 15.5 3.5 8.3 0.7 3.2 4.2 2.8 4.3 2.9 1.9 3.4 4.1 1.9 4.2 4.4 1.9 2.8 2.3 5.1 4.9 4.2 1.3 16.6 20.3 21.9 25.1 17.2 17.2 17.3 6.2 5.2 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL157392.5 ENSG00000282246 10 13610047-13655929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 6.8" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.2;Ciliated cells: 2.7;Club cells: 3.4;Collecting duct cells: 3.5;granulocytes: 2.3" "Cell type enhanced" "Detected in some" "basophil: 3.3;non-classical monocyte: 4.0" "Group enriched" "Detected in many" 7 "granulocytes: 3.3;monocytes: 4.0;T-cells: 1.4" "Low cell line specificity" "Detected in many" HPA047950 Uncertain NA NA "HPA047950: AB_2680221" 1.0 0.0 1.2 1.8 1.9 0.6 0.0 0.5 2.0 0.7 3.7 0.0 0.0 0.4 0.0 0.1 0.0 0.4 2.3 0.4 1.1 0.4 0.5 0.9 1.4 2.6 0.4 1.0 6.8 1.1 0.0 2.2 1.6 2.5 0.6 1.1 0.6 0.4 0.1 3.3 4.0 0.0 1.4 0.7 2.0 2.8 10.1 2.3 2.1 0.7 6.2 3.3 0.2 1.3 1.4 4.5 3.6 0.7 2.5 1.6 0.9 5.8 1.8 2.3 1.4 1.7 3.5 1.0 5.2 5.5 1.9 1.8 3.5 1.5 5.6 0.6 0.6 8.8 0.5 7.4 3.3 3.1 0.6 2.2 2.9 4.9 0.7 4.1 2.0 1.1 1.7 0.9 1.5 1.2 1.6 1.6 1.3 3.1 2.5 6.7 2.8 2.5 9.0 5.8 1.9 4.8 2.6 3.6 2.2 1.0 2.3 3.1 5.4 3.3 0.3 0.0 0.5 0.6 0.4 0.0 0.6 0.2 0.0 0.4 0.3 1.4 1.8 0.0 4.0 0.1 0.0 0.7 8.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 3.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 AL160272.2 ENSG00000285082 9 117704157-117877478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 5.1" NA NA 12.0 3.8 7.2 3.0 4.9 10.1 10.7 4.0 4.5 2.0 2.3 4.7 0.6 2.1 2.5 3.7 1.5 1.6 3.0 4.8 9.6 3.8 2.7 5.3 15.4 5.6 5.1 2.0 6.0 4.5 0.4 4.2 4.6 2.0 2.6 2.9 4.5 1.5 3.0 4.4 3.7 1.8 4.9 21.0 3.4 2.5 5.9 0.0 2.7 2.0 2.1 3.4 7.6 2.0 1.7 4.2 1.9 0.6 1.1 0.5 0.4 5.1 2.0 0.5 0.0 1.6 1.3 0.7 0.4 0.1 0.3 3.4 1.2 0.9 0.5 0.5 0.5 1.3 0.2 0.6 0.8 1.1 0.3 1.8 1.8 0.7 0.0 2.6 0.6 0.7 0.4 1.4 0.6 0.4 0.7 0.6 0.4 3.1 1.2 1.7 0.8 1.9 0.9 0.6 1.1 0.5 0.5 0.8 0.4 2.0 0.9 1.3 1.3 1.9 0.7 1.3 0.7 0.7 2.0 1.4 0.4 1.5 0.6 2.2 2.4 1.3 1.3 1.3 0.9 4.2 1.9 1.3 0.7 0.9 0.7 0.9 0.7 0.6 0.6 2.0 0.9 1.1 3.8 0.6 1.2 1.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL162231.1 ENSG00000187186 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.6" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 34.9;Distal tubular cells: 21.6;Proximal tubular cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 28.3" "Low region specificity" "Detected in all" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: AB_2686161" "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 3.0 6.9 12.1 2.1 21.6 1.8 2.9 6.9 20.2 2.3 1.8 1.9 1.1 2.8 4.0 13.9 1.8 1.8 2.2 9.1 11.8 9.5 4.9 2.5 2.2 1.4 9.6 12.2 7.8 6.2 3.4 13.1 2.3 7.0 3.7 1.2 1.8 4.6 2.1 21.9 2.2 2.0 3.8 5.0 1.0 1.4 68.6 5.3 0.6 3.5 2.0 0.7 1.5 2.5 4.0 11.8 12.0 2.5 3.5 2.9 1.6 0.3 6.0 5.6 7.2 4.6 2.3 5.0 4.8 1.4 3.0 3.5 1.0 2.4 0.0 0.6 3.2 6.0 1.4 3.6 1.7 0.5 12.9 0.6 0.0 28.3 1.7 1.1 2.6 4.5 2.4 2.0 1.8 1.9 4.2 0.8 7.4 3.2 7.4 2.2 0.0 0.5 2.6 4.6 5.3 1.6 0.0 5.3 0.9 5.4 0.0 5.8 9.3 3.4 1.1 8.0 3.3 2.8 7.4 1.1 10.7 14.8 3.4 1.1 7.9 2.6 1.0 13.2 1.5 14.6 12.0 2.5 2.6 1.8 1.3 1.7 4.0 2.3 1.0 0.8 1.6 2.9 1.5 3.5 3.5 0.8 11.8 2.0 1.6 12.1 21.6 6.9 20.2 11.8 9.5 9.6 12.2 7.0 5.3 8.9 9.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.5 34.9 0.0 11.6 21.6 12.0 0.0 0.0 0.0 0.0 9.4 10.4 0.0 0.0 2.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 9.0 0.0 0.0 10.8 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 AL162231.3 ENSG00000258728 9 34646645-34657113 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.0;BEWO: 1.1;HeLa: 1.4;HHSteC: 2.1;NB-4: 2.2;THP-1: 1.6;U-2 OS: 1.0" NA NA 3.2 1.9 2.4 5.0 4.4 3.1 2.6 3.0 2.5 2.8 7.5 1.4 4.4 1.5 4.6 2.6 2.5 4.8 3.6 3.7 1.9 1.9 4.1 17.6 2.7 2.3 1.7 1.5 3.5 1.7 1.5 3.5 8.5 2.2 2.1 1.5 3.8 6.1 4.8 2.5 3.5 10.5 3.0 1.6 3.1 2.4 1.9 2.0 3.9 2.6 2.1 3.6 3.2 2.8 1.5 1.0 0.0 0.7 0.0 0.9 1.2 1.0 0.0 0.0 0.7 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.4 0.3 1.5 0.0 0.4 1.0 1.0 0.5 0.9 0.0 0.0 0.0 0.2 0.0 1.2 2.4 4.4 3.0 2.1 1.9 1.9 1.7 1.5 2.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL163195.3 ENSG00000259060 14 20582892-20609795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 115 "epididymis: 10.8;testis: 12.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AL163636.2 ENSG00000259171 14 20684587-20700576 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "liver: 164.0" "Cell type enhanced" "Detected in some" 31 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 2.2;Ciliated cells: 4.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 12.8;memory B-cell: 4.4;myeloid DC: 6.9" "Group enriched" "Detected in many" 12 "B-cells: 4.4;dendritic cells: 6.9;monocytes: 12.8" "Cell line enhanced" "Detected in many" "ASC diff: 11.2;ASC TERT1: 24.0;Hep G2: 14.9;HSkMC: 10.6;OE19: 37.6" NA NA "unprognostic (1.88e-1)" "unprognostic (3.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-3)" "unprognostic (1.93e-1)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "unprognostic (8.66e-2)" "unprognostic (6.61e-2)" "unprognostic (6.87e-3)" "unprognostic (8.58e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-2)" "unprognostic (5.11e-2)" 34.3 2.1 1.3 6.1 1.6 0.0 33.2 1.0 1.2 29.1 18.6 2.5 13.9 9.8 22.0 21.0 16.8 13.3 26.8 9.1 2.2 1.4 21.5 164.0 14.5 5.5 3.0 1.2 35.6 18.7 1.4 3.0 4.7 2.6 35.2 14.2 11.8 40.5 16.1 7.8 9.9 15.5 19.9 4.0 3.3 22.6 15.0 1.8 0.0 9.3 11.8 8.1 28.9 30.3 4.4 6.9 0.2 12.8 0.0 0.6 3.2 1.3 0.4 1.1 0.0 11.2 24.0 0.0 1.5 3.7 0.0 0.9 0.1 1.6 0.0 0.2 5.6 1.6 0.5 0.3 0.1 0.0 3.5 0.4 0.2 0.0 14.9 0.8 0.0 0.1 10.6 0.8 0.0 0.5 7.3 0.7 1.1 0.0 6.2 1.5 0.0 0.1 0.2 0.0 37.6 0.3 0.2 0.8 1.1 0.4 0.6 0.0 0.1 2.5 0.9 1.0 0.1 1.2 0.0 1.3 1.8 0.5 1.2 0.2 1.2 1.0 0.0 1.9 0.3 1.9 0.0 12.8 0.0 0.0 0.7 0.3 4.4 0.6 0.3 6.9 0.9 0.2 0.1 0.2 0.0 0.0 1.4 0.6 3.2 1.3 1.6 1.0 1.2 2.2 1.4 3.0 1.2 2.6 1.8 11.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL353572.3 ENSG00000283205 9 87956214-87956883 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-2 OS: 1.6" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL354761.1 ENSG00000236543 9 135604345-135618952 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "skin 1: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "BEWO: 13.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL355315.1 ENSG00000249967 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.2;liver: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Lineage enhanced" "Detected in single" "NK-cells: 1.0" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;EFO-21: 3.4;GAMG: 2.8;HBEC3-KT: 2.6;hTERT-RPE1: 5.1" HPA076857 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA076857: AB_2686817" 2.4 1.1 1.9 0.3 2.3 0.3 1.0 4.6 3.3 1.9 0.9 5.5 0.6 0.3 1.1 2.5 0.8 2.7 2.3 4.9 2.6 1.0 22.2 15.1 0.8 0.3 6.4 3.3 0.8 2.4 5.7 0.9 0.6 4.8 0.8 0.3 2.1 0.8 3.9 2.2 0.9 0.8 0.8 5.5 0.9 0.9 0.9 4.6 0.0 0.8 2.5 0.4 1.0 0.9 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.5 3.2 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 3.4 0.5 2.8 1.7 0.0 2.6 1.8 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 1.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 2.3 4.6 2.3 2.6 1.0 6.4 3.3 4.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL358075.4 ENSG00000278139 1 46043661-46176488 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "testis: 43.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HeLa: 4.6;RT4: 15.1" "Not detected" "Not detected" HPA005751 Uncertain NA NA "HPA005751: AB_1855350" 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 1.4 0.0 1.8 0.6 0.0 0.0 0.5 0.0 1.1 0.2 0.0 0.0 2.1 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL365214.3 ENSG00000281613 6 112236806-112350094 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "testis: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "RPTEC TERT1: 9.2" HPA059324 Uncertain NA NA "HPA059324: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.2 0.1 0.0 0.3 0.3 0.5 0.0 0.1 0.0 0.0 0.2 0.5 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 9.2 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL391650.1 ENSG00000236782 1 26169516-26171821 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "retina: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 3.3" "Not detected" "Not detected" NA NA "unprognostic (4.80e-2)" "unprognostic (3.89e-2)" "unprognostic (1.78e-1)" "unprognostic (2.24e-3)" "unprognostic (9.79e-2)" "unprognostic (4.84e-2)" "unprognostic (4.87e-3)" "unprognostic (6.44e-4)" "unprognostic (4.45e-1)" "unprognostic (9.33e-2)" "unprognostic (1.93e-2)" "unprognostic (2.29e-1)" "unprognostic (1.17e-1)" "unprognostic (3.23e-1)" "unprognostic (7.73e-2)" "unprognostic (1.57e-2)" "unprognostic (2.26e-1)" 0.1 0.5 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.7 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.1 1.1 2.4 0.0 0.1 0.1 0.1 0.2 0.0 18.5 0.3 0.1 3.3 0.3 0.5 0.1 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.6 0.2 0.0 0.9 0.0 1.4 0.0 1.0 0.4 0.7 0.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.2 1.0 3.3 0.3 0.0 0.7 0.8 0.0 0.0 0.0 1.0 1.9 0.6 0.4 0.7 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.3 1.4 0.0 0.2 0.7 0.4 2.6 0.3 0.0 1.3 0.9 0.4 0.0 0.5 2.3 0.6 0.2 0.7 1.9 1.1 0.6 0.0 0.0 0.1 1.8 1.3 0.3 1.2 0.4 2.3 0.0 1.2 1.3 0.0 0.3 0.0 1.0 0.6 0.1 0.4 0.3 0.6 0.2 0.6 1.4 1.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 AL451007.3 ENSG00000284188 1 244729898-244730962 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 12.4" "Cell type enriched" "Detected in single" 33 "Distal tubular cells: 3.3" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;NTERA-2: 1.2;SCLC-21H: 1.6" NA NA 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.6 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 2.3 0.0 0.2 1.6 1.5 0.2 0.2 12.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL512428.1 ENSG00000282804 6 24797373-24809798 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.2;lymphoid tissue: 2.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HEK 293: 1.1;HeLa: 1.3;U-138 MG: 1.1;U-251 MG: 1.0;U-266/70: 1.0" NA NA 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.7 1.1 0.1 0.9 0.2 0.8 2.1 3.2 0.6 0.0 1.7 0.1 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 1.0 0.0 0.0 0.5 0.0 0.0 0.9 0.5 0.8 1.7 0.6 1.7 0.4 0.4 0.8 0.3 0.8 1.4 1.7 3.2 0.0 0.0 2.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL590132.1 ENSG00000284299 1 210858125-211134146 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "brain: 17.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 2.1;SH-SY5Y: 4.8;SK-MEL-30: 3.1;T-47d: 2.1" NA NA 0.8 1.3 5.3 1.3 11.4 0.6 0.6 16.5 17.5 0.6 0.7 2.6 0.0 0.7 0.7 0.6 0.6 0.6 0.6 0.6 3.1 0.7 0.6 0.6 0.7 0.0 6.3 0.6 0.6 0.8 0.2 0.6 1.2 0.7 0.7 0.0 0.8 0.6 1.5 0.6 0.6 0.6 0.0 0.7 0.7 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.3 2.1 0.1 0.1 0.0 0.2 4.8 0.0 0.2 3.1 0.0 2.1 0.0 0.0 0.7 0.2 1.2 0.7 0.0 0.0 0.0 0.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL592183.1 ENSG00000273748 Unmapped 54224-83311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 12.2" "Low cell type specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 38.1" HPA049380 Approved NA NA "HPA049380: AB_2680736" 2.1 1.4 1.1 1.2 2.1 0.2 1.4 1.9 2.3 5.7 7.4 2.9 1.7 8.9 2.7 3.5 1.2 0.1 6.4 2.6 1.3 0.7 1.8 1.5 1.9 2.0 3.2 0.6 3.3 1.0 1.3 1.5 2.1 0.2 5.2 4.0 2.9 12.2 6.0 10.0 6.9 6.8 9.0 4.8 21.1 2.1 0.5 11.8 14.7 19.6 3.0 16.8 14.4 8.9 14.6 1.0 16.2 12.9 6.5 4.0 7.8 11.3 3.1 0.3 10.7 27.0 11.8 11.2 3.4 6.2 0.3 16.6 17.9 19.2 1.9 3.4 7.7 22.8 5.9 10.4 22.7 38.1 5.8 0.6 11.9 9.8 1.7 1.8 1.6 16.3 2.4 6.7 13.8 10.8 1.7 17.2 1.3 5.3 1.8 5.5 3.7 11.0 5.6 2.7 1.4 2.3 2.9 20.8 31.1 6.2 15.7 3.3 4.4 8.8 3.7 10.0 5.5 4.3 7.7 12.2 7.3 7.0 3.9 9.9 9.0 8.7 3.2 6.8 6.9 6.0 6.8 4.8 6.0 7.4 11.3 5.7 13.2 2.6 0.0 0.0 13.4 2.3 3.5 2.0 1.3 6.6 2.0 0.1 4.5 0.4 0.0 1.1 0.8 4.8 3.1 15.1 1.6 2.2 0.0 1.2 6.2 13.3 0.0 4.6 6.4 16.9 0.0 3.6 2.9 2.9 0.0 6.7 2.8 4.1 12.9 6.9 0.3 0.9 10.8 1.6 19.2 2.8 7.8 AL592490.1 ENSG00000197991 13 61409858-61427849 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 1.6;testis: 2.3" "Group enriched" "Detected in some" 32 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062669 Approved "Vesicles,Cytokinetic bridge" NA NA Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL603832.3 ENSG00000271810 1 112702614-112711433 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.4;myeloid DC: 1.3;non-classical monocyte: 2.1;plasmacytoid DC: 4.8" "Group enriched" "Detected in many" 10 "dendritic cells: 4.8;monocytes: 2.1" "Cell line enhanced" "Detected in many" "WM-115: 8.3" NA NA "unprognostic (1.42e-2)" "unprognostic (4.26e-2)" "unprognostic (6.22e-2)" "unprognostic (2.69e-2)" "unprognostic (2.41e-2)" "unprognostic (1.03e-3)" "unprognostic (1.01e-2)" "unprognostic (1.48e-1)" "unprognostic (9.33e-2)" "unprognostic (6.66e-2)" "unprognostic (2.23e-1)" "unprognostic (1.93e-4)" "unprognostic (1.53e-3)" "unprognostic (3.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" 0.4 2.3 0.4 0.4 0.5 0.0 1.8 0.7 0.7 0.2 0.4 0.8 0.4 2.5 0.3 0.3 0.0 0.5 0.4 0.5 0.5 0.3 1.4 0.0 0.5 0.7 0.3 3.0 0.3 0.8 0.3 0.6 0.4 3.1 2.1 0.6 0.5 0.0 0.3 1.9 0.6 8.8 0.3 0.0 0.3 0.4 0.3 4.8 0.0 2.1 0.1 0.2 0.5 4.3 0.0 1.1 2.4 0.7 3.5 0.2 2.3 2.2 0.4 1.3 0.6 0.8 0.0 0.7 2.8 1.5 1.1 1.1 2.2 0.2 0.0 0.3 0.5 0.0 0.4 2.7 0.0 0.0 5.5 4.4 2.9 2.4 2.8 5.8 0.4 0.9 0.0 2.1 3.0 0.0 0.0 0.5 1.2 2.4 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.9 3.1 2.0 6.0 1.4 0.0 2.7 2.2 1.8 0.0 0.2 0.0 0.1 0.6 4.2 0.2 8.3 0.0 0.3 0.0 0.0 1.4 0.2 0.3 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 2.1 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL645922.1 ENSG00000244255 6 31927698-31952048 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 115.5" "Group enriched" "Detected in some" 8 "Ciliated cells: 9.4;Club cells: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;Hep G2: 1.6;Karpas-707: 2.4;U-266/84: 1.0" "HPA000951, HPA001817, HPA001832" Approved Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" NA NA "Endoplasmic reticulum, Vesicles" "Cell Junctions" "HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778" "unprognostic (7.68e-2)" "unprognostic (1.86e-2)" 5.3 0.9 0.6 2.9 0.7 0.3 3.9 0.6 0.7 0.7 3.7 0.3 0.0 0.8 0.9 3.0 0.9 1.1 0.8 4.4 0.7 0.6 10.8 115.5 15.8 9.7 0.7 0.0 1.5 0.7 0.3 0.7 5.0 0.6 0.8 0.6 1.1 0.8 0.3 0.8 0.7 4.3 1.5 0.8 9.7 1.3 1.3 0.0 0.3 0.7 0.0 1.3 1.5 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.6 0.7 0.7 0.6 0.7 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL645941.2 ENSG00000248993 6 32937364-32953122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 18.7;lymphoid tissue: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 1.3;intermediate monocyte: 1.5;memory B-cell: 2.6;myeloid DC: 1.7;naive B-cell: 1.0;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 8 "B-cells: 2.6;dendritic cells: 1.7;monocytes: 1.5" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;SK-MEL-30: 1.4;U-698: 1.3" HPA012298 Uncertain NA NA "HPA012298: AB_1853927" "unprognostic (1.33e-1)" "unprognostic (2.53e-1)" "unprognostic (4.98e-1)" "unprognostic (5.56e-4)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.93e-1)" "unprognostic (3.25e-2)" "unprognostic (3.78e-1)" "unprognostic (1.60e-1)" "unprognostic (8.18e-2)" "unprognostic (4.73e-2)" 10.0 2.9 1.7 12.1 2.8 2.3 2.4 1.6 2.0 3.0 5.6 3.7 1.7 4.0 2.8 5.5 1.8 1.7 4.3 5.3 1.8 1.8 8.3 1.7 18.7 10.8 3.8 0.0 2.4 5.0 1.7 2.1 1.9 3.6 2.6 2.0 3.0 7.3 3.8 2.8 2.0 12.7 1.9 5.5 13.2 3.5 1.8 2.7 7.3 7.1 4.7 19.3 2.1 1.9 2.6 1.7 0.2 1.5 0.0 0.2 0.6 0.0 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.3 0.6 0.0 0.0 0.5 0.4 1.3 0.2 0.2 0.2 0.0 1.3 0.2 0.0 1.5 0.0 2.6 0.0 0.1 1.7 1.0 0.0 0.0 0.1 0.0 0.2 1.1 0.2 0.6 1.7 2.8 1.6 1.6 1.8 1.8 3.8 0.0 3.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL662820.1 ENSG00000285064 6 33321386-33329286 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "retina: 26.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.5;neutrophil: 2.4" "Group enriched" "Detected in many" 4 "B-cells: 2.5;granulocytes: 2.4;T-cells: 1.6" "Cell line enhanced" "Detected in some" "U-266/84: 1.6;U-698: 3.2;U-937: 1.6" NA NA 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.5 0.0 2.4 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 2.5 0.3 1.6 2.4 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL662899.1 ENSG00000204422 6 31686962-31714072 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8;brain: 5.3" "Cell type enriched" "Detected in single" 7 "Club cells: 2.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.3;hippocampal formation: 1.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 25 "HEL: 10.9" NA NA "unprognostic (1.83e-1)" "unprognostic (2.84e-1)" "unprognostic (3.49e-1)" 0.1 0.0 2.9 0.1 0.5 3.8 0.1 0.1 5.3 0.4 0.7 0.1 0.1 0.0 0.5 0.7 0.9 0.2 0.4 0.1 1.8 0.2 0.1 0.1 1.1 0.1 0.1 0.1 0.6 0.1 0.3 0.2 0.1 0.7 0.1 0.5 0.1 0.2 0.1 0.1 2.7 0.1 0.1 0.1 1.7 0.0 0.9 0.1 0.6 2.3 0.1 0.1 0.1 0.8 0.8 1.3 2.9 1.5 0.7 0.9 1.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.9 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 1.3 1.7 0.9 1.5 0.6 0.5 0.6 0.6 1.3 0.8 0.4 0.4 2.9 0.7 1.4 1.1 0.6 1.5 2.9 0.5 0.1 5.3 1.8 0.2 0.1 0.1 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL662899.2 ENSG00000263020 6 31666102-31673546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 83.6" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005944, HPA048307" Uncertain NA NA "HPA005944: AB_1847290, HPA048307: AB_2680348" "unprognostic (7.19e-2)" "unprognostic (4.75e-1)" "unprognostic (2.65e-1)" "unprognostic (7.07e-3)" "unprognostic (1.09e-2)" "unprognostic (6.32e-2)" "unprognostic (1.37e-3)" "unprognostic (2.55e-3)" "unprognostic (1.24e-1)" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (3.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" 8.9 7.7 7.6 9.3 9.9 83.6 8.8 16.9 14.5 10.0 9.0 10.0 7.6 7.7 8.0 10.4 10.4 10.9 10.7 9.8 7.4 7.4 11.8 17.2 8.6 10.4 6.8 7.8 12.1 10.7 7.7 8.3 13.3 7.4 10.2 9.4 9.9 10.0 9.8 13.2 15.1 12.9 8.1 6.1 19.1 8.7 11.1 6.4 21.0 11.8 14.4 11.0 9.2 8.3 1.3 2.2 0.4 1.0 1.0 1.1 0.3 1.1 0.9 1.7 2.1 0.0 0.0 0.4 0.0 0.4 1.8 0.7 1.3 1.9 1.6 0.9 1.3 2.2 1.3 0.4 3.8 4.3 1.1 3.1 2.8 0.9 0.6 1.6 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.8 1.3 1.3 0.5 1.1 2.6 2.9 0.2 1.5 0.6 0.0 1.8 0.0 0.0 0.0 0.0 1.3 3.8 0.9 0.8 0.2 0.0 0.7 0.8 0.4 2.0 4.3 0.0 0.0 0.0 0.7 3.7 0.4 1.3 1.6 0.3 0.5 0.4 0.2 0.3 1.1 1.3 0.0 0.4 0.1 0.2 0.2 0.8 0.3 1.0 1.0 2.2 0.2 0.3 7.6 9.9 16.9 14.5 7.4 7.4 6.8 7.8 7.4 6.4 3.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL669918.1 ENSG00000250264 6 32813767-32838822 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 17.2;HDLM-2: 11.4;HEL: 12.4" HPA001312 Approved Approved "Nuclear speckles,Endoplasmic reticulum" NA NA "Nuclear speckles, Endoplasmic reticulum" "HPA001312: AB_1080206" "unprognostic (6.13e-2)" "unprognostic (8.76e-3)" "unprognostic (4.62e-1)" "unprognostic (9.88e-2)" "unprognostic (1.99e-1)" "unprognostic (3.39e-2)" "unprognostic (1.72e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.49e-1)" "unprognostic (8.73e-2)" "unprognostic (2.03e-1)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" 6.5 3.6 2.8 25.5 3.1 3.8 3.6 3.1 3.3 4.8 7.7 3.5 1.0 5.7 4.6 2.5 4.8 3.6 5.7 3.5 2.1 2.6 5.3 10.0 8.5 12.6 3.2 2.8 4.7 2.1 1.7 5.0 2.4 3.6 3.8 3.1 3.6 7.0 1.4 2.5 3.3 15.1 2.7 2.8 18.1 12.3 2.5 3.1 14.0 7.5 3.2 10.6 3.8 3.9 8.6 5.5 8.1 4.8 2.3 4.6 5.1 2.1 3.2 0.0 0.7 1.6 1.7 0.5 0.6 0.3 0.0 0.6 0.0 3.3 17.2 2.0 0.2 0.2 7.8 1.6 1.7 0.6 11.4 0.2 12.4 2.1 0.3 0.5 0.0 0.5 0.0 0.9 0.5 0.2 0.0 0.0 1.9 3.1 2.9 0.2 0.6 1.4 0.9 0.2 0.0 2.9 6.0 0.6 5.5 0.0 0.0 0.3 0.3 0.5 5.3 1.4 0.0 5.1 1.3 0.0 1.3 1.9 0.4 0.7 1.4 2.8 7.6 0.7 3.6 0.4 1.6 3.1 6.1 3.5 3.2 3.4 8.0 2.8 3.9 5.5 8.6 2.1 4.6 8.1 2.3 4.8 5.2 4.2 5.1 2.8 3.1 3.1 3.3 2.1 2.6 3.2 2.8 3.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL672043.1 ENSG00000250719 "Homo sapiens uncharacterized LOC110117498 (LOC110117498), mRNA." 1 46175486-46176478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 64 "testis: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL672142.1 ENSG00000251184 9 128941478-128957021 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;BJ: 4.4;HL-60: 4.0;RH-30: 4.5;U-138 MG: 3.5;U-698: 3.5" NA NA 0.2 0.3 0.7 0.0 1.1 0.0 0.2 1.2 0.6 1.4 0.1 0.0 1.3 1.6 0.0 0.5 0.0 0.3 0.1 0.3 0.3 0.3 0.3 0.5 0.7 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.4 0.7 0.0 0.8 0.3 0.2 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 1.1 3.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.7 0.0 1.1 0.0 0.0 1.4 0.7 1.6 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.7 4.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 2.5 0.0 1.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL772284.2 ENSG00000277535 X 119073226-119076373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 2.2" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL845331.2 ENSG00000259916 2 94588522-94604573 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "adipose tissue: 12.1" "Cell type enriched" "Detected in single" 10 "Proximal tubular cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "ASC diff: 6.8" NA NA "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (8.07e-3)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (9.15e-3)" "unprognostic (6.22e-2)" "unprognostic (4.66e-2)" 12.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL929554.1 ENSG00000261793 9 137168854-137171984 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "salivary gland: 31.6;testis: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 33 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in single" 33 "dendritic cells: 6.5" "Group enriched" "Detected in some" 5 "REH: 10.1;RPMI-8226: 16.7;SK-BR-3: 11.2;T-47d: 6.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 31.6 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.2 0.1 0.2 0.0 10.1 0.0 16.7 0.0 1.3 0.4 0.1 0.0 11.2 0.0 0.0 6.5 0.5 0.0 0.0 0.4 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALAD "ALADH, PBGS" ENSG00000148218 "Aminolevulinate dehydratase" P13716 9 113386317-113401333 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" "Allosteric enzyme, Lyase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 84.2" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021023, HPA022124" Enhanced NA NA 44000000 "HPA021023: AB_1844716, HPA022124: AB_1844717" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "prognostic unfavorable (7.33e-5)" "prognostic favorable (5.64e-4)" "unprognostic (4.16e-2)" "unprognostic (9.49e-2)" "prognostic favorable (8.80e-5)" "unprognostic (2.87e-3)" "unprognostic (3.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.62e-1)" "unprognostic (3.31e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.75e-1)" "unprognostic (1.22e-1)" "unprognostic (3.40e-1)" "unprognostic (1.31e-2)" 19.9 70.3 24.1 6.4 26.3 27.3 13.7 14.0 24.8 8.3 10.5 28.3 8.8 11.6 7.5 11.5 14.6 6.8 13.0 23.3 24.6 20.8 29.9 84.2 8.4 5.9 37.5 20.6 12.3 18.8 24.1 7.2 10.2 27.9 14.5 10.2 9.8 37.2 15.1 10.6 15.6 10.7 8.9 40.1 5.9 18.1 5.4 28.6 4.7 10.9 6.6 7.5 9.0 8.0 7.6 12.1 19.1 13.1 5.5 9.7 7.6 3.3 5.8 4.6 6.4 32.2 22.1 29.3 9.1 15.3 6.0 7.7 8.1 7.0 4.7 5.6 12.9 4.6 12.4 3.3 6.3 3.5 11.7 4.2 9.3 7.3 10.6 7.3 8.5 8.0 18.7 4.7 5.5 2.4 23.9 11.8 7.9 3.5 7.0 9.9 24.5 9.8 8.4 2.3 24.4 11.6 7.7 8.0 8.1 9.4 7.1 4.2 4.0 11.6 14.1 8.3 8.7 14.8 9.8 12.8 5.4 4.1 10.6 5.1 10.5 9.8 3.7 15.1 7.9 5.8 7.2 11.5 19.1 9.7 13.1 5.4 5.9 8.4 5.4 12.1 7.6 8.1 8.9 5.6 5.5 12.7 4.9 8.5 7.6 24.1 26.3 14.0 24.8 24.6 20.8 37.5 20.6 27.9 28.6 14.9 14.1 10.2 9.3 6.3 12.5 50.8 17.8 10.7 9.1 14.0 25.5 36.1 11.6 14.5 4.7 12.8 25.6 70.0 23.3 18.1 9.4 7.0 13.9 55.7 15.4 4.8 8.7 12.9 16.7 6.9 10.9 10.2 11.8 5.4 13.8 5.8 15.3 28.8 13.8 42.7 14.9 6.5 9.9 6.2 7.5 8.0 9.5 6.9 16.9 6.8 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 167.6;liver: 136.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 210.5;Syncytiotrophoblasts: 258.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 55.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favorable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 9.2 167.6 7.8 6.7 10.6 39.1 8.9 17.0 15.4 6.0 11.0 12.0 15.3 11.4 6.3 11.8 10.5 4.7 8.7 24.8 8.8 7.0 14.1 136.4 13.5 10.0 7.6 9.9 5.8 6.1 8.5 5.8 13.4 12.2 7.3 11.1 8.3 15.7 16.9 24.6 6.8 17.4 6.5 7.3 6.3 12.2 9.7 5.0 7.5 7.4 11.4 9.6 12.1 7.6 6.8 8.4 55.0 12.2 8.8 11.3 6.3 10.3 16.1 11.4 10.5 17.8 13.3 31.0 15.2 14.1 20.4 19.8 21.4 19.6 9.7 3.8 10.6 41.4 6.1 16.3 12.5 16.7 18.8 6.4 12.4 12.7 16.2 25.2 20.1 25.0 16.5 11.7 32.4 10.8 7.5 18.6 17.0 7.3 8.0 18.5 8.4 9.5 30.7 9.8 11.9 27.9 5.7 7.1 15.3 17.9 62.7 6.0 4.0 24.6 12.1 13.7 9.6 6.9 28.7 13.3 11.4 11.3 23.5 21.9 11.9 20.5 14.6 12.7 21.9 18.1 55.0 9.2 27.8 6.9 12.2 11.3 6.8 7.2 7.7 8.4 6.0 6.5 7.0 14.2 8.8 10.2 4.8 9.7 6.3 7.8 10.6 17.0 15.4 8.8 7.0 7.6 9.9 12.2 5.0 32.8 47.6 4.5 16.4 15.3 15.1 88.4 35.7 38.8 27.3 22.7 3.9 67.2 48.0 28.5 9.7 25.9 35.4 0.0 27.6 21.7 19.9 18.1 89.4 210.5 62.6 11.1 33.3 25.2 14.6 3.1 12.4 23.3 5.0 73.9 18.6 9.1 33.4 18.7 15.6 25.9 6.8 12.9 27.3 23.7 19.0 14.2 258.6 17.3 16.1 24.3 ALAS2 ASB ENSG00000158578 "5'-aminolevulinate synthase 2" P22557 X 55009055-55031064 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 130.9;placenta: 53.5" "Cell type enriched" "Detected in some" 86 "Erythroid cells: 1168.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 6 "dendritic cells: 2.0" "Group enriched" "Detected in some" 87 "HEL: 32.8;K-562: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (7.82e-2)" "unprognostic (2.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.14e-2)" "unprognostic (2.98e-3)" "unprognostic (5.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (8.68e-2)" "unprognostic (4.07e-2)" "unprognostic (2.72e-1)" "unprognostic (3.45e-1)" "unprognostic (2.32e-2)" "unprognostic (6.63e-3)" "unprognostic (4.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.89e-1)" 1.7 0.4 0.8 0.4 0.8 130.9 0.5 0.2 0.5 0.3 0.4 0.5 0.0 0.4 0.3 0.3 2.3 1.0 0.5 2.9 0.7 0.7 1.6 2.4 17.3 0.3 1.3 0.7 6.1 2.3 0.3 1.0 53.5 2.3 2.6 0.3 1.0 0.5 0.3 3.7 0.4 0.4 1.1 0.9 22.3 0.3 0.5 0.0 0.4 3.2 0.0 0.3 7.0 6.5 0.3 2.0 0.3 0.1 0.0 0.3 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 32.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 2.0 0.0 10.7 0.8 0.8 0.2 0.5 0.7 0.7 1.3 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 1168.1 0.2 0.6 0.2 0.0 0.0 0.8 1.9 0.0 1.7 0.0 1.3 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 ALB ENSG00000163631 Albumin P02768 4 73397114-73421412 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 3075.8" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 49859.9" "Cancer enriched" "Detected in many" 384 "liver cancer: 14213.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enriched" "Detected in some" 39 "Hep G2: 315.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB006262, HPA031024, HPA031025" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus" "Secreted to blood" NA NA 40000000000000 "Golgi apparatus" "Endoplasmic reticulum" "CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704" "unprognostic (1.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.73e-1)" "unprognostic (2.60e-1)" "unprognostic (4.44e-1)" "unprognostic (2.46e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-2)" "unprognostic (2.40e-1)" "unprognostic (6.43e-2)" "unprognostic (3.84e-2)" "unprognostic (5.37e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.23e-2)" "unprognostic (1.05e-3)" "unprognostic (1.02e-2)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.0 4.9 3075.8 0.1 0.1 0.1 0.1 0.1 38.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.1 315.9 0.0 8.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 7.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.5 0.0 2.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 683.8 0.0 0.0 0.0 0.1 12066.1 0.0 0.0 36.6 0.0 0.8 61.3 4.3 2.0 0.0 0.0 1612.0 237.4 2.3 0.2 0.1 0.0 49859.9 8.2 0.0 1.7 1417.3 1529.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 261.7 0.0 0.0 442.7 0.0 0.0 0.4 0.2 0.2 0.1 17.7 22.3 0.0 0.0 ALCAM "CD166, MEMD" ENSG00000170017 "Activated leukocyte cell adhesion molecule" Q13740 3 105366909-105576900 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Cell adhesion, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 122.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 684.9;Ciliated cells: 364.1;Club cells: 315.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 20.7" "Lineage enriched" "Detected in many" 6 "dendritic cells: 20.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 64.5;U-138 MG: 77.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002148, HPA010926" Enhanced "Intracellular and membrane" NA NA 1800000000 "CAB002148: AB_442053, HPA010926: AB_1078449" "unprognostic (6.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.19e-1)" "unprognostic (9.48e-3)" "unprognostic (2.08e-2)" "unprognostic (1.63e-3)" "unprognostic (3.89e-2)" "unprognostic (1.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.15e-4)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (9.57e-2)" "unprognostic (7.76e-2)" 16.6 14.1 23.6 5.2 31.1 4.2 34.2 4.2 25.3 12.9 8.2 25.0 13.9 7.2 7.0 15.4 4.0 20.6 9.9 4.7 23.2 24.3 9.6 19.4 29.6 4.2 45.1 19.7 24.6 15.3 122.5 11.9 5.3 31.5 14.0 6.6 3.0 17.9 17.5 0.9 5.9 7.3 10.8 35.3 3.0 14.2 2.3 43.8 2.2 25.6 2.7 6.2 9.9 5.5 3.5 20.7 3.7 3.2 0.4 1.6 2.0 38.3 14.8 10.6 5.4 16.2 7.1 0.1 31.4 18.4 20.3 28.5 0.1 8.0 2.7 13.1 44.2 11.2 29.8 1.7 25.0 60.1 2.5 2.6 0.3 11.3 0.7 18.2 15.6 0.1 12.6 18.6 25.9 64.5 56.7 22.2 2.8 0.0 4.6 26.6 2.6 2.2 5.7 2.2 12.4 16.8 1.4 0.9 0.1 30.8 4.3 7.7 21.5 3.2 3.1 2.0 4.4 6.0 10.3 46.1 77.7 26.5 3.3 37.2 0.0 0.0 0.2 17.7 3.3 33.2 0.0 3.2 2.4 0.4 1.5 1.4 3.5 1.1 0.7 20.7 2.2 0.2 0.2 3.7 0.4 0.8 7.4 1.6 2.0 23.6 31.1 4.2 24.6 23.2 24.3 45.1 19.7 31.5 43.8 684.9 108.8 7.2 17.0 10.8 3.0 5.6 61.1 364.1 315.1 15.7 2.0 0.6 1.7 16.4 49.7 10.5 7.5 0.0 36.7 0.6 27.3 97.5 10.5 40.4 60.4 1.6 16.1 3.7 38.7 47.9 3.4 105.6 23.6 140.7 15.0 1.3 39.9 5.8 6.0 23.3 0.5 0.0 19.6 2.1 3.4 17.7 0.7 3.2 9.8 69.3 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605929-95656706 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 68.8" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 58.2;Paneth cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Enhanced Mitochondria NA NA 23000 Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favorable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 6.3 10.4 7.1 10.4 7.9 5.2 7.7 7.3 9.3 13.7 20.1 7.2 20.5 33.8 9.3 12.3 12.8 8.5 15.2 7.2 6.2 7.1 13.0 28.9 6.6 7.4 6.7 5.3 14.5 40.7 12.7 17.4 14.3 7.7 9.6 19.4 7.9 68.8 20.5 3.5 9.6 45.4 10.0 5.4 8.6 15.2 8.4 5.4 12.7 25.9 9.7 15.9 8.6 8.2 13.1 5.2 0.3 4.0 13.0 16.3 8.0 18.3 17.4 16.8 44.0 22.6 21.8 18.1 21.5 32.3 21.9 27.6 34.9 14.7 62.6 20.1 33.8 10.6 24.4 33.6 22.1 24.9 17.7 26.4 19.8 12.4 49.5 14.8 34.6 22.2 22.9 13.6 17.8 34.9 36.4 22.9 23.6 18.5 13.2 16.3 26.4 31.2 22.3 19.8 30.5 17.4 29.4 19.2 21.4 25.5 14.0 16.8 16.6 17.1 13.6 15.8 20.1 20.3 16.2 18.9 9.1 14.5 23.4 24.6 15.3 11.3 38.3 17.7 40.1 11.6 0.0 1.4 0.1 15.5 2.7 16.3 13.1 14.2 16.0 5.2 9.0 12.1 13.4 0.3 13.0 4.0 3.1 13.3 8.0 7.1 7.9 7.3 9.3 6.2 7.1 6.7 5.3 7.7 5.4 6.0 8.6 11.5 6.6 10.0 5.7 4.3 10.2 16.0 14.8 19.2 0.0 36.1 1.7 12.5 0.7 5.4 58.2 0.0 18.4 25.8 17.5 15.6 8.1 23.1 10.1 9.5 19.0 4.9 3.2 0.4 8.6 3.1 15.1 2.8 37.5 5.2 12.4 54.7 11.3 7.9 2.8 0.0 5.6 5.1 9.0 7.0 25.3 8.7 30.7 8.1 ALDH1A1 "ALDH1, PUMB1, RALDH1" ENSG00000165092 "Aldehyde dehydrogenase 1 family member A1" P00352 9 72900662-73080442 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 207.2" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3" "Cancer enhanced" "Detected in all" "liver cancer: 399.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 34.2" "Lineage enriched" "Detected in many" 30 "monocytes: 34.2" "Cell line enhanced" "Detected in some" "A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5" "Region enriched" "Detected in all" 6 "midbrain: 171.1" "HPA002123, CAB020690" Enhanced Approved Enhanced Cytosol NA NA 62000000 Cytosol "CAB020690: , HPA002123: AB_1844722" "unprognostic (8.46e-3)" "prognostic favorable (7.77e-5)" "unprognostic (5.59e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-2)" "unprognostic (8.71e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (4.53e-2)" "unprognostic (6.83e-2)" "unprognostic (4.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.24e-3)" "unprognostic (2.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-3)" 20.0 26.9 8.8 12.3 21.4 3.9 10.8 44.8 11.7 33.6 53.6 14.5 65.3 77.1 25.5 87.1 14.5 27.8 38.3 8.9 12.5 5.9 86.7 207.2 31.4 9.4 56.4 3.6 35.8 69.7 0.7 57.5 7.9 14.0 20.0 13.1 30.2 31.8 40.3 12.1 2.7 76.5 17.1 29.1 16.3 75.5 43.0 14.9 2.0 45.8 21.0 16.8 14.1 16.0 0.3 0.5 1.1 34.2 0.0 0.1 10.5 0.0 294.7 0.0 0.0 1.7 0.0 0.1 10.2 0.0 0.0 0.0 9.9 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 90.7 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.5 0.0 1.1 0.0 11.3 0.5 0.0 0.1 0.0 0.5 0.0 0.0 3.3 0.1 52.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 34.2 0.5 0.0 5.8 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.1 0.0 0.4 0.3 0.0 10.5 8.8 21.4 44.8 11.7 12.5 5.9 56.4 3.6 14.0 14.9 89.3 82.8 17.6 12.3 2.4 0.0 2.8 211.5 583.5 271.8 109.9 0.0 1.1 330.0 52.4 8.7 10.5 29.0 23.3 296.8 1.1 30.2 1.8 152.7 620.8 115.7 0.0 52.7 105.0 82.2 16.5 376.3 13.6 6.8 5.4 141.2 0.0 193.4 16.9 194.8 295.4 0.3 25.8 9.2 3.6 3.8 2.8 2.1 20.0 42.1 18.3 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392664-38398661 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 113.9" "Group enriched" "Detected in many" 5 "Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 55.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA 210000 Mitochondria "Nucleoplasm, Vesicles, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 7.4 4.9 2.1 16.8 2.1 0.6 5.4 1.1 5.4 5.8 25.4 1.7 6.1 7.0 27.3 10.7 21.6 16.7 30.8 11.6 3.1 2.0 18.0 55.2 3.5 5.9 2.4 2.0 12.2 14.6 1.4 1.4 1.6 3.0 22.7 11.5 5.2 5.9 18.2 19.4 3.0 11.2 113.9 2.7 2.8 15.8 7.8 1.7 1.6 6.3 7.0 2.0 54.5 8.3 5.9 9.4 1.2 10.5 7.5 10.2 5.1 21.5 20.1 6.2 9.9 8.8 10.5 5.0 10.3 5.2 8.7 9.0 13.4 4.2 13.6 6.2 14.5 13.2 3.0 20.4 21.9 8.7 15.2 8.8 6.7 14.8 39.8 6.4 10.7 7.6 12.5 4.8 7.1 6.2 17.9 8.3 3.3 19.4 13.4 13.2 8.2 0.0 4.3 18.4 55.5 9.0 4.4 37.6 10.4 7.8 9.7 13.6 6.3 7.9 5.2 6.0 6.8 4.9 8.4 5.6 10.1 16.7 8.4 12.9 2.0 3.9 5.4 5.2 11.0 6.8 0.2 4.2 0.2 7.3 9.1 10.2 5.9 7.0 6.6 9.4 3.1 5.8 6.8 1.2 7.5 10.5 1.3 4.8 5.1 2.1 2.1 1.1 5.4 3.1 2.0 2.4 2.0 3.0 1.7 8.9 1.7 3.6 3.8 0.9 1.3 5.6 117.2 0.0 3.4 15.7 2.0 1.3 14.9 60.1 0.5 3.8 7.0 0.0 5.9 40.0 6.2 2.9 9.2 113.4 6.5 0.0 15.0 9.8 3.8 1.3 6.1 4.0 0.0 7.2 16.9 1.3 14.2 3.5 6.3 118.8 0.3 0.0 9.5 0.3 0.6 0.9 1.5 2.9 68.9 2.6 ALDH1L1 "10-fTHF, FTHFD" ENSG00000144908 "Aldehyde dehydrogenase 1 family member L1" O75891 3 126103562-126197994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 48.1;liver: 148.7" "Group enriched" "Detected in many" 6 "Hepatocytes: 554.3;Proximal tubular cells: 175.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.9;Hep G2: 23.9;Karpas-707: 24.7;RPMI-8226: 12.9;RT4: 66.0;U-266/70: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036900, HPA050139" Enhanced Supported Supported Cytosol No No 640000 Cytosol "HPA036900: AB_10672273, HPA050139: AB_2681031" "unprognostic (5.93e-2)" "unprognostic (1.22e-1)" "unprognostic (9.12e-2)" "unprognostic (2.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (4.73e-2)" "unprognostic (3.05e-3)" "unprognostic (8.40e-2)" "prognostic favorable (2.42e-8)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (7.03e-3)" "unprognostic (7.93e-2)" 28.9 12.1 13.7 1.8 17.1 1.2 6.0 8.6 10.9 7.8 4.9 5.7 2.3 1.1 1.9 2.2 3.6 3.4 1.9 8.1 8.9 5.3 48.1 148.7 1.3 1.2 9.2 10.1 11.3 10.2 1.4 0.9 1.1 10.8 3.3 3.3 5.1 34.1 4.1 30.7 1.5 1.3 2.4 7.7 1.1 1.9 4.9 6.2 0.0 1.7 6.2 2.8 11.0 3.1 0.1 0.8 0.8 0.2 0.2 0.4 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.1 0.1 0.4 0.1 0.2 0.0 0.9 0.7 3.2 0.0 0.6 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 23.9 3.2 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 24.7 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 12.9 0.3 66.0 0.1 0.1 0.3 3.2 0.0 0.2 0.0 0.0 0.1 0.4 1.9 0.0 0.0 13.6 4.2 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.4 0.2 0.2 0.2 0.0 0.8 0.1 0.0 13.7 17.1 8.6 10.9 8.9 5.3 9.2 10.1 10.8 6.2 0.0 5.9 4.5 44.7 0.1 0.2 14.9 22.9 10.7 64.8 12.2 0.0 0.0 61.3 2.2 18.0 2.7 2.3 0.0 4.8 0.1 0.8 8.1 25.6 554.3 0.1 0.0 1.2 12.3 15.3 25.4 24.5 2.6 3.3 0.0 9.1 35.7 1.9 0.0 21.2 175.8 1.0 6.5 1.0 1.1 1.2 0.0 0.1 7.0 2.2 48.0 ALDH1L2 "FLJ38508, mtFDH" ENSG00000136010 "Aldehyde dehydrogenase 1 family member L2" Q3SY69 12 105019784-105084577 "Enzymes, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "pancreas: 48.9;salivary gland: 31.6" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 8.3;monocytes: 6.4;Pancreatic endocrine cells: 5.6;Peritubular cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 23.0;ASC TERT1: 31.5;fHDF/TERT166: 35.7;HHSteC: 20.3;HSkMC: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039481, HPA059282" Approved Enhanced Mitochondria No No Mitochondria "HPA039481: AB_10795465, HPA059282: AB_2732633" "unprognostic (5.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.36e-3)" "unprognostic (1.76e-1)" "unprognostic (8.86e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-1)" "unprognostic (5.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.61e-1)" "unprognostic (8.19e-8)" "unprognostic (3.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.53e-3)" "unprognostic (2.52e-5)" 4.2 1.2 3.2 2.7 1.9 0.7 2.7 5.3 2.7 5.5 2.2 0.9 3.3 2.4 2.9 3.2 1.5 2.6 2.7 2.9 1.6 2.0 0.7 0.4 2.7 2.0 2.0 2.1 1.0 48.9 0.7 2.8 1.1 2.5 3.6 2.3 4.8 31.6 4.5 1.0 1.5 1.3 5.4 5.3 1.2 3.7 0.8 1.3 0.0 2.2 1.4 3.0 3.9 2.2 0.2 1.3 0.0 0.1 0.0 0.1 0.1 4.4 0.4 0.2 9.6 23.0 31.5 0.5 14.2 9.2 1.8 4.9 0.5 0.0 0.0 0.6 35.7 0.0 0.0 0.0 0.3 2.3 0.0 0.1 0.2 0.0 1.1 20.3 1.8 0.0 25.5 1.1 4.8 9.1 0.0 1.0 0.0 0.7 12.9 3.7 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 1.3 0.0 0.0 3.3 1.6 0.0 2.9 7.2 0.1 2.1 15.2 0.1 1.4 1.4 0.0 0.7 16.0 4.2 0.0 5.8 6.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.1 3.2 1.9 5.3 2.4 1.6 2.0 2.0 2.1 2.5 1.3 0.0 1.1 0.0 0.1 0.5 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 3.7 0.1 0.0 0.0 8.3 0.3 4.3 0.3 0.0 0.0 0.4 4.8 0.0 1.8 0.3 4.5 3.4 1.1 5.0 6.4 0.0 1.2 5.6 0.0 6.3 0.0 0.5 0.0 3.1 0.4 0.0 0.5 0.2 0.0 0.0 0.1 ALDH2 ENSG00000111275 "Aldehyde dehydrogenase 2 family (mitochondrial)" P05091 12 111766887-111817529 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 279.7" "Cell type enhanced" "Detected in all" 9 "Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 45.8;myeloid DC: 46.6" "Group enriched" "Detected in many" 4 "dendritic cells: 46.6;monocytes: 45.8" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4" HPA051065 Approved NA NA 1400000 "HPA051065: AB_2681332" "unprognostic (9.22e-3)" "unprognostic (1.20e-2)" "unprognostic (4.14e-3)" "prognostic favorable (2.63e-4)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "prognostic favorable (3.95e-7)" "unprognostic (5.62e-3)" "unprognostic (3.00e-1)" "unprognostic (1.16e-1)" "unprognostic (8.22e-2)" "unprognostic (1.51e-1)" "prognostic favorable (5.24e-6)" "unprognostic (9.70e-2)" "unprognostic (3.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (7.71e-4)" 88.9 34.0 42.1 17.0 44.6 9.9 39.6 14.3 30.9 10.4 25.3 17.5 16.8 25.6 9.0 11.6 26.4 10.3 28.5 45.0 30.9 24.2 59.0 279.7 38.1 13.3 34.1 32.6 16.1 14.0 2.2 7.6 4.0 30.6 13.5 26.2 13.1 17.9 30.7 40.1 43.5 25.5 29.4 26.6 8.0 34.9 9.5 23.8 3.3 12.0 28.1 18.2 17.0 22.9 1.4 46.6 10.8 45.8 0.7 0.2 21.7 2.4 3.6 5.3 9.1 25.4 3.8 17.4 2.6 4.7 1.2 0.9 6.5 3.4 0.1 13.0 5.7 3.4 4.5 0.0 1.3 0.7 0.1 1.7 0.2 2.3 17.6 28.4 0.2 0.2 6.9 6.5 4.2 0.1 5.1 7.6 0.2 4.8 0.8 1.1 0.1 0.2 6.3 7.0 41.9 0.6 0.1 0.1 0.5 8.8 0.1 2.1 6.6 6.4 57.1 0.0 10.1 5.7 25.4 0.3 0.1 4.8 0.1 0.1 1.5 0.8 6.9 6.3 0.2 0.1 0.9 45.8 10.8 0.1 20.1 0.2 1.4 0.0 0.1 46.6 1.2 0.1 0.1 2.3 0.7 5.0 15.5 0.1 21.7 42.1 44.6 14.3 30.9 30.9 24.2 34.1 32.6 30.6 23.8 137.0 197.2 37.4 126.5 53.2 67.9 333.7 140.1 95.0 178.6 62.8 17.7 50.7 338.2 110.9 3.4 72.6 272.6 70.0 195.0 101.4 59.3 72.9 29.0 770.8 132.7 33.4 53.0 106.2 211.9 7.0 73.9 169.3 33.7 1397.7 184.2 107.6 110.7 325.4 140.0 645.3 34.9 45.3 77.3 2.7 3.2 109.0 35.2 13.8 218.4 82.3 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 22 "A549: 261.5;OE19: 326.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122" "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favorable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 261.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 13.1 0.0 0.1 0.0 0.1 1.5 0.0 0.6 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 326.9 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 3.0 5.6 0.0 23.3 39.2 0.0 0.4 2.5 100.4 55.7 0.0 0.0 0.0 0.0 0.8 1.3 0.4 3.3 0.0 0.4 0.0 0.6 2.6 2.3 0.0 0.2 0.0 1.7 0.6 0.8 1.9 0.9 1.1 0.0 0.0 4.2 1.9 5.8 5.9 1.8 4.4 0.1 0.0 0.3 0.7 7.3 28.0 0.0 0.0 7.5 32.1 ALDH3B1 ALDH7 ENSG00000006534 "Aldehyde dehydrogenase 3 family member B1" P43353 11 68008578-68029282 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.8" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 39.8" "Group enriched" "Detected in many" 10 "dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9" "Cell line enhanced" "Detected in many" "A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038525 Uncertain NA NA "HPA038525: AB_2676062" "unprognostic (3.50e-1)" "unprognostic (4.22e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.56e-2)" "unprognostic (9.66e-3)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (2.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (8.27e-2)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (2.75e-2)" "unprognostic (6.69e-3)" "unprognostic (1.06e-1)" 9.1 9.8 1.8 5.0 2.5 21.4 2.4 1.3 2.3 6.2 7.8 4.2 1.1 11.8 4.0 7.0 4.0 21.0 13.7 3.1 2.6 2.4 9.3 5.1 28.5 14.3 4.3 1.4 6.6 12.9 0.0 3.8 13.4 3.8 4.6 3.1 7.8 5.7 2.0 2.0 1.8 21.4 4.2 5.6 11.7 10.4 2.9 1.9 0.7 1.7 1.5 3.3 7.6 3.8 0.1 17.6 39.8 32.9 2.9 0.1 9.8 3.3 45.0 0.3 0.9 3.0 9.6 8.1 4.6 7.6 3.3 1.6 1.6 46.3 0.2 8.2 10.6 4.7 3.8 0.1 0.6 0.8 0.1 0.3 0.4 18.1 3.9 19.1 2.6 0.1 7.0 2.0 1.6 4.5 7.5 0.1 0.2 0.1 8.2 5.3 2.7 0.2 2.5 0.3 22.4 2.7 1.0 1.8 24.7 5.4 0.4 0.5 0.2 10.6 8.9 4.4 0.2 10.3 5.8 5.1 4.8 6.7 23.1 1.5 0.1 0.8 0.0 27.3 7.3 2.2 11.8 23.0 39.8 0.0 32.9 0.1 0.1 0.0 0.0 17.6 0.1 0.0 0.0 6.9 2.9 29.1 1.8 0.0 9.8 1.8 2.5 1.3 2.3 2.6 2.4 4.3 1.4 3.8 1.9 107.2 53.7 0.9 2.6 1.9 0.5 2.4 17.8 265.0 76.2 5.2 0.0 0.7 0.0 4.9 18.4 1.9 11.7 0.0 2.2 6.7 8.2 2.5 23.3 2.0 31.5 3.2 2.4 1.3 54.8 7.6 1.7 31.3 3.3 8.2 10.0 2.0 11.4 7.0 1.4 20.0 0.4 0.0 4.2 0.2 0.2 0.9 0.6 0.0 10.0 4.4 ALDH3B2 ALDH8 ENSG00000132746 "Aldehyde dehydrogenase 3 family member B2" P48448 11 67662162-67681200 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MCF7: 31.6;SK-BR-3: 32.7" "Not detected" "Not detected" HPA045132 Approved NA NA "HPA045132: AB_10795993" "unprognostic (2.25e-1)" "unprognostic (2.41e-1)" "unprognostic (1.65e-1)" "unprognostic (8.65e-2)" "unprognostic (2.13e-1)" "unprognostic (6.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-2)" "unprognostic (2.59e-2)" "unprognostic (1.61e-1)" "unprognostic (1.15e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 28.1 0.1 0.1 6.7 0.1 0.1 5.0 0.0 1.5 2.4 48.2 1.5 0.1 0.1 0.1 0.0 0.6 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.6 0.3 11.2 0.1 1.8 0.0 0.1 17.1 4.6 0.1 38.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.1 25.7 34.2 4.6 11.6 1.0 0.1 0.6 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 1.8 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 2.6 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 32.7 0.0 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.9 0.0 1.5 1.4 0.0 0.3 0.0 0.0 0.0 5.2 0.0 8.5 1.7 0.3 0.0 0.0 0.0 0.0 0.2 8.0 0.4 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.2 0.0 0.0 6.2 ALDH4A1 "ALDH4, P5CDh" ENSG00000159423 "Aldehyde dehydrogenase 4 family member A1" P30038 1 18871430-18902781 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.7;liver: 92.6" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 313.9;Proximal tubular cells: 167.5" "Cancer enhanced" "Detected in all" "liver cancer: 72.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Hep G2: 34.6;SK-BR-3: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004645, HPA006401, HPA072759" Enhanced Supported Mitochondria NA NA 40000 Mitochondria "CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: " "unprognostic (1.17e-1)" "prognostic favorable (5.06e-4)" "unprognostic (1.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.15e-1)" "unprognostic (7.67e-2)" "unprognostic (1.28e-1)" "unprognostic (6.18e-2)" "unprognostic (1.92e-1)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-3)" "unprognostic (9.41e-3)" "unprognostic (3.83e-1)" "unprognostic (2.69e-3)" "unprognostic (9.34e-2)" 22.9 4.1 14.4 2.0 18.0 4.6 6.6 3.1 16.8 3.8 2.4 8.6 18.9 1.3 2.5 5.2 11.4 2.7 3.0 12.6 8.6 7.1 73.7 92.6 2.4 1.7 15.9 11.2 2.9 2.2 9.4 2.4 8.3 8.5 12.1 1.6 9.7 2.4 12.1 25.6 8.0 1.3 3.3 2.7 2.1 3.4 1.4 6.6 2.8 3.0 8.9 2.9 8.3 3.6 1.5 7.2 2.6 5.6 0.3 1.4 2.2 5.1 8.0 4.1 12.1 17.4 2.6 10.0 4.9 3.0 5.1 4.1 5.8 3.8 3.4 6.6 6.4 2.4 13.8 6.9 14.7 1.9 1.9 6.1 1.9 1.9 34.6 5.5 1.7 6.2 6.7 8.2 2.8 2.8 3.8 5.7 5.8 7.7 2.5 3.4 13.2 1.7 8.3 2.0 10.6 4.1 10.7 3.4 4.0 5.3 13.0 8.1 3.1 8.7 35.8 6.4 6.5 16.3 2.6 4.7 4.4 5.8 5.3 1.7 2.8 6.6 1.0 1.6 13.5 5.8 0.0 4.1 2.6 1.1 5.6 0.9 1.5 0.7 1.4 7.2 1.1 0.3 0.9 0.6 0.3 3.1 2.4 1.0 2.2 14.4 18.0 3.1 16.8 8.6 7.1 15.9 11.2 8.5 6.6 0.0 3.2 7.2 14.0 6.6 3.1 18.5 38.2 1.4 0.0 43.6 9.8 61.1 39.7 5.6 0.4 2.7 0.4 0.0 0.8 7.2 2.3 9.5 4.6 313.9 11.9 19.1 2.4 16.5 14.0 0.4 1.1 1.4 3.3 17.2 2.9 10.8 2.9 1.5 2.5 167.5 4.2 6.5 4.3 2.1 3.6 4.6 72.4 2.2 3.3 9.7 ALDH5A1 "SSADH, SSDH" ENSG00000112294 "Aldehyde dehydrogenase 5 family member A1" P51649 6 24494852-24537207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 41.1;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029715, HPA029716" Enhanced Supported Mitochondria NA NA 44000 Mitochondria "HPA029715: AB_10599994, HPA029716: AB_10601876" "unprognostic (7.43e-2)" "unprognostic (1.12e-3)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "prognostic favorable (7.61e-6)" "unprognostic (2.38e-2)" "unprognostic (2.17e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.43e-2)" "unprognostic (1.21e-1)" "prognostic favorable (3.68e-4)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.00e-2)" "unprognostic (1.08e-2)" 5.8 4.8 23.7 8.3 27.4 3.1 4.1 13.5 21.5 4.1 6.0 9.5 1.2 7.7 3.9 3.1 5.6 13.5 4.4 9.8 17.3 21.0 18.4 62.6 5.0 8.9 16.0 14.7 5.8 6.6 11.4 4.5 2.2 13.0 6.2 5.7 4.1 3.9 4.3 31.1 6.9 5.4 2.8 10.9 4.8 5.2 3.7 8.8 21.4 12.1 4.9 8.8 6.3 5.5 3.9 3.8 0.4 0.2 1.6 6.8 1.2 3.2 3.0 2.1 3.2 0.0 0.0 3.5 0.3 0.6 0.8 0.5 11.7 0.8 41.1 6.2 0.3 0.7 0.0 3.4 0.4 0.5 4.2 5.7 6.4 1.9 13.4 0.5 9.9 0.8 0.3 1.6 0.1 0.0 2.3 0.0 11.3 3.2 0.0 0.6 7.6 12.0 5.9 0.8 5.8 1.5 13.9 0.6 0.4 2.5 6.6 3.7 3.3 3.8 0.4 4.0 0.9 5.9 5.4 0.0 0.4 2.1 0.1 2.1 5.8 8.6 51.4 0.0 3.1 0.4 0.4 0.1 0.2 1.7 0.0 3.3 3.7 2.4 2.8 0.2 3.9 6.8 5.7 0.4 1.6 0.2 3.8 1.6 1.2 23.7 27.4 13.5 21.5 17.3 21.0 16.0 14.7 13.0 8.8 14.9 22.3 8.8 4.6 1.4 10.6 29.9 5.1 13.4 9.1 7.0 15.7 5.0 1.7 1.8 0.5 3.1 8.4 23.3 0.8 4.3 2.1 5.1 6.9 85.5 3.2 15.9 8.1 6.7 3.8 0.0 3.1 2.0 1.7 0.0 10.5 10.4 1.3 3.5 4.2 24.0 6.5 0.0 1.6 1.4 6.1 2.6 1.6 5.4 16.7 11.5 ALDH6A1 MMSDH ENSG00000119711 "Aldehyde dehydrogenase 6 family member A1" Q02252 14 74056850-74084493 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 140.0;liver: 134.5" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 453.8;Proximal tubular cells: 730.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 25.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029072, HPA029073, HPA029074, HPA029075" Enhanced Enhanced Mitochondria No No 9100 Mitochondria "HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005" "unprognostic (1.45e-1)" "unprognostic (5.38e-2)" "unprognostic (6.89e-2)" "unprognostic (6.95e-3)" "unprognostic (1.46e-1)" "unprognostic (7.93e-2)" "unprognostic (1.11e-3)" "prognostic favorable (4.22e-4)" "unprognostic (1.58e-1)" "unprognostic (9.10e-2)" "unprognostic (3.11e-2)" "unprognostic (2.13e-1)" "prognostic favorable (2.00e-15)" "unprognostic (4.59e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-3)" "unprognostic (1.12e-1)" 14.1 6.9 31.3 2.8 30.9 2.3 6.7 11.6 26.4 8.0 11.0 20.1 4.6 11.0 5.5 5.5 5.0 6.2 4.8 15.6 21.1 14.2 140.0 134.5 4.7 3.0 19.4 18.5 12.3 11.8 16.4 3.2 4.0 14.8 11.0 7.2 7.1 7.8 7.8 10.5 3.4 9.3 5.6 13.1 3.1 9.6 7.4 18.7 2.0 12.1 4.0 3.1 6.3 3.3 4.5 5.6 25.5 3.8 5.5 6.7 2.8 4.6 4.0 5.7 12.1 20.9 10.2 9.2 3.2 6.1 3.5 6.0 9.1 5.2 5.4 7.2 6.9 2.9 2.7 13.0 3.6 7.7 4.8 1.8 2.5 4.2 9.9 23.8 1.3 1.2 15.0 6.6 4.5 11.4 9.2 6.2 12.2 4.0 7.5 2.4 17.8 3.7 2.0 4.5 17.2 2.7 7.6 5.9 7.1 5.6 3.5 2.3 3.6 10.7 11.6 2.8 10.1 29.7 4.8 1.9 4.0 4.9 6.2 1.2 5.1 9.2 5.5 5.2 1.6 3.8 13.3 3.8 25.5 4.5 2.9 6.7 4.5 5.1 5.3 5.6 3.6 6.5 4.6 1.5 5.5 2.4 3.2 3.6 2.8 31.3 30.9 11.6 26.4 21.1 14.2 19.4 18.5 14.8 18.7 35.7 48.4 23.6 21.0 8.1 17.6 73.0 48.4 25.4 29.6 62.8 3.9 22.5 170.8 8.1 19.8 13.5 22.3 0.0 2.7 12.8 13.1 38.6 7.0 453.8 14.9 11.1 16.3 58.3 22.2 15.8 26.7 9.0 23.6 20.8 37.9 90.4 5.6 10.5 45.3 730.1 15.1 12.9 21.7 10.5 3.9 6.5 25.6 6.9 37.0 15.2 ALDH7A1 "ATQ1, EPD, PDE" ENSG00000164904 "Aldehyde dehydrogenase 7 family member A1" P49419 5 126531200-126595418 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023296, HPA053675" Enhanced Supported Mitochondria,Cytosol Yes No 140000 Mitochondria Cytosol "HPA023296: AB_1844738, HPA053675: " "unprognostic (1.37e-1)" "unprognostic (9.67e-2)" "unprognostic (2.07e-2)" "unprognostic (2.20e-2)" "unprognostic (4.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.58e-3)" "unprognostic (9.49e-3)" "unprognostic (7.61e-2)" "unprognostic (7.08e-2)" "unprognostic (2.10e-1)" "unprognostic (1.33e-1)" "prognostic favorable (3.08e-4)" "unprognostic (1.51e-1)" "unprognostic (3.70e-1)" "unprognostic (3.10e-3)" "unprognostic (4.93e-2)" 9.0 14.2 46.0 3.4 39.1 0.8 18.8 11.0 22.5 14.0 11.5 23.1 7.2 9.5 10.5 7.5 13.5 11.9 7.8 10.8 35.0 17.3 46.5 64.4 6.4 3.1 28.7 18.5 27.6 10.8 17.7 5.9 17.7 16.9 17.6 11.2 13.7 15.0 12.2 4.5 11.9 8.1 9.8 20.2 2.8 9.0 4.9 28.4 4.0 19.4 10.1 7.4 7.2 7.1 1.3 9.7 0.7 0.3 0.1 1.8 0.6 15.0 10.0 28.3 46.8 23.5 14.0 36.1 18.1 22.4 21.1 27.2 28.0 14.5 0.0 18.5 14.1 8.8 11.3 8.8 61.1 19.4 0.0 10.6 2.9 14.9 23.8 11.5 0.0 0.0 17.1 14.4 16.4 11.8 15.6 16.8 0.0 0.0 0.0 18.5 9.9 0.6 0.0 19.1 11.1 8.5 9.0 32.1 0.0 20.0 11.5 9.6 11.5 0.0 10.0 10.5 22.7 18.0 0.6 20.4 6.1 18.9 7.0 12.4 0.0 0.0 0.0 3.3 0.0 9.8 0.7 0.3 0.1 0.2 0.0 0.3 1.3 0.3 0.2 2.7 1.1 1.8 1.0 0.3 0.1 0.0 9.7 0.1 0.6 46.0 39.1 11.0 22.5 35.0 17.3 28.7 18.5 16.9 28.4 14.9 24.0 11.8 48.6 23.0 22.4 35.5 25.5 20.1 33.0 40.1 21.6 364.8 64.6 31.9 24.9 14.7 17.8 0.0 12.1 88.6 30.8 28.6 6.9 69.5 42.5 23.8 20.8 20.9 9.4 29.5 23.6 7.4 52.3 12.6 22.1 96.8 15.1 8.6 35.0 241.4 12.2 19.4 17.3 1.0 3.1 14.1 185.9 2.5 43.7 34.8 ALDH8A1 ALDH12 ENSG00000118514 "Aldehyde dehydrogenase 8 family member A1" Q9H2A2 6 134917390-134950122 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 26.2;liver: 90.1" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 29.6;Hepatocytes: 129.5;Proximal tubular cells: 94.1" "Group enriched" "Detected in some" 7 "liver cancer: 26.3;renal cancer: 17.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 5.6;RPTEC TERT1: 6.4;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026292, HPA055414" Enhanced Approved Nucleoplasm,Centrosome NA NA 24000 Centrosome Nucleoplasm "HPA026292: AB_1844741, HPA055414: AB_2682810" "unprognostic (1.12e-1)" "unprognostic (1.48e-1)" "unprognostic (1.88e-1)" "unprognostic (1.75e-1)" "unprognostic (2.70e-2)" "unprognostic (6.32e-2)" "unprognostic (4.30e-3)" "unprognostic (1.12e-1)" "unprognostic (3.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.39e-2)" "unprognostic (3.99e-2)" "prognostic favorable (9.87e-4)" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (2.36e-2)" "unprognostic (5.86e-5)" 0.3 0.3 0.8 0.3 1.0 0.6 0.3 1.9 0.9 0.3 0.6 0.3 0.3 0.2 0.3 0.6 0.3 0.1 0.3 0.3 1.4 0.6 26.2 90.1 0.3 0.3 1.1 0.4 0.3 0.3 0.2 0.3 0.4 0.3 0.3 0.2 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.8 0.3 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.3 1.5 1.1 5.9 0.9 2.3 1.3 0.6 0.2 1.1 1.6 0.8 0.5 0.2 1.4 0.4 0.5 0.1 1.0 0.5 0.7 0.4 0.6 0.0 0.4 1.1 1.1 0.1 0.9 1.2 5.6 3.7 3.9 5.3 0.6 1.5 2.0 1.6 1.8 0.4 0.9 1.2 0.4 1.8 5.4 2.2 0.2 0.1 1.8 2.4 0.3 0.4 1.1 0.1 0.5 0.5 6.4 0.8 1.7 0.6 0.3 0.1 1.3 0.5 0.9 0.3 0.4 0.8 3.2 1.3 1.5 5.6 1.7 0.9 0.7 1.4 0.5 5.9 0.9 0.9 1.3 0.3 0.5 1.0 1.2 0.7 0.1 1.5 1.1 0.9 2.4 2.3 0.4 1.1 1.2 0.6 0.8 1.0 1.9 0.9 1.4 0.6 1.1 0.4 0.3 0.3 3.0 1.1 2.2 0.2 0.0 1.8 0.3 2.5 0.0 1.2 29.6 0.0 0.2 16.6 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.4 0.1 0.0 129.5 0.1 3.2 0.0 3.1 1.3 0.0 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 0.0 94.1 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 ALDOA ENSG00000149925 "Aldolase, fructose-bisphosphate A" P04075 16 30064164-30070457 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 1296.2" "Group enriched" "Detected in some" 13284 "Cardiomyocytes: 1628.0;Cytotrophoblasts: 1088.2;Extravillous trophoblasts: 1710.3;Hofbauer cells: 1077.0;Syncytiotrophoblasts: 1138.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA004177, CAB006252" Enhanced Approved Cytosol NA NA 1200000000 Cytosol "CAB006252: AB_437007, HPA004177: AB_1078128" "unprognostic (2.63e-2)" "unprognostic (3.22e-2)" "unprognostic (6.80e-2)" "unprognostic (1.33e-1)" "unprognostic (6.74e-3)" "unprognostic (4.28e-3)" "prognostic unfavorable (5.79e-5)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.68e-1)" "unprognostic (1.81e-1)" "unprognostic (2.30e-2)" "unprognostic (1.57e-1)" "unprognostic (1.81e-1)" "unprognostic (1.28e-1)" "unprognostic (1.22e-1)" "unprognostic (2.19e-3)" "unprognostic (4.48e-2)" 27.9 30.9 34.7 24.2 42.3 36.0 25.3 31.2 59.7 21.0 32.8 16.3 25.9 29.4 21.9 33.9 73.5 22.1 24.4 109.3 31.6 33.4 28.2 11.1 17.9 34.0 35.0 49.6 23.4 19.4 51.0 25.2 19.9 38.0 23.6 23.5 24.6 37.9 36.9 1296.2 28.4 21.5 30.1 22.7 17.4 24.4 9.2 18.9 18.5 26.6 189.8 29.0 36.8 27.7 61.1 142.9 165.7 166.3 50.5 93.2 217.0 138.8 104.7 31.5 101.2 48.3 55.1 100.7 84.1 87.6 85.8 107.3 74.0 107.1 94.7 137.9 84.8 47.1 106.1 63.2 183.3 63.0 41.6 83.1 77.5 84.0 163.3 75.5 112.6 83.2 75.5 64.7 96.3 64.7 141.5 63.1 44.7 66.6 62.5 90.9 198.0 68.4 93.0 78.4 54.0 88.3 102.2 50.6 211.6 106.8 79.1 63.1 44.4 52.4 221.3 78.4 41.1 94.1 76.4 75.0 126.7 50.6 69.1 90.9 123.6 84.3 86.6 235.7 109.4 100.0 106.7 164.0 130.3 70.2 156.8 79.1 61.1 76.8 72.5 142.9 55.5 73.8 70.3 165.7 50.5 166.3 53.8 93.2 217.0 34.7 42.3 31.2 59.7 31.6 33.4 35.0 49.6 38.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 1628.0 0.0 0.0 0.0 0.0 0.0 1088.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1710.3 0.0 0.0 0.0 0.0 1077.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1138.4 0.0 0.0 0.0 ALDOB ENSG00000136872 "Aldolase, fructose-bisphosphate B" P05062 9 101420578-101435823 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "intestine: 804.1;kidney: 253.1;liver: 598.8" "Group enriched" "Detected in many" 9 "Hepatocytes: 2651.5;Proximal tubular cells: 6429.5" "Cancer enriched" "Detected in many" 31 "liver cancer: 1414.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.4;NB-4: 13.5;RPMI-8226: 15.6;SH-SY5Y: 13.5;U-2197: 5.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA002198, CAB020827" Enhanced NA NA 930000000 "CAB020827: , HPA002198: AB_1078129" "unprognostic (6.58e-3)" "unprognostic (2.83e-1)" "unprognostic (1.43e-3)" "unprognostic (1.03e-1)" "unprognostic (8.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.44e-3)" "unprognostic (4.34e-2)" "unprognostic (4.57e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (7.48e-2)" "unprognostic (1.66e-2)" "unprognostic (2.02e-1)" "unprognostic (2.58e-1)" "unprognostic (5.19e-2)" "unprognostic (1.96e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.2 0.1 334.5 0.2 0.2 145.9 0.2 0.6 0.1 0.1 5.7 0.1 0.1 0.1 253.1 598.8 0.1 0.1 0.1 0.1 0.1 18.3 0.0 0.4 0.1 0.4 0.1 0.0 0.2 0.2 0.1 0.1 0.1 804.1 0.1 0.1 0.2 1.5 0.3 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.4 0.0 3.0 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.4 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.2 13.5 0.2 0.4 0.0 0.2 3.1 15.6 0.0 0.0 2.6 13.5 1.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.7 5.4 0.2 0.4 0.2 1.6 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 48.6 0.0 0.0 1.0 0.9 448.4 0.0 0.0 143.1 0.0 0.0 525.6 3.8 0.0 0.0 62.6 46.7 221.2 0.0 0.0 0.0 0.0 2651.5 0.2 3.2 0.0 50.3 57.0 0.0 0.0 0.0 0.0 6.4 2.6 0.4 297.3 28.8 0.0 6429.5 0.6 0.0 0.0 0.0 0.0 0.0 0.2 5.0 1.5 0.0 ALDOC ENSG00000109107 "Aldolase, fructose-bisphosphate C" P09972 17 28573115-28577264 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 166.7;heart muscle: 56.9" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 100.1;Horizontal cells: 259.0;Rod photoreceptor cells: 259.1" "Cancer enriched" "Detected in all" 6 "glioma: 128.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 63.4;U-266/70: 43.8;U-87 MG: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003282, CAB020828, HPA067442" Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" Yes No 280000000 "Nucleoplasm, Nucleoli fibrillar center" "Vesicles, Cytosol" "CAB020828: , HPA003282: AB_1078130, HPA067442: " "unprognostic (2.90e-1)" "unprognostic (4.45e-3)" "unprognostic (5.69e-3)" "unprognostic (1.43e-1)" "unprognostic (3.56e-1)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (6.03e-3)" "unprognostic (3.90e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-7)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-1)" 26.0 9.4 86.7 4.8 78.9 7.5 9.8 100.1 166.7 3.8 5.3 17.4 0.3 7.0 4.4 4.6 7.1 3.9 4.4 56.9 64.6 54.3 3.3 26.2 4.6 6.5 69.9 51.4 12.8 1.6 4.7 2.3 2.1 98.1 6.0 5.6 16.5 4.2 6.1 1.7 12.5 15.0 4.6 34.4 6.7 8.7 4.6 23.4 0.0 2.1 0.5 10.0 3.4 3.5 12.2 4.6 8.8 4.1 13.7 20.5 8.8 7.5 0.5 3.5 14.7 7.4 7.6 0.7 3.9 8.8 3.0 18.5 4.4 0.7 3.5 4.6 3.4 0.8 9.9 2.4 24.1 5.6 3.1 2.3 6.8 2.8 7.5 6.9 2.5 8.0 7.0 3.4 0.3 6.0 0.4 1.3 7.3 4.6 19.1 2.6 3.6 2.9 8.3 5.5 1.6 3.9 2.4 0.4 63.4 0.4 1.0 9.4 16.7 2.2 18.1 0.1 5.8 9.8 5.6 0.9 0.3 1.4 0.5 0.6 43.8 12.5 2.6 28.6 7.1 0.5 0.1 3.5 1.4 11.4 4.1 16.2 12.2 15.6 9.2 4.6 11.5 20.5 15.1 8.8 13.7 2.3 2.2 19.5 8.8 86.7 78.9 100.1 78.5 64.6 54.3 69.9 51.4 98.1 23.4 0.0 12.0 9.3 17.7 6.6 72.2 19.0 5.1 0.0 7.9 7.0 100.1 1.2 3.3 14.2 0.8 8.4 22.7 0.0 8.9 3.9 7.1 4.4 12.7 50.8 4.4 259.0 20.7 16.5 4.7 0.8 8.6 3.7 23.6 58.7 8.7 81.4 11.6 14.0 9.6 1.6 259.1 12.9 17.6 0.4 3.2 9.5 1.3 17.0 3.3 8.0 ALG1L ALG1L1 ENSG00000189366 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like" Q6GMV1 3 125929275-125937039 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 11.4;urinary bladder: 12.5" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 30.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 11.0;CAPAN-2: 10.0;HaCaT: 10.7;MCF7: 20.7;OE19: 13.1;T-47d: 13.9" HPA036108 Uncertain NA NA "HPA036108: AB_10673344" "unprognostic (7.06e-3)" "unprognostic (1.50e-3)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.40e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-1)" "unprognostic (4.37e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-6)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "prognostic favorable (6.24e-4)" 0.0 0.5 2.3 0.8 1.6 0.0 1.1 0.3 1.8 0.8 0.9 0.0 0.9 11.4 1.3 2.0 0.4 0.1 1.6 2.0 1.0 1.0 0.7 0.0 2.2 1.7 0.7 0.0 1.2 1.2 1.2 0.6 1.6 0.6 5.9 5.5 0.1 0.2 1.0 0.0 1.1 0.5 1.0 2.3 12.5 0.9 3.1 2.4 4.8 0.2 5.3 5.0 2.1 0.7 0.6 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.1 0.3 11.0 10.0 3.0 4.9 0.0 0.2 10.7 0.3 0.0 0.6 0.4 2.5 0.5 1.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 2.9 0.8 1.0 0.0 20.7 0.6 0.2 4.5 13.1 2.6 0.1 0.0 5.0 0.0 0.6 1.7 0.7 0.4 0.1 0.5 2.4 13.9 0.2 0.2 0.1 1.7 0.1 0.0 7.8 1.1 4.0 0.1 0.0 0.7 4.8 0.1 0.2 3.9 0.2 2.1 3.1 2.1 4.2 0.0 1.9 2.3 1.6 0.8 5.3 0.0 2.4 5.0 2.1 0.0 0.3 0.8 1.6 3.0 0.2 0.0 0.0 30.8 3.4 1.8 0.0 2.8 1.7 0.3 1.5 0.0 0.0 0.0 0.3 1.8 1.5 0.6 1.1 0.0 0.2 0.0 1.7 0.0 0.0 1.5 1.7 0.0 1.7 0.0 0.0 0.6 0.4 0.8 2.8 0.7 0.0 0.0 1.2 1.7 1.6 4.4 1.1 0.0 0.2 6.4 ALG1L2 ENSG00000251287 "ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.0;lymphoid tissue: 3.5" "Cell type enhanced" "Detected in some" 5 "Basal glandular cells: 4.9;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Muller glia cells: 4.8" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 4.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 4.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.6;HDLM-2: 1.9;HEL: 1.8;Karpas-707: 1.4;REH: 2.9" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favorable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.1 0.7 4.0 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 1.4 0.0 0.0 0.0 0.5 0.1 0.9 0.0 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.6 0.3 0.3 0.4 0.1 0.0 0.0 0.0 4.0 0.9 0.1 0.0 1.6 0.8 4.9 0.0 1.9 0.2 0.0 1.4 1.2 1.8 3.9 0.2 1.7 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.6 1.8 0.0 0.2 0.2 4.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 4.8 0.0 0.0 2.5 0.3 3.0 0.0 0.1 0.5 0.1 0.0 0.0 0.5 0.6 1.4 ALG3 "CDGS4, D16Ertd36e, Not56, NOT56L" ENSG00000214160 "ALG3, alpha-1,3- mannosyltransferase" Q92685 3 184242301-184249548 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.4" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045103 Enhanced NA NA "HPA045103: AB_10960547" "unprognostic (3.63e-2)" "unprognostic (2.60e-1)" "unprognostic (2.36e-2)" "unprognostic (1.80e-3)" "unprognostic (3.63e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (1.58e-5)" "prognostic unfavorable (8.67e-5)" "unprognostic (6.18e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-3)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (9.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (5.02e-2)" 14.2 24.1 7.7 12.2 10.3 11.6 15.4 7.2 12.9 11.5 15.5 13.7 15.2 14.3 12.8 11.2 20.5 11.5 15.4 13.0 7.3 6.5 19.7 74.4 12.9 16.8 11.5 7.3 12.7 37.7 18.4 11.7 26.6 10.2 14.0 16.0 12.4 20.9 13.7 18.9 18.4 16.3 14.0 7.9 14.9 15.0 20.8 10.1 13.9 15.9 14.9 18.8 17.4 15.8 14.2 30.1 6.0 25.4 18.7 18.0 15.5 20.1 17.6 4.8 16.1 19.4 11.1 16.4 10.9 12.4 14.9 12.8 26.9 13.6 17.8 29.7 13.4 30.2 24.3 17.3 23.6 9.3 12.8 20.1 15.9 13.4 21.6 17.8 25.8 14.4 13.1 19.8 17.6 24.9 7.8 8.1 12.2 15.7 36.0 9.6 24.8 12.5 20.9 15.1 40.2 23.0 13.0 7.5 70.6 16.8 6.7 12.1 10.2 10.1 40.0 17.3 6.1 37.9 14.7 6.5 15.8 10.0 13.8 23.1 19.7 34.6 18.8 14.1 33.9 14.1 0.2 25.4 6.0 16.0 25.0 18.0 14.2 17.3 16.2 30.1 12.3 15.6 15.1 0.9 18.7 19.7 27.4 18.0 15.5 7.7 10.3 7.2 12.9 7.3 6.5 11.5 7.3 10.2 10.1 6.0 14.9 23.1 21.9 22.1 9.4 8.4 22.9 10.7 19.4 19.2 9.8 63.5 6.6 48.3 89.2 15.7 30.3 46.7 54.5 79.0 18.5 26.2 12.7 43.7 62.9 7.9 13.9 14.7 21.8 169.9 11.5 18.6 20.3 15.4 27.2 14.3 42.1 21.0 14.2 23.8 9.9 19.4 19.1 28.7 33.6 23.6 55.0 19.3 41.5 24.2 ALK CD246 ENSG00000171094 "ALK receptor tyrosine kinase" Q9UM73 2 29192774-29921566 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1;pituitary gland: 17.9" "Group enriched" "Detected in some" 12 "Early spermatids: 36.6;Late spermatids: 30.9" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 27.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010694 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA010694: AB_1078133" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.56e-7)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (9.07e-3)" "unprognostic (6.29e-3)" "unprognostic (1.18e-1)" "unprognostic (1.01e-1)" "unprognostic (2.67e-4)" "unprognostic (3.70e-2)" "unprognostic (2.06e-2)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" 1.8 3.1 3.6 1.2 4.4 0.3 1.1 0.5 8.1 0.7 2.1 2.0 0.0 0.7 0.5 0.5 0.6 0.5 1.2 0.4 3.4 4.9 0.4 0.5 1.1 0.5 2.7 4.2 0.6 0.4 0.4 17.9 0.5 5.5 0.5 1.2 2.4 0.9 0.8 0.3 0.9 1.5 0.9 2.1 0.5 0.8 4.9 0.9 0.0 1.6 0.0 0.3 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 3.6 0.0 0.0 0.1 0.3 27.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 4.1 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 4.4 0.5 5.9 3.4 4.9 2.7 4.2 5.5 0.9 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 ALKAL1 "AUGB, FAM150A, UNQ9433" ENSG00000196711 "ALK and LTK ligand 1" Q6UXT8 8 52534037-52565507 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 8.7;prostate: 6.8;urinary bladder: 9.9" "Cell type enhanced" "Detected in some" 28 "Club cells: 2.3;Distal tubular cells: 5.0;Pancreatic endocrine cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.2;HMC-1: 1.6;NTERA-2: 1.9" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Low region specificity" "Detected in all" HPA027368 Uncertain "Secreted - unknown location" NA NA "HPA027368: AB_10602317" "unprognostic (1.18e-1)" "unprognostic (1.13e-4)" "unprognostic (9.47e-2)" "unprognostic (9.64e-2)" "unprognostic (1.52e-1)" "unprognostic (6.60e-2)" "unprognostic (1.70e-4)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (9.58e-3)" 0.0 0.0 0.3 1.6 0.2 0.0 0.0 0.0 0.4 3.2 3.0 0.0 0.0 1.5 0.1 0.0 3.9 0.6 8.7 0.0 0.1 0.2 0.3 1.1 1.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.3 0.2 6.8 0.3 0.0 2.4 0.0 0.0 0.2 2.2 4.6 0.2 0.0 1.0 0.4 0.3 0.3 6.0 0.0 0.0 9.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.1 0.2 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALKAL2 "AUGA, FAM150B" ENSG00000189292 "ALK and LTK ligand 2" Q6UX46 2 279558-288851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 70.8;retina: 81.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 8.3;Ductal cells: 31.1;Proximal tubular cells: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 21 "AF22: 56.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (1.39e-3)" "unprognostic (1.44e-2)" "unprognostic (2.41e-2)" "unprognostic (2.03e-3)" "unprognostic (2.88e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (1.47e-1)" "unprognostic (3.35e-1)" "unprognostic (9.29e-3)" "unprognostic (5.19e-2)" "unprognostic (3.68e-1)" 5.7 70.8 1.6 1.2 4.9 0.1 6.7 0.4 1.2 4.5 2.7 2.2 3.3 1.2 8.2 8.6 2.2 6.8 7.4 1.4 1.3 1.1 36.8 1.8 8.6 6.9 0.4 1.0 24.7 30.3 1.3 3.0 3.9 2.4 1.8 2.3 81.0 2.0 2.9 1.1 4.9 2.6 3.7 3.0 2.9 3.4 22.2 0.6 0.9 2.5 1.4 1.4 2.9 1.8 1.3 0.9 0.0 0.6 1.0 1.9 0.5 0.0 0.0 56.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.4 0.6 1.1 1.3 0.9 0.8 0.1 0.5 1.9 0.9 0.0 1.0 0.0 0.9 1.5 0.5 1.6 4.9 0.4 1.2 1.3 1.1 0.4 1.0 2.4 0.6 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.3 31.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ALKBH5 "FLJ20308, OFOXD1" ENSG00000091542 "AlkB homolog 5, RNA demethylase" Q6P6C2 17 18183078-18209954 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 130.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007196 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA007196: AB_1850461" "unprognostic (1.07e-1)" "unprognostic (1.51e-1)" "unprognostic (2.23e-2)" "unprognostic (1.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.64e-1)" "unprognostic (1.34e-1)" "unprognostic (1.94e-2)" "prognostic favorable (3.75e-4)" "unprognostic (6.54e-2)" "unprognostic (3.99e-2)" "unprognostic (2.88e-2)" "unprognostic (3.22e-2)" "unprognostic (4.68e-3)" "prognostic unfavorable (5.69e-4)" 18.0 19.5 17.1 14.6 21.9 19.1 26.2 23.4 25.3 18.2 21.8 20.1 18.8 15.1 22.1 12.1 17.3 30.5 18.7 45.8 16.5 18.9 16.0 24.2 14.7 16.9 19.0 16.9 20.9 25.0 22.7 20.2 14.8 15.4 19.4 8.9 19.9 23.7 21.1 130.4 12.7 16.9 20.4 15.3 18.8 16.2 29.7 17.6 26.8 23.5 19.5 13.7 26.8 44.8 11.5 8.9 17.6 10.6 7.6 17.0 5.7 33.1 32.0 13.0 23.4 19.1 13.3 11.3 16.0 19.8 26.3 24.5 36.1 8.8 21.0 23.7 17.6 13.9 21.9 19.6 16.9 13.6 23.9 26.7 15.4 18.2 20.1 17.8 11.1 20.7 12.7 11.5 19.7 11.7 16.7 15.2 16.4 16.7 9.6 14.6 24.6 23.9 12.4 11.0 13.9 16.4 21.7 25.7 36.8 7.7 11.4 13.4 17.7 20.0 13.9 18.2 42.7 14.0 9.6 15.4 25.4 17.7 37.2 31.3 11.2 8.5 12.7 46.1 18.2 16.6 4.3 7.2 17.6 15.1 7.4 14.0 7.9 13.6 17.0 8.9 11.5 10.9 11.0 4.6 7.6 10.6 6.6 7.9 5.7 17.1 21.9 23.4 25.3 16.5 18.9 19.0 16.9 15.4 17.6 32.8 25.7 39.8 24.5 57.5 79.0 78.7 25.5 28.1 18.2 26.2 37.3 28.1 71.3 24.0 48.1 37.6 35.4 46.7 27.3 36.7 47.3 36.0 41.4 52.9 29.7 112.8 58.5 27.6 39.9 29.1 38.0 25.6 47.2 17.2 41.8 72.5 28.5 42.4 48.8 81.8 52.8 19.4 44.3 106.7 98.2 48.9 26.3 48.4 31.6 21.6 ALLC ALC ENSG00000151360 Allantoicase 2 3658195-3702671 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 35 "testis: 34.9" "Cell type enriched" "Detected in some" 4 "Early spermatids: 105.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "U-266/84: 11.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.47e-2)" "unprognostic (3.24e-2)" "unprognostic (2.91e-3)" "unprognostic (4.75e-1)" "unprognostic (2.17e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-3)" "unprognostic (5.42e-2)" "unprognostic (1.74e-4)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 3.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 20.8 0.4 0.0 12.9 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.0 ALMS1 KIAA0328 ENSG00000116127 "ALMS1, centrosome and basal body associated protein" 2 73385758-73610793 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 55.4;Late spermatids: 63.9;Rod photoreceptor cells: 38.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RH-30: 24.2" "Low region specificity" "Detected in all" "HPA035276, HPA043200" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Centrosome, Cytosol" Nucleoplasm "HPA035276: , HPA043200: AB_10796689" "unprognostic (2.86e-1)" "unprognostic (9.67e-2)" "unprognostic (2.58e-2)" "unprognostic (4.50e-3)" "unprognostic (1.36e-1)" "unprognostic (6.39e-2)" "unprognostic (2.91e-3)" "unprognostic (7.73e-2)" "unprognostic (1.02e-1)" "unprognostic (8.58e-2)" "unprognostic (4.78e-2)" "unprognostic (1.84e-1)" "unprognostic (3.43e-2)" "unprognostic (1.63e-1)" "unprognostic (7.85e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" 3.4 1.7 3.0 6.5 5.5 6.3 3.9 5.5 4.5 6.0 4.0 5.4 4.3 2.0 7.4 3.9 2.2 7.9 4.3 1.6 3.4 3.5 2.1 2.7 2.5 2.0 5.0 11.0 4.0 6.1 6.6 3.2 3.6 3.6 3.3 4.7 2.3 5.8 2.3 1.8 2.4 4.2 3.2 2.1 2.8 23.2 3.4 6.7 5.1 1.9 3.2 2.9 4.1 0.8 1.3 1.3 0.4 0.5 1.2 0.0 8.5 3.4 6.3 4.6 2.5 4.1 3.9 2.9 3.2 4.8 3.6 3.7 1.2 8.1 1.8 4.9 6.4 3.8 10.6 3.3 7.3 4.8 2.9 5.3 3.7 3.0 2.1 7.4 2.6 3.1 2.0 6.7 3.3 2.3 4.3 7.5 6.0 4.3 4.0 2.5 7.0 3.4 8.1 2.4 3.1 7.8 24.2 3.4 1.2 3.1 5.1 6.1 6.7 1.1 2.7 5.1 1.4 1.8 2.7 6.8 7.1 5.4 7.0 5.0 2.5 8.6 2.6 4.2 3.0 0.0 0.1 1.3 1.2 0.2 0.3 0.2 0.6 0.1 0.1 0.8 0.4 0.6 0.0 0.5 0.4 1.3 0.1 0.0 6.0 9.3 0.0 2.6 2.2 23.1 5.8 2.5 21.4 12.5 10.4 23.6 2.6 0.0 3.9 55.4 8.6 3.8 0.0 3.0 2.2 4.8 3.9 4.7 2.1 2.8 20.6 7.0 0.6 3.0 63.9 7.5 3.1 3.3 2.8 5.6 5.7 2.9 0.0 8.5 1.1 38.5 6.5 3.9 25.2 24.4 2.9 1.6 2.5 4.6 1.8 ALOX12 12S-LOX ENSG00000108839 "Arachidonate 12-lipoxygenase, 12S type" P18054 17 6996065-7010736 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Hydrolase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "A-431: 17.5;HEL: 28.0" "Region enriched" "Detected in single" 5 "olfactory region: 5.4" "HPA010691, CAB019287, HPA064819" Enhanced Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 5800000 Cytosol "Nuclear speckles, Vesicles" "CAB019287: , HPA010691: AB_1844756, HPA064819: " "unprognostic (3.61e-3)" "unprognostic (6.93e-2)" "unprognostic (7.17e-5)" "unprognostic (9.43e-2)" "unprognostic (6.06e-2)" "unprognostic (2.25e-3)" "unprognostic (2.45e-1)" "unprognostic (3.16e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-2)" "unprognostic (3.96e-5)" "unprognostic (4.01e-3)" "unprognostic (2.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (5.90e-2)" "unprognostic (3.47e-2)" 0.3 0.6 0.3 1.5 0.4 2.0 0.3 0.3 1.0 28.6 0.4 0.3 0.3 0.7 3.4 0.5 28.4 0.4 1.6 0.8 0.3 0.1 0.3 0.3 0.5 1.9 0.5 0.3 0.4 0.8 0.0 0.3 0.7 0.4 0.3 0.0 0.4 8.1 0.3 0.5 12.8 0.8 0.3 0.3 1.5 0.3 0.6 0.3 0.3 0.8 22.7 9.5 1.2 42.7 1.1 1.3 4.8 0.9 0.7 0.8 14.3 17.5 2.9 1.3 1.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 2.6 0.6 0.9 0.6 0.0 1.0 2.2 0.0 0.1 0.0 1.9 2.3 28.0 3.9 1.9 0.1 0.2 4.6 0.0 0.0 0.0 0.0 1.7 0.0 1.9 1.8 1.0 0.0 0.2 0.3 0.6 0.9 0.1 0.6 1.0 0.6 0.4 0.0 2.2 0.1 0.6 0.5 0.6 0.2 1.8 1.0 0.7 3.2 1.5 0.9 1.5 0.7 0.5 0.2 0.5 0.9 2.1 0.7 1.8 0.9 1.7 0.7 0.5 0.5 1.1 0.5 0.8 0.7 0.7 0.2 0.4 4.8 0.7 0.4 1.3 0.3 14.3 0.3 0.4 0.3 0.6 0.3 0.1 0.5 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 1.7 ALOX12B 12R-LOX ENSG00000179477 "Arachidonate 12-lipoxygenase, 12R type" O75342 17 8072636-8087703 "Disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 38.9;tongue: 55.3" "Cell type enhanced" "Detected in some" 11 "Horizontal cells: 1.6;Rod photoreceptor cells: 1.1;Suprabasal keratinocytes: 1.6" "Group enriched" "Detected in many" 9 "cervical cancer: 2.6;head and neck cancer: 11.2;melanoma: 4.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "basophil: 7.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.0" "Cell line enhanced" "Detected in some" "HEK 293: 3.2;hTCEpi: 3.6;JURKAT: 6.7;OE19: 3.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA024002 Supported Supported Cytosol NA NA Cytosol "HPA024002: AB_1844757" "unprognostic (1.27e-2)" "unprognostic (1.59e-2)" "unprognostic (4.28e-3)" "unprognostic (1.38e-2)" "unprognostic (3.94e-3)" "unprognostic (1.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-1)" "unprognostic (4.40e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.02e-1)" "unprognostic (8.01e-2)" "unprognostic (3.46e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 1.1 0.1 0.3 7.7 0.1 0.1 0.1 0.1 0.5 0.1 3.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.6 38.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 55.3 11.4 0.1 6.2 0.9 0.2 7.0 0.0 0.2 1.1 0.2 1.2 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 1.0 0.5 0.2 0.2 0.0 0.0 3.2 0.0 0.9 0.2 0.0 0.5 0.0 0.0 3.6 0.2 0.6 0.1 0.0 6.7 0.0 0.0 0.0 0.1 0.3 0.0 0.6 3.8 0.3 2.3 0.0 0.9 0.4 0.0 1.0 1.4 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 2.3 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.5 0.0 0.7 0.9 0.3 0.5 0.0 0.3 1.1 1.0 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.9 0.4 1.6 0.0 0.0 0.0 0.0 ALOX15 15-LOX-1 ENSG00000161905 "Arachidonate 15-lipoxygenase" P16050 17 4630902-4642294 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 27.9;blood: 89.8;lung: 24.4" "Cell type enriched" "Detected in some" 15 "Ciliated cells: 210.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 183 "eosinophil: 89.8" "Lineage enriched" "Detected in single" 183 "granulocytes: 89.8" "Group enriched" "Detected in some" 7 "HMC-1: 16.5;MCF7: 14.3;T-47d: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB004962, CAB004963, HPA013859" Approved NA NA "CAB004962: , CAB004963: , HPA013859: AB_1844758" "unprognostic (5.31e-4)" "unprognostic (1.43e-2)" "unprognostic (2.81e-2)" "unprognostic (8.36e-3)" "unprognostic (2.22e-1)" "unprognostic (8.60e-2)" "unprognostic (2.36e-1)" "unprognostic (2.66e-2)" "unprognostic (1.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.31e-3)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "unprognostic (2.78e-1)" "unprognostic (1.59e-1)" 27.9 0.1 0.2 4.5 1.1 0.2 4.2 0.2 0.3 0.5 2.8 0.2 0.2 1.9 0.2 8.1 0.4 14.4 1.5 2.7 0.3 0.4 0.2 1.7 24.4 1.7 0.5 0.2 3.0 0.2 0.0 6.3 1.5 0.4 0.3 0.9 0.2 1.0 0.2 0.2 2.2 3.7 0.5 0.7 1.1 1.0 1.4 0.4 2.0 0.2 0.2 0.4 1.9 0.2 0.0 0.4 89.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 14.3 0.0 0.3 1.2 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 89.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 1.1 0.2 0.3 0.3 0.4 0.5 0.2 0.4 0.4 0.0 0.6 0.0 0.0 1.3 0.0 0.4 0.0 210.1 5.7 0.0 0.0 1.6 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.1 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.6 6.2 0.0 0.0 0.2 ALOX15B 15-LOX-2 ENSG00000179593 "Arachidonate 15-lipoxygenase, type B" O15296 17 8039017-8049134 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9" "Cell type enhanced" "Detected in many" 26 "Alveolar cells type 2: 58.0;Kupffer cells: 33.3;monocytes: 149.7" "Cancer enhanced" "Detected in all" "prostate cancer: 91.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 6.1;myeloid DC: 6.8" "Group enriched" "Detected in many" 9 "dendritic cells: 6.8;monocytes: 6.1" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 13.0;hTCEpi: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA010562 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA010562: AB_2668305" "unprognostic (1.76e-2)" "unprognostic (6.47e-2)" "unprognostic (2.56e-1)" "unprognostic (2.28e-3)" "unprognostic (1.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.59e-1)" "unprognostic (1.59e-2)" "unprognostic (9.37e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.49e-2)" 8.9 0.6 0.4 0.7 0.6 0.3 57.4 0.1 0.4 7.6 4.6 0.1 0.0 0.2 0.3 0.7 30.6 0.8 0.5 0.2 1.3 0.0 2.9 0.7 44.0 7.1 1.8 0.3 0.8 0.8 0.2 0.9 0.7 1.3 35.9 0.3 0.1 3.6 0.2 0.3 15.4 1.9 0.2 4.1 3.1 1.6 1.0 2.0 0.5 0.8 6.6 4.1 1.1 12.9 0.0 6.8 0.2 6.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 13.0 26.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.7 0.0 0.2 0.0 1.7 0.4 0.6 0.1 0.4 1.3 0.0 1.8 0.3 1.3 2.0 0.0 58.0 0.0 0.5 2.7 0.0 0.3 2.5 2.7 2.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 16.8 1.1 0.0 4.1 0.0 0.0 1.3 33.3 0.0 0.0 1.9 5.0 149.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 1.0 0.7 0.0 0.0 1.8 ALOX5 5-LOX ENSG00000012779 "Arachidonate 5-lipoxygenase" P09917 10 45374176-45446119 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Leukotriene biosynthesis" "Dioxygenase, Hydrolase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8" "Cell type enhanced" "Detected in many" 13 "granulocytes: 194.3;Hofbauer cells: 78.7;Kupffer cells: 81.6;Macrophages: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 7.9;CAPAN-2: 6.1;Daudi: 22.3;HMC-1: 16.0;Karpas-707: 7.0;RT4: 10.5;U-266/70: 10.5;U-698: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071285 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA071285: AB_2686379" "unprognostic (2.57e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.75e-2)" "unprognostic (7.98e-3)" "unprognostic (1.26e-1)" "unprognostic (5.32e-2)" "unprognostic (8.69e-2)" "unprognostic (1.86e-2)" "unprognostic (6.91e-2)" "unprognostic (5.04e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.53e-1)" "prognostic favorable (7.18e-4)" 7.4 3.9 2.9 18.3 7.4 39.9 5.8 13.2 3.2 3.4 6.5 6.4 1.0 4.5 3.2 4.7 4.9 5.4 8.0 6.1 3.9 2.6 4.8 2.6 34.7 36.9 9.0 1.7 2.6 10.0 1.3 1.7 11.2 6.1 7.8 3.4 3.2 6.6 3.4 1.1 2.9 14.4 7.8 8.4 41.8 4.5 2.0 6.2 2.4 3.0 1.4 16.7 27.2 10.5 14.8 11.1 45.2 21.3 0.0 0.5 9.5 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 6.1 22.3 0.8 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 4.3 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.8 0.3 10.5 0.5 0.0 0.0 0.2 0.0 0.1 0.1 0.5 0.0 0.0 1.2 0.0 0.0 10.5 1.9 7.4 0.0 0.1 0.0 36.7 21.3 27.0 0.0 20.0 0.1 14.8 0.5 0.2 11.1 10.4 0.0 0.0 45.2 0.0 19.6 0.3 0.1 9.5 2.9 7.4 13.2 3.2 3.9 2.6 9.0 1.7 6.1 6.2 14.9 58.3 34.9 5.4 1.0 0.8 2.0 15.3 4.0 12.5 8.7 2.0 0.5 0.0 19.2 0.4 0.7 2.1 0.0 18.9 1.4 0.6 3.3 194.3 0.6 78.7 0.0 6.8 2.5 81.6 1.1 0.3 81.2 0.0 18.0 0.7 0.3 17.8 0.0 0.0 0.0 0.2 12.9 0.7 0.4 0.8 1.3 3.4 1.3 0.4 35.5 ALOX5AP FLAP ENSG00000132965 "Arachidonate 5-lipoxygenase activating protein" P20292 13 30713478-30764426 "Disease related genes, Predicted membrane proteins" "Leukotriene biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 296.2;bone marrow: 121.8" "Cell type enhanced" "Detected in many" 12 "granulocytes: 589.5;Hofbauer cells: 445.6;Macrophages: 736.5;monocytes: 250.7;T-cells: 298.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 296.2;eosinophil: 148.4;neutrophil: 194.2;plasmacytoid DC: 136.1" "Group enriched" "Detected in all" 7 "dendritic cells: 136.1;granulocytes: 296.2" "Cell line enhanced" "Detected in some" "HDLM-2: 80.1;HL-60: 42.6;HMC-1: 137.8;THP-1: 53.6;U-937: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026592 Enhanced NA NA "HPA026592: AB_10601115" "unprognostic (1.17e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (4.64e-3)" "unprognostic (7.18e-2)" "unprognostic (7.10e-2)" "unprognostic (7.79e-2)" "unprognostic (1.04e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (7.83e-2)" "unprognostic (6.63e-2)" "prognostic unfavorable (5.68e-4)" "unprognostic (1.33e-1)" "unprognostic (3.19e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-1)" 16.7 12.7 9.6 27.9 17.0 121.8 8.3 1.9 10.7 6.3 7.5 17.1 0.0 6.4 7.7 3.3 6.4 11.5 11.7 10.4 8.0 9.0 10.6 5.8 55.8 33.4 22.0 2.7 5.1 7.9 1.7 3.3 10.6 14.2 5.9 6.6 5.1 9.9 4.9 2.4 2.8 10.9 12.1 23.0 57.6 7.8 5.2 15.5 42.2 4.3 3.7 29.2 11.9 6.5 18.4 136.1 296.2 12.6 3.6 33.2 24.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 19.1 0.2 0.0 0.6 0.1 0.0 0.5 0.0 80.1 0.0 2.3 0.0 0.1 0.1 42.6 137.8 0.1 0.0 0.0 4.8 1.0 0.1 4.1 0.0 0.4 0.2 0.0 2.3 1.5 0.0 0.0 0.0 0.3 0.5 1.5 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.0 53.6 0.1 0.0 0.4 0.0 0.3 8.5 0.0 12.7 0.1 39.4 0.1 296.2 12.6 148.4 22.3 0.6 33.2 16.9 22.3 18.2 7.6 18.4 11.3 11.1 194.2 3.6 0.4 136.1 30.9 24.1 9.6 17.0 1.9 10.7 8.0 9.0 22.0 2.7 14.2 15.5 38.7 140.9 78.7 2.7 21.1 0.0 2.5 17.8 20.1 43.3 0.0 0.0 2.6 13.3 1.9 4.4 5.6 2.8 0.0 0.9 2.8 8.0 1.1 589.5 1.0 445.6 0.0 25.3 9.2 168.8 3.1 4.4 736.5 40.5 250.7 1.0 0.0 3.7 1.5 3.9 1.4 0.0 32.3 4.3 0.3 1.0 21.7 4.1 298.1 1.2 1.3 ALOXE3 "E-LOX, eLOX3" ENSG00000179148 "Arachidonate lipoxygenase 3" Q9BYJ1 17 8095900-8119047 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 30.2" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.9" "Group enriched" "Detected in many" 8 "basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1" "Group enriched" "Detected in some" 5 "gdT-cell: 1.0;naive CD4 T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA023120, HPA078597" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023120: AB_10959300, HPA078597: AB_2732385" "unprognostic (2.40e-1)" "unprognostic (3.01e-2)" "unprognostic (1.87e-3)" "unprognostic (2.09e-4)" "unprognostic (1.07e-2)" "unprognostic (4.06e-2)" "unprognostic (3.56e-4)" "unprognostic (3.60e-1)" "unprognostic (4.65e-2)" "unprognostic (3.82e-2)" "unprognostic (3.72e-1)" "unprognostic (3.66e-5)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" 0.1 0.0 0.1 0.1 1.1 0.0 1.6 1.4 2.3 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 1.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.2 6.6 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.4 0.1 0.5 0.2 0.2 0.1 3.2 0.5 0.9 10.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.2 15.1 0.0 0.0 1.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.7 0.0 0.0 4.8 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 1.4 2.3 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.9 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 1.6 0.9 0.0 0.0 0.7 ALPI ENSG00000163295 "Alkaline phosphatase, intestinal" P09923 2 232456123-232460032 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 406 "intestine: 133.2" "Group enriched" "Detected in some" 6 "Enterocytes: 45.5;Paneth cells: 17.5" "Cancer enhanced" "Detected in many" "liver cancer: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "CACO-2: 12.7" "HPA038764, HPA038765, HPA051699" Supported Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.01e-1)" "unprognostic (7.71e-2)" "unprognostic (4.14e-2)" "unprognostic (1.47e-1)" "unprognostic (9.57e-4)" "unprognostic (8.07e-2)" "unprognostic (1.71e-1)" "unprognostic (9.99e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 63.0 0.0 0.0 57.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.1 0.1 133.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 17.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 ALPK2 HAK ENSG00000198796 "Alpha kinase 2" Q86TB3 18 58481247-58628957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 35.3;skeletal muscle: 35.3;tongue: 12.4" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 79.2;Cone photoreceptor cells: 45.2;monocytes: 31.5" "Cancer enriched" "Detected in some" 6 "renal cancer: 7.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 26.6;BJ hTERT+: 16.2;fHDF/TERT166: 24.0;U-138 MG: 13.5" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected" "Not detected" "HPA027377, HPA027976, HPA028084, HPA029801" Uncertain Approved Cytosol NA NA Cytosol "HPA027377: AB_10600635, HPA027976: AB_10611246, HPA028084: AB_10601996, HPA029801: AB_10602006" "unprognostic (7.35e-2)" "unprognostic (4.91e-2)" "unprognostic (1.64e-1)" "unprognostic (4.60e-3)" "unprognostic (2.64e-1)" "unprognostic (8.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (5.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-2)" 0.8 0.0 0.1 2.8 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.8 0.0 0.4 35.3 0.1 0.0 5.2 2.8 0.1 3.3 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.2 0.4 0.1 35.3 0.3 0.6 0.1 0.1 0.2 1.2 0.6 0.1 5.5 0.3 12.4 7.9 0.5 0.1 0.0 0.5 0.0 1.8 0.0 0.3 0.0 0.0 7.0 0.5 0.0 0.2 1.8 0.1 26.6 16.2 11.2 9.7 1.7 0.0 0.0 2.8 24.0 1.5 0.0 0.0 0.0 11.5 5.8 0.0 0.0 2.2 0.9 1.5 0.0 0.0 1.6 0.0 3.4 0.1 0.3 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 13.5 6.0 1.8 4.5 10.9 9.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 79.2 0.0 0.0 0.0 0.0 45.2 0.0 1.7 0.4 14.2 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.0 2.4 0.5 1.6 0.0 0.6 0.0 15.3 0.3 0.9 0.0 31.5 0.0 2.9 0.3 0.2 0.0 9.8 0.5 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.0 ALPK3 "KIAA1330, MAK, Midori" ENSG00000136383 "Alpha kinase 3" Q96L96 15 84816680-84873482 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 18.4;skeletal muscle: 47.6" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 52.4;Cholangiocytes: 20.4;Exocrine glandular cells: 17.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.5;HDLM-2: 7.1;HUVEC TERT2: 10.2;LHCN-M2: 13.9;NTERA-2: 8.5;RH-30: 25.0;THP-1: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026558 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026558: AB_1844774" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (4.61e-2)" "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.74e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.95e-7)" "unprognostic (1.76e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (4.87e-2)" 3.7 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.5 1.4 0.0 0.1 1.7 0.8 0.2 0.3 18.4 0.0 0.6 1.6 1.3 1.0 0.0 0.1 0.0 2.1 8.8 6.9 0.6 0.4 0.0 0.4 0.2 47.6 0.0 0.2 0.8 0.0 0.0 1.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.1 0.1 0.2 0.0 9.5 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 7.1 1.1 1.1 0.2 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.1 10.2 0.0 0.0 0.0 13.9 0.5 0.0 0.1 8.5 0.2 0.0 0.0 25.0 0.1 0.0 2.6 0.0 0.1 0.0 1.3 0.0 1.3 0.0 6.1 0.2 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.0 2.4 0.5 0.0 0.8 3.1 52.4 20.4 0.0 1.2 8.7 15.7 0.2 0.0 3.1 0.1 4.5 0.0 0.0 17.3 0.6 1.5 0.5 1.1 1.5 7.9 0.0 8.7 2.5 0.3 0.0 0.0 1.9 3.3 8.2 0.3 0.9 13.6 0.2 0.0 1.7 3.0 0.0 8.3 0.2 3.1 0.1 0.6 0.0 0.3 0.8 ALPL "HOPS, TNSALP" ENSG00000162551 "Alkaline phosphatase, liver/bone/kidney" P05186 1 21509372-21578412 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Biomineralization Hydrolase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.3;liver: 52.7;lung: 45.1" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 88.5;Hepatocytes: 25.3;Ito cells: 25.8;Proximal tubular cells: 44.8;Rod photoreceptor cells: 28.1" "Cancer enhanced" "Detected in all" "testis cancer: 199.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 91 "neutrophil: 73.3" "Lineage enriched" "Detected in single" 127 "granulocytes: 73.3" "Cell line enhanced" "Detected in some" "HSkMC: 53.1;hTEC/SVTERT24-B: 41.5;LHCN-M2: 30.2;SCLC-21H: 26.4;SuSa: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007105, HPA008765, CAB020829" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 7300000 Cytosol "CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138" "unprognostic (3.89e-2)" "unprognostic (1.27e-1)" "unprognostic (5.57e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.05e-3)" "unprognostic (6.50e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.17e-2)" "unprognostic (2.48e-3)" "unprognostic (1.74e-1)" "unprognostic (7.28e-2)" "unprognostic (1.73e-2)" "unprognostic (2.27e-1)" "unprognostic (9.70e-3)" "unprognostic (2.58e-1)" 15.9 22.7 4.5 17.6 6.0 2.6 10.6 2.2 7.8 2.2 2.1 4.1 0.7 1.9 3.7 1.1 2.0 5.7 2.8 10.9 5.7 4.2 29.7 52.7 45.1 28.1 5.3 4.8 1.2 4.3 2.4 4.1 2.2 7.7 2.6 1.3 18.3 3.1 6.6 0.9 1.8 2.7 2.5 3.8 19.6 1.8 2.9 2.7 0.5 3.7 1.7 3.9 7.1 8.4 0.5 0.0 73.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 2.0 3.3 0.1 0.7 0.2 0.4 0.2 0.0 0.7 2.3 0.0 0.0 0.0 9.1 0.0 0.1 0.0 0.6 0.0 1.1 1.1 0.5 0.0 0.2 53.1 0.0 41.5 0.1 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 12.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.1 14.8 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 73.3 0.0 0.0 0.0 0.0 0.0 4.5 6.0 2.2 7.8 5.7 4.2 5.3 4.8 7.7 2.7 3.0 88.5 0.5 0.5 0.1 2.6 2.0 0.0 1.4 10.3 0.0 0.0 0.0 6.6 0.0 1.2 7.1 0.0 23.3 0.0 0.3 0.3 1.5 7.0 25.3 0.1 1.6 0.0 25.8 1.0 4.4 0.3 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 44.8 28.1 0.0 1.0 0.3 13.6 0.4 1.3 0.0 0.0 0.3 ALPP ENSG00000163283 "Alkaline phosphatase, placental" P05187 2 232378534-232382889 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "placenta: 240.2" "Group enriched" "Detected in some" 19 "Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HaCaT: 88.1;SiHa: 24.3" "CAB026327, HPA038764, HPA038765, HPA051699" Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (4.86e-2)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (2.60e-1)" "unprognostic (2.44e-3)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.44e-1)" "unprognostic (4.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 240.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.5 1.6 0.5 1.1 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 24.3 8.6 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.7 0.5 0.2 0.5 0.3 0.3 0.3 0.1 1.0 0.4 0.4 1.6 1.1 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.6 0.0 0.0 0.0 ALPPL2 ENSG00000163286 "Alkaline phosphatase, placental like 2" P10696 2 232406843-232410714 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.2;lung: 9.4" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 1: 6.0;Ciliated cells: 1.4;Club cells: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 49.1;testis cancer: 64.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 21.4;HaCaT: 15.7;SuSa: 25.7" "CAB020698, HPA038764, HPA038765, HPA051699" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (1.39e-1)" "unprognostic (6.63e-3)" "unprognostic (1.27e-2)" "unprognostic (2.89e-1)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.67e-1)" "unprognostic (6.72e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.2 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 21.4 0.0 0.0 0.0 0.0 15.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 ALS2 ALS2CR6 ENSG00000003393 "ALS2, alsin Rho guanine nucleotide exchange factor" Q96Q42 2 201700554-201781189 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.8" "Cell type enhanced" "Detected in many" 6 "granulocytes: 45.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 66.8" "Group enriched" "Detected in many" 6 "basophil: 19.0;eosinophil: 5.5" "Lineage enriched" "Detected in all" 10 "granulocytes: 19.0" "Cell line enhanced" "Detected in many" "HMC-1: 53.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 158.8" HPA046588 Enhanced Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA046588: AB_2679709" "unprognostic (3.43e-2)" "unprognostic (2.11e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-3)" "unprognostic (2.72e-1)" "unprognostic (7.47e-2)" "unprognostic (1.04e-3)" "unprognostic (9.17e-2)" "unprognostic (4.16e-2)" "unprognostic (1.52e-1)" "unprognostic (2.99e-1)" "unprognostic (2.83e-2)" "unprognostic (1.09e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (2.10e-1)" "unprognostic (1.84e-1)" 6.9 5.3 8.2 4.2 14.7 7.8 8.1 66.8 15.6 5.9 5.6 10.1 5.5 7.4 10.3 10.7 4.7 6.7 6.4 19.9 8.3 7.3 10.4 18.3 7.9 4.1 6.8 11.0 6.8 5.6 8.8 16.8 7.2 13.6 6.6 6.0 8.5 5.2 5.5 12.2 6.9 8.4 7.4 8.3 5.3 6.7 6.1 9.0 3.5 7.5 5.9 4.5 5.5 5.3 1.2 1.0 19.0 1.2 1.7 1.8 0.7 5.1 3.6 8.8 8.2 6.0 6.5 6.6 9.2 12.4 12.2 14.2 8.4 5.1 0.6 4.0 9.6 8.3 5.3 5.0 9.3 15.5 1.7 5.1 12.2 3.5 4.8 7.4 9.6 53.0 5.6 5.2 10.2 8.8 9.5 12.3 4.9 5.8 3.7 9.2 4.1 3.4 12.7 7.3 3.2 5.5 2.8 4.9 1.8 7.7 7.1 4.1 5.4 5.3 5.8 8.2 22.1 3.7 4.0 7.3 10.8 5.2 3.7 4.6 4.1 5.6 2.1 7.9 1.9 6.8 19.0 0.7 5.5 1.7 1.2 1.8 1.2 1.2 1.2 1.0 1.2 1.3 1.5 0.6 1.7 0.8 0.5 1.8 0.7 8.2 14.7 66.8 15.6 8.3 7.3 6.8 11.0 13.6 9.0 11.9 18.4 1.9 3.3 4.7 14.7 26.3 7.6 13.4 3.4 8.7 27.5 4.6 0.0 5.6 13.0 7.7 5.2 0.0 2.8 2.4 5.9 3.8 45.1 17.1 4.9 7.9 4.6 15.4 3.5 5.3 7.2 5.3 0.0 1.0 6.7 6.8 5.9 3.7 7.8 4.8 14.7 0.0 4.1 6.5 2.8 5.3 5.6 4.3 3.8 3.3 ALS2CL "DKFZp686I0110, FLJ36525, RN49018" ENSG00000178038 "ALS2 C-terminal like" Q60I27 3 46668997-46693704 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 31.8" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1" "Lineage enhanced" "Detected in single" "T-cells: 3.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.8;HaCaT: 11.5;HBEC3-KT: 21.7;hTCEpi: 15.4;RT4: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB046465, HPA048301" Uncertain NA NA "CAB046465: AB_10638285, HPA048301: AB_2680346" "unprognostic (6.38e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-3)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.86e-2)" "unprognostic (1.04e-2)" "unprognostic (1.92e-1)" "unprognostic (8.60e-2)" "unprognostic (4.28e-2)" "unprognostic (1.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-3)" "unprognostic (4.45e-2)" "unprognostic (5.20e-2)" "unprognostic (6.79e-2)" "unprognostic (4.14e-3)" 3.8 1.8 0.7 2.9 1.3 0.6 3.0 5.2 3.3 5.4 5.1 0.9 3.0 4.3 4.2 3.4 22.2 2.6 11.7 5.5 1.7 0.9 15.2 4.2 9.3 2.0 0.7 3.2 1.9 3.5 0.5 4.5 4.3 1.7 2.7 1.5 4.9 7.0 4.3 6.1 31.8 3.3 4.9 1.1 5.9 3.6 0.5 0.2 0.7 9.8 17.9 12.1 5.6 10.7 0.0 0.7 0.0 0.3 0.0 3.1 0.6 6.2 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.2 0.1 20.8 0.0 6.2 0.5 0.3 11.5 0.0 21.7 0.0 0.0 0.0 0.5 2.9 0.0 0.2 0.0 0.0 0.0 15.4 0.0 2.5 0.2 0.6 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 3.0 1.5 0.0 0.0 7.4 5.3 11.4 0.2 0.1 8.3 6.3 0.0 0.4 1.5 0.1 4.4 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 2.0 0.4 0.7 0.0 3.1 0.3 0.0 0.0 0.0 0.0 1.7 0.6 0.7 1.3 5.2 3.3 1.7 0.9 0.7 3.2 1.7 0.2 68.5 11.7 0.8 7.5 13.5 0.0 9.3 20.4 6.7 17.0 10.4 0.0 0.7 0.0 9.4 0.4 7.7 20.0 0.0 11.9 5.7 4.3 11.5 1.1 7.8 2.1 0.0 0.0 7.4 0.0 0.0 0.3 2.2 1.7 1.0 6.0 0.0 17.9 11.6 0.0 0.3 0.0 19.4 4.7 0.9 0.8 14.3 1.7 0.7 9.6 18.7 ALS2CR12 ENSG00000155749 "Amyotrophic lateral sclerosis 2 chromosome region 12" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3;epididymis: 14.4;testis: 29.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 99.0;Early spermatids: 82.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 14.3" "Cell type enhanced" "Detected in many" "neutrophil: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.0;U-2197: 9.6" "Low region specificity" "Detected in many" HPA035793 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.8 0.9 1.5 0.7 3.6 4.3 0.5 0.7 1.1 0.9 0.6 7.6 0.4 0.3 0.7 14.4 1.1 9.9 0.9 4.7 2.1 2.6 1.3 0.7 3.7 1.4 1.0 1.3 5.3 0.7 1.2 1.3 0.9 14.3 0.4 0.9 0.5 0.7 0.7 1.4 1.1 0.9 0.9 0.9 0.8 0.5 29.9 1.3 0.4 1.7 0.4 0.5 0.6 0.4 1.8 0.5 7.3 1.1 2.8 1.5 0.4 0.3 0.4 2.1 1.5 5.7 2.2 0.1 1.5 0.5 1.3 0.9 0.0 0.5 0.7 1.2 2.2 1.0 2.0 0.8 0.2 0.6 1.2 0.2 0.3 2.5 0.7 1.1 2.1 1.9 1.1 0.6 1.3 0.3 1.7 0.2 2.5 1.0 2.9 1.3 0.0 1.1 1.8 0.6 0.8 1.2 0.5 1.0 1.3 0.8 0.5 0.5 1.3 1.6 0.0 7.0 2.2 1.5 2.5 1.6 2.9 1.7 9.6 1.0 1.6 3.1 1.0 2.8 1.0 1.3 5.4 1.1 1.0 1.5 0.5 0.7 0.6 1.0 0.9 0.5 1.8 1.2 1.4 7.3 2.8 0.6 0.4 0.6 0.4 1.5 3.6 0.7 1.0 2.1 2.6 1.0 1.3 14.3 1.3 0.0 0.3 0.0 0.0 0.5 5.4 5.7 0.0 99.0 9.1 0.0 9.8 0.0 3.3 0.0 82.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.3 1.6 0.0 0.0 0.0 16.0 0.6 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.1 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280107-85301784 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.9" "Cell type enriched" "Detected in some" 6 "Melanocytes: 30.4" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.9;HEK 293: 15.4;HUVEC TERT2: 11.3;SK-MEL-30: 18.7;THP-1: 12.2;WM-115: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 1.9 0.0 0.1 0.0 0.2 0.0 4.8 0.0 0.2 5.4 0.1 0.0 0.8 0.0 5.4 8.5 0.1 4.7 0.0 0.1 0.2 0.2 8.3 0.0 0.1 0.0 0.2 0.0 3.6 0.1 0.0 1.6 0.1 0.0 1.6 0.0 13.9 3.8 2.0 0.4 3.3 0.1 1.1 0.0 0.0 0.1 1.5 0.0 0.0 0.2 4.0 0.0 2.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.5 0.0 6.9 0.3 0.0 0.0 15.4 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 6.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.8 4.0 0.0 0.0 18.7 2.9 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.3 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 ALX3 FND ENSG00000156150 "ALX homeobox 3" O95076 1 110059994-110070700 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 19.3" "Group enriched" "Detected in some" 9 "Bipolar cells: 2.4;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 7 "olfactory region: 14.8" "Low region specificity" "Detected in single" HPA074290 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA074290: " "unprognostic (4.28e-1)" "unprognostic (4.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" 0.5 1.8 1.2 1.0 2.7 0.8 2.6 0.9 4.1 0.7 0.4 1.2 0.3 1.6 2.7 0.9 2.6 2.6 1.7 0.7 1.3 1.5 0.8 0.4 1.0 2.3 0.5 1.9 3.1 1.0 0.2 5.3 0.7 0.5 0.8 0.0 19.3 2.0 0.3 2.8 8.0 2.7 0.3 0.4 2.4 0.8 1.8 0.6 0.3 2.1 1.8 0.3 1.4 2.4 0.4 0.0 1.4 0.1 0.0 2.0 0.2 3.3 1.7 4.3 6.3 0.0 0.0 8.1 8.5 11.2 0.0 0.0 3.4 1.5 1.8 3.5 0.1 1.3 5.1 0.0 0.0 0.0 4.5 6.2 1.1 3.9 2.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 4.4 0.0 3.5 2.9 0.5 0.0 3.9 1.4 1.6 4.5 2.4 4.8 3.1 5.4 1.5 0.0 4.5 5.3 7.4 3.9 6.0 5.7 4.8 2.7 3.2 3.3 5.1 4.4 6.4 2.1 3.3 1.2 2.0 5.4 4.8 3.5 0.8 0.1 1.4 0.1 0.0 0.3 0.2 1.1 0.4 0.0 0.4 0.1 2.0 0.0 0.0 0.1 0.0 0.1 0.2 1.2 2.7 0.9 4.1 1.3 1.5 0.5 1.9 0.5 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 ALX4 "FPP, KIAA1788, PFM, PFM2" ENSG00000052850 "ALX homeobox 4" Q9H161 11 44260444-44310166 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 10.5;retina: 14.4" "Group enriched" "Detected in some" 15 "Cardiomyocytes: 17.1;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.4;BJ: 4.5;HAP1: 6.3;HEK 293: 6.5;HEL: 8.8;K-562: 4.1;SiHa: 9.4" "Region enriched" "Detected in single" 8 "olfactory region: 11.1" "Region enriched" "Detected in single" 34 "olfactory region: 27.7" HPA001903 Supported Nucleoplasm NA NA Nucleoplasm "HPA001903: AB_2666495" "unprognostic (7.56e-5)" "unprognostic (1.69e-1)" "unprognostic (5.40e-2)" "unprognostic (2.74e-1)" "unprognostic (7.24e-3)" "unprognostic (2.63e-4)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-4)" "unprognostic (5.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.55e-1)" "unprognostic (1.34e-6)" "unprognostic (3.62e-2)" "unprognostic (2.85e-1)" "unprognostic (2.02e-3)" "unprognostic (2.03e-1)" 1.6 0.1 0.6 0.0 1.6 0.0 10.5 0.7 1.6 2.0 0.1 1.4 0.0 0.0 2.4 2.4 0.5 0.8 0.3 0.9 1.3 0.7 0.3 0.0 0.5 0.0 0.4 2.2 0.2 0.1 0.2 0.3 0.0 0.3 2.0 0.0 14.4 5.6 0.1 3.1 2.8 0.0 1.1 0.2 0.1 0.1 2.5 0.5 0.0 0.4 4.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 0.0 4.5 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.3 0.0 0.0 1.3 6.5 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.7 1.6 1.3 0.7 0.4 2.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986178-34008108 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.0;liver: 63.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2" "Cancer enhanced" "Detected in all" "prostate cancer: 34.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 59.8;U-266/84: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" NA NA 65000 "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favorable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 2.8 8.3 5.2 2.7 8.2 0.9 2.8 4.7 7.8 4.4 14.1 4.3 6.5 6.2 4.0 3.6 8.2 2.3 11.0 3.5 4.5 6.8 68.0 63.6 3.3 2.0 4.5 4.5 2.9 5.1 5.4 4.3 3.2 7.0 13.9 15.5 5.5 25.4 5.4 6.0 2.6 7.4 3.7 3.8 2.9 15.9 2.1 2.1 3.8 3.3 3.4 3.3 5.7 4.5 7.8 10.2 11.2 14.2 9.9 10.0 6.8 4.1 6.6 3.7 4.8 2.6 4.1 6.4 5.5 4.1 2.5 1.9 21.6 5.0 1.3 2.9 7.8 9.7 1.9 0.9 4.0 2.6 4.1 3.5 3.1 4.8 6.2 1.8 1.9 1.0 6.2 2.0 3.3 1.2 3.6 2.8 2.7 1.2 4.9 7.5 3.0 1.6 2.4 3.3 3.0 10.8 1.9 6.3 2.1 11.3 20.7 2.1 2.9 9.1 6.5 5.5 3.2 5.0 1.9 5.2 8.4 1.9 2.1 4.4 59.8 31.1 2.4 2.4 3.9 6.2 0.3 7.1 10.2 10.0 8.8 8.4 7.8 8.7 7.8 10.2 7.0 8.1 6.1 11.2 9.9 14.2 5.3 8.9 6.8 5.2 8.2 4.7 7.8 4.5 6.8 4.5 4.5 7.0 2.1 3.0 2.6 0.0 0.4 0.3 3.3 0.9 7.6 4.0 5.7 1.8 0.0 0.9 5.0 0.7 8.1 0.8 5.0 0.0 3.3 0.9 1.1 0.6 0.0 17.8 0.9 4.8 4.1 1.3 1.2 18.9 0.6 0.8 0.0 1.8 4.5 10.6 2.4 3.5 2.1 33.2 0.8 0.0 0.5 0.7 0.7 0.5 0.2 0.8 4.0 0.3 AMBN ENSG00000178522 Ameloblastin Q9NP70 4 70592256-70607288 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "cervical cancer: 2.6;endometrial cancer: 2.9" "Region enriched" "Detected in some" 5 "basal ganglia: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HEK 293: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036099 Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "HPA036099: " "unprognostic (3.22e-1)" 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.1 0.0 1.2 0.2 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 0.0 2.0 0.0 0.4 0.1 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMBP "EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI" ENSG00000106927 "Alpha-1-microglobulin/bikunin precursor" P02760 9 114060127-114078472 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "liver: 592.2" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 9824.4" "Cancer enriched" "Detected in many" 115 "liver cancer: 2620.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 154 "Hep G2: 168.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001497, CAB069436, HPA075585" Approved Approved "Golgi apparatus,Vesicles,Cytosol" "Secreted to blood" NA NA 71000000000 Vesicles "Golgi apparatus, Cytosol" "CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: " "unprognostic (6.92e-2)" "unprognostic (3.61e-1)" "unprognostic (4.95e-3)" "prognostic favorable (1.20e-4)" "unprognostic (9.79e-2)" "unprognostic (2.90e-1)" "unprognostic (1.04e-3)" "unprognostic (7.59e-2)" "unprognostic (2.83e-2)" "unprognostic (2.04e-1)" "unprognostic (2.14e-1)" "unprognostic (7.84e-2)" "unprognostic (4.36e-2)" "unprognostic (2.89e-3)" "unprognostic (4.66e-2)" "unprognostic (2.97e-3)" "unprognostic (9.45e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.8 0.1 0.0 0.0 1.7 592.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 168.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.0 0.8 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 42.0 0.6 1.3 0.0 0.0 2035.7 0.0 1.2 1.8 0.0 0.0 3.3 105.1 19.2 0.0 0.4 256.9 25.3 0.3 0.1 0.4 0.0 9824.4 0.7 0.0 2.4 175.6 182.3 40.5 0.6 0.0 0.0 6.4 0.9 0.0 22.8 1.1 0.0 9.9 0.0 0.0 0.0 0.2 0.1 0.4 1.1 3.8 1.0 0.3 AMD1 SAMDC ENSG00000123505 "Adenosylmethionine decarboxylase 1" P17707 6 110874770-110895713 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 104.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029281, HPA029282" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029281: AB_10600101, HPA029282: AB_10599965" "prognostic unfavorable (3.87e-4)" "unprognostic (4.68e-2)" "unprognostic (1.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.91e-6)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (6.50e-2)" "unprognostic (2.25e-1)" "unprognostic (4.20e-1)" "prognostic favorable (4.28e-4)" "unprognostic (8.62e-3)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (7.71e-2)" 16.7 15.2 29.7 16.9 35.6 38.1 17.8 27.3 34.2 18.6 18.6 45.7 12.5 14.9 18.9 14.2 28.9 14.7 17.5 18.5 32.5 21.5 25.2 16.9 16.9 18.5 39.0 22.0 16.9 20.2 21.8 26.2 33.8 32.7 104.7 19.4 12.8 17.5 19.2 15.3 14.5 13.5 18.4 38.3 16.7 18.4 15.8 46.0 19.4 25.5 20.1 24.6 12.6 16.8 6.6 12.9 42.0 14.0 6.1 9.2 6.5 20.8 14.3 17.5 33.1 26.5 16.9 22.9 30.1 33.4 23.5 27.7 22.7 13.2 36.9 14.6 19.0 25.0 14.4 41.3 27.2 32.4 21.6 23.9 38.2 13.0 23.8 15.8 32.9 22.9 11.3 25.2 16.2 32.8 8.2 20.4 19.0 28.5 32.2 39.5 12.6 43.7 25.3 21.5 20.8 13.1 24.1 17.6 21.9 26.6 28.0 22.5 16.0 18.3 23.3 26.5 14.9 15.0 28.2 13.4 15.6 11.8 83.0 32.4 8.8 14.3 37.7 18.0 26.4 20.0 15.0 9.8 14.7 7.6 11.6 8.9 6.3 7.6 8.7 12.9 6.6 9.2 9.0 42.0 6.1 14.0 5.8 8.8 6.5 29.7 35.6 27.3 34.2 32.5 21.5 39.0 22.0 32.7 46.0 35.7 72.7 96.8 225.1 280.1 92.0 87.2 86.6 30.8 108.1 52.4 56.9 32.2 124.3 65.9 25.2 75.1 78.4 70.0 59.9 125.5 124.4 304.0 93.3 52.5 68.2 73.1 119.2 47.9 101.7 37.7 40.6 70.6 124.9 74.9 52.0 241.3 72.3 49.3 47.0 70.8 99.1 19.4 119.5 83.5 72.8 251.9 45.7 59.8 63.1 119.5 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943293-95968716 "Enzymes, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 99.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 125.2" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" No NA 410000 Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.1 5.7 0.5 2.4 0.8 2.0 0.9 0.5 1.3 0.7 0.7 0.6 0.4 1.9 0.9 0.5 0.8 0.5 0.7 1.1 0.6 0.5 4.4 99.0 1.3 1.4 0.5 0.4 0.7 1.1 0.0 1.2 0.6 1.0 0.7 0.0 0.8 1.3 0.7 11.3 2.2 1.9 0.6 0.6 2.9 1.9 6.2 0.5 0.7 0.6 0.7 0.7 0.8 0.9 1.5 1.2 3.7 3.8 5.7 1.6 1.4 19.5 4.3 0.3 2.8 0.1 0.0 4.4 0.6 0.2 0.3 0.6 1.9 2.5 1.7 1.9 0.0 1.1 3.7 0.1 0.0 0.1 6.8 0.7 1.9 3.0 3.8 0.0 2.5 21.5 0.0 0.1 0.3 0.0 0.1 0.1 1.7 1.3 26.6 0.0 3.0 1.6 4.8 2.0 0.7 1.0 3.5 0.1 2.2 0.0 1.8 2.2 3.2 17.8 20.0 2.3 0.0 2.1 3.6 0.0 2.8 9.7 3.5 2.4 21.5 25.2 2.7 1.9 5.2 3.1 0.3 1.6 3.7 1.2 1.4 1.1 1.5 0.6 1.6 1.2 1.0 1.0 1.1 1.2 5.7 3.8 0.6 0.3 1.4 0.5 0.8 0.5 0.6 0.6 0.5 0.5 0.4 1.0 0.5 0.0 0.3 2.2 0.2 0.3 0.0 0.4 0.0 0.0 1.2 3.5 0.0 0.5 3.3 0.1 0.6 0.3 0.0 0.0 1.0 0.1 0.3 0.0 0.0 125.2 4.1 1.6 1.7 11.1 3.7 0.0 0.3 1.1 3.3 0.0 0.0 1.9 0.3 0.0 0.0 23.2 0.0 0.0 0.0 1.2 1.9 0.3 0.2 2.9 0.0 0.1 AMELX "AIH1, AMG" ENSG00000125363 "Amelogenin, X-linked" Q99217 X 11293413-11300761 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.9" "Region enhanced" "Detected in single" "amygdala: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.1;OE19: 1.5" "Secreted in other tissues" NA NA "unprognostic (1.76e-1)" "unprognostic (1.00e-1)" "unprognostic (2.00e-1)" 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.3 3.5 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.6 0.5 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMELY AMGL ENSG00000099721 "Amelogenin, Y-linked" Q99218 Y 6865918-6874027 "Predicted secreted proteins" Biomineralization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.2;prostate: 1.2;thyroid gland: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 1.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AMER2 "FAM123A, FLJ25477" ENSG00000165566 "APC membrane recruitment protein 2" Q8N7J2 13 25161684-25172288 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 57.0" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 86.8;Cone photoreceptor cells: 76.6;Horizontal cells: 144.6;Muller glia cells: 354.7;Rod photoreceptor cells: 96.7" "Cancer enriched" "Detected in single" 24 "glioma: 4.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AF22: 5.9;SCLC-21H: 5.0;SuSa: 4.3;U-266/70: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039458 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA039458: AB_10795677" "unprognostic (1.69e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-3)" "unprognostic (2.32e-1)" "unprognostic (3.00e-3)" "unprognostic (5.00e-3)" "unprognostic (7.28e-2)" "unprognostic (2.34e-2)" "unprognostic (5.90e-4)" "unprognostic (1.60e-2)" "unprognostic (1.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (1.34e-1)" 1.2 1.4 15.5 1.2 33.5 1.2 1.2 11.7 57.0 1.2 1.2 24.7 0.0 1.2 1.2 1.2 1.2 2.2 1.2 1.2 19.9 9.7 1.2 1.2 1.2 1.2 41.9 9.2 1.2 1.2 1.1 1.6 1.2 15.8 1.4 1.2 0.0 1.2 1.5 1.4 1.3 1.2 1.2 15.9 1.2 1.2 2.0 47.8 0.0 1.2 0.0 1.2 1.2 0.0 0.4 0.4 1.1 0.4 0.7 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.4 0.0 0.2 0.0 0.1 1.1 0.3 0.2 0.2 0.3 0.3 0.3 0.2 0.2 0.1 0.4 0.3 0.3 0.9 0.7 0.4 0.4 0.3 0.0 15.5 33.5 11.7 20.9 19.9 9.7 41.9 9.2 15.8 47.8 0.0 0.0 0.0 0.0 0.1 86.8 0.8 0.0 0.0 0.0 0.0 76.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 144.6 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 354.7 0.0 0.0 0.0 0.0 96.7 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.1 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755435-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.1" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 6.2;Horizontal cells: 3.2;Intestinal endocrine cells: 14.6;Rod photoreceptor cells: 5.0" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 30.1" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: AB_2682423" "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.5 2.4 4.8 0.7 6.0 0.8 0.5 30.1 13.9 0.5 0.8 0.0 0.0 2.0 0.6 0.5 0.5 0.5 0.5 0.5 2.7 4.3 0.5 0.5 0.5 0.6 1.8 5.6 0.6 3.3 0.4 3.4 0.5 3.0 0.6 0.8 0.7 0.5 0.5 0.5 0.7 1.2 0.5 0.8 0.6 2.5 1.6 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.3 0.3 1.5 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.1 0.2 1.5 0.2 0.1 0.3 0.1 0.0 4.8 6.0 30.1 10.3 2.7 4.3 1.8 5.6 3.0 0.7 0.0 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 14.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AMH MIS ENSG00000104899 "Anti-Mullerian hormone" P03971 19 2249309-2252073 "Disease related genes, Predicted secreted proteins" "Differentiation, Gonadal differentiation" "Growth factor" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 14.3;Horizontal cells: 7.9;Late spermatids: 6.0;Muller glia cells: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 17.8;NTERA-2: 6.8;REH: 7.1;SH-SY5Y: 8.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA066973 Approved Vesicles,Aggresome "Secreted to blood" NA NA 56000 "Vesicles, Aggresome" "HPA066973: AB_2732754" "unprognostic (8.10e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.21e-5)" "unprognostic (8.73e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (8.03e-2)" "unprognostic (8.99e-2)" "unprognostic (2.55e-1)" "unprognostic (3.53e-1)" "unprognostic (5.95e-3)" "unprognostic (1.34e-2)" "unprognostic (8.73e-8)" "unprognostic (4.64e-2)" "unprognostic (4.14e-2)" "unprognostic (2.15e-1)" "unprognostic (2.76e-1)" 0.3 0.2 1.0 0.3 2.8 0.3 0.3 4.8 1.4 0.3 0.5 0.3 0.3 0.2 0.4 0.6 0.3 0.2 0.3 0.3 0.5 1.3 0.3 0.3 0.4 0.5 0.3 0.3 1.1 0.7 0.2 3.5 0.4 0.3 0.3 0.2 0.3 0.3 0.3 2.6 0.4 0.6 0.3 0.3 0.5 0.6 35.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.1 0.4 0.0 0.0 4.5 0.7 0.0 0.0 0.0 0.1 0.2 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 17.8 0.1 0.6 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.6 0.5 0.0 0.5 0.1 1.3 6.8 0.0 1.6 7.1 1.5 0.9 0.0 0.2 0.5 8.2 0.1 0.0 1.5 0.0 0.9 0.0 0.8 0.6 1.4 0.9 2.5 5.0 3.6 0.8 0.3 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 4.8 1.4 0.5 1.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.1 14.3 0.8 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.3 0.6 0.1 0.5 0.0 0.2 0.2 0.4 0.1 0.0 0.2 0.1 7.9 1.2 0.6 0.0 6.0 1.4 0.0 0.0 0.0 0.7 7.2 0.0 0.0 0.4 0.2 2.2 0.0 0.1 0.5 0.4 0.1 0.0 0.0 0.6 0.1 AMHR2 "MISR2, MISRII" ENSG00000135409 "Anti-Mullerian hormone receptor type 2" Q16671 12 53423855-53431534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.1;ovary: 38.2;testis: 15.2" "Group enriched" "Detected in some" 4 "granulocytes: 25.4;Ito cells: 12.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HEL: 28.3;K-562: 15.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "hippocampal formation: 14.3" "HPA060228, HPA069636" Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA060228: AB_2684227, HPA069636: AB_2686163" "unprognostic (5.79e-2)" "unprognostic (3.65e-1)" "unprognostic (3.98e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-3)" "unprognostic (2.33e-1)" "unprognostic (1.44e-2)" "unprognostic (2.91e-1)" "unprognostic (4.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.32e-1)" "unprognostic (2.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.97e-1)" 0.3 27.1 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.6 0.4 0.2 0.4 0.8 0.2 0.0 0.2 1.1 0.3 0.2 0.2 0.2 38.2 8.8 0.1 0.2 0.2 0.3 0.4 0.0 0.2 0.2 0.2 2.5 0.0 0.4 0.5 0.2 3.7 0.3 15.2 0.2 0.2 0.2 0.5 0.3 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 28.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 25.4 0.0 0.1 0.0 0.0 12.3 2.2 1.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 3.9 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504175-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 27.9;Rod photoreceptor cells: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5" "Group enriched" "Detected in many" 21 "NK-cells: 1.9;T-cells: 5.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.6;SK-BR-3: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA046152: AB_2679559" "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 5.3 14.8 11.8 3.7 19.1 1.0 4.7 23.4 33.9 4.8 6.6 4.8 4.0 3.2 5.7 16.4 4.1 4.9 4.3 11.0 12.2 14.3 7.6 3.5 6.4 5.2 9.9 15.0 12.8 9.2 21.1 8.1 3.0 15.6 9.2 3.7 10.3 9.6 11.1 22.4 3.3 4.1 6.5 6.0 4.6 5.0 4.1 5.3 1.7 9.1 1.9 4.6 4.5 3.8 0.1 0.0 0.0 0.1 1.9 5.4 0.9 2.6 1.2 2.7 9.5 3.6 1.5 3.4 4.4 2.2 5.1 2.4 0.5 0.1 0.2 1.2 2.8 1.2 1.4 7.3 0.3 4.3 1.0 0.6 0.0 1.7 0.8 2.9 2.1 5.4 0.7 3.2 1.7 0.0 0.5 1.2 1.5 2.1 0.0 0.1 4.4 0.4 4.4 1.7 2.2 3.0 0.7 0.0 0.4 5.9 1.3 9.6 3.2 1.0 12.6 3.5 1.2 3.6 3.1 1.1 0.2 5.9 3.4 1.8 0.2 0.0 0.0 1.9 0.0 2.7 0.0 0.0 0.0 1.5 0.1 1.6 0.1 2.2 2.5 0.0 0.0 5.4 3.9 0.0 1.9 0.0 0.0 1.5 0.9 11.8 19.1 23.4 33.9 12.2 14.3 9.9 15.0 15.6 5.3 3.0 1.3 0.0 0.4 0.6 27.9 6.7 2.5 0.0 0.0 3.5 3.9 1.0 0.0 1.0 0.0 0.8 1.0 0.0 0.8 0.1 0.6 1.1 0.0 0.8 0.2 4.8 4.6 0.6 0.0 0.0 2.0 0.0 0.0 1.0 0.7 7.1 0.7 0.9 5.3 0.5 8.8 0.0 1.0 0.7 0.9 0.4 0.2 0.0 1.5 0.3 AMIGO2 "ALI1, DEGA" ENSG00000139211 "Adhesion molecule with Ig like domain 2" Q86SJ2 12 47075707-47079951 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 58.0;Ito cells: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054004, HPA059601" Uncertain Approved "Golgi apparatus,Plasma membrane,Cytosol" NA Yes 160000 "Golgi apparatus, Plasma membrane" Cytosol "HPA054004: AB_2682339, HPA059601: AB_2684078" "unprognostic (2.63e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" "unprognostic (3.91e-2)" "unprognostic (3.86e-1)" "unprognostic (1.07e-2)" "unprognostic (3.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-1)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (2.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-2)" "unprognostic (2.95e-1)" "unprognostic (7.47e-2)" "unprognostic (2.29e-3)" 5.6 11.9 5.4 4.0 8.8 1.4 14.5 1.6 6.5 18.3 20.3 3.5 1.9 1.6 19.7 12.4 3.1 21.2 12.4 3.4 2.7 7.5 4.3 2.9 11.9 6.7 2.9 5.1 43.4 2.3 2.0 9.5 7.6 16.2 12.8 5.6 6.7 3.1 7.1 1.5 2.3 7.1 21.0 3.0 9.8 3.5 13.1 3.6 1.6 2.5 4.1 4.5 16.6 15.1 2.8 7.4 0.1 0.2 6.6 14.2 4.3 9.0 22.5 1.4 0.0 0.5 0.0 3.7 3.1 8.5 1.0 0.8 0.0 40.9 0.0 10.3 39.3 25.8 13.6 0.0 25.1 1.2 1.7 0.1 0.0 2.2 0.0 0.8 0.2 0.3 0.2 4.4 26.9 13.3 69.7 3.2 0.2 1.7 0.0 39.3 0.4 0.7 0.0 0.9 4.5 5.7 0.0 10.1 0.0 11.6 53.8 4.1 0.0 16.2 1.9 0.1 0.8 2.4 0.2 0.8 0.5 32.6 0.3 25.1 0.3 0.0 0.0 2.1 0.7 0.6 0.0 0.1 0.0 4.0 0.2 5.4 2.8 6.2 6.2 0.6 1.3 14.2 11.1 0.1 6.6 0.0 7.4 3.6 4.3 5.4 8.8 1.6 6.5 2.7 7.5 2.9 5.1 16.2 3.6 8.9 1.9 5.9 10.4 2.2 21.1 0.8 0.0 2.7 6.8 1.8 0.0 0.7 1.7 4.3 1.2 4.5 0.0 0.0 17.0 23.1 6.7 5.2 6.9 0.8 4.4 0.0 58.0 30.7 3.8 0.9 2.3 2.3 1.7 8.2 2.5 14.9 26.7 0.8 0.7 0.0 4.1 0.0 25.5 0.3 0.7 0.4 7.1 4.4 0.2 13.4 AMMECR1L MGC4268 ENSG00000144233 "AMMECR1 like" Q6DCA0 2 127861630-127885922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "retina: 45.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000590, HPA057234" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA000590: AB_2666037, HPA057234: AB_2683376" "unprognostic (1.34e-1)" "unprognostic (1.29e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.92e-1)" "unprognostic (9.10e-2)" "unprognostic (2.66e-2)" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-2)" "unprognostic (2.27e-2)" "unprognostic (4.06e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-1)" "unprognostic (1.12e-2)" "unprognostic (8.91e-2)" 7.8 6.4 5.2 5.2 5.2 5.0 7.1 5.7 5.2 7.6 5.5 5.2 5.2 4.6 8.7 5.2 6.4 6.9 5.9 5.2 5.2 3.3 5.2 7.7 5.6 5.2 5.2 5.2 7.6 8.8 7.6 5.2 7.3 5.2 6.4 5.7 45.9 5.9 5.2 5.2 7.2 5.8 7.5 5.2 6.8 6.1 7.9 5.2 5.2 6.1 5.2 5.4 5.8 7.3 4.2 5.4 9.0 3.7 3.5 6.1 3.2 12.3 8.3 17.1 14.0 16.2 13.2 16.2 14.6 13.3 16.1 14.6 18.4 9.3 12.1 9.8 14.4 7.6 12.3 16.5 12.2 17.8 14.2 12.1 15.2 12.3 10.4 19.4 15.1 15.7 14.6 26.7 19.8 26.7 15.5 16.9 12.4 13.9 12.1 13.0 8.7 14.0 14.6 13.5 9.5 15.3 14.8 13.7 6.8 12.8 10.8 11.3 12.8 12.1 18.9 29.4 14.6 8.8 10.5 16.7 20.0 18.7 9.3 11.0 10.2 15.0 12.4 9.6 9.7 13.2 1.6 3.2 9.0 4.7 3.7 6.1 3.6 4.5 4.1 4.8 4.2 4.1 3.8 4.3 3.5 3.7 5.4 4.2 3.2 5.2 5.2 5.7 5.2 5.2 3.3 5.2 5.2 5.2 5.2 17.9 7.2 8.2 7.4 16.0 5.1 11.2 7.6 18.7 11.4 3.5 5.9 4.4 0.0 5.2 10.1 6.7 6.3 0.0 4.9 5.8 11.0 10.9 6.9 14.3 3.9 1.6 5.2 8.0 6.6 12.4 6.4 6.1 5.0 1.8 11.6 4.3 7.3 7.0 7.8 4.1 5.5 0.0 8.0 6.3 10.4 13.8 6.4 2.5 9.1 12.5 AMN amnionless ENSG00000166126 "Amnion associated transmembrane protein" Q9BXJ7 14 102922656-102933596 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 97.6" "Cell type enhanced" "Detected in many" 23 "Enterocytes: 1194.2;Paneth cells: 312.1;Proximal tubular cells: 301.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 11.2;Hep G2: 11.0;U-698: 5.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000817 Approved NA NA "HPA000817: AB_1078146" "unprognostic (2.02e-2)" "unprognostic (1.67e-1)" "unprognostic (3.94e-3)" "unprognostic (7.39e-3)" "unprognostic (9.32e-2)" "unprognostic (1.88e-3)" "unprognostic (8.68e-2)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (2.97e-2)" "unprognostic (7.57e-2)" "unprognostic (2.43e-2)" "prognostic favorable (9.62e-5)" "unprognostic (8.02e-2)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" 0.4 0.0 0.1 3.3 0.1 0.0 0.7 0.1 0.1 0.6 44.3 0.1 0.2 19.3 0.2 3.1 2.6 0.6 10.4 0.2 0.1 0.0 17.2 17.8 1.8 0.5 0.1 0.0 0.1 0.2 0.0 0.4 0.2 0.1 0.4 2.1 0.2 0.7 0.0 0.0 0.9 97.6 0.1 0.0 0.6 3.9 0.3 0.1 0.7 0.7 0.1 1.1 0.5 1.0 0.3 1.8 0.0 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 11.2 0.3 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.2 0.0 0.8 11.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.2 1.0 1.6 0.2 1.2 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.7 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.0 0.0 0.2 0.0 1.0 0.6 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.3 0.7 0.6 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 8.9 0.3 7.8 16.6 11.8 2.6 1.0 94.3 2.7 4.5 19.2 0.0 2.5 28.2 1.6 3.6 0.3 1194.2 0.0 0.6 2.9 0.9 12.4 4.6 44.8 0.6 1.6 18.4 0.6 0.6 4.3 0.6 0.2 6.8 0.0 201.5 0.1 6.5 312.1 0.7 301.0 1.2 0.0 0.5 10.0 13.4 18.2 1.1 1.0 192.4 65.0 AMN1 ENSG00000151743 "Antagonist of mitotic exit network 1 homolog" Q8IY45 12 31671137-31729174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.5" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 268.2;Late spermatids: 111.1;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 27.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046157, HPA062290" Approved Approved Centrosome NA NA Centrosome "HPA046157: AB_10965846, HPA062290: AB_2684739" "unprognostic (2.11e-2)" "unprognostic (2.52e-1)" "unprognostic (3.36e-1)" "unprognostic (2.60e-1)" "unprognostic (2.80e-1)" "unprognostic (5.93e-2)" "unprognostic (8.60e-3)" "unprognostic (4.08e-2)" "unprognostic (6.48e-2)" "unprognostic (3.01e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-2)" "unprognostic (2.48e-1)" "unprognostic (4.74e-2)" "unprognostic (1.38e-1)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" 5.3 9.9 24.8 6.1 20.9 3.1 9.0 13.8 28.3 9.6 4.3 11.1 2.9 3.8 10.8 7.9 6.0 17.0 6.9 10.1 22.4 20.9 11.3 5.8 6.5 10.3 19.6 15.2 16.0 8.2 8.5 16.1 5.4 14.8 8.9 4.3 8.9 5.9 7.8 12.8 5.4 4.1 7.3 19.4 8.4 8.4 46.5 16.2 11.7 7.9 4.2 9.0 7.7 5.5 12.3 6.6 27.4 2.7 4.7 9.8 3.4 3.5 7.7 6.3 0.7 6.1 7.9 3.7 3.7 5.8 2.6 5.1 4.0 14.1 1.8 8.5 3.3 20.1 2.0 2.9 4.4 5.4 3.0 3.7 6.2 2.8 5.7 11.0 3.3 3.2 5.2 7.3 4.5 6.4 20.1 14.9 9.6 5.4 5.8 10.0 2.2 1.8 2.6 8.7 7.7 3.7 2.7 10.1 2.9 6.0 8.0 10.1 8.4 4.9 1.3 7.7 14.3 11.9 3.7 8.4 4.5 3.7 3.7 6.8 6.4 6.1 6.3 5.6 3.1 8.4 4.3 2.7 3.3 4.3 1.9 4.3 12.3 4.5 4.6 2.1 11.5 9.8 5.9 27.4 4.7 1.6 6.6 6.7 3.4 24.8 20.9 13.8 28.3 22.4 20.9 19.6 15.2 14.8 16.2 6.0 2.4 19.9 18.4 8.2 10.7 3.1 5.1 13.4 5.7 15.7 25.5 5.7 23.2 7.9 268.2 9.8 2.0 0.0 6.2 4.6 7.4 13.9 7.0 3.2 7.6 28.6 13.8 7.4 6.9 111.1 9.5 4.8 15.1 2.8 1.7 10.1 9.1 0.0 12.7 7.9 40.5 0.0 12.3 84.7 16.4 11.0 6.1 7.5 2.0 23.5 AMOT KIAA1071 ENSG00000126016 Angiomotin Q4VCS5 X 112774503-112840815 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.0;epididymis: 102.0" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 27.9;Cytotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 15.6;HAP1: 16.7;OE19: 13.4;SuSa: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067290, HPA067853" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA067290: AB_2685819, HPA067853: AB_2732773" "unprognostic (1.08e-2)" "unprognostic (5.51e-2)" "unprognostic (2.38e-2)" "unprognostic (3.36e-1)" "unprognostic (3.20e-1)" "unprognostic (8.95e-2)" "unprognostic (3.82e-2)" "prognostic favorable (3.94e-4)" "unprognostic (4.46e-2)" "unprognostic (3.79e-1)" "unprognostic (2.17e-1)" "unprognostic (5.60e-2)" "prognostic favorable (4.21e-9)" "unprognostic (9.54e-2)" "unprognostic (2.59e-2)" "unprognostic (4.50e-2)" "unprognostic (6.44e-2)" 3.7 2.3 18.4 2.0 17.9 1.3 5.5 3.0 14.0 8.1 3.5 13.9 40.0 3.1 4.7 102.0 3.8 9.7 3.1 3.7 15.4 10.9 8.2 2.5 3.0 1.6 14.4 10.3 5.4 2.7 8.4 7.0 14.9 18.0 5.6 4.3 1.2 6.9 27.6 25.2 2.7 3.6 3.5 15.7 2.1 3.3 2.7 13.5 0.1 3.8 9.3 1.8 3.2 4.3 0.5 0.2 0.0 0.6 1.9 1.5 0.2 2.7 0.0 15.6 0.6 0.3 0.3 5.7 0.5 0.0 0.0 0.0 6.5 0.5 0.3 3.2 2.4 0.0 5.6 16.7 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.0 3.5 0.4 3.2 0.1 0.3 0.0 0.0 0.3 0.2 4.2 0.2 6.9 13.4 0.1 5.4 4.8 0.1 7.2 7.1 0.0 5.3 0.0 0.0 6.0 24.5 0.5 0.1 0.1 1.9 4.6 0.0 6.2 0.4 0.0 0.0 0.7 0.0 4.0 0.0 0.0 0.0 1.1 0.4 1.5 0.5 0.7 1.0 0.2 0.2 0.7 0.6 0.0 1.9 0.6 0.2 1.0 0.2 18.4 17.9 3.0 14.0 15.4 10.9 14.4 10.3 18.0 13.5 3.0 1.3 0.0 2.1 1.5 1.0 1.2 0.0 8.1 6.8 27.9 0.0 35.2 1.7 3.4 0.1 3.0 4.6 0.0 1.8 2.6 3.8 8.2 0.0 3.6 5.2 0.0 15.2 3.7 1.5 0.0 6.4 0.6 3.3 2.8 9.2 4.5 2.2 3.5 6.0 14.4 0.4 6.5 3.1 0.5 2.1 1.0 13.3 0.0 6.3 2.2 AMOTL1 JEAP ENSG00000166025 "Angiomotin like 1" Q8IY63 11 94706431-94876753 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 78.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3;NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 36.6;WM-115: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001196 Approved Approved "Cell Junctions,Cytosol" NA NA 11000 Cytosol "Cell Junctions" "HPA001196: AB_1078147" "unprognostic (2.21e-1)" "unprognostic (5.25e-2)" "unprognostic (4.23e-2)" "unprognostic (5.43e-2)" "unprognostic (7.58e-2)" "unprognostic (3.29e-2)" "unprognostic (1.05e-1)" "unprognostic (2.40e-1)" "unprognostic (2.09e-1)" "unprognostic (7.97e-2)" "unprognostic (1.85e-1)" "unprognostic (5.95e-2)" "prognostic favorable (5.03e-6)" "unprognostic (7.47e-3)" "unprognostic (1.39e-1)" "unprognostic (1.68e-2)" "unprognostic (1.29e-2)" 14.4 5.7 3.3 6.9 4.0 0.6 9.2 3.7 4.8 12.8 15.4 2.7 9.1 2.2 16.4 11.4 19.3 7.5 10.9 10.1 3.1 3.9 4.4 4.8 10.0 2.5 3.2 2.5 7.3 10.8 13.5 13.9 25.4 3.5 18.7 4.0 11.3 8.9 13.6 78.2 11.7 4.8 32.8 2.6 6.2 8.1 7.1 1.8 12.9 8.6 21.9 10.1 24.4 9.5 2.3 1.0 0.0 0.7 2.3 0.1 0.5 18.3 5.2 14.0 0.0 15.1 13.2 6.7 10.2 17.8 4.7 5.5 9.6 0.5 0.8 5.0 13.8 3.8 23.9 6.6 36.6 4.9 1.4 5.1 9.9 5.4 0.0 3.5 2.1 0.0 7.8 22.7 16.0 26.8 12.1 9.7 3.9 24.9 0.9 11.0 5.3 6.7 1.3 2.1 0.0 3.5 0.0 25.5 1.5 6.6 7.7 10.7 12.9 0.6 14.1 3.6 9.9 0.7 3.1 8.9 12.9 9.5 0.2 7.0 0.5 0.0 5.2 3.6 0.0 35.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.6 2.3 0.0 0.0 0.0 2.3 0.2 1.0 0.0 0.5 3.3 4.0 3.7 3.0 3.1 3.9 3.2 2.5 3.5 1.8 32.8 28.3 0.9 15.3 31.5 1.9 39.3 7.6 5.3 13.6 7.0 3.9 25.5 0.0 14.1 104.0 28.1 0.0 0.0 14.6 12.7 38.7 10.8 2.3 15.3 4.3 14.3 0.0 28.8 4.3 25.4 7.5 4.7 10.1 1.8 0.0 15.0 12.1 0.0 11.7 2.9 1.1 12.9 26.7 17.0 12.7 23.5 23.3 1.5 0.0 6.4 AMPD1 "MAD, MADA" ENSG00000116748 "Adenosine monophosphate deaminase 1" P23109 1 114673090-114695618 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 212.4" "Cell type enhanced" "Detected in some" 19 "Late spermatids: 1.5;Melanocytes: 1.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 31 "memory B-cell: 3.0" "Lineage enriched" "Detected in single" 31 "B-cells: 3.0" "Cell line enriched" "Detected in single" 32 "U-266/70: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026478, HPA028080" Enhanced "Intracellular and membrane" NA NA "HPA026478: AB_10599969, HPA028080: AB_10600776" "unprognostic (1.98e-3)" "unprognostic (1.43e-3)" "unprognostic (8.75e-3)" "unprognostic (8.03e-2)" "unprognostic (1.95e-2)" "unprognostic (5.61e-3)" "unprognostic (8.21e-2)" "unprognostic (4.29e-3)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.36e-5)" "unprognostic (1.68e-1)" "unprognostic (3.70e-1)" "unprognostic (3.36e-1)" "unprognostic (4.02e-1)" 2.9 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.2 3.3 0.0 0.0 3.5 0.1 3.3 1.4 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.6 1.2 0.0 2.1 1.5 212.4 0.1 1.4 0.0 0.1 0.5 0.7 0.1 0.0 0.0 0.2 25.3 2.8 0.2 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMPD2 SPG63 ENSG00000116337 "Adenosine monophosphate deaminase 2" Q01433 1 109616104-109632051 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 64.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 58.9;Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027137, HPA045760, HPA050590" Approved Enhanced Cytosol NA NA 380000 Cytosol "HPA027137: AB_2672129, HPA045760: AB_2679443, HPA050590: AB_2681184" "unprognostic (2.78e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" "unprognostic (9.01e-2)" "unprognostic (5.25e-2)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (4.02e-1)" "unprognostic (1.23e-1)" "unprognostic (8.10e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.78e-10)" "unprognostic (9.16e-2)" "unprognostic (2.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" 8.1 22.7 20.2 21.7 41.3 64.4 4.9 16.3 26.8 9.5 10.1 9.5 6.3 17.1 9.0 6.0 5.9 11.8 13.2 5.2 21.7 19.4 7.8 13.0 8.2 10.7 14.2 14.2 16.3 9.4 13.0 37.1 10.8 18.3 9.7 5.7 15.7 9.1 12.2 2.1 10.0 11.6 9.1 8.5 15.9 8.3 5.3 12.2 10.3 6.4 3.0 7.5 8.2 8.1 2.8 8.8 29.7 24.5 3.0 4.3 5.4 10.9 12.7 18.7 15.8 16.3 16.3 7.1 15.6 31.9 16.0 15.8 9.7 4.7 5.4 12.0 29.2 10.5 8.6 9.8 14.5 9.9 8.7 13.2 28.5 16.7 10.8 15.3 12.1 30.7 18.3 7.7 21.1 16.4 28.9 13.8 11.9 8.8 14.7 11.4 16.9 17.9 29.0 12.1 10.2 13.6 12.7 7.2 8.4 14.7 6.7 14.5 15.3 10.6 13.0 12.6 7.0 7.3 11.3 13.1 19.8 23.0 24.1 16.0 29.5 14.3 7.8 29.5 18.8 20.6 0.5 9.2 11.2 3.4 19.6 4.3 2.8 3.3 3.4 8.8 1.7 3.8 2.8 29.7 3.0 24.5 1.4 2.6 5.4 20.2 41.3 16.3 26.8 21.7 19.4 14.2 14.2 18.3 12.2 3.0 8.5 8.3 4.7 7.9 35.7 2.5 17.8 4.0 5.7 0.0 58.9 4.0 6.6 9.7 2.9 6.2 3.9 0.0 9.6 7.4 11.8 4.5 3.5 17.8 10.5 49.3 16.8 6.2 37.8 1.3 12.0 28.6 5.0 1.0 8.6 9.1 8.3 0.0 20.1 3.9 5.8 12.9 11.7 4.5 2.6 7.0 2.2 10.1 9.7 3.4 AMPD3 ENSG00000133805 "Adenosine monophosphate deaminase 3" Q01432 11 10308313-10507579 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.2;skeletal muscle: 61.0" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.7;CAPAN-2: 19.3;HMC-1: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038662, HPA047408" Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA038662: AB_2676136, HPA047408: AB_2680034" "unprognostic (2.24e-1)" "unprognostic (3.88e-3)" "unprognostic (1.44e-2)" "prognostic favorable (2.37e-4)" "unprognostic (1.89e-2)" "unprognostic (1.71e-3)" "unprognostic (2.91e-3)" "unprognostic (1.25e-1)" "unprognostic (7.83e-2)" "unprognostic (2.26e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-1)" "unprognostic (3.06e-2)" "unprognostic (7.07e-2)" "unprognostic (4.42e-2)" "unprognostic (2.98e-1)" "unprognostic (2.12e-2)" 2.9 13.7 5.3 13.8 14.0 39.2 2.3 2.3 7.8 3.3 3.4 19.6 0.7 4.7 3.1 4.2 5.2 8.0 4.6 2.1 7.4 7.1 4.2 1.5 4.5 12.7 15.2 5.7 2.3 2.5 24.9 14.5 3.7 11.2 5.5 4.9 4.3 4.7 2.8 61.0 10.8 5.0 3.1 12.8 8.3 4.6 1.4 12.6 14.8 2.7 7.6 14.2 6.1 5.1 7.6 3.9 17.0 6.0 3.3 5.3 2.3 7.6 1.1 0.3 0.1 4.1 2.9 0.4 6.9 24.7 1.7 1.8 3.8 19.3 2.8 0.7 3.1 6.8 4.8 0.1 6.5 5.1 6.9 0.2 6.8 1.0 0.5 1.4 9.2 20.5 10.8 10.2 3.4 4.4 4.3 0.7 4.6 10.3 3.0 5.6 0.2 5.4 12.1 0.9 0.6 6.8 2.0 9.0 9.9 0.3 6.5 2.9 1.5 1.5 0.2 0.4 0.6 0.2 3.1 1.9 7.9 0.1 5.4 0.2 2.7 1.5 3.0 9.0 9.2 0.2 6.6 6.0 17.0 2.3 3.8 5.3 7.6 3.3 2.5 3.9 5.8 3.7 2.5 8.3 3.3 1.6 2.5 1.9 2.3 5.3 14.0 2.3 7.8 7.4 7.1 15.2 5.7 11.2 12.6 0.0 4.6 5.2 8.9 11.1 20.7 5.6 7.6 12.0 7.9 14.0 2.0 0.7 14.9 2.4 7.0 1.0 1.7 46.7 1.4 1.1 1.4 17.1 11.5 0.6 13.4 0.0 9.8 1.8 14.3 14.2 0.9 9.1 3.3 13.6 3.2 6.8 3.9 2.9 0.0 1.0 1.3 0.0 1.7 0.2 0.5 10.9 1.0 2.9 2.2 16.1 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631567 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 57.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.7;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 54.5" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 31.2;ASC TERT1: 18.5;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 14.4;GAMG: 21.3;HBF TERT88: 11.1;U-138 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favorable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.8 2.4 17.4 2.5 17.7 1.0 2.8 29.7 57.2 7.7 2.2 1.8 0.0 1.4 5.1 4.7 4.5 5.7 4.2 6.5 13.5 16.0 3.7 1.4 1.6 1.3 10.4 20.4 1.7 2.9 1.2 12.6 1.0 26.5 2.4 2.5 4.8 1.5 4.2 2.9 1.3 1.9 5.0 4.9 1.9 2.0 3.5 1.5 0.0 1.2 0.2 1.1 2.9 1.7 0.2 1.6 0.0 0.8 0.7 2.9 0.2 0.0 0.0 7.9 0.0 31.2 18.5 0.0 1.1 0.0 12.1 14.4 0.0 0.0 0.0 0.0 2.2 21.3 0.0 0.0 0.0 11.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 10.8 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.1 0.0 0.1 4.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 11.8 8.4 4.1 4.5 0.0 0.1 0.0 8.0 0.1 10.6 0.0 0.8 0.0 2.9 0.2 1.7 0.0 1.0 1.5 0.2 0.2 0.4 2.0 0.0 0.7 0.2 1.6 0.2 0.2 17.4 17.7 29.7 32.9 13.5 16.0 10.4 20.4 26.5 1.5 0.0 0.0 0.5 0.1 0.2 53.7 6.3 0.0 0.0 0.0 0.0 82.5 0.0 1.7 0.1 7.7 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.6 0.0 5.5 14.2 10.2 2.6 0.0 0.0 0.0 0.0 4.7 0.1 0.0 4.6 0.0 54.5 6.5 3.0 0.4 3.0 0.3 0.0 0.0 0.0 0.0 AMTN "RSTI689, UNQ689" ENSG00000187689 Amelotin Q6UX39 4 70518540-70532742 "Disease related genes, Predicted secreted proteins" "Biomineralization, Cell adhesion" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 24.6;salivary gland: 12.9;stomach 1: 6.7" "Cell type enhanced" "Detected in some" 14 "Glandular cells: 1.1;Urothelial cells: 1.3" "Group enriched" "Detected in many" 11 "cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 14.9;hTERT-RPE1: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036136, HPA036137" Uncertain "Secreted in other tissues" NA NA "HPA036136: AB_2674963, HPA036137: AB_10673614" "unprognostic (1.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.86e-2)" "unprognostic (7.35e-2)" "unprognostic (2.55e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.8 12.9 0.0 0.0 0.5 0.0 0.0 0.6 0.0 6.7 0.2 0.0 0.0 0.9 0.9 24.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.9 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 21.2 0.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 AMY1A AMY1 ENSG00000237763 "Amylase, alpha 1A (salivary)" P04745 1 103655290-103664554 "Enzymes, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 100 "salivary gland: 654.0" "Cell type enriched" "Detected in some" 11 "Ciliated cells: 38.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;SH-SY5Y: 2.4" "CAB004310, HPA045394, HPA045399, HPA046980" Enhanced "Secreted to digestive system" NA NA 68000000 "CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 654.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.3 0.6 0.0 1.1 0.7 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.6 0.0 0.1 1.1 0.1 0.3 0.1 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.7 3.0 2.1 0.0 0.8 0.6 0.0 2.4 0.0 38.8 3.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 AMY1B AMY1 ENSG00000174876 "Amylase, alpha 1B (salivary)" P04745 1 103687415-103696680 "Enzymes, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "salivary gland: 302.4" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 34.8" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" NA NA 68000000 "HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (7.34e-2)" "unprognostic (2.59e-1)" "unprognostic (6.05e-2)" "unprognostic (6.08e-2)" "unprognostic (1.96e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 6.5 0.2 0.2 0.2 0.0 0.2 0.2 0.2 4.0 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 23.0 0.0 0.2 0.2 0.2 0.2 0.0 0.2 302.4 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.1 0.3 0.3 0.6 0.0 1.1 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.5 1.2 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.2 0.6 0.0 0.1 1.1 0.1 0.3 0.1 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 3.2 0.0 0.1 0.2 0.0 0.7 0.0 34.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 AMY1C AMY1 ENSG00000187733 "Amylase, alpha 1C (salivary)" P04745 1 103750406-103758690 "Enzymes, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 34.3;salivary gland: 62.5" "Group enriched" "Detected in some" 6 "Alveolar cells type 2: 33.4;Ciliated cells: 95.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "THP-1: 3.7" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" NA NA 68000000 "HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 9.6 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 33.4 0.0 0.0 0.0 0.0 0.4 0.0 95.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMY2A AMY2 ENSG00000243480 "Amylase, alpha 2A (pancreatic)" P04746 1 103616811-103625780 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "pancreas: 1849.4" "Cell type enriched" "Detected in some" 68 "Exocrine glandular cells: 849.6" "Cancer enriched" "Detected in single" 2010 "pancreatic cancer: 200.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.0;U-2 OS: 1.3" "HPA045394, HPA045399, CAB045960, HPA046980" Enhanced "Secreted to digestive system" NA NA 77000000 "CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (3.27e-1)" "unprognostic (1.78e-3)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.13e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.9 1849.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 59.9 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 849.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 AMY2B AMY2 ENSG00000240038 "Amylase, alpha 2B (pancreatic)" P19961 1 103553815-103579534 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pancreas: 939.9" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 31.4;Exocrine glandular cells: 124.1" "Cancer enriched" "Detected in many" 15 "pancreatic cancer: 25.1" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "classical monocyte: 8.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.5;EFO-21: 11.8;HSkMC: 7.8" "HPA045394, HPA045399, HPA046980" Supported "Secreted to digestive system" NA NA 75000000 "HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889" "unprognostic (8.69e-4)" "unprognostic (3.71e-3)" "unprognostic (6.41e-2)" "unprognostic (9.75e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-4)" "unprognostic (1.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-1)" "unprognostic (2.49e-2)" "unprognostic (7.41e-3)" "unprognostic (1.55e-2)" "unprognostic (5.74e-2)" "unprognostic (4.22e-1)" "unprognostic (3.12e-4)" 1.7 0.5 0.8 0.8 1.5 0.4 1.0 2.6 0.8 0.9 0.9 0.8 0.8 0.5 0.8 1.0 0.8 1.5 0.9 1.1 0.8 0.5 1.5 1.1 1.0 1.1 1.0 0.9 1.2 939.9 0.8 1.1 0.8 0.8 0.9 0.4 0.9 145.7 1.0 1.7 1.3 0.9 0.8 0.8 1.0 0.4 0.8 0.8 0.8 2.4 1.1 0.8 0.8 0.8 1.8 2.6 1.9 8.5 0.1 1.1 1.9 0.0 0.6 1.3 0.0 6.4 11.5 1.2 0.9 0.9 0.7 1.7 0.0 0.2 1.1 11.8 0.3 0.0 1.4 0.1 1.4 1.6 1.4 1.8 2.1 4.4 0.9 1.0 2.6 2.8 7.8 7.7 0.8 1.3 2.0 0.2 3.3 0.0 3.5 0.9 0.0 2.1 0.5 0.1 0.1 1.6 0.6 0.0 5.1 6.6 2.1 3.2 0.6 2.7 1.3 0.8 2.1 0.1 1.5 0.9 0.4 1.0 0.5 0.7 4.0 0.1 0.3 2.2 2.0 0.2 0.0 8.5 1.7 0.8 3.9 0.6 1.7 0.3 0.4 2.6 1.8 1.1 0.4 1.9 0.1 3.6 0.8 0.3 1.9 0.8 1.5 2.6 0.8 0.8 0.5 1.0 0.9 0.8 0.8 11.9 16.1 3.2 2.8 4.1 10.0 6.9 5.1 17.4 18.2 1.8 31.4 0.3 0.0 0.7 4.8 1.5 3.6 0.0 124.1 0.2 1.4 1.2 3.5 5.9 1.5 9.5 4.7 1.8 7.0 2.3 2.3 3.1 5.0 1.8 2.5 2.4 1.3 1.4 1.8 0.4 16.2 0.0 2.2 1.7 0.6 2.6 0.2 0.8 2.5 0.9 AMZ1 KIAA1950 ENSG00000174945 "Archaelysin family metallopeptidase 1" Q400G9 7 2679522-2775500 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 3.9;Early spermatids: 18.8;Extravillous trophoblasts: 7.0;Late spermatids: 6.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 4.2;naive B-cell: 2.4;T-reg: 1.0" "Group enriched" "Detected in many" 6 "B-cells: 4.2;T-cells: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 6.2;MCF7: 6.4;SK-BR-3: 4.6;T-47d: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020233 Uncertain NA NA "HPA020233: AB_1844818" "unprognostic (9.08e-3)" "unprognostic (1.66e-1)" "unprognostic (3.23e-3)" "unprognostic (1.81e-1)" "unprognostic (5.72e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-2)" "unprognostic (3.42e-1)" "unprognostic (1.98e-1)" "unprognostic (7.16e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (3.64e-9)" "unprognostic (1.60e-3)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" 0.7 0.7 8.4 1.2 7.1 2.0 0.9 1.4 10.0 3.2 0.6 6.5 0.0 0.8 4.0 0.6 0.7 1.4 1.0 0.9 5.9 4.9 0.5 1.2 2.8 1.2 6.0 4.8 1.4 0.8 0.7 1.1 3.6 4.2 0.8 0.7 0.2 0.6 0.6 0.6 0.8 0.6 3.3 3.8 2.0 0.7 1.4 4.4 0.0 0.7 0.0 1.8 0.7 0.7 4.2 0.1 0.4 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 6.2 2.0 3.0 1.4 2.0 0.0 0.8 0.5 0.2 1.9 0.2 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 6.4 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 4.6 0.0 0.1 24.4 0.0 0.0 0.1 0.1 0.1 0.0 0.9 0.2 0.0 0.5 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.0 4.2 0.1 0.0 0.0 2.4 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 8.4 7.1 1.4 8.7 5.9 4.9 6.0 4.8 4.2 4.4 0.0 0.3 0.0 0.1 0.0 0.6 3.2 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 18.8 0.3 0.0 0.0 0.0 7.0 0.4 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.0 0.0 1.5 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 ANG "RAA1, RNASE5" ENSG00000214274 Angiogenin P03950 14 20684177-20698971 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Stress response" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 371.4" "Cell type enriched" "Detected in many" 21 "Hepatocytes: 4646.2" "Cancer enriched" "Detected in all" 17 "liver cancer: 279.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 18.1;myeloid DC: 10.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 52.5;OE19: 40.2" "Low region specificity" "Detected in many" HPA055896 Approved "Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments" "Secreted to blood" Yes No 308000000 230000000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "Actin filaments" "HPA055896: " "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.77e-2)" "prognostic favorable (6.85e-4)" "unprognostic (5.71e-3)" "unprognostic (6.99e-2)" "prognostic favorable (7.83e-5)" "unprognostic (1.16e-1)" "unprognostic (3.20e-3)" "unprognostic (9.19e-3)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (6.65e-2)" "unprognostic (1.03e-1)" "unprognostic (3.39e-1)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" 17.0 0.9 0.7 2.6 0.7 0.7 16.4 0.5 0.7 14.4 9.0 0.7 6.6 3.5 10.7 10.3 8.0 3.8 13.3 3.8 0.8 0.7 10.6 371.4 6.9 2.3 1.0 0.1 17.7 9.0 1.3 1.1 1.9 0.8 17.5 6.5 5.5 20.2 7.7 3.5 4.0 7.4 9.7 1.5 1.5 7.9 7.1 0.4 0.0 4.2 5.5 3.6 14.3 15.0 4.5 10.4 0.3 18.1 0.0 0.9 4.8 1.3 3.4 0.8 0.0 8.6 10.3 0.1 1.4 3.0 0.4 1.4 2.0 1.8 0.1 0.4 4.2 2.9 1.3 0.9 1.0 0.4 5.8 1.3 0.3 1.9 52.5 1.8 1.3 0.1 8.3 0.8 0.5 1.8 4.3 2.0 1.5 0.0 9.6 1.2 0.2 0.2 0.4 0.2 40.2 3.8 0.2 1.3 3.9 0.8 1.0 0.0 0.1 1.5 0.6 2.3 1.9 1.4 0.2 1.7 0.5 1.0 0.5 0.2 2.0 1.6 0.2 1.1 0.6 1.6 0.0 18.1 0.0 0.3 2.1 0.2 4.5 0.9 0.8 10.4 2.4 0.2 0.2 0.3 0.0 0.1 1.6 0.4 4.8 0.7 0.7 0.5 0.6 0.8 0.7 1.0 0.1 0.8 0.4 26.8 12.4 18.0 36.0 24.2 0.0 0.6 219.1 60.2 18.2 10.4 0.0 1.5 10.0 27.6 0.7 12.2 37.1 23.3 27.7 3.3 31.0 52.1 0.0 4646.2 15.9 0.0 68.2 70.0 110.5 1.1 65.9 16.0 21.9 1.0 138.3 9.1 26.8 17.3 22.6 45.5 0.6 12.9 18.6 0.7 1.0 45.8 7.8 12.1 44.2 29.8 ANGPT4 ENSG00000101280 "Angiopoietin 4" Q9Y264 20 869899-916317 "Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.7;breast: 12.3;cervix, uterine: 16.8" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 21.4;Late spermatids: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 40 "ASC diff: 21.6;BEWO: 30.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB013260, CAB013305" Uncertain "Secreted to blood" NA NA "CAB013260: , CAB013305: " "unprognostic (1.77e-1)" "unprognostic (3.25e-1)" "unprognostic (4.30e-2)" "unprognostic (1.04e-3)" "unprognostic (6.37e-2)" "unprognostic (3.41e-1)" "unprognostic (5.82e-4)" "unprognostic (1.25e-1)" "unprognostic (7.10e-2)" "unprognostic (3.66e-4)" "unprognostic (9.01e-2)" "unprognostic (1.71e-1)" "unprognostic (5.25e-2)" "unprognostic (1.23e-2)" "unprognostic (1.55e-1)" "unprognostic (2.95e-4)" "unprognostic (9.14e-2)" 18.7 0.7 0.1 0.1 0.3 0.1 12.3 0.0 0.5 16.8 1.4 0.6 2.1 0.2 7.1 4.9 1.2 3.5 2.5 1.1 0.1 0.3 0.4 0.1 2.6 0.1 0.3 0.0 4.8 0.2 0.1 0.0 0.4 0.3 1.8 0.1 2.4 1.3 2.2 0.2 1.4 0.3 2.6 0.1 0.1 0.4 3.7 0.0 0.0 2.1 1.6 0.4 1.3 2.2 0.3 0.6 2.4 0.9 0.2 0.3 0.5 0.1 0.0 0.0 0.0 21.6 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.9 0.4 0.2 0.5 0.0 0.1 0.2 0.3 0.6 0.3 0.1 0.2 0.8 0.2 0.6 0.2 0.0 0.5 0.1 0.3 0.0 0.5 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 0.1 0.0 0.0 0.0 21.4 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 13.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 1.1 0.0 0.0 0.0 ANGPTL3 ANGPT5 ENSG00000132855 "Angiopoietin like 3" Q9Y5C1 1 62597487-62606159 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Lipid metabolism" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 276.6" "Group enriched" "Detected in some" 14 "Hepatocytes: 523.1;Proximal tubular cells: 240.8" "Cancer enriched" "Detected in some" 39 "liver cancer: 94.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.1;HL-60: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038097 Approved "Secreted to blood" NA NA 225000000 45000000 "HPA038097: AB_10675628" "unprognostic (2.29e-1)" "unprognostic (8.01e-2)" "unprognostic (2.51e-1)" "unprognostic (4.06e-2)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (4.06e-2)" "unprognostic (1.56e-2)" "unprognostic (8.11e-3)" "unprognostic (6.85e-3)" "unprognostic (2.89e-2)" "unprognostic (1.20e-2)" "unprognostic (1.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.09e-2)" "unprognostic (5.38e-2)" "unprognostic (7.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.7 276.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.3 1.1 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.5 0.0 0.7 0.0 0.2 0.0 0.6 0.1 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.3 7.6 0.0 0.0 5.2 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 523.1 0.1 0.0 0.0 7.4 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 240.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ANGPTL4 "ARP4, FIAF, HFARP, NL2, PGAR, pp1158" ENSG00000167772 "Angiopoietin like 4" Q9BY76 19 8363289-8374373 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 55.5;liver: 68.4;pancreas: 51.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 145.0;Pancreatic endocrine cells: 173.2;Peritubular cells: 123.8" "Cancer enhanced" "Detected in all" "renal cancer: 212.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 5.8;neutrophil: 2.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.8" "Cell line enhanced" "Detected in many" "ASC diff: 16.4;HBEC3-KT: 65.4;LHCN-M2: 17.7;TIME: 33.0;U-138 MG: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA007879, CAB033770" Approved Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 7750000 1500000 "Nucleoplasm, Vesicles" "CAB033770: AB_2057427, HPA007879: AB_1078158" "unprognostic (1.26e-1)" "unprognostic (5.29e-3)" "prognostic unfavorable (7.53e-4)" "unprognostic (1.88e-2)" "unprognostic (7.68e-3)" "unprognostic (3.58e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.50e-4)" "unprognostic (3.18e-1)" "unprognostic (3.90e-3)" "unprognostic (9.69e-3)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.34e-5)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.00e-2)" 55.5 9.6 23.3 13.5 24.7 2.3 33.0 5.1 37.6 3.3 11.8 9.2 0.3 10.6 5.9 1.5 11.8 3.2 8.8 11.4 17.1 5.5 9.4 68.4 9.0 2.7 21.4 3.1 2.9 51.7 2.3 3.3 21.4 36.8 6.7 2.1 2.5 3.9 3.7 5.9 6.5 23.5 6.0 20.6 2.5 4.4 3.7 27.7 0.0 7.1 2.5 3.5 10.7 6.0 0.5 0.3 5.8 0.4 0.8 0.6 0.2 0.0 0.6 0.3 0.9 16.4 3.6 0.1 1.2 0.1 0.2 0.0 0.0 6.0 0.0 9.0 2.5 1.3 0.8 0.0 65.4 0.1 0.5 0.1 0.1 0.2 0.1 0.3 0.0 0.0 1.7 0.2 10.0 0.2 1.8 5.0 0.1 0.3 0.2 17.7 0.5 0.0 0.5 0.1 0.0 0.5 0.3 0.0 0.2 3.2 1.2 0.0 0.1 7.5 0.8 1.1 0.4 1.9 0.1 33.0 19.4 0.1 9.8 0.0 0.0 0.0 0.0 13.3 0.0 3.6 5.8 0.4 0.9 0.4 0.2 0.3 0.5 0.5 0.4 0.2 0.4 0.3 0.3 2.3 0.8 0.2 0.3 0.6 0.2 23.3 24.7 5.1 37.6 17.1 5.5 21.4 3.1 36.8 27.7 35.7 4.3 0.5 32.6 12.5 0.1 3.6 2.5 4.0 10.3 14.0 0.0 5.4 0.0 91.5 0.5 17.6 26.4 0.0 15.3 96.9 44.0 38.8 2.3 145.0 7.4 0.0 0.0 20.9 1.6 0.4 81.4 6.1 8.5 3.6 8.6 4.1 173.2 7.0 123.8 3.7 0.0 32.3 98.2 0.0 0.9 10.0 33.5 1.9 1.7 72.4 ANGPTL5 ENSG00000187151 "Angiopoietin like 5" Q86XS5 11 101890674-101916522 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.4;ovary: 24.9" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 5.6;Leydig cells: 25.6;Melanocytes: 6.8;Peritubular cells: 14.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "ASC diff: 7.9;ASC TERT1: 2.2" "Low region specificity" "Detected in all" HPA038516 Uncertain "Secreted in other tissues" NA NA "HPA038516: AB_10672749" "unprognostic (8.28e-3)" "unprognostic (3.08e-2)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (3.23e-2)" "unprognostic (2.18e-1)" "unprognostic (4.88e-2)" "unprognostic (6.74e-4)" "unprognostic (1.96e-1)" "unprognostic (1.53e-8)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-3)" 9.4 0.3 0.2 0.0 0.3 0.0 6.4 0.2 0.7 1.3 0.3 0.0 0.6 0.1 0.1 5.0 1.0 0.4 0.3 3.7 0.2 0.2 0.1 0.2 1.0 0.1 2.0 0.5 24.9 0.0 0.0 0.3 0.1 0.8 1.4 0.2 0.0 0.5 0.3 1.9 3.5 0.5 1.3 1.7 0.0 0.2 6.2 0.3 0.2 2.4 2.9 0.0 1.8 1.1 0.7 1.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 7.9 2.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.9 0.0 1.0 0.0 0.0 0.2 0.3 0.2 0.7 0.2 0.2 2.0 0.5 0.8 0.3 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 25.6 0.0 6.8 0.0 0.0 0.2 0.0 0.0 14.2 0.0 0.3 0.0 1.4 0.2 0.0 4.8 0.1 0.0 0.0 0.0 ANGPTL6 "AGF, ARP5" ENSG00000130812 "Angiopoietin like 6" Q8NI99 19 10092338-10102796 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 31.8" "Cell type enhanced" "Detected in some" 14 "Cholangiocytes: 2.5;Hepatocytes: 4.9;Hofbauer cells: 2.3;Ito cells: 8.0;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "HMC-1: 36.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 450000 550000 "unprognostic (1.28e-1)" "unprognostic (2.18e-6)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-2)" "unprognostic (5.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.99e-2)" "unprognostic (1.23e-2)" "unprognostic (1.85e-1)" "unprognostic (2.26e-10)" "unprognostic (8.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-2)" "unprognostic (1.32e-1)" 0.3 0.3 0.7 2.1 1.6 2.6 0.3 0.7 2.7 0.2 0.5 0.7 0.5 0.7 0.1 0.2 0.7 0.7 0.9 0.7 0.6 0.7 0.9 31.8 0.5 3.3 1.6 0.2 0.4 1.2 0.0 0.4 2.3 1.4 0.2 0.4 0.1 0.5 0.0 0.1 0.3 2.9 0.2 0.9 3.0 1.6 1.3 0.5 0.3 0.3 0.0 3.4 0.6 0.9 2.9 0.6 0.0 1.4 1.3 2.6 0.9 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.1 0.0 0.3 36.9 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.8 2.8 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 3.2 0.8 1.7 0.1 0.4 0.4 0.0 1.3 0.0 2.6 1.4 1.8 2.9 1.6 1.8 0.6 2.8 1.0 1.6 0.0 1.3 0.7 0.4 2.0 0.9 0.7 1.6 0.7 2.7 0.6 0.7 1.6 0.2 1.4 0.5 0.0 0.0 1.5 0.1 0.2 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.2 1.7 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 4.9 2.3 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.5 4.1 0.0 0.2 1.3 0.0 0.0 ANGPTL7 "AngX, CDT6" ENSG00000171819 "Angiopoietin like 7" O43827 1 11189341-11195981 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.9" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.2;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Melanocytes: 3.3" "Cancer enriched" "Detected in some" 14 "melanoma: 18.4" "Region enriched" "Detected in single" 6 "cerebellum: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "Secreted in other tissues" NA NA 490000 "unprognostic (3.23e-2)" "unprognostic (6.95e-2)" "unprognostic (1.22e-1)" "unprognostic (2.67e-3)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.89e-2)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (1.58e-2)" "unprognostic (3.41e-3)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" 12.8 3.7 0.1 2.0 0.2 0.0 4.8 3.2 0.2 5.4 8.0 0.3 9.3 1.3 1.4 4.3 7.0 1.7 5.9 10.4 0.1 0.3 6.5 0.4 2.1 1.0 0.1 0.4 1.9 0.6 0.0 7.8 0.9 0.5 4.7 2.4 5.3 4.2 11.4 22.9 5.9 2.6 16.5 3.5 0.4 2.2 3.9 0.5 0.1 0.7 13.8 1.4 6.2 4.5 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.2 0.2 0.1 0.3 0.1 0.4 0.5 0.5 3.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANGPTL8 "C19orf80, RIFL, TD26" ENSG00000130173 "Angiopoietin like 8" Q6UXH0 19 11237450-11241943 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid metabolism" Hormone "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 81.0" "Cell type enriched" "Detected in some" 14 "Hepatocytes: 96.9" "Cancer enriched" "Detected in some" 37 "liver cancer: 84.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "Hep G2: 26.8;MCF7: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA042131 Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 836000 320000 "Golgi apparatus" Nucleoplasm "HPA042131: AB_10794413" "unprognostic (2.37e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (3.73e-1)" "unprognostic (2.80e-1)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" "unprognostic (9.67e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (4.57e-1)" "unprognostic (1.75e-2)" 8.0 0.1 0.0 0.6 0.0 0.0 5.1 0.0 0.1 0.1 5.7 0.0 0.0 0.2 0.1 0.8 0.1 0.1 1.0 0.6 0.0 0.0 1.5 81.0 0.1 3.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.8 0.1 0.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.7 26.8 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 15.5 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.7 0.0 0.2 0.0 0.2 0.3 0.7 0.0 0.3 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 96.9 0.1 0.0 0.0 6.7 5.9 1.3 0.9 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANHX ENSG00000227059 "Anomalous homeobox" E9PGG2 12 133218312-133236095 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 9.9" "Cell type enriched" "Detected in some" 12 "Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 55 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.28e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 22.4 0.0 0.0 0.0 0.0 0.0 ANK1 "ANK, SPH1" ENSG00000029534 "Ankyrin 1" P16157 8 41653220-41896762 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 166.5;tongue: 58.3" "Group enriched" "Detected in many" 10 "Cardiomyocytes: 153.6;Cone photoreceptor cells: 82.5;Erythroid cells: 210.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 20.1" "Group enriched" "Detected in some" 8 "memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 7 "B-cells: 10.6;dendritic cells: 3.5" "Group enriched" "Detected in some" 4 "HEL: 38.0;K-562: 39.9;RH-30: 50.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004842, HPA056953" Supported Supported "Intracellular and membrane" NA NA 33000000 "HPA004842: AB_1844827, HPA056953: AB_2683284" "unprognostic (1.05e-1)" "unprognostic (1.30e-1)" "unprognostic (4.22e-3)" "unprognostic (2.31e-3)" "unprognostic (1.76e-7)" "unprognostic (2.03e-1)" "unprognostic (2.15e-1)" "unprognostic (2.52e-1)" "unprognostic (2.95e-1)" "unprognostic (3.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-1)" "unprognostic (1.40e-1)" "unprognostic (3.86e-1)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.04e-1)" 1.2 0.3 0.6 0.7 0.6 14.8 0.3 20.1 3.8 0.2 0.2 0.0 0.0 0.4 0.2 2.7 1.8 0.2 0.3 18.0 0.6 1.2 0.3 0.2 0.4 0.9 4.0 0.4 0.2 0.3 4.3 0.3 0.8 8.3 0.9 0.2 0.5 2.9 0.3 166.5 0.2 0.3 0.2 1.0 0.7 1.1 0.3 0.0 0.0 1.0 58.3 3.8 0.3 0.4 10.6 3.5 1.0 0.2 0.1 0.9 0.7 0.0 5.1 0.1 0.0 0.0 0.9 0.0 1.5 10.2 0.5 0.2 0.0 0.0 2.3 0.4 1.0 0.1 0.8 0.2 0.1 0.2 0.9 0.0 38.0 0.2 0.0 0.0 0.1 0.1 1.3 0.2 0.1 0.0 0.2 0.0 0.0 39.9 0.8 0.6 0.1 0.0 0.5 0.5 0.0 0.0 0.3 50.5 0.2 0.2 0.1 0.7 0.4 0.0 0.7 0.0 1.9 0.6 0.9 0.2 0.1 0.2 8.7 0.0 0.0 0.0 1.4 0.9 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.5 10.6 0.3 0.5 0.1 9.1 0.0 0.0 0.5 0.1 0.0 3.5 0.9 0.7 0.6 0.6 20.1 3.8 0.6 1.2 4.0 0.4 8.3 0.0 0.0 0.0 3.2 1.3 0.6 7.4 153.6 0.0 0.0 0.0 0.0 82.5 0.7 1.7 0.1 6.6 2.1 0.0 210.2 0.0 0.7 0.6 2.2 0.0 0.0 14.9 3.2 1.2 0.0 0.3 2.4 0.3 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.4 0.2 4.7 0.0 3.6 0.2 0.7 0.0 0.3 0.0 0.0 1.5 ANK2 LQT4 ENSG00000145362 "Ankyrin 2" Q01484 4 112818109-113383740 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9" "Cell type enhanced" "Detected in many" 21 "Bipolar cells: 313.8;Cone photoreceptor cells: 451.6;Horizontal cells: 1352.3;Rod photoreceptor cells: 483.8" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 16.5;ASC TERT1: 22.9;RH-30: 31.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008007, CAB015178, HPA035970" Enhanced Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893" "unprognostic (8.33e-2)" "unprognostic (9.47e-2)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.73e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.41e-6)" "unprognostic (1.18e-2)" "unprognostic (3.16e-1)" "unprognostic (1.51e-3)" "unprognostic (2.04e-3)" 17.3 8.7 34.0 6.3 42.1 0.8 10.7 43.7 58.5 20.9 9.5 24.5 0.6 4.3 10.5 4.3 8.3 5.8 13.0 56.7 29.4 30.3 59.8 2.0 4.6 5.1 28.7 38.7 19.0 2.4 1.6 8.6 2.0 42.1 5.4 7.2 7.8 2.6 8.7 66.9 3.5 4.7 15.2 19.0 15.1 3.8 5.8 24.2 0.0 5.6 4.4 4.5 4.5 4.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 10.4 4.2 16.5 22.9 0.0 1.1 1.9 0.7 2.1 4.1 0.0 4.3 1.4 3.7 2.5 0.0 7.6 0.4 0.6 1.9 6.3 2.5 0.0 1.7 1.0 1.0 0.7 9.8 1.7 0.9 4.0 2.7 0.0 0.2 0.0 7.0 3.5 0.1 0.2 0.0 5.4 0.0 1.8 0.5 31.5 0.0 0.1 0.0 8.4 15.8 0.1 0.3 5.4 7.4 0.1 0.6 0.0 3.2 1.8 0.2 1.9 4.2 1.2 0.6 12.9 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 42.1 43.7 54.3 29.4 30.3 28.7 38.7 42.1 24.2 0.0 3.8 0.0 0.0 9.3 313.8 152.3 0.0 1.4 2.3 19.2 451.6 0.1 13.3 0.0 92.0 11.6 0.0 0.0 1.5 0.1 44.2 0.4 1.1 0.4 0.8 1352.3 63.4 0.0 0.0 26.4 33.6 1.0 16.9 1.0 0.0 40.0 0.1 0.0 28.3 129.2 483.8 6.5 20.5 1.1 1.5 8.3 0.0 0.0 0.1 0.1 ANK3 ENSG00000151150 "Ankyrin 3" Q12955 10 60026298-60733490 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 95.4;parathyroid gland: 74.4" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 464.8;Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 219.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 24.0;SK-BR-3: 24.1" "CAB013249, CAB015179, HPA038455" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020" "unprognostic (1.91e-1)" "unprognostic (5.33e-3)" "unprognostic (6.76e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" "unprognostic (1.21e-2)" "unprognostic (3.83e-1)" "unprognostic (2.28e-2)" "prognostic favorable (8.88e-16)" "unprognostic (5.75e-2)" "unprognostic (2.59e-1)" "unprognostic (1.00e-1)" "unprognostic (2.83e-2)" 2.7 3.1 21.1 3.1 24.8 1.1 9.1 95.4 29.1 5.5 10.5 21.5 19.4 15.7 9.7 52.9 7.1 8.2 8.9 31.2 24.4 16.4 38.9 6.6 10.1 2.5 26.8 19.8 5.2 5.0 74.4 10.5 31.9 31.9 8.6 8.8 6.5 16.1 19.4 29.2 16.0 10.6 5.9 16.5 5.9 6.3 3.4 30.0 0.6 17.2 4.6 3.4 5.6 6.6 6.2 3.5 1.7 0.4 2.1 7.7 1.3 4.1 2.3 14.8 0.2 0.0 0.9 11.4 0.3 0.2 0.0 0.2 10.6 8.0 0.2 4.8 0.3 0.4 5.8 7.9 7.1 0.2 0.2 5.3 0.1 4.5 0.0 3.1 0.0 0.2 7.3 4.6 3.8 0.2 12.9 1.7 0.0 2.0 10.0 3.3 13.6 0.0 0.4 6.7 11.0 12.8 0.0 10.6 2.0 2.6 24.0 7.7 1.4 0.3 24.1 0.0 17.3 14.0 0.0 4.8 0.4 1.5 6.5 0.7 0.4 0.0 0.0 2.7 0.1 9.1 1.7 0.4 0.6 4.1 0.3 3.7 6.2 7.0 2.2 0.2 1.9 7.7 1.9 1.1 2.1 0.4 3.5 1.0 1.3 21.1 24.8 95.4 29.1 24.4 16.4 26.8 19.8 31.9 30.0 41.7 132.9 8.9 17.9 16.9 464.8 156.4 15.3 72.3 58.0 50.6 212.1 34.4 16.6 7.2 18.5 2.1 50.2 0.0 7.4 8.8 4.0 13.1 11.6 0.8 3.9 41.3 29.4 12.9 3.2 8.5 25.9 2.9 8.5 7.2 10.6 35.7 5.0 39.0 5.3 48.8 219.9 0.0 0.4 1.1 0.6 15.8 20.9 5.3 16.0 19.2 ANKAR FLJ25415 ENSG00000151687 "Ankyrin and armadillo repeat containing" Q7Z5J8 2 189674290-189761193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.3;testis: 9.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 63.4;Late spermatids: 36.4;Rod photoreceptor cells: 48.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "TIME: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036168 Uncertain Approved "Nucleoplasm,Centriolar satellite" NA NA "Centriolar satellite" Nucleoplasm "HPA036168: AB_10673345" "unprognostic (2.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.06e-2)" "unprognostic (5.41e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-1)" "unprognostic (2.65e-2)" "unprognostic (5.03e-3)" "unprognostic (2.89e-1)" "unprognostic (2.65e-2)" "unprognostic (6.34e-4)" "unprognostic (2.43e-1)" "unprognostic (1.27e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-2)" 0.2 0.4 0.2 0.0 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.0 0.3 0.7 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.2 0.2 1.2 0.3 0.1 0.5 0.3 0.4 0.0 0.2 0.2 0.3 0.0 0.2 0.2 0.6 9.0 0.6 0.1 0.2 0.2 2.3 0.3 0.5 0.4 0.0 0.6 0.1 0.6 0.5 0.4 0.5 0.4 1.1 0.0 0.0 0.7 0.2 0.5 0.9 1.1 0.3 0.3 1.0 0.1 0.8 0.7 0.0 0.3 1.0 0.6 0.6 0.5 1.3 0.0 1.8 0.2 1.3 0.2 0.3 1.4 0.2 0.0 0.0 0.1 0.9 0.3 0.4 0.0 0.5 0.0 0.8 0.7 0.3 0.4 0.0 0.6 2.3 0.0 0.0 0.5 0.3 0.8 0.1 2.4 1.8 2.7 0.8 1.1 0.0 0.0 1.1 0.4 0.1 0.5 0.1 0.2 0.0 0.0 0.5 0.6 0.4 0.1 0.6 0.3 0.1 0.1 2.3 0.2 0.5 0.0 0.0 0.3 0.3 0.0 0.1 3.0 5.1 0.5 5.6 1.1 12.0 4.1 2.5 1.4 3.4 10.4 13.7 1.2 1.7 3.0 63.4 6.8 3.4 0.0 3.7 0.9 4.6 3.6 0.0 2.1 2.1 3.2 0.0 3.7 1.3 36.4 20.1 4.0 6.8 1.0 4.5 8.9 3.5 5.5 13.1 2.1 48.1 6.5 3.3 11.1 4.7 1.1 0.1 4.4 3.8 3.5 ANKDD1B ENSG00000189045 "Ankyrin repeat and death domain containing 1B" A6NHY2 5 75611459-75671846 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "fallopian tube: 5.6;intestine: 4.5" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 6.7;Distal tubular cells: 8.3;Mucus-secreting cells: 6.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 7 "NK-cell: 3.2;T-reg: 1.8" "Group enriched" "Detected in many" 11 "NK-cells: 3.2;T-cells: 1.8" "Cell line enhanced" "Detected in some" "RPMI-8226: 6.7;RPTEC TERT1: 2.7;SH-SY5Y: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059722 Uncertain NA NA "HPA059722: AB_2684112" "unprognostic (5.11e-3)" "unprognostic (2.46e-2)" "unprognostic (3.06e-2)" "unprognostic (6.16e-2)" "unprognostic (3.26e-1)" "unprognostic (2.42e-1)" "unprognostic (2.39e-1)" "unprognostic (7.84e-3)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" "unprognostic (7.36e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.30e-7)" "unprognostic (1.87e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-1)" "unprognostic (1.27e-2)" 0.2 0.6 0.4 0.6 0.8 0.0 0.5 0.0 0.1 0.9 3.3 0.5 0.4 1.1 0.1 5.6 0.5 0.0 0.8 0.8 3.8 0.1 1.2 0.0 0.1 0.1 0.8 2.6 0.7 0.4 0.9 4.5 0.1 0.0 0.0 1.0 0.7 0.5 0.2 0.3 2.5 0.8 0.5 0.3 0.8 0.6 0.0 0.2 0.2 0.1 3.2 1.8 0.7 0.3 0.3 0.0 0.5 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.0 0.1 0.0 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.3 1.3 0.0 0.0 0.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 6.7 2.7 0.1 0.9 1.9 0.0 0.1 0.0 1.1 0.0 0.1 0.2 0.3 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.2 3.2 0.1 0.0 1.8 0.7 0.0 3.7 0.0 0.6 0.5 0.0 0.4 0.0 6.7 2.3 3.5 0.0 1.9 8.3 0.6 0.4 0.3 0.8 0.0 0.9 0.4 0.3 0.4 0.0 0.0 0.3 0.0 0.0 1.8 0.3 0.0 2.0 0.0 1.7 0.0 6.7 0.0 0.5 0.0 1.4 4.3 0.0 0.0 0.0 0.5 0.2 0.5 0.5 0.8 3.8 0.1 ANKEF1 "ANKRD5, dJ839B4.6, FLJ21669" ENSG00000132623 "Ankyrin repeat and EF-hand domain containing 1" Q9NU02 20 9986126-10058303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.0;testis: 22.7" "Group enriched" "Detected in many" 13 "Early spermatids: 319.3;Late spermatids: 291.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 17.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA041151 Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Nucleoli fibrillar center, Plasma membrane, Cytosol" "HPA041151: AB_10796569" "unprognostic (4.72e-2)" "unprognostic (9.86e-2)" "unprognostic (2.31e-2)" "unprognostic (2.09e-1)" "unprognostic (5.38e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.28e-1)" "unprognostic (6.73e-2)" "prognostic favorable (4.44e-4)" "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (3.11e-1)" 5.6 2.9 1.4 2.3 2.4 0.5 3.7 5.7 2.0 2.7 3.1 0.8 11.3 2.9 1.9 4.2 4.7 4.9 4.0 3.2 2.3 2.5 5.7 6.7 2.3 1.3 1.5 1.1 3.6 25.0 5.3 13.6 1.7 4.1 3.4 3.0 3.0 4.2 13.0 1.7 2.9 3.6 1.0 1.2 1.8 5.1 22.7 1.0 3.2 8.6 2.5 3.9 2.1 2.6 2.5 1.6 0.7 0.1 1.5 5.4 1.3 10.0 10.3 1.4 2.5 2.1 1.2 5.9 1.9 0.1 1.8 0.9 5.9 9.1 0.0 3.1 0.4 10.8 8.7 1.8 12.0 2.2 0.0 1.6 1.3 2.0 5.5 1.4 1.1 0.2 3.7 8.6 1.5 1.7 4.2 1.5 3.9 3.8 8.9 0.4 3.1 1.6 0.0 4.3 12.0 2.4 0.0 0.0 6.8 4.4 6.5 7.7 3.9 4.6 10.2 0.0 3.6 8.9 0.9 1.1 1.3 1.4 0.1 1.9 9.2 17.8 1.5 2.6 0.3 1.7 0.0 0.0 0.0 2.8 0.1 5.4 2.5 3.3 2.6 0.2 2.3 4.1 3.0 0.7 1.5 0.0 1.6 3.8 1.3 1.4 2.4 5.7 2.0 2.3 2.5 1.5 1.1 4.1 1.0 3.0 4.1 0.0 2.1 0.2 1.2 1.5 0.0 24.1 2.3 7.0 0.0 1.9 1.7 4.0 319.3 0.7 2.2 0.0 5.4 1.5 0.2 1.6 1.1 7.8 1.1 3.2 5.1 0.0 0.3 291.0 3.1 1.4 0.0 0.0 4.6 1.0 5.4 4.5 3.9 2.1 4.8 0.0 0.1 5.0 2.4 0.3 1.3 1.3 3.4 1.3 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 34.8;Early spermatids: 13.6;Late spermatids: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.1;MOLT-4: 16.8;T-47d: 5.8;U-2197: 5.6" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.9 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.4 16.8 0.0 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 1.5 0.0 1.7 0.0 0.3 0.1 5.8 0.0 0.0 0.0 0.4 5.6 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 0.0 0.6 0.0 0.1 0.5 0.0 0.6 0.0 34.8 0.0 0.0 0.0 0.3 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 1.7 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 6.5 0.3 5.9 2.1 0.4 2.4 0.0 0.0 0.9 ANKK1 X-kinase ENSG00000170209 "Ankyrin repeat and kinase domain containing 1" Q8NFD2 11 113387791-113400418 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.7;tongue: 6.3" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 1.4;Horizontal cells: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 1.4;naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.0;hTCEpi: 6.7;RT4: 3.2;U-266/70: 1.3" "Not detected" "Not detected" HPA012813 Uncertain NA NA "HPA012813: AB_1844832" "unprognostic (5.63e-3)" "unprognostic (6.67e-3)" "unprognostic (5.09e-3)" "unprognostic (6.27e-3)" "unprognostic (5.56e-4)" "unprognostic (7.02e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.50e-1)" "unprognostic (3.15e-1)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (5.39e-6)" "unprognostic (3.17e-2)" "unprognostic (3.83e-2)" "unprognostic (2.79e-1)" "unprognostic (4.65e-2)" 0.6 0.5 0.6 0.6 2.0 0.4 1.2 0.6 1.4 1.5 0.6 0.6 0.6 0.4 0.7 0.9 0.6 3.3 0.6 0.6 0.6 1.2 0.6 0.6 0.6 1.1 0.6 0.6 1.0 0.6 0.4 4.7 0.6 0.6 1.9 0.1 0.6 1.8 1.0 0.7 9.7 0.6 0.6 2.3 0.9 0.2 1.0 0.6 0.6 1.2 6.3 1.5 0.6 1.2 1.3 0.2 1.4 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.1 0.3 3.2 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.6 0.0 0.0 0.2 0.0 1.4 0.1 0.2 0.4 0.1 0.1 0.0 0.1 0.0 0.0 1.3 0.2 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.6 2.0 0.6 1.4 0.6 1.2 0.6 0.6 0.6 0.6 0.0 0.3 0.0 0.6 0.6 0.9 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 ANKLE1 "ANKRD41, FLJ39369, LEMD6" ENSG00000160117 "Ankyrin repeat and LEM domain containing 1" Q8NAG6 19 17281645-17287646 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9" "Group enriched" "Detected in some" 7 "Erythroid cells: 23.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.3" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.3" "Group enriched" "Detected in many" 4 "B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3" "Cell line enhanced" "Detected in many" "Daudi: 30.8;HEL: 12.6;HL-60: 13.5;NB-4: 17.4;U-937: 24.2" "Low region specificity" "Detected in all" "HPA026789, HPA073498" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026789: AB_10611675, HPA073498: AB_2686612" "unprognostic (5.66e-2)" "unprognostic (2.21e-1)" "unprognostic (6.90e-2)" "prognostic unfavorable (4.86e-5)" "unprognostic (2.73e-1)" "unprognostic (1.72e-3)" "unprognostic (2.19e-2)" "unprognostic (2.09e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (7.89e-4)" "unprognostic (5.86e-2)" "unprognostic (0.00e+0)" "unprognostic (2.03e-1)" "unprognostic (1.61e-1)" "unprognostic (2.00e-3)" "unprognostic (4.30e-2)" 0.6 0.5 1.0 12.9 3.1 22.6 0.6 8.3 1.4 0.7 0.7 0.6 0.2 0.3 0.9 1.3 0.5 0.8 0.5 0.2 1.0 1.2 0.5 0.5 1.3 3.7 1.6 0.7 1.7 0.2 0.6 0.9 1.1 1.4 1.0 0.5 0.4 0.7 0.6 0.9 1.4 1.2 0.9 1.2 5.7 0.3 1.0 0.5 8.9 0.6 0.2 5.3 1.0 0.7 3.0 2.2 0.7 4.3 0.0 0.4 0.8 0.1 0.3 1.5 0.8 0.0 0.3 1.5 0.5 0.1 0.3 0.2 7.0 0.4 30.8 0.3 0.1 0.0 0.6 11.9 0.1 0.3 9.3 1.6 12.6 4.9 0.0 0.1 13.5 5.2 0.1 0.4 1.2 0.0 0.3 0.2 2.6 1.6 3.6 0.1 0.2 9.3 17.4 3.8 0.1 1.1 7.5 0.0 3.1 0.1 0.1 0.4 2.7 3.0 0.2 0.2 0.3 0.0 8.9 0.6 0.1 0.5 0.6 0.3 0.3 0.3 10.9 0.1 24.2 0.6 0.0 1.8 0.7 0.0 4.3 0.0 3.0 0.0 0.4 2.2 1.7 0.1 0.0 0.0 0.0 3.1 1.1 0.0 0.8 1.0 3.1 8.3 1.4 1.0 1.2 1.6 0.7 1.4 0.5 0.0 0.3 0.8 0.8 0.7 2.0 0.8 0.0 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.2 0.0 23.3 0.2 0.4 0.4 0.3 1.1 0.0 0.7 0.0 0.0 0.0 0.8 0.0 1.7 1.2 0.0 1.0 0.7 0.2 0.4 0.0 1.4 0.0 1.5 6.5 0.4 0.5 0.9 0.4 0.3 0.0 0.0 0.1 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 147.5;Late spermatids: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.5 4.3 5.2 9.0 7.9 9.8 5.8 6.4 7.3 7.2 5.7 10.3 10.8 5.8 6.6 9.0 5.3 21.8 9.2 3.6 6.1 4.3 5.1 5.1 6.3 7.2 8.7 4.8 7.3 8.0 6.6 5.4 6.4 6.4 5.8 5.1 5.1 6.9 13.6 5.0 7.2 6.2 5.8 6.3 7.3 8.4 45.0 6.7 6.0 6.0 3.4 10.7 5.8 6.0 7.4 4.2 6.9 3.4 2.0 7.5 3.4 5.3 11.7 2.5 4.7 2.3 3.3 10.6 2.5 3.9 2.1 2.9 3.7 11.0 5.3 0.5 2.8 3.2 5.8 4.9 6.0 2.5 9.8 4.0 10.5 5.7 9.8 1.9 5.8 10.1 5.3 14.7 2.0 14.1 6.5 2.2 8.5 9.7 6.8 3.6 5.1 5.3 9.6 2.1 9.2 7.0 15.2 7.7 8.4 3.3 11.5 6.0 4.4 2.1 5.6 7.8 3.2 4.8 9.0 2.7 8.0 2.7 3.1 4.4 15.8 3.9 5.1 4.5 8.9 6.1 0.1 3.3 6.9 7.5 2.6 4.3 4.7 4.8 4.7 4.2 7.4 7.1 5.1 1.3 2.0 3.4 2.8 1.5 3.4 5.2 7.9 6.4 7.3 6.1 4.3 8.7 4.8 6.4 6.7 0.0 7.2 2.7 1.6 0.8 3.4 1.8 2.5 30.8 10.3 3.5 3.9 2.8 1.7 2.2 147.5 2.8 4.3 0.0 3.7 1.6 1.5 2.0 5.7 5.5 2.5 3.2 4.1 3.1 7.0 162.8 3.7 4.0 0.0 4.6 4.6 1.9 2.5 0.0 2.8 2.6 3.5 0.0 1.3 14.7 8.8 1.9 2.4 4.4 4.9 1.4 ANKRD1 "ALRP, C-193, CARP, CVARP, MCARP" ENSG00000148677 "Ankyrin repeat domain 1" Q15327 10 90912096-90921276 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 81 "heart muscle: 398.9;skeletal muscle: 333.3" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 12578.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038736 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoli fibrillar center" Nucleoplasm "HPA038736: AB_2676184" "unprognostic (2.45e-1)" "unprognostic (6.14e-3)" "unprognostic (2.24e-1)" "unprognostic (4.39e-1)" "unprognostic (9.14e-3)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.28e-2)" "unprognostic (6.63e-3)" "unprognostic (2.19e-1)" "unprognostic (3.27e-1)" "unprognostic (4.51e-2)" "unprognostic (3.40e-1)" "unprognostic (2.72e-5)" "unprognostic (3.40e-2)" "unprognostic (2.79e-1)" "unprognostic (7.22e-2)" "unprognostic (3.16e-3)" 1.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 2.1 1.5 0.1 0.1 398.9 0.0 0.0 0.1 0.1 4.5 0.2 0.0 0.0 0.1 0.4 0.1 0.1 0.7 0.1 0.9 0.1 0.0 0.8 0.1 333.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 2.9 1.6 0.5 0.3 0.0 0.4 0.5 1.9 0.6 0.9 0.4 0.2 2.9 0.8 0.5 0.0 0.4 0.5 0.0 1.7 0.1 0.5 0.9 38.0 1.4 0.0 104.9 0.1 4.0 1.0 0.1 0.2 1.3 0.1 0.1 0.0 0.2 11.7 2.3 0.0 0.0 3.7 0.0 0.7 1.8 57.1 35.8 0.0 0.0 0.0 128.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 8.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 41.0 0.0 0.1 179.4 0.3 13.8 0.2 14.1 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.2 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.2 0.4 0.4 0.3 0.7 0.9 0.6 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 848.6 37.7 0.0 1.3 0.0 0.0 12578.5 10.2 1.4 9.1 0.0 0.0 0.1 0.0 19.0 2.0 0.0 0.0 0.0 0.2 0.2 0.2 0.4 3.5 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 ANKRD13B FLJ25555 ENSG00000198720 "Ankyrin repeat domain 13B" Q86YJ7 17 29589769-29614761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 23.2;Horizontal cells: 15.9;Late spermatids: 30.2;Leydig cells: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.7;SH-SY5Y: 32.3;SK-BR-3: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051886, HPA063748" Uncertain Supported Vesicles NA NA Vesicles "HPA051886: AB_2681652, HPA063748: AB_2685112" "unprognostic (1.61e-1)" "unprognostic (2.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (3.10e-4)" "unprognostic (1.84e-1)" "unprognostic (1.84e-1)" "unprognostic (1.03e-2)" "prognostic favorable (7.58e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (9.93e-2)" "unprognostic (1.18e-1)" "unprognostic (3.94e-2)" "unprognostic (5.36e-3)" 8.0 6.6 10.2 4.2 14.3 2.6 12.0 34.9 28.6 7.2 4.2 16.4 2.6 2.7 12.3 3.5 5.4 9.9 7.5 6.4 12.4 9.3 1.7 1.1 3.9 3.6 14.7 10.0 10.5 3.6 5.5 6.9 2.7 7.7 5.2 2.7 3.4 4.8 4.8 8.5 10.0 3.3 8.2 13.7 3.1 3.5 16.1 12.7 2.0 2.8 2.2 2.2 7.2 8.5 0.7 0.3 0.0 0.0 0.1 1.6 0.1 3.7 7.8 8.4 17.8 4.7 4.4 2.7 1.0 0.6 1.4 1.7 3.5 0.6 4.2 3.5 1.6 3.6 13.8 4.9 4.0 0.2 7.0 16.8 2.2 15.4 3.0 1.8 2.0 2.4 4.1 5.3 1.4 2.7 4.8 6.2 7.6 3.5 3.5 1.5 3.5 10.5 5.0 6.7 4.1 6.1 17.0 5.1 11.7 1.7 1.6 28.7 32.3 3.1 24.8 2.8 0.7 4.0 2.5 4.4 3.7 4.1 4.0 3.7 5.8 7.5 5.1 2.6 6.8 2.7 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.6 0.3 0.1 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 10.2 14.3 34.9 17.5 12.4 9.3 14.7 10.0 7.7 12.7 0.0 0.0 0.0 0.7 1.4 4.4 1.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 1.4 23.2 1.5 0.0 0.0 0.5 0.1 1.6 1.0 0.0 0.8 0.1 15.9 2.9 1.8 0.0 30.2 13.6 0.0 0.0 0.0 0.5 1.4 0.6 0.0 7.1 0.0 5.0 0.0 1.4 6.0 4.1 1.5 0.1 0.0 1.0 1.1 ANKRD13D ENSG00000172932 "Ankyrin repeat domain 13D" Q6ZTN6 11 67288547-67302485 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.8" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039950 Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA039950: AB_10796337" "unprognostic (1.10e-1)" "unprognostic (1.18e-3)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (9.83e-3)" "unprognostic (1.58e-1)" "unprognostic (4.87e-3)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (5.06e-3)" "unprognostic (3.71e-2)" "prognostic unfavorable (5.73e-10)" "unprognostic (1.62e-1)" "unprognostic (1.80e-1)" "unprognostic (4.01e-2)" "unprognostic (6.74e-2)" 9.1 9.1 18.2 18.1 17.6 80.8 18.9 20.2 18.7 9.0 7.6 7.7 13.7 8.0 9.0 10.4 14.6 10.2 11.9 8.8 20.2 14.0 8.3 4.5 12.4 20.8 12.4 11.4 9.4 7.7 6.0 17.0 9.2 10.7 12.7 4.5 10.9 17.5 12.0 4.2 28.1 8.6 9.9 9.6 24.1 8.9 6.8 12.0 9.6 6.4 6.2 14.4 14.3 13.4 2.6 8.1 11.4 4.6 3.8 6.7 1.9 6.3 4.5 3.4 8.1 5.2 5.1 6.4 3.9 3.8 4.6 2.9 5.3 7.0 6.9 6.6 4.4 6.2 10.6 2.5 5.0 0.7 9.7 3.0 5.8 6.8 3.0 8.1 6.4 23.5 5.5 7.9 4.1 5.3 6.9 4.3 7.0 4.1 8.4 4.0 10.3 8.6 49.8 3.9 9.8 5.7 21.6 3.7 4.8 6.5 8.7 4.0 6.8 3.4 10.2 27.2 2.7 10.5 18.3 5.5 7.3 4.7 7.4 5.1 8.5 6.1 4.1 9.6 18.0 4.7 7.2 3.3 11.4 6.7 4.6 4.4 2.6 3.8 5.4 1.9 2.4 2.4 5.8 10.8 3.8 3.8 8.1 2.8 1.9 18.2 17.6 20.2 18.7 20.2 14.0 12.4 11.4 10.7 12.0 0.0 22.6 9.3 10.5 12.6 49.4 4.5 2.5 18.7 10.3 15.7 70.7 6.9 1.7 7.8 17.6 14.2 2.6 0.0 6.0 6.4 13.6 15.3 24.3 2.4 17.5 39.7 10.4 25.2 48.3 5.1 20.4 28.1 11.8 14.4 6.2 25.2 7.9 2.9 15.9 1.4 45.9 12.9 12.1 2.8 5.5 22.0 6.3 29.9 6.9 15.7 ANKRD18A "FLJ35740, KIAA2015" ENSG00000180071 "Ankyrin repeat domain 18A" Q8IVF6 9 38571358-38620660 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "bone marrow: 24.4;brain: 11.1;testis: 19.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Muller glia cells: 13.3;Rod photoreceptor cells: 33.7;Spermatocytes: 25.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 16.6" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.02e-2)" "unprognostic (1.07e-1)" "unprognostic (1.42e-3)" "unprognostic (1.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (1.26e-1)" "unprognostic (2.37e-1)" "unprognostic (4.34e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-2)" "unprognostic (1.94e-5)" "unprognostic (2.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.58e-2)" "unprognostic (7.03e-2)" "unprognostic (2.14e-1)" 0.5 0.7 1.4 0.8 9.1 24.4 1.1 0.4 4.1 1.0 2.1 8.5 2.4 0.9 0.7 1.1 1.4 1.2 2.7 1.1 3.0 2.2 1.5 1.2 1.5 0.8 4.8 2.3 0.4 4.1 2.5 3.2 0.7 8.7 1.6 1.5 0.4 0.9 3.9 0.4 2.4 1.5 0.7 11.1 0.5 2.0 19.1 6.9 0.0 3.8 0.0 0.5 0.7 0.8 0.4 0.0 1.1 0.0 0.1 1.7 0.1 4.5 3.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.9 0.0 0.0 0.9 3.4 3.2 0.0 0.0 4.8 0.0 4.8 2.8 0.0 16.6 0.4 0.0 2.3 0.0 3.1 1.7 0.0 7.0 1.6 0.3 0.3 4.3 0.1 0.8 3.6 5.8 2.0 0.0 6.3 6.3 2.1 1.9 1.5 3.0 2.3 0.5 0.1 7.4 2.5 7.9 4.3 0.0 1.3 0.1 0.0 0.3 0.5 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.5 0.0 0.7 0.0 1.3 0.8 0.0 0.4 0.7 1.7 0.5 0.1 0.0 0.0 1.0 0.1 1.4 9.1 0.4 4.1 3.0 2.2 4.8 2.3 8.7 6.9 0.0 1.0 0.0 1.8 0.6 3.9 6.5 0.0 17.4 5.7 1.8 2.0 0.0 1.7 4.4 4.9 0.0 0.7 0.0 2.0 0.1 0.0 2.0 0.0 0.5 0.1 0.0 4.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 3.6 13.3 3.7 2.9 0.4 0.1 33.7 0.0 0.1 25.6 2.0 1.5 0.0 0.0 2.3 0.7 ANKRD18B bA255A11.3 ENSG00000230453 "Ankyrin repeat domain 18B" A2A2Z9 9 33524394-33573009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.9;testis: 26.9" "Group enriched" "Detected in many" 6 "Ciliated cells: 16.0;Early spermatids: 23.8;Muller glia cells: 23.4;Spermatocytes: 37.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 20.8" "HPA046346, HPA046695, HPA049923, HPA051288" Uncertain Approved "Nucleoli,Nucleoli rim,Cytosol" NA NA "Nucleoli, Nucleoli rim" Cytosol "HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421" "unprognostic (4.71e-2)" "unprognostic (1.85e-1)" "unprognostic (4.85e-3)" "unprognostic (1.00e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.29e-4)" "unprognostic (1.45e-2)" "unprognostic (9.84e-2)" "unprognostic (8.65e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-2)" "unprognostic (6.43e-5)" "unprognostic (4.89e-2)" "unprognostic (9.75e-4)" "unprognostic (8.25e-2)" "unprognostic (5.18e-2)" 1.5 0.9 4.3 0.1 0.4 0.2 1.3 12.9 3.9 0.3 0.2 0.2 0.1 0.0 0.5 1.0 2.1 1.0 0.9 0.3 2.1 1.3 0.1 0.4 0.7 0.1 1.0 1.4 0.1 0.1 0.1 1.6 1.3 2.6 2.0 0.3 0.2 0.2 0.1 1.4 5.5 0.2 0.1 1.0 0.9 0.0 26.9 0.1 0.1 0.9 1.6 0.7 1.2 1.1 0.5 0.8 0.1 0.2 0.0 0.8 0.1 7.5 8.5 0.7 0.2 0.3 1.4 0.7 1.6 1.7 2.1 2.3 1.6 0.2 0.2 0.4 0.2 2.3 1.7 4.6 1.6 2.9 0.1 4.6 8.2 9.9 3.1 0.0 2.7 0.6 1.1 4.5 2.9 7.6 0.9 3.9 0.0 4.5 2.1 2.6 1.3 0.2 20.8 7.3 0.3 3.7 0.0 10.5 1.5 1.2 1.8 0.2 7.3 3.5 0.4 0.6 6.8 6.0 10.1 3.9 1.7 7.6 3.5 3.0 1.2 0.8 0.1 0.8 0.1 1.2 0.0 0.1 0.1 0.3 0.1 0.7 0.4 0.2 0.6 0.0 0.5 0.4 0.8 0.1 0.0 0.2 0.8 0.1 0.1 4.3 0.4 12.9 3.9 2.1 1.3 1.0 1.4 2.6 0.1 0.0 0.0 0.0 4.4 1.8 2.6 2.4 2.5 16.0 3.4 1.8 0.0 0.0 0.0 0.6 23.8 0.0 0.3 0.0 0.4 0.2 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.6 0.6 0.1 0.0 0.0 1.6 23.4 0.3 1.4 0.7 0.0 4.3 0.0 0.0 37.6 1.7 2.9 0.0 0.0 1.0 3.5 ANKRD2 ARPP ENSG00000165887 "Ankyrin repeat domain 2" Q9GZV1 10 97572499-97583884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 472.2" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 151.7" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 18 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "A-431: 14.8;A549: 5.1;BJ hTERT+ SV40 Large T+: 5.5;HaCaT: 11.7;RPTEC TERT1: 13.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040842, HPA040884" Enhanced Enhanced Vesicles NA NA Vesicles "HPA040842: AB_10963794, HPA040884: AB_10969453" "unprognostic (1.27e-2)" "unprognostic (9.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.61e-2)" "unprognostic (2.53e-1)" "unprognostic (5.60e-3)" "unprognostic (2.17e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.22e-1)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (4.56e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" 2.3 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.2 2.7 0.0 0.1 47.2 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.3 472.2 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.2 1.1 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 14.8 5.1 0.0 0.0 0.2 0.0 0.4 0.7 0.0 5.5 3.6 0.2 4.6 0.0 0.6 0.1 0.3 11.7 0.0 4.0 3.7 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.6 1.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 13.1 0.7 0.0 0.0 0.0 3.8 0.0 0.3 1.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 151.7 0.0 0.0 0.0 3.5 0.0 0.2 26.6 1.2 0.4 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 1.8 2.2 0.0 0.0 0.0 2.2 3.2 0.3 0.2 0.0 0.0 0.1 ANKRD20A1 "ANKRD20A, DKFZp434A171" ENSG00000260691 "Ankyrin repeat domain 20 family member A1" Q5TYW2 9 67859147-67902094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;testis: 6.5" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.6;Ciliated cells: 4.0;Spermatocytes: 6.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "Karpas-707: 7.1;U-266/70: 11.7;U-266/84: 3.9" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.92e-1)" "unprognostic (4.31e-3)" "unprognostic (3.97e-1)" "unprognostic (2.30e-2)" "unprognostic (5.94e-2)" "unprognostic (2.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-2)" "unprognostic (7.17e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.3 0.1 0.8 0.3 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.9 0.2 0.1 0.0 0.4 0.1 0.3 0.8 0.0 6.5 0.5 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.3 0.0 0.2 0.4 1.4 0.6 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.4 0.9 1.0 0.4 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.4 7.1 0.0 0.0 1.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 2.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 0.6 1.0 11.7 3.9 0.0 0.5 0.0 1.9 0.0 0.0 2.3 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 1.1 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 6.3 1.9 0.0 0.0 0.0 0.9 0.0 ANKRD20A2 ENSG00000183148 "Ankyrin repeat domain 20 family member A2" Q5SQ80 9 40223285-40266392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 1.7;granulocytes: 1.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 16.7;U-266/70: 2.8;U-266/84: 5.0" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.24e-3)" "unprognostic (9.19e-2)" 0.1 0.1 0.4 0.0 1.4 0.2 0.3 1.0 1.2 0.1 0.4 0.0 0.0 0.5 1.2 0.7 0.1 1.9 0.7 0.7 0.3 0.2 1.2 0.0 0.4 0.0 1.4 1.1 0.8 0.0 0.4 1.1 1.1 0.4 0.3 0.2 0.1 0.0 0.1 1.5 0.0 7.6 0.5 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.0 0.6 0.0 0.2 1.3 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.6 16.7 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 2.8 5.0 0.0 0.0 0.0 0.8 0.1 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.2 0.0 0.0 0.1 ANKRD20A3 ENSG00000276203 "Ankyrin repeat domain 20 family member A3" Q5VUR7 9 66106815-66153135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "esophagus: 1.1;lung: 1.3;testis: 2.0" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Horizontal cells: 4.8;Spermatocytes: 16.4;Spermatogonia: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;HDLM-2: 5.2;RPTEC TERT1: 1.4;WM-115: 1.3" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (4.27e-2)" 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.5 0.0 0.1 0.1 0.0 5.2 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.2 0.8 1.8 0.0 5.3 0.0 0.0 3.9 0.0 0.0 0.0 2.0 0.0 1.0 0.0 0.9 0.0 0.0 0.6 3.5 0.0 0.1 4.8 0.0 0.6 1.3 1.8 0.3 0.0 0.0 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.1 16.4 6.5 0.1 0.0 0.0 0.2 1.0 ANKRD20A8P ANKRD20B ENSG00000229089 "Ankyrin repeat domain 20 family member A8, pseudogene" Q5CZ79 2 94811046-94857282 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 3.2;thyroid gland: 5.0" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.7;Cardiomyocytes: 3.0;Club cells: 9.1;granulocytes: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "RT4: 2.8;U-2 OS: 9.8" "HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: " "unprognostic (3.08e-1)" "unprognostic (3.86e-1)" "unprognostic (3.79e-2)" "unprognostic (1.30e-4)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (6.38e-2)" 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 0.0 0.0 0.0 3.0 0.0 1.4 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD22 MGC22805 ENSG00000152766 "Ankyrin repeat domain 22" Q5VYY1 10 88822132-88851818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.2;stomach 1: 27.6;tongue: 29.0" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 33.1;Suprabasal keratinocytes: 89.8;Urothelial cells: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 15.4" "Group enriched" "Detected in many" 13 "granulocytes: 15.4;monocytes: 6.8" "Cell line enhanced" "Detected in some" "A-431: 8.5;CAPAN-2: 27.2;HL-60: 8.0;OE19: 20.7;RT4: 18.4;T-47d: 12.5;U-937: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA012922 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA012922: AB_1844838" "unprognostic (1.86e-1)" "unprognostic (1.48e-3)" "unprognostic (9.73e-3)" "prognostic favorable (8.73e-6)" "unprognostic (1.18e-1)" "unprognostic (2.81e-2)" "unprognostic (2.39e-2)" "unprognostic (1.50e-1)" "unprognostic (4.57e-2)" "unprognostic (7.21e-3)" "prognostic unfavorable (6.15e-4)" "unprognostic (1.09e-3)" "unprognostic (1.05e-2)" "unprognostic (4.87e-3)" "unprognostic (4.17e-2)" "unprognostic (3.18e-3)" "unprognostic (1.01e-3)" 0.4 0.5 2.3 8.4 3.6 5.3 2.3 0.3 3.2 6.7 6.7 0.5 0.0 2.0 0.3 0.2 21.9 0.3 4.3 1.1 4.0 0.6 6.0 1.6 1.3 6.1 3.6 0.2 0.3 40.2 0.1 1.6 0.2 2.7 2.0 7.2 0.1 3.7 0.0 0.3 18.5 2.1 1.3 7.4 8.8 27.6 0.3 1.4 7.9 0.3 29.0 14.6 4.4 8.6 0.1 0.4 15.4 6.8 0.5 0.8 1.2 8.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.1 0.0 0.0 6.7 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.7 6.4 0.1 20.7 0.1 0.0 0.0 0.0 0.1 18.4 0.0 0.0 0.0 1.3 0.0 0.0 12.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.1 0.1 4.8 2.5 0.1 6.8 0.0 0.0 0.4 0.1 0.4 0.1 0.8 0.2 15.4 0.5 1.2 0.4 0.0 1.2 2.3 3.6 0.3 3.2 4.0 0.6 3.6 0.2 2.7 1.4 0.0 3.0 0.0 16.2 33.1 0.0 0.1 10.2 0.0 1.2 7.0 0.0 0.0 0.0 2.6 0.0 0.0 6.4 0.0 5.2 0.0 0.7 10.4 0.0 0.0 2.4 0.0 1.7 0.0 7.2 0.0 0.3 12.3 1.7 1.0 11.8 0.0 4.5 20.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 89.8 0.0 0.7 11.2 29.8 ANKRD23 "DARP, FLJ32449, MARP3" ENSG00000163126 "Ankyrin repeat domain 23" Q86SG2 2 96824526-96857934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 184.5" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "Karpas-707: 29.7" "Not detected" "Not detected" HPA036201 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "HPA036201: AB_10673347" "unprognostic (2.48e-1)" "unprognostic (7.83e-4)" "unprognostic (4.93e-4)" "unprognostic (1.21e-2)" "unprognostic (4.28e-1)" "unprognostic (3.28e-1)" "unprognostic (3.27e-2)" "unprognostic (6.66e-2)" "unprognostic (2.46e-2)" "unprognostic (3.59e-2)" "unprognostic (1.81e-4)" "unprognostic (1.43e-1)" "unprognostic (2.04e-6)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.54e-1)" "unprognostic (2.70e-4)" 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 2.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.7 0.0 0.1 2.2 0.1 184.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 12.2 0.9 0.1 0.1 0.4 0.2 0.5 0.0 0.9 1.2 0.4 0.3 0.5 0.3 0.6 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.2 0.1 0.8 0.7 0.4 0.4 0.1 0.1 0.6 1.4 0.2 0.3 0.4 0.0 0.1 0.1 1.1 0.6 29.7 0.2 0.7 0.3 0.6 0.3 0.1 0.2 1.0 0.0 3.7 0.1 0.7 1.1 0.1 0.2 0.5 0.0 0.1 0.8 0.0 0.2 0.3 0.5 0.5 0.0 1.3 0.5 0.2 0.3 0.8 0.3 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.0 0.9 0.0 0.2 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.7 2.1 2.5 0.0 10.7 2.3 0.0 2.0 0.3 0.0 0.3 3.0 0.6 0.4 0.0 0.9 0.1 0.9 0.4 1.1 1.0 0.2 1.6 0.0 2.5 0.8 1.5 1.4 0.0 0.0 0.0 1.1 1.8 0.1 0.0 2.8 0.0 3.6 0.0 1.9 1.0 0.4 1.1 0.2 0.0 0.6 0.1 ANKRD24 KIAA1981 ENSG00000089847 "Ankyrin repeat domain 24" Q8TF21 19 4183354-4224814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;U-266/70: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041534, HPA048498" Uncertain Uncertain Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA041534: AB_2677537, HPA048498: AB_2680420" "unprognostic (3.70e-2)" "unprognostic (3.96e-3)" "unprognostic (5.23e-9)" "unprognostic (7.03e-2)" "unprognostic (5.01e-2)" "unprognostic (2.31e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.53e-1)" "unprognostic (3.52e-2)" "unprognostic (3.41e-2)" "unprognostic (1.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.27e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-4)" 1.4 2.1 6.0 0.8 8.5 1.1 1.2 1.4 22.1 1.0 1.1 0.8 0.1 1.9 1.0 2.1 0.5 1.4 1.3 0.6 5.1 4.4 1.8 5.5 1.1 1.0 4.1 9.4 1.4 3.3 2.4 3.8 1.9 2.3 4.3 0.9 1.0 1.7 1.7 2.5 1.1 1.5 0.7 2.3 1.5 1.6 7.3 1.8 0.1 1.9 0.1 0.6 0.6 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 3.2 0.3 3.4 0.2 0.1 0.0 0.0 0.1 0.1 0.1 2.0 0.4 0.2 0.2 0.1 0.5 0.0 2.4 0.3 0.1 0.1 0.1 1.8 0.1 0.3 1.8 0.1 0.3 0.8 0.5 0.1 2.0 0.1 5.6 0.0 0.7 0.0 0.1 2.5 0.7 0.7 0.4 0.0 0.4 0.0 0.2 0.9 0.2 0.1 0.1 0.3 0.6 0.7 0.4 0.0 0.1 1.2 0.9 0.0 18.9 1.6 0.1 0.8 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 8.5 1.4 22.1 5.1 4.4 4.1 9.4 2.3 1.8 0.0 3.4 0.0 0.2 0.0 0.8 0.8 2.5 0.0 2.3 0.0 3.9 0.2 0.0 0.1 0.5 0.0 0.3 0.0 0.0 17.7 0.0 0.2 0.0 1.0 0.3 0.0 3.5 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.7 1.1 0.0 0.9 0.0 0.2 0.0 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125788-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "breast: 31.7;testis: 17.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 12.3;Late spermatids: 4.8;Spermatocytes: 23.6" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "A549: 3.9;U-266/70: 15.6" HPA071849 Uncertain Nucleoli NA NA Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 23.6 1.7 0.0 0.2 0.0 0.0 0.0 ANKRD30B NY-BR-1.1 ENSG00000180777 "Ankyrin repeat domain 30B" Q9BXX2 18 14728272-14852738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 42.2" "Group enriched" "Detected in some" 8 "Early spermatids: 10.7;Late spermatids: 11.2;Spermatocytes: 17.0" "Cancer enhanced" "Detected in single" "breast cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 31.8" "HPA060455, HPA071849" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA060455: AB_2684282, HPA071849: " "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (9.74e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-9)" "unprognostic (1.38e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" 0.3 0.2 1.2 0.1 2.5 0.1 2.3 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.9 0.1 0.1 0.1 0.1 0.4 1.2 0.1 0.6 0.1 0.0 0.1 1.0 0.1 0.2 2.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 42.2 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.8 2.6 0.1 31.8 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 1.8 0.9 0.9 0.4 1.2 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 1.7 0.0 10.7 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 11.2 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.4 0.3 0.5 0.0 0.6 0.1 ANKRD30BL "ANKRD30BP3, NCRNA00164" ENSG00000163046 "Ankyrin repeat domain 30B like" A7E2S9 2 132147591-132257969 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 6.4" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 1.2;U-266/70: 1.1" NA NA "unprognostic (1.67e-1)" "unprognostic (1.42e-1)" "unprognostic (5.57e-2)" "unprognostic (2.15e-1)" "unprognostic (2.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.3 0.5 0.1 0.0 0.0 0.0 0.0 ANKRD31 FLJ40191 ENSG00000145700 "Ankyrin repeat domain 31" Q8N7Z5 5 75068275-75236878 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 5.7;testis: 13.2" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 136.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "AN3-CA: 4.4" "Not detected" "Not detected" HPA057566 Enhanced NA NA "HPA057566: AB_2683470" "unprognostic (1.37e-1)" "unprognostic (4.28e-2)" "unprognostic (5.25e-2)" "unprognostic (5.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.72e-2)" "unprognostic (4.81e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-2)" "unprognostic (1.69e-1)" "unprognostic (3.00e-2)" "unprognostic (4.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-1)" 0.5 0.6 1.7 0.3 2.4 0.3 0.8 0.5 2.8 1.7 0.4 0.8 0.0 0.5 0.6 1.0 2.1 0.9 0.7 0.8 1.1 0.5 0.9 0.5 0.4 1.0 0.5 2.2 0.9 0.6 1.5 5.7 0.3 4.3 0.5 0.3 0.8 1.7 0.5 0.3 0.5 0.6 0.9 1.1 0.6 0.5 13.2 0.4 1.7 0.5 0.0 0.7 0.5 1.8 0.5 0.1 0.0 0.0 0.0 2.1 0.2 1.1 0.4 0.7 4.4 0.1 0.4 2.1 0.3 0.3 0.3 0.3 1.1 1.1 0.5 0.5 0.0 1.6 0.1 0.7 0.3 0.5 0.5 0.9 0.6 0.1 0.0 0.1 0.2 0.2 0.3 0.4 0.1 0.6 0.1 0.0 2.1 0.6 1.2 0.0 0.8 1.1 0.1 1.0 0.3 0.0 0.3 0.1 0.0 0.1 0.3 1.2 1.5 0.1 0.1 0.8 0.1 0.9 0.1 0.0 0.9 0.6 0.6 0.3 1.3 1.0 0.8 0.8 0.3 0.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.8 0.6 0.0 0.5 2.1 1.4 0.0 0.0 0.0 0.1 1.8 0.2 1.7 2.4 0.5 2.8 1.1 0.5 0.5 2.2 4.3 0.4 0.0 0.3 0.0 0.3 0.3 2.2 0.8 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.3 3.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 11.5 0.0 0.1 1.6 0.0 0.0 0.0 4.4 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.4 0.0 1.6 12.9 0.0 136.0 21.5 0.1 0.2 0.0 0.0 0.0 ANKRD33 "C12orf7, DKFZp686O1689, PANKY" ENSG00000167612 "Ankyrin repeat domain 33" Q7Z3H0 12 51887960-51891664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "placenta: 21.9;retina: 19.5" "Group enriched" "Detected in some" 23 "Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 154.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA058753 Enhanced NA NA "HPA058753: AB_2683808" "unprognostic (4.42e-2)" "unprognostic (2.13e-5)" "unprognostic (8.25e-4)" "unprognostic (2.37e-1)" "unprognostic (3.25e-5)" "unprognostic (2.42e-1)" "unprognostic (4.07e-1)" "unprognostic (6.21e-2)" "unprognostic (5.51e-10)" "unprognostic (4.41e-3)" "unprognostic (5.56e-2)" "unprognostic (2.18e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.8 21.9 0.0 0.0 0.0 19.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.0 154.5 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 ANKRD33B ENSG00000164236 "Ankyrin repeat domain 33B" A6NCL7 5 10564330-10657816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.3" "Cell type enriched" "Detected in many" 5 "Cone photoreceptor cells: 329.9" "Cancer enhanced" "Detected in many" "renal cancer: 7.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.1;memory B-cell: 1.4" "Group enriched" "Detected in many" 4 "B-cells: 1.4;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "HDLM-2: 27.4;HMC-1: 18.5" "Group enriched" "Detected in many" 9 "amygdala: 13.6;basal ganglia: 16.9;cerebral cortex: 26.5;hippocampal formation: 22.4;olfactory region: 16.5" "Group enriched" "Detected in all" 6 "amygdala: 13.7;basal ganglia: 24.2;cerebral cortex: 30.1;hippocampal formation: 25.2;olfactory region: 26.0" HPA056974 Uncertain Approved Mitochondria NA NA Mitochondria "HPA056974: AB_2683295" "unprognostic (6.19e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-2)" "unprognostic (5.65e-3)" "unprognostic (2.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (4.50e-3)" "unprognostic (4.41e-1)" "unprognostic (2.42e-3)" "unprognostic (1.14e-1)" "unprognostic (1.00e-1)" "prognostic favorable (4.16e-5)" "unprognostic (1.17e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (5.47e-2)" 3.8 1.1 6.3 8.6 9.3 13.2 3.6 1.4 25.3 5.2 3.2 0.1 0.4 0.9 7.8 1.1 3.3 5.4 1.9 7.0 8.4 2.3 10.0 1.5 3.0 5.4 2.0 7.5 1.7 2.7 0.5 1.7 3.5 1.3 3.5 2.0 12.7 2.3 4.4 9.0 11.3 3.3 6.9 1.7 11.1 3.1 5.2 1.1 7.2 1.6 12.5 7.2 4.9 16.6 1.4 0.0 2.1 0.0 0.0 0.4 0.4 2.5 3.8 0.2 0.3 9.0 4.3 11.4 0.7 1.2 1.5 1.8 4.7 2.1 14.0 12.8 2.4 1.8 2.6 1.3 1.3 1.7 27.4 0.9 5.5 3.4 0.0 4.1 4.2 18.5 2.1 1.0 0.8 5.2 0.3 1.9 1.0 1.2 6.8 0.4 0.0 0.2 5.0 3.0 0.0 1.1 1.1 2.9 0.4 5.1 1.8 0.0 0.1 0.0 0.2 0.4 10.0 0.0 5.2 5.4 0.9 5.6 4.6 1.3 8.0 8.7 1.2 0.2 6.8 0.3 0.0 0.0 2.1 0.2 0.0 0.0 1.4 0.4 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.4 6.3 9.3 1.4 25.3 8.4 2.3 2.0 7.5 1.3 1.1 11.9 1.0 1.9 1.7 0.3 14.4 4.5 0.0 0.0 1.2 3.5 329.9 1.0 1.7 1.8 4.9 2.3 0.0 0.0 0.2 0.8 5.0 3.1 0.0 0.0 0.2 6.4 0.0 2.5 0.0 0.0 1.4 0.7 1.7 26.2 0.0 5.8 0.2 0.0 0.0 18.3 67.9 0.0 0.2 0.0 1.9 1.0 0.5 0.5 0.0 1.7 ANKRD34A ANKRD34 ENSG00000272031 "Ankyrin repeat domain 34A" Q69YU3 1 145959442-145964582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 18.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 8.1;Cardiomyocytes: 2.9;Muller glia cells: 1.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.5;T-cells: 3.5" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029642, HPA029643" Uncertain Enhanced Cytosol NA NA Cytosol "HPA029642: AB_10599277, HPA029643: AB_10601878" "unprognostic (1.98e-1)" "unprognostic (5.66e-2)" "unprognostic (1.90e-2)" "unprognostic (1.05e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-2)" "unprognostic (4.36e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-1)" "unprognostic (3.19e-1)" "unprognostic (2.15e-2)" "unprognostic (6.68e-3)" "unprognostic (9.66e-8)" "unprognostic (6.36e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (9.23e-2)" 0.8 1.3 6.4 2.0 10.5 0.3 0.6 7.8 18.1 0.9 0.7 1.2 0.0 1.6 1.5 1.2 0.9 0.7 1.1 1.7 4.2 0.5 0.2 0.7 1.4 0.4 6.7 1.6 0.5 2.0 1.2 0.5 5.7 1.7 0.4 1.3 0.8 2.2 2.3 0.8 1.6 1.6 0.0 1.4 1.1 0.5 1.0 0.0 0.6 0.0 1.5 0.9 0.0 1.5 0.4 0.6 0.3 0.3 3.5 1.0 1.4 0.8 0.7 2.5 3.6 2.8 0.3 2.7 5.2 0.6 1.7 0.2 0.8 2.8 0.3 3.5 1.4 0.6 1.1 0.8 0.4 5.9 1.7 0.2 2.1 0.0 0.5 0.3 2.3 2.5 0.3 2.3 2.6 3.7 0.9 2.3 1.3 6.4 4.0 2.5 1.1 0.8 0.3 0.2 3.1 0.3 0.7 12.6 1.1 0.1 3.5 2.5 0.5 0.1 1.6 0.3 3.6 0.4 0.8 6.3 4.3 5.3 1.4 4.5 8.6 0.4 6.2 2.2 0.5 0.0 0.1 0.6 3.5 0.3 2.6 1.5 1.7 1.9 0.4 1.4 2.3 3.4 0.3 0.3 0.0 0.1 1.7 1.0 0.0 0.0 0.0 0.4 0.2 8.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.5 0.3 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.4 0.3 1.4 0.0 0.7 0.4 0.4 0.1 0.1 0.0 0.0 0.1 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 46.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.7 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ANKRD34C ENSG00000235711 "Ankyrin repeat domain 34C" P0C6C1 15 79293285-79298235 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 5.8;skin 1: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 14.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045329 Approved Mitochondria NA NA Mitochondria "HPA045329: AB_2679291" "unprognostic (3.20e-1)" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.42e-3)" "unprognostic (5.31e-2)" "unprognostic (2.48e-1)" 0.5 0.3 0.6 0.0 0.5 0.0 0.0 5.8 5.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.9 5.0 0.1 0.0 0.3 0.0 2.4 0.0 0.7 0.1 1.2 0.0 0.1 0.1 0.0 0.2 0.2 3.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 42.4" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favorable (9.35e-4)" "prognostic favorable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 2.1 1.2 3.3 1.0 3.7 0.4 3.6 12.1 7.4 16.1 1.7 0.8 0.3 0.5 2.1 1.3 11.4 2.5 1.1 0.8 3.4 3.6 0.4 1.4 0.8 0.5 3.7 3.4 2.8 0.5 0.2 0.3 0.3 8.0 2.5 0.8 0.3 4.2 2.3 5.2 42.4 0.7 1.8 2.0 0.4 1.2 0.8 0.3 0.7 0.3 14.9 13.6 2.3 7.7 0.0 1.3 0.3 5.5 1.5 2.9 1.9 0.1 0.0 0.0 0.0 2.5 11.0 0.3 1.6 4.0 0.5 1.3 0.4 0.0 0.0 0.3 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.3 3.1 0.1 3.8 0.5 0.3 0.1 0.1 0.5 0.0 0.0 0.0 2.4 0.0 0.0 4.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.2 0.0 0.0 5.5 0.0 2.0 2.0 0.3 0.0 0.8 2.9 0.7 0.0 0.6 1.9 0.3 1.5 0.4 1.3 1.5 1.9 3.3 3.7 12.1 7.4 3.4 3.6 3.7 3.4 8.0 0.3 0.0 0.0 0.0 14.7 4.0 1.5 1.2 2.5 4.0 1.2 1.8 0.0 0.1 0.0 0.0 3.6 1.0 0.0 0.0 0.4 0.1 20.2 8.0 19.5 8.6 8.7 0.0 0.0 1.8 1.6 4.7 33.6 1.1 5.0 0.0 0.0 39.3 0.1 0.0 47.7 0.0 1.4 0.0 5.2 0.0 0.9 10.8 0.2 7.5 0.0 12.9 ANKRD36B "FLJ21281, KIAA1641" ENSG00000196912 "Ankyrin repeat domain 36B" Q8N2N9 2 97492663-97589965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 49.5" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "unprognostic (2.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-1)" "unprognostic (8.72e-3)" "unprognostic (5.03e-2)" "unprognostic (7.17e-3)" "unprognostic (4.20e-2)" "unprognostic (4.00e-2)" "unprognostic (2.13e-6)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (7.71e-3)" "unprognostic (6.98e-2)" 1.0 1.5 2.0 2.8 7.0 16.4 3.3 6.8 6.7 1.4 1.7 1.6 0.2 1.3 3.8 2.0 0.5 2.0 2.1 0.8 3.1 1.1 0.4 2.2 2.3 4.3 6.2 3.8 1.7 1.8 3.3 0.7 3.9 1.8 2.7 1.0 2.6 3.0 0.7 3.6 2.1 1.9 1.9 1.7 1.7 7.5 4.0 4.2 1.3 2.8 2.1 1.2 0.8 3.5 2.6 3.4 0.7 2.6 3.0 0.3 3.6 2.3 2.7 2.3 1.6 3.6 1.7 2.6 1.7 1.7 1.9 2.2 4.5 5.2 1.4 2.1 1.6 1.7 1.7 1.2 1.8 1.5 4.2 4.1 4.7 1.6 1.2 3.2 2.4 2.4 2.1 2.1 3.5 4.0 2.2 10.7 5.5 4.4 2.0 0.9 4.0 5.8 1.3 0.8 2.7 5.0 1.3 1.8 1.8 2.3 3.0 4.3 1.9 1.6 1.4 3.6 2.6 3.0 3.3 3.0 3.5 3.5 3.4 6.1 7.7 4.8 1.8 4.3 1.5 3.4 0.7 0.9 2.2 0.3 2.0 2.2 2.6 1.8 0.3 3.5 3.0 2.3 0.5 2.6 0.2 2.6 1.3 0.3 11.9 16.7 6.2 6.2 0.0 34.4 12.2 2.5 30.8 31.8 8.7 19.6 1.3 0.0 6.9 39.2 6.8 2.6 0.0 11.9 3.0 2.6 4.5 22.0 0.6 2.9 15.9 13.8 3.1 2.7 3.6 11.8 3.9 0.0 10.0 9.0 9.5 8.7 4.0 7.1 0.5 35.1 6.5 1.4 49.5 6.8 0.0 0.1 13.8 5.8 10.4 ANKRD36C DKFZp667P0924 ENSG00000174501 "Ankyrin repeat domain 36C" Q5JPF3 2 95836919-95991831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.6" "Cell type enhanced" "Detected in many" 9 "Exocrine glandular cells: 514.5;Pancreatic endocrine cells: 319.5;Urothelial cells: 431.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 25.5" "HPA051757, HPA057661" Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051757: AB_2681594, HPA057661: AB_2683494" "unprognostic (2.21e-1)" "unprognostic (5.39e-2)" "unprognostic (6.32e-2)" "unprognostic (2.50e-1)" "unprognostic (1.83e-1)" "unprognostic (3.79e-3)" "unprognostic (1.29e-1)" "unprognostic (5.57e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.44e-2)" "unprognostic (5.29e-3)" "unprognostic (5.35e-6)" "unprognostic (9.99e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" 2.2 1.0 4.2 1.8 4.1 13.2 5.3 8.0 5.8 3.1 3.1 0.5 2.8 0.7 3.2 1.9 1.8 2.6 4.0 1.5 3.3 1.8 1.2 0.8 2.0 2.7 1.6 1.7 5.6 3.1 1.2 3.9 0.9 3.1 1.6 2.1 2.1 9.2 1.5 0.9 2.9 2.6 1.5 1.9 2.4 4.5 10.1 1.1 2.8 1.6 2.4 4.0 2.5 2.2 11.1 19.6 18.1 2.0 7.2 12.5 0.7 6.6 1.3 2.8 1.9 1.8 4.9 1.0 1.6 1.1 2.1 2.7 1.5 1.5 6.6 2.1 1.1 2.1 1.5 2.5 1.2 2.7 3.8 3.3 2.7 3.2 1.9 0.4 7.8 2.0 1.4 1.0 1.6 0.8 2.1 3.5 9.6 2.6 8.4 2.3 0.9 6.0 2.9 0.6 0.3 25.5 3.2 2.1 2.7 1.0 1.3 2.5 2.2 1.0 1.7 1.1 1.1 0.8 1.9 3.9 2.6 2.9 2.0 1.9 3.2 2.6 7.2 0.7 5.4 1.0 18.1 2.0 1.5 12.5 0.3 8.1 9.2 10.0 8.1 1.4 11.1 8.7 8.5 0.1 7.2 0.5 19.6 8.3 0.7 4.2 4.1 8.0 5.8 3.3 1.8 1.6 1.7 3.1 1.1 35.7 24.0 8.3 28.7 9.5 80.2 21.4 5.1 61.6 79.6 8.7 74.6 0.2 0.0 187.2 85.1 14.3 7.4 23.3 514.5 0.7 15.0 147.9 31.4 1.3 6.9 31.8 20.2 8.0 6.7 8.4 30.2 13.0 13.5 40.5 53.0 17.5 319.5 7.4 34.3 0.3 74.8 19.4 17.0 86.7 12.4 6.5 0.2 28.8 13.0 431.0 ANKRD40 MGC15396 ENSG00000154945 "Ankyrin repeat domain 40" Q6AI12 17 50693190-50707924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021668, HPA021759, HPA074884" Uncertain Approved "Nucleoli fibrillar center,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoli fibrillar center, Cytosol" "HPA021668: AB_1844843, HPA021759: AB_2227411, HPA074884: " "unprognostic (2.73e-1)" "unprognostic (1.82e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (4.99e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (7.02e-4)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (3.84e-2)" "unprognostic (1.53e-1)" "unprognostic (4.77e-2)" "unprognostic (1.00e-2)" "unprognostic (9.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.32e-1)" 25.1 13.0 39.1 9.3 44.1 4.4 20.2 13.7 27.0 12.3 11.3 42.9 7.8 7.4 14.6 9.2 11.9 9.2 10.4 14.8 42.1 29.0 11.5 11.2 14.1 9.6 58.5 15.1 13.8 10.9 19.0 4.9 14.4 26.1 12.2 10.7 7.6 8.8 16.7 59.2 7.8 7.7 17.9 67.2 12.2 9.1 6.4 34.1 4.7 10.9 8.6 8.9 10.6 16.4 9.5 13.3 6.6 10.8 9.6 13.8 3.8 18.9 18.3 16.6 16.6 23.9 19.9 14.5 17.1 18.8 20.1 19.0 38.6 9.7 20.1 24.0 21.9 21.6 10.8 23.6 13.9 32.8 18.5 15.2 27.5 11.9 18.9 13.1 19.1 11.7 17.0 14.3 19.5 24.5 14.7 15.7 16.7 15.5 20.3 16.5 14.8 23.8 6.9 18.3 15.4 17.3 16.3 30.0 14.3 15.7 16.4 8.8 24.6 9.5 13.1 18.3 30.1 15.1 12.8 19.1 27.3 21.6 14.1 21.8 21.5 19.6 18.3 15.0 7.4 22.2 6.6 7.1 2.8 10.9 10.3 12.4 9.5 12.2 12.3 6.6 9.4 11.5 13.8 1.8 9.6 10.8 13.3 8.5 3.8 39.1 44.1 13.7 27.0 42.1 29.0 58.5 15.1 26.1 34.1 14.9 10.7 16.2 21.0 40.1 14.2 28.6 7.6 4.0 3.4 17.4 3.9 14.2 23.2 16.2 1.7 28.1 8.0 0.0 15.0 17.0 18.3 19.2 9.2 16.6 16.6 33.4 5.8 29.4 22.2 0.9 31.7 20.2 25.3 9.0 12.3 15.3 16.3 10.5 35.3 17.4 9.8 45.3 26.1 19.3 23.9 29.1 8.9 19.2 12.8 21.1 ANKRD42 "FLJ37874, PPP1R79, SARP" ENSG00000137494 "Ankyrin repeat domain 42" Q8N9B4 11 83193739-83260694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 73.6;Early spermatids: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039917 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039917: AB_10672894" "unprognostic (6.59e-2)" "unprognostic (9.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.31e-3)" "unprognostic (9.12e-2)" "unprognostic (3.78e-1)" "unprognostic (1.67e-2)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (1.09e-2)" "unprognostic (3.10e-3)" "unprognostic (1.79e-1)" "unprognostic (4.25e-1)" "unprognostic (1.90e-1)" 5.6 14.5 13.9 5.4 22.1 8.3 7.1 4.8 15.1 8.2 5.4 3.0 11.6 5.8 6.9 22.2 5.6 17.2 8.7 5.4 18.1 13.4 12.3 5.2 7.4 4.5 8.2 12.4 9.9 8.6 16.8 17.9 4.5 13.1 8.4 4.8 6.5 6.7 10.3 6.1 6.2 5.3 6.7 8.7 4.8 6.4 41.8 5.3 1.0 13.0 1.5 4.5 6.8 16.1 7.1 4.8 7.9 11.1 5.8 4.3 2.1 3.9 6.9 3.3 6.8 10.7 11.2 3.0 8.1 6.3 4.8 3.0 4.2 4.8 1.7 10.5 7.2 9.7 8.5 3.5 5.5 4.0 2.2 2.8 2.8 9.4 2.7 7.4 7.8 6.6 6.6 6.6 12.1 6.5 9.4 4.9 2.8 8.1 1.6 6.9 5.8 1.1 8.6 2.8 6.1 4.4 1.9 5.0 2.0 16.0 4.7 2.7 3.5 10.5 6.6 2.1 4.6 9.9 4.4 7.1 7.5 5.2 27.2 3.7 2.1 4.7 3.3 5.9 4.9 3.1 7.9 3.6 4.3 4.1 4.1 2.8 7.1 3.7 4.3 4.8 5.2 1.9 3.0 3.0 5.8 11.1 2.0 1.4 2.1 13.9 22.1 4.8 15.1 18.1 13.4 8.2 12.4 13.1 5.3 8.9 13.6 3.2 17.5 10.0 3.0 6.7 7.6 73.6 7.9 7.0 37.3 2.7 8.3 6.6 123.0 7.1 3.6 0.0 5.8 2.7 8.7 10.0 12.8 3.8 4.4 1.6 2.9 9.2 8.2 53.0 8.1 9.0 6.8 6.4 3.2 6.7 5.4 3.6 9.9 11.4 21.3 12.9 8.7 38.6 18.1 13.4 4.6 7.0 3.1 11.2 ANKRD44 PP6-ARS-B ENSG00000065413 "Ankyrin repeat domain 44" Q8N8A2 2 196967017-197311173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.7;lymphoid tissue: 38.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 93.2;Macrophages: 60.1;T-cells: 81.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HMC-1: 20.7;Karpas-707: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030122, HPA056549" Approved Approved "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA030122: AB_10600980, HPA056549: AB_2683170" "unprognostic (3.64e-1)" "unprognostic (1.70e-2)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-1)" "unprognostic (7.04e-5)" "unprognostic (1.97e-2)" "unprognostic (1.58e-3)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (1.33e-1)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" "unprognostic (3.67e-2)" 6.0 6.0 4.9 29.4 8.8 12.5 4.3 3.7 5.1 8.6 6.7 10.8 3.9 3.2 6.5 3.9 4.3 4.9 7.6 6.4 6.4 4.7 5.6 4.5 15.4 36.7 9.4 4.7 5.1 3.5 6.0 6.1 6.4 6.4 5.0 4.8 7.4 8.0 4.7 2.9 3.0 12.6 9.6 8.0 17.8 5.6 7.1 8.9 38.2 5.1 3.0 27.0 9.0 9.8 15.7 9.4 34.7 11.4 12.0 13.4 6.3 1.0 0.6 1.6 1.7 3.9 1.6 0.3 2.5 1.1 1.3 1.2 0.4 0.6 9.0 1.1 2.1 2.3 0.1 0.6 0.5 1.0 26.6 2.3 0.3 3.2 0.1 0.2 6.5 20.7 0.8 0.3 1.3 0.1 1.9 1.7 2.2 1.5 15.0 1.9 1.5 3.1 5.3 0.2 0.3 1.7 5.7 1.9 12.3 3.1 0.8 1.7 7.4 0.8 0.6 7.0 1.3 0.9 6.4 9.3 4.6 2.5 1.3 1.8 3.7 4.4 11.4 3.1 8.2 2.6 21.8 9.5 21.0 13.1 9.8 12.4 11.6 9.8 11.1 9.4 15.7 11.3 13.4 34.7 12.0 11.4 6.2 9.3 6.3 4.9 8.8 3.7 5.1 6.4 4.7 9.4 4.7 6.4 8.9 14.9 19.2 93.2 4.0 3.1 5.0 7.8 25.5 12.0 13.6 10.4 3.9 3.9 1.7 3.0 10.6 6.7 1.1 0.0 4.0 0.7 5.8 3.2 52.0 7.4 16.4 3.2 2.4 44.2 57.8 12.9 14.4 60.1 35.4 19.8 1.1 10.8 3.8 3.5 16.6 1.1 11.1 19.4 6.1 3.0 3.6 3.1 1.1 81.3 0.8 4.3 ANKRD45 "CT117, FLJ45235" ENSG00000183831 "Ankyrin repeat domain 45" Q5TZF3 1 173609561-173669862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8" "Group enriched" "Detected in some" 5 "Ciliated cells: 33.5;Cone photoreceptor cells: 35.3;Early spermatids: 19.6;Late spermatids: 9.9;Spermatocytes: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.5;GAMG: 4.1;HBF TERT88: 4.3;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031655, HPA031656, HPA031657" Enhanced Approved "Plasma membrane,Centrosome,Cytosol" NA NA Cytosol "Plasma membrane, Centrosome" "HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196" "unprognostic (1.93e-1)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-1)" "unprognostic (3.57e-2)" "unprognostic (2.69e-3)" "unprognostic (4.15e-2)" "unprognostic (6.93e-2)" "unprognostic (2.45e-1)" "unprognostic (3.05e-2)" "unprognostic (4.49e-2)" "unprognostic (8.80e-3)" "unprognostic (2.91e-2)" "unprognostic (5.15e-2)" "unprognostic (1.61e-1)" 0.5 1.3 5.9 0.4 14.6 0.5 0.6 1.1 7.0 2.8 0.7 9.0 1.3 0.4 3.3 2.5 0.5 24.8 1.0 0.9 7.7 4.7 2.7 0.5 2.8 0.4 2.4 5.3 2.4 1.0 16.8 7.9 0.4 9.2 1.9 0.5 1.8 0.4 1.2 0.4 0.4 0.5 2.4 2.7 1.3 0.5 20.8 4.2 0.0 1.3 0.0 0.4 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 12.0 0.0 0.0 1.0 2.1 0.1 4.2 3.8 6.5 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 2.3 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.3 0.4 0.0 1.6 10.8 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.0 2.2 0.1 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.9 14.6 1.1 7.0 7.7 4.7 2.4 5.3 9.2 4.2 0.0 1.7 0.0 0.2 0.2 0.5 0.7 0.0 33.5 1.2 5.2 35.3 0.2 1.7 0.6 19.6 1.5 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 9.9 1.7 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.4 0.5 1.8 0.0 0.3 28.6 4.9 0.0 0.1 0.0 0.0 0.1 ANKRD53 "FLJ12056, FLJ36160" ENSG00000144031 "Ankyrin repeat domain 53" Q8N9V6 2 70978380-70985499 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.9" "Group enriched" "Detected in many" 20 "Early spermatids: 135.6;Late spermatids: 386.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 10.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 10.2" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;HHSteC: 4.7;HSkMC: 5.0" "Not detected" "Not detected" HPA049574 Approved NA NA "HPA049574: AB_2680819" "unprognostic (6.11e-3)" "unprognostic (6.51e-2)" "unprognostic (1.70e-3)" "unprognostic (2.68e-1)" "unprognostic (2.01e-2)" "unprognostic (6.31e-3)" "unprognostic (2.20e-1)" "unprognostic (6.35e-2)" "unprognostic (3.53e-1)" "unprognostic (1.27e-1)" "unprognostic (6.39e-3)" "unprognostic (1.83e-1)" "unprognostic (1.13e-2)" "unprognostic (1.68e-3)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" 5.9 1.7 1.3 1.6 1.5 0.4 4.4 2.2 1.1 1.8 3.0 2.7 1.3 1.2 2.8 0.8 1.0 3.7 1.1 0.9 1.7 0.7 1.1 0.4 2.0 1.6 0.1 0.1 5.8 7.9 0.9 2.5 2.1 2.3 1.5 0.4 4.0 6.9 1.4 0.7 0.7 2.7 1.0 0.8 0.7 1.5 19.9 0.7 0.1 2.5 1.4 0.5 1.2 3.8 0.2 10.2 2.1 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.3 3.2 1.5 0.4 0.3 1.3 1.2 1.2 0.6 0.0 0.1 0.1 2.4 0.7 0.2 0.3 0.0 0.1 0.1 0.1 0.7 0.2 0.4 4.7 0.0 0.2 5.0 0.0 1.3 0.1 0.5 1.3 0.1 0.3 0.1 0.8 0.1 0.1 0.4 0.0 0.0 0.3 0.3 0.3 0.1 0.0 0.0 1.4 0.1 0.1 0.0 0.2 0.5 0.1 0.0 1.6 0.8 0.4 1.1 0.0 0.7 0.0 0.1 0.4 0.0 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 1.3 1.5 2.2 1.1 1.7 0.7 0.1 0.1 2.3 0.7 0.0 0.0 0.8 1.7 0.1 1.1 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.7 135.6 0.1 0.0 0.0 0.3 0.9 1.4 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 386.2 3.1 0.0 0.0 0.0 0.0 3.9 0.7 0.0 2.8 1.1 13.4 6.5 1.0 1.8 1.6 0.0 0.2 0.0 0.0 0.1 ANKRD55 FLJ11795 ENSG00000164512 "Ankyrin repeat domain 55" Q3KP44 5 56099678-56233359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 14.3;brain: 20.0;liver: 5.7;lymphoid tissue: 6.1;testis: 16.7" "Group enriched" "Detected in some" 7 "Early spermatids: 143.8;Ito cells: 52.8" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 12.6;eosinophil: 13.1;naive CD4 T-cell: 14.3" "Group enriched" "Detected in many" 67 "granulocytes: 13.1;T-cells: 14.3" "Group enriched" "Detected in some" 6 "HEL: 24.5;HMC-1: 12.7;NB-4: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051049, HPA061649" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA051049: AB_2681326, HPA061649: " "unprognostic (1.00e-4)" "unprognostic (1.58e-4)" "unprognostic (2.63e-1)" "unprognostic (1.93e-1)" "unprognostic (7.78e-4)" "unprognostic (1.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.33e-2)" "unprognostic (1.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.33e-1)" "unprognostic (1.40e-1)" "unprognostic (7.19e-6)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (1.01e-1)" 0.9 0.5 3.3 1.3 20.0 1.4 0.5 0.5 6.7 0.3 0.5 1.5 0.0 0.5 0.3 0.2 0.6 0.6 0.8 0.4 4.3 7.8 1.1 5.7 0.6 6.1 2.3 3.5 0.5 0.3 0.2 0.5 1.4 9.9 0.3 0.7 0.7 2.1 0.3 0.3 0.9 2.4 0.5 4.1 3.0 0.7 16.7 1.8 0.0 0.4 0.0 3.8 1.0 0.3 0.0 0.0 13.1 0.2 0.0 14.3 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.1 0.9 0.0 1.1 12.7 0.0 0.0 0.0 0.0 0.0 3.0 0.0 2.0 0.8 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.3 0.0 1.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.4 0.3 12.6 0.2 13.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 14.3 0.5 1.2 0.0 0.0 0.0 0.6 2.1 3.3 20.0 0.5 6.7 4.3 7.8 2.3 3.5 9.9 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 143.8 1.0 0.0 0.0 0.2 0.3 0.6 0.0 2.3 0.5 0.6 0.0 0.0 52.8 4.1 14.1 0.6 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.7 0.2 0.0 0.0 0.0 3.2 0.5 0.0 1.0 2.2 0.0 0.1 ANKRD6 KIAA0957 ENSG00000135299 "Ankyrin repeat domain 6" Q9Y2G4 6 89433170-89633834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.8" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;intermediate monocyte: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.2;BEWO: 31.2;HAP1: 9.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020693, HPA035694, HPA064642" Approved Enhanced Vesicles NA NA Vesicles "CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310" "unprognostic (3.80e-1)" "unprognostic (3.16e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.29e-2)" "unprognostic (4.95e-2)" "unprognostic (2.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.26e-1)" "unprognostic (1.81e-1)" "unprognostic (1.43e-3)" "unprognostic (2.28e-1)" "unprognostic (3.01e-1)" "unprognostic (2.10e-1)" 3.9 2.2 11.7 3.0 7.8 1.6 3.9 47.8 17.8 5.7 2.9 2.8 1.1 1.0 6.1 4.4 4.9 11.7 5.7 8.9 7.8 9.1 5.4 4.5 5.7 2.5 4.2 12.0 15.6 4.3 9.3 4.2 4.3 7.3 3.6 1.1 6.6 7.7 2.3 4.0 1.9 1.8 5.4 5.0 2.0 2.6 6.1 3.7 2.0 5.6 3.3 2.5 4.4 4.0 0.3 0.1 3.0 2.9 0.6 1.0 0.3 0.0 1.3 10.2 4.3 0.1 0.4 31.2 0.1 0.1 0.0 0.6 0.3 0.8 0.0 1.0 0.0 4.7 0.0 9.3 5.2 0.4 0.0 6.9 3.7 0.0 0.3 0.1 0.0 1.4 0.6 1.4 0.0 0.0 0.0 1.0 0.9 0.3 2.3 0.0 1.1 0.1 0.3 2.9 0.4 1.0 3.6 0.0 0.0 1.5 5.2 6.7 2.4 0.8 6.9 3.4 6.5 2.0 2.2 0.0 1.7 0.6 0.1 0.8 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.4 3.0 1.0 2.9 0.0 0.0 0.7 0.0 0.1 0.3 0.3 0.4 0.7 0.6 0.0 0.0 0.2 0.3 11.7 7.8 47.8 11.6 7.8 9.1 4.2 12.0 7.3 3.7 14.9 14.2 0.0 4.6 0.8 0.6 3.9 10.2 10.7 7.9 1.8 11.8 2.5 10.0 4.8 2.5 4.1 0.0 0.0 10.0 6.5 4.7 1.8 10.4 2.5 2.3 0.0 1.7 4.9 2.7 4.3 8.9 1.1 3.3 3.6 0.0 5.7 4.2 0.0 26.2 3.4 1.6 6.5 3.3 5.4 4.9 1.0 1.6 1.3 0.0 4.3 ANKRD60 "bA196N14.3, C20orf86" ENSG00000124227 "Ankyrin repeat domain 60" Q9BZ19 20 58218495-58228653 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 40 "testis: 7.7" "Group enriched" "Detected in some" 19 "Early spermatids: 3.2;Late spermatids: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060561 Uncertain NA NA "HPA060561: AB_2684318" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ANKRD61 ENSG00000157999 "Ankyrin repeat domain 61" A6NGH8 7 6031376-6036386 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 8.7;testis: 9.1" "Group enriched" "Detected in some" 19 "Early spermatids: 44.1;Late spermatids: 19.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029511, HPA050732" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029511: AB_10602430, HPA050732: " "unprognostic (1.40e-1)" "unprognostic (1.03e-3)" "unprognostic (9.32e-2)" "unprognostic (5.67e-2)" "unprognostic (1.73e-1)" "unprognostic (2.56e-2)" "unprognostic (6.76e-2)" "unprognostic (2.65e-1)" "unprognostic (8.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.98e-1)" "unprognostic (6.68e-2)" "unprognostic (2.73e-2)" "unprognostic (5.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.63e-1)" 0.5 0.5 0.0 0.7 0.2 8.7 0.7 0.5 0.9 0.4 0.3 0.6 0.6 0.0 0.4 0.5 0.2 0.6 0.1 0.1 0.3 0.5 0.5 1.1 0.0 0.8 1.0 0.1 0.5 0.4 0.4 0.0 0.9 0.0 0.6 2.1 0.8 0.0 0.2 0.9 0.9 9.1 0.9 0.0 0.5 0.5 0.6 1.5 0.9 1.1 0.0 0.8 0.3 2.2 6.0 1.8 2.8 0.3 0.3 2.6 1.4 0.4 0.6 0.6 3.0 5.6 1.1 0.6 0.2 2.6 2.2 1.0 0.0 0.7 0.3 0.8 1.5 12.7 0.4 0.2 1.7 2.6 0.4 1.2 0.5 1.1 1.3 0.5 1.7 2.0 1.8 0.7 3.8 0.3 1.8 0.9 0.4 0.7 1.6 0.5 0.3 0.5 2.9 1.4 2.5 1.4 1.6 0.2 2.9 3.0 1.1 1.2 2.4 4.9 2.9 1.8 1.6 1.8 0.9 0.7 1.4 1.5 0.9 1.1 0.0 0.1 1.1 0.0 0.0 0.0 0.8 1.5 0.6 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 ANKRD62 DKFZp779B1634 ENSG00000181626 "Ankyrin repeat domain 62" A6NC57 18 12093853-12129749 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 47.1" "Group enriched" "Detected in some" 12 "Spermatocytes: 42.4;Spermatogonia: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-2 OS: 2.6" HPA059835 Enhanced NA NA "HPA059835: AB_2684136" "unprognostic (2.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-3)" "unprognostic (9.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (6.61e-2)" "unprognostic (7.95e-2)" "unprognostic (3.27e-1)" "unprognostic (2.55e-4)" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (4.52e-3)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.2 0.3 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.3 0.3 0.0 1.4 0.7 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.0 0.6 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.4 0.0 1.0 0.0 0.0 42.4 12.4 1.0 0.0 0.0 0.0 0.3 ANKRD63 ENSG00000230778 "Ankyrin repeat domain 63" C9JTQ0 15 40281444-40282586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 8 "basal ganglia: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;HEK 293: 5.5;HEL: 2.7;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 4.0" "Region enhanced" "Detected in many" "basal ganglia: 50.7" "Region enhanced" "Detected in many" "basal ganglia: 40.3" HPA066743 Approved Mitochondria NA NA Mitochondria "HPA066743: " "unprognostic (9.36e-2)" "unprognostic (7.45e-2)" "unprognostic (8.32e-2)" "unprognostic (4.42e-1)" 0.2 0.2 1.8 0.4 22.4 0.2 0.2 0.3 4.7 0.2 0.2 0.0 0.0 0.2 0.3 0.2 0.2 0.7 0.3 0.5 0.3 0.4 1.3 0.2 0.2 0.3 0.3 1.1 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.5 0.2 0.0 0.7 0.3 0.7 1.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.5 2.7 1.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.1 0.0 0.0 0.2 1.9 0.2 0.0 0.4 1.4 0.0 0.4 0.0 0.1 2.0 0.2 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 22.4 0.3 2.8 0.3 0.4 0.3 1.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD65 ENSG00000235098 "Ankyrin repeat domain 65" E5RJM6 1 1418420-1421769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;fallopian tube: 33.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "myeloid DC: 4.8;plasmacytoid DC: 10.4" "Lineage enriched" "Detected in single" 20 "dendritic cells: 10.4" "Group enriched" "Detected in some" 7 "Hep G2: 20.3;RT4: 20.0;SCLC-21H: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065720 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA065720: AB_2685545" "unprognostic (2.17e-2)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.77e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.64e-1)" "unprognostic (4.39e-1)" "unprognostic (1.16e-1)" "unprognostic (4.43e-2)" "unprognostic (5.14e-2)" "unprognostic (3.02e-3)" "unprognostic (1.81e-2)" "unprognostic (8.04e-2)" "unprognostic (2.76e-2)" 4.6 1.1 12.4 2.8 20.8 0.4 4.2 8.0 13.3 6.7 4.8 21.0 3.7 2.2 4.0 5.6 6.7 33.6 2.7 2.2 12.0 8.6 1.9 0.9 9.9 7.1 37.8 8.2 6.9 13.3 1.1 0.6 6.3 13.7 8.9 1.8 2.1 14.0 21.2 2.8 4.8 2.1 3.8 16.7 1.4 4.3 3.1 28.0 4.2 1.8 1.0 6.3 13.2 3.3 0.5 10.4 0.3 0.3 0.0 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.5 0.0 2.6 0.2 2.5 0.0 0.3 0.2 0.0 0.0 20.3 0.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 2.7 0.0 0.0 20.0 27.7 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 4.8 0.5 0.1 0.4 0.0 0.0 0.0 10.4 0.0 0.2 12.4 20.8 8.0 13.3 12.0 8.6 37.8 8.2 13.7 28.0 20.8 25.3 0.0 11.4 1.9 8.4 0.6 12.7 56.2 20.5 1.8 0.0 21.2 8.3 12.9 0.0 5.0 0.0 0.0 27.8 0.4 3.8 7.3 8.1 0.6 2.0 7.9 1.7 1.8 0.6 0.0 19.2 2.9 3.3 1.8 0.0 16.0 12.0 0.0 27.3 0.3 2.2 0.0 2.6 0.4 0.3 2.8 14.1 0.0 0.0 7.9 ANKRD66 ENSG00000230062 "Ankyrin repeat domain 66" B4E2M5 6 46746917-46759506 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 210.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Region enhanced" "Detected in many" "pons and medulla: 15.0" "Cell type enriched" "Detected in single" 6 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-3)" "unprognostic (2.52e-1)" "unprognostic (2.44e-2)" "unprognostic (2.03e-2)" "unprognostic (9.36e-2)" "unprognostic (4.30e-3)" "unprognostic (2.19e-1)" 0.1 0.2 2.0 0.2 4.3 0.1 0.2 0.0 0.6 1.7 0.1 5.9 0.0 0.1 0.9 12.1 0.1 36.0 0.1 0.1 3.0 3.0 0.1 0.1 7.1 0.2 0.0 0.0 11.1 0.1 0.1 0.5 0.2 15.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.2 0.9 1.9 0.0 0.2 0.1 0.2 0.2 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.3 0.0 0.6 3.0 3.0 0.0 0.0 15.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 210.1 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD7 TSA806 ENSG00000106013 "Ankyrin repeat domain 7" Q92527 7 118214669-118496171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "testis: 184.1" "Group enriched" "Detected in some" 4 "Early spermatids: 2368.8;Spermatocytes: 2786.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 5.2;JURKAT: 5.8;SCLC-21H: 9.8;U-266/70: 12.7;WM-115: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043489, HPA052941" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043489: AB_10959304, HPA052941: " "unprognostic (1.29e-1)" "unprognostic (7.22e-4)" "unprognostic (3.13e-3)" "unprognostic (6.16e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-1)" "unprognostic (5.51e-1)" "unprognostic (9.46e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (1.45e-2)" "unprognostic (1.55e-2)" "unprognostic (3.35e-2)" "unprognostic (3.57e-4)" "unprognostic (3.32e-2)" 0.1 0.1 0.5 0.0 0.8 0.0 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 1.3 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.9 0.0 1.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 3.1 0.4 1.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.2 1.6 0.0 3.1 0.0 0.1 0.3 0.1 1.4 1.0 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.4 0.7 0.0 0.4 0.0 5.8 0.0 2.2 1.4 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 2.4 0.0 0.0 1.9 0.0 0.0 1.2 0.4 0.0 1.1 0.3 0.0 12.7 0.6 0.5 1.8 0.0 4.0 0.0 0.0 1.0 0.4 0.0 0.3 3.1 0.2 0.6 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.8 0.1 1.0 0.4 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 2.5 0.0 0.0 0.0 0.0 0.1 5.0 0.1 2368.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 635.0 36.5 0.0 1.7 0.0 0.0 1.2 0.1 0.0 27.6 1.4 0.0 25.8 0.1 2786.2 17.7 0.1 0.0 0.0 0.0 0.0 ANKRD9 ENSG00000156381 "Ankyrin repeat domain 9" Q96BM1 14 102501760-102509799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.4" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 136.2;Enterocytes: 127.7;Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055985 Uncertain NA NA "HPA055985: AB_2682996" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (3.05e-2)" "unprognostic (1.26e-2)" "unprognostic (7.76e-2)" "unprognostic (7.31e-3)" "unprognostic (6.78e-2)" "unprognostic (3.97e-2)" "unprognostic (3.35e-1)" "unprognostic (2.99e-1)" "unprognostic (3.68e-1)" "unprognostic (1.17e-1)" "prognostic favorable (1.17e-7)" "unprognostic (3.89e-1)" "unprognostic (4.74e-1)" "unprognostic (1.32e-2)" "unprognostic (1.15e-1)" 5.5 5.1 7.1 2.6 4.5 10.0 4.6 5.6 11.8 2.5 12.6 3.6 2.3 31.6 2.0 4.9 5.8 1.5 6.7 27.0 6.0 4.2 6.3 3.8 3.8 0.9 5.5 4.3 2.8 5.2 8.0 1.8 8.3 9.0 5.4 6.8 4.6 7.1 3.9 67.4 6.2 20.5 3.0 6.1 2.6 10.2 10.1 4.6 0.4 2.6 13.3 2.7 4.7 4.1 0.5 0.4 1.2 2.3 0.9 1.1 0.4 9.0 4.3 7.9 7.4 8.2 3.4 12.4 10.9 4.1 4.9 4.9 1.1 6.1 0.0 12.3 3.0 5.5 14.9 3.8 2.2 2.5 6.4 15.6 2.4 7.3 2.0 4.2 0.8 8.0 1.7 13.4 2.7 2.7 3.2 2.1 1.2 4.6 0.8 2.3 7.9 1.2 2.5 3.7 14.1 19.7 12.2 7.4 0.5 5.0 9.4 6.4 6.8 7.7 5.1 13.3 4.8 7.7 3.4 4.8 5.1 6.5 24.5 8.4 7.1 3.8 0.2 6.0 1.7 4.9 0.7 0.4 0.2 0.3 0.5 0.6 0.2 0.3 0.2 0.4 0.5 0.5 0.3 1.2 0.9 2.3 0.4 1.1 0.4 7.1 4.5 5.6 11.8 6.0 4.2 5.5 4.3 9.0 4.6 17.9 5.0 2.0 30.5 11.6 7.4 37.9 17.8 1.4 6.8 14.0 2.0 8.0 77.9 3.1 136.2 5.8 127.7 116.8 4.2 22.7 7.3 36.9 32.2 11.1 23.3 15.9 16.0 6.2 5.7 14.0 5.2 3.6 10.1 0.0 37.8 10.8 4.7 48.6 9.2 11.9 7.2 12.9 5.7 2.3 7.6 17.7 15.3 3.2 43.8 52.4 ANKS1B "AIDA-1, ANKS2, cajalin-2, EB-1" ENSG00000185046 "Ankyrin repeat and sterile alpha motif domain containing 1B" Q7Z6G8 12 98726457-99984654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 66.2;skeletal muscle: 28.2" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 136.4;Horizontal cells: 28.6;Late spermatids: 63.3" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 12.1;ASC TERT1: 7.1;SCLC-21H: 13.2" "HPA044628, HPA078230" Enhanced Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA044628: , HPA078230: " "unprognostic (5.50e-2)" "unprognostic (3.26e-2)" "unprognostic (1.01e-2)" "unprognostic (6.87e-3)" "unprognostic (1.18e-1)" "unprognostic (1.14e-4)" "unprognostic (7.94e-2)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (4.97e-4)" "unprognostic (2.81e-1)" "unprognostic (1.14e-3)" "unprognostic (1.64e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.75e-3)" 2.3 4.5 21.4 1.7 41.2 1.2 3.7 21.0 66.2 3.3 2.3 27.5 0.0 1.5 3.3 2.4 3.9 4.4 2.2 2.2 28.3 17.3 5.4 1.8 2.0 1.6 20.3 24.8 9.7 2.1 1.9 4.4 2.7 16.0 4.1 2.1 0.1 3.8 3.7 28.2 1.9 1.6 3.3 25.8 2.0 1.8 7.6 23.0 0.0 6.3 0.0 1.3 2.1 0.8 2.1 2.4 5.3 3.1 3.1 8.3 1.3 0.3 2.5 12.1 2.9 4.9 7.1 0.7 0.0 1.2 0.9 0.9 0.3 0.9 1.0 0.5 1.8 3.7 0.5 0.1 0.1 0.3 1.5 0.8 0.1 0.8 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.9 0.2 0.7 0.5 0.5 3.5 0.1 2.2 0.9 0.0 0.3 0.1 0.0 13.2 1.4 1.1 3.9 1.5 1.0 4.5 0.1 0.1 1.1 1.1 0.7 0.7 0.1 0.7 0.6 1.1 0.3 1.1 5.3 1.4 2.1 1.7 2.1 2.5 1.9 2.9 1.6 1.3 2.1 2.4 2.3 3.9 3.1 3.1 2.4 8.3 1.3 21.4 41.2 21.0 27.9 28.3 17.3 20.3 24.8 16.0 23.0 3.0 3.8 0.0 1.1 1.0 13.7 2.5 0.0 5.3 2.3 8.7 17.7 0.3 0.0 0.1 136.4 0.7 0.0 0.0 0.0 0.2 3.2 0.4 1.1 0.2 0.5 28.6 0.0 0.6 0.0 63.3 1.1 0.8 5.0 0.0 0.0 1.7 0.0 0.0 5.6 2.6 2.8 6.5 1.4 4.7 4.5 1.3 0.7 1.0 0.0 0.6 ANKS4B "FLJ38819, HARP" ENSG00000175311 "Ankyrin repeat and sterile alpha motif domain containing 4B" Q8N8V4 16 21233665-21253845 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 64.5;kidney: 16.2;liver: 15.0" "Group enriched" "Detected in some" 14 "Enterocytes: 78.6;Hepatocytes: 24.1;Intestinal endocrine cells: 24.1;Mucus-secreting cells: 34.5;Paneth cells: 31.7;Proximal tubular cells: 28.1;Undifferentiated cells: 21.9" "Group enriched" "Detected in many" 8 "colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;HDLM-2: 5.4;Hep G2: 12.8;OE19: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043523, HPA061125" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043523: AB_10966687, HPA061125: " "unprognostic (1.35e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-2)" "unprognostic (3.32e-2)" "unprognostic (8.42e-3)" "unprognostic (8.61e-2)" "unprognostic (2.36e-1)" "unprognostic (9.48e-2)" "unprognostic (2.04e-1)" "unprognostic (4.08e-1)" "unprognostic (1.08e-1)" "unprognostic (9.75e-4)" "unprognostic (5.15e-3)" "unprognostic (1.88e-1)" "unprognostic (4.77e-2)" "unprognostic (4.34e-3)" 0.1 0.1 0.1 4.3 0.2 0.0 0.1 0.9 0.1 0.1 26.9 0.0 0.0 9.3 0.1 1.5 0.1 0.1 9.2 0.1 0.1 0.1 16.2 15.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.5 0.1 64.5 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.6 2.0 0.4 1.1 0.4 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.1 0.0 0.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 3.3 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.5 0.4 0.4 0.3 0.3 0.2 0.5 0.3 0.2 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.6 0.3 0.1 0.1 0.2 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.2 0.6 2.5 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.1 78.6 0.0 1.5 0.0 0.0 0.3 1.1 24.1 0.0 0.0 24.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 34.5 1.2 1.2 31.7 0.0 28.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 21.9 0.3 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favorable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.2 7.9 7.3 12.8 6.1 5.0 4.9 3.8 6.6 4.3 5.2 4.3 3.8 9.7 2.9 5.4 6.2 15.6 5.3 6.4 2.3 13.5 5.5 2.3 4.7 1.8 6.0 1.2 1.6 6.1 8.1 5.9 6.0 5.3 4.9 9.0 16.3 2.3 3.3 8.7 0.5 2.5 11.5 23.5 8.6 6.5 18.1 0.7 7.7 3.3 4.7 5.4 1.6 9.4 4.3 6.2 0.0 2.7 4.9 4.5 4.9 12.2 3.7 4.5 7.6 1.6 6.3 4.4 6.4 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 6.0 8.0 2.4 0.7 1.5 6.1 4.4 12.7 5.3 4.5 12.2 7.9 2.3 3.3 3.6 2.9 3.1 4.2 0.0 7.7 2.5 3.4 3.4 1.1 1.5 1.6 0.0 4.7 1.8 1.5 4.9 2.6 1.1 0.0 1.0 6.8 1.4 7.0 3.5 4.2 5.0 0.6 0.0 2.3 4.2 4.9 1.0 0.9 2.1 7.6 2.4 ANKUB1 C3orf16 ENSG00000206199 "Ankyrin repeat and ubiquitin domain containing 1" A6NFN9 3 149761100-149968385 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 12.2;lung: 11.9;ovary: 10.4" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 100.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 5.2" "Cell type enriched" "Detected in single" 8 "neutrophil: 4.8" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.8" "Cell line enhanced" "Detected in some" "OE19: 4.6" "Low region specificity" "Detected in all" HPA053749 Uncertain NA NA "HPA053749: AB_2682248" "unprognostic (1.71e-2)" "unprognostic (1.89e-4)" "unprognostic (1.01e-1)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-1)" "unprognostic (1.61e-2)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (2.18e-9)" "unprognostic (3.06e-1)" "unprognostic (2.96e-1)" "unprognostic (3.17e-1)" "unprognostic (7.07e-4)" 0.0 0.0 0.8 0.2 1.2 0.6 0.0 0.0 0.3 2.1 0.0 1.8 0.0 0.2 0.9 0.1 0.0 12.2 0.1 0.0 1.5 1.7 0.0 0.0 11.9 0.1 0.0 0.0 10.4 0.1 0.0 1.1 0.1 5.2 0.1 0.0 0.0 0.5 0.0 0.1 0.6 0.1 0.0 0.3 0.2 0.3 2.2 0.8 0.0 0.0 0.6 0.1 0.1 0.0 0.4 0.3 4.8 0.4 0.2 0.3 0.0 0.4 0.6 0.6 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.9 0.9 0.8 0.2 0.0 0.2 1.4 0.4 0.4 0.2 0.5 0.3 0.8 1.9 0.4 0.0 0.4 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.4 0.4 0.8 0.0 0.3 0.5 0.8 0.4 4.6 0.5 0.9 0.6 0.5 0.0 0.8 0.5 0.1 0.4 0.4 0.0 0.3 0.7 0.2 0.0 0.6 0.5 0.2 0.3 0.5 0.4 0.8 0.4 0.7 0.2 0.5 0.4 0.5 0.2 0.1 0.1 0.3 0.1 0.2 0.0 0.4 0.1 0.3 4.8 0.2 0.1 0.3 0.1 0.0 0.8 1.2 0.0 0.3 1.5 1.7 0.0 0.0 5.2 0.8 0.0 1.7 0.0 0.6 0.5 0.0 0.3 0.0 100.4 20.5 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 3.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 ANLN "ANILLIN, scra, Scraps" ENSG00000011426 "Anillin actin binding protein" Q9NQW6 7 36389806-36453791 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.4;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HBF TERT88: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005680, CAB033902, HPA050556, CAB062547, CAB068175" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175" "unprognostic (4.23e-2)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.67e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (5.97e-7)" "prognostic unfavorable (6.99e-5)" "unprognostic (2.69e-2)" "unprognostic (3.66e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (3.13e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.29e-2)" "unprognostic (1.34e-1)" "unprognostic (2.94e-2)" "unprognostic (4.04e-3)" 1.7 0.6 13.9 7.2 10.5 20.9 1.3 1.8 36.7 1.9 3.9 1.6 0.0 2.9 1.3 2.4 12.8 0.6 1.4 0.6 24.0 12.1 0.7 0.8 3.3 4.2 30.5 2.5 0.9 0.4 0.3 0.3 12.9 9.7 0.7 5.5 0.0 0.9 0.3 0.4 8.9 3.4 9.4 63.4 1.6 3.3 9.2 12.5 32.7 0.6 17.7 6.7 2.6 1.3 0.0 0.3 0.6 0.9 0.0 1.7 2.0 68.4 14.4 12.0 9.1 1.6 4.2 12.9 43.2 25.3 52.2 39.2 9.8 21.2 3.4 12.5 21.8 27.8 35.3 9.4 25.2 100.3 2.3 6.8 4.7 16.2 8.1 0.2 6.7 5.5 0.9 1.1 34.0 22.4 6.2 16.2 4.6 9.8 7.3 42.5 10.3 5.7 7.8 13.3 10.5 15.2 4.2 36.0 2.3 11.5 11.2 5.1 6.0 22.7 26.4 3.9 17.4 17.8 7.7 15.3 32.7 36.8 19.2 50.4 3.0 4.8 6.4 11.1 10.9 68.6 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.9 0.5 0.3 0.0 0.6 0.0 0.6 0.0 0.3 0.2 1.7 2.0 13.9 10.5 1.8 7.7 24.0 12.1 30.5 2.5 9.7 12.5 0.0 0.6 0.0 1.0 12.6 0.0 0.6 0.0 2.7 1.2 0.0 0.0 2.5 0.0 0.5 106.8 0.1 0.9 0.0 0.2 20.2 3.5 1.3 0.0 0.0 8.0 0.0 0.0 1.8 1.5 41.2 1.1 2.6 0.0 0.0 2.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.4 20.9 14.9 8.2 2.4 1.5 1.6 1.4 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA032148: AB_2674180, HPA057356: AB_2732610" "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 32.9 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 50.5 0.0 0.6 0.0 0.0 61.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 43.3 4.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.5 0.2 0.3 3.9 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 0.0 0.0 0.0 18.1 15.8 0.0 2.8 25.5 0.0 1.2 0.0 0.0 1.1 0.0 2.9 56.2 2.2 0.0 0.0 0.0 0.6 3.5 9.1 4.6 117.3 0.2 0.0 0.0 4.9 1.6 50.1 1.7 0.9 5.0 0.0 11.4 1.0 0.6 0.0 1.4 0.4 0.3 45.3 42.3 1.4 1.5 40.8 3.4 0.0 0.2 17.8 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.2 0.0 4.0 0.0 0.0 0.2 1.9 0.0 8.6 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.7 0.0 0.8 0.0 0.0 4.1 2.0 0.0 1.7 0.0 0.9 0.1 0.1 0.0 0.0 2.1 1.4 0.0 3.7 1.2 0.0 0.2 0.0 22.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 7.4 1.1 0.0 0.0 0.0 0.0 76.6 1.1 0.0 0.0 58.6 3.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.2 9.5 0.0 1.8 0.0 219.4 0.3 0.0 0.0 0.0 0.0 10.6 0.0 0.0 1.4 0.0 168.7 0.0 0.4 1.5 1.3 0.1 2.1 0.0 0.0 0.0 ANO3 "C11orf25, DYT23, GENX-3947, TMEM16C" ENSG00000134343 "Anoctamin 3" Q9BYT9 11 26309599-26663288 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "brain: 83.1;epididymis: 47.3" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 13.7;Early spermatids: 7.9;Horizontal cells: 7.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "basal ganglia: 83.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 3.2;HDLM-2: 10.4;U-2 OS: 2.8;U-2197: 7.6" "Region enhanced" "Detected in many" "basal ganglia: 142.2" "Region enriched" "Detected in all" 5 "basal ganglia: 149.8" HPA041629 Uncertain NA NA "HPA041629: AB_10793969" "unprognostic (7.01e-3)" "unprognostic (4.31e-1)" "unprognostic (2.94e-1)" "unprognostic (9.29e-2)" "unprognostic (9.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-2)" "unprognostic (1.66e-1)" "unprognostic (2.45e-2)" "unprognostic (7.02e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-4)" "unprognostic (9.48e-3)" "unprognostic (3.50e-2)" "unprognostic (4.33e-1)" "unprognostic (4.01e-1)" 2.8 1.2 6.4 0.5 83.1 0.4 0.6 0.2 13.3 1.1 0.6 0.1 0.0 0.6 0.6 47.3 0.5 0.7 2.0 0.5 7.0 0.6 1.4 1.4 0.8 0.5 1.1 5.4 0.5 0.7 0.5 0.3 0.5 5.9 0.5 0.6 0.0 0.6 0.6 0.4 0.5 0.5 0.7 0.5 0.8 0.5 1.9 9.0 0.0 1.4 0.0 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 2.1 2.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.8 7.6 0.0 0.7 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 83.1 0.2 13.3 7.0 0.6 1.1 5.4 5.9 9.0 0.0 1.3 0.0 0.0 0.0 0.7 0.8 0.0 4.0 0.0 0.0 13.7 0.2 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.6 0.0 7.9 0.0 3.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.3 2.8 1.1 0.0 0.2 0.0 0.0 0.0 ANO4 "FLJ34221, FLJ34272, FLJ35277, TMEM16D" ENSG00000151572 "Anoctamin 4" Q32M45 12 100717526-101128641 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.3;brain: 19.2;seminal vesicle: 14.0" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 3.9;Early spermatids: 4.4;Intestinal endocrine cells: 4.1;Late spermatids: 1.9;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 14.3;LHCN-M2: 6.9;SK-MEL-30: 11.1;TIME: 22.8;WM-115: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053412 Uncertain NA NA "HPA053412: AB_2682140" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "unprognostic (4.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.20e-2)" "unprognostic (2.02e-1)" "unprognostic (3.76e-2)" "unprognostic (1.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-1)" "unprognostic (6.54e-2)" "prognostic favorable (5.48e-5)" "unprognostic (1.16e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.41e-1)" 0.9 20.3 10.3 0.6 16.7 0.6 0.7 2.8 13.0 13.3 0.8 17.2 1.4 1.1 7.9 1.2 0.7 1.0 0.8 0.8 9.5 5.8 0.8 0.6 0.7 0.6 10.9 8.6 13.8 1.6 0.8 2.2 0.7 12.1 8.7 0.9 0.0 3.6 14.0 0.6 0.7 0.9 1.5 4.4 0.6 0.6 2.1 19.2 0.0 0.8 0.0 1.3 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.8 1.1 0.0 5.0 4.5 4.2 2.0 0.0 0.0 0.0 0.0 14.3 0.0 0.2 5.2 4.3 3.9 0.0 0.0 0.0 2.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 6.9 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 11.1 5.8 0.0 0.0 22.8 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 16.7 2.8 13.0 9.5 5.8 10.9 8.6 12.1 19.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 ANO5 "GDD1, LGMD2L, TMEM16E" ENSG00000171714 "Anoctamin 5" Q75V66 11 22193176-22283357 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 82.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 6.6;HAP1: 7.2;HEK 293: 9.0;NTERA-2: 5.0;U-266/84: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058857 Uncertain NA NA "HPA058857: AB_2683835" "unprognostic (5.25e-3)" "unprognostic (1.36e-3)" "unprognostic (2.43e-1)" "unprognostic (7.67e-3)" "unprognostic (3.50e-2)" "unprognostic (5.85e-2)" "unprognostic (8.17e-3)" "unprognostic (2.30e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.54e-4)" "unprognostic (8.55e-2)" "prognostic favorable (2.50e-7)" "unprognostic (3.65e-3)" "unprognostic (2.84e-1)" "unprognostic (2.77e-4)" "unprognostic (7.94e-2)" 1.0 3.8 3.9 0.9 3.8 0.3 0.9 0.9 7.9 1.7 2.6 1.1 1.0 2.9 1.5 1.6 2.4 1.1 1.6 37.7 4.5 4.2 3.1 2.3 1.4 0.6 3.4 6.3 1.0 3.3 26.9 5.0 0.4 3.5 3.8 2.9 2.7 3.4 3.7 43.7 0.5 3.1 4.1 1.9 1.0 3.0 2.3 1.7 0.0 3.9 14.2 0.6 3.2 1.9 0.0 0.9 0.0 1.5 0.0 0.1 0.1 0.0 6.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 1.7 2.4 4.3 0.0 0.0 0.0 0.0 5.0 3.5 0.0 0.1 0.0 0.0 4.5 0.1 4.0 3.7 0.0 0.0 0.0 3.2 3.3 2.5 0.0 0.0 2.9 0.0 0.0 2.9 5.2 0.0 4.0 0.0 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 3.8 0.9 7.9 4.5 4.2 3.4 6.3 3.5 1.7 0.0 5.1 0.5 0.3 0.2 7.2 82.0 0.0 1.4 0.0 1.8 0.0 0.0 1.7 0.9 4.8 2.7 2.6 0.0 2.4 0.0 0.2 1.6 0.0 4.9 0.5 1.6 5.2 3.7 0.8 1.9 0.0 1.3 1.7 0.0 7.5 2.4 1.1 3.5 1.1 2.4 0.4 0.0 0.4 4.1 0.5 0.1 0.0 0.0 3.0 0.1 ANO7 "IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G" ENSG00000146205 "Anoctamin 7" Q6IWH7 2 241188509-241225377 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.3;prostate: 44.7;stomach 1: 15.1" "Group enriched" "Detected in many" 6 "Glandular cells: 15.1;Mucus-secreting cells: 53.7" "Cancer enriched" "Detected in many" 19 "prostate cancer: 32.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "BEWO: 5.6;Hep G2: 5.4;OE19: 5.4" "Low region specificity" "Detected in single" HPA078464 Enhanced "Intracellular and membrane" NA NA "HPA078464: " "unprognostic (1.93e-2)" "unprognostic (3.45e-3)" "unprognostic (1.09e-3)" "unprognostic (5.13e-2)" "unprognostic (1.35e-2)" "unprognostic (8.76e-2)" "unprognostic (3.09e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (8.45e-2)" "unprognostic (2.90e-2)" "unprognostic (4.94e-2)" "unprognostic (4.82e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (2.14e-1)" "unprognostic (2.53e-2)" 0.2 0.0 0.3 6.5 0.4 1.7 0.2 0.2 0.4 0.3 17.3 0.3 0.2 5.3 0.2 0.2 0.2 0.1 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 44.7 4.9 0.2 2.3 0.2 0.2 0.0 17.3 0.5 0.3 0.2 15.1 0.2 0.2 0.2 0.2 0.7 1.0 0.3 0.2 0.0 0.0 0.0 0.8 2.2 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.0 0.2 5.4 0.3 0.0 0.0 1.1 0.0 0.0 0.4 0.5 0.0 0.1 0.3 0.3 0.3 0.0 1.0 0.0 0.0 1.0 0.5 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.1 0.3 0.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.6 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.0 1.4 2.4 0.0 3.6 2.8 1.0 15.1 0.0 2.9 1.2 0.0 2.9 4.3 0.3 0.0 3.1 0.9 1.7 0.0 53.7 1.5 6.0 0.0 2.1 1.4 0.5 0.0 0.4 0.0 1.2 0.0 0.6 0.0 2.4 0.7 ANO8 "KIAA1623, TMEM16H" ENSG00000074855 "Anoctamin 8" Q9HCE9 19 17323223-17334829 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 6.0;Extravillous trophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049206 Uncertain NA NA "HPA049206: AB_2680675" "unprognostic (5.12e-2)" "unprognostic (2.79e-1)" "unprognostic (1.59e-1)" "unprognostic (3.07e-1)" "unprognostic (2.91e-1)" "unprognostic (2.20e-3)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (3.94e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-1)" "unprognostic (5.89e-2)" "unprognostic (3.05e-3)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.48e-2)" "unprognostic (4.59e-2)" 8.5 18.1 19.2 6.6 17.9 3.8 6.6 25.1 30.6 4.3 4.3 11.6 4.9 6.6 5.1 2.2 12.5 4.0 7.9 7.1 15.7 10.6 6.1 6.0 6.6 6.2 13.3 10.3 3.2 7.0 14.4 4.0 5.3 23.3 5.4 4.0 3.2 7.9 4.8 11.1 23.2 6.2 4.5 20.1 5.4 12.2 3.4 14.1 5.3 5.2 5.2 4.4 5.1 5.2 0.1 1.8 0.1 0.1 0.0 0.8 0.1 4.2 3.7 10.4 11.7 3.2 2.2 18.0 4.3 2.5 2.3 2.5 1.7 9.1 0.3 4.7 4.2 3.2 4.0 2.1 3.5 1.3 19.1 5.3 2.9 10.9 2.5 1.6 0.6 4.9 2.5 3.3 2.9 2.1 5.8 1.7 6.9 2.1 4.3 1.4 3.2 3.7 1.1 6.0 4.8 15.6 6.2 2.2 5.1 3.8 7.0 3.9 12.6 4.7 4.5 3.6 3.9 6.4 1.9 1.7 5.3 3.0 16.1 4.7 7.7 6.3 0.7 8.3 5.3 5.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.5 0.5 0.0 0.0 0.1 1.8 0.8 0.1 19.2 17.9 25.1 18.6 15.7 10.6 13.3 10.3 23.3 14.1 6.0 1.7 0.0 0.3 0.8 5.4 1.7 2.5 0.0 1.2 0.0 3.9 2.7 0.0 1.4 0.1 0.3 2.1 0.0 1.4 7.3 0.6 1.2 5.7 3.0 1.5 1.6 0.0 0.6 1.0 0.0 2.0 1.7 0.0 0.0 2.3 2.6 1.5 0.0 0.7 0.5 2.3 0.0 0.9 0.2 0.9 1.3 2.2 0.5 1.5 0.4 ANO9 "PIG5, TMEM16J, TP53I5" ENSG00000185101 "Anoctamin 9" A1A5B4 11 417933-442011 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 72.1;Mucus-secreting cells: 39.0;Paneth cells: 37.1;Undifferentiated cells: 37.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 26.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 41 "B-cells: 2.2;NK-cells: 3.9;T-cells: 7.9" "Cell line enhanced" "Detected in some" "BEWO: 7.0;CAPAN-2: 21.2;HaCaT: 12.3;RPMI-8226: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039948, HPA040112" Approved Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA039948: AB_2676765, HPA040112: " "unprognostic (3.62e-3)" "unprognostic (2.83e-2)" "unprognostic (4.68e-2)" "unprognostic (1.62e-1)" "unprognostic (1.41e-2)" "unprognostic (8.93e-2)" "unprognostic (6.98e-2)" "unprognostic (8.94e-3)" "unprognostic (1.39e-1)" "unprognostic (2.28e-3)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (1.91e-2)" "unprognostic (1.18e-2)" "unprognostic (2.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (8.81e-4)" 0.7 0.1 0.1 17.4 0.2 0.9 1.4 0.1 0.2 1.4 32.1 0.1 1.3 21.5 0.8 4.7 6.8 1.2 6.2 0.4 0.2 0.1 4.8 0.4 5.8 6.3 0.4 0.1 0.5 5.6 0.0 1.6 0.7 0.3 2.6 5.4 0.6 6.2 0.6 0.1 14.4 69.4 0.5 0.5 4.8 4.4 0.4 0.1 11.3 2.2 6.1 17.2 3.4 2.7 2.2 0.1 0.0 0.0 3.9 7.9 1.5 2.0 0.3 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 1.9 21.2 1.5 1.1 0.0 0.0 12.3 0.0 5.0 0.0 1.7 0.0 0.0 0.3 2.9 0.0 0.3 0.0 0.0 3.4 0.0 0.8 0.0 0.0 3.2 0.1 1.3 0.0 2.4 0.4 0.1 0.0 4.4 0.0 0.1 0.0 14.8 3.2 3.0 0.9 0.1 0.2 5.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 5.6 2.2 6.8 3.2 0.1 1.0 3.9 2.9 0.0 3.9 0.0 0.0 7.9 1.5 0.1 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.3 0.1 0.0 8.9 12.7 4.0 4.6 0.0 2.2 5.1 0.0 3.4 3.5 0.0 0.1 0.0 9.2 0.5 0.0 72.1 0.0 5.6 2.6 0.5 2.7 0.0 0.0 0.3 0.0 14.9 0.6 0.0 0.0 0.0 0.2 3.3 1.8 39.0 0.0 8.6 37.1 0.0 2.6 0.0 0.0 1.0 0.1 0.0 5.5 0.1 10.1 37.3 3.9 ANOS1 "ADMLX, KAL, KAL1, KALIG-1, WFDC19" ENSG00000011201 "Anosmin 1" P23352 X 8528874-8732186 "Disease related genes, Predicted secreted proteins" "Cell adhesion, Chemotaxis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5;lung: 37.1;parathyroid gland: 27.7" "Cell type enriched" "Detected in many" 6 "Alveolar cells type 1: 223.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 25.9;NTERA-2: 23.4;U-2 OS: 11.3" "Secreted in brain" NA NA "unprognostic (2.93e-1)" "unprognostic (5.33e-2)" "unprognostic (9.54e-2)" "unprognostic (4.16e-3)" "unprognostic (7.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.55e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-2)" "unprognostic (6.43e-2)" "unprognostic (2.09e-2)" "unprognostic (6.24e-2)" "unprognostic (1.71e-2)" "unprognostic (9.38e-3)" "unprognostic (6.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.56e-2)" 5.4 4.0 13.8 1.3 14.0 0.6 3.6 1.3 18.0 4.5 1.0 7.3 1.3 0.7 0.9 3.2 1.6 1.4 1.9 4.6 11.1 7.9 1.1 1.1 37.1 1.8 5.7 6.0 0.9 0.8 27.7 1.0 1.4 19.3 4.1 1.3 6.0 2.8 4.5 10.9 3.0 0.9 1.1 25.5 1.1 1.1 5.0 8.5 1.3 8.5 1.0 1.2 1.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.4 2.6 0.1 3.5 0.3 3.8 0.0 0.0 0.0 1.0 0.0 1.9 0.2 0.1 25.9 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 23.4 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.3 0.0 1.1 0.3 0.0 3.2 0.0 0.6 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 14.0 1.3 7.6 11.1 7.9 5.7 6.0 19.3 8.5 223.4 9.3 0.0 4.2 0.0 6.4 6.2 0.0 6.7 36.4 0.0 3.9 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 1.5 2.9 1.1 0.0 5.2 0.0 0.0 2.5 2.2 0.0 0.6 1.4 0.0 0.0 0.0 21.4 0.8 0.0 1.1 0.0 1.5 0.0 0.3 0.3 0.7 0.0 0.1 0.0 0.1 0.8 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784889-89815401 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 195.3;kidney: 78.7;pancreas: 93.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "neutrophil: 59.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 59.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" NA NA 1500000000 "Plasma membrane" "CAB002417: AB_563491, HPA004625: AB_2667199" "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 21.3 1.1 0.6 2.9 0.8 9.5 17.0 1.0 1.3 8.2 21.2 0.8 0.5 195.3 1.4 8.4 3.6 1.4 27.7 3.7 0.4 0.3 78.7 37.7 9.7 9.3 0.9 0.9 1.8 93.9 0.0 0.7 14.7 1.3 8.6 4.7 4.0 6.6 1.8 1.6 4.9 155.8 4.3 1.2 7.2 0.8 4.7 0.2 5.6 1.5 4.2 3.8 4.7 3.0 0.0 6.9 59.4 12.8 0.0 0.0 5.5 0.0 5.0 0.0 0.0 61.3 78.5 0.5 78.2 111.8 9.6 8.5 0.5 0.0 0.0 0.9 67.0 0.0 0.0 0.6 0.0 3.8 0.0 0.0 14.7 0.4 11.7 36.1 1.0 71.1 68.7 0.1 30.2 0.0 0.4 87.5 0.0 0.4 0.1 3.7 0.0 0.0 34.7 0.2 0.0 5.3 0.0 0.0 0.8 43.7 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.0 6.8 87.4 42.2 0.0 95.3 0.0 0.0 0.0 0.0 0.1 0.0 2.2 5.7 12.8 10.4 0.0 7.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 59.4 0.0 12.0 0.1 0.0 5.5 0.6 0.8 1.0 1.3 0.4 0.3 0.9 0.9 1.3 0.2 0.0 4.8 8.2 3.1 8.9 0.0 0.8 372.0 2.7 20.5 19.2 0.0 9.7 36.5 10.6 0.1 1.8 993.7 0.0 328.5 12.0 36.3 18.0 24.2 144.7 39.4 0.0 2.9 101.9 51.7 0.0 2.6 46.4 3.3 39.7 10.5 0.0 120.5 201.5 1.4 388.5 0.0 25.8 5.0 0.4 0.1 5.1 5.4 1.0 18.3 1.3 ANTXRL ENSG00000274209 "Anthrax toxin receptor like" A6NF34 10 46286345-46330207 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 3.9;testis: 13.2" "Group enriched" "Detected in some" 43 "Early spermatids: 41.7;Late spermatids: 19.0" "Cancer enriched" "Detected in single" 6 "ovarian cancer: 0.7" "Group enriched" "Detected in some" 5 "basophil: 1.9;neutrophil: 3.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.9" "Cell line enhanced" "Detected in some" "MOLT-4: 2.8;NB-4: 3.0;SCLC-21H: 1.7;U-698: 1.2" NA NA "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (3.65e-3)" "unprognostic (2.59e-2)" "unprognostic (3.40e-1)" "unprognostic (8.11e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.2 0.0 0.0 0.0 0.0 0.5 3.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.2 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 66.2 104.7 4.7 4.9 66.8 63.6 0.3 114.8 71.8 47.5 32.2 3.0 59.9 0.1 38.0 100.1 105.0 81.6 10.1 69.5 37.7 37.5 0.7 5.1 31.1 0.1 53.3 11.0 2.5 36.6 57.6 48.0 94.4 44.0 67.3 6.0 21.0 2.8 58.5 0.2 19.5 6.0 5.9 26.5 42.6 0.0 26.7 0.2 106.8 14.0 0.0 0.0 39.5 1.0 26.5 65.5 0.2 1.7 83.1 55.7 35.1 76.5 58.9 0.4 0.1 0.2 128.7 10.3 83.8 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 541.9 512.9 7.3 2232.0 752.1 0.0 11.9 17.8 1060.0 889.5 59.3 0.0 1215.0 0.0 156.6 6.3 398.1 0.8 0.0 20.0 1352.9 735.1 1709.3 2387.0 2.5 570.9 0.0 5.1 113.5 449.6 2.3 206.0 1058.5 291.8 475.3 1.8 0.2 431.7 0.0 8.9 3.1 0.0 64.7 275.6 0.7 2.9 522.6 5914.0 282.4 0.5 4139.3 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 14 "Exocrine glandular cells: 153.7;Hepatocytes: 62.3;Pancreatic endocrine cells: 198.3" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "OE19: 72.5;PC-3: 32.8;RT4: 44.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005469, HPA074650" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849, HPA074650: " "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favorable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 32.8 0.0 0.1 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 10.2 0.0 2.3 0.0 2.0 0.0 0.0 3.5 7.3 0.0 0.0 0.0 153.7 0.0 0.0 0.6 0.0 62.3 0.0 0.0 0.0 1.3 2.7 0.0 0.0 0.0 0.0 1.0 0.4 0.0 198.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 180.9;Intestinal endocrine cells: 43.0;Mucus-secreting cells: 139.9" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Region enhanced" "Detected in single" "midbrain: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A549: 23.8;HDLM-2: 12.3" "Low region specificity" "Detected in all" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.2 0.1 0.3 0.7 0.5 0.0 0.4 0.1 0.4 0.2 30.3 0.4 41.9 66.5 1.1 2.6 0.2 13.3 38.7 0.1 0.5 0.6 2.1 4.3 0.1 0.1 3.0 0.1 0.9 0.3 0.0 0.1 0.1 0.7 1.1 8.1 0.2 0.2 20.7 0.1 0.1 108.6 0.4 8.0 0.1 0.7 2.3 0.3 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.4 0.5 0.6 3.0 0.1 0.7 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.3 180.9 5.3 0.0 0.0 0.0 0.0 3.3 0.0 0.9 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 43.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 139.9 0.0 0.1 18.7 0.0 18.5 9.5 0.0 0.0 0.0 0.1 0.5 0.0 0.0 20.0 0.0 ANXA2R "AXIIR, C5orf39" ENSG00000177721 "Annexin A2 receptor" Q3ZCQ2 5 43039081-43043170 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 27.5;Ito cells: 22.1;Kupffer cells: 18.7;T-cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 10.1;JURKAT: 12.3;MOLT-4: 10.8;REH: 11.3;U-937: 41.9" HPA051482 Uncertain Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA051482: AB_2681500" "unprognostic (3.38e-2)" "unprognostic (2.00e-3)" "unprognostic (1.21e-2)" "unprognostic (1.92e-2)" "unprognostic (1.40e-2)" "unprognostic (3.92e-3)" "unprognostic (5.65e-3)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (8.14e-2)" "unprognostic (2.13e-2)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.36e-8)" "unprognostic (2.68e-1)" "unprognostic (2.77e-1)" "unprognostic (2.68e-1)" "unprognostic (1.68e-1)" 5.5 1.6 1.3 8.8 4.1 13.1 8.6 1.0 1.5 5.7 4.1 2.0 1.8 2.5 3.6 3.9 4.6 3.7 2.9 2.2 1.7 1.3 2.4 1.4 7.2 19.0 2.6 0.5 2.0 1.1 0.7 1.8 2.6 1.4 5.7 2.2 2.1 2.9 1.9 4.4 2.2 7.5 3.2 1.9 14.9 2.4 2.3 2.0 25.1 3.1 1.8 13.4 5.2 5.6 8.9 1.4 1.5 2.1 6.5 28.9 7.7 0.7 0.7 0.6 0.4 1.1 3.0 0.2 0.2 0.1 0.1 0.3 1.4 0.9 2.8 2.5 0.5 0.8 0.3 1.8 0.2 0.1 4.6 1.4 0.9 1.9 0.6 1.5 1.0 0.4 10.1 0.1 0.8 0.1 0.0 5.6 12.3 0.6 3.6 0.7 1.0 10.8 1.5 0.0 0.6 5.5 11.3 1.4 1.6 0.3 0.4 2.2 0.0 1.0 0.2 0.2 0.1 0.3 1.9 3.5 0.2 0.0 0.3 0.9 1.6 2.3 1.1 1.3 41.9 0.5 1.5 1.1 0.5 16.0 0.7 18.6 8.7 16.6 17.5 1.0 8.9 28.9 21.2 0.9 6.5 2.1 1.4 17.7 7.7 1.3 4.1 1.0 1.5 1.7 1.3 2.6 0.5 1.4 2.0 0.0 16.4 27.5 1.6 3.3 0.0 1.2 2.5 2.7 2.3 0.0 0.0 0.4 0.0 0.2 3.0 15.4 0.2 0.0 0.0 0.9 4.1 1.2 14.0 0.8 7.6 0.0 1.7 22.1 18.7 1.3 1.4 6.9 6.8 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 2.8 0.7 0.8 1.9 0.3 60.4 0.5 0.9 ANXA3 ANX3 ENSG00000138772 "Annexin A3" P12429 4 78551519-78610451 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Phospholipase A2 inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 83.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 547.9;Ductal cells: 468.5;Exocrine glandular cells: 274.5;Pancreatic endocrine cells: 473.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 319 "neutrophil: 51.3" "Lineage enriched" "Detected in single" 319 "granulocytes: 51.3" "Cell line enhanced" "Detected in many" "A-431: 51.5;CACO-2: 52.8;CAPAN-2: 71.5;EFO-21: 43.8;hTERT-HME1: 72.9;OE19: 61.8;RPTEC TERT1: 61.4" "Low region specificity" "Detected in all" "HPA013398, HPA013431" Enhanced Enhanced "Plasma membrane" NA NA 7400000 "Plasma membrane" "HPA013398: AB_1844861, HPA013431: AB_1844862" "unprognostic (2.66e-1)" "unprognostic (5.65e-3)" "unprognostic (4.92e-3)" "unprognostic (8.67e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-3)" "unprognostic (4.17e-2)" "unprognostic (1.87e-1)" "unprognostic (5.09e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (4.82e-2)" "prognostic favorable (8.48e-6)" "unprognostic (2.23e-1)" "unprognostic (2.02e-2)" "unprognostic (7.20e-2)" "unprognostic (3.30e-2)" 20.3 1.1 4.0 7.1 7.4 83.0 16.2 2.4 6.8 7.0 8.5 2.3 0.9 4.2 3.4 4.2 25.0 4.6 11.7 20.5 5.2 5.2 19.8 1.6 46.0 5.7 6.6 5.6 2.8 14.7 6.5 5.8 33.7 10.4 18.8 7.4 2.6 50.8 3.6 14.2 4.1 9.3 5.3 4.0 11.0 23.4 1.8 5.0 2.0 45.3 13.6 7.4 2.8 5.9 0.1 0.0 51.3 0.1 0.0 0.0 0.5 51.5 9.8 0.1 0.1 0.1 0.2 0.0 0.6 0.0 1.5 1.4 52.8 71.5 0.0 43.8 1.8 0.0 20.4 0.0 37.7 2.3 0.2 0.4 4.6 21.1 3.1 6.1 0.6 0.0 0.3 33.4 0.5 72.9 7.6 14.9 1.2 0.1 0.0 0.2 2.0 0.2 0.0 1.6 61.8 7.2 0.0 0.1 0.0 61.4 5.9 0.0 0.0 30.4 7.5 2.1 25.3 1.3 0.6 18.9 0.1 6.8 0.0 11.6 0.4 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 51.3 0.0 0.1 0.0 0.0 0.5 4.0 7.4 2.4 6.8 5.2 5.2 6.6 5.6 10.4 5.0 547.9 38.9 0.0 51.1 22.0 0.0 6.4 58.6 36.1 144.5 36.6 0.0 172.1 14.9 468.5 0.9 32.1 19.7 0.0 274.5 87.0 24.3 117.9 4.7 0.4 16.1 0.0 5.2 20.3 0.0 0.0 2.8 1.7 5.0 36.1 30.9 0.8 473.1 58.5 0.4 1.1 0.3 0.0 9.5 1.2 0.7 5.8 52.5 0.5 28.7 32.0 ANXA4 ANX4 ENSG00000196975 "Annexin A4" P09525 2 69644425-69827100 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 212.1;pancreas: 160.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 1936.3;Ductal cells: 852.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 68.0;Hep G2: 71.0;RPTEC TERT1: 99.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB005076, HPA007393, CAB017560" Enhanced Approved Cytosol NA NA 580000 Cytosol "CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168" "prognostic unfavorable (8.55e-4)" "unprognostic (3.37e-2)" "unprognostic (4.82e-2)" "unprognostic (9.03e-2)" "unprognostic (1.62e-3)" "unprognostic (1.66e-1)" "unprognostic (3.57e-1)" "unprognostic (3.21e-1)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (7.23e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.79e-1)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (3.97e-2)" 18.7 5.9 4.2 12.2 4.3 4.1 9.7 1.3 3.0 16.9 32.7 5.3 12.9 43.2 22.8 11.5 16.1 11.9 212.1 6.8 4.3 3.1 36.2 30.9 19.2 5.9 5.1 2.4 12.3 160.1 5.8 3.3 50.9 11.8 18.1 14.9 10.3 11.7 11.4 6.9 12.9 85.7 12.3 6.5 7.2 16.9 5.6 3.6 4.0 24.7 12.9 8.3 11.0 13.2 17.6 21.3 27.6 23.7 3.6 10.3 8.9 10.8 39.4 0.5 4.9 30.3 26.2 1.8 10.5 15.9 4.3 6.1 5.9 19.5 3.5 68.0 17.1 12.9 16.8 3.8 16.9 4.5 10.0 3.2 5.4 3.6 71.0 21.5 1.8 7.0 15.5 16.7 5.8 14.2 10.2 11.1 1.7 0.3 3.2 11.8 9.8 2.8 3.4 0.9 44.1 5.4 2.9 1.1 4.3 99.5 15.7 0.8 3.7 11.6 16.1 15.8 6.0 5.3 24.5 16.0 8.0 3.9 10.6 5.8 1.3 1.4 0.1 12.4 9.3 5.4 27.6 14.8 11.9 10.3 17.4 7.8 17.6 5.3 7.7 21.3 15.9 0.9 5.8 2.0 3.6 23.7 6.4 5.9 8.9 4.2 4.3 1.3 3.0 4.3 3.1 5.1 2.4 11.8 3.6 190.6 117.9 20.5 84.8 65.9 7.2 9.8 1936.3 278.4 133.1 80.3 5.9 74.2 187.3 852.8 12.6 41.2 479.2 0.0 308.4 326.2 105.4 51.9 108.6 59.2 193.0 7.9 17.9 27.0 44.2 6.5 59.8 61.9 87.7 107.4 167.5 40.5 315.1 293.7 86.7 253.0 56.9 6.5 52.0 11.5 3.6 69.5 367.6 32.5 132.9 90.2 ANXA8 ANX8 ENSG00000265190 "Annexin A8" P13928 10 47460162-47484158 "Predicted intracellular proteins" "Blood coagulation, Hemostasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 41.6;skin 1: 60.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 92.3;Ciliated cells: 25.4;Club cells: 73.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 73.7;HBEC3-KT: 107.5;hTCEpi: 60.8;hTERT-HME1: 23.2;RT4: 27.0" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (8.32e-4)" "unprognostic (2.52e-1)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (5.94e-2)" "unprognostic (2.88e-2)" "unprognostic (2.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.19e-1)" "unprognostic (7.55e-15)" "unprognostic (1.04e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" 0.1 0.0 0.1 3.7 0.1 0.0 2.3 0.1 0.1 2.9 0.4 0.1 0.1 0.0 0.1 1.3 41.6 0.2 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.4 0.1 0.0 0.1 7.7 0.1 1.2 0.0 0.3 0.1 1.8 0.1 60.7 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 2.5 9.5 10.2 0.1 0.0 5.5 1.1 2.1 0.7 0.0 0.5 20.5 2.6 0.0 0.0 0.0 0.0 6.1 0.4 0.0 0.0 0.0 1.3 5.9 0.0 0.4 0.1 0.3 73.7 0.0 107.5 0.0 4.7 0.0 0.0 6.7 0.0 4.4 0.0 0.2 0.0 60.8 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 10.7 3.1 0.0 1.6 0.0 0.5 0.0 0.0 6.4 0.1 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 92.3 8.2 0.0 9.1 1.0 0.0 1.6 5.1 25.4 73.9 3.5 0.0 5.7 0.0 3.2 0.4 0.4 0.7 0.0 0.4 7.2 0.5 1.1 1.1 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.8 5.1 0.0 0.0 15.7 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 75.4;tongue: 34.2" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Cholangiocytes: 17.8;Ciliated cells: 20.1;Club cells: 36.4;Extravillous trophoblasts: 14.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;myeloid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;monocytes: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 72.8;HBEC3-KT: 110.8;hTCEpi: 29.4;SiHa: 26.2" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.7 1.2 35.9 1.2 0.0 0.9 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.9 0.0 0.0 1.1 0.7 0.0 75.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 34.2 13.3 6.9 0.6 0.0 5.0 0.8 3.2 0.5 0.0 0.5 14.5 3.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.3 2.6 0.0 0.1 0.0 0.1 72.8 0.0 110.8 0.0 6.2 0.0 0.0 7.1 0.0 2.6 0.0 0.1 0.0 29.4 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 16.9 0.0 0.0 26.2 2.3 0.0 1.4 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 26.8 1.4 0.0 3.1 0.0 0.0 3.0 17.8 20.1 36.4 0.0 0.0 7.2 0.0 0.7 0.1 0.0 2.0 0.0 0.2 14.1 0.8 1.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.1 5.6 0.3 0.0 0.0 0.0 12.9 0.0 0.2 1.0 1.0 5.3 0.0 0.1 3.0 ANXA9 ANX31 ENSG00000143412 "Annexin A9" O76027 1 150982017-150995634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 62.0;seminal vesicle: 78.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 45.9;Hepatocytes: 14.9;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.5;Hep G2: 14.6;MCF7: 19.5;OE19: 17.0;T-47d: 48.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028404, HPA028698" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028404: AB_10599190, HPA028698: AB_10600227" "unprognostic (4.06e-1)" "unprognostic (1.55e-2)" "unprognostic (3.15e-3)" "unprognostic (2.08e-3)" "unprognostic (2.93e-2)" "unprognostic (4.49e-2)" "unprognostic (1.84e-2)" "unprognostic (3.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "unprognostic (2.97e-1)" "prognostic favorable (8.74e-6)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (8.99e-2)" "unprognostic (1.72e-2)" 2.4 1.1 1.2 0.9 1.2 0.3 2.6 1.3 2.5 2.3 0.9 0.6 62.0 1.4 6.0 11.6 10.7 2.3 12.5 1.9 1.4 1.0 12.1 15.8 1.2 0.5 1.8 0.8 1.8 32.0 9.9 1.2 0.7 1.3 4.1 0.0 1.2 2.5 78.1 0.9 18.9 1.2 0.9 3.2 1.0 1.3 3.6 0.6 1.3 10.4 9.1 21.1 4.5 4.4 0.5 3.8 2.5 3.1 0.1 0.8 0.8 4.0 0.9 1.4 1.4 0.0 0.0 4.1 0.3 0.2 0.0 0.0 12.1 14.5 0.1 0.8 0.0 0.4 2.4 0.0 0.2 0.0 1.2 1.4 2.0 1.4 14.6 0.0 0.7 0.9 0.0 0.1 0.0 0.0 3.2 0.0 0.6 0.9 4.4 0.0 19.5 0.1 1.0 0.3 17.0 0.2 0.9 0.2 4.8 0.0 5.7 2.2 1.2 0.9 10.0 0.5 0.8 48.4 1.2 1.5 0.3 0.4 0.2 0.2 1.3 4.1 6.3 2.1 1.3 1.1 0.0 3.1 1.8 0.1 1.8 0.8 0.5 0.3 0.5 3.8 0.1 0.8 0.2 2.5 0.1 0.4 0.0 0.0 0.8 1.2 1.2 1.3 0.9 1.4 1.0 1.8 0.8 1.3 0.6 0.0 0.6 0.0 0.3 0.1 0.0 0.3 45.9 1.4 0.0 12.2 0.0 1.7 3.3 10.1 0.7 0.0 0.0 0.0 6.8 0.2 0.6 0.1 1.1 14.9 1.8 0.0 0.0 0.0 0.8 0.0 1.4 0.0 1.7 0.0 0.0 0.0 3.1 0.0 1.1 33.2 0.0 0.0 0.1 6.1 0.1 0.0 1.3 0.0 0.4 4.9 AOAH ENSG00000136250 "Acyloxyacyl hydrolase" P28039 7 36512949-36724549 "Enzymes, Predicted secreted proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lymphoid tissue: 57.4" "Cell type enhanced" "Detected in many" 17 "Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 54.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA021666, HPA026716" Approved Uncertain Vesicles "Secreted to blood" NA NA Vesicles "HPA021666: AB_2670799, HPA026716: AB_2671960" "unprognostic (3.55e-2)" "unprognostic (4.03e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-1)" "unprognostic (6.06e-2)" "unprognostic (4.78e-2)" "unprognostic (2.40e-1)" "unprognostic (3.14e-3)" "unprognostic (5.42e-2)" "unprognostic (6.02e-2)" "unprognostic (3.36e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-3)" "unprognostic (1.75e-1)" "unprognostic (1.92e-3)" "unprognostic (2.38e-1)" "unprognostic (1.35e-1)" 8.4 3.4 5.2 17.2 4.9 19.3 2.8 1.9 3.6 3.1 5.3 7.4 0.2 4.9 3.9 7.2 2.5 3.1 8.4 3.4 4.8 3.8 3.1 6.8 9.4 23.2 6.9 2.0 2.1 2.3 0.6 2.4 5.7 5.8 3.8 7.3 3.8 4.5 1.4 1.5 1.6 7.6 4.7 12.6 57.4 3.3 1.4 6.8 14.0 2.9 0.4 10.9 7.2 2.8 0.3 34.8 18.7 54.6 19.2 8.8 31.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.5 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 21.3 0.1 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 7.1 0.0 0.3 54.6 17.6 8.8 47.9 1.8 0.3 0.4 6.1 34.8 0.0 1.0 7.8 18.7 19.2 20.2 0.5 0.1 31.0 5.2 4.9 1.9 3.6 4.8 3.8 6.9 2.0 5.8 6.8 0.0 14.0 8.8 0.0 0.7 0.0 0.4 0.0 1.4 4.5 0.0 0.0 0.2 1.7 0.2 0.4 0.5 5.8 0.0 0.0 0.2 0.5 0.1 4.7 0.6 31.1 0.0 14.9 3.1 110.3 0.4 0.0 54.2 0.0 19.0 0.4 3.2 0.0 1.5 0.4 0.3 0.2 0.0 0.9 0.0 0.0 0.3 0.1 51.7 0.5 0.1 AOC1 "ABP1, DAO" ENSG00000002726 "Amine oxidase, copper containing 1" P19801 7 150824627-150861504 "Enzymes, Predicted secreted proteins" "Heparin-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 108.6;placenta: 240.4" "Cell type enhanced" "Detected in many" 19 "Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 10 "eosinophil: 20.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 20.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4" "Not detected" "Not detected" "HPA031032, HPA031033" Approved "Secreted in other tissues" NA NA 800000 "HPA031032: AB_10670150, HPA031033: AB_10669670" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "unprognostic (2.84e-2)" "unprognostic (6.31e-3)" "unprognostic (8.31e-3)" "unprognostic (9.07e-3)" "unprognostic (6.42e-2)" "unprognostic (1.21e-1)" "unprognostic (1.96e-1)" "unprognostic (3.11e-1)" "prognostic favorable (1.71e-4)" "unprognostic (5.32e-3)" "unprognostic (3.62e-2)" "unprognostic (1.49e-2)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" 0.3 0.3 0.3 6.7 0.3 0.0 0.3 0.3 0.3 0.9 68.3 0.2 1.2 30.2 0.3 3.9 1.7 0.3 4.4 0.3 0.3 0.3 37.9 1.5 0.3 0.6 0.3 0.1 0.3 0.6 0.0 0.3 240.4 0.1 1.3 15.5 0.1 0.4 0.2 0.3 0.8 108.6 0.2 0.3 0.4 2.7 1.8 0.1 0.7 0.3 0.1 1.0 0.4 0.4 0.0 1.0 20.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 2.5 16.4 0.0 2.2 0.0 1.4 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.1 5.0 0.2 1.5 0.0 0.0 0.0 6.0 0.2 0.1 1.8 2.1 0.0 0.7 0.0 0.3 0.6 21.4 0.5 0.2 0.1 0.5 0.0 0.2 0.1 0.1 0.1 0.8 0.0 0.1 0.1 20.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 1.2 258.2 0.0 1.1 13.3 0.0 5.7 0.0 648.3 0.0 3.0 3.0 0.2 0.9 5.7 0.0 2.8 0.0 41.6 0.0 0.0 8.4 0.0 1.3 0.0 115.4 108.6 0.0 2.2 375.2 0.0 73.1 0.0 0.0 0.1 2.8 0.7 0.1 2.9 0.0 80.4 0.3 AOC2 "DAO2, RAO" ENSG00000131480 "Amine oxidase, copper containing 2" O75106 17 42844600-42850707 "Enzymes, Predicted intracellular proteins" "Catecholamine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "retina: 133.5" "Cell type enriched" "Detected in some" 9 "Early spermatids: 28.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.0" "Cell line enhanced" "Detected in many" "ASC diff: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057779 Uncertain "Intracellular and membrane" NA NA "HPA057779: " "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (5.10e-4)" "unprognostic (1.90e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-1)" "unprognostic (4.63e-2)" "unprognostic (2.63e-2)" "unprognostic (1.39e-1)" "unprognostic (3.64e-2)" "unprognostic (2.16e-2)" "unprognostic (8.27e-3)" "unprognostic (4.55e-5)" "unprognostic (3.55e-2)" "unprognostic (2.73e-1)" "unprognostic (1.63e-2)" "prognostic favorable (2.47e-4)" 11.6 1.2 0.9 1.3 3.2 1.8 3.1 3.2 1.6 1.5 1.1 0.9 0.9 0.6 1.5 1.2 1.0 1.5 1.5 1.3 1.2 1.8 0.9 3.6 2.2 1.0 0.9 0.9 1.0 1.2 0.8 2.1 0.9 0.9 1.3 0.5 133.5 1.2 1.2 1.4 1.2 1.0 1.3 1.0 1.7 0.7 6.5 0.9 1.0 1.0 0.9 1.2 1.6 0.9 0.1 0.0 4.0 0.0 0.0 0.6 0.0 0.2 2.8 0.6 3.1 14.3 1.4 7.4 0.9 0.9 2.0 2.8 2.2 0.3 1.1 1.4 0.3 0.9 1.2 2.7 0.7 4.1 2.3 7.3 0.4 1.3 2.2 0.9 0.4 2.8 2.2 2.5 1.9 2.9 0.4 0.5 3.8 0.7 2.6 0.6 0.3 0.6 1.1 1.1 0.3 0.9 1.4 2.9 2.3 0.4 4.4 1.0 0.6 0.1 1.0 4.0 6.0 0.5 0.2 0.5 1.9 4.1 2.5 1.2 5.7 5.6 1.1 0.5 2.6 1.0 0.0 0.0 0.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.9 3.2 3.2 1.6 1.2 1.8 0.9 0.9 0.9 0.9 0.0 0.3 0.0 0.5 0.9 0.2 0.3 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.4 28.8 0.7 0.0 0.0 0.3 0.1 0.2 0.7 0.0 0.8 0.1 0.0 0.0 0.6 0.8 3.3 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 0.6 0.0 0.9 2.1 2.7 1.4 0.0 0.0 0.0 0.5 AOX1 "AO, AOH1" ENSG00000138356 "Aldehyde oxidase 1" Q06278 2 200585868-200677064 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 228.8" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 649.9" "Cancer enriched" "Detected in many" 9 "liver cancer: 122.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040199, HPA040215" Enhanced NA NA 410000 "HPA040199: AB_10795273, HPA040215: AB_10795360" "unprognostic (4.39e-2)" "unprognostic (1.03e-3)" "unprognostic (1.96e-1)" "unprognostic (3.15e-2)" "unprognostic (1.17e-4)" "unprognostic (1.92e-2)" "unprognostic (2.34e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-2)" "unprognostic (5.48e-2)" "unprognostic (2.00e-2)" "prognostic favorable (6.05e-5)" "unprognostic (1.33e-2)" "unprognostic (8.16e-3)" "unprognostic (3.38e-2)" "unprognostic (4.99e-3)" 12.8 55.6 0.1 1.8 0.4 0.2 10.5 0.3 0.2 2.9 3.2 1.3 18.6 0.3 2.0 11.1 3.9 8.1 4.0 3.5 0.3 0.0 20.8 228.8 3.6 7.5 0.2 0.2 12.2 28.5 0.2 0.8 1.9 0.6 4.4 1.0 1.6 2.7 20.1 2.5 3.2 1.7 6.9 0.4 1.7 2.4 10.8 0.2 0.1 4.8 2.7 0.6 7.1 10.6 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.0 0.0 85.8 44.1 0.0 1.4 2.6 1.1 2.1 0.0 0.0 0.0 0.1 1.7 0.5 0.0 0.0 3.9 4.8 0.0 0.1 0.0 1.0 4.3 5.7 0.2 0.0 17.7 1.0 5.6 17.7 1.1 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 6.8 3.0 2.4 0.0 0.5 0.0 0.0 0.6 2.3 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.3 0.2 0.3 0.0 0.2 0.2 0.6 0.2 3.0 0.6 13.7 0.5 1.5 0.0 0.7 12.7 0.0 0.0 3.5 0.0 0.0 10.0 0.6 0.5 1.3 0.0 0.0 22.4 0.1 10.2 8.3 0.0 649.9 0.4 0.0 2.9 15.4 20.2 0.9 68.4 1.6 3.3 0.0 0.0 0.4 18.4 0.0 77.1 111.5 0.0 0.0 2.8 0.7 0.6 1.4 0.0 0.0 0.0 0.3 AP000295.1 ENSG00000249624 21 33229901-33297160 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 8.7" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 8.7;monocytes: 3.9" "Cell line enhanced" "Detected in some" "HEL: 5.7;hTERT-RPE1: 5.7;MOLT-4: 6.1;RH-30: 5.9" NA NA "unprognostic (2.39e-1)" "unprognostic (8.87e-2)" "unprognostic (4.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.62e-1)" "unprognostic (3.83e-1)" "unprognostic (1.33e-2)" "unprognostic (1.12e-1)" "unprognostic (5.46e-2)" "unprognostic (2.92e-2)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (2.33e-2)" 1.7 0.5 0.1 0.4 0.3 2.6 1.0 0.3 0.9 0.9 0.7 0.0 1.0 0.0 0.7 0.5 1.2 0.6 0.1 0.3 1.5 3.2 1.8 0.5 0.3 0.9 1.0 0.9 0.3 1.7 0.5 0.3 0.8 0.0 0.7 0.4 0.8 0.0 0.3 1.7 0.8 0.3 0.5 1.3 2.1 0.2 0.3 0.9 8.7 3.9 1.3 1.1 1.5 0.2 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.7 0.0 1.1 0.0 0.0 0.9 0.0 1.5 0.0 0.0 1.0 0.0 0.7 0.0 5.7 0.0 0.0 0.0 3.0 3.9 2.9 0.3 0.0 3.3 5.7 0.9 2.5 0.6 1.7 0.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 5.9 1.6 0.3 0.0 2.8 0.0 3.5 0.0 0.0 1.6 0.0 0.0 3.1 0.0 0.6 0.0 0.0 2.2 3.9 0.3 0.8 0.0 0.0 0.0 1.3 4.5 0.3 2.8 0.8 0.3 0.9 0.8 0.9 0.1 0.7 0.5 8.7 1.3 3.9 0.6 1.1 1.5 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000311.1 ENSG00000249209 21 33584687-33931607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "blood: 10.8" "Group enriched" "Detected in some" 5 "Ciliated cells: 1.4;Club cells: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 5.4;MAIT T-cell: 7.8;memory CD4 T-cell: 7.9;memory CD8 T-cell: 8.1;naive CD4 T-cell: 7.4;naive CD8 T-cell: 6.9;T-reg: 10.8" "Lineage enriched" "Detected in many" 9 "T-cells: 10.8" "Cell line enhanced" "Detected in many" "U-2 OS: 10.6" HPA039558 Uncertain NA NA "HPA039558: AB_2676570" "unprognostic (4.72e-1)" 0.4 0.4 0.5 1.4 0.6 0.0 0.4 0.8 0.6 0.6 0.5 0.9 0.6 1.8 0.5 0.6 0.3 1.2 0.4 0.4 0.4 0.9 1.0 2.5 0.4 0.7 0.4 0.0 0.3 2.3 0.9 1.1 1.6 0.0 1.2 0.9 0.9 0.0 0.4 0.4 0.9 1.6 0.3 0.0 0.5 0.3 1.1 0.7 1.2 0.4 0.3 10.8 1.2 4.0 0.4 0.1 0.1 0.2 0.0 1.4 0.7 0.0 0.2 0.1 4.4 2.2 0.0 3.5 0.2 0.4 1.9 1.0 0.2 0.0 2.7 0.2 1.1 0.2 0.1 0.4 1.8 1.3 0.5 0.0 0.2 0.2 0.0 0.0 2.6 2.3 5.0 0.0 0.9 2.5 1.0 3.3 5.1 2.4 3.5 0.8 1.4 0.0 1.3 3.7 0.4 3.8 2.4 0.2 4.2 2.3 2.4 0.0 0.2 10.6 0.3 0.2 2.9 1.7 0.6 2.9 0.8 0.0 1.2 0.4 0.3 5.4 0.3 7.8 1.0 7.9 8.1 0.3 1.1 7.4 6.9 0.6 0.3 0.4 0.7 10.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AP000350.4 ENSG00000251357 22 23862188-23895223 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.1;pancreas: 4.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.7;Alveolar cells type 2: 85.7;Ciliated cells: 75.0;Club cells: 73.9;granulocytes: 50.0;Melanocytes: 32.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 6.1;SK-MEL-30: 5.0;THP-1: 5.6" HPA042960 Uncertain NA NA "HPA042960: AB_2678241" 0.2 1.9 0.2 0.8 0.3 0.0 0.1 1.8 0.4 0.9 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.1 0.7 1.6 0.2 0.3 0.4 0.2 0.6 4.2 0.0 0.6 0.1 0.3 0.0 1.9 0.5 0.5 0.6 1.2 0.0 0.7 0.1 0.9 0.2 0.1 0.0 0.2 0.2 4.0 5.1 1.1 0.5 0.7 2.2 0.7 2.7 0.0 0.6 0.3 1.0 0.0 0.3 0.6 0.1 0.3 0.0 0.0 1.3 0.2 2.1 0.0 0.0 1.7 0.0 0.5 0.9 2.0 1.8 0.0 0.1 0.3 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.0 0.8 0.0 6.1 0.0 0.0 2.2 1.0 1.3 0.1 0.0 1.5 0.1 3.1 0.0 0.0 3.9 3.5 0.0 1.9 5.0 0.4 0.6 5.6 0.0 0.0 1.8 1.8 0.0 3.9 0.5 1.4 1.0 1.3 0.5 0.4 0.1 1.1 0.9 0.5 1.7 1.8 2.2 1.0 0.0 4.0 1.5 1.3 0.0 0.7 0.3 5.1 1.3 0.7 35.7 85.7 0.0 0.0 14.5 0.0 0.0 0.0 75.0 73.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 50.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 32.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 AP000646.1 ENSG00000285509 11 121024125-121113108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 2.0;parathyroid gland: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.0" "HPA038593, HPA038594" Uncertain Uncertain Cytosol NA NA Cytosol "HPA038593: AB_10669647, HPA038594: AB_2676103" 0.0 0.0 0.2 0.0 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.5 0.6 0.8 0.2 0.5 0.0 0.8 2.0 2.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.3 0.8 1.7 0.4 0.3 0.4 0.2 1.9 2.4 2.3 0.3 1.1 1.2 0.6 0.7 0.8 1.0 0.0 0.8 0.5 2.5 0.1 0.4 4.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 1.1 1.0 0.0 1.0 0.6 1.6 0.0 0.0 0.2 0.1 0.3 0.0 1.4 0.2 2.5 0.7 0.2 0.7 2.2 3.0 0.8 0.1 0.0 2.5 1.4 0.2 0.0 2.0 0.2 0.5 0.9 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000781.2 ENSG00000254979 11 57387365-57424059 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.8;liver: 8.1" "Cell type enriched" "Detected in some" 5 "granulocytes: 5.8" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 7 "basophil: 6.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 65.5" HPA038515 Supported NA NA "HPA038515: AB_10675800" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.55e-4)" "unprognostic (2.16e-1)" "unprognostic (4.01e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.08e-2)" "unprognostic (1.33e-2)" "unprognostic (1.79e-1)" "unprognostic (1.51e-10)" "unprognostic (4.86e-2)" "unprognostic (1.54e-1)" "unprognostic (5.59e-2)" "unprognostic (3.10e-1)" 7.3 0.0 0.0 0.3 0.0 11.8 3.0 0.0 0.5 0.5 0.5 0.5 0.4 0.0 1.2 0.0 0.9 0.6 0.0 0.0 0.1 8.1 1.0 0.7 0.0 0.2 3.0 0.0 0.1 7.9 0.1 0.2 1.6 0.0 0.9 6.6 0.4 0.0 0.0 0.4 0.3 0.0 1.4 0.7 0.8 0.6 0.7 0.9 6.3 0.6 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.3 9.6 65.5 0.6 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.3 3.0 0.1 0.0 0.0 1.3 0.0 2.9 0.0 0.0 0.3 0.1 0.0 0.1 1.0 0.0 0.0 0.3 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.3 0.3 0.3 0.4 6.3 0.6 0.6 0.7 0.3 0.0 0.0 0.5 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000790.3 ENSG00000284873 11 59938432-59957480 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.4;THP-1: 5.2" NA NA 0.1 0.0 0.0 0.5 0.0 1.6 0.0 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.8 0.0 0.1 0.3 0.0 0.3 0.1 0.3 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.4 0.5 0.0 0.0 0.1 0.7 0.2 0.1 0.0 0.0 0.3 0.3 0.0 0.5 0.0 0.0 0.6 0.0 0.8 0.3 0.1 0.0 0.0 0.1 1.4 0.3 0.4 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 5.2 0.0 0.6 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000790.4 ENSG00000285010 11 59964033-59970146 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 5.9;kidney: 1.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "basophil: 5.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.9" "Group enriched" "Detected in some" 5 "HEL: 2.9;K-562: 7.3" "Secreted - unknown location" NA NA 0.0 0.1 0.4 0.2 0.0 0.7 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.5 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 2.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000812.4 ENSG00000284844 11 72105924-72109329 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.1;cervix, uterine: 1.1;testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.4;RH-30: 1.2;SK-MEL-30: 2.9;WM-115: 1.1" NA NA 0.0 0.0 0.0 1.1 0.0 0.9 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.5 0.5 0.0 0.0 0.0 0.9 0.5 0.2 0.1 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP000812.5 ENSG00000284922 "Leucine-rich repeat-containing protein 51 " 11 72080777-72110782 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "fallopian tube: 26.0;testis: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 6.0;HBEC3-KT: 5.9;MCF7: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039949 Approved Uncertain Microtubules NA NA Microtubules "HPA039949: AB_10960708" 0.7 0.6 2.7 0.6 5.0 0.8 1.1 0.1 3.3 0.6 0.7 5.7 0.9 0.6 1.9 3.1 0.6 26.0 0.6 0.7 2.4 2.1 0.9 1.7 0.6 1.7 3.3 3.3 0.6 2.5 3.7 0.6 4.6 1.0 0.9 2.1 0.6 1.0 0.9 0.6 0.9 1.0 0.8 0.9 0.6 24.2 2.6 0.7 3.7 0.0 0.8 1.1 0.0 0.1 0.0 0.6 0.0 0.0 0.9 0.0 0.5 0.2 0.0 0.5 1.3 0.8 0.4 1.1 1.1 0.8 2.4 0.0 0.5 0.1 0.2 6.0 1.2 1.3 0.8 5.9 1.0 2.4 1.1 0.8 0.4 0.2 0.2 0.0 0.0 1.7 0.0 2.7 0.9 0.4 0.2 1.4 0.1 0.0 0.9 6.6 0.1 0.0 0.3 2.1 0.0 1.5 1.2 0.6 2.1 1.0 0.8 0.0 0.9 0.9 0.1 0.0 2.4 0.4 0.0 0.4 0.3 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002347.1 ENSG00000285231 11 59878809-59896481 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 7.4;testis: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "basophil: 7.4" "Lineage enriched" "Detected in single" 44 "granulocytes: 7.4" "Cell line enhanced" "Detected in some" "Daudi: 1.4;HAP1: 1.4;K-562: 2.4;U-698: 3.1" "Secreted - unknown location" NA NA 0.0 0.0 0.5 0.7 0.0 0.3 0.0 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.4 0.9 1.4 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 2.4 0.3 0.4 0.7 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.5 0.4 0.7 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 3.1 0.0 0.2 0.3 7.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002512.3 ENSG00000284732 11 56459221-56473352 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;bone marrow: 1.9;skin 1: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 1.9" NA NA 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.2 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.7 0.3 1.3 0.3 0.8 0.5 0.0 0.3 0.5 0.2 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.1 0.3 0.4 0.2 0.4 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.9 0.1 0.5 1.9 0.6 0.0 0.0 0.4 0.7 0.6 0.2 1.2 0.0 0.5 0.6 0.1 0.4 0.6 0.8 0.1 0.2 0.1 0.4 0.8 1.1 0.5 0.6 0.7 0.5 0.3 0.7 0.5 0.2 1.0 0.2 0.4 1.2 0.3 0.3 0.3 0.1 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.5 1.3 0.8 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP002748.4 ENSG00000256349 11 66509079-66533613 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 3.4" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NTERA-2: 16.3;THP-1: 4.1" HPA058283 Uncertain Uncertain Midbody NA NA Midbody "HPA058283: AB_2683667" 0.2 0.9 0.0 0.0 0.6 0.0 0.3 0.7 0.2 0.5 0.3 0.0 1.0 0.0 0.1 0.3 0.5 0.0 0.7 0.3 0.7 1.0 0.3 1.4 0.2 0.3 3.4 0.0 0.2 0.1 0.3 0.1 0.4 0.2 0.9 0.0 0.3 0.7 0.3 0.5 0.4 0.0 0.5 0.4 0.7 0.1 0.0 0.7 0.0 1.2 0.6 0.8 1.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.5 0.5 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.7 0.0 0.3 1.2 0.0 0.0 0.3 1.7 0.2 0.0 1.8 0.2 0.8 0.0 0.6 0.2 0.5 16.3 0.9 0.0 0.9 0.0 0.0 0.3 0.8 0.3 0.0 0.3 0.4 0.6 0.2 1.4 4.1 0.0 0.7 0.1 0.0 0.1 0.0 0.2 0.7 0.0 0.2 0.4 0.0 0.2 0.0 0.2 1.2 0.7 0.0 0.3 0.5 0.7 0.0 0.3 0.0 0.0 0.6 0.3 0.5 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP003071.5 ENSG00000284713 11 69155478-69159752 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "stomach 1: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;NB-4: 2.4;RH-30: 2.3" "Not detected" "Not detected" NA NA 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.1 0.9 2.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.7 19.5 1.0 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.6 0.4 0.1 1.0 0.1 0.5 0.2 0.2 1.7 0.1 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.4 0.4 0.3 0.4 0.4 0.2 0.1 0.3 1.2 0.0 1.0 0.5 0.1 0.0 0.9 0.1 2.4 0.3 0.0 1.2 0.5 2.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 sigma 1 subunit" P61966 7 101154400-101161596 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.8" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 291.8;Proximal tubular cells: 208.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" NA Yes "Golgi apparatus, Vesicles" "HPA060945: AB_2684393" "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 7.6 9.7 30.6 7.9 41.1 3.0 10.8 7.9 45.8 6.8 16.5 6.4 4.6 23.3 6.6 10.6 10.9 8.9 9.3 4.2 22.9 14.6 16.6 15.5 6.7 6.9 12.3 25.3 7.9 8.0 6.3 10.5 10.2 10.1 10.9 14.2 4.6 10.4 6.1 3.5 12.3 18.0 7.9 8.7 7.7 13.2 6.9 9.3 4.7 9.3 7.4 8.5 8.7 6.1 4.4 8.2 2.1 5.5 1.9 5.9 4.2 26.4 21.5 14.5 27.4 10.7 17.6 31.4 17.8 12.1 12.1 12.9 11.5 33.8 5.9 31.1 19.4 23.5 13.2 8.3 27.3 10.8 13.4 13.4 4.0 13.5 14.3 13.2 10.8 20.1 19.7 20.9 11.9 5.2 18.1 17.9 13.4 12.9 24.0 29.9 66.0 9.0 23.4 23.1 39.2 43.4 5.7 6.6 12.4 29.1 22.6 11.4 37.3 10.1 26.8 32.4 24.9 11.8 10.1 18.5 17.5 30.5 6.6 12.2 5.4 11.3 11.4 44.4 12.0 35.1 0.8 5.5 0.5 4.2 4.9 3.7 4.4 5.9 4.7 7.4 3.8 3.5 3.2 2.1 1.9 2.8 8.2 5.5 4.2 30.6 41.1 7.9 35.1 22.9 14.6 12.3 25.3 10.1 9.3 6.0 0.0 18.5 25.1 34.5 26.2 1.1 50.9 0.0 2.3 52.4 7.9 145.9 291.8 115.8 1.0 22.5 124.9 0.0 97.6 75.8 26.7 26.8 5.7 37.6 83.8 28.6 86.6 25.2 24.7 2.0 32.5 23.2 50.6 83.0 83.1 23.6 132.7 74.8 20.5 208.8 16.4 19.4 13.3 10.1 80.0 39.6 50.6 15.2 96.8 26.8 AP1S2 "MRX59, MRXS5, PGS, SIGMA1B" ENSG00000182287 "Adaptor related protein complex 1 sigma 2 subunit" P56377 X 15825806-15854931 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 218.0" "Cell type enhanced" "Detected in all" 8 "Hofbauer cells: 225.7;Kupffer cells: 390.4;Macrophages: 350.3" "Cancer enhanced" "Detected in all" "melanoma: 49.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 55.2;monocytes: 74.9" "Cell line enhanced" "Detected in many" "Karpas-707: 67.3;SK-MEL-30: 89.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049894, HPA060945" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA049894: AB_2680939, HPA060945: AB_2684393" "prognostic favorable (9.86e-4)" "unprognostic (4.62e-2)" "unprognostic (2.11e-1)" "unprognostic (1.68e-1)" "unprognostic (2.47e-3)" "unprognostic (3.85e-1)" "unprognostic (2.03e-3)" "unprognostic (5.76e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.53e-6)" "unprognostic (1.85e-2)" "unprognostic (5.61e-2)" "unprognostic (5.08e-2)" "unprognostic (6.35e-2)" "unprognostic (3.13e-1)" "unprognostic (9.34e-2)" "unprognostic (6.47e-2)" 10.1 8.2 21.2 11.7 17.9 12.6 9.7 13.0 17.6 12.0 17.3 9.8 12.6 4.8 25.7 218.0 9.8 5.6 7.0 34.2 12.7 19.9 5.2 5.8 8.9 11.6 16.1 11.8 4.5 4.1 8.2 11.7 13.1 39.7 5.5 8.0 13.3 5.1 13.2 41.4 5.0 8.7 24.9 18.5 14.1 9.9 8.6 11.4 9.8 10.7 8.6 9.6 8.5 5.9 8.2 55.2 12.5 74.9 5.5 8.4 44.8 3.4 2.9 32.5 16.0 6.2 4.1 1.1 10.2 4.8 7.9 10.2 2.1 3.6 5.8 45.5 14.9 14.3 4.0 9.0 2.8 13.3 8.3 14.4 3.5 5.1 3.2 5.4 12.9 3.9 2.4 2.9 7.5 7.7 11.2 15.9 4.7 3.2 67.3 14.3 1.8 3.4 6.8 43.3 1.8 10.7 7.3 23.7 11.8 8.9 0.8 4.0 15.8 4.5 1.4 89.0 23.4 15.2 13.3 8.4 13.6 5.1 18.9 9.5 7.8 17.6 12.3 7.2 5.8 32.9 8.2 74.9 8.0 5.6 67.8 5.4 8.2 5.7 4.5 55.2 7.5 4.1 4.0 12.5 5.5 34.7 17.9 8.4 44.8 21.2 17.9 13.0 17.6 12.7 19.9 16.1 11.8 39.7 11.4 3.0 16.2 80.2 10.9 49.0 31.7 178.0 7.6 1.4 3.4 8.7 11.8 4.7 28.2 12.5 3.9 119.9 7.7 23.3 5.6 16.4 51.9 11.0 77.3 6.4 225.7 11.1 25.8 148.0 390.4 8.9 16.1 350.3 141.7 139.7 7.0 19.0 8.6 11.2 6.7 6.6 34.6 38.8 56.7 25.7 19.4 45.0 4.7 51.1 6.4 5.8 AP1S3 ENSG00000152056 "Adaptor related protein complex 1 sigma 3 subunit" Q96PC3 2 223751686-223838027 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 60.9;Cytotrophoblasts: 43.1;Urothelial cells: 65.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 56.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066782 Approved Supported Vesicles NA NA Vesicles "HPA066782: AB_2685720" "unprognostic (9.45e-3)" "unprognostic (1.79e-1)" "unprognostic (7.52e-2)" "unprognostic (5.80e-2)" "unprognostic (4.37e-2)" "unprognostic (4.89e-1)" "unprognostic (1.65e-3)" "prognostic unfavorable (3.36e-5)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.56e-1)" "unprognostic (2.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.32e-2)" "unprognostic (4.61e-2)" 1.9 1.4 1.6 5.4 3.0 1.8 1.6 2.2 1.9 1.6 1.8 0.2 50.0 3.1 0.8 64.5 5.8 1.7 7.6 1.0 2.3 1.7 7.0 1.9 5.2 3.8 1.1 1.0 0.8 5.1 3.3 6.8 4.6 0.9 2.5 2.0 1.9 4.1 39.6 0.5 1.6 4.1 0.9 1.0 3.1 6.2 1.1 0.4 0.8 10.5 3.1 5.7 8.1 2.9 8.8 5.3 4.9 0.5 0.7 1.6 0.7 9.1 8.6 1.0 3.3 0.5 0.2 4.7 3.8 0.9 1.9 1.7 56.2 7.1 3.6 3.2 0.5 2.0 15.1 2.7 10.4 2.9 5.2 4.4 0.4 13.8 5.7 0.2 1.1 0.4 0.1 11.3 3.4 12.0 4.1 1.3 2.0 0.5 0.8 1.1 3.8 0.1 0.2 1.2 10.5 6.1 1.3 0.0 1.5 17.8 18.0 2.5 0.8 2.0 3.7 1.3 2.2 1.8 1.7 0.7 0.4 2.0 1.0 3.0 3.6 3.1 9.8 1.3 0.4 2.1 4.9 0.5 0.4 1.1 0.3 0.8 8.8 0.5 0.4 2.2 3.5 0.4 0.7 1.9 0.7 0.2 5.3 1.6 0.7 1.6 3.0 2.2 1.9 2.3 1.7 1.1 1.0 0.9 0.4 32.8 7.0 9.5 25.9 3.8 3.2 1.2 0.0 5.3 10.3 10.4 60.9 43.1 8.3 15.5 0.0 1.4 3.8 0.0 16.0 1.5 2.3 25.3 3.5 0.4 4.2 6.4 2.4 0.0 1.9 0.0 0.3 3.4 3.3 11.8 3.2 1.5 29.8 2.9 0.0 2.8 6.2 0.0 1.4 0.2 2.4 3.6 11.0 5.9 3.4 65.3 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 beta 2 subunit" Q13367 15 82659281-82709914 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 17.0;Cone photoreceptor cells: 25.5;Horizontal cells: 12.7;Intestinal endocrine cells: 13.4;Rod photoreceptor cells: 56.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 11.8;SCLC-21H: 19.3;SH-SY5Y: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 1.5 5.4 17.0 2.0 15.5 2.4 1.6 32.3 35.8 1.6 1.6 2.7 0.0 1.8 2.0 2.2 1.6 1.4 1.4 1.1 12.1 11.0 1.3 1.2 1.3 1.6 5.7 18.6 1.8 2.7 8.3 12.3 1.4 16.0 1.7 1.5 3.5 1.7 2.0 1.1 1.8 1.5 1.8 3.7 1.3 2.1 2.6 2.7 0.0 1.7 0.0 1.9 1.8 0.6 1.0 0.5 3.2 1.0 1.1 0.9 0.2 0.2 0.2 5.2 2.0 0.5 0.1 4.6 0.3 0.0 0.6 0.1 0.5 0.5 0.5 3.5 0.1 1.1 0.7 0.5 0.0 0.1 1.6 0.5 0.3 0.5 0.2 0.3 0.4 1.2 0.5 0.6 0.1 0.2 0.3 0.1 1.9 0.6 0.5 0.1 0.8 0.3 0.4 6.0 0.1 0.2 0.3 0.1 0.1 0.0 11.8 19.3 14.9 2.9 0.8 1.3 0.6 0.2 1.0 0.3 0.4 0.8 0.3 1.0 1.0 5.7 0.5 1.4 0.3 0.9 0.7 1.0 0.5 0.6 0.4 0.3 0.6 0.5 0.3 0.1 1.0 0.9 0.5 3.2 1.1 0.6 0.5 0.3 0.2 17.0 15.5 32.3 25.6 12.1 11.0 5.7 18.6 16.0 2.7 0.0 0.6 0.0 1.9 0.3 17.0 0.8 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.3 0.1 0.4 0.8 0.0 0.0 0.1 12.7 13.4 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.5 56.5 0.0 0.4 8.1 3.0 0.1 0.0 0.0 0.0 0.8 AP5B1 "AP-5, DKFZp761E198, PP1030" ENSG00000254470 "Adaptor related protein complex 5 beta 1 subunit" Q2VPB7 11 65775893-65780802 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "neutrophil: 22.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065739, HPA067880" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Vesicles" "Golgi apparatus" "HPA065739: AB_2685550, HPA067880: AB_2685914" "unprognostic (3.64e-1)" "unprognostic (9.40e-2)" "unprognostic (4.37e-3)" "unprognostic (1.45e-2)" "unprognostic (5.56e-3)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "unprognostic (2.15e-1)" "prognostic favorable (2.31e-5)" "unprognostic (2.03e-2)" "unprognostic (2.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.67e-1)" 11.2 6.8 5.3 10.2 8.2 48.6 10.3 10.7 9.1 6.3 6.7 4.0 6.9 9.6 9.8 6.8 13.2 7.2 8.2 6.6 5.7 3.5 7.7 9.3 11.3 13.3 6.0 5.5 4.5 16.1 9.9 5.5 14.8 5.3 6.4 4.2 8.0 10.9 10.7 11.9 10.3 9.5 5.1 5.6 13.0 7.9 3.1 6.2 9.2 7.9 7.4 7.8 11.0 6.5 0.2 0.3 22.5 1.3 0.3 0.4 0.5 10.1 7.9 1.8 10.3 4.9 2.5 14.8 4.3 4.1 4.5 3.6 6.8 4.7 5.8 8.3 3.7 8.4 12.1 5.0 3.3 1.4 9.2 8.7 5.3 8.9 3.3 4.0 6.8 11.1 4.8 6.2 3.1 1.6 3.5 3.5 10.1 11.9 7.6 2.3 7.0 4.3 6.8 3.6 2.4 8.9 13.9 0.3 12.7 3.3 11.5 2.4 4.3 3.2 2.0 19.3 2.1 3.9 10.0 5.5 8.3 7.5 10.6 4.4 7.8 7.9 5.8 5.9 5.8 8.0 0.6 1.3 0.5 0.4 0.8 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 22.5 0.3 1.0 0.2 0.1 0.5 5.3 8.2 10.7 9.1 5.7 3.5 6.0 5.5 5.3 6.2 0.0 9.1 5.2 10.1 2.2 5.2 1.4 5.1 1.4 0.0 7.0 13.7 6.1 1.7 7.4 1.1 2.2 9.5 0.0 11.6 14.8 2.6 4.8 2.3 5.8 13.4 11.1 2.9 1.8 8.1 0.0 0.6 6.1 6.8 7.2 2.2 3.9 8.7 6.2 3.5 6.9 9.6 0.0 3.7 0.2 3.6 1.9 29.2 4.4 3.0 9.5 APBA1 "D9S411E, MINT1, X11" ENSG00000107282 "Amyloid beta precursor protein binding family A member 1" Q02410 9 69427530-69672306 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 65.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.1;BJ hTERT+: 6.0;HAP1: 17.1;SCLC-21H: 6.7;TIME: 7.7;U-138 MG: 7.1;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061287 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA061287: AB_2684467" "unprognostic (4.02e-2)" "unprognostic (4.64e-2)" "unprognostic (7.29e-2)" "unprognostic (8.94e-3)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (4.21e-3)" "unprognostic (8.49e-3)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.46e-5)" "unprognostic (1.60e-1)" "unprognostic (3.09e-2)" "unprognostic (4.99e-3)" "unprognostic (3.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.66e-3)" 2.9 2.9 20.2 1.8 18.6 0.6 4.0 15.5 21.7 4.2 4.1 6.2 0.6 1.7 4.0 1.2 3.4 2.6 3.0 2.9 16.0 19.3 2.3 8.7 1.9 1.6 19.1 13.7 7.5 2.9 14.5 3.5 3.1 15.7 2.2 4.2 2.7 5.5 2.8 4.0 3.8 2.1 2.2 5.5 6.0 1.7 3.5 6.7 0.0 1.5 0.6 1.2 2.4 2.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 3.1 2.3 0.1 7.1 6.0 0.1 0.1 0.0 0.0 0.0 3.3 2.9 0.0 0.1 17.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.0 2.9 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 2.5 6.7 4.4 0.4 0.9 0.1 0.2 0.0 0.0 7.7 7.1 0.8 0.0 0.5 7.1 3.1 0.0 0.2 0.1 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.0 20.2 18.6 15.5 19.7 16.0 19.3 19.1 13.7 15.7 6.7 0.0 0.0 0.0 1.2 1.5 12.7 3.9 0.0 0.0 0.0 0.0 3.9 0.7 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.4 0.6 0.4 0.0 2.8 2.4 65.2 4.1 3.1 2.5 0.0 2.3 0.7 0.0 1.0 1.5 3.9 0.2 0.0 10.3 0.4 9.6 0.0 1.4 0.9 1.3 2.0 0.3 0.0 0.8 0.4 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 33.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 22.5;Horizontal cells: 84.2;T-cells: 21.8" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.8;naive CD8 T-cell: 7.5" "Lineage enriched" "Detected in many" 4 "T-cells: 7.8" "Cell line enhanced" "Detected in some" "HEL: 7.6;SH-SY5Y: 18.7;U-937: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 1.8 3.3 17.6 3.0 12.1 3.0 1.7 33.4 28.9 1.2 2.0 3.6 0.0 2.5 2.1 2.5 6.7 1.4 2.1 1.6 24.2 14.9 1.4 1.8 2.1 3.6 15.1 14.9 1.8 2.6 1.2 2.3 1.6 7.5 3.0 2.1 1.6 1.8 1.7 1.6 1.8 2.7 1.4 16.2 7.9 1.8 5.6 2.7 1.9 1.9 0.0 3.4 2.9 0.4 0.0 0.0 0.1 0.0 1.8 7.8 2.5 0.0 1.4 0.6 3.5 0.0 0.0 0.0 0.8 1.3 0.1 0.5 0.0 0.0 0.0 3.3 0.0 2.2 0.0 0.5 0.0 0.0 0.0 2.9 7.6 0.0 0.1 2.9 0.0 0.2 0.4 2.3 0.4 0.0 0.3 4.0 1.7 4.4 0.1 0.0 0.4 0.2 2.1 1.0 0.0 3.1 0.0 0.3 0.1 0.0 0.0 5.0 18.7 0.0 0.0 0.1 0.1 0.0 0.9 4.0 0.0 4.1 0.0 0.8 0.0 0.1 0.0 0.1 13.4 1.6 0.0 0.0 0.0 1.4 0.0 0.2 0.0 2.1 4.7 0.0 0.0 7.8 7.5 0.1 1.8 0.0 0.0 0.0 2.5 17.6 12.1 33.4 28.9 24.2 14.9 15.1 14.9 7.5 2.7 0.0 1.1 0.0 0.2 0.3 22.5 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 1.6 10.3 0.5 0.0 0.0 5.1 0.1 1.0 0.1 0.0 0.2 0.9 84.2 0.0 3.7 2.4 7.9 1.7 0.0 3.3 0.0 0.0 1.2 5.3 0.0 3.5 0.1 3.1 0.0 3.1 0.6 7.0 0.3 0.1 21.8 0.0 0.1 APBB1 "Fe65, RIR" ENSG00000166313 "Amyloid beta precursor protein binding family B member 1" O00213 11 6395124-6419414 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 34.4" "Lineage enriched" "Detected in many" 5 "T-cells: 34.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038521, HPA038522" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA038521: AB_2676058, HPA038522: AB_2676059" "unprognostic (4.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.84e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (7.30e-2)" "unprognostic (3.22e-3)" "unprognostic (2.36e-1)" "prognostic favorable (1.86e-5)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-13)" "unprognostic (1.32e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" 7.9 14.0 26.0 6.9 26.0 1.9 5.5 54.3 84.6 11.5 9.6 31.1 3.7 4.5 15.7 3.2 9.2 19.7 7.0 21.8 29.5 23.9 9.2 2.3 9.4 7.5 27.0 30.7 21.3 9.5 14.8 15.7 5.4 25.8 10.9 3.3 5.5 8.0 16.5 21.5 4.6 5.2 19.5 36.4 5.9 5.7 7.2 24.7 6.0 7.7 2.5 6.6 7.7 5.8 6.3 0.6 3.0 0.6 5.5 34.4 11.3 0.0 5.9 20.7 9.2 11.2 11.6 0.0 9.7 16.9 16.9 21.3 10.7 4.1 0.0 1.5 17.7 15.2 0.2 18.0 3.0 8.1 10.8 13.6 0.1 3.8 0.3 8.1 0.0 4.1 10.4 0.7 7.9 1.2 14.5 20.9 0.5 0.4 0.3 6.2 0.2 0.2 0.0 7.4 0.3 6.4 0.1 0.8 0.0 0.7 0.0 28.5 16.1 1.4 1.2 6.4 6.6 0.8 1.3 9.2 1.7 10.5 11.2 2.0 5.6 2.6 0.8 8.7 0.0 5.8 3.0 0.6 0.1 9.1 0.5 9.8 2.6 12.7 11.7 0.6 6.3 34.4 20.0 0.5 5.5 0.2 0.1 17.0 11.3 26.0 26.0 54.3 49.3 29.5 23.9 27.0 30.7 25.8 24.7 17.9 4.8 3.2 10.7 4.4 36.4 40.0 10.2 26.8 9.1 5.2 21.6 0.4 21.6 14.5 4.3 13.7 0.5 0.0 3.6 0.6 12.5 8.9 1.1 3.0 1.1 38.1 18.6 19.0 2.8 9.2 8.9 0.8 8.5 3.6 0.7 23.8 7.3 1.1 18.0 19.2 16.8 6.5 18.7 4.2 6.6 2.5 0.7 21.7 0.8 4.4 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438203-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2;lymphoid tissue: 100.5" "Cell type enhanced" "Detected in many" 12 "B-cells: 48.4;Hofbauer cells: 56.0;Kupffer cells: 108.6;Macrophages: 52.4;T-cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.7;MOLT-4: 22.0;REH: 49.7;U-698: 52.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" No NA "Plasma membrane, Cytosol" "HPA017009: AB_2669505, HPA063903: AB_2685147" "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favorable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 18.3 3.9 7.9 27.7 14.2 25.8 10.1 1.2 7.3 2.6 3.9 16.6 0.0 4.5 2.0 1.5 2.9 4.9 7.5 4.8 7.3 4.9 4.8 25.4 11.1 28.2 14.5 3.2 1.5 3.0 1.3 2.7 5.5 11.1 2.5 4.5 1.6 4.0 1.6 1.5 2.8 12.0 4.7 21.9 41.5 5.4 1.3 12.1 100.5 3.0 0.7 26.2 8.0 3.9 11.0 14.8 54.2 10.3 5.3 9.5 3.5 0.0 0.4 0.0 0.0 3.4 5.7 3.0 9.6 1.8 5.5 5.3 0.0 0.0 25.7 0.1 6.4 5.9 0.0 0.0 0.0 7.6 0.0 0.0 18.6 0.0 0.0 0.0 3.5 0.0 8.2 0.0 0.2 0.0 0.6 0.0 10.6 0.0 16.4 0.0 0.0 22.0 4.9 0.0 2.0 0.0 49.7 0.0 18.2 1.5 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.1 1.8 0.0 4.5 0.0 52.9 4.5 18.2 0.0 19.0 7.1 16.1 9.5 6.9 7.7 9.5 8.1 7.9 4.4 11.0 9.3 9.0 54.2 5.3 10.3 14.8 7.6 3.5 7.9 14.2 1.2 7.3 7.3 4.9 14.5 3.2 11.1 12.1 0.0 25.9 48.4 0.0 1.0 0.0 0.9 5.1 6.7 4.5 3.5 0.0 2.0 0.0 4.1 0.3 1.7 0.0 0.0 0.0 14.9 4.1 0.1 22.0 21.5 56.0 0.0 0.0 8.6 108.6 0.0 0.0 52.4 3.3 8.2 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 1.0 0.0 0.9 0.1 1.1 69.3 0.0 0.0 APBB3 FE65L2 ENSG00000113108 "Amyloid beta precursor protein binding family B member 3" O95704 5 140558268-140564781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.6" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005571, HPA076196" Approved Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA005571: AB_1844912, HPA076196: " "unprognostic (7.63e-2)" "unprognostic (4.58e-2)" "unprognostic (1.13e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-3)" "unprognostic (1.44e-1)" "unprognostic (5.06e-2)" "unprognostic (7.22e-2)" "unprognostic (1.98e-1)" "prognostic favorable (6.79e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.06e-6)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.38e-2)" "unprognostic (4.67e-2)" 4.2 5.6 7.5 4.3 9.2 3.3 3.4 26.6 23.8 4.5 4.3 8.2 5.7 2.0 4.7 6.3 4.2 6.0 7.8 8.2 9.7 13.1 3.3 3.4 3.2 2.6 7.9 7.3 4.3 3.5 8.2 11.0 5.7 10.9 5.9 3.6 8.7 8.8 7.4 2.5 3.4 2.8 4.1 4.2 4.7 4.4 11.8 5.5 2.0 6.7 3.3 3.4 3.8 2.3 1.4 1.8 7.7 3.6 0.7 1.4 1.1 0.6 0.7 0.5 2.9 0.0 1.2 5.8 1.4 1.7 2.1 3.9 1.9 1.7 2.4 3.3 2.5 1.3 1.1 0.0 2.2 0.6 2.3 1.2 0.9 5.2 0.1 3.5 0.8 1.0 7.6 0.9 1.8 1.4 0.5 1.5 5.6 0.4 6.6 2.2 1.4 0.3 1.8 1.2 0.7 3.6 0.4 0.7 1.4 1.8 1.5 9.0 4.5 3.8 1.3 5.1 0.3 4.0 3.9 1.1 0.4 1.0 0.0 0.2 2.5 1.9 0.3 0.9 0.6 0.8 7.7 1.4 0.0 1.4 3.6 0.9 0.5 1.0 1.3 1.0 1.4 0.6 1.3 3.3 0.7 0.6 1.8 1.0 1.1 7.5 9.2 26.6 17.4 9.7 13.1 7.9 7.3 10.9 5.5 3.0 9.4 3.4 2.8 2.5 22.6 1.9 12.7 1.4 6.8 5.2 0.0 9.5 5.0 3.3 48.3 5.8 5.0 0.0 1.4 10.2 4.1 2.9 10.4 14.3 11.9 17.5 5.2 7.4 29.1 31.3 5.2 10.2 6.8 4.6 3.6 12.4 2.3 3.2 4.6 3.1 15.7 0.0 3.1 8.4 6.0 2.5 9.8 4.4 2.8 2.4 APC "DP2, DP2.5, DP3, PPP1R46" ENSG00000134982 "APC, WNT signaling pathway regulator" P25054 5 112707498-112846239 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 169.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013349, HPA013362" Supported Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA013349: AB_1844913, HPA013362: " "unprognostic (4.80e-2)" "unprognostic (1.19e-1)" "unprognostic (3.72e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (7.09e-3)" "unprognostic (1.62e-1)" "unprognostic (8.10e-3)" "unprognostic (2.35e-1)" "unprognostic (4.85e-3)" "unprognostic (1.27e-1)" "unprognostic (4.18e-2)" "unprognostic (1.02e-2)" "unprognostic (1.07e-1)" "unprognostic (3.35e-1)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" 7.2 5.4 40.9 6.4 21.7 8.5 6.3 19.1 39.7 6.8 7.1 10.3 2.0 6.6 6.3 3.9 8.4 5.0 5.5 7.4 37.9 12.9 6.9 6.2 6.7 5.6 23.6 20.7 7.6 4.6 13.8 7.2 5.5 39.1 5.9 6.9 4.0 4.0 4.9 7.0 6.1 8.8 8.1 19.1 6.2 5.4 5.3 20.6 3.6 6.5 2.7 6.2 6.2 3.9 3.8 3.0 12.9 2.9 3.0 3.4 1.1 8.3 7.7 12.9 9.4 10.6 8.9 5.3 13.6 6.5 7.6 9.0 6.1 6.8 16.2 13.2 17.3 11.7 6.9 13.2 11.1 12.5 9.7 9.0 12.3 11.2 4.7 5.2 6.2 6.7 7.4 7.7 12.8 8.5 5.3 10.5 7.8 15.1 5.6 10.9 5.8 7.1 3.1 4.6 4.6 2.8 6.0 16.0 7.9 7.0 10.7 13.1 7.9 12.9 5.0 5.5 5.5 7.0 5.1 16.7 15.4 7.4 15.1 10.3 4.4 6.6 6.4 8.5 11.5 8.6 10.4 2.9 5.0 3.4 1.4 2.9 3.1 1.8 2.1 2.3 3.8 2.9 2.8 12.9 3.0 2.5 3.0 1.6 1.1 40.9 21.7 19.1 31.4 37.9 12.9 23.6 20.7 39.1 20.6 47.6 17.6 10.8 8.3 10.0 169.9 48.4 12.7 20.1 26.1 0.0 62.8 4.4 0.0 16.7 6.3 21.0 24.6 0.0 17.0 5.3 10.2 10.3 18.5 12.1 13.8 74.7 26.4 28.8 14.9 4.4 16.4 14.8 16.9 19.0 15.5 21.8 16.3 25.9 18.4 4.2 37.9 38.8 14.3 14.9 26.7 10.2 2.4 10.7 14.2 7.6 APC2 APCL ENSG00000115266 "APC2, WNT signaling pathway regulator" O95996 19 1446302-1473244 "Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 59.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 41.9;Horizontal cells: 42.9;Muller glia cells: 26.1;Rod photoreceptor cells: 10.3" "Cancer enriched" "Detected in some" 27 "glioma: 17.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.5;SCLC-21H: 7.8;SH-SY5Y: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078002 Supported "Cytokinetic bridge,Midbody,Cytosol" Yes No "Cytokinetic bridge, Midbody" Cytosol "HPA078002: AB_2686874" "unprognostic (1.78e-3)" "unprognostic (1.65e-1)" "unprognostic (2.88e-5)" "unprognostic (3.64e-2)" "unprognostic (3.59e-1)" "unprognostic (1.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-2)" "unprognostic (3.45e-2)" "unprognostic (9.49e-3)" "unprognostic (7.39e-2)" "unprognostic (3.70e-2)" "unprognostic (4.99e-2)" "unprognostic (1.98e-3)" 1.5 4.7 17.3 1.4 16.4 1.5 1.3 21.7 59.4 1.4 1.6 20.7 0.0 2.1 1.4 1.4 1.4 1.5 1.6 1.4 16.8 13.9 1.3 1.3 1.4 1.4 15.0 14.0 1.3 2.0 1.3 3.0 1.4 17.1 1.4 1.4 0.8 1.7 1.4 1.6 1.4 1.8 1.5 13.9 1.4 1.4 1.8 14.5 0.0 1.5 0.0 1.3 1.6 0.0 1.1 0.2 0.4 0.0 0.0 0.1 0.1 0.2 0.5 6.5 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.7 0.0 0.0 7.8 26.5 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.5 0.2 0.2 1.9 0.4 0.3 0.7 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 17.3 16.4 21.7 21.3 16.8 13.9 15.0 14.0 17.1 14.5 0.0 0.0 0.0 0.1 0.0 41.9 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 42.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.7 0.0 10.3 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.1 APCDD1 B7323 ENSG00000154856 "APC down-regulated 1" Q8J025 18 10454628-10489948 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 84.9" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 58.3;Cholangiocytes: 38.2;Melanocytes: 75.9;Peritubular cells: 35.3;Suprabasal keratinocytes: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.8;BJ hTERT+: 34.2;HaCaT: 20.8;HHSteC: 9.6;HSkMC: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.21e-1)" "unprognostic (2.85e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.39e-4)" "prognostic favorable (8.23e-4)" "unprognostic (5.61e-3)" "unprognostic (6.79e-3)" "unprognostic (1.24e-1)" "unprognostic (5.59e-3)" "unprognostic (2.59e-2)" "unprognostic (3.14e-1)" "unprognostic (7.77e-2)" "unprognostic (2.04e-3)" "unprognostic (1.77e-1)" "unprognostic (3.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" 32.9 10.6 21.8 5.3 17.9 1.2 15.9 14.4 26.4 27.0 8.7 22.9 3.9 3.2 23.0 11.9 19.7 23.6 30.6 16.8 29.6 11.2 4.3 1.7 7.3 2.3 12.2 17.4 24.1 8.0 1.5 1.9 18.6 20.8 29.0 10.1 12.0 7.9 11.1 5.2 84.9 7.0 11.2 8.9 4.0 13.7 3.6 17.7 0.0 3.0 16.1 4.0 21.6 18.5 0.7 3.3 2.3 0.9 0.1 0.1 0.8 0.0 0.0 15.8 0.0 2.7 0.0 0.0 1.1 34.2 1.5 2.4 0.0 0.0 0.0 0.0 6.3 0.0 20.8 0.1 0.0 1.6 0.0 0.8 0.0 0.0 0.3 9.6 0.0 0.0 19.9 0.7 3.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 1.0 0.8 0.2 2.6 7.3 0.0 0.4 0.0 0.5 0.0 0.2 0.4 0.1 0.0 0.0 1.8 1.0 0.0 0.2 0.0 1.9 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 2.3 2.3 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.8 0.1 0.0 3.3 0.0 0.8 21.8 17.9 14.4 21.7 29.6 11.2 12.2 17.4 20.8 17.7 0.0 13.0 0.0 4.4 58.3 4.8 3.8 38.2 8.1 3.4 3.5 0.0 1.8 0.0 7.2 0.4 9.5 0.0 0.0 0.3 0.3 31.9 7.7 1.1 0.0 1.2 0.0 3.5 1.3 0.8 0.4 8.1 2.6 75.9 0.0 1.0 0.2 0.2 0.0 35.3 0.0 2.2 25.8 16.7 0.2 0.7 47.0 0.8 0.0 0.2 3.9 APCDD1L FLJ90166 ENSG00000198768 "APC down-regulated 1 like" Q8NCL9 20 58459101-58515131 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "salivary gland: 39.2;smooth muscle: 10.9" "Cell type enhanced" "Detected in single" 29 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 43.4;hTEC/SVTERT24-B: 15.4;HUVEC TERT2: 15.6;TIME: 30.5;U-87 MG: 19.2" "Not detected" "Not detected" HPA067015 Uncertain Uncertain Mitochondria No No Mitochondria "HPA067015: AB_2685764" "unprognostic (2.61e-1)" "unprognostic (8.26e-3)" "unprognostic (4.63e-3)" "unprognostic (1.35e-5)" "unprognostic (4.09e-3)" "unprognostic (9.73e-3)" "unprognostic (1.31e-3)" "unprognostic (1.06e-4)" "unprognostic (7.63e-4)" "unprognostic (2.14e-2)" "unprognostic (7.62e-3)" "unprognostic (2.16e-1)" "unprognostic (6.55e-13)" "unprognostic (5.01e-3)" "unprognostic (3.21e-1)" "unprognostic (2.24e-2)" "unprognostic (1.81e-3)" 0.5 0.6 0.2 0.6 0.2 0.0 5.2 0.6 0.1 3.3 1.2 0.1 0.0 0.1 2.4 0.2 0.8 0.0 2.1 5.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.1 3.6 0.7 3.2 39.2 1.7 0.6 0.9 0.8 10.9 0.3 0.0 0.6 0.1 0.0 0.0 0.1 1.0 0.6 6.1 5.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 9.2 0.0 0.9 0.7 0.0 2.8 0.0 0.0 43.4 0.2 0.4 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.3 0.0 15.4 0.2 3.1 15.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.5 6.5 0.4 0.0 8.5 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APCS "MGC88159, PTX2, SAP" ENSG00000132703 "Amyloid P component, serum" P02743 1 159587825-159588865 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 316.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 3479.3" "Cancer enriched" "Detected in some" 25 "liver cancer: 826.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 3.3;RH-30: 4.3;SiHa: 2.2;U-937: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB007817, HPA053294" Supported "Secreted to blood" NA NA 27700000000 76000000000 "CAB007817: AB_598185, HPA053294: AB_2682104" "unprognostic (3.19e-3)" "unprognostic (2.30e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.7 316.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.7 4.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.7 0.2 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 451.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.0 0.0 0.0 70.0 5.1 0.0 0.0 0.0 0.0 3479.3 0.0 0.0 0.0 63.8 73.6 0.0 0.0 0.0 0.0 5.4 0.0 0.0 16.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APELA "ELA, Ende, tdl" ENSG00000248329 "Apelin receptor early endogenous ligand" P0DMC3 4 164877004-164898965 "Predicted secreted proteins" "Angiogenesis, Differentiation, Gastrulation" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 7.8;prostate: 8.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 22.2;Syncytiotrophoblasts: 34.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NTERA-2: 27.8;SuSa: 17.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.97e-2)" "unprognostic (6.97e-2)" "unprognostic (9.83e-4)" "unprognostic (8.92e-3)" "unprognostic (1.43e-3)" "unprognostic (4.50e-2)" "unprognostic (2.21e-1)" "unprognostic (1.71e-1)" "unprognostic (3.38e-3)" "unprognostic (1.68e-1)" "unprognostic (2.18e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-1)" "unprognostic (8.35e-2)" "unprognostic (1.95e-4)" 0.0 0.0 0.0 0.1 0.0 0.2 2.8 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 3.9 0.0 1.5 0.1 0.0 2.2 0.7 0.0 0.0 0.0 7.8 0.0 8.2 0.0 0.0 1.9 0.0 0.0 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.4 0.0 0.6 0.6 2.5 0.3 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.7 0.3 0.7 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.6 0.3 0.3 2.5 0.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 22.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 APH1B "APH-1B, DKFZp564D0372, PSFL" ENSG00000138613 "Aph-1 homolog B, gamma-secretase subunit" Q8WW43 15 63276018-63309126 "Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.1;testis: 75.6" "Cell type enriched" "Detected in many" 5 "Early spermatids: 1096.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (9.92e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-1)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (3.57e-1)" "unprognostic (7.86e-2)" "unprognostic (1.78e-1)" "unprognostic (3.86e-1)" "unprognostic (4.56e-2)" "prognostic favorable (1.05e-4)" "unprognostic (8.44e-2)" "prognostic favorable (2.25e-4)" "unprognostic (4.29e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" 6.7 8.0 5.3 5.9 7.8 4.5 6.9 6.1 7.1 5.0 3.4 12.6 4.8 2.4 6.3 8.0 3.0 10.4 5.1 5.6 5.6 5.8 5.1 2.2 5.8 15.0 6.8 6.2 9.6 2.9 4.3 5.6 5.0 7.4 7.7 2.9 8.6 5.0 5.4 2.5 3.4 4.5 4.6 7.5 9.2 3.2 75.6 3.4 8.0 12.3 2.0 5.0 5.3 4.2 8.4 5.7 16.6 37.1 2.3 4.9 6.5 0.7 4.8 5.3 4.3 12.2 21.5 1.9 6.3 12.9 4.8 8.1 4.4 7.0 6.2 3.0 7.0 9.0 0.7 9.0 2.5 9.1 4.2 1.4 10.8 1.1 0.1 10.1 2.3 17.9 13.5 4.0 7.1 4.8 8.2 10.1 7.9 3.6 4.7 14.9 2.1 3.2 7.3 5.0 1.5 2.5 3.2 2.9 0.1 2.5 4.9 4.7 2.6 2.6 2.1 0.0 5.9 7.8 14.0 6.7 14.3 5.6 2.3 0.9 11.4 18.9 8.4 10.4 14.1 8.3 10.6 12.0 14.8 4.2 22.9 3.4 8.4 4.4 3.8 5.7 6.4 4.8 4.9 16.6 2.3 37.1 2.1 4.2 6.5 5.3 7.8 6.1 7.1 5.6 5.8 6.8 6.2 7.4 3.4 8.9 19.7 15.7 9.4 4.6 7.0 4.5 7.6 22.7 14.8 21.0 2.0 5.2 1.7 24.3 1096.5 10.0 0.5 0.0 5.5 34.4 12.8 9.1 22.0 1.5 48.6 1.6 19.5 17.2 45.1 235.2 22.7 28.9 10.1 26.2 3.8 23.7 13.2 0.0 15.6 5.6 13.6 12.9 13.3 231.2 16.4 3.0 5.0 10.2 2.4 5.2 APLN "apelin, XNPEP2" ENSG00000171388 Apelin Q9ULZ1 X 129645259-129654937 "Predicted secreted proteins" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;placenta: 52.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 2.2;Cardiomyocytes: 5.5;Glandular cells: 1.5;Melanocytes: 1.7" "Group enriched" "Detected in all" 6 "glioma: 44.2;renal cancer: 21.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 106.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.50e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (9.32e-4)" "prognostic unfavorable (6.09e-4)" "unprognostic (4.71e-2)" "unprognostic (2.25e-1)" "unprognostic (3.30e-1)" "unprognostic (9.12e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (2.26e-1)" "unprognostic (8.42e-2)" 3.8 9.7 10.0 2.8 8.0 0.7 2.3 2.0 10.9 0.9 1.2 21.8 0.0 1.5 1.4 1.0 1.3 0.9 1.1 8.3 9.7 10.3 5.2 1.0 13.6 0.8 13.9 7.6 12.5 0.9 0.9 4.3 52.0 14.5 1.5 1.0 0.0 1.3 1.2 2.9 1.2 1.0 2.5 19.3 1.1 1.1 1.6 10.7 0.0 1.6 0.2 0.9 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 0.1 0.4 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.3 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 1.7 0.0 1.5 0.0 0.0 106.9 0.3 0.0 0.4 0.5 0.0 0.0 0.1 0.3 0.0 5.7 0.0 0.1 0.1 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.1 18.1 0.4 0.0 7.8 0.4 0.1 0.0 0.0 7.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 8.0 2.0 8.1 9.7 10.3 13.9 7.6 14.5 10.7 0.0 2.2 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.8 1.2 1.5 1.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.0 0.0 APLNR "AGTRL1, APJ, APJR, FLJ90771" ENSG00000134817 "Apelin receptor" P35414 11 57233577-57237314 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4" "Group enriched" "Detected in some" 5 "Endothelial cells: 24.9;Ito cells: 12.9" "Cancer enhanced" "Detected in all" "glioma: 50.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "AF22: 10.2;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0;SuSa: 4.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB025842 Approved NA NA "CAB025842: " "unprognostic (5.06e-2)" "unprognostic (3.56e-1)" "unprognostic (2.70e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-1)" "unprognostic (6.68e-3)" "unprognostic (1.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (4.72e-1)" "unprognostic (1.77e-3)" "unprognostic (3.27e-2)" "unprognostic (8.13e-2)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" 8.4 2.1 26.1 3.8 14.2 0.0 3.3 3.8 21.0 1.2 2.3 30.8 0.0 1.8 1.6 0.0 1.8 1.2 5.7 7.2 24.8 9.3 2.5 8.0 3.5 4.0 17.3 10.2 1.2 1.4 1.9 1.5 40.4 32.8 1.2 2.8 0.2 1.7 0.8 5.8 3.0 1.7 4.7 63.8 44.1 1.5 1.2 18.2 0.1 3.1 0.6 1.8 3.8 1.5 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 26.1 14.2 3.8 16.3 24.8 9.3 17.3 10.2 32.8 18.2 0.0 0.0 0.0 0.0 2.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.9 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 12.9 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.0 APLP1 APLP ENSG00000105290 "Amyloid beta precursor like protein 1" P51693 19 35867899-35879791 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Endocytosis" Heparin-binding Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 147.5" "Group enriched" "Detected in many" 4 "Bipolar cells: 142.9;Horizontal cells: 152.6" "Cancer enhanced" "Detected in many" "glioma: 63.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 25.4;AN3-CA: 47.1;EFO-21: 24.9;HMC-1: 24.3;SCLC-21H: 27.4;SH-SY5Y: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028970, HPA028971" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 3900000 "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA028970: AB_2672847, HPA028971: AB_10601334" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (9.36e-3)" "prognostic unfavorable (3.87e-4)" "unprognostic (7.32e-3)" "unprognostic (1.26e-2)" "unprognostic (1.04e-3)" "unprognostic (2.24e-2)" "unprognostic (4.98e-2)" "unprognostic (6.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.57e-11)" "unprognostic (1.38e-3)" "unprognostic (7.12e-2)" "unprognostic (5.43e-2)" "prognostic unfavorable (2.65e-5)" 2.6 15.6 37.0 2.9 47.9 1.6 1.6 13.1 147.5 2.4 2.6 91.6 0.0 2.0 2.3 2.1 2.2 2.3 4.3 6.0 53.2 37.4 2.4 1.5 2.4 2.1 54.6 24.6 1.9 32.1 5.6 17.6 1.9 38.4 2.3 2.6 3.3 2.4 2.4 1.5 2.0 2.4 2.9 118.2 1.7 9.6 5.7 36.9 0.0 2.2 0.0 2.2 2.1 0.1 1.5 0.4 2.2 0.7 3.0 0.6 0.2 1.4 10.6 25.4 47.1 2.4 1.0 3.3 2.2 1.1 2.5 0.3 2.5 1.4 0.2 24.9 5.5 8.2 0.7 7.8 0.5 1.7 17.7 0.9 0.1 3.1 1.4 0.7 0.0 24.3 1.1 0.6 1.0 0.0 9.4 0.8 1.8 0.9 0.4 7.2 2.3 0.0 0.0 1.2 4.3 6.2 2.4 0.1 0.3 0.4 0.3 27.4 27.8 8.2 1.1 0.3 7.2 6.1 1.3 0.6 17.1 9.8 9.6 1.4 1.1 0.4 0.1 11.2 0.3 8.6 2.2 0.7 0.4 0.4 0.5 0.3 0.7 0.4 0.6 0.2 1.5 0.5 0.6 2.1 3.0 0.7 0.4 0.2 0.2 37.0 47.9 13.1 54.6 53.2 37.4 54.6 24.6 38.4 36.9 6.0 0.0 0.0 2.4 1.1 142.9 4.8 0.0 0.0 0.0 0.0 11.8 0.3 0.0 2.1 25.2 2.8 0.0 0.0 3.8 4.1 2.1 1.8 0.0 0.0 0.4 152.6 33.6 1.3 0.3 8.5 1.1 0.5 5.0 0.0 0.0 11.9 4.4 0.0 0.0 0.0 24.2 0.0 1.7 9.7 22.2 0.5 0.3 0.0 0.0 1.2 APMAP "BSCv, C20orf3" ENSG00000101474 "Adipocyte plasma membrane associated protein" Q9HDC9 20 24962925-24992979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.8;liver: 100.5" "Cell type enhanced" "Detected in all" 11 "Cytotrophoblasts: 255.8;Hepatocytes: 247.3;Syncytiotrophoblasts: 628.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012863, HPA064700" Uncertain Approved "Plasma membrane" NA NA 80000000 "Plasma membrane" "HPA012863: AB_1845683, HPA064700: AB_2685328" "unprognostic (4.07e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (8.16e-2)" "unprognostic (6.79e-2)" "unprognostic (2.14e-2)" "unprognostic (1.10e-2)" "unprognostic (4.09e-2)" "unprognostic (3.10e-2)" "unprognostic (1.19e-2)" "unprognostic (6.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.99e-3)" "unprognostic (8.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.51e-2)" 43.5 13.0 14.8 12.4 16.1 44.5 23.1 47.3 22.7 11.7 12.3 15.7 17.9 8.9 14.8 31.8 7.5 13.0 13.4 10.2 18.2 20.9 12.9 100.5 14.4 15.9 15.4 17.2 12.3 12.2 18.9 20.2 28.3 17.0 12.5 12.4 11.6 10.6 18.7 9.8 14.0 9.3 13.8 13.7 16.9 10.2 19.9 15.4 10.6 57.9 5.7 9.2 13.0 10.6 5.2 13.9 93.8 13.9 43.2 53.4 40.1 22.9 39.8 20.5 30.7 39.9 21.8 20.8 30.0 32.9 29.0 30.1 23.5 40.8 9.5 35.1 36.0 53.0 42.4 18.7 34.9 34.1 12.7 14.6 10.5 14.4 47.7 31.4 20.5 25.3 29.5 49.5 34.0 24.5 40.0 41.2 15.7 12.4 42.9 28.1 34.5 14.1 23.1 12.9 36.7 36.3 11.7 68.1 19.8 30.9 21.1 33.6 13.0 30.9 53.5 33.2 22.3 19.0 17.2 36.1 34.9 31.3 29.5 44.7 24.4 27.0 10.5 18.4 31.2 33.1 7.4 13.9 26.1 53.4 13.4 33.0 5.1 15.1 38.8 13.9 5.2 11.9 30.9 93.8 43.2 9.0 6.8 9.9 40.1 14.8 16.1 47.3 22.7 18.2 20.9 15.4 17.2 17.0 15.4 17.9 28.3 27.4 38.9 21.6 49.0 14.5 45.9 24.1 21.6 47.1 9.8 255.8 14.9 60.3 22.9 34.6 17.0 23.3 39.8 32.6 32.9 31.8 34.7 247.3 84.5 15.9 17.2 38.6 45.7 27.7 60.1 81.5 43.9 161.5 17.3 35.4 35.7 19.9 77.1 13.0 18.3 38.8 34.0 52.1 79.8 17.6 628.2 145.4 24.7 24.2 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837950 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 573.5" "Cell type enriched" "Detected in many" 33 "Hepatocytes: 19896.2" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 4 "dendritic cells: 3.6;T-cells: 2.4" "Cell line enriched" "Detected in some" 18 "Hep G2: 253.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" NA NA 1450000000000 220000000000 Vesicles Cytosol "CAB016778: , HPA046715: AB_2679768" "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favorable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 24.6 0.2 0.2 55.6 0.2 0.3 0.2 0.1 0.3 1.3 0.2 0.0 0.2 573.5 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 127.9 0.2 0.2 0.4 0.3 11.8 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.5 3.6 0.0 0.7 0.7 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 253.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.3 1.6 0.0 0.2 0.4 1.7 0.7 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 2.4 0.7 0.3 0.0 0.2 1.8 0.8 0.5 0.8 1.7 0.0 0.7 0.0 3.6 2.1 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 3.5 174.9 0.2 0.1 0.6 24.6 596.2 0.0 2.3 0.0 0.0 0.4 0.0 0.1 30.6 1.9 0.9 256.9 1.0 1.1 1.5 0.1 2.3 19896.2 3.1 0.0 1.7 472.6 569.9 110.5 20.8 0.6 0.0 0.0 0.5 0.1 0.2 0.3 4.6 2.2 0.6 6.5 0.7 10.3 9.1 0.5 3.5 2.9 0.3 0.3 APOA2 ENSG00000158874 "Apolipoprotein A2" P02652 1 161222292-161223631 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction, Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 321 "liver: 932.2" "Cell type enriched" "Detected in some" 61 "Hepatocytes: 43650.4" "Cancer enriched" "Detected in many" 329 "liver cancer: 11230.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.1;neutrophil: 2.9" "Group enriched" "Detected in many" 20 "dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1" "Cell line enriched" "Detected in some" 9 "Hep G2: 610.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB025885, HPA072575" Supported "Secreted to blood" NA NA 115000000000 210000000000 "CAB025885: , HPA072575: " "unprognostic (2.05e-1)" "unprognostic (4.70e-2)" "unprognostic (1.12e-1)" "unprognostic (2.99e-1)" "unprognostic (9.82e-2)" "unprognostic (1.92e-1)" "unprognostic (3.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (4.40e-3)" "unprognostic (3.16e-2)" "unprognostic (2.22e-1)" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 932.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.0 2.9 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 67.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 610.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 1.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.9 0.0 0.8 0.7 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 153.8 0.0 0.0 0.0 0.0 647.1 0.0 0.0 0.0 0.0 0.5 1.7 0.0 1.2 0.0 0.0 186.9 0.5 1.1 0.0 0.0 0.0 43650.4 4.6 0.0 0.0 550.0 711.3 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.5 0.0 4.7 0.0 0.0 0.0 APOA4 ENSG00000110244 "Apolipoprotein A4" P06727 11 116820700-116823306 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 593.6" "Cell type enriched" "Detected in single" 618 "Hepatocytes: 61.8" "Cancer enriched" "Detected in some" 29 "liver cancer: 291.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.1;CACO-2: 8.2;Hep G2: 7.7;NB-4: 7.5;RPMI-8226: 12.0;SH-SY5Y: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001352, HPA002549, CAB068250, CAB068251, CAB068252" Enhanced Approved Vesicles "Secreted to blood" NA NA 61200000000 140000000000 Vesicles "CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177" "unprognostic (8.81e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (7.91e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 293.8 0.0 0.0 175.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 93.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 593.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOA5 "APOA-V, RAP3" ENSG00000110243 "Apolipoprotein A5" Q6Q788 11 116789367-116792420 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 209 "liver: 112.2" "Cell type enriched" "Detected in some" 55 "Hepatocytes: 1283.4" "Cancer enriched" "Detected in single" 489 "liver cancer: 112.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 65 "Hep G2: 36.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 114000000 15000000 "unprognostic (1.57e-4)" "unprognostic (4.67e-3)" "unprognostic (5.57e-2)" "unprognostic (2.60e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 36.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.0 1283.4 0.0 0.0 0.0 13.5 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOB ENSG00000084674 "Apolipoprotein B" P04114 2 21001429-21044073 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Atherosclerosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 145 "intestine: 224.8;liver: 442.2" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 2874.2" "Cancer enriched" "Detected in some" 99 "liver cancer: 295.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "Hep G2: 155.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016070, HPA049793" Supported Supported Vesicles,Cytosol "Secreted to blood" NA NA 1490000000000 89000000000 "Vesicles, Cytosol" "CAB016070: AB_626690, HPA049793: AB_2680885" "unprognostic (1.63e-2)" "unprognostic (2.71e-2)" "unprognostic (1.75e-1)" "unprognostic (1.06e-1)" "unprognostic (1.04e-2)" "unprognostic (7.31e-2)" "unprognostic (1.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.43e-2)" "unprognostic (8.89e-3)" "unprognostic (3.01e-1)" "unprognostic (4.59e-3)" "unprognostic (3.60e-3)" "unprognostic (2.89e-2)" "unprognostic (2.38e-1)" "unprognostic (2.99e-1)" "unprognostic (6.23e-2)" 0.3 0.1 0.1 0.0 0.1 0.0 2.3 0.1 0.1 0.1 68.9 0.0 0.0 24.9 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.1 0.1 442.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 224.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.3 0.9 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 155.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.4 0.2 0.1 0.9 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 14.6 293.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.0 2874.2 0.1 0.0 0.0 51.5 53.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 APOBEC1 "APOBEC-1, BEDP, CDAR1, HEPR" ENSG00000111701 "Apolipoprotein B mRNA editing enzyme catalytic subunit 1" P41238 12 7649400-7665903 "Enzymes, Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "intestine: 56.1" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 7.6;Enterocytes: 23.9;Paneth cells: 31.7" "Group enriched" "Detected in some" 9 "colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "CAPAN-2: 6.2;OE19: 8.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (2.35e-1)" "unprognostic (3.80e-4)" "unprognostic (7.96e-3)" "unprognostic (1.79e-1)" "unprognostic (4.38e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 56.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.5 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 APOBEC2 "ARCD1, ARP1" ENSG00000124701 "Apolipoprotein B mRNA editing enzyme catalytic subunit 2" Q9Y235 6 41053304-41064511 "Enzymes, Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 89.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 2.2;CACO-2: 9.0;HSkMC: 3.1;SuSa: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014252, HPA017957" Enhanced NA NA "HPA014252: AB_1844932, HPA017957: AB_1844933" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (1.87e-1)" "unprognostic (2.77e-1)" "unprognostic (2.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (7.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.50e-2)" "unprognostic (1.21e-1)" "unprognostic (3.87e-1)" "unprognostic (2.01e-2)" "unprognostic (7.02e-2)" "unprognostic (3.69e-1)" "unprognostic (1.31e-3)" "unprognostic (2.19e-2)" 1.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 6.1 2.8 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.1 0.0 1.6 0.0 0.1 3.2 0.0 163.0 0.2 0.2 0.4 0.0 0.0 2.2 0.5 0.0 1.3 0.5 53.9 4.2 0.1 0.0 5.5 5.5 3.6 2.4 1.5 4.8 0.4 0.1 0.0 0.5 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 9.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.1 0.0 0.6 0.0 1.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 1.4 0.5 0.4 0.0 0.0 0.2 1.0 0.1 1.3 0.1 0.5 0.5 0.1 0.1 0.0 1.2 0.3 0.0 0.0 0.1 2.4 0.2 0.1 0.0 0.0 0.3 0.4 0.1 1.7 0.3 0.8 0.2 0.5 0.0 1.3 2.0 3.6 4.4 1.3 3.5 4.3 4.0 4.8 1.1 5.5 4.2 4.6 1.6 1.5 2.4 5.5 3.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 2.3 89.6 0.0 0.0 0.0 0.0 2.0 1.4 0.0 2.5 9.7 0.0 0.0 0.0 18.9 5.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 19.0 0.3 0.0 1.7 0.0 0.0 1.0 3.5 0.0 0.0 1.1 2.6 0.0 0.1 0.2 0.2 0.0 1.1 0.0 0.0 0.0 APOBEC3A "ARP3, PHRBN" ENSG00000128383 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3A" P31941 22 38952741-38992778 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5" "Cell type enriched" "Detected in many" 5 "Urothelial cells: 223.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "intermediate monocyte: 113.5" "Lineage enriched" "Detected in many" 7 "monocytes: 113.5" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5" "HPA043237, HPA056980, HPA066719" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (6.45e-3)" "unprognostic (1.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.21e-3)" "unprognostic (1.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.91e-1)" "unprognostic (1.91e-1)" "unprognostic (3.52e-1)" "unprognostic (2.59e-3)" "unprognostic (9.01e-3)" "unprognostic (2.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (4.98e-2)" "unprognostic (3.41e-1)" "unprognostic (1.91e-1)" 4.3 0.2 0.3 11.0 0.4 42.7 0.5 0.2 0.7 1.7 0.8 0.2 0.0 0.6 1.3 1.4 7.2 3.3 3.4 0.9 0.2 0.3 0.7 1.3 16.0 15.8 1.9 0.5 0.7 0.7 0.1 0.3 4.9 0.7 0.3 0.2 2.0 5.9 0.0 1.2 0.3 0.8 0.8 1.7 31.5 0.8 0.4 0.2 1.4 0.7 22.3 29.0 2.7 6.4 0.2 1.2 15.3 113.5 0.1 0.1 15.2 0.7 0.3 0.5 2.5 0.2 0.4 1.1 0.3 0.0 0.0 0.1 0.2 1.6 0.6 1.7 0.2 0.3 2.1 0.6 0.4 0.0 0.8 0.2 0.2 1.7 0.2 0.2 0.3 1.1 0.2 0.9 0.3 0.2 0.3 0.1 0.5 0.3 3.5 0.1 1.3 0.5 0.5 1.1 0.5 0.2 0.9 0.5 0.7 0.6 1.3 1.2 0.6 0.4 1.4 0.2 0.3 1.1 0.1 1.5 1.1 0.9 0.4 0.4 0.5 0.8 1.0 1.4 2.5 1.2 3.5 26.8 0.9 0.0 113.5 0.1 0.2 0.0 0.0 1.2 0.1 0.0 0.0 15.3 0.1 31.1 0.1 0.1 15.2 0.3 0.4 0.2 0.7 0.2 0.3 1.9 0.5 0.7 0.2 26.8 47.2 0.0 9.0 1.1 0.5 0.0 0.0 14.7 33.0 1.8 3.9 0.2 0.0 0.0 0.5 0.1 4.3 23.3 0.2 0.2 0.5 4.8 24.4 0.0 15.6 0.0 0.0 0.6 18.0 0.0 0.3 11.3 15.1 0.0 0.0 0.8 0.8 0.0 0.4 0.0 0.8 0.0 0.9 0.1 0.5 5.9 0.2 1.0 0.0 223.8 APOBEC3B "FLJ21201, PHRBNL" ENSG00000179750 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3B" Q9UH17 22 38982347-38992804 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 4.7;Ductal cells: 7.3;Melanocytes: 6.8;Pancreatic endocrine cells: 5.7;Urothelial cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 10.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 60.7;Karpas-707: 68.8" "HPA056980, HPA066719" Approved Nucleoplasm NA NA Nucleoplasm "HPA056980: AB_2683298, HPA066719: AB_2685711" "unprognostic (2.92e-2)" "prognostic favorable (2.58e-5)" "unprognostic (4.29e-2)" "unprognostic (1.19e-1)" "unprognostic (2.50e-1)" "unprognostic (1.35e-1)" "unprognostic (1.69e-2)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (6.36e-2)" "unprognostic (1.08e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.78e-4)" "unprognostic (8.47e-2)" "unprognostic (2.98e-2)" "unprognostic (2.70e-1)" "unprognostic (1.04e-1)" 1.6 2.3 0.3 4.4 2.2 20.1 1.4 0.3 1.2 2.3 9.9 0.7 0.3 5.8 2.0 2.4 4.6 1.2 2.2 1.6 0.6 0.2 3.6 0.9 2.5 4.3 0.3 0.3 1.7 5.7 0.4 0.3 6.4 0.8 2.1 10.0 1.3 4.8 0.3 4.1 1.9 8.8 1.0 0.7 10.4 3.8 2.0 0.3 5.9 3.3 0.3 12.0 2.0 2.4 10.2 0.8 1.7 5.8 2.2 3.8 5.9 60.7 6.8 2.6 16.4 0.3 1.5 4.5 5.6 4.9 10.8 14.2 13.0 11.1 0.6 5.1 5.6 15.9 26.1 0.3 1.1 10.9 21.9 0.6 17.5 1.5 3.4 0.1 14.5 10.6 0.6 0.1 11.2 0.5 2.2 4.1 0.0 9.8 68.8 16.6 1.6 0.0 8.1 0.0 5.8 6.1 0.4 26.3 21.8 2.2 10.2 0.4 0.0 0.0 0.0 3.7 0.4 8.1 4.2 2.5 11.9 20.8 1.8 0.1 15.3 4.2 0.0 8.5 16.2 24.1 0.5 1.3 0.0 0.3 5.8 0.0 10.2 0.8 0.5 0.8 3.2 0.0 0.4 1.7 2.2 1.8 0.1 3.8 5.9 0.3 2.2 0.3 1.2 0.6 0.2 0.3 0.3 0.8 0.3 0.0 1.7 0.8 2.2 4.7 0.0 0.2 0.0 1.4 2.3 0.0 0.0 0.3 0.0 7.3 0.0 0.0 0.5 0.0 1.6 1.9 0.4 1.2 0.0 0.0 1.8 0.0 0.0 0.0 1.6 0.0 0.0 1.6 6.8 1.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.7 0.0 0.6 9.5 APOBEC3C "APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI" ENSG00000244509 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3C" Q9NRW3 22 39014083-39020352 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 114.8" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB033048, HPA071523" Approved Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB033048: AB_2057401, HPA071523: AB_2686409" "unprognostic (1.79e-3)" "prognostic favorable (1.08e-5)" "unprognostic (4.32e-3)" "unprognostic (3.20e-3)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (5.18e-2)" "unprognostic (2.55e-1)" "unprognostic (1.10e-1)" "unprognostic (1.08e-3)" "unprognostic (7.40e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (8.91e-10)" "unprognostic (5.92e-2)" "unprognostic (1.11e-1)" "unprognostic (4.10e-1)" "unprognostic (3.52e-3)" 13.3 28.0 2.3 15.6 3.4 9.2 8.0 1.1 2.0 21.4 13.1 4.2 27.5 4.5 18.2 23.5 19.6 20.9 13.8 13.0 2.2 2.0 6.3 4.5 11.7 20.9 3.3 2.0 26.4 5.3 0.7 3.3 7.7 3.2 20.7 12.0 12.9 12.3 114.8 3.4 6.9 11.8 17.2 4.2 32.2 8.1 45.6 2.4 16.2 8.7 17.0 45.5 21.8 12.7 48.1 19.7 49.3 42.6 35.2 61.3 26.2 10.6 10.5 1.8 20.8 11.7 24.3 9.1 7.9 15.4 11.6 15.6 10.0 12.2 31.8 5.3 15.5 7.4 11.0 1.8 33.3 11.4 12.0 9.0 30.6 0.5 8.3 12.7 19.9 30.8 26.3 19.4 15.2 3.8 5.8 6.5 0.2 18.7 40.6 23.3 0.1 7.9 10.8 2.8 0.1 23.2 13.9 4.8 26.4 7.7 14.2 0.5 1.4 11.4 0.0 5.7 4.8 0.1 7.3 3.3 6.3 10.8 3.3 3.4 11.0 11.3 2.6 19.3 12.9 16.3 13.6 20.3 49.3 61.3 40.2 42.2 44.6 33.6 54.6 19.7 48.1 11.5 41.1 2.7 35.2 42.6 16.7 30.5 26.2 2.3 3.4 1.1 2.0 2.2 2.0 3.3 2.0 3.2 2.4 3.0 21.0 91.0 37.0 22.3 0.0 17.3 28.1 13.4 12.5 7.0 0.0 3.2 0.0 25.1 1.9 8.9 11.9 116.8 1.2 1.5 27.8 15.7 55.4 0.8 53.0 0.0 25.3 28.8 42.1 4.1 53.5 30.8 42.2 70.3 16.2 24.7 7.9 12.7 35.7 1.0 0.2 25.8 28.8 1.6 1.5 14.3 1.6 91.6 16.1 44.2 APOBEC3D "APOBEC3DE, APOBEC3E, ARP6" ENSG00000243811 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3D" Q96AK3 22 39021113-39033276 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 17.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 11.7;T-cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 8.1;Karpas-707: 31.4" HPA055116 Approved NA NA "HPA055116: AB_2682701" "prognostic favorable (2.51e-5)" "prognostic favorable (1.31e-4)" "unprognostic (2.69e-2)" "prognostic favorable (4.47e-4)" "unprognostic (2.62e-2)" "unprognostic (3.06e-2)" "unprognostic (2.46e-1)" "unprognostic (1.18e-1)" "unprognostic (4.52e-2)" "unprognostic (2.45e-2)" "unprognostic (4.50e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (3.76e-7)" "unprognostic (4.76e-2)" "unprognostic (6.00e-2)" "unprognostic (1.06e-2)" "prognostic favorable (3.01e-4)" 2.5 3.5 1.3 6.5 2.5 1.6 2.8 1.5 1.4 4.1 3.1 0.8 5.8 3.0 4.6 2.7 3.1 4.3 3.3 1.9 1.2 0.7 3.0 1.5 3.8 11.6 1.3 1.5 5.2 3.4 1.1 1.9 3.4 1.6 7.0 3.4 6.2 2.5 3.3 1.8 1.3 7.1 3.8 1.2 17.4 4.2 3.0 1.1 9.2 2.8 1.1 13.7 4.4 3.9 8.9 6.5 5.0 7.2 5.8 10.5 3.5 0.3 0.0 0.2 1.4 2.1 3.8 1.4 0.2 2.2 2.7 3.0 0.6 3.5 3.9 0.6 2.9 1.7 0.4 0.2 0.0 0.8 7.2 0.8 7.1 0.1 0.0 5.5 1.0 8.1 2.5 0.3 4.3 0.0 0.0 2.0 6.0 1.7 31.4 0.1 0.0 3.3 2.3 0.5 0.0 0.3 2.8 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.1 1.0 1.1 0.1 0.3 0.7 0.1 0.8 0.4 0.0 2.0 2.4 0.5 1.1 2.2 1.0 5.0 1.7 4.0 10.5 4.4 6.7 7.9 7.6 9.7 1.0 8.9 3.8 4.8 2.4 5.8 7.2 6.5 7.0 3.5 1.3 2.5 1.5 1.4 1.2 0.7 1.3 1.5 1.6 1.1 3.0 0.3 11.7 1.2 0.9 0.1 0.4 2.5 2.7 1.2 1.8 0.0 1.1 0.0 0.1 0.5 2.1 2.0 0.0 0.2 0.6 2.6 1.1 0.0 0.0 2.1 0.0 1.7 3.1 2.1 0.0 2.8 0.8 3.3 0.0 3.0 0.5 0.1 0.0 1.8 0.0 0.2 0.0 2.5 0.0 0.0 0.6 0.5 9.2 2.3 2.2 APOBEC3G "bK150C2.7, CEM15, dJ494G10.1, FLJ12740, MDS019" ENSG00000239713 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3G" Q9HC16 22 39077005-39087743 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.4" "Cell type enhanced" "Detected in many" 10 "B-cells: 66.5;monocytes: 92.8;T-cells: 124.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 14.8;Daudi: 20.0;HDLM-2: 16.7;Karpas-707: 23.0" "HPA001812, HPA073637" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001812: AB_1078175, HPA073637: " "prognostic favorable (4.78e-4)" "prognostic favorable (4.70e-4)" "unprognostic (8.18e-3)" "prognostic favorable (6.03e-5)" "unprognostic (2.37e-1)" "unprognostic (3.43e-1)" "unprognostic (7.77e-2)" "unprognostic (2.33e-1)" "unprognostic (4.23e-1)" "unprognostic (4.13e-3)" "unprognostic (9.13e-3)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.66e-13)" "unprognostic (3.41e-2)" "unprognostic (5.83e-2)" "unprognostic (2.91e-2)" "prognostic favorable (6.30e-4)" 6.0 6.1 1.9 8.0 2.2 4.8 3.8 1.4 1.8 6.4 4.2 2.8 8.0 1.7 6.1 4.3 3.7 8.8 7.2 4.6 2.4 1.7 4.1 4.1 5.1 16.0 2.5 1.3 12.4 0.9 2.0 3.4 3.4 2.5 5.0 3.3 4.8 3.8 28.0 3.3 1.2 5.6 3.6 3.1 18.9 3.5 15.6 1.4 6.5 3.8 2.6 15.2 7.4 6.0 16.1 8.6 5.9 17.5 35.5 64.4 39.1 1.9 0.0 0.0 0.0 2.5 4.9 0.1 0.4 8.2 9.6 14.8 0.7 11.9 20.0 0.2 3.4 6.1 0.0 0.1 0.6 2.8 16.7 0.0 10.3 0.0 0.1 11.1 3.4 4.9 7.4 0.2 5.2 1.1 0.0 1.3 0.6 0.9 23.0 1.4 0.0 3.8 3.4 0.3 0.0 0.7 7.7 0.0 12.7 0.0 8.8 0.0 0.0 0.2 0.0 1.1 0.9 0.0 6.5 0.0 1.5 0.1 0.0 0.0 0.0 1.9 0.2 1.7 3.1 2.5 4.0 6.8 4.5 64.4 15.1 37.7 16.1 20.2 49.8 8.6 11.6 6.9 30.3 5.9 35.5 17.5 5.5 15.8 39.1 1.9 2.2 1.4 1.8 2.4 1.7 2.5 1.3 2.5 1.4 3.0 12.8 66.5 12.9 1.5 0.2 2.2 2.5 8.1 12.5 0.0 2.0 2.9 5.0 8.7 39.3 8.7 0.0 23.3 2.1 1.2 7.7 7.9 11.6 0.8 27.1 0.0 5.8 10.4 18.7 11.7 17.5 15.2 6.8 92.8 1.7 7.8 2.3 1.5 8.5 1.0 1.0 19.4 8.0 0.7 1.1 1.1 0.8 124.6 1.1 18.5 APOBEC3H ARP10 ENSG00000100298 "Apolipoprotein B mRNA editing enzyme catalytic subunit 3H" Q6NTF7 22 39097224-39104067 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.7;ductus deferens: 14.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 6.2;monocytes: 18.0;T-cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 15.7;MAIT T-cell: 6.6;memory CD4 T-cell: 8.6;memory CD8 T-cell: 13.2;naive CD8 T-cell: 6.4;NK-cell: 11.8;T-reg: 7.5" "Group enriched" "Detected in many" 14 "NK-cells: 11.8;T-cells: 15.7" "Cell line enhanced" "Detected in some" "Daudi: 4.4;HDLM-2: 4.3;Karpas-707: 11.3;U-266/70: 7.5" "HPA021492, HPA058565" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021492: AB_10964888, HPA058565: " "unprognostic (7.09e-3)" "prognostic favorable (1.20e-4)" "unprognostic (1.05e-1)" "unprognostic (6.81e-4)" "unprognostic (3.40e-1)" "unprognostic (1.54e-3)" "unprognostic (2.30e-2)" "unprognostic (1.36e-2)" "unprognostic (2.17e-1)" "unprognostic (3.83e-2)" "unprognostic (5.07e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (8.73e-12)" "unprognostic (1.05e-1)" "unprognostic (1.03e-1)" "unprognostic (6.55e-3)" "prognostic favorable (8.43e-7)" 1.7 2.2 0.7 6.2 1.2 4.9 1.0 0.8 0.9 1.5 2.3 0.9 14.1 0.4 1.7 6.4 1.5 1.9 2.7 5.9 0.7 0.7 2.3 1.3 4.2 5.3 2.0 1.0 0.9 3.8 0.8 2.0 1.3 1.2 1.6 5.6 1.1 3.3 3.6 2.7 0.5 2.7 1.6 2.1 7.5 2.0 4.0 0.3 3.7 1.8 1.2 5.5 3.1 1.5 1.0 0.1 0.0 1.0 11.8 15.7 2.9 0.0 0.7 0.1 0.0 0.0 0.4 3.2 0.0 0.2 0.3 0.1 0.0 0.4 4.4 1.7 0.4 0.0 0.2 0.0 0.9 0.0 4.3 0.5 1.0 0.2 0.1 0.4 0.0 3.3 2.9 2.5 0.3 0.4 0.3 0.0 0.2 0.0 11.3 1.3 1.3 2.0 0.4 0.0 0.1 0.0 2.4 0.0 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.2 0.0 0.0 7.5 1.0 0.2 0.3 1.9 0.1 0.0 0.2 0.0 15.7 0.3 6.6 1.0 8.6 13.2 0.1 0.3 0.5 6.4 0.0 11.8 1.0 0.0 7.5 2.9 0.7 1.2 0.8 0.9 0.7 0.7 2.0 1.0 1.2 0.3 0.0 6.2 0.8 0.5 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.5 0.0 3.8 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 23.2 0.0 0.6 APOBEC4 "C1orf169, FLJ25691, MGC26594, RP1-127C7.4" ENSG00000173627 "Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 4" Q8WW27 1 183646404-183653316 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 15.9;testis: 23.6" "Group enriched" "Detected in some" 5 "Ciliated cells: 93.7;Early spermatids: 101.4;Late spermatids: 71.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.27e-1)" "prognostic favorable (2.65e-4)" "unprognostic (2.61e-1)" "unprognostic (3.84e-2)" "unprognostic (1.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.10e-2)" "unprognostic (4.00e-2)" 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.1 0.2 5.4 0.0 15.9 0.0 0.0 0.1 0.1 0.0 0.0 4.1 0.0 0.0 0.0 5.6 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 23.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 93.7 19.4 0.0 0.0 0.0 0.0 0.0 101.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 71.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 APOBR "APOB100R, APOB48R" ENSG00000184730 "Apolipoprotein B receptor" Q0VD83 16 28494649-28498970 "Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.2" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 90.6;granulocytes: 39.2;Mucus-secreting cells: 42.9;Paneth cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 16.3;HMC-1: 51.1;NB-4: 14.0;THP-1: 10.1;U-937: 12.2" "HPA041667, HPA042093" Enhanced NA NA 400000 "HPA041667: AB_10793972, HPA042093: AB_10795393" "unprognostic (3.16e-1)" "unprognostic (8.01e-3)" "unprognostic (6.19e-3)" "prognostic favorable (3.26e-4)" "unprognostic (5.48e-2)" "unprognostic (4.79e-3)" "unprognostic (1.17e-1)" "unprognostic (5.45e-2)" "unprognostic (1.65e-2)" "unprognostic (7.60e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.16e-2)" "unprognostic (1.07e-1)" "unprognostic (1.25e-2)" 11.5 2.5 1.7 15.1 3.7 24.2 1.9 0.9 2.7 1.4 18.9 2.8 16.0 4.8 1.5 6.9 2.1 3.1 2.8 1.7 2.7 1.7 2.6 3.0 18.9 15.4 4.7 0.4 1.4 1.8 0.4 1.3 4.4 4.0 2.9 12.9 1.2 2.7 22.6 1.0 2.5 8.6 2.2 7.7 34.2 3.1 1.6 4.1 6.3 1.8 2.1 6.4 6.0 4.5 0.1 4.0 14.1 4.9 6.1 2.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.2 0.0 6.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.4 0.6 14.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.5 10.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 12.2 0.0 7.0 4.9 12.5 2.1 2.3 2.0 0.0 1.2 2.0 4.0 0.1 0.3 1.0 14.1 6.1 1.9 0.8 0.3 1.5 1.7 3.7 0.9 2.7 2.7 1.7 4.7 0.4 4.0 4.1 3.0 11.4 0.9 0.2 0.7 0.0 0.6 0.0 1.4 4.5 3.5 0.0 1.5 0.0 0.0 0.0 0.0 90.6 0.0 0.2 12.6 0.9 0.2 39.2 0.8 29.5 0.0 8.7 1.3 22.7 0.0 0.3 30.3 1.7 1.0 42.9 0.0 0.0 63.4 0.0 0.0 0.0 6.5 0.0 0.4 0.1 0.3 4.9 23.6 26.3 0.4 APOC1 ENSG00000130208 "Apolipoprotein C1" P02654 19 44914247-44919349 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "liver: 702.7" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 27093.4" "Cancer enriched" "Detected in all" 21 "liver cancer: 3253.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "myeloid DC: 8.9" "Lineage enriched" "Detected in single" 13 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "Hep G2: 100.3;HSkMC: 62.1;K-562: 26.1;SK-MEL-30: 46.2" "Low region specificity" "Detected in many" HPA051518 Supported "Secreted to blood" NA NA 20300000000 26000000000 "HPA051518: AB_2681519" "unprognostic (3.51e-2)" "unprognostic (3.31e-3)" "unprognostic (1.14e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.47e-1)" "prognostic favorable (1.15e-7)" "unprognostic (9.51e-3)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (1.11e-1)" "unprognostic (2.52e-1)" "unprognostic (7.13e-3)" "unprognostic (3.48e-3)" "unprognostic (1.65e-1)" "unprognostic (2.01e-3)" "unprognostic (1.65e-1)" 1.5 58.9 6.6 1.6 30.0 2.4 3.6 0.6 4.4 1.5 1.8 4.9 0.3 0.9 0.6 2.5 0.4 0.8 1.8 0.4 4.1 7.8 0.6 702.7 12.6 6.1 20.2 1.0 4.1 1.1 0.4 2.6 2.3 6.6 0.6 1.1 1.3 2.0 0.4 1.2 1.4 1.0 0.5 11.7 9.6 1.3 1.0 5.2 1.0 0.7 0.5 1.9 1.2 0.3 0.2 8.9 0.0 0.6 0.2 0.0 0.6 0.4 4.7 2.1 0.9 6.9 7.2 20.3 0.2 0.3 0.8 1.3 9.9 8.9 1.4 1.7 0.1 0.6 0.3 2.8 0.3 0.4 0.0 11.4 6.4 0.6 100.3 6.1 4.7 3.3 62.1 0.5 0.8 0.3 1.7 0.2 0.3 26.1 0.1 0.3 0.6 0.2 0.3 20.4 1.8 1.0 1.0 2.9 0.1 1.3 0.3 0.9 0.6 3.3 0.0 46.2 7.2 0.4 17.4 0.7 0.0 0.3 0.0 0.2 0.8 0.8 1.5 0.1 1.3 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.9 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.6 6.6 30.0 0.6 3.1 4.1 7.8 20.2 1.0 6.6 5.2 107.2 247.1 115.1 4.2 15.0 1.6 0.7 451.0 44.2 99.0 1.8 0.0 32.3 41.4 3.4 0.9 5.6 0.5 186.9 3.5 299.0 64.1 1.9 139.7 27093.4 5056.0 0.0 2.4 451.8 716.3 1.3 250.8 243.1 28.7 215.6 2.2 120.9 3.3 0.0 244.0 10.9 8.3 19.4 5.9 1.4 3.0 15.6 59.8 137.1 2.1 4.9 APOC2 ENSG00000234906 "Apolipoprotein C2" P02655 19 44945982-44949565 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Disease mutation, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 78 "liver: 506.5" "Cell type enriched" "Detected in some" 26 "Hepatocytes: 936.4" "Cancer enriched" "Detected in some" 17 "liver cancer: 49.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 21 "NK-cell: 6.5" "Lineage enriched" "Detected in single" 21 "NK-cells: 6.5" "Group enriched" "Detected in some" 4 "Hep G2: 84.9;THP-1: 156.9" "Not detected" "Not detected" HPA055877 Supported "Secreted to blood" NA NA 43000000000 110000000000 "HPA055877: AB_2682953" "unprognostic (4.28e-2)" "unprognostic (7.73e-3)" "unprognostic (1.33e-1)" "unprognostic (3.66e-2)" "unprognostic (8.91e-2)" "unprognostic (1.90e-1)" "unprognostic (2.07e-1)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (1.96e-2)" "unprognostic (2.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.14e-8)" "unprognostic (1.32e-1)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (9.80e-3)" 0.2 0.4 2.8 0.3 3.7 0.2 0.5 0.4 1.6 0.4 2.1 3.7 0.0 2.8 0.2 0.5 0.3 0.4 0.4 0.2 2.3 2.2 1.2 506.5 2.2 0.8 4.7 0.5 0.2 0.2 0.3 0.2 0.3 2.2 0.2 0.4 0.0 0.3 0.3 0.3 0.4 6.3 0.2 4.7 0.3 0.3 0.2 2.1 0.0 0.2 0.0 0.7 0.3 0.0 0.1 0.3 0.0 0.0 6.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.7 0.2 84.9 0.0 1.8 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 14.1 0.0 0.4 0.0 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.9 0.0 0.0 156.9 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 2.8 3.7 0.4 1.6 2.3 2.2 4.7 0.5 2.2 2.1 0.0 2.9 1.5 0.0 0.6 0.0 0.1 12.7 0.0 0.0 3.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.4 936.4 35.6 0.0 0.0 18.4 13.7 0.0 0.0 11.1 6.8 3.6 0.0 0.0 0.0 0.0 0.7 11.2 0.0 0.0 0.0 0.1 0.0 0.4 0.2 1.3 0.0 0.0 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Cell type enriched" "Detected in some" 60 "Hepatocytes: 64257.6" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "CACO-2: 28.5;Hep G2: 77.0" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" NA NA 106000000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: AB_2732733, HPA073918: " "prognostic favorable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 28.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 77.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 100.1 0.0 0.0 0.0 0.0 858.6 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.8 0.0 0.0 1074.6 0.4 0.3 0.0 0.0 0.0 64257.6 1.0 0.0 0.0 825.6 1072.7 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.2 0.0 0.0 APOC4 ENSG00000267467 "Apolipoprotein C4" P55056 19 44942238-44945496 "Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "liver: 126.0" "Cell type enriched" "Detected in single" 34 "Hepatocytes: 3.4" "Cancer enriched" "Detected in single" 15 "liver cancer: 0.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 4.2;SK-MEL-30: 6.5;TIME: 3.1" HPA062671 Approved "Secreted to blood" NA NA 1000000000 1500000000 "HPA062671: AB_2684828" "unprognostic (1.82e-3)" 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 126.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 3.1 4.3 1.7 0.8 1.2 0.1 0.8 0.0 0.0 0.8 0.0 0.9 1.6 0.0 0.0 1.1 0.2 0.0 0.2 1.1 0.1 0.0 0.2 0.1 0.6 0.4 0.3 0.2 0.4 4.2 0.0 2.6 0.0 0.3 1.2 2.5 0.3 0.0 0.4 0.1 0.0 1.3 1.2 1.9 0.8 1.0 0.4 0.0 0.0 0.1 0.5 0.0 0.6 0.8 0.0 1.5 0.5 0.2 0.7 0.8 6.5 0.2 1.4 0.0 3.1 0.6 0.3 0.4 0.0 0.8 0.9 2.0 0.2 1.3 0.0 2.1 0.8 1.9 0.9 1.7 0.4 0.6 0.9 1.2 0.4 1.4 0.6 0.6 4.3 0.8 0.8 3.1 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOC4-APOC2 ENSG00000224916 "APOC4-APOC2 readthrough (NMD candidate)" 19 44942238-44949565 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 267 "liver: 178.9" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 139.4" "Cancer enriched" "Detected in some" 17 "liver cancer: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "THP-1: 11.6" HPA055877 Supported NA NA "HPA055877: AB_2682953" "unprognostic (1.45e-1)" "unprognostic (4.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.42e-1)" "unprognostic (1.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (4.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" "unprognostic (2.01e-4)" "unprognostic (2.28e-1)" "unprognostic (2.88e-1)" "unprognostic (5.95e-2)" "unprognostic (1.68e-2)" 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.2 0.1 178.9 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.3 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 2.3 139.4 2.2 0.0 0.0 1.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568702-195584205 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "breast: 840.7" "Group enriched" "Detected in many" 5 "Leydig cells: 1923.5;Melanocytes: 975.2;Peritubular cells: 934.8" "Cancer enhanced" "Detected in all" "melanoma: 925.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 6.7" "Lineage enriched" "Detected in single" 10 "B-cells: 6.7" "Group enriched" "Detected in some" 7 "ASC diff: 239.5;ASC TERT1: 129.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 98900000000 220000000000 "Plasma membrane" "HPA040520: AB_2677020" "prognostic favorable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.71e-3)" 134.4 15.2 39.7 5.7 39.9 3.4 840.7 14.7 66.1 75.0 16.4 79.7 10.9 12.9 36.6 30.0 46.1 42.9 36.4 124.7 45.5 29.2 8.5 3.5 11.8 6.5 96.9 28.2 19.4 28.3 9.0 14.3 59.6 50.9 39.7 13.1 99.1 152.5 35.1 110.4 66.0 7.2 30.4 81.6 3.6 28.7 32.0 56.5 0.0 87.7 42.2 6.6 62.1 95.7 6.7 0.1 0.4 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 239.5 129.1 0.3 2.0 0.5 0.0 0.0 13.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 6.5 1.4 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 2.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 25.9 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 39.7 39.9 14.7 39.5 45.5 29.2 96.9 28.2 50.9 56.5 0.0 8.3 0.0 14.6 128.8 0.0 31.1 0.0 40.2 104.6 5.2 0.0 4.1 0.0 0.2 9.1 55.0 0.0 0.0 0.0 5.0 271.0 22.1 0.0 0.0 12.4 0.0 44.5 30.1 0.3 22.5 1923.5 6.2 975.2 1.8 0.9 0.0 1.9 0.0 934.8 0.1 0.0 19.4 80.9 3.8 3.8 89.6 4.9 0.0 0.6 37.7 APOE AD2 ENSG00000130203 "Apolipoprotein E" P02649 19 44905754-44909393 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 226.8;liver: 508.1" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 7873.9;Hofbauer cells: 6293.2;Muller glia cells: 7584.1;Peritubular cells: 4660.8;Proximal tubular cells: 5645.5" "Cancer enhanced" "Detected in all" "liver cancer: 3183.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 167.1;CACO-2: 39.6;Hep G2: 77.6;HSkMC: 122.5;SK-MEL-30: 155.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008363, HPA065539, HPA068768, CAB069921" Enhanced Approved Vesicles "Secreted to blood" NA NA 51800000000 63000000000 Vesicles "CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029" "unprognostic (8.98e-2)" "unprognostic (2.32e-2)" "unprognostic (2.49e-2)" "unprognostic (5.28e-2)" "unprognostic (3.77e-2)" "unprognostic (7.25e-2)" "unprognostic (5.22e-3)" "unprognostic (6.13e-2)" "unprognostic (5.06e-2)" "unprognostic (4.13e-1)" "unprognostic (5.78e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (7.76e-2)" "unprognostic (1.64e-1)" "unprognostic (1.12e-3)" "unprognostic (4.13e-2)" 76.8 226.8 78.4 14.6 106.8 9.7 12.8 26.6 109.8 13.6 15.1 40.3 0.8 7.7 9.4 10.9 2.6 4.3 17.1 6.9 41.4 57.9 121.8 508.1 21.5 46.0 104.0 34.5 23.5 5.2 2.7 4.9 17.2 54.1 6.6 5.2 11.2 8.5 3.4 5.7 33.0 10.2 3.6 35.1 89.2 13.4 12.6 33.9 4.9 6.0 1.3 8.6 11.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.2 167.1 6.8 6.0 0.1 0.3 0.7 0.1 39.6 0.2 0.1 0.8 0.0 0.8 0.5 1.1 0.1 0.0 0.1 0.3 0.2 0.1 77.6 17.2 0.5 0.2 122.5 0.2 1.3 0.1 1.3 0.0 0.0 10.2 0.2 0.1 0.2 0.1 0.2 20.9 0.2 0.1 0.2 0.7 0.1 0.2 0.0 0.4 0.2 0.3 0.1 155.3 12.1 14.3 4.4 0.2 1.1 0.2 0.1 0.1 0.5 0.6 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.4 106.8 26.6 53.4 41.4 57.9 104.0 34.5 54.1 33.9 0.0 10.9 128.8 14.4 830.7 52.9 1.6 384.7 0.0 5.7 216.3 39.3 36.4 578.6 1.8 57.6 21.1 0.3 163.5 0.6 28.5 329.7 3.9 179.1 7873.9 6293.2 36.5 0.0 191.5 425.6 179.9 2434.6 240.8 2353.4 122.6 0.3 7584.1 0.8 0.0 4660.8 5645.5 238.0 219.9 382.4 13.0 8.5 1472.8 62.1 122.2 1.2 4.2 APOF ENSG00000175336 "Apolipoprotein F" Q13790 12 56360569-56362823 "Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "liver: 114.0" "Cell type enriched" "Detected in some" 42 "Hepatocytes: 377.1" "Cancer enriched" "Detected in some" 6 "liver cancer: 34.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "Hep G2: 9.9" "Not detected" "Not detected" "Secreted to blood" NA NA 18000000000 4000000000 "unprognostic (3.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.48e-2)" "unprognostic (8.99e-3)" "unprognostic (9.84e-2)" "unprognostic (3.29e-2)" "unprognostic (2.08e-3)" "unprognostic (7.84e-2)" "unprognostic (4.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.68e-3)" "unprognostic (8.55e-2)" "unprognostic (2.42e-2)" "unprognostic (2.77e-1)" "unprognostic (5.57e-2)" "unprognostic (2.87e-1)" "unprognostic (4.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.9 1.8 0.5 1.1 1.4 0.1 0.2 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.3 0.7 1.0 9.9 0.0 0.9 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.5 0.6 0.4 0.1 0.3 0.2 0.1 0.6 0.1 0.4 0.3 0.5 0.6 0.5 0.4 0.3 0.1 0.4 0.4 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.8 0.4 0.5 0.2 0.4 0.4 1.8 0.5 0.3 0.5 0.2 0.8 1.6 0.7 0.6 0.1 2.1 1.4 1.1 1.3 1.1 0.4 0.9 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.2 0.0 0.0 0.2 7.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.0 377.1 0.0 0.0 0.0 4.9 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 APOH "B2G1, BG" ENSG00000091583 "Apolipoprotein H" P02749 17 66212033-66256525 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 550 "liver: 823.7" "Cell type enriched" "Detected in some" 37 "Hepatocytes: 7635.3" "Cancer enriched" "Detected in many" 232 "liver cancer: 2878.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 20 "Hep G2: 166.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001654, HPA003732, CAB022214" Enhanced Supported "Golgi apparatus" "Secreted to blood" NA NA 247000000000 44000000000 "Golgi apparatus" "CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.39e-7)" "unprognostic (1.26e-1)" "unprognostic (5.99e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (1.10e-6)" "unprognostic (1.26e-2)" "unprognostic (5.76e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 823.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.7 0.9 1.3 1.0 1.3 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 166.9 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.1 0.3 0.0 0.0 1.3 0.4 1.3 0.5 1.3 0.8 0.8 0.6 0.7 1.4 0.9 0.8 0.9 1.0 0.4 0.5 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 46.2 0.0 0.0 0.0 0.0 206.4 1.4 1.2 0.0 0.0 0.0 3.3 0.3 0.1 0.0 0.0 163.5 2.0 0.0 0.0 0.0 0.0 7635.3 0.5 0.0 0.0 134.4 149.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.8 0.0 APOL5 APOLV ENSG00000128313 "Apolipoprotein L5" Q9BWW9 22 35717872-35729483 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 1.8;skeletal muscle: 5.4;testis: 2.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "U-698: 6.2" NA NA "unprognostic (2.23e-1)" "unprognostic (7.61e-4)" "unprognostic (9.34e-2)" "unprognostic (1.39e-2)" "unprognostic (3.23e-1)" "unprognostic (4.18e-2)" "unprognostic (4.37e-5)" "unprognostic (3.23e-2)" "unprognostic (2.78e-2)" "unprognostic (2.94e-2)" "unprognostic (1.59e-1)" 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9" "Group enriched" "Detected in many" 5 "basal ganglia: 5.8;olfactory region: 24.7" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Approved "Nucleoplasm,Plasma membrane" No No "Nucleoplasm, Plasma membrane" "HPA052462: AB_2681841, HPA058882: AB_2683844" "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 109.5 8.8 11.2 9.2 17.7 0.6 34.4 9.8 17.5 25.5 9.0 7.7 2.9 2.5 7.1 7.0 18.8 14.0 18.7 22.3 13.0 11.8 7.4 9.3 7.1 3.4 16.6 3.3 10.0 12.8 17.2 4.7 44.8 16.7 7.2 7.1 8.1 4.4 3.7 16.6 7.4 6.0 28.0 13.9 4.7 5.3 5.4 12.4 5.7 34.4 9.9 3.3 10.9 7.1 2.3 1.7 4.8 0.9 0.8 2.7 0.3 4.3 0.1 26.2 0.8 0.8 1.5 0.2 4.2 7.0 4.3 6.3 1.7 4.6 1.3 0.4 1.6 1.5 1.4 1.0 0.2 7.3 13.2 1.0 0.4 1.3 0.0 1.6 0.6 0.4 1.0 1.2 1.5 3.4 10.9 3.2 2.4 0.4 1.8 2.2 0.9 0.7 0.7 0.1 1.0 0.8 2.0 0.5 0.6 0.5 0.4 2.3 2.4 4.0 0.4 9.6 0.4 0.1 2.1 3.9 1.0 1.4 5.8 3.8 1.3 0.6 1.0 1.5 2.8 4.9 4.8 0.9 0.7 0.9 0.4 1.1 2.2 2.0 1.3 0.6 2.3 1.6 1.0 4.4 0.8 0.6 1.7 2.7 0.3 11.2 17.7 9.8 17.5 13.0 11.8 16.6 3.3 16.7 12.4 6.0 4.0 21.4 2.2 16.1 4.2 7.0 7.6 8.1 9.1 0.0 3.9 1.5 0.0 0.9 1.6 140.0 1.1 70.0 0.4 1.1 8.4 3.7 7.0 1.6 5.1 3.2 3.5 65.7 14.5 1.1 4.0 5.7 27.0 3.6 4.7 64.4 0.8 0.0 0.4 0.3 3.3 109.9 101.3 3.2 0.7 13.6 0.8 20.8 6.3 2.8 APOM "ApoM, G3a, NG20" ENSG00000204444 "Apolipoprotein M" O95445 6 31652416-31658210 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 94.6" "Group enriched" "Detected in many" 9 "Hepatocytes: 596.8;Proximal tubular cells: 592.0" "Cancer enriched" "Detected in all" 13 "liver cancer: 185.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 0.3" "Low region specificity" "Detected in all" "CAB034086, HPA051006" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 7400000000 18000000000 "Golgi apparatus" "CAB034086: AB_1119033, HPA051006: AB_2681307" "unprognostic (2.76e-3)" "unprognostic (1.69e-2)" "unprognostic (8.66e-2)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (3.78e-1)" "unprognostic (1.97e-2)" "unprognostic (1.80e-1)" "unprognostic (6.04e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (7.28e-2)" "unprognostic (5.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-1)" "unprognostic (3.20e-2)" 1.3 1.5 1.8 1.5 1.6 6.8 1.9 1.3 2.0 1.3 1.8 2.2 1.9 2.4 2.3 3.0 1.6 1.5 1.4 1.5 1.5 1.3 15.2 94.6 1.0 3.6 1.7 1.9 3.7 3.3 1.4 1.9 0.7 1.6 1.1 0.9 2.1 3.1 1.6 2.2 2.4 2.4 1.5 2.4 1.3 1.4 6.6 1.1 3.6 2.7 1.7 3.1 1.1 1.0 3.3 1.6 5.8 2.1 1.0 2.2 1.0 2.2 1.1 2.5 4.1 2.1 2.5 0.5 1.5 2.7 1.0 2.4 1.5 3.2 3.4 0.8 2.7 2.0 3.6 1.5 1.6 2.1 2.1 2.6 2.4 1.8 3.2 3.3 4.3 1.2 3.3 1.6 1.0 3.0 2.2 0.9 3.4 4.3 2.2 2.7 3.3 3.6 4.2 2.2 1.6 0.5 2.2 1.8 3.9 2.8 3.2 2.2 1.0 2.2 0.2 1.8 1.2 4.5 3.1 0.4 1.5 0.5 2.9 0.6 4.0 3.5 4.1 1.3 6.6 0.6 5.8 1.9 1.7 1.1 0.9 1.7 3.3 1.3 1.1 1.6 1.9 1.7 1.8 1.7 1.0 2.1 1.4 2.2 1.0 1.8 1.6 1.3 1.8 1.5 1.3 1.7 1.9 1.6 1.1 0.0 6.1 14.3 4.6 5.7 1.2 1.4 10.2 2.7 2.3 14.0 3.9 1.6 64.6 3.5 42.6 1.4 9.3 0.0 6.1 0.8 4.3 3.2 4.7 596.8 4.8 0.0 4.1 6.7 11.4 29.3 8.6 3.4 5.0 0.0 2.5 13.2 5.1 3.1 6.0 592.0 2.3 0.0 2.7 19.1 5.5 5.6 1.0 8.7 3.3 3.7 AQP1 "CHIP28, CO" ENSG00000240583 "Aquaporin 1 (Colton blood group)" P29972 7 30911694-30925516 "Blood group antigen proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 156.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8" "CAB001707, HPA019206" Enhanced Supported "Plasma membrane" NA NA 250000 "Plasma membrane" "CAB001707: , HPA019206: AB_1844965" "unprognostic (4.18e-2)" "unprognostic (7.82e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.02e-1)" "prognostic favorable (6.52e-4)" "unprognostic (1.95e-3)" "unprognostic (1.66e-1)" "unprognostic (3.00e-2)" "unprognostic (3.80e-2)" "unprognostic (4.16e-1)" "unprognostic (2.05e-2)" "prognostic favorable (1.32e-8)" "unprognostic (3.43e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (7.21e-2)" 68.2 8.0 9.9 8.7 17.1 9.4 51.9 10.7 13.0 46.5 18.1 62.1 7.7 10.8 28.0 20.8 58.8 29.0 36.3 46.7 18.1 15.4 156.5 4.2 103.2 9.1 36.9 17.8 16.4 49.9 12.9 4.0 9.1 63.2 32.4 10.6 8.3 19.8 22.7 35.2 24.8 18.2 41.2 56.4 2.9 18.2 15.0 17.8 1.9 21.3 33.5 12.5 36.0 76.7 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.6 0.4 1.8 0.4 1.2 0.4 0.0 0.0 0.2 0.3 0.0 20.9 1.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 7.0 0.0 0.4 0.1 0.0 3.3 0.0 0.1 0.0 0.0 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 5.2 0.1 0.7 0.0 0.2 7.8 1.2 0.6 0.0 3.9 0.1 0.1 0.0 0.0 9.8 0.8 0.3 0.5 0.3 0.0 0.1 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.9 17.1 10.7 13.0 18.1 15.4 36.9 17.8 63.2 17.8 166.7 218.3 2.9 1.1 81.4 1.1 57.7 377.0 6.7 6.8 29.6 7.9 1.9 24.9 35.6 1.9 221.7 4.2 0.0 2.1 3.0 91.5 1.0 1.1 1.3 3.3 0.0 7.0 154.1 1.8 1.6 1.1 9.8 84.4 2.8 18.2 0.3 2.8 19.2 3.2 281.0 0.2 12.9 92.0 0.3 1.3 68.8 6.1 0.0 71.0 1.0 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 59.9" "Group enriched" "Detected in some" 7 "Cholangiocytes: 2.5;granulocytes: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4" "Low region specificity" "Detected in many" "HPA062621, HPA065947" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA062621: , HPA065947: AB_2685584" "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.0 37.2 0.2 0.3 0.1 4.3 0.5 0.7 0.4 0.0 0.0 0.1 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 59.9 0.0 0.0 2.7 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 AQP11 ENSG00000178301 "Aquaporin 11" Q8NBQ7 11 77589391-77610355 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 60.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3" "Cell line enhanced" "Detected in many" "CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042879 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA042879: AB_10794919" "unprognostic (4.95e-2)" "unprognostic (7.61e-2)" "unprognostic (2.15e-2)" "unprognostic (9.62e-5)" "unprognostic (2.42e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (3.48e-2)" "unprognostic (2.65e-1)" "prognostic favorable (9.89e-4)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.73e-2)" "unprognostic (2.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.66e-3)" 1.0 14.5 4.2 0.8 3.5 0.6 1.1 5.0 4.8 0.6 22.4 2.1 0.7 24.7 0.8 1.2 0.5 0.9 2.4 0.7 2.5 4.5 5.2 13.9 0.6 0.9 3.4 3.4 9.3 3.6 0.9 1.8 3.5 3.4 3.9 2.1 3.8 0.8 0.7 1.0 1.0 60.1 0.6 1.5 1.0 2.3 7.4 1.7 0.0 1.6 0.2 0.4 0.8 0.6 2.0 0.1 0.3 0.1 2.0 2.3 0.8 1.0 3.3 1.4 2.2 3.2 0.8 1.4 1.7 0.8 1.6 0.7 7.8 1.6 1.6 0.8 0.7 12.3 1.0 0.5 0.1 0.8 4.8 1.3 1.3 1.1 13.0 1.0 2.7 1.5 0.8 0.3 0.9 0.2 1.9 0.3 0.4 0.8 1.0 1.8 1.6 1.0 1.8 1.4 7.5 3.0 1.4 3.5 0.6 0.9 1.2 1.4 1.0 2.1 0.4 0.8 1.1 1.6 0.4 0.9 1.3 4.1 2.5 1.1 1.1 0.8 1.3 0.4 0.2 1.8 0.0 0.0 0.3 1.9 0.0 1.3 0.3 0.8 1.5 0.1 2.0 2.3 0.7 0.0 2.0 0.1 0.1 0.1 0.8 4.2 3.5 5.0 4.8 2.5 4.5 3.4 3.4 3.4 1.7 0.0 0.0 0.0 0.7 0.1 7.5 0.4 7.6 0.0 0.0 1.8 0.0 6.6 0.0 1.2 30.5 0.3 15.8 0.0 3.4 10.1 0.9 1.2 4.6 21.5 1.0 0.0 4.1 0.0 0.3 51.4 14.4 0.0 1.7 0.0 3.1 29.1 3.7 3.1 10.6 15.3 5.0 0.0 0.7 35.9 5.8 0.1 13.3 0.0 5.6 0.1 AQP12A AQP12 ENSG00000184945 "Aquaporin 12A" Q8IXF9 2 240691845-240698483 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 182 "pancreas: 65.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.8" HPA042216 Supported NA NA "HPA042216: AB_2677905" "unprognostic (9.82e-2)" "unprognostic (1.63e-2)" "unprognostic (9.48e-2)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP12B INSSA3 ENSG00000185176 "Aquaporin 12B" A6NM10 2 240676418-240682906 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 386 "pancreas: 82.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.5" HPA042216 Supported NA NA "HPA042216: AB_2677905" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP2 ENSG00000167580 "Aquaporin 2" P41181 12 49950741-49958881 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Diabetes insipidus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2" "Cell type enriched" "Detected in some" 444 "Collecting duct cells: 3930.9" "Group enriched" "Detected in some" 6 "renal cancer: 1.7;stomach cancer: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "intermediate monocyte: 1.4;non-classical monocyte: 1.3" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.5;EFO-21: 6.9;HEL: 2.0;HMC-1: 4.2;OE19: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA046834 Enhanced NA NA "HPA046834: AB_2679830" "unprognostic (2.10e-1)" "unprognostic (3.77e-2)" "unprognostic (6.96e-3)" "unprognostic (4.48e-3)" "unprognostic (3.60e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (7.38e-3)" "unprognostic (5.92e-2)" "unprognostic (4.60e-2)" "unprognostic (2.01e-2)" "unprognostic (1.11e-1)" 0.1 1.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 178.6 0.0 0.1 3.3 0.1 0.1 0.0 0.6 0.1 0.1 96.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.2 108.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 7.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3930.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Group enriched" "Detected in many" 6 "Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Cell line enhanced" "Detected in many" "HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.6 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 0.1 28.1 1.3 0.1 0.0 13.4 1.3 0.9 51.2 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.0 0.1 28.8 14.3 13.0 1.5 6.2 12.8 5.0 1.1 19.2 0.1 0.2 21.3 2.3 0.2 47.6 0.4 1.1 7.1 32.9 0.0 1.9 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.1 44.2 3.2 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 35.7 265.4 2.2 608.6 1708.5 1.4 2.1 104.4 136.5 215.0 1526.7 2.0 0.6 0.0 27.2 1.3 40.5 4.2 93.5 41.7 1.3 46.3 959.6 19.7 111.7 2.2 0.0 7.9 16.0 3.8 0.0 30.8 32.1 150.1 1.0 63.7 0.3 32.0 2.9 1.1 28.8 0.4 0.0 42.2 0.0 1.0 2172.4 42.0 43.3 3.5 2008.6 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 1024.3" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 1024.3 245.1 0.0 0.6 0.0 2.1 8.5 0.0 37.5 138.8 3.5 5.9 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 3.5 0.5 0.0 1.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 224.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 AQP5 ENSG00000161798 "Aquaporin 5" P55064 12 49961870-49965681 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "salivary gland: 217.9;testis: 76.2" "Group enriched" "Detected in many" 8 "Early spermatids: 1235.0;Late spermatids: 3096.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 87.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 70.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065008 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA065008: AB_2685401" "unprognostic (4.67e-3)" "unprognostic (5.00e-2)" "unprognostic (3.30e-1)" "unprognostic (6.00e-3)" "unprognostic (1.92e-3)" "prognostic favorable (1.75e-5)" "unprognostic (4.13e-3)" "unprognostic (1.02e-2)" "unprognostic (9.39e-2)" "unprognostic (3.70e-3)" "unprognostic (2.88e-3)" "unprognostic (2.46e-3)" "unprognostic (1.69e-4)" "unprognostic (2.53e-1)" "unprognostic (5.28e-2)" "unprognostic (2.51e-3)" "unprognostic (9.11e-3)" 0.2 0.1 0.4 0.2 1.1 0.0 3.8 0.4 0.3 3.0 0.3 0.4 0.3 3.2 0.6 0.8 3.8 0.1 15.6 1.0 0.3 0.3 0.2 0.2 2.3 0.2 0.7 0.2 0.2 0.8 0.1 0.4 0.2 0.3 0.5 0.0 0.4 217.9 0.6 0.9 23.5 0.3 0.6 0.2 0.2 12.0 76.2 0.3 0.2 0.3 2.8 11.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 70.7 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.3 0.3 0.3 0.7 0.2 0.3 0.3 53.6 1.9 0.0 0.4 1.1 0.5 0.3 0.0 8.1 37.5 7.0 0.0 0.0 0.0 0.0 1235.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3096.0 26.4 0.0 280.0 0.0 0.0 45.4 4.3 0.0 18.0 0.0 1.4 19.4 0.3 76.9 15.2 0.6 0.0 0.0 0.0 0.7 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "kidney: 40.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 4.5;Collecting duct cells: 5.2" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.0;OE19: 5.1;SH-SY5Y: 2.1" "Region enriched" "Detected in some" 7 "cerebellum: 23.5" "Low region specificity" "Detected in many" HPA015278 Enhanced NA NA "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 0.6 0.1 1.1 0.0 0.1 0.3 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.5 40.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.5 1.2 0.2 0.2 0.4 0.2 0.3 2.0 0.1 0.3 0.1 0.0 0.0 0.4 0.2 0.0 0.0 1.1 1.2 0.0 0.9 0.0 0.0 0.2 0.3 0.0 0.0 0.2 1.4 0.0 0.1 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.1 1.1 0.0 0.2 0.4 0.6 0.0 0.9 0.0 0.6 0.4 5.1 1.0 1.0 0.1 0.5 0.9 0.0 0.5 2.1 0.7 0.0 0.7 0.3 0.0 0.1 0.0 0.6 0.9 0.0 0.5 0.2 0.2 0.0 0.2 0.2 0.4 1.2 0.2 0.1 0.4 0.1 0.1 0.3 0.1 0.2 0.5 0.8 0.2 0.3 1.1 0.2 0.2 0.2 0.3 0.2 0.6 1.1 0.3 0.3 0.7 0.5 1.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.7 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 AQP7 "AQP7L, AQP9, AQPap" ENSG00000165269 "Aquaporin 7" O14520 9 33383179-33402682 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 81.4;Early spermatids: 99.6;Enterocytes: 64.2;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 6 "T-reg: 2.7" "Lineage enriched" "Detected in single" 15 "T-cells: 2.7" "Cell line enriched" "Detected in some" 52 "ASC diff: 79.4" NA NA "unprognostic (3.25e-2)" "unprognostic (3.81e-3)" "unprognostic (1.25e-5)" "unprognostic (7.22e-3)" "unprognostic (1.50e-1)" "unprognostic (3.32e-1)" "unprognostic (4.67e-2)" "unprognostic (3.06e-2)" "unprognostic (9.99e-2)" "unprognostic (4.65e-2)" "unprognostic (8.56e-4)" "unprognostic (1.21e-1)" "prognostic favorable (9.21e-8)" "unprognostic (2.42e-1)" "unprognostic (1.28e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" 72.7 1.2 0.6 1.3 0.8 0.0 25.6 2.4 0.9 0.6 3.9 0.6 0.6 3.9 0.6 1.1 1.2 1.2 2.3 21.5 0.6 0.0 5.3 5.9 0.6 0.6 0.6 0.6 1.0 3.0 10.2 0.6 0.9 1.2 1.2 0.8 0.8 2.7 0.6 8.8 0.9 5.7 0.6 1.0 0.6 0.3 5.5 0.6 0.8 1.0 3.0 1.6 1.7 0.6 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.5 0.0 0.0 79.4 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.6 0.8 2.4 0.9 0.6 0.0 0.6 0.6 1.2 0.6 6.0 8.2 0.0 0.2 1.3 0.0 81.4 15.3 4.0 1.2 33.2 0.0 0.0 5.0 1.1 99.6 0.8 64.2 0.0 0.2 0.3 0.2 0.4 0.0 16.8 0.1 0.0 0.0 1.8 0.0 14.4 2.0 0.1 0.0 0.0 3.8 0.0 0.3 28.1 1.8 60.8 0.0 6.5 2.1 1.1 0.7 2.3 0.0 0.0 2.1 1.4 AQP8 ENSG00000103375 "Aquaporin 8" O94778 16 25215731-25228940 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "intestine: 40.9;pancreas: 163.4" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 43.3;Exocrine glandular cells: 9.2;granulocytes: 9.2;Intestinal endocrine cells: 12.6;Paneth cells: 16.9" "Group enriched" "Detected in some" 42 "colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "Hep G2: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046259 Enhanced NA NA "HPA046259: AB_10960494" "unprognostic (8.75e-2)" "unprognostic (2.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.93e-2)" "unprognostic (8.67e-2)" "unprognostic (3.34e-3)" "unprognostic (8.47e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-1)" "unprognostic (2.05e-2)" "unprognostic (8.23e-2)" "unprognostic (1.06e-2)" "unprognostic (2.67e-2)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (3.71e-2)" 0.2 0.0 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 40.9 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 163.4 0.0 0.2 0.2 0.2 0.2 19.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.0 5.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 43.3 0.0 9.2 0.1 0.0 0.1 9.2 0.0 0.1 1.6 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.2 0.1 2.5 16.9 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.3 0.0 5.4 0.0 AQP9 "HsT17287, SSC1" ENSG00000103569 "Aquaporin 9" O43315 15 58138169-58185911 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 127.8;liver: 147.0" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 258.5" "Cancer enriched" "Detected in many" 30 "liver cancer: 132.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 20 "neutrophil: 127.8" "Lineage enriched" "Detected in many" 20 "granulocytes: 127.8" "Cell line enriched" "Detected in single" 27 "U-87 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA074762, CAB075684" Enhanced NA NA "CAB075684: , HPA074762: AB_2732267" "unprognostic (1.91e-1)" "unprognostic (1.92e-1)" "unprognostic (7.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.24e-2)" "unprognostic (4.15e-2)" "unprognostic (1.36e-3)" "unprognostic (2.28e-2)" "unprognostic (3.82e-2)" "unprognostic (2.03e-1)" "unprognostic (4.80e-3)" "unprognostic (6.98e-2)" "prognostic unfavorable (5.72e-11)" "unprognostic (8.78e-2)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (8.39e-2)" 7.8 0.3 0.6 12.9 0.7 9.8 0.6 0.7 1.4 0.2 0.3 0.1 1.0 0.0 0.2 7.8 0.7 3.0 0.8 2.0 0.4 0.2 0.8 147.0 8.6 12.0 2.4 0.4 1.2 0.3 2.8 0.4 1.4 0.6 0.4 0.0 0.5 0.4 0.8 0.4 6.9 0.3 1.0 0.5 15.8 0.7 2.5 0.4 0.4 0.5 0.1 0.4 1.3 0.6 0.0 0.2 127.8 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.9 0.1 0.0 0.0 6.2 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 127.8 0.0 2.3 0.0 0.0 1.7 0.6 0.7 0.7 1.4 0.4 0.2 2.4 0.4 0.6 0.4 0.0 19.3 4.3 0.1 0.3 0.0 1.2 5.1 2.7 5.7 0.0 0.0 0.3 0.0 0.1 1.9 0.1 0.0 0.0 0.2 0.5 0.4 0.0 7.0 258.5 43.2 0.0 0.0 8.0 34.5 0.8 0.3 57.7 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.7 1.3 0.0 0.1 AR "AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1" ENSG00000169083 "Androgen receptor" P10275 X 67544032-67730619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 49.0" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 189.5;Leydig cells: 72.2;Peritubular cells: 81.3;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 16 "dendritic cells: 5.4" "Cell line enhanced" "Detected in some" "AF22: 11.3;BJ hTERT+: 9.8;HAP1: 14.4;LHCN-M2: 12.6;RH-30: 20.9;T-47d: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000001, HPA004733, CAB065764" Enhanced Supported Cytosol NA NA Cytosol "CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: " "unprognostic (1.34e-1)" "unprognostic (8.10e-3)" "unprognostic (2.49e-2)" "unprognostic (5.95e-2)" "unprognostic (1.04e-2)" "unprognostic (3.35e-2)" "prognostic favorable (8.77e-4)" "unprognostic (4.99e-2)" "unprognostic (1.72e-1)" "unprognostic (7.79e-2)" "unprognostic (2.30e-1)" "unprognostic (2.29e-1)" "prognostic favorable (1.03e-8)" "unprognostic (8.23e-3)" "unprognostic (8.90e-2)" "unprognostic (4.23e-2)" "unprognostic (7.97e-2)" 10.1 1.2 0.9 1.6 0.9 0.1 10.7 0.4 1.6 34.4 1.9 2.4 25.4 0.2 20.5 20.5 2.2 17.5 4.3 5.7 0.9 1.5 6.3 49.0 1.5 0.2 1.2 0.7 14.4 1.0 0.1 2.3 0.3 1.9 28.0 0.5 3.8 1.6 36.1 8.1 3.9 1.1 7.6 1.9 0.9 1.6 9.3 1.2 5.4 3.1 2.0 1.2 6.3 13.1 0.0 5.4 0.3 0.0 0.1 0.0 0.1 0.0 4.7 11.3 0.0 0.0 0.1 0.0 6.0 9.8 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.0 14.4 0.0 0.1 0.0 1.9 0.0 1.1 0.0 0.7 0.0 0.0 4.6 0.0 1.7 0.0 0.0 3.5 0.1 4.1 1.9 12.6 1.2 0.0 0.0 4.5 0.0 0.0 0.0 20.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 3.2 8.8 5.3 0.2 0.2 2.0 0.1 3.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 5.4 0.0 0.1 0.9 0.9 0.4 1.6 0.9 1.5 1.2 0.7 1.9 1.2 0.0 5.3 0.0 18.1 8.7 0.6 31.3 12.7 6.7 19.4 3.5 0.0 1.9 1.7 7.5 0.9 4.9 0.0 0.0 0.0 0.1 9.4 31.9 1.1 189.5 0.7 0.0 0.0 14.7 1.6 1.6 72.2 2.1 10.1 2.8 0.0 0.2 1.0 0.0 81.3 22.3 0.3 64.7 12.3 0.5 1.0 14.1 0.8 0.0 0.0 15.9 ARAP2 "CENTD1, PARX" ENSG00000047365 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2" Q8WZ64 4 35948221-36244509 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Early spermatids: 113.2;Late spermatids: 89.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 12.0;hTCEpi: 11.3;MOLT-4: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035925 Approved Approved "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "HPA035925: AB_10672075" "unprognostic (2.97e-2)" "unprognostic (8.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.04e-1)" "unprognostic (8.86e-2)" "unprognostic (2.72e-3)" "unprognostic (1.09e-1)" "unprognostic (3.78e-3)" "unprognostic (2.04e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-3)" "unprognostic (2.96e-1)" "unprognostic (4.48e-2)" "unprognostic (4.54e-2)" "unprognostic (3.43e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-2)" 5.2 2.5 16.3 9.1 27.5 32.5 5.2 4.8 20.8 4.2 5.1 18.3 0.3 8.5 3.5 4.1 12.7 3.5 9.2 2.5 16.0 9.5 3.9 8.8 12.7 13.7 24.4 12.1 1.9 6.8 8.2 5.1 3.5 18.4 2.9 5.8 0.7 5.8 3.3 1.4 16.1 8.2 4.4 15.3 10.4 5.8 5.9 32.0 26.4 22.4 4.0 10.2 6.2 7.2 2.4 1.7 0.6 5.8 8.6 5.7 0.7 7.3 0.6 0.7 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.6 12.0 3.5 2.9 0.3 0.0 2.8 1.1 5.8 0.0 0.0 6.6 0.1 2.4 0.2 1.5 4.6 0.0 0.4 11.3 0.0 2.5 4.4 0.0 9.7 0.2 0.6 0.0 3.1 10.7 3.8 0.8 5.1 2.3 5.5 0.0 4.0 8.3 7.5 6.5 0.0 0.4 1.8 2.4 0.4 5.0 1.4 0.0 2.0 6.7 0.0 1.0 0.0 0.0 6.8 0.8 5.3 1.7 0.0 0.8 0.0 5.7 2.7 5.3 2.4 3.2 3.9 0.4 1.4 1.1 2.9 0.6 8.6 5.8 1.7 1.5 0.7 16.3 27.5 4.8 20.8 16.0 9.5 24.4 12.1 18.4 32.0 142.9 21.8 22.6 24.0 34.8 0.3 1.7 10.2 20.1 43.3 7.0 0.0 0.1 6.6 7.2 113.2 13.5 14.6 0.0 8.6 0.2 4.5 28.3 9.2 3.8 7.3 0.0 2.9 3.1 32.3 89.9 2.6 17.8 5.0 16.2 9.2 5.4 15.9 17.5 0.7 4.1 1.0 0.0 1.4 3.2 1.9 59.0 0.7 42.4 6.4 46.4 ARC "Arg3.1, KIAA0278" ENSG00000198576 "Activity regulated cytoskeleton associated protein" Q7LC44 8 142611044-142614472 "Predicted intracellular proteins" "Endocytosis, Transport" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.8;seminal vesicle: 67.7" "Cell type enriched" "Detected in many" 11 "Intestinal endocrine cells: 157.5" "Cancer enriched" "Detected in many" 12 "glioma: 36.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Cell line enhanced" "Detected in some" "AN3-CA: 6.9;HEK 293: 8.5;SCLC-21H: 20.4;U-2 OS: 9.9;U-87 MG: 11.2" "Group enriched" "Detected in many" 5 "amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5" "Group enriched" "Detected in many" 7 "basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5" "HPA056430, CAB079013" Supported Approved Vesicles,Microtubules NA NA "Vesicles, Microtubules" "CAB079013: , HPA056430: AB_2683130" "unprognostic (1.40e-3)" "unprognostic (2.95e-2)" "unprognostic (4.35e-3)" "unprognostic (4.87e-4)" "unprognostic (6.83e-2)" "unprognostic (8.12e-2)" "unprognostic (5.13e-2)" "unprognostic (1.77e-1)" "unprognostic (5.07e-2)" "unprognostic (9.43e-2)" "unprognostic (4.15e-3)" "unprognostic (1.40e-1)" "unprognostic (2.14e-2)" "unprognostic (1.01e-2)" "unprognostic (7.42e-2)" "unprognostic (1.54e-1)" "unprognostic (3.35e-2)" 18.1 15.9 6.1 1.0 6.5 0.7 1.0 0.8 17.0 1.5 0.9 4.2 11.8 0.8 1.4 1.8 0.9 1.2 3.5 0.5 13.9 7.1 1.5 0.7 2.7 0.4 2.4 2.1 0.5 6.2 0.4 25.8 1.8 4.0 1.0 0.6 0.0 0.5 67.7 0.5 3.5 0.7 0.9 1.2 0.7 2.1 0.6 1.1 0.0 1.5 0.8 1.9 0.6 1.5 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.1 0.3 6.9 0.1 0.8 0.0 1.5 0.0 0.3 0.1 0.1 0.0 0.0 0.9 0.2 0.2 0.1 0.5 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 2.9 0.0 0.0 3.2 1.2 1.5 0.0 0.7 0.0 0.0 0.0 20.4 4.8 0.5 0.0 0.2 0.0 0.0 0.1 0.0 1.1 9.9 0.7 0.2 1.9 0.0 0.0 11.2 0.0 2.9 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 6.5 0.8 17.0 13.9 7.1 2.4 2.1 4.0 1.1 0.0 4.0 0.0 11.1 4.5 7.7 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 2.8 0.4 0.0 0.0 0.3 7.4 13.8 0.0 0.0 1.5 3.2 157.5 1.8 0.8 0.0 0.3 1.0 6.8 0.0 1.7 7.8 0.1 0.0 1.8 0.0 2.7 0.0 10.3 0.2 0.7 5.6 0.1 0.7 1.2 2.2 AREG "AREGB, SDGF" ENSG00000109321 Amphiregulin P15514 4 74445134-74455009 "Cancer-related genes, Predicted membrane proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 83.5" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3" "Group enriched" "Detected in many" 9 "granulocytes: 11.6;NK-cells: 3.3" "Cell line enhanced" "Detected in some" "CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5" "Region enriched" "Detected in single" 4 "olfactory region: 1.5" "Low region specificity" "Detected in all" "HPA008720, CAB023519" Approved Approved Mitochondria NA NA 1520000 Mitochondria "CAB023519: AB_2060673, HPA008720: AB_1844978" "unprognostic (1.44e-2)" "unprognostic (1.84e-3)" "unprognostic (3.36e-2)" "unprognostic (2.26e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.90e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (8.32e-5)" "unprognostic (2.56e-2)" "unprognostic (2.49e-3)" "unprognostic (2.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (6.83e-3)" 19.5 1.1 0.4 9.2 2.1 28.9 20.3 0.3 0.4 5.7 6.7 0.2 0.2 0.7 1.7 1.6 22.3 6.0 34.8 13.6 0.5 0.4 2.5 1.7 14.4 13.3 0.4 0.0 5.8 1.0 0.0 7.8 83.5 1.3 1.9 5.0 1.4 3.9 0.9 9.9 3.4 10.0 1.5 1.0 11.3 5.3 4.6 0.0 1.6 1.2 13.4 13.6 8.7 4.6 0.4 0.8 11.6 0.0 3.3 0.4 0.1 1.7 12.2 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.3 42.8 6.8 0.0 0.9 0.0 0.0 1.9 0.0 74.1 0.7 0.0 0.0 0.0 0.3 2.0 23.0 0.2 0.0 0.7 75.5 4.4 161.4 0.1 0.0 0.0 0.1 0.0 1.6 46.5 0.0 0.0 0.0 8.8 4.9 0.0 0.0 0.0 4.2 0.3 0.0 0.0 2.5 0.1 0.0 0.0 1.3 0.0 0.1 0.0 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.2 0.0 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.4 0.2 0.0 0.1 3.3 0.0 0.1 0.0 0.1 0.4 2.1 0.3 0.4 0.5 0.4 0.4 0.0 1.3 0.0 184.6 339.4 82.8 759.9 994.1 0.0 30.5 71.4 92.3 310.5 48.8 0.0 1.3 0.0 52.7 45.1 3.9 632.3 0.0 8.6 1.2 28.2 73.6 633.9 2.9 31.8 0.0 39.8 10.4 189.5 5.9 0.3 134.1 32.1 1.8 188.0 0.0 301.5 221.0 1.1 0.5 0.0 19.4 4.4 52.0 45.0 299.4 0.9 149.6 119.9 1407.8 ARF3 ENSG00000134287 "ADP ribosylation factor 3" P61204 12 48935723-48957551 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.99e-2)" "unprognostic (2.40e-1)" "unprognostic (9.60e-2)" "unprognostic (1.58e-2)" "unprognostic (9.12e-3)" "unprognostic (2.25e-3)" "unprognostic (2.00e-3)" "unprognostic (1.24e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (3.88e-2)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" 20.4 23.0 60.9 24.5 84.1 18.7 17.4 29.2 92.1 23.3 31.1 24.6 12.9 18.5 17.4 23.9 23.3 19.9 16.0 13.0 58.4 45.8 28.7 16.7 22.6 14.8 37.6 48.1 16.3 14.9 43.1 21.4 18.8 38.3 18.6 29.5 15.7 16.8 20.8 4.7 21.5 20.7 23.6 32.1 18.4 17.6 15.5 18.3 15.1 23.0 11.9 21.6 17.2 13.7 5.8 24.7 26.0 18.2 8.2 8.4 8.8 42.2 62.6 27.3 24.2 22.7 16.7 26.1 28.3 35.7 33.2 28.9 82.9 56.0 33.9 42.5 30.7 26.3 35.3 37.7 38.2 30.1 41.4 19.4 55.1 51.5 23.7 14.2 42.0 44.9 18.6 30.3 36.1 21.6 36.3 35.2 23.0 33.5 18.5 28.3 51.7 31.1 22.8 38.6 68.1 33.7 30.1 15.6 22.4 35.8 54.2 28.2 25.8 30.4 35.6 26.5 31.7 60.2 33.7 48.7 24.8 39.9 15.5 17.6 18.1 40.9 24.9 32.7 32.9 14.1 2.6 18.2 12.5 6.7 11.7 5.5 5.8 7.9 8.4 24.7 5.3 4.3 4.9 26.0 8.2 7.7 19.1 6.1 8.8 60.9 84.1 29.2 92.1 58.4 45.8 37.6 48.1 38.3 18.3 23.8 28.6 43.3 36.1 53.5 33.1 8.8 40.8 20.1 20.5 94.2 9.8 48.4 56.3 102.1 36.2 44.2 156.0 0.0 79.0 87.6 43.7 53.8 27.6 42.4 115.5 41.3 68.0 55.9 82.4 73.4 37.7 64.2 42.2 141.5 62.7 40.1 91.5 108.7 35.0 118.3 21.1 32.3 46.2 45.6 58.9 57.5 57.7 36.2 52.3 45.8 ARFGEF2 BIG2 ENSG00000124198 "ADP ribosylation factor guanine nucleotide exchange factor 2" Q9Y6D5 20 48921890-49036693 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 95.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026078, CAB026382" Supported Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "CAB026382: , HPA026078: AB_1844983" "unprognostic (1.50e-2)" "unprognostic (9.56e-3)" "unprognostic (4.14e-2)" "unprognostic (4.94e-3)" "unprognostic (5.30e-2)" "unprognostic (6.94e-2)" "unprognostic (1.57e-2)" "unprognostic (2.99e-1)" "unprognostic (8.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.15e-7)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.85e-1)" "unprognostic (3.90e-2)" 12.9 29.8 9.4 16.6 15.9 15.6 18.7 14.2 21.8 12.7 15.6 12.5 19.2 15.8 13.8 12.4 15.2 10.4 12.8 19.2 11.1 11.0 17.1 20.1 11.5 14.3 11.5 12.6 12.2 21.6 95.3 17.1 15.4 16.1 12.6 17.6 13.4 15.1 24.7 16.2 15.5 16.5 11.6 11.9 14.0 17.4 23.2 8.5 15.5 23.6 11.6 16.0 16.1 11.6 2.5 2.4 7.3 1.7 1.8 2.8 1.0 9.5 11.0 5.1 3.3 9.6 8.8 12.9 8.0 10.8 21.3 10.5 20.0 11.2 13.6 12.2 11.5 19.4 11.5 10.1 12.7 18.5 5.0 3.7 10.1 11.2 18.4 12.4 12.3 11.7 9.0 14.0 14.2 14.9 7.7 14.9 6.6 7.7 13.7 11.3 4.3 7.7 6.8 5.0 11.0 10.1 8.1 13.3 16.6 11.1 13.8 4.6 5.5 23.3 38.4 15.3 6.4 15.4 12.8 18.6 20.6 9.4 10.4 7.4 20.9 18.8 10.1 13.4 6.7 6.9 7.3 1.7 0.7 1.6 1.1 2.8 1.6 1.9 1.8 2.4 2.5 2.7 2.4 0.5 1.8 1.1 2.4 0.5 1.0 9.4 15.9 14.2 21.8 11.1 11.0 11.5 12.6 16.1 8.5 17.9 21.3 13.7 11.9 10.1 14.5 33.1 20.4 12.0 21.6 10.4 13.7 8.6 1.7 8.5 12.6 17.5 21.6 23.3 11.5 7.7 10.3 18.9 15.0 23.1 9.7 11.1 12.0 24.5 14.8 18.7 9.5 11.2 10.1 12.6 22.6 6.2 13.3 20.1 10.6 10.5 15.7 6.5 8.0 25.6 19.6 13.6 25.1 6.4 18.4 12.4 ARFGEF3 "BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33" ENSG00000112379 "ARFGEF family member 3" Q5TH69 6 138161921-138344663 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.2;parathyroid gland: 24.5;salivary gland: 26.6" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 92.2;Ciliated cells: 68.3;Club cells: 81.9;Glandular cells: 88.3;Intestinal endocrine cells: 64.4" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 11.4;RH-30: 10.8;RT4: 15.2;SK-BR-3: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036350 Uncertain NA NA "HPA036350: AB_10672084" "prognostic unfavorable (8.20e-4)" "unprognostic (4.31e-2)" "unprognostic (9.91e-3)" "unprognostic (5.91e-2)" "unprognostic (2.20e-2)" "unprognostic (4.53e-2)" "unprognostic (4.30e-3)" "unprognostic (1.21e-2)" "unprognostic (7.41e-2)" "unprognostic (7.82e-2)" "unprognostic (3.46e-2)" "unprognostic (4.93e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (2.38e-1)" "unprognostic (8.87e-2)" "unprognostic (1.69e-2)" 1.6 5.5 15.1 1.5 15.7 1.1 11.0 26.2 19.7 7.3 5.7 17.1 2.1 3.2 1.5 1.8 1.0 3.4 2.7 1.7 10.9 10.2 3.5 0.7 8.4 0.9 13.9 13.6 0.7 11.2 24.5 9.3 2.4 11.7 15.8 6.6 0.7 26.6 1.9 0.9 1.7 2.9 1.5 12.4 1.1 13.1 1.3 14.5 0.0 2.9 0.0 1.1 4.2 0.9 0.2 0.1 1.0 0.0 0.6 0.1 0.0 6.1 2.4 0.0 0.4 0.0 0.0 3.8 0.3 0.2 0.1 0.0 0.1 0.3 0.0 2.5 0.2 2.2 2.0 3.0 1.5 0.0 0.0 3.9 0.0 1.2 0.7 0.0 2.3 0.0 0.0 0.7 0.0 0.8 2.9 3.3 2.1 0.0 3.9 0.0 11.4 0.0 0.0 2.1 6.6 2.7 0.5 10.8 2.0 2.1 15.2 5.6 0.0 6.2 17.8 0.7 0.2 3.5 0.0 0.3 0.2 1.8 0.0 6.1 1.4 5.0 0.0 2.6 1.4 0.4 1.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.6 0.0 0.1 0.0 0.0 15.1 15.7 26.2 19.7 10.9 10.2 13.9 13.6 11.7 14.5 14.9 92.2 0.0 14.5 0.0 18.5 7.0 17.8 68.3 81.9 3.5 0.0 13.5 3.3 9.0 39.6 8.4 1.1 0.0 21.2 1.6 0.5 88.3 2.3 0.0 1.2 11.1 64.4 8.0 0.0 9.4 0.0 0.0 0.0 3.6 49.0 1.0 14.5 7.0 0.0 0.3 3.1 0.0 0.8 1.0 0.2 0.0 5.1 0.0 13.2 42.2 ARG1 ENSG00000118520 "Arginase 1" P05089 6 131573144-131584332 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 284.1" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 867.5" "Cancer enriched" "Detected in some" 45 "liver cancer: 167.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 24.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 24.4" "Cell line enhanced" "Detected in some" "Daudi: 1.5;Hep G2: 1.7;HL-60: 4.0;RH-30: 1.6;SiHa: 1.8;U-698: 2.2" "Region enhanced" "Detected in single" "cerebellum: 2.7" "Not detected" "Not detected" "HPA003595, CAB009434, HPA024006, CAB056159" Enhanced NA NA 15000000 "CAB009434: AB_2058955, CAB056159: AB_2665582, HPA003595: AB_1078190, HPA024006: AB_1844987" "unprognostic (2.00e-1)" "unprognostic (2.09e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-1)" "unprognostic (9.95e-2)" "unprognostic (7.96e-2)" "unprognostic (7.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.22e-1)" "unprognostic (1.56e-2)" "unprognostic (7.55e-3)" "unprognostic (8.35e-2)" "unprognostic (1.25e-2)" "unprognostic (2.90e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (1.79e-2)" 1.0 0.0 0.1 0.1 0.1 34.3 0.6 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.3 0.1 3.0 0.2 0.0 0.1 284.1 5.1 0.8 0.2 0.1 0.4 0.2 0.0 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.3 14.6 0.1 0.1 0.1 3.5 0.0 0.3 0.1 0.5 0.3 1.7 0.3 0.3 0.7 0.1 0.1 24.4 0.4 0.0 4.7 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.7 0.0 4.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.0 0.5 0.1 0.4 0.1 0.0 0.0 0.0 1.6 0.4 0.0 0.3 0.2 0.1 1.8 0.4 0.3 0.2 0.1 0.5 0.0 0.0 0.2 0.3 0.1 1.0 0.2 2.2 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.1 24.4 0.0 0.4 0.1 4.7 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 13.9 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.0 867.5 0.0 0.0 0.0 25.2 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 ARG2 ENSG00000081181 "Arginase 2" P78540 14 67619798-67651720 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 53.7;thyroid gland: 75.4" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 140.3;Collecting duct cells: 157.1;Syncytiotrophoblasts: 502.9;Urothelial cells: 134.9" "Cancer enhanced" "Detected in all" "prostate cancer: 49.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000663, CAB009435" Enhanced Supported Mitochondria NA NA Mitochondria "CAB009435: AB_2059089, HPA000663: AB_1078192" "unprognostic (8.74e-3)" "unprognostic (3.06e-2)" "unprognostic (1.35e-2)" "unprognostic (2.29e-1)" "unprognostic (2.30e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-3)" "unprognostic (4.62e-3)" "unprognostic (5.37e-2)" "unprognostic (4.66e-3)" "unprognostic (1.72e-1)" "unprognostic (9.39e-2)" "unprognostic (4.26e-1)" "unprognostic (2.31e-1)" "unprognostic (4.34e-1)" "unprognostic (1.26e-1)" 1.5 3.9 2.4 1.7 6.4 0.6 2.7 8.3 5.3 9.3 5.4 0.5 2.0 2.1 3.7 2.3 7.3 0.8 4.9 2.1 3.3 5.5 41.4 2.0 1.7 0.6 3.2 1.7 8.8 2.6 32.1 22.5 4.4 4.6 53.7 1.1 3.4 26.6 3.8 17.2 0.8 10.4 2.2 3.9 0.7 1.4 1.9 2.1 0.1 75.4 13.6 2.2 5.3 4.1 2.5 1.7 2.0 1.4 0.3 2.9 3.4 3.5 0.5 6.2 4.0 0.9 0.0 8.4 2.7 7.5 9.0 15.3 15.3 1.8 6.0 0.7 1.8 4.1 0.8 24.9 11.3 11.0 0.2 6.2 2.7 1.1 17.4 2.7 0.6 16.3 0.4 14.7 4.4 21.5 0.7 15.3 16.1 7.9 0.0 0.6 1.7 0.9 0.6 11.8 1.5 0.2 0.2 0.8 6.8 7.3 5.9 13.8 5.2 1.7 1.7 2.6 15.0 6.4 0.2 3.1 2.7 6.9 0.2 2.0 0.5 0.9 2.0 5.5 3.1 4.6 0.3 1.4 2.0 1.1 0.5 0.5 0.7 0.3 0.9 1.7 2.5 0.6 0.6 1.7 0.3 1.2 0.1 2.9 3.4 2.4 6.4 8.3 5.3 3.3 5.5 3.2 1.7 4.6 2.1 0.0 4.3 3.7 140.3 7.8 5.0 5.0 2.5 2.7 27.3 157.1 9.8 82.0 31.5 9.2 12.3 3.0 14.8 23.3 2.8 5.2 3.7 84.0 6.9 1.5 12.3 9.5 35.3 1.8 0.3 1.0 0.3 3.9 10.1 1.0 4.3 40.7 4.5 3.5 0.4 75.6 16.0 6.5 4.1 7.2 2.6 4.6 502.9 5.0 3.3 134.9 ARGFX ENSG00000186103 "Arginine-fifty homeobox" A6NJG6 3 121570704-121586634 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.6;testis: 2.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 119 "testis cancer: 6.4" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "K-562: 1.7;Karpas-707: 1.5;U-698: 1.9" HPA043049 Uncertain NA NA "HPA043049: AB_2678288" "unprognostic (6.00e-2)" 0.3 0.1 0.2 0.5 0.2 0.9 0.2 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.3 0.3 0.2 0.2 0.0 0.4 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.1 1.1 0.8 0.4 0.0 0.1 0.5 0.1 2.2 0.1 0.0 0.2 0.1 0.4 0.2 3.6 0.8 0.7 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.2 1.0 0.5 0.7 0.0 0.4 0.0 1.1 0.0 0.3 0.4 0.0 0.2 0.0 0.2 1.7 1.5 0.4 0.0 0.0 0.1 0.4 0.8 1.0 0.3 0.0 0.3 0.0 0.0 0.0 0.5 0.4 0.6 0.0 1.4 0.4 0.5 0.0 0.2 0.5 0.0 0.5 1.2 0.5 1.9 0.0 0.2 0.2 0.8 0.3 0.4 0.2 0.4 0.2 0.4 0.1 0.1 0.2 0.4 0.2 0.3 3.6 0.7 0.8 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639949 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.4;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 20.0;Spermatocytes: 24.4;Spermatogonia: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.9 1.5 2.0 17.2 2.9 16.4 3.3 1.1 3.9 1.6 5.4 1.6 0.5 4.3 2.3 0.5 7.5 0.5 4.1 1.4 2.2 1.9 0.8 1.2 2.0 9.4 4.4 0.8 0.8 3.1 0.9 1.0 4.7 2.0 1.2 6.7 0.8 2.0 0.5 1.7 3.2 9.6 3.3 8.9 5.0 2.6 6.4 1.9 35.0 1.0 5.3 10.3 2.6 2.7 0.9 1.7 2.6 1.8 0.5 3.8 1.1 23.5 25.4 20.3 13.4 1.4 3.8 12.2 23.9 13.8 22.8 17.6 17.5 12.0 13.7 7.6 14.0 26.1 17.5 14.3 12.5 30.8 26.9 8.3 43.4 22.9 8.9 0.5 32.3 17.4 1.2 1.5 18.3 14.5 4.3 16.8 27.0 30.0 32.6 26.4 9.6 16.9 10.8 12.7 19.7 14.9 20.1 45.5 10.7 8.1 12.5 19.6 13.5 25.1 13.0 5.4 11.0 18.5 31.0 12.9 30.8 22.8 12.9 25.4 11.9 18.8 37.8 13.2 38.4 26.9 0.1 1.1 2.6 2.3 1.8 0.9 0.9 3.8 3.3 1.7 0.7 1.5 2.0 0.0 0.5 0.3 0.6 2.8 1.1 2.0 2.9 1.1 3.9 2.2 1.9 4.4 0.8 2.0 1.9 0.0 2.9 1.5 0.9 4.2 0.0 0.8 5.1 1.4 2.3 1.8 0.0 2.5 0.0 0.8 2.9 1.1 0.5 0.0 0.7 20.0 1.1 1.0 0.0 1.0 8.0 0.0 0.0 2.5 4.1 3.4 0.6 3.2 0.0 3.6 3.7 0.0 0.5 1.1 0.4 0.2 0.9 6.5 0.9 24.4 18.6 1.9 2.6 3.2 5.1 1.4 ARHGAP11B ENSG00000285077 "Rho GTPase activating protein 11B" Q3KRB8 15 30624494-30638805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.6;intestine: 2.7;stomach 1: 1.9" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 93.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 17.9" HPA064479 Uncertain Uncertain Vesicles NA NA Vesicles "HPA064479: AB_2685272" 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.1 1.1 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.9 0.4 0.0 0.9 0.3 1.0 0.8 0.0 0.0 0.0 1.3 0.0 2.9 0.4 0.0 1.8 0.6 0.6 1.6 0.2 1.0 1.3 0.5 4.6 3.1 0.0 1.4 1.0 1.8 5.3 4.2 0.1 2.5 4.1 0.4 0.0 17.9 1.4 0.4 0.9 0.2 0.4 0.1 0.5 1.1 0.9 1.5 0.0 1.3 7.8 3.9 0.2 2.4 0.6 0.9 1.4 0.3 0.9 1.8 1.2 1.3 4.6 2.7 1.0 1.1 1.3 0.6 0.7 1.5 3.3 1.3 4.8 2.7 0.1 3.0 3.0 2.1 1.4 1.1 3.7 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.3 0.9 0.8 1.0 0.3 0.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.0 11.2 1.0 1.8 3.4 0.7 0.0 1.4 0.0 1.8 5.9 0.0 0.0 0.4 20.2 0.5 1.7 93.5 0.5 0.0 0.9 0.9 1.1 0.8 0.0 3.2 0.0 4.3 5.7 12.8 2.0 2.9 0.0 3.6 4.0 13.2 0.4 3.4 1.1 0.3 2.4 0.0 1.0 13.6 10.0 1.3 0.0 5.3 2.9 0.9 ARHGAP15 BM046 ENSG00000075884 "Rho GTPase activating protein 15" Q53QZ3 2 143091362-143768352 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 62.8;Early spermatids: 89.3;granulocytes: 83.5;T-cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.2;HEL: 25.4;HL-60: 35.8;MOLT-4: 23.7;NB-4: 27.8;THP-1: 37.8;U-698: 28.4;U-937: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA032125 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA032125: AB_10671370" "unprognostic (1.59e-2)" "unprognostic (2.40e-3)" "unprognostic (8.63e-2)" "unprognostic (2.19e-2)" "unprognostic (2.99e-1)" "unprognostic (6.62e-3)" "unprognostic (6.14e-2)" "unprognostic (2.18e-3)" "unprognostic (1.32e-2)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (4.40e-2)" "unprognostic (2.12e-2)" "unprognostic (4.58e-2)" "unprognostic (6.94e-2)" 5.5 2.7 3.6 36.6 4.6 33.5 3.7 0.6 2.9 2.4 4.3 1.5 2.1 2.7 2.1 4.3 3.6 2.4 4.9 5.0 3.8 2.1 4.5 4.8 9.1 36.9 7.8 1.7 1.5 1.2 0.4 1.3 1.6 4.6 3.9 3.3 1.0 8.1 2.2 1.1 1.7 12.2 1.6 11.3 51.8 3.0 3.5 5.9 94.4 4.2 2.2 21.7 6.0 3.9 25.2 14.5 52.0 9.6 28.7 46.0 23.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 25.4 0.1 0.0 0.0 35.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.1 1.2 0.0 0.0 23.7 27.8 0.1 0.0 0.0 13.3 0.1 6.7 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 1.2 37.8 0.1 0.1 0.9 0.0 0.0 0.3 0.1 28.4 0.2 19.0 1.1 38.6 8.6 34.9 26.6 8.8 42.3 25.2 46.0 33.3 14.5 22.5 33.9 28.4 52.0 28.7 9.6 14.4 36.5 23.2 3.6 4.6 0.6 2.9 3.8 2.1 7.8 1.7 4.6 5.9 0.0 14.8 62.8 0.0 4.9 0.0 2.0 0.0 4.0 4.5 0.0 0.0 0.1 0.0 0.0 89.3 2.6 0.0 0.0 0.0 0.3 11.5 0.2 83.5 0.4 19.7 1.6 0.0 6.7 31.4 5.3 13.8 38.9 8.5 19.8 0.0 0.2 0.0 0.0 3.2 0.3 0.2 45.3 28.6 7.1 1.0 4.0 0.2 90.6 0.0 0.1 ARHGAP19 "FLJ00194, MGC14258" ENSG00000213390 "Rho GTPase activating protein 19" Q14CB8 10 97222173-97292673 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 30.4" "Cell type enhanced" "Detected in many" 4 "Ito cells: 12.3;Spermatocytes: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA035777, HPA043231" Uncertain Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA035777: AB_2674777, HPA043231: AB_10796791" "unprognostic (5.88e-2)" "unprognostic (2.39e-2)" "unprognostic (2.47e-2)" "unprognostic (1.91e-2)" "unprognostic (1.68e-1)" "unprognostic (8.79e-3)" "unprognostic (1.60e-3)" "unprognostic (2.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (6.76e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (7.47e-5)" "unprognostic (1.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.23e-2)" "unprognostic (4.29e-2)" 5.6 3.7 5.6 8.8 7.6 18.3 8.6 7.2 5.3 7.4 5.1 11.7 3.2 4.1 6.9 3.4 6.1 6.0 4.0 4.9 5.7 4.6 4.6 3.2 5.5 14.1 10.9 3.6 11.4 3.4 8.0 7.3 6.0 7.4 5.8 5.3 7.3 6.4 3.7 4.0 6.0 6.6 5.3 14.2 12.0 4.3 20.1 7.0 30.4 4.4 5.5 14.3 6.7 5.9 5.5 5.3 15.5 7.3 4.1 6.0 5.1 8.1 2.6 14.6 25.6 0.9 3.9 4.5 4.0 4.1 6.5 4.6 5.2 7.3 18.2 3.4 2.7 3.8 5.5 12.2 5.0 8.2 9.0 6.7 11.9 3.3 3.5 0.9 18.3 12.8 2.0 1.7 4.5 10.4 2.1 8.8 25.9 11.7 9.6 5.6 4.0 16.6 3.9 7.9 5.2 2.4 20.0 12.5 5.1 1.9 3.6 1.1 6.8 3.0 1.5 6.7 5.6 9.1 9.6 4.1 2.6 3.1 4.1 10.4 8.6 8.8 24.6 3.3 21.7 2.9 15.3 7.3 10.2 5.2 6.6 4.9 5.5 5.1 4.8 5.3 5.5 6.0 5.3 15.5 4.1 5.7 3.0 5.9 5.1 5.6 7.6 7.2 5.3 5.7 4.6 10.9 3.6 7.4 7.0 3.0 2.7 3.0 1.2 0.8 2.1 1.2 5.1 5.3 0.0 0.0 0.0 1.1 0.0 1.1 5.9 3.7 1.7 0.0 1.4 3.0 1.8 2.3 4.7 2.6 2.9 6.4 0.0 12.3 8.5 4.9 3.1 4.0 1.7 1.0 1.9 1.6 0.9 3.5 3.9 0.6 1.2 0.0 1.9 11.4 9.6 2.0 0.8 2.5 3.1 1.0 ARHGAP21 "ARHGAP10, KIAA1424" ENSG00000107863 "Rho GTPase activating protein 21" Q5T5U3 10 24583609-24723668 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.8" "Cell type enhanced" "Detected in all" 7 "Muller glia cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036610, HPA057861" Approved Supported "Plasma membrane,Cell Junctions,Actin filaments" NA NA "Cell Junctions, Actin filaments" "Plasma membrane" "HPA036610: AB_10669910, HPA057861: AB_2683546" "unprognostic (7.65e-2)" "unprognostic (1.61e-2)" "unprognostic (1.88e-1)" "unprognostic (5.84e-2)" "unprognostic (2.69e-1)" "unprognostic (3.59e-1)" "unprognostic (1.12e-3)" "unprognostic (5.35e-2)" "unprognostic (9.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-3)" "unprognostic (3.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.53e-1)" "unprognostic (3.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" 19.6 13.6 34.5 7.1 38.5 4.7 15.6 37.9 39.3 16.2 12.0 39.1 4.4 9.4 14.8 6.0 8.4 14.0 13.5 15.0 43.1 25.2 8.5 9.8 15.7 3.5 42.3 24.0 25.5 11.0 12.4 9.7 12.1 27.3 8.2 14.1 6.7 16.0 9.1 10.9 4.7 11.5 13.7 54.8 6.0 19.5 10.4 43.7 2.7 9.8 3.7 4.2 9.2 9.3 0.2 1.6 3.6 1.9 1.0 2.0 1.0 23.0 10.2 25.1 21.3 17.7 25.6 8.6 16.6 11.0 10.2 14.4 7.4 14.7 4.3 5.7 26.3 15.8 15.3 13.2 16.6 15.0 14.1 8.4 25.3 22.0 5.3 10.6 0.0 3.9 10.4 18.2 13.3 14.5 15.2 17.5 6.5 10.7 38.8 20.0 4.5 12.0 0.8 3.8 8.3 5.5 2.6 8.9 2.4 6.9 4.1 4.3 4.4 11.3 6.3 13.5 7.7 6.6 3.6 19.3 14.7 9.4 16.0 11.9 4.3 7.6 3.0 15.1 4.4 9.8 3.6 0.8 1.6 0.5 1.9 0.4 0.2 0.6 1.6 1.3 0.0 2.0 1.2 0.1 1.0 0.9 1.6 1.0 1.0 34.5 38.5 37.9 36.1 43.1 25.2 42.3 24.0 27.3 43.7 80.4 22.0 5.2 10.4 26.3 127.8 32.7 20.4 34.8 61.4 5.2 64.8 19.4 1.7 18.9 4.3 25.3 34.0 23.3 23.9 15.9 47.4 17.6 16.2 18.7 12.1 125.5 15.5 20.9 25.3 5.3 86.0 24.4 18.6 7.2 26.8 217.5 27.9 26.0 55.9 5.7 53.2 25.8 19.4 25.1 33.0 17.7 10.5 10.0 23.4 24.0 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446034-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 32.3" "Group enriched" "Detected in many" 5 "Early spermatids: 51.6;Late spermatids: 92.5;monocytes: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6" "Group enriched" "Detected in many" 29 "B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 28.1;LHCN-M2: 25.4;TIME: 26.9;U-87 MG: 33.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266" "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 3.1 10.2 6.7 12.5 3.0 2.0 7.3 12.2 1.8 2.7 32.3 1.0 1.7 2.1 1.9 1.6 2.2 4.4 3.3 12.5 9.6 1.2 0.8 2.9 6.0 18.3 6.6 7.7 1.5 2.7 1.8 2.2 24.6 3.2 2.8 1.6 3.4 3.2 3.9 3.4 2.5 3.4 27.3 6.2 2.3 4.6 18.4 2.0 6.0 0.4 5.4 3.1 1.9 2.6 2.9 0.0 3.2 0.0 0.0 0.9 2.4 0.5 0.1 0.0 2.1 8.6 1.7 13.1 6.0 1.2 1.7 2.7 0.3 0.0 0.5 5.1 0.9 4.8 0.1 4.4 2.1 0.2 4.5 6.9 0.0 0.0 1.1 0.7 0.8 2.0 4.5 15.0 1.2 28.1 8.2 0.0 6.5 1.2 25.4 0.1 0.1 0.0 2.8 0.0 0.2 0.0 0.0 3.1 2.5 0.2 0.4 2.6 0.6 0.0 0.2 0.2 0.1 0.1 26.9 12.3 0.1 1.6 9.1 0.0 0.0 0.0 33.5 0.1 1.9 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 2.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 10.2 12.5 7.3 9.2 12.5 9.6 18.3 6.6 24.6 18.4 0.0 1.7 1.3 4.2 3.1 1.0 2.4 0.0 6.7 4.5 0.0 2.0 9.2 0.0 2.5 51.6 1.4 0.0 0.0 3.9 0.2 2.6 1.0 0.0 0.0 10.4 0.0 0.0 2.5 9.5 92.5 2.6 11.0 1.7 23.4 0.0 1.5 2.0 0.0 5.6 0.0 1.4 0.0 0.5 1.4 4.2 0.5 0.8 0.0 0.0 0.5 ARHGAP23 KIAA1501 ENSG00000275832 "Rho GTPase activating protein 23" Q9P227 17 38419280-38512392 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 56.6;Ito cells: 51.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 77.1;RT4: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019818, HPA047291" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA019818: AB_1844993, HPA047291: AB_2680012" "unprognostic (3.35e-1)" "unprognostic (5.11e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (6.87e-5)" "unprognostic (9.53e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (1.99e-1)" "unprognostic (5.56e-2)" "unprognostic (1.50e-3)" "prognostic unfavorable (3.24e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.38e-5)" "unprognostic (8.36e-2)" "unprognostic (5.83e-2)" "unprognostic (4.57e-2)" "unprognostic (2.25e-1)" 4.3 2.7 11.7 3.5 32.1 4.2 1.7 3.6 20.1 4.4 1.4 52.4 0.0 1.0 5.1 1.5 13.3 4.0 3.6 7.8 12.6 1.6 0.5 5.7 1.3 42.3 12.6 6.1 0.8 1.5 0.0 9.5 20.2 3.7 0.9 0.9 0.7 6.6 2.1 16.3 1.1 5.5 16.3 10.5 0.5 5.2 39.0 1.4 0.9 0.5 5.0 11.6 2.3 0.0 0.8 0.0 0.1 0.0 0.1 0.1 8.2 4.4 4.0 1.3 2.5 8.5 5.0 11.3 12.8 10.0 5.8 14.7 14.5 0.1 9.4 26.3 5.0 77.1 0.4 16.0 7.1 0.9 0.8 0.0 14.1 0.1 12.8 0.8 0.0 4.9 3.1 7.2 4.6 8.2 10.2 1.5 0.1 2.2 5.6 0.0 2.4 1.5 2.4 0.3 1.7 4.3 8.7 2.7 4.2 30.0 0.9 2.3 6.8 0.0 0.1 5.9 1.7 1.9 14.8 16.9 5.9 3.4 3.0 1.7 1.7 0.4 4.2 2.0 14.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 11.9 1.0 0.0 14.3 8.9 56.6 16.3 2.5 1.4 15.9 3.5 0.0 20.8 0.0 2.6 6.7 24.5 0.0 23.3 1.2 2.1 14.3 5.3 0.0 0.2 4.2 25.4 0.0 51.5 3.7 15.8 8.3 0.9 1.7 0.0 0.2 7.5 4.4 0.0 6.7 0.0 3.3 0.0 7.2 17.6 1.9 22.6 13.8 0.0 0.0 35.6 ARHGAP24 "DKFZP564B1162, FilGAP, FLJ33877" ENSG00000138639 "Rho GTPase activating protein 24" Q8N264 4 85475114-86002670 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 62.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 105.7;Distal tubular cells: 192.3;Proximal tubular cells: 165.1;Syncytiotrophoblasts: 194.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5" "Group enriched" "Detected in many" 4 "B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 36.4;ASC TERT1: 22.1;HHSteC: 21.3;HUVEC TERT2: 39.2;RPTEC TERT1: 22.0;TIME: 27.6;U-138 MG: 19.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014288 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014288: AB_1844994" "unprognostic (2.19e-1)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.95e-2)" "unprognostic (2.81e-1)" "unprognostic (9.22e-2)" "unprognostic (5.75e-3)" "unprognostic (4.28e-3)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (5.91e-2)" "unprognostic (6.45e-2)" "prognostic favorable (1.67e-11)" "unprognostic (1.75e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (8.75e-4)" 21.3 1.9 5.3 16.4 7.9 10.7 17.6 1.8 9.4 5.8 6.2 8.4 2.4 4.8 9.2 7.3 7.7 3.9 7.1 16.8 6.3 7.3 62.5 6.0 9.9 23.8 11.0 3.3 4.1 21.5 6.9 8.2 13.9 9.0 6.7 4.3 8.7 9.0 5.8 7.6 6.2 8.7 13.2 19.8 33.6 15.9 2.8 6.7 2.1 17.8 6.5 24.2 13.0 5.2 23.1 6.5 2.8 8.0 0.0 0.0 1.4 0.9 1.9 1.4 0.0 36.4 22.1 1.5 6.9 9.2 1.7 2.7 0.0 0.0 0.9 2.4 15.4 2.1 0.0 0.0 2.9 3.6 0.0 0.3 1.1 0.2 0.0 21.3 0.1 0.0 16.1 0.3 3.3 1.5 7.8 39.2 0.0 2.0 0.1 14.9 0.0 0.0 0.0 0.1 0.4 3.6 0.1 7.3 3.6 22.0 0.0 0.7 0.7 0.7 1.1 2.4 1.6 0.1 0.0 27.6 19.7 0.4 1.4 0.1 0.1 0.0 1.2 3.3 0.7 6.4 0.0 8.0 0.0 0.0 1.5 0.0 23.1 0.0 0.0 1.9 18.4 0.0 0.0 2.8 0.0 1.1 6.5 0.0 1.4 5.3 7.9 1.8 9.4 6.3 7.3 11.0 3.3 9.0 6.7 53.6 24.5 105.7 2.4 7.2 3.7 22.1 43.3 25.4 10.3 43.6 5.9 36.9 192.3 7.0 17.7 4.9 0.0 0.0 10.3 22.3 17.9 2.2 1.1 6.6 10.1 104.9 2.4 5.5 24.7 6.8 15.5 12.9 18.6 0.0 2.5 40.3 7.3 2.9 11.7 165.1 6.2 6.5 14.0 5.2 4.1 5.5 194.7 0.9 3.0 1.7 ARHGAP25 KIAA0053 ENSG00000163219 "Rho GTPase activating protein 25" P42331 2 68679601-68826833 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 94.2;lymphoid tissue: 48.7" "Cell type enhanced" "Detected in many" 19 "B-cells: 49.9;granulocytes: 196.2;T-cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 94.2" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 75.2" "Group enriched" "Detected in many" 4 "amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4" "Low region specificity" "Detected in many" "HPA035346, HPA061395" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA035346: AB_10601116, HPA061395: AB_2684501" "unprognostic (1.13e-3)" "prognostic favorable (7.72e-4)" "unprognostic (2.45e-2)" "unprognostic (4.44e-3)" "unprognostic (8.07e-2)" "unprognostic (1.36e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.67e-2)" "unprognostic (3.51e-2)" "unprognostic (1.00e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.10e-1)" "unprognostic (4.26e-2)" "unprognostic (3.61e-1)" "unprognostic (4.49e-2)" 7.4 3.5 2.6 33.1 3.6 14.6 5.7 0.9 3.2 3.1 4.9 6.7 1.6 2.5 4.0 10.5 3.5 3.5 7.2 4.3 2.8 2.3 5.7 4.6 12.9 39.0 5.9 1.9 8.1 2.2 0.6 3.1 4.5 4.2 3.7 4.2 3.1 5.7 1.5 2.0 3.3 14.3 3.5 6.3 48.7 3.4 2.2 3.3 20.9 4.0 2.3 40.6 6.1 4.7 23.6 7.5 94.2 12.5 22.8 26.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.1 0.0 0.0 0.7 0.0 5.8 0.0 0.6 0.0 18.7 0.0 0.0 0.3 4.1 75.2 0.0 0.7 0.1 2.4 0.0 0.0 6.4 0.1 6.8 0.0 0.0 4.7 13.1 0.3 0.0 0.0 5.2 1.2 0.2 0.0 1.5 1.2 0.1 0.0 0.0 0.4 0.4 0.0 3.4 1.0 0.0 0.2 0.0 0.1 14.9 7.9 4.7 0.0 9.3 0.1 27.5 8.7 72.8 26.3 10.9 16.4 23.6 11.8 22.7 5.3 14.5 8.5 15.0 94.2 22.8 12.5 7.5 14.2 15.7 2.6 3.6 0.9 3.2 2.8 2.3 5.9 1.9 4.2 3.3 3.0 19.6 49.9 9.3 4.9 0.6 1.4 2.5 9.4 3.4 0.0 0.0 0.3 1.7 0.0 1.5 14.1 0.0 0.0 0.2 0.2 0.9 1.0 196.2 0.6 39.1 0.0 2.9 12.9 22.8 2.2 1.4 21.0 1.7 38.7 0.3 0.3 0.0 0.0 2.5 0.0 0.0 6.5 1.9 0.7 1.3 1.3 0.2 57.3 0.0 2.4 ARHGAP27 "CAMGAP1, FLJ43547, SH3D20, SH3P20" ENSG00000159314 "Rho GTPase activating protein 27" Q6ZUM4 17 45393902-45434421 "Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 38.8" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 60.1;Paneth cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 12.4;HMC-1: 11.6;OE19: 14.6;RT4: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023919, HPA053053" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023919: AB_2059402, HPA053053: AB_2682027" "unprognostic (9.80e-2)" "unprognostic (1.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.89e-3)" "unprognostic (4.66e-1)" "unprognostic (2.69e-2)" "unprognostic (7.69e-2)" "unprognostic (6.89e-2)" "unprognostic (2.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.49e-2)" "unprognostic (1.96e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.21e-4)" 6.0 3.1 4.9 21.9 8.7 15.0 5.5 5.2 6.3 9.3 23.1 6.4 2.7 14.9 3.2 7.8 35.0 4.5 17.4 7.0 7.5 3.2 11.0 2.4 10.5 24.1 8.2 2.4 2.4 3.5 4.3 4.0 9.7 7.5 6.1 13.0 3.8 13.6 9.1 2.6 11.6 38.8 3.8 10.2 28.6 8.8 2.9 8.0 29.4 6.3 5.8 34.1 8.0 15.0 4.1 7.8 10.4 11.2 1.9 3.1 3.5 4.3 4.3 0.1 1.3 0.6 0.3 12.4 0.0 0.2 0.3 0.1 3.8 8.7 4.0 8.5 0.3 1.9 2.8 0.5 0.8 0.2 8.0 2.7 0.2 1.6 2.4 0.1 0.0 11.6 0.6 3.5 0.0 1.3 0.4 2.6 4.3 1.0 7.2 0.3 3.0 3.7 1.3 0.2 14.6 3.6 3.1 0.2 1.3 2.8 18.8 0.6 0.4 0.5 3.7 0.2 1.5 2.9 7.3 4.1 0.0 1.1 0.0 0.4 9.0 5.8 0.8 0.2 1.1 0.0 1.0 4.7 4.2 2.8 9.3 1.8 4.1 1.7 3.1 4.5 3.4 1.4 1.4 10.4 1.9 11.2 7.8 2.3 3.5 4.9 8.7 5.2 6.3 7.5 3.2 8.2 2.4 7.5 8.0 6.0 19.1 20.6 15.4 9.2 2.6 9.8 17.8 2.7 7.9 17.4 3.9 6.4 3.3 4.9 0.8 20.2 60.1 0.0 3.0 8.9 2.5 21.5 4.6 1.5 13.3 1.6 18.4 16.5 38.7 0.9 0.3 16.4 6.8 1.0 29.2 1.2 11.8 59.6 0.0 5.0 1.4 0.0 3.1 2.3 1.9 7.5 11.8 14.9 32.0 47.8 ARHGAP28 "FLJ10312, KIAA1314" ENSG00000088756 "Rho GTPase activating protein 28" Q9P2N2 18 6729718-6915716 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.4" "Group enriched" "Detected in many" 21 "Early spermatids: 446.0;Late spermatids: 371.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 4 "neutrophil: 7.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 7.1" "Cell line enhanced" "Detected in many" "AF22: 22.0;CACO-2: 22.9;SuSa: 16.2;U-2 OS: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030413, HPA030414, HPA030415" Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598" "unprognostic (8.33e-2)" "unprognostic (8.79e-3)" "unprognostic (3.15e-3)" "unprognostic (6.94e-5)" "unprognostic (1.49e-1)" "unprognostic (2.92e-2)" "unprognostic (1.11e-3)" "unprognostic (1.10e-1)" "unprognostic (7.56e-3)" "unprognostic (9.52e-4)" "unprognostic (1.43e-2)" "unprognostic (3.12e-1)" "unprognostic (4.53e-3)" "unprognostic (3.59e-3)" "unprognostic (6.00e-2)" "unprognostic (3.61e-2)" "unprognostic (2.76e-2)" 8.6 1.9 0.9 4.4 0.9 0.3 12.7 0.8 1.0 13.5 5.1 0.1 2.8 1.0 5.7 8.5 1.3 2.1 7.3 4.2 0.9 1.0 6.9 0.7 9.3 2.8 0.8 0.5 9.9 7.4 4.9 1.3 16.1 0.6 9.1 1.3 3.9 1.7 4.2 16.0 2.2 3.4 4.3 1.5 21.5 1.5 39.4 0.0 3.5 5.0 4.2 0.4 4.8 3.9 0.6 0.6 7.1 0.5 0.4 0.3 0.1 0.1 0.1 22.0 2.1 4.3 7.5 3.7 1.8 3.8 1.6 3.6 22.9 0.1 0.1 0.7 0.2 1.1 0.9 0.0 0.5 2.7 0.6 1.2 0.0 1.8 0.1 0.7 0.1 0.1 9.4 0.4 1.9 0.1 0.2 5.1 0.3 0.6 1.8 2.5 0.3 0.3 0.2 6.9 0.2 1.1 0.1 1.5 0.1 0.0 1.8 2.2 9.2 0.1 1.8 0.3 16.2 0.1 0.0 0.7 0.3 10.3 7.3 0.2 0.1 0.0 0.1 3.5 0.2 0.7 1.5 0.5 0.7 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.6 0.2 0.3 7.1 0.4 0.1 0.6 0.1 0.1 0.9 0.9 0.8 1.0 0.9 1.0 0.8 0.5 0.6 0.0 0.0 3.4 0.0 1.0 1.6 1.3 1.4 0.0 0.0 1.2 1.8 19.6 10.8 0.0 0.5 446.0 4.1 0.0 0.0 2.4 2.1 6.6 5.1 0.0 0.0 1.8 0.0 0.0 3.1 0.3 371.7 17.0 0.2 0.0 0.0 0.0 0.1 1.1 0.0 13.4 2.7 0.8 0.0 1.4 9.3 2.5 1.3 5.5 0.0 0.0 1.2 ARHGAP30 FLJ00267 ENSG00000186517 "Rho GTPase activating protein 30" Q7Z6I6 1 161046946-161069970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.1;lymphoid tissue: 45.9" "Cell type enhanced" "Detected in many" 9 "granulocytes: 64.9;Hofbauer cells: 51.2;Kupffer cells: 65.0;Macrophages: 65.9;monocytes: 85.6;T-cells: 106.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 31.5;HL-60: 24.3;HMC-1: 34.3;Karpas-707: 25.5;MOLT-4: 19.7;THP-1: 24.2;U-266/70: 38.3;U-266/84: 25.3;U-698: 26.9;U-937: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036300 Enhanced Supported Vesicles NA NA Vesicles "HPA036300: AB_10601117" "unprognostic (7.31e-2)" "unprognostic (8.83e-3)" "unprognostic (7.46e-3)" "unprognostic (1.77e-3)" "unprognostic (7.41e-2)" "unprognostic (1.68e-3)" "unprognostic (3.05e-1)" "unprognostic (6.78e-3)" "unprognostic (1.94e-2)" "unprognostic (3.89e-2)" "unprognostic (7.91e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.65e-2)" 6.1 3.0 2.6 23.3 3.9 20.4 3.1 0.6 2.4 2.2 3.9 3.5 1.4 3.5 2.0 3.7 8.0 3.3 5.9 4.1 1.9 1.7 3.0 3.3 11.3 27.9 4.3 0.7 1.8 1.8 0.3 1.5 2.5 3.4 2.3 3.2 2.6 6.1 1.8 0.9 11.2 13.7 2.9 4.3 45.9 4.1 1.4 4.5 38.1 2.0 2.4 33.2 5.6 3.8 8.3 12.3 27.1 24.0 10.2 19.7 14.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 31.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 14.6 0.0 10.5 0.0 0.0 0.0 24.3 34.3 0.0 0.3 0.0 0.0 0.0 0.0 15.3 0.1 25.5 0.0 0.2 19.7 5.6 0.0 0.2 0.0 12.4 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 24.2 0.2 0.0 0.1 0.0 0.1 38.3 25.3 26.9 0.1 19.5 0.0 3.3 15.5 17.6 19.7 18.3 15.1 7.1 13.2 16.1 12.3 8.3 11.0 14.7 27.1 10.2 24.0 8.4 13.2 14.7 2.6 3.9 0.6 2.4 1.9 1.7 4.3 0.7 3.4 4.5 3.0 25.1 39.8 2.9 4.9 0.2 1.2 5.1 9.4 11.4 0.0 3.9 0.5 0.0 2.2 2.1 2.1 0.0 0.0 5.3 1.2 0.9 3.8 64.9 1.5 51.2 0.0 0.0 7.4 65.0 0.4 0.3 65.9 5.0 85.6 0.3 0.2 7.6 0.0 0.0 0.5 3.0 0.0 1.4 0.0 0.1 21.5 3.8 106.6 0.3 13.6 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.9" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 115.8;Muller glia cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 21.2;SK-BR-3: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.0 5.9 22.1 3.4 32.8 1.7 9.4 4.7 46.9 8.2 12.3 5.1 1.5 18.4 7.3 8.4 21.9 12.2 6.8 3.8 9.9 6.8 6.5 4.5 5.2 1.5 6.4 21.7 10.2 13.3 14.9 5.3 7.5 5.4 6.0 14.3 4.5 13.4 4.1 6.2 16.0 19.0 5.5 4.3 2.6 10.8 9.2 8.4 5.8 3.6 12.8 12.9 8.0 13.1 1.3 1.6 0.7 2.1 3.0 1.2 0.6 6.4 3.4 10.8 0.0 3.5 3.6 7.8 2.4 3.4 1.5 1.9 7.9 13.4 0.0 3.7 4.7 7.8 14.7 4.9 6.1 3.0 0.0 1.7 0.1 1.7 2.9 1.7 0.0 0.0 3.4 8.0 1.5 9.1 3.4 1.9 5.5 0.3 0.1 2.7 5.0 5.3 0.1 2.9 19.4 3.7 13.1 3.2 1.3 1.7 21.2 10.7 4.3 3.7 23.1 4.4 4.3 12.0 2.0 3.5 5.5 2.9 3.2 4.7 0.1 0.0 0.0 2.4 14.7 3.4 0.0 0.4 0.0 0.3 2.1 1.2 0.0 0.4 0.6 1.0 1.3 0.8 0.2 0.7 3.0 0.7 1.6 0.4 0.6 22.1 32.8 4.7 46.9 9.9 6.8 6.4 21.7 5.4 8.4 6.0 12.6 0.5 10.9 16.3 25.3 3.9 12.7 41.5 28.4 10.4 115.8 17.3 1.7 6.9 12.7 4.9 46.1 0.0 23.7 3.3 11.9 19.8 1.1 13.6 5.4 17.5 39.1 6.2 4.6 10.4 6.4 3.4 15.1 0.0 61.0 120.0 20.3 45.6 12.4 8.6 31.5 19.4 5.9 8.6 5.6 27.1 23.8 1.3 46.4 48.2 ARHGAP36 FLJ30058 ENSG00000147256 "Rho GTPase activating protein 36" Q6ZRI8 X 131058242-131089883 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 21 "thyroid cancer: 62.5" "Region enriched" "Detected in many" 5 "hypothalamus: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 164 "SH-SY5Y: 64.4" "Region enhanced" "Detected in many" "hypothalamus: 104.3" "Group enriched" "Detected in many" 5 "basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1" "HPA002064, HPA076209" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane" Yes NA Nucleoplasm "Vesicles, Plasma membrane" "HPA002064: AB_1078891, HPA076209: " "unprognostic (2.92e-2)" "unprognostic (7.71e-9)" "unprognostic (2.19e-1)" "unprognostic (8.15e-2)" "unprognostic (1.67e-1)" "unprognostic (1.78e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (2.31e-1)" 6.9 58.4 1.4 0.2 3.6 0.1 1.0 0.0 2.7 0.5 0.2 0.0 0.0 0.1 0.1 2.0 0.3 0.2 0.2 0.1 1.0 25.5 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 50.3 0.3 5.4 0.3 0.2 0.6 0.2 0.2 13.7 0.1 0.1 0.1 0.8 0.1 0.2 0.6 0.0 0.5 0.5 4.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 64.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.6 0.0 0.4 1.0 25.5 0.5 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 23.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.1 1.9 3.6 1.0 3.5 0.0 1.2 6.2 7.0 2.0 2.0 2.4 1.7 1.2 1.4 7.0 0.9 0.4 5.3 4.4 1.8 0.2 1.5 0.3 3.3 0.9 2.9 2.0 4.0 0.9 2.1 0.9 3.5 2.3 0.6 2.6 2.4 0.6 7.2 0.9 1.2 12.8 2.8 0.1 0.5 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 7.6 7.6 3.6 5.6 0.7 0.6 7.0 2.0 0.6 2.5 1.6 4.9 4.5 0.8 5.2 0.8 2.6 6.5 1.8 1.9 0.5 0.0 6.8 0.1 5.0 3.1 1.2 0.0 0.8 0.5 3.1 3.2 1.3 1.3 0.8 0.3 7.0 0.0 1.0 12.4 4.2 0.0 3.8 3.1 10.9 3.9 2.9 2.9 2.0 3.9 10.5 7.4 5.8 2.0 3.4 1.4 8.6 1.1 1.9 1.9 0.1 6.3 4.1 0.0 0.1 0.3 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.9 0.0 0.5 3.3 7.1 1.6 0.0 20.1 3.4 3.5 19.6 0.4 0.0 2.2 2.1 0.7 3.9 0.0 2.1 0.7 1.3 1.1 0.0 1.3 0.4 3.2 0.0 1.3 0.0 2.5 2.0 0.0 5.0 0.0 3.6 3.5 1.1 8.6 7.8 1.4 23.7 6.5 1.5 8.1 7.7 2.6 0.5 0.0 4.3 0.6 ARHGAP4 "C1, KIAA0131, p115, RhoGAP4, SrGAP4" ENSG00000089820 "Rho GTPase activating protein 4" P98171 X 153907367-153934999 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 44.8;lymphoid tissue: 48.4" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 71.1;Kupffer cells: 73.8;Macrophages: 43.6;T-cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 26.2;Karpas-707: 26.9;MOLT-4: 25.3;RPMI-8226: 49.8;THP-1: 24.3;U-698: 23.2;U-937: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001012, HPA001083" Enhanced Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA001012: AB_1078201, HPA001083: AB_1078199" "unprognostic (3.54e-2)" "prognostic favorable (3.94e-5)" "prognostic unfavorable (1.97e-5)" "unprognostic (5.79e-2)" "unprognostic (9.42e-2)" "prognostic favorable (3.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.39e-1)" "unprognostic (3.27e-1)" "unprognostic (1.37e-1)" "unprognostic (7.81e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (8.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 7.0 4.8 5.3 24.3 5.8 44.8 5.0 4.5 3.2 3.1 6.5 5.2 2.1 6.0 3.9 7.0 4.4 5.2 6.5 4.2 4.5 3.2 7.4 4.9 13.4 29.1 5.2 0.9 2.6 2.3 0.9 3.5 9.0 4.8 4.2 3.0 5.7 7.5 1.8 1.6 1.8 18.0 3.9 5.9 48.4 4.9 3.6 4.2 43.2 4.2 1.6 29.0 7.1 3.6 10.8 17.7 18.7 30.5 8.5 15.7 12.6 0.4 0.1 0.2 1.7 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.1 12.5 26.2 1.6 0.0 0.2 0.2 1.3 0.0 0.0 7.1 1.0 10.2 0.1 0.5 1.1 18.6 17.3 0.0 0.1 0.0 0.1 0.1 2.6 6.6 0.0 26.9 0.1 1.3 25.3 0.3 0.8 0.1 0.0 12.0 3.5 49.8 0.1 0.2 2.4 3.6 0.2 0.6 0.2 0.3 5.9 24.3 0.5 0.1 0.3 0.2 0.1 16.3 13.9 23.2 0.2 21.7 0.0 5.1 14.1 18.7 15.7 23.1 10.9 10.8 11.2 12.4 14.1 10.4 10.1 10.1 12.0 8.5 30.5 17.7 12.6 12.6 5.3 5.8 4.5 3.2 4.5 3.2 5.2 0.9 4.8 4.2 8.9 33.9 40.2 0.5 3.1 9.8 30.4 2.5 13.4 4.5 17.4 3.9 1.7 5.0 0.7 0.1 10.6 3.9 0.0 0.6 1.2 2.1 0.4 33.5 0.5 71.1 3.2 4.6 4.3 73.8 0.0 0.9 43.6 10.1 12.6 2.1 1.3 0.1 0.0 0.0 0.6 4.4 0.0 0.9 0.5 4.9 1.5 1.1 48.4 3.9 0.4 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 18.6;epididymis: 38.0;skin 1: 26.7" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 3.5;Early spermatids: 3.2;Late spermatids: 2.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.7;HBEC3-KT: 12.2;RPTEC TERT1: 10.8;SK-BR-3: 11.6;T-47d: 14.0" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" No NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.3 0.0 0.3 0.3 0.3 0.0 18.6 0.3 0.5 1.6 0.3 0.4 5.2 0.8 0.6 38.0 15.8 0.0 0.9 0.3 0.3 0.1 4.1 0.3 1.8 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 3.0 0.0 0.3 1.9 5.1 0.3 26.7 0.3 0.7 0.3 0.3 2.6 1.2 0.6 0.3 0.3 5.2 6.6 3.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.1 0.1 0.8 0.0 3.4 0.0 0.0 0.0 0.0 12.2 0.2 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 11.6 0.0 1.5 14.0 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.3 0.3 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.2 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.1;RH-30: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.6 4.6 0.1 2.6 3.5 3.2 0.6 0.9 1.1 2.1 4.4 23.1 0.7 6.5 1.7 4.1 7.8 2.3 1.7 1.1 0.0 2.0 11.2 9.1 1.5 4.6 0.1 0.0 3.3 2.2 4.3 0.7 2.6 1.7 2.8 0.4 0.0 3.5 0.6 1.2 0.0 5.6 6.4 5.7 3.4 16.0 0.4 5.4 15.0 2.5 1.6 7.7 0.3 6.1 10.0 0.8 1.4 3.0 3.0 3.7 3.6 1.7 3.3 0.0 4.5 3.5 2.7 13.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 44.7 4.0 5.1 4.8 2.2 2.6 4.2 10.2 16.0 21.6 3.5 23.6 0.6 1.7 4.1 72.6 2.9 10.0 23.3 3.3 1.8 4.5 10.0 0.0 5.9 1.3 1.6 1.7 9.2 0.3 27.0 1.1 2.2 10.1 0.0 2.8 31.8 6.5 5.7 2.5 15.8 60.0 38.8 12.3 1.9 1.6 3.0 5.4 0.0 2.4 17.3 ARHGAP44 "KIAA0672, RICH-2, RICH2" ENSG00000006740 "Rho GTPase activating protein 44" Q17R89 17 12789539-12991643 "Predicted intracellular proteins" Exocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 33.8" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 168.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 10.5;SK-BR-3: 8.0;SuSa: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038814 Approved NA NA "HPA038814: AB_10673295" "unprognostic (4.30e-2)" "unprognostic (3.48e-1)" "unprognostic (5.18e-3)" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" "unprognostic (1.83e-1)" "unprognostic (1.68e-2)" "unprognostic (5.35e-2)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (4.02e-2)" "unprognostic (3.95e-2)" "unprognostic (6.31e-3)" "unprognostic (7.53e-3)" "unprognostic (3.98e-1)" "unprognostic (9.58e-2)" 3.6 2.5 13.5 4.3 17.2 0.5 2.0 23.6 24.7 2.5 15.4 2.7 3.8 7.5 3.3 3.7 1.6 10.6 5.7 4.5 16.8 11.5 3.2 1.0 12.3 2.0 7.1 11.1 5.1 4.5 33.8 11.3 9.8 15.5 3.7 12.5 4.6 5.6 4.8 2.6 1.5 7.6 3.6 3.4 1.2 3.7 2.5 2.8 0.0 7.3 0.0 2.0 2.3 3.6 0.6 0.0 0.0 0.4 0.3 0.6 0.0 0.4 1.6 1.3 1.0 0.1 0.7 4.4 1.0 5.2 0.3 0.5 0.8 0.2 4.1 0.5 1.7 2.7 0.7 2.8 0.0 0.1 0.3 10.5 0.1 1.6 1.7 0.2 0.0 0.3 0.2 0.4 0.3 0.0 0.0 0.0 6.5 0.3 0.0 0.0 5.1 0.5 0.4 4.4 2.4 0.4 3.8 0.4 0.9 0.1 1.5 4.3 0.3 0.1 8.0 0.1 14.6 1.1 1.5 0.0 4.2 2.4 1.6 0.1 0.0 0.0 0.5 0.9 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.3 0.6 0.2 0.4 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.0 13.5 17.2 23.6 24.7 16.8 11.5 7.1 11.1 15.5 2.8 11.9 10.9 2.0 5.1 2.4 14.1 6.8 15.3 6.7 2.3 8.7 2.0 1.8 0.0 3.5 15.3 1.9 13.4 0.0 3.9 0.9 2.3 4.0 0.0 0.5 0.6 168.5 11.5 3.7 0.8 2.6 4.0 0.0 1.7 0.0 12.8 7.2 4.1 7.0 10.3 0.6 14.4 19.4 8.0 0.7 5.3 1.4 0.7 0.0 29.9 2.8 ARHGAP45 "HA-1, HMHA1, KIAA0223" ENSG00000180448 "Rho GTPase activating protein 45" Q92619 19 1065923-1086628 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 32.1;bone marrow: 35.2;intestine: 23.4;lung: 17.5;lymphoid tissue: 50.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 44.7;Cytotrophoblasts: 32.5;Extravillous trophoblasts: 44.4;Hofbauer cells: 34.5;monocytes: 126.2;Syncytiotrophoblasts: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 22.2;Karpas-707: 31.2;RPMI-8226: 22.1;THP-1: 27.8;U-266/70: 41.1;U-937: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019816, HPA079252" Enhanced NA NA 2200000 "HPA019816: AB_1853923, HPA079252: " "unprognostic (1.34e-1)" "unprognostic (5.13e-3)" "unprognostic (5.17e-3)" "prognostic favorable (6.02e-4)" "unprognostic (2.26e-1)" "prognostic favorable (7.82e-4)" "unprognostic (1.59e-2)" "unprognostic (2.17e-2)" "unprognostic (3.55e-1)" "unprognostic (4.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-2)" "unprognostic (1.00e-1)" "unprognostic (4.59e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (5.33e-2)" 4.9 2.8 2.8 28.3 3.8 35.2 4.3 0.9 2.2 2.1 4.8 3.8 0.6 4.4 2.1 2.6 3.2 3.3 5.4 2.7 3.0 2.2 4.6 3.5 17.5 42.2 5.4 1.2 1.2 1.5 0.5 2.5 5.8 3.9 3.2 1.7 3.2 6.7 1.5 1.2 2.0 23.4 2.0 4.9 50.4 6.1 1.7 4.6 45.0 4.3 1.8 38.4 4.3 4.3 9.3 9.4 15.7 9.2 11.3 32.1 21.0 3.3 0.6 0.0 3.7 0.0 0.0 8.7 0.0 0.0 0.0 0.0 8.8 4.3 22.2 0.9 0.0 0.1 2.9 0.6 0.2 0.0 16.3 0.3 3.0 6.1 1.0 0.1 14.4 17.6 0.0 0.9 0.0 0.0 0.0 0.0 14.4 2.0 31.2 0.0 0.2 16.0 12.9 2.3 0.5 1.6 15.5 0.1 22.1 0.0 0.0 0.1 0.0 5.1 0.0 1.3 0.2 1.1 27.8 1.4 0.0 0.6 0.0 0.0 41.1 17.6 17.8 0.1 21.8 1.6 2.7 9.2 9.8 20.4 9.0 17.8 7.3 23.2 24.2 9.4 9.3 32.1 23.3 15.7 11.3 8.4 5.6 18.2 21.0 2.8 3.8 0.9 2.2 3.0 2.2 5.4 1.2 3.9 4.6 44.7 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 10.4 0.0 32.5 0.0 2.7 0.0 0.0 0.0 0.0 3.3 44.4 0.0 0.0 3.5 0.0 34.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 126.2 0.0 0.0 6.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 63.2 0.0 0.0 0.0 ARHGAP6 rhoGAPX-1 ENSG00000047648 "Rho GTPase activating protein 6" O43182 X 11137543-11665701 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 57.3;seminal vesicle: 58.8" "Cell type enhanced" "Detected in many" 10 "Glandular cells: 77.5;granulocytes: 39.3;Sertoli cells: 45.3;Smooth muscle cells: 47.5" "Cancer enhanced" "Detected in many" "prostate cancer: 12.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 15.1;ASC TERT1: 19.6;HEL: 19.3;HMC-1: 13.6;HSkMC: 19.3;K-562: 14.0;RT4: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001798, HPA036779, HPA064390" Enhanced Supported Cytosol "Intracellular and membrane" NA NA 920000 Cytosol "HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253" "unprognostic (2.36e-1)" "unprognostic (1.68e-2)" "unprognostic (3.49e-2)" "unprognostic (7.31e-2)" "unprognostic (6.34e-2)" "unprognostic (1.69e-2)" "unprognostic (4.70e-2)" "unprognostic (2.79e-1)" "unprognostic (1.70e-1)" "unprognostic (7.46e-4)" "unprognostic (1.53e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.55e-8)" "unprognostic (1.60e-2)" "unprognostic (5.96e-2)" "unprognostic (1.28e-2)" "unprognostic (7.99e-4)" 9.4 1.2 16.7 2.6 10.0 0.7 6.3 0.6 2.9 9.5 11.7 4.1 57.3 2.0 10.2 9.0 4.1 7.6 5.4 3.6 5.6 4.3 6.0 1.1 8.7 1.2 2.3 3.6 15.1 1.9 1.1 6.6 6.2 2.7 24.8 3.7 3.2 2.5 58.8 8.0 2.3 4.2 12.1 3.1 5.0 4.1 2.2 3.3 0.0 25.9 3.1 1.4 14.3 8.0 1.3 0.2 1.0 0.9 0.0 0.1 2.7 0.0 0.0 1.3 0.0 15.1 19.6 0.3 0.1 0.3 0.8 0.5 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.0 0.7 0.0 0.2 19.3 0.0 0.0 5.5 0.0 13.6 19.3 0.0 1.4 0.0 1.7 0.3 0.0 14.0 6.5 0.8 0.0 0.0 0.0 0.3 0.1 0.2 0.0 6.4 8.1 4.6 11.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.8 0.3 3.9 0.1 0.3 0.0 0.0 0.1 0.0 2.1 1.0 0.3 0.5 0.0 0.9 0.0 1.3 0.0 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.7 0.2 0.0 2.7 16.7 10.0 0.6 2.9 5.6 4.3 2.3 3.6 2.7 3.3 0.0 1.7 0.5 15.5 1.8 1.0 2.5 0.0 9.4 4.5 31.4 0.0 0.3 21.6 0.0 0.1 5.5 0.0 0.0 0.9 0.7 8.2 77.5 39.3 0.0 3.8 0.0 1.2 9.8 3.2 0.4 15.0 12.3 5.0 3.6 0.2 5.7 0.5 0.0 9.6 6.1 0.3 45.3 47.5 0.2 0.4 1.5 0.0 0.0 0.0 16.6 ARHGAP8 "BPGAP1, FLJ20185" ENSG00000241484 "Rho GTPase activating protein 8" P85298 22 44752558-44862788 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 18.6;Ductal cells: 23.6;Pancreatic endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 12.4;BEWO: 23.4;CACO-2: 14.8;HEK 293: 20.2;MCF7: 20.9;SK-BR-3: 20.2" HPA069694 Approved Approved Nucleoplasm Yes No Nucleoplasm "HPA069694: AB_2686173" "unprognostic (4.14e-1)" "unprognostic (1.21e-2)" "unprognostic (6.88e-2)" "unprognostic (8.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-2)" "unprognostic (5.51e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-1)" "unprognostic (8.78e-3)" "unprognostic (9.58e-2)" "unprognostic (7.65e-6)" "unprognostic (8.59e-2)" "unprognostic (3.29e-1)" "unprognostic (2.32e-2)" "unprognostic (2.22e-2)" 0.5 0.1 1.7 5.6 0.4 0.2 7.5 0.3 0.4 2.2 10.6 0.6 29.3 1.2 2.6 13.0 5.7 6.1 11.5 0.3 0.3 0.4 18.2 0.9 3.9 0.3 0.3 0.3 0.9 14.6 4.5 5.2 22.4 1.2 10.0 5.7 1.9 28.4 24.8 0.3 1.4 3.6 1.2 0.3 6.7 4.3 3.0 0.3 0.7 15.2 2.4 4.9 2.0 1.8 0.2 0.7 0.2 0.4 0.1 2.2 0.3 12.4 0.1 0.2 0.1 0.0 0.2 23.4 0.1 1.5 0.0 0.1 14.8 6.7 0.1 0.8 0.0 0.2 9.3 4.4 10.7 0.1 0.0 20.2 0.0 0.3 0.1 0.0 0.0 0.2 0.1 4.7 0.1 0.2 0.3 0.0 0.2 0.4 0.3 0.0 20.9 0.0 0.0 3.1 9.4 0.0 0.0 0.0 0.2 5.7 8.5 1.3 0.0 0.0 20.2 0.4 5.3 8.7 0.1 0.1 0.0 0.7 0.1 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.0 0.7 2.2 0.3 1.7 0.4 0.3 0.4 0.3 0.4 0.3 0.3 1.2 0.3 3.0 12.2 0.0 18.6 0.6 0.4 0.8 5.1 4.0 6.8 17.4 3.9 16.5 0.0 23.6 2.3 1.0 2.6 0.0 9.4 0.9 1.3 16.8 0.0 0.0 2.7 0.0 6.9 0.0 0.6 2.5 0.3 0.0 0.0 0.0 7.6 0.5 23.2 3.5 0.4 1.4 0.3 0.0 0.7 0.0 3.9 0.3 5.8 1.0 12.3 15.6 ARHGAP9 "10C, MGC1295" ENSG00000123329 "Rho GTPase activating protein 9" Q9BRR9 12 57472255-57488814 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 56.4;Hofbauer cells: 36.3;Kupffer cells: 39.0;Macrophages: 34.2;T-cells: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 76.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 76.9" "Cell line enhanced" "Detected in some" "HEL: 11.2;HMC-1: 50.1;THP-1: 14.4;U-937: 11.4" "Low region specificity" "Detected in some" HPA078822 Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA078822: " "unprognostic (1.02e-2)" "unprognostic (4.01e-3)" "unprognostic (1.91e-2)" "prognostic favorable (6.61e-5)" "unprognostic (1.24e-1)" "unprognostic (2.38e-3)" "unprognostic (4.79e-2)" "unprognostic (5.56e-3)" "unprognostic (1.28e-2)" "unprognostic (2.80e-1)" "unprognostic (3.05e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.90e-9)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" 5.1 2.5 5.1 33.0 8.0 48.1 4.4 3.7 4.8 1.8 5.4 2.5 0.5 3.6 1.6 1.7 2.7 4.4 4.8 2.4 4.2 1.8 3.5 3.8 11.2 24.1 8.1 0.6 1.2 2.2 0.3 1.5 2.3 5.8 2.5 5.1 2.4 6.0 1.3 0.9 1.4 18.6 2.6 8.5 50.4 3.9 8.8 6.4 19.0 2.6 3.2 28.5 4.7 2.2 8.9 18.9 76.9 17.0 13.1 13.3 11.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 5.9 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.4 6.5 50.1 0.3 0.0 0.0 0.1 0.0 0.0 5.9 0.2 3.3 0.0 0.0 8.9 8.9 0.4 0.0 0.0 3.7 4.3 1.8 0.0 0.0 1.6 1.4 0.0 0.0 0.1 0.2 0.0 14.4 0.3 0.0 0.1 0.0 0.0 4.0 2.7 5.4 0.1 11.4 0.2 8.4 16.6 45.1 9.0 17.0 6.2 7.1 9.9 8.1 13.9 8.9 13.3 9.6 76.9 13.1 12.8 18.9 12.1 11.8 5.1 8.0 3.7 4.8 4.2 1.8 8.1 0.6 5.8 6.4 0.0 23.5 22.6 0.0 1.3 0.0 1.2 0.0 4.0 2.3 0.0 2.0 0.3 0.0 0.0 56.4 1.8 0.0 0.0 0.0 0.4 1.3 0.2 11.5 1.1 36.3 0.0 0.0 4.3 39.0 28.4 1.7 34.2 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.3 0.7 0.0 0.5 28.8 8.5 1.3 0.2 110.8 0.1 0.1 ARHGDIB "GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2" ENSG00000111348 "Rho GDP dissociation inhibitor beta" P52566 12 14942017-14961728 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 669.1;Hofbauer cells: 807.6;Kupffer cells: 661.4;Macrophages: 633.0;T-cells: 892.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.5;HL-60: 119.9;HMC-1: 135.8;JURKAT: 91.1;MOLT-4: 141.9;REH: 119.4;U-698: 109.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018584, HPA051235" Enhanced Supported Cytosol NA NA 120000000 Cytosol "CAB018584: AB_647972, HPA051235: AB_2681398" "unprognostic (2.29e-3)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (9.16e-2)" "unprognostic (1.90e-2)" "unprognostic (2.44e-1)" "unprognostic (1.47e-2)" "unprognostic (3.46e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.74e-1)" "unprognostic (4.42e-3)" "unprognostic (4.97e-2)" "prognostic favorable (3.42e-4)" 40.3 13.4 9.0 66.1 18.4 150.7 27.9 1.8 8.9 14.6 14.5 13.9 3.6 8.5 14.7 13.2 16.9 18.2 18.3 20.5 8.3 7.8 24.5 20.0 41.3 93.9 17.0 3.9 11.7 7.1 3.9 8.1 35.6 11.4 18.0 16.1 20.4 22.4 7.6 13.3 14.7 38.3 15.7 17.9 157.8 11.1 11.2 15.8 221.4 22.7 12.4 108.1 31.2 13.5 114.0 95.5 267.1 151.9 96.3 231.1 333.1 9.4 0.3 0.3 21.0 1.4 1.1 0.1 0.3 0.1 0.1 0.1 1.2 10.4 76.0 4.9 1.7 0.1 10.4 0.0 16.8 1.1 0.1 0.0 102.5 0.2 0.0 0.3 119.9 135.8 0.1 2.1 0.0 1.5 0.3 59.0 91.1 0.5 29.2 1.8 0.0 141.9 86.3 0.4 0.2 0.1 119.4 1.3 34.0 3.3 52.6 0.1 0.0 0.1 13.6 0.1 0.9 0.7 87.3 74.7 0.3 0.7 0.1 2.2 4.8 0.7 109.8 0.3 84.1 0.1 206.0 109.9 267.1 125.6 130.8 123.3 114.0 144.4 140.7 95.5 103.2 141.1 146.5 237.7 96.3 151.9 41.4 231.1 333.1 9.0 18.4 1.8 8.9 8.3 7.8 17.0 3.9 11.4 15.8 56.6 190.4 437.8 45.8 60.7 0.3 8.1 15.3 38.8 80.8 55.8 0.0 51.5 14.9 20.5 1.2 156.9 3.8 23.3 303.9 465.0 49.8 3.3 669.1 4.7 807.6 0.0 1.2 329.0 661.4 2.0 49.5 633.0 86.0 32.5 2.2 1.9 43.8 20.4 55.2 6.1 1.0 239.3 61.4 0.7 1.5 49.1 56.9 892.2 5.7 85.5 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 268727-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 60.4;intestine: 31.7;pancreas: 45.3" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 3.3;Exocrine glandular cells: 9.9;Pancreatic endocrine cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.2;HEK 293: 18.8;MCF7: 24.2;SCLC-21H: 8.5;SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA078260: AB_2732375" "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 3.7 3.1 37.3 1.8 15.6 1.0 1.1 43.3 60.4 1.0 1.8 3.7 0.0 31.7 1.1 2.3 1.1 1.0 0.9 3.6 29.0 27.4 1.0 0.9 1.0 1.0 21.2 21.4 1.0 45.3 0.9 1.7 2.4 12.7 1.1 1.2 0.6 1.3 1.3 2.0 0.9 12.0 1.3 8.6 1.0 9.3 2.0 2.0 0.0 0.9 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.6 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.0 0.7 0.4 0.0 0.1 5.2 0.0 0.0 0.0 18.8 0.0 0.3 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.2 0.0 1.2 0.2 0.0 24.2 0.0 0.3 2.6 1.3 0.0 0.0 0.0 0.4 0.0 0.0 8.5 10.5 0.1 0.1 0.0 0.3 1.8 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.3 15.6 43.3 43.8 29.0 27.4 21.2 21.4 12.7 2.0 0.0 0.0 0.0 0.0 0.3 3.3 0.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.4 0.0 1.3 0.0 9.9 0.2 0.4 0.0 0.0 0.0 0.4 0.0 1.2 1.3 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.9 6.4 0.3 0.0 0.0 2.7 0.0 0.2 0.2 2.5 0.0 0.3 0.0 0.9 0.0 ARHGEF1 "LBCL2, P115-RHOGEF, SUB1.5" ENSG00000076928 "Rho guanine nucleotide exchange factor 1" Q92888 19 41883161-41930150 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 61.0" "Cell type enhanced" "Detected in many" 8 "T-cells: 145.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009502, HPA012924, HPA060784" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363" "prognostic favorable (5.92e-4)" "unprognostic (2.09e-1)" "unprognostic (8.29e-3)" "unprognostic (8.10e-3)" "unprognostic (7.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.99e-2)" "unprognostic (7.28e-2)" "unprognostic (5.88e-2)" "unprognostic (1.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.29e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (3.54e-1)" "unprognostic (1.95e-1)" "unprognostic (8.00e-2)" "unprognostic (4.65e-2)" 15.5 8.4 10.7 40.1 16.5 50.0 13.8 8.7 13.8 11.7 14.1 23.3 9.7 13.7 12.7 9.6 12.2 13.0 14.1 9.3 10.6 6.2 12.4 10.4 23.7 57.8 18.1 8.5 12.5 10.8 7.0 11.8 9.6 11.8 11.4 5.8 12.1 13.1 9.2 5.2 12.9 29.3 9.0 12.2 61.0 17.0 3.7 15.6 43.6 13.4 8.6 40.8 12.4 11.7 11.1 10.8 13.7 26.9 15.4 26.3 14.3 20.0 24.4 5.6 7.0 8.0 8.4 6.6 10.6 16.3 13.5 11.9 7.4 17.3 26.9 19.6 9.7 7.1 11.8 7.2 16.4 4.3 25.2 8.3 21.7 10.5 9.7 11.7 23.1 35.9 10.2 10.9 13.0 8.5 7.2 12.8 24.0 8.5 16.6 7.7 13.8 16.2 18.0 6.4 16.0 19.0 24.5 10.5 15.9 8.3 11.1 3.7 15.7 14.8 6.6 12.1 3.0 7.8 39.6 17.3 17.9 12.1 9.5 16.4 22.6 14.3 23.2 14.6 36.9 28.3 5.1 9.4 13.7 25.1 19.8 20.3 10.8 19.1 26.3 10.8 11.1 20.0 20.4 13.7 15.4 26.9 5.8 19.4 14.3 10.7 16.5 8.7 13.8 10.6 6.2 18.1 8.5 11.8 15.6 6.0 19.5 51.4 11.9 12.9 17.4 2.8 7.6 1.4 2.3 7.0 25.5 11.4 3.3 21.3 1.1 20.3 9.5 0.0 21.5 19.5 14.6 12.3 31.1 9.5 33.0 11.1 20.8 18.4 49.7 0.0 17.8 29.5 18.6 25.2 27.7 10.8 38.4 20.1 15.6 5.8 20.1 25.8 9.8 4.8 8.6 12.9 8.5 145.4 26.3 10.1 ARHGEF10L "FLJ10521, KIAA1626" ENSG00000074964 "Rho guanine nucleotide exchange factor 10 like" Q9HCE6 1 17539835-17697874 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 50.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 40 "classical monocyte: 13.1;intermediate monocyte: 13.0;myeloid DC: 9.7;non-classical monocyte: 3.3" "Group enriched" "Detected in many" 46 "dendritic cells: 9.7;monocytes: 13.1" "Cell line enhanced" "Detected in many" "Hep G2: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026426, HPA026440, HPA028115" Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA026426: AB_10599487, HPA026440: AB_10599422, HPA028115: AB_10602285" "unprognostic (4.34e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "prognostic favorable (8.13e-5)" "unprognostic (3.61e-2)" "unprognostic (7.90e-2)" "unprognostic (2.10e-2)" "unprognostic (1.75e-3)" "unprognostic (1.94e-3)" "unprognostic (5.83e-2)" "prognostic favorable (5.65e-4)" "unprognostic (4.11e-2)" "unprognostic (1.66e-1)" "unprognostic (8.17e-2)" "unprognostic (5.21e-3)" 9.5 6.1 6.2 6.1 6.2 0.7 7.8 31.7 7.5 8.5 13.4 7.1 9.9 9.0 7.7 11.2 14.4 6.4 11.7 16.0 5.7 6.1 16.4 50.7 7.8 2.2 6.3 3.8 5.3 30.2 8.1 2.7 3.3 9.1 6.6 7.4 9.6 13.2 12.3 33.4 13.4 9.7 10.5 5.9 5.4 6.5 3.9 5.9 0.4 10.4 7.4 2.9 9.6 11.9 0.0 9.7 0.2 13.1 0.0 0.0 4.5 5.3 6.1 7.8 2.7 13.3 4.5 5.2 3.6 7.2 4.4 3.7 6.3 16.1 0.0 6.9 6.8 6.1 4.1 1.1 1.9 0.9 0.1 2.0 0.0 6.2 17.7 3.0 0.0 0.0 6.0 3.8 2.7 0.7 8.8 0.8 0.0 0.0 0.1 12.1 5.0 0.0 0.1 3.4 8.1 0.0 0.0 3.1 1.9 9.3 11.1 11.4 8.4 2.8 2.0 8.3 2.3 7.6 6.4 0.0 3.8 4.6 4.5 1.5 0.0 1.6 0.0 5.9 0.1 2.0 0.0 13.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.0 4.5 6.2 6.2 31.7 7.5 5.7 6.1 6.3 3.8 9.1 5.9 3.0 6.1 0.5 4.6 5.0 12.7 31.1 20.4 1.4 9.1 29.6 2.0 0.4 8.3 12.1 8.9 2.7 18.6 0.0 17.5 0.4 6.2 5.5 0.0 35.4 22.2 9.5 36.2 3.1 5.1 6.9 4.6 15.0 3.3 2.8 41.8 12.8 12.3 21.0 6.3 15.5 5.3 12.9 11.4 2.1 1.5 7.5 0.8 0.0 41.6 8.8 ARHGEF15 "ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF" ENSG00000198844 "Rho guanine nucleotide exchange factor 15" O94989 17 8310241-8322516 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.3" "Group enriched" "Detected in some" 5 "Endothelial cells: 35.8;Ito cells: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 46 "HUVEC TERT2: 23.4;TIME: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA044443, HPA063495" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA044443: AB_10960424, HPA063495: AB_2685023" "unprognostic (3.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.18e-2)" "unprognostic (7.09e-3)" "unprognostic (3.82e-1)" "unprognostic (7.29e-4)" "unprognostic (1.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.40e-1)" "unprognostic (1.06e-2)" "unprognostic (1.45e-1)" "unprognostic (2.23e-3)" "unprognostic (4.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.89e-1)" "unprognostic (9.56e-3)" 47.3 3.6 1.5 4.6 2.6 0.3 24.7 0.9 2.8 9.6 5.7 2.0 3.3 3.1 19.9 4.9 5.0 5.9 7.5 18.5 3.8 1.4 9.7 4.2 19.4 3.0 2.2 1.5 6.8 2.8 4.2 3.0 14.1 3.1 8.7 2.1 10.7 3.4 5.1 15.0 4.9 4.1 7.0 1.7 6.9 4.4 2.7 1.1 0.6 8.7 8.4 2.9 9.4 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 0.9 2.8 3.8 1.4 2.2 1.5 3.1 1.1 0.0 4.8 0.5 0.2 2.5 0.8 6.2 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.1 35.8 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 34.4 2.4 3.0 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.1 0.7 0.0 0.3 ARHGEF16 "GEF16, NBR" ENSG00000130762 "Rho guanine nucleotide exchange factor 16" Q5VV41 1 3454426-3481113 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.6;intestine: 45.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 71.7;Extravillous trophoblasts: 39.4;Mucus-secreting cells: 36.4;Paneth cells: 35.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 28.8;MCF7: 16.2;OE19: 19.3;SK-BR-3: 17.8" "Region enriched" "Detected in single" 4 "olfactory region: 5.8" "Not detected" "Not detected" HPA010609 Approved NA NA "HPA010609: AB_1845004" "unprognostic (1.28e-1)" "unprognostic (1.92e-1)" "unprognostic (1.71e-1)" "unprognostic (1.83e-2)" "unprognostic (4.31e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.82e-4)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.79e-2)" "unprognostic (5.39e-2)" "unprognostic (9.16e-2)" "prognostic favorable (1.24e-10)" "unprognostic (6.46e-2)" "unprognostic (2.86e-1)" "unprognostic (1.71e-2)" "unprognostic (3.29e-2)" 1.8 0.1 0.5 7.5 1.0 0.0 2.9 1.1 0.8 2.5 30.4 1.2 11.5 24.8 1.0 4.6 11.4 1.3 28.6 0.5 1.1 0.9 11.7 4.3 3.1 0.5 1.3 0.5 0.9 7.0 4.8 7.7 9.0 2.2 5.7 6.8 1.5 10.1 13.7 0.7 3.4 45.9 1.0 1.9 0.5 15.8 2.3 0.7 0.9 9.0 5.9 5.3 5.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 3.5 0.9 0.1 0.0 0.0 6.2 0.1 0.2 0.2 0.7 10.5 28.8 0.0 6.9 0.0 1.8 9.1 1.5 6.1 0.0 0.0 3.1 0.0 4.3 8.1 0.3 0.0 0.0 0.1 5.9 0.6 0.3 0.6 0.0 0.1 1.1 0.0 0.0 16.2 0.0 0.2 7.0 19.3 0.2 0.0 0.0 1.2 7.3 4.6 4.7 0.9 1.7 17.8 0.4 3.9 7.9 0.3 0.0 0.1 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 1.1 0.8 1.1 0.9 1.3 0.5 2.2 0.7 8.9 4.8 0.0 11.6 2.9 1.0 1.3 12.7 6.7 9.1 15.7 5.9 2.3 13.3 15.0 0.0 0.4 71.7 0.0 11.1 39.4 0.3 4.3 0.0 3.4 1.0 3.2 9.8 0.6 0.0 0.0 0.0 0.7 0.0 1.0 36.4 34.7 20.3 35.7 0.0 8.4 8.1 0.0 0.8 0.4 3.4 0.9 5.6 0.0 24.3 14.8 ARHGEF28 "p190RhoGEF, RGNEF, RIP2" ENSG00000214944 "Rho guanine nucleotide exchange factor 28" Q8N1W1 5 73626158-73941993 "Predicted intracellular proteins" Differentiation "Guanine-nucleotide releasing factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 46.8;Muller glia cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.4;LHCN-M2: 35.3;TIME: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037602 Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "HPA037602: AB_10672282" "unprognostic (1.97e-1)" "prognostic favorable (5.31e-4)" "unprognostic (7.66e-2)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (3.18e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (5.37e-1)" "unprognostic (3.63e-1)" "unprognostic (2.62e-1)" "unprognostic (3.04e-1)" "prognostic favorable (1.91e-6)" "unprognostic (1.07e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-2)" "prognostic favorable (8.98e-4)" 3.4 17.7 3.0 2.7 1.4 0.0 7.7 2.3 2.3 9.7 6.7 1.1 8.6 2.3 11.9 9.7 7.1 7.5 12.0 1.5 1.4 1.9 43.0 5.5 5.5 0.3 1.7 3.2 14.5 19.2 0.2 7.0 1.1 2.5 5.1 2.8 4.3 20.0 9.5 0.9 11.1 3.9 2.7 3.3 2.0 14.8 2.0 1.0 4.1 10.5 6.0 6.0 3.4 6.2 0.0 0.0 0.0 0.0 0.6 1.2 0.1 11.1 7.9 0.0 1.0 1.0 1.4 0.0 4.1 8.2 5.2 5.2 2.3 4.8 0.0 8.8 1.4 11.9 3.8 0.5 6.6 7.9 0.1 1.1 0.2 1.2 10.1 8.3 0.0 0.0 1.3 2.7 8.1 38.4 9.8 17.0 0.2 0.0 0.0 35.3 1.0 0.0 0.0 0.1 2.9 3.2 0.0 2.1 1.3 14.2 6.8 0.7 1.5 2.0 0.3 0.2 0.0 1.7 0.0 22.6 2.6 3.5 0.2 3.8 0.4 0.0 0.0 3.9 0.5 1.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.1 3.0 1.4 2.3 2.3 1.4 1.9 1.7 3.2 2.5 1.0 26.8 13.1 0.0 12.3 22.9 0.7 1.8 28.1 46.8 12.5 29.6 0.0 0.1 13.3 12.3 2.9 8.5 3.0 0.0 9.6 0.2 1.3 9.3 1.1 6.7 0.3 12.7 10.9 1.8 0.3 1.7 9.5 1.3 1.7 1.0 9.6 36.2 17.9 5.7 5.3 18.3 1.0 6.5 3.8 0.7 0.4 22.3 0.1 0.0 6.9 14.9 ARHGEF33 ENSG00000214694 "Rho guanine nucleotide exchange factor 33" A8MVX0 2 38889841-38975449 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 42.5" "Group enriched" "Detected in some" 5 "Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 42.5" "Cell type enriched" "Detected in single" 8 "eosinophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Group enriched" "Detected in some" 4 "BEWO: 9.0;HeLa: 4.0;SiHa: 11.2" "Region enriched" "Detected in single" 32 "cerebellum: 314.4" "Region enriched" "Detected in all" 11 "cerebellum: 47.0" "HPA034661, HPA041051" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA034661: AB_10669679, HPA041051: AB_2677274" "unprognostic (8.38e-2)" "unprognostic (7.05e-4)" "unprognostic (1.95e-1)" "unprognostic (4.67e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-1)" "unprognostic (3.66e-1)" "unprognostic (3.37e-1)" "unprognostic (5.82e-2)" "unprognostic (2.05e-3)" "unprognostic (4.99e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.56e-1)" "unprognostic (2.42e-1)" "unprognostic (1.99e-1)" 0.3 4.0 3.7 1.0 8.6 0.0 1.7 42.5 3.4 2.3 0.7 0.6 0.7 0.1 2.8 5.1 0.7 2.2 1.4 0.8 3.3 3.6 1.4 0.2 1.2 0.5 2.0 2.9 6.8 0.2 2.2 3.5 0.8 3.2 1.7 0.6 0.8 0.4 1.2 0.4 1.3 0.6 1.0 1.5 0.5 0.9 10.1 2.4 0.2 1.4 0.2 0.4 1.2 0.6 0.2 0.1 6.7 0.8 0.0 0.2 0.1 0.3 0.0 0.4 0.2 0.2 0.2 9.0 0.8 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.3 4.0 0.3 0.7 0.4 0.3 0.8 1.0 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.4 0.5 0.3 11.2 0.4 0.0 1.1 0.0 0.3 0.6 0.2 1.5 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.1 0.0 0.6 6.7 0.0 0.8 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 3.7 8.6 42.5 3.4 3.3 3.6 2.0 2.9 3.2 2.4 0.0 1.0 0.0 0.1 0.0 2.5 0.4 0.0 5.3 1.2 0.0 0.0 0.8 0.0 0.1 25.0 0.3 0.0 0.0 0.0 1.3 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.2 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.2 3.1 0.0 0.7 30.7 34.3 0.1 0.5 0.0 0.0 0.2 ARHGEF37 FLJ41603 ENSG00000183111 "Rho guanine nucleotide exchange factor 37" A1IGU5 5 149551947-149634968 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 66.1;seminal vesicle: 73.8" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.0;neutrophil: 4.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "EFO-21: 10.1;HaCaT: 18.5;hTCEpi: 24.5" "Region enhanced" "Detected in some" "cerebellum: 9.5" "Low region specificity" "Detected in all" "HPA043885, HPA053487" Uncertain Approved Cytosol NA NA Cytosol "HPA043885: AB_2678715, HPA053487: AB_2682167" "unprognostic (3.51e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-1)" "unprognostic (3.92e-1)" "unprognostic (1.17e-1)" "unprognostic (6.87e-2)" "unprognostic (1.54e-3)" "unprognostic (1.54e-1)" "unprognostic (2.64e-1)" "unprognostic (6.93e-2)" "unprognostic (2.13e-3)" "unprognostic (1.16e-2)" "prognostic favorable (6.85e-4)" "unprognostic (4.41e-2)" "unprognostic (2.12e-1)" "unprognostic (1.50e-2)" "unprognostic (2.10e-1)" 2.5 2.7 10.8 1.9 13.2 3.0 16.8 6.7 7.1 4.0 10.2 17.5 66.1 4.5 4.4 9.5 7.6 7.4 4.6 6.4 12.8 9.5 4.6 1.4 4.3 1.0 19.1 5.8 2.2 7.0 29.6 5.3 3.6 12.3 16.0 5.2 12.0 23.2 73.8 11.9 29.3 4.8 7.0 31.7 1.0 11.7 4.8 15.1 0.7 2.1 4.8 3.4 6.4 5.4 0.7 1.1 9.0 1.2 0.2 0.8 0.0 3.0 1.2 0.8 3.6 0.2 0.4 2.1 0.4 0.6 0.6 0.6 0.0 4.0 0.4 10.1 0.4 1.1 18.5 0.3 1.8 1.2 0.8 0.9 0.3 1.9 0.2 0.7 0.0 0.5 0.5 24.5 1.9 2.4 2.0 3.0 1.3 0.4 0.7 0.0 0.4 0.5 0.6 0.2 7.5 2.2 0.3 0.4 0.0 4.1 1.5 1.5 3.6 2.2 0.2 0.3 0.4 5.5 0.1 2.4 0.2 0.7 0.0 0.5 0.5 1.0 0.3 0.7 0.1 2.6 9.0 0.9 0.5 0.4 1.2 0.5 0.2 0.3 0.3 0.3 0.7 0.8 0.6 4.9 0.2 0.5 1.1 0.2 0.0 10.8 13.2 6.7 7.1 12.8 9.5 19.1 5.8 12.3 15.1 0.0 5.0 3.7 8.4 6.1 4.1 14.8 15.3 6.7 6.8 8.7 3.9 4.9 0.0 3.2 4.2 6.0 12.6 0.0 4.5 1.2 2.1 9.6 6.9 2.6 2.8 4.8 10.9 6.7 2.8 1.0 1.7 3.7 3.3 4.6 6.1 40.8 4.1 8.0 9.9 1.3 7.3 6.5 4.1 13.2 5.5 8.4 3.8 4.4 7.5 4.5 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 35.5" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 33.6;Ciliated cells: 45.5;Club cells: 18.2" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 3.0;RPTEC TERT1: 16.4;SK-BR-3: 9.0;T-47d: 9.3" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA036510: AB_10672357, HPA045484: AB_2679345" "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.2 0.2 0.2 3.2 0.2 0.0 10.8 0.2 0.2 3.5 7.6 0.0 1.6 2.3 1.4 15.7 0.4 1.1 11.7 0.2 0.2 0.2 13.8 0.4 16.1 0.0 0.2 0.0 1.3 12.9 0.0 35.5 0.4 0.0 14.6 5.6 0.2 13.9 0.5 0.2 1.0 9.6 0.0 0.2 0.2 4.1 0.6 0.0 0.0 8.0 0.7 2.0 0.5 0.4 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 16.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 6.0 33.6 0.0 0.9 0.0 0.0 1.4 2.5 45.5 18.2 12.2 0.0 0.1 8.3 4.2 1.2 0.0 4.1 0.0 5.0 0.1 0.0 13.9 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 7.7 0.0 3.3 5.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.4 ARHGEF39 "C9orf100, FLJ14642" ENSG00000137135 "Rho guanine nucleotide exchange factor 39" Q8N4T4 9 35658875-35675866 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.0" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 86.7;Erythroid cells: 46.7;Late spermatids: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 2.4" "Low region specificity" "Detected in all" HPA061299 Uncertain NA Yes "HPA061299: AB_2684473" "unprognostic (2.93e-1)" "unprognostic (3.90e-1)" "unprognostic (3.31e-2)" "unprognostic (3.40e-2)" "unprognostic (1.65e-1)" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (3.60e-2)" "unprognostic (8.55e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.14e-1)" "unprognostic (9.75e-2)" "unprognostic (6.04e-9)" "unprognostic (3.31e-3)" "unprognostic (3.38e-1)" "unprognostic (5.14e-2)" "unprognostic (1.46e-1)" 1.6 1.4 0.6 10.0 0.6 3.3 1.3 1.7 0.6 1.4 3.7 0.3 0.7 4.1 2.1 1.6 5.6 0.5 3.6 0.9 1.0 0.6 0.9 1.0 1.4 3.7 0.6 0.0 0.8 1.6 0.0 0.6 2.8 0.6 0.8 2.1 0.4 1.4 0.7 0.6 2.0 5.5 1.4 0.6 2.0 2.7 2.9 0.1 18.0 0.5 1.7 7.1 0.9 1.7 1.8 0.9 1.4 1.2 1.7 3.6 0.7 5.3 8.3 7.9 3.9 0.1 0.3 5.3 4.0 1.5 3.5 3.1 9.2 4.3 3.3 2.4 0.6 4.8 4.2 3.9 2.3 1.4 9.8 6.2 5.4 10.7 3.3 0.0 4.5 8.1 0.3 0.2 1.7 1.0 1.2 1.3 4.9 3.7 3.1 1.5 2.7 1.1 2.5 5.0 3.8 2.7 4.5 6.1 2.0 1.3 2.3 5.6 2.2 2.0 4.4 1.2 3.3 6.5 2.6 0.8 2.6 8.3 2.9 2.8 3.1 3.7 1.5 1.5 2.4 5.5 1.2 1.0 0.8 2.4 0.7 3.6 0.9 1.7 2.4 0.9 1.8 0.6 1.6 1.4 1.7 1.2 0.8 1.9 0.7 0.6 0.6 1.7 0.6 1.0 0.6 0.6 0.0 0.6 0.1 0.0 0.0 2.7 1.4 2.4 1.7 1.0 2.5 1.4 1.2 1.8 0.0 1.4 0.0 0.8 86.7 1.1 1.0 46.7 0.7 16.7 1.9 0.9 0.0 0.6 4.4 0.0 3.4 1.8 3.1 30.7 0.9 2.5 5.0 0.0 2.4 1.9 0.6 0.0 0.4 0.3 1.8 0.0 1.7 2.6 3.3 1.8 1.6 1.9 3.6 0.7 ARHGEF4 "ASEF, KIAA1112, STM6" ENSG00000136002 "Rho guanine nucleotide exchange factor 4" Q9NR80 2 130836916-131047263 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.3;skin 1: 35.1" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 23.8;Cone photoreceptor cells: 35.3;Horizontal cells: 27.0;Suprabasal keratinocytes: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 4.3" "Group enriched" "Detected in many" 35 "dendritic cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "AN3-CA: 8.1;HaCaT: 17.7;hTCEpi: 36.7;REH: 8.0;SCLC-21H: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018267 Approved NA NA "HPA018267: AB_1845006" "unprognostic (2.30e-3)" "unprognostic (8.84e-2)" "unprognostic (5.32e-2)" "unprognostic (1.18e-2)" "unprognostic (4.44e-1)" "unprognostic (2.60e-2)" "unprognostic (4.69e-2)" "unprognostic (2.14e-2)" "unprognostic (8.97e-2)" "unprognostic (1.29e-1)" "unprognostic (7.85e-2)" "unprognostic (1.65e-1)" "unprognostic (1.75e-1)" "unprognostic (4.68e-2)" "prognostic favorable (7.00e-4)" "unprognostic (3.93e-3)" "unprognostic (9.71e-3)" 5.4 5.5 24.0 1.5 25.7 0.7 2.0 8.9 37.3 3.5 1.9 14.7 0.5 0.8 2.9 2.1 13.2 8.8 3.4 1.5 28.5 12.7 0.9 1.2 3.6 0.9 15.0 16.5 8.3 13.6 2.4 5.2 0.8 14.9 5.4 1.4 0.6 3.2 9.0 8.0 35.1 1.6 4.5 23.5 0.7 1.5 4.4 20.5 0.0 5.2 10.1 4.0 4.2 6.1 0.0 2.6 0.0 0.0 0.0 4.3 0.6 1.7 1.0 0.4 8.1 0.0 0.0 0.1 2.6 0.1 0.1 0.0 0.3 0.5 0.0 0.1 1.0 1.4 17.7 1.2 4.1 0.0 0.0 0.9 0.0 2.8 0.0 0.3 0.0 0.0 0.0 36.7 0.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.2 3.0 8.0 0.1 0.3 1.2 0.0 22.5 3.4 0.2 3.3 0.2 1.0 0.1 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.8 1.6 0.0 0.0 1.6 4.3 0.0 0.0 0.0 2.6 1.3 0.6 24.0 25.7 8.9 26.6 28.5 12.7 15.0 16.5 14.9 20.5 23.8 0.0 0.0 0.9 15.3 9.6 2.0 2.5 5.3 2.3 0.0 35.3 0.8 0.0 0.8 9.3 0.3 0.1 0.0 0.0 0.2 2.8 1.1 0.0 0.0 0.3 27.0 0.0 0.6 0.3 5.1 4.6 0.8 5.0 1.0 0.8 3.3 1.5 0.0 10.3 0.7 12.4 0.0 1.7 0.7 3.6 17.3 0.2 0.0 0.4 0.6 ARHGEF9 "KIAA0424, PEM-2" ENSG00000131089 "Cdc42 guanine nucleotide exchange factor 9" O43307 X 63634967-63809274 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.6" "Group enriched" "Detected in many" 6 "Bipolar cells: 169.8;Cone photoreceptor cells: 219.9;Horizontal cells: 77.9;Rod photoreceptor cells: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035419, HPA055291" Approved Supported Cytosol NA NA Cytosol "HPA035419: AB_10669859, HPA055291: AB_2682774" "unprognostic (3.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.02e-2)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.66e-1)" "unprognostic (1.98e-3)" "unprognostic (1.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.08e-3)" "unprognostic (1.67e-1)" "prognostic favorable (1.02e-5)" "unprognostic (4.56e-2)" "unprognostic (9.27e-2)" "unprognostic (3.15e-2)" "unprognostic (8.98e-2)" 5.7 9.6 22.6 4.5 42.6 3.2 6.9 19.5 38.2 6.0 8.2 7.1 1.2 10.9 6.2 4.2 7.7 5.4 6.0 22.0 24.6 22.4 6.8 4.1 4.3 4.6 12.5 28.3 10.4 4.8 11.8 8.3 4.4 17.4 8.2 8.7 9.9 4.5 7.0 3.9 7.0 8.1 8.4 8.5 4.9 6.9 2.2 9.9 2.1 6.1 0.8 5.4 7.3 3.2 5.4 3.7 1.8 3.6 11.5 8.5 2.8 4.6 7.1 11.2 7.2 5.1 7.0 0.9 8.5 7.1 7.8 6.8 0.5 5.0 9.8 6.2 5.2 8.3 0.1 5.0 10.4 7.7 13.4 5.1 8.2 3.1 0.4 2.6 4.2 3.6 8.4 4.6 3.9 12.8 7.9 5.2 10.3 1.2 16.1 7.6 6.6 8.4 2.4 7.7 4.8 8.3 12.9 23.0 9.7 4.9 4.2 0.2 3.2 3.9 7.6 4.3 5.2 5.5 4.9 2.6 5.2 5.3 24.5 3.5 5.5 4.2 7.6 6.3 7.5 3.7 1.0 2.8 1.8 8.5 3.6 5.6 3.5 4.6 4.9 3.7 5.4 5.6 5.2 1.6 11.5 2.4 2.9 4.1 2.8 22.6 42.6 19.5 37.2 24.6 22.4 12.5 28.3 17.4 9.9 8.9 10.7 17.4 5.4 5.0 169.8 34.3 2.5 9.4 7.9 10.4 219.9 4.1 11.6 5.5 1.7 8.7 16.0 0.0 7.8 1.2 6.2 4.4 13.9 7.5 8.6 77.9 20.1 11.6 3.2 4.2 14.4 5.6 13.5 1.8 13.8 28.4 6.4 14.0 14.5 16.5 311.4 0.0 18.4 1.4 3.2 5.3 3.7 20.3 19.1 4.8 ARID3A "BRIGHT, DRIL1" ENSG00000116017 "AT-rich interaction domain 3A" Q99856 19 925781-975934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 38.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 156.8;Extravillous trophoblasts: 418.2;Syncytiotrophoblasts: 433.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 64.0;CACO-2: 21.6;K-562: 27.8;THP-1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004793, HPA076330" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004793: AB_1847870, HPA076330: AB_2732309" "unprognostic (1.34e-1)" "unprognostic (2.62e-3)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (1.31e-3)" "unprognostic (5.67e-2)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (5.22e-2)" "unprognostic (2.54e-1)" "prognostic favorable (1.95e-5)" "unprognostic (4.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (3.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.30e-1)" "unprognostic (8.95e-2)" 4.0 2.3 1.7 6.2 2.3 11.5 4.4 4.8 3.8 3.6 5.0 1.6 3.3 4.2 2.9 2.9 4.1 2.7 3.2 2.1 2.2 1.5 4.4 2.6 6.1 7.8 2.8 2.0 1.6 5.5 3.4 4.1 38.3 2.1 2.3 1.8 2.6 2.8 5.6 2.0 3.3 5.0 2.6 2.4 8.3 3.4 17.8 2.5 6.6 2.1 2.1 4.6 4.0 6.9 1.5 9.2 6.4 2.9 1.9 0.5 0.8 1.1 1.5 5.3 1.3 2.2 1.7 64.0 5.0 3.2 2.7 1.8 21.6 0.1 0.4 1.2 1.7 0.6 0.4 2.1 1.1 1.2 6.6 1.5 2.1 1.9 19.4 0.9 7.4 5.5 2.4 1.7 1.7 0.4 0.4 0.9 1.7 27.8 6.2 0.7 1.7 2.8 8.4 5.1 0.8 0.3 6.5 1.6 4.1 0.3 1.1 2.5 4.9 1.6 1.3 0.9 12.3 2.3 19.9 1.5 1.8 2.4 2.5 0.5 14.6 13.0 3.8 1.1 4.3 1.2 0.8 2.4 1.6 0.5 2.1 0.5 1.5 0.3 0.4 1.5 0.9 0.5 0.2 6.4 1.9 2.9 9.2 0.3 0.8 1.7 2.3 4.8 3.8 2.2 1.5 2.8 2.0 2.1 2.5 6.0 3.2 27.9 7.8 13.2 8.8 6.5 0.0 0.0 1.2 14.0 7.9 156.8 8.3 4.8 29.9 7.8 3.2 23.3 2.8 418.2 16.2 7.5 3.5 6.7 78.2 6.4 45.1 9.8 34.1 2.0 6.6 32.5 15.1 35.1 11.2 2.3 9.8 0.0 6.0 4.5 3.3 0.0 12.8 0.6 8.5 13.4 433.4 10.9 4.3 1.8 ARID3C ENSG00000205143 "AT-rich interaction domain 3C" A6NKF2 9 34621379-34628107 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 12 "liver: 16.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "liver cancer: 2.2;ovarian cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.6;Karpas-707: 6.1;T-47d: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.66e-2)" "unprognostic (2.38e-1)" "unprognostic (2.05e-3)" "unprognostic (4.42e-3)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.76e-3)" "unprognostic (1.47e-1)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.21e-2)" "unprognostic (7.79e-2)" "unprognostic (3.28e-14)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (7.91e-2)" "unprognostic (4.26e-3)" 0.0 0.0 0.2 0.0 0.5 0.0 0.2 1.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.0 16.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.1 0.4 2.2 0.3 0.8 0.0 0.6 0.1 0.2 0.6 0.1 0.3 0.1 0.2 0.7 0.2 0.0 0.4 0.0 0.1 4.6 0.6 0.1 0.6 0.0 1.5 0.1 0.2 0.3 1.1 0.1 0.1 0.6 0.1 1.0 0.0 6.1 0.1 0.0 0.1 2.0 0.0 0.3 0.2 0.5 0.1 1.0 0.0 0.0 0.0 0.8 0.2 1.5 0.5 0.0 6.1 0.3 0.0 0.1 0.3 1.3 0.0 1.1 0.9 0.0 0.5 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARID5B "FLJ21150, MRF2" ENSG00000150347 "AT-rich interaction domain 5B" Q14865 10 61901300-62096944 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 860.1;Smooth muscle cells: 627.3;Syncytiotrophoblasts: 769.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015037 Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Cytosol" "HPA015037: AB_1845015" "unprognostic (3.31e-1)" "unprognostic (1.99e-2)" "unprognostic (2.94e-2)" "unprognostic (1.86e-1)" "unprognostic (1.17e-1)" "unprognostic (5.60e-2)" "unprognostic (1.50e-2)" "unprognostic (4.90e-2)" "unprognostic (3.90e-1)" "unprognostic (6.03e-2)" "unprognostic (1.97e-1)" "unprognostic (5.75e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (2.58e-1)" "unprognostic (1.94e-1)" "unprognostic (3.93e-2)" 43.3 5.6 7.8 13.8 9.9 4.2 22.6 3.3 11.5 27.5 14.0 9.5 4.4 6.8 29.4 10.4 14.0 15.6 27.2 16.0 5.9 5.1 14.6 5.7 14.6 14.4 11.8 6.5 18.6 4.3 14.7 11.4 22.4 9.4 16.6 8.2 6.9 14.5 7.3 88.6 15.0 12.1 29.4 10.4 12.7 9.4 7.7 10.5 8.6 7.5 11.7 18.0 22.5 17.1 21.2 1.0 4.3 3.6 5.7 14.7 2.6 0.8 0.3 2.3 5.9 5.2 14.0 0.4 16.9 45.7 12.1 9.5 20.5 0.9 1.4 4.1 16.2 1.7 5.6 8.1 2.5 14.6 5.3 2.4 0.8 4.1 5.1 9.7 0.2 10.1 17.6 1.3 7.1 8.1 10.4 1.4 2.9 0.7 2.3 3.9 2.9 5.5 0.4 0.4 3.9 5.4 6.7 3.9 0.4 7.9 9.2 1.3 1.7 7.5 4.1 4.9 5.5 3.5 0.2 1.3 6.7 9.1 10.1 4.2 0.1 0.0 4.4 5.8 0.3 2.1 4.3 0.6 0.4 7.3 1.4 0.9 19.0 10.5 6.3 1.0 21.2 6.9 4.5 1.2 5.7 3.6 0.5 14.7 2.6 7.8 9.9 3.3 11.5 5.9 5.1 11.8 6.5 9.4 10.5 122.1 57.7 77.2 286.1 860.1 43.7 59.7 12.7 50.9 120.6 48.8 0.0 138.5 84.6 43.9 23.9 62.4 4.7 23.3 12.8 104.6 292.5 224.3 23.2 5.1 46.6 69.9 34.9 106.8 33.2 10.0 140.4 39.6 131.6 60.5 13.2 19.3 30.6 20.9 57.0 145.5 2.8 129.4 627.3 5.7 0.5 417.5 769.7 77.6 30.2 122.9 ARL11 "ARLTS1, FLJ33930" ENSG00000152213 "ADP ribosylation factor like GTPase 11" Q969Q4 13 49628299-49633872 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.5;lymphoid tissue: 18.3" "Cell type enhanced" "Detected in many" 11 "B-cells: 16.7;Hofbauer cells: 27.4;Kupffer cells: 33.0;Macrophages: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 7.3;HMC-1: 10.2;NB-4: 10.2;THP-1: 13.4;U-698: 6.1;U-937: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040855, HPA040887" Uncertain NA NA "HPA040855: AB_10793864, HPA040887: AB_10796229" "unprognostic (1.19e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (2.82e-1)" "unprognostic (7.86e-2)" "unprognostic (1.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.72e-2)" "unprognostic (2.55e-1)" "unprognostic (2.27e-4)" "unprognostic (1.72e-2)" "unprognostic (5.60e-2)" "unprognostic (1.16e-1)" "unprognostic (3.14e-2)" 4.8 2.1 1.7 14.9 4.1 5.4 1.5 0.6 2.5 2.1 1.6 2.1 0.0 2.0 1.3 1.4 3.1 1.3 2.0 1.1 1.4 1.1 1.2 1.1 6.1 13.8 2.9 0.2 0.7 3.3 0.4 1.5 3.8 2.5 1.1 2.6 1.5 2.2 0.4 0.7 1.2 4.1 1.2 3.3 18.3 1.1 1.0 2.4 6.4 1.2 0.0 9.6 2.8 2.5 5.7 4.7 21.5 9.7 0.4 0.5 2.3 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.6 0.0 4.7 10.2 0.1 0.1 0.0 0.0 0.0 0.4 4.8 0.2 0.1 0.0 1.2 4.4 10.2 0.1 0.0 0.0 4.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 3.3 13.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 6.1 0.0 5.9 0.0 10.6 8.7 8.8 0.1 9.7 0.1 4.4 0.2 0.2 4.5 5.7 0.5 0.2 21.5 0.4 7.0 4.7 0.1 2.3 1.7 4.1 0.6 2.5 1.4 1.1 2.9 0.2 2.5 2.4 0.0 1.4 16.7 0.2 0.2 0.5 0.4 2.5 4.0 0.0 0.0 0.0 4.1 0.0 0.0 1.0 0.7 2.6 0.0 0.0 4.2 0.3 0.1 7.0 0.4 27.4 0.0 1.2 1.8 33.0 0.4 0.3 18.9 0.0 5.4 3.0 0.3 0.1 10.7 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 1.3 0.9 2.4 0.3 ARL13A ARL13 ENSG00000174225 "ADP ribosylation factor like GTPase 13A" Q5H913 X 100969708-100990829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.6" "Group enriched" "Detected in some" 23 "Early spermatids: 58.2;Late spermatids: 44.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.7" "HPA037377, HPA037378" Uncertain Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA037377: AB_2675442, HPA037378: AB_10670932" "unprognostic (4.40e-2)" "unprognostic (1.05e-1)" "unprognostic (1.02e-1)" "unprognostic (1.08e-2)" "unprognostic (1.93e-1)" "unprognostic (9.06e-3)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (1.51e-2)" "unprognostic (4.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.46e-1)" "unprognostic (9.37e-4)" "unprognostic (2.14e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.6 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 1.2 0.4 0.1 0.1 0.2 0.3 16.6 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.8 0.2 0.0 0.4 0.1 0.5 0.0 1.1 1.9 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.0 0.0 6.7 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 1.2 1.1 0.7 0.0 1.7 0.1 0.0 0.0 0.0 0.4 0.4 0.3 0.9 0.3 0.0 0.1 0.7 0.0 0.2 0.0 0.4 1.6 0.0 0.1 0.7 0.0 0.4 0.0 0.1 1.2 0.3 0.1 0.0 0.3 2.0 0.6 0.3 0.0 0.0 0.3 0.2 0.2 1.3 0.3 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.5 0.0 0.0 0.0 0.0 0.0 ARL14 "ARF7, FLJ22595" ENSG00000179674 "ADP ribosylation factor like GTPase 14" Q8N4G2 3 160677159-160678452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 44.5;intestine: 49.1;stomach 1: 24.5" "Cell type enhanced" "Detected in some" 21 "Enterocytes: 271.2;Intestinal endocrine cells: 85.5;Mucus-secreting cells: 83.6;Paneth cells: 63.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "memory B-cell: 5.1" "Lineage enriched" "Detected in single" 52 "B-cells: 5.1" "Group enriched" "Detected in some" 4 "A-431: 6.5;CAPAN-2: 25.0;HaCaT: 6.2;OE19: 17.1;RT4: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.65e-1)" "unprognostic (7.26e-3)" "unprognostic (2.64e-2)" "unprognostic (3.70e-3)" "unprognostic (6.36e-2)" "unprognostic (2.47e-3)" "prognostic unfavorable (2.64e-5)" "unprognostic (2.30e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (4.74e-2)" "unprognostic (4.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.2 6.9 0.2 0.0 0.2 0.2 0.2 0.5 26.3 0.3 0.2 16.4 0.2 0.2 0.8 0.2 44.5 0.2 0.2 0.1 0.3 1.5 0.2 0.2 0.2 0.2 0.2 6.7 0.0 0.2 0.2 0.2 1.7 11.8 0.2 0.2 0.2 0.2 0.2 49.1 0.7 0.2 0.2 24.5 0.4 0.2 0.5 0.2 0.6 1.1 6.5 1.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 25.0 0.0 0.5 0.0 3.0 6.2 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 17.1 1.4 0.0 0.0 0.2 2.0 12.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 1.4 0.0 3.1 1.6 0.0 0.0 20.4 1.4 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 271.2 0.0 35.2 0.1 0.0 0.9 9.2 0.0 0.0 0.0 85.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.6 0.0 30.7 63.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 28.8 23.0 ARL14EPL ENSG00000268223 "ADP ribosylation factor like GTPase 14 effector protein like" P0DKL9 5 116032324-116060118 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "placenta: 5.9" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Early spermatids: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.9;MAIT T-cell: 2.9;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 8 "monocytes: 1.9;T-cells: 2.9" "Cell line enriched" "Detected in some" 30 "HDLM-2: 60.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.41e-1)" "unprognostic (3.84e-1)" "unprognostic (2.51e-2)" "unprognostic (6.47e-3)" "unprognostic (1.60e-2)" "unprognostic (3.79e-2)" "unprognostic (4.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" 0.8 0.2 0.1 1.3 1.0 2.5 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.5 0.0 0.1 0.2 0.6 0.1 1.4 1.6 1.1 0.0 0.6 0.0 0.0 1.1 5.9 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.5 0.0 0.5 0.8 0.1 1.8 0.8 0.0 0.1 0.0 1.5 2.3 0.0 0.0 0.0 0.3 1.9 0.0 2.9 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.9 2.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.2 1.1 0.0 1.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ARL4A ARL4 ENSG00000122644 "ADP ribosylation factor like GTPase 4A" P40617 7 12686856-12690934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Group enriched" "Detected in all" 6 "Early spermatids: 1213.7;Late spermatids: 2876.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 61.8;K-562: 73.5" "Low region specificity" "Detected in all" HPA064513 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA064513: AB_2685276" "unprognostic (8.29e-2)" "unprognostic (1.34e-1)" "unprognostic (3.94e-1)" "unprognostic (4.97e-2)" "unprognostic (3.88e-2)" "unprognostic (7.43e-2)" "unprognostic (1.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-2)" "unprognostic (7.27e-3)" "unprognostic (1.74e-1)" "unprognostic (9.29e-2)" "unprognostic (9.42e-3)" "unprognostic (9.49e-3)" 22.6 3.6 12.3 6.7 6.7 30.8 21.5 3.0 15.8 16.9 19.4 3.2 7.4 11.3 13.6 9.9 23.5 11.0 7.5 7.0 6.0 4.6 5.2 6.6 8.6 9.5 10.3 11.0 5.2 3.5 1.8 5.6 19.2 8.5 12.0 13.7 4.0 39.0 6.8 4.2 34.9 44.6 12.8 6.5 9.5 10.3 71.2 6.7 3.7 8.8 9.2 6.5 10.5 25.0 22.8 7.4 3.3 15.4 6.5 17.6 7.3 10.1 10.9 29.0 61.8 4.7 7.8 0.0 4.1 3.8 6.8 4.1 9.6 7.7 0.0 1.8 5.8 17.5 2.9 6.4 5.3 6.9 2.2 4.8 2.1 14.2 8.9 9.7 8.9 3.8 3.5 21.1 4.0 17.9 4.3 16.3 4.1 73.5 10.0 6.9 4.4 0.4 12.6 10.5 29.7 12.5 0.0 10.1 4.7 9.0 4.9 5.3 5.0 6.9 7.3 1.4 7.8 3.6 7.3 5.6 2.7 9.7 10.3 16.7 4.6 6.0 2.3 7.1 3.7 10.9 3.3 7.8 0.3 6.3 13.0 17.6 21.4 15.0 9.7 7.4 22.8 7.4 6.1 1.1 6.5 15.4 6.6 8.9 7.3 12.3 6.7 3.0 15.8 6.0 4.6 10.3 11.0 8.5 6.7 20.8 20.7 36.3 179.9 301.7 21.4 12.9 40.8 100.4 60.3 19.2 80.5 129.5 23.2 34.7 1213.7 160.4 353.7 23.3 25.7 18.5 63.5 47.1 78.5 18.7 55.4 3.2 60.0 103.2 124.4 2876.1 63.9 134.7 114.7 54.1 63.0 9.4 39.9 112.2 25.1 13.0 114.7 12.9 42.2 236.6 53.4 205.1 371.3 38.3 56.5 52.6 ARL4C "ARL7, LAK" ENSG00000188042 "ADP ribosylation factor like GTPase 4C" P56559 2 234493041-234497053 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 168.9;Kupffer cells: 128.2;T-cells: 193.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 38.6;RPTEC TERT1: 72.9;U-2197: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028927 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA028927: AB_10602387" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-3)" "prognostic unfavorable (2.90e-7)" "unprognostic (8.01e-3)" "unprognostic (3.35e-2)" "unprognostic (9.26e-2)" "unprognostic (2.68e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-2)" "unprognostic (3.17e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.69e-8)" "unprognostic (8.57e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.99e-5)" 9.3 6.8 11.1 17.7 9.6 30.3 12.8 19.2 21.2 6.4 6.2 4.9 3.1 3.9 3.6 9.4 13.9 7.6 19.2 3.6 9.1 16.5 8.5 7.9 9.9 28.9 9.4 11.8 2.6 3.6 0.8 5.4 16.8 23.9 6.7 7.4 5.9 14.2 3.6 1.7 15.1 8.1 3.6 5.3 28.0 7.9 1.9 1.8 44.7 2.5 4.4 20.1 14.0 10.8 5.9 17.8 18.7 0.5 18.2 29.7 8.7 7.2 22.5 2.9 0.3 2.6 0.8 7.5 0.7 3.4 0.9 1.6 10.4 14.3 0.0 1.9 1.9 27.4 5.5 2.9 15.6 1.0 6.7 1.0 0.0 0.1 0.1 2.7 0.0 0.6 1.6 10.4 8.8 5.4 38.6 1.5 19.2 0.0 24.2 4.1 1.0 21.0 0.0 3.0 5.4 5.1 0.0 13.0 4.1 72.9 8.1 10.6 1.9 0.2 1.7 1.1 4.8 0.2 0.4 3.3 14.6 5.6 39.9 14.0 12.1 4.4 0.3 25.1 0.0 7.6 18.7 0.4 8.4 29.7 0.5 29.2 5.9 20.7 23.5 3.2 5.7 18.7 20.9 0.7 18.2 0.2 17.8 25.8 8.7 11.1 9.6 19.2 21.2 9.1 16.5 9.4 11.8 23.9 1.8 68.5 22.3 38.9 97.5 110.8 168.9 8.1 50.9 6.7 44.3 14.0 7.9 25.6 0.0 15.7 7.5 16.9 0.2 0.0 4.9 3.3 28.8 51.3 25.6 3.0 29.0 101.7 1.7 9.8 128.2 4.2 0.3 83.9 40.5 43.3 0.0 30.9 11.5 0.0 0.0 1.0 10.8 0.0 16.0 0.4 0.8 37.5 12.2 193.9 0.4 46.5 ARL5C ARL12 ENSG00000141748 "ADP ribosylation factor like GTPase 5C" A6NH57 17 39156894-39167484 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 21.1" "Cell type enriched" "Detected in single" 4 "Bipolar cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 2.7" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.7" "Cell line enhanced" "Detected in some" "HMC-1: 1.4;JURKAT: 1.5;MOLT-4: 3.6;SuSa: 1.0" "Low region specificity" "Detected in many" HPA069849 Uncertain NA NA "HPA069849: AB_2686213" "unprognostic (2.57e-1)" "unprognostic (2.34e-1)" "unprognostic (1.60e-7)" "unprognostic (7.60e-2)" "unprognostic (1.11e-2)" 0.2 0.2 0.2 0.2 0.6 0.0 0.6 0.2 0.5 1.3 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.6 0.2 0.1 0.4 0.1 1.5 0.2 0.0 0.1 3.0 0.0 0.1 0.7 0.4 0.1 0.2 0.8 0.1 1.1 0.3 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 21.1 0.1 0.0 1.3 1.2 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.6 0.2 0.5 0.6 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ARL6IP6 MGC33864 ENSG00000177917 "ADP ribosylation factor like GTPase 6 interacting protein 6" Q8N6S5 2 152717893-152761253 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 127.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 50.7;eosinophil: 45.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 50.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014743 Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA014743: AB_1845030" "unprognostic (4.41e-1)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "unprognostic (9.86e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (5.43e-2)" "unprognostic (2.07e-2)" "unprognostic (2.00e-3)" "unprognostic (4.95e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.14e-1)" "unprognostic (2.67e-1)" "unprognostic (4.57e-1)" "unprognostic (7.39e-2)" 6.1 5.1 8.4 4.2 10.1 14.5 9.4 6.6 11.4 4.7 5.7 10.1 7.9 6.5 5.6 2.5 7.8 5.1 5.6 3.2 11.4 4.9 3.3 2.3 7.2 7.2 15.9 7.4 6.9 3.3 2.6 8.3 10.2 12.9 4.6 4.1 3.4 4.9 4.8 9.7 8.2 6.1 4.7 12.4 8.7 6.0 7.3 13.5 2.5 4.1 4.6 5.4 6.3 18.9 5.7 7.4 50.7 3.5 2.6 5.6 3.6 8.3 5.1 12.5 3.5 3.1 3.8 19.4 10.2 4.1 8.6 10.8 13.5 12.2 14.7 10.3 4.3 4.1 9.6 6.6 4.5 8.9 23.0 14.0 12.0 5.1 12.0 4.2 9.9 11.3 2.8 5.3 9.3 7.5 3.3 6.4 11.0 13.3 9.5 6.6 6.0 10.2 10.7 12.1 2.6 11.6 11.8 12.4 11.8 3.6 6.2 11.0 11.8 9.3 0.9 8.1 4.5 4.2 7.5 8.8 13.7 9.3 9.5 8.9 9.1 9.1 11.9 6.6 8.5 11.2 50.7 2.8 45.4 4.1 3.0 4.2 5.7 4.2 4.1 3.2 4.9 4.3 3.7 7.5 2.6 3.5 7.4 5.6 3.6 8.4 10.1 6.6 11.4 11.4 4.9 15.9 7.4 12.9 13.5 14.9 10.6 31.2 40.7 94.6 5.6 3.9 20.4 17.4 15.9 10.4 3.9 127.9 14.9 23.8 9.4 27.2 12.3 0.0 16.4 114.2 39.0 25.6 26.5 4.7 35.6 7.9 13.3 21.5 27.9 14.2 18.1 34.9 43.9 56.9 21.6 17.2 18.4 17.5 15.9 7.7 14.7 32.3 26.0 21.3 24.3 93.2 90.6 45.0 22.6 48.9 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56525481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;testis: 12.6" "Group enriched" "Detected in some" 11 "Early spermatids: 81.2;Late spermatids: 192.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;REH: 8.7;SCLC-21H: 9.2" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA072942: AB_2686561" "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 1.3 1.1 4.4 0.8 4.9 3.4 2.0 1.5 7.1 1.3 1.3 0.6 2.4 1.0 2.0 1.1 1.1 1.2 2.4 0.8 3.9 3.2 0.5 0.5 0.6 1.0 1.3 2.9 3.0 0.4 0.4 1.6 0.3 8.7 2.2 1.0 1.9 0.9 3.8 0.4 4.1 1.0 3.7 2.5 0.8 1.0 12.6 0.6 0.1 1.1 1.2 0.7 1.5 2.5 2.1 2.2 1.6 0.4 1.4 1.4 0.1 0.0 0.5 0.6 0.5 1.2 2.9 0.1 0.9 0.5 2.1 2.1 0.5 0.7 0.7 0.0 1.5 0.1 0.2 0.4 0.2 1.2 0.1 0.1 0.3 0.0 0.1 2.8 0.3 0.7 4.4 0.7 1.9 0.4 0.4 2.1 0.2 0.2 0.9 2.0 0.0 0.3 0.1 2.2 0.1 1.3 8.7 0.0 0.1 0.1 0.3 9.2 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.4 0.3 0.4 0.0 0.1 0.4 0.4 0.4 0.1 0.0 0.3 0.8 0.4 0.4 0.7 0.4 0.4 1.0 1.2 1.0 0.3 2.1 1.4 0.6 1.6 1.4 0.4 2.2 1.0 0.1 4.4 4.9 1.5 7.1 3.9 3.2 1.3 2.9 8.7 0.6 0.0 1.4 0.0 0.8 5.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 81.2 0.2 0.0 0.0 0.2 0.1 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.3 192.4 1.4 0.0 5.0 0.0 0.3 1.0 0.6 0.0 1.1 0.3 0.0 0.0 0.2 12.2 0.9 1.4 0.0 0.0 0.4 0.3 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Group enriched" "Detected in some" 65 "Early spermatids: 374.1;Late spermatids: 785.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.2 3.8 7.3 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 1.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.8 0.0 0.0 9.7 2.3 0.1 1.3 3.7 0.7 2.8 0.1 4.5 1.1 0.4 6.6 0.8 0.5 0.0 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.2 0.0 0.0 0.5 1.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.2 0.3 4.0 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 0.0 0.0 0.0 1.7 0.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 374.1 0.6 0.0 0.0 0.0 0.0 0.4 0.5 0.0 2.4 0.0 0.0 0.0 0.0 1.6 785.6 7.8 0.0 0.0 0.0 0.1 0.8 0.0 0.0 3.9 0.1 0.1 0.0 0.5 8.9 5.4 0.1 0.0 0.0 0.0 0.3 ARMC2 "bA787I22.1, DKFZp434P0714" ENSG00000118690 "Armadillo repeat containing 2" Q8NEN0 6 108848416-108974472 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 88.3;Early spermatids: 89.1;Late spermatids: 112.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA025809, HPA053696" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA025809: AB_1845032, HPA053696: AB_2682233" "unprognostic (4.42e-2)" "unprognostic (9.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (4.00e-4)" "unprognostic (1.13e-2)" "unprognostic (3.74e-2)" "unprognostic (5.71e-2)" "unprognostic (5.19e-5)" "unprognostic (7.55e-2)" "unprognostic (1.55e-3)" "unprognostic (9.38e-2)" "unprognostic (6.44e-2)" "unprognostic (4.65e-2)" "unprognostic (2.28e-1)" 6.0 5.2 13.3 5.6 19.6 7.8 7.3 9.6 14.7 7.4 4.2 7.9 2.1 2.0 8.2 11.9 3.7 21.5 5.4 9.4 12.2 7.0 4.6 2.8 8.8 4.0 4.0 11.8 6.1 3.3 9.9 20.0 7.0 16.7 4.4 4.9 5.7 3.8 5.2 3.7 5.3 3.5 4.4 6.3 5.8 4.9 31.8 7.1 2.4 11.0 2.8 4.3 4.0 5.0 2.7 4.6 9.5 4.7 4.8 7.0 1.6 3.4 2.1 10.3 6.5 5.1 6.4 2.3 2.1 2.9 5.4 7.2 3.1 3.1 5.4 2.7 3.4 8.3 3.0 5.6 4.2 9.4 1.5 4.8 5.1 4.7 3.2 2.8 7.8 2.3 7.3 5.9 6.2 1.8 7.2 5.0 16.6 2.1 8.4 5.5 2.6 6.7 7.1 3.2 3.3 2.6 7.7 8.5 4.4 4.9 4.1 14.4 5.3 7.3 1.9 5.1 6.0 3.7 4.0 2.5 4.6 2.4 3.8 2.8 3.9 5.2 4.6 7.8 5.5 5.7 4.3 3.5 0.9 3.4 4.7 3.2 1.4 2.7 3.7 2.8 2.7 1.6 3.9 9.5 4.8 3.7 4.6 7.0 1.6 13.3 19.6 9.6 14.7 12.2 7.0 4.0 11.8 16.7 7.1 8.9 3.0 0.0 1.1 0.9 1.5 4.3 2.5 88.3 18.2 0.0 0.0 1.3 0.0 0.8 89.1 1.2 0.0 0.0 0.8 1.7 1.3 0.8 0.0 0.2 3.2 1.6 1.7 0.6 3.7 112.4 6.4 1.3 5.0 0.0 0.3 1.8 0.7 0.0 9.6 1.2 5.2 0.0 2.3 27.6 5.5 1.3 0.5 2.9 0.5 0.7 ARMC3 "CT81, FLJ32827" ENSG00000165309 "Armadillo repeat containing 3" Q5W041 10 22928024-23038523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 40.2;fallopian tube: 38.6;testis: 25.7" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 236.9;Early spermatids: 288.3;Late spermatids: 68.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.0" "Region enhanced" "Detected in many" "pons and medulla: 40.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "CAPAN-2: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037823, HPA037824" Enhanced NA NA "HPA037823: AB_2675689, HPA037824: AB_10671634" "unprognostic (8.11e-3)" "unprognostic (5.78e-2)" "unprognostic (6.63e-2)" "unprognostic (7.81e-3)" "unprognostic (1.01e-1)" "unprognostic (2.28e-1)" "unprognostic (5.23e-1)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (7.37e-3)" "unprognostic (4.02e-1)" "unprognostic (3.61e-2)" "unprognostic (2.97e-1)" "unprognostic (6.21e-3)" "unprognostic (9.53e-4)" "unprognostic (1.40e-2)" 0.3 0.4 3.5 0.3 10.1 0.3 0.4 0.0 1.0 1.9 0.3 11.3 0.0 0.3 1.7 9.0 0.5 38.6 0.3 0.4 4.7 4.1 0.7 0.3 4.1 0.3 1.9 2.2 4.5 0.6 0.3 4.1 0.3 40.2 0.3 0.3 0.0 0.3 0.5 0.3 0.3 0.3 0.4 1.0 0.3 0.3 25.7 6.3 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.9 2.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.3 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 3.5 10.1 0.0 1.0 4.7 4.1 1.9 2.2 40.2 6.3 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 236.9 31.8 0.0 5.9 0.0 0.0 0.4 288.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.0 0.8 0.0 0.0 27.1 1.9 0.0 0.0 0.0 0.0 0.0 ARMC4 "CILD23, DKFZP434P1735, FLJ10376, FLJ10817" ENSG00000169126 "Armadillo repeat containing 4" Q5T2S8 10 27812164-27999048 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.6;pituitary gland: 18.5;testis: 22.0" "Group enriched" "Detected in some" 9 "Ciliated cells: 172.6;Early spermatids: 206.6;Late spermatids: 62.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 6.5;BJ: 6.5;fHDF/TERT166: 7.7;HEK 293: 5.6;NTERA-2: 5.8;RH-30: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA037829 Enhanced NA NA "HPA037829: AB_10670960" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (3.48e-2)" "unprognostic (4.43e-3)" "unprognostic (1.64e-1)" "unprognostic (4.28e-2)" "unprognostic (6.23e-2)" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-3)" "unprognostic (7.72e-2)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.15e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" 0.3 0.9 0.9 0.8 2.2 0.3 0.3 0.1 1.0 2.1 1.2 3.4 0.6 0.1 1.1 3.0 0.4 19.6 1.0 0.4 1.6 1.6 0.3 0.4 2.3 0.2 0.3 1.3 4.3 0.1 0.1 18.5 0.2 5.5 4.9 0.3 0.8 0.1 3.1 0.1 0.1 0.2 2.7 0.9 0.2 0.5 22.0 0.8 0.6 0.5 0.0 0.1 1.0 0.4 0.0 0.3 0.0 0.0 0.0 0.8 0.1 0.1 0.0 6.5 0.0 0.0 0.0 0.3 6.5 2.5 3.6 3.0 0.0 0.3 0.0 0.0 7.7 0.9 0.0 1.0 0.0 4.4 0.0 5.6 0.0 3.2 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 1.3 1.1 1.4 0.0 0.0 0.9 0.0 2.6 0.2 5.8 0.0 1.9 0.1 16.5 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.2 0.6 0.3 0.1 0.0 2.3 0.1 3.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 2.2 0.1 1.0 1.6 1.6 0.3 1.3 5.5 0.8 3.0 4.6 0.0 0.0 0.0 0.0 2.8 0.0 172.6 15.9 0.0 0.0 0.0 0.0 0.0 206.6 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.4 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 9.8 1.1 0.1 0.0 0.0 0.0 0.0 ARMC6 MGC19595 ENSG00000105676 "Armadillo repeat containing 6" Q6NXE6 19 19033575-19060311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 54.4" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041420, HPA041681" Supported Enhanced Cytosol NA NA Cytosol "HPA041420: AB_2677469, HPA041681: AB_10793928" "unprognostic (2.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (3.55e-2)" "unprognostic (2.43e-1)" "unprognostic (8.98e-2)" "unprognostic (2.36e-1)" "unprognostic (7.04e-3)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-2)" "unprognostic (1.70e-1)" "unprognostic (3.73e-2)" "unprognostic (1.40e-1)" 9.8 10.1 10.3 9.6 11.3 12.9 10.6 13.0 20.1 8.5 10.2 10.2 5.7 8.9 9.5 10.0 10.9 9.2 9.5 11.4 10.7 12.0 10.4 54.4 8.0 12.6 10.1 11.4 10.1 6.7 9.2 11.2 10.3 12.6 10.9 8.2 11.0 12.2 8.1 14.8 9.4 7.9 8.4 8.7 11.1 8.3 17.1 7.2 21.4 16.1 12.3 10.7 8.4 7.5 10.3 19.8 6.3 13.9 20.7 16.4 11.8 21.5 14.7 10.8 13.3 5.2 9.0 14.0 14.0 8.2 23.0 17.1 20.6 19.6 32.9 22.8 11.7 8.4 11.0 25.8 16.6 12.7 6.9 36.3 16.5 13.9 16.5 11.6 29.6 19.3 11.3 15.9 15.6 11.0 5.1 14.5 19.6 28.8 12.7 12.5 26.4 31.1 23.8 25.2 24.6 30.4 25.9 9.8 23.5 11.2 14.6 25.0 10.8 11.2 14.4 11.4 7.7 12.3 18.5 9.4 11.8 10.3 16.7 28.6 9.8 17.3 31.6 9.8 40.0 15.3 6.3 13.3 3.5 16.4 13.9 12.3 10.2 9.2 14.2 19.8 10.3 12.0 13.5 2.8 20.7 10.8 12.7 15.9 11.8 10.3 11.3 13.0 20.1 10.7 12.0 10.1 11.4 12.6 7.2 0.0 5.1 8.2 6.4 6.0 13.4 5.3 10.2 2.7 6.8 12.2 11.8 18.4 6.6 16.1 19.0 6.7 8.4 0.0 9.1 16.5 6.6 9.4 1.1 51.6 18.2 4.8 14.5 8.6 16.1 32.0 9.5 8.6 5.0 18.0 9.8 15.6 9.2 12.7 7.8 10.2 16.2 12.9 5.0 15.6 30.0 8.8 10.9 7.9 14.7 4.2 ARMC9 "ARM, FLJ12584, KIAA1868, KU-MEL-1" ENSG00000135931 "Armadillo repeat containing 9" Q7Z3E5 2 231198546-231374837 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 37.1" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 292.6;monocytes: 202.8;Rod photoreceptor cells: 211.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 6.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 70.3;SK-MEL-30: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019041, HPA026671" Approved NA NA "HPA019041: AB_1845035, HPA026671: AB_1845036" "unprognostic (2.90e-1)" "unprognostic (2.86e-1)" "unprognostic (5.35e-2)" "unprognostic (6.26e-2)" "unprognostic (1.99e-2)" "unprognostic (5.57e-2)" "unprognostic (7.20e-4)" "unprognostic (1.58e-2)" "unprognostic (4.85e-2)" "unprognostic (7.17e-3)" "unprognostic (4.14e-1)" "unprognostic (9.15e-2)" "unprognostic (7.43e-2)" "unprognostic (1.30e-2)" "unprognostic (4.19e-2)" "unprognostic (5.57e-2)" "prognostic unfavorable (7.66e-5)" 2.5 15.4 8.4 5.9 12.2 1.6 3.6 5.8 11.8 5.6 13.3 3.6 4.6 2.0 27.3 6.5 6.4 9.5 8.2 2.9 5.1 6.7 5.9 1.6 7.5 1.7 3.8 6.5 11.5 5.9 14.9 17.0 5.9 9.1 6.2 5.7 37.1 3.5 7.6 1.6 2.5 6.8 23.9 2.4 1.5 10.7 11.0 2.5 2.3 8.3 1.1 2.2 8.9 4.0 1.4 0.7 1.7 0.3 6.0 0.8 0.6 5.2 3.0 5.4 4.0 4.3 6.4 2.3 5.9 70.3 7.4 9.8 0.9 2.6 0.6 2.8 18.5 12.1 3.2 6.3 6.2 6.5 0.4 3.9 0.5 3.7 2.9 10.8 1.3 1.4 16.9 2.4 9.8 3.8 19.2 5.5 3.1 1.1 0.1 11.7 7.5 1.5 1.7 11.3 1.9 3.2 2.1 4.7 0.0 8.2 1.7 4.1 8.4 2.3 6.5 57.1 4.8 2.5 1.3 5.7 4.9 2.8 2.9 2.8 6.8 1.7 0.3 8.9 0.2 4.7 1.6 0.3 0.4 0.4 0.2 0.2 1.4 0.5 0.8 0.6 0.9 0.5 0.8 1.7 6.0 0.2 0.7 0.1 0.6 8.4 12.2 5.8 11.8 5.1 6.7 3.8 6.5 9.1 2.5 3.0 32.6 1.4 5.0 1.5 15.3 2.6 5.1 24.1 7.9 3.5 292.6 4.4 1.7 6.8 54.3 2.7 1.8 0.0 15.0 2.7 4.3 2.4 3.5 0.8 8.7 1.6 7.5 3.1 0.0 18.5 13.0 3.9 18.6 202.8 6.2 11.6 9.8 0.0 20.1 3.8 211.5 6.5 4.1 42.0 17.2 0.6 1.8 2.5 8.0 2.0 ARMCX2 "ALEX2, GASP9, KIAA0512" ENSG00000184867 "Armadillo repeat containing, X-linked 2" Q7L311 X 101655281-101659891 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 92.7" "Cell type enhanced" "Detected in many" 7 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 48.1;NTERA-2: 34.7;RH-30: 26.6;SuSa: 27.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005761 Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA005761: AB_10600782" "unprognostic (1.33e-1)" "unprognostic (2.26e-2)" "unprognostic (4.25e-2)" "unprognostic (1.48e-1)" "unprognostic (9.59e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (3.41e-2)" "prognostic favorable (3.45e-5)" "unprognostic (9.06e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.12e-1)" "unprognostic (6.73e-2)" "unprognostic (1.25e-1)" 7.7 21.5 12.5 6.7 19.9 1.0 14.2 17.6 17.5 17.1 11.4 8.2 38.8 3.7 18.4 92.7 6.2 16.7 12.5 18.8 13.2 17.1 13.3 2.6 8.3 4.9 11.8 13.3 28.8 9.8 34.1 38.9 15.4 12.4 17.6 5.3 9.7 23.6 41.8 3.8 3.2 6.2 19.3 9.0 10.9 8.3 6.3 10.7 1.4 35.1 3.6 4.3 13.9 18.9 7.6 1.6 0.0 1.4 4.3 4.4 1.9 0.0 0.0 14.9 0.1 13.3 12.1 0.1 16.3 20.5 0.4 0.4 0.0 6.3 0.0 0.0 21.4 0.0 0.4 0.0 0.3 0.1 0.0 0.5 0.0 17.5 0.0 14.1 0.1 0.0 19.1 5.2 12.8 0.1 20.2 17.3 0.0 0.0 0.1 48.1 0.0 0.0 0.2 34.7 0.9 0.1 4.0 26.6 0.0 0.8 0.0 6.0 11.1 0.0 0.0 0.4 27.9 7.6 0.0 3.8 18.4 19.6 11.5 0.1 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.7 0.0 1.6 1.4 0.7 5.1 1.5 1.5 1.1 7.6 4.2 4.4 0.0 4.3 0.9 1.6 0.9 1.9 12.5 19.9 17.6 17.5 13.2 17.1 11.8 13.3 12.4 10.7 14.9 5.4 4.4 13.8 3.8 11.2 22.2 7.6 2.7 15.9 31.4 7.9 1.0 3.3 8.0 0.1 13.0 0.0 0.0 1.8 0.4 20.2 13.8 2.3 0.4 3.6 1.6 8.7 16.0 2.1 0.4 22.5 4.0 5.0 11.8 2.2 7.0 3.1 0.0 23.0 4.2 9.7 58.2 26.4 1.4 1.1 2.6 4.2 2.5 1.2 6.2 ARMCX4 "CXorf35, GASP4, MGC40053" ENSG00000196440 "Armadillo repeat containing, X-linked 4" X 101418287-101533459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 10.8" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 24.7;Collecting duct cells: 26.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 9.0;hTEC/SVTERT24-B: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000429, HPA051930" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000429: AB_1078210, HPA051930: AB_2681665" "unprognostic (1.92e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.10e-2)" "unprognostic (6.91e-3)" "unprognostic (2.81e-3)" "unprognostic (7.28e-2)" "unprognostic (3.67e-4)" "unprognostic (2.33e-2)" "unprognostic (4.29e-1)" "prognostic favorable (8.20e-5)" "unprognostic (1.94e-2)" "unprognostic (1.40e-2)" "unprognostic (6.94e-3)" "unprognostic (1.69e-1)" "unprognostic (1.88e-1)" "unprognostic (4.92e-2)" 1.5 4.6 1.9 0.8 2.7 0.3 2.9 3.2 5.7 2.4 1.7 0.6 4.0 2.8 0.7 2.8 1.1 1.2 2.0 2.9 1.2 0.5 1.5 0.5 1.9 8.5 1.4 10.8 4.3 1.6 4.1 1.6 1.2 5.7 1.6 2.1 1.5 2.8 1.4 1.3 1.3 0.4 2.4 0.5 2.1 1.4 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.3 0.6 8.2 0.0 4.0 4.2 0.8 5.6 4.4 4.6 9.0 1.9 0.8 0.0 2.2 8.3 0.1 1.0 0.0 0.1 7.6 0.0 0.9 0.6 2.3 0.0 2.3 0.0 3.1 2.6 0.4 10.0 0.0 0.0 8.0 0.0 0.0 0.7 2.0 0.0 0.3 0.3 6.0 0.8 0.0 0.4 6.8 0.0 1.2 1.4 5.6 5.1 0.8 0.0 3.0 1.4 0.6 1.2 3.0 2.1 1.3 6.4 0.0 0.0 0.0 0.0 3.9 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 3.0 5.0 0.5 6.3 2.2 24.7 8.7 0.0 14.7 11.4 26.2 7.9 1.4 14.9 2.2 0.2 7.7 2.6 0.0 2.0 0.6 7.0 8.5 3.5 2.1 2.0 22.3 2.9 4.3 4.6 0.4 9.8 2.0 16.9 2.8 2.7 10.8 2.1 3.5 11.7 4.4 7.4 0.0 11.4 1.0 1.2 3.0 1.3 1.8 3.6 3.9 ARMS2 "ARMD8, LOC387715" ENSG00000254636 "Age-related maculopathy susceptibility 2" P0C7Q2 10 122454653-122457352 "Disease related genes, Predicted intracellular proteins" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 21.2;testis: 6.6" "Group enriched" "Detected in some" 4 "Early spermatids: 16.7;Late spermatids: 45.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HeLa: 1.3;HSkMC: 1.5;SiHa: 1.1;SuSa: 2.1;TIME: 1.3;WM-115: 2.0" HPA067225 Enhanced NA NA "HPA067225: AB_2685806" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (2.61e-2)" "unprognostic (2.84e-2)" "unprognostic (3.49e-2)" "unprognostic (1.98e-2)" "unprognostic (3.47e-3)" "unprognostic (3.60e-2)" "unprognostic (5.29e-5)" "unprognostic (2.53e-2)" "unprognostic (9.46e-3)" "unprognostic (2.68e-2)" "unprognostic (5.25e-2)" 0.5 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.7 0.2 0.2 0.2 0.4 1.7 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 2.3 0.2 0.0 1.0 21.2 0.2 0.2 0.0 0.2 2.7 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.1 0.0 0.0 2.1 0.0 0.0 1.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 16.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.5 0.0 7.2 0.0 0.0 0.0 ARNT2 "bHLHe1, KIAA0307" ENSG00000172379 "Aryl hydrocarbon receptor nuclear translocator 2" Q9HBZ2 15 80404350-80597937 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 73.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 29.2;Intestinal endocrine cells: 22.0;Late spermatids: 28.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.9;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;hTERT-RPE1: 16.7;LHCN-M2: 14.3;SK-MEL-30: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001056, CAB005081" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005081: AB_2243005, HPA001056: AB_1845042" "unprognostic (2.04e-3)" "unprognostic (8.32e-2)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (5.65e-2)" "unprognostic (2.61e-2)" "unprognostic (1.48e-1)" "unprognostic (2.74e-2)" "unprognostic (3.00e-1)" "prognostic favorable (1.46e-6)" "unprognostic (2.20e-1)" "prognostic favorable (7.51e-4)" "unprognostic (2.53e-1)" "unprognostic (2.31e-1)" "unprognostic (3.39e-1)" "unprognostic (3.62e-2)" 1.4 2.3 30.6 2.3 35.5 1.0 1.8 9.1 73.2 4.2 2.4 14.3 0.0 2.0 5.3 7.2 2.3 4.9 2.7 3.7 32.8 17.4 11.5 1.0 4.4 2.3 19.2 23.4 9.3 3.2 4.2 3.6 1.7 11.9 5.1 2.4 2.0 1.5 4.8 7.0 2.3 2.5 3.7 13.2 3.2 3.9 8.0 12.7 0.0 6.0 0.0 2.9 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.8 15.9 0.0 0.1 2.0 0.0 6.7 9.5 7.8 16.0 0.0 0.0 0.0 1.7 8.0 4.1 0.2 5.8 0.3 10.1 0.0 1.6 0.2 0.0 0.5 0.5 0.0 4.0 7.6 0.3 3.4 0.1 16.7 0.0 0.0 0.0 0.1 14.3 7.5 0.0 0.0 3.1 0.0 0.1 0.0 0.2 0.0 3.4 11.2 8.4 11.6 0.8 0.1 17.1 1.0 0.3 0.0 0.0 12.5 2.5 0.3 7.9 0.0 0.0 0.0 4.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 35.5 9.1 36.0 32.8 17.4 19.2 23.4 11.9 12.7 0.0 2.9 0.0 1.1 1.1 15.4 5.9 0.0 2.7 7.9 3.5 7.9 0.1 11.6 6.4 29.2 0.8 0.0 0.0 0.2 3.3 0.9 1.9 2.3 0.0 0.2 1.6 22.0 0.6 0.0 28.4 0.6 0.6 6.8 0.0 0.9 5.7 3.0 2.8 2.8 0.6 9.2 6.5 2.8 1.1 1.5 0.3 2.3 0.0 0.8 1.1 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.0" "Cell type enhanced" "Detected in many" 15 "Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 35.3;U-2197: 48.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059074: AB_2683897" "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.5 1.3 5.7 9.8 5.9 2.2 3.3 3.6 10.6 6.8 3.1 1.1 0.0 2.9 1.5 0.5 30.0 1.5 3.9 1.9 9.1 2.8 1.6 10.3 2.7 5.0 2.1 6.8 0.9 2.3 2.4 1.5 14.7 2.6 1.9 3.5 0.0 9.2 0.9 1.0 7.7 2.8 4.7 2.0 1.2 10.9 2.8 1.3 3.8 1.2 15.4 21.1 5.9 12.5 0.6 1.4 4.5 0.5 0.5 1.5 0.2 21.9 5.6 1.2 0.4 1.1 3.4 17.7 7.8 10.3 5.1 8.0 5.3 17.1 0.2 4.4 3.7 15.8 9.1 3.6 27.4 13.1 35.3 4.7 4.2 3.7 4.4 1.5 8.5 1.8 1.2 2.4 17.8 14.0 8.8 23.9 5.3 2.1 9.0 5.8 2.6 4.6 4.6 9.7 7.5 19.7 8.6 20.7 1.3 4.3 12.6 4.1 0.7 4.0 0.6 0.1 3.1 0.8 2.8 16.2 16.6 9.6 48.3 32.2 1.3 2.4 0.0 14.3 6.9 3.2 4.5 0.5 0.5 0.2 0.3 0.2 0.5 0.2 0.2 1.4 0.6 0.2 0.3 2.4 0.5 0.2 0.3 1.5 0.2 5.7 5.9 3.6 10.6 9.1 2.8 2.1 6.8 2.6 1.3 3.0 2.2 0.0 32.7 0.7 1.1 0.8 17.8 0.0 7.9 8.7 0.0 1.3 0.0 22.0 3.3 4.2 0.7 0.0 23.8 3.5 2.3 33.6 0.0 4.2 1.3 0.0 1.2 3.1 2.8 3.0 0.0 5.0 1.7 26.2 2.7 0.0 57.8 0.0 0.0 0.6 0.0 0.0 2.1 3.4 4.9 1.9 3.5 0.0 0.6 126.8 ARPC1B "ARC41, p40-ARC, p41-ARC" ENSG00000130429 "Actin related protein 2/3 complex subunit 1B" O15143 7 99374249-99394814 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 213.6" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 816.2;Hofbauer cells: 990.8;Kupffer cells: 840.4;monocytes: 924.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 112.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004832 Enhanced Supported Vesicles,Cytosol NA NA 53000000 "Vesicles, Cytosol" "HPA004832: AB_1845044" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (2.84e-3)" "unprognostic (2.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (4.37e-2)" "unprognostic (7.76e-2)" "unprognostic (1.02e-2)" "unprognostic (1.56e-1)" "unprognostic (4.86e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (1.18e-1)" "unprognostic (1.87e-2)" "unprognostic (1.24e-1)" "unprognostic (7.27e-2)" 31.8 17.8 8.7 50.7 14.4 56.4 35.4 1.9 7.7 17.9 30.7 8.4 18.1 32.6 17.4 21.8 16.0 18.3 23.4 24.4 5.7 7.0 27.9 34.8 40.0 92.8 10.7 3.7 11.6 13.0 3.8 13.1 36.2 9.4 15.6 10.5 20.6 18.3 15.1 10.6 10.0 42.3 12.1 10.2 81.8 16.3 10.8 9.3 31.0 23.0 13.7 37.2 19.0 21.1 53.5 133.7 127.2 154.4 38.9 83.4 213.6 16.0 29.2 2.2 6.4 8.5 30.7 22.4 22.3 22.5 9.0 8.0 19.0 62.6 27.9 41.8 24.3 19.7 12.1 2.8 19.7 3.7 22.7 10.5 20.3 8.5 13.1 24.5 20.3 69.1 17.1 10.2 12.7 12.6 18.1 23.7 14.9 22.5 67.3 13.1 74.1 22.4 44.5 8.0 19.0 63.6 18.1 2.0 68.3 18.6 7.9 1.8 5.9 15.2 67.1 112.2 7.6 15.8 41.4 34.6 25.7 21.3 45.3 28.1 12.5 24.9 34.1 25.6 53.0 46.0 53.7 153.2 121.6 53.8 154.4 50.2 53.5 62.8 59.6 133.7 42.8 37.0 49.3 127.2 38.9 142.0 77.9 83.4 213.6 8.7 14.4 1.9 7.7 5.7 7.0 10.7 3.7 9.4 9.3 38.7 80.0 287.6 95.5 53.8 9.2 5.6 119.8 56.2 54.6 123.9 7.9 492.8 21.6 353.0 2.6 242.9 360.5 0.0 368.7 816.2 113.0 95.0 189.2 37.0 990.8 1.6 108.2 201.3 840.4 4.0 34.5 558.1 170.4 924.3 71.7 20.6 324.8 290.8 17.0 73.6 15.8 90.5 96.8 2.1 14.7 32.4 253.6 319.0 152.9 154.0 ARPC5 "ARC16, dJ127C7.3, p16-Arc" ENSG00000162704 "Actin related protein 2/3 complex subunit 5" O15511 1 183620846-183635757 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 154.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022013, HPA031972" Approved Approved "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA 15000000 "Vesicles, Plasma membrane, Cell Junctions, Cytosol" "HPA022013: AB_1845045, HPA031972: " "unprognostic (3.82e-1)" "unprognostic (8.78e-2)" "unprognostic (1.43e-1)" "unprognostic (2.36e-2)" "unprognostic (1.74e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (5.90e-3)" "unprognostic (3.84e-2)" "unprognostic (3.17e-3)" "unprognostic (1.14e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-10)" "unprognostic (3.03e-2)" "unprognostic (4.66e-2)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" 46.6 25.1 24.9 57.5 24.3 25.2 28.9 13.8 24.8 26.6 42.3 26.5 18.6 40.8 39.0 26.7 44.5 29.3 24.6 36.8 28.2 22.3 28.8 29.7 52.3 58.3 28.4 18.7 27.3 21.5 12.4 18.2 84.8 20.0 23.2 29.2 17.0 25.4 16.5 16.4 25.2 47.3 32.8 46.0 79.9 35.6 21.7 23.5 61.2 27.5 22.7 52.8 30.6 30.8 27.4 68.9 154.0 96.6 30.7 40.7 124.3 51.8 28.8 24.8 17.0 20.5 29.3 59.3 71.3 55.0 31.1 25.4 26.0 36.8 47.7 81.2 41.0 20.1 36.1 17.4 24.3 16.5 68.7 15.6 28.8 39.2 22.4 33.4 41.8 56.3 35.4 25.9 37.6 29.9 35.7 36.4 33.8 21.9 39.6 40.2 21.3 39.0 11.3 23.6 40.3 11.1 36.3 22.0 46.0 17.4 26.9 10.8 28.9 74.3 32.1 27.6 27.1 32.2 37.4 81.1 45.4 23.6 50.8 68.6 47.2 52.1 32.7 35.8 30.2 34.9 79.3 80.0 124.1 34.8 89.8 27.7 27.4 34.2 35.5 68.9 24.4 37.1 37.6 154.0 30.7 96.6 32.5 40.7 124.3 24.9 24.3 13.8 21.1 28.2 22.3 28.4 18.7 20.0 23.5 348.4 174.9 170.6 139.1 221.2 29.2 25.0 142.7 81.7 120.6 78.5 13.7 419.1 140.9 316.3 26.2 168.2 202.4 0.0 245.8 625.6 206.8 137.2 247.7 72.7 547.8 36.5 193.8 182.3 533.2 18.6 116.5 649.2 241.3 607.8 124.2 50.0 287.4 192.9 172.5 110.5 24.5 239.3 277.9 83.0 95.6 214.0 166.8 309.6 117.5 206.4 ARPP19 "ARPP-16, ARPP-19, ARPP16, ENSAL" ENSG00000128989 "CAMP regulated phosphoprotein 19" P56211 15 52547045-52569883 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 130.4" "Group enriched" "Detected in all" 6 "Early spermatids: 709.0;Late spermatids: 2356.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056851 Approved NA NA "HPA056851: AB_2683255" "unprognostic (2.83e-1)" "unprognostic (2.80e-1)" "unprognostic (3.44e-1)" "unprognostic (8.09e-2)" "unprognostic (1.58e-1)" "unprognostic (6.14e-2)" "unprognostic (3.63e-2)" "unprognostic (2.33e-2)" "unprognostic (7.21e-2)" "unprognostic (5.67e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.72e-4)" "unprognostic (1.40e-2)" "unprognostic (4.82e-2)" "unprognostic (3.05e-1)" "unprognostic (3.27e-1)" 16.4 15.4 49.2 10.3 130.4 25.7 13.5 18.3 92.3 11.8 10.2 21.1 7.3 8.1 14.1 10.9 15.1 9.8 11.4 22.5 33.7 26.1 16.7 11.9 12.7 12.6 35.5 27.2 13.9 13.0 29.0 12.8 16.0 16.1 11.7 10.5 7.2 8.2 12.6 60.0 8.4 8.6 16.6 40.5 11.7 10.8 22.7 35.4 7.3 16.6 8.5 14.2 13.4 9.0 32.7 20.8 42.7 26.1 30.8 38.5 25.6 25.3 28.5 41.1 18.7 16.5 18.5 21.3 23.4 20.3 17.6 18.0 25.1 12.9 26.8 25.7 16.8 25.6 22.8 28.7 26.5 23.0 90.8 13.5 30.5 29.7 22.2 14.1 28.9 23.0 17.5 27.0 18.1 29.9 21.0 27.4 26.2 18.7 51.6 26.0 28.7 27.5 11.4 25.3 18.1 14.4 29.7 23.6 54.0 25.0 33.0 41.6 33.9 17.3 22.9 22.9 47.2 22.7 20.0 24.6 28.2 20.2 20.1 33.7 24.2 61.9 34.3 19.9 26.2 26.6 22.6 20.1 42.7 25.8 22.2 25.4 32.7 27.5 30.6 16.4 23.1 26.6 29.4 32.6 30.8 26.1 20.8 38.5 25.6 49.2 130.4 18.3 68.1 33.7 26.1 35.5 27.2 16.1 35.4 59.6 51.5 63.1 134.9 191.5 54.1 138.8 73.9 32.1 53.4 59.3 19.6 70.5 114.4 81.9 709.0 75.9 37.7 23.3 58.9 75.9 83.3 162.4 60.1 76.5 63.1 81.0 81.2 73.6 68.3 2356.3 65.6 74.2 156.9 211.0 42.9 79.7 87.4 42.7 101.8 97.6 49.1 71.1 109.3 159.7 203.8 194.7 73.3 79.7 37.8 247.9 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.8;Cardiomyocytes: 3.4;Early spermatids: 1.6;Late spermatids: 2.2" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Region enriched" "Detected in all" 5 "basal ganglia: 146.9" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 12.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 12.1" "Cell line enhanced" "Detected in some" "JURKAT: 46.2;MOLT-4: 27.1;REH: 15.0;RH-30: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017303 Enhanced Supported Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 1.2 1.3 12.3 1.5 146.9 4.6 1.1 27.8 67.9 1.1 1.4 0.3 0.0 1.3 1.1 1.1 3.2 1.1 1.1 1.1 6.8 2.8 2.0 2.9 1.2 1.2 3.9 11.5 1.1 1.1 1.1 1.9 1.1 6.7 2.0 1.5 0.0 1.1 1.3 43.6 1.1 1.4 1.1 0.8 1.2 1.1 1.1 14.8 41.2 1.5 3.5 1.5 1.1 0.1 0.1 12.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 0.0 46.2 0.0 0.1 1.1 0.0 27.1 0.0 0.0 0.0 1.1 15.0 8.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 12.3 146.9 27.8 14.7 6.8 2.8 3.9 11.5 6.7 14.8 0.0 0.0 0.0 0.0 0.0 2.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 ARR3 ARRX ENSG00000120500 "Arrestin 3" P36575 X 70268305-70281840 "Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 62.9" "Cell type enriched" "Detected in some" 14 "Cone photoreceptor cells: 1449.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 3.7;Karpas-707: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA063129 Enhanced NA NA "HPA063129: AB_2732696" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-2)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.02e-3)" "unprognostic (2.77e-7)" "unprognostic (8.64e-2)" "unprognostic (6.53e-2)" "unprognostic (6.06e-2)" "unprognostic (1.43e-1)" 0.3 0.5 0.3 1.0 0.3 0.7 0.3 0.3 0.3 0.3 1.2 0.3 0.3 1.4 0.7 0.3 0.3 0.4 0.7 0.7 0.3 0.2 0.4 0.3 0.3 1.9 0.3 0.3 0.6 0.7 0.0 0.4 0.4 0.3 0.4 0.2 62.9 0.4 0.3 0.5 5.6 3.6 0.3 0.3 0.9 0.8 0.4 0.3 0.3 0.9 0.3 0.3 0.8 0.3 1.3 0.7 0.5 0.4 0.0 1.6 0.3 0.4 0.7 3.2 2.1 0.0 0.0 1.8 1.7 0.0 0.0 0.0 0.6 1.1 1.2 0.3 0.0 0.3 0.7 0.0 0.0 0.0 1.4 3.2 0.4 1.1 0.0 0.0 0.7 1.6 0.1 0.0 0.0 0.0 3.7 0.0 1.0 0.4 5.8 0.0 0.5 1.2 0.6 0.9 0.5 0.6 1.1 0.6 0.1 0.0 1.5 0.4 0.9 0.6 0.2 0.1 2.1 0.1 0.4 2.4 1.5 2.0 1.4 0.1 1.4 0.8 0.8 1.3 2.0 1.4 0.0 0.4 0.5 0.9 0.2 0.0 1.3 0.4 0.0 0.5 0.4 1.6 0.1 0.1 0.0 0.0 0.7 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 45.6 0.2 0.0 0.0 0.0 0.0 1449.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 102.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARRB2 "ARR2, BARR2, DKFZp686L0365" ENSG00000141480 "Arrestin beta 2" P32121 17 4710489-4721499 "Predicted intracellular proteins" "Protein transport, Transport" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 102.8;lymphoid tissue: 66.6" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 226.1;Kupffer cells: 213.1;Macrophages: 203.0;monocytes: 348.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 42.4;HMC-1: 71.5;NB-4: 43.0;U-937: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075177 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA075177: " "unprognostic (1.12e-1)" "prognostic favorable (2.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" "unprognostic (7.43e-2)" "unprognostic (3.37e-2)" "unprognostic (2.62e-3)" "unprognostic (3.85e-2)" "unprognostic (3.05e-2)" "unprognostic (2.58e-1)" "unprognostic (1.66e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.32e-2)" "unprognostic (8.61e-2)" "unprognostic (4.92e-2)" "unprognostic (1.49e-1)" "unprognostic (1.88e-1)" 21.6 15.6 23.7 47.8 18.3 102.8 10.0 28.1 26.3 8.7 16.1 20.4 1.9 23.0 7.4 7.8 7.1 10.8 14.8 10.2 27.3 20.9 10.5 15.6 35.0 31.3 20.1 19.6 8.7 8.3 6.6 10.2 16.0 19.7 7.4 13.2 10.7 8.7 6.2 5.5 5.8 21.0 13.7 21.7 66.6 12.5 5.0 18.3 23.5 6.4 3.2 17.0 15.7 7.1 2.2 18.0 52.9 32.8 5.9 11.4 16.0 3.7 19.9 7.8 7.5 1.5 2.2 4.1 2.9 4.0 8.7 10.9 6.8 3.1 10.4 2.7 2.2 4.2 6.3 12.9 4.1 9.0 24.8 18.8 42.4 10.1 12.0 2.3 18.8 71.5 2.0 5.3 10.7 4.3 5.7 6.6 19.7 2.8 10.5 1.9 6.6 18.8 43.0 4.2 10.0 4.1 22.2 6.9 11.6 3.0 2.0 8.1 11.2 6.6 11.5 5.1 3.4 5.5 8.9 5.7 3.3 6.6 5.6 11.1 4.4 5.9 5.9 8.7 61.3 4.8 22.6 30.4 52.5 11.0 31.5 7.8 2.2 7.1 11.4 18.0 1.9 6.8 9.0 52.9 5.9 32.8 4.4 6.0 16.0 23.7 18.3 28.1 26.3 27.3 20.9 20.1 19.6 19.7 18.3 20.8 44.9 18.5 7.0 10.2 17.4 8.1 10.2 8.1 18.2 3.5 2.0 4.8 13.3 8.8 0.4 9.2 10.3 0.0 6.2 9.4 8.1 3.9 91.4 12.1 226.1 20.6 8.1 19.6 213.1 1.8 4.6 203.0 10.1 348.1 14.3 4.7 7.6 17.3 4.6 12.9 7.5 19.4 5.4 0.5 11.8 7.3 5.0 76.9 11.9 10.5 ARRDC2 "CLONE24945, PP2703" ENSG00000105643 "Arrestin domain containing 2" Q8TBH0 19 18001132-18014102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.7" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 53.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053788, HPA074216" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053788: AB_2682262, HPA074216: " "unprognostic (8.10e-2)" "prognostic favorable (5.93e-4)" "unprognostic (2.20e-3)" "unprognostic (8.67e-2)" "unprognostic (4.81e-3)" "unprognostic (4.26e-3)" "unprognostic (1.82e-1)" "unprognostic (1.06e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.84e-4)" "unprognostic (1.16e-1)" "unprognostic (8.37e-2)" "unprognostic (4.87e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-1)" "prognostic favorable (6.91e-4)" "prognostic favorable (2.92e-4)" 26.7 5.3 10.4 12.5 34.6 39.3 27.7 3.2 19.5 10.9 9.6 28.3 7.3 6.9 7.6 4.7 8.1 8.5 13.1 8.5 14.1 8.2 10.7 9.8 22.6 19.0 47.5 9.0 4.9 6.2 18.7 5.7 8.1 20.1 10.1 7.2 6.0 15.3 11.6 60.7 9.4 13.3 6.7 16.8 18.7 12.1 3.2 32.9 10.5 14.3 4.9 19.1 9.3 11.3 5.9 3.1 3.7 6.3 7.2 16.0 4.7 5.8 10.7 0.2 5.4 4.5 4.1 4.2 3.4 9.8 2.9 2.9 2.4 11.6 11.0 9.8 2.9 4.7 4.0 4.3 3.1 2.3 7.1 6.3 8.4 8.3 3.3 4.1 6.3 12.4 4.4 5.0 3.3 5.1 5.4 4.9 7.1 9.6 0.3 2.7 9.1 4.8 17.5 1.3 13.2 17.7 28.3 0.1 8.2 4.2 5.5 2.6 2.6 5.6 5.7 5.7 0.9 3.4 16.3 10.4 5.0 3.9 16.9 4.3 0.8 0.0 12.4 8.1 24.2 3.9 3.7 6.3 3.7 4.0 5.2 2.8 3.9 6.7 5.1 3.1 5.9 16.0 8.4 2.4 7.2 5.4 2.0 5.0 4.7 10.4 34.6 3.2 19.5 14.1 8.2 47.5 9.0 20.1 32.9 14.9 16.2 24.9 14.4 5.7 0.4 6.2 53.5 16.0 7.9 8.7 0.0 0.6 1.7 8.3 0.7 27.0 6.6 0.0 5.6 7.1 7.8 19.7 26.5 5.4 16.7 0.0 17.7 15.4 24.0 1.0 4.4 39.6 5.0 8.2 8.7 0.9 10.8 7.8 7.1 0.3 0.4 12.9 14.6 0.5 3.7 6.1 1.0 20.8 5.2 23.1 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960698-97973838 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.3" "Cell type enhanced" "Detected in many" 4 "Paneth cells: 45.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.1;BJ: 39.3;HSkMC: 22.2;hTCEpi: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 9.2 9.3 11.4 11.5 18.4 6.7 14.8 3.3 16.3 9.4 27.4 67.3 11.6 11.2 10.7 11.9 11.8 10.8 14.7 9.7 18.7 9.2 14.1 21.8 14.1 6.4 18.1 15.2 7.4 25.0 3.7 6.5 13.0 29.4 8.3 17.0 4.6 6.5 13.5 10.1 25.3 15.3 14.0 48.7 5.9 18.1 10.2 41.9 1.9 14.9 4.5 3.5 11.7 12.4 0.5 2.4 3.1 5.1 0.1 0.1 0.8 2.1 0.0 0.3 5.8 2.6 19.1 0.0 39.3 17.6 5.2 2.3 2.3 1.4 0.0 5.5 1.8 0.5 2.3 1.4 13.7 8.5 0.0 3.6 3.7 0.7 1.5 1.0 2.5 5.9 22.2 33.9 6.0 7.0 7.4 0.2 1.1 5.3 0.0 1.8 7.1 0.4 2.1 1.1 6.5 0.8 0.0 0.3 0.0 10.2 4.8 1.9 3.4 5.9 2.2 10.6 1.2 0.8 3.9 0.0 1.6 1.1 8.2 1.8 0.0 0.0 0.0 3.4 0.4 4.0 2.3 5.1 3.1 0.1 3.6 0.0 0.5 0.0 0.0 2.4 0.4 0.1 0.0 3.0 0.1 0.6 0.6 0.0 0.8 11.4 18.4 3.3 16.3 18.7 9.2 18.1 15.2 29.4 41.9 3.0 7.2 3.2 2.6 22.6 1.6 12.6 15.3 9.4 3.4 21.0 5.9 0.2 6.6 2.4 3.3 5.0 36.0 0.0 7.2 0.1 13.0 10.0 23.1 14.1 18.0 0.0 36.8 6.2 31.5 6.7 4.6 17.3 23.6 0.0 21.7 0.5 8.8 45.6 7.8 1.3 3.1 0.0 16.4 1.4 5.9 27.1 0.6 1.3 20.3 5.9 ARRDC5 ENSG00000205784 "Arrestin domain containing 5" A6NEK1 19 4890437-4902867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 29.1" "Cell type enriched" "Detected in some" 6 "Early spermatids: 233.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 16 "REH: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.85e-2)" "unprognostic (3.83e-5)" "unprognostic (2.53e-1)" "unprognostic (7.22e-5)" "unprognostic (1.70e-1)" "unprognostic (7.16e-5)" "unprognostic (1.65e-2)" "unprognostic (1.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.03e-2)" "unprognostic (8.76e-2)" "unprognostic (6.45e-2)" "unprognostic (7.18e-8)" "unprognostic (1.76e-1)" "unprognostic (3.07e-1)" "unprognostic (1.95e-1)" "unprognostic (3.79e-2)" 0.2 0.0 0.2 0.7 0.2 2.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.2 0.5 2.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 1.0 0.2 0.3 2.3 0.2 29.1 0.2 0.2 0.2 0.2 0.8 0.2 0.2 2.6 3.9 3.3 1.2 1.7 3.5 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 1.2 3.3 3.5 0.9 1.9 2.6 0.7 2.3 1.4 2.5 3.2 3.4 0.2 1.7 0.4 3.9 1.5 0.9 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.9 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.1 38.2 1.1 1.5 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.9 0.1 0.0 4.4 0.0 0.5 ARSE "CDPX, CDPX1" ENSG00000157399 "Arylsulfatase E (chondrodysplasia punctata 1)" P51690 X 2934632-2968310 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 43.0;pancreas: 99.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 43.3;Hepatocytes: 71.2;Proximal tubular cells: 87.6;Undifferentiated cells: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "myeloid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "A549: 32.3;CACO-2: 20.0;GAMG: 13.3;Hep G2: 30.0;NTERA-2: 15.0" "Low region specificity" "Detected in all" "HPA060518, HPA070651" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA060518: AB_2684301, HPA070651: AB_2732160" "unprognostic (2.07e-1)" "unprognostic (6.60e-3)" "prognostic favorable (8.95e-4)" "unprognostic (8.74e-3)" "unprognostic (1.14e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-1)" "unprognostic (8.27e-2)" "unprognostic (5.45e-2)" "unprognostic (2.25e-1)" "unprognostic (2.27e-1)" "unprognostic (2.37e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (4.76e-2)" 0.2 0.1 0.9 2.4 1.1 0.0 0.4 0.3 0.7 0.8 7.9 0.7 1.3 6.5 1.1 2.3 0.3 1.3 8.4 0.4 0.9 0.8 16.6 43.0 0.8 0.2 0.6 1.0 2.5 99.4 0.0 0.4 0.7 0.7 0.4 6.4 0.6 0.2 0.9 0.2 0.1 7.8 0.5 0.6 0.2 1.2 0.7 0.6 0.2 0.2 0.3 0.2 0.2 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.0 32.3 3.0 0.0 0.9 1.7 0.5 1.3 2.8 1.4 1.7 20.0 0.0 0.0 6.1 0.0 13.3 0.0 0.0 0.2 0.8 0.0 2.1 0.0 0.0 30.0 0.8 0.0 0.0 3.2 0.0 1.1 0.0 2.6 1.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 15.0 1.1 0.0 0.9 0.4 0.1 3.5 0.0 0.0 0.1 0.0 0.0 0.9 6.6 0.0 0.0 1.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 3.3 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.3 0.7 0.9 0.8 0.6 1.0 0.7 0.6 0.0 4.1 0.9 0.2 0.1 0.0 0.1 43.3 2.7 0.0 7.0 0.0 0.2 14.9 15.6 0.0 0.3 24.1 23.3 15.0 0.1 0.8 0.1 0.0 71.2 0.2 0.0 19.5 1.3 2.1 0.0 0.3 0.0 3.3 2.8 16.0 0.1 17.1 31.6 3.2 87.6 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 48.8 0.0 ARSF ENSG00000062096 "Arylsulfatase F" P54793 X 3041471-3112726 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3;kidney: 11.5;skin 1: 8.3" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 1.7;Proximal tubular cells: 4.6" "Cancer enhanced" "Detected in some" "glioma: 2.9" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.0;U-266/70: 1.1" HPA000549 Uncertain Cytosol "Secreted in other tissues" NA NA Cytosol "HPA000549: AB_1845055" "unprognostic (2.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.87e-1)" "unprognostic (5.41e-3)" "unprognostic (3.83e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (9.72e-2)" "unprognostic (4.70e-1)" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (3.59e-1)" "unprognostic (1.23e-1)" "unprognostic (9.76e-2)" "unprognostic (1.48e-1)" 0.0 4.6 2.7 0.0 5.3 0.0 0.1 0.0 1.9 0.4 0.0 0.0 0.0 2.5 3.1 0.0 0.0 0.0 1.3 0.5 11.5 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.6 1.5 0.3 0.2 1.9 0.3 0.8 0.3 0.0 0.2 0.4 0.5 0.7 0.0 0.2 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.1 1.1 0.1 0.1 0.8 0.4 0.3 1.9 0.3 0.4 0.2 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.3 0.3 1.2 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 ARSG KIAA1001 ENSG00000141337 "Arylsulfatase G" Q96EG1 17 68259182-68422731 "Predicted intracellular proteins" Hydrolase "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 42.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 51.1;Rod photoreceptor cells: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023245, HPA023285" Enhanced "Intracellular and membrane" NA NA 1600000 "HPA023245: AB_1845056, HPA023285: AB_1845057" "unprognostic (3.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-1)" "unprognostic (1.61e-1)" "unprognostic (9.02e-2)" "unprognostic (3.67e-3)" "unprognostic (4.11e-1)" "unprognostic (1.14e-3)" "unprognostic (5.18e-2)" "unprognostic (5.47e-2)" "unprognostic (6.11e-7)" "unprognostic (4.24e-3)" "prognostic favorable (7.04e-4)" "unprognostic (1.87e-2)" "unprognostic (3.68e-2)" "unprognostic (3.18e-2)" "unprognostic (1.49e-1)" 3.5 8.5 3.0 3.8 7.4 3.8 7.4 11.8 12.6 5.3 2.2 4.2 16.7 1.6 5.6 42.3 6.1 8.8 3.8 5.4 6.0 4.6 4.0 3.2 3.4 13.5 4.4 4.3 7.8 3.0 3.6 7.9 3.3 5.5 2.6 1.9 17.8 4.9 18.9 11.7 5.4 2.6 3.7 2.6 6.1 3.2 5.0 1.5 3.2 11.9 3.5 12.7 2.9 3.1 5.5 9.4 16.3 10.8 4.8 8.5 6.3 2.1 2.3 1.9 2.5 7.2 5.1 6.6 1.9 5.7 4.1 1.7 0.6 3.0 4.7 4.9 2.6 1.0 0.2 3.6 0.9 1.5 5.3 2.9 2.3 2.4 5.6 6.4 5.4 3.8 2.0 1.4 1.2 3.5 7.3 4.1 5.7 2.1 10.3 1.7 6.2 4.9 3.5 2.6 1.1 2.7 0.5 1.7 10.9 5.8 1.3 7.7 0.7 2.4 7.0 11.2 3.4 18.5 6.8 3.6 4.7 0.9 1.7 1.2 10.5 7.6 7.5 3.6 6.2 1.7 7.1 10.8 6.5 8.5 8.0 5.5 5.5 5.4 8.0 9.4 2.3 5.7 8.2 16.3 4.8 7.1 1.8 5.4 6.3 3.0 7.4 11.8 12.6 6.0 4.6 4.4 4.3 5.5 1.5 3.0 2.4 2.9 4.4 3.5 21.6 1.7 5.1 4.0 2.3 12.2 51.1 6.5 8.3 2.4 0.2 6.7 2.6 0.0 4.2 15.8 13.4 9.4 3.5 2.6 8.5 25.4 1.7 19.6 5.6 0.6 12.4 6.5 21.9 12.6 3.3 8.9 2.1 5.8 21.5 9.1 54.0 6.5 6.5 1.2 3.0 3.3 14.1 13.4 1.7 7.1 ARSH ENSG00000205667 "Arylsulfatase family member H" Q5FYA8 X 3006613-3033571 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 3.1;epididymis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;hTERT-RPE1: 1.2;OE19: 1.7;RT4: 1.2;SK-BR-3: 1.2" NA NA "unprognostic (3.43e-1)" "unprognostic (1.95e-1)" "unprognostic (2.01e-2)" "unprognostic (8.90e-2)" "unprognostic (6.79e-2)" "unprognostic (2.56e-2)" "unprognostic (1.83e-1)" "unprognostic (8.56e-4)" "unprognostic (3.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.63e-1)" "unprognostic (2.65e-2)" "unprognostic (6.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 3.7 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARSI "FLJ16069, SPG66" ENSG00000183876 "Arylsulfatase family member I" Q5FYB1 5 150296343-150339307 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.2" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 10.8;granulocytes: 4.6;Melanocytes: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 9.5;HaCaT: 18.5;Hep G2: 11.4;hTEC/SVTERT24-B: 18.6;U-87 MG: 23.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA038386, HPA038398" Uncertain Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA038386: AB_10669781, HPA038398: AB_2675995" "unprognostic (6.08e-2)" "unprognostic (1.70e-2)" "unprognostic (9.41e-3)" "unprognostic (4.77e-3)" "unprognostic (1.54e-3)" "unprognostic (2.83e-3)" "unprognostic (2.76e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.06e-1)" "unprognostic (5.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.26e-1)" "unprognostic (3.39e-7)" "unprognostic (7.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.19e-4)" 2.0 0.5 2.1 4.3 2.0 0.9 0.5 0.7 2.0 4.9 2.1 0.6 0.3 1.0 5.0 1.2 4.2 3.6 2.2 2.4 1.7 1.1 1.4 0.8 6.2 0.4 2.5 1.0 3.3 0.8 0.0 1.8 24.2 2.0 5.5 0.8 6.9 0.8 1.5 1.4 9.2 1.0 5.6 6.6 1.2 1.6 1.1 1.0 0.8 0.6 9.2 1.6 5.2 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 2.2 0.6 0.0 0.0 0.5 0.0 4.7 7.1 9.5 6.9 0.6 1.1 0.0 1.9 6.7 0.8 18.5 0.1 3.1 3.3 0.0 0.0 0.0 0.2 11.4 0.9 0.0 0.0 0.5 2.0 18.6 0.5 6.4 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.1 0.0 3.8 0.5 0.7 6.9 0.0 0.0 0.0 0.1 6.3 0.2 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 2.0 0.7 2.0 1.7 1.1 2.5 1.0 2.0 1.0 0.0 0.0 0.0 0.0 10.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.9 0.0 4.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 20.3 0.0 0.0 2.0 0.5 0.0 0.4 0.8 0.2 0.0 0.8 0.0 0.7 4.1 1.1 0.0 0.0 0.0 ART1 "ART2, CD296" ENSG00000129744 "ADP-ribosyltransferase 1" P52961 11 3645128-3664416 "CD markers, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 20 "skeletal muscle: 50.9;tongue: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051148 Uncertain NA NA "HPA051148: AB_2681363" "unprognostic (3.73e-1)" "unprognostic (4.58e-2)" "unprognostic (3.12e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" 1.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.2 0.1 50.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 13.7 0.5 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ART3 ENSG00000156219 "ADP-ribosyltransferase 3" Q13508 4 76011184-76112802 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 65.9;Spermatocytes: 192.9" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enhanced" "Detected in many" "cerebellum: 29.1" "Cell type enriched" "Detected in single" 5 "gdT-cell: 1.9" "Lineage enriched" "Detected in single" 18 "T-cells: 1.9" "Group enriched" "Detected in some" 8 "NB-4: 6.2;NTERA-2: 16.9;SK-MEL-30: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA011268 Enhanced "Intracellular and membrane" NA NA 45000000 "HPA011268: AB_1845059" "unprognostic (2.45e-1)" "unprognostic (2.84e-2)" "unprognostic (3.12e-2)" "unprognostic (2.77e-3)" "unprognostic (4.53e-2)" "unprognostic (1.34e-1)" "unprognostic (3.34e-1)" "unprognostic (9.85e-4)" "unprognostic (2.35e-1)" "unprognostic (5.10e-2)" "unprognostic (1.64e-2)" "unprognostic (2.95e-1)" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.48e-1)" "unprognostic (2.58e-2)" "unprognostic (6.61e-3)" 3.5 0.6 4.9 0.9 1.9 0.4 0.7 29.1 9.0 1.0 1.3 6.0 0.0 0.6 0.5 1.1 2.5 0.5 0.5 55.1 3.0 0.9 0.5 0.5 0.6 0.5 3.9 2.0 0.5 3.8 0.4 1.1 0.5 2.7 1.0 1.4 0.4 1.3 1.0 85.2 0.5 0.8 0.6 3.0 1.5 0.9 42.6 7.2 0.0 0.5 27.2 0.5 0.6 0.7 0.0 0.0 0.1 0.0 0.0 1.9 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.2 16.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.9 1.9 29.1 9.0 3.0 0.9 3.9 2.0 2.7 7.2 0.0 0.0 0.0 0.4 0.5 0.4 65.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.4 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.0 1.7 0.0 1.7 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.3 0.0 3.1 192.9 19.4 0.3 0.0 0.0 0.0 0.4 ART4 "CD297, DO, DOK1" ENSG00000111339 "ADP-ribosyltransferase 4 (Dombrock blood group)" Q93070 12 14825569-14843533 "Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3" "Cancer enhanced" "Detected in some" "liver cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4" "Region enhanced" "Detected in single" "olfactory region: 2.2" "Low region specificity" "Detected in single" HPA075664 Approved "Rods & Rings" "Secreted to blood" NA NA 11000000 "Rods & Rings" "HPA075664: " "unprognostic (2.50e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.90e-2)" "unprognostic (2.62e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-3)" "unprognostic (1.05e-1)" "unprognostic (1.71e-1)" 2.7 2.0 0.2 1.7 0.2 2.4 2.1 0.2 0.2 1.4 1.3 0.1 1.9 0.0 1.1 3.7 3.1 1.9 6.1 10.1 0.2 0.2 6.6 33.7 2.1 17.0 0.2 0.0 1.3 1.9 0.0 0.4 17.8 0.3 0.8 0.2 0.0 0.7 0.4 1.9 0.5 0.8 1.5 0.2 17.8 0.5 1.4 0.0 0.1 4.6 1.3 1.3 1.3 1.2 0.6 0.6 1.4 0.4 0.6 1.3 0.3 0.0 0.0 0.2 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.4 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.6 0.5 1.3 1.4 0.6 0.2 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.6 0.0 0.8 0.2 1.8 1.4 12.7 0.0 0.0 1.8 11.8 0.1 0.0 0.7 0.4 2.8 0.0 93.5 1.8 1.4 1.9 0.1 0.0 21.3 0.1 0.0 0.0 55.3 7.5 0.0 1.7 0.6 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 12.6 6.5 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 ART5 ENSG00000167311 "ADP-ribosyltransferase 5" Q96L15 11 3638503-3642316 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 12.1;testis: 33.3" "Group enriched" "Detected in some" 4 "Early spermatids: 12.7;Late spermatids: 14.5;Spermatocytes: 15.9" "Cancer enhanced" "Detected in some" "testis cancer: 4.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enriched" "Detected in some" 5 "SuSa: 17.9" "Region enriched" "Detected in single" 5 "olfactory region: 0.5" "Not detected" "Not detected" "HPA041637, HPA044099" Uncertain "Secreted in other tissues" NA NA "HPA041637: AB_2677589, HPA044099: AB_2678808" "unprognostic (6.32e-2)" "unprognostic (3.26e-5)" "unprognostic (4.09e-3)" "unprognostic (2.06e-4)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (2.22e-2)" "unprognostic (1.21e-2)" "unprognostic (5.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.85e-4)" "unprognostic (3.10e-3)" "unprognostic (3.46e-2)" "unprognostic (1.96e-1)" "unprognostic (3.18e-1)" 0.8 0.1 0.3 0.3 0.5 0.0 0.8 0.3 0.6 3.3 0.3 0.3 1.0 0.0 3.3 0.9 0.4 1.5 1.2 2.9 0.3 0.2 0.7 0.6 0.9 0.3 0.3 0.3 9.3 0.3 1.7 0.6 1.7 0.5 1.1 0.0 5.3 1.2 0.8 12.1 0.3 0.4 1.0 0.3 0.5 0.3 33.3 0.5 0.3 3.5 5.2 0.5 0.5 1.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.0 2.2 0.0 0.0 3.7 0.2 1.8 0.9 2.1 0.1 0.0 0.0 0.9 0.2 0.0 0.0 1.8 0.0 0.5 0.0 2.6 0.0 0.4 0.2 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.0 0.2 0.4 0.0 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.8 0.1 17.9 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.6 0.3 0.2 0.3 0.3 0.5 0.5 0.0 2.6 0.0 1.8 0.2 0.4 1.6 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.4 12.7 0.3 0.0 0.0 0.2 0.4 0.7 0.6 0.0 1.7 0.1 0.0 0.0 0.0 0.3 14.5 3.1 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.1 0.3 0.7 0.0 0.2 15.9 1.7 0.3 2.4 0.0 0.0 0.1 ARTN "ENOVIN, EVN, NBN" ENSG00000117407 Artemin Q5T4W7 1 43933320-43937241 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 18.3" "Cell type enriched" "Detected in some" 10 "Urothelial cells: 56.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 29.8;HaCaT: 31.5;HBEC3-KT: 28.0;hTCEpi: 11.8;hTERT-HME1: 9.0" "Region enriched" "Detected in single" 9 "olfactory region: 4.0" "Region enhanced" "Detected in single" "olfactory region: 1.0" "Secreted in other tissues" NA NA "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (1.86e-1)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (3.07e-3)" "unprognostic (1.18e-1)" "unprognostic (3.08e-1)" "prognostic favorable (8.18e-4)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (9.59e-6)" "unprognostic (2.35e-2)" "unprognostic (3.04e-2)" "unprognostic (1.48e-3)" "unprognostic (1.53e-1)" 2.4 1.1 0.7 2.2 2.5 1.2 2.1 4.3 1.7 3.9 3.7 0.5 7.6 0.6 3.6 5.6 4.1 2.0 5.1 2.0 0.6 1.6 6.2 0.4 2.1 0.5 1.0 0.1 2.4 14.4 18.3 8.0 10.4 4.8 10.0 2.5 0.7 5.3 12.4 1.0 1.2 1.1 2.0 2.0 0.6 1.7 2.2 0.7 0.6 1.8 4.4 1.5 4.7 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.8 0.7 0.5 0.4 0.1 0.1 0.1 1.2 0.2 1.2 1.2 0.1 0.7 0.3 0.1 0.4 0.3 31.5 0.0 28.0 0.2 0.1 0.9 0.4 3.0 0.0 0.0 0.1 0.6 0.0 11.8 0.5 9.0 5.4 0.0 0.4 0.3 0.9 0.1 2.1 0.1 1.7 2.6 0.0 1.1 0.5 0.0 0.4 0.1 0.5 0.6 0.2 0.1 0.0 0.6 0.5 5.0 4.5 0.3 0.5 0.2 0.2 1.2 3.0 2.2 0.3 4.0 1.4 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.5 4.3 1.7 0.6 1.6 1.0 0.1 4.8 0.7 0.0 0.0 0.0 2.6 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.1 5.6 0.0 0.8 0.0 0.2 0.0 0.2 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.8 4.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 56.7 ARVCF ENSG00000099889 "ARVCF, delta catenin family member" O00192 22 19969896-20016808 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 21.6;Muller glia cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "K-562: 15.7;SCLC-21H: 15.0;SH-SY5Y: 11.5;U-2 OS: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016162, HPA055264, HPA063675" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (4.00e-2)" "unprognostic (4.28e-2)" "unprognostic (3.35e-1)" "unprognostic (3.18e-2)" "unprognostic (4.79e-3)" "unprognostic (1.67e-2)" "unprognostic (2.06e-2)" "unprognostic (1.71e-2)" "unprognostic (2.09e-3)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (9.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "prognostic favorable (5.76e-6)" 3.4 6.6 9.0 1.8 6.1 6.0 3.2 30.8 11.1 3.4 3.2 7.7 3.5 2.7 4.2 14.6 3.1 2.6 8.0 6.2 8.1 8.1 5.0 4.9 3.9 1.4 3.8 6.8 2.9 8.7 4.9 7.3 2.7 5.9 6.1 1.1 6.4 8.7 4.6 13.4 5.3 3.7 3.6 4.0 13.4 5.2 5.2 2.8 0.5 12.1 1.6 1.5 2.8 1.8 0.0 0.6 0.0 0.2 0.7 1.2 0.8 3.3 0.3 4.5 5.9 0.0 0.0 4.7 0.8 0.3 0.2 0.5 0.9 0.7 1.4 3.7 0.4 0.4 3.1 0.7 1.4 0.0 0.4 5.6 0.4 0.3 3.5 1.3 0.5 1.1 0.1 0.6 0.2 0.2 0.3 3.7 1.0 15.7 0.4 0.0 3.0 0.2 2.1 4.6 1.0 1.8 8.3 0.2 0.4 0.8 0.7 15.0 11.5 0.9 1.4 2.2 0.8 1.2 0.4 1.3 0.1 13.1 0.5 0.3 1.8 0.5 0.4 0.2 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 1.2 0.0 0.7 0.0 0.6 0.0 0.8 9.0 6.1 30.8 8.9 8.1 8.1 3.8 6.8 5.9 2.8 3.0 1.6 0.0 2.6 1.8 8.5 5.0 5.1 1.4 0.0 1.8 21.6 3.8 0.0 7.0 2.1 1.6 1.2 0.0 4.6 1.7 1.9 4.2 0.0 3.2 1.2 4.8 8.6 4.3 1.0 1.3 3.7 0.9 3.3 0.0 6.2 18.8 9.7 0.0 3.2 5.0 7.6 0.0 3.1 2.2 9.2 1.6 3.7 0.0 1.8 0.9 ARX "CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS" ENSG00000004848 "Aristaless related homeobox" Q96QS3 X 25003694-25016420 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 25.2;ovary: 58.7;skeletal muscle: 16.9" "Group enriched" "Detected in some" 6 "Intestinal endocrine cells: 80.5;Leydig cells: 122.0;Peritubular cells: 65.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 9.5;basal ganglia: 6.7;cerebral cortex: 25.2;hippocampal formation: 10.4;olfactory region: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.0;PC-3: 6.2;THP-1: 2.6;U-266/70: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (8.28e-2)" "unprognostic (3.06e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.54e-7)" "unprognostic (9.85e-2)" "unprognostic (7.96e-3)" "unprognostic (1.18e-1)" "unprognostic (2.77e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.06e-6)" "unprognostic (6.01e-2)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" 0.5 0.5 9.5 0.5 6.7 0.5 0.7 0.3 25.2 0.5 1.1 1.9 0.0 2.9 0.5 1.8 0.5 1.1 0.5 0.5 10.4 2.6 0.6 0.5 0.8 0.5 0.9 17.1 58.7 2.7 4.4 0.5 0.5 0.0 0.7 1.1 0.0 0.5 0.5 16.9 0.5 1.0 0.5 0.3 0.6 4.9 13.6 3.1 0.0 0.5 0.5 0.8 0.5 0.5 0.0 0.1 0.6 0.4 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 3.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 6.2 0.7 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.6 0.0 0.0 0.2 0.0 0.0 13.1 0.4 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 9.5 6.7 0.3 25.2 10.4 2.6 0.9 17.1 0.0 3.1 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.0 14.7 3.4 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.1 0.0 80.5 0.0 0.0 1.3 122.0 0.0 0.0 0.0 2.9 0.0 0.5 0.0 65.7 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 1.2 1.1 AS3MT CYT19 ENSG00000214435 "Arsenite methyltransferase" Q9HBK9 10 102869516-102901899 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 92.8;parathyroid gland: 30.0" "Cell type enhanced" "Detected in single" 20 "Club cells: 1.2" "Cancer enhanced" "Detected in single" "liver cancer: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 14.3;REH: 27.2;SH-SY5Y: 14.6;T-47d: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017856 Enhanced Approved Mitochondria NA NA Mitochondria "HPA017856: AB_1847420" "unprognostic (1.11e-1)" "unprognostic (2.02e-4)" "unprognostic (2.45e-1)" "unprognostic (2.25e-1)" "unprognostic (3.39e-1)" "unprognostic (1.66e-1)" "unprognostic (7.02e-4)" "unprognostic (3.22e-1)" "unprognostic (1.42e-1)" "unprognostic (3.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.83e-1)" "unprognostic (3.83e-10)" "unprognostic (1.04e-2)" "unprognostic (4.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" 2.0 92.8 3.7 0.7 8.6 0.5 2.6 4.5 6.4 4.0 2.0 2.2 0.4 1.3 3.8 3.2 2.1 2.1 5.2 10.0 5.7 3.1 7.4 22.4 1.7 0.9 2.8 4.4 3.9 8.7 30.0 2.4 0.5 4.6 4.2 0.8 8.9 2.2 3.4 6.0 1.8 1.3 3.9 2.7 5.6 1.7 3.5 1.6 0.3 3.2 1.0 0.7 1.8 1.8 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 3.9 14.3 8.9 0.3 0.3 2.6 4.1 3.5 6.2 7.6 10.6 0.6 0.2 1.2 5.4 0.3 0.2 12.1 0.7 6.4 0.0 3.5 0.0 1.7 10.4 4.1 0.2 0.1 1.9 1.6 0.8 0.0 11.2 0.2 13.2 0.0 0.2 5.5 0.1 2.4 0.3 6.8 0.0 0.6 27.2 0.0 0.1 1.3 0.1 0.4 14.6 0.0 0.2 1.9 4.9 22.7 0.3 0.1 1.3 0.0 2.0 0.0 0.3 0.2 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.7 8.6 4.5 6.4 5.7 3.1 2.8 4.4 4.6 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASAH2 ENSG00000188611 "N-acylsphingosine amidohydrolase 2" Q9NR71 10 50182778-50248610 "Enzymes, Predicted intracellular proteins" "Apoptosis, Lipid metabolism, Sphingolipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "intestine: 43.9" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 6.0;Muller glia cells: 10.2;Sertoli cells: 6.5" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA061171 Supported Approved "Focal adhesion sites" "Intracellular and membrane" NA NA 1200000 "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (3.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-2)" "unprognostic (3.66e-1)" "unprognostic (4.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (4.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.14e-1)" "unprognostic (8.29e-2)" "unprognostic (1.86e-2)" "unprognostic (5.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" 0.3 1.1 0.6 0.2 0.9 0.0 0.5 0.5 1.3 1.7 0.5 43.9 0.7 0.3 0.7 0.5 0.2 0.9 0.5 1.4 0.6 1.6 0.4 0.2 1.2 1.4 1.5 0.3 1.0 0.4 0.5 0.3 0.9 0.2 0.8 0.7 33.4 0.7 0.6 0.2 2.5 1.1 0.6 0.1 1.0 0.5 0.9 0.9 0.0 0.0 0.0 2.2 0.1 1.8 1.4 1.6 2.2 2.9 1.1 2.0 2.0 1.3 3.8 3.5 1.0 4.6 0.0 2.2 2.7 3.1 1.7 2.1 0.7 4.7 2.3 3.8 1.3 3.8 2.9 1.8 0.4 0.2 0.4 2.6 6.6 7.5 0.5 0.8 0.0 2.5 1.2 2.5 1.5 1.4 0.1 4.8 0.0 4.1 0.0 6.4 1.6 2.1 0.3 2.7 7.3 2.5 1.8 3.3 3.9 1.5 1.0 2.0 1.9 4.4 4.7 6.1 1.9 0.2 0.0 5.5 0.0 1.7 0.0 0.0 0.0 0.7 0.0 2.2 0.9 0.4 1.7 0.0 0.1 1.4 2.1 0.0 0.0 0.0 0.9 0.6 0.1 0.0 0.0 0.0 0.2 0.3 1.8 3.0 0.0 0.0 1.2 0.0 2.0 0.3 0.0 1.1 4.1 0.1 1.3 0.0 1.3 0.2 0.4 0.2 0.0 1.8 0.2 1.6 0.0 0.6 0.0 6.0 1.1 0.0 0.0 0.0 1.2 10.2 1.4 0.0 1.4 0.6 1.8 6.5 0.9 0.9 0.8 0.1 0.2 0.0 0.6 0.1 ASAH2B "ASAH2C, ASAH2L, bA449O16.3, bA98I6.3" ENSG00000204147 "N-acylsphingosine amidohydrolase 2B" P0C7U1 10 50739318-50816495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "intestine: 27.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 19.2" HPA061171 Supported Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA061171: AB_2684442" "unprognostic (6.86e-3)" "unprognostic (1.91e-2)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "unprognostic (1.18e-2)" "unprognostic (5.42e-3)" "unprognostic (5.03e-3)" "unprognostic (2.21e-2)" "unprognostic (1.11e-1)" "unprognostic (3.79e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-3)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" 2.8 8.3 6.5 3.3 10.7 2.3 4.6 4.4 14.5 4.0 4.5 1.5 3.8 27.5 5.1 6.2 4.4 4.8 4.3 7.8 7.2 9.0 7.3 12.2 3.7 2.9 5.7 8.3 5.6 7.6 8.8 12.8 2.1 7.4 6.3 5.3 7.0 6.6 4.4 5.7 3.0 16.0 4.4 3.9 3.0 6.4 5.2 2.0 2.7 5.6 6.8 4.8 3.8 3.4 1.4 3.2 0.5 0.1 0.7 6.0 1.5 1.9 2.0 3.1 5.2 1.1 2.6 2.5 9.7 5.3 5.9 4.9 6.8 4.9 0.1 3.7 2.1 2.0 2.0 3.6 4.1 4.8 3.7 4.0 1.3 5.8 4.5 3.9 1.7 1.9 3.3 4.8 5.6 8.7 1.9 1.2 0.0 6.2 2.5 4.8 4.3 2.8 0.2 4.0 5.5 19.2 0.1 7.3 2.4 3.5 7.2 6.0 12.1 3.3 4.1 3.4 3.5 6.9 1.2 6.4 2.5 11.6 5.3 11.4 3.0 0.4 0.0 12.8 0.0 4.3 0.5 0.1 0.0 2.2 0.0 6.0 0.7 3.5 2.5 0.0 1.4 4.9 4.5 0.4 0.7 0.1 3.2 3.9 1.5 6.5 10.7 4.4 14.5 7.2 9.0 5.7 8.3 7.4 2.0 3.0 0.6 0.5 0.8 1.4 5.5 4.9 2.5 1.4 1.2 5.2 7.9 1.3 5.0 4.1 0.1 1.5 2.0 0.0 4.1 1.2 1.8 1.1 0.0 6.8 0.3 0.0 6.4 1.8 0.0 0.8 1.7 0.0 1.7 0.0 5.1 4.0 3.3 3.4 1.1 4.1 4.4 0.0 2.1 3.7 1.8 0.4 0.5 2.2 4.1 0.8 ASB10 GLC1F ENSG00000146926 "Ankyrin repeat and SOCS box containing 10" Q8WXI3 7 151175698-151187832 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "heart muscle: 12.3;skeletal muscle: 44.0;tongue: 15.3" "Cell type enriched" "Detected in single" 122 "Cardiomyocytes: 12.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079685 Enhanced NA NA "HPA079685: " "unprognostic (6.72e-3)" "unprognostic (1.96e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.2 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 15.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASB11 DKFZp779E2460 ENSG00000165192 "Ankyrin repeat and SOCS box containing 11" Q8WXH4 X 15281697-15315656 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 51.8;skeletal muscle: 50.7;tongue: 29.8" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 7.7;Melanocytes: 6.8" "Cancer enriched" "Detected in single" 20 "melanoma: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 2.2;basal ganglia: 7.7;cerebral cortex: 5.7;hippocampal formation: 2.9;olfactory region: 5.0" "Not detected" "Not detected" NA NA "unprognostic (5.89e-3)" "unprognostic (1.04e-1)" "unprognostic (9.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.42e-2)" "unprognostic (5.54e-2)" "unprognostic (2.04e-2)" "unprognostic (2.36e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (6.21e-2)" 2.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 1.2 1.3 0.1 0.0 51.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 5.0 2.2 0.0 50.7 0.5 0.1 0.0 0.1 0.1 2.8 0.1 0.0 0.0 0.3 29.8 2.3 0.1 0.1 0.6 0.6 0.8 0.3 1.4 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.2 0.4 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.4 0.4 0.3 0.1 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.3 0.8 1.4 0.1 0.6 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.3 0.3 6.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.3 ASB12 FLJ39577 ENSG00000198881 "Ankyrin repeat and SOCS box containing 12" Q8WXK4 X 64224196-64230631 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 43.4;tongue: 11.5" "Cell type enriched" "Detected in some" 4 "Late spermatids: 14.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 4.0;naive B-cell: 1.1;T-reg: 1.0" "Group enriched" "Detected in many" 6 "B-cells: 1.1;granulocytes: 4.0;T-cells: 1.0" "Cell line enhanced" "Detected in some" "AF22: 3.8;HEK 293: 2.1;HL-60: 2.2;HMC-1: 2.7;JURKAT: 2.2;NB-4: 2.2;NTERA-2: 2.3;REH: 2.1;THP-1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA049542 Uncertain NA NA "HPA049542: AB_2680810" "unprognostic (6.52e-2)" "unprognostic (2.31e-1)" "unprognostic (1.48e-2)" "unprognostic (1.06e-3)" "unprognostic (6.76e-2)" "unprognostic (4.23e-2)" "unprognostic (6.50e-2)" "unprognostic (8.25e-2)" "unprognostic (6.75e-2)" "unprognostic (9.69e-3)" "unprognostic (6.75e-3)" "unprognostic (5.18e-2)" "unprognostic (5.12e-2)" "unprognostic (5.15e-2)" "unprognostic (1.35e-1)" "unprognostic (4.32e-2)" "unprognostic (4.63e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.0 1.0 0.7 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.2 43.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.6 11.5 0.7 0.0 0.0 1.1 0.0 4.0 0.3 0.1 1.0 0.3 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.5 0.6 0.0 0.0 0.0 0.9 0.0 0.4 0.0 2.1 1.8 0.0 0.0 0.0 2.2 2.7 0.0 0.5 0.0 0.0 0.0 0.0 2.2 0.3 1.2 0.0 0.1 0.5 2.2 2.3 0.5 0.4 2.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 3.5 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.6 0.0 0.0 0.0 4.0 0.0 0.0 0.3 0.3 0.4 0.0 0.4 0.2 0.0 1.1 0.3 0.2 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 ASB14 DKFZp313L0121 ENSG00000239388 "Ankyrin repeat and SOCS box containing 14" A6NK59 3 57268347-57292682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "skeletal muscle: 26.3;tongue: 33.6" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Cardiomyocytes: 6.7;Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-3)" "unprognostic (1.85e-1)" "unprognostic (3.64e-1)" "unprognostic (7.14e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.37e-3)" "unprognostic (1.81e-4)" "unprognostic (1.11e-1)" "unprognostic (1.37e-1)" "unprognostic (1.24e-2)" "unprognostic (1.45e-2)" "unprognostic (6.69e-2)" "unprognostic (6.87e-2)" "unprognostic (9.68e-2)" "unprognostic (5.93e-2)" "unprognostic (5.71e-3)" 0.7 0.4 0.3 0.6 0.3 1.9 0.7 0.6 0.6 0.4 0.3 0.3 0.3 0.3 0.3 0.6 0.5 0.5 0.3 5.0 0.3 0.3 0.3 0.3 0.6 0.7 0.3 0.3 0.7 2.3 0.0 0.3 0.3 0.3 0.3 0.0 0.6 0.8 0.3 26.3 1.0 0.6 0.3 0.3 0.6 0.5 0.3 0.3 0.3 0.8 33.6 1.3 0.3 0.7 2.4 1.6 0.0 0.5 0.5 0.6 0.1 0.8 0.4 0.6 1.3 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.7 2.3 3.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.7 0.8 1.4 2.8 0.3 0.0 2.7 1.5 0.0 0.0 0.0 0.0 2.1 0.0 1.5 0.4 2.1 0.0 0.4 2.4 3.0 0.6 0.5 1.1 0.5 0.8 0.6 0.0 2.1 0.8 2.7 0.6 1.1 0.3 1.3 1.0 0.5 1.0 0.5 0.8 2.4 2.0 1.5 1.8 1.3 2.3 1.8 0.8 0.0 0.5 0.0 0.2 0.1 0.2 0.7 0.3 0.0 0.4 2.4 0.6 0.6 0.0 0.5 0.2 1.6 0.0 0.1 0.3 0.3 0.6 0.4 0.3 0.3 0.3 0.3 0.3 0.3 3.0 0.3 0.0 0.0 0.0 0.0 6.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASB15 FLJ43370 ENSG00000146809 "Ankyrin repeat and SOCS box containing 15" Q8WXK1 7 123567010-123639481 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "heart muscle: 20.1;skeletal muscle: 52.0;tongue: 28.1" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 44.7;Early spermatids: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.19e-1)" "unprognostic (7.45e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-1)" "unprognostic (6.09e-6)" "unprognostic (7.31e-2)" "unprognostic (6.39e-2)" 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 20.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 52.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 28.1 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 44.7 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 26.9 0.0 0.0 0.0 0.4 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.6 0.0 3.3 0.0 0.0 0.2 0.5 0.0 0.0 4.2 0.0 0.0 0.0 0.4 0.2 0.1 0.9 0.0 0.0 0.4 ASB16 FLJ30165 ENSG00000161664 "Ankyrin repeat and SOCS box containing 16" Q96NS5 17 44170447-44179083 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.4;tongue: 17.6" "Cell type enhanced" "Detected in some" 13 "Horizontal cells: 1.6;Ito cells: 1.3;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 13 "cerebellum: 11.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066834 Approved Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA066834: AB_2685732" "unprognostic (2.72e-2)" "unprognostic (8.47e-3)" "unprognostic (4.24e-2)" "unprognostic (1.46e-1)" "unprognostic (1.12e-1)" "unprognostic (5.95e-2)" "unprognostic (2.45e-2)" "unprognostic (2.31e-3)" "unprognostic (1.03e-2)" "unprognostic (6.13e-2)" "unprognostic (7.23e-4)" "unprognostic (5.84e-2)" "unprognostic (3.97e-2)" "unprognostic (8.53e-3)" "unprognostic (7.33e-2)" "unprognostic (2.20e-1)" "unprognostic (1.07e-3)" 0.9 0.6 0.2 1.3 0.3 1.2 0.5 11.4 0.7 0.6 1.2 0.3 0.9 1.3 1.3 1.9 1.1 1.0 0.6 12.6 0.7 0.4 0.8 0.4 0.7 1.9 0.6 0.2 1.1 7.0 1.6 1.8 0.3 0.8 1.7 0.0 2.7 1.2 0.1 38.4 1.9 1.3 4.1 0.2 1.8 1.3 0.6 0.3 0.0 0.9 17.6 1.1 1.6 1.5 4.4 2.9 9.6 2.4 4.0 4.5 2.7 2.1 4.1 4.9 4.6 0.0 0.0 4.0 4.5 0.0 0.0 0.0 3.1 2.4 3.3 2.8 0.0 1.0 5.1 0.0 0.0 0.0 5.1 7.3 2.1 7.1 3.4 0.0 2.2 6.6 0.0 0.0 0.0 0.0 1.3 0.0 5.0 3.8 8.3 0.0 3.5 2.6 4.1 1.5 0.8 4.9 8.3 4.8 4.9 0.0 3.3 5.1 2.8 2.1 0.6 0.7 1.5 6.4 2.1 2.2 6.2 5.7 3.8 2.8 12.7 6.2 3.1 1.4 3.2 4.1 4.0 2.4 9.6 3.1 2.2 3.7 4.4 3.3 3.0 1.2 3.8 4.5 2.8 7.3 4.0 1.9 2.9 3.2 2.7 0.2 0.3 11.4 0.6 0.7 0.4 0.6 0.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 ASB17 ENSG00000154007 "Ankyrin repeat and SOCS box containing 17" Q8WXJ9 1 75918873-75932431 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 33.3" "Cell type enriched" "Detected in some" 4 "Early spermatids: 933.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 933.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 226.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.7 0.0 0.0 0.0 3.2 1.7 0.0 0.0 0.0 0.0 0.0 ASB18 ENSG00000182177 "Ankyrin repeat and SOCS box containing 18" Q6ZVZ8 2 236194872-236264409 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "heart muscle: 9.8;skeletal muscle: 14.3" "Cell type enriched" "Detected in single" 21 "Cardiomyocytes: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 1.7;HEK 293: 2.4;K-562: 2.8;MCF7: 3.1;PC-3: 1.4;RH-30: 2.5;SiHa: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.12e-1)" "unprognostic (7.33e-3)" "unprognostic (3.07e-1)" "unprognostic (1.78e-6)" "unprognostic (4.75e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.0 1.9 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.4 0.0 2.5 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.0 1.4 0.6 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ASB2 ASB-2 ENSG00000100628 "Ankyrin repeat and SOCS box containing 2" Q96Q27 14 93934153-93976791 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.9" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 40.8;Early spermatids: 26.4;Late spermatids: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 8 "eosinophil: 23.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.8;RPMI-8226: 8.0;U-266/70: 24.0;U-266/84: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001546 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA001546: AB_1078224" "unprognostic (5.65e-4)" "unprognostic (8.19e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.62e-6)" "unprognostic (4.11e-2)" "unprognostic (1.61e-1)" "unprognostic (5.29e-2)" "unprognostic (1.05e-3)" "unprognostic (4.25e-2)" "unprognostic (1.48e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (2.49e-7)" "unprognostic (2.51e-3)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (2.27e-1)" 3.1 0.5 0.2 7.9 0.8 0.4 0.5 0.2 1.7 7.4 14.0 0.0 4.6 2.2 11.9 5.7 7.2 6.5 7.7 17.2 0.2 0.2 0.3 0.3 0.8 2.3 0.3 0.6 2.3 0.3 0.3 0.2 0.3 0.5 8.5 1.5 1.5 1.6 5.8 96.9 0.5 4.4 24.4 0.3 1.5 5.0 0.3 0.0 0.0 0.7 25.7 4.7 14.3 4.5 0.9 2.6 23.1 3.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 24.0 5.3 0.8 0.2 2.5 0.5 0.0 0.0 23.1 0.8 1.0 0.1 0.9 0.8 1.7 2.6 0.2 0.1 0.2 0.0 0.0 3.0 0.1 1.1 0.5 0.2 0.8 0.2 1.7 0.2 0.2 0.3 0.6 0.5 0.0 0.0 0.0 1.4 0.0 0.3 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 26.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 20.6 0.3 1.0 1.7 9.0 0.0 0.9 0.3 0.0 0.4 0.0 1.1 0.0 3.1 0.9 5.9 0.1 2.4 6.9 0.0 0.1 ASB4 ASB-4 ENSG00000005981 "Ankyrin repeat and SOCS box containing 4" Q9Y574 7 95478444-95540232 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "adrenal gland: 28.6;pituitary gland: 40.1;skeletal muscle: 20.7" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.4;Ciliated cells: 2.7;Early spermatids: 1.9;Late spermatids: 1.6" "Cancer enhanced" "Detected in some" "stomach cancer: 1.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 7.0;Hep G2: 11.4;SCLC-21H: 7.2" "Group enriched" "Detected in some" 4 "basal ganglia: 10.0;hypothalamus: 37.1" "Region enriched" "Detected in single" 7 "midbrain: 3.7" HPA055240 Uncertain NA NA "HPA055240: AB_2682753" "unprognostic (1.41e-1)" "unprognostic (3.67e-1)" "unprognostic (1.88e-2)" "unprognostic (2.66e-1)" "unprognostic (3.71e-1)" "unprognostic (2.85e-3)" "unprognostic (1.17e-1)" "unprognostic (3.55e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "unprognostic (2.92e-2)" "unprognostic (4.24e-1)" "unprognostic (9.13e-7)" "unprognostic (1.71e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-1)" "unprognostic (7.23e-2)" 0.3 28.6 0.7 0.1 1.1 0.3 0.2 0.1 1.3 0.1 0.1 1.3 0.1 0.2 0.1 0.3 0.1 0.2 0.4 2.6 0.7 0.6 0.1 1.0 0.4 0.1 1.7 0.5 0.1 0.4 0.0 40.1 1.3 0.2 0.2 0.0 0.1 0.3 0.1 20.7 0.2 0.2 0.1 1.6 0.1 0.4 0.2 0.1 0.2 0.2 2.5 0.4 0.1 0.1 1.0 0.6 1.3 0.3 0.9 0.7 0.0 0.3 7.0 0.3 2.5 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.8 1.3 0.2 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.5 11.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.1 0.3 0.1 0.6 0.0 0.2 0.2 0.3 0.2 0.2 1.6 0.2 0.2 0.0 0.2 0.2 7.2 0.0 0.1 0.4 0.7 0.3 0.1 0.3 0.3 0.4 0.4 0.1 0.2 0.8 0.2 0.4 0.2 0.4 0.2 0.3 0.3 0.5 0.6 0.1 0.7 1.0 0.6 0.5 0.2 1.0 0.7 0.7 1.3 0.9 0.3 0.6 0.3 0.0 0.7 1.1 0.1 1.3 0.7 0.6 1.7 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.0 2.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 229.8" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 165.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 3.6 7.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 229.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 ASB8 "FLJ21255, MGC5540" ENSG00000177981 "Ankyrin repeat and SOCS box containing 8" Q9H765 12 48147788-48181213 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.4" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003299 Approved NA NA "HPA003299: AB_1845072" "unprognostic (1.35e-2)" "unprognostic (1.32e-1)" "unprognostic (2.91e-2)" "unprognostic (8.82e-3)" "unprognostic (1.07e-1)" "unprognostic (1.06e-2)" "unprognostic (2.40e-3)" "unprognostic (3.51e-2)" "unprognostic (3.66e-2)" "unprognostic (1.29e-3)" "unprognostic (3.82e-3)" "unprognostic (1.14e-1)" "prognostic favorable (6.57e-6)" "unprognostic (2.88e-2)" "unprognostic (1.76e-1)" "unprognostic (2.04e-2)" "unprognostic (6.26e-2)" 12.6 12.8 11.1 8.2 13.8 22.7 9.1 18.2 17.2 9.8 9.7 12.2 7.4 9.0 11.5 9.9 10.7 8.3 8.6 19.0 10.2 10.4 13.3 13.4 7.5 9.2 10.9 10.2 9.8 10.3 14.5 14.7 7.7 16.8 9.3 11.5 15.4 10.2 10.0 106.4 9.3 11.3 10.6 9.6 10.1 9.0 8.5 8.8 15.7 10.2 22.3 11.1 10.5 7.2 11.1 9.3 42.7 12.3 13.1 14.2 8.2 9.3 7.6 9.5 13.8 13.9 12.4 6.7 17.9 11.6 11.6 11.1 12.4 11.8 15.7 13.6 14.9 6.7 8.4 14.8 10.2 13.2 19.0 12.2 19.0 10.8 6.4 10.6 18.3 17.7 12.1 9.8 15.2 10.0 21.1 11.7 18.3 14.5 19.8 10.4 8.7 16.6 13.0 3.4 12.0 14.2 11.0 14.4 16.4 9.1 9.9 14.2 9.4 10.6 12.5 10.4 9.0 23.0 12.4 9.0 10.2 7.4 10.2 7.6 17.5 20.5 13.8 12.8 40.7 5.6 25.6 8.7 42.7 12.3 9.7 11.5 11.1 13.3 12.3 8.5 8.9 13.6 14.2 20.7 13.1 12.3 9.3 12.6 8.2 11.1 13.8 18.2 17.2 10.2 10.4 10.9 10.2 16.8 8.8 20.8 23.5 28.9 6.9 6.3 59.5 59.8 22.9 18.7 15.9 15.7 58.9 17.8 34.9 18.5 16.6 20.4 24.8 0.0 19.1 10.9 14.7 9.7 19.7 27.7 21.0 38.1 17.9 17.2 20.0 58.2 22.5 17.2 20.3 19.8 23.8 46.1 15.6 24.3 26.2 29.5 113.0 51.8 15.3 29.3 17.3 9.7 14.3 34.6 21.8 7.4 ASB9 "DKFZP564L0862, FLJ20636, MGC4954" ENSG00000102048 "Ankyrin repeat and SOCS box containing 9" Q96DX5 X 15235288-15270467 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.0" "Cell type enhanced" "Detected in many" 21 "Distal tubular cells: 34.9;Proximal tubular cells: 30.2;Spermatogonia: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "myeloid DC: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 15.1;EFO-21: 12.0;PC-3: 31.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA003014, HPA003060, CAB004997" Enhanced NA NA "CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225" "unprognostic (8.26e-3)" "unprognostic (1.70e-1)" "unprognostic (8.82e-2)" "unprognostic (2.25e-3)" "unprognostic (1.31e-1)" "unprognostic (2.70e-2)" "unprognostic (6.44e-2)" "unprognostic (1.45e-2)" "unprognostic (2.39e-1)" "unprognostic (9.23e-2)" "unprognostic (9.30e-2)" "prognostic unfavorable (4.36e-4)" "unprognostic (2.88e-1)" "unprognostic (2.27e-2)" "unprognostic (9.22e-2)" "unprognostic (1.27e-1)" "unprognostic (2.57e-1)" 1.6 0.9 0.6 1.6 0.4 1.1 2.1 0.5 0.8 2.4 0.9 0.4 1.3 0.7 4.1 6.4 2.1 1.3 4.0 1.5 0.6 0.3 11.6 11.6 3.6 1.6 1.7 0.3 1.1 6.8 0.1 0.6 1.9 0.9 1.6 1.4 1.3 3.0 2.5 1.9 1.0 1.3 1.3 0.5 8.9 2.4 21.0 0.3 4.0 1.3 2.0 3.2 1.0 0.9 0.5 4.3 1.2 1.8 0.5 3.6 1.0 0.8 15.1 0.1 1.4 0.1 0.7 0.4 0.3 1.6 1.7 0.7 3.4 0.1 0.2 12.0 0.5 8.5 4.4 0.0 0.7 1.1 3.0 0.3 3.6 7.5 6.9 0.0 0.0 0.0 4.0 0.1 0.1 0.1 0.2 5.6 1.1 0.0 3.5 1.0 1.2 3.0 0.1 7.1 2.1 31.5 0.0 6.7 3.2 4.7 2.6 1.8 1.5 0.5 0.9 5.2 0.8 0.0 0.4 4.8 0.0 1.1 0.7 2.3 0.2 3.0 0.1 0.5 0.0 8.3 1.2 1.8 0.1 0.2 0.0 2.0 0.2 0.6 0.2 4.3 0.5 3.6 1.0 0.7 0.5 0.1 0.2 0.1 1.0 0.6 0.4 0.5 0.8 0.6 0.3 1.7 0.3 0.9 0.3 0.0 0.0 0.5 0.6 1.6 0.0 0.3 7.6 6.7 1.2 0.0 0.0 0.1 34.9 1.1 2.1 6.0 0.0 0.0 1.8 0.1 1.0 0.6 1.1 12.1 3.8 0.0 10.3 17.8 5.0 5.6 1.7 2.8 15.1 0.0 0.0 0.0 1.3 0.0 0.7 30.2 0.0 0.0 0.3 1.6 128.0 2.8 0.1 0.0 2.0 0.3 ASCL1 "ASH1, bHLHa46, HASH1" ENSG00000139352 "Achaete-scute family bHLH transcription factor 1" P50553 12 102957686-102960516 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3;liver: 23.0;pituitary gland: 29.4" "Cell type enriched" "Detected in some" 7 "Intestinal endocrine cells: 34.9" "Group enriched" "Detected in many" 6 "glioma: 21.4;lung cancer: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "SCLC-21H: 33.4;SH-SY5Y: 18.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029217, HPA076307" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029217: AB_10669595, HPA076307: " "unprognostic (7.92e-2)" "unprognostic (4.37e-3)" "unprognostic (4.55e-2)" "unprognostic (5.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.22e-2)" "unprognostic (1.56e-1)" "unprognostic (2.09e-1)" "unprognostic (4.84e-2)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (7.10e-6)" "unprognostic (3.40e-1)" "unprognostic (2.17e-1)" "unprognostic (3.76e-1)" "unprognostic (5.52e-2)" 0.9 2.8 11.1 0.7 6.9 0.7 0.7 3.3 19.3 1.3 0.9 6.6 0.0 0.9 1.0 0.8 0.7 2.2 0.8 0.7 8.5 5.8 0.8 23.0 1.7 1.4 7.6 4.7 1.6 0.9 0.7 29.4 0.8 13.9 1.1 1.0 0.0 0.7 0.8 0.8 0.7 0.8 0.9 18.7 0.7 3.2 0.9 7.3 6.0 1.0 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 18.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.9 3.3 10.7 8.5 5.8 7.6 4.7 13.9 7.3 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.1 4.8 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 ASCL2 "ASH2, bHLHa45, HASH2" ENSG00000183734 "Achaete-scute family bHLH transcription factor 2" Q99929 11 2268495-2270952 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 21.8;placenta: 16.0" "Cell type enriched" "Detected in many" 12 "Extravillous trophoblasts: 947.6" "Group enriched" "Detected in many" 5 "colorectal cancer: 76.1;stomach cancer: 23.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 18.5;NB-4: 5.4;OE19: 10.0;SCLC-21H: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (2.71e-3)" "prognostic favorable (5.11e-4)" "unprognostic (2.03e-1)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (2.69e-2)" "unprognostic (2.93e-2)" "unprognostic (7.88e-2)" "unprognostic (3.79e-2)" "unprognostic (1.22e-2)" "prognostic favorable (4.73e-4)" "unprognostic (5.85e-2)" "unprognostic (1.45e-6)" "unprognostic (8.86e-3)" "unprognostic (5.48e-2)" "unprognostic (6.12e-4)" "unprognostic (1.07e-3)" 0.5 0.3 0.7 2.2 1.3 0.9 1.1 0.0 1.2 2.7 7.3 1.4 21.8 9.2 3.6 1.2 2.5 0.7 0.4 0.8 0.6 0.4 2.5 1.1 0.9 0.9 1.5 0.6 0.4 1.5 0.0 0.1 16.0 1.1 3.3 3.4 0.1 9.7 9.5 0.6 10.0 7.3 0.2 3.7 3.0 2.8 1.6 1.1 1.1 0.7 0.8 2.7 3.6 3.3 0.1 1.0 8.6 2.0 0.0 3.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.0 5.4 0.4 10.0 0.0 0.0 0.0 0.0 0.0 0.4 15.1 0.0 0.0 0.3 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.5 1.4 8.6 3.0 2.0 0.2 0.1 0.7 1.7 1.0 0.0 0.2 1.7 1.2 0.0 1.7 0.0 0.0 0.3 0.7 1.3 0.0 1.2 0.6 0.4 1.5 0.6 1.1 1.1 0.0 0.0 1.9 12.4 12.0 0.0 0.8 0.0 1.4 0.0 19.2 0.0 15.5 6.6 0.1 0.0 0.7 6.8 0.0 0.0 947.6 0.8 3.8 0.0 0.2 28.4 0.0 75.2 20.3 18.4 0.0 1.7 8.5 1.7 1.0 19.5 0.0 0.0 3.4 1.4 0.3 0.0 0.0 0.3 0.3 11.3 4.1 19.5 8.5 77.9 4.6 ASCL3 "bHLHa42, HASH3, Sgn1" ENSG00000176009 "Achaete-scute family bHLH transcription factor 3" Q9NQ33 11 8937579-8938211 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "salivary gland: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;CACO-2: 1.1;HeLa: 1.0;U-2 OS: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA027032 Uncertain NA NA "HPA027032: AB_10602434" "unprognostic (8.91e-2)" "unprognostic (1.32e-1)" "unprognostic (3.53e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 2.6 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.9 2.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASCL4 "bHLHa44, HASH4" ENSG00000187855 "Achaete-scute family bHLH transcription factor 4" Q6XD76 12 107774385-107776644 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.5;parathyroid gland: 3.1" "Cell type enriched" "Detected in single" 5 "Macrophages: 1.6" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Cell type enhanced" "Detected in single" "myeloid DC: 2.5" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.5" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.7" "Not detected" "Not detected" HPA036116 Uncertain NA NA "HPA036116: AB_10671833" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.86e-2)" "unprognostic (8.88e-4)" "unprognostic (2.09e-5)" "unprognostic (1.40e-1)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.88e-3)" "unprognostic (9.25e-2)" "unprognostic (1.80e-1)" "unprognostic (2.90e-1)" 0.1 0.0 0.7 0.3 0.2 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.9 0.0 0.0 0.7 0.4 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 1.0 0.3 0.0 0.4 0.5 0.4 0.5 0.0 1.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASCL5 bHLHa47 ENSG00000232237 "Achaete-scute family bHLH transcription factor 5" Q7RTU5 1 201113953-201127184 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 5.2;pancreas: 7.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;MCF7: 1.7;OE19: 3.0;PC-3: 2.7;SCLC-21H: 3.1;U-2 OS: 1.7" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 2.1;hippocampal formation: 1.8" NA NA "unprognostic (9.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.52e-2)" "unprognostic (6.32e-2)" "unprognostic (9.43e-2)" "unprognostic (8.04e-3)" "unprognostic (3.17e-2)" "unprognostic (2.37e-1)" "unprognostic (4.84e-2)" "unprognostic (9.50e-2)" "unprognostic (7.48e-2)" "unprognostic (9.82e-2)" "unprognostic (2.25e-7)" "unprognostic (2.95e-1)" "unprognostic (1.38e-1)" "unprognostic (4.70e-2)" "unprognostic (1.48e-2)" 0.2 0.4 2.5 0.3 5.2 0.1 0.2 0.4 1.8 0.2 0.2 1.3 0.2 0.3 1.6 0.2 0.2 0.3 0.2 0.2 1.2 1.8 0.2 0.2 0.6 0.5 0.6 0.2 0.9 7.3 0.1 0.5 0.2 1.9 0.5 0.1 0.2 0.2 0.2 1.4 0.1 0.5 0.2 0.2 0.5 0.5 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.9 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.1 0.3 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 1.1 0.0 1.1 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.7 0.0 0.1 0.2 3.0 2.7 0.0 0.0 0.0 0.0 0.2 3.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 5.2 0.4 1.8 1.2 1.8 0.6 0.2 1.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 ASF1B FLJ10604 ENSG00000105011 "Anti-silencing function 1B histone chaperone" Q9NVP2 19 14119509-14136956 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 39.2;lymphoid tissue: 45.1;testis: 45.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 35.5;Extravillous trophoblasts: 30.7;Spermatocytes: 54.1;Spermatogonia: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 7 "neutrophil: 39.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 39.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054036, HPA069385" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA054036: AB_2682350, HPA069385: " "unprognostic (3.14e-1)" "prognostic favorable (4.45e-5)" "unprognostic (2.41e-3)" "unprognostic (2.40e-1)" "unprognostic (2.15e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.87e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.48e-3)" "prognostic unfavorable (2.22e-16)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (3.92e-2)" "unprognostic (4.31e-2)" 1.3 1.6 0.7 15.1 1.3 10.0 0.9 0.3 0.8 2.0 7.2 0.8 1.1 4.9 0.9 1.9 9.3 0.7 3.0 1.2 0.6 0.4 1.5 1.4 3.1 11.5 0.9 0.3 1.0 0.8 0.0 0.9 3.8 0.9 0.9 7.6 0.7 2.0 0.3 0.7 2.9 5.2 1.5 1.0 6.4 3.1 45.2 0.6 45.1 0.7 6.4 14.0 1.9 2.9 0.8 0.8 39.2 5.2 1.0 3.3 2.0 28.6 11.1 17.5 13.3 1.7 1.6 7.6 15.2 12.5 28.6 36.2 11.5 14.1 27.4 14.0 7.7 12.1 17.6 18.6 10.6 22.5 24.3 13.4 25.9 23.5 8.0 0.1 17.4 16.2 0.3 0.7 16.0 5.5 3.2 11.1 20.0 22.3 38.4 14.0 32.6 35.3 14.8 8.0 30.2 27.1 34.1 25.9 22.6 8.9 12.4 21.4 7.8 18.0 13.3 7.6 4.9 10.0 18.0 5.4 16.6 10.3 41.9 25.1 20.6 20.8 35.0 13.2 32.0 16.1 0.4 4.0 1.0 1.4 5.2 0.8 0.8 1.2 1.5 0.8 0.8 0.7 1.3 39.2 1.0 5.1 0.3 3.3 2.0 0.7 1.3 0.3 0.8 0.6 0.4 0.9 0.3 0.9 0.6 0.0 1.1 4.5 2.3 2.3 0.0 0.4 2.5 0.0 1.2 0.0 0.0 9.2 0.0 1.3 35.5 0.1 2.9 23.3 1.1 30.7 0.4 0.8 4.6 0.0 17.8 0.0 1.2 0.6 7.1 22.9 0.0 4.2 1.7 1.8 3.4 0.4 0.8 2.9 0.7 0.0 0.7 0.0 0.2 54.1 88.8 1.0 8.7 4.4 7.1 0.9 ASGR1 CLEC4H1 ENSG00000141505 "Asialoglycoprotein receptor 1" P07306 17 7173431-7179564 "Predicted intracellular proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 171.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 1020.7" "Cancer enriched" "Detected in many" 90 "liver cancer: 131.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7" "Group enriched" "Detected in many" 13 "dendritic cells: 13.7;monocytes: 39.1" "Cell line enriched" "Detected in some" 30 "Hep G2: 104.5" "Region enriched" "Detected in many" 9 "cerebellum: 49.4" "Not detected" "Not detected" "HPA011954, HPA012852" Enhanced Supported "Vesicles,Cell Junctions" "Intracellular and membrane" NA NA Vesicles "Cell Junctions" "HPA011954: AB_1845079, HPA012852: AB_1845080" "unprognostic (3.56e-3)" "unprognostic (3.57e-1)" "unprognostic (8.76e-2)" "unprognostic (4.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-2)" "unprognostic (5.37e-2)" "unprognostic (2.15e-1)" "unprognostic (2.39e-1)" "unprognostic (8.55e-5)" "unprognostic (1.55e-1)" "unprognostic (8.33e-11)" "unprognostic (1.45e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-3)" "unprognostic (4.46e-3)" 0.2 0.1 0.8 0.9 0.6 0.6 0.2 2.8 1.8 0.1 0.2 0.2 0.2 0.5 0.2 0.1 0.1 0.1 0.7 0.1 0.8 0.8 0.1 171.0 0.7 0.3 0.4 1.2 0.1 0.3 0.9 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.3 0.3 0.5 0.2 2.9 0.2 0.1 1.4 0.1 0.1 0.3 0.1 0.2 13.7 2.1 39.1 0.1 0.3 10.1 0.0 0.1 2.0 0.9 0.0 0.0 0.1 0.1 0.2 0.2 0.3 3.5 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.3 104.5 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.1 1.8 1.6 0.2 0.1 0.1 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 2.1 39.1 0.1 0.1 17.9 0.3 0.1 0.0 0.0 13.7 0.2 0.1 0.1 1.1 0.1 4.5 0.6 0.1 10.1 0.8 0.6 2.8 1.8 0.8 0.8 0.4 1.2 0.7 0.2 0.0 6.6 13.0 1.0 2.9 31.7 1.2 73.9 1.4 2.3 3.5 151.2 3.2 3.3 0.8 212.5 12.7 0.3 23.3 0.2 3.6 2.0 0.8 0.0 1020.7 41.3 14.3 15.0 23.9 110.6 80.2 2.3 18.3 0.0 0.0 0.7 2.6 0.4 0.6 1.1 1.6 39.8 0.0 0.4 4.5 7.8 4.3 10.4 0.7 1.0 2.4 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 154.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 660.0" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 36.9;myeloid DC: 21.7" "Group enriched" "Detected in many" 52 "dendritic cells: 21.7;monocytes: 36.9" "Cell line enriched" "Detected in some" 8 "Hep G2: 107.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA 4700000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 0.2 0.0 0.3 1.4 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 3.4 0.2 0.2 0.0 0.2 154.1 0.5 4.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 21.7 0.5 36.9 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 36.9 0.2 0.0 3.8 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 9.5 0.3 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.0 9.0 14.0 0.0 0.0 0.0 0.0 152.8 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 23.3 0.0 0.1 0.0 0.1 2.3 660.0 6.9 0.0 6.8 16.0 35.5 0.4 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.5 0.0 0.0 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 43.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 3.1;Ciliated cells: 6.7;Club cells: 2.3;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 23.0;SH-SY5Y: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA058870: AB_2683841" "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 2.5 1.7 13.9 1.8 20.3 0.8 2.9 20.1 43.7 5.3 3.1 12.8 0.3 2.3 2.5 1.2 3.4 3.6 4.0 2.2 12.3 14.3 1.6 0.9 1.3 1.3 12.9 8.5 1.4 1.4 5.2 0.5 1.5 10.2 4.5 2.5 1.8 5.6 3.4 1.3 1.5 2.5 3.6 5.4 1.1 4.3 1.4 11.0 0.4 1.1 0.0 1.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.9 4.3 5.7 12.9 1.7 2.7 3.2 1.4 3.7 2.5 2.5 3.0 1.5 1.2 3.0 0.8 1.5 2.0 5.6 4.7 1.4 1.2 15.4 3.9 6.1 1.8 2.5 5.7 14.5 6.8 2.3 0.4 0.6 23.0 0.4 15.2 2.5 0.1 2.0 2.4 5.5 11.3 2.4 4.4 7.6 5.6 5.4 2.6 1.2 0.2 8.5 17.9 3.2 1.1 2.0 1.0 7.0 3.8 0.4 2.5 8.4 1.7 0.7 0.0 0.0 0.0 3.2 5.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 13.9 20.3 20.1 18.3 12.3 14.3 12.9 8.5 10.2 11.0 0.0 0.0 0.0 0.2 0.0 3.1 0.9 0.0 6.7 2.3 1.8 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.6 0.0 0.0 0.3 3.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 1.1 0.8 0.5 0.0 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.1 ASIC2 "ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG" ENSG00000108684 "Acid sensing ion channel subunit 2" Q16515 17 33013087-34174964 "Plasma proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 13.1;cervix, uterine: 6.8;endometrium 1: 9.5;smooth muscle: 3.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 25.0;Collecting duct cells: 8.7;Early spermatids: 15.9;Horizontal cells: 9.5;Late spermatids: 35.7" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 4.3;PC-3: 1.1;RPTEC TERT1: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052112 Enhanced NA NA "HPA052112: AB_2681733" "unprognostic (3.40e-1)" "unprognostic (2.45e-2)" "unprognostic (8.50e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-3)" "unprognostic (5.29e-2)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.44e-1)" 0.4 1.9 8.1 0.4 6.3 0.3 0.7 8.7 13.1 6.8 0.7 1.1 0.0 1.2 9.5 0.5 0.4 1.5 0.5 0.4 7.7 10.0 1.2 0.4 0.5 0.4 4.6 5.5 0.4 0.4 0.3 0.5 0.5 3.7 0.6 0.8 0.2 0.3 1.7 0.3 0.6 1.2 3.9 2.3 0.4 0.5 1.1 0.8 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.0 1.1 0.0 0.0 0.5 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 6.3 8.7 9.6 7.7 10.0 4.6 5.5 3.7 0.8 0.0 0.0 0.0 0.0 0.2 25.0 1.1 0.0 0.0 0.0 8.7 2.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 9.5 5.8 0.0 0.0 35.7 0.3 0.0 1.7 0.0 1.2 0.2 0.1 0.0 0.0 0.0 1.6 0.0 0.4 0.2 0.7 0.0 0.0 0.0 0.5 0.0 ASIC3 "ACCN3, DRASIC, TNaC1" ENSG00000213199 "Acid sensing ion channel subunit 3" Q9UHC3 7 151048292-151052756 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 11.8;Early spermatids: 11.6;Late spermatids: 43.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 17.2;U-266/84: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049155, HPA054805" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA049155: AB_2680657, HPA054805: AB_2732588" "unprognostic (8.71e-3)" "unprognostic (1.09e-1)" "unprognostic (1.92e-4)" "unprognostic (2.73e-1)" "unprognostic (7.06e-2)" "unprognostic (2.02e-2)" "unprognostic (2.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.42e-1)" "unprognostic (4.45e-2)" "unprognostic (8.64e-3)" "unprognostic (1.67e-2)" "unprognostic (1.33e-12)" "unprognostic (1.49e-2)" "unprognostic (7.38e-2)" "unprognostic (1.65e-2)" "unprognostic (5.31e-3)" 2.6 2.4 6.8 0.9 27.1 1.5 1.3 20.1 15.4 3.6 2.3 0.9 0.5 2.9 4.9 3.5 0.6 2.4 1.9 2.4 6.5 5.3 1.5 1.3 2.7 1.9 4.2 9.9 3.0 1.4 1.4 7.1 1.8 6.2 1.9 1.8 0.7 1.7 1.4 9.0 3.5 2.7 2.4 6.0 2.1 2.8 10.2 2.2 0.5 1.1 0.5 1.9 0.9 1.2 0.0 0.0 0.0 0.8 0.0 0.7 0.0 1.3 3.6 1.7 2.4 3.3 0.0 7.4 0.4 0.0 0.3 0.4 0.7 1.6 0.9 0.4 0.2 1.6 2.3 0.9 0.0 0.7 7.8 4.2 1.6 2.7 0.0 0.0 0.1 3.9 0.5 0.5 0.2 0.0 2.6 0.1 0.9 3.8 6.4 0.5 6.0 0.3 0.4 1.7 0.1 2.8 2.9 1.6 0.5 0.3 1.3 2.2 8.6 0.6 0.4 4.1 4.6 1.7 0.4 0.1 1.5 2.2 4.0 1.0 17.2 9.1 0.1 2.1 5.7 1.4 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.8 27.1 20.1 15.4 6.5 5.3 4.2 9.9 6.2 2.2 0.0 0.3 0.0 0.0 0.6 8.6 1.6 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.2 11.6 0.3 0.3 0.0 0.3 0.1 0.5 0.2 9.2 0.6 0.6 6.4 0.0 0.0 0.6 43.6 1.4 0.3 0.0 1.0 0.0 1.9 0.3 0.0 1.8 0.3 5.0 0.0 0.0 9.2 5.1 0.6 0.6 0.0 0.2 0.1 ASIC4 "ACCN4, BNAC4" ENSG00000072182 "Acid sensing ion channel subunit family member 4" Q96FT7 2 219514170-219538772 "Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.7;pituitary gland: 20.6" "Group enriched" "Detected in some" 10 "Bipolar cells: 200.8;Cone photoreceptor cells: 163.0" "Cancer enriched" "Detected in single" 38 "glioma: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "HEL: 19.1;HMC-1: 5.8;K-562: 10.9;SH-SY5Y: 5.2" "Region enhanced" "Detected in many" "basal ganglia: 65.5" "Low region specificity" "Detected in many" "HPA036042, HPA057078" Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Golgi apparatus, Centriolar satellite" "Nucleoplasm, Plasma membrane" "HPA036042: AB_10672998, HPA057078: " "unprognostic (3.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.55e-1)" "unprognostic (1.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.74e-2)" "unprognostic (3.04e-2)" "unprognostic (2.54e-1)" "unprognostic (6.53e-2)" "unprognostic (1.90e-2)" "unprognostic (9.46e-3)" "unprognostic (1.88e-1)" "unprognostic (7.80e-8)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (5.51e-1)" "unprognostic (2.48e-2)" 0.8 3.3 4.9 0.6 4.7 0.5 0.6 6.9 17.7 1.0 0.5 1.6 0.0 0.5 0.8 0.6 0.5 0.6 0.6 0.6 3.9 4.5 0.5 0.6 0.9 0.6 4.8 2.9 0.5 0.5 0.5 20.6 0.6 3.0 0.6 0.5 4.9 0.6 0.8 0.5 0.6 0.5 0.7 1.9 0.6 0.7 1.6 3.1 0.0 0.5 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 4.7 6.9 4.9 3.9 4.5 4.8 2.9 3.0 3.1 0.0 0.0 0.0 1.6 0.1 200.8 0.8 0.0 0.0 0.0 0.0 163.0 1.8 0.0 0.0 2.8 0.1 0.3 0.0 0.3 0.7 0.7 0.5 18.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 8.4 0.0 2.9 0.4 0.0 9.5 0.0 0.4 0.2 0.6 0.3 2.4 0.0 0.4 0.3 ASIC5 "ACCN5, HINAC, INAC" ENSG00000256394 "Acid sensing ion channel subunit family member 5" Q9NY37 4 155829729-155866273 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "intestine: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014903, HPA029444" Approved NA NA "HPA014903: AB_1844498, HPA029444: AB_10611671" "unprognostic (8.52e-5)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 7.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.3 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASIP "AGTIL, ASP" ENSG00000101440 "Agouti signaling protein" P42127 20 34194569-34269344 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.7;epididymis: 18.4;ovary: 24.8" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 25.4;Hofbauer cells: 12.3;Leydig cells: 11.5;Peritubular cells: 9.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "hippocampal formation: 5.4" "Cell type enriched" "Detected in single" 321 "plasmacytoid DC: 43.7" "Lineage enriched" "Detected in single" 321 "dendritic cells: 43.7" "Cell line enhanced" "Detected in some" "CACO-2: 6.6;HSkMC: 5.4;SK-MEL-30: 3.9;U-698: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048636 Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA048636: AB_2680471" "unprognostic (4.81e-2)" "unprognostic (7.46e-2)" "unprognostic (1.97e-3)" "unprognostic (3.26e-2)" "unprognostic (2.24e-1)" "unprognostic (3.07e-2)" "unprognostic (5.13e-2)" "unprognostic (4.57e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (5.53e-6)" "unprognostic (1.02e-1)" "unprognostic (3.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" 0.5 0.1 0.3 0.3 0.3 0.2 1.9 0.3 0.8 2.0 1.0 0.3 0.3 0.0 2.0 18.4 0.3 2.1 0.3 10.3 5.4 0.0 0.3 0.5 0.3 0.4 0.3 0.3 24.8 0.3 0.0 0.3 0.3 0.7 2.5 0.0 0.3 0.3 0.3 0.3 5.4 0.3 0.3 1.3 0.3 0.1 7.1 0.3 0.3 0.3 0.3 0.8 0.5 0.4 0.1 43.7 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.9 0.8 0.5 1.6 0.2 0.2 0.0 0.0 0.0 6.6 0.1 2.4 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.2 1.6 3.4 0.7 1.1 0.0 0.0 0.9 5.4 0.0 0.0 0.0 0.3 0.0 1.6 1.2 2.0 0.0 0.7 0.5 3.5 0.0 0.3 1.4 0.7 0.6 3.0 0.0 0.2 0.6 0.6 0.0 0.4 3.9 1.1 0.7 0.4 0.8 1.2 1.2 0.2 0.6 0.8 0.8 4.0 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.2 0.3 0.3 0.3 0.8 5.4 0.0 0.3 0.3 0.7 0.3 0.0 1.1 0.0 0.0 2.3 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 1.0 1.3 0.0 0.0 0.0 0.1 2.3 0.0 0.0 4.0 12.3 0.0 0.0 4.3 0.3 0.2 11.5 1.7 1.7 0.0 0.0 0.0 0.1 0.0 9.9 4.4 0.0 6.5 1.0 1.6 1.3 2.8 0.7 0.0 0.0 0.0 ASL ENSG00000126522 "Argininosuccinate lyase" P04424 7 66075798-66093558 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 226.8;Hepatocytes: 477.5;Paneth cells: 217.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003696, HPA016646" Enhanced Approved Cytosol NA NA 10000000 Cytosol "CAB003696: AB_425316, HPA016646: AB_1845096" "unprognostic (2.95e-2)" "prognostic unfavorable (4.05e-6)" "unprognostic (4.83e-1)" "unprognostic (4.18e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (2.07e-1)" "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (7.25e-2)" "unprognostic (4.95e-2)" "unprognostic (2.07e-2)" "unprognostic (3.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (8.40e-3)" 5.6 4.8 4.0 8.0 4.3 7.3 5.9 7.2 7.4 5.5 17.2 3.7 7.8 20.8 5.0 7.1 7.7 4.9 19.5 4.3 3.7 4.3 16.0 99.5 8.1 4.5 4.4 6.2 5.9 10.4 3.3 5.8 3.3 7.2 5.4 12.4 5.8 7.1 5.7 2.4 4.1 16.6 3.4 3.2 8.6 12.6 2.1 3.5 1.2 7.1 7.9 5.9 5.2 5.9 8.6 19.3 20.7 18.4 30.4 9.2 10.7 18.2 7.5 4.1 14.8 9.5 7.3 9.0 12.8 11.2 18.3 16.7 16.9 22.6 5.6 20.5 16.8 13.3 5.0 2.6 21.7 5.3 4.6 3.4 7.4 7.3 26.1 17.7 8.4 21.7 13.7 7.9 12.8 20.5 4.6 18.0 4.0 13.1 10.7 10.1 13.0 1.7 11.6 6.2 22.8 9.7 4.5 4.3 19.3 13.3 11.0 7.1 9.7 11.7 40.8 4.4 4.4 17.8 7.6 20.4 23.2 12.0 9.2 16.5 11.7 6.1 7.3 21.9 16.0 18.7 12.1 18.1 20.7 7.7 18.4 6.5 8.6 5.2 6.1 19.3 5.6 3.7 4.0 4.0 30.4 13.8 1.2 9.2 10.7 4.0 4.3 7.2 7.4 3.7 4.3 4.4 6.2 7.2 3.5 17.9 52.0 20.8 16.7 4.8 12.5 7.1 132.5 38.8 15.9 29.6 21.6 19.3 44.7 51.9 3.5 25.6 226.8 0.0 192.3 35.3 14.5 13.1 44.9 477.5 40.4 14.3 51.9 35.6 39.6 4.9 8.6 16.1 8.5 61.3 87.3 6.5 99.6 217.5 7.8 174.9 12.2 12.9 13.9 3.0 5.8 3.8 18.7 27.5 126.5 20.6 ASMT "ASMTY, HIOMT, HIOMTY" ENSG00000196433 "Acetylserotonin O-methyltransferase" P46597 X 1615001-1643081 "Enzymes, Predicted intracellular proteins" "Melatonin biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;epididymis: 7.0" "Cell type enhanced" "Detected in single" 28 "Alveolar cells type 2: 2.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "pons and medulla: 8.8" "Group enriched" "Detected in some" 4 "memory B-cell: 2.2;memory CD8 T-cell: 2.0;naive B-cell: 3.8;NK-cell: 1.0" "Group enriched" "Detected in many" 4 "B-cells: 3.8;NK-cells: 1.0;T-cells: 2.0" "Cell line enhanced" "Detected in some" "BEWO: 2.9;NTERA-2: 1.5;U-266/70: 2.2;U-266/84: 3.7" NA NA "unprognostic (1.84e-2)" "unprognostic (1.63e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (8.55e-4)" "unprognostic (1.54e-1)" "unprognostic (2.27e-2)" "unprognostic (4.30e-3)" "unprognostic (1.56e-1)" "unprognostic (1.43e-3)" "unprognostic (2.64e-1)" "unprognostic (4.04e-3)" "unprognostic (1.49e-1)" "unprognostic (3.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.79e-3)" 0.6 2.3 0.6 1.2 0.7 2.4 0.8 1.2 0.6 1.3 0.8 0.6 0.6 0.3 1.4 7.0 0.6 0.9 0.7 0.6 0.8 0.7 0.6 0.6 0.8 0.8 1.8 0.6 0.7 1.3 0.7 3.8 0.6 8.8 1.0 0.2 0.6 1.2 1.0 0.8 1.6 0.7 0.9 4.1 1.4 0.6 0.6 0.6 0.6 1.1 0.6 0.6 0.6 0.9 3.8 0.0 0.5 0.0 1.0 2.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 2.9 0.2 0.0 0.6 0.0 0.0 0.1 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.8 0.1 0.2 0.8 0.1 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.4 0.0 0.0 0.0 1.3 0.0 2.2 3.7 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.5 2.0 0.0 3.8 0.2 0.1 0.5 1.0 0.0 0.0 0.0 0.1 0.6 0.7 1.2 0.6 0.8 0.7 1.8 0.6 8.8 0.6 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 ASNS ENSG00000070669 "Asparagine synthetase (glutamine-hydrolyzing)" P08243 7 97852118-97872542 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Asparagine biosynthesis" Ligase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 68.0" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 197.3;Erythroid cells: 93.5;Late spermatids: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 8.6;T-cells: 13.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004924, HPA029318, HPA064737" Approved Enhanced Cytosol No No Cytosol "HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341" "unprognostic (3.93e-2)" "unprognostic (2.51e-1)" "unprognostic (6.70e-2)" "prognostic unfavorable (4.24e-4)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.79e-5)" "prognostic unfavorable (9.42e-6)" "unprognostic (2.28e-2)" "unprognostic (9.08e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-3)" "prognostic unfavorable (6.21e-7)" "unprognostic (5.33e-1)" "unprognostic (2.15e-1)" "unprognostic (6.21e-2)" "unprognostic (1.33e-1)" 6.5 7.5 15.9 10.9 21.4 7.6 9.9 31.7 32.3 5.7 10.1 9.4 5.6 6.5 10.0 19.9 10.2 6.9 6.8 9.2 24.5 20.4 6.5 5.9 9.6 16.0 16.3 13.4 19.2 68.0 16.7 16.7 3.2 35.9 9.2 12.7 4.4 49.9 9.3 3.5 13.6 7.8 11.3 20.6 11.0 20.8 16.9 9.2 3.6 16.7 8.2 15.0 9.6 6.6 8.6 1.4 1.5 1.2 2.2 13.2 3.2 19.0 7.3 7.4 60.1 5.9 8.3 18.1 14.1 9.0 6.7 20.2 9.4 7.6 15.0 7.1 28.7 14.0 8.7 19.1 22.3 16.1 18.7 14.1 4.8 3.7 7.0 54.3 30.6 13.5 16.3 75.0 8.8 54.5 3.6 5.5 14.1 26.8 53.3 10.6 40.3 0.9 8.1 10.1 45.6 20.0 2.3 1.4 39.3 4.3 3.7 32.3 24.3 3.6 19.6 76.0 9.9 8.3 21.5 1.4 3.3 22.1 8.8 6.6 63.1 31.5 57.1 41.8 13.9 32.1 1.5 0.3 0.5 3.8 1.2 4.9 8.6 7.4 3.4 1.4 6.2 10.2 5.5 1.5 2.2 0.8 0.1 13.2 3.2 15.9 21.4 31.7 32.3 24.5 20.4 16.3 13.4 35.9 9.2 8.9 4.5 3.7 18.8 11.0 20.1 5.9 12.7 1.4 3.4 8.7 23.6 2.0 6.6 34.4 197.3 3.1 1.7 93.5 52.9 7.7 6.6 17.6 8.1 1.6 1.0 23.8 23.4 2.5 0.6 147.0 8.9 1.8 8.5 11.8 12.9 8.5 38.4 11.9 8.9 3.1 25.4 6.5 12.3 2.3 7.0 9.5 4.7 13.3 7.9 15.2 ASPA "ACY2, ASP" ENSG00000108381 Aspartoacylase P45381 17 3472374-3503419 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.3;kidney: 33.2" "Group enriched" "Detected in many" 4 "Collecting duct cells: 24.4;Leydig cells: 46.1;Melanocytes: 43.9;Peritubular cells: 45.3;Proximal tubular cells: 65.3" "Cancer enhanced" "Detected in some" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 8.3;ASC TERT1: 6.5;CACO-2: 5.5;HSkMC: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022142, HPA022145" Enhanced Approved Cytosol NA NA Cytosol "HPA022142: AB_1845102, HPA022145: AB_1845103" "unprognostic (4.42e-2)" "unprognostic (4.79e-2)" "unprognostic (2.02e-2)" "unprognostic (2.79e-3)" "unprognostic (4.36e-2)" "unprognostic (5.01e-1)" "unprognostic (1.08e-3)" "unprognostic (3.57e-1)" "unprognostic (4.17e-1)" "unprognostic (3.43e-1)" "unprognostic (5.27e-2)" "unprognostic (6.27e-2)" "unprognostic (1.25e-1)" "unprognostic (7.07e-4)" "unprognostic (2.77e-1)" "unprognostic (4.68e-1)" "unprognostic (1.49e-1)" 10.9 4.1 14.5 1.8 37.6 1.7 3.3 3.0 19.4 6.2 3.6 35.2 3.1 9.7 4.1 5.5 4.5 5.0 3.3 2.2 21.9 11.0 33.2 12.6 3.2 1.3 50.2 11.3 2.9 1.0 0.9 0.9 3.1 18.9 4.0 4.6 2.6 1.9 4.8 9.3 4.6 13.3 2.9 22.4 4.6 3.9 5.6 51.3 0.0 1.8 1.1 0.8 4.5 3.5 1.7 1.2 3.6 0.7 1.6 1.3 0.2 0.4 0.2 0.9 0.7 8.3 6.5 0.5 0.4 0.3 0.3 0.3 5.5 0.3 1.1 0.3 1.0 0.5 0.5 0.5 0.3 0.4 2.9 0.3 0.5 0.9 0.4 0.9 0.7 0.8 11.7 0.6 0.7 0.2 0.4 0.1 0.7 0.6 2.0 0.4 0.4 0.4 1.0 0.8 0.4 0.5 0.4 0.5 0.9 0.4 1.7 0.7 0.5 1.6 0.6 1.3 0.8 0.6 0.3 0.6 1.0 0.7 0.7 0.4 1.2 0.6 0.7 0.4 0.6 0.8 3.4 0.7 0.8 1.2 0.6 1.0 1.1 1.0 0.9 0.5 1.7 1.2 1.3 3.6 1.6 0.7 1.2 0.5 0.2 14.5 37.6 3.0 19.4 21.9 11.0 50.2 11.3 18.9 51.3 8.9 1.0 0.0 1.2 4.6 0.4 0.8 5.1 0.0 1.2 24.4 0.0 0.0 6.6 0.0 2.8 0.5 1.0 0.0 0.2 0.1 7.4 0.3 0.0 10.2 0.2 7.9 2.4 4.9 1.5 0.5 46.1 0.8 43.9 0.0 0.1 3.4 0.0 0.0 45.3 65.3 0.5 0.0 4.2 4.8 0.6 1.5 0.1 0.0 1.2 1.7 ASPDH ENSG00000204653 "Aspartate dehydrogenase domain containing" A6ND91 19 50511600-50514690 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.9;kidney: 24.7;liver: 59.8" "Group enriched" "Detected in some" 8 "Hepatocytes: 137.5;Proximal tubular cells: 442.0" "Cancer enriched" "Detected in some" 13 "liver cancer: 24.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 13.6;MOLT-4: 15.9;SH-SY5Y: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042631, HPA042654" Approved Approved Nucleoplasm,Cytosol Yes NA 51000 Nucleoplasm Cytosol "HPA042631: AB_10794530, HPA042654: AB_10794383" "unprognostic (5.79e-2)" "unprognostic (9.47e-2)" "unprognostic (8.97e-3)" "unprognostic (6.13e-3)" "unprognostic (5.13e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-3)" "unprognostic (3.32e-2)" "unprognostic (2.87e-2)" "unprognostic (2.09e-2)" "unprognostic (2.87e-3)" "unprognostic (6.70e-3)" "unprognostic (9.65e-3)" "unprognostic (3.36e-2)" "unprognostic (1.07e-1)" "unprognostic (5.31e-4)" "unprognostic (1.99e-3)" 1.3 3.2 11.7 1.6 16.2 1.3 0.9 7.4 26.9 0.9 1.0 8.9 0.0 6.9 1.1 0.9 1.2 0.9 2.3 1.2 12.9 8.3 24.7 59.8 1.1 1.6 9.2 9.8 0.9 1.5 0.9 7.7 0.9 4.1 1.2 0.9 1.0 2.3 0.9 1.1 1.8 2.9 0.9 5.1 1.4 1.1 1.1 6.6 1.3 1.7 0.0 0.9 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 13.6 0.0 0.6 3.8 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 1.6 0.0 1.6 15.9 0.1 0.0 0.5 0.3 0.3 0.3 1.1 0.0 0.2 1.8 9.5 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 3.7 0.7 2.0 0.2 2.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.7 16.2 7.4 26.9 12.9 8.3 9.2 9.8 4.1 6.6 0.0 0.0 0.9 0.0 0.0 22.8 0.3 2.5 0.0 0.0 8.7 3.9 0.0 38.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 6.8 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 442.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASPG C14orf76 ENSG00000166183 Asparaginase Q86U10 14 104085679-104115581 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 29.7;liver: 88.7" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 19.5;Hepatocytes: 83.1;Proximal tubular cells: 39.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HDLM-2: 3.0;HeLa: 2.5;HMC-1: 3.2;RPTEC TERT1: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA069761 Enhanced NA NA "HPA069761: AB_2686191" "unprognostic (1.45e-2)" "unprognostic (7.43e-3)" "unprognostic (2.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-2)" "unprognostic (1.74e-2)" "unprognostic (1.72e-2)" "unprognostic (3.47e-2)" "unprognostic (1.98e-1)" "unprognostic (2.20e-1)" "unprognostic (2.50e-1)" "unprognostic (1.10e-1)" "unprognostic (8.75e-2)" "unprognostic (7.98e-2)" "unprognostic (3.85e-1)" "unprognostic (1.52e-2)" "unprognostic (2.32e-2)" 0.7 0.5 0.4 0.4 0.5 0.0 2.1 0.4 0.5 1.5 2.3 0.5 0.4 0.5 1.6 1.0 10.2 2.0 0.8 29.7 0.4 0.0 9.8 88.7 1.3 0.9 0.4 0.4 4.9 0.4 0.7 0.4 0.8 0.7 0.4 0.8 1.2 0.8 0.4 0.4 5.2 0.8 1.1 0.4 0.4 1.6 0.9 0.4 0.4 1.3 0.6 1.7 0.5 2.8 0.2 0.0 1.0 0.1 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 1.8 0.8 2.6 0.0 0.0 0.2 0.0 0.0 0.0 3.0 0.0 0.0 2.5 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.1 0.7 1.0 0.0 0.7 0.6 1.9 1.9 1.5 1.2 0.0 0.1 0.8 0.2 1.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.7 0.4 6.0 1.7 0.0 0.1 1.5 1.0 19.5 2.5 2.7 0.0 0.0 0.0 0.1 3.3 0.0 0.4 0.3 8.4 0.0 0.2 0.1 0.6 0.2 0.0 83.1 0.2 4.8 1.7 3.7 0.6 0.0 0.0 0.0 0.0 0.0 10.8 0.2 0.3 5.9 1.1 39.3 0.2 0.0 0.0 0.4 0.7 8.0 0.5 0.0 3.0 2.5 ASPHD1 ENSG00000174939 "Aspartate beta-hydroxylase domain containing 1" Q5U4P2 16 29900375-29919864 "Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.3" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 20.1;Cholangiocytes: 25.5;Exocrine glandular cells: 17.6;Intestinal endocrine cells: 28.3;Pancreatic endocrine cells: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.4;HeLa: 21.0;Hep G2: 28.8" "Low region specificity" "Detected in all" HPA045175 Uncertain NA NA "HPA045175: AB_10959899" "unprognostic (1.58e-1)" "unprognostic (5.50e-2)" "unprognostic (4.74e-3)" "unprognostic (2.20e-3)" "unprognostic (1.34e-3)" "unprognostic (6.96e-2)" "unprognostic (5.75e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (8.37e-2)" "prognostic favorable (7.38e-4)" "unprognostic (5.55e-2)" "unprognostic (6.17e-2)" "unprognostic (1.97e-2)" "unprognostic (1.90e-1)" "unprognostic (2.97e-1)" "unprognostic (9.03e-2)" 1.8 5.5 32.0 2.0 38.6 1.5 2.2 22.0 52.3 2.2 2.4 16.2 0.0 5.1 2.4 1.5 1.4 2.6 12.8 1.5 32.5 17.1 2.3 1.6 2.0 1.6 29.8 19.4 1.8 11.6 2.3 10.6 1.6 17.1 2.5 2.3 0.3 7.0 2.1 1.6 1.4 3.4 2.7 24.6 1.5 15.8 4.3 13.4 0.0 1.4 0.0 1.7 1.8 0.0 0.5 0.0 0.0 0.0 0.8 0.3 0.0 1.2 6.3 0.0 4.7 0.0 0.6 0.3 7.0 1.5 4.6 3.2 15.4 20.4 2.5 17.0 3.2 4.6 0.7 0.6 1.2 0.9 0.3 0.9 1.4 21.0 28.8 9.5 0.1 16.1 5.5 1.2 7.0 0.3 5.4 0.2 3.8 0.0 4.4 1.1 12.2 0.2 0.1 9.5 3.7 5.6 0.3 0.0 0.9 4.1 0.1 16.6 8.6 0.1 10.2 1.6 0.0 3.3 4.4 0.5 2.5 5.3 0.0 1.8 0.3 0.1 0.1 10.1 16.3 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 32.0 38.6 22.0 26.3 32.5 17.1 29.8 19.4 17.1 13.4 0.0 6.1 0.0 3.3 0.6 20.1 0.1 25.5 0.0 0.0 1.8 3.9 0.0 1.7 12.4 1.9 0.2 0.9 0.0 17.6 0.2 0.6 7.7 1.1 0.0 4.3 6.4 28.3 0.0 0.0 0.2 0.3 0.1 1.7 0.0 3.0 0.8 21.8 0.0 0.7 1.9 8.5 0.0 0.5 1.1 1.0 0.5 0.2 0.0 1.9 2.3 ASPHD2 FLJ39838 ENSG00000128203 "Aspartate beta-hydroxylase domain containing 2" Q6ICH7 22 26429273-26445015 "Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.1;Early spermatids: 25.3;Late spermatids: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000820 Uncertain NA NA "HPA000820: AB_1078231" "unprognostic (1.12e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.94e-1)" "unprognostic (9.07e-2)" "unprognostic (2.02e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-2)" "unprognostic (8.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (6.55e-2)" "unprognostic (9.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.11e-2)" 0.9 1.1 7.6 3.8 23.9 2.1 1.1 17.6 13.1 1.8 3.3 1.2 0.3 2.0 2.1 10.5 2.0 0.7 2.7 0.5 5.8 5.0 3.6 0.6 1.5 6.4 3.3 4.4 1.0 1.1 0.4 5.6 2.0 3.9 1.4 3.5 1.1 1.3 1.3 0.6 8.5 2.2 1.4 1.7 4.1 13.0 2.7 4.2 2.4 3.4 0.6 5.3 3.5 1.0 1.7 4.0 0.9 7.7 0.0 1.5 0.7 1.3 0.7 3.5 5.7 0.5 0.3 1.9 1.8 3.9 3.8 5.5 0.0 0.3 1.1 0.4 1.7 3.8 1.6 3.9 6.2 2.1 8.1 5.3 0.3 0.0 0.2 3.6 2.0 0.9 0.7 3.0 2.0 2.6 4.2 4.0 3.1 1.4 19.1 1.1 0.4 1.5 0.8 3.5 7.1 0.8 10.2 2.0 3.0 5.3 0.5 9.7 4.2 1.8 0.2 1.9 2.1 0.2 3.0 3.6 2.4 12.0 0.6 3.7 5.5 1.4 2.4 3.6 7.3 1.5 0.0 2.1 0.9 0.7 5.4 1.5 1.6 1.2 1.2 3.5 1.7 0.8 0.7 0.6 0.0 7.7 4.0 0.7 0.7 7.6 23.9 17.6 11.4 5.8 5.0 3.3 4.4 3.9 4.2 0.0 1.4 5.6 1.4 1.5 11.1 0.4 2.5 0.0 0.0 0.0 9.8 0.2 0.0 0.8 25.3 0.3 0.1 0.0 0.6 9.0 0.7 4.3 0.0 0.0 1.4 6.4 0.0 1.3 2.6 15.7 0.9 1.1 1.7 0.0 3.5 1.5 4.2 0.0 0.7 0.6 10.0 0.0 0.9 1.0 1.4 1.0 0.9 0.5 1.9 3.7 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Abnormal spindle microtubule assembly" Q8IZT6 1 197084128-197146694 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 62.8" "Cell type enhanced" "Detected in many" 16 "Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "plasmacytoid DC: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;T-cells: 2.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB017816 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.7 0.7 0.2 12.4 0.4 13.8 1.5 0.2 0.4 1.2 2.8 0.2 0.2 2.8 0.3 1.5 8.7 0.2 0.4 0.6 0.2 0.2 0.5 1.3 1.9 7.0 0.3 0.2 0.5 0.3 0.0 0.2 1.8 0.5 0.4 2.8 0.3 1.5 0.2 0.5 4.6 3.1 0.8 0.5 4.3 1.7 6.3 0.2 62.8 0.3 5.0 6.9 1.2 2.3 0.0 1.5 0.0 0.0 0.3 2.4 0.0 20.1 11.3 18.3 11.2 1.1 2.5 6.9 16.1 11.3 16.0 12.7 7.8 15.7 20.5 5.7 12.6 7.0 20.3 15.7 6.4 20.0 18.5 11.9 14.4 26.5 7.5 0.2 21.5 10.3 0.2 0.6 12.8 9.0 4.1 16.8 16.6 18.0 24.4 16.4 7.9 17.2 10.0 8.3 16.2 3.1 13.2 25.2 15.1 5.8 5.5 9.6 13.7 22.9 11.8 5.1 11.8 13.2 8.9 12.8 9.9 9.7 17.0 29.2 7.0 9.5 11.9 7.8 5.9 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 2.4 0.0 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.5 0.2 0.0 0.6 3.7 0.6 5.5 0.0 1.0 0.0 0.0 1.2 1.8 0.0 6.4 0.0 0.3 2.9 0.3 0.3 70.0 0.0 13.2 1.3 0.7 1.1 1.0 9.3 0.0 0.0 1.8 4.0 3.3 0.6 3.1 0.0 1.0 1.5 0.5 0.4 0.0 1.4 0.0 0.3 0.0 0.0 32.6 30.2 3.0 3.1 4.9 4.9 1.7 ASPN "FLJ20129, PLAP-1, SLRR1C" ENSG00000106819 Asporin Q9BXN1 9 92456205-92482506 "Disease related genes, Plasma proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 62.1" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 59.6;Fibroblasts: 60.7;Ito cells: 22.7;Sertoli cells: 38.8;Smooth muscle cells: 29.5;Suprabasal keratinocytes: 23.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.7;BJ hTERT+: 5.0;HHSteC: 21.0;HSkMC: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007894, HPA008435, HPA024230" Approved Uncertain Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 33000 Nucleoplasm Cytosol "HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (8.13e-3)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (1.01e-2)" "unprognostic (9.50e-3)" "unprognostic (1.17e-1)" "unprognostic (2.74e-3)" "unprognostic (6.38e-2)" "unprognostic (3.70e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (1.64e-7)" "unprognostic (1.42e-3)" "unprognostic (3.04e-2)" "unprognostic (6.27e-3)" "unprognostic (2.48e-2)" 13.4 2.2 0.5 5.2 1.7 0.0 4.8 0.4 0.7 40.2 14.6 0.6 8.1 2.8 62.1 26.7 15.3 9.9 26.4 31.6 0.6 0.6 3.5 21.9 10.3 0.7 0.9 1.4 7.8 4.7 0.8 1.9 3.7 1.0 12.2 3.6 1.6 2.0 3.6 10.8 3.7 19.7 37.1 0.8 0.8 8.8 6.7 0.4 1.5 7.1 27.7 2.2 24.2 3.8 0.4 0.2 1.9 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 14.7 0.0 2.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 4.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.2 0.1 0.7 0.2 0.0 0.0 0.5 1.7 0.4 0.7 0.6 0.6 0.9 1.4 1.0 0.4 0.0 1.4 0.0 0.0 59.6 0.5 3.6 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 0.3 5.8 0.0 0.0 0.0 0.0 60.7 0.0 1.1 0.4 0.2 0.0 0.0 22.7 0.0 0.2 5.5 0.5 13.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 38.8 29.5 0.0 0.0 23.6 0.0 0.0 0.0 0.0 ASPRV1 "FLJ25084, SASPase, Taps" ENSG00000244617 "Aspartic peptidase retroviral like 1" Q53RT3 2 69960089-69962265 "Plasma proteins, Predicted membrane proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 75.3" "Cell type enhanced" "Detected in some" 18 "Spermatogonia: 3.0;Suprabasal keratinocytes: 9.4" "Group enriched" "Detected in many" 8 "head and neck cancer: 23.1;melanoma: 35.1" "Cell type enriched" "Detected in some" 6 "neutrophil: 11.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "REH: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034809, HPA034810" Enhanced Approved Cytosol NA NA 83000 Cytosol "HPA034809: AB_2674343, HPA034810: AB_10601456" "unprognostic (4.75e-4)" "unprognostic (1.90e-3)" "unprognostic (2.34e-2)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (1.17e-2)" "unprognostic (1.93e-3)" "unprognostic (1.51e-1)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (4.19e-3)" "unprognostic (1.27e-1)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.84e-2)" "unprognostic (2.43e-2)" 0.2 0.2 0.5 0.1 0.6 0.0 5.5 0.8 0.4 0.3 0.0 0.3 0.3 0.6 0.0 0.4 0.1 0.1 0.6 0.7 0.2 0.0 0.1 0.1 0.7 0.9 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.0 75.3 0.2 0.2 1.0 0.4 0.1 0.4 0.0 0.1 0.0 0.6 0.1 1.2 11.2 0.1 0.3 0.9 0.5 0.1 0.7 1.8 3.5 2.3 0.9 0.5 0.4 0.7 0.5 0.3 1.2 0.1 1.3 0.3 0.3 0.4 0.5 1.6 0.2 0.4 2.4 4.7 2.8 0.4 1.2 0.9 2.3 2.0 1.1 0.7 0.4 0.8 0.7 0.4 3.1 1.0 3.6 0.4 0.5 2.0 5.2 1.8 0.4 0.4 8.9 1.0 0.5 0.1 0.1 2.0 0.5 0.2 1.4 1.4 0.4 0.1 1.0 0.3 0.1 1.8 0.1 0.3 3.9 2.4 2.7 0.2 1.6 2.0 0.0 0.1 1.9 0.7 0.1 0.7 0.0 0.3 0.6 0.1 0.1 0.2 0.6 11.2 0.3 0.1 1.2 0.9 0.5 0.0 0.0 0.0 0.1 0.3 1.1 1.2 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.2 0.9 0.0 0.0 0.0 0.6 0.7 0.2 0.0 0.7 0.7 1.4 0.0 0.0 1.1 3.0 9.4 0.3 0.0 0.0 0.1 ASRGL1 "ALP, ALP1, FLJ22316" ENSG00000162174 "Asparaginase like 1" Q7L266 11 62337448-62393412 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.4;cervix, uterine: 68.7;testis: 57.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 275.4;Late spermatids: 421.8;Spermatocytes: 320.2" "Cancer enhanced" "Detected in all" "endometrial cancer: 53.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 51.4;eosinophil: 52.4" "Group enriched" "Detected in many" 4 "granulocytes: 52.4;monocytes: 14.2" "Cell line enhanced" "Detected in many" "EFO-21: 30.5;HAP1: 29.4;RPTEC TERT1: 26.0;SCLC-21H: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029725, HPA055572, CAB070192" Enhanced Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" NA NA Microtubules "Nucleoplasm, Cytokinetic bridge" "CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854" "unprognostic (1.14e-1)" "unprognostic (8.38e-3)" "prognostic favorable (6.14e-4)" "prognostic favorable (1.56e-5)" "unprognostic (5.35e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" "unprognostic (3.54e-2)" "unprognostic (2.71e-1)" "unprognostic (4.44e-1)" "prognostic favorable (4.32e-7)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (5.43e-3)" "unprognostic (1.40e-1)" 3.6 2.6 27.8 3.8 37.0 7.1 4.6 12.3 22.3 68.7 7.9 9.9 2.0 4.1 15.3 7.9 1.4 36.8 9.5 1.7 19.5 19.0 23.8 2.4 6.6 3.3 30.8 11.8 1.6 5.1 1.5 5.7 2.3 16.4 8.6 9.9 4.9 6.4 4.8 2.3 1.2 3.1 3.0 9.6 2.4 5.6 57.6 11.3 2.8 3.7 0.0 3.0 2.9 1.0 0.5 8.2 52.4 14.2 2.5 0.7 4.9 0.8 6.7 7.4 9.6 0.0 0.0 5.8 0.8 0.3 1.3 1.2 11.0 3.0 0.7 30.5 0.1 3.3 0.6 29.4 0.3 1.5 1.1 12.1 0.4 9.1 8.0 0.2 8.1 11.0 0.3 0.1 0.6 0.1 0.4 13.8 16.7 8.2 7.6 0.3 12.8 21.8 5.4 10.1 4.6 5.3 8.9 4.4 4.1 26.0 2.1 40.1 5.7 5.7 9.9 4.9 8.0 5.3 4.1 0.7 0.1 5.6 0.4 3.3 11.7 11.1 1.0 0.3 4.2 3.4 51.4 14.2 52.4 0.6 10.3 0.4 0.5 0.2 0.7 8.2 0.4 0.5 0.7 3.3 2.5 7.2 1.4 0.1 4.9 27.8 37.0 12.3 22.3 19.5 19.0 30.8 11.8 16.4 11.3 6.0 26.7 10.4 1.9 3.1 21.7 1.6 53.5 1.4 3.4 21.0 31.4 1.4 112.7 25.5 275.4 23.3 4.1 0.0 19.3 1.8 3.8 54.4 76.5 2.6 22.5 15.9 45.3 31.9 9.1 421.8 8.1 27.7 1.7 0.0 35.8 78.6 8.8 5.8 6.7 99.6 37.4 12.9 2.3 320.2 48.6 1.1 0.7 6.9 26.0 5.3 ASS1 "ASS, CTLN1" ENSG00000130707 "Argininosuccinate synthase 1" P00966 9 130444929-130501274 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 121.5;liver: 309.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 457.5;Hepatocytes: 809.9;Proximal tubular cells: 889.6;Urothelial cells: 385.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 87.4;HaCaT: 82.8;hTCEpi: 80.5;RPMI-8226: 134.1;THP-1: 100.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020896, HPA020934" Enhanced Approved Nucleoplasm,Cytosol No No 4500000 Cytosol Nucleoplasm "HPA020896: AB_1845117, HPA020934: AB_1845118" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (8.14e-9)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "unprognostic (3.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.02e-2)" "unprognostic (4.24e-2)" "unprognostic (2.92e-3)" "unprognostic (1.41e-2)" "unprognostic (1.05e-1)" "unprognostic (3.14e-1)" "unprognostic (4.72e-3)" 20.6 15.4 4.6 7.1 4.1 0.0 15.7 2.3 5.4 8.3 18.5 3.5 33.9 11.9 12.0 12.6 9.4 16.6 14.0 11.4 3.8 5.7 121.5 309.9 8.0 2.2 3.2 4.3 11.4 7.9 0.5 4.6 8.7 4.5 12.1 16.8 10.7 26.3 40.6 7.4 12.5 26.8 5.9 3.4 2.7 5.2 8.7 2.2 0.8 17.5 7.0 4.5 17.7 8.6 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.7 1.1 1.3 2.2 8.9 22.7 4.3 14.0 87.4 2.8 8.5 5.0 3.3 0.0 9.5 28.9 0.8 82.8 5.8 0.5 1.9 2.0 2.6 0.0 1.8 12.8 31.0 1.7 0.1 15.0 80.5 4.5 8.1 0.0 0.1 37.6 0.4 52.2 2.8 58.1 0.6 24.5 1.8 60.2 2.6 0.1 1.5 134.1 7.6 5.8 33.8 0.5 50.0 52.7 3.9 5.4 36.2 100.4 0.0 1.1 7.0 0.2 1.2 8.7 8.3 2.9 22.0 13.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 4.6 4.1 2.3 5.4 3.8 5.7 3.2 4.3 4.5 2.2 23.8 25.8 33.7 45.3 62.6 0.0 5.0 94.3 20.1 50.0 45.4 0.0 159.6 112.7 79.7 0.8 23.2 457.5 0.0 98.3 5.0 15.7 85.0 5.7 809.9 12.7 0.0 11.5 35.0 18.0 2.7 28.7 2.6 3.3 2.8 129.1 4.8 73.5 143.8 117.4 889.6 0.3 0.0 10.8 1.1 2.0 15.3 120.5 12.5 77.1 385.2 ASTL "ovastacin, SAS1B" ENSG00000188886 "Astacin like metalloendopeptidase" Q6HA08 2 96123850-96138436 "Enzymes, Predicted secreted proteins" Fertilization "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 3.0;fHDF/TERT166: 2.1;JURKAT: 2.3;RT4: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA015620 Uncertain "Secreted in female reproductive system" NA NA "HPA015620: AB_1845121" "unprognostic (3.21e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-2)" "unprognostic (3.45e-4)" "unprognostic (1.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.53e-2)" "unprognostic (5.12e-2)" "unprognostic (3.62e-1)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (2.61e-5)" "unprognostic (3.41e-3)" "unprognostic (1.08e-1)" "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" 0.2 0.1 0.2 0.6 0.4 8.5 0.1 1.3 0.8 0.0 0.5 0.1 0.3 0.4 0.5 0.0 0.4 0.0 0.8 0.0 0.1 0.0 0.5 1.1 0.0 0.2 0.0 0.0 0.8 0.0 0.9 0.2 0.6 2.7 0.0 2.3 1.1 0.0 0.0 2.3 0.2 0.7 0.0 0.7 3.2 0.0 0.3 0.0 0.0 0.0 1.9 1.8 0.3 0.0 0.0 0.0 0.1 0.0 0.4 3.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 1.2 2.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.8 0.0 0.5 1.1 0.9 0.7 0.1 0.0 0.0 0.0 0.4 0.0 3.8 0.8 0.0 0.0 0.3 0.3 0.0 1.4 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 1.2 0.3 1.8 1.8 0.0 0.0 0.3 0.6 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASTN1 ASTN ENSG00000152092 "Astrotactin 1" O14525 1 176857302-177164973 "Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 19.9;brain: 52.5" "Cell type enhanced" "Detected in some" 20 "Horizontal cells: 22.3;Late spermatids: 9.9;Rod photoreceptor cells: 8.8" "Cancer enriched" "Detected in some" 14 "glioma: 15.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.0;NTERA-2: 4.6;SCLC-21H: 2.8;U-2 OS: 3.7;U-266/84: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074112 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA074112: AB_2686662" "unprognostic (4.41e-3)" "unprognostic (1.48e-2)" "unprognostic (4.03e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "unprognostic (7.61e-2)" "unprognostic (2.03e-4)" "unprognostic (3.86e-3)" "unprognostic (1.08e-1)" "unprognostic (4.36e-1)" "unprognostic (1.67e-3)" "unprognostic (1.98e-1)" "unprognostic (6.77e-2)" "unprognostic (4.74e-3)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (1.16e-1)" 1.4 19.9 21.5 1.6 23.8 1.1 1.7 15.0 52.5 1.3 1.5 7.4 1.9 1.5 2.3 5.4 1.2 3.2 1.9 1.7 17.4 13.7 1.3 1.4 1.4 1.2 8.5 18.8 8.9 1.7 1.2 8.2 1.6 9.8 2.4 1.6 2.2 2.0 3.3 1.3 1.1 1.5 2.2 5.8 3.6 1.2 1.9 7.2 0.0 1.2 0.0 1.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 23.8 15.0 27.2 17.4 13.7 8.5 18.8 9.8 7.2 0.0 0.0 0.0 0.0 0.1 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 22.3 0.0 1.8 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 8.8 0.0 0.1 4.2 0.2 0.0 0.1 0.0 0.0 0.0 ASXL3 KIAA1713 ENSG00000141431 "Additional sex combs like 3, transcriptional regulator" Q9C0F0 18 33578233-33751192 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Group enriched" "Detected in many" 6 "Early spermatids: 40.9;Late spermatids: 26.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.1;RPMI-8226: 12.2;SCLC-21H: 4.7;SH-SY5Y: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039539, HPA040034" Uncertain NA NA "HPA039539: , HPA040034: " "unprognostic (2.05e-2)" "unprognostic (6.88e-2)" "unprognostic (2.91e-1)" "unprognostic (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (3.19e-1)" "unprognostic (1.87e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (9.16e-2)" "unprognostic (5.35e-3)" "unprognostic (5.92e-2)" "unprognostic (2.47e-12)" "unprognostic (4.69e-2)" "unprognostic (2.32e-1)" "unprognostic (4.98e-3)" "unprognostic (1.67e-2)" 1.0 0.7 6.6 0.7 5.4 0.4 0.8 0.4 10.3 3.4 1.7 1.7 1.7 1.5 1.4 1.8 0.6 2.6 2.0 2.1 4.0 3.3 2.8 1.3 0.9 0.6 5.4 8.8 9.2 1.7 3.7 2.5 1.0 4.3 2.3 1.1 0.9 1.0 2.8 0.4 0.5 1.8 7.4 5.5 0.8 2.3 6.1 5.4 0.0 3.2 0.0 0.5 1.7 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 12.2 0.0 0.0 4.7 2.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.6 5.4 0.4 10.3 4.0 3.3 5.4 8.8 4.3 5.4 0.0 0.0 0.0 1.0 0.1 0.6 4.0 2.5 0.0 5.7 1.8 0.0 0.4 1.7 1.6 40.9 0.0 1.1 0.0 0.0 0.1 1.3 0.3 1.1 1.8 0.2 1.6 2.9 0.6 0.0 26.2 2.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 1.8 0.9 0.5 0.0 1.0 0.9 1.7 0.0 0.3 0.0 0.2 0.3 ASZ1 "ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3" ENSG00000154438 "Ankyrin repeat, SAM and basic leucine zipper domain containing 1" Q8WWH4 7 117363222-117428123 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 15.7" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 87.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "Daudi: 4.0;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA020558 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020558: AB_1845123" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 87.1 20.1 0.0 0.0 0.0 0.0 0.1 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family, AAA domain containing 2" Q6PL18 8 123319850-123416350 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 74.6;Spermatogonia: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 75.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 4.1 4.9 4.6 12.6 9.2 22.8 7.2 5.6 6.9 14.0 8.6 1.5 13.4 5.3 4.7 5.0 10.7 4.7 3.5 13.7 4.2 6.3 2.2 10.1 9.8 13.7 4.0 4.3 9.9 3.9 3.5 18.7 5.2 4.0 11.4 7.5 2.4 6.8 15.4 13.8 7.2 6.6 5.5 4.1 8.8 6.9 20.2 3.4 53.8 4.8 6.3 12.7 9.9 5.9 4.3 2.3 7.2 2.8 4.0 7.4 1.8 25.5 9.9 14.2 4.8 2.5 3.2 6.2 20.0 6.9 17.3 19.3 7.5 11.1 16.7 6.1 6.3 6.8 12.2 18.9 6.4 27.8 23.2 10.1 30.0 10.7 15.2 1.0 10.9 14.9 1.0 1.0 16.4 5.4 3.7 5.2 9.8 14.0 17.0 12.8 26.4 31.4 8.2 2.5 19.3 9.9 16.4 16.9 9.0 6.1 11.7 18.2 7.9 29.0 75.6 5.1 6.0 15.4 10.4 3.2 13.1 18.1 10.3 24.0 5.5 9.8 15.5 8.6 18.4 10.2 7.2 1.5 5.4 2.9 1.3 4.0 4.3 4.2 4.8 2.3 2.8 2.8 3.0 0.4 4.0 2.8 0.3 7.4 1.8 4.6 9.2 5.6 6.9 4.2 6.3 4.0 4.3 4.0 3.4 6.0 8.3 14.2 19.9 14.1 2.5 22.9 2.5 5.3 11.4 3.5 3.9 8.2 1.7 2.4 46.2 6.7 2.2 23.3 1.9 21.2 7.3 19.9 13.9 14.0 9.7 1.6 1.2 9.2 11.1 17.9 6.9 6.6 1.7 5.4 4.4 5.2 2.7 3.5 13.1 0.9 2.1 0.0 8.6 74.6 90.7 10.7 11.3 15.3 12.8 24.8 ATAD5 "C17orf41, ELG1, FLJ12735, FRAG1" ENSG00000176208 "ATPase family, AAA domain containing 5" Q96QE3 17 30831970-30895869 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.0;lymphoid tissue: 29.9" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 32.2;Spermatogonia: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066823 Approved "Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol" "Intracellular and membrane" Yes No Nucleoplasm "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA066823: " "unprognostic (3.12e-1)" "unprognostic (7.36e-2)" "unprognostic (1.12e-2)" "unprognostic (1.36e-3)" "unprognostic (3.33e-1)" "unprognostic (1.05e-2)" "unprognostic (1.28e-4)" "unprognostic (1.77e-1)" "unprognostic (1.79e-3)" "unprognostic (7.24e-2)" "unprognostic (2.78e-1)" "unprognostic (3.19e-3)" "unprognostic (6.30e-10)" "unprognostic (3.10e-2)" "unprognostic (1.19e-1)" "unprognostic (3.42e-1)" "unprognostic (1.38e-1)" 2.0 1.2 1.1 8.1 3.8 19.0 2.4 9.6 3.2 2.7 3.3 1.2 0.7 2.8 2.1 2.5 4.0 2.0 1.7 1.4 1.8 1.3 1.9 1.4 2.3 6.4 1.9 2.7 3.0 1.7 1.3 3.1 5.3 2.3 1.8 3.1 0.6 2.1 1.2 1.3 4.5 3.4 1.5 1.5 6.3 2.2 4.0 2.6 29.9 1.8 2.7 5.3 1.8 2.7 2.3 2.1 3.1 1.3 3.0 1.6 0.3 4.8 4.0 9.6 9.1 0.2 1.0 3.8 4.2 2.2 4.7 6.8 4.4 3.4 12.9 4.1 2.0 3.2 8.8 6.2 3.2 8.6 2.9 5.4 7.8 5.2 3.0 0.1 15.2 6.4 0.4 0.4 7.0 2.4 0.9 2.4 12.7 12.1 10.9 3.1 2.8 16.9 7.5 5.6 3.5 1.9 11.6 18.2 6.2 1.2 5.1 5.6 5.0 4.8 2.7 2.5 5.5 5.2 6.8 1.9 5.9 7.9 8.3 7.6 3.6 3.8 16.3 2.6 7.2 5.7 1.2 1.0 1.4 1.6 1.3 0.9 1.2 0.9 1.2 0.7 2.3 1.1 1.2 3.1 3.0 0.6 2.1 1.4 0.3 1.1 3.8 9.6 3.2 1.8 1.3 1.9 2.7 2.3 2.6 3.0 2.6 13.3 3.2 4.1 18.5 2.7 0.0 4.0 3.4 3.5 0.0 13.2 0.0 2.7 12.9 2.9 2.2 0.0 2.5 20.4 3.9 1.6 3.5 0.5 7.3 11.1 0.0 2.5 3.2 4.6 3.4 7.2 6.8 10.8 4.5 3.9 2.9 2.9 2.1 0.3 19.9 0.0 6.2 32.2 35.1 4.0 6.6 5.3 9.3 1.4 ATCAY BNIP-H ENSG00000167654 "ATCAY, caytaxin" Q86WG3 19 3879864-3928079 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 70.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 117.5;Cone photoreceptor cells: 21.6;Horizontal cells: 44.5" "Cancer enriched" "Detected in some" 8 "glioma: 15.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 8.3;SCLC-21H: 15.4;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017755 Enhanced NA NA "HPA017755: AB_2669655" "unprognostic (7.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.63e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" "unprognostic (3.05e-2)" "unprognostic (4.89e-2)" "unprognostic (9.83e-4)" "unprognostic (7.22e-2)" "unprognostic (8.78e-3)" "unprognostic (1.78e-1)" "unprognostic (1.36e-1)" "unprognostic (1.24e-2)" "unprognostic (2.67e-1)" 1.3 8.2 19.6 1.8 19.8 1.5 1.3 14.1 70.1 1.8 1.5 3.4 0.1 1.7 1.3 1.3 1.4 1.2 1.4 1.3 16.9 25.5 1.3 1.3 1.3 1.4 12.2 21.4 1.3 1.5 1.2 10.1 1.3 16.0 3.1 1.6 1.1 1.3 4.6 2.3 1.6 1.8 1.4 4.3 1.3 1.6 1.4 4.2 0.0 1.4 0.0 1.2 1.4 0.3 1.4 0.8 3.2 0.7 1.7 0.8 0.6 0.5 0.1 3.2 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.2 0.7 0.5 0.2 0.0 1.7 0.5 0.2 0.0 0.0 0.2 0.3 0.9 1.1 0.2 0.0 1.1 1.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.6 0.6 0.1 0.2 0.2 0.4 8.3 0.1 0.1 0.3 0.5 0.3 0.1 0.2 15.4 10.8 0.2 0.2 0.1 1.5 0.2 0.3 0.5 0.5 0.7 0.5 0.8 0.4 0.3 0.3 0.4 1.6 0.2 2.2 0.7 0.9 0.6 0.5 0.5 0.6 0.7 0.6 0.3 1.4 0.8 0.8 3.2 1.7 0.4 0.8 0.5 0.6 19.6 19.8 14.1 33.0 16.9 25.5 12.2 21.4 16.0 4.2 0.0 4.3 0.0 0.6 0.6 117.5 1.7 2.5 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.4 6.9 0.0 0.1 44.5 0.0 1.3 1.2 0.0 0.0 0.9 3.3 0.0 0.0 5.2 0.0 0.0 0.4 0.0 18.4 0.0 0.5 0.4 0.9 0.4 0.0 0.5 0.0 0.4 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.4" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 644.1;Intestinal endocrine cells: 855.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 12 "dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1" "Cell line enhanced" "Detected in many" "BEWO: 39.9;SuSa: 49.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 41.5 21.5 9.5 41.0 7.1 9.4 30.2 3.0 8.0 30.0 16.2 15.3 36.4 5.0 34.9 28.6 31.4 38.1 33.4 31.8 6.5 6.9 19.4 36.1 42.8 4.6 13.5 6.5 23.1 16.0 15.1 12.4 65.1 9.4 30.4 15.0 8.1 12.1 138.4 13.2 39.5 11.4 76.1 13.0 5.4 31.6 10.7 12.4 1.5 45.5 37.3 7.4 38.3 33.8 0.3 2.2 6.1 8.1 0.0 0.4 0.8 6.1 0.3 12.3 2.6 1.2 3.2 39.9 4.4 3.5 3.8 9.1 8.1 4.6 0.1 2.0 0.2 20.8 3.4 7.3 1.1 6.3 29.1 7.1 0.4 3.6 2.9 22.6 2.6 6.9 5.5 19.8 10.6 24.7 0.7 0.7 7.1 2.8 23.2 0.5 0.8 7.9 1.6 8.8 3.3 2.6 2.3 8.2 5.2 0.5 0.9 5.5 5.6 5.7 10.3 17.3 49.4 6.0 1.9 0.7 1.1 5.9 3.7 2.0 18.3 7.7 2.1 3.6 1.4 3.2 6.1 0.9 0.0 0.4 5.5 0.4 0.1 0.1 0.0 2.2 0.3 0.0 0.0 0.3 0.0 8.1 1.1 0.0 0.8 9.5 7.1 3.0 8.0 6.5 6.9 13.5 6.5 9.4 12.4 393.1 144.2 7.7 234.8 180.1 3.7 604.8 73.9 128.5 135.4 52.4 0.0 136.7 1.7 158.3 2.8 136.2 500.9 0.0 108.1 256.8 236.1 644.1 77.3 21.2 99.6 1.6 855.0 28.8 13.4 2.5 16.1 211.8 165.4 55.1 427.3 12.1 155.6 312.1 1.1 1.2 2.5 97.0 421.2 0.3 2.1 177.2 351.7 6.9 216.0 169.1 ATF5 ENSG00000169136 "Activating transcription factor 5" Q9Y2D1 19 49928702-49933935 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 24 "liver: 470.7" "Cell type enhanced" "Detected in all" 19 "Hepatocytes: 1071.5;monocytes: 428.4" "Cancer enriched" "Detected in all" 7 "liver cancer: 200.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.9;intermediate monocyte: 11.7;myeloid DC: 7.5;plasmacytoid DC: 18.7" "Group enriched" "Detected in all" 7 "dendritic cells: 18.7;monocytes: 11.9" "Cell line enhanced" "Detected in all" "HDLM-2: 45.9;Karpas-707: 79.8;THP-1: 66.5;U-266/84: 101.3;U-698: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030187 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030187: AB_10601666" "unprognostic (2.09e-2)" "prognostic favorable (1.14e-4)" "unprognostic (9.38e-3)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.52e-1)" "unprognostic (6.70e-2)" "unprognostic (3.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.83e-2)" "unprognostic (2.96e-3)" "prognostic unfavorable (3.39e-7)" "unprognostic (3.06e-2)" "unprognostic (8.06e-2)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" 4.6 6.6 2.1 5.0 2.7 2.9 7.0 1.3 2.2 2.4 2.9 2.4 3.9 4.6 2.3 4.0 3.4 2.6 3.1 4.2 2.1 2.1 3.0 470.7 2.8 5.0 2.2 1.4 2.6 3.8 1.4 1.9 4.4 2.1 2.8 1.6 2.6 3.1 2.5 4.3 2.1 4.2 2.5 2.6 3.3 2.8 5.3 1.9 3.8 20.0 3.3 5.5 5.6 7.1 1.1 18.7 2.2 11.9 1.5 1.3 2.5 10.0 7.0 2.7 1.8 2.8 2.4 2.7 7.4 6.2 7.6 4.6 5.3 5.5 9.0 3.7 4.2 5.2 3.6 3.4 3.0 3.6 45.9 3.4 6.1 2.2 4.0 1.9 23.7 17.5 17.0 4.8 5.5 1.3 1.9 3.2 20.1 5.5 79.8 3.7 9.4 3.4 5.2 1.3 2.7 9.5 28.5 2.9 3.6 8.6 13.6 4.3 3.1 17.0 7.3 5.1 1.0 6.0 66.5 5.5 14.8 9.4 1.7 7.5 2.1 101.3 47.6 11.6 9.5 5.5 0.3 11.9 0.7 0.7 11.7 1.3 1.1 0.9 0.9 7.5 0.7 0.7 0.9 2.2 1.5 3.0 18.7 0.9 2.5 2.1 2.7 1.3 2.2 2.1 2.1 2.2 1.4 2.1 1.9 11.9 11.0 53.7 10.0 20.0 3.2 6.9 48.4 9.4 5.7 15.7 5.9 27.8 11.6 11.4 203.6 16.7 30.2 46.7 25.7 13.8 18.6 21.5 5.8 1071.5 79.6 87.4 20.6 44.2 56.2 107.0 12.4 56.5 38.8 428.4 16.5 9.5 17.3 14.4 15.6 28.4 7.2 12.9 15.1 6.2 5.7 21.0 29.7 10.2 18.3 15.5 ATF7IP2 FLJ12668 ENSG00000166669 "Activating transcription factor 7 interacting protein 2" Q5U623 16 10326434-10483638 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 37.0" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 134.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.2;hippocampal formation: 2.5" "HPA041156, HPA041228" Enhanced NA NA "HPA041156: AB_10795536, HPA041228: AB_10795586" "prognostic favorable (4.98e-4)" "unprognostic (3.87e-2)" "unprognostic (1.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.56e-2)" "unprognostic (2.87e-1)" "prognostic favorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (8.85e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.10e-3)" "unprognostic (2.43e-1)" "unprognostic (2.99e-1)" "unprognostic (2.41e-2)" "prognostic favorable (8.57e-5)" 3.6 13.2 4.3 9.6 5.0 6.5 2.7 2.1 6.4 4.3 3.1 1.5 6.0 3.9 4.2 7.7 2.8 6.4 2.5 14.5 5.8 3.7 4.3 16.5 3.6 10.3 3.2 3.7 3.6 12.7 0.5 4.6 4.1 4.4 4.1 2.9 5.4 2.3 2.5 2.0 3.7 4.2 5.1 5.1 6.7 8.1 37.0 3.0 16.8 5.0 2.1 10.7 8.9 2.7 4.1 2.6 0.1 1.0 3.4 12.7 2.3 0.6 1.4 1.2 3.8 3.0 3.5 6.1 1.5 0.3 0.3 0.0 0.4 6.4 0.0 3.1 0.0 1.3 0.9 5.5 1.3 0.4 5.4 3.8 7.2 1.1 5.2 1.4 6.5 3.1 3.9 1.3 0.0 0.0 1.6 2.6 11.5 12.0 0.0 3.5 1.1 8.3 5.2 6.2 8.3 1.3 11.1 0.0 3.6 1.2 2.9 0.0 0.7 6.0 1.2 0.7 4.0 2.1 12.0 1.4 0.0 1.8 0.1 0.0 2.5 6.0 1.0 0.0 4.1 1.7 0.1 0.5 0.0 5.0 1.0 12.7 2.7 5.2 4.9 1.6 4.1 4.4 4.9 0.1 3.4 1.0 2.6 7.3 2.3 4.3 5.0 2.1 6.4 5.8 3.7 3.2 3.7 4.4 3.0 11.9 14.4 46.9 7.9 10.2 17.3 49.5 10.2 72.3 14.8 12.2 94.2 52.3 84.6 12.5 17.3 7.4 7.5 0.0 9.5 50.1 9.8 7.0 1.1 99.0 21.0 4.8 22.2 9.2 21.1 22.0 6.9 22.3 15.1 10.8 12.0 30.2 6.6 21.0 6.3 15.0 35.6 12.9 5.9 134.1 52.0 16.9 22.7 29.7 12.3 23.0 ATG16L2 "ATG16B, FLJ00012, WDR80" ENSG00000168010 "Autophagy related 16 like 2" Q8NAA4 11 72814308-72843674 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.9;lymphoid tissue: 52.0" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 28.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045444, HPA050312" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045444: AB_2679324, HPA050312: AB_2681082" "unprognostic (7.20e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.26e-2)" "unprognostic (2.12e-1)" "unprognostic (1.31e-3)" "unprognostic (1.61e-2)" "unprognostic (4.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.90e-1)" "prognostic favorable (7.06e-4)" "unprognostic (2.49e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.74e-1)" "unprognostic (4.38e-2)" "unprognostic (1.08e-1)" "unprognostic (4.83e-2)" 7.8 6.6 7.1 20.7 8.0 60.9 7.2 7.4 6.2 9.5 9.7 10.5 7.6 5.5 11.9 7.5 10.2 8.3 11.6 5.8 7.4 4.8 7.2 6.5 16.3 16.4 10.7 7.0 10.1 8.0 5.7 11.5 5.2 8.6 7.3 8.9 11.3 10.1 5.5 3.6 35.7 13.1 10.4 7.9 52.0 6.6 2.6 8.3 3.2 6.5 8.0 19.6 8.5 8.5 2.0 4.7 28.5 7.1 2.4 2.6 1.4 1.4 1.3 4.1 3.2 4.9 4.0 2.6 3.2 3.2 1.6 2.5 1.6 3.5 9.6 2.1 4.1 2.9 2.9 0.5 10.8 2.8 7.6 1.6 7.5 6.9 2.7 3.6 9.8 31.3 3.9 1.5 3.6 4.5 17.9 4.9 17.6 1.0 13.2 1.8 4.7 11.3 16.9 0.6 6.4 1.5 5.6 2.9 4.2 5.3 4.9 3.1 2.4 1.3 7.2 3.0 3.4 3.6 13.5 6.8 4.4 1.6 7.9 2.5 6.0 1.5 4.2 1.9 8.8 2.4 2.4 7.1 18.1 1.3 3.9 1.3 1.2 1.9 2.6 4.7 2.0 1.0 1.2 28.5 2.4 4.7 0.8 1.7 1.4 7.1 8.0 7.4 6.2 7.4 4.8 10.7 7.0 8.6 8.3 6.0 18.4 16.7 5.1 14.8 2.6 4.4 5.1 6.7 3.4 5.2 2.0 6.8 0.0 3.7 0.5 7.9 8.0 0.0 0.9 3.1 5.6 2.8 23.0 2.9 15.2 4.8 12.6 12.9 45.9 0.4 9.5 38.5 3.3 16.2 9.0 4.0 2.3 43.6 7.4 1.6 3.7 0.0 6.6 1.6 7.7 15.2 10.3 23.5 10.4 4.2 ATG2A KIAA0404 ENSG00000110046 "Autophagy related 2A" Q2TAZ0 11 64894546-64917248 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 16.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 16.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038715 Uncertain Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA038715: AB_10673474" "unprognostic (3.05e-2)" "unprognostic (2.33e-1)" "unprognostic (7.55e-2)" "unprognostic (1.18e-1)" "unprognostic (3.42e-1)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.37e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-2)" "prognostic favorable (4.79e-5)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" 8.4 8.3 6.0 8.4 10.4 63.7 7.1 12.2 14.3 7.2 9.2 11.6 8.2 10.0 9.5 5.5 6.1 7.7 8.9 6.4 7.0 6.4 9.0 33.2 9.3 7.7 7.5 7.5 11.8 11.7 7.6 8.7 8.9 9.0 8.5 4.3 12.1 9.3 8.4 12.4 15.9 11.4 9.7 6.7 11.1 9.2 8.0 8.2 13.2 8.4 7.8 9.4 7.9 6.2 1.0 2.3 16.5 2.0 1.5 2.6 0.9 9.9 9.7 3.6 9.6 4.7 3.3 9.5 5.5 8.3 7.6 5.6 8.6 7.9 7.2 11.7 4.8 9.8 8.6 3.6 6.6 2.0 6.7 12.4 6.4 14.5 7.7 6.7 5.0 14.9 9.1 5.8 9.6 5.1 4.4 6.3 7.3 12.1 5.9 3.3 16.2 6.0 17.0 4.1 2.8 10.8 6.7 5.6 10.4 4.1 8.6 13.1 5.1 8.1 11.8 10.2 2.8 11.4 6.4 8.0 7.2 7.1 14.2 4.2 11.5 4.0 5.1 10.6 4.0 4.5 2.8 2.0 2.0 2.6 1.9 2.2 0.8 1.7 2.2 1.3 1.0 1.4 2.5 16.5 1.5 1.5 2.3 0.9 0.9 6.0 10.4 12.2 14.3 7.0 6.4 7.5 7.5 9.0 8.2 8.9 14.4 11.8 7.7 25.6 17.0 5.6 2.5 10.7 10.3 8.7 31.4 11.2 1.7 8.3 1.7 9.0 26.4 0.0 8.9 4.7 14.6 10.6 9.2 17.5 9.7 12.7 34.4 8.6 14.6 2.5 11.8 16.9 28.7 10.8 12.8 10.3 12.5 16.1 9.6 5.2 25.4 12.9 10.7 6.2 5.5 33.5 56.0 39.2 15.6 13.5 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 67.1" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 27.7;Late spermatids: 21.7;Syncytiotrophoblasts: 96.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9" "Lineage enriched" "Detected in many" 7 "T-cells: 11.0" "Group enriched" "Detected in some" 5 "BEWO: 17.0;CAPAN-2: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 0.0 0.2 8.8 0.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.5 1.2 15.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 6.1 67.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.8 10.5 0.0 0.1 1.6 0.8 0.2 0.1 0.4 11.0 1.9 0.7 0.0 0.9 0.2 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 5.5 0.4 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 2.0 0.5 0.7 0.0 1.5 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.2 1.3 0.0 1.2 1.1 6.0 1.6 0.0 1.6 11.0 4.1 0.0 0.4 0.1 0.8 5.9 1.9 0.0 0.0 3.2 0.2 0.0 1.7 1.1 0.0 16.0 0.0 0.0 0.0 6.6 0.0 0.3 27.7 1.0 0.0 0.0 0.2 2.3 0.0 0.3 14.9 0.0 1.7 0.0 0.0 3.7 0.0 21.7 0.6 0.2 0.0 0.0 0.0 0.5 2.4 0.0 0.7 0.0 0.4 0.0 0.2 16.9 10.4 0.3 96.6 2.2 0.0 1.1 ATL1 "AD-FSP, FSP1, SPG3, SPG3A" ENSG00000198513 "Atlastin GTPase 1" Q8WXF7 14 50532509-50633068 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 16.0" "Group enriched" "Detected in many" 5 "granulocytes: 16.0;T-cells: 4.3" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;SCLC-21H: 13.8;SH-SY5Y: 12.6;SiHa: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027550 Enhanced NA NA 9500 "HPA027550: AB_10600983" "unprognostic (2.06e-2)" "unprognostic (7.57e-3)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-1)" "unprognostic (7.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.09e-1)" "unprognostic (6.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-1)" "unprognostic (4.95e-2)" "unprognostic (1.23e-2)" 3.4 5.7 19.0 3.6 26.8 1.1 10.1 15.9 52.7 5.7 5.4 12.5 0.4 3.6 7.7 3.3 5.3 6.1 4.8 2.0 23.7 19.6 4.0 1.0 4.3 1.9 15.6 23.9 9.7 2.9 2.5 7.7 1.2 24.2 8.0 5.4 0.9 10.6 8.4 1.2 8.8 4.6 13.4 13.9 1.5 3.2 6.6 13.8 0.0 2.7 0.6 2.1 6.3 2.7 1.7 2.0 16.0 0.6 0.3 4.3 1.3 1.1 1.2 4.1 4.2 0.4 0.0 2.5 4.5 7.1 4.6 5.9 0.0 3.0 2.8 2.0 0.1 3.9 1.2 6.4 1.1 2.0 15.0 1.6 1.4 0.8 0.4 0.2 0.2 2.7 3.0 1.6 6.7 1.4 0.2 0.5 2.8 0.0 0.8 6.8 0.4 1.1 0.8 4.0 1.0 1.3 0.7 10.2 0.4 1.1 2.0 13.8 12.6 14.8 0.9 0.4 0.4 0.1 1.7 0.8 5.0 4.0 0.0 2.2 0.7 3.0 1.2 3.1 0.2 0.3 16.0 0.2 3.9 2.7 0.0 0.4 1.7 1.0 1.9 1.1 1.1 1.5 4.3 0.5 0.3 0.6 2.0 0.2 1.3 19.0 26.8 15.9 34.6 23.7 19.6 15.6 23.9 24.2 13.8 6.0 1.6 0.8 5.9 4.5 22.4 1.0 5.1 16.0 2.3 5.2 0.0 0.3 0.0 10.4 20.4 2.8 8.4 0.0 11.7 0.9 7.1 4.3 5.8 0.0 1.7 11.1 6.9 3.1 0.0 2.6 12.4 2.2 8.5 1.8 2.1 25.7 6.8 6.5 15.9 2.9 6.5 19.4 8.1 24.5 5.3 4.8 0.1 1.3 3.3 3.5 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 29.5" "Cell type enriched" "Detected in some" 36 "Mucus-secreting cells: 198.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HL-60: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049400 Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA049400: " "prognostic favorable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.1 6.4 0.1 0.0 0.1 0.1 0.1 0.1 22.5 0.0 0.0 8.8 0.1 0.0 0.1 0.1 2.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 15.0 0.0 0.1 0.0 0.0 0.1 29.5 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.5 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 ATOH7 "bHLHa13, Math5" ENSG00000179774 "Atonal bHLH transcription factor 7" Q8N100 10 68230624-68232103 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 10.4;liver: 3.9" "Cell type enhanced" "Detected in single" 18 "Cone photoreceptor cells: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 13.4" "Region enriched" "Detected in some" 9 "cerebellum: 32.2" "Low region specificity" "Detected in many" HPA027008 Uncertain NA NA "HPA027008: AB_10600783" "unprognostic (7.17e-2)" "unprognostic (2.81e-1)" "unprognostic (7.66e-2)" "unprognostic (1.86e-2)" "unprognostic (2.20e-3)" "unprognostic (7.40e-2)" "unprognostic (7.76e-2)" "unprognostic (6.16e-2)" "unprognostic (2.46e-1)" "unprognostic (9.28e-4)" "unprognostic (4.96e-3)" "unprognostic (1.17e-1)" "unprognostic (5.06e-4)" "unprognostic (1.72e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (7.18e-2)" 0.4 0.4 5.5 0.2 5.7 0.3 0.4 4.9 10.4 0.5 0.7 0.2 0.0 1.4 1.1 0.9 0.3 0.4 0.4 0.4 3.9 0.9 1.6 3.9 0.2 0.2 0.5 5.0 0.3 1.5 0.2 0.2 0.2 0.2 0.3 0.5 0.0 0.4 0.4 0.5 0.3 1.6 0.5 0.2 0.3 0.7 0.8 0.5 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 13.4 0.5 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 5.7 4.9 10.4 3.9 0.9 0.5 5.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ATOH8 "bHLHa21, FLJ14708, HATH6" ENSG00000168874 "Atonal bHLH transcription factor 8" Q96SQ7 2 85751344-85788066 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 41.8" "Cell type enhanced" "Detected in many" 7 "Club cells: 22.7;Hepatocytes: 31.6;Late spermatids: 19.8;Muller glia cells: 25.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.9;MAIT T-cell: 1.7" "Group enriched" "Detected in many" 12 "monocytes: 2.9;T-cells: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;RH-30: 19.2;RT4: 12.3;TIME: 18.1;U-2197: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028406 Supported Nucleoplasm NA NA Nucleoplasm "HPA028406: AB_2672587" "unprognostic (7.70e-2)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (2.84e-3)" "unprognostic (2.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.78e-1)" "unprognostic (6.28e-3)" "unprognostic (1.56e-1)" "prognostic favorable (8.98e-6)" "unprognostic (3.32e-2)" "prognostic favorable (3.80e-5)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-2)" 36.4 2.4 3.7 2.4 4.3 0.8 19.9 2.9 4.9 10.5 4.0 4.3 4.5 2.7 11.5 2.2 5.0 7.6 5.7 12.9 5.0 2.0 3.6 30.8 21.1 4.5 6.3 2.1 9.7 4.3 1.0 2.3 3.2 5.4 9.0 1.3 6.4 3.5 12.1 25.2 8.4 3.2 5.8 4.1 8.1 4.4 2.0 4.6 0.3 41.8 4.2 1.1 10.4 24.5 0.0 0.2 0.0 2.9 0.0 1.7 0.4 0.0 3.6 5.1 11.4 5.0 0.3 0.1 9.5 1.0 2.9 1.3 0.0 0.0 0.0 3.6 7.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 8.5 0.5 3.3 0.0 0.0 3.7 0.0 0.0 0.0 6.0 1.9 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.1 2.5 0.1 0.0 19.2 0.1 0.0 12.3 8.5 1.8 1.8 0.0 0.6 0.0 0.0 0.0 18.1 4.5 0.2 12.5 0.0 0.0 0.0 0.0 1.5 0.0 8.9 0.0 2.9 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 3.7 4.3 2.9 4.9 5.0 2.0 6.3 2.1 5.4 4.6 8.9 16.5 0.0 6.2 2.3 0.2 11.5 7.6 2.7 22.7 1.8 0.0 0.1 0.0 7.5 11.2 11.7 0.0 0.0 2.0 0.5 9.0 5.6 1.1 31.6 2.4 0.0 4.1 5.5 2.4 19.8 3.1 3.3 1.7 0.0 1.9 25.7 0.9 0.0 0.4 0.3 0.3 0.0 9.4 1.1 0.7 1.3 0.2 0.0 0.8 1.1 ATP10B "ATPVB, FLJ21477, KIAA0715" ENSG00000118322 "ATPase phospholipid transporting 10B (putative)" O94823 5 160563120-160852214 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;intestine: 35.4" "Cell type enhanced" "Detected in some" 11 "Enterocytes: 80.4;Mucus-secreting cells: 52.8;Paneth cells: 67.1;Undifferentiated cells: 77.9" "Group enriched" "Detected in many" 7 "colorectal cancer: 19.0;pancreatic cancer: 4.2;stomach cancer: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "WM-115: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034574 Uncertain NA NA "HPA034574: AB_10669992" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (4.47e-4)" "unprognostic (3.99e-2)" "unprognostic (6.10e-3)" "unprognostic (4.69e-2)" "unprognostic (4.86e-2)" "unprognostic (2.54e-1)" "unprognostic (1.20e-2)" "unprognostic (3.42e-2)" "unprognostic (5.12e-2)" "unprognostic (2.38e-3)" "unprognostic (5.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-1)" "unprognostic (2.14e-1)" 0.5 0.4 4.3 4.1 9.4 0.4 0.7 5.1 10.0 1.7 33.8 27.8 1.5 18.9 0.4 11.4 8.2 0.7 12.8 0.5 5.5 2.8 0.5 0.4 0.5 0.4 13.8 6.8 0.4 4.2 0.4 0.4 0.4 13.1 0.5 35.4 0.0 2.8 1.0 0.4 8.4 21.1 1.6 20.2 0.4 4.1 0.7 14.0 0.0 0.5 0.0 2.5 1.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 9.4 5.1 10.0 5.5 2.8 13.8 6.8 13.1 14.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 25.5 0.0 0.0 1.8 0.0 0.0 0.0 11.1 0.1 0.0 80.4 0.0 17.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.0 0.0 1.7 2.8 52.8 0.0 25.1 67.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 77.9 1.0 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 57.5;Syncytiotrophoblasts: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" "Cell line enhanced" "Detected in many" "HAP1: 24.4" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA050808: AB_2681242" "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favorable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.4 1.0 2.3 1.6 6.7 7.3 0.4 10.4 12.6 5.0 9.0 5.4 9.0 4.6 3.9 16.8 8.5 2.7 24.4 8.7 7.7 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.5 16.5 8.4 2.3 0.0 2.5 13.6 0.5 2.4 0.7 0.8 0.0 1.3 2.8 5.3 0.0 9.1 1.8 1.5 2.9 4.8 1.2 3.1 5.4 2.2 1.2 12.7 12.4 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 3.9 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 8.9 6.9 15.0 7.9 17.1 10.9 3.6 0.0 2.7 2.3 15.7 29.5 27.1 1.7 4.3 1.6 14.0 1.6 0.0 4.1 7.4 11.8 5.8 2.3 4.9 11.7 12.7 9.2 17.8 16.1 0.6 57.5 9.1 6.8 7.2 4.3 28.8 2.7 2.5 23.7 9.1 8.9 25.8 9.8 0.4 2.7 23.6 147.8 11.5 3.7 6.5 ATP12A "#945, 2, ATP1AL1, HK" ENSG00000075673 "ATPase H+/K+ transporting non-gastric alpha2 subunit" P54707 13 24680411-24712493 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 12.3;lymphoid tissue: 38.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Club cells: 18.2" "Cancer enhanced" "Detected in many" "testis cancer: 12.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 5 "T-reg: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enriched" "Detected in some" 8 "SuSa: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039526 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039526: AB_10673534" "unprognostic (8.33e-3)" "unprognostic (3.58e-2)" "unprognostic (2.93e-1)" "unprognostic (5.21e-3)" "unprognostic (2.58e-1)" "unprognostic (1.21e-2)" "unprognostic (8.03e-3)" "unprognostic (2.64e-1)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.67e-1)" "unprognostic (6.80e-2)" "unprognostic (8.22e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.2 1.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 12.3 0.1 0.0 0.1 0.3 0.2 8.8 0.1 6.1 0.0 0.1 0.0 0.1 1.0 0.0 0.2 5.8 0.4 0.3 2.2 0.0 0.4 0.0 0.1 9.8 0.1 0.0 0.1 0.1 0.1 1.0 0.0 1.2 0.2 2.9 38.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.2 1.3 0.3 0.2 0.1 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 5.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.2 ATP13A2 "CLN12, HSA9947, PARK9" ENSG00000159363 "ATPase 13A2" Q9NQ11 1 16985958-17011928 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 6 "dendritic cells: 17.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037038, CAB037111, HPA050910, HPA054717" Enhanced NA NA "CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583" "unprognostic (3.81e-2)" "unprognostic (1.84e-2)" "unprognostic (5.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.33e-7)" "unprognostic (1.04e-1)" "unprognostic (9.71e-3)" "unprognostic (4.51e-1)" "unprognostic (9.85e-3)" "unprognostic (1.85e-1)" "unprognostic (5.75e-2)" "unprognostic (3.25e-2)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (6.84e-3)" 9.6 12.3 21.9 16.3 25.8 8.7 6.7 25.5 45.3 6.0 12.5 12.0 4.7 10.4 5.3 6.1 8.9 7.1 7.6 4.5 23.8 34.6 6.5 2.5 9.6 13.2 28.4 20.3 5.3 30.1 7.8 22.2 10.5 52.2 7.2 8.3 9.6 15.6 7.2 7.5 10.0 11.1 7.3 10.9 16.1 10.7 6.2 9.9 5.2 8.6 2.9 8.1 9.2 5.2 2.1 17.9 0.4 2.9 2.2 2.5 1.1 10.2 10.9 6.0 23.1 5.6 4.8 15.8 6.0 5.7 6.6 6.9 19.0 12.0 4.7 25.6 9.9 5.7 16.2 11.9 21.8 2.3 6.2 22.8 15.9 10.2 9.9 7.3 5.8 7.6 3.8 12.1 18.5 13.5 21.4 12.8 12.2 10.2 8.8 26.8 8.4 6.7 3.2 8.8 24.7 7.4 7.4 22.4 18.2 7.4 15.7 16.0 10.3 27.0 35.1 22.7 7.7 11.8 7.1 12.8 7.3 13.8 12.2 12.0 1.8 2.1 4.8 13.8 31.7 11.6 0.0 1.3 0.3 2.4 2.9 2.5 1.2 1.9 2.0 0.4 2.1 1.0 1.4 0.4 2.2 2.7 17.9 1.5 1.1 21.9 25.8 25.5 45.3 23.8 34.6 28.4 20.3 52.2 9.9 0.0 2.1 3.7 6.3 5.8 30.8 3.2 12.7 2.7 1.2 7.0 33.4 5.1 5.0 12.9 0.9 8.4 28.1 0.0 21.6 28.3 4.7 10.7 9.2 3.2 9.2 44.5 7.5 4.3 12.1 0.2 4.9 4.1 5.0 2.8 12.9 37.2 40.5 45.6 6.0 5.7 34.3 0.0 3.8 12.6 14.9 4.5 7.8 8.7 13.3 10.6 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193402077-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051932 Approved Nucleoplasm NA NA Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.6 0.7 11.2 0.6 11.1 0.6 17.8 2.6 10.1 1.8 2.2 8.4 9.0 0.9 0.6 46.4 11.8 2.7 4.3 0.6 11.1 5.1 0.8 0.7 22.0 0.8 7.5 7.7 0.8 3.9 52.5 3.5 0.6 9.0 0.6 3.2 0.5 4.5 16.7 0.6 11.2 0.6 0.7 6.1 0.7 7.6 0.8 7.5 0.0 51.2 7.8 9.5 0.6 3.7 0.4 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.1 1.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.9 1.0 1.5 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 11.2 11.1 2.6 10.1 11.1 5.1 7.5 7.7 9.0 7.5 59.6 19.6 0.0 0.0 0.1 1.9 0.4 12.7 13.4 22.7 0.0 0.0 0.8 0.0 2.1 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 1.1 0.0 0.2 1.6 0.0 1.8 0.8 0.8 0.0 0.6 1.7 0.0 1.5 0.6 1.2 1.7 0.4 0.2 0.9 0.0 0.0 0.7 1.2 1.4 0.6 0.8 1.7 0.0 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274790-193378843 "Predicted membrane proteins" Translocase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 17.5;salivary gland: 28.9" "Cell type enhanced" "Detected in some" 25 "Club cells: 2.3;Early spermatids: 1.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Region enriched" "Detected in many" 10 "pons and medulla: 15.2" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "PC-3: 1.7;SK-BR-3: 5.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031774" Uncertain NA NA "HPA031771: AB_2674038, HPA031774: AB_2674039" "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.1 0.0 1.4 0.1 1.5 0.1 17.5 0.3 0.9 0.1 0.1 2.8 0.1 0.0 0.3 0.9 0.9 0.0 0.1 0.1 1.0 0.7 0.1 0.1 0.4 0.1 0.9 0.1 0.2 0.1 0.1 0.2 0.1 15.2 0.3 0.0 0.4 28.9 0.1 1.3 5.1 0.1 0.1 0.3 0.1 1.4 0.3 0.1 0.4 1.4 1.3 0.7 0.1 0.1 0.4 0.4 4.1 0.3 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.7 1.0 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.0 0.0 0.2 0.7 0.0 1.7 0.3 1.0 0.0 0.0 0.4 0.7 0.0 0.0 5.8 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.3 1.0 0.0 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.2 0.2 4.1 0.3 0.0 0.4 0.1 0.1 1.4 1.5 0.3 0.9 1.0 0.7 0.9 0.1 15.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP1A1 ENSG00000163399 "ATPase Na+/K+ transporting subunit alpha 1" P05023 1 116372668-116410261 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 195.4;parathyroid gland: 194.4" "Cell type enhanced" "Detected in all" 5 "Enterocytes: 917.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 254.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018702, CAB069993" Enhanced NA NA 380000 "CAB018702: AB_626713, CAB069993: AB_2060979" "unprognostic (6.18e-2)" "unprognostic (2.18e-1)" "unprognostic (6.91e-2)" "unprognostic (1.42e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.80e-1)" "unprognostic (1.21e-2)" "unprognostic (6.32e-2)" "unprognostic (1.61e-2)" "unprognostic (1.65e-1)" "prognostic favorable (8.98e-8)" "unprognostic (4.75e-2)" "unprognostic (1.17e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.01e-4)" 17.4 25.6 22.4 16.2 40.3 10.5 26.9 74.2 67.4 17.8 121.9 14.2 56.1 92.3 13.1 38.3 34.9 17.7 65.8 41.1 26.1 18.7 162.7 34.6 35.1 9.6 19.2 27.6 17.4 78.6 194.4 25.0 19.2 34.1 22.1 65.7 24.1 84.4 53.7 19.0 40.5 195.4 17.7 20.7 13.7 25.0 17.0 13.9 9.1 101.2 13.7 16.2 14.2 23.1 10.3 22.0 6.4 29.7 10.4 30.2 17.2 33.7 12.4 12.9 6.5 26.0 25.3 66.6 20.2 40.3 24.9 35.4 49.8 24.2 26.7 28.6 23.9 25.3 44.1 25.5 42.6 36.3 9.8 28.3 15.5 23.5 42.0 19.9 38.9 21.9 28.1 71.5 29.0 38.3 35.2 30.5 16.3 25.6 25.8 22.0 67.0 15.7 14.1 30.4 53.6 25.0 15.2 30.3 23.6 90.1 34.8 12.7 11.2 31.4 59.6 254.2 33.2 15.7 22.6 26.9 14.2 19.9 36.7 40.9 12.5 9.7 20.5 43.6 22.5 83.4 6.4 13.3 6.1 23.2 20.9 24.8 10.3 26.4 24.9 22.0 5.3 30.2 22.0 1.6 10.4 29.7 11.1 20.3 17.2 22.4 40.3 74.2 67.4 26.1 18.7 19.2 27.6 34.1 13.9 256.1 246.7 58.7 265.3 245.9 76.0 62.7 540.1 113.8 203.6 731.0 375.0 70.1 316.7 432.8 25.0 117.9 917.6 93.5 278.3 130.8 110.9 297.5 43.8 66.4 114.8 96.9 169.4 90.9 77.6 11.5 109.0 130.5 197.4 47.7 304.0 513.0 192.4 264.8 94.7 289.6 141.6 32.3 179.2 17.9 27.5 235.0 56.5 95.6 365.5 236.0 ATP1A2 "FHM2, MHP2" ENSG00000018625 "ATPase Na+/K+ transporting subunit alpha 2" P50993 1 160115759-160143591 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "brain: 109.8;skeletal muscle: 305.8" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 142.4;Muller glia cells: 63.9;Peritubular cells: 37.1;Sertoli cells: 84.1;Smooth muscle cells: 32.5" "Cancer enriched" "Detected in many" 18 "glioma: 91.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 32.9;HHSteC: 9.6;RH-30: 10.7;U-87 MG: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022230 Enhanced NA NA "CAB022230: " "unprognostic (1.08e-2)" "unprognostic (4.42e-2)" "unprognostic (3.41e-2)" "unprognostic (2.83e-1)" "unprognostic (2.83e-1)" "unprognostic (7.98e-2)" "unprognostic (2.16e-2)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (8.85e-2)" "unprognostic (8.63e-4)" "unprognostic (1.70e-2)" "unprognostic (9.40e-3)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (7.16e-2)" "unprognostic (5.32e-3)" 12.6 3.9 61.4 2.8 80.1 2.3 6.5 30.4 109.8 4.7 6.6 27.4 2.4 3.7 4.2 7.4 15.3 6.0 5.3 35.4 42.2 27.0 3.3 2.5 3.8 2.4 45.6 37.9 9.9 2.6 2.4 4.6 3.6 58.0 13.8 5.6 12.5 3.1 14.2 305.8 2.8 4.4 5.4 51.5 2.7 2.8 3.9 28.3 0.0 2.6 17.7 2.5 5.5 1.3 0.6 1.4 1.7 0.4 0.6 0.5 0.3 0.0 0.0 32.9 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 2.9 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 1.3 0.4 0.3 0.3 0.3 0.2 0.4 0.3 0.2 0.7 0.6 0.3 0.5 1.7 0.6 0.2 1.4 0.2 0.3 61.4 80.1 30.4 52.0 42.2 27.0 45.6 37.9 58.0 28.3 0.0 0.0 0.0 0.8 0.5 0.7 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 26.7 0.0 0.0 0.0 0.0 63.9 0.0 0.0 37.1 0.0 1.9 84.1 32.5 0.3 0.2 0.5 0.1 0.0 0.0 0.5 ATP1A3 DYT12 ENSG00000105409 "ATPase Na+/K+ transporting subunit alpha 3" P13637 19 41966582-41997497 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Deafness, Disease mutation, Dystonia, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 146.4;heart muscle: 78.3" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 387.3;Cone photoreceptor cells: 161.0;Horizontal cells: 201.8;Late spermatids: 93.3;Rod photoreceptor cells: 178.0" "Group enriched" "Detected in many" 6 "glioma: 21.6;testis cancer: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "Daudi: 20.7;JURKAT: 13.5;Karpas-707: 13.2;REH: 13.0;SCLC-21H: 49.1;SH-SY5Y: 21.1" "CAB033630, HPA045367, HPA056446" Enhanced Approved NA NA "CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136" "unprognostic (1.90e-1)" "unprognostic (8.65e-2)" "unprognostic (4.57e-2)" "unprognostic (8.20e-3)" "unprognostic (8.94e-2)" "unprognostic (2.52e-1)" "unprognostic (3.16e-2)" "unprognostic (7.66e-2)" "unprognostic (8.02e-2)" "prognostic unfavorable (3.44e-4)" "prognostic favorable (6.15e-5)" "unprognostic (4.02e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "unprognostic (3.45e-1)" "unprognostic (1.27e-1)" 1.9 12.8 34.0 2.5 30.8 2.1 1.8 42.8 146.4 1.8 2.4 4.8 0.0 2.4 1.8 1.8 2.0 1.8 1.9 78.3 48.3 54.6 1.8 1.8 1.9 2.3 39.9 42.6 1.8 2.3 1.8 3.0 1.8 94.4 1.8 2.3 17.3 2.2 1.8 1.8 2.0 2.7 2.2 18.5 2.1 2.0 18.6 6.9 0.0 1.8 0.0 2.1 1.9 0.1 0.3 0.1 0.0 0.0 0.1 2.2 0.3 0.0 0.8 0.3 8.7 0.0 0.0 0.0 0.1 0.0 0.6 0.6 0.3 1.6 20.7 0.9 0.1 2.0 0.2 6.1 0.0 0.2 3.9 1.1 1.8 0.0 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.1 0.1 0.0 13.5 0.0 13.2 0.1 0.3 3.7 0.0 1.1 2.9 5.3 13.0 7.1 0.6 0.0 0.2 49.1 21.1 0.1 1.6 0.0 0.0 1.3 0.9 0.0 1.1 1.1 0.0 0.4 1.3 0.9 4.7 1.9 7.2 0.2 0.0 0.0 0.0 2.2 0.0 0.2 0.3 0.6 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.1 0.7 0.3 34.0 30.8 42.8 66.6 48.3 54.6 39.9 42.6 94.4 6.9 0.0 7.9 0.5 0.3 0.2 387.3 15.7 0.0 0.0 0.0 0.0 161.0 0.0 0.0 0.0 33.6 0.3 0.0 0.0 0.0 0.1 0.6 0.2 1.1 0.0 0.2 201.8 0.0 0.0 0.0 93.3 1.7 0.2 0.0 0.0 0.0 25.9 0.0 0.0 0.4 0.0 178.0 0.0 0.0 21.3 3.2 0.3 0.2 1.9 0.0 0.4 ATP1A4 ATP1AL2 ENSG00000132681 "ATPase Na+/K+ transporting subunit alpha 4" Q13733 1 160151570-160186977 "Enzymes, Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 13.1;seminal vesicle: 19.0;testis: 35.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 20.6;Early spermatids: 67.0;Syncytiotrophoblasts: 31.9" "Group enriched" "Detected in some" 8 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 10.8;HDLM-2: 26.8;RT4: 32.4" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (4.01e-3)" "unprognostic (2.20e-1)" "unprognostic (1.94e-1)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (1.22e-1)" "unprognostic (7.48e-3)" "unprognostic (2.45e-1)" "unprognostic (8.77e-3)" "unprognostic (1.98e-2)" "unprognostic (3.17e-2)" "unprognostic (2.43e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.09e-2)" "prognostic favorable (2.20e-4)" 0.4 0.3 0.4 0.8 0.3 0.0 2.2 0.4 0.3 0.3 0.3 0.0 11.2 0.0 0.2 0.3 0.3 0.3 0.8 0.3 0.3 0.3 0.2 0.2 0.3 3.8 0.3 0.0 0.2 0.2 0.0 0.3 13.1 0.0 0.6 0.0 0.4 1.2 19.0 3.2 0.3 0.5 1.6 0.3 1.1 0.3 35.8 0.0 0.9 0.2 0.2 1.6 8.9 5.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.0 5.5 0.2 0.0 0.8 0.0 0.0 0.0 1.8 0.0 20.6 0.0 0.0 67.0 0.0 0.0 0.0 0.0 11.9 0.4 0.7 1.1 0.0 2.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.2 0.2 0.0 31.9 0.0 0.0 11.2 ATP1B1 ATP1B ENSG00000143153 "ATPase Na+/K+ transporting subunit beta 1" P05026 1 169105697-169132722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 239.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 1634.8;Proximal tubular cells: 927.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 127.3;RPTEC TERT1: 68.9;SH-SY5Y: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012911 Enhanced NA NA 4100000 "HPA012911: AB_1845173" "unprognostic (4.20e-2)" "unprognostic (3.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.85e-2)" "unprognostic (1.95e-1)" "unprognostic (5.34e-2)" "unprognostic (2.22e-1)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (6.80e-2)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "prognostic favorable (7.08e-7)" "unprognostic (1.11e-1)" "unprognostic (5.48e-2)" "unprognostic (1.97e-3)" "unprognostic (9.39e-2)" 3.9 26.3 48.7 8.6 45.1 1.3 14.9 39.4 92.1 8.7 43.8 34.5 11.3 61.3 19.8 11.2 28.7 9.4 50.1 36.0 86.3 68.2 239.7 30.6 16.9 1.9 82.3 52.6 11.5 33.0 130.6 16.7 8.3 111.5 9.8 34.8 15.5 55.7 15.4 55.1 11.2 51.2 17.8 64.0 9.6 69.5 8.4 25.9 0.9 60.1 23.7 13.9 12.3 9.0 1.4 8.4 10.5 3.0 5.6 9.1 1.4 12.3 30.2 9.8 7.5 2.3 0.4 3.4 6.1 5.0 6.4 6.7 36.8 25.0 0.0 23.1 4.8 7.2 14.6 5.4 11.6 6.6 0.1 2.4 0.7 22.8 17.1 3.7 0.5 1.1 1.3 2.9 4.7 6.1 11.2 5.8 0.9 0.1 0.1 7.3 4.7 1.0 1.9 3.9 127.3 6.5 0.1 11.9 2.1 68.9 15.4 7.8 57.2 36.1 36.4 1.6 12.5 7.5 1.2 12.3 4.9 13.2 8.3 21.8 0.7 0.9 0.2 5.9 1.8 6.6 10.5 1.0 0.1 2.9 3.0 1.5 1.4 3.4 1.1 8.4 0.2 1.0 1.1 0.3 5.6 0.9 0.4 9.1 1.4 48.7 45.1 39.4 92.1 86.3 68.2 82.3 52.6 111.5 25.9 223.4 199.8 17.7 144.1 46.6 22.3 136.8 749.1 187.4 257.0 1634.8 13.7 3.9 782.5 509.0 2.8 15.2 580.2 0.0 519.8 7.5 62.9 68.0 22.0 232.9 298.5 548.2 154.6 46.6 63.5 4.1 83.1 111.4 234.5 43.3 240.2 24.3 309.0 614.7 140.0 927.9 48.2 6.5 23.6 8.6 62.0 27.7 8.2 25.4 319.0 251.2 ATP1B2 AMOG ENSG00000129244 "ATPase Na+/K+ transporting subunit beta 2" P14415 17 7646627-7657768 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 148.8" "Group enriched" "Detected in many" 6 "Bipolar cells: 345.9;Cone photoreceptor cells: 235.6;Muller glia cells: 268.9;Rod photoreceptor cells: 188.4" "Cancer enriched" "Detected in many" 17 "glioma: 200.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 13.5;HAP1: 4.1;K-562: 6.1;SuSa: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010698 Supported NA NA 17000 "HPA010698: AB_1845174" "unprognostic (9.39e-2)" "unprognostic (1.86e-2)" "unprognostic (3.89e-3)" "unprognostic (4.96e-3)" "unprognostic (3.90e-3)" "unprognostic (9.33e-2)" "unprognostic (4.86e-1)" "unprognostic (5.93e-2)" "unprognostic (5.43e-2)" "unprognostic (1.29e-2)" "prognostic favorable (1.05e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (3.79e-2)" 4.1 6.5 54.7 2.5 61.6 8.1 2.5 62.9 148.8 9.4 3.4 25.1 0.0 2.7 8.0 15.1 3.4 10.9 4.4 5.0 46.1 33.4 6.9 3.4 3.9 2.9 42.4 41.9 23.3 3.3 3.8 10.8 5.0 68.9 4.6 3.8 28.4 3.3 7.6 4.6 2.7 3.0 5.8 58.7 4.8 2.4 4.3 25.7 0.0 4.4 0.0 2.6 3.3 2.0 1.3 0.7 1.5 1.0 1.3 2.0 0.5 0.0 0.0 13.5 0.6 0.4 0.3 0.1 0.2 0.0 0.5 0.3 0.5 0.0 0.4 0.3 0.1 0.2 0.4 4.1 0.2 0.2 0.1 1.7 0.3 0.1 0.1 0.2 0.1 1.3 0.8 0.0 0.5 0.0 0.1 0.0 0.3 6.1 0.8 0.0 0.4 0.3 0.4 2.8 0.1 0.3 0.2 0.0 0.2 0.1 0.1 0.2 2.6 0.0 0.1 0.1 8.2 0.2 0.3 0.0 0.2 1.0 0.1 0.2 0.5 0.2 0.1 1.2 0.3 0.3 0.9 1.0 0.5 2.0 0.3 1.8 1.3 0.7 1.4 0.3 0.8 1.1 1.0 1.5 1.3 0.2 0.7 0.2 0.5 54.7 61.6 62.9 50.8 46.1 33.4 42.4 41.9 68.9 25.7 0.0 0.0 0.0 0.2 1.6 345.9 2.8 5.1 0.0 0.0 0.0 235.6 0.0 0.0 0.0 0.2 1.8 0.5 23.3 0.0 0.1 2.4 0.4 0.0 0.0 0.3 17.5 0.0 5.5 1.5 0.2 17.3 0.6 0.0 0.0 0.0 268.9 0.0 0.0 43.5 0.1 188.4 25.8 22.8 0.4 6.3 1.0 0.2 0.0 0.0 0.1 ATP1B4 ENSG00000101892 "ATPase Na+/K+ transporting family member beta 4" Q9UN42 X 120362085-120383249 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 47.3;tongue: 26.1" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 4 "HSkMC: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.59e-2)" "unprognostic (6.02e-4)" "unprognostic (5.78e-1)" "unprognostic (5.29e-2)" 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.2 1.7 0.1 0.0 2.4 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 0.0 47.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 26.1 2.5 0.0 0.0 0.7 0.2 1.4 0.3 0.7 0.3 1.0 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.7 0.3 0.3 0.5 0.1 0.2 0.3 3.1 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.7 0.0 0.6 0.5 0.4 0.3 0.2 0.0 0.0 0.3 0.4 0.4 0.1 1.3 0.3 0.3 0.3 0.1 0.2 0.3 0.1 0.2 0.1 0.7 0.3 0.3 1.4 0.7 0.3 0.2 0.2 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP23 "KUB3, XRCC6BP1" ENSG00000166896 "ATP23 metallopeptidase and ATP synthase assembly factor homolog" Q9Y6H3 12 57941541-57957269 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 11.7;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.6;granulocytes: 10.5;Hofbauer cells: 9.7;Proximal tubular cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 15.2;RH-30: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035804, HPA043204" Uncertain Enhanced "Vesicles,Plasma membrane,Cell Junctions,Cytosol" NA NA "Vesicles, Plasma membrane" "Cell Junctions, Cytosol" "HPA035804: AB_10601026, HPA043204: AB_2678361" "unprognostic (2.56e-1)" "unprognostic (1.31e-2)" "unprognostic (8.82e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (5.28e-2)" "unprognostic (5.41e-3)" "unprognostic (1.03e-2)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (4.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-1)" 6.7 4.9 4.3 5.2 5.3 11.3 4.8 6.1 4.8 5.6 8.2 1.3 2.5 3.9 3.2 4.2 7.3 3.1 2.4 6.4 4.2 3.6 5.4 6.2 2.7 6.8 2.7 3.8 4.2 5.8 3.2 3.0 3.5 2.9 5.1 8.2 2.3 3.4 3.3 11.7 5.6 4.3 6.5 3.4 3.7 3.8 39.5 2.0 20.8 4.7 5.9 4.7 6.3 6.2 3.0 4.5 12.0 4.5 2.6 5.6 3.0 2.0 1.5 1.9 2.2 2.8 2.7 1.0 1.9 2.0 2.2 2.1 1.2 2.5 6.9 2.5 1.5 2.2 1.9 1.8 2.0 3.8 3.5 1.8 4.5 1.3 2.0 1.2 9.1 3.1 1.4 1.5 1.3 0.6 2.2 1.5 5.0 4.7 5.0 1.8 3.1 4.9 15.2 1.7 3.4 3.7 3.2 49.9 2.9 1.8 2.6 1.2 1.8 3.1 2.9 1.6 0.9 5.0 8.6 0.8 1.7 2.9 2.2 1.9 4.1 2.1 3.6 1.8 9.8 2.7 7.6 4.5 12.0 3.5 2.4 2.6 3.0 4.0 3.3 4.5 3.0 4.3 4.0 1.9 2.6 4.2 2.1 5.6 3.0 4.3 5.3 6.1 4.8 4.2 3.6 2.7 3.8 2.9 2.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.4 3.5 0.0 11.7 14.9 5.1 0.0 0.0 0.0 0.0 9.4 11.6 0.0 0.0 10.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.8 0.0 0.0 4.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 ATP2A1 "ATP2A, SERCA1" ENSG00000196296 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1" O14983 16 28878405-28904509 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 456.3;tongue: 209.0" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 13.7;Late spermatids: 2.9;Rod photoreceptor cells: 4.6;Spermatogonia: 3.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 19.8" "Region enriched" "Detected in single" 8 "thalamus: 14.3" "Not detected" "Not detected" "CAB002310, CAB032706" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB002310: AB_564139, CAB032706: AB_2061286" "unprognostic (2.37e-1)" "unprognostic (6.81e-2)" "unprognostic (2.23e-5)" "unprognostic (5.35e-2)" "unprognostic (2.27e-1)" "unprognostic (2.04e-1)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.87e-1)" "unprognostic (5.22e-2)" "unprognostic (4.94e-2)" "unprognostic (2.72e-4)" "unprognostic (1.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-2)" 7.6 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.1 1.1 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.6 0.1 12.6 7.0 0.3 456.3 0.2 0.2 0.1 0.1 0.1 0.1 0.9 0.0 0.0 4.2 209.0 6.5 0.2 0.1 1.6 3.1 0.7 0.2 4.7 1.5 0.6 4.8 5.2 9.6 5.8 0.4 1.6 8.9 2.3 1.3 0.4 0.4 2.9 4.4 7.6 2.7 0.4 3.2 5.1 2.4 0.1 0.7 3.8 19.8 2.7 11.8 9.0 0.2 1.1 2.6 4.1 1.1 0.6 0.5 4.9 0.2 14.3 5.2 6.5 0.3 9.7 10.9 6.1 9.7 1.8 7.4 16.9 6.8 5.7 0.0 0.6 6.2 4.9 3.3 4.5 3.4 3.7 3.4 2.7 2.0 3.0 6.3 5.6 2.8 9.5 5.8 7.4 5.9 15.0 2.9 0.0 0.1 0.7 1.0 0.0 1.3 1.6 1.1 1.0 0.0 0.8 1.4 1.3 0.0 4.7 0.2 3.1 1.5 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.3 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.1 1.0 0.0 0.5 0.0 0.2 0.1 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.3 2.9 0.3 0.0 0.0 0.0 0.1 0.5 0.2 0.3 0.0 0.0 4.6 0.0 0.0 1.8 3.0 0.1 0.6 0.0 0.6 0.0 ATP2A2 "ATP2B, DAR, SERCA2" ENSG00000174437 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2" P16615 12 110280756-110351093 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 188.3;skeletal muscle: 319.7" "Cell type enriched" "Detected in all" 12 "Cardiomyocytes: 1592.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062605 Enhanced NA NA 38000000 "HPA062605: AB_2684805" "unprognostic (4.81e-2)" "unprognostic (2.16e-2)" "unprognostic (1.87e-1)" "unprognostic (3.41e-3)" "unprognostic (2.50e-1)" "unprognostic (3.98e-3)" "unprognostic (1.91e-2)" "unprognostic (6.20e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-3)" "unprognostic (2.26e-1)" "unprognostic (5.62e-2)" "unprognostic (9.93e-2)" 8.4 8.8 7.3 8.5 14.5 5.7 7.5 7.4 20.8 8.2 9.6 8.0 8.3 7.3 9.4 10.3 24.1 9.4 9.3 188.3 10.1 5.0 6.7 11.8 8.9 5.6 5.6 13.1 8.5 7.6 8.7 6.1 8.1 10.2 13.0 11.2 22.3 18.3 9.6 319.7 9.3 9.3 14.3 7.4 5.4 7.9 11.9 7.1 3.1 12.6 51.3 12.7 13.4 11.4 0.8 2.2 0.2 4.4 1.7 1.7 0.7 35.5 70.9 35.9 28.8 23.9 30.6 51.8 44.3 55.8 45.0 30.3 51.2 37.9 43.9 37.5 42.1 34.0 52.0 59.4 70.0 51.2 36.3 29.7 38.3 28.4 29.9 40.6 43.7 37.1 32.1 49.4 57.1 55.4 43.3 34.7 23.0 44.6 21.5 36.6 34.1 23.6 27.1 40.9 36.5 35.9 24.9 32.3 36.2 22.2 73.4 38.0 28.5 55.8 45.8 25.9 34.2 61.6 23.6 37.2 41.7 22.4 27.7 33.8 44.2 53.8 49.2 38.0 18.9 47.2 0.0 1.9 0.0 1.7 4.4 0.9 0.7 1.3 1.1 1.9 0.8 1.3 1.2 0.2 1.7 2.3 2.2 1.2 0.7 7.3 14.5 7.4 20.8 10.1 5.0 5.6 13.1 10.2 7.1 41.7 53.9 23.1 78.3 101.7 60.4 1592.4 45.9 96.4 83.0 48.8 60.9 28.0 1.7 40.8 10.7 37.6 123.8 23.3 60.6 31.5 51.2 89.3 43.9 110.5 56.0 79.4 131.8 41.1 50.1 9.0 28.1 40.7 64.1 19.0 80.6 24.0 82.4 70.2 78.1 23.9 39.0 51.8 126.0 61.6 55.1 95.2 25.6 17.0 66.5 93.6 ATP2A3 SERCA3 ENSG00000074370 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3" Q93084 17 3923870-3964464 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 82.4;salivary gland: 88.1" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 61.6;Intestinal endocrine cells: 94.0;Mucus-secreting cells: 112.7;Paneth cells: 46.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 10.9;midbrain: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 39.3;HMC-1: 58.2;JURKAT: 32.7;MOLT-4: 52.0;SK-BR-3: 42.3" "Region enriched" "Detected in some" 15 "cerebellum: 75.4" "Low region specificity" "Detected in many" "HPA007180, CAB010882" Approved NA NA 100000000 "CAB010882: AB_258368, HPA007180: AB_1845177" "unprognostic (4.14e-2)" "prognostic favorable (4.69e-5)" "unprognostic (1.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.02e-2)" "prognostic favorable (2.51e-4)" "unprognostic (8.83e-3)" "unprognostic (2.30e-1)" "unprognostic (8.29e-2)" "unprognostic (3.67e-3)" "unprognostic (3.95e-3)" "unprognostic (1.73e-1)" "unprognostic (1.45e-3)" "unprognostic (1.60e-1)" "unprognostic (3.25e-2)" "unprognostic (1.54e-1)" "unprognostic (1.97e-3)" 2.1 4.9 0.9 36.9 1.6 24.3 2.7 10.9 1.7 2.3 15.4 1.8 48.8 8.1 3.4 2.8 4.5 2.2 16.0 2.6 0.9 0.7 3.4 1.6 7.8 25.6 4.1 1.4 2.1 20.2 0.0 0.8 1.7 1.4 7.4 9.0 8.7 88.1 47.3 0.9 9.4 26.1 3.0 1.0 36.4 25.5 1.6 1.2 82.4 4.2 6.0 47.5 5.4 2.6 8.3 10.8 21.1 1.0 2.5 7.8 3.9 0.0 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.3 39.3 2.4 0.1 0.0 0.1 0.6 0.0 0.0 4.8 0.4 20.5 1.2 0.0 0.3 22.3 58.2 0.0 0.0 0.1 0.0 0.0 0.0 32.7 4.1 25.4 0.0 24.4 52.0 24.0 0.2 11.1 0.3 5.7 0.0 9.0 0.0 0.7 2.5 0.7 0.3 42.3 0.0 0.2 2.6 5.5 0.1 0.0 0.4 0.1 0.0 9.4 2.8 13.8 0.5 15.9 0.0 9.1 1.0 21.1 7.8 0.6 6.1 6.9 4.8 7.2 1.0 8.3 3.6 4.4 9.0 2.5 0.3 10.8 4.2 3.9 0.9 1.6 10.9 1.7 0.9 0.7 4.1 1.4 1.4 1.2 0.0 3.4 44.0 0.4 0.8 0.0 2.2 5.1 1.4 2.3 22.7 0.0 0.2 0.0 1.7 0.1 3.6 61.6 0.0 10.8 0.2 2.0 6.5 33.4 0.8 2.8 0.0 94.0 7.4 3.5 0.0 0.0 2.6 11.8 0.0 112.7 0.2 17.0 46.0 0.7 0.2 0.1 0.0 3.1 0.0 0.7 0.3 0.0 20.8 41.2 2.5 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.8" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 311.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 59.7;LHCN-M2: 92.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 8.7 5.1 23.4 12.5 53.8 40.5 8.8 30.9 44.1 9.0 14.0 4.1 4.0 17.8 8.2 5.8 6.5 8.4 11.3 5.2 29.0 11.8 7.4 10.0 9.2 11.8 7.8 31.5 7.6 7.4 13.7 8.7 11.7 9.2 6.4 14.8 2.9 5.6 6.9 10.9 11.3 12.8 8.7 6.1 12.7 12.4 9.8 16.4 5.7 6.3 6.0 12.3 9.9 7.4 27.1 16.2 41.5 25.6 8.4 16.3 6.2 4.2 21.5 8.5 4.1 12.4 19.7 3.9 13.0 42.9 12.6 20.2 8.6 3.9 8.4 0.9 18.1 14.6 3.8 7.4 3.6 35.5 2.9 8.7 3.0 7.6 7.5 40.3 12.5 5.0 16.3 6.9 39.5 59.7 14.9 3.2 3.2 4.9 3.1 92.7 6.7 3.9 5.4 6.6 5.9 10.3 5.6 27.4 3.5 12.0 19.8 8.0 4.4 15.1 4.3 3.6 18.0 6.3 1.4 2.2 34.5 5.6 12.6 14.2 2.3 3.6 9.0 15.6 3.5 7.6 2.7 13.0 6.7 7.1 13.6 9.0 27.1 12.4 9.0 16.2 27.0 4.6 5.7 41.5 8.4 25.6 2.9 16.3 6.2 23.4 53.8 30.9 44.1 29.0 11.8 7.8 31.5 9.2 16.4 41.7 42.4 79.2 52.7 179.2 311.6 18.9 45.9 29.4 36.4 50.6 145.3 117.8 1.7 21.2 1.8 49.1 113.3 0.0 24.6 36.9 79.9 37.8 30.1 35.8 157.7 286.0 87.9 47.3 100.2 6.0 27.0 213.2 52.3 116.4 24.1 78.6 21.7 48.2 30.1 23.1 99.9 32.3 51.5 12.9 122.1 178.9 191.3 55.4 45.3 59.3 ATP2B2 PMCA2 ENSG00000157087 "ATPase plasma membrane Ca2+ transporting 2" Q01814 3 10324023-10708007 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 85.3;Hepatocytes: 27.0;Horizontal cells: 98.5" "Cancer enhanced" "Detected in some" "liver cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 5.4;RPMI-8226: 15.3;SCLC-21H: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005606 Enhanced NA NA "CAB005606: AB_2243199" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (6.84e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-1)" "unprognostic (3.62e-1)" "unprognostic (4.09e-2)" "unprognostic (4.65e-1)" "unprognostic (5.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.32e-4)" "unprognostic (2.70e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "unprognostic (1.33e-2)" "unprognostic (8.34e-2)" "unprognostic (7.95e-3)" 1.0 1.5 7.6 1.0 23.0 0.9 1.0 39.9 55.1 3.0 1.0 2.4 0.0 1.0 3.2 1.1 1.1 4.3 1.0 1.0 10.0 6.2 1.1 15.2 1.0 1.0 7.9 14.7 1.0 1.1 0.9 1.7 0.9 15.5 1.0 1.0 0.7 28.6 0.9 30.3 1.3 1.0 2.3 2.5 1.0 1.0 1.5 4.2 0.0 0.9 0.0 1.0 0.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 15.3 0.0 0.0 5.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 7.6 23.0 39.9 55.1 10.0 6.2 7.9 14.7 15.5 4.2 0.0 0.0 0.0 0.0 0.5 85.3 7.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 27.0 0.0 98.5 0.0 0.6 1.0 5.7 0.0 0.0 3.3 0.0 0.0 14.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 ATP2B3 "CFAP39, CLA2, PMCA3, SCAX1" ENSG00000067842 "ATPase plasma membrane Ca2+ transporting 3" Q16720 X 153517676-153582939 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 18.6;brain: 23.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 5.0;Extravillous trophoblasts: 8.3;Rod photoreceptor cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.6;SH-SY5Y: 4.3;THP-1: 3.5;U-937: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001583 Enhanced Supported NA NA "HPA001583: AB_1079641" "unprognostic (1.35e-1)" "unprognostic (3.07e-2)" "unprognostic (3.28e-1)" "unprognostic (6.82e-2)" "unprognostic (1.30e-1)" "unprognostic (4.32e-2)" "unprognostic (2.67e-1)" "unprognostic (6.34e-2)" "unprognostic (2.68e-2)" "unprognostic (8.58e-2)" "unprognostic (1.38e-3)" "unprognostic (3.44e-1)" "unprognostic (2.71e-12)" "unprognostic (1.44e-3)" "unprognostic (2.04e-1)" "unprognostic (2.42e-2)" 0.8 18.6 5.4 0.9 11.3 0.8 0.8 16.1 23.2 0.8 0.9 3.9 0.0 0.9 0.9 2.6 0.8 3.1 0.8 0.8 7.8 5.5 1.0 0.8 0.8 0.8 4.3 11.5 0.8 0.9 0.8 1.2 1.7 13.6 0.8 0.8 1.4 1.3 1.3 0.8 0.9 0.9 0.9 1.4 0.8 0.8 1.1 0.9 0.0 0.8 0.0 0.8 0.8 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 4.3 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 11.3 16.1 20.7 7.8 5.5 4.3 11.5 13.6 0.9 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.0;salivary gland: 35.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA052262: AB_2681776, HPA075812: AB_2686765" "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favorable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.3 0.0 2.1 8.0 1.5 6.1 2.5 0.2 2.0 3.5 23.0 0.5 1.9 16.3 1.8 1.9 2.7 4.0 18.8 0.4 1.8 1.9 2.6 0.2 21.9 0.2 1.3 0.7 1.3 0.5 0.0 2.9 4.8 0.7 7.9 21.9 1.0 35.8 0.2 0.9 15.2 14.5 0.5 0.6 0.2 3.4 0.4 0.4 0.3 8.2 2.2 8.1 4.8 7.8 0.0 0.0 2.7 0.0 0.0 0.1 0.0 3.6 0.2 0.4 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 3.4 3.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.1 0.0 11.4 2.9 0.0 0.0 20.2 0.1 0.5 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.2 2.0 1.8 1.9 1.3 0.7 0.7 0.4 29.8 42.2 0.0 12.3 0.6 1.4 0.6 2.5 72.3 29.6 0.0 0.0 1.9 0.0 7.2 3.0 0.6 15.4 0.0 2.3 2.2 0.3 21.6 9.2 0.0 0.2 0.0 32.8 0.0 0.0 1.1 0.0 0.7 1.7 0.0 62.9 1.3 3.1 17.3 0.0 1.9 5.6 0.0 0.5 0.7 0.6 1.0 20.1 0.0 69.5 9.5 ATP4A ATP6A ENSG00000105675 "ATPase H+/K+ transporting alpha subunit" P20648 19 35550043-35563658 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Potassium transport, Transport" Translocase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 120.1" "Group enriched" "Detected in some" 4 "Early spermatids: 7.3;Late spermatids: 15.2" "Cancer enriched" "Detected in single" 21 "stomach cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-138 MG: 1.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA039154, HPA076684" Enhanced NA NA 790000 "HPA039154: AB_10672772, HPA076684: " "unprognostic (3.54e-2)" "unprognostic (6.98e-3)" "unprognostic (2.77e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (9.68e-2)" "unprognostic (1.47e-3)" "unprognostic (3.90e-3)" "unprognostic (3.92e-2)" "unprognostic (4.86e-2)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" 0.1 0.2 0.1 0.1 0.6 0.0 0.1 0.1 0.6 0.1 0.1 3.4 0.1 0.0 0.1 0.1 4.9 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 120.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 1.5 0.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.6 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.6 0.0 0.0 0.0 0.0 0.0 ATP4B ATP6B ENSG00000186009 "ATPase H+/K+ transporting beta subunit" P51164 13 113648804-113658186 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 156.3" "Cell type enriched" "Detected in single" 6 "Distal tubular cells: 1.7" "Cancer enriched" "Detected in some" 12 "stomach cancer: 8.9" "Region enriched" "Detected in single" 9 "cerebral cortex: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 3.9;RPMI-8226: 1.6;SCLC-21H: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045400, HPA052649" Enhanced NA NA "HPA045400: AB_2679314, HPA052649: AB_2681900" "unprognostic (9.92e-2)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (4.86e-1)" "unprognostic (6.43e-3)" "unprognostic (7.81e-3)" "unprognostic (1.95e-1)" "unprognostic (3.22e-1)" "unprognostic (6.50e-2)" "unprognostic (6.65e-4)" "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (3.78e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.1 2.0 0.1 0.0 0.1 0.1 1.5 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 156.3 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.9 0.0 1.6 0.0 0.0 2.6 0.9 0.2 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP5F1D ATP5D ENSG00000099624 "ATP synthase F1 subunit delta" P30049 19 1241746-1244826 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 337.3" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 1442.3;Exocrine glandular cells: 487.7;Proximal tubular cells: 1282.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002865 Approved NA NA 4200000 "HPA002865: AB_1078244" "unprognostic (4.80e-2)" "unprognostic (9.34e-2)" "unprognostic (7.77e-2)" "prognostic favorable (1.23e-4)" "unprognostic (1.64e-2)" "unprognostic (1.95e-1)" "unprognostic (4.63e-2)" "unprognostic (6.75e-2)" "unprognostic (1.38e-1)" "unprognostic (2.91e-1)" "prognostic favorable (4.60e-4)" "unprognostic (6.95e-2)" "prognostic favorable (3.46e-5)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" 30.4 25.7 27.4 13.7 30.1 19.5 19.8 22.6 51.7 14.4 36.7 16.7 16.0 42.7 14.3 14.9 23.9 15.3 18.1 59.3 25.9 20.6 33.3 51.8 12.2 33.4 25.6 24.1 15.2 46.5 15.5 18.4 12.4 28.5 17.6 14.1 17.9 48.1 23.1 337.3 24.3 33.2 21.1 14.5 19.2 33.4 10.2 9.8 21.5 23.0 60.6 22.9 17.6 14.5 67.7 78.2 33.9 64.6 52.8 64.3 50.8 24.4 13.4 4.2 15.7 4.9 7.2 15.7 16.8 7.1 10.0 7.3 14.0 6.5 24.9 10.9 5.8 2.5 21.1 4.7 17.5 1.3 17.2 45.6 15.0 16.5 18.2 12.2 26.3 22.4 14.3 4.8 4.0 5.6 5.6 10.6 16.8 21.8 19.9 4.6 37.2 28.5 19.0 18.2 15.7 66.3 27.2 11.1 51.7 16.6 16.2 16.8 19.3 11.2 17.9 27.7 1.7 13.3 12.5 15.3 9.1 12.5 21.9 13.9 51.0 25.7 9.2 16.9 12.5 13.7 33.9 64.6 27.1 50.7 61.3 61.1 64.8 64.3 55.7 72.1 67.7 59.9 54.9 22.5 52.8 49.0 78.2 62.0 50.8 27.4 30.1 22.6 51.7 25.9 20.6 25.6 24.1 28.5 9.8 14.9 23.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.0 361.2 0.0 333.1 1442.3 304.6 0.0 0.0 0.0 0.0 487.7 366.7 0.0 0.0 4.7 0.0 365.7 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 232.6 0.0 0.0 350.7 0.0 0.0 1282.8 0.0 0.0 0.0 0.0 0.0 0.0 285.4 0.0 0.0 0.0 ATP5MC1 "ATP5G, ATP5G1" ENSG00000159199 "ATP synthase membrane subunit c locus 1" P05496 17 48892765-48895871 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 117.9" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 349.4;Distal tubular cells: 1228.5;Proximal tubular cells: 646.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 210.8" "Low region specificity" "Detected in all" NA NA "unprognostic (3.43e-2)" "prognostic favorable (3.88e-4)" "unprognostic (6.60e-2)" "unprognostic (2.09e-1)" "unprognostic (8.73e-2)" "unprognostic (4.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.53e-1)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (9.42e-3)" "unprognostic (9.78e-2)" "prognostic favorable (8.24e-6)" "unprognostic (2.07e-2)" "unprognostic (5.60e-2)" "unprognostic (1.95e-1)" "unprognostic (2.33e-1)" 11.7 19.2 29.2 16.4 34.2 12.4 17.6 15.8 35.4 13.6 46.8 9.5 11.1 28.3 13.5 24.7 22.2 16.0 13.0 117.9 26.2 21.6 47.9 33.0 11.2 18.3 23.0 28.5 11.0 27.7 15.5 15.0 10.4 27.8 12.3 47.0 10.8 29.5 16.4 103.8 14.3 43.2 19.7 16.1 11.4 21.3 6.1 13.2 8.7 17.3 106.0 21.5 10.4 12.9 67.5 86.3 13.8 52.9 39.3 49.6 49.7 49.3 66.7 21.2 30.9 23.4 28.6 31.3 27.2 22.9 36.4 36.0 44.3 35.6 54.4 65.8 23.5 38.7 45.1 38.0 47.6 54.2 44.7 50.9 52.7 44.1 88.4 16.4 62.8 26.5 23.1 32.5 38.6 42.8 19.6 40.9 44.5 31.4 36.9 41.9 50.8 59.4 29.4 13.2 210.8 65.9 37.9 55.3 87.5 69.2 28.1 31.5 22.9 20.4 43.9 23.1 33.7 64.5 42.9 22.6 23.0 31.6 34.7 34.6 33.7 37.9 72.0 33.1 49.8 27.2 9.1 52.9 13.8 32.2 44.5 38.8 67.5 37.0 34.6 70.1 54.5 49.6 43.1 2.9 39.3 25.7 86.3 31.2 49.7 29.2 34.2 15.8 35.4 26.2 21.6 23.0 28.5 27.8 13.2 44.7 79.4 0.0 0.0 0.0 0.0 0.0 0.0 97.7 91.0 260.0 0.0 349.4 1228.5 161.3 0.0 0.0 0.0 0.0 257.7 210.1 0.0 0.0 67.4 0.0 239.2 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 126.2 0.0 0.0 170.7 0.0 0.0 646.5 0.0 0.0 0.0 0.0 0.0 0.0 185.9 0.0 0.0 0.0 ATP5MC3 ATP5G3 ENSG00000154518 "ATP synthase membrane subunit c locus 3" P48201 2 175176258-175184607 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 189.6" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 786.5;Distal tubular cells: 2259.7;Extravillous trophoblasts: 831.6;Hofbauer cells: 886.9;Proximal tubular cells: 1680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-3)" "unprognostic (1.67e-1)" "prognostic favorable (9.90e-4)" "unprognostic (1.67e-3)" "unprognostic (3.01e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.46e-2)" "unprognostic (6.03e-3)" "unprognostic (1.42e-2)" "unprognostic (7.90e-2)" "unprognostic (4.71e-2)" "unprognostic (1.06e-1)" "prognostic favorable (2.31e-6)" "unprognostic (2.86e-1)" "unprognostic (3.93e-1)" "unprognostic (4.55e-2)" "unprognostic (2.31e-2)" 26.1 26.7 26.6 26.3 28.7 19.8 34.3 26.9 50.9 15.7 51.1 11.4 23.6 61.7 17.4 22.2 38.9 15.5 28.7 189.6 25.8 27.4 63.9 60.8 21.2 34.8 31.1 31.5 13.6 28.4 36.7 19.0 16.8 27.6 17.1 53.3 16.6 34.2 25.0 115.7 20.0 47.3 24.6 18.5 17.6 31.9 12.3 15.8 21.8 19.1 95.9 27.7 19.3 20.2 38.5 78.8 22.6 59.9 34.5 37.2 66.1 33.7 30.2 45.6 50.3 39.1 34.8 51.3 31.3 33.0 44.3 38.7 90.2 28.3 84.3 37.0 34.9 49.0 44.7 57.3 54.1 46.9 35.4 52.8 67.7 44.1 114.0 30.1 87.5 41.0 37.4 41.8 50.0 31.9 34.2 44.4 40.8 73.0 40.5 48.4 46.3 67.5 73.9 59.9 81.6 94.6 53.0 42.1 82.7 86.3 76.8 40.9 26.0 25.2 68.6 68.2 68.1 41.3 71.5 29.6 7.4 35.4 0.2 43.0 32.0 40.4 72.9 42.5 52.8 33.0 17.6 53.4 22.6 33.3 59.9 33.6 38.5 35.3 36.1 78.8 30.4 33.5 35.9 6.2 34.5 53.7 58.3 37.2 66.1 26.6 28.7 26.9 50.9 25.8 27.4 31.1 31.5 27.6 15.8 163.8 131.1 0.0 0.0 0.0 0.0 0.0 0.0 238.3 230.9 294.8 0.0 786.5 2259.7 429.4 0.0 0.0 0.0 0.0 326.9 831.6 0.0 0.0 81.4 0.0 886.9 0.0 0.0 0.0 0.0 0.0 0.0 111.5 0.0 358.9 0.0 0.0 350.5 0.0 0.0 1680.5 0.0 0.0 0.0 0.0 0.0 0.0 577.8 0.0 0.0 0.0 ATP5ME ATP5I ENSG00000169020 "ATP synthase membrane subunit e" P56385 4 672436-674338 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 840.9;Distal tubular cells: 1465.6;Proximal tubular cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035010 Enhanced Supported Mitochondria NA NA 220000 Mitochondria "HPA035010: AB_10669853" "unprognostic (1.42e-1)" "unprognostic (4.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (6.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.32e-1)" "unprognostic (1.35e-3)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (2.46e-3)" "unprognostic (6.89e-2)" "unprognostic (2.18e-1)" "unprognostic (2.48e-1)" "unprognostic (6.45e-3)" 41.2 48.1 69.3 30.8 69.0 34.4 34.2 27.7 67.6 29.3 66.6 28.2 44.4 60.0 20.5 34.1 40.1 23.1 31.6 95.8 62.0 49.2 47.5 68.9 25.8 25.2 68.6 48.7 26.2 57.9 24.5 26.6 19.6 62.2 23.9 43.9 17.8 40.7 37.2 221.8 22.3 55.6 45.8 67.2 23.3 40.7 14.1 47.7 10.9 22.1 98.7 28.1 18.9 31.1 166.1 148.1 142.2 135.7 107.4 127.6 158.4 49.9 47.3 68.2 55.5 57.4 53.4 38.0 48.7 39.0 37.0 32.9 45.4 49.5 25.9 46.9 51.5 60.1 32.0 54.9 76.8 20.3 22.9 101.4 76.2 87.7 113.3 59.7 97.0 33.6 66.2 45.1 42.4 43.0 57.8 45.2 51.7 63.0 28.4 41.9 72.0 83.6 127.1 80.1 88.1 123.8 51.0 49.8 56.4 70.7 87.2 66.2 52.0 35.4 47.7 54.0 44.7 54.5 66.9 52.4 33.3 31.6 29.3 67.9 66.4 109.5 81.9 48.9 66.9 36.4 103.7 135.7 142.2 98.5 112.1 101.0 166.1 121.1 109.2 135.4 123.2 110.3 110.3 122.3 107.4 97.7 148.1 127.6 158.4 69.3 69.0 27.7 67.6 62.0 49.2 68.6 48.7 62.2 47.7 142.9 207.3 0.0 0.0 0.0 0.0 0.0 0.0 337.3 224.1 840.9 0.0 343.2 1465.6 413.4 0.0 0.0 0.0 0.0 598.1 265.5 0.0 0.0 112.8 0.0 580.0 0.0 0.0 0.0 0.0 0.0 0.0 109.4 0.0 485.1 0.0 0.0 478.0 0.0 0.0 1359.9 0.0 0.0 0.0 0.0 0.0 0.0 229.9 0.0 0.0 0.0 ATP5MGL "ATP5K2, ATP5L2, dJ222E13.5" ENSG00000249222 "ATP synthase membrane subunit g like" Q7Z4Y8 22 42639803-42640601 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.9;bone marrow: 4.5" "Cell type enhanced" "Detected in some" 10 "Cytotrophoblasts: 9.5;Distal tubular cells: 5.0;Extravillous trophoblasts: 7.3;Hofbauer cells: 9.6;Syncytiotrophoblasts: 8.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 2.5" HPA044629 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA044629: AB_2679028" "unprognostic (4.53e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-2)" "unprognostic (5.67e-2)" "unprognostic (3.01e-2)" "unprognostic (3.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.70e-2)" "unprognostic (6.74e-2)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-1)" "unprognostic (4.17e-1)" "unprognostic (5.12e-2)" "unprognostic (1.85e-3)" 0.4 0.7 0.4 0.0 0.4 4.5 0.3 0.6 0.5 0.0 0.2 0.4 0.4 2.4 0.3 0.4 0.4 1.2 0.3 0.4 0.4 0.7 0.2 1.0 0.3 0.5 0.4 0.0 0.4 0.0 0.3 0.0 0.9 0.1 0.7 3.1 0.5 0.0 0.3 0.4 1.0 0.3 0.5 0.1 0.5 0.2 1.2 1.0 3.9 1.2 0.6 1.0 1.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.7 0.3 1.0 0.2 0.6 0.3 0.2 0.0 0.0 0.8 0.6 1.2 0.0 2.0 0.7 0.0 0.0 1.2 0.0 0.0 1.0 0.5 0.5 0.8 0.0 0.0 1.4 0.0 0.5 0.8 1.7 1.6 0.1 0.0 0.2 0.0 0.6 0.0 2.5 0.2 0.1 0.0 0.7 0.2 0.4 0.2 0.0 0.0 1.2 0.8 0.9 0.6 0.6 1.2 0.1 0.3 0.7 1.0 2.3 1.2 0.7 0.6 0.6 0.5 1.2 0.9 0.6 0.5 1.2 1.0 0.7 3.9 0.6 0.7 1.0 0.7 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.0 9.5 5.0 0.4 0.0 0.0 0.0 0.0 1.0 7.3 0.0 0.0 2.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 ATP5PB ATP5F1 ENSG00000116459 "ATP synthase peripheral stalk-membrane subunit b" P24539 1 111448864-111462773 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 297.5;Distal tubular cells: 391.3;Extravillous trophoblasts: 335.0;Hofbauer cells: 328.7;Proximal tubular cells: 348.8;Syncytiotrophoblasts: 290.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046067, HPA057347" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA 640000 Mitochondria "HPA046067: AB_10960850, HPA057347: AB_2683416" "unprognostic (4.18e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-3)" "unprognostic (1.73e-2)" "unprognostic (3.56e-2)" "unprognostic (8.18e-2)" "unprognostic (8.52e-3)" "unprognostic (8.82e-2)" "unprognostic (3.67e-2)" "unprognostic (7.18e-3)" "unprognostic (3.29e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.26e-9)" "prognostic favorable (8.07e-4)" "unprognostic (1.60e-1)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" 11.6 16.0 16.8 11.4 22.6 8.0 10.4 30.7 28.8 10.7 30.0 10.4 11.3 16.1 14.4 10.7 21.1 13.7 9.7 57.1 16.4 15.4 30.5 26.2 10.2 14.2 16.1 15.5 12.6 15.3 18.0 13.3 16.3 22.8 13.4 17.8 9.8 20.4 12.4 83.6 9.7 25.4 13.7 13.9 13.7 13.1 11.4 10.1 18.7 18.6 34.0 15.4 15.5 11.5 8.3 10.8 4.3 10.0 5.9 11.9 22.9 15.3 3.5 13.0 10.1 8.4 7.6 8.4 17.0 18.8 17.7 14.7 6.2 7.8 20.9 15.8 11.1 3.8 16.0 18.9 21.0 15.8 16.6 7.4 20.9 4.9 4.1 6.1 26.3 21.1 6.6 9.0 19.4 18.2 4.1 14.1 2.9 18.4 9.2 10.1 7.1 44.9 6.1 9.9 4.0 24.0 11.6 40.6 8.2 14.0 5.2 9.5 3.0 13.2 18.9 13.9 3.1 15.2 9.5 13.6 8.3 14.7 16.2 16.8 12.7 12.1 49.8 20.1 20.0 15.5 1.9 10.0 4.3 9.7 6.4 8.6 7.5 10.8 9.2 10.8 8.3 11.9 7.3 2.9 5.9 5.0 5.9 9.0 22.9 16.8 22.6 30.7 28.8 16.4 15.4 16.1 15.5 22.8 10.1 62.5 73.9 0.0 0.0 0.0 0.0 0.0 0.0 136.5 105.8 118.7 0.0 297.5 391.3 205.2 0.0 0.0 0.0 0.0 172.3 335.0 0.0 0.0 82.5 0.0 328.7 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.0 172.3 0.0 0.0 151.6 0.0 0.0 348.8 0.0 0.0 0.0 0.0 0.0 0.0 290.7 0.0 0.0 0.0 ATP6AP2 "APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR" ENSG00000182220 "ATPase H+ transporting accessory protein 2" O75787 X 40579372-40606848 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 176.7" "Cell type enhanced" "Detected in all" 6 "Hofbauer cells: 584.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003156 Approved NA NA "HPA003156: AB_1078245" "unprognostic (1.45e-1)" "unprognostic (3.80e-3)" "unprognostic (1.30e-1)" "unprognostic (7.19e-2)" "unprognostic (8.58e-3)" "unprognostic (1.29e-1)" "unprognostic (1.63e-3)" "unprognostic (2.01e-2)" "unprognostic (1.00e-1)" "unprognostic (4.15e-2)" "unprognostic (1.45e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.01e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-1)" "unprognostic (1.62e-2)" "unprognostic (2.86e-2)" 25.0 23.8 33.8 17.4 39.3 30.6 31.7 31.5 76.0 35.0 24.0 22.1 13.0 10.0 30.8 25.5 21.4 22.7 23.9 19.3 35.5 36.7 48.7 30.0 30.2 37.9 32.1 34.7 22.3 16.3 176.7 16.1 30.2 37.8 26.4 25.0 21.0 16.8 31.8 8.7 24.0 16.8 35.7 27.8 22.6 15.8 11.9 17.2 16.2 56.1 12.6 19.1 25.7 20.0 16.1 53.2 60.8 78.0 20.0 29.6 85.8 14.7 19.4 14.2 19.1 94.0 59.9 8.8 33.3 51.7 24.6 28.8 11.2 24.3 8.5 16.6 48.6 25.0 15.2 21.8 25.9 33.7 16.6 17.1 10.6 18.9 10.7 34.6 18.9 19.9 51.8 34.7 30.2 24.3 34.7 32.8 8.0 10.7 23.1 37.2 18.6 8.1 16.4 13.1 23.6 21.9 7.7 24.9 28.6 31.8 16.6 10.2 9.5 32.4 20.2 20.3 51.1 26.2 17.4 32.2 31.0 17.0 37.0 11.2 7.2 12.3 8.4 25.6 16.0 24.1 34.4 78.0 60.8 25.9 55.1 27.0 16.1 26.4 26.6 53.2 15.7 29.6 27.0 39.5 20.0 54.1 19.3 24.7 85.8 33.8 39.3 31.5 76.0 35.5 36.7 32.1 34.7 37.8 17.2 53.6 61.1 73.9 115.8 86.4 152.6 26.9 84.1 85.6 72.8 130.9 51.1 152.0 53.0 120.3 3.0 89.3 48.4 70.0 52.6 93.0 160.2 97.5 86.5 55.7 584.5 178.0 54.9 90.9 237.6 4.3 108.7 238.9 141.7 110.0 52.9 170.2 52.8 49.1 142.1 86.4 64.1 103.5 143.2 80.8 23.0 87.3 145.9 82.0 61.8 109.5 ATP6V0A1 "a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1" ENSG00000033627 "ATPase H+ transporting V0 subunit a1" Q93050 17 42458844-42522611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2;parathyroid gland: 65.6" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022144 Enhanced Approved "Nuclear speckles,Golgi apparatus,Vesicles,Cytosol" NA NA 21000 "Golgi apparatus, Vesicles" "Nuclear speckles, Cytosol" "HPA022144: AB_1845189" "unprognostic (3.93e-2)" "unprognostic (2.02e-1)" "unprognostic (4.35e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-2)" "unprognostic (8.69e-2)" "unprognostic (1.84e-2)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.05e-4)" "unprognostic (3.25e-1)" "prognostic favorable (1.28e-4)" "unprognostic (3.07e-1)" "unprognostic (3.68e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (6.90e-4)" 9.4 15.6 19.3 9.3 46.1 9.9 9.1 55.8 66.2 8.0 11.6 25.8 5.1 17.9 11.4 11.1 9.6 9.7 12.2 9.9 23.8 32.8 20.3 11.3 12.7 6.6 23.6 24.8 11.4 9.3 65.6 23.6 11.2 43.3 9.9 11.3 19.7 8.2 10.7 28.9 14.7 12.4 11.7 23.7 11.1 8.8 9.8 13.1 5.2 16.3 6.7 7.8 6.7 6.9 6.3 9.1 14.2 10.5 0.1 2.8 4.2 6.6 13.8 8.5 15.2 14.2 12.4 4.9 4.7 8.8 10.1 13.3 8.8 15.0 1.2 8.7 9.7 13.9 14.5 13.0 8.0 11.8 10.3 13.6 10.7 10.4 6.9 8.8 4.6 19.6 9.1 11.6 16.2 6.9 12.6 7.1 5.0 38.9 42.3 15.0 5.7 1.8 4.1 5.4 8.8 0.1 0.1 8.8 18.6 11.7 5.3 23.4 12.4 7.3 6.7 14.0 11.5 16.3 7.0 4.2 8.6 0.3 12.6 5.6 17.2 23.4 2.5 11.5 0.1 10.0 12.1 10.5 8.0 0.8 3.4 1.2 3.5 0.6 0.1 9.1 6.3 1.0 0.8 14.2 0.1 2.4 4.7 2.8 4.2 19.3 46.1 55.8 65.9 23.8 32.8 23.6 24.8 43.3 13.1 17.9 46.6 27.3 45.1 17.5 158.7 19.5 30.6 6.7 14.8 14.0 276.9 26.4 10.0 14.7 2.4 19.2 44.6 46.7 15.8 13.4 33.9 38.7 23.1 33.6 46.0 90.6 81.5 19.6 33.1 3.1 16.1 25.8 38.8 3.6 23.1 51.9 17.6 38.6 22.3 28.4 349.7 6.5 48.9 38.7 18.5 17.7 83.5 4.4 19.5 10.7 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 40.6;salivary gland: 55.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 35.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.1 0.0 0.5 0.0 0.3 0.0 2.2 0.1 0.4 1.7 0.0 0.3 3.1 0.0 0.3 0.5 2.7 0.0 0.0 0.0 0.4 0.3 40.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.2 1.0 0.2 0.5 0.0 0.3 55.4 1.2 0.0 6.5 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 1.8 7.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 3.1 1.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 3.0 0.1 0.0 0.0 0.0 35.9 1.2 2.0 0.1 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.1 0.4 0.4 0.3 0.3 0.0 0.2 0.1 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.4 1.2 15.7 2.0 11.7 26.6 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.3 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 4.2 0.0 0.0 1.1 ATP6V0B "ATP6F, HATPL, VMA16" ENSG00000117410 "ATPase H+ transporting V0 subunit b" Q99437 1 43974487-43978295 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 173.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 173.6" "Group enriched" "Detected in all" 4 "dendritic cells: 58.0;granulocytes: 173.6;monocytes: 78.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044281 Approved Cytosol NA NA Cytosol "HPA044281: " "unprognostic (1.38e-1)" "unprognostic (2.16e-1)" "unprognostic (1.27e-1)" "unprognostic (5.69e-2)" "unprognostic (5.31e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (7.23e-2)" "prognostic favorable (3.24e-4)" "unprognostic (6.13e-2)" "prognostic favorable (3.62e-6)" "unprognostic (5.55e-2)" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.87e-4)" 20.4 35.7 35.4 21.8 35.3 84.2 28.5 29.1 56.4 23.3 28.3 32.2 26.7 19.2 13.9 35.6 21.9 20.0 22.0 24.8 41.2 44.7 47.6 56.3 25.8 28.5 43.6 31.5 12.9 87.0 32.5 36.3 35.0 33.9 27.0 32.0 32.4 34.8 22.2 27.9 20.1 20.2 19.1 34.8 33.2 25.2 15.3 24.8 16.3 38.7 19.5 24.7 23.2 16.5 23.7 58.0 173.6 78.0 8.8 14.2 87.6 23.7 23.2 19.3 24.2 29.7 15.7 23.6 21.4 31.8 41.6 36.0 24.9 26.0 22.1 19.8 22.6 49.4 19.7 45.0 32.2 19.6 20.7 46.9 27.6 40.1 35.8 47.1 42.9 53.7 19.3 42.5 45.8 40.6 26.7 20.0 31.0 27.5 48.5 34.0 25.1 17.7 71.5 31.8 34.5 49.6 25.1 18.5 60.2 43.3 29.3 45.5 22.5 14.4 57.1 53.6 22.8 23.4 77.2 10.1 21.5 18.3 38.7 51.4 39.3 57.7 24.5 29.2 61.2 33.5 31.9 78.0 64.2 13.2 48.1 13.0 23.7 14.2 12.7 48.1 19.1 10.8 10.9 173.6 8.8 44.0 58.0 13.7 87.6 35.4 35.3 29.1 56.4 41.2 44.7 43.6 31.5 33.9 24.8 74.5 137.9 144.5 130.3 298.3 238.3 92.4 122.3 100.4 66.0 268.7 96.2 165.0 170.8 307.8 2.7 147.4 174.0 23.3 286.0 191.3 151.0 308.8 203.1 213.0 743.7 122.3 214.8 101.3 356.6 8.6 73.1 420.3 266.6 357.1 190.7 203.9 311.9 371.7 61.5 175.0 164.2 77.6 135.2 133.6 224.9 313.3 415.2 116.5 165.6 262.4 ATP6V0D2 "ATP6D2, FLJ38708, VMA6" ENSG00000147614 "ATPase H+ transporting V0 subunit d2" Q8N8Y2 8 85987323-86154228 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 56.8" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 177.4" "Cancer enriched" "Detected in many" 9 "renal cancer: 36.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SK-MEL-30: 5.6;SuSa: 9.2;U-87 MG: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055327, HPA058496" Enhanced Approved Vesicles NA NA Vesicles "HPA055327: AB_2682784, HPA058496: " "unprognostic (3.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (8.43e-3)" "unprognostic (5.36e-5)" "unprognostic (4.02e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (2.32e-2)" "unprognostic (1.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (8.58e-2)" "unprognostic (1.77e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" 6.6 0.3 0.2 1.3 0.3 0.8 0.3 0.2 0.2 0.2 1.5 0.0 11.9 0.7 0.2 1.0 0.2 0.2 0.1 0.2 0.3 0.3 56.8 0.3 12.2 1.2 0.5 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.8 2.0 5.7 1.1 1.2 0.2 0.9 1.0 0.0 0.3 0.4 0.3 0.2 0.0 1.0 0.4 0.3 0.6 0.3 0.2 2.2 1.7 4.6 1.0 2.0 1.5 0.3 0.5 1.2 0.6 0.7 0.0 0.5 2.3 0.0 0.0 1.0 0.3 0.3 0.4 0.3 0.2 0.0 1.6 2.5 0.7 1.6 0.4 0.4 0.1 0.8 1.7 0.1 0.0 0.7 1.4 0.6 0.1 0.9 0.7 1.9 0.4 0.3 0.4 0.7 0.5 0.9 0.0 0.7 0.2 0.3 0.2 0.2 0.2 0.3 0.0 1.1 3.4 0.3 0.1 0.8 5.6 9.2 1.8 0.1 0.3 0.6 0.8 0.7 0.5 0.4 0.2 0.6 8.6 0.6 0.7 2.6 1.0 0.8 1.1 0.5 0.8 1.2 1.0 0.9 0.5 2.2 1.5 1.3 4.6 2.0 1.0 1.7 0.9 0.3 0.2 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 7.0 29.5 0.0 177.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.5 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP6V0E2 "ATP6V0E2L, C7orf32" ENSG00000171130 "ATPase H+ transporting V0 subunit e2" Q8NHE4 7 149872968-149880698 "Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 92.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 112.2;Horizontal cells: 108.1;Muller glia cells: 136.8;Proximal tubular cells: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 51.0" NA NA "unprognostic (8.72e-2)" "unprognostic (4.73e-2)" "unprognostic (3.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.23e-1)" "unprognostic (2.42e-2)" "unprognostic (5.84e-3)" "unprognostic (3.57e-2)" "prognostic favorable (5.80e-4)" "unprognostic (1.21e-1)" "prognostic favorable (8.26e-7)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.48e-3)" 11.8 17.3 60.1 6.5 56.5 3.6 8.6 70.5 92.7 6.4 6.7 26.4 14.2 5.0 4.3 6.2 6.0 13.4 5.9 27.9 73.7 55.3 26.9 27.9 6.8 12.1 61.1 39.7 4.9 11.7 14.0 25.3 3.1 57.1 26.2 5.3 18.7 37.0 24.8 8.7 4.7 4.6 6.3 29.4 8.3 7.3 3.2 12.2 8.4 26.6 2.0 8.1 4.9 1.7 7.0 6.4 1.5 6.9 12.0 30.6 11.2 7.5 21.2 8.8 28.6 3.6 0.6 5.5 3.9 5.4 10.8 11.1 7.4 9.5 15.4 16.6 5.2 11.2 6.7 18.7 6.6 4.6 19.8 20.8 4.8 6.5 42.5 5.3 3.5 10.6 1.2 6.9 11.9 0.7 8.4 8.9 19.5 5.1 7.6 0.7 12.9 2.5 8.0 7.6 9.7 14.9 16.8 0.3 7.2 8.4 8.1 51.0 28.9 5.1 17.8 11.9 2.2 10.0 2.3 1.6 3.1 3.3 32.7 14.5 10.6 13.5 7.4 19.9 6.1 10.1 1.5 3.1 0.7 16.7 5.8 15.4 7.0 21.0 19.5 6.4 6.3 27.5 24.7 0.4 12.0 6.9 3.0 30.6 11.2 60.1 56.5 70.5 66.4 73.7 55.3 61.1 39.7 57.1 12.2 14.9 13.7 15.9 4.7 3.8 112.2 25.4 22.9 6.7 10.3 26.2 23.6 17.3 46.4 40.1 0.1 3.2 0.9 0.0 11.2 2.1 6.7 22.5 10.4 50.4 21.2 108.1 21.4 9.2 6.6 1.3 4.9 9.6 42.2 5.4 16.3 136.8 6.3 0.0 10.6 94.9 61.7 6.5 10.3 0.5 12.4 3.9 4.2 28.7 2.6 3.3 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935868-70965431 "Disease related genes, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 37.9;placenta: 29.0;salivary gland: 106.9" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 12 "monocytes: 1.4;T-cells: 1.0" "Group enriched" "Detected in some" 9 "BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 0.6 0.0 0.1 0.1 0.1 0.0 4.4 0.8 0.2 12.2 0.1 0.1 6.9 0.1 0.5 0.4 0.5 5.0 0.1 0.3 0.1 0.0 37.9 0.1 2.1 0.1 0.1 0.1 2.0 1.1 0.0 1.7 29.0 0.1 0.6 0.0 7.4 106.9 1.1 0.1 11.8 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.3 0.1 1.6 1.1 0.1 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.0 0.2 0.2 0.4 0.8 1.7 2.0 13.8 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.8 0.0 12.7 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.3 0.9 0.4 31.3 0.0 1.8 0.3 0.0 0.3 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 1.8 0.1 0.8 0.4 0.0 1.4 1.2 0.0 7.9 143.1 41.4 0.0 0.6 0.6 0.0 0.0 0.5 41.7 0.7 0.7 0.0 0.0 10.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.3 0.5 0.0 1.1 0.0 3.4 0.0 0.3 0.4 1.3 0.4 54.2 0.0 0.0 0.6 ATP6V1B2 "ATP6B2, HO57, VATB, Vma2, VPP3" ENSG00000147416 "ATPase H+ transporting V1 subunit B2" P21281 8 20197367-20226819 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 69.7;eosinophil: 47.6;intermediate monocyte: 62.5;myeloid DC: 34.5;neutrophil: 116.0;non-classical monocyte: 54.1" "Group enriched" "Detected in all" 10 "dendritic cells: 34.5;granulocytes: 116.0;monocytes: 69.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008147 Enhanced Supported Vesicles NA NA 240000 Vesicles "HPA008147: AB_1845195" "unprognostic (1.90e-1)" "unprognostic (7.24e-3)" "unprognostic (3.62e-2)" "unprognostic (2.57e-1)" "unprognostic (2.84e-2)" "unprognostic (5.59e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (4.68e-2)" "unprognostic (4.23e-3)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "prognostic favorable (8.41e-4)" "unprognostic (2.41e-1)" "unprognostic (2.09e-2)" "unprognostic (2.47e-2)" "unprognostic (5.25e-2)" 17.1 29.9 31.7 25.8 45.0 14.4 13.2 39.2 72.9 12.2 13.9 15.9 5.5 16.2 10.6 12.2 15.3 10.3 14.8 13.9 33.8 47.8 53.9 18.0 22.8 17.5 46.9 47.1 10.9 12.2 18.8 23.6 18.5 64.2 11.0 16.5 17.3 12.8 10.9 18.2 18.2 21.1 15.0 19.2 20.9 10.7 24.0 12.7 10.3 12.7 9.3 17.5 14.3 12.4 4.9 34.5 116.0 69.7 4.8 7.1 51.1 10.8 18.2 22.7 7.4 31.0 19.2 20.4 24.5 15.7 31.6 32.7 20.5 6.4 19.3 10.0 23.3 32.2 9.3 17.9 16.3 33.7 8.1 12.0 13.4 8.2 15.7 36.4 9.5 28.0 17.1 14.9 19.6 18.1 34.9 19.7 25.8 19.9 18.7 33.7 6.1 27.8 11.3 16.8 16.0 8.0 11.5 29.2 10.0 29.2 17.2 17.6 25.4 11.8 16.0 77.9 19.6 20.9 17.5 20.8 15.9 12.2 26.2 19.5 7.6 10.2 22.7 22.0 22.8 40.3 15.9 69.7 47.6 5.7 62.5 6.2 4.9 5.9 6.1 34.5 4.3 6.1 6.0 116.0 4.8 54.1 8.4 7.1 51.1 31.7 45.0 39.2 69.0 33.8 47.8 46.9 47.1 64.2 12.7 23.8 20.2 30.3 24.8 51.5 100.1 14.0 12.7 12.0 11.4 27.9 96.2 100.2 68.0 38.5 22.5 24.8 23.6 46.7 33.2 46.1 30.0 15.5 21.9 30.6 167.3 179.6 71.4 28.3 171.7 15.9 18.1 165.7 99.5 87.4 19.6 39.2 37.2 20.4 26.5 193.9 117.5 12.9 37.6 83.9 46.7 62.6 104.2 27.7 20.0 18.2 ATP6V1C2 "ATP6C2, VMA5" ENSG00000143882 "ATPase H+ transporting V1 subunit C2" Q8NEY4 2 10721649-10785110 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 101.4;Distal tubular cells: 38.1;Intestinal endocrine cells: 39.9;Syncytiotrophoblasts: 141.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 40.6;SK-BR-3: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034734, HPA067305" Approved Uncertain Mitochondria NA NA Mitochondria "HPA034734: AB_2674305, HPA067305: AB_2732763" "unprognostic (2.29e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (6.55e-3)" "unprognostic (2.69e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-3)" "unprognostic (8.53e-2)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" "unprognostic (6.77e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.12e-11)" "unprognostic (6.17e-2)" "unprognostic (3.30e-1)" "unprognostic (2.37e-1)" "unprognostic (8.27e-2)" 1.4 0.9 0.4 0.4 0.5 1.1 2.4 0.5 0.8 21.2 0.8 0.6 49.3 0.1 2.1 30.5 6.9 0.8 0.8 0.7 0.8 0.3 13.2 2.0 0.8 0.5 0.4 0.4 0.9 1.1 0.1 8.9 39.0 0.5 1.8 0.7 54.4 41.8 15.1 0.4 36.7 0.7 0.4 0.6 1.3 0.6 0.8 0.4 0.9 1.4 6.0 3.5 0.5 7.2 1.1 0.8 0.6 1.7 0.9 2.2 1.1 0.3 0.4 1.3 1.5 0.0 0.0 40.6 0.6 0.0 0.0 0.0 0.8 1.0 1.0 0.8 0.0 0.6 0.6 0.6 0.0 0.0 0.5 1.5 0.5 0.6 1.4 0.0 0.9 0.6 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.4 2.0 0.0 1.2 0.3 1.5 1.0 0.6 0.4 0.8 0.7 3.3 0.0 0.9 1.1 1.3 0.3 14.5 0.4 5.5 1.4 2.1 0.2 0.5 1.0 0.6 0.5 3.5 1.0 0.6 0.6 0.8 0.4 0.3 0.8 0.6 2.2 1.7 1.3 1.1 1.0 1.7 0.5 0.9 1.0 0.5 0.0 0.9 0.8 0.8 0.9 1.1 0.4 0.5 0.5 0.8 0.8 0.3 0.4 0.4 0.5 0.4 0.0 1.6 0.0 4.2 0.3 0.0 1.0 0.0 2.7 2.3 7.0 0.0 101.4 38.1 0.0 0.6 0.1 0.0 0.0 0.2 23.0 0.5 0.6 2.3 0.0 12.0 0.0 39.9 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.4 2.0 141.4 0.0 0.6 0.3 ATP6V1E2 "ATP6E1, ATP6EL2, ATP6V1EL2, MGC9341, VMA4" ENSG00000250565 "ATPase H+ transporting V1 subunit E2" Q96A05 2 46490750-46542557 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.4" "Group enriched" "Detected in many" 8 "Early spermatids: 240.2;Late spermatids: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 19.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075092 Enhanced NA NA "HPA075092: " "unprognostic (1.62e-1)" "unprognostic (9.65e-3)" "unprognostic (4.31e-2)" "unprognostic (4.39e-3)" "unprognostic (1.02e-1)" "unprognostic (1.52e-2)" "unprognostic (4.52e-3)" "unprognostic (8.56e-2)" "unprognostic (2.98e-1)" "unprognostic (5.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.58e-1)" "unprognostic (2.19e-1)" "unprognostic (1.43e-1)" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (9.32e-2)" 3.4 3.1 6.2 2.7 5.7 1.9 4.0 1.9 7.7 2.7 2.2 5.0 7.0 1.3 2.4 11.4 1.9 2.5 2.3 2.5 4.3 3.5 3.0 2.7 2.4 3.1 4.4 2.9 3.2 9.0 3.0 4.1 2.3 5.1 3.6 1.7 0.8 6.8 6.0 5.6 4.0 2.0 2.4 4.6 3.1 2.5 28.4 4.4 1.6 2.9 0.6 3.1 2.8 4.6 2.8 4.3 1.1 2.1 0.5 4.3 1.1 8.3 5.2 1.8 4.2 1.7 3.2 0.9 3.0 1.1 1.3 0.7 1.6 1.4 5.0 5.4 2.7 4.2 2.0 4.1 2.0 2.9 7.7 3.6 1.2 0.9 1.2 2.0 2.1 2.5 2.7 19.1 1.8 4.1 1.5 1.3 5.3 3.6 8.8 0.9 5.3 1.4 6.3 3.7 4.2 4.6 3.5 4.4 6.1 2.6 1.8 4.9 10.5 1.9 2.0 4.0 3.2 1.3 1.0 1.2 1.4 5.3 2.5 2.0 4.5 3.5 5.2 2.1 6.5 2.3 0.0 2.1 0.4 2.2 1.0 3.0 2.1 4.0 4.2 1.7 2.8 2.9 4.3 1.1 0.5 1.1 4.3 2.4 1.1 6.2 5.7 1.9 7.7 4.3 3.5 4.4 2.9 5.1 4.4 3.0 0.3 7.5 8.4 5.0 11.9 5.2 2.5 5.3 3.4 3.5 11.8 2.4 8.3 2.7 240.2 2.2 0.4 0.0 2.9 1.9 3.3 4.4 0.0 2.4 1.9 17.5 3.4 3.1 7.3 150.8 9.2 5.6 5.0 5.4 1.2 16.0 3.0 0.0 6.3 3.7 25.0 6.5 4.1 2.7 5.1 7.0 0.7 4.4 1.8 3.9 ATP6V1G2 "ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10" ENSG00000213760 "ATPase H+ transporting V1 subunit G2" O95670 6 31544462-31548427 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "brain: 91.9" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 76.0;Horizontal cells: 28.6;Muller glia cells: 16.3" "Cancer enriched" "Detected in many" 11 "glioma: 15.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 6.4;JURKAT: 4.7;Karpas-707: 7.1" "CAB004616, HPA068667" Enhanced NA NA "CAB004616: AB_667829, HPA068667: " "unprognostic (9.95e-2)" "unprognostic (8.75e-2)" "unprognostic (9.21e-3)" "unprognostic (2.11e-4)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (1.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.78e-2)" "unprognostic (1.41e-5)" "unprognostic (1.36e-1)" "unprognostic (7.22e-3)" "unprognostic (3.94e-2)" "unprognostic (1.77e-1)" "unprognostic (3.86e-2)" "unprognostic (1.02e-1)" 2.8 3.3 41.8 3.5 25.7 1.8 1.6 91.9 53.3 1.8 2.3 8.1 0.0 1.5 2.5 2.4 2.2 1.8 1.9 2.9 39.4 27.1 2.6 1.6 2.0 4.7 26.6 29.5 3.1 2.1 2.9 1.2 1.7 43.7 2.6 2.0 2.0 2.0 3.3 4.3 2.0 2.7 2.1 16.3 3.4 1.9 2.7 6.4 0.0 2.3 0.0 4.8 1.7 0.2 0.7 0.7 0.0 0.1 0.8 1.5 0.1 0.2 1.7 3.1 1.5 1.3 1.7 0.0 0.6 0.0 0.0 0.2 0.0 0.9 1.7 0.7 0.6 0.4 1.4 0.1 0.6 0.1 6.4 0.0 0.5 0.0 0.9 0.2 0.7 0.6 1.3 0.8 0.5 0.3 2.3 0.5 4.7 0.7 7.1 0.8 0.2 3.3 1.1 0.0 0.2 0.5 0.8 0.0 0.7 0.0 0.0 2.8 3.8 0.0 0.0 0.0 0.8 2.0 0.3 1.6 1.9 0.3 0.1 0.0 0.7 1.5 2.4 0.7 0.7 1.4 0.0 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.8 0.7 0.7 1.2 1.5 0.0 0.8 0.0 0.0 1.1 0.1 41.8 25.7 91.9 53.3 39.4 27.1 26.6 29.5 43.7 6.4 0.0 0.3 0.0 0.5 0.3 76.0 2.0 0.0 0.0 0.0 1.8 13.7 0.1 8.3 0.2 0.0 0.5 0.2 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.5 28.6 13.7 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.2 16.3 0.1 0.0 2.1 5.0 9.5 0.0 3.1 0.0 0.7 0.1 0.1 1.9 0.0 0.1 ATP6V1G3 "ATP6G3, Vma10" ENSG00000151418 "ATPase H+ transporting V1 subunit G3" Q96LB4 1 198523222-198540945 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "ductus deferens: 16.9;kidney: 33.4" "Cell type enriched" "Detected in some" 43 "Distal tubular cells: 376.4" "Cancer enriched" "Detected in single" 140 "renal cancer: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028701 Enhanced NA NA "HPA028701: AB_10611681" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 1.8 1.3 0.4 0.0 0.0 0.0 0.6 6.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.5 0.1 1.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 376.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP7B WND ENSG00000123191 "ATPase copper transporting beta" P35670 13 51930436-52012125 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" Translocase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 18.5;liver: 13.5" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 21.6;Early spermatids: 29.4;Late spermatids: 57.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 19.3;CACO-2: 11.1;HEL: 29.3;Hep G2: 10.1;RPTEC TERT1: 17.1" "Low region specificity" "Detected in many" "HPA009137, HPA013187" Supported Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA009137: AB_2668214, HPA013187: AB_1845206" "unprognostic (1.13e-2)" "unprognostic (1.61e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (3.49e-1)" "unprognostic (5.51e-2)" "unprognostic (1.55e-2)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (5.77e-2)" "unprognostic (8.29e-2)" "unprognostic (1.17e-1)" "unprognostic (3.26e-3)" "unprognostic (4.66e-2)" "unprognostic (3.54e-1)" "unprognostic (6.21e-3)" "unprognostic (1.40e-1)" 3.4 0.7 1.8 2.4 2.9 1.8 1.6 7.0 2.8 1.4 6.8 1.1 1.1 10.5 1.6 1.9 1.1 1.9 18.5 1.8 2.1 2.1 2.1 13.5 1.2 1.1 1.6 1.1 2.0 1.7 7.7 1.2 7.1 3.5 1.9 2.6 1.4 3.0 1.1 1.1 0.7 9.6 1.5 1.1 1.6 4.5 7.1 1.6 1.1 1.1 1.1 1.1 2.1 1.1 0.0 0.0 1.0 0.3 0.0 0.5 0.1 0.4 1.6 3.0 2.7 0.6 0.5 19.3 0.8 0.2 0.9 0.7 11.1 0.1 0.0 0.3 1.4 2.1 0.2 2.1 2.4 0.6 0.2 4.1 29.3 0.3 10.1 0.9 0.3 6.9 1.2 2.9 0.1 1.1 1.3 2.1 2.1 7.8 0.0 0.9 0.5 0.1 0.7 1.0 3.7 1.0 1.1 0.8 0.0 17.1 1.9 2.2 1.3 1.1 1.6 1.1 3.4 4.6 0.2 1.1 0.1 1.0 1.6 0.3 0.3 0.4 0.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.8 2.9 7.0 2.8 2.1 2.1 1.6 1.1 3.5 1.6 6.0 0.0 1.7 0.7 0.3 3.0 1.8 0.0 5.3 3.4 1.8 21.6 10.2 0.0 1.5 29.4 1.1 6.1 0.0 0.8 4.4 0.6 1.3 0.0 16.3 2.0 0.0 2.4 3.7 1.0 57.4 2.0 0.0 1.7 0.0 4.0 0.5 1.7 2.9 0.7 1.3 6.7 6.5 0.9 1.1 1.9 0.4 3.8 0.0 4.7 1.1 ATP8A1 ATPIA ENSG00000124406 "ATPase phospholipid transporting 8A1" Q9Y2Q0 4 42408373-42657105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 38.9" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052935 Enhanced Supported Vesicles NA NA 20000 Vesicles "HPA052935: AB_2681992" "unprognostic (8.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (6.59e-2)" "unprognostic (6.82e-3)" "unprognostic (7.69e-2)" "unprognostic (2.02e-3)" "unprognostic (3.99e-1)" "unprognostic (2.99e-3)" "unprognostic (4.39e-2)" "unprognostic (9.71e-2)" "prognostic favorable (5.54e-10)" "unprognostic (2.43e-1)" "unprognostic (3.25e-1)" "unprognostic (8.21e-2)" "unprognostic (2.25e-1)" 5.3 8.6 14.2 8.0 29.6 18.5 4.8 7.2 32.0 3.1 11.3 27.3 8.4 4.2 3.4 11.6 2.9 3.5 2.8 8.0 13.7 8.8 4.0 2.1 10.6 12.5 18.0 17.4 15.1 10.0 38.9 6.9 2.6 15.3 7.9 10.7 3.9 4.4 15.2 16.9 3.2 8.1 3.1 23.1 7.8 10.5 2.8 24.9 8.9 34.9 1.9 10.3 4.5 4.0 4.4 3.8 0.9 3.3 3.2 7.3 0.9 0.0 0.1 0.3 17.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 28.1 8.0 0.1 0.0 1.4 4.0 0.0 0.0 4.4 2.8 9.9 1.0 0.4 0.0 2.4 0.2 0.3 0.0 0.0 0.0 0.3 0.1 6.3 0.0 3.2 0.0 1.2 3.5 0.8 1.3 1.1 0.3 9.7 0.0 3.1 6.1 0.3 3.1 9.3 0.2 5.9 0.0 0.7 1.9 0.0 0.2 0.0 1.3 0.3 0.0 1.1 0.0 5.7 0.4 3.4 0.1 0.0 1.0 0.9 6.0 0.4 3.2 2.6 1.9 6.5 0.9 4.4 2.9 7.3 0.9 3.2 3.3 3.8 1.4 0.9 14.2 29.6 7.2 22.1 13.7 8.8 18.0 17.4 15.3 24.9 26.8 61.4 5.1 1.7 1.3 17.7 12.8 0.0 0.0 9.1 5.2 76.6 0.0 3.3 0.0 3.0 9.3 46.1 0.0 2.2 0.1 2.2 16.2 8.1 1.1 1.5 58.8 81.2 17.8 7.5 2.3 3.1 3.8 3.3 1.8 23.3 1.0 0.8 7.0 1.8 1.4 41.3 0.0 0.3 1.1 4.1 1.3 0.0 21.8 23.1 2.4 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25372071-26025851 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.9;pituitary gland: 37.0;testis: 10.4" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3" "Lineage enriched" "Detected in single" 12 "T-cells: 3.3" "Group enriched" "Detected in some" 4 "HMC-1: 21.6;JURKAT: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: AB_2676809" "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 1.1 4.9 11.2 1.4 11.4 0.8 2.2 34.9 30.2 1.1 1.3 1.3 0.0 1.4 2.1 4.8 0.9 0.9 1.0 1.0 9.4 11.8 1.3 0.8 2.3 1.9 6.7 10.4 1.2 1.9 0.9 37.0 1.2 19.8 1.1 1.3 3.1 1.0 1.0 1.3 0.9 1.5 1.0 3.5 1.3 1.8 10.4 1.4 0.0 1.0 0.0 1.2 1.2 0.3 0.0 0.0 0.2 0.0 0.2 3.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 21.6 0.2 0.0 0.0 0.0 0.6 0.5 9.6 0.0 0.0 1.7 0.3 3.7 0.0 2.0 0.0 0.7 0.0 2.7 1.0 0.2 0.1 3.3 0.0 0.1 0.3 0.1 0.4 0.0 0.4 0.2 0.1 1.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.8 0.6 0.0 0.0 2.3 3.3 0.2 0.2 0.0 0.0 0.7 0.6 11.2 11.4 34.9 18.4 9.4 11.8 6.7 10.4 19.8 1.4 0.0 9.8 0.9 0.1 0.9 20.0 2.2 2.5 0.0 0.0 0.0 90.3 1.2 0.0 0.3 29.4 1.5 0.0 0.0 0.0 0.3 0.4 0.2 4.7 0.0 2.4 20.6 0.0 0.0 0.0 24.5 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.1 0.6 86.2 12.9 0.0 12.9 9.9 0.4 0.9 0.5 0.0 0.0 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803101 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" Translocase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5" "Low region specificity" "Detected in many" "HPA018673, HPA018674" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favorable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favorable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 3.8 2.3 0.0 1.8 0.0 0.0 3.4 0.0 0.3 4.5 21.3 8.9 2.4 0.8 6.7 2.6 4.8 1.8 0.2 0.0 2.1 3.0 3.6 0.0 0.1 0.7 10.7 2.7 1.1 1.3 6.0 19.3 5.8 2.8 0.4 3.6 11.1 2.0 0.2 1.2 13.3 0.0 5.7 0.2 12.8 5.4 6.0 2.0 4.7 2.1 0.7 1.3 0.3 10.2 3.5 0.1 0.1 3.6 6.6 5.0 19.9 19.4 21.0 13.1 2.6 8.9 0.7 6.0 27.5 8.3 15.2 0.1 4.2 24.7 0.2 0.4 0.1 0.9 0.9 1.1 0.2 0.1 1.0 3.8 6.3 11.1 15.5 11.0 0.2 0.1 0.4 12.1 4.9 0.2 0.2 0.2 11.0 1.0 0.1 0.1 0.2 2.9 58.5 0.4 0.3 0.4 12.3 0.1 0.5 3.8 0.6 12.6 17.1 0.6 2.7 4.6 0.2 0.1 0.2 0.4 0.2 0.9 0.8 2.1 0.5 1.3 0.9 1.0 2.7 1.0 0.7 0.5 6.0 0.9 1.0 4.7 0.7 1.2 2.0 0.4 0.3 17.9 18.2 4.5 44.8 6.9 0.7 4.0 33.1 40.2 48.9 38.4 0.0 17.1 0.0 20.8 2.0 26.8 198.4 0.0 45.9 1.9 5.1 74.4 4.6 16.8 2.3 6.4 65.7 30.1 3.8 0.0 0.3 1.3 6.8 1.0 179.9 0.2 33.7 74.8 0.0 0.1 1.1 12.9 17.6 0.3 1.2 14.3 9.2 1.5 138.5 100.6 ATP8B3 ATPIK ENSG00000130270 "ATPase phospholipid transporting 8B3" O60423 19 1782075-1812276 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 55.8" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 8.9;Spermatocytes: 26.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 10.6;Karpas-707: 18.7;U-266/70: 15.6" "Not detected" "Not detected" NA NA "unprognostic (6.50e-2)" "unprognostic (1.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.05e-5)" "unprognostic (6.66e-2)" "unprognostic (7.91e-2)" "unprognostic (1.86e-2)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (2.55e-3)" "unprognostic (1.28e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (4.80e-9)" "unprognostic (8.05e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-2)" "unprognostic (1.19e-1)" 0.6 3.1 0.2 3.1 0.2 7.1 0.6 0.2 0.7 1.5 0.7 0.2 0.2 0.4 1.8 4.3 0.6 0.6 1.0 2.2 0.3 0.2 0.4 1.0 1.9 1.1 0.2 0.5 1.9 0.3 0.3 0.6 0.5 0.4 0.5 0.4 1.1 0.5 1.6 0.2 0.8 0.7 1.0 0.7 4.8 0.4 55.8 0.0 5.5 0.7 1.2 1.5 0.8 1.0 0.1 1.2 1.7 6.9 2.2 2.8 1.2 0.6 5.1 0.6 0.8 0.7 0.5 0.0 2.0 3.1 2.0 1.9 0.0 2.1 2.2 2.3 1.6 0.2 0.1 0.4 0.0 0.9 2.1 0.1 0.7 2.5 1.0 0.2 1.3 10.6 0.2 0.2 0.0 2.2 3.0 0.5 6.5 1.6 18.7 3.3 0.0 1.4 3.9 0.1 0.3 2.4 2.2 0.4 0.3 2.7 0.1 0.0 0.7 0.5 0.0 0.3 0.6 0.6 6.5 4.9 0.1 4.1 0.8 2.1 15.6 7.6 0.6 4.0 6.5 2.6 0.0 2.2 1.7 1.9 6.9 0.8 0.0 1.4 1.1 1.2 0.1 0.6 1.9 0.6 2.2 1.8 0.5 2.8 1.2 0.2 0.2 0.2 0.7 0.3 0.2 0.2 0.5 0.4 0.0 0.0 1.1 0.0 0.6 0.7 1.9 1.4 2.5 0.0 0.0 0.0 2.0 0.1 0.0 0.8 6.2 1.0 0.0 0.0 0.2 0.9 1.4 0.3 1.1 0.8 1.3 0.0 0.0 5.5 3.3 8.9 0.3 0.5 1.7 0.0 0.0 0.8 0.2 0.0 0.4 0.0 0.6 0.0 0.9 26.5 3.2 1.3 0.3 2.5 0.0 0.1 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2" "Group enriched" "Detected in many" 4 "Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 6.9;NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 2.3 1.2 1.6 1.5 2.1 28.1 1.0 0.6 0.9 26.0 1.5 1.7 1.6 0.4 18.2 3.5 0.6 9.5 3.1 0.8 2.5 0.9 1.0 1.2 3.2 0.7 2.7 0.1 3.9 0.4 0.2 1.1 2.9 2.1 0.7 1.2 0.8 0.9 0.6 0.4 0.5 1.1 2.7 3.1 2.3 0.6 0.9 4.6 0.8 0.5 0.8 2.1 1.3 1.5 0.0 2.2 6.9 1.7 10.6 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 5.2 0.0 3.0 0.6 0.0 0.0 5.3 19.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 38.5 0.0 6.9 1.7 2.4 0.5 0.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.8 10.6 0.3 0.0 0.0 0.8 1.6 2.1 0.6 0.9 2.5 0.9 2.7 0.1 2.1 4.6 0.0 3.4 1.3 0.1 1.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 23.4 0.5 0.4 0.0 0.0 1.6 3.3 0.5 19.6 2.8 12.9 0.0 0.0 1.8 29.9 19.9 1.7 17.3 1.7 1.0 0.3 0.5 0.0 0.0 0.7 0.8 0.0 0.0 4.3 0.4 0.6 0.3 2.4 8.6 0.0 0.1 ATP9A "ATPIIA, KIAA0611" ENSG00000054793 "ATPase phospholipid transporting 9A (putative)" O75110 20 51596514-51768634 "Enzymes, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 6.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 6.3;NK-cells: 2.2" "Cell line enhanced" "Detected in many" "EFO-21: 29.3;SK-BR-3: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020699, HPA035630" Enhanced NA NA "CAB020699: , HPA035630: AB_10669526" "unprognostic (5.19e-2)" "unprognostic (5.28e-2)" "unprognostic (3.46e-1)" "unprognostic (1.05e-1)" "unprognostic (3.76e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-2)" "unprognostic (4.79e-2)" "unprognostic (7.45e-2)" "unprognostic (1.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "prognostic favorable (5.67e-5)" "unprognostic (5.82e-2)" "unprognostic (5.81e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" 18.5 8.2 23.7 3.9 31.8 2.0 11.2 29.8 64.7 5.6 12.2 19.9 8.2 9.1 8.6 13.1 8.8 16.9 8.2 7.7 24.3 26.8 6.8 5.4 6.7 2.6 21.1 23.9 13.2 10.0 22.7 8.3 3.6 22.5 14.3 11.3 4.1 14.9 11.3 9.2 4.1 11.5 8.7 18.9 2.2 14.0 12.4 15.8 0.8 18.7 2.9 2.4 7.4 5.6 0.0 0.0 6.3 0.2 2.2 0.8 1.8 9.7 8.3 6.9 15.4 20.3 15.1 0.1 3.5 6.7 2.3 0.7 19.1 20.3 0.0 29.3 14.5 11.7 7.8 9.0 5.1 2.3 7.5 2.7 0.0 9.2 7.7 2.8 0.0 0.0 5.0 10.4 0.5 1.4 5.4 12.5 1.8 0.0 0.0 2.6 13.6 0.7 0.0 1.2 9.9 10.6 1.5 0.0 0.0 4.7 13.7 13.0 9.3 14.0 28.1 5.1 2.5 5.3 0.2 8.1 19.3 5.2 7.5 1.5 0.0 0.1 0.3 5.1 0.0 1.7 6.3 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.4 2.2 0.1 0.0 0.0 1.8 23.7 31.8 29.8 34.9 24.3 26.8 21.1 23.9 22.5 15.8 14.9 12.8 0.0 10.2 2.6 32.1 11.5 30.6 17.4 14.8 17.4 3.9 0.3 1.7 18.0 0.6 5.4 32.5 0.0 14.8 0.2 7.1 27.0 1.1 10.0 4.5 41.3 53.0 11.1 2.7 1.7 12.4 1.6 3.3 0.0 36.1 4.5 21.7 24.6 21.9 1.2 6.4 6.5 7.1 0.9 1.5 3.6 0.2 0.5 19.7 25.5 ATPAF1 "ATP11, Atp11p, FLJ22351" ENSG00000123472 "ATP synthase mitochondrial F1 complex assembly factor 1" Q5TC12 1 46632737-46673867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 73.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 236.9;Early spermatids: 241.4;Late spermatids: 261.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028382, HPA044950" Approved Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA028382: AB_2672574, HPA044950: AB_2679151" "unprognostic (1.34e-1)" "unprognostic (2.97e-3)" "unprognostic (1.18e-2)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (5.97e-2)" "unprognostic (3.53e-1)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (1.19e-2)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "prognostic favorable (5.33e-7)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-1)" "unprognostic (2.62e-1)" 20.6 32.0 32.9 7.5 34.5 7.9 14.0 15.9 31.0 11.1 15.2 16.1 9.3 12.0 7.8 10.8 10.6 9.8 9.0 73.4 22.3 20.8 33.3 31.9 7.5 8.6 28.2 24.9 10.6 18.8 39.5 14.6 11.0 28.5 11.6 16.9 11.9 15.9 10.8 66.9 5.7 11.7 12.7 18.6 6.9 12.8 13.4 18.2 10.8 13.0 13.1 9.4 9.8 6.1 3.1 2.4 5.8 4.2 9.2 6.6 1.8 20.8 17.0 23.0 20.5 25.2 20.4 19.3 15.6 19.6 23.5 19.0 13.6 9.1 12.4 21.0 19.7 20.9 16.2 36.2 20.3 31.8 27.1 28.6 21.9 21.2 23.6 20.3 21.6 1.3 19.9 24.4 25.1 22.0 18.8 14.7 23.3 10.0 24.6 17.9 18.9 31.8 12.0 36.2 18.1 25.7 13.8 6.2 26.9 26.8 16.6 27.3 20.4 26.5 28.2 40.7 27.8 26.0 30.5 12.7 8.1 20.0 16.2 21.2 30.6 27.7 8.5 13.3 8.4 15.1 0.0 2.5 5.8 3.5 4.2 4.6 3.1 3.7 4.0 2.4 1.7 5.2 2.4 2.1 9.2 1.7 1.8 6.6 1.8 32.9 34.5 15.9 31.0 22.3 20.8 28.2 24.9 28.5 18.2 3.0 15.2 20.4 17.4 8.4 34.1 236.9 22.9 8.1 12.5 29.6 25.5 54.8 145.9 19.3 241.4 11.3 22.6 0.0 17.5 23.1 16.9 15.2 16.1 37.5 32.6 44.5 18.5 8.0 16.4 261.4 17.5 11.1 23.6 10.8 33.8 29.9 12.2 10.5 25.1 85.7 23.3 25.8 29.3 25.6 40.1 11.8 39.2 12.5 43.6 16.1 ATRIP "FLJ12343, MGC20625, MGC21482, MGC26740" ENSG00000164053 "ATR interacting protein" Q8WXE1 3 48446710-48467645 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.3" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 5.3;Exocrine glandular cells: 3.3;Pancreatic endocrine cells: 3.5;Suprabasal keratinocytes: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033109, HPA047590" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB033109: AB_634993, HPA047590: AB_2680094" "unprognostic (5.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.85e-1)" "unprognostic (8.87e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "unprognostic (4.72e-2)" "unprognostic (8.88e-3)" "unprognostic (2.66e-1)" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (2.01e-1)" "unprognostic (8.89e-2)" "unprognostic (2.59e-1)" "unprognostic (1.40e-2)" "unprognostic (8.52e-2)" 6.1 5.3 4.9 6.2 5.5 7.1 6.5 9.4 6.4 7.0 5.2 7.2 5.1 3.8 8.2 5.1 7.0 5.7 5.0 5.4 3.5 2.8 5.4 5.4 6.0 5.5 4.8 3.6 6.8 5.3 5.3 5.5 9.2 3.8 6.2 6.0 6.5 5.1 7.2 7.3 8.0 4.6 5.4 3.4 6.3 5.2 38.3 4.6 13.4 9.3 6.6 9.0 5.5 6.2 0.9 2.9 1.0 1.4 1.4 3.4 1.5 7.0 2.9 8.2 6.2 5.0 8.5 8.7 10.7 5.0 13.3 11.1 4.3 5.0 15.7 5.1 4.5 6.2 7.3 9.2 8.4 13.0 9.3 4.7 12.2 13.1 2.9 2.7 11.8 7.8 3.6 2.7 7.1 3.4 2.9 5.8 5.9 9.7 8.1 12.4 3.9 9.9 4.2 6.4 3.6 8.8 6.7 7.5 11.5 4.5 3.5 4.0 5.8 8.6 8.7 3.4 7.7 7.4 4.5 6.5 8.9 5.8 10.7 12.4 9.6 15.3 10.8 4.7 8.9 4.9 0.7 1.4 0.0 3.3 0.8 0.5 0.9 3.0 1.7 0.9 0.5 2.1 3.3 1.0 1.4 1.0 2.9 3.4 1.5 4.9 5.5 9.4 6.4 3.5 2.8 4.8 3.6 3.8 4.6 0.0 1.0 0.0 0.0 2.6 0.8 1.3 0.0 5.3 2.3 0.0 2.0 0.1 0.0 3.0 0.0 0.7 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.8 0.0 0.6 3.5 0.0 0.0 1.5 2.0 0.0 0.9 0.0 0.0 3.3 0.1 0.0 0.0 0.0 ATRNL1 "ALP, FLJ45344, KIAA0534" ENSG00000107518 "Attractin like 1" Q5VV63 10 115093365-115948992 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 40.4;Early spermatids: 37.4;Ito cells: 32.5;Late spermatids: 28.8;Spermatocytes: 41.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "AN3-CA: 20.5;RH-30: 13.7;U-266/70: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038070 Uncertain Approved Nucleoplasm,Mitochondria NA NA 33000000 "Nucleoplasm, Mitochondria" "HPA038070: AB_10697237" "unprognostic (3.85e-2)" "unprognostic (1.89e-1)" "unprognostic (5.88e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.88e-2)" "unprognostic (5.17e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" "unprognostic (2.50e-2)" "unprognostic (1.04e-3)" "unprognostic (3.10e-2)" "unprognostic (2.76e-2)" "unprognostic (1.88e-2)" "unprognostic (2.08e-3)" 0.9 11.7 8.6 0.7 15.9 0.3 2.1 2.2 26.0 0.9 2.3 2.1 1.1 0.8 12.0 1.1 1.5 1.0 0.8 2.9 9.3 5.8 4.8 2.9 0.6 1.0 4.0 15.7 17.5 2.3 0.3 11.1 3.3 8.4 6.9 0.9 2.0 1.8 8.3 3.8 0.6 1.0 13.4 2.0 0.8 0.9 13.0 2.5 0.0 2.0 0.0 0.9 1.1 1.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.2 20.5 0.0 0.0 0.0 0.1 0.4 3.0 4.4 0.1 0.1 0.0 1.4 0.5 4.2 0.0 1.1 0.0 3.5 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 8.6 0.0 8.6 0.0 6.9 9.4 0.2 8.0 0.0 6.7 0.0 0.1 5.9 13.7 8.9 3.1 0.0 3.4 9.9 0.0 0.0 0.2 3.8 1.2 0.0 0.0 0.0 2.5 0.0 2.9 11.3 0.0 3.3 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 15.9 2.2 26.0 9.3 5.8 4.0 15.7 8.4 2.5 0.0 0.0 0.0 0.1 0.6 40.4 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.6 37.4 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.0 0.0 2.2 9.5 0.0 32.5 3.2 28.8 1.4 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.7 0.3 4.4 0.0 0.4 41.3 5.3 0.1 0.2 0.0 0.0 0.0 ATXN3L MJDL ENSG00000123594 "Ataxin 3 like" Q9H3M9 X 13318236-13320399 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 8.0" "Group enriched" "Detected in some" 58 "Early spermatids: 59.4;Late spermatids: 131.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.0" "HPA024123, HPA027539" Uncertain NA NA "HPA024123: AB_1845133, HPA027539: AB_10602435" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 131.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000163635 "Ataxin 7" O15265 3 63898399-64003453 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.4" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 51.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA034989 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA034989: AB_10602596" "unprognostic (1.51e-2)" "unprognostic (2.44e-1)" "unprognostic (5.98e-2)" "unprognostic (2.18e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.22e-4)" "unprognostic (9.65e-2)" "unprognostic (2.76e-2)" "unprognostic (2.46e-1)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "unprognostic (9.77e-3)" "unprognostic (2.56e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (3.45e-2)" 8.8 6.4 4.9 14.5 7.4 19.7 8.9 10.2 6.5 9.5 10.7 4.9 6.7 8.0 10.9 9.2 9.2 7.5 11.4 7.5 5.0 4.3 6.3 8.2 10.2 19.9 6.1 3.1 12.4 21.7 15.3 10.9 15.1 6.0 8.2 8.1 15.1 12.2 7.8 9.6 10.6 12.5 9.2 5.7 11.1 7.2 14.6 6.7 55.4 8.8 8.5 24.2 8.4 10.2 0.9 0.5 11.1 0.5 2.6 5.9 1.1 6.0 4.9 5.0 4.1 5.8 6.6 6.6 3.5 6.5 7.5 6.1 6.9 5.9 5.8 2.1 6.8 8.1 4.0 6.4 6.6 8.0 15.2 2.6 10.1 5.8 2.1 2.9 4.2 12.2 6.3 3.6 11.1 12.4 5.6 5.6 9.6 3.8 17.7 4.6 14.4 8.9 3.5 3.4 4.1 2.2 3.8 4.6 7.0 3.7 7.2 2.0 3.7 7.8 5.2 7.1 4.2 3.6 6.1 7.7 6.5 8.9 9.5 8.1 8.0 8.1 6.4 7.7 7.1 6.2 11.1 0.3 0.9 3.2 0.5 2.6 0.0 5.9 3.4 0.1 0.9 5.7 3.7 1.2 2.6 0.1 0.5 4.7 1.1 4.9 7.4 10.2 6.5 5.0 4.3 6.1 3.1 6.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 ATXN7 "ADCAII, OPCA3, SCA7" ENSG00000285258 "Ataxin 7" O15265 3 63864557-64003462 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.9" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 72.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA034989 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034989: AB_10602596" 0.4 0.0 1.5 2.8 1.3 0.0 2.0 0.7 0.0 2.0 2.0 0.0 0.9 0.8 0.0 1.0 0.9 0.9 2.1 0.5 1.0 3.0 1.9 0.9 0.9 0.5 0.6 0.3 3.1 0.8 0.3 1.5 1.0 0.0 0.8 1.8 0.1 4.9 3.6 8.9 1.9 2.5 4.3 0.7 2.4 0.1 3.5 3.3 3.3 6.1 3.3 3.0 2.5 4.1 5.6 1.5 3.2 6.9 1.1 2.1 4.8 2.8 3.4 2.3 4.9 6.6 2.6 6.3 4.3 2.5 4.6 4.6 5.8 1.9 6.9 5.2 6.8 4.2 2.9 3.9 2.3 9.8 2.9 13.2 3.0 4.0 2.2 1.6 0.8 5.8 2.9 2.5 2.6 3.4 1.1 1.7 6.0 4.9 3.9 2.9 1.4 6.7 4.0 6.1 3.3 3.6 4.7 5.4 4.8 4.3 2.4 4.8 3.6 5.7 1.9 2.7 2.5 1.2 2.9 4.9 2.9 2.4 1.6 4.3 3.5 2.5 8.9 2.5 1.4 3.6 4.3 0.7 8.9 7.8 5.7 20.9 38.7 67.5 0.0 33.1 8.1 5.7 5.2 96.2 0.0 0.0 2.5 11.6 15.5 24.4 0.0 3.7 0.0 4.1 20.9 14.9 17.4 0.0 23.8 25.3 33.7 34.3 6.2 11.8 10.2 11.8 8.2 19.4 28.6 2.0 27.1 12.4 0.3 72.4 0.0 19.6 12.5 15.3 40.4 0.0 40.6 18.2 34.4 AUNIP "AIBp, C1orf135, MGC2603" ENSG00000127423 "Aurora kinase A and ninein interacting protein" Q9H7T9 1 25831913-25859458 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 35.3" "Group enriched" "Detected in some" 5 "Early spermatids: 45.3;Late spermatids: 96.4;Spermatocytes: 33.8;Spermatogonia: 40.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA028730 Uncertain Supported Centrosome NA NA Centrosome "HPA028730: AB_10670830" "unprognostic (8.05e-2)" "unprognostic (1.98e-2)" "unprognostic (3.96e-3)" "prognostic unfavorable (3.94e-4)" "unprognostic (9.51e-2)" "unprognostic (8.86e-2)" "unprognostic (9.70e-6)" "unprognostic (5.00e-3)" "unprognostic (9.06e-3)" "unprognostic (4.59e-3)" "unprognostic (1.42e-3)" "unprognostic (1.12e-2)" "unprognostic (1.01e-6)" "unprognostic (3.61e-2)" "unprognostic (4.41e-2)" "unprognostic (4.70e-2)" "unprognostic (3.62e-1)" 0.4 1.6 2.5 3.4 1.4 7.2 0.6 2.1 4.0 0.5 1.1 0.2 0.1 1.3 0.5 0.8 2.1 0.5 0.4 0.8 2.8 0.9 0.6 0.8 0.6 1.6 0.9 1.4 0.5 0.5 0.2 0.7 7.0 2.6 0.6 1.3 0.0 0.6 1.7 0.9 0.8 1.1 0.5 0.5 1.2 0.8 35.3 0.0 5.3 0.5 3.2 2.3 0.9 0.9 1.4 2.0 4.4 3.5 1.5 2.3 1.1 11.7 3.4 5.4 6.8 0.3 0.4 5.3 6.8 3.1 13.6 11.1 2.8 9.1 11.7 5.2 2.3 4.7 9.6 14.5 6.6 10.9 6.5 11.7 25.6 5.5 4.3 0.1 12.4 11.2 0.3 3.3 8.3 5.8 1.0 3.0 9.0 15.7 5.8 3.7 6.4 9.0 10.6 9.5 7.7 4.3 7.4 10.5 7.2 4.2 3.9 7.9 3.7 9.4 10.7 7.4 6.2 3.9 6.4 1.3 4.0 6.2 8.3 6.0 2.2 4.6 8.7 2.7 20.9 6.4 4.4 2.5 1.7 0.6 3.5 0.4 0.9 1.0 0.8 2.0 1.4 0.9 1.3 2.2 1.5 2.1 1.6 2.3 1.1 2.5 1.4 2.1 4.0 2.8 0.9 0.9 1.4 2.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.1 0.0 0.0 0.0 0.0 2.0 8.3 0.0 0.5 45.3 0.0 0.0 0.0 0.4 10.2 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.8 96.4 2.0 1.0 0.0 1.8 0.0 0.2 0.5 0.0 0.7 0.0 0.2 0.0 0.0 33.8 40.1 0.4 6.2 0.0 0.3 0.2 AURKA "AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7" ENSG00000087586 "Aurora kinase A" O14965 20 56369389-56392337 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 32.3;testis: 41.1" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001454, HPA002636" Enhanced Approved Nucleoplasm,Centrosome,Cytosol Yes Yes "Nucleoplasm, Centrosome, Cytosol" "CAB001454: AB_563420, HPA002636: AB_1845217" "unprognostic (7.73e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (9.40e-5)" "unprognostic (1.92e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (4.69e-3)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.13e-4)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.47e-8)" "unprognostic (1.67e-1)" "unprognostic (6.83e-2)" "unprognostic (9.00e-2)" "unprognostic (5.14e-2)" 3.7 2.3 1.5 12.7 1.3 8.3 3.0 1.3 1.8 1.4 6.7 1.3 0.8 7.3 1.8 1.2 7.7 1.1 3.7 4.1 1.1 1.1 2.4 5.1 2.9 12.3 1.6 0.9 8.3 1.4 0.3 0.7 6.1 1.5 1.0 8.3 1.5 2.7 0.5 6.9 2.1 7.2 2.7 1.3 7.4 4.3 41.1 1.1 32.3 1.2 5.9 13.3 2.4 2.4 3.9 5.2 6.0 8.7 2.0 6.6 2.6 33.0 24.4 16.3 11.5 0.9 2.1 20.7 27.1 12.7 65.7 27.7 68.2 23.2 10.8 18.7 11.1 34.1 26.7 29.0 18.2 70.0 9.8 11.1 19.3 25.0 42.5 0.5 25.8 27.2 1.0 1.9 22.7 20.4 5.2 15.3 17.7 21.9 8.6 27.9 33.7 15.4 20.0 14.9 27.1 25.1 11.7 31.5 12.0 10.5 8.7 14.1 7.6 37.9 43.6 18.2 15.6 25.8 16.1 8.8 28.6 28.3 15.8 38.2 12.1 14.0 18.8 15.4 15.0 23.6 0.2 5.3 6.0 1.9 8.7 2.9 3.9 3.3 1.9 5.2 1.4 1.5 1.5 3.7 2.0 4.8 1.2 6.6 2.6 1.5 1.3 1.3 1.8 1.1 1.1 1.6 0.9 1.5 1.1 0.0 3.2 4.5 1.1 1.0 1.0 3.4 2.5 1.4 2.3 3.5 2.0 9.8 1.7 3.9 16.9 1.6 5.3 70.0 4.2 59.5 3.8 0.7 55.2 2.4 14.8 1.6 5.8 3.1 2.4 9.5 1.4 5.5 0.0 18.0 5.7 3.5 3.6 3.5 0.4 1.9 2.5 6.5 2.1 16.2 31.6 1.0 6.9 4.9 9.8 1.4 AURKB "Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5" ENSG00000178999 "Aurora kinase B" Q96GD4 17 8204733-8210600 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.7;lymphoid tissue: 59.9" "Group enriched" "Detected in many" 6 "Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB005862, HPA037708" Enhanced Enhanced Nucleoplasm,Midbody Yes Yes Nucleoplasm Midbody "CAB005862: AB_449204, HPA037708: AB_2675623" "unprognostic (4.76e-2)" "unprognostic (3.61e-3)" "unprognostic (2.25e-1)" "unprognostic (3.14e-2)" "unprognostic (2.27e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.99e-3)" "unprognostic (9.41e-3)" "unprognostic (3.47e-2)" "unprognostic (4.61e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.77e-2)" "unprognostic (2.93e-1)" "unprognostic (6.76e-2)" "unprognostic (3.77e-1)" 1.2 1.3 0.4 22.1 0.6 19.7 2.0 0.6 0.6 2.6 5.8 0.5 0.9 5.9 0.9 1.3 17.1 0.3 2.2 1.0 0.4 0.2 1.4 1.8 2.4 17.8 0.4 0.4 0.8 0.6 0.0 0.4 3.8 0.8 0.9 5.5 0.7 2.7 0.4 2.1 5.0 8.1 1.3 0.7 11.2 4.2 1.2 0.4 59.9 0.5 8.0 19.1 2.1 5.0 2.3 0.8 1.2 0.6 0.5 10.9 1.4 41.6 28.6 42.7 20.5 0.9 1.4 16.4 20.0 10.8 41.5 38.3 37.0 12.6 41.6 10.4 7.9 17.3 30.7 30.9 13.7 34.3 18.2 50.8 24.8 16.4 31.2 0.1 13.0 24.4 0.7 0.6 24.3 15.2 4.1 19.0 27.4 15.4 16.1 18.1 19.8 47.5 18.6 26.5 13.7 12.7 32.2 39.3 17.2 9.0 8.2 9.3 13.2 17.8 8.0 13.6 13.3 14.0 8.8 7.4 16.6 17.1 14.9 52.0 11.8 7.8 31.3 8.0 19.9 33.6 0.0 0.6 0.9 0.6 0.4 0.2 1.6 1.9 3.1 0.8 2.3 0.2 1.0 1.2 0.5 0.3 0.2 10.9 1.4 0.4 0.6 0.6 0.6 0.4 0.2 0.4 0.4 0.8 0.4 0.0 0.3 2.2 0.3 3.9 0.0 1.1 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.4 46.7 0.0 76.2 4.7 0.4 4.6 0.6 23.9 0.0 0.0 4.9 6.3 0.0 0.6 4.4 1.7 0.0 4.2 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.3 0.7 2.0 2.0 7.6 2.5 6.3 1.4 AURKC "ARK3, AurC, STK13" ENSG00000105146 "Aurora kinase C" Q9UQB9 19 57230802-57235548 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "testis: 72.0" "Group enriched" "Detected in many" 4 "Early spermatids: 101.7;Spermatocytes: 69.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "NTERA-2: 30.0" "Low region specificity" "Detected in all" HPA034859 Uncertain NA NA "HPA034859: AB_10670298" "unprognostic (7.27e-2)" "unprognostic (1.76e-1)" "unprognostic (6.45e-2)" "unprognostic (8.07e-3)" "unprognostic (3.29e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (7.02e-2)" "unprognostic (1.13e-1)" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-5)" "unprognostic (4.26e-2)" "unprognostic (1.61e-1)" "unprognostic (1.55e-1)" "unprognostic (6.46e-4)" 0.6 0.5 0.9 0.9 1.2 0.7 1.5 0.7 2.0 0.4 0.6 0.6 0.2 0.0 0.8 1.3 0.5 0.6 2.6 0.9 0.9 1.1 0.8 1.8 1.3 2.2 1.2 0.2 0.4 0.5 0.1 1.3 1.2 1.7 0.5 0.8 1.1 0.5 0.9 2.3 0.6 0.4 1.1 2.1 3.4 0.4 72.0 0.6 0.7 0.8 1.0 1.3 0.5 0.4 2.1 1.0 1.7 1.0 1.0 0.6 0.2 0.2 0.1 0.7 0.3 0.2 0.7 0.3 1.3 0.6 0.9 3.5 0.9 0.1 0.0 0.1 0.5 0.8 0.0 0.0 0.7 0.6 0.0 3.8 0.1 0.3 0.0 1.1 0.0 0.2 0.9 0.7 0.7 0.5 1.1 0.6 0.4 0.1 0.0 1.2 0.0 1.1 0.6 30.0 0.1 0.8 0.1 0.2 0.6 0.7 1.2 1.4 0.4 0.0 0.2 0.1 0.1 0.1 1.3 0.3 0.2 4.2 0.3 0.7 1.4 1.9 0.6 0.8 0.0 0.0 0.0 0.1 1.7 0.6 1.0 0.0 1.9 0.0 0.0 0.9 2.1 0.0 0.0 0.1 1.0 0.3 1.0 0.0 0.2 0.9 1.2 0.7 1.6 0.9 1.1 1.2 0.2 1.7 0.6 0.0 0.3 0.0 0.6 1.0 2.5 1.2 0.0 1.4 3.4 1.8 0.0 0.4 1.7 1.5 101.7 0.6 0.0 0.0 0.9 0.7 0.4 1.1 0.0 0.0 3.2 0.0 1.7 1.8 1.3 11.5 1.4 1.0 5.0 1.8 0.0 1.7 0.9 0.3 0.4 0.3 0.8 6.5 0.5 69.6 19.2 1.0 0.2 0.0 0.4 1.4 AVIL "ADVIL, DOC6, FLJ12386, p92" ENSG00000135407 Advillin O75366 12 57797376-57818704 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 26.7;Rod photoreceptor cells: 20.0" "Cancer enhanced" "Detected in all" "glioma: 9.1" "Region enriched" "Detected in many" 5 "cerebellum: 9.8" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 6.7;RH-30: 12.8;U-266/84: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058864 Approved NA NA "HPA058864: AB_2683838" "unprognostic (3.86e-2)" "unprognostic (9.86e-3)" "unprognostic (4.36e-2)" "unprognostic (3.38e-3)" "unprognostic (1.36e-1)" "unprognostic (7.79e-4)" "unprognostic (1.42e-1)" "unprognostic (7.44e-2)" "unprognostic (9.13e-2)" "unprognostic (8.02e-2)" "unprognostic (1.04e-2)" "unprognostic (1.07e-2)" "unprognostic (2.57e-4)" "unprognostic (2.44e-1)" "unprognostic (9.41e-2)" "unprognostic (3.29e-1)" "prognostic favorable (2.71e-4)" 1.0 4.0 0.9 1.9 1.4 0.2 1.1 9.8 1.2 0.9 13.6 0.9 0.9 3.0 0.9 3.4 0.9 1.3 2.6 1.2 0.9 0.6 1.4 1.3 2.2 0.9 0.9 0.9 2.0 3.9 0.0 2.1 1.0 1.9 1.6 1.3 1.4 1.4 1.0 9.3 6.0 21.4 0.9 1.5 1.1 1.0 0.9 1.3 0.9 3.4 0.9 0.9 1.7 1.1 2.3 1.3 9.0 1.4 0.6 2.0 0.1 0.5 0.6 4.4 3.0 1.1 2.1 0.3 0.4 0.2 0.0 0.3 0.1 1.6 6.7 0.6 0.7 0.0 2.4 0.1 0.0 0.5 0.0 2.1 0.7 1.5 1.4 0.4 2.7 0.1 1.5 1.1 0.2 0.6 0.1 0.6 0.7 0.5 2.9 0.0 0.6 0.0 2.9 0.4 0.0 1.4 0.1 12.8 0.5 0.2 1.3 0.9 0.1 0.5 0.4 1.5 1.0 1.0 0.0 0.3 1.9 0.2 1.4 0.0 1.3 4.8 0.8 0.8 0.5 0.5 0.4 1.4 2.3 1.2 0.6 1.3 1.2 2.0 1.0 0.6 2.3 1.9 1.4 9.0 0.6 1.0 1.3 0.6 0.1 0.9 1.4 9.8 1.2 0.9 0.6 0.9 0.9 1.9 1.3 3.0 11.4 2.7 2.9 2.6 26.7 0.6 10.2 1.4 4.5 3.5 17.7 0.9 0.0 4.0 5.0 4.0 2.9 0.0 5.3 0.8 3.1 2.9 1.1 2.4 1.9 7.9 7.5 12.3 3.2 2.0 3.7 2.6 3.3 1.8 4.3 16.9 4.0 4.2 0.7 0.5 20.0 6.5 2.5 0.9 1.5 3.6 2.4 2.5 4.0 2.5 AVP "ADH, ARVP" ENSG00000101200 "Arginine vasopressin" P01185 20 3082556-3084724 "Disease related genes, Predicted secreted proteins" "Hormone, Vasoactive, Vasoconstrictor" "Diabetes insipidus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "brain: 270.1" "Group enriched" "Detected in some" 5 "Late spermatids: 18.7;Proximal tubular cells: 32.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 18 "hypothalamus: 270.1" "Cell type enriched" "Detected in some" 6 "eosinophil: 6.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.1" "Cell line enriched" "Detected in single" 13 "NB-4: 7.1" "Region enriched" "Detected in some" 10 "hypothalamus: 273.6" "Group enriched" "Detected in some" 633 "basal ganglia: 1065.4;hypothalamus: 1058.2" "CAB025318, HPA071892" Enhanced Supported "Secreted to blood" NA NA 19300 "CAB025318: , HPA071892: AB_2732190" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" 0.7 0.9 11.7 0.4 15.0 4.2 0.0 0.0 0.9 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 270.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.1 11.7 15.0 0.0 0.9 3.4 270.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.8 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 AVPR1A AVPR1 ENSG00000166148 "Arginine vasopressin receptor 1A" P37288 12 63142759-63150942 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 34.9;liver: 71.2" "Group enriched" "Detected in some" 9 "Hepatocytes: 50.5;Sertoli cells: 77.6;Smooth muscle cells: 34.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "ASC diff: 6.9;Karpas-707: 15.4;U-266/84: 10.7" "Group enriched" "Detected in some" 5 "basal ganglia: 7.1;hypothalamus: 4.4" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (2.82e-1)" "unprognostic (9.90e-3)" "unprognostic (2.90e-1)" "unprognostic (1.59e-1)" "unprognostic (1.43e-3)" "unprognostic (3.79e-2)" "unprognostic (2.60e-1)" "unprognostic (3.58e-6)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.38e-3)" "unprognostic (4.65e-3)" "unprognostic (1.25e-1)" "unprognostic (4.77e-2)" "unprognostic (4.66e-4)" 26.4 34.9 0.3 2.8 0.3 0.0 6.3 0.2 0.4 9.7 4.2 0.5 1.1 0.2 16.5 2.1 2.5 3.7 3.4 2.5 0.3 0.3 4.2 71.2 0.7 1.5 0.3 0.0 3.8 1.5 1.1 1.0 1.2 0.6 3.2 0.5 0.5 1.1 2.4 4.4 1.3 0.8 7.5 0.3 0.5 1.5 1.8 0.0 0.6 6.1 3.0 0.4 6.2 2.6 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.2 0.3 0.7 0.0 6.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.3 0.3 0.2 0.4 0.3 0.3 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.1 3.2 2.5 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 50.5 0.2 0.0 0.0 0.6 1.3 0.0 2.6 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.3 77.6 34.1 0.2 0.2 0.3 0.1 0.0 0.0 0.3 AVPR1B AVPR3 ENSG00000198049 "Arginine vasopressin receptor 1B" P47901 1 206109692-206117699 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "pituitary gland: 52.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;NTERA-2: 1.0;PC-3: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075404 Enhanced NA NA "HPA075404: AB_2732291" "unprognostic (4.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.82e-1)" "unprognostic (2.82e-1)" "unprognostic (2.87e-1)" "unprognostic (1.08e-2)" "unprognostic (3.33e-1)" "unprognostic (2.96e-2)" "unprognostic (6.23e-2)" "unprognostic (7.65e-2)" "unprognostic (1.86e-1)" "unprognostic (6.66e-3)" 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.5 0.1 1.3 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 52.8 0.1 0.1 0.2 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 1.0 0.0 3.6 0.0 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AVPR2 "DIR, DIR3, V2R" ENSG00000126895 "Arginine vasopressin receptor 2" P30518 X 153902531-153907166 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes insipidus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 8.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 47.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 26 "intermediate monocyte: 6.2;non-classical monocyte: 5.3" "Lineage enriched" "Detected in single" 28 "monocytes: 6.2" "Cell line enhanced" "Detected in some" "EFO-21: 5.7;SCLC-21H: 6.6;U-266/84: 6.0;U-698: 6.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "cerebellum: 7.9" NA NA "unprognostic (3.05e-2)" "unprognostic (5.62e-2)" "unprognostic (1.99e-4)" "unprognostic (2.50e-4)" "unprognostic (2.76e-1)" "unprognostic (7.10e-6)" "unprognostic (3.80e-3)" "unprognostic (1.17e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-2)" "unprognostic (4.21e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.08e-2)" "unprognostic (1.87e-1)" "unprognostic (4.38e-1)" "unprognostic (9.83e-2)" 8.9 0.1 0.0 0.1 0.0 0.9 7.1 1.2 0.0 2.1 1.5 0.7 2.7 0.0 0.8 2.6 1.4 6.3 0.0 0.0 4.7 0.0 1.9 1.1 0.0 0.1 0.6 0.2 0.0 0.1 1.1 0.0 1.2 0.8 4.3 2.2 1.3 1.0 0.0 0.0 1.2 0.0 1.9 0.2 1.8 2.1 0.0 0.2 0.0 6.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 2.8 5.7 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.2 2.2 0.9 0.0 0.1 2.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 2.7 0.0 0.1 1.4 1.6 0.2 0.0 0.1 2.5 1.1 2.5 0.1 0.0 6.6 1.2 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 1.1 6.0 6.3 0.0 1.6 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 3.0 2.2 0.0 0.0 0.9 0.0 1.4 0.0 1.4 0.0 47.1 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 AWAT1 DGAT2L3 ENSG00000204195 "Acyl-CoA wax alcohol acyltransferase 1" Q58HT5 X 70234655-70240627 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 3.8;skin 1: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA063412 Enhanced NA NA "HPA063412: AB_2685009" "unprognostic (1.12e-1)" "unprognostic (1.78e-1)" "unprognostic (1.96e-2)" "unprognostic (4.90e-2)" "unprognostic (2.08e-1)" "unprognostic (6.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AWAT2 "DGAT2L4, MFAT" ENSG00000147160 "Acyl-CoA wax alcohol acyltransferase 2" Q6E213 X 70040542-70049938 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "breast: 5.7;skin 1: 14.0" "Cell type enhanced" "Detected in single" 30 "Spermatocytes: 1.2" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 2.4;PC-3: 2.6;SK-BR-3: 1.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA062748 Approved NA NA "HPA062748: AB_2684862" "unprognostic (3.41e-2)" "unprognostic (1.06e-1)" "unprognostic (2.99e-2)" "unprognostic (4.11e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 AXDND1 "C1orf125, FLJ32940" ENSG00000162779 "Axonemal dynein light chain domain containing 1" Q5T1B0 1 179365720-179554735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 18.0" "Group enriched" "Detected in some" 7 "Early spermatids: 179.9;Late spermatids: 188.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.8;HBF TERT88: 1.9;SH-SY5Y: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071114 Enhanced NA NA "HPA071114: AB_2686345" "unprognostic (1.67e-2)" "unprognostic (8.37e-2)" "unprognostic (2.81e-2)" "unprognostic (1.05e-1)" "unprognostic (3.34e-1)" "unprognostic (1.73e-1)" "unprognostic (3.78e-4)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-3)" "unprognostic (2.09e-2)" "unprognostic (1.31e-1)" "unprognostic (5.17e-3)" "unprognostic (1.92e-1)" "unprognostic (5.48e-2)" "unprognostic (5.04e-2)" "unprognostic (2.25e-1)" 0.0 0.5 0.1 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 1.7 1.2 0.3 18.0 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.2 0.0 2.1 0.4 0.0 0.6 0.0 0.4 0.0 0.0 0.9 0.0 0.0 2.8 0.9 0.3 0.9 0.2 0.0 0.9 0.3 0.1 0.0 0.5 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 1.0 0.0 0.9 0.0 0.3 0.0 1.1 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.1 1.2 0.6 0.0 0.0 0.3 1.7 0.0 0.0 0.2 0.8 0.7 0.0 0.2 0.7 0.5 0.0 0.1 1.0 1.4 0.0 0.8 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.1 0.1 0.0 0.6 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.8 0.0 4.0 1.2 0.0 2.0 0.1 0.0 0.0 179.9 0.0 5.5 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 188.8 1.4 0.2 0.0 0.0 0.6 0.4 0.3 1.4 1.8 0.0 0.4 0.0 0.0 27.1 3.2 0.0 0.1 0.0 3.3 0.1 AZGP1 "ZA2G, ZAG" ENSG00000160862 "Alpha-2-glycoprotein 1, zinc-binding" P25311 7 99966720-99976157 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 158.8;salivary gland: 270.5" "Group enriched" "Detected in many" 6 "Glandular cells: 2272.6;Hepatocytes: 3981.0" "Group enriched" "Detected in many" 12 "breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0" "Region enriched" "Detected in single" 4 "olfactory region: 0.9" "HPA012582, HPA012876, CAB016087, CAB032276" Enhanced Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 55200000000 160000000000 Vesicles Nucleoplasm "CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: " "unprognostic (8.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.41e-1)" "unprognostic (5.42e-3)" "unprognostic (4.98e-2)" "unprognostic (5.74e-3)" "prognostic favorable (2.90e-4)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (1.79e-1)" "prognostic favorable (1.53e-4)" "unprognostic (2.18e-1)" "unprognostic (2.08e-2)" "unprognostic (9.80e-2)" "unprognostic (3.51e-3)" 6.4 0.0 1.1 1.3 1.7 0.0 64.1 1.1 1.4 1.1 1.4 1.5 0.9 1.4 0.9 1.2 1.3 0.0 2.2 9.0 1.2 0.4 18.0 158.8 3.0 0.9 2.7 1.2 1.0 55.3 0.0 0.9 1.0 1.3 62.4 0.0 1.6 270.5 2.5 1.0 11.5 1.5 0.9 1.1 0.9 14.4 1.2 1.7 0.9 1.0 3.0 3.2 1.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 4.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 1.6 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.4 0.0 49.6 0.0 0.0 0.5 38.9 0.0 0.0 0.0 0.6 0.2 7.9 3.8 0.0 13.0 0.0 0.0 0.1 0.0 0.6 0.3 0.6 0.2 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 1.7 1.1 1.4 1.2 0.4 2.7 1.2 1.3 1.7 20.8 187.7 32.0 321.8 3.8 0.0 94.8 420.4 5.3 50.0 5.2 2.0 0.0 39.7 11.0 1.3 0.4 8.5 46.7 221.1 0.0 0.2 2272.6 3.5 3981.0 0.0 0.0 11.9 58.3 79.1 3.1 0.9 0.3 59.1 3.6 5.4 22.6 173.5 5.8 0.0 512.3 0.2 0.0 1.1 4.3 0.4 8.4 0.0 15.2 6.3 497.4 AZIN2 "ADC, KIAA1945, ODC-p, ODC1L, ODCp" ENSG00000142920 "Antizyme inhibitor 2" Q96A70 1 33081104-33120530 "Predicted intracellular proteins" "Polyamine biosynthesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1;testis: 22.9" "Group enriched" "Detected in many" 23 "Early spermatids: 190.6;Late spermatids: 686.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 17.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 14.3;SK-MEL-30: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028527 Approved Cytosol NA NA Cytosol "HPA028527: AB_10602077" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.16e-3)" "unprognostic (7.50e-2)" "unprognostic (8.28e-2)" "unprognostic (4.56e-2)" "unprognostic (1.15e-4)" "unprognostic (9.19e-3)" "unprognostic (3.89e-2)" "unprognostic (1.54e-2)" "unprognostic (1.06e-3)" "unprognostic (2.16e-1)" "unprognostic (3.18e-1)" "unprognostic (6.91e-2)" "unprognostic (2.91e-1)" "unprognostic (9.45e-2)" "unprognostic (2.41e-1)" 1.5 5.3 7.8 3.1 11.9 0.2 3.6 5.8 14.6 5.1 4.4 23.1 0.5 1.4 3.8 3.4 1.7 7.0 4.1 5.7 10.1 7.8 3.5 0.9 2.5 1.9 10.2 12.2 9.9 3.0 4.4 2.9 1.4 13.6 3.9 3.0 3.4 3.5 3.6 0.9 1.8 1.3 3.4 18.1 1.9 1.8 22.9 10.1 0.7 4.3 0.0 3.0 2.3 1.9 0.2 17.9 3.5 0.0 0.0 1.6 0.7 0.5 0.6 2.0 1.2 1.0 4.5 0.6 0.7 3.1 3.2 2.6 0.3 2.6 0.0 0.9 0.5 1.7 1.4 1.4 0.6 0.9 0.0 0.0 0.1 0.1 0.5 4.9 0.0 0.2 4.4 2.8 2.6 1.0 14.3 0.4 0.7 0.1 0.2 2.3 0.0 0.2 0.9 1.0 0.3 0.4 1.4 1.9 0.1 2.2 0.1 0.4 2.1 0.5 0.0 18.4 1.9 0.8 0.3 0.1 0.7 1.4 2.2 0.4 1.1 0.0 0.0 4.9 0.0 0.8 3.5 0.0 0.0 1.3 0.0 1.4 0.2 1.4 1.4 0.0 0.0 1.6 1.6 0.0 0.0 0.0 17.9 0.0 0.7 7.8 11.9 5.8 12.8 10.1 7.8 10.2 12.2 13.6 10.1 0.0 4.8 2.0 2.4 0.0 7.1 0.8 0.0 4.0 1.2 1.8 17.7 0.4 0.0 1.3 190.6 1.1 4.2 0.0 1.2 0.4 1.2 1.5 0.0 0.0 1.1 6.4 1.2 1.8 0.3 686.4 5.8 0.4 0.0 2.8 1.2 9.9 1.2 4.8 7.1 2.6 7.6 6.5 0.9 18.8 5.9 0.0 0.2 1.5 2.5 0.8 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 238.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 3.3;Kupffer cells: 4.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.3;neutrophil: 7.6" "Group enriched" "Detected in many" 6 "granulocytes: 7.6;monocytes: 3.3" "Cell line enriched" "Detected in some" 7 "THP-1: 154.5" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 290000 Vesicles "HPA055851: AB_2682943, HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.3 0.2 0.4 0.2 0.5 238.2 0.6 0.0 0.6 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.2 0.8 0.2 34.6 0.4 0.5 0.2 1.5 15.3 0.2 0.2 0.0 0.5 0.1 0.1 0.9 3.8 0.2 0.2 0.2 0.2 0.6 0.2 1.0 0.4 0.2 0.2 0.1 18.6 0.2 1.2 0.0 20.6 1.3 0.0 0.2 0.1 0.4 0.0 0.8 7.6 3.3 0.0 0.3 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 3.3 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 7.6 0.0 0.5 0.0 0.0 4.1 0.4 0.5 0.0 0.6 0.4 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 3.3 0.0 0.0 0.0 4.6 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.0 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105384 "Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 36.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 52.9;Cardiomyocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.9;NK-cell: 16.7" "Group enriched" "Detected in many" 7 "granulocytes: 4.9;NK-cells: 16.7" "Cell line enhanced" "Detected in many" "PC-3: 17.2;RT4: 52.6" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles NA NA 290000 Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 3.8 5.4 14.0 3.0 24.5 3.1 7.4 17.2 24.7 15.5 2.3 5.5 2.6 1.5 8.3 6.9 5.4 10.4 7.1 36.8 15.4 21.6 14.3 1.0 10.8 3.5 11.3 16.2 13.8 7.8 6.5 8.5 10.0 17.7 8.9 2.0 7.5 14.8 6.7 1.1 2.2 1.9 7.2 7.6 4.2 7.5 6.2 5.0 1.1 19.5 2.3 3.9 10.5 4.7 1.4 1.4 4.9 0.2 16.7 0.7 0.5 6.7 0.2 3.1 0.1 0.3 1.0 0.1 3.7 3.3 8.2 2.8 4.4 5.1 0.0 15.1 3.1 4.9 1.5 0.0 6.6 2.7 0.1 0.0 3.7 2.8 0.0 4.8 0.1 0.1 10.1 2.0 2.2 0.5 6.4 12.1 0.0 0.0 0.0 3.3 10.9 0.0 0.0 7.5 0.1 17.2 0.1 0.0 0.1 3.9 52.6 6.3 0.0 9.5 3.5 2.7 1.4 14.5 5.5 0.0 0.1 6.6 0.2 0.1 1.5 0.0 0.0 5.8 0.0 0.0 4.9 0.2 0.0 0.4 0.1 0.4 1.4 0.2 0.4 1.4 0.3 0.5 0.7 0.4 16.7 0.0 1.0 0.0 0.5 14.0 24.5 17.2 24.7 15.4 21.6 11.3 16.2 17.7 5.0 17.9 2.1 3.4 4.2 4.4 52.9 51.9 0.0 2.7 10.3 14.0 11.8 18.5 10.0 3.0 0.6 6.8 0.0 0.0 7.4 10.2 16.9 4.9 10.3 0.0 8.4 6.4 1.7 6.7 1.3 1.7 6.6 4.6 10.1 7.2 0.0 10.8 7.2 0.0 4.9 13.6 7.2 0.0 13.3 3.7 16.8 2.3 4.2 1.8 0.4 4.1 B3GALNT2 MGC39558 ENSG00000162885 "Beta-1,3-N-acetylgalactosaminyltransferase 2" Q8NCR0 1 235449923-235504481 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 35.7" "Cell type enriched" "Detected in many" 7 "Cone photoreceptor cells: 237.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012502, HPA050662" Approved Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus" "HPA012502: AB_1845228, HPA050662: AB_2681209" "unprognostic (5.50e-2)" "unprognostic (3.16e-3)" "unprognostic (6.60e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-2)" "unprognostic (1.28e-1)" "unprognostic (7.59e-3)" "unprognostic (1.96e-2)" "unprognostic (3.39e-2)" "unprognostic (3.38e-1)" "unprognostic (7.19e-3)" "unprognostic (2.89e-1)" "unprognostic (1.99e-1)" "unprognostic (5.52e-2)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (8.34e-3)" 5.0 6.3 3.9 4.3 5.1 1.3 8.4 4.7 4.5 5.4 7.6 3.5 5.1 3.3 8.0 8.7 10.3 6.1 9.7 7.9 2.8 2.9 3.7 4.6 3.7 3.1 3.0 3.2 5.9 35.7 9.8 8.9 4.5 4.7 8.3 5.8 8.5 8.7 7.3 21.6 6.1 6.9 16.9 2.5 3.3 9.2 5.8 3.9 4.7 7.1 7.0 5.0 9.7 5.9 1.5 5.7 2.4 2.7 1.9 1.9 1.3 9.9 6.5 7.2 10.7 11.7 9.9 17.4 8.7 7.9 6.6 6.1 5.0 8.9 5.2 11.5 9.9 4.3 12.6 14.0 10.2 8.2 10.2 9.7 3.3 8.3 5.7 7.4 10.7 3.7 7.1 6.6 6.8 16.5 5.0 10.1 14.1 8.0 7.0 6.2 4.7 6.7 3.9 10.3 6.3 3.7 7.4 12.0 13.2 4.2 11.8 9.3 11.9 15.1 5.7 7.5 3.1 11.0 10.9 9.9 5.8 9.6 9.8 11.6 10.2 8.4 3.2 3.8 7.7 13.4 2.4 2.3 1.1 1.1 2.7 1.7 1.5 0.8 1.9 5.7 1.1 1.0 1.3 0.2 1.9 2.5 3.1 0.5 1.3 3.9 5.1 4.7 4.5 2.8 2.9 3.0 3.2 4.7 3.9 8.9 5.3 6.4 25.1 27.7 18.9 5.4 2.5 5.3 4.5 5.2 237.6 17.0 0.0 5.8 13.0 6.7 7.3 0.0 6.1 5.6 8.1 23.5 5.7 4.4 3.5 27.0 8.6 4.3 3.1 4.5 9.8 7.9 1.7 9.0 4.6 7.8 7.6 4.3 15.2 0.8 17.3 0.0 14.4 16.6 34.1 26.0 18.8 5.3 5.2 31.0 B3GALT1 beta3Gal-T1 ENSG00000172318 "Beta-1,3-galactosyltransferase 1" Q9Y5Z6 2 167868948-167874041 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1" "Cell type enhanced" "Detected in some" 9 "Enterocytes: 3.1;Mucus-secreting cells: 4.2;Undifferentiated cells: 5.2" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "AN3-CA: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.98e-2)" "unprognostic (4.34e-2)" "unprognostic (1.12e-2)" "unprognostic (7.22e-2)" "unprognostic (1.67e-1)" "unprognostic (4.23e-3)" "unprognostic (2.49e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.94e-2)" "unprognostic (8.72e-2)" "unprognostic (6.44e-2)" "unprognostic (2.30e-3)" "unprognostic (8.34e-2)" "unprognostic (1.98e-2)" "unprognostic (1.44e-1)" "unprognostic (3.79e-1)" 0.1 0.6 0.5 0.0 1.6 0.0 0.3 0.9 5.1 0.2 5.6 0.0 0.2 0.3 0.0 0.8 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.8 0.0 0.1 5.8 0.1 0.9 7.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 1.4 0.8 2.0 0.5 1.0 2.4 0.4 0.0 0.0 2.2 28.6 0.2 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 1.0 0.0 0.1 0.0 0.4 0.0 1.9 0.3 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.6 0.0 0.5 0.0 2.6 2.0 0.5 0.3 0.6 0.3 0.7 1.1 0.7 0.7 0.2 1.4 2.4 1.3 1.5 1.0 0.3 0.8 0.6 0.4 0.0 2.2 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 3.1 0.0 0.2 0.0 0.2 0.1 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 4.2 1.9 0.0 0.0 1.4 0.2 1.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 5.2 0.0 B3GALT2 beta3Gal-T2 ENSG00000162630 "Beta-1,3-galactosyltransferase 2" O43825 1 193179045-193186654 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;gallbladder: 19.0;heart muscle: 25.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 47.7;Cardiomyocytes: 27.8;Cholangiocytes: 15.3;Leydig cells: 29.4;Peritubular cells: 19.8" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 11.9" "Lineage enriched" "Detected in single" 57 "T-cells: 11.9" "Group enriched" "Detected in some" 4 "AF22: 16.4;ASC TERT1: 7.5;LHCN-M2: 11.1;WM-115: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078659 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA078659: AB_2686887" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (1.91e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (1.58e-3)" "unprognostic (2.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.63e-1)" "unprognostic (2.44e-1)" "unprognostic (6.14e-4)" "unprognostic (4.41e-2)" "unprognostic (8.10e-3)" "unprognostic (2.72e-1)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (4.56e-3)" 0.7 2.0 11.3 1.3 8.9 0.7 0.9 1.4 32.9 0.8 1.7 1.2 0.9 1.6 0.6 1.8 1.2 0.7 19.0 25.1 10.1 7.9 1.7 0.8 2.6 0.7 5.7 19.1 13.8 0.8 0.4 0.9 0.9 5.0 6.5 2.0 0.3 0.5 7.1 0.6 0.7 4.1 0.8 6.5 1.4 2.1 1.4 4.7 0.0 1.8 0.0 1.6 2.0 0.7 0.0 0.2 0.1 0.0 0.0 11.9 0.3 0.0 0.0 16.4 0.0 0.4 7.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.2 0.0 11.9 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.3 0.3 11.3 8.9 1.4 32.9 10.1 7.9 5.7 19.1 5.0 4.7 0.0 0.3 0.0 0.0 0.2 47.7 27.8 15.3 4.0 0.0 1.8 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.3 2.3 0.0 0.2 7.9 2.9 1.3 0.3 0.0 29.4 0.1 0.0 0.0 0.3 1.7 0.4 0.0 19.8 0.0 5.8 0.0 0.4 0.0 0.0 0.3 0.0 5.1 0.4 0.0 B3GALT5 "B3GalT-V, B3T5, beta3Gal-T5, GLCT5" ENSG00000183778 "Beta-1,3-galactosyltransferase 5" Q9Y2C3 21 39556442-39673137 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8" "Group enriched" "Detected in many" 5 "Enterocytes: 85.3;Intestinal endocrine cells: 27.7;Mucus-secreting cells: 45.4;Paneth cells: 85.2;Undifferentiated cells: 35.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "basal ganglia: 15.8" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.6;RPTEC TERT1: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054092, HPA054684" Approved "Intracellular and membrane" NA NA "HPA054092: AB_2682375, HPA054684: AB_2682573" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "prognostic favorable (6.36e-4)" "unprognostic (9.23e-2)" "unprognostic (4.62e-2)" "unprognostic (4.06e-2)" "unprognostic (2.04e-1)" "unprognostic (2.48e-1)" "unprognostic (3.25e-2)" "unprognostic (7.86e-3)" "unprognostic (1.67e-1)" "unprognostic (6.09e-4)" "unprognostic (1.12e-1)" "unprognostic (2.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" 0.1 0.3 0.5 3.1 15.8 0.1 1.8 0.3 1.5 3.0 16.2 0.6 0.0 19.4 1.4 1.6 2.3 1.0 12.9 0.2 1.3 1.5 0.6 0.3 0.2 0.1 0.7 0.1 0.7 6.2 0.1 7.9 0.7 2.2 1.0 27.1 2.2 5.5 0.1 0.2 1.1 23.4 0.7 2.0 0.2 3.8 0.6 3.6 1.8 1.1 0.8 14.8 1.1 5.9 0.2 0.2 1.0 0.2 0.3 0.2 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.1 0.5 0.0 2.1 0.1 22.0 1.4 3.7 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.6 0.1 0.8 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 0.3 0.0 0.2 0.0 0.0 0.5 15.8 0.3 1.5 1.3 1.5 0.7 0.1 2.2 3.6 0.0 0.0 0.0 0.2 0.0 6.7 1.7 10.2 1.4 7.9 5.2 0.0 0.0 0.0 6.5 0.3 0.0 85.3 0.0 4.1 0.0 0.0 0.4 4.6 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.6 0.0 0.0 0.0 45.4 1.4 6.0 85.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 35.9 6.7 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134411918 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 76.0" "Cell type enhanced" "Detected in some" 30 "Bipolar cells: 34.2;Horizontal cells: 22.3;Muller glia cells: 119.7" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.8;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AF22: 17.4;HMC-1: 19.3;NTERA-2: 16.7;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468, HPA074314" Enhanced Enhanced Vesicles "Secreted in brain" NA NA Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 1.5 5.8 38.9 1.7 23.7 2.1 5.6 9.2 76.0 1.7 1.5 25.8 0.0 1.8 1.6 1.7 1.4 1.6 1.7 1.5 43.4 14.9 2.1 6.0 1.8 3.3 30.3 19.5 1.5 1.7 1.4 0.9 1.4 19.7 4.2 1.5 2.1 2.2 1.8 1.4 1.8 1.6 1.5 45.1 2.1 6.0 1.8 25.2 0.0 7.7 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 17.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 3.0 0.0 0.7 0.9 1.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 16.7 0.8 0.0 0.3 0.0 1.2 0.0 0.1 2.3 6.4 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.8 1.9 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.4 38.9 23.7 9.2 33.7 43.4 14.9 30.3 19.5 19.7 25.2 0.0 0.0 0.0 0.0 0.0 34.2 1.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.9 0.1 22.3 1.7 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 119.7 0.0 0.0 0.4 2.3 6.3 0.0 0.0 0.2 0.1 0.0 0.1 3.2 0.0 0.1 B3GAT2 GlcAT-S ENSG00000112309 "Beta-1,3-glucuronyltransferase 2" Q9NPZ5 6 70856679-70957038 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 27.2" "Cell type enriched" "Detected in many" 9 "Horizontal cells: 301.9" "Group enriched" "Detected in some" 20 "glioma: 4.7;testis cancer: 1.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 20 "SCLC-21H: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012059 Uncertain NA NA "HPA012059: AB_2061050" "unprognostic (7.10e-3)" "unprognostic (7.81e-2)" "unprognostic (1.63e-1)" "unprognostic (1.10e-3)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.96e-2)" "unprognostic (4.88e-2)" "unprognostic (4.22e-2)" "unprognostic (9.16e-4)" "unprognostic (8.09e-2)" "unprognostic (7.43e-3)" "unprognostic (6.88e-7)" "unprognostic (2.72e-2)" "unprognostic (3.35e-2)" "unprognostic (2.53e-2)" "unprognostic (3.45e-3)" 1.8 1.5 9.5 1.9 7.8 1.6 1.1 3.2 27.2 0.8 1.1 26.2 0.0 2.3 1.4 1.1 1.4 1.1 1.4 1.5 19.2 11.5 1.0 1.3 1.2 2.0 9.7 13.6 1.1 2.2 0.8 0.5 1.2 21.0 1.3 0.9 0.4 1.5 0.9 1.5 1.9 2.4 1.1 17.3 2.0 1.5 2.9 16.3 0.0 1.5 0.0 0.9 1.3 0.9 1.2 1.0 2.0 1.2 1.1 2.2 0.2 0.3 0.0 0.6 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.1 0.1 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.5 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.2 0.3 0.2 0.0 0.2 22.7 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 1.3 1.2 1.2 1.0 1.0 0.9 1.0 1.5 2.1 0.4 1.2 1.7 1.8 2.0 1.1 1.1 1.0 2.2 0.2 9.5 7.8 3.2 11.2 19.2 11.5 9.7 13.6 21.0 16.3 0.0 2.1 16.6 7.9 22.7 12.4 0.8 7.6 0.0 0.0 15.7 21.6 5.1 0.0 5.0 6.6 7.5 11.0 0.0 3.3 2.8 10.3 14.9 0.0 7.7 7.0 301.9 0.0 3.7 5.3 4.0 18.4 11.1 13.5 11.8 4.1 17.1 7.1 7.0 12.7 0.5 21.5 12.9 8.2 17.4 32.2 17.3 5.9 13.1 3.8 9.9 B3GNT3 "B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3" ENSG00000179913 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3" Q9Y2A9 19 17794828-17813082 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 69.9;intestine: 61.6;placenta: 56.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 53.5;Cytotrophoblasts: 51.9;Enterocytes: 58.5;Mucus-secreting cells: 40.2;Paneth cells: 42.5;Syncytiotrophoblasts: 57.1;Urothelial cells: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "A-431: 16.5;BEWO: 16.3;CAPAN-2: 44.2;OE19: 40.5;RT4: 15.8;SK-BR-3: 15.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA024298 Enhanced "Intracellular and membrane" NA NA "HPA024298: AB_1845236" "unprognostic (1.10e-1)" "unprognostic (5.19e-2)" "unprognostic (1.84e-1)" "unprognostic (4.84e-3)" "unprognostic (1.10e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (3.26e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (7.38e-2)" "unprognostic (1.26e-1)" "unprognostic (7.10e-2)" "unprognostic (2.57e-2)" 0.4 0.2 0.2 8.7 0.3 0.0 1.8 0.2 0.3 3.5 25.3 0.0 12.0 16.6 0.4 1.2 15.1 0.6 69.9 0.5 0.2 0.3 11.4 2.5 1.0 1.2 0.2 0.0 0.3 9.1 0.0 0.3 56.0 0.0 4.4 22.4 0.3 24.4 12.8 0.3 2.0 61.6 1.9 0.2 0.3 21.8 0.3 0.0 0.3 0.4 2.6 18.3 10.2 5.4 0.0 0.0 0.0 0.0 0.0 3.2 0.6 16.5 4.4 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.2 44.2 0.0 11.3 0.0 0.0 1.6 0.0 5.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.1 40.5 7.1 0.0 0.0 0.4 9.8 15.8 0.0 0.0 0.0 15.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 2.9 0.5 1.3 0.1 0.0 0.4 53.5 0.0 6.8 15.7 0.0 51.9 1.7 15.2 0.0 0.5 58.5 0.0 24.8 5.9 0.7 7.2 5.7 0.0 5.1 0.0 15.6 0.6 0.0 0.0 0.0 0.0 0.0 1.0 40.2 0.0 23.5 42.5 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 57.1 0.0 20.6 43.1 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203543-122208952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;skin 1: 8.5" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.6;Proximal tubular cells: 6.1;Spermatogonia: 2.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.2;hTCEpi: 9.9;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA055261: AB_2682765" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.7 3.2 7.3 0.8 6.8 4.6 0.8 16.3 9.1 0.5 0.7 0.5 0.0 1.0 0.6 0.7 1.8 1.1 1.1 0.8 4.9 4.0 6.1 0.6 1.1 0.9 1.5 7.3 0.8 0.8 0.8 1.9 0.8 4.0 0.7 0.6 1.0 1.7 0.7 1.1 8.5 1.0 0.6 0.6 1.0 0.7 2.0 0.3 0.0 0.8 0.3 0.8 0.6 0.5 0.8 1.0 0.8 1.7 0.4 1.9 0.4 5.5 1.0 0.4 2.2 0.2 0.1 1.0 0.1 0.0 0.3 0.7 3.5 0.5 0.5 1.0 0.0 0.4 2.0 2.7 2.2 0.2 8.2 2.8 0.2 1.5 0.3 0.6 0.7 1.1 0.7 9.9 0.1 0.5 0.8 0.0 2.0 1.6 0.7 0.2 4.9 0.0 0.7 0.6 0.2 2.0 0.4 0.6 1.0 1.4 0.6 1.4 1.8 1.6 1.0 0.5 0.9 7.6 0.1 0.1 0.5 2.8 0.5 0.3 0.6 5.0 1.2 0.5 0.8 0.3 0.8 0.4 0.2 0.8 0.1 0.4 0.8 1.3 0.2 0.2 0.5 1.9 0.2 0.5 0.4 1.7 1.0 0.6 0.4 7.3 6.8 16.3 8.1 4.9 4.0 1.5 7.3 4.0 0.3 0.0 2.6 0.0 0.7 1.1 0.1 0.4 0.0 1.4 1.2 0.0 0.0 0.4 1.7 1.0 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.4 0.6 0.0 6.1 0.1 0.0 0.2 0.5 2.6 1.3 0.5 0.5 0.3 0.4 B3GNT5 "B3GN-T5, beta3Gn-T5" ENSG00000176597 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5" Q9BYG0 3 183253244-183298504 "Enzymes, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.2" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7" "Region enriched" "Detected in single" 12 "cerebellum: 16.5" "Low region specificity" "Detected in all" HPA017292 Uncertain Approved Nucleoli NA NA Nucleoli "HPA017292: AB_1845237" "unprognostic (2.17e-1)" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (4.83e-3)" "unprognostic (1.89e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (7.10e-3)" "unprognostic (7.78e-2)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.23e-6)" "unprognostic (4.20e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.18e-2)" "unprognostic (2.71e-1)" "unprognostic (3.53e-2)" "unprognostic (8.10e-3)" 8.6 1.4 2.2 6.1 2.3 31.6 4.3 1.2 2.5 6.4 29.8 5.4 2.1 17.5 3.2 5.4 23.5 5.4 10.1 3.3 3.0 2.9 3.5 3.0 11.2 5.1 4.0 0.7 4.2 3.5 1.8 5.1 19.8 4.5 3.9 9.2 3.2 8.7 2.5 6.6 8.0 80.2 2.9 6.3 2.3 5.1 2.9 2.3 1.0 4.6 18.9 8.9 5.0 10.6 0.1 1.1 9.0 1.5 0.0 0.3 0.4 16.1 1.5 8.7 5.3 7.3 21.6 7.9 0.2 0.4 1.7 1.4 3.2 8.5 0.0 1.0 0.0 30.4 7.4 8.9 25.2 1.4 0.0 5.5 0.8 0.7 0.0 9.3 8.1 4.0 10.1 30.7 1.3 23.0 2.3 15.7 0.0 9.2 0.0 13.8 0.0 0.0 2.6 3.6 9.5 14.0 2.5 4.4 0.0 5.3 4.5 0.4 8.3 4.5 0.0 1.9 4.1 0.0 9.9 23.1 0.4 3.4 0.5 3.9 0.0 0.0 0.0 3.3 19.2 8.6 0.0 1.5 1.5 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 0.4 2.2 2.3 1.2 2.5 3.0 2.9 4.0 0.7 4.5 2.3 6.0 17.4 0.0 55.5 57.9 7.1 2.0 12.7 101.7 27.3 5.2 21.6 24.4 1.7 15.7 9.9 10.0 77.7 0.0 10.5 9.4 7.4 42.6 13.9 0.4 25.3 3.2 36.7 3.1 9.7 19.2 1.4 50.1 11.8 11.8 73.1 3.2 25.3 42.1 0.4 4.3 12.7 0.0 3.4 0.9 0.4 74.2 132.0 0.7 26.9 125.2 B3GNT6 B3Gn-T6 ENSG00000198488 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6" Q6ZMB0 11 77034398-77041973 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9" "Cell type enriched" "Detected in some" 38 "Mucus-secreting cells: 60.5" "Group enriched" "Detected in some" 14 "colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.3;neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 2.0;RPMI-8226: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA039805 Enhanced "Intracellular and membrane" NA NA "HPA039805: AB_2676690" "unprognostic (1.71e-1)" "prognostic favorable (2.31e-4)" "unprognostic (4.79e-2)" "unprognostic (5.42e-2)" "unprognostic (7.64e-2)" "unprognostic (1.95e-1)" "unprognostic (2.72e-1)" "unprognostic (1.23e-2)" "unprognostic (7.77e-2)" "unprognostic (2.19e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-1)" 0.2 0.2 0.3 6.6 0.4 0.0 0.2 0.3 0.4 0.5 15.8 0.0 0.0 3.7 0.2 0.0 2.5 0.2 0.9 0.2 0.3 0.3 0.2 0.2 1.4 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 12.4 0.0 1.6 0.0 0.2 0.2 9.4 0.0 0.2 0.2 17.9 0.6 0.0 0.0 0.2 3.4 17.5 0.2 0.3 0.4 0.3 2.3 0.2 0.8 0.5 0.2 0.1 0.0 0.5 0.5 0.0 0.2 0.2 0.1 0.2 0.5 0.1 1.2 0.2 0.7 0.3 0.0 0.5 0.0 0.1 0.6 0.1 0.4 0.2 0.2 0.1 0.2 0.0 0.6 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 2.0 0.2 0.5 0.7 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.1 0.3 0.4 0.5 0.3 0.1 0.2 0.2 2.3 0.2 0.3 0.4 0.2 0.5 0.2 0.2 0.2 0.0 0.4 0.3 0.3 2.2 0.8 0.0 0.3 0.1 0.2 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 B3GNT7 beta3GnT7 ENSG00000156966 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7" Q8NFL0 2 231395543-231401164 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.7;intestine: 41.2" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 99.1;Mucus-secreting cells: 119.1;Undifferentiated cells: 275.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 19.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.0;HEL: 11.8;THP-1: 10.5;WM-115: 18.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013881, HPA035625, HPA035626" Enhanced Approved "Golgi apparatus,Mitotic spindle,Cytosol" "Intracellular and membrane" NA NA 2100000 "Golgi apparatus" "Mitotic spindle, Cytosol" "HPA013881: , HPA035625: AB_10601118, HPA035626: AB_2674707" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (4.57e-3)" "unprognostic (1.46e-2)" "unprognostic (1.28e-2)" "unprognostic (2.69e-1)" "unprognostic (1.36e-1)" "unprognostic (2.31e-2)" "unprognostic (6.18e-2)" "unprognostic (5.82e-2)" "unprognostic (2.17e-2)" "unprognostic (7.77e-2)" "unprognostic (4.27e-3)" "unprognostic (6.96e-2)" "unprognostic (1.18e-1)" "prognostic favorable (6.00e-4)" "unprognostic (3.57e-1)" 3.0 10.3 5.3 2.3 4.9 5.5 1.9 0.9 3.2 1.2 28.0 3.8 0.8 12.2 1.6 3.5 1.9 3.6 93.7 26.8 4.2 4.4 1.4 1.3 17.7 1.8 4.0 2.0 13.0 18.9 6.7 8.9 10.7 3.2 1.6 35.5 2.0 4.0 2.3 0.4 2.4 41.2 1.1 1.9 6.7 17.1 1.6 2.2 1.2 4.2 1.7 3.9 1.2 0.6 7.1 4.2 0.4 0.3 19.9 2.0 0.5 0.5 2.1 0.2 0.4 0.1 0.2 0.8 0.2 0.8 0.1 0.1 1.0 15.0 1.7 4.6 0.2 0.1 3.9 0.2 0.0 0.1 0.2 0.4 11.8 0.3 0.7 0.1 0.1 0.6 0.1 1.1 0.1 0.2 0.8 0.2 0.3 0.3 0.3 0.1 0.6 0.1 0.5 4.9 5.8 2.6 0.2 0.0 0.2 0.5 1.3 0.4 0.6 0.2 1.3 0.5 5.7 0.5 10.5 0.2 0.3 0.3 0.2 0.1 1.8 0.6 0.5 0.3 0.1 18.2 0.3 0.0 0.4 2.0 0.3 0.4 7.1 0.0 0.2 4.2 5.1 0.1 0.5 0.1 19.9 0.3 2.1 0.1 0.5 5.3 4.9 0.9 3.2 4.2 4.4 4.0 2.0 3.2 2.2 38.7 24.6 2.2 1.2 2.1 0.2 0.8 84.1 75.0 33.0 1.8 2.0 0.4 0.0 13.5 0.3 0.7 75.7 0.0 73.7 52.0 2.2 11.2 9.2 0.0 9.0 0.0 99.1 3.7 7.0 0.9 1.4 13.6 3.3 4.6 119.1 0.5 58.2 46.0 7.8 0.1 1.6 0.0 1.4 0.7 1.3 2.4 1.7 6.9 275.6 13.2 B3GNT8 "B3GALT7, beta3Gn-T8, BGALT15" ENSG00000177191 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8" Q7Z7M8 19 41425359-41428730 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.3;esophagus: 21.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 39.9;Collecting duct cells: 22.7;Enterocytes: 42.4;Paneth cells: 46.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 29.9;neutrophil: 43.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 43.3" "Cell line enhanced" "Detected in some" "HMC-1: 10.0;HUVEC TERT2: 5.4;K-562: 4.4;THP-1: 5.0;U-937: 8.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043669 Enhanced "Intracellular and membrane" NA NA 43000000 "HPA043669: AB_2678608" "unprognostic (6.89e-2)" "unprognostic (2.46e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (6.44e-3)" "unprognostic (6.51e-3)" "unprognostic (1.84e-2)" "unprognostic (9.92e-3)" "unprognostic (7.30e-2)" "unprognostic (2.56e-2)" "prognostic favorable (9.31e-6)" "unprognostic (5.04e-2)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" 0.7 0.2 0.0 0.9 0.0 2.7 0.7 0.0 0.0 5.0 7.3 13.0 0.9 0.0 21.5 0.4 0.0 1.9 0.0 0.0 1.5 0.0 4.6 0.1 0.0 0.0 0.6 0.0 0.6 0.1 1.3 2.0 2.8 2.2 0.1 2.2 12.5 0.3 0.0 4.3 1.0 0.0 0.3 0.9 1.2 8.4 0.0 1.6 43.3 6.7 0.4 8.1 1.7 0.3 0.0 0.3 0.1 0.5 2.2 0.5 0.6 0.2 0.0 0.1 3.1 0.0 0.1 0.8 1.5 0.0 2.1 0.0 0.5 0.0 0.1 0.4 0.0 0.1 1.6 0.8 0.7 10.0 2.7 1.9 0.1 0.1 0.0 5.4 0.2 4.4 0.3 0.0 0.8 0.0 2.9 0.7 0.0 0.1 0.2 0.6 0.0 0.2 1.1 1.4 0.9 0.0 0.2 0.0 0.3 0.0 5.0 1.9 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 8.1 0.0 21.7 4.3 29.9 0.7 3.3 8.1 0.0 0.3 1.5 1.6 0.0 0.0 0.1 43.3 0.4 6.7 0.1 0.1 1.7 6.0 39.9 0.0 4.4 1.5 0.2 0.4 0.0 1.4 1.2 22.7 0.0 0.5 3.3 4.6 0.0 1.0 42.4 0.0 0.6 1.9 2.3 5.7 4.7 0.0 10.9 0.0 14.5 1.8 9.1 0.0 1.4 3.2 0.0 1.8 19.3 0.0 2.2 46.0 0.7 0.0 0.2 0.0 1.4 0.0 0.0 1.5 1.9 1.3 13.6 11.3 B4GALNT1 "beta1-4GalNAc-T, GALGT, SPG26" ENSG00000135454 "Beta-1,4-N-acetyl-galactosaminyltransferase 1" Q00973 12 57623410-57633355 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 8.1;Horizontal cells: 20.6;Sertoli cells: 6.5;Smooth muscle cells: 6.6" "Cancer enriched" "Detected in many" 6 "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Lineage enhanced" "Detected in single" "T-cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 22.0;HDLM-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008968 Enhanced "Intracellular and membrane" NA NA 9500 "HPA008968: AB_1078253" "unprognostic (3.18e-1)" "unprognostic (8.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.33e-3)" "unprognostic (2.54e-1)" "unprognostic (2.70e-3)" "unprognostic (3.73e-5)" "unprognostic (1.26e-2)" "unprognostic (1.72e-1)" "unprognostic (2.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.18e-14)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (1.44e-2)" "unprognostic (4.92e-4)" 3.0 2.1 12.9 2.3 16.4 1.0 1.5 26.5 32.4 1.9 2.4 1.0 0.0 1.4 2.2 3.8 1.3 1.4 1.5 3.9 15.3 11.2 1.3 1.3 1.7 1.6 6.5 14.3 1.0 1.2 1.1 1.0 1.3 11.6 4.2 2.2 1.6 3.2 6.8 8.1 1.6 1.9 3.2 2.3 1.3 1.4 1.6 2.3 0.0 1.3 0.6 1.8 1.5 0.9 0.0 0.0 0.0 0.0 0.8 1.9 0.0 2.8 14.7 3.2 5.7 0.2 0.0 0.0 1.4 3.0 6.0 6.4 0.9 7.7 0.8 22.0 4.1 13.6 1.4 2.5 1.1 2.0 18.7 0.9 0.2 3.7 4.8 0.2 0.7 1.4 0.0 0.4 3.6 0.2 2.4 0.1 3.3 2.3 4.6 1.0 3.8 0.6 0.0 3.8 0.3 2.9 0.0 4.4 2.3 0.0 0.0 12.3 3.1 0.8 0.4 0.1 0.2 2.7 1.0 0.0 3.6 8.3 6.9 9.1 11.5 8.6 0.8 8.1 0.9 9.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.9 16.4 26.5 25.9 15.3 11.2 6.5 14.3 11.6 2.3 0.0 0.0 0.0 0.0 0.3 8.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.2 0.2 1.1 0.1 0.0 0.0 0.1 20.6 0.0 0.0 0.0 0.4 2.6 0.0 3.3 4.6 0.0 0.8 0.6 0.0 2.8 0.0 1.9 6.5 6.6 0.3 0.9 0.0 0.0 0.0 0.0 0.1 B4GALNT2 "Cad, GALGT2, Sda" ENSG00000167080 "Beta-1,4-N-acetyl-galactosaminyltransferase 2" Q8NHY0 17 49132460-49176840 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.6;lymphoid tissue: 30.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 5.2;Enterocytes: 5.1;Mucus-secreting cells: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA015721 Approved NA NA "HPA015721: AB_1845245" "unprognostic (4.39e-4)" "unprognostic (3.18e-1)" "unprognostic (8.26e-3)" "unprognostic (2.03e-4)" "unprognostic (1.72e-2)" "unprognostic (2.62e-2)" "unprognostic (3.67e-2)" "unprognostic (7.67e-2)" "unprognostic (4.06e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-1)" "prognostic favorable (1.29e-5)" "unprognostic (3.53e-1)" "unprognostic (1.31e-1)" "unprognostic (7.81e-3)" "unprognostic (2.15e-1)" 0.3 0.8 0.4 30.9 0.5 2.2 0.4 0.3 0.5 0.3 19.6 0.3 0.3 0.7 0.3 0.3 0.5 0.4 4.0 0.3 0.3 0.3 8.3 0.3 1.1 0.8 0.3 0.3 0.3 0.5 0.0 0.4 0.7 0.6 0.3 7.9 0.4 1.7 0.3 0.3 1.8 11.9 1.3 1.1 0.8 5.3 0.7 0.3 0.3 10.3 0.3 0.8 0.3 1.4 2.0 1.2 2.3 0.6 0.6 1.6 0.2 1.5 3.0 2.9 5.2 0.1 0.1 1.5 2.2 1.6 0.1 0.2 6.1 2.4 3.6 3.6 0.1 1.1 1.7 1.1 0.1 0.4 3.1 3.2 3.9 7.3 3.6 0.1 1.9 6.2 0.3 2.1 0.6 0.3 1.3 0.0 2.8 2.2 5.9 0.1 1.8 2.5 2.7 3.6 0.5 1.5 4.2 1.3 1.1 8.4 2.4 2.7 2.6 1.0 1.4 1.2 3.2 3.2 2.6 1.2 3.7 2.3 2.4 1.2 4.5 1.4 3.8 1.3 2.6 1.6 2.3 0.6 0.9 1.1 0.5 0.6 1.3 1.2 0.8 0.5 2.0 1.6 1.5 1.2 0.6 0.3 1.2 0.6 0.2 0.4 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.3 0.0 1.0 0.0 0.0 0.3 0.0 0.4 0.0 1.4 1.2 5.2 0.0 0.0 1.7 0.4 0.5 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 B4GALNT3 "B4GalNac-T3, FLJ16224, FLJ40362" ENSG00000139044 "Beta-1,4-N-acetyl-galactosaminyltransferase 3" Q6L9W6 12 460364-563509 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 43.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 46.6;Late spermatids: 64.3;Paneth cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 26.2;HDLM-2: 9.2;HEK 293: 9.2;NTERA-2: 11.6;U-937: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011404 Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus" Vesicles "HPA011404: AB_1845242" "unprognostic (2.38e-2)" "unprognostic (9.59e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.69e-10)" "unprognostic (4.22e-2)" "unprognostic (4.63e-2)" "unprognostic (1.46e-2)" "unprognostic (9.53e-3)" "unprognostic (3.29e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (9.99e-3)" "unprognostic (2.82e-1)" "unprognostic (2.48e-2)" "unprognostic (2.98e-1)" 0.3 5.7 1.4 2.1 3.8 1.5 1.1 0.3 8.2 6.1 12.8 0.6 0.4 0.8 8.5 2.9 6.0 3.4 9.6 16.8 5.6 0.9 4.1 0.3 6.2 0.2 0.9 1.7 2.1 7.9 2.5 14.7 0.1 2.0 1.6 9.8 1.5 3.8 1.1 2.7 11.0 1.7 1.9 0.5 0.4 43.1 8.0 0.1 1.0 2.1 9.1 4.1 1.8 4.0 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 26.2 0.0 0.0 0.0 0.0 6.5 5.0 0.0 0.7 0.0 0.5 2.9 6.5 0.7 0.0 9.2 9.2 0.0 0.0 1.3 0.0 0.1 3.9 0.0 4.6 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 7.9 0.5 0.4 3.6 0.0 6.3 5.5 3.1 2.0 0.6 0.2 0.7 4.2 0.6 2.0 0.0 0.0 2.0 0.2 0.6 0.0 0.1 0.1 0.0 11.3 4.4 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 3.8 0.3 8.2 5.6 0.9 0.9 1.7 2.0 0.1 0.0 6.5 0.0 4.8 6.6 0.0 11.8 2.5 6.7 5.7 8.7 0.0 0.0 0.0 8.9 25.7 0.0 46.6 0.0 4.2 0.1 0.6 8.9 0.0 0.0 0.6 0.0 9.9 0.0 0.0 64.3 0.0 0.0 0.0 1.0 18.8 0.0 12.7 36.2 0.0 0.0 0.0 0.0 0.9 1.9 1.4 15.2 0.0 1.7 20.2 13.6 B4GALNT4 "FLJ25045, NGalNAc-T1" ENSG00000182272 "Beta-1,4-N-acetyl-galactosaminyltransferase 4" Q76KP1 11 369796-382116 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1;ovary: 18.6" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 17.5;Cardiomyocytes: 11.2;Horizontal cells: 31.8;Muller glia cells: 40.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.2;NTERA-2: 18.0;SCLC-21H: 22.4;SH-SY5Y: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043276, HPA053126" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol "Intracellular and membrane" NA No "Nucleoplasm, Cytosol" Vesicles "HPA043276: , HPA053126: AB_2682049" "unprognostic (6.11e-2)" "unprognostic (7.82e-2)" "unprognostic (1.79e-1)" "unprognostic (6.92e-3)" "unprognostic (5.36e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.69e-3)" "unprognostic (4.99e-3)" "unprognostic (1.52e-10)" "unprognostic (9.01e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-4)" "unprognostic (1.25e-1)" 1.6 2.5 20.6 2.8 16.7 1.2 3.5 26.5 35.1 5.9 2.0 8.6 0.8 2.4 8.6 2.4 1.8 8.7 2.1 1.4 17.6 16.8 1.2 1.1 1.3 1.6 11.5 14.9 18.6 1.8 6.3 6.1 1.1 13.0 3.8 1.6 2.3 4.0 3.7 1.1 3.8 2.9 3.1 8.3 1.5 1.5 1.8 11.0 0.0 1.1 0.0 1.7 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.6 20.2 11.5 0.0 0.0 4.7 3.6 0.9 1.6 0.5 2.0 0.0 0.0 2.7 0.4 3.2 0.7 2.7 4.8 0.5 0.0 6.8 0.0 6.4 6.2 0.2 0.0 4.9 0.4 2.9 0.1 2.2 7.3 0.2 1.0 6.1 0.0 0.0 5.9 0.2 0.0 18.0 0.3 7.9 0.0 0.0 2.6 0.2 0.0 22.4 27.3 1.3 1.0 0.2 2.2 7.9 0.0 4.9 1.1 6.4 1.9 0.2 0.0 0.9 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.6 16.7 26.5 21.2 17.6 16.8 11.5 14.9 13.0 11.0 0.0 0.0 0.0 1.3 0.7 17.5 11.2 0.0 0.0 0.0 1.8 3.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 31.8 1.7 0.0 0.0 0.0 2.8 0.0 3.3 0.0 0.0 40.9 0.3 0.0 1.1 0.0 8.1 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.0 0.4 B4GALT6 beta4GalT-VI ENSG00000118276 "Beta-1,4-galactosyltransferase 6" Q9UBX8 18 31622247-31685836 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Group enriched" "Detected in many" 4 "Bipolar cells: 67.0;Cone photoreceptor cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Group enriched" "Detected in many" 5 "NK-cells: 3.8;T-cells: 1.1" "Cell line enhanced" "Detected in many" "WM-115: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020701, HPA058284" Approved "Intracellular and membrane" NA NA "CAB020701: , HPA058284: AB_2683668" "unprognostic (3.79e-1)" "unprognostic (4.52e-1)" "unprognostic (6.54e-3)" "unprognostic (2.23e-4)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.31e-2)" "unprognostic (4.50e-2)" "unprognostic (5.18e-1)" "unprognostic (1.13e-1)" "prognostic favorable (5.65e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.40e-5)" "unprognostic (5.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (4.00e-1)" 3.6 13.8 7.8 2.8 16.0 4.4 2.1 20.6 22.3 2.2 3.5 2.6 0.0 7.7 2.5 2.2 4.8 2.5 7.2 3.8 10.7 7.9 3.7 2.7 1.8 1.2 6.1 10.0 4.3 2.1 7.3 14.8 2.7 16.3 5.8 3.6 13.2 4.6 4.4 3.3 2.2 9.7 1.7 3.1 1.5 3.4 5.4 2.3 5.0 2.1 1.5 1.0 3.6 2.1 0.0 0.5 0.0 0.4 3.8 1.1 0.3 2.3 5.4 9.7 5.4 0.1 0.2 3.6 0.7 0.0 0.1 0.0 10.0 2.0 3.7 4.5 0.9 11.7 0.9 5.1 4.3 0.6 14.5 4.5 4.8 0.5 0.2 1.1 8.8 0.8 1.0 0.9 1.4 3.1 4.9 5.3 8.8 0.7 0.0 0.0 1.4 9.8 0.6 4.2 2.8 2.9 18.4 1.7 0.0 1.1 4.9 5.1 8.1 3.5 0.6 6.3 8.2 0.6 2.7 5.3 11.0 2.3 0.0 5.9 3.6 0.2 7.6 4.5 8.0 51.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.9 0.5 0.0 0.0 1.1 0.0 3.8 0.4 0.0 0.0 0.3 7.8 16.0 20.6 22.3 10.7 7.9 6.1 10.0 16.3 2.3 0.0 0.3 0.0 0.7 4.8 67.0 6.7 0.0 0.0 1.2 1.8 37.3 0.4 3.3 1.3 3.6 2.3 3.1 0.0 1.0 0.2 1.7 1.5 0.0 1.7 0.6 12.7 2.9 3.7 0.8 3.3 1.1 0.0 0.0 0.0 2.6 3.3 1.7 2.5 2.5 1.1 4.7 0.0 0.9 0.5 10.2 1.5 0.2 0.5 2.9 0.6 B4GAT1 "B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT" ENSG00000174684 "Beta-1,4-glucuronyltransferase 1" O43505 11 66345372-66347692 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 71.1;Horizontal cells: 149.4;Muller glia cells: 83.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015484 Uncertain "Intracellular and membrane" NA NA 48000000 "HPA015484: AB_1845235" "unprognostic (1.80e-1)" "unprognostic (7.20e-2)" "unprognostic (1.70e-1)" "unprognostic (3.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.45e-1)" "unprognostic (9.23e-2)" "unprognostic (1.59e-1)" "unprognostic (2.65e-2)" "unprognostic (3.43e-3)" "prognostic favorable (3.55e-5)" "unprognostic (2.20e-1)" "unprognostic (3.50e-1)" "unprognostic (1.23e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-1)" "unprognostic (2.76e-3)" 8.3 24.8 29.3 3.6 47.1 1.0 5.4 28.5 69.5 7.8 6.5 11.8 4.2 9.5 10.0 9.5 5.2 10.5 6.0 19.6 33.3 57.9 15.0 9.7 9.7 3.7 24.7 32.0 18.9 12.8 11.9 15.6 12.9 31.0 10.2 4.9 10.1 9.1 14.2 12.9 5.8 7.2 8.5 13.2 5.1 7.7 4.4 11.6 1.1 10.7 1.7 2.8 5.5 4.1 5.6 6.8 0.4 1.1 3.9 9.7 4.2 4.0 10.2 11.7 14.2 13.1 11.9 15.5 7.1 16.5 11.1 9.1 7.6 5.8 3.3 30.2 6.5 9.5 6.5 12.4 7.9 5.4 6.6 22.6 0.5 8.4 29.1 7.8 2.6 1.0 11.5 6.1 6.9 2.9 36.8 13.0 5.7 3.1 5.3 5.2 6.8 6.2 7.2 7.9 4.0 10.9 9.0 9.1 5.9 11.5 1.0 7.0 13.3 6.1 4.1 27.5 7.6 16.6 2.6 7.5 8.7 6.4 11.0 3.6 10.3 7.1 1.9 14.7 2.2 10.1 0.0 1.1 0.0 7.1 0.4 9.7 5.6 7.8 7.6 2.8 3.5 9.2 8.4 0.4 3.9 0.2 6.8 5.3 4.2 29.3 47.1 28.5 59.9 33.3 57.9 24.7 32.0 31.0 11.6 20.8 9.6 6.9 1.2 0.0 71.1 36.7 28.1 5.3 3.4 19.2 55.0 47.1 5.0 5.9 0.3 19.1 8.1 0.0 5.3 19.6 10.0 1.2 1.1 22.2 11.1 149.4 4.7 22.7 2.4 0.9 30.2 0.4 0.0 1.8 9.9 83.3 5.0 3.5 38.2 15.1 37.5 25.8 8.6 1.2 2.6 0.0 15.1 2.2 7.6 0.3 B9D2 "MGC4093, MKS10" ENSG00000123810 "B9 domain containing 2" Q9BPU9 19 41354421-41364173 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.6" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 45.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042229, HPA042618" Enhanced NA NA "HPA042229: AB_10959591, HPA042618: AB_10960695" "unprognostic (9.25e-2)" "unprognostic (1.82e-3)" "unprognostic (1.66e-1)" "unprognostic (9.68e-3)" "unprognostic (1.23e-1)" "unprognostic (2.19e-3)" "unprognostic (1.04e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (2.58e-1)" "unprognostic (8.22e-3)" "unprognostic (4.50e-1)" "unprognostic (1.62e-2)" "unprognostic (1.13e-1)" "unprognostic (1.35e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-3)" 4.7 9.5 6.5 7.8 9.7 14.2 5.2 2.8 7.6 6.4 6.3 3.5 11.1 6.4 7.6 10.9 4.5 20.5 11.1 4.8 5.8 7.1 9.5 5.8 11.2 12.2 4.5 3.7 4.3 7.6 2.5 6.6 6.8 8.4 5.9 3.6 2.7 6.6 7.7 2.9 3.7 5.2 5.1 3.3 8.7 6.0 10.1 5.4 13.5 7.6 4.4 5.6 6.2 6.8 5.4 9.4 45.6 12.2 7.2 8.5 6.7 6.2 20.7 5.2 4.6 1.9 3.0 1.3 4.0 4.4 6.3 4.2 5.5 4.7 1.8 14.2 4.4 2.8 1.7 3.5 5.2 1.5 6.3 5.6 4.7 7.1 4.6 3.9 5.6 11.2 3.5 3.4 5.6 1.5 4.6 6.9 5.7 4.0 5.8 2.9 5.6 5.7 7.8 2.7 2.6 6.4 4.7 1.3 5.5 5.2 3.8 4.5 3.8 7.2 2.7 3.3 1.1 3.5 11.5 10.5 7.7 4.2 4.1 7.6 2.9 2.4 3.4 8.3 6.6 4.6 12.6 12.2 8.8 4.2 6.9 5.2 5.4 7.6 5.5 8.3 3.9 8.0 5.3 45.6 7.2 5.2 9.4 8.5 6.7 6.5 9.7 2.8 7.6 5.8 7.1 4.5 3.7 8.4 5.4 0.0 6.5 14.5 7.8 3.7 1.3 2.0 22.9 69.6 15.9 19.2 7.9 7.3 31.5 14.0 19.1 9.5 13.3 0.0 14.5 11.7 6.6 8.3 11.6 2.9 11.6 0.0 14.9 9.2 8.9 26.7 2.6 7.7 3.3 3.6 11.7 5.8 11.6 37.4 6.0 24.8 5.5 6.5 4.1 15.9 13.2 2.9 5.7 10.9 8.1 9.5 BAALC ENSG00000164929 "BAALC, MAP3K1 and KLF4 binding" Q8WXS3 8 103140710-103230305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 121.3" "Cell type enhanced" "Detected in many" 16 "Ito cells: 27.0;Muller glia cells: 94.5" "Cancer enriched" "Detected in many" 8 "glioma: 139.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "NK-cell: 6.9" "Lineage enriched" "Detected in single" 25 "NK-cells: 6.9" "Cell line enhanced" "Detected in some" "AF22: 24.9;BJ hTERT+: 8.7;SCLC-21H: 13.6;SH-SY5Y: 10.0;U-87 MG: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027132, HPA068307" Approved Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA027132: AB_10600985, HPA068307: AB_2685971" "unprognostic (1.68e-1)" "unprognostic (9.17e-3)" "unprognostic (1.40e-2)" "unprognostic (4.62e-4)" "unprognostic (1.75e-2)" "unprognostic (2.84e-2)" "unprognostic (1.39e-1)" "unprognostic (7.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.99e-2)" "unprognostic (4.17e-2)" "unprognostic (2.18e-2)" "unprognostic (7.58e-2)" "unprognostic (2.51e-3)" "unprognostic (2.76e-2)" "unprognostic (1.70e-1)" "unprognostic (9.27e-3)" 7.8 11.1 42.3 3.2 51.9 3.9 3.0 12.5 121.3 2.8 2.9 18.9 0.0 2.3 3.0 2.0 2.2 4.6 2.9 3.2 38.1 34.5 2.8 3.4 4.9 2.6 48.3 25.1 2.7 2.6 1.9 5.2 5.7 41.4 2.0 2.9 0.0 2.1 2.4 3.0 2.7 2.8 3.1 51.2 8.8 2.4 2.6 24.6 0.0 2.8 0.0 2.2 2.8 0.3 0.2 0.1 0.0 0.0 6.9 0.1 0.4 0.2 1.4 24.9 0.2 0.2 7.4 0.0 1.3 8.7 0.0 0.1 0.2 0.0 0.1 0.2 4.7 0.1 0.4 0.4 0.0 0.0 0.0 1.5 0.2 0.3 0.0 0.6 0.0 0.5 1.5 1.4 0.3 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.1 0.5 0.1 0.1 0.5 0.0 0.0 13.6 10.0 0.3 0.0 0.0 2.3 0.1 0.1 1.4 7.9 0.5 0.2 0.5 0.0 0.1 0.1 37.1 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.0 0.1 0.0 0.4 42.3 51.9 12.5 43.6 38.1 34.5 48.3 25.1 41.4 24.6 0.0 2.6 0.0 0.7 4.8 2.5 0.6 12.7 17.4 1.2 0.0 0.0 0.0 6.6 17.6 3.0 18.8 0.0 0.0 21.5 0.0 2.6 0.4 0.0 0.5 1.0 0.0 17.0 27.0 2.2 5.6 1.4 0.7 13.5 8.2 0.0 94.5 6.5 0.0 0.0 0.0 2.9 0.0 3.0 0.0 0.1 3.4 0.0 1.7 0.0 0.8 BAAT BAT ENSG00000136881 "Bile acid-CoA:amino acid N-acyltransferase" Q14032 9 101360417-101383519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Serine esterase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 128.4" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 745.7" "Cancer enriched" "Detected in many" 42 "liver cancer: 181.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021251, HPA021330" Enhanced Uncertain Vesicles NA NA 470000 Vesicles "HPA021251: AB_1845247, HPA021330: AB_2670674" "unprognostic (2.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.97e-2)" "unprognostic (9.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.68e-2)" "prognostic favorable (4.97e-4)" "unprognostic (2.14e-2)" "unprognostic (6.19e-2)" "unprognostic (4.43e-4)" "unprognostic (3.65e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.24e-7)" "unprognostic (1.74e-1)" "unprognostic (2.12e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.8 0.0 0.1 0.1 0.2 128.4 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.7 0.1 0.1 6.1 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.1 0.3 3.4 0.1 0.6 0.2 0.0 0.3 0.3 0.1 0.2 0.5 0.3 0.1 0.5 0.2 2.4 0.0 0.9 0.3 0.0 1.0 0.1 0.0 0.1 0.0 0.8 0.7 0.4 0.5 0.1 0.2 0.3 1.0 2.6 0.7 0.2 1.1 0.2 0.6 0.2 0.3 0.4 0.4 0.2 0.5 0.2 0.0 0.2 0.1 0.6 0.6 0.2 0.4 0.4 0.6 0.5 0.5 0.2 0.6 0.3 0.2 0.0 0.7 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.8 0.4 89.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 745.7 0.0 0.0 0.0 11.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 BABAM2 "BRCC4, BRCC45, BRE" ENSG00000158019 "BRISC and BRCA1 A complex member 2" Q9NXR7 2 27889941-28338901 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "adrenal gland: 172.1" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 71.3;monocytes: 45.1;Proximal tubular cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017926, HPA048867" Enhanced Supported Cytosol NA NA Cytosol "HPA017926: AB_1845443, HPA048867: " "unprognostic (1.28e-1)" "unprognostic (2.30e-1)" "unprognostic (1.53e-3)" "unprognostic (1.61e-3)" "unprognostic (1.89e-1)" "unprognostic (2.68e-3)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.03e-1)" "unprognostic (2.38e-2)" "unprognostic (8.98e-2)" "unprognostic (2.13e-1)" "unprognostic (6.52e-2)" "unprognostic (4.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.74e-2)" "unprognostic (2.91e-2)" "unprognostic (1.22e-2)" 14.5 172.1 11.7 11.4 19.3 16.9 12.3 9.6 21.3 14.3 11.2 11.3 14.2 8.8 23.2 17.1 12.0 15.5 15.6 25.2 12.5 12.7 25.0 17.1 11.5 18.9 9.9 13.8 16.7 14.5 21.8 23.5 11.6 13.4 11.8 13.1 16.3 10.3 15.6 28.7 11.5 11.1 18.2 9.1 16.7 11.6 26.3 6.7 13.9 11.9 13.6 15.7 14.2 11.8 23.5 39.7 38.6 30.2 24.8 31.7 23.6 14.6 16.1 13.1 13.7 16.9 22.7 12.9 7.4 18.8 14.1 14.6 13.7 15.1 16.6 25.1 17.9 11.3 9.8 10.6 19.4 20.7 14.0 14.0 19.9 7.0 15.2 24.5 10.3 16.2 55.4 17.0 19.6 20.4 17.7 14.9 15.7 10.1 18.3 19.5 12.3 12.0 12.6 9.9 19.3 10.6 11.1 20.8 16.0 40.5 7.7 8.6 13.7 8.7 15.5 14.8 13.9 11.0 13.7 12.0 13.4 17.9 12.3 10.1 20.8 20.2 21.8 24.9 28.4 14.0 38.6 30.2 12.3 28.5 24.0 31.7 23.5 24.2 26.8 39.7 17.9 23.1 22.0 16.0 24.8 23.3 15.8 27.8 23.6 11.7 19.3 9.6 21.3 12.5 12.7 9.9 13.8 13.4 6.7 3.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 16.0 10.3 38.4 0.0 38.1 71.3 42.4 0.0 0.0 0.0 0.0 39.2 30.4 0.0 0.0 29.1 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 45.1 0.0 0.0 21.6 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 53.0;pancreas: 161.1" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 111.9;Early spermatids: 89.1;Late spermatids: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.76e-4)" 6.5 7.1 12.1 3.8 18.8 2.2 5.5 9.6 22.4 9.8 4.6 42.5 2.7 3.4 9.3 5.6 7.6 8.6 9.1 5.9 16.9 12.4 6.8 12.1 7.3 2.8 28.8 15.0 11.4 161.1 12.8 4.2 6.3 26.4 6.5 4.7 6.9 5.3 9.9 6.2 7.2 3.6 11.7 53.0 5.7 4.9 4.1 21.4 0.0 6.3 2.3 2.8 6.7 5.5 4.0 2.2 0.7 3.2 2.2 6.7 1.1 3.9 4.7 9.7 14.8 32.2 34.7 0.4 21.3 18.6 10.4 8.5 3.6 6.3 0.8 5.2 38.6 7.8 6.9 10.3 6.1 8.5 2.3 5.5 2.4 7.9 4.3 15.9 0.8 0.5 30.0 9.6 13.2 12.9 25.7 8.9 1.4 0.8 0.4 19.0 14.3 0.6 1.9 6.3 4.1 10.4 1.8 4.4 0.8 4.4 2.2 12.6 14.1 7.9 1.0 2.3 8.9 10.2 2.7 12.2 18.7 2.0 19.5 6.8 0.3 0.3 0.4 8.8 1.2 13.0 0.6 2.0 0.7 2.0 3.2 5.2 4.0 6.7 5.3 2.2 1.8 3.1 2.7 0.0 2.2 1.3 1.3 6.3 1.1 12.1 18.8 9.6 21.7 16.9 12.4 28.8 15.0 26.4 21.4 17.9 8.5 0.0 3.8 4.1 53.4 8.1 17.8 4.0 20.5 5.2 111.9 0.8 5.0 4.7 89.1 5.2 1.5 0.0 17.3 0.9 11.5 2.8 2.3 31.6 7.9 54.0 20.8 6.7 12.6 222.6 17.8 5.8 3.3 1.8 2.4 16.6 5.8 4.0 20.8 5.4 48.1 6.5 6.6 3.2 1.7 3.0 0.7 1.0 2.7 2.5 BACH2 BTBD25 ENSG00000112182 "BTB domain and CNC homolog 2" Q9BYV9 6 89926529-90296908 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 187.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "naive B-cell: 15.4" "Lineage enriched" "Detected in many" 4 "B-cells: 15.4" "Group enriched" "Detected in some" 6 "Daudi: 52.7;U-698: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051384, HPA058384" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051384: AB_2681462, HPA058384: AB_2683700" "unprognostic (4.00e-3)" "unprognostic (3.17e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-4)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.42e-2)" "unprognostic (8.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (3.12e-3)" "unprognostic (4.22e-1)" "unprognostic (9.87e-3)" "unprognostic (2.10e-2)" "unprognostic (1.83e-1)" "unprognostic (2.03e-1)" "unprognostic (3.87e-4)" 2.9 2.1 5.3 29.8 5.6 18.5 4.1 11.4 6.9 5.4 2.2 6.3 1.0 1.3 6.8 2.1 1.9 3.0 2.3 2.6 5.2 2.9 1.7 5.8 5.8 26.7 5.2 4.0 6.3 4.0 5.8 1.9 2.4 4.9 3.7 1.7 0.9 5.2 2.2 7.9 5.4 6.5 2.8 5.2 7.6 1.8 3.4 6.9 26.9 2.0 2.4 20.6 4.8 3.3 15.4 0.2 1.8 0.0 1.5 3.7 0.4 0.3 0.0 1.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 52.7 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 1.2 0.0 0.0 3.4 2.1 4.6 0.0 0.1 1.0 0.0 0.5 0.0 0.4 7.2 1.3 0.9 0.0 0.1 1.7 4.9 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.5 0.1 30.9 0.2 0.5 0.4 1.8 0.0 0.7 0.4 0.0 0.8 2.1 0.8 0.7 0.2 15.4 3.7 2.4 0.0 1.5 0.0 0.2 0.1 0.4 5.3 5.6 11.4 6.9 5.2 2.9 5.2 4.0 4.9 6.9 0.0 0.3 43.2 8.5 6.6 5.6 2.0 0.0 0.0 3.4 3.5 39.3 0.1 0.0 4.4 17.2 1.1 0.0 0.0 2.4 0.2 5.3 14.0 0.0 2.4 0.5 187.5 0.0 2.5 0.3 5.3 5.5 0.9 3.3 0.0 0.1 0.6 3.8 0.0 4.2 0.0 1.9 0.0 1.7 0.0 1.5 6.8 0.0 5.1 0.0 3.1 BAG2 ENSG00000112208 "BCL2 associated athanogene 2" O95816 6 57172326-57189833 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 67.0;urinary bladder: 51.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 76.8;Early spermatids: 102.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018862, HPA019918" Enhanced Supported "Intermediate filaments,Cytosol" NA NA Cytosol "Intermediate filaments" "HPA018862: AB_2669957, HPA019918: AB_2670317" "unprognostic (3.93e-1)" "unprognostic (1.62e-1)" "unprognostic (2.60e-1)" "unprognostic (1.33e-1)" "unprognostic (5.63e-2)" "unprognostic (8.32e-3)" "prognostic unfavorable (6.72e-6)" "unprognostic (1.10e-1)" "unprognostic (7.79e-5)" "unprognostic (6.20e-3)" "unprognostic (4.71e-2)" "unprognostic (6.56e-2)" "unprognostic (6.07e-3)" "unprognostic (5.97e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (1.26e-4)" "unprognostic (6.24e-3)" 3.4 3.5 3.7 8.7 2.8 1.2 4.6 4.1 3.4 18.4 24.5 0.8 14.8 1.9 29.4 9.5 13.4 5.9 6.9 17.2 3.3 3.5 3.7 3.8 4.1 2.3 3.3 2.3 15.4 1.5 0.6 4.5 6.7 3.4 23.7 4.3 2.6 1.5 15.1 9.9 1.7 5.7 67.0 3.4 1.3 7.4 6.7 2.6 1.6 7.6 6.0 1.9 51.0 17.1 5.9 1.4 0.9 0.4 3.3 6.1 1.9 9.5 5.3 2.2 7.9 5.6 16.1 6.3 15.4 14.7 11.1 10.7 6.8 4.9 3.2 14.8 24.3 9.1 1.7 12.8 1.3 10.7 10.1 9.4 9.3 8.0 15.3 8.6 8.1 2.1 7.8 0.7 9.1 8.6 6.7 8.6 7.4 18.6 4.5 10.9 0.7 5.7 6.8 8.5 0.2 5.5 5.3 6.3 6.3 13.3 1.5 2.9 2.6 6.9 0.5 5.5 10.8 1.2 7.1 11.7 6.4 10.4 13.4 15.2 3.1 2.9 7.0 5.6 3.2 0.6 0.1 0.3 0.9 3.3 0.4 3.9 5.9 3.1 3.3 1.4 4.3 6.1 5.1 0.3 3.3 0.1 0.5 3.2 1.9 3.7 2.8 4.1 3.4 3.3 3.5 3.3 2.3 3.4 2.6 3.0 3.0 20.8 4.4 2.2 6.0 33.9 0.0 6.7 2.3 3.5 11.8 76.8 1.7 8.4 102.4 3.6 0.3 0.0 3.0 11.5 50.7 7.0 4.6 13.2 13.1 9.5 1.7 1.8 3.1 24.6 28.7 4.0 6.8 14.4 0.2 6.1 6.8 0.6 36.4 22.7 15.5 6.5 35.4 43.2 6.8 3.3 15.8 8.4 0.6 1.8 BAG3 ENSG00000151929 "BCL2 associated athanogene 3" O95817 10 119651370-119677819 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis Chaperone "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 115.2;vagina: 160.1" "Group enriched" "Detected in many" 5 "Basal glandular cells: 723.0;Cardiomyocytes: 186.4;Glandular cells: 269.5;Urothelial cells: 305.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.6" "Lineage enriched" "Detected in many" 7 "T-cells: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018493, HPA020586" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 890000 "Plasma membrane, Cytosol" "HPA018493: AB_1845257, HPA020586: AB_1845258" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (2.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (5.31e-3)" "unprognostic (4.51e-3)" "unprognostic (3.32e-2)" "unprognostic (1.98e-2)" "unprognostic (1.46e-2)" "unprognostic (1.30e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.46e-2)" "unprognostic (3.03e-2)" 17.8 14.1 18.8 7.7 25.7 2.7 38.3 18.4 20.7 11.7 14.1 7.3 6.5 6.3 10.1 10.6 23.3 8.7 17.0 38.2 20.6 14.3 16.8 10.1 14.3 5.9 20.9 4.5 7.3 9.3 27.6 8.8 16.5 27.4 14.4 6.7 5.5 14.6 12.9 115.2 18.5 5.6 20.4 35.8 4.4 15.1 8.1 20.6 1.3 11.1 32.7 12.8 14.0 160.1 0.3 0.8 0.4 1.1 0.2 7.6 1.0 26.5 30.2 8.5 10.9 21.9 15.4 15.8 24.3 20.6 18.6 16.0 12.8 13.0 1.0 11.6 20.8 24.2 39.6 8.6 42.8 12.9 13.0 14.2 1.4 8.1 15.9 18.6 0.0 6.1 15.5 24.8 13.5 21.4 19.8 20.7 4.7 11.3 6.6 18.4 38.0 1.4 5.9 3.3 8.9 34.6 0.1 12.0 4.6 14.0 6.0 1.5 1.4 9.6 17.1 12.5 9.6 10.7 3.5 25.8 9.8 8.5 13.2 34.6 6.1 3.6 0.6 18.3 0.4 7.4 0.0 1.0 0.0 1.2 1.1 2.0 0.3 4.4 1.5 0.8 0.0 7.6 2.7 0.4 0.2 0.5 0.2 3.0 1.0 18.8 25.7 18.4 20.7 20.6 14.3 20.9 4.5 27.4 20.6 20.8 36.3 0.9 723.0 70.5 2.3 186.4 10.2 29.4 46.6 7.0 17.7 35.8 23.2 16.0 20.3 50.1 18.0 0.0 22.4 39.6 80.3 269.5 24.1 13.7 29.0 1.6 36.8 27.6 7.2 25.2 20.8 15.4 52.3 5.4 12.1 30.3 26.4 8.2 22.6 33.1 1.0 19.4 68.0 17.1 15.1 66.6 61.4 5.7 10.6 305.7 BAG5 ENSG00000166170 "BCL2 associated athanogene 5" Q9UL15 14 103556544-103562831 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.8" "Group enriched" "Detected in many" 18 "Early spermatids: 1517.7;Late spermatids: 1363.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016429 Enhanced Approved Vesicles NA NA Vesicles "HPA016429: AB_1845261" "unprognostic (3.02e-2)" "unprognostic (2.98e-2)" "unprognostic (1.05e-2)" "unprognostic (6.26e-2)" "unprognostic (2.54e-1)" "unprognostic (5.22e-2)" "unprognostic (1.99e-3)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (4.77e-3)" "unprognostic (2.34e-1)" "unprognostic (3.80e-2)" "prognostic favorable (1.58e-8)" "unprognostic (2.51e-1)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (2.53e-1)" 16.0 6.7 8.4 8.1 9.4 13.2 10.6 14.8 10.6 11.5 10.1 10.6 9.5 7.0 11.7 9.5 13.6 9.3 7.4 7.3 8.9 8.4 13.5 8.5 8.8 9.3 8.7 7.6 11.4 7.0 9.0 13.2 16.1 10.3 10.3 8.4 8.2 10.4 11.2 9.3 13.1 11.5 10.7 9.7 11.9 8.4 69.8 8.6 11.1 17.0 10.7 11.8 11.7 9.4 10.1 15.3 22.8 21.2 14.7 14.2 12.7 14.8 13.5 16.1 14.4 14.9 15.2 18.1 17.0 11.9 12.2 11.4 11.1 17.5 26.2 15.1 16.6 11.3 21.4 12.8 18.0 19.5 12.0 9.6 17.3 15.8 8.3 9.5 22.6 17.7 10.7 23.3 12.8 16.0 11.2 12.6 18.1 13.8 19.3 16.4 17.8 21.0 10.1 9.6 22.4 16.5 21.5 20.3 11.1 19.9 37.9 18.7 12.5 19.9 16.2 12.9 11.3 21.0 12.2 16.9 13.3 11.6 20.8 17.3 13.3 20.8 30.8 15.1 11.8 16.6 22.8 14.1 12.8 11.6 15.7 13.9 8.3 12.8 10.8 15.3 10.1 14.2 12.9 10.7 14.7 21.2 7.2 11.3 12.7 8.4 9.4 14.8 10.6 8.9 8.4 8.7 7.6 10.3 8.6 41.7 22.4 14.7 37.9 61.2 33.1 19.9 10.2 44.2 52.4 33.2 25.5 21.0 56.3 22.2 1517.7 34.2 17.1 0.0 16.6 14.3 26.3 32.2 31.2 20.3 18.5 71.5 30.4 53.4 26.7 1363.6 46.1 24.1 30.4 10.8 21.9 45.7 20.5 15.3 62.9 24.8 33.8 32.3 19.8 36.3 41.3 78.4 34.1 26.6 20.0 58.6 BAHCC1 "BAHD2, KIAA1447" ENSG00000266074 "BAH domain and coiled-coil containing 1" 17 81395475-81466332 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 22.2" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 47.8;Cone photoreceptor cells: 21.6;Horizontal cells: 31.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.4;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 8 "dendritic cells: 1.1;granulocytes: 1.4" "Cell line enhanced" "Detected in many" "HL-60: 11.0;MOLT-4: 13.6;NB-4: 46.8;REH: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023386, HPA076910" Approved Approved Nucleoli NA NA Nucleoli "HPA023386: AB_1859537, HPA076910: AB_2732325" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-2)" "unprognostic (5.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.05e-2)" "prognostic favorable (7.38e-4)" "unprognostic (1.43e-1)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.18e-1)" "unprognostic (2.18e-1)" "unprognostic (3.78e-2)" 5.9 4.8 5.0 3.0 8.3 8.1 3.6 22.2 7.4 5.1 3.1 10.6 1.1 6.0 4.5 2.3 2.5 3.8 5.6 2.2 4.8 2.8 1.1 4.4 1.1 8.5 5.7 6.0 4.3 5.3 3.2 1.6 4.9 4.4 1.5 9.5 6.1 3.8 6.2 4.4 5.5 4.0 3.2 4.9 3.6 4.4 10.4 9.6 2.5 1.6 0.5 3.7 4.4 0.0 1.1 1.4 0.1 0.0 0.0 0.0 1.7 3.0 2.2 7.3 0.8 1.2 1.0 1.3 1.1 0.7 0.4 0.5 0.8 0.0 2.0 1.5 1.0 1.8 1.0 0.8 0.1 0.0 3.3 2.4 0.7 0.9 0.7 11.0 2.3 2.0 0.3 0.6 0.6 1.1 0.8 2.8 1.7 0.0 0.3 1.0 13.6 46.8 0.1 1.1 2.0 14.3 1.5 0.0 0.9 0.1 10.2 1.6 1.6 0.0 5.8 0.2 0.3 8.8 1.0 4.0 0.5 2.1 0.6 0.0 0.0 0.0 0.0 5.1 0.7 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 6.0 9.6 0.0 1.4 0.0 47.8 5.8 15.3 4.0 6.8 3.5 21.6 0.1 1.7 2.8 0.5 4.7 3.2 0.0 3.7 0.1 4.3 1.3 0.0 3.0 0.5 31.8 8.1 4.9 5.1 0.0 6.9 1.3 0.0 1.0 4.2 7.5 1.6 0.0 5.3 0.8 16.8 0.0 2.0 1.5 7.8 0.0 0.0 0.0 4.5 0.7 BAIAP2L2 "FLJ22582, pinkbar" ENSG00000128298 "BAI1 associated protein 2 like 2" Q6UXY1 22 38084889-38110670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 59.1;intestine: 80.9" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 80.5;Intestinal endocrine cells: 26.6;Mucus-secreting cells: 46.3;Paneth cells: 30.2;Undifferentiated cells: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 8.7;OE19: 26.6;RPTEC TERT1: 16.8;SK-MEL-30: 21.0;WM-115: 16.5" "Region enhanced" "Detected in many" "olfactory region: 4.5" "Low region specificity" "Detected in many" HPA003043 Approved NA NA "HPA003043: AB_2227864" "unprognostic (2.15e-1)" "unprognostic (4.23e-2)" "unprognostic (9.82e-2)" "unprognostic (5.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (1.37e-3)" "unprognostic (2.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-3)" "unprognostic (1.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.23e-2)" "unprognostic (4.51e-2)" 0.8 0.3 2.0 8.1 1.7 0.3 0.7 1.6 3.9 1.3 39.7 0.3 0.1 48.6 0.8 3.4 10.6 0.6 59.1 0.3 2.0 0.8 15.1 1.4 0.3 0.6 0.7 2.6 0.5 0.9 0.2 1.4 1.1 0.2 0.8 7.1 0.3 1.4 0.3 0.6 1.0 80.9 0.6 0.7 0.5 4.7 2.2 0.1 0.1 1.2 1.4 3.5 0.4 1.3 0.0 0.2 0.0 0.7 0.0 1.0 0.0 0.3 7.2 0.0 0.1 0.2 1.0 2.1 1.9 0.0 0.0 0.1 7.1 1.0 0.2 3.3 1.9 0.0 1.3 0.0 0.1 0.0 0.4 1.1 0.6 0.1 8.7 0.4 0.0 1.1 0.1 0.4 3.7 0.6 0.0 0.0 0.7 0.4 0.4 0.0 1.2 0.4 0.3 0.8 26.6 0.1 0.5 0.0 0.4 16.8 1.3 0.5 0.3 0.3 2.9 21.0 0.2 2.2 0.2 0.1 0.1 1.2 0.1 0.0 3.5 0.5 0.2 0.0 0.1 16.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 2.0 1.7 1.6 3.9 2.0 0.8 0.7 2.6 0.2 0.1 0.0 0.0 0.0 0.2 0.7 3.2 1.1 22.9 0.0 0.0 0.0 2.0 0.2 1.7 0.5 0.5 0.0 80.5 0.0 0.0 1.1 0.6 0.3 0.0 0.8 0.4 6.4 26.6 0.6 0.3 0.0 1.1 0.0 5.0 0.0 46.3 0.5 3.2 30.2 1.1 17.7 1.3 0.0 0.3 1.0 1.3 1.0 0.3 0.0 32.5 0.3 BAIAP3 "BAP3, KIAA0734" ENSG00000007516 "BAI1 associated protein 3" O94812 16 1333601-1349441 "Predicted intracellular proteins" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.1;pituitary gland: 88.2" "Group enriched" "Detected in many" 6 "Ciliated cells: 33.5;Intestinal endocrine cells: 48.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.1;MCF7: 6.1;RT4: 5.5" "Region enhanced" "Detected in many" "hypothalamus: 144.1" "Low region specificity" "Detected in all" "HPA015627, HPA015979" Uncertain Supported NA NA "HPA015627: AB_10603678, HPA015979: " "unprognostic (1.37e-2)" "unprognostic (3.93e-2)" "unprognostic (2.44e-2)" "unprognostic (3.92e-3)" "unprognostic (4.43e-2)" "unprognostic (1.10e-1)" "unprognostic (2.25e-1)" "unprognostic (1.06e-1)" "unprognostic (5.60e-2)" "unprognostic (6.75e-3)" "unprognostic (1.44e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.52e-5)" "unprognostic (5.26e-2)" "unprognostic (3.11e-1)" "unprognostic (7.12e-3)" "unprognostic (6.43e-2)" 2.2 20.6 30.6 1.3 16.5 1.2 1.4 0.2 24.1 1.4 1.9 9.5 0.7 4.3 1.6 2.6 1.0 28.1 0.9 1.5 19.4 38.4 2.8 3.0 3.1 1.5 4.1 39.1 1.2 7.8 5.1 88.2 2.1 18.5 3.5 1.1 0.0 4.6 3.0 2.8 1.5 3.8 0.4 4.2 2.6 7.0 7.6 6.1 0.0 0.7 0.0 1.1 1.0 0.5 4.9 0.0 1.8 0.0 1.3 1.6 0.3 0.1 2.3 4.1 1.3 0.4 0.0 1.1 0.2 0.1 0.2 0.0 3.6 20.1 0.3 2.8 0.0 0.2 0.1 0.0 0.2 0.0 0.2 1.3 0.1 0.3 1.4 0.4 0.0 2.8 0.0 0.0 0.2 0.1 0.2 0.1 0.4 0.6 0.0 0.0 6.1 0.0 0.8 2.4 1.0 3.5 0.6 0.0 3.8 2.4 5.5 0.5 0.2 0.0 1.9 0.1 1.1 4.3 0.3 0.3 0.0 2.3 0.5 0.0 1.6 0.5 0.1 0.1 0.4 0.1 0.0 0.0 0.5 1.0 0.0 0.5 4.9 0.5 1.6 0.0 0.3 0.0 0.1 1.8 1.3 0.0 0.0 0.0 0.3 30.6 16.5 0.2 24.1 19.4 38.4 4.1 39.1 18.5 6.1 0.0 0.0 4.5 3.6 0.5 0.6 1.2 0.0 33.5 5.7 5.2 0.0 0.2 0.0 0.5 3.2 1.6 2.6 0.0 0.2 0.2 0.4 3.5 0.0 5.3 0.1 0.0 48.2 3.7 0.0 1.1 0.6 0.0 1.7 0.0 1.5 0.8 0.3 0.0 0.0 0.2 0.6 6.5 0.8 3.1 1.3 0.4 0.9 0.9 2.7 1.7 BAMBI NMA ENSG00000095739 "BMP and activin membrane bound inhibitor" Q13145 10 28677342-28682939 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 46.8;seminal vesicle: 52.4" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 40.8;Muller glia cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 34.0;SK-MEL-30: 40.6;SuSa: 79.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010819, HPA010866" Approved Approved "Nucleoli fibrillar center,Vesicles,Lipid droplets" NA NA Vesicles "Nucleoli fibrillar center, Lipid droplets" "HPA010819: AB_2668371, HPA010866: AB_10601686" "unprognostic (7.02e-3)" "unprognostic (4.52e-2)" "unprognostic (1.28e-2)" "unprognostic (3.17e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (9.42e-6)" "unprognostic (1.09e-1)" "unprognostic (6.45e-3)" "unprognostic (1.05e-1)" "unprognostic (2.03e-3)" "unprognostic (9.29e-2)" "prognostic favorable (5.25e-4)" "unprognostic (1.01e-1)" "unprognostic (3.24e-1)" "unprognostic (2.38e-2)" "unprognostic (2.10e-2)" 2.0 24.7 6.7 1.8 6.9 3.0 13.6 2.2 6.3 3.9 2.3 12.9 15.5 1.1 10.1 2.0 1.1 2.8 3.0 22.8 6.7 6.4 11.2 12.9 5.7 3.1 12.0 2.9 46.8 3.9 7.4 4.5 20.9 10.5 6.5 2.8 30.4 3.8 52.4 1.2 2.7 1.1 12.7 10.8 9.0 2.3 4.8 7.9 0.1 0.6 2.1 1.3 13.8 11.6 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.2 8.6 0.8 0.4 1.0 0.0 5.2 2.1 0.7 3.3 2.1 34.0 3.6 0.1 1.3 1.5 2.0 2.5 2.1 0.3 1.5 2.1 4.7 8.0 1.3 12.9 1.2 0.4 10.7 0.7 0.5 2.2 0.3 20.9 0.5 0.4 4.5 3.9 0.6 14.1 0.0 0.6 15.6 7.2 2.1 0.0 1.6 0.7 2.7 8.2 1.4 1.1 2.8 16.5 40.6 79.5 4.8 0.6 0.0 2.2 1.6 3.6 1.0 0.1 2.9 0.0 0.2 1.8 14.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.7 6.9 2.2 4.8 6.7 6.4 12.0 2.9 10.5 7.9 8.9 5.1 1.7 4.8 3.5 5.1 19.6 40.8 1.4 3.4 10.4 3.9 11.0 1.7 16.1 0.0 3.1 2.0 0.0 0.2 13.7 21.0 16.5 1.1 11.5 5.8 6.4 25.7 19.6 0.6 1.0 3.1 1.4 15.1 1.0 3.4 39.2 7.7 4.3 2.1 13.0 5.2 0.0 4.4 1.7 7.6 1.1 7.1 1.3 1.9 6.4 BANF2 "BAF-L, BAF2, BAFL, C20orf179, dJ803K15.1" ENSG00000125888 "Barrier to autointegration factor 2" Q9H503 20 17693672-17735871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 58.7" "Group enriched" "Detected in some" 131 "Early spermatids: 777.2;Late spermatids: 1997.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 6.3;SCLC-21H: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA042635 Approved NA NA "HPA042635: AB_10795707" "unprognostic (2.08e-1)" "unprognostic (9.15e-2)" "unprognostic (6.42e-3)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (3.42e-1)" "unprognostic (3.18e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 11.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 58.7 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 777.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1997.8 10.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 10.6 5.3 0.0 0.0 0.0 0.0 0.0 BANK1 "BANK, FLJ20706" ENSG00000153064 "B cell scaffold protein with ankyrin repeats 1" Q8NDB2 4 101411286-102074812 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0" "Cell type enriched" "Detected in many" 6 "B-cells: 268.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 15 "memory B-cell: 61.4;naive B-cell: 46.2" "Lineage enriched" "Detected in many" 17 "B-cells: 61.4" "Cell line enhanced" "Detected in some" "Daudi: 10.4;HEL: 8.1;HL-60: 7.3;U-266/70: 25.0" "Low region specificity" "Detected in many" HPA037002 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037002: AB_10672383" "unprognostic (1.59e-2)" "unprognostic (2.08e-2)" "unprognostic (6.43e-2)" "unprognostic (1.60e-1)" "unprognostic (1.28e-3)" "unprognostic (1.73e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-2)" "unprognostic (1.01e-1)" "unprognostic (9.97e-2)" "unprognostic (4.25e-2)" "unprognostic (7.89e-2)" "unprognostic (2.80e-1)" "unprognostic (2.18e-1)" "unprognostic (2.75e-2)" "unprognostic (6.09e-3)" "unprognostic (1.75e-1)" 3.3 2.9 0.7 45.4 0.9 2.0 1.9 2.1 0.7 0.7 1.3 0.7 1.4 0.7 0.4 1.2 6.0 1.0 1.6 0.9 0.8 0.7 2.0 0.5 4.9 30.3 0.7 0.2 0.9 0.6 0.0 3.7 0.5 0.6 2.2 1.1 0.5 7.7 1.8 0.4 0.6 18.0 0.3 0.8 67.0 2.5 1.3 0.7 4.8 5.5 0.4 42.3 6.5 1.1 61.4 2.0 3.6 0.3 0.2 0.0 2.1 0.0 2.3 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.3 0.5 0.0 3.6 10.4 1.0 0.0 0.0 0.1 0.1 1.1 0.3 0.0 0.0 8.1 2.1 0.0 0.1 7.3 0.0 0.5 0.3 0.0 0.0 0.9 0.1 0.0 0.0 3.1 0.5 0.4 0.0 0.4 0.0 0.3 4.4 0.1 0.5 0.0 0.3 4.8 2.1 0.0 0.2 0.1 0.0 0.0 0.4 1.9 1.0 0.0 0.5 0.0 0.0 25.0 0.0 1.7 0.1 4.1 0.0 1.5 0.3 3.6 0.0 0.1 0.0 61.4 0.0 0.0 2.0 46.2 0.0 0.0 0.1 0.2 0.0 1.0 0.0 2.1 0.7 0.9 2.1 0.7 0.8 0.7 0.7 0.2 0.6 0.7 41.7 21.9 268.2 2.1 0.1 0.2 0.4 0.0 2.7 17.0 3.5 0.0 1.8 0.0 0.2 1.9 0.4 0.0 0.0 0.2 0.6 1.0 5.2 1.1 0.0 1.2 0.0 0.0 0.0 2.7 1.8 0.0 7.7 5.0 0.0 0.0 1.1 2.5 0.2 0.4 2.4 0.0 0.0 0.0 1.4 3.2 1.0 0.2 2.5 0.4 4.0 BARHL1 ENSG00000125492 "BarH like homeobox 1" Q9BZE3 9 132582185-132590266 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 44 "brain: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "cerebellum: 23.8;pons and medulla: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 105 "SCLC-21H: 19.8" "Group enriched" "Detected in some" 5 "cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1" "Region enhanced" "Detected in many" "cerebellum: 16.3" HPA004809 Enhanced NA NA "HPA004809: AB_1078266" "unprognostic (2.29e-1)" "unprognostic (6.42e-2)" "unprognostic (8.07e-2)" "unprognostic (9.31e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.2 0.0 0.2 0.9 0.0 0.0 0.0 40.1 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.9 0.0 0.5 2.2 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BARHL2 ENSG00000143032 "BarH like homeobox 2" Q9NY43 1 90711539-90717237 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 29.3" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 22.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 42 "cerebellum: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.5;HEK 293: 8.9;HEL: 1.3;HMC-1: 2.5;JURKAT: 1.5" "Region enriched" "Detected in some" 5 "cerebellum: 14.5" "Region enriched" "Detected in many" 20 "cerebellum: 48.3" NA NA "unprognostic (1.83e-1)" "unprognostic (1.73e-1)" "unprognostic (6.80e-2)" "unprognostic (3.10e-1)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 8.9 1.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.1 3.6 0.0 0.0 0.0 0.0 0.0 BARX1 ENSG00000131668 "BARX homeobox 1" Q9HBU1 9 93951622-93955372 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 59.7" "Cell type enhanced" "Detected in single" 23 "Early spermatids: 2.6" "Cancer enhanced" "Detected in many" "stomach cancer: 19.3" "Region enhanced" "Detected in single" "hippocampal formation: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 15.6;HMC-1: 37.3;NTERA-2: 11.0;THP-1: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA055858 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA055858: AB_2682947" "unprognostic (6.19e-4)" "unprognostic (4.81e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.16e-6)" "unprognostic (4.96e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (1.46e-2)" "unprognostic (5.20e-3)" "unprognostic (1.23e-2)" "unprognostic (8.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (9.68e-13)" "unprognostic (7.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.60e-1)" "unprognostic (2.16e-2)" 4.3 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.2 2.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.4 1.5 0.0 0.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 59.7 5.6 0.0 0.0 0.5 12.3 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 11.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 3.2 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 BARX2 ENSG00000043039 "BARX homeobox 2" Q9UMQ3 11 129375940-129452279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB033311, HPA064966, HPA068414" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984" "unprognostic (4.25e-2)" "unprognostic (2.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.22e-5)" "unprognostic (3.85e-2)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (1.43e-3)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.15e-1)" "unprognostic (8.39e-2)" "unprognostic (3.48e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.06e-4)" 0.1 0.0 0.3 1.6 0.5 0.0 6.0 0.6 0.9 8.7 4.4 1.4 0.3 7.1 0.6 1.8 49.8 6.8 5.0 0.1 0.5 0.4 1.9 0.1 0.5 0.1 0.7 0.2 1.0 6.9 0.0 0.6 1.5 4.1 1.5 1.9 0.0 78.3 0.7 1.0 11.2 7.9 0.0 1.6 0.0 2.6 1.2 0.2 0.4 0.5 40.7 36.4 0.2 22.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.4 7.8 0.0 1.9 0.0 60.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 1.5 0.0 2.3 0.0 0.0 0.0 7.7 0.3 0.0 0.0 14.7 0.0 0.1 0.1 0.0 0.0 7.4 0.0 0.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.9 0.5 0.4 0.7 0.2 4.1 0.2 0.0 1.4 0.0 99.1 38.2 0.4 0.4 2.5 6.7 6.8 0.0 0.0 10.6 6.6 18.2 6.5 0.3 27.5 0.0 0.6 6.4 2.3 15.2 0.0 0.0 1.6 0.0 1.7 0.0 0.0 1.3 0.0 0.8 10.1 0.0 12.2 0.8 5.0 22.1 0.4 1.4 0.2 0.0 0.7 0.0 1.1 72.1 3.5 0.0 15.8 102.1 BASP1 "CAP-23, CAP23, NAP-22, NAP22" ENSG00000176788 "Brain abundant membrane attached signal protein 1" P80723 5 17065598-17276843 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.3;epididymis: 126.9" "Cell type enhanced" "Detected in many" 10 "monocytes: 416.6;Muller glia cells: 714.2;Syncytiotrophoblasts: 617.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 42.4" "Lineage enriched" "Detected in many" 17 "granulocytes: 42.4" "Cell line enhanced" "Detected in many" "GAMG: 63.6;HeLa: 111.9;SiHa: 107.5" "Low region specificity" "Detected in many" "HPA045218, HPA050333" Enhanced Enhanced "Plasma membrane" NA NA 85000000 "Plasma membrane" "HPA045218: AB_2679263, HPA050333: AB_2681090" "unprognostic (3.35e-2)" "unprognostic (3.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.25e-11)" "unprognostic (1.95e-3)" "unprognostic (1.04e-1)" "unprognostic (3.61e-2)" "unprognostic (1.70e-1)" 9.2 6.7 64.3 28.4 37.4 31.1 4.8 37.2 107.3 16.2 5.2 4.0 15.1 3.8 15.5 126.9 4.0 3.6 12.7 4.4 65.0 55.8 4.2 7.7 9.1 30.2 30.1 56.6 11.7 2.5 3.6 6.4 36.4 21.9 32.2 5.5 7.9 3.8 11.5 1.6 6.0 5.7 14.2 11.0 21.9 9.2 2.2 4.3 3.7 3.6 1.3 35.4 17.6 13.0 2.5 1.6 42.4 1.1 0.6 0.1 0.2 0.0 16.7 20.9 0.0 10.0 10.7 29.9 20.9 6.9 17.6 18.7 0.8 0.0 6.5 2.9 14.9 63.6 1.3 13.3 14.6 22.9 2.6 7.5 0.0 111.9 0.0 22.4 12.9 0.1 18.4 18.2 19.9 16.8 22.6 19.0 0.0 0.0 0.0 18.7 24.0 0.0 11.8 15.4 0.0 5.1 0.0 0.0 3.6 6.3 4.1 13.4 2.8 107.5 9.9 0.0 48.5 0.0 13.4 24.2 23.3 0.0 1.9 3.3 0.2 0.0 3.5 23.5 16.0 3.0 6.2 1.1 7.8 0.0 0.4 0.0 1.8 0.0 0.0 1.6 2.5 0.0 0.0 42.4 0.6 0.6 0.1 0.1 0.2 64.3 37.4 37.2 107.3 65.0 55.8 30.1 56.6 21.9 4.3 8.9 7.4 119.4 82.9 191.9 32.5 1.2 0.0 54.9 18.2 8.7 11.8 112.9 0.0 0.6 0.4 8.9 0.0 23.3 3.0 281.6 123.4 116.0 26.5 0.9 53.1 230.4 0.0 41.7 176.3 0.0 0.6 106.8 27.0 416.6 0.3 714.2 1.2 0.0 0.0 0.0 54.1 0.0 24.5 0.0 1.5 51.4 617.6 1.0 0.6 11.2 BATF "B-ATF, BATF1, SFA-2" ENSG00000156127 "Basic leucine zipper ATF-like transcription factor" Q16520 14 75522425-75547015 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.1;lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 226.5;T-cells: 75.6;Urothelial cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "T-cells: 41.1" "Cell line enhanced" "Detected in some" "HDLM-2: 82.7;MCF7: 31.1;RT4: 19.5;SK-BR-3: 15.9;U-937: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059588, HPA064962" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059588: AB_2684074, HPA064962: AB_2685392" "unprognostic (3.33e-3)" "unprognostic (4.87e-3)" "prognostic unfavorable (8.30e-4)" "prognostic favorable (5.35e-6)" "unprognostic (3.02e-2)" "prognostic favorable (7.91e-5)" "unprognostic (1.14e-2)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (6.72e-2)" "unprognostic (7.17e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (3.74e-9)" "unprognostic (4.74e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-1)" "prognostic favorable (4.30e-4)" 4.9 1.3 0.9 15.8 4.7 13.8 7.6 0.2 1.9 2.8 2.8 0.2 1.0 2.0 1.3 1.4 2.6 1.9 7.0 3.1 1.0 0.7 1.9 3.0 7.9 20.2 2.1 0.2 1.6 1.6 0.5 1.2 3.7 1.9 5.2 1.1 1.0 6.0 8.3 0.9 2.8 8.0 2.6 2.7 26.6 5.7 0.7 1.9 6.2 2.7 3.4 23.1 10.4 7.3 7.1 9.0 5.0 8.9 6.4 41.1 8.4 1.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.7 0.0 1.8 0.0 0.3 2.7 2.2 8.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 2.4 0.0 31.1 1.0 6.7 0.0 13.0 0.0 0.2 0.0 1.4 0.0 19.5 0.0 0.0 0.0 15.9 0.6 0.0 1.4 4.3 0.0 0.0 0.0 1.0 0.0 7.7 8.2 0.0 0.0 23.0 0.0 1.2 8.9 2.7 19.6 4.9 15.4 7.1 21.4 25.1 9.0 5.2 8.6 18.1 5.0 6.4 4.2 1.0 41.1 8.4 0.9 4.7 0.2 1.9 1.0 0.7 2.1 0.2 1.9 1.9 8.9 43.8 23.6 46.3 4.7 0.0 0.2 2.5 9.4 13.6 3.5 0.0 0.3 0.0 0.3 0.5 0.7 0.0 0.0 2.3 0.2 3.3 20.8 226.5 0.8 49.2 0.0 0.0 3.1 16.0 0.2 0.0 19.3 5.0 9.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.9 75.6 0.0 57.9 BATF3 "JDP1, JUNDM1, SNFT" ENSG00000123685 "Basic leucine zipper ATF-like transcription factor 3" Q9NR55 1 212686418-212699985 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.8" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8" "Group enriched" "Detected in many" 36 "dendritic cells: 16.5;monocytes: 26.8" "Cell line enriched" "Detected in some" 12 "HDLM-2: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075858 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA075858: " "unprognostic (3.87e-2)" "unprognostic (2.10e-2)" "unprognostic (4.29e-2)" "unprognostic (6.85e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (3.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.08e-1)" "unprognostic (6.47e-2)" "unprognostic (1.28e-2)" "unprognostic (1.75e-1)" "unprognostic (6.43e-10)" "unprognostic (9.88e-2)" "unprognostic (5.19e-2)" "unprognostic (3.90e-1)" "unprognostic (7.08e-2)" 10.4 1.3 6.7 6.3 9.4 5.4 3.5 0.4 5.2 2.0 2.4 3.3 0.2 1.4 1.8 0.4 1.8 2.6 3.8 4.1 5.5 2.1 2.6 2.3 7.2 8.7 9.5 2.8 3.1 3.2 1.2 1.3 4.6 4.3 2.3 1.6 0.5 2.2 1.2 1.5 1.1 4.3 3.7 4.7 9.5 3.2 1.1 7.1 5.0 2.1 2.6 4.9 3.0 6.0 0.2 16.5 0.6 26.8 0.3 0.4 2.4 0.3 0.9 0.1 0.0 0.0 0.6 0.7 0.5 1.1 1.1 1.2 0.0 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.2 0.8 93.1 2.2 0.0 0.3 0.0 0.2 4.2 0.6 0.1 0.0 2.2 0.3 0.1 0.0 7.7 0.1 1.1 0.2 0.0 3.2 1.7 0.4 0.0 1.5 0.6 0.4 0.0 1.0 0.0 0.2 0.1 0.3 0.0 0.0 0.4 0.0 3.0 0.0 0.5 2.1 0.1 2.4 0.1 0.2 0.5 1.5 3.8 1.1 0.0 4.1 0.0 0.0 18.0 0.0 0.2 0.0 0.0 16.5 0.0 0.0 0.0 0.6 0.3 26.8 0.0 0.4 2.4 6.7 9.4 0.4 5.2 5.5 2.1 9.5 2.8 4.3 7.1 3.0 1.1 0.5 2.2 5.0 0.1 0.3 0.0 4.0 2.3 0.0 0.0 0.8 0.0 0.7 0.3 5.8 0.0 0.0 0.3 36.2 8.5 6.6 4.7 0.2 4.6 0.0 0.0 6.2 10.5 0.8 0.9 24.9 1.7 98.2 0.0 0.2 1.3 0.0 0.0 0.5 0.4 0.0 25.8 1.1 4.3 2.5 3.8 1.0 0.0 0.9 BBIP1 "bA348N5.3, BBIP10, BBS18, NCRNA00081" ENSG00000214413 "BBSome interacting protein 1" A8MTZ0 10 110898730-110919274 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.3" "Group enriched" "Detected in many" 4 "Early spermatids: 454.9;Late spermatids: 380.0;Spermatocytes: 296.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055206 Approved NA NA "HPA055206: AB_2682737" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "unprognostic (1.50e-1)" "unprognostic (6.25e-3)" "unprognostic (3.08e-2)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (6.26e-2)" "unprognostic (2.60e-2)" "unprognostic (3.00e-2)" "unprognostic (6.79e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.81e-1)" "unprognostic (3.85e-2)" 11.9 17.4 20.2 12.0 19.3 6.3 11.4 15.3 20.8 12.6 8.7 15.4 8.8 8.2 11.7 19.3 9.7 15.3 9.7 13.1 20.6 18.1 21.1 17.2 9.5 13.5 22.4 17.8 14.9 9.5 13.1 25.7 10.5 16.3 12.6 8.3 10.8 6.3 13.2 8.3 4.9 7.7 12.4 25.0 10.6 9.2 70.3 22.8 9.3 15.8 8.9 11.9 10.4 7.7 4.2 4.8 27.5 7.4 3.5 9.7 3.8 8.9 12.6 14.1 14.9 17.0 22.7 4.3 11.5 23.1 13.2 17.8 5.9 11.4 5.3 8.3 18.4 13.4 9.0 9.6 12.2 20.1 9.9 11.8 9.0 11.2 8.0 23.9 7.6 16.3 13.4 11.4 17.6 32.5 29.9 21.1 9.8 6.6 21.5 15.5 5.5 9.9 10.8 6.1 6.3 7.5 4.3 25.8 7.8 20.5 6.1 10.6 17.7 8.6 3.8 18.7 9.6 4.6 6.7 15.5 9.5 12.2 12.1 15.7 11.9 10.2 8.0 27.3 13.7 8.0 10.8 5.9 22.7 5.2 7.4 6.1 4.2 7.8 6.3 4.8 3.7 9.7 8.0 27.5 3.5 6.3 4.3 8.8 3.8 20.2 19.3 15.3 20.8 20.6 18.1 22.4 17.8 16.3 22.8 23.8 7.7 20.0 29.9 10.0 30.5 15.4 25.5 66.9 14.8 21.0 29.5 16.5 89.5 31.8 454.9 23.2 10.4 0.0 30.0 19.5 22.3 24.6 16.1 20.9 17.8 42.9 16.3 17.8 22.7 380.0 43.1 21.0 21.9 18.0 17.0 32.5 30.9 9.3 31.8 50.6 60.4 51.8 31.1 296.8 30.6 10.5 10.3 25.5 10.3 23.7 BBOF1 "C14orf45, CCDC176" ENSG00000119636 "Basal body orientation factor 1" Q8ND07 14 74019353-74082863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 326.6;Early spermatids: 164.7;Late spermatids: 84.6;Spermatocytes: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA003090, HPA003136, HPA075108" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA "Nucleoplasm, Plasma membrane" "Centriolar satellite" "HPA003090: AB_1845571, HPA003136: AB_1078330, HPA075108: " "unprognostic (1.84e-2)" "unprognostic (1.31e-1)" "unprognostic (5.71e-2)" "prognostic favorable (6.34e-4)" "unprognostic (1.11e-2)" "unprognostic (1.29e-2)" "unprognostic (1.28e-2)" "unprognostic (2.08e-1)" "unprognostic (1.85e-1)" "unprognostic (4.62e-2)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (1.40e-3)" "unprognostic (6.14e-2)" "unprognostic (2.57e-1)" "unprognostic (7.93e-2)" "unprognostic (6.04e-3)" 5.3 3.5 9.4 4.1 12.5 6.0 8.4 4.3 12.5 7.7 6.5 4.4 8.5 2.5 8.2 16.4 6.1 24.1 6.6 4.8 11.5 8.2 10.6 2.8 7.6 2.2 7.3 9.2 5.8 3.2 6.1 17.4 3.0 22.3 6.4 4.2 5.8 4.4 8.9 5.3 3.7 2.7 7.7 13.8 1.8 3.9 37.7 6.7 2.5 14.5 2.6 2.6 7.0 3.4 1.5 5.0 2.4 0.1 2.1 4.2 3.0 4.8 2.8 1.2 8.0 5.4 12.0 1.0 4.2 6.0 4.3 4.1 1.0 3.3 4.7 1.2 5.1 1.8 1.2 1.6 0.7 4.9 0.7 0.9 0.5 2.7 1.0 4.6 2.3 0.3 5.7 4.0 9.6 1.2 6.8 1.5 8.9 2.5 0.9 3.1 3.8 7.4 1.2 0.4 0.4 2.0 2.7 3.1 0.8 7.4 1.2 4.9 3.1 8.2 3.3 2.2 1.3 8.5 0.2 3.5 5.3 3.8 7.1 1.2 1.8 4.2 2.9 15.7 0.3 1.5 2.4 0.1 0.2 3.4 0.0 4.0 1.3 3.2 2.2 0.2 1.5 4.2 3.4 2.4 2.1 0.0 5.0 0.6 3.0 9.4 12.5 4.3 12.5 11.5 8.2 7.3 9.2 22.3 6.7 11.9 7.2 0.0 4.2 0.0 7.2 0.0 5.1 326.6 55.7 3.5 27.5 1.6 13.3 7.3 164.7 2.2 0.4 23.3 3.1 2.2 3.0 3.9 1.1 2.5 2.0 6.4 2.4 4.9 0.6 84.6 10.0 1.7 0.0 1.0 3.2 5.7 2.4 0.0 5.6 14.4 27.4 0.0 0.0 82.2 13.0 0.0 0.8 3.2 0.8 2.8 BBOX1 "BBH, BBOX, G-BBH, gamma-BBH" ENSG00000129151 "Gamma-butyrobetaine hydroxylase 1" O75936 11 27040725-27127809 "Enzymes, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 139.4;liver: 39.3" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1023.7" "Group enriched" "Detected in many" 6 "glioma: 23.7;renal cancer: 59.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTCEpi: 16.2;RPTEC TERT1: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007600, HPA027823" Enhanced Approved Uncertain "Vesicles,Actin filaments" NA NA 25000 Vesicles "Actin filaments" "HPA007600: AB_1845284, HPA027823: AB_10602394" "unprognostic (9.96e-3)" "unprognostic (1.80e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (7.03e-2)" "unprognostic (6.66e-2)" "unprognostic (7.05e-3)" "unprognostic (1.13e-2)" "unprognostic (3.03e-1)" "unprognostic (6.89e-2)" "unprognostic (2.03e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.45e-5)" "unprognostic (1.71e-2)" "unprognostic (2.70e-1)" "unprognostic (3.22e-1)" "unprognostic (1.73e-3)" 0.9 0.5 9.2 0.5 7.1 0.5 8.2 3.9 7.5 1.5 0.6 4.9 0.1 0.5 0.6 3.6 5.7 3.8 3.6 0.5 7.9 6.3 139.4 39.3 0.6 0.6 10.9 4.3 0.5 0.8 0.5 8.3 1.3 9.2 0.7 0.5 0.0 2.2 2.0 0.6 16.4 0.5 0.5 7.1 0.5 0.6 0.6 5.8 0.0 8.9 1.6 0.7 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 16.2 0.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.5 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 7.1 3.9 7.5 7.9 6.3 10.9 4.3 9.2 5.8 0.0 1.1 0.0 5.5 7.2 0.0 0.0 17.8 6.7 2.3 43.6 0.0 0.1 189.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 25.4 0.0 0.0 0.0 0.6 1.2 1.1 0.0 0.0 1.7 0.0 0.0 11.3 0.1 0.0 0.4 1023.7 0.3 0.0 0.4 0.0 0.1 31.2 0.2 0.0 0.0 2.2 BCAM "CD239, LU" ENSG00000187244 "Basal cell adhesion molecule (Lutheran blood group)" P50895 19 44809059-44821421 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 101.8" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 519.9;Cytotrophoblasts: 537.1;Syncytiotrophoblasts: 362.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 493.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 31.4;HaCaT: 64.1;SK-BR-3: 60.2;T-47d: 34.1;U-2 OS: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005654 Enhanced Approved "Nucleoli fibrillar center" NA NA 16000000 "Nucleoli fibrillar center" "HPA005654: AB_2667378" "unprognostic (5.63e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.31e-4)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.01e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (2.61e-3)" "unprognostic (1.41e-1)" "prognostic favorable (5.94e-6)" "unprognostic (1.83e-2)" "unprognostic (5.74e-2)" "unprognostic (2.14e-2)" "unprognostic (9.97e-3)" 28.9 7.2 4.9 8.1 5.4 1.4 33.1 3.4 8.7 33.5 8.5 4.4 17.8 5.7 24.8 26.5 15.6 46.3 23.2 23.8 4.5 4.2 101.8 13.2 41.6 5.8 4.4 6.5 30.4 17.8 5.8 9.8 28.7 7.0 42.7 2.4 21.4 17.8 27.3 16.7 12.7 7.4 12.5 3.8 14.2 9.6 13.6 2.6 5.7 93.0 23.7 8.5 14.2 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 9.4 0.2 26.2 0.1 0.1 31.4 2.8 1.3 2.3 1.5 14.1 18.0 0.0 14.5 0.3 0.1 64.1 2.3 16.0 0.7 0.0 1.6 0.0 1.9 19.5 5.3 0.0 3.5 2.6 6.2 0.8 0.9 7.5 1.4 0.0 1.5 0.1 0.3 3.7 0.1 0.2 2.9 2.1 3.3 0.1 3.1 0.7 19.6 4.6 0.0 0.1 11.6 60.2 0.7 3.0 34.1 1.0 3.8 0.6 29.5 0.7 1.3 0.1 0.3 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 5.4 3.4 8.7 4.5 4.2 4.4 6.5 7.0 2.6 6.0 10.5 0.5 101.3 36.1 0.6 9.0 38.2 2.7 18.2 519.9 0.0 537.1 69.6 23.4 0.8 63.2 5.1 0.0 3.5 27.0 13.6 65.7 0.0 27.0 38.8 0.0 50.0 39.9 5.9 0.8 27.3 8.0 15.1 0.0 4.7 26.3 14.4 17.5 14.2 123.1 0.5 155.2 124.6 2.2 14.9 21.5 362.4 0.0 10.5 34.4 BCAN "BEHAB, CSPG7, MGC13038" ENSG00000132692 Brevican Q96GW7 1 156641390-156659532 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 144.2" "Group enriched" "Detected in some" 22 "Horizontal cells: 103.3;Melanocytes: 177.2" "Group enriched" "Detected in many" 77 "glioma: 348.5;melanoma: 75.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 8.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 8.2" "Cell line enhanced" "Detected in many" "HDLM-2: 24.7;K-562: 34.8;U-266/70: 20.9;U-266/84: 40.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007865, CAB025862" Enhanced Supported "Secreted in brain" NA NA 98000 "CAB025862: , HPA007865: AB_1078299" "unprognostic (7.14e-2)" "unprognostic (3.14e-1)" "unprognostic (1.95e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (4.80e-2)" "unprognostic (6.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-2)" "unprognostic (9.47e-3)" "unprognostic (2.76e-2)" "unprognostic (8.54e-2)" "unprognostic (5.40e-1)" "unprognostic (1.90e-1)" 1.4 5.8 51.8 1.6 35.9 1.3 1.4 10.4 144.2 2.3 2.4 30.5 1.3 4.6 2.7 9.5 1.6 2.4 3.1 1.5 40.8 22.9 1.4 1.3 1.5 1.5 26.6 21.5 1.4 1.3 1.3 0.7 1.7 15.1 1.4 1.3 4.3 2.0 2.4 1.6 9.0 5.0 2.4 13.0 1.6 2.4 2.0 26.7 0.0 1.4 0.0 1.3 2.3 0.3 0.6 0.0 8.2 0.4 0.0 0.0 0.0 14.0 9.7 0.0 2.6 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.3 6.9 0.0 15.0 0.0 0.3 9.9 0.1 0.0 0.0 24.7 0.9 2.4 6.4 8.0 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.3 0.0 1.3 34.8 6.9 0.0 4.0 0.0 0.0 0.7 7.5 1.4 0.0 16.1 0.0 0.0 1.7 0.0 0.2 0.0 0.0 14.6 0.8 0.0 0.9 3.0 0.0 8.0 2.9 3.8 20.9 40.2 0.0 2.9 6.5 1.1 8.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 35.9 10.4 33.3 40.8 22.9 26.6 21.5 15.1 26.7 0.0 0.0 0.0 0.0 6.2 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.4 103.3 1.7 0.0 0.0 4.3 0.3 0.0 177.2 0.0 0.0 1.9 0.4 0.0 0.0 0.0 2.3 0.0 1.9 5.4 6.4 1.5 0.0 0.0 0.0 0.0 BCAR3 "AND-34, NSP2, SH2D3B" ENSG00000137936 "BCAR3, NSP family adaptor protein" O75815 1 93561786-93847150 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 59.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4;memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014858 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA014858: AB_1845302" "unprognostic (9.16e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.60e-3)" "prognostic unfavorable (8.41e-4)" "prognostic unfavorable (5.42e-4)" "prognostic unfavorable (8.92e-7)" "unprognostic (2.44e-1)" "unprognostic (3.66e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.51e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.13e-1)" "unprognostic (1.14e-1)" "unprognostic (7.05e-2)" "unprognostic (1.87e-1)" 26.0 10.4 10.1 11.6 14.2 0.9 23.1 8.6 8.1 10.2 14.1 10.0 6.2 12.4 5.7 5.9 8.9 9.4 15.5 10.6 10.6 8.0 15.5 11.0 12.8 11.8 11.7 5.6 11.2 4.1 4.5 4.6 59.5 10.6 11.2 15.7 10.1 20.5 14.5 19.5 13.3 14.8 10.6 9.7 5.4 15.2 7.3 8.0 2.6 10.0 6.6 11.7 12.7 17.7 4.5 1.7 4.4 1.1 0.0 0.3 0.1 15.3 6.6 12.4 0.9 5.4 4.2 10.7 15.9 27.8 13.1 8.1 1.1 11.5 2.5 5.5 24.5 17.1 9.6 0.3 20.6 11.5 1.1 0.3 0.0 4.8 2.8 9.7 0.1 0.0 5.0 22.8 13.6 46.2 12.7 14.4 0.3 0.4 0.1 35.5 2.3 0.3 0.0 3.9 6.7 22.9 1.0 17.9 0.3 34.4 19.5 0.4 1.0 7.7 8.3 9.9 5.0 9.3 0.6 16.9 19.6 5.0 8.3 21.0 1.3 0.5 0.3 2.9 0.0 7.1 4.4 0.0 0.1 0.0 1.1 0.0 4.5 0.1 0.0 0.8 2.5 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.1 10.1 14.2 8.6 8.1 10.6 8.0 11.7 5.6 10.6 8.0 3.0 7.4 7.4 102.8 8.8 1.0 6.7 7.6 10.7 9.1 14.0 0.0 23.0 23.2 11.1 8.4 17.3 20.2 0.0 5.6 70.7 9.3 24.4 3.5 9.4 10.3 20.6 14.3 5.5 4.3 11.2 9.5 8.1 18.6 16.2 20.7 4.3 17.7 20.7 1.1 15.6 0.4 71.1 19.3 3.2 2.9 8.9 15.8 0.0 10.0 114.7 BCAS1 "AIBC1, NABC1" ENSG00000064787 "Breast carcinoma amplified sequence 1" O75363 20 53936777-54070594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 134.0;intestine: 40.3;stomach 1: 85.5" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 100.4;Enterocytes: 78.0;Mucus-secreting cells: 285.2;Paneth cells: 94.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 20.6;RT4: 41.6;SK-BR-3: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033558, HPA051816, HPA054745" Enhanced Approved Vesicles NA NA Vesicles "CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (6.20e-2)" "unprognostic (7.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-1)" "unprognostic (3.80e-1)" "unprognostic (1.19e-1)" "unprognostic (5.25e-2)" "unprognostic (2.91e-2)" "unprognostic (4.70e-3)" "unprognostic (3.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (7.77e-3)" 1.3 1.0 49.8 3.8 63.4 0.9 2.8 5.4 37.2 5.1 36.9 97.6 0.0 10.7 1.6 2.1 4.7 1.7 5.4 0.9 51.6 35.6 1.7 0.9 2.4 1.1 75.3 14.7 0.9 1.0 0.8 0.3 0.9 69.7 19.1 40.3 0.0 2.9 1.0 0.9 1.1 17.1 2.4 134.0 1.1 85.5 2.5 49.2 0.0 0.8 0.0 4.1 21.8 1.1 1.6 0.2 1.0 0.2 0.3 5.7 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.0 0.0 0.0 0.0 20.6 0.0 0.5 0.0 0.2 0.0 41.6 0.0 0.0 0.0 87.1 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.5 0.2 0.1 0.5 0.2 3.0 1.6 1.0 0.3 0.0 0.5 0.2 0.1 1.0 0.3 0.2 0.2 5.7 0.2 49.8 63.4 5.4 32.3 51.6 35.6 75.3 14.7 69.7 49.2 8.9 0.6 1.3 5.9 0.7 0.0 2.0 5.1 100.4 22.7 3.5 0.0 0.1 1.7 0.9 13.2 0.1 78.0 0.0 20.6 0.1 0.9 33.5 4.6 0.0 0.1 0.0 8.1 0.6 0.0 13.6 0.3 1.6 15.1 0.0 285.2 0.9 13.8 94.5 0.0 0.0 0.5 0.0 0.3 10.5 5.3 0.3 0.0 0.7 33.5 44.2 BCAS4 "CNOL, FLJ20495" ENSG00000124243 "Breast carcinoma amplified sequence 4" Q8TDM0 20 50794894-50882676 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.9;lymphoid tissue: 31.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 114.6;B-cells: 70.5;granulocytes: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 28.9;naive B-cell: 28.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 38.9;U-698: 34.6" "Low region specificity" "Detected in all" HPA038812 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA038812: AB_10795141" "unprognostic (3.48e-1)" "unprognostic (1.60e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (8.35e-2)" "unprognostic (2.98e-1)" "unprognostic (2.47e-3)" "unprognostic (1.04e-3)" "unprognostic (2.83e-1)" "unprognostic (1.57e-2)" "unprognostic (1.23e-2)" "unprognostic (2.33e-1)" "unprognostic (2.35e-2)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" "unprognostic (4.30e-2)" 1.8 2.3 7.3 29.1 12.9 3.9 4.5 6.2 12.8 4.8 4.2 2.3 4.2 2.4 5.4 7.2 4.7 3.6 3.8 3.1 13.8 7.5 7.0 1.4 3.8 28.5 7.1 9.2 3.0 3.6 9.2 5.4 5.0 5.2 7.7 1.9 8.8 4.9 7.1 2.1 2.1 8.6 6.0 2.0 12.2 4.5 5.1 2.2 9.2 5.9 0.0 31.6 7.6 5.3 28.9 7.0 0.6 0.1 6.9 12.9 5.3 4.9 8.9 0.7 3.9 1.4 3.7 1.5 6.4 5.8 4.6 3.3 4.2 3.0 38.9 2.4 2.7 9.3 7.4 4.4 9.3 2.7 2.5 3.9 0.2 3.5 3.5 2.0 0.0 0.2 1.2 5.4 3.5 1.7 5.8 0.2 3.1 0.1 0.2 1.6 17.3 1.5 0.1 3.2 0.7 7.2 12.2 1.2 0.4 2.1 4.5 4.0 4.1 10.0 9.6 0.2 3.5 19.0 0.4 0.2 5.0 7.3 5.0 1.5 0.6 2.9 34.6 2.0 0.3 0.4 0.6 0.1 0.1 6.2 0.1 3.5 28.9 3.8 7.5 0.1 28.7 12.9 10.3 0.6 6.9 0.1 7.0 3.1 5.3 7.3 12.9 6.2 12.8 13.8 7.5 7.1 9.2 5.2 2.2 20.8 114.6 70.5 24.1 1.8 5.8 14.8 5.1 37.5 33.0 8.7 2.0 24.9 34.9 9.7 1.3 1.6 0.0 0.0 2.7 3.1 14.6 11.2 104.6 0.2 2.6 7.9 32.2 1.3 1.5 0.4 1.4 1.4 5.0 1.8 2.2 6.9 6.3 0.0 2.8 3.3 5.5 6.5 14.6 3.0 10.6 2.0 9.2 25.8 1.2 21.3 BCAT1 BCT1 ENSG00000060982 "Branched chain amino acid transaminase 1" P54687 12 24810022-24949459 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Branched-chain amino acid biosynthesis" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 52.7" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 113.0;Early spermatids: 140.5;Exocrine glandular cells: 118.7;Late spermatids: 235.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 14.7" "Group enriched" "Detected in many" 9 "dendritic cells: 5.4;monocytes: 14.7" "Cell line enhanced" "Detected in many" "HDLM-2: 51.9;NTERA-2: 59.6;RH-30: 65.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048592 Uncertain NA NA 85000 "HPA048592: AB_2680454" "unprognostic (1.90e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (3.05e-5)" "unprognostic (9.49e-3)" "unprognostic (4.22e-2)" "unprognostic (4.77e-3)" "unprognostic (1.97e-3)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.38e-4)" "prognostic unfavorable (4.95e-4)" "unprognostic (5.44e-2)" "unprognostic (7.55e-2)" "prognostic unfavorable (8.54e-4)" 12.5 6.1 5.2 6.9 5.7 2.6 6.3 1.3 7.8 4.3 3.0 2.6 0.0 1.4 8.6 3.9 2.9 7.8 4.7 2.4 4.7 7.9 1.8 1.8 13.8 7.4 11.3 2.9 8.3 52.7 1.1 19.1 14.0 18.5 2.0 3.1 12.3 4.4 1.4 1.3 1.2 3.8 5.9 6.3 2.4 2.4 7.3 2.0 7.1 1.7 0.7 5.3 4.3 6.3 1.1 5.4 1.0 14.7 0.0 0.2 0.8 6.0 2.4 22.5 0.0 6.5 12.7 11.6 12.4 8.3 7.0 11.8 13.6 17.1 22.5 0.0 20.6 1.3 2.4 16.0 0.1 18.8 51.9 3.1 18.3 0.4 7.3 23.5 20.7 6.7 16.4 0.4 17.8 3.7 15.2 23.7 11.7 17.6 0.2 5.9 0.1 13.0 5.8 59.6 0.0 1.6 0.0 65.0 0.3 0.0 2.1 0.0 12.3 0.0 0.0 0.1 25.2 0.0 8.9 31.0 4.2 15.7 16.7 11.6 2.7 2.7 31.4 14.8 12.5 0.0 0.0 2.1 0.0 0.0 3.4 0.1 1.1 0.0 0.1 5.4 0.0 0.0 0.0 1.0 0.0 14.7 3.3 0.2 0.8 5.2 5.7 1.3 7.4 4.7 7.9 11.3 2.9 18.5 2.0 14.9 21.3 0.8 0.1 7.7 113.0 1.9 2.5 0.0 1.2 0.0 2.0 45.4 1.7 1.4 140.5 9.0 0.0 0.0 118.7 16.8 13.4 0.3 11.5 0.0 64.2 39.7 0.0 9.8 81.1 235.6 6.6 40.9 6.8 26.2 0.0 5.2 79.2 0.0 3.9 0.0 9.2 6.5 1.4 1.7 1.1 6.4 18.8 0.7 0.0 0.1 BCCIP "BCCIPalpha, TOK-1" ENSG00000107949 "BRCA2 and CDKN1A interacting protein" Q9P287 10 125823546-125853695 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 132.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038011 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038011: AB_2675784" "unprognostic (1.05e-1)" "unprognostic (2.38e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-2)" "unprognostic (3.54e-2)" "unprognostic (1.38e-2)" "unprognostic (1.93e-3)" "unprognostic (2.51e-1)" "unprognostic (3.04e-2)" "unprognostic (6.62e-3)" "unprognostic (1.88e-1)" "unprognostic (1.30e-3)" "unprognostic (1.90e-3)" "unprognostic (4.75e-2)" "unprognostic (1.58e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" 24.0 25.0 27.9 28.8 28.0 32.3 33.4 28.0 30.2 20.8 23.0 15.0 27.8 19.7 21.1 35.9 27.6 21.3 17.9 28.7 28.7 21.3 35.0 45.9 19.0 27.6 23.6 22.0 28.0 29.2 19.8 27.6 19.8 33.5 27.3 26.3 14.4 34.7 26.7 132.7 19.3 23.5 29.7 35.6 27.2 28.2 28.6 24.1 24.6 26.0 32.0 28.7 24.0 47.9 30.9 30.7 16.1 35.4 26.0 33.8 19.0 54.8 28.5 32.4 35.8 18.5 20.4 27.1 29.5 28.3 36.5 34.0 46.6 36.9 38.6 18.6 27.0 27.5 30.5 55.3 41.8 51.2 35.5 37.5 38.8 24.6 51.4 23.4 53.2 24.7 20.9 25.3 43.5 46.1 27.8 34.7 36.5 42.8 19.8 30.9 32.8 34.4 53.8 25.0 46.3 43.1 33.0 34.1 23.1 32.3 26.4 17.2 17.6 22.0 36.2 36.2 27.6 19.5 23.7 23.2 17.1 30.1 25.1 53.1 20.3 22.6 57.4 33.5 27.8 13.1 12.4 28.7 16.1 24.6 34.7 33.8 30.9 28.2 26.8 30.7 28.9 31.9 28.6 4.7 26.0 35.4 26.5 29.7 19.0 27.9 28.0 28.0 30.2 28.7 21.3 23.6 22.0 33.5 24.1 59.6 61.1 29.0 39.2 59.4 23.5 74.2 22.9 92.3 78.5 22.7 21.6 35.7 66.3 28.3 8.2 26.2 18.0 23.3 38.0 30.2 29.3 38.3 25.5 42.9 32.0 15.9 24.8 24.5 28.9 7.7 34.2 29.8 21.9 35.1 20.2 25.8 38.2 14.0 29.4 48.8 23.1 25.8 31.5 79.8 108.7 45.7 28.3 24.9 31.1 42.9 BCHE "CHE1, CHE2, E1" ENSG00000114200 Butyrylcholinesterase P06276 3 165772904-165837472 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 145.4" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 360.7" "Group enriched" "Detected in many" 6 "glioma: 24.0;liver cancer: 13.7;melanoma: 18.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Karpas-707: 131.7" "Low region specificity" "Detected in all" HPA001560 Approved "Secreted to blood" NA NA 13000000000 "HPA001560: AB_1078271" "unprognostic (4.74e-2)" "unprognostic (2.00e-1)" "unprognostic (9.21e-4)" "unprognostic (8.19e-8)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (5.04e-2)" "unprognostic (6.15e-2)" "unprognostic (9.59e-2)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" "unprognostic (3.18e-3)" "unprognostic (4.46e-5)" "unprognostic (2.17e-2)" "unprognostic (5.92e-2)" "unprognostic (4.26e-4)" 14.0 3.9 6.7 6.2 4.3 0.4 1.9 3.6 9.1 24.4 15.5 4.7 8.3 1.8 20.2 13.4 20.0 18.0 2.2 7.8 6.1 4.4 2.8 145.4 3.7 0.7 5.5 2.7 10.3 1.1 0.4 1.2 0.5 4.7 4.7 5.3 0.7 1.0 10.5 1.1 2.8 6.4 13.9 3.4 3.7 1.9 1.8 6.1 1.0 0.8 0.4 0.5 9.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.9 0.0 1.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 4.2 0.2 0.0 1.4 4.4 0.6 5.2 0.0 131.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.8 10.9 0.1 0.0 0.0 0.1 0.0 0.0 7.5 0.0 5.8 0.0 0.0 3.2 0.0 0.0 1.3 0.5 0.0 0.2 1.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.3 3.6 4.3 6.1 4.4 5.5 2.7 4.7 6.1 0.0 0.0 0.0 0.3 4.8 0.9 4.3 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 1.5 0.0 0.0 0.0 0.0 2.2 0.2 0.0 360.7 0.1 1.6 0.0 6.2 5.3 5.5 2.0 0.0 18.6 0.0 0.0 34.4 0.0 0.0 0.0 2.9 1.0 0.0 4.6 0.3 0.1 3.0 0.0 0.0 0.0 0.1 BCKDHB ENSG00000083123 "Branched chain keto acid dehydrogenase E1 subunit beta" P21953 6 80106647-80346270 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Maple syrup urine disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 56.4;Hepatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031580, HPA031956" Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" Yes No Mitochondria Nucleoli "HPA031580: AB_10696054, HPA031956: " "unprognostic (4.23e-1)" "unprognostic (1.61e-1)" "unprognostic (9.50e-3)" "unprognostic (9.37e-3)" "unprognostic (1.66e-1)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (2.30e-2)" "unprognostic (1.94e-1)" "unprognostic (7.32e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "prognostic favorable (5.54e-9)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (1.49e-2)" 13.9 12.0 9.9 9.0 12.2 5.8 18.1 9.5 14.3 10.2 17.3 22.7 9.4 9.1 11.6 7.7 10.2 10.9 7.4 14.7 11.9 7.6 24.7 58.6 6.4 8.1 11.3 11.2 13.9 12.1 13.7 15.5 5.5 14.1 13.1 16.5 11.7 30.5 10.3 8.2 8.6 11.8 11.5 16.7 5.3 15.0 10.0 12.4 11.2 12.5 7.9 7.7 14.0 8.2 9.1 10.3 2.6 4.3 13.4 15.7 5.2 7.0 2.6 10.0 13.4 10.2 8.9 8.0 5.0 10.4 8.3 11.4 4.3 9.7 20.0 5.4 12.0 9.7 7.1 5.5 6.6 11.6 24.8 8.2 9.9 6.9 5.8 11.3 14.0 4.5 8.5 6.8 5.7 7.1 7.4 9.8 15.6 8.3 17.9 18.5 3.9 5.1 8.2 7.4 15.4 3.4 13.0 31.1 17.1 22.9 10.8 6.7 9.5 8.5 7.1 5.0 11.5 9.1 10.8 4.2 5.0 3.4 4.5 6.7 12.8 12.5 6.6 6.1 10.5 7.4 2.6 3.4 0.8 8.5 4.0 11.1 9.1 7.2 7.2 6.6 9.1 9.6 10.0 0.7 13.4 4.3 10.3 15.7 5.2 9.9 12.2 9.5 14.3 11.9 7.6 11.3 11.2 14.1 12.4 8.9 15.2 6.7 10.1 7.6 7.0 26.0 10.2 16.0 14.8 5.2 2.0 15.7 23.2 6.8 56.4 9.0 12.4 0.0 9.0 6.6 13.0 8.6 16.1 55.0 10.2 3.2 11.5 11.1 9.8 4.1 8.1 6.1 15.1 10.0 28.8 14.6 4.5 11.5 8.1 25.2 8.2 6.5 8.9 7.7 4.8 10.8 8.7 8.9 15.3 9.8 BCL11A "BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856" ENSG00000119866 "B cell CLL/lymphoma 11A" Q9H165 2 60450520-60555154 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 107.1" "Cell type enhanced" "Detected in many" 8 "B-cells: 89.5;Erythroid cells: 93.5;Horizontal cells: 49.3;Suprabasal keratinocytes: 61.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 39.6;naive B-cell: 53.7;plasmacytoid DC: 107.1" "Group enriched" "Detected in many" 16 "B-cells: 53.7;dendritic cells: 107.1" "Cell line enhanced" "Detected in many" "Daudi: 20.7;MOLT-4: 19.1;REH: 19.5;U-698: 42.7;U-937: 13.7" "Group enriched" "Detected in all" 5 "amygdala: 42.3;basal ganglia: 57.1;cerebral cortex: 62.7;hippocampal formation: 65.3;olfactory region: 101.8" "Group enriched" "Detected in all" 4 "basal ganglia: 58.3;cerebral cortex: 93.2;hippocampal formation: 97.2;olfactory region: 128.9" "CAB014891, HPA029003, HPA075941" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB014891: , HPA029003: AB_2672863, HPA075941: " "unprognostic (4.10e-3)" "unprognostic (6.72e-2)" "unprognostic (4.50e-2)" "unprognostic (9.41e-3)" "unprognostic (2.37e-1)" "unprognostic (4.47e-3)" "unprognostic (2.53e-2)" "unprognostic (1.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.45e-1)" "unprognostic (4.27e-4)" "unprognostic (1.23e-2)" "unprognostic (2.35e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-1)" "unprognostic (4.40e-2)" "unprognostic (2.99e-2)" 1.5 2.4 6.6 13.9 14.6 17.0 5.5 1.8 34.5 3.9 8.6 0.2 0.1 7.6 1.8 1.4 13.6 4.8 2.2 4.7 14.5 3.4 1.7 1.5 3.0 21.2 3.5 14.4 1.6 11.3 1.2 3.9 0.9 9.6 4.8 5.1 0.0 11.4 2.0 1.4 24.9 11.4 2.9 2.0 13.5 3.3 2.0 2.6 20.9 2.4 4.0 30.4 3.6 7.8 53.7 107.1 1.3 5.1 1.0 0.1 1.2 0.2 0.0 1.7 0.0 0.3 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 20.7 0.1 0.0 0.0 4.2 6.4 3.0 0.0 0.3 6.2 0.0 0.2 0.1 0.0 7.4 0.0 0.7 1.7 0.0 1.0 1.7 1.0 7.0 0.3 0.1 0.0 0.0 19.1 7.6 11.8 3.0 0.1 19.5 0.5 7.9 0.0 0.3 8.4 2.0 0.1 0.1 0.1 3.5 0.1 3.6 0.5 0.1 4.9 0.1 0.0 0.3 0.0 42.7 0.0 13.7 0.6 0.4 2.9 0.5 0.0 5.1 0.1 39.6 0.0 0.0 10.7 53.7 0.1 0.1 1.3 1.0 3.7 107.1 0.1 1.2 6.6 14.6 1.8 34.5 14.5 3.4 3.5 14.4 9.6 2.6 0.0 9.0 89.5 14.8 41.1 0.5 12.2 5.1 5.3 7.9 1.8 0.0 0.5 5.0 7.7 9.4 1.2 8.4 93.5 5.6 0.7 5.1 4.2 9.3 0.0 32.9 49.3 19.0 0.6 8.2 3.6 0.3 17.9 15.1 6.4 11.7 0.1 5.4 13.6 0.0 0.3 0.1 0.0 1.3 1.6 5.9 61.1 0.7 0.0 24.2 4.1 BCL11B "CTIP-2, CTIP2, hRIT1-alpha, ZNF856B" ENSG00000127152 "B cell CLL/lymphoma 11B" Q9C0K0 14 99169287-99271524 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease mutation, Mental retardation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6" "Group enriched" "Detected in many" 8 "Basal keratinocytes: 55.8;Suprabasal keratinocytes: 62.4;T-cells: 48.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 13.7" "Group enriched" "Detected in many" 8 "gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 14 "T-cells: 7.4" "Group enriched" "Detected in some" 6 "JURKAT: 24.7;MOLT-4: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049117 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA049117: AB_2680639" "unprognostic (1.64e-5)" "unprognostic (4.66e-2)" "unprognostic (2.35e-2)" "unprognostic (1.87e-2)" "unprognostic (9.37e-2)" "unprognostic (5.97e-2)" "unprognostic (4.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (1.60e-6)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (3.31e-3)" "prognostic favorable (7.48e-4)" 0.3 0.4 4.4 6.6 13.7 5.2 1.3 0.3 3.8 0.8 1.3 0.1 0.0 2.3 1.9 0.8 3.9 0.3 3.0 0.8 4.8 1.0 0.3 0.5 1.1 10.8 0.8 2.6 0.2 0.1 0.0 0.1 0.0 0.6 0.6 1.7 0.3 5.0 0.7 0.1 17.6 3.0 0.2 0.7 4.9 2.1 0.4 1.6 25.4 0.9 1.5 8.8 2.0 2.3 0.0 0.0 0.1 0.0 0.5 7.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.0 24.7 0.0 2.8 0.0 1.6 29.5 0.4 0.3 2.2 0.0 4.6 0.0 0.0 0.0 1.6 2.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.0 1.8 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.1 3.3 0.0 3.0 0.0 4.5 3.7 0.0 0.0 7.4 4.9 0.0 0.5 0.0 0.0 3.0 1.1 4.4 13.7 0.3 3.8 4.8 1.0 0.8 2.6 0.6 1.6 3.0 0.0 2.7 1.6 55.8 0.1 3.1 5.1 0.0 1.2 0.0 0.0 0.1 1.7 0.3 0.0 0.1 4.3 0.0 0.4 0.0 1.1 0.2 4.7 0.0 0.2 0.0 1.2 4.3 1.2 0.2 0.6 0.7 5.0 0.0 2.6 0.0 0.7 4.3 0.0 0.3 0.0 0.0 3.3 0.7 4.9 62.4 0.0 48.4 6.9 0.6 BCL2A1 "ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1" ENSG00000140379 "BCL2 related protein A1" Q16548 15 79960889-79971446 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.7;bone marrow: 105.7;lung: 45.6" "Group enriched" "Detected in many" 4 "granulocytes: 217.9;Hofbauer cells: 208.5;Macrophages: 391.0;monocytes: 632.2" "Cancer enhanced" "Detected in all" "melanoma: 39.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "eosinophil: 37.1;intermediate monocyte: 25.3;neutrophil: 72.7;non-classical monocyte: 47.2" "Group enriched" "Detected in all" 6 "granulocytes: 72.7;monocytes: 47.2" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 96.8" NA NA "unprognostic (3.19e-3)" "unprognostic (2.61e-1)" "unprognostic (3.99e-2)" "unprognostic (3.54e-3)" "unprognostic (9.65e-3)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-2)" "unprognostic (4.01e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.61e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" 21.6 0.9 1.9 22.6 4.0 105.7 1.8 0.5 1.8 1.0 2.0 0.4 0.0 1.0 0.7 1.0 3.0 4.9 3.6 9.8 2.2 1.3 1.8 5.2 45.6 24.9 11.8 0.0 3.7 1.0 0.2 2.2 3.8 3.8 1.6 1.3 0.8 2.3 0.3 1.4 0.6 4.4 2.7 8.2 32.8 1.9 4.6 4.0 4.3 2.3 1.4 11.1 4.8 7.1 9.3 3.4 72.7 47.2 2.8 5.7 5.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 0.7 0.3 0.0 0.0 0.0 0.2 0.4 0.5 20.6 0.3 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 96.8 0.0 0.0 1.0 0.0 10.5 0.9 0.0 0.2 0.1 0.0 0.7 0.4 6.6 4.9 3.3 5.6 37.1 3.6 25.3 2.0 9.3 4.7 4.7 3.4 5.9 5.7 5.3 72.7 2.8 47.2 0.6 1.0 5.8 1.9 4.0 0.5 1.8 2.2 1.3 11.8 0.0 3.8 4.0 20.8 84.6 34.0 0.8 9.7 0.0 2.5 0.0 16.0 17.0 1.8 0.0 1.6 1.7 1.9 0.9 3.7 0.0 0.0 1.3 2.1 4.1 1.0 217.9 0.2 208.5 0.0 0.0 2.5 63.4 0.8 0.0 391.0 32.1 632.2 0.0 0.1 4.1 0.0 0.0 0.6 0.0 0.0 7.6 0.1 0.2 8.9 3.8 29.4 0.0 1.4 BCL2L10 "BCL-B, Boo, Diva" ENSG00000137875 "BCL2 like 10" Q9HD36 15 52109263-52112775 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.3" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 5.5;Distal tubular cells: 11.6;Proximal tubular cells: 7.5;Suprabasal keratinocytes: 7.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 6.0" "Group enriched" "Detected in some" 6 "basophil: 4.1;memory B-cell: 1.6;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 28 "B-cells: 1.6;dendritic cells: 2.6;granulocytes: 4.1" "Cell line enriched" "Detected in some" 8 "NB-4: 27.5" HPA042222 Approved NA NA "HPA042222: AB_10794271" "unprognostic (5.33e-4)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (3.22e-4)" "unprognostic (1.19e-2)" "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "unprognostic (4.80e-3)" "unprognostic (8.86e-2)" "unprognostic (3.47e-2)" "unprognostic (9.52e-2)" "unprognostic (3.83e-1)" "unprognostic (2.18e-9)" "unprognostic (9.59e-2)" "unprognostic (1.86e-1)" "unprognostic (1.92e-1)" "unprognostic (3.20e-2)" 1.0 3.5 1.0 2.4 6.0 0.3 2.1 1.4 1.6 2.8 3.6 0.1 0.0 3.9 1.1 1.2 6.1 1.3 3.4 0.1 0.5 1.7 6.5 15.3 0.1 1.2 0.3 1.1 0.9 4.2 0.8 3.7 0.2 0.3 2.5 1.7 0.3 1.8 0.4 0.3 10.0 8.1 0.5 0.3 1.6 1.8 0.9 0.5 0.5 0.8 4.3 1.0 2.3 3.9 1.6 2.6 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 3.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 1.0 6.0 1.4 1.6 0.5 1.7 0.3 1.1 0.3 0.5 0.0 0.0 0.0 4.2 5.5 0.9 0.3 2.5 0.0 0.0 0.0 0.0 0.0 11.6 2.0 0.0 0.0 4.6 0.0 1.3 0.2 0.1 1.7 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 1.0 0.6 0.0 0.4 7.5 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 2.2 4.7 BCL2L14 "BCL-G, BCLG" ENSG00000121380 "BCL2 like 14" Q9BZR8 12 12049844-12211084 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 40.1;testis: 29.8" "Group enriched" "Detected in many" 11 "Early spermatids: 317.4;Late spermatids: 661.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Lineage enhanced" "Detected in single" "T-cells: 3.0" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.1;NTERA-2: 3.9;OE19: 5.0;RT4: 4.7;SuSa: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040665, HPA059846" Enhanced Uncertain Cytosol NA NA Cytosol "HPA040665: AB_10964282, HPA059846: " "unprognostic (3.65e-4)" "unprognostic (4.95e-3)" "unprognostic (1.68e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-1)" "unprognostic (2.70e-4)" "unprognostic (1.10e-1)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "unprognostic (4.59e-5)" "unprognostic (1.06e-2)" "unprognostic (1.06e-2)" "unprognostic (5.79e-6)" "unprognostic (3.83e-2)" "unprognostic (3.37e-2)" "unprognostic (2.82e-2)" "unprognostic (1.73e-8)" 0.1 0.1 0.1 5.3 0.2 0.0 0.3 0.1 0.1 0.3 17.6 0.1 0.1 11.5 0.1 0.4 0.4 0.2 7.7 0.1 0.1 0.1 0.3 0.3 1.3 1.6 0.1 0.1 0.4 11.2 0.0 0.1 0.1 0.1 1.6 13.3 0.1 0.8 0.1 0.1 0.1 40.1 0.1 0.1 0.9 7.8 29.8 0.1 4.1 0.1 0.3 1.2 2.5 0.2 0.9 0.0 0.1 0.2 0.0 3.0 0.3 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.9 5.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.7 0.9 1.4 0.7 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 3.0 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.9 0.0 2.6 0.3 0.3 0.4 2.5 2.7 4.5 1.8 0.0 0.1 0.0 0.3 317.4 0.3 31.5 0.0 6.6 0.0 0.4 3.1 0.0 0.0 0.2 0.0 6.4 0.0 0.0 661.8 5.2 0.0 0.0 6.4 42.7 0.0 3.3 17.5 3.5 0.0 0.7 6.5 0.0 5.2 2.7 0.4 0.1 0.0 26.4 7.8 BCL2L15 "Bfk, C1orf178, FLJ22588" ENSG00000188761 "BCL2 like 15" Q5TBC7 1 113878168-113887547 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 84.0" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 93.5;Exocrine glandular cells: 101.2;Pancreatic endocrine cells: 70.7;Undifferentiated cells: 44.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.6;neutrophil: 1.9" "Group enriched" "Detected in many" 6 "granulocytes: 1.9;T-cells: 1.6" "Group enriched" "Detected in some" 5 "CAPAN-2: 19.5;EFO-21: 6.7;OE19: 21.8;RPTEC TERT1: 5.8" "Region enriched" "Detected in single" 32 "cerebellum: 36.9" "Low region specificity" "Detected in many" "HPA029732, HPA029733" Enhanced NA NA "HPA029732: AB_10599615, HPA029733: AB_10600422" "unprognostic (5.96e-2)" "unprognostic (6.41e-3)" "unprognostic (5.82e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.16e-1)" "unprognostic (6.23e-3)" "unprognostic (4.97e-4)" "unprognostic (1.74e-1)" "unprognostic (2.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.27e-2)" "unprognostic (1.49e-1)" "unprognostic (2.42e-7)" "unprognostic (5.20e-2)" "unprognostic (2.24e-2)" "unprognostic (9.04e-3)" "unprognostic (4.27e-2)" 0.4 0.2 0.4 3.8 0.4 5.7 0.4 0.9 0.4 2.6 30.5 0.4 0.7 25.4 0.6 2.4 2.3 0.5 4.9 0.4 0.4 0.2 1.3 0.4 0.7 0.4 0.4 0.4 0.6 9.4 0.0 0.4 0.4 0.4 0.5 18.8 0.4 0.4 0.4 0.4 0.2 84.0 0.4 0.4 0.5 9.4 0.6 0.4 0.4 0.4 0.9 0.6 0.8 0.6 0.0 0.0 1.9 0.3 0.0 1.6 0.4 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 1.8 0.3 0.2 0.0 21.8 0.0 0.0 0.3 0.4 5.8 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 1.2 0.5 0.0 0.0 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.4 0.4 0.4 0.9 0.4 0.4 0.2 0.4 0.4 0.4 0.4 0.0 2.2 0.8 4.4 0.3 1.7 0.3 7.6 4.0 9.1 22.7 5.9 0.1 0.0 2.7 1.2 0.0 93.5 0.0 101.2 0.0 0.8 2.1 0.0 0.0 0.6 1.6 2.4 0.0 0.6 0.0 0.0 2.1 0.0 2.8 33.4 0.5 70.7 17.3 0.0 0.2 2.4 0.0 1.0 0.5 0.7 1.0 0.1 1.3 44.4 13.9 BCL6 "BCL5, BCL6A, LAZ3, ZBTB27, ZNF51" ENSG00000113916 "B cell CLL/lymphoma 6" P41182 3 187721377-187745727 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Immunity, Inflammatory response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 114.3" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 63.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 63.4" "Cell line enhanced" "Detected in many" "ASC diff: 27.3;Daudi: 42.9;HSkMC: 31.1;U-698: 59.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000307, HPA004899, HPA050645" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199" "unprognostic (5.36e-2)" "unprognostic (3.29e-2)" "unprognostic (1.63e-3)" "unprognostic (2.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.34e-3)" "unprognostic (2.62e-2)" "unprognostic (3.33e-3)" "unprognostic (8.75e-2)" "unprognostic (2.04e-2)" "unprognostic (1.63e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.27e-9)" "unprognostic (5.22e-2)" "unprognostic (7.82e-2)" "unprognostic (5.67e-2)" "unprognostic (2.58e-2)" 47.1 14.3 21.8 23.2 25.9 50.6 48.0 58.7 23.7 21.2 21.2 19.2 11.5 4.1 17.7 8.8 20.9 28.3 22.3 18.6 21.5 8.0 10.1 20.1 26.3 24.5 31.6 9.3 20.2 15.6 9.1 23.3 7.5 28.5 17.3 5.8 15.9 19.1 11.8 114.3 36.4 8.1 24.4 50.1 27.2 16.1 10.2 26.6 18.9 14.8 10.4 22.4 24.9 20.0 3.9 5.6 63.4 15.4 0.9 1.3 5.2 1.2 3.6 3.6 0.8 27.3 21.8 3.9 4.3 10.5 5.0 5.3 2.6 2.0 42.9 3.1 5.4 3.1 2.1 1.2 2.8 4.3 9.0 1.4 0.0 1.8 6.1 14.2 0.5 0.2 31.1 18.2 6.1 9.4 16.3 2.8 1.1 0.4 7.4 4.8 1.4 1.4 0.3 0.3 0.7 2.7 11.9 1.8 0.2 3.5 6.3 0.8 0.0 5.0 2.1 2.8 8.3 9.4 1.5 5.6 12.1 1.9 4.4 2.0 5.5 1.8 59.6 6.6 1.6 8.5 1.6 6.9 4.1 1.3 8.7 1.3 1.4 0.8 1.2 5.6 3.9 0.5 0.6 63.4 0.9 15.4 0.9 0.6 5.2 21.8 25.9 58.7 23.7 21.5 8.0 31.6 9.3 28.5 26.6 17.9 76.9 6.5 13.3 42.0 11.0 60.5 17.8 25.4 22.7 15.7 19.6 1.1 0.0 9.2 12.3 27.7 1.6 0.0 10.6 2.0 36.2 28.7 10.5 44.4 11.2 0.0 4.6 9.8 56.3 6.2 26.7 26.7 33.7 3.6 1.1 40.1 8.7 0.0 17.7 1.1 9.6 32.3 96.4 0.4 0.7 53.8 3.4 10.7 1.9 21.9 BCO1 "BCDO, BCDO1, BCMO, BCMO1, FLJ10730" ENSG00000135697 "Beta-carotene oxygenase 1" Q9HAY6 16 81238448-81291142 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 28.1;retina: 62.0" "Cell type enhanced" "Detected in some" 13 "Mucus-secreting cells: 7.2;Paneth cells: 2.5;Proximal tubular cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 12.8;EFO-21: 9.7;HAP1: 3.7;NTERA-2: 5.2;RPTEC TERT1: 9.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043811 Uncertain "Actin filaments,Centriolar satellite" NA NA "Actin filaments, Centriolar satellite" "HPA043811: AB_10962487" "unprognostic (2.78e-1)" "unprognostic (3.88e-3)" "unprognostic (2.61e-1)" "unprognostic (3.32e-1)" "unprognostic (4.05e-2)" "unprognostic (8.01e-4)" "unprognostic (1.65e-1)" "unprognostic (2.99e-2)" "unprognostic (1.58e-3)" "unprognostic (7.26e-2)" "unprognostic (2.97e-2)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.48e-1)" "unprognostic (5.07e-2)" "unprognostic (1.09e-1)" 0.1 0.0 1.3 0.2 1.4 0.0 0.2 0.2 1.6 0.3 28.1 0.3 1.4 11.0 0.7 0.5 0.7 0.6 1.4 0.1 1.7 1.9 4.2 2.5 0.3 0.1 0.8 0.1 2.0 0.4 0.0 1.9 0.1 5.9 1.3 3.6 62.0 1.3 2.8 0.6 0.3 16.9 0.4 0.4 0.1 2.3 0.2 0.3 0.3 0.2 0.5 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 2.6 0.0 9.7 0.0 0.4 0.1 3.7 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.2 0.8 0.0 0.0 0.0 0.0 9.8 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.2 1.6 1.7 1.9 0.8 0.1 5.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.0 1.4 0.0 0.0 0.0 7.2 0.0 0.4 2.5 1.1 5.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 1.7 0.6 BCO2 "B-DIOX-II, BCDO2, FLJ34464" ENSG00000197580 "Beta-carotene oxygenase 2" Q9BYV7 11 112175467-112224699 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.9;liver: 44.0" "Cell type enhanced" "Detected in many" 17 "Cone photoreceptor cells: 386.8;Horizontal cells: 127.1;Rod photoreceptor cells: 238.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 5 "NK-cells: 2.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HHSteC: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA061542 Supported NA NA "HPA061542: " "unprognostic (2.92e-1)" "unprognostic (1.89e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-2)" "unprognostic (7.60e-3)" "unprognostic (1.88e-1)" "unprognostic (3.18e-2)" "unprognostic (6.40e-2)" "unprognostic (2.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.36e-4)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (1.07e-2)" "unprognostic (1.34e-1)" 2.3 14.7 4.0 0.9 6.8 0.8 1.3 1.9 4.6 1.2 1.5 5.9 0.3 1.1 2.0 2.8 2.1 9.5 6.0 28.9 3.5 3.9 1.6 44.0 1.8 0.9 10.5 2.6 1.5 1.3 0.8 16.3 3.9 9.5 1.3 1.1 12.4 1.1 1.5 17.3 1.5 1.6 4.4 11.0 1.0 1.1 2.4 9.8 0.0 1.9 1.0 1.3 1.3 2.7 0.3 0.5 0.3 0.6 2.8 0.2 0.0 0.1 1.3 0.6 0.8 0.5 0.6 0.0 0.4 0.3 0.1 0.7 0.0 7.6 0.5 0.6 0.9 0.7 1.6 0.0 0.3 0.5 0.1 0.2 1.0 0.7 0.5 16.4 0.5 0.3 0.1 3.1 0.2 0.5 1.5 0.1 0.1 0.2 0.4 0.1 0.1 0.6 1.6 0.1 0.8 0.2 0.4 0.2 0.2 0.3 0.3 0.6 0.3 0.6 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.0 3.4 0.4 0.1 0.6 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.5 0.2 0.0 0.0 0.3 2.8 0.2 0.2 0.0 0.0 4.0 6.8 1.9 4.6 3.5 3.9 10.5 2.6 9.5 9.8 3.0 1.9 3.7 15.0 3.0 12.6 42.5 38.2 53.5 9.1 5.2 386.8 0.2 0.0 2.8 2.2 4.0 7.0 0.0 1.8 0.3 5.6 7.3 5.7 78.4 0.9 127.1 7.9 15.4 3.0 1.7 3.7 2.6 1.7 4.6 0.7 13.3 1.2 3.5 3.5 1.0 238.0 0.0 4.6 5.4 2.4 2.8 0.6 3.9 2.9 8.9 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "liver: 156.0" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 20.3;U-937: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030947, HPA058709" Enhanced Approved Mitochondria NA NA Mitochondria "HPA030947: AB_10669548, HPA058709: AB_2683797" "unprognostic (2.72e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favorable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 3.5 2.8 6.6 5.2 11.2 4.7 4.6 18.1 13.8 4.0 13.9 4.6 6.3 9.6 2.1 3.6 12.9 5.5 6.1 19.6 6.3 5.8 6.0 156.0 2.0 4.2 5.9 9.1 3.0 2.8 5.8 3.6 1.4 7.7 4.5 11.1 6.2 8.6 4.4 7.3 8.0 13.7 2.4 3.5 2.3 4.7 1.8 3.6 5.4 5.2 11.3 7.4 3.6 3.6 6.1 4.6 2.9 1.6 4.7 9.9 4.0 10.4 1.4 0.6 5.4 0.9 0.0 0.0 1.2 1.0 5.4 3.1 9.4 3.5 0.0 15.6 0.3 0.4 4.9 4.7 2.5 2.1 0.1 0.0 5.5 3.6 3.2 4.0 12.3 5.8 1.6 2.9 2.1 4.6 0.5 1.3 6.3 0.0 4.2 0.1 18.6 9.5 8.3 4.1 20.3 1.9 9.0 2.0 14.3 5.8 4.8 9.9 4.3 3.8 0.5 2.0 0.2 12.5 10.3 0.1 0.3 1.8 0.0 9.8 4.8 9.1 0.1 0.3 35.0 0.6 2.9 1.6 0.6 5.9 0.2 8.2 6.1 6.5 5.3 4.2 5.5 9.9 5.9 0.0 4.7 0.3 4.6 4.2 4.0 6.6 11.2 18.1 13.8 6.3 5.8 5.9 9.1 7.7 3.6 3.0 6.5 8.0 8.1 8.2 20.4 35.0 17.8 49.5 10.3 12.2 19.6 1.6 44.7 4.7 7.8 1.5 56.7 0.0 4.9 3.6 5.1 6.8 1.1 92.8 7.2 17.5 26.2 4.9 3.3 10.3 5.2 5.5 15.1 0.0 38.7 16.2 2.2 31.6 3.9 12.1 32.8 0.0 5.4 14.1 4.7 9.5 1.6 9.6 56.2 11.9 BDH2 "DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308" ENSG00000164039 "3-hydroxybutyrate dehydrogenase 2" Q9BUT1 4 103079435-103099883 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 139.1" "Cell type enhanced" "Detected in many" 16 "Distal tubular cells: 179.1;Proximal tubular cells: 617.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 41.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036028, HPA036029" Enhanced Supported Cytosol NA NA Cytosol "HPA036028: AB_10670674, HPA036029: AB_2674909" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (1.64e-1)" "prognostic favorable (5.21e-4)" "unprognostic (3.92e-1)" "unprognostic (2.28e-1)" "unprognostic (3.82e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.37e-1)" "unprognostic (1.95e-1)" "prognostic favorable (4.45e-13)" "unprognostic (2.54e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.75e-4)" "unprognostic (9.69e-3)" 12.4 33.1 22.6 7.7 26.0 2.8 17.6 9.6 18.5 15.7 18.9 14.8 12.3 36.7 11.6 18.8 10.4 16.6 13.5 14.9 26.6 15.4 139.1 39.3 13.8 6.0 38.2 15.6 26.2 8.3 23.5 14.8 8.1 29.0 13.0 11.2 27.0 10.2 15.2 6.9 7.9 34.8 10.2 29.7 6.7 11.8 7.2 32.4 10.4 25.1 12.0 7.6 11.0 11.8 9.5 7.5 1.4 4.1 11.6 18.5 7.5 2.6 4.5 25.9 7.8 27.1 30.1 3.7 6.2 16.0 5.9 10.0 3.6 10.3 10.7 10.9 9.5 2.4 1.2 13.4 10.0 6.8 6.3 8.1 2.0 6.6 11.8 17.4 6.2 3.1 24.0 9.4 10.1 2.3 27.0 19.9 17.7 6.5 3.4 22.7 1.4 27.8 6.1 7.8 2.4 2.1 20.1 25.0 6.3 41.3 5.0 3.5 12.5 11.0 5.8 7.0 11.4 5.2 5.1 12.2 7.0 3.7 4.4 2.4 6.5 6.5 11.0 9.3 7.5 5.8 1.4 4.1 0.2 11.9 1.8 12.8 9.5 12.1 11.3 5.8 9.0 14.2 15.3 0.3 11.6 0.3 7.5 18.5 7.5 22.6 26.0 9.6 18.5 26.6 15.4 38.2 15.6 29.0 32.4 29.8 52.6 3.4 39.4 27.0 1.3 8.5 38.2 22.7 33.0 102.9 0.0 6.7 179.1 38.9 1.1 24.3 37.4 0.0 19.3 13.9 51.4 21.0 18.5 63.8 17.7 3.2 22.0 28.3 13.2 2.1 64.7 10.3 21.9 19.8 19.9 45.8 21.4 14.1 73.2 617.5 2.2 12.9 24.2 0.7 1.7 23.3 2.9 17.3 23.0 33.1 BDKRB1 "B1BKR, BKR1, bradyb1" ENSG00000100739 "Bradykinin receptor B1" P46663 14 96255824-96268967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.1;lymphoid tissue: 17.1" "Cell type enhanced" "Detected in many" 20 "Basal keratinocytes: 36.2;Fibroblasts: 10.8;Suprabasal keratinocytes: 15.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 2.1" "Cell type enriched" "Detected in single" 19 "T-reg: 1.8" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.8;HHSteC: 12.2;hTEC/SVTERT24-B: 11.4;U-2197: 12.6;U-87 MG: 41.9" "Low region specificity" "Detected in single" HPA002935 Approved NA NA "HPA002935: AB_1078274" "unprognostic (6.15e-2)" "unprognostic (2.78e-2)" "unprognostic (9.40e-2)" "unprognostic (3.06e-3)" "unprognostic (6.76e-2)" "unprognostic (1.11e-2)" "unprognostic (3.31e-2)" "unprognostic (2.34e-3)" "unprognostic (2.23e-2)" "unprognostic (2.96e-2)" "unprognostic (4.80e-3)" "unprognostic (2.36e-1)" "unprognostic (9.96e-6)" "unprognostic (2.33e-1)" "unprognostic (8.82e-2)" "unprognostic (2.33e-3)" "unprognostic (4.66e-2)" 7.3 0.0 0.2 17.1 0.2 0.0 0.8 2.1 0.6 5.4 3.7 0.2 0.2 1.8 0.7 2.8 10.4 4.8 16.1 2.3 0.2 0.0 2.4 0.6 3.7 0.2 0.2 0.2 4.5 7.9 0.0 0.2 3.0 0.4 2.2 2.8 0.7 1.5 1.1 0.4 2.4 3.7 5.7 0.2 0.6 3.3 2.3 0.2 0.2 0.8 4.6 2.0 13.7 5.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.6 0.0 0.4 1.1 4.0 0.0 1.0 11.8 1.2 0.2 0.0 0.2 0.0 0.0 6.9 0.6 1.1 0.0 0.1 1.9 0.1 0.0 0.0 1.2 0.0 12.2 0.0 0.0 0.4 1.0 11.4 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.7 0.1 0.0 3.6 0.0 0.1 0.0 0.4 0.0 3.3 1.1 0.0 0.1 0.0 0.0 0.0 4.5 0.2 12.6 0.7 2.2 4.1 0.0 41.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.2 2.1 0.6 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.3 0.0 1.5 36.2 0.2 0.4 0.0 2.7 0.0 0.0 0.0 0.2 6.6 1.6 0.7 0.1 2.9 0.0 1.1 0.3 10.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 3.5 0.4 0.0 0.0 0.0 1.0 0.5 1.5 15.1 1.3 0.0 0.0 2.6 BDNF ENSG00000176697 "Brain derived neurotrophic factor" P23560 11 27654893-27722058 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;smooth muscle: 10.5" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 35.7;Cardiomyocytes: 9.6;Smooth muscle cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 22.7;BJ hTERT+ SV40 Large T+: 17.4;BJ hTERT+ SV40 Large T+ RasG12V: 13.2;HBF TERT88: 16.7;U-138 MG: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009564, HPA031440, HPA056104" Enhanced Supported "Nuclear speckles,Mitochondria" "Secreted to blood" NA NA 16000000 "Nuclear speckles, Mitochondria" "CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: AB_2683038" "unprognostic (1.25e-2)" "unprognostic (2.84e-1)" "unprognostic (4.35e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-2)" "unprognostic (6.82e-2)" "unprognostic (2.39e-2)" "unprognostic (2.21e-1)" "unprognostic (3.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.22e-2)" "unprognostic (3.88e-2)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (2.84e-3)" 0.9 1.3 5.0 0.6 4.5 0.5 0.6 9.4 14.5 1.6 0.8 0.6 0.7 0.8 0.7 8.2 1.4 0.5 2.1 5.8 8.5 5.7 0.9 0.5 4.1 0.4 2.5 4.7 1.2 1.0 0.2 2.3 3.7 12.7 4.9 0.4 3.0 0.9 4.2 1.3 2.1 0.5 10.5 1.0 0.6 0.9 1.3 0.0 0.0 2.3 0.0 0.4 3.2 1.2 0.1 0.4 0.0 0.2 0.1 1.0 0.1 1.6 6.7 0.2 0.0 2.4 1.9 0.0 22.7 4.4 17.4 13.2 0.0 2.6 0.0 2.1 8.2 0.3 1.0 0.1 0.2 16.7 0.1 0.1 0.0 2.2 0.0 10.1 0.1 0.1 5.9 2.2 3.8 2.2 10.6 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.1 0.0 1.8 0.0 1.3 0.0 2.5 0.0 0.1 0.6 4.3 0.0 0.0 1.0 0.1 0.0 7.5 24.4 4.1 9.4 5.0 0.3 0.0 0.0 9.4 0.6 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.1 0.7 0.4 0.0 0.1 0.0 0.4 1.0 0.1 5.0 4.5 9.4 9.4 8.5 5.7 2.5 4.7 12.7 0.0 35.7 0.3 0.0 0.2 0.6 4.7 9.6 0.0 0.0 0.0 1.8 3.9 0.2 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.3 4.1 0.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.7 0.0 0.0 0.1 0.2 0.0 0.0 0.3 1.5 0.0 6.6 0.4 0.7 0.0 0.6 0.0 0.0 0.0 BEAN1 SCA31 ENSG00000166546 "Brain expressed associated with NEDD4 1" Q3B7T3 16 66427297-66493529 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 4.8;Early spermatids: 8.4;Extravillous trophoblasts: 8.9;Late spermatids: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 5.2" "Cell line enhanced" "Detected in some" "AN3-CA: 9.7;BEWO: 4.9;RPTEC TERT1: 8.6;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053851 Uncertain Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA053851: AB_2682280" "unprognostic (1.92e-1)" "unprognostic (5.79e-4)" "unprognostic (3.83e-2)" "unprognostic (3.38e-3)" "unprognostic (1.01e-1)" "unprognostic (4.04e-2)" "unprognostic (2.16e-1)" "unprognostic (1.13e-1)" "unprognostic (4.89e-1)" "unprognostic (1.59e-1)" "unprognostic (2.13e-3)" "unprognostic (4.18e-2)" "unprognostic (3.38e-2)" "unprognostic (1.63e-1)" "unprognostic (3.10e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-2)" 1.2 1.2 2.9 1.1 2.5 2.9 1.2 6.9 9.6 1.2 0.7 0.1 0.0 0.6 1.2 1.9 1.8 1.9 1.4 3.0 4.6 4.1 0.9 1.1 1.4 0.9 2.3 3.2 1.4 1.9 0.1 0.4 4.5 11.6 1.0 0.9 5.0 1.9 0.4 3.6 3.2 0.8 0.8 1.7 1.2 1.2 3.1 0.2 0.0 1.9 3.1 0.9 1.0 1.0 0.3 2.4 5.2 0.5 0.4 0.2 0.1 0.8 1.0 1.0 9.7 0.3 0.1 4.9 0.3 0.0 0.1 0.1 0.0 1.0 0.1 0.6 0.3 0.6 0.2 0.1 0.1 0.3 0.0 0.7 0.0 0.2 0.7 0.7 0.1 0.0 0.7 1.9 0.6 0.3 1.4 0.0 0.2 0.1 0.3 0.2 0.5 0.0 0.4 0.3 0.1 0.6 0.1 0.2 0.5 8.6 0.6 0.1 0.2 0.2 0.2 1.4 0.7 0.2 0.1 0.3 0.4 2.7 0.1 0.4 0.5 0.1 0.1 5.6 0.2 1.4 0.4 0.5 1.9 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 0.1 5.2 0.4 0.2 2.4 0.1 0.1 2.9 2.5 6.9 9.6 4.6 4.1 2.3 3.2 11.6 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.2 8.4 0.3 0.0 0.0 0.0 8.9 0.6 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 8.0 0.3 0.0 3.3 0.0 0.0 0.0 1.0 0.0 2.1 0.0 0.9 0.0 0.5 2.9 0.3 0.1 2.4 0.0 0.0 0.3 BEGAIN KIAA1446 ENSG00000183092 "Brain enriched guanylate kinase associated" Q9BUH8 14 100537147-100587413 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 135.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "eosinophil: 6.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.8" "Group enriched" "Detected in some" 7 "HeLa: 21.8;SH-SY5Y: 53.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002899 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA002899: AB_1078277" "unprognostic (2.98e-4)" "unprognostic (2.75e-3)" "unprognostic (2.66e-2)" "unprognostic (2.66e-4)" "unprognostic (2.77e-3)" "unprognostic (1.93e-2)" "unprognostic (5.16e-2)" "unprognostic (6.35e-2)" "unprognostic (3.83e-1)" "unprognostic (4.33e-2)" "unprognostic (4.15e-2)" "unprognostic (5.47e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (3.11e-1)" "unprognostic (2.75e-1)" "unprognostic (2.60e-1)" 1.8 5.5 16.4 1.1 10.8 6.4 1.5 24.9 21.6 1.3 1.3 0.9 0.0 4.6 2.0 1.8 1.4 3.0 2.5 1.5 15.3 7.1 0.9 0.8 1.0 1.3 4.4 6.0 3.5 13.0 2.3 8.2 3.1 3.6 2.6 0.9 2.1 2.8 2.7 0.9 1.3 3.0 1.7 2.0 3.3 1.0 2.6 1.4 5.4 1.0 0.4 1.3 0.8 0.6 0.6 1.0 6.8 1.5 0.0 0.4 0.1 0.3 1.3 0.7 4.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.2 0.2 1.0 0.1 0.2 0.0 0.0 0.0 0.4 2.0 21.8 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.5 0.0 0.0 0.3 0.2 0.0 0.0 1.7 0.1 0.6 0.5 0.1 0.7 0.0 0.1 2.7 0.0 0.0 1.2 53.1 1.2 0.0 1.2 0.0 0.3 5.4 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.1 1.3 0.1 6.8 0.0 1.5 0.0 0.6 0.4 0.0 0.0 0.2 0.1 0.0 0.6 0.0 1.4 1.0 0.0 0.1 16.4 10.8 24.9 17.3 15.3 7.1 4.4 6.0 3.6 1.4 0.0 1.1 0.0 1.4 2.2 1.5 1.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.3 0.6 0.7 0.0 6.9 0.2 1.4 0.5 9.2 0.0 0.2 135.1 0.0 0.0 0.0 0.6 1.7 0.7 1.7 1.8 0.0 0.7 4.1 0.0 6.3 0.0 2.4 0.0 0.3 0.9 0.4 1.8 0.1 0.0 0.2 0.3 BEND2 "CXorf20, MGC33653" ENSG00000177324 "BEN domain containing 2" Q8NDZ0 X 18162931-18220883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 23.2" "Cell type enhanced" "Detected in some" 16 "Leydig cells: 17.3;Peritubular cells: 12.4;Sertoli cells: 6.5;Spermatocytes: 24.7;Spermatogonia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 4.1;neutrophil: 1.8" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.1" "Cell line enhanced" "Detected in single" "HeLa: 1.6" "HPA009420, HPA013142" Enhanced NA NA "HPA009420: AB_2064489, HPA013142: AB_2668784" "unprognostic (2.23e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 4.1 0.4 0.4 0.4 5.1 0.4 0.2 0.4 0.8 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.5 0.2 0.1 0.2 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.1 0.4 1.6 0.2 0.1 0.5 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.5 0.5 0.8 0.3 0.5 0.1 0.5 0.4 0.3 0.3 0.3 0.3 0.7 0.0 0.4 0.4 0.0 0.2 0.3 0.4 0.4 0.2 0.1 0.8 0.4 0.2 0.4 0.1 0.9 0.2 0.8 0.2 0.7 0.4 4.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 0.2 0.1 0.4 0.3 0.4 1.8 0.4 0.1 0.3 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 1.4 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 6.5 0.2 24.7 6.1 0.4 0.0 0.0 0.0 0.3 BEND3 KIAA1553 ENSG00000178409 "BEN domain containing 3" Q5T5X7 6 107065182-107115269 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 12.6" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 5.9;Late spermatids: 5.2" "Cancer enhanced" "Detected in all" "testis cancer: 12.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017891, HPA062067" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA017891: AB_2064595, HPA062067: AB_2684675" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "unprognostic (9.47e-3)" "unprognostic (4.25e-3)" "unprognostic (1.04e-1)" "unprognostic (2.43e-2)" "unprognostic (8.37e-8)" "unprognostic (1.59e-1)" "unprognostic (9.71e-2)" "unprognostic (3.99e-2)" "unprognostic (2.71e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (8.65e-2)" "unprognostic (3.49e-1)" "unprognostic (1.09e-1)" "unprognostic (4.37e-1)" 1.8 1.9 1.4 1.8 2.5 1.8 5.6 4.0 2.2 1.6 3.6 1.3 0.8 3.0 2.4 4.2 2.5 2.3 3.6 3.8 1.1 1.3 3.1 4.4 2.0 1.5 1.8 0.8 1.9 12.6 1.8 2.3 1.5 3.3 2.6 3.9 1.3 3.4 1.0 5.0 1.4 4.1 2.5 1.8 2.8 5.0 4.6 1.5 2.4 1.9 3.9 3.6 2.2 1.2 1.5 1.3 2.0 1.0 0.8 1.7 0.4 2.8 4.1 11.3 6.4 1.3 1.0 9.3 1.1 1.5 1.5 1.8 4.6 2.1 8.4 2.9 2.9 2.6 2.8 12.2 6.3 2.5 3.3 6.1 2.3 3.0 5.1 1.1 6.0 3.0 2.5 2.6 2.2 3.2 1.2 1.9 4.0 6.3 3.5 1.9 5.7 5.1 4.6 15.8 7.1 2.6 7.0 3.3 5.5 2.4 8.4 11.5 5.6 3.6 6.1 2.3 6.0 3.6 4.8 2.2 4.1 3.9 1.9 5.4 2.4 3.2 8.6 1.4 4.7 3.2 2.0 0.8 1.5 1.2 1.0 0.9 1.5 1.1 1.1 0.5 1.1 0.8 1.7 1.6 0.8 1.0 1.3 1.2 0.4 1.4 2.5 4.0 1.8 1.1 1.3 1.8 0.8 3.3 1.5 3.0 2.4 0.0 0.8 2.6 1.4 2.8 0.0 1.4 2.3 0.0 5.9 0.8 0.0 0.8 4.2 0.8 0.4 0.0 1.5 1.2 0.6 1.0 0.0 0.6 0.6 0.0 1.2 0.0 1.0 5.2 0.9 0.5 0.0 0.0 2.2 0.2 0.9 0.0 0.0 0.8 1.4 0.0 2.1 0.6 2.5 2.6 0.7 0.0 3.0 0.7 BEND4 "CCDC4, FLJ35632, FLJ43965" ENSG00000188848 "BEN domain containing 4" Q6ZU67 4 42110938-42152878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 26.7" "Group enriched" "Detected in some" 7 "Muller glia cells: 10.2;Spermatogonia: 35.8" "Group enriched" "Detected in some" 43 "prostate cancer: 6.3;testis cancer: 5.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "memory B-cell: 1.1;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 12 "B-cells: 3.3" "Cell line enhanced" "Detected in some" "HAP1: 23.9;HEK 293: 5.8;HEL: 14.6;MOLT-4: 8.9;SuSa: 11.8;U-698: 9.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036850 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA036850: AB_10600787" "unprognostic (3.62e-4)" "unprognostic (3.82e-1)" "unprognostic (4.82e-2)" "unprognostic (5.96e-3)" "unprognostic (2.97e-3)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (5.58e-2)" "unprognostic (6.71e-3)" "unprognostic (1.68e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (1.49e-1)" "unprognostic (4.58e-3)" "unprognostic (4.24e-1)" 0.4 0.3 3.9 5.0 1.0 1.6 0.3 0.2 2.6 0.2 0.6 0.0 0.0 0.5 0.4 0.2 0.3 0.2 0.4 0.3 2.8 1.9 0.3 0.5 1.0 3.7 2.8 1.1 0.6 0.3 0.1 3.8 0.8 1.8 6.4 0.7 0.2 0.8 0.2 0.2 0.2 2.8 0.4 0.4 4.8 0.5 26.7 0.3 4.8 0.3 0.0 3.0 0.7 2.3 3.3 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 23.9 0.0 0.0 0.0 5.8 14.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 8.9 0.0 4.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.9 1.0 0.2 2.6 2.8 1.9 2.8 1.1 1.8 0.3 0.0 0.0 0.9 0.1 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.2 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 35.8 0.0 0.0 0.0 0.0 0.0 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955126-57027342 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Group enriched" "Detected in many" 8 "Bipolar cells: 68.2;Horizontal cells: 39.7" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 11.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.2;fHDF/TERT166: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: AB_2682002" "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.5 3.1 12.0 2.0 10.7 1.0 1.1 29.2 29.7 5.8 1.7 2.5 0.6 0.8 3.2 1.3 1.8 1.1 5.2 3.1 11.2 10.0 1.0 0.5 1.0 1.2 11.3 8.6 2.9 0.8 2.8 1.1 2.7 33.0 3.4 2.2 0.2 1.0 3.4 4.3 1.5 1.2 4.8 7.2 1.2 1.3 1.5 4.1 0.0 1.3 0.0 1.3 3.9 1.6 0.0 11.1 0.0 0.0 2.1 0.0 0.1 3.4 1.5 0.8 0.4 12.1 20.2 3.3 10.4 10.1 4.7 5.4 0.1 1.6 0.0 3.4 18.4 6.5 0.4 1.2 0.5 5.9 1.5 0.6 2.2 4.9 0.2 3.2 6.3 0.1 8.7 2.9 6.4 2.9 8.0 3.1 8.7 2.8 6.0 9.4 3.5 3.8 1.6 2.9 0.1 0.8 0.0 0.1 1.6 1.7 3.4 4.1 4.1 6.9 0.9 0.8 4.2 0.2 3.8 3.9 14.2 0.4 9.6 2.2 8.3 9.1 2.7 8.3 4.4 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 11.1 0.0 0.1 12.0 10.7 29.2 20.8 11.2 10.0 11.3 8.6 33.0 4.1 0.0 0.0 0.0 0.2 0.8 68.2 3.6 0.0 0.0 1.2 0.0 3.9 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.2 6.9 0.6 0.0 0.0 0.1 39.7 0.0 1.8 0.0 0.6 1.7 2.1 3.3 0.0 0.0 3.7 0.3 0.0 2.8 0.3 4.1 0.0 1.9 0.5 4.1 0.9 0.0 0.0 0.0 0.0 BEST1 "BEST, BMD, RP50, VMD2" ENSG00000167995 "Bestrophin 1" O76090 11 61949821-61965515 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 218.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 70.9;Macrophages: 85.3" "Group enriched" "Detected in some" 6 "glioma: 2.0;melanoma: 6.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 23.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.3" "Cell line enhanced" "Detected in some" "ASC diff: 9.4;SK-MEL-30: 33.5;U-266/70: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057464 Enhanced NA NA "HPA057464: AB_2683444" "unprognostic (2.41e-3)" "unprognostic (3.67e-2)" "unprognostic (5.91e-3)" "unprognostic (1.21e-1)" "unprognostic (1.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.07e-3)" "unprognostic (2.06e-1)" "unprognostic (4.27e-10)" "unprognostic (1.38e-1)" "unprognostic (4.93e-2)" "unprognostic (3.59e-3)" "unprognostic (2.72e-3)" 5.2 2.9 7.4 9.5 11.8 26.4 2.3 1.6 12.6 2.0 1.4 16.0 0.7 2.1 2.6 9.6 3.0 2.6 6.2 2.5 9.2 5.3 1.4 1.1 4.7 2.5 14.8 6.0 3.7 2.2 0.5 1.4 2.8 9.4 1.6 1.3 218.0 1.2 1.9 0.7 3.0 2.0 2.1 16.9 5.4 1.3 3.9 13.3 0.3 2.3 0.4 0.6 3.9 2.3 0.3 1.6 23.3 2.8 0.1 0.1 0.9 0.5 0.5 0.2 0.4 9.4 2.0 0.9 0.7 1.2 0.2 0.8 0.3 0.3 0.1 1.3 0.6 1.3 0.7 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.6 2.9 0.1 0.3 2.7 1.1 1.2 2.6 1.2 0.0 0.5 0.5 5.3 1.2 0.3 0.1 0.4 0.0 0.5 1.3 0.0 0.1 0.2 0.0 1.3 0.7 0.5 1.0 0.1 33.5 0.5 0.5 1.3 0.1 0.6 0.4 0.5 0.2 9.0 0.5 0.5 3.4 0.4 1.0 1.5 2.3 2.1 0.1 2.7 0.1 0.3 0.1 0.1 1.6 0.1 0.1 0.0 23.3 0.1 2.8 0.3 0.1 0.9 7.4 11.8 1.6 5.9 9.2 5.3 14.8 6.0 9.4 13.3 23.8 66.0 6.0 5.8 32.3 1.8 3.2 12.7 37.5 62.6 1.8 0.0 12.7 0.0 2.4 6.6 8.3 19.1 0.0 2.9 18.2 15.0 9.1 70.9 4.7 33.7 0.0 9.9 22.7 60.1 1.8 14.1 85.3 52.3 4.6 10.3 6.0 3.0 14.4 6.3 4.8 9.0 6.5 8.3 1.6 2.8 28.5 17.0 10.2 10.9 5.4 BEST2 "FLJ20132, VMD2L1" ENSG00000039987 "Bestrophin 2" Q8NFU1 19 12751702-12758458 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 25.2;retina: 28.7;skin 1: 11.7" "Cell type enriched" "Detected in some" 62 "Mucus-secreting cells: 105.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 3.5" HPA046229 Approved NA NA "HPA046229: AB_10966140" "unprognostic (3.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.54e-2)" "unprognostic (1.02e-1)" "unprognostic (5.74e-2)" "unprognostic (4.02e-3)" "unprognostic (2.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (2.43e-1)" "unprognostic (3.46e-3)" "unprognostic (9.18e-6)" "unprognostic (3.45e-2)" "unprognostic (6.95e-2)" "unprognostic (2.90e-1)" "unprognostic (1.64e-5)" 0.2 0.1 0.2 4.1 0.2 1.8 0.3 0.2 1.3 0.4 25.2 0.2 0.2 0.0 0.2 0.7 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.2 2.2 0.2 0.2 0.4 0.2 0.4 0.2 0.2 0.2 0.2 12.8 28.7 0.6 0.2 0.2 11.7 11.5 0.5 0.2 0.2 0.1 0.3 0.2 0.2 0.4 1.5 5.2 0.2 1.0 3.1 2.7 2.2 0.8 1.7 2.1 1.2 0.9 0.7 2.3 3.5 0.0 0.4 1.6 1.0 0.0 0.5 0.7 2.6 3.6 2.9 0.9 1.2 0.7 1.8 0.0 0.5 0.6 3.3 1.6 2.4 3.3 0.9 0.4 1.2 5.2 0.5 0.3 0.4 0.3 1.4 0.3 0.6 0.6 1.5 0.5 3.0 0.8 1.9 3.0 0.2 2.6 0.4 1.3 0.5 1.0 1.2 1.9 1.9 1.5 0.7 0.6 2.7 1.8 0.9 2.6 0.9 1.0 1.6 2.1 0.9 1.3 1.1 1.3 2.7 1.9 1.7 0.5 0.4 1.4 0.8 1.1 2.2 1.0 0.8 0.2 3.1 2.1 2.1 2.2 1.7 0.5 2.7 0.7 1.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 1.6 0.1 BEST3 "MGC13168, MGC40411, VMD2L3" ENSG00000127325 "Bestrophin 3" Q8N1M1 12 69643360-69699476 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 125.0" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 7.9;Late spermatids: 13.0;Muller glia cells: 7.5" "Cancer enriched" "Detected in single" 9 "glioma: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "REH: 18.7;RPMI-8226: 20.1;U-698: 33.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054582 Approved NA NA "HPA054582: AB_2682530" "unprognostic (1.53e-1)" "unprognostic (7.00e-2)" "unprognostic (9.83e-2)" "unprognostic (1.67e-2)" "unprognostic (5.15e-3)" "unprognostic (2.26e-3)" "unprognostic (7.30e-7)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (5.36e-2)" "unprognostic (1.19e-1)" "unprognostic (4.08e-2)" "unprognostic (4.82e-2)" "unprognostic (4.47e-2)" "unprognostic (3.03e-1)" 1.6 0.5 1.7 0.1 1.9 2.4 0.6 6.3 9.3 0.2 0.2 0.9 0.0 0.2 0.2 2.4 1.7 0.1 0.2 0.4 1.8 0.7 0.4 0.3 0.1 0.2 1.8 0.6 0.2 1.0 0.1 0.7 0.3 1.2 1.7 0.2 0.1 1.9 0.1 125.0 0.9 0.1 0.1 1.9 0.1 0.1 2.5 1.0 0.5 0.2 21.9 0.7 0.1 0.0 1.2 0.9 1.7 0.5 0.6 1.0 0.7 0.1 0.2 0.7 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.4 0.1 0.2 1.3 0.3 0.0 1.1 0.1 0.0 0.0 0.4 0.2 0.0 0.5 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.8 0.1 0.0 0.0 0.7 0.3 0.3 18.7 0.6 20.1 1.0 0.1 0.4 0.0 0.1 0.1 0.0 1.3 0.2 0.0 0.1 0.2 0.5 0.1 0.7 0.1 0.2 33.5 1.4 0.0 0.1 0.3 0.5 0.3 0.5 0.4 0.8 1.2 1.0 0.7 0.3 0.8 1.0 1.0 1.7 0.6 0.4 0.9 0.4 0.7 1.7 1.9 6.3 1.5 1.8 0.7 1.8 0.6 1.2 1.0 0.0 0.0 0.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.9 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.0 0.0 0.0 1.7 0.0 0.0 7.5 0.4 0.0 0.0 2.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 BEST4 VMD2L2 ENSG00000142959 "Bestrophin 4" Q8NFU0 1 44783585-44787705 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 34.3" "Cell type enriched" "Detected in some" 35 "Paneth cells: 745.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 7.4;U-698: 5.3" "Low region specificity" "Detected in all" HPA058564 Uncertain NA NA "HPA058564: AB_2683759" "unprognostic (5.76e-2)" "unprognostic (1.22e-1)" "unprognostic (3.15e-2)" "unprognostic (6.20e-2)" "unprognostic (6.51e-3)" "unprognostic (1.09e-1)" "unprognostic (8.39e-2)" "unprognostic (1.45e-3)" "unprognostic (1.04e-1)" "unprognostic (8.97e-2)" "unprognostic (5.72e-2)" "unprognostic (1.29e-1)" "unprognostic (2.69e-5)" "unprognostic (1.43e-1)" "unprognostic (3.72e-1)" "unprognostic (1.28e-1)" "unprognostic (4.13e-3)" 0.5 1.1 0.6 1.4 2.5 0.4 0.5 2.1 0.7 1.2 32.7 0.5 0.5 8.8 0.7 2.6 0.5 7.2 0.5 0.5 1.0 3.2 0.5 0.5 1.1 0.5 0.5 0.5 0.5 0.5 0.4 1.8 0.5 0.5 0.5 15.9 0.5 0.5 0.5 0.5 1.8 34.3 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 3.0 0.9 0.7 0.1 0.9 2.8 0.4 0.2 0.6 1.1 1.2 0.4 0.4 3.5 0.8 0.4 0.3 0.1 0.4 1.5 0.3 1.5 0.4 0.8 1.6 0.3 0.2 0.4 0.8 0.7 0.2 1.9 7.4 0.4 0.0 0.9 0.7 0.9 0.4 0.7 1.8 1.0 1.3 0.2 0.6 0.2 0.2 0.0 0.5 2.4 0.2 0.2 0.4 0.3 0.7 0.5 0.1 2.5 0.9 0.3 0.2 0.3 0.8 1.2 0.1 1.7 0.5 0.5 0.5 0.5 1.2 0.3 5.3 1.2 0.3 0.2 0.1 0.1 0.5 1.1 0.1 2.7 3.0 1.9 2.8 0.0 2.0 1.0 1.8 0.7 0.9 0.0 0.9 2.2 0.4 0.6 2.5 2.1 0.7 1.0 3.2 0.5 0.5 0.5 0.5 0.0 0.0 0.8 0.7 0.2 0.7 0.4 0.0 21.4 3.4 5.2 0.0 0.3 1.7 0.5 0.0 0.3 15.8 0.0 0.7 0.1 0.2 0.4 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.9 0.3 0.0 0.0 3.4 1.0 0.4 745.7 0.4 0.6 0.1 0.0 0.3 0.5 0.7 0.5 0.2 1.3 5.0 0.4 BEX1 ENSG00000133169 "Brain expressed X-linked 1" Q9HBH7 X 103062651-103064240 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 150.2;pituitary gland: 64.3" "Group enriched" "Detected in many" 4 "Bipolar cells: 321.5;Horizontal cells: 343.2;Muller glia cells: 473.7;Rod photoreceptor cells: 119.7" "Cancer enhanced" "Detected in many" "glioma: 111.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 60.3;HBF TERT88: 67.4;HL-60: 147.5;hTERT-RPE1: 104.5;SCLC-21H: 46.2;U-937: 46.2" "HPA045384, HPA078630" Approved Approved Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "prognostic favorable (6.43e-4)" "unprognostic (1.51e-1)" "unprognostic (8.92e-2)" "unprognostic (2.94e-2)" "unprognostic (1.66e-1)" "unprognostic (7.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-2)" "unprognostic (5.28e-3)" "unprognostic (2.09e-1)" "prognostic favorable (8.16e-8)" "unprognostic (1.14e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (7.34e-2)" 1.8 37.4 66.4 2.8 65.1 16.3 1.9 44.7 150.2 1.8 3.0 6.2 0.0 3.3 7.7 25.2 1.6 10.1 1.8 3.6 77.4 81.0 4.5 3.0 2.1 1.7 38.9 67.8 9.5 30.9 48.1 64.3 1.5 35.8 3.8 3.1 4.7 2.2 2.9 1.3 1.5 3.9 3.3 24.3 2.3 5.0 27.5 12.0 0.0 12.1 0.0 1.5 1.5 0.4 2.4 0.2 6.4 0.5 1.7 3.1 1.5 0.0 0.0 3.7 0.0 0.0 0.0 0.1 2.1 0.0 40.6 60.3 0.0 0.0 0.0 0.0 15.1 13.0 0.0 0.0 0.0 67.4 0.0 0.1 12.3 0.0 8.0 0.7 147.5 0.2 0.9 0.0 8.8 0.0 104.5 0.0 11.8 0.0 0.0 8.1 0.0 27.7 0.0 33.6 9.3 6.0 0.0 0.0 0.7 0.0 0.0 46.2 26.6 0.0 0.0 0.1 0.6 0.0 41.7 0.0 0.0 13.9 0.1 1.5 7.2 0.2 0.0 5.4 46.2 2.6 0.6 0.5 6.4 0.7 0.1 0.7 1.2 2.0 1.2 0.1 2.4 3.1 1.4 1.2 1.7 0.4 0.2 0.9 1.5 66.4 65.1 44.7 89.0 77.4 81.0 38.9 67.8 35.8 12.0 0.0 0.3 0.5 7.8 7.7 321.5 8.2 20.4 0.0 1.2 5.2 37.3 0.3 61.3 6.4 9.3 2.8 0.4 0.0 11.5 0.1 0.4 6.9 0.0 0.0 1.3 343.2 76.4 28.8 7.5 16.7 7.5 0.3 6.8 1.8 0.4 473.7 10.3 2.3 2.5 12.7 119.7 0.0 2.2 15.4 14.7 5.6 0.5 0.0 0.9 1.4 BEX2 DJ79P11.1 ENSG00000133134 "Brain expressed X-linked 2" Q9BXY8 X 103309346-103311046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 79.2;epididymis: 67.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 354.8;Muller glia cells: 185.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8" "Cell line enhanced" "Detected in many" "GAMG: 18.6;hTCEpi: 31.0;NTERA-2: 29.9;SCLC-21H: 44.0;SH-SY5Y: 20.0" "HPA045384, HPA078630" Uncertain Uncertain Cytosol NA NA Cytosol "HPA045384: AB_2679305, HPA078630: " "unprognostic (7.56e-2)" "unprognostic (7.08e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (8.54e-7)" "unprognostic (3.21e-1)" "unprognostic (1.65e-1)" "unprognostic (4.27e-2)" "prognostic favorable (1.52e-4)" "unprognostic (7.36e-3)" "unprognostic (6.82e-2)" "unprognostic (8.22e-3)" "unprognostic (6.63e-2)" "prognostic favorable (3.05e-13)" "unprognostic (4.14e-3)" "unprognostic (6.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" 1.7 39.6 49.1 4.1 62.6 6.8 10.9 44.9 79.2 5.8 4.7 11.5 3.0 2.7 14.7 67.1 3.0 8.9 4.8 7.3 53.4 57.6 26.4 1.4 6.6 7.3 32.5 40.3 29.0 13.5 29.6 40.1 5.0 29.6 12.4 4.1 11.5 11.1 12.8 2.5 4.2 4.2 5.7 18.7 7.9 6.5 13.2 13.6 3.1 52.8 1.3 9.2 3.7 2.2 18.0 3.5 4.0 0.1 21.3 26.8 7.1 0.0 0.8 3.8 0.0 0.0 0.0 14.8 0.1 2.0 2.6 3.7 2.6 1.2 0.0 10.4 0.0 18.6 0.6 0.0 3.0 2.2 0.0 8.0 0.4 0.4 0.1 15.2 0.0 8.2 0.9 31.0 1.2 9.5 5.8 0.1 10.7 5.3 0.2 0.3 1.3 6.2 0.0 29.9 0.0 2.6 0.0 0.0 0.0 1.2 1.1 44.0 20.0 2.0 0.4 6.6 3.7 3.6 0.0 0.0 0.0 3.0 0.1 0.6 10.1 6.4 0.0 5.0 0.0 0.4 4.0 0.1 0.3 8.5 0.1 11.8 18.0 16.8 9.8 0.5 15.0 26.8 19.2 0.5 21.3 0.0 3.5 11.3 7.1 49.1 62.6 44.9 60.5 53.4 57.6 32.5 40.3 29.6 13.6 14.9 49.0 36.6 86.3 28.0 178.0 20.2 56.0 13.4 63.7 108.2 41.2 66.0 354.8 40.3 13.3 11.7 2.0 0.0 36.9 9.9 3.3 54.5 12.7 0.8 6.1 114.4 96.4 1.8 0.0 48.7 14.7 4.7 25.3 1.8 25.1 185.5 28.0 7.0 20.8 145.1 106.4 6.5 4.5 14.0 6.0 23.3 53.3 21.7 17.2 43.8 BEX5 NGFRAP1L1 ENSG00000184515 "Brain expressed X-linked 5" Q5H9J7 X 102153708-102156057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 198.7;Distal tubular cells: 116.0" "Cancer enhanced" "Detected in all" "endometrial cancer: 45.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.6;MAIT T-cell: 11.2;memory CD4 T-cell: 8.5;memory CD8 T-cell: 5.9;naive CD4 T-cell: 12.4;naive CD8 T-cell: 7.4;NK-cell: 6.5;T-reg: 7.9" "Group enriched" "Detected in many" 6 "NK-cells: 6.5;T-cells: 12.4" "Group enriched" "Detected in some" 4 "HAP1: 9.0;Karpas-707: 34.8" "Low region specificity" "Detected in all" HPA059058 Enhanced NA NA "HPA059058: AB_2683894" "unprognostic (1.88e-2)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (2.63e-3)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" "unprognostic (5.25e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.23e-1)" "unprognostic (2.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.63e-2)" "prognostic favorable (1.97e-4)" "unprognostic (3.79e-1)" "unprognostic (8.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.48e-2)" 2.7 12.1 35.4 2.9 28.1 1.8 6.0 18.7 49.7 3.6 4.0 3.5 2.9 3.3 4.8 24.8 1.8 4.1 9.5 2.4 31.2 41.7 13.4 2.6 5.7 3.6 22.5 26.1 10.5 13.0 15.3 25.1 0.5 26.1 5.1 4.8 3.7 7.8 3.5 0.8 2.2 2.7 3.0 15.7 3.0 5.8 9.2 3.7 0.0 15.6 0.0 5.6 1.9 1.2 1.6 0.6 0.0 0.0 6.5 12.4 2.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.1 0.8 9.0 0.2 0.0 0.0 0.4 2.9 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 1.4 0.2 0.1 3.3 1.3 34.8 0.1 3.8 0.2 0.0 4.1 0.0 1.4 0.0 0.0 0.1 3.2 0.0 5.0 0.5 0.0 0.0 0.0 0.7 0.8 0.0 3.3 0.2 2.4 0.3 0.0 4.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 11.2 1.6 8.5 5.9 0.0 0.7 12.4 7.4 0.0 6.5 0.0 0.6 7.9 2.3 35.4 28.1 18.7 47.2 31.2 41.7 22.5 26.1 26.1 3.7 3.0 3.5 10.4 20.3 13.3 53.8 17.5 198.7 12.0 12.5 36.6 0.0 0.0 116.0 15.2 1.1 18.5 0.7 0.0 19.4 0.0 6.6 16.6 22.0 11.5 0.2 54.0 34.4 30.1 0.6 4.7 2.3 2.4 28.7 10.0 18.9 32.2 8.8 0.0 0.4 16.5 22.1 0.0 4.1 2.1 1.1 9.8 0.0 10.1 5.6 9.1 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133399995-133475222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.7" "Group enriched" "Detected in some" 4 "B-cells: 10.7;Melanocytes: 5.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "T-reg: 12.7" "Lineage enriched" "Detected in single" 48 "T-cells: 12.7" "Group enriched" "Detected in some" 7 "Daudi: 5.7;U-698: 6.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.9 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 BGLAP OCN ENSG00000242252 "Bone gamma-carboxyglutamate protein" P02818 1 156241962-156243321 "FDA approved drug targets, Predicted secreted proteins" Biomineralization "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.0" "Cell type enhanced" "Detected in some" 13 "Melanocytes: 3.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "NK-cell: 2.2;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 16 "dendritic cells: 4.2;NK-cells: 2.2" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 7.5;U-87 MG: 6.4" "Secreted to blood" NA NA 15500000 430000 "unprognostic (2.50e-2)" "unprognostic (4.49e-2)" "unprognostic (3.82e-4)" "unprognostic (1.13e-1)" "unprognostic (1.57e-1)" "unprognostic (8.44e-5)" "unprognostic (2.63e-2)" "unprognostic (6.54e-2)" "unprognostic (5.64e-2)" "unprognostic (2.00e-1)" "unprognostic (1.53e-3)" "unprognostic (4.70e-2)" "unprognostic (9.67e-6)" "unprognostic (3.02e-2)" "unprognostic (1.72e-1)" "unprognostic (4.34e-2)" "unprognostic (8.64e-3)" 1.6 0.7 6.0 6.7 6.9 2.2 1.4 5.2 11.0 1.1 9.3 6.2 0.0 3.2 4.8 1.4 0.8 2.3 1.7 0.7 4.3 2.9 1.2 1.6 1.4 2.3 6.2 6.8 3.4 0.8 1.5 1.3 3.1 9.7 2.1 3.4 0.0 3.6 2.8 2.2 6.8 6.4 3.9 8.4 2.1 2.3 0.3 4.1 0.6 1.6 0.0 1.2 0.7 1.2 0.0 4.2 0.2 0.0 2.2 0.1 0.1 0.3 0.7 1.6 0.5 0.0 0.5 1.2 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.4 0.0 0.7 0.6 0.0 0.4 0.0 1.8 0.9 0.0 2.0 1.1 0.5 0.0 0.4 0.0 0.6 0.6 0.6 7.5 0.6 1.5 0.5 2.2 0.0 1.9 0.0 1.4 0.8 0.1 0.3 0.9 0.1 1.4 0.6 0.0 0.2 1.8 0.6 0.3 0.7 0.3 1.1 0.0 0.0 0.0 0.4 0.4 0.4 2.7 2.5 1.4 6.4 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 4.2 0.0 0.1 6.0 6.9 5.2 11.0 4.3 2.9 6.2 6.8 9.7 4.1 0.0 0.0 0.0 0.9 1.3 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.0 0.2 0.2 1.1 0.6 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.4 0.0 3.3 0.0 0.1 0.3 0.0 0.0 0.4 1.1 0.5 6.5 0.0 0.5 0.9 1.1 0.3 0.0 0.6 0.7 BHLHA15 "bHLHa15, BHLHB8, MIST1" ENSG00000180535 "Basic helix-loop-helix family member a15" Q7RTS1 7 98211427-98212979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "pancreas: 145.8;salivary gland: 95.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 7 "B-cells: 1.7" "Group enriched" "Detected in some" 8 "Karpas-707: 17.1;RPMI-8226: 31.7;U-266/70: 37.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034083, HPA047834" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "CAB034083: AB_2065216, HPA047834: AB_2680172" "unprognostic (2.80e-2)" "unprognostic (9.45e-3)" "unprognostic (8.10e-2)" "unprognostic (6.66e-2)" "unprognostic (4.33e-3)" "unprognostic (1.10e-2)" "unprognostic (4.05e-2)" "unprognostic (1.37e-1)" "unprognostic (3.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (3.70e-4)" "unprognostic (3.36e-1)" "unprognostic (1.94e-1)" "unprognostic (2.95e-1)" "unprognostic (8.25e-3)" 0.1 0.1 0.2 0.8 0.2 0.0 0.1 0.1 0.2 0.3 1.2 0.0 3.5 0.9 0.1 0.1 0.4 0.1 0.8 0.1 0.3 0.2 0.3 4.7 0.5 1.8 0.1 0.0 0.0 145.8 0.0 0.4 0.0 0.0 1.6 0.1 0.0 95.2 6.8 0.4 0.2 0.8 0.0 0.1 1.9 6.2 0.1 0.0 0.0 0.2 1.2 2.7 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 1.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 17.1 0.0 0.3 0.0 0.0 0.5 1.2 0.5 0.2 0.0 31.7 0.0 0.0 1.9 0.7 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 37.9 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BHLHA9 "bHLHa9, BHLHF42" ENSG00000205899 "Basic helix-loop-helix family member a9" Q7RTU4 17 1270559-1271460 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "brain: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HDLM-2: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (9.27e-2)" "unprognostic (2.63e-1)" "unprognostic (2.99e-1)" "unprognostic (7.74e-2)" 0.1 0.0 1.4 0.0 0.3 0.0 0.0 0.4 4.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 1.6 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.4 3.2 0.9 1.6 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BHLHB9 "GASP3, KIAA1701, p60TRP" ENSG00000198908 "Basic helix-loop-helix family member b9" Q6PI77 X 102720688-102753540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 21.1" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 11.3;Cone photoreceptor cells: 11.8;Muller glia cells: 11.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000887 Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA000887: AB_2666130" "unprognostic (4.07e-2)" "unprognostic (4.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.70e-3)" "unprognostic (6.42e-3)" "unprognostic (2.36e-1)" "unprognostic (2.40e-3)" "unprognostic (5.06e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (2.74e-2)" "unprognostic (4.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.43e-1)" "unprognostic (7.46e-2)" "unprognostic (4.95e-2)" "unprognostic (8.88e-2)" 2.8 6.4 8.6 1.6 13.0 2.7 3.7 15.3 20.6 5.5 3.4 8.7 2.3 2.1 7.5 5.8 2.9 4.5 3.0 4.9 8.9 12.5 6.3 3.8 2.6 1.5 7.2 12.7 9.9 3.6 9.1 7.1 4.8 21.1 7.2 2.9 3.9 3.6 8.2 4.8 3.4 2.5 7.2 6.3 2.7 2.5 4.4 7.3 1.7 6.6 1.2 2.0 4.1 3.4 0.7 0.3 0.9 0.2 5.3 2.0 0.5 0.5 4.0 13.1 3.9 4.2 2.5 5.3 3.5 4.7 5.8 11.1 3.4 2.4 0.0 3.7 3.9 3.8 2.8 7.2 3.8 6.5 0.0 4.3 1.0 3.3 0.7 6.7 0.7 1.3 4.4 3.4 2.6 0.3 5.3 5.8 0.2 3.0 3.6 5.0 2.2 2.6 0.4 7.6 1.4 3.0 1.4 3.8 0.0 3.8 5.8 5.8 5.5 3.8 1.1 0.4 4.9 3.3 1.8 5.9 1.5 4.0 2.2 3.3 1.9 4.8 0.0 3.6 0.9 2.4 0.9 0.2 0.2 1.0 0.1 0.9 0.4 1.1 2.0 0.1 0.7 1.3 1.7 0.7 5.3 0.1 0.3 1.6 0.5 8.6 13.0 15.3 20.6 8.9 12.5 7.2 12.7 21.1 7.3 6.0 1.0 0.0 1.0 1.5 11.3 7.0 2.5 0.0 1.2 3.5 11.8 3.3 6.6 1.2 0.0 2.1 0.5 0.0 0.7 0.8 2.5 1.7 0.0 1.0 1.1 3.2 4.6 3.7 2.1 0.4 2.6 0.0 0.0 1.0 0.6 11.0 0.2 0.0 2.5 1.7 6.0 6.5 1.0 3.9 6.5 1.0 1.1 0.0 1.1 0.6 BHLHE22 "Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20" ENSG00000180828 "Basic helix-loop-helix family member e22" Q8NFJ8 8 64580367-64583628 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.7" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 28.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 23 "THP-1: 41.9" "Group enriched" "Detected in many" 5 "amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8" "Group enriched" "Detected in all" 8 "amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6" "HPA064128, HPA064872, HPA067500" Enhanced NA NA "HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855" "unprognostic (9.17e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-2)" "unprognostic (2.28e-5)" "unprognostic (7.22e-3)" "unprognostic (6.47e-4)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (6.58e-2)" "unprognostic (1.52e-1)" "unprognostic (3.71e-2)" "unprognostic (2.86e-7)" "unprognostic (3.20e-2)" "unprognostic (2.29e-1)" "unprognostic (6.72e-3)" "unprognostic (1.86e-1)" 2.9 1.3 30.7 2.9 1.4 0.3 1.7 21.1 15.8 1.7 1.7 1.2 0.3 1.1 0.5 0.4 2.2 0.6 1.1 0.8 27.2 2.1 0.5 1.3 1.4 2.4 1.7 6.5 0.4 1.3 0.5 1.2 0.2 3.4 0.5 1.4 2.5 1.2 5.4 0.5 0.8 1.7 1.1 2.6 2.9 1.1 0.7 0.2 0.0 0.6 0.0 1.3 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 1.4 21.1 10.6 27.2 2.1 1.7 6.5 3.4 0.2 0.0 0.0 0.0 0.0 1.0 28.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.4 0.0 2.5 0.0 6.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 BHLHE23 "bA305P22.3, Beta4, BHLHB4, bHLHe23" ENSG00000125533 "Basic helix-loop-helix family member e23" Q8NDY6 20 63005927-63007035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8" "Cell type enriched" "Detected in single" 34 "Cardiomyocytes: 3.4" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "MOLT-4: 16.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.0" HPA030575 Uncertain NA NA "HPA030575: AB_10601459" "unprognostic (1.74e-1)" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.8 0.0 4.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 16.8 0.7 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BHLHE41 "BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1" ENSG00000123095 "Basic helix-loop-helix family member e41" Q9C0J9 12 26120026-26125127 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 333.3;Cone photoreceptor cells: 172.8;Horizontal cells: 236.8;Muller glia cells: 283.4;Rod photoreceptor cells: 289.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 35 "memory B-cell: 5.3;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 54 "B-cells: 5.3" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 33.8;Karpas-707: 14.3;RT4: 44.7;U-266/70: 19.2;U-87 MG: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056035, HPA077617" Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056035: AB_2683017, HPA077617: " "unprognostic (1.57e-3)" "unprognostic (1.57e-2)" "unprognostic (2.32e-2)" "unprognostic (6.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" "unprognostic (5.86e-2)" "unprognostic (2.59e-1)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.96e-2)" "prognostic unfavorable (8.73e-5)" "unprognostic (5.23e-2)" "unprognostic (1.65e-1)" "unprognostic (5.61e-3)" "prognostic favorable (1.09e-4)" 7.0 11.7 23.8 5.8 32.3 1.2 10.7 22.9 26.9 30.6 7.6 33.3 3.0 2.8 6.9 15.6 3.2 34.5 14.1 14.7 25.9 19.6 3.8 1.4 9.1 6.0 38.9 14.0 10.9 6.4 6.2 11.2 8.3 28.3 8.2 9.1 19.0 13.4 11.7 58.9 3.8 4.3 4.3 49.6 6.2 4.4 4.0 44.0 0.9 43.6 6.4 13.3 16.5 6.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 7.6 3.5 1.7 0.8 1.3 0.1 0.5 0.0 4.8 0.0 0.7 1.5 11.4 4.0 0.1 0.6 0.4 0.0 0.6 0.3 0.0 0.0 0.3 1.9 0.1 0.5 0.4 2.8 5.5 33.8 0.0 0.0 0.0 14.3 0.8 0.4 0.0 1.3 3.7 1.3 2.8 0.0 0.6 10.9 1.8 44.7 0.0 0.0 0.5 0.2 10.1 0.2 0.0 0.0 2.3 2.6 3.1 0.3 2.0 19.2 11.0 0.0 16.5 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 32.3 22.9 26.9 25.9 19.6 38.9 14.0 28.3 44.0 0.0 0.6 22.9 50.0 5.4 333.3 33.5 33.1 42.8 10.3 27.9 172.8 22.2 0.0 35.8 0.2 4.8 10.8 0.0 19.8 2.4 18.8 38.9 5.7 0.0 71.2 236.8 12.6 3.1 2.7 0.4 27.9 35.2 13.5 47.7 3.0 283.4 13.9 5.7 25.1 2.1 289.4 6.5 6.6 0.5 0.4 2.9 5.9 0.0 3.3 52.5 BHMG1 HMGDC ENSG00000237452 "Basic helix-loop-helix and HMG-box containing 1" C9JSJ3 19 45733251-45764534 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 33 "testis: 17.8" "Group enriched" "Detected in some" 15 "Spermatocytes: 24.2;Spermatogonia: 22.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Daudi: 3.5;K-562: 8.3" "Not detected" "Not detected" HPA049521 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049521: AB_2680803" "unprognostic (4.15e-2)" "unprognostic (2.97e-2)" "unprognostic (2.64e-1)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-3)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (1.15e-2)" "unprognostic (1.08e-1)" "unprognostic (6.53e-12)" "unprognostic (2.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-3)" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.0 3.5 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 8.3 0.3 0.0 1.3 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.9 0.4 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 24.2 22.0 0.0 0.0 0.0 0.0 0.0 BHMT BHMT1 ENSG00000145692 "Betaine--homocysteine S-methyltransferase" Q93088 5 79111779-79132290 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "kidney: 105.9;liver: 216.2" "Group enriched" "Detected in some" 8 "Hepatocytes: 455.1;Proximal tubular cells: 647.0" "Cancer enhanced" "Detected in some" "liver cancer: 90.6;renal cancer: 50.4" "Region enhanced" "Detected in single" "hippocampal formation: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;NTERA-2: 3.6;SCLC-21H: 2.3" "Not detected" "Not detected" "HPA038285, HPA058310" Enhanced Supported Cytosol No NA 9200000 Cytosol "HPA038285: AB_10675791, HPA058310: AB_2683675" "unprognostic (2.61e-2)" "unprognostic (4.12e-1)" "unprognostic (4.45e-1)" "unprognostic (4.14e-3)" "unprognostic (5.62e-2)" "unprognostic (4.14e-1)" "prognostic favorable (7.32e-4)" "unprognostic (5.33e-2)" "unprognostic (1.51e-1)" "unprognostic (1.13e-1)" "unprognostic (9.66e-4)" "unprognostic (6.42e-2)" "unprognostic (8.26e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.30e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.1 1.5 0.0 105.9 216.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 4.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.4 0.0 1.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.3 0.0 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.2 2.5 0.0 0.0 15.7 0.0 0.0 66.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 455.1 0.0 0.0 0.0 3.7 9.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 647.0 0.1 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.3 BHMT2 ENSG00000132840 "Betaine--homocysteine S-methyltransferase 2" Q9H2M3 5 79069717-79089466 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "kidney: 87.9;liver: 122.9" "Cell type enhanced" "Detected in many" 25 "Distal tubular cells: 81.2;Hepatocytes: 181.0;Proximal tubular cells: 412.5" "Group enriched" "Detected in many" 14 "liver cancer: 79.6;renal cancer: 52.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;Hep G2: 38.1;hTEC/SVTERT24-B: 23.4;U-87 MG: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA044573 Enhanced NA NA 1400000 "HPA044573: AB_10795044" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-2)" "unprognostic (3.76e-2)" "unprognostic (4.40e-2)" "unprognostic (2.90e-3)" "unprognostic (1.56e-2)" "unprognostic (1.95e-1)" "unprognostic (1.87e-2)" "unprognostic (2.45e-3)" "unprognostic (1.41e-2)" "unprognostic (1.02e-1)" "unprognostic (1.76e-2)" "unprognostic (5.05e-2)" "unprognostic (1.49e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-3)" 9.3 4.4 1.7 0.9 2.0 0.2 8.2 1.1 1.0 1.7 3.4 1.1 2.9 0.6 3.2 10.5 3.5 1.4 2.9 3.3 1.5 1.5 87.9 122.9 0.6 0.4 1.6 1.0 1.9 0.5 0.5 3.2 0.3 3.5 3.0 0.8 8.2 0.8 4.0 2.2 0.4 1.3 10.5 2.2 0.3 2.4 1.4 0.9 0.0 4.6 1.9 0.4 6.4 4.4 0.9 0.5 3.2 0.4 2.4 0.7 0.3 0.0 0.0 0.0 0.0 4.4 3.2 1.5 3.8 9.1 2.1 4.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.1 38.1 3.5 0.2 0.0 3.9 0.0 23.4 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.8 0.2 0.0 2.5 0.4 0.7 0.4 0.3 0.5 0.5 0.6 0.4 0.2 0.9 0.6 0.7 3.2 2.4 0.2 0.5 0.4 0.3 1.7 2.0 1.1 1.0 1.5 1.5 1.6 1.0 3.5 0.9 6.0 0.3 0.5 0.4 0.7 1.5 3.5 0.0 0.0 0.0 43.6 2.0 0.2 81.2 0.1 0.3 1.6 0.0 0.0 0.0 0.3 7.3 0.4 0.0 181.0 0.3 0.0 1.2 3.1 3.3 0.0 25.3 1.1 0.0 0.0 0.0 4.8 0.0 0.0 35.0 412.5 1.1 6.5 1.7 0.5 0.4 0.9 0.2 0.0 0.0 0.9 BICC1 ENSG00000122870 "BicC family RNA binding protein 1" Q9H694 10 58513140-58831437 "Disease related genes, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.0" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 119.8;Collecting duct cells: 82.0;Distal tubular cells: 66.3;Ductal cells: 87.3;Leydig cells: 65.9;Proximal tubular cells: 113.1" "Cancer enhanced" "Detected in all" "renal cancer: 25.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "basophil: 8.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "A549: 19.9;BJ hTERT+: 21.1;CACO-2: 31.3;RPTEC TERT1: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070797 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA070797: " "unprognostic (1.27e-1)" "unprognostic (1.57e-3)" "unprognostic (3.61e-1)" "unprognostic (1.96e-1)" "unprognostic (6.09e-3)" "unprognostic (1.72e-1)" "unprognostic (9.98e-3)" "unprognostic (1.79e-2)" "unprognostic (6.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.40e-3)" "unprognostic (7.16e-2)" "unprognostic (6.44e-2)" "unprognostic (1.37e-3)" "unprognostic (4.19e-2)" "unprognostic (6.23e-2)" "unprognostic (2.94e-2)" 11.8 5.7 1.1 5.7 1.5 0.2 9.4 0.5 2.5 9.8 5.1 1.1 4.8 1.0 7.8 12.3 8.1 7.1 11.6 12.1 1.1 1.4 43.0 2.5 5.8 5.2 0.9 2.2 19.0 24.2 0.8 4.6 3.2 2.1 7.8 3.9 18.7 4.8 4.1 22.4 6.5 2.8 6.0 3.9 2.7 3.2 4.9 0.8 0.8 5.1 7.5 3.2 8.6 10.4 0.1 1.1 8.7 0.3 1.0 0.2 0.1 0.0 19.9 0.3 0.0 6.4 8.3 0.0 13.1 21.1 11.9 14.3 31.3 4.2 0.0 13.8 13.3 3.1 0.2 2.1 2.3 16.7 0.0 2.0 0.0 2.6 0.0 4.1 0.0 0.0 12.9 0.7 9.3 10.1 14.9 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 1.3 0.0 5.0 0.0 49.5 2.4 0.0 2.5 0.0 0.1 1.1 0.8 0.0 0.2 0.0 2.9 2.7 0.5 1.6 0.0 0.0 0.0 8.4 0.0 2.7 8.7 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.2 1.0 0.3 0.9 0.1 0.1 1.1 1.5 0.5 2.5 1.1 1.4 0.9 2.2 2.1 0.8 0.0 0.3 0.5 1.1 6.4 0.1 2.2 119.8 17.4 2.3 82.0 0.0 0.4 66.3 87.3 4.0 0.4 0.0 0.0 3.1 0.2 29.2 2.0 0.0 0.5 2.7 0.0 3.5 5.5 0.6 2.2 65.9 0.5 20.3 1.8 1.0 7.5 22.7 0.0 47.0 113.1 0.2 6.5 13.7 0.0 2.1 4.1 3.4 0.0 0.8 0.1 BICD1 ENSG00000151746 "BICD cargo adaptor 1" Q96G01 12 32106835-32383633 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.0" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 26.0;Cone photoreceptor cells: 35.3;Muller glia cells: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041309 Approved Approved Vesicles NA NA Vesicles "HPA041309: AB_10804000" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-6)" "unprognostic (5.93e-2)" "unprognostic (4.57e-1)" "unprognostic (3.64e-1)" "unprognostic (8.19e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" 6.2 5.3 11.7 8.3 10.6 4.1 5.3 39.0 13.7 19.9 4.4 9.2 1.9 3.3 13.8 10.4 3.1 14.8 7.7 6.0 10.7 7.6 6.7 1.9 6.6 8.6 6.6 10.9 29.0 2.5 12.6 9.9 12.1 8.3 6.5 4.5 5.6 3.7 4.1 4.6 2.9 4.5 8.2 8.3 10.4 4.0 4.4 8.0 8.8 9.5 1.9 7.4 6.2 4.9 5.4 6.3 0.1 0.9 2.8 4.7 1.6 8.3 6.7 4.4 2.7 4.1 4.6 4.2 9.8 4.2 9.8 6.6 6.2 5.0 13.2 7.4 8.9 10.3 3.3 18.5 7.7 14.1 8.3 5.4 13.6 5.1 3.3 4.8 11.0 8.3 3.1 3.6 10.8 8.8 13.0 9.4 11.6 7.0 22.2 4.2 3.3 11.9 4.1 37.5 3.1 6.0 9.2 13.3 7.7 11.3 4.5 17.4 10.4 6.5 0.4 6.1 27.0 5.3 2.9 10.4 13.8 13.1 9.2 13.3 7.5 10.6 21.3 9.2 5.7 16.1 0.0 0.9 0.0 3.5 0.3 4.7 5.4 3.2 2.2 1.5 5.2 3.6 2.8 0.1 2.8 0.0 6.3 4.1 1.6 11.7 10.6 39.0 13.7 10.7 7.6 6.6 10.9 8.3 8.0 14.9 0.6 11.7 4.6 0.3 26.0 7.8 0.0 2.7 11.4 8.7 35.3 0.4 1.7 7.4 0.5 14.6 0.5 0.0 4.2 0.4 5.0 5.5 0.0 0.4 5.4 22.3 6.3 14.1 1.0 0.7 3.7 2.5 8.5 3.6 0.0 32.7 5.7 0.0 4.2 1.9 17.8 0.0 6.6 2.1 9.8 2.0 0.2 5.0 2.3 3.1 BICDL1 "BICDR-1, CCDC64, FLJ26450" ENSG00000135127 "BICD family like cargo adaptor 1" Q6ZP65 12 119989869-120094494 "Predicted intracellular proteins" "Neurogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 29.9;skin 1: 20.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 12.2;Distal tubular cells: 19.9;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 27.4;MCF7: 14.8;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061116 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA061116: AB_2684433" "unprognostic (2.17e-1)" "prognostic favorable (6.50e-4)" "unprognostic (1.68e-3)" "unprognostic (3.05e-2)" "unprognostic (6.81e-4)" "prognostic favorable (3.15e-4)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.63e-2)" "unprognostic (3.31e-3)" "unprognostic (7.26e-2)" "prognostic favorable (3.93e-5)" "prognostic favorable (1.21e-5)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (2.15e-1)" 4.0 0.8 2.7 3.8 2.3 0.7 0.9 11.9 6.5 0.8 0.9 1.3 0.0 16.5 7.5 0.7 1.4 0.0 3.1 5.1 29.9 0.5 0.7 8.7 1.5 0.0 1.1 1.2 18.4 0.1 0.9 1.0 1.4 0.1 0.0 20.5 1.1 0.0 0.7 2.3 8.6 8.0 6.3 6.0 1.2 3.5 0.5 0.1 0.9 0.8 0.2 3.4 0.7 1.8 5.7 0.3 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 5.1 3.2 9.0 2.4 0.0 5.1 4.3 0.7 0.9 0.0 0.6 0.9 0.0 2.5 9.8 0.0 1.1 9.5 0.0 27.4 0.0 0.3 0.0 0.0 7.8 0.3 1.1 0.0 14.8 6.4 0.1 11.7 13.6 2.7 0.7 0.5 2.4 3.5 4.6 17.3 1.2 2.0 5.4 1.4 3.0 12.4 4.5 0.0 0.1 1.6 0.0 0.1 2.3 8.7 3.5 0.3 1.3 0.9 0.9 0.0 0.0 3.4 0.0 1.3 0.5 3.4 2.9 0.0 0.5 2.6 2.0 0.0 0.2 0.8 0.1 0.6 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.2 0.0 0.5 19.9 0.8 0.0 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.7 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.1;pancreas: 54.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.4;Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 15.7;Ductal cells: 27.6;Exocrine glandular cells: 43.8;Pancreatic endocrine cells: 34.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "eosinophil: 2.6;neutrophil: 3.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "A-431: 6.5;BEWO: 11.5;CAPAN-2: 10.6;HaCaT: 16.5;MCF7: 16.0;RT4: 7.6;SK-BR-3: 8.2;T-47d: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favorable (9.04e-4)" 0.4 0.0 0.4 2.5 0.4 0.0 2.9 0.4 0.4 6.2 7.9 0.4 8.3 5.7 1.0 2.0 31.1 2.2 11.0 0.4 0.4 0.0 1.2 0.4 5.3 0.4 0.4 0.4 0.9 54.1 3.6 0.9 0.5 0.4 5.1 3.5 0.4 13.9 8.3 1.1 13.7 6.9 1.0 0.4 0.4 10.2 0.5 0.4 0.4 2.3 8.6 12.4 6.1 12.0 0.1 0.1 3.5 0.0 0.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 10.6 0.0 0.0 0.0 0.0 16.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.1 0.0 4.6 0.0 0.1 0.0 0.2 0.0 7.6 0.1 0.0 0.0 8.2 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 19.4 0.0 0.0 0.0 0.0 0.0 0.0 22.7 22.7 15.7 0.0 4.0 3.3 27.6 0.0 0.0 0.0 0.0 43.8 3.8 0.0 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 34.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 BID ENSG00000015475 "BH3 interacting domain death agonist" P55957 22 17734138-17774770 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 96.5;bone marrow: 55.0" "Cell type enriched" "Detected in many" 4 "monocytes: 750.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 44.3;eosinophil: 68.5;intermediate monocyte: 75.7;myeloid DC: 36.3;neutrophil: 96.5;non-classical monocyte: 92.8;plasmacytoid DC: 25.3" "Group enriched" "Detected in all" 6 "dendritic cells: 36.3;granulocytes: 96.5;monocytes: 92.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000722, CAB003771" Enhanced Supported Cytosol NA NA 2400000 Cytosol "CAB003771: AB_365478, HPA000722: AB_1078283" "unprognostic (1.59e-1)" "unprognostic (5.51e-2)" "unprognostic (5.02e-2)" "unprognostic (3.04e-2)" "unprognostic (4.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.84e-2)" "unprognostic (5.21e-3)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-13)" "unprognostic (4.66e-3)" "unprognostic (1.59e-1)" "unprognostic (3.55e-3)" "unprognostic (2.18e-2)" 13.0 5.2 16.8 21.7 18.7 55.0 8.5 17.1 23.0 3.9 12.2 9.3 1.0 11.2 4.3 7.1 6.7 4.9 11.3 9.6 17.8 12.8 6.1 31.9 13.7 22.5 16.5 6.3 3.7 8.9 4.3 3.5 6.9 8.1 7.1 8.3 4.5 8.0 3.8 11.3 4.7 13.0 5.3 10.9 29.1 9.5 2.4 9.2 21.0 5.5 5.9 12.8 16.2 9.4 5.5 36.3 96.5 92.8 11.6 10.1 37.0 28.7 22.9 4.0 11.7 3.9 7.8 5.1 14.2 11.6 11.5 9.9 13.3 17.2 4.9 11.2 6.2 13.0 24.6 3.4 3.4 6.4 9.3 17.1 23.1 9.1 24.0 4.7 23.6 26.9 7.2 8.4 11.3 2.7 9.3 11.5 17.2 17.3 6.8 5.7 56.8 40.4 33.6 12.0 31.4 12.7 18.7 8.5 7.3 3.1 37.4 23.4 17.2 2.8 10.1 9.8 1.7 20.2 33.2 19.8 6.6 9.5 10.9 11.1 10.2 15.9 18.1 20.1 27.0 8.8 13.8 44.3 68.5 8.8 75.7 8.2 5.5 8.1 9.6 36.3 3.2 6.4 7.5 96.5 11.6 92.8 25.3 10.1 37.0 16.8 18.7 17.1 23.0 17.8 12.8 16.5 6.3 8.1 9.2 14.9 22.1 36.9 41.1 63.8 3.1 13.7 17.8 13.4 27.3 8.7 2.0 8.3 6.6 60.2 0.5 31.8 19.7 23.3 44.8 3.0 39.1 84.8 24.3 33.8 122.1 0.0 32.7 22.1 65.9 0.2 4.9 183.3 55.6 750.2 32.8 2.8 60.9 54.6 3.9 14.7 1.2 0.0 22.7 0.9 13.8 56.3 4.2 45.7 42.4 157.1 BIK NBK ENSG00000100290 "BCL2 interacting killer" Q13323 22 43110748-43129712 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;lymphoid tissue: 26.4" "Cell type enhanced" "Detected in many" 10 "Pancreatic endocrine cells: 75.6;Paneth cells: 122.8;Urothelial cells: 176.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "eosinophil: 28.8;memory B-cell: 7.8;plasmacytoid DC: 24.0" "Group enriched" "Detected in many" 5 "B-cells: 7.8;dendritic cells: 24.0;granulocytes: 28.8" "Cell line enhanced" "Detected in many" "A-431: 29.4;CAPAN-2: 15.0;Daudi: 14.7;U-698: 57.0" HPA051360 Approved NA NA "HPA051360: AB_2681453" "unprognostic (1.18e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.09e-1)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.86e-3)" "unprognostic (3.27e-1)" "unprognostic (2.71e-2)" "unprognostic (4.36e-3)" "unprognostic (2.36e-1)" "prognostic favorable (7.45e-5)" "unprognostic (1.38e-2)" "unprognostic (2.56e-1)" "unprognostic (4.08e-2)" "unprognostic (3.04e-1)" 0.2 2.2 0.1 23.0 0.9 3.5 4.7 0.1 0.7 3.1 7.7 0.3 8.6 3.5 0.7 2.0 10.5 3.0 19.1 0.6 0.5 0.2 4.2 0.7 2.8 11.1 0.4 0.1 1.8 3.1 0.6 1.1 0.6 0.5 11.9 5.3 0.9 20.9 4.8 0.1 3.1 6.7 0.6 0.6 3.6 13.2 3.0 0.1 4.3 1.8 5.2 26.4 2.7 5.0 7.8 24.0 28.8 1.2 0.3 4.2 2.6 29.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.6 15.0 14.7 1.4 0.0 0.3 6.6 1.6 0.6 0.0 0.2 2.2 0.0 0.1 1.6 0.2 6.9 1.4 0.0 3.0 0.0 0.0 0.1 0.0 3.2 0.1 0.7 0.0 7.5 5.4 9.5 2.3 8.0 2.4 0.0 0.0 6.7 0.3 0.8 0.5 0.0 1.0 2.8 2.0 1.1 0.5 9.6 0.2 0.0 0.8 0.1 0.3 3.6 5.5 57.0 0.0 0.7 0.0 0.7 1.2 28.8 1.2 0.3 1.9 7.8 4.2 1.8 4.3 3.4 2.8 1.5 4.8 0.3 0.3 24.0 2.8 2.6 0.1 0.9 0.1 0.7 0.5 0.2 0.4 0.1 0.5 0.1 0.0 3.4 4.5 21.5 11.2 0.0 0.4 22.9 30.8 14.8 7.0 0.0 0.9 6.6 56.1 0.2 1.4 22.9 23.3 14.5 0.9 1.1 51.8 0.0 0.5 0.9 0.0 48.4 6.7 1.9 0.0 0.0 1.9 33.7 10.0 37.7 0.0 75.6 122.8 0.7 12.3 0.0 0.0 1.9 0.2 12.9 10.3 0.8 7.2 55.7 176.3 BIN1 "AMPH2, AMPHL, SH3P9" ENSG00000136717 "Bridging integrator 1" O00499 2 127048027-127107355 "Disease related genes, Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "skeletal muscle: 399.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 141.1;Proximal tubular cells: 176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0" "Group enriched" "Detected in many" 9 "B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001945, HPA003894, HPA005437" Enhanced Supported Cytosol NA NA 1200000 Cytosol "CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284" "unprognostic (2.20e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" "unprognostic (9.65e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.55e-1)" "unprognostic (1.02e-3)" "unprognostic (1.85e-1)" "unprognostic (1.42e-3)" "unprognostic (1.26e-2)" "unprognostic (2.57e-1)" "unprognostic (2.41e-3)" "unprognostic (3.22e-3)" 9.5 12.1 21.0 6.7 26.8 3.7 4.2 10.3 24.9 6.2 5.4 36.2 3.6 5.3 5.6 7.3 8.8 7.8 6.4 3.1 24.8 15.2 10.3 4.9 4.6 9.3 26.8 15.8 6.8 5.3 7.3 4.9 6.5 17.3 9.2 4.4 7.9 4.9 7.2 399.9 2.7 5.0 11.6 22.1 10.4 6.1 3.1 26.8 0.0 4.7 30.8 7.3 9.0 7.9 34.1 4.0 1.1 0.6 31.2 45.0 22.4 15.1 8.3 10.1 11.9 30.1 24.2 3.4 4.6 10.0 11.0 7.2 32.0 9.4 0.0 14.2 8.6 6.4 2.0 4.4 7.5 2.9 1.7 1.2 4.4 13.7 2.1 27.2 0.0 0.8 22.1 1.8 23.8 4.3 14.4 14.9 1.5 0.9 0.5 13.5 0.3 1.4 12.7 7.5 33.8 9.5 3.5 11.1 1.4 38.9 0.0 6.6 18.7 16.7 6.5 5.1 11.2 0.4 2.8 17.7 12.7 12.5 16.1 15.3 0.4 0.4 0.0 18.7 0.8 5.8 0.1 0.6 0.1 37.0 0.3 32.5 32.2 38.4 36.9 2.8 34.1 36.2 34.4 1.1 31.2 0.5 4.0 45.0 22.4 21.0 26.8 10.3 24.9 24.8 15.2 26.8 15.8 17.3 26.8 8.9 10.6 66.3 7.8 16.6 141.1 4.5 33.1 0.0 4.5 14.0 117.8 1.6 31.5 12.8 13.4 15.7 11.3 0.0 26.0 3.7 58.0 22.0 2.3 15.3 125.1 28.6 44.2 12.9 18.1 43.3 72.8 30.7 21.9 1.8 25.6 20.3 17.5 21.0 28.7 176.2 129.8 12.9 30.2 1.1 7.5 7.9 2.4 89.9 41.2 8.1 BIN2 BRAP-1 ENSG00000110934 "Bridging integrator 2" 12 51281038-51324668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 85.3;bone marrow: 38.0;lymphoid tissue: 24.8" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 77.7;Extravillous trophoblasts: 144.3;Syncytiotrophoblasts: 132.6;T-cells: 174.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 23.8;HMC-1: 40.6;Karpas-707: 17.7;NB-4: 40.4;RPMI-8226: 15.8;THP-1: 34.2;U-937: 22.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038666, HPA038667" Enhanced Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA038666: AB_2676139, HPA038667: AB_2676140" "unprognostic (8.44e-3)" "prognostic favorable (1.33e-4)" "unprognostic (2.48e-1)" "prognostic favorable (6.34e-4)" "unprognostic (4.63e-1)" "unprognostic (2.00e-3)" "unprognostic (1.21e-1)" "unprognostic (3.59e-2)" "unprognostic (3.72e-2)" "unprognostic (7.47e-2)" "unprognostic (5.71e-2)" "unprognostic (3.29e-1)" "unprognostic (1.65e-3)" "unprognostic (4.03e-1)" "unprognostic (3.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-1)" 4.6 1.8 3.5 12.3 4.7 38.0 1.7 1.8 2.0 2.3 3.3 3.6 0.7 2.2 1.4 2.8 2.2 1.4 3.6 2.2 3.1 2.1 2.5 3.1 7.7 23.9 4.4 0.9 1.8 2.3 0.0 1.7 8.4 3.2 1.8 3.6 1.5 4.7 0.6 1.9 2.0 3.3 2.3 4.1 18.3 2.6 3.5 3.9 24.8 1.9 0.7 17.5 4.4 1.9 10.5 17.1 85.3 59.9 35.8 47.7 61.4 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 23.8 0.0 0.0 0.0 9.9 40.6 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 17.7 0.0 0.1 6.9 40.4 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 34.2 0.0 0.0 0.0 0.0 0.0 9.5 0.0 2.3 0.0 22.4 0.0 85.3 30.9 37.4 47.7 49.0 38.5 8.1 32.4 39.8 17.1 10.5 25.3 33.5 61.0 35.8 59.9 6.3 40.9 61.4 3.5 4.7 1.8 2.0 3.1 2.1 4.4 0.9 3.2 3.9 3.0 27.8 26.9 0.1 0.6 0.0 0.6 2.5 6.7 4.5 1.8 0.0 77.7 14.9 0.0 19.8 1.0 1.2 0.0 0.0 144.3 1.9 0.1 53.3 0.9 50.9 0.0 1.2 8.6 57.8 18.7 0.6 49.5 1.7 10.0 9.1 0.0 0.0 3.5 0.4 0.7 0.0 0.0 0.7 32.5 7.7 0.5 132.6 174.0 6.9 0.0 BIRC3 "API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49" ENSG00000023445 "Baculoviral IAP repeat containing 3" Q13489 11 102317450-102339403 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.0;lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" 16 "granulocytes: 530.1;monocytes: 1925.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 32.9;naive B-cell: 32.9" "Group enriched" "Detected in many" 10 "B-cells: 32.9;T-cells: 17.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.4;Daudi: 33.7;HDLM-2: 31.9;hTERT-HME1: 33.6;U-266/70: 22.5;U-266/84: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002317 Enhanced Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002317: AB_1846748" "prognostic favorable (3.60e-4)" "unprognostic (2.89e-1)" "prognostic favorable (9.35e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.28e-4)" "unprognostic (5.83e-3)" "unprognostic (2.23e-1)" "unprognostic (3.88e-3)" "unprognostic (9.62e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.03e-4)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.66e-6)" "unprognostic (6.42e-2)" "unprognostic (6.23e-3)" "unprognostic (1.00e-1)" "unprognostic (3.85e-2)" 6.9 3.3 1.4 43.9 2.3 5.1 5.4 0.5 2.0 5.3 13.1 0.5 2.8 6.8 2.9 3.7 8.4 3.9 13.9 6.0 2.2 1.3 10.8 12.5 21.8 46.3 2.8 1.2 3.4 7.0 1.1 14.5 0.9 2.2 8.7 6.2 1.1 9.2 4.7 2.2 5.5 46.0 7.3 3.0 34.9 15.9 3.2 2.7 34.2 3.0 4.1 34.0 12.6 6.2 32.9 0.8 2.0 2.6 2.5 17.1 2.8 6.5 5.3 0.0 0.1 0.1 0.7 0.6 0.5 4.4 0.6 0.7 0.9 38.4 33.7 17.4 0.3 5.5 3.6 0.0 0.9 2.1 31.9 0.1 0.1 1.6 0.2 6.6 0.5 0.7 0.7 4.7 2.1 33.6 1.2 0.1 2.7 0.1 0.0 0.8 0.0 2.3 0.3 0.1 3.1 0.2 0.0 0.3 1.7 8.7 3.4 0.0 0.1 0.5 0.6 0.3 0.2 1.7 0.3 1.7 7.3 0.8 0.4 6.7 22.5 19.2 11.9 1.3 1.9 0.9 2.0 0.9 0.4 1.4 2.2 2.5 32.9 10.7 3.5 0.8 32.9 7.5 2.2 0.5 2.5 2.6 0.3 17.1 2.8 1.4 2.3 0.5 2.0 2.2 1.3 2.8 1.2 2.2 2.7 134.0 68.1 285.1 318.0 89.9 0.3 12.0 76.5 30.8 73.9 38.4 0.0 1.7 6.6 193.4 1.3 50.1 284.0 46.7 153.8 0.5 71.9 371.3 530.1 3.4 11.1 0.0 14.5 7.4 18.1 1.3 4.6 71.9 182.2 1925.2 27.1 0.1 190.8 361.2 2.1 8.8 0.0 0.0 133.5 0.5 0.4 73.9 0.5 89.3 29.9 164.7 BIRC5 "API4, EPR-1, survivin" ENSG00000089685 "Baculoviral IAP repeat containing 5" O15392 17 78214186-78225636 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Protease inhibitor, Repressor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.6;testis: 51.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 73.9;Erythroid cells: 116.8;Extravillous trophoblasts: 134.7;Spermatocytes: 133.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 14.0" "Lineage enriched" "Detected in many" 6 "T-cells: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA002830, CAB004270" Enhanced Supported "Cytokinetic bridge" Yes Yes "Cytokinetic bridge" "CAB004270: AB_628302, HPA002830: AB_1857672" "unprognostic (8.04e-2)" "unprognostic (3.51e-2)" "unprognostic (4.48e-3)" "unprognostic (2.72e-3)" "unprognostic (3.37e-1)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.28e-6)" "prognostic unfavorable (4.49e-4)" "unprognostic (3.56e-3)" "unprognostic (4.53e-3)" "unprognostic (2.87e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.77e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.16e-1)" 2.3 1.5 0.4 14.1 0.7 20.8 5.3 0.7 0.6 1.9 4.8 0.3 0.2 4.6 0.9 1.4 13.4 0.4 2.2 2.4 0.5 0.4 1.3 2.2 2.4 9.7 0.6 0.2 0.9 0.8 0.0 0.4 6.1 0.5 0.9 5.2 0.2 2.1 0.2 0.6 3.5 4.7 2.4 0.7 6.3 3.2 51.4 0.3 61.6 0.5 14.4 11.7 2.0 3.2 2.5 0.8 0.5 0.0 2.2 14.0 3.0 32.0 30.0 27.1 29.3 1.7 2.8 10.0 24.7 13.9 35.3 23.2 24.5 12.7 33.1 10.1 14.3 26.7 17.1 27.4 15.8 30.9 11.1 38.0 21.8 17.7 28.8 0.2 20.9 16.4 0.9 1.1 19.5 14.5 5.1 24.9 25.0 27.3 28.0 27.1 18.6 44.6 20.0 20.1 22.7 52.8 23.3 44.0 25.5 8.3 11.9 33.5 23.1 18.9 21.5 16.8 13.8 28.4 19.9 9.3 42.7 37.9 18.4 35.1 20.3 16.3 38.2 15.6 8.8 37.1 0.0 0.0 0.0 0.7 0.0 0.2 2.5 4.3 2.8 0.8 0.3 0.0 0.4 0.5 2.2 0.0 0.3 14.0 3.0 0.4 0.7 0.7 0.6 0.5 0.4 0.6 0.2 0.5 0.3 0.0 30.7 18.5 1.0 7.2 0.5 2.0 5.1 4.0 17.0 0.0 0.0 17.0 0.0 1.2 73.9 0.6 1.8 116.8 0.0 134.7 7.2 0.9 9.2 1.6 43.1 0.0 2.9 11.1 11.1 29.8 2.8 11.5 1.7 0.0 3.4 0.4 0.4 3.4 0.7 0.0 0.5 6.5 1.0 133.1 40.7 5.6 16.0 7.5 15.2 4.0 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 63.7" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.2 0.4 0.0 6.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.7 1.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.6 0.1 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.3 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 46.0 2.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 BIRC8 "hILP2, ILP-2, RNF136" ENSG00000163098 "Baculoviral IAP repeat containing 8" Q96P09 19 53289601-53291626 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 246 "testis: 24.5" "Group enriched" "Detected in some" 30 "Early spermatids: 9.2;Late spermatids: 15.6;Spermatocytes: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.4 0.0 0.0 0.0 0.0 0.0 BIVM-ERCC5 ENSG00000270181 "BIVM-ERCC5 readthrough" 13 102799110-102875994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 10.6" "Group enriched" "Detected in some" 28 "Alveolar cells type 2: 2.9;Ciliated cells: 1.4;Club cells: 4.5;granulocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;HEK 293: 12.2;HeLa: 5.2;PC-3: 6.7;SCLC-21H: 3.4" "HPA045845, HPA050126, HPA050374" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106" "unprognostic (6.01e-2)" 1.0 1.0 2.7 3.7 4.5 1.1 1.4 10.6 5.7 1.0 2.9 1.3 2.6 1.0 2.1 1.1 1.0 2.6 1.0 1.9 2.7 3.2 2.4 2.3 1.5 2.2 2.7 1.0 1.9 1.0 2.7 1.3 2.6 2.0 1.0 1.1 1.0 2.7 1.0 1.0 1.0 2.6 0.6 1.8 2.6 1.2 2.3 0.3 1.7 1.5 1.0 1.0 1.0 0.0 2.8 0.0 1.4 1.3 2.9 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.6 0.0 3.0 0.3 0.0 0.0 0.0 12.2 0.0 5.2 0.0 0.5 2.5 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.4 0.1 3.4 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 2.9 0.0 0.7 1.0 2.8 0.0 0.2 0.1 0.0 1.3 0.0 0.0 0.3 1.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLCAP BC10 ENSG00000166619 "Bladder cancer associated protein" P62952 20 37492472-37527931 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 102.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 72.5" "Low region specificity" "Detected in all" HPA047390 Approved Nucleoli NA NA Nucleoli "HPA047390: AB_2680025" "unprognostic (1.05e-2)" "unprognostic (7.91e-3)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.08e-2)" "unprognostic (1.27e-2)" "unprognostic (3.49e-1)" "unprognostic (3.51e-1)" "unprognostic (4.45e-1)" "unprognostic (1.91e-3)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.04e-3)" "unprognostic (1.96e-2)" "unprognostic (7.62e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.28e-5)" 18.9 16.7 31.6 12.9 89.5 10.7 16.4 23.2 40.1 14.3 15.6 13.3 11.4 17.6 9.8 19.9 18.5 50.5 17.9 23.5 26.5 44.4 21.3 23.8 12.2 12.5 22.5 28.3 15.1 7.9 15.4 34.4 26.1 27.6 18.9 18.8 13.4 17.7 21.1 102.5 30.3 18.9 13.4 13.4 14.2 12.4 12.2 10.6 8.5 14.0 27.3 17.8 20.2 12.7 48.0 20.5 26.6 22.2 17.0 28.4 18.7 27.0 8.0 9.4 9.7 18.2 14.0 13.3 13.0 12.6 11.6 9.5 27.8 22.1 14.1 13.0 18.0 11.1 52.5 7.0 53.9 12.1 2.9 6.3 4.6 17.8 25.7 11.7 9.1 6.1 17.8 58.1 11.1 21.1 9.6 16.1 10.3 4.4 10.6 23.3 15.2 7.5 7.2 7.5 15.3 22.5 7.2 35.1 9.4 13.3 72.5 8.6 10.4 15.6 45.3 10.5 10.1 14.9 8.7 15.3 30.1 7.7 10.5 5.5 5.8 7.2 6.8 12.5 8.4 5.3 26.6 22.2 25.9 18.7 21.5 20.4 37.5 21.4 19.8 20.5 48.0 28.4 22.0 23.2 17.0 19.3 8.8 20.6 18.7 31.6 89.5 23.2 40.1 26.5 44.4 22.5 28.3 27.6 10.6 74.5 32.3 42.7 79.2 130.6 42.3 49.4 35.7 64.3 67.1 38.4 21.6 98.9 69.6 30.6 58.8 43.9 49.9 0.0 29.8 68.6 31.1 44.2 29.9 70.6 48.4 39.7 39.3 74.3 36.4 108.7 27.6 35.6 33.7 16.2 50.0 37.9 37.4 28.1 55.9 41.1 33.0 32.3 28.8 23.1 23.8 107.4 54.3 33.2 29.7 128.8 BLID BRCC2 ENSG00000259571 "BH3-like motif containing, cell death inducer" Q8IZY5 11 122115354-122116215 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 5.0;hTEC/SVTERT24-B: 2.8;hTERT-HME1: 2.5;hTERT-RPE1: 2.7;LHCN-M2: 3.8;U-87 MG: 4.6" NA NA 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 1.1 0.3 0.8 0.3 1.1 0.5 0.2 0.4 0.5 0.2 0.0 0.2 1.4 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.9 0.6 0.8 0.0 2.3 1.4 0.6 0.4 0.0 0.1 0.0 0.1 1.0 5.0 0.1 0.0 1.4 1.5 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.6 2.8 2.5 2.7 0.4 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.1 0.2 1.1 0.0 0.0 0.0 4.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLK MGC10442 ENSG00000136573 "BLK proto-oncogene, Src family tyrosine kinase" P51451 8 11486894-11564604 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8" "Cell type enriched" "Detected in some" 52 "B-cells: 93.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 47.8;naive B-cell: 33.9" "Lineage enriched" "Detected in many" 5 "B-cells: 47.8" "Cell line enhanced" "Detected in some" "Daudi: 44.0;REH: 11.9;RPMI-8226: 14.5;U-698: 21.5;U-87 MG: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB005093, HPA069571" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "CAB005093: AB_2274756, HPA069571: AB_2732137" "unprognostic (6.50e-5)" "unprognostic (4.22e-3)" "unprognostic (5.64e-2)" "unprognostic (1.42e-1)" "unprognostic (3.45e-1)" "unprognostic (5.98e-6)" "unprognostic (1.59e-2)" "unprognostic (8.94e-4)" "unprognostic (1.02e-3)" "unprognostic (9.83e-3)" "unprognostic (1.22e-2)" "unprognostic (4.66e-2)" "unprognostic (9.05e-6)" "unprognostic (5.62e-2)" "unprognostic (5.43e-2)" "unprognostic (2.19e-1)" "unprognostic (1.16e-1)" 0.5 0.2 0.1 32.3 0.1 1.7 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.3 0.1 0.0 1.9 0.2 0.4 0.3 0.1 0.1 1.3 0.5 0.6 27.6 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.3 2.4 0.0 0.1 0.1 23.5 0.0 0.1 31.9 1.4 0.2 0.0 3.9 0.7 0.4 39.8 2.5 0.4 47.8 4.3 0.1 0.0 0.0 9.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.9 0.0 14.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.3 3.8 21.5 9.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.8 47.8 0.3 1.1 0.0 33.9 0.2 0.1 0.1 0.0 0.0 4.3 0.4 1.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 93.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "Bloom syndrome RecQ like helicase" P54132 15 90717327-90816165 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 36.7" "Cell type enhanced" "Detected in many" 6 "B-cells: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 1.8 0.4 3.1 11.4 1.5 5.5 0.6 4.7 2.6 0.7 1.9 0.9 0.5 1.4 1.2 1.1 2.9 0.4 1.3 1.0 2.3 2.4 0.9 0.5 2.0 7.7 2.8 0.2 0.9 0.4 0.0 1.2 3.6 0.5 0.7 2.5 0.7 7.8 0.0 1.7 0.6 2.8 0.5 1.9 6.7 1.4 4.9 0.5 36.7 0.6 3.1 9.3 1.4 0.7 7.4 1.2 4.3 1.6 4.6 5.0 1.6 5.5 7.8 8.8 5.1 0.0 0.4 5.5 4.1 1.2 4.7 5.1 6.9 3.9 14.2 2.6 1.1 5.9 9.2 13.5 3.7 6.1 8.6 10.0 14.9 8.5 2.2 0.0 14.3 7.4 0.0 0.0 4.7 2.4 0.6 3.3 7.7 12.8 4.4 4.9 3.4 10.7 7.8 9.3 12.1 1.7 10.9 16.5 5.5 1.1 9.9 6.5 6.1 3.3 4.5 2.6 8.6 3.1 11.7 1.8 3.4 6.3 3.5 8.8 3.3 13.2 14.8 1.9 10.1 5.9 2.5 1.0 4.3 3.1 1.2 4.8 7.4 2.8 3.8 1.2 4.3 2.0 2.2 0.8 4.6 1.6 1.2 5.0 1.6 3.1 1.5 4.7 1.7 2.3 2.4 2.8 0.2 0.5 0.5 3.0 12.8 18.6 0.5 0.2 2.9 8.4 0.0 9.4 6.8 0.0 2.0 1.8 1.7 0.9 2.0 0.7 0.0 0.0 0.6 6.5 1.5 0.6 12.7 0.5 4.8 0.0 0.0 2.5 9.7 1.6 0.0 3.8 0.0 1.0 1.2 1.2 0.8 0.0 0.4 0.0 6.5 0.0 0.4 12.0 11.8 0.5 0.8 8.7 2.3 0.3 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248195-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 67.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 59000000 "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 11.2 8.3 9.0 17.1 10.2 8.5 14.2 12.1 14.5 10.5 9.8 8.5 9.6 6.7 13.1 12.2 15.7 8.4 10.1 9.7 7.5 7.2 13.6 7.5 13.6 20.3 9.5 8.5 8.8 15.3 15.0 8.3 14.6 9.2 8.4 8.5 7.3 12.8 9.5 15.0 67.5 10.0 15.7 11.1 13.2 9.2 12.4 8.6 24.7 9.3 15.5 13.6 10.8 11.7 4.6 6.6 0.9 5.7 9.8 17.3 6.3 10.2 16.2 15.6 10.8 10.7 11.5 7.6 9.5 5.9 15.1 13.0 23.7 3.0 30.4 17.0 7.7 6.8 7.1 33.8 13.0 12.8 8.0 26.6 18.6 14.5 20.1 15.7 33.9 11.5 13.6 0.9 11.8 6.8 12.4 22.1 25.5 39.7 12.4 6.2 7.7 42.0 24.8 15.0 0.0 7.6 36.4 40.6 20.1 12.0 9.1 36.1 12.9 8.4 16.5 10.4 28.2 11.2 17.5 14.0 9.3 18.8 4.1 16.8 15.0 30.9 41.1 7.1 0.0 12.4 0.0 5.7 0.9 10.5 3.9 17.3 4.6 12.6 13.7 6.5 4.2 11.6 12.3 0.7 9.8 1.9 6.6 12.4 6.3 9.0 10.2 12.1 14.5 7.5 7.2 9.5 8.5 9.2 8.6 3.0 13.0 12.3 14.0 14.2 18.2 16.5 12.7 6.7 2.3 10.4 11.8 41.1 6.6 14.9 8.2 17.9 8.9 0.0 12.2 31.7 13.3 8.5 43.8 6.6 22.1 12.7 17.2 28.3 21.8 5.2 15.0 10.4 10.1 10.0 7.6 10.9 8.9 8.6 23.3 17.0 16.0 6.5 15.3 9.7 16.7 11.0 23.0 18.7 10.7 5.9 BLNK "BASH, bca, BLNK-s, Ly57, SLP-65, SLP65" ENSG00000095585 "B cell linker" Q8WV28 10 96191702-96271587 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7;lymphoid tissue: 47.1" "Cell type enhanced" "Detected in many" 5 "B-cells: 42.3;Collecting duct cells: 38.4;Syncytiotrophoblasts: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 35.9;naive B-cell: 31.0;plasmacytoid DC: 50.7" "Group enriched" "Detected in many" 117 "B-cells: 35.9;dendritic cells: 50.7" "Group enriched" "Detected in some" 6 "Daudi: 18.3;REH: 44.3;RPMI-8226: 24.4;U-698: 66.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009333, CAB016291, HPA038309, HPA038310" Enhanced Supported "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane, Cytoplasmic bodies" "CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946" "unprognostic (4.86e-2)" "unprognostic (6.05e-3)" "unprognostic (1.00e-2)" "unprognostic (2.73e-2)" "unprognostic (2.29e-1)" "unprognostic (1.63e-3)" "unprognostic (1.08e-2)" "unprognostic (5.19e-2)" "unprognostic (2.97e-1)" "unprognostic (1.02e-1)" "unprognostic (8.94e-2)" "unprognostic (3.73e-1)" "unprognostic (1.84e-2)" "unprognostic (5.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.46e-3)" "prognostic favorable (2.67e-6)" 2.3 2.0 6.9 22.1 8.9 4.2 3.0 1.3 4.8 6.2 15.0 13.7 9.8 17.7 1.9 15.3 31.1 2.7 9.9 1.5 6.4 3.6 18.9 29.5 3.2 24.4 8.9 4.4 1.4 10.4 9.3 2.4 5.0 9.2 5.4 8.5 2.4 9.5 11.5 1.2 6.3 20.6 1.2 16.7 41.7 13.3 1.4 8.7 3.6 6.4 12.8 47.1 6.8 11.8 35.9 50.7 0.2 0.3 0.3 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 44.3 0.0 24.4 0.2 3.4 0.0 0.0 0.0 4.2 0.0 0.0 6.2 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 66.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 35.9 0.0 0.0 4.4 31.0 0.0 0.0 0.2 0.3 0.0 50.7 0.0 1.8 6.9 8.9 1.3 4.8 6.4 3.6 8.9 4.4 9.2 8.7 6.0 7.7 42.3 18.6 1.0 0.0 0.7 28.1 1.4 2.3 38.4 0.0 16.5 23.2 7.3 2.1 0.0 10.2 0.0 12.2 11.6 0.3 4.4 1.1 22.1 20.5 0.0 4.7 3.7 6.9 1.1 0.3 9.7 1.7 3.6 16.7 0.0 5.5 20.4 0.0 1.8 0.0 6.5 0.2 0.2 0.1 1.3 34.7 0.5 20.1 24.2 BLVRB "FLR, SDR43U1" ENSG00000090013 "Biliverdin reductase B" P30043 19 40447765-40465840 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 137.6" "Cell type enhanced" "Detected in all" 13 "Erythroid cells: 2523.0;Hofbauer cells: 895.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 73.4" "Group enriched" "Detected in all" 7 "dendritic cells: 54.8;monocytes: 73.4" "Cell line enhanced" "Detected in many" "A549: 81.2;K-562: 73.7;OE19: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041698, HPA041937" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No 440000000 Cytosol "Nucleoplasm, Vesicles, Plasma membrane" "HPA041698: AB_10796781, HPA041937: AB_10794308" "unprognostic (1.86e-1)" "unprognostic (1.14e-2)" "unprognostic (4.23e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (1.20e-2)" "unprognostic (8.56e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.30e-1)" "unprognostic (2.70e-1)" "unprognostic (2.02e-1)" "unprognostic (5.11e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" 36.9 17.9 10.9 12.8 12.2 137.6 28.9 3.5 10.9 17.0 26.7 7.7 18.5 20.9 14.1 19.6 45.3 14.6 19.0 31.0 8.2 8.6 31.8 72.4 37.3 30.0 11.7 9.6 21.3 19.4 5.7 5.6 32.2 13.8 22.9 7.7 17.5 27.1 22.1 43.4 16.7 26.4 22.1 9.7 47.1 31.1 7.6 7.9 6.6 24.3 42.9 24.4 29.9 22.1 8.6 54.8 9.1 73.4 4.0 5.3 34.4 34.2 81.2 1.1 12.1 11.3 10.9 9.6 4.3 12.7 5.9 11.5 15.9 31.1 11.5 33.5 7.7 19.2 11.0 4.1 9.4 1.2 19.5 3.5 17.5 12.2 9.6 26.1 0.2 5.1 10.6 17.9 7.9 4.4 6.0 6.2 4.3 73.7 20.9 6.9 53.2 0.9 1.0 0.3 64.3 22.7 8.1 3.8 18.6 7.4 23.1 0.0 1.8 13.1 34.7 13.2 1.6 33.7 2.6 6.7 15.8 16.9 24.2 2.3 11.4 13.4 4.3 41.1 6.9 6.1 5.0 73.4 2.6 4.6 33.7 4.4 8.6 4.0 4.0 54.8 5.4 4.2 3.3 9.1 4.0 16.9 11.5 5.3 34.4 10.9 12.2 3.5 10.9 8.2 8.6 11.7 9.6 13.8 7.9 205.4 126.9 50.2 283.1 114.9 10.9 116.8 180.9 95.0 73.9 92.5 5.9 76.7 225.5 197.9 7.2 54.2 483.6 2523.0 231.2 82.2 103.0 212.9 41.6 520.7 895.0 9.5 43.0 55.9 549.4 16.6 115.1 152.9 136.7 94.6 130.3 62.8 228.4 480.5 88.4 302.1 11.3 32.3 73.1 2.1 3.6 114.0 62.5 43.7 144.8 253.2 BMF FLJ00065 ENSG00000104081 "Bcl2 modifying factor" Q96LC9 15 40087890-40108892 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 81.0" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 12.7;monocytes: 14.4;Pancreatic endocrine cells: 13.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 19.8;HMC-1: 22.4;hTERT-RPE1: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010120 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA010120: AB_1845385" "unprognostic (2.94e-1)" "unprognostic (4.92e-3)" "unprognostic (7.63e-2)" "unprognostic (4.44e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.83e-4)" "prognostic unfavorable (6.32e-4)" "unprognostic (1.42e-2)" "unprognostic (4.26e-1)" "unprognostic (3.75e-1)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-2)" "unprognostic (2.35e-2)" 5.3 2.9 1.3 13.5 1.9 15.8 6.1 2.3 2.0 10.9 9.9 2.1 13.0 11.9 12.4 4.7 2.8 8.3 6.7 3.4 1.3 1.6 6.5 3.9 7.7 18.4 2.8 0.9 8.9 8.1 1.8 2.8 5.7 2.5 7.0 4.5 7.2 9.2 10.8 4.6 4.0 23.2 5.8 3.0 18.1 6.7 4.1 2.1 81.0 18.6 3.1 15.0 7.5 3.7 5.1 3.3 5.2 6.0 0.0 1.4 0.9 0.4 0.6 11.5 2.5 0.3 0.5 7.8 0.0 1.8 0.2 0.5 11.5 0.8 3.3 3.7 0.5 3.5 2.4 2.8 0.0 0.0 7.9 2.3 1.7 19.8 2.6 1.1 0.3 22.4 5.8 0.6 0.2 0.2 29.0 3.0 2.4 0.9 1.4 1.0 0.6 1.1 8.4 3.1 5.7 0.4 2.1 2.6 9.5 0.5 2.6 6.1 5.0 2.2 5.8 5.1 12.9 3.4 6.7 2.3 0.4 1.6 0.3 0.1 14.2 13.3 2.0 0.8 1.6 1.3 0.1 4.2 3.6 0.2 4.9 0.4 5.1 0.4 1.4 2.7 1.8 0.7 0.1 5.2 0.0 6.0 3.3 1.2 0.9 1.3 1.9 2.3 2.0 1.3 1.6 2.8 0.9 2.5 2.1 3.0 2.1 10.0 1.0 1.0 0.0 1.6 7.6 0.0 5.7 0.0 0.0 0.6 0.0 8.9 1.0 2.1 5.1 0.0 12.7 1.1 1.9 2.6 0.0 0.9 7.6 0.0 1.2 1.8 10.8 0.0 1.7 6.1 0.0 14.4 1.5 0.3 13.9 0.3 0.7 2.2 0.4 0.0 0.8 0.2 1.1 0.5 1.5 0.7 1.3 0.9 BMP1 PCOLC ENSG00000168487 "Bone morphogenetic protein 1" P13497 8 22164736-22212326 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "lung: 72.2;placenta: 106.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014572 Enhanced "Secreted to extracellular matrix" NA NA 2100000 "HPA014572: AB_1845390" "unprognostic (1.24e-1)" "unprognostic (8.01e-2)" "unprognostic (3.75e-2)" "unprognostic (5.89e-2)" "unprognostic (1.34e-2)" "unprognostic (6.76e-2)" "unprognostic (9.53e-2)" "unprognostic (2.64e-3)" "unprognostic (1.66e-1)" "unprognostic (9.75e-3)" "unprognostic (7.05e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (3.37e-9)" "unprognostic (2.11e-2)" "unprognostic (6.57e-2)" "unprognostic (1.50e-3)" "unprognostic (3.34e-2)" 6.9 11.7 2.7 3.6 4.6 1.1 5.9 7.8 4.2 8.1 5.8 3.1 3.7 4.4 9.4 5.2 4.8 7.7 5.4 3.4 2.6 1.3 4.9 9.2 72.2 3.2 3.4 1.5 5.2 3.7 2.8 2.2 106.2 3.5 6.5 4.7 4.6 2.4 4.6 2.4 6.8 5.7 11.0 3.6 3.2 2.9 2.2 3.6 1.0 7.1 2.4 2.9 9.9 9.5 0.0 0.9 0.1 1.4 0.8 2.2 0.4 4.6 4.8 1.3 6.2 15.2 11.3 6.8 20.2 16.8 10.3 9.6 2.5 3.0 1.1 12.7 18.5 6.4 10.1 1.5 5.3 2.0 1.0 2.1 1.7 7.3 2.8 12.4 0.7 3.4 12.8 8.5 8.0 2.6 18.3 10.0 0.6 2.1 2.0 5.6 1.7 0.4 1.0 0.8 6.9 2.6 1.1 3.3 4.9 8.9 0.7 0.8 3.3 14.6 0.8 3.3 5.6 0.9 2.0 12.6 2.7 5.9 6.5 5.9 1.0 0.6 0.2 5.3 2.7 7.4 0.0 1.4 0.0 2.2 0.7 1.4 0.0 0.4 1.0 0.0 0.0 0.3 1.7 0.1 0.8 0.5 0.9 0.0 0.4 2.7 4.6 7.8 4.2 2.6 1.3 3.4 1.5 3.5 3.6 6.0 61.3 0.5 5.3 5.6 1.5 3.0 2.5 1.4 2.3 5.2 0.0 2.4 0.0 21.2 0.5 10.5 18.6 0.0 7.1 8.6 24.4 2.5 15.0 15.8 4.1 1.6 2.9 14.1 4.0 0.5 9.5 3.5 10.1 0.0 5.5 3.2 11.4 11.0 10.3 3.1 1.0 25.8 18.4 0.9 3.6 4.5 20.4 1.9 9.7 6.4 BMP10 ENSG00000163217 "Bone morphogenetic protein 10" O95393 2 68865481-68871517 "Predicted secreted proteins" "Cell adhesion" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "heart muscle: 110.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "T-reg: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Group enriched" "Detected in some" 9 "JURKAT: 6.3;MOLT-4: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 120000 "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.1 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMP15 GDF9B ENSG00000130385 "Bone morphogenetic protein 15" O95972 X 50910784-50916607 "Disease related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 2.2;testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BMP3 ENSG00000152785 "Bone morphogenetic protein 3" P12645 4 81030965-81057531 "Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;lung: 21.0;urinary bladder: 18.7" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 25.1;Club cells: 20.5;Enterocytes: 20.2;Paneth cells: 23.7" "Cancer enhanced" "Detected in some" "urothelial cancer: 7.5" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 3.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "AF22: 10.6;Daudi: 16.1;RT4: 13.5;SK-BR-3: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (5.21e-3)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (3.36e-2)" "unprognostic (2.73e-3)" "unprognostic (9.11e-2)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.16e-4)" "unprognostic (2.26e-2)" "unprognostic (3.86e-1)" "unprognostic (1.11e-1)" "unprognostic (4.22e-2)" 2.4 0.5 1.4 3.8 0.6 0.8 4.5 0.8 0.7 0.9 15.0 0.0 0.3 3.5 0.2 0.3 4.2 1.1 2.5 0.2 0.7 1.0 0.3 0.2 21.0 0.5 0.3 0.4 3.0 1.0 0.0 0.4 0.0 0.5 3.7 7.9 2.9 6.9 0.0 0.6 0.7 11.2 1.5 0.9 0.2 2.2 0.3 0.0 0.0 0.3 1.6 2.3 18.7 10.5 3.5 0.0 0.6 0.1 1.2 0.1 0.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 13.5 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.5 0.1 0.0 0.5 1.2 0.0 0.0 0.0 0.2 1.4 0.6 0.8 0.7 0.7 1.0 0.3 0.4 0.5 0.0 3.0 25.1 0.0 0.6 0.1 2.2 1.1 0.0 9.4 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.6 0.2 0.2 23.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 5.5 3.0 BMP4 BMP2B ENSG00000125378 "Bone morphogenetic protein 4" P12644 14 53949736-53958761 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 72.4" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 24.5;Fibroblasts: 40.5;Syncytiotrophoblasts: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 1.8;intermediate monocyte: 2.9;memory CD4 T-cell: 2.5;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.1;non-classical monocyte: 4.3" "Group enriched" "Detected in many" 12 "monocytes: 4.3;T-cells: 3.3" "Cell line enhanced" "Detected in many" "CACO-2: 24.9;CAPAN-2: 62.6;Hep G2: 66.6;OE19: 44.9;SuSa: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006863, HPA066235" Uncertain "Secreted to blood" NA NA 162000000 "CAB006863: , HPA066235: AB_2685641" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.29e-1)" "unprognostic (5.20e-3)" "unprognostic (3.39e-2)" "unprognostic (3.32e-1)" "unprognostic (2.78e-2)" "unprognostic (3.11e-1)" "unprognostic (3.45e-3)" "unprognostic (7.67e-2)" "unprognostic (2.45e-3)" "unprognostic (7.06e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (1.24e-1)" 7.9 7.8 1.2 3.6 2.0 0.0 10.3 8.1 3.1 8.6 11.7 3.6 3.5 7.8 5.9 2.7 6.0 5.4 9.9 8.3 2.1 0.8 6.1 2.8 8.2 3.4 2.4 2.6 12.0 2.1 0.0 4.1 21.4 11.9 18.0 14.5 72.4 6.4 9.4 7.3 9.4 11.0 11.0 3.7 2.7 11.9 2.4 2.6 1.6 7.3 4.5 4.0 13.0 22.5 0.0 0.3 0.0 4.3 0.0 3.3 0.9 3.1 8.3 0.4 0.3 0.1 0.0 0.1 1.6 7.1 4.3 3.3 24.9 62.6 0.0 20.8 0.0 0.4 15.2 1.8 0.2 2.3 0.8 1.2 0.0 1.7 66.6 4.2 0.0 0.2 0.0 0.6 2.0 0.1 13.1 12.4 1.4 0.0 0.0 2.0 1.4 1.0 0.0 2.9 44.9 0.7 0.0 2.2 0.0 6.0 0.2 0.0 0.0 0.0 0.2 0.2 37.5 8.2 0.3 0.6 0.1 19.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.8 0.0 0.3 2.9 0.0 0.0 2.5 0.5 0.3 0.0 3.3 1.1 0.0 0.0 4.3 0.1 0.0 0.9 1.2 2.0 8.1 3.1 2.1 0.8 2.4 2.6 11.9 2.6 8.9 8.2 0.5 3.7 24.5 0.0 4.5 10.2 6.7 2.3 5.2 0.0 24.0 3.3 4.8 1.6 7.7 0.5 0.0 0.2 15.8 40.5 1.8 1.1 1.3 3.4 0.0 0.0 23.4 0.3 0.4 9.8 0.2 3.3 0.0 3.1 0.5 23.8 0.8 1.4 1.9 1.1 0.0 7.4 1.2 2.3 15.3 29.1 0.0 0.8 1.3 BMP5 ENSG00000112175 "Bone morphogenetic protein 5" P22003 6 55753645-55875564 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.7;prostate: 29.4;retina: 21.2" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 4.9;Erythroid cells: 23.3;Fibroblasts: 12.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 22.6;U-2 OS: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (2.84e-4)" "unprognostic (9.07e-4)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.21e-2)" "unprognostic (1.58e-1)" "unprognostic (2.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (6.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-1)" "unprognostic (4.76e-2)" 2.1 0.6 0.2 3.3 0.2 0.1 1.5 0.7 0.7 0.2 4.3 0.0 0.0 5.0 0.1 0.2 1.9 0.2 1.5 3.4 0.3 0.2 1.6 1.9 14.3 0.2 2.0 1.4 0.2 1.2 0.1 5.0 42.7 5.2 29.4 4.7 21.2 1.7 0.0 7.0 0.2 10.2 5.5 3.6 0.1 1.9 0.2 0.0 0.0 1.5 5.0 0.1 11.8 1.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.7 0.3 0.2 2.0 1.4 5.2 0.0 0.0 4.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.4 12.4 0.0 0.0 0.0 2.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 BMP6 "VGR, VGR1" ENSG00000153162 "Bone morphogenetic protein 6" P22004 6 7726797-7881422 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.4" "Group enriched" "Detected in some" 4 "Endothelial cells: 9.0;Ito cells: 19.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 4.0;neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 59.0;Karpas-707: 30.6;SiHa: 25.7;TIME: 27.0;U-266/84: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002773, HPA062683" Approved Approved Mitochondria "Secreted to blood" No No 4970000 21000 Mitochondria "CAB002773: , HPA062683: AB_2684832" "prognostic favorable (6.45e-4)" "unprognostic (2.99e-1)" "unprognostic (4.20e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (7.27e-2)" "unprognostic (4.66e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.29e-3)" 10.5 1.5 1.7 1.3 2.8 0.0 7.7 0.2 1.1 2.5 2.7 1.9 2.1 0.0 1.5 1.1 1.6 3.8 1.7 1.4 6.6 1.4 5.8 0.7 2.2 5.8 0.1 0.0 2.8 17.4 1.5 2.2 1.1 2.2 1.4 1.7 2.0 2.0 1.9 3.4 3.4 1.5 0.5 1.8 2.9 1.7 0.3 0.4 4.0 0.0 0.0 0.2 2.1 0.3 0.9 0.1 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.4 0.6 0.1 0.4 0.0 0.0 0.0 2.0 5.6 8.7 0.5 0.3 0.3 6.0 0.0 0.0 0.2 1.0 3.8 59.0 0.0 0.0 30.6 0.0 0.1 0.0 0.0 0.3 0.2 4.2 0.2 0.0 5.3 0.2 0.0 4.4 0.0 25.7 0.0 0.0 3.9 0.0 0.0 27.0 0.0 1.7 0.1 0.8 3.9 13.4 0.0 0.9 0.0 0.5 4.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.3 0.0 0.0 2.3 0.0 0.0 0.2 0.0 2.1 0.0 0.3 0.0 0.0 0.2 0.0 2.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.5 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 19.0 1.0 1.8 0.0 0.0 1.7 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 108.5;Muller glia cells: 38.0;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "Daudi: 42.0;MCF7: 48.6;OE19: 22.8;RPMI-8226: 18.6;SK-BR-3: 31.7;U-698: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" NA NA 248000 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: AB_2683518" "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 42.0 10.8 0.0 2.2 12.2 1.3 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.0 3.0 22.8 0.0 0.0 0.0 18.6 0.0 0.0 0.1 4.6 1.3 31.7 0.1 4.0 0.2 0.1 0.1 0.0 2.9 0.0 0.0 0.0 0.0 57.4 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 6.0 2.1 0.0 11.4 12.2 3.8 12.4 0.0 2.7 2.3 1.8 0.0 108.5 0.0 0.0 3.9 1.5 0.0 0.0 0.0 14.4 10.8 4.9 21.8 0.0 9.3 1.6 2.4 0.0 0.0 3.3 0.3 0.0 3.3 0.0 0.0 38.0 0.0 0.0 0.4 1.6 2.4 0.0 0.9 1.4 1.4 8.4 47.6 0.5 0.2 10.6 BMP8A ENSG00000183682 "Bone morphogenetic protein 8a" Q7Z5Y6 1 39491646-39525935 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "thyroid gland: 45.6" "Group enriched" "Detected in some" 74 "Early spermatids: 42.2;Late spermatids: 125.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 16.2;U-266/70: 7.9;U-266/84: 7.1" "Secreted to blood" NA NA "unprognostic (9.62e-3)" "unprognostic (2.11e-2)" "unprognostic (7.79e-2)" "unprognostic (1.22e-1)" "unprognostic (1.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.91e-3)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (5.33e-3)" "unprognostic (2.95e-9)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" 0.7 1.0 1.7 1.2 2.0 0.9 0.5 0.8 3.6 3.3 1.0 8.5 0.0 1.4 3.7 1.2 0.7 2.0 2.6 1.2 1.9 1.3 0.6 0.5 0.7 5.6 4.6 1.1 8.9 3.8 0.5 0.9 1.0 4.8 1.0 0.6 0.4 1.3 1.8 1.4 1.6 2.2 1.9 8.3 1.4 1.0 4.0 2.3 1.7 45.6 0.0 0.6 0.9 0.9 0.7 0.0 0.0 0.6 0.0 0.1 0.4 0.4 0.8 0.4 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.0 0.4 1.9 0.0 1.7 0.3 3.9 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.2 2.9 0.0 1.7 0.0 2.1 1.1 0.2 0.1 0.5 0.3 2.4 0.1 0.1 1.5 0.4 0.1 0.2 1.2 0.3 0.7 2.9 0.1 0.0 0.7 16.2 0.0 7.9 7.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 2.0 0.8 3.6 1.9 1.3 4.6 1.1 4.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 BMP8B "BMP8, OP-2" ENSG00000116985 "Bone morphogenetic protein 8b" P34820 1 39757182-39788861 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 21.9;thyroid gland: 26.8" "Group enriched" "Detected in some" 15 "Early spermatids: 74.8;Late spermatids: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 47.4;U-266/70: 14.3;U-266/84: 20.5;WM-115: 22.9" "Secreted to blood" NA NA "unprognostic (1.53e-3)" "unprognostic (7.29e-2)" "unprognostic (2.18e-1)" "unprognostic (6.64e-3)" "unprognostic (8.79e-2)" "unprognostic (3.44e-2)" "unprognostic (7.27e-2)" "unprognostic (7.56e-2)" "unprognostic (1.88e-1)" "unprognostic (7.41e-2)" "unprognostic (2.68e-1)" "unprognostic (4.72e-4)" "unprognostic (1.79e-2)" "unprognostic (3.15e-1)" "unprognostic (9.67e-2)" "unprognostic (8.68e-3)" "unprognostic (4.82e-1)" 2.8 8.1 5.5 2.4 6.7 1.4 1.6 2.5 4.1 3.8 13.2 6.9 8.2 7.5 2.6 14.2 3.5 2.3 2.1 1.6 5.0 3.3 1.6 1.0 3.1 3.6 6.1 5.5 1.4 9.9 6.6 5.8 2.3 2.8 5.1 4.0 3.6 3.6 4.7 1.2 3.2 21.9 2.1 3.6 2.4 3.0 3.1 6.2 0.4 26.8 3.4 3.1 2.1 3.3 1.7 0.2 0.8 0.7 2.6 1.9 0.3 1.0 1.9 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 2.2 0.0 0.7 0.0 0.3 0.2 1.7 0.0 0.0 0.4 2.3 1.9 1.6 0.1 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 7.6 0.1 1.5 0.0 1.0 0.3 1.1 0.7 1.1 6.5 2.5 1.6 1.1 5.4 1.4 1.7 0.1 5.3 0.4 1.3 47.4 0.0 0.0 0.1 1.7 0.1 14.3 20.5 0.8 0.0 1.5 22.9 0.8 0.7 0.1 0.5 0.3 0.6 1.7 0.2 1.9 0.1 0.7 0.3 0.4 0.6 2.6 0.3 0.2 0.1 0.3 5.5 6.7 2.5 4.1 5.0 3.3 6.1 5.5 2.8 6.2 0.0 2.6 0.0 0.5 0.3 0.2 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 74.8 0.0 3.5 0.0 3.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 1.2 0.0 0.0 77.6 1.1 0.3 5.0 0.0 2.0 0.1 3.1 2.9 0.7 0.0 0.4 0.0 2.2 0.5 0.3 0.0 0.0 0.0 0.7 0.7 BMPR1B "ALK6, CDw293" ENSG00000138696 "Bone morphogenetic protein receptor type 1B" O00238 4 94757968-95158448 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Chondrogenesis "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.0;ductus deferens: 25.1;prostate: 25.3;seminal vesicle: 32.0" "Group enriched" "Detected in many" 5 "Ciliated cells: 14.7;Club cells: 22.7;Collecting duct cells: 57.6;Glandular cells: 28.8;Intestinal endocrine cells: 17.6;Melanocytes: 27.0;Muller glia cells: 44.8" "Cancer enhanced" "Detected in many" "breast cancer: 32.4;prostate cancer: 24.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 18.7;MCF7: 9.4;SH-SY5Y: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.40e-3)" "prognostic favorable (2.84e-4)" "unprognostic (1.57e-1)" "unprognostic (4.22e-2)" "unprognostic (1.92e-1)" "unprognostic (2.86e-2)" "unprognostic (2.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.97e-2)" "unprognostic (3.93e-1)" "unprognostic (1.62e-3)" "unprognostic (7.89e-4)" "unprognostic (6.22e-2)" "unprognostic (3.81e-3)" "unprognostic (2.63e-2)" 1.1 5.6 12.7 0.8 15.0 0.7 1.7 11.6 12.7 28.0 1.2 5.5 25.1 0.7 5.3 3.2 1.1 14.3 3.4 1.3 13.4 5.9 9.3 1.4 2.4 0.5 5.4 8.6 7.6 1.7 0.6 2.4 1.2 12.1 25.3 0.8 0.7 1.4 32.0 3.3 1.4 0.6 1.2 7.5 1.4 2.8 4.3 11.2 10.8 0.8 0.1 0.6 0.7 0.7 0.4 0.5 1.9 0.9 0.8 1.6 0.3 0.0 18.7 5.0 0.0 2.0 4.6 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.8 0.0 1.0 2.9 6.9 0.0 0.0 4.6 0.0 1.1 0.0 0.5 0.4 0.0 2.8 7.6 2.8 5.7 0.3 0.0 0.0 0.0 0.0 7.2 9.4 0.6 0.1 1.8 0.1 3.2 0.1 2.8 0.1 3.6 0.1 0.2 15.6 0.2 2.5 2.5 0.7 1.9 0.0 0.0 4.0 3.2 0.1 3.4 0.0 0.0 0.0 1.5 0.0 0.4 1.9 0.3 0.5 0.4 0.5 0.7 0.4 0.6 0.3 0.3 0.3 0.5 0.5 0.8 0.8 0.9 0.5 1.6 0.3 12.7 15.0 11.6 11.8 13.4 5.9 5.4 8.6 12.1 11.2 6.0 0.0 0.0 1.3 2.4 0.2 3.6 5.1 14.7 22.7 57.6 0.0 0.0 1.7 2.9 1.1 0.3 0.0 0.0 0.3 0.2 1.4 28.8 0.0 0.0 0.1 0.0 17.6 4.9 0.0 1.6 2.8 0.3 27.0 0.0 0.0 44.8 0.7 0.0 3.5 0.0 1.2 0.0 1.4 1.6 1.3 1.9 0.0 0.0 0.0 1.0 BMX "ETK, PSCTK3" ENSG00000102010 "BMX non-receptor tyrosine kinase" P51813 X 15464246-15556529 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell adhesion, Stress response" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 57.1" "Group enriched" "Detected in some" 9 "Endothelial cells: 18.5;Ito cells: 51.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 105 "granulocytes: 10.5" "Cell line enriched" "Detected in single" 121 "HUVEC TERT2: 90.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001048, CAB032495" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB032495: AB_2290760, HPA001048: AB_1078289" "unprognostic (7.80e-2)" "unprognostic (4.92e-3)" "unprognostic (1.16e-2)" "unprognostic (4.07e-3)" "unprognostic (2.69e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-3)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.06e-1)" "unprognostic (1.26e-2)" "unprognostic (1.84e-2)" "unprognostic (3.64e-2)" "unprognostic (1.26e-1)" "unprognostic (2.81e-2)" 8.2 0.3 0.1 1.0 0.7 3.6 5.4 0.1 0.3 2.2 5.5 0.1 4.6 2.4 2.6 57.1 1.5 2.5 2.6 10.5 0.5 0.0 0.2 0.9 3.7 6.5 0.4 0.0 1.4 0.9 0.2 0.6 2.6 0.7 2.2 1.4 0.5 1.5 0.6 4.2 1.6 5.5 2.2 0.4 2.4 1.5 1.9 0.1 0.2 2.2 1.1 0.8 2.8 2.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.7 0.1 0.0 1.4 0.0 0.5 0.3 0.0 1.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.1 0.0 4.1 51.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 BNC1 "BNC, HsT19447" ENSG00000169594 "Basonuclin 1" Q01954 15 83255903-83284714 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.4;testis: 27.5;tongue: 20.2" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 78.8;Early spermatids: 37.3;Late spermatids: 74.8;Suprabasal keratinocytes: 51.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 16.3;HBEC3-KT: 37.1;hTCEpi: 41.7;hTERT-HME1: 40.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063183, HPA066947, HPA077428" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345" "unprognostic (1.86e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (5.55e-2)" "unprognostic (4.06e-2)" "unprognostic (2.47e-2)" "unprognostic (2.45e-2)" "unprognostic (7.91e-2)" "unprognostic (8.89e-4)" "unprognostic (6.94e-2)" "unprognostic (4.13e-1)" "unprognostic (3.85e-3)" "unprognostic (8.46e-3)" "unprognostic (2.20e-1)" "unprognostic (2.95e-3)" "unprognostic (1.01e-2)" 12.7 0.1 0.0 1.6 0.1 0.0 0.9 0.0 0.4 2.7 1.5 0.1 0.0 0.0 0.4 10.8 13.4 0.8 0.1 1.4 0.1 0.0 0.1 0.1 0.7 1.3 0.2 0.2 0.6 0.0 0.0 0.0 1.9 0.5 0.4 0.0 0.7 1.7 0.2 0.1 7.9 0.2 0.3 0.3 0.1 0.0 27.5 0.0 6.0 0.2 20.2 3.7 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 1.4 2.1 0.0 0.6 0.1 7.1 10.0 0.0 0.1 0.0 0.3 4.3 0.0 16.3 0.8 37.1 12.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 1.8 41.7 6.3 40.7 1.5 6.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.7 0.0 0.0 4.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 9.7 78.8 0.0 0.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 37.3 0.5 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.1 0.0 0.0 1.3 0.0 74.8 0.6 0.5 8.5 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 16.3 5.9 51.1 0.0 0.0 0.0 4.6 BNC2 "BSN2, FLJ20043" ENSG00000173068 "Basonuclin 2" Q6ZN30 9 16409503-16870843 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 35.8;ovary: 37.0" "Group enriched" "Detected in many" 4 "granulocytes: 21.9;Leydig cells: 83.4;Peritubular cells: 63.6;Proximal tubular cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "gdT-cell: 5.8" "Lineage enriched" "Detected in many" 5 "T-cells: 5.8" "Cell line enhanced" "Detected in many" "HSkMC: 18.5;Karpas-707: 22.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA018525, HPA059419" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018525: AB_1845402, HPA059419: AB_2732637" "unprognostic (2.68e-1)" "unprognostic (2.89e-1)" "unprognostic (3.64e-2)" "unprognostic (1.14e-2)" "unprognostic (1.56e-2)" "unprognostic (5.07e-2)" "unprognostic (2.81e-2)" "unprognostic (2.50e-1)" "unprognostic (1.94e-2)" "unprognostic (6.05e-2)" "unprognostic (5.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (6.74e-2)" "unprognostic (1.14e-3)" 4.3 1.0 0.5 5.1 0.7 0.3 4.3 0.5 0.7 19.8 7.6 1.8 2.9 0.8 35.8 5.5 3.8 14.3 9.3 3.8 1.2 0.5 7.6 0.4 2.6 0.9 0.9 0.5 37.0 0.5 2.7 1.5 2.2 2.3 6.4 2.1 11.0 1.3 4.8 7.6 2.9 2.8 23.1 2.0 0.5 3.0 4.7 1.0 0.9 1.7 3.6 1.3 8.5 9.0 0.1 0.0 0.0 0.0 1.0 5.8 3.2 0.1 0.9 0.7 0.0 10.1 12.5 1.6 6.2 10.9 4.5 3.7 0.0 0.0 0.0 2.1 4.2 3.3 0.0 2.9 0.0 4.6 0.1 1.2 0.1 2.9 0.0 7.8 0.0 0.2 18.5 0.0 9.5 0.0 7.8 10.0 0.0 0.0 22.5 6.3 0.0 0.0 1.5 3.7 0.0 5.7 0.0 7.1 15.0 3.4 0.2 0.1 0.5 0.0 0.0 10.6 4.9 0.0 0.0 9.8 10.5 7.8 8.5 11.4 0.1 0.0 0.1 4.3 1.4 1.4 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 1.0 0.0 0.0 0.0 3.2 0.5 0.7 0.5 0.7 1.2 0.5 0.9 0.5 2.3 1.0 0.0 2.1 0.0 0.6 9.0 2.1 4.3 0.0 1.4 1.2 0.0 0.0 2.4 0.0 0.5 5.0 6.8 0.3 0.0 0.3 1.6 11.6 0.1 21.9 0.0 6.1 0.0 0.0 11.6 2.1 1.8 83.4 2.2 10.1 0.0 0.0 2.3 0.1 0.0 63.6 31.8 0.2 6.5 7.4 0.7 5.1 4.8 1.0 1.5 0.0 0.0 BNIP3 Nip3 ENSG00000176171 "BCL2 interacting protein 3" Q12983 10 131966455-131982013 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.7" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 391.8;Proximal tubular cells: 579.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003015, CAB011676" Supported Uncertain Cytosol NA NA Cytosol "CAB011676: , HPA003015: AB_1078290" "unprognostic (1.01e-3)" "unprognostic (1.42e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.58e-2)" "unprognostic (1.62e-3)" "unprognostic (6.57e-3)" "unprognostic (1.12e-1)" "unprognostic (2.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (4.55e-4)" "unprognostic (2.37e-3)" "unprognostic (1.04e-1)" "unprognostic (3.29e-2)" "unprognostic (2.98e-1)" 19.3 12.0 18.3 4.0 18.6 3.0 8.7 13.5 28.3 7.7 4.6 13.0 5.1 4.0 6.0 11.4 8.1 6.0 7.9 43.3 16.9 14.6 27.6 53.4 6.7 4.6 16.5 14.2 19.3 122.7 6.0 7.3 13.0 22.6 18.2 2.9 5.2 19.2 6.6 48.0 9.0 4.5 6.0 13.3 4.9 6.4 6.0 11.1 3.3 10.8 6.2 4.0 9.2 7.3 6.1 3.0 5.1 3.5 2.2 23.4 8.9 72.0 5.8 4.2 11.7 11.2 11.9 21.6 17.6 16.3 13.3 38.0 1.2 1.6 0.1 28.6 10.1 15.5 4.4 8.8 25.0 50.1 3.8 6.7 2.5 3.7 16.7 15.0 3.3 2.0 8.2 6.3 12.9 13.1 56.2 9.2 4.5 6.6 0.2 21.7 5.7 1.6 18.4 3.5 0.5 17.5 4.0 2.1 6.1 14.5 1.2 5.5 12.9 3.6 7.4 10.0 18.6 4.5 4.6 10.5 18.8 6.3 7.0 13.9 12.3 10.5 10.0 68.2 0.1 3.2 2.2 3.5 5.1 9.8 2.3 10.4 5.7 13.9 10.3 3.0 6.1 23.4 15.4 0.9 2.2 3.1 2.3 13.2 8.9 18.3 18.6 13.5 28.3 16.9 14.6 16.5 14.2 22.6 11.1 44.7 40.9 23.1 75.3 26.6 87.6 141.4 101.9 89.7 48.9 80.3 37.3 149.9 255.4 174.2 61.9 44.2 3.5 0.0 75.7 295.7 56.6 118.1 0.0 391.8 65.8 314.6 77.8 54.6 21.8 85.4 65.0 16.1 32.1 39.7 6.7 125.3 189.3 1.9 97.2 579.1 50.2 38.8 23.8 33.5 100.7 11.4 206.9 25.4 4.8 42.9 BNIPL "BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753" ENSG00000163141 "BCL2 interacting protein like" Q7Z465 1 151036570-151047600 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.5;skin 1: 68.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 14.9;Suprabasal keratinocytes: 49.9;Urothelial cells: 20.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "T-47d: 33.1" "Group enriched" "Detected in some" 9 "basal ganglia: 1.4;cerebellum: 2.7" "Low region specificity" "Detected in some" HPA019946 Uncertain Cytosol NA NA Cytosol "HPA019946: AB_2732424" "unprognostic (2.62e-1)" "unprognostic (7.59e-3)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.50e-4)" "unprognostic (6.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.32e-3)" "unprognostic (3.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.88e-4)" "unprognostic (1.91e-1)" "unprognostic (8.43e-11)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" "prognostic favorable (4.32e-4)" "unprognostic (6.81e-2)" 0.1 0.1 0.2 0.1 0.2 0.3 6.4 0.2 0.2 9.7 0.1 0.1 9.4 0.1 0.6 0.6 42.5 1.0 0.1 0.2 0.2 0.0 0.5 0.2 6.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 3.2 0.1 3.4 0.1 0.3 7.1 21.0 0.7 68.6 0.2 0.8 0.1 0.1 0.6 1.0 0.1 0.2 2.7 25.8 23.2 5.0 18.2 1.8 0.8 3.2 0.6 0.5 1.7 0.4 0.3 0.2 0.5 0.6 0.3 0.3 0.6 0.3 0.0 0.2 0.1 1.1 0.4 0.6 0.5 0.0 0.1 1.3 0.7 0.2 0.4 0.8 0.8 0.9 0.5 0.2 0.1 0.5 0.6 0.0 2.4 0.1 0.2 0.9 0.0 0.9 0.5 0.5 0.2 1.5 0.6 0.9 0.5 0.7 0.4 0.3 0.2 0.3 0.5 0.3 1.1 0.5 0.4 0.7 0.2 1.9 33.1 0.2 0.7 0.7 0.4 0.2 0.1 1.5 1.1 3.1 0.0 0.2 0.6 2.7 0.6 0.7 1.7 0.6 1.4 0.5 1.0 1.2 0.3 1.8 1.0 0.6 3.2 0.5 0.6 0.8 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.1 14.9 12.1 0.0 5.4 13.6 0.4 0.3 0.0 9.4 10.3 10.4 0.0 1.5 0.0 0.0 5.9 0.3 0.4 0.0 0.0 0.3 1.3 6.2 0.0 0.0 0.3 0.0 0.0 3.7 1.2 0.9 0.9 0.8 3.3 0.0 0.1 0.5 0.0 0.0 0.0 0.3 1.4 0.0 0.2 0.5 0.1 49.9 2.2 0.8 0.2 20.9 BOD1L2 "BOD1P, FAM44C, MGC33608" ENSG00000228075 "Biorientation of chromosomes in cell division 1 like 2" Q8IYS8 18 57147062-57150300 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "testis: 197.8" "Group enriched" "Detected in some" 10 "Early spermatids: 1355.5;Late spermatids: 3669.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.7" HPA036293 Uncertain NA NA "HPA036293: AB_10673127" "unprognostic (2.35e-3)" "unprognostic (3.72e-1)" "unprognostic (2.47e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1355.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3669.5 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 12.9 0.0 249.0 21.5 0.0 0.0 0.0 0.0 0.0 BOK "BCL2L9, BOKL, MGC4631" ENSG00000176720 "BOK, BCL2 family apoptosis regulator" Q9UMX3 2 241551424-241574138 "Plasma proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.0;brain: 64.1" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 80.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "TIME: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.16e-2)" "unprognostic (3.01e-2)" "unprognostic (1.24e-3)" "unprognostic (6.30e-2)" "unprognostic (8.63e-2)" "unprognostic (1.33e-1)" "unprognostic (2.24e-3)" "unprognostic (1.16e-2)" "unprognostic (8.45e-2)" "unprognostic (2.33e-1)" "unprognostic (2.47e-2)" "unprognostic (2.27e-1)" "prognostic favorable (1.09e-9)" "unprognostic (9.48e-3)" "unprognostic (6.81e-2)" "unprognostic (2.46e-1)" "unprognostic (1.09e-1)" 56.0 5.4 15.0 4.5 44.5 0.8 25.6 8.6 24.7 10.5 13.7 45.2 3.3 5.9 15.4 12.0 20.1 13.2 15.5 4.4 19.8 16.0 10.9 46.2 13.8 2.6 64.1 12.8 5.5 11.0 2.9 2.0 4.3 38.6 14.7 4.0 3.0 7.7 19.1 2.1 12.9 4.9 14.1 44.8 3.7 8.5 4.4 56.2 0.0 5.4 3.0 2.7 13.2 13.8 0.0 0.0 0.0 0.0 1.4 5.7 1.5 14.2 3.6 6.5 14.9 11.2 6.7 1.8 11.6 4.6 15.4 15.9 6.5 6.0 0.0 4.0 20.6 3.8 13.4 0.7 11.7 5.8 0.0 0.1 0.0 3.7 16.7 9.3 0.1 0.5 6.7 12.1 6.4 1.8 11.6 18.3 1.0 2.5 0.0 15.0 18.3 0.0 0.1 4.0 16.0 11.0 0.1 10.7 0.0 9.9 0.3 5.8 2.2 5.3 3.5 9.3 8.0 10.0 0.5 26.3 0.0 22.4 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.7 0.0 0.6 0.0 1.7 2.3 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.0 1.5 15.0 44.5 8.6 24.7 19.8 16.0 64.1 12.8 38.6 56.2 6.0 28.0 0.0 9.5 6.4 0.1 9.0 30.6 0.0 3.4 10.4 0.0 1.1 13.3 19.0 0.1 11.3 4.9 0.0 9.7 8.4 9.4 20.7 0.0 80.6 0.7 0.0 10.9 10.4 3.3 1.1 5.8 0.6 1.7 0.0 2.9 1.4 22.3 2.9 9.9 21.6 0.8 0.0 6.2 0.2 3.8 11.2 5.1 0.0 3.6 11.2 BOLA2 "BOLA2A, My016" ENSG00000183336 "BolA family member 2" Q9H3K6 16 29443056-29454964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.6" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 2.4;Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" 2.3 3.6 3.6 9.0 3.6 9.5 2.2 1.3 2.0 1.4 5.6 13.5 1.6 0.0 4.6 1.2 1.5 3.1 3.3 2.7 3.2 3.5 2.7 6.6 3.4 0.6 7.2 0.7 3.6 2.9 1.8 0.8 7.1 1.2 4.6 2.5 10.7 0.5 3.6 6.0 7.2 5.5 1.8 1.2 2.3 2.3 25.6 21.4 15.8 20.7 10.4 20.1 18.1 14.2 23.4 3.9 8.4 1.5 2.2 12.4 4.7 2.3 4.5 5.9 10.7 12.9 5.2 14.8 1.4 7.2 8.3 1.9 7.8 0.3 14.6 35.6 11.8 8.9 23.5 3.8 7.7 12.8 1.9 4.4 9.2 2.6 0.9 5.0 17.2 5.3 12.3 2.5 28.7 9.7 13.3 10.7 7.6 21.8 18.0 5.8 25.8 3.8 5.8 10.0 11.1 2.6 23.2 4.4 0.8 7.5 5.5 5.0 9.2 5.8 10.2 9.9 22.6 12.0 9.4 10.4 10.8 9.9 8.2 19.3 15.8 16.5 20.7 16.0 25.6 15.6 16.7 14.8 20.6 11.9 13.7 3.7 10.4 17.4 21.4 20.1 18.1 0.0 2.4 0.0 0.2 0.1 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.5 0.0 0.7 0.1 0.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.2 0.0 0.2 0.3 BOLA2B ENSG00000169627 "BolA family member 2B" Q9H3K6 16 30192934-30194306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 47.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 89.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 80.0;Hep G2: 72.9;MCF7: 69.2" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 180000 Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" "unprognostic (2.49e-1)" "unprognostic (4.60e-3)" "unprognostic (8.49e-2)" "unprognostic (3.02e-3)" "unprognostic (9.80e-4)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (1.25e-1)" "unprognostic (3.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (2.94e-1)" "unprognostic (5.29e-1)" "unprognostic (2.21e-2)" "unprognostic (4.91e-3)" 5.3 6.2 10.0 8.5 8.3 17.6 4.5 6.7 8.8 5.1 13.8 6.1 3.9 14.7 5.8 5.6 9.7 3.3 6.7 11.9 8.2 6.1 7.4 5.4 4.9 15.6 8.9 3.9 5.2 8.3 1.8 6.5 5.5 4.7 4.1 8.5 5.0 7.9 3.9 5.9 7.4 11.2 4.2 8.5 10.8 9.2 7.8 5.6 9.2 3.9 7.7 13.7 7.8 24.9 47.7 32.4 24.8 33.5 25.6 33.6 26.2 15.2 49.2 4.8 11.7 1.6 1.9 15.7 3.7 2.3 3.5 4.9 29.3 15.9 4.6 18.2 1.0 6.3 8.3 2.7 7.1 0.6 14.3 80.0 9.9 28.1 72.9 3.5 6.3 13.1 1.1 4.7 6.0 2.4 1.2 6.1 14.7 6.5 15.5 3.1 69.2 17.8 18.6 14.5 7.0 51.6 15.6 7.1 34.0 4.6 24.8 14.7 14.6 2.0 21.3 4.9 1.5 9.6 9.2 4.8 8.1 6.5 14.0 14.0 26.0 16.1 16.2 11.7 16.9 12.0 14.3 25.5 24.8 28.6 33.5 29.7 47.7 30.3 31.7 21.4 38.1 22.2 31.8 4.3 25.6 29.2 32.4 33.6 26.2 10.0 8.3 6.7 8.8 8.2 6.1 8.9 3.9 4.7 5.6 14.9 16.3 3.7 2.1 5.6 0.8 89.6 33.1 42.8 39.8 22.7 2.0 6.5 39.7 11.7 27.2 8.0 36.6 0.0 21.1 4.3 5.6 3.1 27.9 18.1 10.1 1.6 27.7 15.4 27.7 21.6 2.3 10.1 6.8 13.6 24.2 4.1 21.3 25.4 1.4 21.3 2.0 6.5 5.1 4.3 6.8 9.8 3.2 17.5 23.3 3.3 BOLL BOULE ENSG00000152430 "Boule homolog, RNA binding protein" Q8N9W6 2 197726879-197786762 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 83.6" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 119.5;Late spermatids: 97.5;Spermatocytes: 256.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "T-reg: 4.7" "Lineage enriched" "Detected in single" 12 "T-cells: 4.7" "Cell line enhanced" "Detected in some" "MCF7: 1.6;U-266/70: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018678, HPA048813" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Midbody ring,Cytosol" NA NA Cytosol "Nucleoli fibrillar center, Plasma membrane, Midbody ring" "HPA018678: AB_1845411, HPA048813: AB_2680529" "unprognostic (3.55e-2)" "unprognostic (1.69e-1)" "unprognostic (6.05e-2)" "unprognostic (3.08e-2)" "unprognostic (7.93e-2)" "unprognostic (3.20e-1)" "unprognostic (3.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.80e-1)" "unprognostic (3.08e-1)" "unprognostic (9.49e-2)" "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 83.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.3 0.6 0.6 0.0 0.0 0.7 0.4 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.5 0.0 1.6 0.0 0.2 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.2 3.5 0.6 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.5 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 256.1 39.8 0.0 0.0 0.0 0.0 0.0 BORA "C13orf34, FLJ22624" ENSG00000136122 "Bora, aurora kinase A activator" Q6PGQ7 13 72727749-72756198 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.5" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 9.8;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040866 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA Yes "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA040866: AB_10794868" "unprognostic (9.93e-2)" "unprognostic (7.18e-2)" "unprognostic (4.57e-2)" "unprognostic (7.09e-2)" "unprognostic (1.49e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-4)" "unprognostic (2.65e-2)" "unprognostic (2.82e-3)" "unprognostic (6.18e-2)" "unprognostic (1.08e-2)" "unprognostic (2.11e-2)" "unprognostic (5.32e-12)" "unprognostic (7.04e-3)" "unprognostic (2.88e-1)" "unprognostic (9.93e-2)" "unprognostic (2.28e-2)" 3.7 3.0 2.3 10.9 3.2 10.9 6.8 5.8 4.2 3.3 9.0 1.8 6.3 6.9 3.1 5.9 7.1 3.2 3.2 2.3 2.6 2.2 4.3 4.3 7.7 11.8 4.3 1.5 3.1 5.6 0.8 6.3 6.8 4.4 4.0 9.1 2.2 4.6 6.7 2.1 6.1 10.6 3.5 5.3 8.9 5.5 7.0 4.6 26.5 5.0 5.8 12.4 5.6 4.5 5.0 5.7 7.2 5.4 4.6 8.3 3.7 22.3 3.9 12.7 8.6 1.6 1.6 9.0 7.5 6.7 11.8 12.9 10.3 12.9 14.6 4.3 4.3 6.9 9.6 11.4 7.3 15.7 13.5 6.3 18.0 6.3 8.4 1.5 33.9 11.7 1.3 1.9 5.3 11.6 2.6 9.8 15.5 8.2 6.3 8.5 5.2 15.2 9.8 5.6 23.3 4.6 11.1 7.5 6.5 4.0 5.8 3.4 4.0 7.5 7.3 5.4 10.1 4.9 12.4 3.5 3.3 7.5 5.7 9.5 5.4 4.9 10.5 9.2 16.1 8.2 7.2 3.1 1.6 6.6 5.4 5.8 4.6 5.7 6.4 5.7 5.0 4.7 8.3 0.7 4.6 3.3 3.2 5.9 3.7 2.3 3.2 5.8 4.2 2.6 2.2 4.3 1.5 4.4 4.6 3.0 3.2 2.4 1.3 0.6 1.9 0.2 0.0 2.7 2.3 1.8 2.0 3.9 0.0 1.5 1.0 0.2 2.3 0.0 2.2 9.8 0.7 1.4 1.1 0.0 3.8 7.9 0.0 3.1 5.1 0.8 0.9 2.9 0.0 1.8 1.9 1.0 1.4 2.6 1.1 0.5 2.1 12.9 1.9 1.2 4.7 1.0 2.4 2.5 4.0 1.3 BORCS6 "C17orf59, FLJ20014" ENSG00000196544 "BLOC-1 related complex subunit 6" Q96GS4 17 8188333-8190907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 27.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045415, HPA060791" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA045415: AB_10964575, HPA060791: AB_2684367" "unprognostic (2.11e-1)" "unprognostic (7.22e-3)" "unprognostic (3.25e-2)" "prognostic favorable (2.78e-4)" "unprognostic (3.84e-2)" "unprognostic (9.91e-3)" "unprognostic (7.51e-2)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" "unprognostic (6.93e-2)" "prognostic favorable (2.60e-4)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (2.18e-2)" "unprognostic (4.38e-2)" "unprognostic (3.28e-1)" "unprognostic (3.10e-2)" 3.1 4.5 3.5 3.8 3.4 2.8 2.6 3.2 3.9 2.3 4.4 6.3 3.7 2.9 5.5 2.3 1.6 4.4 3.4 2.6 3.9 3.7 3.7 4.8 3.7 2.3 8.4 4.7 2.1 3.0 2.9 1.9 4.3 4.3 11.5 6.2 5.5 2.1 2.8 6.8 3.9 2.1 2.7 3.7 3.3 2.9 13.4 11.3 27.0 12.0 14.5 17.4 10.5 4.7 5.5 2.0 4.0 4.1 3.0 7.7 3.5 3.8 3.3 3.6 3.0 3.4 4.3 7.8 2.7 3.4 6.9 2.9 4.0 1.1 12.9 12.1 3.3 5.4 4.7 4.7 1.9 7.3 3.1 4.3 3.0 3.5 3.2 5.3 6.5 3.6 9.2 2.0 5.3 6.5 5.6 1.4 3.0 6.3 7.9 2.4 6.5 4.5 2.8 2.3 5.3 3.7 2.7 2.9 2.0 4.0 3.1 4.4 2.1 1.8 3.4 3.7 14.0 6.2 2.0 3.0 7.0 2.5 21.4 10.1 27.0 16.2 10.3 13.1 12.8 13.7 17.4 11.3 13.4 13.2 14.6 9.5 14.5 12.0 9.9 12.4 10.5 8.9 8.3 18.6 2.3 0.0 19.9 0.0 10.2 0.0 1.2 5.2 5.9 17.2 6.6 8.9 1.7 5.3 11.9 0.0 15.4 9.9 1.0 2.8 3.5 5.8 18.2 17.5 1.2 8.6 20.3 2.7 5.5 8.7 0.0 23.4 10.5 20.4 10.0 12.4 6.3 7.4 16.6 32.3 0.0 6.7 1.1 0.0 5.1 21.8 9.0 1.4 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Group enriched" "Detected in all" 5 "Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 38.0;RT4: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 69000000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.5 5.5 7.4 9.9 8.5 5.0 7.4 13.7 16.6 5.3 8.0 2.2 6.1 5.5 4.1 7.6 10.6 3.7 7.8 7.5 9.4 38.0 6.8 3.2 5.1 2.5 5.8 6.0 4.2 4.9 6.9 10.0 5.5 8.2 19.3 7.0 9.2 7.0 12.6 2.2 9.8 8.4 7.6 9.3 5.3 7.5 5.3 4.0 12.1 61.1 6.3 10.7 6.3 7.7 6.8 8.2 5.1 3.9 14.7 8.5 2.0 11.4 11.1 11.5 13.2 6.9 14.7 5.8 14.5 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 8.9 26.7 14.4 18.4 34.7 20.3 20.5 15.3 29.4 14.8 26.2 2.0 35.3 109.5 38.4 2.2 11.9 5.1 303.7 15.9 28.0 17.1 21.1 24.3 4.3 13.3 19.1 12.6 8.0 7.3 5.1 9.5 11.3 21.9 19.8 3.8 18.6 36.1 3.5 11.3 47.1 11.6 6.5 24.7 27.9 22.5 11.5 308.5 21.5 4.5 13.7 BPHL "Bph-rp, MCNAA, VACVase" ENSG00000137274 "Biphenyl hydrolase like" Q86WA6 6 3118374-3153578 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 61.6;liver: 47.9" "Cell type enhanced" "Detected in many" 12 "Proximal tubular cells: 218.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036752, HPA036753" Enhanced Approved Mitochondria NA NA 13000 Mitochondria "HPA036752: AB_10673662, HPA036753: AB_2675291" "unprognostic (2.93e-1)" "unprognostic (1.29e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-1)" "unprognostic (3.72e-3)" "unprognostic (1.84e-1)" "unprognostic (8.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.97e-4)" "unprognostic (4.59e-2)" "unprognostic (9.46e-3)" "prognostic favorable (5.16e-7)" "unprognostic (1.60e-2)" "unprognostic (1.51e-2)" "unprognostic (6.98e-2)" "unprognostic (5.20e-2)" 12.8 9.8 8.4 5.1 12.1 4.0 8.1 6.0 10.1 6.7 19.4 6.3 4.5 19.8 6.1 17.8 8.8 7.1 8.2 6.8 7.5 9.6 61.6 47.9 3.8 4.9 7.8 5.9 5.1 9.8 4.8 8.4 3.7 10.3 5.9 6.4 6.4 8.4 4.1 12.0 6.4 29.1 7.0 6.9 2.7 6.5 7.0 3.8 4.9 4.6 8.8 5.6 6.2 5.6 15.8 13.1 7.3 11.2 11.1 11.7 6.5 13.9 11.0 18.0 16.0 11.3 10.6 8.6 7.1 12.0 15.9 14.0 13.0 15.0 16.6 14.3 11.7 14.8 13.8 16.2 16.5 37.0 19.7 10.5 8.1 8.3 16.8 3.6 10.0 4.4 8.5 7.6 15.6 23.1 9.8 23.3 13.3 7.2 8.5 24.5 20.5 12.2 6.0 13.4 14.7 24.7 12.8 20.2 16.5 12.8 15.8 17.3 13.6 10.6 5.7 27.5 23.1 17.4 4.9 8.2 19.9 16.5 11.8 13.2 7.1 21.6 13.7 4.3 5.8 22.4 7.3 8.7 0.1 7.7 11.2 9.9 15.8 8.9 7.6 13.1 11.8 8.5 11.7 1.0 11.1 6.3 7.3 4.7 6.5 8.4 12.1 6.0 10.1 7.5 9.6 7.8 5.9 10.3 3.8 6.0 9.4 4.7 8.7 7.9 11.6 3.9 35.7 45.5 14.8 15.7 19.6 23.1 59.7 24.9 0.4 7.1 17.1 0.0 11.8 27.7 12.2 7.5 2.3 62.1 19.8 15.9 15.4 3.7 1.8 0.7 13.8 10.5 30.4 21.6 10.1 11.0 17.9 10.8 13.1 218.9 7.2 6.5 9.5 6.7 21.5 8.2 11.7 5.3 16.3 6.8 BPI BPIFD1 ENSG00000101425 "Bactericidal/permeability-increasing protein" P17213 20 38304123-38337505 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 197.4" "Group enriched" "Detected in some" 6 "Early spermatids: 167.9;Late spermatids: 173.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "classical monocyte: 13.6;neutrophil: 6.4" "Group enriched" "Detected in many" 18 "granulocytes: 6.4;monocytes: 13.6" "Cell line enhanced" "Detected in some" "BJ: 1.3;BJ hTERT+: 2.1;HL-60: 5.2;RPMI-8226: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA061284 Enhanced "Secreted to blood" NA NA 7290000 "HPA061284: AB_2684465" "unprognostic (9.30e-4)" "unprognostic (5.49e-2)" "unprognostic (1.97e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.56e-1)" "unprognostic (4.50e-2)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (1.14e-1)" "unprognostic (2.60e-2)" "unprognostic (1.50e-1)" "unprognostic (8.83e-6)" "unprognostic (2.66e-4)" "unprognostic (9.29e-2)" "unprognostic (2.32e-2)" "unprognostic (9.47e-3)" 0.2 0.1 0.0 0.1 0.1 197.4 0.2 0.1 0.8 1.8 0.1 0.3 0.0 0.1 0.6 0.5 0.1 0.2 0.2 15.3 0.0 0.0 0.6 0.5 6.0 0.1 0.0 0.0 1.7 0.1 0.1 0.5 2.8 0.3 0.2 0.1 0.2 0.3 0.4 0.6 0.3 0.1 0.1 0.1 10.5 0.1 41.7 0.1 5.3 1.3 0.0 0.1 0.1 0.7 0.0 0.5 6.4 13.6 0.0 0.0 6.7 0.0 0.0 0.6 0.0 0.2 0.3 0.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 13.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.5 0.0 0.0 6.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 8.3 0.0 167.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 0.0 1.3 0.0 173.1 16.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 17.3 27.0 0.0 0.0 0.0 1.8 1.1 0.1 0.0 0.0 0.0 0.0 BPIFA1 "bA49G10.5, LUNX, PLUNC, SPLUNC1" ENSG00000198183 "BPI fold containing family A member 1" Q9NP55 20 33235995-33243311 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9" "Cell type enriched" "Detected in some" 26 "Ciliated cells: 116.4" "Cancer enriched" "Detected in many" 27 "lung cancer: 262.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6" "Not detected" "Not detected" CAB025669 Supported "Secreted in other tissues" NA NA 1200000 "CAB025669: " "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (3.65e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 11.9 25.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 116.4 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFA2 "bA49G10.1, C20orf70, PSP, SPLUNC2" ENSG00000131050 "BPI fold containing family A member 2" Q96DR5 20 33161768-33181412 "Predicted secreted proteins" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 265 "salivary gland: 1210.9" "Cell type enhanced" "Detected in some" 19 "Club cells: 1.2;Collecting duct cells: 3.5;Late spermatids: 2.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 3.7;RT4: 4.4;SK-BR-3: 1.7" "Not detected" "Not detected" HPA044006 Enhanced "Secreted to digestive system" NA NA "HPA044006: AB_10963580" "unprognostic (9.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (6.14e-4)" 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.4 0.1 1.2 0.1 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1210.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.6 1.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFA3 "bA49G10.4, C20orf71, SPLUNC3" ENSG00000131059 "BPI fold containing family A member 3" Q9BQP9 20 33217310-33227758 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 86.6" "Group enriched" "Detected in some" 99 "Early spermatids: 659.6;Late spermatids: 2410.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062708 Enhanced "Secreted in male reproductive system" NA NA "HPA062708: AB_2684843" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 659.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2410.5 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 6.5 0.0 15.6 7.9 0.0 0.0 0.0 0.0 0.0 BPIFB1 "bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP" ENSG00000125999 "BPI fold containing family B member 1" Q8TDL5 20 33273480-33309878 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9" "Group enriched" "Detected in some" 16 "Ciliated cells: 887.4;Club cells: 1261.4" "Cancer enhanced" "Detected in many" "stomach cancer: 75.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.0;OE19: 6.6;RT4: 3.9;SK-BR-3: 7.9" "Region enriched" "Detected in single" 7 "olfactory region: 6.2" "Not detected" "Not detected" HPA024256 Enhanced "Secreted in other tissues" NA NA 7500000 "HPA024256: AB_1845664" "unprognostic (2.42e-1)" "unprognostic (5.41e-2)" "unprognostic (3.67e-2)" "unprognostic (3.09e-1)" "unprognostic (6.72e-2)" "unprognostic (3.43e-2)" "unprognostic (9.37e-3)" "unprognostic (1.14e-1)" "unprognostic (2.82e-1)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (1.36e-7)" "unprognostic (3.30e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" 0.1 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.2 100.1 0.1 0.3 0.1 3.7 0.5 0.2 23.3 0.0 0.3 0.3 0.2 0.0 0.1 0.1 101.0 0.1 0.1 0.1 0.1 0.1 0.0 4.7 0.1 0.1 0.9 0.0 0.1 38.8 0.8 1.0 0.0 0.1 0.1 0.1 0.1 76.9 1.1 0.1 0.2 0.2 29.6 115.1 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 6.6 0.0 0.7 0.0 0.3 0.0 3.9 0.0 0.0 0.0 7.9 0.0 0.1 0.6 0.0 0.6 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.1 8.9 17.7 0.0 0.4 1.1 0.0 0.4 5.1 887.4 1261.4 0.0 0.0 0.2 0.0 0.1 66.1 0.2 0.0 0.0 0.2 0.1 0.9 1.9 3.5 0.0 0.2 0.0 0.0 0.0 0.0 66.3 0.3 0.3 1.7 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.9 0.4 0.4 0.1 0.0 0.0 0.7 BPIFB2 "BPIL1, C20orf184, dJ726C3.2, LPLUNC2" ENSG00000078898 "BPI fold containing family B member 2" Q8N4F0 20 33007600-33023709 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 218.0;salivary gland: 191.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 2.8;Glandular cells: 6.1;Hepatocytes: 1.5;Late spermatids: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 552 "Hep G2: 69.5" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Not detected" "Not detected" "HPA049491, HPA060121" Enhanced Approved Vesicles "Intracellular and membrane" NA NA 68000 Vesicles "HPA049491: AB_2680792, HPA060121: AB_2684207" "unprognostic (1.94e-1)" "prognostic favorable (1.97e-5)" "unprognostic (2.24e-4)" "unprognostic (9.48e-2)" "unprognostic (9.81e-2)" "unprognostic (2.02e-3)" "unprognostic (1.72e-2)" "unprognostic (2.71e-1)" "unprognostic (9.28e-2)" "unprognostic (5.35e-1)" "unprognostic (8.19e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 191.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.6 218.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 7.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 BPIFB3 "C20orf185, dJ726C3.4, LPLUNC3, RYA3" ENSG00000186190 "BPI fold containing family B member 3" P59826 20 33055424-33073628 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 1.2;pituitary gland: 2.8;salivary gland: 3.1;testis: 3.0" "Cell type enhanced" "Detected in single" 30 "Early spermatids: 1.6" "Cancer enriched" "Detected in single" 7 "ovarian cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "HEL: 8.3;HMC-1: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA045741 Uncertain "Intracellular and membrane" NA NA "HPA045741: AB_2679439" "unprognostic (4.33e-2)" "unprognostic (1.06e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFB4 "C20orf186, dJ726C3.5, LPLUNC4" ENSG00000186191 "BPI fold containing family B member 4" P59827 20 33079644-33111751 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 4.0;pituitary gland: 12.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HSkMC: 5.4;U-2 OS: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (1.32e-1)" "unprognostic (1.16e-1)" "unprognostic (1.61e-1)" "unprognostic (2.75e-2)" "unprognostic (1.31e-3)" "unprognostic (4.70e-2)" "unprognostic (3.42e-2)" "unprognostic (2.03e-1)" "unprognostic (3.98e-4)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (8.97e-2)" 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 12.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 BPIFB6 "BPIL3, LPLUNC6" ENSG00000167104 "BPI fold containing family B member 6" Q8NFQ5 20 33031648-33044047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "salivary gland: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043057 Uncertain "Intracellular and membrane" NA NA "HPA043057: AB_10796683" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPIFC "BPIL2, dJ149A16.7" ENSG00000184459 "BPI fold containing family C" Q8NFQ6 22 32413847-32464484 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "skin 1: 39.5;tongue: 16.4" "Group enriched" "Detected in some" 32 "Early spermatids: 16.4;Late spermatids: 6.5;Suprabasal keratinocytes: 4.1" "Group enriched" "Detected in some" 11 "head and neck cancer: 1.6;melanoma: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 56 "basophil: 5.5" "Lineage enriched" "Detected in single" 56 "granulocytes: 5.5" "Group enriched" "Detected in some" 5 "HDLM-2: 3.4;hTCEpi: 1.7;SCLC-21H: 4.7;U-87 MG: 2.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.74e-1)" "unprognostic (3.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (2.58e-1)" "unprognostic (3.48e-2)" "unprognostic (2.74e-1)" "unprognostic (2.58e-1)" "unprognostic (2.76e-3)" "unprognostic (1.41e-2)" "unprognostic (2.80e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 2.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 39.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 16.4 0.8 0.0 0.4 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.5 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.1 0.0 0.0 0.0 0.0 BPY2 "BPY2A, VCY2, VCY2A" ENSG00000183753 "Basic charge, Y-linked, 2" O14599 Y 22973819-23005465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 2.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPY2B VCY2B ENSG00000183795 "Basic charge, Y-linked, 2B" O14599 Y 24607560-24639207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 2.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BPY2C VCY2C ENSG00000185894 "Basic charge, Y-linked, 2C" O14599 Y 25030901-25062548 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 2.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BRAP "BRAP2, IMP, RNF52" ENSG00000089234 "BRCA1 associated protein" Q7Z569 12 111642146-111685986 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.9" "Group enriched" "Detected in many" 5 "Early spermatids: 224.1;Late spermatids: 273.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040357, HPA058820" Approved Supported "Nuclear membrane,Cytosol" NA NA Cytosol "Nuclear membrane" "HPA040357: AB_10967924, HPA058820: AB_2683827" "unprognostic (7.02e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.65e-6)" "unprognostic (2.14e-1)" "unprognostic (9.24e-3)" "unprognostic (2.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (3.66e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-2)" "unprognostic (8.08e-2)" 9.8 9.9 9.8 7.2 11.6 26.5 9.6 10.0 12.8 8.3 9.3 10.0 8.0 8.6 10.1 7.0 9.4 8.4 7.3 8.8 8.6 8.7 8.4 9.3 7.9 9.7 9.2 8.5 9.7 7.8 9.4 10.4 9.8 12.0 8.3 9.0 6.7 8.9 9.7 19.1 12.7 9.3 9.1 11.1 9.6 7.9 55.9 10.1 12.4 9.5 5.6 10.4 10.2 11.8 12.7 11.7 25.7 13.5 16.6 18.5 11.6 9.9 14.6 12.0 13.7 12.8 10.8 20.0 13.9 11.7 16.2 12.5 19.6 6.9 19.1 8.4 13.1 9.2 12.2 16.7 11.4 17.4 12.2 10.8 23.6 9.1 13.1 16.2 20.7 16.0 12.2 16.2 14.0 22.8 14.0 14.0 13.3 24.5 6.3 13.3 12.5 17.2 20.0 16.1 10.5 15.4 16.0 13.0 17.0 10.7 20.9 14.9 11.0 16.3 13.9 13.6 14.4 15.3 13.2 12.9 10.4 9.7 9.4 9.8 16.1 20.3 21.1 9.9 11.5 11.4 16.1 13.0 24.0 14.7 13.5 14.3 12.7 15.4 14.7 11.7 12.5 14.6 14.8 25.7 16.6 10.6 8.4 18.5 11.6 9.8 11.6 10.0 12.8 8.6 8.7 9.2 8.5 12.0 10.1 20.8 9.1 7.5 8.2 10.0 8.1 10.6 17.8 13.4 10.3 10.4 27.5 11.4 5.0 11.0 224.1 9.3 12.8 0.0 6.6 12.6 8.5 9.9 8.1 7.9 9.3 3.2 9.2 8.6 6.4 273.6 12.4 11.3 3.3 20.8 10.6 7.8 11.8 10.5 12.7 11.9 11.5 6.5 10.7 49.2 33.7 11.0 18.8 10.1 9.3 11.2 BRCA2 "BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11" ENSG00000139618 "BRCA2, DNA repair associated" P51587 13 32315474-32400266 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.2;testis: 16.9" "Group enriched" "Detected in many" 4 "Erythroid cells: 23.3;monocytes: 31.5;Spermatocytes: 75.1;Spermatogonia: 82.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026815 Uncertain Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA026815: AB_10602692" "unprognostic (9.36e-2)" "unprognostic (2.50e-1)" "unprognostic (4.50e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (2.01e-1)" "unprognostic (6.97e-3)" "unprognostic (4.06e-2)" "unprognostic (3.07e-9)" "unprognostic (2.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.88e-1)" "unprognostic (1.32e-1)" 2.4 1.0 0.6 13.8 0.6 11.6 3.2 0.6 0.6 1.8 4.0 0.2 0.2 1.4 1.5 2.7 3.0 1.0 0.7 2.1 0.6 0.7 1.0 1.4 3.5 5.3 0.7 0.5 1.4 3.3 0.4 0.7 7.0 0.8 0.9 2.0 0.1 1.8 0.3 3.3 1.8 3.2 0.8 2.1 6.6 1.5 16.9 0.1 23.2 0.9 4.8 4.2 1.3 1.7 1.3 1.9 0.4 0.2 1.5 0.8 0.0 4.0 3.5 6.1 4.6 0.6 1.6 6.2 4.3 2.7 5.0 4.6 8.3 5.3 14.2 2.9 2.1 6.9 5.4 5.0 2.5 9.7 9.2 2.7 9.0 2.2 3.2 0.2 12.8 4.5 0.4 0.3 9.2 6.4 0.5 4.1 7.2 5.9 4.9 5.7 4.6 10.3 7.6 7.2 4.6 1.9 10.1 15.7 2.7 1.3 4.3 2.3 4.4 5.2 2.3 2.1 2.2 2.7 6.4 3.2 5.8 6.2 6.4 6.0 1.9 2.9 7.3 3.0 5.1 5.5 0.1 0.2 0.2 0.3 0.2 0.1 0.9 0.4 0.2 0.2 1.3 0.6 0.8 0.4 1.5 0.2 1.9 0.4 0.0 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.5 0.8 0.1 8.9 1.6 1.9 2.8 2.3 0.0 1.6 0.0 4.0 2.3 0.0 0.0 9.1 0.0 1.8 4.3 3.6 1.0 23.3 1.4 9.1 3.5 0.6 3.5 0.8 8.2 0.0 1.2 2.5 6.7 2.5 2.0 13.2 3.3 31.5 3.0 0.2 1.1 1.5 1.1 0.6 0.0 12.9 2.0 75.1 82.4 1.1 4.6 3.8 5.3 1.4 BRDT "BRD6, CT9" ENSG00000137948 "Bromodomain testis associated" Q58F21 1 91949371-92014426 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, mRNA processing, mRNA splicing, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 66.4" "Group enriched" "Detected in some" 5 "Early spermatids: 993.1;Spermatocytes: 377.5" "Group enriched" "Detected in some" 10 "lung cancer: 1.3;testis cancer: 6.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 28 "BEWO: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB012237 Approved NA NA "CAB012237: AB_304756" "unprognostic (5.00e-2)" "unprognostic (2.86e-1)" "unprognostic (2.22e-3)" "unprognostic (2.24e-1)" "unprognostic (1.49e-1)" "unprognostic (5.25e-2)" "unprognostic (2.53e-3)" "unprognostic (6.26e-2)" "unprognostic (1.97e-1)" "unprognostic (4.22e-13)" "unprognostic (2.70e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (2.00e-3)" 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 3.9 1.4 1.0 1.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 21.5 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.5 0.0 0.1 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.1 3.9 1.4 0.9 1.0 0.4 0.9 0.5 0.4 0.6 0.2 1.1 0.9 0.6 2.9 1.0 0.4 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 993.1 0.1 0.0 0.0 0.0 19.8 0.4 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 130.3 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 377.5 18.3 0.0 16.2 0.5 0.0 0.0 BRICD5 "C16orf79, MGC21830" ENSG00000182685 "BRICHOS domain containing 5" Q6PL45 16 2209253-2211950 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7;testis: 42.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 10.7;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 11.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA063522 Approved "Nucleoplasm,Actin filaments" NA NA "Actin filaments" Nucleoplasm "HPA063522: AB_2685029" "prognostic favorable (9.74e-4)" "unprognostic (7.12e-3)" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (2.02e-1)" "unprognostic (4.62e-2)" "unprognostic (4.34e-3)" "unprognostic (7.56e-2)" "prognostic favorable (7.01e-4)" "unprognostic (9.84e-3)" "unprognostic (2.65e-2)" "unprognostic (9.79e-2)" "unprognostic (2.88e-1)" "unprognostic (3.57e-1)" "prognostic favorable (8.06e-5)" 2.0 4.0 3.2 3.7 4.9 3.0 2.0 29.7 5.3 2.0 2.0 2.0 2.0 5.4 2.8 2.0 2.0 1.6 2.0 2.9 3.5 4.4 2.9 2.0 2.1 4.6 3.1 2.8 2.0 3.0 2.2 3.6 2.9 2.5 2.4 0.5 9.9 3.7 4.0 9.1 2.7 5.2 2.0 3.3 6.3 2.7 42.8 2.0 2.4 6.1 2.0 2.0 2.0 2.0 0.8 0.6 2.3 0.8 0.8 1.7 0.4 2.8 5.6 7.7 4.4 1.2 1.3 14.1 2.7 0.5 1.5 2.3 7.1 7.0 1.6 1.8 0.5 1.8 7.6 1.0 1.0 1.1 5.2 3.4 1.7 13.4 1.8 0.7 0.7 4.4 1.5 2.1 2.3 0.5 2.3 0.9 6.4 1.9 4.0 0.6 7.6 4.8 10.8 7.5 0.9 3.2 14.8 5.8 5.0 1.7 2.2 5.4 4.9 2.7 3.4 2.6 3.7 3.4 4.0 2.2 7.4 6.0 6.4 2.3 12.1 5.2 4.0 1.4 4.5 3.5 0.4 0.7 2.2 0.6 0.8 0.3 0.3 0.3 0.1 0.6 0.8 1.7 0.4 2.3 0.8 0.2 0.4 0.4 0.4 3.2 4.9 29.7 5.3 3.5 4.4 3.1 2.8 2.5 2.0 3.0 4.1 0.0 0.5 0.3 10.7 0.4 0.0 4.0 0.0 5.2 23.6 1.6 0.0 0.8 2.1 1.1 1.8 0.0 0.5 0.7 1.0 0.8 4.6 1.0 1.1 4.8 1.2 1.8 2.2 5.9 1.1 2.5 1.7 1.0 1.2 4.3 0.7 0.0 2.5 0.3 11.0 0.0 0.5 3.9 1.9 1.0 0.7 0.0 2.3 0.4 BRINP1 "DBC1, DBCCR1, FAM5A" ENSG00000078725 "BMP/retinoic acid inducible neural specific 1" O60477 9 119153458-119369467 "Predicted intracellular proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.0" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 7.5;Cone photoreceptor cells: 23.6;Ito cells: 4.9;Proximal tubular cells: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 9.2;NTERA-2: 17.6;SCLC-21H: 7.8;SH-SY5Y: 3.4;SuSa: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038828 Approved Uncertain Microtubules "Intracellular and membrane" NA NA Microtubules "HPA038828: AB_10670909" "unprognostic (8.60e-5)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (5.09e-5)" "unprognostic (1.12e-1)" "unprognostic (1.14e-2)" "unprognostic (1.37e-1)" "unprognostic (2.98e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (2.28e-4)" "unprognostic (1.51e-2)" "unprognostic (5.06e-3)" "unprognostic (1.39e-3)" "unprognostic (1.56e-1)" "unprognostic (7.59e-2)" "unprognostic (1.41e-1)" 1.0 5.6 17.7 1.0 16.5 0.9 3.8 19.7 47.0 1.4 1.1 5.1 0.0 1.1 1.2 7.2 1.2 1.0 2.7 2.8 16.0 12.4 3.0 1.7 1.1 0.9 7.4 10.7 1.0 0.9 1.0 1.0 0.9 5.8 2.9 1.0 0.2 1.7 7.6 1.2 0.9 1.7 1.0 9.7 1.3 1.0 1.5 5.1 0.0 1.3 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 17.6 0.0 0.0 0.0 1.8 0.0 0.1 0.0 7.8 3.4 0.0 0.0 0.0 6.5 0.7 0.0 0.0 1.2 1.9 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 16.5 19.7 32.2 16.0 12.4 7.4 10.7 5.8 5.1 0.0 0.0 0.0 0.4 0.0 7.5 0.6 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 2.4 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 8.8 2.3 0.0 0.3 0.7 0.7 0.0 0.0 0.0 0.0 0.1 BRINP2 "DBCCR1L2, FAM5B" ENSG00000198797 "BMP/retinoic acid inducible neural specific 2" Q9C0B6 1 177171497-177282422 "Predicted secreted proteins, Transporters" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 11.5;brain: 27.9" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 14.3" "Cancer enriched" "Detected in some" 5 "glioma: 11.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050681 Uncertain "Secreted in other tissues" NA NA "HPA050681: " "unprognostic (7.78e-2)" "unprognostic (4.49e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.43e-2)" "unprognostic (1.77e-1)" "unprognostic (5.77e-2)" "unprognostic (1.23e-2)" "unprognostic (1.95e-2)" "unprognostic (2.20e-4)" "unprognostic (8.95e-2)" "unprognostic (1.78e-2)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (2.60e-2)" "unprognostic (4.82e-3)" 0.4 11.5 12.2 0.3 8.2 0.3 1.9 0.4 27.9 0.3 0.4 0.6 0.0 0.3 0.5 0.9 0.3 0.6 0.4 0.4 7.0 6.0 0.3 0.4 0.3 0.3 4.5 3.6 0.3 0.3 0.3 2.0 1.0 0.8 0.4 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.4 1.5 0.5 0.3 1.8 0.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 2.6 3.0 0.0 0.0 0.0 0.0 9.7 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 8.2 0.4 15.9 7.0 6.0 4.5 3.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 BRINP3 "DBCCR1L, DBCCR1L1, FAM5C" ENSG00000162670 "BMP/retinoic acid inducible neural specific 3" Q76B58 1 190097662-190478404 "Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4;intestine: 18.6" "Cell type enriched" "Detected in some" 7 "Early spermatids: 35.8" "Group enriched" "Detected in some" 14 "breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054693 Uncertain "Secreted in other tissues" NA NA "HPA054693: AB_2682575" "unprognostic (3.18e-2)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" "unprognostic (8.25e-2)" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (9.84e-2)" "unprognostic (4.58e-3)" 0.7 2.4 11.3 1.0 11.9 0.3 2.0 18.4 30.4 0.5 7.2 2.1 0.0 5.3 0.6 3.7 2.2 0.9 2.0 5.6 8.9 12.2 2.8 0.4 1.6 0.3 6.0 12.7 0.4 0.3 0.4 0.4 0.3 7.4 7.8 7.6 0.0 1.6 6.3 0.4 0.4 18.6 1.0 6.8 0.3 0.7 3.7 2.7 0.0 2.4 0.0 0.5 1.1 0.3 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 11.3 11.9 18.4 19.1 8.9 12.2 6.0 12.7 7.4 2.7 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.0 35.8 0.0 4.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 1.9 0.0 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61681266-61863521 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.1" "Group enriched" "Detected in many" 11 "Early spermatids: 136.2;Late spermatids: 148.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.2;granulocytes: 2.1;T-cells: 3.7" "Cell line enhanced" "Detected in many" "MCF7: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 1.0 0.9 0.7 6.3 3.5 9.1 1.1 0.6 1.4 1.4 2.6 0.2 0.6 2.8 1.5 1.2 3.7 0.8 1.8 0.4 0.5 0.5 0.6 2.3 1.3 4.0 0.5 0.9 2.1 1.3 0.1 0.4 1.7 0.7 1.0 2.8 0.4 1.4 0.0 0.4 2.7 5.5 1.0 0.5 2.3 1.3 10.8 0.4 30.1 0.4 2.0 6.6 1.3 1.7 2.2 0.5 2.1 0.3 0.6 3.7 0.5 12.5 4.3 12.4 7.1 0.4 1.1 2.7 11.6 6.8 12.4 16.1 4.4 4.0 7.5 2.7 2.4 3.6 4.5 6.4 2.4 16.8 1.9 7.8 7.6 6.8 5.4 0.1 9.8 4.5 0.2 0.1 9.9 2.6 1.7 2.7 7.4 5.3 5.1 7.8 42.2 15.5 3.4 2.7 3.0 3.7 9.7 23.9 3.6 1.7 5.7 5.0 12.9 4.5 1.6 1.8 4.9 4.2 3.8 2.3 18.3 13.4 6.7 13.3 3.2 6.1 8.0 3.7 4.7 4.5 2.1 0.3 1.5 0.5 0.2 0.6 2.2 1.2 0.6 0.4 1.8 1.8 0.9 1.0 0.6 0.2 0.5 3.7 0.5 0.7 3.5 0.6 1.4 0.5 0.5 0.5 0.9 0.7 0.4 0.0 0.3 1.5 1.3 2.1 0.1 0.5 0.0 1.4 6.8 0.0 0.0 0.7 0.0 0.3 136.2 0.3 0.9 0.0 0.2 2.5 0.6 0.1 0.0 3.0 1.4 0.0 0.0 0.6 0.3 148.4 1.1 0.4 3.3 1.0 1.5 0.3 0.5 0.0 1.1 0.0 0.2 0.0 0.9 13.3 4.5 0.4 0.2 0.8 2.5 0.3 BRS3 "BB3, BB3R" ENSG00000102239 "Bombesin receptor subtype 3" P32247 X 136487887-136493780 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 27.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basal ganglia: 3.6;hypothalamus: 2.8" "Cell type enhanced" "Detected in some" "naive B-cell: 1.2;naive CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "B-cells: 1.2;T-cells: 1.0" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Group enriched" "Detected in some" 9 "basal ganglia: 1.6;hypothalamus: 7.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.49e-1)" "unprognostic (1.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (3.73e-6)" "unprognostic (1.59e-1)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" 0.1 0.1 0.1 0.1 3.6 0.0 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.2 27.4 0.1 2.4 0.1 0.1 0.1 2.8 0.1 0.1 0.1 0.1 0.1 0.1 2.9 0.3 0.0 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.4 0.4 0.1 2.8 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 BRSK1 KIAA1811 ENSG00000160469 "BR serine/threonine kinase 1" Q8TDC3 19 55282072-55312533 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 65.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5" "Cancer enhanced" "Detected in all" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021212, HPA061719" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA021212: AB_1845455, HPA061719: AB_2684593" "unprognostic (1.42e-3)" "unprognostic (2.92e-2)" "unprognostic (1.20e-1)" "unprognostic (6.69e-3)" "unprognostic (2.71e-1)" "unprognostic (4.21e-2)" "unprognostic (3.06e-6)" "unprognostic (4.24e-1)" "unprognostic (2.06e-2)" "unprognostic (3.04e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (7.98e-6)" "unprognostic (1.16e-1)" "unprognostic (6.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" 1.4 9.8 28.6 3.2 23.6 1.0 1.6 26.7 65.0 1.8 2.2 7.9 0.1 3.3 5.4 3.7 3.0 2.3 3.9 6.5 33.4 20.0 1.4 0.8 1.7 2.4 20.4 14.8 2.4 2.6 12.4 11.0 1.5 13.3 3.8 1.9 2.8 2.5 4.6 1.0 1.1 2.6 4.9 9.2 1.5 1.9 4.4 7.2 0.0 3.0 0.0 1.6 3.2 0.7 0.0 0.3 0.0 0.9 0.1 0.8 0.2 0.3 1.3 15.5 8.2 0.0 0.6 0.1 2.4 3.4 3.3 4.9 5.9 2.7 3.1 1.7 2.8 3.1 0.1 3.2 0.1 3.1 14.6 12.8 2.0 1.6 0.6 3.3 0.6 6.0 2.2 0.3 3.4 0.0 12.9 0.1 8.2 2.8 19.1 3.0 0.8 3.7 0.7 11.2 0.3 1.0 8.5 3.9 0.5 0.2 0.0 26.2 23.6 0.0 0.4 5.7 4.6 1.3 1.7 0.0 6.4 6.8 3.5 4.6 15.8 11.6 7.1 6.5 1.4 21.4 0.0 0.9 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.2 28.6 23.6 26.7 40.2 33.4 20.0 20.4 14.8 13.3 7.2 0.0 2.2 0.0 1.0 0.1 30.8 0.8 0.0 0.0 1.2 1.8 2.0 0.0 0.0 0.3 0.8 0.3 12.3 0.0 0.0 0.0 0.5 0.8 0.0 0.0 1.4 36.5 3.4 0.0 7.8 0.0 0.6 0.4 0.0 0.0 1.0 3.2 0.2 0.0 4.6 0.8 10.2 0.0 1.0 3.9 6.5 0.0 0.0 0.8 1.2 0.1 BRSK2 "C11orf7, PEN11B, STK29" ENSG00000174672 "BR serine/threonine kinase 2" Q8IWQ3 11 1389899-1462689 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle, Cell division, Exocytosis, Mitosis, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 34.9;pancreas: 78.8" "Group enriched" "Detected in some" 6 "Bipolar cells: 79.7;Cone photoreceptor cells: 33.4;Horizontal cells: 65.2;Muller glia cells: 24.5;Rod photoreceptor cells: 27.0" "Cancer enhanced" "Detected in many" "glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 13 "NK-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 9.1;AN3-CA: 9.9;CACO-2: 7.9;HAP1: 7.4;NTERA-2: 15.3;SCLC-21H: 35.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073690 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA073690: " "unprognostic (5.47e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.05e-2)" "unprognostic (3.63e-1)" "unprognostic (6.42e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.17e-7)" "unprognostic (3.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "unprognostic (1.86e-1)" 1.5 3.5 13.6 1.5 12.8 1.3 1.3 30.8 34.9 1.3 1.5 10.0 0.0 1.7 1.4 1.3 1.3 1.4 1.9 1.5 15.6 10.6 1.4 1.3 1.4 1.3 8.3 17.2 1.4 78.8 1.6 4.6 1.8 9.5 1.6 1.4 2.2 1.6 1.4 1.5 1.5 1.9 1.4 6.5 1.3 1.9 5.5 9.2 0.0 1.9 0.0 1.3 1.3 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.0 9.1 9.9 0.1 0.3 0.0 0.1 0.1 0.7 0.3 7.9 0.5 0.0 1.4 0.1 0.1 0.0 7.4 0.0 0.6 0.9 3.9 0.0 0.0 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.9 0.2 0.0 0.3 0.1 0.0 0.1 0.9 0.0 0.0 15.3 2.7 1.2 0.0 0.0 0.0 0.1 0.1 35.8 5.3 1.8 0.1 2.5 0.2 0.2 0.4 0.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 13.6 12.8 30.8 23.3 15.6 10.6 8.3 17.2 9.5 9.2 0.0 0.0 0.0 0.1 0.2 79.7 2.2 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.0 0.2 65.2 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 24.5 0.5 0.0 1.1 0.0 27.0 6.5 8.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 BSN ZNF231 ENSG00000164061 "Bassoon presynaptic cytomatrix protein" Q9UPA5 3 49554489-49671545 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 36.9" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 10.7;Horizontal cells: 23.8;Late spermatids: 9.1;Rod photoreceptor cells: 9.1;Spermatogonia: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 3.8;SCLC-21H: 9.1;SH-SY5Y: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034757 Enhanced NA NA "HPA034757: AB_10671233" "unprognostic (8.57e-2)" "unprognostic (3.45e-1)" "unprognostic (7.31e-2)" "unprognostic (3.50e-4)" "unprognostic (7.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (5.46e-3)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (6.21e-5)" "unprognostic (2.50e-3)" "unprognostic (5.38e-5)" "unprognostic (9.33e-2)" "unprognostic (3.03e-1)" "unprognostic (2.30e-1)" "unprognostic (7.34e-2)" 1.2 3.9 23.0 1.3 22.4 1.1 1.2 25.4 36.9 1.3 1.2 1.8 0.0 1.3 1.5 7.0 1.2 1.4 1.2 1.3 13.1 5.1 1.4 1.3 1.3 1.2 3.9 19.1 1.6 2.1 1.7 4.4 1.3 7.9 1.3 1.2 0.7 1.3 1.4 1.4 1.3 1.3 1.3 1.6 1.3 1.7 5.1 4.0 0.0 1.4 0.0 1.1 1.1 0.3 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.2 0.4 2.1 1.4 0.1 0.0 0.8 0.0 0.0 0.1 0.1 0.5 0.4 2.4 0.5 0.0 0.4 0.3 0.3 0.0 0.1 0.5 1.0 0.3 0.7 1.1 0.0 0.4 1.0 0.1 0.0 0.0 0.4 0.0 0.0 1.5 3.8 0.4 0.1 0.8 0.4 0.2 1.7 0.3 1.0 0.0 0.2 0.4 0.0 0.5 9.1 5.6 0.8 0.1 0.1 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.3 1.0 0.2 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 23.0 22.4 25.4 36.9 13.1 5.1 3.9 19.1 7.9 4.0 0.0 0.0 0.0 0.0 0.0 10.7 2.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.1 23.8 0.0 0.6 0.0 9.1 1.1 0.0 1.7 0.0 0.0 2.9 0.2 0.0 0.4 0.1 9.1 0.0 0.4 6.6 8.0 0.1 0.1 0.0 0.0 0.1 BSND "BART, DFNB73" ENSG00000162399 "Barttin CLCNK type accessory beta subunit" Q8WZ55 1 54998193-55011784 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 3.9;kidney: 12.3;salivary gland: 4.2" "Group enriched" "Detected in some" 37 "Collecting duct cells: 8.7;Distal tubular cells: 21.6" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.5" "Group enriched" "Detected in some" 5 "basophil: 1.3;neutrophil: 3.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.9" "Cell line enriched" "Detected in single" 20 "RPMI-8226: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053836, HPA060617" Enhanced NA NA "HPA053836: AB_2682277, HPA060617: AB_2732651" "unprognostic (3.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.27e-2)" "unprognostic (6.97e-3)" "unprognostic (3.35e-1)" "unprognostic (8.97e-3)" "unprognostic (2.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.93e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-2)" "unprognostic (1.68e-2)" "unprognostic (1.57e-1)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.9 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.3 0.2 0.5 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.9 0.1 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 8.7 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 BSPH1 "BSP1, ELSPBP2" ENSG00000188334 "Binder of sperm protein homolog 1" Q075Z2 19 47968046-47992170 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "epididymis: 97.1" "Cell type enhanced" "Detected in single" 34 "Bipolar cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 1.2;HMC-1: 1.4;NB-4: 4.6" "Not detected" "Not detected" HPA048335 Enhanced "Secreted in male reproductive system" NA NA "HPA048335: AB_2732546" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BSPRY FLJ20150 ENSG00000119411 "B-box and SPRY domain containing" Q5W0U4 9 113349541-113371233 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 67.7;salivary gland: 68.2" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "basal ganglia: 20.8" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 8.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 8.0" "Cell line enhanced" "Detected in some" "A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042889, HPA077485" Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042889: AB_10795515, HPA077485: " "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "unprognostic (1.18e-1)" "unprognostic (2.20e-3)" "unprognostic (1.68e-1)" "unprognostic (2.10e-3)" "unprognostic (4.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (1.95e-2)" "prognostic favorable (4.56e-14)" "unprognostic (1.15e-3)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.70e-1)" 0.2 1.6 1.0 4.6 20.8 2.1 6.1 4.1 1.4 2.9 5.4 0.4 7.9 3.6 1.0 6.4 14.2 1.9 8.5 1.4 0.6 0.7 9.3 0.4 4.1 0.6 0.7 1.3 0.3 37.8 67.7 10.1 1.7 0.6 2.4 4.5 2.7 68.2 4.8 0.1 12.4 6.8 0.4 0.3 0.3 10.4 2.1 1.8 1.2 28.2 10.7 5.4 1.5 3.2 0.0 8.0 0.0 0.0 0.0 0.4 0.1 18.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.8 11.6 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 2.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.4 0.1 0.0 0.0 27.0 0.3 0.0 0.4 31.4 0.0 0.4 0.0 14.1 1.8 3.9 6.2 0.0 0.0 13.6 0.0 0.8 13.7 1.9 0.0 0.0 0.0 0.0 0.0 4.4 5.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.0 0.0 0.1 1.0 20.8 4.1 1.4 0.6 0.7 0.7 1.3 0.6 1.8 6.0 5.8 2.4 1.7 0.9 0.6 1.6 15.3 2.7 4.5 26.2 5.9 8.1 33.2 59.2 0.1 0.1 12.9 0.0 58.0 0.7 0.4 15.4 3.5 0.8 1.2 0.0 19.7 0.0 0.0 0.2 0.0 0.1 10.1 1.8 19.3 0.3 56.5 14.0 0.0 15.3 9.1 0.0 0.0 0.5 2.3 12.4 5.6 0.5 24.3 13.9 BST1 CD157 ENSG00000109743 "Bone marrow stromal cell antigen 1" Q10588 4 15702950-15738313 "CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.5;bone marrow: 54.9;intestine: 61.3" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 39.0;Kupffer cells: 36.4;Macrophages: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 52.7;neutrophil: 59.5" "Group enriched" "Detected in many" 105 "dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7" "Cell line enhanced" "Detected in many" "THP-1: 37.1;TIME: 20.4;U-937: 24.2;WM-115: 22.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050121 Uncertain "Intracellular and membrane" NA NA 170000000 "HPA050121: AB_2681025" "unprognostic (2.95e-1)" "unprognostic (3.61e-1)" "unprognostic (1.27e-1)" "unprognostic (4.00e-2)" "unprognostic (7.49e-2)" "unprognostic (2.89e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (1.84e-1)" "unprognostic (1.08e-1)" "unprognostic (4.06e-2)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (3.11e-1)" "unprognostic (1.57e-2)" "unprognostic (1.95e-1)" 14.3 2.0 1.1 5.6 2.0 54.9 6.6 0.8 1.5 7.2 33.8 1.5 2.1 20.4 6.4 7.0 4.6 5.6 10.3 14.5 1.8 0.8 6.6 3.7 9.4 9.6 1.3 1.9 5.5 1.0 0.4 1.3 8.0 1.3 7.5 4.0 5.4 2.8 2.2 3.4 3.5 61.3 7.9 1.5 13.6 2.4 2.4 1.2 2.8 3.5 2.9 1.8 7.5 16.1 0.4 16.6 59.5 52.7 0.1 0.3 19.6 0.2 5.5 0.5 0.4 13.5 3.2 0.7 10.5 1.0 9.6 10.8 0.1 5.7 0.3 0.9 5.3 0.2 0.1 1.5 0.2 8.2 0.3 0.2 2.5 0.3 0.2 3.4 3.3 7.3 2.7 0.7 6.1 0.5 0.4 1.5 2.3 0.3 0.2 5.6 0.1 1.0 1.9 1.2 0.4 1.1 0.3 0.7 0.2 0.3 0.3 0.7 2.1 0.2 0.3 7.0 0.5 0.2 37.1 20.4 0.3 0.5 3.7 0.4 0.2 0.0 0.3 1.3 24.2 22.1 7.6 52.7 3.9 0.2 19.8 0.3 0.4 0.1 0.1 16.6 0.2 0.2 0.1 59.5 0.1 13.6 5.5 0.2 19.6 1.1 2.0 0.8 1.5 1.8 0.8 1.3 1.9 1.3 1.2 3.0 3.0 0.0 0.8 4.0 0.2 0.8 5.1 2.7 1.2 1.8 0.0 14.0 1.7 4.1 2.7 2.1 3.2 0.0 2.3 18.7 18.6 0.5 16.1 1.8 39.0 0.0 1.2 3.7 36.4 0.7 2.8 29.9 13.5 0.0 7.0 0.3 0.8 7.0 2.1 6.7 0.0 6.5 10.8 2.3 1.2 2.6 5.9 0.0 16.6 2.7 BST2 "CD317, tetherin" ENSG00000130303 "Bone marrow stromal cell antigen 2" Q10589 19 17402939-17405648 "CD markers, Plasma proteins, Predicted membrane proteins" "Antiviral defense, B-cell activation, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 101.0" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 338.9;Ito cells: 362.2;Leydig cells: 321.0;Peritubular cells: 394.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 79.0;Karpas-707: 76.6" HPA017060 Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA017060: AB_1845467" "prognostic favorable (6.69e-4)" "unprognostic (1.75e-1)" "unprognostic (8.42e-3)" "unprognostic (8.93e-3)" "unprognostic (4.87e-2)" "unprognostic (2.25e-1)" "unprognostic (2.26e-1)" "unprognostic (1.07e-1)" "unprognostic (3.25e-1)" "unprognostic (6.46e-2)" "unprognostic (6.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.56e-9)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" 29.6 72.2 8.4 31.1 9.8 13.6 27.9 2.5 7.6 14.4 12.0 5.6 24.8 6.9 13.4 36.7 8.6 26.8 30.1 13.9 7.9 4.9 24.7 30.8 44.9 16.6 10.0 5.2 101.0 6.9 0.3 8.6 31.5 8.8 15.6 4.8 8.4 11.4 17.5 6.0 3.2 14.0 11.3 9.0 32.9 12.3 8.5 9.4 10.3 10.3 5.9 12.3 14.0 42.4 26.2 74.1 35.8 66.4 57.9 32.6 54.5 39.6 0.0 0.1 18.3 0.0 0.1 6.3 0.1 3.1 58.6 79.0 18.6 35.8 30.8 43.3 24.4 1.8 0.1 26.7 2.9 1.8 33.9 0.2 0.4 64.3 18.1 33.6 14.5 39.0 0.1 0.0 19.4 0.0 0.5 14.9 0.7 17.5 76.6 0.0 10.9 6.9 25.4 20.1 0.0 51.4 12.9 0.1 64.2 13.9 0.1 0.0 0.1 40.5 1.5 48.8 1.6 30.7 20.5 0.1 0.2 1.4 0.0 0.4 39.6 51.6 20.4 0.1 57.4 0.2 35.8 61.6 21.0 32.6 66.4 30.8 21.0 27.5 30.2 50.7 26.2 22.5 25.6 20.3 57.9 59.3 74.1 24.8 54.5 8.4 9.8 2.5 7.6 7.9 4.9 10.0 5.2 8.8 9.4 53.6 16.5 81.0 13.1 29.5 0.0 4.5 50.9 14.7 38.7 47.1 0.0 7.1 31.5 19.8 9.9 239.7 1.6 0.0 1.0 55.9 84.0 7.2 225.9 155.9 338.9 0.0 1.2 362.2 153.7 4.5 321.0 191.2 70.9 239.0 1.4 1.3 2.2 3.5 394.2 0.7 1.9 161.7 150.2 1.4 1.2 22.8 11.0 126.9 2.6 30.3 BSX BSX1 ENSG00000188909 "Brain specific homeobox" Q3C1V8 11 122977570-122981720 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.9;pituitary gland: 1.7;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "HDLM-2: 1.5;SCLC-21H: 2.7;SH-SY5Y: 2.0" "Region enriched" "Detected in single" 5 "hypothalamus: 5.3" "Region enriched" "Detected in single" 8 "hypothalamus: 4.5" HPA015654 Uncertain NA NA "HPA015654: AB_1845470" 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 1.7 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.8 0.0 4.9 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTBD1 ENSG00000064726 "BTB domain containing 1" Q9H0C5 15 83016422-83067354 "Predicted intracellular proteins" "Differentiation, Myogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.2" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024263, HPA067671" Enhanced Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA024263: , HPA067671: AB_2685882" "unprognostic (1.63e-1)" "unprognostic (4.61e-2)" "unprognostic (1.35e-1)" "unprognostic (5.54e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (4.80e-2)" "unprognostic (1.65e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-7)" "unprognostic (8.94e-3)" "unprognostic (8.27e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" 11.6 9.4 17.6 7.9 17.3 10.4 10.0 11.9 22.5 9.2 11.0 13.8 4.7 10.8 8.5 9.8 10.4 10.9 9.8 35.0 17.0 14.3 13.0 11.3 8.1 11.1 17.0 11.5 8.5 6.1 12.8 10.0 8.0 18.0 10.6 12.3 6.9 8.7 8.7 96.2 6.6 10.6 9.3 18.2 9.2 7.9 18.4 11.5 10.5 12.7 21.3 11.0 9.8 7.4 4.6 8.8 9.3 6.7 3.9 7.2 2.1 15.4 14.9 13.2 12.9 20.8 35.9 6.9 22.5 30.8 19.5 21.7 9.4 16.1 31.1 28.0 25.2 16.2 19.6 28.8 18.0 23.1 24.8 23.5 26.4 22.3 13.4 24.5 24.9 29.5 29.2 16.3 13.2 19.8 25.3 28.6 12.2 23.4 17.5 41.0 8.1 18.9 13.0 18.4 13.6 16.5 19.3 33.5 15.4 19.6 36.8 23.1 16.6 26.1 21.7 36.9 18.8 16.3 21.0 28.7 22.1 16.5 30.4 31.1 18.0 27.7 30.3 23.9 42.3 15.3 2.2 4.9 9.3 5.5 5.4 4.9 4.5 5.2 7.2 8.8 4.6 5.9 5.8 2.9 3.9 6.7 3.8 4.8 2.1 17.6 17.3 11.9 22.5 17.0 14.3 17.0 11.5 18.0 11.5 14.9 4.3 16.8 11.9 13.5 8.9 78.3 7.6 30.8 21.6 10.4 5.9 7.1 14.9 12.7 24.1 14.7 14.8 23.3 9.1 11.1 13.3 10.4 17.3 9.2 16.1 11.1 22.3 14.7 23.0 20.5 8.1 19.5 11.8 19.0 11.5 7.3 12.1 17.3 10.6 12.1 7.8 6.5 13.2 44.2 14.9 10.7 6.8 15.8 16.5 15.9 BTBD11 "ABTB2B, FLJ33957" ENSG00000151136 "BTB domain containing 11" A6QL63 12 107318413-107659642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 61.8" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 4.6;Peritubular cells: 3.9;Suprabasal keratinocytes: 6.8;Urothelial cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 19.3;Hep G2: 10.2;MOLT-4: 12.9;PC-3: 9.1;RT4: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055898, HPA061334" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055898: AB_2682964, HPA061334: " "unprognostic (3.40e-2)" "unprognostic (4.06e-1)" "unprognostic (2.37e-1)" "unprognostic (7.85e-2)" "unprognostic (8.78e-3)" "unprognostic (4.82e-2)" "unprognostic (3.52e-1)" "unprognostic (2.12e-1)" "unprognostic (1.52e-1)" "unprognostic (5.92e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.92e-8)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (3.33e-2)" "unprognostic (9.07e-3)" 0.9 1.1 3.7 2.4 6.6 3.3 2.7 4.6 10.2 6.8 1.0 2.2 3.2 1.1 1.3 1.5 24.1 0.8 1.2 1.0 2.9 9.4 3.7 1.4 1.0 4.0 8.3 3.0 0.6 1.2 61.8 3.2 2.0 19.0 3.1 1.0 1.7 6.2 1.6 0.9 8.4 1.6 1.0 4.9 1.5 1.0 1.1 1.2 24.8 14.4 9.5 9.0 2.3 7.9 0.3 1.3 2.8 0.8 0.3 7.2 1.2 0.1 19.3 3.9 0.0 1.5 0.4 0.0 0.4 0.0 0.2 0.0 0.2 3.1 0.0 4.8 0.1 1.8 7.0 3.9 7.3 0.2 0.0 1.2 0.0 0.1 10.2 0.0 0.1 0.0 1.6 3.1 0.0 2.3 3.0 0.5 8.0 0.0 0.0 0.1 0.6 12.9 1.5 4.0 0.4 9.1 0.0 6.2 0.0 0.0 8.7 5.0 1.9 0.0 0.2 0.0 0.4 0.4 0.5 0.8 0.0 0.2 0.0 1.5 0.0 0.0 0.0 5.1 2.0 0.0 1.3 0.8 1.1 2.1 0.3 7.2 0.1 2.4 1.4 1.3 0.3 3.0 2.7 2.8 0.3 0.6 0.2 1.1 1.2 3.7 6.6 4.6 10.2 2.9 9.4 8.3 3.0 19.0 1.2 0.0 0.0 0.0 3.1 4.6 1.0 1.7 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.8 0.0 0.5 0.3 1.6 3.4 0.0 0.8 0.0 0.6 2.0 0.0 0.0 0.0 0.3 0.2 0.0 3.9 0.6 0.3 0.0 1.1 0.0 0.0 6.8 0.3 0.0 0.0 3.8 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271306-122338162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 9.1;testis: 27.6;urinary bladder: 17.9" "Group enriched" "Detected in some" 19 "Early spermatids: 100.4;Late spermatids: 53.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 29 "T-reg: 2.8" "Lineage enriched" "Detected in single" 29 "T-cells: 2.8" "Cell line enriched" "Detected in some" 8 "RT4: 27.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.3 0.0 0.6 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.6 0.3 0.3 0.2 0.3 0.3 0.9 0.4 0.3 4.4 0.3 0.3 1.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 9.1 0.3 0.3 2.3 0.3 0.0 27.6 0.3 0.3 0.3 0.3 0.3 17.9 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.3 27.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 0.5 0.3 0.3 0.9 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.2 2.5 0.0 0.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.9 100.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 53.9 0.6 0.0 0.0 0.0 0.0 0.0 1.3 2.9 0.4 0.8 0.0 0.0 0.2 3.7 0.9 2.8 0.1 0.0 0.0 0.8 BTBD17 "BTBD17A, LGALS3BPL, TANGO10A" ENSG00000204347 "BTB domain containing 17" A6NE02 17 74356416-74361946 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 18.2" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 9.5;testis cancer: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Group enriched" "Detected in some" 20 "AF22: 3.9;NTERA-2: 5.1;SCLC-21H: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025022 Approved "Secreted in brain" NA NA "HPA025022: AB_2067352" "unprognostic (2.63e-1)" "unprognostic (2.77e-1)" "unprognostic (4.82e-5)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (9.89e-3)" 0.4 1.5 5.4 0.4 5.1 0.4 0.4 5.6 18.2 0.4 0.4 2.7 0.0 1.2 0.4 0.4 0.4 0.4 0.4 0.4 3.7 5.7 0.4 0.4 0.4 0.4 3.8 1.8 0.4 0.4 0.4 0.2 0.4 6.1 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.5 0.4 3.7 0.6 1.4 0.5 2.2 0.0 0.6 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.1 5.6 8.2 3.7 5.7 3.8 1.8 6.1 2.2 0.0 0.0 0.0 0.0 0.0 0.8 2.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 BTBD18 ENSG00000233436 "BTB domain containing 18" B2RXH4 11 57743514-57751781 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.5;testis: 7.0" "Group enriched" "Detected in some" 8 "Bipolar cells: 1.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 1.4;Spermatocytes: 1.5;Spermatogonia: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;Hep G2: 2.5;PC-3: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049325 Uncertain NA NA "HPA049325: AB_2680713" "unprognostic (6.68e-2)" "unprognostic (3.13e-2)" "unprognostic (3.43e-1)" "unprognostic (4.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.47e-2)" "unprognostic (8.69e-3)" "unprognostic (4.84e-3)" "unprognostic (1.77e-1)" "unprognostic (2.96e-1)" "unprognostic (7.17e-3)" "unprognostic (5.95e-3)" "unprognostic (1.42e-2)" "unprognostic (2.34e-2)" "unprognostic (3.15e-1)" "unprognostic (3.34e-1)" "unprognostic (2.88e-1)" 0.0 0.0 0.1 0.1 0.3 1.2 0.0 0.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 1.4 0.1 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 2.5 0.8 0.3 1.0 0.3 2.1 0.2 0.3 0.4 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.5 2.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.7 0.4 0.0 0.1 1.6 0.5 0.4 0.1 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.1 0.4 0.5 0.6 0.1 0.1 0.5 0.0 0.6 0.6 0.5 0.6 0.4 0.2 0.0 0.6 0.0 0.2 1.0 0.1 0.9 1.1 0.7 0.2 2.5 2.1 0.9 0.3 0.3 0.6 0.8 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.5 3.4 0.0 0.0 0.0 0.0 0.0 BTBD3 "dJ742J24.1, KIAA0952" ENSG00000132640 "BTB domain containing 3" Q9Y2F9 20 11890723-11926609 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 74.6;Horizontal cells: 62.0;Rod photoreceptor cells: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 66.5;HeLa: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041424, HPA042048" Uncertain Supported Vesicles NA NA Vesicles "HPA041424: AB_10794667, HPA042048: AB_10796469" "unprognostic (3.93e-2)" "unprognostic (2.25e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-3)" "unprognostic (4.24e-3)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.51e-5)" "prognostic unfavorable (6.94e-4)" "unprognostic (4.87e-2)" "unprognostic (2.95e-1)" "unprognostic (1.07e-2)" "unprognostic (7.05e-2)" "unprognostic (6.66e-2)" "unprognostic (7.68e-3)" "unprognostic (1.67e-1)" "unprognostic (6.29e-2)" "unprognostic (1.37e-2)" 8.9 18.5 32.9 5.5 25.2 8.7 10.4 53.8 40.7 12.2 17.1 32.4 3.8 8.7 15.8 10.1 8.3 12.9 11.1 11.1 56.8 19.8 9.8 6.2 10.0 3.0 25.6 21.2 9.0 10.6 10.5 6.7 33.6 20.9 13.0 14.7 8.4 10.9 9.3 11.5 16.7 8.7 13.8 24.3 6.0 21.2 11.7 22.5 4.1 9.6 5.0 2.5 13.8 7.3 0.3 2.9 0.6 6.3 1.4 0.7 1.1 1.8 5.3 14.5 66.5 3.0 3.2 3.9 5.9 3.8 6.7 4.3 3.0 2.9 0.5 5.0 8.6 2.7 4.9 7.4 4.2 11.0 0.0 6.6 1.9 52.5 6.4 3.1 3.0 1.1 5.7 5.2 6.0 4.9 3.7 3.8 3.3 3.3 5.1 6.7 1.3 3.6 2.8 6.9 7.7 1.5 4.9 2.9 1.8 6.1 9.2 6.3 11.2 16.6 6.8 14.3 8.1 4.0 3.1 2.9 3.7 9.4 3.4 6.5 1.9 2.5 0.0 2.4 0.8 24.0 0.0 2.2 0.2 0.0 3.4 0.0 0.1 0.0 0.0 2.9 0.3 0.7 0.0 0.6 1.4 6.3 2.0 0.0 1.1 32.9 25.2 53.8 40.7 56.8 19.8 25.6 21.2 20.9 22.5 14.9 5.9 2.2 9.5 14.7 12.7 15.9 5.1 26.8 10.3 5.2 74.6 15.7 3.3 8.2 6.5 18.0 15.7 0.0 7.3 3.3 12.0 11.8 2.3 6.6 7.2 62.0 20.1 31.9 4.7 8.8 15.3 5.6 13.5 1.0 9.1 16.3 8.1 21.0 8.1 5.4 54.4 6.5 8.6 6.7 14.0 15.1 18.2 0.0 11.5 8.4 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031355: AB_10611812" "prognostic favorable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favorable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 25.9 9.4 19.9 9.4 17.7 11.8 53.4 18.1 27.0 13.6 14.6 5.4 15.2 14.1 9.9 14.7 17.4 11.4 13.6 19.8 17.9 12.9 9.7 12.3 17.7 11.3 11.3 15.9 13.1 5.6 7.7 12.4 7.7 9.5 13.1 11.7 11.6 20.5 12.6 73.0 19.4 14.3 14.4 6.1 9.3 13.7 24.7 6.2 8.2 9.3 31.3 10.6 11.5 22.3 2.4 2.7 4.6 1.6 0.6 8.1 1.1 17.7 14.3 7.8 20.7 25.2 17.6 0.0 16.5 15.0 25.6 17.5 11.1 16.4 5.6 10.1 24.0 5.3 24.0 15.0 15.9 12.7 14.5 12.2 4.1 20.8 0.0 17.3 12.5 8.0 18.2 22.0 11.8 9.6 10.0 20.4 19.0 0.0 0.1 13.6 25.3 13.1 5.1 3.3 16.9 24.7 14.2 0.0 5.2 9.7 19.7 12.9 5.5 15.5 12.5 12.2 5.7 25.6 16.1 13.6 20.7 0.5 30.2 20.4 3.7 5.0 2.7 21.3 5.8 16.0 0.6 1.1 4.6 4.1 1.6 4.0 2.4 4.3 4.2 1.1 1.3 3.3 2.3 0.7 0.6 1.2 2.7 8.1 1.1 19.9 17.7 18.1 27.0 17.9 12.9 11.3 15.9 9.5 6.2 23.8 18.7 1.5 22.6 10.4 23.3 21.0 17.8 20.1 21.6 10.4 5.9 2.2 18.3 5.1 9.8 13.5 20.8 0.0 0.0 3.1 9.6 22.7 24.3 12.8 6.7 19.1 19.5 9.8 7.6 25.6 8.6 8.9 11.8 2.8 24.7 14.8 0.8 14.4 7.1 7.8 16.4 12.9 8.2 8.9 7.9 11.0 1.8 7.5 16.9 20.0 BTBD8 ENSG00000189195 "BTB domain containing 8" Q5XKL5 1 92080305-92184725 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 42.3" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.2" "Low region specificity" "Detected in all" "HPA024216, HPA035311" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA024216: AB_1852385, HPA035311: AB_10671933" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (1.99e-1)" "unprognostic (3.06e-2)" "unprognostic (1.83e-1)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-2)" "unprognostic (2.97e-1)" "unprognostic (2.82e-2)" "unprognostic (8.42e-2)" "unprognostic (3.73e-3)" "unprognostic (5.04e-2)" "unprognostic (9.49e-2)" "unprognostic (2.39e-2)" "unprognostic (3.15e-1)" 3.4 4.6 11.7 1.2 27.3 0.7 3.3 20.3 42.3 2.3 2.4 4.0 0.6 1.7 3.4 4.7 2.0 3.3 2.3 2.8 7.8 2.1 2.4 1.9 2.5 1.4 4.5 23.3 5.0 2.7 5.1 6.0 2.5 16.4 3.3 2.5 1.2 2.8 2.7 2.3 1.8 2.1 2.0 6.6 1.8 2.4 8.3 9.9 0.2 3.7 0.0 1.1 4.7 2.7 0.5 0.8 0.6 0.7 0.9 2.3 0.4 2.7 2.2 1.6 0.0 5.0 10.2 5.5 1.8 2.5 1.5 1.8 0.5 3.2 1.2 6.5 1.6 6.0 0.8 1.2 3.2 2.3 2.8 1.8 2.1 0.6 0.9 1.1 1.1 1.2 6.0 2.7 0.9 1.8 6.8 1.5 2.9 2.5 0.8 2.8 1.7 0.8 2.1 1.7 3.8 1.7 1.8 1.6 0.2 3.2 2.0 0.9 1.5 2.9 1.4 1.4 3.0 2.3 1.6 1.0 1.9 1.2 1.1 0.7 2.1 0.9 0.0 1.5 0.2 0.4 0.0 0.6 0.0 2.3 0.1 0.5 0.5 1.0 0.9 0.0 0.5 1.8 1.4 0.6 0.9 0.7 0.8 0.9 0.4 11.7 27.3 20.3 42.3 7.8 2.1 4.5 23.3 16.4 9.9 0.0 2.6 0.0 1.0 0.3 8.7 0.7 5.1 5.3 5.7 5.2 5.9 1.9 1.7 3.1 4.5 0.6 1.7 0.0 2.5 0.9 1.1 1.8 0.0 0.8 0.6 3.2 0.0 1.3 2.4 0.5 5.5 1.3 1.7 1.8 2.3 6.5 3.2 2.9 3.5 1.1 16.7 0.0 0.5 3.7 8.2 0.5 1.1 0.5 2.3 0.9 BTC ENSG00000174808 Betacellulin P35070 4 74744759-74794686 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.5" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 45.5;Club cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.4;MCF7: 5.8;RPTEC TERT1: 9.9;SK-BR-3: 6.6" "Not detected" "Not detected" "Secreted to blood" NA NA 314000 "unprognostic (7.36e-2)" "unprognostic (4.99e-2)" "unprognostic (7.04e-2)" "unprognostic (7.76e-3)" "unprognostic (3.87e-3)" "unprognostic (1.01e-3)" "unprognostic (1.05e-1)" "unprognostic (7.17e-3)" "unprognostic (2.68e-2)" "unprognostic (8.81e-2)" "unprognostic (1.50e-2)" "unprognostic (5.35e-1)" "prognostic favorable (6.10e-5)" "unprognostic (2.33e-1)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (2.31e-3)" 3.0 1.2 1.0 5.2 2.2 0.0 3.7 0.3 2.8 2.2 23.5 1.2 3.1 3.0 2.4 5.6 9.9 6.1 10.3 2.5 1.3 1.3 3.7 0.8 3.4 0.2 0.8 1.0 3.6 2.9 5.2 4.5 0.9 2.1 3.7 5.9 7.0 6.8 3.6 0.6 12.4 11.3 8.3 0.6 0.4 6.9 0.8 0.9 0.4 5.2 1.9 2.3 5.6 3.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 1.2 0.0 16.4 0.0 3.5 0.0 2.4 0.5 0.0 0.1 0.0 0.0 0.3 0.1 0.6 0.0 0.2 0.0 0.0 0.0 1.2 0.4 0.1 2.7 0.1 0.0 0.0 0.1 0.4 5.8 0.1 0.0 0.1 1.7 2.5 0.0 0.0 0.0 9.9 4.7 0.2 0.0 2.4 6.6 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.3 2.8 0.3 0.0 0.0 2.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 2.2 0.3 2.8 1.3 1.3 0.8 1.0 2.1 0.9 8.9 6.7 0.0 3.8 0.6 1.7 0.5 0.0 45.5 17.0 10.4 2.0 0.3 0.0 3.2 1.4 0.2 3.6 0.0 5.1 0.0 0.6 3.9 0.0 0.2 0.1 0.0 11.5 3.1 0.0 0.0 0.3 0.0 0.0 0.0 9.0 10.6 3.4 6.5 0.0 1.1 5.2 0.0 3.8 0.0 0.0 2.6 0.2 0.0 6.8 6.0 BTG1 APRO2 ENSG00000133639 "BTG anti-proliferation factor 1" P62324 12 92140278-92145897 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 190.7" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 2444.1;Suprabasal keratinocytes: 2626.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005972 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005972: AB_1078303" "prognostic favorable (4.36e-5)" "unprognostic (1.43e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-3)" "unprognostic (1.10e-1)" "unprognostic (5.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (2.50e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.95e-7)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (5.79e-2)" "unprognostic (9.81e-2)" 52.0 22.1 11.5 58.3 13.4 126.9 114.4 66.8 10.4 41.7 40.1 5.5 21.9 15.5 30.1 22.0 28.7 27.9 39.9 49.2 11.9 8.1 22.2 58.1 85.6 190.7 10.4 8.2 29.1 64.2 17.6 17.1 23.4 13.3 28.7 18.1 21.0 19.0 25.9 31.6 70.6 34.3 26.0 24.6 77.1 26.4 19.0 8.9 148.9 15.7 14.3 58.2 54.2 35.2 58.3 6.6 94.3 14.0 47.1 95.2 26.1 7.0 8.8 9.7 1.1 36.3 50.4 4.2 7.9 17.4 5.3 5.3 5.2 2.4 7.5 1.6 8.3 8.4 4.8 3.2 8.8 9.9 9.0 6.8 1.5 6.1 2.7 36.8 5.5 2.6 43.0 26.7 12.1 37.5 23.5 10.6 5.0 5.2 10.0 6.0 7.2 3.9 17.7 2.3 7.7 10.0 13.4 5.4 2.3 16.3 14.6 5.4 10.8 9.8 7.6 25.5 7.8 32.0 12.8 3.4 6.0 1.8 4.6 4.8 13.8 7.4 12.5 4.7 4.4 6.7 22.3 13.6 94.3 17.0 10.6 20.1 44.5 34.3 29.8 6.6 58.3 95.2 39.1 52.3 47.1 14.0 6.2 39.2 26.1 11.5 13.4 66.8 10.4 11.9 8.1 10.4 8.2 13.3 8.9 89.3 164.0 1133.8 898.4 2444.1 509.3 99.7 695.5 18.7 63.7 165.7 184.6 344.9 271.9 357.5 306.7 258.8 666.0 140.2 222.2 261.3 225.7 728.6 288.8 235.3 359.2 400.5 434.2 206.2 468.4 134.9 265.8 682.9 933.0 1485.2 192.1 767.8 308.3 596.2 227.4 96.3 342.5 530.3 1116.5 68.9 113.5 2626.0 1122.8 1563.2 226.0 1040.3 BTG4 "APRO3, PC3B" ENSG00000137707 "BTG anti-proliferation factor 4" Q9NY30 11 111467526-111512354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 24.8" "Group enriched" "Detected in some" 6 "Early spermatids: 46.0;Late spermatids: 57.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Karpas-707: 8.6;U-266/70: 6.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA057157 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA057157: AB_2683354" "unprognostic (1.58e-1)" "unprognostic (2.68e-3)" "unprognostic (3.20e-2)" "unprognostic (2.80e-4)" "unprognostic (1.42e-2)" "unprognostic (3.14e-1)" "unprognostic (9.39e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.2 0.0 0.2 0.4 6.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.7 1.6 0.1 0.0 0.0 1.0 0.0 8.6 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.4 0.0 0.4 6.0 2.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.7 3.4 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 8.2 1.2 0.0 0.0 0.0 0.0 0.0 BTK "AGMX1, ATK, IMD1, PSCTK1, XLA" ENSG00000010671 "Bruton tyrosine kinase" Q06187 X 101349447-101390796 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 77.5;lymphoid tissue: 37.0" "Cell type enhanced" "Detected in some" 19 "B-cells: 86.8;granulocytes: 203.6;Hofbauer cells: 50.3;Kupffer cells: 53.4;Macrophages: 53.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 77.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 29.5;HEL: 40.9;HMC-1: 147.5;U-937: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001198, HPA002028, CAB016689" Enhanced Supported "Plasma membrane,Cytosol" NA NA 610000 "Plasma membrane, Cytosol" "CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306" "unprognostic (3.19e-2)" "unprognostic (2.51e-3)" "unprognostic (1.06e-2)" "unprognostic (3.66e-2)" "unprognostic (5.69e-2)" "unprognostic (3.76e-3)" "unprognostic (6.55e-2)" "unprognostic (3.58e-3)" "unprognostic (6.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (2.08e-3)" "unprognostic (7.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (8.14e-2)" 7.3 2.4 3.3 23.5 5.6 14.0 2.6 0.8 3.6 2.3 3.0 4.7 0.3 2.2 1.9 2.6 2.4 2.0 3.7 3.3 3.3 2.5 2.2 2.5 10.7 25.1 5.4 1.2 1.2 1.5 0.2 1.4 3.2 4.1 2.5 4.5 1.5 3.2 1.0 1.0 2.5 12.9 3.3 10.8 37.0 3.1 1.3 6.3 4.0 1.7 1.8 36.7 5.8 2.0 13.7 13.2 77.5 20.7 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 16.4 147.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 11.5 0.2 0.0 0.0 12.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.3 0.2 14.0 0.0 21.4 0.0 77.5 11.3 19.3 0.0 18.1 0.0 13.7 0.0 0.0 13.2 13.7 0.0 0.0 4.5 0.0 20.7 6.0 0.0 6.1 3.3 5.6 0.8 3.6 3.3 2.5 5.4 1.2 4.1 6.3 3.0 12.8 86.8 0.1 0.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.2 0.6 0.0 23.3 0.0 0.4 0.5 0.0 203.6 0.0 50.3 0.0 0.0 1.3 53.4 0.0 0.3 53.0 3.3 52.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.4 1.6 0.3 1.6 0.8 0.0 0.1 BTLA "BTLA1, CD272" ENSG00000186265 "B and T lymphocyte associated" Q7Z6A9 3 112463968-112499561 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 37.2;lymphoid tissue: 30.9" "Cell type enhanced" "Detected in some" 26 "B-cells: 26.7;Melanocytes: 6.8;T-cells: 5.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 22.6;naive B-cell: 37.2" "Lineage enriched" "Detected in many" 4 "B-cells: 37.2" "Cell line enhanced" "Detected in some" "ASC diff: 2.5;Daudi: 2.0;JURKAT: 1.3;U-698: 6.3" "Not detected" "Not detected" "HPA047211, HPA062029" Enhanced NA NA "HPA047211: AB_2679983, HPA062029: AB_2684665" "unprognostic (1.13e-3)" "unprognostic (2.13e-3)" "unprognostic (5.79e-4)" "unprognostic (1.01e-4)" "unprognostic (7.08e-2)" "unprognostic (7.74e-6)" "unprognostic (6.20e-3)" "unprognostic (7.59e-3)" "unprognostic (5.98e-2)" "unprognostic (1.53e-5)" "unprognostic (2.33e-2)" "unprognostic (1.23e-1)" "unprognostic (1.57e-5)" "unprognostic (2.57e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-1)" "unprognostic (1.42e-2)" 0.6 0.3 0.3 20.3 0.4 1.2 1.1 0.4 0.3 0.5 1.2 0.1 0.0 0.9 0.4 0.1 2.3 0.5 1.0 0.4 0.3 0.3 1.0 0.5 1.2 30.9 0.3 0.0 0.4 0.3 0.0 0.4 0.3 0.1 0.5 0.9 0.2 5.7 0.4 0.3 0.5 6.0 0.2 0.4 18.6 1.7 0.6 0.0 14.6 0.9 1.1 19.4 2.8 0.5 37.2 8.6 0.1 0.0 0.1 5.1 2.4 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.1 22.6 5.1 2.4 1.5 37.2 4.8 4.7 0.1 0.1 0.0 8.6 1.1 2.4 0.3 0.4 0.4 0.3 0.3 0.3 0.3 0.0 0.1 0.0 0.0 0.3 26.7 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.6 1.3 3.0 0.0 1.1 6.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 5.3 0.0 0.0 BTN1A1 "BT, BTN, BTN1" ENSG00000124557 "Butyrophilin subfamily 1 member A1" Q13410 6 26501221-26510422 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 27.4" "Cell type enhanced" "Detected in single" 32 "B-cells: 1.9" "Cancer enhanced" "Detected in single" "breast cancer: 0.6" "Cell type enhanced" "Detected in some" "memory B-cell: 5.6;naive B-cell: 2.6" "Lineage enriched" "Detected in many" 4 "B-cells: 5.6" "Cell line enriched" "Detected in some" 5 "CACO-2: 10.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011126, CAB037340" Supported "Secreted in female reproductive system" NA NA "CAB037340: , HPA011126: AB_1845491" "unprognostic (4.07e-2)" "unprognostic (1.40e-1)" "unprognostic (1.90e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.77e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" "unprognostic (3.24e-3)" "unprognostic (2.85e-1)" "unprognostic (1.88e-1)" "unprognostic (5.35e-10)" "unprognostic (4.62e-2)" "unprognostic (1.38e-1)" "unprognostic (4.14e-2)" "unprognostic (5.31e-4)" 0.0 0.0 0.0 0.2 0.0 0.0 27.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 1.0 1.6 0.0 1.3 0.0 0.6 0.1 0.0 5.6 0.0 0.7 1.2 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 5.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 BTNL2 "BTL-II, BTN7, HSBLMHC1" ENSG00000204290 "Butyrophilin like 2" Q9UIR0 6 32393963-32407128 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;Karpas-707: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.04e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-2)" "unprognostic (8.13e-4)" "unprognostic (3.74e-2)" "unprognostic (1.33e-1)" "unprognostic (1.21e-1)" "unprognostic (3.04e-1)" "unprognostic (9.36e-2)" "unprognostic (2.41e-3)" "unprognostic (2.07e-1)" "unprognostic (3.67e-1)" "unprognostic (8.03e-2)" 0.0 1.0 0.7 0.0 1.3 0.0 0.1 0.2 0.5 0.2 0.0 1.3 0.3 0.2 0.0 0.3 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 1.0 0.0 0.1 0.0 3.0 0.1 0.9 0.0 0.3 0.7 0.5 0.4 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BTNL3 "BTN9.1, BTNLR" ENSG00000168903 "Butyrophilin like 3" Q6UXE8 5 180988845-181006727 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 82.5" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 102.3;Mucus-secreting cells: 20.3;Paneth cells: 51.8;Undifferentiated cells: 16.9" "Group enriched" "Detected in some" 7 "colorectal cancer: 5.5;pancreatic cancer: 1.2;stomach cancer: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 178 "neutrophil: 17.8" "Lineage enriched" "Detected in single" 178 "granulocytes: 17.8" "Cell line enhanced" "Detected in some" "BEWO: 1.0;CACO-2: 2.5;HMC-1: 1.0;RPMI-8226: 2.5;U-266/84: 2.4" NA NA "unprognostic (4.07e-2)" "unprognostic (3.64e-2)" "unprognostic (9.21e-2)" "unprognostic (4.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.57e-2)" "unprognostic (2.19e-2)" "unprognostic (5.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" 0.1 0.0 0.1 2.1 0.1 0.0 0.1 0.1 0.1 0.1 32.5 0.1 0.1 44.2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 9.4 0.1 0.1 0.1 0.1 0.0 82.5 0.1 0.1 0.5 0.4 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 102.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 2.4 1.8 0.3 1.1 0.0 0.0 0.0 0.0 20.3 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 BTNL8 "BTN9.2, FLJ21458" ENSG00000113303 "Butyrophilin like 8" Q6UX41 5 180899077-180950906 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "blood: 57.9;intestine: 111.7" "Cell type enriched" "Detected in some" 4 "Enterocytes: 87.2" "Group enriched" "Detected in some" 12 "colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "neutrophil: 57.9" "Lineage enriched" "Detected in single" 213 "granulocytes: 57.9" "Group enriched" "Detected in some" 28 "CACO-2: 22.3;OE19: 31.8" HPA039738 Enhanced NA NA "HPA039738: AB_2676656" "unprognostic (4.31e-1)" "unprognostic (6.85e-6)" "unprognostic (6.99e-2)" "unprognostic (1.48e-1)" "unprognostic (6.33e-2)" "unprognostic (1.91e-1)" "unprognostic (6.27e-3)" "unprognostic (6.07e-2)" "unprognostic (3.08e-3)" "unprognostic (3.28e-1)" "unprognostic (1.67e-1)" "unprognostic (9.02e-2)" "unprognostic (4.96e-3)" "unprognostic (2.93e-1)" "unprognostic (1.42e-1)" "unprognostic (4.43e-1)" "unprognostic (1.17e-2)" 1.1 0.2 0.1 2.2 0.4 2.3 0.5 0.3 0.7 0.2 37.6 0.1 0.1 43.8 0.2 0.2 0.2 0.6 9.3 0.3 0.3 0.1 0.4 0.3 1.9 2.0 0.3 0.2 0.2 0.5 0.0 0.2 0.2 0.5 0.1 9.7 0.4 0.1 0.1 0.3 0.1 111.7 0.1 0.5 2.2 2.5 3.5 0.3 0.3 0.9 0.2 0.1 0.1 0.7 0.0 0.0 57.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 31.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.1 0.2 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.9 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.3 0.7 0.3 0.1 0.3 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 10.2 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 87.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.5 15.4 5.3 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.4 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 0.0 BTNL9 "BTN8, FLJ32535" ENSG00000165810 "Butyrophilin like 9" Q6UXG8 5 181040225-181061523 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.2;breast: 76.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 138.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Group enriched" "Detected in many" 6 "B-cells: 3.8;granulocytes: 1.3" "Group enriched" "Detected in some" 4 "OE19: 7.5;U-698: 28.3" "Not detected" "Not detected" HPA043429 Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA043429: AB_10961264" "unprognostic (2.69e-1)" "unprognostic (1.44e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.07e-1)" "unprognostic (1.43e-1)" "prognostic favorable (1.55e-9)" "unprognostic (2.15e-2)" "unprognostic (8.51e-2)" "unprognostic (1.78e-1)" "unprognostic (1.93e-3)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.71e-2)" "unprognostic (3.43e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-2)" 128.2 2.5 1.5 5.3 1.7 0.3 76.8 1.0 1.8 3.2 11.3 0.8 3.5 0.7 3.9 3.7 2.9 6.0 3.7 11.0 3.4 1.3 3.4 3.0 25.4 2.7 2.5 1.2 1.0 2.0 3.0 1.6 4.3 1.5 3.4 1.5 3.8 3.0 3.5 34.4 2.0 1.9 3.2 2.1 12.7 2.0 3.0 0.9 1.1 6.1 4.0 5.5 3.1 18.3 3.8 0.4 1.3 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.1 0.2 1.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 2.9 1.1 0.2 0.1 0.0 0.5 3.3 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.7 0.3 0.0 0.1 0.1 0.1 0.1 7.5 1.8 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.1 4.4 0.1 0.0 0.2 0.1 28.3 0.1 0.0 0.0 1.0 0.3 0.5 0.2 0.1 0.1 3.8 0.2 0.2 0.1 1.9 0.2 0.2 1.3 0.3 0.1 0.4 0.0 0.1 1.5 1.7 1.0 1.8 3.4 1.3 2.5 1.2 1.5 0.9 0.0 6.7 3.0 0.6 2.1 0.4 27.4 0.0 4.0 1.2 0.0 0.0 0.0 3.3 0.0 0.3 29.2 0.0 0.0 0.2 0.1 0.2 0.3 1.1 0.4 0.1 0.0 4.1 138.7 12.7 1.1 2.0 1.0 3.3 0.0 4.0 0.2 0.1 0.0 0.4 0.0 0.3 12.9 2.1 4.3 11.1 1.9 0.1 0.5 1.1 0.6 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637698-110678114 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 56.5;testis: 30.9" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 68.1" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 1.1 0.9 0.5 15.8 1.0 8.9 0.6 0.3 1.0 1.2 2.8 0.4 0.0 2.4 0.7 2.3 5.8 0.5 1.0 1.1 0.5 0.5 0.9 0.8 2.1 11.6 0.6 0.2 1.0 0.7 0.0 0.4 2.4 0.5 0.7 4.3 0.4 1.4 0.0 0.5 1.8 3.1 1.4 1.3 7.9 1.8 30.9 0.1 56.5 0.6 5.7 12.1 2.5 2.0 1.8 2.4 3.0 0.2 1.4 6.1 1.1 30.3 8.9 23.4 14.7 1.0 1.7 12.4 15.8 10.4 27.5 20.8 18.7 17.5 20.6 9.8 9.1 25.8 13.3 29.9 11.5 34.2 16.3 14.6 68.1 9.5 14.9 0.2 19.6 19.3 0.4 0.7 21.2 10.5 3.9 16.1 23.1 29.8 43.0 22.5 10.0 32.8 16.4 22.6 10.8 16.9 21.8 20.0 31.4 5.6 9.6 15.7 6.8 11.2 9.6 8.5 14.9 7.5 16.6 6.6 12.5 20.5 9.4 21.9 22.5 21.1 25.3 8.5 15.2 22.0 3.0 0.0 0.7 0.6 0.2 0.9 1.8 2.5 1.0 0.8 1.4 1.6 1.5 0.0 1.4 0.1 2.4 6.1 1.1 0.5 1.0 0.3 1.0 0.5 0.5 0.6 0.2 0.5 0.1 0.0 1.0 7.8 0.2 0.5 0.0 0.8 0.0 1.4 2.3 0.0 0.0 1.3 0.0 0.2 8.3 0.0 0.0 0.0 0.0 8.1 0.3 0.2 0.0 0.2 6.6 0.0 0.0 1.3 1.3 4.7 0.3 1.7 0.0 1.0 0.9 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.0 68.0 14.1 0.4 0.6 2.5 2.0 0.9 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221136 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.5;testis: 25.6" "Group enriched" "Detected in many" 7 "Spermatocytes: 66.9;Spermatogonia: 28.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.8;plasmacytoid DC: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA008419 Supported Cytosol Yes Yes Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 1.0 0.9 0.3 18.4 0.6 11.4 1.5 0.4 0.5 1.3 4.0 0.4 0.1 3.3 1.1 0.8 6.5 0.5 1.1 0.6 0.4 0.4 0.8 0.7 1.8 8.7 0.4 0.3 0.6 0.5 0.0 0.4 3.4 0.5 0.6 4.4 0.3 1.6 0.1 0.7 2.3 2.9 1.2 0.6 5.4 1.7 25.6 0.1 49.5 0.5 3.1 10.6 1.1 2.0 2.8 2.8 0.0 0.2 0.7 0.7 0.5 21.8 11.1 35.5 14.1 0.9 2.5 11.5 20.8 11.7 22.3 19.4 16.2 8.4 19.8 11.7 7.5 20.5 24.7 33.5 11.3 24.3 17.0 18.0 28.9 28.7 15.0 0.0 26.1 15.9 0.5 0.6 13.6 12.8 4.4 16.1 22.9 24.9 21.1 22.2 7.4 20.4 15.9 24.0 18.4 12.7 21.9 29.2 15.0 6.8 11.1 23.2 14.3 12.8 12.3 4.5 16.2 14.3 13.5 9.3 17.1 18.1 17.0 18.4 11.1 18.8 32.4 9.1 29.3 22.2 0.0 0.0 0.0 0.2 0.2 0.3 2.4 0.7 0.6 0.7 2.8 0.1 0.4 0.0 0.7 0.1 2.8 0.0 0.5 0.3 0.6 0.4 0.5 0.4 0.4 0.4 0.3 0.5 0.1 3.0 1.4 0.8 0.3 0.7 0.4 0.4 0.0 0.0 3.4 0.0 0.0 1.3 0.0 0.3 2.5 0.0 0.3 0.0 0.0 5.1 0.4 0.2 0.0 0.2 4.3 0.0 0.0 1.3 0.6 2.4 1.4 1.5 0.0 0.0 1.4 0.0 0.8 0.8 0.4 0.0 0.1 6.5 0.0 66.9 28.8 0.3 0.7 0.8 1.7 0.4 BUB1B-PAK6 ENSG00000259288 "BUB1B-PAK6 readthrough" 15 40217428-40276396 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA031124 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.83e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-2)" 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BVES "HBVES, POP1, POPDC1" ENSG00000112276 "Blood vessel epicardial substance" Q8NE79 6 105096822-105137174 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.3;skeletal muscle: 37.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 31.1;Early spermatids: 24.1;Late spermatids: 42.6;Sertoli cells: 12.9;Spermatocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 1.2;granulocytes: 2.9" "Cell line enhanced" "Detected in many" "RH-30: 18.7;WM-115: 18.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA014788, HPA018176" Enhanced Supported "Plasma membrane,Cell Junctions" Yes NA "Plasma membrane, Cell Junctions" "HPA014788: AB_1845504, HPA018176: AB_1845503" "unprognostic (2.91e-1)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.73e-2)" "unprognostic (5.46e-2)" "unprognostic (3.66e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-2)" "unprognostic (8.37e-2)" "unprognostic (4.49e-2)" "unprognostic (2.29e-2)" "unprognostic (8.92e-2)" "unprognostic (5.84e-3)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "unprognostic (2.02e-2)" "unprognostic (3.24e-4)" 2.9 1.0 2.3 2.4 7.6 0.6 8.9 0.7 4.1 2.6 11.5 6.7 6.7 1.7 5.3 2.8 5.3 2.5 2.1 29.3 2.8 2.5 1.5 0.7 2.3 0.9 10.4 1.3 1.2 1.0 0.8 3.5 3.5 6.1 5.4 3.5 3.6 1.6 10.0 37.1 0.8 2.7 19.4 10.7 0.7 5.9 10.0 6.3 0.0 1.6 8.6 0.8 10.3 8.6 0.5 1.2 2.9 0.3 0.4 0.4 0.1 0.8 1.2 4.8 0.8 7.0 9.7 2.1 3.6 2.5 5.6 7.4 0.3 0.0 0.0 0.0 6.7 9.3 0.0 2.0 1.2 5.2 0.0 1.7 0.0 0.6 0.2 1.5 0.0 0.4 5.6 4.3 8.6 0.7 4.2 2.4 2.0 0.1 12.1 12.2 0.1 0.1 0.6 1.0 0.0 0.0 3.4 18.7 0.0 0.0 0.0 6.2 10.8 2.3 0.0 4.8 3.6 0.0 12.2 5.5 8.9 0.0 0.0 9.3 1.1 0.5 0.0 5.3 0.0 18.8 2.9 0.3 0.3 0.2 0.1 0.2 0.3 0.2 0.4 0.0 0.5 0.3 0.3 1.7 0.4 0.1 1.2 0.1 0.1 2.3 7.6 0.7 4.1 2.8 2.5 10.4 1.3 6.1 6.3 0.0 0.0 0.0 0.2 0.2 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 1.9 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 1.7 0.0 0.0 2.5 0.0 42.6 1.1 0.5 0.0 1.8 0.0 0.0 0.2 0.0 3.2 0.0 0.0 12.9 3.9 12.5 5.1 0.6 0.1 0.0 0.0 0.1 BX072566.1 ENSG00000277630 Unmapped 108007-139659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 96 "testis: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 2.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX088645.1 ENSG00000283378 9 61330717-61453030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "blood: 21.7;bone marrow: 14.1" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "neutrophil: 21.7" "Lineage enriched" "Detected in single" 182 "granulocytes: 21.7" "Cell line enhanced" "Detected in some" "A549: 21.5;SiHa: 4.7;TIME: 6.8;WM-115: 18.9" NA NA 0.1 0.0 0.0 14.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.0 0.0 0.1 0.0 21.7 0.0 0.0 0.0 0.0 1.0 21.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.7 2.3 0.3 1.6 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.5 1.4 1.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.7 0.0 0.3 2.4 0.0 0.7 0.3 0.6 4.7 0.1 1.4 0.2 0.1 0.1 6.8 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX248415.1 ENSG00000276911 1 196819745-196959210 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 938 "liver: 93.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 2.6" "HPA038915, HPA040726, HPA049813" Supported "Secreted to blood" NA NA "HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX255925.3 ENSG00000284976 9 137217452-137219361 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 30.6;pancreas: 25.2" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 21.2;Pancreatic endocrine cells: 23.6;Proximal tubular cells: 6.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA 0.6 3.0 0.4 1.6 0.3 5.0 1.2 0.3 0.8 3.8 7.1 0.3 0.8 5.3 0.6 3.5 30.6 1.1 12.4 2.1 0.3 1.7 1.2 1.5 2.3 0.3 0.3 0.5 25.2 0.7 0.3 1.5 0.3 3.1 0.5 0.3 14.6 1.4 1.1 6.2 8.9 0.9 0.3 1.9 7.0 15.0 0.3 0.3 0.5 15.0 15.1 1.0 0.3 1.8 4.9 3.7 2.3 2.0 2.9 5.6 5.5 9.1 5.4 7.0 2.5 2.5 21.2 6.5 3.5 6.8 4.9 8.4 6.4 8.1 4.6 2.3 5.1 20.2 3.4 4.7 1.5 8.9 9.5 4.7 21.5 7.5 4.2 6.9 15.8 3.3 4.4 7.7 2.1 1.8 3.1 7.9 11.5 6.9 2.3 15.5 6.1 20.0 9.3 12.6 31.6 15.5 7.3 9.4 2.9 5.5 7.0 8.0 5.8 7.1 5.0 2.0 18.3 10.9 3.7 10.5 12.0 16.9 8.0 5.5 9.3 7.0 6.0 8.0 7.8 0.0 1.9 3.7 1.8 2.3 2.9 1.5 1.4 1.1 1.2 1.8 0.8 0.8 3.3 2.0 1.2 4.9 1.4 5.6 6.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.5 0.0 0.0 5.0 5.3 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 23.6 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BX276092.9 ENSG00000283599 X 71667542-71671524 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;SK-BR-3: 4.7;U-87 MG: 2.8" NA NA 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BZW2 "HSPC028, MST017, MSTP017" ENSG00000136261 "Basic leucine zipper and W2 domains 2" Q9Y6E2 7 16646131-16706523 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 104.4;skeletal muscle: 89.7" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 786.3;Syncytiotrophoblasts: 638.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022813, HPA026709" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Actin filaments, Cytosol" "HPA022813: AB_1845511, HPA026709: AB_10600752" "unprognostic (2.27e-3)" "unprognostic (1.77e-3)" "unprognostic (5.91e-2)" "unprognostic (4.79e-3)" "unprognostic (2.80e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (7.86e-8)" "unprognostic (9.13e-3)" "unprognostic (8.49e-3)" "unprognostic (2.81e-2)" "unprognostic (1.83e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.00e-1)" "unprognostic (1.66e-1)" "unprognostic (6.77e-2)" "unprognostic (1.25e-1)" 10.6 7.2 4.2 7.8 8.5 10.1 13.5 3.4 8.9 7.9 13.6 3.4 22.0 7.7 7.6 7.6 17.9 7.1 6.1 70.8 4.4 2.8 8.4 10.2 8.1 11.4 3.5 5.8 6.4 12.3 1.8 5.7 104.4 2.5 9.8 16.2 13.2 10.1 25.3 89.7 16.8 8.0 16.6 2.8 8.4 15.6 3.5 3.4 14.5 13.6 41.1 11.1 16.8 10.3 17.2 37.3 1.7 20.3 20.1 23.6 16.3 17.0 16.5 28.1 40.6 13.8 24.4 25.2 24.3 32.0 24.1 25.6 40.0 25.9 39.7 29.0 18.8 17.6 35.5 33.1 27.8 31.9 5.3 19.1 24.8 18.7 22.5 14.3 33.8 15.6 18.7 15.1 21.0 38.8 18.7 34.3 29.2 47.3 8.6 19.5 20.0 17.1 39.2 28.7 50.3 34.2 20.6 18.4 41.8 22.8 31.1 36.0 21.2 9.6 85.9 12.8 33.8 37.8 29.4 19.5 19.1 24.1 28.0 26.8 16.5 17.2 56.0 9.3 42.6 68.2 0.9 17.4 1.7 11.0 20.3 17.9 17.2 16.1 14.9 37.3 15.8 23.6 19.5 0.7 20.1 14.5 14.4 11.9 16.3 4.2 8.5 3.4 8.9 4.4 2.8 3.5 5.8 2.5 3.4 20.8 55.0 24.4 57.3 51.2 48.9 247.1 10.2 32.1 46.6 45.4 60.9 187.5 49.7 33.5 5.3 35.0 23.9 0.0 56.6 786.3 42.5 23.4 20.7 12.2 59.0 6.4 29.3 9.8 28.9 4.8 11.2 28.7 23.6 49.5 35.3 13.3 39.9 31.7 9.2 14.7 83.3 6.5 31.1 4.7 3.8 45.0 638.0 16.2 80.3 79.3 C10orf105 FLJ00245 ENSG00000214688 "Chromosome 10 open reading frame 105" Q8TEF2 10 71711702-71737824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 20.1;lymphoid tissue: 8.6" "Group enriched" "Detected in some" 13 "Early spermatids: 8.0;Late spermatids: 3.6;Melanocytes: 3.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.3;myeloid DC: 1.6;non-classical monocyte: 4.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 4.8" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.60e-3)" "unprognostic (6.76e-3)" "unprognostic (5.45e-1)" "unprognostic (4.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.37e-6)" "unprognostic (5.25e-2)" "unprognostic (2.10e-3)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.35e-1)" "unprognostic (7.37e-2)" "unprognostic (4.64e-1)" "unprognostic (1.53e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" 1.2 0.7 6.8 2.8 8.8 1.8 0.5 0.7 5.6 0.7 0.8 20.1 0.0 1.0 0.8 0.3 0.9 0.8 1.2 0.6 8.9 10.6 0.4 0.7 1.1 3.7 11.7 5.2 1.0 0.3 0.4 0.1 0.8 13.7 0.6 0.7 0.0 0.6 0.4 0.8 1.9 1.3 0.6 4.2 8.6 0.5 3.0 8.7 0.5 0.4 0.0 2.0 1.2 0.2 0.0 1.6 0.7 4.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.9 0.0 0.0 0.1 0.0 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 4.3 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 4.8 0.0 0.0 0.3 6.8 8.8 0.7 4.9 8.9 10.6 11.7 5.2 13.7 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 C10orf113 bA165O3.1 ENSG00000204683 "Chromosome 10 open reading frame 113" Q5VZT2 10 21125763-21146559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "salivary gland: 1.2;testis: 4.8" "Group enriched" "Detected in some" 4 "Early spermatids: 3.0;Late spermatids: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;hTCEpi: 1.2;RT4: 2.0" HPA037013 Uncertain NA NA "HPA037013: AB_10672106" "unprognostic (2.55e-2)" "unprognostic (6.57e-2)" "unprognostic (4.18e-1)" "unprognostic (5.00e-1)" "unprognostic (3.11e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.8 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 C10orf120 bA318C4.1 ENSG00000183559 "Chromosome 10 open reading frame 120" Q5SQS8 10 122697709-122699822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 25.6" "Cell type enriched" "Detected in some" 9 "Early spermatids: 609.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 609.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 C10orf128 Em:AC084727.5 ENSG00000204161 "Chromosome 10 open reading frame 128" Q5T292 10 49154725-49188585 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 61.0" "Cell type enhanced" "Detected in many" 13 "granulocytes: 69.2;Hofbauer cells: 64.2;Macrophages: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 61.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 61.0" "Cell line enhanced" "Detected in some" "HDLM-2: 61.2;HEL: 14.8;K-562: 28.5;U-87 MG: 30.8;U-937: 26.5" "Low region specificity" "Detected in many" HPA058166 Approved NA NA "HPA058166: AB_2683627" "unprognostic (1.33e-1)" "unprognostic (5.67e-4)" "unprognostic (1.34e-2)" "unprognostic (1.21e-1)" "unprognostic (4.50e-2)" "unprognostic (4.13e-2)" "unprognostic (5.86e-3)" "unprognostic (9.13e-3)" "unprognostic (2.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.11e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.86e-5)" "unprognostic (2.45e-2)" "unprognostic (2.22e-2)" "unprognostic (8.69e-3)" "unprognostic (1.24e-1)" 21.6 2.6 5.9 12.9 15.0 2.8 19.4 1.7 9.2 13.1 9.9 19.2 4.6 7.0 11.0 10.0 8.6 9.4 14.7 14.2 9.2 6.7 4.1 7.3 21.1 18.7 27.6 6.5 3.7 3.3 10.1 3.0 8.6 15.0 6.8 11.8 9.6 7.6 6.6 6.7 5.6 17.4 16.8 33.7 23.3 6.7 4.7 20.6 1.5 8.0 9.7 18.0 15.3 13.7 9.1 4.6 61.0 0.9 0.0 9.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 61.2 0.0 14.8 0.0 0.0 0.0 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 28.5 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 30.8 26.5 0.0 6.0 0.9 61.0 5.5 0.3 9.1 9.1 3.5 5.4 4.6 2.8 0.2 1.6 4.5 0.0 0.1 0.1 2.7 2.3 5.9 15.0 1.7 9.2 9.2 6.7 27.6 6.5 15.0 20.6 3.0 0.3 8.5 0.1 5.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.5 0.0 0.0 0.4 20.1 0.0 0.0 0.0 0.7 1.5 0.1 69.2 0.4 64.2 0.0 0.0 9.2 12.1 0.9 0.3 25.7 1.7 0.0 0.0 2.7 0.0 0.0 0.4 0.0 0.0 19.4 1.4 0.7 0.2 4.8 0.9 13.1 0.0 0.3 C10orf142 ENSG00000277288 "Chromosome 10 open reading frame 142" B7Z368 10 44292569-44294649 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 3.8;pancreas: 2.6" "Group enriched" "Detected in some" 9 "Early spermatids: 4.0;Late spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;RPMI-8226: 4.3;U-2 OS: 1.6;U-2197: 10.7;U-87 MG: 3.9" NA NA "unprognostic (3.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.75e-1)" "unprognostic (7.31e-2)" "unprognostic (4.17e-3)" "unprognostic (6.17e-2)" "unprognostic (2.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.80e-1)" "unprognostic (1.14e-1)" "unprognostic (2.51e-3)" 1.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 1.1 0.0 0.3 0.0 1.0 3.8 0.0 0.8 0.1 1.8 0.0 2.6 0.0 0.0 0.0 0.0 1.1 0.1 1.3 0.7 0.1 0.0 2.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.7 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 1.6 10.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf53 Em:AC069546.1 ENSG00000178645 "Chromosome 10 open reading frame 53" Q8N6V4 10 49679651-49710261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "testis: 50.8" "Group enriched" "Detected in some" 14 "Early spermatids: 416.3;Late spermatids: 1039.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.9;U-937: 1.7" HPA037951 Enhanced NA NA "HPA037951: AB_10671382" "unprognostic (9.09e-2)" 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.6 0.1 0.6 0.0 0.2 0.0 0.4 0.0 0.2 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.2 0.2 0.1 0.7 0.1 0.5 0.0 0.0 0.8 3.9 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.3 0.1 0.2 0.0 0.4 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.2 0.0 1.7 0.3 0.1 0.3 0.1 0.4 0.0 0.7 0.1 0.3 0.1 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1039.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 51.2 4.4 0.0 0.0 0.0 0.0 0.0 C10orf55 bA417O11.3 ENSG00000222047 "Chromosome 10 open reading frame 55" Q5SWW7 10 73909969-73922777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 14.0" "Cell type enhanced" "Detected in some" 13 "Basal glandular cells: 6.4;Distal tubular cells: 6.6;Early spermatids: 11.8;Sertoli cells: 6.5;Urothelial cells: 5.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 4.9;hTERT-RPE1: 3.4;RPTEC TERT1: 7.6;U-251 MG: 3.3" HPA045739 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045739: AB_10961861" "unprognostic (5.50e-2)" "unprognostic (1.82e-1)" "unprognostic (1.84e-2)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (9.68e-3)" "unprognostic (5.61e-3)" "unprognostic (4.99e-2)" "unprognostic (8.84e-2)" "unprognostic (3.62e-3)" "unprognostic (1.30e-1)" "unprognostic (2.15e-3)" "unprognostic (1.27e-1)" "unprognostic (3.90e-2)" "unprognostic (5.94e-3)" "unprognostic (3.13e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 14.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.1 0.0 0.3 1.6 0.4 0.3 0.0 4.8 0.0 0.3 0.2 1.5 4.9 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.4 0.6 1.0 3.4 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.1 0.0 7.6 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.5 11.8 0.0 0.0 0.0 0.6 0.0 0.2 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 6.5 0.3 0.0 0.2 0.1 0.0 0.0 0.0 5.4 C10orf62 bA548K23.1 ENSG00000203942 "Chromosome 10 open reading frame 62" Q5T681 10 97589727-97590934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 81.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 7737.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;Hep G2: 2.9;T-47d: 2.1" HPA072947 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA072947: AB_2686562" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-1)" "unprognostic (5.36e-2)" "unprognostic (3.62e-1)" "unprognostic (1.20e-1)" "unprognostic (3.63e-2)" "unprognostic (2.53e-2)" "unprognostic (2.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.5 2.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1574.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7737.3 36.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.3 0.0 6.5 0.0 33.1 18.8 0.0 0.0 0.0 0.0 0.0 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23201916-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 35.7;Ciliated cells: 49.5;Late spermatids: 23.1;Spermatocytes: 63.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 5.3;SiHa: 8.5" HPA038131 Approved Approved Vesicles,Microtubules,Mitochondria NA No "Vesicles, Microtubules, Mitochondria" "HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.1 0.1 1.3 1.7 2.6 0.2 0.0 0.1 1.9 0.3 0.5 0.4 1.3 0.5 0.2 4.6 0.1 7.3 0.2 3.2 1.6 1.4 5.0 0.5 4.0 0.3 0.9 0.5 1.8 0.3 0.4 9.0 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.6 1.9 0.4 0.0 0.7 0.2 0.1 13.8 0.6 0.0 0.6 0.7 0.1 0.1 0.1 1.1 1.1 1.0 0.5 1.1 4.2 0.0 1.5 0.1 1.9 0.2 0.0 0.5 0.4 0.2 0.1 2.0 1.7 0.1 2.4 0.2 0.2 1.6 0.2 5.3 0.2 0.7 1.7 0.5 0.4 0.1 0.7 0.4 1.0 0.1 0.0 0.6 1.7 0.7 1.0 0.2 0.0 0.2 0.2 0.8 0.0 0.3 0.1 0.5 0.9 0.1 0.1 0.1 0.2 0.4 1.7 0.4 0.9 0.4 8.5 0.4 0.1 0.3 0.3 0.3 0.2 0.4 1.5 0.4 0.1 1.1 0.2 0.1 2.5 0.2 0.1 1.0 0.5 0.6 0.7 0.3 0.6 1.1 1.5 0.8 0.1 1.0 1.1 1.0 0.8 1.1 0.3 1.1 4.2 0.0 1.3 2.6 0.1 1.9 1.6 1.4 0.9 0.5 1.2 0.6 35.7 3.7 0.0 0.0 2.5 0.1 1.1 0.0 49.5 3.4 0.0 0.0 0.0 1.7 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 12.2 0.8 6.5 0.0 63.7 2.1 1.1 0.0 0.0 0.0 0.0 C10orf71 FLJ45913 ENSG00000177354 "Chromosome 10 open reading frame 71" Q711Q0 10 49299193-49327487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 104.2;tongue: 35.0" "Cell type enriched" "Detected in single" 478 "Cardiomyocytes: 47.8" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "K-562: 9.2;RH-30: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA057556 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA057556: AB_2683467" "unprognostic (1.25e-2)" "unprognostic (3.97e-2)" "unprognostic (4.16e-2)" "unprognostic (5.58e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" 2.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 2.0 1.7 0.1 0.0 13.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 3.3 15.3 0.1 0.0 0.0 0.3 0.0 0.0 1.1 0.0 104.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.5 35.0 3.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf82 "Em:AC016825.4, MGC33547" ENSG00000165863 "Chromosome 10 open reading frame 82" Q8WW14 10 116663696-116670264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 12.7;testis: 44.7" "Group enriched" "Detected in some" 97 "Early spermatids: 967.9;Late spermatids: 1530.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 127 "basophil: 12.7" "Lineage enriched" "Detected in single" 127 "granulocytes: 12.7" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 4.9;NTERA-2: 2.7;SuSa: 5.6;T-47d: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043022 Approved Mitochondria Yes NA Mitochondria "HPA043022: " "unprognostic (9.98e-2)" "unprognostic (2.09e-2)" "unprognostic (8.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.63e-2)" "unprognostic (9.52e-2)" "unprognostic (3.46e-3)" "unprognostic (3.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.50e-2)" "unprognostic (8.00e-2)" "unprognostic (1.47e-3)" "unprognostic (2.61e-2)" "unprognostic (1.94e-2)" "unprognostic (1.73e-1)" "unprognostic (1.07e-1)" 0.4 1.1 0.4 0.9 1.2 0.2 1.0 0.8 3.3 0.4 0.7 0.0 1.0 0.3 0.3 1.5 1.2 0.3 0.3 0.5 0.4 1.3 0.5 0.3 0.2 0.2 0.4 0.9 3.2 0.9 0.2 1.2 0.3 4.1 1.1 0.4 0.6 1.8 1.1 0.2 0.4 0.6 0.7 2.0 0.3 0.4 44.7 0.0 0.0 3.3 0.0 0.2 0.4 1.9 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.8 3.3 0.4 1.3 0.4 0.9 4.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 967.9 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1530.3 8.3 0.0 1.7 0.0 0.8 0.0 0.1 0.0 4.9 0.0 0.0 12.9 0.0 10.2 7.8 0.0 0.0 0.0 0.6 0.3 C10orf90 "bA422P15.2, FATS, FLJ32938" ENSG00000154493 "Chromosome 10 open reading frame 90" Q96M02 10 126424997-126670446 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 30.9;breast: 9.2;salivary gland: 18.6;testis: 12.3" "Group enriched" "Detected in some" 27 "Early spermatids: 96.0;Late spermatids: 93.2" "Cancer enriched" "Detected in some" 5 "melanoma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "SK-MEL-30: 49.5;U-2197: 15.1;U-266/84: 10.6;U-87 MG: 15.7;WM-115: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038648, HPA075229" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA038648: AB_10672721, HPA075229: " "unprognostic (1.21e-2)" "unprognostic (3.34e-1)" "unprognostic (7.50e-2)" "unprognostic (2.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.30e-2)" "unprognostic (1.98e-3)" "unprognostic (5.06e-2)" "unprognostic (9.34e-3)" "unprognostic (3.73e-2)" "unprognostic (9.52e-2)" "unprognostic (1.22e-1)" "unprognostic (5.06e-11)" "unprognostic (2.69e-3)" "unprognostic (9.91e-3)" "unprognostic (1.26e-1)" "unprognostic (2.88e-1)" 1.9 0.8 7.5 1.0 21.5 0.8 9.2 1.4 18.7 0.9 0.9 30.9 0.0 0.7 0.8 0.8 0.9 0.7 1.1 0.8 10.8 5.9 0.9 0.8 0.8 0.7 26.0 5.9 0.9 1.1 0.7 0.5 1.3 14.4 0.9 1.0 1.7 18.6 0.7 0.9 1.9 0.8 0.8 17.2 0.8 0.7 12.3 28.0 0.0 1.3 0.0 2.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.1 0.0 2.0 0.0 15.1 0.3 0.0 10.6 0.0 15.7 0.0 12.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 21.5 1.4 11.3 10.8 5.9 26.0 5.9 14.4 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 96.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 93.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 3.5 0.0 0.0 0.0 C10orf95 FLJ14280 ENSG00000120055 "Chromosome 10 open reading frame 95" 10 102449837-102451543 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 12.7" "Cell type enhanced" "Detected in many" 11 "Rod photoreceptor cells: 16.7;Syncytiotrophoblasts: 31.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 11.5;JURKAT: 11.4" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (2.31e-1)" "unprognostic (7.76e-3)" "unprognostic (3.19e-1)" "unprognostic (5.62e-3)" "unprognostic (4.02e-1)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (5.98e-2)" "unprognostic (1.50e-2)" "unprognostic (1.01e-1)" "unprognostic (4.42e-2)" "unprognostic (2.39e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (1.22e-2)" "unprognostic (4.80e-3)" 0.0 1.0 0.4 1.2 0.4 1.1 0.0 1.0 1.2 1.7 1.4 0.0 0.0 2.0 0.7 12.7 0.9 9.7 1.2 0.0 0.4 1.0 0.0 9.8 2.2 0.0 0.2 8.9 4.2 0.0 2.6 7.0 0.9 1.0 0.0 10.1 3.4 3.4 0.1 3.6 1.9 0.0 0.0 1.9 3.2 0.9 0.0 0.1 5.0 2.7 4.1 0.5 0.0 9.3 5.6 1.6 1.2 8.4 11.6 4.5 5.4 1.0 0.1 2.2 0.0 0.0 4.8 0.2 0.0 0.0 0.0 4.4 9.5 4.7 2.2 0.0 0.7 9.5 0.0 0.4 0.0 4.1 11.5 3.0 3.9 3.6 0.0 4.1 3.0 0.1 1.8 0.0 0.1 3.1 0.0 11.4 5.2 4.0 0.0 4.3 2.2 3.9 2.2 1.9 3.2 6.6 0.1 5.2 1.1 2.0 8.8 1.3 2.3 1.5 3.0 1.8 4.7 0.3 0.4 0.2 1.1 0.2 0.5 3.5 2.7 3.2 0.2 6.2 0.1 1.6 1.2 1.5 7.4 0.5 7.0 9.3 8.2 7.6 3.2 7.5 11.6 9.7 1.0 8.4 0.2 5.6 8.2 4.5 0.0 2.7 2.2 2.8 1.3 4.5 0.0 2.5 9.4 6.8 5.2 9.8 2.1 3.3 1.4 0.0 0.7 1.3 0.0 1.0 1.5 0.2 3.0 0.0 0.2 2.1 3.2 1.2 0.6 0.3 0.0 0.6 0.7 0.0 2.8 1.7 1.5 0.7 0.0 0.7 3.0 16.7 0.0 0.1 0.4 1.7 1.4 31.8 2.9 2.8 2.3 C10orf99 "AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833" ENSG00000188373 "Chromosome 10 open reading frame 99" Q6UWK7 10 84173738-84185294 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1" "Group enriched" "Detected in some" 11 "Enterocytes: 485.1;Mucus-secreting cells: 220.7;Paneth cells: 599.4;Undifferentiated cells: 289.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 32.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050920 Enhanced "Secreted in other tissues" NA NA "HPA050920: AB_2681274" "unprognostic (3.13e-2)" "unprognostic (1.43e-1)" "unprognostic (6.04e-2)" "unprognostic (1.78e-2)" "unprognostic (7.46e-3)" "unprognostic (2.05e-1)" "unprognostic (7.98e-2)" "unprognostic (2.04e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (3.70e-1)" "unprognostic (4.67e-2)" 0.1 0.0 0.0 48.4 0.0 0.0 0.1 0.0 0.1 22.5 63.5 0.0 0.2 0.0 2.6 0.0 93.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 66.0 0.0 5.9 0.7 0.0 8.8 5.4 3.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 95.1 21.6 17.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 485.1 0.0 0.0 0.0 0.0 0.6 4.6 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 220.7 0.0 0.0 599.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 289.2 36.8 C11orf16 ENSG00000176029 "Chromosome 11 open reading frame 16" Q9NQ32 11 8920076-8933006 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 19.1;lymphoid tissue: 10.8" "Cell type enriched" "Detected in some" 17 "Ciliated cells: 135.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enhanced" "Detected in some" "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.0;T-reg: 1.6" "Group enriched" "Detected in many" 9 "monocytes: 1.0;T-cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 1.5;CACO-2: 1.6;EFO-21: 1.6" "Low region specificity" "Detected in some" NA NA "unprognostic (5.32e-3)" "unprognostic (1.03e-2)" "unprognostic (4.09e-3)" "prognostic favorable (3.32e-4)" "unprognostic (1.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.94e-5)" "unprognostic (6.40e-4)" "unprognostic (1.58e-2)" "unprognostic (9.99e-2)" "unprognostic (4.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.71e-1)" "unprognostic (1.13e-3)" 0.0 0.2 0.5 0.0 0.8 0.0 0.2 0.0 0.3 2.3 0.0 0.7 0.0 0.1 0.6 3.1 0.0 19.1 0.0 0.0 0.8 1.3 0.4 0.0 5.2 0.0 0.0 0.0 2.8 0.0 0.0 1.6 0.0 2.9 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 2.7 0.0 10.8 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.1 1.6 0.0 0.9 1.3 1.3 0.5 0.0 0.0 1.5 0.4 0.0 0.0 0.0 1.6 0.2 0.1 1.6 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.4 0.0 0.7 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 1.2 0.1 0.0 0.0 0.6 0.9 0.6 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.7 0.0 1.1 0.0 0.0 0.3 0.4 0.0 0.7 1.0 0.5 0.3 0.2 0.0 0.3 0.0 0.2 0.6 1.1 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.5 0.8 0.0 0.3 0.8 1.3 0.0 0.0 2.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 135.1 7.9 5.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 C11orf21 ENSG00000110665 "Chromosome 11 open reading frame 21" Q9P2W6 11 2295645-2303049 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 60.5;granulocytes: 15.1;Kupffer cells: 14.3;Macrophages: 12.4;T-cells: 17.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 30.8;HL-60: 11.6;NB-4: 10.7;THP-1: 7.5;U-937: 13.1" HPA037607 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA037607: AB_10672909" "unprognostic (5.25e-3)" "unprognostic (2.65e-4)" "unprognostic (1.35e-1)" "unprognostic (4.61e-3)" "unprognostic (4.32e-2)" "unprognostic (3.58e-4)" "unprognostic (8.98e-4)" "unprognostic (2.37e-3)" "unprognostic (1.87e-1)" "unprognostic (1.15e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (8.84e-4)" "unprognostic (8.50e-2)" "unprognostic (9.54e-2)" "unprognostic (3.55e-1)" "unprognostic (4.07e-2)" 1.5 0.4 0.7 8.7 0.5 30.4 0.7 0.2 0.7 1.5 0.8 1.7 0.8 0.2 1.6 1.3 0.7 1.0 5.4 15.6 0.4 0.4 1.0 1.3 5.2 8.5 2.2 0.9 0.7 0.6 0.0 0.8 0.8 1.0 0.8 0.8 1.4 9.3 0.1 0.4 0.8 3.3 0.6 1.4 16.0 2.0 0.9 1.0 6.4 1.1 2.7 11.5 1.0 0.9 2.6 7.3 29.5 23.2 9.5 10.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 30.8 0.0 0.1 0.3 11.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 13.1 0.0 29.5 6.3 18.7 10.6 13.1 7.3 2.0 3.6 8.4 7.3 2.6 5.4 7.5 5.5 9.5 23.2 0.7 2.6 6.4 0.7 0.5 0.2 0.7 0.4 0.4 2.2 0.9 1.0 1.0 0.0 6.2 1.9 0.0 0.3 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 15.1 0.0 3.4 0.0 0.0 1.3 14.3 0.0 0.0 12.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 17.5 0.0 0.0 C11orf24 DM4E3 ENSG00000171067 "Chromosome 11 open reading frame 24" Q96F05 11 68261335-68272001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 63.4" "HPA012411, HPA012748" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012411: , HPA012748: AB_1845526" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (2.31e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.56e-1)" "unprognostic (2.68e-2)" "unprognostic (4.99e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.60e-9)" "unprognostic (2.18e-2)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (8.67e-3)" 12.9 9.3 6.6 12.9 10.6 2.7 14.7 6.7 13.7 14.1 32.6 23.3 8.4 35.2 21.8 12.3 8.6 12.2 19.2 19.1 9.1 6.5 10.0 44.3 12.6 14.4 10.3 8.1 14.1 17.5 5.8 8.1 12.6 14.5 12.2 11.8 14.7 22.1 12.6 6.9 8.9 65.7 21.5 13.8 11.3 13.5 7.8 10.3 3.4 9.2 11.4 18.8 14.6 10.5 23.7 16.4 9.3 11.0 5.5 9.2 6.9 12.5 13.0 7.7 15.0 18.7 19.0 9.0 30.3 19.7 15.3 15.8 27.4 7.8 5.7 9.4 37.6 13.9 14.2 11.4 13.6 9.9 6.2 6.7 6.0 13.2 18.3 15.1 5.1 20.3 15.7 10.2 23.2 9.5 9.2 6.1 3.0 10.5 9.4 12.9 15.6 1.2 7.4 12.9 20.4 15.8 2.3 13.2 29.3 6.9 6.0 5.1 9.5 9.9 7.9 63.4 6.7 7.4 4.3 6.7 24.1 14.9 30.3 13.3 11.6 11.3 5.3 19.3 4.0 23.1 9.3 7.2 7.5 9.2 11.0 6.2 17.3 5.3 5.7 12.0 23.7 5.0 5.3 1.1 5.5 8.1 16.4 4.8 6.9 6.6 10.6 6.7 13.7 9.1 6.5 10.3 8.1 14.5 10.3 8.9 2.2 11.5 8.0 12.5 3.7 8.5 12.7 10.7 4.5 8.7 2.0 12.7 1.7 14.5 2.8 6.4 37.3 0.0 27.1 24.7 18.1 10.2 43.9 99.7 14.5 0.0 4.6 9.2 12.1 5.6 13.0 12.4 27.0 21.6 33.5 6.6 21.8 12.4 15.2 8.8 2.9 12.9 17.9 12.7 20.6 9.8 8.8 4.9 12.8 7.9 C11orf40 NOV1 ENSG00000171987 "Chromosome 11 open reading frame 40" Q8WZ69 11 4571423-4577820 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "epididymis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPMI-8226: 1.4;SK-MEL-30: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf42 MGC34805 ENSG00000180878 "Chromosome 11 open reading frame 42" Q8N5U0 11 6205566-6211132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 27.9" "Group enriched" "Detected in some" 136 "Early spermatids: 149.9;Late spermatids: 529.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.2;HeLa: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063404 Enhanced Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane, Vesicles" "HPA063404: AB_2685006" "unprognostic (4.79e-2)" "unprognostic (1.83e-1)" "unprognostic (3.18e-1)" "unprognostic (2.56e-1)" "unprognostic (1.39e-3)" "unprognostic (3.49e-3)" "unprognostic (2.05e-1)" "unprognostic (5.39e-2)" "unprognostic (1.26e-1)" "unprognostic (3.50e-2)" "unprognostic (9.30e-2)" "unprognostic (6.47e-3)" "unprognostic (7.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (2.07e-2)" "unprognostic (4.74e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 1.0 1.2 0.1 0.2 0.1 0.1 1.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.3 27.9 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.4 0.0 0.1 0.0 0.5 2.5 0.4 1.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 2.1 0.8 0.6 0.1 0.0 0.3 1.9 0.0 0.0 0.0 0.6 4.2 0.0 4.8 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.9 0.4 0.0 0.8 0.9 0.4 1.5 0.3 1.3 0.8 1.2 0.2 0.0 0.4 1.2 0.3 0.2 1.1 0.5 0.6 0.4 0.9 0.4 1.0 0.4 2.0 0.3 0.5 1.1 0.4 0.7 1.8 0.4 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 529.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 C11orf53 MGC50104 ENSG00000150750 "Chromosome 11 open reading frame 53" Q8IXP5 11 111245805-111286401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 7.6" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 51.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA056128, HPA073101" Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA056128: AB_2683046, HPA073101: " "unprognostic (3.51e-2)" "unprognostic (3.60e-2)" "unprognostic (4.84e-2)" "unprognostic (5.84e-2)" "unprognostic (1.94e-1)" "unprognostic (8.07e-3)" "unprognostic (5.60e-3)" "unprognostic (3.09e-1)" "unprognostic (2.50e-1)" "unprognostic (9.95e-2)" "unprognostic (8.66e-2)" "unprognostic (3.52e-2)" 1.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 2.6 1.2 1.6 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.8 0.0 0.6 1.2 0.4 2.4 4.1 0.0 3.2 0.0 3.0 0.0 0.0 0.0 4.5 7.6 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 11.2 0.0 2.1 0.0 51.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.5 0.0 0.0 6.6 0.3 0.0 0.0 0.0 2.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 3.5 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 123.3;liver: 55.9" "Group enriched" "Detected in all" 5 "Cholangiocytes: 165.6;Distal tubular cells: 150.9;Hepatocytes: 260.8;Proximal tubular cells: 596.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA 640000 "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favorable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 6.0 10.2 5.0 4.3 7.6 1.8 7.2 6.7 6.0 5.9 12.0 7.7 7.8 12.2 6.4 7.3 6.8 7.5 10.6 8.5 5.3 5.0 123.3 55.9 8.0 4.6 8.4 5.1 8.5 13.9 5.6 11.6 5.7 7.3 9.7 10.0 8.9 8.3 6.5 14.2 5.2 20.0 6.7 9.3 5.2 8.4 5.1 7.8 8.9 11.3 5.3 5.3 6.9 4.9 10.6 12.4 37.6 11.7 9.3 11.9 7.2 3.8 5.5 12.7 7.8 9.9 11.4 14.8 5.3 8.8 5.4 7.5 2.1 21.6 15.7 35.4 10.2 6.0 9.0 14.6 3.9 7.5 15.8 5.0 8.6 12.8 10.1 11.3 7.2 4.6 10.6 7.5 10.0 7.2 14.6 8.7 10.9 11.3 11.0 5.5 3.0 13.1 10.0 4.6 25.6 8.8 12.5 16.5 24.8 30.9 7.4 6.5 8.3 9.7 12.2 11.7 9.9 27.1 5.7 5.7 5.5 4.4 9.6 2.8 4.9 14.3 15.5 4.2 11.9 9.4 23.7 11.7 27.3 9.0 8.5 9.3 10.6 9.3 10.2 8.9 9.5 11.5 10.1 37.6 9.3 7.4 12.4 11.9 7.2 5.0 7.6 6.7 6.0 5.3 5.0 8.4 5.1 7.3 7.8 59.6 41.2 13.2 10.0 4.8 16.3 31.1 165.6 41.5 40.9 45.4 15.7 42.4 150.9 13.7 7.6 15.8 55.5 23.3 12.2 12.2 12.6 30.6 15.0 260.8 15.3 14.3 21.4 22.7 28.8 4.7 23.9 10.6 8.5 13.6 34.5 17.1 11.1 37.0 21.5 596.3 16.8 6.5 7.2 31.1 12.4 8.7 51.8 10.2 31.6 13.7 C11orf65 MGC33948 ENSG00000166323 "Chromosome 11 open reading frame 65" Q8NCR3 11 108308519-108467531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 45.0" "Cell type enriched" "Detected in many" 5 "Early spermatids: 513.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (8.05e-2)" "unprognostic (4.89e-2)" "unprognostic (1.62e-1)" "unprognostic (2.11e-2)" "unprognostic (4.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.07e-1)" "unprognostic (5.78e-2)" "unprognostic (3.54e-5)" "unprognostic (2.72e-1)" "unprognostic (2.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (8.87e-2)" "unprognostic (2.50e-2)" 1.0 1.7 2.6 1.1 3.8 0.6 1.1 3.5 2.6 1.0 0.9 3.6 1.4 0.6 0.9 3.3 1.0 2.0 1.3 1.2 2.0 1.2 2.7 2.9 1.6 1.1 2.0 2.5 1.2 3.1 2.2 6.3 0.9 3.1 1.1 0.9 2.0 1.6 2.4 0.9 1.2 1.0 0.8 2.2 1.2 1.1 45.0 3.5 2.4 2.2 0.2 0.9 1.0 1.1 1.2 1.9 1.8 1.6 0.8 2.7 0.5 1.3 0.4 1.0 1.7 1.9 3.6 2.7 1.1 0.5 0.4 0.3 1.9 4.2 1.4 4.1 1.1 1.7 2.1 2.8 2.2 1.2 1.6 1.4 1.9 0.6 0.2 1.3 1.6 0.3 3.9 1.2 0.8 4.7 1.0 1.1 6.2 3.5 1.6 3.1 2.0 1.8 1.2 0.7 3.3 1.5 1.4 1.3 1.8 2.3 1.2 3.7 0.6 1.7 0.8 1.6 0.8 7.1 0.3 1.8 1.5 1.9 0.6 0.2 2.5 1.3 5.4 1.4 1.8 1.3 1.8 0.4 0.0 0.5 1.6 2.7 0.6 0.6 0.6 0.2 1.2 1.6 0.8 0.1 0.8 0.5 1.9 1.4 0.5 2.6 3.8 3.5 2.6 2.0 1.2 2.0 2.5 3.1 3.5 0.0 0.6 0.0 1.4 0.3 15.9 0.9 0.0 6.7 2.3 3.5 29.5 1.3 3.3 1.5 513.5 0.6 0.0 0.0 1.8 0.7 0.6 0.3 2.3 1.8 0.6 6.4 1.2 0.6 0.0 49.6 4.9 0.1 3.3 0.0 0.6 7.6 0.9 0.0 3.9 4.4 47.4 6.5 0.0 106.7 32.6 0.1 0.8 0.0 0.6 0.8 C11orf70 MGC13040 ENSG00000137691 "Chromosome 11 open reading frame 70" Q9BRQ4 11 102047443-102084560 "Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.5;testis: 54.7" "Group enriched" "Detected in many" 9 "Ciliated cells: 186.0;Early spermatids: 270.4;Spermatocytes: 221.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 16.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038585 Enhanced Approved Centrosome NA NA Centrosome "HPA038585: AB_10795357" "unprognostic (9.70e-2)" "unprognostic (3.18e-1)" "unprognostic (3.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.05e-1)" "unprognostic (2.04e-1)" "unprognostic (4.16e-2)" "unprognostic (2.62e-1)" "unprognostic (3.03e-2)" "unprognostic (5.00e-2)" "unprognostic (2.66e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-6)" "unprognostic (1.76e-2)" "unprognostic (8.68e-3)" "unprognostic (2.94e-2)" "unprognostic (6.73e-3)" 2.5 3.7 2.9 1.1 4.2 0.1 3.1 0.7 1.4 5.9 1.6 5.4 11.6 0.8 5.3 11.9 2.3 25.5 4.9 1.7 3.9 4.5 3.0 0.3 7.2 1.2 1.7 1.3 7.5 0.8 3.7 13.7 4.0 16.0 5.6 0.8 4.2 1.1 7.0 0.5 1.6 0.8 5.5 1.9 0.2 1.6 54.7 2.2 0.0 3.3 1.1 0.8 3.8 2.5 0.6 0.3 2.3 0.6 0.3 0.4 0.2 0.0 6.7 6.8 0.0 6.1 14.8 0.2 2.6 6.8 3.7 5.2 0.5 8.7 0.0 1.6 5.2 1.8 1.7 1.6 0.8 2.7 0.0 1.0 0.0 1.1 0.0 4.3 0.0 0.0 6.3 8.5 9.5 6.4 7.2 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 10.0 1.9 7.5 0.0 8.6 0.1 0.0 0.0 7.6 0.0 1.0 0.9 2.9 8.9 2.1 0.1 0.0 0.0 3.0 0.0 0.4 1.6 0.6 0.4 0.3 0.2 0.2 0.5 0.3 0.3 0.1 0.6 0.4 0.3 2.3 0.3 0.2 0.3 0.2 0.2 2.9 4.2 0.7 1.4 3.9 4.5 1.7 1.3 16.0 2.2 0.0 3.4 0.0 5.8 10.2 0.3 0.0 2.5 186.0 13.6 0.0 2.0 6.6 0.0 0.0 270.4 0.1 0.0 0.0 0.0 0.2 8.0 1.2 1.1 0.0 0.4 0.0 9.1 1.3 0.0 24.5 10.6 1.1 5.0 0.0 0.4 7.8 0.0 0.0 5.3 0.0 0.8 12.9 2.8 221.4 17.7 4.0 1.6 0.0 0.0 1.8 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 83.2" "Group enriched" "Detected in many" 15 "Early spermatids: 502.7;Late spermatids: 1567.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA063943, HPA074787" Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA063943: AB_2685157, HPA074787: AB_2686712" "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favorable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 3.9 7.3 5.7 3.4 12.1 2.2 5.7 4.1 8.1 4.2 4.9 10.2 5.6 5.5 3.7 18.0 3.2 5.4 3.9 5.4 6.9 6.1 10.6 15.0 3.9 4.3 10.3 4.7 5.0 6.9 8.7 6.9 2.5 6.7 5.6 4.6 5.7 7.2 5.0 9.9 5.6 5.1 2.1 5.7 5.4 5.2 83.2 12.2 6.4 9.5 4.7 3.2 3.1 3.1 10.5 13.6 14.5 17.7 13.2 11.9 11.3 1.2 3.3 3.5 11.1 5.3 3.1 2.5 0.5 1.4 1.4 1.3 2.7 19.9 5.3 7.1 0.8 6.9 5.1 2.3 2.3 1.7 6.1 1.4 4.0 2.4 5.3 5.0 2.3 4.5 5.0 2.6 1.8 5.6 1.6 1.7 8.9 4.1 5.0 2.6 4.5 4.2 3.5 1.8 4.4 2.1 3.1 2.8 13.6 3.1 2.4 9.6 3.8 12.5 1.4 1.9 3.8 9.4 1.3 1.7 0.3 5.2 3.9 0.9 4.9 7.9 4.1 0.7 5.5 1.4 11.7 17.7 11.1 10.3 11.1 6.3 7.0 7.0 7.1 10.6 10.5 11.4 11.9 14.5 13.2 12.2 13.6 7.7 11.3 5.7 12.1 4.1 8.1 6.9 6.1 10.3 4.7 6.7 12.2 3.0 11.2 1.5 13.8 2.4 9.8 18.7 0.0 24.1 5.7 5.2 3.9 14.3 69.6 12.0 502.7 7.0 13.5 0.0 16.8 2.2 3.7 14.4 5.8 0.0 10.1 12.7 17.4 0.0 0.0 1567.4 12.0 9.1 5.0 10.0 19.0 23.4 11.0 17.5 8.5 59.7 12.5 6.5 4.1 23.4 8.8 2.3 12.2 1.7 15.1 9.5 C11orf74 "FLJ38678, HEPIS, NWC" ENSG00000166352 "Chromosome 11 open reading frame 74" Q86VG3 11 36594493-36659290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 66.1" "Cell type enhanced" "Detected in all" 6 "Ciliated cells: 158.0;Early spermatids: 129.9;Late spermatids: 113.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044880 Uncertain Approved Aggresome,Cytosol NA NA "Aggresome, Cytosol" "HPA044880: AB_10796908" "unprognostic (9.22e-3)" "unprognostic (6.79e-2)" "unprognostic (3.23e-2)" "unprognostic (7.47e-2)" "unprognostic (5.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.13e-2)" "unprognostic (9.86e-2)" "unprognostic (2.36e-1)" "unprognostic (3.65e-2)" "unprognostic (8.52e-2)" "unprognostic (1.92e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (1.24e-1)" "unprognostic (3.24e-1)" 10.7 13.1 16.0 4.2 18.8 8.6 11.5 15.5 20.8 10.5 15.4 8.7 8.3 5.5 11.8 18.5 9.5 25.3 10.1 28.1 14.3 15.4 17.1 13.1 8.1 4.1 17.2 16.5 17.8 10.2 12.5 23.1 7.9 19.6 13.3 8.3 9.0 8.6 8.2 26.5 3.8 7.5 13.1 15.5 5.7 9.7 33.1 14.5 3.5 66.1 10.8 4.0 12.5 7.3 0.3 18.6 7.5 12.5 8.5 8.2 5.8 5.3 9.1 20.1 15.6 16.5 28.3 8.0 11.2 12.7 11.6 20.5 0.3 8.6 0.0 8.8 11.4 15.1 2.3 13.6 15.3 23.0 0.0 22.0 8.8 5.1 9.9 13.8 12.0 2.2 17.8 11.9 7.7 10.9 19.0 19.0 7.9 11.8 0.0 12.8 9.0 2.1 9.9 12.8 3.1 13.9 8.6 24.5 5.2 16.1 1.8 0.5 23.9 11.5 3.0 18.4 18.7 18.4 6.5 12.1 15.9 11.4 21.0 9.5 3.3 6.1 0.0 13.9 14.4 8.2 7.5 12.5 0.7 1.1 9.7 3.7 0.0 3.3 2.8 13.7 0.3 8.2 2.0 0.7 8.5 9.1 18.6 0.4 5.8 16.0 18.8 15.5 20.8 14.3 15.4 17.2 16.5 19.6 14.5 8.9 9.1 2.7 12.3 7.7 14.0 55.4 12.7 158.0 33.0 22.7 3.9 16.8 58.0 26.2 129.9 15.7 4.5 23.3 23.7 15.9 19.7 14.0 15.0 16.4 23.0 9.5 5.2 17.2 16.1 113.0 14.1 11.0 20.3 5.4 8.9 16.0 20.5 10.5 14.5 48.4 10.4 6.5 21.7 91.8 26.8 10.7 6.3 4.3 12.8 9.3 C11orf86 FLJ22675 ENSG00000173237 "Chromosome 11 open reading frame 86" A6NJI1 11 66975277-66977004 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "intestine: 57.7" "Cell type enriched" "Detected in some" 5 "Enterocytes: 358.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 6.9;SiHa: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA039348 Uncertain NA NA "HPA039348: AB_10673421" "unprognostic (1.54e-2)" "unprognostic (7.67e-3)" "unprognostic (3.02e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "prognostic unfavorable (8.97e-4)" "unprognostic (4.17e-1)" "prognostic unfavorable (6.97e-5)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.69e-2)" "unprognostic (3.58e-3)" 0.1 4.0 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 24.4 0.1 0.1 33.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.5 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 3.0 0.1 0.1 0.1 0.1 0.0 57.7 0.2 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 23.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 358.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.7 66.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.1 C11orf87 "LOC399947, LOH11CR1A, NEURIM1" ENSG00000185742 "Chromosome 11 open reading frame 87" Q6NUJ2 11 109422120-109429114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 32.3" "Cell type enriched" "Detected in some" 17 "Horizontal cells: 19.1" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 4.0;fHDF/TERT166: 15.8;SCLC-21H: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034656 Approved NA NA "HPA034656: AB_10600788" "unprognostic (5.42e-2)" "unprognostic (2.09e-1)" "unprognostic (2.28e-1)" "unprognostic (8.55e-2)" "unprognostic (3.87e-2)" "unprognostic (1.85e-1)" "unprognostic (1.63e-1)" "unprognostic (1.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.44e-2)" "unprognostic (2.45e-1)" "unprognostic (5.28e-5)" "unprognostic (8.38e-2)" "unprognostic (9.65e-2)" "unprognostic (2.72e-6)" 0.7 1.0 5.8 0.7 18.1 0.7 0.8 2.7 32.3 2.3 0.8 1.5 0.0 0.8 2.2 1.2 0.8 1.1 0.7 0.7 8.3 3.8 0.8 0.7 0.7 0.7 2.5 12.0 0.7 0.7 0.7 0.3 0.8 11.1 0.9 0.7 0.0 0.8 0.8 0.7 0.8 0.7 0.8 1.2 2.2 0.8 0.8 0.1 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.6 0.0 0.1 0.2 4.0 1.9 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 18.1 2.7 27.7 8.3 3.8 2.5 12.0 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C11orf88 FLJ46266 ENSG00000183644 "Chromosome 11 open reading frame 88" Q6PI97 11 111514785-111537031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.8;fallopian tube: 53.7" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 1019.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.7" "Region enriched" "Detected in many" 4 "pons and medulla: 48.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 4.6;Karpas-707: 4.9;SuSa: 3.7;U-266/70: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.25e-1)" "unprognostic (3.07e-5)" "unprognostic (3.85e-4)" "unprognostic (4.16e-2)" "unprognostic (4.44e-5)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "unprognostic (5.49e-3)" "unprognostic (2.86e-1)" "unprognostic (9.96e-3)" "unprognostic (2.70e-1)" "unprognostic (4.40e-2)" "unprognostic (6.80e-3)" "unprognostic (7.57e-2)" "unprognostic (6.22e-2)" "unprognostic (8.45e-2)" "unprognostic (1.11e-1)" 0.2 0.2 5.7 0.3 10.9 0.3 0.2 0.2 1.0 5.8 0.2 5.7 0.0 0.4 2.2 13.1 0.2 53.7 0.4 0.2 7.3 7.6 0.2 0.2 13.9 0.3 0.6 0.2 8.3 0.2 0.2 0.5 0.4 48.8 0.3 0.2 0.0 0.3 0.3 0.2 0.3 0.3 0.2 1.1 0.3 0.3 13.5 1.5 0.1 0.7 0.0 0.2 0.2 0.0 0.7 0.6 2.6 0.5 0.6 0.4 0.0 0.3 1.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.1 0.0 4.6 2.1 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.2 0.4 0.4 0.0 0.5 0.0 0.4 0.0 0.7 0.1 4.9 0.0 0.5 0.3 0.2 0.2 0.0 0.5 0.0 0.8 0.0 0.1 0.2 0.2 0.5 0.3 0.1 0.0 3.7 0.9 0.0 0.0 0.7 0.6 0.7 0.9 2.8 0.4 0.2 0.4 0.3 0.9 1.7 0.5 1.2 0.3 0.2 0.4 0.5 0.2 0.1 0.4 0.7 0.3 0.3 2.6 0.6 0.5 0.6 0.4 0.0 5.7 10.9 0.2 1.0 7.3 7.6 0.6 0.2 48.8 1.5 3.0 6.9 0.0 0.2 0.0 0.0 4.4 0.0 1019.8 70.5 0.0 0.0 0.1 0.0 0.0 106.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 31.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.1 7.1 0.0 0.0 0.0 0.0 0.5 C11orf91 ENSG00000205177 "Chromosome 11 open reading frame 91" Q3C1V1 11 33698261-33700801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 10.1;Late spermatids: 2.3;Sertoli cells: 6.5;Spermatocytes: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.2;hTERT-HME1: 9.8;HUVEC TERT2: 7.8;TIME: 11.9;U-2197: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047064, HPA050487" Uncertain Supported Vesicles NA NA Vesicles "HPA047064: AB_2679920, HPA050487: AB_2681142" "unprognostic (9.22e-3)" "unprognostic (1.51e-2)" "unprognostic (1.76e-1)" "unprognostic (6.60e-2)" "unprognostic (1.62e-2)" "unprognostic (3.63e-2)" "unprognostic (2.31e-1)" "unprognostic (5.68e-3)" "unprognostic (7.41e-2)" "unprognostic (2.97e-2)" "unprognostic (1.99e-2)" "unprognostic (3.01e-1)" "unprognostic (8.33e-2)" "unprognostic (4.06e-2)" "unprognostic (3.95e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" 7.2 0.2 1.2 2.1 3.0 0.9 2.1 0.3 1.3 0.3 0.3 0.3 0.3 0.0 0.4 0.9 4.3 0.3 7.2 0.7 0.4 0.6 0.9 0.9 1.4 0.3 0.7 0.3 0.6 1.9 0.0 0.3 1.0 1.3 0.3 0.0 0.3 0.9 0.3 0.4 1.3 0.3 0.8 0.8 0.3 2.7 16.6 0.3 0.6 0.3 0.3 0.3 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.0 1.7 0.0 0.8 0.4 0.2 0.6 0.0 0.1 1.8 0.2 0.6 0.5 15.2 1.2 0.4 0.0 0.0 2.9 0.8 0.3 0.0 0.0 0.0 0.1 1.2 9.8 0.5 7.8 0.2 0.0 2.4 3.7 0.0 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.0 1.1 2.0 0.0 0.3 0.0 1.5 0.1 0.5 0.0 0.0 11.9 1.1 0.3 9.8 0.3 0.7 0.5 0.0 2.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.0 0.3 1.3 0.4 0.6 0.7 0.3 1.3 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.2 5.4 0.2 0.0 0.1 0.0 0.0 1.1 C11orf94 ENSG00000234776 "Chromosome 11 open reading frame 94" C9JXX5 11 45906513-45907282 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 28 "testis: 43.4" "Group enriched" "Detected in some" 120 "Early spermatids: 302.2;Late spermatids: 133.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 3.9;U-266/84: 3.2" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.55e-1)" "unprognostic (2.71e-1)" "unprognostic (2.28e-1)" "unprognostic (2.36e-1)" "unprognostic (7.28e-2)" "unprognostic (5.99e-2)" "unprognostic (6.21e-3)" "unprognostic (1.97e-1)" "unprognostic (1.43e-1)" "unprognostic (7.11e-2)" "unprognostic (3.33e-2)" "unprognostic (4.24e-2)" "unprognostic (9.05e-4)" "unprognostic (1.90e-1)" "unprognostic (1.10e-1)" "unprognostic (3.28e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 43.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 1.0 0.0 1.4 0.0 2.6 3.9 1.1 2.4 0.0 1.4 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.3 0.6 1.4 0.0 0.0 1.2 1.9 1.1 1.4 0.6 1.5 0.8 0.0 0.0 0.5 0.0 0.0 0.6 1.1 0.0 1.1 1.2 0.0 1.5 1.0 2.0 0.0 2.4 3.2 0.0 1.7 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 302.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.3 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.8 1.1 0.0 0.0 0.0 0.0 0.0 C11orf96 AG2 ENSG00000187479 "Chromosome 11 open reading frame 96" 11 43942505-43944338 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 152.0" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 445.9;Sertoli cells: 297.5;Smooth muscle cells: 1129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038843 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" No NA "Nucleoplasm, Focal adhesion sites, Cytosol" "HPA038843: AB_10673296" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.28e-2)" "unprognostic (8.15e-3)" "unprognostic (5.49e-2)" "unprognostic (3.42e-3)" "unprognostic (8.11e-3)" "unprognostic (1.15e-2)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (2.34e-5)" "unprognostic (2.65e-2)" "unprognostic (2.07e-1)" "unprognostic (1.18e-2)" "unprognostic (3.19e-2)" 68.2 81.2 4.9 23.4 17.4 3.4 42.6 2.6 10.5 39.7 32.2 3.3 6.6 12.4 35.1 41.5 16.3 69.3 70.0 34.3 8.8 7.9 17.9 67.7 61.9 4.9 7.6 4.7 152.0 18.1 3.8 14.2 14.6 32.8 28.6 6.2 7.6 2.3 12.8 38.2 10.1 17.2 22.9 15.3 12.7 31.3 41.7 4.2 0.0 16.7 14.0 2.3 62.9 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.7 0.8 0.5 0.0 0.3 3.3 0.2 1.4 0.0 0.0 0.7 65.3 0.0 0.0 6.0 1.9 0.0 0.7 0.9 3.1 1.3 0.8 0.0 7.6 0.0 1.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 17.4 2.6 7.1 8.8 7.9 7.6 4.7 32.8 4.2 6.0 166.6 0.0 14.6 82.5 15.3 5.3 0.0 1.4 2.3 0.0 2.0 1.1 0.0 2.2 3.5 30.5 0.0 0.0 0.5 3.5 142.9 42.4 12.8 2.5 3.3 1.6 0.0 114.8 6.9 5.8 199.6 9.5 165.4 0.0 0.0 2.3 2.8 0.0 445.9 0.0 7.6 297.5 1129.9 1.6 1.4 77.3 2.6 2.5 0.0 35.8 C11orf97 LINC01171 ENSG00000257057 "Chromosome 11 open reading frame 97" A0A1B0GVM6 11 94512432-94532123 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.2;fallopian tube: 22.9;testis: 17.9" "Group enriched" "Detected in some" 9 "Ciliated cells: 200.8;Early spermatids: 155.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "HL-60: 1.0;RPTEC TERT1: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (4.18e-1)" "unprognostic (4.70e-1)" "unprognostic (9.64e-3)" "unprognostic (9.44e-3)" "unprognostic (3.86e-3)" 0.1 0.1 3.4 0.1 19.2 0.4 0.1 0.0 3.4 1.1 0.1 1.5 0.0 0.1 0.8 7.0 0.1 22.9 0.3 0.1 8.2 1.1 1.7 5.5 0.1 0.0 1.9 1.8 0.8 0.1 0.0 0.1 14.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 17.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.0 5.1 200.8 20.5 0.0 0.0 0.3 0.0 0.4 155.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.0 0.0 19.4 1.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 1.8 5.0 0.0 0.0 0.0 9.2 11.9 0.0 0.0 0.0 0.0 0.0 C11orf98 C11orf48 ENSG00000278615 "Chromosome 11 open reading frame 98" E9PRG8 11 62662816-62665217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 92.7" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 24.1;Hepatocytes: 12.8;monocytes: 11.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (3.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (3.30e-1)" "unprognostic (8.35e-2)" "unprognostic (3.02e-3)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (2.14e-2)" "unprognostic (4.33e-2)" "unprognostic (1.29e-2)" "unprognostic (4.70e-3)" 9.5 9.4 8.3 14.4 10.5 8.3 8.9 4.6 14.1 8.0 14.2 8.8 7.9 11.9 6.4 8.5 11.0 9.5 9.0 16.0 9.0 15.8 27.0 8.7 17.4 9.2 8.4 11.7 10.0 7.1 6.7 8.6 10.4 10.5 13.9 5.7 9.7 9.1 19.9 8.8 15.7 7.6 7.4 15.8 13.0 9.1 7.8 18.9 12.3 10.3 18.0 9.9 7.9 79.4 70.0 92.7 49.8 62.4 79.2 65.5 55.2 34.9 25.3 30.5 14.8 16.8 13.9 27.8 19.3 32.0 22.2 36.5 31.1 34.7 42.4 17.3 22.1 37.3 24.9 28.0 23.1 37.4 14.9 34.3 21.6 36.5 21.5 53.1 31.5 17.6 32.9 33.2 33.3 19.2 25.2 29.6 41.8 16.6 26.8 70.9 38.2 48.2 41.2 41.1 30.5 29.2 23.3 43.4 35.5 28.7 21.7 24.4 22.0 61.8 37.6 20.6 66.3 19.3 21.3 24.2 32.5 61.1 49.4 16.4 25.0 31.8 31.5 21.4 30.3 70.0 48.3 92.7 54.3 49.6 59.4 79.4 60.7 66.8 41.7 69.7 55.4 68.6 51.7 62.4 49.8 70.0 79.2 65.5 8.9 3.2 0.0 0.2 0.0 0.0 0.0 5.1 24.1 10.3 1.8 0.0 1.2 1.7 3.3 1.3 0.0 0.7 0.0 2.0 1.6 0.2 0.2 10.5 12.8 1.4 0.0 0.0 4.3 7.6 0.8 1.1 1.6 0.0 11.8 0.6 0.2 4.5 1.4 0.7 4.5 0.5 6.5 0.0 0.6 0.6 0.0 1.5 5.0 1.1 0.5 C12orf10 "Gamm1, MYG, MYG1" ENSG00000139637 "Chromosome 12 open reading frame 10" Q9HB07 12 53299686-53307177 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 85.6" "Group enriched" "Detected in all" 6 "Early spermatids: 413.5;Late spermatids: 787.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038626, HPA038627" Approved Supported Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA038626: AB_10674692, HPA038627: AB_2676123" "unprognostic (5.33e-2)" "unprognostic (4.41e-2)" "unprognostic (6.77e-2)" "unprognostic (2.44e-2)" "unprognostic (3.59e-1)" "unprognostic (7.56e-2)" "unprognostic (1.61e-3)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-1)" "unprognostic (2.81e-1)" "unprognostic (6.41e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.61e-1)" 16.1 18.7 21.5 13.0 18.4 13.7 17.8 18.4 32.2 17.9 15.1 14.0 18.7 14.3 17.7 18.3 15.9 28.4 16.6 20.2 19.7 21.3 18.8 15.7 13.0 23.6 25.0 23.9 33.3 27.6 20.6 15.7 11.7 27.7 14.6 11.9 14.3 19.4 19.7 22.4 15.7 13.1 17.7 14.3 12.1 16.2 85.6 12.9 19.4 24.1 18.3 15.0 17.3 15.0 26.1 31.1 12.2 27.4 19.2 33.3 23.2 13.2 30.5 10.8 17.2 11.7 17.7 1.3 8.8 14.2 20.1 14.6 27.6 14.4 12.7 20.9 12.2 11.2 15.0 15.1 19.1 11.0 10.6 29.6 13.2 25.2 32.0 27.4 13.6 8.9 17.6 14.6 18.5 18.9 20.2 17.9 15.1 0.7 26.4 13.5 62.3 18.3 22.4 18.0 13.6 29.5 17.2 10.3 29.7 17.3 14.8 21.8 21.0 9.9 19.5 21.4 6.6 30.6 13.0 11.6 19.7 18.6 14.1 13.8 23.9 24.8 14.1 25.0 11.6 15.1 7.8 27.4 12.2 18.3 20.6 27.5 26.1 24.6 18.4 31.1 22.0 25.9 23.4 6.9 19.2 15.4 19.4 33.3 23.2 21.5 18.4 18.4 32.2 19.7 21.3 25.0 23.9 27.7 12.9 20.8 13.4 38.4 38.3 34.7 24.1 14.2 33.1 28.1 13.6 29.6 11.8 30.6 66.3 54.6 413.5 33.7 29.6 23.3 80.2 49.2 43.7 27.1 13.9 21.5 61.3 9.5 48.4 28.3 41.7 787.6 47.5 41.2 32.1 34.3 43.5 34.6 50.7 40.7 42.8 99.0 31.7 38.8 57.5 104.3 80.3 34.9 21.6 34.8 48.6 26.8 C12orf40 FLJ40126 ENSG00000180116 "Chromosome 12 open reading frame 40" Q86WS4 12 39626167-39908300 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 26.4" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 7.1;Late spermatids: 4.1;Spermatocytes: 21.8;Spermatogonia: 4.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "K-562: 7.7" "Low region specificity" "Detected in single" HPA039032 Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039032: AB_2676316" "unprognostic (1.75e-1)" "unprognostic (2.76e-6)" "unprognostic (3.45e-1)" "unprognostic (1.96e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.8 4.7 0.0 0.0 0.0 0.0 0.0 C12orf42 FLJ25323 ENSG00000179088 "Chromosome 12 open reading frame 42" Q96LP6 12 103237591-103496010 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 45.4" "Group enriched" "Detected in some" 18 "Early spermatids: 327.9;Late spermatids: 270.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 7.4;naive B-cell: 8.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 1.7;NTERA-2: 1.1;SCLC-21H: 1.6;U-266/70: 4.0" NA NA "unprognostic (9.21e-2)" "unprognostic (1.63e-2)" "unprognostic (2.96e-2)" "unprognostic (1.05e-2)" "unprognostic (2.66e-1)" "unprognostic (9.83e-2)" "unprognostic (3.39e-2)" "unprognostic (6.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.61e-1)" "unprognostic (8.96e-4)" "unprognostic (4.89e-2)" "unprognostic (2.20e-3)" "unprognostic (3.89e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-2)" "unprognostic (3.30e-1)" 0.0 0.0 0.4 0.6 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 45.4 0.0 0.4 0.0 0.0 1.0 0.1 0.0 8.3 1.5 0.0 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.6 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 7.4 1.9 2.3 0.2 8.3 2.1 2.3 0.0 0.0 0.0 1.5 2.9 1.3 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 327.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 270.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.9 2.0 0.0 0.0 0.0 0.0 0.0 C12orf45 MGC40397 ENSG00000151131 "Chromosome 12 open reading frame 45" Q8N5I9 12 104986310-105074197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 82.3" "Lineage enriched" "Detected in all" 13 "dendritic cells: 82.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038722 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA038722: AB_10673118" "unprognostic (1.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.52e-1)" "unprognostic (2.02e-2)" "unprognostic (4.75e-3)" "unprognostic (1.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.26e-1)" "unprognostic (4.31e-2)" "unprognostic (2.34e-1)" "unprognostic (5.20e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.58e-10)" "unprognostic (1.46e-1)" "unprognostic (8.71e-2)" "unprognostic (2.42e-2)" "unprognostic (2.19e-2)" 12.1 11.4 14.1 14.4 14.4 15.9 10.8 6.5 15.4 9.0 13.6 9.4 12.4 14.9 9.6 10.0 11.1 7.3 7.1 9.2 12.3 11.5 8.0 18.8 7.7 14.6 11.4 11.0 10.2 35.3 2.7 10.8 7.9 16.0 10.3 11.7 7.5 21.6 13.8 7.7 10.6 10.6 9.7 9.6 12.3 14.1 8.1 9.7 11.0 12.1 8.5 15.4 9.0 11.1 5.9 82.3 1.2 6.2 4.7 5.5 3.5 9.4 13.5 6.5 16.6 5.5 5.6 30.2 8.5 2.1 5.2 2.9 13.5 4.8 18.1 8.6 3.8 13.1 6.3 5.4 12.9 5.8 5.1 9.7 12.0 6.9 18.5 8.1 17.9 9.5 8.3 5.5 7.8 8.5 8.7 8.4 15.2 10.0 4.7 5.0 15.8 11.8 30.7 12.7 14.2 19.6 15.9 7.9 40.8 7.0 12.4 8.4 6.1 8.2 17.7 12.7 12.4 14.7 7.3 4.0 13.1 8.5 11.1 12.9 9.9 11.2 19.1 6.1 12.6 12.3 1.2 6.2 0.1 2.6 5.2 3.2 5.9 3.5 3.2 18.7 4.4 3.6 3.4 0.7 4.7 2.9 82.3 5.5 3.5 14.1 14.4 6.5 15.4 12.3 11.5 11.4 11.0 16.0 9.7 6.0 33.1 19.3 31.8 34.7 9.6 34.4 28.1 25.4 31.8 31.4 23.6 29.8 23.2 25.1 16.4 17.7 9.1 0.0 47.4 53.7 16.7 19.3 19.7 42.3 33.7 3.2 12.0 10.4 20.2 8.5 14.1 56.0 37.1 52.3 18.7 15.6 38.0 18.4 9.6 32.1 11.1 0.0 28.3 17.2 30.2 28.5 18.4 20.8 25.3 32.5 C12orf49 FLJ21415 ENSG00000111412 "Chromosome 12 open reading frame 49" Q9H741 12 116710185-116738070 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 41.4" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026905 Uncertain "Secreted - unknown location" NA NA 260000 "HPA026905: AB_10603446" "unprognostic (2.74e-3)" "unprognostic (1.41e-1)" "unprognostic (3.66e-2)" "unprognostic (9.19e-2)" "unprognostic (1.30e-1)" "unprognostic (5.76e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (2.56e-1)" "unprognostic (4.78e-2)" "unprognostic (2.62e-2)" "unprognostic (3.72e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.91e-11)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (8.46e-2)" "unprognostic (1.73e-1)" 6.2 8.6 10.9 8.6 14.1 6.3 8.6 5.4 16.9 4.7 12.2 10.1 6.1 7.6 5.3 10.4 9.0 4.4 6.8 6.3 8.8 10.0 13.0 9.1 20.4 9.0 10.8 7.2 4.7 7.6 7.3 6.7 5.2 19.6 4.7 9.9 5.9 14.7 5.6 3.6 6.9 8.2 4.8 9.2 7.8 11.9 8.7 7.0 14.0 41.4 5.5 9.7 5.8 4.3 9.4 7.3 6.4 5.4 4.7 8.2 2.6 7.4 10.1 9.4 9.3 11.0 8.8 11.8 5.2 7.0 5.9 5.1 19.9 5.7 19.3 10.3 7.2 8.8 9.7 13.0 8.0 6.7 15.3 10.4 5.5 5.4 18.9 7.7 10.4 17.0 10.6 10.1 7.7 8.7 10.0 8.8 13.0 5.8 4.5 9.4 11.2 9.4 9.7 15.0 11.4 11.8 14.2 6.3 8.4 14.9 20.3 8.7 10.8 8.5 8.6 15.5 11.1 10.4 10.9 11.4 8.8 12.2 12.3 10.2 9.3 27.5 27.0 14.3 10.9 10.3 4.1 4.3 6.4 8.1 5.4 8.2 9.4 6.4 6.5 3.8 8.2 5.7 7.5 3.0 4.7 3.7 7.3 6.4 2.6 10.9 14.1 5.4 16.9 8.8 10.0 10.8 7.2 19.6 7.0 95.3 22.2 23.2 16.8 17.5 10.8 5.4 17.8 5.3 15.9 27.9 11.8 10.3 41.4 55.0 36.4 11.9 30.9 0.0 36.3 30.5 10.3 25.5 6.9 6.4 36.5 28.6 15.5 16.5 15.9 20.7 8.9 14.4 16.9 22.6 16.9 6.7 43.3 34.5 8.9 49.7 12.2 6.5 10.4 12.7 36.3 13.4 15.0 24.9 18.7 49.8 C12orf50 FLJ35821 ENSG00000165805 "Chromosome 12 open reading frame 50" Q8NA57 12 87980035-88034037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 37.8" "Group enriched" "Detected in some" 9 "Early spermatids: 660.0;Late spermatids: 913.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 1.0;SK-MEL-30: 2.7" "Region enhanced" "Detected in single" "thalamus: 0.8" "Not detected" "Not detected" NA NA "unprognostic (2.23e-2)" "unprognostic (6.61e-3)" "unprognostic (4.91e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (4.80e-2)" "unprognostic (1.34e-1)" "unprognostic (6.03e-2)" "unprognostic (8.85e-3)" "unprognostic (3.47e-1)" "unprognostic (2.84e-7)" "unprognostic (6.31e-2)" "unprognostic (2.17e-2)" "unprognostic (3.03e-1)" "unprognostic (7.20e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.4 66.2 0.0 0.2 0.1 1.0 0.4 0.0 80.3 87.6 0.0 0.0 0.0 0.0 0.1 660.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 36.0 0.0 0.1 0.0 0.0 1.3 0.0 913.6 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.8 0.0 0.0 9.1 4.5 0.0 0.0 0.0 0.0 0.0 C12orf54 MGC35033 ENSG00000177627 "Chromosome 12 open reading frame 54" Q6X4T0 12 48482503-48496512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 34.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 2100.5" "Group enriched" "Detected in some" 9 "cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 2.8;HBEC3-KT: 9.4;hTCEpi: 2.6;hTERT-HME1: 5.6" HPA073090 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA073090: " "unprognostic (2.59e-3)" "unprognostic (5.49e-2)" "unprognostic (7.94e-3)" "unprognostic (2.60e-2)" "unprognostic (2.48e-2)" "unprognostic (8.99e-2)" "unprognostic (5.96e-2)" "unprognostic (1.62e-1)" "unprognostic (8.01e-2)" "unprognostic (1.36e-4)" "unprognostic (2.37e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (1.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.92e-1)" 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 34.8 0.1 0.1 0.1 0.1 0.9 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 9.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.6 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.6 0.0 22.3 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.1 444.4 0.1 0.0 0.0 0.0 0.1 0.4 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2100.5 10.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 12.4 0.2 0.0 6.5 1.4 12.9 6.4 1.9 0.0 0.0 0.0 8.4 C12orf56 ENSG00000185306 "Chromosome 12 open reading frame 56" Q8IXR9 12 64264762-64391192 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.9;testis: 15.0" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 49.8;Late spermatids: 26.6;Muller glia cells: 11.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "hTEC/SVTERT24-B: 10.1;SCLC-21H: 8.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA056986 Enhanced NA NA "HPA056986: AB_2683300" "unprognostic (5.85e-3)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.36e-1)" "unprognostic (9.24e-2)" "unprognostic (9.35e-4)" "unprognostic (1.79e-4)" "unprognostic (9.63e-2)" "unprognostic (1.67e-1)" "unprognostic (9.51e-2)" "unprognostic (6.22e-3)" "unprognostic (4.00e-2)" "unprognostic (2.38e-4)" "unprognostic (8.86e-2)" "unprognostic (3.91e-2)" "unprognostic (3.40e-2)" "unprognostic (1.69e-2)" 0.3 0.1 0.1 0.0 0.5 0.2 0.1 1.3 0.2 1.8 0.4 0.9 1.0 0.0 0.1 0.0 1.8 0.2 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.6 0.3 0.4 0.2 0.1 2.7 0.5 0.0 0.0 1.6 0.1 0.0 0.1 0.2 0.1 15.0 0.0 8.9 0.0 0.6 0.9 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.2 0.1 0.5 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 10.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.1 8.5 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.3 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 4.9 5.0 0.0 49.8 0.0 0.0 0.0 0.0 3.6 0.4 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 26.6 0.0 0.4 0.0 0.0 1.0 11.8 0.2 0.0 0.4 7.1 0.7 0.0 0.0 4.2 1.3 0.3 1.5 0.0 0.6 1.4 C12orf60 MGC47869 ENSG00000182993 "Chromosome 12 open reading frame 60" Q5U649 12 14803572-14906586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5" "Cell type enriched" "Detected in many" 7 "Early spermatids: 342.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043911 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043911: AB_10963941" "unprognostic (3.71e-2)" "unprognostic (7.02e-2)" "unprognostic (1.72e-1)" "unprognostic (6.39e-2)" "unprognostic (4.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.72e-1)" "unprognostic (3.09e-2)" "unprognostic (8.56e-2)" "unprognostic (1.18e-1)" "unprognostic (8.25e-3)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (7.09e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-2)" 1.7 8.9 2.6 2.3 9.9 1.7 1.8 1.9 4.7 1.5 1.3 4.8 1.6 0.7 1.1 2.9 1.3 2.9 1.8 5.4 3.7 2.0 4.8 8.7 2.0 3.2 6.3 4.7 1.5 2.1 1.7 3.8 1.6 7.2 2.1 1.2 5.1 1.9 1.4 2.5 1.3 1.4 0.8 9.2 5.5 1.9 22.5 4.9 1.7 3.3 1.0 2.0 1.5 1.7 3.9 1.1 3.6 1.4 3.3 4.5 1.2 2.5 2.8 2.8 8.1 3.1 2.2 2.5 1.9 1.0 2.0 2.4 1.2 2.8 2.2 2.3 0.6 3.0 2.9 3.1 6.2 2.7 5.0 3.1 1.7 0.8 1.9 2.5 2.6 0.9 1.1 3.8 2.0 4.2 2.7 3.8 3.6 2.8 0.5 2.7 0.8 1.0 1.5 9.6 3.8 1.6 3.1 4.8 3.3 3.6 0.8 2.0 2.5 4.1 1.0 3.6 8.6 3.2 1.2 2.9 1.8 2.0 1.4 2.1 1.4 0.9 7.3 2.2 2.4 2.5 0.3 1.3 3.6 2.3 1.4 3.7 3.9 1.9 3.3 1.1 2.6 4.5 3.8 0.3 3.3 0.8 1.0 3.6 1.2 2.6 9.9 1.9 4.7 3.7 2.0 6.3 4.7 7.2 4.9 0.0 0.0 7.5 0.4 0.2 3.3 3.3 0.0 5.3 2.3 5.2 19.6 1.4 6.6 1.3 342.1 2.3 0.0 0.0 1.0 1.7 1.2 0.4 0.0 0.8 1.0 1.6 0.0 0.0 1.2 51.4 2.8 1.1 0.0 3.6 0.1 2.5 0.6 0.0 2.5 2.9 16.1 19.4 1.0 10.5 7.9 0.9 0.2 2.5 0.3 0.3 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.2 9.9 11.2 21.9 5.6 6.0 6.8 11.9 7.6 12.1 8.9 10.6 8.5 17.8 10.3 3.8 12.3 10.5 12.1 6.5 11.6 13.3 10.8 21.0 9.7 9.2 12.6 9.7 10.6 6.3 15.8 8.8 18.2 18.7 7.8 25.5 22.1 7.4 8.0 6.2 23.3 18.0 8.5 12.1 15.2 17.4 13.3 16.5 11.3 8.2 23.8 10.3 13.3 6.8 12.4 8.4 10.8 11.4 8.8 13.2 15.8 11.9 12.0 12.2 14.0 16.3 8.6 12.9 17.2 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 38.7 45.0 27.9 34.0 40.3 32.8 41.3 15.3 17.4 20.5 24.4 13.7 36.6 51.4 17.6 17.3 20.3 14.7 23.3 9.4 19.4 29.7 17.7 14.0 27.0 12.6 42.9 9.2 16.5 7.5 5.0 35.1 13.2 23.6 37.9 16.9 33.9 12.4 13.3 39.6 23.9 34.3 12.9 33.9 63.0 26.2 31.6 9.0 44.9 20.0 7.1 C12orf71 LOC728858 ENSG00000214700 "Chromosome 12 open reading frame 71" A8MTZ7 12 27081058-27082514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 4.1;bone marrow: 3.8;skin 1: 2.5;testis: 7.4" "Cell type enriched" "Detected in some" 8 "Early spermatids: 9.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "NK-cell: 4.1" "Lineage enriched" "Detected in single" 23 "NK-cells: 4.1" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;JURKAT: 2.1" "HPA038359, HPA058728" Uncertain Approved Cytosol NA NA Cytosol "HPA038359: , HPA058728: AB_2683800" "unprognostic (1.14e-1)" "unprognostic (9.86e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (2.36e-1)" "unprognostic (6.78e-3)" "unprognostic (9.90e-2)" "unprognostic (3.13e-1)" "unprognostic (7.12e-3)" "unprognostic (1.02e-1)" "unprognostic (6.73e-3)" "unprognostic (1.96e-1)" "unprognostic (4.15e-8)" "unprognostic (4.85e-2)" "unprognostic (9.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.1 0.0 0.1 0.4 0.1 3.8 0.2 0.8 0.3 0.4 0.1 0.2 0.1 0.0 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.5 2.5 0.4 0.0 0.0 0.5 0.1 7.4 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.5 0.2 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 5.7 0.0 1.2 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.4 0.1 0.0 0.0 0.5 0.3 0.9 0.4 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.3 0.0 0.4 0.2 0.1 0.9 0.0 0.6 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 C12orf73 "DKFZp547P055, FLJ13975" ENSG00000204954 "Chromosome 12 open reading frame 73" Q69YU5 12 103950202-103965708 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038883 Uncertain Approved "Plasma membrane,Centrosome,Mitochondria" "Secreted - unknown location" NA NA "Centrosome, Mitochondria" "Plasma membrane" "HPA038883: AB_10794735" "unprognostic (9.24e-2)" "unprognostic (3.26e-3)" "unprognostic (3.66e-3)" "unprognostic (7.20e-2)" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.98e-4)" "unprognostic (8.96e-2)" "unprognostic (1.86e-2)" "unprognostic (3.79e-2)" "unprognostic (3.03e-3)" "unprognostic (2.07e-1)" "unprognostic (1.33e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (6.27e-2)" "prognostic favorable (1.61e-4)" 6.7 11.4 14.3 8.3 14.5 4.4 9.7 15.5 17.5 7.2 7.4 11.4 7.2 7.7 9.5 13.2 7.0 8.9 5.5 11.1 13.0 14.6 9.4 8.3 5.8 10.0 13.3 13.3 11.5 9.7 9.4 21.0 7.3 13.6 10.7 9.5 8.3 8.3 11.1 43.8 9.0 7.7 7.9 14.1 7.0 9.9 10.1 13.8 11.4 11.5 12.9 10.2 6.6 6.9 11.7 11.3 8.6 5.1 12.0 14.5 3.9 5.9 11.1 16.9 10.3 4.9 6.4 11.0 6.4 3.9 7.2 5.9 11.8 5.2 7.0 8.6 3.9 6.3 9.6 10.0 8.2 5.5 10.1 20.3 10.6 16.3 14.8 7.2 15.6 9.7 5.7 9.4 3.6 6.4 17.6 6.6 20.6 13.6 4.8 6.6 6.8 17.3 23.6 8.2 5.7 19.0 10.0 6.3 6.9 9.4 8.0 27.7 9.5 6.5 11.3 14.9 7.6 19.3 8.5 3.3 8.8 4.9 6.5 6.5 13.1 20.1 14.7 10.0 8.9 7.7 7.3 5.1 8.6 10.5 4.2 10.4 11.7 9.8 10.0 7.2 10.7 14.5 13.5 1.4 12.0 3.8 11.3 13.8 3.9 14.3 14.5 15.5 17.5 13.0 14.6 13.3 13.3 13.6 13.8 6.0 5.0 6.7 8.5 5.4 16.5 14.9 7.6 13.4 5.7 8.7 0.0 9.7 23.2 20.3 59.5 6.7 9.2 0.0 10.6 10.4 7.6 8.0 9.2 11.6 14.8 7.9 10.9 6.2 8.3 25.4 8.1 7.1 1.7 11.8 10.9 12.3 16.5 3.5 8.1 17.7 13.1 6.5 7.2 23.1 21.2 4.5 7.4 4.9 11.5 7.0 C12orf74 ENSG00000214215 "Chromosome 12 open reading frame 74" Q32Q52 12 92702843-92708549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "memory B-cell: 3.7;naive B-cell: 3.1" "Lineage enriched" "Detected in single" 21 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.7;RT4: 2.5;SK-BR-3: 2.8" HPA062856 Approved "Nucleoplasm,Nuclear bodies,Aggresome" NA NA Nucleoplasm "Nuclear bodies, Aggresome" "HPA062856: " "unprognostic (2.75e-2)" "unprognostic (4.33e-2)" "unprognostic (2.28e-3)" "unprognostic (4.55e-3)" "unprognostic (7.95e-4)" "unprognostic (2.23e-1)" "unprognostic (2.57e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (5.84e-2)" "unprognostic (5.83e-4)" "unprognostic (3.03e-1)" "unprognostic (5.89e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 12.3 0.1 0.0 0.2 0.1 0.1 2.1 0.7 0.0 3.6 0.3 0.7 6.9 1.7 4.5 0.3 0.2 0.1 0.1 1.3 0.5 6.6 1.9 0.1 0.0 1.0 1.1 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.9 0.9 0.1 0.2 1.8 0.0 0.1 2.6 2.1 0.5 0.0 0.1 0.2 0.0 10.5 2.5 1.4 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 2.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C12orf75 "AGD3, OCC-1, OCC1" ENSG00000235162 "Chromosome 12 open reading frame 75" Q8TAD7 12 105235290-105396097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 97.7" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 712.9;Extravillous trophoblasts: 1087.5;Proximal tubular cells: 486.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 97.7" "Group enriched" "Detected in many" 6 "dendritic cells: 97.7;T-cells: 26.3" "Cell line enhanced" "Detected in many" "BJ: 120.7;BJ hTERT+: 67.7;fHDF/TERT166: 55.7;RPTEC TERT1: 55.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065311 Uncertain Approved Vesicles NA NA Vesicles "HPA065311: AB_2685463" "unprognostic (5.96e-2)" "unprognostic (3.85e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (6.73e-2)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (8.61e-2)" "unprognostic (1.01e-1)" "unprognostic (2.60e-2)" "unprognostic (1.33e-1)" "unprognostic (7.00e-2)" "prognostic favorable (1.69e-5)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "unprognostic (4.47e-3)" 7.1 3.4 5.5 17.1 5.3 4.2 14.3 3.4 3.3 22.3 10.9 4.9 57.0 4.1 12.8 9.5 5.7 9.7 48.8 3.6 3.5 6.4 37.5 1.4 8.1 6.0 5.4 2.5 7.7 26.8 15.2 2.5 15.0 4.6 19.6 10.2 1.3 3.4 54.9 16.8 5.7 7.7 3.1 4.7 5.7 22.4 28.4 3.7 13.5 2.0 6.5 8.7 4.7 18.1 2.7 97.7 4.3 0.2 9.6 26.3 11.3 5.3 8.6 2.2 1.9 8.3 16.0 3.9 120.7 67.7 25.8 14.7 17.2 0.4 1.5 48.4 55.7 4.3 9.0 4.7 6.5 28.7 29.1 8.9 5.0 2.4 3.3 1.1 3.7 5.2 6.7 1.6 8.8 9.7 15.2 3.3 9.6 0.2 8.0 25.2 1.8 15.6 33.8 5.1 2.0 19.5 2.7 5.8 1.4 55.8 0.5 9.8 2.3 4.7 1.0 1.9 6.2 3.0 0.9 5.8 26.9 10.1 10.4 15.0 4.6 7.3 7.4 6.1 1.2 7.3 4.3 0.1 0.1 25.9 0.0 12.4 2.7 11.2 26.3 3.4 1.7 3.2 16.2 0.5 9.6 0.2 97.7 20.5 11.3 5.5 5.3 3.4 3.3 3.5 6.4 5.4 2.5 4.6 3.7 3.0 3.2 69.2 50.0 89.1 3.6 0.6 236.9 100.4 25.0 177.9 3.9 20.0 712.9 456.1 123.1 11.9 114.3 0.0 196.9 1087.5 96.3 39.4 2.3 1.5 26.7 60.4 320.1 10.4 2.1 216.0 14.4 17.3 57.3 34.3 54.4 2.0 293.7 42.5 4.6 486.9 4.8 6.5 176.9 110.5 92.4 53.4 34.0 103.3 55.5 26.7 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: AB_2677797" "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favorable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.3 9.4 11.4 10.3 8.2 16.9 12.6 5.6 3.2 5.4 4.1 7.7 6.2 7.8 6.7 2.5 4.2 12.6 4.7 4.6 4.1 11.6 10.0 7.8 14.3 15.5 7.8 12.7 15.3 13.5 15.4 4.7 8.7 19.7 8.5 12.7 11.6 20.5 5.6 6.8 6.4 20.9 8.9 4.0 8.6 12.2 7.0 12.6 9.8 6.2 22.9 12.4 7.0 5.2 12.5 12.0 11.4 6.6 10.8 8.3 6.0 6.3 3.3 9.4 10.8 6.4 9.1 7.3 4.7 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 29.8 14.2 10.7 13.8 7.0 23.3 6.3 20.4 36.1 10.3 15.7 2.0 24.1 29.9 10.0 16.2 13.1 6.3 0.0 13.2 8.0 13.6 10.2 4.7 17.3 22.8 30.2 5.8 16.5 19.2 9.0 24.2 16.1 18.6 15.4 11.0 32.3 9.6 7.0 31.8 32.3 20.5 6.5 14.4 26.2 10.1 7.4 10.1 20.8 10.7 5.8 C13orf42 LINC00371 ENSG00000226792 "Chromosome 13 open reading frame 42" 13 51082119-51200252 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 3.2" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 1: 3.0" "Cancer enriched" "Detected in single" 46 "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 11.0;NTERA-2: 13.9;SuSa: 3.4" "Not detected" "Not detected" NA NA "unprognostic (9.77e-2)" "unprognostic (5.61e-2)" "unprognostic (1.73e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C13orf46 ENSG00000283199 "Chromosome 13 open reading frame 46" 13 113953705-113974079 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 21.7" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ciliated cells: 1.4;Club cells: 1.2;Exocrine glandular cells: 1.3" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBF TERT88: 3.0;hTEC/SVTERT24-B: 3.6;RPMI-8226: 4.2;T-47d: 3.0;U-138 MG: 3.1" NA NA 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.8 0.4 0.1 0.1 0.1 0.5 2.4 0.1 0.1 0.1 0.1 4.8 0.0 0.1 0.1 1.0 1.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 4.9 21.7 0.1 0.1 0.5 0.1 0.1 0.4 0.1 0.0 0.0 1.3 0.1 0.0 0.6 0.0 0.3 0.2 0.8 0.7 0.5 0.5 0.0 0.3 0.3 0.7 0.4 0.0 1.3 0.0 0.9 1.4 0.9 0.0 0.0 0.1 3.0 0.0 0.1 1.7 1.9 0.0 0.2 0.1 0.0 0.5 0.0 3.6 1.0 0.4 0.5 0.0 0.0 0.2 0.8 0.0 0.4 0.1 0.0 0.1 0.6 0.5 0.3 4.2 0.2 0.0 0.1 0.0 0.3 1.3 1.1 0.5 3.0 0.3 0.8 3.1 2.1 0.7 1.1 0.0 0.0 0.0 1.1 0.4 1.1 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C14orf132 C14orf88 ENSG00000227051 "Chromosome 14 open reading frame 132" Q9NPU4 14 96039324-96093889 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 49.2" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 35.7;Bipolar cells: 42.6;Horizontal cells: 60.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 22.1;SCLC-21H: 24.4;SH-SY5Y: 24.2;U-87 MG: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.47e-2)" "unprognostic (2.50e-2)" "unprognostic (1.27e-1)" "unprognostic (1.82e-1)" "unprognostic (4.42e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.51e-2)" "unprognostic (5.55e-3)" "unprognostic (1.47e-2)" "unprognostic (3.09e-2)" "unprognostic (1.33e-5)" "prognostic unfavorable (4.95e-4)" 4.1 14.3 22.4 3.6 16.6 0.9 5.8 43.5 49.2 20.4 6.2 15.1 10.9 2.8 17.8 14.7 6.8 21.8 5.5 4.2 24.4 16.7 3.9 2.0 12.5 1.5 15.0 16.6 3.9 3.5 1.0 17.5 1.5 13.8 6.3 5.1 4.6 1.9 20.7 1.8 13.5 4.7 21.5 19.8 3.7 5.7 2.0 8.0 0.0 1.8 3.1 1.9 4.5 3.9 1.1 0.6 0.4 0.1 0.1 3.5 0.8 0.0 2.9 14.2 4.4 10.4 10.5 0.0 4.8 10.8 6.3 3.9 0.0 0.0 0.0 1.1 10.7 4.2 0.3 1.7 0.4 5.5 0.0 0.6 0.0 0.5 0.0 1.2 0.0 0.1 5.6 0.5 5.9 0.4 0.0 0.1 1.4 0.0 0.0 2.9 22.1 0.3 0.0 6.9 0.0 0.0 12.6 2.3 0.0 5.1 10.1 24.4 24.2 3.7 0.4 0.6 4.0 13.2 0.6 0.0 5.1 3.0 8.3 0.0 0.0 0.0 0.0 21.5 0.0 2.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.4 0.0 1.1 3.5 0.7 0.4 0.1 0.0 0.6 0.3 0.8 22.4 16.6 43.5 25.7 24.4 16.7 15.0 16.6 13.8 8.0 35.7 8.8 0.0 2.5 2.4 42.6 1.1 2.5 21.4 5.7 7.0 19.6 0.1 5.0 4.8 3.0 6.5 0.0 0.0 0.2 0.6 12.0 1.8 1.1 3.9 0.2 60.4 8.6 20.3 1.2 2.7 14.7 0.5 8.5 0.0 0.0 3.4 1.6 0.0 12.7 0.0 5.6 0.0 6.1 0.3 0.6 6.8 0.2 0.0 0.0 1.6 C14orf177 FLJ25773 ENSG00000176605 "Chromosome 14 open reading frame 177" Q52M58 14 98711613-98717761 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "blood: 1.6;testis: 5.4" "Group enriched" "Detected in some" 50 "Early spermatids: 7.2;Late spermatids: 5.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "Not detected" "Not detected" HPA018091 Uncertain NA NA "HPA018091: AB_1848845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C14orf178 FLJ25976 ENSG00000197734 "Chromosome 14 open reading frame 178" Q8N769 14 77760830-77769742 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 8.5;testis: 13.7" "Cell type enhanced" "Detected in single" 23 "Early spermatids: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 4.7;TIME: 5.0" HPA062581 Uncertain NA NA "HPA062581: AB_2684799" "unprognostic (2.50e-2)" "unprognostic (1.65e-3)" "unprognostic (1.84e-2)" "unprognostic (2.06e-1)" "unprognostic (7.93e-2)" "unprognostic (1.71e-1)" "unprognostic (8.96e-2)" "unprognostic (7.33e-4)" "unprognostic (2.10e-1)" "unprognostic (1.48e-1)" "unprognostic (9.45e-3)" "unprognostic (1.06e-1)" "unprognostic (1.23e-2)" "unprognostic (9.20e-2)" 0.8 0.7 4.6 1.4 2.6 3.9 1.0 1.7 3.2 0.8 0.9 1.7 0.0 0.8 1.4 4.5 1.5 0.8 1.5 1.0 1.5 1.4 0.8 0.8 0.7 2.0 1.5 0.4 1.6 0.5 1.5 1.9 2.5 2.5 1.0 0.8 1.5 1.1 0.6 1.7 4.9 0.9 0.3 1.4 1.1 0.6 13.7 0.8 0.4 2.1 0.6 1.3 1.1 0.7 6.5 8.5 1.5 3.1 5.1 4.2 1.5 0.2 1.1 2.7 1.9 2.2 0.0 1.2 0.4 0.3 0.6 0.5 4.7 2.4 0.9 0.6 1.1 1.3 1.0 0.3 0.0 1.1 0.6 1.6 0.5 1.0 2.2 0.7 0.8 1.8 0.5 0.0 0.0 1.6 1.6 0.0 2.1 0.4 1.3 0.5 1.7 1.7 1.7 2.0 0.6 0.0 1.2 0.3 0.7 0.0 2.2 1.9 0.4 1.6 2.2 0.1 0.6 1.3 0.3 5.0 1.1 1.1 1.3 0.2 1.4 0.9 1.7 0.7 2.3 0.4 0.2 1.1 0.4 4.2 3.1 2.9 3.5 1.4 1.9 0.5 6.5 3.0 2.3 1.5 5.1 2.4 8.5 0.4 1.5 4.6 2.6 1.7 3.2 1.5 1.4 1.5 0.4 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.0 0.0 0.0 C14orf180 "C14orf77, NRAC" ENSG00000184601 "Chromosome 14 open reading frame 180" Q8N912 14 104579684-104590515 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;heart muscle: 55.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 2.6;Cardiomyocytes: 6.1;Horizontal cells: 3.2;Ito cells: 3.1" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Region enriched" "Detected in single" 11 "pons and medulla: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "ASC diff: 8.4" NA NA "unprognostic (2.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (1.60e-1)" "unprognostic (3.19e-3)" "unprognostic (1.89e-1)" "unprognostic (3.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.32e-1)" "unprognostic (9.80e-2)" 23.2 1.2 0.0 1.7 0.2 0.1 9.8 0.0 0.1 0.5 3.8 0.7 6.7 0.3 0.3 4.7 0.2 0.4 0.7 55.1 0.0 0.3 0.7 1.9 0.2 0.3 0.0 0.0 0.3 0.7 0.1 0.6 0.7 3.9 0.4 0.2 2.0 1.7 1.2 2.5 0.1 0.5 0.5 0.0 0.2 0.5 0.4 0.0 0.0 0.2 1.3 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 C14orf37 UT2 ENSG00000139971 "Chromosome 14 open reading frame 37" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 32.1;Club cells: 20.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.2;AN3-CA: 7.0;fHDF/TERT166: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" NA NA 270000 "Plasma membrane" "HPA001580: AB_2666366, HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 2.8 5.3 11.4 1.5 11.7 1.8 2.4 10.1 14.0 4.1 2.3 3.9 1.1 1.6 6.7 4.0 1.9 4.7 3.9 6.3 8.6 4.6 16.5 2.2 1.8 1.1 5.1 7.8 9.3 2.4 9.2 5.8 1.4 21.5 4.0 2.7 3.9 2.0 3.3 1.2 2.5 1.8 5.0 3.3 1.3 3.0 5.1 5.0 0.0 3.4 0.3 0.9 2.6 3.0 0.3 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 11.2 7.0 5.5 2.3 0.0 2.2 1.7 0.4 0.3 0.5 0.1 0.0 0.7 12.2 1.4 0.1 3.5 0.0 0.5 0.1 1.1 0.0 0.0 0.5 0.2 0.0 5.6 2.4 0.2 0.2 0.2 3.1 0.5 0.9 0.1 0.3 1.4 0.3 0.0 0.0 5.2 0.0 2.3 1.6 0.3 2.7 4.5 0.5 1.3 0.1 0.1 0.0 0.3 3.3 0.3 0.2 0.1 1.7 4.2 0.6 2.9 0.4 0.3 0.0 3.5 0.3 1.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 11.4 11.7 10.1 14.0 8.6 4.6 5.1 7.8 21.5 5.0 3.0 6.5 0.0 7.4 1.3 3.5 0.0 0.0 32.1 20.5 0.0 0.0 0.2 0.0 0.0 1.7 3.0 0.0 0.0 0.0 0.3 4.5 1.3 4.7 2.0 0.1 0.0 0.0 3.1 2.6 0.0 9.2 1.1 3.3 0.0 2.3 9.4 0.0 0.0 9.9 0.0 2.7 0.0 1.4 2.3 2.3 1.8 0.2 1.3 0.3 5.4 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 70.5" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 1.0 2.7 0.0 0.6 0.2 0.0 0.1 0.0 0.5 0.5 0.8 0.0 0.0 0.3 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 1.7 0.0 0.6 16.9 0.0 0.2 1.6 0.0 1.6 6.7 0.1 3.8 0.0 0.3 0.1 0.5 0.0 0.6 14.9 0.0 0.0 0.4 1.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 4.7 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.6 0.0 0.1 0.0 21.7 0.0 0.0 1.6 0.0 17.6 0.2 2.3 0.0 1.1 0.0 4.8 0.0 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.6 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.7 0.0 1.0 0.0 0.0 70.5 6.1 0.0 0.0 0.0 0.0 0.1 C15orf39 "DKFZP434H132, FLJ46337" ENSG00000167173 "Chromosome 15 open reading frame 39" Q6ZRI6 15 75195643-75212169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.7" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.9" "Group enriched" "Detected in many" 5 "dendritic cells: 5.7;granulocytes: 16.9;monocytes: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039961, HPA041907" Enhanced Enhanced Cytosol NA NA Cytosol "HPA039961: AB_10673024, HPA041907: AB_2677736" "unprognostic (3.53e-2)" "unprognostic (1.66e-1)" "unprognostic (4.57e-2)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (2.00e-1)" "unprognostic (2.20e-2)" "unprognostic (3.46e-2)" "prognostic favorable (7.94e-4)" "unprognostic (3.38e-2)" "unprognostic (2.74e-1)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (2.95e-1)" "unprognostic (1.14e-1)" 14.7 10.2 3.5 9.6 5.3 36.1 9.0 2.5 4.1 11.8 8.5 3.1 3.8 7.9 16.5 5.8 13.1 11.5 13.9 7.7 3.5 3.3 5.6 5.3 11.7 11.6 3.3 2.2 23.3 11.4 5.2 7.5 24.4 3.9 10.0 3.9 7.7 12.5 5.3 4.4 9.9 7.6 10.0 3.3 21.1 6.6 71.7 3.2 11.1 7.8 9.0 17.0 10.5 13.7 0.8 5.7 16.9 10.4 2.2 1.3 2.2 7.7 15.9 3.4 4.0 4.7 3.1 10.5 2.2 4.6 2.6 2.8 19.6 10.8 17.5 7.6 3.3 9.6 10.5 14.8 6.8 0.7 17.1 16.7 34.7 7.7 13.4 5.4 9.9 35.9 4.0 5.4 5.6 2.6 3.3 6.7 6.7 14.8 26.2 0.8 4.6 9.5 12.2 10.8 5.2 6.4 8.7 2.6 18.6 1.6 6.1 10.1 3.2 5.2 12.1 8.2 3.6 4.1 12.7 5.7 4.6 7.0 8.3 6.5 19.0 11.9 10.1 4.6 19.3 4.5 4.8 4.2 12.2 1.3 8.2 1.0 0.8 0.7 0.9 2.7 0.5 0.6 0.8 16.9 2.2 10.4 5.7 0.9 2.2 3.5 5.3 2.5 4.1 3.5 3.3 3.3 2.2 3.9 3.2 23.8 5.6 6.0 5.7 13.3 0.2 1.6 7.6 6.7 9.1 3.5 0.0 9.9 0.0 13.8 38.4 10.0 5.4 0.0 12.4 13.9 12.0 4.3 17.3 1.5 10.6 0.0 7.5 9.8 20.8 54.3 10.9 11.3 6.8 12.6 5.9 0.7 14.8 23.2 10.3 1.4 1.9 12.9 10.5 11.2 5.3 12.4 17.5 6.4 7.4 12.7 C15orf41 "FLJ22851, HH114, MGC11326" ENSG00000186073 "Chromosome 15 open reading frame 41" Q9Y2V0 15 36579611-36810248 "Disease related genes, Predicted intracellular proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 79.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 94.8;Early spermatids: 108.6;Late spermatids: 112.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061023 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA061023: AB_2684417" "unprognostic (1.82e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (2.93e-3)" "unprognostic (2.27e-2)" "unprognostic (2.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.40e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-6)" "unprognostic (1.22e-2)" "unprognostic (4.54e-2)" "unprognostic (1.62e-4)" "unprognostic (1.58e-1)" 2.3 4.1 3.4 4.1 8.9 0.8 2.4 4.2 4.1 5.5 4.0 2.8 3.5 4.9 8.8 2.7 7.0 3.3 4.7 79.9 2.5 2.4 2.3 2.8 2.9 1.9 3.1 2.3 3.6 1.9 2.7 3.5 1.8 2.8 5.4 2.7 2.7 3.5 5.3 7.9 4.2 3.0 16.0 3.4 2.0 2.8 4.9 3.7 2.8 2.2 7.2 3.9 7.7 6.2 3.6 2.4 0.4 2.1 4.9 7.8 2.0 13.2 7.1 9.0 3.4 9.9 12.1 3.7 6.4 3.2 8.1 6.7 9.8 5.3 2.1 6.5 15.6 6.0 24.4 9.3 5.5 9.4 1.0 6.5 6.9 6.6 7.1 9.0 6.0 5.2 9.0 6.1 6.9 3.8 6.2 7.7 6.8 8.8 2.2 11.1 6.0 1.8 3.4 4.9 6.1 3.6 5.5 2.5 1.4 5.2 18.2 5.2 3.3 4.3 4.3 3.4 7.0 4.0 9.2 5.4 8.0 4.4 5.3 1.7 5.4 7.4 9.8 10.1 10.5 7.3 0.0 0.8 0.4 4.3 2.1 3.9 3.6 3.4 4.2 2.4 3.5 4.1 3.5 0.1 4.9 0.8 1.8 7.8 2.0 3.4 8.9 4.2 4.1 2.5 2.4 3.1 2.3 2.8 3.7 0.0 0.6 0.8 16.5 9.6 7.7 94.8 5.1 2.7 2.3 0.0 31.4 6.8 5.0 3.4 108.6 4.5 1.3 0.0 1.2 5.6 4.6 5.1 0.0 2.1 1.7 7.9 1.2 4.9 2.2 112.4 2.8 1.3 1.7 0.0 2.0 2.7 3.9 0.0 3.5 1.4 15.6 0.0 6.2 4.4 4.7 8.5 9.0 2.2 2.4 22.3 C15orf48 "MIR147BHG, NMES1" ENSG00000166920 "Chromosome 15 open reading frame 48" Q9C002 15 45430529-45448761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 95.5;lymphoid tissue: 56.1;testis: 47.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 2464.8;Exocrine glandular cells: 1795.4;Pancreatic endocrine cells: 2949.0;Paneth cells: 2168.3;Undifferentiated cells: 1451.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.2;intermediate monocyte: 3.7;myeloid DC: 3.0;neutrophil: 2.1" "Group enriched" "Detected in many" 10 "dendritic cells: 3.0;granulocytes: 2.1;monocytes: 3.7" "Cell line enhanced" "Detected in some" "A-431: 21.6;CAPAN-2: 40.7;GAMG: 41.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012943 Enhanced NA NA "HPA012943: AB_2668774" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (7.83e-2)" "unprognostic (1.17e-1)" "unprognostic (9.74e-3)" "unprognostic (1.48e-3)" "unprognostic (1.28e-3)" "unprognostic (1.59e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-3)" "unprognostic (5.95e-2)" "unprognostic (8.86e-2)" "unprognostic (2.37e-1)" "unprognostic (6.51e-2)" "unprognostic (1.39e-1)" "unprognostic (3.66e-1)" 0.6 0.1 0.4 56.1 0.4 7.2 2.9 0.4 0.4 9.0 87.2 0.5 26.0 6.0 0.9 0.9 33.5 0.6 6.0 2.8 0.4 0.1 1.4 1.6 11.2 0.4 0.4 0.4 0.6 3.3 0.0 0.4 10.6 0.5 2.5 95.5 0.8 6.1 21.5 0.5 14.9 54.6 3.1 0.8 0.6 10.8 47.2 0.4 1.6 0.9 33.1 19.6 1.4 10.9 0.0 3.0 2.1 3.7 0.0 0.2 1.6 21.6 5.3 0.0 0.1 0.3 0.0 0.9 1.1 7.8 1.4 4.0 0.8 40.7 0.0 1.0 0.1 41.1 0.5 0.6 0.3 3.4 2.4 0.5 0.0 0.1 0.1 3.7 0.0 9.4 0.4 0.3 7.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.0 0.5 0.0 9.7 0.1 0.0 0.1 0.1 0.8 1.7 0.0 0.2 1.3 2.5 0.1 4.6 0.4 0.5 0.2 0.1 0.5 0.3 0.2 0.7 0.3 0.1 0.7 0.2 0.1 0.0 3.2 0.3 0.2 3.7 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 2.1 0.0 0.4 0.5 0.0 1.6 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.5 0.4 14.9 19.6 4.5 8.9 59.0 0.6 0.8 79.0 9.4 5.7 5.2 0.0 201.6 3.3 743.8 142.7 6.0 2464.8 0.0 1795.4 122.1 24.0 129.7 33.4 0.2 417.3 108.1 620.4 1.8 8.8 208.7 6.6 354.6 55.6 852.2 1284.5 0.4 2949.0 2168.3 7.1 14.2 1.1 0.0 22.1 577.6 53.2 53.4 138.4 4.3 1451.5 477.3 C15orf53 FLJ35695 ENSG00000175779 "Chromosome 15 open reading frame 53" Q8NAA6 15 38628005-39180499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 8.0;gallbladder: 6.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.1;Distal tubular cells: 1.7;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Pancreatic endocrine cells: 1.0;T-cells: 2.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 1.2" "Cell type enriched" "Detected in single" 10 "T-reg: 8.0" "Lineage enriched" "Detected in single" 81 "T-cells: 8.0" "Group enriched" "Detected in some" 9 "HEL: 4.7;HMC-1: 3.6" HPA041914 Uncertain NA NA "HPA041914: AB_10794640" "unprognostic (9.94e-3)" "unprognostic (3.48e-2)" "unprognostic (2.30e-1)" "unprognostic (5.38e-5)" "unprognostic (1.02e-1)" "unprognostic (8.93e-2)" "unprognostic (2.01e-1)" "unprognostic (4.30e-1)" "unprognostic (3.58e-1)" "unprognostic (4.30e-5)" "unprognostic (2.59e-1)" "unprognostic (4.17e-2)" "unprognostic (2.54e-1)" "unprognostic (2.49e-3)" 0.2 0.1 0.1 2.8 0.1 0.2 0.2 0.4 0.1 0.3 1.9 0.0 0.0 0.3 0.3 1.8 0.7 0.3 6.3 0.2 0.1 0.1 0.3 0.2 2.3 0.5 0.3 0.0 1.3 0.1 0.0 0.1 0.0 1.2 0.2 0.3 0.0 1.3 0.1 0.2 0.6 1.0 0.8 0.7 1.7 0.5 0.2 0.0 0.1 0.2 2.4 3.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.3 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 C15orf59 "INSYN1, LOC388135, MGC131524" ENSG00000205363 "Chromosome 15 open reading frame 59" Q2T9L4 15 73735431-73752747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 24.1;heart muscle: 16.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 8.5;Cardiomyocytes: 12.5;Muller glia cells: 6.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 11.6;fHDF/TERT166: 7.7;HEK 293: 7.9;NTERA-2: 4.9;SK-BR-3: 6.9;U-2 OS: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favorable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 1.2 1.9 9.3 0.4 9.7 0.0 0.9 5.5 24.1 2.2 0.7 0.3 1.0 2.4 9.4 6.5 1.5 16.2 9.1 8.3 3.5 0.0 1.7 0.0 14.4 4.8 1.0 0.0 0.7 0.2 4.5 0.2 0.7 10.1 1.4 8.4 1.0 2.1 4.2 0.0 0.8 1.9 0.4 0.4 1.6 3.8 0.8 0.6 1.5 0.5 0.8 0.5 0.0 0.0 0.5 2.9 1.8 11.6 0.2 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.1 1.0 7.7 1.6 3.0 2.5 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.9 0.0 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.7 1.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.6 6.9 0.7 1.8 3.1 0.2 0.1 1.9 6.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.3 0.4 0.2 0.3 0.3 0.3 0.4 0.1 0.8 0.5 0.5 1.5 0.8 0.3 0.6 0.3 0.0 0.0 0.3 0.0 0.4 0.0 8.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" NA NA "Nucleoli, Vesicles" Cytosol "HPA062820: AB_2684874" "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favorable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.2 4.6 1.2 5.1 5.4 7.8 3.3 1.9 3.4 3.5 2.8 3.5 3.0 3.6 4.1 2.1 4.1 5.0 4.6 1.3 2.9 2.1 10.9 3.8 3.5 4.6 3.5 4.7 3.2 8.1 3.5 1.1 4.3 2.5 1.6 11.1 4.3 8.0 1.1 2.4 3.8 7.7 1.9 3.4 5.8 5.2 2.6 13.1 2.5 3.0 6.8 5.1 3.3 3.2 5.8 2.3 2.8 7.2 1.6 4.7 7.2 5.9 4.8 7.6 11.0 8.7 2.0 9.2 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 20.8 9.1 25.1 28.7 59.6 71.3 69.8 20.4 6.7 7.9 15.7 35.3 35.6 68.0 21.1 136.1 26.6 30.6 0.0 25.8 25.7 33.5 30.2 33.5 33.8 26.4 12.7 26.0 17.2 20.2 22.0 38.0 16.0 35.4 7.2 47.0 62.2 24.4 38.6 24.1 54.0 68.8 32.3 28.3 136.2 21.8 53.2 17.2 31.9 43.0 15.6 C15orf62 LOC643338 ENSG00000188277 "Chromosome 15 open reading frame 62" A8K5M9 15 40770080-40772449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8" "Group enriched" "Detected in some" 5 "Basal glandular cells: 2.8;Glandular cells: 4.5;Horizontal cells: 3.2;Urothelial cells: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.0;SK-BR-3: 6.4" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Low region specificity" "Detected in all" HPA044636 Approved NA NA "HPA044636: AB_10794052" "unprognostic (9.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.52e-1)" "unprognostic (2.83e-2)" "unprognostic (5.56e-2)" "unprognostic (2.24e-2)" "unprognostic (5.37e-3)" "unprognostic (7.68e-3)" "unprognostic (1.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "unprognostic (3.40e-1)" 1.5 0.9 0.8 1.5 1.1 1.5 1.1 4.0 1.7 1.7 1.0 0.8 0.8 2.0 1.1 0.8 22.8 0.9 1.4 0.8 0.8 0.6 0.9 1.9 1.6 2.1 1.1 0.8 1.3 0.9 0.0 1.3 0.8 0.9 1.1 0.0 0.8 5.4 1.8 1.9 11.9 1.8 0.8 0.8 1.5 1.2 0.9 0.8 1.8 1.0 18.8 21.9 0.9 3.8 0.4 0.7 0.0 0.1 0.4 1.0 0.1 0.6 0.5 1.8 2.3 0.7 0.2 0.4 0.8 0.2 0.1 0.2 2.0 2.5 1.1 2.0 0.0 1.6 4.5 0.8 0.0 0.0 1.6 1.9 1.1 4.1 0.6 0.0 0.9 1.4 0.2 1.0 0.0 0.1 2.0 0.6 0.8 0.9 1.4 0.0 0.5 1.4 1.8 0.7 3.0 0.8 1.6 0.3 0.6 20.0 1.7 4.0 1.0 0.6 6.4 0.2 0.7 2.2 1.5 0.9 2.2 1.0 2.0 0.7 1.6 1.0 1.0 0.7 3.3 0.8 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.9 0.6 0.0 0.4 1.0 1.0 0.0 0.4 0.0 0.7 0.8 0.1 0.8 1.1 4.0 0.9 0.8 0.6 1.1 0.8 0.9 0.8 0.0 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.5 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.3 8.8 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408548-55418764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 27.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 50.9;Early spermatids: 140.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 2.3;granulocytes: 6.5;monocytes: 1.6" "Cell line enhanced" "Detected in many" "hTCEpi: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067189 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA067189: AB_2685800" "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favorable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 3.4 3.1 6.5 0.9 7.4 0.8 5.4 2.4 6.7 7.7 5.2 3.7 5.4 2.9 3.7 11.2 3.4 13.7 5.3 7.0 6.0 7.6 11.2 1.9 3.8 2.2 5.2 6.8 4.6 11.0 6.2 17.2 1.2 12.0 5.8 6.2 2.8 27.6 5.3 8.7 2.4 2.5 3.7 3.4 1.9 7.8 11.3 4.6 1.7 7.1 0.6 1.8 3.6 1.5 2.3 0.6 6.5 1.6 0.0 0.7 0.4 0.8 1.7 2.9 1.8 4.5 6.7 0.5 1.6 2.2 1.4 2.8 0.0 1.5 1.3 4.4 5.2 3.5 1.3 0.0 2.7 0.5 2.4 2.0 1.2 10.1 0.4 8.8 2.9 1.6 2.8 14.9 4.2 1.2 7.8 2.7 0.0 2.3 4.3 6.2 2.2 0.1 9.3 0.9 5.3 3.3 0.5 0.0 11.2 7.6 0.0 7.9 4.8 2.0 3.4 12.8 1.6 6.9 2.8 1.9 2.4 0.9 2.5 0.9 1.9 5.0 1.2 6.2 7.2 1.2 6.5 1.1 3.9 0.5 1.6 0.0 1.9 0.1 0.7 0.6 2.3 0.1 0.0 2.1 0.0 0.8 0.2 0.0 0.4 6.5 7.4 2.4 6.7 6.0 7.6 5.2 6.8 12.0 4.6 3.0 0.6 0.8 3.6 1.1 0.8 7.3 2.5 50.9 4.5 5.2 0.0 1.0 14.9 7.1 140.3 3.6 2.1 0.0 9.6 1.1 3.1 4.5 4.6 1.0 2.5 3.2 3.5 3.1 1.9 6.8 4.0 0.2 3.3 1.0 16.7 3.6 7.0 11.5 5.3 16.8 7.5 6.5 2.8 5.8 2.8 1.5 0.0 0.0 4.6 1.7 C16orf45 FLJ32618 ENSG00000166780 "Chromosome 16 open reading frame 45" Q96MC5 16 15434295-15625028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.3" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 125.3;Late spermatids: 336.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 11.1" "Lineage enriched" "Detected in many" 4 "T-cells: 11.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 33.1;U-2197: 24.0;U-87 MG: 41.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041114, HPA063757" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA041114: AB_10794542, HPA063757: " "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (1.67e-2)" "unprognostic (6.96e-2)" "unprognostic (3.79e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.53e-4)" "unprognostic (3.23e-2)" "unprognostic (1.90e-2)" "unprognostic (1.16e-2)" "unprognostic (3.64e-2)" "unprognostic (5.28e-2)" "prognostic favorable (1.75e-4)" "unprognostic (3.79e-3)" "unprognostic (8.31e-2)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" 11.5 10.2 38.8 6.8 27.6 1.3 8.4 30.6 72.3 28.4 10.4 10.1 3.8 5.9 21.3 12.7 14.2 12.3 14.6 28.7 39.2 30.4 9.4 12.9 6.0 4.1 21.8 33.8 26.1 5.6 2.2 11.3 1.4 61.3 15.0 6.2 8.5 6.5 17.8 25.5 4.9 4.4 21.5 12.5 5.3 7.6 13.8 12.0 0.0 5.7 4.4 3.0 14.2 10.7 2.7 0.5 0.6 0.1 0.2 11.1 1.5 0.4 10.7 4.5 0.4 20.2 17.2 0.0 5.8 20.1 5.2 2.9 0.0 0.2 0.0 1.3 33.1 12.7 0.0 1.2 1.6 2.7 0.2 0.2 2.5 4.1 0.3 6.6 0.0 4.4 8.4 1.7 11.6 0.2 8.6 8.0 4.7 0.1 0.1 7.7 6.4 1.4 0.2 5.7 0.1 4.1 0.3 6.1 0.0 2.8 1.8 8.9 8.7 0.3 2.9 1.8 0.8 0.1 0.1 4.6 11.7 6.0 24.0 2.9 2.0 4.6 0.0 41.3 0.0 2.8 0.1 0.1 0.2 11.1 0.0 2.0 2.7 2.1 6.2 0.5 1.6 2.0 3.3 0.6 0.2 0.1 0.3 2.7 1.5 38.8 27.6 30.6 52.4 39.2 30.4 21.8 33.8 61.3 12.0 0.0 0.3 0.0 14.8 7.9 42.1 49.5 5.1 17.4 12.5 1.8 13.7 0.0 26.6 13.2 125.3 26.0 0.0 0.0 72.8 0.0 29.8 4.3 11.5 11.9 0.8 17.5 15.6 17.8 3.2 336.0 18.4 10.9 13.5 18.0 0.0 7.6 41.6 0.0 45.3 7.0 15.7 12.9 42.0 35.1 15.8 5.1 0.1 1.8 0.0 8.8 C16orf46 FLJ32702 ENSG00000166455 "Chromosome 16 open reading frame 46" Q6P387 16 81053497-81077267 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 80.6;Late spermatids: 78.6;Spermatocytes: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041136, HPA041379" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041136: AB_10795535, HPA041379: AB_10794666" "unprognostic (7.73e-2)" "unprognostic (2.17e-1)" "unprognostic (2.59e-1)" "unprognostic (1.02e-2)" "unprognostic (1.83e-1)" "unprognostic (9.93e-2)" "unprognostic (1.81e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (1.93e-1)" "unprognostic (8.06e-2)" "unprognostic (1.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.58e-1)" "unprognostic (3.53e-1)" "unprognostic (7.06e-3)" "unprognostic (8.72e-2)" 2.0 2.5 5.2 1.8 6.8 2.2 3.1 3.3 8.6 2.8 1.4 3.5 1.3 1.3 2.8 4.4 1.7 8.6 2.0 1.4 5.8 5.8 2.4 3.0 2.2 1.1 5.9 6.0 1.7 2.6 2.9 14.4 3.2 8.6 3.0 1.4 3.5 2.0 2.4 2.5 1.0 1.0 1.9 4.2 1.1 1.1 25.2 2.5 1.5 8.9 0.5 1.3 1.9 1.3 0.2 0.4 1.1 0.4 0.0 2.0 0.0 2.8 0.5 1.1 0.5 5.2 1.0 2.6 0.6 3.6 2.0 1.2 0.6 4.0 0.7 1.8 0.7 2.5 1.0 1.1 2.0 3.6 0.6 0.7 0.8 2.3 2.7 3.1 1.0 2.2 2.1 1.6 4.7 2.9 2.2 1.7 1.4 1.7 1.4 1.6 2.0 0.3 5.5 1.3 1.0 0.6 2.2 0.3 0.4 3.5 1.7 1.5 1.4 4.0 1.3 0.7 1.7 1.2 1.4 1.4 0.9 0.4 0.8 0.7 1.5 2.1 1.6 1.8 1.4 1.0 0.0 0.4 1.1 0.2 0.0 2.0 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.4 0.0 0.0 5.2 6.8 3.3 8.6 5.8 5.8 5.9 6.0 8.6 2.5 0.0 2.9 0.0 8.1 1.6 2.1 2.0 0.0 20.1 3.4 0.0 3.9 6.3 5.0 0.8 80.6 1.6 0.0 0.0 0.4 13.6 2.3 6.0 0.0 2.9 2.8 0.0 1.2 1.3 1.2 78.6 7.5 1.0 5.0 0.0 1.2 2.9 0.4 0.0 7.1 3.1 7.0 0.0 2.0 32.0 4.9 2.4 5.3 0.0 0.9 5.5 C16orf54 FLJ35681 ENSG00000185905 "Chromosome 16 open reading frame 54" Q6UWD8 16 29742463-29746006 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.2;lymphoid tissue: 41.8" "Cell type enhanced" "Detected in some" 12 "B-cells: 44.1;granulocytes: 32.4;Kupffer cells: 20.5;T-cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 13.6;HL-60: 13.7;HMC-1: 8.9;MOLT-4: 11.2;NB-4: 9.3;THP-1: 16.2;U-937: 7.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060546 Uncertain NA NA "HPA060546: AB_2684317" "unprognostic (2.09e-3)" "unprognostic (1.58e-3)" "unprognostic (1.30e-2)" "unprognostic (1.92e-4)" "unprognostic (2.08e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-3)" "unprognostic (2.90e-2)" "unprognostic (2.44e-3)" "unprognostic (1.06e-2)" "unprognostic (1.34e-1)" "unprognostic (2.32e-1)" "unprognostic (9.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.18e-2)" "unprognostic (1.91e-1)" "unprognostic (2.36e-1)" 2.7 0.9 0.8 19.9 0.8 23.2 1.2 0.6 0.7 2.8 3.8 1.3 0.2 1.7 1.3 1.4 2.4 2.1 4.7 2.2 0.8 1.0 1.9 1.3 7.1 41.8 1.1 0.5 0.8 1.0 0.0 0.8 1.6 0.8 1.8 2.2 1.4 6.8 0.2 1.0 0.9 9.3 0.8 1.2 25.4 3.3 0.7 0.8 35.6 1.3 2.3 27.8 3.1 1.8 26.5 14.7 95.2 20.0 36.1 40.7 26.2 3.9 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 2.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.2 0.0 0.0 13.7 8.9 0.3 0.0 0.0 0.0 0.0 0.0 4.9 0.1 3.9 0.0 0.1 11.2 9.3 0.8 0.0 0.0 6.4 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 16.2 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.2 7.5 0.1 42.6 18.4 61.9 40.7 16.8 38.5 26.5 40.5 35.6 13.0 21.8 33.7 34.7 95.2 36.1 20.0 14.7 21.2 26.2 0.8 0.8 0.6 0.7 0.8 1.0 1.1 0.5 0.8 0.8 3.0 6.6 44.1 0.1 0.5 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 32.4 0.4 6.3 0.0 10.4 2.5 20.5 0.0 0.0 14.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 1.1 47.3 0.0 0.0 C16orf71 "DKFZp686H2240, FLJ43261" ENSG00000166246 "Chromosome 16 open reading frame 71" Q8IYS4 16 4734272-4749396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 14.1;testis: 48.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 18.7;Early spermatids: 20.4;Late spermatids: 45.3;Spermatocytes: 48.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 7.6;U-2197: 8.3" HPA049468 Enhanced Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA049468: AB_2680779" "unprognostic (1.24e-2)" "unprognostic (8.87e-2)" "unprognostic (2.39e-1)" "prognostic favorable (7.49e-4)" "unprognostic (7.06e-2)" "unprognostic (2.17e-2)" "unprognostic (5.36e-3)" "unprognostic (2.21e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-2)" "unprognostic (6.79e-3)" "unprognostic (1.13e-1)" "unprognostic (8.56e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.54e-5)" "unprognostic (1.65e-1)" 0.3 0.5 0.7 0.3 1.9 0.0 0.3 1.0 1.0 0.9 0.3 2.4 0.6 0.2 0.6 2.5 0.4 14.1 0.8 0.3 1.1 1.0 1.0 1.1 1.7 0.1 0.7 0.5 1.2 0.4 0.8 1.7 0.1 3.6 0.5 0.1 0.4 1.3 1.1 0.4 0.2 0.3 0.4 0.5 0.2 0.3 48.9 0.7 0.2 1.1 0.0 0.4 0.3 0.5 1.4 4.1 0.0 1.1 0.0 0.7 0.4 0.6 3.3 0.7 1.9 4.4 1.9 1.4 1.8 1.6 1.5 1.9 1.5 1.4 0.1 1.8 2.7 4.4 1.5 1.7 1.7 0.3 0.7 1.1 0.4 2.4 0.1 1.4 1.4 0.6 0.5 0.4 5.8 1.6 1.1 0.8 1.3 1.1 0.9 1.5 7.6 0.4 1.2 1.0 2.1 1.6 0.5 0.8 2.2 4.0 0.7 4.9 1.8 1.8 1.5 0.6 1.3 6.7 0.4 0.6 1.2 1.4 8.3 0.9 3.3 2.6 0.8 0.7 0.4 1.3 0.0 0.7 0.0 0.2 0.2 0.0 0.0 0.7 0.1 0.9 1.4 0.4 0.5 0.0 0.0 1.1 4.1 0.0 0.4 0.7 1.9 1.0 1.0 1.1 1.0 0.7 0.5 3.6 0.7 0.0 0.6 0.0 0.2 0.0 0.8 0.8 0.0 18.7 5.7 0.0 3.9 0.2 0.0 0.5 20.4 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 45.3 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 1.3 1.7 0.0 0.0 48.1 6.6 0.0 0.1 0.0 0.0 0.0 C16orf74 MGC17624 ENSG00000154102 "Chromosome 16 open reading frame 74" Q96GX8 16 85690084-85751129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.6" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 26.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5" "Low region specificity" "Detected in all" HPA049367 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA049367: AB_2680730" "unprognostic (1.16e-1)" "unprognostic (2.21e-2)" "unprognostic (6.74e-3)" "unprognostic (2.15e-3)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.08e-3)" "unprognostic (4.22e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.40e-1)" "unprognostic (1.76e-3)" "unprognostic (2.51e-1)" "unprognostic (3.55e-1)" "unprognostic (2.15e-2)" "unprognostic (9.07e-3)" 2.7 0.7 6.3 5.6 3.9 9.3 6.8 0.6 3.3 4.7 3.0 1.4 10.8 1.5 2.1 3.7 6.8 1.5 2.4 1.8 9.2 1.7 2.0 0.8 2.0 11.7 2.0 2.1 0.9 2.1 3.9 1.0 44.6 1.6 7.1 1.3 18.8 4.5 9.5 1.5 6.3 4.2 3.9 1.5 12.9 3.0 1.4 1.5 0.4 4.7 6.2 10.3 18.9 10.0 26.3 8.8 10.3 8.2 3.3 8.3 5.4 12.2 4.1 0.1 1.7 1.9 2.1 5.1 1.5 2.0 4.8 1.3 3.1 11.5 0.1 17.4 1.2 2.0 17.7 0.7 34.3 2.7 0.0 2.7 0.0 1.8 0.3 5.2 0.3 0.0 4.5 29.3 4.6 20.1 3.6 15.6 2.1 0.0 0.0 0.1 10.3 0.0 18.7 1.1 13.2 11.8 0.5 0.0 1.0 0.0 14.0 3.9 1.0 6.2 3.2 3.1 1.4 30.5 5.2 15.9 3.1 8.0 1.3 4.4 4.3 3.1 13.5 0.0 4.4 0.6 0.0 8.2 10.3 0.6 2.7 2.2 20.4 4.5 3.6 8.8 26.3 7.6 4.7 3.2 3.3 0.8 0.1 8.3 5.4 6.3 3.9 0.6 3.3 9.2 1.7 2.0 2.1 1.6 1.5 3.0 0.6 38.4 47.6 8.2 17.9 1.2 0.0 1.4 3.4 1.8 55.0 38.4 3.3 2.8 1.3 2.1 0.0 0.0 1.0 13.5 4.8 4.1 0.0 0.0 4.3 14.3 0.0 1.3 0.8 0.0 3.1 1.6 18.6 0.0 0.0 8.8 2.2 0.0 3.2 1.7 69.6 0.0 3.4 0.9 6.4 6.0 62.1 0.9 0.0 43.2 C16orf78 MGC33367 ENSG00000166152 "Chromosome 16 open reading frame 78" Q8WTQ4 16 49373823-49399431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 96 "testis: 30.6" "Group enriched" "Detected in some" 116 "Early spermatids: 327.3;Late spermatids: 1170.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 327.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1170.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.5 0.0 5.9 1.9 0.0 0.0 0.0 0.0 0.0 C16orf86 FLJ41802 ENSG00000159761 "Chromosome 16 open reading frame 86" Q6ZW13 16 67666816-67668758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.9" "Group enriched" "Detected in many" 7 "Early spermatids: 83.1;Spermatocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 7.0;T-47d: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA073475 Enhanced NA NA "HPA073475: AB_2686607" "unprognostic (1.01e-2)" "unprognostic (1.38e-2)" "unprognostic (6.33e-2)" "unprognostic (5.20e-2)" "unprognostic (2.16e-1)" "unprognostic (9.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.87e-2)" "unprognostic (4.05e-1)" "unprognostic (8.35e-3)" "prognostic favorable (1.47e-4)" "unprognostic (1.59e-1)" "prognostic favorable (2.12e-7)" "unprognostic (1.34e-1)" "unprognostic (4.22e-1)" "unprognostic (5.92e-2)" "unprognostic (3.05e-1)" 4.6 3.4 2.0 2.9 5.9 1.6 2.6 8.6 4.0 2.5 2.9 2.6 5.8 0.9 3.0 4.2 2.8 2.8 4.7 4.1 1.9 2.3 3.7 3.6 2.4 3.6 2.6 2.1 2.3 1.9 4.6 2.2 2.4 3.9 3.5 1.3 2.6 2.9 3.1 6.7 1.3 1.9 2.6 3.0 3.1 1.6 26.9 3.0 4.5 2.6 1.3 2.2 2.9 1.8 5.9 10.2 4.1 3.3 1.2 2.6 2.5 0.3 1.0 1.4 0.5 2.0 1.8 1.3 1.8 3.6 0.8 1.2 0.1 0.0 0.1 0.9 1.9 0.0 0.2 0.2 0.4 0.3 0.0 0.2 0.2 0.2 0.0 3.7 0.1 1.9 7.0 0.2 1.5 0.2 1.2 1.6 3.0 0.3 4.3 1.8 0.0 0.2 0.9 0.6 0.6 0.0 2.6 0.0 3.0 4.3 0.2 1.0 0.5 0.0 0.0 0.2 0.3 4.4 0.6 0.1 0.2 0.1 0.9 0.1 0.5 1.2 1.2 1.5 0.2 0.3 1.7 3.3 4.1 1.1 1.0 1.8 2.9 2.6 1.5 5.3 5.9 0.9 1.7 1.1 1.2 1.1 10.2 1.8 2.5 2.0 5.9 8.6 4.0 1.9 2.3 2.6 2.1 3.9 3.0 0.0 3.0 8.1 3.0 1.3 7.1 1.4 2.5 0.0 2.3 5.2 5.9 1.1 6.6 2.1 83.1 4.6 0.0 0.0 0.6 0.4 4.3 0.8 11.5 2.9 5.3 4.8 2.9 8.6 4.8 10.7 5.2 3.4 3.3 6.4 0.6 10.4 0.9 0.0 7.1 10.9 7.4 0.0 2.3 77.5 2.7 1.4 0.7 4.4 0.3 0.8 C16orf89 MGC45438 ENSG00000153446 "Chromosome 16 open reading frame 89" Q6UX73 16 5044122-5066110 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.8;thyroid gland: 79.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 2: 191.8;Club cells: 122.8;Distal tubular cells: 96.2" "Group enriched" "Detected in many" 14 "lung cancer: 64.7;thyroid cancer: 145.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.9;Hep G2: 5.9;HHSteC: 3.1;NTERA-2: 3.6;U-2197: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013613, HPA016934" Enhanced "Secreted to blood" NA NA 1200000 "HPA013613: AB_1845584, HPA016934: AB_2732417" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.97e-1)" "unprognostic (6.29e-2)" "unprognostic (3.79e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (1.01e-2)" "unprognostic (9.23e-2)" "unprognostic (2.65e-1)" "unprognostic (6.39e-2)" "unprognostic (3.25e-2)" "unprognostic (6.64e-3)" "unprognostic (3.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (8.48e-3)" 6.0 1.7 7.7 4.4 9.3 0.3 4.7 5.1 8.6 7.3 2.3 5.2 0.3 5.9 1.4 30.3 2.5 4.6 15.3 7.1 6.1 3.0 5.6 0.3 35.8 0.5 6.2 7.4 1.9 8.2 0.3 1.9 0.5 5.3 4.0 1.9 5.0 11.5 0.6 0.2 0.4 2.8 6.2 7.4 0.4 28.0 1.4 2.9 0.0 79.3 2.7 1.4 4.3 1.8 1.1 0.9 3.3 0.5 1.3 0.6 0.2 0.1 0.2 0.0 0.4 4.9 0.1 0.8 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.4 0.6 1.4 5.9 3.1 0.2 0.5 1.4 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.3 0.0 0.3 1.6 0.7 3.6 0.0 0.1 0.5 0.1 0.3 0.0 0.5 0.6 0.4 0.3 0.7 1.1 0.7 0.4 0.0 0.2 0.6 0.3 5.0 0.3 0.4 0.2 0.1 0.4 0.2 0.1 3.3 0.5 0.7 0.4 0.4 0.3 0.7 0.4 0.4 0.2 1.1 0.5 0.6 1.9 1.3 0.2 0.9 0.3 0.2 7.7 9.3 5.1 8.6 6.1 3.0 6.2 7.4 5.3 2.9 41.7 191.8 0.0 1.8 0.3 0.2 2.6 0.0 29.4 122.8 0.0 0.0 0.1 96.2 0.0 1.4 0.0 0.0 0.0 7.2 0.1 7.0 3.7 4.7 0.0 4.6 0.0 0.0 0.0 0.0 1.2 8.6 0.6 0.0 0.0 0.3 0.1 0.7 0.0 13.8 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.8 C16orf90 LOC646174 ENSG00000215131 "Chromosome 16 open reading frame 90" A8MZG2 16 3493484-3495480 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 111 "testis: 27.8" "Group enriched" "Detected in some" 9 "Early spermatids: 189.7;Late spermatids: 419.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.4;NTERA-2: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (1.96e-2)" "unprognostic (1.03e-3)" "unprognostic (3.17e-1)" "unprognostic (2.18e-1)" "unprognostic (1.08e-1)" "unprognostic (9.33e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (6.29e-3)" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.7 0.0 1.4 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 0.5 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 189.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 419.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 33.8 2.2 0.0 0.0 0.0 0.0 0.0 C16orf92 FLJ25404 ENSG00000167194 "Chromosome 16 open reading frame 92" Q96LL3 16 30023334-30027736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.0" "Group enriched" "Detected in some" 27 "Early spermatids: 79.3;Late spermatids: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;MCF7: 2.4;NTERA-2: 2.4;RPMI-8226: 3.9;SCLC-21H: 13.1;SH-SY5Y: 3.0" NA NA "unprognostic (2.48e-1)" "unprognostic (4.97e-2)" 0.1 1.8 0.4 0.1 0.2 0.4 0.1 1.2 3.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 17.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 2.3 0.0 2.4 0.5 0.1 2.4 0.0 0.0 0.6 0.1 3.9 0.0 0.0 13.1 3.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.6 0.8 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.2 0.4 0.4 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 C16orf95 ENSG00000260456 "Chromosome 16 open reading frame 95" Q9H693 16 87083562-87317420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 47.2" "Group enriched" "Detected in many" 9 "Early spermatids: 56.7;Erythroid cells: 23.3;Late spermatids: 77.4;Sertoli cells: 25.8;Spermatocytes: 52.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA040850, HPA067924" Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA040850: AB_10794882, HPA067924: AB_2685924" "unprognostic (3.51e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-2)" "unprognostic (4.30e-2)" "unprognostic (3.92e-2)" "unprognostic (4.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.45e-1)" "unprognostic (1.97e-2)" "unprognostic (1.09e-1)" "unprognostic (6.71e-2)" "unprognostic (1.79e-1)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.61e-2)" "unprognostic (1.23e-1)" 1.5 1.7 1.7 1.0 2.6 2.2 0.8 1.5 2.0 0.5 1.0 1.5 1.2 1.2 0.7 1.2 0.5 0.8 1.2 1.0 1.7 1.4 1.1 2.6 0.7 0.9 1.9 0.9 0.7 2.1 1.0 0.9 0.5 1.8 0.6 0.6 0.9 1.1 1.2 3.0 0.5 1.2 1.2 1.3 0.7 1.1 47.2 1.1 1.2 0.7 0.6 0.9 0.7 0.4 3.4 6.0 1.1 6.0 1.5 5.7 3.2 3.2 9.1 3.2 3.8 3.7 2.2 5.4 3.0 1.2 3.0 2.3 4.4 5.2 8.1 8.6 0.6 3.3 2.7 2.9 2.0 1.4 3.9 5.3 7.6 3.2 5.9 3.2 0.8 1.5 3.8 0.7 3.4 1.1 1.5 2.8 6.0 6.7 4.1 3.6 8.4 2.8 6.9 2.9 2.0 5.5 6.4 1.4 4.6 1.7 1.3 4.0 3.3 7.4 0.4 2.5 1.2 4.5 3.6 3.3 5.5 2.4 3.2 2.8 12.6 10.2 15.4 7.4 7.6 3.7 0.0 4.9 1.1 4.9 4.8 3.6 3.4 4.3 4.5 4.5 2.9 3.5 5.7 0.8 1.5 6.0 6.0 5.1 3.2 1.7 2.6 1.5 2.0 1.7 1.4 1.9 0.9 1.8 1.1 0.0 1.0 2.2 0.4 1.4 2.3 2.0 2.5 1.4 0.0 0.0 2.0 1.9 1.7 2.8 56.7 0.6 4.9 23.3 3.0 2.7 1.1 0.4 0.0 4.2 2.5 1.6 0.0 2.5 1.5 77.4 3.1 1.6 0.0 3.6 2.5 2.4 3.6 2.9 4.9 2.4 2.0 25.8 0.5 52.2 4.3 0.5 0.9 1.5 5.3 0.3 C16orf96 ENSG00000205832 "Chromosome 16 open reading frame 96" A6NNT2 16 4556490-4600714 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 36.0" "Group enriched" "Detected in some" 4 "Early spermatids: 7.6;Late spermatids: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;REH: 4.2;SCLC-21H: 2.0;U-266/70: 1.4" NA NA "unprognostic (2.94e-3)" "unprognostic (1.55e-1)" "unprognostic (3.57e-4)" "unprognostic (1.12e-1)" "unprognostic (4.47e-2)" "unprognostic (5.21e-3)" "unprognostic (1.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.26e-1)" "unprognostic (1.36e-2)" "unprognostic (1.06e-5)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.22e-1)" "unprognostic (9.23e-2)" "unprognostic (4.24e-4)" "unprognostic (2.66e-1)" 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.2 0.6 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.5 0.4 0.1 0.4 0.1 0.1 0.6 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.7 0.1 0.1 0.7 0.1 0.0 36.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.6 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.5 2.4 0.0 0.1 4.2 0.0 0.5 0.0 0.0 2.0 0.2 0.6 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.4 0.1 0.0 1.4 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.4 0.5 0.4 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 C17orf100 LOC388327 ENSG00000256806 "Chromosome 17 open reading frame 100" 17 6651718-6693202 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 18.4" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 26.3;Late spermatids: 35.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.6;SH-SY5Y: 11.5" HPA046824 Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA046824: AB_2679825" "unprognostic (9.24e-3)" "unprognostic (1.79e-1)" "unprognostic (3.16e-1)" "unprognostic (6.37e-3)" "unprognostic (1.56e-1)" "unprognostic (1.90e-2)" "unprognostic (1.19e-1)" "unprognostic (8.99e-2)" "unprognostic (2.69e-1)" "unprognostic (2.02e-3)" "unprognostic (2.58e-3)" "unprognostic (4.72e-2)" "unprognostic (5.54e-3)" "unprognostic (4.52e-2)" "unprognostic (9.68e-2)" "unprognostic (9.44e-2)" "unprognostic (7.65e-2)" 0.8 1.5 1.4 1.6 3.3 0.1 1.4 3.8 5.6 2.3 2.4 4.0 1.2 3.6 1.5 2.8 2.1 1.7 1.5 0.3 1.5 2.2 18.4 1.2 3.5 1.3 2.5 1.1 8.5 2.5 9.1 0.6 3.0 2.2 1.6 0.8 5.2 1.1 0.3 9.3 4.3 0.7 1.6 2.2 2.8 3.6 2.3 1.6 3.3 0.2 1.1 1.7 0.5 5.7 3.1 7.5 2.4 2.5 5.5 1.9 1.3 2.5 5.7 1.8 0.8 1.6 2.7 0.7 4.1 1.7 3.4 3.8 1.8 1.5 2.9 1.3 4.4 4.9 1.1 2.6 2.5 6.5 7.5 1.4 2.6 11.6 2.0 0.2 3.9 2.3 2.5 0.8 1.8 5.0 1.0 8.0 1.8 1.5 2.2 2.8 1.6 2.4 0.8 2.3 1.7 3.1 0.9 2.3 3.4 1.1 5.9 11.5 3.4 0.4 3.9 1.8 3.0 0.4 1.5 1.6 3.3 0.9 1.3 2.1 1.4 1.0 1.4 0.5 3.7 5.7 1.9 7.5 2.5 2.4 3.4 4.3 4.6 2.9 3.1 5.7 5.5 3.0 1.8 2.5 2.3 1.0 3.0 1.9 0.0 1.7 0.0 4.6 2.5 3.7 0.3 0.0 2.7 5.7 0.0 2.0 1.3 1.7 3.4 26.3 1.0 5.9 0.0 2.9 1.4 1.5 3.9 9.2 0.0 1.1 1.6 7.5 0.0 0.0 35.6 0.9 1.0 1.7 1.0 5.4 5.2 2.8 3.5 1.8 2.1 5.2 6.5 2.5 11.1 4.2 2.6 1.3 0.5 3.0 4.7 C17orf107 ENSG00000205710 "Chromosome 17 open reading frame 107" Q6ZR85 17 4899418-4902932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.7;salivary gland: 26.0" "Group enriched" "Detected in many" 11 "Early spermatids: 54.2;Late spermatids: 207.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 6.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 5.5;HMC-1: 7.3;hTCEpi: 6.7" "Not detected" "Not detected" HPA069713 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069713: AB_2686181" "prognostic favorable (5.06e-5)" "unprognostic (1.63e-1)" "unprognostic (2.43e-1)" "unprognostic (1.51e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-3)" "unprognostic (9.61e-2)" "unprognostic (5.03e-2)" "unprognostic (4.15e-1)" "unprognostic (2.05e-1)" "prognostic favorable (8.61e-4)" "unprognostic (1.17e-1)" "prognostic favorable (2.68e-4)" "unprognostic (9.29e-2)" "unprognostic (2.65e-1)" "unprognostic (2.71e-1)" "unprognostic (3.12e-1)" 2.4 3.7 5.0 2.3 5.1 4.2 3.0 7.7 8.7 3.9 1.4 0.2 5.9 2.1 1.9 5.9 1.3 1.8 3.3 15.3 3.8 4.3 2.2 8.8 2.9 1.0 1.6 4.2 6.4 7.7 6.2 25.7 1.5 1.7 4.5 0.9 2.1 26.0 6.4 0.6 3.3 1.6 1.2 2.2 2.1 4.6 4.7 0.6 0.1 1.9 0.6 2.7 3.3 1.9 0.0 0.0 6.7 0.2 0.0 0.9 0.1 0.7 0.8 1.0 0.3 2.2 1.7 1.5 3.9 0.5 0.2 0.6 0.7 0.7 0.4 0.6 5.5 0.0 1.4 0.1 0.5 0.3 0.1 0.8 2.1 0.6 0.8 3.1 0.0 7.3 1.8 6.7 0.1 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.7 0.1 0.6 0.3 1.9 0.8 0.3 0.2 2.9 0.3 0.3 0.1 0.5 0.6 2.3 0.3 0.5 0.7 1.1 0.5 0.3 0.7 0.6 0.5 0.6 0.6 0.1 0.5 0.1 0.3 0.0 0.2 0.8 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.8 6.7 0.0 0.1 0.0 0.0 0.1 5.0 5.1 7.7 8.7 3.8 4.3 1.6 4.2 1.7 0.6 0.0 2.2 0.9 2.5 1.5 0.5 12.3 0.0 0.0 1.2 0.0 0.0 0.3 1.7 0.3 54.2 0.7 0.0 0.0 1.1 1.6 2.2 2.2 11.5 3.4 0.9 4.8 0.0 0.6 1.5 207.3 1.4 4.3 1.7 0.0 1.6 0.0 0.8 0.0 1.1 1.6 0.6 0.0 3.1 1.0 1.1 1.1 4.3 0.7 0.2 0.9 C17orf47 FLJ40121 ENSG00000181013 "Chromosome 17 open reading frame 47" Q8NEP4 17 58541587-58544368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 26.7" "Group enriched" "Detected in some" 57 "Early spermatids: 7.5;Late spermatids: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;hTERT-RPE1: 1.1;Karpas-707: 1.5;MCF7: 2.6;SCLC-21H: 1.5;T-47d: 1.6" HPA028424 Uncertain NA NA "HPA028424: AB_10601690" "unprognostic (4.97e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (2.65e-1)" "unprognostic (4.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.62e-3)" "unprognostic (4.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.62e-8)" "unprognostic (9.29e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-3)" "unprognostic (3.37e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.3 0.1 0.1 0.1 0.1 0.5 0.0 0.3 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.4 0.3 26.7 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 2.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.4 0.0 1.5 0.0 2.6 0.0 0.1 0.1 0.3 0.3 0.2 0.0 0.0 0.0 0.1 1.5 0.3 0.1 0.2 0.0 0.4 1.6 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 C17orf50 ENSG00000270806 "Chromosome 17 open reading frame 50" Q8WW18 17 35760897-35765079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 63.6" "Group enriched" "Detected in some" 88 "Early spermatids: 590.0;Late spermatids: 956.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.3;dendritic cells: 3.5;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "HaCaT: 10.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA043184, HPA063464" Supported Nucleoplasm Yes NA Nucleoplasm "HPA043184: AB_2678358, HPA063464: " "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (4.36e-2)" "unprognostic (4.01e-2)" "unprognostic (5.84e-2)" "unprognostic (5.12e-3)" "unprognostic (2.04e-2)" "unprognostic (1.97e-2)" "unprognostic (7.94e-2)" "unprognostic (5.36e-2)" "unprognostic (1.14e-2)" "unprognostic (2.71e-1)" "unprognostic (6.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.5 0.0 0.6 0.2 3.7 0.6 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.6 0.0 0.3 0.0 0.5 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.6 1.9 2.3 2.0 1.2 0.0 1.9 3.5 3.7 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 590.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 956.8 7.8 0.0 0.0 0.0 0.6 1.0 0.0 0.0 5.3 0.5 0.0 6.5 0.0 8.4 6.1 0.0 0.0 0.0 0.6 0.1 C17orf51 "FLJ12977, FLJ31874, FLJ33618" ENSG00000212719 "Chromosome 17 open reading frame 51" A8MQB3 17 21524790-21574458 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 41.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 20.9;Early spermatids: 18.9;Horizontal cells: 23.8;Rod photoreceptor cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA052106 Enhanced Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA052106: AB_2681728" "unprognostic (1.99e-1)" "unprognostic (5.29e-2)" "unprognostic (6.35e-3)" "unprognostic (2.78e-3)" "unprognostic (3.72e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-3)" "unprognostic (5.80e-2)" "unprognostic (2.55e-1)" "unprognostic (1.53e-1)" "unprognostic (2.51e-3)" "unprognostic (7.42e-3)" "unprognostic (2.29e-2)" "unprognostic (1.23e-1)" "unprognostic (3.17e-1)" "unprognostic (6.42e-5)" "unprognostic (9.05e-3)" 6.1 7.2 8.0 4.2 8.4 0.8 3.0 41.2 20.5 5.3 4.5 5.2 3.1 3.2 8.3 10.1 3.2 6.7 3.6 6.5 8.6 7.3 4.0 3.8 3.0 3.0 5.9 8.1 5.9 6.6 7.8 8.9 2.1 5.5 6.3 3.2 3.8 5.0 7.0 7.3 3.0 2.4 6.6 5.0 3.3 4.1 9.2 5.9 1.2 2.9 2.2 3.0 4.0 4.7 4.2 4.1 1.2 3.9 2.6 6.0 1.8 2.6 6.2 2.3 8.0 7.4 7.0 2.2 7.2 3.6 5.2 6.0 12.2 0.4 3.5 4.1 3.9 6.4 0.3 9.9 3.8 8.7 11.1 15.4 0.7 5.7 5.1 13.8 0.9 3.9 6.6 3.4 10.6 11.6 1.9 3.7 9.5 1.9 0.8 4.4 0.0 7.7 0.4 4.4 3.3 5.2 7.5 4.9 0.5 1.9 0.5 5.2 0.9 6.7 0.2 5.3 8.7 0.1 0.3 6.7 6.2 6.3 14.7 8.6 2.3 2.8 13.7 7.4 1.3 7.2 0.0 3.9 0.0 4.0 1.8 3.1 2.2 1.9 1.8 1.9 4.2 6.0 5.1 1.2 2.6 1.0 4.1 1.7 1.8 8.0 8.4 41.2 14.5 8.6 7.3 5.9 8.1 5.5 5.9 0.0 0.6 1.5 4.4 4.4 20.9 3.3 0.0 4.0 2.3 1.8 15.7 0.4 5.0 1.8 18.9 2.8 0.0 0.0 3.1 1.5 6.1 2.9 0.0 2.6 1.1 23.8 1.2 1.3 0.3 11.5 5.8 1.3 5.0 0.0 1.3 5.2 1.6 0.0 7.8 2.1 28.0 0.0 7.9 13.0 6.5 1.9 0.2 0.9 0.9 1.2 C17orf53 MGC3130 ENSG00000125319 "Chromosome 17 open reading frame 53" Q8N3J3 17 44141906-44162476 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA synthesis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1" "Cell type enhanced" "Detected in some" 12 "Extravillous trophoblasts: 7.0;Late spermatids: 5.5;Spermatocytes: 8.9;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA023004, HPA023393, HPA024430" Uncertain Approved Nucleoplasm,Cytosol NA Yes "Nucleoplasm, Cytosol" "HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879" "unprognostic (1.72e-1)" "unprognostic (5.95e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.59e-1)" "unprognostic (7.37e-2)" "prognostic unfavorable (3.46e-4)" "prognostic unfavorable (9.39e-4)" "unprognostic (1.90e-1)" "unprognostic (2.89e-1)" "unprognostic (3.66e-4)" "unprognostic (2.86e-1)" "unprognostic (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (5.88e-2)" "unprognostic (3.65e-2)" "unprognostic (8.40e-2)" 2.0 0.7 0.5 3.5 0.4 13.4 2.0 2.8 1.4 1.2 1.5 0.6 0.5 1.4 1.3 1.1 4.0 0.9 1.4 1.9 0.8 0.7 0.8 0.8 1.3 2.4 0.5 0.2 1.3 1.2 0.7 0.7 2.3 1.0 1.0 1.7 0.6 1.1 1.1 1.8 2.4 2.2 1.1 0.5 1.9 1.0 32.1 0.4 8.2 0.5 1.5 4.8 0.8 1.7 1.4 3.7 0.9 1.1 0.3 2.0 0.6 7.5 9.5 7.5 6.7 0.6 2.1 8.9 5.9 5.2 11.5 12.6 9.7 4.7 8.1 5.3 5.2 12.0 6.6 9.7 9.4 10.2 9.1 12.2 5.2 8.7 6.5 0.3 5.7 6.5 1.7 1.4 14.2 7.1 1.5 4.8 8.9 11.7 10.6 5.6 5.6 13.5 8.5 5.1 3.5 9.3 8.5 12.0 10.0 2.7 6.1 4.7 2.7 3.6 3.6 2.9 8.9 7.2 6.6 2.2 11.1 8.7 7.5 8.6 6.1 10.2 7.0 5.2 4.4 6.3 0.0 1.1 0.9 1.1 0.8 0.4 0.8 0.8 0.2 0.4 1.4 0.6 0.4 0.0 0.3 0.4 3.7 2.0 0.6 0.5 0.4 2.8 1.4 0.8 0.7 0.5 0.2 1.0 0.4 0.0 0.0 0.5 0.6 1.6 0.2 0.8 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.5 2.5 0.1 0.0 0.0 0.2 7.0 0.7 0.3 0.0 0.2 2.5 0.0 0.0 0.0 0.0 5.5 0.3 0.0 0.0 0.0 0.2 0.5 0.7 0.0 1.1 0.2 0.0 0.0 0.3 8.9 13.0 1.0 1.5 0.0 0.6 0.3 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 74.5" "Cell type enhanced" "Detected in some" 30 "Early spermatids: 846.4;Late spermatids: 397.1;Spermatocytes: 173.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 4 "dendritic cells: 5.8;granulocytes: 2.5" "Cell line enhanced" "Detected in some" "JURKAT: 2.4;MCF7: 11.0;THP-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA044415 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 74.5 0.1 0.2 0.0 0.1 0.1 0.0 0.0 1.0 5.8 2.5 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.0 0.0 0.6 0.7 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.6 0.0 11.0 0.3 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 2.7 0.3 0.0 0.1 0.1 0.0 1.7 1.3 0.2 0.0 1.5 0.0 0.0 0.6 0.0 0.1 0.5 0.0 1.0 0.3 0.0 1.8 0.2 0.0 0.6 2.5 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 846.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 397.1 8.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 173.7 15.3 0.1 0.0 0.0 0.0 0.0 C17orf67 ENSG00000214226 "Chromosome 17 open reading frame 67" Q0P5P2 17 56791913-56838773 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 24.4" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 10.0;MOLT-4: 15.3;PC-3: 10.6" "Region enriched" "Detected in single" 5 "olfactory region: 3.8" "Low region specificity" "Detected in many" HPA043479 Approved "Secreted - unknown location" NA NA "HPA043479: AB_10964083" "unprognostic (2.78e-2)" "unprognostic (5.24e-2)" "unprognostic (1.83e-1)" "unprognostic (3.54e-3)" "unprognostic (1.69e-3)" "unprognostic (1.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.47e-1)" "unprognostic (4.63e-2)" "unprognostic (2.82e-3)" "unprognostic (9.64e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-5)" "unprognostic (2.49e-1)" "unprognostic (3.27e-1)" "unprognostic (2.20e-2)" "unprognostic (1.43e-3)" 3.2 1.9 5.5 3.4 7.3 1.0 7.4 9.9 6.2 5.1 2.2 2.0 3.5 1.9 5.2 4.0 2.4 3.3 4.8 2.2 5.2 2.9 2.1 3.3 3.1 3.9 6.4 1.6 4.4 3.3 2.1 3.2 2.2 5.8 4.9 1.4 1.3 2.8 3.5 1.7 2.0 2.7 4.8 3.6 6.9 2.8 3.8 8.5 9.1 2.4 0.5 2.7 5.2 24.4 3.8 1.1 0.9 0.8 0.6 3.9 1.0 3.3 2.2 1.4 1.5 0.7 1.0 0.6 2.0 2.5 1.7 2.0 2.7 1.1 1.8 3.5 0.8 1.8 1.7 1.0 0.5 1.7 10.0 3.7 1.7 2.3 1.7 0.9 1.3 3.4 0.4 2.7 1.2 1.1 1.3 1.7 3.6 1.6 8.6 1.1 2.6 15.3 2.3 1.3 1.0 10.6 3.3 2.7 1.9 1.2 0.9 0.7 1.8 2.0 0.4 1.0 0.5 2.2 0.9 2.3 1.8 4.5 1.2 1.4 3.6 8.9 1.0 1.3 1.5 0.6 0.0 0.5 0.9 0.6 0.7 1.2 3.8 1.9 2.6 0.4 2.3 2.0 2.5 0.8 0.6 0.8 1.1 3.9 1.0 5.5 7.3 9.9 6.2 5.2 2.9 6.4 1.6 5.8 8.5 3.0 0.0 7.8 11.9 2.1 10.8 0.8 10.2 1.4 0.0 7.0 13.7 0.1 0.0 2.8 7.5 10.1 5.4 0.0 1.2 0.7 2.8 10.1 1.1 4.4 2.3 4.8 8.5 4.3 6.1 5.3 7.2 3.2 1.7 4.6 2.0 2.4 1.9 2.5 1.1 0.0 18.8 0.0 3.1 11.5 6.8 1.5 0.2 6.4 1.7 5.5 C17orf78 FLJ39647 ENSG00000278505 "Chromosome 17 open reading frame 78" Q8N4C9 17 37375986-37392708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 401 "intestine: 83.8" "Cell type enhanced" "Detected in some" 14 "Late spermatids: 1.5;Spermatocytes: 1.4" "Group enriched" "Detected in some" 8 "colorectal cancer: 0.8;stomach cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;NB-4: 1.6;RPMI-8226: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.73e-3)" "unprognostic (1.91e-1)" "unprognostic (8.98e-2)" "unprognostic (4.90e-3)" "unprognostic (5.31e-2)" "unprognostic (7.83e-2)" "unprognostic (2.59e-2)" "unprognostic (2.02e-1)" "unprognostic (7.62e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (5.53e-6)" "unprognostic (1.94e-2)" "unprognostic (7.23e-3)" "unprognostic (4.85e-2)" "unprognostic (3.19e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.2 0.0 1.6 0.2 0.0 0.3 0.2 0.1 1.5 0.1 0.0 0.9 0.7 0.2 0.0 0.2 0.0 0.3 0.0 0.3 0.1 0.1 0.8 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410327-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.2" "Group enriched" "Detected in many" 11 "Early spermatids: 432.9;Late spermatids: 984.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 8.9;U-2197: 11.8" HPA023583 Approved Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.1 4.9 6.0 2.4 10.6 1.9 2.7 5.2 8.7 3.9 3.6 4.2 4.4 2.2 3.5 4.5 2.4 13.6 6.6 3.8 5.2 6.1 7.6 1.9 3.8 2.8 4.0 7.6 3.8 3.8 3.4 8.2 1.4 6.2 3.3 2.9 4.2 3.5 5.8 4.3 2.5 4.7 1.9 2.8 2.1 2.4 53.2 2.9 5.0 6.9 1.8 1.9 3.1 1.8 0.4 0.9 2.7 0.4 0.8 1.4 0.2 2.6 3.8 1.8 2.2 1.0 0.8 0.9 2.0 1.3 1.5 0.9 0.1 4.0 0.7 1.5 4.3 1.2 8.9 4.8 1.0 1.4 0.3 0.6 1.9 3.3 0.3 3.4 0.4 0.8 1.0 2.5 3.3 0.4 2.2 1.5 4.4 0.3 0.1 1.0 2.2 6.4 3.4 2.8 7.9 1.2 0.7 0.4 2.4 6.2 2.2 0.6 2.1 2.4 3.4 0.5 3.2 2.0 2.9 1.4 1.8 0.9 11.8 0.8 0.2 0.2 0.0 2.3 0.9 1.1 0.4 0.4 2.7 0.3 0.2 0.0 0.2 0.2 0.8 0.5 0.4 1.4 1.3 0.2 0.8 0.4 0.9 0.0 0.2 6.0 10.6 5.2 8.7 5.2 6.1 4.0 7.6 6.2 2.9 3.0 5.1 0.0 3.8 3.0 4.3 5.3 10.2 62.9 11.4 19.2 19.6 0.9 53.0 10.2 432.9 1.8 10.5 23.3 3.1 0.2 3.7 3.9 2.3 4.7 1.7 1.6 15.4 1.8 0.0 984.3 7.8 2.5 3.3 4.6 9.3 10.0 4.7 5.8 6.0 19.3 22.2 6.5 2.1 58.4 13.3 0.9 0.7 0.0 8.5 0.9 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835088-38841455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 10.7" "Cell type enriched" "Detected in some" 14 "Early spermatids: 184.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "hTCEpi: 7.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" NA NA "Intermediate filaments" Nucleoli "HPA051696: AB_2681576" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 1.3 0.5 0.4 0.4 0.2 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 0.0 7.9 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.0 1.2 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.0 1.0 0.5 0.0 1.3 0.3 0.5 0.0 0.2 0.2 0.5 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 184.7 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.2 1.3 0.0 0.0 0.0 0.0 0.0 C17orf99 "GLPG464, UNQ464" ENSG00000187997 "Chromosome 17 open reading frame 99" Q6UX52 17 78146353-78166177 "Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 13.5" "Cell type enriched" "Detected in some" 53 "Erythroid cells: 93.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.2;non-classical monocyte: 1.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "HaCaT: 5.6;HMC-1: 11.6;K-562: 6.5" HPA029655 Uncertain "Secreted to blood" NA NA "HPA029655: AB_10601691" "unprognostic (3.55e-5)" "unprognostic (1.87e-2)" "unprognostic (2.06e-1)" "unprognostic (1.22e-1)" "unprognostic (1.88e-1)" "unprognostic (1.45e-3)" "unprognostic (1.47e-3)" "unprognostic (2.39e-1)" "unprognostic (3.86e-1)" "unprognostic (9.77e-2)" "unprognostic (2.05e-2)" "unprognostic (5.13e-2)" "unprognostic (1.38e-4)" "unprognostic (6.58e-2)" "unprognostic (4.72e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" 0.2 0.0 0.1 0.1 0.1 13.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.7 0.9 0.1 0.1 0.1 0.0 0.1 0.1 1.6 1.2 0.1 0.1 0.6 0.1 0.0 0.1 1.9 0.1 0.2 0.0 0.1 0.4 0.1 0.1 2.0 0.6 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.1 0.1 1.1 1.9 0.9 1.2 0.0 0.0 1.1 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 11.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.2 0.1 0.7 0.0 0.0 0.0 1.2 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 93.5 0.4 0.4 0.4 0.5 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.6 0.2 0.0 0.1 0.6 C18orf25 "ARKL1, MGC12909, RNF111L1" ENSG00000152242 "Chromosome 18 open reading frame 25" Q96B23 18 46173553-46266991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051314, HPA051899" Approved Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA051314: AB_2681438, HPA051899: AB_2681657" "unprognostic (1.44e-2)" "unprognostic (2.32e-1)" "unprognostic (2.08e-2)" "unprognostic (5.77e-3)" "unprognostic (4.46e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.97e-1)" "unprognostic (7.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.43e-1)" "unprognostic (5.80e-2)" "unprognostic (3.27e-2)" "unprognostic (1.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" 5.3 4.9 5.8 6.4 8.2 18.6 6.5 10.1 10.1 6.1 4.9 5.5 6.5 4.4 7.7 5.3 54.0 6.2 3.8 11.4 4.8 4.9 5.4 6.2 5.9 6.8 5.3 6.5 5.9 5.0 15.3 6.3 7.3 8.3 5.2 5.7 9.5 11.3 4.8 13.1 6.2 5.5 5.7 4.7 6.3 5.1 7.8 5.7 8.2 7.4 10.2 11.8 7.2 12.7 8.1 11.0 19.0 11.0 2.8 11.1 5.5 11.2 11.3 9.5 10.8 6.8 6.2 12.2 16.4 8.7 17.6 15.0 8.7 13.0 8.7 15.7 11.1 6.3 25.8 17.6 11.1 19.2 14.5 5.6 7.6 9.7 6.5 11.8 14.3 10.4 5.7 13.1 20.5 17.1 10.3 6.9 8.2 8.5 10.4 9.7 8.5 10.8 7.3 8.4 3.9 4.5 9.9 11.3 12.8 16.9 20.4 13.4 7.0 12.0 8.6 8.5 12.1 5.6 8.9 10.1 16.1 11.5 3.9 15.1 13.7 11.6 14.1 8.3 15.2 17.2 4.2 7.5 15.4 5.7 8.4 9.9 5.9 11.1 8.6 7.4 8.1 8.0 6.3 19.0 2.8 11.0 11.0 7.1 5.5 5.8 8.2 10.1 10.1 4.8 4.9 5.3 6.5 8.3 5.7 11.9 10.8 11.5 9.5 22.3 13.2 26.0 10.2 8.1 4.5 14.0 19.6 5.7 1.7 7.4 2.1 15.5 9.5 0.0 5.7 8.3 10.4 10.0 15.0 12.5 7.9 12.7 11.5 8.0 10.4 2.5 7.5 11.4 6.8 4.6 8.3 9.8 14.0 10.5 9.9 6.5 29.9 19.4 10.8 16.7 12.4 27.9 20.4 11.7 9.2 16.9 C18orf54 "LAS2, MGC33382" ENSG00000166845 "Chromosome 18 open reading frame 54" Q8IYD9 18 54357917-54385218 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 21.4;testis: 25.2" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 73.3;Extravillous trophoblasts: 22.1;Late spermatids: 23.0;Spermatocytes: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040704 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA040704: AB_10959454" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (5.29e-2)" "unprognostic (8.63e-3)" "unprognostic (2.40e-1)" "unprognostic (1.05e-1)" "unprognostic (5.60e-6)" "unprognostic (1.11e-2)" "unprognostic (7.85e-3)" "unprognostic (2.55e-2)" "unprognostic (5.91e-3)" "unprognostic (1.13e-2)" "unprognostic (3.06e-5)" "unprognostic (2.29e-1)" "unprognostic (4.21e-1)" "unprognostic (1.28e-2)" "unprognostic (7.05e-2)" 2.9 1.3 2.8 4.8 7.7 2.0 2.1 4.5 4.3 4.1 2.4 3.8 1.0 1.3 3.6 1.1 2.0 1.9 2.1 2.0 3.3 2.2 1.6 0.9 2.5 4.0 10.0 3.4 2.5 1.1 1.9 1.0 21.4 5.7 1.8 2.3 0.7 1.4 1.6 1.0 1.8 2.0 2.7 5.8 4.3 1.5 25.2 6.7 9.3 1.9 1.2 4.0 2.1 3.2 1.4 0.6 1.9 4.1 0.8 2.1 0.6 5.8 3.4 14.6 6.9 3.6 6.3 4.9 9.7 4.2 9.8 12.6 2.2 3.1 4.3 2.7 3.2 4.3 6.3 10.1 5.3 12.8 14.4 3.2 4.2 3.7 3.7 0.8 4.8 4.6 2.1 1.1 13.3 6.2 4.2 11.7 5.7 4.4 9.4 14.0 1.8 5.2 3.0 7.2 1.1 6.7 4.0 10.8 3.0 4.8 4.0 8.1 4.6 4.0 1.7 2.2 8.7 2.5 4.1 10.5 18.2 8.0 3.0 5.3 5.7 6.4 6.4 4.8 8.2 12.8 1.9 0.7 0.3 1.3 0.8 1.2 0.9 1.1 0.9 0.6 1.4 1.0 1.2 0.0 0.8 4.1 0.3 2.1 0.6 2.8 7.7 4.5 4.3 3.3 2.2 10.0 3.4 5.7 6.7 0.0 1.1 0.0 0.6 0.3 1.6 1.2 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.1 73.3 2.6 0.1 0.0 0.2 22.1 1.5 0.3 0.0 0.0 2.1 0.0 0.0 4.9 2.8 23.0 1.4 1.7 1.7 1.8 0.6 2.3 0.3 0.0 0.7 0.2 0.7 0.0 1.4 34.4 16.0 0.4 1.7 0.7 0.8 0.7 C18orf63 DKFZP781G0119 ENSG00000206043 "Chromosome 18 open reading frame 63" Q68DL7 18 74315813-74359187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 17.4" "Cell type enriched" "Detected in some" 14 "Spermatocytes: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.1" "Not detected" "Not detected" HPA042233 Approved Mitochondria NA NA Mitochondria "HPA042233: AB_10960843" "unprognostic (1.40e-1)" "unprognostic (1.43e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 47.2 3.4 0.0 0.0 0.0 0.0 0.0 C19orf12 "DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43" ENSG00000131943 "Chromosome 19 open reading frame 12" Q9NSK7 19 29698886-29715789 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 57.4" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046930 Approved Supported Cytosol NA NA Cytosol "HPA046930: AB_10962836" "unprognostic (1.76e-1)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.01e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.54e-1)" "unprognostic (9.94e-3)" "unprognostic (7.93e-3)" "unprognostic (5.27e-2)" "unprognostic (1.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (3.22e-1)" "unprognostic (1.22e-3)" 57.4 14.7 11.9 7.6 11.3 2.3 33.9 10.5 14.3 7.2 7.7 5.8 5.4 10.8 7.1 7.6 7.5 6.2 8.7 14.0 9.5 11.6 11.5 36.9 5.6 11.4 10.3 10.7 7.8 9.6 7.7 6.9 7.4 11.1 6.7 5.5 10.5 9.5 7.6 27.5 8.2 9.6 7.6 6.5 7.5 6.0 4.2 5.2 8.9 5.4 9.2 7.4 7.2 11.0 3.7 4.3 2.3 2.1 5.6 14.3 6.0 10.5 20.9 10.3 12.8 25.6 15.9 15.9 12.5 12.5 12.6 16.4 10.0 4.3 8.6 13.4 15.8 11.4 4.6 8.6 5.3 8.5 22.6 15.1 9.6 6.9 17.2 14.4 7.4 12.8 18.1 11.2 7.5 6.1 10.1 11.3 5.4 7.3 11.2 13.0 7.3 5.2 5.4 6.1 9.2 5.2 10.3 10.6 6.6 9.6 10.6 6.3 13.3 7.5 9.8 19.6 11.0 4.1 8.3 11.3 26.7 20.8 10.8 11.3 15.8 14.0 6.4 15.9 4.5 11.1 0.9 2.0 1.0 14.3 2.1 8.2 3.7 8.1 10.2 1.8 3.2 8.5 10.5 2.3 5.6 2.1 4.3 9.7 6.0 11.9 11.3 10.5 14.3 9.5 11.6 10.3 10.7 11.1 5.2 11.9 13.6 13.0 9.8 11.3 15.3 26.8 2.5 8.1 7.9 8.7 5.9 25.1 13.3 15.4 1.3 9.0 12.0 0.0 20.0 23.3 16.7 9.2 16.1 57.8 13.4 4.8 3.5 12.9 11.3 1.5 26.7 10.8 10.1 27.1 6.4 10.3 17.3 10.5 27.6 30.5 8.4 6.5 10.3 3.6 4.1 6.8 18.3 17.0 8.1 7.5 C19orf18 MGC41906 ENSG00000177025 "Chromosome 19 open reading frame 18" Q8NEA5 19 57958437-57974534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 22.6" "Cell type enriched" "Detected in many" 5 "Early spermatids: 83.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 4.6;HEK 293: 6.6;RT4: 4.4" "HPA014527, HPA079195" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA014527: AB_1845612, HPA079195: " "unprognostic (5.38e-2)" "unprognostic (6.36e-3)" "unprognostic (3.70e-2)" "prognostic favorable (5.07e-4)" "unprognostic (4.85e-2)" "unprognostic (9.50e-2)" "unprognostic (2.75e-1)" "unprognostic (5.40e-3)" "unprognostic (5.78e-2)" "unprognostic (1.64e-1)" "unprognostic (4.08e-5)" "unprognostic (1.11e-2)" "unprognostic (8.75e-5)" "unprognostic (1.53e-1)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (1.05e-3)" 1.1 1.7 1.4 1.1 1.8 0.4 3.6 1.1 1.1 1.1 1.3 1.1 1.1 0.8 1.4 5.6 1.1 1.8 1.4 4.2 1.9 1.8 1.1 1.1 1.1 1.1 2.1 1.1 1.3 1.1 1.0 3.6 1.1 3.1 2.7 0.8 1.1 1.2 1.6 4.2 1.2 1.1 1.1 2.3 1.1 0.8 22.6 1.1 1.1 1.3 1.1 1.1 1.1 1.1 2.8 1.6 0.7 0.9 0.8 1.2 0.4 0.2 0.0 1.9 4.6 1.1 1.5 1.4 2.2 0.5 0.6 1.4 0.0 0.4 0.5 1.0 0.6 0.5 0.1 0.1 0.0 1.5 0.0 6.6 0.4 0.0 1.5 1.7 0.0 1.1 1.8 2.7 0.1 0.4 1.6 0.3 1.0 0.2 0.0 3.3 0.0 0.9 0.0 0.1 0.0 0.4 1.3 0.0 1.2 1.1 4.4 2.0 0.5 0.9 0.0 0.6 1.5 1.6 1.5 0.9 0.3 0.5 0.6 0.5 0.9 3.9 0.1 0.0 0.0 0.5 0.0 0.6 0.7 0.1 0.2 0.0 2.8 1.0 0.6 1.6 1.3 0.6 1.2 0.5 0.8 0.9 1.0 0.0 0.4 1.4 1.8 1.1 1.1 1.9 1.8 2.1 1.1 3.1 1.1 3.0 2.1 0.0 0.4 0.3 0.5 3.2 0.0 2.7 2.3 0.0 0.0 0.3 0.0 1.7 83.6 1.0 0.4 0.0 0.2 0.5 0.8 0.5 0.0 1.3 0.4 0.0 0.0 3.7 1.0 16.0 2.0 0.0 1.7 1.0 1.8 1.8 0.7 0.0 0.7 0.2 2.8 6.5 1.2 3.5 2.2 0.5 0.2 0.0 1.1 0.3 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304161-38305009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 105.8;tongue: 78.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 11 "myeloid DC: 15.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.1" "Cell line enhanced" "Detected in some" "A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 6.9 0.6 0.5 16.4 0.7 0.3 5.0 0.5 0.8 14.5 58.8 0.6 3.5 34.6 3.9 4.3 88.4 18.2 45.2 9.9 0.8 0.3 5.8 1.0 34.8 0.6 0.7 1.4 4.9 0.8 0.0 2.0 10.0 1.7 10.3 18.2 1.2 21.5 6.8 2.8 53.3 105.8 2.9 3.1 1.9 28.7 1.5 0.5 1.5 4.4 78.5 39.2 16.2 35.1 0.1 15.1 1.4 0.6 0.3 0.4 14.6 70.1 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 66.8 0.0 40.1 0.0 0.0 26.3 0.0 64.8 0.0 0.0 0.0 0.0 22.7 1.8 0.5 0.0 0.0 0.0 67.9 0.0 43.6 0.1 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.1 0.1 57.5 61.8 0.0 0.0 0.0 41.0 20.8 0.1 0.0 41.0 29.7 0.0 0.1 9.2 0.2 14.6 0.0 20.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.6 1.4 0.3 0.0 0.3 0.1 0.2 0.1 15.1 0.1 0.4 0.3 0.9 0.3 0.0 0.9 0.0 14.6 0.5 0.7 0.5 0.8 0.8 0.3 0.7 1.4 1.7 0.5 497.3 155.5 7.0 25.1 200.2 0.0 1.4 298.1 195.4 353.8 52.4 0.0 5.2 1.7 144.5 0.4 9.8 1588.2 0.0 683.1 1.0 5.6 22.7 39.1 0.0 1.3 0.0 73.3 4.9 1.6 2.8 3.7 8.2 1.7 4.6 800.2 0.0 1532.5 1006.5 0.0 21.6 0.0 0.0 5.0 1.4 1.9 304.5 2.6 0.0 506.3 112.5 C19orf38 HIDE1 ENSG00000214212 "Chromosome 19 open reading frame 38" A8MVS5 19 10836575-10869790 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;bone marrow: 54.4" "Cell type enhanced" "Detected in many" 18 "Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7" "Group enriched" "Detected in many" 19 "dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7" "Cell line enriched" "Detected in some" 4 "U-937: 32.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012150, HPA055027" Uncertain "Golgi apparatus,Plasma membrane,Cytosol" No NA Cytosol "Golgi apparatus, Plasma membrane" "HPA012150: AB_10603448, HPA055027: " "unprognostic (6.65e-3)" "prognostic favorable (2.43e-4)" "unprognostic (6.44e-4)" "unprognostic (6.98e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-3)" "unprognostic (3.56e-1)" "unprognostic (8.27e-2)" "unprognostic (5.60e-2)" "unprognostic (6.02e-2)" "unprognostic (9.74e-2)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.75e-7)" "unprognostic (2.31e-1)" "unprognostic (4.00e-2)" "unprognostic (1.03e-2)" "unprognostic (2.11e-2)" 2.7 1.2 2.1 6.9 4.0 54.4 1.8 0.7 3.1 2.0 1.3 4.8 0.0 1.3 0.9 4.0 0.9 2.6 2.1 5.6 2.4 2.1 1.4 2.3 12.8 19.6 4.2 0.6 1.6 1.3 0.3 1.0 1.9 3.8 1.6 1.0 1.5 1.0 0.8 2.3 0.6 1.7 2.3 6.3 22.3 1.2 15.0 3.7 4.1 0.7 0.5 2.0 2.8 3.5 2.1 26.2 37.3 58.7 1.2 0.8 20.7 1.5 0.0 0.1 0.3 1.5 0.8 0.1 0.2 0.0 0.3 0.6 0.1 0.2 3.8 0.3 0.0 0.1 0.1 0.2 0.2 0.2 1.7 0.4 0.2 0.0 0.0 1.1 2.5 0.4 4.1 0.4 0.7 0.2 0.1 0.1 0.4 0.2 8.1 0.1 1.4 0.1 5.9 0.3 0.2 0.3 2.8 0.0 1.9 0.0 0.1 0.2 0.1 0.8 0.0 0.6 0.1 0.1 5.6 0.0 0.0 0.0 0.7 0.0 4.9 2.3 1.1 0.0 32.8 0.0 1.2 44.3 26.1 0.1 48.7 0.2 2.1 0.1 0.1 26.2 1.2 0.8 0.2 37.3 1.2 58.7 0.5 0.3 20.7 2.1 4.0 0.7 3.1 2.4 2.1 4.2 0.6 3.8 3.7 0.0 2.6 12.3 0.3 0.7 0.0 0.6 0.0 2.7 1.2 1.8 2.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 1.1 0.6 1.1 0.4 2.3 0.9 21.2 0.0 0.0 0.0 101.9 5.3 0.9 32.6 1.7 24.4 0.5 2.3 0.2 3.5 0.7 0.4 1.0 6.5 0.1 27.0 15.8 0.6 0.6 0.8 0.3 0.6 C19orf47 FLJ36888 ENSG00000160392 "Chromosome 19 open reading frame 47" Q8N9M1 19 40319536-40348527 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 35.4;skeletal muscle: 118.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 39.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 20.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041843, HPA046309" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA041843: AB_10959886, HPA046309: AB_10960266" "prognostic favorable (6.50e-4)" "unprognostic (1.35e-3)" "unprognostic (1.80e-1)" "prognostic unfavorable (7.10e-5)" "unprognostic (2.75e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.26e-1)" "unprognostic (1.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.47e-2)" "unprognostic (3.25e-2)" "unprognostic (6.23e-2)" "unprognostic (1.62e-2)" "unprognostic (5.28e-2)" "unprognostic (2.77e-1)" "unprognostic (3.28e-2)" 3.2 2.9 4.5 4.2 5.7 4.7 4.4 5.8 9.1 3.5 3.3 9.2 3.6 3.8 3.8 3.1 7.4 2.8 3.5 35.4 4.2 3.8 2.9 4.4 3.4 4.5 6.2 5.0 3.6 3.8 3.7 3.7 4.8 5.6 4.5 2.5 3.6 4.9 4.6 118.0 5.2 3.6 3.7 4.8 3.7 3.0 10.0 5.3 5.0 3.8 6.4 4.7 4.1 5.0 2.1 1.6 20.2 1.6 1.7 2.3 1.3 12.9 19.9 8.4 9.1 5.0 4.5 11.6 13.4 6.2 12.7 15.4 16.5 5.4 15.1 7.5 6.3 6.7 6.5 10.2 12.3 5.3 18.5 12.5 12.3 12.4 12.5 3.7 12.4 8.0 4.5 7.3 17.1 6.1 3.4 7.7 14.1 15.0 8.9 10.7 12.6 18.5 7.0 5.4 10.4 7.6 18.4 13.8 7.6 4.1 11.4 10.8 8.8 14.4 13.6 5.2 5.2 8.1 10.3 10.1 16.0 11.2 10.8 18.3 10.7 14.7 15.0 6.8 11.9 11.0 20.2 1.6 4.7 1.3 1.4 1.6 1.6 2.3 2.1 1.6 2.1 1.6 1.2 5.7 1.7 1.6 1.6 1.6 1.3 4.5 5.7 5.8 9.1 4.2 3.8 6.2 5.0 5.6 5.3 3.0 3.2 0.0 2.4 4.2 2.9 39.1 2.5 1.4 2.3 0.0 2.0 9.1 0.0 3.2 8.0 3.7 2.9 0.0 3.9 11.7 4.7 1.6 4.6 3.8 5.8 3.2 3.5 5.5 5.6 17.1 1.7 2.6 5.0 2.8 2.8 2.9 3.3 0.0 6.3 2.4 1.8 6.5 2.1 14.9 5.5 6.0 13.3 2.2 2.3 1.4 C19orf57 MGC11271 ENSG00000132016 "Chromosome 19 open reading frame 57" Q0VDD7 19 13882348-13906452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.9" "Cell type enhanced" "Detected in many" 10 "Rod photoreceptor cells: 7.7;Spermatocytes: 16.3;Spermatogonia: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;T-cells: 4.9" "Low cell line specificity" "Detected in many" "HPA044012, HPA054615" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044012: AB_10964782, HPA054615: AB_2682543" "unprognostic (1.71e-1)" "unprognostic (3.48e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (2.12e-1)" "prognostic favorable (5.14e-4)" "unprognostic (5.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.06e-1)" "unprognostic (1.36e-1)" "unprognostic (7.60e-2)" "unprognostic (4.43e-2)" "unprognostic (1.57e-4)" "unprognostic (1.21e-3)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (5.73e-2)" 2.5 0.9 4.6 1.9 5.5 4.0 4.2 12.8 9.1 2.6 6.9 5.8 0.8 7.7 1.8 3.7 6.2 5.6 1.9 1.1 5.4 3.1 1.3 2.2 1.6 1.9 7.2 3.7 2.8 10.8 3.3 1.6 0.9 6.3 2.4 3.0 1.4 4.4 1.9 1.3 14.2 5.6 1.2 5.9 1.8 2.9 22.9 4.1 2.3 1.4 0.5 1.8 2.1 4.5 0.1 2.6 0.0 0.2 0.6 4.9 1.1 9.4 0.3 7.2 4.0 2.1 0.4 4.8 2.7 1.1 3.2 3.1 5.9 1.4 10.5 14.8 1.1 1.9 4.8 2.1 0.9 1.1 1.5 4.6 4.4 3.9 0.1 0.6 2.2 9.8 0.4 0.7 2.0 0.3 0.5 0.7 5.9 3.0 4.2 1.0 3.1 8.4 4.9 1.0 3.3 7.2 9.3 2.7 0.6 1.2 2.2 6.3 2.4 10.4 1.9 3.0 0.6 2.0 2.1 0.0 5.9 3.2 13.4 0.7 7.6 1.6 5.3 3.6 7.2 9.0 0.0 0.1 0.0 4.9 0.0 0.5 0.0 0.2 1.1 0.0 0.1 0.4 2.5 0.0 0.6 0.2 2.6 0.0 1.1 4.6 5.5 12.8 9.1 5.4 3.1 7.2 3.7 6.3 4.1 0.0 0.0 0.0 2.6 1.4 1.9 1.2 0.0 0.0 1.2 0.0 2.0 0.4 3.3 0.4 0.5 0.5 1.8 0.0 1.0 0.3 0.8 0.5 0.0 0.0 0.5 1.6 0.0 0.6 0.8 1.4 2.6 0.0 1.7 1.0 2.5 1.4 0.4 5.8 1.8 0.0 7.7 0.0 1.4 16.3 10.0 2.6 0.7 0.0 2.5 1.8 C19orf66 "FLJ11286, IRAV, RyDEN" ENSG00000130813 "Chromosome 19 open reading frame 66" Q9NUL5 19 10086122-10093252 "Predicted intracellular proteins" "Antiviral defense" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 24.9;BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042001 Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042001: AB_10794167" "prognostic favorable (4.04e-4)" "unprognostic (1.21e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (2.19e-2)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (6.57e-2)" "unprognostic (4.22e-3)" "unprognostic (2.34e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (8.96e-11)" "unprognostic (5.92e-2)" "unprognostic (1.81e-1)" "unprognostic (4.41e-3)" "prognostic favorable (1.35e-4)" 9.8 13.8 13.7 17.6 12.1 9.0 9.9 10.6 16.9 14.5 11.2 8.4 10.3 9.6 12.6 14.1 8.9 16.4 15.5 6.9 11.0 13.9 11.5 55.8 11.6 14.4 9.0 13.5 14.5 10.0 14.1 12.8 9.8 10.0 12.4 6.1 11.6 13.0 15.8 3.7 7.6 14.2 9.7 8.6 14.0 8.3 3.7 8.6 9.8 11.9 5.4 13.0 12.9 10.1 8.8 6.7 11.6 12.0 17.5 21.2 10.0 2.8 1.6 1.7 1.3 6.6 8.9 0.7 3.3 18.4 24.9 26.4 0.2 2.4 1.7 1.0 8.7 7.5 1.2 0.8 6.2 0.4 12.0 0.0 5.2 1.2 4.1 12.9 1.8 2.9 16.0 4.6 3.9 0.6 8.3 7.1 7.2 0.7 6.9 5.0 2.3 5.9 3.5 0.4 2.6 2.5 5.4 0.0 3.2 3.7 4.4 0.2 1.5 4.8 0.4 14.1 0.1 0.2 4.7 5.2 2.1 1.0 2.8 0.4 8.4 2.6 0.4 5.7 1.6 4.2 11.1 8.3 11.6 15.9 7.4 21.2 8.8 13.5 17.1 6.7 6.9 11.5 12.1 10.8 17.5 12.0 1.3 13.9 10.0 13.7 12.1 10.6 16.9 11.0 13.9 9.0 13.5 10.0 8.6 20.8 26.6 27.2 22.7 13.4 62.6 2.5 22.9 16.0 37.5 26.2 35.3 4.8 14.9 28.5 8.9 40.5 24.0 0.0 30.6 5.1 30.4 24.7 31.1 94.1 28.7 52.4 17.9 46.1 23.4 23.8 37.7 26.6 16.9 57.7 15.9 33.5 32.5 20.1 35.7 11.1 32.9 71.1 26.4 1.6 3.2 13.2 2.2 64.3 11.5 18.6 C19orf67 ENSG00000188032 "Chromosome 19 open reading frame 67" A6NJJ6 19 14081619-14085875 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 6 "testis: 11.6" "Group enriched" "Detected in some" 41 "Early spermatids: 22.1;Late spermatids: 23.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;BEWO: 1.8;Hep G2: 2.2;hTCEpi: 1.1;U-266/70: 1.1;U-266/84: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.21e-1)" "unprognostic (6.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.45e-4)" "unprognostic (1.25e-1)" "unprognostic (6.81e-2)" "unprognostic (1.41e-1)" "unprognostic (4.76e-3)" "unprognostic (9.22e-2)" "unprognostic (1.65e-3)" "unprognostic (4.20e-3)" "unprognostic (3.74e-1)" "unprognostic (1.63e-2)" "unprognostic (3.25e-1)" "unprognostic (1.36e-1)" "unprognostic (1.51e-2)" "unprognostic (1.94e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.9 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 1.0 0.1 1.4 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.5 1.9 0.3 0.8 0.8 0.3 0.2 0.0 0.2 1.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.9 0.5 2.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.7 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.1 1.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.8 0.4 0.8 1.9 0.8 0.3 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 22.1 0.0 0.0 0.0 0.6 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.1 C19orf71 LOC100128569 ENSG00000183397 "Chromosome 19 open reading frame 71" A6NCJ1 19 3539154-3544030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 88.8" "Group enriched" "Detected in some" 58 "Early spermatids: 515.2;Late spermatids: 237.4" "Cancer enriched" "Detected in all" 5 "melanoma: 23.7" "Region enriched" "Detected in all" 4 "cerebellum: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "HeLa: 27.3;SK-MEL-30: 16.6;WM-115: 59.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048654 Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Endoplasmic reticulum" "HPA048654: AB_2680480" "unprognostic (1.06e-1)" "unprognostic (1.21e-1)" "unprognostic (7.04e-3)" "unprognostic (7.37e-2)" "unprognostic (4.74e-2)" "prognostic favorable (2.35e-4)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (7.23e-2)" "unprognostic (3.13e-2)" "prognostic favorable (2.03e-5)" "unprognostic (6.19e-2)" "prognostic favorable (2.02e-5)" "unprognostic (5.52e-3)" "unprognostic (1.02e-1)" "unprognostic (3.84e-2)" "unprognostic (1.97e-3)" 1.6 2.3 1.6 4.1 2.2 5.1 1.6 9.8 2.2 1.7 1.6 2.0 1.6 4.7 2.5 1.9 1.6 2.6 1.6 1.6 1.6 1.3 3.5 1.6 2.1 4.9 1.8 1.9 2.8 4.2 0.0 4.5 1.6 1.7 2.2 0.0 1.6 7.6 1.6 1.6 7.4 3.9 1.6 1.6 5.2 3.2 88.8 1.8 1.6 6.3 1.6 1.6 1.7 1.6 0.3 0.5 0.0 0.2 0.0 0.7 0.1 5.3 4.4 1.4 2.0 0.0 0.0 2.9 3.4 0.0 0.0 0.0 2.7 1.6 0.9 2.6 0.0 7.4 4.8 0.0 0.2 0.0 5.4 2.6 0.7 27.3 0.8 0.0 0.7 3.4 0.0 0.0 0.1 0.0 1.6 0.0 2.5 3.7 4.9 0.0 3.8 1.1 1.7 1.2 0.1 1.3 1.8 2.1 5.0 0.0 2.1 3.4 3.1 5.9 3.0 16.6 0.7 3.3 1.7 4.5 2.7 3.6 8.2 3.1 3.9 1.0 1.4 8.1 3.2 59.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.2 0.5 0.0 0.1 1.6 2.2 9.8 2.2 1.6 1.3 1.8 1.9 1.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 515.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 6.5 0.0 2.8 1.5 0.0 0.1 0.0 0.0 0.0 C19orf81 ENSG00000235034 "Chromosome 19 open reading frame 81" C9J6K1 19 50649445-50659310 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 10.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 19.2;Early spermatids: 20.8;Muller glia cells: 31.4;Rod photoreceptor cells: 22.2;Spermatocytes: 21.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 9.3;HMC-1: 3.4;JURKAT: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060238 Enhanced Approved Vesicles,Aggresome NA NA "Vesicles, Aggresome" "HPA060238: AB_2684228" "unprognostic (2.29e-2)" "unprognostic (2.75e-2)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (3.39e-2)" "unprognostic (2.03e-2)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.48e-2)" "unprognostic (6.01e-4)" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (1.95e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.4 0.0 0.0 0.0 0.7 0.0 0.0 1.2 9.3 0.9 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 2.7 2.2 1.8 0.0 0.0 0.5 1.5 0.5 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 1.1 0.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 0.1 0.0 0.0 0.0 1.2 1.9 15.4 1.2 0.0 0.0 0.0 19.2 7.9 0.0 11.6 7.6 20.8 0.2 0.0 0.0 1.1 0.2 0.5 5.4 0.0 0.0 0.9 11.1 0.0 1.8 0.0 2.5 0.6 0.0 5.0 4.6 0.0 31.4 7.2 0.0 0.7 0.0 22.2 0.0 1.2 21.5 3.2 3.8 0.0 0.0 0.0 0.1 C19orf84 ENSG00000262874 "Chromosome 19 open reading frame 84" I3L1E1 19 51388289-51390574 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.0" "Cell type enhanced" "Detected in some" 24 "Late spermatids: 1.8;Spermatogonia: 3.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.5;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 6 "dendritic cells: 1.7;T-cells: 1.5" "Cell line enriched" "Detected in some" 8 "K-562: 12.3" "Low region specificity" "Detected in all" HPA068082 Uncertain Approved Vesicles NA NA Vesicles "HPA068082: AB_2685949" "unprognostic (5.94e-2)" "unprognostic (7.72e-2)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.13e-3)" "unprognostic (9.28e-4)" "unprognostic (1.31e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (3.84e-1)" "unprognostic (2.61e-7)" "unprognostic (8.30e-3)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (3.99e-3)" 0.0 0.0 0.1 0.3 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.6 0.1 0.0 0.0 0.1 0.3 0.4 0.0 0.4 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.0 39.0 0.2 1.0 0.0 0.2 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.2 0.2 0.2 0.6 0.1 0.4 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 C19orf85 ENSG00000283567 "Chromosome 19 open reading frame 85" 19 55463002-55464707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lung: 1.7;seminal vesicle: 1.3;testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 15.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1GALT1C1 "C1GALT2, COSMC" ENSG00000171155 "C1GALT1 specific chaperone 1" Q96EU7 X 120625793-120630150 "Disease related genes, Predicted membrane proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 83.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.1" "Low region specificity" "Detected in all" "HPA010666, HPA015632" Approved Approved Vesicles NA NA Vesicles "HPA010666: , HPA015632: AB_1845625" "prognostic unfavorable (5.66e-4)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (5.26e-3)" "unprognostic (4.34e-2)" "unprognostic (2.50e-1)" "unprognostic (2.18e-2)" "unprognostic (8.10e-2)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (3.98e-2)" "unprognostic (4.48e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (3.78e-2)" 16.5 28.0 8.4 11.1 9.2 3.0 21.1 9.0 9.9 19.2 16.7 10.8 16.5 12.7 13.0 23.1 15.0 15.1 11.6 17.7 9.0 10.9 25.9 35.2 12.4 12.9 11.0 7.5 13.2 18.8 18.7 83.5 13.3 11.5 14.1 19.4 10.9 19.4 15.5 7.4 5.8 20.6 12.4 12.0 16.5 14.6 9.6 10.6 16.3 19.8 12.3 12.4 13.9 12.3 17.2 23.0 31.3 22.3 15.1 23.8 16.2 8.5 8.3 4.6 7.9 73.1 13.9 7.3 15.7 22.2 8.3 15.8 5.4 27.6 5.6 7.9 31.6 16.0 12.1 9.0 7.6 13.3 9.4 10.9 3.6 7.7 7.9 11.4 6.2 5.7 12.1 6.9 10.3 3.5 20.9 26.1 2.8 2.2 6.6 9.7 11.6 2.1 5.9 5.2 28.9 8.4 0.9 3.6 15.2 16.8 5.8 5.1 4.8 14.9 10.2 7.8 8.8 8.9 6.1 23.9 3.8 4.7 15.3 14.6 2.8 4.2 4.4 14.0 12.4 8.4 13.3 17.7 27.0 17.6 22.3 19.4 17.2 22.9 19.0 20.1 10.6 23.8 18.9 31.3 15.1 17.5 23.0 21.0 16.2 8.4 9.2 9.0 9.9 9.0 10.9 11.0 7.5 11.5 10.6 6.0 7.2 13.4 18.7 6.1 8.1 14.1 12.7 26.8 18.2 36.6 2.0 47.7 13.3 34.2 2.5 22.5 15.3 0.0 39.1 41.4 29.1 13.7 2.3 19.2 21.2 19.1 13.3 20.3 15.1 4.4 21.0 19.0 28.7 23.4 19.1 19.0 25.0 17.6 18.0 16.1 8.2 6.5 20.3 4.4 7.9 6.4 16.7 13.8 18.9 20.6 C1GALT1C1L ENSG00000223658 "C1GALT1-specific chaperone 1 like" P0DN25 2 43675151-43676322 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 9.2" "Cell type enhanced" "Detected in some" 19 "Muller glia cells: 4.5;Rod photoreceptor cells: 3.7;Spermatocytes: 17.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 16.0;U-2 OS: 10.1" "Low region specificity" "Detected in all" NA NA "unprognostic (2.18e-1)" "unprognostic (3.71e-2)" "unprognostic (2.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.32e-1)" "unprognostic (5.71e-3)" "unprognostic (2.19e-3)" "unprognostic (4.91e-2)" "unprognostic (2.78e-2)" "unprognostic (2.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.67e-1)" "unprognostic (7.73e-2)" "unprognostic (3.81e-3)" "unprognostic (8.88e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-2)" 1.5 1.2 1.0 0.2 1.7 0.0 5.1 0.0 2.8 1.6 1.6 0.1 1.8 0.0 5.7 9.2 0.6 1.5 1.1 8.0 0.5 2.3 0.0 0.3 0.5 3.9 0.1 1.5 2.9 0.0 0.0 1.0 3.1 3.0 0.7 1.7 1.4 3.5 0.7 0.0 0.4 4.7 1.6 0.4 0.3 7.8 1.4 0.0 1.6 0.8 0.2 1.5 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 3.1 1.6 0.1 0.2 0.5 1.1 1.3 0.6 4.6 0.0 4.6 0.3 4.0 0.3 0.0 0.3 2.5 0.0 3.5 2.0 1.5 0.9 1.1 0.0 0.0 2.0 0.8 3.1 0.1 1.6 3.2 0.0 2.4 0.0 0.3 4.7 0.0 4.3 0.0 0.0 0.0 0.0 1.8 0.0 4.0 1.0 0.2 16.0 0.0 0.2 3.0 0.4 1.1 3.1 0.0 4.1 10.1 0.2 0.9 0.0 2.4 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 1.0 0.4 2.5 2.7 1.2 0.0 0.0 0.2 0.0 0.8 2.0 0.0 0.0 0.0 0.5 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.3 4.5 0.3 0.0 1.8 0.3 3.7 0.0 0.0 17.7 2.3 0.0 0.1 0.0 0.2 0.0 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 65.3" "Group enriched" "Detected in some" 119 "Early spermatids: 1095.9;Late spermatids: 535.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "K-562: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1095.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 535.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 0.0 0.0 0.0 C1orf105 ENSG00000180999 "Chromosome 1 open reading frame 105" O95561 1 172420688-172468831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 28.8;testis: 23.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 112.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enriched" "Detected in some" 8 "BEWO: 25.0" "Not detected" "Not detected" NA NA "unprognostic (2.50e-2)" "unprognostic (2.48e-4)" "unprognostic (7.11e-2)" "unprognostic (1.12e-2)" "unprognostic (7.07e-4)" "unprognostic (1.27e-3)" "unprognostic (3.02e-2)" "unprognostic (1.47e-2)" "unprognostic (8.22e-2)" "unprognostic (1.92e-1)" "unprognostic (1.18e-1)" "unprognostic (7.65e-4)" "unprognostic (3.85e-1)" "unprognostic (1.94e-1)" 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 7.0 0.3 0.0 0.0 28.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.1 1.1 0.0 0.1 1.2 0.0 1.7 0.6 0.4 0.0 0.1 0.0 0.0 23.0 0.0 0.2 0.1 3.6 0.3 0.0 0.0 0.1 0.0 2.6 0.2 0.0 0.5 0.2 0.0 0.2 0.3 0.1 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 3.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.6 0.2 0.0 0.3 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.5 0.4 0.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 112.5 0.0 0.0 0.0 0.5 8.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 12.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 0.0 0.0 0.0 24.1 2.0 0.0 1.5 0.0 0.0 0.0 C1orf112 FLJ10706 ENSG00000000460 "Chromosome 1 open reading frame 112" Q9NSG2 1 169662007-169854080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 24.6" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 27.7;Spermatogonia: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023778, HPA024451" Uncertain Approved Mitochondria NA NA Mitochondria "HPA023778: AB_1848665, HPA024451: AB_1848667" "unprognostic (4.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (9.56e-5)" "unprognostic (1.33e-1)" "unprognostic (9.40e-2)" "unprognostic (2.50e-3)" "unprognostic (2.09e-1)" "unprognostic (9.11e-3)" "unprognostic (8.79e-2)" "unprognostic (3.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.65e-8)" "unprognostic (1.76e-1)" "unprognostic (2.81e-2)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" 3.4 3.1 3.3 7.4 4.9 10.1 5.0 8.4 3.6 5.2 3.2 5.0 2.2 1.5 4.8 3.5 4.0 2.2 1.8 2.3 2.7 2.4 2.6 5.2 2.6 7.4 5.0 1.5 3.3 2.6 20.1 3.7 4.2 4.5 3.2 5.3 4.9 3.3 4.9 1.9 3.1 3.3 3.6 3.6 4.2 3.0 19.7 5.9 24.6 3.2 2.9 9.5 4.0 3.3 2.9 2.7 4.3 4.9 4.9 1.6 1.6 16.5 8.9 11.7 6.0 1.9 2.6 17.3 11.0 5.7 16.2 16.5 9.9 14.6 14.8 5.0 3.6 5.7 13.6 14.6 7.7 18.6 8.7 8.6 14.0 12.0 7.2 0.6 18.2 6.2 0.8 1.1 12.0 2.9 1.9 6.8 9.1 22.5 25.3 13.1 4.0 15.8 5.1 15.4 11.8 6.4 12.0 13.1 10.0 2.2 8.4 8.6 9.0 6.9 11.6 3.6 11.6 11.0 9.5 4.9 13.1 10.4 9.5 14.9 6.9 10.3 15.7 4.9 13.6 12.6 4.3 1.8 2.2 1.3 4.5 1.0 2.9 1.6 1.4 2.7 2.8 0.6 1.4 0.3 4.9 4.9 0.7 1.6 1.6 3.3 4.9 8.4 3.6 2.7 2.4 5.0 1.5 4.5 5.9 0.0 3.5 2.2 2.6 1.5 3.8 0.4 0.0 2.7 1.2 0.0 5.9 6.0 0.0 2.3 5.9 2.1 0.9 0.0 3.0 7.4 2.3 0.8 4.6 3.0 5.0 1.6 0.0 4.3 3.1 3.1 2.0 3.0 3.3 1.0 1.0 2.6 2.5 0.0 3.5 0.4 6.5 6.5 1.2 27.7 17.7 0.9 3.2 1.9 1.6 1.4 C1orf115 FLJ14146 ENSG00000162817 "Chromosome 1 open reading frame 115" Q9H7X2 1 220689845-220699157 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 32.9;intestine: 32.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 168.2;Hepatocytes: 103.9;Syncytiotrophoblasts: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6" "Lineage enhanced" "Detected in single" "B-cells: 3.6" "Cell line enhanced" "Detected in many" "Hep G2: 23.6;HUVEC TERT2: 19.4;TIME: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (5.16e-2)" "prognostic favorable (6.52e-4)" "unprognostic (1.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.03e-1)" "unprognostic (5.69e-3)" "unprognostic (8.65e-2)" "prognostic favorable (5.12e-5)" "unprognostic (3.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.74e-2)" "unprognostic (4.24e-1)" "unprognostic (4.54e-2)" "unprognostic (9.21e-3)" "unprognostic (1.07e-1)" 12.4 1.6 16.2 3.2 27.0 0.0 8.9 3.1 32.9 3.9 8.1 2.1 2.4 30.6 3.1 5.8 2.9 3.8 4.6 4.7 9.6 2.9 14.4 27.6 6.2 1.7 2.5 17.8 4.9 3.9 8.5 6.2 19.0 5.7 8.6 6.2 3.3 20.2 2.8 3.3 2.6 32.1 3.2 1.1 12.7 5.5 2.8 3.7 1.0 5.5 1.1 2.2 2.1 2.3 3.6 0.2 0.0 0.6 0.0 0.9 0.3 0.6 2.8 0.1 4.0 0.0 0.0 11.5 0.8 3.1 1.6 7.3 2.8 2.9 0.0 1.2 0.2 3.4 0.1 6.6 1.3 1.5 0.0 6.6 0.1 0.6 23.6 3.8 0.0 0.1 0.5 2.2 0.1 0.8 0.0 19.4 0.0 1.7 0.0 0.1 2.5 0.0 0.1 4.8 7.8 2.0 0.0 0.0 0.2 3.5 3.7 2.1 2.9 0.0 4.8 11.6 7.3 7.9 0.1 36.2 0.0 0.0 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.8 0.0 0.3 1.9 0.9 0.2 0.2 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 16.2 27.0 3.1 32.9 9.6 2.9 2.5 17.8 5.7 3.7 3.0 7.0 9.9 3.4 3.1 11.4 12.2 10.2 1.4 5.7 29.6 5.9 57.1 33.2 10.0 1.1 33.7 168.2 0.0 14.6 51.0 2.4 13.3 0.0 103.9 5.6 0.0 8.1 11.1 4.7 1.9 2.8 1.1 8.5 7.2 22.1 5.6 13.2 46.0 18.0 52.2 3.9 0.0 3.1 0.3 3.9 1.5 153.8 0.5 13.3 2.1 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018521-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 163.8;Alveolar cells type 2: 71.9;Club cells: 78.5;Urothelial cells: 120.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.2;CAPAN-2: 32.4;HaCaT: 40.0;HBEC3-KT: 38.4;hTCEpi: 20.4;RPTEC TERT1: 18.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 7900 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favorable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.2 0.3 0.2 1.6 0.2 0.0 4.1 0.2 0.4 7.1 8.3 0.3 0.2 8.4 1.0 1.1 49.4 0.6 14.0 0.2 0.3 0.1 4.3 1.1 42.8 0.2 0.2 0.2 0.5 7.0 0.0 0.9 1.4 0.4 18.8 2.7 0.3 12.5 1.9 0.3 14.4 16.5 0.6 0.2 0.4 20.3 0.4 0.2 0.4 6.8 16.0 37.1 6.1 12.3 0.0 0.0 0.7 0.0 0.1 0.0 1.8 18.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.4 0.0 2.1 0.0 0.0 40.0 0.0 38.4 0.0 0.0 0.0 3.3 0.3 0.5 0.0 0.0 0.2 0.0 20.4 0.0 11.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.0 0.0 0.0 0.0 18.7 4.8 0.0 0.1 0.3 3.6 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.4 0.2 163.8 71.9 0.0 39.9 18.4 0.0 42.3 28.1 41.5 78.5 10.4 0.0 0.0 13.3 21.7 4.8 0.0 31.1 0.0 21.6 0.0 0.5 57.3 5.8 0.0 0.2 0.0 10.3 0.0 0.0 3.3 0.3 0.6 0.0 0.0 16.3 0.0 41.6 7.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 20.5 0.0 0.0 7.4 120.4 C1orf127 FLJ37118 ENSG00000175262 "Chromosome 1 open reading frame 127" 1 10946471-10982037 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 5.1;skeletal muscle: 17.3" "Cell type enriched" "Detected in some" 11 "Intestinal endocrine cells: 19.5" "Cancer enriched" "Detected in single" 9 "pancreatic cancer: 2.8" "Group enriched" "Detected in some" 4 "classical monocyte: 1.7;myeloid DC: 4.2" "Group enriched" "Detected in many" 30 "dendritic cells: 4.2;monocytes: 1.7" "Cell line enriched" "Detected in some" 4 "THP-1: 7.6" HPA027654 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA027654: AB_10611814" "unprognostic (1.82e-2)" "unprognostic (8.57e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-2)" "unprognostic (9.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-2)" "unprognostic (8.47e-2)" "unprognostic (1.59e-2)" "unprognostic (3.31e-1)" "unprognostic (1.34e-1)" "unprognostic (1.04e-1)" "unprognostic (4.03e-1)" 0.1 0.6 0.0 0.0 0.4 0.0 0.0 3.3 0.0 0.0 0.2 0.6 0.0 0.0 0.5 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.3 0.5 0.8 0.0 5.1 0.0 0.2 0.1 0.0 0.5 0.2 0.0 17.3 0.0 0.2 0.0 0.1 0.5 2.5 0.6 0.1 0.0 0.0 0.0 0.0 4.2 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 1.4 0.5 0.0 0.0 7.6 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 19.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 C1orf141 ENSG00000203963 "Chromosome 1 open reading frame 141" Q5JVX7 1 67092165-67231853 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 14.9;fallopian tube: 12.8;testis: 18.7" "Group enriched" "Detected in some" 4 "Ciliated cells: 84.3;Early spermatids: 83.3;Late spermatids: 78.9;Muller glia cells: 34.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 14.9" "Group enriched" "Detected in some" 5 "basophil: 2.5;neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Cell line enriched" "Detected in single" 37 "HEL: 18.1" "Low region specificity" "Detected in all" HPA035316 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA035316: AB_10600886" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (1.01e-1)" "unprognostic (2.20e-2)" 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.1 1.3 0.3 0.1 1.9 0.0 0.0 0.1 1.1 0.0 12.8 0.2 0.0 2.6 1.8 0.1 0.1 2.0 0.1 0.3 0.7 1.8 0.0 0.0 1.0 0.0 14.9 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 18.7 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 2.5 0.1 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 18.1 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.5 1.1 2.6 0.1 1.3 2.6 1.8 0.3 0.7 14.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 84.3 15.9 0.0 0.0 0.0 0.0 0.0 83.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 78.9 1.7 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.7 0.0 1.3 0.0 0.0 6.0 0.7 0.0 0.1 0.0 0.0 0.0 C1orf146 ENSG00000203910 "Chromosome 1 open reading frame 146" Q5VVC0 1 92217940-92245813 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 12.7" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (2.89e-2)" "unprognostic (4.26e-3)" "unprognostic (1.81e-1)" "unprognostic (5.37e-3)" "unprognostic (8.77e-2)" "unprognostic (1.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-3)" "unprognostic (1.90e-1)" "unprognostic (7.13e-2)" "unprognostic (4.17e-2)" "unprognostic (2.78e-7)" "unprognostic (3.36e-2)" "unprognostic (6.76e-2)" "unprognostic (3.17e-1)" "unprognostic (5.19e-3)" 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.3 1.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 12.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.5 0.5 2.6 0.1 0.7 0.5 0.0 0.4 0.0 0.9 2.3 0.0 0.5 1.1 0.3 0.0 0.6 0.7 0.0 1.2 2.1 0.3 0.0 0.1 0.8 0.3 0.0 0.0 0.5 1.0 0.9 0.7 0.0 0.0 0.7 1.9 0.5 0.3 0.9 0.0 0.6 0.3 1.7 0.0 0.8 0.0 1.3 1.1 1.7 0.7 0.1 0.0 0.6 0.2 0.3 0.0 1.6 0.7 0.1 0.4 1.2 0.0 1.4 0.2 1.2 1.0 1.2 0.9 1.0 0.9 1.9 0.4 0.9 0.5 1.0 0.5 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.2 0.4 0.1 0.5 0.3 0.2 2.6 0.7 0.1 0.5 0.0 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 7.5 0.0 0.0 0.0 0.0 0.0 C1orf158 MGC35194 ENSG00000157330 "Chromosome 1 open reading frame 158" Q8N1D5 1 12746215-12763699 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 23.5;testis: 74.6" "Group enriched" "Detected in some" 13 "Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5" "Region enhanced" "Detected in many" "pons and medulla: 9.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA028396 Uncertain Cytosol NA NA Cytosol "HPA028396: AB_10603451" "unprognostic (1.11e-2)" "unprognostic (4.94e-3)" "unprognostic (4.62e-1)" "unprognostic (8.00e-2)" "unprognostic (4.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.45e-1)" "unprognostic (3.51e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.7 0.0 2.4 0.3 0.0 0.0 0.2 0.9 0.0 6.2 0.0 0.0 0.4 4.2 0.1 23.5 0.1 0.0 1.0 1.4 0.0 0.0 2.8 0.1 0.2 0.1 4.8 0.1 0.0 0.4 0.1 9.3 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.2 0.1 0.1 74.6 0.9 0.0 0.5 0.0 0.1 0.0 0.0 0.9 0.6 2.3 0.6 1.1 0.8 0.1 0.5 1.3 1.1 0.7 0.6 0.0 1.0 0.1 0.3 0.2 0.2 1.3 0.7 1.1 0.3 0.3 0.4 0.4 0.1 0.1 0.2 0.2 0.7 1.1 1.9 0.5 0.0 0.9 1.0 0.1 0.7 0.3 0.1 0.4 0.1 0.5 0.9 1.4 0.3 0.5 0.2 0.7 1.5 0.3 0.5 0.6 0.3 0.9 0.1 0.5 1.9 0.8 0.5 0.6 0.3 1.4 0.7 0.2 0.5 0.5 0.8 0.4 0.8 0.6 0.5 1.2 1.0 1.1 0.5 1.6 0.6 0.5 0.7 0.5 0.6 0.5 0.5 0.5 0.1 0.9 0.8 0.7 2.3 1.1 0.6 0.6 0.4 0.1 0.7 2.4 0.0 0.2 1.0 1.4 0.2 0.1 9.3 0.9 3.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 105.7 7.9 0.0 0.0 0.0 0.0 0.0 148.7 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 65.2 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 7.9 1.3 0.0 0.0 0.0 0.0 0.1 C1orf162 MGC24133 ENSG00000143110 "Chromosome 1 open reading frame 162" Q8NEQ5 1 111473792-111478512 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 119.1;lymphoid tissue: 86.6" "Cell type enhanced" "Detected in many" 18 "granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7" HPA026988 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA026988: AB_10600887" "unprognostic (8.79e-2)" "unprognostic (5.18e-3)" "unprognostic (1.14e-2)" "unprognostic (2.11e-1)" "unprognostic (5.20e-2)" "unprognostic (5.96e-2)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.69e-2)" "unprognostic (1.86e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (3.14e-6)" "unprognostic (1.29e-2)" "unprognostic (3.15e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-1)" 39.8 9.3 9.2 25.1 17.9 37.5 20.1 4.6 9.3 5.2 6.3 4.9 0.8 2.7 5.4 7.4 4.9 10.2 11.7 14.8 13.4 4.7 17.3 14.8 40.1 86.6 17.5 1.9 5.8 4.5 1.3 9.7 5.6 15.3 5.0 6.9 5.0 5.9 2.5 7.2 3.6 8.3 13.5 31.0 78.1 5.8 6.1 13.9 10.6 6.2 1.1 20.0 7.2 6.7 24.7 83.3 98.7 119.1 40.1 27.8 74.8 0.1 0.0 0.1 0.3 0.1 0.2 0.2 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 45.4 0.1 0.1 0.1 0.0 0.2 22.1 3.7 0.0 0.9 0.3 0.3 0.3 0.6 0.2 0.2 0.1 0.1 0.1 0.1 12.3 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.1 17.5 0.0 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.1 36.7 0.5 68.4 82.5 98.7 14.2 119.1 4.1 17.5 17.7 8.2 83.3 24.7 27.8 16.8 11.4 40.1 86.3 24.9 5.0 74.8 9.2 17.9 4.6 9.3 13.4 4.7 17.5 1.9 15.3 13.9 20.8 66.7 71.8 0.5 7.0 3.7 3.1 12.7 1.4 7.9 7.0 2.0 1.1 0.0 0.2 33.3 3.7 0.6 0.0 0.2 1.2 5.8 0.7 175.8 6.4 198.4 0.0 1.7 17.8 675.1 60.1 2.6 367.2 11.8 1.0 0.0 0.3 0.2 0.0 0.7 0.6 3.9 32.3 4.2 1.8 1.7 5.6 1.4 95.6 0.6 0.3 C1orf167 "DKFZp434E1410, RP11-56N19.2" ENSG00000215910 "Chromosome 1 open reading frame 167" Q5SNV9 1 11761787-11789585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 22 "testis: 34.0" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Early spermatids: 12.6;Late spermatids: 13.2;Spermatocytes: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 52 "U-698: 26.4" HPA039114 Enhanced NA NA "HPA039114: AB_10673606" "unprognostic (2.93e-3)" "unprognostic (1.34e-2)" "unprognostic (7.48e-3)" "unprognostic (3.96e-1)" "unprognostic (2.38e-4)" "unprognostic (2.71e-1)" "unprognostic (5.55e-3)" "unprognostic (3.92e-2)" "unprognostic (5.10e-2)" "unprognostic (4.90e-3)" "unprognostic (3.96e-2)" "unprognostic (8.38e-5)" "unprognostic (5.46e-4)" "unprognostic (1.52e-1)" "unprognostic (2.71e-1)" "unprognostic (2.38e-2)" 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.1 34.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.9 1.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.8 1.6 0.0 1.1 1.0 0.6 0.4 0.0 0.0 1.2 3.5 0.0 0.5 1.7 0.9 12.6 1.0 0.7 0.0 7.3 0.2 4.1 1.8 0.0 0.0 0.4 4.8 0.0 4.9 0.8 13.2 5.8 0.3 0.0 0.0 0.0 0.3 3.6 2.9 3.5 3.7 0.3 0.0 4.1 14.1 3.4 1.5 0.2 0.0 0.0 3.1 C1orf185 FLJ27485 ENSG00000204006 "Chromosome 1 open reading frame 185" Q5T7R7 1 51102234-51148086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 23.8" "Cell type enriched" "Detected in some" 14 "Early spermatids: 474.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 1.1;THP-1: 1.2" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 474.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.0 1.8 0.0 0.0 0.0 0.0 0.0 C1orf189 ENSG00000163263 "Chromosome 1 open reading frame 189" Q5VU69 1 154199372-154206333 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 11.9;fallopian tube: 41.8;testis: 21.0" "Cell type enhanced" "Detected in some" 31 "Ciliated cells: 28.1;Early spermatids: 63.9;Late spermatids: 12.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.2" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045779 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus, Plasma membrane" "HPA045779: AB_2679448" "unprognostic (8.23e-3)" "unprognostic (5.55e-3)" "unprognostic (2.39e-2)" "unprognostic (2.01e-3)" "unprognostic (2.50e-3)" "unprognostic (2.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.24e-2)" "unprognostic (8.78e-3)" "unprognostic (1.36e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (3.75e-2)" "unprognostic (2.06e-1)" "unprognostic (9.79e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.4 0.1 0.6 0.5 0.1 0.1 0.2 2.2 0.1 0.8 0.1 0.0 0.7 11.9 0.1 41.8 0.1 0.1 0.8 1.1 0.1 0.3 5.6 0.1 0.1 0.1 4.2 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 21.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.3 3.2 1.0 0.0 1.6 0.3 0.1 0.0 1.8 0.0 1.4 0.0 1.0 0.6 0.8 2.1 0.0 3.4 0.9 1.3 0.4 0.0 0.2 0.5 1.4 2.3 0.0 1.4 2.1 0.8 2.7 2.3 2.1 0.6 0.8 2.6 1.9 0.8 0.0 0.0 0.0 1.4 1.2 0.4 1.0 3.7 0.8 0.3 3.3 1.3 3.8 0.4 1.5 0.9 0.0 0.0 0.9 0.0 0.0 0.0 2.7 0.3 2.5 0.0 1.9 0.0 2.0 1.3 1.2 2.3 2.3 0.5 0.4 0.5 0.0 0.0 0.1 1.5 0.2 1.0 0.0 0.2 0.1 0.4 0.3 0.8 0.2 1.6 3.2 0.0 0.5 0.0 0.4 0.3 0.4 0.6 0.1 0.2 0.8 1.1 0.1 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 C1orf194 ENSG00000179902 "Chromosome 1 open reading frame 194" Q5T5A4 1 109105951-109113857 "Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 36.5;fallopian tube: 60.2;testis: 77.6" "Group enriched" "Detected in some" 10 "Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8" "Region enriched" "Detected in many" 5 "pons and medulla: 36.5" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031144, HPA049684" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA031144: AB_10602109, HPA049684: AB_2680849" "unprognostic (9.91e-3)" "unprognostic (7.60e-3)" "unprognostic (2.28e-2)" "prognostic favorable (1.36e-4)" "unprognostic (3.03e-1)" "unprognostic (1.14e-2)" "unprognostic (4.53e-1)" "unprognostic (3.91e-3)" "unprognostic (5.27e-2)" "unprognostic (9.21e-3)" "unprognostic (3.98e-3)" "unprognostic (1.52e-1)" "unprognostic (6.08e-6)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (5.94e-3)" "unprognostic (3.27e-3)" 0.3 0.4 1.5 0.3 6.8 0.3 0.4 0.3 2.6 1.8 0.3 12.3 0.0 0.4 1.0 11.1 0.4 60.2 0.3 0.3 3.0 1.6 0.3 0.3 7.5 0.4 0.5 1.8 10.3 0.7 0.4 2.7 0.3 36.5 0.4 0.4 0.0 0.3 0.3 0.3 0.3 0.4 0.4 0.7 0.3 0.5 77.6 2.3 0.0 0.5 0.0 0.3 0.5 0.2 0.2 0.0 5.3 0.0 0.0 0.3 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 6.3 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 6.8 0.3 2.6 3.0 1.6 0.5 1.8 36.5 2.3 0.0 2.6 0.0 0.2 0.0 0.6 2.0 0.0 776.3 56.9 0.0 0.0 0.0 0.0 0.0 1757.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 2679.4 19.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 17.7 0.0 0.0 6.5 0.0 176.3 13.0 0.1 0.0 0.0 0.0 0.0 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281883-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 105.5;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 5.4" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "A-431: 7.4;BEWO: 8.3;CACO-2: 7.8;CAPAN-2: 25.2;OE19: 20.3;SK-BR-3: 8.8;T-47d: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA013788 Uncertain Uncertain "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.3 0.1 0.3 6.5 0.3 0.0 7.4 0.3 0.3 3.9 28.6 0.4 7.4 20.6 1.0 10.9 11.2 2.6 20.7 0.3 0.3 0.1 25.2 3.3 13.5 0.3 0.3 0.3 1.0 29.8 3.0 9.6 6.1 0.4 4.4 14.4 0.4 25.8 7.2 0.3 10.6 64.0 0.5 0.3 0.3 14.6 1.1 0.3 1.0 32.1 7.8 7.7 3.4 5.2 0.1 0.3 5.4 0.3 0.4 0.2 0.0 7.4 0.0 0.0 0.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 7.8 25.2 0.0 0.1 0.0 0.0 5.7 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.2 0.6 4.8 3.0 0.2 0.0 8.8 0.0 1.4 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 0.3 20.8 10.7 0.8 5.9 1.0 0.0 0.0 22.9 4.0 4.5 21.0 0.0 11.1 24.9 17.9 0.1 0.0 105.5 0.0 29.5 2.9 0.2 10.4 0.0 0.9 0.6 0.0 32.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.2 0.0 16.3 49.1 0.0 39.3 0.0 0.0 0.2 0.1 0.0 2.3 3.9 0.0 31.2 7.8 C1orf216 FLJ38984 ENSG00000142686 "Chromosome 1 open reading frame 216" Q8TAB5 1 35713875-35719472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 22.3;Rod photoreceptor cells: 26.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028299, HPA031343" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA028299: AB_10601122, HPA031343: AB_2673834" "unprognostic (1.17e-1)" "unprognostic (2.43e-2)" "unprognostic (9.84e-2)" "unprognostic (1.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (2.23e-1)" "unprognostic (3.81e-1)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.86e-1)" "prognostic unfavorable (7.68e-10)" "unprognostic (3.31e-1)" "unprognostic (3.08e-1)" "unprognostic (2.48e-1)" "unprognostic (5.93e-2)" 4.3 4.4 12.5 2.1 10.5 1.1 2.4 5.0 22.1 4.7 3.5 1.0 4.1 5.0 2.1 2.5 3.0 4.0 12.1 9.7 0.7 1.8 3.1 2.4 7.0 3.5 1.2 2.0 1.8 1.6 3.1 2.0 1.1 4.4 5.1 2.9 1.2 7.0 5.2 2.2 1.2 3.4 1.4 2.5 2.4 1.4 2.5 3.2 0.1 3.7 0.8 7.3 3.0 3.4 8.0 4.4 5.7 20.1 14.8 2.9 9.8 11.5 14.5 13.9 4.7 7.3 4.3 7.1 14.3 11.9 3.3 10.9 6.4 12.5 14.0 5.2 25.7 11.7 1.3 7.6 12.7 17.0 15.1 8.2 10.4 3.3 10.7 9.4 3.2 10.2 11.6 15.5 5.6 5.1 10.9 6.4 3.7 6.8 3.4 5.8 3.5 5.0 4.0 5.9 5.9 9.3 1.9 19.0 2.7 3.6 5.7 11.2 11.8 9.4 8.8 10.1 3.5 8.7 3.2 11.8 12.3 18.4 0.0 3.2 0.1 5.9 3.7 1.9 2.5 4.7 7.3 3.2 1.4 1.1 4.4 0.1 0.8 2.7 0.7 1.6 3.0 0.0 2.1 0.0 2.9 5.4 18.4 6.4 0.0 0.0 1.2 1.8 13.7 2.0 0.0 5.5 10.2 6.0 0.0 0.0 2.4 1.2 4.7 1.8 4.6 1.7 6.9 22.3 1.7 5.5 4.0 6.8 7.8 5.4 15.1 8.2 0.0 16.2 2.2 0.0 19.4 0.7 26.6 0.0 6.9 2.8 2.2 4.0 0.9 5.0 0.3 1.4 C1orf226 FLJ13137 ENSG00000239887 "Chromosome 1 open reading frame 226" A1L170 1 162366908-162386818 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.6" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 27.5;Early spermatids: 20.6;Hepatocytes: 22.6;Late spermatids: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 13.2;HEL: 16.9" "Low region specificity" "Detected in all" "HPA052251, HPA074060" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA052251: AB_2681775, HPA074060: " "prognostic favorable (2.60e-4)" "unprognostic (1.30e-1)" "unprognostic (2.69e-2)" "unprognostic (1.59e-2)" "unprognostic (6.71e-3)" "unprognostic (9.80e-2)" "unprognostic (8.55e-2)" "unprognostic (1.65e-1)" "unprognostic (2.05e-1)" "unprognostic (4.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-3)" "prognostic favorable (4.44e-5)" "unprognostic (9.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.13e-4)" 1.5 8.2 1.5 3.4 1.5 1.2 7.1 4.8 2.0 3.7 18.0 1.5 1.5 4.9 1.9 1.6 4.4 2.5 3.2 1.5 1.6 2.4 5.2 15.2 3.0 1.5 1.8 1.5 2.0 3.5 1.4 6.9 18.9 1.5 3.2 8.3 2.0 8.2 7.6 1.5 3.3 28.6 2.4 2.3 2.2 5.8 2.7 1.5 1.5 1.5 7.4 5.1 2.2 1.5 0.0 0.0 0.8 0.7 0.0 0.0 0.2 13.2 0.7 10.9 8.3 0.3 0.0 0.2 1.2 1.1 0.8 0.4 1.5 6.1 0.0 9.1 0.2 4.0 9.7 3.2 0.7 0.5 0.2 4.4 16.9 0.5 7.4 0.2 0.0 0.1 1.2 0.8 0.0 0.6 3.0 3.3 1.8 1.4 0.1 0.2 4.3 0.6 0.0 6.8 11.9 6.1 0.2 1.7 0.0 9.3 5.4 4.7 3.2 4.5 1.2 2.6 4.2 4.9 0.7 2.3 0.0 1.4 0.2 3.3 6.3 0.0 0.0 1.6 0.2 0.7 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 1.5 1.5 4.8 2.0 1.6 2.4 1.8 1.5 1.5 1.5 3.0 1.6 0.0 1.4 0.7 0.7 3.3 2.5 1.4 1.2 14.0 27.5 0.0 0.0 0.8 20.6 1.1 8.0 0.0 2.0 0.1 0.6 3.7 0.0 22.6 0.1 6.4 2.4 3.7 1.0 30.4 2.0 0.0 0.0 0.0 10.3 6.5 1.7 3.5 1.8 0.0 0.3 0.0 0.2 0.7 0.7 1.3 0.1 0.0 5.6 2.0 C1orf228 "MGC33556, NCRNA00082, p40" ENSG00000198520 "Chromosome 1 open reading frame 228" Q6PIY5 1 44674692-44725591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.0;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 46.8;Early spermatids: 45.0;granulocytes: 81.7;Late spermatids: 39.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 8.6;MOLT-4: 7.1;NB-4: 10.1;U-937: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034769 Uncertain Uncertain Cytosol NA NA Cytosol "HPA034769: AB_10670979" "unprognostic (2.01e-5)" "unprognostic (4.28e-3)" "unprognostic (7.27e-2)" "prognostic favorable (8.64e-4)" "unprognostic (9.23e-2)" "unprognostic (7.43e-3)" "unprognostic (3.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.49e-2)" "unprognostic (9.34e-3)" "unprognostic (1.22e-2)" "unprognostic (9.38e-2)" "unprognostic (1.25e-10)" "unprognostic (1.99e-4)" "unprognostic (1.50e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-3)" 0.9 2.2 6.3 0.7 11.2 4.3 1.5 3.2 6.8 1.7 1.0 5.6 3.9 0.7 3.1 6.8 1.3 14.0 1.5 0.6 6.5 2.4 1.4 7.0 2.0 1.5 1.4 7.5 4.5 1.4 3.0 5.4 0.8 7.7 1.8 0.9 3.3 1.6 1.4 0.5 1.7 0.8 0.9 2.4 0.8 1.4 17.9 5.4 0.2 1.3 0.0 1.0 0.8 0.8 1.4 6.2 10.4 2.7 0.5 2.3 1.8 0.2 0.3 2.0 0.1 0.7 2.6 0.5 0.0 0.3 0.5 0.3 0.5 4.3 0.3 0.3 0.9 1.0 0.5 0.0 0.0 0.0 1.1 0.2 1.0 2.6 0.6 0.2 8.6 5.1 2.0 0.3 0.8 0.0 1.5 0.2 0.3 0.1 0.8 0.2 0.1 7.1 10.1 0.1 0.6 0.1 3.7 0.2 2.4 0.9 0.0 1.4 0.9 0.0 1.4 1.1 1.4 0.4 4.5 0.0 0.3 0.3 0.4 0.0 0.3 0.3 0.2 0.3 13.7 0.4 10.4 2.7 7.5 0.3 0.8 0.1 0.7 1.5 1.0 1.3 1.4 2.2 2.3 1.2 0.5 0.1 6.2 0.1 1.8 6.3 11.2 3.2 6.8 6.5 2.4 1.4 7.5 7.7 5.4 6.0 5.0 14.5 0.4 0.7 1.1 0.0 0.0 46.8 9.1 0.0 11.8 0.3 0.0 0.0 45.0 0.0 0.3 0.0 0.0 0.1 0.7 0.4 81.7 3.2 10.7 1.6 9.8 0.0 15.0 39.8 0.3 6.1 0.0 0.0 0.6 6.1 0.0 0.0 0.7 0.0 4.3 6.5 0.3 2.3 14.3 0.6 0.1 1.0 0.6 0.1 C1orf232 ENSG00000282872 "Chromosome 1 open reading frame 230" A0A0U1RR37 1 26164161-26168581 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "fallopian tube: 1.4;testis: 2.2;thyroid gland: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 8.9" "Region enriched" "Detected in single" 4 "cerebellum: 1.8" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 C1orf53 ENSG00000203724 "Chromosome 1 open reading frame 53" Q5VUE5 1 197902647-197907367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 20.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.5" "Lineage enriched" "Detected in many" 4 "monocytes: 10.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065352 Approved Vesicles,Aggresome NA NA Vesicles Aggresome "HPA065352: AB_2685477" "prognostic favorable (1.63e-4)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (2.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.90e-3)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (5.53e-3)" "unprognostic (9.85e-2)" "unprognostic (1.12e-1)" "unprognostic (8.58e-3)" "unprognostic (1.37e-1)" 3.3 10.8 6.5 1.5 3.2 1.7 2.1 1.0 6.6 3.1 5.6 2.8 4.0 4.2 1.6 6.2 3.2 1.7 4.7 7.5 4.8 4.0 8.6 20.9 5.0 2.4 2.7 2.9 2.9 8.2 0.5 6.0 2.9 3.7 2.7 3.0 4.5 4.8 1.5 6.6 1.2 4.3 2.2 1.6 2.2 3.5 4.7 3.5 0.1 4.6 2.1 1.4 1.6 1.5 0.1 2.6 0.0 10.5 0.0 0.8 1.1 4.3 5.2 0.4 2.0 2.7 8.1 3.0 6.7 4.4 5.3 2.8 4.7 3.1 7.2 10.6 7.1 1.3 1.7 1.7 1.2 0.6 2.3 13.6 4.3 3.9 7.9 1.2 9.6 6.3 4.7 3.9 1.9 0.7 3.3 2.0 1.3 1.2 1.6 3.2 6.5 0.5 8.5 4.4 4.4 7.7 1.0 2.8 2.8 8.3 6.3 16.0 12.0 8.3 1.5 2.4 2.1 3.7 3.6 4.5 6.4 7.3 8.9 3.9 3.3 2.4 1.7 4.2 2.9 6.5 0.0 3.6 0.0 0.4 10.5 0.0 0.0 0.2 0.8 2.6 0.1 0.4 0.4 0.0 0.0 5.1 0.7 0.1 1.1 6.5 3.2 1.0 6.6 4.8 4.0 2.7 2.9 3.7 3.5 8.9 8.8 1.4 3.8 2.3 1.9 10.2 28.1 10.7 9.1 21.0 0.0 16.4 16.6 8.2 12.9 1.1 7.3 0.0 12.1 8.3 6.7 6.1 1.1 53.9 8.1 3.2 7.5 2.5 4.0 1.0 13.0 3.7 8.5 1.8 11.1 4.7 9.5 11.5 9.9 19.5 3.8 0.0 1.9 6.1 2.3 2.5 9.8 0.7 15.3 4.3 C1orf56 "FLJ20519, MENT" ENSG00000143443 "Chromosome 1 open reading frame 56" Q9BUN1 1 151047740-151051986 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 54.8;testis: 67.7" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 336.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037429, HPA037430" Enhanced "Secreted to blood" NA NA 90000000 "HPA037429: AB_10671755, HPA037430: AB_2675473" "unprognostic (7.60e-2)" "unprognostic (8.26e-2)" "unprognostic (1.09e-2)" "unprognostic (3.83e-1)" "unprognostic (4.31e-2)" "unprognostic (2.83e-2)" "unprognostic (1.11e-2)" "unprognostic (3.81e-3)" "unprognostic (1.59e-2)" "unprognostic (2.70e-3)" "unprognostic (3.28e-3)" "unprognostic (5.29e-2)" "unprognostic (3.61e-2)" "unprognostic (3.61e-2)" "unprognostic (6.16e-2)" "unprognostic (2.26e-1)" "unprognostic (4.79e-2)" 3.3 6.4 2.9 2.0 3.6 0.9 3.1 3.8 3.5 3.7 2.7 5.2 5.1 2.9 3.4 5.6 3.1 4.3 4.6 5.6 3.1 2.1 4.0 6.4 2.6 2.8 3.3 2.0 4.8 7.0 3.9 6.3 3.0 3.4 4.7 1.2 4.3 6.5 6.4 4.0 3.3 2.0 3.8 2.3 2.7 3.1 67.7 3.8 0.7 7.1 1.2 1.7 3.3 3.0 16.3 7.8 54.8 15.4 15.5 28.4 1.0 4.0 8.1 2.8 1.3 4.8 4.7 2.6 2.3 3.4 1.5 1.2 3.5 5.8 0.9 3.7 2.5 3.2 5.5 1.6 0.3 0.8 5.2 1.8 1.0 6.4 4.3 3.3 1.1 0.8 3.4 1.8 2.3 0.8 2.9 2.2 1.8 2.1 2.1 1.3 15.8 1.5 2.8 4.7 3.2 4.6 1.3 2.8 2.9 1.2 2.3 3.8 7.4 7.4 3.8 5.3 5.6 7.5 3.0 2.3 2.0 3.6 5.3 2.0 5.0 3.9 12.7 3.8 0.6 2.5 54.8 7.3 13.7 27.8 15.4 20.8 14.2 24.2 24.2 5.5 16.3 20.6 28.4 20.2 15.5 12.7 7.8 13.7 1.0 2.9 3.6 3.8 3.5 3.1 2.1 3.3 2.0 3.4 3.8 6.0 8.5 68.1 31.4 57.5 18.6 7.0 48.4 6.7 10.3 40.1 19.6 38.8 33.2 18.8 336.7 30.8 8.0 46.7 12.8 26.9 47.4 29.5 39.1 34.7 28.3 17.5 14.3 63.3 73.4 44.3 26.4 65.6 84.4 83.0 12.5 13.8 26.2 17.5 24.1 24.8 24.2 25.8 37.6 148.7 13.6 72.8 74.8 126.9 12.0 45.1 C1orf61 CROC4 ENSG00000125462 "Chromosome 1 open reading frame 61" Q13536 1 156404250-156430701 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 29 "brain: 184.8" "Group enriched" "Detected in some" 7 "Late spermatids: 222.1;Muller glia cells: 843.1" "Cancer enriched" "Detected in some" 116 "glioma: 77.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 6.3;MAIT T-cell: 5.2" "Lineage enriched" "Detected in single" 34 "T-cells: 6.3" "Cell line enriched" "Detected in some" 6 "BEWO: 17.3" NA NA "unprognostic (6.20e-2)" "unprognostic (2.46e-3)" "unprognostic (3.32e-1)" "unprognostic (1.28e-1)" "unprognostic (7.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.35e-2)" "unprognostic (9.00e-2)" "unprognostic (1.75e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-2)" "unprognostic (3.64e-2)" "unprognostic (8.16e-7)" "unprognostic (5.87e-3)" "unprognostic (9.89e-2)" "unprognostic (1.44e-2)" "unprognostic (5.88e-2)" 2.0 1.9 71.9 1.9 69.5 2.1 2.0 20.2 184.8 1.9 2.0 19.3 0.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 48.9 45.2 1.9 2.0 1.9 2.1 65.3 23.6 1.9 1.9 2.0 0.0 1.9 27.4 1.9 2.0 1.4 2.0 1.9 1.9 1.9 2.0 2.0 22.7 2.1 1.9 3.1 14.8 0.0 1.9 0.0 2.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.5 0.0 0.8 0.0 0.3 0.0 0.0 17.3 0.0 0.0 0.0 0.1 0.3 0.3 1.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.8 1.4 0.8 0.0 0.5 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.9 0.3 0.4 0.0 0.0 0.0 6.3 0.0 5.2 0.0 1.5 3.3 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.6 0.5 71.9 69.5 20.2 43.5 48.9 45.2 65.3 23.6 27.4 14.8 0.0 1.1 0.0 0.2 0.6 8.1 2.4 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 76.9 0.3 0.0 0.0 0.5 2.2 0.3 0.2 0.0 0.0 0.8 0.0 1.2 0.6 0.0 222.1 0.9 0.0 0.0 0.0 0.0 843.1 0.0 0.0 1.1 0.0 21.1 0.0 0.3 37.7 5.3 0.0 4.0 1.3 0.0 0.1 C1orf68 "LEP7, XP32" ENSG00000198854 "Chromosome 1 open reading frame 68" Q5T750 1 152719522-152720470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 123.1" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 68.4" "Group enriched" "Detected in some" 13 "head and neck cancer: 2.4;melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA057942 Approved "Plasma membrane,Cytosol" NA NA 61000 "Plasma membrane" Cytosol "HPA057942: " "unprognostic (1.73e-1)" "unprognostic (7.46e-2)" "unprognostic (9.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 68.4 0.0 0.0 0.0 0.0 C1orf87 "CREF, MGC34837" ENSG00000162598 "Chromosome 1 open reading frame 87" Q8N0U7 1 59987269-60073770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;fallopian tube: 33.4" "Group enriched" "Detected in some" 6 "Ciliated cells: 156.6;Early spermatids: 60.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in many" 4 "basal ganglia: 19.1;pons and medulla: 17.7" "Cell type enriched" "Detected in single" 19 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;HSkMC: 3.3;SCLC-21H: 1.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA031366, HPA031368" Enhanced NA NA "HPA031366: AB_2673847, HPA031368: AB_10600795" "unprognostic (1.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.83e-2)" "unprognostic (1.92e-2)" "unprognostic (6.69e-2)" "unprognostic (7.11e-2)" "unprognostic (8.95e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" 0.3 0.3 3.2 0.3 19.1 0.3 0.3 0.0 0.9 1.7 0.3 3.4 0.0 0.3 0.9 4.8 0.3 33.4 0.3 0.3 3.8 4.5 0.5 0.3 6.8 0.3 1.3 0.7 5.1 0.4 0.7 0.8 0.3 17.7 0.4 0.3 2.5 3.4 0.6 0.3 0.3 0.3 0.3 0.9 0.3 0.3 1.2 3.6 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.2 19.1 0.0 0.9 3.8 4.5 1.3 0.7 17.7 3.6 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 156.6 19.4 1.8 0.0 0.0 0.0 0.0 60.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.0 0.0 C1orf94 MGC15882 ENSG00000142698 "Chromosome 1 open reading frame 94" Q6P1W5 1 34166883-34219131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 24.6" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 53.5;Late spermatids: 24.4;Spermatocytes: 12.2" "Cancer enriched" "Detected in single" 10 "glioma: 1.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 11.4;U-87 MG: 33.0" "Low region specificity" "Detected in many" HPA045805 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045805: AB_10969626" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (9.77e-2)" "unprognostic (4.09e-2)" "unprognostic (1.65e-2)" "unprognostic (2.31e-1)" 0.0 0.1 0.6 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 24.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.2 1.8 0.5 0.7 0.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 53.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 12.2 0.5 0.0 0.0 0.0 0.0 0.0 C1QA ENSG00000173372 "Complement C1q A chain" P02745 1 22636506-22639608 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 204.0" "Cell type enhanced" "Detected in many" 28 "Hofbauer cells: 1354.3;Kupffer cells: 3186.4;Macrophages: 679.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "intermediate monocyte: 50.3;non-classical monocyte: 37.5" "Lineage enriched" "Detected in single" 57 "monocytes: 50.3" "Cell line enhanced" "Detected in some" "HMC-1: 3.9;NB-4: 2.3;RPMI-8226: 11.7;SCLC-21H: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002350, CAB009823" Supported "Secreted to blood" NA NA 1100000000 "CAB009823: AB_2228238, HPA002350: AB_1078552" "unprognostic (1.97e-1)" "unprognostic (1.14e-2)" "unprognostic (1.98e-3)" "unprognostic (3.07e-2)" "unprognostic (6.10e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" "unprognostic (1.99e-1)" "unprognostic (4.42e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (1.58e-6)" "unprognostic (1.54e-1)" "unprognostic (2.11e-3)" "unprognostic (2.75e-2)" "unprognostic (7.30e-2)" 51.4 33.0 12.4 19.3 21.0 5.3 40.6 1.9 10.9 10.8 20.3 8.0 2.1 22.1 8.2 25.9 11.3 15.5 22.6 43.9 9.2 10.4 14.4 27.6 60.7 94.4 17.2 4.6 9.5 11.9 2.4 9.6 33.6 15.8 16.0 15.9 12.2 9.4 7.5 7.9 4.3 24.7 24.8 26.8 204.0 11.6 12.3 16.6 7.5 10.9 5.4 8.4 24.1 12.8 0.0 0.8 0.1 50.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.5 0.0 0.0 0.8 0.5 11.7 0.0 0.0 5.2 1.6 0.1 0.0 0.0 0.0 0.9 0.1 0.4 0.0 0.3 0.7 0.2 1.5 0.0 0.1 0.2 0.2 0.1 0.0 1.2 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 37.5 0.0 0.0 2.1 12.4 21.0 1.9 10.9 9.2 10.4 17.2 4.6 15.8 16.6 32.8 68.3 87.4 1.4 16.4 0.4 9.2 53.5 28.1 33.0 0.0 0.0 7.6 0.0 0.0 1.7 7.3 0.0 0.0 0.2 8.7 13.9 1.2 19.8 15.7 1354.3 0.0 1.7 93.3 3186.4 4.5 12.0 679.3 25.3 1.0 0.0 0.0 0.0 0.0 0.4 1.0 0.3 77.6 9.0 0.5 2.0 14.6 15.2 15.8 0.0 1.0 C1QB ENSG00000173369 "Complement C1q B chain" P02746 1 22652762-22661538 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 262.8" "Group enriched" "Detected in many" 4 "Hofbauer cells: 1215.3;Kupffer cells: 2993.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 66 "intermediate monocyte: 41.9;non-classical monocyte: 26.9" "Lineage enriched" "Detected in single" 83 "monocytes: 41.9" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HaCaT: 2.8;NB-4: 2.6;SH-SY5Y: 2.9;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052116 Approved "Secreted to blood" NA NA 4700000000 "HPA052116: AB_2681735" "unprognostic (1.42e-1)" "unprognostic (3.36e-2)" "unprognostic (5.61e-3)" "unprognostic (8.20e-2)" "unprognostic (5.93e-2)" "unprognostic (4.09e-1)" "unprognostic (1.25e-1)" "unprognostic (2.35e-1)" "unprognostic (2.87e-2)" "unprognostic (2.21e-1)" "unprognostic (2.63e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (9.58e-6)" "unprognostic (4.14e-2)" "unprognostic (7.76e-3)" "unprognostic (4.83e-2)" "unprognostic (2.35e-2)" 76.7 42.3 30.3 22.0 54.5 7.1 17.6 3.3 27.8 12.1 28.2 27.6 1.4 30.0 9.0 25.5 10.8 21.5 33.2 19.8 19.8 17.0 21.8 51.5 87.9 84.1 45.7 6.8 9.8 11.2 4.2 14.4 41.2 35.7 15.0 24.6 17.2 13.9 9.3 9.2 4.3 30.5 41.9 52.2 262.8 14.4 11.7 38.1 7.4 9.8 3.7 9.5 36.8 6.6 0.0 0.5 0.1 41.9 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.2 2.6 1.6 0.0 0.0 1.6 1.1 1.9 0.0 0.0 1.9 2.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.3 2.9 0.1 0.5 0.5 0.3 0.6 0.0 0.5 0.0 0.0 41.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 26.9 0.0 0.0 1.4 30.3 54.5 3.3 27.8 19.8 17.0 45.7 6.8 35.7 38.1 11.9 23.2 50.8 1.6 5.6 1.0 5.0 35.7 6.7 19.4 3.5 0.0 5.3 0.0 0.0 1.5 5.9 0.3 0.0 0.0 7.3 6.4 1.6 10.5 14.4 1215.3 0.0 0.0 59.5 2993.5 4.2 7.8 520.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.7 3.4 58.2 1.4 0.2 1.0 4.0 8.0 25.4 0.0 1.1 C1QC C1QG ENSG00000159189 "Complement C1q C chain" P02747 1 22643630-22648110 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 192.2" "Group enriched" "Detected in many" 21 "Hofbauer cells: 1118.0;Kupffer cells: 1266.9;Macrophages: 421.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "intermediate monocyte: 28.4" "Lineage enriched" "Detected in single" 284 "monocytes: 28.4" "Cell line enhanced" "Detected in some" "HL-60: 1.8;NB-4: 2.7;RPMI-8226: 6.7;SH-SY5Y: 2.0;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001471, CAB009828" Supported "Secreted to blood" NA NA 513000000 1300000000 "CAB009828: AB_2067541, HPA001471: AB_1078553" "unprognostic (2.97e-1)" "unprognostic (6.80e-2)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (7.40e-2)" "unprognostic (2.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.40e-1)" "unprognostic (1.66e-2)" "unprognostic (7.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.06e-1)" "unprognostic (1.63e-3)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" 50.5 35.7 24.2 24.6 39.2 5.9 15.6 2.5 18.3 9.8 21.8 19.9 1.2 30.0 8.5 23.4 9.7 17.0 26.8 22.6 17.5 13.6 14.4 41.2 48.2 75.1 34.8 6.1 8.5 7.8 2.6 10.2 34.8 30.2 15.0 15.7 14.8 13.2 8.3 8.0 4.6 33.1 27.1 34.5 192.2 15.5 10.3 29.1 10.7 8.3 4.0 9.5 28.3 6.0 0.0 0.0 0.0 28.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.7 2.7 0.7 0.0 0.0 1.6 0.9 6.7 0.0 0.0 1.2 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.3 2.9 0.0 0.3 0.3 0.4 0.0 0.0 0.7 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.5 24.2 39.2 2.5 18.3 17.5 13.6 34.8 6.1 30.2 29.1 6.0 6.9 29.4 1.1 7.9 0.0 1.4 22.9 1.4 5.7 0.0 0.0 4.9 0.0 0.0 2.1 2.1 0.0 0.0 0.2 7.9 5.3 0.4 4.7 5.1 1118.0 0.0 0.0 29.4 1266.9 1.8 5.8 421.7 6.8 40.5 0.0 0.3 0.0 0.0 1.1 0.2 0.4 45.3 1.8 0.3 0.9 5.6 8.2 12.9 0.0 0.6 C1QL1 "C1QRF, C1QTNF14, CRF" ENSG00000131094 "Complement C1q like 1" O75973 17 44959693-44968071 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.5" "Cell type enriched" "Detected in some" 51 "Horizontal cells: 635.6" "Cancer enriched" "Detected in all" 7 "glioma: 116.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 18.2;SH-SY5Y: 13.0;U-2 OS: 45.6;U-251 MG: 13.7;U-87 MG: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (3.63e-3)" "unprognostic (3.15e-2)" "unprognostic (2.05e-2)" "unprognostic (7.65e-2)" "unprognostic (3.40e-3)" "unprognostic (2.34e-1)" "unprognostic (6.64e-3)" "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (1.31e-8)" "unprognostic (2.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.61e-2)" "unprognostic (3.04e-1)" 2.5 2.3 20.2 2.0 9.7 1.3 1.5 4.9 42.5 1.6 2.9 12.7 0.0 5.2 5.0 2.0 2.5 1.8 1.8 1.8 14.4 16.3 6.4 1.4 1.3 1.3 13.3 10.4 1.3 4.3 1.2 0.7 1.3 35.2 11.6 1.8 10.3 1.4 1.4 1.2 1.6 3.9 2.5 12.8 1.3 4.4 1.6 8.5 0.0 1.4 0.0 1.2 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.6 0.6 9.2 0.2 0.0 0.2 0.3 0.4 0.3 0.8 0.3 0.3 0.1 1.5 0.2 2.8 0.3 1.5 0.1 0.1 5.9 3.9 0.0 4.2 0.0 1.1 0.0 1.1 0.2 0.0 0.4 0.1 3.2 0.0 1.6 0.0 0.1 0.2 0.5 1.9 0.0 1.5 0.2 5.6 3.2 0.1 0.1 0.0 0.2 18.2 13.0 7.8 0.7 0.6 0.5 2.1 0.1 0.0 0.7 45.6 0.5 13.7 0.5 0.0 0.0 14.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 9.7 4.9 13.9 14.4 16.3 13.3 10.4 35.2 8.5 0.0 0.0 0.0 0.2 0.2 6.4 0.8 5.1 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.0 635.6 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.4 0.1 0.0 0.0 0.0 10.6 0.0 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 C1QL2 "C1QTNF10, CTRP10" ENSG00000144119 "Complement C1q like 2" Q7Z5L3 2 119156243-119158889 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 15.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 2.7;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "GAMG: 1.9;NTERA-2: 2.2;SCLC-21H: 7.3" "Region enhanced" "Detected in many" "hippocampal formation: 25.0" "Low region specificity" "Detected in many" HPA057934 Uncertain "Secreted in brain" NA NA "HPA057934: AB_2683558" "unprognostic (6.95e-2)" "unprognostic (9.74e-2)" "unprognostic (4.48e-3)" "unprognostic (1.08e-1)" "unprognostic (9.91e-4)" "unprognostic (2.60e-5)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 0.7 0.7 15.3 0.7 6.8 0.7 1.1 0.9 15.1 0.7 0.7 3.1 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.8 15.4 9.0 0.7 0.8 0.7 1.3 4.5 5.4 0.7 0.7 0.7 0.3 0.7 1.3 0.7 0.7 2.4 1.0 0.7 0.7 0.9 0.7 0.7 1.5 0.8 0.7 1.1 3.1 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 6.8 0.9 15.1 15.4 9.0 4.5 5.4 1.3 3.1 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.0 7.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C1QL3 "C1ql, C1QTNF13, CTRP13, K100" ENSG00000165985 "Complement C1q like 3" Q5VWW1 10 16513743-16522005 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.8" "Cell type enhanced" "Detected in some" 28 "Cardiomyocytes: 1.2;Rod photoreceptor cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HDLM-2: 24.9;SCLC-21H: 15.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 99.4;cerebral cortex: 74.9;hippocampal formation: 78.6" "Secreted in brain" NA NA "unprognostic (7.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (8.19e-3)" "unprognostic (6.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.89e-2)" "unprognostic (2.76e-2)" "unprognostic (2.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "prognostic favorable (6.29e-5)" "unprognostic (3.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.59e-2)" "unprognostic (6.12e-2)" 1.2 1.5 24.8 1.0 14.6 0.5 0.5 7.4 33.8 0.5 0.6 0.1 0.0 2.6 0.7 0.4 0.7 0.5 0.6 1.4 22.8 4.3 1.9 0.8 0.9 1.3 1.4 23.4 0.4 0.9 0.4 0.3 0.6 2.3 1.0 0.4 0.2 1.0 0.5 1.7 1.6 1.2 0.4 0.9 1.0 0.9 0.5 0.0 0.0 1.6 0.0 0.5 1.2 0.4 1.0 0.9 0.8 2.0 0.7 2.8 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.6 0.8 2.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 24.9 0.3 1.4 0.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.2 0.1 0.1 0.9 0.9 0.1 0.9 0.2 1.4 0.1 0.5 15.4 1.3 1.3 0.2 0.8 0.3 0.1 0.2 0.0 0.0 0.1 0.7 0.0 0.6 0.8 0.7 0.1 1.4 0.6 0.0 1.1 0.8 2.1 2.0 1.3 1.0 1.6 1.8 0.5 0.8 1.7 2.8 0.2 0.7 1.4 0.9 1.7 0.6 24.8 14.6 7.4 29.5 22.8 4.3 1.4 23.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1QL4 "C1QTNF11, CTRP11" ENSG00000186897 "Complement C1q like 4" Q86Z23 12 49332411-49337188 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;testis: 7.4" "Group enriched" "Detected in some" 11 "Early spermatids: 21.0;Horizontal cells: 23.8;Late spermatids: 67.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 27.9;HAP1: 4.3;PC-3: 4.7;U-2 OS: 7.4" "Region enhanced" "Detected in some" "midbrain: 7.4" "Group enriched" "Detected in some" 5 "midbrain: 5.1;pons and medulla: 9.7" "Secreted in brain" NA NA "unprognostic (1.97e-2)" "unprognostic (2.77e-2)" "unprognostic (4.87e-2)" "unprognostic (7.37e-2)" "unprognostic (4.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.49e-3)" "unprognostic (8.64e-3)" "unprognostic (2.89e-1)" "unprognostic (5.11e-3)" "unprognostic (7.62e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (9.73e-2)" "unprognostic (2.85e-2)" "unprognostic (9.40e-2)" "unprognostic (3.72e-2)" 0.4 0.3 2.0 0.1 1.0 0.1 0.4 0.4 2.3 0.7 0.1 0.3 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.6 2.4 0.8 0.2 0.1 0.1 1.4 0.0 0.6 0.1 0.1 0.4 0.1 9.2 0.2 0.1 0.8 0.1 0.1 0.4 1.7 0.1 0.2 2.1 0.4 0.1 7.4 0.9 0.0 3.6 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.3 27.9 0.0 0.0 0.1 0.0 0.1 0.4 1.5 0.7 0.1 0.3 1.6 0.0 1.6 0.0 4.3 0.0 0.5 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.6 0.0 0.0 0.5 0.1 4.7 0.1 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.2 1.3 0.0 0.6 0.1 0.0 0.4 7.4 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.4 2.1 0.6 2.4 1.4 0.0 9.2 0.9 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.0 0.0 67.3 0.9 0.0 3.3 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.8 0.0 0.5 1.6 1.4 0.1 0.0 0.0 0.0 0.0 C1QTNF1 "CTRP1, FLJ90694, GIP, ZSIG37" ENSG00000173918 "C1q and TNF related 1" Q9BXJ1 17 79022814-79049788 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.5" "Group enriched" "Detected in many" 5 "Ito cells: 145.5;Sertoli cells: 103.5;Smooth muscle cells: 105.0;Syncytiotrophoblasts: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 84.6;BJ hTERT+: 19.8;HHSteC: 32.0;HSkMC: 17.0;U-87 MG: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB025429, HPA051101" Uncertain Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 314000000 30000 "Nucleoplasm, Cytosol" "CAB025429: , HPA051101: AB_2681343" "unprognostic (2.58e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (1.20e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" "unprognostic (7.11e-2)" "unprognostic (3.18e-1)" "unprognostic (1.07e-2)" "unprognostic (1.23e-2)" "unprognostic (7.48e-2)" "unprognostic (9.81e-3)" "unprognostic (5.83e-2)" "prognostic unfavorable (9.09e-9)" "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (1.95e-2)" 62.4 18.3 1.7 7.4 4.3 0.4 60.5 1.3 5.1 14.3 10.3 5.2 30.8 2.5 11.0 14.2 10.2 14.4 19.1 77.5 2.0 4.1 9.5 19.4 9.7 16.6 4.8 2.5 25.2 7.5 10.1 4.2 34.0 7.6 13.3 3.3 19.6 13.8 51.8 11.9 8.6 6.1 6.9 2.5 14.3 6.1 8.8 2.8 1.3 26.9 13.3 5.0 14.8 27.5 0.5 0.3 1.9 0.3 1.2 0.4 0.0 0.0 8.2 0.0 0.0 84.6 7.6 0.0 4.2 19.8 1.8 3.5 0.6 4.0 0.0 0.4 1.2 5.2 0.2 0.2 0.1 1.3 0.0 0.9 0.0 3.1 0.4 32.0 0.0 0.0 17.0 0.0 3.8 0.2 2.6 2.4 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.9 8.6 0.0 5.5 0.1 0.0 0.1 0.3 1.6 2.7 0.4 7.9 0.3 0.0 0.0 0.3 9.0 0.2 1.0 1.2 0.0 0.0 0.0 20.0 0.0 0.8 1.9 0.3 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.1 0.5 0.2 0.4 0.4 1.2 0.2 0.3 0.0 0.0 1.7 4.3 1.3 4.2 2.0 4.1 4.8 2.5 7.6 2.8 0.0 1.1 0.0 0.6 5.8 0.0 9.4 10.2 0.0 0.0 1.8 0.0 17.3 0.0 13.9 0.1 10.5 1.3 0.0 5.3 1.2 14.4 1.2 0.0 1.5 2.3 0.0 4.6 145.5 10.5 0.0 9.8 0.7 3.3 19.0 6.8 0.5 3.2 2.9 3.2 0.0 0.3 103.5 105.0 0.0 0.7 4.0 39.6 0.5 4.5 0.5 C1QTNF12 "ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127" ENSG00000184163 "C1q and TNF related 12" Q5T7M4 1 1242446-1246722 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 11.0;skin 1: 7.8" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 10.0;Proximal tubular cells: 37.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.6;NK-cell: 2.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "EFO-21: 8.3;U-2 OS: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024107 Uncertain Approved Vesicles "Secreted to blood" NA NA 38200000 Vesicles "HPA024107: AB_2101207" "unprognostic (1.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.45e-1)" "unprognostic (1.24e-2)" "unprognostic (6.60e-3)" "unprognostic (2.43e-1)" "unprognostic (2.67e-3)" "unprognostic (1.01e-2)" "unprognostic (2.58e-1)" "unprognostic (1.05e-2)" "unprognostic (8.02e-3)" "unprognostic (1.10e-2)" "unprognostic (9.68e-3)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.09e-1)" "unprognostic (1.20e-1)" 1.0 0.0 0.5 0.2 0.0 0.0 0.5 0.2 0.2 0.1 3.4 11.0 0.1 0.0 1.2 0.2 0.1 0.2 0.0 1.0 3.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 1.2 0.4 0.0 0.1 7.8 10.4 0.1 0.2 0.0 0.3 2.4 0.2 0.1 0.0 0.4 0.3 0.6 2.6 0.3 2.2 0.4 0.2 0.3 0.0 0.0 0.6 0.4 0.1 1.6 1.1 0.0 0.1 0.0 0.6 0.4 0.1 8.3 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.1 0.1 0.1 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.1 0.9 0.6 0.1 0.3 0.0 1.3 0.0 0.0 1.2 0.3 0.0 0.0 0.7 0.0 0.6 0.1 0.0 0.0 8.2 0.1 0.0 1.7 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.6 0.3 0.4 0.0 2.6 2.2 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.2 0.0 0.0 0.0 0.0 0.7 10.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 37.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 C1QTNF3 "2310005P21Rik, Corcs, Cors, Cors-26, CTRP3" ENSG00000082196 "C1q and TNF related 3" Q9BXJ4 5 34019448-34043832 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "salivary gland: 171.5" "Group enriched" "Detected in many" 27 "Early spermatids: 150.0;Late spermatids: 294.3;Muller glia cells: 207.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 198 "U-266/84: 132.6" "HPA064996, HPA066011" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 44100000 27000000 "Golgi apparatus" "HPA064996: AB_2685399, HPA066011: AB_2685597" "unprognostic (7.71e-2)" "unprognostic (2.81e-3)" "unprognostic (5.83e-2)" "unprognostic (6.58e-2)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-3)" "unprognostic (5.18e-2)" "unprognostic (1.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.89e-3)" "unprognostic (1.80e-1)" "unprognostic (9.38e-3)" "unprognostic (2.35e-1)" 4.4 0.3 5.7 2.7 6.4 0.2 4.5 9.6 3.4 2.4 7.9 1.8 4.8 2.1 2.5 3.9 22.5 2.0 3.6 0.9 4.2 3.1 4.0 0.5 2.6 0.5 4.3 1.4 1.1 1.0 0.3 0.7 0.8 3.7 30.2 6.6 2.4 171.5 3.2 1.3 1.4 5.5 14.4 5.6 0.5 8.4 7.9 2.6 0.6 1.0 3.6 0.7 13.1 3.2 0.4 0.1 0.4 0.0 0.0 1.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.1 0.1 132.6 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.1 0.4 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.4 5.7 6.4 9.6 2.8 4.2 3.1 4.3 1.4 3.7 2.6 3.0 1.3 1.5 0.6 5.0 4.5 0.4 7.6 1.4 1.2 3.5 0.0 0.8 1.7 0.7 150.0 3.1 0.7 0.0 1.2 0.4 7.4 0.6 0.0 1.5 1.1 7.9 1.7 0.6 0.6 294.3 1.7 1.3 6.8 0.0 1.4 207.9 0.5 0.0 2.5 2.0 7.8 0.0 1.9 7.5 1.7 5.1 0.3 0.7 2.1 0.4 C1QTNF4 "CTRP4, ZACRP4" ENSG00000172247 "C1q and TNF related 4" Q9BXJ3 11 47589664-47594659 "Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.8" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 34.8;Leydig cells: 42.6;Muller glia cells: 41.3;Peritubular cells: 36.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "REH: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041032 Approved "Secreted in brain" NA NA "HPA041032: AB_10671170" "unprognostic (1.84e-3)" "unprognostic (1.58e-1)" "unprognostic (8.98e-4)" "unprognostic (8.19e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-3)" "unprognostic (6.78e-2)" "unprognostic (6.11e-2)" "unprognostic (6.35e-2)" "unprognostic (4.00e-1)" "unprognostic (4.91e-4)" "unprognostic (1.22e-1)" "unprognostic (8.22e-6)" "unprognostic (6.02e-3)" "unprognostic (1.00e-1)" "unprognostic (2.80e-2)" "unprognostic (6.28e-2)" 2.5 1.5 14.2 1.4 34.2 4.1 1.6 16.8 37.8 1.6 1.5 2.0 0.0 1.7 2.1 1.4 1.3 1.5 1.6 1.4 9.7 7.1 1.4 1.4 1.4 1.5 7.9 15.5 3.3 2.2 6.3 4.7 1.4 14.5 1.8 1.4 0.0 1.3 1.7 1.8 1.5 1.6 1.8 5.2 1.6 1.5 2.0 3.7 0.0 1.5 0.0 1.4 1.3 0.3 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.0 0.7 0.0 0.0 11.2 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 34.2 16.8 37.8 9.7 7.1 7.9 15.5 14.5 3.7 0.0 0.0 0.0 6.0 2.2 14.1 0.4 0.0 0.0 0.0 3.5 15.7 1.0 3.3 0.0 9.0 2.6 0.0 0.0 0.2 2.2 11.3 3.8 0.0 0.2 2.6 4.8 0.0 2.5 0.0 34.8 42.6 0.0 10.1 0.0 0.0 41.3 0.2 0.0 36.0 0.4 22.2 25.8 3.1 11.3 26.6 1.6 3.0 0.0 0.0 1.4 C1QTNF5 "CTRP5, DKFZp586B0621, LORD" ENSG00000223953 "C1q and TNF related 5" Q9BXJ0 11 119338939-119340940 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 30.5" "Cell type enriched" "Detected in single" 4 "Ductal cells: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 9.4;HHSteC: 19.0;hTERT-RPE1: 14.9;HUVEC TERT2: 28.0;TIME: 25.6" "Low region specificity" "Detected in all" "CAB025607, HPA038604" Uncertain "Secreted to blood" NA NA 219000000 1600000 "CAB025607: , HPA038604: AB_2676110" 13.6 3.2 3.7 4.3 4.0 0.0 6.4 3.1 7.1 6.4 6.1 7.9 1.5 5.5 7.1 8.3 3.7 3.8 19.0 10.2 3.9 3.6 7.3 3.2 8.9 3.6 8.1 2.3 6.2 3.1 1.2 4.2 5.0 9.6 4.3 2.7 30.5 3.2 3.2 4.2 3.1 5.8 10.9 5.4 5.7 4.3 3.1 5.2 0.0 4.1 4.6 1.1 8.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 9.4 2.6 0.1 2.3 0.1 0.3 1.4 0.0 0.0 0.0 1.0 7.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 19.0 0.0 0.0 4.5 0.0 0.1 0.0 14.9 28.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.5 0.5 0.0 0.0 25.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.0 3.1 3.2 3.9 3.6 8.1 2.3 9.6 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180167-37199385 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 23.7;placenta: 79.5" "Cell type enriched" "Detected in many" 12 "Extravillous trophoblasts: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 45.0;RT4: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" No No 354000000 Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 3.3 4.4 1.2 4.2 1.6 0.8 2.5 1.2 1.8 7.8 2.5 1.3 1.6 1.0 23.7 7.2 1.6 5.2 6.2 3.1 1.4 0.7 3.9 7.9 9.2 3.1 1.2 1.3 5.9 2.3 1.4 1.4 79.5 1.7 4.3 2.5 4.4 2.2 3.4 1.5 3.1 3.2 5.7 1.8 4.6 1.8 3.5 1.2 1.6 2.4 1.7 1.8 5.1 2.7 2.4 1.1 1.8 0.5 4.0 3.8 1.0 6.7 8.4 4.4 1.5 0.8 8.9 13.4 1.4 2.8 1.1 0.8 1.5 9.9 0.0 5.7 2.3 0.6 14.0 0.1 3.4 0.5 1.9 1.1 1.1 3.2 1.5 3.1 0.0 0.9 12.3 1.9 0.9 0.2 3.0 10.6 0.3 0.0 3.1 0.4 45.0 0.0 0.2 2.8 1.0 0.1 0.1 0.0 1.1 10.2 20.8 0.7 5.7 0.4 8.1 1.1 2.4 2.8 0.2 3.6 0.4 2.3 0.1 0.0 6.5 0.1 0.0 0.9 0.8 1.2 1.0 0.5 1.5 0.7 0.5 0.8 0.8 1.3 1.0 0.5 2.4 2.9 2.2 1.8 4.0 0.3 1.1 3.8 1.0 1.2 1.6 1.2 1.8 1.4 0.7 1.2 1.3 1.7 1.2 0.0 0.0 3.0 1.4 1.3 0.9 1.1 2.5 4.0 2.3 1.8 0.0 4.2 1.7 1.9 1.7 1.4 2.6 0.0 1.0 349.8 8.9 0.6 1.1 5.0 8.4 0.0 0.0 11.6 1.0 6.2 0.6 0.9 5.0 1.0 2.1 4.2 2.0 3.5 0.4 1.3 0.7 0.0 3.3 7.0 4.0 0.3 28.8 2.5 3.9 1.0 C1QTNF7 CTRP7 ENSG00000163145 "C1q and TNF related 7" Q9BXJ2 4 15339818-15446166 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 39.6" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 15.1;Fibroblasts: 10.3;Leydig cells: 21.0;Peritubular cells: 29.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.7" "Group enriched" "Detected in some" 5 "ASC diff: 9.2;ASC TERT1: 6.4;HSkMC: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB007055, HPA051797, HPA055392" Uncertain Approved Vesicles "Secreted to blood" NA NA 238000000 Vesicles "CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596" "unprognostic (6.61e-2)" "unprognostic (4.50e-2)" "unprognostic (6.16e-2)" "unprognostic (6.50e-4)" "unprognostic (1.24e-1)" "unprognostic (4.98e-3)" "unprognostic (2.31e-2)" "unprognostic (7.69e-3)" "unprognostic (7.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.97e-4)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (7.56e-3)" "unprognostic (7.28e-3)" 16.0 0.9 0.6 24.7 0.8 0.0 7.4 0.3 0.7 39.6 12.0 0.5 3.3 0.6 24.6 10.1 17.3 6.2 20.3 5.4 0.6 0.6 4.0 1.0 7.9 0.5 0.8 0.5 15.9 1.3 0.0 1.4 5.4 0.8 22.0 3.2 5.4 2.7 2.4 2.2 3.5 4.1 22.1 0.7 10.2 10.4 4.4 0.1 0.3 4.2 13.0 2.0 16.3 15.8 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 6.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3.4 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.3 0.7 0.6 0.6 0.8 0.5 0.8 0.1 0.0 0.0 0.0 0.0 3.2 15.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 10.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 21.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 29.7 1.0 0.9 6.5 8.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 C1QTNF8 "CTRP8, UNQ5829" ENSG00000184471 "C1q and TNF related 8" P60827 16 1090005-1096244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.6;brain: 2.1;fallopian tube: 4.5;pituitary gland: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.3;HEK 293: 1.0" "Not detected" "Not detected" HPA056438 Uncertain "Secreted - unknown location" NA NA "HPA056438: AB_2683134" "unprognostic (8.65e-2)" "unprognostic (2.56e-2)" "unprognostic (5.46e-2)" 0.0 2.6 0.7 0.0 1.7 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.8 2.1 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C1QTNF9 "AQL1, C1QTNF9A, CTRP9, MGC48915" ENSG00000240654 "C1q and TNF related 9" P0C862 13 24307166-24322535 "Predicted secreted proteins, Transporters" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 15.2;skeletal muscle: 14.1" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 1.2;Collecting duct cells: 1.8;Early spermatids: 1.5;Endothelial cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.9;OE19: 1.8" HPA056632 Uncertain "Secreted to blood" NA NA 210000000 "HPA056632: AB_2683197" "unprognostic (1.18e-2)" "unprognostic (3.22e-2)" "unprognostic (2.44e-2)" "unprognostic (3.14e-3)" "unprognostic (9.22e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-2)" "unprognostic (3.63e-2)" "unprognostic (1.03e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-2)" "unprognostic (4.16e-2)" "unprognostic (3.29e-4)" "unprognostic (1.38e-2)" "unprognostic (1.41e-1)" "unprognostic (1.67e-1)" "unprognostic (2.22e-1)" 5.6 0.3 0.2 2.4 0.9 0.3 4.9 0.1 0.2 0.7 2.8 0.1 0.1 1.1 1.6 1.6 4.8 0.3 1.9 15.2 0.9 0.3 0.3 0.8 0.4 0.4 0.2 0.1 0.4 1.2 0.5 0.2 4.8 0.1 2.6 0.7 0.1 0.9 1.0 14.1 0.6 1.2 1.8 0.2 0.6 1.1 1.6 0.1 0.3 0.5 5.2 0.9 1.0 7.1 0.5 0.7 0.7 0.3 0.0 0.2 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.5 0.1 0.9 0.0 1.3 0.7 0.5 0.3 0.0 0.0 0.2 0.1 0.0 0.5 0.4 0.7 0.0 0.4 0.0 0.0 0.1 0.5 0.3 0.1 0.0 0.5 0.0 0.0 0.5 0.3 1.7 0.0 1.9 0.7 1.2 0.2 1.8 1.3 0.2 0.2 0.0 0.5 0.5 0.1 0.2 0.5 0.0 0.2 0.3 0.4 0.2 0.0 0.4 0.6 1.1 0.4 0.8 0.3 0.5 0.7 0.7 1.1 0.1 0.1 0.0 0.2 0.1 0.0 0.5 0.1 0.2 0.0 0.5 0.0 0.2 0.7 0.0 0.3 0.7 0.0 0.0 0.2 0.9 0.1 0.1 0.9 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 C1QTNF9B CTRP9B ENSG00000205863 "C1q and TNF related 9B" B2RNN3 13 23890525-23902655 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 17.7;testis: 8.5" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 1.6;Late spermatids: 1.4" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 8.6;OE19: 6.5" HPA056632 Uncertain "Secreted - unknown location" NA NA "HPA056632: AB_2683197" "unprognostic (3.43e-1)" "unprognostic (3.42e-1)" "unprognostic (2.18e-2)" "unprognostic (9.51e-2)" "unprognostic (2.18e-1)" "unprognostic (4.10e-2)" "unprognostic (2.43e-1)" "unprognostic (3.32e-3)" "unprognostic (1.52e-2)" "unprognostic (7.26e-2)" "unprognostic (3.01e-3)" "unprognostic (7.04e-2)" "unprognostic (5.56e-3)" "unprognostic (3.89e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (1.34e-1)" 1.5 0.5 0.6 0.3 0.5 0.0 0.8 0.0 0.5 0.1 0.6 0.3 0.5 0.0 1.4 0.1 0.5 3.2 4.4 1.3 0.1 0.1 0.1 0.0 0.1 0.2 0.5 0.0 1.1 0.4 4.8 0.0 1.5 0.0 3.5 17.7 0.2 0.4 0.0 1.4 0.6 8.5 0.5 0.0 0.8 0.2 2.3 3.0 1.7 1.6 1.3 1.2 0.5 1.3 3.0 1.2 1.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 1.2 1.9 0.3 0.0 0.1 2.4 3.1 0.0 0.0 0.0 1.9 2.5 0.7 1.6 1.6 0.3 0.3 0.7 0.1 0.0 0.0 0.0 1.5 0.0 8.6 0.7 1.6 0.0 2.0 0.4 0.1 2.0 6.5 3.0 1.2 1.5 2.4 0.0 0.2 3.7 0.1 1.8 0.1 3.0 0.9 0.9 0.4 0.2 2.9 0.8 0.2 1.8 2.6 0.4 1.3 3.6 1.1 0.6 0.0 0.8 1.7 1.2 1.1 0.4 1.0 0.2 0.1 0.6 2.3 0.4 0.6 0.0 1.3 1.6 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 C1R ENSG00000159403 "Complement C1r" P00736 12 7080209-7092607 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 370.2" "Group enriched" "Detected in many" 5 "Fibroblasts: 462.9;Hepatocytes: 1385.8;Leydig cells: 1057.9;Peritubular cells: 364.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "ASC diff: 181.7;ASC TERT1: 92.7;BJ hTERT+: 80.0;BJ hTERT+ SV40 Large T+ RasG12V: 49.3;HSkMC: 107.4" "Low region specificity" "Detected in all" "HPA001251, HPA001551" Uncertain Uncertain Nucleoplasm,Cytosol "Secreted to blood" NA NA 14000000000 "Nucleoplasm, Cytosol" "HPA001251: AB_2666252, HPA001551: AB_10754818" "unprognostic (1.55e-2)" "unprognostic (8.97e-2)" "unprognostic (3.46e-2)" "unprognostic (1.92e-1)" "unprognostic (1.47e-2)" "unprognostic (2.66e-2)" "unprognostic (1.94e-2)" "unprognostic (2.05e-1)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (1.94e-14)" "unprognostic (3.54e-2)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.59e-2)" 45.8 17.4 2.6 18.1 3.8 0.0 82.0 1.4 2.8 36.7 24.5 2.4 11.2 5.0 27.2 66.8 38.1 33.3 46.7 49.5 1.9 1.8 27.5 370.2 25.3 46.8 3.5 2.0 103.5 11.4 1.4 6.3 10.3 4.6 47.8 15.3 17.7 12.8 13.2 16.0 10.7 14.4 53.2 6.2 35.1 19.8 39.3 1.9 2.3 30.6 20.7 15.1 46.8 83.8 0.4 0.0 2.5 0.4 3.2 3.4 0.8 0.1 1.5 0.1 1.3 181.7 92.7 0.1 20.4 80.0 24.2 49.3 0.2 0.3 0.0 0.6 15.9 1.6 0.3 1.7 0.8 3.4 1.9 0.1 0.0 0.6 0.6 34.9 0.1 0.2 107.4 0.5 11.0 0.8 18.4 0.4 0.1 0.0 2.5 3.1 0.0 0.9 0.1 0.8 0.0 0.1 1.1 0.5 0.1 0.1 0.9 0.0 0.3 14.7 0.4 0.4 0.2 0.0 0.0 0.0 5.8 0.9 26.7 0.1 0.1 0.4 0.0 8.3 0.1 0.8 0.0 0.4 2.0 1.6 0.1 2.0 0.0 1.4 3.4 0.0 0.4 2.8 2.9 2.5 3.2 0.0 0.0 1.4 0.8 2.6 3.8 1.4 2.8 1.9 1.8 3.5 2.0 4.6 1.9 20.8 84.7 28.4 53.6 48.5 0.2 14.6 168.2 6.7 34.2 17.4 2.0 2.9 3.3 164.2 3.5 51.3 0.3 23.3 39.1 4.8 462.9 14.1 9.3 1385.8 10.3 0.0 0.0 128.9 25.4 9.4 1057.9 10.1 50.6 2.8 0.6 15.1 74.1 0.6 364.9 5.0 0.9 168.1 97.8 5.7 4.1 35.0 4.3 13.1 0.7 9.8 C1RL "C1r-LP, C1RL1" ENSG00000139178 "Complement C1r subcomponent like" Q9NZP8 12 7089587-7109273 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.1" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 133.0;Leydig cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 31.8;HSkMC: 35.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA011338, CAB026172" Supported "Secreted to blood" NA NA 5500000000 20000000000 "CAB026172: , HPA011338: AB_1847111" "prognostic favorable (7.92e-4)" "unprognostic (7.76e-2)" "unprognostic (3.91e-3)" "unprognostic (5.25e-3)" "unprognostic (2.92e-3)" "unprognostic (9.60e-2)" "unprognostic (2.75e-3)" "unprognostic (7.76e-2)" "unprognostic (1.22e-1)" "unprognostic (4.34e-1)" "unprognostic (9.58e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.52e-7)" "unprognostic (1.75e-1)" "unprognostic (5.74e-2)" "unprognostic (2.52e-1)" "unprognostic (2.26e-3)" 16.5 31.2 3.8 10.0 5.5 6.1 14.2 1.2 4.9 12.1 13.5 3.2 10.5 6.0 12.4 14.9 13.3 14.5 14.7 10.0 2.5 1.6 21.4 96.1 14.2 13.1 4.5 2.7 21.3 23.8 5.2 15.7 4.2 6.4 16.5 7.2 11.3 16.9 11.5 11.1 7.8 9.5 15.4 9.3 12.7 11.1 7.2 4.7 2.8 14.4 8.1 7.0 15.5 16.4 2.2 1.7 11.7 2.5 0.6 1.4 0.9 2.2 6.0 0.6 6.0 18.5 31.8 4.2 3.7 17.3 3.7 11.3 3.8 10.4 0.9 3.2 3.0 3.8 5.0 1.6 6.4 1.5 9.3 0.3 3.5 5.9 8.8 15.0 0.7 17.3 35.2 12.1 2.4 7.4 18.1 3.9 1.9 2.8 2.3 2.3 0.1 0.5 0.7 1.1 0.5 0.2 2.0 0.0 0.7 10.5 10.1 0.4 1.3 12.7 1.6 2.3 1.1 1.5 3.1 3.3 3.4 6.3 3.9 0.7 1.7 0.7 0.1 6.4 2.5 1.5 7.2 1.5 8.0 1.4 2.3 0.6 2.2 1.4 1.0 1.7 1.1 0.9 0.8 11.7 0.6 2.5 0.9 0.8 0.9 3.8 5.5 1.2 4.9 2.5 1.6 4.5 2.7 6.4 4.7 14.9 30.5 9.5 12.8 3.4 0.4 2.1 20.4 14.7 28.4 5.2 2.0 0.1 1.7 24.9 0.1 10.8 7.8 0.0 46.6 0.2 11.9 10.2 3.5 133.0 3.0 0.0 4.1 23.4 9.8 0.9 51.5 10.7 3.3 10.0 8.1 3.4 26.2 7.0 19.1 7.6 1.0 0.0 5.1 0.5 0.7 2.8 0.1 13.1 8.4 7.3 C1S ENSG00000182326 "Complement C1s" P09871 12 6988259-7071032 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 351.6" "Cell type enhanced" "Detected in many" 21 "Hepatocytes: 2464.3;Leydig cells: 1104.9;Peritubular cells: 601.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 6.2" "Lineage enriched" "Detected in single" 17 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "ASC diff: 99.3;ASC TERT1: 132.1;BJ hTERT+: 42.1;HSkMC: 70.1" "Low region specificity" "Detected in all" "CAB016722, HPA018852" Supported Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 93000000000 13000000000 Nucleoplasm Cytosol "CAB016722: , HPA018852: AB_1847112" "unprognostic (2.72e-3)" "unprognostic (7.31e-2)" "unprognostic (9.37e-2)" "unprognostic (1.39e-2)" "unprognostic (1.05e-2)" "unprognostic (9.63e-2)" "prognostic favorable (7.73e-4)" "unprognostic (6.38e-2)" "unprognostic (1.16e-1)" "unprognostic (6.14e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (7.44e-15)" "unprognostic (2.02e-2)" "unprognostic (5.68e-3)" "unprognostic (1.19e-2)" "unprognostic (5.39e-2)" 48.7 16.6 3.3 18.7 4.1 0.0 55.7 1.9 3.1 35.3 31.1 2.9 12.7 6.8 32.2 50.0 38.3 46.4 47.2 34.4 2.5 1.1 18.0 351.6 31.4 21.1 6.3 3.2 98.8 15.5 1.9 6.0 8.5 6.5 52.1 18.6 26.1 14.6 12.4 18.2 14.7 19.2 47.6 8.8 32.5 24.6 37.2 2.3 3.2 30.5 22.7 18.8 48.6 73.0 0.2 0.1 6.2 0.3 0.2 0.1 0.0 0.0 2.2 0.1 1.3 99.3 132.1 0.4 17.9 42.1 9.5 17.4 0.0 0.2 0.0 2.4 22.2 2.5 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.6 4.7 29.9 0.2 0.1 70.1 0.3 7.7 0.5 11.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.1 10.9 0.2 0.2 2.1 0.0 0.0 0.0 4.4 0.3 16.9 0.0 0.0 0.0 0.1 9.5 0.1 0.2 0.6 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.1 6.2 0.2 0.1 0.1 0.0 0.0 3.3 4.1 1.9 3.1 2.5 1.1 6.3 3.2 6.5 2.3 14.9 34.2 18.3 17.5 67.8 0.6 21.4 152.8 6.7 20.5 3.5 0.0 2.9 1.7 170.0 5.7 37.8 0.0 46.7 37.9 3.5 388.0 7.4 4.7 2464.3 7.1 4.8 0.0 105.6 49.3 8.8 1104.9 9.4 84.4 1.8 0.0 15.1 43.6 0.0 601.8 4.1 0.9 135.8 123.7 5.0 4.1 47.0 2.2 4.3 0.0 3.0 C2 ENSG00000166278 "Complement C2" P06681 6 31897785-31945672 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 132.7" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 2: 116.0;Hepatocytes: 339.0;Hofbauer cells: 221.2" "Cancer enriched" "Detected in all" 9 "liver cancer: 100.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5" "Lineage enriched" "Detected in single" 8 "monocytes: 6.5" "Group enriched" "Detected in some" 5 "Hep G2: 17.3;Karpas-707: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" CAB016775 Supported "Secreted to blood" NA NA 52000000000 "CAB016775: " "unprognostic (2.05e-1)" "unprognostic (1.22e-1)" "unprognostic (7.68e-2)" "unprognostic (1.49e-3)" "unprognostic (7.40e-2)" "unprognostic (3.34e-2)" "unprognostic (1.36e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-1)" "unprognostic (2.59e-3)" "unprognostic (3.27e-2)" "unprognostic (3.15e-3)" "prognostic unfavorable (2.64e-7)" "unprognostic (2.05e-1)" "unprognostic (4.42e-2)" "unprognostic (7.37e-2)" "unprognostic (2.55e-2)" 9.2 3.2 0.9 4.8 1.5 0.8 5.0 1.2 1.3 2.0 5.3 1.8 1.6 2.5 2.0 4.8 1.9 3.3 3.2 5.4 0.8 0.8 13.1 132.7 19.4 13.1 1.2 0.3 2.7 2.1 0.8 2.8 7.6 1.7 1.8 4.3 2.9 2.4 1.5 0.7 1.6 6.6 3.5 1.8 12.1 1.9 2.0 1.0 1.8 1.2 0.8 3.4 2.7 1.5 0.2 0.5 0.8 6.5 0.1 0.3 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.6 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 17.3 0.3 0.0 0.2 0.9 0.1 0.2 0.0 0.2 0.0 0.3 0.1 54.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.1 2.4 0.1 0.1 0.2 0.2 0.0 0.2 6.7 1.0 0.2 0.3 0.0 0.1 2.9 0.0 0.1 6.4 0.1 0.1 0.1 0.1 0.5 0.2 0.3 0.2 0.8 0.1 6.5 0.0 0.1 1.2 0.9 1.5 1.2 1.2 0.8 0.8 1.2 0.3 1.7 1.0 23.8 116.0 3.0 1.0 3.0 1.4 0.4 10.2 9.4 6.8 1.8 0.0 1.6 0.0 0.4 0.1 0.7 2.8 23.3 2.4 1.8 15.8 5.9 3.5 339.0 221.2 1.6 2.4 25.2 60.2 0.8 6.4 8.4 3.3 10.0 4.1 0.0 7.1 15.3 1.1 30.0 0.8 0.0 2.3 0.6 0.9 2.5 3.3 3.2 3.9 2.5 C20orf141 dJ860F19.4 ENSG00000258713 "Chromosome 20 open reading frame 141" Q9NUB4 20 2814987-2815833 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 42 "testis: 63.6" "Group enriched" "Detected in some" 145 "Early spermatids: 1209.3;Late spermatids: 3211.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 20.7;U-2197: 5.5" "Not detected" "Not detected" NA NA "unprognostic (4.52e-1)" "unprognostic (1.40e-2)" "unprognostic (1.35e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1209.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3211.9 11.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 13.1 0.0 0.2 6.5 0.0 15.2 6.9 0.0 0.7 0.0 0.0 0.0 C20orf144 "bclt, dJ63M2.6" ENSG00000149609 "Chromosome 20 open reading frame 144" Q9BQM9 20 33662284-33665619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 165 "testis: 53.4" "Group enriched" "Detected in many" 120 "Early spermatids: 1862.6;Late spermatids: 1796.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.4;PC-3: 1.5" HPA019029 Enhanced NA NA "HPA019029: AB_2670016" "unprognostic (2.16e-2)" "unprognostic (2.04e-2)" "unprognostic (2.32e-2)" "unprognostic (4.37e-2)" "unprognostic (2.09e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" "unprognostic (3.21e-2)" "unprognostic (2.13e-1)" "unprognostic (3.64e-2)" "unprognostic (4.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-1)" "unprognostic (3.36e-2)" "unprognostic (5.66e-2)" "unprognostic (2.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 2.9 0.0 0.6 2.6 0.7 0.2 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 1862.6 0.0 0.0 0.0 0.0 0.2 1.0 0.9 1.1 0.0 0.2 0.0 0.0 0.0 0.8 1796.7 15.3 1.8 11.8 0.0 0.0 0.2 0.1 0.0 10.3 0.0 2.0 6.5 0.9 13.0 10.2 1.4 0.2 1.0 0.0 0.4 C20orf173 dJ477O4.4 ENSG00000125975 "Chromosome 20 open reading frame 173" Q96LM9 20 35523186-35529652 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 89 "testis: 28.3" "Group enriched" "Detected in some" 80 "Early spermatids: 471.4;Late spermatids: 118.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" NA NA "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 471.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 C20orf202 ENSG00000215595 "Chromosome 20 open reading frame 202" A1L168 20 1203454-1208274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 8.2" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 1.8;Early spermatids: 2.9;Late spermatids: 1.6;Sertoli cells: 6.5" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Lineage enriched" "Detected in single" 11 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "Daudi: 4.1;U-266/70: 3.1;U-266/84: 1.4" "Low region specificity" "Detected in all" HPA042786 Uncertain NA NA "HPA042786: AB_10795760" "unprognostic (8.20e-2)" "unprognostic (1.66e-1)" "unprognostic (7.27e-2)" "unprognostic (2.73e-2)" "unprognostic (3.49e-3)" "unprognostic (1.92e-3)" "unprognostic (1.15e-2)" "unprognostic (7.41e-3)" "unprognostic (1.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (7.55e-2)" "unprognostic (5.82e-3)" "unprognostic (7.98e-2)" "unprognostic (5.70e-3)" "unprognostic (1.26e-1)" "unprognostic (7.24e-3)" 1.3 0.1 1.3 0.2 1.0 0.0 0.7 2.6 0.8 0.3 0.7 0.6 0.2 0.0 0.6 1.0 1.5 1.1 1.2 1.1 0.9 0.2 3.2 0.3 1.4 0.0 0.7 1.0 0.4 8.2 0.1 0.5 0.8 1.4 1.0 1.1 2.5 0.3 1.7 0.4 0.6 1.4 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.2 0.0 0.4 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.1 4.1 0.1 0.0 0.3 0.2 0.1 0.2 0.1 1.0 0.3 0.4 0.0 1.0 0.2 0.4 0.0 0.2 0.1 0.0 0.4 0.2 0.0 0.0 1.2 1.2 0.0 0.3 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.3 3.1 1.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf203 FLJ33706 ENSG00000198547 "Chromosome 20 open reading frame 203" Q8NBC4 20 32631652-32673941 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;ovary: 2.1" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 14.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 4.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 4.2" "Cell line enhanced" "Detected in some" "HEL: 7.7;HMC-1: 5.4;NB-4: 2.3;U-266/70: 1.6" NA NA "unprognostic (6.24e-2)" "unprognostic (3.39e-3)" "unprognostic (8.39e-3)" "unprognostic (2.06e-1)" "unprognostic (1.19e-2)" "unprognostic (6.70e-3)" "unprognostic (7.53e-2)" "unprognostic (2.52e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (1.00e-2)" "unprognostic (1.39e-3)" "unprognostic (1.25e-10)" "unprognostic (3.37e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (7.46e-5)" 0.1 0.0 0.0 0.3 0.3 1.1 0.2 0.0 0.0 1.0 1.1 0.4 1.1 0.0 0.5 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.8 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.7 0.0 0.0 0.0 0.4 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.1 0.3 2.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.4 0.0 1.1 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.0 2.7 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 C20orf204 "DKFZp434G015, FLJ27267, LINC00176, NCRNA00176, PRR17" ENSG00000196421 "Chromosome 20 open reading frame 204" 20 64034344-64039962 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "blood: 8.2;brain: 11.2;lymphoid tissue: 19.1" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 6 "ovarian cancer: 7.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.2;naive CD8 T-cell: 6.6" "Lineage enriched" "Detected in single" 10 "T-cells: 8.2" "Cell line enriched" "Detected in some" 6 "Hep G2: 32.8" "Low region specificity" "Detected in many" NA NA "unprognostic (2.84e-1)" "unprognostic (4.02e-2)" "unprognostic (2.36e-2)" "unprognostic (2.49e-1)" "unprognostic (9.66e-2)" "unprognostic (3.49e-2)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (3.50e-1)" "unprognostic (9.20e-3)" "unprognostic (4.43e-3)" "unprognostic (4.34e-2)" "unprognostic (2.49e-6)" "unprognostic (5.83e-2)" "unprognostic (4.58e-2)" "unprognostic (1.88e-2)" "unprognostic (2.79e-4)" 1.3 0.0 0.0 0.7 0.0 0.2 0.0 11.2 0.0 0.7 1.2 0.0 0.3 0.6 0.1 2.0 0.2 0.7 1.0 1.1 0.0 0.0 0.8 1.2 9.8 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.6 0.0 2.3 0.1 0.0 1.2 0.4 0.8 0.0 19.1 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.8 8.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.7 1.1 0.0 0.0 8.2 6.6 0.4 0.8 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3768387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.7" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 123.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 64.7" "Group enriched" "Detected in many" 5 "classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2" "Group enriched" "Detected in all" 5 "dendritic cells: 38.5;monocytes: 46.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol NA NA 87000 "Nucleoplasm, Cytosol" "HPA047483: AB_2680064" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 23.1 9.7 10.2 11.8 64.7 51.9 17.2 4.9 15.8 12.0 22.6 7.7 3.7 10.3 16.9 10.9 14.4 18.7 26.6 7.3 9.2 14.4 5.0 5.4 8.4 13.5 14.5 6.1 20.9 8.5 3.9 5.3 6.7 13.7 18.3 4.9 5.0 9.0 7.1 11.2 9.6 9.4 22.3 5.7 13.4 21.2 6.0 13.2 6.0 5.4 7.9 6.1 27.4 10.3 7.8 38.5 1.1 46.6 5.8 8.5 13.8 34.4 36.4 5.7 24.3 11.9 6.5 9.0 8.9 5.9 16.5 12.1 24.9 13.1 21.6 8.7 10.4 22.0 29.7 15.3 22.3 6.3 5.0 27.4 12.2 7.4 44.4 8.5 17.5 5.4 9.2 9.4 21.0 10.5 5.7 11.1 15.8 21.7 13.6 8.5 48.7 23.1 41.7 24.6 24.1 49.5 17.9 14.0 25.5 10.3 12.6 25.7 11.7 8.1 36.1 17.8 2.7 8.0 22.0 6.8 23.1 16.0 36.6 27.2 10.5 17.5 16.0 6.8 33.3 11.3 0.2 28.1 0.4 5.9 46.6 8.5 7.8 7.0 7.8 38.5 7.3 8.0 7.8 1.1 5.8 42.2 7.3 6.4 13.8 10.2 64.7 4.9 15.8 9.2 14.4 14.5 6.1 13.7 13.2 0.0 3.5 24.6 18.0 21.5 9.4 2.8 7.6 1.4 2.3 10.4 2.0 15.9 24.9 31.1 8.2 25.0 10.5 70.0 26.1 38.9 26.3 9.4 23.0 14.7 123.1 1.6 15.1 13.5 94.5 13.7 30.2 60.1 35.4 4.6 10.2 20.0 28.5 16.4 23.3 27.0 12.7 64.7 66.1 18.7 30.1 28.7 6.1 16.2 30.3 20.0 C20orf85 "bA196N14.1, LLC1" ENSG00000124237 "Chromosome 20 open reading frame 85" Q9H1P6 20 58150904-58161150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 113.6;testis: 62.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 1056.0;Early spermatids: 339.0;Late spermatids: 299.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 57.9" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 3.5" "Region enriched" "Detected in single" 5 "basal ganglia: 1.5" "Low region specificity" "Detected in many" "HPA058271, HPA065540" Enhanced NA NA "HPA058271: AB_2683661, HPA065540: AB_2685510" "unprognostic (4.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "unprognostic (6.46e-2)" "unprognostic (3.62e-1)" "unprognostic (2.79e-2)" 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.1 7.4 0.0 0.5 0.2 0.0 1.4 26.9 0.0 113.6 0.0 0.0 0.1 0.8 0.0 0.0 29.4 0.3 0.0 0.0 29.0 0.0 0.0 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 62.8 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.1 0.8 0.0 0.0 1.5 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1056.0 97.8 0.0 0.0 0.0 0.0 0.0 339.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 299.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 78.9 1.9 0.0 0.0 0.0 0.0 0.0 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "fallopian tube: 27.2;lymphoid tissue: 22.7;pituitary gland: 25.1" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 203.4;Erythroid cells: 140.2;Intestinal endocrine cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 29.3" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: AB_2674468" "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favorable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.3 1.8 2.2 4.3 5.0 11.1 5.2 3.6 3.1 3.2 3.5 4.6 3.3 4.7 2.2 9.7 3.1 27.2 3.2 2.6 2.9 2.9 1.3 1.3 9.1 5.9 2.9 1.8 8.0 3.2 1.4 25.1 2.1 5.8 2.3 2.7 1.9 2.5 1.7 1.6 5.3 4.3 1.5 1.8 2.8 3.7 5.7 2.2 22.7 1.8 2.1 4.6 1.7 2.1 2.1 1.8 8.2 0.5 0.7 1.8 0.9 12.1 5.6 14.8 9.2 1.5 2.0 8.2 7.5 2.8 5.3 5.2 2.5 9.0 8.8 1.9 2.1 6.2 9.8 3.9 3.2 1.6 9.2 8.6 14.1 14.6 1.4 0.3 4.0 8.1 0.9 0.7 3.7 0.9 1.9 3.3 22.0 8.0 23.5 4.3 5.0 19.8 5.4 6.3 3.4 2.8 29.3 6.7 7.8 1.6 2.3 12.2 7.6 5.6 4.0 1.8 3.3 9.9 8.0 2.2 3.2 9.3 3.2 4.5 9.5 4.2 4.2 5.7 17.5 8.4 8.2 0.5 1.1 0.9 0.3 0.5 0.2 1.1 1.2 0.1 2.1 1.8 1.4 0.7 0.7 0.2 1.8 1.3 0.9 2.2 5.0 3.6 3.1 2.9 2.9 2.9 1.8 5.8 2.2 3.0 1.6 3.0 1.2 0.8 17.1 3.6 0.0 203.4 22.7 1.8 25.5 3.5 0.0 1.9 13.4 1.1 2.3 140.2 0.9 5.4 3.6 1.8 2.3 1.6 3.4 4.8 66.7 3.7 1.8 25.4 4.9 2.7 0.0 1.0 3.5 4.3 1.1 3.5 2.5 0.6 28.6 0.0 2.1 52.4 42.1 1.3 1.1 2.6 5.9 0.7 C21orf62 "B37, C21orf120, PRED81" ENSG00000205929 "Chromosome 21 open reading frame 62" Q9NYP8 21 32793564-32813743 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 40.8;Distal tubular cells: 19.9" "Cancer enriched" "Detected in some" 6 "glioma: 11.0" "Region enriched" "Detected in many" 4 "pons and medulla: 13.4" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "AF22: 7.2;RPTEC TERT1: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016899 Enhanced "Secreted - unknown location" NA NA "HPA016899: AB_1845704" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (1.23e-1)" "unprognostic (4.37e-3)" "unprognostic (9.56e-2)" "unprognostic (3.05e-3)" "unprognostic (2.95e-2)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.59e-1)" "unprognostic (1.65e-1)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" 2.2 0.4 1.6 1.1 2.1 0.3 0.3 0.3 2.4 0.1 0.3 3.9 0.0 0.1 0.2 8.4 0.3 1.2 0.4 0.4 3.0 2.4 18.2 0.3 0.2 0.2 1.5 1.0 16.2 5.6 0.1 38.6 0.1 13.4 4.1 0.1 0.0 0.3 0.3 0.3 0.3 0.6 0.3 1.8 0.2 0.3 0.4 3.1 0.0 0.2 0.0 1.1 0.2 0.3 0.0 0.4 1.1 0.0 0.0 1.7 0.1 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.4 1.7 0.1 1.6 2.1 0.3 2.4 3.0 2.4 1.5 1.0 13.4 3.1 0.0 0.0 0.5 0.8 0.8 5.1 0.1 40.8 0.0 0.0 5.2 5.9 1.1 19.9 0.0 1.2 0.6 0.0 0.0 0.0 0.4 1.1 0.3 0.0 0.0 0.2 0.0 2.9 2.5 0.6 0.0 3.7 0.0 3.3 0.0 0.0 5.6 0.0 0.0 1.8 2.1 6.2 0.0 0.4 0.9 1.1 0.9 0.2 1.7 0.0 0.3 C22orf15 "FLJ36561, N27C7-3" ENSG00000169314 "Chromosome 22 open reading frame 15" Q8WYQ4 22 23763021-23765861 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "fallopian tube: 22.3" "Cell type enriched" "Detected in some" 13 "Ciliated cells: 200.8" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.7" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 3.0;BJ: 2.2;BJ hTERT+: 4.8;HSkMC: 2.0;hTERT-RPE1: 6.5;MOLT-4: 3.0" "Secreted in female reproductive system" NA NA "unprognostic (2.37e-2)" "unprognostic (3.28e-3)" "unprognostic (1.28e-1)" "prognostic favorable (8.53e-5)" "unprognostic (1.86e-2)" "unprognostic (2.07e-2)" "unprognostic (4.38e-2)" "unprognostic (6.14e-2)" "unprognostic (3.60e-2)" "unprognostic (7.70e-2)" "unprognostic (4.58e-2)" "unprognostic (2.60e-1)" "unprognostic (9.79e-2)" "unprognostic (2.29e-1)" "unprognostic (3.02e-1)" "unprognostic (3.28e-2)" "unprognostic (3.08e-3)" 0.0 0.1 1.0 0.0 1.7 0.4 0.1 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 22.3 0.2 0.0 1.4 1.9 0.0 0.0 2.7 0.2 0.0 0.5 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.0 0.0 1.8 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.2 4.8 0.0 0.5 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 6.5 0.8 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.6 1.0 0.8 0.4 0.5 1.8 0.5 0.0 0.0 0.0 2.9 0.0 0.2 0.0 2.6 0.0 0.0 0.1 0.5 0.0 0.0 200.8 15.9 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.6 0.1 2.3 0.0 0.0 0.0 0.0 1.3 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.1 12.7 3.8 0.3 0.0 0.0 0.0 0.0 C22orf23 "EVG1, FLJ32787, LOC84645" ENSG00000128346 "Chromosome 22 open reading frame 23" Q9BZE7 22 37943050-37953669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 189.0" "Group enriched" "Detected in some" 4 "Early spermatids: 211.4;Late spermatids: 246.7;Spermatocytes: 159.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 17.1;U-138 MG: 17.6;U-87 MG: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000650 Approved Nucleoplasm NA NA Nucleoplasm "HPA000650: AB_2732391" "unprognostic (6.09e-3)" "unprognostic (3.02e-1)" "unprognostic (1.09e-1)" "unprognostic (2.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.80e-1)" "unprognostic (7.42e-5)" "unprognostic (1.50e-2)" "unprognostic (2.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.04e-1)" "unprognostic (5.80e-2)" "unprognostic (8.18e-3)" "unprognostic (4.21e-1)" "unprognostic (1.09e-1)" "unprognostic (1.82e-2)" "unprognostic (8.46e-2)" 0.9 0.9 1.3 2.0 1.8 0.7 0.8 1.7 3.3 1.2 4.1 2.8 0.8 0.8 3.7 2.8 6.1 6.0 2.5 1.8 1.7 1.7 1.2 1.1 2.7 1.0 1.9 2.0 2.2 3.4 0.1 2.2 2.0 5.5 1.8 0.0 2.0 4.1 1.4 1.8 11.3 1.2 1.2 3.2 0.8 3.8 189.0 1.2 0.8 3.4 0.9 0.9 5.2 1.6 0.7 0.3 0.9 0.2 0.1 1.4 0.2 3.5 2.8 6.2 5.7 0.1 0.2 7.6 9.8 0.3 0.3 0.4 3.3 3.2 1.8 2.9 0.2 6.4 17.1 0.2 0.1 0.3 3.5 7.3 1.0 2.3 2.3 0.2 2.8 2.5 0.2 0.1 1.1 0.1 8.6 0.0 1.4 1.2 1.1 0.0 2.2 0.1 1.7 0.9 3.5 2.5 3.3 8.8 0.7 0.1 15.6 3.1 2.3 4.6 1.7 5.5 10.4 2.1 3.9 14.9 17.6 5.9 13.7 5.2 2.5 1.1 0.9 26.5 1.3 9.9 0.9 0.1 0.0 1.3 0.2 1.4 0.7 0.3 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.2 1.3 1.8 1.7 1.8 1.7 1.7 1.9 2.0 5.5 1.2 0.0 3.7 0.0 0.1 0.2 0.1 0.0 0.0 50.9 2.3 0.0 0.0 0.1 1.7 0.3 211.4 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 246.7 6.4 0.0 0.0 0.0 0.0 2.0 0.2 0.0 4.9 1.4 0.5 0.0 0.0 159.9 4.3 0.0 0.0 0.0 0.0 0.0 C22orf31 "bK747E2.1, HS747E2A" ENSG00000100249 "Chromosome 22 open reading frame 31" O95567 22 29058672-29061844 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.4;testis: 12.7" "Group enriched" "Detected in some" 15 "Early spermatids: 55.4;Late spermatids: 34.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "OE19: 1.4" "Not detected" "Not detected" "HPA000604, HPA068522" Uncertain Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA000604: AB_1079086, HPA068522: " 0.0 0.4 0.9 0.0 3.4 0.0 0.4 0.4 0.9 0.5 0.3 0.2 0.4 1.6 0.5 0.5 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.8 1.1 0.0 0.2 0.4 0.0 0.2 0.3 0.5 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.6 12.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.4 0.6 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.9 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.0 0.0 0.0 C22orf42 ENSG00000205856 "Chromosome 22 open reading frame 42" Q6IC83 22 32149006-32159322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 12.9;testis: 28.6" "Group enriched" "Detected in some" 7 "Early spermatids: 73.0;Late spermatids: 23.6" "Group enriched" "Detected in some" 5 "pancreatic cancer: 0.8;prostate cancer: 1.0" "Group enriched" "Detected in some" 14 "hypothalamus: 12.9;pons and medulla: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.5" HPA019531 Enhanced NA NA "HPA019531: AB_1853016" "unprognostic (5.67e-2)" "unprognostic (6.13e-3)" "unprognostic (8.21e-3)" "unprognostic (7.06e-2)" "unprognostic (4.54e-2)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.4 0.0 3.8 0.0 5.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.5 1.0 28.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.1 12.9 0.6 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 C22orf46 "CTA-216E10.6, FLJ23584" ENSG00000184208 "Chromosome 22 open reading frame 46" C9J442 22 41688939-41698136 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 19.8" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 65.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA052741 Uncertain Approved Nucleoplasm,Nucleoli "Secreted - unknown location" NA NA Nucleoplasm Nucleoli "HPA052741: AB_2681933" "unprognostic (3.76e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.38e-2)" "unprognostic (3.32e-2)" "unprognostic (7.03e-2)" "unprognostic (1.20e-1)" "unprognostic (3.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" 3.9 2.0 8.1 3.1 6.8 1.0 3.9 2.2 5.7 2.7 2.4 2.3 3.1 4.5 1.7 2.4 2.7 4.8 8.7 7.5 2.7 2.3 2.2 3.1 12.8 5.2 1.4 8.3 3.5 2.1 3.3 2.8 2.8 3.0 3.3 3.3 2.6 2.9 19.8 2.8 2.4 6.2 3.5 3.1 2.2 1.5 1.1 0.4 0.1 2.6 3.5 1.2 0.7 8.8 4.5 11.1 6.8 8.2 8.7 10.1 7.5 8.1 6.4 8.6 4.5 5.8 5.5 5.5 6.2 6.3 4.1 5.7 5.8 7.7 19.7 5.4 6.1 9.4 3.8 4.8 4.5 12.0 6.9 7.8 10.7 7.6 4.9 1.6 8.6 9.9 8.2 5.6 14.6 3.5 5.5 4.5 13.4 3.5 5.1 9.2 6.1 5.4 6.1 2.7 4.2 8.7 7.9 11.3 8.5 9.0 5.5 4.3 8.4 14.4 4.4 3.9 17.5 17.8 5.1 5.0 5.5 11.4 0.1 0.5 0.0 0.7 0.4 0.9 1.1 1.1 1.1 0.2 0.5 0.9 1.2 0.1 3.5 2.6 0.4 0.7 0.7 11.9 16.5 7.1 3.9 1.9 9.4 18.9 5.1 8.1 11.4 7.0 13.7 8.3 1.7 4.2 65.6 7.1 8.4 0.0 4.2 5.8 4.9 2.0 7.0 4.0 4.2 3.2 2.9 9.2 7.3 8.2 4.9 8.3 1.7 9.0 7.2 9.7 3.7 3.7 6.0 1.3 6.2 0.0 3.5 12.0 11.5 2.3 7.1 15.8 4.0 1.4 C2CD2 "C21orf25, C21orf258, DKFZP586F0422, TMEM24L" ENSG00000157617 "C2 calcium dependent domain containing 2" Q9Y426 21 41885112-41953890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 56.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 51.0;Cone photoreceptor cells: 78.5;Ito cells: 42.4;Rod photoreceptor cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 38.7;SK-BR-3: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030922, HPA030924" Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA030922: AB_2673660, HPA030924: AB_10669873" "unprognostic (3.02e-3)" "unprognostic (3.69e-2)" "unprognostic (2.21e-2)" "unprognostic (9.63e-2)" "unprognostic (3.15e-3)" "unprognostic (2.93e-2)" "unprognostic (2.39e-2)" "unprognostic (3.44e-2)" "unprognostic (3.00e-2)" "unprognostic (4.39e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-1)" "prognostic unfavorable (7.68e-5)" "unprognostic (1.99e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-2)" "unprognostic (1.48e-1)" 23.9 56.9 5.4 6.1 8.0 1.1 21.0 2.7 7.0 5.8 5.8 7.6 10.9 3.5 6.3 6.1 5.4 4.9 7.8 3.6 5.9 5.1 5.3 4.2 9.6 9.1 12.8 4.5 11.7 10.7 19.4 3.8 4.2 10.9 8.8 4.3 11.8 8.1 9.4 2.7 10.1 4.4 5.6 11.7 20.7 5.7 2.7 9.1 5.7 4.8 3.9 5.3 7.0 23.9 1.1 1.4 0.9 1.3 1.9 2.8 0.7 6.1 2.6 1.8 4.2 38.7 10.7 7.2 4.3 6.8 2.7 2.5 4.0 7.0 0.1 2.4 8.4 6.7 0.7 6.5 4.5 3.5 0.4 2.9 1.1 3.2 3.2 5.2 0.4 0.0 6.8 4.2 14.5 5.7 6.0 12.8 0.3 3.8 0.0 7.2 0.5 0.9 1.2 10.2 2.6 8.9 0.6 2.7 3.7 4.0 13.0 3.0 1.3 4.7 21.3 3.8 3.8 5.6 2.7 4.4 6.5 0.9 2.1 3.5 2.4 3.5 0.5 19.0 3.6 1.3 0.0 1.3 0.0 1.3 0.8 0.5 0.5 1.2 0.5 1.4 1.1 2.8 1.6 0.9 1.9 0.7 0.2 1.5 0.7 5.4 8.0 2.7 7.0 5.9 5.1 12.8 4.5 10.9 9.1 3.0 13.3 6.4 6.8 3.7 51.0 2.0 5.1 4.0 5.7 3.5 78.5 9.6 0.0 5.0 0.1 12.0 2.3 0.0 7.1 3.7 6.1 12.9 0.0 4.5 3.2 1.6 4.7 42.4 7.8 0.0 3.4 2.9 1.7 0.0 7.3 3.5 7.9 6.8 2.1 2.8 35.1 12.9 15.6 0.0 2.3 2.3 7.8 1.7 7.1 12.4 C2CD2L "KIAA0285, TMEM24" ENSG00000172375 "C2CD2 like" O14523 11 119102198-119118544 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011044 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Nuclear membrane, Cytosol" "HPA011044: AB_2668414" "unprognostic (3.43e-2)" "unprognostic (2.81e-2)" "unprognostic (1.03e-3)" "prognostic favorable (4.92e-4)" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (2.25e-3)" "unprognostic (3.37e-3)" "unprognostic (5.28e-2)" "unprognostic (2.09e-1)" "unprognostic (3.99e-3)" "unprognostic (8.19e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.02e-2)" "unprognostic (8.32e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" 5.2 7.0 15.9 7.3 33.1 14.7 4.8 18.2 31.2 5.8 10.3 7.5 8.3 18.7 4.1 6.1 9.4 10.9 6.3 7.9 15.8 13.6 6.3 7.3 8.3 8.5 9.1 12.6 3.9 7.5 7.8 14.2 4.8 11.7 4.8 8.8 5.6 8.7 7.0 8.3 12.5 19.4 6.1 7.3 9.2 5.5 2.6 9.1 7.0 5.5 6.7 6.6 6.6 5.3 0.4 1.1 5.7 4.2 1.7 1.6 1.1 3.4 2.5 3.5 7.2 4.6 1.9 2.2 5.2 4.6 5.2 4.4 4.1 3.6 5.2 13.7 3.6 5.3 7.7 4.4 2.2 2.1 8.1 3.7 20.4 3.3 2.9 6.1 5.8 29.8 2.3 4.6 9.7 3.6 5.7 3.2 7.8 8.4 9.3 4.8 9.1 6.5 14.1 1.3 8.4 6.9 4.1 3.2 5.9 5.1 2.2 11.0 6.2 2.2 11.7 3.3 1.4 20.6 7.8 3.9 4.8 1.6 5.7 9.1 4.1 2.4 2.0 3.0 10.1 5.3 1.1 3.0 5.7 0.6 3.2 1.0 0.4 1.4 1.4 1.1 0.1 1.6 0.8 1.0 1.7 4.2 0.7 1.6 1.1 15.9 33.1 18.2 31.2 15.8 13.6 9.1 12.6 11.7 9.1 6.0 6.2 2.2 1.4 9.5 14.6 2.0 2.5 13.4 4.5 1.8 35.3 0.8 3.3 2.8 2.6 5.0 25.7 0.0 2.4 1.2 2.0 2.9 2.3 4.3 7.9 20.6 1.2 15.4 12.9 1.5 2.0 9.7 6.8 7.2 5.5 4.8 4.2 10.1 1.4 3.3 29.7 6.5 3.1 2.3 1.9 9.5 0.9 8.7 4.5 1.6 C2CD4A "FAM148A, NLF1" ENSG00000198535 "C2 calcium dependent domain containing 4A" Q8NCU7 15 62066977-62070917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "endometrium 1: 6.8;liver: 25.9;pancreas: 20.4;pituitary gland: 21.9" "Cell type enhanced" "Detected in some" 19 "Exocrine glandular cells: 5.5;Intestinal endocrine cells: 20.0;Pancreatic endocrine cells: 5.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 19 "OE19: 24.1;RPTEC TERT1: 21.7" NA NA "unprognostic (3.85e-2)" "unprognostic (6.68e-2)" "unprognostic (5.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.32e-1)" "unprognostic (5.38e-3)" "unprognostic (5.49e-3)" "unprognostic (3.85e-1)" "unprognostic (1.67e-1)" "unprognostic (9.21e-2)" "unprognostic (3.89e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.72e-2)" "unprognostic (2.07e-2)" "unprognostic (6.26e-2)" "unprognostic (3.35e-1)" 0.3 1.0 0.5 1.3 0.4 0.3 0.5 0.2 0.7 1.0 1.2 0.1 0.1 2.2 6.8 0.3 0.2 0.1 0.9 0.2 0.4 0.9 2.5 25.9 2.0 0.3 0.3 0.1 0.4 20.4 0.0 21.9 0.8 1.3 1.1 1.4 0.2 1.2 0.1 0.8 1.1 1.1 0.1 0.4 0.2 2.2 0.2 0.1 1.2 0.9 0.1 1.2 1.3 0.1 0.8 0.9 2.5 0.5 0.9 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 24.1 0.1 0.1 0.0 0.1 21.7 0.5 0.9 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.5 0.4 0.4 0.2 0.4 0.5 0.4 0.2 0.1 0.8 0.5 0.3 2.5 0.9 0.2 0.9 1.0 0.1 0.5 0.4 0.2 0.4 0.4 0.9 0.3 0.1 1.3 0.1 0.0 0.0 0.0 1.7 0.5 0.1 0.8 0.0 1.4 3.4 0.0 0.0 0.0 1.7 1.5 0.0 2.6 0.2 0.0 5.5 0.0 0.2 2.6 0.0 0.0 0.1 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.7 0.2 5.6 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 C2CD4B "FAM148B, NLF2" ENSG00000205502 "C2 calcium dependent domain containing 4B" A6NLJ0 15 62163535-62165283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "pancreas: 192.0" "Group enriched" "Detected in many" 6 "Endothelial cells: 53.8;Intestinal endocrine cells: 205.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;HUVEC TERT2: 6.2;NTERA-2: 2.5;SCLC-21H: 1.8;TIME: 1.3" HPA046880 Uncertain NA NA "HPA046880: AB_10959458" "unprognostic (6.60e-2)" "prognostic favorable (4.22e-4)" "unprognostic (2.24e-2)" "unprognostic (1.25e-1)" "unprognostic (4.15e-1)" "unprognostic (4.06e-3)" "unprognostic (2.29e-1)" "unprognostic (5.02e-2)" "unprognostic (3.36e-2)" "unprognostic (2.33e-1)" "unprognostic (5.30e-2)" "unprognostic (1.83e-1)" "unprognostic (6.16e-3)" "unprognostic (7.89e-2)" "unprognostic (5.24e-1)" "unprognostic (8.64e-3)" "unprognostic (1.48e-1)" 12.1 1.0 0.2 4.3 0.5 3.0 7.9 0.1 0.7 1.7 2.0 0.3 0.4 2.2 3.7 3.2 3.2 1.2 5.0 2.0 0.3 0.3 0.7 1.7 9.2 0.7 0.5 0.0 1.6 192.0 0.7 2.5 1.4 0.6 2.2 0.6 0.5 0.9 1.0 2.8 1.6 1.8 1.5 0.9 0.4 7.8 1.0 0.2 4.6 0.9 4.1 0.6 3.9 4.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.3 0.3 0.3 0.5 0.0 0.6 0.2 3.0 8.5 0.0 2.3 6.1 0.8 1.2 7.6 0.0 1.2 1.8 0.0 0.0 0.0 1.1 0.0 53.8 1.7 0.0 20.3 0.0 4.1 2.3 2.3 0.4 0.3 0.0 205.6 6.2 1.3 0.0 0.0 0.2 3.3 2.8 9.3 0.0 15.9 0.6 0.0 0.0 0.5 0.0 2.3 0.0 0.4 6.0 0.0 0.0 1.1 2.0 C2CD4C "FAM148C, KIAA1957, NLF3" ENSG00000183186 "C2 calcium dependent domain containing 4C" Q8TF44 19 405438-409170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 2.9;Ito cells: 3.1;Muller glia cells: 1.7;Rod photoreceptor cells: 6.6;Spermatogonia: 1.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.4;MCF7: 5.1;NTERA-2: 7.5;SCLC-21H: 13.4;U-2 OS: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055915 Uncertain Approved Vesicles NA NA Vesicles "HPA055915: AB_2682968" "unprognostic (1.29e-1)" "unprognostic (9.43e-2)" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (9.39e-3)" "unprognostic (2.14e-1)" "unprognostic (1.67e-1)" "unprognostic (9.81e-2)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.43e-2)" "unprognostic (5.04e-2)" "unprognostic (5.09e-2)" "unprognostic (1.74e-1)" 6.9 2.1 15.8 1.7 7.4 0.8 5.4 1.0 19.4 2.2 1.3 0.7 0.0 2.0 2.4 0.9 1.2 1.6 8.6 2.2 7.1 13.5 1.6 1.0 1.5 1.2 4.7 10.8 0.9 1.1 0.9 1.7 2.0 6.5 1.1 1.0 2.2 1.1 1.0 3.1 2.4 1.8 1.3 3.0 1.2 1.6 1.9 3.0 0.0 6.7 0.0 0.9 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 1.5 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 2.4 0.0 0.7 0.0 0.9 2.8 2.8 0.2 0.1 7.4 1.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.1 5.1 0.0 0.0 7.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.4 3.9 1.2 0.0 0.0 0.7 0.2 0.0 0.0 0.1 8.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 7.4 1.0 18.2 7.1 13.5 4.7 10.8 6.5 3.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 6.6 0.0 0.0 0.7 1.9 0.3 0.0 0.0 0.0 0.0 C2CD4D FAM148D ENSG00000225556 "C2 calcium dependent domain containing 4D" B7Z1M9 1 151837819-151840557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 4.1;skin 1: 4.9" "Cell type enhanced" "Detected in some" 10 "Distal tubular cells: 8.3;Intestinal endocrine cells: 5.2;Syncytiotrophoblasts: 8.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0;T-reg: 2.2" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Cell line enriched" "Detected in some" 9 "HDLM-2: 20.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.17e-3)" "unprognostic (5.08e-1)" "unprognostic (3.00e-1)" "unprognostic (3.60e-2)" "unprognostic (1.62e-2)" "unprognostic (9.03e-4)" "unprognostic (2.69e-1)" "unprognostic (9.66e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.84e-3)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (2.41e-3)" "unprognostic (1.51e-1)" "unprognostic (2.62e-1)" "unprognostic (3.28e-2)" 0.4 0.8 0.9 0.7 0.6 0.0 0.4 1.9 2.3 0.1 1.0 0.5 0.0 0.0 0.6 0.5 0.7 0.4 1.6 0.8 0.9 0.2 0.8 0.8 1.4 0.0 2.6 0.0 1.2 0.0 1.0 0.1 4.1 0.6 0.4 4.9 0.6 0.0 3.3 0.5 1.9 0.5 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.1 2.1 0.0 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 20.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.7 0.0 0.0 2.0 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.1 1.5 1.1 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 1.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.8 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 8.3 0.2 0.0 0.1 0.3 0.0 0.4 0.1 0.0 1.5 0.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.6 0.0 3.3 0.0 2.1 0.9 0.5 2.6 0.4 0.6 0.3 0.0 0.0 0.2 0.2 0.9 8.9 1.3 2.3 0.7 C2CD6 "ALS2CR11, FLJ25351" ENSG00000155754 "C2 calcium dependent domain containing 6" Q53TS8 2 201487425-201619178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 35.2" "Cell type enhanced" "Detected in some" 22 "Club cells: 1.2;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.3;HSkMC: 3.4;hTEC/SVTERT24-B: 3.3;SCLC-21H: 3.9;THP-1: 3.2;U-2197: 12.4" NA NA "unprognostic (2.64e-1)" "unprognostic (1.14e-1)" "unprognostic (8.77e-3)" "unprognostic (7.13e-6)" "unprognostic (1.33e-1)" "unprognostic (4.38e-2)" "unprognostic (2.16e-1)" "unprognostic (4.81e-2)" "unprognostic (3.15e-2)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (2.10e-1)" "unprognostic (5.13e-10)" "unprognostic (1.95e-1)" "unprognostic (6.35e-2)" "unprognostic (2.00e-1)" "unprognostic (2.18e-1)" 0.7 0.9 0.6 0.2 1.2 0.2 0.4 0.4 1.0 0.3 0.3 1.0 0.0 0.3 0.4 0.3 0.4 0.3 0.6 1.9 1.1 0.5 0.3 0.2 0.4 0.3 2.7 0.2 0.9 0.2 0.2 6.1 0.3 2.9 0.5 0.2 1.5 0.2 0.3 0.3 0.4 0.2 0.8 2.2 0.3 0.2 35.2 0.9 0.0 0.3 0.0 0.2 0.4 0.3 0.8 0.7 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.4 3.3 0.6 0.5 0.5 0.1 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.4 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.3 0.4 0.1 0.0 3.2 0.0 0.0 1.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.7 0.8 0.5 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.6 1.2 0.4 1.0 1.1 0.5 2.7 0.2 2.9 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf15 MGC29762 ENSG00000273045 "Chromosome 2 open reading frame 15" Q8WU43 2 99141485-99151487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 22.2" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 12.0;Distal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.2;NK-cells: 6.5;T-cells: 7.4" "Cell line enhanced" "Detected in many" "RT4: 11.0;SCLC-21H: 11.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.61e-2)" "unprognostic (7.88e-2)" "unprognostic (4.22e-2)" "unprognostic (4.85e-2)" "unprognostic (2.06e-1)" "unprognostic (6.99e-2)" "unprognostic (5.37e-2)" "unprognostic (9.05e-3)" "unprognostic (1.62e-2)" "prognostic favorable (4.95e-4)" "unprognostic (2.54e-3)" "unprognostic (1.04e-1)" "prognostic favorable (1.23e-4)" "unprognostic (2.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.08e-1)" "unprognostic (2.97e-2)" 1.0 1.7 4.2 1.2 7.7 1.6 5.4 9.3 4.9 3.9 4.9 0.9 5.4 5.9 1.8 9.3 2.5 6.1 3.9 0.7 7.4 4.5 12.1 1.2 2.1 6.3 3.4 2.9 2.0 6.0 8.0 22.2 1.6 3.7 2.2 3.5 2.1 5.8 4.6 0.7 2.7 4.5 0.3 3.5 2.6 5.5 3.4 2.3 2.4 9.5 0.8 2.1 3.7 1.4 3.2 0.5 1.3 0.4 6.5 7.4 2.2 8.6 1.4 0.3 1.1 0.1 0.0 6.5 0.0 0.7 0.4 0.3 9.2 6.2 3.7 2.8 0.0 0.7 5.4 1.3 1.2 0.0 0.7 3.9 0.3 1.4 5.6 0.1 1.2 1.6 0.1 2.0 0.0 0.7 0.3 0.0 4.9 0.3 0.7 0.3 7.6 1.1 1.6 2.0 4.7 2.0 0.6 0.1 4.2 8.9 11.0 11.0 1.4 0.7 8.8 0.3 1.6 7.1 0.4 0.0 0.4 0.4 0.3 0.3 2.5 4.1 1.2 0.2 1.1 0.1 0.2 0.4 0.3 3.2 0.2 7.4 3.2 4.9 4.0 0.3 3.2 6.8 3.3 1.3 6.5 0.2 0.5 2.6 2.2 4.2 7.7 9.3 4.9 7.4 4.5 3.4 2.9 3.7 2.3 3.0 1.9 1.3 1.9 0.2 5.3 0.3 2.5 12.0 2.3 7.0 5.9 5.0 13.3 4.7 1.6 0.2 0.0 0.0 2.6 0.6 0.2 1.7 0.0 0.0 0.6 6.4 1.2 0.0 0.0 0.0 0.6 0.7 0.0 0.0 2.7 4.3 2.9 3.2 0.4 6.3 8.4 0.0 0.2 3.0 2.4 0.3 1.7 0.5 2.7 1.1 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 22.3" "Cell type enriched" "Detected in some" 10 "Early spermatids: 68.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.3;SiHa: 4.5" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Approved "Nucleoplasm,Nuclear bodies" No No "Nuclear bodies" Nucleoplasm "HPA052136: AB_2681742, HPA056962: AB_2683290" "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.2 1.0 0.5 0.1 0.4 0.5 0.2 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.6 22.3 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.0 0.3 0.3 1.0 0.0 0.6 0.1 1.6 1.6 2.3 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 2.1 0.8 2.0 0.0 1.5 0.5 0.0 0.0 0.0 1.4 0.4 3.0 1.2 1.6 0.0 1.7 1.3 0.0 0.0 0.2 0.0 1.1 0.2 0.9 1.2 2.2 0.1 0.4 0.0 0.8 0.4 0.8 0.0 1.2 1.3 0.6 0.0 1.5 6.3 1.1 4.5 1.2 0.6 0.4 1.0 1.1 2.7 1.5 2.1 1.0 1.0 0.4 0.0 1.9 0.5 0.3 2.1 0.0 1.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.3 0.0 0.8 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 68.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 1.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 C2orf42 FLJ20558 ENSG00000115998 "Chromosome 2 open reading frame 42" Q9NWW7 2 70149880-70248615 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.2" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 194.1;Late spermatids: 86.2;Spermatocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031840, HPA031841, HPA031842" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068" "unprognostic (8.49e-2)" "unprognostic (2.09e-1)" "unprognostic (2.52e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.20e-3)" "unprognostic (2.26e-1)" "unprognostic (3.73e-1)" "prognostic favorable (5.94e-5)" "unprognostic (4.66e-2)" "unprognostic (9.41e-2)" "unprognostic (2.11e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (2.49e-3)" 6.2 5.9 6.2 4.3 8.7 3.1 6.8 10.7 11.8 6.4 4.5 11.5 6.6 3.2 6.6 8.5 5.0 8.7 5.7 4.2 7.2 6.4 6.3 11.2 4.5 8.2 7.3 6.2 8.3 5.0 8.6 8.2 5.9 6.7 5.0 4.0 7.4 4.6 5.8 4.8 4.9 4.6 5.8 6.1 6.7 4.4 41.2 8.2 9.7 6.2 2.1 8.3 6.2 7.5 12.8 6.6 8.0 6.6 17.9 14.2 9.0 4.9 8.4 8.0 7.2 15.9 9.8 9.0 12.0 8.0 10.1 8.4 6.4 4.6 6.2 7.0 7.5 16.1 7.0 8.1 6.8 10.7 11.0 7.2 7.5 5.9 6.4 14.2 6.2 7.6 11.6 13.0 9.2 11.9 10.5 9.3 8.2 6.3 24.8 12.7 4.7 8.0 8.8 5.6 8.4 9.0 7.7 10.7 11.5 8.2 6.0 6.6 6.6 6.4 11.0 12.1 5.7 4.7 7.5 7.2 8.8 6.1 8.1 9.6 13.3 13.2 6.4 7.2 10.0 7.7 1.9 6.6 8.0 11.2 6.1 14.2 12.8 11.4 13.4 6.6 11.5 13.2 13.7 7.0 17.9 6.1 6.0 12.6 9.0 6.2 8.7 10.7 11.8 7.2 6.4 7.3 6.2 6.7 8.2 0.0 2.1 11.8 2.6 2.3 6.6 2.4 0.0 5.3 1.2 5.2 0.0 7.4 6.6 3.1 194.1 2.6 2.9 0.0 2.1 3.0 4.0 2.7 2.3 5.8 3.8 0.0 1.2 5.5 3.5 86.2 6.9 2.7 3.3 1.0 2.2 7.0 1.7 2.9 7.4 5.4 3.9 0.0 3.1 42.3 11.7 3.8 8.0 6.4 2.1 1.8 C2orf50 FLJ25143 ENSG00000150873 "Chromosome 2 open reading frame 50" Q96LR7 2 11133053-11146790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.3;fallopian tube: 21.1" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 38.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "pons and medulla: 17.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.1;JURKAT: 3.3;T-47d: 3.6" "Not detected" "Not detected" HPA062894 Enhanced NA NA "HPA062894: AB_2684897" "unprognostic (6.29e-2)" "unprognostic (1.33e-1)" "unprognostic (3.53e-4)" "unprognostic (1.92e-3)" "unprognostic (3.35e-2)" "unprognostic (6.19e-2)" "unprognostic (3.55e-1)" "unprognostic (1.31e-1)" "unprognostic (3.32e-1)" "unprognostic (2.98e-2)" "unprognostic (2.00e-2)" "unprognostic (2.45e-1)" "unprognostic (3.97e-4)" "unprognostic (7.03e-2)" "unprognostic (2.92e-1)" "unprognostic (8.25e-3)" "unprognostic (7.36e-2)" 0.4 0.5 2.1 0.5 2.7 0.7 0.6 0.5 4.0 1.2 0.3 2.2 0.0 0.6 0.7 5.5 0.2 21.1 0.4 0.2 4.1 3.2 0.6 0.3 4.0 0.6 1.0 1.7 5.0 0.5 0.3 3.8 0.4 17.3 0.5 0.3 0.0 1.1 0.3 0.4 0.6 0.4 0.4 0.6 0.6 0.4 0.6 0.5 0.0 0.5 0.0 0.5 0.2 0.0 1.1 0.8 2.0 0.7 1.3 2.4 0.4 0.3 1.7 0.8 0.4 0.1 0.2 0.8 0.2 0.4 0.6 0.5 0.8 4.1 0.3 0.6 0.3 0.6 0.8 2.5 0.2 0.5 1.7 0.5 0.3 0.2 0.5 0.0 0.2 0.8 0.1 0.3 0.1 0.3 0.6 0.0 3.3 0.2 1.4 0.0 2.9 0.7 0.4 0.6 0.7 0.5 1.7 0.0 0.3 0.4 0.6 1.2 0.7 0.2 0.8 0.6 0.6 3.6 0.7 1.2 0.4 0.5 0.2 0.4 1.2 0.4 0.2 0.6 0.2 0.6 1.8 0.6 0.5 0.5 0.3 0.4 0.9 0.8 0.7 0.8 1.1 2.4 0.7 2.0 1.3 0.7 0.5 0.8 0.4 2.1 2.7 0.5 4.0 4.1 3.2 1.0 1.7 17.3 0.5 0.0 2.6 0.0 0.4 0.0 0.2 0.3 0.0 38.8 5.7 0.0 7.9 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.4 0.0 3.2 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.1 C2orf54 FLJ22671 ENSG00000172478 "Chromosome 2 open reading frame 54" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 50.6;Intestinal endocrine cells: 48.2;Paneth cells: 56.1;Suprabasal keratinocytes: 22.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.4" "Group enriched" "Detected in some" 6 "CACO-2: 21.6;HaCaT: 16.2;SK-BR-3: 57.4" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.3 0.0 0.3 1.5 0.3 0.0 0.9 0.3 0.3 8.9 3.9 0.3 0.3 6.3 0.7 0.4 63.8 0.3 0.3 0.3 0.3 0.0 2.8 2.8 5.5 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.7 0.3 0.5 1.1 0.3 7.6 0.3 0.3 18.6 3.6 0.3 0.3 0.3 1.0 0.3 0.3 1.0 0.3 35.5 28.6 0.8 19.1 0.8 0.1 0.7 0.2 3.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.6 1.4 0.1 0.1 0.0 0.0 16.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 5.3 0.1 3.2 1.0 0.0 0.0 57.4 0.0 0.0 0.4 0.2 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.8 0.1 0.2 0.1 3.4 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 50.6 1.7 0.0 0.8 2.5 0.0 0.3 0.0 1.4 10.3 1.8 0.0 1.1 5.0 1.4 0.0 0.0 2.1 0.0 3.2 0.1 0.4 1.3 0.0 3.4 0.0 0.0 48.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 10.5 56.1 0.0 12.6 0.0 0.0 0.2 0.0 0.0 22.7 0.2 0.0 1.2 6.3 C2orf66 UNQ6411 ENSG00000187944 "Chromosome 2 open reading frame 66" Q6UXQ4 2 196805002-196810276 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 7.0;pituitary gland: 6.4" "Cell type enriched" "Detected in some" 12 "Early spermatids: 27.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 9.4;RT4: 3.5;TIME: 3.9" HPA020869 Uncertain Uncertain Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA020869: AB_1851545" "unprognostic (1.19e-1)" "unprognostic (4.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.19e-1)" "unprognostic (3.48e-2)" "unprognostic (1.61e-2)" "unprognostic (6.80e-3)" "unprognostic (3.05e-2)" "unprognostic (1.95e-1)" "unprognostic (4.10e-3)" "unprognostic (4.54e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-5)" "unprognostic (1.84e-1)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (1.86e-2)" 7.0 4.0 0.4 0.2 0.7 0.2 1.0 0.1 0.4 0.0 0.2 0.0 0.1 1.2 0.1 1.1 0.4 0.7 0.4 2.8 0.3 0.0 0.2 0.0 0.7 0.3 0.6 0.0 6.4 0.1 0.3 0.4 0.0 0.2 0.0 2.8 0.3 0.1 0.0 0.2 0.0 2.6 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.4 1.1 0.5 0.3 0.0 0.5 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 1.1 0.2 0.3 0.6 9.4 1.0 0.1 0.0 0.1 0.8 0.7 1.4 0.2 0.2 0.2 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 3.5 0.4 0.2 0.0 0.1 0.1 0.4 0.0 0.0 3.9 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 C2orf70 LOC339778 ENSG00000173557 "Chromosome 2 open reading frame 70" A6NJV1 2 26562582-26579532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 11.5;testis: 44.9" "Group enriched" "Detected in some" 16 "Early spermatids: 140.3;Late spermatids: 288.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062453 Enhanced Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA062453: AB_2684769" "unprognostic (5.44e-2)" "unprognostic (9.30e-3)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (1.99e-2)" "unprognostic (9.40e-6)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (6.49e-4)" "unprognostic (4.58e-2)" "unprognostic (1.52e-1)" "unprognostic (2.98e-1)" "unprognostic (2.01e-1)" "unprognostic (2.16e-3)" "unprognostic (7.08e-3)" 0.1 0.3 1.1 0.3 2.2 0.0 0.3 0.1 0.8 0.5 1.0 3.1 2.3 0.3 0.4 5.2 0.2 11.5 0.6 1.4 1.1 2.7 0.7 0.1 1.0 0.1 0.8 0.7 2.7 4.5 0.0 1.2 0.1 4.4 0.4 0.6 0.0 3.1 1.7 0.2 0.1 0.2 0.1 0.7 0.1 7.6 44.9 0.5 0.0 3.1 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 3.8 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.2 0.1 0.8 1.1 2.7 0.8 0.7 4.4 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 13.4 0.0 0.0 0.0 0.0 1.7 0.6 140.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 2.3 0.0 0.0 0.0 2.9 0.0 0.0 288.4 1.7 0.0 0.0 0.0 1.3 0.0 0.3 0.0 1.8 0.5 0.0 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 C2orf71 "FLJ34931, RP54" ENSG00000179270 "Chromosome 2 open reading frame 71" A6NGG8 2 29060976-29074261 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 28.6" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.28e-3)" "unprognostic (1.23e-1)" "unprognostic (1.13e-1)" "unprognostic (3.15e-1)" "unprognostic (1.88e-1)" "unprognostic (5.88e-3)" "unprognostic (6.68e-3)" "unprognostic (1.21e-1)" "unprognostic (6.61e-2)" "unprognostic (3.81e-2)" "unprognostic (2.37e-1)" "unprognostic (2.08e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-4)" 0.2 0.1 0.4 0.1 0.9 0.0 0.2 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.4 0.1 3.6 0.7 0.3 1.3 0.1 1.1 0.1 0.5 0.4 2.0 0.1 0.0 0.3 0.1 0.1 0.5 0.0 28.6 0.4 0.1 0.7 0.7 0.1 0.1 0.5 0.1 0.2 1.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.7 0.7 0.3 0.5 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.9 1.4 0.0 0.0 0.0 0.0 29.5 0.0 1.7 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 52.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037490-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.5;placenta: 23.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favorable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 1.0 0.9 6.5 0.9 8.4 0.8 1.6 1.7 10.1 0.8 7.8 9.9 0.0 2.3 0.8 1.1 0.9 0.9 1.8 0.8 7.7 4.7 1.4 22.5 1.2 0.8 5.1 7.9 0.8 6.1 1.7 1.7 23.9 8.2 2.0 2.5 0.8 1.0 0.9 0.8 0.8 2.6 1.0 2.2 0.8 4.2 0.9 5.9 0.0 0.8 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 5.6 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.1 1.5 0.8 0.8 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.4 1.7 10.1 7.7 4.7 5.1 7.9 8.2 5.9 0.0 0.0 1.9 0.0 0.1 0.6 0.3 33.1 0.0 0.0 0.0 0.0 1.4 1.7 2.0 7.3 0.0 15.3 0.0 1.8 9.0 0.0 0.9 0.0 111.5 0.5 0.0 4.7 3.7 2.5 25.8 0.3 0.0 1.7 0.0 13.2 9.7 1.0 62.8 3.9 1.4 0.3 0.0 0.1 0.5 0.9 0.0 4.3 0.0 24.3 0.1 C2orf73 FLJ40298 ENSG00000177994 "Chromosome 2 open reading frame 73" Q8N5S3 2 54330034-54383742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.8;pituitary gland: 11.9;testis: 39.2" "Group enriched" "Detected in some" 10 "Early spermatids: 988.4;Late spermatids: 409.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enhanced" "Detected in single" "B-cells: 1.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;BJ hTERT+: 1.3;CAPAN-2: 1.3;HSkMC: 1.5;hTERT-RPE1: 4.3;RPTEC TERT1: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055221, HPA059596" Uncertain NA NA "HPA055221: AB_2682744, HPA059596: AB_2684077" "unprognostic (1.56e-2)" "unprognostic (7.00e-3)" "unprognostic (1.51e-2)" "unprognostic (1.39e-2)" "unprognostic (5.46e-2)" "unprognostic (2.74e-2)" "unprognostic (6.69e-3)" "unprognostic (2.36e-2)" "unprognostic (1.62e-3)" "unprognostic (7.69e-2)" "unprognostic (3.00e-2)" "unprognostic (5.01e-3)" "unprognostic (1.17e-2)" "unprognostic (8.99e-2)" "unprognostic (3.80e-2)" 0.4 0.9 2.0 0.3 6.4 0.3 0.4 0.9 1.6 0.7 0.4 4.1 1.6 0.3 0.6 3.5 0.4 7.3 0.3 0.4 2.7 1.2 0.8 0.4 1.6 0.3 0.9 4.4 0.9 0.9 1.0 11.9 0.3 11.8 0.6 0.3 0.3 0.4 0.6 0.4 0.4 0.4 0.3 1.5 0.4 0.4 39.2 1.7 0.0 1.7 0.0 0.3 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.4 0.6 0.0 2.1 0.0 0.0 1.3 0.0 0.7 0.0 1.3 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.5 0.3 0.8 0.0 4.3 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.4 0.9 1.6 2.7 1.2 0.9 4.4 11.8 1.7 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 68.3 14.8 3.5 0.0 0.0 5.0 0.1 988.4 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 409.8 7.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.9 2.5 2.0 0.0 0.0 57.5 7.3 0.1 0.0 0.0 0.0 0.1 C2orf78 "COG5373, FLJ43987, hCG1989538" ENSG00000187833 "Chromosome 2 open reading frame 78" A6NCI8 2 73784189-73817147 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 141 "testis: 14.0" "Cell type enriched" "Detected in some" 13 "Early spermatids: 42.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 4.1;U-266/70: 1.7;U-266/84: 1.2" "Not detected" "Not detected" NA NA "unprognostic (5.25e-2)" "unprognostic (6.56e-3)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.7 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 C2orf80 "GONDA1, LOC389073" ENSG00000188674 "Chromosome 2 open reading frame 80" Q0P641 2 208165343-208190073 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 41 "glioma: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Cell line enhanced" "Detected in some" "NTERA-2: 5.9" "Low region specificity" "Detected in all" HPA042639 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042639: AB_10794915" "unprognostic (6.36e-2)" "unprognostic (2.12e-1)" "unprognostic (2.95e-1)" "unprognostic (3.05e-1)" "unprognostic (1.83e-1)" "unprognostic (2.98e-2)" 0.9 1.0 20.8 1.3 20.8 2.4 0.9 0.4 35.3 0.7 1.1 1.1 0.0 1.0 1.0 0.9 2.2 1.0 1.4 0.9 16.3 14.2 0.9 1.1 1.0 1.1 8.0 13.1 1.0 0.7 0.8 0.4 0.9 9.6 1.1 1.1 0.5 1.4 1.4 1.2 2.0 1.3 0.9 2.1 1.0 1.2 1.7 2.4 0.0 1.1 0.0 0.8 0.9 0.0 1.5 1.7 8.4 1.2 1.0 0.7 0.2 0.4 0.5 2.7 0.9 0.0 0.0 0.2 0.6 0.6 0.0 0.0 1.0 1.2 1.5 1.0 0.3 0.6 0.4 0.0 0.0 0.0 0.4 0.3 1.0 1.3 0.4 0.0 1.2 1.8 0.4 0.5 0.3 0.3 0.3 0.0 0.5 0.6 1.5 0.0 0.8 0.0 1.6 5.9 0.4 1.8 0.4 0.3 0.4 0.0 1.2 0.8 1.3 0.3 0.9 0.2 0.4 0.5 0.0 0.8 0.5 0.3 0.4 0.5 0.8 0.3 1.1 0.0 0.6 0.9 4.3 1.2 0.9 0.7 0.7 0.5 0.9 0.7 0.7 0.3 1.5 0.6 0.7 8.4 1.0 0.5 1.7 0.3 0.2 20.8 20.8 0.4 23.1 16.3 14.2 8.0 13.1 9.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C2orf81 "hCG40743, LOC388963" ENSG00000284308 "Chromosome 2 open reading frame 81" 2 74414176-74421591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.9;testis: 20.0" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 17.4;Early spermatids: 35.6;Late spermatids: 23.4;Spermatocytes: 16.4" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 12.2;RPMI-8226: 11.6;SCLC-21H: 15.2;SH-SY5Y: 16.5" "HPA049564, HPA054835" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA049564: , HPA054835: AB_2682620" 0.4 0.9 2.2 1.2 5.5 0.5 0.9 1.2 3.4 1.3 0.8 2.6 8.2 0.9 2.2 4.9 1.6 17.9 2.0 0.7 2.1 1.9 0.0 2.5 3.0 0.0 2.8 3.2 1.6 4.9 13.7 1.0 1.9 1.8 0.2 3.2 1.3 3.5 0.8 0.3 1.1 0.7 0.0 2.1 1.7 20.0 0.8 5.3 2.1 0.7 1.9 1.9 0.0 6.5 13.2 0.2 1.8 3.1 3.4 1.3 3.5 6.6 2.0 7.4 2.3 1.9 0.7 0.6 2.2 0.6 0.7 0.4 4.1 8.6 1.6 1.0 1.8 1.3 0.1 1.7 0.7 4.8 0.5 0.9 0.5 0.1 1.1 1.8 1.9 1.1 4.4 0.9 0.9 2.6 0.0 4.7 0.3 1.4 1.1 12.2 2.2 4.5 4.0 2.1 1.5 1.1 0.7 11.6 2.6 1.5 15.2 16.5 2.1 3.3 0.9 0.3 3.1 1.6 0.1 0.7 3.3 2.3 1.8 3.2 5.6 2.8 4.6 1.7 1.5 0.1 1.8 0.0 0.6 1.8 0.3 5.7 0.7 0.8 6.2 6.5 3.4 1.5 0.2 3.1 1.4 13.2 0.6 1.3 0.0 3.7 0.0 1.0 0.6 0.6 1.1 2.5 17.4 4.5 3.5 0.0 0.0 5.0 2.9 35.6 1.4 0.1 0.0 1.9 0.0 2.1 0.6 0.0 0.0 0.0 3.2 6.9 2.5 2.1 23.4 3.1 3.0 3.3 9.0 1.6 4.8 2.0 0.0 7.1 4.2 3.5 6.5 3.9 16.4 1.5 0.6 0.0 0.0 1.1 0.2 C2orf83 DKFZp547H025 ENSG00000042304 "Chromosome 2 open reading frame 83" Q53S99 2 227610090-227648606 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "placenta: 16.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 1.6;Late spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-2197: 12.6" HPA030319 Approved NA NA "HPA030319: AB_10602112" "unprognostic (1.12e-2)" "unprognostic (1.03e-1)" 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C2orf88 "MGC13057, smAKAP" ENSG00000187699 "Chromosome 2 open reading frame 88" Q9BSF0 2 189879609-190203484 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.6;testis: 40.7" "Group enriched" "Detected in many" 10 "Early spermatids: 1093.0;Enterocytes: 313.0;Late spermatids: 1008.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 16.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.7;naive B-cell: 1.8;neutrophil: 7.0;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 2.7;dendritic cells: 2.6;granulocytes: 7.0" "Group enriched" "Detected in some" 6 "HEL: 41.9;K-562: 34.9;RT4: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049549 Approved NA NA 230000 "HPA049549: AB_2680812" "unprognostic (1.20e-4)" "unprognostic (9.17e-2)" "unprognostic (4.50e-2)" "prognostic favorable (4.97e-4)" "unprognostic (6.09e-3)" "unprognostic (4.55e-2)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "prognostic unfavorable (9.39e-4)" "unprognostic (5.29e-3)" "unprognostic (2.66e-1)" "unprognostic (1.18e-1)" "prognostic favorable (7.79e-4)" "unprognostic (2.64e-2)" "unprognostic (2.72e-1)" "unprognostic (6.95e-2)" "unprognostic (1.18e-3)" 2.3 5.0 6.7 6.1 8.4 4.7 5.3 1.8 5.7 29.8 21.7 13.0 4.0 20.0 9.7 2.7 3.1 12.5 2.4 9.8 7.0 5.2 6.6 3.2 2.5 1.9 14.0 4.9 2.6 9.8 4.5 2.3 5.5 8.5 5.0 22.8 2.4 16.1 6.1 7.1 3.4 55.6 2.4 14.6 3.3 3.3 40.7 13.3 0.0 6.1 8.9 3.0 3.3 8.1 2.7 2.6 7.0 0.5 0.1 0.1 14.9 0.0 0.1 0.3 0.1 1.4 4.8 0.3 0.1 0.2 0.1 0.4 1.3 0.1 0.3 5.7 0.4 2.4 0.1 1.2 0.0 0.6 0.2 0.7 41.9 0.1 2.6 0.1 0.2 0.0 2.2 0.1 2.3 0.1 0.0 0.1 0.1 34.9 2.8 0.6 0.1 0.1 0.3 0.1 0.1 0.0 0.1 1.6 0.2 0.9 23.0 0.3 0.9 0.0 0.0 4.4 0.8 0.0 0.4 0.3 0.3 0.3 0.1 0.1 0.2 0.7 0.8 0.4 0.2 0.1 0.0 0.5 0.7 0.0 0.0 0.0 2.7 0.0 0.1 0.1 1.8 0.0 0.0 7.0 0.1 0.0 2.6 0.0 14.9 6.7 8.4 1.8 5.1 7.0 5.2 14.0 4.9 8.5 13.3 3.0 0.3 1.5 11.9 1.3 8.0 33.6 0.0 0.0 0.0 3.5 23.6 0.1 16.6 0.5 1093.0 5.3 313.0 46.7 13.1 0.2 6.9 1.4 0.0 2.8 0.2 7.9 4.1 73.6 7.8 1008.6 9.2 1.3 25.3 0.0 43.5 2.5 5.7 80.7 5.6 22.7 11.0 0.0 2.7 24.1 5.4 1.9 0.3 1.3 23.0 2.4 C2orf91 ENSG00000205086 "Chromosome 2 open reading frame 91" Q6ZV80 2 41935368-41954266 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;lung: 4.7" "Cell type enhanced" "Detected in single" 22 "Alveolar cells type 1: 3.0" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.8" "Region enhanced" "Detected in some" "midbrain: 5.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AN3-CA: 5.2;HDLM-2: 17.9" HPA042517 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" Nucleoplasm "HPA042517: AB_10795508" "unprognostic (9.49e-3)" "unprognostic (2.24e-2)" "unprognostic (1.73e-1)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (8.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (3.92e-2)" "unprognostic (1.16e-1)" "unprognostic (4.79e-2)" "unprognostic (1.08e-2)" "unprognostic (2.91e-2)" "unprognostic (7.61e-2)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" 0.3 2.1 0.3 0.3 1.3 1.5 0.3 0.3 0.8 0.4 0.3 0.8 0.2 0.0 0.4 1.0 0.3 0.3 0.3 0.5 0.3 0.4 0.9 0.3 4.7 0.9 5.1 0.2 0.4 0.4 0.4 0.5 0.2 1.9 0.8 0.2 0.8 3.5 0.2 0.2 1.3 0.3 0.2 2.2 0.6 1.3 1.1 0.2 0.2 0.2 0.2 0.6 0.2 0.3 1.2 1.4 2.8 1.2 1.2 0.9 0.3 0.2 0.4 0.7 5.2 0.2 0.1 0.3 0.1 0.1 0.0 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.1 0.1 17.9 0.3 0.2 0.4 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.1 0.1 0.3 0.4 0.1 0.0 0.6 0.1 0.1 0.3 0.2 1.8 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.2 1.3 1.2 1.4 0.6 0.9 0.5 0.6 0.7 0.5 1.4 1.2 0.7 0.9 2.8 1.2 1.0 1.3 0.4 0.3 0.3 1.3 0.3 0.8 0.3 0.4 5.1 0.2 1.9 0.2 3.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 C2orf92 LINC01125 ENSG00000228486 "Chromosome 2 open reading frame 92" 2 97664217-97703064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 12 "testis: 32.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 6.9;Ciliated cells: 2.7;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.5;HDLM-2: 5.1" NA NA "unprognostic (5.53e-2)" "unprognostic (8.76e-2)" "unprognostic (1.65e-2)" "unprognostic (2.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.09e-3)" "unprognostic (9.29e-2)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.98e-3)" "unprognostic (2.76e-2)" "unprognostic (7.45e-7)" "unprognostic (5.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.11e-1)" "unprognostic (5.23e-5)" 0.7 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 2.4 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 1.4 0.3 1.6 2.6 0.2 0.2 0.2 1.4 0.0 32.1 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.0 0.4 0.0 4.5 0.8 2.2 1.6 0.6 0.0 0.2 0.3 0.3 0.0 0.4 1.3 0.7 0.4 0.0 0.0 0.0 0.0 2.0 5.1 0.0 2.0 0.4 0.0 0.0 1.2 0.2 1.5 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.5 1.2 0.3 0.2 2.6 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 2.5 2.1 1.1 1.6 0.2 1.4 1.8 0.7 2.7 0.0 0.6 0.6 0.1 0.3 0.1 0.4 1.9 2.4 1.4 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 C3 "ARMD9, C3a, C3b, CPAMD1" ENSG00000125730 "Complement C3" P01024 19 6677704-6730562 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism" "Age-related macular degeneration, Disease mutation, FDA approved drug targets, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "liver: 611.7" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 4080.2" "Cancer enhanced" "Detected in all" "liver cancer: 1213.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 13.3" "Group enriched" "Detected in many" 4 "granulocytes: 4.2;monocytes: 13.3" "Group enriched" "Detected in many" 7 "BJ hTERT+: 48.5;EFO-21: 102.2;Hep G2: 105.6;HSkMC: 75.4;SiHa: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003563, CAB004209, HPA020432" Enhanced "Secreted to blood" NA NA 1260000000000 250000000000 "CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118" "unprognostic (3.26e-3)" "unprognostic (3.91e-1)" "unprognostic (3.92e-1)" "unprognostic (5.98e-3)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "prognostic favorable (8.11e-4)" "unprognostic (1.99e-1)" "unprognostic (9.26e-2)" "unprognostic (5.80e-2)" "unprognostic (8.12e-3)" "unprognostic (5.48e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.63e-2)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.88e-1)" 59.7 34.1 9.3 20.0 19.6 1.0 47.3 0.7 10.2 28.3 17.8 13.9 3.7 3.2 9.1 19.9 17.9 38.8 37.9 57.6 7.0 4.1 21.6 611.7 22.6 25.2 12.3 2.2 42.4 22.2 3.1 3.0 2.7 12.8 12.7 9.6 3.9 18.7 7.6 6.8 5.8 15.1 19.1 29.6 1.6 12.6 11.2 10.7 0.1 10.3 3.2 14.1 25.2 38.2 1.2 0.8 4.2 13.3 2.0 0.4 0.8 8.4 3.0 0.0 0.0 1.5 5.1 10.3 0.7 48.5 0.9 1.7 0.5 6.7 0.2 102.2 0.0 7.5 6.3 0.0 5.8 0.9 3.1 0.0 0.4 4.5 105.6 2.3 0.8 1.2 75.4 1.7 8.4 3.8 1.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 4.4 0.8 0.0 0.0 28.2 0.0 0.0 0.0 2.3 1.1 0.4 0.8 1.0 0.6 0.4 0.2 0.5 0.5 10.4 0.6 0.0 1.7 1.5 0.9 0.4 2.7 0.3 0.7 0.3 0.2 0.8 1.2 0.4 0.4 4.2 2.0 13.3 0.7 0.2 0.8 9.3 19.6 0.7 10.2 7.0 4.1 12.3 2.2 12.8 10.7 71.5 405.7 102.4 11.5 24.5 0.0 13.3 822.9 29.4 84.2 15.7 0.0 1.2 5.0 273.3 34.0 21.5 0.3 70.0 114.7 2.1 60.9 11.5 4.7 4080.2 36.1 0.0 0.0 120.9 123.3 75.5 209.4 25.1 33.7 25.2 0.6 0.5 589.9 0.0 10.3 39.2 3.7 6.5 22.8 3.2 7.9 19.2 2.3 24.5 0.4 12.3 C3AR1 "AZ3B, C3AR" ENSG00000171860 "Complement C3a receptor 1" Q16581 12 8058302-8066471 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 101.1" "Group enriched" "Detected in many" 4 "granulocytes: 35.8;Hofbauer cells: 141.5;Kupffer cells: 97.6;Macrophages: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 101.1;eosinophil: 56.9;intermediate monocyte: 34.5;non-classical monocyte: 47.0" "Group enriched" "Detected in many" 18 "granulocytes: 101.1;monocytes: 47.0" "Cell line enriched" "Detected in some" 9 "HMC-1: 67.4" "Low region specificity" "Detected in many" CAB009405 Enhanced NA NA "CAB009405: AB_2066739" "unprognostic (1.11e-2)" "unprognostic (5.67e-2)" "unprognostic (5.06e-2)" "unprognostic (4.14e-2)" "unprognostic (6.60e-2)" "unprognostic (1.50e-1)" "unprognostic (4.81e-2)" "unprognostic (2.78e-1)" "unprognostic (6.10e-2)" "unprognostic (8.04e-2)" "unprognostic (1.59e-1)" "unprognostic (3.50e-2)" "unprognostic (8.22e-2)" "unprognostic (4.96e-2)" "unprognostic (9.24e-3)" "unprognostic (2.09e-2)" "unprognostic (8.16e-2)" 34.1 10.0 11.7 35.1 15.5 17.4 10.7 1.9 7.6 7.2 5.8 15.5 0.7 4.9 4.8 6.7 3.8 7.3 15.0 7.3 9.7 7.2 9.2 10.0 21.1 29.7 16.7 3.5 4.9 5.5 2.9 3.5 19.8 13.3 4.8 6.4 5.2 7.8 4.0 3.6 2.7 9.1 13.9 23.4 25.2 4.9 5.8 16.2 1.9 3.2 1.5 4.8 12.9 3.7 0.0 4.0 101.1 47.0 0.5 3.8 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.2 1.9 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 5.9 0.0 0.0 0.6 7.8 67.4 0.3 0.0 0.1 0.2 0.1 0.3 0.5 1.6 3.9 0.2 0.0 0.3 2.8 0.0 0.0 0.0 0.0 1.4 7.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.3 0.2 0.2 0.0 0.1 0.1 0.0 0.2 4.3 3.0 0.2 101.1 13.6 56.9 2.9 34.5 3.8 0.0 1.5 2.0 4.0 0.0 0.3 1.2 1.8 0.5 47.0 0.3 1.5 7.8 11.7 15.5 1.9 7.6 9.7 7.2 16.7 3.5 13.3 16.2 0.0 4.8 1.4 0.0 0.5 0.0 0.4 2.5 1.4 4.5 0.0 2.0 0.5 0.0 0.0 1.9 0.3 0.0 0.0 0.2 1.0 0.9 0.0 35.8 0.8 141.5 0.0 0.0 1.8 97.6 2.7 1.1 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.4 0.7 0.0 0.1 0.5 1.3 11.7 0.0 0.0 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675099-14773034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 30.9" "Group enriched" "Detected in some" 27 "Early spermatids: 16.4;Late spermatids: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HEL: 12.2;U-698: 9.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 12.2 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.5 0.8 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 C3orf22 MGC34728 ENSG00000180697 "Chromosome 3 open reading frame 22" Q8N5N4 3 126526999-126558965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "testis: 28.3" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1235.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "MCF7: 1.5;SCLC-21H: 1.0" "Not detected" "Not detected" HPA059199 Enhanced NA NA "HPA059199: AB_2683946" "unprognostic (2.10e-1)" "unprognostic (5.14e-5)" "unprognostic (2.55e-1)" "unprognostic (9.21e-2)" "unprognostic (2.01e-1)" "unprognostic (2.75e-1)" "unprognostic (1.08e-3)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1235.7 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 8.6 3.8 0.0 0.0 0.0 0.0 0.0 C3orf30 "FLJ32859, TSCPA" ENSG00000163424 "Chromosome 3 open reading frame 30" Q96M34 3 119146150-119160042 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 156 "testis: 46.4" "Group enriched" "Detected in some" 128 "Early spermatids: 547.1;Late spermatids: 266.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.9;HEL: 1.3" HPA062468 Enhanced NA NA "HPA062468: AB_2684772" "unprognostic (4.06e-3)" "unprognostic (3.67e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 547.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 266.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.0 C3orf36 FLJ22173 ENSG00000221972 "Chromosome 3 open reading frame 36" Q3SXR2 3 133928145-133929812 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "lung: 8.2;seminal vesicle: 14.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 6.6;HeLa: 1.7;TIME: 5.2" HPA046432 Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA046432: AB_2679664" "unprognostic (3.56e-1)" "unprognostic (3.28e-2)" "unprognostic (1.87e-1)" "unprognostic (5.29e-3)" "unprognostic (4.64e-4)" "unprognostic (5.05e-3)" "unprognostic (8.18e-5)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.03e-2)" "unprognostic (1.15e-2)" "unprognostic (2.22e-1)" "unprognostic (7.85e-2)" "unprognostic (4.79e-3)" "unprognostic (2.08e-1)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" 1.1 1.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.2 1.3 0.0 0.6 1.1 0.8 0.7 0.0 0.0 1.9 0.0 8.2 0.1 0.0 0.0 0.7 1.6 0.2 0.1 2.3 0.3 0.4 14.7 0.0 0.1 1.4 1.0 0.0 1.5 0.8 0.0 2.7 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf49 ENSG00000163632 "Chromosome 3 open reading frame 49" Q96BT1 3 63819362-63848636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Group enriched" "Detected in some" 12 "Early spermatids: 19.9;Late spermatids: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.7" "Not detected" "Not detected" HPA053582 Uncertain Approved Vesicles,Centrosome,Cytosol NA NA Cytosol "Vesicles, Centrosome" "HPA053582: AB_2682199" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (4.81e-2)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-1)" "unprognostic (2.14e-2)" "unprognostic (9.29e-3)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.61e-3)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (5.79e-2)" "unprognostic (1.07e-1)" 0.4 0.1 0.5 0.4 1.0 0.9 0.4 1.8 4.0 0.4 0.4 0.4 0.4 1.3 0.5 0.4 1.7 0.4 0.4 0.8 0.5 0.5 0.4 0.6 0.6 0.4 0.4 0.4 1.2 1.3 0.0 0.4 0.4 0.4 0.4 0.0 0.4 0.5 0.4 2.6 2.0 0.4 0.4 0.4 0.4 0.3 3.6 0.4 0.4 0.7 0.4 0.4 0.5 0.4 1.1 0.5 1.7 0.9 2.2 1.1 0.1 0.7 2.0 1.0 1.3 0.0 0.3 1.2 1.7 0.0 0.1 0.0 1.2 1.0 2.6 0.4 0.0 0.7 1.1 0.0 0.1 0.3 1.5 1.8 2.2 4.7 0.5 0.0 0.8 0.8 0.2 0.1 0.0 0.1 0.5 0.0 0.9 1.3 1.2 0.0 4.4 1.2 1.2 1.3 1.2 0.4 1.7 1.1 2.5 0.1 1.1 1.2 0.8 0.3 2.6 0.3 0.3 0.7 1.0 1.5 0.8 1.0 1.7 2.0 0.8 2.4 0.5 2.7 3.7 1.0 1.7 0.6 0.2 1.1 0.4 0.4 0.6 0.6 0.8 0.4 1.1 1.1 1.0 1.2 2.2 0.9 0.5 0.8 0.1 0.5 1.0 1.8 1.3 0.5 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.3 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 41.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;U-698: 20.8" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.1 1.0 0.3 5.3 0.7 0.4 1.9 0.3 0.4 1.0 9.1 0.0 6.9 2.8 1.7 1.5 2.7 1.0 12.4 3.0 0.4 0.4 7.1 0.5 6.3 0.8 0.3 0.0 0.6 41.2 0.0 8.7 6.1 0.5 5.4 9.0 0.6 3.9 9.6 1.5 22.3 12.7 4.2 0.3 0.8 10.6 1.0 0.0 20.8 10.7 4.3 3.6 6.1 6.1 0.8 0.8 0.0 0.0 0.0 2.7 1.0 8.7 1.4 2.4 0.0 0.3 0.0 3.2 6.9 2.9 4.0 4.6 14.9 4.7 0.3 1.3 2.0 4.6 6.2 2.8 1.7 7.6 0.0 2.3 6.0 2.0 0.7 1.8 0.0 0.0 0.5 3.5 3.6 6.1 2.8 0.9 0.0 1.5 1.5 3.0 0.6 0.2 0.0 5.2 5.6 1.9 0.2 7.9 0.0 7.1 7.7 0.3 0.6 2.6 2.7 2.5 2.9 4.0 0.0 2.2 1.4 2.4 0.0 0.0 5.5 0.0 20.8 1.2 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.4 0.8 2.7 1.3 0.5 0.3 1.5 0.6 0.0 0.0 0.0 0.8 0.0 1.0 0.3 0.7 0.3 0.4 0.4 0.4 0.3 0.0 0.5 0.0 14.9 7.7 0.5 112.5 28.8 0.0 1.4 5.1 13.4 22.7 17.4 0.0 15.2 0.0 29.6 24.4 0.3 14.6 0.0 31.2 16.0 1.7 75.6 0.0 0.0 1.6 0.0 11.3 0.6 0.3 18.2 0.3 0.3 1.7 4.6 32.5 0.0 53.5 5.9 0.4 1.7 0.0 0.0 3.3 1.8 5.5 29.4 62.7 0.8 5.4 119.7 C3orf56 FLJ40141 ENSG00000214324 "Chromosome 3 open reading frame 56" Q8N813 3 127193131-127198185 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 3.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;U-937: 1.0" NA NA "unprognostic (1.12e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 C3orf62 FLJ43654 ENSG00000188315 "Chromosome 3 open reading frame 62" Q6ZUJ4 3 49268602-49277909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "blood: 25.0;testis: 76.9" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 25.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 25.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043328 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA043328: AB_10795613" "prognostic favorable (3.93e-4)" "unprognostic (4.87e-3)" "unprognostic (3.70e-3)" "unprognostic (2.35e-2)" "unprognostic (9.51e-2)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.20e-4)" "prognostic favorable (8.88e-4)" "unprognostic (1.28e-1)" "unprognostic (9.40e-3)" "prognostic favorable (8.15e-4)" "unprognostic (7.23e-2)" "unprognostic (3.27e-2)" "prognostic favorable (3.29e-5)" "unprognostic (2.46e-1)" "unprognostic (4.79e-1)" "prognostic favorable (1.62e-5)" 4.2 5.5 3.2 4.4 4.0 7.4 2.7 6.6 4.8 3.8 3.6 2.8 4.4 3.1 3.5 4.9 3.7 4.1 5.0 3.5 3.7 4.3 2.7 2.8 3.9 4.5 3.3 4.0 8.0 4.7 2.4 4.5 2.6 3.6 4.1 2.3 5.7 4.4 2.2 3.7 3.5 2.7 3.6 3.6 7.0 2.6 76.9 3.3 2.2 3.7 2.2 3.3 4.8 7.5 1.2 1.6 25.0 3.2 0.6 1.0 0.7 4.8 2.9 6.9 8.7 5.7 5.2 3.9 2.9 4.9 2.6 3.9 4.1 3.7 9.6 4.6 4.4 5.4 3.8 3.5 3.2 3.0 8.5 4.0 6.3 6.1 4.6 2.0 8.9 11.9 4.0 9.5 3.8 7.1 4.5 3.1 5.6 7.1 7.3 2.2 3.0 6.6 6.4 4.9 3.8 4.2 5.0 3.6 5.0 4.3 11.2 5.3 7.2 8.0 6.1 10.4 5.4 3.1 9.9 3.5 3.6 8.8 6.1 5.3 6.7 10.9 8.3 2.7 8.6 4.9 1.5 3.2 3.4 0.8 1.2 0.9 1.2 0.9 0.8 0.7 0.9 0.9 0.8 25.0 0.6 1.4 1.6 1.0 0.7 3.2 4.0 6.6 4.8 3.7 4.3 3.3 4.0 3.6 3.3 8.9 17.3 3.0 3.1 6.1 11.5 7.8 7.6 9.4 11.4 10.4 21.6 5.2 0.0 4.1 9.1 5.8 4.3 0.0 3.4 3.6 5.3 5.4 2.3 5.7 9.0 4.8 5.2 8.0 17.3 12.8 8.1 9.2 8.5 9.0 8.6 6.5 4.3 3.5 8.1 4.9 13.5 0.0 3.8 64.4 6.5 7.5 3.4 6.4 6.3 2.0 C3orf67 "FLJ42117, FLJ42930" ENSG00000163689 "Chromosome 3 open reading frame 67" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 10.4;testis: 28.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 80.6;Late spermatids: 61.4;Spermatocytes: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2;T-reg: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 2.2;T-cells: 2.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.5 1.8 1.2 1.0 4.3 0.3 0.6 0.5 2.0 1.5 0.7 0.5 0.0 0.1 0.6 1.6 10.4 3.4 0.7 0.4 0.9 0.9 0.7 1.9 0.6 1.8 0.5 0.9 0.7 0.8 1.3 8.4 1.3 1.3 1.0 0.9 1.6 2.6 0.4 0.2 0.4 0.3 0.5 0.6 0.4 0.5 28.4 0.5 0.4 0.4 2.0 3.6 0.3 2.9 2.2 0.0 0.0 0.1 0.1 2.2 0.3 10.5 1.7 3.0 0.0 1.8 5.8 0.0 5.0 1.7 2.2 1.8 0.9 3.5 11.0 1.7 1.2 0.0 1.1 4.7 2.4 4.0 1.7 0.3 0.0 1.8 0.0 1.0 0.0 0.0 1.1 2.4 4.7 3.8 2.8 4.6 7.3 8.4 0.1 3.0 1.4 0.5 0.0 3.7 3.4 7.5 10.6 0.0 4.5 2.4 0.1 7.7 3.6 1.4 1.0 3.2 5.1 3.4 0.0 0.1 0.2 3.4 5.5 2.3 4.5 9.4 2.1 2.6 0.0 7.0 0.0 0.1 0.0 0.2 0.0 0.0 1.7 0.7 0.0 0.0 2.2 0.1 0.7 0.0 0.1 0.0 0.0 2.2 0.3 1.2 4.3 0.5 2.0 0.9 0.9 0.5 0.9 1.3 0.5 0.0 0.0 0.0 1.5 0.8 0.1 0.8 0.0 13.4 2.3 1.8 0.0 0.7 1.7 3.2 80.6 0.9 0.0 0.0 0.3 1.6 1.6 0.9 0.0 1.7 0.8 0.0 2.4 0.6 0.3 61.4 2.0 0.2 1.7 0.0 0.5 0.6 4.1 0.0 1.1 0.8 0.3 0.0 1.2 27.9 15.8 0.1 0.5 0.0 1.2 1.4 C3orf70 ENSG00000187068 "Chromosome 3 open reading frame 70" A6NLC5 3 185078050-185153014 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 26.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 17.4;Melanocytes: 37.1;Peritubular cells: 46.7" "Cancer enhanced" "Detected in many" "glioma: 10.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "RH-30: 4.7;SCLC-21H: 19.5;SK-BR-3: 8.4;WM-115: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041861 Uncertain Approved Cytosol NA NA Cytosol "HPA041861: AB_10804119" "unprognostic (1.45e-1)" "unprognostic (2.17e-3)" "unprognostic (3.92e-3)" "unprognostic (2.77e-1)" "unprognostic (2.31e-1)" "unprognostic (6.62e-4)" "unprognostic (5.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-1)" "unprognostic (5.98e-3)" "unprognostic (9.91e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.06e-1)" "unprognostic (8.48e-2)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" 4.6 2.3 14.4 4.7 13.8 0.9 2.0 7.9 18.2 7.2 12.1 11.1 7.9 5.3 12.1 6.1 10.1 6.8 6.1 3.3 11.1 10.2 1.6 1.3 2.4 1.3 11.4 7.1 5.9 1.1 4.0 1.4 2.9 10.5 10.2 8.2 5.2 5.5 16.4 1.5 2.9 6.5 26.6 11.1 4.2 4.4 7.5 7.0 0.0 2.4 1.0 1.7 13.2 3.3 1.2 1.2 3.4 1.6 1.7 1.1 0.5 0.0 0.1 2.3 0.0 0.0 0.1 0.1 3.0 0.1 0.5 0.0 1.4 0.0 0.0 0.0 0.3 0.1 0.1 1.0 0.0 0.2 0.0 0.8 2.5 0.1 0.7 0.0 0.4 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.1 1.0 2.2 0.2 0.1 4.7 0.1 0.0 0.5 19.5 0.2 0.9 8.4 0.5 0.1 0.6 2.2 0.8 0.0 2.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 10.5 3.4 1.2 1.7 0.8 1.0 1.0 1.0 0.8 0.8 0.6 1.2 1.0 1.1 3.3 1.7 1.6 1.2 0.7 0.5 14.4 13.8 7.9 9.6 11.1 10.2 11.4 7.1 10.5 7.0 0.0 0.0 1.5 0.2 3.7 17.4 1.2 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.1 1.0 2.3 4.0 0.0 0.2 0.6 2.3 0.3 0.0 0.0 3.1 3.2 1.2 4.9 0.6 1.2 3.1 0.0 37.1 1.0 8.1 1.3 0.2 0.0 46.7 0.0 6.2 6.5 15.8 7.9 12.5 1.6 0.7 0.0 5.3 0.3 C3orf80 ENSG00000180044 "Chromosome 3 open reading frame 80" F5H4A9 3 160225496-160228213 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.0;intestine: 8.6" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 4.5;Horizontal cells: 6.4;Intestinal endocrine cells: 4.1;Spermatocytes: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 57.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047439 Uncertain NA NA "HPA047439: AB_10965171" "unprognostic (5.34e-2)" "unprognostic (2.31e-1)" "unprognostic (6.35e-2)" "unprognostic (6.62e-3)" "unprognostic (1.92e-3)" "unprognostic (6.70e-3)" "unprognostic (4.28e-3)" "unprognostic (1.69e-1)" "unprognostic (4.64e-3)" "unprognostic (1.51e-1)" "unprognostic (9.20e-2)" "unprognostic (2.65e-1)" "unprognostic (6.09e-10)" "unprognostic (1.32e-2)" "unprognostic (1.78e-2)" "unprognostic (4.11e-3)" "unprognostic (5.00e-2)" 1.3 0.4 5.2 1.6 9.3 1.4 0.7 5.4 25.0 0.5 8.6 0.1 0.0 1.8 1.2 0.5 5.7 0.3 1.4 0.6 4.3 2.0 0.6 0.8 2.0 0.3 1.7 9.3 0.3 0.4 1.4 0.7 0.3 1.2 1.8 3.3 0.0 0.6 0.8 0.2 0.2 1.3 1.8 0.5 2.7 2.5 1.3 0.0 0.0 0.5 0.0 0.4 2.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.1 0.7 4.8 1.3 0.0 0.0 0.9 57.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.1 11.7 0.0 0.0 0.2 0.0 1.4 0.1 0.0 0.0 0.4 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 9.3 5.4 25.0 4.3 2.0 1.7 9.3 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 6.4 4.1 1.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 2.1 0.5 0.0 0.0 0.0 0.0 0.0 C3orf84 ENSG00000236980 "Chromosome 3 open reading frame 84" H3BNL1 3 49177632-49191858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 10.8" "Group enriched" "Detected in some" 89 "Early spermatids: 89.8;Late spermatids: 61.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "NB-4: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 C3orf85 FLJ22763 ENSG00000241224 "Chromosome 3 open reading frame 85" 3 109118252-109150514 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "intestine: 50.1" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 108.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.2;CACO-2: 5.0;RPMI-8226: 1.5;SH-SY5Y: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.10e-2)" "unprognostic (9.48e-3)" "unprognostic (3.80e-4)" "unprognostic (1.15e-1)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 36.2 0.0 0.6 0.0 0.0 0.0 0.4 0.0 6.8 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4A "C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG" ENSG00000244731 "Complement C4A (Rodgers blood group)" P0C0L4 6 31982024-32002681 "Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Inflammatory response, Innate immunity" "Blood group antigen" "Disease mutation, FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 49.5" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 36.1;Ciliated cells: 8.1;Club cells: 25.0" "Cancer enhanced" "Detected in many" "liver cancer: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 25.4;HSkMC: 36.1;U-266/70: 8.4;U-266/84: 16.0" "CAB009811, CAB032603, HPA046356, HPA048287, HPA050103" Supported "Secreted to blood" NA NA 342000000 98000000000 "CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016" "unprognostic (2.13e-1)" "unprognostic (3.02e-2)" "unprognostic (3.74e-2)" "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (3.09e-2)" "unprognostic (2.48e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (3.20e-2)" "unprognostic (5.20e-2)" "unprognostic (3.97e-2)" "unprognostic (8.63e-2)" 2.7 17.5 1.3 4.3 1.1 0.0 3.3 0.0 0.1 0.4 3.0 2.9 1.6 5.8 0.7 3.5 0.8 2.7 0.7 0.9 12.8 49.5 6.7 1.4 0.9 8.0 2.6 0.0 2.2 0.0 1.5 1.7 1.3 0.0 0.0 0.1 1.2 0.0 0.7 2.9 4.1 0.3 8.1 1.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 25.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 8.4 16.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 36.1 0.0 0.0 0.0 0.0 4.7 0.0 8.1 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4B "C4B1, C4B3, C4F, CH, CO4, CPAMD3" ENSG00000224389 "Complement C4B (Chido blood group)" P0C0L5 6 32014762-32035418 "Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Inflammatory response, Innate immunity" "Blood group antigen" "FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 30.7;liver: 52.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 95.9;Cardiomyocytes: 44.1;Club cells: 42.1" "Cancer enhanced" "Detected in many" "liver cancer: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 53.7" "HPA046356, HPA048287, HPA050103" Approved "Secreted to blood" NA NA 97000000000 "HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016" "unprognostic (1.29e-1)" "unprognostic (2.99e-2)" "unprognostic (5.50e-3)" "unprognostic (1.30e-1)" "unprognostic (8.09e-2)" "unprognostic (6.24e-2)" "unprognostic (6.09e-2)" "unprognostic (1.05e-1)" "unprognostic (4.81e-2)" "unprognostic (1.12e-1)" "unprognostic (6.24e-2)" "unprognostic (6.86e-2)" "unprognostic (1.04e-1)" "unprognostic (3.12e-2)" "unprognostic (1.30e-1)" "unprognostic (3.99e-3)" "unprognostic (1.11e-2)" 3.7 30.7 0.9 0.0 0.7 0.0 1.3 0.0 0.9 0.7 2.3 0.9 1.4 0.0 0.0 4.7 2.4 2.6 0.4 0.9 7.2 52.4 2.0 0.7 0.7 7.2 2.7 1.0 1.8 0.5 0.5 2.7 2.0 0.4 0.0 0.0 1.0 3.8 0.6 1.4 0.8 0.7 5.7 1.6 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 3.3 0.2 0.0 10.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 95.9 0.0 0.0 0.0 0.0 44.1 0.0 14.7 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.1 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4BPA C4BP ENSG00000123838 "Complement component 4 binding protein alpha" P04003 1 207104262-207144972 "Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 377.2" "Group enriched" "Detected in some" 14 "Alveolar cells type 1: 458.5;Alveolar cells type 2: 461.5;Hepatocytes: 752.2" "Cancer enriched" "Detected in many" 7 "liver cancer: 434.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 153 "neutrophil: 21.6" "Lineage enriched" "Detected in single" 153 "granulocytes: 21.6" "Cell line enriched" "Detected in some" 5 "Hep G2: 28.7" "HPA000926, HPA001578" Enhanced "Secreted to blood" NA NA 30800000000 34000000000 "HPA000926: AB_1078355, HPA001578: AB_1078354" "unprognostic (3.85e-4)" "unprognostic (9.07e-2)" "unprognostic (2.06e-1)" "prognostic favorable (6.37e-5)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "prognostic favorable (2.24e-4)" "unprognostic (3.64e-2)" "unprognostic (1.94e-1)" "unprognostic (5.90e-4)" "unprognostic (4.47e-2)" "unprognostic (2.58e-1)" "unprognostic (5.51e-7)" "unprognostic (9.74e-2)" "unprognostic (2.52e-2)" "unprognostic (6.92e-2)" "unprognostic (2.66e-1)" 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.6 0.2 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 377.2 26.0 0.1 0.1 0.1 0.3 1.8 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 21.6 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 28.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 458.5 461.5 0.0 0.0 0.0 0.0 0.1 30.6 6.7 40.9 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 23.3 16.0 0.0 0.0 0.4 3.5 752.2 0.2 0.0 0.0 23.4 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.1 C4BPB C4BP ENSG00000123843 "Complement component 4 binding protein beta" P20851 1 207088842-207099993 "Plasma proteins, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 156.5" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 556.0" "Cancer enriched" "Detected in many" 19 "liver cancer: 83.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 16 "dendritic cells: 3.6;T-cells: 2.5" "Group enriched" "Detected in some" 16 "CACO-2: 38.6;HeLa: 16.0;Hep G2: 50.1;OE19: 18.8" "Low region specificity" "Detected in all" HPA051620 Approved "Secreted to blood" NA NA 265000000000 1300000000 "HPA051620: AB_2681554" "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" "unprognostic (3.26e-1)" "unprognostic (2.07e-3)" "unprognostic (1.72e-1)" "unprognostic (2.54e-2)" "unprognostic (4.58e-3)" "unprognostic (9.49e-2)" "unprognostic (1.37e-1)" "unprognostic (4.25e-1)" "unprognostic (6.39e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (8.25e-2)" 0.5 0.0 0.1 0.5 0.1 0.0 0.3 0.1 0.1 0.5 2.0 0.1 0.1 0.6 0.1 0.9 0.2 0.1 1.0 0.6 0.1 0.0 0.2 156.5 0.6 0.1 0.1 0.1 9.9 2.2 0.0 0.1 1.3 0.1 0.3 0.3 0.1 0.2 0.1 0.2 0.0 0.9 0.2 0.1 0.1 1.5 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 3.6 0.0 0.0 0.0 2.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.6 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 50.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.5 0.8 0.0 0.0 0.0 3.6 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 11.9 1.3 1.5 0.0 0.0 0.0 0.4 45.9 2.7 4.5 0.0 0.0 0.7 1.7 11.0 3.9 0.0 3.1 0.0 76.8 0.1 0.2 0.2 0.0 556.0 1.6 0.0 1.7 9.8 9.4 1.8 0.0 0.4 0.0 1.0 3.4 0.0 52.0 11.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 2.3 0.0 C4orf17 DKFZP434G072 ENSG00000138813 "Chromosome 4 open reading frame 17" Q53FE4 4 99511004-99542303 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "testis: 31.8" "Cell type enriched" "Detected in some" 48 "Early spermatids: 129.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HHSteC: 2.0" "Low region specificity" "Detected in all" "HPA060374, HPA060564" Uncertain NA NA "HPA060374: AB_2684268, HPA060564: AB_2684319" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 C4orf19 FLJ11017 ENSG00000154274 "Chromosome 4 open reading frame 19" Q8IY42 4 37453941-37623495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 37.7;placenta: 38.3" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 45.7;Exocrine glandular cells: 45.6;Pancreatic endocrine cells: 48.4;Paneth cells: 37.4;Syncytiotrophoblasts: 39.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 11.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.4" "Group enriched" "Detected in some" 5 "OE19: 25.1;RT4: 32.3;SK-BR-3: 13.0;T-47d: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043458, HPA052894" Enhanced Supported "Cell Junctions" No No "Cell Junctions" "HPA043458: AB_10960696, HPA052894: AB_2681982" "unprognostic (8.83e-2)" "unprognostic (7.86e-2)" "unprognostic (3.00e-3)" "unprognostic (2.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.59e-3)" "unprognostic (5.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.66e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.49e-11)" "unprognostic (1.33e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (8.19e-3)" 2.0 0.5 2.6 1.5 2.7 1.6 2.2 2.8 5.4 6.5 14.6 2.5 2.3 10.3 4.2 1.9 2.1 1.7 7.4 0.7 4.4 1.7 11.9 26.2 2.8 0.0 3.1 2.5 0.6 37.7 5.8 6.1 38.3 6.2 1.9 14.0 1.9 22.2 9.8 0.6 1.7 11.0 2.3 3.8 0.6 12.4 1.5 2.2 0.0 1.3 1.0 3.3 5.9 2.9 0.9 2.2 11.4 2.1 1.2 1.2 0.3 0.0 0.0 1.3 0.1 0.0 0.0 1.7 0.3 0.0 0.0 0.0 5.2 2.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.2 25.1 0.7 0.0 3.2 0.0 5.1 32.3 0.4 0.1 0.2 13.0 0.4 1.7 46.3 0.2 0.2 0.1 1.9 0.0 0.6 0.0 0.0 0.2 0.0 2.6 2.2 0.9 2.1 2.5 0.8 0.3 0.5 0.3 0.5 0.5 0.3 0.9 0.8 1.2 11.4 1.2 0.2 2.2 0.9 0.3 2.6 2.7 2.8 5.4 4.4 1.7 3.1 2.5 6.2 2.2 0.0 13.0 1.3 4.9 0.2 0.2 0.2 22.9 6.7 0.0 10.4 0.0 5.1 10.0 18.9 1.0 0.1 45.7 0.0 45.6 4.6 0.2 5.3 0.0 11.5 0.6 0.0 9.2 0.0 0.0 1.3 0.0 0.0 3.3 1.0 28.4 4.3 48.4 37.4 0.0 7.9 1.0 0.0 0.1 0.1 0.0 0.0 39.7 0.0 28.5 13.7 C4orf22 ENSG00000197826 "Chromosome 4 open reading frame 22" Q6V702 4 80335720-80963756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;fallopian tube: 19.8;testis: 34.8" "Cell type enhanced" "Detected in some" 25 "Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 8.4;pons and medulla: 22.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Cell line enhanced" "Detected in some" "A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.1 1.4 0.1 8.4 0.1 0.3 0.6 0.2 0.9 0.1 5.1 0.1 0.3 0.4 7.8 0.2 19.8 0.3 0.1 2.8 2.5 0.4 0.1 5.9 0.3 0.1 0.1 3.5 0.1 0.1 1.2 0.1 22.0 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.1 0.1 34.8 2.4 2.9 0.7 0.0 0.2 0.1 0.0 2.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 1.9 0.0 4.0 0.7 0.1 0.1 0.0 0.0 1.1 0.0 1.4 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 1.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.4 8.4 0.6 0.2 2.8 2.5 0.1 0.1 22.0 2.4 0.0 1.0 0.0 0.1 0.0 0.6 0.0 0.0 163.3 23.9 0.0 0.0 0.0 0.0 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 40.9 2.3 0.0 0.0 0.0 0.0 0.0 C4orf36 MGC26744 ENSG00000163633 "Chromosome 4 open reading frame 36" Q96KX1 4 86876205-86892422 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 14.0" "Group enriched" "Detected in many" 11 "Early spermatids: 140.3;Late spermatids: 253.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 1.8;cerebral cortex: 1.6;hippocampal formation: 3.3;pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.8;CAPAN-2: 4.6;hTCEpi: 3.8;hTERT-HME1: 5.5" HPA057434 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA057434: AB_2683438" "unprognostic (2.01e-1)" "unprognostic (2.68e-1)" "unprognostic (7.78e-2)" "unprognostic (4.76e-2)" "unprognostic (7.31e-2)" "unprognostic (5.68e-2)" "unprognostic (5.93e-3)" "unprognostic (2.39e-2)" "unprognostic (5.20e-2)" "unprognostic (2.77e-1)" "unprognostic (2.76e-2)" "unprognostic (2.55e-1)" "prognostic favorable (7.69e-5)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (4.28e-2)" "unprognostic (7.75e-2)" 0.6 0.2 0.1 0.7 1.8 0.0 2.1 0.4 1.6 1.7 0.3 0.7 0.0 0.3 1.0 0.4 1.0 0.4 0.0 1.4 3.3 0.2 0.6 0.5 0.9 0.0 0.2 0.4 1.7 0.5 0.0 2.6 0.2 1.4 1.3 0.3 0.1 0.6 0.3 0.1 4.2 0.1 0.6 0.3 0.8 0.2 14.0 0.0 0.0 0.8 0.0 0.4 0.5 0.8 0.1 0.9 0.3 0.0 0.0 0.1 0.0 5.8 0.5 0.3 0.2 0.0 0.3 1.2 2.9 0.8 0.7 0.0 0.3 4.6 0.0 0.5 0.0 0.1 2.6 0.4 2.6 0.7 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 0.0 5.5 0.1 0.0 0.2 0.4 0.1 0.0 2.7 1.8 0.2 0.8 1.2 0.0 1.4 0.0 0.0 0.9 2.4 0.7 1.8 0.8 0.4 0.0 0.5 1.1 0.0 0.0 0.6 1.0 0.3 0.4 0.2 0.9 0.3 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 1.8 0.4 1.6 3.3 0.2 0.2 0.4 1.4 0.0 0.0 0.0 3.4 9.5 4.4 4.8 18.1 12.7 0.0 0.0 0.0 9.8 0.9 0.0 0.0 140.3 7.1 10.2 0.0 0.0 1.6 3.8 3.9 0.0 2.4 2.8 1.6 2.9 4.3 5.4 253.3 4.9 1.5 1.7 0.0 7.4 6.3 0.3 9.3 3.2 0.0 6.8 6.5 3.1 3.7 7.0 8.9 8.1 2.2 5.2 3.9 C4orf45 FLJ25371 ENSG00000164123 "Chromosome 4 open reading frame 45" Q96LM5 4 158893134-159038760 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 16.1" "Cell type enriched" "Detected in some" 5 "Early spermatids: 290.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.7;U-2197: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (2.13e-1)" "unprognostic (9.87e-2)" "unprognostic (5.71e-2)" "unprognostic (2.55e-1)" "unprognostic (2.17e-1)" "unprognostic (7.82e-2)" "unprognostic (1.21e-1)" "unprognostic (3.09e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 0.3 0.2 0.3 0.0 0.3 0.0 0.4 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 290.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 2.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.0 0.0 6.5 0.0 2.4 2.1 0.0 0.0 0.0 0.0 0.0 C4orf46 "LOC201725, RCDG1" ENSG00000205208 "Chromosome 4 open reading frame 46" Q504U0 4 158666679-158672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047287, HPA052670" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047287: AB_2680011, HPA052670: " "unprognostic (2.71e-1)" "unprognostic (2.38e-1)" "unprognostic (1.41e-2)" "unprognostic (2.57e-1)" "unprognostic (2.26e-1)" "unprognostic (6.10e-2)" "unprognostic (6.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.71e-2)" "unprognostic (4.20e-2)" "unprognostic (1.35e-1)" "unprognostic (5.29e-2)" "unprognostic (4.56e-2)" "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (5.69e-2)" "unprognostic (9.06e-3)" 4.5 4.6 4.2 5.4 5.6 16.7 4.3 6.4 5.5 5.4 4.5 10.7 2.4 4.2 7.2 5.1 5.5 4.2 4.0 5.1 4.5 3.7 3.9 2.7 4.8 7.7 7.3 3.5 6.4 5.8 2.2 3.1 6.3 5.3 4.1 6.1 7.2 4.1 3.4 2.8 4.1 4.4 5.7 6.6 5.4 4.3 25.5 7.3 26.3 6.1 5.8 7.2 5.3 5.0 4.0 5.1 4.9 4.9 8.6 5.8 3.4 6.9 4.2 10.4 15.3 4.6 4.8 5.2 11.9 8.2 13.8 12.1 3.7 6.3 12.5 1.9 6.0 5.1 3.9 9.0 6.1 18.1 17.0 4.6 18.8 4.8 5.0 1.6 14.3 10.4 2.8 2.2 11.2 4.9 4.6 10.0 12.6 8.2 31.5 18.9 3.7 27.2 12.9 7.1 4.5 5.6 19.8 5.9 5.5 4.2 3.5 5.7 17.3 5.2 4.8 4.3 5.4 4.0 11.5 5.3 21.5 9.8 11.9 9.8 7.2 9.1 15.7 5.4 12.8 8.2 4.9 4.7 4.5 4.9 3.9 3.7 4.0 4.0 4.8 5.1 3.9 5.5 5.8 1.6 8.6 4.9 4.4 4.1 3.4 4.2 5.6 6.4 5.5 4.5 3.7 7.3 3.5 5.3 7.3 3.0 2.6 10.0 5.2 21.4 5.6 3.6 0.0 1.4 0.0 1.8 3.9 7.4 6.6 3.2 0.9 4.5 2.6 0.0 2.6 9.4 12.3 4.9 6.9 2.1 8.0 9.5 7.5 4.3 10.8 1.5 4.4 4.4 18.6 27.1 4.0 4.2 4.0 2.9 5.6 2.1 25.5 6.5 8.2 32.0 14.2 13.7 2.7 7.7 3.6 4.1 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8;fallopian tube: 20.3;testis: 20.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 125.8;Early spermatids: 125.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;hTERT-RPE1: 8.3;U-87 MG: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Uncertain Vesicles NA NA Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.9 0.5 4.4 0.7 13.3 0.8 3.7 1.7 4.0 1.8 0.7 3.6 0.8 0.6 2.2 12.3 0.7 20.3 1.8 1.2 3.8 3.8 2.4 1.0 3.3 0.5 2.4 2.9 3.0 1.3 1.0 7.1 0.7 20.8 1.2 0.7 2.1 1.0 1.4 0.6 1.9 0.7 1.0 4.7 0.8 0.5 20.6 5.5 0.0 7.3 0.0 0.6 1.0 0.6 0.1 0.7 4.1 0.6 0.9 0.6 0.2 3.9 0.0 0.4 2.1 0.8 4.1 1.2 0.1 0.3 0.3 0.5 0.6 2.4 0.1 0.8 0.1 0.4 0.3 0.5 0.6 0.9 0.8 0.7 0.0 0.1 0.6 1.0 0.0 0.3 0.9 0.9 1.0 0.4 8.3 0.0 0.9 0.5 0.2 3.0 0.5 0.0 0.0 0.5 0.0 1.5 0.1 0.0 0.3 1.1 0.1 2.2 1.0 0.7 0.1 2.4 0.8 0.2 0.6 1.2 0.6 0.3 0.0 0.1 1.7 0.0 0.0 10.0 0.0 0.2 0.0 0.6 0.6 0.2 0.1 0.4 0.0 0.6 0.6 0.2 0.1 0.1 0.2 4.1 0.9 0.2 0.7 0.0 0.2 4.4 13.3 1.7 4.0 3.8 3.8 2.4 2.9 20.8 5.5 3.0 1.0 0.0 0.5 0.6 0.6 0.5 0.0 125.8 17.0 3.5 9.8 0.1 1.7 1.2 125.8 0.6 0.0 0.0 0.5 1.2 0.8 1.2 0.0 0.0 0.2 1.6 0.0 1.3 0.3 7.5 0.6 0.4 1.7 0.0 0.0 1.6 1.4 0.0 0.7 3.2 14.2 0.0 1.0 3.5 4.3 0.5 0.2 0.0 0.0 0.3 C4orf48 ENSG00000243449 "Chromosome 4 open reading frame 48" Q5BLP8 4 2041993-2043970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 78.4;brain: 37.2" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 378.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 38.6;NB-4: 27.7;PC-3: 83.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052447 Uncertain Approved Cytosol "Secreted to blood" NA NA 32000 Cytosol "HPA052447: AB_2681837" "unprognostic (7.96e-2)" "unprognostic (2.57e-3)" "unprognostic (2.08e-1)" "unprognostic (3.20e-2)" "unprognostic (4.01e-2)" "unprognostic (8.26e-2)" "unprognostic (4.85e-3)" "unprognostic (2.51e-3)" "unprognostic (2.28e-3)" "unprognostic (1.80e-1)" "unprognostic (1.95e-2)" "unprognostic (5.55e-2)" "unprognostic (3.42e-2)" "unprognostic (5.38e-3)" "unprognostic (2.68e-1)" "unprognostic (5.55e-2)" "unprognostic (3.17e-3)" 11.4 7.8 25.5 9.7 22.2 5.6 4.8 7.7 37.2 3.4 19.7 18.2 3.2 6.5 4.1 3.0 1.2 3.2 3.1 3.8 26.4 26.2 5.2 2.5 4.7 8.7 24.8 15.6 2.9 16.8 5.6 19.8 5.3 14.9 3.9 3.1 4.3 5.1 4.3 3.3 3.7 16.6 2.4 30.7 9.6 9.8 13.9 15.7 1.2 2.2 0.7 2.4 2.6 2.6 29.8 49.4 67.5 78.4 4.5 31.0 28.4 7.8 6.5 1.3 6.1 0.6 0.9 8.7 7.5 1.5 1.4 1.3 4.4 4.7 1.0 7.3 0.2 2.5 2.2 0.1 0.8 0.4 4.7 38.6 2.5 3.5 2.5 1.3 5.1 17.3 0.7 1.4 0.3 0.0 0.4 1.4 4.3 8.1 0.0 0.9 4.8 5.7 27.7 3.9 0.4 83.8 13.2 2.0 2.5 1.2 2.9 10.5 14.8 3.7 0.1 10.1 0.1 2.0 2.4 6.4 3.6 7.8 2.7 8.4 5.9 5.1 0.0 3.6 3.1 5.0 11.5 78.4 67.5 21.5 50.6 22.0 29.8 27.8 23.9 44.2 22.6 16.0 16.7 59.0 4.5 44.0 49.4 31.0 28.4 25.5 22.2 7.7 37.2 26.4 26.2 24.8 15.6 14.9 15.7 0.0 3.4 61.1 5.3 19.5 14.6 6.1 17.8 6.7 3.4 190.1 0.0 7.5 59.7 304.2 76.9 29.1 185.6 23.3 194.2 111.5 25.9 12.6 109.2 8.9 199.3 17.5 225.6 114.2 260.9 247.7 17.8 117.6 310.4 64.9 97.5 43.9 199.3 378.7 26.5 6.8 11.5 12.9 12.8 61.7 167.2 8.8 11.0 64.3 73.8 9.2 C4orf50 FLJ46481 ENSG00000181215 "Chromosome 4 open reading frame 50" Q6ZRC1 4 5897373-6018507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "brain: 6.0" "Cell type enhanced" "Detected in some" 15 "Horizontal cells: 1.6;Late spermatids: 1.1;Muller glia cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 5.0" NA NA "unprognostic (7.02e-3)" "unprognostic (6.55e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-1)" "unprognostic (1.19e-1)" "unprognostic (6.64e-3)" "unprognostic (1.11e-1)" "unprognostic (4.35e-2)" "unprognostic (9.94e-5)" "unprognostic (4.31e-2)" "unprognostic (4.86e-3)" "unprognostic (2.61e-1)" "unprognostic (2.88e-6)" "unprognostic (3.29e-1)" "unprognostic (2.23e-1)" "unprognostic (2.47e-2)" "unprognostic (4.68e-2)" 0.0 0.5 1.0 0.2 6.0 0.2 0.0 0.0 4.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.7 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C4orf51 ENSG00000237136 "Chromosome 4 open reading frame 51" C9J302 4 145680115-145771032 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "testis: 10.8" "Cell type enriched" "Detected in some" 14 "Early spermatids: 60.4" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.0;CAPAN-2: 1.3" "Not detected" "Not detected" NA NA "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (4.37e-1)" "unprognostic (1.32e-1)" "unprognostic (2.19e-3)" "unprognostic (8.13e-2)" "unprognostic (2.16e-1)" "unprognostic (3.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.48e-1)" "unprognostic (1.98e-1)" "unprognostic (6.07e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 4.4 1.2 0.0 0.0 0.0 0.0 0.0 C5 "C5a, C5b, CPAMD4" ENSG00000106804 "Complement C5" P01031 9 120952335-121050276 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "liver: 259.9" "Cell type enriched" "Detected in many" 12 "Hepatocytes: 458.7" "Cancer enriched" "Detected in many" 17 "liver cancer: 73.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 20.5;Hep G2: 21.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA029339 Supported "Secreted to blood" NA NA 113000000000 46000000000 "HPA029339: AB_10601125" "unprognostic (2.51e-1)" "unprognostic (5.88e-3)" "unprognostic (2.50e-3)" "unprognostic (1.57e-2)" "unprognostic (5.05e-2)" "unprognostic (9.52e-3)" "prognostic favorable (9.43e-4)" "unprognostic (1.83e-1)" "unprognostic (3.19e-2)" "unprognostic (1.55e-1)" "unprognostic (2.35e-2)" "unprognostic (4.41e-2)" "unprognostic (1.46e-5)" "unprognostic (5.91e-2)" "unprognostic (1.20e-1)" "unprognostic (3.67e-2)" "unprognostic (2.75e-1)" 0.5 0.3 0.4 0.3 0.5 0.3 0.4 0.3 0.3 0.4 1.1 0.3 0.3 0.7 0.5 0.7 0.3 0.6 0.4 0.3 0.4 0.3 1.1 259.9 2.3 0.3 0.4 0.3 0.7 4.7 0.8 0.7 0.3 0.4 0.6 0.2 0.3 0.3 0.4 0.3 0.7 3.2 0.3 0.5 0.3 1.2 0.4 0.3 0.3 0.3 0.3 0.3 0.5 0.4 1.8 2.1 1.8 1.6 0.1 1.2 0.5 1.1 20.5 4.7 8.3 6.1 7.1 0.2 2.5 2.6 0.7 1.5 0.6 2.0 3.0 0.1 1.3 2.8 8.1 0.2 0.2 1.1 0.6 0.0 1.2 1.0 21.6 1.1 0.7 0.5 3.1 0.4 1.5 2.7 1.3 0.7 1.2 0.5 2.8 1.6 4.0 0.3 0.1 1.2 5.0 8.0 1.8 2.1 0.3 1.3 0.6 1.2 4.9 1.1 0.0 2.0 3.4 1.6 2.7 0.9 2.1 0.1 5.5 2.4 1.7 1.2 1.2 1.6 2.8 5.0 0.0 1.6 1.8 0.3 0.4 1.2 1.8 0.6 0.5 2.1 1.0 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.5 0.4 0.5 0.3 0.3 0.4 0.3 0.4 0.3 0.4 0.3 6.0 25.8 2.2 1.0 0.9 4.5 0.6 38.2 5.3 12.5 1.8 0.0 0.1 1.7 0.1 1.3 0.5 0.0 0.0 0.4 0.0 0.8 0.7 0.0 458.7 1.5 6.4 0.0 8.0 12.9 1.7 2.8 3.1 0.0 1.8 0.4 3.9 1.1 0.0 8.5 7.8 2.5 0.0 1.2 1.8 2.3 1.1 0.0 0.7 0.9 0.1 C5AR1 "C5A, C5AR, C5R1, CD88" ENSG00000197405 "Complement C5a receptor 1" P21730 19 47290023-47322066 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 131.1;Kupffer cells: 223.6;Macrophages: 162.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 75.8" "Group enriched" "Detected in many" 42 "granulocytes: 75.8;monocytes: 20.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 6.0;HMC-1: 7.5;U-87 MG: 9.0;U-937: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002720, HPA014520, HPA048012" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB002720: , HPA014520: AB_1846337, HPA048012: " "unprognostic (5.95e-2)" "prognostic favorable (4.71e-4)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (4.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-2)" "unprognostic (4.41e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (9.55e-4)" "unprognostic (2.02e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (1.96e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.82e-2)" "unprognostic (6.54e-2)" 33.7 8.0 1.9 34.9 7.0 46.2 8.7 0.7 3.0 5.6 6.0 3.7 1.6 1.0 4.1 4.9 3.5 14.3 16.5 11.7 7.6 3.2 5.3 9.1 38.1 26.9 3.8 1.2 7.6 3.6 1.3 27.9 12.8 10.9 4.2 1.9 7.8 2.9 1.1 7.0 1.1 3.0 11.4 11.2 48.8 4.2 6.3 1.3 2.3 2.5 1.7 3.4 12.2 2.7 0.1 1.1 75.8 20.5 0.1 0.1 2.6 1.4 5.4 0.3 0.5 1.0 0.4 1.1 1.0 0.6 0.3 0.1 0.2 6.0 0.5 1.1 1.2 0.7 2.0 0.7 0.8 0.2 1.0 0.7 0.2 5.0 0.8 0.7 2.7 7.5 0.8 3.0 0.6 0.9 0.9 0.0 0.3 0.3 2.6 0.2 1.5 0.3 3.4 1.9 0.3 0.9 0.3 0.2 0.4 1.8 1.3 0.0 0.1 0.5 0.6 0.8 0.9 0.4 3.1 0.0 0.1 3.2 0.4 0.3 0.4 0.4 0.3 9.0 9.1 0.3 7.0 8.9 6.9 0.1 15.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 75.8 0.1 20.5 0.2 0.0 2.6 1.9 7.0 0.7 3.0 7.6 3.2 3.8 1.2 10.9 1.3 3.0 33.4 11.3 0.6 4.5 0.8 2.0 2.5 52.2 26.1 1.8 2.0 0.8 3.3 0.0 0.6 1.7 1.1 0.0 0.0 0.9 2.6 0.5 23.3 3.4 131.1 0.0 0.0 3.1 223.6 0.0 0.6 162.7 5.0 14.4 0.7 0.4 0.1 0.0 0.0 1.1 4.2 12.9 1.7 0.5 1.1 2.6 1.3 0.0 0.9 0.3 C5AR2 "C5L2, GPR77" ENSG00000134830 "Complement component 5a receptor 2" Q9P296 19 47332147-47347327 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.1;lymphoid tissue: 17.3" "Cell type enhanced" "Detected in many" 12 "Ito cells: 31.3;Kupffer cells: 30.9;Macrophages: 18.2" "Cancer enhanced" "Detected in many" "breast cancer: 3.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 9.4;eosinophil: 7.0;neutrophil: 21.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 21.1" "Group enriched" "Detected in some" 5 "MCF7: 17.1;T-47d: 21.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA016629 Uncertain NA NA "HPA016629: AB_1849312" "unprognostic (5.00e-2)" "unprognostic (2.31e-2)" "unprognostic (4.33e-2)" "unprognostic (2.00e-6)" "unprognostic (2.88e-1)" "unprognostic (1.13e-2)" "unprognostic (1.02e-2)" "unprognostic (2.13e-1)" "unprognostic (2.25e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (6.05e-2)" "unprognostic (3.73e-5)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-3)" 7.2 1.7 1.1 7.4 1.6 9.2 4.7 0.3 3.5 2.0 1.9 1.7 0.0 0.9 1.5 4.1 3.3 2.8 2.9 3.2 3.6 1.0 2.4 3.1 7.5 6.8 1.3 2.2 2.0 1.4 0.4 1.4 3.9 2.9 0.8 0.9 1.9 1.9 0.6 0.8 2.2 2.0 1.8 4.5 17.3 1.6 3.8 0.3 0.0 1.4 4.4 13.6 5.6 2.0 0.3 0.4 21.1 2.7 0.2 0.4 0.4 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.4 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.1 4.0 0.1 0.0 0.7 1.3 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.0 17.1 0.0 2.0 0.2 0.0 0.0 0.2 0.2 2.2 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 21.2 0.2 0.1 0.7 0.2 0.4 0.1 0.3 0.2 0.8 0.7 1.2 0.1 9.4 1.7 7.0 0.2 1.5 0.2 0.2 0.1 0.1 0.4 0.3 0.1 0.1 21.1 0.2 2.7 0.2 0.4 0.4 1.1 1.6 0.3 3.5 3.6 1.0 1.3 2.2 2.9 0.3 3.0 3.4 1.9 2.4 0.3 1.1 1.4 0.0 1.4 4.5 1.8 2.0 0.1 0.0 0.0 4.3 0.7 0.0 0.0 0.0 0.1 0.3 1.7 1.1 0.8 7.1 0.0 0.0 31.3 30.9 2.9 0.0 18.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 3.8 0.0 0.4 0.2 0.4 0.6 0.1 1.3 0.0 2.0 C5orf38 "CEI, IRX2NB" ENSG00000186493 "Chromosome 5 open reading frame 38" Q86SI9 5 2752131-2755397 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.9" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 32.4;Distal tubular cells: 87.9;Melanocytes: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 38.2;HaCaT: 13.1;hTCEpi: 20.9;MCF7: 11.1;SiHa: 16.0;SK-BR-3: 15.0" HPA073667 Approved "Golgi apparatus,Vesicles" "Secreted - unknown location" NA NA "Golgi apparatus, Vesicles" "HPA073667: AB_2686624" "unprognostic (5.00e-3)" "unprognostic (4.10e-2)" "unprognostic (1.71e-2)" "unprognostic (3.72e-5)" "unprognostic (4.08e-2)" "unprognostic (2.24e-2)" "unprognostic (2.67e-2)" "unprognostic (8.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.33e-2)" "unprognostic (7.60e-2)" "unprognostic (3.84e-7)" "unprognostic (2.60e-2)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (5.60e-2)" 8.3 0.5 4.5 0.6 7.6 0.5 16.3 10.4 3.0 0.6 1.1 1.5 9.8 0.7 0.7 6.8 4.1 0.6 0.6 2.4 6.0 7.0 6.6 0.5 19.4 1.1 10.5 2.0 0.5 3.8 5.0 2.6 4.3 14.8 5.9 0.7 3.4 34.9 3.9 0.9 10.6 0.5 0.5 12.2 0.7 11.2 1.5 4.7 0.0 5.0 1.6 2.4 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 6.9 0.0 3.0 2.1 38.2 4.9 3.9 3.3 2.9 1.9 0.0 0.0 0.0 0.9 0.0 13.1 0.7 3.8 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 20.9 0.8 2.7 0.0 0.0 0.0 0.0 0.0 0.8 11.1 0.0 0.1 1.0 4.3 0.0 0.0 1.4 0.0 4.3 0.0 1.0 0.0 16.0 15.0 0.0 2.3 6.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 7.6 10.4 0.3 6.0 7.0 10.5 2.0 14.8 4.7 11.9 8.3 0.0 13.3 21.9 0.0 0.6 0.0 1.4 6.8 12.2 0.0 32.4 87.9 0.0 0.7 0.6 0.0 0.0 0.2 12.9 3.0 11.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 0.0 0.5 37.1 0.0 1.3 0.0 0.5 0.0 0.4 0.7 0.6 0.0 17.8 0.4 0.9 18.7 12.2 0.0 1.2 2.4 C5orf46 "MGC23985, SSSP1" ENSG00000178776 "Chromosome 5 open reading frame 46" Q6UWT4 5 147880726-147906538 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "salivary gland: 107.9;skin 1: 42.7" "Group enriched" "Detected in some" 7 "Early spermatids: 262.3;Late spermatids: 107.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.3" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058999, HPA079692" Supported Approved "Nuclear speckles,Mitochondria" "Secreted in other tissues" NA NA "Nuclear speckles" Mitochondria "HPA058999: , HPA079692: " "unprognostic (1.72e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.26e-4)" "unprognostic (9.75e-3)" "unprognostic (2.95e-3)" "unprognostic (1.69e-3)" "unprognostic (1.99e-2)" "unprognostic (3.08e-2)" "unprognostic (2.22e-1)" "unprognostic (4.96e-2)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.75e-9)" "unprognostic (6.48e-3)" "unprognostic (3.47e-2)" "unprognostic (6.01e-2)" "unprognostic (2.79e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 5.2 2.0 0.1 0.6 0.1 0.1 0.1 0.0 0.3 0.6 0.2 0.0 0.2 3.0 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 0.6 0.0 0.1 4.3 0.4 0.4 0.0 0.2 107.9 0.4 0.6 42.7 0.1 1.0 0.1 0.1 0.0 6.5 0.2 0.2 0.1 1.1 0.6 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 4.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.1 5.1 0.0 0.0 0.0 4.6 25.5 0.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.1 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 8.7 25.5 0.0 0.0 1.8 0.0 0.1 0.0 12.4 262.3 0.0 0.0 0.0 2.9 0.1 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 107.1 1.7 0.0 3.3 1.0 0.0 6.7 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.8 18.1 1.1 0.0 0.0 0.1 C5orf47 LOC133491 ENSG00000185056 "Chromosome 5 open reading frame 47" Q569G3 5 173973779-174006140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "testis: 70.1" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 567.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-266/84: 4.5" "Low region specificity" "Detected in many" NA NA "unprognostic (7.54e-2)" "unprognostic (4.81e-3)" "unprognostic (3.81e-1)" "unprognostic (1.64e-2)" "unprognostic (1.31e-2)" "unprognostic (3.94e-1)" "unprognostic (8.72e-3)" "unprognostic (2.00e-2)" "unprognostic (2.82e-1)" "unprognostic (4.09e-2)" "unprognostic (3.03e-3)" "unprognostic (2.59e-1)" "unprognostic (2.63e-1)" "unprognostic (2.99e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 15.2 6.4 0.0 0.0 1.0 0.0 1.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 567.4 86.7 0.0 0.0 0.0 0.0 0.0 C5orf49 LOC134121 ENSG00000215217 "Chromosome 5 open reading frame 49" A4QMS7 5 7830378-7851490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 35.9;fallopian tube: 65.6;testis: 28.9" "Group enriched" "Detected in many" 13 "Ciliated cells: 337.3;Early spermatids: 639.5;Late spermatids: 261.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.2;CAPAN-2: 2.0;RPTEC TERT1: 2.3;SCLC-21H: 1.5;T-47d: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043759 Enhanced NA NA "HPA043759: AB_2678655" "unprognostic (1.55e-1)" "unprognostic (5.82e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-2)" "unprognostic (2.13e-3)" "unprognostic (4.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-1)" "unprognostic (7.93e-2)" "unprognostic (7.54e-3)" "unprognostic (1.85e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (2.28e-2)" "unprognostic (2.20e-2)" 1.0 1.3 9.7 1.0 16.9 0.8 1.6 0.5 7.4 3.0 0.9 12.2 1.2 1.0 2.1 9.9 0.9 65.6 1.3 0.9 10.4 12.4 3.5 1.3 10.1 0.9 5.7 6.3 6.9 2.4 2.7 5.9 0.9 35.9 2.3 0.9 0.7 0.9 2.0 0.9 1.1 0.9 1.1 2.7 0.9 1.4 28.9 4.0 0.0 1.6 0.0 0.9 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 1.2 0.0 0.0 0.0 0.2 0.0 2.3 0.1 1.5 0.8 0.9 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 16.9 0.5 7.4 10.4 12.4 5.7 6.3 35.9 4.0 0.0 4.8 0.0 1.7 0.0 0.3 0.3 0.0 337.3 31.8 8.7 0.0 0.1 3.3 3.5 639.5 0.1 0.0 0.0 0.8 2.6 1.3 7.2 1.1 0.8 0.1 1.6 5.2 0.0 0.0 261.9 8.1 0.9 3.3 0.0 0.1 2.4 1.5 0.0 3.5 29.2 3.5 6.5 0.0 11.1 4.7 0.5 0.2 0.0 0.0 0.7 C5orf52 ENSG00000187658 "Chromosome 5 open reading frame 52" A6NGY3 5 157671553-157680143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.2" "Group enriched" "Detected in some" 40 "Early spermatids: 361.8;Late spermatids: 1330.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.7" NA NA "unprognostic (3.20e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-2)" "unprognostic (3.50e-1)" "unprognostic (3.64e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.0 0.7 0.0 0.9 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 361.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1330.4 7.2 0.0 0.0 0.0 0.0 0.0 0.1 4.0 6.0 0.0 0.0 6.5 0.0 21.2 4.1 0.0 0.0 0.0 1.2 0.0 C5orf58 ENSG00000234511 "Chromosome 5 open reading frame 58" C9J3I9 5 170232447-170252575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 78.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "U-266/84: 37.7" NA NA "unprognostic (9.24e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (5.55e-2)" "unprognostic (2.92e-1)" "unprognostic (1.35e-1)" "unprognostic (5.33e-6)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (8.48e-2)" "unprognostic (1.85e-1)" "unprognostic (2.78e-1)" "unprognostic (3.29e-10)" "unprognostic (4.83e-3)" "unprognostic (5.45e-2)" "unprognostic (3.94e-2)" "unprognostic (8.27e-2)" 0.4 0.2 0.1 0.9 0.1 2.0 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.4 0.1 0.1 0.0 0.1 0.1 1.3 0.7 0.1 0.1 0.2 0.1 0.0 0.1 0.3 0.3 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.3 0.1 0.4 1.0 0.0 78.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.3 1.1 2.0 3.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.5 0.5 0.0 0.0 0.0 0.0 0.0 1.4 37.7 0.0 0.0 0.5 0.0 0.0 0.8 1.5 2.3 0.9 1.2 0.0 1.3 2.0 0.1 0.1 1.3 3.1 3.3 2.0 1.1 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 C5orf60 ENSG00000204661 "Chromosome 5 open reading frame 60" A6NFR6 5 179641544-179645046 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 3.7;testis: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 2.2;Karpas-707: 2.5;RT4: 1.6" HPA065431 Enhanced NA NA "HPA065431: " "unprognostic (3.47e-3)" "unprognostic (1.00e-1)" "unprognostic (3.23e-1)" "unprognostic (2.62e-1)" "unprognostic (5.66e-5)" "unprognostic (1.18e-1)" "unprognostic (2.65e-2)" "unprognostic (1.71e-1)" "unprognostic (3.50e-3)" "unprognostic (7.11e-2)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (9.47e-2)" "unprognostic (2.16e-1)" "unprognostic (8.76e-2)" "unprognostic (1.72e-2)" 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 1.8 1.1 3.7 1.1 2.4 1.2 0.2 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.3 0.1 0.0 0.2 0.0 0.1 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.5 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.3 2.5 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 1.6 0.4 0.9 0.0 1.0 0.1 0.7 0.2 0.0 0.0 0.8 0.3 0.3 0.0 1.0 0.6 0.0 0.0 0.2 0.5 3.2 1.1 1.2 0.8 0.5 0.3 1.1 0.6 0.6 0.4 1.8 0.9 1.2 3.7 2.4 0.5 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C5orf67 ENSG00000225940 "Chromosome 5 open reading frame 67" F2Z3F1 5 56511567-56606232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;kidney: 9.3;retina: 16.3" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in some" 5 "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9" "Group enriched" "Detected in some" 7 "CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4" HPA054214 Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoli "Nucleoplasm, Vesicles" "HPA054214: " "unprognostic (7.28e-2)" "unprognostic (1.41e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-3)" "unprognostic (6.58e-2)" "unprognostic (7.93e-2)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (8.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (3.62e-2)" 0.4 0.0 0.2 0.2 1.2 0.4 1.0 0.2 0.2 0.4 0.8 0.4 0.2 1.5 0.6 17.9 0.4 0.4 0.2 0.2 0.6 0.2 9.3 0.2 0.4 0.6 0.7 0.2 0.2 0.2 0.0 0.2 0.2 6.1 0.2 0.0 16.3 1.1 0.2 0.2 0.8 1.6 0.2 0.2 1.5 0.1 0.2 0.2 0.2 2.1 0.2 0.2 0.2 0.2 0.1 1.5 3.3 1.9 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.3 0.0 9.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 3.3 0.0 1.9 1.5 0.4 0.1 0.2 1.2 0.2 0.2 0.6 0.2 0.7 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6 ENSG00000039537 "Complement C6" P13671 5 41142234-41261438 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 176.1" "Group enriched" "Detected in some" 7 "Cholangiocytes: 132.5;Ciliated cells: 99.0;Hepatocytes: 342.0;Leydig cells: 111.4" "Group enriched" "Detected in many" 7 "liver cancer: 49.0;pancreatic cancer: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 5.2;ASC TERT1: 7.3;HSkMC: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043823, CAB069427" Enhanced "Secreted to blood" NA NA 7600000000 "CAB069427: AB_1614336, HPA043823: AB_10960262" "unprognostic (9.79e-2)" "unprognostic (1.96e-2)" "unprognostic (5.94e-3)" "unprognostic (3.02e-2)" "unprognostic (1.67e-1)" "unprognostic (1.18e-1)" "unprognostic (1.12e-3)" "unprognostic (4.66e-2)" "unprognostic (3.72e-2)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (3.04e-3)" "prognostic favorable (4.31e-4)" "unprognostic (2.69e-4)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" 2.3 0.1 0.2 0.1 0.2 0.0 1.0 0.1 0.2 0.3 0.5 0.5 0.1 0.1 0.2 2.7 0.3 8.8 2.4 24.1 0.2 0.0 5.2 176.1 0.9 0.8 0.1 0.1 3.2 10.1 0.0 0.4 0.4 0.6 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.8 0.1 0.2 0.1 0.4 1.7 0.1 0.1 0.4 0.7 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.6 0.1 0.0 0.0 3.9 0.0 0.0 0.0 16.8 132.5 99.0 13.6 0.0 0.0 0.0 0.0 4.4 8.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 342.0 0.0 0.0 0.0 3.7 8.6 25.4 111.4 0.1 0.0 0.0 0.0 0.0 0.9 0.2 0.4 0.8 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 C6orf10 TSBP ENSG00000204296 "Chromosome 6 open reading frame 10" Q5SRN2 6 32288526-32371912 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 28.6" "Cell type enriched" "Detected in some" 12 "Early spermatids: 313.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 1.1;U-2197: 1.3" HPA047479 Approved Cytosol NA NA Cytosol "HPA047479: " "unprognostic (1.00e-1)" "unprognostic (2.24e-1)" "unprognostic (1.05e-1)" "unprognostic (5.63e-2)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (4.32e-4)" "unprognostic (2.42e-1)" "unprognostic (8.19e-2)" "unprognostic (6.56e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 C6orf118 "bA85G2.1, MGC23884" ENSG00000112539 "Chromosome 6 open reading frame 118" Q5T5N4 6 165279664-165309607 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 23.9;pituitary gland: 10.4;testis: 9.6" "Group enriched" "Detected in some" 7 "Ciliated cells: 329.2;Early spermatids: 104.0" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 7.4;SCLC-21H: 4.3" "Low region specificity" "Detected in many" "HPA029787, HPA029789" Approved Uncertain Mitochondria NA NA Mitochondria "HPA029787: AB_10599999, HPA029789: AB_10601002" "unprognostic (2.84e-1)" "unprognostic (3.09e-4)" "unprognostic (2.70e-2)" "unprognostic (7.99e-2)" "unprognostic (5.34e-2)" "unprognostic (1.41e-1)" "unprognostic (2.50e-1)" "unprognostic (4.27e-2)" "unprognostic (4.89e-2)" "unprognostic (8.18e-9)" "unprognostic (3.22e-3)" "unprognostic (3.03e-2)" "unprognostic (6.55e-3)" "unprognostic (4.50e-1)" 0.3 0.3 4.4 0.3 11.4 0.3 0.3 0.1 0.8 1.5 0.3 7.5 0.1 0.3 1.0 7.2 0.3 23.9 0.3 0.3 4.3 2.7 0.3 0.3 4.7 0.3 0.3 1.0 3.4 0.3 0.3 10.4 0.3 14.5 0.3 0.3 0.0 0.3 0.4 0.3 0.3 0.3 0.3 0.8 0.3 0.3 9.6 3.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 7.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.4 0.1 0.8 4.3 2.7 0.3 1.0 14.5 3.9 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.0 329.2 22.7 0.0 0.0 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.1 C6orf132 bA7K24.2 ENSG00000188112 "Chromosome 6 open reading frame 132" Q5T0Z8 6 42101118-42142619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 118.2;Glandular cells: 119.1;Pancreatic endocrine cells: 145.1;Urothelial cells: 193.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 20.6;CACO-2: 18.8;CAPAN-2: 15.6;OE19: 61.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044588 Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA044588: AB_10794293" "unprognostic (7.09e-2)" "unprognostic (8.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.24e-3)" "unprognostic (1.60e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (6.78e-2)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.31e-1)" "unprognostic (4.26e-3)" "unprognostic (1.04e-2)" "unprognostic (5.53e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" 1.3 0.5 0.2 3.7 0.2 0.2 4.2 0.3 0.3 13.3 20.9 0.2 1.4 15.7 0.7 1.2 66.1 2.6 15.5 0.5 0.2 0.1 6.2 0.6 5.9 0.2 0.2 0.2 1.4 20.8 1.1 2.2 3.1 0.2 6.8 5.3 0.2 16.6 4.0 1.2 24.8 37.2 0.7 0.2 0.2 16.2 0.4 0.2 0.6 12.5 49.3 54.3 4.8 17.5 2.1 1.9 3.5 1.3 0.9 1.2 0.7 20.6 0.2 0.0 0.0 0.1 2.4 10.2 1.2 1.5 2.9 3.0 18.8 15.6 0.0 2.2 2.0 0.0 13.9 0.0 6.2 1.9 1.7 2.9 1.0 1.8 4.2 0.7 0.0 0.0 1.4 11.7 2.2 3.3 1.1 0.0 0.1 0.5 0.2 0.6 7.2 0.2 0.1 1.4 61.4 0.5 0.0 0.0 0.1 2.2 9.3 1.1 0.0 1.8 12.6 0.0 1.5 9.2 0.1 0.3 0.1 1.3 5.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.9 1.3 1.7 0.8 0.8 0.6 1.0 0.8 0.8 1.4 2.1 0.9 1.2 3.5 0.9 0.5 1.9 0.5 0.7 0.2 0.2 0.3 0.3 0.2 0.1 0.2 0.2 0.2 0.2 41.7 17.6 0.0 50.1 46.6 0.8 3.6 40.8 61.6 53.4 48.8 19.6 10.6 0.0 41.6 12.9 0.5 80.5 0.0 118.2 0.5 8.4 119.1 1.1 0.0 0.7 4.8 7.0 1.8 1.6 91.9 0.6 1.2 11.8 5.4 33.6 0.5 145.1 43.5 1.4 5.6 7.4 0.0 2.1 4.3 8.3 71.6 3.4 2.2 37.9 193.5 C6orf141 MGC46457 ENSG00000197261 "Chromosome 6 open reading frame 141" Q5SZD1 6 49550646-49561907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;gallbladder: 18.9" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 36.7;Ductal cells: 32.6;Intestinal endocrine cells: 102.0;Suprabasal keratinocytes: 31.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "basal ganglia: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 8.0;HaCaT: 8.8;HeLa: 7.0;hTCEpi: 6.9;PC-3: 12.0;T-47d: 7.5" HPA036199 Uncertain Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA036199: AB_2675002" "prognostic favorable (3.92e-6)" "unprognostic (1.58e-1)" "unprognostic (9.87e-2)" "prognostic favorable (1.15e-4)" "unprognostic (4.95e-2)" "unprognostic (2.15e-2)" "unprognostic (1.39e-3)" "unprognostic (8.13e-2)" "unprognostic (7.02e-2)" "unprognostic (2.85e-2)" "unprognostic (6.37e-3)" "unprognostic (1.41e-1)" "unprognostic (1.89e-8)" "unprognostic (2.33e-2)" "unprognostic (5.81e-1)" "unprognostic (3.77e-1)" "unprognostic (4.43e-1)" 4.7 0.2 1.0 3.0 30.6 0.0 4.9 3.1 1.8 3.7 2.1 0.3 4.4 10.5 4.4 3.6 2.9 1.9 18.9 0.4 0.3 0.4 0.3 1.1 0.6 0.6 0.5 0.1 0.5 3.3 0.0 2.0 0.2 2.8 1.1 1.4 0.0 2.2 0.9 1.2 4.6 1.4 1.4 0.3 0.1 9.1 3.1 2.9 0.0 1.1 0.4 0.8 1.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.1 0.0 0.0 0.0 0.0 1.6 0.8 0.9 0.0 0.0 0.2 3.3 0.0 0.5 1.5 8.0 8.8 1.0 2.3 0.0 0.0 5.6 0.0 7.0 0.0 0.3 0.0 0.0 0.3 6.9 0.0 5.0 2.7 1.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.3 1.2 12.0 0.0 0.0 0.0 1.6 5.2 0.2 0.0 2.2 0.0 0.0 0.4 7.5 0.0 2.7 0.4 0.0 0.0 5.7 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 30.6 3.1 1.3 0.3 0.4 0.5 0.1 2.8 2.9 0.0 1.9 0.0 22.6 36.7 0.0 2.0 7.6 5.3 12.5 0.0 0.0 2.9 0.0 32.6 0.2 8.8 2.0 0.0 8.1 15.4 0.9 2.7 0.0 0.0 0.8 0.0 102.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 7.8 7.0 0.4 0.0 0.0 0.0 0.9 0.5 0.5 31.5 1.7 0.0 1.7 13.2 C6orf15 STG ENSG00000204542 "Chromosome 6 open reading frame 15" Q6UXA7 6 31111223-31112559 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix, uterine: 5.6;lymphoid tissue: 7.3;skin 1: 10.8;tongue: 11.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "RH-30: 8.3;U-2 OS: 3.7" "Not detected" "Not detected" HPA001436 Uncertain "Secreted - unknown location" NA NA "HPA001436: AB_2243752" "unprognostic (2.73e-2)" "unprognostic (5.39e-2)" "unprognostic (1.46e-2)" "unprognostic (3.19e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "unprognostic (3.35e-1)" "unprognostic (3.42e-2)" "unprognostic (1.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.3 10.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 7.3 0.0 11.5 3.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C6orf163 ENSG00000203872 "Chromosome 6 open reading frame 163" Q5TEZ5 6 87344849-87365463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 20.2" "Group enriched" "Detected in some" 26 "Early spermatids: 164.9;Late spermatids: 171.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 1.4" "Low region specificity" "Detected in all" "HPA044797, HPA052927" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044797: AB_10962365, HPA052927: AB_2681990" "unprognostic (4.98e-2)" "unprognostic (6.42e-2)" "unprognostic (1.65e-1)" "unprognostic (2.33e-2)" "unprognostic (4.18e-2)" "unprognostic (3.49e-2)" "unprognostic (7.55e-3)" "unprognostic (3.96e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (5.60e-4)" "unprognostic (6.66e-2)" "unprognostic (3.77e-3)" "unprognostic (1.46e-1)" "unprognostic (1.93e-2)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" 0.7 0.8 0.5 0.5 4.3 3.2 1.3 0.7 1.0 0.8 0.8 1.5 0.5 0.0 1.4 3.0 0.5 2.3 0.5 1.0 0.9 0.4 0.6 0.9 1.7 0.9 0.5 0.5 3.3 1.1 1.7 1.8 0.5 4.6 1.2 1.2 0.5 1.2 0.5 1.5 2.4 1.1 0.5 0.5 1.7 0.8 20.2 1.2 0.5 1.1 0.5 0.8 0.6 0.6 1.4 0.7 3.4 0.9 1.2 1.8 0.4 0.2 0.6 3.0 4.5 0.5 3.3 3.6 0.0 0.0 0.6 1.0 1.3 0.9 1.8 0.5 0.4 1.9 0.8 1.2 2.6 0.0 1.6 1.8 2.3 1.0 1.0 0.0 1.1 0.6 1.6 1.5 0.8 0.8 1.3 0.5 1.9 3.5 1.6 0.4 0.7 0.3 1.5 0.7 0.1 0.2 4.0 1.0 0.1 1.9 2.9 2.3 1.2 0.3 0.5 1.2 3.2 0.6 1.3 1.0 1.8 1.4 0.9 1.4 0.5 0.8 0.3 0.2 2.1 1.1 0.5 0.7 0.3 1.8 0.4 0.9 1.3 1.8 1.2 0.7 1.4 1.7 1.8 3.4 1.2 0.9 0.4 1.0 0.4 0.5 4.3 0.7 1.0 0.9 0.4 0.5 0.5 4.6 1.2 0.0 0.3 0.0 0.3 0.3 0.6 1.7 2.5 1.4 0.0 0.0 0.0 0.4 0.0 0.1 164.9 0.0 0.2 0.0 0.0 0.3 0.4 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.2 171.0 2.3 0.0 1.7 0.0 0.3 0.0 0.1 0.0 1.8 0.4 0.5 6.5 0.4 2.1 1.6 0.1 0.7 0.0 0.2 0.3 C6orf201 dJ1013A10.5 ENSG00000185689 "Chromosome 6 open reading frame 201" Q7Z4U5 6 4079206-4130951 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 46 "testis: 27.6" "Group enriched" "Detected in some" 22 "Early spermatids: 387.3;Late spermatids: 525.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (1.11e-2)" "unprognostic (3.87e-1)" "unprognostic (3.91e-2)" "unprognostic (4.85e-3)" "unprognostic (1.22e-3)" "unprognostic (2.69e-3)" "unprognostic (3.47e-1)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (9.86e-2)" "unprognostic (4.72e-3)" "unprognostic (3.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (3.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 6.7 3.4 0.0 0.0 0.0 0.0 0.0 387.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 525.7 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.4 0.0 0.0 20.4 3.2 0.0 0.2 0.0 0.0 0.0 C6orf222 DKFZp779B1540 ENSG00000189325 "Chromosome 6 open reading frame 222" P0C671 6 36315757-36336885 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 46.7" "Cell type enhanced" "Detected in some" 19 "Enterocytes: 125.0;Exocrine glandular cells: 39.2;Intestinal endocrine cells: 39.2;Mucus-secreting cells: 42.5;Pancreatic endocrine cells: 35.0;Paneth cells: 28.1" "Group enriched" "Detected in some" 19 "colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;Daudi: 2.8;OE19: 6.2;REH: 2.8;RT4: 1.4;U-937: 3.1" "Low region specificity" "Detected in all" "HPA038407, HPA058189" Uncertain NA NA "HPA038407: AB_10669644, HPA058189: AB_2683634" "unprognostic (1.97e-5)" "unprognostic (5.46e-3)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (7.52e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (6.75e-2)" "unprognostic (3.04e-2)" "unprognostic (4.55e-2)" "unprognostic (3.16e-2)" "unprognostic (3.98e-1)" "unprognostic (1.66e-4)" 0.1 0.0 0.1 0.7 0.1 0.0 0.1 0.1 0.2 0.1 14.0 0.1 0.1 19.8 0.1 0.1 0.1 0.0 1.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 4.7 0.0 0.1 0.1 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.2 46.7 0.1 0.1 0.1 5.8 1.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 1.3 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 2.8 0.0 0.5 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 1.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 0.0 125.0 0.0 39.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 39.2 0.0 0.0 1.1 0.3 0.0 0.0 1.8 42.5 0.0 35.0 28.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.3 0.9 C6orf223 MGC45491 ENSG00000181577 "Chromosome 6 open reading frame 223" Q8N319 6 44000580-44005958 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 23.6;lung: 9.4" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 2.7;Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 12.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.9;JURKAT: 18.7;RPTEC TERT1: 22.6;THP-1: 9.4" "HPA035765, HPA046117" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA035765: AB_2797225, HPA046117: AB_10964082" "unprognostic (2.94e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-2)" "unprognostic (4.31e-2)" "unprognostic (2.74e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.59e-4)" "unprognostic (7.06e-3)" "unprognostic (2.34e-4)" "unprognostic (1.39e-3)" "unprognostic (2.70e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (2.95e-1)" "unprognostic (5.15e-2)" "unprognostic (2.62e-1)" "unprognostic (1.31e-1)" 0.1 0.4 1.1 1.3 0.9 0.5 23.6 0.2 3.0 0.7 1.4 0.0 0.0 1.8 0.8 4.7 0.1 0.2 6.9 2.9 1.1 0.8 4.9 1.4 9.4 2.8 0.1 1.2 0.1 2.4 0.1 0.8 0.2 0.9 0.2 0.7 3.4 3.1 0.1 0.3 0.5 3.1 0.2 0.0 0.7 0.2 0.3 0.0 1.0 2.1 1.1 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.3 0.0 18.7 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.2 0.3 0.0 0.1 1.9 3.4 1.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.2 3.0 1.1 0.8 0.1 1.2 0.9 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.6 0.5 1.4 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.4 C6orf229 ENSG00000260286 "Chromosome 6 open reading frame 229" H3BNL8 6 24797321-24798889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 6.4;testis: 25.2" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 20.1;Early spermatids: 14.7;Late spermatids: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;CACO-2: 1.1;Daudi: 1.9;NB-4: 1.1;SCLC-21H: 1.6;U-937: 1.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" NA NA "unprognostic (1.28e-1)" "unprognostic (1.16e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 25.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.1 0.6 6.4 1.0 0.4 1.9 0.1 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.7 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.4 1.1 0.0 1.1 1.0 0.4 0.9 0.4 1.9 1.3 0.9 1.2 0.6 2.1 1.3 0.9 6.4 0.4 0.3 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 2.3 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 C6orf52 ENSG00000137434 "Chromosome 6 open reading frame 52" Q5T4I8 6 10671418-10694797 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 17.7" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 33.5;Early spermatids: 33.2;Late spermatids: 22.3;Spermatocytes: 32.4;Spermatogonia: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 8.7;NB-4: 7.7" "Low region specificity" "Detected in all" HPA051142 Uncertain Approved "Nuclear speckles,Intermediate filaments" No No "Nuclear speckles" "Intermediate filaments" "HPA051142: AB_2681359" "unprognostic (1.14e-2)" "unprognostic (2.21e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.50e-5)" "unprognostic (9.12e-2)" "unprognostic (2.96e-1)" "unprognostic (1.11e-3)" "unprognostic (1.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-2)" "unprognostic (3.92e-2)" "unprognostic (9.31e-3)" "unprognostic (7.65e-2)" 1.6 2.4 5.6 1.4 4.8 0.9 3.0 2.7 4.3 1.2 1.5 4.4 5.5 7.7 1.4 9.0 0.9 8.0 1.2 0.7 4.9 5.3 3.8 1.4 1.7 1.1 4.5 3.2 1.9 7.7 1.5 2.9 1.5 4.4 3.1 1.0 0.7 1.8 1.7 1.2 2.5 2.1 0.9 4.0 1.0 1.6 17.7 2.6 1.6 2.1 1.0 1.6 1.0 2.0 0.7 1.0 4.7 1.0 1.4 6.2 0.6 1.1 2.7 2.5 2.2 0.9 0.0 4.4 0.2 0.1 0.3 0.6 3.0 2.4 0.1 4.0 0.0 2.9 0.2 2.4 0.0 1.0 1.4 4.2 0.6 0.5 0.4 0.0 0.8 0.4 0.5 3.9 1.1 1.5 0.3 0.0 2.5 4.7 0.3 1.1 8.7 1.8 7.7 2.3 1.6 3.0 1.5 0.2 1.0 1.2 0.6 5.0 3.1 0.9 0.6 4.9 2.6 0.2 1.5 0.4 2.0 0.7 1.5 1.8 3.6 7.5 1.5 3.5 1.1 1.9 0.0 0.5 4.7 1.2 1.0 0.4 0.5 1.5 1.3 1.0 0.7 0.7 0.6 0.6 1.4 0.7 0.8 6.2 0.6 5.6 4.8 2.7 4.3 4.9 5.3 4.5 3.2 4.4 2.6 0.0 2.4 0.0 1.7 1.3 1.8 0.5 2.5 33.5 1.2 3.5 2.0 2.4 5.0 3.1 33.2 1.0 1.1 0.0 5.3 2.1 1.5 1.5 0.0 1.6 1.0 1.6 2.9 2.5 0.3 22.3 2.0 0.7 3.3 2.8 0.5 3.8 2.8 2.9 0.0 8.1 0.6 0.0 2.1 32.4 23.4 1.3 1.1 0.0 1.8 0.7 C6orf58 LEG1 ENSG00000184530 "Chromosome 6 open reading frame 58" Q6P5S2 6 127519455-127591817 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 48 "intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6" "Cell type enriched" "Detected in single" 14 "Early spermatids: 8.7" "Group enriched" "Detected in some" 6 "pancreatic cancer: 17.1;stomach cancer: 14.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 5.1;RPMI-8226: 6.4;WM-115: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036263, HPA041449" Enhanced "Secreted to digestive system" NA NA 41000 "HPA036263: AB_10673349, HPA041449: AB_2677486" "unprognostic (1.49e-1)" "unprognostic (8.55e-2)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (3.86e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (3.26e-2)" "unprognostic (7.72e-3)" "unprognostic (1.69e-1)" "unprognostic (6.62e-4)" "unprognostic (2.10e-2)" "unprognostic (2.31e-1)" "unprognostic (1.53e-2)" "unprognostic (8.99e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.0 98.4 0.1 0.0 2.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 2.3 0.0 0.1 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 189.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 54.2 0.2 0.0 0.0 0.1 122.6 1.7 0.1 0.1 1.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.2 0.1 0.3 0.3 0.2 0.0 0.9 0.2 0.4 0.5 5.1 0.1 0.0 0.0 0.8 0.8 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.5 0.0 0.1 0.5 0.2 0.4 0.9 0.3 0.2 0.2 0.2 0.0 6.4 0.6 0.1 0.2 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 1.4 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.2 C7 ENSG00000112936 "Complement C7" P10643 5 40909252-40982939 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 199.9" "Group enriched" "Detected in many" 11 "Ito cells: 387.4;Leydig cells: 980.0;Sertoli cells: 304.0" "Cancer enhanced" "Detected in all" "pancreatic cancer: 73.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "ASC diff: 38.5;HHSteC: 50.9;HSkMC: 70.0;SH-SY5Y: 47.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA001465 Approved "Secreted to blood" NA NA 67000000000 "HPA001465: AB_1078554" "unprognostic (5.01e-2)" "unprognostic (3.74e-2)" "unprognostic (7.40e-2)" "unprognostic (4.68e-3)" "unprognostic (5.35e-2)" "unprognostic (1.43e-3)" "prognostic favorable (5.89e-4)" "unprognostic (6.67e-2)" "unprognostic (3.45e-1)" "unprognostic (2.21e-2)" "unprognostic (1.33e-1)" "unprognostic (1.93e-3)" "unprognostic (2.24e-2)" "unprognostic (6.10e-3)" "unprognostic (1.12e-1)" "unprognostic (2.14e-1)" "unprognostic (2.06e-3)" 54.4 99.5 0.8 7.4 1.6 0.0 10.5 1.1 1.0 30.2 34.7 3.1 14.8 2.5 36.8 48.6 55.3 47.7 48.2 79.7 0.9 0.3 81.3 41.0 29.1 69.0 3.9 1.5 199.9 32.4 3.0 5.2 55.4 3.7 52.5 4.8 1.4 5.1 17.5 1.9 1.8 17.0 43.3 3.2 33.6 17.9 44.6 0.7 3.1 32.4 1.1 7.2 39.9 29.6 0.7 0.4 1.6 0.3 1.5 0.4 0.0 0.0 0.0 0.0 0.0 38.5 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.9 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.2 0.3 0.1 0.2 0.2 0.2 0.0 0.7 0.3 0.4 1.1 1.5 0.3 0.4 0.0 0.0 0.8 1.6 1.1 1.0 0.9 0.3 3.9 1.5 3.7 0.7 6.0 5.5 0.0 0.2 0.6 0.5 39.5 7.6 0.0 4.5 0.0 0.0 0.2 0.0 0.2 2.5 13.1 0.0 0.0 1.2 0.0 17.7 0.6 1.1 2.4 0.4 41.3 52.7 387.4 14.9 7.4 980.0 1.6 0.0 1.0 0.0 4.5 0.9 0.0 17.0 0.0 0.7 304.0 5.1 2.3 1.3 0.5 0.2 0.0 1.9 0.5 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Group enriched" "Detected in many" 17 "Early spermatids: 399.0;Late spermatids: 665.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.8 2.0 4.5 5.2 1.8 1.0 2.5 1.2 4.9 3.7 5.6 3.9 2.7 7.2 1.9 2.2 14.6 1.1 5.0 1.4 4.0 3.4 4.9 3.4 0.2 5.2 4.3 5.5 8.3 3.1 3.9 3.0 0.7 2.6 0.7 6.2 5.1 4.0 0.9 0.0 5.6 7.0 1.8 6.6 1.8 7.0 5.2 1.1 2.5 3.6 1.3 3.8 1.2 4.9 4.6 6.6 0.8 9.2 1.0 2.3 6.2 0.0 1.8 18.0 5.7 10.3 0.7 5.3 10.6 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 0.0 5.3 2.9 2.3 1.0 0.9 1.0 2.5 5.3 0.0 0.0 0.0 2.8 3.3 1.0 399.0 2.2 2.5 0.0 3.4 2.1 2.5 0.9 0.0 1.0 2.4 0.0 4.1 1.8 5.0 665.4 6.6 2.9 3.3 4.6 2.8 7.7 3.2 6.5 4.9 0.6 0.5 0.0 2.1 31.4 12.4 0.5 1.9 4.3 6.0 0.9 C7orf33 ENSG00000170279 "Chromosome 7 open reading frame 33" Q8WU49 7 148590565-148615860 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "retina: 3.9;testis: 2.0" "Cell type enhanced" "Detected in some" 19 "Cone photoreceptor cells: 2.0;Early spermatids: 1.1;Extravillous trophoblasts: 4.0;Late spermatids: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "SCLC-21H: 7.2" NA NA "unprognostic (4.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 C7orf57 ENSG00000164746 "Chromosome 7 open reading frame 57" Q8NEG2 7 48035511-48061304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;fallopian tube: 20.9;testis: 11.4" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 143.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 20.0" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Cell line enhanced" "Detected in some" "GAMG: 6.2;hTERT-HME1: 9.8;U-266/70: 5.8;U-698: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021286 Enhanced NA NA "HPA021286: AB_1845760" "unprognostic (1.74e-2)" "unprognostic (4.82e-2)" "unprognostic (3.13e-2)" "unprognostic (1.28e-2)" "unprognostic (2.77e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.37e-1)" "unprognostic (4.98e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-5)" "unprognostic (5.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.42e-3)" "unprognostic (1.20e-1)" 0.2 0.2 2.3 0.2 5.0 0.5 0.3 0.1 1.0 0.8 0.2 3.5 0.0 0.3 0.9 7.1 1.4 20.9 0.2 0.3 3.7 4.0 0.3 0.2 4.3 0.3 0.1 0.4 1.6 0.1 0.7 0.4 0.2 20.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.7 0.2 0.2 11.4 2.1 0.0 0.5 1.8 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.6 2.3 0.1 0.7 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.5 0.3 0.4 0.0 2.4 0.0 0.2 0.1 6.2 0.3 0.0 1.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.8 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.1 0.0 0.3 0.8 0.0 0.0 0.1 0.6 0.9 0.4 0.6 5.8 0.8 3.3 1.4 0.0 0.9 0.0 0.0 0.0 0.6 0.0 2.3 0.0 0.6 0.6 0.1 0.0 0.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 2.3 5.0 0.1 1.0 3.7 4.0 0.1 0.4 20.0 2.1 0.0 4.8 0.0 0.0 0.0 0.0 0.8 0.0 143.2 22.7 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 9.4 0.4 0.0 0.0 0.0 0.0 0.0 C7orf61 IMAGE:4839025 ENSG00000185955 "Chromosome 7 open reading frame 61" Q8IZ16 7 100456615-100464271 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 80.4" "Group enriched" "Detected in many" 48 "Early spermatids: 438.3;Late spermatids: 271.6" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 22.2;NB-4: 8.1;TIME: 13.0" HPA060395 Enhanced Approved Vesicles NA NA Vesicles "HPA060395: AB_2684274" "unprognostic (1.88e-1)" "unprognostic (5.02e-1)" "unprognostic (1.26e-2)" "unprognostic (7.70e-5)" "unprognostic (1.65e-1)" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.26e-1)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (2.53e-1)" "unprognostic (6.39e-13)" "unprognostic (9.54e-2)" "unprognostic (2.93e-1)" "unprognostic (1.33e-2)" "unprognostic (1.24e-2)" 0.5 0.3 2.8 0.6 3.1 1.2 0.5 1.4 3.4 0.5 0.5 0.5 0.5 0.1 0.8 0.8 0.5 0.7 0.6 0.5 3.0 2.3 0.5 0.5 0.5 0.8 3.2 0.5 1.0 0.5 0.4 0.9 0.6 0.6 0.5 0.2 0.5 0.5 0.7 0.5 0.7 0.5 0.5 3.1 1.0 0.1 80.4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.6 1.3 1.2 0.8 2.9 0.2 0.8 0.2 0.7 0.8 0.9 2.0 0.3 0.3 1.3 0.2 0.7 0.9 0.4 0.6 1.5 0.8 1.2 0.6 0.3 0.0 0.5 0.8 1.5 1.2 1.7 0.0 1.1 0.4 0.3 0.3 0.4 0.8 1.2 2.1 22.2 2.1 0.6 1.1 1.3 2.1 0.4 8.1 0.5 0.3 1.0 2.1 0.0 0.4 0.3 0.3 0.0 0.0 0.5 0.7 1.3 0.4 0.4 2.2 13.0 1.2 2.0 2.5 0.4 0.3 0.2 0.8 0.2 1.9 0.1 0.0 1.2 0.0 0.8 0.7 0.3 0.0 1.1 0.6 0.6 0.1 0.1 1.6 1.3 0.8 0.4 0.0 2.9 0.2 2.8 3.1 1.4 1.5 3.0 2.3 3.2 0.5 0.6 0.5 0.0 0.0 0.0 0.4 7.3 1.5 0.9 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 438.3 1.5 0.3 0.0 0.0 0.3 1.3 0.6 0.0 0.0 0.8 3.2 0.0 0.0 0.3 271.6 7.2 1.7 5.0 1.0 0.2 6.3 0.3 0.0 3.5 0.0 0.0 6.5 0.8 3.6 2.5 5.4 0.1 0.0 0.4 0.4 C7orf77 ENSG00000275356 "Chromosome 7 open reading frame 77" A4D0Y5 7 124777292-124790689 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "liver: 2.1;lung: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HDLM-2: 9.6" NA NA "unprognostic (9.32e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 C8A ENSG00000157131 "Complement C8 alpha chain" P07357 1 56854806-56918221 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 305 "liver: 210.3" "Cell type enriched" "Detected in some" 11 "Hepatocytes: 254.8" "Cancer enriched" "Detected in single" 279 "liver cancer: 85.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Hep G2: 5.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 3400000000 "unprognostic (3.73e-3)" "unprognostic (2.44e-1)" "unprognostic (1.28e-1)" "unprognostic (6.40e-2)" "unprognostic (9.82e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 210.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.3 4.3 0.0 0.0 0.0 0.0 254.8 0.0 0.0 0.0 6.2 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C8B ENSG00000021852 "Complement C8 beta chain" P07358 1 56929210-56966140 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "liver: 240.9" "Cell type enriched" "Detected in some" 11 "Hepatocytes: 251.9" "Cancer enriched" "Detected in some" 181 "liver cancer: 107.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 47 "basophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Cell line enriched" "Detected in some" 5 "Hep G2: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023694 Supported "Secreted to blood" NA NA 3600000000 "HPA023694: AB_1847128" "unprognostic (6.65e-2)" "prognostic favorable (9.31e-5)" "unprognostic (2.37e-1)" "unprognostic (2.37e-1)" "unprognostic (1.29e-2)" "unprognostic (6.57e-2)" "unprognostic (5.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 240.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 5.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 23.3 0.6 0.0 0.0 0.0 0.0 251.9 0.1 0.0 0.0 6.2 5.3 8.9 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 C8G ENSG00000176919 "Complement C8 gamma chain" P07360 9 136945246-136946974 "Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 165.8" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 942.4" "Cancer enriched" "Detected in all" 58 "liver cancer: 260.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Group enriched" "Detected in many" 18 "dendritic cells: 1.5;T-cells: 3.4" "Cell line enriched" "Detected in some" 13 "HMC-1: 61.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA046269 Approved "Secreted to blood" NA NA 1500000000 "HPA046269: AB_2679606" "unprognostic (5.00e-2)" "unprognostic (4.05e-3)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.94e-1)" "unprognostic (4.53e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-3)" "unprognostic (2.79e-1)" "unprognostic (1.88e-1)" "unprognostic (3.67e-1)" "unprognostic (2.96e-2)" "unprognostic (3.00e-1)" "unprognostic (5.02e-3)" "unprognostic (2.16e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.05e-2)" 0.2 0.7 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 6.0 0.2 0.2 14.6 0.2 0.2 0.2 0.2 2.7 0.2 0.2 0.1 0.4 165.8 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.8 0.3 12.1 0.2 0.2 0.6 0.6 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 1.5 0.0 0.1 0.0 3.4 0.3 0.1 0.9 0.1 0.2 0.1 0.0 0.6 0.3 0.0 0.0 0.0 1.1 0.6 1.1 0.7 0.0 0.2 1.0 0.0 0.1 0.0 1.1 0.1 0.4 1.7 4.6 0.0 0.1 61.0 0.0 0.2 0.2 0.0 0.2 0.2 0.4 0.1 0.6 0.2 0.8 0.1 0.5 0.0 0.1 0.2 0.1 0.2 0.9 0.2 0.5 0.2 0.2 0.2 1.7 0.3 0.1 1.5 0.4 0.7 0.3 0.1 0.1 0.2 0.3 0.5 0.0 0.2 0.5 0.2 0.0 0.1 0.0 3.4 0.0 0.4 0.0 0.7 1.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.5 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.3 48.4 0.0 0.0 0.0 2.0 0.3 0.0 0.2 0.8 0.4 38.4 0.0 0.7 0.8 0.2 0.1 9.2 942.4 0.2 0.0 1.7 22.7 24.1 0.9 0.0 0.0 0.0 0.0 0.7 0.8 0.6 3.5 0.7 1.4 0.5 0.0 0.0 0.7 0.7 0.4 2.9 3.8 1.7 0.1 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 16.0;Ciliated cells: 28.1;Club cells: 6.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;HEK 293: 5.8;LHCN-M2: 5.1;RH-30: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" No NA "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: AB_2682030" "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.3 0.2 1.4 4.5 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.2 0.3 0.3 0.8 0.2 0.1 5.8 0.7 1.0 0.4 0.3 0.1 0.5 0.1 0.6 0.8 1.6 0.3 0.1 0.7 0.3 1.0 5.1 0.6 0.1 0.5 2.6 0.0 0.1 0.2 5.4 0.1 0.6 0.4 1.1 0.2 0.3 0.3 0.0 0.6 2.6 0.2 0.1 1.0 0.6 3.4 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 14.9 16.0 0.0 0.6 1.4 1.2 1.2 0.0 28.1 6.8 0.0 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.9 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 1.0 0.2 0.2 0.6 0.3 0.0 0.0 0.4 C8orf46 MGC33510 ENSG00000169085 "Chromosome 8 open reading frame 46" Q8TAG6 8 66460003-66518524 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 51.7" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 1.4;Hepatocytes: 2.4;Leydig cells: 2.6;Peritubular cells: 1.8" "Cancer enriched" "Detected in many" 6 "glioma: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 6.5;LHCN-M2: 4.0;SK-MEL-30: 4.4;T-47d: 5.6;WM-115: 5.6" "Group enriched" "Detected in many" 8 "amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3" "Low region specificity" "Detected in all" HPA075134 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA075134: AB_2686736" "unprognostic (6.87e-2)" "unprognostic (7.85e-2)" "unprognostic (2.01e-1)" "unprognostic (8.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (7.53e-4)" "unprognostic (7.87e-3)" "unprognostic (1.45e-1)" "unprognostic (1.19e-1)" "unprognostic (8.22e-2)" "unprognostic (1.82e-1)" "unprognostic (6.36e-3)" "unprognostic (3.53e-4)" "unprognostic (1.86e-1)" "unprognostic (4.98e-2)" "unprognostic (2.91e-2)" 1.2 1.4 14.9 1.2 16.6 1.2 1.2 1.8 51.7 1.6 1.2 16.3 0.0 1.0 1.6 1.3 1.5 1.2 1.7 2.2 39.1 8.3 1.3 1.2 1.4 1.4 13.8 19.4 1.1 1.8 1.1 0.2 1.1 10.9 2.2 1.3 0.0 1.7 5.3 3.1 1.4 1.4 2.0 17.9 1.2 1.1 1.4 10.0 0.0 1.3 0.0 1.1 1.5 0.2 0.0 0.7 0.0 0.0 0.0 0.7 0.1 3.1 0.2 0.4 2.0 0.0 0.1 0.0 0.3 0.3 0.5 0.1 0.0 3.0 0.0 0.3 3.0 6.5 0.1 0.0 0.0 2.2 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 4.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 1.3 0.1 0.5 0.0 0.0 0.0 4.4 0.4 5.6 0.0 0.0 0.4 0.7 0.2 2.7 0.1 1.1 0.0 1.1 0.1 5.6 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.9 16.6 1.8 26.7 39.1 8.3 13.8 19.4 10.9 10.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.4 0.1 0.0 0.0 0.6 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 C8orf48 FLJ25402 ENSG00000164743 "Chromosome 8 open reading frame 48" Q96LL4 8 13566843-13568287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7;testis: 17.3" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 23.2;Late spermatids: 38.1;Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 13.1;U-87 MG: 11.2;WM-115: 8.4" "Low region specificity" "Detected in all" "HPA026107, HPA027440" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA026107: AB_10600765, HPA027440: AB_10601678" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (5.07e-2)" "unprognostic (9.01e-2)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (4.84e-3)" "unprognostic (7.70e-2)" "unprognostic (1.76e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-1)" "unprognostic (1.41e-3)" "unprognostic (7.74e-4)" "unprognostic (1.78e-1)" "unprognostic (8.42e-3)" "unprognostic (8.70e-2)" 2.7 0.7 3.6 1.2 11.7 0.1 3.7 0.8 2.9 3.0 1.3 0.9 0.2 0.9 2.3 6.0 1.4 3.9 2.5 4.0 2.8 1.6 4.1 1.7 2.4 1.2 1.7 3.0 2.1 1.2 0.5 1.5 2.8 2.8 2.2 1.0 2.4 2.2 1.0 0.9 2.7 0.9 1.9 1.1 1.1 1.9 17.3 1.5 0.0 8.9 0.3 0.5 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.1 1.7 0.0 5.9 5.9 0.0 5.2 5.8 2.8 4.8 0.0 0.0 0.0 0.0 2.7 13.1 0.6 0.2 1.0 5.5 0.0 0.5 0.5 0.0 0.0 2.1 0.0 0.9 1.9 3.5 3.8 1.0 0.7 3.6 0.0 0.1 0.0 7.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 3.1 0.0 0.2 5.8 2.0 0.0 0.0 1.6 4.9 4.8 5.7 4.6 0.0 0.0 0.0 11.2 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 11.7 0.8 2.9 2.8 1.6 1.7 3.0 2.8 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 1.4 1.2 0.0 2.0 0.0 0.0 2.6 23.2 0.5 0.0 0.0 1.0 0.0 3.1 0.0 0.0 0.5 0.1 0.0 0.0 1.3 0.0 38.1 4.6 0.0 5.0 0.0 0.0 0.9 0.3 0.0 2.8 2.4 4.3 6.5 4.1 9.9 2.0 0.4 0.0 0.0 0.0 0.1 C8orf74 ENSG00000171060 "Chromosome 8 open reading frame 74" Q6P047 8 10672637-10700593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 30.2" "Group enriched" "Detected in some" 103 "Early spermatids: 154.4;Late spermatids: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA027986 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA027986: AB_10600762" "unprognostic (4.24e-2)" "unprognostic (5.62e-2)" "unprognostic (4.68e-2)" "unprognostic (5.54e-2)" "unprognostic (2.37e-2)" "unprognostic (1.56e-4)" "unprognostic (6.82e-2)" "unprognostic (2.20e-2)" 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.2 0.1 30.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.1 0.0 0.6 1.4 0.5 0.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.3 0.0 0.5 0.5 0.3 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.8 0.8 0.3 0.3 0.0 0.2 0.1 0.3 0.3 0.0 0.3 0.1 0.2 0.3 0.4 0.5 0.1 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 281.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 C8orf86 FLJ43582 ENSG00000196166 "Chromosome 8 open reading frame 86" Q6ZUL3 8 38510834-38528662 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;intestine: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.2" HPA025066 Uncertain NA NA "HPA025066: AB_1848937" "unprognostic (9.54e-2)" "unprognostic (9.14e-3)" "unprognostic (2.38e-2)" "unprognostic (2.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" 0.5 0.2 0.6 0.1 0.4 0.6 0.2 1.5 0.9 0.2 0.2 3.9 0.2 0.2 0.3 0.4 0.6 0.1 0.7 0.7 0.5 0.8 0.0 0.0 0.5 0.2 0.3 0.0 1.1 0.0 0.2 0.1 0.3 0.0 1.0 0.6 1.8 0.0 0.3 0.2 0.7 0.5 0.0 0.0 0.3 0.1 1.3 0.7 2.3 0.6 1.4 0.7 0.2 0.1 0.0 0.2 0.6 0.7 2.2 0.3 1.8 0.4 0.1 0.2 0.5 0.3 0.5 0.3 0.0 0.5 1.0 0.1 0.0 0.2 0.9 0.3 0.0 1.0 0.0 0.5 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.6 0.7 0.0 1.4 0.1 1.6 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.5 0.3 0.6 0.4 0.3 0.5 1.2 0.0 0.7 0.6 0.5 1.2 0.1 0.6 1.0 0.6 0.4 0.3 0.1 2.0 0.6 0.4 0.5 0.3 0.5 0.9 0.5 0.5 0.3 1.3 0.7 0.7 2.3 1.4 0.4 0.7 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 C8orf88 ENSG00000253250 "Chromosome 8 open reading frame 88" P0DMB2 8 90958637-90985257 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.2" "Cell type enhanced" "Detected in many" 25 "Early spermatids: 490.5;Late spermatids: 116.9;Spermatocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 28.1" "Low region specificity" "Detected in all" HPA078486 Enhanced NA NA "HPA078486: " "unprognostic (2.17e-1)" "unprognostic (7.00e-2)" "unprognostic (2.51e-2)" "unprognostic (2.95e-4)" "unprognostic (4.07e-2)" "unprognostic (1.19e-1)" "unprognostic (8.44e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.71e-2)" "unprognostic (9.89e-2)" "unprognostic (7.18e-2)" "unprognostic (6.04e-2)" "unprognostic (2.59e-3)" "unprognostic (1.17e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (6.23e-6)" 7.2 2.6 4.7 6.0 5.1 6.0 7.6 1.3 3.0 12.7 15.4 2.1 17.3 1.6 11.8 14.3 11.5 5.9 11.3 28.2 4.0 3.2 4.9 0.8 4.0 2.8 2.8 1.3 10.4 1.2 0.5 3.0 2.2 3.6 15.2 3.8 9.3 1.5 15.6 2.1 3.6 3.8 39.6 4.1 2.0 8.3 55.2 2.5 8.7 12.1 2.2 1.1 25.8 8.0 2.0 5.6 0.1 0.0 7.6 2.7 0.8 0.0 1.1 6.1 0.5 6.6 6.5 0.1 6.8 10.3 9.1 13.6 0.1 1.8 0.1 0.6 6.6 9.8 0.0 0.1 0.4 17.2 0.0 17.8 19.0 5.6 0.0 28.1 0.0 0.6 6.3 0.0 10.4 16.9 12.9 0.8 6.1 11.4 11.0 13.5 0.0 17.4 6.7 1.4 0.0 0.1 0.0 12.4 0.0 6.7 0.0 5.3 9.3 0.3 0.0 8.9 7.3 0.0 0.9 3.8 11.1 18.8 0.1 7.2 15.5 15.2 9.7 10.9 0.0 4.8 0.0 0.0 0.1 1.8 0.0 2.5 1.7 1.6 1.8 0.5 2.0 1.3 2.7 0.0 7.6 0.0 5.6 1.0 0.8 4.7 5.1 1.3 3.0 4.0 3.2 2.8 1.3 3.6 2.5 0.0 0.6 0.5 6.7 16.8 0.0 10.3 2.5 0.0 0.0 3.5 0.0 0.1 5.0 0.6 490.5 5.6 0.0 23.3 0.0 0.7 7.0 3.1 2.3 0.0 0.6 0.0 0.0 6.2 0.6 116.9 17.5 1.5 10.1 1.0 0.0 0.4 2.3 0.0 20.5 1.4 0.0 19.4 13.9 171.9 14.3 23.2 0.0 1.8 0.0 1.0 C8orf89 ENSG00000274443 "Chromosome 8 open reading frame 89" P0DMQ9 8 73241329-73259502 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 8.8;testis: 10.5" "Group enriched" "Detected in some" 5 "Early spermatids: 6.8;Spermatocytes: 16.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 8.8" "Lineage enriched" "Detected in many" 8 "B-cells: 8.8" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;BJ hTERT+: 1.1;HEK 293: 1.3;HHSteC: 1.2;hTCEpi: 1.8;hTERT-RPE1: 1.0;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.52e-3)" "unprognostic (1.64e-1)" "unprognostic (7.11e-2)" "unprognostic (2.38e-1)" "unprognostic (6.34e-2)" "unprognostic (3.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.20e-1)" "unprognostic (3.19e-1)" "unprognostic (1.17e-1)" "unprognostic (4.01e-2)" "unprognostic (4.62e-4)" "unprognostic (5.50e-2)" "unprognostic (2.16e-1)" "unprognostic (9.26e-2)" "unprognostic (6.32e-2)" 0.3 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.5 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.7 0.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.1 0.0 10.5 0.0 1.0 0.0 8.8 0.9 0.0 0.2 1.1 0.3 0.3 0.2 0.0 0.4 0.0 3.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.2 0.2 0.0 0.9 8.8 0.3 0.2 0.0 1.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.1 0.6 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 2.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.8 0.2 0.0 0.2 0.0 0.0 0.1 C9 ENSG00000113600 "Complement C9" P02748 5 39284262-39424868 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity" "Age-related macular degeneration, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 577 "liver: 419.5" "Cell type enriched" "Detected in some" 39 "Hepatocytes: 1782.7" "Cancer enriched" "Detected in single" 244 "liver cancer: 90.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "JURKAT: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002151, HPA029577" Uncertain "Secreted to blood" NA NA 69600000000 97000000000 "CAB002151: AB_563670, HPA029577: AB_10603779" "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (1.50e-1)" "unprognostic (2.01e-1)" "unprognostic (6.58e-2)" "unprognostic (1.30e-1)" "unprognostic (2.91e-1)" "unprognostic (5.49e-3)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (2.19e-2)" "unprognostic (9.43e-5)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.3 22.9 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.0 23.3 0.0 0.0 0.4 0.0 0.0 1782.7 0.9 0.0 0.0 46.1 41.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 2.1 1.4 0.0 0.2 1.3 0.0 0.0 C9orf116 "MGC29761, PIERCE1, RbEST47" ENSG00000160345 "Chromosome 9 open reading frame 116" Q5BN46 9 135495181-135501734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 63.3;testis: 47.8" "Group enriched" "Detected in many" 5 "Ciliated cells: 473.8;Early spermatids: 387.4;Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 22.6;T-47d: 23.4;U-2197: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021439, HPA065287" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021439: AB_1845799, HPA065287: AB_2732732" "unprognostic (9.02e-2)" "unprognostic (1.36e-2)" "unprognostic (1.93e-1)" "prognostic favorable (3.53e-5)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (4.23e-1)" "unprognostic (2.58e-1)" "unprognostic (5.30e-2)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (4.23e-3)" "unprognostic (3.86e-2)" "unprognostic (8.75e-2)" "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" 1.5 7.2 8.0 1.0 9.2 1.0 2.2 1.5 6.2 4.1 1.1 6.2 8.2 1.1 3.3 22.1 1.0 63.3 2.7 1.5 9.6 9.3 7.8 1.5 9.8 0.9 4.9 4.9 9.3 4.5 3.3 7.6 1.5 19.9 2.0 1.3 1.7 2.0 5.0 1.4 1.2 1.0 1.3 2.6 1.0 1.8 47.8 2.6 0.1 6.7 0.2 1.2 2.2 0.3 1.7 0.9 0.1 2.6 1.8 4.2 1.1 5.9 10.3 4.5 7.1 2.0 4.3 0.9 4.0 2.9 4.9 3.3 3.9 6.0 1.0 5.4 2.7 2.7 4.1 5.0 2.2 4.2 0.3 4.6 0.0 11.4 11.9 5.6 0.8 2.8 3.0 1.7 2.4 0.8 4.0 2.3 4.8 5.5 0.8 2.3 22.6 3.0 1.0 9.6 9.3 12.1 4.7 2.2 3.7 11.6 4.3 4.4 4.7 5.7 2.4 0.6 2.2 23.4 1.0 1.1 2.8 3.7 24.2 1.5 2.7 6.6 0.9 8.4 0.3 0.8 0.1 2.6 0.0 1.9 1.6 4.2 0.7 1.3 1.4 0.9 1.7 2.4 1.8 0.0 1.8 0.4 0.4 1.6 1.1 8.0 9.2 1.5 6.2 9.6 9.3 4.9 4.9 19.9 2.6 8.9 5.6 0.0 2.5 0.8 4.6 1.4 7.6 473.8 29.6 14.0 13.7 9.7 10.0 23.1 387.4 1.5 0.7 0.0 7.0 1.8 2.7 2.3 1.1 1.6 3.1 3.2 1.2 0.6 1.9 493.5 7.5 1.9 0.0 3.6 1.0 6.5 9.2 1.4 7.1 40.0 15.4 0.0 1.0 87.1 20.2 0.3 3.8 0.0 1.7 1.4 C9orf129 bA165J3.3 ENSG00000204352 "Chromosome 9 open reading frame 129" Q5T035 9 93318199-93346414 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in many" 4 "brain: 12.7;testis: 4.3" "Group enriched" "Detected in some" 41 "Early spermatids: 17.5;Late spermatids: 49.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NTERA-2: 7.0" HPA071515 Uncertain Mitochondria NA NA Mitochondria "HPA071515: " "unprognostic (1.12e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-1)" "unprognostic (9.47e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (3.45e-1)" 0.7 0.6 5.9 1.3 7.2 0.7 0.7 4.7 12.7 1.4 0.8 0.7 0.0 1.1 0.9 2.0 1.0 1.3 0.6 0.9 4.3 5.7 0.6 0.7 0.7 0.7 3.2 9.3 0.6 1.1 0.6 0.6 0.8 4.3 1.0 0.8 0.6 0.6 1.2 1.3 0.6 0.8 1.0 2.1 1.0 1.1 4.3 1.1 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 7.2 4.7 12.7 4.3 5.7 3.2 9.3 4.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 C9orf131 MGC41945 ENSG00000174038 "Chromosome 9 open reading frame 131" Q5VYM1 9 35041095-35045991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 46.6" "Group enriched" "Detected in some" 32 "Early spermatids: 99.2;Late spermatids: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 4.0;RT4: 14.0" "Not detected" "Not detected" HPA022029 Approved Mitochondria NA NA Mitochondria "HPA022029: AB_10960628" "unprognostic (1.10e-2)" "unprognostic (8.99e-2)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-3)" "unprognostic (2.47e-1)" "unprognostic (6.57e-2)" "unprognostic (3.66e-1)" "unprognostic (9.45e-2)" "unprognostic (4.63e-2)" "unprognostic (1.75e-2)" "unprognostic (2.37e-2)" "unprognostic (9.34e-2)" "unprognostic (1.82e-1)" "unprognostic (9.90e-4)" "unprognostic (4.19e-3)" 0.2 0.1 0.2 0.2 0.3 1.3 0.3 0.6 0.3 1.0 0.2 0.2 0.2 0.0 2.2 0.8 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.3 0.7 0.2 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.8 0.5 0.2 0.2 0.2 0.2 0.2 46.6 0.2 0.2 0.3 0.2 0.2 0.3 0.2 1.0 0.1 2.7 0.5 0.9 1.4 0.0 3.4 0.1 0.3 0.8 0.7 0.0 1.0 1.0 0.0 0.0 0.0 0.9 1.8 0.7 0.3 0.0 1.2 2.2 0.0 0.0 0.4 0.3 0.5 1.2 4.0 0.9 0.0 0.4 1.2 0.0 0.5 0.0 0.0 0.0 0.5 1.4 3.4 2.4 0.0 0.5 0.7 1.8 0.6 1.0 0.0 0.0 0.3 0.0 0.3 14.0 0.3 0.0 1.2 0.0 0.5 0.6 0.8 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.9 1.3 0.3 0.5 1.5 2.7 0.5 0.0 0.5 0.0 0.0 0.5 0.4 1.4 0.0 1.0 0.5 0.8 1.3 0.9 0.0 0.1 0.1 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 99.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 26.1 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 0.3 0.0 0.5 0.0 0.0 0.0 C9orf135 ENSG00000204711 "Chromosome 9 open reading frame 135" Q5VTT2 9 69820793-69906232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;fallopian tube: 31.8;pituitary gland: 35.4;testis: 18.4" "Group enriched" "Detected in some" 4 "Ciliated cells: 279.7;Cone photoreceptor cells: 72.6;Early spermatids: 105.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 7.8" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Group enriched" "Detected in some" 5 "naive CD4 T-cell: 3.3;naive CD8 T-cell: 4.0;T-reg: 3.6" "Lineage enriched" "Detected in single" 41 "T-cells: 4.0" "Group enriched" "Detected in some" 4 "HAP1: 9.5;NTERA-2: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021261, HPA021325" Uncertain NA NA "HPA021261: AB_1845811, HPA021325: AB_1845812" "unprognostic (1.05e-2)" "unprognostic (4.39e-1)" "unprognostic (1.97e-1)" "unprognostic (1.39e-1)" "unprognostic (1.90e-1)" "unprognostic (5.22e-3)" "unprognostic (5.72e-1)" "unprognostic (3.25e-3)" "unprognostic (4.11e-2)" "unprognostic (2.04e-1)" "unprognostic (7.60e-2)" 0.1 0.5 3.2 0.1 2.4 0.1 0.1 0.0 0.1 0.8 0.1 3.1 0.0 0.1 0.6 9.8 0.1 31.8 1.3 0.1 2.2 2.2 1.3 0.3 7.0 0.1 0.3 0.0 3.2 0.7 3.1 35.4 0.1 17.6 0.1 0.1 0.4 0.2 0.4 0.5 0.1 0.1 0.1 0.4 0.1 0.2 18.4 0.4 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.1 0.0 0.0 3.3 4.0 0.0 0.0 0.0 0.0 3.6 0.1 3.2 2.4 0.0 0.1 2.2 2.2 0.3 0.0 17.6 0.4 0.0 1.3 0.0 0.0 0.3 0.0 2.4 0.0 279.7 35.2 1.8 72.6 0.1 14.9 0.3 105.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.1 0.0 1.7 0.0 0.0 5.6 2.3 0.6 0.0 0.0 0.0 0.4 0.3 0.0 0.7 1.9 0.3 0.0 0.0 16.4 1.1 0.1 0.0 0.0 0.0 0.3 C9orf152 bA470J20.2 ENSG00000188959 "Chromosome 9 open reading frame 152" Q5JTZ5 9 110190048-110208189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7" "Cell type enhanced" "Detected in many" 16 "Mucus-secreting cells: 113.3;Undifferentiated cells: 69.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.5" "Cell line enriched" "Detected in some" 8 "OE19: 57.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA050769 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA050769: AB_2681230" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "prognostic favorable (7.22e-5)" "unprognostic (2.28e-1)" "unprognostic (1.79e-3)" "unprognostic (6.86e-2)" "unprognostic (1.34e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (5.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (4.57e-1)" "unprognostic (2.49e-1)" "unprognostic (1.06e-2)" 0.4 0.0 0.4 1.7 0.4 0.0 6.1 0.4 0.4 5.3 16.1 0.5 10.5 9.1 1.0 0.4 2.4 1.5 7.1 0.4 0.4 0.0 0.4 0.5 3.6 0.4 0.4 0.4 0.4 3.9 0.0 0.8 0.4 0.4 11.6 20.9 0.4 34.3 17.0 0.4 3.8 7.0 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 1.6 5.2 1.3 0.4 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 57.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 8.9 12.3 0.0 2.5 0.2 0.0 0.2 22.9 5.3 10.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 7.7 0.0 9.9 0.0 0.2 16.2 0.0 0.9 0.1 0.0 24.9 0.0 0.0 0.0 0.0 0.2 10.1 0.0 113.3 0.0 5.3 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 69.7 4.7 C9orf153 bA507D14.1 ENSG00000187753 "Chromosome 9 open reading frame 153" Q5TBE3 9 86220265-86259657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 24.5" "Group enriched" "Detected in some" 70 "Early spermatids: 170.5;Late spermatids: 185.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 4.5" HPA079466 Approved "Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane" NA NA "Nuclear bodies, Plasma membrane" "Nucleoplasm, Vesicles" "HPA079466: " "unprognostic (2.03e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.30e-3)" "unprognostic (7.49e-2)" "unprognostic (2.75e-2)" "unprognostic (3.37e-1)" "unprognostic (6.85e-2)" "unprognostic (9.70e-2)" "unprognostic (1.49e-1)" "unprognostic (2.01e-6)" "unprognostic (9.43e-2)" "unprognostic (1.92e-1)" "unprognostic (9.64e-2)" "unprognostic (2.10e-1)" 0.1 0.2 0.1 0.1 0.1 2.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.0 0.6 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 24.5 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.5 0.6 0.2 0.8 1.1 0.0 0.6 2.2 0.0 1.2 0.1 1.3 1.6 1.2 0.0 0.0 0.8 0.0 2.5 2.4 0.9 2.3 1.7 0.5 1.2 2.0 1.6 0.6 1.0 0.1 2.8 0.4 0.1 0.4 1.1 0.3 4.5 1.5 0.0 0.0 1.0 2.8 0.0 1.9 1.7 0.1 0.8 0.4 0.7 0.1 1.6 0.4 0.8 3.0 0.3 0.0 0.3 0.1 0.0 0.0 0.4 1.1 0.0 0.6 0.2 0.9 2.1 0.2 0.8 2.0 0.3 0.7 0.1 0.5 1.0 0.6 0.2 0.1 1.1 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.8 0.3 0.0 0.8 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 170.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.9 2.6 0.0 1.7 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.0 0.0 0.2 1.8 1.3 0.1 0.1 0.0 0.0 0.3 C9orf16 "EST00098, FLJ12823, MGC4639" ENSG00000171159 "Chromosome 9 open reading frame 16" Q9BUW7 9 128160260-128163928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 98.6" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 689.6;Urothelial cells: 732.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020725 Uncertain Approved Microtubules NA NA Microtubules "HPA020725: AB_1845816" "unprognostic (8.85e-2)" "prognostic favorable (7.60e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (6.42e-3)" "unprognostic (3.98e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.13e-5)" "unprognostic (8.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-3)" "unprognostic (2.13e-1)" "unprognostic (3.09e-3)" "unprognostic (4.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.00e-3)" "unprognostic (2.48e-2)" 19.6 83.4 70.6 13.9 34.4 38.7 13.1 16.9 59.7 16.3 17.0 12.1 13.3 16.9 12.3 10.3 16.8 16.9 18.7 22.7 98.6 20.3 16.0 12.2 13.5 23.9 27.4 22.1 14.2 35.0 4.2 14.7 9.5 19.1 15.6 6.9 16.1 27.0 25.4 14.0 31.4 15.4 15.1 12.1 24.3 20.1 12.1 9.1 33.2 13.3 13.7 16.6 31.0 16.4 52.3 43.6 58.3 37.1 45.5 73.7 42.0 9.2 12.4 6.4 39.4 4.8 10.9 16.5 8.8 7.4 7.4 5.9 6.1 24.4 10.4 18.2 3.7 1.5 26.2 1.9 7.1 0.3 19.7 15.9 7.3 14.8 12.3 8.7 8.0 18.9 8.2 10.6 3.8 1.9 5.7 10.5 29.5 19.4 20.8 3.9 54.3 27.2 35.2 15.4 19.0 23.5 25.9 4.2 43.3 9.3 8.0 17.7 26.3 15.8 14.1 18.4 1.7 15.8 7.5 12.5 7.6 18.4 9.6 7.5 20.4 14.8 15.6 21.5 11.3 7.6 53.4 37.1 58.3 50.1 30.4 54.0 50.7 58.0 48.8 40.7 52.3 46.6 47.1 42.3 45.5 25.6 43.6 73.7 42.0 70.6 34.4 16.9 59.7 98.6 20.3 27.4 22.1 19.1 9.1 6.0 3.7 150.4 291.1 175.2 71.1 28.3 124.9 13.4 20.5 336.8 13.7 81.7 261.9 196.7 136.2 148.4 198.7 23.3 311.7 68.6 88.9 227.8 162.3 95.5 224.6 17.5 391.5 115.4 207.4 689.6 71.1 196.6 212.6 198.4 171.2 31.1 204.1 127.0 78.1 126.0 32.1 71.1 160.2 36.3 46.0 204.0 50.5 263.3 158.6 732.8 C9orf24 "bA573M23.4, CBE1, MGC32921, MGC33614, NYD-SP22, SMRP1" ENSG00000164972 "Chromosome 9 open reading frame 24" Q8NCR6 9 34379019-34397832 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 47.6;fallopian tube: 76.2;testis: 23.7" "Group enriched" "Detected in many" 10 "Ciliated cells: 1197.9;Early spermatids: 656.4;Late spermatids: 2140.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 17.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053008 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053008: AB_2682015" "unprognostic (3.62e-3)" "unprognostic (9.06e-3)" "unprognostic (1.00e-1)" "prognostic favorable (3.23e-5)" "unprognostic (7.66e-2)" "unprognostic (1.21e-2)" "unprognostic (2.40e-1)" "unprognostic (1.25e-1)" "unprognostic (2.72e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.50e-1)" "unprognostic (7.43e-3)" "unprognostic (4.72e-2)" "unprognostic (1.90e-2)" 1.5 1.2 12.7 1.0 20.0 0.8 1.0 1.5 10.8 3.3 1.6 12.2 0.0 2.1 1.3 7.2 1.1 76.2 1.0 4.8 11.2 11.0 1.9 1.0 10.3 0.9 5.3 6.4 6.2 1.5 0.8 3.1 0.9 47.6 1.5 1.3 0.0 2.0 1.1 1.6 1.2 4.3 1.2 2.0 0.9 1.4 23.7 3.0 0.0 1.2 0.1 1.0 0.9 0.0 0.6 0.4 0.1 0.1 0.9 3.6 0.5 0.8 0.0 1.6 0.6 0.3 0.0 1.3 0.6 0.6 0.3 1.4 1.4 0.0 0.3 0.6 0.0 0.7 1.2 0.5 0.2 0.0 2.3 1.3 0.0 1.6 4.1 0.0 0.1 2.0 0.3 0.2 0.4 0.0 0.5 0.6 1.0 0.0 0.6 0.2 0.0 1.3 0.9 0.6 1.2 0.9 0.6 0.1 0.1 0.5 0.1 1.6 0.6 0.0 0.4 0.1 0.1 1.1 0.0 0.0 1.3 1.0 0.5 0.9 2.5 1.4 0.4 1.4 0.2 2.5 0.0 0.0 0.0 1.1 0.1 0.0 0.6 1.3 0.4 0.4 0.0 3.6 1.1 0.1 0.9 0.0 0.0 1.7 0.5 12.7 20.0 1.5 10.8 11.2 11.0 5.3 6.4 47.6 3.0 6.0 13.7 0.0 2.6 1.9 1.0 34.3 2.5 1197.9 128.5 7.0 0.0 0.5 61.3 0.5 656.4 1.0 15.5 0.0 1.3 0.2 0.5 2.8 8.1 2.9 0.4 0.0 11.6 1.8 0.3 2140.7 9.8 2.5 0.0 0.0 9.8 1.2 0.3 6.2 6.7 5.7 0.8 32.3 0.3 10.8 3.8 0.9 0.5 0.0 16.4 1.7 C9orf40 FLJ10110 ENSG00000135045 "Chromosome 9 open reading frame 40" Q8IXQ3 9 74946581-74952886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 43.7;Spermatocytes: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042167 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA 290000 "Nucleoplasm, Cytosol" Centrosome "HPA042167: AB_10797382" "unprognostic (2.10e-1)" "unprognostic (7.65e-2)" "unprognostic (2.94e-1)" "unprognostic (7.65e-2)" "unprognostic (6.27e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (6.12e-2)" "unprognostic (1.11e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" "unprognostic (6.15e-3)" "unprognostic (6.78e-3)" "unprognostic (3.74e-2)" "unprognostic (4.21e-2)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" 6.2 4.0 8.3 9.7 8.0 9.0 18.8 8.1 12.4 5.1 9.9 5.6 2.8 14.3 5.2 3.0 5.2 3.6 5.0 3.6 7.4 8.4 4.1 5.1 2.8 8.4 8.4 5.6 4.2 3.5 6.6 4.4 6.5 6.7 3.9 9.2 2.2 3.0 4.8 4.7 3.5 18.7 4.9 11.2 5.4 3.6 31.1 5.1 10.5 3.0 3.4 8.0 5.0 16.0 1.8 0.9 5.3 0.5 0.0 2.1 0.3 16.8 3.7 9.7 3.9 3.9 5.1 18.1 13.5 4.2 9.4 10.2 1.0 5.3 15.3 4.0 3.3 15.8 5.0 7.6 0.7 15.1 20.6 11.8 8.1 6.8 6.4 3.2 9.7 12.9 2.5 5.1 5.2 3.7 3.8 2.9 11.2 11.4 10.4 12.3 4.7 17.1 11.4 11.4 8.9 11.4 16.0 7.6 3.7 3.9 4.1 10.6 4.7 5.9 5.0 4.0 9.0 6.1 7.5 3.7 8.5 9.6 11.6 11.7 20.0 14.9 9.7 6.5 10.9 9.1 1.8 0.2 5.3 1.0 0.4 0.4 1.8 1.1 1.0 0.2 1.3 2.1 1.3 0.5 0.0 0.5 0.9 1.2 0.3 8.3 8.0 8.1 12.4 7.4 8.4 8.4 5.6 6.7 5.1 3.0 0.3 6.0 3.5 2.2 7.2 43.7 0.0 1.4 0.0 3.5 7.9 15.9 1.7 2.7 9.5 8.6 12.7 0.0 2.7 19.6 4.0 2.4 0.0 3.4 9.3 1.6 1.2 9.2 3.3 1.3 4.0 1.7 1.7 3.6 4.9 4.5 2.9 8.6 4.9 1.4 13.1 0.0 4.2 46.8 10.7 4.5 10.3 3.2 15.2 3.8 C9orf43 MGC17358 ENSG00000157653 "Chromosome 9 open reading frame 43" Q8TAL5 9 113410054-113429684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 39.4" "Group enriched" "Detected in some" 7 "Early spermatids: 78.7;Late spermatids: 167.1;Spermatocytes: 82.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA021310 Approved Cytosol NA NA Cytosol "HPA021310: AB_1845825" "unprognostic (2.91e-2)" "unprognostic (9.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.18e-1)" "unprognostic (2.63e-1)" "unprognostic (6.58e-3)" "unprognostic (2.06e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (8.90e-2)" "unprognostic (1.97e-2)" "unprognostic (5.96e-3)" "unprognostic (1.51e-1)" "unprognostic (7.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-2)" "unprognostic (1.63e-1)" 0.5 1.6 1.5 0.4 2.4 1.8 1.3 2.1 2.3 0.5 0.4 1.6 0.2 0.4 0.4 1.6 0.5 0.9 0.6 0.4 1.4 0.8 1.0 1.7 0.5 0.6 0.8 1.9 1.0 3.5 1.3 3.8 0.5 1.6 0.7 0.5 1.0 0.9 0.7 0.4 0.8 0.5 0.3 1.8 0.6 0.6 39.4 1.0 0.6 1.0 0.0 0.6 0.5 0.5 1.5 1.3 2.3 1.5 1.0 2.1 0.8 1.2 1.2 0.6 1.9 1.5 0.8 0.9 0.6 1.1 1.7 1.3 1.3 1.0 3.3 1.1 0.3 3.8 2.4 0.7 1.7 0.7 2.7 0.5 2.9 2.1 0.6 1.3 0.5 0.4 1.8 2.6 2.2 2.6 1.1 1.5 3.9 1.7 3.1 0.9 2.4 1.4 0.8 0.9 1.5 3.9 0.8 0.7 1.9 1.8 0.6 3.1 0.7 3.0 1.4 1.7 1.4 4.1 0.3 0.2 2.6 0.6 1.7 2.6 2.0 3.6 5.0 1.4 1.1 0.9 0.0 0.7 0.0 1.5 1.5 0.0 1.5 0.8 2.1 0.8 0.8 1.4 2.1 2.3 1.0 0.3 1.3 0.1 0.8 1.5 2.4 2.1 2.3 1.4 0.8 0.8 1.9 1.6 1.0 0.0 0.0 0.8 0.5 0.6 1.7 0.0 0.0 10.7 2.3 0.0 0.0 0.4 1.7 0.3 78.7 0.3 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.3 167.1 2.0 0.6 0.0 1.0 0.0 2.3 1.1 0.0 1.4 0.7 2.6 0.0 0.0 82.6 16.0 0.0 0.0 0.0 0.0 0.5 C9orf50 FLJ35803 ENSG00000179058 "Chromosome 9 open reading frame 50" Q5SZB4 9 129612225-129620776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 9.4" "Group enriched" "Detected in some" 16 "Early spermatids: 60.3;Late spermatids: 168.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 2.9;MCF7: 4.4" HPA026743 Enhanced NA NA "HPA026743: AB_1845829" "unprognostic (2.23e-1)" "unprognostic (3.80e-2)" "unprognostic (3.27e-1)" "unprognostic (2.05e-1)" "unprognostic (3.79e-3)" "unprognostic (5.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" "unprognostic (9.28e-2)" "unprognostic (1.58e-1)" "unprognostic (6.14e-2)" "unprognostic (4.20e-2)" "unprognostic (4.01e-2)" "unprognostic (6.08e-2)" "unprognostic (1.24e-1)" "unprognostic (4.44e-3)" "unprognostic (5.28e-2)" 0.0 0.4 1.5 0.1 1.2 0.2 0.0 0.9 2.5 0.2 0.2 0.0 0.2 0.0 0.0 1.5 1.5 0.0 1.0 1.4 0.4 0.0 0.1 0.1 1.1 0.0 0.0 0.1 0.5 0.2 0.1 0.0 0.8 1.5 0.0 0.0 0.0 0.4 0.8 0.3 0.1 9.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.7 0.3 1.9 0.2 0.8 0.0 0.5 1.7 1.2 0.5 0.0 0.6 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 1.1 0.0 0.0 1.4 0.3 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.6 4.4 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.6 0.2 0.1 1.6 0.4 0.2 0.0 0.1 0.4 0.0 0.0 1.2 0.3 0.2 0.1 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 2.5 0.0 0.0 3.5 0.0 0.0 5.0 0.2 60.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 168.5 0.9 0.0 0.0 0.0 0.0 7.0 0.2 0.0 1.8 0.5 0.2 0.0 0.5 1.2 2.2 0.0 0.0 0.0 0.0 0.1 C9orf57 ENSG00000204669 "Chromosome 9 open reading frame 57" Q5W0N0 9 72051376-72072721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 114 "testis: 31.4" "Cell type enriched" "Detected in some" 16 "Spermatocytes: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 3.2" NA NA "unprognostic (3.26e-2)" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 C9orf66 FLJ31158 ENSG00000183784 "Chromosome 9 open reading frame 66" Q5T8R8 9 212824-215741 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 20.9;kidney: 17.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 60.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 20.9" "Group enriched" "Detected in many" 4 "granulocytes: 20.9;monocytes: 6.0" "Cell line enhanced" "Detected in some" "BEWO: 3.6;MCF7: 3.7;RT4: 3.6;THP-1: 7.8" HPA035652 Uncertain NA NA "HPA035652: AB_10601151" "unprognostic (1.24e-1)" "unprognostic (7.20e-2)" "unprognostic (7.64e-2)" "unprognostic (1.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (2.94e-2)" "unprognostic (9.48e-2)" "unprognostic (6.65e-3)" "unprognostic (9.92e-2)" "unprognostic (5.66e-2)" "prognostic favorable (1.32e-5)" "unprognostic (2.04e-2)" "unprognostic (1.63e-1)" "unprognostic (2.73e-2)" "unprognostic (3.10e-3)" 0.5 3.1 0.3 0.3 0.9 1.7 0.7 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.5 0.1 0.3 0.3 0.3 0.1 17.8 0.5 0.3 0.3 0.3 0.3 0.5 1.3 1.9 0.3 0.3 0.3 0.7 0.0 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 1.4 0.2 0.7 0.8 0.3 1.3 0.3 0.3 0.4 0.3 2.0 3.0 20.9 6.0 1.6 0.6 0.6 0.1 0.4 0.3 0.4 0.1 0.1 3.6 0.1 0.0 0.2 0.1 0.7 2.1 0.4 1.0 0.3 0.4 0.6 0.1 0.0 0.0 0.3 1.1 0.3 0.5 0.3 0.1 0.9 1.2 0.2 0.1 0.1 0.0 0.1 0.0 0.2 1.9 0.8 0.0 3.7 0.2 2.4 0.4 0.1 0.8 0.4 0.3 2.1 0.1 3.6 0.6 0.4 0.0 0.2 0.5 0.3 1.6 7.8 1.1 0.3 0.8 0.5 0.2 0.9 0.4 0.1 0.2 1.3 0.7 7.0 4.9 8.0 0.3 3.3 0.1 1.8 0.6 0.4 3.0 2.0 0.1 0.2 20.9 1.6 6.0 0.7 0.1 0.6 0.3 0.9 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.8 0.0 0.3 2.0 1.5 1.0 0.6 1.1 2.5 1.4 0.0 10.4 13.7 8.5 10.0 1.1 0.0 0.3 0.0 0.0 4.7 1.7 0.7 1.5 0.0 0.4 4.9 0.0 3.4 0.0 3.1 0.0 0.9 3.8 0.0 6.4 2.6 0.8 1.1 0.0 0.4 60.2 3.2 6.5 1.0 2.2 5.5 0.1 3.9 2.1 0.2 1.4 C9orf84 FLJ32779 ENSG00000165181 "Chromosome 9 open reading frame 84" Q5VXU9 9 111686173-111795008 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 33.0" "Group enriched" "Detected in some" 5 "Early spermatids: 46.5;Spermatocytes: 81.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 15 "granulocytes: 4.1" "Cell line enriched" "Detected in some" 5 "U-2 OS: 22.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA032108 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA032108: AB_10669884" "unprognostic (2.63e-1)" "unprognostic (1.83e-4)" "unprognostic (9.12e-2)" "unprognostic (3.17e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (9.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.22e-2)" "unprognostic (1.65e-1)" "unprognostic (8.14e-2)" "unprognostic (2.30e-1)" "unprognostic (8.33e-5)" "unprognostic (6.93e-2)" "unprognostic (2.84e-1)" "unprognostic (3.77e-1)" "unprognostic (7.31e-2)" 0.1 2.9 0.1 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.0 0.3 0.6 0.2 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 1.1 33.0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.2 0.2 4.1 0.0 0.1 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 4.8 1.1 0.4 0.0 0.0 0.3 0.0 0.0 22.4 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 0.1 0.0 0.6 1.2 0.0 1.4 1.2 0.0 2.0 0.0 13.3 0.0 46.5 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.6 0.0 11.5 2.8 0.0 0.0 0.0 0.0 0.2 0.9 0.0 3.5 0.0 0.3 6.5 0.0 81.0 5.5 0.0 0.0 0.0 0.0 0.7 C9orf92 Em:AL513424.1 ENSG00000205549 "Chromosome 9 open reading frame 92" A6NGG3 9 16203935-16276313 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "kidney: 3.3" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 4.3;Glandular cells: 2.1;Proximal tubular cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.7;BJ hTERT+: 4.4;HBF TERT88: 2.6;PC-3: 1.4;SH-SY5Y: 1.3;U-2197: 4.8" NA NA "unprognostic (1.06e-1)" "unprognostic (4.77e-2)" "unprognostic (3.74e-2)" "unprognostic (5.47e-2)" "unprognostic (1.20e-1)" "unprognostic (5.04e-1)" "unprognostic (5.09e-2)" 0.6 0.0 0.3 0.5 0.3 0.0 0.6 0.0 0.5 0.5 0.6 0.5 1.7 1.2 0.0 1.2 1.4 0.0 0.6 0.5 3.3 0.4 0.0 0.1 1.3 1.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.0 0.0 1.7 2.8 0.0 1.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 1.2 0.6 4.8 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 CA1 Car1 ENSG00000133742 "Carbonic anhydrase 1" P00915 8 85327608-85379014 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 156.0;intestine: 203.6" "Cell type enriched" "Detected in some" 19 "Erythroid cells: 11890.7" "Group enriched" "Detected in some" 10 "colorectal cancer: 3.4;stomach cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 1207 "HEL: 169.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006558, CAB025790" Enhanced NA NA 7800000000 "CAB025790: , HPA006558: AB_1845989" "unprognostic (1.44e-1)" "unprognostic (7.56e-2)" "unprognostic (1.70e-1)" "unprognostic (3.57e-3)" "unprognostic (2.08e-2)" "unprognostic (1.66e-1)" "unprognostic (2.84e-2)" "unprognostic (2.03e-2)" "unprognostic (1.73e-2)" "unprognostic (6.12e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (5.61e-2)" "unprognostic (3.01e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" 1.8 0.4 0.5 11.5 0.5 156.0 0.4 0.3 0.4 0.3 95.4 1.5 0.0 0.0 0.3 0.0 0.6 0.7 0.0 17.6 0.5 0.4 0.8 2.9 32.2 0.2 0.9 0.0 0.8 0.5 0.0 1.0 24.0 0.6 1.1 203.6 2.6 0.3 0.1 3.1 0.2 0.4 3.2 0.5 14.3 0.3 0.3 0.0 0.2 7.5 0.0 0.2 4.5 16.0 0.7 0.7 0.0 0.3 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.5 0.5 0.5 0.3 0.4 0.5 0.4 0.9 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 624.8 11890.7 0.0 0.0 0.0 0.1 23.0 0.6 0.0 0.0 44.0 1.3 1.6 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.0 422.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 0.0 CA10 "CA-RPX, CARPX, HUCEP-15" ENSG00000154975 "Carbonic anhydrase 10" Q9NS85 17 51630313-52160017 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 59.5;cervix, uterine: 23.4" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 230.7;Early spermatids: 106.6;Late spermatids: 56.3" "Cancer enhanced" "Detected in some" "glioma: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.2;RT4: 3.8;SCLC-21H: 11.7;SuSa: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054825, HPA057837" Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA054825: AB_2682617, HPA057837: AB_2683542" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" "unprognostic (3.43e-1)" "unprognostic (8.22e-2)" "unprognostic (4.43e-3)" "unprognostic (1.02e-3)" "unprognostic (1.01e-1)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (7.21e-3)" "unprognostic (9.18e-5)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" 0.5 3.8 14.4 0.5 6.3 0.5 0.5 59.5 36.7 23.4 0.8 1.7 0.0 0.8 0.7 0.5 0.6 0.7 0.6 0.5 8.0 12.4 7.8 0.5 0.5 0.5 7.0 5.0 2.5 0.8 0.5 1.8 14.2 18.3 0.5 0.7 2.9 1.5 0.5 0.5 0.5 1.1 0.6 4.2 0.5 0.6 6.0 1.3 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 2.2 3.8 11.7 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 6.3 59.5 17.9 8.0 12.4 7.0 5.0 18.3 1.3 0.0 0.0 0.0 0.0 0.0 230.7 0.3 0.0 0.0 0.0 3.5 3.9 0.0 13.3 0.0 106.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 56.3 1.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 9.7 0.0 0.0 0.9 1.0 0.0 0.1 0.0 0.0 0.0 CA11 "CARP2, CARPX1" ENSG00000063180 "Carbonic anhydrase 11" O75493 19 48637942-48646312 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 72.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;hTERT-RPE1: 24.4;SCLC-21H: 16.7;U-266/84: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041778 Approved Vesicles,Microtubules "Secreted in brain" NA NA "Vesicles, Microtubules" "HPA041778: AB_10794525" "unprognostic (1.39e-1)" "prognostic favorable (4.33e-4)" "unprognostic (2.59e-3)" "unprognostic (5.72e-2)" "unprognostic (1.54e-1)" "unprognostic (9.80e-3)" "unprognostic (6.02e-2)" "prognostic favorable (2.11e-5)" "unprognostic (3.79e-2)" "unprognostic (2.98e-1)" "prognostic favorable (8.60e-5)" "unprognostic (4.88e-2)" "unprognostic (8.64e-3)" "unprognostic (1.21e-1)" "unprognostic (7.15e-2)" "unprognostic (4.09e-3)" "unprognostic (1.75e-1)" 2.3 9.6 60.2 2.3 58.2 1.5 4.1 54.1 87.7 3.8 2.5 4.5 1.7 5.3 17.7 16.0 3.5 10.5 3.5 2.9 44.1 12.2 4.2 1.2 3.2 3.0 18.5 31.6 24.6 3.3 16.7 5.4 1.3 8.9 4.6 2.0 2.7 4.0 8.4 5.0 6.6 4.0 10.7 11.0 2.8 3.1 2.7 17.8 0.1 4.3 0.8 3.4 2.1 1.8 3.4 4.5 0.0 1.1 2.6 3.7 1.4 1.0 6.3 11.6 23.3 1.6 0.6 0.3 0.7 7.4 0.8 1.7 1.5 8.1 3.8 0.9 0.8 2.2 2.5 4.7 2.3 0.7 0.8 6.7 1.7 3.4 0.1 1.5 0.1 5.2 2.8 4.7 0.7 1.0 24.4 0.9 10.4 2.9 10.7 0.3 2.4 2.0 0.7 5.1 3.7 2.5 1.3 0.5 7.9 5.1 0.2 16.7 9.7 0.8 0.9 1.4 3.3 3.3 0.4 0.0 2.1 7.8 0.0 0.2 10.2 17.0 0.7 2.9 2.2 1.0 0.0 0.9 0.0 3.7 1.1 3.1 2.4 2.9 2.8 1.6 3.4 3.6 3.3 0.0 2.6 0.0 4.5 3.0 1.4 60.2 58.2 54.1 63.8 44.1 12.2 18.5 31.6 8.9 17.8 3.0 7.2 9.7 6.4 6.4 72.7 5.3 20.4 8.1 9.1 29.6 15.7 0.6 21.6 6.9 10.0 7.1 7.4 0.0 8.7 0.3 5.1 4.8 5.8 34.1 5.9 27.0 12.6 8.0 21.9 4.7 20.4 8.8 8.5 4.6 4.2 24.9 4.6 3.5 25.1 19.8 25.0 6.5 8.0 0.9 3.6 9.5 0.3 8.7 4.5 5.8 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63382161 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 103.5" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 155.1;Enterocytes: 240.0;Paneth cells: 157.9;Suprabasal keratinocytes: 220.4" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 39.0;ASC TERT1: 41.1;RT4: 41.3;SK-BR-3: 33.1;T-47d: 53.4;U-138 MG: 57.0;U-87 MG: 68.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008773, CAB025181, CAB062549, CAB068179" Enhanced NA NA 29000 "CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394" "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 3.7 0.3 4.7 15.0 27.4 0.3 14.5 3.7 2.3 15.7 32.0 2.6 5.0 0.4 9.8 12.3 42.8 8.5 2.6 1.6 4.9 1.4 103.5 0.3 1.2 0.3 1.8 0.2 2.1 43.8 0.3 3.9 5.9 16.9 3.8 30.3 8.5 8.2 17.9 0.5 44.1 2.4 18.1 0.1 0.4 2.2 1.3 6.7 0.0 1.7 18.4 25.9 10.6 14.5 0.3 0.2 0.6 0.7 0.3 0.2 0.0 0.0 39.0 0.6 0.1 5.2 41.1 2.1 2.8 2.5 0.4 0.7 0.2 0.1 0.0 9.6 2.3 15.4 0.2 0.0 1.9 1.1 0.0 1.4 0.0 2.6 0.0 0.1 0.0 0.0 15.5 2.1 11.9 3.8 0.0 0.5 0.0 0.0 0.0 0.5 22.4 0.0 0.0 0.6 0.0 6.1 0.0 0.0 0.0 0.0 41.3 0.3 0.0 0.1 33.1 0.0 0.4 53.4 0.0 0.0 57.0 3.0 1.8 0.0 0.0 0.0 0.0 68.4 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.7 0.2 0.1 0.0 4.7 27.4 3.7 1.3 4.9 1.4 1.8 0.2 16.9 6.7 0.0 5.8 1.5 18.6 155.1 0.0 0.6 0.0 2.7 3.4 38.4 0.0 0.4 46.4 14.9 12.0 0.0 240.0 0.0 48.3 1.7 5.1 14.8 1.1 0.0 0.6 0.0 8.1 0.0 0.0 3.0 0.0 2.2 21.9 0.0 92.2 2.5 15.0 157.9 0.0 59.0 0.2 0.0 3.9 0.0 0.0 220.4 1.5 0.0 95.7 16.3 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.5;OE19: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles NA NA 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favorable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.2 0.3 0.7 0.1 0.5 0.5 0.3 0.8 0.9 0.1 2.4 5.8 4.5 0.3 0.4 1.0 5.1 1.9 1.8 2.3 0.1 1.3 0.8 12.5 1.6 5.3 1.2 0.2 0.5 1.9 0.4 0.2 1.0 1.5 1.3 0.5 3.1 2.4 2.1 0.0 0.2 0.2 0.3 24.6 0.3 0.2 1.8 0.1 6.7 0.2 0.2 0.0 0.4 0.0 1.3 0.9 0.4 0.6 1.2 2.3 3.3 0.1 1.3 1.0 0.4 1.5 4.8 1.8 2.2 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 3.0 7.7 1.4 2.1 1.5 1.5 5.2 5.1 10.7 12.5 12.2 31.4 0.2 8.3 3.2 9.1 2.1 16.9 0.0 1.4 0.2 3.1 2.1 0.0 4.7 0.9 0.0 4.6 9.8 3.0 10.4 0.0 2.2 5.0 0.0 3.2 2.0 3.1 4.9 0.0 16.1 5.1 0.0 1.0 1.2 2.3 2.8 0.2 1.0 3.4 1.8 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257159-150265078 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1" "Group enriched" "Detected in some" 16 "Cardiomyocytes: 44.5;Melanocytes: 50.6;Muller glia cells: 123.0" "Group enriched" "Detected in many" 7 "glioma: 4.9;melanoma: 23.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "AF22: 28.7;AN3-CA: 17.0;NTERA-2: 22.3;SK-MEL-30: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favorable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.1 0.3 4.6 0.2 5.2 0.9 0.3 1.4 6.8 0.1 1.7 10.8 0.1 0.3 0.1 0.5 1.6 1.3 0.7 4.4 6.4 4.1 0.3 6.3 0.2 0.2 11.3 3.2 1.4 0.3 0.8 0.1 0.3 4.4 3.2 0.7 29.4 0.6 16.5 24.1 3.7 0.6 0.5 20.9 0.3 0.8 0.5 2.7 0.1 0.9 0.1 0.1 0.2 0.1 2.8 2.2 2.1 2.0 0.2 1.6 0.2 0.2 0.0 28.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 22.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.1 57.1 4.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.0 0.9 1.3 1.6 2.0 0.6 2.0 1.0 1.2 0.2 2.8 1.2 1.3 2.1 0.2 0.5 2.2 0.0 0.2 4.6 5.2 1.4 4.7 6.4 4.1 11.3 3.2 4.4 2.7 3.0 0.3 0.0 0.2 1.9 1.4 44.5 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.0 50.6 0.0 0.0 123.0 1.2 0.0 3.2 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.4 CA2 "CA-II, CAII, Car2" ENSG00000104267 "Carbonic anhydrase 2" P00918 8 85463852-85481493 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Lyase "Disease mutation, FDA approved drug targets, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 108.1;stomach 1: 171.5" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 870.3;Erythroid cells: 2055.8;Muller glia cells: 1176.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 33.8;HEK 293: 142.4;THP-1: 59.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001550, CAB010102" Enhanced NA Yes 790000000 "CAB010102: AB_626796, HPA001550: AB_1078393" "unprognostic (6.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.05e-2)" "unprognostic (1.63e-1)" "unprognostic (2.59e-1)" "unprognostic (9.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.72e-2)" "unprognostic (1.07e-1)" "unprognostic (5.23e-2)" "unprognostic (1.57e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.57e-6)" "unprognostic (2.45e-1)" "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (6.49e-3)" 1.6 2.2 24.4 21.5 32.6 32.4 6.9 4.3 23.2 1.3 108.1 28.9 42.0 46.9 0.9 2.2 5.6 0.9 33.0 4.3 29.1 14.5 53.5 43.0 10.2 1.3 49.0 14.2 0.5 9.1 3.1 2.0 3.5 65.0 0.8 105.6 7.0 14.0 54.2 9.2 13.3 7.6 6.0 27.5 2.5 171.5 5.1 58.3 0.0 3.8 2.4 1.1 1.0 1.4 1.9 8.0 20.3 8.2 0.0 4.4 17.5 0.5 0.3 1.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 1.2 0.0 0.0 33.8 4.9 1.7 0.0 0.0 142.4 4.4 2.5 0.0 0.0 3.1 0.6 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.4 11.2 0.0 2.7 0.1 0.0 0.5 1.1 0.0 0.0 0.7 0.0 0.0 1.3 0.0 59.7 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 20.3 3.1 4.4 0.1 8.2 4.4 0.6 0.0 0.4 8.0 1.9 0.0 0.0 6.8 0.0 7.1 0.8 0.0 17.5 24.4 32.6 4.3 23.2 29.1 14.5 49.0 14.2 65.0 58.3 14.9 56.8 27.3 1.0 80.5 23.5 18.5 400.0 0.0 1.2 153.5 60.9 10.7 295.1 50.5 65.5 14.6 870.3 2055.8 9.9 311.4 6.4 1.1 16.1 101.2 34.8 12.7 29.2 1.8 8.2 179.8 3.1 46.0 70.9 1.0 94.2 1176.2 10.3 374.2 2.1 304.9 61.5 0.0 7.3 1.7 2.3 97.6 14.3 5.7 229.3 0.3 CA3 "CAIII, Car3" ENSG00000164879 "Carbonic anhydrase 3" P07451 8 85373436-85449040 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "skeletal muscle: 347.5" "Cell type enriched" "Detected in some" 14 "Erythroid cells: 280.4" "Group enriched" "Detected in many" 7 "glioma: 23.1;prostate cancer: 9.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "HEL: 23.8;RH-30: 40.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB004967, HPA021775, HPA026700" Enhanced NA NA 31000000 "CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991" "prognostic favorable (4.24e-6)" "unprognostic (1.40e-1)" "unprognostic (1.50e-2)" "unprognostic (2.22e-3)" "unprognostic (4.71e-2)" "unprognostic (8.43e-3)" "unprognostic (3.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-1)" "unprognostic (4.71e-2)" "unprognostic (3.54e-1)" "unprognostic (3.19e-2)" "unprognostic (1.18e-1)" "unprognostic (9.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.19e-1)" 18.0 0.4 0.2 0.1 0.2 0.5 0.6 0.2 0.1 0.5 0.3 0.0 0.1 0.1 0.6 29.0 9.5 1.0 0.2 1.3 0.2 0.1 0.2 0.2 4.1 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 6.6 0.0 0.0 5.5 0.2 347.5 0.3 0.4 1.4 0.1 0.1 0.3 0.5 0.0 0.0 0.3 14.1 3.4 0.7 0.5 0.5 1.8 0.0 0.0 0.0 0.8 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 23.8 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 40.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 3.0 3.4 0.0 0.9 0.5 0.0 0.8 7.6 0.0 0.0 0.0 5.9 0.6 0.0 0.7 20.2 0.0 0.7 280.4 0.2 0.0 0.6 0.5 0.0 0.0 0.4 0.0 0.0 1.8 0.3 4.7 0.3 0.0 0.0 0.0 0.3 16.0 0.2 1.7 0.0 0.5 1.4 0.0 0.1 0.5 0.9 0.9 1.4 0.0 0.6 0.3 CA4 "CAIV, Car4, RP17" ENSG00000167434 "Carbonic anhydrase 4" P22748 17 60149936-60170899 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 81.7" "Cell type enriched" "Detected in many" 43 "Paneth cells: 2128.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 50.1" "Cell type enriched" "Detected in some" 7 "neutrophil: 37.0" "Lineage enriched" "Detected in single" 370 "granulocytes: 37.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.5;NTERA-2: 3.4;OE19: 3.9;RPTEC TERT1: 1.9;SuSa: 2.6" "Region enriched" "Detected in all" 5 "cerebellum: 336.9" "Low region specificity" "Detected in many" "HPA011089, HPA017258" Enhanced NA NA 190000 "HPA011089: AB_1845996, HPA017258: AB_1845997" "unprognostic (2.07e-2)" "unprognostic (7.85e-2)" "unprognostic (1.55e-2)" "unprognostic (7.78e-3)" "unprognostic (8.42e-2)" "unprognostic (1.19e-1)" "unprognostic (3.19e-2)" "unprognostic (5.84e-2)" "unprognostic (7.76e-2)" "unprognostic (9.74e-2)" "unprognostic (1.54e-1)" "unprognostic (1.71e-2)" "unprognostic (2.68e-3)" "unprognostic (8.59e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-2)" 32.2 0.9 3.4 9.8 4.4 5.7 46.4 50.1 11.8 2.3 81.7 2.0 31.5 1.4 2.3 17.4 0.9 1.7 12.2 8.8 4.7 2.6 12.0 0.3 33.3 2.4 3.5 5.2 1.9 9.5 3.3 5.1 3.2 3.0 2.4 54.9 20.3 4.8 24.0 10.0 1.0 3.2 1.1 2.1 4.9 2.5 1.2 0.3 0.2 23.1 5.0 0.2 1.7 7.9 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.5 0.8 0.1 0.0 0.3 0.0 0.0 0.3 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 3.9 0.0 0.0 0.2 1.3 1.9 0.0 0.7 0.3 0.2 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.7 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 50.1 11.8 4.7 2.6 3.5 5.2 3.0 0.3 0.0 3.7 0.0 0.2 1.3 0.0 9.2 0.0 1.4 1.2 14.0 0.0 0.0 28.2 3.1 0.2 15.8 49.7 0.0 0.2 0.0 1.5 0.1 11.5 0.0 0.5 0.0 18.6 1.8 0.0 0.0 0.6 0.8 0.0 0.0 27.9 0.0 0.1 2128.8 0.0 18.6 0.0 6.5 17.9 0.0 0.0 1.0 0.0 0.0 32.8 0.3 CA5A "CA5, CAV, CAVA" ENSG00000174990 "Carbonic anhydrase 5A" P35218 16 87881546-87936529 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 26.4" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 35.0" "Cancer enriched" "Detected in single" 26 "liver cancer: 2.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Hep G2: 6.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (1.91e-1)" "unprognostic (8.64e-3)" "unprognostic (3.36e-2)" "unprognostic (6.11e-2)" "unprognostic (2.49e-2)" "unprognostic (2.96e-1)" "unprognostic (8.39e-3)" "unprognostic (3.50e-3)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (6.55e-2)" "unprognostic (4.23e-2)" "unprognostic (7.99e-3)" "unprognostic (1.77e-1)" "unprognostic (5.03e-3)" "unprognostic (3.37e-2)" "unprognostic (2.76e-2)" 0.0 0.0 0.3 0.8 0.4 2.7 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.3 0.0 26.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.7 0.1 0.0 0.3 0.8 0.0 0.3 0.1 0.0 0.0 0.0 1.9 1.6 4.7 1.1 1.9 1.1 0.4 0.2 0.3 0.3 0.7 0.1 0.0 0.5 0.4 0.1 0.0 0.1 0.5 0.6 0.6 0.2 0.2 0.3 0.6 0.2 0.3 0.1 0.4 0.3 0.4 1.1 6.8 0.0 0.4 1.7 0.8 0.0 0.2 0.4 0.5 0.3 0.5 0.4 1.6 0.1 0.5 0.2 1.0 0.5 0.3 0.6 0.4 0.4 0.2 0.2 0.6 0.4 0.2 0.2 0.3 0.1 0.5 0.6 0.3 0.4 0.8 0.2 0.5 0.3 0.7 0.4 0.4 0.6 0.9 0.4 4.1 1.1 1.0 0.8 0.7 0.8 0.9 0.8 0.6 0.3 1.9 1.1 1.1 4.7 1.9 0.7 1.6 0.5 0.4 0.0 4.3 0.0 2.5 0.3 1.7 1.4 0.0 2.7 2.3 1.8 3.9 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.4 1.4 5.8 35.0 0.1 3.2 0.0 1.3 0.6 0.8 0.3 1.9 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.0 2.6 0.0 0.0 0.3 0.6 0.3 0.2 0.0 0.0 1.3 CA6 ENSG00000131686 "Carbonic anhydrase 6" P23280 1 8945867-8975092 "Enzymes, Predicted secreted proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "salivary gland: 1237.9" "Cell type enriched" "Detected in single" 404 "Melanocytes: 170.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 15.4" "Lineage enriched" "Detected in many" 10 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "Daudi: 5.5;U-2197: 4.8" "Not detected" "Not detected" "HPA028550, HPA028692" Enhanced "Secreted to digestive system" NA NA 34000000 "HPA028550: AB_10600105, HPA028692: AB_10601883" "unprognostic (2.54e-5)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.37e-1)" "unprognostic (2.90e-1)" "unprognostic (9.28e-2)" "unprognostic (2.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.73e-1)" "unprognostic (5.93e-2)" "unprognostic (4.41e-2)" "unprognostic (4.29e-5)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "unprognostic (2.35e-1)" 0.3 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1237.9 0.0 0.1 24.9 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.6 0.4 1.5 0.3 0.4 15.4 1.6 1.2 0.5 0.9 1.8 0.3 0.3 1.4 0.9 0.1 0.2 0.6 1.0 1.6 5.5 0.6 0.5 1.3 1.6 0.4 0.1 0.8 0.6 0.6 0.8 2.0 1.1 0.4 2.0 2.0 0.0 1.0 0.9 0.1 1.2 0.7 1.4 0.7 3.4 0.1 0.8 1.0 1.5 1.1 1.0 0.8 1.5 0.6 0.3 0.2 1.0 1.0 0.9 0.2 0.9 0.3 0.9 1.5 0.8 0.3 2.8 1.5 4.8 1.2 1.5 0.5 1.7 0.6 1.8 1.4 1.1 0.3 0.2 0.4 0.2 0.4 0.3 0.8 2.8 0.0 0.6 5.6 15.4 1.5 0.4 0.2 0.4 0.3 1.6 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 170.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CA7 ENSG00000168748 "Carbonic anhydrase 7" P43166 16 66844379-66854153 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 37.2" "Cell type enriched" "Detected in some" 58 "Paneth cells: 2512.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;HAP1: 1.8;NTERA-2: 1.6;REH: 3.4;SCLC-21H: 2.7;THP-1: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047237 Uncertain NA NA "HPA047237: AB_2679994" "unprognostic (8.77e-4)" "unprognostic (5.23e-4)" "unprognostic (1.57e-1)" "unprognostic (1.96e-2)" "unprognostic (2.19e-1)" "unprognostic (2.16e-2)" "unprognostic (7.90e-2)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "unprognostic (9.62e-2)" "unprognostic (1.69e-2)" "unprognostic (7.12e-3)" "unprognostic (8.47e-2)" "unprognostic (5.20e-1)" "unprognostic (1.90e-2)" "unprognostic (6.46e-2)" 0.2 0.2 3.2 0.4 7.5 0.2 0.2 3.9 7.7 0.2 37.2 0.3 0.0 4.8 0.3 0.9 0.3 0.2 0.2 0.2 6.3 0.5 0.2 0.2 0.2 0.2 0.7 2.9 0.2 0.2 0.2 0.0 0.2 1.8 0.2 32.0 0.0 1.1 0.4 0.2 0.2 22.8 1.0 0.1 0.2 0.2 0.5 1.3 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.9 3.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 7.5 3.9 7.7 6.3 0.5 0.7 2.9 1.8 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 2512.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 25.5 0.0 CA8 "CALS, CARP" ENSG00000178538 "Carbonic anhydrase 8" P35219 8 60187347-60281412 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.0;brain: 26.8;parathyroid gland: 56.8" "Cell type enhanced" "Detected in many" 11 "Intestinal endocrine cells: 33.7;Mucus-secreting cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 20 "basophil: 41.0" "Lineage enriched" "Detected in many" 20 "granulocytes: 41.0" "Cell line enhanced" "Detected in some" "HEK 293: 11.6;JURKAT: 11.4;K-562: 21.0;NB-4: 12.1;OE19: 18.4" "Region enriched" "Detected in some" 37 "cerebellum: 1413.4" "Region enriched" "Detected in all" 9 "cerebellum: 163.0" "HPA024748, CAB025545, CAB047309" Enhanced NA NA "CAB025545: , CAB047309: , HPA024748: AB_1846003" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "unprognostic (4.43e-2)" "unprognostic (3.46e-3)" "unprognostic (6.67e-2)" "unprognostic (3.19e-1)" "unprognostic (3.85e-2)" "unprognostic (3.54e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.79e-5)" "unprognostic (3.23e-2)" "unprognostic (1.68e-2)" "unprognostic (2.12e-1)" "unprognostic (1.71e-2)" "unprognostic (1.95e-1)" "unprognostic (1.41e-1)" 2.3 1.5 9.2 1.1 11.6 1.1 6.5 26.8 6.9 6.3 2.2 3.6 0.6 1.8 2.8 12.8 0.9 2.5 1.0 3.8 7.8 6.0 7.4 0.6 1.6 1.0 4.2 5.3 0.7 3.0 56.8 9.8 8.1 3.4 3.3 3.1 1.5 6.6 0.9 2.0 0.9 1.7 1.3 1.9 1.3 5.9 9.3 6.2 1.7 0.7 1.3 1.0 1.3 2.1 0.1 2.0 41.0 0.0 0.0 0.0 0.0 0.0 2.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.1 0.0 11.6 4.9 0.0 0.0 3.9 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 11.4 21.0 0.2 0.0 0.0 3.3 12.1 0.2 18.4 0.0 0.0 0.0 0.2 0.4 0.9 5.3 0.0 0.0 1.1 0.0 2.4 4.9 0.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 41.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.2 11.6 26.8 6.9 7.8 6.0 4.2 5.3 3.4 6.2 0.0 3.7 0.0 0.2 0.9 0.9 3.3 0.0 1.4 6.8 3.5 0.0 7.7 3.3 4.0 7.7 5.3 0.4 0.0 5.4 0.3 3.4 1.8 0.0 0.0 7.4 0.0 33.7 0.0 2.7 3.6 1.4 0.2 6.8 0.0 16.7 2.3 1.5 2.9 1.4 0.0 0.8 0.0 0.4 3.6 4.5 0.4 1.1 0.0 2.3 0.1 CA9 "CAIX, MN" ENSG00000107159 "Carbonic anhydrase 9" Q16790 9 35673856-35681159 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8" "Cell type enhanced" "Detected in some" 25 "Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 7.3" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9" "Region enriched" "Detected in some" 4 "cerebellum: 13.8" "Low region specificity" "Detected in some" "CAB005100, CAB017107, HPA055207" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738" "unprognostic (8.01e-3)" "unprognostic (1.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (1.47e-2)" "unprognostic (3.90e-2)" "unprognostic (1.29e-1)" "unprognostic (6.24e-3)" "unprognostic (1.13e-1)" "prognostic unfavorable (2.22e-7)" "unprognostic (7.29e-2)" "prognostic favorable (9.50e-4)" "unprognostic (2.97e-3)" "unprognostic (8.67e-2)" 1.0 0.1 0.0 0.1 0.3 0.0 0.0 7.3 0.7 0.5 7.2 0.1 0.2 6.7 0.1 1.5 0.3 0.1 70.4 0.7 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.7 47.4 0.0 0.2 0.7 0.4 0.2 0.0 0.1 0.0 0.0 0.0 2.6 8.0 0.0 0.4 0.0 70.8 1.4 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 1.1 0.0 0.0 0.4 0.1 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.3 20.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.3 7.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 3.9 0.0 0.3 53.5 0.0 0.0 0.0 0.0 0.0 0.0 27.8 178.0 0.0 0.0 0.0 46.4 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 12.2 1.4 0.0 0.0 1.0 0.1 1.5 33.9 0.0 0.7 0.0 0.0 0.0 0.4 0.9 2.7 2.8 0.2 0.0 0.2 0.3 CABCOCO1 "bA63A2.1, C10orf107, Em:AC022398.2, MGC44593" ENSG00000183346 "Ciliary associated calcium binding coiled-coil 1" Q8IVU9 10 61662961-61766766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 33.1;testis: 18.6" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 163.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041398 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA041398: AB_10794374" "unprognostic (1.89e-3)" "unprognostic (7.37e-2)" "unprognostic (2.23e-1)" "prognostic favorable (1.79e-4)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (5.52e-2)" "unprognostic (4.43e-2)" "unprognostic (3.31e-1)" "unprognostic (1.16e-1)" "unprognostic (1.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.52e-3)" "unprognostic (2.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.33e-2)" 1.5 1.2 6.3 0.7 5.7 0.5 2.1 0.4 6.8 6.1 1.6 9.5 3.0 1.0 5.2 7.6 0.9 33.1 3.8 0.7 8.1 7.3 2.6 0.9 10.3 0.9 8.1 5.8 4.1 1.6 10.0 5.2 1.4 13.7 5.9 1.3 1.5 1.7 3.7 0.6 0.8 0.9 3.0 14.8 1.9 0.9 18.6 5.6 0.0 1.9 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.4 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.1 0.9 0.9 0.5 0.1 0.0 0.1 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 5.7 0.4 6.8 8.1 7.3 8.1 5.8 13.7 5.6 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 163.3 13.6 3.5 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CABLES1 "FLJ35924, HsT2563" ENSG00000134508 "Cdk5 and Abl enzyme substrate 1" Q8TDN4 18 23134564-23260467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 40.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 24.3;Cone photoreceptor cells: 27.5;Ito cells: 29.4;Melanocytes: 27.0" "Cancer enriched" "Detected in all" 5 "melanoma: 38.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 4.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 42.9;U-266/70: 62.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073649 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" "HPA073649: AB_2732233" "unprognostic (1.27e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "prognostic favorable (4.71e-6)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (4.80e-2)" "unprognostic (7.81e-2)" 12.0 2.9 22.3 1.6 31.5 1.8 40.6 8.6 23.4 4.7 4.1 3.0 0.0 6.0 7.7 2.7 5.6 9.2 4.2 3.2 13.9 11.9 10.8 8.0 17.0 2.0 17.2 12.9 3.3 2.0 31.3 2.6 8.4 13.6 2.8 4.2 17.1 17.0 3.9 1.1 13.5 5.1 5.7 3.8 2.6 11.6 2.8 9.2 0.3 12.2 0.2 1.8 5.4 7.1 0.3 0.5 0.0 0.2 4.2 0.4 0.0 3.5 4.0 3.3 0.2 2.0 0.1 5.8 0.8 4.9 1.2 0.7 2.6 6.4 0.2 3.8 4.1 12.1 3.2 2.5 0.6 0.9 0.1 5.5 0.2 11.0 10.2 1.8 0.6 0.2 1.2 0.6 1.5 1.7 7.7 13.3 0.6 0.1 4.6 3.3 8.3 0.0 2.4 2.1 17.8 13.2 0.8 12.0 13.7 6.0 8.7 3.2 2.3 7.3 9.2 42.9 2.5 14.8 2.0 22.1 13.8 0.1 0.4 1.0 62.0 23.5 7.5 0.0 5.3 4.6 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.1 0.3 0.3 0.0 0.4 0.0 4.2 0.2 0.5 0.1 0.0 22.3 31.5 8.6 23.4 13.9 11.9 17.2 12.9 13.6 9.2 20.8 24.3 3.9 1.7 4.5 1.6 1.4 10.2 2.7 3.4 3.5 27.5 0.7 1.7 1.0 1.4 1.5 4.6 0.0 2.0 0.9 2.7 0.6 0.0 7.8 12.8 0.0 3.4 29.4 3.1 2.8 0.0 3.5 27.0 0.0 3.9 0.7 1.5 4.8 5.6 14.6 17.4 0.0 1.6 0.0 2.5 5.8 0.2 0.0 2.0 1.6 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 33.1;Late spermatids: 16.4;Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: AB_2681743" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.3 3.3 5.9 5.6 5.6 8.3 2.8 15.1 10.2 3.4 4.4 3.6 1.3 3.6 3.7 3.6 3.7 4.7 3.0 10.5 4.3 5.5 2.6 3.6 2.9 5.7 4.9 5.3 4.3 3.7 4.1 5.8 4.3 7.2 4.1 4.1 3.1 3.6 4.2 5.4 5.2 4.9 4.3 3.5 4.1 3.8 34.9 5.4 5.1 5.7 2.6 5.2 4.1 3.2 1.4 1.1 1.0 1.1 1.5 4.1 0.5 9.3 7.0 12.2 12.4 1.9 2.7 1.7 5.3 5.3 14.9 6.9 25.4 5.4 9.4 4.6 3.4 20.4 6.0 7.4 3.5 5.8 4.2 4.1 11.0 3.7 6.1 3.4 4.4 5.7 1.7 4.0 4.3 1.6 2.6 3.4 12.3 2.8 8.3 3.3 11.5 11.6 3.5 4.0 9.4 8.1 16.1 10.3 4.1 2.2 6.2 6.6 10.2 7.8 10.4 2.1 4.8 7.0 6.8 3.5 13.8 4.2 18.1 5.5 8.0 6.5 11.2 12.4 5.1 7.2 0.0 0.9 0.2 2.7 1.1 1.5 1.4 1.9 2.1 1.1 1.1 1.0 1.2 1.0 1.5 1.1 0.9 4.1 0.5 5.9 5.6 15.1 10.2 4.3 5.5 4.9 5.3 7.2 5.4 3.0 1.7 2.2 0.5 0.8 6.4 6.7 0.0 0.0 3.4 0.0 3.9 0.9 1.7 1.7 33.1 1.5 1.5 0.0 2.0 0.5 2.1 0.9 0.0 1.5 1.7 12.7 3.4 1.8 2.4 16.4 1.7 1.5 0.0 0.0 3.3 1.6 1.9 2.9 3.2 0.7 2.9 0.0 0.9 16.7 7.3 1.8 1.9 0.0 2.5 0.5 CABP1 ENSG00000157782 "Calcium binding protein 1" Q9NZU7 12 120640552-120667324 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 90.6" "Group enriched" "Detected in many" 8 "Bipolar cells: 128.1;Horizontal cells: 305.1" "Cancer enhanced" "Detected in some" "renal cancer: 2.2" "Region enhanced" "Detected in many" "cerebral cortex: 90.6" "Cell type enhanced" "Detected in single" "myeloid DC: 3.1" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.1" "Cell line enhanced" "Detected in some" "AF22: 3.9;NTERA-2: 9.3;RT4: 5.3;SCLC-21H: 4.4;U-87 MG: 11.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 177.9" HPA051438 Uncertain "Intracellular and membrane" NA NA "HPA051438: AB_2681486" "unprognostic (2.57e-1)" "unprognostic (4.79e-2)" "unprognostic (1.92e-4)" "unprognostic (1.16e-1)" "unprognostic (4.13e-3)" "unprognostic (6.28e-2)" "unprognostic (4.61e-2)" "unprognostic (2.85e-1)" "unprognostic (8.12e-3)" "unprognostic (7.59e-2)" "unprognostic (1.04e-2)" "unprognostic (6.60e-2)" "unprognostic (7.73e-3)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (3.61e-2)" "unprognostic (2.85e-1)" 9.0 2.0 26.2 1.0 18.1 0.4 1.1 13.1 90.6 1.8 2.0 0.3 0.2 1.1 2.6 3.6 1.7 2.0 1.3 3.7 29.3 5.7 8.9 0.5 0.9 0.6 6.7 18.4 1.2 0.9 3.7 1.0 1.4 3.5 1.9 1.9 1.0 0.8 3.9 2.6 0.8 1.4 2.5 2.5 1.0 1.6 0.9 0.0 0.0 0.6 0.0 0.6 2.1 0.6 0.0 3.1 0.5 0.4 0.0 0.0 0.2 0.2 0.7 3.9 1.2 0.0 0.1 0.0 0.1 0.4 0.2 0.2 0.3 0.0 0.0 0.6 0.0 1.6 0.3 3.4 0.0 0.2 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.4 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.3 0.4 0.1 9.3 2.9 0.6 2.3 0.0 0.0 3.7 5.3 4.4 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 11.9 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.0 0.2 26.2 18.1 13.1 90.6 29.3 5.7 6.7 18.4 3.5 0.0 0.0 0.0 0.0 0.2 0.1 128.1 1.6 0.0 0.0 0.0 1.8 0.0 0.1 26.6 0.0 1.5 3.0 0.0 0.0 0.0 0.2 1.4 0.3 0.0 0.0 0.2 305.1 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.4 8.2 0.0 0.0 2.1 2.2 10.1 19.4 13.3 0.2 1.9 0.3 0.2 0.0 0.0 0.1 CABP2 DFNB93 ENSG00000167791 "Calcium binding protein 2" Q9NPB3 11 67518912-67524517 "Disease related genes, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 10.7" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 54.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.9" "Region enriched" "Detected in single" 22 "cerebellum: 5.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.5 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CABP4 CSNB2B ENSG00000175544 "Calcium binding protein 4" P57796 11 67452406-67460313 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 12.6;lymphoid tissue: 12.3;retina: 26.9" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 217.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "non-classical monocyte: 12.6" "Lineage enriched" "Detected in single" 15 "monocytes: 12.6" "Cell line enriched" "Detected in some" 4 "HMC-1: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.24e-1)" "unprognostic (1.26e-1)" "unprognostic (4.23e-2)" "unprognostic (1.22e-2)" "unprognostic (3.78e-3)" "unprognostic (2.91e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.49e-1)" "unprognostic (1.44e-2)" "unprognostic (2.32e-3)" "unprognostic (2.57e-1)" "unprognostic (7.10e-4)" "unprognostic (5.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.10e-1)" "unprognostic (3.44e-3)" 2.2 1.0 2.0 0.6 0.8 0.3 2.2 0.4 1.0 2.5 0.8 1.3 3.0 1.1 0.9 3.6 0.6 0.9 1.3 1.7 0.9 0.7 1.1 1.4 2.6 4.9 1.6 1.0 0.4 0.9 0.1 0.3 2.9 1.4 2.3 0.8 26.9 1.5 1.6 3.0 0.8 1.6 0.6 1.2 12.3 2.7 0.5 0.4 0.4 1.6 0.5 0.6 1.0 0.5 0.3 0.5 0.8 12.6 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.0 3.8 0.1 0.0 0.0 22.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.3 1.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.6 0.1 0.1 0.2 0.9 0.3 0.1 0.1 0.2 0.5 0.3 0.1 0.1 0.8 0.2 12.6 0.1 0.0 0.1 2.0 0.8 0.4 1.0 0.9 0.7 1.6 1.0 1.4 0.4 0.0 0.3 1.9 1.1 0.8 13.3 1.6 5.1 1.4 0.0 5.2 133.5 0.1 0.0 1.3 0.2 2.1 0.0 0.0 1.3 0.2 0.2 1.5 0.0 0.0 3.1 12.7 0.0 4.3 5.4 0.0 0.3 1.4 1.7 0.0 0.3 15.1 1.1 0.0 0.0 0.3 217.8 0.0 0.4 0.0 0.2 0.3 0.7 0.0 0.0 1.0 CABP5 CaBP3 ENSG00000105507 "Calcium binding protein 5" Q9NP86 19 48029953-48044053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 53.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 87.0;Rod photoreceptor cells: 222.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.2" "Cell line enhanced" "Detected in single" "HBF TERT88: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA043698 Enhanced NA NA "HPA043698: AB_10797147" 0.0 0.1 0.1 0.0 0.2 2.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.2 0.2 0.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 53.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.2 0.0 0.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 9.9 0.1 0.2 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.0 0.3 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 222.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CABP7 MGC57793 ENSG00000100314 "Calcium binding protein 7" Q86V35 22 29720084-29731839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.3;pancreas: 9.6" "Cell type enriched" "Detected in some" 24 "Cardiomyocytes: 24.3" "Cancer enhanced" "Detected in some" "pancreatic cancer: 3.9" "Region enhanced" "Detected in all" "hippocampal formation: 30.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HEL: 12.7;SCLC-21H: 12.6;SH-SY5Y: 4.0;U-2 OS: 4.2" "Group enriched" "Detected in many" 5 "cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1" "Region enhanced" "Detected in all" "hippocampal formation: 65.6" HPA016439 Uncertain NA NA "HPA016439: AB_2669357" "unprognostic (1.88e-1)" "unprognostic (4.75e-2)" "unprognostic (1.18e-1)" "unprognostic (5.37e-2)" "unprognostic (4.55e-1)" "unprognostic (2.29e-4)" "unprognostic (2.05e-3)" "unprognostic (7.96e-2)" "unprognostic (8.69e-3)" "unprognostic (3.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.22e-1)" "unprognostic (7.44e-7)" "unprognostic (1.25e-4)" "unprognostic (3.60e-2)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" 0.4 6.0 2.7 0.5 2.6 0.8 0.3 7.2 6.5 0.3 0.5 1.2 0.0 1.5 0.3 1.8 0.7 0.4 0.5 0.3 30.3 2.0 0.3 0.3 0.4 0.5 3.9 1.2 0.4 9.6 0.3 0.1 0.3 16.9 0.4 0.5 2.4 0.8 0.4 0.6 1.0 3.8 0.4 4.1 0.5 0.4 1.2 2.8 0.0 0.7 0.0 0.3 0.4 0.0 0.6 0.6 1.8 1.6 0.5 1.4 0.6 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.7 12.7 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.4 0.0 0.0 12.6 4.0 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.2 4.2 0.1 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.8 1.8 0.8 1.3 0.5 0.6 1.1 0.5 0.6 0.4 1.0 1.4 1.3 0.5 1.6 0.6 0.5 0.6 2.7 2.6 7.2 3.0 30.3 2.0 3.9 1.2 16.9 2.8 0.0 0.0 0.0 0.0 0.0 0.2 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CABS1 "C4orf35, CLPH, FLJ32897, NYD-SP26" ENSG00000145309 "Calcium binding protein, spermatid associated 1" Q96KC9 4 70334966-70337116 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "testis: 75.3" "Group enriched" "Detected in some" 102 "Early spermatids: 1181.5;Late spermatids: 2745.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "NTERA-2: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044016, HPA055352" Enhanced NA NA "HPA044016: AB_10964494, HPA055352: AB_2682790" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1181.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2745.2 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 19.3 5.9 0.0 0.0 0.0 0.0 0.0 CABYR "CBP86, CT88, FSP-2" ENSG00000154040 "Calcium binding tyrosine phosphorylation regulated" O75952 18 24138956-24161603 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 91.1" "Group enriched" "Detected in some" 47 "Early spermatids: 2235.7;Late spermatids: 2707.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 6.3;memory B-cell: 6.6;naive B-cell: 7.1;neutrophil: 2.9" "Group enriched" "Detected in many" 5 "B-cells: 7.1;granulocytes: 6.3" "Cell line enhanced" "Detected in many" "SiHa: 18.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040703, HPA047801" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040703: AB_2677087, HPA047801: AB_2680159" "unprognostic (1.18e-3)" "unprognostic (4.18e-1)" "unprognostic (1.73e-1)" "unprognostic (2.65e-1)" "unprognostic (5.26e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (7.24e-3)" "unprognostic (1.58e-1)" "unprognostic (3.21e-4)" "unprognostic (2.52e-2)" "unprognostic (5.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 0.8 1.2 3.9 0.7 3.2 0.7 2.3 0.7 4.8 3.0 0.7 3.5 0.0 0.7 1.5 1.2 1.0 1.8 1.0 0.5 3.6 2.1 0.6 0.5 0.6 0.8 3.1 3.0 0.9 0.7 0.4 9.5 0.7 5.4 1.0 0.8 0.6 0.9 1.0 0.6 1.1 0.7 1.7 2.3 0.7 0.8 91.1 2.9 0.0 0.7 0.0 0.7 1.5 0.6 7.1 0.7 6.3 0.5 1.3 1.0 0.4 3.4 9.1 2.5 1.3 2.9 7.1 10.9 6.1 3.9 7.5 8.2 1.8 6.8 0.1 5.0 9.1 0.3 3.3 2.6 5.3 8.1 0.4 4.1 0.2 4.9 2.0 4.0 0.3 0.4 8.6 8.5 9.8 2.6 3.7 2.2 0.4 0.0 0.2 2.0 1.0 0.1 0.3 8.1 0.4 5.3 0.5 0.3 0.1 3.3 4.2 5.3 6.6 18.6 3.8 0.3 1.6 8.6 0.9 1.2 0.6 1.8 2.5 0.1 0.2 0.2 0.0 3.6 0.7 0.3 6.3 0.5 1.0 0.4 0.3 0.2 6.6 0.5 0.5 0.2 7.1 0.4 1.0 2.9 1.3 0.5 0.7 0.2 0.4 3.9 3.2 0.7 4.8 3.6 2.1 3.1 3.0 5.4 2.9 0.0 0.0 0.0 0.8 0.2 1.9 0.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.6 2235.7 0.0 0.0 0.0 0.2 0.4 0.4 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.0 2707.1 21.6 0.0 1.7 0.0 0.0 0.0 0.2 0.2 20.5 0.0 1.8 19.4 0.4 52.7 14.1 0.0 0.0 0.0 0.0 0.1 CACNA1A "APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6" ENSG00000141837 "Calcium voltage-gated channel subunit alpha1 A" O00555 19 13206442-13633025 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 77.9" "Group enriched" "Detected in many" 8 "Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 77.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SCLC-21H: 31.2;U-87 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064258, HPA068138, HPA071902" Enhanced Supported Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA064258: AB_2685229, HPA068138: , HPA071902: " "unprognostic (1.09e-1)" "unprognostic (3.73e-3)" "unprognostic (2.27e-1)" "unprognostic (2.78e-4)" "unprognostic (4.00e-2)" "unprognostic (2.29e-3)" "unprognostic (5.47e-2)" "unprognostic (3.13e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-2)" "prognostic favorable (4.32e-4)" "unprognostic (5.31e-3)" "unprognostic (5.03e-6)" "unprognostic (6.29e-2)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (6.25e-2)" 2.2 5.3 7.6 1.0 12.2 0.7 0.9 77.9 19.7 0.8 1.5 1.8 0.0 3.9 1.2 2.8 0.7 2.2 0.8 1.1 5.7 5.1 0.7 0.5 0.7 1.3 3.9 7.3 1.1 3.0 0.7 1.5 0.6 7.2 0.8 1.7 1.2 0.9 0.8 1.3 0.7 2.8 0.9 3.3 1.3 7.7 1.9 2.8 0.0 0.7 0.0 1.0 0.8 0.3 2.8 0.8 1.9 1.1 0.8 0.8 0.4 0.0 0.1 0.0 3.9 0.1 0.3 0.0 1.6 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.1 0.9 0.0 0.2 0.4 0.0 0.1 0.0 0.1 31.2 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.0 17.6 0.0 0.4 1.9 0.4 0.7 0.5 0.5 0.8 2.8 0.5 0.3 0.4 1.7 0.6 0.7 1.6 0.8 1.1 0.8 0.6 0.4 7.6 12.2 77.9 17.4 5.7 5.1 3.9 7.3 7.2 2.8 6.0 2.7 1.3 1.4 0.6 68.3 2.2 0.0 6.7 2.3 1.8 15.7 0.0 0.0 0.6 22.1 4.2 0.0 0.0 0.3 0.1 2.1 0.8 1.1 0.0 0.5 235.2 205.4 1.8 1.3 17.9 1.1 2.1 0.0 1.0 1.1 2.9 1.9 0.0 0.4 2.0 6.2 0.0 4.2 4.1 5.1 0.1 0.2 4.3 0.8 0.9 CACNA1B "CACNL1A5, CACNN, Cav2.2" ENSG00000148408 "Calcium voltage-gated channel subunit alpha1 B" Q00975 9 137877789-138124624 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 5.9;Horizontal cells: 6.4;Late spermatids: 3.6;Spermatocytes: 5.1;Spermatogonia: 9.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 21.2" "Low region specificity" "Detected in all" "HPA022919, HPA044347" Uncertain Approved Mitochondria NA NA Mitochondria "HPA022919: , HPA044347: AB_10960837" "unprognostic (1.34e-3)" "unprognostic (2.70e-2)" "unprognostic (8.08e-2)" "unprognostic (2.51e-7)" "unprognostic (8.10e-2)" "unprognostic (1.51e-2)" "unprognostic (1.33e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.36e-2)" "unprognostic (9.73e-4)" "unprognostic (5.98e-2)" "unprognostic (6.63e-6)" "unprognostic (4.25e-2)" "unprognostic (4.72e-1)" "unprognostic (7.77e-3)" "unprognostic (8.69e-2)" 0.5 6.2 5.7 0.7 8.7 0.5 0.5 18.7 18.9 1.2 0.8 0.2 0.0 0.6 0.6 1.7 0.4 6.6 1.4 1.0 4.5 7.3 0.4 1.2 0.5 0.5 2.9 9.1 0.5 1.2 0.4 4.8 0.4 3.6 1.6 0.8 0.4 0.4 1.3 0.4 0.9 0.7 0.8 4.5 0.6 0.6 8.1 1.4 0.0 0.9 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 4.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 8.7 18.7 10.9 4.5 7.3 2.9 9.1 3.6 1.4 0.0 0.0 0.0 0.0 0.0 5.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.0 0.0 2.4 0.0 0.0 0.4 0.0 1.5 0.0 0.0 5.1 9.3 0.0 0.0 0.0 0.0 0.0 CACNA1C "CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS" ENSG00000151067 "Calcium voltage-gated channel subunit alpha1 C" Q13936 12 1970786-2697950 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Host-virus interaction, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Brugada syndrome, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 32.5" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 284.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 4.2" "Group enriched" "Detected in many" 19 "NK-cells: 4.2;T-cells: 1.2" "Cell line enriched" "Detected in some" 17 "HDLM-2: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039796, CAB079031" Enhanced Approved NA NA "CAB079031: , HPA039796: AB_10673019" "unprognostic (1.76e-1)" "unprognostic (1.19e-1)" "unprognostic (6.29e-2)" "unprognostic (9.35e-2)" "unprognostic (3.71e-2)" "unprognostic (1.60e-2)" "unprognostic (4.68e-2)" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (1.03e-5)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-7)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (6.90e-2)" "unprognostic (3.39e-2)" 3.8 2.5 8.6 6.0 7.7 1.4 2.4 7.1 11.7 11.2 26.5 1.3 7.4 2.4 29.7 4.5 5.2 4.3 7.1 32.5 5.5 4.0 2.7 1.4 4.7 2.0 2.4 6.6 2.7 3.2 1.5 8.1 5.1 3.9 7.9 3.8 6.5 2.4 8.1 2.3 1.7 5.2 28.8 1.9 3.5 7.2 11.3 1.7 0.0 2.0 1.1 1.7 12.6 5.4 0.0 0.1 0.0 0.1 4.2 1.2 0.2 0.0 0.0 0.0 0.0 1.6 1.1 0.1 1.7 2.0 1.1 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 47.6 0.4 0.6 0.0 0.0 1.2 0.0 0.0 2.7 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.3 2.6 0.0 0.0 0.0 0.0 2.2 0.1 0.6 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.5 0.7 0.0 0.0 0.9 0.7 0.0 4.2 0.1 0.1 0.4 0.2 8.6 7.7 7.1 11.7 5.5 4.0 2.4 6.6 3.9 1.7 0.0 0.0 0.0 1.2 0.6 15.3 42.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 27.5 2.9 0.0 0.0 0.0 0.2 2.5 1.4 0.0 0.0 0.2 284.4 35.2 2.5 0.0 64.7 0.9 0.0 0.0 0.0 0.6 6.1 0.3 0.2 3.9 0.0 1.2 12.9 17.5 2.6 5.8 0.1 0.1 0.0 0.4 2.4 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell type enhanced" "Detected in single" 15 "Cardiomyocytes: 1.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.1 0.0 0.0 0.0 1.1 1.4 0.0 2.3 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 0.0 0.0 0.0 0.0 0.1 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 CACNA1F "AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2" ENSG00000102001 "Calcium voltage-gated channel subunit alpha1 F" O60840 X 49205063-49233371 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Sensory transduction, Transport, Vision" "Calcium channel, Ion channel, Voltage-gated channel" "Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "retina: 55.8" "Group enriched" "Detected in some" 15 "Bipolar cells: 66.5;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 91.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 2.8;U-266/70: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA068379 Enhanced NA NA "HPA068379: AB_2732782" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (4.25e-3)" "unprognostic (1.56e-2)" "unprognostic (8.46e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.04e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (6.08e-7)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.77e-3)" 0.7 0.8 1.8 0.7 1.5 4.0 1.8 5.3 2.0 0.7 1.0 0.7 0.7 1.9 0.7 2.7 0.7 1.0 0.7 0.7 0.8 0.6 0.7 0.7 1.4 2.7 0.7 0.7 0.7 1.4 0.0 0.7 0.7 0.7 0.7 1.5 55.8 1.2 0.9 0.7 2.4 3.7 0.7 0.7 1.8 1.0 0.7 0.7 0.7 1.2 0.7 0.9 0.7 0.7 1.4 4.6 2.0 0.9 0.5 1.0 0.2 0.2 2.5 0.2 0.0 0.6 0.0 2.5 0.4 0.2 0.0 0.0 0.1 0.9 1.4 0.5 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.5 0.6 0.1 0.8 0.6 0.0 0.4 0.0 0.2 0.8 0.8 1.0 0.3 0.0 2.8 1.3 1.5 1.1 1.9 0.0 0.1 0.0 0.5 0.4 1.5 0.6 0.0 0.0 0.1 0.0 0.9 0.9 1.5 1.0 0.2 0.3 0.3 0.1 4.6 1.6 0.1 0.8 0.4 0.0 0.9 0.7 0.6 0.6 0.5 0.5 0.7 0.8 0.4 0.8 1.4 0.5 1.0 2.0 0.5 0.9 4.6 0.7 0.2 1.8 1.5 5.3 2.0 0.8 0.6 0.7 0.7 0.7 0.7 0.0 0.3 0.0 0.1 0.0 66.5 1.2 0.0 0.0 0.0 1.8 125.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.3 5.5 0.0 0.0 0.4 0.0 91.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 CACNA1G "Cav3.1, NBR13" ENSG00000006283 "Calcium voltage-gated channel subunit alpha1 G" O43497 17 50561068-50627474 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.8;cervix, uterine: 13.6" "Cell type enriched" "Detected in some" 26 "Bipolar cells: 147.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 13.4;GAMG: 5.0;HeLa: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004714 Uncertain NA NA "HPA004714: AB_1078368" "unprognostic (1.90e-2)" "unprognostic (5.83e-2)" "unprognostic (2.85e-2)" "unprognostic (1.08e-1)" "unprognostic (4.00e-1)" "unprognostic (9.89e-2)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.02e-4)" "unprognostic (1.47e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (4.87e-12)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.56e-3)" "unprognostic (6.63e-2)" 1.7 1.0 3.5 0.9 5.2 1.3 2.1 22.8 17.1 13.6 1.0 2.7 0.0 0.9 7.4 1.0 1.6 5.7 1.2 3.8 2.4 8.8 0.7 1.1 0.9 1.2 5.3 7.9 7.1 0.6 0.6 0.4 1.4 6.1 2.5 0.8 4.3 1.1 1.6 0.8 3.9 0.8 2.1 5.9 0.9 0.9 1.7 2.3 0.0 1.2 0.0 1.0 1.0 3.9 1.3 1.3 2.7 0.8 0.7 1.4 0.0 0.0 13.4 3.1 3.5 0.9 0.1 0.2 0.1 0.0 0.1 0.2 2.8 0.5 0.0 1.0 0.1 5.0 0.5 1.6 0.0 0.3 1.8 0.6 0.9 4.6 0.7 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.1 0.7 0.0 0.0 1.2 1.0 0.8 1.4 1.1 0.0 0.0 0.2 4.1 1.8 2.8 0.1 0.0 2.4 0.2 0.1 0.3 1.4 3.9 0.5 0.1 1.0 0.1 0.0 0.6 0.1 0.5 0.5 0.8 0.6 1.4 0.4 0.7 0.8 0.7 0.8 0.2 1.3 0.9 1.0 2.7 0.7 0.4 1.3 0.5 0.0 3.5 5.2 22.8 17.1 2.4 8.8 5.3 7.9 6.1 2.3 0.0 0.0 0.0 0.1 1.6 147.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 3.6 0.4 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.7 0.0 3.6 0.3 0.2 2.5 0.1 0.0 0.0 0.0 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153121-1221772 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 49.5" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favorable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 5.0 6.8 5.1 4.2 12.0 0.3 3.3 0.3 4.3 17.5 28.1 1.6 10.2 5.4 25.7 5.9 16.3 11.7 26.0 2.2 2.5 2.1 4.7 5.5 3.5 0.7 1.0 2.8 31.8 2.1 6.6 14.8 1.9 2.0 21.0 2.2 4.2 1.7 24.9 2.9 4.8 8.5 49.5 1.1 0.5 9.7 11.7 2.1 0.0 5.2 1.4 0.5 34.6 20.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 10.9 1.9 15.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 6.5 1.9 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 1.9 2.9 0.0 0.0 28.9 0.0 0.0 5.9 9.6 2.2 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.7 8.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.0 0.3 4.3 2.5 2.1 1.0 2.8 2.0 2.1 0.0 0.0 0.0 0.0 1.3 16.2 1.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 1.2 0.0 0.0 0.0 0.0 0.2 3.3 4.6 8.1 0.1 0.0 10.4 0.6 0.0 13.2 7.8 0.0 0.0 0.0 0.3 0.8 0.7 0.0 24.4 0.8 1.0 25.8 16.5 1.8 4.5 3.0 0.0 0.0 0.0 0.5 CACNA1I Cav3.3 ENSG00000100346 "Calcium voltage-gated channel subunit alpha1 I" Q9P0X4 22 39570753-39689737 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 18.4" "Cancer enhanced" "Detected in single" "thyroid cancer: 2.1" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;SK-BR-3: 6.1;T-47d: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.60e-2)" "unprognostic (3.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-1)" "unprognostic (7.21e-2)" "unprognostic (5.20e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-2)" "unprognostic (6.14e-3)" "unprognostic (1.57e-1)" "unprognostic (3.78e-2)" "unprognostic (8.27e-4)" 0.0 4.6 3.4 1.9 5.8 1.3 0.2 8.1 7.5 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.0 5.0 3.6 0.0 0.0 0.2 4.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.4 1.3 0.5 1.1 4.1 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 6.1 0.0 0.4 3.6 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.5 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 18.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CACNA1S "CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5" ENSG00000081248 "Calcium voltage-gated channel subunit alpha1 S" Q13698 1 201039512-201112566 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 83.1" "Cell type enhanced" "Detected in some" 21 "Cardiomyocytes: 1.4;Cone photoreceptor cells: 5.9;Early spermatids: 1.4;Late spermatids: 3.3;Rod photoreceptor cells: 1.2" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "BEWO: 5.5;HSkMC: 7.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 13 "olfactory region: 5.3" "CAB009507, HPA048892, HPA056815" Enhanced NA NA "CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242" "unprognostic (2.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.52e-3)" "unprognostic (4.53e-2)" "unprognostic (2.84e-1)" "unprognostic (2.23e-1)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (4.72e-3)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (7.36e-2)" "unprognostic (1.57e-1)" 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.0 83.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CACNA2D1 "CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3" ENSG00000153956 "Calcium voltage-gated channel auxiliary subunit alpha2delta 1" P54289 7 81946444-82443798 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.0" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 89.3;Early spermatids: 53.8;Intestinal endocrine cells: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 49.0;HUVEC TERT2: 20.6;SH-SY5Y: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008213, HPA008621" Enhanced "Intracellular and membrane" NA NA 310000000 "HPA008213: AB_1233654, HPA008621: AB_1845863" "unprognostic (5.07e-3)" "unprognostic (2.21e-1)" "unprognostic (4.27e-3)" "unprognostic (2.92e-2)" "unprognostic (2.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.70e-1)" "unprognostic (3.22e-1)" "unprognostic (3.76e-1)" "unprognostic (2.05e-1)" "unprognostic (6.24e-3)" "unprognostic (2.23e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (4.28e-3)" "unprognostic (2.13e-1)" "unprognostic (9.18e-2)" "unprognostic (1.03e-4)" 9.9 13.4 15.7 4.2 18.1 0.7 4.3 8.8 20.8 5.7 11.3 7.3 1.0 5.0 7.1 2.9 5.4 4.1 6.3 25.8 12.7 14.9 8.0 1.8 3.6 2.2 6.3 15.6 7.8 2.0 1.9 8.3 4.2 8.6 12.8 5.3 1.9 3.3 6.6 59.0 4.7 3.5 13.0 5.6 4.3 5.5 3.7 8.0 0.0 16.9 14.6 3.3 6.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 4.0 0.0 7.1 9.0 0.0 8.7 5.6 4.3 4.3 0.0 1.3 0.0 0.0 7.5 5.4 0.0 4.2 0.0 5.7 0.0 5.6 0.2 5.6 0.0 4.6 1.9 0.0 5.3 0.0 15.1 0.0 49.0 20.6 0.0 0.0 0.0 9.7 0.0 0.0 0.0 4.7 0.0 1.8 0.8 0.8 0.0 0.3 0.3 8.0 23.9 1.7 0.0 0.0 4.4 0.0 0.0 14.7 7.7 5.8 7.6 0.0 0.0 0.0 0.0 6.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 18.1 8.8 20.8 12.7 14.9 6.3 15.6 8.6 8.0 0.0 1.7 0.0 4.0 5.0 30.7 89.3 0.0 1.4 2.3 7.0 17.7 0.0 0.0 0.0 53.8 9.0 0.0 0.0 0.0 0.0 11.0 11.4 24.3 0.0 0.2 23.8 37.2 1.3 0.0 25.0 9.5 0.4 1.7 1.0 0.2 5.8 0.6 0.0 5.6 9.9 6.0 6.5 17.6 1.0 2.3 5.6 0.1 0.0 0.0 1.4 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362799-50504244 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 86.1" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 145.9" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles NA NA 1000000 Vesicles "HPA034771: AB_10603555, HPA071829: AB_2686454" "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.9 1.6 1.3 11.1 1.1 1.4 14.9 6.5 1.1 1.7 0.9 0.6 1.4 1.7 1.2 0.9 1.1 0.9 7.6 1.7 9.1 1.6 0.5 86.1 1.3 3.9 3.2 2.2 4.0 3.8 6.0 1.9 6.1 3.0 2.0 6.1 1.5 1.4 1.7 2.6 1.7 1.4 1.4 1.5 4.1 5.8 2.5 0.2 2.3 0.1 0.7 0.7 0.7 1.8 0.3 0.7 0.1 2.3 3.6 1.1 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 8.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 6.4 66.5 0.2 0.1 0.0 2.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.2 0.0 2.7 1.8 2.6 2.0 0.0 1.3 3.6 2.2 0.0 2.3 0.1 0.3 3.2 1.1 1.6 11.1 14.9 6.5 1.7 9.1 3.9 3.2 6.1 2.5 71.5 145.9 0.0 0.3 1.3 7.2 3.0 0.0 4.0 4.5 1.8 19.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.7 19.7 0.0 0.1 0.0 1.2 0.6 0.0 2.3 0.3 0.0 0.0 0.0 3.5 4.0 0.6 0.0 1.8 0.4 10.0 12.9 0.8 1.6 11.1 0.5 0.2 1.0 0.4 0.3 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;skeletal muscle: 19.5" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 28.9;Early spermatids: 77.9;Late spermatids: 41.2;Syncytiotrophoblasts: 56.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.2;HAP1: 2.8;HeLa: 14.0" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm NA NA 49000 Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 1.5 10.3 6.4 1.3 21.9 1.0 1.5 2.4 23.2 1.5 2.0 1.4 0.2 1.4 1.4 4.0 2.1 2.1 1.6 5.1 8.9 8.0 3.8 1.1 2.2 2.2 4.8 12.8 6.7 1.2 1.1 2.4 2.1 9.0 3.4 1.7 2.4 1.9 4.4 19.5 1.2 1.7 2.4 1.7 1.6 1.9 3.9 4.2 0.0 2.1 3.6 2.1 1.0 2.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 1.7 0.2 14.0 0.0 0.8 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 6.4 21.9 2.4 16.1 8.9 8.0 4.8 12.8 9.0 4.2 0.0 0.0 0.0 0.3 0.2 9.8 28.9 0.0 1.4 1.2 0.0 7.9 8.4 6.6 0.0 77.9 0.1 0.0 0.0 0.6 2.3 2.4 0.2 0.0 0.0 5.4 0.0 0.0 0.6 7.9 41.2 2.6 10.3 0.0 0.0 0.0 4.3 0.8 0.0 1.4 0.1 1.3 6.5 1.9 5.0 2.2 0.1 56.9 0.0 0.0 0.4 CACNA2D4 ENSG00000151062 "Calcium voltage-gated channel auxiliary subunit alpha2delta 4" Q7Z3S7 12 1791957-1918836 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 47.0" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 147.3;Early spermatids: 53.8;Late spermatids: 92.6;Rod photoreceptor cells: 96.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 4.5;monocytes: 6.6;T-cells: 6.7" "Cell line enhanced" "Detected in some" "Hep G2: 5.4;HL-60: 3.2;HMC-1: 17.0;NB-4: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA031952 Uncertain NA NA "HPA031952: AB_10600798" "unprognostic (5.04e-2)" "unprognostic (2.82e-2)" "unprognostic (5.32e-1)" "unprognostic (7.50e-2)" "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.10e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-1)" "unprognostic (3.30e-3)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (1.62e-5)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.04e-1)" "unprognostic (2.13e-1)" 1.8 0.7 0.6 2.2 0.9 2.2 0.8 0.1 1.1 1.4 0.8 0.6 0.2 2.3 1.1 0.5 0.8 0.3 1.6 1.6 0.8 0.5 1.5 0.3 1.4 2.2 1.2 0.2 0.4 1.5 0.1 3.9 2.1 1.0 0.7 0.3 47.0 0.7 0.5 0.2 0.2 1.4 1.5 1.3 2.2 0.6 1.7 0.7 1.2 0.5 0.9 1.4 2.3 0.5 0.0 4.5 0.2 6.6 0.6 6.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 5.4 0.3 3.2 17.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 6.6 0.0 3.5 2.4 6.7 0.0 1.6 2.5 4.5 0.0 0.9 0.5 0.2 0.6 0.7 0.2 0.9 2.3 0.6 0.9 0.1 1.1 0.8 0.5 1.2 0.2 1.0 0.7 0.0 3.4 2.4 0.6 0.8 44.5 0.7 5.1 1.4 1.2 0.0 147.3 0.1 0.0 0.5 53.8 0.6 3.2 0.0 0.4 0.2 1.4 0.2 15.0 0.8 21.9 0.0 1.2 1.8 30.8 92.6 0.9 23.8 3.3 3.6 2.5 3.2 0.2 2.9 0.4 0.9 96.3 0.0 1.2 9.2 3.2 0.5 0.1 11.8 4.3 0.2 CACNB1 CACNLB1 ENSG00000067191 "Calcium voltage-gated channel auxiliary subunit beta 1" Q02641 17 39173456-39197703 "FDA approved drug targets, Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 130.9" "Cell type enhanced" "Detected in many" 7 "Melanocytes: 5.0;Muller glia cells: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023343 Approved NA NA "HPA023343: AB_1845866" "unprognostic (3.44e-2)" "unprognostic (1.89e-2)" "unprognostic (1.69e-3)" "prognostic unfavorable (3.80e-4)" "unprognostic (3.99e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-2)" "unprognostic (2.80e-3)" "unprognostic (4.43e-1)" "unprognostic (1.04e-3)" "unprognostic (5.98e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-11)" "unprognostic (7.62e-2)" "unprognostic (2.30e-1)" "unprognostic (1.34e-2)" "unprognostic (7.44e-3)" 2.0 2.4 7.8 2.2 14.9 1.6 2.0 5.4 22.0 3.3 2.3 2.0 6.0 1.7 2.3 3.7 4.2 2.3 2.0 2.8 8.6 6.4 1.3 1.1 3.0 2.1 3.3 11.0 2.6 1.4 1.6 2.0 1.8 7.6 3.6 2.2 0.8 3.4 5.7 130.9 5.8 1.7 2.4 1.9 2.0 1.8 2.3 2.1 1.7 2.0 7.3 1.8 1.8 1.6 0.1 3.1 0.1 1.2 1.8 3.2 0.8 6.0 2.7 3.4 7.9 3.9 4.7 0.1 3.7 4.5 3.5 4.3 2.0 6.2 10.5 3.8 5.4 4.9 5.7 3.3 6.0 2.6 5.0 3.8 1.5 6.5 0.8 7.9 0.3 1.0 5.2 2.0 7.2 8.2 4.5 2.4 6.6 0.9 9.2 3.6 1.7 7.5 2.7 2.4 0.9 2.0 5.1 11.4 4.6 1.4 2.0 8.6 5.3 2.1 11.6 3.5 1.3 8.2 4.1 3.4 6.2 7.2 4.6 3.6 4.3 1.4 1.7 5.1 0.0 2.5 0.0 1.2 0.0 2.0 0.6 3.2 0.1 1.9 2.6 0.5 0.1 0.6 1.2 0.1 1.8 0.3 3.1 0.5 0.8 7.8 14.9 5.4 22.0 8.6 6.4 3.3 11.0 7.6 2.1 3.0 2.7 0.0 0.5 2.6 2.4 1.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.5 2.4 1.0 0.0 0.0 0.8 0.1 2.5 1.2 0.0 0.0 0.9 0.0 0.0 0.6 0.6 1.7 1.7 1.0 5.0 0.0 1.0 8.3 1.2 0.0 1.1 0.0 1.1 0.0 2.5 1.0 1.1 2.6 0.1 1.0 0.6 0.7 CACNB3 CACNLB3 ENSG00000167535 "Calcium voltage-gated channel auxiliary subunit beta 3" P54284 12 48813794-48828941 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.7" "Lineage enriched" "Detected in single" 9 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "U-937: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059515 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA059515: AB_2684047" "unprognostic (1.77e-2)" "unprognostic (4.84e-2)" "unprognostic (2.16e-3)" "unprognostic (2.12e-2)" "unprognostic (8.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.06e-1)" "unprognostic (3.60e-2)" "unprognostic (3.27e-2)" "unprognostic (2.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.04e-1)" "unprognostic (5.44e-3)" "unprognostic (6.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" 3.8 3.7 27.4 2.9 22.4 1.2 4.2 18.5 42.9 11.9 9.1 1.5 3.0 3.8 22.6 8.1 11.6 16.1 6.7 2.6 16.4 12.2 3.9 1.3 6.1 1.7 10.0 14.5 24.1 2.1 2.8 4.2 5.3 4.4 5.7 7.8 3.4 4.5 9.1 2.1 7.8 5.8 20.4 2.4 2.2 4.7 4.7 2.3 4.6 6.1 3.4 3.6 7.5 6.9 0.2 0.5 0.0 0.3 0.0 4.7 0.5 6.6 5.3 8.9 18.2 10.9 7.7 5.4 6.8 14.5 10.2 6.0 1.7 5.5 0.8 9.0 11.5 1.7 7.1 8.1 7.5 3.8 7.8 2.4 3.5 4.3 0.2 4.3 0.6 3.9 4.9 4.5 4.2 2.1 28.4 11.6 7.4 0.4 2.8 6.5 16.6 8.3 0.9 5.5 6.9 4.5 9.5 2.0 2.6 7.4 12.6 12.7 12.5 2.1 15.2 5.0 7.5 10.4 2.9 11.0 6.5 9.2 3.1 3.7 3.3 1.3 0.2 5.4 44.2 2.0 0.0 0.3 0.0 0.9 0.1 0.4 0.2 1.8 1.8 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.4 4.7 0.5 27.4 22.4 18.5 42.9 16.4 12.2 10.0 14.5 4.4 2.3 3.0 7.0 0.0 3.1 2.6 1.0 2.4 0.0 2.7 2.3 1.8 3.9 0.5 1.7 8.6 0.7 3.1 8.4 0.0 3.7 9.3 6.6 2.8 1.1 0.0 1.5 0.0 9.8 3.1 0.6 1.8 12.4 2.3 1.7 5.4 9.1 0.9 8.5 5.8 10.3 0.6 1.0 0.0 10.8 0.5 5.9 4.4 0.9 4.4 11.7 1.4 CACNB4 EJM4 ENSG00000182389 "Calcium voltage-gated channel auxiliary subunit beta 4" O00305 2 151832768-152099475 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.7" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 38.2;Glandular cells: 25.1;Horizontal cells: 19.1" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in all" 4 "basal ganglia: 28.0;cerebellum: 35.7;cerebral cortex: 21.7;olfactory region: 10.9;pons and medulla: 9.8" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.0" "Cell line enriched" "Detected in some" 4 "HMC-1: 21.2" HPA015601 Approved NA NA "HPA015601: AB_1845873" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" "unprognostic (3.70e-1)" "unprognostic (9.42e-4)" "unprognostic (1.23e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.55e-2)" "unprognostic (7.26e-3)" "unprognostic (3.93e-2)" "unprognostic (9.55e-3)" "unprognostic (2.45e-1)" 1.6 1.7 5.2 1.3 28.0 1.7 3.2 35.7 28.0 1.4 1.2 2.6 0.0 1.2 1.4 1.7 3.1 1.1 2.1 1.1 4.5 4.4 2.8 0.9 3.9 1.1 4.3 10.9 1.3 1.2 1.0 3.8 2.1 9.8 3.9 1.4 0.9 2.1 3.9 0.8 11.7 1.1 4.2 3.0 1.2 1.6 4.1 3.4 0.0 3.1 0.0 2.2 3.5 0.8 0.4 1.3 7.0 0.6 0.2 0.1 0.1 0.0 0.0 0.7 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.9 0.0 2.0 0.0 0.1 0.3 3.3 0.0 0.2 4.1 0.0 0.2 21.2 0.2 0.1 0.4 0.0 1.6 0.0 0.8 0.0 0.5 0.2 0.0 0.2 0.3 0.5 0.1 0.6 1.8 0.2 0.6 1.2 0.6 1.4 0.8 0.0 0.0 0.0 0.1 3.4 0.9 0.0 1.9 2.2 0.7 0.4 0.4 0.0 0.0 0.5 4.9 0.1 1.2 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.4 0.1 0.1 7.0 0.2 0.0 1.3 0.0 0.1 5.2 28.0 35.7 21.7 4.5 4.4 4.3 10.9 9.8 3.4 11.9 38.2 0.8 10.5 11.0 3.1 0.9 0.0 1.4 5.7 3.5 3.9 0.1 3.3 0.3 0.8 0.6 0.0 0.0 1.3 0.0 3.9 25.1 0.0 0.0 2.6 19.1 0.0 0.6 0.8 1.7 3.1 2.4 1.7 0.0 0.0 1.9 1.2 0.0 4.2 0.6 3.3 0.0 0.7 0.5 0.0 7.2 0.0 0.7 0.0 12.2 CACNG1 CACNLG ENSG00000108878 "Calcium voltage-gated channel auxiliary subunit gamma 1" Q06432 17 67044590-67056797 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 126.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HSkMC: 8.3;SH-SY5Y: 2.6" "Region enriched" "Detected in single" 6 "basal ganglia: 3.0" "Not detected" "Not detected" NA NA "unprognostic (1.76e-1)" "unprognostic (9.83e-3)" "unprognostic (1.75e-5)" "unprognostic (2.60e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.84e-3)" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (3.03e-1)" "unprognostic (1.94e-1)" 5.7 0.4 0.3 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 126.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.7 25.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG2 "MGC138502, MGC138504, stargazin" ENSG00000166862 "Calcium voltage-gated channel auxiliary subunit gamma 2" Q9Y698 22 36563921-36703558 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 30.7" "Group enriched" "Detected in some" 5 "Bipolar cells: 10.8;Horizontal cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "SCLC-21H: 7.8;SH-SY5Y: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.54e-2)" "unprognostic (3.06e-1)" "unprognostic (8.80e-3)" "unprognostic (2.34e-2)" "unprognostic (3.07e-2)" 0.7 2.7 5.6 0.8 6.4 0.9 0.7 30.7 21.9 0.6 0.7 0.3 0.0 0.8 0.6 0.6 0.7 0.6 0.6 0.6 3.8 4.7 0.7 0.7 0.7 0.7 2.9 7.8 0.6 1.1 0.6 2.7 0.7 6.9 0.7 0.7 0.1 0.6 0.6 1.0 0.8 0.8 0.7 1.7 0.7 0.7 1.0 0.8 0.0 0.7 0.0 0.6 0.7 0.1 0.3 1.0 1.0 0.3 0.3 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 7.8 3.5 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.3 0.2 0.0 0.3 0.4 0.4 1.0 0.3 0.2 1.0 0.2 0.1 5.6 6.4 30.7 12.3 3.8 4.7 2.9 7.8 6.9 0.8 0.0 0.0 0.0 0.1 0.0 10.8 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG3 ENSG00000006116 "Calcium voltage-gated channel auxiliary subunit gamma 3" O60359 16 24255553-24362801 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 32.2" "Cell type enriched" "Detected in some" 46 "Horizontal cells: 166.8" "Cancer enriched" "Detected in single" 15 "glioma: 0.7" "Group enriched" "Detected in many" 6 "amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077238 Enhanced NA NA "HPA077238: " "unprognostic (5.61e-2)" "unprognostic (3.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.17e-1)" 0.4 1.8 12.8 0.4 13.1 0.5 0.3 0.2 32.2 0.3 0.4 0.1 0.0 0.3 0.3 0.4 0.3 0.4 0.3 0.3 12.7 2.2 0.3 0.4 0.3 0.4 1.8 2.3 0.4 0.3 0.3 0.0 0.4 0.3 0.4 0.4 0.1 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.4 0.4 0.6 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.2 0.9 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.8 13.1 0.2 20.0 12.7 2.2 1.8 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.8 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 97.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 3.9 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 10.3 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 3.9 1.7 0.0 0.0 0.1 2.1 0.0 2.7 3.9 97.2 0.9 2.5 0.0 10.0 9.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 3.0 2.2 0.0 1.1 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.2 3.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 CACNG5 ENSG00000075429 "Calcium voltage-gated channel auxiliary subunit gamma 5" Q9UF02 17 66835117-66885486 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 6.5;lymphoid tissue: 3.3;retina: 8.8" "Cell type enriched" "Detected in single" 17 "Horizontal cells: 4.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.6;SuSa: 1.3;THP-1: 1.6" "Region enhanced" "Detected in all" "olfactory region: 152.3" "Low region specificity" "Detected in all" HPA050115 Uncertain NA NA "HPA050115: AB_2681022" "unprognostic (1.85e-3)" "unprognostic (3.84e-2)" "unprognostic (1.44e-1)" "unprognostic (2.46e-6)" "unprognostic (4.52e-2)" "unprognostic (1.29e-1)" 0.3 0.3 2.7 0.7 2.6 0.3 0.3 1.7 6.5 0.4 0.7 6.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.4 2.1 2.0 1.0 0.3 0.3 3.3 1.1 2.3 0.3 0.7 0.3 0.8 0.3 0.7 0.5 0.5 8.8 0.3 0.3 0.3 0.4 0.7 0.3 1.7 1.3 0.3 0.7 3.8 0.0 0.3 0.0 3.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 3.6 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.6 1.7 6.5 2.1 2.0 1.1 2.3 0.7 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53992288-54012669 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 11.4;skeletal muscle: 45.4" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 5.3;Horizontal cells: 1.6;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 96 "basophil: 11.4;eosinophil: 7.8" "Lineage enriched" "Detected in single" 114 "granulocytes: 11.4" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 22.3;HHSteC: 5.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.2 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.4 0.0 45.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 12.7 0.3 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 1.1 0.0 22.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.8 0.0 0.1 0.1 0.0 0.0 0.0 2.1 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.2 1.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.9 0.0 2.6 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.0 11.4 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 CACNG7 ENSG00000105605 "Calcium voltage-gated channel auxiliary subunit gamma 7" P62955 19 53909335-53943941 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "brain: 54.4" "Cell type enriched" "Detected in some" 17 "Horizontal cells: 127.1" "Cancer enriched" "Detected in some" 16 "glioma: 29.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.8;GAMG: 7.5;HMC-1: 20.9;hTERT-RPE1: 26.3;SH-SY5Y: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.11e-2)" "unprognostic (7.18e-2)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (1.01e-5)" "unprognostic (1.51e-1)" "unprognostic (7.36e-2)" 1.2 1.8 22.2 1.3 15.6 1.2 1.2 22.7 54.4 1.2 1.3 8.3 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 21.4 13.7 1.2 1.2 1.3 1.2 16.5 10.3 1.2 1.3 1.2 1.8 1.2 9.9 1.2 1.2 0.3 1.2 1.3 1.2 1.2 1.4 1.3 13.5 1.2 1.3 1.5 4.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 26.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 20.9 0.2 0.0 0.0 0.0 26.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 1.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 15.6 22.7 25.9 21.4 13.7 16.5 10.3 9.9 4.5 0.0 0.0 0.0 0.0 0.0 7.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 CACNG8 ENSG00000142408 "Calcium voltage-gated channel auxiliary subunit gamma 8" Q8WXS5 19 53963040-53990215 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 7.9;brain: 22.8" "Cell type enriched" "Detected in many" 7 "Horizontal cells: 47.7" "Cancer enriched" "Detected in single" 5 "glioma: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4" "Cell type enriched" "Detected in some" 7 "basophil: 7.9" "Lineage enriched" "Detected in single" 17 "granulocytes: 7.9" "Group enriched" "Detected in some" 5 "AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041351 Enhanced NA NA "HPA041351: AB_10796666" "unprognostic (7.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.06e-1)" "unprognostic (5.29e-4)" "unprognostic (9.66e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (9.40e-3)" "unprognostic (6.13e-2)" "unprognostic (2.03e-1)" "unprognostic (7.63e-2)" "unprognostic (2.58e-1)" "unprognostic (2.82e-8)" "unprognostic (1.10e-1)" "unprognostic (1.35e-1)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" 0.4 0.4 9.4 0.4 9.1 0.6 0.4 0.7 22.8 0.3 0.3 2.1 0.0 0.4 0.5 0.4 0.3 0.4 0.4 0.3 20.3 5.4 0.3 0.3 0.4 0.4 2.3 2.0 0.4 0.3 0.5 0.0 0.3 1.5 0.4 0.4 0.0 0.4 0.3 0.9 0.7 0.4 0.4 0.9 0.4 0.6 1.5 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 7.9 0.2 0.3 0.3 0.1 0.0 2.1 6.4 0.2 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.9 2.4 0.5 0.0 1.0 0.0 21.3 0.3 0.0 0.0 0.2 7.6 2.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.1 0.1 0.0 0.2 0.2 0.0 13.0 0.1 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.1 7.9 0.2 1.1 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.3 0.1 0.1 9.4 9.1 0.7 13.6 20.3 5.4 2.3 2.0 1.5 0.0 0.0 0.0 0.0 1.0 1.4 0.9 2.8 0.0 4.0 1.2 1.8 0.0 0.0 0.0 1.4 0.4 1.9 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 47.7 0.0 3.1 1.5 1.1 0.0 0.0 0.0 0.0 0.4 1.0 0.1 0.0 0.4 0.0 1.5 0.0 0.8 5.0 6.4 1.0 0.1 0.0 0.5 1.0 CACYBP "S100A6BP, SIP" ENSG00000116161 "Calcyclin binding protein" Q9HB71 1 174999163-175011715 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 117.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025753, HPA057038" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA025753: AB_1845878, HPA057038: AB_2683318" "unprognostic (4.70e-3)" "unprognostic (9.92e-2)" "unprognostic (5.55e-2)" "unprognostic (2.22e-1)" "unprognostic (1.25e-1)" "unprognostic (8.96e-3)" "prognostic unfavorable (1.12e-6)" "unprognostic (1.50e-2)" "unprognostic (2.03e-2)" "prognostic favorable (1.39e-5)" "unprognostic (4.55e-2)" "unprognostic (1.87e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.41e-1)" "unprognostic (4.44e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" 15.1 15.9 38.3 20.3 39.7 24.6 36.2 36.1 46.5 16.0 16.7 10.7 12.5 13.3 14.0 22.5 13.9 15.6 12.7 13.0 36.9 39.1 23.4 18.5 13.3 25.2 33.8 22.8 26.5 10.1 21.4 17.2 19.1 33.1 17.0 18.6 7.9 11.8 17.2 29.8 12.6 14.0 14.4 29.0 13.3 11.7 23.3 27.5 16.2 19.1 12.6 23.9 16.6 117.2 26.7 20.1 17.3 30.2 25.3 29.0 25.8 30.3 21.0 30.9 13.2 10.3 11.6 19.9 23.3 13.8 30.2 22.1 21.6 19.0 32.0 24.3 16.5 21.7 16.6 38.5 17.0 31.3 16.9 23.5 24.0 20.7 23.1 7.8 32.2 15.1 7.8 10.5 24.8 15.0 15.6 21.2 28.8 48.0 18.0 21.7 11.3 49.5 29.5 29.4 45.8 9.8 22.4 22.0 36.9 21.5 24.3 21.3 20.5 15.8 27.7 24.0 43.6 21.5 28.2 10.9 17.2 18.4 24.0 37.3 17.4 50.0 71.0 14.4 28.3 19.9 17.3 16.1 15.9 19.0 24.4 22.1 26.7 27.5 23.0 20.1 20.4 29.0 25.7 8.7 25.3 30.2 16.6 28.5 25.8 38.3 39.7 36.1 46.5 36.9 39.1 33.8 22.8 33.1 27.5 80.4 34.1 105.0 107.7 103.9 56.2 89.6 38.2 80.3 52.4 33.2 58.9 184.6 129.3 83.6 75.6 64.3 63.7 23.3 82.6 245.4 120.8 92.6 91.1 35.8 172.4 28.6 114.6 40.5 47.3 21.9 79.7 120.6 102.9 341.8 42.9 55.2 88.9 53.2 69.3 119.5 79.1 32.3 106.6 100.9 149.2 74.9 120.0 115.4 82.3 81.3 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958981-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 214.8;Cone photoreceptor cells: 488.9;Rod photoreceptor cells: 463.1" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 5.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.0" "Cell line enhanced" "Detected in some" "AF22: 6.4;AN3-CA: 18.4;U-266/70: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced NA NA 350000 "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 5.8 6.3 33.5 2.1 22.7 1.7 3.6 44.8 52.7 2.3 3.0 7.0 0.0 2.0 2.0 2.2 2.7 4.6 2.6 4.2 28.6 11.7 1.9 2.5 2.2 1.8 16.3 31.0 2.3 2.4 3.0 5.5 1.9 24.2 3.4 2.7 8.8 2.3 6.2 4.9 2.0 2.6 2.1 14.0 2.0 3.2 2.2 20.5 0.0 2.1 0.0 1.8 2.0 1.1 1.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 2.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 22.7 44.8 49.5 28.6 11.7 16.3 31.0 24.2 20.5 0.0 0.6 0.0 0.3 0.9 214.8 4.4 0.0 0.0 1.2 0.0 488.9 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.1 1.0 0.7 0.0 0.0 0.3 89.0 1.7 4.9 0.0 1.7 1.7 0.0 3.3 0.0 0.0 62.5 0.2 0.0 0.4 0.0 463.1 0.0 0.8 0.4 1.1 0.9 0.0 0.0 0.0 0.3 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.5;placenta: 43.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 103.2;Fibroblasts: 46.4;Horizontal cells: 33.4;Melanocytes: 23.6;Muller glia cells: 35.4" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 19.8;HSkMC: 66.3;hTERT-HME1: 35.5;U-2 OS: 9.9;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Supported Approved Cytosol "Intracellular and membrane" NA NA 790000 Cytosol "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (5.75e-4)" 8.9 5.4 23.3 8.5 41.0 0.9 6.1 88.4 96.5 18.0 8.8 6.9 0.7 3.2 2.2 1.6 7.2 3.2 4.1 4.3 23.2 27.4 1.1 1.1 2.9 7.8 18.5 22.4 1.2 2.0 1.0 7.4 43.1 30.4 1.7 8.9 4.5 2.6 3.6 2.0 7.7 6.4 4.1 9.6 7.6 2.8 2.4 4.6 0.0 4.8 0.7 5.9 10.2 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 19.8 0.0 0.0 66.3 0.0 0.0 35.5 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.1 0.0 0.0 1.5 0.0 0.0 2.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 41.0 88.4 55.6 23.2 27.4 18.5 22.4 30.4 4.6 0.0 0.3 0.0 0.0 6.0 103.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.1 4.0 0.0 0.0 0.0 0.4 46.4 0.1 0.0 0.0 1.0 33.4 0.0 4.3 0.0 4.7 0.6 0.0 23.6 0.0 0.0 35.4 0.0 0.0 0.0 0.0 7.5 0.0 3.9 0.9 1.7 3.8 0.6 0.0 0.0 0.0 CADM4 "IGSF4C, Necl-4, SynCAM4, TSLL2" ENSG00000105767 "Cell adhesion molecule 4" Q8NFZ8 19 43622368-43639839 "Predicted membrane proteins" "Cell adhesion" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.9" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 19.9;Proximal tubular cells: 22.7" "Cancer enhanced" "Detected in all" "glioma: 108.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 8 "dendritic cells: 4.7" "Cell line enriched" "Detected in many" 5 "WM-115: 112.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012612 Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 5900000 "Nuclear membrane" Nucleoplasm "HPA012612: AB_1851530" "unprognostic (8.80e-3)" "unprognostic (2.57e-2)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (2.87e-1)" "unprognostic (9.29e-3)" "unprognostic (1.78e-1)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (5.03e-1)" "unprognostic (3.19e-3)" "unprognostic (3.81e-1)" "prognostic favorable (2.28e-6)" "unprognostic (1.39e-1)" "unprognostic (3.35e-2)" "unprognostic (2.59e-1)" "unprognostic (3.93e-2)" 3.0 12.6 29.7 3.4 31.0 0.9 6.6 22.2 68.9 4.6 5.3 32.8 2.5 3.0 10.4 6.7 10.8 3.0 3.7 5.5 31.2 26.5 13.2 3.4 3.1 1.8 37.2 20.4 5.2 10.9 26.1 7.5 1.1 29.1 13.7 2.8 4.9 13.3 10.8 5.0 10.8 3.0 6.8 47.8 1.9 4.0 1.9 26.4 0.0 3.3 1.7 3.4 2.9 2.9 0.1 4.7 0.6 0.3 0.0 0.0 0.0 8.8 2.5 13.7 17.9 0.0 0.3 0.7 0.4 0.7 1.2 1.9 3.8 1.5 0.0 3.3 0.1 0.7 2.1 3.0 1.8 1.5 0.1 2.4 0.0 0.6 5.6 1.6 0.0 1.4 0.5 4.0 6.6 0.2 6.5 0.8 0.8 0.9 0.1 0.1 1.3 1.3 0.1 1.5 1.8 0.9 7.1 0.1 0.8 1.8 1.8 1.6 8.8 0.9 2.7 3.5 2.1 2.0 0.4 0.3 0.1 21.2 0.1 0.8 1.3 0.8 0.0 1.0 0.1 112.4 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 4.7 0.0 0.0 29.7 31.0 22.2 34.0 31.2 26.5 37.2 20.4 29.1 26.4 0.0 1.7 0.0 17.0 4.4 16.4 2.8 5.1 1.4 1.2 7.0 2.0 0.2 5.0 10.4 17.6 1.9 0.0 0.0 2.7 0.1 1.1 19.9 0.0 2.6 0.4 19.1 0.0 4.3 0.0 14.7 0.3 0.0 13.5 0.0 0.3 15.4 4.2 0.0 1.4 22.7 3.7 0.0 4.7 0.5 0.8 7.4 0.0 0.5 1.0 12.8 CADPS "CAPS, CAPS1, KIAA1121, UNC-31" ENSG00000163618 "Calcium dependent secretion activator" Q9ULU8 3 62398346-62875389 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.0" "Group enriched" "Detected in many" 7 "Bipolar cells: 784.0;Cone photoreceptor cells: 591.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 11 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "OE19: 9.2;SCLC-21H: 16.5;SK-MEL-30: 7.3;U-698: 10.5;U-87 MG: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059328 Enhanced Approved Vesicles NA NA Vesicles "HPA059328: AB_2683982" "unprognostic (3.46e-3)" "unprognostic (1.40e-2)" "unprognostic (1.61e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (3.12e-2)" "unprognostic (9.27e-2)" "unprognostic (5.73e-2)" "unprognostic (2.08e-3)" "unprognostic (3.21e-1)" "unprognostic (4.20e-3)" "unprognostic (1.90e-2)" "unprognostic (2.04e-1)" "unprognostic (7.91e-3)" "unprognostic (5.35e-3)" 1.2 17.2 18.2 2.8 16.0 1.0 1.6 22.4 58.0 4.0 3.5 2.4 0.0 3.9 1.5 3.4 1.1 1.1 3.2 11.6 21.9 24.7 1.1 1.1 1.6 1.4 33.7 18.4 2.8 13.5 0.9 19.6 1.1 43.6 4.5 3.3 5.3 1.3 3.8 1.0 2.2 4.0 1.7 7.1 1.4 4.1 3.2 2.7 0.0 1.1 0.0 1.6 1.2 0.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 9.2 0.0 0.1 0.0 0.0 0.0 0.0 16.5 1.2 0.0 0.0 7.3 0.3 0.0 0.0 0.0 1.4 0.1 2.7 0.7 0.0 1.4 10.5 17.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.2 16.0 22.4 32.0 21.9 24.7 33.7 18.4 43.6 2.7 0.0 3.4 0.0 0.2 1.1 784.0 16.5 5.1 0.0 0.0 0.0 591.0 0.1 0.0 2.1 0.9 0.1 0.3 0.0 0.3 0.0 2.6 0.3 41.5 0.0 0.0 44.5 92.0 0.0 0.0 0.9 14.1 0.0 8.5 0.0 1.9 16.8 1.2 0.2 2.5 0.0 60.9 0.0 1.2 0.2 0.2 0.1 0.0 0.0 0.4 0.3 CADPS2 CAPS2 ENSG00000081803 "Calcium dependent secretion activator 2" Q86UW7 7 122318425-122886759 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 105.4" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 31.6;Collecting duct cells: 38.4;Muller glia cells: 28.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 20.3;Karpas-707: 26.5;OE19: 29.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 325.7" HPA056398 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA056398: AB_2683117" "unprognostic (1.93e-1)" "unprognostic (5.05e-2)" "unprognostic (1.91e-1)" "unprognostic (3.67e-3)" "unprognostic (8.69e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (1.33e-1)" "unprognostic (4.07e-1)" "unprognostic (4.33e-2)" "unprognostic (3.93e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.01e-7)" "unprognostic (9.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.71e-2)" "unprognostic (3.45e-2)" 5.1 11.2 5.1 1.9 7.1 0.0 9.5 105.4 21.1 16.5 5.3 1.4 13.3 6.1 16.3 16.4 5.7 5.7 8.0 4.6 6.8 8.8 20.3 6.2 9.0 1.3 14.0 9.3 5.2 13.2 15.4 17.7 2.7 7.0 10.4 5.4 4.7 23.0 11.5 2.6 2.4 4.7 11.2 4.1 3.3 9.8 1.9 1.4 0.4 9.4 2.4 1.6 4.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.4 2.5 0.1 0.2 6.3 1.4 6.4 0.0 5.9 0.0 0.0 2.9 0.2 0.0 0.2 0.8 0.6 0.0 5.2 2.0 0.0 11.4 8.2 0.0 0.1 2.6 1.1 1.0 0.8 5.7 20.3 0.0 0.0 26.5 0.1 13.9 0.0 0.0 5.9 29.0 10.0 0.0 0.0 10.5 0.3 6.6 10.3 0.0 0.2 11.5 0.5 1.6 4.4 0.0 5.8 2.2 1.5 0.0 4.1 7.9 0.3 0.0 8.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 7.1 105.4 21.1 6.8 8.8 14.0 9.3 7.0 1.4 8.9 31.6 0.0 7.7 1.9 0.0 10.1 5.1 8.1 17.0 38.4 0.0 0.2 14.9 4.7 5.5 19.6 4.5 0.0 9.4 0.3 3.8 16.7 1.1 10.2 0.3 3.2 4.6 16.0 2.7 5.3 8.9 1.1 3.3 0.0 11.6 28.4 6.6 2.9 9.6 6.9 1.3 0.0 5.1 0.5 2.5 1.3 0.2 0.0 7.6 7.4 CAGE1 "bA69L16.7, CT95, CTAG3" ENSG00000164304 "Cancer antigen 1" Q8TC20 6 7326656-7389743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 13.2" "Group enriched" "Detected in some" 16 "Early spermatids: 105.2;Late spermatids: 45.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SuSa: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029832 Uncertain NA NA "HPA029832: AB_10602412" "unprognostic (1.34e-1)" "unprognostic (4.82e-2)" "unprognostic (1.80e-2)" "unprognostic (2.25e-4)" "unprognostic (4.80e-2)" "unprognostic (4.24e-1)" "unprognostic (2.44e-3)" "unprognostic (3.88e-2)" "unprognostic (2.79e-2)" "unprognostic (8.80e-2)" "unprognostic (1.09e-2)" "unprognostic (3.23e-1)" "unprognostic (4.38e-6)" "unprognostic (4.71e-2)" "unprognostic (3.29e-2)" "unprognostic (1.62e-4)" "unprognostic (1.60e-1)" 0.2 0.2 0.3 0.2 1.5 0.4 0.2 0.9 1.1 0.2 0.2 0.6 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 1.2 0.9 0.7 0.0 0.2 1.8 0.1 1.8 0.2 1.4 0.2 0.2 0.5 0.6 0.1 0.2 0.2 0.2 0.2 0.2 0.4 0.2 13.2 0.0 0.8 0.2 0.8 0.2 0.2 0.2 1.1 1.2 1.5 0.4 0.4 0.6 0.0 0.1 0.3 0.3 0.3 0.0 0.2 0.0 0.0 0.1 0.5 0.3 0.7 0.3 0.6 0.4 0.0 0.5 0.3 0.6 0.5 0.1 0.7 0.2 0.0 0.2 0.4 0.5 0.1 0.2 0.2 0.0 0.6 0.2 0.2 0.4 0.2 0.5 1.3 0.1 0.9 0.2 0.3 0.4 0.5 0.4 0.1 0.3 0.4 0.2 0.4 0.6 0.3 0.6 1.1 0.3 1.8 0.2 0.6 0.4 0.7 0.4 0.4 0.3 0.5 0.8 1.0 0.2 0.4 0.3 1.0 0.4 0.5 0.6 0.3 0.4 0.3 0.4 0.3 0.1 1.1 0.4 0.4 1.5 0.4 0.4 1.2 0.2 0.0 0.3 1.5 0.9 1.1 0.5 0.2 0.7 0.0 1.4 0.0 0.0 0.0 0.8 0.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 105.2 0.1 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 45.2 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.7 0.0 0.4 4.6 2.1 0.3 0.1 0.5 0.0 0.5 CALB1 CALB ENSG00000104327 "Calbindin 1" P05937 8 90058608-90095475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 15 "brain: 73.8;kidney: 121.9" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 26.2;Cone photoreceptor cells: 86.4;Distal tubular cells: 26.6;Horizontal cells: 93.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.4" "Group enriched" "Detected in many" 7 "granulocytes: 6.4;monocytes: 2.5" "Cell line enhanced" "Detected in many" "A-431: 39.3;EFO-21: 59.6;NTERA-2: 19.4;SuSa: 25.6" "Region enhanced" "Detected in many" "cerebellum: 483.1" "Group enriched" "Detected in all" 4 "basal ganglia: 88.7;cerebellum: 312.3" "CAB002138, HPA023099, HPA056734" Enhanced Approved Vesicles NA NA Vesicles "CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220" "unprognostic (2.19e-1)" "unprognostic (2.28e-3)" "unprognostic (2.61e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.82e-1)" "unprognostic (5.39e-2)" "unprognostic (2.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.37e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (2.11e-1)" "unprognostic (7.88e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-1)" 1.6 1.2 19.6 1.4 73.8 1.0 1.4 66.0 10.9 3.1 1.3 0.5 0.0 1.0 1.0 2.0 1.7 2.0 0.9 1.0 13.8 15.2 121.9 1.5 2.1 1.0 2.8 6.4 0.9 2.0 1.3 3.2 2.2 12.8 0.9 1.4 0.8 1.3 0.8 1.4 1.7 1.1 1.2 14.7 1.1 1.3 2.1 10.6 0.0 1.4 0.0 1.0 1.0 0.1 0.5 0.6 6.4 2.5 0.0 0.2 1.0 39.3 2.1 8.9 0.6 0.2 1.4 1.2 0.6 4.0 0.3 0.5 0.3 4.7 0.2 59.6 0.0 0.6 13.7 12.8 15.8 2.7 0.1 0.7 1.4 16.5 0.3 1.7 0.2 0.7 0.6 5.1 0.8 7.8 2.1 10.6 0.7 2.7 1.1 10.5 0.2 0.6 0.1 19.4 0.5 8.0 0.3 0.2 0.7 4.7 0.3 1.4 0.9 10.7 0.7 0.1 25.6 0.5 0.5 0.0 1.5 8.4 1.9 3.4 1.0 1.3 0.3 0.2 0.1 0.1 2.6 0.5 1.5 0.2 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.2 6.4 0.0 2.5 0.6 0.0 1.0 19.6 73.8 66.0 10.9 13.8 15.2 2.8 6.4 12.8 10.6 0.0 0.0 0.0 0.0 0.0 20.2 1.6 0.0 0.0 0.0 26.2 86.4 0.0 26.6 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.8 3.4 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 17.8 0.2 0.0 0.0 0.0 12.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 CALB2 CAL2 ENSG00000172137 "Calbindin 2" P22676 16 71358713-71390438 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 50.6;brain: 118.9" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 89.2;granulocytes: 237.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.2;HEL: 24.0;HMC-1: 52.2;U-2 OS: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000106, HPA007305, HPA007306" Enhanced Supported Enhanced Cytosol NA NA 6400 Cytosol "CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385" "unprognostic (1.10e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.78e-5)" "unprognostic (1.75e-3)" "unprognostic (5.80e-2)" "unprognostic (1.43e-1)" "unprognostic (1.59e-1)" "unprognostic (4.55e-3)" "unprognostic (4.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.06e-3)" "unprognostic (1.35e-2)" "unprognostic (5.54e-4)" "unprognostic (1.97e-3)" "unprognostic (6.30e-2)" "unprognostic (4.72e-2)" "unprognostic (1.04e-2)" 50.6 11.6 10.1 5.1 7.5 0.9 18.2 31.2 9.9 1.7 8.9 1.7 0.0 1.7 1.4 3.0 3.0 2.4 2.0 2.2 5.9 74.2 0.9 0.9 2.1 0.9 17.7 7.5 5.6 1.4 0.9 3.0 0.9 118.9 1.1 6.0 4.9 2.1 1.3 1.0 1.0 2.7 2.7 7.5 0.9 1.2 14.6 1.5 0.0 0.8 0.2 1.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.7 6.6 0.0 0.2 0.0 1.3 0.2 0.1 0.2 0.0 0.0 8.2 0.0 0.1 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.2 0.0 0.0 52.2 0.0 0.0 0.5 0.1 0.1 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 14.9 0.1 1.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 7.5 31.2 9.9 5.9 74.2 17.7 7.5 118.9 1.5 8.9 11.1 0.0 0.0 0.2 3.5 0.3 0.0 2.7 0.0 0.0 5.9 0.0 0.0 1.7 2.1 0.1 0.0 0.0 89.2 0.1 0.4 0.1 237.6 0.0 0.1 28.6 0.0 0.0 0.0 2.3 5.8 0.0 5.0 0.0 0.0 2.5 10.4 0.0 0.0 0.0 6.7 0.0 0.3 0.3 3.6 0.0 0.1 0.0 0.0 0.1 CALCA CALC1 ENSG00000110680 "Calcitonin related polypeptide alpha" "P01258, P06881" 11 14966668-14972354 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "parathyroid gland: 122.2;thyroid gland: 55.3" "Cell type enriched" "Detected in some" 5 "Collecting duct cells: 34.9" "Cancer enriched" "Detected in many" 7 "lung cancer: 64.7" "Region enriched" "Detected in single" 48 "pons and medulla: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.9;hTERT-HME1: 1.8;Karpas-707: 1.8;SCLC-21H: 3.5" "Region enriched" "Detected in many" 5 "pons and medulla: 60.6" "HPA059886, HPA064453" Enhanced Supported "Secreted to blood" NA NA 51500 "HPA059886: , HPA064453: " "unprognostic (1.97e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (5.99e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (6.45e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" "unprognostic (3.33e-2)" "unprognostic (7.49e-2)" "unprognostic (6.74e-2)" "unprognostic (2.53e-3)" "unprognostic (1.02e-2)" 0.2 0.0 0.1 0.3 0.4 0.0 0.8 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 6.2 16.8 0.6 0.0 0.1 0.0 0.0 0.1 122.2 0.2 0.0 19.8 1.2 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.3 1.5 4.6 0.0 0.0 0.0 0.6 55.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.1 0.2 0.0 0.2 0.1 0.0 19.8 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 34.9 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 6.5 0.0 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.5 0.0 0.0 0.0 1.3 CALCB "CALC2, CGRP-II, FLJ30166" ENSG00000175868 "Calcitonin related polypeptide beta" P10092 11 14904997-15082342 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 14.3;pancreas: 7.9;thyroid gland: 26.0" "Cell type enhanced" "Detected in some" 23 "Basal keratinocytes: 1.1;Melanocytes: 5.0;Spermatogonia: 2.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Group enriched" "Detected in many" 8 "hypothalamus: 13.5;pons and medulla: 14.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 6.3;Karpas-707: 11.3;SH-SY5Y: 3.9;U-266/70: 16.9" "Region enriched" "Detected in single" 7 "pons and medulla: 10.1" HPA059886 Supported "Secreted to blood" NA NA "HPA059886: " "unprognostic (7.84e-2)" "unprognostic (4.07e-1)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.02e-1)" "unprognostic (8.40e-2)" "unprognostic (1.75e-1)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "unprognostic (3.32e-2)" "unprognostic (4.87e-2)" "unprognostic (1.16e-1)" "unprognostic (1.02e-2)" "unprognostic (2.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" 0.5 0.2 0.0 1.6 1.6 0.3 1.5 1.5 0.8 0.3 1.5 0.0 0.0 0.9 0.4 0.3 0.3 0.2 0.3 0.9 0.0 13.5 0.4 1.1 1.3 1.0 0.7 0.2 0.2 7.9 0.3 2.7 0.4 14.3 0.4 0.5 1.8 0.7 0.2 1.2 0.3 0.8 0.4 3.9 0.9 0.3 1.4 0.3 0.6 26.0 0.0 0.3 0.3 0.0 0.2 0.3 1.1 0.2 1.8 1.2 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.3 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 2.0 0.1 0.4 0.1 0.0 11.3 0.0 0.0 0.0 0.7 3.0 0.1 0.1 0.5 0.0 0.2 0.0 0.0 1.2 3.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 16.9 0.6 0.4 2.3 0.0 0.0 0.0 0.2 1.1 0.8 0.1 1.2 0.0 0.5 0.7 0.3 0.2 1.2 1.1 0.6 1.8 0.0 0.0 0.1 0.4 0.0 1.6 1.5 0.8 0.0 13.5 0.7 0.2 14.3 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 2.1 0.0 0.1 0.0 0.0 0.0 CALCR CTR ENSG00000004948 "Calcitonin receptor" 7 93424487-93574730 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;kidney: 7.5" "Group enriched" "Detected in some" 14 "Early spermatids: 13.2;Late spermatids: 4.4" "Cancer enriched" "Detected in single" 5 "renal cancer: 1.1" "Region enhanced" "Detected in many" "hypothalamus: 10.8" "Cell type enhanced" "Detected in single" "classical monocyte: 1.1" "Lineage enhanced" "Detected in single" "monocytes: 1.1" "Group enriched" "Detected in some" 7 "MCF7: 2.4;RPTEC TERT1: 4.0;SuSa: 7.7;T-47d: 7.7" "Group enriched" "Detected in some" 5 "basal ganglia: 6.7;hypothalamus: 28.7" "Low region specificity" "Detected in all" "HPA028962, HPA061428" Enhanced Supported NA NA "HPA028962: AB_10602339, HPA061428: AB_2732661" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (3.88e-2)" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "unprognostic (3.43e-1)" "unprognostic (7.73e-5)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (8.70e-2)" "unprognostic (1.86e-2)" "unprognostic (6.68e-2)" "unprognostic (2.71e-3)" "unprognostic (1.46e-3)" "unprognostic (1.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.05e-2)" 0.3 0.7 1.4 0.0 2.1 0.0 1.3 0.1 1.5 0.5 0.2 0.0 0.0 0.1 0.1 0.5 0.3 0.1 0.4 0.4 2.1 10.8 7.5 0.1 0.9 0.0 0.8 0.0 0.7 0.1 0.3 3.2 2.1 5.9 0.1 0.2 0.2 1.4 0.0 3.7 0.1 0.2 0.3 2.5 0.1 0.1 2.3 0.7 0.0 0.1 2.5 0.7 0.1 0.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 7.7 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 2.1 0.1 1.5 2.1 10.8 0.8 0.0 5.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 CALCRL "CGRPR, CRLR" ENSG00000064989 "Calcitonin receptor like receptor" Q16602 2 187343129-187448460 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.0" "Group enriched" "Detected in many" 9 "Endothelial cells: 183.3;Ito cells: 192.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3" "Group enriched" "Detected in many" 6 "dendritic cells: 11.2;monocytes: 3.3" "Cell line enriched" "Detected in some" 4 "HUVEC TERT2: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008070, HPA046515" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA008070: AB_1845912, HPA046515: AB_2679681" "unprognostic (7.06e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (3.44e-3)" "unprognostic (7.60e-3)" "unprognostic (9.25e-3)" "unprognostic (4.14e-2)" "unprognostic (7.71e-3)" "unprognostic (3.32e-1)" "unprognostic (3.77e-1)" "unprognostic (3.44e-1)" "unprognostic (1.51e-3)" "unprognostic (1.90e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" 42.4 5.2 4.9 6.4 3.8 0.2 19.6 7.3 9.4 21.2 12.6 2.6 4.0 3.1 17.9 6.8 16.3 6.5 13.4 15.1 4.5 3.8 16.5 12.5 91.0 16.9 4.7 3.5 15.2 3.7 8.2 5.3 6.4 7.5 10.7 5.3 7.5 8.4 4.4 5.0 4.2 5.6 14.5 18.1 9.1 5.0 7.9 2.8 2.3 16.9 11.8 4.7 10.6 14.0 0.2 11.2 0.1 3.3 1.2 1.1 1.1 0.0 0.0 3.2 0.0 2.3 0.6 0.0 0.2 0.4 0.0 0.4 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 1.8 0.0 0.0 1.6 0.1 0.1 0.7 0.2 62.5 0.0 0.0 0.8 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.1 14.7 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.0 0.2 0.0 0.0 0.1 2.3 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 11.2 0.0 1.1 0.2 0.1 1.2 1.2 3.3 0.0 1.1 4.9 3.8 7.3 3.7 4.5 3.8 4.7 3.5 7.5 2.8 0.0 14.0 0.8 2.3 8.2 0.1 7.0 2.5 2.7 4.5 0.0 0.0 0.3 3.3 0.1 0.5 183.3 0.0 0.0 0.4 0.1 5.4 1.7 4.7 2.1 0.9 0.0 0.0 192.8 14.2 0.4 7.2 7.7 10.1 20.8 0.0 0.0 0.1 0.0 2.5 12.3 0.0 6.5 6.6 1.2 0.4 5.9 0.2 0.0 0.0 1.2 CALD1 "CDM, H-CAD, L-CAD" ENSG00000122786 "Caldesmon 1" Q05682 7 134744252-134970728 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 224.5" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 1615.7;Peritubular cells: 1885.2;Sertoli cells: 2257.2;Smooth muscle cells: 2337.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 79.3;fHDF/TERT166: 128.9;U-138 MG: 82.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000006, HPA008066, HPA017330" Enhanced Enhanced "Plasma membrane,Actin filaments" Yes No 110000000 "Plasma membrane, Actin filaments" "CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917" "unprognostic (2.16e-2)" "unprognostic (1.19e-2)" "unprognostic (2.80e-3)" "unprognostic (3.05e-2)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (6.52e-3)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" 38.6 17.4 6.7 33.4 11.1 0.0 26.6 11.9 9.1 83.1 141.0 6.0 111.4 12.6 82.3 59.8 122.8 45.8 46.3 20.1 7.7 5.0 33.5 39.6 26.1 12.9 8.7 8.5 76.3 6.9 4.1 17.8 57.4 8.9 87.8 25.1 10.9 12.4 133.3 15.3 12.9 39.2 224.5 8.5 35.9 64.5 29.7 9.7 2.1 20.3 14.1 5.3 205.3 70.4 0.1 0.2 4.3 0.2 0.4 0.2 5.9 12.1 8.0 18.1 15.9 62.7 50.9 17.9 71.6 79.3 24.6 27.3 14.5 0.3 0.0 17.1 128.9 16.4 2.9 11.5 21.3 33.5 0.1 3.9 0.4 9.5 9.8 41.3 0.0 0.0 39.0 15.9 27.5 15.6 37.8 20.7 0.0 0.0 0.1 36.7 0.0 0.0 0.2 21.6 0.0 2.8 0.1 16.1 0.0 5.0 3.3 3.1 7.9 25.1 3.3 9.6 57.0 0.7 0.1 55.2 82.7 14.5 15.7 24.3 0.0 0.0 0.0 28.7 0.0 61.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 4.3 0.4 0.0 0.0 0.0 5.9 6.7 11.1 11.9 9.1 7.7 5.0 8.7 8.5 8.9 9.7 20.8 21.2 22.4 285.3 373.4 156.1 350.6 211.5 9.4 25.0 41.8 5.9 146.5 19.9 303.7 58.2 355.4 0.0 23.3 20.1 802.8 618.3 367.0 4.7 529.8 38.7 87.4 3.5 505.2 24.5 42.4 1615.7 35.2 318.9 11.8 0.9 180.9 118.9 0.0 1885.2 249.0 13.7 2257.2 2337.7 6.8 10.3 150.2 231.4 15.0 0.2 28.3 CALHM1 FAM26C ENSG00000185933 "Calcium homeostasis modulator 1" Q8IU99 10 103453387-103458888 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sensory transduction, Taste, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.7;kidney: 2.4;lymphoid tissue: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.2;U-266/70: 4.4;U-266/84: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA061816 Enhanced NA NA "HPA061816: " "unprognostic (2.46e-1)" "unprognostic (2.66e-1)" "unprognostic (2.38e-1)" "unprognostic (1.30e-1)" "unprognostic (5.65e-3)" "unprognostic (3.44e-2)" "unprognostic (2.86e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.44e-1)" "unprognostic (2.21e-8)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" "unprognostic (1.38e-2)" 0.0 0.0 1.1 0.5 0.3 0.8 0.0 3.4 5.7 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 1.2 2.5 2.4 0.0 0.0 0.4 1.3 0.1 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.2 0.3 0.1 0.2 0.0 2.0 0.2 0.0 1.0 1.6 0.8 1.6 1.3 1.0 0.2 0.4 0.3 0.3 0.4 0.1 0.0 0.5 0.4 0.1 0.1 0.2 0.0 0.2 0.3 0.2 0.0 0.3 0.4 0.1 0.3 0.3 0.4 0.7 0.3 0.9 0.2 0.0 0.0 0.4 0.2 0.2 0.1 0.4 0.5 0.0 0.3 0.2 1.1 0.3 0.5 0.0 0.8 0.4 0.0 0.5 0.4 0.3 4.2 0.3 0.5 0.6 0.3 0.2 1.0 0.1 0.5 0.0 0.0 1.0 0.4 0.3 0.2 0.4 4.4 5.0 0.6 0.5 1.1 0.1 0.6 0.6 0.4 1.0 1.6 0.2 0.5 0.4 1.0 1.6 1.0 0.4 0.9 0.8 1.3 1.4 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALHM3 "bA225H22.7, FAM26A" ENSG00000183128 "Calcium homeostasis modulator 3" Q86XJ0 10 103472804-103479240 "Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Taste, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.8;testis: 2.0" "Cell type enhanced" "Detected in some" 23 "Cardiomyocytes: 1.1;Early spermatids: 2.2;Extravillous trophoblasts: 5.4;Late spermatids: 1.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.5" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;myeloid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "U-266/84: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018205 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA018205: AB_2069267" "unprognostic (2.88e-1)" "unprognostic (4.00e-1)" "unprognostic (3.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.87e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (1.44e-1)" "unprognostic (4.89e-2)" "unprognostic (3.07e-1)" "unprognostic (5.05e-2)" "unprognostic (1.53e-1)" 0.2 0.1 0.5 0.0 0.6 0.0 0.0 0.2 0.7 0.3 0.1 0.8 0.3 0.9 0.0 0.3 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.4 2.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 2.0 0.0 0.0 0.2 0.4 0.0 1.5 0.0 1.8 0.0 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.3 3.3 0.4 1.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 17.4 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 CALHM4 "C6orf78, FAM26D, FLJ32239" ENSG00000164451 "Calcium homeostasis modulator family member 4" Q5JW98 6 116529013-116558868 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "placenta: 29.7;skin 1: 9.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 45.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 2.8;SuSa: 6.2" "Intracellular and membrane" NA NA "unprognostic (7.95e-2)" "unprognostic (3.44e-4)" "unprognostic (1.99e-1)" "unprognostic (1.44e-2)" 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 29.7 1.4 0.0 0.0 0.2 0.0 0.0 0.5 9.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 0.1 0.0 2.8 0.0 0.3 0.2 0.2 0.3 0.0 0.3 0.6 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 6.2 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 CALHM6 "C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5" ENSG00000188820 "Calcium homeostasis modulator family member 6" Q5R3K3 6 116461370-116463779 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.3;lymphoid tissue: 58.7" "Cell type enriched" "Detected in some" 7 "Hofbauer cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 83.9;non-classical monocyte: 95.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 10.0;Karpas-707: 16.7;RPMI-8226: 56.6;U-937: 21.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (1.14e-2)" "unprognostic (2.31e-2)" "unprognostic (6.46e-3)" "unprognostic (7.15e-3)" "unprognostic (9.53e-3)" "unprognostic (4.10e-2)" "unprognostic (2.69e-1)" "unprognostic (1.68e-1)" "unprognostic (8.19e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (9.31e-10)" "unprognostic (1.69e-1)" "unprognostic (2.12e-2)" "unprognostic (3.85e-3)" "unprognostic (9.25e-3)" 3.0 2.7 2.8 19.6 5.2 12.9 3.1 1.1 2.1 1.5 3.4 1.5 1.7 3.9 1.1 1.3 2.0 1.5 3.9 4.3 3.1 3.2 2.9 8.1 4.2 30.6 2.6 1.8 2.8 1.0 0.4 2.5 4.6 3.4 3.1 2.2 2.7 4.2 0.7 1.0 0.9 8.1 3.7 5.1 58.7 2.2 3.3 1.7 7.3 2.1 1.9 7.5 3.5 1.4 39.6 23.3 13.8 95.3 3.1 3.8 17.8 2.3 0.0 0.2 0.1 0.2 0.7 4.3 0.0 0.4 0.7 0.5 0.0 0.3 0.0 1.3 0.5 0.0 0.0 0.1 0.0 1.6 0.2 0.1 10.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 16.7 2.0 0.0 0.9 1.7 1.3 0.0 0.0 0.8 0.0 56.6 0.8 0.1 1.0 0.0 5.4 0.0 4.0 0.6 0.1 2.6 0.0 0.0 0.0 0.0 0.3 4.3 0.0 0.0 0.1 21.5 1.4 1.8 24.7 5.5 2.1 83.9 2.1 27.0 2.9 1.9 23.3 39.6 3.8 1.9 13.8 3.1 95.3 10.2 0.3 17.8 2.8 5.2 1.1 2.1 3.1 3.2 2.6 1.8 3.4 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 9.1 4.9 0.0 0.0 0.0 0.0 118.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 18.0 0.0 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 CALM1 "CALML2, CAMI, DD132, PHKD" ENSG00000198668 "Calmodulin 1" P0DP23 14 90396502-90408261 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 176.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018558, HPA044999" Supported Approved Vesicles NA NA Vesicles "CAB018558: AB_2069454, HPA044999: AB_2679177" "unprognostic (5.35e-3)" "unprognostic (3.96e-1)" "unprognostic (4.99e-3)" "unprognostic (2.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.52e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" "prognostic favorable (5.62e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.49e-4)" "unprognostic (2.66e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.38e-5)" 47.5 28.1 141.5 26.9 148.2 57.2 21.5 149.6 176.0 27.4 55.9 49.4 20.7 53.9 20.3 41.7 58.8 48.6 29.5 52.3 139.8 86.1 61.5 39.0 38.7 27.8 85.2 100.1 20.9 22.6 41.4 27.6 38.6 106.1 33.7 60.5 22.2 33.2 43.5 100.2 19.3 50.6 42.6 71.1 29.3 35.6 22.3 49.8 12.6 22.7 18.8 37.8 32.7 21.8 45.7 42.8 90.3 53.7 88.8 118.3 109.4 26.9 37.6 44.9 17.2 50.5 44.5 38.4 49.8 42.7 38.5 41.8 40.0 47.9 29.2 26.0 58.7 18.1 45.2 28.1 69.2 64.2 56.8 18.0 30.9 32.4 36.6 27.7 46.8 24.9 27.9 34.6 37.7 13.4 25.6 86.8 20.3 14.2 40.1 52.7 91.7 15.4 45.8 26.1 74.4 52.6 30.9 40.1 19.7 31.8 83.3 94.1 39.5 43.5 76.2 27.8 38.9 50.4 16.4 53.8 32.5 20.8 34.0 41.4 22.4 50.6 32.1 51.4 39.4 45.1 90.3 31.8 71.0 96.0 37.9 118.3 45.7 102.5 101.0 42.8 35.7 74.8 88.1 47.0 88.8 53.7 40.5 105.6 109.4 141.5 148.2 149.6 176.0 139.8 86.1 85.2 100.1 106.1 49.8 360.3 314.0 329.2 485.1 503.7 1352.9 743.7 341.4 1962.0 494.8 378.6 115.8 358.0 389.6 484.7 100.9 794.0 1033.1 23.3 391.9 774.4 358.4 298.0 468.8 297.5 680.0 570.5 576.0 585.0 268.2 58.5 195.1 732.5 595.5 1203.7 393.5 1076.8 427.8 540.1 470.2 1073.9 291.0 310.4 582.3 94.1 162.2 507.4 959.8 581.7 530.3 385.0 CALM3 PHKD ENSG00000160014 "Calmodulin 3" P0DP25 19 46601074-46610793 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 181.1" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 1472.6;Late spermatids: 2084.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA044999 Approved NA NA "HPA044999: AB_2679177" "unprognostic (3.39e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" "unprognostic (9.81e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.01e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-1)" "unprognostic (1.07e-1)" "prognostic favorable (9.10e-4)" "unprognostic (2.72e-1)" 23.0 29.0 113.3 27.0 142.8 30.5 15.6 76.6 181.1 27.4 31.6 21.5 8.2 37.4 24.5 18.8 22.5 25.9 25.2 47.5 120.2 75.6 23.4 25.3 19.3 29.7 70.1 110.8 37.4 19.3 16.5 16.0 24.5 90.5 25.6 30.0 17.8 12.4 31.6 52.7 15.3 41.7 31.3 34.7 18.5 22.8 44.7 20.5 27.1 22.3 8.6 30.6 28.5 17.4 13.0 17.4 82.2 34.2 18.8 35.3 26.8 52.7 62.2 73.3 25.8 38.8 52.0 15.8 54.0 49.6 53.3 71.3 52.5 51.2 45.1 22.7 86.6 37.7 37.2 72.8 47.0 68.0 54.9 47.1 61.8 30.4 60.0 21.0 49.0 84.7 50.8 16.0 41.3 33.2 41.1 66.0 52.4 45.5 67.8 50.5 36.1 47.3 109.8 34.3 82.8 24.5 83.4 39.0 17.1 50.5 66.5 37.2 39.6 44.0 29.6 17.2 76.0 34.3 53.1 47.2 28.9 50.3 22.1 42.1 42.6 34.3 36.7 29.4 39.9 37.9 28.5 30.2 46.3 13.0 34.2 11.7 13.0 18.7 17.4 17.4 11.5 21.7 14.0 82.2 18.8 33.2 10.4 35.3 26.8 113.3 142.8 76.6 181.1 120.2 75.6 70.1 110.8 90.5 20.5 38.7 58.6 96.7 64.3 50.8 127.6 153.9 81.5 71.0 31.8 66.3 11.8 167.0 220.5 222.6 1472.6 81.0 327.1 327.1 193.5 389.2 117.3 73.9 104.9 82.7 633.9 84.2 117.6 106.8 253.0 2084.0 99.0 107.0 87.7 757.4 160.9 101.7 206.9 178.9 115.2 292.8 57.1 90.5 138.2 657.1 168.6 57.6 154.6 174.0 160.4 94.5 CALML3 CLP ENSG00000178363 "Calmodulin like 3" P27482 10 5524009-5526771 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 108.7;skin 1: 40.8;vagina: 42.4" "Cell type enhanced" "Detected in some" 15 "Basal glandular cells: 28.0;Basal keratinocytes: 25.2;Proximal tubular cells: 19.5;Suprabasal keratinocytes: 48.1;Urothelial cells: 18.8" "Group enriched" "Detected in many" 15 "cervical cancer: 150.9;head and neck cancer: 196.3;lung cancer: 59.9;melanoma: 47.8;urothelial cancer: 43.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A-431: 16.9;hTCEpi: 6.7;RPMI-8226: 4.5" "Not detected" "Not detected" "CAB010070, HPA044999" Approved NA NA 500000 "CAB010070: , HPA044999: AB_2679177" "unprognostic (1.02e-3)" "unprognostic (1.18e-2)" "unprognostic (4.33e-2)" "unprognostic (1.37e-1)" "unprognostic (1.29e-2)" "unprognostic (2.16e-1)" "unprognostic (2.93e-1)" "unprognostic (3.11e-1)" "unprognostic (1.02e-2)" "unprognostic (9.64e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-2)" "unprognostic (1.71e-1)" "unprognostic (2.56e-1)" "unprognostic (1.65e-1)" "unprognostic (4.43e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 24.5 0.0 0.0 0.0 0.0 108.7 0.2 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 29.8 0.0 0.1 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 42.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 25.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.3 1.1 1.7 0.0 0.5 0.0 0.0 0.0 0.0 19.5 0.4 0.0 0.3 0.6 0.0 48.1 0.0 0.0 0.0 18.8 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206110 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.0;gallbladder: 28.4;intestine: 91.6" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 174.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 39.2;non-classical monocyte: 44.0" "Lineage enriched" "Detected in many" 10 "monocytes: 44.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 2.4 2.5 1.8 12.0 1.1 0.8 2.2 2.6 1.0 3.2 40.3 2.2 7.7 34.0 1.5 7.8 5.1 7.3 28.4 1.4 2.6 0.7 12.6 12.3 3.1 2.6 0.9 1.3 2.3 5.3 0.0 3.1 2.1 8.4 4.3 21.8 3.1 1.9 6.7 1.4 1.7 91.6 2.7 1.0 5.3 5.4 2.4 0.6 1.1 1.5 1.3 1.3 1.9 2.0 0.0 4.5 1.8 44.0 0.0 0.0 2.8 2.5 7.8 5.7 3.5 0.6 1.0 4.0 1.6 1.5 2.6 2.6 14.9 16.1 2.5 2.0 1.1 2.3 10.8 12.8 2.3 1.0 2.1 12.4 4.1 13.3 5.2 2.3 3.5 5.5 1.1 3.4 1.5 2.2 2.1 2.9 5.2 3.9 2.9 0.6 7.2 5.7 7.7 4.9 12.0 2.3 8.5 5.6 5.1 0.9 4.3 2.9 3.4 2.5 2.3 6.8 1.8 1.7 3.4 2.5 3.8 3.5 6.6 6.3 10.6 6.3 7.0 2.4 6.9 1.3 0.0 6.5 0.0 0.0 39.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.8 0.0 44.0 0.2 0.0 2.8 1.8 1.1 2.6 1.0 2.6 0.7 0.9 1.3 8.4 0.6 0.0 1.0 0.9 0.6 1.3 8.8 0.3 15.3 174.0 26.1 3.5 0.0 0.4 0.0 2.0 4.8 1.9 38.6 0.0 3.9 0.4 1.0 1.2 0.0 7.2 3.1 7.9 7.5 6.7 11.9 0.0 3.4 3.4 0.0 0.0 15.0 1.7 1.8 38.6 6.3 5.8 2.2 0.0 0.3 0.0 0.5 1.8 0.1 1.8 18.3 1.1 CALML5 CLSP ENSG00000178372 "Calmodulin like 5" Q9NZT1 10 5498697-5499555 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "salivary gland: 129.5;skin 1: 212.5" "Cell type enriched" "Detected in some" 6 "Suprabasal keratinocytes: 341.5" "Group enriched" "Detected in many" 6 "breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "A-431: 95.2" "Not detected" "Not detected" HPA040725 Enhanced Approved "Plasma membrane,Cytosol" NA NA 75000000 "Plasma membrane, Cytosol" "HPA040725: AB_10793863" "unprognostic (7.68e-3)" "unprognostic (5.06e-3)" "unprognostic (5.64e-2)" "prognostic favorable (2.59e-5)" "unprognostic (4.82e-2)" "unprognostic (2.67e-1)" "unprognostic (1.37e-1)" "unprognostic (8.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.79e-1)" "unprognostic (1.71e-1)" "unprognostic (4.99e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 8.0 0.3 0.2 6.7 0.2 0.2 0.2 0.0 1.0 0.2 4.8 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 129.5 0.2 1.8 212.5 0.2 0.2 0.2 0.2 0.0 0.2 0.2 3.1 0.2 10.9 8.2 0.2 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.2 24.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 341.5 0.0 0.0 0.0 1.4 CALML6 CAGLP ENSG00000169885 "Calmodulin like 6" Q8TD86 1 1914827-1917296 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "skeletal muscle: 51.4;tongue: 73.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.9" "Not detected" "Not detected" NA NA "unprognostic (3.85e-2)" "unprognostic (3.04e-2)" "unprognostic (1.59e-4)" "unprognostic (1.66e-1)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-3)" "unprognostic (9.72e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-2)" "unprognostic (9.76e-2)" "unprognostic (5.21e-10)" "unprognostic (5.06e-3)" "unprognostic (1.93e-1)" "unprognostic (1.23e-2)" "unprognostic (6.48e-2)" 0.2 0.0 0.1 0.1 0.6 0.1 0.2 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.3 2.1 0.0 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.3 0.1 0.1 0.7 0.1 0.1 1.8 0.2 51.4 0.8 0.1 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.1 73.7 0.7 0.1 0.5 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 4.9 1.5 0.9 2.9 1.0 0.0 0.4 0.5 0.0 2.9 1.0 0.1 1.2 0.3 1.5 0.3 0.5 0.0 0.7 0.3 0.0 1.1 0.0 0.4 0.1 0.6 2.1 3.0 0.4 0.3 0.4 0.2 0.2 0.0 1.7 0.1 1.0 0.0 0.1 0.9 0.7 0.8 1.5 0.1 2.5 0.5 0.2 0.2 0.5 0.0 0.3 0.1 2.6 0.8 0.3 0.0 0.1 0.0 2.7 0.1 1.5 0.3 2.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.6 0.7 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 4.8;Early spermatids: 5.1;Spermatocytes: 6.9;Spermatogonia: 11.4;Suprabasal keratinocytes: 8.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "Karpas-707: 31.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 31.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 4.8 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 5.0 4.8 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 0.0 0.0 0.0 0.2 2.1 0.1 4.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.3 3.2 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.7 0.0 0.6 0.0 0.0 6.9 11.4 8.5 0.1 0.0 0.0 0.1 CALR3 "CRT2, CT93, FLJ25355, MGC26577" ENSG00000269058 "Calreticulin 3" Q96L12 19 16479057-16496192 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" Chaperone "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 43.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 46.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTCEpi: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB025749, HPA043355, HPA048460" Enhanced "Intracellular and membrane" NA NA "CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403" "unprognostic (1.19e-1)" "unprognostic (3.84e-1)" "unprognostic (7.17e-2)" "unprognostic (4.34e-1)" "unprognostic (2.32e-1)" "unprognostic (2.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (1.18e-2)" "unprognostic (6.69e-7)" "unprognostic (1.60e-1)" "unprognostic (2.78e-1)" "unprognostic (6.28e-3)" "unprognostic (6.34e-3)" 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 43.6 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.3 0.8 2.2 0.1 0.0 0.6 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.7 0.2 0.0 1.1 0.0 1.0 0.9 0.6 0.1 0.0 0.1 0.2 1.1 0.2 0.0 1.3 1.4 0.9 0.0 0.0 0.5 0.0 1.1 0.0 3.9 0.0 0.0 0.1 0.0 0.8 1.0 0.0 0.0 0.0 0.5 0.4 1.3 1.1 0.0 0.0 0.0 0.0 0.9 1.1 1.0 0.1 0.7 0.7 0.5 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 1.4 1.8 1.1 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 1.2 0.2 0.0 0.2 1.3 0.6 0.1 2.2 0.0 0.0 0.8 0.0 0.1 0.5 0.4 0.8 0.8 0.4 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.0 0.0 CALY "CALCYON, DRD1IP, NSG3" ENSG00000130643 "Calcyon neuron specific vesicular protein" Q9NYX4 10 133324072-133336935 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "adrenal gland: 26.5;brain: 98.9;pituitary gland: 47.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 84.4;Horizontal cells: 68.3;Intestinal endocrine cells: 18.7;Rod photoreceptor cells: 31.1" "Group enriched" "Detected in some" 14 "glioma: 1.7;pancreatic cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3;naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.7;U-266/70: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042283 Enhanced NA NA "HPA042283: AB_10794417" "unprognostic (1.43e-2)" "unprognostic (7.84e-2)" "unprognostic (3.77e-3)" "unprognostic (1.41e-2)" "unprognostic (7.32e-2)" "unprognostic (9.81e-3)" "unprognostic (2.56e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.23e-2)" "unprognostic (4.19e-10)" "unprognostic (8.04e-3)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" "unprognostic (1.63e-1)" 1.8 26.5 27.1 2.7 57.4 1.8 1.8 12.7 67.1 1.7 2.6 3.6 0.0 5.0 1.7 1.9 1.8 2.0 1.8 1.7 31.8 98.9 1.7 1.7 1.9 2.0 25.1 39.8 1.7 6.3 1.7 47.7 1.7 33.9 1.8 2.4 0.7 2.1 2.0 1.7 1.9 3.8 2.1 14.3 1.9 4.1 4.3 4.8 0.0 1.9 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.1 0.8 0.3 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.8 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 1.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.7 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 27.1 57.4 12.7 45.9 31.8 98.9 25.1 39.8 33.9 4.8 0.0 0.0 0.0 0.0 0.2 84.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 68.3 18.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 8.1 0.9 0.0 0.4 0.2 31.1 0.0 0.8 1.4 2.6 0.0 0.2 0.0 0.0 0.0 CAMK1 CaMKI ENSG00000134072 "Calcium/calmodulin dependent protein kinase I" Q14012 3 9757342-9769992 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Differentiation, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 60.5;blood: 59.4" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 76.7;Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 59.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 59.4" "Cell line enriched" "Detected in many" 4 "HMC-1: 94.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031904, HPA051409" Approved Approved Cytosol NA NA 550000 Cytosol "CAB031904: AB_630964, HPA051409: AB_2681473" "unprognostic (4.43e-2)" "unprognostic (3.05e-1)" "unprognostic (1.68e-1)" "unprognostic (1.29e-1)" "unprognostic (1.11e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.53e-2)" "unprognostic (3.32e-1)" "unprognostic (9.74e-2)" "unprognostic (1.37e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "unprognostic (7.76e-2)" "unprognostic (1.72e-1)" "unprognostic (3.67e-2)" "unprognostic (3.01e-1)" 27.1 60.5 28.0 11.7 26.0 3.5 34.1 12.4 31.2 9.5 10.7 4.4 5.8 6.8 12.6 10.5 7.1 12.6 8.9 10.2 21.4 14.0 13.1 20.7 9.2 10.4 10.3 19.9 21.5 4.5 7.4 7.9 5.1 10.1 18.6 8.1 6.8 5.1 15.1 4.7 3.3 8.3 18.4 7.2 7.1 8.1 13.4 5.6 0.6 7.0 3.7 10.4 9.5 10.3 0.0 3.2 59.4 9.2 0.7 0.4 0.9 0.1 3.7 3.0 0.0 15.4 5.7 7.5 8.8 4.9 10.1 9.6 5.4 0.6 0.2 2.0 5.9 1.5 0.6 0.0 1.1 6.3 0.1 21.6 11.9 7.0 7.5 8.6 1.0 94.0 6.0 0.9 14.2 1.5 8.3 8.4 0.2 1.5 0.2 3.7 2.2 0.0 8.7 2.1 0.1 5.8 0.0 0.1 0.2 6.0 0.6 1.0 3.8 1.5 0.1 0.8 1.3 0.9 15.2 4.4 4.6 5.7 6.5 11.0 0.1 0.0 0.2 9.8 3.3 0.6 3.3 4.8 59.4 0.0 9.2 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.2 0.7 9.2 0.1 0.4 0.9 28.0 26.0 12.4 31.2 21.4 14.0 10.3 19.9 10.1 5.6 0.0 1.9 6.4 17.8 4.4 8.1 0.0 10.2 1.4 2.3 10.4 2.0 0.4 8.3 13.1 1.5 22.7 2.0 0.0 3.6 1.0 11.6 14.9 31.0 21.2 76.7 0.0 5.8 17.8 40.5 3.9 33.4 50.8 5.0 19.0 1.3 30.9 6.0 3.5 42.5 35.3 8.0 58.2 35.0 1.1 1.1 3.3 0.7 7.5 5.5 10.8 CAMK1G "CLICKIII, dJ272L16.1, VWS1" ENSG00000008118 "Calcium/calmodulin dependent protein kinase IG" Q96NX5 1 209583717-209613938 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.4;ovary: 29.2" "Group enriched" "Detected in some" 6 "Peritubular cells: 6.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.6;hTERT-RPE1: 6.9;SK-MEL-30: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.17e-2)" "unprognostic (9.64e-2)" "unprognostic (1.73e-1)" "unprognostic (1.49e-3)" "unprognostic (2.56e-2)" "unprognostic (1.93e-1)" "unprognostic (6.79e-2)" "unprognostic (3.98e-1)" "unprognostic (3.59e-3)" "unprognostic (8.55e-3)" "unprognostic (3.17e-2)" "unprognostic (1.14e-2)" "unprognostic (4.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.27e-1)" "unprognostic (9.10e-2)" "unprognostic (3.43e-2)" 0.7 3.5 7.5 0.9 34.4 1.0 0.7 1.3 27.8 1.1 0.8 0.7 1.2 0.8 1.8 6.1 0.6 0.9 1.5 0.6 10.9 9.2 6.9 0.9 1.2 0.8 3.6 17.7 29.2 1.3 0.6 2.0 2.8 3.9 4.6 0.8 0.6 0.6 7.4 0.6 0.6 0.8 2.3 0.9 6.1 0.7 1.4 2.7 0.0 0.7 0.0 0.8 1.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 1.9 0.3 0.8 0.2 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.0 0.0 1.2 0.6 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 11.6 0.0 6.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 1.6 0.0 0.0 0.2 2.0 0.2 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 34.4 1.3 27.8 10.9 9.2 3.6 17.7 3.9 2.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 6.3 0.3 0.0 6.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 CAMK2A "CAMKA, CaMKIINalpha, KIAA0968" ENSG00000070808 "Calcium/calmodulin dependent protein kinase II alpha" Q9UQM7 5 150219491-150290291 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "brain: 105.7;skeletal muscle: 50.1" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3" "Cancer enriched" "Detected in single" 13 "glioma: 6.0" "Group enriched" "Detected in all" 6 "amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1" "Group enriched" "Detected in all" 4 "amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1" "Low region specificity" "Detected in all" "CAB004330, HPA051783, HPA051785, HPA053973" Supported Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 21000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (7.20e-3)" "unprognostic (6.47e-3)" "unprognostic (6.16e-3)" "unprognostic (4.85e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-3)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (3.07e-1)" "unprognostic (1.05e-1)" "unprognostic (4.49e-2)" "unprognostic (1.41e-2)" "unprognostic (2.00e-8)" "unprognostic (2.71e-4)" "unprognostic (1.68e-1)" "unprognostic (1.70e-2)" "unprognostic (1.36e-3)" 1.3 1.7 60.7 1.3 50.6 1.3 1.1 1.4 105.7 1.8 1.3 3.7 0.0 1.2 2.1 1.4 1.9 1.7 1.3 3.7 74.6 10.5 1.6 1.2 1.5 1.2 5.1 39.8 1.3 1.1 1.1 0.4 1.3 2.4 1.6 1.3 0.0 1.2 1.4 50.1 1.6 1.3 2.5 1.7 1.2 1.3 1.2 2.3 0.0 1.2 0.0 1.1 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 0.0 0.5 1.3 0.8 0.7 0.0 0.1 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.5 0.2 1.7 0.0 1.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 9.6 0.0 0.1 0.2 0.3 2.6 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 60.7 50.6 1.4 99.6 74.6 10.5 5.1 39.8 2.4 2.3 0.0 0.0 0.0 0.0 3.1 0.1 11.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.4 0.8 0.0 0.0 1.1 0.0 0.2 1.3 0.2 0.0 0.0 0.0 CAMK2B "CAM2, CAMK2, CAMKB" ENSG00000058404 "Calcium/calmodulin dependent protein kinase II beta" Q13554 7 44217150-44334577 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7" "Cell type enriched" "Detected in many" 11 "Bipolar cells: 838.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006849, HPA026307, HPA051783, HPA051785, HPA053973" Enhanced Supported Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA 680000 "Plasma membrane" "Cell Junctions, Cytosol" "CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (1.88e-3)" "unprognostic (4.49e-2)" "unprognostic (3.55e-3)" "unprognostic (1.36e-2)" "unprognostic (5.25e-2)" "unprognostic (2.90e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-1)" "unprognostic (1.17e-2)" "unprognostic (1.60e-2)" "unprognostic (5.23e-7)" "unprognostic (7.04e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (3.95e-2)" 1.4 8.1 20.6 1.4 46.7 1.2 2.0 60.1 81.9 1.2 1.4 4.0 0.7 1.7 1.3 18.8 2.0 1.8 1.2 39.2 36.5 18.0 1.7 3.5 1.2 1.8 10.3 21.3 1.1 3.3 5.6 9.9 1.1 13.4 3.0 1.4 2.7 1.8 2.2 70.7 1.8 1.6 1.2 4.1 1.3 2.4 2.3 4.8 0.0 7.7 2.4 2.0 1.1 0.0 1.3 1.0 3.2 1.2 3.2 1.2 0.8 0.0 0.3 0.2 0.3 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.2 0.8 0.0 1.1 2.4 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 5.3 0.0 0.2 0.1 0.0 2.4 0.1 0.9 0.1 0.0 0.0 42.0 2.2 0.2 0.0 0.0 0.1 1.9 0.2 0.2 0.2 0.4 0.2 0.0 0.5 0.4 0.1 0.2 0.0 0.2 3.2 0.7 1.0 0.8 0.9 1.2 1.1 1.0 0.5 0.5 1.3 1.2 1.1 2.0 3.2 1.2 1.0 0.9 0.8 20.6 46.7 60.1 42.4 36.5 18.0 10.3 21.3 13.4 4.8 0.0 0.0 0.0 27.8 1.0 838.1 74.9 2.5 0.0 0.0 0.0 43.2 0.0 8.3 0.0 0.8 0.6 0.0 0.0 0.0 0.1 0.4 2.6 4.6 4.4 0.2 57.2 39.0 0.0 1.2 2.1 1.7 0.0 1.7 0.0 0.0 14.1 0.1 0.0 0.0 0.8 46.7 0.0 0.9 0.0 1.7 0.4 0.2 0.0 0.0 0.7 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 39.8" "Cell line enhanced" "Detected in all" "PC-3: 46.3;SK-BR-3: 58.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 170000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 9.1 8.8 27.4 9.4 20.7 17.4 6.8 22.2 53.8 9.0 37.3 13.3 9.7 19.7 20.1 9.1 20.6 13.2 10.6 6.7 22.8 24.4 11.6 5.9 10.7 8.9 26.8 31.2 6.4 5.7 8.0 6.0 15.8 38.6 18.5 15.5 8.5 12.4 29.8 73.0 9.1 18.1 29.6 29.8 11.0 14.2 3.8 13.4 4.4 6.4 7.6 8.7 26.5 10.8 4.2 7.1 39.8 5.6 9.8 9.2 5.0 11.1 8.0 7.3 13.9 5.3 8.7 8.6 7.6 13.2 10.6 8.7 12.5 12.0 8.2 8.1 9.8 4.1 17.4 5.7 6.5 8.4 7.5 6.8 5.6 6.2 5.6 2.6 7.6 9.5 4.6 5.9 10.5 7.3 16.3 9.0 10.6 6.1 12.4 5.8 7.8 12.7 11.4 5.3 6.8 46.3 11.6 7.6 4.3 5.5 16.2 3.8 8.8 4.4 58.3 3.7 5.6 10.9 4.8 11.0 7.9 12.7 4.2 10.3 3.8 4.5 7.7 8.4 21.9 2.8 8.5 5.6 39.8 7.5 2.3 9.2 4.2 8.4 8.0 7.1 3.9 8.1 7.9 36.4 9.8 4.0 2.4 8.1 5.0 27.4 20.7 22.2 53.8 22.8 24.4 26.8 31.2 38.6 13.4 14.9 9.4 11.5 7.6 8.4 55.8 6.1 15.3 6.7 9.1 7.0 94.2 130.5 11.6 10.6 1.9 18.0 50.5 0.0 17.2 36.6 11.5 7.3 16.1 7.8 22.8 25.4 23.0 12.3 13.6 2.3 11.8 10.5 11.8 5.4 20.0 16.3 16.9 51.8 17.7 27.0 74.1 45.3 50.6 0.5 10.6 11.0 67.9 22.4 26.2 10.7 CAMK2N1 CaMKIINalpha ENSG00000162545 "Calcium/calmodulin dependent protein kinase II inhibitor 1" Q7Z7J9 1 20482391-20486220 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 128.2" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 287.0;Mucus-secreting cells: 362.0;Proximal tubular cells: 363.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 4.4" "Group enriched" "Detected in many" 15 "B-cells: 1.5;T-cells: 4.4" "Cell line enhanced" "Detected in many" "AN3-CA: 50.5;CAPAN-2: 47.1;Hep G2: 38.1;SK-BR-3: 38.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075200 Approved NA NA "HPA075200: " "unprognostic (1.67e-1)" "unprognostic (2.70e-3)" "unprognostic (9.71e-3)" "unprognostic (3.13e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (1.37e-7)" "prognostic unfavorable (5.49e-4)" "prognostic unfavorable (1.66e-4)" "unprognostic (4.77e-2)" "unprognostic (1.31e-1)" "unprognostic (7.48e-3)" "unprognostic (1.93e-2)" "unprognostic (1.40e-3)" "unprognostic (4.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.96e-2)" "unprognostic (1.31e-2)" 4.9 30.8 128.2 4.8 50.1 1.0 10.7 12.4 120.1 9.1 40.3 26.9 5.9 38.0 11.8 19.7 12.2 5.1 13.8 5.9 76.6 39.3 37.8 25.6 18.7 1.6 42.1 71.0 11.0 4.9 9.3 9.6 6.2 27.6 15.1 37.6 2.2 14.4 21.4 3.7 3.0 40.4 12.0 44.3 6.1 7.3 2.9 28.8 0.0 2.9 0.1 4.0 9.6 5.7 1.5 0.0 0.2 0.0 0.0 4.4 0.2 14.4 4.1 3.6 50.5 7.0 13.0 0.5 12.4 28.2 2.2 1.1 4.6 47.1 1.4 3.5 5.0 1.8 24.3 1.0 21.2 1.4 2.6 0.9 0.3 0.2 38.1 7.7 0.0 1.5 2.0 9.9 1.3 5.1 4.7 3.9 1.0 1.4 0.1 25.1 3.9 0.0 0.1 0.6 25.4 0.9 1.3 2.2 0.0 14.2 21.8 13.9 3.9 6.7 38.2 3.6 2.5 7.3 0.1 1.1 8.5 11.1 11.6 4.9 0.0 0.0 0.6 29.0 3.1 5.2 0.0 0.0 0.0 4.4 0.0 3.2 1.5 1.6 1.2 0.0 0.1 0.8 1.2 0.2 0.0 0.0 0.0 0.0 0.2 128.2 50.1 12.4 120.1 76.6 39.3 42.1 71.0 27.6 28.8 3.0 0.6 3.2 10.1 8.2 245.7 11.4 165.6 0.0 0.0 235.5 5.9 0.2 193.9 19.5 0.6 5.7 254.6 0.0 37.1 1.7 48.3 27.2 1.1 187.5 0.2 81.0 287.0 9.2 1.8 2.1 58.1 2.7 37.1 1.0 362.0 62.5 84.0 239.1 88.4 363.7 31.9 129.4 28.8 0.9 1.9 6.6 1.7 7.5 148.5 23.2 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261463 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5" "Cell type enriched" "Detected in some" 11 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA050835: AB_2681253, HPA075200: " "unprognostic (7.28e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 1.3 14.2 22.2 1.3 9.6 1.1 1.3 29.7 38.3 1.3 1.3 3.2 0.0 1.4 1.2 1.2 1.2 1.3 1.3 1.2 12.3 32.7 1.3 1.7 1.2 1.2 18.0 8.2 1.1 37.0 2.0 12.5 1.3 25.1 1.4 1.3 1.1 1.2 1.4 1.1 1.2 1.4 1.4 9.3 1.2 1.7 1.3 4.5 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.0 11.3 0.2 1.4 0.6 0.4 0.4 1.0 0.3 4.2 2.7 2.8 0.4 0.5 0.4 2.8 0.2 5.5 1.5 0.7 0.5 1.5 9.3 0.4 0.3 0.2 0.4 0.1 0.2 1.4 0.3 0.7 0.4 1.9 0.6 0.0 0.3 0.0 3.3 0.4 6.0 0.1 0.1 8.1 0.2 3.7 19.0 5.5 1.6 0.6 2.2 20.0 4.3 1.8 0.5 0.1 0.1 6.1 0.1 0.0 20.8 9.1 1.9 3.3 2.2 3.3 2.7 4.8 1.2 1.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 22.2 9.6 29.7 38.3 12.3 32.7 18.0 8.2 25.1 4.5 0.0 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.0 58.8 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 4.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 CAMK4 CaMK-GR ENSG00000152495 "Calcium/calmodulin dependent protein kinase IV" Q16566 5 111223653-111494886 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.9;lymphoid tissue: 71.7" "Cell type enhanced" "Detected in many" 27 "Bipolar cells: 47.8;Early spermatids: 236.0;Late spermatids: 80.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 14.1;memory CD4 T-cell: 10.3;memory CD8 T-cell: 7.8;naive CD4 T-cell: 19.8;naive CD8 T-cell: 10.9;T-reg: 11.3" "Lineage enriched" "Detected in single" 26 "T-cells: 19.8" "Cell line enhanced" "Detected in many" "HDLM-2: 39.4;JURKAT: 27.3;MOLT-4: 12.0;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004347, HPA011753, HPA017206" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949" "unprognostic (2.99e-5)" "unprognostic (7.19e-2)" "unprognostic (3.43e-3)" "unprognostic (5.11e-2)" "unprognostic (4.75e-3)" "unprognostic (3.48e-2)" "unprognostic (7.66e-4)" "unprognostic (7.22e-3)" "unprognostic (2.49e-1)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.23e-5)" "unprognostic (2.42e-2)" "unprognostic (3.01e-2)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" 1.1 6.5 9.5 6.4 34.2 4.6 1.0 48.9 16.5 1.8 2.3 1.0 0.0 2.4 1.3 0.8 1.4 0.9 2.7 0.9 5.9 3.2 1.4 2.5 1.9 12.0 2.3 6.8 1.4 0.9 0.3 1.3 0.6 3.4 5.8 2.5 0.1 1.7 2.6 0.8 0.9 3.8 1.5 2.0 4.2 2.6 13.8 6.6 71.7 1.0 0.0 8.1 2.8 1.1 0.7 0.0 0.4 0.0 0.6 19.8 3.4 0.0 0.0 1.4 0.9 0.3 1.1 0.0 0.3 3.0 3.6 3.6 0.0 0.0 0.0 1.9 0.1 2.4 0.1 3.0 0.3 2.6 39.4 2.4 0.5 1.3 0.0 0.1 0.2 0.1 0.1 0.0 7.6 0.8 2.2 0.6 27.3 0.0 1.4 0.2 0.0 12.0 0.0 1.8 0.0 0.1 1.8 2.3 0.1 1.3 0.0 8.6 15.4 0.5 0.0 2.6 0.1 0.0 0.2 0.0 7.5 4.4 0.0 6.6 1.2 0.1 0.0 3.6 0.0 2.8 0.0 0.0 0.0 2.8 0.0 14.1 0.7 10.3 7.8 0.0 0.2 19.8 10.9 0.4 0.6 0.0 0.0 11.3 3.4 9.5 34.2 48.9 15.1 5.9 3.2 2.3 6.8 3.4 6.6 0.0 0.6 4.2 0.2 1.0 47.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 236.0 0.7 0.0 0.0 0.0 0.1 1.6 0.4 4.6 0.2 0.2 0.0 0.0 0.6 1.0 80.4 3.7 1.1 0.0 0.0 0.1 2.1 0.8 0.0 1.4 0.0 4.1 0.0 4.5 3.2 6.1 0.9 0.0 29.9 0.0 0.3 CAMKK1 "CAMKKA, DKFZp761M0423, MGC34095" ENSG00000004660 "Calcium/calmodulin dependent protein kinase kinase 1" Q8N5S9 17 3860315-3894891 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.9;salivary gland: 27.1" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 36.4;Rod photoreceptor cells: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 18.2;U-87 MG: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009111, HPA028062" Approved Supported Cytosol No No Cytosol "CAB009111: AB_2068406, HPA028062: AB_1845954" "unprognostic (1.39e-2)" "unprognostic (2.13e-1)" "unprognostic (8.66e-3)" "unprognostic (4.40e-3)" "unprognostic (2.94e-3)" "unprognostic (4.79e-2)" "unprognostic (1.98e-1)" "unprognostic (4.47e-3)" "unprognostic (8.23e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.65e-4)" "unprognostic (1.98e-1)" "unprognostic (1.59e-1)" "unprognostic (7.19e-2)" "unprognostic (8.70e-2)" "unprognostic (8.36e-2)" "unprognostic (3.10e-1)" 4.3 10.2 15.3 5.1 21.4 3.7 4.7 23.2 38.9 4.1 3.2 2.2 4.0 3.1 7.5 5.2 4.2 3.7 3.8 5.7 13.8 6.8 1.5 1.0 4.0 2.5 5.5 16.0 6.0 7.5 5.0 10.1 2.3 11.2 3.3 3.1 2.5 27.1 11.2 2.2 7.8 3.7 6.2 2.2 4.3 2.9 6.1 5.0 1.7 7.2 2.3 2.5 5.6 4.9 0.1 1.6 5.6 4.1 0.0 1.0 1.1 4.9 8.5 0.9 4.3 3.1 5.5 0.3 3.4 3.7 3.3 1.5 3.1 1.5 3.0 3.7 6.6 3.4 14.7 2.3 4.2 2.0 0.1 7.8 3.4 18.2 1.1 3.1 0.5 2.7 4.2 3.6 6.2 2.1 2.9 1.5 4.4 2.6 0.1 1.6 1.3 4.1 1.9 1.0 7.2 8.1 2.1 3.7 3.4 3.5 3.1 5.0 2.8 1.3 10.2 2.2 0.5 3.9 1.1 2.0 5.7 7.7 7.3 2.8 0.4 0.2 0.1 20.8 2.9 0.7 0.0 1.8 3.6 0.6 3.9 1.0 0.0 0.6 0.5 1.6 0.1 0.6 0.3 5.6 0.0 4.1 0.8 0.0 1.1 15.3 21.4 23.2 38.9 13.8 6.8 5.5 16.0 11.2 5.0 6.0 15.1 8.5 1.9 3.3 36.4 5.7 0.0 1.4 5.7 1.8 15.7 0.2 0.0 0.4 0.0 4.4 0.5 0.0 1.4 0.1 4.5 1.4 16.2 0.2 3.8 7.9 4.1 3.1 1.9 0.4 1.1 3.6 8.5 0.0 1.4 3.8 0.8 0.0 1.1 0.0 24.1 0.0 2.0 0.1 1.4 4.6 0.2 0.7 2.3 0.8 CAMKK2 "CAMKK, CAMKKB, KIAA0787, MGC15254" ENSG00000110931 "Calcium/calmodulin dependent protein kinase kinase 2" Q96RR4 12 121237691-121298308 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 125.5" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 58.8;Late spermatids: 64.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 125.5" "Group enriched" "Detected in many" 5 "classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5" "Group enriched" "Detected in all" 5 "dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017389, HPA063713" Approved Supported Supported Cytosol NA NA Cytosol "HPA017389: AB_1845956, HPA063713: " "unprognostic (5.08e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-1)" "unprognostic (3.08e-1)" "unprognostic (1.88e-1)" "unprognostic (1.12e-1)" "unprognostic (2.62e-3)" "unprognostic (2.80e-2)" "unprognostic (1.93e-1)" "unprognostic (7.76e-2)" "unprognostic (5.01e-2)" "unprognostic (1.70e-1)" "unprognostic (1.75e-1)" "unprognostic (4.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" 11.7 6.5 19.7 7.8 30.2 13.8 8.8 125.5 45.5 9.0 9.5 7.1 2.6 12.8 8.6 5.3 8.3 11.8 6.3 6.9 11.2 5.1 7.1 8.9 9.6 6.9 6.2 17.3 10.5 5.8 6.4 4.1 7.5 9.1 12.2 9.7 6.2 7.5 13.2 5.1 9.1 13.2 10.3 6.2 14.1 7.6 3.6 5.8 5.2 6.1 4.5 7.2 7.2 7.4 2.2 7.2 26.1 19.4 3.6 2.2 6.3 12.5 9.4 7.0 13.5 21.1 19.7 10.7 10.4 11.0 8.5 7.8 9.8 5.4 19.4 8.7 21.0 6.0 10.4 8.6 11.2 6.7 13.3 16.9 9.6 6.3 9.6 14.3 21.9 9.2 12.7 16.6 8.0 18.2 11.5 19.9 14.8 11.1 10.5 8.2 12.1 24.3 18.0 5.1 10.5 10.7 15.8 8.2 17.2 8.2 14.0 26.9 10.8 13.6 7.3 8.6 5.9 18.2 26.8 14.5 7.0 5.7 5.9 5.7 40.3 23.9 14.7 13.1 15.4 6.9 0.7 14.2 26.1 2.1 19.4 2.2 2.2 1.7 1.9 7.2 1.2 1.5 1.7 17.2 3.6 16.5 1.6 1.3 6.3 19.7 30.2 125.5 45.5 11.2 5.1 6.2 17.3 9.1 5.8 8.9 3.5 4.1 5.1 7.0 21.6 7.0 20.4 8.1 6.8 8.7 2.0 7.4 3.3 8.7 15.7 17.5 18.2 0.0 9.0 6.7 12.5 10.8 5.8 18.3 7.1 58.8 33.0 12.9 13.9 64.8 19.0 13.7 8.5 15.4 15.9 5.1 7.5 11.5 29.7 8.4 6.4 19.4 21.3 0.7 2.4 5.3 2.9 7.1 15.6 5.8 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49870222 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 36 "brain: 77.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.3;Cone photoreceptor cells: 2.0;Early spermatids: 4.6;Horizontal cells: 3.2;Late spermatids: 6.5" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 5.3;HAP1: 7.0;NTERA-2: 25.2;RPMI-8226: 4.8;SCLC-21H: 8.6;SH-SY5Y: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 1.2 2.1 20.7 1.2 77.2 1.2 1.2 0.5 62.8 1.2 1.2 1.7 0.0 1.2 1.2 1.2 1.2 1.2 1.2 1.2 33.4 11.7 1.2 1.2 1.2 1.2 3.3 23.5 1.2 1.2 1.2 1.8 1.2 2.1 1.2 1.2 0.0 1.2 1.2 1.2 1.3 1.2 1.2 1.9 1.2 1.3 2.1 6.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 5.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.1 0.7 0.1 25.2 0.0 0.1 0.8 0.0 4.8 0.0 0.0 8.6 5.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.7 77.2 0.5 34.0 33.4 11.7 3.3 23.5 2.1 6.0 0.0 0.0 0.0 0.0 0.2 2.3 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.2 1.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.7 0.1 0.2 0.0 0.1 0.0 CAMP "CAP18, FALL-39, FALL39, LL37" ENSG00000164047 "Cathelicidin antimicrobial peptide" 3 48223347-48225491 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 63.7;bone marrow: 201.8;epididymis: 275.0" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 14.1;Glandular cells: 10.4;Late spermatids: 6.8;Spermatogonia: 4.9" "Cancer enhanced" "Detected in many" "testis cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "neutrophil: 63.7" "Lineage enriched" "Detected in many" 12 "granulocytes: 63.7" "Cell line enhanced" "Detected in some" "Daudi: 13.6;hTCEpi: 9.5;U-698: 39.4" "Low region specificity" "Detected in single" "CAB015949, CAB016522, HPA029874" Enhanced "Secreted to blood" NA NA 617000000 "CAB015949: , CAB016522: , HPA029874: AB_10600859" "unprognostic (2.14e-2)" "prognostic favorable (5.73e-4)" "unprognostic (4.59e-2)" "unprognostic (2.62e-1)" "unprognostic (9.41e-2)" "unprognostic (4.57e-5)" "unprognostic (3.09e-1)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.65e-2)" "unprognostic (1.32e-1)" "unprognostic (8.08e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-1)" "unprognostic (1.71e-1)" "unprognostic (1.80e-2)" "unprognostic (1.03e-2)" 0.2 0.1 0.1 0.1 0.2 201.8 0.2 0.1 0.1 0.1 0.1 0.0 14.7 0.0 0.0 275.0 0.1 0.2 0.0 0.5 0.1 0.1 0.1 0.2 1.5 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.2 0.0 0.1 1.1 0.1 0.1 0.1 2.6 0.0 0.1 10.1 0.1 4.0 0.0 0.4 0.4 0.1 0.2 0.4 0.1 0.5 1.5 63.7 5.2 0.5 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 39.4 0.0 1.5 0.0 5.5 1.1 15.8 0.0 1.7 0.0 0.5 0.0 0.0 1.5 0.3 0.0 0.0 63.7 0.5 5.2 0.8 0.0 10.9 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.2 0.0 0.2 10.4 0.0 0.0 3.3 0.0 0.0 0.6 0.6 6.8 0.9 0.8 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 0.0 0.0 0.0 0.0 0.4 CAMSAP3 "KIAA1543, Nezha, PPP1R80" ENSG00000076826 "Calmodulin regulated spectrin associated protein family member 3" Q9P1Y5 19 7595902-7618304 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 33.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 20.1;Hep G2: 11.4;SK-BR-3: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043830, HPA062149" Enhanced Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA043830: AB_10795879, HPA062149: AB_2684698" "unprognostic (3.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (7.90e-3)" "unprognostic (3.66e-1)" "unprognostic (3.87e-3)" "unprognostic (7.00e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-1)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "prognostic favorable (7.55e-7)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (3.72e-2)" "unprognostic (1.59e-3)" 0.8 2.8 8.0 1.9 9.2 0.9 4.1 12.0 15.5 4.5 11.4 0.8 13.5 20.9 1.5 8.0 14.7 4.8 7.6 0.9 5.2 4.8 9.7 14.2 4.5 1.1 2.6 6.5 1.0 15.7 4.2 6.2 3.6 7.0 6.7 4.1 8.8 22.1 16.0 1.1 33.9 17.7 1.0 1.0 1.1 14.5 9.1 1.1 0.9 9.6 2.5 5.7 4.1 6.9 0.0 0.1 0.0 0.0 0.0 0.6 0.0 8.4 1.4 0.2 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 20.1 4.5 2.3 3.6 0.0 0.9 7.5 3.3 2.2 0.0 1.5 7.7 0.0 0.3 11.4 0.0 0.0 3.5 0.0 4.3 0.0 0.3 0.3 0.0 3.4 0.7 0.0 0.0 9.6 0.1 0.1 5.2 6.2 3.7 0.5 0.0 2.8 1.5 4.5 6.5 6.9 1.0 9.8 0.0 1.3 8.2 1.3 0.0 0.0 1.6 0.0 0.3 4.0 0.7 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 8.0 9.2 12.0 15.5 5.2 4.8 2.6 6.5 7.0 1.1 8.9 19.2 0.0 2.4 8.8 22.3 0.8 17.8 0.0 4.5 8.7 0.0 0.4 3.3 5.2 4.4 0.6 31.9 0.0 10.2 0.6 0.3 9.0 5.7 20.3 0.2 9.5 12.6 0.6 1.3 2.7 1.4 0.4 0.0 0.0 18.0 1.3 11.5 21.0 0.0 11.3 12.8 0.0 0.7 0.5 1.7 16.6 0.5 0.9 14.0 4.3 CAMTA2 KIAA0909 ENSG00000108509 "Calmodulin binding transcription activator 2" O94983 17 4967992-4987652 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027835, HPA051147" Supported "Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol" NA NA Nucleoplasm "Vesicles, Actin filaments, Mitochondria, Cytosol" "HPA027835: , HPA051147: AB_2681362" "unprognostic (2.82e-1)" "unprognostic (3.06e-1)" "unprognostic (1.11e-2)" "unprognostic (1.01e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (2.78e-2)" "unprognostic (7.08e-2)" "prognostic favorable (6.00e-8)" "unprognostic (3.42e-2)" "unprognostic (9.02e-2)" "unprognostic (3.73e-2)" "unprognostic (1.20e-1)" "unprognostic (4.56e-2)" "unprognostic (1.19e-1)" 9.8 6.4 27.0 9.2 25.2 6.4 5.4 63.6 44.9 6.2 8.0 6.4 3.8 7.3 6.2 3.1 8.4 6.8 6.1 8.0 33.8 17.4 5.5 4.2 8.8 6.2 11.7 19.1 6.7 11.7 14.8 21.3 5.1 18.5 6.8 8.0 5.5 8.7 9.1 20.1 8.6 9.0 10.5 6.5 8.7 8.0 9.0 8.8 2.7 6.5 2.9 6.5 6.5 4.7 1.3 2.2 5.7 8.1 1.1 2.7 2.1 8.0 14.4 2.7 3.8 18.1 12.6 5.6 7.8 8.7 7.4 6.6 3.6 2.2 9.5 7.6 12.2 6.3 8.2 10.2 12.2 4.2 13.3 13.2 6.0 7.8 4.0 10.4 3.5 25.8 8.7 15.3 7.0 11.0 9.0 12.3 7.4 9.7 8.7 6.9 5.3 6.2 2.2 0.4 9.6 6.0 5.4 3.0 3.7 8.4 8.5 3.7 3.2 4.9 9.0 2.4 4.8 7.9 3.5 16.3 5.9 3.5 6.2 12.7 4.4 4.7 3.4 14.4 7.0 5.7 1.0 2.2 1.8 2.7 3.0 2.1 1.3 1.2 2.5 1.4 0.9 1.8 2.0 5.7 1.1 8.1 2.2 1.1 2.1 27.0 25.2 63.6 44.9 33.8 17.4 11.7 19.1 18.5 8.8 3.0 13.7 8.3 3.5 6.2 12.1 5.9 15.3 5.3 3.4 10.4 9.8 5.2 1.7 6.8 29.0 6.9 16.3 0.0 9.8 6.8 6.8 5.5 12.7 11.9 7.7 33.4 10.9 14.1 9.2 39.5 9.5 8.0 3.3 8.2 13.1 4.3 9.1 12.4 8.9 10.5 9.6 12.9 12.3 5.2 7.6 9.2 10.4 10.2 9.5 3.4 CAND2 "KIAA0667, TIP120B, Tp120b" ENSG00000144712 "Cullin associated and neddylation dissociated 2 (putative)" O75155 3 12796472-12871916 "Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 76.2" "Cell type enriched" "Detected in many" 6 "Early spermatids: 98.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 18.4;REH: 11.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005777 Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA005777: AB_2667431" "unprognostic (6.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.52e-3)" "unprognostic (6.09e-2)" "unprognostic (4.22e-1)" "unprognostic (2.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.67e-2)" "unprognostic (2.00e-2)" "unprognostic (9.03e-2)" "unprognostic (6.36e-3)" "unprognostic (1.03e-1)" "unprognostic (4.78e-5)" "unprognostic (1.31e-2)" "unprognostic (2.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.96e-3)" 2.9 2.8 6.4 1.4 7.6 1.4 1.4 7.2 11.8 2.3 3.2 3.7 0.5 1.5 3.7 2.6 2.6 3.6 2.1 17.8 4.7 4.3 1.7 1.7 1.9 1.4 2.7 5.5 3.3 2.5 6.4 4.9 1.4 3.1 3.0 1.4 4.2 2.2 3.4 76.2 1.6 1.7 5.2 2.2 2.2 2.1 11.4 2.6 0.1 2.4 11.1 1.2 3.0 5.0 1.2 0.2 0.7 0.5 0.0 2.2 0.6 0.7 1.5 5.8 0.2 0.2 0.1 0.3 1.7 0.6 3.1 4.3 0.8 0.3 0.9 1.7 0.8 0.8 0.2 6.4 0.1 2.8 1.6 18.4 1.3 2.2 1.2 4.9 0.1 0.1 1.3 0.3 3.1 0.1 3.3 0.7 6.8 4.7 0.9 0.9 3.0 2.3 0.7 4.1 0.4 1.8 11.4 1.1 0.9 0.2 1.3 3.9 5.2 0.1 0.8 1.0 1.1 1.7 5.6 0.4 0.9 1.0 0.9 1.2 1.5 9.0 8.7 0.5 1.1 1.9 0.0 0.5 0.0 1.2 0.2 0.6 1.2 0.6 2.2 0.1 0.5 1.3 0.9 0.7 0.0 0.1 0.2 1.6 0.6 6.4 7.6 7.2 11.8 4.7 4.3 2.7 5.5 3.1 2.6 3.0 0.6 0.0 0.7 0.3 13.3 3.6 0.0 0.0 1.2 1.8 9.8 0.1 0.0 0.6 98.3 1.0 0.0 0.0 0.0 0.1 1.3 0.4 0.0 2.1 3.2 12.7 0.0 1.8 0.0 17.8 4.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.6 0.5 2.5 0.0 1.7 1.4 3.8 0.1 0.1 0.7 0.0 0.3 CAP1 CAP ENSG00000131236 "Cyclase associated actin cytoskeleton regulatory protein 1" Q01518 1 40040233-40072649 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 201.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 203.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030124 Approved Approved Cytosol NA NA 270000000 Cytosol "HPA030124: AB_10600799" "unprognostic (1.80e-3)" "unprognostic (1.23e-3)" "unprognostic (5.68e-2)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (1.44e-6)" "unprognostic (5.37e-2)" "unprognostic (4.87e-1)" "unprognostic (1.98e-1)" "unprognostic (3.33e-3)" "unprognostic (1.09e-1)" "unprognostic (6.22e-2)" "unprognostic (1.39e-1)" "unprognostic (7.08e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" 70.0 31.8 33.3 68.7 41.0 74.6 42.4 16.6 37.4 40.1 58.2 42.7 25.2 37.9 69.4 28.9 60.9 44.6 36.9 27.2 28.6 26.6 56.6 52.0 58.2 63.7 37.2 26.9 44.5 22.6 29.7 22.5 74.4 39.5 42.0 57.7 31.3 39.8 39.7 20.6 37.1 58.9 62.9 42.7 79.9 44.6 39.0 30.0 62.4 40.2 32.6 83.1 53.3 40.8 27.4 70.6 201.2 106.1 37.2 57.6 115.5 44.9 19.5 24.7 14.6 35.1 32.9 36.8 79.7 48.2 45.0 45.4 28.1 47.8 35.0 32.5 65.6 30.8 28.3 29.6 58.4 62.1 46.7 17.5 54.8 21.5 22.1 32.3 33.8 156.3 33.6 30.1 68.7 38.9 50.7 37.9 20.3 20.4 23.5 67.3 13.3 26.8 18.5 40.0 33.0 21.9 20.3 32.8 21.4 47.6 47.6 11.7 24.6 33.9 39.3 54.2 51.1 18.2 203.6 67.5 38.5 35.0 20.1 67.5 19.2 37.6 32.1 50.6 37.7 50.4 95.4 60.2 201.2 57.6 88.9 45.3 27.4 41.7 55.1 70.6 26.3 35.4 47.9 128.3 37.2 106.1 27.7 55.1 115.5 33.3 41.0 16.6 37.4 28.6 26.6 37.2 26.9 39.5 30.0 113.2 90.0 165.3 126.1 99.7 40.3 13.7 86.6 73.6 78.5 108.2 25.5 179.9 94.5 335.8 422.5 137.1 167.8 0.0 239.7 381.4 126.1 105.8 219.9 66.5 383.8 39.7 73.1 171.2 376.6 351.4 81.4 395.6 94.5 634.8 120.1 147.6 544.5 150.5 166.2 105.9 41.2 161.7 157.2 125.6 45.8 116.1 198.9 232.9 110.6 183.3 CAP2 ENSG00000112186 "Cyclase associated actin cytoskeleton regulatory protein 2" P40123 6 17393216-17557792 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 165.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 110.1;Ciliated cells: 48.2;Sertoli cells: 32.3;Smooth muscle cells: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "LHCN-M2: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050530, HPA054147" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA050530: AB_2681159, HPA054147: AB_2682400" "unprognostic (7.27e-2)" "unprognostic (5.71e-3)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (4.86e-1)" "unprognostic (2.23e-2)" "unprognostic (9.94e-2)" "unprognostic (3.58e-2)" "unprognostic (7.72e-2)" "unprognostic (1.65e-1)" "unprognostic (6.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-1)" "unprognostic (8.05e-2)" "unprognostic (1.75e-3)" 5.8 4.1 13.8 3.0 20.1 0.7 3.9 7.5 26.4 5.6 7.7 1.9 2.0 1.9 9.2 5.9 7.0 5.8 3.8 31.2 19.9 8.7 3.3 2.0 2.1 1.1 5.3 17.3 2.1 1.6 3.2 1.7 6.2 8.6 8.4 3.6 2.9 2.5 10.1 165.7 0.9 2.6 13.1 2.0 1.6 3.3 1.1 1.3 0.0 2.3 14.5 1.3 4.6 6.4 0.0 0.0 0.0 0.0 0.0 2.9 0.1 5.1 8.1 15.7 18.7 0.1 0.0 3.4 18.5 13.5 15.2 13.9 2.6 2.3 0.0 17.4 19.8 21.3 2.7 6.9 6.9 22.1 0.0 2.6 0.0 5.2 8.8 1.5 0.0 0.0 1.1 3.4 7.7 3.3 24.9 0.7 0.0 0.0 0.0 32.1 8.3 0.0 0.0 5.9 0.2 4.6 1.7 20.8 0.3 8.0 2.1 2.0 3.9 6.2 20.1 10.9 30.1 22.2 3.7 0.0 12.3 11.7 0.3 16.2 0.0 0.0 0.0 4.1 0.0 16.8 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 20.1 7.5 26.4 19.9 8.7 5.3 17.3 8.6 1.3 3.0 1.0 0.0 3.5 1.6 13.5 110.1 2.5 48.2 5.7 1.8 3.9 14.9 3.3 2.4 0.1 1.0 0.0 0.0 0.6 10.7 8.2 1.4 0.0 1.8 1.9 7.9 5.8 4.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 5.0 3.6 2.0 4.6 16.1 2.0 32.3 40.1 0.1 2.1 0.6 31.4 0.0 1.5 0.7 CAPG "AFCP, MCP" ENSG00000042493 "Capping actin protein, gelsolin like" P40121 2 85394748-85418432 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 121.1" "Cell type enhanced" "Detected in many" 10 "granulocytes: 535.8;Hofbauer cells: 1102.8;monocytes: 603.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 81.3;HMC-1: 116.7;SK-MEL-30: 84.8;U-937: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018843, HPA019080, HPA019092" Enhanced Enhanced Nucleoplasm "Intracellular and membrane" Yes No 6700000 Nucleoplasm "HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980" "unprognostic (2.82e-2)" "unprognostic (1.37e-1)" "unprognostic (8.80e-2)" "unprognostic (1.28e-2)" "unprognostic (4.37e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-5)" "unprognostic (8.83e-2)" "unprognostic (3.22e-2)" "unprognostic (1.54e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-1)" "prognostic favorable (2.96e-4)" "unprognostic (1.45e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-3)" "unprognostic (7.89e-3)" 44.3 4.9 10.1 18.3 10.8 32.4 17.6 3.3 7.6 19.9 13.8 17.6 17.7 6.8 14.0 16.0 52.3 12.9 25.2 4.1 8.5 6.5 35.4 2.9 44.3 26.9 14.7 4.8 10.6 8.9 40.3 5.2 15.6 11.9 15.0 11.0 7.6 22.5 19.3 2.6 39.2 11.5 9.9 17.6 10.9 25.9 8.4 10.0 21.2 31.5 28.1 40.2 27.0 31.1 50.1 121.1 79.0 97.4 48.3 9.7 67.5 22.8 11.0 0.0 1.0 7.8 17.0 11.8 8.7 0.9 8.6 8.5 1.3 81.3 2.9 12.4 16.3 9.1 26.7 0.0 17.1 3.7 17.6 0.6 8.2 20.2 4.8 6.1 4.6 116.7 14.7 13.2 7.8 9.7 0.4 5.6 16.9 0.9 6.8 5.9 19.3 12.3 54.3 3.4 17.1 14.6 12.3 1.3 1.3 32.6 11.4 0.1 0.1 10.9 14.7 84.8 6.3 6.1 58.0 21.6 18.4 4.0 0.6 0.3 0.1 0.6 1.2 41.7 61.9 0.2 79.0 97.4 58.2 1.1 36.4 3.4 50.1 9.7 3.7 121.1 37.1 2.8 1.3 14.1 48.3 10.3 84.1 9.6 67.5 10.1 10.8 3.3 7.6 8.5 6.5 14.7 4.8 11.9 10.0 17.9 29.8 86.2 131.0 107.6 0.5 1.1 63.7 9.4 23.9 300.1 0.0 25.0 179.1 90.0 3.2 5.8 101.1 0.0 81.2 260.0 55.7 64.5 535.8 0.9 1102.8 1.6 27.6 3.1 175.5 12.5 43.4 306.0 140.0 603.3 55.7 37.8 257.6 119.4 21.2 88.5 1.1 12.9 23.5 6.3 40.4 148.2 29.9 59.9 86.5 209.1 CAPN11 ENSG00000137225 "Calpain 11" Q9UMQ6 6 44158811-44184402 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 63.7" "Group enriched" "Detected in some" 13 "Early spermatids: 16.7;Late spermatids: 7.9;Spermatocytes: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NTERA-2: 4.4;TIME: 11.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB018070, HPA030955" Enhanced NA NA "CAB018070: AB_2069481, HPA030955: AB_2673672" "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (1.64e-2)" "unprognostic (2.75e-1)" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (3.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.29e-1)" "unprognostic (8.96e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (3.62e-6)" "unprognostic (2.38e-2)" "unprognostic (3.51e-1)" "unprognostic (2.27e-2)" "unprognostic (8.89e-2)" 1.1 0.3 0.1 0.2 0.1 0.2 1.9 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.6 0.3 0.2 0.1 0.1 0.0 63.7 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.4 1.2 1.3 0.1 0.1 0.8 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.4 0.4 0.0 0.0 0.0 0.3 4.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.2 11.1 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.4 0.1 0.2 1.3 0.1 0.0 1.2 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.7 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.0 7.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 24.2 0.9 0.0 0.0 0.0 0.0 0.0 CAPN12 ENSG00000182472 "Calpain 12" Q6ZSI9 19 38730187-38769904 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Group enriched" "Detected in many" 7 "basophil: 24.5;NK-cell: 12.7" "Group enriched" "Detected in many" 7 "granulocytes: 24.5;NK-cells: 12.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 17.6" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "hippocampal formation: 3.6" HPA053322 Approved "Nucleoplasm,Focal adhesion sites" NA NA "Focal adhesion sites" Nucleoplasm "HPA053322: AB_2682111" "unprognostic (1.81e-1)" "unprognostic (4.48e-2)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-3)" "unprognostic (7.20e-2)" "unprognostic (2.45e-2)" "unprognostic (1.29e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (5.90e-6)" "unprognostic (7.04e-2)" "unprognostic (4.01e-2)" "unprognostic (3.00e-1)" "unprognostic (4.59e-2)" 0.6 0.4 0.2 4.7 0.2 0.2 0.7 0.2 0.3 4.2 4.1 0.1 5.6 1.2 1.1 1.0 1.2 3.6 21.0 0.7 1.0 0.4 7.1 21.8 2.0 1.8 0.2 0.1 0.4 5.0 0.2 0.7 0.5 2.4 2.2 0.7 0.4 34.3 3.0 0.3 4.5 1.9 0.5 0.4 4.9 1.6 0.6 0.1 0.4 0.4 1.6 5.2 1.5 1.0 1.7 0.0 24.5 0.0 12.7 2.6 0.7 0.2 1.8 0.1 0.0 0.3 0.1 2.2 0.1 0.0 0.0 0.1 3.2 0.1 0.7 0.1 0.0 0.3 1.3 0.0 0.8 0.0 0.1 0.0 0.3 0.7 0.9 0.0 0.0 17.6 0.8 2.5 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.2 1.9 0.0 0.1 0.0 0.1 0.4 0.1 0.4 0.1 1.4 0.0 0.0 0.1 0.0 0.4 0.9 0.7 0.0 0.1 0.0 0.7 24.5 0.0 1.8 2.6 0.0 2.5 1.5 0.7 1.3 0.0 1.7 0.0 0.6 0.4 12.7 0.0 0.0 0.5 0.7 0.2 0.2 0.2 0.3 1.0 0.4 0.2 0.1 2.4 0.1 11.9 27.1 15.9 8.0 8.4 1.2 0.6 50.9 5.3 5.7 5.2 0.0 1.5 0.0 9.1 0.4 1.8 4.2 0.0 6.3 8.2 1.1 2.3 4.7 12.7 0.9 0.0 3.5 1.3 1.0 0.2 0.6 2.0 3.3 0.0 18.8 1.7 4.0 3.5 0.4 16.5 0.6 0.0 1.7 0.3 2.4 8.3 2.4 25.4 16.4 4.3 CAPN13 FLJ23523 ENSG00000162949 "Calpain 13" Q6MZZ7 2 30722771-30820542 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 67.3;pancreas: 20.4;stomach 1: 17.6" "Cell type enhanced" "Detected in many" 8 "Club cells: 21.6;Enterocytes: 20.8;Intestinal endocrine cells: 14.5;Undifferentiated cells: 17.1;Urothelial cells: 20.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RT4: 9.0;SK-BR-3: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029496, HPA029497, HPA030034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281" "unprognostic (7.42e-2)" "unprognostic (1.19e-1)" "unprognostic (7.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.56e-2)" "unprognostic (1.51e-1)" "unprognostic (1.68e-1)" "unprognostic (1.32e-3)" "unprognostic (2.17e-1)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.96e-2)" "unprognostic (3.64e-1)" "unprognostic (3.32e-2)" "unprognostic (5.03e-2)" "unprognostic (4.28e-3)" 0.2 0.0 0.5 0.5 0.4 0.0 4.8 0.2 0.2 6.2 39.6 0.3 0.2 13.0 1.1 0.6 1.1 0.5 7.4 0.2 0.8 0.4 2.0 0.2 9.4 0.2 0.7 0.3 0.4 20.4 0.6 1.2 0.2 0.2 5.2 16.0 0.2 1.0 0.2 0.2 0.1 67.3 1.6 1.0 0.2 17.6 0.2 0.2 0.2 0.2 0.5 1.0 3.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 9.0 0.1 0.4 0.0 21.7 0.0 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.2 0.8 0.4 0.7 0.3 0.2 0.2 6.0 1.9 0.0 7.5 0.0 0.0 1.7 0.0 8.1 21.6 1.8 0.0 0.0 0.0 0.7 0.8 0.0 20.8 0.0 4.8 0.0 0.0 1.9 1.1 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 1.5 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.1 20.1 CAPN14 ENSG00000214711 "Calpain 14" A8MX76 2 31173056-31233858 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "esophagus: 92.6;lymphoid tissue: 25.0" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 8.0" "Group enriched" "Detected in some" 7 "cervical cancer: 2.9;head and neck cancer: 2.3;lung cancer: 0.8;stomach cancer: 1.4;urothelial cancer: 0.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enriched" "Detected in some" 6 "U-266/70: 7.9" "Not detected" "Not detected" NA NA "unprognostic (5.81e-3)" "unprognostic (1.20e-1)" "unprognostic (4.57e-2)" "unprognostic (1.88e-2)" "unprognostic (3.85e-2)" "unprognostic (3.30e-1)" "unprognostic (3.61e-2)" "unprognostic (4.67e-2)" "unprognostic (1.71e-1)" "unprognostic (3.14e-1)" "unprognostic (3.77e-1)" "unprognostic (1.60e-1)" "unprognostic (3.71e-4)" "unprognostic (8.42e-2)" "unprognostic (6.84e-2)" "unprognostic (1.91e-1)" "unprognostic (4.47e-4)" 0.1 0.1 0.2 0.0 0.3 0.0 0.2 0.5 0.3 1.1 0.1 0.0 0.0 0.0 0.4 0.0 92.6 0.1 0.0 0.2 0.2 0.3 0.1 0.4 0.2 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.2 3.2 25.0 0.2 0.4 1.3 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.4 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.4 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.3 0.5 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 8.0 CAPN3 "CANP3, LGMD2, LGMD2A, nCL-1, p94" ENSG00000092529 "Calpain 3" P20807 15 42359500-42412318 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.6;skeletal muscle: 210.9" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 403.1;Late spermatids: 111.1;Melanocytes: 457.2" "Cancer enriched" "Detected in some" 10 "melanoma: 9.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 23 "SK-MEL-30: 77.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040052 Enhanced NA NA "HPA040052: AB_2676821" "unprognostic (1.06e-2)" "unprognostic (1.31e-1)" "unprognostic (4.00e-2)" "unprognostic (8.71e-2)" "unprognostic (1.53e-1)" "unprognostic (1.72e-2)" "unprognostic (2.11e-4)" "unprognostic (3.12e-3)" "unprognostic (2.82e-1)" "unprognostic (2.47e-1)" "unprognostic (2.37e-3)" "unprognostic (3.26e-2)" "unprognostic (3.91e-4)" "unprognostic (5.56e-3)" "unprognostic (2.43e-1)" "unprognostic (8.93e-3)" "unprognostic (1.38e-1)" 5.7 1.8 13.0 2.3 32.1 16.7 3.8 3.1 22.9 2.1 2.4 65.6 0.0 2.2 3.1 47.0 4.2 2.5 3.0 3.6 19.9 11.5 22.1 6.3 6.7 3.4 50.7 19.5 3.1 1.4 3.4 1.7 2.0 39.0 3.0 3.2 5.0 3.1 3.1 210.9 19.7 2.3 2.8 52.6 3.3 2.1 4.1 47.3 0.0 1.6 27.6 3.0 2.7 2.3 1.5 1.7 0.9 2.6 1.3 3.2 1.4 0.1 0.2 0.2 0.3 3.3 3.2 0.3 1.2 0.7 0.1 0.2 0.3 0.2 0.0 0.4 0.6 0.1 1.8 0.1 1.3 0.1 0.3 0.3 0.2 0.5 1.0 0.1 0.5 0.6 2.1 2.0 0.2 0.5 0.7 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.5 0.1 0.0 0.2 0.5 0.0 0.7 0.8 0.5 0.0 0.0 0.0 0.1 77.0 0.3 0.0 1.8 0.3 0.0 0.1 1.6 0.2 0.4 0.7 0.0 0.2 0.9 0.7 0.0 2.6 0.0 2.8 0.6 2.8 0.4 0.3 1.0 1.7 1.5 0.2 3.2 0.9 1.3 0.2 1.6 1.3 1.4 13.0 32.1 3.1 22.9 19.9 11.5 50.7 19.5 39.0 47.3 11.9 34.6 0.0 0.8 17.9 1.5 0.3 0.0 0.0 5.7 1.8 2.0 0.5 1.7 0.0 403.1 0.7 1.6 0.0 0.0 0.4 0.8 0.6 1.1 6.6 24.8 0.0 0.0 2.5 4.5 111.1 4.9 4.6 457.2 1.0 1.8 3.6 0.0 4.5 3.2 36.6 3.7 0.0 0.8 9.4 4.9 7.4 2.7 1.9 1.9 0.7 CAPN5 "ADNIV, HTRA3, nCL-3, VRNI" ENSG00000149260 "Calpain 5" O15484 11 77066932-77126155 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.5;intestine: 47.8" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 114.7;Mucus-secreting cells: 72.0;Paneth cells: 69.1;Undifferentiated cells: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.8" "Lineage enriched" "Detected in single" 5 "T-cells: 4.8" "Cell line enhanced" "Detected in many" "OE19: 44.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033237, HPA072319" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB033237: AB_2069673, HPA072319: AB_2686512" "unprognostic (6.81e-3)" "unprognostic (1.31e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (3.47e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (5.30e-2)" "unprognostic (2.52e-1)" "unprognostic (2.21e-2)" "unprognostic (5.35e-3)" "unprognostic (4.64e-1)" "unprognostic (3.17e-3)" "unprognostic (8.58e-3)" "unprognostic (3.25e-1)" "unprognostic (2.31e-2)" "unprognostic (2.30e-3)" 3.9 7.1 5.6 19.5 5.4 1.5 3.9 6.3 10.8 7.4 34.1 6.0 4.8 32.7 6.3 8.3 18.3 6.6 49.5 4.4 5.4 4.6 8.7 26.8 2.8 1.2 3.7 7.0 15.4 3.2 0.7 3.3 2.6 10.2 9.3 27.9 7.4 4.7 7.5 1.8 1.9 47.8 9.3 4.1 2.2 29.3 22.0 2.3 0.6 3.1 4.6 7.3 9.8 6.3 0.2 0.7 0.0 0.9 0.0 4.8 2.1 0.3 5.5 3.7 3.6 13.9 13.4 0.3 5.5 9.6 5.7 4.2 3.2 1.6 0.2 4.0 9.6 6.5 0.2 1.5 0.4 2.4 0.3 0.3 1.1 0.1 0.3 3.5 0.1 0.3 6.6 0.6 9.2 2.2 8.0 6.6 2.6 0.1 0.1 10.6 7.7 0.9 0.1 3.1 44.2 4.3 0.8 12.5 0.2 1.9 6.9 0.2 6.7 1.3 1.0 2.5 2.4 0.8 0.0 13.7 11.1 6.6 15.3 0.7 0.4 0.7 0.0 5.7 0.1 2.6 0.0 0.7 0.0 4.8 0.9 0.4 0.0 0.5 1.6 0.7 0.2 2.4 2.5 0.0 0.0 0.2 0.3 0.0 2.1 5.6 5.4 6.3 10.8 5.4 4.6 3.7 7.0 10.2 2.3 0.0 0.3 0.8 0.2 1.4 1.5 1.7 28.1 4.0 7.9 22.7 0.0 0.0 1.7 9.0 0.9 2.1 114.7 0.0 29.7 0.4 6.2 2.3 0.0 37.5 0.8 1.6 21.5 2.5 1.8 1.1 11.5 1.2 6.8 0.0 72.0 6.4 15.2 69.1 4.2 5.9 1.8 0.0 2.2 0.4 2.3 0.6 0.0 0.0 49.0 1.4 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245103-111270523 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 62.9;placenta: 173.5" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.2;plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA040259 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 1.7 0.0 0.2 1.7 0.2 0.0 6.0 0.3 0.3 3.9 4.2 0.2 23.4 0.2 18.2 62.9 2.4 2.9 2.6 0.4 0.2 0.0 5.1 0.4 0.3 1.1 0.2 0.4 1.9 4.1 0.0 0.2 173.5 0.3 3.6 2.2 2.1 5.6 21.7 1.7 1.0 1.3 2.0 0.3 1.0 7.2 2.8 0.2 0.5 1.7 4.7 2.9 1.4 2.6 0.1 2.0 0.8 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.8 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.3 0.4 0.3 0.0 14.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.3 10.2 0.0 0.0 7.0 0.0 35.2 3.3 5.0 0.0 0.0 0.0 0.0 0.6 165.5 2.6 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 2.7 0.0 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 117.5 0.0 0.0 0.3 CAPN8 nCL-2 ENSG00000203697 "Calpain 8" A6NHC0 1 223538007-223665734 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 32.0;stomach 1: 85.8" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 123.4;Club cells: 94.4;Mucus-secreting cells: 49.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 28.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "OE19: 51.0;RT4: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073939 Approved "Nucleoplasm,Nuclear membrane,Vesicles" No NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA073939: AB_2686646" "unprognostic (4.87e-3)" "unprognostic (2.58e-1)" "unprognostic (1.89e-1)" "unprognostic (2.06e-2)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (7.97e-3)" "unprognostic (1.19e-1)" "unprognostic (1.26e-1)" "unprognostic (8.08e-2)" "unprognostic (2.72e-3)" "unprognostic (3.55e-1)" "unprognostic (4.12e-6)" "unprognostic (6.95e-2)" "unprognostic (5.59e-2)" "unprognostic (3.83e-2)" "unprognostic (5.44e-3)" 0.2 0.0 0.5 10.3 0.3 0.0 7.5 0.2 0.3 1.0 7.9 0.6 0.2 2.2 0.3 3.3 0.6 0.4 32.0 0.2 0.2 0.1 2.5 0.2 13.0 0.2 0.2 0.2 0.2 8.0 0.0 0.2 0.8 0.2 4.6 9.9 0.2 4.6 0.3 0.3 1.5 4.0 3.2 0.2 0.2 85.8 0.4 0.2 0.3 0.2 1.5 1.2 15.1 3.9 0.4 0.0 1.1 0.0 0.0 1.4 1.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.1 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 51.0 1.6 0.0 0.0 0.0 0.6 30.2 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.9 0.7 0.0 0.0 0.1 1.4 1.1 0.0 0.0 0.0 0.0 1.5 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 26.8 123.4 0.0 6.0 0.1 0.0 2.2 15.3 24.1 94.4 24.4 0.0 0.1 0.0 0.4 1.4 0.0 30.0 0.0 19.7 0.0 0.0 3.3 10.4 0.0 0.5 0.0 2.9 0.0 0.0 3.5 1.7 0.4 0.0 0.0 49.6 0.0 21.9 16.9 3.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 13.2 15.4 CAPN9 "GC36, nCL-4" ENSG00000135773 "Calpain 9" O14815 1 230747384-230802003 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.6;lung: 19.8;stomach 1: 35.8" "Group enriched" "Detected in many" 10 "Alveolar cells type 1: 23.8;Mucus-secreting cells: 67.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 6 "OE19: 11.9;SCLC-21H: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020398, CAB033483, HPA062050" Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: " "unprognostic (2.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.60e-2)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.49e-2)" "unprognostic (3.36e-2)" "unprognostic (2.30e-2)" "unprognostic (4.61e-2)" "unprognostic (3.44e-2)" "unprognostic (9.10e-2)" "unprognostic (1.60e-1)" "unprognostic (5.97e-5)" "unprognostic (1.51e-1)" "unprognostic (2.08e-1)" "unprognostic (4.60e-2)" "unprognostic (2.16e-1)" 0.2 0.7 0.4 7.0 0.3 0.0 0.2 0.3 0.5 0.4 10.4 0.4 0.2 3.9 0.2 0.2 0.7 1.5 12.7 0.2 0.5 0.2 0.2 0.2 19.8 0.2 0.6 0.2 0.3 0.2 0.0 0.6 0.2 0.2 0.8 13.7 0.2 8.1 0.2 1.3 0.0 17.6 0.2 1.1 0.2 35.8 0.2 0.2 0.2 0.2 1.0 7.1 3.7 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 0.6 11.9 0.0 0.4 0.0 0.0 0.0 0.1 17.1 0.0 0.0 0.5 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.3 0.4 0.5 0.2 0.6 0.2 0.2 0.2 23.8 4.8 0.0 0.5 0.0 0.0 3.3 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.2 4.5 0.0 3.5 0.0 0.2 0.0 0.0 0.4 2.3 0.0 0.1 0.0 2.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 67.4 0.2 1.1 3.5 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 1.0 CAPNS2 "MGC12536, MGC14804" ENSG00000256812 "Calpain small subunit 2" Q96L46 16 55566672-55567687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 56.0;skin 1: 44.1;tongue: 45.6" "Group enriched" "Detected in some" 12 "Basal keratinocytes: 78.1;Suprabasal keratinocytes: 130.6" "Group enriched" "Detected in many" 15 "cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 6.9;intermediate monocyte: 2.1" "Group enriched" "Detected in many" 9 "granulocytes: 6.9;monocytes: 2.1" "Cell line enriched" "Detected in some" 10 "hTCEpi: 71.5" "Not detected" "Not detected" "HPA059749, HPA076768" Enhanced Approved Cytosol NA NA Cytosol "HPA059749: AB_2732639, HPA076768: AB_2732322" "unprognostic (3.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.77e-3)" "unprognostic (4.14e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (7.21e-2)" "unprognostic (3.38e-2)" "unprognostic (3.62e-1)" "unprognostic (2.42e-2)" "unprognostic (4.48e-1)" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" 0.1 0.0 0.1 0.1 0.4 0.2 3.4 0.1 0.1 5.8 0.1 0.1 0.1 0.0 0.4 0.1 56.0 0.3 0.1 0.1 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.2 6.7 0.1 0.6 44.1 0.1 1.3 0.1 0.1 0.0 0.1 0.1 0.3 0.1 45.6 14.6 12.3 10.8 0.0 0.5 6.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 71.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 6.9 0.0 2.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 9.0 78.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 1.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 130.6 1.9 0.0 0.0 8.1 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine 19 5911707-5915877 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4;fallopian tube: 116.0" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 1030.6" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Region enhanced" "Detected in all" "pons and medulla: 71.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 36.6;U-266/70: 10.1" "Low region specificity" "Detected in many" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 2.6 4.1 8.0 4.3 14.7 4.3 2.8 1.4 3.3 12.4 3.3 34.4 15.6 3.1 9.1 49.4 2.8 116.0 13.6 2.0 13.4 6.6 8.9 5.0 25.4 4.4 8.0 7.8 26.7 6.5 2.5 7.5 17.7 71.4 9.4 2.0 3.3 7.7 12.7 2.0 5.7 5.0 2.9 7.5 7.6 9.4 2.1 17.9 0.4 7.8 0.9 2.5 8.8 11.3 4.9 4.0 5.2 2.2 5.3 4.8 2.4 1.1 1.1 0.7 3.5 1.3 1.8 2.2 0.6 0.4 0.2 0.3 0.8 7.5 0.8 2.2 0.9 0.5 1.4 0.3 0.3 0.1 2.4 1.0 0.6 2.2 2.0 1.2 0.6 1.8 2.3 2.1 0.2 0.5 2.5 0.5 2.6 0.5 2.9 0.4 2.1 1.4 2.0 0.6 8.8 5.7 1.7 0.3 2.3 1.0 3.2 0.7 2.6 0.5 36.6 3.7 2.0 2.3 2.3 1.0 0.6 0.4 2.7 9.7 10.1 3.4 0.7 4.3 1.0 1.4 3.3 2.2 1.6 4.8 1.8 2.6 3.1 3.0 3.6 2.1 4.9 2.4 2.0 5.2 5.3 1.6 4.0 3.2 2.4 8.0 14.7 1.4 3.3 13.4 6.6 8.0 7.8 71.4 17.9 11.9 16.8 0.8 29.9 4.2 2.2 1.9 0.0 1030.6 124.0 115.1 3.9 21.6 29.9 26.7 4.7 3.8 3.9 0.0 5.2 16.2 21.6 27.6 5.8 0.0 4.6 6.4 18.4 0.0 0.0 4.0 4.4 4.4 10.1 1.8 19.7 7.2 24.2 2.9 4.6 3.6 3.9 6.5 4.2 0.5 0.4 3.6 17.2 0.0 7.4 100.9 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 96.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039542, HPA040004" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome Yes No Nucleoli "Nucleoplasm, Vesicles, Centrosome" "HPA039542: , HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.3 3.7 1.0 0.3 1.9 1.4 0.1 0.7 0.2 2.0 2.2 0.0 1.7 0.3 3.3 0.5 0.8 0.8 0.0 1.6 1.4 1.2 0.6 1.5 0.6 0.0 0.0 0.2 0.0 0.6 1.0 1.7 0.3 12.1 0.2 1.3 0.3 0.6 2.6 0.0 1.8 1.4 0.5 0.0 0.5 0.0 0.0 0.2 2.6 0.0 2.1 1.0 0.2 0.1 1.2 0.2 1.2 0.5 0.8 1.9 0.8 0.4 0.3 0.2 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 8.9 3.2 0.0 2.5 1.5 0.7 7.1 2.5 96.4 17.0 5.2 3.9 1.0 5.0 0.8 21.6 1.7 0.0 0.0 1.5 0.5 1.7 1.5 0.0 1.5 0.5 1.6 0.0 2.5 1.8 11.5 5.8 0.9 0.0 0.0 1.7 5.8 0.4 0.0 6.7 2.5 20.8 0.0 1.4 9.1 0.9 0.5 0.2 0.0 0.6 0.5 CAPSL MGC26610 ENSG00000152611 "Calcyphosine like" Q8WWF8 5 35904295-35938779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 34.9;epididymis: 18.3;fallopian tube: 59.4" "Group enriched" "Detected in some" 5 "Ciliated cells: 455.0;Early spermatids: 136.1;Late spermatids: 117.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 14.1;ovarian cancer: 3.4" "Region enriched" "Detected in many" 7 "pons and medulla: 34.9" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Group enriched" "Detected in some" 4 "BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.9;REH: 7.8;U-698: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046811, HPA058495" Enhanced Approved Nucleoplasm,Microtubules No No "Nucleoplasm, Microtubules" "HPA046811: AB_2679819, HPA058495: AB_2683735" "unprognostic (1.16e-1)" "unprognostic (3.40e-2)" "unprognostic (2.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.20e-2)" "unprognostic (7.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.92e-3)" "unprognostic (4.42e-1)" "unprognostic (3.62e-4)" "unprognostic (1.46e-1)" "unprognostic (1.36e-2)" "unprognostic (1.52e-1)" 0.1 0.2 3.6 0.1 4.4 0.2 0.2 0.0 0.5 2.4 0.1 4.3 0.4 0.1 1.3 18.3 0.2 59.4 0.2 0.2 5.2 5.3 0.7 0.1 11.8 0.1 0.3 0.0 6.7 0.4 0.1 17.0 0.2 34.9 0.2 0.1 0.0 0.4 0.4 0.2 0.2 0.1 0.2 0.8 0.1 0.2 5.4 0.5 0.5 3.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 7.5 6.4 0.0 0.0 2.2 0.0 0.9 0.1 0.0 0.1 0.0 4.9 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.4 0.0 0.0 1.3 2.2 0.0 0.5 0.0 0.0 19.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 4.4 0.0 0.3 5.2 5.3 0.3 0.0 34.9 0.5 3.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 455.0 51.2 1.8 0.0 0.0 1.7 0.0 136.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 117.8 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 3.2 1.1 0.0 0.0 0.0 0.0 0.0 CAPZA1 ENSG00000116489 "Capping actin protein of muscle Z-line alpha subunit 1" P52907 1 112619173-112671619 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB045963 Approved NA NA 45000000 "CAB045963: AB_11126023" "unprognostic (7.06e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-3)" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.54e-6)" "unprognostic (1.17e-3)" "unprognostic (3.15e-2)" "unprognostic (3.82e-3)" "unprognostic (4.59e-3)" "unprognostic (9.50e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (2.42e-1)" "unprognostic (2.82e-1)" 16.0 13.3 12.1 22.1 20.1 26.7 11.7 16.3 19.2 10.7 17.0 14.5 17.4 13.6 18.8 21.7 32.9 9.9 11.9 9.4 20.6 12.9 15.3 15.7 17.8 28.7 16.3 17.3 10.6 12.3 6.4 15.7 17.3 15.2 14.8 20.3 17.2 13.9 20.1 8.2 18.7 16.9 13.0 17.7 28.3 13.8 35.9 15.2 6.2 25.0 9.8 37.7 15.1 17.1 31.7 32.6 82.9 62.7 22.1 38.9 47.9 43.3 12.9 22.8 18.7 29.2 33.6 28.5 35.1 37.4 36.8 33.0 17.1 18.8 49.0 25.5 42.7 16.7 21.0 31.1 38.3 46.3 33.8 16.0 42.6 22.2 21.7 34.7 75.7 56.5 36.6 29.6 36.1 34.7 22.0 41.8 21.3 43.1 29.1 52.6 25.6 36.1 33.8 22.3 27.1 28.1 27.2 46.2 23.9 32.7 30.7 16.0 17.1 42.3 38.9 28.5 19.0 20.0 67.6 47.2 29.9 29.2 48.2 42.9 19.8 18.0 53.1 51.2 58.4 67.3 49.8 40.5 48.0 29.3 59.4 32.3 31.7 32.5 35.1 32.6 23.8 18.4 29.6 82.9 22.1 62.7 25.7 38.9 47.9 12.1 20.1 16.3 19.2 20.6 12.9 16.3 17.3 15.2 15.2 26.8 43.5 158.7 59.0 160.6 30.5 17.9 53.5 41.5 43.3 96.0 23.6 121.2 77.9 89.9 361.4 69.7 94.6 46.7 97.7 174.0 101.1 82.8 91.1 66.8 207.4 41.3 58.7 85.3 269.4 164.6 52.9 192.3 116.4 196.6 82.9 29.6 126.3 122.4 51.9 57.9 29.7 64.7 68.9 141.5 47.5 207.9 153.9 169.4 80.5 127.7 CAPZA3 "CAPPA3, Gsg3" ENSG00000177938 "Capping actin protein of muscle Z-line alpha subunit 3" Q96KX2 12 18738101-18739187 "Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 67.5" "Group enriched" "Detected in some" 140 "Early spermatids: 2196.6;Late spermatids: 4664.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA038688 Enhanced NA NA "HPA038688: AB_2676151" "unprognostic (5.56e-2)" "unprognostic (1.43e-1)" "unprognostic (4.45e-3)" "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.3 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2196.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4664.1 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 6.5 0.0 22.6 11.1 0.0 0.0 0.0 0.0 0.0 CARD10 "BIMP1, CARMA3" ENSG00000100065 "Caspase recruitment domain family member 10" Q9BWT7 22 37490362-37519542 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.6" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 21.7;Enterocytes: 29.9;Pancreatic endocrine cells: 26.6;Paneth cells: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.1;U-2197: 36.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029359, HPA055612" Approved Approved "Vesicles,Intermediate filaments,Cytosol" No No "Vesicles, Intermediate filaments" Cytosol "HPA029359: AB_10601354, HPA055612: AB_2682861" "unprognostic (9.12e-3)" "unprognostic (2.28e-1)" "unprognostic (7.51e-2)" "prognostic favorable (3.47e-4)" "unprognostic (4.54e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (7.73e-6)" "unprognostic (3.66e-2)" "unprognostic (7.70e-2)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "unprognostic (3.68e-2)" "unprognostic (2.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.34e-1)" "unprognostic (4.31e-2)" "unprognostic (9.69e-2)" 8.1 6.8 3.5 4.5 2.3 0.0 10.2 1.5 2.7 5.7 16.4 2.4 4.1 23.7 9.8 6.4 6.8 5.9 14.1 7.6 1.7 1.1 14.0 10.5 7.0 2.4 1.6 1.3 6.8 8.9 1.6 1.7 4.9 3.8 5.6 6.2 5.6 12.6 3.2 8.0 7.3 33.6 4.1 1.3 3.3 7.0 11.1 1.3 0.7 5.6 13.5 3.9 4.9 9.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 13.1 9.6 1.8 1.3 0.0 3.9 8.7 1.2 2.8 5.6 4.4 6.0 9.4 0.0 4.7 2.3 5.4 18.5 2.1 24.1 1.7 0.0 5.2 0.3 6.1 9.2 2.4 0.2 0.8 1.3 5.0 10.7 13.8 4.5 11.3 0.0 1.3 0.0 4.2 4.5 0.0 0.8 3.1 7.1 5.8 0.0 17.2 1.3 8.3 2.3 0.6 1.0 9.2 4.1 0.9 2.2 4.4 0.7 14.9 4.2 12.3 36.1 6.9 0.0 0.0 0.0 13.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 3.5 2.3 1.5 2.7 1.7 1.1 1.6 1.3 3.8 1.3 0.0 1.3 0.0 3.4 7.6 0.2 3.1 10.2 0.0 1.2 3.5 0.0 0.1 1.7 21.7 7.8 14.7 29.9 0.0 17.3 1.5 1.1 3.6 0.0 3.9 0.1 0.0 7.5 12.3 0.0 4.3 0.0 0.4 5.0 0.0 17.6 0.0 26.6 21.0 0.7 10.5 0.1 0.0 1.2 0.5 3.4 3.3 0.0 0.0 8.1 7.1 CARD11 "BIMP3, CARMA1" ENSG00000198286 "Caspase recruitment domain family member 11" Q9BXL7 7 2906141-3043945 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.4;lymphoid tissue: 44.7" "Cell type enhanced" "Detected in some" 13 "B-cells: 19.1;Pancreatic endocrine cells: 15.2;T-cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 40.6;K-562: 16.2;RT4: 30.6;U-698: 36.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052984 Approved NA NA "HPA052984: AB_2682005" "unprognostic (3.12e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (4.81e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-1)" "unprognostic (2.31e-1)" "unprognostic (5.65e-2)" "unprognostic (5.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (6.68e-8)" "unprognostic (3.74e-2)" "unprognostic (4.75e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.10e-4)" 1.2 1.7 1.4 44.7 1.0 9.0 0.9 0.7 1.4 1.7 1.4 1.2 0.6 1.9 0.8 0.5 2.7 1.2 11.4 0.8 1.4 2.3 1.9 1.4 3.8 25.0 2.1 0.5 0.9 1.4 0.1 1.0 0.5 1.1 2.8 1.2 1.2 6.7 1.0 0.3 0.5 14.2 1.4 2.9 27.4 3.9 1.4 1.5 22.8 1.3 1.7 28.6 9.4 5.2 4.6 21.4 0.3 0.0 3.3 5.5 1.8 5.4 0.8 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 10.7 12.0 40.6 10.1 0.0 0.0 9.1 0.0 0.1 0.1 13.8 0.4 0.0 1.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 7.8 4.5 16.2 0.0 0.0 0.1 1.5 0.0 15.3 6.8 0.0 1.9 0.0 10.1 3.9 30.6 0.1 0.5 0.0 0.0 0.0 6.4 0.0 0.8 5.1 0.0 4.1 0.0 0.0 4.2 0.0 36.2 0.0 0.0 0.0 0.3 0.0 0.0 5.5 0.0 5.2 3.8 3.2 3.6 0.6 4.6 2.1 3.8 0.1 3.3 0.0 21.4 2.2 1.8 1.4 1.0 0.7 1.4 1.4 2.3 2.1 0.5 1.1 1.5 0.0 0.0 19.1 0.3 0.0 0.4 1.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 4.7 0.0 0.5 0.3 5.7 0.0 1.5 0.0 0.0 0.0 1.5 0.0 0.3 2.2 3.3 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.3 0.0 24.5 0.0 3.1 CARD14 "BIMP2, CARMA2, PSORS2" ENSG00000141527 "Caspase recruitment domain family member 14" Q9BXL6 17 80169992-80209331 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.1;skin 1: 17.3;tongue: 12.3" "Cell type enhanced" "Detected in some" 5 "Ciliated cells: 4.0;Glandular cells: 4.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 7.3;SK-BR-3: 10.0;T-47d: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023388 Supported Aggresome,Cytosol NA NA Cytosol Aggresome "HPA023388: AB_1846020" "unprognostic (9.79e-3)" "unprognostic (3.86e-2)" "unprognostic (4.26e-1)" "unprognostic (1.05e-5)" "unprognostic (2.65e-2)" "unprognostic (1.37e-2)" "unprognostic (2.92e-4)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (2.63e-1)" "unprognostic (3.01e-1)" "unprognostic (5.48e-2)" "unprognostic (1.62e-8)" "unprognostic (2.52e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-1)" 0.4 1.9 0.4 0.9 0.4 0.1 3.2 0.4 0.7 4.0 0.4 0.4 0.4 2.1 0.8 1.0 12.1 0.3 0.6 0.4 0.4 0.3 0.7 1.1 0.7 1.0 0.4 0.4 1.0 0.4 0.0 0.4 3.0 0.6 2.1 0.0 0.4 6.2 3.6 0.6 17.3 1.6 0.4 1.5 1.8 0.5 0.8 0.4 0.4 0.4 12.3 10.7 1.3 5.8 2.0 0.0 0.0 0.5 0.0 0.4 0.1 3.9 0.6 0.6 0.2 0.0 0.0 3.9 0.2 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.8 0.0 2.0 0.2 0.0 0.3 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.3 1.3 0.0 7.3 0.0 0.0 0.1 2.6 0.5 0.0 1.6 0.4 0.0 3.1 0.5 0.1 0.0 10.0 1.6 0.6 22.0 0.0 0.2 0.1 0.5 0.4 0.0 2.1 0.2 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.3 2.0 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.4 0.4 0.4 0.7 0.4 0.3 0.4 0.4 0.6 0.4 0.0 1.4 0.0 3.4 1.5 0.8 0.8 2.5 4.0 1.2 0.0 0.0 0.2 0.0 0.6 0.6 0.5 0.0 0.0 2.0 0.3 0.5 4.0 0.0 0.0 0.7 0.0 0.0 0.6 3.2 0.0 0.3 0.7 1.7 0.0 0.0 2.2 1.3 0.0 0.4 0.0 0.9 0.0 0.0 0.7 0.4 2.6 1.3 0.0 0.1 3.3 CARD16 "COP, COP1, PSEUDO-ICE" ENSG00000204397 "Caspase recruitment domain family member 16" Q5EG05 11 105041326-105101431 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.3;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 242.8;Macrophages: 269.3;monocytes: 172.3;Paneth cells: 336.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 38.8;HHSteC: 68.1;HUVEC TERT2: 31.2;TIME: 28.5" "HPA053981, HPA062805" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA053981: AB_2682332, HPA062805: AB_2684871" "unprognostic (2.25e-3)" "unprognostic (6.56e-2)" "unprognostic (1.49e-1)" "unprognostic (8.12e-2)" "unprognostic (4.45e-3)" "unprognostic (1.76e-1)" "unprognostic (4.71e-1)" "unprognostic (8.68e-2)" "unprognostic (1.56e-1)" "unprognostic (1.17e-2)" "unprognostic (5.12e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.93e-7)" "unprognostic (2.81e-1)" "unprognostic (6.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.19e-1)" 11.4 4.0 3.8 21.9 6.8 20.9 8.1 2.3 4.3 5.5 13.3 1.7 4.2 16.3 4.4 4.9 9.0 5.4 11.1 6.4 4.7 2.6 8.1 7.3 30.2 14.5 6.4 3.0 7.6 7.2 0.0 3.2 28.5 6.2 8.2 11.8 4.1 5.8 4.4 4.1 5.6 20.2 5.6 9.2 52.1 7.5 2.1 6.2 6.2 5.5 7.4 11.5 10.9 12.8 23.4 57.8 126.3 110.3 19.4 47.9 68.9 0.3 0.0 0.0 38.8 1.0 5.3 0.2 0.8 2.7 0.1 0.7 0.3 0.0 4.0 5.4 2.3 5.8 2.7 0.3 5.6 0.0 16.5 0.0 0.8 0.7 0.4 68.1 5.3 0.0 9.6 2.9 3.9 2.7 0.4 31.2 0.2 0.0 0.0 0.0 0.0 1.8 4.6 0.0 0.0 0.1 4.4 0.1 5.1 0.1 2.5 0.0 0.0 6.1 0.8 19.4 1.4 0.8 12.8 28.5 2.7 0.3 1.7 0.1 0.0 0.8 0.0 3.1 17.9 0.6 44.0 85.3 61.6 26.4 110.3 25.1 23.4 24.1 25.3 57.8 17.9 14.3 21.8 126.3 19.4 97.2 6.7 47.9 68.9 3.8 6.8 2.3 4.3 4.7 2.6 6.4 3.0 6.2 6.2 26.8 49.5 67.7 15.9 23.8 0.0 8.7 28.1 18.7 42.1 14.0 0.0 7.7 1.7 5.9 0.2 66.1 70.9 0.0 19.4 3.1 27.9 3.8 59.9 2.1 81.0 0.0 15.7 50.3 242.8 0.7 19.0 269.3 13.5 172.3 70.7 0.0 7.0 336.9 17.0 0.4 0.0 6.5 9.9 0.1 0.6 13.7 10.9 108.6 47.2 28.3 CARD17 INCA ENSG00000255221 "Caspase recruitment domain family member 17" Q5XLA6 11 105092469-105101431 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 14.4;skin 1: 6.7" "Cell type enhanced" "Detected in single" 17 "Basal keratinocytes: 1.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "T-reg: 14.4" "Lineage enriched" "Detected in many" 5 "T-cells: 14.4" "Cell line enriched" "Detected in some" 6 "AN3-CA: 5.9" NA NA "unprognostic (1.02e-1)" "unprognostic (3.86e-2)" "unprognostic (1.12e-2)" "unprognostic (5.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.26e-1)" "unprognostic (3.28e-1)" "unprognostic (2.56e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.99e-1)" "unprognostic (4.51e-9)" "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (2.45e-1)" "unprognostic (2.21e-2)" 1.3 0.1 1.2 1.9 1.1 0.2 0.3 0.1 1.5 1.4 0.8 0.1 0.1 0.0 0.1 0.1 4.5 0.0 0.7 0.1 0.1 0.1 0.8 0.2 1.5 3.4 2.5 0.1 0.1 0.1 0.0 0.1 0.9 1.1 0.7 0.0 0.1 0.5 0.1 0.1 6.7 0.9 0.1 0.1 1.8 0.1 0.1 0.9 0.1 0.1 4.0 3.1 2.0 2.0 0.0 1.2 3.1 1.3 0.0 14.4 0.9 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.3 0.1 0.9 1.2 1.9 0.0 3.5 1.0 1.2 0.0 0.1 0.4 3.1 0.0 0.3 0.1 14.4 0.9 1.2 1.1 0.1 1.5 0.1 0.1 2.5 0.1 1.1 0.9 0.0 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.0 CARD18 "ICEBERG, pseudo-ICE, UNQ5804" ENSG00000255501 "Caspase recruitment domain family member 18" P57730 11 105137721-105139726 "Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 8.2;skin 1: 26.7;tongue: 6.6" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 2.9;Early spermatids: 8.2;Late spermatids: 4.2;Suprabasal keratinocytes: 1.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.1" "Region enriched" "Detected in single" 9 "basal ganglia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.5;hTCEpi: 5.5;OE19: 4.4;U-2 OS: 5.8" HPA038582 Approved NA NA "HPA038582: AB_10960549" "unprognostic (3.90e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (3.42e-1)" 0.1 0.0 0.1 0.1 1.2 0.0 8.2 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 2.9 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.0 0.1 0.3 0.1 0.1 26.7 0.1 0.1 0.1 0.1 0.0 0.5 0.1 1.8 0.1 6.6 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 6.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.8 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.9 0.0 0.0 0.0 CARD9 ENSG00000187796 "Caspase recruitment domain family member 9" Q9H257 9 136361903-136373681 "Disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;bone marrow: 19.4;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 19.6;Horizontal cells: 14.3;Kupffer cells: 14.8;Macrophages: 18.4;monocytes: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 24.5;non-classical monocyte: 20.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.8;HMC-1: 33.2;NB-4: 24.1;THP-1: 29.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059502 Enhanced NA NA "HPA059502: AB_2684042" "unprognostic (7.03e-2)" "unprognostic (5.61e-2)" "unprognostic (8.62e-3)" "unprognostic (2.06e-2)" "unprognostic (2.75e-1)" "unprognostic (2.11e-2)" "unprognostic (3.89e-3)" "unprognostic (6.36e-2)" "unprognostic (2.64e-1)" "unprognostic (1.55e-2)" "unprognostic (7.68e-3)" "unprognostic (6.97e-2)" "unprognostic (2.02e-6)" "unprognostic (2.52e-1)" "unprognostic (4.87e-3)" "unprognostic (3.06e-1)" "unprognostic (1.06e-1)" 1.7 2.4 3.6 8.8 10.4 19.4 2.2 2.7 6.4 2.1 1.9 5.5 0.3 2.7 1.4 1.9 1.7 3.3 4.2 1.7 4.0 2.4 2.0 2.3 4.8 6.6 8.1 2.0 1.6 1.0 0.6 1.5 2.3 5.0 2.7 1.0 1.5 2.9 2.2 0.8 4.8 3.8 2.0 4.8 15.9 1.7 0.8 6.9 0.9 0.8 1.5 4.6 2.5 1.8 0.0 11.3 4.6 24.5 0.3 0.4 5.1 0.0 0.0 0.3 0.0 0.0 0.0 2.7 5.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 9.8 0.1 3.2 2.4 6.1 33.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 24.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.2 7.4 0.0 7.9 0.0 0.0 2.3 29.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 7.3 0.1 2.3 14.6 4.6 0.0 24.5 0.4 0.0 0.0 0.0 11.3 0.0 0.0 0.0 1.1 0.3 20.5 0.1 0.3 5.1 3.6 10.4 2.7 6.4 4.0 2.4 8.1 2.0 5.0 6.9 0.0 5.8 0.0 0.6 1.5 0.0 1.7 0.0 0.0 6.8 3.5 0.0 0.3 1.7 0.1 0.7 0.3 0.0 0.0 0.0 0.3 2.0 0.1 10.4 0.0 19.6 14.3 0.0 1.3 14.8 4.6 0.3 18.4 1.7 11.8 0.0 5.7 0.0 0.0 0.0 0.2 1.0 0.0 1.2 0.9 1.3 1.5 0.3 1.3 0.0 0.3 CARM1 PRMT4 ENSG00000142453 "Coactivator associated arginine methyltransferase 1" Q86X55 19 10871513-10923070 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 64.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032961, HPA043561, HPA048073, HPA069313" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: " "unprognostic (9.46e-2)" "unprognostic (3.61e-1)" "unprognostic (2.94e-2)" "unprognostic (2.23e-1)" "unprognostic (2.69e-2)" "unprognostic (3.13e-2)" "unprognostic (1.66e-3)" "unprognostic (3.76e-2)" "unprognostic (7.81e-2)" "unprognostic (6.18e-2)" "unprognostic (9.31e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (7.88e-6)" "unprognostic (1.71e-2)" "unprognostic (6.26e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (8.37e-4)" 12.2 8.8 12.3 12.6 16.1 13.2 9.6 12.5 17.7 15.8 14.0 9.3 9.0 11.5 19.6 9.1 20.5 14.8 12.4 14.7 11.2 7.2 9.3 14.5 8.9 12.4 7.8 10.2 13.0 16.9 8.2 6.9 15.3 9.5 12.6 10.2 12.0 11.4 13.2 64.3 12.5 12.0 15.6 6.6 9.8 11.1 17.5 8.6 9.4 10.0 12.7 15.6 15.8 15.9 1.3 1.6 0.3 1.4 0.1 2.6 0.4 22.6 16.9 24.2 32.8 20.2 27.7 23.2 16.3 28.3 24.2 23.3 26.0 8.3 31.2 19.6 28.4 12.2 21.7 24.7 24.5 15.3 34.9 20.1 9.6 11.0 31.5 17.3 14.4 12.5 18.9 16.0 16.5 20.0 13.8 30.6 24.9 22.9 28.1 14.2 40.9 25.1 12.4 29.9 15.2 28.1 35.1 12.4 36.3 14.6 11.7 17.6 16.9 11.6 14.1 15.7 12.6 14.1 12.4 18.3 29.2 16.5 27.7 19.0 27.4 21.6 27.3 19.2 23.2 12.6 0.0 1.4 0.2 1.2 1.4 0.5 1.3 0.9 2.6 1.3 1.3 1.0 0.9 0.3 0.1 0.7 1.6 0.8 0.4 12.3 16.1 12.5 17.7 11.2 7.2 7.8 10.2 9.5 8.6 8.9 13.5 11.5 4.9 6.9 31.0 0.8 17.8 8.1 6.8 8.7 49.1 16.3 6.6 11.8 25.6 5.7 28.0 46.7 16.9 26.3 10.3 10.9 1.1 23.7 22.3 42.9 26.5 11.1 17.8 13.0 26.2 7.5 5.0 28.9 25.6 10.2 20.3 25.9 18.0 7.3 19.9 6.5 9.2 25.8 16.4 6.0 10.1 4.1 21.2 9.0 CARMIL2 "LRRC16C, RLTPR" ENSG00000159753 "Capping protein regulator and myosin 1 linker 2" Q6F5E8 16 67644919-67657569 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 47.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 22.3;JURKAT: 16.7;MOLT-4: 21.8;REH: 36.8;RPMI-8226: 20.0;U-698: 37.2" "Low region specificity" "Detected in all" HPA041402 Approved NA NA "HPA041402: AB_10795591" "unprognostic (1.63e-2)" "unprognostic (1.17e-2)" "unprognostic (1.35e-2)" "unprognostic (6.37e-2)" "unprognostic (5.47e-3)" "unprognostic (4.27e-4)" "unprognostic (1.38e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.90e-5)" "unprognostic (4.07e-2)" "unprognostic (5.14e-10)" "unprognostic (2.25e-1)" "unprognostic (1.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.57e-2)" 0.7 0.6 5.8 23.0 6.4 5.5 0.3 5.9 7.4 0.6 2.0 0.4 0.3 1.9 0.6 1.0 1.9 0.3 2.4 0.5 10.0 3.9 0.9 0.3 1.8 24.4 2.3 0.4 0.4 3.0 0.1 2.8 0.5 0.6 0.5 0.8 0.5 6.1 0.7 0.5 0.4 8.0 0.5 0.7 12.9 1.9 0.7 0.4 47.7 0.4 0.5 21.6 2.5 0.3 1.5 1.1 0.0 0.0 1.7 2.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 6.5 0.2 0.0 0.2 0.0 3.3 0.2 22.3 0.4 0.0 0.0 0.0 2.1 0.0 0.0 4.9 2.8 1.3 0.1 0.4 0.2 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.3 0.3 0.0 0.3 21.8 11.0 3.9 0.1 0.1 36.8 0.0 20.0 0.0 0.0 5.7 0.6 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.3 0.7 0.0 0.1 6.4 11.2 37.2 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.7 0.9 2.7 0.7 0.1 1.5 0.8 0.5 0.0 1.7 0.0 1.1 2.5 0.4 5.8 6.4 5.9 7.4 10.0 3.9 2.3 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CARMIL3 "BC008134, C14orf121, crml-1, LRRC16B" ENSG00000186648 "Capping protein regulator and myosin 1 linker 3" Q8ND23 14 24052000-24069728 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 30.6;pituitary gland: 7.8;skin 1: 9.4" "Cell type enriched" "Detected in single" 8 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 8.4;HMC-1: 5.9;Karpas-707: 5.3;SCLC-21H: 8.7;SH-SY5Y: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030596 Uncertain NA NA "HPA030596: AB_10603012" "unprognostic (2.67e-2)" "unprognostic (2.07e-3)" "unprognostic (1.50e-1)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (1.29e-4)" "unprognostic (6.13e-2)" "unprognostic (8.92e-4)" "unprognostic (4.02e-1)" "unprognostic (7.08e-2)" "unprognostic (1.39e-4)" "unprognostic (4.49e-2)" "unprognostic (1.17e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-2)" "unprognostic (4.19e-1)" "unprognostic (2.16e-1)" 0.6 1.6 6.5 1.4 5.2 1.0 0.8 30.6 7.9 0.6 0.9 3.3 0.0 2.3 0.6 0.5 1.0 0.6 1.6 0.4 7.4 5.2 1.0 0.8 0.9 1.4 2.8 2.4 0.6 1.3 0.5 7.8 0.5 7.2 0.8 1.0 1.7 1.6 0.7 0.5 9.4 1.6 0.7 2.9 1.0 1.2 3.1 2.8 0.0 1.0 0.0 2.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.1 0.3 0.0 0.0 1.4 0.0 0.1 0.1 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.3 1.3 0.0 0.5 0.1 0.1 0.6 0.0 0.0 0.0 0.1 8.7 4.2 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 5.2 30.6 7.7 7.4 5.2 2.8 2.4 7.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CARNS1 "ATPGD1, KIAA1394" ENSG00000172508 "Carnosine synthase 1" A5YM72 11 67414968-67425607 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "brain: 88.7;skeletal muscle: 64.8" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 3.0;Cardiomyocytes: 11.7;Intestinal endocrine cells: 2.9" "Group enriched" "Detected in many" 5 "glioma: 4.1;thyroid cancer: 10.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 20 "B-cells: 1.9;NK-cells: 1.3;T-cells: 3.2" "Cell line enriched" "Detected in some" 12 "RPMI-8226: 13.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038569 Enhanced "Intracellular and membrane" NA NA "HPA038569: AB_2676089" "unprognostic (1.07e-4)" "unprognostic (4.33e-3)" "unprognostic (2.00e-2)" "unprognostic (6.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.05e-1)" "unprognostic (7.28e-2)" "unprognostic (7.54e-3)" "unprognostic (1.29e-1)" "unprognostic (1.82e-1)" "unprognostic (5.19e-3)" "unprognostic (1.00e-1)" "unprognostic (6.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.83e-3)" "unprognostic (8.33e-2)" 2.9 1.3 9.2 1.5 24.3 1.5 1.2 3.0 23.9 1.3 1.4 88.7 0.0 1.5 1.2 2.5 2.0 1.5 1.6 5.3 19.7 10.2 1.2 1.3 1.5 2.1 36.9 14.5 1.4 1.6 2.0 0.4 1.1 30.6 1.8 1.3 0.0 1.3 1.3 64.8 1.3 1.9 1.3 51.1 1.8 2.1 1.1 28.1 0.0 2.3 0.9 1.6 1.1 0.3 1.9 0.1 0.0 0.0 1.3 3.2 0.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.3 0.5 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.8 0.0 0.2 0.0 0.3 0.0 0.2 0.1 0.4 0.1 0.1 1.0 0.6 0.2 0.2 0.0 0.1 0.1 13.1 0.0 0.0 0.1 0.2 0.1 0.8 0.2 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 1.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 2.9 0.0 1.4 1.7 1.0 3.1 0.1 1.9 1.3 3.2 0.0 1.3 0.0 0.0 0.7 0.9 9.2 24.3 3.0 22.2 19.7 10.2 36.9 14.5 30.6 28.1 3.0 0.3 1.5 0.1 0.2 0.0 11.7 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 1.7 0.0 0.2 0.6 0.0 1.3 0.0 0.0 CARTPT CART ENSG00000164326 "CART prepropeptide" Q16568 5 71719163-71721048 "FDA approved drug targets, Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "adrenal gland: 67.5;brain: 101.4" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.8;Cone photoreceptor cells: 7.9;Early spermatids: 12.3;Glandular cells: 4.8;Intestinal endocrine cells: 6.8;Rod photoreceptor cells: 7.6" "Cancer enriched" "Detected in many" 9 "breast cancer: 117.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NB-4: 1.1;SH-SY5Y: 3.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 179.9" "CAB025515, HPA046278, CAB079776" Enhanced Supported "Secreted to blood" NA NA "CAB025515: , CAB079776: , HPA046278: AB_10961570" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (3.45e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.14e-1)" 1.6 67.5 8.0 2.8 22.3 0.5 5.8 0.1 29.0 0.5 3.4 2.1 0.0 3.5 0.6 0.9 3.5 0.7 0.6 0.5 31.1 101.4 0.5 0.5 0.5 0.5 1.0 4.5 0.5 5.3 0.5 1.7 0.5 54.1 3.3 3.1 1.6 0.5 0.5 0.5 0.5 1.4 8.1 8.6 0.5 3.4 1.9 9.7 0.0 3.4 0.0 0.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 22.3 0.1 29.0 31.1 101.4 1.0 4.5 54.1 9.7 0.0 0.0 0.0 0.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 6.8 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.1 0.0 7.6 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 CASC1 "FLJ10921, LAS1, PPP1R54" ENSG00000118307 "Cancer susceptibility 1" Q6TDU7 12 25108420-25195162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.1;pituitary gland: 21.5;testis: 25.3" "Group enriched" "Detected in many" 4 "Ciliated cells: 190.1;Early spermatids: 245.8;Late spermatids: 64.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Group enriched" "Detected in many" 5 "B-cells: 2.6;granulocytes: 4.2" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039662 Enhanced NA NA "HPA039662: AB_10795468" "unprognostic (6.42e-3)" "unprognostic (1.26e-2)" "unprognostic (1.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.62e-1)" "unprognostic (1.85e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (2.22e-1)" "unprognostic (3.91e-2)" "unprognostic (6.21e-4)" "unprognostic (2.54e-2)" "prognostic favorable (3.13e-4)" "unprognostic (2.01e-1)" "unprognostic (8.74e-3)" "unprognostic (7.16e-2)" "unprognostic (1.19e-1)" 0.6 1.0 3.1 0.5 7.6 0.8 2.0 0.7 4.6 2.7 0.6 3.7 1.9 0.2 2.2 12.4 0.9 17.1 1.0 0.9 3.5 4.0 3.6 0.3 4.8 0.7 1.5 4.1 5.4 1.3 5.5 21.5 0.4 12.2 1.4 0.3 1.1 1.0 3.4 0.4 1.4 0.4 0.7 2.4 0.5 1.0 25.3 2.5 0.0 5.2 0.0 0.4 0.6 0.6 2.6 0.7 4.2 0.4 0.2 0.6 0.3 0.5 1.1 1.2 0.9 0.0 0.7 0.7 0.0 0.9 0.8 0.8 0.1 3.3 3.4 1.1 0.0 0.4 0.6 0.1 0.6 0.7 1.0 0.2 0.0 0.1 0.0 0.0 0.4 1.3 0.0 0.5 0.6 0.0 1.9 0.0 3.2 1.7 1.1 0.0 0.0 0.5 1.3 0.4 0.4 0.0 1.1 0.5 0.0 3.2 0.3 2.1 0.8 0.5 0.0 0.6 1.5 3.2 0.2 0.0 0.2 2.6 1.6 0.3 1.4 0.6 2.7 0.9 0.6 0.6 0.4 0.3 0.8 0.3 0.3 0.3 1.6 0.1 0.6 0.1 2.6 0.4 0.5 4.2 0.2 0.4 0.7 0.0 0.3 3.1 7.6 0.7 4.6 3.5 4.0 1.5 4.1 12.2 2.5 0.0 2.7 0.0 1.1 0.2 2.0 2.0 0.0 190.1 18.2 5.2 5.9 0.2 6.6 0.4 245.8 0.4 0.0 0.0 0.2 0.1 0.5 0.6 1.1 0.0 0.1 1.6 0.0 0.0 0.0 64.6 2.0 0.3 0.0 0.0 0.0 3.0 0.2 0.0 3.5 3.7 11.9 0.0 0.0 38.6 7.4 0.1 0.1 0.0 0.0 0.3 CASC10 "bA418C1.3, C10orf114" ENSG00000204682 "Cancer susceptibility 10" Q5T4H9 10 21492658-21497262 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;liver: 13.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 5.9;Proximal tubular cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 10.3;AF22: 10.4;AN3-CA: 14.4;BEWO: 13.9;SK-BR-3: 9.1" HPA064131 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA064131: AB_2685196" "unprognostic (2.69e-2)" "unprognostic (1.46e-2)" "unprognostic (5.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (3.22e-2)" "unprognostic (1.34e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (2.00e-1)" "unprognostic (8.55e-2)" "unprognostic (1.85e-1)" "unprognostic (4.04e-3)" "unprognostic (1.09e-3)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (5.86e-4)" 1.8 2.6 8.9 0.9 6.2 0.9 0.9 2.0 8.0 2.5 0.8 6.1 0.1 1.0 1.3 1.1 1.2 2.4 1.7 3.8 11.8 3.8 6.3 13.6 1.5 1.3 3.3 4.2 2.6 1.3 3.7 3.3 7.2 2.7 1.9 0.7 2.0 1.0 1.8 5.0 3.3 0.9 1.5 2.2 0.8 0.9 2.6 5.3 0.1 5.6 0.0 0.8 2.3 1.6 0.6 0.4 2.2 0.3 1.0 0.4 0.2 1.7 10.3 10.4 14.4 1.9 1.0 13.9 0.9 0.4 0.1 0.2 1.6 3.6 0.5 1.5 0.8 1.8 2.2 1.8 0.6 0.1 0.3 1.9 0.1 1.5 2.3 0.5 0.0 0.1 1.3 1.8 0.1 0.2 1.5 0.9 0.6 0.6 0.1 0.1 1.6 0.7 0.6 1.4 0.0 0.9 0.8 0.1 0.0 2.1 1.5 1.4 5.1 4.8 9.1 0.6 3.5 1.7 7.9 2.5 0.9 8.1 0.2 1.1 0.1 0.2 0.1 4.5 0.0 4.5 1.5 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.1 0.0 0.6 0.2 0.4 2.2 1.0 0.3 0.4 0.2 0.2 8.9 6.2 2.0 8.0 11.8 3.8 3.3 4.2 2.7 5.3 0.0 0.6 0.0 0.4 1.0 2.3 2.2 0.0 2.7 0.0 1.8 0.0 2.0 5.0 0.0 0.2 3.7 0.0 0.0 0.0 2.3 1.9 0.1 0.0 5.9 0.7 4.8 0.0 3.7 0.3 0.0 4.4 0.0 1.7 0.0 0.0 2.9 0.2 0.0 1.8 10.5 0.6 0.0 0.3 0.2 0.2 0.6 3.2 0.0 0.0 0.1 CASKIN1 "ANKS5A, KIAA1306" ENSG00000167971 "CASK interacting protein 1" Q8WXD9 16 2177180-2196525 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 30.4" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 19.0;Cone photoreceptor cells: 7.9;Horizontal cells: 39.7;Muller glia cells: 18.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HDLM-2: 17.0;HEK 293: 3.8;SCLC-21H: 7.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055990, HPA076882, CAB079050" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB079050: , HPA055990: AB_2682997, HPA076882: " "unprognostic (4.91e-2)" "unprognostic (2.48e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (8.02e-2)" "unprognostic (6.58e-2)" "unprognostic (4.59e-1)" "unprognostic (2.21e-4)" "unprognostic (2.67e-2)" "unprognostic (2.62e-1)" "unprognostic (9.70e-3)" "unprognostic (1.72e-1)" "unprognostic (7.34e-3)" "unprognostic (3.39e-1)" 1.1 1.8 17.7 1.2 18.1 1.1 1.4 15.0 30.4 1.5 1.2 2.3 0.0 1.2 1.5 1.3 1.2 1.4 1.2 2.5 16.4 12.8 1.3 1.1 1.1 1.1 12.4 11.7 1.2 1.5 1.9 1.4 1.2 11.1 1.8 1.2 1.8 2.5 1.4 1.3 2.2 1.3 1.2 2.8 1.1 1.3 1.8 4.0 0.0 1.6 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 4.6 0.0 0.0 2.2 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.9 0.0 0.0 0.0 1.2 0.3 0.0 17.0 3.8 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.1 0.0 1.3 0.0 1.0 0.8 0.0 0.0 0.9 0.0 0.4 0.2 0.0 7.8 3.8 0.1 0.2 0.2 0.2 1.0 0.5 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 18.1 15.0 21.7 16.4 12.8 12.4 11.7 11.1 4.0 0.0 0.0 0.0 0.2 0.3 19.0 2.3 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 39.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.6 0.2 0.0 0.0 0.0 5.1 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.0 CASP1 "ICE, IL1BC" ENSG00000137752 "Caspase 1" P29466 11 105025443-105035250 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 64.2;lymphoid tissue: 40.7" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 83.5;Kupffer cells: 119.3;Macrophages: 125.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 38.4;HBEC3-KT: 18.2;HHSteC: 20.6;U-937: 45.4" "Region enhanced" "Detected in many" "olfactory region: 22.8" "Low region specificity" "Detected in all" "CAB002685, HPA003056" Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB002685: , HPA003056: AB_1846037" "unprognostic (1.21e-3)" "unprognostic (3.02e-1)" "unprognostic (9.47e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (1.21e-1)" "unprognostic (5.24e-2)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (6.67e-2)" "unprognostic (2.75e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.03e-2)" "unprognostic (2.30e-2)" "unprognostic (3.18e-1)" "unprognostic (5.19e-2)" 7.4 3.9 6.6 15.1 17.0 8.2 6.9 3.5 7.0 4.1 12.8 2.2 2.9 34.0 3.0 4.2 10.6 4.3 7.3 4.9 9.3 3.0 6.4 5.8 20.5 16.2 16.7 2.6 4.4 3.4 0.2 3.7 8.7 13.3 6.1 13.9 3.7 7.0 3.2 1.6 9.9 37.2 5.2 17.4 40.7 5.6 1.5 11.0 4.1 3.7 5.6 9.0 9.7 13.2 7.3 39.6 40.5 64.2 11.1 34.3 31.2 0.4 0.1 0.0 1.8 2.0 4.3 0.3 1.9 38.4 4.8 13.5 0.0 0.2 6.2 0.8 2.2 8.9 2.7 0.0 18.2 1.1 4.0 0.0 0.3 0.2 0.4 20.6 7.2 0.0 7.3 12.9 3.9 10.6 12.6 2.1 0.1 0.0 0.0 1.1 0.0 0.2 10.1 0.0 0.0 0.1 6.0 0.1 4.9 0.1 3.0 0.1 0.1 5.7 0.4 8.4 0.0 0.4 16.7 2.4 4.4 0.2 0.4 0.5 0.0 1.7 0.0 2.8 45.4 0.9 12.3 42.8 23.2 25.4 64.2 34.3 7.3 18.1 22.0 39.6 6.0 9.9 16.4 40.5 11.1 64.0 1.4 22.2 31.2 6.6 17.0 3.5 7.0 9.3 3.0 16.7 2.6 13.3 11.0 17.9 35.4 32.0 33.0 23.1 0.0 2.6 12.7 12.0 11.4 10.4 0.0 1.3 1.7 15.7 0.0 24.1 33.9 0.0 11.7 1.0 13.1 5.7 15.1 1.7 83.5 0.0 5.8 17.8 119.3 0.2 3.1 125.6 5.0 34.3 32.1 0.0 4.7 49.2 3.2 1.0 0.1 0.0 5.4 0.0 0.0 19.4 0.9 48.4 29.9 41.4 CASP10 MCH4 ENSG00000003400 "Caspase 10" Q92851 2 201182881-201229406 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.4" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 18.0" "Low region specificity" "Detected in all" "CAB003780, HPA017059" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB003780: AB_289592, HPA017059: AB_1846040" "unprognostic (4.01e-2)" "unprognostic (8.24e-2)" "unprognostic (4.80e-1)" "unprognostic (1.28e-3)" "unprognostic (4.74e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.05e-7)" "unprognostic (3.23e-2)" "unprognostic (2.19e-2)" "unprognostic (4.49e-2)" "unprognostic (1.38e-2)" 16.0 3.3 3.4 10.1 3.4 14.9 7.6 1.9 3.3 7.0 17.7 4.4 4.3 18.6 8.3 8.2 10.4 4.9 7.2 4.8 3.6 3.0 10.3 7.8 14.2 10.4 4.1 1.4 3.4 6.1 1.4 2.1 8.5 4.7 5.0 11.9 4.1 6.9 6.9 3.6 5.4 42.4 4.8 5.6 26.1 8.7 2.1 2.5 17.1 6.8 8.2 17.9 9.4 6.1 7.8 6.0 4.7 15.4 7.1 7.1 5.8 2.9 2.4 0.1 0.2 0.1 0.2 5.2 0.5 3.5 0.3 1.4 3.1 6.9 0.2 5.0 1.8 1.2 2.0 0.1 1.6 0.9 1.4 3.3 8.4 2.5 10.4 1.2 5.6 9.1 0.3 1.4 3.8 0.3 0.2 18.0 3.6 10.0 12.4 0.3 0.1 10.7 5.2 0.3 4.1 1.5 5.9 0.3 12.4 6.3 4.2 0.1 0.1 2.8 0.1 1.4 2.3 0.1 5.3 7.3 0.2 0.5 2.4 0.1 13.5 8.0 0.3 3.4 4.3 0.1 4.7 9.6 0.6 6.2 13.5 5.2 7.8 5.2 3.4 5.3 5.0 7.1 6.0 1.9 7.1 15.4 6.0 1.0 5.8 3.4 3.4 1.9 3.3 3.6 3.0 4.1 1.4 4.7 2.5 17.9 7.7 16.2 2.5 5.4 0.0 1.7 7.6 14.7 5.7 8.7 0.0 0.9 1.7 11.0 0.8 24.0 35.4 23.3 9.2 0.6 3.7 3.0 7.0 5.8 8.1 0.0 2.4 20.9 21.0 0.0 0.6 16.1 6.8 11.8 18.2 0.5 8.3 24.6 0.0 6.8 0.3 0.0 2.1 0.0 0.0 4.0 0.3 13.1 11.0 7.9 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 83.9" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "hTCEpi: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: AB_2672101" "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 83.9 0.6 0.0 0.0 0.1 CASP2 "ICH1, MGC2181, NEDD2, PPP1R57" ENSG00000106144 "Caspase 2" P42575 7 143288215-143307696 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 45.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012175, HPA050678" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB012175: , HPA050678: AB_2681214" "unprognostic (6.96e-2)" "prognostic favorable (7.38e-4)" "unprognostic (2.74e-2)" "unprognostic (7.51e-2)" "unprognostic (4.24e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (1.74e-2)" "unprognostic (1.34e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.91e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.66e-3)" "unprognostic (9.48e-2)" "unprognostic (1.19e-1)" "unprognostic (1.64e-1)" 10.5 6.5 6.6 10.7 6.7 26.8 10.2 9.6 10.9 9.6 8.5 9.0 8.2 8.2 10.8 7.8 14.1 8.4 5.7 6.1 5.7 4.1 7.3 5.8 9.8 15.8 6.9 6.1 8.7 8.1 12.1 6.6 11.3 7.3 7.6 10.2 10.1 11.6 5.8 4.3 14.2 14.0 7.4 6.3 18.6 7.5 8.6 6.9 45.7 8.9 8.0 23.0 7.4 10.2 18.5 11.8 33.2 17.7 13.4 21.4 7.6 10.9 10.3 11.6 20.5 6.5 7.7 6.2 11.2 5.1 10.3 11.3 10.2 12.4 20.8 10.7 7.1 7.9 10.8 11.6 8.9 13.8 18.2 8.9 12.3 16.2 7.0 3.5 23.9 15.4 5.3 7.3 12.5 4.4 4.7 8.8 16.4 10.2 13.3 10.9 10.8 41.6 25.2 14.6 10.7 10.5 30.6 6.0 12.7 6.1 9.3 12.7 14.3 22.3 9.7 7.1 8.3 10.6 9.2 9.8 9.2 6.4 16.5 11.2 11.1 10.9 24.2 10.3 28.5 16.7 33.2 10.8 9.3 14.9 11.9 14.6 15.8 20.6 15.4 9.8 18.5 15.4 17.8 12.3 13.4 17.7 11.8 21.4 7.6 6.6 6.7 9.6 10.9 5.7 4.1 6.9 6.1 7.3 6.9 8.9 8.8 17.9 5.4 13.5 4.7 5.3 25.5 2.7 3.4 7.0 7.9 16.2 3.3 7.7 35.5 13.9 6.5 0.0 6.6 12.8 8.7 5.5 9.3 4.4 8.8 6.4 10.3 14.7 15.4 38.5 10.9 12.1 20.3 11.8 10.3 4.0 7.6 3.5 7.8 3.3 14.0 0.0 8.4 10.1 29.4 12.0 4.8 20.8 13.3 6.0 CASP3 "apopain, CPP32, CPP32B, Yama" ENSG00000164305 "Caspase 3" P42574 4 184627696-184649509 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 76.7;eosinophil: 62.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in all" "Karpas-707: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000091, HPA002643, CAB008381" Enhanced Approved Nucleoplasm,Mitochondria NA NA 310000 Mitochondria Nucleoplasm "CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048" "unprognostic (1.38e-1)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "prognostic favorable (2.24e-4)" "unprognostic (2.29e-3)" "unprognostic (3.58e-2)" "unprognostic (9.57e-3)" "unprognostic (5.86e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (1.70e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.30e-5)" "unprognostic (1.41e-2)" "unprognostic (5.74e-3)" "unprognostic (1.30e-1)" "unprognostic (4.05e-3)" 20.7 11.6 10.8 16.9 10.5 16.7 10.0 22.3 9.2 10.4 25.4 12.8 12.5 32.3 13.9 11.5 22.8 8.9 12.0 8.8 10.0 8.8 10.6 18.7 12.4 23.6 10.2 8.5 8.3 10.0 4.6 13.6 29.4 9.7 8.8 20.9 8.2 13.0 10.0 12.6 9.5 49.7 9.3 12.6 26.5 18.7 6.4 10.9 44.7 7.8 13.5 24.3 16.2 11.0 4.2 5.2 76.7 10.6 9.2 9.9 7.0 8.3 4.7 18.7 8.9 11.6 15.5 10.8 25.3 19.2 17.8 10.3 8.5 7.1 11.7 4.0 12.3 8.4 7.2 14.8 9.0 20.3 30.0 8.1 18.7 3.7 19.7 13.9 15.2 17.8 21.1 11.0 11.3 9.1 12.8 22.0 12.1 15.4 74.2 18.3 3.6 24.0 14.2 18.5 9.3 5.9 17.4 8.8 11.3 15.3 13.8 10.7 11.7 10.9 10.0 14.2 19.4 5.4 9.9 14.9 8.1 7.5 6.0 11.7 34.5 32.3 8.0 9.9 10.6 11.5 76.7 4.2 62.8 5.5 6.8 5.7 4.2 5.1 7.8 5.2 3.1 3.9 5.8 5.8 9.2 10.6 4.1 9.9 7.0 10.8 10.5 22.3 9.2 10.0 8.8 10.2 8.5 9.7 10.9 17.9 12.0 18.6 18.8 43.3 17.6 14.1 5.1 25.4 20.5 12.2 0.0 41.4 11.6 16.0 7.6 23.3 28.6 0.0 20.9 27.1 16.9 14.4 17.3 12.9 20.5 12.7 17.3 20.9 25.1 3.2 6.9 17.5 28.7 55.9 34.1 13.8 20.4 19.9 7.1 6.5 10.2 12.9 14.4 7.5 14.2 25.0 43.0 36.2 21.5 31.5 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969436 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 82.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavorable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 10.6 6.3 0.5 9.7 0.5 6.1 9.4 0.0 0.0 4.7 3.5 8.9 3.5 5.9 14.1 5.8 7.3 4.9 0.5 0.5 6.7 16.5 14.0 10.5 1.0 7.5 16.8 0.0 3.0 10.7 5.8 4.0 11.2 1.9 1.6 10.4 8.8 4.3 2.0 19.0 8.2 0.2 4.2 11.3 8.2 8.0 20.5 29.3 82.8 43.2 29.6 35.7 46.8 6.4 2.1 0.0 2.8 13.7 31.4 5.3 11.0 21.6 17.8 25.0 5.3 29.1 3.3 23.8 14.3 21.5 10.7 0.0 19.1 17.0 3.8 0.1 8.6 1.6 13.9 33.8 8.7 4.2 28.5 28.6 21.2 29.7 21.3 30.9 0.1 0.2 0.0 13.5 0.6 5.0 10.2 0.0 14.4 6.3 3.8 4.1 2.9 14.9 10.2 0.1 0.0 10.2 7.2 10.1 0.2 2.9 12.7 16.0 18.8 6.5 16.5 7.7 0.0 0.0 0.0 9.6 19.8 13.1 14.9 39.1 7.0 31.5 43.2 34.6 20.5 24.2 30.1 29.3 20.0 14.8 22.0 82.8 29.6 33.5 4.9 35.7 46.8 56.6 57.5 87.2 53.6 49.6 0.0 3.6 40.8 72.3 54.6 21.0 0.0 113.8 13.3 118.8 0.5 68.8 12.0 0.0 164.0 65.7 45.5 29.4 33.5 26.8 101.8 0.0 20.1 65.1 148.5 1.3 27.0 95.5 28.7 63.1 28.2 1.9 153.2 9.9 19.4 30.9 0.1 6.5 22.7 0.2 0.6 40.1 96.9 117.6 17.5 68.0 CASP5 ICE(rel)III ENSG00000137757 "Caspase 5" P51878 11 104994235-105023168 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 22.3;intestine: 31.0;lymphoid tissue: 12.3" "Cell type enhanced" "Detected in some" 14 "Enterocytes: 12.9;Mucus-secreting cells: 5.2;Paneth cells: 10.5;Undifferentiated cells: 4.9" "Group enriched" "Detected in some" 7 "colorectal cancer: 3.9;stomach cancer: 1.3" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "intermediate monocyte: 10.5;neutrophil: 7.8;non-classical monocyte: 22.3" "Group enriched" "Detected in many" 14 "granulocytes: 7.8;monocytes: 22.3" "Cell line enriched" "Detected in some" 7 "HHSteC: 9.3" NA NA "unprognostic (4.30e-2)" "unprognostic (8.86e-2)" "unprognostic (1.07e-1)" "unprognostic (4.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.22e-2)" "unprognostic (9.90e-2)" "unprognostic (8.29e-3)" "unprognostic (1.47e-1)" "unprognostic (4.38e-3)" "unprognostic (7.39e-3)" "unprognostic (3.25e-1)" "unprognostic (1.82e-9)" "unprognostic (7.30e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (1.50e-1)" 0.6 0.3 0.3 11.8 1.0 0.0 0.3 0.2 0.8 0.2 13.3 0.2 0.0 8.2 0.2 0.2 0.3 0.5 0.1 0.4 2.9 0.3 0.4 1.2 2.7 10.5 0.4 0.2 0.2 0.3 0.0 0.9 0.5 2.0 0.4 11.3 0.2 0.3 0.0 0.8 0.2 31.0 1.4 2.1 12.3 0.4 0.3 0.3 0.3 0.3 0.3 0.1 0.9 0.3 0.0 1.0 7.8 22.3 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.3 1.2 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 10.5 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 7.8 0.0 22.3 0.3 0.0 0.6 0.3 1.0 0.2 0.8 2.9 0.3 0.4 0.2 2.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 12.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.7 0.7 0.0 2.4 0.0 0.0 5.2 0.0 0.2 10.5 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 4.9 0.0 CASP6 MCH2 ENSG00000138794 "Caspase 6" P55212 4 109688622-109703583 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 42.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003775, HPA011337, HPA024303" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052" "unprognostic (1.07e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.64e-5)" "unprognostic (1.45e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "unprognostic (3.03e-3)" "unprognostic (9.87e-2)" "unprognostic (2.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.15e-2)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (8.74e-3)" "unprognostic (2.18e-1)" "unprognostic (2.41e-1)" "prognostic favorable (9.93e-4)" 8.1 6.1 3.6 6.7 4.3 5.3 14.3 2.8 3.8 6.9 25.5 2.8 4.5 23.4 5.9 4.3 8.7 5.3 11.7 4.9 4.0 2.0 11.0 14.3 5.6 8.5 5.0 1.6 7.0 13.0 2.3 6.4 4.3 4.5 8.1 19.5 3.4 8.0 10.3 3.4 6.5 42.8 14.0 6.6 9.1 9.2 2.7 4.3 14.5 11.2 3.3 8.4 8.2 12.7 4.4 8.0 8.5 7.0 5.6 21.3 8.0 12.6 4.1 8.5 7.7 6.2 6.1 12.6 7.1 4.9 6.4 6.9 6.8 26.1 1.3 8.3 7.3 8.9 5.9 10.1 11.2 5.1 20.1 6.6 11.1 3.7 6.0 5.0 11.1 7.9 6.7 8.4 6.1 1.5 8.6 12.1 15.1 14.4 39.6 10.3 7.1 28.7 7.0 6.5 8.7 7.5 10.0 5.4 6.9 21.0 12.0 9.0 6.7 7.5 13.6 4.2 10.7 5.8 4.1 10.2 7.1 7.5 3.4 8.0 5.8 10.5 1.4 9.2 13.4 3.6 8.5 5.3 6.3 4.9 4.8 5.3 4.1 17.8 9.3 6.0 4.4 21.3 11.8 1.1 5.6 7.0 8.0 16.4 8.0 3.6 4.3 2.8 3.8 4.0 2.0 5.0 1.6 4.5 4.3 14.9 13.4 8.5 9.5 9.6 5.2 3.3 30.6 25.4 20.5 19.2 5.9 16.7 8.3 35.9 2.0 9.2 52.0 0.0 40.5 34.0 12.1 6.6 9.3 17.8 17.1 0.0 56.7 6.2 8.6 1.6 11.8 8.5 1.7 25.2 48.2 12.8 42.5 56.1 9.2 26.3 1.3 6.5 6.9 1.7 8.3 10.2 4.8 12.8 64.3 7.8 CASP7 "CMH-1, ICE-LAP3, MCH3" ENSG00000165806 "Caspase 7" P55210 10 113679162-113730907 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 64.8" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 95.7;monocytes: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB025563 Enhanced NA NA "CAB025563: " "prognostic favorable (2.11e-4)" "unprognostic (3.18e-2)" "unprognostic (2.82e-2)" "unprognostic (2.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-1)" "unprognostic (2.63e-3)" "unprognostic (3.96e-1)" "unprognostic (2.04e-1)" "unprognostic (1.22e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (5.90e-4)" "unprognostic (5.45e-3)" "unprognostic (2.62e-1)" "unprognostic (2.86e-1)" "unprognostic (4.33e-3)" 16.5 7.8 8.6 12.3 8.7 3.4 22.1 4.7 11.3 13.3 35.5 5.9 9.8 30.8 12.6 6.1 12.0 9.5 7.8 9.0 7.6 3.9 14.1 15.7 16.2 12.2 7.3 2.7 11.0 18.4 5.7 9.6 10.2 9.1 11.9 28.5 5.8 21.8 10.5 9.7 10.9 64.8 9.3 12.4 12.3 21.0 4.3 8.0 12.0 8.4 8.1 11.3 10.6 36.6 9.6 8.6 14.6 17.1 5.4 12.2 7.4 11.0 12.0 9.8 5.2 18.0 15.9 6.8 12.9 20.1 23.1 28.9 8.9 19.3 11.8 7.7 11.7 8.6 9.8 12.1 9.7 16.3 18.2 16.3 7.6 8.9 14.9 12.1 8.1 10.1 10.3 6.5 13.1 5.4 10.3 30.4 11.3 2.0 16.1 8.5 15.0 19.1 6.3 1.7 12.5 7.3 19.6 40.0 7.0 18.3 8.2 0.8 5.9 9.9 14.4 6.8 9.8 17.1 7.2 14.6 5.1 9.9 5.4 10.6 11.9 7.4 0.3 5.2 15.2 5.8 14.6 12.5 9.4 9.6 17.1 8.4 9.6 8.3 12.2 8.6 7.3 6.5 8.7 2.1 5.4 14.0 1.1 11.1 7.4 8.6 8.7 4.7 11.3 7.6 3.9 7.3 2.7 9.1 8.0 8.9 10.5 14.3 19.4 17.5 0.6 2.2 15.3 32.1 19.4 21.0 0.0 10.1 10.0 37.1 0.2 17.1 95.7 23.3 34.0 21.2 17.6 27.4 12.7 14.7 15.3 0.0 9.2 12.9 13.3 0.0 8.9 18.5 6.8 108.2 66.5 7.6 35.7 66.6 3.9 19.2 1.6 19.4 12.8 1.0 26.0 12.9 9.2 15.8 32.0 27.1 CASP8 "Casp-8, FLICE, MACH, MCH5" ENSG00000064012 "Caspase 8" Q14790 2 201233443-201287711 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.5" "Cell type enhanced" "Detected in many" 5 "T-cells: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001302, CAB002047, HPA005688, HPA006191" Approved Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535" "unprognostic (5.21e-3)" "unprognostic (2.10e-1)" "unprognostic (1.83e-2)" "unprognostic (9.69e-3)" "unprognostic (2.09e-1)" "unprognostic (5.60e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.10e-1)" "unprognostic (4.79e-2)" "prognostic favorable (1.25e-4)" "unprognostic (7.75e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.27e-6)" "unprognostic (7.67e-3)" "unprognostic (2.43e-1)" "unprognostic (2.53e-1)" "unprognostic (4.53e-3)" 14.1 10.6 2.0 31.6 2.6 27.1 10.2 1.4 1.8 7.9 18.5 3.9 7.0 9.6 9.6 12.0 11.7 9.1 12.1 4.4 2.1 2.3 16.4 14.8 17.1 28.3 3.9 1.1 8.2 7.6 1.8 5.9 12.3 3.2 9.8 8.7 4.4 9.6 8.4 2.7 7.4 34.7 5.1 5.0 37.7 7.4 3.8 2.7 43.7 6.7 10.7 43.4 9.6 7.3 13.8 13.7 52.5 17.0 22.2 26.4 12.0 14.5 12.4 3.6 10.1 10.1 14.8 5.6 6.4 6.3 7.6 12.6 16.6 25.4 1.6 14.1 4.9 13.7 7.4 7.9 7.6 15.1 9.4 7.2 14.2 10.1 15.8 8.2 11.0 15.4 12.8 18.8 14.4 11.3 6.4 7.2 12.3 12.7 31.6 6.9 6.0 14.3 11.6 5.9 8.0 11.1 10.8 7.5 25.9 14.3 16.2 1.1 0.5 8.3 13.8 8.2 3.5 3.6 8.6 9.0 8.2 8.6 4.3 5.0 28.7 12.8 9.9 12.3 14.8 7.7 20.7 13.0 24.9 25.0 17.0 23.1 13.8 20.5 26.4 13.7 7.8 13.3 16.9 52.5 22.2 15.6 6.1 24.0 12.0 2.0 2.6 1.4 1.8 2.1 2.3 3.9 1.1 3.2 2.7 23.8 26.1 34.1 10.1 6.6 1.5 1.6 7.6 16.0 18.2 5.2 9.8 7.5 13.3 9.0 5.6 7.1 19.8 0.0 7.3 10.3 3.8 8.1 23.2 10.4 11.2 0.0 4.1 5.5 25.6 0.7 2.3 21.7 6.8 19.8 13.0 0.1 9.6 12.7 0.7 20.0 0.4 0.0 1.4 0.7 0.4 6.8 2.9 55.4 12.1 12.7 CASQ1 "CASQ, PDIB1" ENSG00000143318 "Calsequestrin 1" P31415 1 160190556-160201886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 320.9;tongue: 83.5" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007845, CAB015170, HPA026823" Enhanced Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Nucleoplasm, Mitochondria" "CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557" "unprognostic (1.87e-2)" "unprognostic (3.97e-3)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" "unprognostic (2.03e-2)" "unprognostic (6.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.65e-3)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (2.87e-2)" "unprognostic (3.01e-2)" "unprognostic (3.21e-3)" "unprognostic (9.04e-4)" "unprognostic (1.80e-1)" "unprognostic (1.58e-1)" "prognostic favorable (8.93e-5)" 6.1 0.1 0.5 0.0 0.3 0.1 0.2 0.3 2.0 0.1 0.1 0.0 0.1 0.0 0.1 11.9 3.9 0.2 0.1 4.0 0.4 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.5 0.0 1.3 0.0 0.2 4.5 0.4 320.9 0.1 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.0 0.9 83.5 4.7 0.4 0.1 0.9 0.0 0.9 0.7 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 10.6 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 20.2 0.2 0.0 0.0 0.0 0.1 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.0 36.1 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.9 0.7 0.2 0.0 0.1 0.0 0.5 0.1 0.1 0.0 0.9 0.1 0.1 0.9 0.2 0.1 0.0 0.3 0.0 0.5 0.3 0.3 2.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 16.7 0.0 1.4 0.0 0.0 2.0 1.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.4 0.0 13.0 0.0 0.8 1.4 1.0 0.0 3.8 0.0 0.0 0.3 CASQ2 PDIB2 ENSG00000118729 "Calsequestrin 2" O14958 1 115700007-115768781 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 697.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.7" "Cell line enriched" "Detected in single" 19 "HSkMC: 17.7" "Region enriched" "Detected in many" 5 "cerebellum: 48.4" "Low region specificity" "Detected in single" "HPA027285, HPA055298" Enhanced "Intracellular and membrane" NA NA "HPA027285: AB_1845933, HPA055298: AB_2682777" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (9.70e-3)" "unprognostic (1.28e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.03e-4)" "unprognostic (1.78e-1)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (7.20e-3)" "unprognostic (1.82e-2)" "unprognostic (1.80e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.25e-5)" 4.9 0.6 0.4 1.8 0.7 0.1 1.6 0.7 0.5 4.3 11.1 0.6 1.1 0.6 6.2 6.3 13.6 3.0 1.9 172.4 0.4 0.5 0.7 0.2 1.1 0.2 0.6 0.5 5.0 0.3 0.5 0.2 0.3 1.0 12.1 3.1 4.6 1.8 3.6 46.5 1.0 3.2 45.9 0.5 0.2 3.5 1.9 0.0 0.0 1.4 17.2 1.8 36.4 1.8 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.7 0.5 0.4 0.5 0.6 0.5 1.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 697.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 90.5 23.9 0.1 0.2 0.3 0.0 0.0 0.0 0.0 CASR "FHH, GPRC2A, HHC, HHC1, NSHPT" ENSG00000036828 "Calcium sensing receptor" P41180 3 122183683-122291629 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 155.3" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 13.2;Cholangiocytes: 33.1;Ciliated cells: 28.1;Club cells: 10.3;Distal tubular cells: 11.6;Intestinal endocrine cells: 11.1" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 5.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039686, HPA050335" Enhanced NA NA "HPA039686: AB_10673536, HPA050335: AB_2681092" "unprognostic (1.97e-2)" "unprognostic (7.40e-2)" "unprognostic (8.20e-4)" "unprognostic (3.15e-1)" "unprognostic (8.55e-4)" "unprognostic (1.58e-1)" "unprognostic (7.32e-2)" "unprognostic (7.67e-2)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (1.91e-5)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 21.0 0.0 0.1 0.2 18.1 0.5 0.0 0.0 0.1 0.0 0.6 12.1 155.3 0.6 0.0 0.2 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.6 0.3 0.2 0.2 0.5 0.3 0.0 0.1 1.6 0.0 0.1 0.7 0.0 1.4 0.5 1.1 0.3 0.8 1.1 0.2 0.6 1.3 0.7 1.1 0.3 0.3 0.7 0.7 0.0 0.0 0.1 0.6 0.9 1.1 0.9 0.4 0.8 0.5 0.2 0.2 0.3 0.8 0.1 1.4 1.1 1.1 0.0 0.7 0.8 0.4 0.4 0.5 0.2 0.5 0.2 1.1 0.6 2.0 0.3 0.7 0.5 0.9 1.4 0.8 0.7 0.6 0.5 0.6 4.0 1.5 0.6 0.8 0.9 0.5 0.3 1.7 1.0 0.3 1.3 1.0 1.9 1.0 0.3 1.7 1.1 0.5 0.7 0.6 1.0 1.0 0.3 0.1 0.9 0.2 0.9 0.7 0.9 0.9 0.1 1.4 0.7 0.6 1.1 0.8 0.2 0.5 1.1 0.2 0.0 0.0 0.0 0.6 0.1 0.2 0.1 0.0 0.2 0.0 23.8 13.2 0.0 0.0 0.0 0.0 0.8 33.1 28.1 10.3 3.5 0.0 0.0 11.6 3.7 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 11.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.2 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 CASS4 "C20orf32, HEFL, HEPL" ENSG00000087589 "Cas scaffolding protein family member 4" Q9NQ75 20 56412112-56460387 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.8;lung: 16.7" "Cell type enhanced" "Detected in some" 15 "granulocytes: 13.9;Kupffer cells: 8.0;Macrophages: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 10.8;neutrophil: 33.8" "Lineage enriched" "Detected in many" 10 "granulocytes: 33.8" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 6.6;HEL: 10.7;HMC-1: 32.8;K-562: 13.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB034217 Approved NA NA 890000 "CAB034217: AB_2071598" "unprognostic (9.55e-3)" "unprognostic (2.53e-2)" "unprognostic (2.44e-2)" "unprognostic (8.51e-2)" "unprognostic (3.04e-1)" "unprognostic (1.56e-3)" "unprognostic (2.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-1)" "unprognostic (4.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.19e-2)" "unprognostic (7.27e-4)" "unprognostic (5.33e-2)" "unprognostic (3.65e-2)" "unprognostic (6.50e-2)" "unprognostic (8.16e-2)" 3.3 1.7 2.0 13.0 2.2 2.4 1.7 1.3 4.5 1.7 1.4 6.1 0.0 1.8 2.5 0.9 1.4 1.6 3.5 1.6 2.4 1.5 1.6 2.2 16.7 12.1 1.9 3.1 2.4 1.5 0.4 1.3 6.6 3.4 1.4 1.3 2.7 1.8 2.5 1.3 1.5 2.9 1.8 2.9 9.2 1.5 1.1 2.2 4.1 1.3 1.1 4.3 3.0 1.4 0.0 3.4 33.8 1.9 1.4 2.3 1.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.6 0.2 0.1 0.3 0.1 2.3 0.1 0.1 6.6 0.1 0.1 0.1 0.0 0.4 0.1 0.1 10.7 0.1 0.6 0.2 0.3 32.8 0.7 0.2 0.2 0.0 0.3 0.0 0.2 13.2 0.1 0.4 0.1 0.2 4.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 1.4 0.1 0.2 1.9 10.8 0.7 0.4 1.0 0.0 1.2 1.3 3.4 0.0 2.3 2.0 33.8 1.4 0.0 1.2 0.6 1.1 2.0 2.2 1.3 4.5 2.4 1.5 1.9 3.1 3.4 2.2 0.0 1.4 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 13.9 0.9 2.3 0.0 0.0 0.6 8.0 0.0 0.0 6.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.2 0.0 0.0 CAST ENSG00000153113 Calpastatin P20810 5 96525267-96779595 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 201.9" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 948.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009491, HPA036881, HPA036882, HPA075906" Enhanced Enhanced "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 18000000 "Endoplasmic reticulum, Cytosol" "Plasma membrane" "CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: " "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.91e-2)" "unprognostic (4.68e-2)" "unprognostic (1.45e-1)" "unprognostic (3.79e-1)" "unprognostic (4.53e-3)" "unprognostic (1.94e-2)" "unprognostic (6.11e-3)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.66e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.16e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (4.98e-4)" 38.3 20.7 10.4 25.0 16.3 22.1 32.0 8.7 21.7 38.0 44.6 10.5 18.6 25.6 24.8 25.9 87.4 19.5 25.5 98.5 11.9 10.6 27.2 38.2 29.5 21.1 14.3 12.5 26.9 14.8 22.3 25.3 52.6 24.8 30.0 34.5 12.7 38.7 23.2 201.9 40.7 56.3 36.2 18.7 21.7 22.2 21.2 15.6 10.1 25.6 51.2 34.1 42.2 57.0 24.5 32.7 12.4 48.0 18.3 26.6 27.2 48.5 40.0 6.8 17.7 41.1 76.6 24.0 34.6 49.0 27.7 36.1 9.9 29.6 7.0 32.7 46.9 41.3 82.6 12.9 47.1 33.5 45.1 12.2 9.0 42.4 11.7 31.6 5.9 15.7 34.6 43.6 39.7 64.9 38.7 30.9 5.4 7.5 22.7 33.7 15.3 2.9 0.2 5.3 13.2 14.9 2.7 23.0 12.0 55.0 20.5 28.7 6.9 35.3 19.4 22.6 16.2 11.8 6.4 41.1 37.8 16.1 25.2 34.9 7.6 20.2 3.3 42.9 3.2 10.4 2.5 48.0 7.0 26.6 29.0 25.2 24.5 23.9 26.5 32.7 22.7 12.2 16.3 12.4 18.3 32.2 9.0 24.2 27.2 10.4 16.3 8.7 21.7 11.9 10.6 14.3 12.5 24.8 15.6 375.2 182.6 82.4 358.6 212.9 34.7 740.0 140.1 410.9 277.5 102.9 17.7 150.3 112.7 215.3 948.1 166.8 282.7 280.4 218.0 79.9 187.6 259.7 169.0 148.0 103.8 12.7 136.3 108.6 206.2 312.7 159.3 211.5 124.9 235.4 207.6 36.8 240.8 170.9 137.6 98.2 16.9 90.5 162.6 20.9 10.1 220.1 117.7 139.5 143.0 490.4 CASTOR2 "GATSL1, GATSL2" ENSG00000274070 "Cytosolic arginine sensor for mTORC1 subunit 2" A6NHX0 7 74964818-75024798 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 7.5;skeletal muscle: 28.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in all" "testis cancer: 11.6" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "A549: 22.3" HPA057229 Uncertain NA NA "HPA057229: AB_2683374" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (3.23e-1)" "unprognostic (1.31e-1)" "unprognostic (8.28e-2)" "unprognostic (2.78e-5)" "unprognostic (1.28e-2)" "unprognostic (1.45e-1)" "unprognostic (1.04e-2)" "unprognostic (1.35e-2)" "unprognostic (6.27e-2)" "unprognostic (9.72e-3)" "unprognostic (1.11e-1)" "unprognostic (3.30e-1)" "unprognostic (2.50e-1)" "unprognostic (9.20e-3)" 1.3 1.2 4.1 0.4 4.8 4.4 0.7 2.6 7.5 1.1 1.9 5.0 0.0 1.8 1.7 1.2 2.1 1.4 1.7 2.7 5.6 0.8 0.1 0.8 0.1 3.3 4.5 3.7 3.6 1.4 1.3 2.2 4.2 1.7 0.4 1.1 2.1 2.1 28.1 0.9 1.1 1.7 2.8 0.3 0.7 2.1 4.0 2.1 0.4 1.4 0.8 0.9 0.5 0.0 0.0 2.2 0.0 0.0 0.3 0.0 2.5 22.3 3.4 10.6 4.6 2.3 7.6 2.7 2.1 1.8 1.9 7.9 1.0 0.4 1.8 5.8 3.3 1.3 6.7 1.8 1.3 2.0 3.4 1.8 9.1 8.2 1.9 0.4 3.1 5.4 0.8 4.4 0.6 0.8 3.6 4.7 3.2 1.1 1.2 4.4 3.6 1.3 5.9 3.2 2.6 8.5 2.5 2.4 4.5 5.1 10.5 5.8 3.0 5.6 0.6 4.6 3.4 0.7 4.9 3.0 5.2 5.3 0.9 1.2 3.5 2.7 1.9 2.0 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CASTOR3 "DKFZp686B07267, GATS, STAG3OS" ENSG00000239521 "CASTOR family member 3" Q8NAP1 7 100200653-100272218 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.8;skeletal muscle: 20.4" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 6.0;Ciliated cells: 14.7;Club cells: 7.9;Ductal cells: 5.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.3;HMC-1: 3.5" HPA043176 Uncertain NA NA "HPA043176: AB_10794883" "unprognostic (8.29e-2)" "prognostic favorable (7.56e-7)" "unprognostic (7.67e-2)" "unprognostic (5.96e-2)" "unprognostic (3.46e-2)" "unprognostic (1.96e-1)" "unprognostic (2.66e-3)" "unprognostic (9.42e-2)" "unprognostic (3.90e-1)" "unprognostic (2.50e-1)" "unprognostic (4.00e-3)" "unprognostic (1.62e-1)" "unprognostic (3.56e-3)" "unprognostic (5.14e-3)" "unprognostic (4.44e-2)" "unprognostic (1.92e-1)" "unprognostic (4.86e-2)" 1.8 1.6 3.8 1.3 8.2 4.4 1.5 10.0 10.2 1.8 1.4 14.8 0.0 1.2 2.1 1.2 1.5 1.7 2.1 1.7 4.5 1.4 1.2 1.5 1.8 6.5 5.6 2.6 1.7 1.2 2.6 1.3 10.4 1.6 1.3 0.6 1.9 2.1 20.4 1.4 2.1 1.5 5.3 1.4 1.2 1.5 7.4 2.6 1.5 2.5 1.4 1.2 0.0 0.8 0.0 1.8 0.3 0.6 1.6 0.1 0.5 4.3 1.6 0.0 0.3 0.0 2.6 0.0 0.3 0.3 0.4 1.6 0.3 0.2 2.0 0.3 0.7 0.5 0.1 0.7 0.0 2.8 0.5 0.1 0.4 1.1 0.2 0.0 3.5 0.0 0.9 0.3 0.0 0.3 0.9 2.4 0.1 0.5 0.0 0.3 2.5 0.2 0.3 0.4 1.3 0.9 0.3 0.0 0.7 0.0 2.6 3.0 0.6 0.0 0.0 1.4 0.0 0.0 1.2 0.1 0.6 0.0 0.0 1.8 2.0 0.9 0.1 0.1 0.3 0.0 0.0 1.6 1.6 0.3 0.5 0.8 0.3 0.1 0.0 0.0 0.9 0.6 1.8 0.6 0.1 0.0 0.0 0.1 6.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 7.9 3.5 0.0 3.8 0.0 5.8 0.0 0.0 0.0 0.0 4.3 1.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 CAT ENSG00000121691 Catalase P04040 11 34438925-34472062 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Mitogen, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 258.3;liver: 184.8" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 350.4;Hepatocytes: 400.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 13 "eosinophil: 258.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 258.3" "Cell line enhanced" "Detected in many" "HL-60: 76.4;THP-1: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001515, HPA051282, HPA055838" Enhanced Enhanced Vesicles NA NA 960000000 Vesicles "CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937" "unprognostic (3.62e-2)" "unprognostic (2.72e-1)" "unprognostic (3.59e-3)" "unprognostic (5.43e-2)" "unprognostic (4.44e-2)" "unprognostic (5.80e-3)" "prognostic favorable (9.67e-4)" "unprognostic (9.95e-3)" "unprognostic (3.22e-1)" "unprognostic (7.23e-2)" "unprognostic (3.34e-2)" "unprognostic (9.77e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.01e-1)" "unprognostic (7.31e-2)" "unprognostic (4.77e-2)" "unprognostic (6.59e-3)" 70.0 33.0 9.4 10.1 9.6 54.2 36.1 3.1 7.7 15.3 26.6 18.6 15.7 22.2 13.5 9.5 14.8 14.2 19.0 22.4 10.7 5.2 50.4 184.8 26.1 21.3 14.5 6.0 11.0 24.7 7.1 5.0 16.4 10.2 23.2 11.3 11.4 14.5 13.2 27.8 19.7 29.2 11.6 11.3 17.9 15.9 6.2 11.6 23.4 41.7 14.9 11.5 20.4 24.9 7.6 19.9 258.3 17.5 5.5 5.0 17.8 6.2 6.9 5.1 8.0 49.2 21.4 10.8 8.0 10.1 8.9 9.8 3.9 6.3 15.4 7.7 15.7 13.2 14.9 8.5 8.6 9.9 13.5 7.8 13.0 7.4 22.2 5.8 76.4 6.5 11.5 6.0 2.7 1.1 12.6 10.8 9.4 26.9 6.4 11.2 5.9 15.6 13.6 0.0 29.4 16.8 11.1 24.2 12.6 24.5 23.7 2.6 4.1 8.9 14.4 11.8 0.0 20.7 63.8 7.6 5.4 5.2 13.4 4.7 5.2 2.9 3.3 10.6 52.6 3.9 12.5 17.5 258.3 3.2 14.7 3.8 7.6 3.8 3.6 19.9 6.8 3.8 4.0 17.1 5.5 15.5 13.4 5.0 17.8 9.4 9.6 3.1 7.7 10.7 5.2 14.5 6.0 10.2 11.6 211.4 229.6 40.9 69.6 25.6 11.8 38.0 73.9 89.7 77.3 69.8 25.5 60.5 190.6 26.7 2.1 31.6 91.9 350.4 23.0 26.6 50.3 53.0 22.1 400.0 121.0 0.0 46.1 49.7 114.9 3.8 72.5 85.2 25.3 295.8 48.0 21.2 16.4 52.6 72.9 233.4 17.7 77.6 65.1 4.1 9.6 23.7 33.9 35.5 72.9 69.8 CATIP "C2orf62, MGC50811" ENSG00000158428 "Ciliogenesis associated TTC17 interacting protein" Q7Z7H3 2 218356856-218368099 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 12.0;fallopian tube: 24.5" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 10.0;Early spermatids: 9.5;Late spermatids: 13.2;Proximal tubular cells: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 11 "BEWO: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044818 Supported NA NA "HPA044818: AB_10959301" "unprognostic (7.11e-3)" "unprognostic (2.37e-1)" "unprognostic (3.95e-2)" "unprognostic (1.70e-3)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-2)" "unprognostic (1.69e-2)" "unprognostic (3.44e-1)" "unprognostic (1.95e-3)" "unprognostic (1.46e-1)" "unprognostic (2.72e-1)" "unprognostic (9.93e-2)" "unprognostic (1.19e-1)" 0.2 0.2 1.5 0.2 3.3 0.2 0.1 0.1 0.6 2.1 0.1 5.7 4.9 0.1 0.7 12.0 0.2 24.5 1.2 0.1 2.1 2.7 3.6 0.1 2.7 0.2 0.4 1.9 3.6 5.5 2.6 1.7 2.0 9.3 1.3 0.1 0.3 0.1 1.6 0.1 0.1 0.1 0.2 0.4 0.3 0.2 9.5 1.8 0.0 5.7 0.0 0.2 0.7 0.0 0.0 0.5 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 1.5 3.3 0.1 0.6 2.1 2.7 0.4 1.9 9.3 1.8 0.0 0.3 0.5 0.1 0.0 0.0 0.8 5.1 1.4 0.0 5.2 0.0 1.6 10.0 0.9 9.5 0.1 0.0 0.0 0.2 1.1 0.2 0.5 0.0 0.0 1.0 0.0 0.0 0.6 3.2 13.2 0.6 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.0 8.4 0.0 0.0 0.1 5.5 0.2 0.0 3.9 0.0 0.0 0.1 CATSPER1 CATSPER ENSG00000175294 "Cation channel sperm associated 1" Q8NEC5 11 66016752-66026517 "Disease related genes, Predicted membrane proteins" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "blood: 12.8;testis: 38.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 28.9;granulocytes: 99.1;Hofbauer cells: 20.8;Kupffer cells: 18.5;Macrophages: 20.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 12.8;classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 6.6;HEL: 4.4;HMC-1: 8.4;U-2 OS: 3.6" "Low region specificity" "Detected in many" NA NA "unprognostic (2.21e-2)" "unprognostic (3.00e-2)" "unprognostic (2.67e-2)" "unprognostic (1.91e-1)" "unprognostic (3.96e-3)" "unprognostic (1.71e-1)" "unprognostic (6.09e-3)" "unprognostic (1.88e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-3)" "unprognostic (5.99e-3)" "unprognostic (1.61e-2)" "unprognostic (2.12e-8)" "unprognostic (8.79e-3)" "unprognostic (9.02e-3)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 12.8 5.9 3.3 0.2 2.1 1.6 0.7 0.0 0.0 0.0 0.1 0.1 0.3 1.3 0.6 0.5 0.1 7.2 0.0 6.6 1.3 2.4 0.0 0.0 1.4 0.8 0.0 0.0 4.4 0.3 0.1 0.0 0.0 8.4 0.1 0.0 0.5 0.9 1.6 0.4 0.0 0.0 0.1 1.2 0.0 0.0 0.7 0.0 0.0 0.5 0.0 2.4 0.1 2.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.3 1.9 3.6 0.2 0.3 0.0 0.0 0.0 1.3 0.5 1.0 12.8 5.9 0.1 0.2 0.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.5 3.3 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 28.9 0.0 0.0 0.0 0.6 5.3 0.4 0.0 99.1 0.0 20.8 0.0 0.0 1.8 18.5 2.1 0.9 20.3 1.7 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.4 0.3 0.3 4.3 0.0 0.3 CATSPER2 ENSG00000166762 "Cation channel sperm associated 2" Q96P56 15 43628503-43668118 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 43.7" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 239.5;Rod photoreceptor cells: 241.8;Spermatocytes: 77.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 12.8" NA NA "unprognostic (6.88e-3)" "unprognostic (6.79e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.05e-1)" "unprognostic (1.05e-2)" "unprognostic (7.11e-3)" "unprognostic (1.48e-2)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.37e-2)" "unprognostic (3.74e-3)" "unprognostic (1.15e-1)" "unprognostic (6.04e-2)" "unprognostic (8.87e-2)" "unprognostic (8.23e-5)" 1.1 0.9 1.1 1.1 1.4 3.2 1.3 9.0 1.1 1.1 1.7 1.1 1.1 2.7 1.1 5.2 1.9 1.1 1.1 1.1 1.1 1.3 1.1 1.1 1.1 1.3 1.1 1.1 1.4 1.1 4.0 3.0 1.1 1.1 1.3 1.9 1.1 1.1 1.9 1.1 4.8 3.1 1.1 1.6 1.1 1.3 43.7 1.1 1.1 1.7 1.1 1.1 1.2 1.1 3.3 1.8 2.3 1.2 1.8 2.9 0.2 2.5 3.5 1.5 5.6 0.0 0.0 2.6 0.9 2.2 1.6 3.8 0.8 1.4 3.0 1.3 0.6 1.9 5.4 1.4 4.9 1.5 2.5 6.8 8.6 12.8 1.2 2.3 2.0 2.8 0.3 3.9 2.2 5.5 4.2 2.0 5.4 3.4 3.2 0.5 0.6 1.6 3.4 0.5 3.3 1.5 2.3 1.8 1.4 3.1 4.0 3.4 1.2 1.5 2.1 0.1 2.1 4.1 2.0 0.5 4.0 1.7 0.0 2.3 0.6 0.3 5.9 2.7 6.1 1.4 0.4 1.2 0.5 1.3 0.5 1.6 3.3 1.1 1.8 0.8 1.7 1.5 2.9 2.3 1.8 1.2 1.8 0.5 0.2 1.1 1.4 9.0 1.1 1.1 1.3 1.1 1.1 1.1 1.1 0.0 5.0 4.4 7.4 6.3 51.5 2.9 2.5 8.1 7.9 7.0 239.5 4.4 3.3 2.4 53.6 4.5 3.9 0.0 2.3 1.9 2.6 5.8 9.2 3.4 3.7 36.5 20.6 7.4 2.2 22.9 5.8 5.0 1.7 1.8 4.4 11.3 1.8 3.5 6.7 4.2 241.8 0.0 3.1 77.5 8.3 6.9 2.5 3.2 8.2 7.1 CATSPER3 CACRC ENSG00000152705 "Cation channel sperm associated 3" Q86XQ3 5 134967906-135011707 "Predicted membrane proteins, Transporters" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 31.9" "Group enriched" "Detected in some" 39 "Early spermatids: 152.2;Late spermatids: 43.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 7.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (2.59e-2)" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.26e-1)" "unprognostic (4.26e-2)" "unprognostic (1.57e-2)" "unprognostic (4.87e-2)" "unprognostic (2.63e-1)" "unprognostic (3.71e-2)" "unprognostic (8.00e-2)" "unprognostic (2.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (5.58e-3)" "unprognostic (9.39e-2)" "unprognostic (1.51e-1)" "unprognostic (4.96e-3)" 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.5 0.4 0.5 0.4 0.8 0.4 0.4 0.4 0.4 0.6 1.0 0.4 0.4 0.4 0.4 0.6 0.8 0.2 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 2.7 0.3 0.4 0.4 0.4 0.4 0.3 31.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.3 1.4 0.4 0.6 3.2 1.8 0.4 0.4 3.6 1.4 1.6 1.1 0.4 0.8 0.6 0.3 7.2 0.6 2.0 3.1 1.4 1.8 0.3 0.7 1.1 2.3 1.2 0.7 1.9 2.7 0.3 2.0 1.2 0.7 0.9 0.8 0.4 1.8 0.6 2.8 0.7 0.0 0.9 1.5 2.6 0.5 1.6 1.5 2.3 0.4 2.7 1.9 1.9 0.6 0.8 3.1 0.5 1.1 1.1 1.3 1.0 1.1 1.2 1.4 2.2 1.0 0.1 1.3 0.3 1.6 1.2 1.0 0.4 0.7 2.3 0.5 0.0 0.6 0.0 0.4 0.1 0.0 0.8 0.7 0.7 1.4 3.3 1.8 0.7 0.4 3.2 0.1 0.7 0.0 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.5 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 152.2 0.1 0.0 0.0 1.0 0.2 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.3 43.8 1.4 0.0 0.0 1.0 0.0 0.4 0.3 0.0 0.7 1.0 2.5 0.0 0.3 2.1 1.1 0.3 0.1 0.0 0.1 0.0 CATSPER4 ENSG00000188782 "Cation channel sperm associated 4" Q7RTX7 1 26190561-26202968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;hTCEpi: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA045257 Enhanced NA NA "HPA045257: AB_10968995" "unprognostic (7.20e-2)" "unprognostic (2.06e-2)" "unprognostic (4.56e-2)" "unprognostic (2.69e-2)" "unprognostic (3.49e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-2)" "unprognostic (2.16e-1)" "unprognostic (3.06e-1)" "unprognostic (6.78e-2)" "unprognostic (6.98e-2)" "unprognostic (6.67e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.1;Exocrine glandular cells: 9.3;Pancreatic endocrine cells: 11.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;OE19: 4.0;U-937: 3.7" "Not detected" "Not detected" HPA035134 Uncertain Uncertain Vesicles NA NA Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.6 0.1 0.0 0.6 0.0 0.0 1.4 0.0 0.2 0.4 0.9 0.3 0.4 0.4 0.6 0.7 1.2 0.6 0.0 0.0 0.3 0.2 0.9 1.1 0.0 0.2 15.1 1.0 0.3 0.0 0.9 0.7 3.7 0.0 1.7 4.2 1.2 0.1 0.0 0.8 2.0 2.0 0.9 0.6 0.5 0.3 0.4 0.2 1.1 0.2 0.7 1.6 0.4 0.6 0.0 0.7 1.6 0.0 0.0 1.8 0.2 0.3 0.0 0.0 2.3 3.8 1.1 0.9 0.0 0.1 0.6 0.0 0.5 0.7 1.4 2.0 0.4 1.2 2.2 0.0 1.6 0.8 0.6 0.7 0.4 0.5 1.5 0.0 1.0 0.5 0.2 0.4 2.2 0.6 0.7 0.2 4.0 0.5 0.3 0.0 0.0 0.4 0.9 1.6 0.1 0.0 0.8 1.5 1.7 0.4 2.1 0.9 0.2 0.2 0.0 0.3 0.9 0.8 0.3 0.2 3.7 1.0 1.1 0.2 0.6 1.1 0.0 1.5 0.4 1.6 1.0 0.0 0.2 1.1 1.4 0.4 0.7 0.2 0.2 0.0 0.4 3.0 1.0 0.0 0.2 0.1 0.0 0.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 1.6 11.1 0.0 0.3 0.0 9.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 1.0 2.1 0.0 11.1 0.9 0.0 0.5 0.0 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.4 0.3 CATSPERD "MGC39581, TMEM146" ENSG00000174898 "Cation channel sperm associated auxiliary subunit delta" Q86XM0 19 5720677-5778734 "Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 32.8" "Group enriched" "Detected in some" 13 "Ciliated cells: 194.1;Early spermatids: 109.5;Late spermatids: 120.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 60 "HEL: 13.2" "Not detected" "Not detected" HPA024056 Enhanced NA NA "HPA024056: AB_1858093" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (3.77e-3)" "unprognostic (9.91e-2)" "unprognostic (3.74e-2)" "unprognostic (6.85e-2)" "unprognostic (2.63e-3)" "unprognostic (2.19e-2)" "unprognostic (5.18e-2)" "unprognostic (2.50e-1)" "unprognostic (5.95e-8)" "unprognostic (2.54e-2)" "unprognostic (9.92e-2)" "unprognostic (2.83e-1)" "unprognostic (3.74e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 32.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.5 0.6 0.0 0.1 0.1 0.1 0.1 0.0 2.1 0.0 0.1 0.3 0.0 0.4 0.0 194.1 6.8 0.0 0.0 0.0 0.0 0.0 109.5 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 120.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 11.1 1.1 1.3 0.2 0.0 0.0 0.0 CATSPERE "C1orf101, MGC33370" ENSG00000179397 "Catsper channel auxiliary subunit epsilon" Q5SY80 1 244454377-244641177 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 26.9" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 16.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.7;hTERT-RPE1: 2.6" "Low region specificity" "Detected in many" NA NA "unprognostic (3.22e-1)" "unprognostic (4.50e-2)" "unprognostic (2.02e-1)" "unprognostic (7.31e-2)" "unprognostic (3.32e-1)" "unprognostic (2.50e-3)" "unprognostic (3.76e-3)" "unprognostic (5.39e-4)" "unprognostic (1.96e-2)" "unprognostic (3.41e-2)" "unprognostic (4.37e-4)" "unprognostic (4.43e-2)" "unprognostic (9.09e-2)" "unprognostic (1.76e-1)" "unprognostic (5.79e-2)" "unprognostic (6.74e-3)" "unprognostic (5.85e-2)" 0.9 1.1 1.3 0.5 3.2 1.1 1.2 1.7 2.7 1.2 0.5 4.6 0.4 0.5 1.6 4.1 0.6 2.1 0.9 0.5 3.1 1.3 1.4 1.5 1.0 1.8 1.2 1.3 1.4 2.4 2.6 2.2 0.9 3.2 1.0 0.5 1.3 0.9 1.1 1.0 0.7 0.7 1.5 2.8 0.9 0.7 26.9 0.7 0.5 1.6 0.0 0.6 1.0 0.8 0.8 0.9 0.8 0.1 0.1 0.8 0.1 0.3 0.0 0.6 0.0 1.3 2.7 0.2 1.5 1.5 0.2 0.2 0.0 0.7 0.5 1.8 1.7 0.0 0.7 0.4 0.2 0.5 0.0 1.5 0.0 0.4 0.1 0.9 0.0 1.4 2.2 0.7 0.2 0.0 2.6 0.7 0.7 0.2 0.5 0.2 0.0 0.2 0.3 0.3 0.0 0.2 1.4 0.0 0.0 0.8 0.0 1.6 1.0 0.7 0.0 0.3 0.4 0.1 0.8 1.8 0.1 0.0 0.0 1.0 0.9 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.7 0.0 0.2 0.8 0.1 0.3 0.0 0.6 0.8 0.1 0.0 0.1 0.1 0.9 0.2 0.1 1.3 3.2 1.7 2.7 3.1 1.3 1.2 1.3 3.2 0.7 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 16.0 2.3 1.8 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Group enriched" "Detected in many" 7 "Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.5 0.2 1.8 0.8 0.0 4.2 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.7 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.3 0.0 0.8 0.0 0.5 0.5 0.1 0.8 0.0 1.4 0.0 4.3 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.8 2.0 0.1 0.4 0.6 0.4 0.9 0.2 0.7 0.4 0.0 0.3 0.0 1.0 0.7 0.0 0.8 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 0.0 2.4 1.7 1.9 2.3 1.1 2.4 2.5 0.0 0.0 1.8 0.0 1.0 0.0 0.8 23.9 1.5 14.0 0.0 0.6 0.2 1.5 1.8 1.1 0.5 2.8 1.6 1.7 1.8 0.8 27.8 1.7 2.6 0.0 1.8 1.5 1.9 0.5 3.5 2.1 1.1 1.1 0.0 1.0 31.9 2.7 1.6 1.1 2.5 2.0 1.4 CATSPERZ "C11orf20, DKFZP566E164, TEX40" ENSG00000219435 "Catsper channel auxiliary subunit zeta" Q9NTU4 11 64300391-64304770 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "testis: 139.5" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.7;CACO-2: 15.6;PC-3: 9.3;T-47d: 7.6" HPA052822 Approved Nucleoplasm NA NA Nucleoplasm "HPA052822: AB_2797245" "unprognostic (1.89e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (8.23e-2)" "unprognostic (2.18e-1)" "unprognostic (1.11e-1)" "unprognostic (5.66e-4)" "unprognostic (5.96e-2)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" 0.1 0.0 0.5 0.0 0.4 0.0 0.8 0.1 0.9 0.2 0.1 0.1 0.2 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 139.5 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.5 0.4 0.6 0.6 0.0 0.3 0.0 0.0 4.1 0.3 0.0 0.5 1.0 5.7 0.0 0.3 0.0 0.0 15.6 3.2 0.1 0.2 0.2 0.2 3.4 3.2 0.5 0.1 0.0 0.0 1.5 0.1 1.0 0.1 0.0 0.0 0.1 0.3 1.0 0.0 0.0 0.2 0.0 1.6 0.7 0.2 0.7 0.0 0.7 1.1 4.5 9.3 1.7 0.0 2.0 4.5 1.5 0.1 0.9 1.7 0.5 0.2 0.3 7.6 0.4 0.3 0.2 0.1 2.1 0.0 0.4 0.1 0.5 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.6 0.4 0.0 0.0 0.5 0.4 0.1 0.3 0.5 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 29.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733800-8841808 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 65.8;tongue: 44.6" "Cell type enhanced" "Detected in some" 28 "Cardiomyocytes: 18.9;Early spermatids: 4.4;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 46.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.3 2.3 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 1.3 0.1 65.8 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 44.6 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 CAVIN3 "cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC" ENSG00000170955 "Caveolae associated protein 3" Q969G5 11 6318946-6320647 "Predicted intracellular proteins" "Biological rhythms" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 73.7" "Cell type enhanced" "Detected in many" 18 "Exocrine glandular cells: 224.8;Extravillous trophoblasts: 73.0;monocytes: 53.3;Pancreatic endocrine cells: 141.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 8.1;myeloid DC: 22.4" "Group enriched" "Detected in many" 5 "dendritic cells: 22.4;monocytes: 8.1" "Cell line enhanced" "Detected in many" "A-431: 30.2;BJ: 29.1;HaCaT: 23.3;NTERA-2: 19.3;TIME: 34.5;U-87 MG: 32.7;WM-115: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055136, HPA073327" Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055136: AB_2682711, HPA073327: AB_2686595" "unprognostic (7.92e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.12e-2)" "unprognostic (2.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.69e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.37e-1)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.21e-6)" "unprognostic (3.85e-2)" "unprognostic (1.70e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-2)" 30.2 5.1 0.9 14.2 1.6 0.8 12.6 0.8 2.9 38.3 16.1 1.8 14.2 5.8 31.6 32.2 20.3 13.4 15.3 16.8 0.9 1.0 8.6 2.6 9.8 6.8 2.2 3.5 14.0 5.6 1.0 1.7 22.0 2.8 20.9 2.3 11.1 5.0 11.0 12.1 6.8 7.9 34.7 1.3 9.8 11.3 73.7 0.4 0.7 5.5 14.5 4.3 26.5 16.5 0.0 22.4 0.1 8.1 0.1 3.1 2.7 30.2 2.8 0.0 0.1 1.2 5.2 0.0 29.1 9.0 4.0 4.1 0.0 0.0 0.0 9.7 4.1 0.4 23.3 0.0 1.8 0.5 7.6 0.0 0.0 3.0 0.0 3.1 0.0 0.1 3.4 2.4 1.5 1.2 0.0 7.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 19.3 0.1 0.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 10.4 0.0 6.3 0.1 0.0 0.1 34.5 0.0 0.1 11.3 0.1 0.0 0.2 0.0 32.7 0.0 34.7 0.0 8.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 22.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.1 2.7 0.9 1.6 0.8 2.9 0.9 1.0 2.2 3.5 2.8 0.4 11.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 3.0 33.2 6.0 0.0 0.0 0.0 0.0 224.8 73.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 53.3 0.0 0.0 141.7 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 CAVIN4 "cavin-4, MURC" ENSG00000170681 "Caveolae associated protein 4" Q5BKX8 9 100578079-100587906 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 83.8;tongue: 52.4" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "NTERA-2: 10.3;SCLC-21H: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA020973, HPA020987, HPA021021" Enhanced Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082" "unprognostic (9.54e-5)" "unprognostic (1.68e-2)" "unprognostic (2.50e-2)" "unprognostic (3.76e-2)" "unprognostic (4.92e-2)" "unprognostic (4.56e-3)" "unprognostic (1.14e-4)" "unprognostic (3.36e-2)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (4.02e-1)" "unprognostic (1.74e-8)" "unprognostic (1.14e-1)" "unprognostic (3.39e-1)" "unprognostic (3.68e-3)" "unprognostic (1.55e-3)" 3.5 0.0 0.3 0.1 0.6 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.0 0.2 2.7 1.9 0.0 0.1 16.4 0.5 0.3 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.8 0.0 83.8 0.1 0.0 0.1 0.7 0.0 0.1 1.4 0.0 0.1 0.2 52.4 1.6 0.0 0.0 0.4 0.3 1.4 0.4 0.7 0.7 0.0 0.5 0.4 7.4 2.7 1.6 2.4 5.3 1.3 1.0 1.0 1.2 0.0 0.5 0.3 0.3 0.6 2.6 0.3 3.5 0.1 2.1 1.7 2.5 0.0 1.2 0.0 0.5 0.3 0.4 5.9 0.3 1.0 0.6 1.8 1.3 1.8 0.2 0.3 4.6 0.1 2.0 0.3 10.3 1.1 0.8 3.0 6.9 0.0 0.8 0.4 15.8 4.2 0.2 0.3 1.4 5.0 0.2 0.2 1.3 1.8 1.5 1.3 1.1 0.4 1.3 0.7 2.0 0.1 1.3 0.6 0.3 0.2 0.5 0.4 0.2 0.2 0.7 0.5 0.1 0.4 0.5 0.5 1.4 0.7 0.3 0.3 0.2 0.0 0.3 0.6 0.5 0.3 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN beta subunit associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;pituitary gland: 13.1" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 18.9;Early spermatids: 35.1;Late spermatids: 59.2" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 8.7" HPA012777 Approved Nucleoplasm NA NA Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 2.3 8.1 7.2 1.5 12.1 1.0 1.2 3.6 17.9 1.2 1.3 5.2 0.0 1.3 1.8 1.1 1.5 1.1 1.8 1.5 8.5 5.6 1.8 1.5 1.4 1.1 3.3 4.7 2.9 2.1 1.6 13.1 1.4 10.6 1.4 1.0 1.2 1.2 1.5 1.3 4.5 1.1 1.2 6.5 1.2 1.9 3.0 2.2 0.0 1.3 0.0 1.2 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.0 5.3 0.2 0.6 1.5 4.4 1.3 0.9 1.0 2.4 0.2 0.0 5.0 1.0 0.5 2.4 0.8 0.9 0.2 0.9 1.1 0.1 1.7 1.4 2.3 0.1 1.8 1.2 0.5 1.1 0.3 0.9 0.7 1.2 2.8 0.1 0.6 4.0 0.0 1.3 3.7 0.3 2.2 4.4 0.8 0.3 0.2 0.6 3.2 8.7 0.0 0.1 4.5 0.2 0.6 0.9 1.7 1.9 5.6 5.2 1.6 0.5 0.5 0.0 1.5 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 12.1 3.6 17.9 8.5 5.6 3.3 4.7 10.6 2.2 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.2 35.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.2 3.2 0.0 1.3 1.0 59.2 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.4 0.1 1.1 0.0 0.0 9.8 4.1 0.0 0.0 0.0 0.0 0.1 CBFA2T3 "ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4" ENSG00000129993 "CBFA2/RUNX1 translocation partner 3" O75081 16 88874858-88977204 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 11.5;Mucus-secreting cells: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 26.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 21.4;K-562: 37.4;MCF7: 17.3;MOLT-4: 19.0;NB-4: 23.1;REH: 37.6;T-47d: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA059931, HPA062423, HPA065890" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575" "unprognostic (2.47e-1)" "unprognostic (2.03e-2)" "unprognostic (9.24e-3)" "unprognostic (2.62e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.13e-3)" "unprognostic (1.69e-2)" "unprognostic (1.25e-1)" "unprognostic (2.10e-1)" "unprognostic (7.30e-3)" "unprognostic (2.38e-1)" "unprognostic (7.04e-5)" "unprognostic (2.18e-1)" "unprognostic (4.08e-2)" "unprognostic (4.62e-2)" "unprognostic (9.35e-3)" 10.0 1.7 3.6 11.3 7.4 8.2 6.1 26.0 5.4 2.3 3.9 1.3 1.4 3.9 3.2 2.1 2.1 1.9 2.5 6.2 3.0 3.0 0.7 2.0 6.4 9.5 2.0 3.8 0.9 24.9 0.7 2.7 3.8 2.3 3.7 1.5 3.1 4.5 2.9 14.2 2.6 5.5 1.5 1.2 14.7 3.5 3.2 2.2 75.9 2.4 2.0 10.3 3.6 4.8 3.7 11.6 3.6 4.9 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.4 0.0 0.0 0.0 5.6 10.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 37.4 0.2 0.0 17.3 19.0 23.1 0.4 0.0 0.0 37.6 0.3 3.7 0.0 0.0 7.4 1.6 0.8 0.1 0.1 0.1 17.1 6.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 12.4 0.0 6.5 0.0 1.1 2.7 2.7 0.0 3.2 0.0 3.7 0.0 0.0 7.1 2.1 0.0 0.0 3.6 0.1 4.9 11.6 0.0 1.7 3.6 7.4 26.0 5.4 3.0 3.0 2.0 3.8 2.3 2.2 0.0 1.4 11.5 5.1 2.3 7.7 1.6 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.2 0.0 3.6 0.9 0.0 2.4 0.1 1.6 2.5 5.8 5.7 2.4 0.0 3.5 2.5 2.8 0.0 2.0 6.4 0.0 1.0 13.5 0.1 1.4 0.0 0.7 0.5 1.2 19.4 11.2 0.2 4.5 1.9 0.2 1.0 0.8 3.8 CBL "c-Cbl, CBL2, RNF55" ENSG00000110395 "Cbl proto-oncogene" P22681 11 119206276-119313926 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004350, HPA027956" Enhanced Supported Cytosol NA NA Cytosol "CAB004350: AB_2244054, HPA027956: AB_10601094" "unprognostic (2.52e-1)" "unprognostic (1.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-2)" "unprognostic (2.92e-1)" "unprognostic (4.10e-3)" "unprognostic (9.75e-2)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.03e-2)" "unprognostic (5.23e-2)" "unprognostic (5.21e-2)" "unprognostic (5.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" 9.9 5.5 9.1 17.0 11.1 11.1 8.8 10.7 12.0 6.2 7.5 8.7 3.0 5.7 9.9 5.3 7.5 7.4 6.3 5.9 8.0 9.6 5.5 4.0 10.3 16.3 8.1 6.9 6.3 5.6 16.6 4.1 9.1 9.3 5.3 7.5 6.4 5.4 7.1 3.9 7.4 8.6 10.6 8.9 13.3 7.3 32.3 5.1 40.9 6.0 5.5 15.6 7.6 7.7 1.8 3.3 11.8 3.7 0.6 1.9 1.0 6.3 4.8 16.9 10.6 5.1 6.0 10.0 6.9 7.2 6.7 6.6 10.3 7.9 15.1 6.2 8.7 13.8 9.3 11.6 5.9 14.7 8.6 2.7 15.5 3.7 3.1 6.2 18.0 17.7 5.3 6.5 17.0 18.4 7.1 16.5 14.8 12.5 6.3 12.0 6.9 9.6 10.1 8.8 5.7 5.4 10.4 8.5 2.8 5.9 5.1 2.3 7.1 12.8 5.6 4.6 12.1 5.8 15.2 13.7 10.4 7.4 7.2 9.0 2.1 3.1 12.3 4.2 15.6 7.4 0.8 3.2 2.4 1.3 3.7 1.1 1.8 1.6 1.3 3.3 1.8 1.8 1.9 11.8 0.6 3.1 1.8 1.4 1.0 9.1 11.1 10.7 12.0 8.0 9.6 8.1 6.9 9.3 5.1 8.9 8.8 18.8 4.9 16.0 12.4 5.9 7.6 1.4 4.5 10.4 43.2 5.2 1.7 5.8 22.7 17.8 6.3 0.0 5.8 8.0 8.0 6.2 3.5 2.6 15.0 12.7 8.1 19.0 52.9 32.8 7.2 29.9 15.1 5.4 4.3 17.5 8.7 8.6 12.0 3.1 33.8 25.8 17.6 38.1 26.2 19.2 5.8 20.0 4.5 9.5 CBLC "CBL-3, CBL-SL, RNF57" ENSG00000142273 "Cbl proto-oncogene C" Q9ULV8 19 44777869-44800634 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 105.9;Pancreatic endocrine cells: 67.6;Paneth cells: 84.2;Undifferentiated cells: 54.6;Urothelial cells: 56.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 19.0;BEWO: 13.1;CACO-2: 12.9;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.3;OE19: 16.9;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB008087, HPA035266" Approved Approved Nucleoplasm,Aggresome NA NA Nucleoplasm Aggresome "CAB008087: AB_2228531, HPA035266: AB_2674542" "unprognostic (1.58e-1)" "unprognostic (2.25e-1)" "unprognostic (8.21e-3)" "unprognostic (1.55e-1)" "unprognostic (3.04e-2)" "unprognostic (3.91e-2)" "unprognostic (1.67e-1)" "unprognostic (2.13e-2)" "unprognostic (3.82e-1)" "unprognostic (7.39e-2)" "unprognostic (1.06e-2)" "unprognostic (1.85e-1)" "prognostic favorable (3.11e-6)" "unprognostic (3.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.90e-2)" "unprognostic (2.21e-3)" 0.1 0.0 0.5 8.5 0.2 0.0 4.8 0.1 0.4 4.4 39.5 0.1 3.2 29.5 1.7 1.7 22.0 1.4 18.8 0.1 0.6 0.0 4.9 15.1 1.3 0.1 0.1 0.3 0.8 18.1 0.9 0.7 4.1 0.2 6.9 6.9 0.5 11.4 5.2 0.1 20.8 66.8 0.4 0.1 0.1 10.2 1.6 0.1 0.5 1.9 13.2 15.7 7.6 8.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 19.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 12.9 26.3 0.0 0.0 0.0 0.0 18.4 0.0 16.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.9 0.0 0.0 0.0 0.0 0.0 16.0 0.1 0.0 0.0 14.6 0.0 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.4 0.6 0.0 0.1 0.3 0.2 0.1 0.0 1.6 0.0 28.6 13.4 0.0 0.2 5.1 5.3 11.4 7.0 0.0 4.6 1.7 37.5 0.0 0.1 105.9 0.0 42.7 1.3 0.4 14.4 0.0 8.5 0.3 0.0 16.7 0.0 0.0 0.0 0.0 0.9 0.0 1.0 35.8 0.0 67.6 84.2 0.0 9.9 0.0 0.0 0.4 0.0 1.7 22.5 2.1 0.7 54.6 56.4 CBLL2 "CT138, FLJ25735, HAKAIL, ZNF645" ENSG00000175809 "Cbl proto-oncogene like 2" Q8N7E2 X 22272943-22274461 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "testis: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CBLN1 ENSG00000102924 "Cerebellin 1 precursor" P23435 16 49277917-49281831 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 106.6" "Group enriched" "Detected in some" 6 "Early spermatids: 80.9;Late spermatids: 214.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.5" "Region enriched" "Detected in many" 12 "cerebellum: 106.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "NTERA-2: 16.7;SCLC-21H: 53.2" "Region enriched" "Detected in many" 9 "cerebellum: 688.3" "Region enriched" "Detected in all" 15 "cerebellum: 300.1" "Secreted in brain" NA NA 2900000 "unprognostic (1.39e-2)" "unprognostic (1.88e-2)" "unprognostic (1.53e-1)" "unprognostic (3.16e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-2)" "unprognostic (9.65e-3)" "unprognostic (1.18e-2)" "unprognostic (6.31e-2)" "unprognostic (1.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.04e-2)" "unprognostic (7.68e-2)" "unprognostic (2.45e-1)" "unprognostic (1.06e-2)" "prognostic favorable (7.10e-4)" "unprognostic (1.60e-2)" 9.9 0.8 0.9 0.1 1.0 0.0 1.2 106.6 4.9 2.0 0.4 0.4 0.4 0.6 5.9 1.4 0.8 0.9 9.0 4.2 0.7 9.2 0.2 0.7 0.1 0.9 4.5 1.0 0.5 2.4 0.0 0.9 0.4 4.6 0.3 0.4 1.1 0.7 3.0 0.5 0.3 0.5 1.5 2.3 0.1 0.5 16.0 0.4 0.2 0.6 0.6 2.4 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 1.1 1.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.2 1.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 106.6 1.4 0.7 9.2 4.5 1.0 4.6 0.4 0.0 0.0 0.0 0.0 0.0 3.3 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 80.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.6 12.7 0.0 0.0 214.3 2.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.4 0.0 1.5 25.8 4.4 17.6 4.5 0.1 0.0 0.0 0.0 0.0 CBLN2 ENSG00000141668 "Cerebellin 2 precursor" Q8IUK8 18 72536680-72638521 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 33.8" "Cell type enriched" "Detected in some" 7 "Intestinal endocrine cells: 36.4" "Cancer enriched" "Detected in single" 7 "breast cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA 1300000 "unprognostic (2.03e-2)" "unprognostic (3.52e-1)" "unprognostic (1.13e-3)" "unprognostic (9.09e-5)" "unprognostic (7.10e-2)" "unprognostic (6.27e-3)" "unprognostic (7.39e-2)" "unprognostic (2.17e-1)" "unprognostic (1.37e-4)" "unprognostic (5.01e-4)" "unprognostic (8.15e-2)" "unprognostic (6.07e-4)" "unprognostic (7.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (4.93e-2)" 0.6 0.7 5.4 0.8 10.4 0.4 0.6 0.8 33.8 1.0 2.9 0.9 0.0 2.5 0.5 0.4 0.5 0.5 0.4 0.4 4.5 9.5 1.5 0.9 0.4 0.5 7.0 16.4 0.6 0.4 0.4 0.3 0.4 17.8 1.8 2.6 1.9 0.4 8.2 0.4 0.9 3.8 1.5 2.6 0.4 0.6 0.6 0.0 0.0 0.4 0.0 1.3 0.5 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.8 33.8 4.5 9.5 7.0 16.4 17.8 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 1.0 0.1 0.0 0.0 0.0 0.0 CBLN3 ENSG00000139899 "Cerebellin 3 precursor" Q6UW01 14 24426532-24430954 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 105.2" "Cell type enhanced" "Detected in some" 8 "Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 23 "cerebellum: 105.2" "Cell type enhanced" "Detected in some" "memory B-cell: 1.5;naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9" "Region enriched" "Detected in some" 25 "cerebellum: 481.8" "Region enriched" "Detected in some" 47 "cerebellum: 583.0" HPA041266 Enhanced Supported Approved Nucleoplasm "Secreted in brain" NA NA Nucleoplasm "HPA041266: AB_10674430" "unprognostic (5.02e-2)" "unprognostic (3.26e-1)" "unprognostic (1.43e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (4.39e-4)" "unprognostic (5.39e-3)" "unprognostic (1.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.16e-2)" "unprognostic (9.76e-2)" "unprognostic (6.20e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (6.20e-6)" "unprognostic (2.75e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (9.02e-2)" 2.1 7.7 1.2 4.5 1.3 0.0 1.2 105.2 1.7 1.8 1.1 1.9 1.0 0.6 1.3 4.8 1.0 1.2 3.1 1.6 1.0 1.1 1.2 1.4 1.3 7.9 1.3 1.4 3.3 1.0 1.0 1.3 1.7 4.6 1.2 0.7 1.7 1.6 1.6 1.4 1.6 1.3 1.3 2.0 7.4 1.4 1.6 1.1 1.1 1.2 1.5 5.3 1.9 1.3 2.3 0.3 0.1 0.8 0.0 0.3 0.0 1.1 1.0 0.5 1.9 5.0 10.9 0.3 4.2 8.6 1.7 2.2 0.5 2.0 1.8 0.9 2.6 1.9 0.3 0.6 2.3 1.1 12.7 0.4 0.0 3.5 0.8 2.8 0.3 0.7 18.9 1.0 2.1 1.7 7.0 1.5 0.8 0.5 14.2 2.1 0.6 0.0 0.5 0.1 1.1 1.1 0.0 0.0 1.3 1.0 0.4 0.7 0.4 0.3 0.1 0.6 0.3 0.6 0.4 6.6 6.1 1.2 2.5 0.2 9.9 2.3 2.0 0.3 0.8 1.0 0.0 0.0 0.1 0.0 0.8 0.3 1.5 0.1 0.1 0.0 2.3 0.2 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 1.3 105.2 1.7 1.0 1.1 1.3 1.4 4.6 1.1 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.5 0.0 1.0 0.5 2.3 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 3.6 0.2 0.8 0.8 0.0 1.4 0.5 0.3 0.0 1.2 0.0 0.1 0.5 0.7 0.0 0.4 0.5 CBLN4 "CBLNL1, dJ885A10.1" ENSG00000054803 "Cerebellin 4 precursor" Q9NTU7 20 55997440-56005472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.5;brain: 16.8;epididymis: 11.8" "Cell type enriched" "Detected in some" 4 "Peritubular cells: 35.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 49 "SH-SY5Y: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074497 Supported "Secreted in brain" NA NA 10000000 "HPA074497: " "unprognostic (3.61e-1)" "unprognostic (8.43e-3)" "unprognostic (2.43e-1)" "unprognostic (1.61e-2)" "unprognostic (1.99e-1)" "unprognostic (4.00e-1)" "unprognostic (3.25e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (3.88e-1)" "unprognostic (9.63e-2)" "unprognostic (1.74e-1)" "unprognostic (1.40e-3)" "unprognostic (3.22e-4)" "unprognostic (7.50e-2)" "unprognostic (3.58e-2)" "unprognostic (1.79e-3)" 1.3 23.5 11.9 0.3 8.9 0.2 1.8 0.1 16.8 2.8 0.3 0.5 0.8 0.3 1.2 11.8 0.3 5.4 0.9 0.2 5.9 14.8 1.0 1.3 1.1 0.2 1.6 5.0 2.2 1.2 0.4 0.1 0.5 2.4 0.4 0.2 0.1 0.3 0.7 0.5 0.3 0.3 0.6 0.4 0.2 0.7 2.7 0.0 0.0 1.3 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 8.9 0.1 16.8 5.9 14.8 1.6 5.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.6 8.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 35.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CBR1 "CBR, SDR21C1" ENSG00000159228 "Carbonyl reductase 1" P16152 21 36069941-36073166 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 176.1" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 641.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA018433, CAB034291" Enhanced Approved Nucleoplasm,Cytosol NA NA 12000000 Nucleoplasm Cytosol "CAB034291: AB_2070856, HPA018433: AB_1846109" "prognostic favorable (2.18e-4)" "unprognostic (9.78e-2)" "unprognostic (3.25e-2)" "unprognostic (2.14e-1)" "unprognostic (6.47e-3)" "unprognostic (1.69e-1)" "unprognostic (1.19e-1)" "unprognostic (6.37e-2)" "unprognostic (4.56e-2)" "unprognostic (1.28e-1)" "unprognostic (7.20e-2)" "unprognostic (4.00e-1)" "prognostic favorable (4.75e-4)" "unprognostic (2.37e-1)" "unprognostic (2.47e-1)" "unprognostic (6.13e-3)" "unprognostic (2.47e-2)" 9.6 22.9 31.7 8.4 41.6 3.7 8.5 12.0 35.8 14.6 63.4 75.9 6.5 176.1 9.3 17.1 40.2 9.6 15.1 7.8 37.7 24.7 35.2 77.2 11.7 8.5 57.3 25.2 10.4 8.0 8.9 7.9 11.7 51.6 16.7 16.8 10.4 23.1 15.0 8.7 34.4 118.1 11.6 48.1 10.0 41.4 5.7 41.9 3.6 11.3 29.8 14.3 12.4 17.1 17.0 29.9 17.1 51.4 19.1 29.2 37.0 25.3 39.1 4.8 12.3 25.1 25.4 0.2 28.5 20.5 15.6 18.7 14.4 14.9 6.4 18.8 26.5 30.1 18.7 9.8 27.9 12.0 31.5 23.1 19.1 22.8 9.8 14.4 10.6 17.6 12.4 35.2 15.1 6.6 17.9 16.6 0.0 0.0 4.7 14.3 25.1 5.3 11.1 0.0 0.0 28.6 0.0 0.1 17.7 41.4 12.7 14.0 12.5 27.5 40.0 32.4 3.9 18.9 14.8 16.7 17.5 7.4 44.3 20.6 32.0 57.9 0.1 32.1 10.6 25.3 1.8 36.6 17.1 18.1 51.4 15.3 17.0 22.7 16.9 29.9 15.6 29.2 21.4 2.5 19.1 38.6 10.4 22.7 37.0 31.7 41.6 12.0 35.8 37.7 24.7 57.3 25.2 51.6 41.9 113.2 54.7 13.0 59.4 113.9 11.9 19.9 81.5 111.1 96.7 90.7 2.0 102.1 641.6 73.2 5.9 17.8 131.2 46.7 60.9 77.8 54.3 48.6 34.6 203.8 78.0 3.2 37.1 54.6 65.5 2.9 113.6 47.2 86.0 102.8 58.6 65.5 81.3 71.8 124.5 200.8 7.4 25.8 60.8 4.2 11.3 108.0 74.6 30.9 77.6 42.0 CBR3 SDR21C2 ENSG00000159231 "Carbonyl reductase 3" O75828 21 36134912-36146566 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 68.2" "Group enriched" "Detected in many" 4 "Basal glandular cells: 23.4;Basal keratinocytes: 63.1;Glandular cells: 36.1;Leydig cells: 62.7;Melanocytes: 62.4;monocytes: 36.1;Peritubular cells: 71.1;Smooth muscle cells: 20.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 11.9;NK-cells: 4.9;T-cells: 17.9" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 43.6" "Low region specificity" "Detected in all" HPA018434 Uncertain Approved Nucleoplasm,Cytosol Yes NA "Nucleoplasm, Cytosol" "HPA018434: AB_1846110" "unprognostic (3.64e-3)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.22e-2)" "unprognostic (6.12e-2)" "unprognostic (2.98e-2)" "unprognostic (3.75e-1)" "unprognostic (9.10e-2)" "prognostic unfavorable (5.95e-6)" "unprognostic (3.13e-1)" "unprognostic (1.80e-1)" "unprognostic (3.99e-3)" "unprognostic (1.94e-1)" 9.2 1.5 5.4 3.0 13.9 0.9 12.2 3.1 4.7 8.6 3.8 1.4 4.1 2.4 5.5 8.8 27.6 4.1 4.9 4.9 3.6 2.9 1.6 0.4 3.5 3.4 3.8 6.1 9.3 1.2 0.3 1.2 2.2 2.5 7.2 2.9 3.3 21.8 4.2 2.4 16.3 2.6 10.5 2.3 1.5 2.7 4.3 2.7 0.9 2.3 68.2 14.1 7.1 8.0 11.9 1.2 0.4 0.5 4.9 17.9 6.2 12.2 3.5 1.5 3.1 12.0 18.6 2.4 13.4 15.9 15.4 12.3 0.1 2.6 0.0 3.9 13.7 5.4 5.7 2.0 2.7 6.2 16.7 6.4 0.5 3.7 0.1 1.0 0.0 0.0 2.6 0.3 10.7 1.4 7.4 9.3 1.4 0.0 0.1 4.5 9.2 1.1 5.4 1.2 3.8 15.5 2.6 2.9 23.9 5.1 5.2 0.8 1.1 10.2 12.5 19.5 0.8 3.7 1.4 6.4 10.0 0.8 11.2 12.9 0.6 0.2 0.0 10.4 0.3 17.9 0.0 0.3 0.0 1.2 0.2 1.5 11.9 13.0 4.0 1.2 10.6 17.9 12.3 0.4 4.9 0.5 0.3 5.1 6.2 5.4 13.9 3.1 4.7 3.6 2.9 3.8 6.1 2.5 2.7 0.0 2.7 0.0 23.4 63.1 0.2 0.2 5.1 5.3 11.4 0.0 0.0 0.9 8.3 3.3 0.5 11.3 1.1 0.0 0.6 0.2 7.7 36.1 5.7 0.0 7.4 0.0 0.0 8.6 3.7 1.1 62.7 5.6 62.4 36.1 8.9 1.4 2.1 1.1 71.1 0.0 0.4 0.0 20.3 0.4 0.2 40.8 0.2 1.3 2.9 11.5 CBS HIP4 ENSG00000160200 Cystathionine-beta-synthase P35520 21 43053191-43076943 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Allosteric enzyme, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 55.7;pancreas: 43.0" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 3.5;Hepatocytes: 2.6;Melanocytes: 5.0;Smooth muscle cells: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 84 "neutrophil: 8.3" "Lineage enriched" "Detected in single" 84 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "BEWO: 40.8;HAP1: 38.9;HHSteC: 52.7;MCF7: 45.1;RPMI-8226: 43.1" HPA001223 Supported Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (4.86e-2)" "unprognostic (1.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.68e-4)" "unprognostic (3.62e-1)" "unprognostic (6.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.50e-2)" "unprognostic (2.13e-1)" "unprognostic (1.61e-2)" "unprognostic (6.73e-3)" "unprognostic (2.62e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" 1.3 1.5 6.5 2.4 5.1 0.4 1.0 12.3 6.7 4.8 1.3 2.0 0.8 1.6 0.9 0.8 0.8 2.0 2.1 2.0 5.6 5.5 1.3 55.7 1.7 1.4 4.8 2.8 13.9 43.0 0.3 1.4 1.4 2.3 4.0 0.7 2.8 9.3 3.4 0.8 0.6 2.9 1.4 3.7 0.8 2.7 2.2 3.3 0.8 5.0 0.8 0.9 2.6 0.8 0.0 0.0 8.3 0.0 0.0 0.0 0.0 6.4 3.9 5.1 20.0 11.5 7.4 40.8 8.0 2.0 3.3 3.4 12.0 0.3 0.0 4.3 15.0 0.0 0.4 38.9 2.8 0.6 0.0 4.9 2.7 15.6 14.4 52.7 1.6 3.8 4.5 0.4 3.6 3.2 3.0 8.8 18.9 30.1 22.7 2.5 45.1 2.8 0.0 4.8 14.6 6.8 0.0 0.0 43.1 0.1 3.6 10.6 15.6 17.4 1.0 7.5 4.3 6.2 20.4 1.2 0.2 10.0 0.1 0.8 7.9 6.3 9.0 3.7 2.4 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 6.5 5.1 12.3 5.2 5.6 5.5 4.8 2.8 2.3 3.3 0.0 0.3 0.0 0.0 0.3 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.2 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.0 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.9 0.1 0.0 0.0 0.0 CBSL ENSG00000274276 "Cystathionine-beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.5;liver: 21.2;pancreas: 18.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "neutrophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "AN3-CA: 36.5;NTERA-2: 67.6;SH-SY5Y: 21.6;U-266/70: 21.3" HPA001223 Supported Approved Nucleoli,Vesicles NA NA 190000 Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 0.0 0.0 0.0 0.0 0.0 11.5 1.8 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 21.2 0.0 0.0 1.6 18.5 0.0 0.0 1.8 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 12.2 36.5 0.0 0.0 0.4 7.6 4.4 2.8 8.5 0.1 4.9 0.0 0.0 0.0 4.7 3.2 0.0 3.9 1.7 0.0 9.6 0.0 0.0 0.0 0.2 0.0 5.2 4.2 14.2 0.0 7.1 0.0 0.0 0.8 0.2 16.9 0.1 0.0 5.7 0.6 67.6 0.0 0.0 0.0 0.0 0.0 11.0 0.0 14.1 21.6 0.0 1.1 14.7 0.0 0.0 0.0 0.0 0.7 0.0 4.7 1.5 21.3 7.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CBWD2 ENSG00000136682 "COBW domain containing 2" Q8IUF1 2 113437691-113496189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 97.9;monocytes: 81.2;Suprabasal keratinocytes: 104.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (4.14e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (7.69e-2)" "unprognostic (2.17e-1)" "unprognostic (2.16e-3)" "unprognostic (1.31e-3)" "unprognostic (3.69e-2)" "unprognostic (1.72e-2)" "unprognostic (5.85e-2)" "unprognostic (1.39e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (7.57e-3)" 2.0 5.7 3.2 2.6 6.0 0.3 4.3 7.0 4.1 5.6 3.6 0.9 4.1 4.9 5.9 2.1 2.5 9.1 3.1 4.5 8.9 6.6 1.8 1.3 3.2 3.0 3.6 7.7 5.3 3.4 4.1 3.6 4.3 5.0 15.0 1.7 2.2 5.0 1.6 2.3 3.3 1.2 6.2 2.5 4.2 2.5 7.8 26.5 13.8 27.4 7.5 10.4 17.5 8.0 4.8 5.4 6.1 14.1 6.5 10.1 6.3 4.0 5.0 6.5 8.2 5.0 10.6 19.3 6.6 22.7 6.8 5.6 7.0 6.7 3.6 15.0 8.8 8.7 15.3 4.7 3.7 4.2 6.1 4.3 7.2 4.3 9.5 8.9 5.7 5.0 11.6 7.2 8.6 11.7 12.5 6.4 15.4 10.7 5.6 14.1 27.8 13.1 13.0 14.8 4.3 16.3 2.4 2.7 18.9 7.7 10.8 10.6 4.2 5.9 2.5 6.0 4.5 18.7 5.6 6.9 23.0 9.9 4.2 27.4 13.8 5.2 27.1 5.6 7.3 7.9 6.1 26.5 7.8 6.8 6.2 7.5 7.5 21.2 6.5 10.4 17.5 8.9 15.6 26.1 9.5 97.9 11.0 42.0 15.3 37.5 18.2 14.0 15.7 14.3 33.2 23.7 12.9 14.6 8.4 0.0 12.5 11.1 14.6 8.9 15.1 10.6 8.4 12.7 2.4 6.7 8.8 11.8 10.0 23.9 25.3 81.2 8.2 9.5 12.7 12.9 16.3 23.0 12.3 0.0 15.5 16.8 11.1 104.9 21.6 10.9 14.4 9.7 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 34.4" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 3.8 6.0 4.4 6.6 4.9 4.0 6.5 5.7 5.1 2.7 4.7 4.2 2.9 2.1 5.4 3.0 1.8 2.9 4.8 4.4 7.7 11.1 2.9 5.7 4.5 3.6 10.7 4.2 5.0 5.5 4.1 3.2 3.7 3.6 5.2 4.9 7.6 2.8 3.9 5.0 6.3 3.2 5.1 4.3 4.5 3.5 20.3 24.4 34.4 33.9 5.7 14.0 19.9 21.3 15.9 7.8 12.1 5.8 1.9 10.3 10.7 4.2 4.5 5.3 4.4 21.0 24.7 10.4 7.7 21.0 26.2 14.3 21.0 12.4 38.0 9.2 9.5 36.2 21.0 7.4 17.9 11.9 4.8 6.5 8.2 10.8 9.0 10.5 28.3 17.3 20.2 6.6 13.7 20.9 23.9 11.4 25.5 26.7 9.5 24.3 26.9 5.1 9.2 12.1 7.8 17.6 10.6 13.1 15.1 7.6 20.8 5.0 7.0 17.9 11.5 20.5 11.9 47.4 30.3 21.0 26.5 12.6 9.1 33.9 24.8 11.6 27.2 10.0 20.3 10.8 11.9 24.4 18.4 11.7 10.9 34.4 5.7 19.0 18.3 14.0 19.9 23.8 25.9 16.0 14.0 12.9 27.1 24.2 7.6 40.2 34.2 10.4 27.5 11.9 1.7 5.1 3.3 7.5 11.7 0.0 10.0 6.7 4.7 7.5 11.6 7.3 4.6 11.1 4.1 7.4 13.0 1.7 4.6 8.7 5.0 22.6 6.5 4.3 6.9 14.0 2.8 5.0 34.5 6.5 5.3 10.1 5.0 18.7 12.9 10.2 8.1 9.5 CBWD6 CBWD7 ENSG00000215126 "COBW domain containing 6" Q4V339 9 41131306-41199261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "blood: 9.3;liver: 6.1" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 34.9;Melanocytes: 13.5;Suprabasal keratinocytes: 37.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 12.5;PC-3: 19.4" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (9.48e-2)" "unprognostic (6.02e-2)" "unprognostic (1.62e-2)" "unprognostic (1.91e-2)" "unprognostic (1.30e-2)" "unprognostic (6.28e-2)" "unprognostic (5.92e-2)" "unprognostic (3.71e-2)" "unprognostic (2.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.24e-2)" "unprognostic (1.09e-1)" "unprognostic (2.28e-4)" "unprognostic (5.65e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (9.94e-4)" 0.1 5.2 2.2 0.4 2.4 2.0 2.8 1.0 2.0 0.2 0.3 1.2 0.1 0.0 0.2 0.0 1.6 1.3 2.8 1.5 2.1 6.1 0.1 0.0 1.2 0.2 1.3 0.0 0.5 0.0 0.6 0.0 2.8 2.5 4.3 0.4 0.9 0.0 1.2 0.3 0.2 0.1 0.3 0.2 0.2 0.1 4.8 4.0 2.5 9.3 0.6 4.3 2.8 1.4 0.3 0.6 0.3 0.7 1.9 1.2 7.9 8.9 9.2 0.0 3.0 0.9 1.9 0.4 6.4 0.4 1.3 11.7 0.2 0.3 1.9 7.5 0.5 4.2 2.1 0.0 2.3 0.7 0.2 1.1 6.1 7.6 0.7 7.0 0.6 1.0 1.1 12.5 1.2 3.4 0.6 1.9 3.2 19.4 0.8 7.8 2.6 8.2 0.5 0.9 1.0 1.9 0.7 0.9 1.8 0.6 1.2 11.7 0.1 0.9 0.4 0.8 3.5 0.6 10.3 1.2 0.8 0.9 1.6 5.9 2.5 0.8 6.8 1.4 4.8 4.3 3.5 3.3 1.8 3.0 3.4 0.9 0.6 9.3 4.0 1.8 2.8 3.0 6.2 0.0 0.0 34.9 0.0 0.0 0.0 2.7 4.5 5.2 0.0 4.4 3.3 3.7 0.0 0.0 0.0 0.0 4.3 5.7 3.1 0.0 8.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 13.5 2.8 0.0 0.0 4.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 37.5 5.3 0.0 0.0 0.0 CBX2 "CDCA6, MGC10561" ENSG00000173894 "Chromobox 2" Q14781 17 79778132-79787983 "Disease related genes, Predicted intracellular proteins" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.9;testis: 16.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 27.9;Late spermatids: 28.1;Spermatogonia: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 32.1;SH-SY5Y: 24.4;SK-BR-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023083 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA023083: AB_2671063" "unprognostic (1.37e-2)" "unprognostic (1.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.72e-2)" "unprognostic (2.25e-11)" "unprognostic (1.05e-1)" "unprognostic (7.77e-2)" "unprognostic (6.34e-3)" "unprognostic (1.86e-3)" "unprognostic (1.66e-1)" "unprognostic (1.25e-8)" "unprognostic (1.34e-1)" "unprognostic (3.33e-2)" "unprognostic (2.37e-3)" "unprognostic (2.07e-1)" 2.1 0.6 1.6 1.3 2.5 3.4 8.1 0.5 1.5 1.7 0.8 0.6 2.9 0.6 4.0 3.4 6.0 1.7 1.1 3.3 0.8 0.7 1.3 0.9 2.2 2.2 1.8 1.1 4.1 2.2 0.4 0.5 3.9 1.3 1.3 0.4 1.0 2.1 1.5 1.3 3.4 1.0 1.2 0.8 2.5 0.9 16.5 1.8 17.9 1.7 6.8 2.4 1.5 3.5 0.8 0.4 0.0 0.6 0.0 0.4 0.2 2.5 6.9 12.8 23.3 0.1 0.2 4.6 0.9 0.4 0.4 0.8 7.1 0.5 9.9 2.0 0.1 1.6 1.3 14.8 0.4 0.3 1.4 8.0 0.5 7.5 4.7 0.5 3.0 2.1 0.2 0.9 0.2 0.6 0.5 2.6 10.7 6.8 0.8 0.4 10.4 15.5 7.3 12.7 3.4 8.1 32.1 9.6 6.0 0.5 3.5 15.7 24.4 4.0 46.6 2.7 6.4 8.4 4.5 1.8 4.6 13.7 1.4 1.7 3.0 1.5 6.1 0.2 8.1 5.4 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.6 0.4 0.0 0.2 1.6 2.5 0.5 1.5 0.8 0.7 1.8 1.1 1.3 1.8 0.0 0.0 0.0 0.2 0.9 0.6 2.0 0.0 0.0 0.0 1.8 2.0 0.2 1.7 3.5 27.9 6.7 0.0 0.0 0.8 1.1 0.8 0.8 0.0 0.5 1.1 0.0 0.0 2.5 0.6 28.1 0.6 0.0 3.3 1.0 0.4 2.3 0.9 0.0 0.7 0.5 0.2 0.0 0.0 1.1 16.1 1.3 0.2 0.0 0.0 0.5 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839429 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.0;SK-MEL-30: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: AB_2668603" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 7.1 9.9 11.6 11.3 14.8 109.1 7.0 9.0 22.5 5.9 6.2 20.4 6.3 8.3 5.9 6.3 14.8 6.7 10.3 12.0 12.9 12.9 6.5 15.3 9.0 13.9 15.4 10.8 9.3 16.8 16.2 14.8 17.0 13.9 8.9 4.8 14.5 12.9 6.9 3.8 20.6 8.5 5.2 12.6 16.3 10.8 5.5 13.1 29.2 8.3 6.7 19.2 8.6 7.1 3.6 4.2 5.2 1.7 1.0 3.8 1.3 10.8 9.7 3.0 12.7 1.9 1.7 8.3 4.9 2.9 1.8 1.9 7.0 6.1 4.2 7.0 1.9 4.0 5.6 3.2 3.2 1.3 4.5 6.2 2.3 9.3 13.0 9.2 12.4 18.6 2.3 19.3 1.6 3.0 3.0 1.5 12.4 7.2 23.7 1.9 7.8 17.0 12.7 1.6 11.3 9.8 17.7 3.0 18.8 2.5 5.2 3.1 5.9 7.4 39.0 43.4 1.3 9.2 19.9 3.8 10.6 9.4 6.5 6.3 20.5 10.4 11.8 6.7 10.8 14.0 3.9 1.4 4.1 2.4 1.5 1.8 3.3 3.1 3.3 0.9 3.6 3.8 3.5 5.2 1.0 1.7 4.2 0.5 1.3 11.6 14.8 9.0 22.5 12.9 12.9 15.4 10.8 13.9 13.1 3.0 14.9 15.9 2.2 20.7 30.6 37.0 12.7 9.4 9.1 1.8 21.6 27.3 0.0 7.5 0.1 13.5 11.5 23.3 6.4 3.3 11.4 6.6 6.9 13.5 11.7 19.1 50.6 20.3 20.6 0.6 4.0 10.2 16.9 4.6 38.4 26.1 7.5 15.9 5.3 2.6 40.4 6.5 11.0 0.0 2.5 26.8 7.2 16.0 26.7 4.8 CBY3 ENSG00000204659 "Chibby family member 3" A6NI87 5 179678583-179680974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.8" "Group enriched" "Detected in some" 122 "Early spermatids: 194.9;Late spermatids: 243.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;BEWO: 1.9;HDLM-2: 5.3;HeLa: 3.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069037 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA069037: AB_2686069" "unprognostic (1.33e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (1.76e-1)" "unprognostic (8.68e-3)" "unprognostic (7.69e-3)" "unprognostic (5.71e-2)" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (6.10e-4)" "unprognostic (2.69e-2)" "unprognostic (1.67e-2)" "unprognostic (9.76e-3)" "unprognostic (7.85e-2)" "unprognostic (5.04e-3)" "unprognostic (4.98e-2)" 0.4 0.6 1.1 0.5 1.3 0.2 0.4 0.8 1.2 0.4 0.4 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.4 0.4 1.1 1.3 0.4 0.4 0.4 0.8 1.9 0.4 0.9 1.1 0.0 0.6 0.4 0.4 0.5 0.0 0.4 0.4 0.4 1.1 1.6 0.9 0.4 2.1 1.2 0.9 15.8 0.4 0.4 0.9 0.4 0.4 0.4 0.4 2.9 1.2 0.1 1.0 0.4 2.1 0.6 0.0 0.5 0.0 2.8 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.3 0.3 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.4 0.0 1.1 0.1 0.9 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.1 1.4 0.1 0.6 0.1 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.7 0.0 0.5 0.0 2.0 1.0 1.1 1.2 2.1 0.7 1.2 2.9 2.1 1.3 0.1 0.4 0.1 0.9 1.4 0.6 1.1 1.3 0.8 0.5 1.1 1.3 1.9 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 194.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 243.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 CC2D2B "bA248J23.4, bA690P14.3, C10orf130, C10orf131" ENSG00000188649 "Coiled-coil and C2 domain containing 2B" Q6DHV5 10 95907603-96032684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA044091, HPA072122" Enhanced Approved "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA044091: AB_2732514, HPA072122: AB_2686489" "unprognostic (6.38e-2)" "unprognostic (5.95e-2)" "unprognostic (1.47e-1)" "unprognostic (5.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-3)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (8.18e-3)" "unprognostic (2.11e-3)" "unprognostic (9.11e-4)" "unprognostic (1.93e-2)" "unprognostic (4.34e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-1)" 0.5 1.7 1.0 1.7 1.0 1.7 0.6 0.3 3.1 0.8 0.8 0.6 2.3 0.2 0.8 1.3 2.0 0.8 0.6 0.6 0.6 0.3 0.9 1.1 0.9 0.8 0.2 0.0 0.4 0.7 0.9 0.0 0.5 0.1 1.6 2.6 0.9 1.2 0.7 1.4 0.6 10.6 4.0 0.0 1.0 1.1 4.1 1.0 1.8 1.0 0.8 2.9 0.5 1.2 4.0 3.9 7.2 0.2 0.4 4.1 3.9 0.4 0.6 0.1 4.2 0.8 5.1 3.1 0.0 4.0 2.8 0.3 0.2 0.0 4.9 8.8 9.2 3.4 3.2 0.0 9.8 0.6 0.7 0.0 0.4 0.1 1.7 0.3 1.3 7.9 3.0 0.9 2.5 4.5 3.3 8.5 3.0 6.6 11.6 3.5 4.3 0.7 1.3 7.1 3.8 4.3 1.1 2.7 5.1 7.0 4.4 3.4 4.5 4.5 3.1 5.6 2.6 11.0 0.1 3.4 10.0 2.9 0.0 1.0 0.2 1.9 0.3 2.9 3.4 1.4 1.1 0.9 4.1 1.3 0.4 1.8 0.8 0.8 1.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCBE1 "FLJ30681, KIAA1983" ENSG00000183287 "Collagen and calcium binding EGF domains 1" Q6UXH8 18 59430940-59697380 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 28.0" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 14.3;Ito cells: 12.3;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "hippocampal formation: 10.0" "Group enriched" "Detected in some" 7 "basophil: 9.6;neutrophil: 2.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 9.6" "Cell line enhanced" "Detected in many" "BJ: 26.8;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+ RasG12V: 25.7;HBF TERT88: 30.8;hTERT-HME1: 41.8;LHCN-M2: 46.9;TIME: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA041361, HPA041374" Uncertain Supported "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA041361: AB_10796667, HPA041374: AB_10794515" "unprognostic (3.09e-1)" "unprognostic (5.01e-2)" "unprognostic (9.54e-5)" "unprognostic (1.66e-2)" "unprognostic (2.40e-2)" "unprognostic (5.68e-5)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (2.17e-2)" "unprognostic (3.62e-3)" "unprognostic (4.04e-3)" "unprognostic (1.64e-1)" "unprognostic (7.45e-2)" "unprognostic (2.02e-2)" 10.0 12.6 2.4 3.8 1.1 0.4 3.5 0.4 2.0 16.8 15.8 0.6 8.2 0.8 12.1 2.8 2.3 6.9 6.9 2.1 10.0 0.5 3.1 4.3 16.5 3.6 0.4 2.1 28.0 0.8 0.4 2.6 0.3 1.7 3.0 2.3 9.1 1.0 3.5 10.6 3.3 3.0 4.9 0.3 0.3 1.7 2.1 1.3 0.2 1.0 0.0 0.7 2.9 5.1 0.8 0.4 9.6 0.3 0.8 0.3 0.2 5.2 0.4 0.0 0.0 4.2 13.1 8.2 26.8 27.5 19.5 25.7 0.0 0.1 0.1 0.0 10.6 4.6 0.5 0.0 17.3 30.8 0.1 0.1 0.0 0.1 0.1 9.7 0.1 0.0 8.8 0.7 15.2 41.8 8.4 0.9 0.0 0.0 0.1 46.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.5 0.1 0.2 0.0 0.0 0.2 2.0 0.0 0.1 25.2 0.0 2.7 3.9 0.0 0.1 0.0 0.0 1.3 0.1 0.6 9.6 0.3 0.8 0.3 0.2 0.2 0.4 0.2 0.2 0.1 0.8 0.3 0.3 2.7 0.8 0.2 0.4 0.2 0.2 2.4 1.1 0.4 2.0 10.0 0.5 0.4 2.1 1.7 1.3 3.0 2.2 0.0 1.1 4.0 7.2 0.8 2.5 1.4 3.4 0.0 7.9 0.6 0.0 0.1 0.5 0.7 0.0 0.0 0.2 0.6 3.1 1.1 1.1 0.0 0.3 14.3 0.0 12.3 1.5 0.2 8.9 0.5 6.8 0.0 0.0 1.1 0.5 0.0 0.4 0.0 42.0 0.0 4.1 0.0 0.7 3.8 0.7 0.0 0.0 0.7 CCDC102B "ACY1L, AN, C18orf14, FLJ23594, HsT1731" ENSG00000150636 "Coiled-coil domain containing 102B" Q68D86 18 68715209-69055189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 33.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 113.6;Late spermatids: 49.0;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.8;BJ hTERT+: 20.8;fHDF/TERT166: 18.7;HSkMC: 11.5;Karpas-707: 7.4" "Not detected" "Not detected" "HPA040623, HPA048194" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA040623: AB_10805715, HPA048194: AB_2680309" "unprognostic (3.92e-2)" "unprognostic (1.62e-1)" "unprognostic (5.58e-2)" "unprognostic (9.50e-3)" "unprognostic (7.13e-2)" "unprognostic (3.50e-1)" "unprognostic (7.87e-3)" "unprognostic (1.36e-1)" "unprognostic (5.59e-2)" "unprognostic (8.62e-3)" "unprognostic (1.95e-1)" "unprognostic (6.04e-2)" "prognostic unfavorable (2.90e-6)" "unprognostic (2.21e-2)" "unprognostic (2.12e-2)" "unprognostic (8.00e-3)" "unprognostic (3.13e-3)" 8.7 4.2 6.4 4.7 7.1 1.3 4.4 3.2 8.0 4.2 4.8 4.9 2.9 2.3 4.0 6.4 4.7 2.9 16.9 4.7 6.0 5.4 5.9 3.3 16.4 11.5 7.0 5.0 3.3 3.1 3.2 5.0 33.7 8.7 4.0 6.1 4.0 3.2 2.2 2.1 2.9 3.9 6.4 9.3 3.3 4.7 4.3 7.0 1.7 6.8 5.0 2.9 16.9 4.0 0.9 11.5 0.4 0.3 1.3 2.6 0.3 0.0 0.0 2.9 0.2 2.7 10.8 0.2 0.6 20.8 0.2 0.3 0.1 0.3 0.1 0.4 18.7 0.3 0.2 0.1 0.2 0.3 0.9 0.3 0.6 0.0 0.9 5.3 0.1 0.3 11.5 0.4 0.3 2.6 0.4 0.1 1.4 0.0 7.4 1.7 0.0 0.4 0.2 0.6 0.1 0.3 0.9 0.2 0.3 0.1 0.0 1.3 1.1 0.1 0.0 0.0 1.2 0.2 0.9 2.9 0.4 0.2 0.1 0.2 3.2 0.2 0.5 1.5 1.2 1.8 0.0 0.1 0.4 1.4 0.3 1.3 0.6 0.8 1.1 0.3 0.9 2.6 1.6 0.0 1.3 0.2 11.5 0.3 0.3 6.4 7.1 3.2 8.0 6.0 5.4 7.0 5.0 8.7 7.0 0.0 2.1 0.5 0.6 0.6 5.6 7.4 0.0 1.4 3.4 3.5 5.9 0.7 5.0 0.6 113.6 4.5 0.0 0.0 1.5 0.5 3.6 0.5 2.3 0.6 3.0 6.4 0.0 4.3 2.2 49.0 30.0 3.1 0.0 2.8 0.2 10.8 0.3 0.3 8.5 4.5 12.2 77.6 22.5 1.6 2.7 0.5 0.2 1.0 0.4 0.5 CCDC103 "CILD17, FLJ13094, FLJ34211, PR46b" ENSG00000167131 "Coiled-coil domain containing 103" Q8IW40 17 44899142-44905390 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 19.6;testis: 35.5" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 12.8;RPTEC TERT1: 10.0;U-87 MG: 11.3" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" "unprognostic (9.40e-3)" "unprognostic (1.75e-1)" "unprognostic (5.60e-2)" "unprognostic (1.99e-2)" "unprognostic (4.50e-2)" "unprognostic (7.43e-2)" "unprognostic (2.80e-1)" "unprognostic (2.34e-1)" "unprognostic (1.27e-1)" "unprognostic (4.35e-2)" "unprognostic (4.69e-1)" "unprognostic (1.05e-1)" "unprognostic (3.60e-1)" 0.6 2.3 2.6 0.9 6.3 0.6 1.2 0.5 4.7 1.4 0.9 2.9 1.6 0.5 1.7 2.8 0.4 19.6 2.8 0.4 2.5 3.0 2.7 0.7 1.9 0.3 1.5 3.9 3.5 0.8 1.9 2.1 0.5 4.3 0.9 0.7 1.6 1.2 1.5 0.3 0.7 0.4 1.2 1.0 0.4 0.9 35.5 1.0 0.2 3.5 0.1 0.5 0.7 0.4 0.8 2.5 3.0 3.7 0.7 0.4 2.4 2.2 12.8 1.9 2.4 2.8 2.3 1.6 1.0 3.8 1.8 1.3 2.4 4.2 0.3 2.1 0.9 5.5 3.9 0.8 1.8 1.0 7.9 1.4 0.6 2.7 0.0 1.8 1.6 0.3 1.6 3.0 1.9 0.7 3.7 1.3 0.9 1.7 0.3 0.1 2.4 0.0 0.7 0.4 2.1 1.9 0.3 0.7 0.5 10.0 1.3 5.1 1.0 0.5 0.4 2.3 1.1 3.4 1.7 1.0 0.8 2.0 1.0 1.9 0.4 0.5 0.4 11.3 0.8 0.3 1.2 3.7 3.0 0.3 1.9 0.4 0.0 0.0 0.4 2.5 0.8 0.4 0.3 0.5 0.7 1.7 0.8 0.1 2.4 2.6 6.3 0.5 4.7 2.5 3.0 1.5 3.9 4.3 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CCDC105 FLJ40365 ENSG00000160994 "Coiled-coil domain containing 105" Q8IYK2 19 15010744-15023269 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 94 "testis: 38.7" "Cell type enriched" "Detected in some" 8 "Early spermatids: 149.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA058585 Approved NA NA "HPA058585: AB_2683763" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 CCDC110 "CT52, KM-HN-1, MGC33607" ENSG00000168491 "Coiled-coil domain containing 110" Q8TBZ0 4 185445182-185471759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.9;testis: 49.2" "Cell type enhanced" "Detected in many" 31 "Early spermatids: 458.9;Late spermatids: 84.6;Spermatocytes: 151.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Cell line enhanced" "Detected in some" "SCLC-21H: 11.0;U-266/70: 9.1;U-266/84: 10.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.18e-1)" "unprognostic (7.26e-3)" "unprognostic (5.42e-2)" "unprognostic (9.84e-4)" "unprognostic (3.72e-2)" "unprognostic (3.08e-3)" "unprognostic (1.95e-5)" "unprognostic (4.92e-2)" "unprognostic (5.81e-2)" "unprognostic (9.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.64e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.37e-1)" "unprognostic (1.84e-1)" "unprognostic (1.21e-2)" "unprognostic (1.21e-2)" 0.7 0.8 0.8 1.1 5.0 0.0 1.8 3.4 1.6 1.9 1.5 0.2 2.2 0.4 0.7 2.7 1.3 1.5 0.6 0.8 1.0 1.0 1.6 0.6 0.5 0.5 0.8 1.0 2.5 15.9 0.4 8.5 0.3 3.0 2.4 0.9 0.9 4.6 1.7 2.9 0.6 0.6 0.7 0.7 0.6 1.5 49.2 1.2 0.0 6.2 0.0 0.5 2.8 1.6 0.8 0.0 0.0 0.0 0.0 2.8 0.2 0.5 0.0 0.3 0.2 2.8 3.1 0.1 0.0 0.0 0.0 0.2 0.0 2.0 3.3 0.5 0.0 2.9 0.4 2.1 0.0 0.2 1.9 2.6 0.0 0.1 0.0 1.4 0.0 0.0 0.8 0.0 1.2 0.0 1.7 1.0 0.9 0.2 0.3 3.5 0.8 0.0 0.0 0.3 0.3 1.6 0.2 0.0 0.5 0.7 0.0 11.0 2.3 0.0 1.1 1.0 0.5 4.9 0.0 0.6 0.4 0.9 0.2 0.1 9.1 10.7 0.0 5.1 0.0 0.7 0.0 0.0 0.0 0.4 0.0 1.1 0.8 0.1 0.4 0.0 0.2 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.8 5.0 3.4 1.6 1.0 1.0 0.8 1.0 3.0 1.2 0.0 0.0 0.0 0.4 0.2 0.5 3.9 0.0 8.1 0.0 1.8 0.0 0.0 1.7 1.7 458.9 1.0 0.0 0.0 2.9 0.1 1.1 0.4 0.0 0.4 0.1 0.0 0.0 2.5 0.0 84.6 6.6 0.0 3.3 0.0 0.7 2.4 3.4 0.0 5.6 0.8 5.0 0.0 1.4 151.8 4.1 0.4 0.0 0.0 0.7 0.0 CCDC112 MGC39633 ENSG00000164221 "Coiled-coil domain containing 112" Q8NEF3 5 115267188-115296831 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 227.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 50.4" "Low region specificity" "Detected in all" "HPA045120, HPA050621" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in male reproductive system" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA045120: AB_2679222, HPA050621: AB_2681191" "unprognostic (1.88e-2)" "unprognostic (5.10e-2)" "unprognostic (4.63e-2)" "unprognostic (5.60e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.32e-6)" "unprognostic (4.30e-2)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (3.33e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.51e-6)" "unprognostic (7.00e-2)" "unprognostic (2.79e-2)" "unprognostic (8.61e-2)" "unprognostic (4.10e-3)" 5.5 4.3 9.7 5.7 13.2 7.0 7.7 12.6 12.8 6.5 9.8 7.0 4.3 8.1 6.6 7.3 6.3 4.9 3.9 6.4 11.0 9.0 3.5 1.7 6.1 4.8 9.7 7.6 2.9 13.2 6.5 12.1 3.0 12.6 7.7 10.6 1.9 6.8 8.6 4.5 5.5 6.8 7.7 14.0 5.3 7.0 40.4 11.8 3.7 4.7 3.2 4.7 7.1 4.8 5.3 11.0 11.6 5.5 3.1 3.8 2.1 5.4 2.7 5.5 8.7 3.5 6.8 1.3 4.9 2.6 3.7 4.3 1.2 3.1 6.7 4.1 3.4 5.5 3.5 5.7 2.8 7.8 5.3 4.4 4.4 4.1 1.7 4.7 5.8 2.3 3.1 3.4 4.8 6.4 4.3 5.7 6.1 1.8 5.5 4.9 4.2 8.7 5.0 6.0 5.1 4.8 9.3 6.8 50.4 3.6 2.0 8.3 10.8 5.3 3.4 14.6 3.9 5.7 8.5 5.6 4.9 3.3 9.3 6.8 6.1 5.9 1.4 3.3 4.6 2.9 0.2 5.5 11.6 3.4 4.4 3.8 3.2 2.6 2.9 5.9 5.3 3.4 2.3 3.6 3.1 5.0 11.0 0.1 2.1 9.7 13.2 12.6 12.8 11.0 9.0 9.7 7.6 12.6 11.8 14.9 12.3 12.3 4.6 12.6 28.3 14.6 2.5 12.0 9.1 5.2 9.8 0.6 5.0 24.4 6.8 8.0 11.9 0.0 22.6 1.7 8.5 6.1 9.2 2.6 28.4 9.5 38.9 6.7 23.9 13.4 3.7 28.0 13.5 42.3 28.0 10.3 27.1 14.0 3.9 2.9 24.3 12.9 13.0 227.3 60.7 19.7 0.5 5.3 31.6 3.4 CCDC113 "DKFZp434N1418, HSPC065" ENSG00000103021 "Coiled-coil domain containing 113" Q9H0I3 16 58231157-58283836 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 39.1" "Group enriched" "Detected in many" 6 "Ciliated cells: 254.3;Early spermatids: 154.5;Late spermatids: 128.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 7.9" "Lineage enriched" "Detected in single" 18 "granulocytes: 7.9" "Cell line enhanced" "Detected in many" "SiHa: 24.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040759, HPA040869" Uncertain NA NA "HPA040759: AB_2677121, HPA040869: AB_2677180" "unprognostic (8.50e-2)" "unprognostic (3.39e-2)" "prognostic favorable (8.65e-4)" "prognostic favorable (7.01e-4)" "unprognostic (2.40e-1)" "unprognostic (4.87e-4)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "unprognostic (3.21e-1)" "unprognostic (4.59e-1)" "unprognostic (2.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.09e-2)" "unprognostic (1.21e-1)" "unprognostic (6.74e-2)" "unprognostic (1.65e-3)" "unprognostic (5.61e-2)" 3.2 4.3 9.2 2.0 13.5 1.1 3.8 3.5 16.4 4.0 2.4 10.3 3.8 1.3 3.3 6.7 2.9 39.1 2.8 5.0 9.9 9.0 3.1 2.8 5.3 1.6 6.3 10.4 4.7 2.5 13.6 5.5 3.4 9.7 3.8 2.8 3.6 2.1 3.5 4.1 3.7 1.5 2.7 4.9 1.2 2.8 21.0 4.5 0.0 4.1 1.8 1.4 3.0 1.4 0.4 0.4 7.9 0.3 0.2 0.3 0.1 4.7 4.0 1.8 7.4 4.1 4.4 5.9 2.8 1.8 2.4 0.6 0.5 6.2 0.1 3.8 0.9 2.6 0.7 0.6 2.6 2.3 0.5 1.4 0.1 3.1 0.5 4.1 2.4 0.6 2.3 4.7 0.6 6.5 1.5 0.4 2.3 4.2 0.0 0.6 3.4 0.1 0.7 2.7 0.3 6.0 1.4 0.0 0.9 4.2 1.3 1.9 3.1 24.1 2.0 1.1 0.8 7.0 2.4 0.2 2.5 2.5 1.6 0.8 1.9 1.2 1.2 5.8 1.5 1.7 7.9 0.2 0.2 0.2 0.3 0.2 0.4 0.3 0.1 0.4 0.4 0.2 0.2 1.5 0.2 0.1 0.2 0.1 0.1 9.2 13.5 3.5 16.4 9.9 9.0 6.3 10.4 9.7 4.5 0.0 3.2 0.0 1.3 0.5 6.1 8.9 5.1 254.3 30.7 1.8 11.8 0.0 3.3 4.9 154.5 1.4 0.3 0.0 3.3 1.4 1.5 1.6 0.0 1.8 0.1 3.2 1.2 0.6 0.0 128.4 4.4 0.6 1.7 0.0 1.5 7.8 2.3 0.0 3.9 0.8 11.7 0.0 2.1 24.5 9.7 1.4 0.9 0.0 0.8 0.8 CCDC114 "CILD20, FLJ32926" ENSG00000105479 "Coiled-coil domain containing 114" Q96M63 19 48296457-48321894 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.9;testis: 6.3" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 109.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.4" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;Karpas-707: 2.6;U-266/70: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042524 Approved NA NA "HPA042524: AB_10795706" "unprognostic (8.55e-2)" "unprognostic (2.40e-2)" "unprognostic (2.70e-5)" "unprognostic (1.54e-2)" "unprognostic (5.09e-4)" "unprognostic (1.16e-1)" "unprognostic (2.33e-2)" "unprognostic (3.02e-2)" "unprognostic (1.46e-1)" "unprognostic (1.82e-1)" "unprognostic (7.93e-2)" "unprognostic (1.30e-1)" "unprognostic (7.50e-3)" "unprognostic (4.35e-2)" "unprognostic (4.25e-2)" "unprognostic (1.30e-1)" "unprognostic (5.15e-2)" 0.0 0.0 0.8 0.0 1.9 0.8 0.1 0.0 0.2 1.1 0.0 0.0 0.4 0.3 0.0 9.9 0.0 0.0 1.6 2.3 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.2 0.4 0.1 0.1 0.0 0.2 0.5 0.0 1.3 0.0 0.0 0.2 0.2 0.2 6.3 0.4 0.0 0.0 0.0 0.5 0.3 1.0 0.4 0.3 0.4 0.0 0.2 0.7 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.6 0.4 0.9 0.0 0.1 0.4 0.1 0.0 0.0 1.1 0.2 1.6 0.2 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.4 0.5 0.0 1.2 0.5 2.6 0.0 0.2 0.4 1.7 0.0 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.5 0.1 0.5 0.6 0.4 0.0 1.6 0.2 0.0 0.4 0.3 0.0 0.3 4.8 1.5 0.0 0.3 0.2 0.0 0.9 0.2 0.4 0.3 0.0 0.4 0.5 0.3 0.3 0.0 0.2 0.2 0.3 1.0 0.3 0.4 0.3 0.0 0.0 0.0 4.3 0.0 0.1 0.1 0.5 0.4 0.0 109.7 10.3 0.0 0.0 0.1 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 3.5 0.0 0.0 1.6 0.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.4 1.3 0.1 0.0 0.0 0.0 0.0 CCDC116 FLJ36046 ENSG00000161180 "Coiled-coil domain containing 116" Q8IYX3 22 21632716-21637327 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 45.3" "Group enriched" "Detected in some" 32 "Early spermatids: 150.4;Late spermatids: 130.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 6.0;JURKAT: 10.1" NA NA "unprognostic (7.01e-2)" "unprognostic (6.01e-4)" "unprognostic (1.04e-1)" "unprognostic (6.85e-3)" "unprognostic (1.34e-2)" "unprognostic (1.15e-1)" "unprognostic (1.67e-2)" "unprognostic (5.13e-2)" "unprognostic (2.01e-1)" "unprognostic (4.75e-2)" "unprognostic (1.37e-3)" "unprognostic (4.14e-1)" "unprognostic (5.79e-4)" "unprognostic (1.82e-1)" "unprognostic (3.13e-2)" "unprognostic (2.47e-2)" "unprognostic (8.64e-2)" 0.3 0.1 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.6 0.5 0.2 0.2 0.0 0.8 0.7 0.2 0.4 0.3 0.5 0.2 0.0 0.2 0.2 0.3 0.3 0.2 0.2 0.7 0.2 0.3 0.2 0.6 0.2 0.6 0.2 0.2 0.4 0.6 0.4 0.2 0.7 0.2 0.2 0.4 0.3 45.3 0.2 0.2 0.5 0.2 0.4 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.5 0.9 0.6 0.1 1.2 1.3 0.0 0.6 0.3 0.1 0.4 0.8 0.9 0.3 0.7 0.4 0.3 0.2 0.2 0.3 0.6 0.3 0.4 0.3 0.1 0.1 6.0 0.1 0.1 0.5 0.1 0.1 0.1 10.1 2.4 0.3 0.2 2.0 2.2 0.1 0.1 0.1 0.2 0.8 0.9 0.0 0.0 0.5 0.2 0.5 0.1 0.3 0.0 0.1 0.6 0.3 0.0 1.9 2.2 0.6 0.2 2.5 1.4 0.3 1.0 1.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 150.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 130.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 2.3 1.0 0.0 0.2 0.0 0.0 0.0 CCDC121 "FLJ13646, FLJ43364" ENSG00000176714 "Coiled-coil domain containing 121" Q6ZUS5 2 27625639-27629012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 32.1;Early spermatids: 126.1;Late spermatids: 35.6;Spermatocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 12.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051791 Uncertain Approved "Actin filaments,Cytosol" NA NA "Actin filaments, Cytosol" "HPA051791: AB_2681611" "unprognostic (1.52e-1)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (3.93e-1)" "unprognostic (1.28e-1)" "unprognostic (4.71e-3)" "prognostic favorable (4.12e-4)" "unprognostic (4.03e-2)" "unprognostic (1.23e-1)" "unprognostic (5.65e-4)" "unprognostic (7.78e-2)" "prognostic favorable (1.87e-5)" "unprognostic (2.50e-1)" "unprognostic (1.72e-1)" "unprognostic (7.86e-2)" "unprognostic (5.42e-2)" 4.4 3.6 7.4 2.0 12.2 1.4 5.9 7.0 10.3 5.8 3.6 5.5 6.7 2.6 5.5 5.3 5.9 8.3 3.0 6.3 9.0 5.2 6.2 3.2 4.5 2.3 13.3 6.0 11.7 3.9 8.3 7.3 3.8 9.3 7.3 3.5 3.4 5.7 8.5 3.6 3.3 3.0 4.6 10.8 4.3 3.8 27.5 11.2 1.0 8.1 1.7 2.5 4.4 3.0 3.1 1.7 12.5 4.0 2.6 3.0 1.3 3.7 4.3 5.9 6.5 10.7 4.8 7.3 1.9 1.0 1.9 0.9 3.2 3.4 1.9 3.1 1.2 5.7 3.5 4.3 1.5 2.1 2.6 4.6 1.2 2.5 4.1 2.0 1.7 3.4 1.6 5.2 1.1 2.8 3.3 3.9 0.9 5.0 2.6 2.8 3.1 1.3 1.7 6.1 4.7 2.1 6.3 14.3 3.2 4.1 2.9 7.7 8.8 1.5 7.2 2.3 5.0 5.9 4.0 2.1 1.7 6.4 1.4 5.2 1.6 1.7 2.8 4.2 2.4 2.1 2.0 2.4 12.5 0.6 3.4 1.7 3.1 1.9 0.7 1.7 2.7 3.0 2.2 5.1 2.6 4.0 0.5 0.3 1.3 7.4 12.2 7.0 10.3 9.0 5.2 13.3 6.0 9.3 11.2 6.0 1.6 0.0 1.3 0.6 4.9 2.8 5.1 32.1 2.3 0.0 19.6 2.5 6.6 2.8 126.1 4.2 1.3 0.0 1.0 1.9 1.9 1.0 0.0 1.5 1.6 3.2 1.2 4.3 0.3 35.6 8.1 2.5 1.7 1.0 1.2 11.6 1.5 0.0 6.3 2.9 10.0 12.9 0.7 33.1 10.9 1.0 1.5 1.5 1.7 0.7 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597379-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.4" "Group enriched" "Detected in many" 18 "Early spermatids: 588.1;Late spermatids: 350.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 75.4" "Lineage enriched" "Detected in all" 18 "granulocytes: 75.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 31000000 "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.7 8.1 8.7 4.4 9.2 6.9 19.5 11.6 13.2 7.4 6.5 5.6 5.8 8.7 8.0 5.3 6.6 6.7 6.2 5.7 13.8 8.9 7.6 11.7 6.5 9.3 10.5 3.9 7.4 9.8 12.2 12.6 4.6 11.1 6.0 6.5 5.8 7.5 6.5 10.0 6.6 9.4 6.7 12.9 6.1 6.8 41.3 8.1 5.4 9.9 5.0 8.6 7.0 7.7 3.8 3.0 75.4 3.6 2.9 4.1 2.9 4.8 3.4 7.5 9.5 12.6 7.1 17.3 6.1 6.0 5.3 7.7 3.6 1.6 10.4 9.7 5.1 10.1 2.8 3.2 2.9 6.9 2.2 4.3 1.8 1.4 4.6 5.1 4.7 9.3 7.5 8.5 1.7 1.6 4.4 7.0 4.4 4.1 3.0 6.3 2.2 3.2 5.7 3.5 6.4 4.3 2.2 11.9 3.1 5.5 2.2 4.6 8.6 6.3 6.1 4.5 12.2 5.1 4.4 8.4 3.1 5.6 7.1 4.8 8.4 8.3 7.4 3.5 6.9 16.9 75.4 3.6 16.4 3.0 3.3 3.7 3.8 3.3 3.5 3.0 3.2 4.1 3.2 6.9 2.9 3.1 0.6 3.6 2.9 8.7 9.2 11.6 13.2 13.8 8.9 10.5 3.9 11.1 8.1 6.0 7.2 7.1 7.0 16.9 12.6 8.3 7.6 9.4 3.4 12.2 7.9 9.0 6.6 10.1 588.1 10.5 5.8 0.0 8.0 5.6 10.4 7.1 6.9 12.7 6.2 7.9 14.5 10.4 5.1 350.6 10.6 7.9 13.5 6.4 8.6 7.2 8.1 6.2 13.4 7.2 12.6 12.9 12.2 26.8 23.8 20.7 16.9 7.5 5.6 5.9 CCDC129 FLJ38344 ENSG00000180347 "Coiled-coil domain containing 129" Q6ZRS4 7 31514071-31658720 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.2;salivary gland: 10.9" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 8.2;Intestinal endocrine cells: 1.7;Late spermatids: 5.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 1.6;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.7;U-2 OS: 5.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024103 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA024103: AB_1846132" "unprognostic (1.11e-2)" "unprognostic (1.39e-1)" "unprognostic (1.57e-1)" "unprognostic (1.78e-5)" "unprognostic (9.72e-3)" "unprognostic (1.78e-1)" "unprognostic (3.89e-2)" "unprognostic (6.42e-3)" "unprognostic (1.01e-1)" "unprognostic (5.77e-2)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" 0.1 0.0 0.1 0.6 2.0 0.1 3.3 7.9 0.3 3.7 0.9 1.2 0.0 2.1 1.1 0.2 0.1 0.1 0.1 0.0 0.4 1.4 0.1 0.0 0.4 0.0 5.0 0.0 0.0 0.2 0.0 0.4 0.9 17.2 0.1 0.2 0.0 10.9 0.0 0.0 4.5 0.9 1.1 0.2 0.0 0.8 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.8 1.1 0.0 0.1 1.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.1 2.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 2.7 0.0 0.0 0.0 5.6 0.2 0.3 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.7 0.2 0.1 0.1 0.8 1.0 0.4 1.1 0.1 0.0 0.8 0.0 0.1 0.1 2.0 7.9 0.3 0.4 1.4 5.0 0.0 17.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42692663-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.2;fallopian tube: 13.6;testis: 15.0" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 24.5;Ciliated cells: 50.9;Distal tubular cells: 14.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;ASC diff: 2.4;Daudi: 1.3;HDLM-2: 3.0;NTERA-2: 1.5" "Low region specificity" "Detected in all" HPA047429 Approved Supported Centrosome NA NA Centrosome "HPA047429: AB_2680043" "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.7 1.0 3.0 0.7 12.2 0.6 0.7 0.8 4.0 1.3 0.9 6.3 2.3 1.1 2.1 7.0 0.7 13.6 1.5 1.7 3.7 2.7 1.1 1.7 2.5 0.7 1.9 4.6 1.5 2.0 1.0 3.7 0.7 8.1 0.7 1.4 1.5 1.6 1.1 2.0 0.6 1.1 0.9 3.4 0.8 0.8 15.0 2.5 0.0 1.9 0.3 0.6 0.7 0.5 0.0 0.0 0.1 0.2 0.5 1.2 0.2 0.0 0.0 0.0 1.1 2.4 0.9 0.8 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 3.0 0.9 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 3.0 12.2 0.8 4.0 3.7 2.7 1.9 4.6 8.1 2.5 0.0 1.1 0.0 0.2 0.9 24.5 1.1 2.5 50.9 7.9 3.5 3.9 0.1 14.9 0.8 11.5 0.5 0.2 0.0 0.2 0.4 1.0 0.9 1.1 0.0 2.4 0.0 0.0 0.6 0.8 12.4 1.4 1.8 1.7 2.8 0.1 1.5 0.2 0.6 0.7 2.5 5.4 0.0 0.7 8.8 5.1 1.0 0.0 0.0 0.0 0.6 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.7;testis: 109.6" "Group enriched" "Detected in many" 4 "Early spermatids: 629.8;Late spermatids: 1449.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 18.6;U-937: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010646, HPA071015" Enhanced Approved Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles" "Plasma membrane" "HPA010646: , HPA071015: AB_2686334" "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 2.1 4.0 11.2 2.6 11.7 1.8 2.4 34.7 28.7 2.9 6.5 8.3 2.6 2.4 3.9 2.9 2.5 2.8 2.8 4.9 12.5 20.0 1.5 1.5 1.9 3.0 15.3 16.6 2.8 1.8 1.8 3.8 2.2 11.2 9.9 3.5 13.9 2.0 11.0 3.5 1.6 2.6 17.3 9.7 1.9 2.4 109.6 7.4 0.7 1.7 0.0 2.4 6.4 2.0 0.1 0.6 1.3 0.3 2.7 1.6 0.3 0.7 0.9 7.2 4.8 3.9 3.4 1.2 2.7 3.6 2.8 2.6 1.0 0.6 3.6 0.3 3.7 11.4 1.5 4.6 0.5 2.6 10.2 4.6 6.3 1.7 0.0 1.3 0.7 13.6 3.7 0.5 3.0 0.2 2.5 1.6 6.0 2.2 3.8 1.1 1.4 4.6 1.9 10.0 0.0 2.9 11.4 1.3 1.7 0.2 1.3 4.2 12.6 1.7 2.0 2.8 2.7 0.1 1.7 1.4 4.5 2.6 2.1 2.1 2.2 0.9 3.8 18.6 27.4 1.1 0.0 0.3 1.3 1.4 0.0 1.6 0.0 1.5 1.1 0.6 0.1 0.0 1.0 0.1 2.7 0.1 0.1 0.0 0.3 11.2 11.7 34.7 28.7 12.5 20.0 15.3 16.6 11.2 7.4 0.0 0.3 0.0 0.8 0.5 255.8 6.5 2.5 2.7 1.2 0.0 92.3 0.1 0.0 0.5 629.8 1.6 0.0 0.0 1.3 0.2 0.9 1.2 0.0 0.0 5.0 38.1 0.0 0.6 0.8 1449.2 16.7 0.9 0.0 1.0 0.0 22.8 0.8 0.0 7.1 0.0 16.0 6.5 2.8 193.1 9.4 0.4 0.3 2.2 0.0 0.4 CCDC140 FLJ32447 ENSG00000163081 "Coiled-coil domain containing 140" Q96MF4 2 222298147-222305217 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.6;salivary gland: 1.2;skeletal muscle: 3.1;skin 1: 1.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.2;BJ hTERT+ SV40 Large T+: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;NB-4: 3.8;RH-30: 2.1;SK-MEL-30: 4.0;WM-115: 2.4" "HPA042500, HPA048166" Uncertain NA NA "HPA042500: AB_2678028, HPA048166: AB_2680295" "unprognostic (2.50e-2)" "unprognostic (3.54e-1)" "unprognostic (5.25e-2)" 0.3 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.1 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.2 0.0 0.5 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 2.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CCDC141 "CAMDI, FLJ39502" ENSG00000163492 "Coiled-coil domain containing 141" 2 178829757-179050086 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 47.5;lung: 17.6" "Cell type enhanced" "Detected in many" 22 "Alveolar cells type 2: 19.8;Cardiomyocytes: 103.0;Early spermatids: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 12.9" "Group enriched" "Detected in many" 9 "B-cells: 7.6;T-cells: 12.9" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Daudi: 4.1;HEL: 9.5;RH-30: 5.1;U-266/70: 6.1;U-698: 8.5" HPA012718 Approved Nucleoplasm NA NA Nucleoplasm "HPA012718: AB_2072055" "unprognostic (1.58e-1)" "unprognostic (1.85e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-1)" "unprognostic (8.62e-3)" "unprognostic (4.25e-2)" "unprognostic (2.98e-2)" "unprognostic (2.51e-1)" "unprognostic (1.40e-1)" "unprognostic (1.74e-2)" "unprognostic (5.33e-2)" "unprognostic (8.03e-3)" "unprognostic (7.71e-8)" "unprognostic (2.50e-2)" "unprognostic (1.52e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-1)" 1.6 0.6 0.5 7.5 0.6 0.9 4.9 0.5 0.5 0.7 1.2 0.1 0.5 0.2 0.8 2.2 2.5 0.6 6.3 47.5 0.6 0.6 0.5 0.5 17.6 4.4 0.6 0.0 0.8 3.8 0.2 0.5 0.8 1.1 1.0 0.3 1.8 0.6 0.3 9.3 0.5 0.7 1.7 0.7 1.8 0.6 1.6 0.0 11.0 0.7 2.1 7.4 1.4 1.2 7.6 0.0 0.4 0.0 1.1 12.9 0.4 0.2 0.0 0.1 0.3 0.0 0.1 2.0 0.0 0.1 0.0 0.2 6.4 0.5 4.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 3.5 0.2 9.5 0.3 0.0 0.0 1.7 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.6 0.1 0.1 0.1 0.3 3.4 0.6 0.7 0.2 5.1 1.6 0.0 0.1 0.2 0.2 0.1 0.3 0.1 1.1 0.3 0.4 0.1 0.3 0.2 0.3 0.0 6.1 0.1 8.5 0.3 0.5 0.6 0.3 0.0 0.2 0.3 0.0 0.2 6.6 2.1 1.4 0.0 7.6 6.4 4.8 0.4 1.1 0.0 0.0 12.9 0.4 0.5 0.6 0.5 0.5 0.6 0.6 0.6 0.0 1.1 0.0 6.0 19.8 0.5 0.0 0.1 1.4 103.0 10.2 2.7 1.2 0.0 0.0 0.0 0.0 2.5 34.6 3.6 0.0 0.0 1.2 0.2 0.4 0.0 5.8 0.0 0.0 6.4 0.0 0.0 0.3 12.9 1.1 0.8 1.7 0.0 0.0 3.8 0.2 0.0 1.8 0.0 0.6 6.5 1.4 0.0 0.2 0.1 0.0 5.0 0.0 0.1 CCDC144A "FLJ43983, KIAA0565" ENSG00000170160 "Coiled-coil domain containing 144A" A2RUR9 17 16689537-16777881 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 44.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 52.2;Cone photoreceptor cells: 51.1;Early spermatids: 46.7;Rod photoreceptor cells: 51.7;Spermatocytes: 128.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.1;TIME: 9.4" "HPA022996, HPA047220, HPA047851, HPA066260" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: " "unprognostic (8.54e-2)" "unprognostic (4.49e-3)" "unprognostic (1.07e-1)" "unprognostic (8.34e-2)" "unprognostic (1.10e-1)" "unprognostic (2.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.69e-2)" "unprognostic (6.95e-2)" "unprognostic (2.60e-2)" "unprognostic (2.73e-1)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (9.49e-2)" "unprognostic (3.32e-1)" "unprognostic (1.41e-1)" "unprognostic (1.74e-1)" 3.7 1.9 2.5 2.7 3.5 5.5 2.7 12.0 3.6 2.1 3.1 2.8 0.4 0.9 5.4 3.9 1.3 2.6 1.7 2.5 4.7 0.8 1.0 1.5 2.8 2.3 4.3 1.8 7.3 5.4 0.2 16.7 3.7 10.3 3.0 1.4 1.7 2.2 1.5 2.4 3.7 2.0 2.5 4.2 2.4 2.2 44.4 2.8 2.4 1.8 0.4 1.5 2.8 4.9 1.0 0.8 0.8 1.3 1.0 3.8 0.0 0.6 3.9 0.9 2.4 3.5 11.1 0.4 0.2 0.0 0.2 0.2 4.9 0.1 0.5 3.4 6.8 0.3 6.0 5.0 0.3 0.3 3.5 0.3 0.5 0.5 0.4 0.2 0.7 3.2 2.0 0.1 2.3 0.2 1.1 0.1 0.2 0.5 0.3 2.2 0.2 0.1 1.2 0.8 1.0 0.4 1.5 0.2 0.1 0.1 4.7 1.3 1.4 0.7 0.2 1.4 2.0 4.0 0.2 9.4 0.8 0.5 5.3 1.5 6.7 6.9 0.2 0.4 7.0 1.8 0.7 0.6 0.3 2.2 0.5 1.4 1.0 2.1 1.4 0.4 0.5 3.8 1.9 0.8 1.0 1.3 0.8 2.1 0.0 2.5 3.5 12.0 3.6 4.7 0.8 4.3 1.8 10.3 2.8 0.0 9.3 3.0 6.4 3.5 52.2 2.5 2.5 5.3 2.3 0.0 51.1 4.2 0.0 1.6 46.7 6.5 1.3 0.0 0.0 5.8 8.2 6.7 25.4 1.7 3.5 31.8 1.2 3.7 5.1 2.9 6.6 4.9 5.0 0.0 2.0 8.3 2.2 3.4 8.5 0.5 51.7 6.5 5.7 128.1 36.1 3.1 1.6 6.9 1.6 5.1 CCDC144NL MGC87631 ENSG00000205212 "Coiled-coil domain containing 144 family, N-terminal like" Q6NUI1 17 20836447-20896140 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.1;testis: 10.6" "Group enriched" "Detected in some" 4 "Early spermatids: 7.2;Rod photoreceptor cells: 7.5;Spermatocytes: 25.8;Spermatogonia: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "U-2 OS: 26.7" HPA023457 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA023457: AB_2671217" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (7.53e-2)" "unprognostic (5.17e-2)" "unprognostic (6.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" 0.3 0.9 0.9 0.2 13.1 0.5 1.0 2.4 6.6 0.3 0.4 1.4 0.0 0.5 1.5 0.3 0.3 0.9 0.2 0.5 1.2 1.1 0.3 0.6 0.5 0.5 1.7 1.4 1.3 0.4 0.2 1.2 0.8 4.5 1.6 0.5 0.6 0.3 1.8 0.8 0.3 0.2 1.2 4.5 0.4 0.5 10.6 0.0 0.4 0.4 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 26.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 13.1 2.4 6.6 1.2 1.1 1.7 1.4 4.5 0.0 0.0 0.3 0.0 0.6 0.2 1.7 0.4 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 7.2 0.7 0.0 0.0 0.0 1.6 0.9 0.5 0.0 0.0 0.4 1.6 1.2 0.0 0.0 1.3 2.8 0.3 1.7 0.0 0.0 1.4 0.1 0.0 1.1 0.3 7.5 0.0 0.9 25.8 7.3 0.3 0.1 0.0 0.0 0.4 CCDC146 KIAA1505 ENSG00000135205 "Coiled-coil domain containing 146" Q8IYE0 7 77122434-77329533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7;fallopian tube: 27.9" "Cell type enhanced" "Detected in many" 22 "Ciliated cells: 570.2;Early spermatids: 154.6;Spermatocytes: 113.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "pons and medulla: 32.7" "Cell type enhanced" "Detected in many" "eosinophil: 12.5;neutrophil: 14.0" "Group enriched" "Detected in many" 4 "granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA020082, HPA020105" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA020082: AB_1852410, HPA020105: AB_2072056" "unprognostic (3.07e-3)" "unprognostic (9.94e-3)" "unprognostic (1.56e-1)" "unprognostic (2.54e-3)" "unprognostic (1.85e-1)" "prognostic favorable (7.37e-4)" "unprognostic (1.95e-3)" "unprognostic (8.02e-3)" "unprognostic (4.05e-4)" "unprognostic (1.73e-1)" "unprognostic (4.63e-1)" "unprognostic (4.09e-2)" "unprognostic (7.38e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-1)" "unprognostic (2.70e-3)" "unprognostic (5.58e-3)" 1.8 0.8 6.5 1.9 7.2 1.3 1.9 1.8 8.3 4.3 3.2 4.5 2.7 1.9 3.7 9.1 3.5 27.9 2.6 1.4 7.4 3.4 4.2 1.3 4.9 2.2 1.6 4.2 6.4 1.8 2.9 10.9 1.5 32.7 3.4 2.2 4.4 3.9 1.8 1.6 7.4 2.2 2.4 2.8 2.8 2.5 22.2 2.9 0.5 6.3 0.9 2.0 3.1 3.4 1.0 1.8 14.0 0.7 5.0 4.4 0.6 1.0 1.5 4.5 2.4 2.9 3.0 0.5 1.1 1.1 1.1 1.9 0.0 7.6 2.5 0.2 0.3 4.6 1.6 0.6 1.4 1.9 3.0 0.5 2.9 2.0 1.3 0.9 3.3 2.4 1.8 2.2 2.0 0.3 3.7 1.0 2.5 0.0 2.8 0.3 0.3 2.6 4.7 0.5 1.0 1.1 7.0 0.8 0.3 4.6 0.8 3.4 2.3 1.7 1.5 0.9 1.4 1.4 1.1 1.4 1.7 0.7 2.4 0.7 4.5 6.9 2.1 4.0 4.9 4.0 0.6 0.5 12.5 4.4 0.7 3.1 1.0 1.9 3.0 0.8 0.2 1.2 1.9 14.0 5.0 0.3 1.8 1.4 0.6 6.5 7.2 1.8 8.3 7.4 3.4 1.6 4.2 32.7 2.9 3.0 8.9 2.4 2.2 6.4 7.3 28.3 2.5 570.2 84.2 5.2 58.9 0.9 18.3 2.3 154.6 4.9 2.7 0.0 1.4 0.4 13.1 3.6 5.8 0.8 1.4 4.8 1.7 35.6 5.6 25.2 11.2 6.0 5.0 0.0 1.0 10.6 1.5 5.1 6.0 14.1 53.5 6.5 15.8 113.3 10.8 3.0 2.1 5.1 3.0 4.2 CCDC148 MGC125588 ENSG00000153237 "Coiled-coil domain containing 148" Q8NFR7 2 158171081-158456753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 5.9;testis: 6.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 40.2;Cone photoreceptor cells: 53.0;Early spermatids: 22.4;Rod photoreceptor cells: 29.6" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 9 "basophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;HBF TERT88: 4.3;hTEC/SVTERT24-B: 2.8;RPTEC TERT1: 3.3;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042626 Uncertain Uncertain "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA042626: AB_10806244" "unprognostic (1.88e-1)" "unprognostic (5.90e-2)" "unprognostic (3.31e-2)" "unprognostic (1.94e-4)" "unprognostic (3.29e-1)" "unprognostic (7.65e-2)" "unprognostic (1.23e-1)" "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (7.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (5.77e-2)" "unprognostic (3.35e-2)" "prognostic favorable (2.54e-4)" "unprognostic (6.57e-3)" 0.1 0.5 0.6 0.0 0.8 0.0 1.8 1.9 0.3 1.4 0.0 0.0 0.6 2.4 0.0 3.3 0.4 0.0 0.7 0.8 4.3 0.1 0.6 0.0 0.5 1.3 0.1 5.9 1.9 0.0 0.4 0.0 1.0 0.7 0.0 0.2 0.0 0.0 1.0 0.0 0.0 6.5 1.8 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.2 0.0 1.3 0.0 0.8 1.0 0.0 0.0 0.1 0.9 0.0 1.1 2.3 1.1 6.1 0.1 0.1 0.9 0.4 0.5 0.0 0.3 4.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.4 0.0 0.2 0.0 0.1 0.5 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.3 0.4 4.2 0.2 0.3 0.4 0.5 1.3 2.4 0.3 0.0 0.4 0.5 0.1 0.2 0.6 0.7 0.0 1.0 0.0 0.4 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 9.1 2.0 0.0 40.2 3.4 7.0 53.0 0.0 11.6 5.6 22.4 0.2 0.0 0.0 1.6 0.0 0.5 0.8 0.0 1.0 0.1 4.8 0.0 1.8 0.0 3.8 0.9 0.0 0.0 1.0 0.0 5.2 3.4 0.0 1.8 4.8 29.6 6.5 0.3 7.5 1.5 0.4 0.0 0.0 0.0 1.6 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2;testis: 19.4" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 34.8;Erythroid cells: 23.3;Spermatocytes: 93.6;Spermatogonia: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 1.9 1.3 2.2 2.5 3.9 3.2 5.2 1.2 2.4 1.6 2.2 2.2 0.3 1.3 2.2 2.9 2.4 2.1 1.5 0.9 1.9 1.2 1.2 2.4 2.6 2.0 1.6 0.8 1.7 2.3 1.7 3.8 1.6 1.6 3.0 1.6 1.5 7.7 2.2 0.8 3.7 1.8 1.2 3.3 2.5 1.5 19.4 2.3 16.2 1.3 2.6 2.9 2.6 2.2 1.5 1.1 6.7 1.7 2.3 3.9 1.3 4.7 0.9 6.4 0.0 0.5 1.8 0.0 5.2 6.4 4.9 6.1 0.1 4.0 5.6 4.6 1.8 9.8 3.8 2.7 3.5 8.9 4.7 1.1 6.9 0.8 1.5 0.2 2.0 4.0 0.4 2.5 10.2 5.1 0.9 3.7 7.2 4.6 5.8 10.3 1.0 4.2 2.3 1.5 4.1 5.9 5.3 11.7 1.8 0.7 2.0 3.6 3.2 3.0 0.3 1.3 3.2 7.3 1.8 2.6 10.1 2.3 4.4 6.4 1.4 1.5 4.9 1.4 11.3 6.7 6.7 1.3 1.7 2.4 1.7 2.5 0.8 2.2 3.9 0.4 1.5 3.1 3.4 0.8 2.3 1.7 1.1 3.7 1.3 2.2 3.9 1.2 2.4 1.9 1.2 1.6 0.8 1.6 2.3 3.0 1.4 0.9 1.3 4.4 4.7 0.6 0.0 4.0 3.4 0.0 0.0 0.4 0.0 2.0 34.8 3.0 0.0 23.3 2.9 0.2 1.7 1.4 9.2 1.0 2.8 3.2 1.2 0.6 3.3 21.2 4.0 2.6 3.3 0.0 1.2 3.4 1.3 0.0 2.1 0.7 2.5 6.5 2.0 93.6 24.9 3.3 0.1 2.2 0.6 0.3 CCDC150 FLJ39660 ENSG00000144395 "Coiled-coil domain containing 150" Q8NCX0 2 196639554-196763490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.7;testis: 11.9" "Group enriched" "Detected in many" 4 "Early spermatids: 24.9;Late spermatids: 16.8;Melanocytes: 6.8;Proximal tubular cells: 9.8;Spermatocytes: 26.5;Spermatogonia: 13.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048104 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA048104: AB_2680264" "unprognostic (1.92e-1)" "unprognostic (3.75e-1)" "unprognostic (2.95e-1)" "unprognostic (2.58e-4)" "unprognostic (9.88e-2)" "unprognostic (1.42e-3)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (5.91e-4)" "unprognostic (2.01e-2)" "unprognostic (3.16e-2)" "unprognostic (9.17e-3)" "unprognostic (5.66e-4)" "unprognostic (7.29e-2)" "unprognostic (1.99e-2)" "unprognostic (4.35e-2)" "unprognostic (2.69e-5)" 0.5 0.4 1.0 2.9 5.2 1.5 0.5 2.6 3.1 0.4 1.0 2.4 0.0 0.6 0.5 0.6 1.6 0.6 0.6 0.5 1.3 0.5 6.7 3.4 0.5 0.8 3.1 0.3 0.5 0.5 0.5 1.0 0.7 2.9 0.4 0.9 0.1 0.4 0.2 0.6 0.6 0.8 1.2 3.1 0.6 0.6 11.9 3.9 3.9 0.4 2.9 2.1 0.6 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.6 7.2 4.6 0.2 0.4 3.2 1.6 0.8 1.3 3.4 2.4 1.5 1.2 0.9 1.3 1.1 2.1 2.9 1.3 3.3 6.6 4.1 2.5 3.5 3.9 0.0 1.3 1.1 0.0 0.2 1.6 0.9 0.4 0.8 2.5 3.2 3.0 0.9 0.7 1.2 2.1 4.1 0.5 1.7 2.7 1.2 0.9 0.5 0.7 7.9 1.4 1.2 0.7 0.3 4.0 1.1 0.8 1.4 2.5 2.1 2.3 1.4 1.3 1.3 2.1 1.0 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 5.2 2.6 3.1 1.3 0.5 3.1 0.3 2.9 3.9 3.0 1.7 0.8 1.5 1.3 3.9 1.6 0.0 4.0 0.0 0.0 2.0 1.1 1.7 0.3 24.9 1.1 0.0 0.0 0.3 1.7 2.5 1.4 3.5 3.9 1.0 1.6 0.0 1.3 1.0 16.8 1.4 1.5 6.8 0.0 0.7 1.6 0.4 0.2 1.8 9.8 0.7 0.0 0.9 26.5 13.8 0.9 0.6 0.8 1.1 1.1 CCDC151 MGC20983 ENSG00000198003 "Coiled-coil domain containing 151" A5D8V7 19 11420604-11435782 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7;fallopian tube: 18.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 30.8;Distal tubular cells: 24.9;Kupffer cells: 37.0;Muller glia cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;memory B-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 4.1;T-47d: 9.4;U-87 MG: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA044184, HPA054626" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA044184: AB_10959331, HPA054626: AB_2682547" "unprognostic (1.50e-1)" "unprognostic (6.59e-2)" "unprognostic (2.05e-3)" "unprognostic (4.41e-3)" "unprognostic (1.35e-2)" "unprognostic (6.30e-2)" "unprognostic (4.41e-3)" "unprognostic (2.32e-2)" "unprognostic (2.22e-1)" "unprognostic (5.09e-2)" "unprognostic (6.76e-4)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (4.27e-2)" "unprognostic (1.85e-1)" "unprognostic (2.35e-1)" "unprognostic (2.05e-1)" 0.8 3.1 5.7 0.6 9.9 0.6 0.6 4.4 7.7 1.6 0.6 4.0 1.4 0.6 1.0 2.8 0.6 18.2 0.6 1.2 7.7 4.3 2.0 0.8 2.7 0.6 2.3 4.6 2.5 0.6 9.8 10.4 1.4 12.7 0.8 0.6 0.7 4.0 1.8 0.5 0.5 0.6 0.6 1.7 1.9 0.9 8.5 5.4 0.0 2.1 0.0 0.7 0.6 0.4 1.5 0.7 0.1 2.3 0.0 0.0 0.1 0.5 0.1 1.2 0.1 0.1 0.4 1.0 0.5 0.1 0.6 0.7 0.1 0.0 0.3 0.5 0.2 2.3 0.2 0.9 0.5 0.0 1.0 1.0 0.4 0.6 0.0 0.5 0.0 0.5 0.3 0.0 0.6 0.0 1.0 0.0 0.2 0.0 0.9 0.2 0.8 0.0 0.1 0.5 0.3 2.2 0.4 0.1 1.4 0.7 0.0 4.1 2.7 1.2 0.2 0.1 0.5 9.4 0.4 0.0 1.5 0.3 3.5 0.1 3.4 2.7 0.2 3.7 0.6 0.1 0.0 0.6 0.0 0.0 2.3 0.0 1.5 0.0 0.0 0.7 0.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 5.7 9.9 4.4 7.7 7.7 4.3 2.3 4.6 12.7 5.4 0.0 0.0 3.0 0.6 0.8 0.9 1.2 2.5 30.8 3.4 12.2 0.0 0.4 24.9 0.2 9.6 0.9 0.0 0.0 0.2 0.4 4.3 0.1 4.6 0.5 4.1 1.6 0.0 12.3 37.0 11.5 2.6 3.0 6.8 0.0 0.0 30.6 0.1 0.0 0.7 0.5 2.7 6.5 5.1 15.3 2.9 0.4 1.0 0.0 0.0 0.3 CCDC152 LOC100129792 ENSG00000198865 "Coiled-coil domain containing 152" Q4G0S7 5 42756801-42802360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.8;pituitary gland: 24.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 56.6;Muller glia cells: 33.6;Spermatocytes: 65.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 10.6;JURKAT: 10.6;U-2 OS: 19.2;U-266/84: 12.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036240 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036240: AB_10671242" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (3.14e-2)" "unprognostic (1.44e-3)" "unprognostic (3.24e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (6.25e-3)" "unprognostic (9.08e-2)" "unprognostic (1.16e-1)" "unprognostic (7.29e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-3)" "unprognostic (5.40e-2)" "unprognostic (4.63e-2)" "unprognostic (2.14e-3)" 4.0 6.0 7.5 2.5 10.2 1.6 3.0 1.0 8.4 2.1 2.3 4.1 0.5 5.0 2.7 1.9 2.0 1.6 6.1 4.6 7.1 3.2 3.6 52.8 3.2 8.6 4.9 5.5 8.2 2.1 0.0 24.3 2.8 20.9 2.1 0.3 1.9 2.1 0.3 1.5 3.1 12.4 0.6 8.8 6.9 1.9 5.7 8.5 8.5 1.7 0.5 3.0 2.9 3.1 3.6 10.0 0.3 0.7 6.2 6.1 1.3 0.3 0.1 0.8 0.1 2.7 3.5 0.0 4.6 0.1 0.0 0.3 0.0 0.2 0.0 0.3 2.0 3.4 3.6 0.0 0.0 0.4 0.0 0.3 0.2 10.6 4.4 2.7 0.1 0.0 4.4 0.0 1.9 0.0 7.0 1.4 10.6 0.5 1.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.3 5.3 0.0 0.1 0.0 4.2 0.4 0.1 0.1 0.2 19.2 4.4 0.1 0.1 12.8 0.1 5.6 0.1 0.1 0.1 0.1 0.1 4.0 0.7 4.9 2.2 3.0 5.0 0.7 3.6 4.0 6.1 0.3 6.2 0.3 10.0 1.9 1.3 7.5 10.2 1.0 8.4 7.1 3.2 4.9 5.5 20.9 8.5 56.6 31.3 4.9 0.2 3.3 13.9 8.1 0.0 6.7 13.6 1.8 0.0 1.3 0.0 0.6 5.7 3.5 2.3 0.0 1.0 1.0 10.4 0.3 9.2 4.0 2.3 31.8 1.2 4.9 10.5 5.3 6.1 2.9 3.3 1.0 2.5 33.6 2.0 2.9 7.1 0.5 2.2 0.0 6.6 65.5 22.6 3.4 1.5 10.9 1.2 0.3 CCDC153 LOC283152 ENSG00000248712 "Coiled-coil domain containing 153" Q494R4 11 119189638-119196769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0" "Cell type enriched" "Detected in many" 7 "Ciliated cells: 151.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 15.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.1" "Cell line enhanced" "Detected in many" "T-47d: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041497 Uncertain Uncertain Cytosol NA NA Cytosol "HPA041497: AB_10794378" "unprognostic (4.66e-2)" "unprognostic (1.86e-2)" "unprognostic (3.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-3)" "unprognostic (5.19e-2)" "unprognostic (9.43e-3)" "unprognostic (1.36e-1)" "unprognostic (2.36e-1)" "unprognostic (2.92e-3)" "unprognostic (1.15e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-3)" "unprognostic (1.98e-3)" 1.4 1.1 2.2 0.6 4.8 3.8 0.8 0.5 0.9 1.4 0.6 2.0 0.5 0.5 1.1 5.3 1.5 15.8 3.1 2.0 2.6 3.9 1.5 0.6 5.2 0.5 0.5 0.5 1.7 0.5 3.3 20.0 1.3 9.8 0.5 0.6 0.5 0.7 1.6 0.5 1.4 0.8 0.7 1.2 0.8 1.6 2.8 2.4 0.5 1.1 0.5 0.9 0.7 0.5 0.4 1.6 15.1 2.4 0.3 0.6 0.7 2.2 3.0 1.8 1.8 0.3 0.3 4.4 1.3 1.5 0.6 0.7 4.9 7.7 1.5 6.4 0.3 2.2 1.6 0.4 1.5 0.1 3.0 2.5 7.2 2.2 3.3 1.1 2.3 0.9 0.7 1.0 1.6 0.4 2.4 1.5 1.6 2.1 2.9 0.1 8.9 1.5 2.2 0.9 3.2 5.2 2.0 2.5 1.4 0.5 2.2 2.4 1.2 3.0 1.5 1.7 1.2 13.1 2.7 3.0 3.3 2.6 2.0 2.7 1.2 1.8 1.2 1.5 1.3 4.0 0.4 2.4 3.8 0.3 1.5 0.2 0.4 0.2 0.4 1.6 0.4 0.6 0.5 15.1 0.3 1.5 1.6 0.4 0.7 2.2 4.8 0.5 0.9 2.6 3.9 0.5 0.5 9.8 2.4 0.0 6.7 0.0 1.3 2.5 0.0 0.2 0.0 151.3 20.5 7.0 0.0 3.5 0.0 0.8 2.5 1.5 3.3 0.0 1.8 2.9 1.3 0.9 0.0 1.3 3.1 0.0 1.7 3.1 3.5 4.8 0.3 3.4 3.3 5.4 2.7 0.9 1.0 7.0 2.5 2.9 1.9 6.5 6.2 6.6 3.4 1.9 2.7 0.0 1.8 2.0 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" A6NI56 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.8" "Cell type enhanced" "Detected in many" 19 "Cone photoreceptor cells: 7.9;Early spermatids: 36.6;Spermatocytes: 12.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.5;SCLC-21H: 26.6;U-266/70: 4.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 5.4" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323" "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 1.5 0.6 1.5 1.1 1.6 0.5 4.5 1.4 1.0 0.7 2.6 1.3 0.4 0.0 1.5 0.7 0.2 0.7 0.9 1.2 0.4 0.4 2.5 0.5 1.3 1.1 0.0 3.9 0.6 2.9 0.0 1.2 0.8 1.2 2.9 1.2 0.2 0.7 3.4 3.7 10.8 2.8 0.6 0.2 0.6 0.7 0.0 0.8 0.1 0.0 1.1 0.0 7.5 0.3 0.2 0.5 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.3 0.1 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.5 0.0 3.8 0.2 0.0 0.1 2.2 0.1 0.1 0.0 0.1 26.6 0.4 0.1 0.1 1.1 0.1 0.8 1.9 0.0 0.4 0.1 0.3 0.0 4.8 1.2 0.0 0.0 3.8 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.3 0.5 2.5 1.4 0.0 3.5 7.9 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.1 0.0 0.7 6.4 0.0 0.0 0.8 4.4 1.4 0.5 1.7 0.0 0.0 3.2 0.0 0.0 0.4 0.2 3.9 0.0 1.0 12.0 1.3 0.4 0.0 0.0 0.0 0.1 CCDC155 "FLJ32658, KASH5" ENSG00000161609 "Coiled-coil domain containing 155" Q8N6L0 19 49388218-49417994 "Predicted intracellular proteins, Predicted membrane proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 51.2" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 33.3;Early spermatids: 16.4;Spermatocytes: 87.2;Spermatogonia: 19.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enriched" "Detected in single" 39 "cerebellum: 7.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.1;U-266/70: 8.6;U-698: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA019937, HPA019940" Enhanced NA NA "HPA019937: AB_1848877, HPA019940: AB_1848879" "unprognostic (1.31e-1)" "unprognostic (4.23e-2)" "unprognostic (2.28e-2)" "unprognostic (1.09e-2)" "unprognostic (3.99e-1)" "unprognostic (1.79e-1)" "unprognostic (6.41e-2)" "unprognostic (5.31e-2)" "unprognostic (8.96e-2)" "unprognostic (1.84e-1)" "unprognostic (1.06e-1)" "unprognostic (2.57e-1)" "unprognostic (7.11e-9)" "unprognostic (6.50e-2)" "unprognostic (4.18e-1)" "unprognostic (3.08e-3)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.2 0.6 0.0 1.7 0.1 0.9 0.4 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 8.6 1.3 2.1 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 33.3 1.2 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 7.9 0.0 0.0 0.0 10.2 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 9.7 0.0 0.0 87.2 19.0 0.0 0.0 0.0 0.0 0.0 CCDC157 ENSG00000187860 "Coiled-coil domain containing 157" Q569K6 22 30356635-30378658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 11.5;testis: 43.7" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 38.8;Early spermatids: 94.7;Late spermatids: 106.4;Spermatocytes: 37.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042943 Uncertain NA NA "HPA042943: AB_10794767" "unprognostic (3.69e-3)" "unprognostic (1.72e-4)" "unprognostic (4.35e-2)" "unprognostic (1.24e-2)" "unprognostic (3.61e-1)" "unprognostic (7.74e-3)" "unprognostic (8.72e-4)" "unprognostic (1.35e-2)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (6.89e-4)" "unprognostic (2.33e-2)" "unprognostic (2.60e-2)" "unprognostic (4.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.42e-1)" "unprognostic (3.45e-2)" 0.9 1.8 4.3 1.5 5.9 2.5 2.0 3.3 4.0 1.6 1.4 2.5 2.2 1.5 1.6 3.0 1.4 11.5 2.0 1.1 4.4 5.8 3.3 1.0 3.5 2.0 2.3 1.9 2.1 3.0 1.7 4.5 0.9 5.9 1.6 0.9 2.1 2.4 1.7 0.9 1.8 1.1 0.9 1.2 1.8 1.4 43.7 1.8 1.3 4.4 1.2 1.2 1.1 0.8 1.6 2.3 6.7 1.6 1.9 2.3 1.2 2.8 3.3 3.0 5.7 1.8 1.1 3.7 1.5 1.9 2.9 2.9 4.2 2.2 2.5 1.9 1.5 4.3 2.8 1.6 2.0 1.6 1.7 7.0 1.4 3.1 2.4 2.0 2.7 2.4 1.1 1.4 5.3 0.9 2.0 1.8 3.8 2.2 2.3 2.4 2.8 3.4 2.8 3.8 1.9 1.8 2.9 1.7 2.2 7.0 3.0 10.3 6.7 4.6 1.7 1.8 2.3 5.5 1.2 3.1 2.8 3.6 1.8 1.2 1.9 0.9 2.1 4.5 1.6 2.3 2.0 1.6 2.0 2.1 1.1 2.3 0.9 1.8 2.1 0.9 1.6 1.1 1.8 6.7 1.9 1.4 2.3 1.4 1.2 4.3 5.9 3.3 4.0 4.4 5.8 2.3 1.9 5.9 1.8 3.0 3.5 0.5 2.2 1.1 5.9 0.8 2.5 38.8 9.1 8.7 11.8 2.0 0.0 4.5 94.7 2.3 1.8 0.0 2.1 2.0 2.6 1.0 2.3 0.8 1.6 6.4 1.2 4.3 1.5 106.4 3.4 2.5 0.0 1.0 1.1 3.9 2.7 2.9 2.5 5.6 27.3 0.0 2.7 37.4 16.4 1.5 2.9 2.5 1.7 1.3 CCDC158 FLJ25770 ENSG00000163749 "Coiled-coil domain containing 158" Q5M9N0 4 76312997-76421868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 26.3" "Group enriched" "Detected in some" 52 "Early spermatids: 54.8;Late spermatids: 56.3;Spermatocytes: 86.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.2;SiHa: 1.5;WM-115: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (3.31e-2)" "unprognostic (1.63e-1)" "unprognostic (7.49e-2)" "unprognostic (3.30e-2)" "unprognostic (3.29e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-3)" "unprognostic (6.99e-2)" "unprognostic (1.57e-1)" "unprognostic (9.70e-2)" "unprognostic (1.08e-3)" "unprognostic (2.18e-1)" "unprognostic (9.77e-3)" "unprognostic (6.22e-2)" "unprognostic (3.65e-2)" "unprognostic (9.29e-2)" "unprognostic (2.68e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.2 0.2 1.2 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 26.3 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 1.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 54.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 56.3 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 86.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC160 ENSG00000203952 "Coiled-coil domain containing 160" A6NGH7 X 134237047-134246207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 21.9" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 32.1;Distal tubular cells: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 25.7;RPTEC TERT1: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.45e-3)" "unprognostic (2.79e-2)" "prognostic favorable (2.31e-4)" "unprognostic (1.98e-1)" "unprognostic (5.11e-4)" "unprognostic (4.22e-2)" "unprognostic (2.07e-2)" "prognostic favorable (7.62e-6)" "unprognostic (3.32e-2)" "unprognostic (4.51e-2)" "prognostic favorable (2.21e-4)" "unprognostic (5.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.75e-1)" "unprognostic (2.44e-3)" 0.5 0.3 4.2 0.5 3.5 0.5 6.0 2.8 3.6 4.6 0.5 2.5 7.1 0.4 1.3 4.2 0.8 5.0 1.9 0.4 5.1 5.2 9.6 0.3 3.1 0.8 7.7 3.0 2.2 2.0 8.0 1.2 0.5 7.5 3.5 0.4 0.9 21.9 11.7 1.5 0.6 0.3 0.4 5.8 0.8 1.6 3.0 6.5 0.0 0.6 0.5 0.4 1.4 0.6 0.3 0.2 0.2 0.1 0.1 0.5 0.0 0.0 0.0 25.7 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 7.1 2.0 0.0 0.1 0.0 0.3 0.3 2.6 3.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.5 0.0 0.2 0.3 0.4 0.0 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 4.2 3.5 2.8 3.6 5.1 5.2 7.7 3.0 7.5 6.5 0.0 0.0 0.0 1.1 0.0 0.0 0.4 2.5 32.1 10.3 8.7 0.0 0.0 38.1 2.0 10.7 0.0 0.0 0.0 0.0 0.1 0.6 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.6 0.0 1.7 0.0 0.0 2.9 0.3 0.0 0.4 5.7 0.4 0.0 0.0 5.9 8.7 0.0 0.0 0.0 0.0 1.4 CCDC166 ENSG00000255181 "Coiled-coil domain containing 166" P0CW27 8 143706694-143708109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 7.8" "Cell type enriched" "Detected in some" 4 "Early spermatids: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025058 Uncertain NA NA "HPA025058: AB_2671717" "unprognostic (2.65e-1)" "unprognostic (3.64e-1)" "unprognostic (6.18e-2)" "unprognostic (4.97e-1)" "unprognostic (1.67e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 CCDC167 "C6orf129, dJ153P14.2" ENSG00000198937 "Coiled-coil domain containing 167" Q9P0B6 6 37482920-37499922 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 242.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 9 "U-698: 175.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045215 Uncertain Approved Cytosol NA NA Cytosol "HPA045215: AB_10962866" "unprognostic (1.82e-1)" "prognostic favorable (7.59e-4)" "unprognostic (6.99e-2)" "unprognostic (3.66e-1)" "unprognostic (2.86e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.73e-1)" "unprognostic (7.67e-2)" "unprognostic (3.41e-3)" "unprognostic (2.71e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.71e-7)" "unprognostic (1.57e-1)" "unprognostic (4.06e-1)" "unprognostic (2.44e-1)" "unprognostic (1.95e-1)" 6.4 10.3 16.1 11.6 18.9 12.7 10.2 11.3 15.5 12.6 10.5 12.8 11.4 6.3 8.7 25.2 13.6 11.5 6.2 17.3 13.8 12.1 10.2 29.5 7.0 23.0 18.1 9.1 4.6 14.9 6.9 8.4 9.6 15.8 12.2 13.0 5.0 16.2 7.7 10.5 6.5 8.2 16.7 22.8 15.1 7.5 18.8 16.9 32.1 11.5 11.2 35.5 8.7 8.7 24.8 9.9 23.6 6.0 8.6 70.0 26.4 3.1 7.2 16.6 11.5 4.5 8.0 6.1 3.7 3.0 5.8 6.5 7.6 4.7 17.1 8.5 6.3 11.3 2.4 10.7 8.7 5.9 14.2 19.7 8.1 3.1 19.1 4.8 7.9 3.2 3.7 18.0 6.2 5.7 4.1 18.0 18.0 5.0 14.9 9.9 10.3 14.8 6.5 0.9 9.0 4.6 9.2 5.9 12.6 7.9 6.2 11.3 13.3 5.6 5.5 8.7 15.2 6.0 8.2 4.5 3.9 7.6 2.1 3.8 11.0 10.7 175.0 3.7 17.0 10.9 4.8 6.0 23.6 26.1 5.9 31.1 24.8 43.5 32.8 9.9 17.0 20.1 19.4 1.8 8.6 4.9 6.3 70.0 26.4 16.1 18.9 11.3 15.5 13.8 12.1 18.1 9.1 15.8 16.9 6.0 10.1 32.8 22.2 12.6 8.6 42.5 33.1 16.0 7.9 14.0 7.9 52.7 26.6 58.7 80.7 18.0 15.3 140.2 43.7 96.5 31.5 33.2 15.0 109.5 77.5 14.3 24.2 29.4 18.3 242.2 12.0 25.9 52.3 29.7 18.8 29.8 51.7 14.4 17.7 66.3 8.5 6.5 20.8 95.7 92.0 13.2 24.8 54.9 25.8 27.3 CCDC168 "C13orf40, FLJ40176" ENSG00000175820 "Coiled-coil domain containing 168" Q8NDH2 13 102729369-102759070 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 23.7" "Cell type enriched" "Detected in some" 32 "Early spermatids: 828.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0" "HPA048184, HPA058793, HPA078547" Uncertain Approved Nucleoli,Centrosome,Cytosol NA NA "Nucleoli, Centrosome" Cytosol "HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: " "unprognostic (2.06e-1)" "unprognostic (7.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-4)" "unprognostic (2.09e-2)" "unprognostic (3.68e-2)" "unprognostic (2.74e-1)" "unprognostic (5.05e-2)" "unprognostic (3.61e-1)" "unprognostic (2.89e-3)" "unprognostic (1.73e-1)" "unprognostic (1.44e-5)" "unprognostic (2.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.85e-1)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.2 0.7 0.1 0.0 0.0 1.6 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 1.3 1.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.3 828.1 0.0 0.0 0.0 0.3 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.8 26.2 2.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 1.1 1.4 0.0 0.3 0.0 0.0 0.1 CCDC169 "C13orf38, LOC728591, RP11-251J8.1" ENSG00000242715 "Coiled-coil domain containing 169" A6NNP5 13 36222008-36297840 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "testis: 46.7" "Group enriched" "Detected in many" 14 "Early spermatids: 732.1;Late spermatids: 1719.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 17.5;U-937: 10.3" "Low region specificity" "Detected in single" NA NA "unprognostic (9.12e-3)" "unprognostic (1.05e-1)" "unprognostic (7.09e-2)" "unprognostic (2.38e-1)" "unprognostic (3.51e-2)" "unprognostic (7.26e-4)" "unprognostic (6.91e-2)" "unprognostic (3.31e-2)" "unprognostic (5.78e-3)" "unprognostic (2.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.80e-1)" "unprognostic (1.09e-1)" "unprognostic (8.65e-2)" "unprognostic (2.26e-2)" "unprognostic (1.14e-2)" 0.5 0.7 0.7 0.5 2.2 2.2 0.7 0.4 1.8 0.6 0.9 0.5 5.6 0.3 1.3 2.4 0.5 0.5 0.4 0.5 0.7 0.7 0.9 0.4 0.4 0.3 0.7 1.6 0.4 0.5 2.5 0.4 3.9 1.5 1.1 0.4 0.8 0.4 10.2 0.7 0.5 0.5 3.5 1.3 0.4 0.6 46.7 0.2 0.0 0.5 0.0 0.1 2.0 0.5 1.4 0.6 2.2 0.7 0.9 0.9 0.1 0.2 0.5 0.9 0.4 1.6 2.9 6.0 1.0 1.3 0.7 0.7 0.3 0.3 0.7 0.6 0.3 3.0 0.5 5.8 0.2 1.6 0.8 0.6 5.1 1.3 0.3 4.1 17.5 0.5 2.0 1.3 0.7 1.1 1.3 3.6 0.4 4.3 1.8 3.0 0.2 0.5 6.3 0.5 0.1 0.4 0.5 1.5 0.4 0.7 2.5 0.8 2.6 0.4 0.7 0.3 5.3 0.5 7.0 1.2 1.0 2.6 0.8 2.0 0.8 0.7 0.2 0.9 10.3 0.9 1.2 0.7 0.3 0.8 0.5 0.9 0.7 0.6 0.6 0.6 1.4 0.7 0.7 2.2 0.9 0.6 0.6 0.2 0.1 0.7 2.2 0.4 1.8 0.7 0.7 0.7 1.6 1.5 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.0 1.2 1.8 3.9 2.5 0.0 0.0 732.1 0.0 0.0 0.0 0.0 3.5 0.6 0.7 0.0 0.0 0.4 3.2 1.2 0.0 0.0 1719.4 12.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 6.7 3.7 0.0 12.9 0.1 86.1 14.8 0.1 4.7 0.0 0.0 0.6 CCDC169-SOHLH2 C13orf38-SOHLH2 ENSG00000250709 "CCDC169-SOHLH2 readthrough" 13 36168794-36297842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 42.2" "Cell type enhanced" "Detected in single" 35 "Late spermatids: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;HEL: 2.3;HL-60: 6.2;LHCN-M2: 2.4;NB-4: 3.5;SuSa: 2.3;U-937: 5.0" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (5.56e-2)" "unprognostic (3.93e-1)" "unprognostic (3.60e-2)" "unprognostic (4.66e-1)" "unprognostic (2.17e-1)" "unprognostic (1.84e-2)" "unprognostic (6.12e-2)" "unprognostic (3.43e-2)" 0.4 0.5 0.5 0.2 1.8 0.2 0.4 0.4 1.4 0.5 0.8 0.3 4.9 0.2 1.0 2.0 0.3 0.4 0.3 1.1 0.5 0.6 0.7 0.3 0.3 0.2 0.5 1.3 0.4 0.4 0.3 0.3 3.3 1.1 0.6 0.3 0.5 0.4 9.1 0.5 0.3 0.4 3.0 1.0 0.3 0.6 42.2 0.0 0.0 0.4 0.0 0.2 1.6 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.3 6.2 0.0 0.1 0.0 0.8 0.0 0.3 0.8 0.0 0.1 0.0 2.4 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.1 0.0 2.3 0.1 1.1 0.6 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 5.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.4 1.4 0.5 0.6 0.5 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC17 FLJ33084 ENSG00000159588 "Coiled-coil domain containing 17" Q96LX7 1 45620044-45624057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6" "Cell type enriched" "Detected in many" 12 "Ciliated cells: 291.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Region enriched" "Detected in single" 4 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA028338 Enhanced NA NA "HPA028338: AB_10669641" "unprognostic (3.53e-5)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (3.55e-3)" "unprognostic (3.31e-1)" "unprognostic (9.21e-3)" "unprognostic (6.97e-2)" "unprognostic (1.30e-2)" "unprognostic (8.55e-2)" "unprognostic (1.07e-1)" "unprognostic (4.46e-3)" "unprognostic (2.91e-1)" "unprognostic (8.37e-7)" "unprognostic (1.20e-1)" "unprognostic (1.96e-1)" "unprognostic (2.92e-1)" "unprognostic (5.91e-3)" 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.0 3.2 0.1 0.4 0.0 0.2 0.5 24.5 0.0 31.0 0.0 0.0 0.2 0.1 0.0 0.1 23.0 0.1 0.0 0.0 9.6 0.1 0.0 1.6 0.2 1.4 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.1 0.1 1.1 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 2.3 0.1 0.4 1.0 1.3 0.3 0.0 0.1 0.0 0.4 0.3 2.3 1.1 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.3 1.8 0.1 1.0 0.2 0.0 0.1 0.0 3.0 1.1 0.0 0.2 0.4 0.0 0.0 0.2 0.3 0.9 0.0 0.0 2.0 1.2 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 1.4 0.3 3.0 2.6 0.0 0.2 1.0 0.0 1.6 0.0 291.7 25.0 0.0 0.0 0.3 5.0 0.4 0.0 0.7 3.2 0.0 0.8 0.1 0.4 0.4 1.1 0.9 0.6 0.0 1.2 0.6 0.8 0.2 1.1 1.4 0.0 1.0 1.6 0.3 0.9 1.9 2.1 0.6 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.0 1.5 0.3 CCDC170 "bA282P11.1, C6orf97, FLJ23305" ENSG00000120262 "Coiled-coil domain containing 170" Q8IYT3 6 151494030-151621193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 19.4;fallopian tube: 33.0" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 481.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 16.1" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 14.2;T-47d: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027114, HPA027185" Enhanced Approved "Golgi apparatus,Cell Junctions" NA NA "Golgi apparatus" "Cell Junctions" "HPA027114: AB_2732435, HPA027185: AB_2672151" "unprognostic (7.46e-2)" "unprognostic (3.54e-2)" "unprognostic (6.93e-2)" "prognostic favorable (3.64e-4)" "unprognostic (2.13e-1)" "unprognostic (8.79e-3)" "unprognostic (2.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.56e-2)" "unprognostic (1.40e-2)" "unprognostic (3.93e-2)" "unprognostic (2.17e-1)" "unprognostic (5.21e-2)" 3.0 6.2 2.1 1.4 6.7 0.3 4.0 0.4 2.4 3.9 0.9 6.5 0.3 2.6 5.2 19.4 0.6 33.0 1.5 3.3 3.7 3.6 1.6 1.5 9.7 3.6 1.3 1.4 14.4 0.5 0.3 1.5 1.6 16.1 1.2 0.7 3.9 0.5 0.6 0.8 0.6 1.2 1.5 1.2 2.9 1.8 5.9 1.5 0.7 5.7 0.6 0.8 1.7 1.2 0.1 1.8 8.6 4.1 0.1 0.1 0.9 0.0 0.2 0.5 0.0 0.5 0.4 0.0 0.1 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.1 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.1 8.3 0.1 0.9 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.5 3.1 8.6 0.1 4.1 0.1 0.1 0.0 0.0 1.8 0.1 0.1 0.1 2.9 0.1 3.7 0.1 0.1 0.9 2.1 6.7 0.4 2.4 3.7 3.6 1.3 1.4 16.1 1.5 3.0 1.0 0.5 0.2 0.6 0.3 0.8 0.0 481.8 62.6 0.0 21.6 0.1 0.0 0.2 38.6 0.3 0.4 0.0 1.0 0.1 1.7 1.0 3.5 1.1 9.6 0.0 0.0 1.3 14.3 64.1 6.6 18.9 0.0 1.8 0.0 2.5 1.7 2.9 0.0 3.5 0.7 0.0 1.2 2.4 1.0 0.9 0.0 0.0 0.0 0.4 CCDC172 "C10orf96, MGC35062" ENSG00000182645 "Coiled-coil domain containing 172" P0C7W6 10 116324428-116380029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 23.4" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 116.5" "Cancer enriched" "Detected in single" 14 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "NTERA-2: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.85e-2)" 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.5 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 116.5 24.9 0.0 0.0 0.0 0.0 0.0 CCDC173 "C2orf77, LOC129881" ENSG00000154479 "Coiled-coil domain containing 173" Q0VFZ6 2 169645425-169694433 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 19.5;testis: 53.4" "Group enriched" "Detected in many" 8 "Ciliated cells: 338.6;Early spermatids: 622.4;Spermatocytes: 260.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 15.3;HMC-1: 3.7;SCLC-21H: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042995, HPA048454" Uncertain NA NA "HPA042995: AB_2678260, HPA048454: AB_2680400" "unprognostic (1.66e-2)" "unprognostic (2.68e-2)" "unprognostic (2.27e-1)" "unprognostic (3.16e-2)" "unprognostic (9.20e-2)" "unprognostic (4.18e-2)" "unprognostic (3.56e-3)" "unprognostic (3.05e-1)" "unprognostic (3.14e-2)" "unprognostic (1.69e-1)" "unprognostic (5.26e-6)" "unprognostic (8.73e-2)" "unprognostic (1.20e-1)" "unprognostic (2.20e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-2)" "unprognostic (1.41e-1)" 0.6 0.6 2.8 0.9 5.1 2.5 1.4 0.7 3.5 1.3 0.6 5.6 1.8 0.8 1.8 7.8 0.6 11.0 1.0 0.5 4.8 3.2 2.1 0.8 4.0 0.5 1.3 2.6 4.1 1.4 1.3 19.5 0.5 14.3 0.7 0.7 0.7 0.5 1.0 0.4 0.5 0.7 0.8 1.4 0.5 0.7 53.4 4.0 0.0 3.1 0.0 0.4 0.5 0.5 0.3 0.4 2.2 0.9 0.2 1.0 0.1 0.7 1.2 1.2 0.3 0.0 0.1 1.3 0.6 0.0 0.7 0.1 0.4 0.2 0.2 0.2 0.0 1.1 0.9 1.1 1.4 1.0 0.1 0.7 15.3 1.1 0.4 0.0 1.5 3.7 0.0 0.2 2.0 0.0 0.9 0.0 0.8 3.4 0.1 0.0 1.8 0.3 0.4 0.3 0.4 0.8 0.0 0.0 0.0 0.5 0.7 3.9 1.0 0.1 0.0 0.1 0.4 0.9 0.1 0.1 0.4 0.2 1.1 0.5 0.6 0.4 0.4 0.9 0.0 0.4 2.2 0.2 0.0 0.3 0.9 1.0 0.3 0.2 0.5 0.3 0.2 0.3 0.3 0.8 0.2 0.0 0.4 0.0 0.1 2.8 5.1 0.7 2.9 4.8 3.2 1.3 2.6 14.3 4.0 8.9 8.8 0.0 2.3 0.1 2.1 0.0 0.0 338.6 53.4 1.8 7.9 0.1 5.0 0.2 622.4 0.3 0.0 0.0 0.4 1.4 0.5 0.7 2.3 0.6 0.0 0.0 0.0 1.3 0.0 43.6 6.9 0.6 1.7 0.0 0.0 6.3 0.2 0.0 6.3 1.6 13.2 12.9 0.1 260.2 9.4 0.0 0.1 0.5 0.0 0.6 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SCLC-21H: 1.7" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 1.2 0.0 7.9 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 11.8 0.0 0.0 16.5 1.3 0.0 0.0 0.0 2.6 0.0 CCDC177 "C14orf162, PLPL" ENSG00000267909 "Coiled-coil domain containing 177" Q9NQR7 14 69569816-69574837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 17.5" "Group enriched" "Detected in some" 9 "Bipolar cells: 15.0;Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 9.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.9;HDLM-2: 1.0;NTERA-2: 2.9;SCLC-21H: 5.6;SH-SY5Y: 1.1;SK-BR-3: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.21e-1)" "unprognostic (2.33e-2)" "unprognostic (6.94e-3)" "unprognostic (1.34e-2)" "unprognostic (2.64e-3)" "unprognostic (1.77e-3)" "unprognostic (6.34e-4)" "unprognostic (2.58e-2)" "unprognostic (1.19e-1)" "unprognostic (1.99e-2)" "unprognostic (3.16e-1)" "unprognostic (7.84e-5)" "unprognostic (2.15e-4)" "unprognostic (3.81e-1)" "unprognostic (1.45e-1)" 0.4 1.1 3.2 0.4 3.7 0.3 1.0 17.5 8.5 0.3 0.3 0.2 0.0 0.3 0.4 3.1 0.4 0.4 0.3 0.3 2.2 1.6 0.3 0.6 0.3 0.3 0.5 4.4 0.4 0.3 0.3 0.3 0.3 2.3 0.3 0.3 1.8 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 1.5 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 1.1 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.7 17.5 8.5 2.2 1.6 0.5 4.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 15.0 1.1 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 CCDC178 "C18orf34, FLJ44050" ENSG00000166960 "Coiled-coil domain containing 178" Q5BJE1 18 32937402-33441101 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.3;breast: 18.4;testis: 16.4" "Group enriched" "Detected in some" 6 "Early spermatids: 58.8;Late spermatids: 53.2;Spermatocytes: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "HUVEC TERT2: 9.4;U-87 MG: 8.3" "Not detected" "Not detected" NA NA "unprognostic (1.15e-2)" "unprognostic (2.66e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (9.88e-2)" "unprognostic (2.58e-1)" "unprognostic (2.75e-1)" "unprognostic (2.58e-3)" "unprognostic (2.92e-1)" "unprognostic (5.95e-4)" "unprognostic (4.12e-2)" "unprognostic (7.31e-2)" "unprognostic (4.94e-4)" "unprognostic (2.86e-1)" "unprognostic (1.42e-3)" "unprognostic (9.03e-3)" 23.3 0.2 0.1 0.6 0.3 0.0 18.4 0.1 0.6 7.1 3.2 0.1 3.5 0.5 2.7 3.0 2.9 1.3 2.7 1.0 0.3 0.2 3.0 0.1 2.0 1.0 0.2 0.1 4.8 0.1 0.0 0.6 0.5 0.2 8.6 0.4 0.1 0.9 2.3 3.2 0.7 0.6 1.7 0.2 9.8 0.7 16.4 0.1 0.3 1.5 0.5 0.5 3.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.3 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 8.3 0.0 58.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 53.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.1 30.7 8.1 0.3 0.0 0.0 0.0 0.0 CCDC179 ENSG00000255359 "Coiled-coil domain containing 179" H3BU77 11 22846931-22860426 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 41.8" "Group enriched" "Detected in some" 128 "Early spermatids: 1036.4;Late spermatids: 1370.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.8;U-266/70: 1.0" "Region enriched" "Detected in single" 6 "cerebellum: 3.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1036.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1370.7 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 9.4 2.8 0.0 0.0 0.0 0.0 0.0 CCDC18 NY-SAR-41 ENSG00000122483 "Coiled-coil domain containing 18" Q5T9S5 1 93179919-93278730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0" "Group enriched" "Detected in many" 4 "Spermatocytes: 128.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028035 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA028035: AB_10601795" "unprognostic (8.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-1)" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (1.49e-4)" "unprognostic (4.36e-4)" "unprognostic (1.02e-1)" "unprognostic (1.44e-2)" "unprognostic (3.41e-2)" "unprognostic (1.63e-2)" "unprognostic (3.50e-2)" "unprognostic (3.64e-13)" "unprognostic (4.94e-2)" "unprognostic (9.19e-2)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" 3.8 2.3 2.7 20.0 4.3 13.4 4.6 3.7 2.7 2.2 3.2 0.4 2.9 2.5 1.8 4.0 3.2 1.8 1.7 2.6 3.4 1.9 2.0 3.0 3.8 11.9 1.7 1.8 2.8 1.5 0.7 4.8 1.9 2.6 1.9 4.1 1.3 2.0 3.1 6.2 3.1 3.4 2.3 3.8 6.0 2.3 12.6 2.5 15.8 2.1 2.8 8.2 2.9 3.3 12.2 11.9 6.0 3.9 1.1 2.7 0.5 15.7 5.3 12.4 3.9 3.0 3.2 6.5 9.8 5.2 10.1 10.3 2.7 5.4 20.4 5.5 5.2 9.9 7.5 5.4 7.7 14.7 10.1 7.1 14.0 11.3 4.8 1.1 14.5 6.5 2.1 0.6 7.6 7.5 2.8 6.5 9.2 14.9 15.8 13.4 2.2 6.9 5.9 11.3 4.3 6.6 9.0 14.8 6.0 4.9 7.1 5.5 3.5 13.9 7.1 4.1 5.8 3.4 8.5 5.0 11.9 8.4 7.6 11.1 6.8 8.8 12.3 2.5 13.0 3.1 3.4 3.8 5.3 2.4 3.9 2.7 8.8 2.2 2.1 1.6 12.2 1.7 2.0 6.0 1.1 3.5 11.9 2.2 0.5 2.7 4.3 3.7 2.7 3.4 1.9 1.7 1.8 2.6 2.5 17.9 11.1 17.6 6.5 3.7 2.4 8.1 0.0 6.7 4.5 3.5 3.9 2.6 0.0 1.9 17.7 3.7 1.7 0.0 2.6 5.8 6.8 3.3 18.5 2.9 7.2 1.6 0.0 4.3 12.4 8.5 5.8 19.5 3.3 9.0 2.5 1.1 1.8 3.5 6.0 1.0 0.6 6.5 5.7 128.6 37.7 6.4 2.4 14.1 3.1 6.4 CCDC180 "BDAG1, C9orf174, DKFZp434I2420, KIAA1529" ENSG00000197816 "Coiled-coil domain containing 180" Q9P1Z9 9 97307304-97378524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 54.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 104.4;Early spermatids: 106.3;Late spermatids: 128.7;Spermatocytes: 49.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;memory B-cell: 1.5" "Group enriched" "Detected in many" 14 "B-cells: 1.5;T-cells: 1.1" "Cell line enhanced" "Detected in many" "HDLM-2: 6.6;U-266/70: 9.6;U-266/84: 6.8" "Low region specificity" "Detected in some" NA NA "unprognostic (9.92e-2)" "unprognostic (9.73e-2)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-3)" "unprognostic (2.94e-2)" "unprognostic (3.52e-2)" "unprognostic (2.94e-1)" "unprognostic (1.52e-1)" "unprognostic (5.53e-5)" "unprognostic (2.33e-2)" "unprognostic (7.34e-3)" "unprognostic (1.64e-1)" "unprognostic (2.54e-1)" "unprognostic (1.41e-2)" "unprognostic (7.50e-3)" 0.5 0.8 1.2 0.3 4.1 0.3 1.1 8.4 2.2 1.2 0.9 4.8 0.7 0.0 1.8 5.7 0.5 8.4 0.6 0.7 1.5 1.5 1.0 0.5 3.1 0.7 1.4 0.3 2.7 0.9 1.4 5.4 0.9 8.1 1.1 0.6 0.5 0.7 0.9 0.8 0.3 0.7 1.2 1.6 0.9 0.6 54.4 1.2 0.9 4.2 0.3 0.5 0.7 1.0 1.5 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.9 1.5 0.9 1.1 3.4 0.0 0.6 1.1 1.1 0.9 1.5 0.9 0.0 1.8 0.0 0.9 0.0 1.1 0.0 0.3 6.6 0.6 2.3 1.8 0.8 0.3 2.8 3.7 1.9 1.3 0.0 0.5 4.0 0.0 2.9 1.5 1.3 0.0 0.2 0.6 3.0 1.1 0.0 0.2 0.0 0.3 0.4 0.8 1.1 1.5 1.3 0.3 0.0 1.0 0.5 1.0 0.8 0.0 1.1 0.5 2.9 1.6 9.6 6.8 0.0 0.2 0.0 2.8 0.0 0.0 0.0 1.1 0.0 0.6 1.5 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.2 4.1 8.4 2.2 1.5 1.5 1.4 0.3 8.1 1.2 0.0 10.9 0.0 0.5 0.3 12.2 0.6 2.5 104.4 19.4 0.0 19.6 0.1 1.7 0.3 106.3 1.4 0.4 0.0 1.2 0.0 0.8 0.4 9.2 0.0 0.4 12.7 1.2 3.7 0.6 128.7 1.7 1.9 1.7 4.6 0.8 4.4 0.3 0.0 2.8 11.2 27.5 0.0 0.5 49.3 5.1 0.1 0.3 1.5 1.1 0.3 CCDC181 "C1orf114, FLJ25846" ENSG00000117477 "Coiled-coil domain containing 181" Q5TID7 1 169394870-169460669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 22.3;testis: 29.2" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 168.6;Early spermatids: 201.9;Rod photoreceptor cells: 81.8;Spermatocytes: 143.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "AF22: 7.2;GAMG: 7.4;NTERA-2: 13.8;SCLC-21H: 8.5;SH-SY5Y: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027189, HPA027275, HPA027281, HPA027312" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA027189: AB_10599252, HPA027275: AB_10602172, HPA027281: AB_10601452, HPA027312: AB_10601349" "unprognostic (2.45e-1)" "unprognostic (2.20e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-3)" "unprognostic (3.00e-1)" "unprognostic (5.97e-2)" "unprognostic (6.87e-2)" "unprognostic (2.15e-3)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (4.89e-4)" "unprognostic (4.03e-2)" "unprognostic (3.06e-2)" "unprognostic (1.18e-2)" "unprognostic (8.41e-2)" 0.8 3.3 6.3 1.0 8.3 0.9 0.9 5.9 8.4 2.6 0.7 1.6 0.4 0.7 4.6 2.7 0.9 14.5 4.6 2.3 6.6 9.9 7.5 0.6 2.4 0.6 5.2 5.0 8.0 3.0 17.3 22.3 0.5 8.7 2.9 0.7 5.3 0.8 2.9 0.7 1.1 0.9 2.7 4.9 0.5 1.2 29.2 4.1 0.0 1.1 0.0 0.5 1.4 0.8 0.1 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.3 7.2 0.1 0.2 0.2 0.2 0.1 0.0 1.8 3.8 0.1 0.1 0.1 0.1 0.0 7.4 0.1 0.3 0.0 0.3 0.2 1.6 1.7 0.1 0.0 0.0 1.9 0.1 0.7 0.0 0.4 0.0 0.2 0.1 5.7 0.1 0.1 1.3 0.1 4.3 0.0 13.8 0.1 0.0 0.0 5.9 0.1 1.1 0.0 8.5 10.0 0.0 0.3 0.5 4.0 0.0 0.0 0.5 1.4 4.5 0.2 6.1 2.1 1.8 0.0 2.8 0.1 5.5 3.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 6.3 8.3 5.9 8.4 6.6 9.9 5.2 5.0 8.7 4.1 3.0 6.6 0.0 0.1 0.0 68.6 5.8 0.0 168.6 38.7 8.7 62.8 0.0 13.3 0.9 201.9 0.4 0.0 0.0 1.4 0.0 0.0 0.3 1.1 0.0 0.1 23.8 18.5 0.6 0.0 50.5 2.8 0.0 0.0 0.0 0.0 18.7 0.7 0.0 9.9 14.1 81.8 6.5 1.7 143.9 41.9 0.0 0.1 0.0 0.0 0.6 CCDC182 ENSG00000166329 "Coiled-coil domain containing 182" A6NF36 17 57744481-57745312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 21.5" "Group enriched" "Detected in some" 92 "Early spermatids: 201.1;Late spermatids: 143.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "REH: 3.1;THP-1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA023446 Uncertain NA NA "HPA023446: AB_1859510" "unprognostic (1.22e-1)" "unprognostic (3.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 CCDC183 "bA216L13.7, KIAA1984, MGC15438" ENSG00000213213 "Coiled-coil domain containing 183" Q5T5S1 9 136796350-136807741 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 26.4" "Group enriched" "Detected in many" 8 "Early spermatids: 186.3;Late spermatids: 116.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 4.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.5" "Cell line enhanced" "Detected in some" "Hep G2: 2.1;HL-60: 1.4;HSkMC: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043812 Uncertain NA NA "HPA043812: AB_10961860" "unprognostic (2.91e-1)" "unprognostic (8.34e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.27e-2)" "unprognostic (2.37e-1)" "unprognostic (6.89e-5)" "unprognostic (3.45e-2)" "unprognostic (2.26e-2)" "unprognostic (6.49e-2)" "unprognostic (8.16e-3)" "unprognostic (4.32e-2)" "unprognostic (6.98e-2)" "unprognostic (1.86e-2)" "unprognostic (1.30e-1)" "unprognostic (6.20e-2)" "unprognostic (5.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.6 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.8 0.2 3.4 0.4 0.0 4.0 2.3 1.8 0.0 2.0 1.7 0.9 186.3 0.2 2.6 0.0 0.6 0.8 1.5 3.7 0.0 0.5 0.4 4.8 7.5 1.3 1.5 116.1 2.6 0.7 3.3 1.0 5.9 2.9 1.2 20.1 3.5 0.7 4.4 6.5 0.9 3.2 0.8 0.1 5.8 1.3 4.9 0.8 CCDC184 "C12orf68, LOC387856" ENSG00000177875 "Coiled-coil domain containing 184" Q52MB2 12 48183584-48185926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Group enriched" "Detected in many" 4 "Early spermatids: 51.8;Sertoli cells: 45.3" "Cancer enhanced" "Detected in many" "glioma: 6.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.2;AF22: 9.9;hTERT-RPE1: 3.8;SH-SY5Y: 6.7;U-2 OS: 4.0;U-87 MG: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039947, HPA041715" Uncertain Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA039947: AB_2676764, HPA041715: AB_2677634" "unprognostic (2.02e-1)" "unprognostic (1.16e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.61e-2)" "unprognostic (4.59e-1)" "unprognostic (1.33e-2)" "unprognostic (6.65e-2)" "unprognostic (9.79e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (1.07e-1)" "unprognostic (5.87e-4)" "unprognostic (1.08e-2)" "unprognostic (2.39e-2)" "unprognostic (2.55e-1)" "unprognostic (2.36e-2)" 2.0 11.4 9.0 2.3 14.4 0.8 1.3 14.9 30.5 3.0 1.8 2.2 0.1 1.1 6.1 1.3 1.7 1.3 3.3 1.9 9.3 17.6 1.3 1.3 1.5 1.0 11.5 10.6 8.8 1.3 8.7 7.3 5.1 23.7 1.6 1.5 0.8 0.9 2.3 2.2 1.5 2.1 3.6 3.6 1.4 1.5 5.1 0.4 0.0 1.2 0.5 0.8 2.1 1.8 0.0 0.3 0.6 0.2 0.0 1.2 0.3 0.0 4.2 9.9 0.4 0.8 0.8 0.0 0.3 1.8 0.5 0.8 0.5 0.1 0.0 0.2 0.3 2.6 0.1 1.0 0.2 0.1 2.3 0.2 0.0 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.1 0.0 3.8 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 6.7 0.8 0.1 0.2 0.2 0.0 0.0 0.2 1.1 4.0 0.0 0.2 0.0 0.0 0.0 5.0 0.0 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 1.2 0.4 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 9.0 14.4 14.9 30.5 9.3 17.6 11.5 10.6 23.7 0.4 0.0 0.0 0.0 0.2 0.0 2.3 0.6 0.0 9.4 1.2 0.0 0.0 0.7 0.0 0.2 51.8 1.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.9 4.8 5.1 8.6 0.0 10.9 0.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 2.1 0.0 6.6 45.3 2.7 5.6 0.9 0.0 1.3 0.0 0.0 0.0 CCDC185 "C1orf65, FLJ35728" ENSG00000178395 "Coiled-coil domain containing 185" Q8N715 1 223393417-223395470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 150 "testis: 31.6" "Cell type enriched" "Detected in some" 15 "Early spermatids: 545.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.71e-1)" "unprognostic (1.55e-2)" "unprognostic (2.41e-6)" "unprognostic (9.69e-2)" "unprognostic (1.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.53e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.37e-3)" "unprognostic (3.13e-1)" "unprognostic (2.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 3.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 545.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.0 0.0 CCDC187 MGC50722 ENSG00000260220 "Coiled-coil domain containing 187" A0A096LP49 9 136249971-136306901 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 10.2;testis: 35.9" "Group enriched" "Detected in some" 5 "Early spermatids: 100.2;Late spermatids: 351.2" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Cell type enriched" "Detected in single" 5 "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 7 "RPMI-8226: 14.8;SCLC-21H: 4.6" NA NA "unprognostic (1.11e-1)" "unprognostic (9.60e-3)" "unprognostic (1.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (4.31e-2)" "unprognostic (6.18e-2)" "unprognostic (1.72e-1)" "unprognostic (2.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (5.54e-2)" "unprognostic (8.93e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 35.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 14.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 41.5 6.8 1.8 0.0 0.0 0.0 0.0 100.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 351.2 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.0 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148427-20151065 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.1;testis: 23.1" "Group enriched" "Detected in some" 125 "Early spermatids: 318.9;Late spermatids: 769.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 47 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 47 "dendritic cells: 4.7" "Cell line enhanced" "Detected in some" "AF22: 5.8;SCLC-21H: 8.0;SH-SY5Y: 10.5;TIME: 4.2;U-2 OS: 4.5" "Not detected" "Not detected" HPA049901 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA049901: AB_2680943" "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.1 0.9 0.4 0.5 0.6 0.5 0.5 1.4 1.2 0.4 0.4 0.4 0.4 1.0 0.6 0.4 0.4 0.4 0.4 0.4 0.4 1.9 0.4 0.4 0.6 0.7 0.5 0.4 0.4 0.4 0.0 6.1 0.8 0.4 0.4 0.0 0.4 0.4 0.4 0.7 1.5 0.5 0.4 0.4 1.8 0.8 23.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.8 0.3 0.0 0.7 0.0 1.7 0.8 1.4 0.9 0.1 0.1 0.0 0.2 0.8 0.2 0.3 0.0 0.0 0.1 0.2 0.0 1.4 0.2 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.6 0.0 0.1 0.9 0.2 3.8 1.2 0.5 0.0 0.3 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 8.0 10.5 0.5 0.0 0.6 0.1 0.0 0.1 4.2 2.4 4.5 3.0 0.2 0.7 0.1 0.2 3.9 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.6 1.4 0.6 0.4 1.9 0.5 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 318.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 769.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.0 CCDC189 "C16orf93, MGC104706" ENSG00000196118 "Coiled-coil domain containing 189" A1A4V9 16 30757423-30762710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.7" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 91.0;Early spermatids: 152.5;Late spermatids: 229.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041806, HPA046289, HPA075094" Approved Approved Cytosol NA NA Cytosol "HPA041806: AB_2677684, HPA046289: AB_2679615, HPA075094: " "unprognostic (5.84e-2)" "unprognostic (3.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.45e-4)" "unprognostic (3.60e-2)" "unprognostic (5.41e-3)" "unprognostic (7.76e-5)" "unprognostic (1.66e-2)" "unprognostic (1.82e-2)" "unprognostic (5.11e-3)" "unprognostic (2.15e-4)" "unprognostic (1.22e-3)" "unprognostic (1.06e-7)" "unprognostic (1.75e-3)" "unprognostic (2.14e-1)" "unprognostic (6.63e-2)" "unprognostic (3.41e-2)" 1.0 4.2 4.7 3.1 5.3 11.0 4.8 0.9 6.4 3.2 2.8 2.9 5.5 2.0 2.2 15.0 1.2 15.6 4.2 0.8 5.5 6.8 4.5 0.9 5.5 1.9 7.5 3.3 3.1 3.0 4.4 10.3 1.2 7.6 3.0 3.1 2.3 3.4 5.1 0.4 1.8 1.4 1.3 1.3 1.9 2.0 23.7 2.2 2.3 6.3 1.6 3.4 1.7 0.8 1.2 13.0 6.2 3.1 1.8 1.1 0.8 7.2 5.0 1.5 5.9 1.6 1.9 0.4 2.8 1.0 3.0 2.3 0.4 5.4 0.3 4.8 2.1 1.6 9.1 0.8 4.5 1.2 0.8 11.8 1.9 10.3 3.1 0.3 3.0 2.1 0.4 0.4 5.5 4.5 4.5 2.2 2.0 2.7 1.3 2.1 3.7 3.1 6.0 2.3 2.2 2.7 3.1 1.9 5.6 6.7 0.1 5.1 1.8 3.0 8.3 1.9 1.5 8.2 3.8 1.9 1.5 1.3 2.6 2.8 3.9 2.2 2.7 8.8 7.7 0.7 1.2 1.3 6.2 0.2 1.4 1.1 1.2 0.0 0.2 1.8 0.1 0.0 0.4 0.6 1.8 3.1 13.0 0.1 0.8 4.7 5.3 0.9 6.4 5.5 6.8 7.5 3.3 7.6 2.2 0.0 1.9 0.0 3.2 0.0 0.4 0.0 0.0 91.0 6.8 7.0 3.9 2.0 5.0 3.3 152.5 1.0 0.0 46.7 2.6 0.9 1.0 5.3 1.1 0.8 4.0 0.0 2.4 0.0 1.5 229.1 6.9 2.3 0.0 4.6 2.2 3.3 1.5 0.9 4.6 6.2 11.7 0.0 0.0 45.1 9.6 0.0 2.1 1.0 1.7 3.0 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 8.3;lung: 7.2;tongue: 7.5" "Cell type enriched" "Detected in some" 27 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles NA NA Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.2 0.1 1.1 0.2 1.7 0.0 0.2 0.2 0.9 0.3 0.2 0.2 0.2 0.0 0.2 0.8 8.3 1.1 1.3 1.0 1.2 0.7 0.2 0.2 7.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.2 0.3 0.2 0.1 0.7 0.2 0.6 0.2 7.5 2.4 0.3 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 4.1 2.6 5.1 5.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.4 0.0 9.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.2 0.6 1.2 0.7 0.4 0.2 0.2 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 48.2 0.0 1.8 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 CCDC192 LINC01183 ENSG00000230561 "Coiled-coil domain containing 192" P0DO97 5 127703389-127941634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 16.5" "Cell type enhanced" "Detected in single" 16 "Exocrine glandular cells: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.3" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 6.5;EFO-21: 1.8;HDLM-2: 1.7;HSkMC: 2.7;NTERA-2: 1.4;U-266/70: 3.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (2.64e-1)" "unprognostic (4.24e-2)" "unprognostic (9.22e-2)" "unprognostic (1.09e-2)" "unprognostic (2.44e-2)" "unprognostic (3.01e-2)" "unprognostic (4.07e-5)" "unprognostic (2.46e-2)" "unprognostic (9.34e-2)" "unprognostic (8.18e-2)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "unprognostic (1.52e-6)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 6.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.3 0.2 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CCDC194 ENSG00000269720 "Coiled-coil domain containing 194" A0A1B0GVG4 19 17390509-17394158 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "ovary: 2.3;placenta: 1.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.4;PC-3: 2.2;U-266/70: 2.3;U-266/84: 1.7" "Not detected" "Not detected" NA NA "unprognostic (1.50e-3)" "unprognostic (1.37e-1)" "unprognostic (1.87e-4)" "unprognostic (2.75e-3)" "unprognostic (1.41e-1)" "unprognostic (1.28e-2)" "unprognostic (3.09e-1)" "unprognostic (9.87e-2)" "unprognostic (3.07e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (2.64e-2)" "unprognostic (5.22e-14)" "unprognostic (1.04e-1)" "unprognostic (6.70e-3)" "unprognostic (2.60e-1)" "unprognostic (1.86e-2)" 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.8 0.7 0.9 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.7 1.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.4 0.0 2.2 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.7 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC195 ENSG00000283428 "Coiled-coil domain containing 195" A0A1B0GUA6 2 224703764-224716365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 1.0;lymphoid tissue: 2.1;skeletal muscle: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Daudi: 7.0;RPMI-8226: 2.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC196 "C14orf53, LINC00238, NCRNA00238" ENSG00000196553 "Coiled-coil domain containing 196" A0A1B0GTZ2 14 66411704-66498677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 38 "testis: 45.9" "Cell type enhanced" "Detected in single" 30 "Proximal tubular cells: 1.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.0" "Not detected" "Not detected" NA NA "unprognostic (2.96e-2)" "unprognostic (6.53e-2)" "unprognostic (6.56e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (4.47e-1)" "unprognostic (7.20e-2)" "unprognostic (9.22e-2)" "unprognostic (3.60e-6)" "unprognostic (5.72e-2)" "unprognostic (7.10e-2)" "unprognostic (6.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC197 "C14orf48, LINC00521" ENSG00000175699 "Coiled-coil domain containing 197" 14 93987225-94008863 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "testis: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HeLa: 1.5;Karpas-707: 3.4;U-266/70: 4.8" "Not detected" "Not detected" NA NA "unprognostic (5.01e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.5 0.3 0.4 0.6 0.1 0.3 0.0 0.2 0.6 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.7 0.3 0.0 0.0 2.1 0.4 0.2 0.0 0.0 0.1 0.4 0.2 1.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.7 0.0 0.3 0.2 0.2 0.3 0.2 0.0 0.8 0.6 0.2 0.0 0.1 4.8 0.1 0.1 0.0 0.2 0.2 0.5 0.3 0.0 0.3 0.0 0.1 0.3 0.3 0.1 0.0 0.9 0.4 0.6 0.3 0.4 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC198 "C14orf105, FLJ10650" ENSG00000100557 "Coiled-coil domain containing 198" Q9NVL8 14 57469301-57493867 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 25.8;kidney: 75.8;pancreas: 21.8" "Group enriched" "Detected in some" 5 "Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1" "Cancer enhanced" "Detected in many" "renal cancer: 25.1" "Region enhanced" "Detected in single" "pons and medulla: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "A549: 9.3;RPTEC TERT1: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029202 Uncertain Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA029202: AB_10600754" "unprognostic (1.45e-1)" "unprognostic (3.65e-1)" "unprognostic (2.38e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.21e-1)" "unprognostic (5.45e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.92e-4)" "unprognostic (6.07e-2)" "unprognostic (2.77e-1)" "unprognostic (1.61e-3)" 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.6 0.1 0.6 0.1 0.0 1.6 0.7 0.4 25.8 0.1 15.3 17.7 0.1 0.1 0.2 75.8 17.7 0.1 0.0 0.1 0.0 6.1 21.8 0.0 0.1 0.1 1.5 0.1 0.0 0.0 0.1 0.8 0.1 0.4 0.1 0.0 0.3 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.3 0.1 2.7 1.9 4.5 0.9 3.4 5.0 3.6 0.0 9.3 0.0 0.3 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.9 0.9 0.4 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.3 0.3 0.1 0.2 0.1 0.2 0.1 0.0 0.2 27.7 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.3 0.7 0.5 0.1 0.1 0.3 0.4 0.3 1.4 0.3 0.2 3.1 0.9 0.6 2.1 0.4 2.6 2.1 4.2 3.0 0.2 2.7 3.5 5.0 4.5 3.4 0.6 1.9 5.0 3.6 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 1.5 0.0 3.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 58.0 18.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 165.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC27 FLJ32825 ENSG00000162592 "Coiled-coil domain containing 27" Q2M243 1 3746460-3771645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "testis: 53.3" "Group enriched" "Detected in some" 46 "Early spermatids: 60.7;Late spermatids: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "THP-1: 6.2" HPA044395 Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA044395: AB_10962987" "unprognostic (1.36e-1)" "unprognostic (6.67e-3)" "unprognostic (3.23e-4)" "unprognostic (3.13e-2)" "unprognostic (3.42e-1)" "unprognostic (2.07e-1)" "unprognostic (1.79e-2)" "unprognostic (7.18e-2)" "unprognostic (1.20e-1)" "unprognostic (2.17e-2)" "unprognostic (2.54e-3)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "unprognostic (2.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 CCDC28B "MGC1203, RP4-622L5.5" ENSG00000160050 "Coiled-coil domain containing 28B" Q9BUN5 1 32200386-32205387 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 66.7" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 86.5;monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 140.1" "Low region specificity" "Detected in all" HPA028589 Uncertain NA NA "HPA028589: AB_10602175" "prognostic favorable (2.92e-4)" "unprognostic (6.01e-3)" "unprognostic (1.04e-1)" "unprognostic (2.61e-2)" "unprognostic (2.59e-3)" "unprognostic (5.18e-2)" "unprognostic (7.50e-3)" "unprognostic (7.87e-2)" "unprognostic (5.15e-2)" "unprognostic (1.79e-2)" "prognostic favorable (1.10e-5)" "unprognostic (2.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.44e-2)" "unprognostic (1.67e-1)" "unprognostic (7.83e-2)" "unprognostic (1.07e-2)" 2.0 6.5 7.0 4.1 7.2 3.4 1.6 12.4 6.5 2.2 3.1 2.0 1.4 2.4 3.1 3.2 3.2 2.7 3.9 8.6 6.3 4.6 2.9 1.1 2.0 6.8 5.0 6.0 3.4 3.5 4.4 10.1 3.0 4.3 2.7 1.7 4.7 4.0 2.6 66.7 2.6 1.9 3.8 3.6 3.4 2.8 11.7 5.2 4.5 3.2 11.7 4.7 3.2 1.9 9.3 14.2 3.1 4.3 15.8 15.6 8.4 4.6 1.5 10.3 9.9 3.0 3.8 0.8 3.3 4.8 5.8 3.9 3.0 5.3 10.2 5.4 3.9 0.9 1.3 8.3 3.9 1.1 11.6 11.7 13.2 7.1 1.8 4.2 0.3 4.5 4.7 1.8 6.6 0.1 5.5 7.9 17.0 8.5 1.3 3.8 0.6 17.2 2.6 10.4 1.3 2.5 18.3 5.0 8.2 5.3 0.7 19.9 8.8 4.8 1.0 5.8 6.2 3.2 3.9 4.7 3.3 4.4 4.5 2.1 2.8 0.7 0.6 5.6 17.8 3.1 3.1 4.3 0.9 15.6 2.0 7.8 7.8 7.4 13.2 9.8 9.3 12.4 12.3 0.4 15.8 0.5 14.2 9.6 8.4 7.0 7.2 12.4 6.5 6.3 4.6 5.0 6.0 4.3 5.2 0.0 6.7 6.7 5.3 8.0 29.4 12.8 10.2 2.7 1.2 12.2 21.6 1.7 29.9 17.1 11.4 9.0 0.5 23.3 6.6 3.2 31.7 3.0 3.5 0.8 9.8 22.3 86.5 8.6 3.4 22.6 18.7 4.8 16.9 107.4 5.3 16.1 9.1 1.7 15.9 3.3 43.3 0.0 21.7 2.7 11.9 6.8 1.8 22.9 3.3 1.3 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 89.3" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA Nucleoplasm Cytosol "HPA062425: AB_2684759" "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 37.1 5.0 14.0 2.5 9.0 0.2 33.6 4.9 15.0 23.0 4.2 2.9 3.4 2.9 16.2 18.6 26.9 21.8 89.3 11.0 8.0 3.0 4.2 8.5 8.0 12.3 4.3 8.7 39.1 2.9 3.8 4.2 9.6 3.2 14.3 3.4 8.8 2.8 10.3 12.0 55.7 5.5 11.8 3.4 9.8 5.8 11.0 3.1 10.4 8.3 9.6 2.0 12.4 14.2 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.2 1.2 6.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.5 0.0 7.5 1.3 13.6 2.5 0.4 22.3 5.7 0.0 0.2 0.0 0.5 0.0 0.0 1.7 1.6 0.3 0.0 10.7 0.6 0.5 0.0 0.1 0.7 0.1 0.0 3.7 1.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 2.6 1.1 4.9 0.7 0.0 3.3 0.0 0.0 0.0 0.0 14.8 0.8 0.2 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 14.0 9.0 4.9 15.0 8.0 3.0 4.3 8.7 3.2 3.1 0.0 0.0 0.0 6.2 44.5 1.0 4.4 0.0 0.0 1.2 0.0 0.0 0.2 1.7 0.0 0.2 8.3 0.0 0.0 0.0 0.1 9.1 1.9 0.0 0.2 0.3 0.0 0.0 8.0 0.0 1.1 20.8 1.6 13.5 0.0 0.0 0.5 0.1 0.0 57.0 0.3 1.9 32.3 95.9 0.0 3.8 32.5 0.2 0.0 0.0 1.0 CCDC30 "FLJ20972, LOC728621, PFD6L" ENSG00000186409 "Coiled-coil domain containing 30" Q5VVM6 1 42463330-42654664 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.1" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 140.5;Club cells: 35.2;Early spermatids: 48.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 18 "HMC-1: 16.5" "HPA036344, HPA036345" Approved NA NA "HPA036344: AB_10795572, HPA036345: AB_10796213" "unprognostic (3.21e-2)" "unprognostic (8.48e-2)" "unprognostic (3.33e-1)" "unprognostic (4.46e-2)" "unprognostic (2.35e-1)" "unprognostic (5.72e-3)" "unprognostic (6.77e-3)" "unprognostic (7.68e-3)" "unprognostic (4.61e-3)" "unprognostic (1.41e-2)" "unprognostic (3.51e-3)" "unprognostic (1.98e-1)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.13e-1)" "unprognostic (5.70e-3)" "unprognostic (6.95e-3)" 1.4 1.7 5.5 1.2 11.1 1.1 2.5 4.1 7.9 3.2 1.4 1.9 9.2 1.1 2.1 14.3 1.1 8.0 1.9 1.2 4.9 3.7 5.5 1.2 6.5 1.1 2.2 6.0 3.2 2.1 6.8 27.1 1.4 13.7 2.3 1.1 1.7 1.5 9.5 1.1 1.3 1.3 1.3 2.0 1.8 1.2 12.4 2.2 0.0 5.3 0.0 1.2 1.4 1.4 0.6 0.5 2.9 0.3 0.4 0.8 0.2 0.2 0.1 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 16.5 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.9 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.2 0.2 0.3 2.9 0.3 0.9 0.4 0.1 0.4 0.4 0.3 0.1 0.4 0.6 0.8 0.4 1.6 0.4 0.2 0.5 0.6 0.2 5.5 11.1 4.1 7.9 4.9 3.7 2.2 6.0 13.7 2.2 6.0 14.6 0.0 2.4 1.1 4.7 2.4 5.1 140.5 35.2 7.0 7.9 1.1 1.7 4.4 48.5 2.9 2.2 0.0 2.1 0.9 2.0 2.0 9.2 0.8 1.1 6.4 2.9 2.5 3.2 30.7 5.5 2.7 1.7 3.6 1.6 5.7 1.4 1.1 6.7 6.3 8.7 6.5 3.6 20.9 4.3 0.9 1.5 1.8 1.2 2.2 CCDC33 "CT61, FLJ32855" ENSG00000140481 "Coiled-coil domain containing 33" Q8N5R6 15 74202705-74336472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "fallopian tube: 35.9;testis: 41.5" "Group enriched" "Detected in some" 7 "Ciliated cells: 54.9;Early spermatids: 47.3;Late spermatids: 37.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 12.3;SCLC-21H: 7.0;SH-SY5Y: 8.5" "Low region specificity" "Detected in many" NA NA "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.13e-3)" "unprognostic (6.37e-3)" "unprognostic (2.16e-1)" "unprognostic (3.16e-3)" "unprognostic (3.68e-2)" "unprognostic (9.87e-2)" "unprognostic (2.05e-2)" "unprognostic (4.46e-1)" "unprognostic (4.18e-2)" "unprognostic (6.12e-2)" "unprognostic (9.37e-2)" 0.0 0.2 0.8 0.0 2.6 0.0 0.0 0.0 0.2 0.9 0.3 2.7 0.7 0.0 0.5 3.0 0.0 35.9 0.5 0.0 1.1 1.4 0.0 0.0 3.4 0.0 0.0 0.0 3.9 0.0 0.0 0.2 0.2 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.2 0.0 0.3 41.5 0.8 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.3 0.0 1.2 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 7.0 8.5 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.1 1.1 1.4 0.0 0.0 3.3 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 54.9 6.8 0.0 0.0 0.0 0.0 0.2 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.0 1.5 0.0 0.0 0.0 CCDC34 "L15, NY-REN-41, RAMA3" ENSG00000109881 "Coiled-coil domain containing 34" Q96HJ3 11 27330827-27363868 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.5" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 280.3;Spermatocytes: 327.2;Spermatogonia: 197.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 37.6;U-266/70: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037574 Uncertain Approved "Nuclear membrane,Nucleoli fibrillar center" NA NA "Nuclear membrane, Nucleoli fibrillar center" "HPA037574: AB_10795136" "unprognostic (8.23e-3)" "unprognostic (1.09e-3)" "unprognostic (7.47e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-2)" "unprognostic (6.40e-2)" "prognostic unfavorable (1.32e-7)" "unprognostic (9.09e-2)" "unprognostic (1.34e-3)" "prognostic favorable (8.52e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (4.97e-2)" "unprognostic (4.14e-2)" "unprognostic (1.64e-2)" "unprognostic (6.11e-2)" 2.7 4.7 9.3 6.8 17.1 8.3 8.4 3.8 11.7 4.2 6.6 2.1 3.8 7.9 4.1 8.6 5.9 9.7 4.0 3.2 9.0 7.5 4.1 3.4 2.8 4.3 5.6 6.2 7.7 4.8 7.2 12.5 3.9 11.1 5.4 7.4 3.3 3.6 3.8 2.8 4.7 6.3 2.8 4.5 3.3 6.9 31.5 4.4 14.8 6.7 5.3 6.0 3.3 3.9 4.8 2.4 0.4 3.6 4.1 7.1 1.3 10.2 11.8 10.1 10.1 1.9 4.1 7.2 6.5 2.6 7.5 7.3 6.6 2.0 11.5 4.7 3.7 10.5 9.5 9.8 4.3 13.4 4.4 14.2 9.0 15.0 16.5 0.9 8.9 3.5 1.4 3.1 6.2 2.8 3.1 5.3 16.4 9.1 3.8 7.5 7.4 17.2 14.2 10.6 7.0 10.8 17.5 37.6 1.6 2.8 3.3 7.7 10.2 10.4 4.6 4.5 5.7 12.3 4.8 2.6 11.3 10.6 21.4 15.5 37.5 34.0 8.1 10.5 0.4 9.6 0.0 0.2 0.4 3.6 1.0 4.5 3.5 4.5 4.8 1.0 4.8 5.4 3.3 0.0 4.1 3.6 2.4 7.1 1.3 9.3 17.1 3.8 11.7 9.0 7.5 5.6 6.2 11.1 4.4 0.0 1.7 5.2 22.4 20.3 10.0 8.1 35.7 119.1 23.9 22.7 11.8 26.0 16.6 12.7 280.3 10.6 8.9 93.5 10.8 18.1 15.8 12.5 6.9 14.9 18.8 3.2 20.7 8.0 10.5 39.6 19.8 8.4 13.5 6.4 32.6 21.5 5.5 7.0 19.4 11.2 19.5 6.5 4.7 327.2 197.3 18.1 13.5 8.7 69.8 7.8 CCDC36 "CT74, FLJ25320" ENSG00000173421 "Coiled-coil domain containing 36" Q8IYA8 3 49198428-49258104 "Predicted intracellular proteins" "Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.4" "Group enriched" "Detected in some" 8 "Early spermatids: 51.2;Late spermatids: 32.2;Spermatocytes: 85.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.9;hTEC/SVTERT24-B: 13.3;LHCN-M2: 5.5;U-2197: 7.2;WM-115: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA045690, HPA069534" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045690: AB_10964634, HPA069534: AB_2686146" "unprognostic (1.54e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-2)" "unprognostic (1.49e-2)" "unprognostic (9.94e-3)" "unprognostic (2.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.36e-2)" "unprognostic (5.51e-4)" "unprognostic (3.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.59e-2)" "unprognostic (6.33e-2)" 6.5 1.7 0.8 1.8 0.8 0.4 3.6 0.8 0.7 3.7 2.2 0.7 2.1 0.4 6.3 1.2 1.1 1.3 1.4 1.9 0.9 0.4 0.5 0.4 1.4 0.5 1.1 0.1 5.0 0.4 0.2 0.4 1.4 2.0 0.6 0.4 2.6 2.0 0.8 1.6 0.8 0.6 3.9 0.4 0.7 0.6 35.4 0.3 0.0 1.3 0.3 0.6 1.2 0.9 0.9 0.6 3.6 0.3 0.8 0.5 0.2 0.0 0.2 0.1 0.2 2.8 3.1 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.5 0.0 0.2 2.4 0.0 13.3 0.0 0.0 1.7 0.1 0.0 0.3 5.5 0.0 0.0 0.2 3.5 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 2.5 7.2 0.1 0.1 0.1 0.1 0.0 0.2 3.6 2.1 0.3 0.6 0.4 0.2 0.3 0.8 0.4 0.3 0.1 0.9 0.4 0.5 3.6 0.8 0.2 0.6 0.3 0.2 0.8 0.8 0.8 0.7 0.9 0.4 1.1 0.1 2.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.8 5.9 0.0 0.0 0.0 51.2 2.4 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.3 0.0 0.0 0.6 0.0 32.2 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.9 0.0 0.0 85.6 6.8 0.4 0.1 0.0 0.0 0.0 CCDC38 FLJ40089 ENSG00000165972 "Coiled-coil domain containing 38" Q502W7 12 95867048-95942974 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.0" "Cell type enhanced" "Detected in some" 33 "Early spermatids: 66.8;Late spermatids: 12.6;Spermatocytes: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.76e-1)" "unprognostic (1.49e-1)" "unprognostic (7.54e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-1)" "unprognostic (5.22e-2)" "unprognostic (1.61e-3)" "unprognostic (3.29e-1)" "unprognostic (5.11e-2)" "unprognostic (8.37e-2)" "unprognostic (1.17e-3)" "unprognostic (2.25e-2)" "unprognostic (2.32e-1)" "unprognostic (1.14e-1)" "unprognostic (1.59e-1)" "unprognostic (4.96e-5)" "unprognostic (1.08e-2)" 0.1 0.7 0.1 0.1 0.2 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 3.3 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.1 0.7 0.0 37.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.7 3.0 0.5 0.7 0.7 0.1 0.5 1.5 0.9 0.8 0.5 0.2 0.7 0.3 0.1 0.4 0.7 0.7 0.5 0.7 0.3 0.2 2.0 1.0 0.8 0.2 0.8 1.4 1.3 1.2 1.2 0.6 0.2 1.1 0.3 0.4 0.6 1.0 0.2 0.5 0.1 2.8 0.2 1.4 0.2 0.4 0.8 1.2 0.6 0.2 1.3 0.6 0.3 0.7 0.4 0.7 1.5 3.4 1.5 0.9 1.8 0.9 0.6 1.0 0.3 0.9 0.9 1.8 0.2 1.8 2.1 1.2 1.1 0.5 0.9 1.4 0.5 0.9 0.6 0.3 0.4 0.5 0.4 0.3 0.2 1.2 0.6 0.7 3.0 0.7 0.2 0.7 0.6 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.6 0.3 12.6 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 17.9 1.5 0.0 0.1 0.0 0.0 0.0 CCDC39 "CILD14, DKFZp434A128, FAP59" ENSG00000145075 "Coiled-coil domain containing 39" 3 180614008-180870933 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 12.4" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;ASC TERT1: 2.7;HSkMC: 3.8;HUVEC TERT2: 1.2" NA NA "unprognostic (3.37e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (1.09e-1)" "unprognostic (4.03e-2)" "unprognostic (1.35e-4)" "unprognostic (1.34e-1)" "unprognostic (6.62e-2)" "unprognostic (6.88e-2)" "unprognostic (9.65e-2)" "unprognostic (1.33e-1)" "unprognostic (5.76e-2)" "unprognostic (1.88e-4)" "unprognostic (7.40e-2)" "unprognostic (2.33e-1)" "unprognostic (1.22e-3)" "unprognostic (1.16e-4)" 7.9 0.5 0.4 1.0 0.4 1.5 2.6 0.4 0.4 10.7 2.2 0.0 0.7 0.1 5.2 4.8 1.1 1.0 2.2 2.3 0.4 0.4 0.4 0.8 1.1 0.3 0.4 0.0 7.5 0.5 0.0 1.1 0.3 0.2 2.0 0.3 4.7 1.6 0.1 12.4 0.8 0.6 6.0 0.4 4.5 0.6 8.3 0.0 0.0 0.6 1.8 0.0 2.4 0.9 0.5 0.1 1.1 0.8 0.1 0.7 0.0 0.0 0.0 0.0 0.2 1.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.4 3.8 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.4 0.7 0.1 0.6 0.4 0.6 0.2 0.0 0.5 0.4 0.5 1.1 0.1 0.1 0.1 0.1 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC39 ENSG00000284862 "Coiled-coil domain containing 39" Q9UFE4 3 180602858-180679500 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 200.8;Cone photoreceptor cells: 60.9;Early spermatids: 78.4;Late spermatids: 44.6;Rod photoreceptor cells: 44.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA035363, HPA035364" Enhanced NA NA "HPA035363: AB_2674588, HPA035364: AB_10601095" 0.0 1.7 1.1 3.6 7.5 1.8 0.0 0.3 2.9 0.6 0.1 3.3 0.0 3.1 2.0 10.4 1.2 5.8 3.4 1.4 1.7 0.1 0.0 5.7 10.3 0.0 1.3 4.6 0.3 0.0 6.4 0.0 23.3 0.7 0.0 1.4 1.6 0.0 0.2 10.7 2.7 0.0 0.2 4.2 1.6 12.4 1.1 0.0 3.5 0.0 0.0 1.9 0.0 1.2 0.6 0.0 0.2 0.7 1.5 0.3 3.9 2.6 8.3 2.2 0.0 0.0 2.7 1.9 0.0 0.0 0.0 3.1 3.7 10.5 3.5 0.0 1.8 3.5 0.1 0.0 0.0 5.8 5.0 5.0 6.8 6.7 0.0 8.0 4.9 0.0 0.0 0.0 0.0 8.9 0.0 10.2 3.4 0.7 0.3 1.0 4.0 0.1 5.1 1.8 5.2 5.5 2.7 13.2 0.0 5.6 3.9 4.4 2.3 2.3 1.5 4.0 5.7 5.2 6.3 6.9 3.0 2.2 6.5 6.6 4.5 10.9 4.4 7.6 1.4 0.0 0.2 0.0 0.8 0.1 1.5 1.2 0.4 0.0 0.2 0.3 1.1 0.3 0.0 0.7 0.2 0.6 1.1 0.3 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 200.8 13.6 0.0 60.9 0.0 0.0 0.0 78.4 0.0 0.0 0.0 0.2 0.0 1.7 0.2 0.0 0.0 0.0 1.6 0.0 16.0 1.9 44.6 12.4 0.0 1.7 0.0 0.0 2.4 0.0 0.0 9.2 0.0 44.0 6.5 0.0 32.4 6.1 0.5 0.0 0.0 0.0 0.0 CCDC40 "CILD15, FAP172, FLJ20753, FLJ32021, KIAA1640" ENSG00000141519 "Coiled-coil domain containing 40" Q4G0X9 17 80036632-80100613 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 24.3;testis: 29.5" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 105.7;Rod photoreceptor cells: 28.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 14.0;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022974 Enhanced Approved Microtubules NA NA Microtubules "HPA022974: AB_1848791" "unprognostic (5.89e-3)" "unprognostic (2.30e-1)" "unprognostic (8.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.53e-2)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.04e-5)" "unprognostic (7.38e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (1.86e-1)" "unprognostic (2.84e-1)" "unprognostic (1.91e-3)" "unprognostic (4.26e-2)" 3.4 3.6 3.0 3.0 10.4 1.0 3.6 2.5 5.1 3.2 2.4 10.2 2.3 1.3 4.5 10.1 1.5 24.3 3.8 3.8 6.2 4.8 5.5 2.3 5.5 1.5 3.3 3.1 4.5 3.2 3.6 10.2 1.4 19.4 4.4 1.3 4.8 2.5 4.1 2.6 2.2 2.6 2.8 3.5 2.3 3.2 29.5 5.0 0.0 6.0 1.2 1.2 2.0 1.4 0.9 0.5 2.5 0.4 0.7 1.1 0.1 2.4 7.9 7.2 8.0 0.9 1.1 1.9 2.3 1.7 2.0 2.1 0.8 3.4 0.3 1.1 1.6 3.4 0.8 1.8 1.7 0.5 0.1 1.5 0.1 3.9 3.8 1.7 0.2 2.6 1.9 2.5 2.5 0.2 3.5 1.1 1.4 0.9 0.0 1.6 2.7 0.1 0.5 3.3 3.4 2.7 2.0 4.0 0.0 4.1 1.6 14.0 10.2 3.5 1.7 1.6 4.1 3.2 0.2 1.3 4.5 2.7 2.9 0.5 2.3 0.7 0.3 1.0 0.2 2.2 1.7 0.4 0.4 0.5 0.2 1.1 0.5 0.3 0.2 0.0 0.9 0.5 0.4 2.5 0.7 0.2 0.5 0.1 0.1 3.0 10.4 2.5 5.1 6.2 4.8 3.3 3.1 19.4 5.0 11.9 6.9 0.5 1.9 0.6 3.9 3.1 0.0 105.7 14.8 7.0 13.7 0.3 1.7 2.3 9.4 1.1 0.0 0.0 1.3 0.8 1.0 1.9 0.0 1.0 1.2 11.1 2.9 1.8 1.9 5.4 1.1 1.4 0.0 0.0 1.2 6.0 0.9 0.0 3.2 1.6 28.4 0.0 1.0 18.4 5.2 0.3 0.2 0.0 0.4 0.9 CCDC42 "CCDC42A, FLJ32734" ENSG00000161973 "Coiled-coil domain containing 42" Q96M95 17 8729934-8745219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 119.7" "Cell type enhanced" "Detected in some" 32 "Early spermatids: 31.7;Late spermatids: 35.2;Spermatocytes: 135.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HDLM-2: 2.1;JURKAT: 1.0;REH: 3.8;U-266/84: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" NA NA "unprognostic (1.66e-1)" "unprognostic (2.92e-2)" "unprognostic (2.30e-2)" "unprognostic (3.60e-2)" "unprognostic (9.24e-2)" "unprognostic (1.13e-4)" "unprognostic (8.35e-2)" "unprognostic (9.71e-2)" "unprognostic (3.06e-2)" "unprognostic (4.36e-3)" "unprognostic (6.08e-2)" "unprognostic (1.04e-5)" "unprognostic (5.74e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.32e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 119.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.7 0.0 1.9 0.5 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 1.4 2.0 1.9 1.3 0.2 1.2 0.4 0.6 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 6.5 0.0 135.7 1.9 0.0 0.1 0.0 0.0 0.0 CCDC43 FLJ31795 ENSG00000180329 "Coiled-coil domain containing 43" Q96MW1 17 44673069-44689779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 50.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023078, HPA023391" Enhanced Enhanced Cytosol NA NA Cytosol "HPA023078: , HPA023391: AB_1846146" "unprognostic (6.05e-2)" "unprognostic (8.91e-2)" "unprognostic (8.75e-3)" "unprognostic (3.58e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (3.42e-5)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.11e-1)" 10.4 10.4 14.3 8.5 15.6 13.8 10.0 14.9 14.7 7.9 9.3 9.8 7.2 9.1 8.2 9.0 10.7 7.6 6.1 16.3 13.8 10.4 11.2 7.5 7.5 9.6 11.9 9.2 7.3 9.4 12.3 5.8 14.2 14.4 9.8 12.0 6.9 8.9 7.6 50.6 8.8 8.8 8.6 14.4 9.8 8.5 7.3 9.6 10.9 10.8 17.1 10.9 9.1 7.8 11.5 17.5 10.7 17.9 15.8 14.7 10.0 12.3 14.8 14.1 12.4 9.6 14.3 25.9 18.9 11.2 18.6 18.3 20.0 13.3 21.6 14.7 15.3 13.3 9.7 23.2 21.8 27.1 26.3 27.0 19.3 24.4 29.4 17.3 27.0 14.6 12.8 22.2 19.3 26.4 12.8 18.0 17.8 20.3 15.1 18.8 15.3 26.3 19.2 14.5 11.7 19.1 17.1 35.5 18.6 19.0 8.1 14.2 14.0 13.8 11.1 19.1 22.2 28.4 18.4 15.5 23.1 17.0 13.7 25.0 15.4 19.4 25.0 16.9 15.8 16.4 10.5 16.0 10.7 12.9 17.9 11.9 9.3 12.2 14.3 17.5 11.5 12.0 13.0 3.3 15.8 11.7 12.4 14.7 10.0 14.3 15.6 14.9 14.7 13.8 10.4 11.9 9.2 14.4 9.6 11.9 16.0 19.3 8.6 11.7 21.9 35.1 12.7 21.4 21.6 8.7 9.8 36.1 33.2 19.2 0.6 20.0 10.5 23.3 21.3 38.6 13.5 9.4 32.3 12.4 26.9 20.6 17.2 16.5 17.8 2.7 13.0 21.6 20.3 18.0 14.4 17.4 18.5 10.5 12.0 25.8 19.2 6.5 17.6 3.5 10.4 9.8 21.2 12.1 19.9 7.1 CCDC54 "FLJ25362, NYD-SP17, SP17" ENSG00000138483 "Coiled-coil domain containing 54" Q8NEL0 3 107377194-107378637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "testis: 53.5" "Group enriched" "Detected in some" 156 "Early spermatids: 1268.4;Late spermatids: 2231.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 9 "B-cells: 1.9" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;SuSa: 1.2;U-138 MG: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (9.56e-3)" "unprognostic (1.56e-1)" "unprognostic (2.16e-1)" "unprognostic (2.98e-1)" "unprognostic (5.27e-2)" "unprognostic (9.79e-2)" "unprognostic (7.38e-3)" "unprognostic (1.53e-2)" "unprognostic (7.32e-2)" "unprognostic (5.20e-2)" "unprognostic (1.87e-3)" "unprognostic (8.75e-4)" "unprognostic (5.58e-2)" "unprognostic (5.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.5 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.5 0.0 0.0 0.5 1.2 0.2 0.4 0.0 1.6 0.7 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1268.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2231.2 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 11.2 5.7 0.0 0.0 0.0 0.0 0.0 CCDC60 MGC39827 ENSG00000183273 "Coiled-coil domain containing 60" Q8IWA6 12 119334712-119541047 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;fallopian tube: 21.1;smooth muscle: 17.5;testis: 25.7" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 56.2;Early spermatids: 123.2;Late spermatids: 58.3;Urothelial cells: 34.1" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "pons and medulla: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HBEC3-KT: 1.7;HeLa: 1.2;RT4: 1.8;SuSa: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-1)" "unprognostic (2.05e-2)" "unprognostic (7.73e-3)" "unprognostic (2.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-3)" "unprognostic (1.00e-1)" "unprognostic (2.70e-1)" "unprognostic (1.70e-1)" "unprognostic (2.93e-2)" "unprognostic (3.56e-3)" "unprognostic (3.92e-1)" "unprognostic (4.29e-2)" "unprognostic (4.11e-1)" "unprognostic (2.54e-1)" 0.1 0.0 1.8 0.6 3.3 0.0 0.0 0.0 0.1 6.9 2.1 5.2 3.6 0.2 1.4 4.9 2.8 21.1 0.2 0.1 2.4 2.6 0.1 0.1 3.2 0.1 0.1 0.0 5.3 0.1 0.0 0.1 0.6 22.0 5.4 5.7 8.9 3.5 2.1 0.2 0.2 0.2 17.5 0.4 0.1 0.4 25.7 0.3 0.0 0.1 0.4 2.6 10.8 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 5.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.3 0.0 0.1 2.4 2.6 0.1 0.0 22.0 0.3 0.0 0.0 0.0 21.4 0.7 0.2 0.3 0.0 56.2 3.4 0.0 13.7 0.0 0.0 0.0 123.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 0.9 0.0 0.0 0.0 7.2 0.2 0.1 0.0 0.4 0.0 0.9 0.0 0.0 9.9 1.9 0.0 0.0 0.0 0.5 34.1 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774327-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 44.3" "Group enriched" "Detected in some" 7 "Early spermatids: 148.4;Late spermatids: 50.4;Spermatocytes: 78.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 7.7" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: AB_2683805" "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.2 0.3 0.1 0.3 0.1 0.1 0.3 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.2 0.1 0.1 0.2 0.3 0.0 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 1.1 2.4 0.6 0.8 1.9 0.4 0.4 0.5 0.3 1.0 0.1 0.7 0.9 0.2 0.3 0.8 0.3 0.3 0.7 1.6 0.2 0.0 0.4 0.3 0.5 0.2 0.4 0.7 0.7 2.6 0.3 0.2 0.0 1.7 2.1 0.3 1.0 1.1 0.4 0.2 0.1 1.8 0.9 0.8 1.1 0.3 0.2 3.4 0.4 0.1 1.9 2.0 0.8 0.3 0.6 0.3 1.5 0.0 0.3 0.9 1.2 0.6 0.1 1.7 0.4 0.9 7.7 0.4 0.4 1.0 0.7 0.7 0.0 0.7 0.5 1.5 0.6 0.4 0.5 0.3 0.9 0.3 0.3 0.4 0.2 1.0 0.8 0.7 2.4 0.8 0.3 1.1 1.9 0.4 0.3 0.3 0.3 0.7 0.7 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.5 1.2 0.8 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 148.4 0.2 0.0 0.0 0.2 0.4 0.3 0.5 0.0 0.0 0.1 1.6 0.0 0.0 0.3 50.4 2.8 0.0 1.7 0.0 0.0 0.8 0.1 0.0 2.5 0.0 1.1 12.9 0.0 78.8 3.0 0.6 0.0 0.0 0.1 0.1 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 26.2" "Group enriched" "Detected in some" 54 "Early spermatids: 233.1;Late spermatids: 164.1" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "MCF7: 9.9" "Region enriched" "Detected in single" 9 "cerebellum: 10.3" "Not detected" "Not detected" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: AB_2684561" "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 164.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.7 3.4 0.0 0.1 0.0 0.0 0.0 CCDC65 "CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28" ENSG00000139537 "Coiled-coil domain containing 65" Q8IXS2 12 48904110-48931840 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.5;testis: 53.2" "Group enriched" "Detected in many" 6 "Ciliated cells: 180.7;Early spermatids: 85.1;Spermatocytes: 50.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 13.7" "Group enriched" "Detected in many" 11 "gdT-cell: 8.9;MAIT T-cell: 9.5;memory CD4 T-cell: 7.6;memory CD8 T-cell: 7.1;naive CD4 T-cell: 4.7;naive CD8 T-cell: 6.3;T-reg: 4.1" "Lineage enriched" "Detected in single" 15 "T-cells: 9.5" "Cell line enhanced" "Detected in many" "HeLa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038520, HPA057573" Uncertain Approved "Vesicles,Centriolar satellite" NA NA Vesicles "Centriolar satellite" "HPA038520: AB_10672714, HPA057573: AB_2683473" "unprognostic (3.06e-2)" "unprognostic (1.17e-1)" "unprognostic (4.22e-2)" "unprognostic (4.20e-3)" "unprognostic (1.44e-2)" "unprognostic (3.43e-2)" "unprognostic (2.86e-2)" "unprognostic (5.79e-3)" "unprognostic (3.23e-1)" "unprognostic (9.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.03e-4)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "unprognostic (7.80e-2)" "unprognostic (1.34e-2)" "unprognostic (6.16e-2)" 0.3 0.4 2.2 0.6 5.1 1.1 0.5 0.6 2.2 1.6 0.3 4.5 0.5 0.4 1.3 5.1 0.3 22.5 1.1 0.3 2.9 3.2 2.0 0.2 5.0 0.8 0.6 2.0 2.7 0.7 1.1 3.9 0.2 13.7 0.3 0.1 2.1 0.4 0.5 0.3 1.3 0.5 0.2 0.7 1.0 0.3 53.2 1.0 0.0 2.2 0.0 0.3 0.3 0.2 0.3 0.0 0.1 0.0 0.6 9.5 2.2 1.2 4.8 2.2 4.2 0.1 0.0 2.2 1.1 0.1 0.6 2.1 5.8 2.9 1.6 1.7 0.0 0.7 1.4 0.0 0.1 0.9 2.7 2.3 2.6 7.3 2.1 0.3 2.1 2.4 0.0 0.1 1.2 0.0 3.5 0.0 1.4 1.1 0.6 0.1 2.8 0.7 2.8 4.7 1.7 1.2 1.5 1.0 1.8 3.5 3.1 1.2 2.0 1.3 1.7 1.6 3.5 4.5 1.8 2.0 1.6 1.7 1.8 0.9 2.2 2.2 1.5 1.7 1.8 0.4 0.0 0.0 0.0 8.9 0.0 9.5 0.3 7.6 7.1 0.0 0.3 4.7 6.3 0.1 0.6 0.0 0.0 4.1 2.2 2.2 5.1 0.6 2.2 2.9 3.2 0.6 2.0 13.7 1.0 0.0 0.6 0.0 0.1 0.8 1.2 0.4 0.0 180.7 17.0 0.0 11.8 0.1 6.6 0.6 85.1 0.1 0.0 0.0 0.5 0.1 0.3 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 10.8 1.4 0.0 1.7 0.0 0.0 1.9 0.4 0.0 2.1 2.4 10.7 0.0 0.4 50.9 4.7 0.1 0.1 7.5 0.0 0.1 CCDC68 SE57-1 ENSG00000166510 "Coiled-coil domain containing 68" Q9H2F9 18 54901509-54959508 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 73.4;Enterocytes: 61.4;Pancreatic endocrine cells: 55.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.1;HHSteC: 10.8;HSkMC: 11.9;RT4: 8.0;TIME: 21.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040865, HPA048197" Supported Approved "Golgi apparatus,Cytosol" No NA "Golgi apparatus" Cytosol "HPA040865: AB_2677176, HPA048197: AB_2680310" "unprognostic (1.36e-2)" "prognostic unfavorable (4.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.38e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (2.65e-2)" "unprognostic (6.29e-2)" "unprognostic (2.71e-1)" "unprognostic (1.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.28e-4)" "unprognostic (1.77e-2)" "unprognostic (9.71e-2)" "unprognostic (6.12e-2)" "unprognostic (2.38e-1)" 5.6 3.0 1.2 7.7 2.4 0.3 5.8 0.6 4.7 5.5 20.7 0.8 3.1 14.8 4.5 2.5 2.1 2.6 9.1 5.7 1.7 1.7 5.6 9.9 15.2 2.3 2.0 4.7 15.4 2.8 0.5 15.7 23.9 4.4 5.2 13.9 9.3 2.2 13.0 7.7 1.0 40.1 2.1 1.6 5.8 10.5 7.4 0.1 0.0 3.5 2.1 1.0 3.0 4.2 0.8 0.6 1.1 2.2 0.5 1.0 0.5 8.1 2.5 0.0 0.0 2.4 6.7 0.0 0.2 3.2 0.5 0.5 4.4 4.8 0.0 6.0 0.0 0.0 0.1 0.6 5.2 0.4 0.0 1.2 0.6 2.9 0.9 10.8 0.0 0.0 11.9 0.0 2.5 0.1 0.0 3.8 0.0 0.0 0.1 0.3 0.6 0.0 0.1 0.0 5.8 2.8 0.2 0.0 0.2 0.9 8.0 0.0 1.9 2.5 0.8 0.1 1.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 1.1 0.7 0.7 0.4 0.8 0.6 0.6 0.6 0.5 0.4 0.8 0.9 1.0 0.7 0.5 2.2 0.6 0.5 0.5 1.2 2.4 0.6 4.7 1.7 1.7 2.0 4.7 4.4 0.1 17.9 9.3 0.5 9.7 0.2 0.0 3.2 5.1 4.0 14.8 1.8 0.0 1.7 1.7 4.7 73.4 26.3 61.4 0.0 31.6 2.2 5.8 20.5 8.1 5.7 0.3 0.0 5.8 29.4 2.7 24.0 3.1 0.2 0.0 1.8 16.2 3.4 55.0 38.6 0.7 4.3 0.0 6.5 0.7 1.2 1.5 0.0 5.0 0.0 17.1 3.6 CCDC69 "DKFZP434C171, FLJ13705" ENSG00000198624 "Coiled-coil domain containing 69" A6NI79 5 151181052-151224145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 99.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 65.4;Cardiomyocytes: 112.2;Ciliated cells: 64.3;Kupffer cells: 76.6;T-cells: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.9;Daudi: 53.9;U-266/70: 34.5;U-698: 34.8" "Low region specificity" "Detected in many" "HPA043648, HPA052896" Uncertain Approved "Golgi apparatus,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Golgi apparatus, Actin filaments" "HPA043648: AB_10795877, HPA052896: AB_2681983" "prognostic favorable (3.21e-4)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (5.62e-2)" "unprognostic (8.63e-3)" "unprognostic (3.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.00e-1)" "unprognostic (9.29e-2)" "unprognostic (3.85e-2)" "unprognostic (1.55e-2)" "unprognostic (3.67e-1)" "unprognostic (4.31e-2)" "unprognostic (3.69e-1)" "unprognostic (2.93e-1)" "unprognostic (2.01e-1)" 31.6 33.7 2.1 33.4 3.2 10.9 99.8 1.7 4.7 7.3 43.4 2.5 6.6 5.7 12.2 7.3 28.1 12.7 14.0 57.6 2.2 2.5 3.8 12.6 23.7 23.2 4.3 0.9 11.4 15.3 5.3 6.1 21.4 8.4 17.2 5.8 9.0 5.5 8.7 87.1 4.5 14.9 53.0 5.1 21.7 15.6 6.7 2.2 13.3 5.1 18.8 17.7 37.2 58.4 11.4 20.4 18.0 10.7 11.9 11.7 8.3 2.1 0.2 0.1 1.8 34.9 3.7 1.2 0.4 3.4 0.6 0.5 0.4 0.2 53.9 1.9 0.1 0.9 0.1 0.8 0.6 0.2 0.0 0.7 6.8 0.0 3.3 5.7 2.5 9.9 8.9 0.0 0.2 0.0 0.6 3.4 0.2 6.5 12.1 0.0 0.0 11.5 6.3 2.0 0.0 4.4 9.8 0.2 3.3 0.1 1.5 0.0 0.2 0.6 0.9 0.4 0.9 0.5 6.3 8.4 0.2 1.7 0.1 0.4 34.5 16.1 34.8 0.4 6.1 0.0 18.0 10.7 12.3 11.7 8.6 10.2 5.9 9.1 11.0 9.3 11.4 7.3 6.7 9.2 11.9 8.2 20.4 6.6 8.3 2.1 3.2 1.7 4.7 2.2 2.5 4.3 0.9 8.4 2.2 11.9 65.4 52.4 2.4 2.3 0.6 112.2 2.5 64.3 13.6 1.8 0.0 6.2 0.0 2.4 0.4 52.5 0.0 0.0 17.5 5.9 5.8 3.7 33.5 30.4 6.9 6.4 1.7 19.0 76.6 1.3 5.2 14.3 10.1 13.6 0.0 2.5 9.5 0.0 7.4 2.4 1.2 12.9 12.8 0.2 0.5 1.1 29.6 67.1 0.2 18.4 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Group enriched" "Detected in many" 8 "Early spermatids: 397.3;Late spermatids: 669.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Yes No Nucleoli "Mitotic spindle, Cytosol" "HPA075536: AB_2686755" "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.6 2.9 0.8 3.6 2.5 1.9 1.3 2.3 0.9 0.8 2.5 0.6 3.8 1.9 1.2 1.6 2.3 1.3 1.4 1.4 3.2 6.8 0.3 1.1 2.0 0.7 4.3 1.1 1.9 1.8 0.7 1.7 0.7 1.6 1.0 3.0 1.5 6.7 3.3 0.4 0.8 0.6 0.7 1.4 2.8 1.6 3.7 0.3 2.4 0.6 1.9 1.9 0.4 0.5 1.6 1.1 1.9 1.5 3.9 2.0 2.4 2.6 1.3 2.1 1.4 2.0 2.6 7.5 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 6.0 7.5 0.8 1.0 1.6 8.6 6.7 0.0 1.4 4.5 1.8 3.9 0.6 1.7 3.1 397.3 2.3 1.4 0.0 3.0 1.0 1.2 0.8 11.6 0.0 1.6 0.0 2.9 0.0 0.0 669.2 8.9 2.3 1.7 1.0 2.0 2.7 2.3 0.0 6.7 0.6 25.0 12.9 1.0 70.9 6.1 1.0 0.1 1.5 1.7 0.6 CCDC70 "DKFZP434K1172, FLJ25853" ENSG00000123171 "Coiled-coil domain containing 70" Q6NSX1 13 51861981-51866232 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 470 "testis: 46.9" "Group enriched" "Detected in some" 107 "Early spermatids: 883.6;Late spermatids: 1905.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "TIME: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA079644 Enhanced "Secreted in male reproductive system" NA NA "HPA079644: " "unprognostic (5.73e-3)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 883.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1905.5 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 13.0 4.7 0.0 0.0 0.0 0.0 0.0 CCDC71L "C7orf74, FLJ36031" ENSG00000253276 "Coiled-coil domain containing 71 like" Q8N9Z2 7 106656765-106660996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.9" "Cell type enhanced" "Detected in many" 5 "Smooth muscle cells: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067925 Approved Approved "Golgi apparatus,Actin filaments,Cytosol" NA NA "Golgi apparatus, Actin filaments" Cytosol "HPA067925: AB_2685925" "unprognostic (1.51e-1)" "prognostic unfavorable (9.08e-4)" "unprognostic (7.26e-2)" "unprognostic (1.10e-2)" "unprognostic (1.78e-2)" "unprognostic (1.95e-3)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (2.38e-3)" "unprognostic (6.03e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.53e-6)" "unprognostic (3.34e-2)" "unprognostic (3.72e-1)" "unprognostic (2.26e-1)" "unprognostic (6.35e-2)" 19.5 5.2 2.4 13.2 2.2 8.8 10.6 0.6 3.8 7.8 8.4 2.5 5.8 4.3 10.3 6.5 6.3 19.7 9.2 6.3 3.5 2.3 9.0 42.9 11.2 10.8 1.8 2.7 13.4 6.3 3.2 3.7 4.0 2.3 9.3 4.0 8.1 16.5 4.9 6.7 3.2 8.3 7.0 2.4 17.0 9.0 12.7 2.2 35.3 9.1 2.9 6.8 12.5 10.8 2.3 2.4 7.3 1.2 1.6 2.9 0.8 10.4 2.2 3.2 3.8 7.3 7.0 0.0 16.2 20.7 6.3 6.8 0.3 6.6 7.1 5.6 27.1 12.0 1.1 1.5 4.6 5.2 16.5 3.8 0.8 0.4 0.0 11.5 3.5 8.5 5.9 2.8 2.8 1.6 13.2 21.7 4.0 23.5 17.4 7.4 3.0 4.7 5.5 7.0 0.8 7.7 6.5 0.9 1.4 3.2 0.6 1.4 9.7 10.3 3.7 22.4 7.1 1.7 4.3 9.6 14.0 1.3 1.6 6.2 17.0 1.5 5.7 10.8 4.6 15.3 7.2 1.0 3.0 2.0 0.8 1.5 2.3 1.6 1.5 0.7 1.7 0.8 1.2 7.3 1.6 1.2 2.4 2.9 0.8 2.4 2.2 0.6 3.8 3.5 2.3 1.8 2.7 2.3 2.2 3.0 12.3 4.9 31.2 7.2 4.0 5.3 5.1 8.1 0.0 5.2 2.0 2.4 10.0 6.8 0.9 15.0 9.7 0.0 9.3 5.7 23.0 9.8 11.5 26.7 7.5 6.4 6.3 32.5 11.1 1.6 20.1 12.8 11.8 6.4 6.2 4.5 10.3 11.5 16.6 3.9 4.8 0.0 44.3 5.6 3.6 4.4 2.7 7.9 9.0 13.3 CCDC73 NY-SAR-79 ENSG00000186714 "Coiled-coil domain containing 73" Q6ZRK6 11 32602246-32794658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 13.7" "Group enriched" "Detected in some" 8 "Spermatocytes: 70.1;Spermatogonia: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 2.8;MOLT-4: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA038668, HPA038669" Uncertain NA NA "HPA038668: AB_10673292, HPA038669: AB_2676142" "unprognostic (9.41e-3)" "unprognostic (2.46e-2)" "unprognostic (2.36e-1)" "unprognostic (8.65e-2)" "unprognostic (5.79e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.73e-4)" "unprognostic (1.74e-1)" "unprognostic (2.02e-2)" "unprognostic (2.10e-2)" "unprognostic (3.27e-2)" "unprognostic (1.62e-5)" "unprognostic (3.87e-1)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "unprognostic (1.20e-3)" 0.2 0.6 0.2 0.2 0.2 0.7 0.2 0.8 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.4 1.0 0.2 0.4 0.2 0.2 1.7 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.1 0.0 13.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 0.5 1.3 0.0 0.0 0.2 0.2 0.0 0.5 0.5 0.0 0.0 0.4 2.8 0.0 0.0 0.1 0.1 0.4 0.5 0.1 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.0 0.3 0.9 0.1 0.0 0.9 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.4 0.0 0.3 5.9 1.2 0.4 0.2 0.5 0.2 0.4 0.2 0.0 0.7 0.3 0.4 0.2 0.3 0.0 0.3 0.2 0.2 0.0 0.4 0.3 0.4 1.3 1.6 0.4 0.4 0.2 0.8 0.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.2 0.2 0.2 0.8 0.4 0.2 0.5 0.2 0.2 0.2 0.2 3.0 1.1 0.0 0.3 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 1.7 0.0 2.5 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.9 0.2 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.8 0.6 6.5 0.0 70.1 32.4 0.0 0.1 0.0 0.0 0.4 CCDC74A FLJ40345 ENSG00000163040 "Coiled-coil domain containing 74A" Q96AQ1 2 131527675-131533666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.1;testis: 41.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 107.1;Early spermatids: 339.1;Late spermatids: 203.8;Spermatocytes: 157.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 3.3" "Lineage enhanced" "Detected in single" "dendritic cells: 3.3" "Cell line enhanced" "Detected in many" "NTERA-2: 19.3;SCLC-21H: 15.9" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (5.11e-4)" "unprognostic (2.89e-3)" "unprognostic (6.49e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.91e-1)" "unprognostic (1.36e-2)" "unprognostic (2.18e-3)" "unprognostic (1.71e-1)" "unprognostic (2.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.70e-7)" "unprognostic (7.28e-3)" "prognostic favorable (4.92e-4)" "unprognostic (5.96e-2)" "unprognostic (3.53e-2)" 1.3 12.8 5.8 2.7 6.5 0.2 6.8 1.1 4.4 5.6 1.9 3.2 4.7 0.9 7.1 7.1 1.9 26.1 5.1 2.2 5.1 6.8 3.0 0.5 3.0 0.9 2.2 4.1 7.1 1.5 13.3 14.1 0.9 13.6 5.2 1.3 2.4 1.8 5.1 0.9 3.5 0.8 5.9 3.0 1.0 1.0 41.2 1.9 2.2 2.6 0.9 1.2 4.5 2.7 0.0 3.3 0.0 0.1 0.0 0.8 0.2 0.0 3.9 4.0 0.2 5.8 14.1 0.3 3.4 5.6 3.1 2.3 0.1 6.0 1.5 2.1 5.2 5.3 3.0 1.7 1.0 1.3 3.9 7.5 0.0 3.8 0.1 0.7 0.1 0.3 4.6 0.4 3.1 0.0 6.2 1.2 8.5 2.2 4.4 2.8 2.4 8.5 2.3 19.3 1.5 2.6 4.1 0.0 1.8 7.9 0.0 15.9 11.5 0.4 0.6 0.6 1.6 5.5 0.8 1.3 0.9 3.0 12.2 2.5 0.9 0.7 0.5 13.1 0.4 5.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 3.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 5.8 6.5 1.1 4.4 5.1 6.8 2.2 4.1 13.6 1.9 0.0 0.3 0.0 8.2 4.5 0.4 0.4 2.5 107.1 11.4 7.0 0.0 0.3 6.6 6.5 339.1 0.5 0.0 0.0 0.6 0.3 12.3 7.9 0.0 0.0 0.3 0.0 7.5 1.8 0.0 203.8 34.2 1.8 1.7 0.0 0.3 7.7 2.1 0.0 64.3 2.4 0.9 0.0 3.1 157.3 16.4 5.3 0.2 0.0 1.5 4.8 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.4;testis: 22.7" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 66.9;Early spermatids: 268.8;Late spermatids: 93.0;Spermatocytes: 141.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6;SH-SY5Y: 15.1" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 0.0 1.4 2.8 0.1 2.4 0.0 0.4 0.0 2.2 8.3 0.1 0.0 3.5 0.6 0.1 12.4 1.1 0.1 3.0 4.0 1.0 0.0 1.0 0.1 0.9 2.1 0.2 7.5 7.7 0.0 2.7 0.0 0.2 2.5 0.0 0.1 0.0 1.0 1.4 0.0 0.0 22.7 3.7 0.0 0.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.9 2.9 0.1 2.7 5.8 0.6 2.2 1.2 0.3 0.5 0.8 0.7 0.1 3.6 2.0 3.4 1.0 0.2 0.3 0.4 2.0 5.5 0.0 6.9 0.1 0.3 0.1 0.2 1.2 0.0 0.9 0.0 3.6 0.2 1.4 0.1 1.7 0.8 2.0 0.0 0.0 5.9 0.5 6.0 4.5 0.0 3.2 1.7 0.0 10.6 15.1 1.6 0.1 0.3 0.7 6.0 0.7 0.4 1.1 5.0 6.1 0.5 0.1 0.2 0.0 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.0 0.3 0.0 2.0 0.5 0.4 0.4 2.5 66.9 3.4 5.2 0.0 0.1 3.3 1.1 268.8 0.1 0.0 0.0 0.2 0.7 2.4 3.9 0.0 0.0 0.3 3.2 10.9 0.0 0.0 93.0 9.5 0.2 0.0 0.0 0.0 3.5 0.0 0.0 11.7 0.3 0.0 0.0 2.1 141.1 14.6 1.0 0.1 0.0 0.0 0.3 CCDC78 "C16orf25, FLJ34512" ENSG00000162004 "Coiled-coil domain containing 78" A2IDD5 16 722582-726954 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 57.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.8;RPMI-8226: 10.3;SCLC-21H: 12.4;U-266/70: 10.2" NA NA "unprognostic (1.10e-1)" "unprognostic (6.48e-2)" "unprognostic (2.62e-4)" "unprognostic (1.02e-2)" "unprognostic (1.24e-1)" "unprognostic (2.58e-2)" "unprognostic (3.47e-2)" "unprognostic (2.06e-2)" "unprognostic (9.39e-2)" "unprognostic (1.48e-1)" "unprognostic (7.82e-3)" "unprognostic (6.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.45e-3)" "unprognostic (5.20e-1)" "unprognostic (1.44e-1)" "unprognostic (7.22e-3)" 0.3 1.1 3.6 1.1 11.3 1.2 0.5 2.0 1.2 2.5 0.4 6.4 1.3 0.3 1.1 21.3 0.3 47.9 0.6 0.4 4.3 4.7 0.4 0.4 13.3 1.1 1.9 0.1 5.7 0.3 0.7 2.3 0.6 20.1 0.6 0.5 0.3 0.7 1.0 0.4 0.4 0.6 0.4 2.6 0.9 0.9 1.1 1.7 0.2 0.5 0.1 1.6 1.0 0.1 0.4 1.2 1.3 0.0 1.2 3.2 0.1 0.5 1.0 1.2 2.9 1.3 1.2 1.4 1.1 2.5 0.6 0.4 0.4 4.8 1.0 1.1 0.6 0.8 0.8 2.7 1.5 0.1 8.8 0.0 2.4 1.4 0.0 1.5 0.8 1.6 3.8 0.9 0.4 4.4 3.1 0.4 2.9 0.3 3.3 0.9 6.1 0.0 2.1 1.8 2.2 0.3 2.1 0.9 10.3 4.2 1.8 12.4 1.2 1.1 7.3 0.6 0.6 4.7 1.6 1.0 1.0 0.4 0.0 0.1 10.2 0.2 2.7 1.0 1.2 2.8 0.0 0.0 1.3 0.2 0.0 3.2 0.4 0.1 1.9 0.0 0.1 0.0 0.0 0.0 1.2 0.0 1.2 0.1 0.1 3.6 11.3 2.0 1.2 4.3 4.7 1.9 0.1 20.1 1.7 0.0 0.0 0.5 0.1 0.0 3.2 0.4 0.0 57.6 5.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.4 0.0 0.0 0.8 3.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.1 0.0 1.3 0.0 0.0 CCDC8 "3M3, DKFZp564K0322, PPP1R20" ENSG00000169515 "Coiled-coil domain containing 8" Q9H0W5 19 46410372-46413584 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 25.5;Distal tubular cells: 33.2;Leydig cells: 65.6;Peritubular cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "neutrophil: 3.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.6" "Cell line enhanced" "Detected in many" "AF22: 12.0;AN3-CA: 14.3;HSkMC: 13.1;K-562: 12.5;RH-30: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041993 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041993: AB_10795388" "unprognostic (3.05e-3)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.39e-3)" "unprognostic (3.69e-1)" "unprognostic (6.64e-2)" "unprognostic (5.16e-2)" "unprognostic (7.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (5.72e-2)" "prognostic favorable (1.72e-5)" "unprognostic (5.43e-3)" "unprognostic (5.77e-2)" "unprognostic (4.09e-2)" "unprognostic (4.18e-3)" 2.7 13.3 3.0 2.1 3.8 0.6 7.6 0.9 2.3 18.9 2.4 5.1 6.2 0.8 15.5 17.3 2.9 19.0 9.7 18.9 3.1 2.3 7.9 0.7 7.1 0.9 2.4 2.9 39.4 19.2 8.5 9.9 5.6 4.6 12.1 1.1 10.0 8.7 7.5 3.0 2.2 1.6 6.7 2.0 1.8 1.7 9.0 2.6 4.2 11.8 2.6 1.4 4.8 5.8 0.4 0.3 3.6 0.4 0.2 0.2 0.1 1.2 0.1 12.0 14.3 3.2 4.0 5.8 6.1 0.0 1.4 0.6 0.0 0.1 0.1 8.2 4.8 0.2 0.1 0.1 9.5 0.6 0.0 6.0 0.0 0.1 0.6 10.7 0.0 0.1 13.1 0.0 3.4 10.0 0.2 0.0 0.1 12.5 0.0 4.4 0.0 0.0 0.8 8.7 0.0 0.0 0.4 16.2 0.0 10.5 0.0 1.9 0.1 0.0 0.0 0.0 9.7 0.1 2.9 1.1 0.8 3.2 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.4 0.2 0.2 3.6 0.2 0.3 0.3 0.1 0.1 3.0 3.8 0.9 2.3 3.1 2.3 2.4 2.9 4.6 2.6 0.0 0.6 0.0 5.7 0.8 0.0 25.5 10.2 2.7 6.8 10.4 0.0 5.8 33.2 11.1 0.3 0.4 0.0 0.0 0.9 7.8 9.9 0.5 1.1 0.0 1.5 0.0 0.0 1.3 0.0 1.3 65.6 0.9 1.7 0.0 0.0 13.3 5.9 0.0 54.5 0.8 0.4 12.9 7.2 0.3 4.5 0.1 1.7 0.0 0.0 0.5 CCDC80 "DRO1, SSG1, URB" ENSG00000091986 "Coiled-coil domain containing 80" Q76M96 3 112596794-112649530 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 130.0;endometrium 1: 143.8" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 452.4;Fibroblasts: 524.3;Late spermatids: 232.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 48.6;fHDF/TERT166: 113.6;hTERT-RPE1: 221.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002266 Approved "Secreted to extracellular matrix" NA NA 57000 "HPA002266: AB_1078423" "unprognostic (1.26e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-2)" "unprognostic (3.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.53e-2)" "unprognostic (2.30e-3)" "unprognostic (1.99e-3)" "unprognostic (8.40e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.86e-5)" "unprognostic (5.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.26e-4)" 49.5 3.3 1.4 16.4 3.1 0.0 39.4 3.1 3.3 130.0 14.9 3.4 54.7 1.1 143.8 94.7 34.2 17.4 39.7 87.6 2.3 2.8 10.7 2.1 17.0 10.1 3.0 1.0 53.3 6.6 2.5 2.7 6.0 7.2 28.6 12.7 8.7 8.7 21.7 4.1 19.2 8.6 81.3 14.0 19.8 12.0 14.0 3.3 4.1 20.4 29.6 10.8 57.3 33.8 2.9 3.0 2.9 1.3 1.3 2.1 0.2 2.2 0.9 11.6 0.5 48.6 38.7 0.6 32.1 9.7 10.8 15.8 0.2 0.1 0.1 1.2 113.6 1.0 3.0 0.4 0.4 11.4 2.1 0.1 0.0 2.6 0.0 10.2 0.0 0.0 38.2 1.3 15.9 1.0 221.6 2.5 0.0 0.0 0.1 31.8 0.0 0.0 0.0 2.8 0.0 0.3 0.0 1.2 0.0 0.3 0.0 0.0 0.2 4.7 0.2 0.1 2.2 0.1 0.0 12.6 31.8 5.2 6.0 13.9 0.1 0.0 0.1 9.4 0.0 5.1 2.9 1.3 0.9 1.6 0.8 1.6 1.7 1.6 1.3 0.5 2.9 2.1 1.9 1.7 1.3 0.8 3.0 1.1 0.2 1.4 3.1 3.1 1.7 2.3 2.8 3.0 1.0 7.2 3.3 6.0 12.8 0.0 3.8 54.1 0.6 19.6 0.0 33.5 9.1 5.2 0.0 40.0 1.7 22.1 452.4 12.8 0.0 0.0 1.1 85.3 524.3 1.2 1.1 0.5 8.3 0.0 0.0 56.4 2.7 232.6 71.4 5.8 136.7 3.6 0.4 119.7 10.8 0.0 32.5 0.0 1.7 19.4 127.8 6.0 3.2 45.2 23.3 0.0 0.0 1.7 CCDC81 "FLJ16339, FLJ23514" ENSG00000149201 "Coiled-coil domain containing 81" Q6ZN84 11 86374736-86423109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.2;fallopian tube: 28.9" "Cell type enhanced" "Detected in some" 20 "Ciliated cells: 56.2;Early spermatids: 14.1;Extravillous trophoblasts: 30.4;Sertoli cells: 12.9" "Cancer enhanced" "Detected in single" "testis cancer: 1.5" "Region enriched" "Detected in many" 8 "pons and medulla: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.5;BJ hTERT+: 4.1;HBF TERT88: 4.3;SuSa: 4.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.02e-1)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (2.30e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (7.00e-3)" "unprognostic (8.54e-3)" "unprognostic (1.46e-3)" "unprognostic (2.82e-1)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.14e-4)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (2.27e-1)" "unprognostic (6.62e-2)" 0.5 0.3 0.9 0.3 1.6 0.3 0.3 0.4 0.7 1.6 0.3 7.4 0.8 0.0 2.0 4.5 0.3 28.9 0.5 0.3 1.5 1.8 0.2 0.1 1.5 1.1 0.5 0.6 4.3 0.1 0.3 5.5 3.1 15.2 0.6 0.3 0.8 0.1 0.9 0.7 0.2 0.2 1.1 0.7 0.3 0.2 5.6 1.7 0.0 0.5 0.4 0.4 0.6 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.3 2.4 0.0 0.8 0.3 0.9 7.5 4.1 1.2 0.9 0.8 0.7 0.4 3.0 1.1 0.3 0.5 1.2 0.2 4.3 0.5 0.4 0.8 0.2 0.7 0.4 0.4 0.5 0.2 1.4 2.2 0.6 1.2 1.4 0.6 0.4 0.1 1.0 1.2 1.0 2.2 0.2 1.0 0.0 0.4 0.2 0.7 0.6 0.0 0.4 0.4 0.3 0.6 0.0 4.7 0.4 0.9 0.4 1.9 1.0 1.7 0.2 0.1 0.6 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.6 0.4 0.7 1.5 1.8 0.5 0.6 15.2 1.7 3.0 0.3 0.0 0.2 0.2 0.8 0.9 0.0 56.2 9.1 0.0 0.0 0.9 0.0 0.1 14.1 0.2 0.0 0.0 0.0 30.4 0.3 0.3 0.0 0.0 2.1 0.0 0.0 3.1 0.0 2.1 1.4 0.3 0.0 1.0 0.0 0.3 0.0 0.0 0.7 0.0 0.7 12.9 0.4 0.4 0.2 0.5 2.3 0.0 0.0 0.1 CCDC83 "CT148, FLJ42119, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 27.7" "Group enriched" "Detected in some" 11 "Early spermatids: 142.1;Late spermatids: 149.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "MCF7: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.8 0.8 0.3 0.6 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.7 0.3 0.3 0.2 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.3 7.9 0.1 0.4 0.0 1.3 0.0 0.1 0.0 0.1 0.6 0.3 0.1 0.1 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.8 0.6 0.3 0.6 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.3 0.5 1.8 0.3 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 142.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 13.1 1.3 0.0 0.0 0.0 0.0 0.0 CCDC85A KIAA1912 ENSG00000055813 "Coiled-coil domain containing 85A" Q96PX6 2 56184123-56386173 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.8" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 23.8;Fibroblasts: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 2.3" "Lineage enriched" "Detected in single" 23 "B-cells: 2.3" "Cell line enhanced" "Detected in some" "Daudi: 22.8;fHDF/TERT166: 37.2;U-266/70: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043106, HPA057020" Uncertain "Intracellular and membrane" NA NA "HPA043106: AB_10794770, HPA057020: AB_2683311" "unprognostic (2.29e-1)" "unprognostic (1.28e-1)" "unprognostic (6.87e-2)" "unprognostic (3.66e-2)" "unprognostic (7.87e-2)" "unprognostic (7.62e-2)" "unprognostic (3.07e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-1)" "unprognostic (6.55e-5)" "unprognostic (3.28e-2)" "unprognostic (1.00e-1)" "unprognostic (2.88e-2)" "unprognostic (1.83e-2)" 16.0 1.4 10.5 1.3 7.5 0.4 7.8 3.4 18.8 4.2 1.6 4.9 3.0 0.9 9.3 1.6 1.4 3.5 2.1 6.5 7.9 8.5 1.9 0.7 8.1 1.1 6.6 10.2 1.2 1.4 3.0 1.0 14.4 8.8 3.4 1.4 1.0 1.9 4.5 7.2 2.7 1.3 7.3 10.6 1.4 1.3 1.0 5.2 0.0 13.5 2.2 1.3 1.8 3.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.3 0.4 0.0 5.7 0.5 5.0 0.5 0.0 0.0 22.8 0.8 37.2 0.0 1.0 0.0 0.0 2.9 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 1.7 0.1 0.0 0.6 2.8 4.9 0.0 0.0 3.1 0.6 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.1 0.0 0.0 1.1 2.7 0.0 7.5 4.0 1.1 0.0 0.4 16.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 7.5 3.4 18.8 7.9 8.5 6.6 10.2 8.8 5.2 23.8 1.1 0.0 0.5 3.0 4.4 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 5.1 0.0 0.0 0.3 0.0 7.1 0.3 0.0 0.0 1.7 0.0 1.2 5.5 0.0 5.9 0.3 0.3 5.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 1.4 0.0 2.2 0.0 0.4 1.1 0.1 0.0 0.0 0.1 CCDC85B DIPA ENSG00000175602 "Coiled-coil domain containing 85B" Q15834 11 65890112-65891635 "Predicted intracellular proteins" "Differentiation, Growth regulation, Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 24.5" "Cell type enhanced" "Detected in many" 5 "Ito cells: 384.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 35.4;WM-115: 81.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054415 Uncertain NA NA "HPA054415: AB_2682481" "unprognostic (4.58e-2)" "unprognostic (1.64e-2)" "unprognostic (9.74e-2)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (8.01e-2)" "unprognostic (3.99e-2)" "unprognostic (2.43e-2)" "unprognostic (3.02e-2)" "unprognostic (1.31e-1)" "unprognostic (9.87e-2)" "unprognostic (5.33e-2)" "prognostic unfavorable (3.78e-5)" "unprognostic (4.44e-1)" "unprognostic (1.69e-1)" "unprognostic (1.60e-1)" "unprognostic (9.87e-2)" 16.6 6.4 17.5 4.8 13.2 6.5 2.5 5.0 16.3 1.9 3.6 4.1 3.5 0.8 1.4 3.0 2.0 6.6 18.9 5.9 2.9 3.3 6.0 2.5 9.5 3.8 3.8 1.8 1.5 3.2 4.9 0.5 3.7 3.0 24.5 3.7 3.5 1.3 2.9 12.9 5.5 2.4 1.8 1.0 2.5 2.2 10.6 8.6 9.6 5.2 8.3 13.6 2.5 20.6 3.2 0.7 2.8 0.9 1.7 2.6 22.3 2.3 0.8 0.9 0.8 9.1 11.4 16.6 1.1 11.3 8.4 0.3 1.2 0.0 12.5 5.8 8.5 1.7 2.6 1.4 7.4 4.3 1.5 0.5 0.7 1.1 3.9 2.7 1.7 6.5 4.2 0.5 6.5 5.0 23.9 8.4 0.5 35.4 13.4 5.3 10.1 0.4 0.6 5.8 6.3 4.7 2.9 18.3 0.2 2.2 2.5 19.4 11.1 11.2 24.2 20.3 4.6 4.8 2.7 23.2 6.4 81.6 0.9 4.7 9.6 8.7 3.3 11.7 10.6 10.4 12.0 4.3 8.7 13.6 11.1 1.2 8.3 5.2 8.6 7.7 2.5 0.0 3.4 118.7 131.9 244.8 167.9 22.0 30.6 2.7 4.5 34.9 141.4 17.0 28.2 26.9 5.1 272.3 18.5 0.0 60.2 45.1 96.3 67.9 86.2 36.2 89.3 95.3 55.3 384.9 146.4 10.0 78.2 114.3 148.5 101.8 30.1 64.2 39.2 11.5 94.7 25.8 85.0 161.7 178.3 3.9 18.1 185.4 15.9 164.8 37.3 80.0 CCDC86 MGC2574 ENSG00000110104 "Coiled-coil domain containing 86" Q9H6F5 11 60842071-60851081 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 200.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041117, HPA041540" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA041117: AB_10794984, HPA041540: AB_10794299" "unprognostic (2.93e-1)" "unprognostic (6.59e-2)" "unprognostic (2.38e-1)" "unprognostic (1.47e-3)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.36e-5)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.65e-3)" "unprognostic (9.52e-2)" "unprognostic (1.25e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-1)" "unprognostic (3.76e-2)" "unprognostic (7.54e-3)" "unprognostic (2.90e-1)" "unprognostic (2.16e-1)" "unprognostic (6.25e-2)" 13.5 12.4 7.3 8.6 11.0 6.1 11.2 3.3 11.2 5.8 6.7 7.9 3.4 7.4 8.4 5.0 9.3 7.4 8.3 9.3 6.7 6.4 8.1 11.4 5.4 8.2 10.0 6.0 11.3 13.6 200.8 12.7 7.3 8.5 11.9 4.7 6.7 6.4 6.2 20.2 10.4 6.2 7.3 6.7 9.3 7.7 47.8 8.7 10.2 7.9 12.6 6.5 8.6 6.5 6.9 20.0 5.0 19.5 4.2 8.5 6.7 21.0 28.7 7.1 20.5 5.8 9.6 9.7 14.2 11.1 26.1 14.0 24.4 14.2 25.8 27.2 7.7 18.6 19.8 24.0 17.1 12.0 9.1 26.6 13.1 12.7 34.0 19.2 20.5 22.5 10.9 13.0 24.1 15.3 3.8 19.3 14.2 41.9 13.3 12.7 24.9 30.8 31.3 28.7 12.5 41.3 21.0 10.7 64.9 9.1 9.0 16.1 10.4 9.1 21.1 16.6 4.7 21.3 8.2 12.6 26.0 16.0 35.3 30.7 11.2 16.5 27.9 21.3 22.2 31.4 2.6 9.1 5.0 6.5 19.5 6.9 6.9 6.9 6.0 20.0 6.5 8.5 7.4 0.7 4.2 6.3 11.2 6.2 6.7 7.3 11.0 3.3 11.2 6.7 6.4 10.0 6.0 8.5 8.7 0.0 2.1 3.0 15.4 32.7 9.3 0.4 2.5 0.0 4.5 1.8 7.9 15.9 6.6 20.4 19.7 6.8 2.6 0.0 10.4 14.1 9.5 18.2 4.7 2.4 16.0 3.2 6.9 3.7 2.8 10.6 10.6 7.9 15.1 4.6 4.9 3.6 13.7 3.5 5.6 5.4 7.9 19.4 20.2 37.1 19.1 27.0 6.9 6.1 9.7 15.5 CCDC87 FLJ10786 ENSG00000182791 "Coiled-coil domain containing 87" Q9NVE4 11 66590176-66593083 "Predicted intracellular proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 31.1" "Group enriched" "Detected in some" 5 "Early spermatids: 20.7;Spermatocytes: 12.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.2" "Lineage enhanced" "Detected in single" "dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "A549: 3.7;SCLC-21H: 6.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.48e-2)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (6.37e-2)" "unprognostic (2.25e-3)" "unprognostic (2.71e-2)" "unprognostic (8.59e-3)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (5.17e-2)" "unprognostic (2.16e-3)" "unprognostic (2.56e-2)" "unprognostic (3.97e-3)" "unprognostic (8.25e-2)" "unprognostic (2.29e-1)" "unprognostic (3.39e-2)" "unprognostic (2.42e-1)" 0.3 0.6 1.9 0.4 2.2 0.1 0.5 1.1 2.4 0.6 0.5 0.7 2.0 0.3 0.5 3.4 0.4 0.7 0.4 0.5 0.6 0.7 0.9 0.5 0.3 0.2 0.5 1.0 0.4 0.5 3.0 3.5 0.2 0.9 0.5 0.3 2.3 0.7 1.3 0.5 0.4 0.3 0.6 0.4 0.3 0.5 31.1 0.3 0.0 1.7 0.1 0.2 0.5 0.3 0.0 2.2 0.1 0.5 0.0 0.0 0.0 1.2 3.7 0.6 0.9 1.0 0.5 0.5 0.2 1.1 0.8 0.4 2.4 1.0 0.0 1.5 0.5 1.6 1.8 0.6 0.2 0.4 0.5 0.2 0.6 0.8 0.4 0.9 0.1 0.6 0.4 0.7 0.1 0.0 0.6 0.6 0.6 0.4 0.4 0.8 1.4 0.7 0.5 0.9 2.3 0.6 1.1 0.9 0.0 1.4 0.2 6.7 0.9 1.6 1.4 0.2 1.0 1.7 0.2 0.0 0.1 0.4 0.7 0.3 0.1 0.5 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.2 0.0 0.0 1.9 2.2 1.1 2.4 0.6 0.7 0.5 1.0 0.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.4 20.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.9 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 1.5 0.0 0.0 12.9 1.5 0.0 0.0 0.0 0.0 0.1 CCDC88A "APE, FLJ10392, GIV, GRDN, HkRP1, KIAA1212" ENSG00000115355 "Coiled-coil domain containing 88A" Q3V6T2 2 55287842-55419895 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA replication, Neurogenesis" "Guanine-nucleotide releasing factor" "Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 37.5" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 462.8;Late spermatids: 376.6;monocytes: 275.1;Spermatocytes: 379.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 18.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038101, HPA038102" Enhanced NA NA "HPA038101: AB_10670654, HPA038102: AB_2675833" "unprognostic (1.20e-1)" "unprognostic (2.86e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.06e-4)" "unprognostic (1.91e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (4.86e-4)" "unprognostic (8.51e-2)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (3.18e-3)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.98e-8)" "unprognostic (1.42e-2)" "unprognostic (2.61e-1)" "unprognostic (5.74e-3)" "unprognostic (8.96e-3)" 7.7 8.5 20.0 11.6 21.9 11.8 5.7 12.7 24.4 7.5 4.4 17.1 0.7 3.4 6.6 3.1 5.0 4.0 6.9 6.2 20.8 15.5 4.1 7.3 11.4 13.7 24.2 23.1 6.1 7.6 3.8 6.7 7.1 24.5 4.5 4.8 2.8 4.1 5.2 5.5 3.8 3.6 8.1 25.3 9.4 4.8 37.5 25.2 9.1 4.1 1.9 12.8 7.9 3.3 1.5 18.1 3.5 5.4 0.9 1.1 1.4 8.3 7.3 17.4 7.0 11.5 9.7 1.5 12.2 11.4 7.3 8.0 0.8 4.6 22.4 7.6 12.4 11.1 0.1 11.0 7.3 18.3 25.9 6.4 15.4 7.9 10.6 4.9 25.8 10.3 6.2 1.4 17.0 11.1 10.5 19.2 18.2 16.3 36.8 20.0 0.1 12.2 15.1 14.3 0.1 9.4 14.6 27.6 0.0 8.8 4.4 9.1 13.4 21.7 0.0 11.1 10.6 0.4 7.5 13.4 21.2 14.3 14.0 14.8 11.1 8.6 9.8 14.9 21.0 8.9 3.5 5.4 1.5 1.1 5.2 0.6 1.5 0.4 0.9 8.5 0.5 0.5 0.5 0.6 0.9 4.6 18.1 0.2 1.4 20.0 21.9 12.7 20.8 20.8 15.5 24.2 23.1 24.5 25.2 11.9 30.4 22.3 5.8 7.4 170.6 39.5 5.1 16.0 18.2 5.2 35.3 4.1 1.7 3.6 462.8 24.3 0.0 23.3 14.4 15.3 28.2 3.3 142.7 13.9 106.1 74.7 10.4 25.8 132.1 376.6 27.6 134.0 15.1 275.1 0.0 108.0 22.6 0.0 26.9 6.2 63.3 32.3 23.1 379.7 71.8 5.6 1.9 9.6 0.0 2.4 CCDC88B "BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3" ENSG00000168071 "Coiled-coil domain containing 88B" A6NC98 11 64340223-64357534 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HMC-1: 40.7;Karpas-707: 10.6;THP-1: 16.2;U-937: 11.7" "Not detected" "Not detected" HPA026652 Approved Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA Centrosome "Nucleoplasm, Cytosol" "HPA026652: AB_1846168" "unprognostic (1.18e-2)" "unprognostic (3.33e-3)" "unprognostic (3.65e-1)" "unprognostic (1.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (1.55e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-1)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.77e-2)" "unprognostic (7.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.83e-2)" 3.5 2.5 5.2 29.5 5.4 32.5 2.7 23.7 2.8 2.6 6.1 4.5 6.9 3.2 2.0 1.3 4.2 2.5 8.5 2.3 4.1 2.6 2.0 1.6 11.4 18.6 8.6 2.2 1.3 2.1 0.7 1.6 1.4 6.5 2.9 2.9 1.7 7.5 8.9 0.8 1.9 11.1 1.3 7.2 26.6 3.3 7.3 6.5 16.8 1.9 2.7 20.8 4.1 2.8 3.0 3.5 11.3 6.5 7.1 4.6 1.6 0.1 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.6 9.3 1.4 0.5 0.2 0.8 0.0 0.2 0.0 10.1 0.0 7.0 1.8 0.5 0.4 4.3 40.7 0.0 0.0 0.1 0.0 0.6 0.2 3.0 0.2 10.6 0.3 0.4 5.8 3.6 0.3 1.7 0.2 5.5 0.1 8.6 0.1 0.1 2.3 0.0 0.0 0.2 0.5 0.0 1.2 16.2 0.0 0.0 0.3 0.0 0.1 2.3 0.7 7.5 0.5 11.7 0.2 3.6 6.5 7.6 4.6 4.7 1.4 2.2 2.7 3.8 2.1 3.0 2.6 3.2 11.3 7.1 3.1 3.5 0.8 1.6 5.2 5.4 23.7 2.8 4.1 2.6 8.6 2.2 6.5 6.5 0.0 12.5 29.6 3.8 2.4 39.7 11.9 0.0 8.1 3.4 8.7 0.0 2.6 0.0 11.0 9.4 4.3 33.2 0.0 24.8 4.1 2.6 3.4 25.5 7.2 12.7 0.0 17.3 8.0 22.4 10.9 1.4 23.3 5.0 22.6 20.8 11.7 25.7 31.7 0.7 2.3 4.4 0.0 2.3 12.5 1.5 1.4 1.1 31.6 17.9 14.8 CCDC88C "DAPLE, HkRP2, KIAA1509, SCA40" ENSG00000015133 "Coiled-coil domain containing 88C" Q9P219 14 91271323-91417844 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Guanine-nucleotide releasing factor" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.5" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 127.2;T-cells: 71.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 18.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 19.6;SCLC-21H: 23.8;U-266/70: 20.9;U-266/84: 29.4" "Low region specificity" "Detected in all" HPA005832 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA005832: AB_1079202" "unprognostic (7.28e-2)" "unprognostic (2.33e-3)" "unprognostic (7.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.47e-4)" "unprognostic (3.07e-2)" "prognostic favorable (2.90e-4)" "unprognostic (1.48e-1)" "unprognostic (2.13e-1)" "unprognostic (4.77e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.80e-4)" "unprognostic (7.48e-2)" "unprognostic (2.22e-1)" "unprognostic (2.15e-2)" "unprognostic (4.35e-2)" 3.6 0.9 2.7 31.1 18.7 15.0 6.9 0.9 2.3 3.0 8.9 1.8 15.5 9.6 4.7 4.0 8.9 9.7 11.8 2.2 2.0 2.4 5.0 2.6 11.1 34.5 2.0 0.3 2.0 14.8 6.7 4.0 1.8 1.6 6.4 4.7 4.1 12.1 11.7 1.5 4.5 9.6 6.0 2.9 14.5 8.1 4.8 3.7 18.5 2.5 6.0 27.6 7.1 5.3 2.3 1.8 5.2 3.2 3.1 11.0 2.8 3.1 2.9 3.3 3.9 0.0 0.0 15.1 0.0 0.0 0.0 0.0 3.0 4.7 13.5 2.5 0.0 0.1 0.1 4.8 2.7 0.0 11.3 1.8 3.5 1.9 4.2 0.3 7.0 3.0 0.0 4.0 0.0 0.0 0.2 3.7 19.6 4.1 16.9 0.0 10.2 7.0 9.3 3.3 2.4 4.4 5.8 0.1 4.5 0.8 4.5 23.8 5.3 2.0 6.9 1.6 2.5 3.7 6.5 1.1 0.0 0.0 0.0 0.0 20.9 29.4 6.9 0.0 6.3 0.0 5.2 3.2 1.3 9.0 1.8 8.7 2.3 6.1 9.3 1.8 1.9 3.9 5.8 2.6 3.1 2.5 1.5 11.0 2.8 2.7 18.7 0.9 2.3 2.0 2.4 2.0 0.3 1.6 3.7 3.0 27.4 43.1 14.2 8.2 0.0 18.3 10.2 127.2 21.6 14.0 0.0 2.8 0.0 4.0 6.8 12.6 18.6 0.0 5.1 1.7 4.1 16.5 2.3 1.0 5.4 0.0 23.0 16.5 20.3 14.0 3.7 5.0 1.7 1.0 13.4 7.0 6.2 20.1 2.8 11.5 0.0 0.0 4.4 4.1 22.2 8.3 1.5 71.0 16.1 16.3 CCDC89 FLJ38159 ENSG00000179071 "Coiled-coil domain containing 89" Q8N998 11 85684866-85686277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.6" "Cell type enriched" "Detected in some" 11 "Early spermatids: 332.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.4;GAMG: 5.2;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040628 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA040628: AB_2677053" "unprognostic (5.81e-2)" "unprognostic (1.93e-1)" "unprognostic (1.99e-1)" "unprognostic (3.04e-2)" "unprognostic (5.37e-2)" "unprognostic (6.38e-2)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.87e-1)" "unprognostic (9.16e-2)" "unprognostic (2.00e-1)" "unprognostic (2.41e-3)" "unprognostic (7.75e-3)" "unprognostic (5.10e-2)" "unprognostic (8.47e-2)" "unprognostic (3.52e-1)" 0.7 0.9 0.9 0.1 1.8 0.0 1.3 6.4 1.3 1.5 0.6 2.0 0.9 0.1 2.8 0.9 0.3 10.5 1.1 1.0 1.2 1.2 1.4 0.3 1.2 0.6 0.9 1.2 5.9 0.2 2.7 5.2 0.7 3.7 1.7 0.7 0.9 0.4 1.9 0.7 0.5 0.5 2.6 1.2 0.4 1.1 40.6 0.9 0.1 0.4 0.2 0.0 0.7 0.7 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.1 3.8 5.0 0.2 1.4 0.0 0.0 0.1 0.2 0.0 0.1 5.4 4.2 5.2 1.9 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 2.6 0.0 0.0 2.8 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 4.3 0.0 0.3 2.8 7.3 1.8 0.0 0.9 0.0 0.1 0.6 0.0 0.0 3.7 0.0 8.3 3.4 0.0 3.7 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 6.4 1.3 1.2 1.2 0.9 1.2 3.7 0.9 0.0 1.1 0.0 0.0 0.2 0.1 0.0 0.0 29.4 1.2 0.0 0.0 0.0 0.0 0.0 332.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 1.3 6.4 0.0 0.6 1.2 13.3 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.2 1.2 0.5 0.0 0.1 3.4 0.9 0.3 0.0 0.0 0.0 0.1 CCDC96 FLJ90575 ENSG00000173013 "Coiled-coil domain containing 96" Q2M329 4 7040849-7042939 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 52.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 53.5;Early spermatids: 56.9;Late spermatids: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047546 Enhanced NA NA "HPA047546: AB_2680082" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "unprognostic (7.95e-2)" "prognostic favorable (4.05e-4)" "unprognostic (1.22e-2)" "unprognostic (3.51e-3)" "unprognostic (1.77e-1)" "unprognostic (9.24e-3)" "unprognostic (1.01e-2)" "unprognostic (3.92e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.43e-1)" "prognostic favorable (3.80e-5)" "unprognostic (4.37e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.10e-2)" 0.8 1.4 1.7 0.5 3.9 1.1 1.2 1.1 2.6 0.8 0.6 2.4 0.6 0.9 0.9 3.3 0.8 10.5 1.0 0.5 2.4 2.7 1.2 0.5 1.7 0.7 1.5 2.4 3.0 1.3 1.1 3.0 0.5 4.0 0.9 0.6 0.8 0.9 1.2 0.6 1.6 0.6 0.7 1.2 0.8 1.0 52.9 1.5 0.0 1.5 0.5 0.6 0.6 1.0 0.6 1.6 0.5 3.8 0.4 1.6 0.6 1.6 4.6 2.4 2.0 3.2 2.2 0.5 4.6 2.8 5.2 3.1 1.6 4.1 1.0 1.3 2.6 6.9 2.1 0.9 2.1 1.6 0.1 0.7 1.0 2.1 1.1 1.6 1.3 2.6 2.0 2.2 3.1 0.4 0.6 2.1 3.2 0.7 0.4 3.3 3.9 2.7 1.6 1.0 1.5 2.8 1.1 1.6 0.3 9.1 1.6 6.7 1.5 3.7 1.7 0.8 2.4 1.7 2.4 2.3 4.3 1.2 2.7 3.5 0.0 0.1 0.9 3.4 0.1 1.4 0.0 1.6 0.0 0.3 3.8 0.7 0.6 0.4 0.0 1.6 0.0 0.3 1.6 0.5 0.4 2.9 0.0 0.0 0.6 1.7 3.9 1.1 2.6 2.4 2.7 1.5 2.4 4.0 1.5 0.0 3.7 0.0 0.7 0.6 2.5 0.8 0.0 53.5 10.3 3.5 11.8 0.6 1.7 2.0 56.9 1.4 0.5 0.0 1.0 0.5 0.7 1.1 0.0 0.8 1.1 0.0 5.2 2.5 1.8 64.6 2.8 2.6 1.7 1.8 1.1 6.7 1.4 2.9 3.9 4.3 18.2 0.0 0.4 13.7 4.0 0.9 0.5 0.0 0.8 0.7 CCER1 "C12orf12, MGC26598" ENSG00000197651 "Coiled-coil glutamate rich protein 1" Q8TC90 12 90905622-90955176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 51.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 348.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 348.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 5.9 1.3 0.0 0.0 0.0 0.0 0.0 CCER2 ENSG00000262484 "Coiled-coil glutamate rich protein 2" I3L3R5 19 38908980-38912158 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5;skin 1: 9.9" "Cell type enriched" "Detected in some" 9 "Melanocytes: 585.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.0;THP-1: 4.0" "Low region specificity" "Detected in many" HPA069716 Uncertain "Secreted - unknown location" NA NA "HPA069716: AB_2686183" "unprognostic (6.58e-2)" "unprognostic (2.24e-2)" "unprognostic (5.03e-3)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (2.76e-3)" "unprognostic (3.88e-2)" "unprognostic (2.16e-1)" "unprognostic (5.97e-2)" "unprognostic (1.45e-1)" "unprognostic (4.08e-3)" "unprognostic (3.82e-2)" "unprognostic (1.01e-9)" "unprognostic (1.75e-2)" "unprognostic (3.87e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.32e-4)" 0.9 1.0 2.7 1.1 5.1 2.4 1.6 4.7 4.6 1.2 0.9 2.7 0.4 1.3 1.5 1.6 3.9 1.0 0.6 0.6 3.1 2.4 0.9 2.1 0.9 1.5 2.5 0.4 1.0 0.6 1.4 2.6 0.7 9.5 1.1 0.9 1.4 1.1 1.2 4.4 9.9 1.4 0.8 3.5 1.2 1.1 4.0 1.4 0.4 0.8 0.4 0.8 0.4 0.4 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.3 4.0 1.0 0.4 0.7 0.2 0.8 0.0 0.0 0.1 0.2 0.3 1.5 2.8 0.3 0.2 0.2 0.4 0.6 0.1 0.0 1.1 1.3 0.2 0.8 0.0 0.0 1.6 1.6 0.4 0.7 0.3 0.0 0.1 0.0 2.8 0.7 2.7 0.0 2.7 0.6 1.2 0.9 0.2 0.5 2.0 0.4 0.7 0.3 1.9 1.2 0.8 0.5 0.5 0.0 0.3 3.0 4.0 0.0 0.2 2.0 0.1 0.1 1.8 1.3 0.7 0.3 2.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 2.7 5.1 4.7 4.6 3.1 2.4 2.5 0.4 9.5 1.4 3.0 0.0 0.0 0.0 68.3 3.0 0.1 2.5 0.0 0.0 1.8 3.9 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.5 0.2 0.0 1.2 0.0 0.0 3.7 0.3 0.5 585.4 0.0 0.2 1.8 0.1 0.0 0.0 0.1 3.8 0.0 0.1 0.9 1.6 2.6 0.2 0.0 0.6 0.0 CCHCR1 "C6orf18, HCR" ENSG00000204536 "Coiled-coil alpha-helical rod protein 1" Q8TD31 6 31142439-31158238 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 50.1" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 64.7;Late spermatids: 110.5;Spermatocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054167 Supported Cytosol NA NA Cytosol "HPA054167: AB_2682403" "unprognostic (6.68e-2)" "unprognostic (7.98e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (3.11e-3)" "unprognostic (2.23e-3)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (5.36e-3)" "unprognostic (1.65e-1)" "unprognostic (2.07e-1)" "unprognostic (3.85e-3)" "unprognostic (1.06e-1)" "unprognostic (4.35e-2)" "unprognostic (3.57e-1)" "unprognostic (4.17e-2)" 2.4 2.7 5.6 2.8 6.2 1.2 3.1 5.2 6.4 3.7 4.5 2.9 9.1 9.4 6.3 5.6 3.9 8.0 2.9 2.5 4.0 2.7 4.3 2.9 3.0 5.5 4.1 5.6 5.5 7.6 1.7 2.5 1.5 4.5 5.3 3.2 3.4 3.5 6.8 10.1 7.0 5.9 3.9 2.6 3.4 6.6 50.1 3.8 4.3 6.2 3.1 4.2 3.4 4.0 2.0 3.4 1.4 2.1 2.5 4.3 2.3 22.0 1.7 6.2 0.9 3.8 4.5 5.8 1.9 0.6 0.3 0.7 8.8 0.4 2.9 10.5 4.9 13.8 0.9 0.3 8.9 0.9 3.2 14.1 10.4 7.3 6.7 2.2 0.2 6.9 5.8 1.0 4.1 0.9 4.5 4.7 16.3 4.1 6.1 2.6 1.6 3.8 11.6 0.3 0.8 0.1 7.0 8.3 5.4 5.7 2.2 17.4 2.9 7.2 0.0 1.8 3.8 2.4 5.5 0.6 9.2 2.9 0.2 5.5 14.3 8.2 11.9 1.9 2.5 0.9 0.3 2.1 1.4 2.9 0.9 2.5 1.3 2.6 4.3 1.5 2.0 4.0 4.0 0.6 2.5 1.2 3.4 4.0 2.3 5.6 6.2 5.2 6.4 4.0 2.7 4.1 5.6 4.5 3.8 3.0 3.2 4.8 12.9 8.7 8.6 6.9 7.6 8.1 9.1 3.5 0.0 2.2 10.0 8.2 64.7 4.9 32.8 0.0 9.4 6.0 6.1 6.6 0.0 5.7 5.9 14.3 28.2 1.8 4.6 110.5 9.2 3.6 6.8 12.6 26.1 5.8 8.3 10.5 11.0 7.3 1.9 6.5 4.7 80.8 16.7 5.1 1.1 4.6 28.1 6.4 CCIN "BTBD20, KBTBD14" ENSG00000185972 Calicin Q13939 9 36169394-36171334 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 72.9" "Cell type enriched" "Detected in some" 5 "Early spermatids: 864.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "myeloid DC: 1.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 3.6;BJ: 5.5;fHDF/TERT166: 6.6;hTEC/SVTERT24-B: 8.2;TIME: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.10e-2)" "unprognostic (9.26e-3)" "unprognostic (6.27e-2)" "unprognostic (8.26e-6)" "unprognostic (1.78e-2)" "unprognostic (5.38e-2)" "unprognostic (1.57e-2)" "unprognostic (7.74e-3)" "unprognostic (5.43e-3)" "unprognostic (4.49e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-1)" "unprognostic (5.98e-5)" "unprognostic (3.27e-3)" "unprognostic (7.86e-2)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 0.2 0.2 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.7 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.1 0.0 72.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.4 3.6 5.5 0.5 0.1 0.2 0.0 0.0 0.0 1.5 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 2.2 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 11.0 0.1 1.8 0.3 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 864.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.6 184.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.1 4.2 2.6 0.0 0.1 0.0 0.0 0.0 CCK ENSG00000187094 Cholecystokinin P06307 3 42257825-42266207 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 95.1;intestine: 71.6" "Group enriched" "Detected in some" 5 "Glandular cells: 57.6;Melanocytes: 38.8;Muller glia cells: 33.0" "Group enriched" "Detected in many" 5 "glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "OE19: 72.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 565.3" "HPA045039, HPA069515" Enhanced Supported "Secreted to blood" NA NA "HPA045039: , HPA069515: AB_2732135" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (1.92e-1)" "unprognostic (1.40e-3)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.39e-3)" "unprognostic (1.97e-2)" "unprognostic (3.91e-1)" "unprognostic (8.77e-2)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (1.37e-1)" "unprognostic (5.10e-2)" 0.9 1.1 59.0 1.1 29.8 0.8 0.9 0.2 95.1 0.8 11.3 1.4 0.0 71.6 0.8 0.8 0.9 0.9 0.9 0.9 35.8 10.8 0.8 0.9 1.1 0.8 8.0 26.9 0.8 1.1 0.8 4.1 9.4 1.3 13.5 0.9 0.0 0.8 1.0 0.8 0.9 10.5 1.0 1.3 0.8 1.7 1.7 0.5 0.0 0.8 0.0 0.8 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 0.0 0.0 0.3 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.0 29.8 0.2 95.1 35.8 10.8 8.0 26.9 1.3 0.5 0.0 0.0 0.0 1.0 5.0 1.1 0.3 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.2 57.6 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 38.8 0.0 0.0 33.0 0.5 0.0 0.0 0.0 3.2 0.0 2.1 0.0 0.4 1.1 8.8 0.0 0.0 3.3 CCKAR ENSG00000163394 "Cholecystokinin A receptor" P32238 4 26481400-26490462 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 47.5;stomach 1: 14.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 4.3;RH-30: 1.3;U-2 OS: 1.3" "Region enhanced" "Detected in some" "hypothalamus: 8.3" "Low region specificity" "Detected in all" NA NA "unprognostic (7.48e-2)" "unprognostic (3.70e-2)" "unprognostic (7.13e-2)" "unprognostic (3.08e-2)" "unprognostic (3.36e-1)" "unprognostic (3.79e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.6 0.0 0.0 1.3 0.3 0.0 1.3 0.0 47.5 0.1 0.1 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.6 0.0 14.0 0.2 0.1 0.2 0.0 1.0 7.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.1 1.3 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCKBR ENSG00000110148 "Cholecystokinin B receptor" P32239 11 6259736-6272127 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 12.9;pancreas: 34.7;stomach 1: 21.4" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 1.4;Exocrine glandular cells: 1.2;Spermatogonia: 1.1" "Cancer enriched" "Detected in some" 8 "testis cancer: 9.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 39.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.82e-1)" "unprognostic (4.62e-2)" "unprognostic (1.79e-3)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (6.34e-4)" "unprognostic (8.01e-2)" "unprognostic (3.01e-2)" "unprognostic (9.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.06e-1)" "unprognostic (2.92e-1)" "unprognostic (1.30e-2)" 0.3 0.4 6.5 0.3 5.6 0.3 0.3 10.8 12.9 0.3 0.3 0.0 0.0 0.6 0.4 0.3 0.3 0.6 0.4 0.3 3.3 0.8 0.3 0.3 0.3 0.3 1.0 6.9 0.3 34.7 0.3 0.4 0.4 2.1 0.9 0.3 0.3 0.3 0.4 0.4 0.8 0.3 0.3 0.3 0.3 21.4 0.6 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.5 5.6 10.8 12.9 3.3 0.8 1.0 6.9 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.2 0.0 0.0 0.0 CCL1 "I-309, P500, SCYA1, SISe, TCA3" ENSG00000108702 "C-C motif chemokine ligand 1" P22362 17 34360328-34363231 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2" "Cell type enriched" "Detected in some" 4 "granulocytes: 9.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Group enriched" "Detected in some" 4 "classical monocyte: 2.0;intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 20 "monocytes: 2.0" "Cell line enriched" "Detected in some" 41 "HMC-1: 128.7" "Region enriched" "Detected in single" 4 "hippocampal formation: 2.2" HPA049861 Uncertain "Secreted to blood" NA NA 84400 "HPA049861: AB_2680919" "unprognostic (6.52e-2)" "unprognostic (4.81e-3)" "unprognostic (5.84e-2)" "unprognostic (5.01e-1)" "unprognostic (6.04e-1)" "unprognostic (2.71e-1)" "unprognostic (1.37e-1)" 0.1 0.0 0.2 0.2 2.5 0.0 0.1 0.1 0.9 0.1 0.5 0.1 0.1 0.0 0.1 0.8 0.1 0.2 0.4 0.1 0.5 0.3 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 7.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 1.8 0.1 6.7 0.1 3.2 0.5 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 2.5 0.1 0.8 0.5 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CCL11 "eotaxin, MGC22554, SCYA11" ENSG00000172156 "C-C motif chemokine ligand 11" P51671 17 34285668-34288334 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 31.0;intestine: 29.6;lymphoid tissue: 29.2" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "BJ hTERT+: 14.3" "Not detected" "Not detected" "Secreted to blood" NA NA 88500 "unprognostic (4.61e-2)" "unprognostic (1.45e-1)" "prognostic favorable (8.70e-4)" "unprognostic (8.18e-2)" "prognostic favorable (1.99e-4)" "unprognostic (9.91e-2)" "unprognostic (8.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (1.45e-1)" "unprognostic (9.64e-8)" "unprognostic (2.66e-2)" "unprognostic (1.05e-3)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" 2.6 0.4 0.2 29.2 0.2 0.0 0.2 0.2 0.2 4.5 29.6 0.4 0.6 17.3 3.5 0.0 20.7 0.8 12.0 31.0 0.2 0.2 7.0 1.2 7.3 0.3 0.2 0.0 2.6 11.6 0.2 1.1 0.0 0.2 16.1 8.0 0.0 0.2 0.3 0.5 0.2 18.7 10.2 0.2 1.2 18.2 0.6 0.0 0.7 0.4 0.0 0.8 12.1 5.8 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 14.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL14 "CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2" ENSG00000276409 "C-C motif chemokine ligand 14" Q16627 17 35983291-35987004 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 80.7;lymphoid tissue: 98.4" "Cell type enriched" "Detected in many" 16 "Ito cells: 1401.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "HUVEC TERT2: 35.9" "CAB004423, HPA030268" Uncertain "Secreted to blood" NA NA 5200000 19000000 "CAB004423: AB_627716, HPA030268: AB_10603782" "unprognostic (4.13e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "unprognostic (3.55e-3)" "unprognostic (2.50e-1)" "unprognostic (1.99e-2)" "unprognostic (8.79e-5)" "unprognostic (1.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (6.33e-3)" "unprognostic (3.00e-2)" "unprognostic (7.27e-3)" "unprognostic (1.36e-2)" "unprognostic (3.95e-1)" "unprognostic (3.52e-1)" "unprognostic (1.14e-1)" 56.3 5.1 0.0 5.9 0.0 0.0 80.7 0.0 0.0 37.6 8.4 0.0 16.6 0.0 37.6 11.1 20.9 9.1 17.3 27.5 0.0 8.7 34.2 26.4 39.1 0.0 0.0 12.4 0.8 2.0 6.5 0.0 0.0 23.5 0.7 4.1 6.5 11.4 21.9 7.5 3.9 19.1 0.0 98.4 0.2 15.0 0.0 1.3 17.6 16.7 6.2 25.3 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 7.0 0.1 1.6 0.0 0.1 28.1 4.0 1.2 0.0 0.0 0.0 0.0 0.0 22.9 57.6 1.7 0.0 0.0 0.0 0.2 0.2 1.1 5.9 0.2 0.0 0.0 1401.9 89.1 43.1 1.4 0.0 0.0 0.0 1.0 0.0 0.0 3.5 0.0 1.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 1.3 0.6 0.1 CCL15 "HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3" ENSG00000275718 "C-C motif chemokine ligand 15" Q16663 17 35996440-36002038 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 36.4;liver: 17.9" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 260.2;Mucus-secreting cells: 154.9;Paneth cells: 333.1;Undifferentiated cells: 126.3" "Cancer enhanced" "Detected in many" "liver cancer: 11.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "Hep G2: 25.4;OE19: 14.9" HPA058608 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 7900000 "Golgi apparatus" Vesicles "HPA058608: AB_2683776" "unprognostic (1.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.31e-2)" "unprognostic (1.40e-1)" "unprognostic (8.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" "unprognostic (2.41e-2)" "unprognostic (1.96e-2)" "unprognostic (9.94e-2)" "unprognostic (1.15e-1)" "unprognostic (1.07e-2)" "prognostic favorable (3.02e-4)" 0.0 0.0 0.0 6.1 0.0 0.0 0.6 0.0 0.0 0.1 18.0 0.0 0.0 11.6 0.0 0.4 0.0 1.1 7.4 0.8 0.0 6.4 17.9 2.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 15.8 0.0 0.0 0.0 0.0 0.4 36.4 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.7 1.0 2.2 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.7 0.4 0.2 2.2 0.9 0.1 1.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.7 60.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 260.2 0.0 0.6 0.0 0.0 0.0 9.2 31.0 0.1 0.0 68.9 1.8 0.6 0.0 0.0 0.0 0.0 0.0 154.9 0.0 0.6 333.1 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 126.3 0.1 CCL16 "CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4" ENSG00000275152 "C-C motif chemokine ligand 16" O15467 17 35976493-35981496 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "liver: 79.1" "Cell type enriched" "Detected in some" 14 "Hepatocytes: 244.8" "Cancer enriched" "Detected in single" 154 "liver cancer: 49.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "Hep G2: 15.0" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 2780000 20000000 "unprognostic (3.85e-1)" "unprognostic (4.71e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-2)" "unprognostic (2.72e-1)" "unprognostic (4.58e-2)" "unprognostic (2.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-2)" "unprognostic (3.57e-1)" "unprognostic (1.40e-3)" "unprognostic (1.66e-2)" "unprognostic (2.32e-1)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 244.8 0.0 0.0 0.0 17.8 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CCL17 "ABCD-2, SCYA17, TARC" ENSG00000102970 "C-C motif chemokine ligand 17" Q92583 16 57404767-57416062 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.0" "Cell type enriched" "Detected in some" 685 "monocytes: 21217.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 1.8;myeloid DC: 1.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 613 "HDLM-2: 231.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" CAB002583 Uncertain "Secreted to blood" NA NA 248000 "CAB002583: AB_564022" "unprognostic (4.62e-3)" "prognostic favorable (1.91e-5)" "unprognostic (5.83e-2)" "unprognostic (3.52e-4)" "unprognostic (4.51e-2)" "unprognostic (1.78e-3)" "unprognostic (4.44e-1)" "unprognostic (3.41e-2)" "unprognostic (6.36e-2)" "unprognostic (4.28e-2)" "unprognostic (4.11e-1)" "unprognostic (2.91e-2)" "unprognostic (6.04e-2)" "unprognostic (2.35e-1)" "unprognostic (7.72e-3)" "unprognostic (4.14e-3)" "prognostic favorable (5.80e-4)" 0.9 0.2 0.3 8.7 0.3 0.0 2.0 0.3 0.4 1.3 1.2 0.3 0.3 0.0 0.5 0.8 4.8 0.4 3.0 1.5 0.3 0.2 1.7 0.6 9.7 8.6 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.5 0.6 3.2 0.5 7.4 0.3 0.3 3.3 6.7 2.5 0.3 1.4 0.7 0.9 0.3 39.0 2.0 1.3 6.2 4.5 1.5 1.8 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 231.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.3 0.5 0.3 0.0 3.2 0.0 0.0 9.6 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 31.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.9 0.0 21217.8 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.4 CCL18 "AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18" ENSG00000275385 "C-C motif chemokine ligand 18" P55774 17 36064280-36072032 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9" "Cell type enriched" "Detected in some" 5 "Hofbauer cells: 197.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.5" "Secreted to blood" NA NA 55500000 940000 "unprognostic (8.91e-2)" "unprognostic (2.96e-2)" "unprognostic (5.71e-2)" "unprognostic (9.64e-2)" "unprognostic (1.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.96e-1)" "unprognostic (2.50e-1)" "unprognostic (3.11e-2)" "unprognostic (1.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.68e-1)" "unprognostic (3.63e-1)" "unprognostic (4.87e-2)" 18.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 3.1 0.0 0.0 1.6 0.0 5.8 3.2 0.0 0.4 41.4 0.0 0.0 1.3 77.9 61.9 0.0 0.0 3.7 0.3 0.0 0.0 5.9 0.0 0.2 2.5 0.0 0.2 0.0 0.0 0.3 3.4 4.1 0.0 3.7 0.3 1.6 0.0 43.8 2.2 4.3 16.7 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 8.5 0.0 0.2 0.0 9.4 25.0 0.0 0.0 0.4 0.0 0.0 24.7 0.3 0.0 0.0 0.0 0.3 2.1 0.0 4.7 0.0 197.4 0.0 0.0 0.0 2.2 3.6 0.0 40.3 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 3.0 1.4 0.0 0.0 0.0 CCL19 "CKb11, ELC, exodus-3, MIP-3b, SCYA19" ENSG00000172724 "C-C motif chemokine ligand 19" Q99731 9 34689567-34691277 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 418.9" "Cell type enhanced" "Detected in some" 22 "Basal keratinocytes: 66.3;Melanocytes: 87.7;monocytes: 186.7;Smooth muscle cells: 46.2;Suprabasal keratinocytes: 47.2" "Cancer enhanced" "Detected in all" "testis cancer: 118.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "intermediate monocyte: 2.3" "Lineage enriched" "Detected in single" 6 "monocytes: 2.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.0;Daudi: 2.6;HDLM-2: 7.6;HL-60: 1.9;K-562: 1.6;TIME: 3.8" "Low region specificity" "Detected in some" HPA067758 Enhanced "Secreted to blood" NA NA 195000 "HPA067758: AB_2685897" "prognostic favorable (2.88e-5)" "prognostic favorable (9.91e-6)" "unprognostic (8.25e-3)" "unprognostic (1.16e-1)" "unprognostic (1.65e-1)" "unprognostic (1.67e-2)" "unprognostic (1.30e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (8.36e-3)" "unprognostic (8.31e-2)" "unprognostic (2.43e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (7.98e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-1)" "unprognostic (1.87e-1)" 22.5 0.6 1.2 82.3 1.1 0.0 10.2 0.8 1.3 5.8 4.7 1.5 1.5 1.0 1.5 5.9 16.3 3.4 10.4 16.5 0.8 0.7 11.8 12.8 13.6 418.9 2.1 1.0 3.4 1.7 0.0 2.0 0.6 1.5 7.0 11.0 7.4 23.1 1.0 0.7 8.7 40.2 4.5 2.2 8.2 9.0 2.8 0.6 73.1 14.9 9.9 90.9 13.4 2.3 0.0 0.0 0.3 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.6 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.2 1.1 0.8 1.3 0.8 0.7 2.1 1.0 1.5 0.6 0.0 0.0 0.0 0.0 66.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 87.7 186.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 46.2 0.2 0.2 47.2 0.0 0.0 0.0 0.1 CCL20 "CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38" ENSG00000115009 "C-C motif chemokine ligand 20" P78556 2 227805739-227817564 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Antibiotic, Antimicrobial, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 266.2;Glandular cells: 185.4;Paneth cells: 292.5;Urothelial cells: 548.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "MAIT T-cell: 6.6" "Lineage enriched" "Detected in single" 10 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "GAMG: 36.0;Hep G2: 19.3;NB-4: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 28000 "unprognostic (2.40e-1)" "unprognostic (1.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (7.06e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.53e-3)" "unprognostic (1.37e-1)" "unprognostic (5.21e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.19e-8)" "unprognostic (1.39e-1)" "unprognostic (2.75e-1)" "unprognostic (1.63e-1)" "unprognostic (1.82e-1)" 5.6 0.1 0.4 23.3 0.9 1.5 0.4 0.3 0.4 7.1 5.5 0.3 0.3 4.4 3.9 1.5 11.8 2.0 48.5 1.5 0.4 0.2 7.1 17.2 36.8 16.3 0.4 0.3 1.5 1.9 0.0 0.3 0.9 1.3 2.0 7.8 0.4 4.0 0.3 0.5 4.3 18.2 1.0 1.3 0.5 2.8 1.6 0.4 1.8 0.5 18.3 50.9 19.6 2.5 0.3 0.6 0.0 0.3 0.0 6.6 0.3 0.2 0.8 0.4 0.4 1.8 3.7 0.5 0.2 1.1 0.1 0.4 2.1 0.3 0.7 2.5 0.0 36.0 0.4 0.1 4.8 0.8 0.5 0.8 0.1 1.6 19.3 1.4 2.7 0.2 5.8 1.0 1.1 1.3 0.5 0.0 0.6 0.1 3.0 0.3 0.2 0.2 14.0 0.9 2.8 0.4 0.3 5.0 0.5 0.1 8.5 0.3 0.2 0.2 0.8 0.5 0.4 0.7 2.8 1.4 1.8 2.4 4.1 0.4 0.5 1.6 1.1 2.9 1.9 3.8 0.0 0.3 0.0 0.1 0.1 6.6 0.2 2.7 1.4 0.3 0.3 0.4 0.3 0.0 0.0 0.2 0.6 1.0 0.3 0.4 0.9 0.3 0.4 0.4 0.2 0.4 0.3 1.3 0.4 44.7 86.3 5.0 266.2 105.6 0.2 0.8 30.6 20.1 105.8 17.4 0.0 0.1 0.0 133.7 2.4 0.2 119.7 0.0 2.5 0.3 3.3 185.4 5.7 1.0 30.6 1.6 55.7 0.0 2.2 0.0 0.0 33.0 1.7 16.2 60.3 0.0 31.3 292.5 0.0 2.4 0.1 0.0 3.8 0.0 0.9 56.7 0.7 16.0 52.5 548.3 CCL21 "6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4" ENSG00000137077 "C-C motif chemokine ligand 21" O00585 9 34709005-34710124 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 430.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 129.0;Melanocytes: 136.7;Smooth muscle cells: 67.0;Suprabasal keratinocytes: 120.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.7;HL-60: 2.3;K-562: 3.9;RH-30: 2.5;U-937: 1.9" "Low region specificity" "Detected in many" HPA051210 Enhanced "Secreted to blood" NA NA 198000 770000 "HPA051210: AB_2681390" "unprognostic (3.06e-3)" "unprognostic (7.19e-3)" "unprognostic (9.89e-2)" "unprognostic (5.50e-2)" "unprognostic (4.51e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" "unprognostic (8.07e-2)" "unprognostic (4.15e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (8.99e-3)" "unprognostic (3.50e-3)" "unprognostic (1.58e-1)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 24.4 6.5 0.3 83.5 0.4 0.0 18.0 0.3 0.4 13.6 25.5 0.4 5.9 3.7 26.8 23.7 80.1 23.0 23.2 18.8 0.3 0.0 19.6 11.0 30.5 430.9 0.3 0.3 13.8 3.3 0.0 0.4 7.4 0.5 9.4 11.9 0.7 96.9 4.1 4.7 7.6 71.2 10.6 0.3 35.9 10.7 5.5 0.3 2.3 91.0 44.8 181.2 15.7 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.7 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.2 0.8 0.0 0.0 1.0 2.5 0.6 0.0 0.0 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.5 0.0 0.8 0.0 0.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.4 0.3 0.0 0.3 0.3 0.5 0.3 20.8 38.2 0.0 0.0 129.0 0.0 7.7 0.0 18.7 23.9 1.8 0.0 0.1 0.0 8.4 4.2 47.5 0.0 0.0 3.3 0.2 3.5 0.0 10.5 0.0 0.5 0.0 0.0 49.7 0.8 2.7 0.6 7.4 136.7 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 67.0 0.0 0.2 120.3 0.2 0.0 0.0 0.1 CCL22 "A-152E5.1, ABCD-1, DC/B-CK, MDC, MGC34554, SCYA22, STCP-1" ENSG00000102962 "C-C motif chemokine ligand 22" O00626 16 57358772-57366190 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 89.8" "Cell type enriched" "Detected in some" 532 "monocytes: 9361.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 18 "HDLM-2: 33.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 617000 "unprognostic (2.67e-2)" "unprognostic (7.68e-3)" "prognostic favorable (2.98e-4)" "prognostic favorable (2.23e-6)" "unprognostic (8.87e-2)" "prognostic favorable (9.17e-5)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (1.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.15e-2)" "unprognostic (7.71e-2)" "unprognostic (3.43e-2)" "unprognostic (3.12e-2)" "unprognostic (3.88e-2)" 10.5 0.6 0.3 27.7 0.5 0.3 1.9 0.2 0.3 1.6 1.3 0.0 0.4 1.0 0.6 0.5 4.6 0.4 2.6 0.4 0.3 0.3 0.6 0.5 4.6 11.9 0.3 0.0 0.3 0.9 0.0 0.3 0.2 0.1 0.7 5.4 0.1 5.9 0.2 0.3 7.1 7.4 0.7 0.3 5.5 1.1 0.3 0.0 89.8 0.7 5.9 31.8 3.6 1.6 3.1 2.6 3.7 0.8 1.4 0.7 0.5 0.4 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.0 0.9 0.0 0.0 0.1 33.2 0.1 0.1 0.2 0.3 0.0 0.1 1.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.1 0.1 1.2 0.0 1.8 0.2 0.1 0.1 1.4 0.0 0.1 0.2 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 3.6 0.8 0.6 0.6 0.4 0.4 3.1 0.5 0.4 2.6 1.6 0.6 0.7 3.7 1.4 0.4 1.0 0.4 0.5 0.3 0.5 0.2 0.3 0.3 0.3 0.3 0.0 0.1 0.0 3.0 0.6 0.0 0.2 6.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 1.7 4.0 0.0 0.2 0.0 0.0 17.6 0.0 0.7 0.2 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.3 9361.9 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.9 0.1 0.0 0.0 0.1 CCL23 "Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23" ENSG00000274736 "C-C motif chemokine ligand 23" P55773 17 36013056-36017968 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.3" "Cell type enriched" "Detected in some" 13 "Ito cells: 276.2" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 173 "eosinophil: 50.3" "Lineage enriched" "Detected in single" 173 "granulocytes: 50.3" "Group enriched" "Detected in some" 4 "HEL: 12.9;THP-1: 27.6" HPA042015 Uncertain "Secreted to blood" NA NA 937000 57000 "HPA042015: AB_10794039" "unprognostic (1.65e-3)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (9.50e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-1)" "unprognostic (1.20e-4)" "unprognostic (2.17e-1)" "unprognostic (6.49e-2)" "unprognostic (1.08e-2)" "unprognostic (7.05e-2)" "unprognostic (6.93e-2)" "unprognostic (1.35e-3)" "unprognostic (2.18e-1)" "unprognostic (2.76e-1)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" 5.8 0.5 0.0 13.1 0.0 2.1 3.7 0.0 0.5 2.1 2.0 0.0 1.0 0.0 1.8 3.0 1.3 1.5 2.2 4.6 0.0 3.0 5.9 7.9 8.0 0.3 0.0 1.2 0.0 0.0 0.5 1.5 0.2 1.7 7.2 0.7 0.0 1.1 0.5 0.4 1.0 8.4 0.0 2.0 0.0 0.1 0.0 0.4 1.1 0.6 0.5 3.0 0.0 0.2 0.1 50.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.2 0.2 50.3 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 3.0 2.9 0.0 0.2 1.4 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.9 9.0 0.4 0.0 0.0 0.0 0.2 0.1 9.3 1.5 6.8 0.0 0.0 276.2 21.2 0.0 0.0 1.7 1.7 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.2 0.8 0.4 0.1 CCL24 "Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24" ENSG00000106178 "C-C motif chemokine ligand 24" O00175 7 75811665-75823356 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "colorectal cancer: 67.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 3.3" "Lineage enriched" "Detected in single" 5 "monocytes: 3.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.8;EFO-21: 2.7;HMC-1: 2.7;OE19: 4.1;RH-30: 3.4;U-2 OS: 9.4" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 276000 "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.26e-2)" "unprognostic (1.44e-2)" "unprognostic (5.56e-2)" "unprognostic (1.73e-1)" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (3.15e-1)" "unprognostic (2.84e-1)" "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" 8.2 0.5 0.3 5.7 0.3 0.0 0.8 0.3 0.3 0.6 12.2 0.3 0.2 9.4 0.4 0.6 1.0 0.4 1.1 0.5 0.3 0.3 0.6 3.8 23.3 21.2 0.3 0.2 0.6 0.4 0.0 0.4 0.3 0.3 0.5 33.1 0.6 0.6 0.5 0.4 0.7 26.8 0.5 0.3 63.3 1.0 1.0 0.2 1.2 0.5 0.9 2.8 13.4 0.7 0.0 0.6 0.0 3.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.0 8.8 0.2 2.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.4 0.7 0.2 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.0 4.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 9.4 0.0 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL25 "Ckb15, SCYA25, TECK" ENSG00000131142 "C-C motif chemokine ligand 25" O15444 19 8052767-8062650 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 23 "intestine: 136.8;lymphoid tissue: 185.2" "Cell type enhanced" "Detected in single" 22 "Extravillous trophoblasts: 1.1" "Group enriched" "Detected in many" 5 "liver cancer: 25.4;stomach cancer: 33.5;testis cancer: 6.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory B-cell: 1.8;NK-cell: 7.0" "Group enriched" "Detected in many" 12 "B-cells: 1.8;NK-cells: 7.0" "Cell line enhanced" "Detected in some" "BEWO: 4.9;HEL: 5.0;NB-4: 3.9;REH: 10.3;RPMI-8226: 3.0;SH-SY5Y: 3.4" HPA055883 Approved "Secreted to blood" NA NA 183000000 "HPA055883: AB_2682955" "unprognostic (9.22e-3)" "unprognostic (3.13e-4)" "unprognostic (1.12e-1)" "unprognostic (1.29e-1)" "unprognostic (2.87e-1)" "unprognostic (9.30e-3)" "unprognostic (2.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (8.85e-3)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-4)" "unprognostic (6.43e-2)" "unprognostic (3.86e-1)" "unprognostic (6.57e-2)" "unprognostic (2.17e-1)" 0.1 0.1 0.3 0.0 0.2 0.0 0.1 0.2 0.2 0.1 64.9 0.0 0.0 91.9 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 136.8 0.0 0.2 0.4 0.1 0.4 0.0 185.2 0.1 0.0 0.0 0.1 0.1 1.8 0.1 0.0 0.0 7.0 0.3 0.4 0.0 0.0 0.1 0.8 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.4 0.0 3.9 0.2 0.0 0.5 10.3 0.0 3.0 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.1 1.1 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.0 0.3 0.2 0.0 7.0 0.0 0.0 0.0 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CCL26 "eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1" ENSG00000006606 "C-C motif chemokine ligand 26" Q9Y258 7 75769533-75789896 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 16.6;retina: 50.2" "Cell type enhanced" "Detected in some" 12 "Leydig cells: 15.5;Sertoli cells: 12.9;Smooth muscle cells: 17.5" "Cancer enhanced" "Detected in many" "testis cancer: 14.0" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 27 "intermediate monocyte: 2.7" "Lineage enriched" "Detected in single" 27 "monocytes: 2.7" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 10.6;PC-3: 30.2;U-2 OS: 8.6" "Not detected" "Not detected" "Secreted to blood" NA NA 117000 "unprognostic (1.14e-1)" "unprognostic (4.17e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (3.52e-2)" "unprognostic (2.18e-2)" "unprognostic (6.17e-2)" "unprognostic (3.02e-1)" "unprognostic (8.71e-2)" "unprognostic (7.93e-2)" "unprognostic (2.47e-1)" "unprognostic (1.05e-11)" "unprognostic (2.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.73e-1)" "unprognostic (6.29e-3)" 1.7 2.9 0.4 0.5 0.6 0.0 1.4 0.4 0.9 2.8 0.8 0.9 1.0 0.4 0.8 2.3 1.1 1.9 1.3 3.3 0.6 0.0 1.5 0.4 1.2 4.1 1.2 0.4 16.6 0.4 5.9 13.6 0.4 3.3 1.3 8.7 50.2 1.0 0.4 0.4 1.4 0.7 1.6 0.8 0.4 0.6 1.5 0.6 0.8 0.8 0.8 0.9 1.0 3.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.7 0.9 0.0 0.4 3.1 2.8 5.9 0.3 2.0 0.0 4.7 2.6 0.2 1.3 0.1 0.0 3.9 0.0 0.6 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.4 10.6 0.1 1.6 0.0 0.0 5.2 0.0 2.0 0.7 0.0 0.0 6.6 0.4 30.2 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.2 5.1 8.6 2.7 1.7 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.4 0.9 0.6 0.0 1.2 0.4 3.3 0.6 0.0 0.0 0.0 1.0 1.0 0.4 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.4 1.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 1.9 0.4 15.5 0.0 0.0 0.0 3.3 0.3 0.3 0.0 4.6 0.0 1.6 12.9 17.5 0.0 0.0 1.6 0.0 0.0 0.5 0.4 CCL27 "ALP, CTACK, CTAK, ESkine, ILC, PESKY, SCYA27, skinkine" ENSG00000213927 "C-C motif chemokine ligand 27" Q9Y4X3 9 34661880-34664048 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 96.5" "Group enriched" "Detected in some" 25 "Basal keratinocytes: 625.7;Suprabasal keratinocytes: 877.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.0" "Group enriched" "Detected in many" 15 "B-cells: 1.0;T-cells: 2.0" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HAP1: 3.5;SuSa: 3.5" "Not detected" "Not detected" HPA073848 Enhanced "Secreted to blood" NA NA 436000 "HPA073848: AB_2732243" 0.1 0.0 0.1 0.1 0.1 0.1 5.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 96.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 8.0 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.1 5.5 1.8 1.6 0.5 0.0 0.0 0.5 0.0 0.9 0.0 0.3 0.1 0.0 0.2 2.1 3.5 0.0 2.4 2.1 0.0 0.0 1.8 0.8 0.7 0.0 0.0 3.0 1.9 0.6 0.0 0.6 0.0 1.3 0.5 2.3 1.2 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.6 0.0 2.8 0.0 0.4 1.6 0.0 0.0 0.2 3.5 1.5 0.0 0.0 2.5 2.0 2.0 0.0 0.3 1.0 0.1 0.9 0.4 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 625.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 6.4 0.0 0.0 0.0 0.2 0.7 1.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.8 0.3 0.0 30.4 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.5 3.9 1.1 877.6 1.6 0.0 0.0 0.1 CCL28 "CCK1, MEC, SCYA28" ENSG00000151882 "C-C motif chemokine ligand 28" Q9NRJ3 5 43376645-43412391 "Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "salivary gland: 207.1" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 56.0;Ductal cells: 64.1;Enterocytes: 76.4;Exocrine glandular cells: 59.4;Paneth cells: 62.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.0;EFO-21: 8.6;SiHa: 19.4;SK-MEL-30: 10.6;T-47d: 26.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA077434 Supported "Secreted to blood" NA NA 700000000 "HPA077434: AB_2732346" "unprognostic (1.04e-2)" "unprognostic (2.66e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-2)" "unprognostic (8.85e-4)" "unprognostic (4.93e-3)" "unprognostic (1.20e-3)" "unprognostic (3.56e-2)" "unprognostic (4.91e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (1.43e-4)" "unprognostic (4.43e-1)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (2.52e-1)" "unprognostic (1.78e-1)" "unprognostic (6.53e-2)" 1.2 0.6 0.8 5.3 0.6 0.6 15.7 0.4 0.8 4.0 8.2 0.2 0.2 6.2 1.4 1.0 2.0 1.1 5.2 0.9 0.6 0.7 1.9 1.0 1.5 2.5 0.6 0.6 0.9 29.8 1.2 1.5 3.1 0.7 1.3 7.6 4.1 207.1 1.1 0.4 2.7 4.9 0.3 1.1 3.0 3.9 1.1 0.5 1.1 9.0 8.4 5.4 1.1 1.4 6.7 1.3 3.8 0.4 4.3 7.7 1.9 0.5 0.0 0.1 0.1 0.6 0.1 3.2 0.4 0.3 0.0 0.0 1.3 7.0 0.0 8.6 0.2 0.0 1.1 0.0 0.1 0.0 0.1 0.2 0.5 0.8 0.0 0.5 0.1 0.1 0.7 1.8 0.1 0.3 0.3 0.0 0.1 0.0 0.2 0.8 0.2 1.1 0.1 0.1 0.0 1.1 0.0 0.0 0.3 0.1 0.9 0.2 0.1 19.4 0.7 10.6 0.2 26.3 5.1 0.1 0.1 0.8 0.1 0.1 0.5 0.0 0.1 0.0 0.1 5.8 3.8 0.4 0.4 4.8 0.3 3.7 5.5 5.3 3.9 0.8 6.7 6.4 4.6 1.2 4.3 0.2 1.3 7.7 1.9 0.8 0.6 0.4 0.8 0.6 0.7 0.6 0.6 0.7 0.5 0.0 4.8 11.5 4.7 2.4 0.0 0.3 56.0 28.1 12.5 5.2 0.0 4.7 5.0 64.1 2.2 3.3 76.4 0.0 59.4 2.7 2.8 13.2 11.5 1.6 2.2 0.0 3.5 5.5 1.2 0.4 11.5 0.2 16.9 1.0 43.5 8.5 28.2 62.6 4.6 0.0 0.6 0.0 2.2 5.1 2.3 1.1 2.3 10.1 28.3 10.1 CCL3 "G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3" ENSG00000277632 "C-C motif chemokine ligand 3" P10147 17 36088256-36090169 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.7;lymphoid tissue: 18.0" "Group enriched" "Detected in many" 5 "Hofbauer cells: 1808.9;Macrophages: 912.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.2" "Group enriched" "Detected in many" 5 "B-cells: 4.5;granulocytes: 4.0;T-cells: 10.2" "Cell line enhanced" "Detected in some" "Karpas-707: 27.4;U-266/70: 46.9;U-266/84: 118.9" "Secreted to blood" NA NA 138000 "unprognostic (2.41e-1)" "unprognostic (1.87e-1)" "unprognostic (1.45e-1)" "unprognostic (7.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.66e-1)" "unprognostic (3.54e-1)" "unprognostic (8.90e-2)" "unprognostic (7.92e-3)" "unprognostic (2.00e-1)" "unprognostic (7.20e-2)" "unprognostic (2.05e-1)" "unprognostic (8.92e-3)" "unprognostic (1.08e-1)" "unprognostic (9.29e-2)" "unprognostic (1.55e-2)" "unprognostic (1.23e-2)" 5.3 4.3 0.0 5.7 1.6 35.7 2.4 0.5 6.0 0.9 0.9 11.6 0.0 0.8 0.7 1.4 0.4 0.4 3.5 3.4 0.0 0.5 7.9 15.1 5.8 0.0 0.0 2.0 0.4 1.8 0.0 5.7 3.7 0.5 0.9 1.7 1.0 0.2 1.2 0.0 0.8 1.1 0.0 18.0 0.2 3.7 0.0 1.8 0.8 0.5 1.8 2.3 0.0 4.5 0.2 4.0 0.8 1.1 10.2 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.1 46.9 118.9 0.0 0.2 0.0 0.0 0.1 0.8 4.0 10.2 0.5 0.3 1.4 0.3 2.8 0.2 4.5 0.0 3.0 4.0 1.1 0.5 0.0 0.0 4.6 0.0 48.5 43.9 1.0 24.7 1.5 1.6 0.0 4.0 7.9 0.0 0.0 15.8 0.0 0.4 1.2 6.7 0.0 0.0 0.2 19.5 26.9 0.9 23.1 3.2 1808.9 0.0 0.0 19.0 262.3 1.3 1.7 912.4 89.4 37.9 0.0 1.9 0.2 0.0 0.0 0.7 3.6 6.5 9.2 0.5 0.2 25.2 45.4 235.3 0.0 1.1 CCL3L1 "CCL3L3, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1" ENSG00000276085 "C-C motif chemokine ligand 3 like 1" P16619 17 36194869-36196758 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.7;brain: 16.5" "Group enriched" "Detected in some" 18 "Hofbauer cells: 308.0;Macrophages: 77.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 7.7;neutrophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.7" "Group enriched" "Detected in some" 38 "U-266/70: 22.8;U-266/84: 45.4" "Secreted to blood" NA NA "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "unprognostic (5.37e-2)" "unprognostic (1.46e-1)" "unprognostic (9.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.36e-2)" "unprognostic (3.69e-1)" "unprognostic (5.75e-2)" "unprognostic (5.55e-2)" "unprognostic (2.40e-2)" "unprognostic (3.66e-1)" "unprognostic (9.08e-2)" "unprognostic (2.09e-1)" "unprognostic (3.21e-1)" "unprognostic (1.90e-2)" "unprognostic (8.58e-2)" 0.4 0.1 0.0 3.5 2.2 17.7 0.2 0.0 9.0 0.7 0.4 16.5 0.0 0.4 0.6 0.6 0.1 0.2 1.9 0.1 0.0 0.6 2.7 4.0 0.9 0.0 0.1 1.2 0.3 0.1 0.0 3.0 4.4 0.9 0.3 1.9 2.3 0.4 0.1 0.1 0.6 0.3 0.2 2.7 0.3 2.5 0.0 1.3 0.3 0.6 0.7 0.9 0.0 0.0 0.1 7.7 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 22.8 45.4 0.5 0.0 0.0 0.0 0.3 0.1 7.7 0.9 0.0 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.1 3.0 10.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 1.0 0.0 2.3 0.0 308.0 0.0 0.0 0.0 0.0 0.0 0.0 77.5 0.0 2.8 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 11.0 0.0 0.0 0.0 CCL4 "Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4" ENSG00000275302 "C-C motif chemokine ligand 4" P13236 17 36103590-36105621 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 69.3;lung: 23.1;lymphoid tissue: 20.8" "Cell type enhanced" "Detected in many" 16 "Hofbauer cells: 716.7;Macrophages: 396.6;T-cells: 809.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5" "Lineage enriched" "Detected in many" 17 "T-cells: 69.3" "Group enriched" "Detected in some" 23 "Karpas-707: 5.2;U-266/70: 11.5;U-266/84: 5.5" CAB007805 Approved "Secreted to blood" NA NA 144000 "CAB007805: AB_598177" "unprognostic (6.03e-2)" "unprognostic (2.48e-2)" "prognostic favorable (3.54e-4)" "prognostic favorable (1.97e-5)" "unprognostic (2.06e-1)" "unprognostic (7.02e-2)" "unprognostic (9.08e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.97e-4)" "unprognostic (3.45e-1)" "unprognostic (8.57e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (3.71e-1)" "unprognostic (1.30e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-2)" 2.3 2.6 0.0 3.7 0.4 9.3 5.7 0.1 3.6 0.9 2.9 1.4 0.5 0.2 1.6 0.8 1.7 1.6 4.4 3.8 0.0 1.3 5.7 23.1 20.8 1.1 0.0 3.4 0.9 0.0 0.2 4.3 0.9 1.1 1.0 3.9 1.6 1.6 0.5 0.0 0.9 1.4 1.5 10.4 2.3 0.3 0.0 1.0 1.6 2.0 4.3 1.9 0.8 1.8 0.4 4.0 0.6 3.0 69.3 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 5.5 0.3 0.0 0.0 0.0 1.7 0.2 4.0 69.3 0.0 21.8 0.9 7.7 40.6 0.1 1.8 2.3 30.5 1.6 3.0 0.6 0.4 0.0 11.6 0.0 85.1 30.1 1.1 13.9 1.0 10.2 5.1 10.7 12.5 0.0 0.0 7.8 0.0 0.4 21.7 11.3 0.4 0.0 0.3 9.8 13.1 1.2 58.9 4.3 716.7 1.6 1.2 14.7 198.1 23.7 0.9 396.6 49.0 1.8 0.1 1.2 0.1 0.0 0.4 1.8 5.1 0.0 11.3 0.4 0.2 12.7 21.6 809.7 0.0 1.6 CCL4L2 ENSG00000276070 "C-C motif chemokine ligand 4 like 2" Q8NHW4 17 36210924-36212878 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.8;bone marrow: 18.7;lung: 15.2" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 323.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 41.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 41.8" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HMC-1: 8.2;U-266/70: 12.7" "Secreted to blood" NA NA "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" "unprognostic (2.46e-2)" "unprognostic (1.44e-2)" "unprognostic (1.16e-1)" "unprognostic (6.07e-2)" "unprognostic (3.82e-1)" "unprognostic (3.19e-1)" "unprognostic (1.53e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (1.93e-1)" "unprognostic (1.27e-2)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" "unprognostic (8.51e-2)" "unprognostic (1.99e-3)" 0.8 2.4 0.0 4.5 0.6 18.7 8.0 0.3 4.6 0.9 0.4 2.3 0.0 0.6 0.3 0.3 0.1 0.0 4.5 2.1 0.0 0.7 5.0 15.2 8.1 0.6 0.3 0.1 0.1 1.0 0.0 1.0 0.5 0.7 0.8 1.0 1.6 0.0 0.0 0.0 0.5 0.5 0.0 2.6 0.0 0.4 0.4 0.3 0.0 0.9 1.8 1.9 0.0 0.0 0.0 41.8 0.1 0.3 5.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 1.9 1.0 0.0 0.1 0.0 0.2 0.1 41.8 5.6 0.0 1.3 0.0 0.2 3.2 0.0 0.0 0.0 3.3 6.3 0.3 0.0 0.0 0.0 1.5 0.0 10.6 0.0 0.2 0.3 0.4 6.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.6 0.0 0.0 0.0 5.4 3.1 0.5 4.7 0.2 323.5 1.6 0.0 4.3 51.8 0.4 0.0 52.5 1.7 0.0 0.0 0.7 0.1 0.0 0.0 0.0 2.3 12.9 0.4 0.0 0.1 0.4 8.0 78.4 0.0 1.5 CCL5 "D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228" ENSG00000271503 "C-C motif chemokine ligand 5" P13501 17 35871491-35880793 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 169.0" "Cell type enriched" "Detected in many" 5 "T-cells: 1814.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 157.7;memory CD8 T-cell: 169.0" "Lineage enriched" "Detected in many" 4 "T-cells: 169.0" "Cell line enriched" "Detected in some" 4 "NB-4: 73.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" CAB078447 Enhanced "Secreted to blood" NA NA 20100000 8200000 "CAB078447: AB_223462" "unprognostic (3.91e-3)" "unprognostic (1.50e-3)" "unprognostic (8.63e-2)" "prognostic favorable (1.34e-5)" "unprognostic (1.36e-3)" "unprognostic (6.37e-3)" "unprognostic (8.70e-2)" "unprognostic (2.64e-2)" "prognostic favorable (2.42e-4)" "unprognostic (3.26e-3)" "unprognostic (1.64e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.70e-2)" "unprognostic (7.55e-2)" "unprognostic (8.56e-3)" "unprognostic (3.73e-2)" 3.6 2.4 0.0 28.8 0.1 17.1 2.6 0.0 0.2 6.0 14.7 1.0 0.6 7.1 5.0 7.2 5.2 1.7 20.5 7.5 0.0 2.7 4.7 29.8 33.5 2.8 0.0 5.9 2.3 0.0 0.1 4.8 1.7 7.8 4.0 8.0 5.5 6.4 2.8 0.0 38.7 2.3 2.2 38.8 6.9 1.9 0.0 12.2 1.6 5.5 27.9 11.5 0.0 1.2 1.1 9.9 0.6 40.8 169.0 106.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 2.4 2.9 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.1 11.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 73.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.1 0.0 17.1 0.0 0.1 0.0 0.1 0.0 2.2 0.8 0.1 0.0 15.7 0.2 9.9 0.6 0.7 157.7 0.4 103.8 1.2 36.7 169.0 1.1 0.7 8.8 99.3 4.6 40.8 0.5 0.9 0.5 106.5 92.3 350.0 25.5 1.0 6.5 1.1 2.5 0.0 52.2 76.2 1.8 0.0 1.4 1.7 0.8 0.8 18.0 2.6 46.7 0.2 0.7 6.0 1.5 74.4 4.7 28.5 0.0 1.7 48.5 34.1 0.0 0.3 29.5 11.8 2.8 0.3 0.8 1.7 3.5 0.4 5.3 0.4 0.0 7.1 1.0 0.7 5.5 13.4 1814.4 1.1 1.6 CCL7 "FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7" ENSG00000108688 "C-C motif chemokine ligand 7" P80098 17 34270221-34272242 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adipose tissue: 11.5;bone marrow: 22.3" "Cell type enriched" "Detected in some" 8 "Hofbauer cells: 60.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "classical monocyte: 1.1" "Lineage enriched" "Detected in single" 12 "monocytes: 1.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 15.5;BJ hTERT+ SV40 Large T+: 3.2;BJ hTERT+ SV40 Large T+ RasG12V: 4.0;HSkMC: 4.7" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 29700 "unprognostic (7.66e-2)" "unprognostic (1.05e-2)" "unprognostic (8.53e-2)" "unprognostic (4.65e-2)" "unprognostic (2.54e-2)" "unprognostic (9.54e-2)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (2.63e-2)" "unprognostic (2.27e-3)" "unprognostic (7.04e-2)" "unprognostic (1.99e-8)" "unprognostic (2.83e-1)" "unprognostic (8.74e-2)" "unprognostic (3.74e-1)" "unprognostic (1.79e-2)" 11.5 0.6 0.0 2.6 0.0 22.3 0.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.7 0.9 0.1 0.1 0.5 0.2 1.2 0.0 0.1 0.0 1.3 0.4 0.0 0.1 1.7 0.3 0.5 1.0 0.0 0.2 0.0 0.1 0.2 0.2 2.2 0.1 0.1 1.2 0.5 0.0 1.4 0.3 0.0 0.0 0.5 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 2.4 0.0 1.7 15.5 3.2 4.0 0.0 0.0 0.0 0.5 1.1 0.0 1.4 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 4.7 0.0 1.3 0.0 0.0 1.4 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.6 CCL8 "HC14, MCP-2, SCYA8" ENSG00000108700 "C-C motif chemokine ligand 8" P80075 17 34319036-34321402 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.7" "Cell type enriched" "Detected in some" 13 "Smooth muscle cells: 106.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "classical monocyte: 5.8" "Lineage enriched" "Detected in single" 8 "monocytes: 5.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;EFO-21: 4.1;HSkMC: 6.1" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 32000 "unprognostic (7.51e-2)" "unprognostic (3.20e-1)" "unprognostic (1.90e-2)" "unprognostic (4.03e-2)" "unprognostic (8.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.52e-1)" "unprognostic (1.65e-1)" "unprognostic (9.97e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.05e-7)" "unprognostic (1.39e-1)" "unprognostic (1.88e-2)" "unprognostic (5.65e-2)" "unprognostic (3.41e-2)" 10.6 2.8 1.0 7.2 1.2 0.2 4.4 0.6 1.6 0.8 12.0 1.4 1.1 6.9 3.4 3.8 1.2 2.9 3.7 2.4 0.8 0.7 2.8 2.1 8.4 1.3 0.8 0.9 5.3 0.8 6.0 1.6 19.7 1.1 1.5 8.0 5.0 1.1 2.9 1.5 1.3 13.1 4.1 2.4 3.1 1.9 1.6 0.2 2.1 3.0 4.0 2.7 4.4 0.8 0.7 0.2 0.0 5.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.0 1.9 0.0 1.8 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 1.2 0.6 1.6 0.8 0.7 0.8 0.9 1.1 0.2 0.0 0.0 0.0 0.2 3.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.5 0.0 0.0 1.6 0.0 2.8 0.1 0.0 0.0 7.7 0.0 0.0 0.0 0.6 0.8 0.0 4.6 5.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 106.5 0.0 0.0 4.6 0.1 0.0 0.0 0.1 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffolding protein" Q9NUG4 20 32010450-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 22.4;Ito cells: 20.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 10.6;HUVEC TERT2: 12.5;NTERA-2: 6.8;RH-30: 4.7;SCLC-21H: 11.6;TIME: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008434: AB_1845671, HPA071063: AB_2686339" "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 7.2 1.8 2.1 1.8 2.0 0.2 15.0 2.1 2.2 4.4 1.4 1.7 2.1 1.2 7.1 2.3 1.9 2.6 2.4 5.4 2.0 1.7 3.1 1.0 15.1 1.3 2.3 1.5 1.8 1.0 1.4 1.4 6.7 2.5 1.9 1.2 4.9 1.4 2.0 3.5 1.5 1.6 3.2 1.4 53.0 1.4 1.6 1.6 0.2 3.0 5.2 1.0 2.0 4.6 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.5 1.3 0.0 0.0 0.0 3.5 0.0 0.0 6.8 0.2 0.0 0.8 4.7 0.2 0.0 0.0 11.6 1.3 0.3 0.0 0.0 1.7 3.7 0.0 6.3 0.1 2.0 0.0 0.0 0.2 0.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.1 2.0 2.1 2.2 2.0 1.7 2.3 1.5 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.5 3.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 20.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.3 0.0 0.0 0.0 0.0 CCNA1 CT146 ENSG00000133101 "Cyclin A1" P78396 13 36431520-36442882 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;parathyroid gland: 24.2;testis: 50.4" "Group enriched" "Detected in some" 6 "Early spermatids: 98.3;Late spermatids: 70.5;Spermatocytes: 99.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 20.7;ovarian cancer: 18.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 108 "basophil: 24.5" "Lineage enriched" "Detected in single" 233 "granulocytes: 24.5" "Cell line enriched" "Detected in some" 4 "HMC-1: 87.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA060646, HPA077614" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA060646: AB_2684336, HPA077614: " "unprognostic (1.92e-3)" "unprognostic (1.21e-1)" "unprognostic (4.69e-3)" "unprognostic (1.89e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (1.24e-1)" "unprognostic (4.01e-3)" "unprognostic (1.64e-1)" "unprognostic (4.04e-6)" "unprognostic (7.04e-3)" "unprognostic (2.45e-1)" "unprognostic (1.42e-1)" "unprognostic (2.63e-2)" 0.4 0.8 7.3 0.4 6.2 1.3 0.6 0.2 4.7 4.0 0.3 1.6 0.0 0.4 2.6 4.7 0.3 11.1 0.6 0.3 4.5 5.9 0.3 0.2 1.0 1.0 1.9 5.5 1.2 0.5 24.2 4.8 0.2 3.1 0.3 0.3 0.1 0.4 0.2 1.3 0.2 0.3 5.1 1.0 0.3 0.4 50.4 0.4 0.2 0.4 0.0 0.5 0.4 0.6 0.1 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 3.8 0.3 3.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.8 87.1 0.0 8.5 0.1 0.7 1.4 0.2 0.4 0.0 0.1 0.0 1.0 0.1 17.0 0.6 0.0 2.1 0.0 2.0 0.0 0.6 0.0 0.6 1.4 0.0 2.0 0.0 0.4 0.0 17.0 1.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 21.5 0.1 24.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 6.2 0.2 4.7 4.5 5.9 1.9 5.5 3.1 0.4 0.0 1.1 0.0 0.5 0.6 0.2 0.3 0.0 16.0 3.4 0.0 0.0 0.0 0.0 0.1 98.3 0.1 0.0 0.0 0.0 0.6 0.4 0.2 4.7 0.0 0.2 0.0 0.0 0.0 0.0 70.5 2.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 2.5 0.0 0.8 6.5 0.1 99.1 2.5 0.4 0.2 0.0 0.0 0.7 CCNA2 "CCN1, CCNA" ENSG00000145386 "Cyclin A2" P20248 4 121816444-121823933 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 122.3" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 70.0;Extravillous trophoblasts: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 6.8" "Group enriched" "Detected in many" 5 "NK-cells: 1.7;T-cells: 6.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB000114, HPA020626" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB000114: AB_563675, HPA020626: AB_1847376" "unprognostic (4.02e-2)" "unprognostic (1.93e-1)" "unprognostic (7.66e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "prognostic unfavorable (9.17e-5)" "prognostic unfavorable (4.27e-4)" "unprognostic (3.92e-3)" "unprognostic (2.65e-2)" "prognostic unfavorable (4.43e-6)" "unprognostic (8.38e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (6.07e-2)" "unprognostic (1.59e-1)" 3.2 1.5 1.3 18.6 1.7 21.6 1.8 5.1 1.2 2.5 6.3 1.0 0.8 6.6 2.2 2.1 11.7 1.7 2.4 3.2 1.8 1.8 1.7 1.6 3.4 15.6 1.6 0.8 4.5 0.9 0.5 3.2 12.0 1.3 2.2 7.8 1.0 2.1 0.8 1.1 4.2 7.4 2.4 1.8 8.9 2.9 8.4 0.8 122.3 1.4 18.8 18.4 2.5 5.1 0.3 0.9 0.6 0.3 1.7 6.8 1.9 38.7 10.1 27.7 11.8 1.5 3.8 22.7 27.1 11.9 36.0 26.8 22.0 24.1 35.7 7.3 14.2 12.7 13.1 34.8 15.9 29.7 17.1 16.1 28.6 13.4 21.3 0.3 43.1 20.3 1.0 1.2 14.9 8.9 5.7 21.5 19.0 40.7 35.9 28.5 13.9 54.9 25.0 21.8 24.3 11.3 25.2 53.7 17.4 10.2 7.7 11.8 12.5 14.2 17.4 7.5 21.7 14.5 18.3 12.7 16.9 25.7 17.8 25.8 22.8 24.1 40.9 9.7 43.9 18.7 0.0 0.3 0.6 0.2 0.1 0.1 0.3 2.0 1.4 0.9 0.1 0.0 0.5 0.3 1.7 0.3 0.1 6.8 1.9 1.3 1.7 5.1 1.2 1.8 1.8 1.6 0.8 1.3 0.8 0.0 0.6 0.0 0.7 2.5 1.1 0.7 0.0 2.7 1.2 0.0 11.8 5.7 0.0 0.3 4.8 0.7 1.5 70.0 0.2 72.3 3.3 1.1 0.0 1.5 21.0 0.0 1.2 2.5 7.5 1.5 0.9 2.9 1.7 0.0 3.1 1.3 0.4 1.5 1.1 0.0 14.2 0.0 0.9 6.1 7.9 1.1 7.1 3.2 6.4 1.3 CCNB1 CCNB ENSG00000134057 "Cyclin B1" P14635 5 69167010-69178245 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 71.4" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 610.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB000115, CAB003804, HPA030741, HPA061448" Enhanced Enhanced Cytosol Yes Yes Cytosol "CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522" "unprognostic (4.12e-2)" "unprognostic (2.75e-2)" "unprognostic (1.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.78e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.54e-7)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.43e-2)" "unprognostic (1.63e-2)" "unprognostic (2.49e-3)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.44e-1)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.15e-3)" 3.2 4.6 2.7 23.9 4.8 20.5 4.6 6.5 5.6 4.4 9.9 1.6 1.6 9.3 3.5 2.8 28.8 3.3 3.5 1.9 3.5 4.2 4.6 2.9 3.4 23.6 4.0 4.2 3.7 4.0 1.6 2.6 12.1 11.5 2.6 14.2 1.7 5.3 1.7 2.0 6.4 8.7 6.4 2.5 9.1 7.1 21.7 1.3 71.4 6.3 23.3 30.1 5.3 7.5 13.2 5.1 2.4 4.1 6.5 14.7 5.5 58.6 40.6 55.8 49.6 2.9 5.0 131.7 26.0 19.5 68.6 58.1 60.0 55.4 36.1 31.7 23.9 78.7 37.0 56.1 56.8 77.0 35.4 27.7 22.9 33.9 41.4 0.9 19.9 26.2 2.2 3.6 39.3 27.4 6.3 36.6 35.4 27.6 28.7 55.8 55.9 27.2 23.7 31.0 19.5 25.8 28.7 40.2 37.0 25.1 21.7 28.4 17.9 44.7 21.1 19.2 32.8 40.3 20.9 15.3 15.3 49.7 27.6 64.9 14.4 26.6 50.4 21.2 34.9 47.0 2.4 1.8 1.2 2.8 4.1 4.0 13.2 7.6 6.7 5.1 8.6 2.5 2.4 1.0 6.5 1.9 4.2 14.7 5.5 2.7 4.8 6.5 5.6 3.5 4.2 4.0 4.2 11.5 1.3 0.0 0.3 5.2 4.8 10.2 4.2 1.5 2.5 13.4 4.5 5.2 2.0 53.5 1.7 5.3 63.8 1.8 2.9 46.7 1.2 610.8 11.3 3.6 2.3 3.0 50.4 0.0 1.2 6.2 6.0 9.4 2.8 4.4 3.3 3.6 4.6 2.8 2.5 0.0 2.5 4.3 2.9 6.5 3.1 28.8 70.2 6.4 34.7 4.4 11.5 2.7 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105078-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.2;testis: 73.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "T-reg: 17.8" "Lineage enriched" "Detected in many" 6 "T-cells: 17.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 2.0 1.1 0.4 21.0 0.4 24.7 2.5 0.3 0.6 1.8 5.5 0.5 0.2 5.2 1.0 1.5 11.3 0.5 1.6 1.2 0.4 0.4 1.0 1.0 1.9 12.0 0.4 0.3 0.8 0.7 0.0 0.4 6.7 0.4 1.1 6.3 0.4 2.1 0.6 0.4 3.6 5.1 2.0 1.3 5.2 3.0 73.9 0.2 70.2 0.8 10.3 16.0 1.8 3.4 1.8 2.3 0.7 0.1 3.0 17.8 1.8 28.7 25.3 41.6 10.3 1.9 3.8 22.1 23.8 15.3 36.9 30.4 40.9 17.7 26.7 17.3 15.4 21.6 35.5 39.3 20.2 34.9 27.7 21.1 34.6 29.6 23.2 0.5 25.7 22.3 1.4 2.7 15.9 20.3 7.2 25.0 33.0 34.9 42.9 27.8 20.9 29.3 37.5 30.7 12.4 15.0 34.3 58.9 27.1 11.6 20.3 25.9 17.5 32.6 17.7 21.5 34.0 30.7 25.7 13.0 18.4 31.2 20.2 45.3 19.1 28.7 47.5 12.0 58.9 25.9 0.0 0.1 0.6 0.1 0.0 0.2 1.8 3.9 4.1 2.3 0.9 0.0 0.1 0.7 3.0 0.0 0.1 17.8 1.8 0.4 0.4 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.2 0.0 1.1 7.8 1.0 4.2 0.0 0.3 0.0 1.4 2.3 0.0 0.0 26.7 0.0 0.4 102.4 0.4 1.7 163.5 0.2 106.5 1.1 1.7 0.0 0.8 25.3 0.0 2.9 3.1 10.7 30.4 4.0 4.2 0.0 3.6 5.5 0.0 0.5 1.7 1.8 0.0 0.2 0.0 0.0 88.2 36.6 5.4 13.6 3.2 12.4 2.0 CCNB3 ENSG00000147082 "Cyclin B3" Q8WWL7 X 50202713-50351910 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8" "Cell type enhanced" "Detected in some" 20 "Sertoli cells: 12.9;Spermatocytes: 17.4;Spermatogonia: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;GAMG: 6.1" "Low region specificity" "Detected in all" HPA000496 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA000496: AB_1078605" "unprognostic (1.57e-1)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-3)" "unprognostic (8.11e-2)" "unprognostic (1.86e-1)" "unprognostic (1.82e-2)" "unprognostic (1.34e-2)" "unprognostic (1.48e-3)" "unprognostic (6.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.67e-1)" "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (4.51e-2)" "unprognostic (2.63e-2)" 0.7 0.7 0.9 0.3 3.5 0.2 0.8 0.4 1.7 0.4 0.4 5.8 0.0 0.4 0.3 11.6 0.4 0.7 0.6 0.6 1.3 1.5 0.7 1.1 0.7 0.4 2.4 2.0 0.4 0.9 0.7 3.7 0.9 4.3 0.5 0.4 0.0 0.5 0.8 1.4 1.0 0.3 0.3 6.1 0.6 1.0 14.8 1.3 0.1 0.9 1.1 0.5 0.4 0.2 0.3 0.3 0.0 0.5 0.0 2.2 0.1 0.3 1.3 0.7 0.4 0.2 0.2 0.0 0.1 0.2 0.2 0.3 1.1 4.3 1.2 0.8 0.3 6.1 0.2 0.6 0.4 0.2 1.1 1.4 0.9 0.0 0.0 1.2 0.9 0.9 0.7 0.2 0.3 0.8 0.1 0.4 3.2 0.1 3.5 1.1 0.0 0.6 0.1 0.6 0.5 0.0 0.0 1.5 0.1 0.2 0.4 0.1 0.8 0.4 0.2 0.9 0.5 3.0 0.2 0.4 1.8 3.1 0.8 0.5 0.9 0.6 1.9 0.5 0.4 0.2 0.0 0.0 0.0 2.2 0.5 0.3 0.3 0.5 0.0 0.3 0.3 0.4 1.0 0.0 0.0 0.3 0.0 0.1 0.1 0.9 3.5 0.4 1.7 1.3 1.5 2.4 2.0 4.3 1.3 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.6 0.6 0.9 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 12.9 0.0 17.4 3.8 0.1 0.0 0.0 0.0 0.0 CCND3 ENSG00000112576 "Cyclin D3" P30281 6 41934933-42050357 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 129.2;lymphoid tissue: 142.5" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 197.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 94.2;REH: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000116, HPA042871" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB000116: , HPA042871: " "unprognostic (4.53e-2)" "unprognostic (4.45e-2)" "unprognostic (2.45e-1)" "unprognostic (4.40e-3)" "unprognostic (1.01e-1)" "unprognostic (9.80e-2)" "unprognostic (3.40e-2)" "unprognostic (5.25e-2)" "unprognostic (7.76e-2)" "unprognostic (3.45e-1)" "unprognostic (9.17e-2)" "unprognostic (6.39e-2)" "unprognostic (2.45e-3)" "unprognostic (9.12e-2)" "unprognostic (1.71e-1)" "prognostic favorable (8.08e-6)" "unprognostic (2.11e-1)" 20.2 39.8 16.1 28.9 17.5 74.7 36.0 13.3 19.8 13.3 17.3 11.3 14.1 16.0 10.8 10.4 13.5 13.4 19.0 16.3 15.4 14.5 13.7 8.0 32.1 83.8 14.1 15.5 11.1 10.9 5.0 10.1 21.9 9.3 14.2 11.4 10.2 18.1 14.4 6.5 14.6 22.0 11.7 11.5 51.2 18.0 7.4 10.0 142.5 26.8 9.3 32.8 13.0 16.6 24.1 42.4 129.2 45.8 39.0 52.8 66.2 9.2 33.7 3.5 7.8 6.4 13.2 40.9 10.8 6.2 11.2 8.2 6.3 4.2 39.7 18.4 7.2 10.0 5.7 9.4 13.2 5.8 6.7 6.1 62.9 15.0 5.1 14.1 10.2 55.6 12.5 8.7 10.8 4.1 3.4 13.7 26.7 31.7 3.9 16.0 12.5 94.2 49.4 1.5 28.4 7.2 89.5 13.7 4.4 25.9 6.2 12.0 3.1 9.2 11.8 5.3 4.7 7.3 40.2 22.9 12.5 6.9 10.7 12.1 2.5 2.0 62.1 7.3 21.7 7.5 129.2 30.5 87.7 52.8 35.1 37.0 16.4 36.4 42.5 42.4 24.1 42.8 45.0 42.8 39.0 45.8 27.8 23.2 66.2 16.1 17.5 13.3 19.8 15.4 14.5 14.1 15.5 9.3 10.0 56.6 64.8 78.2 82.2 24.0 9.3 21.8 56.0 16.0 18.2 19.2 5.9 150.0 24.9 17.1 12.1 47.0 34.6 93.5 21.5 66.5 22.6 44.0 25.5 3.9 39.8 11.1 9.2 55.9 111.4 7.4 38.3 68.6 35.4 7.2 16.9 35.9 21.6 28.8 48.8 13.2 14.6 45.3 26.8 1.7 5.7 19.7 197.8 130.7 19.5 56.2 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197176 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.4" "Cell type enhanced" "Detected in all" 12 "Cytotrophoblasts: 313.6;Syncytiotrophoblasts: 883.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "HEL: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: AB_2677282" "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 15.6 10.9 3.4 12.6 5.3 55.4 17.5 10.8 9.5 8.8 9.4 5.6 11.5 7.6 11.3 10.7 18.3 10.4 9.6 14.1 3.9 6.9 8.2 8.4 11.6 23.6 6.1 5.6 5.6 13.4 5.2 9.6 24.1 9.3 8.8 9.0 7.7 11.3 12.8 21.1 12.0 12.9 8.2 6.0 12.8 11.8 5.9 5.4 8.3 15.6 5.9 11.0 15.9 11.7 5.4 2.9 16.9 8.0 4.6 7.6 1.6 0.3 0.4 0.6 0.3 1.6 1.1 0.6 0.4 2.0 0.4 0.4 0.5 0.4 0.6 0.5 1.4 0.2 0.6 1.4 0.6 0.3 0.9 1.4 16.9 0.8 0.6 1.2 0.8 1.0 2.0 1.6 0.2 0.6 1.7 1.3 0.3 1.0 0.6 0.6 0.0 0.5 1.9 1.2 0.7 0.5 0.5 0.6 1.5 2.2 0.7 0.8 1.3 0.6 0.5 0.4 0.7 0.1 1.6 1.6 0.5 0.2 1.3 0.3 2.0 0.7 0.3 1.7 1.8 0.5 16.9 1.9 4.9 5.2 3.3 5.4 4.4 5.6 5.1 1.6 5.4 5.9 6.1 6.1 4.6 8.0 2.9 7.6 1.6 3.4 5.3 10.8 9.5 3.9 6.9 6.1 5.6 9.3 5.4 44.7 55.2 77.3 44.9 30.8 27.2 52.0 35.7 92.3 50.0 27.9 19.6 313.6 76.3 59.3 11.5 45.0 55.7 140.2 52.3 67.6 49.5 41.5 54.4 28.2 77.3 42.9 44.4 47.9 82.6 10.0 43.7 59.8 60.8 151.5 49.4 52.2 58.5 56.1 27.6 38.5 63.1 45.3 48.9 65.4 36.8 35.3 883.1 83.0 45.2 73.2 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811898-29824308 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3;placenta: 46.7" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1526.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 81.6" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.6 6.8 2.4 4.5 2.9 23.3 0.6 6.3 3.3 0.8 3.0 1.7 1.1 2.3 1.2 0.6 4.7 0.7 2.2 4.4 2.3 2.8 1.2 0.7 1.1 4.6 1.9 1.9 0.9 1.4 1.7 1.0 46.7 2.8 1.1 3.8 1.5 3.2 1.2 2.2 4.4 2.5 3.0 1.7 4.6 2.0 12.3 1.6 4.1 1.6 2.1 5.9 2.7 2.5 2.7 1.6 1.6 1.9 0.0 1.4 0.5 4.1 8.6 6.6 9.4 1.4 1.6 81.6 6.6 1.4 2.9 3.6 8.7 8.4 3.5 15.7 2.9 3.8 1.3 7.8 3.4 4.2 11.1 4.8 2.9 8.4 9.1 1.1 11.5 7.9 1.7 1.9 4.0 0.5 0.9 3.5 3.5 11.8 1.6 4.4 6.2 6.3 3.3 11.0 9.4 2.0 9.5 7.7 2.6 2.2 6.6 5.6 4.7 9.5 11.7 1.0 10.1 2.6 8.6 2.0 6.9 25.9 4.1 4.4 6.6 4.6 23.9 3.9 1.4 3.7 0.0 0.1 0.0 0.6 1.9 1.1 2.7 0.5 0.4 1.6 0.2 0.1 0.9 1.6 0.0 1.9 0.0 1.4 0.5 2.4 2.9 6.3 3.3 2.3 2.8 1.9 1.9 2.8 1.6 0.0 1.1 0.8 1.0 4.2 2.4 2.8 0.0 0.0 2.3 0.0 0.0 112.5 0.0 0.4 7.1 1.1 1.7 0.0 0.6 1526.8 4.8 1.9 0.0 0.0 37.5 3.2 2.9 1.3 0.3 2.6 1.1 1.1 1.7 0.0 2.7 1.8 1.0 2.9 2.1 0.2 0.8 6.5 3.1 14.1 19.5 5.3 96.8 2.2 3.8 2.4 CCNE2 CYCE2 ENSG00000175305 "Cyclin E2" O96020 8 94879770-94896678 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.2;brain: 22.2;testis: 18.9" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 50.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 8.8" "Group enriched" "Detected in many" 4 "NK-cells: 2.2;T-cells: 8.8" "Cell line enhanced" "Detected in many" "Karpas-707: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007825, CAB019374" Enhanced NA Yes "CAB007825: AB_598148, CAB019374: " "unprognostic (1.80e-2)" "unprognostic (4.81e-2)" "unprognostic (7.49e-2)" "unprognostic (2.08e-2)" "unprognostic (2.36e-1)" "prognostic favorable (5.87e-4)" "unprognostic (8.37e-4)" "prognostic unfavorable (8.77e-4)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.64e-2)" "unprognostic (1.04e-2)" "unprognostic (7.01e-12)" "unprognostic (1.81e-2)" "unprognostic (1.50e-1)" "unprognostic (1.06e-2)" "unprognostic (3.03e-1)" 1.3 0.9 3.1 4.9 11.3 24.2 1.5 3.3 6.3 1.7 4.0 10.4 0.0 2.6 1.3 0.1 3.6 1.0 1.7 0.9 5.7 3.5 0.9 1.6 1.7 7.9 8.0 6.5 1.4 2.3 0.5 1.1 3.1 11.8 1.3 4.3 0.6 1.5 0.0 0.8 4.4 3.1 1.4 22.2 1.9 2.9 18.9 4.9 12.7 1.1 2.4 7.0 1.9 1.9 1.1 1.3 1.1 0.3 2.2 8.8 1.1 17.9 2.4 9.6 5.9 1.2 2.2 6.6 18.5 6.4 11.6 11.5 4.3 8.1 9.4 12.6 7.8 3.6 9.5 7.4 6.7 15.8 6.6 6.8 19.0 10.1 1.6 0.1 7.6 11.6 0.6 0.4 8.4 0.8 2.5 5.9 11.7 8.1 39.7 16.5 5.2 29.0 3.5 3.2 14.4 5.5 20.7 16.5 4.5 3.2 10.1 13.9 5.8 12.4 3.3 2.3 1.2 16.7 8.0 5.0 12.4 8.1 9.1 16.5 7.6 7.9 22.9 10.0 13.9 9.0 0.0 0.3 0.2 1.6 0.3 0.5 0.7 2.0 2.3 1.3 1.1 0.6 1.3 1.1 2.2 0.3 0.1 8.8 1.1 3.1 11.3 3.3 5.7 5.7 3.5 8.0 6.5 11.8 4.9 6.0 1.7 0.0 0.8 3.8 2.0 1.7 0.0 1.4 2.3 1.8 5.9 2.6 0.0 0.2 5.6 2.1 8.2 0.0 0.2 7.0 1.1 1.0 0.0 0.9 3.8 7.9 0.0 3.1 2.7 6.1 1.1 1.7 0.0 0.0 2.4 1.0 0.1 0.6 0.4 0.0 4.2 6.5 2.1 50.4 5.0 3.3 1.6 6.9 1.7 0.4 CCNF "FBX1, FBXO1" ENSG00000162063 "Cyclin F" P41002 16 2429394-2458854 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.7" "Cell type enriched" "Detected in many" 6 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060596, HPA070495, HPA071600" Enhanced Supported Centrosome NA Yes Centrosome "HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424" "unprognostic (3.87e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-3)" "unprognostic (3.70e-3)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (7.46e-7)" "unprognostic (2.45e-2)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-2)" "unprognostic (1.10e-2)" "unprognostic (4.25e-2)" "unprognostic (2.74e-1)" 2.1 1.8 4.1 6.0 3.2 9.2 5.1 11.6 4.9 2.1 3.0 1.9 3.6 4.4 1.5 3.4 8.1 1.5 1.5 1.8 4.3 3.9 1.7 1.6 2.2 10.5 1.9 3.1 1.8 1.7 0.8 1.8 3.8 2.4 3.0 3.2 0.7 3.2 3.4 2.5 7.2 3.2 1.8 1.7 4.7 2.6 5.1 2.3 35.7 1.6 3.4 14.2 5.0 2.9 2.7 1.4 0.1 1.1 4.1 3.1 1.7 8.4 13.4 12.9 11.8 0.8 1.2 10.1 10.2 5.0 14.3 11.0 26.6 10.4 17.9 3.5 5.7 4.2 14.4 21.3 7.9 6.8 12.7 10.1 19.6 13.9 8.1 1.0 12.8 12.9 0.8 1.0 10.1 4.8 1.8 10.6 15.1 20.8 11.7 7.2 18.4 18.7 8.5 12.7 9.1 6.1 31.4 15.1 16.0 3.9 3.7 12.5 7.0 15.2 13.3 2.8 6.7 14.2 6.6 7.3 7.9 20.5 5.6 10.6 7.2 8.6 30.9 2.3 12.8 10.7 0.0 1.1 0.0 2.8 0.6 1.7 2.7 1.5 3.1 0.5 2.6 1.2 1.7 0.1 4.1 0.9 1.4 2.2 1.7 4.1 3.2 11.6 4.9 4.3 3.9 1.9 3.1 2.4 2.3 0.0 4.6 0.8 2.1 2.5 4.6 1.7 0.0 0.0 2.3 1.8 11.8 0.8 0.0 1.0 0.8 1.3 0.7 70.0 0.5 10.5 0.9 1.2 1.1 0.8 5.0 7.9 1.2 1.8 1.6 0.0 1.7 1.0 5.0 1.0 1.9 0.6 0.9 0.0 2.5 0.2 1.3 0.0 2.7 2.1 5.1 1.0 1.6 1.5 1.8 1.4 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047158-77076005 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 248.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533" "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 49.0 26.6 48.1 47.1 45.8 50.3 121.1 101.3 248.9 66.3 56.8 21.6 36.9 25.6 56.7 69.0 56.2 50.7 45.2 87.7 44.8 34.1 48.2 34.5 64.7 70.1 55.8 33.5 94.9 65.4 36.5 33.1 35.4 46.7 61.4 34.9 32.7 45.5 62.9 64.3 38.5 45.8 61.6 58.1 41.3 42.4 53.0 20.3 55.4 81.2 28.2 60.0 82.7 62.6 49.2 42.9 70.5 39.8 33.6 56.2 24.3 24.6 14.8 48.4 42.2 72.8 66.6 18.5 19.1 46.7 30.2 29.2 18.2 37.6 45.6 29.3 47.8 18.9 12.9 33.0 66.7 48.2 32.3 13.0 27.3 17.3 17.3 71.5 46.8 55.2 52.0 79.9 27.8 68.4 86.9 42.3 24.1 23.3 49.7 42.9 28.4 60.8 44.3 21.2 17.3 9.2 38.2 45.7 19.2 45.0 28.2 61.4 33.6 25.3 38.9 30.8 35.4 22.1 20.0 28.6 37.0 22.1 39.3 25.9 27.6 12.5 48.2 31.3 32.4 23.9 43.1 32.9 70.5 31.7 33.4 44.9 46.6 52.4 47.2 37.3 49.2 56.2 47.4 47.0 33.6 39.8 42.9 44.8 24.3 48.1 45.8 101.3 248.9 44.8 34.1 55.8 33.5 46.7 20.3 160.8 205.6 381.1 554.3 375.7 387.2 381.6 262.4 87.0 102.4 186.7 64.8 225.4 673.1 338.9 56.4 305.8 254.0 186.9 291.0 357.2 371.0 733.0 274.5 108.3 295.2 171.6 395.9 297.7 542.3 122.9 559.2 420.6 381.3 312.8 295.3 254.5 414.7 272.5 929.9 450.1 187.1 543.3 450.1 159.5 349.2 345.0 317.4 433.7 302.4 523.8 CCNI2 FLJ16793 ENSG00000205089 "Cyclin I family member 2" Q6ZMN8 5 132747445-132754403 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 17.4;seminal vesicle: 15.7" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Mucus-secreting cells: 3.3;Muller glia cells: 4.2;Paneth cells: 2.9;Undifferentiated cells: 3.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.0" HPA056288 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA056288: AB_2683086" "unprognostic (3.84e-2)" "unprognostic (2.44e-3)" "prognostic favorable (8.21e-4)" "unprognostic (5.97e-2)" "unprognostic (3.39e-1)" "unprognostic (6.71e-3)" "unprognostic (1.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (1.77e-1)" "unprognostic (4.95e-1)" "unprognostic (1.71e-7)" "unprognostic (1.58e-1)" 0.3 0.7 3.4 5.6 3.5 0.3 0.3 8.4 4.7 1.2 5.8 3.5 17.4 7.8 0.2 0.7 0.5 0.8 5.2 0.6 3.9 2.6 3.8 0.3 0.7 1.7 3.9 0.5 0.3 7.4 0.4 0.9 0.5 4.1 1.7 6.5 1.5 8.4 15.7 0.7 0.7 8.9 0.4 7.2 0.8 5.5 1.4 3.9 7.0 0.8 0.7 2.1 2.4 0.3 0.3 0.1 0.7 0.1 0.2 2.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.4 0.0 0.6 24.0 0.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 1.4 1.0 0.3 0.3 0.0 0.0 0.0 0.0 1.7 3.7 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.3 0.1 2.7 0.3 2.1 2.1 0.0 0.3 1.8 0.9 0.3 0.2 0.1 0.1 2.7 0.3 3.4 3.5 8.4 2.8 3.9 2.6 3.9 0.5 4.1 3.9 0.0 0.3 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.4 1.7 0.0 1.7 0.0 1.4 0.1 0.0 0.9 1.1 0.0 0.1 1.6 1.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 3.3 4.2 1.2 2.9 0.0 0.3 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 3.5 0.6 CCNJL FLJ14166 ENSG00000135083 "Cyclin J like" Q8IV13 5 160249106-160345396 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 48.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 25.5;Mucus-secreting cells: 27.9;Paneth cells: 20.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 19 "cerebellum: 48.9" "Group enriched" "Detected in some" 19 "neutrophil: 13.5;NK-cell: 4.1" "Group enriched" "Detected in many" 35 "granulocytes: 13.5;NK-cells: 4.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.8;WM-115: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049970 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049970: AB_2680974" "unprognostic (1.09e-2)" "unprognostic (2.36e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.50e-3)" "unprognostic (1.79e-1)" "unprognostic (4.31e-2)" "unprognostic (1.60e-4)" "unprognostic (1.26e-2)" "unprognostic (6.92e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.75e-2)" "unprognostic (6.27e-3)" "unprognostic (6.63e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.10e-4)" "prognostic favorable (8.02e-4)" 1.0 3.0 0.9 3.4 1.2 1.3 2.1 48.9 1.5 2.1 9.0 0.9 1.5 1.8 1.1 1.5 0.8 1.0 1.0 4.4 2.5 0.8 2.7 1.2 9.0 2.5 1.5 1.1 5.3 0.2 0.0 17.0 1.7 2.1 2.0 7.9 3.9 7.6 2.0 0.6 0.4 2.7 1.0 0.9 5.8 4.4 10.7 1.2 4.8 8.4 1.7 2.6 4.0 5.4 0.1 0.2 13.5 0.0 4.1 0.0 0.2 3.0 11.3 9.2 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.4 4.9 8.8 0.0 8.7 0.1 7.7 3.8 1.2 26.8 0.7 0.0 0.2 4.8 4.0 3.5 0.1 0.0 1.0 0.0 2.3 1.5 6.7 5.7 6.8 3.1 0.0 0.0 2.9 1.6 0.0 7.9 8.5 0.0 6.3 1.8 3.0 1.0 7.1 14.3 3.1 8.3 1.5 2.3 10.2 3.6 5.1 0.5 8.2 1.6 10.3 0.0 5.6 0.0 0.0 0.0 0.0 0.0 20.3 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 13.5 4.1 0.0 0.2 0.0 0.2 0.9 1.2 48.9 1.5 2.5 0.8 1.5 1.1 2.1 1.2 20.8 25.5 0.0 1.2 0.2 0.6 4.8 0.0 1.4 7.9 3.5 0.0 0.0 5.0 2.6 0.7 0.9 3.6 0.0 0.2 0.0 1.3 0.8 1.1 0.0 0.1 0.0 2.4 1.8 0.0 3.0 2.0 0.1 5.0 1.0 27.9 7.3 1.1 20.1 2.5 0.0 0.0 0.0 1.0 0.5 5.7 0.4 0.0 0.0 2.3 1.6 CCNO "CCNU, FLJ22422, UDG2, UNG2" ENSG00000152669 "Cyclin O" P22674 5 55231152-55233680 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation" Cyclin "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 28.1;epididymis: 18.2;seminal vesicle: 23.2" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 66.9;Collecting duct cells: 31.4;Exocrine glandular cells: 25.0;Spermatocytes: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 6.6;PC-3: 5.5;T-47d: 8.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA050090 Uncertain NA NA "HPA050090: AB_2681011" "unprognostic (3.44e-2)" "unprognostic (5.20e-2)" "unprognostic (5.28e-2)" "prognostic favorable (6.78e-4)" "unprognostic (3.96e-2)" "unprognostic (2.60e-1)" "unprognostic (3.18e-3)" "prognostic favorable (7.60e-4)" "unprognostic (3.54e-2)" "unprognostic (2.10e-1)" "unprognostic (1.92e-1)" "unprognostic (3.09e-1)" "unprognostic (3.03e-2)" "prognostic favorable (5.10e-4)" "unprognostic (1.81e-1)" "unprognostic (9.49e-2)" "unprognostic (8.88e-3)" 0.7 0.8 1.3 0.8 7.2 0.6 0.7 1.7 4.5 1.9 1.2 1.3 28.1 1.4 1.1 18.2 0.9 4.0 3.5 0.6 1.3 2.0 2.2 0.7 1.3 0.8 0.1 1.6 1.4 9.5 3.0 5.4 0.8 4.3 1.8 0.5 1.6 6.5 23.2 0.5 3.1 2.1 0.6 0.1 0.6 5.3 12.2 0.1 0.0 7.4 0.8 0.9 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.4 3.8 0.0 1.5 0.3 0.0 6.6 0.0 0.0 0.5 0.6 0.0 4.0 0.0 2.7 0.0 2.4 3.0 0.1 0.0 0.0 0.0 5.1 0.1 2.9 0.4 0.0 0.4 1.0 0.0 0.7 0.0 0.0 0.5 0.0 2.0 0.2 0.0 0.0 2.0 0.0 0.1 0.5 0.4 5.5 2.0 0.4 0.1 1.4 0.9 3.0 0.0 4.7 1.2 1.0 0.0 8.9 0.5 0.3 0.0 3.2 3.7 1.6 3.5 1.8 0.0 2.4 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 7.2 1.7 4.5 1.3 2.0 0.1 1.6 4.3 0.1 0.0 1.0 0.0 4.2 0.9 3.4 0.4 5.1 66.9 10.3 31.4 5.9 0.6 0.0 3.0 5.4 0.3 3.8 0.0 25.0 1.5 0.3 7.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 2.2 1.1 0.3 1.7 0.0 1.9 0.0 12.1 1.4 0.4 0.7 0.2 0.0 0.2 43.9 18.1 2.0 0.2 0.0 1.5 5.4 CCP110 "CP110, KIAA0419" ENSG00000103540 "Centriolar coiled-coil protein 110" O43303 16 19523811-19553408 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.0" "Cell type enhanced" "Detected in all" 8 "Ciliated cells: 147.2;Spermatocytes: 156.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039402 Approved Supported Centrosome NA NA Centrosome "HPA039402: AB_10671041" "unprognostic (2.83e-1)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-1)" "unprognostic (4.88e-2)" "unprognostic (9.68e-2)" "unprognostic (3.25e-2)" "unprognostic (2.68e-1)" "unprognostic (6.50e-2)" "unprognostic (1.92e-2)" "unprognostic (8.99e-3)" "unprognostic (2.74e-2)" "unprognostic (1.82e-1)" "unprognostic (3.01e-2)" "unprognostic (1.37e-1)" 5.2 5.9 19.0 6.0 39.1 12.6 9.0 19.1 28.4 7.6 4.5 13.2 4.6 3.7 8.9 7.3 6.4 13.0 5.7 4.4 23.6 15.0 4.5 3.4 8.1 7.1 40.0 13.3 10.6 3.7 9.6 17.2 4.6 20.6 7.3 5.5 2.1 4.8 7.1 4.3 5.5 4.5 7.6 16.0 5.8 6.1 31.6 36.6 10.9 6.9 1.9 7.1 5.7 6.6 4.5 4.0 13.0 5.3 2.3 5.6 2.5 11.3 5.2 13.1 12.6 6.5 5.9 6.7 12.2 7.0 10.9 12.3 4.2 6.1 16.7 7.7 5.9 8.2 8.0 13.4 3.8 18.3 7.6 6.1 8.3 7.3 7.3 3.3 21.4 10.8 2.8 5.3 12.2 7.5 6.7 8.3 17.2 8.7 8.4 12.6 8.8 21.8 8.3 10.0 5.4 4.0 27.9 24.4 5.8 5.0 4.8 25.8 13.1 13.1 6.3 3.9 9.1 11.5 13.1 4.9 12.7 8.4 8.5 9.9 9.4 8.7 12.2 8.1 9.2 7.4 13.0 3.8 6.7 5.5 3.6 3.5 3.3 4.9 5.2 4.0 4.5 5.6 3.2 7.7 2.3 5.3 2.6 3.9 2.5 19.0 39.1 19.1 28.4 23.6 15.0 40.0 13.3 20.6 36.6 29.8 28.8 15.2 7.6 11.9 15.8 10.9 12.7 147.2 39.8 22.7 31.4 9.2 5.0 8.1 3.0 7.7 5.6 23.3 4.1 5.8 15.8 11.8 27.9 5.5 6.2 28.6 1.2 9.8 14.6 6.4 19.5 9.8 10.1 5.4 8.7 16.7 6.6 6.6 15.6 3.8 64.9 19.4 13.7 156.0 36.8 12.8 20.5 11.7 6.0 5.9 CCR1 "CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1" ENSG00000163823 "C-C motif chemokine receptor 1" P32246 3 46201709-46208396 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.0;lymphoid tissue: 40.2" "Group enriched" "Detected in many" 17 "Extravillous trophoblasts: 72.1;Hofbauer cells: 97.6;Kupffer cells: 150.1;Macrophages: 66.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 78.3;RPMI-8226: 36.0;U-266/70: 13.8;U-266/84: 40.5" "Low region specificity" "Detected in all" NA NA "unprognostic (3.95e-1)" "unprognostic (2.17e-1)" "unprognostic (1.20e-1)" "unprognostic (2.16e-1)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" "unprognostic (4.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.09e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.08e-1)" "unprognostic (5.52e-3)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" 21.2 6.0 5.1 23.8 8.4 11.2 4.9 1.0 3.7 1.9 2.9 7.2 0.5 3.9 2.0 5.1 2.0 4.5 6.7 4.1 5.4 3.2 4.4 9.6 11.6 26.3 9.0 1.6 2.8 2.3 1.0 2.6 14.9 6.9 2.3 4.1 2.9 3.3 1.3 1.4 1.4 4.5 8.5 11.6 40.2 2.9 1.2 8.7 2.2 1.8 1.0 5.5 6.9 1.5 0.9 15.3 32.5 34.0 22.1 15.3 11.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 36.0 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.2 0.0 8.2 0.0 0.2 0.0 0.0 0.0 13.8 40.5 0.0 7.0 6.1 0.1 21.5 34.0 6.8 3.1 21.4 15.3 0.9 0.0 2.5 15.3 0.0 0.0 0.4 32.5 22.1 13.1 5.5 0.0 11.8 5.1 8.4 1.0 3.3 5.4 3.2 9.0 1.6 6.9 8.7 3.0 4.0 5.4 0.0 0.8 0.0 0.4 0.0 2.7 2.3 0.0 0.0 0.6 1.7 0.0 0.2 0.5 0.0 0.0 0.0 72.1 1.5 0.0 3.5 0.8 97.6 0.0 0.0 2.5 150.1 0.0 0.0 66.6 5.0 0.0 0.0 0.4 0.1 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 1.5 2.4 5.7 0.0 0.0 CCR10 GPR2 ENSG00000184451 "C-C motif chemokine receptor 10" P46092 17 42678889-42683917 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 12.0;Sertoli cells: 19.4;Smooth muscle cells: 10.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 31.1" "Group enriched" "Detected in many" 9 "dendritic cells: 10.9;T-cells: 31.1" "Cell line enhanced" "Detected in some" "Karpas-707: 8.8;RPMI-8226: 6.4;U-266/70: 18.1;U-266/84: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011684, HPA048007, HPA069188" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB011684: AB_731502, HPA048007: AB_2680232, HPA069188: AB_2686100" "unprognostic (3.25e-2)" "unprognostic (2.71e-2)" "unprognostic (5.70e-2)" "unprognostic (2.41e-2)" "unprognostic (5.25e-2)" "unprognostic (2.23e-3)" "unprognostic (5.18e-4)" "unprognostic (1.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.56e-1)" "unprognostic (1.21e-3)" "unprognostic (1.01e-2)" "unprognostic (2.32e-11)" "unprognostic (2.84e-2)" "unprognostic (1.53e-1)" "unprognostic (1.88e-2)" "unprognostic (1.87e-1)" 10.0 5.4 5.7 4.8 5.3 0.7 3.0 7.3 7.3 3.9 9.7 0.9 1.5 5.1 5.8 1.4 1.5 4.5 1.5 2.5 3.5 5.0 1.6 0.5 2.2 12.5 1.9 5.0 5.2 2.6 0.4 14.0 2.3 4.1 2.1 1.0 1.1 4.0 2.0 9.1 1.1 8.7 1.8 4.4 4.3 5.0 2.2 1.2 0.5 1.5 0.3 3.6 1.0 2.0 2.3 10.9 0.1 0.3 0.0 31.1 0.7 0.5 0.8 1.1 5.0 0.3 0.8 1.2 2.5 0.5 0.2 0.4 0.7 0.3 0.1 0.3 0.3 2.2 0.9 0.0 0.1 0.2 2.3 1.2 0.0 3.2 0.4 0.7 0.0 0.3 0.8 0.0 0.4 0.0 0.9 0.2 0.3 2.6 8.8 0.0 0.3 0.1 2.4 0.6 0.0 1.2 0.6 0.2 6.4 1.1 0.0 0.8 1.1 0.7 0.0 0.2 0.5 0.8 0.9 2.4 2.9 0.6 0.9 0.3 18.1 8.2 2.6 1.4 0.7 0.9 0.0 0.3 0.1 0.2 0.0 0.1 2.3 5.2 2.6 0.2 2.1 0.6 0.8 0.0 0.0 0.1 10.9 31.1 0.7 5.7 5.3 7.3 7.3 3.5 5.0 1.9 5.0 4.1 1.2 0.0 0.0 0.0 0.2 0.7 12.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.3 0.4 1.4 0.0 0.0 0.5 0.2 2.3 0.3 0.0 0.0 1.7 1.6 1.7 1.3 1.8 1.8 5.2 1.2 5.0 5.4 0.1 2.0 0.2 0.0 2.5 0.6 3.1 19.4 10.3 0.7 0.7 0.3 0.0 0.5 0.4 0.1 CCR2 "CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R" ENSG00000121807 "C-C motif chemokine receptor 2" P41597 3 46353734-46360928 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Host-virus interaction, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 96.3;lymphoid tissue: 36.1" "Cell type enriched" "Detected in some" 6 "Kupffer cells: 61.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 96.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 48.6;THP-1: 23.0;U-266/70: 111.8;U-266/84: 44.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" CAB003793 Approved NA NA "CAB003793: AB_344889" "unprognostic (1.09e-2)" "unprognostic (6.28e-4)" "unprognostic (3.49e-2)" "unprognostic (6.35e-4)" "unprognostic (1.89e-2)" "unprognostic (4.16e-4)" "unprognostic (8.06e-2)" "prognostic favorable (5.87e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (3.12e-1)" "unprognostic (1.56e-1)" "unprognostic (5.52e-3)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (4.88e-2)" "unprognostic (4.19e-1)" 2.5 1.3 0.6 20.7 0.8 0.9 1.9 0.5 0.8 4.3 5.8 0.5 1.5 5.6 2.6 2.4 6.1 2.2 2.5 1.8 0.6 0.6 3.7 1.8 8.6 30.1 1.6 0.1 1.7 1.7 0.0 0.8 2.1 1.8 3.7 4.0 2.6 10.2 3.5 0.8 1.3 7.3 5.6 1.5 36.1 3.7 1.5 0.5 3.6 2.0 3.5 5.9 5.8 1.7 1.6 29.0 96.3 28.4 2.5 19.3 13.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 48.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 111.8 44.5 0.0 0.0 0.8 0.0 96.3 28.4 0.4 2.5 2.6 19.3 1.6 5.2 4.2 29.0 0.3 0.1 0.1 0.7 2.5 0.0 23.0 2.3 13.5 0.6 0.8 0.5 0.8 0.6 0.6 1.6 0.1 1.8 0.5 0.0 2.2 7.8 0.0 0.2 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 3.1 61.3 0.4 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 CCR3 "CC-CKR-3, CD193, CKR3, CMKBR3" ENSG00000183625 "C-C motif chemokine receptor 3" P51677 3 46163604-46266706 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "blood: 175.9" "Cell type enhanced" "Detected in some" 17 "granulocytes: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 22 "basophil: 175.9;eosinophil: 152.0" "Lineage enriched" "Detected in many" 92 "granulocytes: 175.9" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB003795, HPA069514" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "CAB003795: AB_562259, HPA069514: " "unprognostic (1.56e-2)" "unprognostic (6.65e-3)" "unprognostic (1.01e-1)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (3.25e-3)" "unprognostic (3.11e-7)" "unprognostic (4.36e-2)" "unprognostic (3.35e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (3.94e-2)" "unprognostic (3.17e-6)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (2.41e-1)" "unprognostic (9.81e-2)" 0.6 0.2 0.3 2.9 1.1 0.4 0.3 0.2 0.8 0.3 1.3 0.2 0.2 2.9 0.8 0.2 0.4 0.5 1.3 0.3 0.2 0.2 0.5 1.2 5.8 0.6 0.3 0.2 0.2 0.3 0.0 0.3 7.0 0.7 1.0 1.4 0.9 2.4 0.2 3.2 3.6 5.1 1.6 0.5 2.7 2.2 0.4 0.2 0.6 1.8 2.8 0.6 4.0 0.3 0.0 0.2 175.9 0.0 0.0 1.9 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.7 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.2 0.0 25.5 0.0 2.1 0.1 0.0 0.0 0.7 0.0 0.8 0.0 0.6 0.0 0.1 0.2 0.0 0.1 2.8 2.2 0.0 0.0 0.5 0.0 175.9 0.0 152.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.2 1.9 0.3 0.3 1.1 0.2 0.8 0.2 0.2 0.3 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CCR4 "CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5" ENSG00000183813 "C-C motif chemokine receptor 4" P51679 3 32951574-32956349 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.9;lymphoid tissue: 57.1" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 1.4;granulocytes: 2.3;Horizontal cells: 4.8;T-cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 28.9" "Lineage enriched" "Detected in single" 48 "T-cells: 28.9" "Cell line enriched" "Detected in some" 17 "HDLM-2: 67.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031613 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031613: AB_10601096" "unprognostic (4.63e-3)" "unprognostic (8.70e-3)" "unprognostic (2.82e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (4.59e-7)" "unprognostic (3.02e-1)" "unprognostic (5.05e-3)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (5.53e-4)" "unprognostic (1.54e-1)" "unprognostic (1.40e-1)" 1.5 0.6 0.3 12.6 0.4 1.5 1.1 0.3 0.3 1.1 1.1 0.1 0.7 0.4 1.0 0.6 1.6 0.8 3.8 0.8 0.3 0.3 1.8 0.9 6.0 24.1 0.3 0.0 0.5 0.5 0.5 0.5 0.1 0.1 1.5 1.2 0.8 4.3 0.2 1.8 2.2 5.0 0.4 0.4 10.2 1.3 2.7 0.0 57.1 1.3 2.8 29.7 8.6 1.1 0.2 0.2 0.5 0.1 0.1 28.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 67.1 0.0 4.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.9 1.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.2 0.1 0.2 0.1 6.0 1.8 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.2 28.9 0.8 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.3 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.0 0.1 0.0 2.2 0.0 0.4 CCR5 "CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22" ENSG00000160791 "C-C motif chemokine receptor 5 (gene/pseudogene)" P51681 3 46370854-46376206 "CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5" "Cell type enhanced" "Detected in some" 17 "Hofbauer cells: 4.9;Kupffer cells: 4.1;Macrophages: 16.2;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 24.5" "Lineage enriched" "Detected in many" 4 "T-cells: 24.5" "Cell line enhanced" "Detected in some" "JURKAT: 2.5;Karpas-707: 12.0;U-266/84: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.32e-3)" "unprognostic (1.94e-3)" "unprognostic (1.89e-3)" "prognostic favorable (7.42e-5)" "unprognostic (1.80e-2)" "prognostic favorable (9.33e-5)" "unprognostic (3.38e-3)" "unprognostic (9.90e-3)" "unprognostic (7.65e-2)" "unprognostic (6.22e-2)" "unprognostic (1.36e-1)" "unprognostic (5.34e-2)" "unprognostic (1.14e-3)" "unprognostic (8.34e-2)" "unprognostic (4.69e-2)" "unprognostic (3.14e-2)" "unprognostic (2.42e-2)" 7.1 2.3 3.4 13.8 6.1 0.8 2.1 0.8 2.5 2.3 3.0 3.0 0.8 3.8 3.7 4.0 2.6 2.6 5.0 3.6 1.6 2.0 2.7 3.0 9.3 11.9 8.1 0.5 3.0 2.1 0.4 1.9 1.2 4.0 2.8 3.8 3.5 4.4 2.5 0.8 1.1 7.2 2.9 6.1 14.6 6.0 0.9 5.9 2.0 2.6 1.5 13.9 5.7 2.0 0.3 5.5 5.6 2.1 3.2 24.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 12.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.4 5.1 0.0 0.0 0.3 0.0 5.6 1.1 0.0 6.7 2.1 24.5 0.3 2.9 9.7 5.5 0.0 0.3 2.6 0.3 3.2 0.0 5.2 4.5 1.5 3.4 6.1 0.8 2.5 1.6 2.0 8.1 0.5 4.0 5.9 0.0 1.7 0.9 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 4.9 0.0 0.0 1.3 4.1 0.0 0.0 16.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13.1 0.0 0.0 CCR6 "BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22" ENSG00000112486 "C-C motif chemokine receptor 6" P51684 6 167111807-167139696 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 30.7;intestine: 9.9;lymphoid tissue: 33.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 21.0;Late spermatids: 20.6;T-cells: 11.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "MAIT T-cell: 30.7;memory B-cell: 23.8;memory CD4 T-cell: 11.9;naive B-cell: 28.2;T-reg: 20.9" "Group enriched" "Detected in many" 5 "B-cells: 28.2;T-cells: 30.7" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6;Hep G2: 14.1;OE19: 4.9" "Region enriched" "Detected in single" 8 "basal ganglia: 0.9" "Not detected" "Not detected" "CAB006820, HPA014488" Approved NA NA "CAB006820: , HPA014488: AB_1846639" "unprognostic (1.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.07e-3)" "unprognostic (2.08e-1)" "unprognostic (8.43e-2)" "unprognostic (2.05e-4)" "unprognostic (2.39e-1)" "unprognostic (4.98e-3)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (4.19e-2)" "unprognostic (4.26e-2)" "unprognostic (2.68e-4)" "unprognostic (3.74e-2)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" 0.5 0.3 1.0 24.4 1.5 1.3 1.1 0.3 1.1 0.6 3.0 0.1 0.0 1.4 0.3 0.8 2.1 0.5 3.1 0.3 0.9 0.9 1.0 0.5 3.3 27.3 0.6 0.0 0.3 0.3 0.0 0.4 0.5 0.2 0.5 1.2 0.3 5.0 0.8 0.3 1.1 9.9 0.0 0.4 23.4 2.2 2.7 0.1 3.7 0.6 2.1 33.7 4.8 0.4 28.2 5.4 0.2 0.0 0.4 30.7 2.5 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 1.3 0.3 0.0 0.0 0.0 0.3 0.2 0.1 2.6 0.7 0.1 0.3 14.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.1 4.9 0.0 0.2 0.2 0.2 0.4 0.0 0.8 0.4 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.8 0.1 0.3 0.5 0.3 0.4 0.0 0.2 0.6 0.0 0.0 0.1 1.6 0.0 30.7 23.8 11.9 4.7 5.4 28.2 0.1 0.0 0.2 0.4 0.0 0.6 20.9 2.5 1.0 1.5 0.3 1.1 0.9 0.9 0.6 0.0 0.2 0.1 0.0 6.2 21.0 0.3 0.9 0.9 0.0 0.0 1.4 3.4 0.0 2.0 0.0 1.7 0.1 5.7 0.0 0.0 0.0 0.2 0.0 0.7 0.1 2.3 0.8 0.1 0.0 0.0 1.3 0.0 20.6 0.0 5.1 1.7 4.6 0.3 0.4 0.1 0.0 0.4 0.3 3.8 0.0 0.1 2.3 0.4 0.4 0.1 11.4 0.0 0.1 CCR7 "BLR2, CD197, CDw197, CMKBR7, EBI1" ENSG00000126353 "C-C motif chemokine receptor 7" P32248 17 40553769-40565472 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "blood: 252.3;lymphoid tissue: 110.6" "Cell type enriched" "Detected in many" 6 "monocytes: 2758.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 252.3" "Lineage enriched" "Detected in many" 4 "T-cells: 252.3" "Cell line enriched" "Detected in some" 79 "HDLM-2: 175.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB003796, HPA031383, HPA074467" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693" "prognostic favorable (3.84e-4)" "prognostic favorable (8.03e-6)" "unprognostic (2.26e-3)" "unprognostic (1.32e-3)" "unprognostic (2.35e-3)" "prognostic favorable (7.61e-7)" "unprognostic (2.71e-4)" "unprognostic (2.58e-2)" "unprognostic (4.48e-2)" "unprognostic (4.68e-4)" "unprognostic (1.10e-2)" "unprognostic (3.11e-1)" "unprognostic (1.08e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.02e-1)" "unprognostic (7.95e-2)" 2.8 0.4 0.2 26.0 0.2 5.2 1.7 0.2 0.3 2.2 1.2 0.3 0.8 0.3 1.2 0.5 1.4 2.3 2.0 1.9 0.2 0.2 1.5 1.7 3.4 110.6 0.3 0.2 1.5 0.3 0.0 1.0 1.0 0.4 1.3 2.1 0.7 8.4 0.2 0.2 1.1 16.2 0.2 0.4 20.3 1.8 1.2 0.3 57.1 2.0 1.2 53.8 4.2 1.3 58.8 2.9 2.3 0.3 44.1 252.3 109.3 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 175.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.1 1.1 0.2 0.0 0.0 1.1 0.3 0.2 3.1 0.1 3.6 37.2 53.3 15.3 0.2 58.8 252.3 133.9 2.3 44.1 0.2 2.9 30.3 109.3 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.3 0.0 5.9 116.5 1.4 4.4 0.0 0.3 0.0 0.0 2.3 1.8 0.0 111.5 0.0 0.4 0.1 0.1 0.0 0.0 6.9 6.3 3.3 0.0 2.3 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 12.9 15.1 2758.4 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.0 3.9 0.2 0.5 3.9 432.7 16.2 0.0 3.3 CCR8 "CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1" ENSG00000179934 "C-C motif chemokine receptor 8" P51685 3 39329706-39333511 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 19.8" "Lineage enriched" "Detected in single" 30 "T-cells: 19.8" "Cell line enriched" "Detected in some" 22 "HDLM-2: 50.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042383 Enhanced NA NA "HPA042383: AB_2732497" "unprognostic (2.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.38e-2)" "unprognostic (7.63e-4)" "unprognostic (3.31e-1)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (3.37e-2)" "unprognostic (7.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.65e-8)" "unprognostic (7.96e-2)" "unprognostic (2.24e-2)" "unprognostic (2.56e-1)" "unprognostic (4.14e-1)" 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 0.2 0.3 0.5 0.1 0.1 0.0 0.3 0.1 0.8 0.1 2.1 0.2 0.2 0.2 0.5 0.3 1.4 2.8 0.1 0.1 0.2 0.3 0.0 0.2 0.1 0.1 0.4 1.3 0.1 0.5 0.1 0.2 1.0 1.2 0.1 0.4 1.7 0.8 0.3 0.1 19.3 0.4 1.2 3.5 5.3 0.3 0.0 0.0 0.0 0.0 0.6 19.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 19.8 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCR9 "CDw199, GPR-9-6, GPR28" ENSG00000173585 "C-C motif chemokine receptor 9" P51686 3 45886504-45903177 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 130.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 17.5;naive B-cell: 9.2;T-reg: 5.7" "Group enriched" "Detected in many" 42 "B-cells: 17.5;T-cells: 5.7" "Cell line enriched" "Detected in single" 50 "MOLT-4: 49.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB006839 Uncertain NA NA "CAB006839: " "unprognostic (3.08e-3)" "unprognostic (3.37e-1)" "unprognostic (5.56e-2)" "unprognostic (1.78e-1)" "unprognostic (8.65e-3)" "unprognostic (7.88e-3)" "unprognostic (4.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.00e-1)" "unprognostic (1.77e-1)" "unprognostic (8.06e-2)" "unprognostic (1.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.88e-1)" "unprognostic (4.34e-1)" "unprognostic (2.27e-1)" "unprognostic (7.20e-3)" 0.1 0.1 0.1 1.8 0.1 0.7 0.1 0.1 0.3 0.1 2.2 0.1 0.1 7.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.2 0.1 10.7 0.1 0.2 2.2 0.3 0.1 0.1 130.2 0.1 0.1 0.7 0.1 0.1 17.5 0.2 0.0 0.0 0.0 5.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 17.5 2.2 1.8 0.2 9.2 0.3 0.1 0.0 0.0 0.0 0.2 5.7 1.8 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CCRL2 "ACKR5, CKRX, CRAM-A, CRAM-B, HCR" ENSG00000121797 "C-C motif chemokine receptor like 2" O00421 3 46407163-46412997 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 31.4" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 16.9;Hofbauer cells: 40.0;Macrophages: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 16.5;OE19: 6.6;PC-3: 12.8;TIME: 12.5;U-266/84: 6.7" "Low region specificity" "Detected in many" HPA043238 Approved NA NA "HPA043238: AB_10794924" "unprognostic (3.94e-1)" "unprognostic (7.02e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.64e-1)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (4.10e-2)" "unprognostic (4.17e-2)" "unprognostic (9.73e-2)" "unprognostic (1.98e-2)" "unprognostic (5.17e-2)" "unprognostic (1.78e-1)" "unprognostic (3.04e-2)" "unprognostic (2.57e-1)" "prognostic favorable (9.67e-5)" 31.4 1.4 1.3 9.2 1.5 6.0 9.0 0.6 1.2 1.8 9.5 0.9 2.8 9.5 3.5 1.4 1.8 1.3 4.5 2.3 1.5 1.3 2.0 3.4 13.7 4.3 1.9 0.9 2.3 4.8 0.3 1.3 3.9 1.8 2.4 8.8 1.7 1.4 0.7 2.6 1.1 16.9 1.9 2.9 11.2 4.5 2.3 1.2 9.4 1.9 1.3 3.0 3.6 3.5 2.5 7.7 5.6 16.7 5.4 3.9 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.2 0.5 3.8 0.0 16.5 0.0 0.0 0.0 1.0 0.2 0.0 0.0 4.2 0.2 0.0 5.9 3.5 2.2 0.1 4.2 0.0 1.3 2.1 0.0 6.6 12.8 0.3 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 12.5 0.5 0.2 0.6 0.2 0.0 6.7 0.2 6.5 5.1 0.0 5.6 12.1 3.2 2.4 16.7 2.9 1.4 1.4 3.9 7.7 2.5 0.9 2.2 2.0 5.4 7.8 2.4 3.7 3.6 1.3 1.5 0.6 1.2 1.5 1.3 1.9 0.9 1.8 1.2 0.0 6.6 5.1 0.1 1.8 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.2 0.0 0.5 0.0 9.0 16.9 0.0 7.4 0.9 0.9 0.2 9.2 0.4 40.0 0.0 0.0 5.5 16.4 0.0 0.0 28.2 1.7 7.2 14.9 0.0 7.8 6.8 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 2.1 6.9 7.2 0.9 CCSAP "C1orf96, CSAP, FLJ41471" ENSG00000154429 "Centriole, cilia and spindle associated protein" Q6IQ19 1 229321005-229343294 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.6;placenta: 28.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 92.0;Syncytiotrophoblasts: 85.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028402, HPA043443" Enhanced Supported NA NA "HPA028402: AB_10603681, HPA043443: AB_2678485" "unprognostic (4.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.63e-1)" "unprognostic (1.18e-1)" "unprognostic (3.26e-1)" "unprognostic (4.97e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.50e-13)" "unprognostic (9.67e-2)" "unprognostic (4.93e-1)" "unprognostic (4.15e-2)" "unprognostic (1.03e-1)" 3.4 3.9 19.3 4.9 20.5 13.3 6.8 29.9 39.6 3.7 3.1 9.8 1.4 3.8 3.7 3.0 4.1 2.3 3.7 3.1 14.1 8.9 2.2 3.8 4.8 4.6 9.8 20.7 6.9 3.0 4.3 5.7 28.7 8.9 4.7 3.7 4.9 4.7 3.8 3.0 13.3 3.4 3.0 10.7 5.3 3.4 2.7 11.3 8.5 2.8 0.4 4.2 3.7 2.8 1.0 1.9 5.8 3.2 0.5 2.0 0.4 6.6 3.6 4.8 8.8 3.3 3.0 39.3 4.8 2.4 5.5 5.3 4.4 4.1 4.2 3.6 4.2 4.5 5.2 10.2 3.6 5.6 7.7 9.9 4.4 3.6 3.2 2.0 7.1 8.7 1.1 2.9 4.3 5.5 4.4 3.9 9.8 5.9 6.4 4.4 2.2 20.1 7.6 4.4 5.0 5.3 5.9 12.3 2.8 2.6 4.1 9.8 13.2 9.0 5.5 4.6 4.2 4.3 10.0 2.5 4.8 7.4 6.5 7.4 5.9 9.1 3.1 5.7 7.2 5.6 5.8 1.5 3.1 0.9 3.0 2.0 0.5 1.1 1.3 1.3 1.0 1.1 0.9 2.4 0.5 3.2 1.9 1.4 0.4 19.3 20.5 29.9 22.1 14.1 8.9 9.8 20.7 8.9 11.3 8.9 1.4 0.9 5.3 7.2 92.0 3.3 0.0 1.4 2.3 1.8 39.3 12.5 5.0 1.4 30.4 1.5 0.7 23.3 0.3 30.8 4.0 6.4 0.0 2.6 9.8 17.5 2.4 1.8 13.2 17.3 0.0 17.3 5.0 1.8 2.5 11.3 0.5 0.0 2.5 0.0 42.1 0.0 3.9 0.5 0.9 14.3 85.1 4.4 1.5 5.4 CCSER1 "FAM190A, KIAA1680" ENSG00000184305 "Coiled-coil serine rich protein 1" Q9C0I3 4 90127535-91601913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0" "Group enriched" "Detected in many" 8 "Cone photoreceptor cells: 166.9;Early spermatids: 257.4;Late spermatids: 243.9;Rod photoreceptor cells: 81.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.0;myeloid DC: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;OE19: 6.3;RT4: 3.2;SCLC-21H: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041880, HPA054709" Uncertain NA NA "HPA041880: AB_10796461, HPA054709: AB_2682581" "unprognostic (4.03e-4)" "unprognostic (4.21e-3)" "unprognostic (6.45e-2)" "unprognostic (2.44e-2)" "unprognostic (3.32e-1)" "unprognostic (3.45e-2)" "unprognostic (5.61e-2)" "unprognostic (8.13e-2)" "unprognostic (1.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.87e-1)" "unprognostic (2.04e-1)" "unprognostic (2.42e-6)" "unprognostic (1.21e-1)" "unprognostic (1.14e-1)" "unprognostic (1.64e-4)" "unprognostic (6.94e-2)" 2.9 6.4 2.4 1.9 5.2 3.4 4.5 17.0 7.6 2.2 3.4 0.0 6.3 2.0 2.1 2.1 2.1 4.1 1.9 4.7 7.4 1.9 5.6 1.7 2.1 2.3 1.8 7.6 1.9 3.3 1.7 10.4 1.4 2.1 3.0 1.8 2.9 5.0 7.1 1.7 3.0 6.4 1.7 2.5 2.7 2.6 11.4 0.5 0.0 4.6 0.0 2.6 4.9 5.9 1.0 1.0 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.1 0.0 0.2 0.2 0.2 0.0 0.0 4.0 0.2 1.0 0.8 0.1 0.0 1.4 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.4 0.0 0.2 0.1 0.2 0.4 6.3 0.7 0.1 0.0 0.3 0.3 3.2 3.4 1.3 0.0 1.0 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.9 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 2.4 5.2 17.0 7.6 7.4 1.9 1.8 7.6 2.1 0.5 6.0 2.7 5.0 12.5 3.9 22.4 10.7 2.5 0.0 3.4 3.5 166.9 2.8 8.3 1.1 257.4 1.4 10.3 0.0 2.9 3.8 0.5 6.8 4.7 0.0 0.9 4.8 3.4 3.7 0.6 243.9 2.8 2.2 1.7 1.0 4.9 2.3 4.7 3.5 1.1 1.7 81.5 6.5 0.3 3.2 2.8 1.9 1.5 0.0 3.4 13.2 CCT6B "Cctz2, TSA303" ENSG00000132141 "Chaperonin containing TCP1 subunit 6B" Q92526 17 34927859-34981078 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 71.5" "Group enriched" "Detected in many" 21 "Early spermatids: 252.6;Late spermatids: 121.4;Spermatocytes: 273.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042996, HPA045576, HPA049949" Uncertain Approved Cytosol NA NA Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "unprognostic (1.56e-1)" "unprognostic (1.72e-2)" "unprognostic (2.99e-3)" "unprognostic (6.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.12e-3)" "unprognostic (3.61e-2)" "unprognostic (1.75e-1)" "unprognostic (1.44e-3)" "unprognostic (9.56e-3)" "unprognostic (3.61e-2)" "unprognostic (4.82e-7)" "unprognostic (1.24e-1)" "unprognostic (4.30e-1)" "unprognostic (4.23e-4)" "unprognostic (1.49e-1)" 1.3 1.7 1.0 0.7 2.8 1.5 2.7 1.3 1.9 1.1 0.7 2.4 1.9 0.6 0.9 3.2 0.8 1.3 0.6 0.8 1.3 1.0 1.9 2.6 0.5 0.6 1.6 1.7 1.2 1.2 1.3 1.3 0.4 2.0 1.3 0.5 1.3 1.5 1.3 2.2 1.3 0.6 0.8 2.2 0.7 0.9 71.5 0.8 0.7 1.4 1.1 0.8 0.9 0.7 2.5 6.2 2.2 2.7 3.8 2.7 1.3 0.9 1.2 3.2 1.4 4.2 2.6 1.1 1.6 6.6 2.8 3.9 0.8 2.5 6.0 0.6 2.9 2.0 1.2 0.2 0.9 0.8 0.7 2.4 0.9 0.2 0.7 5.7 2.8 0.9 3.5 1.7 0.3 3.3 0.5 0.7 1.0 0.6 6.2 3.0 2.3 0.6 6.2 1.7 0.4 0.8 2.9 1.5 14.4 1.7 1.0 3.7 1.8 2.9 1.2 4.9 0.7 2.4 2.9 0.7 1.2 0.1 1.5 0.8 5.5 1.2 5.8 1.3 1.8 1.6 0.0 2.7 2.2 1.6 2.7 1.7 2.5 1.8 1.1 6.2 2.3 2.7 2.6 0.1 3.8 2.6 1.4 0.9 1.3 1.0 2.8 1.3 1.9 1.3 1.0 1.6 1.7 2.0 0.8 0.0 1.9 0.0 1.9 2.2 1.5 3.8 2.5 6.7 3.4 1.8 0.0 1.3 3.3 2.6 252.6 0.7 0.7 0.0 7.0 0.4 2.6 1.9 2.3 3.4 1.3 0.0 0.0 1.3 2.2 121.4 10.0 1.5 5.0 0.0 2.5 8.3 2.3 0.9 3.9 5.5 2.4 0.0 1.4 273.4 9.7 2.3 0.7 0.5 1.7 3.0 CCT8L2 CESK1 ENSG00000198445 "Chaperonin containing TCP1 subunit 8 like 2" Q96SF2 22 16590751-16592810 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 187 "testis: 18.6" "Group enriched" "Detected in some" 46 "Early spermatids: 137.7;Late spermatids: 71.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.9 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 CD101 "IGSF2, V7" ENSG00000134256 "CD101 molecule" Q93033 1 117001750-117036476 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;lung: 17.5" "Cell type enhanced" "Detected in some" 9 "Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.7" "Group enriched" "Detected in many" 17 "dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4" "Cell line enriched" "Detected in some" 9 "HMC-1: 25.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA049527, HPA057763" Approved Uncertain Mitochondria NA NA 42000 Mitochondria "HPA049527: , HPA057763: AB_2683519" "unprognostic (1.25e-1)" "unprognostic (7.95e-3)" "unprognostic (5.40e-3)" "unprognostic (4.10e-3)" "unprognostic (2.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.03e-2)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (7.29e-3)" "unprognostic (3.15e-1)" "unprognostic (4.54e-2)" "unprognostic (7.15e-6)" "unprognostic (7.00e-2)" "unprognostic (8.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.28e-2)" 0.9 1.7 0.8 11.3 1.1 5.7 0.8 0.2 1.1 1.3 5.0 0.6 1.2 4.6 1.7 0.4 1.8 1.5 1.4 2.6 1.1 0.5 1.3 0.8 17.5 4.0 1.3 0.2 1.0 2.3 0.0 0.8 0.5 1.1 1.6 3.2 0.7 2.1 1.3 0.5 1.8 10.9 1.6 2.0 7.8 1.8 0.9 1.2 6.4 0.9 2.4 7.4 2.4 1.8 0.1 12.2 33.7 17.4 0.0 1.2 2.5 0.4 0.0 0.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.2 1.9 0.1 0.0 0.0 1.1 0.1 0.8 0.0 0.0 0.1 25.3 0.3 1.3 0.0 0.1 0.2 0.2 0.5 0.1 0.6 0.1 1.5 0.0 2.9 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.4 0.6 0.4 0.5 0.3 0.6 0.9 0.6 0.5 0.1 0.4 0.5 0.2 0.2 0.1 0.0 0.7 1.9 1.5 0.0 7.6 33.7 0.1 10.0 0.7 0.1 0.2 1.2 12.2 0.0 0.3 1.2 0.3 0.0 17.4 0.0 1.1 2.5 0.8 1.1 0.2 1.1 1.1 0.5 1.3 0.2 1.1 1.2 0.0 1.4 0.5 0.1 1.1 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.5 0.0 0.2 0.1 1.1 0.4 0.7 0.0 1.7 0.0 6.2 1.3 0.3 7.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.2 0.0 0.0 1.4 0.0 4.6 0.1 0.1 CD109 "CPAMD7, DKFZp762L1111, FLJ38569" ENSG00000156535 "CD109 molecule" Q6YHK3 6 73695785-73828316 "CD markers, Plasma proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "parathyroid gland: 203.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 36.9;Endothelial cells: 28.0;Hofbauer cells: 36.5;Suprabasal keratinocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 62.8;BJ hTERT+: 38.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008992, HPA015723" Enhanced Supported "Plasma membrane,Cytosol" NA NA 120000000 "Plasma membrane" Cytosol "HPA008992: , HPA015723: AB_2732415" "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (7.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.17e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-3)" "unprognostic (1.23e-3)" "unprognostic (7.49e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-3)" "unprognostic (8.81e-2)" "prognostic unfavorable (2.65e-4)" "prognostic unfavorable (7.96e-5)" "unprognostic (9.50e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (4.68e-4)" 27.4 1.5 1.6 1.9 2.2 1.9 6.5 0.4 1.9 15.0 7.1 3.4 2.0 1.5 22.5 8.5 22.4 3.4 2.4 8.2 1.8 1.4 3.5 1.4 14.5 1.4 1.7 1.4 2.8 1.2 203.4 0.6 5.0 3.0 7.1 2.1 0.6 4.2 2.2 4.1 12.4 2.4 12.6 4.5 1.7 1.5 3.3 2.8 6.3 1.7 16.8 4.7 8.7 8.0 0.3 2.6 1.4 0.4 0.6 0.4 0.3 9.4 8.5 0.5 0.0 12.9 62.8 0.0 8.6 38.5 2.8 6.2 0.0 5.5 0.0 5.3 17.7 6.2 26.6 0.9 17.2 3.8 2.6 1.5 3.3 6.9 1.4 2.7 0.0 0.0 17.3 13.7 5.3 21.5 9.9 20.3 1.0 0.0 0.0 12.9 0.2 0.2 0.0 0.6 0.0 5.5 0.7 2.4 11.6 1.2 1.1 0.0 0.0 19.5 0.1 8.4 0.4 0.2 1.5 18.8 26.9 3.7 4.8 7.4 0.1 5.3 0.0 10.8 0.0 23.8 0.6 0.4 0.3 0.2 0.2 0.1 0.2 0.3 0.2 2.6 0.3 0.4 0.2 1.4 0.6 0.2 1.4 0.1 0.3 1.6 2.2 0.4 1.9 1.8 1.4 1.7 1.4 3.0 2.8 3.0 1.7 0.8 6.2 36.9 0.3 11.1 0.0 2.7 12.5 0.0 0.0 0.3 1.7 0.1 18.2 28.0 0.0 0.0 0.0 0.4 7.8 5.8 2.3 0.4 36.5 0.0 0.0 19.0 2.8 17.2 0.6 15.3 21.9 4.6 0.0 0.0 0.3 0.0 0.0 15.9 0.1 0.0 14.6 0.7 3.2 38.1 1.1 2.2 0.0 6.4 CD14 ENSG00000170458 "CD14 molecule" P08571 5 140631728-140633701 "Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 189.4;liver: 165.8" "Cell type enhanced" "Detected in many" 25 "Hofbauer cells: 2162.9;Ito cells: 448.7;Kupffer cells: 633.7;Macrophages: 438.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 189.4" "Group enriched" "Detected in many" 5 "granulocytes: 52.3;monocytes: 189.4" "Cell line enhanced" "Detected in many" "A549: 9.1;CACO-2: 13.9;SiHa: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001887, HPA002127, CAB033631, CAB072865, CAB072866" Enhanced Approved Vesicles "Secreted to blood" NA NA 2750000000 15000000000 Vesicles "CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.42e-3)" "unprognostic (3.89e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" "unprognostic (4.71e-3)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.80e-5)" "unprognostic (1.20e-2)" "unprognostic (6.87e-3)" "unprognostic (8.12e-2)" "unprognostic (6.92e-2)" 27.9 44.1 9.0 42.7 25.2 9.8 11.7 3.5 8.9 5.6 10.0 6.0 1.8 5.4 5.6 24.0 4.5 12.0 14.6 18.9 11.7 7.4 12.7 165.8 23.8 34.7 21.6 2.9 14.2 5.3 4.3 10.1 37.3 18.9 8.5 9.2 14.6 28.5 5.8 10.2 3.5 12.1 21.4 18.2 35.5 6.6 6.5 17.3 2.2 7.9 5.8 6.6 15.9 3.8 0.5 23.6 52.3 189.4 0.2 0.4 124.2 0.1 9.1 0.1 0.6 1.3 0.3 0.5 0.9 4.2 1.3 1.6 13.9 2.2 0.4 0.7 5.0 1.1 3.9 0.0 1.7 0.2 0.1 0.9 0.3 0.5 1.8 4.9 1.0 0.4 4.0 0.2 0.2 1.3 0.4 0.0 0.2 0.2 0.2 1.3 0.3 0.0 0.6 0.2 0.2 0.3 0.3 0.4 1.1 0.2 0.0 2.4 1.0 16.7 0.4 0.5 0.2 0.3 1.7 0.6 0.2 0.3 1.5 1.3 0.7 0.9 0.5 0.4 0.4 0.1 0.4 189.4 1.0 0.3 36.6 0.4 0.5 0.2 0.2 23.6 0.1 0.3 0.2 52.3 0.2 4.8 1.3 0.1 124.2 9.0 25.2 3.5 8.9 11.7 7.4 21.6 2.9 18.9 17.3 8.9 44.2 23.9 3.1 4.5 9.5 2.5 28.1 6.7 6.8 1.8 0.0 15.3 1.7 3.3 1.3 13.8 7.9 0.0 1.6 12.6 12.3 2.2 8.1 323.7 2162.9 31.8 6.9 448.7 633.7 3.2 4.6 438.8 8.5 0.0 4.5 36.9 2.3 8.5 4.9 5.4 3.5 32.3 9.2 0.7 0.9 3.8 38.6 5.9 5.1 3.0 CD160 "BY55, NK1, NK28" ENSG00000117281 "CD160 molecule" O95971 1 145719471-145739288 "CD markers, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.9;brain: 15.2;intestine: 19.9;lymphoid tissue: 17.4" "Cell type enriched" "Detected in some" 5 "T-cells: 48.4" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 15.2" "Group enriched" "Detected in many" 9 "gdT-cell: 33.9;MAIT T-cell: 14.4;memory CD8 T-cell: 22.9;naive CD8 T-cell: 27.3;NK-cell: 23.2" "Group enriched" "Detected in many" 11 "NK-cells: 23.2;T-cells: 33.9" "Cell line enhanced" "Detected in many" "HeLa: 4.7" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (6.54e-4)" "unprognostic (1.06e-1)" "unprognostic (4.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.33e-1)" "unprognostic (3.40e-2)" "unprognostic (1.35e-1)" "unprognostic (8.25e-3)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (2.24e-2)" "unprognostic (7.49e-3)" "unprognostic (3.48e-5)" "unprognostic (4.05e-2)" "unprognostic (2.03e-1)" "unprognostic (2.89e-2)" "unprognostic (2.92e-4)" 0.6 0.2 2.2 3.6 2.6 5.1 0.6 15.2 3.1 0.8 9.3 0.4 0.3 5.6 0.8 1.4 0.9 0.6 1.2 0.6 1.6 2.2 0.5 5.9 3.8 6.0 1.6 0.3 1.1 2.2 0.0 0.4 1.8 0.6 1.3 1.0 0.9 3.0 0.4 1.0 1.1 19.9 1.4 1.0 17.4 0.8 0.8 0.3 2.9 0.4 0.3 3.1 0.7 0.3 0.2 0.3 2.7 0.4 23.2 33.9 20.2 1.4 1.0 1.6 0.9 0.0 0.3 0.3 0.1 0.0 0.2 0.1 0.6 0.1 1.7 1.3 0.2 0.1 1.7 0.2 0.2 0.1 3.5 1.7 3.1 4.7 1.3 0.1 2.1 3.2 0.2 0.4 0.1 0.3 0.7 0.0 1.7 0.8 1.5 0.1 1.5 1.2 4.0 1.2 0.8 2.9 0.3 0.2 1.1 0.0 0.6 1.2 1.6 0.9 1.3 0.6 1.2 1.5 2.0 1.8 1.4 0.6 0.8 3.0 2.4 1.6 0.6 0.7 2.4 0.2 2.7 0.1 0.1 33.9 0.1 14.4 0.2 0.4 22.9 0.0 0.2 0.2 27.3 1.7 23.2 0.4 0.3 0.0 20.2 2.2 2.6 15.2 3.1 1.6 2.2 1.6 0.3 0.6 0.3 0.0 0.0 0.0 0.2 0.1 2.1 0.2 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 2.8 0.1 0.5 0.0 0.4 0.0 0.0 0.3 2.3 0.5 0.0 6.4 0.0 1.8 3.1 6.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 2.6 0.0 0.2 0.0 0.1 0.1 0.1 48.4 0.0 0.1 CD163 "M130, MM130, SCARI1" ENSG00000177575 "CD163 molecule" Q86VB7 12 7470813-7503893 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Acute phase, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 113.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 1509.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 28.2;myeloid DC: 25.3" "Group enriched" "Detected in many" 40 "dendritic cells: 25.3;monocytes: 28.2" "Cell line enhanced" "Detected in some" "ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB002432, HPA046404, HPA051974" Enhanced Supported "Plasma membrane" "Secreted to blood" NA NA 903000000 1600000000 "Plasma membrane" "CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (5.02e-3)" "unprognostic (2.72e-1)" "unprognostic (6.17e-3)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.84e-2)" "unprognostic (8.77e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (1.20e-2)" 66.7 23.8 2.1 44.6 7.2 4.1 23.2 2.8 4.9 11.3 25.3 1.6 1.4 3.5 7.2 16.8 11.3 20.1 13.2 15.7 2.8 1.8 43.9 38.9 81.0 99.8 6.9 0.5 10.3 6.7 3.1 11.7 31.9 9.9 6.8 6.5 9.8 8.6 2.2 15.2 4.0 12.5 37.2 5.7 113.6 10.2 19.6 4.3 3.4 15.5 2.9 3.5 20.1 8.3 0.0 25.3 0.6 28.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 1.8 1.0 0.4 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.3 5.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.5 0.1 0.0 0.1 0.9 0.1 0.0 0.0 0.2 0.5 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.9 0.3 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 28.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 6.3 2.1 7.2 2.8 2.4 2.8 1.8 6.9 0.5 9.9 4.3 3.0 8.8 9.3 0.2 1.3 0.0 3.4 10.2 2.7 9.1 0.0 2.0 1.3 0.0 0.0 2.5 1.9 0.0 0.0 0.0 1.5 1.6 0.1 4.7 5.9 221.9 0.0 0.0 28.3 1509.4 3.9 4.6 104.2 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.1 116.4 0.3 3.9 1.7 0.9 2.5 5.0 0.0 0.0 CD163L1 "CD163B, M160, SCARI2, WC1" ENSG00000177675 "CD163 molecule like 1" Q9NR16 12 7346685-7479897 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.4;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4" HPA015663 Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Intracellular and membrane" NA NA 170000 "Centrosome, Cytosol" Nucleoplasm "HPA015663: AB_2072575" "unprognostic (1.25e-3)" "unprognostic (1.77e-1)" "unprognostic (1.42e-2)" "unprognostic (7.46e-3)" "unprognostic (2.29e-2)" "unprognostic (7.79e-2)" "unprognostic (9.39e-2)" "unprognostic (4.44e-3)" "unprognostic (1.07e-1)" "unprognostic (8.35e-2)" "unprognostic (1.08e-1)" "unprognostic (3.08e-1)" "unprognostic (1.26e-6)" "unprognostic (8.59e-2)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.69e-1)" 5.0 1.7 1.2 19.1 1.2 0.0 2.5 0.8 1.6 1.4 9.2 0.3 1.0 5.5 1.2 8.5 1.8 1.3 2.6 3.2 1.2 1.0 1.7 1.5 2.8 14.6 1.1 0.7 1.0 1.0 0.1 1.4 6.8 3.3 1.4 15.1 2.7 2.5 1.4 1.1 1.4 18.4 1.8 1.0 31.2 2.6 4.6 0.2 9.5 1.7 6.4 12.9 4.3 1.2 0.2 0.7 0.7 0.8 0.0 0.0 0.2 0.2 0.4 0.2 0.0 1.0 0.3 0.0 0.8 1.8 0.2 0.8 0.0 1.4 0.0 0.3 0.8 9.2 0.0 0.0 1.1 1.4 8.2 0.0 0.0 0.4 1.2 0.0 0.5 0.0 0.3 0.0 0.2 3.3 0.6 8.9 0.0 0.1 4.7 5.2 0.0 0.0 6.6 0.2 0.0 0.0 1.5 1.5 1.8 0.0 0.0 1.2 5.6 4.3 6.8 0.0 0.3 0.0 5.5 8.3 3.0 2.7 0.3 0.0 0.1 0.1 0.0 19.4 0.4 5.7 0.0 0.8 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 1.2 0.8 1.6 1.2 1.0 1.1 0.7 3.3 0.2 0.0 0.0 0.0 0.0 1.1 2.9 0.7 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.2 0.7 0.0 0.0 1.2 0.3 0.5 0.1 0.0 0.4 6.9 0.0 0.0 0.0 4.1 1.1 0.0 3.3 13.5 0.0 0.0 1.0 2.0 1.1 0.0 0.0 1.7 19.4 8.0 3.4 0.7 1.1 0.2 0.0 0.0 0.1 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.8" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA062915: AB_2684903" "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.2 0.1 0.5 0.0 2.3 0.1 0.4 3.2 0.4 0.7 1.2 0.0 0.4 12.6 13.4 26.8 0.1 0.1 0.4 0.4 0.4 0.3 7.4 0.1 0.1 0.6 3.3 0.3 0.4 5.8 0.1 1.1 2.4 0.2 1.0 12.9 0.3 0.1 8.1 0.1 0.1 0.1 0.1 0.2 1.0 0.4 0.1 0.9 5.9 6.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.7 2.0 0.1 0.0 0.0 0.1 1.0 0.0 1.0 0.0 0.0 4.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.4 0.4 0.4 0.1 0.6 1.1 0.4 0.0 3.0 0.0 8.0 2.6 0.0 0.6 0.0 62.9 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 0.0 0.0 0.0 3.1 CD177 "HNA2A, NB1, PRV1" ENSG00000204936 "CD177 molecule" 19 43353659-43363172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 67.6;intestine: 43.5;lymphoid tissue: 33.9;vagina: 30.8" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 90.9;Glandular cells: 37.4;Mucus-secreting cells: 26.4;Paneth cells: 43.8" "Cancer enhanced" "Detected in many" "prostate cancer: 27.6" "Cell type enriched" "Detected in some" 7 "neutrophil: 11.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 11.3" "Cell line enriched" "Detected in some" 24 "RPMI-8226: 46.0" "HPA041820, HPA046601, HPA077640" Enhanced "Intracellular and membrane" NA NA "HPA041820: AB_2677691, HPA046601: AB_2679716, HPA077640: " "unprognostic (4.32e-2)" "prognostic favorable (3.66e-4)" "unprognostic (1.04e-2)" "unprognostic (2.04e-3)" "unprognostic (1.61e-1)" "unprognostic (3.89e-2)" "unprognostic (7.10e-2)" "unprognostic (2.94e-1)" "unprognostic (2.05e-1)" "unprognostic (1.45e-1)" "unprognostic (8.38e-2)" "unprognostic (1.90e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.16e-1)" "unprognostic (5.01e-2)" "unprognostic (1.24e-1)" 1.0 0.0 0.0 8.3 0.0 67.6 0.7 0.0 0.9 2.3 39.5 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 17.3 0.0 0.0 2.1 16.6 26.6 0.1 0.0 2.0 1.0 0.0 0.0 0.4 1.9 17.3 43.5 0.9 0.0 0.0 0.0 0.0 0.0 0.6 4.8 33.9 0.0 1.1 0.0 2.0 1.3 7.2 2.3 0.8 30.8 0.0 0.0 11.3 1.6 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.3 0.3 0.0 0.0 0.0 1.2 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 46.0 0.7 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 1.6 0.0 0.9 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.5 0.3 0.0 90.9 0.0 0.2 0.0 0.0 37.4 0.0 0.0 0.0 0.0 8.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.2 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.1 CD180 "LY64, Ly78, RP105" ENSG00000134061 "CD180 molecule" Q99467 5 67179613-67196799 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.2;lymphoid tissue: 38.7" "Cell type enhanced" "Detected in some" 20 "B-cells: 49.6;Hofbauer cells: 63.1;Kupffer cells: 16.8;monocytes: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 28.7;naive B-cell: 29.2" "Group enriched" "Detected in many" 23 "B-cells: 29.2;dendritic cells: 8.5;monocytes: 11.6" "Group enriched" "Detected in some" 10 "Daudi: 23.3;Karpas-707: 21.9;U-266/70: 17.8;U-266/84: 24.7;U-698: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003740 Enhanced NA NA "HPA003740: AB_1078450" "unprognostic (9.33e-2)" "unprognostic (4.58e-2)" "unprognostic (2.81e-3)" "unprognostic (5.85e-3)" "unprognostic (2.25e-2)" "unprognostic (4.04e-3)" "unprognostic (1.09e-1)" "unprognostic (4.95e-2)" "unprognostic (5.83e-2)" "unprognostic (3.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.09e-1)" "unprognostic (1.16e-1)" "unprognostic (3.70e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" 9.6 1.6 1.4 24.3 3.2 1.9 5.7 0.6 1.3 1.0 2.1 1.6 0.0 1.8 0.9 1.0 1.7 1.3 1.5 4.6 1.2 1.1 2.5 2.7 3.0 30.4 4.1 0.6 1.5 1.0 0.2 1.1 2.9 2.2 1.5 2.5 0.4 3.1 0.4 0.6 0.7 8.4 1.6 3.5 38.7 1.9 0.8 2.8 1.9 1.2 0.2 31.3 4.1 0.8 29.2 8.5 0.3 11.6 0.7 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.1 17.8 24.7 6.5 0.0 1.4 0.0 0.0 4.1 0.3 0.0 7.4 0.0 28.7 0.0 0.0 8.0 29.2 0.0 0.0 0.3 0.7 11.6 8.5 0.0 2.8 1.4 3.2 0.6 1.3 1.2 1.1 4.1 0.6 2.2 2.8 0.0 0.3 49.6 0.1 0.3 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.3 0.0 0.0 0.2 0.2 0.4 0.0 2.3 0.0 63.1 0.0 0.0 0.0 16.8 1.0 0.0 9.7 0.0 13.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.1 CD19 ENSG00000177455 "CD19 molecule" P15391 16 28931939-28939346 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 47.6;intestine: 16.7;lymphoid tissue: 40.3" "Cell type enriched" "Detected in some" 6 "B-cells: 94.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 93 "memory B-cell: 36.0;naive B-cell: 47.6" "Lineage enriched" "Detected in single" 106 "B-cells: 47.6" "Cell line enhanced" "Detected in some" "Daudi: 53.4;REH: 28.3;U-698: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB016110 Enhanced NA NA "CAB016110: AB_626952" "unprognostic (3.27e-3)" "unprognostic (1.19e-3)" "unprognostic (6.63e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-3)" "unprognostic (3.11e-5)" "unprognostic (2.61e-1)" "unprognostic (6.96e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-3)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (5.41e-6)" "unprognostic (2.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-1)" "unprognostic (2.07e-1)" 0.4 0.2 0.2 37.0 0.2 2.3 0.2 0.1 0.2 0.2 0.9 0.1 0.0 0.2 0.2 0.1 1.4 0.3 0.2 0.2 0.2 0.2 0.7 0.3 1.4 32.0 0.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.4 0.5 0.1 5.9 0.0 0.1 0.1 16.7 0.0 0.2 40.3 1.3 1.9 0.0 2.4 0.7 0.2 38.7 1.8 0.3 47.6 0.0 0.4 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 47.6 0.1 0.0 0.3 0.0 0.1 0.0 0.0 1.8 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.1 94.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.9 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 0.6 3.6 0.3 0.4 3.3 0.0 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 6.1 3.0 0.0 0.6 0.0 0.4 0.0 CD1A CD1 ENSG00000158477 "CD1a molecule" P06126 1 158254137-158258269 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 105.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 6.5;Kupffer cells: 1.6;Macrophages: 2.9;Melanocytes: 1.7;Suprabasal keratinocytes: 6.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4" "Group enriched" "Detected in many" 35 "B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9" "Group enriched" "Detected in some" 86 "JURKAT: 21.2;MOLT-4: 33.8" "CAB000009, HPA010734" Enhanced NA NA "CAB000009: AB_2073290, HPA010734: AB_1078452" "unprognostic (7.21e-5)" "prognostic favorable (6.37e-4)" "unprognostic (1.37e-5)" "unprognostic (2.55e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-2)" "unprognostic (9.93e-4)" "unprognostic (1.49e-2)" "unprognostic (3.12e-1)" "unprognostic (3.86e-2)" "unprognostic (6.99e-2)" "unprognostic (5.12e-2)" "unprognostic (5.49e-5)" "unprognostic (5.58e-2)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.1 0.9 0.1 0.0 1.0 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.2 0.1 8.0 0.0 0.6 0.1 0.1 0.0 0.2 0.1 1.8 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.2 0.1 0.9 0.1 0.1 20.9 0.3 0.1 0.1 1.4 0.3 0.2 0.1 105.1 0.1 1.0 2.7 0.4 1.1 6.8 10.2 0.0 5.9 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.7 0.2 6.8 0.0 0.0 10.2 5.4 0.1 0.0 0.0 0.0 0.2 0.2 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 CD1B CD1 ENSG00000158485 "CD1b molecule" P29016 1 158327951-158331531 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "lymphoid tissue: 188.8" "Cell type enriched" "Detected in some" 6 "Macrophages: 17.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "myeloid DC: 16.3" "Lineage enriched" "Detected in many" 6 "dendritic cells: 16.3" "Cell line enriched" "Detected in some" 5 "MOLT-4: 112.0" HPA021824 Approved Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA021824: AB_1846262" "unprognostic (7.72e-3)" "unprognostic (1.55e-4)" "unprognostic (1.66e-5)" "unprognostic (1.04e-2)" "unprognostic (1.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.89e-4)" "unprognostic (2.27e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (9.53e-2)" "unprognostic (3.23e-1)" "unprognostic (3.52e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (3.53e-2)" 0.8 0.1 0.2 1.9 0.2 0.0 0.6 0.2 0.2 0.8 0.6 0.3 0.2 0.0 0.3 0.2 0.9 0.7 1.3 0.2 0.2 0.0 0.6 0.3 1.7 4.0 0.2 0.2 0.3 0.3 0.0 0.2 0.2 0.2 0.2 5.6 0.2 0.6 0.2 0.2 6.2 0.8 0.3 0.2 1.9 0.9 0.2 0.2 188.8 0.4 0.4 2.4 0.5 0.8 0.0 16.3 0.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 112.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 17.4 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 CD1C CD1 ENSG00000158481 "CD1c molecule" P29017 1 158289786-158293630 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 70.8;lymphoid tissue: 111.4" "Cell type enhanced" "Detected in some" 21 "B-cells: 37.2;Macrophages: 73.3;Melanocytes: 18.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 18.6;myeloid DC: 70.8" "Group enriched" "Detected in many" 8 "B-cells: 18.6;dendritic cells: 70.8" "Group enriched" "Detected in some" 9 "JURKAT: 11.0;MOLT-4: 34.8" NA NA 240000 "unprognostic (2.55e-3)" "prognostic favorable (1.79e-5)" "unprognostic (1.75e-5)" "unprognostic (3.09e-5)" "unprognostic (3.12e-2)" "unprognostic (8.13e-3)" "unprognostic (2.01e-1)" "unprognostic (3.80e-3)" "unprognostic (7.11e-3)" "unprognostic (1.87e-1)" "unprognostic (7.41e-2)" "unprognostic (1.93e-1)" "unprognostic (1.04e-1)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (8.05e-2)" "unprognostic (1.99e-1)" 1.8 0.4 0.5 8.2 0.6 0.0 2.2 0.5 0.5 1.1 1.2 0.5 1.3 0.4 1.4 1.2 1.8 1.6 5.1 0.6 0.5 0.3 1.6 1.5 2.8 13.2 0.6 0.5 0.7 0.7 0.0 0.6 0.7 0.6 1.0 4.8 0.9 3.0 1.0 0.6 5.5 11.7 1.3 0.5 24.6 1.2 0.8 0.5 111.4 1.0 2.4 20.5 1.4 1.3 18.6 70.8 0.2 5.9 0.9 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 34.8 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.1 5.9 0.0 0.0 5.1 0.0 18.6 0.0 0.0 70.8 9.3 0.0 0.0 0.2 0.9 0.6 0.3 0.1 3.3 0.5 0.6 0.5 0.5 0.5 0.3 0.6 0.5 0.6 0.5 0.0 6.9 37.2 0.0 11.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.1 2.3 0.0 3.5 0.0 4.0 0.0 0.0 0.0 5.9 3.3 0.0 73.3 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 6.5 0.0 0.0 0.0 0.0 CD1D ENSG00000158473 "CD1d molecule" P15813 1 158179947-158184896 "Cancer-related genes, CD markers, Predicted membrane proteins" "Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.5;lymphoid tissue: 17.8" "Cell type enhanced" "Detected in many" 15 "B-cells: 27.5;Kupffer cells: 52.9;Macrophages: 34.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5" "Group enriched" "Detected in many" 8 "dendritic cells: 49.5;monocytes: 49.5" "Cell line enriched" "Detected in some" 4 "JURKAT: 45.7" "Low region specificity" "Detected in all" "CAB016107, HPA072662" Enhanced Supported "Endoplasmic reticulum" NA NA 720000 "Endoplasmic reticulum" "CAB016107: AB_626960, HPA072662: AB_2686545" "unprognostic (8.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (3.85e-1)" "unprognostic (9.67e-3)" "unprognostic (2.37e-1)" "unprognostic (3.52e-1)" "unprognostic (2.23e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (2.12e-5)" "unprognostic (9.31e-3)" "unprognostic (2.35e-1)" "unprognostic (2.32e-2)" "unprognostic (3.38e-1)" 1.5 1.2 0.0 8.6 0.0 2.6 1.2 0.0 0.0 0.8 2.5 9.5 1.5 0.0 0.4 1.4 2.0 1.4 0.0 0.1 1.6 10.5 2.3 5.5 0.2 0.3 0.7 0.0 0.6 0.0 1.4 3.7 0.7 0.3 0.6 0.0 12.2 2.2 0.4 17.8 1.4 1.4 1.8 3.4 1.6 0.5 6.3 49.5 2.5 49.5 0.1 0.1 23.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 2.9 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.1 0.0 3.2 0.4 0.0 0.6 0.0 0.0 45.7 0.0 0.0 0.0 0.0 11.2 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.3 0.0 3.1 0.4 0.0 49.5 0.1 0.0 22.4 0.1 6.3 0.0 0.0 49.5 4.7 0.0 0.0 2.5 0.1 3.6 0.5 0.0 23.5 0.0 5.1 27.5 0.4 0.2 0.4 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 1.2 2.2 0.0 0.0 0.1 0.2 0.0 1.1 5.3 11.3 1.6 2.4 4.3 52.9 0.9 0.0 34.3 0.0 10.0 2.0 0.3 0.0 3.7 0.0 0.0 0.1 0.0 0.5 0.5 0.9 0.1 0.1 0.0 3.9 0.0 CD1E ENSG00000158488 "CD1e molecule" P15812 1 158353696-158357553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 308.0" "Cell type enriched" "Detected in some" 9 "Macrophages: 75.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "myeloid DC: 29.7" "Lineage enriched" "Detected in many" 13 "dendritic cells: 29.7" "Cell line enriched" "Detected in some" 42 "MOLT-4: 171.9" "Not detected" "Not detected" HPA057769 Uncertain "Intracellular and membrane" NA NA "HPA057769: AB_2683522" "unprognostic (7.94e-3)" "unprognostic (1.85e-5)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "unprognostic (1.54e-3)" "unprognostic (1.24e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (8.55e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (8.50e-2)" "unprognostic (2.45e-1)" 1.0 0.2 0.7 2.8 0.7 0.0 1.1 0.7 0.7 1.5 1.0 0.7 0.7 1.2 0.9 0.7 7.0 1.9 3.9 0.7 0.7 0.2 2.0 0.7 2.4 4.7 0.7 0.7 0.7 0.8 0.0 0.7 0.7 0.7 1.8 4.8 0.8 1.9 0.8 0.8 11.5 2.1 0.8 0.7 3.8 3.1 0.9 0.7 308.0 1.0 1.3 8.1 2.4 2.7 0.0 29.7 0.0 2.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 171.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.1 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.7 0.7 0.7 0.7 0.2 0.7 0.7 0.7 0.7 3.0 0.3 0.0 0.0 7.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.6 0.0 0.0 0.0 6.4 0.0 0.0 75.9 8.5 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 6.1 0.1 0.0 0.0 0.0 CD2 SRBC ENSG00000116824 "CD2 molecule" P06729 1 116754385-116769228 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 101.7;lymphoid tissue: 164.4" "Cell type enriched" "Detected in many" 11 "T-cells: 299.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "gdT-cell: 44.4;MAIT T-cell: 42.5;memory CD4 T-cell: 65.3;memory CD8 T-cell: 74.2;naive CD4 T-cell: 34.2;naive CD8 T-cell: 52.4;NK-cell: 101.7;T-reg: 62.3" "Group enriched" "Detected in many" 9 "NK-cells: 101.7;T-cells: 74.2" "Group enriched" "Detected in some" 24 "HDLM-2: 58.9;JURKAT: 39.9;MOLT-4: 43.3" "Region enhanced" "Detected in single" "basal ganglia: 0.3" "Low region specificity" "Detected in some" "CAB002430, HPA003883" Enhanced NA NA "CAB002430: AB_442057, HPA003883: AB_1846263" "prognostic favorable (4.36e-4)" "prognostic favorable (1.47e-4)" "unprognostic (3.34e-3)" "prognostic favorable (1.69e-5)" "unprognostic (1.52e-1)" "prognostic favorable (7.46e-5)" "unprognostic (9.32e-3)" "unprognostic (1.61e-2)" "prognostic favorable (3.97e-5)" "prognostic favorable (7.72e-4)" "unprognostic (4.18e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (4.82e-6)" "unprognostic (6.16e-2)" "unprognostic (6.61e-2)" "unprognostic (2.73e-2)" "unprognostic (7.63e-3)" 3.0 1.1 0.6 14.5 0.5 2.4 1.7 0.5 0.6 2.9 6.0 0.6 0.6 4.8 1.7 2.1 3.8 3.1 4.8 1.4 0.6 0.6 3.3 2.5 8.1 33.0 1.2 0.6 1.9 1.6 0.0 1.0 1.0 1.0 2.9 4.7 2.3 4.1 1.3 1.0 1.2 18.8 0.9 1.8 28.8 6.5 1.1 0.8 164.4 3.5 3.4 30.8 7.7 2.7 0.3 9.3 1.4 0.5 101.7 74.2 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.9 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.1 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.5 0.1 44.4 0.3 42.5 0.3 65.3 74.2 9.3 0.2 34.2 52.4 1.4 101.7 0.2 2.0 62.3 45.9 0.6 0.5 0.5 0.6 0.6 0.6 1.2 0.6 1.0 0.8 3.0 27.0 1.5 0.4 4.4 0.0 0.8 0.0 0.0 4.5 3.5 0.0 0.0 0.0 0.0 13.2 2.4 0.0 0.0 0.0 0.0 2.1 0.1 4.7 0.9 0.7 0.0 2.9 9.8 7.0 4.0 0.6 8.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 4.7 0.2 0.2 3.1 0.0 299.5 0.1 0.1 CD200 "MOX1, MOX2, MRC, OX-2" ENSG00000091972 "CD200 molecule" P41217 3 112332347-112362812 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 63.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 82.9;Intestinal endocrine cells: 36.9;Syncytiotrophoblasts: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "memory B-cell: 9.9;naive B-cell: 36.4" "Lineage enriched" "Detected in many" 25 "B-cells: 36.4" "Cell line enhanced" "Detected in some" "AF22: 31.9;HHSteC: 11.7;NTERA-2: 19.9;REH: 17.0;SH-SY5Y: 9.8;SK-MEL-30: 11.7;WM-115: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031149 Approved NA NA "HPA031149: AB_10600694" "unprognostic (1.84e-1)" "unprognostic (5.08e-2)" "unprognostic (1.79e-1)" "unprognostic (2.03e-3)" "unprognostic (4.97e-1)" "unprognostic (1.21e-2)" "unprognostic (9.29e-2)" "unprognostic (2.25e-2)" "unprognostic (3.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.06e-2)" "unprognostic (2.80e-1)" "unprognostic (4.49e-2)" "unprognostic (1.22e-2)" 12.8 9.5 18.1 10.9 34.3 1.8 7.1 20.9 38.3 16.0 4.5 11.0 1.5 2.6 21.4 5.7 7.0 20.3 10.1 5.8 17.3 42.4 4.9 1.0 7.2 17.7 12.7 19.3 9.3 3.8 10.9 27.9 63.5 19.6 9.7 6.5 7.5 5.4 13.0 1.4 2.8 4.3 13.9 8.4 4.4 3.4 2.3 6.7 12.7 12.4 1.6 17.6 13.9 3.9 36.4 1.1 1.2 0.1 0.6 1.4 1.3 0.0 0.0 31.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.4 0.0 3.4 0.1 0.1 0.1 0.3 0.0 0.1 0.2 11.7 0.0 0.0 0.2 0.1 0.6 0.0 0.1 4.5 0.0 0.0 0.3 0.0 0.0 0.4 0.1 19.9 0.0 0.0 17.0 0.0 0.2 0.2 0.0 8.4 9.8 0.0 0.1 11.7 6.2 0.0 0.1 0.0 0.1 1.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 34.7 1.2 0.1 0.1 0.1 0.0 1.4 9.9 0.8 0.2 0.5 36.4 0.9 0.5 0.7 0.6 0.1 1.1 0.4 1.3 18.1 34.3 20.9 38.3 17.3 42.4 12.7 19.3 19.6 6.7 3.0 14.5 33.0 11.5 3.8 24.4 0.4 0.0 4.0 2.3 1.8 0.0 2.3 0.0 0.3 20.1 82.9 0.7 0.0 0.0 7.3 5.6 4.6 2.3 0.0 0.8 3.2 36.9 1.8 0.0 21.1 0.3 1.9 8.5 24.4 5.5 5.6 0.3 2.9 0.0 0.0 2.5 0.0 4.1 0.5 0.2 2.9 63.5 0.7 5.8 17.2 CD200R1 "CD200R, HCRTR2, MOX2R, OX2R" ENSG00000163606 "CD200 receptor 1" Q8TD46 3 112921209-112975122 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 46.7;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" 11 "Erythroid cells: 23.3;granulocytes: 14.0;Hofbauer cells: 24.1;Ito cells: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 46.7;eosinophil: 12.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 46.7" "Cell line enriched" "Detected in some" 8 "HEL: 25.6" HPA068512 Supported "Plasma membrane" "Intracellular and membrane" NA NA 1500000 "Plasma membrane" "HPA068512: AB_2732784" "unprognostic (1.49e-2)" "unprognostic (1.06e-2)" "unprognostic (2.55e-1)" "unprognostic (1.97e-2)" "unprognostic (1.53e-1)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-3)" "unprognostic (8.30e-2)" "unprognostic (1.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.77e-1)" "unprognostic (7.84e-3)" "unprognostic (1.25e-1)" "unprognostic (5.12e-3)" 3.6 1.6 1.0 9.5 1.4 1.8 3.8 0.8 1.4 5.0 3.5 0.3 1.5 2.0 3.9 5.4 7.5 1.3 2.7 5.8 1.0 1.2 1.4 3.4 4.3 9.0 1.0 0.0 1.0 1.1 0.5 1.0 7.8 0.4 4.2 3.5 2.4 2.5 1.6 0.9 3.4 3.3 1.7 0.9 21.2 1.7 2.5 0.5 15.8 2.0 3.9 17.0 3.8 2.0 2.3 5.8 46.7 0.8 0.6 3.7 1.3 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 25.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 46.7 0.8 12.7 1.0 0.4 1.8 2.3 3.7 2.1 5.8 1.2 3.6 1.7 0.2 0.6 0.1 0.1 1.0 1.3 1.0 1.4 0.8 1.4 1.0 1.2 1.0 0.0 0.4 0.5 0.0 1.4 2.9 0.1 1.6 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 23.3 0.0 0.1 1.3 0.0 14.0 0.0 24.1 0.0 0.0 19.6 4.7 0.0 0.0 3.6 5.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.6 0.6 7.5 0.0 0.1 CD200R1L "CD200R2, CD200RLa" ENSG00000206531 "CD200 receptor 1 like" Q6Q8B3 3 112815709-112846856 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 85 "blood: 31.3;testis: 7.8" "Group enriched" "Detected in some" 28 "Early spermatids: 13.7;Late spermatids: 33.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 304 "basophil: 31.3" "Lineage enriched" "Detected in single" 313 "granulocytes: 31.3" "Cell line enhanced" "Detected in some" "A-431: 4.0;CACO-2: 3.6;CAPAN-2: 1.3;RPMI-8226: 1.9" NA NA "unprognostic (3.80e-1)" "unprognostic (1.88e-1)" "unprognostic (2.37e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-2)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 31.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 33.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CD207 "CLEC4K, Langerin" ENSG00000116031 "CD207 molecule" Q9UJ71 2 70830214-70835822 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5;skin 1: 42.3" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 3.5;Macrophages: 1.5;Melanocytes: 5.0;monocytes: 2.8;Suprabasal keratinocytes: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "myeloid DC: 4.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 4.0" "Cell line enriched" "Detected in some" 4 "AN3-CA: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002222, HPA011216" Enhanced Uncertain Cytosol No NA Cytosol "CAB002222: AB_563850, HPA011216: AB_1078453" "unprognostic (1.45e-2)" "unprognostic (8.28e-3)" "unprognostic (9.34e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-3)" "unprognostic (1.05e-1)" "unprognostic (4.86e-2)" "unprognostic (3.45e-1)" "unprognostic (1.63e-1)" "unprognostic (7.92e-4)" "unprognostic (2.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" 0.5 0.1 0.1 1.8 0.1 0.0 1.4 0.1 0.1 2.4 1.7 0.1 0.1 1.6 1.1 0.4 9.7 0.3 2.9 0.3 0.1 0.1 0.2 0.9 3.7 0.2 0.1 0.1 0.2 0.2 0.0 1.1 0.1 0.1 1.0 1.1 0.4 1.2 0.2 0.1 42.3 2.6 0.1 0.1 1.5 0.4 0.4 0.1 3.3 0.2 11.3 16.5 0.3 1.9 0.0 4.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 14.1 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 0.3 2.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 CD209 "CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1" ENSG00000090659 "CD209 molecule" Q9NNX6 19 7739994-7747564 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in some" 25 "Hofbauer cells: 3.0;Kupffer cells: 14.6;Macrophages: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.7;intermediate monocyte: 3.5;myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 14 "THP-1: 8.8" "CAB032436, CAB033831" Supported "Intracellular and membrane" NA NA 970000 "CAB032436: AB_639039, CAB033831: AB_1121347" "unprognostic (2.76e-1)" "unprognostic (1.15e-2)" "unprognostic (5.36e-3)" "unprognostic (1.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" "unprognostic (5.45e-2)" "unprognostic (3.83e-2)" "unprognostic (2.10e-2)" "unprognostic (1.24e-1)" "unprognostic (9.65e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (6.17e-2)" "unprognostic (1.09e-1)" 20.3 4.5 0.5 4.1 1.8 0.0 6.8 4.5 0.9 2.0 5.6 0.7 0.3 7.2 1.1 7.3 2.4 3.3 4.4 7.8 0.4 0.7 2.2 5.0 3.7 47.9 1.1 0.5 1.8 3.8 0.4 1.0 12.1 1.8 3.6 7.4 3.2 3.0 0.7 3.5 1.6 10.1 5.2 0.9 1.4 2.6 2.1 0.3 2.3 2.1 2.1 1.3 6.8 1.6 0.3 3.4 0.9 3.7 0.3 0.2 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.6 0.0 0.1 0.0 0.1 0.2 8.8 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 3.7 0.2 0.2 3.5 0.1 0.2 0.1 0.1 3.4 0.3 0.1 0.2 0.9 0.3 0.1 0.3 0.1 1.0 0.5 1.8 4.5 0.9 0.4 0.7 1.1 0.5 1.8 0.3 0.0 0.0 0.5 0.1 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 3.0 0.0 0.0 0.0 14.6 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.1 CD22 "SIGLEC-2, SIGLEC2" ENSG00000012124 "CD22 molecule" P20273 19 35319261-35347355 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.3;lymphoid tissue: 77.8;ovary: 35.4" "Group enriched" "Detected in some" 12 "B-cells: 68.1;granulocytes: 94.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 25 "memory B-cell: 29.8;naive B-cell: 39.3" "Lineage enriched" "Detected in many" 28 "B-cells: 39.3" "Cell line enhanced" "Detected in some" "Daudi: 69.8;REH: 20.6;U-698: 55.5;WM-115: 12.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002418, HPA024353" Enhanced NA NA "CAB002418: AB_563529, HPA024353: AB_10600695" "unprognostic (2.80e-3)" "unprognostic (3.99e-2)" "unprognostic (6.79e-3)" "unprognostic (9.17e-2)" "unprognostic (3.07e-1)" "unprognostic (6.45e-3)" "unprognostic (3.79e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (2.47e-1)" "unprognostic (1.75e-3)" "unprognostic (1.98e-2)" "unprognostic (1.48e-2)" "unprognostic (9.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" 2.1 1.0 5.5 57.9 6.8 3.1 0.5 0.7 3.2 1.4 1.0 0.9 0.5 0.4 1.4 0.9 4.4 7.9 2.9 0.8 9.9 4.2 1.4 0.6 5.5 52.6 9.8 0.5 35.4 0.5 0.0 0.7 1.0 0.9 2.8 1.5 1.1 5.9 1.1 0.5 0.0 11.6 2.0 13.5 64.1 1.4 1.2 0.6 5.0 1.1 2.3 77.8 4.3 0.9 39.3 1.3 0.3 0.3 0.0 0.0 1.4 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.3 69.8 1.4 0.0 3.9 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 3.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 20.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 55.5 0.5 0.2 12.7 0.0 0.0 0.0 0.0 0.3 0.0 29.8 0.0 0.0 1.3 39.3 0.0 0.0 0.3 0.0 0.2 1.1 0.0 1.4 5.5 6.8 0.7 3.2 9.9 4.2 9.8 0.5 0.9 0.6 3.0 4.8 68.1 0.4 0.2 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.4 0.6 0.4 94.6 0.0 7.0 0.0 0.0 1.8 6.4 0.0 3.4 2.3 1.7 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.9 0.4 0.1 0.5 0.0 0.0 CD226 "DNAM-1, DNAM1, PTA1, TLiSA1" ENSG00000150637 "CD226 molecule" Q15762 18 69831158-69961803 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.9;parathyroid gland: 82.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 12.8;Kupffer cells: 11.2;monocytes: 21.6;T-cells: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5" "Group enriched" "Detected in many" 11 "NK-cells: 14.0;T-cells: 19.4" "Group enriched" "Detected in some" 6 "HEL: 45.3;HMC-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015715, HPA015865" Supported Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" NA No 27000000 "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA015715: AB_1846278, HPA015865: " "unprognostic (1.42e-4)" "unprognostic (1.30e-3)" "unprognostic (9.01e-3)" "unprognostic (3.49e-5)" "unprognostic (4.15e-1)" "unprognostic (9.52e-4)" "unprognostic (3.68e-3)" "unprognostic (2.93e-2)" "unprognostic (3.43e-1)" "unprognostic (3.31e-3)" "unprognostic (8.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (2.20e-1)" "unprognostic (3.91e-2)" "unprognostic (2.27e-1)" "unprognostic (3.58e-2)" 1.2 0.6 1.0 7.5 2.0 1.7 0.8 0.7 0.9 1.5 2.9 0.3 0.1 1.1 1.0 1.4 0.8 0.8 1.4 0.9 1.9 1.3 1.3 3.1 5.2 14.0 1.7 0.0 1.0 0.6 82.5 2.4 0.6 1.3 0.9 1.2 2.4 5.4 0.6 1.1 0.4 6.0 1.3 4.2 31.9 1.4 1.8 0.5 6.4 1.8 2.6 10.1 2.0 1.6 0.4 1.5 0.9 0.6 14.0 19.4 6.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 2.4 0.0 45.3 0.1 0.0 0.0 0.3 20.2 0.0 0.5 0.1 0.3 0.0 0.0 0.4 0.1 4.7 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.1 5.5 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.5 19.4 0.4 7.3 0.4 16.1 11.8 1.5 0.1 9.0 9.7 0.9 14.0 0.6 0.1 5.5 6.6 1.0 2.0 0.7 0.9 1.9 1.3 1.7 0.0 1.3 0.5 3.0 5.1 0.8 0.3 0.0 2.4 1.6 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 6.6 0.1 0.0 0.0 0.3 0.0 0.4 0.2 12.8 0.5 1.4 0.0 0.0 2.5 11.2 7.5 0.9 7.8 0.0 21.6 0.0 1.4 0.2 0.0 0.7 0.0 3.7 0.0 0.3 0.3 0.5 0.4 0.0 25.4 0.0 0.1 CD24 CD24A ENSG00000272398 "CD24 molecule" 6 106969831-106975627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "kidney: 383.7" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 1347.9;Exocrine glandular cells: 3019.5;Pancreatic endocrine cells: 1516.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 26 "eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0" "Group enriched" "Detected in many" 202 "B-cells: 23.4;granulocytes: 30.4" "Cell line enhanced" "Detected in many" "NTERA-2: 66.4;RPTEC TERT1: 313.7;SK-BR-3: 91.2" "HPA045879, CAB078471" Approved Enhanced Vesicles "Intracellular and membrane" NA NA Vesicles "CAB078471: AB_10983158, HPA045879: AB_2732523" "prognostic unfavorable (2.44e-5)" "unprognostic (6.64e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.87e-1)" "unprognostic (1.41e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (7.58e-4)" "unprognostic (2.32e-1)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (2.28e-2)" "unprognostic (1.51e-1)" "unprognostic (5.10e-2)" "unprognostic (2.92e-1)" "unprognostic (1.16e-1)" "unprognostic (2.01e-1)" "unprognostic (3.13e-1)" 0.5 0.5 12.8 2.4 9.9 17.9 25.5 0.5 2.9 69.5 30.6 0.7 1.6 1.2 34.5 5.9 38.1 6.0 25.1 4.2 22.7 383.7 0.8 0.7 0.9 4.8 7.2 15.6 40.0 0.0 5.7 48.2 13.0 3.2 21.2 0.7 15.9 16.6 0.4 0.5 0.8 2.2 4.9 0.7 16.4 0.5 6.5 0.4 48.8 1.2 11.3 4.0 8.1 23.4 0.0 30.4 0.1 0.0 0.0 0.6 23.4 14.5 0.2 1.9 0.0 0.0 27.5 0.0 0.1 0.1 0.0 0.2 0.1 2.3 7.2 0.0 1.0 48.5 8.2 18.3 0.1 0.0 0.1 0.0 17.9 1.0 0.0 0.3 0.1 0.1 21.1 0.2 1.2 1.1 0.1 0.0 0.5 0.0 0.4 29.4 0.1 0.1 66.4 52.2 5.6 54.8 0.0 0.2 313.7 60.5 41.1 30.3 16.6 91.2 0.0 31.1 42.1 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.1 31.0 0.3 0.1 0.1 0.1 0.0 30.4 0.0 0.0 0.0 23.4 0.0 0.0 0.0 15.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 145.9 106.6 139.4 57.2 0.0 6.5 1.1 1003.8 691.9 180.9 1235.3 2.0 679.9 1347.9 1087.4 21.0 2.3 819.9 0.0 3019.5 709.4 9.3 444.2 10.4 3.8 61.3 0.0 552.5 53.4 8.9 32.3 9.5 11.8 0.0 55.9 391.5 1.1 1516.5 703.5 2.1 408.2 0.5 6.5 0.4 0.5 4.9 0.0 466.9 12.5 734.9 281.9 CD244 "2B4, NAIL, NKR2B4, Nmrk, SLAMF4" ENSG00000122223 "CD244 molecule" Q9BZW8 1 160830160-160862855 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 75.8;lymphoid tissue: 22.1" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 9.6;Kupffer cells: 15.1;T-cells: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 75.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 75.8" "Cell line enhanced" "Detected in some" "HEL: 10.9;HMC-1: 38.3;NB-4: 7.5;U-937: 15.3" "Not detected" "Not detected" NA NA "unprognostic (6.11e-3)" "unprognostic (1.54e-2)" "unprognostic (1.85e-2)" "unprognostic (6.95e-6)" "unprognostic (5.79e-2)" "unprognostic (1.43e-4)" "unprognostic (1.93e-2)" "unprognostic (7.36e-2)" "unprognostic (3.36e-1)" "unprognostic (2.85e-1)" "unprognostic (1.60e-1)" "unprognostic (2.32e-1)" "unprognostic (5.40e-4)" "unprognostic (1.71e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.79e-1)" 2.9 0.4 0.5 3.3 0.5 8.6 0.6 0.3 0.7 0.9 3.1 0.4 1.6 2.8 1.4 0.7 1.0 0.7 1.7 2.0 0.5 0.5 0.7 4.1 5.3 7.4 1.7 0.0 1.6 0.5 0.0 0.5 1.8 1.1 1.6 1.2 1.0 1.6 0.9 1.1 0.5 6.0 2.6 1.5 22.1 0.8 2.8 0.6 0.7 0.6 0.0 4.0 1.5 0.8 0.0 7.9 75.8 13.2 14.0 14.8 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.2 3.5 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 15.3 0.0 75.8 8.2 20.1 14.8 11.2 7.3 0.0 0.8 8.1 7.9 0.0 1.1 7.8 0.6 14.0 13.2 0.4 0.0 11.3 0.5 0.5 0.3 0.7 0.5 0.5 1.7 0.0 1.1 0.6 3.0 9.6 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 1.6 0.0 0.2 0.0 3.5 0.0 0.6 0.0 0.0 0.0 15.1 1.9 1.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.0 CD247 "CD3H, CD3Q, CD3Z" ENSG00000198821 "CD247 molecule" P20963 1 167430640-167518610 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 62.8;lymphoid tissue: 129.5" "Cell type enriched" "Detected in many" 10 "T-cells: 248.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 26 "gdT-cell: 62.8;MAIT T-cell: 35.4;memory CD4 T-cell: 32.4;memory CD8 T-cell: 36.7;naive CD4 T-cell: 41.3;naive CD8 T-cell: 33.5;NK-cell: 33.4;T-reg: 39.0" "Group enriched" "Detected in many" 31 "NK-cells: 33.4;T-cells: 62.8" "Group enriched" "Detected in some" 25 "HDLM-2: 46.4;JURKAT: 34.6;MOLT-4: 48.9" "Region enhanced" "Detected in single" "thalamus: 0.7" "Low region specificity" "Detected in all" "CAB004651, HPA008750" Enhanced NA NA "CAB004651: AB_425347, HPA008750: AB_1857863" "prognostic favorable (9.12e-4)" "unprognostic (3.21e-3)" "unprognostic (7.09e-3)" "prognostic favorable (8.63e-6)" "unprognostic (1.99e-2)" "prognostic favorable (3.98e-4)" "unprognostic (1.79e-2)" "unprognostic (1.11e-2)" "unprognostic (5.46e-3)" "unprognostic (9.73e-3)" "unprognostic (1.33e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (1.60e-1)" "unprognostic (5.33e-2)" "unprognostic (4.02e-2)" "unprognostic (5.94e-3)" 2.3 0.5 0.9 13.5 2.1 17.8 1.3 1.2 1.1 1.4 4.4 0.7 0.7 2.9 1.5 1.6 1.4 1.2 2.9 1.0 0.8 1.4 1.9 3.2 7.3 24.3 1.0 0.5 1.0 0.5 0.0 0.6 1.3 0.7 2.0 1.8 1.7 3.3 0.4 1.4 0.6 9.8 0.8 0.9 28.6 2.7 0.9 0.5 129.5 1.8 0.9 18.1 3.5 1.4 1.5 0.4 1.4 0.2 33.4 62.8 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.1 0.0 62.8 0.2 35.4 1.5 32.4 36.7 0.2 0.5 41.3 33.5 1.4 33.4 0.1 0.4 39.0 31.4 0.9 2.1 1.2 1.1 0.8 1.4 1.0 0.5 0.7 0.5 3.0 26.0 2.2 0.1 1.3 0.2 0.4 2.5 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.7 0.1 5.8 0.6 0.3 3.2 0.0 5.5 5.9 0.0 0.0 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.1 1.5 0.5 0.1 248.3 0.0 0.0 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Cell line enhanced" "Detected in some" "ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 27000000 "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 68.1 67.2 0.0 29.4 44.3 2.2 2.0 0.0 0.0 0.0 0.7 59.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.5 0.0 0.0 71.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 0.0 0.0 0.0 0.0 11.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 2.5 0.0 0.0 0.0 2.5 70.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.4 69.3 0.0 11.8 1.0 0.0 3.6 0.4 0.0 19.1 0.0 0.0 32.3 12.2 0.1 0.0 7.2 3.7 0.0 0.0 0.0 CD27 "S152, TNFRSF7, Tp55" ENSG00000139193 "CD27 molecule" P26842 12 6444867-6451718 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 82.3;lymphoid tissue: 60.4" "Group enriched" "Detected in some" 10 "B-cells: 95.4;Erythroid cells: 70.0;Melanocytes: 92.8;T-cells: 73.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 82.3" "Group enriched" "Detected in many" 7 "B-cells: 41.8;T-cells: 82.3" "Group enriched" "Detected in some" 141 "Daudi: 65.2;U-698: 36.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB002420, HPA038936" Enhanced NA NA 28000 "CAB002420: AB_563539, HPA038936: AB_2676278" "unprognostic (2.75e-3)" "prognostic favorable (3.77e-5)" "unprognostic (8.87e-3)" "prognostic favorable (2.90e-4)" "unprognostic (2.35e-1)" "prognostic favorable (6.65e-7)" "unprognostic (3.56e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.50e-4)" "unprognostic (1.31e-3)" "unprognostic (4.32e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.80e-1)" "unprognostic (3.15e-1)" "unprognostic (1.28e-1)" "unprognostic (7.35e-2)" 1.1 0.6 0.4 40.8 0.5 2.0 1.2 0.4 0.4 1.7 10.0 0.2 0.5 5.3 0.8 0.6 4.9 1.6 3.7 0.9 0.4 0.4 1.7 1.0 2.9 49.5 0.4 0.1 1.0 0.5 0.0 0.6 0.4 0.2 1.3 2.9 1.2 10.7 1.4 0.4 0.6 19.4 0.2 0.6 45.7 3.7 0.5 0.1 33.5 3.1 2.3 60.4 9.1 1.2 41.8 0.3 0.8 0.1 8.3 82.3 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.8 0.1 0.1 16.7 0.1 28.7 41.8 40.1 37.5 0.1 10.5 55.6 39.1 0.8 8.3 0.1 0.3 82.3 22.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.1 0.0 8.2 95.4 0.1 2.1 1.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 70.0 0.0 0.0 1.9 0.2 1.1 1.0 0.2 0.0 1.2 1.3 2.5 0.0 0.3 0.2 92.8 0.0 0.0 0.3 0.0 0.0 0.4 0.4 1.3 0.0 0.2 0.1 0.0 2.8 0.2 73.4 0.0 0.0 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.9 0.1 0.0 0.2 0.0 0.0 0.0 11.9 10.1 3.0 4.2 0.0 1.9 0.0 0.2 0.3 1.5 0.2 0.0 5.2 9.9 34.2 0.0 3.4 0.1 0.0 22.8 0.0 0.0 0.2 0.0 6.3 9.3 3.1 5.9 0.3 0.0 1.1 9.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.9 0.0 0.1 10.9 6.5 2.0 0.2 37.9 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 11.9 10.7 0.5 1.2 4.0 1.4 6.5 0.0 4.0 3.4 0.0 0.0 4.9 0.0 6.4 0.2 6.3 0.8 0.0 3.7 20.2 1.9 0.9 26.7 1.0 4.9 0.0 0.0 10.4 1.9 0.0 0.3 7.7 3.3 73.9 0.1 0.6 12.0 0.0 0.4 0.4 0.1 0.0 0.9 0.5 0.7 2.3 37.2 1.3 0.2 2.2 CD28 ENSG00000178562 "CD28 molecule" P10747 2 203706475-203738912 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.7;lymphoid tissue: 48.6" "Group enriched" "Detected in some" 8 "Hofbauer cells: 25.7;T-cells: 16.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 32.7" "Lineage enriched" "Detected in many" 6 "T-cells: 32.7" "Group enriched" "Detected in some" 14 "Karpas-707: 73.8;RPMI-8226: 33.8;U-266/70: 60.7;U-266/84: 54.2" "Region enhanced" "Detected in single" "olfactory region: 1.3" "Low region specificity" "Detected in all" HPA070003 Enhanced NA NA "HPA070003: AB_2686226" "unprognostic (5.54e-2)" "unprognostic (2.16e-4)" "unprognostic (1.90e-3)" "unprognostic (2.49e-3)" "unprognostic (3.44e-2)" "unprognostic (6.07e-5)" "unprognostic (9.09e-2)" "unprognostic (4.66e-2)" "unprognostic (3.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-1)" "unprognostic (1.68e-1)" "unprognostic (5.78e-5)" "unprognostic (4.77e-2)" "unprognostic (2.93e-2)" "unprognostic (7.79e-2)" "unprognostic (8.96e-2)" 5.1 0.6 0.4 14.2 0.5 1.9 3.3 0.3 0.4 1.1 1.6 0.4 0.2 0.6 1.1 2.3 1.5 2.1 3.0 4.5 0.4 0.5 1.7 1.5 3.8 23.3 0.5 0.2 1.4 0.6 0.0 0.6 11.0 0.2 1.2 1.3 1.2 3.1 0.8 0.7 1.0 7.2 0.9 0.8 9.0 1.6 0.9 0.0 48.6 1.5 0.8 29.9 4.5 1.4 0.1 0.0 5.1 0.2 0.0 32.7 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 73.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 54.2 0.5 0.0 0.0 0.0 0.5 0.2 0.3 3.0 0.1 18.2 0.1 19.4 9.5 0.0 0.1 17.0 6.5 5.1 0.0 0.1 0.0 32.7 4.7 0.4 0.5 0.3 0.4 0.4 0.5 0.5 0.2 0.2 0.0 0.0 2.2 2.2 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 1.1 0.0 25.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 16.6 0.0 0.0 CD300A "CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60" ENSG00000167851 "CD300a molecule" Q9UGN4 17 74466416-74484796 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 81.1;brain: 28.7;lymphoid tissue: 57.8" "Group enriched" "Detected in some" 4 "granulocytes: 57.8;Hofbauer cells: 101.1;Kupffer cells: 71.3;Macrophages: 86.9;T-cells: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 42.2;NB-4: 17.2;RPMI-8226: 33.2" "HPA010971, HPA011645" Approved Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2800000 "Plasma membrane" "Vesicles, Cytosol" "HPA010971: , HPA011645: AB_1846988" "unprognostic (1.99e-1)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.30e-2)" "unprognostic (2.73e-1)" "unprognostic (2.01e-1)" "unprognostic (1.04e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.17e-2)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (5.97e-2)" "unprognostic (5.45e-3)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" 8.6 4.5 9.8 16.0 17.7 11.9 4.4 2.2 11.5 2.0 4.8 3.7 0.0 6.0 1.9 1.3 2.1 2.1 7.7 3.4 7.3 4.2 3.0 7.5 10.6 19.0 20.1 0.3 1.5 2.1 0.3 3.0 6.9 12.6 2.8 4.7 2.3 3.0 1.3 1.1 2.3 7.4 6.0 28.7 57.8 2.4 1.5 17.4 4.1 1.9 0.5 6.0 5.4 2.1 2.2 19.4 81.1 45.7 52.1 29.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 17.2 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.4 0.0 81.1 20.4 57.3 29.5 45.7 6.2 2.2 6.1 8.7 19.4 0.6 2.3 7.1 71.6 52.1 44.2 18.1 0.3 19.2 9.8 17.7 2.2 11.5 7.3 4.2 20.1 0.3 12.6 17.4 0.0 11.9 15.7 0.0 0.8 0.0 0.4 2.5 0.0 1.2 0.0 0.0 0.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.0 0.5 0.1 57.8 0.8 101.1 0.0 0.0 3.1 71.3 0.0 0.0 86.9 3.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.5 0.5 1.3 25.9 0.0 0.1 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Group enriched" "Detected in some" 12 "granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" NA NA "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.4 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 15.0 0.0 29.5 0.0 0.0 0.0 28.1 0.0 0.0 33.8 1.7 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 CD300E "CD300LE, CLM2, IREM2" ENSG00000186407 "CD300e molecule" Q496F6 17 74609887-74623738 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.5;bone marrow: 22.5;lymphoid tissue: 21.0" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 25.2;Club cells: 15.9;Kupffer cells: 69.4;Macrophages: 16.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "classical monocyte: 22.7;intermediate monocyte: 36.5;non-classical monocyte: 36.3" "Lineage enriched" "Detected in many" 6 "monocytes: 36.5" "Cell line enhanced" "Detected in some" "HeLa: 1.7;SCLC-21H: 1.5" "Low region specificity" "Detected in single" HPA015570 Uncertain NA NA "HPA015570: AB_1846294" "unprognostic (1.70e-1)" "unprognostic (6.82e-2)" "unprognostic (1.76e-1)" "unprognostic (2.63e-2)" "unprognostic (1.42e-2)" "unprognostic (2.12e-1)" "unprognostic (1.68e-2)" "unprognostic (7.80e-3)" "unprognostic (4.51e-1)" "unprognostic (1.53e-1)" "unprognostic (2.69e-2)" "unprognostic (5.15e-2)" "unprognostic (4.19e-7)" "unprognostic (1.90e-2)" "unprognostic (2.00e-4)" "unprognostic (7.38e-3)" "unprognostic (1.19e-1)" 8.5 0.7 0.5 21.0 0.6 22.5 0.7 1.2 1.0 0.5 1.2 0.3 0.0 0.0 0.7 3.0 0.9 1.5 1.9 2.0 0.5 0.5 2.5 1.1 14.3 9.4 0.5 0.2 1.0 0.8 0.0 0.5 1.7 0.7 0.6 0.2 1.1 0.6 1.6 1.6 0.6 0.7 5.3 0.9 14.3 0.8 0.7 0.3 0.2 1.2 0.8 0.8 1.8 0.6 0.0 5.9 0.5 36.5 0.0 0.0 11.6 0.2 0.0 1.1 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.1 1.1 0.0 0.5 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.0 1.7 0.8 0.0 0.9 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.5 0.2 0.5 0.0 0.9 0.2 0.8 0.5 0.2 0.4 0.2 0.0 0.2 0.1 0.6 1.5 0.5 0.3 0.0 0.1 1.2 0.6 0.0 0.0 0.5 0.7 0.7 0.2 0.9 0.0 0.1 0.0 0.7 0.5 0.0 22.7 0.1 0.0 36.5 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.5 0.0 36.3 0.1 0.0 11.6 0.5 0.6 1.2 1.0 0.5 0.5 0.5 0.2 0.7 0.3 6.0 25.2 1.4 0.0 0.6 0.2 0.3 0.0 2.7 15.9 1.8 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 3.5 0.2 4.1 0.0 0.0 0.6 69.4 0.0 0.0 16.8 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 CD300LB "CLM7, TREM5" ENSG00000178789 "CD300 molecule like family member b" A8K4G0 17 74521174-74531474 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9" "Group enriched" "Detected in some" 8 "Hofbauer cells: 6.5;Kupffer cells: 10.1;Macrophages: 10.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 30.7" "Group enriched" "Detected in many" 52 "dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0" "Group enriched" "Detected in some" 6 "HL-60: 4.6;NB-4: 6.0;THP-1: 4.7;U-937: 2.8" HPA060449 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060449: " "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.37e-1)" "unprognostic (4.39e-2)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (6.41e-2)" "unprognostic (7.69e-2)" "unprognostic (2.05e-1)" "unprognostic (2.95e-2)" "unprognostic (6.24e-2)" "unprognostic (3.32e-1)" "unprognostic (2.49e-4)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (7.08e-2)" "unprognostic (4.01e-2)" 20.7 0.9 0.2 10.9 0.5 8.8 2.0 0.4 0.5 0.6 0.8 0.3 0.1 0.7 0.7 1.0 1.1 1.2 2.8 1.6 1.5 0.4 1.2 1.0 4.4 6.5 1.2 0.1 2.0 2.3 0.0 0.7 1.1 1.0 0.8 1.1 1.6 1.2 0.1 0.3 0.4 2.0 2.2 0.6 6.6 0.7 0.7 0.1 0.9 0.6 0.1 2.2 2.6 0.7 0.0 10.5 30.7 13.0 0.3 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.6 13.0 30.7 0.0 5.6 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.1 13.8 0.3 0.7 6.6 0.0 4.2 0.2 0.5 0.4 0.5 1.5 0.4 1.2 0.1 1.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.6 10.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CD300LD "CD300D, CMRF35A4" ENSG00000204345 "CD300 molecule like family member d" Q6UXZ3 17 74579365-74592283 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.5;bone marrow: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "neutrophil: 8.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.5" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;RPMI-8226: 2.7" HPA027756 Uncertain NA NA "HPA027756: AB_10601097" "unprognostic (8.03e-2)" "unprognostic (3.30e-1)" 0.3 0.2 0.1 2.2 0.1 3.2 0.2 0.2 0.3 0.4 0.2 0.0 0.2 0.0 0.2 0.4 0.3 0.3 0.1 0.1 0.1 0.2 0.9 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 1.6 0.9 0.1 0.1 1.4 0.2 1.7 0.1 0.6 0.4 0.1 0.5 0.7 8.5 0.7 0.8 1.3 0.2 0.4 0.3 0.5 1.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.4 0.6 0.3 0.5 0.6 0.5 0.3 0.5 0.0 0.5 0.2 0.2 1.6 0.7 0.0 1.2 4.5 0.6 0.4 0.3 0.5 0.6 0.0 0.5 0.5 1.8 0.2 1.4 0.2 0.6 0.5 0.0 0.6 0.4 0.6 2.7 0.5 0.8 0.5 0.5 0.7 0.5 0.0 0.6 0.6 0.1 0.5 0.6 0.5 1.1 0.0 0.9 0.3 0.6 0.2 0.3 0.4 0.8 0.4 0.4 0.4 0.7 0.2 0.3 0.3 0.2 0.7 0.5 0.5 0.4 8.5 0.8 0.4 0.5 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD300LF "CD300f, CLM1, IGSF13, IREM1, NKIR" ENSG00000186074 "CD300 molecule like family member f" Q8TDQ1 17 74694311-74712978 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 13 "granulocytes: 22.0;Hofbauer cells: 21.0;Kupffer cells: 28.8;Macrophages: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 47.8" "Group enriched" "Detected in many" 46 "dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1" "Group enriched" "Detected in some" 6 "THP-1: 16.0;U-937: 30.9" HPA013712 Supported NA NA "HPA013712: AB_2668874" "unprognostic (6.51e-2)" "unprognostic (1.49e-3)" "unprognostic (3.81e-2)" "unprognostic (4.00e-2)" "unprognostic (8.51e-2)" "unprognostic (6.74e-2)" "unprognostic (1.79e-1)" "unprognostic (3.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (9.60e-2)" "unprognostic (4.14e-2)" "unprognostic (7.75e-2)" "unprognostic (4.79e-2)" 3.3 1.0 1.2 9.8 3.1 18.2 0.9 1.5 1.3 0.8 2.3 3.1 0.0 2.7 0.7 0.7 0.9 1.1 1.9 2.4 1.3 1.2 1.1 1.5 24.1 15.6 3.8 0.5 0.9 0.9 0.0 1.0 2.1 2.6 1.4 2.6 0.8 1.9 0.3 0.5 0.5 3.4 2.3 5.8 29.1 1.0 0.7 2.4 1.1 0.8 0.0 4.2 2.8 0.8 0.0 13.5 47.8 38.1 0.7 0.1 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 30.9 0.0 8.4 20.2 47.8 0.0 34.4 0.1 0.0 0.0 0.0 13.5 0.0 0.0 0.0 15.9 0.7 38.1 1.4 0.0 8.2 1.2 3.1 1.5 1.3 1.3 1.2 3.8 0.5 2.6 2.4 0.0 8.3 0.0 0.0 0.1 0.2 0.1 2.5 0.0 5.7 0.0 2.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.0 0.0 21.0 0.0 0.0 1.3 28.8 0.0 0.0 32.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CD300LG "CLM9, Trem4" ENSG00000161649 "CD300 molecule like family member g" Q6UXG3 17 43847148-43863629 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 76.1;breast: 45.4" "Cell type enhanced" "Detected in some" 19 "Ito cells: 6.7;Leydig cells: 12.0;Peritubular cells: 29.0;Sertoli cells: 12.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.0;NB-4: 1.1" NA NA 870000 "unprognostic (2.38e-2)" "unprognostic (2.06e-3)" "unprognostic (2.63e-1)" "unprognostic (2.72e-1)" "unprognostic (3.18e-1)" "unprognostic (2.73e-1)" "unprognostic (1.40e-4)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (2.01e-2)" "unprognostic (4.08e-3)" "unprognostic (8.69e-4)" "unprognostic (2.12e-5)" "unprognostic (1.30e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-2)" "unprognostic (1.57e-1)" 76.1 0.9 0.1 2.8 0.2 0.0 45.4 0.1 0.5 2.2 6.1 0.1 1.2 0.0 1.7 5.4 1.5 1.8 1.7 10.5 0.1 0.0 1.9 1.4 4.6 0.5 0.1 0.2 0.8 1.1 0.2 0.1 25.2 0.2 2.6 0.1 1.4 1.7 0.8 8.2 3.1 0.9 0.3 0.1 1.1 1.0 16.0 0.1 2.1 1.2 1.7 0.2 1.5 7.8 0.5 1.6 2.4 0.2 0.6 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 2.0 0.3 0.0 0.6 0.2 0.0 0.2 0.0 1.0 0.0 0.7 0.1 0.0 0.4 0.3 0.4 0.0 0.5 1.0 0.4 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.7 0.0 0.1 0.2 0.8 0.2 0.1 0.0 0.2 0.6 0.4 0.3 0.1 0.6 0.3 0.4 0.1 0.1 2.4 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.2 1.6 0.5 0.2 0.2 1.2 0.6 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.7 0.3 1.5 12.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 12.9 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 CD302 "BIMLEC, CLEC13A, DCL-1, KIAA0022" ENSG00000241399 "CD302 molecule" Q8IX05 2 159768630-159798255 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.8" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 257.0;Kupffer cells: 378.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 190 "dendritic cells: 17.0;granulocytes: 19.1;monocytes: 20.8" "Cell line enriched" "Detected in many" 5 "ASC diff: 77.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 16000 "unprognostic (2.52e-1)" "unprognostic (5.44e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.03e-1)" "unprognostic (6.88e-2)" "unprognostic (1.68e-2)" "unprognostic (9.12e-3)" "unprognostic (5.29e-3)" "unprognostic (2.37e-2)" "unprognostic (4.38e-2)" "unprognostic (2.14e-1)" "unprognostic (4.67e-3)" "unprognostic (1.75e-2)" "unprognostic (6.61e-2)" "unprognostic (7.45e-2)" "unprognostic (3.61e-3)" 27.1 9.4 5.0 6.1 5.9 10.1 28.6 3.3 4.3 13.8 13.8 4.0 2.6 8.7 11.4 11.0 7.9 9.7 11.7 13.7 5.6 3.3 9.3 113.8 22.9 23.3 5.9 2.7 16.3 9.0 4.7 4.0 7.0 6.3 11.5 7.7 13.7 7.7 7.8 6.1 4.9 13.9 12.1 8.7 18.9 8.5 9.2 5.9 0.7 26.6 6.3 3.4 12.4 23.8 0.0 17.0 19.1 20.8 0.0 0.0 7.5 0.0 0.5 0.4 0.0 77.9 16.3 0.0 1.9 7.8 2.3 3.4 0.6 0.7 0.1 0.8 4.1 2.5 0.0 1.6 0.8 3.1 0.5 2.6 3.0 0.5 1.1 3.9 5.8 2.1 12.9 0.4 2.5 0.0 1.9 5.7 0.0 0.2 2.7 2.8 0.2 0.0 4.2 0.7 0.0 2.3 0.0 0.6 0.0 0.4 0.2 0.9 1.0 0.6 1.8 1.8 1.3 1.5 5.6 2.0 4.5 0.0 0.1 1.2 0.3 0.0 0.0 3.1 0.5 1.0 6.2 20.8 19.1 0.0 16.4 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 19.1 0.0 15.6 4.5 0.0 7.5 5.0 5.9 3.3 4.3 5.6 3.3 5.9 2.7 6.3 5.9 41.7 80.3 9.3 14.0 6.0 3.3 3.7 30.6 26.8 45.5 3.5 0.0 2.0 0.0 3.0 26.4 18.4 5.6 0.0 3.1 7.4 29.6 22.5 29.0 257.0 40.0 3.2 9.2 67.5 378.3 12.0 113.6 127.8 18.6 4.6 23.7 1.5 3.1 13.3 88.1 3.3 2.2 64.7 17.5 21.4 11.6 3.9 2.3 7.5 18.6 8.6 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "Cell line enhanced" "Detected in some" "HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0" "CAB011442, HPA035832, HPA064807" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356" "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 28.5 0.1 0.0 0.0 37.9 28.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 7.2 0.0 0.0 0.0 18.1 0.0 0.0 8.7 0.0 1.5 20.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.2 0.2 4.9 0.4 0.6 0.0 0.1 2.4 0.0 3.3 28.0 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 0.0 10.7 1.4 0.5 1.5 0.1 0.6 0.0 1.4 1.2 0.0 0.0 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.4 1.5 0.3 73.9 0.8 67.4 0.0 0.0 8.6 119.1 1.3 0.3 56.4 1.7 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.5 0.9 0.7 1.7 0.0 0.3 CD36 "FAT, GP3B, GP4, GPIV, SCARB3" ENSG00000135218 "CD36 molecule" P16671 7 80369575-80679277 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Transport" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 464.3;breast: 156.1" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 491.8;Hofbauer cells: 1111.0;Ito cells: 465.9;Sertoli cells: 685.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9" "Group enriched" "Detected in many" 45 "dendritic cells: 56.9;monocytes: 104.4" "Group enriched" "Detected in some" 5 "ASC diff: 82.7;HEL: 39.3" "Low region specificity" "Detected in many" "HPA002018, CAB025866, HPA071026" Enhanced Enhanced "Golgi apparatus" NA NA 92000000 "Golgi apparatus" "CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170" "unprognostic (7.16e-2)" "unprognostic (1.80e-2)" "unprognostic (1.06e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (9.35e-2)" "unprognostic (2.64e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-3)" "unprognostic (1.18e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (4.47e-4)" "unprognostic (7.05e-3)" "unprognostic (4.87e-2)" "unprognostic (2.73e-3)" 464.3 3.6 1.2 8.9 1.3 10.9 156.1 0.5 0.5 1.8 31.8 0.6 3.3 9.8 1.8 7.5 7.5 3.3 7.2 76.8 1.8 1.9 2.2 13.3 11.5 4.8 0.6 0.3 2.5 3.9 3.1 0.8 37.9 2.9 9.2 3.5 0.8 4.6 2.3 23.6 5.4 23.4 4.7 0.8 42.8 5.0 6.0 0.5 2.7 13.6 15.3 1.4 9.4 19.2 0.3 56.9 1.8 104.4 0.7 0.2 60.2 0.0 0.0 0.2 0.1 82.7 0.8 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.1 0.0 0.1 0.1 39.3 0.1 6.3 0.0 0.0 0.0 8.0 3.1 0.0 0.0 1.9 0.2 0.0 1.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.0 0.7 2.7 4.5 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.1 0.0 13.5 10.4 0.9 104.4 0.3 0.2 30.4 0.2 0.3 0.0 0.0 56.9 0.0 0.1 0.0 1.8 0.7 7.5 14.3 0.1 60.2 1.2 1.3 0.5 0.5 1.8 1.9 0.6 0.3 2.9 0.5 6.0 69.8 5.2 0.1 6.5 0.0 491.8 7.6 0.0 5.7 7.0 0.0 8.5 0.0 0.0 9.2 46.6 0.0 163.5 0.0 9.4 14.4 0.7 14.0 12.1 1111.0 0.0 0.0 465.9 196.7 2.3 0.6 68.0 15.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.3 685.6 31.5 4.7 0.7 4.1 15.3 1.3 0.0 0.1 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.4;lymphoid tissue: 109.6" "Cell type enhanced" "Detected in many" 18 "B-cells: 979.0;granulocytes: 262.7;Hofbauer cells: 303.3;Kupffer cells: 224.9;Macrophages: 253.6;T-cells: 359.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 67.2;HMC-1: 66.6;RPMI-8226: 23.9;THP-1: 23.9;U-698: 14.8;U-937: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 7.3 3.1 3.4 62.9 4.8 48.7 3.7 1.0 3.1 1.9 4.2 8.5 0.0 3.2 2.0 2.2 5.9 2.9 5.2 10.4 3.8 3.8 4.3 2.7 25.3 109.6 6.9 1.7 2.5 1.6 0.5 1.9 5.4 4.7 3.5 1.7 2.7 10.7 1.4 1.1 2.0 39.3 1.7 14.5 88.1 5.1 2.9 5.0 47.9 3.4 1.7 86.8 10.2 2.4 163.4 53.7 84.4 62.8 27.9 43.5 58.8 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.0 11.8 0.0 0.1 0.0 2.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 3.7 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.6 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 14.8 0.0 17.8 0.0 42.8 58.2 71.7 34.3 53.4 34.7 137.2 41.8 36.4 41.1 163.4 43.5 36.3 84.4 27.9 62.8 53.7 40.9 58.8 3.4 4.8 1.0 3.1 3.8 3.8 6.9 1.7 4.7 5.0 8.9 20.5 979.0 1.1 10.4 12.4 1.2 2.5 1.4 4.5 1.8 5.9 1.6 0.0 0.3 98.9 4.3 0.4 0.0 0.0 1.5 5.4 0.5 262.7 2.5 303.3 0.0 1.2 14.1 224.9 158.6 2.6 253.6 27.0 43.3 0.5 1.1 0.0 5.3 0.7 2.5 5.2 0.0 0.5 1.1 0.9 10.3 2.4 359.8 0.4 0.9 CD38 ENSG00000004468 "CD38 molecule" P28907 4 15778275-15853230 "Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins" "Hydrolase, Receptor, Transferase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 94.9;seminal vesicle: 104.1" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 15.3" "Group enriched" "Detected in all" 4 "B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3" "Cell line enhanced" "Detected in some" "Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6" "Low region specificity" "Detected in all" "CAB002493, HPA022132, CAB025255, HPA052381" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807" "unprognostic (1.27e-2)" "unprognostic (8.06e-3)" "unprognostic (1.06e-2)" "prognostic favorable (9.68e-4)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (2.74e-1)" "unprognostic (8.51e-2)" "unprognostic (5.87e-2)" "unprognostic (6.15e-6)" "unprognostic (5.23e-1)" "unprognostic (4.34e-1)" "unprognostic (6.63e-6)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (2.12e-2)" "unprognostic (2.13e-1)" 4.1 3.3 3.8 17.6 8.5 9.3 2.6 0.7 12.0 1.0 3.2 10.4 14.6 4.3 0.7 0.9 2.3 2.4 1.5 5.0 4.0 4.2 1.2 5.4 4.7 16.1 4.9 3.1 0.6 0.7 0.0 2.5 0.6 3.1 10.8 2.7 4.4 2.8 104.1 14.2 0.5 6.2 0.9 1.8 20.6 2.0 0.7 2.5 94.9 2.8 2.0 13.2 7.6 0.9 9.0 5.1 1.3 2.2 15.3 2.3 3.7 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 50.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 14.2 0.0 0.0 12.8 3.1 0.0 0.0 0.0 10.3 0.0 8.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 2.2 0.2 0.0 0.0 0.0 0.0 11.0 0.1 9.6 0.1 2.4 0.1 0.0 1.7 0.0 1.1 2.2 0.3 9.0 1.4 1.2 4.1 6.6 2.3 1.8 1.3 15.3 1.4 5.1 2.1 3.7 3.8 8.5 0.7 6.2 4.0 4.2 4.9 3.1 3.1 2.5 3.0 10.8 23.4 0.4 0.0 0.0 0.8 0.0 49.5 18.2 0.0 9.8 0.2 0.0 0.0 1.6 0.1 0.0 46.7 0.0 0.0 0.5 10.7 39.1 1.3 4.6 0.0 0.0 3.1 31.1 0.0 0.0 10.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 2.2 1.4 0.0 0.5 30.5 0.7 0.1 CD3D T3D ENSG00000167286 "CD3d molecule" P04234 11 118338954-118342744 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 108.7;lymphoid tissue: 181.4" "Cell type enriched" "Detected in many" 12 "T-cells: 532.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 53 "gdT-cell: 105.6;MAIT T-cell: 68.6;memory CD4 T-cell: 88.1;memory CD8 T-cell: 97.6;naive CD4 T-cell: 78.8;naive CD8 T-cell: 98.6;T-reg: 108.7" "Lineage enriched" "Detected in many" 63 "T-cells: 108.7" "Cell line enhanced" "Detected in some" "JURKAT: 69.9;MOLT-4: 149.5;NB-4: 27.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB013055, HPA071778" Enhanced Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB013055: , HPA071778: " "prognostic favorable (3.00e-4)" "prognostic favorable (8.46e-5)" "unprognostic (1.05e-2)" "prognostic favorable (1.73e-7)" "unprognostic (6.00e-2)" "prognostic favorable (1.70e-4)" "unprognostic (3.82e-1)" "unprognostic (2.40e-2)" "unprognostic (2.24e-3)" "unprognostic (1.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (9.00e-2)" "unprognostic (2.02e-1)" "unprognostic (3.66e-2)" "prognostic favorable (6.16e-4)" 2.6 0.8 0.5 17.4 0.7 4.8 1.7 0.5 0.7 1.3 4.1 0.7 0.8 4.1 1.2 1.6 3.2 1.9 2.9 1.0 0.7 0.4 2.6 1.9 6.1 40.8 0.9 0.5 1.0 1.2 0.0 0.7 0.8 0.7 2.2 4.3 1.1 9.0 0.8 0.7 1.3 19.3 1.0 1.5 28.6 4.4 0.8 0.5 181.4 2.7 2.8 32.6 5.7 2.4 0.5 0.3 1.7 0.3 0.2 108.7 64.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.9 5.7 0.0 0.0 0.0 149.5 27.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.2 105.6 0.2 68.6 0.5 88.1 97.6 0.3 0.2 78.8 98.6 1.7 0.2 0.3 0.3 108.7 64.9 0.5 0.7 0.5 0.7 0.7 0.4 0.9 0.5 0.7 0.5 6.0 45.4 3.0 0.3 13.6 0.0 2.5 0.0 2.7 4.5 3.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 5.1 0.1 11.6 2.0 0.6 0.0 1.2 9.8 7.6 0.4 0.0 6.1 11.8 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 5.6 0.0 0.0 10.3 0.2 532.0 0.3 0.0 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304545-118316175 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 294.2" "Cell type enriched" "Detected in some" 31 "T-cells: 377.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 36 "gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8" "Group enriched" "Detected in many" 29 "NK-cells: 21.8;T-cells: 62.0" "Group enriched" "Detected in some" 67 "JURKAT: 80.1;MOLT-4: 108.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 3.9 1.0 0.5 16.7 0.7 6.8 1.9 0.5 0.7 2.1 4.7 0.9 0.7 4.4 2.0 1.4 3.3 3.0 4.0 1.4 0.5 0.5 3.3 2.6 7.3 40.9 1.3 0.6 1.5 1.3 0.0 0.9 1.2 0.9 2.6 3.9 1.9 6.4 1.1 0.8 1.3 21.1 1.1 1.9 34.5 4.6 1.2 0.5 294.2 3.4 2.1 37.8 6.3 3.0 0.2 0.9 1.4 0.2 21.8 62.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.1 0.1 0.3 0.0 0.0 108.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.4 0.0 0.1 0.0 1.3 0.2 0.2 59.5 0.1 50.2 0.1 50.7 55.7 0.1 0.2 61.3 62.0 1.4 21.8 0.2 0.9 46.8 32.9 0.5 0.7 0.5 0.7 0.5 0.5 1.3 0.6 0.9 0.5 0.0 11.3 4.5 0.3 4.6 0.0 0.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 6.5 0.2 0.0 0.0 0.0 0.0 1.0 0.1 7.0 0.8 0.3 0.0 0.0 12.3 7.3 0.0 0.0 2.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 4.6 0.2 377.3 0.2 0.3 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 187.6" "Cell type enriched" "Detected in some" 18 "T-cells: 153.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 30 "gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2" "Lineage enriched" "Detected in many" 37 "T-cells: 46.7" "Group enriched" "Detected in some" 53 "JURKAT: 24.1;MOLT-4: 64.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 1.1 0.6 0.4 7.1 0.4 0.5 0.8 0.3 0.3 0.7 2.3 0.4 0.4 2.0 0.9 0.6 1.5 1.1 1.9 0.6 0.4 0.4 1.2 0.9 2.4 17.2 0.5 0.2 0.7 0.7 0.0 0.5 0.4 0.3 1.0 1.6 0.9 2.9 0.3 5.9 0.6 8.1 0.2 0.8 11.5 2.4 0.5 0.2 187.6 1.4 1.7 19.2 2.5 1.1 0.1 0.2 1.2 0.2 0.2 46.7 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.8 0.2 0.0 0.2 64.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.2 0.2 43.5 0.1 25.6 0.1 36.1 37.1 0.1 0.1 37.6 46.7 1.2 0.2 0.1 0.2 34.2 14.1 0.4 0.4 0.3 0.3 0.4 0.4 0.5 0.2 0.3 0.2 3.0 8.6 0.8 0.0 2.1 0.1 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.8 1.3 0.1 0.0 0.0 6.2 2.8 0.4 0.0 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 0.2 0.0 2.0 0.2 153.8 0.0 0.0 CD4 ENSG00000010610 "CD4 molecule" P01730 12 6786858-6820808 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 111.5;parathyroid gland: 78.4" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 121.3;Ito cells: 382.4;Kupffer cells: 192.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 17 "classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4" "Group enriched" "Detected in many" 20 "dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1" "Group enriched" "Detected in some" 6 "HEL: 34.3;HL-60: 13.8;NB-4: 19.7;THP-1: 39.0;U-937: 36.7" "Region enriched" "Detected in single" 15 "basal ganglia: 41.4" "Not detected" "Not detected" "CAB000011, HPA004252, HPA004472, CAB068180" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465" "unprognostic (1.39e-2)" "unprognostic (1.12e-2)" "unprognostic (2.75e-2)" "prognostic favorable (2.16e-4)" "unprognostic (7.76e-2)" "unprognostic (4.82e-3)" "unprognostic (3.70e-2)" "unprognostic (2.74e-2)" "unprognostic (7.04e-2)" "unprognostic (2.40e-1)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (1.06e-1)" "unprognostic (4.65e-3)" "unprognostic (9.08e-3)" "unprognostic (2.95e-1)" 13.8 5.4 6.1 16.0 5.8 4.4 5.6 1.2 4.3 4.5 5.1 8.6 1.8 3.6 3.5 8.3 3.0 5.5 7.3 5.4 4.9 4.4 6.1 32.2 24.0 30.8 6.3 3.1 3.0 3.1 78.4 3.4 10.9 6.2 4.1 6.5 5.7 5.4 3.9 1.9 3.5 9.5 5.2 10.2 49.1 3.9 2.8 5.7 111.5 3.9 4.1 18.6 8.6 3.2 0.1 46.7 1.9 42.5 0.3 29.1 33.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 34.3 0.0 0.2 3.8 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 19.7 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.1 42.2 0.3 0.3 42.5 1.1 0.0 29.1 0.1 29.3 0.1 24.8 0.1 1.9 0.3 33.3 46.7 26.4 33.6 6.1 5.8 1.2 4.3 4.9 4.4 6.3 3.1 6.2 5.7 0.0 6.9 8.2 0.2 3.1 1.5 1.6 15.3 26.8 3.4 3.5 0.0 0.8 5.0 0.0 0.0 2.8 0.0 0.0 0.3 0.9 5.4 0.1 7.0 7.8 121.3 4.8 0.0 382.4 192.9 0.0 15.5 72.7 5.0 39.7 0.0 14.3 0.0 0.0 14.2 1.1 0.1 12.9 4.2 0.0 0.1 1.9 1.0 28.4 0.0 0.3 CD40LG "CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP" ENSG00000102245 "CD40 ligand" P29965 X 136648193-136660390 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7" "Cell type enriched" "Detected in some" 4 "T-cells: 24.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1" "Lineage enriched" "Detected in single" 58 "T-cells: 29.2" "Cell line enriched" "Detected in some" 14 "MOLT-4: 22.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA045827, HPA072480" Enhanced "Secreted to blood" NA NA 776000 "HPA045827: AB_10959606, HPA072480: " "unprognostic (1.94e-5)" "unprognostic (1.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.27e-3)" "unprognostic (4.71e-2)" "unprognostic (3.56e-5)" "unprognostic (3.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.77e-1)" "unprognostic (2.14e-4)" "unprognostic (1.87e-1)" "unprognostic (1.55e-1)" "unprognostic (6.70e-4)" "unprognostic (2.15e-1)" "unprognostic (5.19e-2)" "unprognostic (2.36e-3)" "unprognostic (2.92e-2)" 2.0 0.5 0.3 22.4 0.3 1.4 1.2 0.3 0.3 2.0 3.3 0.1 0.0 1.7 1.5 1.3 1.6 1.6 2.6 1.1 0.4 0.4 1.6 1.1 4.0 14.6 0.4 0.0 0.7 0.6 0.0 0.4 0.2 0.3 1.0 3.1 1.0 4.9 1.3 0.4 1.1 8.7 0.5 0.6 9.9 1.7 0.6 0.1 33.7 1.4 2.0 26.1 3.0 1.4 0.0 0.0 0.5 0.0 0.2 29.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 9.4 0.0 22.9 0.0 29.2 4.1 0.0 0.0 28.1 0.2 0.5 0.2 0.0 0.0 3.3 4.7 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.3 0.1 0.0 3.7 0.0 0.0 1.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.6 5.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 1.8 0.0 24.5 0.0 0.0 CD48 "BCM1, BLAST, hCD48, mCD48, SLAMF2" ENSG00000117091 "CD48 molecule" P09326 1 160678746-160711851 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.3;lymphoid tissue: 86.3" "Group enriched" "Detected in many" 5 "B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5" "CAB002497, HPA055146" Enhanced Supported "Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 2600000 "Plasma membrane" "Nucleoli fibrillar center, Cytosol" "CAB002497: AB_563586, HPA055146: AB_2682716" "prognostic favorable (3.91e-4)" "unprognostic (1.72e-3)" "prognostic favorable (4.17e-4)" "unprognostic (1.58e-3)" "unprognostic (2.36e-1)" "unprognostic (1.71e-3)" "unprognostic (2.09e-2)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (3.02e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.36e-4)" "unprognostic (3.21e-1)" "unprognostic (4.69e-2)" "unprognostic (9.38e-2)" "unprognostic (8.51e-2)" 5.5 1.4 1.0 44.6 0.9 23.1 2.8 0.6 0.7 3.2 5.0 0.5 1.1 3.2 1.9 2.5 7.3 2.1 4.8 1.8 1.0 1.0 3.6 3.1 15.4 86.3 1.6 0.3 2.3 1.5 0.0 1.3 2.2 0.8 2.8 5.7 2.4 13.9 1.5 1.3 1.2 21.2 1.7 3.8 66.6 5.0 1.3 0.2 50.8 2.9 3.6 58.0 8.6 2.6 34.6 53.6 35.8 74.1 24.9 57.9 81.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 4.6 43.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 14.2 0.0 0.0 13.5 6.7 0.0 0.0 0.0 0.8 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 61.5 15.8 0.0 11.7 0.0 28.2 52.2 35.8 42.4 74.1 57.9 34.6 48.3 48.8 53.6 27.9 49.7 52.5 13.4 24.9 73.5 9.4 36.4 81.3 1.0 0.9 0.6 0.7 1.0 1.0 1.6 0.3 0.8 0.2 0.0 14.8 233.4 0.5 4.8 0.0 0.8 5.1 4.0 2.3 3.5 0.0 0.7 1.7 0.1 0.0 0.7 0.0 23.3 0.2 0.7 3.1 0.2 88.9 1.8 87.6 0.0 1.2 8.6 195.5 0.4 1.7 131.8 37.1 8.2 0.0 0.0 0.1 0.0 0.4 1.5 0.0 0.0 0.7 0.4 0.1 2.6 0.3 297.5 0.0 0.3 CD5 "LEU1, T1" ENSG00000110448 "CD5 molecule" P06127 11 61102395-61127852 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.3;lymphoid tissue: 96.2" "Group enriched" "Detected in some" 4 "Muller glia cells: 9.6;T-cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "gdT-cell: 12.9;MAIT T-cell: 9.3;memory CD4 T-cell: 31.2;memory CD8 T-cell: 20.6;naive CD4 T-cell: 25.9;naive CD8 T-cell: 19.5;T-reg: 36.3" "Lineage enriched" "Detected in many" 32 "T-cells: 36.3" "Group enriched" "Detected in some" 65 "JURKAT: 12.0;MOLT-4: 38.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB015392, CAB020308, HPA043416, HPA060839" Enhanced NA NA "CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376" "prognostic favorable (4.05e-4)" "prognostic favorable (9.16e-5)" "unprognostic (2.33e-1)" "prognostic favorable (9.00e-5)" "unprognostic (1.02e-2)" "prognostic favorable (7.41e-6)" "unprognostic (2.45e-3)" "unprognostic (1.37e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.25e-2)" "unprognostic (5.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.94e-5)" "unprognostic (4.78e-2)" "unprognostic (1.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.06e-1)" 2.1 0.6 0.5 19.4 0.4 6.5 1.3 0.3 0.6 1.6 2.5 0.3 0.3 1.7 1.1 1.7 1.9 1.4 3.9 0.8 0.6 1.3 1.9 1.1 7.1 28.8 0.4 0.1 1.1 0.9 0.0 0.8 0.4 0.3 1.4 1.5 1.6 15.5 1.3 0.6 1.3 10.2 0.4 0.7 13.8 4.8 1.3 0.1 96.2 1.7 2.4 42.2 5.4 1.5 1.1 1.1 0.4 0.7 0.1 36.3 14.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 12.9 0.1 9.3 0.4 31.2 20.6 0.9 1.1 25.9 19.5 0.4 0.1 0.7 1.1 36.3 14.6 0.5 0.4 0.3 0.6 0.6 1.3 0.4 0.1 0.3 0.1 0.0 1.7 0.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.1 0.0 0.0 1.3 0.0 0.8 0.0 0.6 3.3 1.8 0.0 9.6 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.3 0.5 0.3 0.0 18.7 0.0 0.1 CD52 "CDW52, EDDM5, HE5" ENSG00000169442 "CD52 molecule" P31358 1 26317957-26320523 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 495.7;epididymis: 978.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 1214.9;granulocytes: 550.2;Hofbauer cells: 593.7;Macrophages: 676.6;T-cells: 760.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Daudi: 76.1;REH: 111.3;U-266/84: 111.2;U-698: 123.2" NA NA "prognostic favorable (1.85e-5)" "unprognostic (3.28e-3)" "unprognostic (1.93e-2)" "prognostic favorable (2.06e-4)" "unprognostic (4.18e-2)" "prognostic favorable (4.45e-4)" "unprognostic (9.11e-2)" "unprognostic (2.98e-2)" "unprognostic (7.73e-3)" "unprognostic (6.27e-2)" "unprognostic (4.58e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (3.64e-1)" "unprognostic (6.14e-2)" "unprognostic (7.95e-2)" "unprognostic (1.26e-1)" 9.5 0.9 0.8 23.0 1.4 5.7 4.7 0.3 0.8 0.9 3.7 0.3 93.2 1.0 1.1 978.9 2.9 1.5 2.2 1.5 0.6 0.2 3.5 3.2 43.4 54.6 0.8 0.6 0.8 1.0 0.0 0.7 0.7 0.7 1.7 2.5 1.3 5.7 2.9 0.4 1.9 39.6 1.1 1.2 98.7 2.7 5.3 0.4 24.7 3.2 2.1 30.4 4.3 1.7 292.0 87.6 258.4 194.6 94.3 308.1 495.7 0.2 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 76.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.7 11.9 0.0 0.0 0.0 0.0 0.0 0.0 4.9 2.5 0.1 0.0 0.5 0.8 6.8 0.3 0.0 0.0 111.3 0.1 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.1 1.0 0.0 1.3 0.1 0.0 0.2 0.0 0.1 0.3 111.2 123.2 0.0 1.9 0.0 12.4 126.8 258.4 194.7 194.6 155.1 292.0 244.1 190.3 87.6 273.7 166.6 171.2 9.6 94.3 167.6 28.6 308.1 495.7 0.8 1.4 0.3 0.8 0.6 0.2 0.8 0.6 0.7 0.4 62.5 287.6 1214.9 0.7 40.3 0.0 6.0 2.5 32.1 92.1 47.1 0.0 2.7 0.0 0.2 0.7 22.7 0.7 0.0 0.2 4.3 18.8 0.4 550.2 1.5 593.7 0.0 0.0 17.8 203.9 1.3 0.0 676.6 101.3 2.8 1.9 0.0 0.1 2.9 0.0 7.6 0.0 0.0 3.3 0.2 0.2 27.5 4.7 760.6 0.2 0.8 CD53 "MOX44, TSPAN25" ENSG00000143119 "CD53 molecule" P19397 1 110873154-110899928 "CD markers, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 146.7;lymphoid tissue: 103.0" "Group enriched" "Detected in many" 7 "B-cells: 233.1;granulocytes: 158.2;Hofbauer cells: 322.4;Kupffer cells: 293.3;Macrophages: 340.3;T-cells: 289.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 87.2;HDLM-2: 37.5;HMC-1: 54.9;Karpas-707: 34.2;U-266/70: 47.3;U-698: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047216 Enhanced NA NA "HPA047216: AB_2679986" "unprognostic (2.93e-2)" "unprognostic (1.25e-2)" "unprognostic (7.45e-3)" "unprognostic (1.02e-3)" "unprognostic (8.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.96e-1)" "unprognostic (6.07e-2)" "unprognostic (2.83e-2)" "unprognostic (2.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (9.58e-2)" "unprognostic (4.95e-2)" "unprognostic (1.33e-1)" "unprognostic (7.72e-2)" 29.7 8.1 6.1 50.6 10.3 20.4 6.6 1.6 5.8 4.5 9.6 7.6 1.2 6.7 4.3 6.0 5.5 9.9 11.0 6.4 6.4 5.9 9.6 8.8 28.9 93.8 13.3 2.7 4.7 3.8 0.8 3.1 10.6 8.5 5.2 10.5 4.5 10.1 2.3 2.3 2.2 35.2 10.0 14.9 103.0 7.5 4.8 10.0 37.2 4.6 4.1 82.1 15.2 4.0 97.5 74.6 138.0 97.0 59.2 91.8 146.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 37.5 0.0 4.6 0.0 0.0 0.0 10.4 54.9 0.0 0.0 0.0 0.0 0.0 0.0 25.0 1.9 34.2 0.0 0.0 17.7 12.4 0.0 0.0 0.0 17.2 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 15.7 3.1 0.0 0.0 0.0 0.1 47.3 21.4 27.0 0.2 12.1 0.6 138.0 87.0 54.1 91.8 93.3 82.8 97.5 67.5 80.8 74.6 83.3 49.2 70.8 136.2 59.2 97.0 61.4 85.0 146.7 6.1 10.3 1.6 5.8 6.4 5.9 13.3 2.7 8.5 10.0 14.9 35.6 233.1 0.4 6.3 0.0 0.8 5.1 8.1 15.9 1.8 0.0 1.7 0.0 0.0 0.2 7.2 0.0 23.3 0.2 4.2 5.0 0.3 158.2 1.7 322.4 0.0 0.0 15.4 293.3 0.9 2.0 340.3 37.1 39.7 0.0 0.0 0.2 0.0 0.4 1.1 0.6 6.5 0.7 0.1 0.7 4.8 3.4 289.1 0.0 0.3 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736491 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 285.5" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 1502.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 217.5;U-2197: 180.1" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 98000000 "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favorable (1.39e-10)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 96.7 41.0 36.7 26.3 44.3 23.8 76.0 25.9 32.7 44.8 36.9 24.0 57.9 16.5 45.4 132.8 68.4 53.2 67.6 90.5 35.6 38.4 100.0 61.0 86.4 39.8 39.7 25.8 39.3 52.3 60.6 48.0 285.5 68.7 47.4 37.7 51.4 114.8 62.6 70.6 43.4 25.0 52.4 32.9 26.2 54.7 28.1 23.1 16.1 85.9 57.7 40.0 51.2 63.4 13.5 20.5 42.8 4.8 17.7 60.4 11.1 16.8 15.8 4.7 13.8 109.9 86.2 2.7 96.0 107.2 24.1 28.2 7.3 50.7 1.3 17.2 103.4 28.7 19.0 8.6 95.8 33.8 26.8 13.1 1.7 56.0 11.0 30.0 10.1 5.8 40.0 24.2 20.4 98.3 66.8 146.8 5.9 11.8 39.0 151.5 15.4 4.7 4.2 2.6 31.1 82.5 1.8 14.6 13.5 72.7 28.8 3.2 4.4 33.4 15.5 17.6 13.9 11.8 1.0 217.5 55.4 13.3 180.1 33.3 17.3 33.8 1.6 47.6 0.0 96.2 30.5 4.8 42.8 11.3 1.6 14.4 13.5 24.0 12.7 20.5 10.6 15.7 9.3 28.4 17.7 0.9 10.5 60.4 11.1 36.7 44.3 25.9 32.7 35.6 38.4 39.7 25.8 68.7 23.1 253.1 215.4 44.4 795.7 254.1 47.4 262.5 430.6 580.9 208.1 230.3 31.4 513.5 139.3 1251.4 102.0 802.4 90.2 140.2 547.4 330.2 284.0 787.9 136.2 175.7 400.2 44.5 160.2 566.0 129.7 49.4 219.8 141.1 1204.5 272.3 85.9 184.1 823.9 122.8 192.3 162.3 45.0 271.7 576.8 86.8 27.6 248.5 699.7 62.8 98.2 1502.4 CD5L "API6, Spalpha" ENSG00000073754 "CD5 molecule like" O43866 1 157830914-157898256 "Plasma proteins, Predicted secreted proteins" "Apoptosis, Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 178.3" "Group enriched" "Detected in some" 28 "Hofbauer cells: 208.7;Kupffer cells: 384.3" "Cancer enriched" "Detected in some" 5 "liver cancer: 4.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.2" "Lineage enriched" "Detected in single" 13 "monocytes: 1.2" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;Karpas-707: 2.0;REH: 2.0;RH-30: 1.2;U-266/70: 3.6" "Not detected" "Not detected" "HPA065686, HPA068384" Enhanced "Secreted to blood" NA NA 4030000000 6800000000 "HPA065686: AB_2685532, HPA068384: AB_2685979" "unprognostic (2.96e-1)" "unprognostic (2.90e-1)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "prognostic favorable (8.88e-5)" "unprognostic (1.73e-2)" "unprognostic (4.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.56e-1)" "unprognostic (5.95e-3)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" "unprognostic (3.63e-1)" 0.2 0.0 0.1 0.1 0.1 2.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 21.3 0.2 2.6 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 178.3 0.0 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 2.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 208.7 0.0 0.0 10.4 384.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 CD6 Tp120 ENSG00000013725 "CD6 molecule" P30203 11 60971680-61020377 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.0;lymphoid tissue: 58.1" "Group enriched" "Detected in some" 5 "B-cells: 10.7;T-cells: 34.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 34 "gdT-cell: 12.4;MAIT T-cell: 11.1;memory CD4 T-cell: 23.0;memory CD8 T-cell: 21.4;naive CD4 T-cell: 15.5;naive CD8 T-cell: 11.1;T-reg: 10.1" "Lineage enriched" "Detected in single" 52 "T-cells: 23.0" "Group enriched" "Detected in some" 12 "JURKAT: 7.8;MOLT-4: 28.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB002489, CAB016252" Enhanced "Secreted to blood" NA NA 5270000 110000 "CAB002489: AB_563605, CAB016252: AB_631163" "prognostic favorable (1.95e-4)" "prognostic favorable (1.57e-5)" "unprognostic (4.47e-2)" "prognostic favorable (2.41e-4)" "unprognostic (2.06e-2)" "prognostic favorable (5.10e-6)" "unprognostic (8.45e-3)" "unprognostic (8.21e-3)" "unprognostic (2.87e-3)" "unprognostic (5.32e-3)" "unprognostic (2.07e-1)" "unprognostic (5.35e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "unprognostic (6.19e-2)" "unprognostic (5.96e-2)" 1.5 0.5 0.8 26.4 0.4 5.5 0.9 0.5 1.4 1.3 3.3 0.6 0.8 2.2 1.4 1.5 1.9 1.3 5.0 1.3 0.7 1.8 1.6 1.1 6.9 25.6 1.7 0.5 0.7 0.8 0.0 0.6 0.6 0.4 1.2 1.6 1.2 7.0 0.3 0.3 0.9 13.0 0.7 0.9 18.4 3.4 0.9 0.1 58.1 1.6 1.9 42.0 3.7 1.3 0.4 0.1 0.3 0.0 0.0 23.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.0 28.9 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.4 0.0 11.1 0.4 23.0 21.4 0.1 0.4 15.5 11.1 0.3 0.0 0.0 0.0 10.1 5.1 0.8 0.4 0.5 1.4 0.7 1.8 1.7 0.5 0.4 0.1 0.0 4.5 10.7 0.2 1.8 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.8 0.4 0.0 0.0 0.6 0.1 0.3 0.1 0.0 0.9 2.1 1.6 0.0 1.3 1.2 0.0 0.3 2.0 3.3 1.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.9 0.3 0.8 1.3 0.2 34.6 0.1 0.3 CD68 "DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1" ENSG00000129226 "CD68 molecule" P34810 17 7579467-7582113 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 179.1;lymphoid tissue: 139.1" "Group enriched" "Detected in many" 6 "Hofbauer cells: 1656.8;Kupffer cells: 486.8;Macrophages: 440.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1" "Group enriched" "Detected in many" 11 "dendritic cells: 68.4;monocytes: 179.1" "Cell line enhanced" "Detected in many" "ASC diff: 74.5;U-87 MG: 117.4" "Low region specificity" "Detected in all" "CAB000051, CAB000066, HPA048982, CAB072861, CAB072862" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587" "unprognostic (2.16e-2)" "unprognostic (1.47e-2)" "unprognostic (6.46e-2)" "unprognostic (1.49e-3)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.75e-4)" "unprognostic (2.83e-2)" "unprognostic (1.31e-1)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (1.58e-1)" "unprognostic (8.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.65e-2)" 118.4 28.5 12.5 46.8 21.6 46.8 40.9 2.9 11.2 27.1 38.1 15.5 2.1 57.0 9.6 24.1 26.9 17.3 33.7 39.0 10.1 6.9 20.9 43.1 84.4 102.5 21.1 4.4 15.8 7.5 2.1 8.5 34.7 15.7 12.1 18.5 12.8 22.2 4.4 16.1 9.4 58.3 15.6 26.0 139.1 17.6 9.4 16.3 13.3 8.8 12.3 21.1 31.4 19.1 3.7 68.4 11.0 179.1 0.9 0.5 125.6 35.7 7.3 0.4 0.5 74.5 28.4 0.3 11.4 31.2 15.2 17.7 1.5 10.8 0.4 13.0 33.1 27.0 1.6 0.1 7.2 10.3 0.3 1.3 5.7 1.8 8.6 6.3 2.8 32.2 9.0 1.5 31.7 23.4 25.1 3.9 0.6 2.2 3.7 14.6 0.2 0.2 2.5 0.4 9.3 5.3 0.4 0.6 21.1 3.1 1.6 0.2 0.4 9.5 4.8 11.1 0.3 0.2 21.9 12.4 19.3 1.2 19.3 14.9 0.2 0.3 0.2 117.4 7.0 9.7 10.1 155.1 0.9 0.4 179.1 0.5 3.7 0.2 0.3 40.9 2.0 0.3 0.2 11.0 0.9 170.1 68.4 0.3 125.6 12.5 21.6 2.9 11.2 10.1 6.9 21.1 4.4 15.7 16.3 0.0 22.4 23.8 26.4 14.0 0.0 0.0 7.6 9.4 13.6 5.2 0.0 7.2 5.0 60.6 0.6 16.8 36.0 0.0 137.4 51.8 33.7 27.3 40.6 16.3 1656.8 0.0 4.7 13.5 486.8 1.1 6.1 440.3 37.1 60.5 7.1 0.2 92.4 25.9 1.8 31.1 1.2 25.8 13.3 0.3 0.2 12.5 27.9 12.5 10.2 68.9 CD69 CLEC2C ENSG00000110848 "CD69 molecule" Q07108 12 9752486-9760901 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;lymphoid tissue: 56.4" "Cell type enhanced" "Detected in many" 27 "B-cells: 256.7;granulocytes: 1372.7;T-cells: 467.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 14.8;T-cells: 18.3" "Cell line enhanced" "Detected in some" "HL-60: 12.7;JURKAT: 8.5;K-562: 24.5;MOLT-4: 8.7;U-266/70: 10.0;U-698: 11.3;U-937: 41.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002503, HPA050525" Enhanced NA NA "CAB002503: AB_563625, HPA050525: AB_2681157" "prognostic favorable (3.31e-5)" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "unprognostic (7.10e-3)" "unprognostic (4.76e-3)" "unprognostic (9.53e-3)" "unprognostic (9.73e-3)" "unprognostic (1.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.88e-2)" "unprognostic (3.32e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" 10.1 2.2 1.3 19.9 1.4 52.1 7.0 0.5 0.9 9.0 9.6 4.6 0.8 2.8 5.1 5.1 10.6 6.4 13.6 3.1 2.0 2.2 4.7 6.2 27.0 31.6 4.5 0.6 3.4 1.4 0.9 3.4 1.9 3.5 7.4 8.0 3.3 6.0 2.0 1.5 3.3 14.3 5.0 8.3 43.3 4.3 4.5 1.6 56.4 5.5 6.1 26.7 27.4 5.9 3.9 0.0 3.1 0.1 14.8 18.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.7 12.7 0.6 0.0 0.0 0.0 0.0 0.0 0.2 8.5 24.5 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.1 11.3 0.0 41.9 0.0 0.7 0.1 3.1 13.7 0.0 18.3 3.3 8.7 9.9 0.0 3.9 12.6 9.2 0.2 14.8 0.0 0.0 4.3 3.8 1.3 1.4 0.5 0.9 2.0 2.2 4.5 0.6 3.5 1.6 38.7 196.1 256.7 1.7 16.5 0.0 0.8 0.0 2.7 9.1 1.8 0.0 0.5 0.0 0.0 0.2 3.9 0.3 23.3 0.0 0.2 14.6 1.2 1372.7 1.0 17.1 0.0 0.0 6.7 6.0 0.0 0.0 57.6 32.1 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 2.0 0.0 0.2 15.8 1.6 467.3 0.0 1.3 CD7 "GP40, LEU-9, Tp40, TP41" ENSG00000173762 "CD7 molecule" P09564 17 82314868-82317602 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 54.1;lymphoid tissue: 127.6" "Cell type enriched" "Detected in many" 29 "T-cells: 440.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 54.1" "Group enriched" "Detected in many" 21 "NK-cells: 54.1;T-cells: 19.0" "Cell line enhanced" "Detected in some" "BEWO: 5.6;Hep G2: 21.4;JURKAT: 11.4;MOLT-4: 48.7" "CAB002594, HPA039079" Enhanced NA NA "CAB002594: , HPA039079: AB_2676337" "unprognostic (3.14e-3)" "prognostic favorable (5.51e-4)" "unprognostic (1.89e-2)" "prognostic favorable (2.03e-5)" "unprognostic (7.69e-3)" "unprognostic (1.09e-3)" "unprognostic (3.28e-2)" "unprognostic (1.34e-1)" "prognostic favorable (2.69e-4)" "unprognostic (3.16e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-1)" "prognostic unfavorable (7.75e-11)" "unprognostic (4.69e-2)" "unprognostic (1.55e-1)" "unprognostic (1.97e-1)" "unprognostic (1.55e-3)" 4.7 0.7 0.5 23.4 0.4 14.5 1.7 0.4 0.3 1.9 8.0 0.3 0.5 7.7 1.8 1.9 3.4 2.4 3.5 1.4 0.5 0.6 2.8 4.1 9.5 50.2 0.9 0.0 1.6 1.0 0.0 1.0 4.0 0.4 2.7 1.0 1.8 6.0 1.1 0.5 1.0 17.5 0.5 1.6 33.0 4.6 0.9 0.1 127.6 2.2 1.0 33.3 4.6 2.2 0.1 1.7 0.6 0.1 54.1 19.0 7.1 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 21.4 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 17.6 0.0 15.1 0.1 7.9 12.8 0.0 0.0 19.0 18.9 0.6 54.1 0.1 1.7 6.8 7.1 0.5 0.4 0.4 0.3 0.5 0.6 0.9 0.0 0.4 0.1 0.0 0.0 5.6 0.5 6.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.9 4.2 0.0 0.5 5.2 6.4 1.7 8.1 2.4 3.2 1.6 0.0 12.9 15.2 0.0 0.0 5.8 11.8 0.0 0.6 0.0 0.2 0.8 0.0 0.6 0.0 0.0 2.2 0.0 0.4 3.9 1.6 440.5 0.9 1.7 CD70 "CD27L, CD27LG, TNFSF7" ENSG00000125726 "CD70 molecule" P32970 19 6583183-6604103 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 12.7" "Cell type enriched" "Detected in some" 23 "monocytes: 417.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 13.9;T-reg: 23.3" "Group enriched" "Detected in many" 38 "B-cells: 13.9;T-cells: 23.3" "Cell line enhanced" "Detected in many" "SiHa: 36.8;THP-1: 30.2;U-251 MG: 44.7;U-266/70: 79.5;U-266/84: 57.5" HPA046582 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA046582: " "unprognostic (8.71e-2)" "unprognostic (9.91e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-4)" "unprognostic (1.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.29e-4)" "unprognostic (1.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (2.57e-2)" "unprognostic (1.40e-1)" "unprognostic (2.27e-1)" "unprognostic (2.08e-1)" 5.3 0.2 0.2 9.3 0.2 1.4 2.2 0.9 0.9 1.4 4.1 0.2 0.1 1.0 0.4 1.8 4.0 0.7 0.8 0.4 0.2 0.2 1.7 0.4 1.9 6.1 0.4 0.1 0.3 0.4 0.0 0.3 0.3 0.2 0.9 3.1 0.2 3.1 1.2 1.2 3.3 5.2 0.7 0.5 11.8 1.7 1.9 0.1 3.2 0.8 1.8 12.7 3.1 1.1 13.9 0.1 0.2 0.0 0.4 23.3 0.9 0.2 7.5 0.0 14.8 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 14.2 0.8 0.0 16.3 10.4 9.1 0.7 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.0 0.4 0.1 0.0 8.7 6.2 2.4 0.0 0.0 0.2 0.4 0.2 0.0 0.2 17.8 0.1 0.0 13.7 3.8 0.0 3.0 4.8 0.0 0.0 0.0 36.8 0.0 0.1 0.0 0.1 30.2 0.2 0.1 6.6 0.0 44.7 79.5 57.5 25.6 8.2 4.5 2.8 0.2 0.0 0.0 1.9 0.0 4.8 13.9 3.2 5.0 0.0 4.0 0.4 1.3 0.1 0.4 0.0 0.1 23.3 0.9 0.2 0.2 0.9 0.9 0.2 0.2 0.4 0.1 0.2 0.1 0.0 0.0 18.2 0.1 5.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 1.1 0.0 0.3 0.0 1.7 1.3 0.0 0.0 0.0 1.7 3.3 417.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 4.6 0.0 10.2 0.0 0.0 CD72 "CD72b, LYB2" ENSG00000137101 "CD72 molecule" P21854 9 35609533-35646810 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 75.5;lymphoid tissue: 59.7" "Cell type enriched" "Detected in some" 4 "B-cells: 82.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 34.3;naive B-cell: 75.5" "Lineage enriched" "Detected in many" 22 "B-cells: 75.5" "Cell line enhanced" "Detected in some" "Daudi: 12.7;Karpas-707: 8.2;REH: 5.3;U-698: 28.3" "Region enriched" "Detected in single" 7 "basal ganglia: 3.6" "Low region specificity" "Detected in single" "CAB002505, HPA044658" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB002505: AB_563629, HPA044658: AB_2679039" "unprognostic (1.13e-2)" "unprognostic (1.26e-2)" "unprognostic (1.21e-2)" "unprognostic (8.82e-2)" "unprognostic (1.87e-2)" "unprognostic (7.81e-2)" "unprognostic (7.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.29e-2)" "unprognostic (2.02e-2)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (2.49e-8)" "unprognostic (1.42e-1)" "unprognostic (2.32e-2)" "unprognostic (1.23e-1)" "unprognostic (3.59e-2)" 1.9 1.2 0.8 16.6 1.1 2.6 1.3 0.6 0.6 0.7 0.9 0.2 0.5 0.3 0.8 2.1 0.8 0.7 1.6 0.6 0.8 0.7 1.5 2.3 2.2 26.8 0.8 0.1 0.5 1.4 0.5 1.6 1.5 1.1 0.9 0.3 1.1 3.4 0.1 0.5 0.8 5.2 0.6 1.8 59.7 0.8 0.8 0.2 1.5 1.4 0.3 22.2 4.9 0.6 75.5 3.4 0.2 0.6 1.7 0.7 2.5 0.1 0.0 0.4 0.2 0.7 3.9 0.1 0.2 0.1 0.3 0.5 0.0 0.1 12.7 0.0 0.2 0.1 0.0 0.0 0.1 0.4 1.2 0.3 0.4 0.0 0.0 0.4 0.2 2.8 1.1 0.0 0.2 0.3 0.6 0.0 2.8 0.0 8.2 0.7 0.0 0.2 1.7 0.1 0.0 0.1 5.3 0.0 3.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.2 28.3 0.5 0.4 0.0 0.0 0.3 0.0 0.5 0.6 0.7 34.3 0.2 0.3 3.4 75.5 0.1 0.4 0.2 1.7 0.0 1.8 0.3 2.5 0.8 1.1 0.6 0.6 0.8 0.7 0.8 0.1 1.1 0.2 0.0 1.1 82.7 0.3 0.9 0.0 0.6 2.5 1.4 0.0 3.5 0.0 0.1 0.0 0.6 0.1 0.5 0.5 0.0 0.6 0.2 0.6 0.4 0.0 0.0 19.7 0.0 1.7 0.6 16.7 0.0 0.9 8.0 0.0 1.8 0.0 0.5 1.2 0.0 0.4 0.3 0.7 0.0 0.8 0.2 1.2 1.0 0.2 4.9 0.3 0.1 CD74 DHLAG ENSG00000019582 "CD74 molecule" P04233 5 150401637-150412929 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 504.7" "Cell type enhanced" "Detected in many" 16 "Hofbauer cells: 4588.2;Macrophages: 7133.7;monocytes: 15196.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 191.6;intermediate monocyte: 303.5;memory B-cell: 467.7;myeloid DC: 437.9;naive B-cell: 504.7;non-classical monocyte: 140.0;plasmacytoid DC: 303.2" "Group enriched" "Detected in all" 5 "B-cells: 504.7;dendritic cells: 437.9;monocytes: 303.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 118.2;Daudi: 181.9;HDLM-2: 261.1;REH: 157.4;RPMI-8226: 107.2;U-266/70: 87.7;U-698: 100.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002506, HPA010592" Enhanced Supported "Golgi apparatus" NA NA 90000 "Golgi apparatus" "CAB002506: AB_563630, HPA010592: AB_1078482" "prognostic favorable (1.06e-4)" "unprognostic (1.48e-2)" "unprognostic (4.80e-3)" "prognostic favorable (6.53e-6)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (2.05e-1)" "unprognostic (3.69e-3)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (2.20e-2)" "unprognostic (2.64e-1)" "unprognostic (5.44e-3)" "unprognostic (1.73e-1)" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (4.24e-2)" 137.8 95.7 53.2 177.0 81.4 40.7 104.2 8.4 43.5 89.6 68.2 79.0 30.0 98.3 60.0 73.9 43.6 68.1 81.3 104.1 46.9 43.5 168.3 60.1 222.5 310.1 78.3 23.1 53.4 34.1 15.1 51.0 27.9 79.8 72.6 63.6 72.9 123.0 55.4 40.5 56.6 182.8 55.1 123.1 372.1 77.3 23.7 68.1 201.1 83.4 45.6 288.2 91.7 47.0 504.7 437.9 76.1 303.5 42.2 41.2 238.1 1.9 0.0 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.0 23.6 118.2 181.9 7.3 0.0 0.5 0.5 0.0 0.0 0.0 261.1 0.0 5.9 0.1 14.4 0.3 0.4 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 72.4 0.0 0.0 0.2 0.8 0.3 0.0 0.0 157.4 0.2 107.2 0.5 7.7 0.3 0.5 0.3 0.2 5.2 1.2 4.8 21.8 0.2 0.6 0.5 0.5 0.2 87.7 9.4 100.8 42.2 8.2 38.5 6.3 191.6 76.1 16.8 303.5 18.7 467.7 14.8 24.8 437.9 504.7 7.8 13.5 16.8 42.2 140.0 303.2 41.2 238.1 53.2 81.4 8.4 43.5 46.9 43.5 78.3 23.1 79.8 68.1 390.1 2012.6 3694.0 133.2 635.9 0.3 57.9 405.1 591.6 683.6 476.3 0.0 29.1 99.5 571.4 6.9 1116.8 170.9 23.3 476.1 19.5 234.4 182.3 395.1 56.2 4588.2 1.6 233.2 353.6 3259.2 11.0 108.4 7133.7 1135.4 15196.0 331.4 14.5 306.9 131.5 16.6 759.6 8.0 161.7 171.2 2.3 7.6 503.4 34.8 370.6 168.2 195.9 CD79A "IGA, MB-1" ENSG00000105369 "CD79a molecule" P11912 19 41877120-41881372 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 125.3;intestine: 43.5;lymphoid tissue: 119.2" "Cell type enriched" "Detected in some" 6 "B-cells: 739.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 106.4;naive B-cell: 125.3" "Lineage enriched" "Detected in many" 41 "B-cells: 125.3" "Group enriched" "Detected in some" 24 "Daudi: 159.2;REH: 49.5;U-698: 138.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB000019 Enhanced NA NA "CAB000019: AB_2244527" "prognostic favorable (8.45e-5)" "unprognostic (1.63e-3)" "unprognostic (4.13e-3)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.23e-2)" "unprognostic (8.11e-3)" "unprognostic (9.41e-3)" "unprognostic (1.12e-2)" "unprognostic (2.53e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (6.08e-2)" "unprognostic (3.39e-1)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" 1.3 0.6 0.5 103.8 0.5 5.4 1.3 0.5 0.5 1.8 6.3 0.1 0.1 4.9 0.6 0.2 4.4 1.0 2.3 0.8 0.5 0.5 2.3 0.9 4.3 114.9 0.5 0.1 0.6 0.6 0.0 0.5 0.5 0.1 1.0 3.4 1.8 13.6 1.2 0.5 0.5 43.5 0.2 0.5 108.1 9.7 0.8 0.1 32.0 2.4 1.9 119.2 6.8 1.0 125.3 3.0 0.7 0.3 0.2 2.3 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 49.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.8 0.1 138.6 0.0 4.7 0.0 0.7 0.1 0.5 0.1 0.1 0.0 106.4 0.3 0.1 0.2 125.3 0.4 2.3 0.4 0.2 0.3 3.0 0.8 4.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.1 0.1 0.0 3.7 739.3 0.4 1.5 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 22.3 0.2 0.6 0.2 0.0 0.0 0.8 0.0 0.0 1.8 3.1 0.0 0.3 1.7 131.6 2.8 0.3 0.0 105.8 0.0 0.4 0.6 0.0 0.0 0.4 0.0 0.6 1.3 0.1 6.5 0.6 0.1 CD79B "B29, IGB" ENSG00000007312 "CD79b molecule" P40259 17 63928740-63932354 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 138.8;lymphoid tissue: 56.6" "Cell type enriched" "Detected in many" 8 "B-cells: 486.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 100.6;naive B-cell: 138.8" "Lineage enriched" "Detected in many" 6 "B-cells: 138.8" "Cell line enhanced" "Detected in some" "Daudi: 117.7;REH: 38.7;U-698: 161.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009178, CAB009751, HPA044107" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: " "unprognostic (3.90e-3)" "unprognostic (1.61e-3)" "unprognostic (5.21e-2)" "unprognostic (3.45e-3)" "unprognostic (4.22e-3)" "prognostic favorable (2.35e-4)" "unprognostic (1.82e-1)" "unprognostic (9.25e-3)" "unprognostic (3.89e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (2.87e-2)" "unprognostic (2.50e-3)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (4.28e-2)" "unprognostic (2.75e-1)" 1.7 0.7 0.4 50.6 0.4 11.1 1.2 0.3 0.4 0.6 1.7 0.3 0.3 0.7 0.6 0.5 2.6 0.6 1.4 3.4 0.4 0.2 2.3 1.7 1.3 56.6 0.4 0.3 0.6 1.6 0.0 9.0 0.5 0.3 1.0 1.3 0.8 8.9 0.9 1.2 0.9 22.4 0.5 0.4 56.0 1.8 0.6 0.3 3.7 1.4 1.7 46.6 4.5 0.9 138.8 4.2 0.5 25.0 3.4 9.2 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 38.7 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.8 0.1 0.0 0.4 0.0 0.0 5.9 5.7 161.1 0.0 0.2 0.0 0.5 1.1 0.0 4.2 16.5 4.8 100.6 5.4 2.8 4.2 138.8 3.7 2.2 0.5 3.4 25.0 0.6 9.2 9.0 0.4 0.4 0.3 0.4 0.4 0.2 0.4 0.3 0.3 0.3 0.0 2.2 486.9 0.3 3.9 0.0 0.8 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 7.1 0.0 23.3 0.0 0.4 4.3 0.3 15.0 0.5 4.7 0.0 1.2 62.0 14.1 1.1 1.1 3.5 20.3 1.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 3.3 0.7 0.1 2.8 0.3 34.6 0.0 0.1 CD80 "B7-1, B7.1, CD28LG, CD28LG1" ENSG00000121594 "CD80 molecule" P33681 3 119524293-119559602 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 17.5" "Cell type enriched" "Detected in some" 22 "monocytes: 113.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 4.3;non-classical monocyte: 1.1;T-reg: 3.3" "Group enriched" "Detected in many" 24 "B-cells: 4.3;monocytes: 1.1;T-cells: 3.3" "Cell line enhanced" "Detected in some" "Daudi: 8.2;HDLM-2: 29.0;Karpas-707: 12.1;U-266/70: 5.2" "Low region specificity" "Detected in all" "CAB025368, HPA050092" Enhanced "Intracellular and membrane" NA NA "CAB025368: , HPA050092: AB_2681012" "unprognostic (2.36e-1)" "unprognostic (1.55e-2)" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (3.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.14e-3)" "unprognostic (1.02e-2)" "unprognostic (4.96e-3)" "unprognostic (1.16e-2)" "unprognostic (1.15e-1)" "unprognostic (9.03e-8)" "unprognostic (3.20e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (1.94e-2)" 0.7 0.6 0.4 11.7 0.3 1.5 1.2 0.3 0.3 0.6 0.7 0.3 0.7 1.3 0.4 0.6 0.7 0.3 1.0 0.5 0.9 0.3 0.7 2.0 6.2 7.4 0.4 0.0 0.3 0.9 0.0 1.1 0.7 0.6 0.6 1.7 0.8 3.9 0.2 0.5 0.4 2.4 0.2 0.8 17.5 0.6 0.4 0.0 5.6 1.6 0.8 17.2 1.8 0.4 4.3 0.1 0.0 1.1 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.3 0.5 0.3 0.1 0.6 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.2 0.4 0.3 0.3 0.3 0.9 0.3 0.4 0.0 0.6 0.0 0.0 1.0 0.5 0.0 0.6 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 3.9 0.0 0.0 5.2 0.0 113.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 CD83 "BL11, HB15" ENSG00000112149 "CD83 molecule" Q01151 6 14117256-14136918 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.0;lymphoid tissue: 64.5" "Cell type enhanced" "Detected in many" 22 "granulocytes: 239.5;Macrophages: 184.4;monocytes: 891.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.2;HDLM-2: 26.2;U-698: 44.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002509, HPA041454" Enhanced NA NA "CAB002509: AB_563641, HPA041454: AB_2677489" "unprognostic (2.22e-3)" "unprognostic (1.92e-2)" "unprognostic (1.22e-1)" "unprognostic (6.39e-2)" "unprognostic (5.83e-2)" "unprognostic (3.02e-2)" "unprognostic (1.00e-2)" "unprognostic (9.05e-3)" "unprognostic (9.05e-2)" "unprognostic (3.91e-2)" "unprognostic (7.37e-2)" "unprognostic (6.68e-2)" "prognostic favorable (3.49e-4)" "unprognostic (2.30e-1)" "unprognostic (7.07e-2)" "unprognostic (1.40e-2)" "unprognostic (2.46e-2)" 14.0 8.3 6.1 64.5 5.7 70.0 7.5 14.2 11.8 17.0 2.0 24.7 3.4 1.8 3.7 8.3 3.6 1.8 9.9 2.6 7.3 12.7 9.7 6.0 29.0 19.5 7.8 2.2 9.7 1.6 2.2 4.1 3.4 10.8 5.2 3.8 3.5 16.4 7.8 1.8 2.6 6.9 2.7 11.1 16.5 2.2 4.0 2.8 33.8 2.3 6.2 57.5 16.4 9.8 19.1 5.2 1.3 15.4 2.6 3.6 2.3 6.6 0.3 5.0 6.9 7.3 1.7 0.1 1.8 6.8 3.2 5.7 0.5 4.4 29.2 5.6 0.5 6.7 0.7 1.9 2.1 10.8 26.2 2.8 4.0 8.6 0.8 0.2 5.8 6.4 1.9 0.9 3.1 1.0 1.0 0.1 10.1 0.8 0.0 0.3 2.4 4.6 11.0 2.0 1.2 1.3 4.5 10.9 4.1 2.3 6.6 1.1 2.0 0.4 0.2 5.0 3.0 1.2 4.7 0.1 5.0 3.1 0.7 4.5 0.3 0.0 44.9 1.1 8.0 7.5 0.0 1.7 1.1 2.7 10.7 2.9 11.5 2.5 2.2 5.2 19.1 1.8 2.1 1.3 2.6 15.4 1.8 3.6 2.3 6.1 5.7 14.2 11.8 7.3 12.7 7.8 2.2 10.8 2.8 17.9 74.6 42.7 9.5 44.0 3.5 25.4 2.5 5.3 9.1 10.4 5.9 1.4 3.3 0.6 0.4 16.9 2.6 0.0 1.3 2.2 18.7 12.7 239.5 0.8 140.3 1.6 23.1 3.1 66.8 1.1 0.3 184.4 42.2 891.9 3.3 3.1 1.6 0.0 0.0 15.8 2.6 0.0 26.8 0.9 12.1 33.6 2.3 13.8 3.5 2.8 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 177.3;Hofbauer cells: 84.2;Kupffer cells: 123.8;Macrophages: 52.0;monocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.6;HEL: 24.3;HL-60: 6.8;HMC-1: 27.7;MOLT-4: 6.7;U-698: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" NA NA 36000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: AB_2686274" "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 15.9 4.8 3.8 18.5 4.5 6.7 3.7 1.3 3.4 3.3 3.2 7.9 7.7 2.5 2.5 4.3 2.7 3.1 6.4 5.0 3.8 3.0 3.1 5.1 9.2 26.0 6.0 2.2 1.8 4.3 0.9 1.9 7.1 5.3 3.7 4.7 2.4 4.3 9.8 1.6 2.7 9.6 4.1 11.1 25.6 3.5 2.8 5.9 13.8 2.9 2.3 16.3 5.8 2.7 5.1 5.4 21.0 7.3 1.0 8.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 6.8 27.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.1 0.0 0.0 6.7 5.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 1.5 0.0 21.0 7.3 11.0 6.9 6.3 5.2 5.1 5.9 8.2 5.4 4.7 3.5 6.3 1.0 1.0 2.4 3.2 7.9 6.1 3.8 4.5 1.3 3.4 3.8 3.0 6.0 2.2 5.3 5.9 0.0 8.3 23.1 0.7 2.2 0.2 1.2 5.1 1.4 2.3 0.0 0.0 0.4 0.0 0.0 0.6 2.6 0.0 0.0 0.2 0.3 0.8 0.6 177.3 0.9 84.2 0.0 0.0 5.5 123.8 0.5 0.6 52.0 5.0 78.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 2.0 0.8 42.4 0.0 0.7 CD86 "B7-2, B7.2, CD28LG2" ENSG00000114013 "CD86 molecule" P42081 3 122055366-122121139 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.0;brain: 26.1" "Cell type enriched" "Detected in many" 5 "monocytes: 760.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 25.6;intermediate monocyte: 26.4;memory B-cell: 13.6;myeloid DC: 25.9;naive B-cell: 8.0;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 17 "B-cells: 13.6;dendritic cells: 25.9;monocytes: 27.0" "Cell line enriched" "Detected in some" 7 "HDLM-2: 80.7" "Low region specificity" "Detected in all" "CAB004319, HPA026802" Approved Supported "Plasma membrane" NA NA 220000 "Plasma membrane" "CAB004319: AB_627200, HPA026802: " "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (3.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (7.72e-3)" "unprognostic (1.21e-1)" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (9.72e-2)" "unprognostic (1.70e-2)" "unprognostic (9.78e-2)" "unprognostic (8.67e-2)" 10.5 4.7 7.1 23.6 9.5 6.0 3.6 1.5 6.3 2.9 4.3 9.8 0.6 2.5 2.6 5.2 2.8 3.3 10.4 3.5 7.3 6.0 4.0 7.8 13.0 17.8 11.7 3.0 2.5 2.3 2.1 2.6 10.3 8.1 3.1 5.6 3.0 3.6 1.8 1.3 2.4 6.9 5.1 26.1 22.5 3.4 2.4 10.3 7.7 2.3 2.1 15.0 9.2 2.2 13.6 25.9 0.3 27.0 1.2 0.4 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 4.3 0.1 9.6 0.0 0.2 0.0 0.0 25.6 0.2 0.0 26.4 0.0 13.6 0.1 0.1 25.9 8.0 0.0 0.0 0.3 1.2 27.0 2.6 0.4 9.3 7.1 9.5 1.5 6.3 7.3 6.0 11.7 3.0 8.1 10.3 0.0 10.6 25.1 0.0 3.2 0.0 0.2 0.0 0.0 4.5 1.8 0.0 1.6 0.0 0.2 3.0 0.2 0.0 0.0 2.9 0.5 1.7 0.3 2.3 0.8 106.9 0.0 0.0 1.8 111.1 1.3 0.0 155.5 6.8 760.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 3.4 1.6 0.0 0.0 0.3 CD8A CD8 ENSG00000153563 "CD8a molecule" P01732 2 86784610-86808396 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "blood: 82.2;lymphoid tissue: 262.3" "Cell type enriched" "Detected in some" 11 "T-cells: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8" "Lineage enriched" "Detected in many" 20 "T-cells: 82.2" "Cell line enhanced" "Detected in some" "JURKAT: 5.0;MOLT-4: 17.5;RPMI-8226: 4.0" "Low region specificity" "Detected in many" "CAB000012, HPA037756, CAB075722" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 500000 "Plasma membrane" "CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648" "unprognostic (1.29e-3)" "prognostic favorable (4.54e-4)" "unprognostic (9.26e-3)" "prognostic favorable (6.15e-6)" "unprognostic (7.28e-2)" "unprognostic (2.79e-3)" "unprognostic (1.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-2)" "unprognostic (1.56e-2)" 2.4 1.4 1.4 7.4 2.8 6.8 1.5 1.4 1.2 2.1 5.3 0.8 0.8 4.2 1.5 2.1 2.0 2.1 4.5 1.6 1.2 1.6 1.3 2.1 6.0 23.8 1.0 0.5 1.7 1.2 0.0 0.9 0.6 0.7 2.3 1.9 1.8 3.0 1.1 0.8 0.7 12.2 0.7 1.7 46.4 5.4 1.0 0.5 262.3 2.2 1.6 8.1 3.8 1.9 0.0 0.1 0.6 0.1 4.0 82.2 17.4 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.8 17.5 1.1 0.6 0.2 0.3 0.1 0.9 4.0 0.0 0.4 0.9 2.4 0.2 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.3 0.9 0.0 0.0 0.1 0.1 0.1 0.0 4.8 0.0 36.7 0.0 0.3 82.2 0.0 0.0 0.3 77.8 0.6 4.0 0.1 0.1 0.1 17.4 1.4 2.8 1.4 1.2 1.2 1.6 1.0 0.5 0.7 0.5 0.0 5.8 1.5 0.2 1.8 0.1 2.9 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.5 0.2 2.3 0.8 0.1 0.0 0.0 5.5 1.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.9 0.5 0.4 1.6 0.1 65.4 0.0 0.1 CD8B CD8B1 ENSG00000172116 "CD8b molecule" P10966 2 86815339-86861924 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 132.1;lymphoid tissue: 61.5" "Cell type enriched" "Detected in some" 7 "T-cells: 61.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1" "Lineage enriched" "Detected in many" 40 "T-cells: 132.1" "Cell line enriched" "Detected in some" 55 "RPMI-8226: 158.6" "CAB004353, HPA029164" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB004353: AB_627211, HPA029164: AB_2672936" "unprognostic (1.83e-3)" "unprognostic (1.98e-3)" "unprognostic (2.22e-2)" "prognostic favorable (7.88e-7)" "unprognostic (6.23e-2)" "unprognostic (7.05e-3)" "unprognostic (1.11e-2)" "unprognostic (2.59e-2)" "unprognostic (5.50e-3)" "unprognostic (5.91e-2)" "unprognostic (9.25e-2)" "unprognostic (4.60e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (7.84e-2)" "unprognostic (3.00e-1)" "unprognostic (1.86e-2)" "unprognostic (4.33e-2)" 1.2 0.7 1.0 5.3 1.0 3.9 1.0 1.3 1.3 21.2 1.1 1.0 1.0 2.5 1.2 1.0 1.0 1.1 1.8 1.0 1.0 1.8 1.0 1.0 2.7 14.4 1.7 1.0 1.3 1.0 6.4 7.4 1.0 2.2 1.3 1.3 1.0 1.0 1.0 1.0 0.9 11.4 1.0 1.5 12.7 2.3 1.0 1.0 61.5 1.5 1.0 8.1 1.8 1.3 0.1 0.1 3.2 0.1 0.1 132.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 158.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.1 10.0 0.0 0.2 73.5 0.0 0.1 0.5 132.1 0.7 0.1 0.1 0.1 0.2 36.3 1.0 1.0 1.3 1.3 1.0 1.8 1.7 1.0 2.2 1.0 6.0 8.5 0.8 1.7 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 1.3 5.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 2.5 0.0 61.8 1.2 0.1 CD8B2 CD8BP ENSG00000254126 "CD8b2 molecule" 2 106487364-106544297 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "blood: 20.6;lymphoid tissue: 35.1" "Group enriched" "Detected in some" 16 "Club cells: 1.2;Proximal tubular cells: 2.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 9 "memory CD8 T-cell: 12.0;naive CD8 T-cell: 20.6" "Lineage enriched" "Detected in many" 15 "T-cells: 20.6" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 93.5" NA NA "unprognostic (9.34e-3)" "unprognostic (7.84e-2)" "unprognostic (2.32e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-1)" "unprognostic (5.54e-2)" "unprognostic (1.18e-1)" "unprognostic (5.27e-1)" "unprognostic (1.28e-2)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.90e-2)" "unprognostic (9.67e-3)" 0.1 0.0 0.1 1.1 0.4 0.2 0.0 0.6 0.6 1.9 0.3 0.0 0.0 0.4 0.1 0.2 0.2 0.0 0.2 0.0 0.7 2.8 0.4 0.4 5.3 0.0 0.0 0.2 0.0 2.8 0.8 0.1 0.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.9 1.6 0.0 0.0 35.1 0.0 0.3 9.0 0.3 0.0 0.0 0.0 1.3 0.0 0.2 20.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 9.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.0 1.7 0.0 0.0 12.0 0.0 0.0 0.0 20.6 0.1 0.2 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD96 TACTILE ENSG00000153283 "CD96 molecule" P40200 3 111292719-111665750 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 32.0;lymphoid tissue: 82.4" "Cell type enriched" "Detected in many" 6 "T-cells: 148.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "NK-cells: 20.0;T-cells: 32.0" "Cell line enhanced" "Detected in some" "HEL: 6.8;JURKAT: 7.7;MOLT-4: 29.8;RT4: 27.6;U-937: 24.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066754 Enhanced NA NA 37000 "HPA066754: AB_2685714" "unprognostic (1.06e-3)" "unprognostic (3.95e-3)" "unprognostic (4.16e-3)" "unprognostic (1.91e-5)" "unprognostic (4.72e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.12e-2)" "unprognostic (3.48e-2)" "unprognostic (6.06e-2)" "unprognostic (4.84e-3)" "unprognostic (2.44e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.02e-6)" "unprognostic (3.12e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-2)" "prognostic favorable (5.23e-5)" 5.7 0.9 0.4 18.6 0.5 8.6 3.1 0.6 0.4 2.2 7.1 0.6 0.5 3.6 1.7 1.8 3.4 2.1 3.5 1.3 0.4 0.5 2.3 2.7 9.7 21.9 1.5 0.2 1.4 0.8 0.0 1.1 1.1 1.0 2.6 3.7 2.5 4.0 1.6 0.6 1.3 13.4 1.4 2.0 14.2 3.5 1.0 0.4 82.4 4.8 2.3 23.9 9.9 3.2 5.5 0.1 3.8 0.2 20.0 32.0 11.2 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 6.8 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.6 0.0 7.7 0.1 0.9 0.0 0.0 29.8 0.1 0.3 0.0 0.0 0.0 0.9 0.2 0.2 27.6 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 2.7 0.8 0.0 0.1 24.7 5.3 0.5 0.1 3.8 20.2 0.0 32.0 2.8 18.6 23.5 0.1 5.5 19.4 23.6 0.8 20.0 0.2 0.1 11.8 11.2 0.4 0.5 0.6 0.4 0.4 0.5 1.5 0.2 1.0 0.4 17.9 24.2 7.5 0.6 2.9 1.6 0.8 0.0 2.7 17.0 1.8 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.1 2.8 0.3 15.1 0.8 0.2 0.0 0.0 0.6 5.1 0.0 0.3 2.5 3.3 0.0 0.0 0.2 0.0 0.2 0.0 0.5 2.2 0.0 0.9 0.5 0.4 2.8 1.6 148.1 0.0 0.4 CD99 MIC2 ENSG00000002586 "CD99 molecule (Xg blood group)" P14209 X 2691133-2741309 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 359.1;breast: 433.0;heart muscle: 347.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 124.8" "Low region specificity" "Detected in all" "CAB000020, HPA035304" Supported Approved "Golgi apparatus" NA NA 34000000 "Golgi apparatus" "CAB000020: AB_2076419, HPA035304: AB_10672861" "unprognostic (3.71e-3)" "unprognostic (2.90e-1)" "unprognostic (5.97e-3)" "unprognostic (7.01e-3)" "unprognostic (2.14e-2)" "unprognostic (6.98e-3)" "unprognostic (3.89e-3)" "unprognostic (1.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.87e-7)" "unprognostic (2.11e-2)" "unprognostic (2.18e-1)" "unprognostic (5.37e-2)" "unprognostic (3.61e-2)" 45.7 14.1 85.8 14.4 100.5 11.1 433.0 45.7 60.9 243.9 31.8 4.5 4.5 19.9 258.4 18.3 26.1 22.2 35.2 347.0 103.4 14.7 66.4 24.6 24.5 16.6 161.0 56.6 187.4 28.9 3.3 67.0 138.7 185.5 30.5 20.6 4.5 18.1 37.7 18.9 28.0 23.8 31.1 359.1 18.5 21.7 23.3 101.3 4.5 15.2 4.5 16.1 24.7 208.8 32.7 62.6 4.3 47.1 32.1 107.1 103.6 23.9 27.5 30.8 41.6 124.8 94.6 18.5 64.2 100.7 40.4 58.9 39.7 16.9 1.6 12.6 89.1 22.5 9.4 12.3 16.1 33.6 32.6 31.0 4.6 19.2 34.5 39.6 7.3 36.7 58.8 20.0 22.1 15.6 28.0 73.6 25.3 5.7 0.0 38.1 18.8 63.9 25.0 10.0 2.7 30.0 10.8 25.7 45.4 23.3 16.4 0.1 13.6 15.4 13.9 38.6 81.3 12.3 22.9 67.9 49.8 8.4 47.6 21.6 0.1 0.0 10.5 33.3 18.4 31.1 1.8 47.1 1.5 107.1 11.6 60.4 32.7 72.6 94.6 44.6 20.2 26.8 57.1 4.3 32.1 2.6 62.6 74.3 103.6 85.8 100.5 45.7 60.9 103.4 14.7 161.0 56.6 185.5 101.3 59.6 70.1 119.1 149.0 222.5 0.9 77.6 76.5 73.6 67.1 68.0 0.0 181.3 11.6 139.8 5.6 366.2 95.9 70.0 121.0 161.2 556.7 292.3 222.0 87.0 661.4 0.0 77.6 437.1 220.0 13.6 597.5 294.4 656.3 138.9 114.0 38.7 162.8 176.3 480.5 50.9 3.0 336.3 416.7 17.9 45.6 194.8 102.9 472.0 184.3 245.6 CD99L2 "CD99B, MIC2L1" ENSG00000102181 "CD99 molecule like 2" Q8TCZ2 X 150766337-150898816 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.2" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038782, HPA038783, HPA061400" Enhanced Supported "Plasma membrane" NA NA 790000 "Plasma membrane" "HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660" "unprognostic (2.10e-2)" "unprognostic (2.62e-3)" "unprognostic (3.12e-3)" "unprognostic (6.03e-3)" "unprognostic (1.22e-1)" "unprognostic (2.66e-1)" "unprognostic (5.56e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.74e-5)" "unprognostic (5.50e-2)" "unprognostic (5.13e-2)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (9.23e-2)" "prognostic unfavorable (8.74e-4)" 27.1 16.5 23.3 9.2 30.1 4.5 17.8 27.5 56.7 19.2 12.6 21.0 5.5 6.7 17.6 16.5 9.7 17.6 12.4 32.1 26.3 32.0 14.0 17.0 14.9 9.6 30.5 26.6 26.0 8.4 9.7 8.7 21.5 43.1 13.9 7.4 11.9 8.3 22.0 72.2 6.7 8.0 20.8 31.9 12.5 8.0 7.6 13.3 3.0 7.3 6.9 7.0 10.7 7.7 7.2 10.7 9.4 15.1 8.8 8.9 8.4 2.3 23.0 8.7 10.8 46.3 29.0 2.6 19.0 22.3 9.6 13.8 1.6 2.9 8.3 46.1 33.0 7.2 3.7 11.9 12.9 8.0 19.4 9.3 3.6 5.5 2.3 12.5 6.0 6.9 27.3 4.2 7.1 13.5 15.0 11.2 6.6 2.4 22.0 12.0 4.9 5.3 8.8 3.6 1.9 12.5 5.3 7.1 11.4 9.4 1.5 11.6 5.9 7.4 6.4 8.5 6.7 1.8 10.4 13.2 14.2 4.4 18.4 13.6 18.7 30.9 8.1 17.8 12.1 10.7 9.4 11.2 7.6 8.8 9.9 7.8 6.4 8.2 8.9 10.7 7.2 8.3 8.5 2.8 8.8 15.1 7.8 5.9 8.4 23.3 30.1 27.5 55.2 26.3 32.0 30.5 26.6 43.1 13.3 14.9 8.5 4.5 2.7 2.7 23.3 35.5 12.7 1.4 7.9 12.2 17.7 8.7 5.0 4.0 0.3 11.4 3.4 0.0 4.5 3.8 12.3 3.3 7.0 22.1 9.1 49.3 8.1 14.7 16.2 1.5 19.2 4.7 10.1 9.0 2.4 16.9 3.8 2.9 28.3 9.7 15.5 0.0 9.0 1.5 5.1 1.1 11.3 4.4 3.0 1.1 CDA CDD ENSG00000158825 "Cytidine deaminase" P32320 1 20588948-20618908 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.5;bone marrow: 68.0" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 126.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 126.5" "Cell line enhanced" "Detected in many" "A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA064202 Enhanced Approved Nucleoplasm NA NA 3700000 Nucleoplasm "HPA064202: AB_2685211" "unprognostic (2.38e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (2.86e-1)" "unprognostic (2.56e-1)" "unprognostic (8.02e-2)" "unprognostic (3.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.68e-3)" "unprognostic (2.64e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (8.56e-5)" "unprognostic (2.94e-2)" "unprognostic (5.03e-2)" "unprognostic (8.47e-3)" "unprognostic (2.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.89e-3)" 4.0 1.4 1.5 4.0 1.5 68.0 2.2 1.1 2.4 19.0 8.6 1.7 2.0 2.6 6.7 3.5 38.3 2.9 1.8 5.9 1.7 1.6 12.5 42.1 8.4 9.1 2.0 1.3 2.9 0.8 1.2 0.7 30.8 3.5 4.2 10.2 4.5 6.9 1.5 3.2 7.0 24.7 4.3 1.9 11.8 1.2 2.9 0.9 0.9 3.0 23.3 10.5 3.1 16.5 0.0 1.3 126.5 21.7 0.0 0.1 7.1 42.9 4.2 0.0 0.0 0.0 1.3 0.0 3.3 0.9 0.8 3.4 0.2 28.6 0.0 1.6 6.8 1.8 15.1 0.8 11.2 2.2 0.0 0.8 0.0 40.6 5.4 0.3 0.0 0.0 1.9 1.8 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 5.0 20.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 51.0 0.0 0.0 0.5 0.0 1.2 0.7 0.0 1.7 3.9 0.2 0.0 0.0 0.0 0.5 18.0 0.0 16.3 21.7 43.3 0.0 11.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 126.5 0.0 9.3 0.2 0.0 7.1 1.5 1.5 1.1 2.4 1.7 1.6 2.0 1.3 3.5 0.9 3.0 1.4 0.9 0.2 1.3 0.1 2.8 2.5 0.0 0.0 5.2 0.0 0.2 36.5 2.4 0.6 4.4 120.2 0.0 1.3 2.7 1.0 0.9 0.0 94.4 6.1 0.0 0.0 28.8 118.1 0.8 0.3 3.7 0.0 0.0 12.5 0.0 70.1 48.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 2.1 1.5 4.9 0.3 CDC14A "cdc14, Cdc14A1, Cdc14A2, DFNB105" ENSG00000079335 "Cell division cycle 14A" Q9UNH5 1 100345001-100520278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Hearing" "Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Group enriched" "Detected in many" 6 "Early spermatids: 165.7;Late spermatids: 161.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023783 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA023783: AB_1846352" "unprognostic (3.72e-2)" "unprognostic (2.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (1.54e-3)" "unprognostic (1.38e-1)" "unprognostic (9.27e-4)" "unprognostic (4.88e-3)" "unprognostic (6.30e-2)" "unprognostic (3.97e-3)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (6.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (6.66e-2)" 6.2 2.4 5.8 6.5 5.5 13.7 12.2 1.8 6.2 7.7 11.8 4.8 2.2 7.2 15.1 4.8 3.4 13.7 3.6 4.1 8.8 3.5 6.6 2.4 12.3 15.4 3.8 5.4 5.8 6.7 9.8 8.1 7.6 4.6 10.0 6.3 8.3 7.7 3.9 4.3 5.6 22.6 5.0 3.2 9.6 6.0 38.2 4.7 12.0 6.1 3.4 11.3 5.8 8.4 4.8 6.1 11.6 3.7 3.9 13.0 4.1 2.2 1.8 5.9 6.7 2.2 1.6 4.1 2.9 1.9 2.9 2.3 6.2 1.9 1.1 2.1 1.7 2.3 1.7 4.0 1.6 2.9 2.3 9.9 4.0 1.7 2.0 0.8 5.4 7.1 1.3 0.4 3.1 1.0 1.4 5.1 2.4 30.6 3.5 4.2 1.0 4.3 6.0 3.6 1.4 2.3 4.7 7.6 1.1 2.0 5.1 1.1 1.9 3.0 2.9 4.0 3.0 1.3 7.0 2.2 1.6 3.6 2.7 1.7 1.7 0.6 1.7 1.9 5.0 0.9 11.6 3.7 8.4 7.3 3.3 13.0 4.8 11.3 8.4 3.5 3.1 11.0 5.8 5.5 3.9 2.3 6.1 5.6 4.1 5.8 5.5 1.8 6.2 8.8 3.5 3.8 5.4 4.6 4.7 3.0 5.6 2.2 4.2 3.3 0.2 5.3 0.0 28.1 5.7 1.8 3.9 1.7 0.0 2.7 165.7 9.3 12.8 0.0 1.7 0.8 4.7 6.6 14.0 1.5 2.3 0.0 4.6 6.2 4.6 161.3 4.6 4.3 5.0 5.4 4.7 9.1 2.5 8.7 0.7 1.7 3.6 0.0 2.8 1.9 3.0 2.0 1.8 10.2 2.7 2.3 CDC20 "CDC20A, p55CDC" ENSG00000117399 "Cell division cycle 20" Q12834 1 43358955-43363203 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.0;testis: 73.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB004525, HPA045842, HPA055288" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes "Nucleoplasm, Cytosol" "CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773" "unprognostic (1.66e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-2)" "unprognostic (2.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.00e-8)" "unprognostic (9.06e-3)" "unprognostic (1.17e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (8.55e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.01e-1)" "unprognostic (1.29e-2)" 1.3 1.2 0.6 16.6 1.1 20.2 1.8 0.8 1.3 2.1 6.2 2.8 0.4 5.8 1.1 1.6 17.8 0.4 1.9 1.2 0.9 0.5 2.2 1.2 1.8 13.4 1.1 0.7 0.9 0.5 0.0 0.4 3.9 1.2 0.8 7.0 0.4 2.9 0.4 0.6 4.6 6.4 2.8 1.2 7.8 4.4 73.2 0.7 42.0 1.2 11.7 21.7 1.9 4.2 4.5 0.9 0.8 0.1 9.8 11.2 2.7 52.6 25.7 35.9 23.4 1.2 3.2 34.4 24.4 21.9 71.2 38.0 40.3 43.8 30.5 14.3 22.4 25.1 37.1 39.2 46.6 59.5 23.9 29.0 44.6 25.4 24.9 0.3 31.1 16.3 1.0 2.2 49.4 44.8 6.2 30.1 29.3 20.1 21.0 32.2 20.4 29.9 19.1 45.4 25.1 34.6 43.5 49.3 19.3 17.3 14.0 21.2 10.4 43.1 29.2 13.5 28.8 20.5 39.4 15.6 21.3 50.0 23.6 75.6 16.1 14.3 31.6 15.3 38.8 31.7 0.0 0.1 0.0 0.4 0.0 0.0 4.5 3.3 3.6 0.9 0.9 0.1 0.3 0.8 9.8 0.0 0.2 11.2 2.7 0.6 1.1 0.8 1.3 0.9 0.5 1.1 0.7 1.2 0.7 0.0 0.6 16.2 2.0 9.3 0.0 0.7 0.0 2.7 1.2 0.0 0.0 13.4 0.0 2.1 97.6 0.7 3.2 70.0 0.3 127.9 4.1 2.0 0.0 1.0 30.9 0.0 0.0 8.0 5.0 7.0 2.6 5.2 0.0 2.8 2.9 0.2 0.7 0.0 1.8 2.1 2.6 0.0 1.4 74.9 48.1 7.3 8.9 1.3 15.5 2.6 CDC20B FLJ37927 ENSG00000164287 "Cell division cycle 20B" Q86Y33 5 55112995-55173175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 33.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.5;T-47d: 3.3;U-87 MG: 1.3" "Region enriched" "Detected in single" 4 "hypothalamus: 0.4" HPA053900 Uncertain NA NA "HPA053900: AB_2682299" "unprognostic (7.39e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-2)" "unprognostic (1.78e-3)" "unprognostic (9.94e-2)" "unprognostic (1.59e-2)" "unprognostic (3.12e-1)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (7.84e-3)" "unprognostic (2.83e-2)" "unprognostic (3.06e-1)" "unprognostic (5.15e-4)" "unprognostic (1.99e-2)" "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.29e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.8 0.1 0.1 5.5 0.1 0.1 0.1 0.1 2.9 0.1 4.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.1 0.0 0.4 0.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.3 0.0 3.3 0.0 0.4 0.0 0.2 0.8 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.4 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.7 0.5 0.1 0.1 0.0 0.2 0.1 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188402 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 106.0" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005855, HPA008803" Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA005855: AB_1846364, HPA008803: " "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.8 1.2 1.1 5.5 1.1 13.0 0.8 0.7 1.2 1.1 3.3 0.6 1.0 1.8 0.6 0.9 3.9 0.4 2.2 0.7 1.3 2.4 1.2 0.9 0.7 4.1 1.4 0.2 2.1 3.6 0.4 2.3 4.2 1.2 1.0 4.0 1.5 1.8 0.5 0.7 0.8 2.1 0.8 0.7 3.6 1.3 19.4 0.2 23.0 1.6 8.8 7.4 0.8 1.3 1.7 0.9 0.5 0.1 0.0 1.0 0.1 7.6 3.8 18.1 9.7 0.6 1.2 12.5 10.6 4.0 13.4 10.9 16.4 4.0 22.8 4.2 2.8 8.5 5.8 30.9 7.3 14.2 7.4 16.3 29.1 6.9 8.1 0.6 20.5 8.5 0.6 1.1 16.6 7.2 1.6 5.0 17.0 23.1 12.1 7.2 4.1 25.6 16.0 26.4 7.0 8.7 11.5 11.9 12.4 3.4 7.2 8.5 10.6 6.6 7.7 3.4 12.0 4.0 14.6 2.5 6.6 10.2 7.3 14.5 6.1 18.2 35.8 4.9 22.9 5.5 0.0 0.0 0.5 0.4 0.0 0.0 1.7 0.6 0.2 0.9 0.0 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.1 1.1 1.1 0.7 1.2 1.3 2.4 1.4 0.2 1.2 0.2 0.0 0.0 0.0 0.4 0.3 0.0 106.0 0.0 0.0 0.0 0.0 2.0 1.9 0.0 0.5 14.7 0.1 0.3 0.0 0.8 5.7 0.5 0.4 0.0 0.2 2.5 0.0 1.2 1.3 0.3 22.9 1.4 0.0 0.0 0.0 1.5 0.5 0.9 0.0 1.8 0.2 0.4 0.0 0.4 15.8 13.7 0.0 0.2 0.0 3.2 0.3 CDC25C "CDC25, PPP1R60" ENSG00000158402 "Cell division cycle 25C" P30307 5 138285265-138338355 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 23.3;testis: 22.3" "Group enriched" "Detected in some" 4 "Early spermatids: 32.9;Late spermatids: 35.1;Spermatocytes: 36.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.1;T-reg: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB003800, HPA066991" Approved Enhanced "Nuclear speckles" No Yes "Nuclear speckles" "CAB003800: AB_562081, HPA066991: AB_2685760" "unprognostic (2.45e-3)" "unprognostic (5.89e-3)" "prognostic favorable (2.49e-4)" "unprognostic (9.72e-3)" "unprognostic (2.17e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.03e-6)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.56e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-3)" "unprognostic (1.00e-1)" "unprognostic (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.43e-1)" "unprognostic (2.59e-1)" "unprognostic (3.06e-1)" 1.1 0.6 0.3 6.7 0.4 5.2 1.1 0.4 0.6 0.6 3.3 0.1 0.7 3.0 0.3 0.6 2.5 0.2 0.4 0.7 0.4 0.4 0.4 0.6 0.7 2.6 0.4 0.3 0.3 0.3 0.0 0.4 1.9 0.3 0.4 4.0 0.0 1.2 0.7 0.2 1.1 3.7 0.5 0.3 1.7 1.2 22.3 0.2 23.3 0.3 1.8 5.0 0.6 0.9 1.0 0.1 0.7 0.0 2.1 2.7 0.5 13.3 5.6 18.8 14.5 0.4 1.9 4.7 8.1 8.7 18.4 25.4 13.5 26.0 6.2 6.8 4.9 20.2 7.3 15.5 12.4 17.8 5.1 10.6 4.7 7.6 10.0 0.1 3.2 4.9 0.4 0.5 10.9 9.0 1.9 11.8 13.5 6.9 12.3 11.2 7.4 8.7 8.1 4.8 10.6 6.1 5.7 17.2 7.3 3.2 4.1 9.5 5.9 18.1 5.5 8.6 17.3 9.2 6.7 3.5 10.2 8.6 7.0 12.9 7.5 6.1 6.1 4.0 6.8 7.7 0.0 0.0 0.1 0.6 0.0 0.0 1.0 0.5 0.3 0.0 0.2 0.0 0.0 0.7 2.1 0.0 0.1 2.7 0.5 0.3 0.4 0.4 0.6 0.4 0.4 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 32.9 0.0 0.3 0.0 0.0 5.7 0.2 0.3 0.0 0.2 2.2 0.0 0.0 0.0 0.3 35.1 1.7 1.2 0.0 1.0 0.6 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 36.3 8.3 0.4 1.1 0.0 1.6 0.1 CDC37L1 "CDC37B, FLJ20639, HARC" ENSG00000106993 "Cell division cycle 37 like 1" Q7L3B6 9 4679559-4708398 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HDLM-2: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021175 Approved Supported Cytosol NA NA Cytosol "HPA021175: AB_10959752" "unprognostic (1.18e-2)" "unprognostic (8.52e-2)" "unprognostic (2.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.38e-2)" "unprognostic (3.66e-3)" "unprognostic (2.71e-2)" "unprognostic (9.89e-2)" "unprognostic (7.82e-3)" "unprognostic (2.78e-2)" "unprognostic (7.97e-2)" "prognostic favorable (2.66e-7)" "unprognostic (8.54e-2)" "unprognostic (1.91e-1)" "unprognostic (2.91e-2)" "unprognostic (4.28e-2)" 14.9 12.6 10.4 7.1 15.4 5.6 10.5 12.4 14.9 12.2 10.0 7.1 11.2 7.8 10.9 12.0 15.8 10.1 11.6 28.6 11.2 12.6 13.4 42.0 8.4 9.0 10.0 9.9 12.4 15.1 9.3 13.7 7.5 17.3 13.0 6.5 6.2 9.4 11.1 58.8 8.1 8.0 17.9 8.8 6.3 9.5 10.8 8.9 7.0 12.2 14.0 7.2 18.0 16.1 10.7 6.2 14.8 6.8 8.1 20.7 7.9 7.2 6.6 3.5 5.6 12.7 9.4 5.4 8.6 5.9 5.2 6.0 2.1 4.5 4.6 2.4 6.2 3.5 3.2 3.9 5.2 5.1 54.0 3.3 12.3 7.2 5.7 7.6 4.9 5.1 6.0 6.8 3.9 6.2 5.8 3.7 4.2 1.4 7.2 5.8 3.5 3.8 10.2 8.9 4.8 2.3 3.1 4.3 2.6 7.4 3.0 10.1 5.0 6.3 5.2 4.2 4.7 4.2 4.7 4.0 7.9 3.7 4.4 5.6 5.6 8.8 3.4 7.0 3.5 2.5 14.8 5.7 11.0 13.3 5.3 13.1 10.7 13.4 14.0 5.4 10.5 20.7 18.5 6.8 8.1 6.8 6.2 12.1 7.9 10.4 15.4 12.4 14.9 11.2 12.6 10.0 9.9 17.3 8.9 26.8 16.5 11.2 38.4 58.5 28.6 62.3 20.4 17.4 17.0 15.7 31.4 15.6 41.4 28.4 8.6 17.6 12.9 0.0 36.2 13.7 33.8 56.3 23.1 91.2 10.4 19.1 17.1 15.4 11.2 3.9 33.4 16.0 38.8 13.6 14.9 28.6 23.9 11.5 34.3 49.1 21.9 32.3 48.6 69.4 49.7 50.2 28.3 26.1 10.7 43.1 CDC42EP3 "BORG2, CEP3, UB1" ENSG00000163171 "CDC42 effector protein 3" Q9UKI2 2 37641882-37738468 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 107.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034986, HPA061792" Approved Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA034986: AB_10602207, HPA061792: AB_2732670" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-2)" "unprognostic (4.11e-3)" "unprognostic (2.38e-2)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (1.72e-1)" "unprognostic (1.84e-1)" "unprognostic (3.81e-1)" "unprognostic (3.14e-3)" "unprognostic (7.30e-3)" "unprognostic (1.97e-1)" "unprognostic (2.97e-1)" "unprognostic (4.53e-2)" 19.7 2.1 5.1 5.7 5.8 18.9 14.0 2.4 6.6 13.6 14.4 2.9 1.8 0.9 33.3 6.6 5.0 8.6 4.9 14.3 2.6 1.8 8.4 3.0 10.6 5.7 3.2 2.3 7.7 7.4 1.1 5.5 6.0 3.8 24.9 4.9 7.9 5.8 28.5 27.8 5.3 6.3 25.4 3.2 6.9 5.4 60.2 2.7 14.8 6.4 3.5 5.2 14.9 8.2 7.2 8.4 51.9 30.3 10.1 21.8 13.8 16.9 6.5 3.8 0.2 14.7 7.8 5.8 14.6 39.0 22.9 16.7 12.1 6.8 3.1 11.6 34.6 7.0 8.1 4.7 17.4 23.4 11.3 1.3 5.4 6.7 0.0 28.6 1.2 0.3 23.4 16.3 19.7 43.9 37.3 13.3 1.2 0.8 2.4 107.3 0.1 0.7 9.5 7.6 0.2 4.0 0.4 28.3 1.6 16.5 8.2 4.1 11.5 7.1 5.2 8.8 7.0 1.7 10.1 9.8 27.4 7.1 7.1 14.9 4.5 6.0 1.0 11.3 8.2 37.9 11.0 21.8 1.7 20.2 15.3 21.8 7.2 13.1 17.3 8.4 2.9 4.4 11.1 51.9 10.1 30.3 0.2 9.4 13.8 5.1 5.8 2.4 6.6 2.6 1.8 3.2 2.3 3.8 2.7 6.0 37.0 25.9 93.8 33.0 7.6 91.1 12.7 83.0 18.2 29.6 33.4 23.8 8.3 19.5 42.0 51.9 2.6 0.0 14.1 58.6 26.9 25.1 130.1 1.3 10.6 95.3 39.5 55.3 42.4 92.4 14.1 52.8 190.6 1.8 36.9 27.1 17.9 3.5 119.2 3.7 11.7 0.0 18.7 64.4 13.2 11.8 10.1 74.3 5.8 35.2 CDC42EP5 "Borg3, CEP5" ENSG00000167617 "CDC42 effector protein 5" Q6NZY7 19 54465026-54473264 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.7" "Group enriched" "Detected in many" 4 "Enterocytes: 254.3;Glandular cells: 236.7;Mucus-secreting cells: 305.7;Paneth cells: 150.3;Undifferentiated cells: 129.3;Urothelial cells: 346.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;ASC TERT1: 1.9;BEWO: 1.4;CACO-2: 2.6;HBEC3-KT: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA043449 Approved NA NA "HPA043449: AB_10961041" "unprognostic (7.67e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-1)" "unprognostic (3.36e-1)" "unprognostic (7.30e-3)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (6.49e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.73e-2)" "unprognostic (5.41e-2)" "unprognostic (6.37e-3)" "prognostic favorable (1.36e-4)" 11.0 1.8 0.0 9.6 0.1 1.8 8.1 0.0 1.8 12.9 32.7 0.4 2.7 1.8 6.1 4.5 7.3 4.1 7.2 7.2 0.0 0.0 4.2 1.8 9.4 10.4 0.7 0.0 5.9 3.8 1.8 1.1 5.8 0.4 17.0 1.8 4.4 9.8 2.9 4.7 2.7 29.4 6.3 0.9 4.8 6.1 7.9 0.0 4.4 2.8 5.3 6.5 17.7 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.9 1.4 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 56.5 9.2 0.8 0.6 0.0 0.0 0.0 17.4 0.0 0.1 0.0 3.0 5.1 12.7 254.3 0.0 10.0 10.1 32.7 236.7 9.2 0.4 0.8 0.0 37.5 27.6 1.0 5.4 9.5 0.0 16.9 1.0 305.7 15.2 11.1 150.3 8.5 0.3 2.2 6.5 5.7 0.2 0.1 6.6 0.6 0.7 129.3 346.2 CDC45 "CDC45L, CDC45L2" ENSG00000093009 "Cell division cycle 45" O75419 22 19479459-19520612 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000614, CAB009459" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA Yes Nucleoplasm "Centrosome, Cytosol" "CAB009459: AB_2078507, HPA000614: AB_1078487" "unprognostic (5.56e-2)" "unprognostic (6.12e-3)" "unprognostic (1.17e-3)" "unprognostic (3.42e-3)" "unprognostic (3.57e-1)" "unprognostic (7.42e-2)" "prognostic unfavorable (6.95e-6)" "unprognostic (6.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (8.94e-4)" "unprognostic (7.28e-2)" "unprognostic (0.00e+0)" "unprognostic (7.62e-3)" "unprognostic (2.02e-1)" "unprognostic (8.52e-2)" "unprognostic (1.10e-1)" 0.9 0.9 0.3 8.4 0.5 15.7 0.9 0.3 0.6 1.3 3.4 0.3 0.2 2.2 0.6 1.4 6.2 0.4 0.8 1.6 0.7 0.3 0.8 1.4 1.3 7.5 0.4 0.2 0.7 0.5 0.1 0.4 3.5 0.4 0.7 4.3 0.2 1.3 0.2 0.4 2.1 3.1 1.1 0.4 4.2 1.8 43.5 0.2 25.4 0.5 7.2 10.2 1.3 1.9 0.7 0.9 1.6 0.5 1.8 3.2 1.9 13.2 11.1 13.9 10.9 0.6 1.3 5.9 16.4 7.7 18.9 18.8 8.5 7.4 14.8 5.8 4.9 7.5 12.8 14.8 10.8 17.0 18.0 25.0 19.8 12.6 9.3 0.7 28.7 10.9 0.4 0.5 14.5 6.5 1.8 9.5 15.3 87.8 18.7 11.0 17.7 23.3 13.6 4.2 25.7 8.4 19.4 23.1 6.5 4.4 12.7 18.0 9.5 8.9 9.8 2.8 6.5 6.4 12.8 3.6 14.8 23.7 11.2 14.9 6.4 11.8 17.2 7.8 14.4 19.7 0.0 0.2 0.0 2.2 0.0 0.0 0.7 1.4 2.3 0.6 0.0 1.0 0.7 1.6 1.8 0.5 0.9 3.2 1.9 0.3 0.5 0.3 0.6 0.7 0.3 0.4 0.2 0.4 0.2 0.0 0.0 0.8 0.4 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.9 88.0 0.3 0.4 46.7 0.0 16.8 1.0 0.2 0.0 0.0 6.2 0.0 0.0 3.7 0.6 6.1 0.6 0.9 0.0 0.0 0.8 0.0 0.1 0.0 0.7 0.0 0.0 6.5 0.9 23.9 49.8 1.6 4.1 1.3 2.5 0.4 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287633-40304657 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 5 "dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4" "Cell line enhanced" "Detected in many" "SK-BR-3: 86.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 1.8 2.9 3.1 10.8 2.6 16.8 1.5 2.3 6.0 2.7 5.8 0.8 2.7 5.3 1.9 1.6 9.0 1.3 5.4 1.6 1.9 1.4 1.8 5.1 2.8 10.6 1.0 1.5 1.5 3.6 1.1 1.2 9.4 0.8 1.4 5.6 0.2 3.2 4.1 0.9 2.3 7.9 2.4 1.6 7.7 2.7 14.8 1.2 30.0 1.3 5.0 10.1 4.1 3.0 0.7 6.2 0.2 0.3 2.2 3.4 1.2 25.4 17.6 21.3 15.1 1.1 2.3 19.5 27.8 8.3 24.4 29.5 20.0 11.4 20.6 17.4 5.9 14.1 37.1 18.4 12.6 24.3 10.9 14.5 16.7 21.0 17.9 0.7 22.8 10.3 0.6 0.9 28.2 16.9 2.6 7.3 14.2 30.5 19.3 11.8 13.3 33.1 5.5 17.5 15.1 6.5 24.4 51.9 19.4 4.0 28.7 14.6 13.1 25.3 86.7 8.6 17.4 17.6 19.8 6.1 17.6 25.2 28.8 32.9 8.1 17.5 39.7 15.2 15.1 19.2 0.1 0.3 0.0 1.3 0.0 0.9 0.7 1.2 2.1 1.4 0.7 0.9 2.1 0.2 2.2 0.0 6.2 3.4 1.2 3.1 2.6 2.3 6.0 1.9 1.4 1.0 1.5 0.8 1.2 0.0 1.3 2.2 1.1 3.8 0.0 0.6 0.0 0.0 1.2 0.0 0.0 12.0 0.0 1.2 1.4 0.5 1.1 23.3 0.6 27.7 2.4 1.1 0.0 0.9 6.8 0.0 0.0 1.8 1.3 0.2 2.6 1.3 0.0 0.0 1.7 0.3 1.2 2.9 0.7 0.2 0.3 12.9 1.0 11.4 23.0 1.4 14.0 2.5 4.6 2.0 CDCA2 "PPP1R81, Repo-Man" ENSG00000184661 "Cell division cycle associated 2" Q69YH5 8 25458997-25507920 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 38.8;testis: 17.7" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 22.0;Early spermatids: 29.6;Extravillous trophoblasts: 12.3;Late spermatids: 14.4;Sertoli cells: 12.9;Spermatocytes: 45.9;Spermatogonia: 28.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.6;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026293, HPA030049" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "HPA026293: AB_1846384, HPA030049: AB_10600862" "unprognostic (2.12e-1)" "unprognostic (4.75e-3)" "prognostic favorable (9.62e-4)" "unprognostic (2.92e-2)" "unprognostic (9.69e-2)" "unprognostic (3.56e-2)" "unprognostic (2.50e-5)" "unprognostic (1.47e-3)" "unprognostic (6.06e-2)" "unprognostic (2.91e-3)" "unprognostic (1.32e-3)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.30e-14)" "unprognostic (1.36e-2)" "unprognostic (4.02e-1)" "unprognostic (1.91e-1)" "unprognostic (5.30e-2)" 0.8 0.5 0.3 11.3 0.5 5.5 0.6 0.3 0.3 0.7 3.3 0.2 0.0 1.3 0.5 0.2 2.8 0.3 0.1 0.6 0.3 0.3 0.5 0.5 0.6 4.4 0.4 0.2 0.4 0.3 0.0 0.4 3.3 0.3 0.5 2.0 0.1 0.7 0.0 0.4 1.0 3.3 0.6 1.0 3.9 0.8 17.7 0.4 38.8 0.4 3.5 5.9 0.6 1.0 0.7 0.0 0.0 0.0 2.6 1.9 0.8 14.8 14.1 13.1 10.9 1.1 2.0 8.7 16.7 9.9 14.6 14.6 12.0 6.8 17.6 7.2 6.9 15.8 13.6 18.2 8.5 21.6 6.6 5.2 18.0 10.2 6.4 0.3 8.0 8.8 1.1 0.5 10.2 6.9 1.4 10.5 10.6 14.2 20.4 13.3 5.8 22.4 3.8 13.4 10.3 6.2 11.6 14.5 6.4 4.1 8.1 5.5 5.9 14.1 6.8 6.6 6.6 7.5 3.9 7.2 10.9 17.5 20.5 15.4 3.4 6.9 18.7 7.8 10.5 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.1 0.0 0.0 2.6 0.0 0.0 1.9 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.4 0.0 0.6 0.8 0.5 1.0 0.4 22.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.2 29.6 0.0 0.0 0.0 0.0 12.3 0.4 0.4 0.0 0.0 3.3 0.0 0.0 1.3 1.9 14.4 1.1 1.2 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.5 0.3 12.9 0.7 45.9 28.1 0.6 1.4 1.9 1.2 0.4 CDCA3 "GRCC8, TOME-1" ENSG00000111665 "Cell division cycle associated 3" Q99618 12 6844793-6852066 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.6;lymphoid tissue: 51.0" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 53.0;Erythroid cells: 46.7;Extravillous trophoblasts: 60.9;Spermatocytes: 57.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 8.8" "Cell type enhanced" "Detected in many" "T-reg: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA026587 Approved Cytosol NA Yes Cytosol "HPA026587: AB_1846386" "unprognostic (3.05e-1)" "unprognostic (1.32e-1)" "unprognostic (9.85e-2)" "unprognostic (1.63e-2)" "unprognostic (2.42e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.51e-5)" "prognostic unfavorable (9.77e-5)" "unprognostic (3.88e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-3)" "unprognostic (8.81e-2)" "unprognostic (0.00e+0)" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.11e-1)" "unprognostic (4.94e-2)" 1.6 1.9 1.0 19.2 1.8 9.9 1.9 8.8 2.2 2.0 17.3 1.2 1.2 15.5 2.3 2.0 6.9 1.0 2.9 2.2 1.1 1.6 1.3 0.9 1.9 10.8 1.3 0.7 3.7 0.6 0.3 6.9 4.7 1.2 2.2 5.3 0.7 2.4 0.4 0.7 4.3 34.6 2.0 1.4 5.2 2.4 18.2 1.1 51.0 1.3 8.5 15.1 1.6 2.8 1.6 2.3 0.5 0.6 0.8 7.7 0.9 30.1 21.8 22.3 13.5 1.3 2.0 25.9 19.9 12.2 32.8 22.9 32.3 26.0 16.7 2.5 15.0 23.8 20.8 14.3 13.7 32.6 25.1 15.9 15.0 14.6 21.0 0.2 11.1 14.3 0.9 1.1 17.6 9.6 8.0 13.9 11.8 12.4 10.9 31.2 23.6 16.2 12.9 26.1 20.3 16.9 16.4 19.4 9.4 10.9 8.5 3.4 6.7 18.0 16.8 6.2 24.9 6.6 10.8 6.1 16.0 20.7 10.4 33.4 5.6 5.6 26.1 7.5 13.9 28.1 0.0 0.6 0.0 0.5 0.3 0.8 1.6 1.3 1.9 0.7 0.8 0.6 1.2 0.5 0.8 0.5 2.3 7.7 0.9 1.0 1.8 8.8 2.2 1.1 1.6 1.3 0.7 1.2 1.1 0.0 0.3 0.8 1.2 2.6 10.5 1.0 0.0 0.0 0.0 0.0 53.0 3.3 0.0 0.9 5.9 0.4 9.5 46.7 0.3 60.9 2.6 1.0 4.6 0.8 15.7 6.4 1.2 3.1 3.5 5.4 1.7 2.7 0.0 1.8 5.7 1.4 0.3 0.8 0.4 0.7 18.0 6.5 0.4 57.5 14.9 1.6 7.1 0.8 10.9 0.6 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 38.3" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 133.3;Spermatogonia: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 4.5 2.6 1.7 11.5 2.6 38.3 4.1 8.3 3.2 8.7 3.7 2.6 4.5 4.1 5.6 4.0 16.6 4.1 4.2 2.4 1.5 1.3 2.8 3.0 5.1 9.1 2.7 1.4 5.0 6.2 1.6 1.9 12.4 3.3 4.6 2.7 3.3 5.3 2.2 1.3 21.8 4.4 3.1 2.3 6.7 3.6 12.8 2.3 24.9 5.1 11.2 15.0 3.7 8.8 7.4 4.2 8.3 4.3 10.6 14.7 5.5 15.2 15.9 18.4 13.9 3.1 5.2 24.1 22.8 7.0 17.9 15.7 19.4 19.5 20.0 12.5 8.0 13.7 24.5 12.8 26.3 10.5 21.9 10.1 12.7 13.6 16.2 3.9 22.4 10.7 3.7 8.2 13.8 13.0 6.0 12.1 17.5 13.9 20.8 12.4 37.4 20.8 15.1 13.6 13.3 36.4 20.2 26.8 7.4 6.0 17.7 10.8 13.3 21.8 8.8 17.5 8.5 17.2 15.1 18.7 15.9 20.2 21.7 30.2 7.7 9.5 20.5 13.3 11.4 26.2 0.9 3.6 8.3 10.9 3.9 13.3 7.4 11.4 14.7 3.9 5.2 6.8 8.0 1.3 10.6 4.3 4.2 8.9 5.5 1.7 2.6 8.3 3.2 1.5 1.3 2.7 1.4 3.3 2.3 0.0 2.1 10.4 19.9 57.1 3.0 0.6 0.0 8.1 3.4 1.8 0.0 53.6 3.3 12.9 6.4 9.0 1.1 23.3 6.2 133.3 12.5 7.7 28.8 2.1 21.5 12.7 2.9 7.4 6.2 4.3 7.8 10.6 16.9 10.8 4.4 3.4 9.1 3.5 5.6 1.4 2.7 6.5 10.3 31.0 64.2 58.6 21.6 17.5 6.0 48.5 CDCA5 ENSG00000146670 "Cell division cycle associated 5" Q96FF9 11 65066300-65084164 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9" "Group enriched" "Detected in many" 5 "Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "NK-cell: 5.8;T-reg: 4.2" "Group enriched" "Detected in many" 4 "NK-cells: 5.8;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023691, HPA076007" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA023691: AB_1846392, HPA076007: " "unprognostic (3.14e-2)" "unprognostic (4.20e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.15e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (8.21e-6)" "unprognostic (1.41e-3)" "unprognostic (7.55e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (8.72e-6)" "unprognostic (2.16e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.55e-3)" "unprognostic (1.86e-1)" "unprognostic (1.35e-1)" "unprognostic (8.97e-2)" 1.3 1.3 1.1 12.3 1.1 27.4 4.3 1.0 2.8 1.6 3.8 0.6 0.0 3.3 0.9 1.4 7.9 0.7 1.4 1.3 1.1 0.9 1.3 1.3 1.9 9.5 1.1 0.5 0.8 0.7 0.2 0.7 5.5 1.3 0.9 4.7 0.1 1.5 0.1 0.7 2.4 3.6 1.7 0.7 5.7 2.1 27.9 0.2 39.9 0.7 6.6 9.9 1.5 2.3 1.2 0.8 0.3 0.5 5.8 4.2 1.4 30.7 17.6 16.9 14.3 1.1 1.8 14.1 22.0 9.2 25.8 20.6 18.0 18.7 28.0 12.7 7.1 30.4 21.3 27.3 12.1 25.2 28.0 11.9 25.2 12.8 15.1 0.1 26.8 20.4 0.6 1.1 24.1 11.2 2.7 7.8 33.6 28.5 51.8 15.7 25.5 37.8 27.7 26.6 15.2 21.4 33.2 18.7 26.7 5.3 11.8 22.0 16.5 14.1 20.2 14.9 11.0 26.0 13.2 4.9 23.4 24.2 24.6 24.4 26.2 41.5 45.6 9.4 16.6 24.1 0.0 0.2 0.3 0.8 0.0 0.1 0.7 1.1 0.6 0.8 1.2 0.1 0.8 0.1 5.8 0.5 0.7 4.2 1.4 1.1 1.1 1.0 2.8 1.1 0.9 1.1 0.5 1.3 0.2 0.0 0.3 0.8 0.8 3.4 0.8 0.8 0.0 0.0 1.2 0.0 2.0 3.7 1.7 0.9 41.6 0.9 0.9 0.0 0.7 30.6 1.8 0.4 3.5 0.0 9.5 1.6 0.0 1.3 2.8 84.2 2.6 1.9 0.0 3.6 2.3 0.8 0.5 0.0 1.4 0.3 0.2 0.0 0.3 40.4 22.0 0.9 3.1 1.9 2.8 1.0 CDCA7 "FLJ14736, JPO1" ENSG00000144354 "Cell division cycle associated 7" Q9BWT1 2 173354820-173368997 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.4" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 40.4;Leydig cells: 49.8;Peritubular cells: 32.5;Undifferentiated cells: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 9.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 61.8" "Group enriched" "Detected in many" 4 "basal ganglia: 8.3;olfactory region: 21.4" "Low region specificity" "Detected in all" HPA005565 Supported Nucleoplasm,Cytosol No Yes "Nucleoplasm, Cytosol" "HPA005565: AB_2078680" "unprognostic (1.67e-3)" "unprognostic (2.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" "unprognostic (2.16e-1)" "unprognostic (1.44e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (7.54e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.96e-2)" "unprognostic (2.83e-1)" "unprognostic (8.97e-3)" "unprognostic (0.00e+0)" "unprognostic (4.53e-3)" "unprognostic (1.96e-1)" "unprognostic (2.04e-1)" "unprognostic (2.47e-2)" 1.1 0.6 1.2 28.0 1.5 9.7 1.8 0.5 1.4 8.3 12.3 2.8 2.6 14.9 7.9 1.7 12.9 2.3 6.6 0.9 2.0 1.4 0.8 0.4 1.3 17.2 1.3 2.2 1.1 2.9 0.0 0.4 7.3 3.4 3.2 14.8 1.1 3.3 0.6 4.3 8.3 16.4 1.5 2.0 2.9 7.6 8.1 2.0 71.4 0.9 10.5 24.0 2.3 8.0 2.6 4.2 0.3 0.7 3.6 9.4 2.7 9.8 7.6 17.9 19.4 0.8 3.3 18.7 6.0 2.1 14.2 16.0 11.7 12.6 27.6 7.6 3.6 5.5 10.3 28.4 10.7 20.7 13.2 15.6 6.2 5.5 14.8 0.9 40.4 5.9 2.7 0.9 7.7 6.5 1.8 6.4 36.5 14.9 6.3 4.1 7.9 61.8 40.7 21.1 23.4 5.3 43.7 13.6 17.5 6.9 8.7 5.2 9.2 9.4 3.1 5.0 16.7 0.0 15.9 2.9 9.3 4.0 3.0 10.9 1.7 3.7 38.8 5.8 22.5 7.8 0.0 0.7 0.0 1.4 0.0 0.5 2.6 3.9 7.6 4.2 0.3 0.3 1.4 0.3 3.6 0.0 0.6 9.4 2.7 1.2 1.5 0.5 1.4 2.0 1.4 1.3 2.2 3.4 2.0 0.0 1.1 1.4 12.6 18.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.4 1.1 6.7 0.0 0.2 21.5 2.6 2.4 0.0 0.0 8.9 0.0 11.7 0.0 0.8 1.8 49.8 1.6 3.3 0.0 19.1 0.6 0.7 7.0 32.5 0.0 0.0 0.0 4.3 9.4 30.1 13.9 8.5 6.9 66.1 1.7 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Cell type enhanced" "Detected in many" 7 "Spermatogonia: 61.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 5 "olfactory region: 22.0" "HPA027169, HPA074623" Approved Supported Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058, HPA074623: " "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.7 6.8 6.4 0.1 3.5 4.5 0.0 16.2 13.9 12.6 17.9 2.5 18.0 41.3 5.3 13.9 25.1 12.2 10.1 16.6 25.5 0.0 6.7 9.9 20.1 1.6 4.5 25.9 0.1 8.3 3.0 9.7 28.5 13.0 24.8 32.3 13.6 0.0 9.7 7.4 32.7 9.3 36.5 3.9 8.4 32.9 22.9 27.5 3.5 3.7 23.5 19.2 7.3 4.5 7.4 8.5 11.0 11.7 10.5 13.8 17.0 23.9 19.5 21.3 14.6 53.4 13.2 35.0 13.5 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 17.9 20.3 28.9 22.5 24.2 0.2 26.3 2.5 6.7 31.8 0.0 2.0 0.5 3.3 6.7 2.6 3.7 1.5 0.0 5.3 0.2 4.3 7.7 8.1 3.4 9.6 12.7 10.3 2.5 10.2 3.6 3.7 3.5 8.5 0.0 26.4 2.4 4.9 3.5 2.5 0.0 2.1 12.9 12.3 2.7 61.1 6.8 0.2 2.5 24.4 3.9 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.4 12.4 23.5 17.0 1.0 2.0 15.8 21.5 10.8 38.0 27.0 19.4 21.3 34.6 8.7 13.7 15.3 16.2 27.0 14.2 40.4 23.0 12.1 31.1 13.3 15.3 0.2 29.9 16.1 0.8 1.0 21.4 19.0 4.3 16.8 24.9 26.2 37.2 27.4 12.7 27.5 18.4 27.2 16.6 17.2 26.9 32.1 19.8 8.6 11.9 20.9 9.2 23.6 11.1 14.5 21.1 16.3 11.4 10.1 18.7 19.9 10.7 33.5 25.3 32.9 47.2 8.8 27.8 21.4 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 0.0 0.3 9.3 0.8 3.0 1.1 0.4 5.1 8.1 0.0 0.0 0.0 2.2 0.0 1.1 0.8 0.2 4.2 0.0 0.6 20.9 0.9 0.6 0.0 1.0 9.5 1.6 3.5 1.8 3.1 2.2 1.4 4.6 1.7 2.8 5.1 0.0 1.6 4.9 1.1 0.5 0.8 19.4 0.0 82.1 41.4 2.4 2.4 3.2 6.3 0.9 CDCP2 ENSG00000157211 "CUB domain containing protein 2" Q5VXM1 1 54132968-54153770 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.4" HPA031143 Uncertain "Secreted - unknown location" NA NA "HPA031143: AB_10611819" "unprognostic (1.08e-1)" "unprognostic (5.16e-2)" "unprognostic (1.71e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-2)" "unprognostic (4.73e-2)" "unprognostic (5.29e-2)" "unprognostic (2.86e-2)" "unprognostic (2.57e-1)" "unprognostic (1.33e-1)" "unprognostic (1.67e-2)" "unprognostic (7.67e-6)" "unprognostic (2.37e-1)" "unprognostic (1.48e-1)" "unprognostic (5.12e-1)" "unprognostic (2.21e-2)" 0.5 0.3 0.1 0.1 0.5 0.3 0.9 0.1 0.6 1.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.2 0.0 2.2 0.2 0.1 0.6 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.7 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDH1 "CD324, UVO, uvomorulin" ENSG00000039068 "Cadherin 1" P12830 16 68737225-68835548 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 125.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "myeloid DC: 2.8;plasmacytoid DC: 8.5" "Lineage enriched" "Detected in single" 18 "dendritic cells: 8.5" "Cell line enhanced" "Detected in some" "BEWO: 107.1;CACO-2: 36.0;CAPAN-2: 50.3;HaCaT: 48.6;hTCEpi: 34.3;MCF7: 29.7;OE19: 31.7;RT4: 37.0;T-47d: 32.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857" Enhanced Supported "Golgi apparatus,Plasma membrane,Cell Junctions" NA NA 22000000 "Plasma membrane, Cell Junctions" "Golgi apparatus" "CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369" "unprognostic (3.95e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-3)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (5.04e-3)" "unprognostic (1.63e-1)" "unprognostic (5.47e-2)" "unprognostic (2.85e-1)" "unprognostic (1.19e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.21e-1)" "unprognostic (2.62e-1)" "unprognostic (2.51e-1)" "unprognostic (5.92e-2)" 1.1 0.7 1.3 14.8 1.5 0.5 15.3 0.8 1.1 14.4 63.8 1.8 42.4 25.5 4.7 18.6 48.5 9.7 48.9 0.8 1.5 1.0 24.2 64.9 24.4 0.5 1.8 0.9 5.6 71.5 62.2 13.2 55.2 2.8 28.9 25.9 11.8 66.6 43.7 0.8 30.5 125.5 1.5 1.1 3.5 21.6 2.1 1.8 11.7 83.0 26.2 32.6 16.8 21.7 0.0 8.5 0.0 0.0 0.3 0.4 0.1 21.6 2.2 0.0 0.0 0.0 0.0 107.1 0.0 0.0 0.0 0.0 36.0 50.3 0.0 0.4 0.0 0.0 48.6 0.0 24.1 0.0 4.2 0.6 0.0 0.1 7.7 0.0 0.0 0.2 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.1 0.8 31.7 0.1 0.0 0.0 0.3 8.8 37.0 1.3 0.1 0.2 0.0 9.1 15.2 32.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.8 0.0 0.0 0.0 0.0 0.3 0.0 8.5 0.1 0.1 1.3 1.5 0.8 1.1 1.5 1.0 1.8 0.9 2.8 1.8 122.1 58.7 0.9 101.9 83.6 0.0 0.8 152.8 73.6 64.8 155.3 0.0 97.3 1.7 107.7 0.0 1.2 202.1 0.0 98.3 22.3 4.1 170.0 1.1 44.7 10.1 0.0 83.2 0.6 1.5 0.0 0.3 6.3 50.6 5.4 180.9 0.0 193.9 160.9 0.4 3.3 0.0 0.0 4.7 0.0 0.1 114.9 42.2 0.0 125.1 204.2 CDH10 ENSG00000040731 "Cadherin 10" Q9Y6N8 5 24487100-24644978 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 45.4" "Cell type enhanced" "Detected in single" 14 "Bipolar cells: 1.1" "Group enriched" "Detected in some" 7 "glioma: 5.3;prostate cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.8;HAP1: 5.6;hTERT-RPE1: 5.2;SuSa: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010651 Approved NA NA "HPA010651: AB_1078370" "unprognostic (4.31e-3)" "unprognostic (2.77e-1)" "unprognostic (1.88e-1)" "unprognostic (3.66e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-3)" "unprognostic (6.27e-2)" "unprognostic (1.59e-7)" "unprognostic (1.65e-2)" "unprognostic (1.41e-1)" "unprognostic (8.74e-3)" 0.9 2.1 9.4 0.8 9.6 0.8 1.0 45.4 34.0 0.9 1.1 1.5 0.0 0.9 0.9 0.8 0.9 0.9 1.2 0.9 9.4 5.2 1.0 0.8 1.1 0.8 3.6 13.4 0.8 0.9 0.8 2.1 0.8 6.0 8.6 1.3 0.0 0.8 1.4 0.8 0.8 1.1 0.9 7.0 0.8 1.0 1.4 3.7 0.0 0.8 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 15.2 0.0 0.0 0.0 1.9 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.6 45.4 21.3 9.4 5.2 3.6 13.4 6.0 3.7 0.0 0.0 0.0 0.0 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 CDH11 "CAD11, OB" ENSG00000140937 "Cadherin 11" P55287 16 64943753-65126112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 71.0" "Group enriched" "Detected in many" 5 "Fibroblasts: 97.0;Ito cells: 32.5;Leydig cells: 48.6;Muller glia cells: 51.3;Peritubular cells: 72.9;Sertoli cells: 25.8;Smooth muscle cells: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 48.0;BJ hTERT+: 27.9;fHDF/TERT166: 65.6;HSkMC: 45.2;PC-3: 56.5;U-2197: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013072 Enhanced NA NA 70000 "CAB013072: AB_2533068" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.50e-1)" "unprognostic (6.93e-2)" "unprognostic (6.00e-2)" "unprognostic (1.02e-1)" "unprognostic (6.96e-2)" "unprognostic (1.28e-1)" "unprognostic (2.09e-1)" "unprognostic (2.30e-2)" "unprognostic (3.74e-2)" "unprognostic (6.75e-2)" "prognostic unfavorable (2.48e-9)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (1.26e-1)" "unprognostic (5.07e-3)" 8.1 3.6 5.5 9.2 12.1 0.3 6.1 5.5 8.8 24.1 4.3 7.5 2.4 2.7 25.9 5.9 3.0 6.8 22.4 4.6 7.3 5.1 4.8 1.0 20.8 5.9 7.8 8.5 71.0 1.7 1.2 6.0 44.2 8.3 8.0 4.9 22.2 7.3 9.7 2.5 5.7 3.4 20.5 10.6 35.1 5.1 4.0 5.4 0.1 4.8 1.9 4.9 18.4 11.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 7.4 16.3 0.0 48.0 27.9 12.4 7.1 0.9 0.0 0.0 0.0 65.6 0.0 0.0 0.0 0.3 8.9 0.0 0.4 0.0 0.2 0.0 6.2 0.0 2.9 45.2 0.0 15.1 3.0 0.0 3.5 0.0 0.0 0.0 6.6 0.0 0.0 0.0 3.8 7.2 56.5 0.1 7.5 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 25.6 3.5 38.6 13.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 12.1 5.5 8.8 7.3 5.1 7.8 8.5 8.3 5.4 3.0 0.0 0.0 1.1 3.4 11.0 2.8 2.5 0.0 4.5 0.0 0.0 1.8 0.0 0.0 2.4 9.0 0.0 0.0 0.0 1.4 97.0 0.8 0.0 0.0 4.2 0.0 0.0 32.5 0.0 3.1 48.6 1.1 5.0 0.0 0.0 51.3 0.6 0.0 72.9 1.0 1.1 25.8 24.7 0.6 1.1 2.8 4.7 0.0 0.0 0.4 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Group enriched" "Detected in some" 12 "Bipolar cells: 17.4;Horizontal cells: 19.1;Rod photoreceptor cells: 55.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.3;SCLC-21H: 7.6;U-2 OS: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles NA NA Vesicles "HPA029325: AB_2672998" "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.0 1.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.3 0.2 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 0.0 0.0 0.0 0.0 0.1 17.4 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 55.7 0.0 0.0 2.2 1.2 0.0 0.1 0.0 0.0 0.0 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 1.3;Ito cells: 1.3;Melanocytes: 1.7;Muller glia cells: 1.5;Spermatocytes: 1.6;Spermatogonia: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RH-30: 57.9" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in all" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" NA NA 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: AB_2686328" "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 57.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.6 0.3 0.0 0.0 1.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.6 4.3 0.0 0.1 0.0 0.0 0.0 CDH16 ENSG00000166589 "Cadherin 16" O75309 16 66908122-66918984 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 139.7" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 586.2" "Cancer enriched" "Detected in many" 15 "renal cancer: 96.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 96 "RPTEC TERT1: 71.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB013526, HPA036260" Enhanced NA NA "CAB013526: , HPA036260: AB_2675027" "unprognostic (1.07e-1)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (9.81e-2)" "unprognostic (4.24e-3)" "unprognostic (5.81e-2)" "unprognostic (5.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-2)" "prognostic favorable (1.02e-7)" "unprognostic (2.19e-1)" "unprognostic (1.99e-1)" "unprognostic (7.36e-3)" "unprognostic (2.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.3 0.0 3.5 0.1 3.4 0.2 0.0 0.0 0.0 139.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 586.2 0.0 0.0 63.0 0.1 2.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 105.4 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.0 0.4 0.0 CDH17 "cadherin, HPT-1" ENSG00000079112 "Cadherin 17" Q12864 8 94127171-94217303 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 184.4" "Group enriched" "Detected in some" 51 "Enterocytes: 404.8;Intestinal endocrine cells: 104.0;Mucus-secreting cells: 149.4;Paneth cells: 316.3;Undifferentiated cells: 191.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 156.4;stomach cancer: 54.9" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "neutrophil: 12.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 12.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.9;OE19: 94.0;U-266/70: 36.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023614, HPA023616, CAB025143, HPA026556" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA 3400000 "Cell Junctions" Nucleoplasm "CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897" "unprognostic (2.08e-1)" "unprognostic (5.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (3.02e-1)" "unprognostic (3.06e-2)" "unprognostic (5.60e-2)" "unprognostic (3.38e-3)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.47e-2)" "unprognostic (3.74e-2)" "unprognostic (2.36e-1)" "unprognostic (1.29e-1)" "unprognostic (1.31e-1)" "unprognostic (7.33e-2)" "unprognostic (1.46e-2)" 0.3 0.2 0.2 17.6 0.3 0.3 0.3 0.2 0.2 0.3 88.9 0.2 0.2 54.5 0.4 0.3 0.4 0.4 7.0 0.6 0.2 0.3 0.3 0.3 0.3 0.5 0.2 0.2 0.3 0.4 0.0 0.3 0.2 0.2 0.4 44.0 0.2 0.3 0.2 0.3 0.2 184.4 1.4 0.2 0.6 0.3 0.3 0.2 0.3 0.2 0.2 0.5 0.4 0.3 1.5 0.8 12.1 1.0 1.4 0.6 0.1 0.0 4.0 0.2 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 21.9 1.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 94.0 0.1 0.2 0.0 0.7 0.1 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.3 0.1 36.3 0.0 0.1 0.1 0.1 0.2 2.5 1.0 1.2 0.5 0.8 0.3 0.6 0.5 0.4 0.8 1.5 0.5 0.6 12.1 1.4 0.5 0.7 0.5 0.1 0.2 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 404.8 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 104.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 149.4 0.0 0.0 316.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 191.5 0.0 CDH18 "CDH14, EY-CADHERIN" ENSG00000145526 "Cadherin 18" Q13634 5 19472951-20575873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 105.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 68.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 105.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 5.8;GAMG: 10.1;hTERT-RPE1: 5.3;U-2 OS: 9.1;U-2197: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014416 Uncertain "Intracellular and membrane" NA NA "HPA014416: AB_2668996" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (5.26e-7)" "unprognostic (6.36e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (8.78e-2)" "unprognostic (3.30e-2)" "unprognostic (1.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.76e-2)" 0.7 9.3 6.9 0.7 7.1 0.7 0.6 105.4 23.2 1.0 0.6 0.0 0.0 0.7 0.6 0.6 0.7 0.7 0.7 0.6 4.6 8.1 0.9 0.6 0.7 0.8 1.8 8.3 0.7 1.2 2.1 11.3 0.6 7.1 0.8 0.7 2.2 0.6 0.8 0.9 0.8 0.7 0.6 2.2 0.7 0.6 3.7 1.3 0.0 0.6 0.0 0.6 0.6 0.3 0.7 0.3 1.2 0.5 0.6 0.4 0.5 1.5 0.0 0.3 0.0 0.9 3.8 3.4 0.2 2.1 0.1 0.6 0.0 0.0 0.0 5.8 0.0 10.1 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 2.3 5.3 0.0 0.1 0.2 0.7 0.4 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.0 1.8 9.1 8.0 0.0 2.2 0.0 0.0 2.6 0.0 0.0 1.1 0.5 0.3 0.4 0.1 0.2 0.3 0.2 0.2 0.2 0.7 0.4 0.4 1.2 0.6 0.4 0.3 0.2 0.5 6.9 7.1 105.4 14.1 4.6 8.1 1.8 8.3 7.1 1.3 0.0 0.0 0.0 0.8 0.0 3.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 68.6 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.3 0.0 0.0 2.1 2.4 0.0 0.2 0.0 0.0 0.0 CDH19 CDH7 ENSG00000071991 "Cadherin 19" Q9H159 18 66501083-66604138 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.1" "Group enriched" "Detected in some" 4 "Ito cells: 20.9;Melanocytes: 42.2" "Cancer enriched" "Detected in some" 21 "melanoma: 16.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Group enriched" "Detected in some" 12 "SK-MEL-30: 20.1;WM-115: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056332 Uncertain NA NA 160000 "HPA056332: AB_2683102" "unprognostic (1.63e-2)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (3.14e-2)" "unprognostic (1.93e-1)" "unprognostic (3.79e-1)" "unprognostic (1.02e-1)" "unprognostic (4.39e-2)" "unprognostic (9.33e-2)" "unprognostic (2.25e-2)" "unprognostic (4.58e-3)" "unprognostic (8.16e-3)" "unprognostic (8.21e-2)" "unprognostic (1.56e-5)" 4.5 7.5 4.1 5.4 17.4 0.5 2.3 0.9 10.2 6.4 17.9 5.7 4.6 3.8 1.6 3.2 11.7 2.4 4.7 37.1 5.2 2.3 1.1 7.0 2.1 0.5 22.0 5.5 2.0 2.2 0.6 1.1 5.2 13.1 4.7 5.2 6.9 4.5 7.6 6.0 2.6 5.9 7.2 12.5 4.0 5.8 1.9 20.0 0.0 1.7 2.7 0.4 5.7 12.6 0.2 0.0 1.3 0.1 0.2 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.0 2.3 0.1 0.0 0.1 0.0 35.9 0.0 0.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 4.1 17.4 0.9 10.2 5.2 2.3 22.0 5.5 13.1 20.0 0.0 0.0 0.0 0.1 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.9 1.2 0.0 4.9 0.0 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.7 0.3 0.0 0.0 0.0 0.4 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27950966-28177446 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.6;parathyroid gland: 35.4" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 330.4;Cone photoreceptor cells: 141.4;Hepatocytes: 98.3;Muller glia cells: 175.2;Rod photoreceptor cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.4;neutrophil: 4.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "AF22: 56.7;BJ: 40.9;fHDF/TERT166: 84.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 160000000 "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760" "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 29.6 9.8 1.5 9.4 0.5 0.5 5.7 16.1 3.2 2.0 8.0 0.2 0.8 3.1 1.9 0.6 4.7 1.7 77.6 9.9 9.6 9.2 23.3 0.7 1.1 6.0 9.1 3.4 0.7 35.4 5.4 0.5 5.9 1.4 0.8 6.8 0.5 4.6 0.4 0.5 0.9 3.2 6.7 5.9 2.5 19.6 7.4 0.9 2.8 0.0 1.0 1.0 1.3 0.0 0.0 4.4 0.0 0.7 0.9 0.0 0.0 4.5 56.7 0.0 9.0 1.8 0.0 40.9 12.4 16.7 15.3 0.0 0.0 0.0 22.0 84.6 8.0 6.0 9.3 0.0 23.7 0.1 5.9 0.0 15.3 14.0 8.6 0.0 0.0 0.8 0.1 38.3 6.7 38.6 14.6 2.5 0.0 0.0 13.0 0.0 10.3 0.0 7.6 0.0 4.9 0.0 6.7 7.8 0.0 1.8 14.8 25.6 0.0 0.0 4.5 23.2 0.0 0.0 2.3 36.2 11.5 0.5 29.6 0.0 0.0 0.0 6.9 0.0 27.8 4.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 0.0 0.0 9.8 9.4 5.7 10.1 9.9 9.6 6.0 9.1 5.9 7.4 0.0 1.1 5.0 0.0 0.2 23.9 330.4 58.6 2.7 1.2 10.4 141.4 0.2 0.0 5.6 31.9 3.6 0.0 0.0 0.3 0.0 1.2 0.0 0.0 98.3 0.3 3.2 0.0 18.4 1.9 11.0 2.0 0.4 3.3 0.0 0.0 175.2 12.4 0.0 12.0 40.6 92.8 6.5 5.3 3.3 28.8 0.0 0.2 0.0 0.0 0.1 CDH20 "Cdh7, CDH7L3" ENSG00000101542 "Cadherin 20" Q9HBT6 18 61333582-61555773 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 8.8;brain: 32.8" "Group enriched" "Detected in some" 8 "Bipolar cells: 15.9;Muller glia cells: 13.4" "Cancer enriched" "Detected in single" 15 "glioma: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 4.5" "Lineage enriched" "Detected in single" 39 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "AF22: 3.2;ASC diff: 10.1;HHSteC: 4.7;SH-SY5Y: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015490 Uncertain NA NA "HPA015490: AB_1845900" "unprognostic (2.15e-1)" "unprognostic (1.66e-2)" "unprognostic (1.42e-2)" "unprognostic (3.68e-3)" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.87e-2)" "unprognostic (1.40e-2)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (3.82e-2)" "unprognostic (1.27e-1)" "unprognostic (3.01e-2)" "unprognostic (1.93e-1)" 8.8 1.2 13.4 1.1 13.7 1.0 1.2 6.9 32.8 1.5 1.1 16.8 0.0 1.0 1.1 2.3 2.5 1.3 1.1 1.1 16.0 7.3 1.2 1.0 1.0 1.1 20.4 9.8 1.0 1.3 1.0 1.1 1.1 12.6 1.5 1.0 0.5 1.0 1.1 3.4 2.0 1.0 1.1 12.8 1.2 1.1 1.4 18.9 0.0 1.2 0.5 1.0 1.1 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.4 0.0 0.0 3.2 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 13.4 13.7 6.9 14.0 16.0 7.3 20.4 9.8 12.6 18.9 0.0 0.0 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.0 CDH22 "C20orf25, dJ998H6.1" ENSG00000149654 "Cadherin 22" Q9UJ99 20 46173733-46308498 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 9.4;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 6.8;Late spermatids: 5.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012164, HPA012715" Uncertain Supported NA NA "HPA012164: AB_1845902, HPA012715: " "unprognostic (2.41e-4)" "unprognostic (1.72e-2)" "unprognostic (3.10e-1)" "unprognostic (4.32e-3)" "unprognostic (3.39e-2)" "unprognostic (4.73e-1)" "unprognostic (4.32e-1)" "unprognostic (2.54e-2)" "unprognostic (5.54e-2)" "unprognostic (4.50e-4)" "unprognostic (2.62e-1)" "unprognostic (3.09e-1)" "unprognostic (7.26e-3)" "unprognostic (5.93e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (9.83e-2)" 0.7 4.2 10.2 0.5 5.7 0.5 0.8 55.8 15.5 0.7 0.6 1.0 0.0 0.6 0.7 0.7 1.2 4.0 0.5 1.0 3.5 3.7 0.7 0.5 0.6 0.5 1.2 8.7 0.9 4.2 0.5 1.1 0.5 3.0 1.5 0.7 1.8 1.0 1.8 1.2 10.4 0.9 0.5 1.9 0.5 0.9 1.4 1.3 0.0 0.7 0.0 0.5 0.5 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 10.2 5.7 55.8 14.8 3.5 3.7 1.2 8.7 3.0 1.3 0.0 0.0 0.0 1.1 0.7 9.4 2.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 5.4 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 CDH23 "CDHR23, DFNB12, USH1D" ENSG00000107736 "Cadherin related 23" Q9H251 10 71396934-71815947 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 28.9" "Group enriched" "Detected in many" 4 "Early spermatids: 60.1;Late spermatids: 52.6;Muller glia cells: 81.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.4;non-classical monocyte: 19.9" "Lineage enhanced" "Detected in many" "monocytes: 19.9" "Group enriched" "Detected in some" 4 "RT4: 16.5;SCLC-21H: 6.9" HPA017232 Approved NA NA 14000 "HPA017232: AB_1845903" "unprognostic (6.76e-2)" "unprognostic (2.86e-3)" "unprognostic (3.82e-2)" "unprognostic (3.13e-3)" "unprognostic (1.07e-1)" "unprognostic (5.52e-2)" "unprognostic (7.93e-2)" "unprognostic (2.88e-1)" "unprognostic (6.44e-3)" "unprognostic (4.67e-2)" "unprognostic (2.05e-1)" "unprognostic (9.23e-3)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "prognostic favorable (3.40e-4)" 11.9 3.6 4.9 2.7 6.1 2.6 4.2 12.8 4.7 3.7 1.7 6.5 1.6 1.6 8.4 4.7 2.1 5.7 3.1 3.0 3.4 4.1 0.7 10.3 6.1 2.2 5.6 2.6 25.1 12.1 22.6 0.9 0.9 27.4 5.9 1.8 28.9 1.6 1.3 3.4 2.1 2.0 3.1 3.5 5.1 1.5 6.8 6.2 5.0 1.5 2.0 2.0 4.8 4.0 0.0 5.7 3.2 19.9 0.0 0.4 1.4 0.0 0.9 1.0 1.6 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.5 0.1 0.2 0.1 0.0 1.2 0.6 1.7 0.0 0.0 0.1 1.7 1.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.2 0.1 1.9 0.5 0.0 1.4 0.0 0.1 0.0 16.5 6.9 1.5 0.9 0.2 0.2 1.5 0.2 2.8 0.0 0.0 1.4 0.0 0.0 0.8 0.1 0.2 1.9 1.3 0.0 0.0 3.3 2.9 0.1 14.4 0.3 0.0 0.1 0.0 2.7 0.0 0.1 0.4 3.2 0.0 19.9 5.7 0.0 1.4 4.9 6.1 12.8 4.7 3.4 4.1 5.6 2.6 27.4 6.2 0.0 1.1 0.0 4.1 0.7 1.4 3.1 0.0 0.0 1.2 1.8 0.0 1.1 0.0 0.3 60.1 2.9 1.1 0.0 0.4 2.3 1.9 1.8 0.0 15.8 2.2 0.0 6.9 3.1 9.4 52.6 2.3 6.8 6.8 0.0 0.7 81.1 0.2 3.2 0.7 0.5 3.0 6.5 2.1 3.0 0.9 1.0 0.2 0.5 0.4 2.0 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958427-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.1;prostate: 15.3" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 45.5;Club cells: 18.2;Glandular cells: 12.1;Syncytiotrophoblasts: 12.5" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "RT4: 34.7" "Low region specificity" "Detected in single" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.5 0.8 0.7 1.2 1.3 0.8 2.0 1.1 3.8 0.7 0.7 0.7 0.5 1.3 0.7 3.8 2.5 0.7 0.7 1.2 1.0 0.7 0.7 2.9 0.7 1.3 0.7 2.0 0.7 0.7 1.9 0.7 1.4 15.3 0.4 1.4 2.8 0.7 1.0 0.4 0.7 0.7 1.6 0.7 1.9 0.7 0.7 4.2 0.7 0.7 16.1 6.2 1.3 0.0 0.9 1.6 1.4 0.0 0.2 0.4 0.0 0.5 0.1 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.6 0.6 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.1 0.0 0.2 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.4 0.4 0.0 0.1 0.0 0.0 0.6 0.0 34.7 0.7 0.1 0.3 0.2 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.2 2.0 1.1 1.2 1.0 1.3 0.7 1.4 0.7 6.0 6.7 0.0 0.9 0.1 0.7 0.6 0.0 45.5 18.2 0.0 0.0 1.4 0.0 0.0 2.7 2.1 0.0 0.0 0.0 0.0 0.2 12.1 1.1 0.0 0.5 0.0 0.0 0.0 1.5 1.1 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 12.5 0.0 0.0 6.7 CDH3 "CDHP, PCAD" ENSG00000062038 "Cadherin 3" P22223 16 68636189-68722616 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.0;retina: 40.5" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "pons and medulla: 16.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA001767, CAB002487" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB002487: AB_563446, HPA001767: AB_1078376" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-1)" "unprognostic (4.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (1.22e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.41e-5)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (1.33e-3)" "unprognostic (8.56e-2)" 2.2 0.1 1.0 2.5 1.2 0.0 8.7 1.5 1.1 10.5 1.0 2.2 3.0 0.3 9.4 10.3 23.5 8.9 1.4 0.4 1.1 0.8 8.3 0.2 3.6 2.1 0.6 0.4 32.6 0.4 0.5 3.6 6.4 16.0 11.7 0.5 40.5 9.3 4.4 0.1 21.2 0.4 4.1 1.5 10.0 0.7 2.2 0.1 44.0 2.0 26.1 20.1 2.5 6.7 0.9 0.6 1.4 0.5 0.6 0.8 0.2 24.9 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 14.9 9.3 0.0 0.1 0.0 0.0 69.1 0.6 33.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.6 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 1.3 0.2 2.1 0.0 0.0 0.0 29.9 11.3 0.1 0.0 0.2 0.0 11.8 12.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.2 0.4 0.2 0.3 0.6 0.5 0.4 0.1 0.9 0.6 0.8 1.4 0.6 0.2 0.6 0.2 0.2 1.0 1.2 1.5 1.1 1.1 0.8 0.6 0.4 16.0 0.1 14.9 2.9 0.0 49.5 54.0 0.8 1.2 0.0 4.0 13.6 14.0 2.0 21.3 0.0 31.6 0.2 0.5 0.0 0.0 28.5 1.2 3.3 13.1 1.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.6 1.2 57.3 1.8 1.4 0.2 60.0 0.0 8.9 0.0 0.4 0.0 1.9 0.2 0.7 26.8 5.3 0.0 0.4 48.9 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252426-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8" "Group enriched" "Detected in some" 6 "Horizontal cells: 15.9;Muller glia cells: 21.8" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "AF22: 8.1;hTERT-HME1: 10.7;U-2 OS: 14.5;U-251 MG: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA015613: AB_2732414" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 1.0 1.2 17.4 0.7 15.8 0.9 0.9 1.3 13.6 0.9 0.7 4.0 0.0 0.8 0.9 0.7 1.4 2.6 0.9 1.0 10.2 6.9 0.8 0.9 1.0 0.9 2.8 11.8 6.2 2.0 0.7 0.5 0.9 3.3 0.8 0.7 0.6 1.5 3.6 9.8 2.7 0.8 0.7 1.6 10.2 0.8 1.9 3.1 0.0 1.7 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.9 8.1 0.0 0.1 0.6 0.1 2.2 0.0 4.1 0.4 0.2 0.0 0.0 0.2 2.7 2.6 2.9 0.0 4.4 1.7 0.2 0.0 0.0 0.1 0.1 5.6 0.0 0.1 0.8 1.1 0.8 10.7 2.2 0.8 0.3 0.0 0.0 1.6 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.6 0.0 0.8 1.9 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 14.5 0.1 25.3 4.7 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 17.4 15.8 1.3 13.6 10.2 6.9 2.8 11.8 3.3 3.1 3.0 0.0 0.0 0.5 0.2 1.2 1.2 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 21.8 0.2 0.0 0.4 0.0 1.8 0.0 0.5 0.1 1.7 0.3 0.0 0.0 0.0 0.1 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 113.8;TIME: 97.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 0.0 10.4 0.0 0.0 3.7 0.0 14.6 7.6 0.0 1.2 1.8 0.0 3.3 0.0 0.1 33.0 155.1 0.0 0.0 0.0 40.7 3.1 0.1 3.5 1.5 2.1 0.0 0.0 190.9 29.5 47.7 5.8 2.3 11.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.1 13.4 0.2 2.6 67.5 0.0 0.0 0.0 CDH6 ENSG00000113361 "Cadherin 6" P55285 5 31193750-31329146 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 73.8" "Cell type enhanced" "Detected in some" 14 "Ductal cells: 30.0;Pancreatic endocrine cells: 38.4;Proximal tubular cells: 100.9;Sertoli cells: 45.3;Smooth muscle cells: 69.4" "Group enriched" "Detected in many" 5 "ovarian cancer: 15.0;renal cancer: 28.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "EFO-21: 106.5" "Low region specificity" "Detected in many" "HPA007047, HPA007403, HPA007456, CAB025274" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 1200000 "Plasma membrane, Cell Junctions" "CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373" "unprognostic (3.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" "unprognostic (1.58e-2)" "unprognostic (7.61e-3)" "unprognostic (9.04e-2)" "unprognostic (2.68e-1)" "unprognostic (2.74e-2)" "unprognostic (5.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (8.29e-3)" "unprognostic (1.22e-3)" "unprognostic (2.67e-1)" "unprognostic (6.22e-2)" "unprognostic (2.09e-2)" 6.7 1.9 3.4 2.2 7.5 0.6 3.9 1.1 8.4 7.0 2.1 2.4 1.0 2.1 4.5 8.4 3.8 10.0 13.4 3.0 3.3 4.3 73.8 1.4 6.5 1.1 5.0 4.8 3.5 1.3 2.5 2.1 5.3 5.6 2.4 1.7 20.4 1.4 2.9 1.9 1.8 2.0 4.0 6.3 1.4 1.8 0.9 5.5 0.0 3.5 3.3 1.3 4.4 3.4 0.6 0.5 1.7 0.5 0.7 0.4 0.3 0.0 0.4 13.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 106.5 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.4 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.4 1.3 0.3 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.6 0.3 0.4 1.7 0.7 0.5 0.5 0.3 0.3 3.4 7.5 1.1 6.7 3.3 4.3 5.0 4.8 5.6 5.5 0.0 0.3 0.0 0.0 0.8 7.9 1.7 25.5 0.0 3.4 10.4 0.0 0.0 23.2 30.0 0.2 1.4 0.0 0.0 2.5 0.0 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.8 0.0 0.3 38.4 0.0 0.4 100.9 0.7 45.3 69.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 CDH7 ENSG00000081138 "Cadherin 7" Q9ULB5 18 65750252-65890341 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 16.7" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 44.1" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 17.3;HEK 293: 3.2;Karpas-707: 6.3;RH-30: 8.3;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061419 Supported NA NA "HPA061419: AB_2684511" "unprognostic (2.81e-3)" "unprognostic (6.95e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (3.45e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-3)" "unprognostic (2.88e-1)" "unprognostic (4.28e-4)" "unprognostic (2.70e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-1)" 0.4 0.6 2.6 0.3 4.3 0.6 0.4 15.3 7.5 0.3 0.3 0.0 0.0 0.4 0.3 0.6 0.3 0.3 0.4 0.4 0.5 2.5 0.3 0.6 0.4 0.3 1.5 2.1 1.6 0.3 0.3 1.2 0.3 16.7 3.6 0.5 1.3 0.4 1.9 1.0 0.5 0.3 0.2 1.3 0.4 0.3 1.8 0.1 0.7 0.5 0.0 0.4 0.3 0.2 0.8 0.5 1.9 0.4 0.6 0.4 0.1 0.0 0.2 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.1 8.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.8 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 3.9 0.0 0.0 1.2 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.8 0.4 0.4 1.9 0.6 0.3 0.5 0.2 0.1 2.6 4.3 15.3 5.2 0.5 2.5 1.5 2.1 16.7 0.1 0.0 0.0 0.0 0.5 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 4.1 6.5 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.1 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 10.1;Ciliated cells: 4.0;Early spermatids: 3.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "AF22: 7.0;fHDF/TERT166: 6.1;HaCaT: 13.9;LHCN-M2: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.1 0.0 13.9 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 16.8 0.0 0.0 0.0 1.3 0.0 1.3 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 0.0 0.3 0.0 0.7 0.1 10.1 1.1 0.0 4.0 1.2 0.0 0.0 0.9 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.2 0.0 0.4 1.2 2.6 0.1 0.2 0.0 0.0 0.6 CDH9 ENSG00000113100 "Cadherin 9" Q9ULB4 5 26880600-27121150 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 46.8" "Cell type enhanced" "Detected in single" 37 "Proximal tubular cells: 3.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6" "Cell type enhanced" "Detected in some" "neutrophil: 8.3" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 8.3" "Cell line enhanced" "Detected in some" "K-562: 9.4;NTERA-2: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007167 Approved Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA007167: AB_1078489" "unprognostic (1.49e-1)" "unprognostic (2.27e-4)" 0.7 0.5 46.8 1.0 24.6 2.8 0.7 0.5 23.7 0.5 0.8 0.0 0.0 0.6 0.9 1.2 0.7 0.5 0.7 0.5 15.9 3.5 10.5 0.5 0.6 1.6 1.2 15.6 0.6 1.1 1.0 0.5 0.8 1.5 1.0 1.2 0.0 0.5 0.1 0.5 1.9 1.5 0.8 0.6 0.8 0.9 3.7 2.6 0.0 1.9 0.0 1.7 0.5 0.5 4.1 0.9 8.3 1.1 0.1 0.8 1.1 2.5 0.9 0.5 0.8 0.4 0.0 1.6 0.0 0.9 0.3 0.7 0.0 0.9 1.3 0.3 0.3 0.2 0.3 0.1 0.6 0.0 0.1 0.3 0.5 0.7 2.5 0.0 0.0 1.6 0.6 0.7 0.0 0.0 0.0 0.2 0.8 9.4 2.3 0.0 1.5 0.8 0.5 13.9 0.2 0.5 0.3 0.3 0.4 0.5 0.5 3.1 0.3 0.0 0.4 0.5 2.7 0.5 0.9 1.7 0.1 0.8 0.8 0.3 2.8 1.0 4.4 1.0 1.0 0.8 1.3 0.2 0.4 0.2 0.7 0.6 4.1 0.4 0.2 0.1 2.5 0.3 0.5 8.3 0.1 1.1 0.9 0.8 1.1 46.8 24.6 0.5 23.7 15.9 3.5 1.2 15.6 1.5 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194635-84219621 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 357.4;Rod photoreceptor cells: 231.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Region enhanced" "Detected in many" "basal ganglia: 31.2" "Cell type enriched" "Detected in single" 11 "NK-cell: 10.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 10.5" "Cell line enhanced" "Detected in some" "HAP1: 10.5;HEK 293: 5.4;HEL: 6.3;K-562: 4.5;NTERA-2: 4.6;RPTEC TERT1: 17.2" "Region enriched" "Detected in some" 21 "olfactory region: 408.8" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" NA NA "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.3 1.2 1.9 0.7 31.2 0.5 2.3 0.9 7.7 2.8 12.3 2.2 0.0 0.3 0.6 2.2 4.8 0.6 0.5 0.9 3.4 2.1 0.5 0.5 0.4 0.7 1.5 3.1 0.8 0.4 0.3 1.5 0.4 9.3 0.9 22.6 42.5 1.0 2.2 0.7 86.8 5.3 0.9 1.2 3.0 0.4 0.4 3.0 2.4 0.4 3.3 0.9 0.4 1.5 0.0 0.0 0.0 0.0 10.5 0.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 2.0 0.0 0.0 5.4 6.3 0.0 0.0 0.2 0.0 0.2 0.0 2.3 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.5 4.6 0.0 0.0 0.0 0.0 1.4 17.2 0.0 3.6 0.8 0.0 0.0 0.0 2.7 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.1 1.9 31.2 0.9 7.7 3.4 2.1 1.5 3.1 9.3 3.0 0.0 0.3 0.0 0.3 45.4 19.5 1.0 0.0 0.0 1.2 0.0 357.4 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 4.8 12.2 0.0 0.3 0.0 0.0 0.0 3.3 0.0 35.5 25.1 0.0 24.6 0.0 0.1 231.3 0.0 0.2 0.0 0.0 59.0 0.0 2.9 47.2 0.1 CDHR2 "FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC" ENSG00000074276 "Cadherin related family member 2" Q9BYE9 5 176542511-176595974 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 179.8" "Group enriched" "Detected in many" 9 "Early spermatids: 170.9;Enterocytes: 298.9;Late spermatids: 532.5;Paneth cells: 175.4" "Group enriched" "Detected in many" 14 "colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 22.2" "Region enriched" "Detected in single" 6 "hypothalamus: 2.5" "Not detected" "Not detected" "HPA012569, HPA017053" Enhanced NA NA 3600000 "HPA012569: AB_1845298, HPA017053: AB_1845297" "unprognostic (1.34e-2)" "unprognostic (8.90e-4)" "unprognostic (3.82e-2)" "unprognostic (8.51e-2)" "unprognostic (5.10e-4)" "unprognostic (4.24e-3)" "unprognostic (6.66e-2)" "unprognostic (2.06e-3)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (7.66e-3)" "unprognostic (1.75e-1)" "prognostic favorable (9.29e-4)" "unprognostic (6.58e-2)" "unprognostic (3.55e-1)" "unprognostic (2.30e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 2.5 0.3 0.0 0.1 0.1 0.3 0.1 80.0 0.1 0.1 67.2 0.1 0.8 0.1 0.2 7.1 0.1 0.1 0.4 3.0 26.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 2.9 0.5 0.1 0.1 0.1 0.1 179.8 0.1 0.1 0.1 2.8 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.3 0.0 0.1 0.1 0.0 0.3 0.3 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.2 0.6 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.3 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 12.7 0.0 0.0 1.8 0.0 0.0 0.0 2.9 170.9 0.0 298.9 0.0 0.9 0.0 0.0 0.0 0.0 5.6 0.0 0.0 32.2 0.0 0.3 532.5 1.4 0.0 0.0 0.0 34.1 1.5 9.3 175.4 2.1 11.8 0.2 0.0 0.0 4.1 1.9 0.0 0.1 0.0 6.6 0.0 CDHR3 "CDH28, FLJ23834, FLJ44366" ENSG00000128536 "Cadherin related family member 3" Q6ZTQ4 7 105876796-106033773 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 51.9;lung: 28.9;ovary: 22.3" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 341.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 15.9" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 6.9;granulocytes: 1.8" "Cell line enhanced" "Detected in some" "AF22: 7.9;Daudi: 10.1;WM-115: 6.8" "Low region specificity" "Detected in many" HPA011218 Supported Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA011218: AB_1078886" "unprognostic (4.38e-4)" "unprognostic (9.18e-2)" "unprognostic (8.16e-3)" "unprognostic (8.08e-3)" "unprognostic (5.23e-2)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (1.18e-3)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.18e-1)" "unprognostic (2.77e-2)" "unprognostic (3.70e-3)" "unprognostic (3.51e-3)" 0.4 0.6 2.2 0.6 3.3 0.5 2.5 4.4 1.4 2.4 7.6 4.9 1.1 1.1 2.4 14.9 5.9 51.9 0.2 3.3 3.1 2.1 0.7 0.6 28.9 0.4 1.1 0.3 22.3 0.3 0.1 1.4 0.1 15.9 0.3 0.9 0.1 0.3 0.6 0.5 0.4 12.0 1.7 0.6 0.2 4.6 2.2 1.2 0.1 1.4 0.4 0.7 0.3 0.1 6.9 0.2 1.8 0.2 0.3 0.7 0.1 0.1 0.4 7.9 1.4 2.8 2.7 0.2 0.7 0.6 0.3 0.2 0.0 0.1 10.1 0.0 0.5 1.1 0.1 1.9 0.0 0.3 0.9 1.2 0.0 0.2 0.7 0.0 0.2 0.4 1.0 0.3 0.5 0.0 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.1 1.8 2.8 0.6 0.0 0.0 0.4 0.1 0.1 0.6 2.9 0.0 0.8 0.5 1.4 0.0 0.0 0.4 1.4 0.5 1.5 0.0 0.0 0.0 3.3 0.2 0.3 6.8 0.1 0.1 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 6.9 0.3 0.1 1.8 0.3 0.2 0.2 0.7 0.1 2.2 3.3 4.4 1.4 3.1 2.1 1.1 0.3 15.9 1.2 3.0 7.2 0.0 1.6 2.4 4.5 1.2 2.5 341.3 55.7 0.0 0.0 0.5 5.0 0.5 5.4 1.0 2.8 0.0 0.5 0.2 1.5 0.5 3.5 1.7 0.1 0.0 28.7 0.0 0.0 2.5 2.6 0.6 8.5 0.0 3.6 9.5 0.2 2.9 1.4 4.4 1.0 6.5 1.7 1.4 3.1 1.8 0.2 0.7 2.9 0.4 CDHR4 "CDH29, VLLR9392" ENSG00000187492 "Cadherin related family member 4" A6H8M9 3 49790732-49799835 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 37.8;fallopian tube: 42.7" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 132.5" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 6.8" "Region enhanced" "Detected in some" "pons and medulla: 5.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.7;HeLa: 4.5" "Region enhanced" "Detected in many" "basal ganglia: 17.7" "Low region specificity" "Detected in single" HPA076277 Enhanced "Intracellular and membrane" NA NA "HPA076277: AB_2732306" "unprognostic (1.50e-4)" "unprognostic (4.87e-2)" "unprognostic (6.00e-2)" "unprognostic (2.00e-3)" "unprognostic (2.37e-2)" "unprognostic (2.45e-3)" "unprognostic (6.35e-7)" "unprognostic (1.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.12e-1)" "unprognostic (9.61e-2)" "unprognostic (2.35e-1)" "unprognostic (9.07e-11)" "unprognostic (2.65e-1)" "unprognostic (3.70e-2)" "unprognostic (1.13e-2)" "unprognostic (2.37e-1)" 0.2 0.1 0.4 0.1 1.6 0.3 0.1 0.0 0.0 4.9 0.2 1.9 0.0 0.1 1.3 37.8 0.1 42.7 0.1 0.1 0.7 0.9 0.1 0.1 11.4 0.1 0.0 0.0 8.0 0.0 0.0 0.8 0.6 5.7 0.1 0.1 0.0 0.1 0.2 0.1 0.9 0.1 0.3 0.2 0.0 0.1 3.9 0.0 0.0 0.0 0.5 0.2 0.2 0.1 1.1 1.5 3.0 4.1 1.3 0.4 5.8 0.5 1.8 0.5 0.3 0.5 4.7 0.3 0.4 0.1 1.0 1.0 0.0 2.7 0.0 0.2 1.1 0.6 0.5 0.1 0.0 0.3 0.3 0.3 0.8 4.5 1.0 0.0 0.3 0.5 0.7 1.5 0.8 0.3 1.2 0.0 0.3 0.2 0.7 0.0 0.0 0.0 0.8 0.3 0.6 0.2 0.8 0.2 0.0 0.0 0.3 0.1 0.1 1.6 1.1 0.0 0.1 0.2 0.1 0.0 0.6 0.2 0.7 0.1 0.7 2.4 0.1 2.2 1.3 0.0 3.0 4.1 0.4 0.4 1.6 0.3 0.4 0.3 0.3 1.5 1.1 0.3 0.4 2.5 1.3 0.2 0.5 0.2 5.8 0.4 1.6 0.0 0.0 0.7 0.9 0.0 0.0 5.7 0.0 0.0 4.3 0.0 0.1 0.1 0.0 0.4 0.0 132.5 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.4 0.5 0.0 0.0 0.0 0.0 0.1 CDHR5 "FLJ20219, MU-PCDH, MUCDHL, MUPCDH" ENSG00000099834 "Cadherin related family member 5" Q9HBB8 11 616565-626078 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 296.7" "Group enriched" "Detected in many" 6 "Enterocytes: 1223.0;Paneth cells: 645.3" "Group enriched" "Detected in many" 17 "colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7" "Region enriched" "Detected in single" 7 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009081, HPA009173, CAB025004" Enhanced "Intracellular and membrane" NA NA 170000000 "CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429" "unprognostic (7.65e-2)" "unprognostic (1.42e-1)" "unprognostic (9.85e-2)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-3)" "unprognostic (4.89e-2)" "unprognostic (3.85e-2)" "unprognostic (5.75e-2)" "unprognostic (6.36e-2)" "unprognostic (7.95e-2)" "unprognostic (5.07e-2)" "unprognostic (5.01e-2)" "unprognostic (3.90e-1)" "unprognostic (8.85e-2)" "unprognostic (2.29e-1)" "unprognostic (2.14e-2)" 0.1 0.3 0.1 8.1 0.1 0.0 0.1 0.1 0.1 0.1 118.7 0.4 0.0 34.3 0.1 0.8 0.1 0.2 12.1 0.1 0.2 0.1 10.9 43.8 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.2 0.0 1.6 0.1 21.3 5.1 0.1 0.0 0.1 0.1 296.7 0.8 0.1 0.1 1.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.4 14.9 0.0 0.1 0.1 2.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.8 10.2 0.0 0.0 1.8 0.0 0.0 11.6 0.3 2.6 0.0 1223.0 0.0 1.2 0.0 0.0 0.0 13.8 103.1 0.1 0.0 89.1 4.9 5.0 13.1 0.0 0.0 0.0 0.0 152.8 0.0 2.0 645.3 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 129.4 0.0 CDK1 "CDC2, CDC28A" ENSG00000170312 "Cyclin dependent kinase 1" P06493 10 60778331-60794852 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis" "Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 88.4" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 6.1;T-reg: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003387, CAB003799" Enhanced Supported Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "CAB003799: AB_344898, HPA003387: AB_1846356" "unprognostic (6.34e-2)" "prognostic favorable (8.81e-4)" "unprognostic (1.90e-1)" "unprognostic (6.82e-2)" "unprognostic (6.67e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (1.10e-6)" "prognostic unfavorable (7.88e-4)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.15e-6)" "unprognostic (1.80e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.27e-1)" "unprognostic (2.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" 4.1 2.2 0.8 17.8 2.4 17.8 4.4 0.7 1.6 4.2 6.5 1.1 3.4 6.1 2.9 4.8 19.0 1.5 2.4 2.3 0.9 0.7 3.1 1.7 5.7 15.1 1.7 0.6 2.2 1.0 0.5 4.4 13.3 1.2 1.5 8.3 1.0 3.8 2.9 1.0 4.9 8.3 2.7 2.5 8.3 5.0 13.8 1.2 88.4 1.8 16.7 20.1 3.2 6.9 0.9 1.7 0.0 0.2 6.1 5.7 1.8 48.9 18.6 49.6 19.6 3.2 5.0 20.4 37.0 27.0 45.2 43.6 43.6 43.3 44.9 14.4 10.1 16.6 30.5 33.7 21.5 47.1 31.9 24.6 23.5 18.4 25.3 0.6 36.0 24.3 0.9 2.1 29.2 28.5 10.3 27.1 29.6 35.9 55.3 50.2 13.0 45.3 25.9 21.8 29.6 39.3 39.4 46.2 22.0 17.2 16.3 23.3 20.4 24.9 37.8 19.2 28.1 40.8 22.1 11.1 19.3 41.2 20.3 50.6 21.7 34.8 40.5 16.6 40.4 23.9 0.0 0.0 0.0 0.5 0.2 0.5 0.9 1.5 2.7 0.5 0.5 0.5 1.5 0.0 6.1 0.2 1.7 5.7 1.8 0.8 2.4 0.7 1.6 0.9 0.7 1.7 0.6 1.2 1.2 0.0 2.7 2.2 3.6 35.3 1.0 0.5 0.0 14.7 7.9 17.4 0.0 11.0 3.3 0.7 8.8 4.5 1.7 280.4 0.0 116.8 5.1 1.0 0.0 0.8 46.3 0.0 2.9 9.8 15.3 6.3 2.0 8.8 1.7 1.8 4.0 1.0 0.3 0.0 0.7 2.1 0.5 0.0 1.4 104.2 29.6 16.3 18.4 7.0 5.6 6.0 CDK15 "ALS2CR7, PFTAIRE2, PFTK2" ENSG00000138395 "Cyclin dependent kinase 15" Q96Q40 2 201790461-201895550 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.2;ovary: 9.8" "Group enriched" "Detected in some" 13 "Early spermatids: 23.2;granulocytes: 76.3;Late spermatids: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 52 "basophil: 3.5;eosinophil: 6.9" "Lineage enriched" "Detected in single" 69 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 14.9;BJ hTERT+ SV40 Large T+ RasG12V: 12.2;HBF TERT88: 18.6;HMC-1: 35.2;LHCN-M2: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015786 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA015786: AB_1844780" "unprognostic (2.51e-1)" "unprognostic (2.73e-1)" "unprognostic (2.84e-2)" "unprognostic (1.30e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-1)" "unprognostic (4.79e-2)" "unprognostic (1.07e-1)" "unprognostic (1.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.64e-2)" "unprognostic (1.80e-2)" "unprognostic (7.38e-2)" "unprognostic (9.99e-5)" "unprognostic (6.31e-2)" "unprognostic (1.48e-2)" "unprognostic (1.05e-2)" 1.3 0.2 0.1 5.2 0.1 0.0 3.7 0.3 0.1 3.4 2.3 0.1 0.1 0.3 4.1 20.2 1.1 1.0 4.2 0.3 0.1 0.0 0.4 0.1 3.3 0.1 0.1 0.1 9.8 0.2 0.0 0.5 0.1 0.1 2.0 0.7 1.4 0.6 0.3 0.7 1.1 3.0 3.9 0.1 0.1 1.1 2.5 0.1 0.1 0.2 1.2 1.2 1.6 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 1.7 0.0 3.2 14.9 5.6 12.2 0.0 1.5 0.0 0.0 1.3 0.2 0.0 0.0 0.0 18.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 35.2 2.1 0.0 1.5 0.8 0.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.2 0.0 0.0 0.2 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 CDK16 "FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1" ENSG00000102225 "Cyclin dependent kinase 16" Q00536 X 47217860-47229997 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 91.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000974, HPA001366, CAB016535" Approved Approved "Plasma membrane,Microtubules,Cytosol" NA NA "Microtubules, Cytosol" "Plasma membrane" "CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584" "unprognostic (2.37e-3)" "unprognostic (6.93e-2)" "unprognostic (2.96e-2)" "unprognostic (1.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.02e-6)" "unprognostic (2.85e-1)" "unprognostic (5.59e-2)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (1.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.89e-3)" "unprognostic (2.55e-1)" 22.0 20.1 32.3 13.9 25.0 26.6 17.6 51.5 49.0 17.2 19.3 15.5 17.0 16.4 14.8 12.8 23.8 18.8 14.1 47.3 29.2 18.0 19.9 12.7 14.0 10.8 22.0 21.1 16.7 18.6 22.8 14.9 18.6 28.5 12.7 14.7 13.7 20.1 16.1 91.2 17.0 15.3 18.2 14.8 12.0 14.7 28.7 12.1 10.4 20.9 36.3 12.6 12.9 12.1 8.5 13.5 8.5 10.7 6.3 7.7 5.7 40.6 31.2 30.0 44.3 22.0 18.9 30.0 19.4 23.9 29.5 22.0 35.1 19.8 9.8 12.4 34.7 54.7 23.1 31.9 41.3 19.9 11.7 50.6 10.6 43.9 27.3 28.6 11.1 24.9 23.6 26.4 41.8 50.5 24.7 26.4 10.3 15.7 16.7 25.8 35.4 9.7 25.6 23.5 15.4 33.8 10.3 23.7 17.1 22.2 32.3 25.4 19.2 52.6 40.7 20.0 36.5 36.3 13.7 26.5 19.8 32.4 30.1 23.1 13.2 12.8 9.5 17.4 52.0 22.1 3.1 8.8 8.5 4.8 10.7 6.2 3.8 6.2 7.7 11.6 8.5 5.6 5.8 4.2 6.3 9.6 13.5 6.0 5.7 32.3 25.0 51.5 49.0 29.2 18.0 22.0 21.1 28.5 12.1 0.0 6.7 15.3 27.9 28.8 24.3 37.2 15.3 4.0 4.5 29.6 3.9 23.1 46.4 30.2 25.1 15.7 50.5 0.0 32.2 31.3 23.1 37.6 5.7 14.8 21.7 28.6 26.9 20.3 19.6 46.6 15.8 10.3 32.1 12.6 30.7 16.0 41.5 33.6 12.4 28.2 12.9 0.0 19.8 18.1 16.8 30.4 21.7 10.2 41.6 53.3 CDK18 "PCTAIRE3, PCTK3" ENSG00000117266 "Cyclin dependent kinase 18" Q07002 1 205504595-205532793 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 98.7;heart muscle: 58.9" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 69.8;Paneth cells: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 20.1;HeLa: 17.7;hTERT-RPE1: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045429 Approved Approved "Actin filaments" No No "Actin filaments" "HPA045429: AB_10961257" "unprognostic (7.95e-2)" "unprognostic (3.42e-1)" "unprognostic (1.51e-1)" "unprognostic (1.33e-1)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (7.06e-3)" "unprognostic (2.93e-1)" "unprognostic (2.95e-1)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (5.07e-6)" "unprognostic (6.07e-2)" "unprognostic (1.45e-1)" "unprognostic (6.12e-2)" "prognostic favorable (2.81e-5)" 2.6 4.3 13.6 2.7 31.8 1.0 2.4 4.2 25.0 7.6 6.9 38.1 20.2 17.3 3.4 4.0 2.7 5.7 6.4 58.9 22.1 16.2 13.7 4.7 6.5 1.9 47.8 16.7 7.5 10.7 3.7 4.0 9.6 22.1 3.1 6.1 5.3 16.5 23.5 3.9 1.6 15.1 4.8 98.7 3.5 9.1 0.9 36.4 0.4 4.8 1.4 2.5 3.7 4.7 0.1 1.4 0.0 2.1 0.6 0.9 0.6 11.7 0.8 0.1 0.6 0.0 0.0 12.7 0.2 2.4 0.5 3.1 5.3 8.8 7.0 1.8 0.1 1.0 10.6 2.6 20.1 0.5 1.9 2.3 1.6 17.7 5.4 2.3 0.0 0.0 1.3 1.0 0.0 0.4 17.2 0.0 10.0 0.1 8.5 0.1 9.5 0.6 0.3 10.0 3.4 0.4 0.9 0.0 8.8 1.9 7.5 4.1 1.6 3.6 1.7 7.8 14.7 7.9 3.4 0.0 0.0 4.8 0.0 0.0 2.4 1.1 1.4 0.1 5.0 2.0 0.0 0.8 0.0 0.1 2.1 0.9 0.0 0.2 0.0 1.4 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.6 13.6 31.8 4.2 19.7 22.1 16.2 47.8 16.7 22.1 36.4 0.0 0.3 0.0 6.7 3.1 4.7 25.0 7.6 0.0 1.2 69.8 0.0 4.9 6.6 15.9 1.6 1.9 20.6 0.0 5.8 1.9 4.8 1.9 0.0 3.9 5.1 0.0 5.8 1.3 1.6 2.8 0.9 3.6 3.3 7.2 12.9 19.1 6.3 98.2 1.4 15.4 1.2 6.5 12.5 1.4 10.0 1.1 1.6 0.5 11.5 5.9 CDK19 "bA346C16.3, CDC2L6, CDK11, KIAA1028" ENSG00000155111 "Cyclin dependent kinase 19" Q9BWU1 6 110609978-110815958 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 84.5;Late spermatids: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 8.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007053 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA007053: AB_1233803" "unprognostic (1.66e-2)" "unprognostic (1.84e-1)" "unprognostic (3.63e-1)" "unprognostic (3.00e-3)" "unprognostic (1.62e-1)" "unprognostic (2.66e-3)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" "unprognostic (2.00e-3)" "unprognostic (3.94e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (4.72e-5)" "unprognostic (1.75e-1)" "unprognostic (9.78e-2)" "unprognostic (6.51e-2)" "unprognostic (9.50e-3)" 5.3 3.3 18.1 6.1 29.4 9.7 6.0 13.8 21.3 6.6 6.3 31.1 2.4 4.8 9.6 3.7 7.8 5.3 7.8 4.1 20.8 10.1 6.3 4.6 6.2 8.0 22.1 12.9 9.7 3.1 8.0 4.1 10.5 14.4 25.8 6.1 3.4 4.5 5.9 3.2 7.9 5.9 7.1 20.8 7.0 6.5 16.4 26.3 6.1 5.8 1.3 8.4 5.9 6.4 1.3 1.8 8.5 2.2 1.3 0.8 0.6 3.6 3.9 13.7 16.5 7.4 10.7 7.1 11.9 12.7 4.5 5.9 4.9 4.1 9.3 4.3 8.3 9.0 2.1 5.2 2.5 10.3 11.5 3.0 15.8 5.8 5.7 4.5 6.4 11.9 7.3 5.6 6.1 9.5 11.3 4.4 7.9 4.8 13.0 9.6 5.9 8.6 9.6 1.3 5.2 2.7 9.2 7.0 3.5 5.2 6.7 7.0 13.0 9.0 7.4 10.6 4.8 2.5 23.6 4.9 9.4 5.0 18.9 7.2 1.4 1.9 8.0 9.9 8.7 9.7 3.3 2.2 1.5 0.8 1.2 0.8 1.1 0.7 0.7 1.8 1.3 0.5 0.7 8.5 1.3 0.7 0.9 0.8 0.6 18.1 29.4 13.8 21.3 20.8 10.1 22.1 12.9 14.4 26.3 3.0 16.2 8.1 13.2 8.8 17.3 6.2 12.7 4.0 7.9 15.7 15.7 5.4 1.7 7.5 84.5 11.7 13.8 0.0 4.1 17.1 10.8 49.2 6.9 10.5 14.4 22.3 12.1 14.7 33.3 95.4 10.0 18.4 25.3 3.6 14.2 34.3 6.0 17.5 15.2 5.6 14.1 6.5 8.5 38.1 14.1 14.2 6.6 12.8 12.9 7.4 CDK5 PSSALRE ENSG00000164885 "Cyclin dependent kinase 5" Q00535 7 151053812-151058530 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Lissencephaly, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008909, HPA064535" Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Nucleoplasm, Plasma membrane" "Cell Junctions" "CAB008909: , HPA064535: AB_2685280" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (4.22e-2)" "unprognostic (1.43e-1)" "unprognostic (1.10e-1)" "unprognostic (3.48e-1)" "unprognostic (5.67e-3)" "unprognostic (1.05e-2)" "unprognostic (1.22e-1)" "unprognostic (5.78e-3)" "unprognostic (6.25e-3)" "unprognostic (3.35e-1)" "unprognostic (4.47e-2)" "unprognostic (1.46e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" 4.5 11.3 24.4 6.9 30.4 6.1 5.3 13.6 36.1 5.3 6.1 6.7 4.5 7.9 4.5 17.4 6.5 5.0 6.2 5.8 25.0 19.7 9.0 7.7 5.3 6.0 15.4 15.4 3.2 5.8 8.9 7.9 5.3 20.8 5.8 6.3 3.2 6.0 6.3 5.7 6.5 6.2 6.0 8.6 5.2 5.7 3.1 7.7 6.8 6.0 3.6 6.9 6.7 3.1 6.6 21.5 9.0 21.7 9.5 14.9 10.6 11.7 14.1 13.2 21.5 14.6 10.7 6.6 7.8 12.8 15.3 12.6 10.0 11.0 11.6 27.9 9.6 22.8 8.4 21.2 11.8 7.0 9.1 12.6 12.7 12.4 9.9 9.6 10.2 23.9 11.6 8.9 12.6 3.9 21.4 10.3 18.2 12.9 8.5 15.3 22.7 27.6 21.0 14.5 18.9 22.3 13.5 5.4 12.9 13.3 8.9 8.4 35.9 11.2 13.8 14.7 12.6 6.4 9.0 8.7 15.1 3.9 11.3 14.5 19.7 21.5 4.5 23.7 14.8 27.0 7.8 19.0 9.0 6.9 21.7 5.4 6.6 6.8 6.8 21.5 5.9 5.1 6.2 2.8 9.5 16.4 12.8 14.9 10.6 24.4 30.4 13.6 36.1 25.0 19.7 15.4 15.4 20.8 7.7 0.0 5.9 11.5 6.4 3.2 11.5 3.2 7.6 8.1 7.9 10.4 2.0 20.0 33.2 19.0 0.6 6.3 7.1 0.0 16.6 10.2 6.6 5.0 31.0 9.6 37.8 0.0 8.6 6.2 21.6 0.9 4.4 14.3 10.1 20.8 9.1 11.5 18.7 14.4 10.6 24.0 4.7 6.5 5.0 2.6 9.7 5.5 7.6 8.5 9.6 7.6 CDK5R1 "Nck5a, p35, p35nck5a" ENSG00000176749 "Cyclin dependent kinase 5 regulatory subunit 1" Q15078 17 32486619-32491256 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 58.8" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 43.2;Early spermatids: 15.1;Late spermatids: 13.7;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 32.2;SK-MEL-30: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000252 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000252: AB_2665953" "unprognostic (1.08e-1)" "unprognostic (9.13e-2)" "unprognostic (1.79e-2)" "unprognostic (3.65e-1)" "unprognostic (1.97e-1)" "unprognostic (8.09e-2)" "unprognostic (2.74e-5)" "unprognostic (1.81e-2)" "unprognostic (3.32e-1)" "unprognostic (2.18e-1)" "unprognostic (5.90e-2)" "unprognostic (5.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.60e-1)" "unprognostic (7.92e-2)" "unprognostic (8.81e-2)" "unprognostic (1.03e-1)" 1.6 3.3 21.9 6.4 21.1 4.9 1.8 26.0 58.8 1.2 1.6 3.6 0.0 2.0 1.6 1.0 5.5 1.5 1.6 1.6 21.4 17.3 1.5 1.3 1.4 11.5 7.6 24.5 3.2 2.0 1.3 3.0 1.4 7.8 1.4 1.5 0.9 1.2 1.3 1.8 2.2 2.0 1.3 4.1 7.7 2.2 5.2 3.2 1.2 1.1 0.3 12.3 1.7 1.1 0.6 1.8 2.9 0.9 0.7 4.2 1.5 2.0 1.2 5.3 1.7 0.6 1.0 0.6 1.2 0.7 1.5 2.0 3.1 0.5 1.0 1.2 1.1 1.3 1.0 2.0 1.3 2.1 0.4 4.0 0.3 0.5 1.2 0.2 0.6 1.1 0.6 3.2 1.6 1.3 0.6 1.1 3.7 2.0 1.2 3.3 0.8 1.8 0.8 3.4 0.7 1.1 1.5 3.2 3.7 0.7 0.9 32.2 8.7 1.2 0.7 23.1 0.8 1.3 2.4 1.1 2.2 3.3 0.8 3.3 0.6 0.8 1.0 1.9 3.0 5.2 0.0 0.9 1.2 2.3 0.8 1.8 0.6 3.1 1.3 0.2 0.5 4.2 2.6 2.9 0.7 0.4 1.8 0.4 1.5 21.9 21.1 26.0 37.3 21.4 17.3 7.6 24.5 7.8 3.2 0.0 1.0 1.4 0.4 1.3 10.4 2.8 0.0 0.0 0.0 0.0 43.2 0.5 0.0 0.1 15.1 0.6 0.2 0.0 0.5 0.3 0.4 0.9 0.0 0.8 0.8 1.6 0.0 1.3 3.8 13.7 0.0 0.4 3.3 0.0 0.8 17.0 1.1 0.2 0.7 1.2 5.6 0.0 1.4 3.2 5.7 1.1 0.9 4.4 0.9 0.3 CDK5R2 "NCK5AI, P39, p39nck5ai" ENSG00000171450 "Cyclin dependent kinase 5 regulatory subunit 2" Q13319 2 218959655-218962162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 48.6;pituitary gland: 14.3" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 64.6;Cone photoreceptor cells: 19.6;Horizontal cells: 14.3;Intestinal endocrine cells: 21.9;Rod photoreceptor cells: 45.1" "Cancer enhanced" "Detected in some" "glioma: 3.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 18.6;SH-SY5Y: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.96e-1)" "unprognostic (6.53e-2)" "unprognostic (3.85e-5)" "unprognostic (1.73e-6)" "unprognostic (3.67e-2)" "unprognostic (2.83e-4)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (1.78e-1)" "unprognostic (6.71e-3)" "unprognostic (3.53e-3)" "unprognostic (2.34e-10)" "unprognostic (1.54e-1)" "unprognostic (1.64e-4)" "unprognostic (6.46e-2)" 1.2 7.0 13.2 1.6 26.0 1.2 1.2 8.3 48.6 1.2 1.5 2.2 0.0 1.7 1.2 1.2 1.2 1.2 1.2 1.2 16.5 14.4 1.2 1.2 1.2 1.2 10.0 11.9 1.2 2.6 1.2 14.3 1.2 13.8 1.2 1.4 4.4 1.2 1.2 1.2 1.2 1.8 1.3 1.6 1.2 2.7 1.6 2.0 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 0.0 2.2 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 18.6 13.5 0.7 0.0 0.1 0.5 0.0 0.0 0.0 0.2 1.4 0.0 0.3 0.0 0.0 0.0 0.6 0.1 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 26.0 8.3 42.2 16.5 14.4 10.0 11.9 13.8 2.0 0.0 0.0 0.0 0.0 0.0 64.6 0.4 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 14.3 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.0 0.0 45.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 CDK6 PLSTIRE ENSG00000105810 "Cyclin dependent kinase 6" Q00534 7 92604921-92836594 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 219.8;Late spermatids: 186.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 93.5;REH: 45.7" "Low region specificity" "Detected in all" "HPA002637, CAB004363" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB004363: AB_627242, HPA002637: AB_1846432" "unprognostic (1.29e-1)" "unprognostic (5.98e-3)" "unprognostic (9.07e-2)" "unprognostic (2.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.24e-2)" "unprognostic (3.39e-1)" "unprognostic (2.42e-3)" "unprognostic (7.19e-2)" "unprognostic (7.78e-3)" "prognostic unfavorable (3.86e-6)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.09e-1)" "unprognostic (7.88e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (2.33e-5)" 6.6 11.3 6.0 9.1 7.5 22.5 5.9 2.4 6.0 7.8 10.0 9.6 5.7 7.5 6.0 5.9 8.5 4.6 7.8 6.6 6.9 4.2 6.5 7.5 7.3 7.4 7.0 5.2 5.0 10.0 25.7 4.2 20.5 7.5 6.1 9.2 4.4 10.9 6.1 2.0 11.6 9.4 9.8 7.5 6.3 10.8 5.4 8.0 74.6 4.3 9.2 10.3 6.7 9.0 3.6 5.6 6.5 4.8 3.9 7.1 2.3 6.2 2.9 8.0 5.1 2.3 2.6 1.7 6.4 4.0 3.2 3.0 7.8 4.8 4.8 3.7 4.3 2.0 3.8 4.4 9.2 7.6 10.5 3.1 12.0 5.5 7.5 1.4 7.4 0.6 2.6 5.0 4.3 20.4 3.0 1.2 19.6 11.5 13.3 5.7 1.2 93.5 0.8 2.5 7.9 2.6 45.7 28.1 8.1 4.4 0.1 4.2 27.3 0.7 2.2 3.7 6.1 0.1 12.3 4.7 10.5 16.5 4.1 12.9 7.1 0.1 6.4 1.5 25.5 13.9 4.9 1.9 6.5 5.2 3.9 5.9 2.0 5.5 5.6 4.0 3.6 7.1 4.0 1.1 3.9 4.8 5.6 2.8 2.3 6.0 7.5 2.4 6.0 6.9 4.2 7.0 5.2 7.5 8.0 23.8 3.0 11.9 19.5 53.5 0.2 14.8 25.5 4.0 27.3 21.0 0.0 42.7 8.3 31.7 219.8 24.1 11.0 0.0 20.1 3.4 21.6 18.1 24.3 18.4 15.0 0.0 16.1 7.4 23.4 186.0 4.6 21.9 18.6 20.8 46.7 0.5 63.1 14.0 3.2 5.1 0.0 6.5 22.1 2.6 46.4 44.2 14.8 20.3 68.3 23.3 CDKL2 "KKIAMRE, P56" ENSG00000138769 "Cyclin dependent kinase like 2" Q92772 4 75578005-75630716 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 55.4;Ciliated cells: 28.1;Spermatocytes: 46.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Cell line enhanced" "Detected in some" "A-431: 5.7;HEK 293: 3.8;HHSteC: 4.4;RPTEC TERT1: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040672 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA040672: AB_10794744" "unprognostic (2.07e-1)" "unprognostic (9.96e-2)" "unprognostic (6.91e-2)" "unprognostic (3.80e-5)" "unprognostic (3.43e-2)" "unprognostic (2.71e-2)" "unprognostic (1.59e-1)" "unprognostic (8.14e-3)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (5.85e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.88e-15)" "unprognostic (5.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-1)" "unprognostic (7.52e-2)" 0.7 2.4 7.1 1.2 11.1 0.7 1.2 7.7 13.2 1.7 2.0 6.2 0.0 1.0 1.7 2.3 2.3 4.1 1.4 1.3 5.1 6.7 11.8 0.7 9.2 1.3 7.1 7.0 3.8 1.6 5.7 8.9 0.7 12.5 2.0 2.4 3.4 1.2 2.0 0.7 0.9 0.9 1.5 7.4 0.9 1.5 27.7 6.1 0.0 6.9 0.0 2.0 1.1 0.9 0.4 0.0 0.2 0.0 0.0 1.6 0.1 5.7 0.7 0.3 0.0 0.3 0.3 0.0 0.3 1.8 2.4 2.0 0.5 1.2 0.1 0.9 0.1 2.3 0.8 0.0 0.5 2.3 0.2 3.8 0.0 0.2 0.0 4.4 0.0 0.1 1.5 2.1 0.4 0.8 1.9 0.1 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 8.2 0.3 3.1 2.5 0.0 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.4 1.6 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 1.2 0.1 7.1 11.1 7.7 13.2 5.1 6.7 7.1 7.0 12.5 6.1 23.8 55.4 0.0 0.4 0.1 16.6 0.8 0.0 28.1 7.9 8.7 3.9 0.0 6.6 2.0 24.5 0.0 0.0 0.0 0.2 0.5 0.2 0.3 1.1 0.0 0.1 9.5 1.7 0.6 0.0 16.4 1.7 0.5 1.7 0.0 0.2 10.4 0.1 0.0 1.1 20.7 19.5 0.0 0.0 46.8 1.7 0.3 0.2 1.0 2.6 0.1 CDKL3 NKIAMRE ENSG00000006837 "Cyclin dependent kinase like 3" Q8IVW4 5 134286350-134371047 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Group enriched" "Detected in many" 8 "Early spermatids: 261.7;Late spermatids: 219.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA027751 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA027751: AB_10601256" "unprognostic (4.70e-2)" "unprognostic (2.15e-2)" "unprognostic (2.35e-1)" "unprognostic (1.48e-1)" "unprognostic (1.43e-1)" "unprognostic (3.98e-2)" "unprognostic (3.43e-3)" "unprognostic (5.93e-2)" "unprognostic (2.12e-3)" "unprognostic (1.49e-1)" "unprognostic (8.47e-4)" "unprognostic (2.82e-1)" "unprognostic (9.85e-4)" "unprognostic (8.33e-2)" "unprognostic (4.88e-2)" "unprognostic (7.10e-3)" "unprognostic (3.43e-3)" 2.5 2.7 7.0 2.2 7.1 1.6 2.5 7.0 8.5 2.6 2.4 5.9 5.5 2.3 3.9 5.3 2.6 3.7 2.6 6.6 6.1 6.5 4.5 2.8 2.2 2.5 8.0 4.3 3.0 2.4 3.2 6.5 2.2 8.6 2.8 2.6 3.9 2.0 3.2 7.5 2.7 2.5 4.6 8.4 2.7 2.2 33.4 9.3 1.3 3.9 2.1 3.0 2.8 2.2 1.5 2.7 1.0 1.1 1.4 4.0 1.3 1.0 2.1 3.1 2.2 5.4 4.6 1.3 2.9 2.6 1.3 3.2 1.9 1.5 2.7 1.8 1.8 6.0 0.9 2.6 1.8 2.6 2.9 2.0 1.4 2.3 3.3 3.3 0.6 0.9 2.2 4.7 3.9 1.2 2.2 1.3 6.5 1.5 1.2 3.5 1.1 2.1 8.0 2.1 0.6 1.0 3.4 1.3 0.8 1.7 0.9 4.8 1.4 2.1 0.5 3.5 3.7 1.8 1.6 0.9 2.6 0.6 3.5 1.0 3.3 4.4 5.2 4.0 2.1 2.0 0.0 0.9 1.0 0.9 1.1 4.0 1.5 1.4 2.5 2.7 1.0 3.8 3.8 0.2 1.4 0.4 1.6 2.3 1.3 7.0 7.1 7.0 8.5 6.1 6.5 8.0 4.3 8.6 9.3 0.0 3.0 0.0 5.7 9.6 12.7 1.6 0.0 5.3 3.4 5.2 3.9 2.4 8.3 2.6 261.7 3.6 0.5 0.0 4.4 1.6 6.9 4.0 3.5 1.8 3.1 6.4 2.9 3.1 0.6 219.5 4.6 4.0 10.1 2.8 0.7 10.0 1.5 0.9 8.5 6.1 9.6 0.0 5.6 30.5 13.2 9.7 3.8 3.2 1.1 3.3 CDKL4 ENSG00000205111 "Cyclin dependent kinase like 4" Q5MAI5 2 39175646-39229588 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.2;testis: 7.9" "Group enriched" "Detected in some" 14 "Alveolar cells type 1: 3.0;Ciliated cells: 8.1;Club cells: 3.4;Early spermatids: 8.3;Late spermatids: 4.5;Spermatocytes: 6.5;Spermatogonia: 3.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "memory B-cell: 1.6;T-reg: 3.2" "Group enriched" "Detected in many" 25 "B-cells: 1.6;T-cells: 3.2" "Cell line enhanced" "Detected in some" "HAP1: 1.9;HL-60: 5.0;RT4: 3.4;SH-SY5Y: 6.8" "Low region specificity" "Detected in many" HPA067895 Uncertain NA NA "HPA067895: AB_2685920" "unprognostic (3.57e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (3.29e-1)" "unprognostic (7.46e-3)" "unprognostic (3.26e-2)" "unprognostic (4.26e-1)" "unprognostic (3.82e-2)" "unprognostic (6.13e-3)" "unprognostic (1.77e-2)" "unprognostic (8.43e-2)" "unprognostic (8.45e-4)" "unprognostic (8.59e-2)" "unprognostic (4.95e-1)" "unprognostic (3.08e-1)" "unprognostic (3.26e-2)" 0.3 1.1 0.3 0.0 0.6 0.0 0.3 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.1 0.1 0.5 0.9 0.2 0.0 0.4 0.1 0.2 0.3 0.3 0.0 1.6 1.2 0.4 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.3 7.9 0.3 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.5 0.4 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.1 0.3 0.7 0.3 5.0 1.1 0.3 0.0 0.1 0.0 0.2 0.1 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.0 0.0 0.2 3.4 0.6 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 3.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 8.1 3.4 0.0 0.0 0.2 0.0 0.2 8.3 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.3 0.0 0.0 6.5 3.8 0.0 0.0 0.0 0.0 0.0 CDKL5 "CFAP247, EIEE2, STK9" ENSG00000008086 "Cyclin dependent kinase like 5" O76039 X 18425583-18653629 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 76.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 7.7" "Cell line enhanced" "Detected in many" "A549: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002847, CAB011577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB011577: AB_727019, HPA002847: AB_1080107" "unprognostic (7.01e-2)" "unprognostic (4.86e-2)" "unprognostic (1.41e-1)" "unprognostic (1.25e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" "unprognostic (9.63e-3)" "unprognostic (2.05e-3)" "unprognostic (1.66e-1)" "prognostic favorable (5.54e-4)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.99e-1)" 3.3 3.2 8.0 1.8 24.7 3.2 4.3 3.9 28.0 5.4 2.7 7.7 1.8 1.5 4.5 2.8 5.2 2.8 3.1 5.0 8.0 3.7 6.3 2.2 6.9 1.4 3.5 13.2 6.7 4.5 6.2 5.0 5.4 5.9 6.7 2.2 2.0 3.9 4.4 3.0 3.5 1.9 4.0 5.7 2.3 4.9 14.0 5.7 1.6 5.1 0.8 2.1 5.6 4.6 0.7 1.0 7.7 1.0 0.5 0.6 0.2 1.7 12.3 3.5 3.1 3.3 4.5 2.5 2.0 3.8 2.8 3.2 4.0 2.3 1.9 0.4 1.3 5.5 0.5 4.0 3.0 5.9 0.5 2.6 0.0 7.1 3.2 1.6 0.1 0.8 2.6 3.1 6.8 7.1 1.7 1.3 2.2 0.1 2.0 4.2 1.7 0.8 0.8 7.2 1.6 3.0 0.7 3.8 0.1 2.5 9.0 0.7 4.5 4.5 1.1 2.2 7.4 1.7 0.7 7.3 4.3 1.9 7.9 1.5 0.3 0.1 0.3 2.4 0.5 4.2 7.7 1.0 2.1 0.6 0.6 0.3 0.2 0.4 0.3 0.3 0.7 0.6 0.6 4.7 0.5 0.6 1.0 0.2 0.2 8.0 24.7 3.9 28.0 8.0 3.7 3.5 13.2 5.9 5.7 23.8 19.0 0.0 8.3 0.8 16.1 12.0 5.1 6.7 9.1 7.0 31.4 20.0 6.6 5.7 27.2 4.5 0.0 0.0 8.1 2.5 3.1 18.1 1.1 3.0 3.7 76.3 2.4 4.9 5.3 41.5 5.5 1.8 0.0 2.8 1.9 27.7 6.6 0.0 4.9 7.5 19.5 32.3 4.2 2.3 9.8 1.1 39.6 0.8 1.5 24.3 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885773 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.3;placenta: 105.6" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 482.4;Extravillous trophoblasts: 1267.0;Syncytiotrophoblasts: 1874.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 26.1;non-classical monocyte: 60.3" "Lineage enriched" "Detected in many" 12 "monocytes: 60.3" "Cell line enhanced" "Detected in many" "EFO-21: 8.4;HeLa: 8.7;RPMI-8226: 11.4;SH-SY5Y: 23.3;SiHa: 16.3;SK-MEL-30: 8.9" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 53.6 20.7 3.3 5.4 11.9 3.4 13.0 0.9 9.2 10.6 6.9 18.4 3.9 3.3 8.3 5.2 9.9 8.5 7.7 6.9 8.5 5.4 22.7 3.0 5.1 1.8 28.7 4.9 30.9 7.9 1.5 4.0 105.6 11.5 7.2 1.9 8.3 3.1 5.9 27.6 3.0 7.9 6.3 27.9 7.1 7.4 4.3 14.5 0.3 2.0 7.6 2.1 11.2 9.8 0.0 5.0 1.4 60.3 0.0 0.3 2.5 0.1 0.0 1.1 0.0 0.3 0.3 1.2 0.2 0.4 0.2 0.0 2.2 0.2 0.0 8.4 0.1 0.1 0.3 0.2 0.2 0.1 3.8 0.8 0.1 8.7 0.0 2.3 0.0 1.0 1.7 1.1 0.0 0.1 0.1 0.2 0.0 1.8 0.6 0.3 0.0 0.0 4.0 7.5 0.3 2.7 1.5 0.0 11.4 0.5 0.0 2.5 23.3 16.3 0.2 8.9 0.6 0.1 1.9 0.3 0.0 1.6 0.0 0.0 4.9 0.0 0.0 0.0 1.3 4.6 1.4 0.2 0.2 0.1 26.1 0.3 0.0 0.1 0.1 5.0 0.0 0.2 0.0 0.3 0.0 60.3 0.0 0.1 2.5 3.3 11.9 0.9 5.6 8.5 5.4 28.7 4.9 11.5 14.5 3.0 7.2 0.8 96.5 9.5 7.1 23.0 22.9 5.3 10.3 29.6 5.9 482.4 13.3 9.2 178.7 49.1 4.0 0.0 0.5 1267.0 69.5 86.8 0.0 3.0 79.4 7.9 102.1 54.6 16.1 196.4 68.7 19.6 33.7 1.0 14.2 61.0 3.5 2.5 41.8 39.1 25.4 32.3 35.6 1.4 2.7 10.3 1874.3 3.9 5.2 72.7 CDKN2A "ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf" ENSG00000147889 "Cyclin dependent kinase inhibitor 2A" "P42771, Q8N726" 9 21967753-21995301 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.6;pituitary gland: 39.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 178.1;Late spermatids: 275.2;Pancreatic endocrine cells: 259.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 22.6" "Group enriched" "Detected in many" 8 "B-cells: 7.2;T-cells: 22.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 50.2;HEK 293: 56.9;HeLa: 53.2;SK-MEL-30: 53.1" "Low region specificity" "Detected in some" "CAB000093, CAB000445, CAB018232, HPA047838" Enhanced Supported Nucleoli NA NA Nucleoli "CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174" "unprognostic (3.41e-2)" "unprognostic (4.51e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (1.82e-7)" "unprognostic (5.22e-2)" "prognostic favorable (5.19e-4)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.76e-7)" "unprognostic (9.41e-2)" "unprognostic (1.22e-2)" "unprognostic (3.05e-2)" "unprognostic (3.55e-1)" 5.4 8.6 2.9 4.5 3.9 1.8 5.3 1.7 3.1 1.2 2.5 4.4 0.1 1.2 1.2 1.9 6.3 3.0 2.6 0.7 1.7 1.0 0.9 1.2 3.0 3.0 3.6 1.6 1.5 1.5 8.5 39.3 6.7 5.0 1.9 1.1 1.2 2.4 2.9 0.9 1.3 3.7 1.0 3.0 8.9 6.0 13.0 1.9 3.9 1.4 3.0 14.0 2.7 1.5 7.2 0.2 0.8 1.8 0.4 22.6 2.2 2.1 0.0 0.3 14.1 0.1 0.1 6.1 2.3 0.0 19.7 35.1 3.5 50.2 7.2 32.3 1.6 0.0 6.0 5.9 36.5 15.9 31.0 56.9 0.0 53.2 2.3 1.5 3.6 3.0 3.8 0.0 19.8 11.0 42.3 2.0 0.0 0.0 33.0 18.0 0.1 0.3 0.0 0.4 4.0 29.3 0.0 13.4 26.5 4.0 0.0 33.1 2.3 38.2 6.3 53.1 1.7 7.5 0.1 6.6 0.1 0.4 0.0 0.1 14.7 8.3 29.5 0.0 9.5 0.1 0.8 1.3 0.2 6.2 0.6 9.7 7.2 8.0 11.0 0.2 7.0 0.5 4.7 0.4 0.4 1.8 0.0 22.6 2.2 2.9 3.9 1.7 3.1 1.7 1.0 3.6 1.6 5.0 1.9 0.0 0.0 1.5 0.7 1.5 0.2 4.0 0.0 14.7 1.2 10.4 0.0 20.9 0.0 32.4 178.1 2.2 6.9 0.0 22.9 52.3 3.6 10.0 4.6 0.0 6.6 0.0 68.2 0.6 8.2 275.2 2.8 1.8 8.5 26.2 6.2 0.8 259.8 10.5 1.8 0.0 0.0 0.0 1.0 5.7 4.1 0.4 7.7 12.5 2.3 34.0 CDKN2B "CDK4I, INK4B, MTS2, P15, p15INK4b, TP15" ENSG00000147883 "Cyclin dependent kinase inhibitor 2B" P42772 9 22002903-22009363 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 140.1;Pancreatic endocrine cells: 107.4;Urothelial cells: 219.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9" "Lineage enriched" "Detected in single" 16 "monocytes: 10.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7;HaCaT: 16.2;HeLa: 15.3;hTERT-RPE1: 28.4;SiHa: 20.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000349, HPA052838, HPA063327" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB000349: , HPA052838: , HPA063327: AB_2684987" "unprognostic (2.30e-1)" "unprognostic (9.23e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.47e-6)" "unprognostic (2.10e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (2.01e-1)" "unprognostic (3.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (9.14e-3)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.28e-2)" 22.4 1.4 1.4 7.3 1.1 0.0 25.1 0.8 1.2 6.6 35.4 1.4 1.5 14.1 2.6 0.8 27.0 1.2 1.4 1.4 1.6 0.8 0.5 0.6 9.9 2.3 2.0 0.8 0.8 1.0 3.9 7.8 3.7 3.4 3.1 13.4 0.7 5.1 3.2 6.5 8.6 47.0 3.2 1.0 4.4 3.9 3.3 1.3 1.1 0.8 9.8 12.5 2.8 16.6 0.0 0.6 0.0 10.9 0.0 0.4 1.3 0.0 0.0 0.1 0.9 13.6 18.7 0.3 0.6 0.0 2.1 5.9 1.5 4.1 0.0 1.7 1.0 0.0 16.2 0.3 3.2 2.6 1.1 5.0 0.0 15.3 0.7 6.9 0.4 2.7 3.9 0.0 2.7 12.0 28.4 2.0 0.0 0.0 7.2 3.4 1.2 0.0 0.0 0.7 0.8 9.4 0.0 0.9 0.3 4.6 0.0 2.6 0.0 20.5 5.3 14.7 12.6 1.1 0.0 5.3 0.0 0.3 0.0 0.0 6.9 3.9 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.1 3.9 0.0 0.0 0.4 0.3 0.6 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.1 1.3 1.4 1.1 0.8 1.2 1.6 0.8 2.0 0.8 3.4 1.3 62.5 7.9 0.9 16.4 4.7 1.2 2.4 2.5 4.0 3.4 5.2 0.0 0.8 0.0 50.3 4.4 2.5 140.1 0.0 34.0 0.4 7.2 41.1 0.0 0.0 1.2 0.0 7.5 2.5 14.8 1.7 0.6 4.0 3.3 1.8 21.9 3.7 107.4 49.1 1.1 0.0 6.7 0.0 6.3 13.8 3.3 21.1 2.6 0.0 11.2 219.8 CDKN2D "INK4D, p19" ENSG00000129355 "Cyclin dependent kinase inhibitor 2D" P55273 19 10566462-10569059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;bone marrow: 119.4" "Cell type enhanced" "Detected in all" 6 "Spermatocytes: 111.8;Spermatogonia: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 32.8;MOLT-4: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011201, HPA043546" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB011201: AB_261049, HPA043546: AB_2678545" "unprognostic (3.08e-1)" "prognostic favorable (1.02e-4)" "unprognostic (3.57e-2)" "unprognostic (1.49e-2)" "unprognostic (3.29e-2)" "unprognostic (1.37e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.08e-1)" "unprognostic (1.08e-2)" "unprognostic (6.55e-2)" "unprognostic (3.28e-1)" "unprognostic (1.50e-1)" "unprognostic (3.27e-3)" "unprognostic (9.90e-2)" "unprognostic (4.52e-1)" "unprognostic (4.43e-2)" "unprognostic (1.40e-1)" 5.5 4.7 27.9 6.8 24.2 119.4 4.1 14.3 28.7 2.6 3.9 4.2 0.5 3.9 2.4 2.5 3.8 3.0 4.0 8.4 22.9 17.9 2.7 2.1 6.6 11.1 14.3 14.3 2.8 2.8 2.6 3.4 4.8 11.8 2.5 3.6 2.4 3.2 3.0 6.3 6.0 3.5 4.6 5.7 9.7 2.8 10.9 3.6 18.6 1.8 2.8 8.4 4.2 2.4 17.3 16.0 44.1 10.7 11.9 11.3 9.5 11.0 1.7 5.7 3.7 3.0 4.7 1.4 7.3 8.6 8.1 7.1 2.2 2.7 3.1 2.4 7.7 8.2 2.3 1.9 1.8 2.9 12.3 4.6 32.8 2.0 3.6 3.5 3.3 26.6 1.9 6.1 4.1 3.1 6.7 2.2 19.5 1.3 27.0 8.0 1.5 40.4 17.3 1.1 8.5 8.5 6.6 5.5 1.8 3.6 0.9 8.0 4.2 5.1 3.9 5.6 1.1 3.5 8.7 1.7 9.6 4.9 15.8 10.8 16.9 5.7 5.7 10.1 5.6 6.8 35.9 5.6 23.5 10.0 6.8 8.0 17.3 8.3 11.3 5.4 15.9 7.9 9.4 44.1 11.9 10.7 16.0 6.7 9.5 27.9 24.2 14.3 28.7 22.9 17.9 14.3 14.3 11.8 3.6 6.0 9.5 48.4 13.8 20.6 28.1 8.5 2.5 5.3 3.4 5.2 11.8 2.4 8.3 6.0 15.3 15.3 5.8 46.7 4.3 7.1 11.0 10.0 20.7 3.0 8.7 44.5 6.9 20.3 36.0 8.5 6.6 24.1 28.7 10.8 5.8 17.7 9.9 10.5 5.6 3.4 29.5 19.4 30.3 111.8 87.1 29.0 4.1 44.9 3.6 23.8 CDKN3 "CDI1, KAP" ENSG00000100526 "Cyclin dependent kinase inhibitor 3" Q16667 14 54396849-54420218 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 80.3" "Cell type enriched" "Detected in many" 4 "Early spermatids: 2056.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 16.1" "Group enriched" "Detected in all" 5 "NK-cells: 5.8;T-cells: 16.1" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005285, HPA039311, HPA058874" Enhanced Cytosol NA Yes Cytosol "CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842" "unprognostic (3.46e-2)" "unprognostic (9.95e-2)" "unprognostic (5.79e-2)" "unprognostic (6.78e-3)" "unprognostic (2.73e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-3)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.50e-3)" "unprognostic (2.85e-3)" "prognostic unfavorable (7.46e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.71e-1)" "unprognostic (7.30e-2)" "unprognostic (7.92e-2)" "unprognostic (4.31e-2)" 2.4 1.0 1.6 6.5 1.7 12.8 1.5 1.5 2.5 1.0 4.5 0.2 0.2 3.8 0.9 1.1 4.4 0.7 0.9 3.0 1.4 1.9 1.0 1.1 1.1 8.8 1.7 1.9 0.9 0.7 0.0 1.0 2.3 2.8 0.9 5.8 0.9 1.7 0.1 3.9 1.8 4.0 2.2 1.0 2.3 1.8 80.3 0.3 18.3 1.1 6.4 9.5 2.1 1.8 2.0 1.6 1.1 1.4 5.8 16.1 2.9 55.2 21.2 16.3 16.3 2.7 3.3 9.4 13.2 19.5 28.2 31.2 16.0 27.6 27.2 9.7 20.6 29.7 40.7 24.7 16.0 52.7 32.6 11.9 13.8 15.3 26.4 2.0 17.2 9.8 1.2 1.0 17.6 30.7 9.9 17.9 26.4 6.9 34.8 33.8 39.3 23.8 14.0 5.7 54.1 46.0 14.8 14.4 5.9 14.9 12.1 6.7 8.5 24.2 14.3 10.5 12.8 29.6 14.7 6.5 12.5 42.9 19.7 31.2 8.4 9.7 18.7 20.9 24.9 22.8 0.0 1.3 1.1 1.2 1.4 0.6 2.0 5.2 4.3 1.6 0.9 2.7 2.2 0.9 5.8 0.9 1.2 16.1 2.9 1.6 1.7 1.5 2.5 1.4 1.9 1.7 1.9 2.8 0.3 0.0 0.0 0.8 3.1 8.2 1.4 9.3 0.0 0.0 1.2 1.8 2.0 9.8 0.0 2.8 2056.4 2.0 2.9 256.9 2.1 27.0 6.6 2.2 6.9 1.8 31.5 4.8 7.5 4.9 7.5 483.1 19.8 5.7 1.7 3.6 6.2 1.2 2.0 6.2 9.9 1.7 2.3 0.0 2.1 159.2 36.4 5.6 3.4 7.0 12.8 1.4 CDNF ARMETL1 ENSG00000185267 "Cerebral dopamine neurotrophic factor" Q49AH0 10 14819250-14838575 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 30.8" "Group enriched" "Detected in many" 16 "Early spermatids: 89.1;Late spermatids: 214.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 15.6;U-266/70: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044587 Uncertain "Secreted in other tissues" NA NA "HPA044587: AB_10795881" "unprognostic (2.80e-3)" "unprognostic (2.51e-2)" "unprognostic (6.20e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (4.14e-2)" "unprognostic (1.25e-1)" "unprognostic (4.81e-2)" "unprognostic (1.08e-1)" "unprognostic (8.66e-2)" "unprognostic (6.93e-2)" "unprognostic (2.31e-2)" "unprognostic (3.62e-1)" 3.8 3.3 2.1 4.1 2.4 0.5 3.5 1.9 2.4 3.5 2.2 3.2 5.6 2.1 2.3 10.0 1.9 4.5 2.3 3.7 2.3 2.2 3.8 9.4 1.4 2.8 2.8 3.8 3.2 7.7 5.1 3.5 1.7 3.8 3.4 1.3 4.7 8.8 4.5 30.8 5.0 1.8 1.2 3.1 1.6 2.8 10.0 2.5 2.0 4.4 16.1 2.7 3.0 1.9 1.4 1.9 0.3 0.5 2.7 5.4 0.9 0.5 0.6 1.8 0.8 3.3 2.8 0.3 1.7 2.9 0.9 0.8 1.4 1.5 5.1 1.2 0.7 0.1 0.7 0.0 0.1 1.1 0.4 1.4 0.8 0.7 0.4 2.3 0.4 0.2 2.1 1.4 0.3 1.6 1.5 1.0 2.2 1.8 4.0 1.9 1.2 0.8 1.0 1.1 1.1 0.6 0.8 1.3 15.6 0.5 0.1 1.7 2.1 0.4 1.2 2.0 0.8 2.5 0.4 0.9 0.5 0.6 2.3 0.2 7.7 2.5 0.8 1.0 0.3 0.1 0.1 0.4 0.3 1.4 0.5 0.6 1.4 1.2 1.9 1.1 1.3 4.9 2.6 0.2 2.7 0.5 1.9 5.4 0.9 2.1 2.4 1.9 2.4 2.3 2.2 2.8 3.8 3.8 2.5 0.0 2.1 2.0 1.5 1.8 1.0 1.7 0.0 8.1 3.4 0.0 2.0 0.8 3.3 0.9 89.1 0.5 0.0 0.0 3.2 1.1 0.8 1.0 0.0 5.0 0.3 0.0 0.0 0.6 1.9 214.2 1.1 0.4 0.0 0.0 0.2 1.9 0.6 0.0 1.1 2.8 0.9 0.0 0.7 9.5 4.9 0.1 1.1 0.0 0.6 0.6 CDO1 ENSG00000129596 "Cysteine dioxygenase type 1" Q16878 5 115804733-115816954 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 142.1;seminal vesicle: 53.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 255.3;Hepatocytes: 126.0;Syncytiotrophoblasts: 403.0" "Group enriched" "Detected in many" 6 "glioma: 33.6;liver cancer: 74.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 20 "memory CD4 T-cell: 4.1;T-reg: 1.2" "Lineage enriched" "Detected in single" 41 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "AF22: 23.0;ASC diff: 28.4;ASC TERT1: 11.0;GAMG: 8.3;HAP1: 8.1;NTERA-2: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036573, HPA057503" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036573: AB_10696658, HPA057503: AB_2683451" "unprognostic (2.34e-2)" "unprognostic (3.31e-2)" "unprognostic (1.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.91e-5)" "unprognostic (1.14e-3)" "unprognostic (2.63e-1)" "unprognostic (7.23e-2)" "unprognostic (9.28e-3)" "unprognostic (6.69e-2)" "unprognostic (1.58e-1)" "unprognostic (2.74e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-1)" "unprognostic (2.06e-2)" 31.9 6.2 9.3 1.7 11.2 0.8 9.9 7.6 9.4 3.4 1.5 3.7 36.4 1.0 3.1 42.6 1.8 4.9 3.7 7.6 7.3 9.0 1.7 142.1 3.9 2.3 6.5 5.5 8.7 4.7 1.0 6.5 17.7 14.5 4.0 1.3 19.2 2.8 53.7 3.5 1.1 1.1 2.6 5.3 1.8 1.2 5.0 4.3 0.0 2.8 2.5 1.6 2.4 2.1 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 23.0 0.0 28.4 11.0 0.1 0.6 0.2 2.2 2.2 0.0 0.0 0.0 0.0 0.2 8.3 0.0 8.1 0.0 3.2 0.0 4.0 0.7 0.0 0.6 0.1 0.0 0.0 4.1 0.0 0.3 0.0 0.6 2.9 0.0 0.0 0.0 2.6 0.0 0.5 0.1 8.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 9.3 11.2 7.6 9.4 7.3 9.0 6.5 5.5 14.5 4.3 0.0 2.2 0.0 0.5 0.7 16.3 1.6 0.0 0.0 0.0 1.8 5.9 255.3 0.0 6.0 5.8 3.2 0.0 0.0 0.2 7.4 16.4 1.0 0.0 126.0 20.1 1.6 1.7 21.5 4.9 8.9 84.3 0.2 1.7 1.0 0.0 31.8 0.5 0.0 35.3 0.6 2.9 12.9 3.3 1.5 0.2 1.1 403.0 0.0 0.0 0.1 CDR1 "CDR, CDR34, CDR62A" ENSG00000184258 "Cerebellar degeneration related protein 1" P51861 X 140782405-140784871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 56.2" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 139.0;Horizontal cells: 33.4;Muller glia cells: 111.9;Rod photoreceptor cells: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;BJ: 6.6;MOLT-4: 4.2;U-87 MG: 24.4" "Low region specificity" "Detected in all" HPA073147 Approved "Nucleoplasm,Golgi apparatus,Centrosome" NA NA "Nucleoplasm, Golgi apparatus, Centrosome" "HPA073147: AB_2686574" "unprognostic (7.10e-2)" "unprognostic (2.87e-2)" "unprognostic (2.85e-1)" "unprognostic (3.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.41e-3)" "unprognostic (1.46e-4)" "unprognostic (1.55e-1)" "unprognostic (1.84e-1)" 3.2 1.3 9.1 0.5 26.3 0.0 0.0 56.2 28.7 0.0 0.1 0.2 0.4 0.0 0.6 0.2 1.5 1.5 9.2 2.8 0.1 0.0 0.6 0.1 3.7 0.1 3.9 0.0 7.1 0.4 0.1 0.0 0.6 0.0 0.2 9.4 0.1 0.0 3.6 0.9 0.5 0.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 3.4 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 139.0 0.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.9 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 CDR2L HUMPPA ENSG00000109089 "Cerebellar degeneration related protein 2 like" Q86X02 17 74987632-75005800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.0" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 21.1;Pancreatic endocrine cells: 19.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 27.4;U-138 MG: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022015 Enhanced Approved Cytosol NA NA Cytosol "HPA022015: AB_1846462" "unprognostic (4.60e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-2)" "unprognostic (3.85e-2)" "unprognostic (2.17e-1)" "unprognostic (7.36e-3)" "unprognostic (9.22e-2)" "unprognostic (1.78e-2)" "unprognostic (9.11e-2)" "unprognostic (2.11e-1)" "unprognostic (4.21e-2)" "unprognostic (1.84e-1)" "unprognostic (5.89e-2)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" 9.5 6.1 7.0 4.2 18.7 0.8 20.1 40.0 14.3 6.8 9.9 19.1 4.2 31.0 14.3 2.1 4.3 6.8 12.9 8.3 11.7 8.3 6.9 2.3 8.9 1.8 22.0 6.9 2.4 6.3 4.3 4.1 10.2 21.9 5.4 2.7 2.7 10.2 8.3 3.2 3.1 15.8 8.3 25.1 2.2 17.7 5.6 14.0 0.0 3.2 1.0 1.7 7.0 10.1 0.3 0.1 0.0 0.4 0.0 0.1 1.5 6.3 18.2 4.0 8.5 7.2 6.3 1.8 9.3 4.1 5.4 6.9 10.8 5.9 0.0 9.8 16.1 4.9 17.0 4.8 2.2 3.6 0.1 8.2 0.0 11.3 6.9 4.1 0.7 0.3 3.7 3.6 12.9 1.3 3.9 11.6 1.4 2.7 0.9 5.7 5.7 0.8 0.6 5.3 15.1 9.0 2.9 6.2 2.7 14.3 4.0 7.0 23.8 11.7 27.4 0.8 2.5 7.5 1.2 8.2 28.1 6.0 17.6 5.8 0.9 0.5 0.0 7.8 2.2 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 1.5 7.0 18.7 40.0 14.3 11.7 8.3 22.0 6.9 21.9 14.0 14.9 0.0 0.0 1.9 5.4 2.4 3.6 15.3 2.7 2.3 5.2 0.0 2.2 13.3 10.7 5.4 10.0 0.7 0.0 6.2 0.4 7.5 5.2 0.0 0.0 1.2 0.0 4.7 4.9 0.3 21.1 2.6 1.0 1.7 1.0 3.2 0.8 19.1 0.0 2.5 1.8 2.5 0.0 7.3 2.1 1.9 2.0 1.9 0.0 0.6 11.5 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 9.8;testis: 12.8" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.1 1.8 0.0 0.9 0.0 0.0 0.7 0.2 0.0 2.4 0.3 2.9 0.0 0.8 9.8 0.3 0.7 0.7 0.0 0.0 0.1 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.1 1.8 0.3 0.6 2.6 0.1 2.1 4.4 1.3 0.0 0.0 0.2 2.6 12.8 1.6 3.0 2.0 4.1 0.4 0.1 0.0 0.3 0.1 2.1 0.0 2.4 6.8 0.2 2.0 0.2 0.7 0.2 0.5 1.5 0.2 0.7 5.1 15.6 0.1 0.4 1.3 1.6 28.6 0.4 0.3 0.4 2.4 0.3 0.1 9.7 0.2 0.2 0.0 0.1 0.3 0.9 0.6 0.4 0.1 0.1 0.4 0.0 1.2 0.8 0.1 0.4 0.2 0.2 7.1 0.8 0.0 0.4 0.0 1.9 3.7 0.1 0.2 2.3 2.0 0.1 0.8 0.1 0.1 1.2 0.5 1.4 0.0 0.4 0.6 2.9 0.0 1.7 0.1 0.8 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.1 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 0.3 CDRT15 ENSG00000223510 "CMT1A duplicated region transcript 15" Q96T59 17 14235673-14236862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.1;testis: 19.0" "Group enriched" "Detected in some" 16 "Early spermatids: 60.5;Late spermatids: 42.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 6.9" HPA055952 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA055952: AB_2682983" "unprognostic (3.27e-2)" "unprognostic (1.77e-2)" "unprognostic (8.61e-2)" "unprognostic (9.33e-2)" "unprognostic (5.15e-3)" "unprognostic (2.90e-1)" "unprognostic (6.16e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-3)" "unprognostic (2.66e-1)" "unprognostic (2.55e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-7)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (6.81e-2)" "unprognostic (2.38e-2)" 0.1 0.3 0.0 1.5 0.0 0.5 0.1 0.3 0.1 0.2 0.2 0.9 0.1 0.0 0.4 0.2 0.4 0.2 0.1 0.1 0.1 0.5 0.2 3.8 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.1 5.1 1.0 0.0 0.3 1.1 0.4 19.0 0.5 0.0 0.2 0.2 0.2 0.3 0.5 0.1 0.0 2.0 0.0 1.3 2.3 1.6 3.7 0.0 0.0 0.9 1.4 0.0 0.0 0.1 4.4 0.6 3.7 0.9 0.0 0.5 1.7 0.0 0.0 0.0 3.7 6.9 2.1 3.8 3.1 0.0 1.7 2.7 0.0 0.0 0.0 0.0 1.4 0.0 1.8 1.7 0.8 0.0 0.9 1.8 2.7 1.5 2.6 2.3 1.4 0.7 1.5 0.0 1.9 1.8 3.3 0.4 1.0 0.6 5.2 0.8 0.9 2.0 6.0 0.8 1.4 1.6 1.2 1.4 1.7 0.9 2.8 4.3 0.0 0.1 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 CDRT15L2 ENSG00000214819 "CMT1A duplicated region transcript 15 like 2" A8MXV6 17 20579724-20580911 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 15.3" "Cell type enriched" "Detected in some" 7 "Early spermatids: 54.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.4;AN3-CA: 1.7;Hep G2: 1.3;HMC-1: 1.4;U-138 MG: 2.3" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.1 1.7 0.0 0.0 1.0 0.3 0.0 0.2 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.8 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.2 0.7 0.0 2.3 0.0 0.0 0.3 0.9 0.2 0.5 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.5 0.7 0.0 0.0 0.0 0.0 0.0 CDRT4 FLJ36674 ENSG00000239704 "CMT1A duplicated region transcript 4" 17 15436015-15503608 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 36.8" "Group enriched" "Detected in some" 19 "Early spermatids: 68.3;Late spermatids: 129.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Group enriched" "Detected in many" 5 "granulocytes: 3.9;NK-cells: 1.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Hep G2: 13.2;NB-4: 10.0" "Low region specificity" "Detected in many" HPA021590 Uncertain Approved Mitochondria NA NA Mitochondria "HPA021590: AB_1848906" "unprognostic (5.46e-6)" "unprognostic (9.47e-2)" "unprognostic (7.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.51e-2)" "unprognostic (7.74e-3)" "unprognostic (9.29e-2)" "unprognostic (2.12e-2)" "unprognostic (3.93e-2)" "unprognostic (1.39e-1)" "unprognostic (2.10e-5)" "unprognostic (2.00e-3)" "unprognostic (1.74e-6)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (4.18e-1)" "unprognostic (9.27e-2)" 2.0 3.2 2.0 2.0 2.3 3.3 6.5 3.7 2.6 2.6 2.3 2.3 2.0 0.2 2.5 17.7 2.0 4.4 2.0 2.0 2.0 2.4 2.0 2.0 3.7 2.8 2.7 2.8 5.3 4.1 0.9 10.9 2.0 2.0 4.1 3.0 2.0 5.0 2.7 2.0 14.6 2.0 2.0 2.0 2.9 2.7 36.8 2.0 2.0 5.3 2.0 2.0 2.1 2.8 0.4 0.3 3.9 0.1 1.1 1.8 0.5 3.2 3.2 4.0 1.2 3.0 2.3 3.8 1.1 3.1 1.4 1.3 1.9 1.1 0.0 1.5 1.6 0.2 1.2 4.4 3.6 2.2 0.6 0.6 0.4 2.0 13.2 0.9 1.1 5.5 3.1 4.4 2.0 4.9 6.1 3.3 1.4 0.7 2.0 3.4 0.5 1.2 10.0 1.6 0.4 1.1 0.9 0.1 0.0 3.3 2.5 0.6 1.7 1.1 0.7 1.0 8.1 1.4 2.5 3.3 0.8 1.5 1.5 1.2 2.7 1.0 0.2 0.0 0.3 0.4 3.9 0.0 0.4 0.9 0.0 0.6 0.4 0.4 0.8 0.1 0.4 0.1 0.4 0.2 1.1 0.1 0.3 1.8 0.5 2.0 2.3 3.7 2.6 2.0 2.4 2.7 2.8 2.0 2.0 0.0 0.6 0.0 0.1 0.1 1.4 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.5 68.3 0.0 0.3 0.0 0.0 0.3 0.2 0.3 2.3 0.0 0.1 0.0 0.0 0.0 0.0 129.6 0.0 0.0 0.0 1.0 1.7 0.3 0.7 1.5 0.0 0.0 1.6 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.6 0.3 CDS1 ENSG00000163624 "CDP-diacylglycerol synthase 1" Q92903 4 84582979-84651338 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.0" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.5;hTCEpi: 25.6;OE19: 19.7;SK-BR-3: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036187, HPA064546" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA036187: AB_10601797, HPA064546: AB_2732714" "unprognostic (8.74e-2)" "unprognostic (7.11e-2)" "prognostic favorable (5.22e-4)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-3)" "unprognostic (3.11e-1)" "unprognostic (2.62e-1)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (6.67e-2)" "prognostic favorable (0.00e+0)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-1)" "unprognostic (2.06e-1)" 0.9 4.6 7.4 2.5 10.4 0.4 6.7 13.3 12.9 4.3 16.7 3.3 9.3 24.8 2.0 19.1 17.4 20.5 8.8 0.5 7.4 8.4 11.9 0.6 10.6 0.8 6.4 4.7 5.5 4.5 19.3 7.1 19.7 14.1 6.1 13.6 4.2 11.2 4.3 0.2 12.9 48.0 0.8 2.4 1.0 11.5 5.1 2.3 0.9 19.3 7.9 6.1 3.5 7.4 0.0 2.1 0.0 0.0 0.0 0.4 0.0 11.4 0.2 0.6 0.1 0.0 0.0 12.0 0.0 0.1 0.3 0.2 4.8 20.5 0.0 0.9 0.0 2.4 12.1 3.7 10.2 0.1 0.8 5.7 0.0 1.8 1.1 0.0 0.3 0.8 0.1 25.6 0.0 3.7 0.4 0.0 0.7 0.0 0.0 0.0 8.1 0.1 0.0 1.7 19.7 0.8 0.0 0.0 2.4 5.7 8.7 4.8 0.1 1.3 27.8 0.0 2.3 8.5 0.2 0.0 0.0 0.6 1.2 1.5 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 10.4 13.3 12.9 7.4 8.4 6.4 4.7 14.1 2.3 14.9 36.5 0.5 24.3 25.8 16.5 1.6 17.8 105.7 27.3 38.4 9.8 49.0 3.3 23.6 5.9 2.1 44.6 0.0 20.1 9.6 1.5 29.0 0.0 0.0 10.4 20.6 21.5 1.8 2.2 3.1 0.6 5.6 0.0 1.0 45.1 28.4 30.8 31.6 0.4 14.7 28.1 0.0 1.3 2.3 3.8 47.3 47.9 0.0 47.2 32.3 CDSN D6S586E ENSG00000204539 Corneodesmosin 6 31115090-31120446 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 19.2;skin 1: 109.3;tongue: 29.7" "Group enriched" "Detected in some" 6 "granulocytes: 4.6;Suprabasal keratinocytes: 4.5" "Group enriched" "Detected in some" 8 "head and neck cancer: 2.4;melanoma: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "A-431: 5.9" "Group enriched" "Detected in some" 5 "amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0" "Not detected" "Not detected" "HPA044730, HPA054184" Enhanced "Secreted in other tissues" NA NA "HPA044730: AB_10964923, HPA054184: AB_2682409" "unprognostic (1.46e-1)" "unprognostic (6.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (8.80e-2)" "unprognostic (8.13e-2)" "unprognostic (3.92e-4)" "unprognostic (3.92e-3)" "unprognostic (1.74e-4)" "unprognostic (6.34e-2)" "unprognostic (2.75e-1)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 29.7 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.1 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803213-88809258 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 25.2;esophagus: 7.1" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 46.7;Extravillous trophoblasts: 78.3;Spermatogonia: 28.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 39.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.4 0.4 0.7 2.7 0.9 25.2 0.4 0.0 1.2 1.2 2.5 2.9 0.3 0.0 7.1 0.3 0.0 0.1 0.6 2.2 0.5 0.6 0.9 3.2 1.7 0.0 0.4 0.9 2.1 2.0 0.3 1.0 0.8 0.1 0.0 3.3 3.2 0.3 0.8 3.1 1.7 3.3 0.1 2.1 0.2 1.9 3.7 2.1 3.5 0.9 1.7 4.0 0.7 9.7 10.2 4.4 7.5 0.2 0.9 17.9 6.6 1.8 5.2 3.3 20.8 10.0 14.4 7.4 1.4 3.5 12.6 5.6 4.5 1.7 5.1 23.9 13.5 9.0 17.4 0.0 7.6 5.9 0.4 0.3 5.3 1.1 0.4 1.6 18.6 21.9 4.8 1.9 24.1 31.3 39.6 11.5 3.0 8.2 33.5 6.0 12.6 1.1 7.4 10.7 7.9 11.5 3.6 5.0 2.0 11.4 15.7 1.7 7.3 11.7 11.0 9.7 17.9 15.5 19.8 5.4 19.5 8.8 0.5 0.9 3.5 2.7 0.5 1.1 1.2 2.7 2.7 1.0 3.7 4.0 2.4 2.1 1.7 0.7 2.1 3.0 0.7 0.0 0.6 7.5 3.4 10.0 0.2 1.6 2.5 2.7 2.3 1.8 0.0 24.8 1.7 1.0 0.2 1.2 2.1 46.7 0.0 78.3 1.3 1.7 0.0 0.9 16.4 0.0 2.4 0.6 4.1 0.7 0.3 2.5 1.7 2.8 9.3 1.1 0.5 0.0 0.4 1.0 1.8 0.0 2.0 2.7 28.5 6.1 20.7 3.2 18.0 3.4 CDX1 ENSG00000113722 "Caudal type homeobox 1" P47902 5 150166795-150184558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 83.7" "Group enriched" "Detected in some" 4 "Enterocytes: 265.6;Mucus-secreting cells: 170.9;Paneth cells: 276.3;Undifferentiated cells: 217.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 125.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+: 11.4;SuSa: 6.9" "Region enhanced" "Detected in single" "thalamus: 0.3" "Not detected" "Not detected" HPA055196 Enhanced NA NA "HPA055196: AB_2682734" "unprognostic (2.50e-3)" "unprognostic (3.90e-1)" "unprognostic (1.65e-2)" "unprognostic (1.09e-2)" "unprognostic (5.89e-2)" "unprognostic (1.54e-2)" "unprognostic (2.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.59e-1)" "unprognostic (2.96e-1)" "unprognostic (1.83e-7)" "unprognostic (2.10e-1)" "unprognostic (4.25e-1)" "unprognostic (5.42e-3)" "unprognostic (2.16e-3)" 0.2 0.1 0.1 18.6 0.2 0.0 0.2 0.1 0.2 0.2 63.6 0.2 0.1 19.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 38.5 0.1 0.1 0.1 0.1 0.2 83.7 1.5 0.1 0.1 0.1 0.9 0.1 0.5 0.1 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.3 0.0 11.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 2.1 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 170.9 0.0 0.0 276.3 1.4 0.0 0.0 0.0 2.4 3.0 8.9 0.3 0.1 0.0 217.4 0.0 CDX2 CDX3 ENSG00000165556 "Caudal type homeobox 2" Q99626 13 27962137-27971139 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "intestine: 21.2" "Group enriched" "Detected in some" 7 "Enterocytes: 190.4;Intestinal endocrine cells: 60.0;Mucus-secreting cells: 200.2;Paneth cells: 129.8;Undifferentiated cells: 183.4" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 63.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 14.7;CAPAN-2: 4.9;HEK 293: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002221, HPA045669, HPA049580" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823" "unprognostic (1.42e-1)" "unprognostic (2.41e-1)" "unprognostic (2.92e-1)" "unprognostic (8.11e-3)" "unprognostic (4.19e-6)" "unprognostic (1.73e-4)" "unprognostic (1.71e-1)" "unprognostic (1.58e-1)" "unprognostic (5.51e-2)" "unprognostic (6.07e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.7 4.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 8.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 20.8 0.0 0.0 190.4 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 200.2 0.0 1.1 129.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 183.4 0.1 CDX4 ENSG00000131264 "Caudal type homeobox 4" O14627 X 73447254-73455245 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skin 1: 5.3;testis: 3.3" "Cell type enhanced" "Detected in some" 22 "Spermatogonia: 1.4;Suprabasal keratinocytes: 1.0" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 2.0;SuSa: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043714, HPA056528" Uncertain Approved "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA043714: , HPA056528: AB_2683166" "unprognostic (1.97e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 1.4 1.0 0.0 0.0 0.0 0.0 CDY1 CDY1A ENSG00000172288 "Chromodomain Y-linked 1" Q9Y6F8 Y 25622162-25624902 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 47 "testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDY1B ENSG00000172352 "Chromodomain Y-linked 1B" Q9Y6F8 Y 24045229-24048019 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 72 "testis: 7.2" "Cell type enhanced" "Detected in single" 40 "Early spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDY2A CDY2 ENSG00000182415 "Chromodomain Y-linked 2A" Q9Y6F7 Y 18025787-18028597 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 50 "epididymis: 3.8;testis: 6.0" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-266/84: 1.2" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDY2B CDY ENSG00000129873 "Chromodomain Y-linked 2B" Q9Y6F7 Y 17877410-17880220 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066682 Supported NA NA "HPA066682: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CDYL2 FLJ38866 ENSG00000166446 "Chromodomain Y like 2" Q8N8U2 16 80597906-80804329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7" "Cell type enhanced" "Detected in many" 7 "monocytes: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 1.9;non-classical monocyte: 7.1" "Lineage enriched" "Detected in single" 7 "monocytes: 7.1" "Cell line enhanced" "Detected in many" "HDLM-2: 10.5;HUVEC TERT2: 16.1;MCF7: 13.7;TIME: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041016 Approved NA NA "HPA041016: AB_10794183" "unprognostic (8.63e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-3)" "prognostic favorable (6.13e-4)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "unprognostic (2.40e-1)" "unprognostic (2.30e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (4.33e-2)" "unprognostic (9.11e-2)" "unprognostic (2.12e-1)" "unprognostic (3.69e-3)" 4.6 2.6 11.5 5.2 16.8 7.8 8.0 24.7 17.2 7.4 2.1 1.0 4.3 5.2 4.3 3.4 3.3 1.7 2.9 2.1 7.2 6.6 6.0 3.3 3.7 6.0 5.1 9.1 1.3 2.2 7.9 2.0 22.8 7.6 16.0 2.6 0.7 4.1 10.3 1.3 1.9 4.6 4.9 5.4 3.7 3.0 16.5 5.0 0.9 2.6 0.0 5.3 5.3 5.2 0.0 0.4 0.9 7.1 0.0 0.7 0.2 0.0 0.0 0.2 0.0 3.9 3.9 3.2 3.9 2.6 1.0 0.3 0.1 1.9 0.3 1.3 2.4 0.0 0.1 0.1 3.9 0.5 10.5 2.1 1.4 5.6 0.1 0.2 0.1 0.2 1.2 1.5 2.1 1.9 5.9 16.1 1.3 0.0 0.1 0.5 13.7 0.0 0.0 1.2 0.1 4.3 0.0 0.0 0.0 6.4 4.9 1.0 0.0 0.5 3.3 0.0 1.0 3.2 2.3 23.8 0.1 7.0 0.0 1.0 0.0 0.0 0.0 2.5 3.0 0.0 0.7 0.4 0.9 0.2 1.9 0.0 0.0 0.2 0.7 0.4 0.0 0.2 0.4 0.0 0.0 7.1 0.1 0.5 0.2 11.5 16.8 24.7 17.2 7.2 6.6 5.1 9.1 7.6 5.0 3.0 1.7 0.0 2.5 2.5 0.0 1.2 5.1 0.0 1.2 3.5 0.0 8.7 3.3 2.2 9.2 4.4 1.3 0.0 3.6 5.1 3.2 12.5 0.0 4.0 2.2 0.0 1.2 8.0 9.8 14.1 2.6 1.5 0.0 26.2 2.8 0.5 2.7 0.0 4.2 4.6 0.4 0.0 2.9 1.6 5.7 1.0 13.6 2.2 1.2 2.6 CEACAM1 "BGP, BGP1, CD66a" ENSG00000079385 "Carcinoembryonic antigen related cell adhesion molecule 1" P13688 19 42507304-42561234 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 234.8;Enterocytes: 131.5;Glandular cells: 256.0;Urothelial cells: 472.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "eosinophil: 20.6;neutrophil: 12.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.6" "Group enriched" "Detected in some" 4 "CAPAN-2: 11.7;Hep G2: 33.3;OE19: 32.1;RT4: 21.9;SK-MEL-30: 24.6" "CAB002146, HPA011041" Enhanced "Intracellular and membrane" NA NA 180000000 "CAB002146: AB_563614, HPA011041: AB_1078481" "unprognostic (7.13e-3)" "unprognostic (2.15e-1)" "unprognostic (2.67e-2)" "prognostic favorable (6.32e-7)" "unprognostic (3.04e-1)" "unprognostic (1.80e-3)" "unprognostic (1.21e-1)" "unprognostic (4.45e-2)" "unprognostic (4.43e-1)" "unprognostic (5.46e-3)" "unprognostic (4.87e-2)" "unprognostic (4.03e-1)" "unprognostic (1.92e-2)" "unprognostic (1.88e-1)" "unprognostic (1.06e-1)" "unprognostic (7.55e-2)" "unprognostic (5.52e-3)" 5.3 5.0 0.4 30.2 0.7 15.8 5.3 0.5 0.5 7.7 58.7 0.9 2.5 11.8 3.5 1.5 35.6 1.7 4.3 3.8 0.5 0.5 24.0 46.1 5.4 8.6 1.8 0.0 2.5 1.0 0.0 3.7 16.8 1.0 8.8 35.6 1.7 20.7 5.4 0.9 1.7 54.9 3.0 1.5 5.5 3.6 1.3 0.7 1.2 2.3 18.5 46.5 7.8 12.7 1.9 0.1 20.6 1.8 0.0 1.5 0.3 0.1 2.2 0.1 0.1 0.0 0.0 5.6 0.0 0.1 0.4 0.2 0.9 11.7 0.7 4.7 0.0 1.2 0.3 0.0 3.1 0.1 0.0 0.2 0.1 0.1 33.3 0.7 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.5 0.0 0.4 0.1 0.0 0.1 32.1 0.6 0.6 0.0 0.5 0.2 21.9 0.1 0.0 0.0 0.0 24.6 3.2 0.1 0.0 0.8 0.1 0.2 0.1 0.1 0.7 0.0 1.3 0.0 0.1 0.1 0.4 0.0 20.6 0.0 0.9 0.2 1.9 0.5 0.2 0.1 0.3 0.4 0.1 12.7 0.0 1.8 0.0 1.5 0.3 0.4 0.7 0.5 0.5 0.5 0.5 1.8 0.0 1.0 0.7 6.0 10.9 15.9 234.8 1.1 5.7 1.6 7.6 4.0 7.9 0.0 3.9 0.8 0.0 16.9 2.1 7.1 131.5 0.0 13.8 7.8 1.7 256.0 9.2 32.6 1.1 4.8 16.6 51.5 6.5 0.0 0.0 3.0 6.8 1.0 22.4 1.4 43.2 84.3 0.7 10.5 6.6 0.0 1.8 4.3 2.8 0.9 0.6 4.9 9.8 472.9 CEACAM16 DFNA4B ENSG00000213892 "Carcinoembryonic antigen related cell adhesion molecule 16" Q2WEN9 19 44699151-44710714 "Disease related genes, Predicted secreted proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.9;pancreas: 7.0" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 1.1;Rod photoreceptor cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;RH-30: 1.5;T-47d: 2.8;U-266/70: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045075 Uncertain "Secreted in other tissues" NA NA "HPA045075: AB_10959617" "unprognostic (1.27e-1)" "unprognostic (3.73e-1)" "unprognostic (3.12e-1)" "unprognostic (3.32e-2)" "unprognostic (4.72e-1)" "unprognostic (1.42e-2)" "unprognostic (7.76e-2)" "unprognostic (3.59e-2)" "unprognostic (7.81e-3)" "unprognostic (3.88e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "unprognostic (1.86e-1)" "unprognostic (7.94e-2)" 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 7.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.7 0.0 0.0 0.0 0.0 5.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 CEACAM18 ENSG00000213822 "Carcinoembryonic antigen related cell adhesion molecule 18" A8MTB9 19 51478622-51490952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 62 "intestine: 31.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.8;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 8.6;OE19: 7.0;RT4: 2.8" "Not detected" "Not detected" HPA059487 Uncertain Approved Midbody NA NA Midbody "HPA059487: AB_2684036" "unprognostic (1.12e-1)" "unprognostic (1.87e-2)" "unprognostic (1.00e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 16.6 0.0 0.0 14.6 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 31.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 7.0 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEACAM20 UNQ9366 ENSG00000273777 "Carcinoembryonic antigen related cell adhesion molecule 20" 19 44501677-44529788 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 64.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "liver cancer: 1.2;prostate cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.04e-2)" "unprognostic (5.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (1.23e-2)" "unprognostic (3.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.07e-2)" "unprognostic (7.58e-2)" "unprognostic (2.14e-5)" "unprognostic (7.13e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CEACAM21 "FLJ13540, R29124_1" ENSG00000007129 "Carcinoembryonic antigen related cell adhesion molecule 21" Q3KPI0 19 41549518-41586844 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7" "Group enriched" "Detected in some" 4 "B-cells: 4.4;Early spermatids: 5.3;granulocytes: 4.6;Hofbauer cells: 7.6;Ito cells: 14.1;Kupffer cells: 6.9;Late spermatids: 7.8;Macrophages: 4.6;T-cells: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 9.8;Karpas-707: 7.8;U-266/70: 8.6;U-937: 6.5" HPA043411 Uncertain NA NA "HPA043411: AB_10794886" "unprognostic (2.55e-1)" "unprognostic (1.61e-3)" "unprognostic (5.73e-2)" "prognostic favorable (1.89e-5)" "unprognostic (2.57e-1)" "unprognostic (8.02e-4)" "unprognostic (3.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "unprognostic (3.37e-6)" "unprognostic (2.09e-1)" "unprognostic (3.67e-1)" "unprognostic (1.12e-3)" "unprognostic (1.37e-1)" 1.8 1.2 1.6 18.5 1.7 21.1 1.3 1.0 1.4 3.5 3.8 2.4 0.0 1.2 3.9 1.4 1.5 1.4 1.1 2.1 2.0 7.2 1.4 1.8 7.2 19.2 8.4 0.5 1.1 0.7 0.3 1.0 2.4 1.9 1.2 1.2 2.0 4.3 6.2 0.5 0.6 5.0 0.9 3.3 22.7 1.4 1.5 1.6 11.1 1.2 0.7 22.4 2.9 0.8 6.9 7.0 13.0 4.6 10.3 19.1 10.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.8 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 8.6 1.5 1.6 0.0 6.5 0.0 0.0 2.6 10.8 19.1 4.6 12.8 6.7 16.5 13.1 2.8 6.9 14.2 13.8 13.0 10.3 2.8 7.0 14.6 10.1 1.6 1.7 1.0 1.4 2.0 7.2 8.4 0.5 1.9 1.6 0.0 0.0 4.4 0.2 0.0 0.0 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.3 1.3 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 7.6 0.0 0.0 14.1 6.9 7.8 0.0 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 10.0 0.0 0.0 CEACAM3 "CD66d, CGM1" ENSG00000170956 "Carcinoembryonic antigen related cell adhesion molecule 3" P40198 19 41796437-41811553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.0;bone marrow: 35.4" "Cell type enriched" "Detected in some" 12 "Paneth cells: 35.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "neutrophil: 60.0" "Lineage enriched" "Detected in many" 7 "granulocytes: 60.0" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;PC-3: 3.8" HPA011041 Approved NA NA "HPA011041: AB_1078481" "unprognostic (1.60e-1)" "unprognostic (1.14e-1)" "unprognostic (2.23e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (8.09e-3)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "unprognostic (1.62e-1)" "unprognostic (8.07e-2)" "unprognostic (1.32e-2)" "unprognostic (1.32e-1)" "unprognostic (4.68e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-1)" 0.9 0.3 0.3 3.6 0.8 35.4 0.7 0.2 0.8 0.6 1.0 0.0 0.0 0.2 0.4 0.2 1.2 0.7 0.4 5.1 0.4 0.3 0.4 1.1 14.0 11.5 1.8 0.1 0.7 1.0 0.2 0.3 4.6 0.5 0.3 0.3 1.4 0.8 0.2 1.5 0.2 0.6 0.4 0.3 10.7 0.4 0.9 0.2 1.6 0.5 0.3 2.7 0.8 0.6 0.0 0.8 60.0 8.9 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 60.0 0.0 8.9 0.0 0.0 0.6 0.3 0.8 0.2 0.8 0.4 0.3 1.8 0.1 0.5 0.2 3.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.8 0.0 0.0 0.0 1.2 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.1 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEACAM4 CGM7 ENSG00000105352 "Carcinoembryonic antigen related cell adhesion molecule 4" O75871 19 41618971-41627074 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 41.5;bone marrow: 22.5;lymphoid tissue: 30.2" "Group enriched" "Detected in some" 7 "Kupffer cells: 39.1;Macrophages: 11.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 4 "neutrophil: 41.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 41.5" "Cell line enriched" "Detected in some" 6 "U-937: 9.5" NA NA "unprognostic (1.10e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (4.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.83e-2)" "unprognostic (9.11e-2)" "unprognostic (5.59e-2)" "unprognostic (1.79e-2)" "unprognostic (1.97e-1)" "unprognostic (1.04e-1)" "unprognostic (2.17e-1)" "unprognostic (2.09e-9)" "unprognostic (3.65e-2)" "unprognostic (2.95e-2)" "unprognostic (1.47e-1)" "unprognostic (4.34e-1)" 1.8 0.5 0.2 5.5 0.5 22.5 0.5 0.1 1.0 0.4 0.5 0.1 0.2 0.4 0.4 3.3 1.0 1.0 1.6 3.4 0.9 0.3 2.2 1.2 6.4 30.2 1.7 0.1 0.5 1.5 0.0 0.7 1.1 0.9 0.9 0.3 1.6 0.9 0.2 0.3 0.3 1.4 1.2 1.2 27.5 0.8 0.6 0.3 1.0 0.4 0.0 1.4 0.9 0.5 0.1 7.9 41.5 10.3 0.0 3.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 10.3 1.8 0.0 7.5 0.0 0.1 0.4 0.0 7.9 0.0 0.2 0.0 41.5 0.0 3.2 0.0 3.5 3.5 0.2 0.5 0.1 1.0 0.9 0.3 1.7 0.1 0.9 0.3 0.0 3.8 0.5 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 39.1 0.0 0.0 11.5 1.7 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEACAM5 "CD66e, CEA" ENSG00000105388 "Carcinoembryonic antigen related cell adhesion molecule 5" P06731 19 41708585-41729798 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6" "Cell type enhanced" "Detected in some" 19 "Enterocytes: 233.4;Mucus-secreting cells: 290.9;Paneth cells: 482.9;Undifferentiated cells: 102.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 1007.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "OE19: 35.9" "CAB000021, CAB000022, HPA011041, HPA019758" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 19000000 "Plasma membrane" "CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326" "unprognostic (1.54e-2)" "unprognostic (7.59e-2)" "unprognostic (5.49e-3)" "unprognostic (1.80e-1)" "unprognostic (1.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.49e-1)" "unprognostic (2.11e-1)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (8.67e-9)" "unprognostic (2.92e-1)" "unprognostic (2.71e-2)" "unprognostic (6.31e-2)" "unprognostic (1.85e-1)" 0.1 0.1 0.1 78.8 0.1 0.0 0.1 0.1 0.2 12.5 117.1 0.2 0.1 2.5 0.9 0.1 103.5 0.3 1.2 0.1 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.5 0.1 0.3 118.2 0.2 6.8 0.1 0.1 0.6 12.8 3.3 0.1 0.1 20.1 0.2 0.1 0.6 0.2 29.4 100.6 2.0 14.1 0.6 0.6 1.8 0.7 0.6 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 35.9 0.7 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.3 0.8 0.3 0.2 0.1 0.5 0.2 0.3 0.6 0.6 0.4 0.5 1.8 0.6 0.7 0.5 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 29.8 2.6 0.0 0.6 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.3 0.3 0.0 233.4 0.0 0.8 0.0 0.0 7.8 4.6 0.0 0.0 0.0 63.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 290.9 0.0 12.4 482.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 102.6 36.7 CEACAM6 "CD66c, NCA" ENSG00000086548 "Carcinoembryonic antigen related cell adhesion molecule 6" P40199 19 41750977-41772208 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 81.4;gallbladder: 75.7;lung: 129.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 875.4;Club cells: 255.9;Paneth cells: 283.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Group enriched" "Detected in many" 6 "granulocytes: 2.6;monocytes: 1.3" "Cell line enriched" "Detected in some" 11 "OE19: 196.2" "CAB008370, HPA011041" Enhanced NA NA 79000000 "CAB008370: AB_592067, HPA011041: AB_1078481" "unprognostic (1.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.62e-2)" "unprognostic (8.22e-2)" "unprognostic (1.39e-1)" "unprognostic (9.06e-3)" "unprognostic (2.32e-2)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "unprognostic (5.22e-2)" "unprognostic (3.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.42e-4)" "unprognostic (4.08e-1)" "unprognostic (8.71e-3)" "unprognostic (2.85e-1)" "unprognostic (7.68e-2)" 0.3 0.3 0.3 7.4 0.3 29.7 0.3 0.3 0.3 16.8 35.3 0.2 0.1 5.8 0.9 0.2 81.4 1.1 75.7 2.3 0.3 0.3 0.3 0.8 129.1 0.1 0.3 0.1 0.3 1.7 0.0 0.3 32.1 0.2 0.9 43.1 0.2 50.1 0.1 0.3 2.1 12.8 0.9 0.3 0.8 2.6 0.3 0.1 1.0 0.3 25.3 58.1 2.3 21.0 0.1 0.3 2.6 1.3 0.1 0.3 5.2 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 196.2 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.6 0.1 0.5 0.3 0.0 5.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 875.4 62.6 0.0 2.8 0.0 0.0 0.0 81.5 95.0 255.9 0.0 0.0 0.0 0.0 44.8 0.0 0.0 46.4 0.0 13.9 0.0 0.0 19.2 6.9 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.1 0.0 93.7 283.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 105.5 CEACAM7 "CEA, CGM2" ENSG00000007306 "Carcinoembryonic antigen related cell adhesion molecule 7" Q14002 19 41673307-41706976 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 100.5;lymphoid tissue: 60.9" "Group enriched" "Detected in some" 7 "Ductal cells: 63.3;Enterocytes: 92.9;Paneth cells: 145.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 66.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.4;OE19: 3.4;U-2 OS: 1.2;U-266/84: 2.0" "HPA069621, HPA073910" Enhanced "Intracellular and membrane" NA NA "HPA069621: AB_2686162, HPA073910: " "unprognostic (5.24e-2)" "unprognostic (2.72e-1)" "unprognostic (1.64e-2)" "unprognostic (6.03e-2)" "unprognostic (2.07e-2)" "unprognostic (4.30e-2)" "unprognostic (3.61e-2)" "unprognostic (1.74e-1)" "unprognostic (4.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.14e-1)" 0.1 0.1 0.1 60.9 0.1 0.0 0.1 0.1 0.1 9.2 90.0 0.1 0.1 0.0 0.6 0.1 21.1 0.3 5.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.0 0.0 0.1 0.3 0.1 0.3 100.5 0.2 1.5 0.1 0.1 0.5 0.2 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 12.1 19.4 6.1 13.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.1 2.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 1.2 0.0 0.0 0.0 0.0 63.3 0.0 0.0 92.9 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 14.7 0.0 1.6 145.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 7.4 CEACAM8 "CD66b, CGM6" ENSG00000124469 "Carcinoembryonic antigen related cell adhesion molecule 8" P31997 19 42580241-42595055 "CD markers, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 71.0;placenta: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 4.2;non-classical monocyte: 3.0" "Group enriched" "Detected in many" 6 "granulocytes: 4.2;monocytes: 3.0" "Low cell line specificity" "Detected in some" CAB033676 Approved "Intracellular and membrane" NA NA 15000000 "CAB033676: AB_1125678" "unprognostic (2.01e-1)" "unprognostic (4.52e-2)" "unprognostic (3.31e-1)" "unprognostic (6.30e-2)" "unprognostic (2.68e-1)" "unprognostic (1.62e-1)" "unprognostic (1.71e-2)" "unprognostic (7.77e-2)" "unprognostic (9.62e-2)" 0.2 0.0 0.1 0.0 0.1 71.0 0.1 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.6 0.1 0.1 0.1 0.4 4.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 35.6 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.1 10.1 0.0 0.1 0.1 1.9 0.1 0.0 0.0 0.0 0.7 0.5 0.1 4.2 3.0 0.6 0.4 4.1 0.9 0.3 1.2 2.1 0.0 0.5 0.3 1.4 0.0 0.0 0.1 0.2 0.4 1.2 0.3 0.5 0.6 0.5 0.0 0.3 0.0 0.2 0.3 0.5 0.7 0.7 0.1 0.8 0.7 0.0 0.1 0.1 0.1 0.3 0.0 0.8 0.7 1.6 0.0 0.3 0.4 0.9 0.6 0.3 0.1 0.5 0.5 1.3 0.4 0.5 0.8 0.8 0.1 0.3 1.2 0.5 1.3 0.9 0.8 1.4 0.3 1.5 0.5 1.5 1.4 0.8 0.8 1.3 0.7 0.6 0.5 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.5 0.3 0.4 4.2 0.6 3.0 0.1 0.1 4.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CEBPA "C/EBP-alpha, CEBP" ENSG00000245848 "CCAAT/enhancer binding protein alpha" P49715 19 33299934-33302564 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.3;liver: 44.3" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 84.7;Hofbauer cells: 76.1;Suprabasal keratinocytes: 150.2;Syncytiotrophoblasts: 177.5" "Cancer enhanced" "Detected in all" "liver cancer: 70.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.0;non-classical monocyte: 11.8" "Group enriched" "Detected in many" 13 "dendritic cells: 4.1;granulocytes: 11.0;monocytes: 11.8" "Cell line enhanced" "Detected in some" "BEWO: 43.5;Hep G2: 23.3;NB-4: 24.0;THP-1: 86.8;U-937: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA052734, HPA065037, HPA067937" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927" "unprognostic (1.80e-1)" "unprognostic (7.62e-3)" "unprognostic (2.09e-3)" "unprognostic (2.21e-2)" "unprognostic (3.38e-1)" "unprognostic (3.99e-2)" "unprognostic (1.94e-1)" "unprognostic (2.43e-3)" "unprognostic (5.95e-2)" "unprognostic (3.96e-2)" "unprognostic (3.09e-1)" "unprognostic (9.45e-2)" "unprognostic (8.02e-3)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (2.72e-2)" 40.7 1.5 2.3 7.6 4.6 8.4 52.3 2.1 4.0 3.5 9.0 5.2 1.1 9.0 2.2 2.1 6.1 2.4 6.4 6.6 3.9 2.4 2.0 44.3 39.9 10.3 4.1 3.1 1.3 9.0 4.5 1.7 17.4 2.7 3.8 5.1 1.9 5.6 1.6 15.4 23.7 12.7 2.9 6.6 3.0 3.5 1.2 2.6 2.2 2.5 10.7 3.5 5.4 7.9 0.1 4.1 11.0 11.8 0.0 0.6 1.5 0.5 1.1 0.0 1.5 12.5 0.0 43.5 0.0 0.3 0.0 0.0 5.3 0.0 0.0 0.6 0.0 0.2 2.0 1.2 0.1 0.0 7.5 1.5 0.0 0.0 23.3 0.2 7.6 9.3 0.5 5.6 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 2.6 0.0 24.0 1.1 13.1 0.6 0.0 0.0 0.2 0.0 3.8 0.0 0.3 0.1 0.1 0.1 1.4 3.0 86.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 27.8 0.0 11.0 6.0 0.0 0.6 9.4 0.6 0.0 0.1 0.4 4.1 0.1 0.2 0.4 2.1 0.0 11.8 0.2 0.0 1.5 2.3 4.6 2.1 4.0 3.9 2.4 4.1 3.1 2.7 2.6 14.9 27.8 1.4 20.5 33.2 0.7 0.4 25.5 6.7 5.7 0.0 0.0 27.5 3.3 0.6 0.0 0.6 62.2 0.0 5.0 35.2 6.1 11.7 1.1 84.7 76.1 0.0 4.1 1.3 21.4 0.0 2.8 23.2 5.0 1.0 22.1 8.0 2.1 31.3 1.4 3.7 0.3 0.0 4.1 0.2 0.7 150.2 177.5 1.0 26.9 9.5 CEBPB "C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5" ENSG00000172216 "CCAAT/enhancer binding protein beta" P17676 20 50190734-50192689 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 121.9" "Cell type enhanced" "Detected in many" 7 "Smooth muscle cells: 658.6;Suprabasal keratinocytes: 699.3;Syncytiotrophoblasts: 1179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.6" "Group enriched" "Detected in many" 8 "granulocytes: 13.6;monocytes: 6.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB004213, HPA061355, HPA062267" Supported Enhanced Nucleoplasm Yes No Nucleoplasm "CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (1.24e-2)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "unprognostic (2.24e-2)" "unprognostic (1.32e-1)" "unprognostic (1.40e-3)" "unprognostic (1.79e-2)" "unprognostic (9.85e-3)" "unprognostic (9.26e-3)" "unprognostic (6.55e-2)" "prognostic unfavorable (2.44e-12)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.45e-2)" "unprognostic (7.63e-2)" 56.9 54.7 7.0 35.9 9.9 21.1 34.4 1.8 6.2 22.8 25.2 6.4 8.0 8.0 19.4 11.2 19.2 21.7 20.2 33.6 8.4 4.4 15.3 92.5 51.3 20.4 9.5 3.0 33.6 18.6 4.1 7.4 75.1 7.7 21.1 5.0 14.0 14.6 11.7 121.9 23.9 19.4 12.6 9.5 40.3 15.3 14.3 8.1 1.5 46.1 25.3 10.7 30.8 30.6 0.4 1.2 13.6 6.1 0.4 0.5 0.5 7.4 3.4 0.3 4.1 19.3 7.6 33.5 10.1 16.0 7.0 6.2 3.4 6.9 4.9 19.4 4.1 34.4 10.2 1.0 9.9 4.7 3.5 2.5 1.5 4.4 5.0 23.8 2.4 9.8 8.1 26.3 8.9 15.8 14.6 0.9 5.1 7.1 9.1 4.3 2.8 1.1 5.3 2.1 7.1 9.9 3.5 1.0 5.5 2.3 1.8 2.0 1.3 8.4 20.9 45.0 2.3 5.5 13.8 1.3 14.6 11.1 12.4 9.7 19.4 8.0 4.3 26.6 5.6 6.3 5.9 3.0 9.1 0.4 5.3 0.1 0.4 0.4 0.5 1.2 0.3 0.3 0.2 13.6 0.4 6.1 0.0 0.2 0.5 7.0 9.9 1.8 6.2 8.4 4.4 9.5 3.0 7.7 8.1 32.8 78.5 51.8 281.2 643.3 2.2 40.0 84.1 21.4 31.8 43.6 0.0 157.2 26.6 27.6 4.6 30.6 66.5 0.0 11.5 550.7 468.0 220.5 50.7 350.5 326.4 3.2 64.1 81.0 362.0 5.0 120.0 403.2 205.8 1.8 77.9 46.2 16.6 52.6 90.5 50.0 3.3 155.2 658.6 0.7 9.1 699.3 1179.1 63.8 45.7 245.2 CEBPE CRP1 ENSG00000092067 "CCAAT/enhancer binding protein epsilon" Q15744 14 23117304-23119616 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 87.1;bone marrow: 29.4" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 6.4" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" "Cell type enriched" "Detected in single" 201 "eosinophil: 87.1" "Lineage enriched" "Detected in single" 237 "granulocytes: 87.1" "Group enriched" "Detected in some" 4 "HL-60: 59.4;NB-4: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002928, CAB005113" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB005113: AB_631240, HPA002928: AB_1078494" "unprognostic (1.33e-2)" "unprognostic (4.76e-2)" "unprognostic (4.19e-2)" "unprognostic (2.04e-1)" "unprognostic (5.01e-2)" "unprognostic (1.66e-3)" "unprognostic (2.84e-1)" "unprognostic (1.49e-2)" "unprognostic (3.33e-2)" "unprognostic (5.69e-2)" "unprognostic (9.03e-2)" "unprognostic (2.22e-1)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.57e-2)" "unprognostic (8.19e-2)" 0.3 0.0 0.1 0.8 0.2 29.4 0.1 0.1 1.3 0.1 0.1 0.1 0.1 1.4 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.1 0.2 2.7 0.2 0.3 0.1 0.1 0.1 0.0 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.9 0.1 0.3 7.7 0.4 0.1 0.1 2.6 0.1 0.1 0.8 0.2 0.1 0.0 0.1 87.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 10.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 30.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.3 87.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 1.3 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.6 1.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CECR2 KIAA1740 ENSG00000099954 "CECR2, histone acetyl-lysine reader" Q9BXF3 22 17359949-17558149 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1;skeletal muscle: 30.6" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 94.7" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.8;HAP1: 11.7;K-562: 6.4;NTERA-2: 18.7;SCLC-21H: 8.4;SuSa: 7.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002943 Approved Approved Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA002943: AB_1078496" "unprognostic (2.46e-2)" "unprognostic (4.10e-2)" "unprognostic (7.99e-2)" "unprognostic (1.92e-3)" "unprognostic (7.48e-3)" "unprognostic (2.46e-3)" "unprognostic (2.49e-1)" "unprognostic (6.67e-2)" "unprognostic (8.18e-2)" "unprognostic (3.94e-1)" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (8.13e-6)" "unprognostic (1.13e-1)" "unprognostic (1.59e-1)" "unprognostic (6.56e-2)" "unprognostic (1.94e-2)" 1.8 1.3 4.6 1.0 8.8 1.5 2.0 25.1 8.4 1.1 1.2 10.6 0.8 1.0 4.3 1.7 1.4 2.5 1.0 4.4 6.1 2.8 1.9 6.5 4.1 0.9 8.0 4.0 5.4 5.6 0.8 8.4 4.7 5.8 2.3 1.1 4.9 1.9 1.1 30.6 1.6 1.2 2.2 5.7 1.4 1.1 6.0 8.0 0.0 2.7 2.2 0.9 2.3 2.5 0.2 0.1 0.9 0.8 0.5 0.1 0.0 0.1 0.0 12.8 4.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 11.7 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 6.4 0.0 0.0 0.1 0.0 0.4 18.7 0.0 0.0 1.4 0.8 0.0 0.0 4.1 8.4 0.0 0.0 0.1 0.7 7.8 1.3 2.0 0.1 0.1 2.8 0.0 0.0 4.8 1.1 1.0 0.0 0.0 0.1 0.3 0.8 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.9 0.5 0.1 0.0 0.0 0.0 4.6 8.8 25.1 5.0 6.1 2.8 8.0 4.0 5.8 8.0 6.0 8.8 0.0 0.8 0.0 21.9 10.0 0.0 1.4 1.2 1.8 159.0 7.6 0.0 0.0 3.1 1.9 0.0 0.0 0.2 2.0 0.3 1.6 0.0 9.7 0.6 4.8 0.0 3.7 0.0 3.2 1.1 0.0 0.0 0.0 0.0 22.4 0.2 0.0 1.1 1.1 94.7 6.5 1.0 1.5 15.5 0.1 27.6 0.0 0.0 3.7 CEL "BSSL, MODY8" ENSG00000170835 "Carboxyl ester lipase" 9 133061978-133071861 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 348 "pancreas: 1584.8" "Cell type enriched" "Detected in some" 19 "Exocrine glandular cells: 809.5" "Cancer enriched" "Detected in many" 29 "pancreatic cancer: 469.3" "Region enriched" "Detected in single" 9 "cerebral cortex: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "JURKAT: 9.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA008023, HPA052701" Enhanced "Secreted to digestive system" NA NA "HPA008023: AB_1846509, HPA052701: AB_2681921" "prognostic unfavorable (4.14e-4)" "unprognostic (2.30e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-2)" "unprognostic (2.22e-1)" "unprognostic (2.48e-1)" "unprognostic (1.49e-1)" "unprognostic (6.27e-2)" "unprognostic (3.04e-2)" "unprognostic (1.47e-2)" "unprognostic (2.51e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-3)" "unprognostic (2.98e-1)" "unprognostic (4.41e-1)" "unprognostic (4.37e-2)" "unprognostic (1.02e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.1 0.2 2.9 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 3.5 0.2 0.2 0.2 0.8 1584.8 0.0 4.5 0.2 0.2 0.2 0.0 0.2 0.2 4.5 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 1.6 0.2 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.4 1.1 4.2 2.6 1.4 1.0 4.2 0.8 0.5 0.6 0.8 1.2 0.8 1.2 2.0 0.8 0.7 2.9 0.9 7.8 0.2 2.5 1.6 2.1 0.5 2.7 0.6 0.9 7.9 2.1 5.1 0.7 0.5 1.8 0.8 9.9 1.3 1.0 0.7 1.7 1.2 4.1 6.9 0.9 1.3 2.3 1.2 0.9 0.5 3.6 7.2 1.7 0.9 0.9 0.4 6.3 1.3 3.7 0.6 2.0 2.6 2.3 0.5 0.5 4.2 1.0 0.0 2.0 1.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.2 2.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 1.7 0.0 0.7 1.6 2.5 0.0 0.0 0.0 0.0 0.1 3.3 1.7 0.2 0.0 3.3 0.0 809.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 11.8 0.0 1.1 42.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.3 0.3 0.0 1.2 1.7 CELA1 ELA1 ENSG00000139610 "Chymotrypsin like elastase family member 1" Q9UNI1 12 51328443-51346679 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 6.3;blood: 12.6;pancreas: 11.8" "Group enriched" "Detected in some" 6 "Exocrine glandular cells: 15.1;Kupffer cells: 7.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Cell type enhanced" "Detected in many" "basophil: 9.0;naive CD4 T-cell: 12.6" "Group enriched" "Detected in many" 7 "granulocytes: 9.0;T-cells: 12.6" "Cell line enriched" "Detected in some" 4 "BEWO: 11.0" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (3.54e-2)" "unprognostic (1.64e-1)" "unprognostic (4.73e-2)" "unprognostic (2.73e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.13e-1)" "unprognostic (3.59e-2)" "unprognostic (3.83e-3)" "unprognostic (2.52e-1)" "unprognostic (1.46e-1)" 0.0 6.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 11.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.9 9.0 1.6 0.2 12.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.0 1.6 0.1 1.1 0.8 0.4 0.3 2.7 0.8 0.9 0.0 12.6 5.9 0.2 0.2 0.9 0.0 0.3 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 15.1 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 CELA2A ELA2A ENSG00000142615 "Chymotrypsin like elastase family member 2A" P08217 1 15456728-15472091 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1559 "pancreas: 2376.3" "Cell type enriched" "Detected in some" 19 "Exocrine glandular cells: 6761.1" "Cancer enriched" "Detected in single" 3819 "pancreatic cancer: 463.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 5.0;K-562: 1.1;U-2 OS: 1.6" "Secreted to digestive system" NA NA "unprognostic (9.78e-2)" "unprognostic (3.33e-2)" "unprognostic (5.60e-2)" "unprognostic (5.27e-2)" "unprognostic (3.63e-3)" "unprognostic (2.35e-1)" "unprognostic (4.14e-1)" "unprognostic (1.96e-2)" "unprognostic (1.38e-1)" "unprognostic (2.48e-1)" "unprognostic (3.94e-9)" "unprognostic (4.10e-2)" "unprognostic (3.42e-1)" "unprognostic (3.55e-2)" 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 2376.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 1.2 0.0 0.0 0.0 1.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.1 0.0 0.0 0.0 6761.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 36.1 0.0 0.0 361.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CELA2B "ELA2B, RP11-265F14.2" ENSG00000215704 "Chymotrypsin like elastase family member 2B" P08218 1 15465909-15491400 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 188 "pancreas: 697.9" "Cell type enriched" "Detected in some" 42 "Exocrine glandular cells: 1081.3" "Cancer enriched" "Detected in single" 574 "pancreatic cancer: 69.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.7;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.7" "Cell line enriched" "Detected in some" 5 "U-138 MG: 9.3" "Secreted to digestive system" NA NA "unprognostic (4.36e-3)" "unprognostic (5.45e-2)" "unprognostic (6.66e-2)" "unprognostic (5.31e-3)" "unprognostic (4.47e-3)" "unprognostic (1.37e-3)" "unprognostic (4.66e-2)" "unprognostic (6.32e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-1)" "unprognostic (2.94e-1)" "unprognostic (3.85e-2)" "unprognostic (1.22e-6)" "unprognostic (2.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.88e-1)" "unprognostic (7.80e-2)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 697.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.7 0.2 0.0 0.5 0.0 0.1 1.5 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.7 1.0 1.8 0.7 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.2 1.1 0.0 0.0 0.0 0.0 0.4 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.5 0.4 0.0 0.0 9.3 0.0 0.0 0.0 0.9 0.1 0.3 0.4 0.0 0.0 3.7 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1081.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CELA3A "ELA3, ELA3A" ENSG00000142789 "Chymotrypsin like elastase family member 3A" P09093 1 22001656-22012539 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2051 "pancreas: 2541.2" "Cell type enriched" "Detected in some" 31 "Exocrine glandular cells: 30160.2" "Cancer enriched" "Detected in some" 2497 "pancreatic cancer: 1481.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "MOLT-4: 21.6" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (1.27e-1)" "unprognostic (2.71e-1)" "unprognostic (1.79e-1)" "unprognostic (6.32e-2)" "unprognostic (2.67e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 2541.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 29.3 0.0 0.0 0.0 30160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.3 0.0 0.0 164.1 0.0 0.0 964.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CELA3B "CBPP, ELA3B" ENSG00000219073 "Chymotrypsin like elastase family member 3B" P08861 1 21977021-21998642 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 196 "pancreas: 1614.4" "Cell type enriched" "Detected in some" 24 "Exocrine glandular cells: 12399.8" "Cancer enriched" "Detected in single" 1218 "pancreatic cancer: 408.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA028086, HPA045650" Supported Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA028086: AB_2672482, HPA045650: AB_2679407" "unprognostic (2.89e-1)" "unprognostic (4.01e-3)" "unprognostic (6.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (6.40e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1614.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.9 5.3 8.2 3.0 2.3 3.2 0.9 0.6 5.0 1.7 1.3 2.5 1.5 2.2 1.2 1.8 1.8 1.7 5.4 2.7 5.5 2.7 1.5 2.2 1.6 1.0 0.5 0.0 2.5 4.1 2.4 4.9 4.0 1.3 1.9 3.2 2.3 2.4 1.5 0.0 2.7 2.5 3.6 2.5 5.6 0.4 2.6 2.2 1.5 1.4 0.9 3.5 3.6 0.9 4.3 0.0 3.6 3.2 1.8 3.5 0.8 0.3 3.7 2.6 2.8 3.7 2.9 1.6 2.3 1.0 4.9 4.8 2.5 1.9 4.8 0.6 5.1 2.5 1.8 3.1 3.0 2.0 3.7 2.2 2.8 1.4 5.9 3.2 3.0 8.2 2.3 1.7 5.3 2.9 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 65.6 0.0 4.9 0.0 12399.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.0 0.9 0.0 0.0 105.6 0.0 0.0 510.5 7.0 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 CELF3 "BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4" ENSG00000159409 "CUGBP Elav-like family member 3" Q5SZQ8 1 151702404-151716814 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.8;brain: 44.0;pituitary gland: 31.2" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 93.5;Cone photoreceptor cells: 37.3;Horizontal cells: 19.1;Intestinal endocrine cells: 50.7" "Group enriched" "Detected in many" 5 "glioma: 4.4;pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 28.6;SH-SY5Y: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006292 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA006292: AB_10602250" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (7.67e-2)" "unprognostic (1.96e-1)" "unprognostic (1.75e-1)" "unprognostic (6.64e-2)" "unprognostic (1.38e-1)" "unprognostic (3.02e-2)" "unprognostic (3.12e-1)" "unprognostic (3.48e-3)" "unprognostic (3.49e-3)" "unprognostic (6.90e-2)" "unprognostic (1.82e-8)" "unprognostic (8.50e-2)" "unprognostic (9.01e-2)" "unprognostic (2.41e-1)" "unprognostic (3.05e-2)" 1.1 16.8 21.4 1.4 28.9 1.1 1.0 29.2 44.0 1.0 2.1 2.0 0.0 5.0 1.0 1.0 1.1 2.1 1.0 1.0 19.5 16.2 1.1 1.0 1.1 1.0 5.3 15.3 1.0 8.8 1.0 31.2 1.2 3.7 1.1 2.1 3.7 1.0 1.0 1.0 1.0 3.8 1.2 1.5 1.0 8.5 2.0 4.4 0.0 1.1 0.0 1.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 28.6 20.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 28.9 29.2 29.1 19.5 16.2 5.3 15.3 3.7 4.4 0.0 0.0 0.0 0.0 0.0 93.5 0.8 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 19.1 50.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.0 0.0 0.3 4.8 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 CELF4 BRUNOL4 ENSG00000101489 "CUGBP Elav-like family member 4" Q9BZC1 18 37243047-37566037 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 69.1" "Group enriched" "Detected in many" 5 "Bipolar cells: 75.9;Horizontal cells: 278.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013322, HPA037986" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA013322: , HPA037986: AB_10673035" "unprognostic (7.87e-3)" "unprognostic (2.31e-2)" "unprognostic (4.31e-3)" "unprognostic (3.42e-7)" "unprognostic (2.95e-2)" "unprognostic (2.95e-2)" "unprognostic (3.72e-3)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.92e-2)" "unprognostic (1.00e-2)" "unprognostic (3.49e-1)" "unprognostic (1.69e-2)" "unprognostic (2.48e-1)" "unprognostic (8.32e-3)" "unprognostic (6.13e-2)" 1.4 10.7 40.2 1.7 25.2 1.1 1.3 45.3 69.1 1.1 1.6 0.9 0.0 1.6 1.3 1.5 1.4 1.3 2.0 1.7 27.0 26.3 1.4 1.3 1.4 1.6 13.5 26.3 2.0 4.2 1.2 8.1 1.7 13.1 1.5 1.3 0.5 2.5 1.1 8.3 2.0 1.9 1.3 3.7 1.7 1.6 3.9 5.6 0.0 2.3 0.0 1.0 1.2 0.0 0.7 0.5 2.4 0.9 0.9 0.9 0.4 0.1 0.1 0.5 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.2 0.7 0.0 0.1 0.4 0.0 0.1 0.0 0.5 0.3 0.0 1.2 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.1 0.4 1.1 0.0 0.2 0.1 0.0 1.4 0.0 0.1 31.7 7.7 0.8 0.2 0.0 0.2 0.2 0.1 0.0 1.0 0.4 0.2 0.1 2.0 0.3 0.1 0.1 0.1 0.1 2.4 0.5 0.5 0.7 0.6 0.7 0.7 0.4 0.4 0.3 0.7 0.8 0.9 1.3 0.9 0.9 0.5 0.6 0.4 40.2 25.2 45.3 31.1 27.0 26.3 13.5 26.3 13.1 5.6 0.0 0.0 0.0 1.4 0.3 75.9 1.5 0.0 0.0 0.0 0.0 39.3 0.2 0.0 0.2 37.5 0.6 0.3 0.0 0.9 0.1 0.7 2.1 0.0 0.0 6.4 278.1 12.2 1.3 0.0 19.6 0.6 0.0 0.0 0.0 0.0 6.0 4.1 0.0 4.9 1.3 20.9 0.0 0.0 10.0 4.3 0.5 0.2 0.0 0.1 0.8 CELF5 BRUNOL5 ENSG00000161082 "CUGBP Elav-like family member 5" Q8N6W0 19 3224703-3297076 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 35.8" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 91.5" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 6.1;REH: 7.5;SCLC-21H: 7.8;SH-SY5Y: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042012, HPA060336" Enhanced Supported NA NA "HPA042012: AB_10796896, HPA060336: AB_2684256" "unprognostic (1.09e-1)" "unprognostic (9.24e-2)" "unprognostic (9.25e-3)" "unprognostic (3.48e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (1.35e-1)" "unprognostic (4.70e-3)" "unprognostic (1.11e-2)" "unprognostic (1.74e-3)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" "unprognostic (1.25e-1)" "unprognostic (8.07e-2)" 0.8 1.1 16.2 0.8 21.2 0.7 1.5 19.6 35.8 0.8 1.0 0.8 0.0 0.8 1.3 1.1 0.8 1.5 0.7 0.8 9.5 12.2 0.8 0.8 0.8 0.7 2.6 15.5 7.1 1.1 2.6 0.5 0.8 3.4 0.9 1.0 0.0 2.0 1.0 1.3 0.8 0.9 0.8 0.9 0.8 1.2 2.5 2.7 0.2 0.8 0.0 0.7 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.4 1.3 1.7 0.0 0.0 1.3 0.0 0.1 0.1 0.0 0.0 0.3 0.0 1.0 0.0 0.4 0.1 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.1 0.1 0.0 1.0 0.1 0.0 6.1 2.4 0.1 7.5 0.0 0.0 0.0 0.0 7.8 4.7 0.3 0.5 0.0 0.3 0.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 21.2 19.6 19.6 9.5 12.2 2.6 15.5 3.4 2.7 0.0 0.0 0.0 1.7 0.3 91.5 1.7 5.1 0.0 0.0 0.0 0.0 0.3 0.0 0.5 15.0 0.0 0.2 0.0 0.2 0.1 0.2 1.6 0.0 0.4 0.1 7.9 1.2 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.9 2.0 0.7 0.0 2.1 0.0 3.5 0.0 0.5 1.1 8.3 0.3 0.0 0.0 1.2 0.8 CELF6 BRUNOL6 ENSG00000140488 "CUGBP Elav-like family member 6" Q96J87 15 72284727-72320129 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Group enriched" "Detected in some" 9 "Ciliated cells: 1.4;Cone photoreceptor cells: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 7.7;U-937: 4.2" "HPA046985, HPA053526" Uncertain NA NA "HPA046985: AB_2679891, HPA053526: AB_2682178" "unprognostic (6.83e-3)" "unprognostic (7.06e-3)" "unprognostic (9.55e-2)" "unprognostic (2.77e-1)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-4)" "unprognostic (1.16e-1)" "unprognostic (1.14e-2)" "unprognostic (2.16e-1)" 2.0 9.8 18.4 1.6 14.0 3.9 2.3 10.6 18.5 4.5 3.3 2.1 0.7 1.7 6.8 12.6 0.8 5.6 3.2 2.0 13.7 17.5 5.9 1.7 2.7 2.7 5.2 17.3 8.5 1.5 2.2 12.3 2.9 13.7 3.5 2.8 3.8 1.7 7.2 0.7 2.5 3.1 3.5 5.5 3.1 2.0 7.2 2.6 0.7 7.3 0.7 2.1 1.8 2.1 0.3 0.1 1.2 0.0 0.3 0.7 0.1 0.0 0.0 0.3 0.1 1.4 0.7 0.8 0.1 0.4 0.0 0.4 0.0 0.0 1.5 0.0 0.1 0.0 0.7 0.5 0.0 0.2 0.5 0.7 0.1 0.0 1.4 0.9 0.3 2.5 1.3 3.2 0.1 0.2 0.7 0.0 1.2 0.0 3.2 0.0 0.0 0.2 0.6 0.0 0.0 0.0 3.1 0.2 0.2 0.2 1.5 1.3 2.4 0.0 0.2 2.8 0.4 0.0 0.4 0.0 0.0 0.5 2.6 0.1 7.7 2.2 0.1 0.1 4.2 0.0 0.0 0.0 1.2 0.7 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 18.4 14.0 10.6 18.5 13.7 17.5 5.2 17.3 13.7 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109250019-109275750 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.7;skin 1: 27.8" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 92.2;Muller glia cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.2;HaCaT: 24.9;MCF7: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol NA NA Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 1.5 2.3 12.6 1.1 16.0 0.9 5.4 9.2 31.7 6.9 1.8 13.7 3.4 1.4 3.1 4.3 10.9 18.8 1.8 5.3 17.1 8.1 5.6 1.2 1.8 1.3 10.0 15.4 1.2 4.8 7.8 2.3 1.6 8.3 3.5 1.4 5.4 6.4 10.4 9.3 27.8 1.5 2.4 14.1 1.0 2.0 11.0 8.6 0.5 10.9 2.7 3.2 2.3 6.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 7.0 6.6 25.2 4.6 0.0 0.0 6.8 0.8 0.6 1.5 0.4 1.0 0.2 1.2 5.7 0.5 1.2 24.9 6.5 4.0 0.8 0.1 2.7 0.5 6.0 1.4 0.5 0.3 3.2 0.1 9.8 0.6 0.4 5.7 0.3 4.0 4.1 0.3 0.0 28.7 0.7 0.3 8.1 0.8 1.2 6.4 2.3 0.3 5.5 2.4 10.2 4.8 3.8 8.5 5.4 6.2 8.0 1.6 0.0 0.0 4.6 0.4 6.2 1.6 0.4 0.3 1.4 0.5 2.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 16.0 9.2 31.7 17.1 8.1 10.0 15.4 8.3 8.6 8.9 5.3 0.0 4.8 14.0 7.2 9.4 5.1 2.7 4.5 17.4 3.9 1.9 1.7 2.2 4.9 0.8 0.5 0.0 0.4 1.0 1.0 2.1 1.1 5.9 0.9 92.2 1.7 0.0 0.0 5.3 3.1 0.5 10.1 0.0 0.3 32.3 1.7 0.0 18.0 2.7 5.2 6.5 2.0 0.9 3.4 19.9 0.5 0.0 1.2 5.7 CELSR3 "ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2" ENSG00000008300 "Cadherin EGF LAG seven-pass G-type receptor 3" Q9NYQ7 3 48636469-48662915 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;pituitary gland: 11.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 16.2;Cone photoreceptor cells: 15.7;Horizontal cells: 28.6;Intestinal endocrine cells: 8.6;Rod photoreceptor cells: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 4 "T-cells: 1.5" "Cell line enhanced" "Detected in many" "HDLM-2: 13.1;SH-SY5Y: 15.0;SiHa: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062866 Approved NA NA "HPA062866: AB_2684886" "unprognostic (7.80e-2)" "unprognostic (3.80e-2)" "unprognostic (4.89e-1)" "unprognostic (9.12e-4)" "unprognostic (1.51e-1)" "unprognostic (1.59e-6)" "unprognostic (3.61e-6)" "unprognostic (1.86e-1)" "unprognostic (1.46e-3)" "unprognostic (5.07e-2)" "unprognostic (2.13e-3)" "unprognostic (2.87e-3)" "unprognostic (3.26e-3)" "unprognostic (9.53e-2)" "unprognostic (1.42e-1)" "unprognostic (3.86e-2)" "unprognostic (1.73e-1)" 0.7 4.0 10.9 1.2 8.3 1.7 0.8 19.7 11.1 0.6 1.3 0.0 0.0 1.2 0.8 1.2 0.6 0.7 0.7 0.5 7.1 1.4 0.6 0.6 0.8 1.4 2.0 10.4 0.9 2.6 1.4 11.2 1.0 3.6 0.7 1.2 1.4 0.6 0.8 0.5 1.2 1.3 0.8 3.3 1.0 2.1 5.4 1.4 0.0 0.9 0.0 1.0 0.7 0.7 0.3 0.1 0.0 0.1 0.2 1.5 0.4 3.9 2.9 4.9 2.9 0.6 0.9 1.3 0.3 0.5 0.6 0.9 5.5 3.0 0.8 0.8 0.2 2.5 0.5 1.5 0.2 0.3 13.1 0.8 1.3 11.3 2.0 0.9 1.3 2.1 0.4 3.9 0.3 7.0 0.2 0.0 2.8 0.5 4.0 1.0 4.2 0.1 0.0 2.7 1.4 1.3 0.3 0.7 4.1 0.0 2.7 11.0 15.0 13.2 0.3 0.5 0.7 6.5 2.5 0.1 4.8 4.7 6.4 2.3 0.3 7.2 3.5 3.4 0.9 7.6 0.0 0.1 0.0 1.0 0.0 0.2 0.3 0.2 0.2 0.1 0.0 0.3 1.5 0.0 0.2 0.0 0.0 1.1 0.4 10.9 8.3 19.7 11.1 7.1 1.4 2.0 10.4 3.6 1.4 0.0 0.3 0.5 0.1 0.3 16.2 2.5 0.0 0.0 0.0 0.0 15.7 0.2 0.0 0.1 2.8 0.0 0.4 0.0 0.0 0.2 0.2 0.1 1.1 0.4 0.2 28.6 8.6 0.6 0.0 1.6 0.3 0.0 0.0 0.0 1.8 0.8 0.2 0.0 0.0 0.0 11.2 0.0 0.0 5.9 3.4 0.4 0.1 0.0 0.2 0.0 CEMIP "HYBID, IR2155535, KIAA1199, TMEM2L" ENSG00000103888 "Cell migration inducing hyaluronan binding protein" Q8WUJ3 15 80779343-80951776 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "endometrium 1: 33.9;lymphoid tissue: 116.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 2.5;Club cells: 7.9;Cone photoreceptor cells: 5.9;Fibroblasts: 7.2;Horizontal cells: 3.2;Intestinal endocrine cells: 4.6;Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 42.9;BJ hTERT+: 67.9;fHDF/TERT166: 53.9;HSkMC: 37.1;hTERT-RPE1: 40.5;U-138 MG: 19.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 560000 "unprognostic (1.14e-3)" "unprognostic (6.80e-2)" "unprognostic (5.95e-2)" "unprognostic (3.15e-3)" "unprognostic (3.49e-3)" "unprognostic (6.80e-2)" "unprognostic (5.47e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (1.36e-1)" "unprognostic (5.27e-10)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.65e-4)" 6.7 2.1 1.7 11.6 5.0 1.7 1.0 6.8 8.9 2.4 6.9 6.4 2.6 1.2 33.9 7.8 7.1 7.0 2.8 6.4 2.2 2.8 1.1 1.0 16.6 116.9 14.1 9.4 5.3 1.4 0.7 9.1 2.9 15.6 2.5 2.4 15.4 5.9 3.2 4.3 6.2 1.6 0.9 13.6 2.0 1.3 3.3 1.1 0.0 4.4 0.7 5.0 6.5 3.1 0.9 1.5 0.6 0.5 0.2 1.3 0.2 0.1 1.6 0.3 0.2 0.1 0.6 0.2 42.9 67.9 1.1 0.9 0.5 0.2 0.2 0.1 53.9 0.2 1.0 0.0 0.1 0.2 0.1 0.4 0.1 0.2 3.5 0.4 0.1 0.2 37.1 0.0 8.4 0.0 40.5 0.0 0.2 0.2 0.1 1.0 0.9 0.1 0.1 0.2 14.2 1.9 0.2 0.0 0.1 0.0 0.7 2.7 0.1 0.7 0.1 3.6 0.6 0.2 0.0 0.2 19.6 0.1 1.4 0.7 0.1 0.1 0.2 2.1 0.3 1.3 0.0 0.3 0.0 0.4 0.4 0.1 0.6 0.0 0.2 0.0 0.9 0.0 0.7 0.6 0.2 0.5 1.5 1.3 0.2 1.7 5.0 6.8 8.9 2.2 2.8 14.1 9.4 15.6 1.1 0.0 1.0 0.0 0.4 0.0 2.5 0.8 0.0 0.0 7.9 0.0 5.9 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.1 7.2 0.8 1.1 0.0 0.3 3.2 4.6 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.4 0.9 CEND1 "BM88, FLJ90066" ENSG00000184524 "Cell cycle exit and neuronal differentiation 1" Q8N111 11 787104-790123 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 85.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 89.3;Horizontal cells: 71.5" "Cancer enriched" "Detected in many" 13 "glioma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 7.6;Karpas-707: 17.0;SCLC-21H: 30.5;SH-SY5Y: 11.4;U-266/70: 11.9;U-87 MG: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042527 Enhanced Supported Approved Mitochondria NA NA Mitochondria "HPA042527: AB_2678038" "unprognostic (4.62e-3)" "unprognostic (1.34e-4)" "unprognostic (9.66e-3)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.38e-5)" "unprognostic (2.20e-3)" "unprognostic (4.11e-2)" "unprognostic (6.72e-2)" "unprognostic (2.60e-2)" "unprognostic (2.26e-1)" "unprognostic (2.00e-3)" "unprognostic (4.24e-3)" "unprognostic (1.94e-3)" "unprognostic (4.43e-2)" "unprognostic (1.71e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" 1.9 8.2 28.5 2.9 34.7 1.8 1.8 46.5 85.2 1.8 2.3 8.3 1.3 2.5 1.9 2.0 2.2 1.8 1.9 2.1 34.2 25.3 2.1 1.8 1.8 2.1 32.0 30.7 1.8 1.9 1.9 5.1 1.8 42.4 3.2 1.9 2.1 1.8 3.6 1.8 1.9 2.7 2.3 10.2 1.8 1.9 1.9 5.9 0.0 1.8 0.0 2.0 2.1 0.1 3.6 0.2 0.0 0.7 0.0 1.9 0.3 0.0 0.4 0.4 0.7 0.1 0.1 0.1 0.7 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.3 7.6 0.3 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 17.0 0.3 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 30.5 11.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 11.9 3.2 0.7 15.9 0.1 0.2 0.0 0.0 0.0 0.9 0.7 0.3 3.6 1.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.3 28.5 34.7 46.5 65.2 34.2 25.3 32.0 30.7 42.4 5.9 0.0 0.0 0.0 0.1 0.1 89.3 0.4 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 71.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 17.6 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 CENPA "CenH3, CENP-A" ENSG00000115163 "Centromere protein A" P49450 2 26764289-26801067 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 53.7" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 27.3;Hofbauer cells: 12.7;Spermatogonia: 18.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB008371, HPA073086" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB008371: AB_591074, HPA073086: AB_2686569" "unprognostic (3.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (1.13e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (2.88e-8)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.69e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.21e-3)" "unprognostic (0.00e+0)" "unprognostic (5.74e-2)" "unprognostic (1.33e-1)" "unprognostic (7.68e-2)" "unprognostic (2.07e-1)" 1.2 0.9 0.2 12.1 0.2 3.5 3.0 0.2 0.2 1.3 3.5 0.4 0.3 5.3 0.9 1.5 8.5 0.1 1.2 1.5 0.2 0.3 0.8 0.7 1.4 8.2 0.3 0.0 0.5 0.7 0.0 0.3 3.1 0.3 0.5 3.2 0.1 1.7 0.0 0.3 4.5 3.6 0.8 0.3 4.9 1.8 7.8 0.0 53.7 0.4 9.2 10.0 1.3 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 31.2 7.2 11.2 6.2 0.9 1.8 9.3 9.7 7.4 13.1 11.3 5.2 10.2 9.4 6.3 3.5 15.4 9.2 10.0 5.1 13.0 27.9 9.8 15.9 3.3 8.7 0.3 9.2 17.8 0.1 0.6 5.2 7.2 2.0 6.7 11.6 12.8 19.5 10.3 10.5 13.3 14.2 10.0 10.4 13.3 15.9 20.0 10.4 5.7 1.4 9.6 9.7 9.3 10.4 7.6 4.0 6.2 9.9 4.8 8.1 20.6 9.6 16.0 19.4 19.2 38.4 3.9 19.0 15.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.4 0.0 0.4 0.0 0.2 27.3 1.0 0.9 0.0 0.0 12.7 0.0 4.1 2.5 1.6 0.0 0.9 1.8 1.7 0.0 3.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 7.1 18.1 4.5 2.9 1.7 3.7 2.1 CENPE "KIF10, PPP1R61" ENSG00000138778 "Centromere protein E" Q02224 4 103105806-103198409 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein, Motor protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.3;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 93.5;Spermatocytes: 69.2;Spermatogonia: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA042294 Enhanced Approved Nucleoplasm,Microtubules,Cytosol NA Yes "Microtubules, Cytosol" Nucleoplasm "HPA042294: AB_10797386" "unprognostic (1.62e-1)" "unprognostic (1.03e-1)" "unprognostic (5.64e-3)" "unprognostic (2.55e-2)" "unprognostic (1.65e-1)" "unprognostic (3.44e-2)" "unprognostic (2.40e-8)" "unprognostic (2.49e-3)" "unprognostic (1.59e-2)" "unprognostic (3.38e-1)" "unprognostic (4.88e-5)" "unprognostic (1.15e-2)" "unprognostic (0.00e+0)" "unprognostic (9.95e-3)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (2.37e-1)" 2.7 0.9 0.6 9.4 1.5 11.3 0.7 0.2 1.3 1.0 2.1 0.5 0.0 1.9 0.7 1.9 5.9 0.5 0.8 2.5 2.0 0.8 1.3 0.6 1.4 7.3 1.9 0.6 0.7 0.5 0.1 0.4 3.1 1.4 0.7 2.7 0.2 2.2 0.8 0.4 2.2 2.4 1.4 1.3 3.3 1.6 6.6 0.6 25.1 0.6 5.9 6.4 1.5 1.9 0.6 0.5 5.7 3.0 0.8 1.4 0.2 20.9 6.0 21.9 10.6 1.5 3.4 4.3 19.1 9.6 14.3 9.5 9.5 11.4 14.2 4.9 7.0 10.0 9.4 15.7 7.7 22.6 17.7 5.8 16.7 12.6 6.9 0.2 19.8 9.7 1.0 0.6 11.4 9.6 3.2 12.0 13.0 17.3 17.0 18.3 7.6 15.6 8.9 7.0 8.5 9.4 10.5 20.5 4.7 4.0 4.2 10.1 6.0 16.9 11.8 4.6 8.8 6.7 7.0 13.0 13.8 14.5 14.3 19.5 8.3 14.2 14.8 7.7 11.1 14.6 5.7 0.1 0.7 0.2 0.6 0.0 0.6 0.4 0.4 0.2 0.2 0.1 0.3 0.1 0.8 3.0 0.5 1.4 0.2 0.6 1.5 0.2 1.3 2.0 0.8 1.9 0.6 1.4 0.6 3.0 2.1 0.0 1.0 3.2 7.1 1.4 0.0 0.0 1.2 0.0 7.9 2.4 0.0 0.4 3.4 2.8 0.5 93.5 0.0 22.1 1.5 1.3 6.9 0.8 11.2 0.0 1.2 4.3 7.3 0.7 0.9 5.5 0.0 8.2 1.4 1.4 1.3 0.6 2.5 0.0 2.5 0.0 2.5 69.2 47.7 2.5 3.0 2.5 4.7 0.6 CENPF hcp-1 ENSG00000117724 "Centromere protein F" P49454 1 214603195-214664588 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis" "Developmental protein" "Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 19.5;lymphoid tissue: 67.5" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052382, HPA064308, CAB070134" Enhanced Supported Nucleoplasm Yes Yes Nucleoplasm "CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711" "unprognostic (2.80e-1)" "unprognostic (2.16e-1)" "unprognostic (2.65e-1)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" "unprognostic (2.58e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.58e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" "unprognostic (1.89e-2)" "unprognostic (4.12e-1)" 1.6 1.5 1.0 10.7 1.3 19.5 1.1 0.4 0.9 2.1 5.6 0.3 0.0 4.6 1.2 1.7 9.4 0.8 0.4 1.7 0.6 0.6 1.0 0.8 3.2 6.2 0.6 0.5 1.4 0.6 0.0 0.4 6.4 0.8 0.7 4.5 0.4 1.9 0.0 0.5 4.7 6.4 1.6 1.5 3.8 2.3 9.4 0.6 67.5 0.6 7.6 7.6 1.4 2.9 0.3 0.3 0.0 0.0 0.7 1.9 0.2 32.6 18.5 39.9 20.8 1.5 2.0 15.6 20.2 8.3 12.2 12.0 14.7 20.2 31.1 12.0 11.2 11.0 20.3 24.6 13.2 20.7 27.1 15.4 25.5 28.4 20.9 0.2 36.1 14.0 0.7 1.0 17.5 20.2 3.5 12.7 14.3 23.0 18.6 21.7 12.4 21.3 14.4 35.3 9.8 8.2 22.7 56.4 10.2 11.9 8.1 18.7 25.5 27.3 18.2 10.5 22.2 21.7 13.8 16.7 22.1 26.0 18.3 41.7 14.3 15.4 29.9 9.6 26.1 19.5 0.0 0.0 0.0 0.4 0.0 0.1 0.2 1.4 0.4 0.3 0.3 1.9 0.8 0.0 0.7 0.0 0.3 1.7 0.2 1.0 1.3 0.4 0.9 0.6 0.6 0.6 0.5 0.8 0.6 0.0 1.9 40.2 1.2 8.2 3.2 1.9 2.5 26.8 14.8 0.0 0.0 9.1 0.0 1.8 32.4 2.8 1.3 303.7 0.4 74.0 7.7 1.0 1.1 1.9 26.4 1.6 0.0 9.8 11.2 9.4 1.1 9.9 1.7 0.0 5.3 1.1 0.5 0.0 2.8 0.0 2.8 0.0 0.3 20.9 88.3 4.8 4.2 10.9 15.5 0.9 CENPH ENSG00000153044 "Centromere protein H" Q9H3R5 5 69189548-69210357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.8;testis: 37.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 70.0;Spermatocytes: 122.1;Spermatogonia: 250.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036494 Approved Supported "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "HPA036494: AB_10673354" "unprognostic (1.49e-1)" "prognostic favorable (6.86e-4)" "unprognostic (1.73e-2)" "unprognostic (3.16e-2)" "unprognostic (2.32e-1)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.22e-5)" "unprognostic (6.14e-3)" "unprognostic (6.85e-2)" "prognostic favorable (2.50e-4)" "unprognostic (4.21e-2)" "unprognostic (8.80e-2)" "prognostic unfavorable (5.11e-15)" "unprognostic (1.17e-1)" "unprognostic (3.94e-1)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" 4.0 1.9 2.9 15.2 3.1 19.1 5.5 2.1 3.0 3.9 4.7 1.2 0.7 4.2 2.9 3.1 7.7 2.5 2.8 4.4 2.7 2.1 1.9 2.2 3.6 11.1 2.6 3.7 3.6 1.6 1.6 2.7 6.8 1.8 2.4 5.5 1.6 3.0 1.5 3.6 6.0 4.0 2.4 2.6 6.2 2.5 37.3 1.8 31.8 1.8 10.2 12.2 3.1 4.3 12.1 6.1 2.5 3.6 7.5 9.8 4.2 18.4 5.7 26.8 20.9 1.7 5.6 14.3 9.1 9.7 20.3 22.0 7.8 23.5 39.7 10.9 5.3 11.8 13.8 17.5 21.0 26.0 12.0 12.0 9.2 9.8 7.7 0.6 13.3 9.5 2.2 4.3 13.2 14.6 5.8 6.8 21.7 16.3 15.8 15.6 10.3 42.8 19.1 23.2 6.0 4.9 26.7 35.3 30.6 6.4 6.8 18.5 24.7 10.0 6.8 8.0 15.2 9.5 9.0 3.3 10.1 17.0 13.4 22.6 19.5 29.5 31.8 15.6 27.0 19.1 0.6 1.8 2.5 4.5 3.0 7.3 11.8 7.6 5.7 2.8 12.1 9.8 8.3 0.4 7.5 3.6 6.1 8.7 4.2 2.9 3.1 2.1 3.0 2.7 2.1 2.6 3.7 1.8 1.8 0.0 1.6 22.3 12.1 32.5 3.6 2.2 5.1 13.4 6.8 0.0 0.0 23.0 0.0 5.8 21.9 5.7 1.2 70.0 7.9 41.3 7.8 4.5 4.7 0.8 15.0 0.0 1.2 5.5 5.6 22.4 3.4 11.0 8.5 5.4 7.2 5.2 5.5 2.9 4.6 2.9 3.0 19.4 6.6 122.1 250.2 16.8 8.4 13.1 13.0 6.2 CENPI "CENP-I, FSHPRH1, LRPR1, Mis6" ENSG00000102384 "Centromere protein I" Q92674 X 101098218-101163681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.3" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 3.8;Hofbauer cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061297 Supported "Nuclear bodies,Cytosol" NA Yes "Nuclear bodies" Cytosol "HPA061297: AB_2684471" "unprognostic (3.10e-3)" "unprognostic (9.71e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (5.78e-6)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (3.62e-3)" "unprognostic (1.20e-3)" "unprognostic (4.51e-2)" "unprognostic (2.50e-13)" "unprognostic (1.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.42e-1)" 2.6 1.8 1.5 10.8 4.7 9.1 4.0 1.7 2.9 3.7 3.9 3.6 0.0 4.0 4.1 2.2 7.1 2.7 2.8 1.7 1.8 1.4 1.5 1.6 2.9 7.7 3.3 1.8 4.5 1.2 0.3 1.3 3.6 2.6 1.8 5.3 1.2 2.0 0.8 1.5 4.5 3.8 4.3 4.3 4.0 3.3 4.6 2.7 18.3 1.3 4.1 11.0 3.1 3.7 2.6 2.9 4.8 2.8 3.2 3.3 1.2 16.8 11.6 14.4 11.1 1.8 3.3 6.4 18.3 9.8 18.6 37.6 15.6 10.8 12.4 6.5 7.2 28.7 9.9 21.0 9.7 26.0 7.7 5.3 7.6 16.6 5.9 0.2 10.0 8.4 1.3 0.8 24.6 3.1 5.3 15.8 9.0 5.3 22.8 17.9 11.9 9.9 3.6 11.1 8.0 14.4 9.3 20.8 8.0 4.6 10.1 9.2 4.8 22.4 6.3 3.8 13.7 6.3 3.2 6.4 17.5 14.7 16.2 14.5 3.7 8.5 14.0 6.9 13.4 13.5 2.2 2.1 2.3 2.0 2.8 1.3 2.6 2.0 2.6 1.0 2.1 1.6 1.7 4.8 3.2 2.6 2.9 3.3 1.2 1.5 4.7 1.7 2.9 1.8 1.4 3.3 1.8 2.6 2.7 0.0 0.0 0.8 0.0 0.2 0.4 0.4 0.0 0.0 1.2 0.0 0.0 0.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 3.8 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.6 0.0 0.3 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 1.0 0.1 0.2 0.0 0.5 0.0 CENPK "CENP-K, FKSG14, SOLT" ENSG00000123219 "Centromere protein K" Q9BS16 5 65517766-65563171 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.5;testis: 29.0" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 40.2;Spermatocytes: 80.1;Spermatogonia: 74.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA Yes "unprognostic (4.04e-2)" "unprognostic (1.77e-2)" "unprognostic (1.57e-2)" "unprognostic (5.04e-2)" "unprognostic (1.85e-1)" "unprognostic (3.04e-3)" "unprognostic (3.69e-4)" "unprognostic (3.22e-3)" "unprognostic (9.59e-3)" "unprognostic (3.32e-2)" "unprognostic (3.16e-3)" "unprognostic (1.98e-2)" "unprognostic (6.33e-15)" "unprognostic (2.22e-1)" "unprognostic (2.97e-1)" "unprognostic (8.42e-2)" "unprognostic (3.11e-1)" 1.8 1.5 1.9 22.8 2.9 16.1 2.5 2.7 2.4 2.0 6.2 0.6 1.0 5.8 3.0 3.3 9.8 2.2 2.0 1.7 1.3 1.0 1.8 1.6 3.2 9.7 1.1 1.2 1.8 1.2 0.6 0.9 3.7 1.4 1.7 8.8 0.8 2.7 0.2 0.6 6.6 6.9 2.1 1.3 7.0 3.7 29.0 2.0 35.5 1.4 8.8 11.2 2.1 4.1 3.4 1.0 2.0 0.6 5.5 18.3 7.7 22.4 14.7 30.9 10.5 1.6 4.5 14.7 24.6 9.4 21.2 26.9 12.3 34.6 13.7 9.2 8.3 21.6 14.1 11.8 12.5 33.9 15.6 10.2 14.7 18.5 11.7 0.6 17.2 13.3 2.0 1.8 20.5 9.9 3.9 20.1 15.0 10.8 20.7 21.1 7.4 29.0 19.5 14.8 6.4 6.1 18.1 29.6 15.2 13.8 12.2 13.0 10.5 19.0 7.9 9.7 12.1 14.5 12.8 6.9 16.4 17.0 11.2 28.5 10.9 17.6 28.7 15.3 25.9 17.8 2.0 0.4 1.3 6.1 0.6 9.0 2.4 13.2 7.7 1.0 3.4 18.3 13.5 1.1 5.5 0.6 0.9 12.8 7.7 1.9 2.9 2.7 2.4 1.3 1.0 1.1 1.2 1.4 2.0 0.0 4.3 17.9 4.8 20.9 1.0 0.8 0.0 4.0 10.3 0.0 0.0 13.5 1.7 2.9 22.9 3.2 1.3 23.3 0.9 40.2 3.1 1.6 2.3 0.8 18.4 0.0 0.0 3.7 1.0 14.0 1.4 7.9 1.7 1.0 6.9 0.6 1.6 2.8 1.4 0.0 1.0 0.0 1.4 80.1 74.5 7.0 5.6 15.8 11.8 2.7 CENPL "C1orf155, dJ383J4.3, FLJ31044" ENSG00000120334 "Centromere protein L" Q8N0S6 1 173799550-173824720 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 29.5" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 70.0;Spermatocytes: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044520 Uncertain NA Yes "HPA044520: AB_10794500" "unprognostic (8.72e-3)" "unprognostic (2.82e-2)" "unprognostic (3.39e-1)" "unprognostic (1.34e-3)" "unprognostic (7.89e-2)" "unprognostic (7.88e-3)" "unprognostic (6.43e-6)" "unprognostic (8.18e-2)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.60e-4)" "unprognostic (1.78e-3)" "unprognostic (5.00e-2)" "unprognostic (1.46e-10)" "unprognostic (2.16e-2)" "unprognostic (4.41e-2)" "unprognostic (3.10e-2)" "unprognostic (3.09e-1)" 4.0 2.7 3.1 3.8 3.7 10.9 3.1 5.0 3.8 3.6 3.0 2.8 1.7 3.0 2.5 1.5 4.2 1.8 2.0 2.2 3.0 2.5 2.1 1.4 2.6 7.8 3.9 1.7 2.6 1.4 1.5 2.3 3.8 4.0 2.3 3.9 1.8 2.9 1.8 2.8 3.2 2.9 3.0 2.9 6.6 2.6 13.7 4.5 29.5 2.3 1.9 7.2 3.2 3.7 6.0 5.3 4.2 1.4 10.6 8.4 3.2 16.3 4.4 8.4 11.1 2.5 4.3 6.2 14.7 8.6 15.0 10.6 5.7 8.7 11.7 7.0 7.5 6.1 10.8 8.7 6.9 16.8 10.7 4.3 9.0 4.9 3.3 1.3 13.4 9.1 2.1 2.3 10.6 8.6 2.9 8.7 9.3 15.1 17.7 13.8 3.8 10.8 5.9 8.7 11.3 24.7 11.5 10.5 10.1 5.3 4.6 8.4 7.1 11.4 14.2 9.5 7.1 10.1 10.8 5.4 18.5 12.5 9.3 16.7 9.8 16.9 19.3 6.0 9.8 16.4 4.2 1.3 2.7 6.1 1.4 6.9 4.3 5.6 6.8 1.2 6.0 7.1 7.6 1.0 10.6 0.9 5.3 8.4 3.2 3.1 3.7 5.0 3.8 3.0 2.5 3.9 1.7 4.0 4.5 8.9 3.0 10.5 4.2 4.1 4.9 3.6 2.5 1.4 2.3 1.8 13.7 6.0 0.0 2.2 1.7 3.8 2.8 70.0 3.2 13.3 5.0 5.5 4.6 0.0 5.5 1.6 1.7 1.3 2.7 2.2 4.4 4.3 5.0 4.6 4.1 2.8 2.5 2.9 1.8 0.8 3.8 0.0 6.2 34.3 11.5 5.3 4.9 10.8 3.0 3.1 CENPM "C22orf18, CENP-M, MGC861, Pane1" ENSG00000100162 "Centromere protein M" Q9NSP4 22 41938721-41947164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;lymphoid tissue: 41.5" "Cell type enhanced" "Detected in many" 11 "B-cells: 48.5;Ciliated cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 19.5;T-reg: 23.3" "Group enriched" "Detected in many" 7 "B-cells: 19.5;T-cells: 23.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042404, HPA056500" Enhanced Enhanced Cytosol NA NA Cytosol "HPA042404: AB_2677981, HPA056500: AB_2683156" "unprognostic (3.78e-2)" "prognostic favorable (3.40e-5)" "unprognostic (7.15e-3)" "unprognostic (2.65e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.50e-5)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.99e-7)" "unprognostic (9.54e-3)" "unprognostic (2.44e-1)" "unprognostic (8.73e-2)" "unprognostic (5.61e-2)" 1.6 1.4 1.1 31.9 0.9 18.2 3.8 1.9 1.2 1.7 6.9 1.1 0.4 6.0 1.4 2.2 8.9 9.6 4.3 3.2 1.0 0.8 2.1 1.4 4.2 17.0 1.0 0.4 1.4 0.6 0.0 0.4 3.4 0.8 1.2 3.7 1.1 3.3 0.9 0.5 6.3 7.2 1.1 0.9 9.7 4.5 13.5 0.4 41.5 0.9 5.5 18.8 3.2 3.3 19.5 0.3 0.8 0.1 2.9 23.3 4.0 22.2 22.9 12.8 8.4 1.0 0.9 5.5 11.0 5.7 19.3 19.7 26.5 11.9 28.9 8.3 5.7 12.5 8.6 9.6 11.2 4.8 8.3 40.1 13.5 24.5 18.4 1.0 25.6 15.4 0.8 0.8 12.4 5.8 2.0 7.2 26.8 10.2 28.0 11.2 34.4 25.5 26.8 6.9 13.5 17.0 24.6 12.8 30.1 7.8 13.3 14.7 2.8 16.9 10.1 5.8 2.2 9.6 16.7 3.6 18.8 28.1 12.4 18.2 15.0 10.4 26.7 6.5 21.4 20.5 0.8 0.1 0.0 3.2 0.0 4.3 13.1 9.4 4.1 0.3 19.5 1.8 2.4 0.5 2.9 0.0 0.2 23.3 4.0 1.1 0.9 1.9 1.2 1.0 0.8 1.0 0.4 0.8 0.4 0.0 4.3 48.5 2.2 1.8 2.1 0.4 0.0 109.7 1.2 0.0 0.0 14.1 14.9 1.9 2.9 0.3 4.9 23.3 0.6 28.0 3.1 1.8 2.3 0.8 35.5 3.2 7.5 4.3 3.1 4.0 1.1 6.5 6.8 2.8 35.1 0.1 1.4 8.6 0.4 0.2 0.5 0.0 0.0 37.0 36.7 0.9 7.3 17.3 19.2 3.8 CENPO "CENP-O, MGC11266" ENSG00000138092 "Centromere protein O" Q9BU64 2 24793136-24822376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 28.7;testis: 28.9" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 9.5;Spermatocytes: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046189 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA046189: AB_2679579" "unprognostic (1.67e-2)" "unprognostic (2.42e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.79e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (1.73e-6)" "unprognostic (5.56e-2)" "unprognostic (4.02e-1)" "unprognostic (4.81e-2)" "unprognostic (5.93e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (5.71e-13)" "unprognostic (4.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" 6.9 6.0 6.6 7.6 7.8 15.4 6.3 6.2 11.9 4.4 6.6 8.3 2.6 6.5 4.6 3.9 6.3 3.6 3.4 3.3 8.4 6.4 5.3 3.5 4.9 9.2 6.2 6.5 6.6 4.9 4.2 5.2 6.7 7.9 4.4 7.9 3.6 4.1 2.8 5.6 7.9 6.0 4.6 6.3 6.6 4.8 28.9 5.7 28.7 5.0 6.5 11.4 4.7 4.9 1.6 4.1 0.3 1.2 2.1 3.5 1.3 13.9 16.6 19.3 10.2 2.3 3.6 10.7 16.9 10.1 24.1 18.5 21.1 7.1 9.7 2.0 10.5 14.1 7.5 18.9 6.5 16.2 12.6 9.9 15.3 10.5 14.0 1.1 12.7 11.6 1.7 1.1 24.0 5.3 4.4 11.1 11.7 17.8 11.1 14.8 9.8 17.4 9.3 13.8 9.5 10.5 14.1 25.0 5.2 6.1 8.6 12.7 13.9 10.0 7.9 3.7 9.1 7.6 5.4 7.1 22.3 20.4 7.4 18.8 6.8 9.0 19.7 6.9 12.5 17.0 0.0 1.2 0.0 3.5 0.9 1.5 1.6 1.6 2.0 1.9 1.3 1.2 2.7 0.3 2.1 1.1 4.1 2.7 1.3 6.6 7.8 6.2 11.9 8.4 6.4 6.2 6.5 7.9 5.7 3.0 2.1 1.4 0.6 1.0 1.0 4.5 0.0 0.0 1.2 3.5 0.0 1.9 1.7 1.4 3.2 0.9 1.8 0.0 1.2 9.5 2.0 0.5 1.1 0.8 4.1 1.6 0.0 2.5 1.8 7.0 0.3 1.0 1.7 1.0 1.6 1.5 1.0 0.0 1.1 1.4 0.3 0.0 1.4 12.0 7.5 1.3 2.4 0.8 1.3 0.7 CENPP "CENP-P, RP11-19J3.3" ENSG00000188312 "Centromere protein P" Q6IPU0 9 92325484-92620533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 56.2;Suprabasal keratinocytes: 88.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021787, HPA058945" Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA021787: AB_1846524, HPA058945: AB_2683860" "unprognostic (5.48e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.20e-1)" "unprognostic (2.43e-3)" "unprognostic (2.64e-2)" "prognostic favorable (3.65e-4)" "unprognostic (4.88e-5)" "unprognostic (8.06e-2)" "unprognostic (3.51e-3)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (6.68e-3)" "unprognostic (9.20e-8)" "unprognostic (1.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.11e-1)" "unprognostic (2.04e-1)" 5.0 5.1 6.8 8.9 8.8 15.5 4.9 14.9 7.4 6.0 3.8 3.5 1.4 4.5 6.4 4.1 8.4 3.6 4.6 4.3 5.4 4.6 3.5 3.2 3.5 7.8 6.1 4.5 4.6 7.5 7.8 9.4 5.3 6.8 4.8 4.5 5.5 5.0 2.8 11.8 30.0 3.2 4.8 4.4 5.4 3.0 8.7 6.5 14.8 3.0 7.4 9.1 4.4 8.0 6.7 4.8 4.1 10.3 5.1 8.2 4.0 7.9 5.0 7.1 5.1 2.9 3.2 6.7 8.4 4.7 10.5 8.4 2.3 4.6 10.1 3.9 2.7 9.7 9.6 6.8 4.6 9.8 14.4 8.0 10.3 4.5 3.3 1.5 21.1 10.0 3.4 2.6 10.2 6.6 1.4 5.3 10.0 11.1 14.7 8.0 5.0 29.6 6.4 5.7 15.0 9.5 10.0 11.6 11.3 1.6 8.0 15.8 5.5 9.5 6.1 3.0 5.3 3.2 6.5 2.5 10.3 5.1 15.5 12.0 9.8 11.4 13.3 11.5 10.5 9.3 3.0 3.2 4.1 4.9 10.3 8.2 6.7 5.3 4.1 3.6 5.7 5.0 4.8 0.8 5.1 5.1 4.8 5.7 4.0 6.8 8.8 14.9 7.4 5.4 4.6 6.1 4.5 6.8 6.5 0.0 0.3 1.5 3.6 56.2 6.4 2.0 2.5 0.0 1.2 0.0 7.9 2.7 1.7 0.9 15.3 3.1 0.7 0.0 2.0 8.2 5.6 2.1 0.0 0.8 13.9 1.6 1.2 1.3 1.3 3.6 4.0 3.0 13.5 0.0 0.6 2.5 1.2 0.0 4.6 1.1 7.5 6.5 6.7 11.1 5.7 88.2 3.2 4.3 1.7 2.4 CENPS "APITD1, CENP-S, FAAP16, MHF1" ENSG00000175279 "Centromere protein S" Q8N2Z9 1 10430443-10442809 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 42.8" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 50.9;Distal tubular cells: 31.5;Proximal tubular cells: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-1)" "prognostic favorable (1.24e-4)" "unprognostic (3.06e-3)" "unprognostic (2.21e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (4.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.26e-3)" "unprognostic (2.95e-2)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.04e-3)" "unprognostic (4.23e-2)" "unprognostic (4.66e-2)" "unprognostic (1.87e-1)" "unprognostic (9.21e-2)" 2.8 7.3 6.5 3.8 12.9 5.5 3.7 3.1 10.3 4.3 4.7 3.2 6.0 8.9 4.0 9.4 6.6 7.2 5.5 3.0 5.5 5.2 20.0 5.8 3.6 4.1 4.5 6.9 3.5 7.5 10.6 11.7 3.1 6.1 5.2 5.5 4.5 7.1 6.1 2.7 3.0 6.4 5.6 3.4 3.5 4.9 42.8 4.9 6.5 9.4 5.8 4.3 4.8 3.6 8.5 6.6 1.0 6.9 2.4 6.5 2.6 19.7 13.1 9.3 13.3 7.5 6.2 4.9 11.2 11.9 14.2 11.5 6.0 14.0 15.1 10.2 9.9 8.4 15.6 8.4 12.4 16.2 12.9 8.8 8.9 11.1 12.5 4.7 29.8 11.7 3.8 6.4 15.9 9.9 5.8 8.7 15.9 12.2 13.4 14.3 14.8 14.0 17.8 13.1 16.9 13.4 15.1 10.8 17.7 17.8 7.0 11.8 10.9 12.1 13.6 12.7 8.1 16.4 16.2 4.9 15.8 19.3 14.2 19.1 3.4 8.4 18.3 14.8 33.7 20.2 0.0 2.0 1.0 4.1 3.1 5.3 8.5 5.8 4.2 2.4 7.6 6.5 5.4 1.0 2.4 6.9 6.6 5.4 2.6 6.5 12.9 3.1 10.3 5.5 5.2 4.5 6.9 6.1 4.9 6.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 50.9 14.8 5.2 0.0 16.2 31.5 14.6 0.0 0.0 0.0 0.0 9.7 8.4 0.0 0.0 3.5 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 7.8 0.0 0.0 72.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 CENPS-CORT APITD1-CORT ENSG00000251503 "CENPS-CORT readthrough" 1 10430102-10452153 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 29.9" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 6.7;Club cells: 1.2;Proximal tubular cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (2.73e-1)" "unprognostic (8.54e-4)" "unprognostic (7.66e-2)" "unprognostic (1.08e-1)" "unprognostic (7.28e-2)" "unprognostic (4.61e-2)" "unprognostic (9.73e-3)" "unprognostic (6.21e-2)" "unprognostic (1.67e-2)" "unprognostic (4.97e-3)" "unprognostic (9.53e-2)" "unprognostic (1.96e-1)" "unprognostic (9.32e-4)" "unprognostic (2.31e-1)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (5.06e-2)" 1.2 1.9 4.5 1.3 6.6 10.6 1.9 1.8 5.1 1.3 2.0 1.0 2.6 3.3 1.2 3.2 2.1 2.1 2.3 1.2 3.5 3.6 4.4 2.2 1.3 2.2 3.4 3.1 1.2 3.4 1.5 5.9 1.0 2.7 1.8 0.8 1.7 3.2 2.7 1.1 1.3 2.4 2.4 1.9 1.6 2.7 29.9 2.0 2.9 4.6 2.5 2.2 1.1 1.4 9.0 2.9 1.9 1.4 3.2 4.5 1.6 8.4 12.2 6.5 0.6 0.9 0.9 1.1 8.4 1.7 13.2 5.3 5.2 2.9 8.0 4.6 1.5 2.7 5.1 4.2 3.4 0.9 7.2 5.8 14.5 3.2 8.9 0.2 19.3 8.1 0.0 1.8 9.1 0.8 2.5 1.6 4.4 3.8 5.0 0.4 4.5 6.6 5.6 2.7 2.0 5.6 7.3 6.7 8.1 2.5 1.7 3.0 4.1 10.1 4.2 2.0 1.8 3.1 4.3 3.5 6.5 13.6 4.0 7.3 1.2 3.5 11.8 5.2 20.9 5.9 0.0 1.0 1.0 0.9 1.4 1.4 6.9 1.7 2.8 1.2 9.0 1.7 1.3 1.9 3.2 0.9 2.9 4.5 1.6 4.5 6.6 1.8 5.1 3.5 3.6 3.4 3.1 2.7 2.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPU "CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1" ENSG00000151725 "Centromere protein U" Q71F23 4 184694618-184734133 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 353.4;Late spermatids: 668.4;Spermatocytes: 448.9;Spermatogonia: 166.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 14.1;eosinophil: 14.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.3" "Cell line enhanced" "Detected in many" "Karpas-707: 58.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022048 Supported "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA022048: AB_1853985" "unprognostic (1.47e-1)" "unprognostic (9.88e-2)" "unprognostic (5.02e-2)" "unprognostic (2.37e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (4.39e-3)" "prognostic unfavorable (7.51e-4)" "unprognostic (1.67e-3)" "unprognostic (3.34e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.11e-9)" "unprognostic (2.19e-2)" "unprognostic (7.40e-3)" "unprognostic (4.46e-2)" "unprognostic (2.74e-1)" 2.7 1.7 1.4 7.8 1.0 30.7 3.1 1.2 1.3 2.8 4.4 1.2 2.9 2.8 1.4 3.2 11.2 0.9 1.7 1.0 1.2 0.6 1.4 2.3 2.0 9.5 1.3 0.2 1.1 1.3 0.7 0.6 7.0 1.0 2.0 5.1 0.9 3.5 0.5 1.2 7.1 5.2 1.5 1.0 5.8 2.3 50.2 0.6 30.0 0.9 7.3 9.1 1.6 4.5 0.8 1.7 14.3 2.8 3.0 2.5 0.7 23.3 6.6 28.4 14.3 1.5 2.5 15.1 14.1 6.3 11.6 8.0 7.9 13.5 19.5 1.3 6.6 8.9 9.4 23.4 14.4 11.8 9.4 9.3 16.8 6.0 4.0 0.2 29.6 11.7 1.2 0.7 14.2 2.7 3.9 12.0 20.2 18.4 58.6 21.6 15.5 38.0 18.9 15.0 5.6 8.9 30.1 9.2 5.7 6.4 9.0 20.1 21.4 10.2 13.1 10.7 12.1 18.0 16.2 7.2 10.4 13.5 10.6 16.2 8.7 8.7 16.0 14.5 23.0 33.9 14.1 0.7 14.3 0.6 1.9 0.4 0.8 1.0 1.0 0.5 0.8 0.6 0.8 0.1 3.0 2.8 1.7 2.5 0.7 1.4 1.0 1.2 1.3 1.2 0.6 1.3 0.2 1.0 0.6 8.9 2.7 6.0 3.6 12.4 0.9 2.4 2.5 6.7 10.3 1.8 0.0 13.0 3.3 4.4 353.4 0.7 1.1 23.3 2.2 45.0 5.2 2.9 9.2 0.8 18.2 0.0 0.0 1.3 5.4 668.4 8.3 9.9 0.0 7.2 5.6 0.3 2.7 0.0 6.3 0.6 1.3 19.4 1.0 448.9 166.7 18.7 6.3 4.4 8.5 5.4 CENPVL1 "CENPVP1, PRR6L1" ENSG00000223591 "Centromere protein V like 1" X 51710512-51712131 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.6;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.2;PC-3: 2.8;SH-SY5Y: 1.6;SuSa: 1.1;U-2 OS: 2.9" NA NA 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPVL2 CENPVP2 ENSG00000283093 "Centromere protein V like 2" X 51681212-51682831 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.6;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.2;PC-3: 2.8;SH-SY5Y: 1.6;SuSa: 1.1;U-2 OS: 2.9" NA NA 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPVL3 CENPVP3 ENSG00000224109 "Centromere protein V like 3" X 51617024-51618968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 4.7;testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 4.9;PC-3: 15.9;U-2 OS: 11.0" NA NA "unprognostic (3.07e-2)" "unprognostic (1.48e-1)" 0.0 1.4 0.6 0.0 4.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CENPW "C6orf173, CUG2" ENSG00000203760 "Centromere protein W" Q5EE01 6 126340174-126348875 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.2" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 184.2;Extravillous trophoblasts: 133.8;Spermatocytes: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067285 Supported Nucleoplasm NA NA Nucleoplasm "HPA067285: AB_2685818" "unprognostic (3.51e-3)" "unprognostic (2.35e-1)" "unprognostic (3.26e-3)" "unprognostic (9.61e-3)" "unprognostic (3.78e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.21e-5)" "unprognostic (1.11e-2)" "unprognostic (2.82e-2)" "unprognostic (9.07e-2)" "unprognostic (5.86e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.22e-1)" 5.5 3.3 3.3 14.8 2.6 27.1 5.2 1.4 4.9 9.9 9.6 1.3 7.7 5.3 17.4 12.4 16.8 5.9 3.5 2.2 5.3 1.5 2.9 2.7 4.0 9.1 1.3 4.5 4.8 1.7 0.0 2.0 4.8 1.6 4.7 11.7 1.8 6.5 2.9 2.1 5.8 7.0 10.5 1.8 5.5 5.0 43.2 0.8 28.6 2.0 21.4 17.0 4.6 7.9 5.2 14.6 2.6 15.2 5.6 8.9 5.0 20.6 14.1 26.6 23.6 3.0 3.2 23.2 16.5 11.9 23.1 28.1 42.5 13.9 24.5 15.0 10.4 36.6 25.5 21.8 26.3 32.2 28.1 40.4 23.7 36.3 44.7 0.9 34.2 17.5 1.8 3.0 19.1 14.2 6.5 24.4 33.3 39.2 15.6 19.0 33.5 27.9 56.4 16.3 17.8 21.4 29.7 18.2 17.0 10.2 9.2 28.8 12.9 14.0 12.6 18.7 22.5 12.5 33.4 13.6 21.2 23.3 29.5 45.3 11.0 21.0 43.6 12.7 43.7 25.2 2.6 13.2 1.8 1.7 15.2 0.6 5.2 3.7 3.4 12.3 2.3 2.9 2.4 2.5 5.6 10.1 14.6 8.9 5.0 3.3 2.6 1.4 4.9 5.3 1.5 1.3 4.5 1.6 0.8 0.0 1.6 16.4 7.3 33.8 1.4 0.3 10.2 0.0 4.5 1.8 2.0 26.4 5.0 14.3 184.2 5.6 11.8 70.0 15.8 133.8 19.2 8.6 13.8 5.7 55.0 3.2 7.5 11.6 18.0 15.9 17.8 25.1 8.5 12.6 13.0 2.2 12.7 11.5 8.5 0.9 1.1 0.0 9.2 97.1 73.0 25.3 17.7 4.5 21.3 31.8 CEP112 "CCDC46, MGC33887" ENSG00000154240 "Centrosomal protein 112" Q8N8E3 17 65635538-66192084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.5" "Group enriched" "Detected in many" 7 "Early spermatids: 912.3;Late spermatids: 1163.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 17.0;RH-30: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024481 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA024481: AB_1846153" "unprognostic (9.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.93e-1)" "unprognostic (6.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.11e-3)" "unprognostic (1.43e-2)" "unprognostic (7.99e-2)" "unprognostic (4.48e-3)" "unprognostic (3.37e-2)" "unprognostic (1.39e-3)" "unprognostic (3.50e-2)" "unprognostic (4.46e-3)" "unprognostic (1.02e-2)" "unprognostic (1.26e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" 10.0 3.8 6.0 9.0 8.3 1.7 9.6 2.9 6.5 11.5 6.7 1.9 14.9 1.9 8.8 10.2 4.3 6.9 6.6 7.4 5.9 4.3 5.2 2.9 6.9 2.2 4.3 3.4 7.7 4.3 8.4 28.3 6.6 6.8 8.6 3.2 7.2 2.9 13.9 9.5 3.1 2.9 9.8 7.4 7.9 4.5 39.5 4.3 4.2 6.8 6.9 1.8 6.6 13.6 3.0 4.1 4.3 1.3 2.9 2.7 0.5 2.5 5.3 7.0 2.0 3.8 7.8 0.2 2.3 4.1 2.9 2.7 0.7 1.1 0.9 2.3 5.1 8.3 0.3 1.5 1.5 4.2 1.4 2.4 0.1 2.3 0.9 1.7 0.3 0.1 4.6 2.6 2.7 0.8 5.9 8.9 1.4 0.1 2.7 17.0 0.3 2.6 0.2 0.7 0.5 2.2 0.7 40.1 0.2 3.2 0.1 1.9 3.9 2.5 0.2 1.8 6.4 2.0 0.2 3.9 7.8 4.4 2.0 3.5 1.2 1.0 0.1 2.4 0.1 2.8 2.9 1.3 1.1 1.1 0.6 1.9 1.0 2.7 1.2 0.7 3.0 1.7 1.4 4.3 2.9 0.8 4.1 1.7 0.5 6.0 8.3 2.9 6.5 5.9 4.3 4.3 3.4 6.8 4.3 8.9 27.3 0.8 2.4 2.3 21.5 23.0 2.5 37.5 26.1 1.8 19.6 0.6 1.7 5.2 912.3 18.7 0.0 0.0 4.1 1.2 8.5 1.8 2.3 0.2 1.4 1.6 1.7 8.6 0.6 1163.2 23.0 4.4 13.5 0.0 0.0 14.1 4.6 0.0 18.7 2.8 150.6 12.9 7.2 22.8 13.1 1.4 0.1 0.9 1.5 1.4 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915015-102001058 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 47.3" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 254.3;Horizontal cells: 96.9;Spermatocytes: 115.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 10.0;EFO-21: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 7.6 11.1 9.0 2.4 20.2 2.4 8.3 16.8 14.8 7.9 4.2 5.0 4.2 2.0 9.1 6.7 5.3 17.5 4.9 4.5 9.6 8.3 3.8 1.4 6.1 3.3 7.5 10.2 11.4 5.0 6.4 47.3 2.6 12.4 6.6 4.8 3.2 3.2 7.6 2.3 8.5 2.7 7.3 9.2 3.1 4.0 19.2 8.9 0.5 7.4 1.5 2.5 3.9 9.7 2.5 4.8 1.4 0.5 3.3 2.0 0.5 0.9 2.2 1.1 1.3 10.0 5.5 0.5 2.1 1.8 1.0 0.9 0.6 3.0 1.3 9.5 1.9 4.4 0.9 1.3 2.4 0.9 3.1 1.5 0.3 3.7 1.2 1.1 0.2 0.3 1.9 4.7 1.3 2.8 5.1 3.0 1.3 0.3 0.4 2.5 1.1 1.1 0.3 0.8 1.1 1.7 0.2 1.1 0.2 2.0 1.2 2.7 4.2 1.3 1.9 0.3 2.0 3.7 0.4 1.7 3.3 1.9 1.0 2.2 2.2 1.2 0.2 3.2 0.3 1.3 0.7 0.5 1.0 2.0 0.1 0.9 1.8 1.2 1.6 0.4 2.5 1.7 1.7 1.4 3.3 0.2 4.8 0.3 0.5 9.0 20.2 16.8 14.8 9.6 8.3 7.5 10.2 12.4 8.9 8.9 7.0 0.5 4.6 0.0 17.6 7.5 5.1 254.3 43.3 17.4 43.2 1.2 3.3 2.0 13.5 3.0 0.0 0.0 0.3 0.7 3.5 2.8 0.0 0.0 0.3 96.9 64.4 3.1 0.0 6.9 49.8 1.4 0.0 0.0 10.3 26.8 1.0 0.0 48.1 4.4 47.8 6.5 1.6 115.1 25.4 0.0 0.1 7.0 1.3 2.0 CEP128 "C14orf145, C14orf61" ENSG00000100629 "Centrosomal protein 128" Q6ZU80 14 80476983-80959517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 61.2" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 22.7;monocytes: 15.4;Spermatocytes: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.6;T-cells: 9.6" "Cell line enhanced" "Detected in many" "Karpas-707: 25.8;MOLT-4: 22.1;U-266/70: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000602, HPA001116, HPA018498" Uncertain Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "HPA000602: , HPA001116: AB_1078323, HPA018498: AB_1845560" "unprognostic (6.13e-3)" "unprognostic (5.82e-2)" "unprognostic (1.65e-2)" "unprognostic (3.49e-2)" "unprognostic (4.32e-2)" "unprognostic (5.93e-2)" "unprognostic (2.64e-2)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (1.87e-1)" "unprognostic (3.42e-1)" "unprognostic (1.94e-2)" "unprognostic (2.60e-3)" "unprognostic (1.21e-1)" "unprognostic (3.37e-1)" "unprognostic (2.45e-1)" "unprognostic (1.48e-1)" 3.8 2.0 5.2 6.5 7.6 10.5 7.5 13.6 5.4 3.4 3.6 4.2 2.7 3.2 4.0 2.2 4.4 4.8 2.0 3.1 3.8 2.5 2.4 2.0 3.8 8.1 6.9 3.1 4.4 2.1 4.2 8.6 2.3 4.5 2.9 3.3 2.3 4.5 3.2 3.1 5.1 3.0 4.0 5.5 6.3 3.1 9.0 6.8 61.2 5.7 3.1 9.1 6.0 4.4 2.2 8.6 1.7 0.8 1.1 9.6 0.8 6.0 3.2 2.9 2.3 0.7 1.1 1.5 6.9 2.0 4.0 4.0 2.1 3.5 14.0 1.2 2.0 2.6 3.2 3.1 2.0 7.7 7.9 1.9 2.7 3.9 1.1 0.3 2.7 3.6 0.2 0.5 5.7 3.1 0.7 3.0 7.1 3.3 25.8 3.7 3.8 22.1 1.4 2.2 1.6 4.0 3.9 7.0 11.0 0.8 3.1 3.7 1.7 5.5 2.2 1.2 2.9 2.5 2.1 2.8 8.8 4.8 2.4 6.7 46.5 1.8 6.2 2.5 3.7 3.0 0.0 0.8 1.7 2.9 0.3 2.3 2.2 3.2 2.2 2.5 0.9 2.8 1.3 0.1 1.1 0.5 8.6 9.6 0.8 5.2 7.6 13.6 5.4 3.8 2.5 6.9 3.1 4.5 6.8 3.0 3.2 6.7 2.4 3.5 6.7 3.9 0.0 22.7 9.1 3.5 2.0 1.0 0.0 1.2 6.1 1.7 0.0 0.0 1.0 7.0 1.9 0.6 2.3 0.0 2.2 6.4 1.2 1.3 0.0 3.1 1.4 5.5 3.3 15.4 0.6 7.1 0.8 0.0 1.4 0.4 15.0 6.5 2.0 17.7 3.4 1.5 1.9 4.1 1.2 1.3 CEP135 "CEP4, FLJ13621, KIAA0635" ENSG00000174799 "Centrosomal protein 135" Q66GS9 4 55948871-56033363 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.1" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 56.2;monocytes: 85.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073950 Uncertain "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA073950: " "unprognostic (2.75e-1)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.06e-2)" "unprognostic (3.63e-1)" "unprognostic (3.42e-2)" "unprognostic (4.65e-3)" "unprognostic (4.78e-3)" "unprognostic (1.83e-3)" "unprognostic (9.89e-3)" "unprognostic (9.50e-2)" "unprognostic (2.27e-1)" "unprognostic (6.02e-9)" "unprognostic (7.55e-2)" "unprognostic (5.54e-2)" "unprognostic (1.95e-1)" "prognostic favorable (6.11e-5)" 5.5 3.0 2.9 13.8 6.0 12.8 5.2 5.1 5.3 8.5 4.6 3.1 7.5 4.3 12.8 4.5 4.7 7.4 4.5 3.4 5.3 3.4 5.7 2.9 7.0 13.0 5.8 3.9 9.6 4.5 4.1 6.9 8.1 4.5 4.4 4.6 2.5 3.7 5.9 2.3 5.4 6.2 7.1 5.5 11.1 3.6 9.3 4.6 27.1 5.0 4.5 10.1 4.8 5.6 9.2 8.7 11.9 4.4 7.1 7.5 2.0 6.9 3.8 10.7 10.0 2.2 4.3 4.6 6.9 4.9 6.4 7.5 4.3 7.3 18.9 5.3 3.1 5.1 3.3 11.1 4.3 12.1 5.1 7.1 6.6 5.7 3.8 2.4 11.9 10.4 3.3 3.4 8.0 5.8 2.9 5.3 9.7 12.1 9.1 6.5 4.2 16.6 7.4 6.7 3.5 4.2 12.1 5.1 3.9 4.6 5.2 7.7 8.1 6.2 4.2 5.1 6.7 5.7 7.7 5.2 8.7 14.2 10.3 12.1 5.0 3.5 12.9 4.4 9.4 10.6 11.9 3.4 4.2 4.7 4.1 4.3 4.6 6.0 4.5 2.1 9.2 7.5 4.8 7.0 7.1 4.4 8.7 3.7 2.0 2.9 6.0 5.1 5.3 5.3 3.4 5.8 3.9 4.5 4.6 6.0 14.3 15.9 7.2 8.0 12.6 7.3 2.5 22.7 14.8 7.0 9.8 15.3 3.3 7.8 56.2 15.3 3.9 23.3 4.7 11.7 5.9 4.3 13.9 1.8 9.0 25.4 5.2 12.3 9.2 11.4 5.5 17.8 5.0 85.6 4.3 4.7 11.0 5.7 7.8 9.0 21.0 6.5 6.6 53.2 43.8 5.8 8.0 16.0 5.2 5.5 CEP170 "FAM68A, KAB, KIAA0470" ENSG00000143702 "Centrosomal protein 170" Q5SW79 1 243124428-243255348 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.7" "Group enriched" "Detected in many" 37 "Early spermatids: 1512.0;Late spermatids: 3749.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042151, HPA045597, HPA045787" Uncertain Enhanced "Mitotic spindle,Centrosome,Cytosol" Yes No Centrosome "Mitotic spindle, Cytosol" "HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453" "unprognostic (2.97e-1)" "unprognostic (2.49e-3)" "unprognostic (8.84e-2)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (7.60e-2)" "unprognostic (6.83e-5)" "unprognostic (8.05e-2)" "unprognostic (9.88e-3)" "unprognostic (7.09e-2)" "unprognostic (3.52e-2)" "unprognostic (6.65e-2)" "prognostic unfavorable (1.30e-9)" "unprognostic (2.21e-2)" "unprognostic (2.17e-1)" "unprognostic (6.49e-3)" "unprognostic (9.62e-3)" 9.5 6.1 13.7 10.8 13.2 36.5 6.8 27.7 23.2 7.4 5.4 11.4 3.1 3.1 9.1 5.2 5.5 6.4 11.1 8.6 12.8 11.2 3.8 6.7 8.4 7.3 19.3 13.7 13.3 2.8 2.8 10.8 9.8 20.2 5.0 4.2 3.3 4.2 5.5 9.3 4.2 4.7 7.4 25.8 7.8 4.2 53.7 18.0 11.6 14.4 3.3 8.9 8.6 6.6 9.4 8.4 12.3 10.1 2.8 4.7 2.1 6.0 5.1 13.2 11.1 8.2 15.9 2.9 16.1 9.6 12.1 11.5 3.2 5.9 4.5 9.9 13.7 4.1 3.0 11.3 6.9 17.3 10.0 6.5 4.7 4.8 2.2 7.1 8.2 8.8 10.0 1.9 38.6 16.9 27.7 28.2 2.7 11.3 4.7 15.3 1.3 5.0 4.4 16.6 1.2 14.5 9.0 9.4 1.5 2.5 1.0 19.1 25.7 8.2 0.7 7.7 10.8 2.8 11.2 31.1 22.6 6.7 12.1 18.5 4.6 5.9 9.0 12.0 7.5 51.9 3.5 8.3 7.6 1.9 10.0 2.7 3.6 3.8 1.6 8.4 9.4 4.7 2.7 12.3 2.8 10.1 5.5 2.9 2.1 13.7 13.2 27.7 15.8 12.8 11.2 19.3 13.7 20.2 18.0 17.9 16.6 13.7 4.2 13.5 41.1 19.0 7.6 25.4 11.4 12.2 5.9 3.1 0.0 18.9 1512.0 31.0 0.7 0.0 6.1 6.7 26.8 3.3 22.0 6.8 31.5 42.9 10.4 18.4 34.9 3749.4 40.9 70.8 21.9 31.5 1.9 11.4 19.1 0.0 33.2 2.1 18.3 25.8 15.7 71.0 23.8 10.0 1.6 7.0 1.6 3.1 CEP19 "C3orf34, MGC14126" ENSG00000174007 "Centrosomal protein 19" Q96LK0 3 196706277-196712293 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 26.8;Early spermatids: 19.5;Spermatocytes: 38.6;Spermatogonia: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 12.9;eosinophil: 17.5;neutrophil: 45.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 45.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047614, HPA071138" Enhanced Supported Centrosome NA NA Centrosome "HPA047614: AB_2680103, HPA071138: AB_2686348" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (5.11e-2)" "unprognostic (9.31e-2)" "unprognostic (5.51e-3)" "unprognostic (4.66e-2)" "unprognostic (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (2.36e-2)" "unprognostic (1.91e-1)" "unprognostic (3.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.33e-2)" 3.2 5.2 10.2 5.7 11.7 2.4 2.4 7.3 10.8 3.6 2.3 3.0 2.6 2.0 3.3 6.2 3.2 8.0 3.8 2.4 8.4 9.0 5.2 2.3 3.2 5.0 6.5 6.0 3.8 1.4 6.1 9.2 3.9 8.3 3.5 2.2 2.5 2.3 4.4 1.3 3.3 2.0 3.0 4.4 6.1 1.7 17.5 4.4 8.3 5.1 0.4 6.3 4.0 2.6 1.4 3.4 45.3 1.3 2.3 3.5 1.2 5.2 3.7 5.1 3.1 11.7 9.0 1.5 4.3 8.1 4.6 6.0 1.8 3.5 3.9 12.2 2.1 10.1 2.3 3.4 1.1 5.5 5.4 3.4 5.9 1.9 0.5 4.7 2.7 7.6 4.1 5.1 6.0 1.6 8.5 1.9 4.8 3.2 4.8 4.7 2.7 6.7 4.8 2.6 2.3 6.1 7.9 3.1 2.7 4.9 0.5 5.1 3.6 5.8 0.8 6.5 4.6 4.6 5.2 1.5 5.4 1.2 8.3 2.8 14.8 14.1 8.0 7.7 6.9 5.2 12.9 1.3 17.5 1.8 0.9 2.0 1.1 2.6 2.3 0.8 1.4 3.5 2.2 45.3 2.3 1.0 3.4 1.4 1.2 10.2 11.7 7.3 10.8 8.4 9.0 6.5 6.0 8.3 4.4 0.0 1.3 2.7 1.0 1.8 4.5 2.0 0.0 26.8 2.3 1.8 0.0 1.4 5.0 1.6 19.5 4.5 0.0 0.0 0.7 1.2 3.7 1.0 1.1 0.2 2.7 4.8 0.0 5.5 3.8 3.1 6.1 2.5 0.0 14.4 0.2 7.6 1.0 0.0 4.9 3.5 7.4 0.0 1.9 38.6 38.7 0.6 0.3 3.2 0.4 0.1 CEP295NL "DDC8, KIAA1731NL" ENSG00000178404 "CEP295 N-terminal like" Q96MC4 17 78870910-78903217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.7" "Group enriched" "Detected in some" 129 "Early spermatids: 285.7;Late spermatids: 373.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 4.0;Karpas-707: 3.2;TIME: 3.2;U-2 OS: 5.5" "HPA023609, HPA024619, HPA025717" Uncertain Approved Vesicles NA NA Vesicles "HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900" "unprognostic (1.68e-3)" "unprognostic (4.56e-2)" "unprognostic (2.62e-1)" "unprognostic (5.04e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (9.03e-2)" "unprognostic (8.16e-2)" "unprognostic (9.80e-2)" "unprognostic (2.08e-1)" "unprognostic (3.89e-3)" "unprognostic (3.65e-3)" "unprognostic (1.03e-1)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.75e-3)" 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 37.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 3.5 0.4 0.1 0.1 0.0 0.7 0.1 0.0 0.9 0.2 0.6 4.0 1.7 0.1 0.6 1.1 0.2 0.6 0.0 1.1 0.6 2.5 0.1 0.0 0.2 0.6 0.0 0.0 0.0 1.3 0.3 0.4 0.2 0.1 0.4 0.0 1.2 0.0 0.2 0.4 0.1 0.0 3.2 0.1 0.0 0.3 0.0 0.3 0.0 0.6 0.8 0.5 0.1 0.2 0.0 0.1 0.9 0.5 0.4 0.7 0.9 0.1 1.1 3.2 1.4 5.5 1.7 0.7 1.2 1.6 0.0 0.0 0.1 1.7 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 3.5 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 285.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.3 373.8 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 CEP41 "DKFZp762H1311, FLJ22445, JBTS15, TSGA14" ENSG00000106477 "Centrosomal protein 41" Q9BYV8 7 130393771-130442433 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Autism, Autism spectrum disorder, Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 34.2;testis: 35.3" "Group enriched" "Detected in many" 5 "Early spermatids: 412.1;Late spermatids: 114.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024090 Uncertain NA NA "HPA024090: AB_10966276" "unprognostic (3.87e-2)" "unprognostic (5.96e-2)" "prognostic favorable (4.54e-4)" "unprognostic (1.17e-3)" "unprognostic (2.88e-2)" "unprognostic (1.32e-2)" "unprognostic (1.26e-7)" "unprognostic (1.80e-1)" "unprognostic (2.89e-1)" "unprognostic (8.45e-3)" "unprognostic (4.63e-2)" "unprognostic (1.37e-1)" "unprognostic (7.76e-2)" "unprognostic (7.72e-2)" "unprognostic (3.35e-2)" "unprognostic (9.87e-2)" "unprognostic (1.57e-1)" 3.4 6.0 4.8 3.7 11.7 3.8 4.6 3.5 11.4 3.9 3.0 10.5 3.0 2.5 4.8 3.6 2.6 9.2 3.8 2.9 5.6 7.0 3.3 2.5 3.3 4.5 5.8 6.5 5.2 3.5 7.0 11.4 4.9 8.0 3.2 4.5 5.2 34.2 4.1 1.8 2.4 2.4 5.2 6.5 5.0 2.7 35.3 5.0 12.2 3.9 3.3 4.2 3.6 2.5 3.3 6.0 5.9 5.1 8.3 17.1 5.6 7.9 8.9 10.5 12.9 3.8 5.5 3.0 8.6 6.1 8.3 8.1 4.4 9.6 13.1 5.7 6.8 17.2 8.7 11.5 7.4 12.5 4.0 3.5 4.6 4.2 2.6 5.8 7.8 4.2 6.5 5.0 11.2 4.1 7.9 12.4 10.1 2.2 2.9 12.4 5.4 22.8 7.8 9.1 10.2 7.8 19.6 13.8 0.4 4.8 5.7 20.5 15.0 7.1 14.1 8.7 6.1 4.0 7.2 6.0 12.0 3.5 9.2 12.6 7.7 20.5 14.5 11.8 8.6 17.7 5.9 3.4 3.6 7.5 5.1 4.7 2.8 5.3 5.0 6.0 3.3 8.7 17.1 0.6 8.3 2.5 2.9 4.6 5.6 4.8 11.7 3.5 11.4 5.6 7.0 5.8 6.5 8.0 5.0 8.9 2.6 3.7 5.8 1.5 18.5 3.1 0.0 50.9 5.7 8.7 35.3 13.4 10.0 10.8 412.1 5.3 2.1 0.0 8.0 8.0 6.3 3.9 11.5 3.0 15.7 14.3 13.8 13.5 8.5 114.4 9.8 7.7 5.0 2.8 5.2 11.2 7.3 3.5 7.8 3.9 21.0 6.5 2.2 52.6 37.5 1.4 16.0 7.2 5.1 6.7 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496632-93529092 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 52.9;testis: 19.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "T-reg: 4.4" "Lineage enriched" "Detected in single" 24 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023430 Approved Supported "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 3.2 1.4 0.5 12.1 0.4 3.1 3.6 0.3 0.6 2.0 5.2 0.3 0.2 4.6 0.8 1.5 11.6 0.6 2.5 0.7 0.4 0.5 1.5 0.7 4.4 10.1 0.6 0.2 0.8 0.6 0.0 0.7 3.8 0.5 0.8 6.5 0.4 2.3 0.2 0.7 3.0 5.2 3.5 1.1 4.8 3.2 19.3 0.3 52.9 0.7 10.8 11.0 2.7 3.3 0.1 0.1 0.0 0.0 0.0 4.4 0.0 51.9 20.8 13.8 17.6 1.5 3.2 7.7 28.6 20.3 27.2 28.2 22.1 28.0 13.9 12.7 18.5 18.3 29.7 16.7 14.0 32.7 41.8 8.7 5.2 12.9 7.5 0.1 9.0 12.2 0.7 1.0 29.0 35.4 8.1 25.0 23.1 4.7 26.4 30.7 12.0 23.7 13.7 5.4 16.2 15.2 10.3 22.7 7.6 12.3 6.5 5.7 8.0 22.0 6.8 17.3 11.0 17.9 9.2 15.6 17.3 24.2 23.6 46.9 11.8 16.0 17.0 13.5 34.0 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.5 0.4 0.3 0.6 0.4 0.5 0.6 0.2 0.5 0.3 0.0 2.2 0.8 0.6 3.2 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.6 15.9 0.0 0.3 0.0 0.2 14.7 0.4 0.1 0.0 0.2 10.9 0.0 0.0 2.5 4.1 3.8 0.3 5.4 0.0 0.0 1.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 35.6 19.5 1.1 1.3 1.9 2.3 0.9 CEP85 "CCDC21, DKFZP434L0117" ENSG00000130695 "Centrosomal protein 85" Q6P2H3 1 26234153-26279038 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 15.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028252 Approved Approved "Nucleoli,Golgi apparatus,Centrosome,Cytosol" NA NA "Nucleoli, Golgi apparatus" "Centrosome, Cytosol" "HPA028252: AB_1846142" "unprognostic (1.08e-1)" "unprognostic (2.59e-2)" "unprognostic (1.74e-2)" "unprognostic (4.16e-2)" "unprognostic (2.66e-1)" "unprognostic (5.30e-3)" "prognostic unfavorable (4.39e-6)" "unprognostic (3.72e-2)" "unprognostic (5.30e-2)" "unprognostic (8.24e-2)" "unprognostic (9.18e-2)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (7.33e-3)" "unprognostic (5.41e-2)" "unprognostic (1.02e-2)" "unprognostic (2.60e-2)" 2.1 2.7 4.8 3.8 11.0 12.4 3.1 7.7 8.8 2.4 3.7 15.5 4.6 3.5 2.6 3.3 5.6 2.7 2.6 19.4 5.5 4.0 3.8 3.7 3.2 5.3 20.4 4.9 2.4 3.3 4.4 4.7 3.6 7.8 3.0 4.5 4.0 3.5 2.5 87.8 8.4 3.3 2.9 10.4 4.3 3.7 26.8 13.5 12.1 5.4 5.5 6.6 3.0 3.8 2.4 3.8 15.6 5.0 2.1 3.4 2.8 13.5 6.7 10.8 11.5 3.0 2.8 21.3 6.9 3.2 9.5 10.2 8.6 12.7 12.9 9.4 2.8 5.2 12.0 12.1 5.7 9.6 9.4 10.5 18.2 13.2 9.1 3.1 16.6 20.2 1.4 5.7 8.0 5.8 4.5 4.2 17.5 24.5 18.0 7.0 4.9 15.9 20.2 10.5 6.7 11.2 16.3 12.6 12.0 4.8 2.1 18.4 8.5 9.7 8.1 8.0 6.2 7.4 11.9 4.9 7.8 13.0 9.1 10.6 14.2 20.7 16.1 4.8 29.3 14.7 3.4 4.6 15.6 3.0 4.4 2.5 2.4 2.0 2.3 3.8 1.3 1.8 3.4 0.5 2.1 5.0 1.3 3.2 2.8 4.8 11.0 7.7 8.8 5.5 4.0 20.4 4.9 7.8 13.5 0.0 2.1 0.0 4.2 6.2 9.6 26.8 2.5 1.4 4.5 5.2 11.8 2.0 6.6 1.7 0.8 1.8 3.9 0.0 1.1 3.6 2.1 2.2 2.3 2.5 4.3 0.0 1.7 1.8 5.2 2.3 1.4 4.0 1.7 4.6 3.1 1.3 2.1 3.4 0.4 0.8 10.1 0.0 1.0 43.5 37.7 5.4 34.9 3.5 4.7 3.2 CEP85L "bA57K17.2, C6orf204, NY-BR-15" ENSG00000111860 "Centrosomal protein 85 like" Q5SZL2 6 118460772-118710075 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 35.7" "Group enriched" "Detected in many" 13 "Early spermatids: 409.4;Late spermatids: 601.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029137, HPA029138, HPA029139" Uncertain NA NA "HPA029137: AB_10600657, HPA029138: AB_10600874, HPA029139: AB_10601220" "unprognostic (3.25e-2)" "unprognostic (1.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.82e-1)" "unprognostic (2.19e-2)" "unprognostic (2.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.01e-2)" "unprognostic (8.37e-2)" "unprognostic (2.03e-1)" "unprognostic (1.39e-3)" "unprognostic (8.45e-2)" "unprognostic (2.87e-5)" "unprognostic (2.72e-3)" "unprognostic (2.44e-1)" "unprognostic (1.64e-1)" "unprognostic (1.85e-2)" 5.4 7.3 4.5 17.6 6.8 12.9 4.4 15.5 8.4 5.8 4.2 4.4 3.5 2.6 6.5 3.9 4.4 5.6 5.0 5.5 5.1 4.2 2.9 3.3 6.5 15.7 7.9 3.1 10.4 7.1 6.5 14.6 5.7 6.3 4.9 3.7 5.1 8.3 6.0 18.8 2.8 6.3 12.9 5.5 9.1 10.2 35.7 7.4 29.1 4.1 8.8 12.1 8.4 8.8 4.4 5.3 15.3 11.6 6.7 7.5 3.7 1.0 0.9 5.8 3.3 3.2 5.9 22.7 3.0 4.4 2.6 3.0 0.2 0.3 5.5 0.9 4.3 2.2 1.4 2.6 4.2 4.9 2.8 2.8 7.2 1.6 0.6 2.6 0.5 2.3 3.4 2.3 3.2 3.6 5.3 3.9 8.1 7.0 5.3 4.4 0.8 12.9 3.3 1.7 0.1 1.3 3.1 4.5 1.2 3.2 2.5 3.3 2.0 2.2 0.1 4.1 4.8 0.7 2.8 3.1 4.3 2.4 3.7 4.6 6.8 5.0 5.2 3.5 2.4 4.3 1.5 10.4 8.6 6.9 11.6 7.0 3.4 5.6 5.5 5.3 4.4 7.5 6.1 15.3 6.7 9.6 2.5 4.3 3.7 4.5 6.8 15.5 8.4 5.1 4.2 7.9 3.1 6.3 7.4 6.0 5.8 11.5 10.4 6.2 30.3 27.8 0.0 4.0 1.2 3.5 9.8 21.8 1.7 3.2 409.4 24.4 0.0 0.0 3.6 5.0 16.5 4.8 8.1 5.0 7.3 31.8 2.9 13.5 27.7 601.9 29.7 15.0 21.9 3.6 0.5 7.0 7.0 0.2 27.3 1.7 9.0 19.4 32.5 36.4 37.9 4.3 18.5 30.5 0.4 7.1 CER1 DAND4 ENSG00000147869 "Cerberus 1, DAN family BMP antagonist" O95813 9 14719724-14722717 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;epididymis: 5.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 82 "testis cancer: 17.3" "Group enriched" "Detected in many" 8 "basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 6.4;NTERA-2: 11.8;SCLC-21H: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019917 Uncertain "Secreted - unknown location" NA NA "HPA019917: AB_1846539" "unprognostic (2.98e-2)" "unprognostic (5.36e-2)" "unprognostic (5.99e-2)" 0.1 0.0 0.1 0.1 2.5 0.1 0.2 2.2 1.1 0.1 0.2 0.1 0.1 0.7 0.7 5.5 0.1 0.0 0.4 0.2 0.1 0.2 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.2 0.1 0.1 1.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 2.2 1.1 0.1 0.2 0.1 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: AB_2681545" "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavorable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.5 6.1 6.9 7.3 55.6 59.3 5.9 30.9 29.2 8.1 6.1 2.2 0.4 0.0 12.7 50.4 6.9 6.5 3.0 4.1 3.1 2.4 4.9 0.5 5.6 3.3 17.0 1.1 17.3 32.8 2.2 8.8 2.1 33.5 9.1 0.6 2.8 7.6 10.5 18.1 0.4 11.7 0.4 0.4 4.7 0.9 4.8 1.3 3.8 3.6 1.0 1.9 6.9 8.4 3.5 2.3 6.8 2.3 10.1 21.6 5.9 29.6 4.7 8.9 6.9 0.1 20.4 3.4 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 6.0 13.0 0.0 6.2 7.9 1.1 3.2 0.0 6.7 21.6 10.4 0.0 14.3 0.0 10.7 2.0 7.1 0.0 0.0 2.9 48.9 70.1 3.9 8.1 0.0 5.9 6.4 0.0 18.4 0.6 1.5 22.5 4.7 38.8 1.0 0.0 0.1 6.9 0.0 24.8 0.5 0.7 6.5 15.6 1.0 19.0 3.6 16.4 2.5 0.0 2.0 CERKL RP26 ENSG00000188452 "Ceramide kinase like" Q49MI3 2 181536676-181680665 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell type enhanced" "Detected in some" 21 "Ciliated cells: 52.2;Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 20.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 11 "cerebellum: 49.5;pons and medulla: 13.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 26.5;HL-60: 14.7;JURKAT: 17.0;MOLT-4: 35.5;NB-4: 31.3;SCLC-21H: 23.9;THP-1: 14.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 31.8" "HPA035443, HPA035444, HPA043203" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: " "unprognostic (7.52e-3)" "unprognostic (6.13e-3)" "unprognostic (2.09e-1)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (2.71e-3)" "unprognostic (2.59e-1)" "unprognostic (1.39e-2)" "unprognostic (2.76e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.25e-4)" "unprognostic (4.54e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (3.07e-2)" "unprognostic (8.45e-2)" 1.2 0.6 1.2 9.2 2.0 14.4 1.1 49.5 2.5 3.7 1.7 4.2 0.4 3.1 1.0 5.3 0.6 5.8 4.1 0.5 2.9 1.3 8.1 1.3 5.0 13.8 0.6 1.4 2.9 0.8 0.1 2.1 2.0 13.7 1.0 0.0 6.8 1.0 0.4 0.5 0.5 6.4 0.4 1.0 17.9 2.8 1.1 1.1 0.4 0.9 0.4 1.1 4.3 1.3 4.0 5.2 12.6 12.7 4.7 6.9 4.2 0.0 0.5 0.6 0.0 0.0 0.1 0.0 4.2 0.1 0.1 0.1 0.0 0.1 4.4 0.0 0.1 2.6 2.6 0.1 0.1 0.1 0.0 0.4 26.5 0.3 0.0 0.1 14.7 0.7 0.2 0.3 0.1 0.2 4.0 0.0 17.0 0.0 4.7 0.0 0.0 35.5 31.3 0.6 0.0 0.2 7.6 2.2 0.6 0.3 0.0 23.9 0.7 0.0 0.0 0.1 0.2 0.0 14.8 2.4 1.2 0.6 0.1 1.0 11.4 6.4 2.0 0.9 9.9 10.8 2.0 4.7 12.6 4.5 12.7 3.7 4.0 6.4 6.9 5.2 3.4 3.5 4.5 0.7 4.7 10.9 2.9 1.4 4.2 1.2 2.0 49.5 2.5 2.9 1.3 0.6 1.4 13.7 1.1 3.0 0.3 0.0 0.1 0.0 0.4 0.7 0.0 52.2 7.9 0.0 17.7 0.0 8.3 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 7.8 20.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.3" "Cell type enriched" "Detected in some" 5 "Late spermatids: 85.2" "Cancer enhanced" "Detected in many" "glioma: 13.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3" HPA045724 Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 2.4 4.7 28.9 2.3 32.9 1.7 1.7 12.5 86.3 2.2 2.1 40.5 0.0 1.6 2.0 2.1 2.5 2.1 3.9 3.4 29.5 23.2 1.6 1.6 1.9 1.6 31.9 20.5 4.3 2.4 1.7 3.2 1.9 33.8 2.0 1.8 1.8 2.3 2.1 17.8 2.0 1.9 3.0 37.8 1.7 1.8 15.7 22.2 0.0 2.4 0.0 1.6 2.6 0.4 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.1 1.8 10.9 17.7 0.6 0.2 0.3 1.2 0.1 3.1 2.2 8.7 0.6 0.0 13.0 0.8 2.5 0.1 8.0 0.3 1.2 0.0 18.1 0.1 0.4 6.5 1.4 1.8 0.2 0.6 0.1 1.0 0.3 3.5 0.7 0.1 1.1 0.1 2.1 4.5 0.1 19.4 13.3 0.0 0.3 0.0 0.3 0.3 2.4 0.0 9.3 9.3 0.4 0.0 7.9 3.7 3.0 10.8 0.3 0.0 2.5 1.7 2.5 0.3 0.2 0.0 0.0 0.6 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 28.9 32.9 12.5 35.7 29.5 23.2 31.9 20.5 33.8 22.2 0.0 0.0 0.0 0.1 0.5 2.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 18.9 0.4 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 85.2 1.1 0.0 1.7 0.0 0.0 9.2 0.0 0.0 1.1 0.0 1.2 0.0 0.3 0.9 2.7 0.4 0.2 0.0 0.0 0.0 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027262, HPA078737" Approved Supported "Nuclear membrane,Endoplasmic reticulum" NA NA 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717, HPA078737: " "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.5 28.0 23.6 50.6 70.5 43.3 17.7 26.1 38.4 49.9 34.3 29.3 45.3 22.5 43.7 41.1 31.2 29.2 32.7 27.9 41.0 30.5 26.7 31.0 19.6 35.4 51.0 35.2 38.4 39.4 36.0 44.0 54.9 60.5 31.1 32.5 33.2 51.5 62.2 38.5 23.0 20.3 36.1 85.2 50.0 26.3 16.0 35.8 54.0 21.7 21.8 34.0 28.8 51.3 29.9 30.7 61.0 53.4 24.1 36.1 16.3 32.6 46.0 33.4 37.5 141.2 40.6 15.1 36.6 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 62.5 51.6 17.2 31.4 21.4 7.0 2.2 101.9 21.4 14.8 50.6 3.9 65.8 11.6 88.6 6.4 42.6 55.1 0.0 80.3 35.9 56.4 34.0 35.8 187.2 49.9 3.2 23.6 32.5 43.8 3.8 52.0 30.4 35.4 20.8 32.1 25.3 90.5 30.8 37.8 65.4 8.2 38.8 25.5 11.8 5.2 13.7 45.3 37.6 28.9 27.6 CERS3 "LASS3, MGC27091" ENSG00000154227 "Ceramide synthase 3" Q8IU89 15 100400395-100544995 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.6;skin 1: 29.0;testis: 37.9" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 16.8;Early spermatids: 19.4;Late spermatids: 12.5;Spermatocytes: 33.6;Suprabasal keratinocytes: 43.8" "Cancer enhanced" "Detected in some" "head and neck cancer: 14.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "hTCEpi: 38.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006092, HPA024356" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA006092: AB_1079236, HPA024356: AB_1852721" "unprognostic (5.01e-3)" "unprognostic (3.43e-2)" "unprognostic (6.47e-4)" "unprognostic (2.35e-2)" "unprognostic (5.58e-2)" "unprognostic (1.68e-1)" "unprognostic (6.84e-3)" "unprognostic (3.23e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.31e-5)" "unprognostic (2.65e-1)" "unprognostic (4.74e-4)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-3)" 0.4 0.0 0.4 0.4 0.4 0.0 1.9 0.4 0.4 6.0 0.4 0.4 0.4 0.0 0.4 0.4 25.6 0.3 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 3.6 0.4 0.4 29.0 0.4 0.4 0.4 0.4 0.0 37.9 0.4 0.4 0.4 0.4 8.5 0.4 11.2 0.0 0.0 1.5 0.6 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 0.2 0.2 0.0 0.7 0.3 0.0 0.0 3.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 3.6 16.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 33.6 0.4 43.8 0.0 0.0 0.0 7.4 CES1 "CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1" ENSG00000198848 "Carboxylesterase 1" P23141 16 55802851-55833337 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Serine esterase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 355.0" "Group enriched" "Detected in many" 7 "Cholangiocytes: 565.6;Hepatocytes: 2145.0" "Cancer enriched" "Detected in all" 6 "liver cancer: 711.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 18 "classical monocyte: 32.6;myeloid DC: 32.9" "Group enriched" "Detected in many" 20 "dendritic cells: 32.9;monocytes: 32.6" "Group enriched" "Detected in some" 5 "Hep G2: 96.2;THP-1: 103.6" "Not detected" "Not detected" "HPA012023, HPA046717" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" No NA 40000000 "Endoplasmic reticulum" "HPA012023: AB_1846554, HPA046717: AB_2679770" "unprognostic (1.04e-2)" "unprognostic (9.85e-2)" "unprognostic (2.94e-1)" "unprognostic (1.28e-1)" "unprognostic (1.55e-3)" "unprognostic (7.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (3.51e-1)" "unprognostic (5.74e-2)" "unprognostic (4.62e-2)" "unprognostic (3.29e-2)" "unprognostic (1.91e-2)" "unprognostic (5.32e-2)" "unprognostic (1.92e-1)" "unprognostic (2.87e-1)" "prognostic unfavorable (9.92e-4)" 27.1 1.7 0.3 0.5 0.4 2.1 24.7 0.4 0.6 3.1 8.9 0.5 1.5 2.4 7.3 2.1 4.5 6.7 57.7 8.1 0.3 0.0 0.7 355.0 19.8 2.3 0.3 0.6 3.9 1.3 0.0 0.8 1.1 0.6 11.2 1.0 3.8 3.9 4.0 1.6 1.4 3.5 10.2 0.7 4.4 7.0 1.0 0.3 0.4 1.7 2.3 1.5 8.2 16.1 0.2 32.9 0.2 32.6 0.1 1.6 12.1 0.0 0.6 0.0 0.0 14.4 0.0 0.4 0.0 0.0 0.0 0.0 6.7 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 20.8 0.0 0.0 32.6 0.1 1.3 1.8 0.5 0.2 0.2 1.6 32.9 0.2 0.2 0.4 0.2 0.1 0.4 1.7 0.1 12.1 0.3 0.4 0.4 0.6 0.3 0.0 0.3 0.6 0.6 0.3 14.9 74.9 21.0 2.5 14.8 0.0 0.6 565.6 202.1 28.4 15.7 0.0 0.4 0.0 16.2 77.2 1.5 0.0 70.0 17.2 0.8 45.8 1.1 5.8 2145.0 18.9 0.0 36.2 43.0 88.2 134.3 17.3 20.4 37.1 0.0 0.0 8.3 0.9 0.2 93.0 0.5 0.5 0.0 7.2 0.9 1.0 10.2 0.7 20.3 0.0 1.7 CES2 "CE-2, CES2A1, iCE" ENSG00000172831 "Carboxylesterase 2" O00748 16 66934444-66945096 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "esophagus: 46.7;intestine: 146.9;liver: 78.6" "Group enriched" "Detected in many" 4 "Enterocytes: 912.6;Hepatocytes: 449.6;Paneth cells: 448.9;Undifferentiated cells: 459.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA018897 Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA 7500000 "Golgi apparatus" "Endoplasmic reticulum, Cytosol" "HPA018897: AB_1846558" "unprognostic (8.15e-3)" "unprognostic (1.82e-2)" "unprognostic (1.32e-1)" "unprognostic (2.67e-3)" "unprognostic (2.74e-2)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (1.31e-1)" "unprognostic (6.93e-2)" "unprognostic (7.99e-2)" "unprognostic (1.73e-3)" "unprognostic (2.66e-2)" "prognostic favorable (1.50e-5)" "unprognostic (8.01e-2)" "unprognostic (1.53e-1)" "unprognostic (4.14e-2)" "unprognostic (1.38e-1)" 5.8 15.3 8.5 8.8 11.7 2.4 5.1 13.0 15.9 9.5 42.3 12.1 11.2 146.9 7.0 11.9 46.7 6.1 14.5 15.2 7.4 6.6 22.5 78.6 6.7 4.6 8.2 10.7 8.4 12.0 10.0 6.8 7.3 10.3 9.7 42.6 13.0 12.7 7.9 11.6 8.9 117.3 10.4 5.6 7.8 10.9 8.5 8.2 9.0 11.7 14.1 12.1 7.6 11.6 6.9 8.9 5.0 10.6 7.9 10.7 5.2 6.9 9.1 9.6 12.8 9.5 8.9 7.3 7.9 12.8 9.3 11.9 9.8 11.5 8.1 7.9 10.3 7.0 18.0 7.0 19.9 7.3 7.2 9.7 7.9 5.2 18.4 13.4 10.4 14.0 12.9 37.7 13.2 22.1 11.5 6.9 5.7 11.1 6.0 15.7 4.4 9.3 8.7 5.2 7.5 9.2 11.0 9.7 9.5 26.4 12.1 6.2 8.2 25.8 6.5 6.7 3.9 11.2 12.9 8.5 12.3 6.5 7.6 5.9 12.0 14.3 9.6 18.9 8.2 9.2 4.7 10.4 4.7 10.1 7.8 9.2 6.1 7.7 10.7 8.9 6.9 9.5 8.6 5.0 7.9 10.6 7.7 6.8 5.2 8.5 11.7 13.0 15.9 7.4 6.6 8.2 10.7 10.3 8.2 29.8 24.0 25.9 13.7 17.3 28.5 25.4 137.6 42.8 12.5 50.6 19.6 13.0 31.5 21.9 1.5 9.8 912.6 0.0 29.5 5.6 12.7 14.5 27.6 449.6 16.6 27.0 23.2 25.2 27.6 1.3 17.3 13.9 10.1 5.4 141.3 17.6 37.9 448.9 17.0 124.1 22.7 32.3 11.3 42.6 10.2 17.9 11.3 18.7 459.3 15.2 CES3 "ES31, FLJ21736" ENSG00000172828 "Carboxylesterase 3" Q6UWW8 16 66961237-66975148 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.8;liver: 26.7" "Group enriched" "Detected in many" 5 "Enterocytes: 66.2;Hepatocytes: 40.9;Intestinal endocrine cells: 18.9;Mucus-secreting cells: 31.1;Paneth cells: 60.4;Undifferentiated cells: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;Daudi: 8.9;JURKAT: 14.6;U-937: 7.6" "Not detected" "Not detected" "HPA041008, HPA041307" Approved Approved "Nuclear membrane,Endoplasmic reticulum" "Intracellular and membrane" NA NA 1200000 "Nuclear membrane, Endoplasmic reticulum" "HPA041008: AB_2677247, HPA041307: AB_2677400" "unprognostic (3.91e-3)" "unprognostic (1.22e-1)" "unprognostic (1.94e-2)" "unprognostic (8.99e-3)" "unprognostic (9.32e-2)" "unprognostic (7.84e-4)" "prognostic favorable (7.26e-5)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.43e-2)" "unprognostic (1.84e-2)" "unprognostic (1.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-2)" 0.5 0.1 0.8 13.3 1.3 0.2 1.0 1.6 1.3 0.6 40.7 0.7 1.4 16.8 0.4 0.7 2.2 1.5 3.0 0.7 1.5 1.0 6.8 26.7 0.9 0.2 0.8 1.1 0.5 7.8 0.0 1.1 0.4 2.2 0.4 17.9 1.1 5.9 0.6 12.9 0.5 41.8 0.5 0.9 0.2 4.6 0.9 0.6 0.5 0.4 2.4 0.5 0.4 0.3 0.7 0.6 2.7 0.6 0.3 0.9 0.2 0.4 3.2 0.4 8.1 0.3 0.2 1.3 0.3 0.2 0.4 0.5 0.5 4.0 8.9 2.7 0.0 0.2 0.7 1.2 0.6 0.1 1.5 6.0 4.4 1.3 2.6 0.1 1.0 0.7 0.3 1.0 0.9 0.2 0.3 0.0 14.6 2.8 1.9 0.3 1.2 1.5 1.6 1.4 2.7 0.5 1.4 0.7 1.4 0.1 0.5 0.4 0.9 0.2 6.1 0.2 0.7 5.4 6.8 0.4 0.4 2.6 0.7 0.2 1.0 3.6 1.3 0.3 7.6 0.2 0.6 0.6 2.7 0.3 0.3 0.5 0.5 0.6 0.4 0.6 0.7 0.9 0.6 2.0 0.3 0.4 0.3 0.9 0.2 0.8 1.3 1.6 1.3 1.5 1.0 0.8 1.1 2.2 0.6 3.0 7.0 0.8 0.0 0.5 0.0 1.0 5.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 66.2 0.0 0.8 0.0 0.0 0.2 1.1 40.9 0.2 0.0 18.9 0.0 3.2 2.6 0.0 1.4 0.0 0.0 31.1 0.2 1.0 60.4 1.1 8.2 0.0 0.0 0.0 0.6 1.3 0.3 0.0 0.0 31.9 0.1 CES4A "CES8, FLJ37464" ENSG00000172824 "Carboxylesterase 4A" Q5XG92 16 66988589-67009758 "Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 32.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 49.5;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 19.8" "Not detected" "Not detected" HPA035701 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA035701: AB_10696357" "unprognostic (6.34e-2)" "unprognostic (2.09e-1)" "unprognostic (3.18e-1)" "unprognostic (3.26e-2)" "unprognostic (1.99e-1)" "unprognostic (6.20e-2)" "unprognostic (2.12e-2)" "unprognostic (2.04e-2)" "unprognostic (5.78e-3)" "unprognostic (3.93e-2)" "unprognostic (2.02e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.20e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-3)" 3.2 3.6 12.9 2.4 11.8 2.2 3.6 8.7 13.8 2.6 1.7 8.5 3.5 2.3 1.6 13.0 2.2 32.3 2.0 3.2 9.1 2.6 3.9 11.7 3.1 1.4 5.8 13.7 2.1 3.0 3.3 10.0 2.2 7.2 2.1 1.7 2.1 4.2 3.5 5.8 13.9 2.3 1.4 2.4 1.5 2.3 2.0 9.9 0.0 5.0 1.0 2.0 2.4 1.6 0.9 1.6 0.0 5.0 0.0 1.6 1.3 0.3 1.2 0.1 0.0 1.0 0.9 0.0 0.1 0.4 0.1 0.0 0.0 1.5 0.0 0.1 1.5 0.0 0.7 0.0 0.2 0.0 19.8 0.0 0.0 0.9 0.0 0.1 0.0 4.7 1.6 3.3 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.5 0.2 0.0 1.2 0.0 0.2 0.9 0.9 4.3 2.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 4.6 1.3 0.0 1.8 0.0 0.0 0.0 2.1 0.0 0.7 3.3 0.9 0.9 1.6 1.1 1.6 0.0 1.2 0.2 0.0 0.0 5.0 1.5 0.4 1.3 12.9 11.8 8.7 13.8 9.1 2.6 5.8 13.7 7.2 9.9 0.0 10.7 2.7 3.8 4.7 21.1 2.7 7.6 49.5 6.8 5.2 13.7 3.5 1.7 0.9 1.4 0.4 4.0 0.0 1.4 0.4 4.1 3.9 9.2 19.7 4.5 0.0 8.6 1.3 3.8 0.8 12.7 2.9 0.0 6.4 1.7 12.1 0.9 5.8 12.0 1.0 16.1 0.0 1.0 27.7 4.8 4.5 3.8 2.9 2.6 4.8 CES5A "CAUXIN, CES4C1, CES5, CES7, FLJ31547" ENSG00000159398 "Carboxylesterase 5A" Q6NT32 16 55846154-55956031 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "epididymis: 43.4" "Group enriched" "Detected in some" 4 "Cholangiocytes: 2.5;Collecting duct cells: 5.2;Hepatocytes: 5.5" "Cancer enhanced" "Detected in single" "liver cancer: 0.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 44 "U-266/70: 13.3" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.07e-1)" "unprognostic (2.55e-1)" "unprognostic (6.34e-2)" "unprognostic (4.82e-2)" "unprognostic (3.78e-1)" "unprognostic (2.33e-1)" "unprognostic (3.12e-2)" "unprognostic (1.72e-7)" "unprognostic (1.55e-2)" "unprognostic (2.27e-1)" 0.1 0.1 0.7 0.1 0.6 0.0 0.1 0.1 0.8 0.1 0.1 0.1 3.6 0.0 0.1 43.4 0.1 0.0 1.4 0.1 0.8 0.5 0.1 6.6 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.3 0.1 1.2 0.1 0.1 1.8 0.1 0.0 1.7 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.8 0.8 0.5 1.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CETN1 "CEN1, CETN" ENSG00000177143 "Centrin 1" Q12798 18 580357-582114 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 181 "testis: 87.7" "Group enriched" "Detected in some" 21 "Early spermatids: 689.4;Late spermatids: 278.5;Spermatocytes: 249.2" "Cancer enriched" "Detected in single" 10 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028956, CAB037244, HPA069157" Enhanced NA NA "CAB037244: AB_476871, HPA028956: AB_10601798, HPA069157: " "unprognostic (1.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 689.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 278.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 19.4 0.0 249.2 10.0 0.0 0.0 0.0 0.0 0.0 CETN2 "CALT, CEN2" ENSG00000147400 "Centrin 2" P41208 X 152826973-152830777 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 97.3" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 902.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028956 Approved NA NA "HPA028956: AB_10601798" "unprognostic (3.32e-1)" "prognostic favorable (7.54e-6)" "unprognostic (7.73e-2)" "unprognostic (2.14e-2)" "unprognostic (2.14e-1)" "unprognostic (5.73e-3)" "unprognostic (9.58e-3)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "prognostic favorable (9.97e-4)" "unprognostic (5.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-3)" "unprognostic (5.90e-2)" "unprognostic (1.25e-2)" "unprognostic (1.34e-1)" "unprognostic (2.20e-1)" 11.7 17.1 26.6 7.8 26.4 9.1 16.7 7.5 25.3 27.3 16.7 11.4 23.8 6.3 27.5 48.3 16.6 97.3 13.0 13.5 30.0 30.8 29.4 12.6 15.9 6.7 21.2 24.0 24.2 8.6 14.8 26.7 11.1 54.2 21.1 10.9 9.9 10.4 33.0 10.2 7.3 7.0 22.1 19.8 8.0 10.5 11.2 10.3 9.9 34.6 11.7 8.6 17.9 12.4 9.1 15.4 26.2 10.1 8.8 11.5 8.7 39.6 18.1 22.6 16.9 30.0 32.6 9.0 17.3 20.8 22.9 17.6 8.2 21.4 14.2 45.6 23.1 37.1 15.6 15.6 21.5 27.3 6.3 11.3 3.1 9.8 23.7 11.3 13.2 3.6 19.6 28.4 21.2 11.3 27.6 18.0 11.3 8.3 5.9 22.1 18.5 9.8 14.5 7.8 33.1 23.4 8.7 16.4 14.6 41.5 9.8 11.1 14.4 11.5 12.0 10.1 21.3 12.9 10.2 16.8 16.2 13.1 32.0 19.2 6.0 7.9 22.4 34.3 8.0 7.9 12.9 8.8 26.2 9.6 10.1 11.5 9.1 9.4 10.5 10.3 7.8 10.2 10.3 8.4 8.8 10.0 15.4 8.0 8.7 26.6 26.4 7.5 25.3 30.0 30.8 21.2 24.0 54.2 10.3 47.6 33.1 28.2 43.9 20.0 12.7 33.0 63.7 902.0 128.5 160.5 5.9 57.1 202.2 81.0 41.5 28.7 10.1 0.0 36.1 56.2 42.6 31.4 23.2 48.9 44.6 12.7 35.6 49.7 20.1 61.7 62.7 25.9 35.4 28.9 26.5 78.1 33.5 8.6 105.0 253.7 23.4 19.4 49.9 46.0 63.6 26.7 34.7 31.6 26.1 42.6 CETN3 CEN3 ENSG00000153140 "Centrin 3" O15182 5 90392261-90409786 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.1" "Cell type enriched" "Detected in all" 5 "Spermatocytes: 417.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035608, HPA063704" Enhanced Supported Centrosome NA NA Centrosome "HPA035608: AB_10601098, HPA063704: AB_2685097" "unprognostic (2.08e-1)" "unprognostic (7.31e-2)" "unprognostic (2.41e-1)" "unprognostic (1.86e-1)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "prognostic unfavorable (2.22e-4)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (8.77e-2)" "unprognostic (5.03e-1)" "unprognostic (5.64e-2)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.53e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" 8.6 11.6 13.7 8.0 16.3 3.6 12.4 11.5 17.9 11.5 8.9 8.7 8.9 5.2 11.0 11.5 11.4 12.0 5.6 14.4 15.6 11.4 10.6 6.9 12.1 9.3 18.2 13.2 17.1 5.8 11.8 34.3 10.0 20.6 10.3 10.7 5.9 7.8 9.7 11.7 8.2 5.6 7.7 37.2 7.6 6.7 63.1 16.5 7.3 7.9 6.1 10.5 7.5 9.6 17.2 19.9 9.4 10.5 11.4 14.9 4.7 16.1 7.1 29.0 5.9 16.3 22.2 17.4 17.7 10.9 17.0 21.2 10.8 19.9 30.6 17.7 8.3 32.8 11.6 24.7 23.9 28.1 24.5 11.4 15.6 10.7 13.5 11.7 11.4 9.7 13.9 15.7 12.4 20.6 17.6 10.6 23.9 19.6 13.7 19.0 10.7 18.9 18.1 10.2 5.7 18.5 17.2 20.2 15.6 15.0 6.0 15.9 16.2 17.2 8.8 12.5 26.9 16.7 15.5 11.9 10.2 14.6 14.2 23.6 12.8 22.7 27.2 12.0 25.9 10.3 7.8 6.7 9.4 9.3 8.1 9.7 17.2 10.3 9.9 7.4 14.6 14.9 11.9 0.8 11.4 10.5 19.9 8.0 4.7 13.7 16.3 11.5 17.9 15.6 11.4 18.2 13.2 20.6 16.5 17.9 31.4 22.9 31.3 12.7 17.9 44.5 22.9 77.6 27.3 34.9 17.7 56.1 81.2 17.8 15.5 19.2 7.9 46.7 8.9 55.5 21.6 16.4 5.8 38.4 22.1 20.6 23.1 49.1 23.8 25.0 40.9 8.8 18.6 19.8 18.7 79.2 11.7 18.4 30.4 29.3 24.5 58.2 23.1 417.2 55.6 13.8 34.9 20.8 22.4 16.2 CETP BPIFF ENSG00000087237 "Cholesteryl ester transfer protein" P11597 16 56961850-56983845 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Atherosclerosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.5;lymphoid tissue: 54.5" "Group enriched" "Detected in some" 27 "Ito cells: 70.6;Kupffer cells: 86.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.1;plasmacytoid DC: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 5.2;HUVEC TERT2: 8.8;TIME: 5.1" "Secreted to blood" NA NA 2470000000 380000000 "unprognostic (6.52e-2)" "unprognostic (4.17e-3)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" "unprognostic (4.01e-3)" "unprognostic (4.03e-3)" "unprognostic (3.56e-2)" "unprognostic (1.41e-1)" "unprognostic (3.05e-3)" "unprognostic (4.92e-3)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" "unprognostic (7.62e-2)" "unprognostic (2.20e-2)" "unprognostic (4.08e-2)" "unprognostic (7.34e-2)" "unprognostic (9.97e-2)" 16.0 1.9 0.6 4.8 1.0 2.0 4.8 0.3 0.7 0.3 0.9 0.3 0.2 0.3 0.3 0.7 1.3 0.3 1.8 3.1 0.7 0.5 4.1 23.5 2.9 54.5 0.7 0.7 0.6 0.6 0.3 3.0 17.7 0.9 0.7 0.1 9.7 7.7 0.5 0.4 0.5 1.7 0.2 0.7 36.7 0.5 0.4 0.0 3.7 4.6 0.1 3.4 0.7 0.3 1.7 5.8 0.3 5.1 4.2 0.2 2.3 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.9 1.1 1.7 0.0 0.1 0.0 0.1 0.0 0.0 0.4 8.8 0.5 0.0 0.8 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.8 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 5.1 0.4 0.0 0.6 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.9 0.0 0.2 1.2 0.0 1.7 0.0 0.0 0.7 0.3 0.1 0.0 0.3 4.2 5.1 5.8 0.1 2.3 0.6 1.0 0.3 0.7 0.7 0.5 0.7 0.7 0.9 0.0 0.0 2.6 2.7 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.8 0.4 0.0 0.0 0.0 1.0 2.4 0.0 0.0 70.6 86.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 0.0 0.0 CFAP100 "CCDC37, FLJ40083, MIA1" ENSG00000163885 "Cilia and flagella associated protein 100" Q494V2 3 126394939-126436556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 38.7;fallopian tube: 29.2;testis: 21.9" "Group enriched" "Detected in some" 4 "Early spermatids: 282.0;Late spermatids: 505.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Group enriched" "Detected in many" 6 "basal ganglia: 14.7;pons and medulla: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;BEWO: 1.4;HaCaT: 1.2;Hep G2: 1.1;NTERA-2: 1.2" "Low region specificity" "Detected in all" HPA046354 Enhanced NA NA "HPA046354: AB_2679634" "unprognostic (1.79e-2)" "unprognostic (3.75e-3)" "unprognostic (7.17e-5)" "unprognostic (1.61e-3)" "unprognostic (6.75e-2)" "unprognostic (9.99e-3)" "unprognostic (1.47e-1)" "unprognostic (7.83e-2)" "unprognostic (1.61e-1)" "unprognostic (3.70e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.70e-5)" "unprognostic (3.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.96e-2)" "unprognostic (3.58e-4)" 0.3 0.3 1.6 0.3 14.7 0.3 0.3 0.0 0.8 3.2 0.3 10.9 0.0 0.3 1.5 12.0 0.3 29.2 0.3 0.3 4.5 3.0 0.4 0.3 8.2 0.4 0.1 1.1 3.4 0.3 0.3 1.9 0.3 38.7 0.3 0.3 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 21.9 4.5 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 14.7 0.0 0.8 4.5 3.0 0.1 1.1 38.7 4.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 88.3 21.6 0.0 0.0 0.0 0.0 0.0 282.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 505.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.0 6.5 0.0 4.1 1.2 0.0 0.0 0.0 0.0 0.0 CFAP126 "C1orf192, Flattop, Fltp" ENSG00000188931 "Cilia and flagella associated protein 126" Q5VTH2 1 161364731-161367874 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 53.4;fallopian tube: 85.7" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 370.7" "Not detected" "Not detected" "Region enriched" "Detected in all" 7 "pons and medulla: 53.4" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;RPTEC TERT1: 2.5;SCLC-21H: 2.5;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045904 Enhanced NA NA "HPA045904: AB_10960411" 0.7 0.7 5.8 0.7 7.5 0.7 1.1 1.2 2.7 3.0 0.7 23.3 0.0 0.7 2.7 14.8 0.7 85.7 0.8 0.7 7.0 8.0 1.8 0.8 8.1 0.7 4.1 3.9 11.2 0.8 0.7 3.3 0.7 53.4 0.8 0.7 0.0 0.7 1.2 2.8 0.7 0.7 0.7 3.3 0.7 0.7 15.3 4.3 0.0 2.7 0.1 0.8 0.7 0.0 0.0 0.1 0.6 0.5 0.0 1.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.8 7.5 1.2 2.7 7.0 8.0 4.1 3.9 53.4 4.3 6.0 2.6 0.0 0.5 0.0 0.4 0.0 0.0 370.7 35.2 0.0 0.0 0.0 0.0 0.3 53.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 1.1 1.0 0.1 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.1 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706989-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 348.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 19.8;pons and medulla: 30.2" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favorable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.4 0.4 3.1 0.3 19.8 0.3 0.3 0.1 0.4 5.3 0.3 7.0 1.6 0.2 1.0 24.0 0.8 44.8 0.6 0.4 4.6 5.8 0.4 0.3 6.1 0.4 0.0 0.0 4.4 0.9 0.2 4.4 0.3 30.2 0.4 0.2 0.0 0.5 1.3 0.4 0.6 0.3 0.2 0.5 0.4 0.4 11.5 3.5 0.0 0.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 9.3 0.9 1.2 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.9 1.3 1.4 1.4 0.0 2.3 4.6 0.0 0.0 0.0 3.4 1.1 0.9 7.6 2.3 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.5 0.0 2.8 3.1 0.7 0.0 6.6 1.3 0.5 0.9 1.7 4.9 2.0 0.9 1.5 0.0 0.4 6.4 1.1 1.9 3.6 0.7 0.2 3.2 0.3 1.7 1.9 1.5 5.0 0.8 1.0 2.6 1.2 0.8 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 19.8 0.1 0.3 4.6 5.8 0.0 0.0 30.2 3.5 8.9 10.9 0.0 0.2 0.0 0.6 0.0 0.0 348.0 51.2 0.0 0.0 0.0 1.7 0.3 44.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.2 0.2 0.0 0.0 0.0 0.3 61.4 0.3 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.7 0.3 0.2 0.0 0.0 11.4 1.1 0.0 0.0 0.0 0.2 0.1 CFAP161 "C15orf26, FLJ38615" ENSG00000156206 "Cilia and flagella associated protein 161" Q6P656 15 81007033-81149175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 42.8;Club cells: 6.8;Early spermatids: 13.4;Spermatocytes: 11.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Region enhanced" "Detected in many" "pons and medulla: 18.0" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HEL: 42.4;K-562: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076975 Supported NA NA "HPA076975: " "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.05e-4)" "unprognostic (1.57e-3)" "unprognostic (2.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (3.33e-2)" "unprognostic (3.13e-1)" "unprognostic (1.29e-3)" "unprognostic (8.93e-2)" "unprognostic (1.47e-1)" "unprognostic (9.24e-2)" "unprognostic (6.22e-2)" 0.8 0.4 2.3 0.4 5.2 0.9 0.6 0.4 1.1 1.5 0.4 6.8 0.2 0.2 1.1 5.4 0.4 22.4 0.5 1.1 3.3 3.3 0.5 0.5 4.0 0.3 0.6 1.1 4.2 2.7 0.2 9.9 2.1 18.0 0.4 0.3 14.9 0.5 0.5 0.5 0.9 0.4 0.6 0.8 0.9 0.5 18.2 1.5 0.0 1.0 0.0 0.6 0.5 0.2 0.0 0.3 2.3 0.4 0.0 0.7 7.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 42.4 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.1 0.5 0.0 0.9 0.0 14.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.6 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.5 0.4 0.0 0.2 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.1 2.3 0.0 0.1 0.1 0.0 7.3 2.3 5.2 0.4 1.1 3.3 3.3 0.6 1.1 18.0 1.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 42.8 6.8 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 11.9 2.5 0.0 0.0 0.0 0.0 0.1 CFAP206 "C6orf165, dJ382I10.1, FLJ25974" ENSG00000272514 "Cilia and flagella associated protein 206" Q8IYR0 6 87407983-87464465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 17.7;testis: 60.5" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 80.3;Early spermatids: 214.5;Spermatocytes: 42.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "MCF7: 4.5;RPTEC TERT1: 5.4;T-47d: 9.1" "HPA044891, HPA072261" Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA044891: AB_10960832, HPA072261: AB_2686501" "unprognostic (4.31e-1)" "unprognostic (8.75e-3)" "unprognostic (2.40e-1)" "unprognostic (2.31e-1)" "unprognostic (5.51e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (4.68e-3)" "unprognostic (3.13e-2)" "unprognostic (3.99e-3)" "unprognostic (9.08e-3)" "unprognostic (4.22e-2)" "unprognostic (1.46e-1)" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" 0.2 0.5 1.3 0.3 3.0 0.2 0.5 0.3 2.2 0.9 0.3 3.0 0.2 0.3 0.7 3.4 0.2 17.7 0.4 0.3 2.1 2.0 1.5 0.3 2.4 0.2 0.7 1.4 2.7 0.3 0.8 2.6 0.4 8.1 0.5 0.2 0.3 0.3 0.5 0.2 0.3 0.2 0.3 0.5 0.2 0.2 60.5 0.6 0.0 1.4 0.0 0.2 0.4 0.1 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 1.0 0.5 2.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.2 1.0 0.0 0.0 0.0 2.1 1.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.4 1.2 1.1 0.6 0.4 0.5 0.3 0.1 9.1 0.2 0.0 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 3.0 0.3 2.2 2.1 2.0 0.7 1.4 8.1 0.6 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 80.3 13.6 0.0 0.0 0.1 1.7 0.1 214.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.1 0.7 0.4 0.0 0.0 42.3 2.0 0.0 0.0 0.0 0.0 0.0 CFAP221 "FAP221, PCDP1" ENSG00000163075 "Cilia and flagella associated protein 221" Q4G0U5 2 119544432-119662251 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.4;testis: 26.3" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 179.3;Early spermatids: 143.9;Late spermatids: 216.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 3.7;RPTEC TERT1: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.98e-1)" "unprognostic (1.70e-1)" "unprognostic (5.27e-2)" "unprognostic (7.62e-3)" "unprognostic (6.26e-4)" "unprognostic (3.52e-2)" "unprognostic (2.58e-1)" "unprognostic (7.71e-3)" "unprognostic (1.72e-1)" "unprognostic (3.75e-2)" "unprognostic (1.16e-1)" "unprognostic (2.90e-3)" "unprognostic (2.21e-3)" "unprognostic (8.96e-3)" "unprognostic (3.06e-2)" "unprognostic (7.03e-3)" "unprognostic (2.19e-1)" 0.8 2.2 4.1 0.8 8.2 1.4 0.6 1.0 9.5 2.2 0.6 4.5 0.1 9.6 1.7 6.3 0.7 28.4 2.6 1.1 8.7 4.6 9.8 1.7 8.4 0.8 2.5 6.9 3.7 10.6 1.9 7.7 1.1 11.9 1.0 0.7 3.1 0.6 1.1 0.7 1.6 1.5 0.6 2.0 0.9 2.8 26.3 2.0 0.0 3.1 0.0 0.8 0.9 0.6 1.9 1.3 3.8 1.0 1.7 1.4 0.3 0.3 0.6 2.4 0.4 0.5 0.2 0.6 0.0 0.0 0.2 0.0 3.5 0.5 0.6 2.3 0.1 1.4 0.4 0.1 0.3 0.3 0.5 2.0 0.4 3.7 0.8 0.6 0.4 0.9 0.3 0.1 0.2 0.0 0.2 0.2 0.8 0.4 1.4 0.1 0.6 0.8 1.7 0.6 0.5 0.3 1.0 0.1 0.3 10.7 1.1 1.3 1.5 0.3 0.4 0.2 0.9 2.9 0.9 0.6 0.4 1.1 0.5 0.4 0.3 0.4 0.9 0.3 0.5 0.3 1.8 1.0 0.9 1.1 0.7 0.8 0.9 1.0 0.7 0.4 1.9 1.4 1.1 3.8 1.7 0.9 1.3 0.7 0.3 4.1 8.2 1.0 9.5 8.7 4.6 2.5 6.9 11.9 2.0 0.0 27.0 0.0 0.1 0.0 2.9 1.7 7.6 179.3 23.9 7.0 27.5 0.1 23.2 13.4 143.9 0.4 0.0 0.0 16.2 0.0 0.7 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.0 216.0 2.6 0.4 0.0 1.0 0.0 3.4 8.9 0.0 2.1 6.4 32.9 0.0 0.7 49.1 15.3 0.0 0.0 0.0 0.0 0.0 CFAP43 "bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96" ENSG00000197748 "Cilia and flagella associated protein 43" Q8NDM7 10 104129888-104232362 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5;epididymis: 21.6;fallopian tube: 37.7;testis: 40.3" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 424.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.2;U-266/70: 6.5;U-266/84: 5.3" "Low region specificity" "Detected in many" NA NA "unprognostic (1.20e-2)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "unprognostic (6.46e-3)" "unprognostic (2.03e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (1.78e-1)" "unprognostic (1.56e-1)" "unprognostic (2.80e-1)" "unprognostic (6.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.76e-1)" "unprognostic (3.41e-1)" "unprognostic (3.35e-2)" "unprognostic (9.11e-4)" "unprognostic (6.67e-2)" 0.5 0.9 5.3 0.6 15.3 0.5 2.4 0.9 4.4 4.6 0.6 7.1 3.2 0.7 2.7 21.6 0.5 37.7 1.1 0.5 6.0 7.5 2.5 0.8 9.1 0.6 1.1 1.9 5.2 1.3 4.3 10.9 0.7 25.5 1.3 0.6 1.8 1.2 1.5 0.5 1.1 0.8 0.6 1.7 0.6 0.9 40.3 2.9 0.0 4.1 0.1 0.6 0.7 0.3 0.0 0.0 0.5 0.4 0.0 1.1 0.0 3.2 1.2 1.1 2.1 0.0 0.7 0.2 0.0 0.9 0.7 0.5 0.2 8.2 0.0 0.1 0.0 3.0 1.1 0.2 1.2 1.5 0.4 1.4 0.0 0.5 0.5 0.2 0.0 0.3 0.8 1.1 0.9 0.6 1.8 0.3 0.6 2.3 0.2 0.0 2.0 0.2 0.4 0.3 0.8 0.5 0.2 0.0 0.0 2.9 0.0 1.8 1.8 0.8 0.1 1.6 1.1 1.1 0.0 0.1 0.3 0.7 1.0 0.4 6.5 5.3 0.7 0.5 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 1.1 0.0 5.3 15.3 0.9 4.4 6.0 7.5 1.1 1.9 25.5 2.9 3.0 5.9 0.0 0.7 0.0 1.1 0.8 0.0 424.3 70.5 1.8 9.8 0.1 0.0 0.7 71.7 0.3 0.0 0.0 0.0 0.1 0.0 0.9 5.8 0.0 0.1 0.0 3.5 0.6 0.0 43.4 1.4 0.0 0.0 1.0 0.0 1.2 0.2 0.0 2.1 1.0 8.9 0.0 0.0 53.3 3.8 0.0 0.0 0.0 0.0 0.3 CFAP44 "FLJ11142, WDR52" ENSG00000206530 "Cilia and flagella associated protein 44" Q96MT7 3 113286947-113441610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.2;epididymis: 20.2;testis: 20.3" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 192.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067258 Uncertain NA NA "HPA067258: AB_2685814" "unprognostic (2.83e-1)" "unprognostic (7.07e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.35e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-4)" "unprognostic (6.73e-2)" "unprognostic (1.10e-1)" "unprognostic (2.89e-1)" "unprognostic (1.62e-2)" "unprognostic (2.18e-3)" "unprognostic (2.13e-6)" "unprognostic (8.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.77e-2)" "prognostic favorable (7.09e-6)" 1.5 1.2 2.8 1.5 10.1 1.4 3.6 3.9 2.3 2.8 2.3 15.4 0.7 1.1 3.2 20.2 1.6 11.1 1.6 1.7 6.1 1.3 2.6 1.9 7.0 2.1 1.2 1.0 8.8 4.0 6.0 5.8 1.1 38.2 3.9 3.9 0.8 5.7 1.9 1.3 3.7 2.9 1.2 2.0 1.8 3.5 20.3 5.9 0.9 3.4 0.7 1.9 2.6 2.6 1.3 0.3 0.8 0.2 0.1 0.7 0.0 3.9 2.6 4.2 4.5 2.8 4.0 5.6 1.8 0.9 1.2 2.3 1.3 2.3 4.4 0.6 1.1 1.5 4.8 2.8 1.4 2.4 1.9 3.0 3.0 7.9 1.5 0.1 4.9 3.0 0.9 3.3 1.0 1.1 4.5 0.9 4.3 1.2 2.8 1.5 2.5 2.7 4.9 2.7 5.3 6.1 3.3 1.1 0.7 2.1 6.3 4.3 4.7 2.7 0.6 2.6 2.5 3.3 3.5 2.8 3.4 3.7 1.3 1.7 3.9 2.2 0.4 2.1 3.0 2.7 0.0 0.2 0.8 0.4 0.1 0.4 0.4 0.5 0.0 0.0 1.3 0.7 0.4 0.6 0.1 0.0 0.3 0.2 0.0 2.8 10.1 3.9 2.3 6.1 1.3 1.2 1.0 38.2 5.9 8.9 10.7 0.0 1.8 0.0 7.0 5.3 0.0 192.7 34.2 3.5 19.6 0.8 0.0 1.9 46.7 2.2 1.0 0.0 2.6 0.8 0.7 3.3 10.5 3.0 0.5 7.9 0.0 0.6 1.2 38.2 5.8 0.0 0.0 0.0 5.2 5.3 2.0 0.0 6.3 1.1 20.3 0.0 0.9 25.0 4.8 0.0 0.7 0.0 3.7 1.7 CFAP45 "CCDC19, NESG1" ENSG00000213085 "Cilia and flagella associated protein 45" Q9UL16 1 159872364-159900163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 35.5;testis: 29.7" "Group enriched" "Detected in many" 5 "Ciliated cells: 306.5;Early spermatids: 187.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 6.0;neutrophil: 4.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "BEWO: 11.2;HEL: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042204, HPA043618" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA042204: AB_10966555, HPA043618: AB_10959305" "unprognostic (1.88e-1)" "unprognostic (4.15e-2)" "unprognostic (3.95e-1)" "unprognostic (5.18e-3)" "unprognostic (4.78e-3)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (2.57e-1)" "unprognostic (1.76e-1)" "unprognostic (5.21e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-12)" "unprognostic (2.95e-1)" "unprognostic (1.87e-1)" "unprognostic (3.83e-3)" "unprognostic (1.65e-1)" 0.3 0.3 2.0 0.4 7.5 0.6 0.5 0.0 0.2 2.5 0.2 11.9 0.0 0.4 1.3 10.5 0.4 35.5 0.2 0.5 3.1 2.8 0.3 0.2 6.1 0.3 0.1 0.1 7.3 0.1 0.1 0.2 3.3 12.5 0.2 0.2 0.0 0.2 0.5 0.2 0.3 0.2 0.4 0.5 0.5 0.6 29.7 3.4 0.0 0.7 0.0 0.3 0.4 0.1 0.7 0.3 6.0 0.3 0.2 0.5 0.2 2.5 0.6 0.0 0.0 0.1 0.3 11.2 1.3 1.6 2.4 1.0 1.9 3.3 1.1 0.5 0.6 1.3 1.6 0.3 0.3 1.4 0.6 0.3 14.5 0.6 0.1 0.7 1.2 0.5 1.0 0.8 2.6 0.9 3.4 1.7 0.4 1.5 0.5 0.4 3.5 0.2 1.1 0.6 2.1 1.2 0.0 1.2 0.5 0.4 0.6 1.0 0.2 1.3 3.9 0.4 3.4 3.8 0.2 2.2 1.0 3.0 2.0 2.4 1.2 0.0 0.4 5.4 0.5 0.8 0.0 0.3 6.0 0.0 0.3 0.0 0.5 0.3 0.5 0.3 0.7 0.0 0.5 4.9 0.2 0.0 0.3 0.0 0.2 2.0 7.5 0.0 0.1 3.1 2.8 0.1 0.1 12.5 3.4 0.0 3.7 0.0 0.7 0.0 0.0 0.8 0.0 306.5 54.6 5.2 0.0 1.5 0.0 1.4 187.0 2.3 0.0 0.0 2.0 6.4 0.4 0.9 3.5 0.0 0.4 0.0 0.0 1.3 1.6 33.1 2.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.4 0.4 0.0 0.0 0.4 19.0 2.3 0.0 0.7 0.0 0.0 1.1 CFAP46 "bA288G11.4, bA288G11.5, bB137A17.2, bB137A17.3, C10orf123, C10orf124, C10orf92, C10orf93, DKFZp434A1721, FLJ25954, TTC40" ENSG00000171811 "Cilia and flagella associated protein 46" Q8IYW2 10 132808392-132942823 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.8;testis: 35.5" "Group enriched" "Detected in many" 5 "Ciliated cells: 108.4;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 75.3;Spermatocytes: 65.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "non-classical monocyte: 2.7" "Lineage enhanced" "Detected in single" "monocytes: 2.7" "Cell line enhanced" "Detected in some" "AN3-CA: 2.0;CAPAN-2: 2.5;HAP1: 3.4;RPTEC TERT1: 3.1;SH-SY5Y: 3.6" "Low region specificity" "Detected in all" "HPA037786, HPA038034, HPA038867, HPA038868" Uncertain NA NA "HPA037786: AB_10672392, HPA038034: AB_2675796, HPA038867: AB_2676246, HPA038868: AB_2676247" "unprognostic (2.83e-2)" "unprognostic (4.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (1.83e-1)" "unprognostic (4.11e-1)" "unprognostic (5.40e-2)" "unprognostic (6.41e-3)" "unprognostic (1.39e-1)" "unprognostic (1.64e-4)" "unprognostic (1.21e-2)" "unprognostic (8.08e-2)" "unprognostic (4.56e-3)" "unprognostic (2.08e-2)" 0.4 0.7 3.4 0.4 6.7 0.4 0.6 0.7 4.6 1.1 0.4 6.8 2.7 0.6 0.6 9.9 0.7 8.7 0.6 0.8 5.3 3.9 2.4 0.6 2.1 0.4 2.7 3.8 2.3 0.9 1.5 4.2 0.4 9.0 0.5 0.4 1.5 0.6 1.0 32.8 0.5 0.6 0.4 0.9 0.5 3.1 35.5 2.0 0.0 3.5 0.0 0.4 0.4 0.2 0.0 0.0 0.0 2.7 0.7 0.0 0.0 0.0 0.1 0.6 2.0 0.0 0.0 0.0 0.9 0.0 0.6 0.1 0.0 2.5 0.0 0.2 0.1 0.3 0.8 3.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.1 0.4 0.0 0.0 0.0 0.0 3.1 0.0 0.1 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.7 0.0 0.0 0.0 3.4 6.7 0.7 4.6 5.3 3.9 2.7 3.8 9.0 2.0 0.0 7.4 0.0 0.2 0.0 4.4 3.4 0.0 108.4 17.0 7.0 90.3 0.0 5.0 3.9 11.5 0.4 0.0 0.0 0.2 0.0 0.2 0.5 3.5 0.0 0.5 1.6 0.0 4.3 0.8 9.4 1.1 0.0 0.0 0.0 0.0 3.8 1.5 0.0 2.1 4.8 75.3 0.0 0.3 65.8 6.8 0.0 0.0 0.0 0.0 0.2 CFAP47 "CHDC2, CXorf22, CXorf30, CXorf59, FLJ36601, MGC34831, RP13-11B7.1" ENSG00000165164 "Cilia and flagella associated protein 47" Q6ZTR5 X 35919734-36385319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 12.8;pituitary gland: 24.5" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 37.5;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Karpas-707: 4.2;U-266/70: 7.8" "HPA044633, HPA054859" Uncertain NA NA "HPA044633: AB_10960684, HPA054859: AB_2682627" "unprognostic (1.88e-1)" "unprognostic (4.38e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (1.09e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-1)" "unprognostic (4.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (5.61e-2)" "unprognostic (1.50e-5)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "unprognostic (1.48e-2)" "unprognostic (5.19e-3)" 0.3 0.3 2.0 0.2 5.9 0.2 0.3 0.3 1.2 0.9 0.3 6.2 1.2 0.2 0.7 7.0 0.3 12.8 0.2 0.3 3.7 1.3 0.4 0.5 3.7 0.2 1.2 1.5 5.3 0.3 2.3 24.5 0.3 12.4 0.3 0.2 2.0 0.3 0.3 0.3 0.3 0.3 0.2 1.1 0.3 0.3 2.1 2.7 0.0 1.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 4.2 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 0.3 1.2 3.7 1.3 1.2 1.5 12.4 2.7 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 37.5 4.5 1.8 7.9 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.1 0.0 0.0 2.5 5.1 0.0 0.0 0.0 0.0 0.0 CFAP52 "FLJ37528, WDR16, WDRPUH" ENSG00000166596 "Cilia and flagella associated protein 52" Q8N1V2 17 9576627-9643459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 29.5;fallopian tube: 46.9;testis: 26.8" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 149.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023247, HPA030635" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023247: AB_1858797, HPA030635: " "unprognostic (1.76e-2)" "unprognostic (2.31e-1)" "unprognostic (1.38e-1)" "unprognostic (1.68e-2)" "unprognostic (2.09e-1)" "unprognostic (2.04e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-2)" "unprognostic (2.11e-1)" "unprognostic (3.66e-1)" "unprognostic (2.22e-2)" "unprognostic (2.66e-1)" "unprognostic (7.85e-2)" "unprognostic (1.85e-1)" "unprognostic (9.23e-2)" "unprognostic (4.50e-2)" "unprognostic (7.09e-2)" 0.4 0.6 3.7 0.4 8.4 0.4 0.4 0.3 2.5 2.6 0.4 8.5 0.1 0.9 1.3 6.4 0.4 46.9 0.5 0.4 5.9 6.0 0.5 0.4 3.9 0.3 0.5 0.5 4.8 0.3 0.7 5.4 0.5 29.5 0.5 0.3 0.7 1.3 0.5 0.3 0.5 0.9 0.3 1.1 0.4 0.4 26.8 3.5 0.0 0.8 0.0 0.3 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 1.6 1.9 0.0 0.7 1.3 0.9 0.9 0.0 0.1 0.0 0.0 0.1 3.9 0.0 0.4 0.0 1.4 2.2 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.4 0.1 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 4.8 0.0 0.7 0.3 6.2 0.2 3.3 0.0 0.1 0.4 0.9 0.8 0.0 0.7 1.3 0.0 0.9 2.9 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.7 8.4 0.3 2.5 5.9 6.0 0.5 0.5 29.5 3.5 0.0 2.9 0.0 0.2 0.0 0.4 0.3 0.0 149.9 18.2 0.0 5.9 0.5 1.7 0.0 21.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 1.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 1.8 0.2 2.0 0.0 0.0 25.2 0.3 0.0 0.8 0.0 0.0 0.1 CFAP53 "CCDC11, FLJ32743" ENSG00000172361 "Cilia and flagella associated protein 53" Q96M91 18 50227193-50266522 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Ciliopathy, Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.1;fallopian tube: 19.7;testis: 44.9" "Group enriched" "Detected in many" 11 "Ciliated cells: 397.5;Early spermatids: 589.3;Late spermatids: 341.5;Spermatocytes: 416.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 17.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.5" "Low region specificity" "Detected in some" "HPA041069, HPA066142" Enhanced Approved Midbody Yes No Midbody "HPA041069: AB_10805835, HPA066142: AB_2732739" "unprognostic (1.73e-2)" "unprognostic (1.13e-2)" "unprognostic (5.83e-2)" "unprognostic (3.12e-3)" "unprognostic (3.31e-2)" "unprognostic (1.19e-1)" "unprognostic (3.64e-4)" "unprognostic (2.90e-2)" "unprognostic (3.68e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "prognostic favorable (5.85e-4)" "unprognostic (3.22e-1)" "unprognostic (1.17e-2)" "unprognostic (4.34e-3)" "unprognostic (4.61e-3)" 0.4 1.0 2.1 0.4 4.8 0.6 1.0 2.9 1.0 1.6 0.3 4.9 1.7 0.4 1.0 9.3 0.3 19.7 0.7 0.4 2.7 3.3 2.2 0.4 4.5 0.4 1.0 1.1 4.8 1.6 2.7 12.3 0.4 17.1 1.1 0.3 1.2 0.8 2.5 1.4 0.9 0.4 0.5 1.4 0.4 0.5 44.9 2.2 0.2 4.3 0.0 0.4 0.5 0.4 2.1 1.0 2.2 1.0 1.4 1.2 0.4 2.4 1.6 1.0 2.0 1.4 2.7 1.8 0.5 0.3 0.3 0.4 0.2 2.1 1.4 1.4 0.5 0.6 1.0 0.8 1.0 0.5 1.1 1.5 0.5 0.8 0.2 0.8 1.0 0.9 0.8 4.1 1.1 9.5 2.2 0.7 3.8 2.7 0.7 0.6 2.3 2.3 0.5 0.5 0.5 1.0 0.3 0.5 2.0 2.9 0.0 1.7 1.3 0.3 0.1 0.8 2.8 1.3 0.2 0.1 1.4 1.0 0.9 0.8 4.3 1.5 0.3 1.6 1.1 0.3 2.2 0.4 0.0 0.9 1.0 0.5 0.5 0.4 0.9 0.4 2.1 1.2 0.8 0.1 1.4 0.4 1.0 1.0 0.4 2.1 4.8 2.9 1.0 2.7 3.3 1.0 1.1 17.1 2.2 6.0 3.4 0.0 1.6 0.0 3.9 0.4 0.0 397.5 38.7 8.7 7.9 1.4 8.3 2.0 589.3 0.6 0.0 0.0 0.6 0.4 0.7 1.4 1.1 0.9 0.4 1.6 0.0 1.8 0.0 341.5 7.8 0.6 0.0 1.8 0.1 3.4 1.2 0.0 5.3 14.3 8.3 6.5 0.0 416.0 28.2 0.0 0.6 0.0 0.3 0.9 CFAP54 "C12orf55, C12orf63, FLJ31514, FLJ44112" ENSG00000188596 "Cilia and flagella associated protein 54" Q96N23 12 96489571-96875555 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7;testis: 15.1" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 65.5;Alveolar cells type 2: 54.7;Ciliated cells: 195.4;Club cells: 78.5" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 16.5;pons and medulla: 30.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.8;TIME: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039897 Enhanced Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA039897: AB_10674427" "unprognostic (1.87e-4)" "unprognostic (3.63e-2)" "unprognostic (8.07e-2)" "unprognostic (7.89e-2)" "unprognostic (4.66e-2)" "unprognostic (5.55e-2)" "unprognostic (2.75e-2)" "unprognostic (2.91e-2)" "unprognostic (6.16e-2)" "unprognostic (8.40e-2)" "unprognostic (2.86e-1)" "unprognostic (2.36e-1)" "unprognostic (3.55e-5)" "unprognostic (2.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.26e-2)" "unprognostic (8.00e-2)" 1.0 0.9 3.4 1.9 16.5 4.5 1.4 1.0 3.4 2.0 1.4 9.5 1.8 2.3 3.3 8.6 1.2 8.9 1.5 0.9 5.3 3.6 1.4 1.5 8.1 1.9 1.3 3.1 3.8 0.7 1.3 11.7 0.9 30.7 1.7 1.5 0.3 1.8 1.9 1.8 2.9 1.5 1.9 1.7 1.9 1.6 15.1 5.2 0.0 2.4 0.5 1.6 1.0 1.1 2.7 1.6 3.7 1.4 1.5 1.7 0.1 1.6 0.8 1.4 1.8 0.8 1.2 1.2 1.4 0.3 0.4 0.6 0.8 2.4 1.4 2.1 0.5 1.3 1.3 0.7 0.4 0.5 2.3 1.0 1.4 3.1 0.8 0.2 2.7 1.7 0.4 0.5 2.0 0.8 2.9 10.8 1.3 0.7 5.0 1.4 0.7 1.2 2.4 2.4 0.6 1.5 1.5 1.5 1.7 3.1 1.9 2.4 1.7 1.3 0.8 1.5 1.6 2.3 0.7 12.9 2.5 3.0 2.2 2.4 5.6 2.4 1.1 1.7 1.2 1.7 3.7 1.4 1.4 1.7 0.9 1.4 1.4 1.3 1.3 0.4 2.7 1.6 1.5 3.7 1.5 1.1 1.6 1.0 0.1 3.4 16.5 1.0 3.4 5.3 3.6 1.3 3.1 30.7 5.2 65.5 54.7 0.9 0.2 0.0 3.0 0.8 0.0 195.4 78.5 0.0 21.6 0.2 0.0 0.0 22.0 1.6 0.0 0.0 0.0 0.2 0.3 0.2 34.9 0.0 0.2 0.0 1.2 0.0 0.6 12.3 0.3 0.0 0.0 0.0 0.0 10.9 0.2 0.0 0.0 0.0 7.8 0.0 0.0 11.1 6.9 0.0 0.0 0.0 0.0 0.3 CFAP57 "FLJ32000, WDR65" ENSG00000243710 "Cilia and flagella associated protein 57" Q96MR6 1 43172149-43254358 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.6;testis: 29.2" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 6.9;HDLM-2: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002736, HPA028623" Enhanced Approved Cytosol NA NA Cytosol "HPA002736: AB_2272982, HPA028623: AB_10603234" "unprognostic (1.15e-2)" "unprognostic (2.29e-3)" "unprognostic (2.16e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.50e-2)" "unprognostic (3.71e-1)" "unprognostic (2.42e-2)" "unprognostic (1.02e-1)" "unprognostic (1.39e-1)" "unprognostic (4.11e-1)" "unprognostic (2.05e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-2)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-2)" "unprognostic (7.78e-2)" 0.4 0.4 1.6 0.3 6.7 0.2 0.6 0.1 1.8 1.6 0.3 4.2 0.0 0.3 1.0 9.1 0.4 25.6 0.5 0.4 3.6 2.7 1.5 2.7 4.7 0.2 0.3 1.4 7.1 0.9 0.4 5.9 0.5 12.7 0.7 0.3 0.3 0.5 0.5 0.4 0.9 0.3 0.3 0.4 0.2 0.4 29.2 0.4 0.0 1.9 0.0 0.3 0.5 0.2 3.2 2.4 0.7 4.8 1.2 1.5 1.4 2.9 1.0 0.8 0.6 0.2 0.2 0.9 1.1 1.8 1.4 1.4 0.9 1.2 0.3 1.3 2.4 0.8 6.9 0.4 0.9 2.6 4.5 0.2 0.4 0.6 0.6 0.5 0.0 0.3 0.2 1.2 1.1 0.4 1.9 2.0 0.4 0.2 0.1 0.2 0.1 0.3 0.3 1.4 0.2 0.1 0.4 1.0 0.2 3.0 0.5 1.2 0.5 1.4 0.2 1.1 0.8 1.7 0.5 3.9 0.2 1.5 0.7 0.8 0.4 0.6 0.3 0.3 0.8 0.9 0.5 1.1 0.7 1.4 2.0 1.4 2.2 1.4 1.2 2.4 3.2 1.3 1.3 0.0 1.2 4.8 1.9 1.5 1.4 1.6 6.7 0.1 1.8 3.6 2.7 0.3 1.4 12.7 0.4 6.0 0.3 0.0 0.1 0.0 0.4 0.4 0.0 156.6 10.3 0.0 5.9 0.8 0.0 0.3 22.1 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.1 1.6 0.0 0.6 0.0 21.6 0.9 0.0 0.0 3.6 0.0 0.5 0.2 0.0 0.7 1.4 0.8 0.0 0.0 18.7 3.3 0.0 0.0 0.0 0.0 0.1 CFAP58 "bA554P13.1, C10orf80, CCDC147, FLJ35908" ENSG00000120051 "Cilia and flagella associated protein 58" Q5T655 10 104353764-104455090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 10.9;testis: 17.5" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 104.4;Early spermatids: 40.7;Late spermatids: 47.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 6.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 55 "granulocytes: 5.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 5.2;U-2 OS: 10.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036555, HPA071938" Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA036555: AB_10673622, HPA071938: " "unprognostic (5.32e-1)" "unprognostic (2.59e-1)" "unprognostic (6.26e-2)" "unprognostic (1.57e-3)" "unprognostic (5.41e-3)" "unprognostic (1.01e-1)" "unprognostic (9.62e-2)" "unprognostic (5.64e-2)" "unprognostic (3.11e-1)" "unprognostic (2.18e-1)" "unprognostic (8.93e-2)" "unprognostic (3.15e-1)" "unprognostic (1.65e-1)" "unprognostic (3.97e-2)" "unprognostic (6.81e-2)" "unprognostic (4.19e-2)" "unprognostic (1.59e-1)" 0.3 0.5 0.8 0.6 2.0 0.4 0.3 0.7 1.0 3.0 0.3 2.9 0.3 0.1 2.3 0.3 0.3 10.9 0.3 3.0 1.4 1.5 0.3 0.3 2.1 0.3 0.3 0.3 2.0 0.3 1.5 1.9 0.4 6.8 0.4 0.0 0.6 0.3 0.4 1.4 0.2 0.3 0.8 0.3 0.3 0.1 17.5 0.7 0.3 0.8 0.3 0.4 0.3 0.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.2 0.6 0.2 1.7 5.2 1.0 2.8 0.0 0.0 4.0 0.4 0.6 3.0 0.3 0.0 0.3 3.2 0.4 0.2 0.9 1.2 0.0 0.6 0.5 0.7 0.6 2.2 0.8 2.8 2.2 1.7 0.1 1.1 1.2 1.4 0.0 0.0 1.1 0.3 0.0 0.0 0.4 0.3 0.5 0.6 0.0 0.6 0.4 0.0 0.2 0.9 1.2 0.3 0.6 3.4 1.1 10.9 0.6 3.0 0.4 0.1 0.2 1.2 1.3 3.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.8 2.0 0.7 1.0 1.4 1.5 0.3 0.3 6.8 0.7 0.0 0.3 0.0 0.1 0.0 0.0 6.1 0.0 104.4 17.0 0.0 0.0 0.1 0.0 0.2 40.7 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.1 0.0 47.0 0.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 1.1 0.0 0.3 0.0 0.6 14.9 1.9 0.0 0.1 0.0 0.0 0.1 CFAP61 "C20orf26, CaM-IP3, dJ1002M8.3, DKFZP434K156" ENSG00000089101 "Cilia and flagella associated protein 61" Q8NHU2 20 20052514-20360702 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.1;heart muscle: 14.8;pituitary gland: 15.0;skeletal muscle: 23.9;testis: 25.5" "Group enriched" "Detected in some" 4 "Early spermatids: 72.8;Late spermatids: 61.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.3;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 4.3;HMC-1: 4.2;SCLC-21H: 9.7;SK-MEL-30: 3.8;U-87 MG: 7.3" "Low region specificity" "Detected in all" HPA009079 Approved NA NA "HPA009079: AB_1078344" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (6.73e-2)" "unprognostic (1.38e-3)" "unprognostic (6.20e-3)" "unprognostic (3.67e-3)" "unprognostic (8.58e-4)" "unprognostic (8.24e-2)" "unprognostic (8.29e-2)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.56e-1)" "unprognostic (2.76e-4)" "unprognostic (2.77e-1)" "unprognostic (9.27e-2)" "unprognostic (3.10e-3)" "unprognostic (3.06e-1)" 0.2 1.2 1.0 0.2 9.5 0.1 0.5 0.6 2.6 0.9 0.2 5.3 0.8 0.1 1.1 4.5 0.2 15.1 0.3 14.8 4.0 1.9 1.1 0.2 3.5 0.2 0.9 2.0 3.3 0.5 1.0 15.0 0.2 11.4 0.5 0.2 0.1 0.3 0.4 23.9 0.5 0.3 0.3 0.7 0.2 0.3 25.5 1.1 0.0 1.1 0.0 0.2 0.2 0.2 0.0 1.5 0.0 0.0 0.6 2.3 0.0 0.4 1.3 0.2 0.5 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.0 0.7 4.3 0.1 0.0 1.8 0.1 0.2 0.0 0.1 1.2 1.5 0.0 0.4 0.0 0.0 0.0 4.2 0.0 0.7 0.0 0.0 0.2 0.0 0.6 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.4 0.3 0.0 0.3 2.1 0.7 0.0 9.7 0.2 0.3 0.4 3.8 0.0 0.7 0.0 0.7 0.0 0.4 0.6 0.4 1.4 0.4 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.5 0.0 0.0 1.0 9.5 0.6 2.6 4.0 1.9 0.9 2.0 11.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 9.8 0.0 16.0 4.5 1.8 3.9 0.0 0.0 0.0 72.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 61.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 8.2 5.1 0.0 0.0 0.0 0.0 0.0 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 29.2;testis: 20.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Region enhanced" "Detected in many" "pons and medulla: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.1" "HPA055156, HPA063406" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA055156: AB_2682720, HPA063406: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favorable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.2 0.4 1.8 0.3 6.4 0.3 0.3 0.0 2.1 2.2 0.4 5.4 0.3 0.3 0.9 6.0 0.2 29.2 0.6 0.2 2.9 3.2 0.5 0.2 3.6 0.3 0.4 1.2 4.2 0.6 0.3 6.1 0.2 16.3 0.3 0.5 2.8 0.4 0.4 0.2 0.2 0.7 0.2 0.6 0.3 0.6 20.4 2.5 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.5 0.0 1.1 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 2.4 0.1 0.0 0.0 0.0 1.2 0.0 1.5 4.0 0.0 0.1 0.7 0.6 1.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.8 6.4 0.0 2.1 2.9 3.2 0.4 1.2 16.3 2.5 0.0 3.4 0.0 0.1 0.0 0.7 0.0 7.6 53.5 12.5 0.0 11.8 0.0 0.0 0.4 163.7 0.0 0.5 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 28.1 0.0 0.0 138.9 0.6 0.0 0.0 0.0 25.9 0.8 1.4 0.0 0.7 0.9 20.7 0.0 0.0 15.4 4.1 0.0 0.0 0.0 3.4 0.0 CFAP70 "FLJ25765, TTC18" ENSG00000156042 "Cilia and flagella associated protein 70" Q5T0N1 10 73253759-73358859 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.2;testis: 22.3" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 329.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037582, HPA070304" Enhanced NA NA "HPA037582: AB_2675560, HPA070304: AB_2732153" "unprognostic (2.29e-3)" "unprognostic (4.42e-2)" "unprognostic (1.12e-1)" "unprognostic (1.43e-2)" "unprognostic (2.41e-1)" "unprognostic (9.94e-2)" "unprognostic (2.81e-1)" "unprognostic (4.60e-2)" "unprognostic (2.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-3)" "unprognostic (5.95e-3)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.16e-1)" 1.6 3.8 3.8 1.1 7.1 0.6 3.9 3.3 4.3 2.6 0.8 8.2 8.7 1.6 2.1 13.8 0.9 17.3 1.8 1.4 4.2 5.3 4.0 2.2 3.3 1.0 3.7 3.8 4.0 2.4 10.1 27.2 0.8 14.7 4.2 0.9 4.0 2.9 8.5 1.2 3.5 0.8 1.3 4.4 1.4 1.7 22.3 6.5 0.5 6.1 0.5 1.1 0.8 1.0 2.7 1.2 1.1 0.5 1.5 4.1 1.0 1.8 2.1 2.5 2.1 4.2 3.6 0.7 0.9 0.3 0.6 0.6 1.7 7.7 0.9 1.3 0.3 1.6 1.2 1.3 1.7 0.9 1.7 3.7 1.5 1.9 1.8 0.4 0.8 0.9 2.2 4.1 1.3 1.1 3.1 0.0 5.2 0.7 5.0 0.7 3.0 2.0 1.6 0.8 1.7 9.0 1.3 2.0 3.9 3.8 0.6 3.4 0.3 0.8 1.6 1.3 1.5 3.1 1.3 1.4 0.6 2.1 0.9 2.2 5.1 2.8 2.2 2.9 1.7 0.6 0.2 0.1 1.1 1.0 0.5 2.2 1.8 2.0 1.6 0.6 2.7 4.1 3.6 0.3 1.5 0.4 1.2 1.8 1.0 3.8 7.1 3.3 4.3 4.2 5.3 3.7 3.8 14.7 6.5 8.9 6.7 0.5 3.6 0.0 14.8 1.9 2.5 329.2 67.1 5.2 27.5 1.0 3.3 1.1 45.6 1.1 0.0 0.0 0.5 0.1 0.4 6.0 2.3 1.1 0.4 6.4 4.7 1.8 0.3 32.5 4.4 0.4 0.0 0.0 0.6 23.4 0.3 0.0 2.8 1.8 30.3 6.5 0.2 52.5 12.2 0.0 0.2 0.0 0.8 2.5 CFAP73 "CCDC42B, MIA2" ENSG00000186710 "Cilia and flagella associated protein 73" A6NFT4 12 113149858-113159276 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;epididymis: 17.8;fallopian tube: 35.5" "Group enriched" "Detected in some" 8 "Ciliated cells: 42.8;Club cells: 11.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Region enhanced" "Detected in many" "pons and medulla: 27.2" "Cell type enhanced" "Detected in some" "naive B-cell: 1.0;naive CD4 T-cell: 1.3" "Group enriched" "Detected in many" 9 "B-cells: 1.0;T-cells: 1.3" "Cell line enhanced" "Detected in some" "Daudi: 6.4;REH: 3.3;T-47d: 3.9;U-698: 13.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048539 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA048539: AB_2680434" "unprognostic (2.42e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.90e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.18e-3)" "unprognostic (6.49e-2)" "unprognostic (2.94e-1)" "unprognostic (1.33e-1)" "unprognostic (3.14e-1)" "unprognostic (5.68e-2)" "unprognostic (3.43e-2)" "unprognostic (1.62e-4)" "unprognostic (2.03e-4)" "unprognostic (1.60e-1)" "unprognostic (4.03e-2)" "unprognostic (1.55e-2)" 0.2 0.3 4.3 0.5 16.9 2.0 0.3 0.5 0.9 3.1 0.3 15.3 1.0 0.5 1.0 17.8 0.6 35.5 0.4 0.2 5.8 6.1 0.6 0.2 5.7 0.9 0.2 0.9 6.8 0.3 0.7 0.9 0.2 27.2 0.3 0.3 0.0 2.2 0.9 0.5 4.5 0.6 0.2 1.1 0.5 3.9 1.5 4.7 0.0 0.5 0.5 1.3 0.4 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 3.1 6.4 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.3 2.2 0.2 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.4 0.0 0.0 1.1 0.3 1.1 0.4 1.2 0.2 3.3 0.0 0.5 0.9 0.7 0.6 0.1 0.0 0.9 0.0 0.3 3.9 0.0 0.2 0.1 1.1 0.3 0.2 0.6 0.2 13.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 4.3 16.9 0.5 0.9 5.8 6.1 0.2 0.9 27.2 4.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 42.8 11.4 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CFAP74 "C1orf222, FLJ45476, KIAA1751" ENSG00000142609 "Cilia and flagella associated protein 74" Q9C0B2 1 1921951-2003837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;fallopian tube: 12.1;testis: 26.4" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 33.5;Late spermatids: 12.8;Spermatocytes: 21.5;Spermatogonia: 12.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028521, HPA029274, HPA030240" Enhanced NA NA "HPA028521: AB_10601881, HPA029274: AB_10601997, HPA030240: AB_2732455" "unprognostic (5.41e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (9.12e-3)" "unprognostic (3.95e-2)" "unprognostic (2.21e-1)" "unprognostic (2.21e-2)" "unprognostic (1.81e-1)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.47e-1)" "unprognostic (1.26e-6)" "unprognostic (1.28e-1)" "unprognostic (2.11e-1)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" 0.4 2.3 1.3 0.5 4.8 1.6 0.3 11.8 3.8 1.7 0.4 3.9 0.4 0.4 1.0 6.6 1.6 12.1 1.2 0.3 1.9 1.8 0.2 1.7 3.1 1.0 0.8 1.5 2.5 0.1 0.3 2.4 0.5 5.4 0.2 0.4 0.0 0.5 0.7 1.2 5.5 0.3 0.2 0.4 0.4 0.3 26.4 1.0 0.0 1.9 0.0 0.2 0.9 0.1 1.4 1.2 1.5 1.4 1.9 1.1 0.1 1.6 0.0 2.5 1.5 0.0 3.6 2.1 0.3 0.0 0.0 1.2 3.5 0.3 2.1 3.1 0.6 1.6 0.6 0.0 0.6 0.5 1.9 2.9 4.3 5.2 2.3 0.6 3.3 1.4 2.3 2.2 0.0 0.0 1.0 0.0 1.4 6.0 1.6 1.2 0.6 1.6 1.1 1.9 0.2 2.6 1.7 0.7 1.0 0.0 3.4 3.2 1.2 0.6 0.3 0.1 0.7 0.7 0.9 3.6 2.0 2.0 0.9 2.3 2.2 0.8 2.2 0.2 3.3 1.0 0.3 1.4 1.1 0.8 0.6 0.3 1.0 0.6 0.5 0.5 1.4 0.8 1.1 1.5 1.9 0.9 1.2 0.6 0.1 1.3 4.8 11.8 3.8 1.9 1.8 0.8 1.5 5.4 1.0 0.0 2.6 0.0 0.9 0.0 1.4 1.6 0.0 33.5 7.9 0.0 7.9 0.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.8 0.1 0.0 0.0 4.9 1.3 12.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 21.5 12.4 0.0 0.7 0.0 0.0 0.4 CFAP77 "C9orf171, FLJ46082" ENSG00000188523 "Cilia and flagella associated protein 77" Q6ZQR2 9 132410043-132573317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 30.9;testis: 22.0" "Group enriched" "Detected in some" 6 "Ciliated cells: 66.9;Early spermatids: 92.0;Late spermatids: 37.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.8;SH-SY5Y: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021329, HPA024647, HPA061069" Enhanced Approved Cytosol NA NA Cytosol "HPA021329: AB_1848950, HPA024647: AB_10601126, HPA061069: AB_2732657" "unprognostic (7.28e-4)" "unprognostic (5.68e-2)" "unprognostic (5.25e-2)" "prognostic favorable (7.31e-4)" "unprognostic (1.70e-2)" "unprognostic (1.74e-1)" "unprognostic (3.01e-1)" "unprognostic (2.31e-2)" "unprognostic (1.34e-1)" "unprognostic (1.54e-1)" "unprognostic (1.77e-1)" "unprognostic (2.41e-3)" "unprognostic (2.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" 0.2 0.2 1.6 0.2 4.5 0.2 0.2 1.6 0.3 1.6 0.2 8.4 0.0 0.2 0.7 8.8 0.2 30.9 0.2 4.2 2.5 2.5 0.2 0.2 5.5 0.2 0.1 0.0 9.7 0.3 0.2 1.7 0.2 8.9 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 22.0 1.6 0.0 0.3 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.4 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.8 0.0 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.2 1.8 6.6 0.0 0.0 0.0 0.5 0.3 0.0 0.6 1.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.5 1.6 0.1 2.5 2.5 0.1 0.0 8.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 5.7 0.0 0.0 0.0 0.0 0.0 92.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.5 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 2.4 0.0 0.0 10.7 2.3 0.0 0.1 0.0 0.0 0.0 CFAP97D1 C17orf105 ENSG00000231256 "CFAP97 domain containing 1" B2RV13 17 43780435-43787612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053028 Approved NA NA "HPA053028: AB_2682020" "unprognostic (7.80e-2)" "unprognostic (5.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.64e-2)" "unprognostic (1.87e-1)" "unprognostic (1.36e-1)" "unprognostic (1.98e-1)" "unprognostic (2.77e-1)" "unprognostic (4.80e-2)" "unprognostic (3.09e-1)" "unprognostic (4.49e-1)" "unprognostic (1.73e-1)" "unprognostic (6.24e-2)" "unprognostic (2.28e-3)" "unprognostic (1.41e-1)" 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.1 45.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.9 3.0 1.0 1.3 0.7 0.3 1.0 0.1 0.2 1.0 0.2 0.2 0.5 0.4 0.0 0.0 0.2 0.4 0.6 0.8 0.2 0.1 0.9 0.6 0.3 0.4 0.3 0.4 0.7 1.8 1.2 0.6 0.1 0.4 0.9 0.5 0.0 0.8 0.6 0.9 0.5 0.9 0.5 1.0 0.1 0.1 1.2 2.0 0.6 0.2 0.5 0.9 0.7 0.2 0.3 0.6 1.1 1.0 0.6 0.6 0.7 1.3 1.5 1.8 0.6 1.0 1.7 0.9 0.4 0.4 0.5 0.2 0.7 1.6 0.7 2.1 1.0 0.9 0.7 0.6 0.5 0.8 0.5 0.3 0.4 1.5 0.7 0.7 3.0 1.3 0.7 0.9 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP97D2 ENSG00000283361 "CFAP97 domain containing 2" 13 114154691-114223084 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 7.7;brain: 8.4;fallopian tube: 22.4;pancreas: 7.8" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 34.8" "Cell type enriched" "Detected in single" 12 "naive CD8 T-cell: 7.7" "Lineage enriched" "Detected in single" 78 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "HL-60: 1.8;NTERA-2: 1.0" NA NA 0.0 0.0 0.5 0.0 7.0 0.8 0.0 0.0 1.4 0.3 0.0 8.4 0.0 0.0 0.0 2.1 0.0 22.4 0.0 0.0 1.9 0.0 0.0 2.6 0.3 0.0 2.0 3.6 7.8 0.0 0.1 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 2.4 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP99 ENSG00000206113 "Cilia and flagella associated protein 99" D6REC4 4 2418974-2462942 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;fallopian tube: 8.8;testis: 37.2" "Group enriched" "Detected in some" 6 "Ciliated cells: 5.3;Club cells: 3.4;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Early spermatids: 6.3;Late spermatids: 9.5;Rod photoreceptor cells: 5.5;Spermatocytes: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 3.4;SCLC-21H: 1.6;T-47d: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.54e-3)" "unprognostic (6.46e-3)" "unprognostic (1.12e-1)" "unprognostic (2.31e-3)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-2)" "unprognostic (5.22e-2)" "unprognostic (1.89e-1)" "unprognostic (8.14e-2)" "unprognostic (7.93e-5)" "unprognostic (1.15e-1)" "unprognostic (5.97e-3)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (6.94e-2)" "unprognostic (3.49e-1)" 0.0 1.7 0.8 0.1 5.5 0.0 0.1 0.0 0.6 0.4 0.1 3.5 0.0 0.1 0.5 4.5 0.0 8.8 0.2 0.0 2.4 0.6 0.3 2.9 0.0 0.0 0.0 0.8 0.8 0.0 2.9 0.0 9.9 0.1 0.1 1.0 0.1 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.3 37.2 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.2 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.6 3.4 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.4 0.0 0.2 0.6 1.3 1.3 0.8 0.2 0.1 0.0 0.6 1.1 0.0 1.6 0.7 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.8 0.1 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 3.4 3.5 3.9 0.0 0.0 0.1 6.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 5.5 0.0 0.0 7.2 0.7 0.0 0.0 0.0 0.0 0.1 CFB "BF, BFD, H2-Bf" ENSG00000243649 "Complement factor B" P00751 6 31945650-31952084 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 29 "liver: 461.5" "Group enriched" "Detected in many" 8 "Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1" "Cancer enhanced" "Detected in all" "liver cancer: 78.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1" "HPA000951, HPA001817, HPA001832, CAB016381" Supported Approved "Endoplasmic reticulum,Vesicles,Cell Junctions" "Secreted to blood" NA NA 879000000 180000000000 "Endoplasmic reticulum, Vesicles" "Cell Junctions" "CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778" "prognostic favorable (2.76e-5)" "unprognostic (1.02e-1)" "unprognostic (1.44e-1)" "unprognostic (7.94e-2)" "unprognostic (1.82e-2)" "unprognostic (8.56e-2)" "unprognostic (8.08e-3)" "unprognostic (8.81e-2)" "unprognostic (3.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" 9.3 1.0 0.3 4.1 0.4 0.3 2.4 0.2 0.4 1.3 9.0 0.4 0.9 3.2 0.5 3.7 2.2 4.0 8.9 3.3 0.2 0.0 16.1 461.5 2.5 2.1 0.7 0.1 2.8 5.8 0.4 1.0 4.0 1.0 4.0 1.6 2.6 3.1 0.3 0.5 0.5 4.7 2.6 0.6 0.8 4.1 1.4 0.3 0.3 1.8 0.5 1.7 1.6 0.4 0.1 1.6 0.0 0.8 0.0 0.2 0.0 0.0 1.8 0.1 0.1 6.1 6.0 0.0 0.0 0.3 1.6 0.6 0.0 7.1 0.1 5.3 11.6 0.3 0.0 0.0 1.9 1.4 0.4 0.3 0.4 0.3 0.6 0.0 0.7 0.1 19.1 0.1 0.9 0.6 0.6 0.2 0.1 0.2 0.7 0.1 0.1 0.1 0.4 0.3 0.0 0.1 0.2 0.4 0.2 1.7 0.0 0.0 0.0 0.6 1.2 0.2 0.0 0.0 0.2 0.0 0.2 0.5 0.3 0.4 0.6 1.9 0.5 3.2 0.6 0.5 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.3 0.4 0.2 0.3 0.2 0.0 0.7 0.1 1.0 0.3 0.0 20.0 14.0 0.7 0.7 0.1 0.4 20.4 24.1 40.9 5.2 0.0 0.0 3.3 523.0 0.0 2.4 5.0 0.0 173.6 0.1 6.0 9.0 0.0 158.3 0.8 0.0 2.4 11.6 13.2 0.0 2.6 1.2 0.0 31.5 6.7 0.8 492.1 11.8 0.0 11.2 0.7 0.0 3.8 0.1 0.0 1.6 1.4 1.9 11.2 1.8 CFC1 "CRYPTIC, HTX2" ENSG00000136698 "Cripto, FRL-1, cryptic family 1" P0CG37 2 130592168-130599575 "Disease related genes, Predicted secreted proteins" Gastrulation "Developmental protein" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4" "Cell type enriched" "Detected in some" 5 "Intestinal endocrine cells: 19.8" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "RPMI-8226: 19.3;SCLC-21H: 11.0;SuSa: 5.1" HPA041773 Uncertain "Secreted - unknown location" NA NA "HPA041773: AB_2677664" "unprognostic (6.65e-2)" "unprognostic (2.19e-3)" "unprognostic (1.11e-3)" "unprognostic (2.01e-1)" 0.1 0.1 0.9 0.0 2.1 0.0 0.0 2.3 1.1 0.1 0.5 0.1 0.1 0.1 0.0 1.2 0.1 0.3 0.2 13.0 0.1 0.0 0.0 0.0 2.5 0.1 21.9 0.0 22.4 0.0 7.6 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 11.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFC1B ENSG00000152093 "Cripto, FRL-1, cryptic family 1B" P0CG36 2 130521197-130528604 "Predicted secreted proteins" Gastrulation "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "brain: 3.4;pancreas: 13.0;pituitary gland: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 2.2;U-2 OS: 2.1" HPA041773 Approved "Secreted - unknown location" NA NA "HPA041773: AB_2677664" 0.3 0.1 0.4 0.1 1.6 0.1 0.1 1.5 0.5 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.3 0.1 0.3 0.1 3.4 0.2 0.1 0.2 0.1 0.6 0.1 0.1 13.0 0.1 8.1 0.1 1.0 0.8 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.6 1.5 0.5 0.1 3.4 0.6 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFH "ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS" ENSG00000000971 "Complement factor H" P08603 1 196651878-196747504 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity" "Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 295.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 1052.9" "Cancer enriched" "Detected in all" 9 "liver cancer: 151.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 16.5" "Lineage enriched" "Detected in single" 27 "T-cells: 16.5" "Cell line enhanced" "Detected in many" "HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7" "CAB016385, CAB016769, HPA038922, HPA049176, HPA053326" Supported Approved Vesicles "Secreted to blood" NA NA 396000000000 110000000000 Vesicles "CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113" "unprognostic (2.40e-1)" "unprognostic (9.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.39e-2)" "unprognostic (5.40e-3)" "unprognostic (1.80e-1)" "unprognostic (3.75e-3)" "unprognostic (7.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (9.08e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (6.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" 28.6 5.5 1.6 3.7 3.8 0.1 8.8 2.6 2.7 10.4 9.1 1.0 3.9 3.7 2.5 8.7 15.2 3.4 17.0 47.3 2.0 1.2 7.0 295.2 11.0 10.3 5.3 1.7 40.9 1.9 1.7 4.3 5.1 5.3 10.3 10.4 6.3 19.0 3.3 10.0 11.5 8.1 12.6 4.2 3.3 5.8 6.4 2.9 0.7 22.0 22.8 5.8 17.2 16.8 0.0 0.1 0.6 0.1 0.0 16.5 1.0 0.0 13.6 0.0 0.0 21.4 12.1 0.0 5.5 13.5 0.7 2.9 0.0 2.5 0.0 2.0 0.0 0.0 0.4 0.0 5.0 0.5 0.2 0.0 4.1 16.2 0.0 26.9 0.1 0.0 26.3 0.0 4.0 1.7 81.0 16.8 0.0 15.3 0.5 19.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.6 4.3 0.0 47.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 16.2 0.2 0.1 0.1 0.1 0.0 0.0 2.9 0.0 1.2 0.0 0.1 0.0 1.8 0.0 16.5 0.0 6.0 3.5 0.1 0.0 0.4 1.4 0.6 0.0 0.0 0.0 0.0 1.0 1.6 3.8 2.6 2.7 2.0 1.2 5.3 1.7 5.3 2.9 8.9 14.5 21.0 47.7 39.3 0.4 6.2 30.6 119.1 131.9 5.2 0.0 0.0 0.0 1.9 1.5 55.0 0.0 0.0 0.7 0.0 200.9 8.6 3.5 1052.9 0.9 0.0 0.0 57.1 34.9 3.6 262.9 6.0 42.2 0.0 0.0 0.3 6.4 0.0 130.4 0.0 1.4 6.5 36.8 0.7 0.6 33.4 0.1 10.2 0.0 49.2 CFHR1 "CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2" ENSG00000244414 "Complement factor H related 1" Q03591 1 196819757-196832189 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 174 "liver: 218.9" "Cell type enhanced" "Detected in some" 13 "Cholangiocytes: 7.6;Erythroid cells: 23.3;Hepatocytes: 8.9;Ito cells: 17.2;Kupffer cells: 14.9" "Cancer enriched" "Detected in single" 798 "liver cancer: 182.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HeLa: 3.2;HL-60: 4.8;U-266/70: 6.3" "HPA038915, HPA038922, HPA040726" Supported Approved Vesicles "Secreted to blood" NA NA 15000000000 Vesicles "HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101" "unprognostic (2.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.88e-2)" "prognostic favorable (8.71e-6)" "unprognostic (3.02e-1)" "unprognostic (3.70e-1)" "unprognostic (2.50e-1)" "unprognostic (8.48e-2)" "unprognostic (7.21e-4)" "unprognostic (7.01e-4)" "unprognostic (1.13e-1)" "unprognostic (6.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 218.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.3 0.2 2.7 1.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.7 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.2 0.2 4.8 0.8 0.2 0.0 0.0 0.0 1.0 0.1 1.0 0.3 2.4 0.8 0.0 1.5 0.0 0.9 0.0 0.0 0.8 2.0 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.2 0.5 0.4 0.0 1.4 0.9 0.4 0.2 0.2 6.3 0.0 1.1 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 3.0 0.0 0.0 0.1 0.3 0.0 1.4 7.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 23.3 0.0 0.0 1.0 0.0 0.0 8.9 4.2 0.0 0.0 17.2 14.9 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.6 0.0 0.2 0.0 0.0 0.1 CFHR2 "CFHL2, FHR2, HFL3" ENSG00000080910 "Complement factor H related 2" P36980 1 196943772-196959226 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 1462 "liver: 146.2" "Group enriched" "Detected in some" 19 "Erythroid cells: 23.3;Hepatocytes: 31.8" "Cancer enriched" "Detected in single" 175 "liver cancer: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.9;TIME: 1.2" "HPA038915, HPA040726, HPA049813" Supported "Secreted to blood" NA NA 5700000000 "HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895" "unprognostic (1.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 146.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFHR3 "CFHL3, DOWN16, FHR-3, FHR3, HLF4" ENSG00000116785 "Complement factor H related 3" Q02985 1 196774795-196795406 "Plasma proteins, Predicted secreted proteins" "Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 171 "liver: 121.9" "Cell type enhanced" "Detected in some" 18 "B-cells: 5.3;Erythroid cells: 23.3;Hepatocytes: 11.3;Ito cells: 9.2;Kupffer cells: 8.5" "Cancer enriched" "Detected in single" 80 "liver cancer: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.4;SuSa: 3.1;T-47d: 6.9;U-266/70: 12.6" "Secreted to blood" NA NA 582000000 3800000000 "unprognostic (1.73e-1)" "unprognostic (2.11e-1)" "unprognostic (7.16e-2)" "unprognostic (6.77e-2)" "unprognostic (4.46e-1)" "unprognostic (4.20e-3)" "prognostic favorable (2.86e-5)" "unprognostic (1.78e-1)" "unprognostic (2.05e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (6.11e-3)" "unprognostic (2.06e-10)" "unprognostic (2.67e-4)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.32e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 121.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.4 0.0 0.6 0.2 0.1 1.4 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.9 0.0 0.1 0.0 0.0 3.4 0.1 0.0 0.0 0.4 0.5 0.0 1.4 0.0 0.0 0.0 0.7 0.0 3.1 6.9 0.0 0.0 0.1 0.3 0.3 0.0 12.6 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.3 0.4 0.6 0.1 0.5 0.3 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.6 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.5 0.0 0.0 11.3 0.0 0.0 1.7 9.2 8.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 CFHR4 "CFHL4, FHR-4, FHR4" ENSG00000134365 "Complement factor H related 4" Q92496 1 196850241-196918972 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 188 "liver: 61.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 31.7" "Cancer enriched" "Detected in single" 145 "liver cancer: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.0;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 5.0;U-266/84: 2.1" "Secreted to blood" NA NA 180000000 "unprognostic (5.97e-1)" "prognostic favorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (4.79e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (4.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 61.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.6 2.5 0.0 5.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 3.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFHR5 "CFHL5, FHR-5, FHR5" ENSG00000134389 "Complement factor H related 5" Q9BXR6 1 196977556-197009674 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "liver: 85.5" "Cell type enriched" "Detected in some" 24 "Hepatocytes: 88.3" "Cancer enriched" "Detected in single" 396 "liver cancer: 57.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.0" "HPA038915, HPA040726" Supported "Secreted to blood" NA NA 1700000000 "HPA038915: AB_2676269, HPA040726: AB_2677101" "unprognostic (9.12e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.3 0.0 0.0 0.0 3.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFI "C3b-INA, FI, IF, KAF" ENSG00000205403 "Complement factor I" P05156 4 109740694-109802179 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 90.7;liver: 198.4" "Cell type enhanced" "Detected in many" 18 "Hepatocytes: 510.3;Muller glia cells: 130.7;Proximal tubular cells: 205.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 29.5;Hep G2: 46.8;HSkMC: 19.5;RPTEC TERT1: 52.4" "HPA001143, CAB016777, HPA024061" Supported "Secreted to blood" NA NA 11000000000 "CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129" "unprognostic (1.04e-1)" "unprognostic (5.79e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (1.55e-2)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" "unprognostic (3.00e-1)" "unprognostic (2.00e-2)" "unprognostic (5.42e-3)" "unprognostic (1.41e-1)" "unprognostic (3.61e-1)" "unprognostic (8.63e-2)" "unprognostic (1.29e-1)" "unprognostic (3.42e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.06e-4)" 9.5 13.2 1.5 2.3 1.4 0.0 3.9 0.9 2.5 5.0 4.1 1.1 2.9 4.9 5.0 12.0 4.4 9.7 9.3 6.2 1.6 0.8 90.7 198.4 7.2 3.1 1.8 0.7 10.6 7.6 0.5 3.8 3.2 2.6 3.9 0.7 6.8 3.6 3.6 1.4 0.5 4.6 3.0 3.0 7.8 1.7 3.6 1.6 0.5 5.3 2.3 1.4 3.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 29.5 0.0 9.4 0.1 0.2 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.1 46.8 2.0 0.0 0.0 19.5 0.0 0.0 0.0 1.3 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.4 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.9 2.5 1.6 0.8 1.8 0.7 2.6 1.6 11.9 34.5 6.7 10.2 0.9 2.4 1.9 107.0 2.7 36.4 61.1 2.0 0.1 26.6 36.3 0.2 49.6 1.1 0.0 27.7 0.1 3.8 1.7 3.5 510.3 0.6 1.6 0.0 54.6 14.3 0.2 15.5 1.7 0.0 2.8 0.7 130.7 34.8 2.9 0.0 205.0 5.6 0.0 3.2 0.7 0.5 1.0 0.2 4.4 0.6 10.3 CFL2 NEM7 ENSG00000165410 "Cofilin 2" Q9Y281 14 34706769-34714823 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 88.5;skeletal muscle: 185.9" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 498.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037078, HPA045599" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 90000000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB037078: AB_259128, HPA045599: AB_2679383" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (1.59e-1)" "unprognostic (3.02e-2)" "unprognostic (2.80e-3)" "unprognostic (3.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.92e-2)" "unprognostic (2.48e-2)" "unprognostic (1.27e-1)" "unprognostic (1.65e-2)" "unprognostic (3.13e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (2.16e-5)" 14.0 16.5 15.9 8.8 17.7 5.0 6.7 13.6 16.6 13.7 23.2 25.8 9.2 4.7 21.3 10.2 20.7 11.2 7.2 88.5 19.0 14.5 8.7 33.0 7.8 3.7 22.7 10.6 12.9 3.0 9.3 4.5 10.3 28.9 22.4 8.6 7.8 5.4 31.8 185.9 2.6 6.7 38.1 24.6 4.2 11.9 6.9 20.1 0.5 9.0 30.8 3.4 34.7 9.3 8.5 2.9 3.6 1.8 3.2 5.8 1.6 17.8 16.1 10.4 6.7 10.6 39.5 5.8 31.2 36.0 29.9 31.9 12.1 7.7 6.4 12.8 49.7 22.4 3.5 22.1 6.6 52.7 0.9 9.2 1.3 19.1 28.6 17.3 1.6 1.0 29.9 2.3 25.5 14.1 21.0 29.6 0.9 2.0 5.1 36.7 5.0 1.3 0.9 3.4 3.1 24.8 1.1 32.9 1.0 10.8 3.7 2.1 8.9 20.3 4.4 10.5 8.0 9.7 1.6 26.0 29.8 19.8 14.0 14.9 7.1 4.6 2.4 10.9 2.4 7.0 3.6 1.8 2.1 3.7 1.8 5.8 8.5 4.3 4.0 2.9 5.0 3.4 3.5 0.7 3.2 0.8 2.8 3.6 1.6 15.9 17.7 13.6 16.6 19.0 14.5 22.7 10.6 28.9 20.1 98.3 34.5 15.9 86.3 17.7 51.4 498.3 15.3 6.7 14.8 21.0 19.6 25.2 51.4 41.2 2.2 46.0 0.9 0.0 34.0 52.6 52.9 52.5 5.7 99.2 13.2 73.1 9.1 43.6 14.0 6.5 52.9 10.4 28.7 7.2 3.4 80.2 30.0 4.2 92.6 79.1 57.2 32.3 125.1 51.4 51.5 16.9 17.8 14.9 3.7 53.3 CFP PFC ENSG00000126759 "Complement factor properdin" P27918 X 47623172-47630305 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3" "Group enriched" "Detected in many" 17 "Ito cells: 122.2;Kupffer cells: 303.6;Macrophages: 129.1;monocytes: 486.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6" "Group enriched" "Detected in many" 40 "dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7" "Cell line enhanced" "Detected in some" "EFO-21: 21.2;HEL: 4.6;HMC-1: 5.3;NB-4: 10.1;U-937: 7.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA072644 Approved Vesicles "Secreted to blood" NA NA 8500000000 Vesicles "HPA072644: " "unprognostic (2.77e-3)" "unprognostic (2.21e-3)" "unprognostic (1.00e-1)" "unprognostic (2.15e-2)" "unprognostic (4.15e-2)" "unprognostic (9.66e-5)" "unprognostic (9.90e-3)" "unprognostic (1.30e-2)" "unprognostic (5.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (2.70e-1)" "unprognostic (1.97e-2)" "unprognostic (2.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.62e-2)" "unprognostic (2.17e-1)" 3.3 1.0 0.7 10.3 0.9 39.4 1.6 0.7 0.6 0.6 2.0 0.2 0.6 0.5 0.7 3.1 1.8 2.5 2.1 4.3 0.6 0.6 1.3 21.6 8.7 41.3 0.4 0.0 0.7 0.4 0.0 0.7 1.6 0.3 0.8 0.4 1.2 3.1 0.6 1.4 1.0 2.1 2.6 0.4 39.3 1.1 0.8 0.0 6.0 0.9 1.3 5.6 2.1 0.9 0.4 86.2 64.3 106.7 1.1 2.1 70.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 21.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 4.6 0.1 0.0 0.1 1.1 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.0 10.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.2 0.9 0.0 0.0 0.5 0.1 0.4 0.3 0.1 0.1 7.0 0.0 9.0 102.4 3.2 0.2 106.7 0.2 0.4 1.4 0.1 86.2 0.1 2.1 0.7 64.3 1.1 70.6 2.7 1.1 70.7 0.7 0.9 0.7 0.6 0.6 0.6 0.4 0.0 0.3 0.0 0.0 14.5 8.5 0.1 3.5 3.2 0.8 2.5 4.0 4.5 0.0 0.0 0.3 0.0 0.2 0.1 1.0 0.0 0.0 0.6 0.4 1.6 0.2 1.1 1.7 15.7 1.6 0.0 122.2 303.6 0.0 0.9 129.1 5.0 486.9 0.0 0.2 0.4 0.0 1.1 0.4 1.7 0.0 0.9 0.0 0.2 2.6 0.3 3.3 0.6 0.0 CFTR "ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR" ENSG00000001626 "Cystic fibrosis transmembrane conductance regulator" P13569 7 117465784-117715971 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Isomerase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 103.0" "Cell type enriched" "Detected in many" 5 "Ductal cells: 325.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.9;pancreatic cancer: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "CACO-2: 12.8;MOLT-4: 48.1;U-266/70: 26.3" "Low region specificity" "Detected in some" "Region enriched" "Detected in single" 5 "olfactory region: 6.3" "CAB001951, HPA021939, HPA079652" Enhanced NA NA "CAB001951: , HPA021939: AB_1846578, HPA079652: " "unprognostic (6.38e-3)" "unprognostic (9.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.44e-2)" "unprognostic (8.74e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (3.20e-3)" "unprognostic (1.13e-1)" "unprognostic (8.89e-2)" "unprognostic (1.55e-2)" "unprognostic (2.14e-2)" "unprognostic (4.78e-3)" "unprognostic (1.24e-1)" "unprognostic (2.58e-1)" "unprognostic (9.08e-2)" "unprognostic (6.64e-2)" 0.4 0.2 0.4 10.5 0.4 0.0 0.3 0.3 0.3 2.5 19.8 0.1 0.8 10.5 0.6 2.1 0.4 0.4 15.8 0.3 0.4 0.3 1.1 1.4 5.7 0.1 0.5 0.1 0.3 103.0 0.0 0.3 0.1 0.1 1.5 12.5 0.1 22.4 0.1 0.3 1.1 24.2 0.3 0.7 0.3 0.6 0.9 0.1 0.1 0.3 0.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.3 0.4 0.3 0.5 0.1 0.1 0.1 6.0 48.7 0.0 1.7 0.0 0.4 1.2 43.3 9.4 23.9 0.0 0.0 0.0 0.0 325.5 2.9 0.0 19.4 0.0 3.7 0.0 0.1 3.6 1.1 0.2 0.0 0.0 6.9 0.0 0.0 1.6 0.3 0.0 0.0 11.8 11.5 0.6 21.5 37.7 0.0 0.0 0.0 0.0 0.3 1.8 0.4 0.0 0.0 0.0 64.4 3.9 CGA "FSHA, GPHa, GPHA1, HCG, LHA, TSHA" ENSG00000135346 "Glycoprotein hormones, alpha polypeptide" P01215 6 87085498-87095406 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "pituitary gland: 398.8;placenta: 489.3" "Cell type enriched" "Detected in some" 30 "Syncytiotrophoblasts: 71349.9" "Cancer enhanced" "Detected in many" "testis cancer: 13.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 28 "BEWO: 73.5;SuSa: 141.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hypothalamus: 69.2" "CAB023350, HPA029698" Enhanced "Secreted to blood" NA NA "CAB023350: AB_617281, HPA029698: AB_2673153" "unprognostic (1.66e-1)" "unprognostic (2.10e-1)" "unprognostic (3.22e-5)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.69e-2)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (4.32e-2)" "unprognostic (8.32e-2)" "unprognostic (9.15e-3)" 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 398.8 489.3 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.6 0.0 0.1 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.2 1.9 3.5 1.5 1.1 2.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 141.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.1 1.0 1.7 0.5 0.7 1.3 0.8 1.4 0.6 2.2 1.2 2.1 3.5 1.1 1.5 1.9 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 1223.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2346.5 0.1 1.5 0.0 0.0 567.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 71349.9 0.0 0.0 0.3 CGAS "C6orf150, cGAS, MB21D1" ENSG00000164430 "Cyclic GMP-AMP synthase" Q8N884 6 73413515-73452276 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity" "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 32.0" "Cell type enriched" "Detected in some" 4 "monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 18.6;RH-30: 21.5;RPMI-8226: 22.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA031700, HPA031702" Enhanced Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite" Cytosol "HPA031700: AB_10601693, HPA031702: AB_2673999" "unprognostic (2.49e-1)" "unprognostic (2.36e-1)" "unprognostic (4.61e-2)" "unprognostic (4.95e-2)" "unprognostic (2.49e-2)" "unprognostic (1.81e-1)" "unprognostic (4.84e-3)" "unprognostic (1.01e-2)" "unprognostic (9.80e-2)" "unprognostic (4.25e-2)" "unprognostic (2.20e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.27e-7)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-1)" 6.5 2.0 2.9 10.5 4.5 18.5 8.1 1.2 3.9 4.7 3.7 3.4 2.1 4.1 5.5 2.8 5.3 3.9 4.3 3.2 2.8 2.9 2.5 1.9 9.6 11.8 7.2 0.6 3.4 3.8 2.3 1.8 4.8 4.4 6.6 3.1 2.2 4.2 2.9 1.9 1.8 5.2 3.6 4.7 12.8 3.5 1.7 4.3 6.2 3.9 4.2 15.5 6.6 32.0 6.3 12.5 13.3 12.9 3.0 6.0 3.9 8.9 3.0 0.1 0.1 0.6 1.3 0.0 4.5 1.9 5.9 6.5 9.9 6.8 0.1 9.8 2.1 3.2 4.6 5.0 0.0 6.3 14.9 0.0 7.8 3.8 0.0 2.1 6.0 5.5 0.9 1.6 5.8 0.0 0.0 1.8 0.0 0.0 18.6 4.3 3.7 0.0 13.6 2.9 1.1 5.5 11.6 21.5 22.6 0.0 3.7 0.1 0.0 7.9 0.2 4.7 0.1 0.0 16.2 2.1 0.0 4.3 3.9 0.1 4.0 8.8 0.1 0.0 8.6 5.9 13.3 9.2 13.2 4.6 12.9 3.6 6.3 6.0 4.6 5.4 4.8 1.4 2.6 5.8 3.0 7.8 12.5 5.8 3.9 2.9 4.5 1.2 3.9 2.8 2.9 7.2 0.6 4.4 4.3 3.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 5.3 1.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 3.5 0.6 0.0 0.0 4.7 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 47.7 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CGB1 ENSG00000267631 "Chorionic gonadotropin beta subunit 1" A6NKQ9 19 49035610-49036895 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "pancreas: 8.4" "Cell type enriched" "Detected in single" 125 "Syncytiotrophoblasts: 58.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 20.5" "HPA038925, HPA038934" Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.9 0.0 0.1 0.1 0.0 0.0 0.5 0.3 4.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.0 0.0 0.0 CGB2 ENSG00000104818 "Chorionic gonadotropin beta subunit 2" 19 49031912-49033238 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.1;testis: 4.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.05e-2)" 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 1.0 0.9 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.1 1.4 0.4 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.3 4.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 3.4 0.0 0.4 0.0 0.0 0.1 0.0 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 3.0 10.2 12.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 6.5 0.0 0.5 1.1 0.0 33.4 0.0 0.0 0.0 CGB3 CGB ENSG00000104827 "Chorionic gonadotropin beta subunit 3" P0DN86 19 49022869-49024333 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.7;placenta: 15.0" "Cell type enriched" "Detected in some" 38 "Syncytiotrophoblasts: 724.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9;testis cancer: 4.2" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enriched" "Detected in some" 20 "BEWO: 39.7" "CAB000042, CAB010884, HPA038925, HPA038934" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.39e-1)" "unprognostic (7.88e-2)" "unprognostic (6.92e-2)" "unprognostic (1.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 6.7 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 1.3 0.5 0.0 0.0 0.1 0.2 0.0 1.9 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 724.1 0.0 0.0 0.0 CGB5 HCG ENSG00000189052 "Chorionic gonadotropin beta subunit 5" P0DN86 19 49043884-49045311 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 105.2" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 16.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "BEWO: 46.9;U-251 MG: 21.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.38e-1)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "prognostic unfavorable (1.18e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.47e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 12.7 105.2 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.2 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 CGB7 CG-beta-a ENSG00000196337 "Chorionic gonadotropin beta subunit 7" P0DN87 19 49054275-49058860 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 8.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (9.53e-2)" "unprognostic (1.99e-1)" "unprognostic (1.87e-1)" "unprognostic (3.53e-1)" "unprognostic (4.60e-5)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (8.37e-2)" "unprognostic (2.88e-2)" "unprognostic (4.80e-2)" "unprognostic (8.83e-4)" "unprognostic (1.54e-1)" "unprognostic (3.89e-8)" "unprognostic (1.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.05e-1)" "unprognostic (9.28e-2)" 0.3 0.2 0.3 0.3 0.3 0.0 0.8 0.3 1.5 1.7 0.3 0.3 3.7 0.3 1.2 0.5 4.0 1.0 2.0 2.0 0.4 0.2 1.0 0.3 0.8 0.3 0.3 0.3 0.9 2.5 0.0 2.7 3.7 1.3 4.6 0.0 0.8 1.3 3.9 6.4 8.1 0.3 0.3 0.3 0.3 0.0 1.5 0.3 0.3 0.9 2.2 0.3 2.4 2.7 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.8 0.2 1.5 0.0 0.2 7.1 0.6 0.0 1.4 1.2 1.2 2.6 0.0 0.1 1.3 2.1 5.7 0.2 4.8 0.5 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.4 6.9 0.4 0.7 1.6 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.0 0.1 0.1 1.4 0.1 0.1 1.7 1.0 0.2 0.2 2.3 2.3 0.0 10.4 0.3 0.4 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.3 1.5 0.4 0.2 0.3 0.3 1.3 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 49.1 0.0 0.0 0.0 CGB8 ENSG00000213030 "Chorionic gonadotropin beta subunit 8" P0DN86 19 49047638-49049106 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "pituitary gland: 7.0;placenta: 22.2" "Cell type enriched" "Detected in some" 15 "Syncytiotrophoblasts: 37.1" "Cancer enhanced" "Detected in some" "testis cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 61.9;U-251 MG: 21.5" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.35e-2)" "unprognostic (1.72e-1)" "unprognostic (7.44e-3)" "unprognostic (4.70e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 22.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.3 1.4 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.9 0.0 0.2 0.0 1.2 2.6 0.2 21.5 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 CGN KIAA1319 ENSG00000143375 Cingulin Q9P2M7 1 151510510-151538692 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 110.2;Ciliated cells: 50.9;Enterocytes: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 36.9;CAPAN-2: 24.3;OE19: 23.6;RT4: 17.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017193, HPA027586, HPA027587, HPA027657" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 24000000 "Plasma membrane, Cell Junctions" "CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527" "unprognostic (1.57e-1)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (8.74e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (8.38e-2)" "unprognostic (4.61e-1)" "unprognostic (2.11e-2)" "unprognostic (2.96e-3)" "unprognostic (7.10e-2)" "prognostic favorable (5.84e-10)" "unprognostic (2.66e-1)" "unprognostic (3.00e-1)" "unprognostic (8.28e-2)" "unprognostic (2.10e-2)" 3.9 0.3 2.1 8.5 5.1 0.0 4.1 11.9 3.5 2.2 18.0 3.7 15.5 23.9 1.0 3.5 5.9 6.1 11.9 0.5 1.4 1.4 10.7 15.0 12.4 0.2 5.0 1.0 1.4 25.3 22.1 4.7 1.9 4.8 4.6 11.6 1.8 19.8 14.4 0.2 11.6 44.1 1.8 1.9 0.2 13.6 6.4 4.3 0.9 3.6 2.3 4.3 6.9 3.8 1.2 0.9 2.6 1.0 1.6 2.4 0.1 11.5 1.3 1.1 1.9 0.0 0.0 14.8 0.0 0.0 0.3 0.4 36.9 24.3 0.5 4.0 0.0 2.0 11.1 3.6 2.0 0.2 6.9 2.4 1.0 0.5 0.7 0.0 0.2 1.6 0.0 0.4 0.5 0.3 0.0 0.1 3.3 0.5 3.5 0.0 10.7 2.0 0.2 9.5 23.6 1.0 2.2 1.2 1.7 7.8 17.9 3.7 1.9 0.7 11.3 0.4 4.5 13.9 0.1 0.2 0.1 3.6 0.2 0.5 3.3 3.2 2.0 0.1 1.3 0.9 1.1 1.0 0.4 2.4 0.4 0.7 0.7 0.7 0.5 0.1 1.2 0.8 1.4 2.6 1.6 0.5 0.9 0.7 0.1 2.1 5.1 11.9 3.5 1.4 1.4 5.0 1.0 4.8 4.3 110.2 25.7 0.0 3.7 0.2 2.7 0.4 15.3 50.9 26.1 3.5 0.0 2.1 0.0 19.2 0.0 0.0 85.9 0.0 22.2 0.2 0.3 9.6 0.0 25.2 0.2 0.0 9.9 0.0 0.0 0.5 0.6 0.7 3.3 3.6 26.7 16.6 34.9 40.1 0.7 2.6 1.4 0.0 0.3 0.7 7.1 1.6 0.3 0.0 21.4 13.9 CGNL1 "FLJ14957, JACOP, KIAA1749, PCING" ENSG00000128849 "Cingulin like 1" Q0VF96 15 57375967-57550727 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 81.1;Hepatocytes: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 29.4;SuSa: 22.4;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013500, HPA056911, HPA069214" Enhanced Supported "Nuclear bodies,Cell Junctions" No No "Cell Junctions" "Nuclear bodies" "CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102" "unprognostic (1.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.52e-2)" "prognostic favorable (3.55e-4)" "unprognostic (3.22e-1)" "unprognostic (1.51e-3)" "prognostic favorable (5.58e-4)" "unprognostic (4.32e-2)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (4.05e-2)" "unprognostic (1.91e-2)" "prognostic favorable (1.37e-6)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (1.88e-3)" "unprognostic (1.18e-2)" 3.1 8.7 10.8 1.7 9.8 0.6 14.6 3.2 12.2 25.7 2.0 7.3 8.9 1.4 14.9 4.9 7.7 7.0 2.7 13.6 11.2 7.8 54.8 26.2 15.3 1.3 8.3 5.9 8.1 13.6 12.5 2.9 20.8 10.9 27.6 2.3 11.1 32.0 12.7 1.0 7.4 1.7 10.6 5.3 0.8 9.0 5.2 9.7 1.3 15.0 4.2 8.0 10.0 14.6 0.5 0.2 1.1 0.1 0.3 0.2 0.0 0.0 0.7 7.4 0.0 0.0 0.0 0.1 0.1 1.6 0.6 1.4 4.6 0.0 0.0 6.5 0.9 1.1 0.0 3.5 0.0 1.0 0.0 0.5 0.0 0.0 3.1 0.1 0.0 0.0 0.2 0.2 0.7 0.0 2.5 29.4 0.3 0.0 0.0 1.1 1.3 0.0 0.1 3.6 2.0 0.3 0.0 3.7 0.1 2.5 0.0 0.1 0.4 0.0 2.8 0.0 22.4 0.3 0.3 18.0 0.0 1.9 0.0 1.0 0.0 0.0 0.0 0.1 3.3 0.0 0.9 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.2 1.1 0.3 0.0 0.2 0.1 0.0 10.8 9.8 3.2 12.2 11.2 7.8 8.3 5.9 10.9 9.7 47.6 81.1 0.0 10.9 4.0 0.4 19.4 17.8 2.7 18.2 21.0 0.0 0.8 34.9 6.9 2.5 13.5 0.2 23.3 11.6 0.7 19.3 30.4 1.1 49.7 0.3 0.0 12.6 22.1 1.0 11.5 18.4 2.4 6.8 1.0 3.2 37.1 5.1 0.0 26.2 32.9 1.3 0.0 2.8 0.5 0.4 2.0 1.1 0.5 2.9 7.6 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119115 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 9.8;Peritubular cells: 8.1;Spermatogonia: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 18.7;SK-BR-3: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" NA NA 22000 "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 5.0 3.0 15.7 1.4 28.8 2.2 7.1 14.8 31.6 2.1 3.2 2.8 0.2 4.6 5.6 2.0 3.4 5.9 4.6 2.8 16.1 13.8 3.4 10.3 0.9 0.8 8.5 15.9 11.0 3.8 0.4 1.4 0.7 10.3 5.1 4.6 0.8 13.7 1.4 3.1 2.1 6.3 6.4 2.6 1.0 13.4 4.0 3.6 0.0 0.7 1.6 2.8 4.0 0.5 1.0 0.9 0.9 1.0 0.9 1.1 0.6 3.5 3.0 0.1 3.8 9.0 3.4 0.2 4.3 0.0 0.4 0.1 0.8 2.9 0.0 1.2 8.5 1.1 0.2 0.6 0.9 0.2 0.0 1.8 0.1 5.2 7.6 8.4 2.3 0.3 2.3 8.7 1.2 1.0 5.7 0.3 0.5 0.1 0.1 0.5 11.1 1.7 3.1 1.0 18.7 8.3 0.1 0.0 0.2 0.0 0.1 8.7 13.0 8.4 38.0 4.3 0.1 12.2 6.4 0.0 0.0 3.4 0.0 0.3 1.1 0.3 0.3 0.0 0.1 4.9 0.9 1.0 0.0 0.7 0.8 0.5 1.0 1.0 0.7 0.5 0.7 0.6 1.1 0.6 0.9 0.4 0.9 0.7 0.6 15.7 28.8 14.8 20.5 16.1 13.8 8.5 15.9 10.3 3.6 0.0 0.0 0.0 0.1 0.6 9.8 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 1.4 0.1 1.3 2.2 0.0 3.9 0.3 0.0 0.0 3.1 0.8 1.3 4.0 0.0 0.0 0.0 4.2 0.5 1.2 0.0 8.1 3.6 2.0 0.0 0.9 2.1 13.6 0.4 0.1 0.0 0.0 0.1 CH25H ENSG00000138135 "Cholesterol 25-hydroxylase" O95992 10 89205629-89207314 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4" "Group enriched" "Detected in many" 5 "Club cells: 17.0;Smooth muscle cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC diff: 7.4;ASC TERT1: 3.8;fHDF/TERT166: 26.3;HSkMC: 6.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (6.07e-3)" "unprognostic (2.96e-3)" "unprognostic (1.57e-1)" "unprognostic (5.11e-2)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "unprognostic (8.65e-3)" "unprognostic (7.74e-2)" "unprognostic (4.76e-2)" "unprognostic (2.62e-5)" "unprognostic (2.47e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.29e-2)" 18.5 6.8 5.1 8.5 30.7 4.1 7.9 1.0 15.7 5.2 3.6 22.6 2.4 4.3 1.6 17.6 18.4 7.4 18.3 4.2 11.3 6.5 2.8 4.7 17.0 4.6 9.4 1.6 3.4 1.8 2.2 9.8 5.4 44.4 5.7 7.5 5.3 2.3 2.1 2.1 3.2 6.8 6.9 41.9 2.6 6.2 0.6 2.2 7.2 3.0 8.5 5.7 14.0 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.4 3.8 0.0 0.0 2.5 0.6 0.7 0.0 0.0 0.0 0.9 26.3 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 6.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.5 0.0 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 30.7 1.0 10.6 11.3 6.5 9.4 1.6 44.4 2.2 3.0 4.3 0.0 4.4 6.2 0.0 0.4 0.0 6.7 17.0 0.0 0.0 0.1 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 7.6 0.9 1.1 0.0 7.9 1.6 0.0 3.1 4.7 0.0 0.3 8.7 6.8 0.0 0.0 0.6 0.1 0.0 0.7 0.0 0.3 6.5 61.8 0.0 0.0 5.8 0.1 0.7 0.0 4.7 CHAC1 MGC4504 ENSG00000128965 "ChaC glutathione specific gamma-glutamylcyclotransferase 1" Q9BUX1 15 40952962-40956519 "Enzymes, Predicted intracellular proteins" "Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 29.9;Exocrine glandular cells: 24.3;Pancreatic endocrine cells: 16.5;Urothelial cells: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 1.8;monocytes: 1.1;T-cells: 1.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;HHSteC: 26.8;hTCEpi: 42.4;SK-MEL-30: 30.0;U-266/70: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042708, HPA043505" Approved Approved Mitochondria NA NA Mitochondria "HPA042708: AB_2678125, HPA043505: AB_2678518" "unprognostic (6.04e-3)" "unprognostic (2.81e-2)" "unprognostic (7.47e-2)" "unprognostic (2.84e-3)" "unprognostic (6.57e-3)" "unprognostic (2.00e-2)" "unprognostic (5.59e-2)" "unprognostic (2.43e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (3.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.23e-7)" "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-2)" "unprognostic (3.91e-2)" 6.0 1.0 2.6 1.5 2.1 1.7 1.0 1.7 5.6 1.1 1.9 0.3 1.1 1.9 1.1 1.8 18.6 1.5 5.7 2.2 2.6 4.8 3.1 14.1 1.5 1.1 2.6 2.2 11.3 53.0 0.9 1.3 1.1 6.2 1.5 1.1 0.2 39.9 1.3 52.4 1.3 1.5 1.1 5.3 1.1 11.2 0.9 1.0 0.0 1.7 4.7 4.6 2.7 2.7 1.8 0.1 0.2 1.1 0.0 1.3 0.2 2.8 1.9 0.5 8.8 1.4 1.0 3.6 17.0 35.1 1.8 5.0 4.7 0.7 0.8 1.3 1.5 5.6 1.9 3.8 1.4 1.3 3.2 0.7 0.7 0.5 0.0 26.8 2.2 0.0 12.0 42.4 5.5 7.7 0.5 1.7 19.6 2.3 4.0 1.5 1.6 1.6 0.0 1.6 9.7 6.6 1.4 0.0 3.8 0.9 1.1 1.7 2.5 0.5 3.0 30.0 1.1 1.1 16.0 0.5 0.3 5.3 0.4 3.0 26.3 5.6 3.4 1.6 3.1 4.0 0.0 0.4 0.0 1.3 0.4 0.0 1.8 0.2 0.8 0.1 0.0 0.0 1.0 0.2 0.0 1.1 0.0 0.0 0.2 2.6 2.1 1.7 5.6 2.6 4.8 2.6 2.2 6.2 1.0 0.0 1.3 1.5 3.4 2.5 2.3 3.5 2.5 0.0 1.2 0.0 2.0 0.2 29.9 7.5 0.1 0.5 2.8 0.0 24.3 0.2 0.5 5.1 0.0 0.4 0.3 0.0 3.4 1.8 0.8 0.0 0.3 0.4 5.0 1.8 1.5 0.3 16.5 0.3 0.0 0.1 0.4 0.0 0.5 1.4 0.7 3.8 2.9 0.0 1.5 11.8 CHADL SLRR4B ENSG00000100399 "Chondroadherin like" Q6NUI6 22 41229510-41240934 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 45.8;salivary gland: 14.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 19.4;Melanocytes: 16.9;Muller glia cells: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 16.2;Hep G2: 4.4;hTCEpi: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005696, HPA024654" Uncertain "Secreted to extracellular matrix" NA NA "HPA005696: AB_1079724, HPA024654: AB_1846615" "unprognostic (6.14e-2)" "unprognostic (4.42e-3)" "unprognostic (1.49e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (9.51e-3)" "unprognostic (2.20e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (2.83e-3)" "unprognostic (1.51e-2)" "unprognostic (4.67e-8)" "unprognostic (8.36e-3)" "unprognostic (4.10e-1)" "unprognostic (3.40e-1)" "unprognostic (4.09e-2)" 3.2 6.3 8.6 0.7 20.3 1.2 2.4 2.7 22.4 2.8 4.1 45.8 0.4 2.0 1.5 2.1 4.3 3.1 3.4 6.9 12.7 9.8 1.3 1.7 2.8 1.0 18.6 10.1 2.8 4.5 0.5 1.7 0.9 17.2 4.6 0.5 7.3 14.2 5.3 2.6 7.0 1.8 1.2 39.8 1.0 3.3 2.0 20.3 0.0 4.0 0.2 0.6 1.8 1.3 0.3 4.2 1.6 1.4 0.0 1.6 1.2 0.8 0.3 0.3 0.4 0.2 0.1 16.2 0.6 0.0 0.1 0.3 0.2 0.1 0.2 0.1 0.9 0.1 0.7 0.0 0.9 0.0 0.2 0.3 0.0 0.4 4.4 0.5 0.2 0.1 1.5 4.6 0.4 0.0 0.1 0.5 0.3 0.1 0.6 0.0 0.4 0.2 0.7 0.4 0.4 0.6 0.2 0.7 0.2 0.3 0.4 1.0 0.2 1.7 0.3 0.2 0.1 0.1 1.6 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.1 0.3 0.2 2.1 0.0 0.6 1.6 0.7 1.4 0.9 0.0 0.6 1.0 0.5 0.3 1.6 0.7 0.7 0.0 0.2 4.2 0.1 1.2 8.6 20.3 2.7 15.2 12.7 9.8 18.6 10.1 17.2 20.3 6.0 2.1 0.0 7.2 3.5 1.9 2.6 2.5 5.3 1.2 3.5 0.0 2.1 6.6 1.6 19.4 1.0 0.5 0.0 1.0 5.2 2.1 4.6 0.0 2.4 4.1 0.0 2.9 1.8 0.0 6.2 3.4 0.8 16.9 0.0 0.6 37.9 1.0 0.0 2.8 4.2 1.3 0.0 0.5 0.4 1.1 3.1 1.3 0.0 1.2 4.3 CHAF1B "CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7" ENSG00000159259 "Chromatin assembly factor 1 subunit B" Q13112 21 36385378-36419015 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.7" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021679, CAB033604" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB033604: AB_2229411, HPA021679: AB_1846621" "unprognostic (2.28e-2)" "prognostic favorable (5.44e-5)" "prognostic favorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (3.28e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (6.14e-6)" "unprognostic (2.14e-2)" "unprognostic (1.89e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-2)" "unprognostic (6.27e-2)" "unprognostic (7.66e-6)" "unprognostic (5.89e-2)" "unprognostic (5.00e-3)" "unprognostic (9.12e-2)" "unprognostic (1.36e-1)" 2.4 1.4 2.8 3.7 5.9 9.3 4.1 7.2 9.4 2.4 3.0 2.0 1.2 2.8 3.9 2.8 4.4 2.3 1.6 2.9 2.0 2.7 1.7 1.4 2.1 4.5 1.8 4.1 2.7 6.9 3.1 2.1 2.1 3.8 2.9 3.6 4.6 5.2 1.6 20.7 4.4 3.1 2.4 1.5 2.5 2.1 6.2 0.2 12.3 1.7 3.6 7.3 1.8 2.6 2.8 1.3 3.7 0.8 4.4 5.1 1.7 14.8 9.0 15.4 8.7 1.2 3.1 8.4 10.5 6.1 13.0 13.7 10.1 7.9 11.6 4.7 5.4 13.3 5.0 15.8 7.0 10.6 11.7 12.3 18.0 9.7 7.1 0.8 11.5 8.8 1.9 1.7 12.2 5.3 2.6 6.1 14.4 15.7 10.9 6.6 10.3 17.8 6.7 10.7 13.5 6.6 26.2 8.3 6.7 4.5 7.4 9.3 7.7 16.1 12.3 5.8 6.5 9.6 7.8 3.7 10.7 5.3 9.4 12.2 8.0 14.8 13.6 6.8 12.7 13.4 3.1 0.8 1.0 3.7 0.4 3.3 2.6 2.9 2.8 0.7 2.8 1.9 3.0 3.7 4.4 0.7 1.3 5.1 1.7 2.8 5.9 7.2 9.4 2.0 2.7 1.8 4.1 3.8 0.2 0.0 2.4 2.2 5.1 2.5 1.3 0.9 0.0 2.7 3.4 3.5 0.0 4.4 0.0 6.5 7.1 2.1 0.5 0.0 1.9 7.5 1.7 3.3 2.3 0.4 3.7 1.6 0.0 1.3 1.9 5.9 0.6 1.1 5.0 1.8 2.1 2.0 1.8 0.0 0.0 0.2 2.2 6.5 0.5 8.9 13.2 2.0 2.1 1.7 3.7 2.1 CHAT ENSG00000070748 "Choline O-acetyltransferase" P28329 10 49609095-49665104 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Acyltransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.4;placenta: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "basal ganglia: 5.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "NB-4: 15.9" "Region enhanced" "Detected in many" "basal ganglia: 18.4" "Group enriched" "Detected in all" 4 "basal ganglia: 7.7;pons and medulla: 8.1" "CAB002313, HPA048547, CAB079053" Supported Supported NA NA "CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437" "unprognostic (2.34e-2)" "unprognostic (6.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (2.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.09e-1)" 0.2 0.0 0.2 0.3 5.4 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.2 1.6 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.9 0.0 0.2 10.4 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 1.1 0.2 0.4 0.2 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 1.0 0.3 0.2 0.6 1.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 1.1 15.9 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.7 0.4 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.2 0.3 0.4 0.1 0.5 0.3 1.0 0.4 0.1 0.6 0.5 0.3 0.0 0.6 0.1 1.0 0.2 0.0 0.2 5.4 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHCHD10 "C22orf16, N27C7-4" ENSG00000250479 "Coiled-coil-helix-coiled-coil-helix domain containing 10" Q8WYQ3 22 23765834-23768443 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 127.0;skeletal muscle: 226.6" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 2117.1;Enterocytes: 1174.4;Hepatocytes: 1666.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003440 Enhanced Supported Mitochondria NA NA Mitochondria "HPA003440: AB_1078348" "unprognostic (3.88e-2)" "unprognostic (2.36e-3)" "unprognostic (8.90e-2)" "unprognostic (9.80e-2)" "unprognostic (7.68e-2)" "unprognostic (5.97e-3)" "unprognostic (1.59e-1)" "unprognostic (1.85e-1)" "unprognostic (2.23e-2)" "unprognostic (2.40e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" "prognostic favorable (2.15e-7)" "unprognostic (5.19e-3)" "unprognostic (2.06e-1)" "unprognostic (5.68e-3)" "unprognostic (2.62e-3)" 23.1 14.9 25.8 16.4 33.9 5.7 20.0 11.8 31.0 17.3 39.4 9.6 18.3 30.6 6.1 15.5 20.2 7.6 11.3 127.0 23.7 23.5 40.4 86.1 8.3 16.9 25.8 18.4 4.8 24.3 36.4 12.7 11.7 14.5 11.7 31.6 24.3 33.7 22.2 226.6 7.2 30.2 12.8 12.2 13.0 17.3 4.1 9.6 3.0 27.8 73.1 15.8 13.8 9.3 9.4 7.3 7.6 7.8 0.8 5.0 1.0 5.8 16.0 4.9 20.7 10.9 6.9 8.0 2.1 5.6 5.9 6.8 29.8 8.0 18.0 5.5 10.1 3.2 18.9 27.0 8.5 5.3 5.8 29.4 4.6 12.6 28.1 18.5 13.3 21.4 13.4 22.5 8.9 2.4 1.2 7.1 3.9 8.2 11.6 5.2 29.7 4.1 8.4 3.6 47.6 40.5 15.6 0.8 41.5 27.6 13.3 8.7 4.6 2.8 35.5 27.2 9.7 12.7 10.4 3.1 0.2 0.1 3.6 0.0 4.5 2.0 12.4 4.8 11.1 2.6 0.2 3.9 7.6 2.8 7.8 1.9 9.4 3.2 4.0 1.7 7.8 5.0 3.6 0.1 0.8 6.9 7.3 3.7 1.0 25.8 33.9 11.8 31.0 23.7 23.5 25.8 18.4 14.5 9.6 11.9 8.0 277.6 303.6 42.7 134.9 422.5 295.5 4.0 11.4 397.8 108.0 25.5 2117.1 75.8 24.6 33.8 1174.4 46.7 46.5 229.6 58.5 151.0 86.1 1666.3 550.7 93.8 298.3 76.1 204.5 13.0 45.1 214.4 354.3 26.2 653.9 94.8 45.8 623.8 27.6 877.4 179.8 122.9 200.9 26.5 44.5 38.3 88.0 85.8 692.8 383.5 CHCHD3 "FLJ20420, Mic19, MINOS3, PPP1R22" ENSG00000106554 "Coiled-coil-helix-coiled-coil-helix domain containing 3" Q9NX63 7 132784868-133082088 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 109.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042935 Enhanced Supported Mitochondria NA NA 110000 Mitochondria "HPA042935: AB_10794538" "unprognostic (1.53e-1)" "unprognostic (2.50e-1)" "unprognostic (4.15e-2)" "unprognostic (3.00e-3)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.39e-2)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.15e-4)" "unprognostic (4.98e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-1)" "unprognostic (8.03e-2)" 15.2 15.8 9.9 13.4 11.6 15.4 13.7 10.1 14.2 10.5 17.3 9.8 7.9 19.9 13.2 9.7 10.5 9.7 10.4 42.6 9.5 8.9 23.2 17.9 11.7 10.6 10.4 8.0 11.6 9.8 13.9 17.0 10.7 10.9 10.5 18.3 11.5 10.6 11.1 109.1 9.0 20.5 13.9 9.7 12.2 13.9 6.4 10.8 19.7 14.6 30.1 13.2 12.9 13.6 19.0 28.2 15.4 29.9 21.2 19.9 15.3 23.4 24.1 24.5 33.8 17.7 16.3 14.5 23.0 21.9 26.3 29.2 28.3 26.1 19.5 9.2 14.6 58.5 16.5 28.3 19.8 37.2 25.5 26.8 20.1 24.9 16.4 35.2 45.1 15.0 14.7 13.7 36.0 37.7 13.2 18.3 25.8 42.8 17.9 24.3 30.9 65.6 39.6 40.2 37.9 27.9 32.7 35.9 27.9 25.6 19.5 31.3 39.1 19.1 15.1 43.5 17.5 12.6 27.1 15.1 25.2 10.8 39.4 41.2 17.3 22.1 49.2 39.7 38.7 35.3 14.9 21.8 15.4 16.1 29.9 15.3 19.0 14.7 15.5 28.2 11.7 13.0 14.5 3.1 21.2 24.1 24.6 19.9 15.3 9.9 11.6 10.1 14.2 9.5 8.9 10.4 8.0 10.9 10.8 23.8 19.2 25.3 26.1 31.0 23.1 116.2 40.8 29.4 28.4 14.0 21.6 64.7 106.1 46.3 76.6 29.3 40.2 0.0 53.2 67.5 37.3 25.3 33.5 19.2 67.5 14.3 34.4 16.0 24.0 74.9 29.1 38.1 35.4 59.5 46.7 22.9 42.8 21.0 33.2 67.4 23.8 32.3 50.9 12.7 24.7 35.3 57.2 35.5 71.7 35.4 CHD1 ENSG00000153922 "Chromodomain helicase DNA binding protein 1" O14646 5 98853985-98928957 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022236 Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA022236: AB_2670915" "unprognostic (2.63e-1)" "unprognostic (2.31e-1)" "unprognostic (1.09e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (7.15e-2)" "unprognostic (6.50e-2)" "unprognostic (1.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-1)" "unprognostic (4.94e-2)" "unprognostic (3.15e-1)" "prognostic unfavorable (7.25e-6)" "unprognostic (2.69e-1)" "unprognostic (3.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.17e-1)" 13.0 7.4 5.5 15.8 7.5 41.7 10.2 14.9 5.5 9.4 9.3 4.7 7.9 6.6 11.3 7.5 7.6 10.8 10.6 6.8 4.9 3.1 7.3 10.1 12.1 8.8 8.8 3.2 18.1 8.3 9.3 12.0 11.1 6.4 7.7 7.4 5.6 8.1 11.5 13.2 8.2 12.3 8.3 7.2 17.2 8.6 12.0 7.4 70.1 8.1 5.5 9.3 10.4 11.3 10.1 7.1 16.7 8.2 8.1 8.4 2.2 11.0 10.2 23.9 16.2 8.1 8.4 20.9 11.5 7.5 9.3 12.2 12.6 8.6 9.4 11.2 6.6 15.2 9.2 18.7 12.6 19.5 14.7 14.1 16.6 12.1 9.6 8.9 15.9 12.9 7.2 5.2 16.2 16.4 6.3 11.2 30.8 20.0 14.5 9.3 8.9 31.6 6.9 16.0 3.5 12.4 26.9 16.7 14.0 8.2 10.6 11.2 9.6 14.7 7.7 18.6 13.0 7.5 11.0 12.7 20.1 10.8 12.5 20.2 10.1 10.6 19.9 11.0 16.0 12.0 11.4 8.2 10.7 6.5 7.5 8.2 10.1 6.1 6.1 7.1 9.4 8.4 6.6 16.7 8.1 7.1 5.2 6.3 2.2 5.5 7.5 14.9 5.5 4.9 3.1 8.8 3.2 6.4 7.4 44.7 61.6 41.0 98.1 138.2 37.4 25.7 20.4 61.6 79.6 34.9 41.2 44.3 6.6 31.7 85.6 50.1 37.2 0.0 27.6 32.9 75.7 63.5 85.6 26.0 30.8 31.8 30.5 36.2 71.6 14.8 30.0 68.0 64.1 52.3 28.7 17.0 29.9 35.1 18.0 11.0 50.1 45.3 96.8 51.7 52.7 164.7 75.5 54.3 26.9 58.2 CHD5 ENSG00000116254 "Chromodomain helicase DNA binding protein 5" Q8TDI0 1 6101793-6180123 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.4;pituitary gland: 22.3;testis: 16.4" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 60.3;Early spermatids: 202.3;Horizontal cells: 212.9;Late spermatids: 67.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 17.0;U-2 OS: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015809 Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Nuclear speckles" Cytosol "HPA015809: " "unprognostic (5.03e-4)" "unprognostic (1.89e-1)" "unprognostic (2.47e-3)" "unprognostic (9.40e-6)" "unprognostic (1.91e-2)" "unprognostic (2.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.95e-2)" "unprognostic (6.64e-4)" "unprognostic (1.34e-1)" "unprognostic (1.34e-4)" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.96e-1)" "unprognostic (1.98e-1)" 1.1 7.9 19.8 1.3 17.1 1.0 1.0 12.1 41.4 1.2 1.4 0.7 0.0 1.3 1.2 1.2 1.5 1.2 1.2 1.6 15.3 10.1 1.3 1.0 1.2 1.0 4.3 19.1 1.1 1.4 1.3 22.3 1.0 8.0 1.9 1.3 2.3 1.2 4.8 1.2 1.0 1.4 1.2 1.6 1.1 1.2 16.4 0.8 0.0 1.0 0.0 1.0 1.1 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.5 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 17.0 0.2 0.2 0.0 0.0 0.0 2.9 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.8 17.1 12.1 34.2 15.3 10.1 4.3 19.1 8.0 0.8 0.0 0.0 0.0 0.0 0.1 60.3 1.7 0.0 0.0 0.0 3.5 11.8 0.0 0.0 0.0 202.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 212.9 0.0 0.0 0.0 67.4 0.9 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.4 0.0 48.3 0.0 0.9 3.4 17.0 0.4 0.0 0.0 0.0 0.0 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678778-60868028 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 227.8;Muller glia cells: 155.9;Rod photoreceptor cells: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5" "Cell line enhanced" "Detected in many" "AF22: 26.3;SCLC-21H: 24.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 110.3" HPA053075 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA053075: AB_2682035" "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.9 2.2 7.0 7.9 11.2 25.1 4.1 47.1 9.0 2.3 5.7 13.4 3.1 5.9 2.6 3.2 5.1 3.2 3.1 4.1 8.1 4.3 3.6 3.6 4.7 7.0 8.1 3.3 1.4 6.4 12.4 9.9 5.6 9.9 2.9 5.5 6.4 5.7 2.8 10.3 5.7 6.6 2.4 7.5 6.1 4.5 4.3 12.2 1.6 5.4 2.2 7.3 2.9 5.9 12.2 0.6 12.6 0.6 0.0 5.5 0.4 3.9 2.0 26.3 4.6 0.1 0.0 8.3 0.2 0.0 0.9 0.8 4.9 3.7 7.6 0.5 0.0 1.2 2.4 13.5 3.9 0.8 2.9 7.2 17.9 3.3 6.4 1.1 5.4 3.3 0.5 3.0 0.0 4.4 1.6 3.9 6.2 1.3 6.8 0.6 4.0 8.4 6.2 18.0 3.9 0.9 17.6 6.2 2.4 2.0 4.5 24.0 11.9 0.7 3.0 7.3 9.7 5.3 5.1 4.5 0.3 4.3 0.3 2.1 7.3 4.2 11.9 1.5 0.6 6.7 10.4 0.3 12.6 2.6 0.1 3.3 8.0 2.9 0.9 0.1 12.2 5.5 2.0 7.1 0.0 0.6 0.6 0.2 0.4 7.0 11.2 47.1 6.5 8.1 4.3 8.1 3.3 9.9 12.2 29.8 17.4 46.9 22.3 27.0 32.3 30.7 30.6 20.1 23.9 15.7 227.8 7.1 1.7 15.6 11.9 29.6 17.6 0.0 9.7 5.5 7.1 31.3 38.3 9.5 11.9 66.7 83.8 27.0 12.9 7.6 0.9 10.3 20.3 19.8 30.6 155.9 13.9 22.6 0.4 4.2 196.3 0.0 4.4 4.9 3.4 28.2 5.1 13.8 21.7 25.1 CHDH ENSG00000016391 "Choline dehydrogenase" Q8NE62 3 53812335-53846390 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.6;liver: 24.0" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 53.5;Proximal tubular cells: 81.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 6.4;T-reg: 2.8" "Group enriched" "Detected in many" 15 "granulocytes: 6.4;T-cells: 2.8" "Cell line enhanced" "Detected in some" "CACO-2: 8.0;Hep G2: 24.6;OE19: 17.7;T-47d: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036633, HPA058130" Enhanced NA NA "HPA036633: AB_10670841, HPA058130: AB_2683615" "unprognostic (3.40e-3)" "unprognostic (1.17e-2)" "unprognostic (2.26e-3)" "unprognostic (7.17e-3)" "unprognostic (9.15e-2)" "unprognostic (1.17e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-1)" "unprognostic (4.35e-3)" "unprognostic (4.57e-2)" "unprognostic (5.12e-2)" "prognostic favorable (1.88e-8)" "unprognostic (3.37e-2)" "unprognostic (2.42e-1)" "unprognostic (8.26e-2)" "unprognostic (2.29e-2)" 0.7 2.2 11.6 2.3 9.7 0.9 7.8 12.9 10.2 4.1 8.8 8.2 0.8 8.3 3.2 3.8 1.0 2.8 5.5 3.3 13.8 4.0 36.6 24.0 2.6 1.4 11.9 6.5 1.6 15.5 8.0 5.9 0.8 10.0 5.4 9.4 3.3 13.7 1.5 3.8 1.6 14.0 1.4 6.4 0.7 8.1 4.5 13.0 0.0 4.1 0.1 1.6 0.8 1.0 0.3 0.1 6.4 0.1 0.1 2.8 0.1 0.3 3.3 0.8 0.1 0.0 0.0 3.7 0.2 0.4 0.0 0.0 8.0 0.6 0.3 0.6 0.6 0.1 0.0 5.3 0.0 0.0 0.0 2.8 0.0 1.1 24.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.8 0.5 0.0 4.7 0.0 0.1 5.2 17.7 0.6 0.0 1.4 5.6 3.7 2.9 2.2 2.8 1.3 0.1 0.0 0.7 8.1 0.1 0.0 0.0 0.6 0.1 0.7 0.7 1.0 0.0 0.0 0.0 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.1 2.8 0.1 11.6 9.7 12.9 10.2 13.8 4.0 11.9 6.5 10.0 13.0 3.0 5.0 2.7 6.1 6.0 16.8 7.6 53.5 6.7 10.3 10.4 13.7 2.5 6.6 15.1 21.5 0.7 23.4 0.0 11.9 1.8 2.1 17.6 6.9 38.9 0.3 1.6 46.0 1.3 1.9 28.5 5.5 1.9 3.3 0.0 34.1 13.4 9.1 17.5 14.5 81.4 14.6 0.0 1.9 3.3 1.9 4.5 0.7 1.5 45.1 1.2 CHEK1 CHK1 ENSG00000149554 "Checkpoint kinase 1" O14757 11 125625136-125676255 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 80.0;seminal vesicle: 66.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 33.1;Extravillous trophoblasts: 31.3;Spermatogonia: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.7" "Lineage enriched" "Detected in many" 6 "T-cells: 11.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" HPA044364 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044364: AB_2678913" "unprognostic (6.74e-2)" "unprognostic (3.63e-1)" "prognostic favorable (3.62e-4)" "unprognostic (5.54e-2)" "unprognostic (2.17e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.70e-6)" "unprognostic (3.95e-3)" "unprognostic (1.26e-3)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.10e-6)" "unprognostic (1.75e-1)" "prognostic unfavorable (1.04e-8)" "unprognostic (2.89e-2)" "unprognostic (2.64e-1)" "unprognostic (8.16e-2)" "unprognostic (1.33e-1)" 3.0 2.5 2.5 9.0 2.8 14.9 2.1 1.1 2.2 2.5 5.2 1.3 80.0 5.0 1.9 10.2 6.5 1.7 3.6 1.5 2.4 2.4 3.7 2.0 1.8 9.6 3.0 1.2 3.8 4.0 25.5 3.5 3.8 1.5 2.9 6.3 1.6 2.6 66.8 1.2 2.9 5.2 2.3 3.0 3.6 2.8 7.2 1.5 22.4 1.8 4.5 8.8 3.8 3.3 1.9 1.8 1.9 0.7 1.2 11.7 1.0 13.0 10.6 23.9 14.5 4.9 10.5 10.4 18.3 8.8 11.7 12.6 25.9 28.8 34.0 18.8 7.2 15.6 15.7 14.6 9.6 14.5 21.3 6.7 63.1 8.9 13.2 1.5 32.2 12.0 5.4 2.0 14.8 10.5 7.0 13.9 23.2 32.0 30.0 15.4 6.7 47.8 15.8 24.2 21.3 9.6 29.1 22.3 17.9 10.8 17.4 15.1 16.0 15.0 10.4 4.4 16.9 28.0 10.5 9.3 16.9 14.4 8.1 16.8 6.7 12.0 48.5 6.2 24.3 19.8 1.9 0.5 0.3 1.3 0.7 1.2 1.9 3.5 1.6 1.1 1.5 3.3 2.0 0.4 1.2 0.4 1.8 11.7 1.0 2.5 2.8 1.1 2.2 2.4 2.4 3.0 1.2 1.5 1.5 3.0 0.3 6.0 4.4 5.6 1.4 3.7 33.1 2.7 5.7 7.0 0.0 9.6 3.3 3.7 3.3 1.9 3.3 23.3 1.0 31.3 5.6 2.0 0.0 0.8 9.4 0.0 1.7 4.9 0.0 2.2 1.4 2.4 0.0 4.6 5.6 2.7 2.4 3.7 1.1 6.8 1.5 0.0 4.1 23.3 60.3 4.3 6.5 4.4 12.0 1.4 CHGA ENSG00000100604 "Chromogranin A" P10645 14 92923080-92935293 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 577.6" "Cell type enriched" "Detected in many" 49 "Intestinal endocrine cells: 6314.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 114.8" "Region enhanced" "Detected in many" "cerebral cortex: 97.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 134 "SCLC-21H: 44.3;SH-SY5Y: 120.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000023, HPA017369, CAB040544, CAB055506, CAB058688" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 295000000 78000000 Vesicles "CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698" "prognostic favorable (7.85e-5)" "unprognostic (4.89e-2)" "unprognostic (5.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.43e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (4.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.85e-1)" "unprognostic (8.81e-13)" "unprognostic (1.07e-2)" "unprognostic (1.77e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (3.99e-4)" 2.0 81.9 6.6 3.1 18.7 1.3 1.3 0.5 97.9 1.9 36.1 4.0 0.0 15.8 1.3 1.3 1.2 1.3 1.3 1.2 11.2 14.0 1.3 1.2 1.4 1.2 8.0 36.1 1.2 15.9 577.6 81.1 1.2 17.1 2.0 7.9 0.4 1.3 1.3 1.2 1.3 38.8 1.3 2.5 1.3 51.9 32.5 0.7 0.0 5.9 0.0 1.2 1.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.3 120.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.6 18.7 0.5 97.9 11.2 14.0 8.0 36.1 17.1 0.7 0.0 0.0 0.0 0.2 0.8 10.3 2.2 0.0 0.0 0.0 0.0 27.5 0.3 0.0 0.0 1.0 0.1 14.4 0.0 0.3 0.1 0.2 4.0 0.0 0.0 1.2 15.9 6314.9 0.0 0.0 3.6 36.8 0.0 6.8 3.6 28.7 3.2 76.4 23.0 129.0 0.0 11.3 0.0 0.3 4.9 2.2 0.0 0.2 0.0 9.0 0.1 CHGB "SCG1, SgI" ENSG00000089199 "Chromogranin B" P05060 20 5911430-5925361 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 424.9;pituitary gland: 177.5" "Cell type enriched" "Detected in many" 11 "Intestinal endocrine cells: 997.5" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 154.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.6;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Group enriched" "Detected in some" 23 "SCLC-21H: 66.7;SH-SY5Y: 102.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008759, CAB009403, HPA012602" Enhanced Supported Enhanced Vesicles "Intracellular and membrane" NA NA 24000000 Vesicles "CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706" "unprognostic (1.79e-3)" "unprognostic (7.72e-2)" "unprognostic (3.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (7.96e-3)" "unprognostic (2.86e-1)" "unprognostic (6.18e-3)" "unprognostic (7.93e-2)" "prognostic favorable (9.96e-4)" "unprognostic (8.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "unprognostic (2.73e-1)" "unprognostic (1.01e-2)" 3.4 424.9 8.2 1.4 10.2 0.8 1.0 82.5 16.4 0.8 3.0 2.1 1.2 7.7 0.9 1.3 0.8 2.5 0.8 7.6 20.7 15.4 1.7 0.7 1.0 1.1 7.2 9.1 3.0 17.0 0.8 177.5 0.8 51.8 5.6 2.5 0.7 0.9 1.2 2.1 0.9 4.4 0.9 2.3 0.8 19.7 2.4 0.8 0.0 1.9 0.4 0.9 0.8 0.1 0.0 0.6 0.0 0.0 0.0 2.6 0.2 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.7 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 66.7 102.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.4 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.2 8.2 10.2 82.5 16.4 20.7 15.4 7.2 9.1 51.8 0.8 3.0 3.7 0.0 8.2 3.8 86.9 51.2 0.0 8.1 1.2 66.3 19.6 0.0 1.7 0.4 6.1 3.4 1.7 0.0 0.3 0.0 2.3 2.3 0.0 0.0 0.1 71.5 997.5 0.0 0.3 6.0 0.9 1.5 6.8 1.8 2.8 9.3 37.4 5.8 0.4 0.1 49.6 12.9 1.4 50.2 27.7 3.1 0.2 0.0 1.4 3.0 CHI3L1 "GP39, YKL40" ENSG00000133048 "Chitinase 3 like 1" P36222 1 203178931-203186749 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Inflammatory response" Antimicrobial "Asthma, Cancer-related genes, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 336.4" "Cell type enriched" "Detected in many" 7 "Hofbauer cells: 335.7" "Cancer enriched" "Detected in all" 8 "glioma: 1313.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 490 "neutrophil: 81.3" "Lineage enriched" "Detected in single" 490 "granulocytes: 81.3" "Cell line enhanced" "Detected in some" "ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 14 "olfactory region: 10.7" HPA077365 Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 25100000 230000000 "Golgi apparatus" Vesicles "HPA077365: " "unprognostic (2.11e-3)" "unprognostic (1.21e-1)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" "unprognostic (6.01e-3)" "unprognostic (8.81e-2)" "unprognostic (2.09e-1)" "unprognostic (1.48e-1)" "unprognostic (4.46e-2)" "unprognostic (1.30e-1)" "unprognostic (7.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-2)" "unprognostic (3.43e-2)" "unprognostic (1.14e-2)" "unprognostic (9.39e-3)" 19.0 0.8 20.3 53.4 58.0 81.6 23.9 1.2 69.4 4.3 2.1 5.0 0.0 0.9 4.3 25.5 3.5 10.2 1.9 2.6 9.1 17.8 11.9 336.4 10.0 12.4 32.3 3.6 4.5 2.5 0.8 22.9 4.7 66.4 1.5 1.6 9.1 19.3 1.1 10.5 10.0 2.2 3.3 23.5 2.9 1.7 3.4 6.5 0.9 2.0 1.7 14.6 61.5 4.0 0.0 0.0 81.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 40.7 90.8 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 80.6 0.0 0.2 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.4 0.0 38.1 0.2 0.0 0.0 0.2 4.8 0.0 37.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.3 0.0 0.1 0.0 0.0 0.1 20.3 58.0 1.2 28.9 9.1 17.8 32.3 3.6 66.4 6.5 6.0 39.7 0.0 19.4 3.8 0.0 0.8 2.5 4.0 15.9 26.2 0.0 1.2 0.0 49.4 0.0 0.4 0.0 0.0 0.0 0.9 2.2 2.2 0.0 28.7 335.7 0.0 0.0 0.0 0.3 0.0 0.9 3.9 13.5 1.8 0.0 40.4 3.1 0.0 0.0 0.1 1.8 0.0 1.7 0.0 0.0 1.0 0.7 0.0 0.0 1.6 CHI3L2 "YKL-39, YKL39" ENSG00000064886 "Chitinase 3 like 2" Q15782 1 111200771-111243440 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 86.7;salivary gland: 47.2" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 113.5;B-cells: 47.6;Leydig cells: 69.3" "Cancer enriched" "Detected in many" 8 "glioma: 104.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 36.0" "Group enriched" "Detected in many" 4 "B-cells: 16.8;T-cells: 36.0" "Group enriched" "Detected in some" 5 "JURKAT: 113.5;MOLT-4: 59.4" "Low region specificity" "Detected in all" HPA005443 Approved "Secreted to blood" NA NA 480000 "HPA005443: AB_1078510" "unprognostic (1.02e-2)" "unprognostic (4.34e-2)" "unprognostic (1.37e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (9.10e-5)" "prognostic favorable (2.19e-4)" "unprognostic (7.12e-2)" "unprognostic (1.39e-1)" "unprognostic (1.49e-3)" "unprognostic (1.26e-2)" "unprognostic (1.32e-2)" "unprognostic (2.44e-2)" "prognostic unfavorable (8.59e-7)" "unprognostic (7.15e-3)" "unprognostic (7.68e-2)" "unprognostic (1.39e-3)" "unprognostic (1.20e-1)" 8.3 0.9 3.9 38.7 11.9 0.9 13.4 0.3 11.9 0.7 2.5 5.9 0.3 0.4 0.6 3.7 2.2 0.7 4.4 20.8 8.3 8.3 3.0 0.3 21.0 19.1 5.6 1.2 1.4 0.3 0.1 1.6 5.8 7.3 3.9 1.0 4.2 47.2 0.3 3.0 3.2 2.6 1.2 28.4 18.4 2.5 4.4 2.1 86.7 4.2 4.2 39.4 19.3 1.7 16.8 0.5 0.9 1.2 6.4 36.0 10.1 0.0 0.0 0.0 0.1 16.8 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.1 0.6 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.2 0.0 0.3 4.0 0.0 0.0 0.1 0.9 0.0 113.5 0.0 0.2 0.0 0.0 59.4 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.1 0.9 0.1 13.2 4.2 0.0 0.4 0.3 1.2 0.1 8.7 0.3 2.2 14.3 6.1 14.3 0.3 16.8 36.0 13.6 0.9 6.4 0.2 0.5 3.6 10.1 3.9 11.9 0.3 5.4 8.3 8.3 5.6 1.2 7.3 2.1 8.9 113.5 47.6 1.0 2.1 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.2 0.0 9.7 3.7 0.1 0.0 0.0 0.3 0.6 2.6 3.7 2.3 0.0 1.0 0.0 1.2 0.0 1.3 9.4 69.3 1.7 15.1 0.0 0.0 0.0 1.1 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.2 1.1 2.6 6.4 0.0 0.4 CHIA "AMCase, CHIT2, TSA1902" ENSG00000134216 "Chitinase, acidic" Q9BZP6 1 111290862-111320566 "Enzymes, Predicted intracellular proteins" "Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "stomach 1: 66.6" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 2: 22.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.8;stomach cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC diff: 6.0;HAP1: 3.1" "Low region specificity" "Detected in single" HPA059193 Approved "Intracellular and membrane" NA NA "HPA059193: AB_2683942" "unprognostic (8.00e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.99e-2)" "unprognostic (7.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.06e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.5 0.8 0.3 0.1 0.1 0.1 0.0 0.5 1.0 13.2 0.2 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 66.6 0.5 0.1 0.1 0.5 0.1 0.1 0.1 0.1 1.6 0.7 0.0 0.1 0.6 0.6 0.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.5 0.0 0.0 0.2 0.5 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.7 0.2 0.2 0.0 1.6 0.6 0.0 0.0 0.6 0.0 0.7 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 22.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHIT1 "CHI3, CHIT" ENSG00000133063 "Chitinase 1" Q13231 1 203212827-203273641 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 99.9;lymphoid tissue: 106.5" "Cell type enriched" "Detected in single" 44 "Hofbauer cells: 42.8" "Cancer enhanced" "Detected in many" "testis cancer: 31.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 2.9;non-classical monocyte: 1.1" "Group enriched" "Detected in many" 4 "granulocytes: 2.9;monocytes: 1.1" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA010575, HPA074844" Enhanced "Secreted to blood" NA NA 26400000 58000000 "HPA010575: AB_1078512, HPA074844: " "unprognostic (5.80e-3)" "prognostic favorable (2.02e-4)" "unprognostic (2.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.87e-2)" "unprognostic (2.28e-2)" "unprognostic (7.55e-2)" "unprognostic (6.36e-3)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.38e-1)" "unprognostic (1.03e-1)" "unprognostic (1.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" 99.9 0.2 0.2 0.4 0.3 26.7 5.5 0.1 0.3 5.9 0.6 0.5 0.1 0.0 2.5 0.2 0.3 0.1 0.2 0.6 0.2 0.1 0.1 0.4 22.1 106.5 0.4 0.1 1.4 1.1 0.0 0.2 0.4 0.5 0.6 0.5 0.3 0.3 0.1 0.1 0.3 0.7 0.2 9.4 4.3 0.1 0.1 0.1 2.3 0.9 0.2 0.5 0.1 0.3 0.5 0.2 2.9 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 1.7 0.2 0.0 0.0 0.1 0.0 0.2 0.0 1.8 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.9 0.0 1.1 0.2 0.0 1.3 0.2 0.3 0.1 0.3 0.2 0.1 0.4 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 42.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CHL1 "CALL, FLJ44930, L1CAM2, MGC132578" ENSG00000134121 "Cell adhesion molecule L1 like" O00533 3 196596-409417 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.9" "Cell type enhanced" "Detected in many" 16 "Basal keratinocytes: 20.4;Ciliated cells: 18.7;Muller glia cells: 74.3" "Cancer enhanced" "Detected in many" "glioma: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 56 "memory B-cell: 4.5;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 67 "B-cells: 6.7" "Group enriched" "Detected in some" 5 "SK-MEL-30: 45.2;WM-115: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003345, CAB026120" Enhanced "Intracellular and membrane" NA NA 6900000000 "CAB026120: , HPA003345: AB_1078516" "unprognostic (5.54e-2)" "unprognostic (2.08e-1)" "unprognostic (7.45e-2)" "unprognostic (7.14e-3)" "unprognostic (1.16e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-2)" "unprognostic (2.22e-1)" "unprognostic (5.14e-1)" "unprognostic (1.06e-1)" "unprognostic (7.81e-2)" "unprognostic (3.51e-1)" "prognostic favorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (6.07e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" 12.8 4.7 17.8 7.9 32.1 1.1 8.4 7.3 62.9 2.9 10.8 5.0 0.9 4.6 3.9 2.4 8.8 2.8 5.1 10.0 21.2 19.0 17.2 1.5 5.3 5.8 11.1 28.7 16.5 2.4 2.0 3.7 0.8 17.8 3.1 8.1 2.3 7.1 6.9 0.9 12.1 6.1 5.5 9.9 3.3 3.9 2.2 7.5 0.0 1.7 0.0 3.3 2.4 5.3 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 32.1 7.3 36.1 21.2 19.0 11.1 28.7 17.8 7.5 0.0 0.0 0.0 0.6 20.4 1.0 16.1 2.5 18.7 18.2 10.4 0.0 0.0 10.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 6.5 9.0 1.1 1.0 0.0 1.6 0.0 2.5 0.3 1.1 2.6 0.0 3.3 0.0 0.0 74.3 0.1 0.0 0.0 17.0 1.8 0.0 1.0 3.2 0.1 10.7 0.0 0.0 0.0 0.6 CHMP1B "C18orf2, CHMP1.5, Vps46B" ENSG00000255112 "Charged multivesicular body protein 1B" Q7LBR1 18 11851396-11854449 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 250.9" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061997, HPA062896" Supported Supported Nucleoplasm,Midbody Yes No "Nucleoplasm, Midbody" "HPA061997: AB_2684653, HPA062896: AB_2684898" "unprognostic (6.73e-2)" "unprognostic (5.35e-2)" "unprognostic (1.09e-2)" "unprognostic (6.74e-3)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" "unprognostic (1.44e-1)" "unprognostic (8.44e-3)" "unprognostic (1.90e-1)" "unprognostic (9.44e-3)" "unprognostic (2.37e-3)" "unprognostic (9.20e-2)" "prognostic favorable (7.37e-8)" "unprognostic (1.88e-2)" "unprognostic (1.59e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-1)" 16.0 13.6 14.9 12.5 11.6 19.5 13.3 8.8 16.0 10.1 14.1 10.0 13.8 14.0 10.4 14.7 14.5 9.1 14.6 17.0 11.2 12.3 12.2 11.2 11.3 14.0 11.6 11.9 11.3 11.2 9.7 12.4 11.8 12.1 10.3 14.1 9.4 12.6 29.5 250.9 15.2 20.4 11.6 13.8 11.3 12.8 6.8 10.0 14.2 19.9 19.4 9.9 14.3 10.1 6.7 13.1 34.4 16.5 7.4 9.1 10.6 12.3 12.1 15.7 13.3 20.6 14.5 22.8 13.2 22.4 9.0 12.1 15.6 12.4 7.7 19.9 14.3 15.1 10.6 7.1 18.4 8.1 7.1 8.8 5.5 18.5 12.8 15.3 21.2 9.6 21.0 39.9 10.1 23.5 20.3 13.0 17.6 9.4 10.0 14.2 15.3 14.6 16.3 6.6 39.4 6.1 7.5 8.1 13.1 24.1 17.0 15.3 15.3 22.5 10.6 20.2 15.3 8.6 19.6 19.0 20.3 10.7 16.0 14.1 12.0 13.7 9.8 18.8 9.9 9.6 10.9 16.5 27.7 7.2 15.3 6.6 6.5 6.7 8.5 13.1 6.7 8.4 7.7 34.4 7.4 15.0 11.7 9.1 10.6 14.9 11.6 8.8 16.0 11.2 12.3 11.6 11.9 12.1 10.0 62.5 46.0 82.1 114.0 372.7 31.1 17.9 56.0 44.2 44.3 125.6 7.9 122.5 51.4 101.8 65.5 63.6 178.4 0.0 71.3 124.5 68.5 78.7 149.7 34.7 112.4 27.0 137.9 43.0 124.4 36.5 35.1 124.4 150.1 100.0 90.8 29.6 115.6 199.9 35.0 109.2 14.1 77.6 64.8 16.4 20.6 450.0 211.8 80.6 63.8 219.0 CHMP4C "MGC22825, Shax3, VPS32C" ENSG00000164695 "Charged multivesicular body protein 4C" Q96CF2 8 81732434-81759515 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 45.3" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 63.1;Pancreatic endocrine cells: 59.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "NK-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.2;hTCEpi: 22.9;hTERT-HME1: 18.7;OE19: 31.3;RPTEC TERT1: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023799 Enhanced NA NA "HPA023799: AB_1846670" "unprognostic (3.98e-2)" "unprognostic (6.75e-3)" "unprognostic (1.58e-1)" "unprognostic (5.19e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (9.33e-5)" "unprognostic (7.54e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.99e-2)" "prognostic favorable (1.96e-6)" "unprognostic (3.29e-3)" "unprognostic (4.95e-1)" "unprognostic (2.67e-1)" "prognostic favorable (6.45e-4)" 1.3 5.0 0.5 3.4 1.2 0.1 8.2 0.3 0.7 4.4 26.4 0.4 17.4 21.1 1.5 10.9 16.9 4.2 14.5 4.1 0.6 0.5 12.8 11.7 7.0 0.7 0.6 0.8 1.3 31.8 6.1 13.8 17.5 3.0 8.2 7.4 2.6 30.7 16.1 0.4 21.5 45.3 1.1 0.7 5.6 11.9 1.9 0.4 1.1 20.5 11.5 8.0 6.5 10.2 1.3 0.4 1.4 0.4 5.3 0.2 0.3 15.7 3.3 0.0 0.1 0.0 0.0 7.4 0.8 0.9 0.0 0.0 6.1 18.2 0.0 12.9 0.0 2.8 9.6 0.1 6.8 0.0 0.0 7.9 0.3 4.6 5.8 0.3 0.0 0.0 0.0 22.9 0.0 18.7 6.9 0.0 0.0 4.2 5.5 0.0 7.8 0.0 0.1 0.0 31.3 6.6 0.0 0.0 3.5 16.1 9.5 3.5 0.0 4.3 7.2 0.0 4.0 10.5 0.1 0.0 0.0 4.0 0.0 0.1 2.9 1.8 0.0 0.0 0.0 0.0 1.4 0.4 0.2 0.2 0.1 0.2 1.3 0.2 0.1 0.1 0.6 0.2 0.2 1.2 5.3 0.2 0.4 0.1 0.3 0.5 1.2 0.3 0.7 0.6 0.5 0.6 0.8 3.0 0.4 23.8 15.5 1.4 29.9 4.0 0.0 3.9 15.3 26.8 26.1 5.2 0.0 34.9 21.6 39.1 0.3 3.1 50.3 0.0 63.1 32.3 1.3 22.9 1.1 6.7 3.9 0.0 8.7 2.5 0.0 0.4 0.0 0.3 8.5 0.0 34.7 0.0 59.5 40.3 0.0 17.0 0.0 0.0 3.4 0.0 0.0 15.3 37.2 0.7 26.6 26.3 CHMP7 MGC29816 ENSG00000147457 "Charged multivesicular body protein 7" Q8WUX9 8 23243637-23262000 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.1" "Cell type enhanced" "Detected in many" 4 "B-cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 31.7" "Group enriched" "Detected in all" 12 "B-cells: 15.2;T-cells: 31.7" "Cell line enhanced" "Detected in all" "Daudi: 24.9;U-698: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036119 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036119: AB_10673000" "unprognostic (2.94e-3)" "unprognostic (1.64e-1)" "unprognostic (7.59e-3)" "unprognostic (4.51e-2)" "unprognostic (2.47e-1)" "unprognostic (2.83e-3)" "unprognostic (9.00e-2)" "unprognostic (1.84e-1)" "unprognostic (6.44e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (8.98e-3)" "unprognostic (1.88e-2)" "unprognostic (6.80e-3)" "unprognostic (2.06e-1)" "unprognostic (7.54e-2)" "unprognostic (2.30e-1)" 6.4 12.7 7.3 29.2 7.4 15.4 11.0 10.5 9.2 7.5 9.2 5.6 6.4 8.1 10.0 4.5 7.5 7.3 7.6 9.8 6.3 8.0 6.9 7.4 7.2 48.8 7.8 5.8 8.1 12.4 4.4 7.0 5.3 7.3 7.4 7.3 4.1 12.5 7.9 13.8 7.5 13.7 9.8 6.5 26.2 10.5 7.0 6.8 76.1 7.7 5.9 43.3 9.3 13.7 15.2 1.3 1.8 1.9 1.8 31.7 11.8 3.9 5.3 2.9 4.9 2.7 2.7 3.3 3.3 2.3 4.7 4.0 6.1 3.0 24.9 3.9 2.3 4.5 3.7 2.7 3.9 1.8 6.7 5.0 5.2 6.9 3.2 2.4 1.3 7.5 2.3 2.7 4.6 1.3 2.6 3.8 10.8 5.8 3.4 2.7 3.9 4.4 5.8 4.7 3.8 4.1 1.8 2.4 3.4 2.4 5.1 3.7 3.6 2.5 3.7 1.4 1.6 4.0 2.8 4.3 5.8 3.8 4.1 2.5 9.9 5.2 29.8 4.5 4.2 4.3 0.4 1.9 1.8 2.5 1.7 5.2 14.6 16.6 7.7 1.3 15.2 31.7 17.9 1.7 1.8 1.2 1.1 17.3 11.8 7.3 7.4 10.5 9.2 6.3 8.0 7.8 5.8 7.3 6.8 6.0 6.4 49.8 13.7 12.0 9.2 11.6 7.6 5.3 4.5 14.0 3.9 13.5 16.6 17.9 32.6 9.8 13.9 0.0 13.8 15.6 10.2 11.9 11.5 6.4 13.8 12.7 13.2 6.2 6.3 8.9 9.2 9.2 15.1 12.6 11.8 18.4 16.4 10.8 9.9 16.1 10.1 6.5 13.4 14.2 15.2 9.4 17.3 8.7 9.9 17.6 CHN1 "ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2" ENSG00000128656 "Chimerin 1" P15882 2 174799363-175005369 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 145.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 88.1;Horizontal cells: 73.1;Muller glia cells: 49.1" "Cancer enhanced" "Detected in all" "glioma: 18.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0" "Lineage enriched" "Detected in single" 35 "T-cells: 10.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 60.2;BJ hTERT+ SV40 Large T+ RasG12V: 30.4" "Low region specificity" "Detected in all" HPA036111 Approved Cytosol NA NA Cytosol "HPA036111: AB_10671241" "unprognostic (3.18e-3)" "unprognostic (4.19e-2)" "unprognostic (9.69e-2)" "unprognostic (3.42e-3)" "unprognostic (1.92e-1)" "unprognostic (2.65e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "unprognostic (3.71e-2)" "unprognostic (1.34e-2)" "unprognostic (5.29e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (7.31e-3)" "unprognostic (4.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.46e-2)" 3.8 5.2 63.4 3.4 60.8 1.0 2.4 9.1 145.3 4.7 2.5 4.4 0.2 1.7 3.9 15.1 3.2 2.9 4.7 5.2 74.0 21.4 2.1 1.4 7.1 7.4 21.4 51.7 2.8 1.9 31.7 5.2 14.4 23.0 7.2 2.6 3.1 1.4 4.6 1.2 1.9 1.8 5.5 5.1 2.7 2.1 7.5 9.1 0.0 4.0 0.0 7.2 4.5 1.2 0.2 0.2 0.0 0.0 0.1 10.0 1.1 0.0 3.3 14.9 4.2 4.6 21.2 0.1 14.4 60.2 20.7 30.4 0.1 1.9 0.1 0.4 21.7 10.4 0.5 19.0 0.4 8.3 0.2 8.3 2.6 4.9 1.4 10.2 1.4 0.3 18.8 0.5 10.0 3.2 4.6 7.6 7.1 0.1 0.6 15.2 2.8 6.8 0.6 17.6 0.5 5.1 2.2 21.0 0.1 0.2 0.1 18.4 19.9 11.4 0.1 1.7 9.7 0.7 0.3 2.3 8.8 1.3 2.8 5.2 1.7 8.0 0.2 1.9 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.7 0.2 9.0 2.9 0.0 0.0 1.3 0.3 0.0 0.1 0.0 0.2 10.0 1.1 63.4 60.8 9.1 135.3 74.0 21.4 21.4 51.7 23.0 9.1 3.0 3.4 1.9 0.3 3.9 88.1 6.1 0.0 1.4 4.5 3.5 25.5 1.1 0.0 0.2 17.1 14.0 0.0 0.0 0.5 1.0 16.0 0.7 0.0 0.6 2.4 73.1 2.4 6.2 0.0 18.2 2.8 1.0 6.8 0.0 0.0 49.1 0.6 0.0 4.9 0.0 13.5 12.9 26.9 17.0 14.5 3.1 1.7 4.4 0.0 0.3 CHN2 "ARHGAP3, RhoGAP3" ENSG00000106069 "Chimerin 2" P52757 7 29146569-29514328 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.2;intestine: 44.3" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 299.6;Early spermatids: 94.3;Hepatocytes: 85.0;Late spermatids: 83.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.6;HMC-1: 36.3" "HPA018989, HPA019026" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA018989: AB_1846681, HPA019026: " "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (6.87e-2)" "unprognostic (2.56e-1)" "unprognostic (1.52e-1)" "unprognostic (8.12e-2)" "unprognostic (6.87e-2)" "unprognostic (1.19e-1)" "unprognostic (6.64e-2)" "unprognostic (4.71e-2)" "unprognostic (7.54e-2)" "unprognostic (7.85e-2)" "unprognostic (1.61e-2)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (1.15e-2)" "unprognostic (1.58e-3)" 2.7 4.4 7.9 3.3 21.8 1.4 2.1 89.2 14.7 6.6 14.1 19.2 0.3 44.3 2.7 2.1 1.9 5.0 4.8 6.9 10.5 7.0 8.2 22.0 3.7 2.0 34.7 6.9 13.4 13.9 0.5 1.9 6.4 16.5 5.3 5.9 4.6 1.6 2.9 2.7 1.5 36.3 3.0 16.5 5.1 4.2 2.3 29.2 0.8 4.7 0.0 1.7 3.5 4.0 0.3 8.5 3.9 11.2 9.3 2.5 2.6 0.1 0.4 1.6 0.0 0.0 0.0 9.7 0.0 0.0 0.4 0.0 5.1 1.5 0.5 3.1 0.1 0.6 2.7 5.1 0.0 0.0 9.1 1.7 18.6 0.8 9.9 0.1 0.0 36.3 0.0 3.4 0.0 0.7 0.0 1.9 3.0 0.7 0.2 0.1 0.2 5.0 0.2 0.6 3.4 1.8 0.4 0.0 1.0 9.4 6.3 9.7 0.7 2.2 3.3 5.9 5.5 0.3 1.0 0.2 0.5 0.1 0.0 0.2 1.8 7.1 0.0 0.1 1.1 0.7 3.9 10.5 0.1 2.5 11.2 1.8 0.3 0.4 2.2 8.5 0.2 0.5 1.0 0.6 9.3 6.4 1.0 0.0 2.6 7.9 21.8 89.2 14.7 10.5 7.0 34.7 6.9 16.5 29.2 6.0 5.1 1.4 0.6 2.4 299.6 10.6 2.5 10.7 3.4 3.5 41.2 22.2 0.0 0.2 94.3 5.5 13.6 0.0 1.8 28.5 3.4 1.2 23.1 85.0 15.9 6.4 37.7 1.8 19.1 83.5 4.6 19.6 16.9 0.0 18.9 8.5 0.3 12.9 4.6 1.6 15.0 0.0 1.1 2.3 5.9 0.5 13.7 15.2 8.6 0.6 CHODL "C21orf68, FLJ12627, MT75, PRED12" ENSG00000154645 Chondrolectin Q9H9P2 21 17901263-18267373 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 59.6" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 8 "T-cells: 4.9" "Cell line enhanced" "Detected in some" "U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6" "Group enriched" "Detected in many" 4 "basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4" "Region enriched" "Detected in all" 6 "olfactory region: 208.8" "HPA017282, HPA057559" Enhanced Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA017282: AB_1846687, HPA057559: " "unprognostic (3.91e-1)" "unprognostic (3.18e-2)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.18e-6)" "unprognostic (6.74e-2)" "unprognostic (6.82e-2)" "unprognostic (1.06e-3)" "unprognostic (6.79e-2)" "unprognostic (8.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.87e-1)" "unprognostic (4.83e-2)" "unprognostic (1.02e-1)" 2.3 1.9 0.8 2.1 6.8 0.0 1.1 0.5 0.8 0.3 2.3 0.5 4.0 1.5 0.7 1.1 1.4 0.5 0.8 3.4 1.3 8.2 4.7 0.0 0.3 0.3 1.4 0.8 0.5 0.0 0.5 2.1 1.7 8.6 8.2 3.4 1.4 0.6 1.8 1.3 2.1 0.9 0.4 2.2 12.3 0.7 59.6 1.1 0.1 0.9 4.3 1.1 1.1 1.1 0.4 0.6 0.0 0.1 0.4 4.9 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.1 0.0 2.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.1 0.0 0.6 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.3 0.0 1.1 0.9 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.1 10.0 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.7 0.0 4.9 0.4 0.3 0.8 0.1 0.2 0.0 1.1 0.0 0.4 0.1 0.6 1.0 0.3 0.8 6.8 0.5 0.8 1.3 8.2 1.4 0.8 8.6 1.1 0.0 0.0 0.0 0.6 3.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.2 1.1 1.7 1.9 0.5 1.0 0.0 0.3 CHORDC1 "CHP-1, CHP1" ENSG00000110172 "Cysteine and histidine rich domain containing 1" Q9UHD1 11 90201160-90223364 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 100.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041040 Approved Approved Cytosol NA NA 51000 Cytosol "HPA041040: AB_10794185" "unprognostic (2.29e-3)" "unprognostic (3.08e-1)" "unprognostic (5.26e-2)" "unprognostic (3.10e-2)" "unprognostic (3.27e-1)" "unprognostic (1.85e-2)" "prognostic unfavorable (4.93e-7)" "unprognostic (1.84e-1)" "unprognostic (1.04e-3)" "unprognostic (5.27e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (4.23e-2)" "unprognostic (2.63e-1)" "unprognostic (2.59e-1)" "unprognostic (1.52e-1)" 13.9 17.8 24.9 18.1 31.9 17.8 22.2 29.9 30.7 12.5 10.9 9.0 10.6 10.6 13.8 17.3 13.1 13.2 12.4 17.1 23.6 24.6 11.0 16.2 12.4 21.3 37.8 12.9 19.8 9.5 14.1 47.6 21.3 33.7 14.8 13.2 6.1 9.6 13.0 12.9 12.4 9.0 12.8 39.8 15.3 12.1 13.1 40.2 14.2 16.8 8.7 23.3 14.9 100.9 12.6 11.9 7.9 12.5 14.5 15.5 9.3 9.4 27.3 9.1 6.0 8.8 4.9 13.8 11.8 3.9 11.3 10.0 38.9 7.5 16.7 19.8 5.0 22.5 12.9 26.6 6.2 14.0 14.8 13.5 16.4 15.9 18.5 6.9 11.7 11.0 1.8 7.2 10.7 12.5 6.6 8.9 10.2 24.0 7.4 13.4 4.8 10.9 16.0 10.7 32.8 22.7 16.4 5.7 9.2 9.4 4.3 8.7 3.7 13.0 10.5 4.7 11.5 17.4 5.5 8.5 8.4 18.6 12.7 13.9 3.4 26.7 13.3 2.6 17.3 7.6 6.8 7.7 7.9 12.0 12.5 12.9 12.6 13.1 12.5 11.9 10.8 14.0 13.3 2.3 14.5 8.0 9.2 15.5 9.3 24.9 31.9 29.9 30.7 23.6 24.6 37.8 12.9 33.7 40.2 17.9 24.3 33.4 113.0 62.8 44.2 28.5 2.5 52.2 37.5 10.4 127.6 34.0 10.0 19.8 71.4 32.2 10.7 0.0 14.1 67.3 45.9 65.4 86.4 13.9 34.7 62.0 65.9 11.6 17.8 51.1 30.2 35.8 27.0 28.9 14.1 20.9 20.9 17.5 29.4 18.8 54.7 12.9 42.6 80.0 39.0 71.5 42.6 45.9 12.5 68.6 CHP2 ENSG00000166869 "Calcineurin like EF-hand protein 2" O43745 16 23754627-23758951 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 105.8;skin 1: 36.8" "Group enriched" "Detected in many" 5 "Enterocytes: 496.3;Paneth cells: 262.3;Undifferentiated cells: 147.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.4" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 8.3;hTERT-RPE1: 11.8;NB-4: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB072806 Approved NA NA "CAB072806: " "unprognostic (4.82e-1)" "unprognostic (3.40e-1)" "unprognostic (4.93e-2)" "unprognostic (1.01e-2)" "unprognostic (8.85e-2)" "unprognostic (3.54e-1)" "unprognostic (4.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.38e-1)" "unprognostic (5.31e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-5)" "unprognostic (2.21e-1)" "unprognostic (5.97e-2)" "unprognostic (7.84e-2)" "unprognostic (9.01e-2)" 0.3 0.0 0.3 8.8 0.5 0.0 0.5 0.4 0.7 2.3 37.4 0.7 0.8 54.8 0.4 0.6 0.4 0.1 0.3 0.3 0.3 0.1 0.5 0.3 0.5 0.3 1.2 0.3 0.3 0.3 0.0 0.3 0.8 0.8 1.4 26.2 0.4 0.6 0.5 0.3 36.8 105.8 0.9 0.9 0.3 0.0 2.9 0.6 0.5 0.3 0.5 0.4 6.2 1.4 1.5 1.3 2.5 0.9 0.4 0.9 0.1 1.1 2.5 0.8 0.7 1.5 1.5 1.5 3.3 1.2 0.5 1.2 0.7 2.6 0.5 1.1 2.8 1.4 1.6 0.5 3.2 0.7 0.7 0.2 0.5 4.6 1.9 1.9 0.4 0.8 1.1 1.0 2.9 8.3 11.8 1.4 0.5 1.4 1.2 1.4 0.2 0.1 9.6 0.4 0.5 2.4 0.3 0.2 1.5 1.2 1.3 0.7 0.9 1.0 0.3 0.1 0.8 0.2 0.2 1.4 0.6 0.9 0.9 0.2 0.5 0.2 0.3 0.0 0.6 0.6 1.2 0.9 0.2 0.9 0.5 0.5 0.7 0.6 0.7 0.4 1.5 0.9 0.8 2.5 0.4 0.5 1.3 0.3 0.1 0.3 0.5 0.4 0.7 0.3 0.1 1.2 0.3 0.8 0.6 0.0 0.0 0.0 7.7 9.2 0.0 0.0 0.0 5.3 7.9 1.8 0.0 0.7 0.0 0.0 0.4 0.0 496.3 0.0 0.0 2.0 0.2 1.5 4.6 0.0 0.1 0.0 8.7 0.0 0.0 0.2 0.0 0.3 1.7 0.0 59.0 0.0 0.0 262.3 0.0 6.3 0.0 0.0 0.1 0.0 0.1 59.0 0.6 0.0 147.7 26.8 CHRD ENSG00000090539 Chordin Q9H2X0 3 184380073-184390736 "Plasma proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8;liver: 48.3" "Cell type enhanced" "Detected in many" 18 "Fibroblasts: 9.7;Hepatocytes: 33.8;Smooth muscle cells: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.6;Hep G2: 15.1;SuSa: 5.6;U-2 OS: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035827 Approved "Secreted in other tissues" NA NA 120000 "HPA035827: AB_10669657" "unprognostic (2.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.63e-2)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.88e-1)" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.12e-2)" "unprognostic (6.55e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (5.53e-3)" "unprognostic (1.85e-1)" "unprognostic (9.84e-2)" "unprognostic (7.99e-3)" 8.9 6.2 8.9 3.1 6.4 0.4 4.2 32.8 15.9 13.0 2.9 2.4 1.8 2.7 14.9 6.4 3.2 5.7 3.9 4.6 6.5 1.1 10.1 48.3 3.0 2.2 1.8 7.0 7.9 13.9 0.8 2.5 3.8 4.7 4.2 1.6 2.6 2.0 8.3 4.9 3.2 3.0 7.0 2.9 4.6 3.4 1.2 1.8 0.0 3.2 2.3 0.9 3.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.1 0.1 1.9 0.5 0.0 0.3 0.2 3.6 0.0 0.0 1.4 0.4 1.4 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.1 15.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.5 0.0 0.0 0.9 0.0 0.1 0.1 0.1 5.6 1.9 0.0 0.0 0.0 5.2 0.0 0.5 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 6.4 32.8 15.9 6.5 1.1 1.8 7.0 4.7 1.8 0.0 0.0 0.0 0.0 2.4 0.5 3.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 2.6 0.0 9.7 0.1 0.0 33.8 0.5 0.0 0.0 4.9 2.9 0.0 3.4 0.0 1.7 0.0 0.0 0.0 1.8 0.0 2.1 3.3 0.5 6.5 10.3 0.2 0.2 1.0 0.1 0.0 0.0 0.1 CHRDL2 BNF1 ENSG00000054938 "Chordin like 2" Q6WN34 11 74696429-74731385 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 64.5;endometrium 1: 76.5;gallbladder: 109.2" "Group enriched" "Detected in some" 5 "Cholangiocytes: 22.9;Hepatocytes: 76.1" "Cancer enhanced" "Detected in many" "stomach cancer: 14.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 6.1;PC-3: 3.2;SiHa: 6.1;TIME: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA021771, HPA076522" Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 5600000 Vesicles "HPA021771: AB_1846689, HPA076522: " "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (7.24e-2)" "unprognostic (3.41e-3)" "unprognostic (9.45e-2)" "unprognostic (2.09e-1)" "unprognostic (4.08e-2)" "unprognostic (4.33e-2)" "unprognostic (6.64e-2)" "unprognostic (2.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.23e-1)" "unprognostic (7.58e-6)" "unprognostic (8.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (6.08e-4)" 1.0 0.0 0.0 39.3 0.2 0.0 1.7 0.1 0.3 64.5 27.9 0.1 1.0 1.4 76.5 47.6 4.3 2.9 109.2 35.8 0.1 0.1 1.0 14.5 0.8 0.5 0.0 0.0 6.7 1.0 0.4 0.1 1.5 0.4 8.0 0.9 0.9 0.2 3.5 2.6 0.3 3.5 45.3 0.6 0.8 24.1 7.6 0.0 0.1 0.2 3.2 1.1 22.6 8.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 1.0 6.1 0.7 0.0 1.3 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.0 3.2 0.0 0.6 0.0 0.0 0.0 0.1 0.2 6.1 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.5 0.4 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.4 0.2 0.0 2.2 22.9 0.0 0.0 8.7 0.0 0.0 0.0 5.8 9.7 0.5 0.0 0.0 9.0 0.0 0.9 0.8 0.0 76.1 0.1 0.0 0.0 2.5 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.7 0.0 0.0 0.0 1.0 0.2 1.9 0.0 0.1 0.0 0.0 0.5 CHRFAM7A "CHRNA7-DR1, D-10" ENSG00000166664 "CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion" Q494W8 15 30357766-30393849 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.2;parathyroid gland: 6.3" "Cell type enhanced" "Detected in some" 15 "Horizontal cells: 11.1;Spermatocytes: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HEL: 6.0;RH-30: 4.8;SH-SY5Y: 6.2;U-937: 6.4" NA NA "unprognostic (3.61e-2)" "unprognostic (1.52e-1)" "unprognostic (5.59e-2)" "unprognostic (2.66e-3)" "unprognostic (2.40e-1)" "unprognostic (2.02e-1)" "unprognostic (3.55e-1)" "unprognostic (7.20e-2)" "unprognostic (3.53e-1)" "unprognostic (7.45e-2)" "unprognostic (2.41e-1)" "unprognostic (4.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.71e-4)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" 0.9 3.5 1.3 1.1 1.3 6.2 0.4 0.0 2.5 0.6 0.4 0.7 0.3 0.2 0.1 0.8 0.4 2.4 0.9 1.6 0.2 0.0 1.2 0.5 2.8 0.6 0.9 6.3 1.0 0.0 1.0 0.6 0.2 0.5 0.1 0.4 1.8 0.6 1.6 0.8 0.9 5.5 3.2 0.2 0.8 0.5 0.2 2.8 5.2 2.1 1.0 0.3 0.4 0.0 0.6 1.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 2.3 0.0 6.3 0.0 0.0 0.0 3.7 6.0 0.2 0.6 0.1 1.2 2.1 0.4 0.0 0.2 0.0 3.1 0.6 1.4 0.6 0.0 1.8 0.0 0.0 0.6 0.7 0.2 0.0 0.0 4.8 0.0 1.5 1.9 0.4 6.2 0.0 0.0 0.0 0.8 0.1 1.3 2.6 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 2.1 5.2 0.3 0.7 0.1 0.2 0.0 0.0 2.8 0.1 0.0 0.3 0.0 1.0 0.1 0.6 0.1 0.4 0.0 0.0 0.0 0.7 0.0 1.1 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.3 0.0 1.0 0.0 0.0 0.4 1.1 0.0 0.7 11.1 1.2 0.6 0.3 0.0 0.0 0.0 0.0 1.8 2.5 0.8 0.6 0.0 1.4 0.0 0.0 0.0 0.1 3.0 1.9 0.0 0.0 0.0 1.0 1.5 CHRM1 ENSG00000168539 "Cholinergic receptor muscarinic 1" P11229 11 62908679-62921807 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.7;prostate: 28.2;salivary gland: 25.3" "Group enriched" "Detected in some" 6 "Glandular cells: 2.0;Melanocytes: 3.3;Mucus-secreting cells: 2.1" "Cancer enriched" "Detected in some" 16 "prostate cancer: 27.9" "Group enriched" "Detected in many" 10 "amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MCF7: 4.9;OE19: 15.2" "Group enriched" "Detected in many" 9 "amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8" "HPA014101, CAB022366" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022366: , HPA014101: AB_1854210" "unprognostic (3.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.89e-2)" "unprognostic (1.91e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-1)" "unprognostic (8.57e-4)" "unprognostic (4.88e-1)" "unprognostic (6.43e-2)" "unprognostic (1.75e-1)" 0.5 3.7 13.2 0.8 22.0 0.5 3.2 0.2 34.7 0.6 1.3 0.5 0.0 1.0 0.7 0.6 0.8 0.8 0.7 0.6 14.2 1.7 0.7 0.6 2.9 0.6 1.4 14.0 0.5 1.2 1.0 0.1 0.8 0.1 28.2 1.3 1.3 25.3 0.6 0.6 2.6 1.3 0.6 0.3 0.6 1.9 0.6 1.8 0.0 0.8 0.0 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.4 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 22.0 0.2 34.7 14.2 1.7 1.4 14.0 0.1 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 CHRM2 ENSG00000181072 "Cholinergic receptor muscarinic 2" P08172 7 136868669-137020255 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 45.4" "Cancer enhanced" "Detected in single" "stomach cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 15.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 44.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022338, HPA029795" Approved NA NA "CAB022338: , HPA029795: AB_10601357" "unprognostic (3.51e-2)" "unprognostic (3.73e-4)" "unprognostic (5.77e-2)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (4.00e-1)" "unprognostic (2.69e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-3)" 0.8 0.9 3.6 7.2 1.9 0.3 0.8 0.8 6.0 0.9 8.9 0.0 0.0 0.9 0.8 0.3 0.8 0.8 25.5 35.0 0.9 0.9 0.8 1.2 1.0 0.2 0.9 2.2 0.8 0.8 0.2 0.9 1.7 15.7 5.4 3.9 0.0 0.8 0.2 0.8 0.8 3.7 32.8 5.0 0.8 2.7 2.3 1.5 0.0 0.8 0.0 0.2 14.0 1.8 0.0 0.2 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 9.2 0.1 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.2 0.0 0.0 3.6 1.9 0.8 6.0 0.9 0.9 0.9 2.2 15.7 1.5 0.0 0.0 0.0 0.0 0.0 4.9 45.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 CHRM3 ENSG00000133019 "Cholinergic receptor muscarinic 3" P20309 1 239386565-239915452 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 17.2;Early spermatids: 14.2;Exocrine glandular cells: 14.9;Paneth cells: 23.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 8.7" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Group enriched" "Detected in many" 18 "monocytes: 1.2;T-cells: 2.3" "Cell line enhanced" "Detected in some" "RPMI-8226: 10.2;SH-SY5Y: 32.5;U-266/70: 13.5;U-266/84: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024106, HPA048036" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA024106: AB_1854211, HPA048036: AB_2680238" "unprognostic (1.63e-1)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (4.11e-3)" "unprognostic (3.48e-3)" "unprognostic (5.81e-2)" "unprognostic (2.30e-3)" "unprognostic (5.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" "unprognostic (6.44e-2)" "unprognostic (5.34e-4)" "unprognostic (3.04e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (4.88e-2)" 0.8 0.0 2.1 1.4 1.8 0.0 0.8 0.8 8.7 0.8 5.9 0.8 0.8 0.8 1.4 0.8 6.6 0.3 0.8 0.8 2.5 1.8 0.8 0.8 1.5 0.8 0.8 1.1 4.3 8.7 0.2 0.8 0.8 0.8 3.8 2.2 39.8 13.7 2.5 0.8 0.7 1.2 3.3 0.8 1.0 4.8 1.7 0.8 1.3 1.3 0.8 1.6 7.1 0.8 0.0 0.0 0.0 1.2 0.0 2.3 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.5 0.3 2.3 1.6 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.6 5.6 0.5 0.8 0.0 0.0 2.9 2.7 5.1 0.0 0.7 10.2 0.4 0.5 0.0 32.5 0.0 0.1 0.1 2.7 1.1 0.0 0.0 1.3 0.5 0.1 0.3 13.5 9.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 1.2 0.7 0.0 0.5 0.4 0.0 0.0 2.3 0.7 0.0 0.0 0.7 0.0 0.5 0.2 2.1 1.8 0.8 8.7 2.5 1.8 0.8 1.1 0.8 0.8 0.0 3.0 0.0 1.4 0.0 17.2 0.8 0.0 2.7 1.2 0.0 0.0 2.6 1.7 0.3 14.2 1.1 2.6 0.0 14.9 0.8 0.5 2.3 1.1 0.0 0.4 0.0 3.4 1.3 0.0 2.6 0.0 0.0 6.8 0.0 2.4 0.2 3.7 23.2 0.4 0.7 0.4 0.0 0.3 5.2 2.0 0.0 0.5 0.0 6.6 0.1 CHRM4 ENSG00000180720 "Cholinergic receptor muscarinic 4" P08173 11 46385098-46386608 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.0;SCLC-21H: 14.5;U-2 OS: 4.2" "Group enriched" "Detected in many" 6 "amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4" "Group enriched" "Detected in many" 7 "amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1" "CAB022444, HPA072083" Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "CAB022444: , HPA072083: " "unprognostic (7.11e-2)" "unprognostic (3.79e-1)" "unprognostic (5.31e-2)" "unprognostic (7.38e-2)" "unprognostic (8.63e-3)" "unprognostic (1.38e-1)" "unprognostic (6.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (2.96e-3)" "unprognostic (4.08e-3)" "unprognostic (5.02e-2)" "unprognostic (3.83e-2)" "unprognostic (3.64e-1)" "unprognostic (1.71e-1)" "unprognostic (3.56e-1)" "unprognostic (5.08e-2)" 0.0 0.5 1.1 0.2 11.7 1.6 0.0 0.0 6.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.2 8.0 0.1 0.0 17.2 0.8 4.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 3.0 0.0 0.1 0.2 0.1 1.5 0.2 0.3 0.3 0.0 2.6 0.1 1.8 0.1 0.0 2.2 0.3 0.5 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.6 0.2 0.0 1.1 0.2 0.2 0.6 0.1 0.2 0.0 5.0 0.0 0.0 0.1 14.5 0.4 0.4 0.1 0.1 0.3 0.1 2.4 0.0 0.4 4.2 0.0 0.1 0.8 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968720-34067457 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 22.8" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 3.0;Early spermatids: 5.2;Extravillous trophoblasts: 13.6;Late spermatids: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.8" "Group enriched" "Detected in some" 5 "BEWO: 5.5;HMC-1: 19.3" "Region enhanced" "Detected in many" "hypothalamus: 15.4" "Low region specificity" "Detected in many" HPA013172 Uncertain NA NA "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.3 0.5 1.2 0.9 15.7 1.3 2.1 0.8 6.9 0.3 0.4 5.1 0.0 1.1 0.5 0.8 0.5 0.3 0.6 0.3 6.8 4.4 0.6 0.9 0.4 1.0 5.8 4.5 0.5 1.0 0.1 0.5 4.8 17.8 0.6 0.3 0.0 0.5 0.1 0.7 1.8 1.8 0.2 22.8 0.7 0.6 5.2 0.0 0.0 2.3 0.0 0.3 0.4 0.3 0.3 0.9 4.8 0.3 0.2 0.3 0.0 0.1 0.2 0.8 0.3 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.7 0.3 0.2 0.0 0.5 19.3 0.4 0.0 0.2 0.1 0.2 0.0 0.5 0.6 1.2 0.1 0.2 0.2 2.2 0.2 0.2 0.3 0.1 0.3 0.2 0.0 0.4 0.4 0.3 0.3 0.7 0.2 0.2 0.2 1.2 0.2 0.2 0.2 0.2 0.1 0.9 0.3 0.4 0.1 0.2 0.3 1.5 0.3 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.1 0.2 4.8 0.2 0.1 0.9 0.2 0.0 1.2 15.7 0.8 6.9 6.8 4.4 5.8 4.5 17.8 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 1.7 0.0 5.2 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.7 0.0 0.7 0.0 0.0 0.0 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 96.7" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 1.6;Melanocytes: 1.7;T-cells: 1.8" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Cell type enriched" "Detected in single" 27 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.6" "Group enriched" "Detected in some" 18 "LHCN-M2: 89.4;RH-30: 73.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA071554 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA071554: AB_2686416" "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 4.5 0.0 0.5 0.5 0.1 0.0 0.6 0.0 0.4 0.7 1.7 0.0 0.1 0.2 0.0 4.6 1.2 0.0 0.0 0.3 2.0 0.1 0.0 0.2 0.7 0.9 0.1 0.0 0.0 0.0 0.0 12.1 0.2 0.0 2.4 1.0 0.0 1.5 0.0 96.7 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.5 0.0 4.5 1.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 89.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.1 0.0 0.4 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 CHRNA10 ENSG00000129749 "Cholinergic receptor nicotinic alpha 10 subunit" Q9GZZ6 11 3665587-3671384 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 33.6" "Cell type enhanced" "Detected in some" 5 "Ciliated cells: 2.7" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 6 "olfactory region: 8.9" "Not detected" "Not detected" NA NA "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (4.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.50e-1)" "unprognostic (3.79e-2)" "unprognostic (2.74e-1)" "unprognostic (6.90e-5)" "unprognostic (4.35e-2)" "unprognostic (1.06e-5)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (2.32e-1)" "unprognostic (4.39e-3)" 0.2 0.2 0.2 0.4 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.4 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.3 0.6 0.4 0.3 0.1 0.3 0.1 0.0 0.7 0.1 0.7 0.1 0.3 0.1 33.6 0.4 0.2 0.1 0.0 1.0 0.2 0.3 0.5 0.1 0.1 0.0 0.3 0.3 2.2 0.6 0.2 1.0 0.2 1.4 1.5 2.1 2.8 0.9 0.3 1.4 1.7 0.4 1.3 1.3 1.1 2.5 2.5 1.0 0.8 1.1 3.1 1.6 0.9 1.1 1.6 5.2 0.7 3.9 0.5 1.2 0.6 2.7 0.9 1.0 0.9 0.3 0.5 0.8 3.1 2.0 0.6 1.0 0.4 1.5 4.1 2.9 2.6 2.0 2.8 0.9 0.4 1.0 2.0 1.9 0.8 0.9 0.9 1.5 1.8 0.6 3.2 0.7 1.8 2.3 1.3 2.1 0.7 1.7 1.3 0.9 1.3 1.2 0.0 0.4 0.4 1.0 0.0 0.3 0.0 0.8 0.2 0.1 0.3 0.4 0.5 2.2 0.2 0.6 0.3 0.6 0.2 0.0 0.3 0.0 0.6 1.5 1.6 0.8 0.0 2.7 0.0 0.0 0.0 0.3 0.0 0.2 1.2 0.6 0.7 0.0 0.4 0.2 0.3 0.6 0.0 0.8 0.5 1.6 0.0 1.3 0.8 0.4 0.3 0.0 1.7 1.0 0.7 1.3 0.2 0.0 0.4 0.0 0.7 0.0 0.9 0.2 0.4 1.0 0.2 0.0 0.8 0.6 CHRNA2 ENSG00000120903 "Cholinergic receptor nicotinic alpha 2 subunit" Q15822 8 27459761-27479883 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 11.6;prostate: 33.5" "Cell type enhanced" "Detected in single" 22 "Glandular cells: 1.6" "Cancer enriched" "Detected in single" 421 "prostate cancer: 30.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.8;plasmacytoid DC: 1.0" "Group enriched" "Detected in many" 14 "dendritic cells: 1.0;granulocytes: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 1.4;SiHa: 2.0;U-2197: 1.8;U-266/84: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (2.23e-2)" "unprognostic (3.19e-1)" "unprognostic (6.19e-2)" "unprognostic (6.29e-3)" "unprognostic (1.19e-2)" "unprognostic (2.13e-1)" "unprognostic (1.91e-1)" "unprognostic (7.60e-2)" "unprognostic (1.70e-1)" "unprognostic (1.47e-1)" 0.3 0.8 1.2 0.6 2.0 1.2 2.1 2.0 11.6 0.3 0.3 11.3 0.0 0.6 0.3 1.4 0.3 0.4 0.4 0.4 1.6 2.9 0.3 0.4 0.6 0.4 1.6 0.6 0.3 0.6 0.4 0.5 0.3 7.0 33.5 0.3 2.4 0.3 0.4 0.4 0.5 0.6 0.3 0.8 0.4 0.4 0.4 1.0 2.4 0.4 0.0 0.4 0.4 0.1 0.0 1.0 1.8 0.0 0.0 0.1 1.8 0.0 0.0 0.1 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.7 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.5 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.7 1.8 0.2 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.0 0.0 1.8 1.2 2.0 2.0 11.6 1.6 2.9 1.6 0.6 7.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNA3 ENSG00000080644 "Cholinergic receptor nicotinic alpha 3 subunit" P32297 15 78593052-78621295 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 33.6;lymphoid tissue: 57.2;retina: 74.1" "Cell type enriched" "Detected in some" 18 "Cone photoreceptor cells: 155.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 86.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029430 Enhanced NA NA "HPA029430: AB_10603785" "unprognostic (2.28e-1)" "unprognostic (3.45e-1)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.16e-3)" "unprognostic (1.97e-1)" "unprognostic (4.28e-2)" "unprognostic (7.20e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-4)" "unprognostic (2.65e-3)" "unprognostic (2.76e-1)" "unprognostic (1.53e-1)" "unprognostic (4.48e-1)" 0.4 33.6 0.8 4.0 2.4 0.1 0.3 6.0 0.4 0.5 8.2 0.7 0.2 1.2 0.5 0.1 0.5 0.1 0.8 0.4 0.2 0.8 0.1 0.1 0.3 2.8 0.4 0.0 0.1 0.2 0.1 1.5 0.2 1.2 0.6 3.4 74.1 0.2 0.6 0.1 0.6 2.9 2.8 0.2 0.2 3.6 0.9 0.5 57.2 0.2 0.2 0.7 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 16.4 86.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.4 6.0 0.4 0.2 0.8 0.4 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 4.2 0.6 0.0 0.0 0.0 0.0 155.1 0.0 1.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.7 2.5 0.1 0.0 0.0 0.0 8.5 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.1 CHRNA4 "BFNC, EBN, EBN1" ENSG00000101204 "Cholinergic receptor nicotinic alpha 4 subunit" P43681 20 63343223-63378401 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.4;liver: 38.8;parathyroid gland: 21.6" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 131.9" "Cancer enhanced" "Detected in some" "liver cancer: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2 OS: 7.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6" CAB034064 Uncertain NA NA "CAB034064: AB_2080535" "unprognostic (3.40e-1)" "unprognostic (1.71e-1)" "unprognostic (2.87e-2)" "unprognostic (3.98e-1)" "unprognostic (8.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.74e-1)" "unprognostic (2.10e-3)" "unprognostic (5.72e-4)" "unprognostic (9.02e-3)" "unprognostic (9.79e-4)" "unprognostic (6.77e-2)" "unprognostic (1.08e-1)" "unprognostic (3.81e-2)" 0.6 0.8 5.2 0.6 8.7 0.6 0.6 3.1 14.5 0.6 0.6 11.0 0.0 0.6 0.6 0.6 0.6 2.0 0.6 0.6 5.1 6.8 2.1 38.8 0.7 0.6 11.3 8.2 0.7 0.6 21.6 1.0 0.6 16.4 1.3 0.6 5.7 0.6 0.6 0.6 0.6 0.6 0.6 3.9 4.8 0.6 1.9 3.9 0.0 1.2 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 8.7 3.1 14.5 5.1 6.8 11.3 8.2 16.4 3.9 0.0 0.0 0.0 0.0 0.0 20.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 131.9 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.8 2.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 CHRNA5 ENSG00000169684 "Cholinergic receptor nicotinic alpha 5 subunit" P30532 15 78565520-78595269 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 33.9" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 9.6;Spermatogonia: 32.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054381 Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Focal adhesion sites" "Plasma membrane" "HPA054381: AB_2682468" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" "unprognostic (3.20e-3)" "unprognostic (6.66e-2)" "unprognostic (1.29e-3)" "unprognostic (7.03e-5)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.34e-2)" "unprognostic (1.31e-2)" "unprognostic (4.52e-2)" "unprognostic (8.97e-2)" "unprognostic (6.50e-11)" "unprognostic (4.37e-1)" "unprognostic (5.39e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" 2.9 3.3 1.7 4.4 1.7 0.6 4.9 1.8 1.7 2.7 6.4 0.4 1.6 7.8 4.7 1.9 4.0 1.1 16.3 2.4 1.7 1.8 0.9 1.8 1.4 2.0 1.9 0.3 1.7 11.8 0.0 0.7 2.1 1.2 3.6 7.1 3.5 1.7 0.7 5.8 1.0 6.8 6.1 1.3 1.9 5.3 9.8 0.6 4.5 1.6 2.9 4.4 5.7 33.9 0.9 1.1 3.4 1.6 1.6 1.4 0.7 6.7 17.4 9.5 5.2 1.1 0.8 3.8 4.9 2.4 5.5 10.0 6.6 32.1 4.0 12.2 1.0 14.8 6.0 18.1 7.3 5.6 8.1 21.7 7.4 13.6 6.6 0.6 5.0 10.5 0.3 1.3 1.5 2.0 2.0 10.2 5.6 7.2 5.2 3.5 14.7 6.3 1.7 7.7 13.3 4.8 8.1 10.9 4.0 6.6 16.1 16.0 23.5 11.9 11.6 5.5 5.6 25.8 1.3 2.2 7.5 9.0 5.5 15.5 6.1 25.0 4.5 4.5 8.1 6.9 3.0 1.6 2.5 0.8 1.6 0.4 0.3 0.8 0.5 0.9 0.9 1.4 1.4 3.4 1.6 1.3 1.1 0.3 0.7 1.7 1.7 1.8 1.7 1.7 1.8 1.9 0.3 1.2 0.6 0.0 0.0 0.0 7.8 2.9 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 1.0 1.0 0.0 0.0 1.8 9.6 0.4 5.2 0.0 0.0 0.9 4.8 3.4 0.0 0.0 1.2 0.3 0.8 1.7 0.0 6.3 0.2 0.7 0.0 0.4 0.2 0.5 0.0 2.1 3.2 32.1 1.4 0.8 1.3 1.5 2.7 CHRNA6 ENSG00000147434 "Cholinergic receptor nicotinic alpha 6 subunit" Q15825 8 42752620-42796392 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;retina: 5.1" "Cell type enhanced" "Detected in single" 19 "Rod photoreceptor cells: 1.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 3.4" "Lineage enriched" "Detected in single" 8 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "Daudi: 7.9;HDLM-2: 5.0;HMC-1: 2.4;JURKAT: 2.3;RPMI-8226: 2.0;U-698: 6.9" "Group enriched" "Detected in some" 7 "midbrain: 24.1;thalamus: 7.0" "Region enriched" "Detected in all" 6 "midbrain: 93.1" NA NA "unprognostic (1.91e-1)" "unprognostic (7.49e-2)" "unprognostic (2.66e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (7.60e-4)" "unprognostic (4.99e-2)" "unprognostic (2.48e-2)" "unprognostic (7.73e-2)" "unprognostic (6.24e-2)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (2.63e-1)" "unprognostic (3.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.27e-3)" "unprognostic (3.66e-2)" 0.1 2.2 0.6 0.6 0.6 0.0 0.9 8.3 3.8 1.2 0.1 1.7 1.4 0.0 0.9 0.0 0.1 1.7 0.2 0.1 0.8 1.6 1.1 0.1 0.4 0.7 4.3 1.7 0.6 0.3 0.0 0.5 0.2 3.6 0.1 0.1 5.1 1.3 1.5 0.1 0.1 0.2 0.0 0.8 0.2 0.1 1.3 0.0 2.0 0.8 0.0 2.8 0.2 0.1 0.4 0.1 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.3 0.0 0.1 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.6 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.6 8.3 3.8 0.8 1.6 4.3 1.7 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNA7 ENSG00000175344 "Cholinergic receptor nicotinic alpha 7 subunit" P36544 15 31923438-32173018 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.2" "Cell type enhanced" "Detected in some" 14 "Cholangiocytes: 5.1;Enterocytes: 7.1;Horizontal cells: 15.9;Spermatogonia: 7.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 6.3;RT4: 12.2;SH-SY5Y: 6.9;SK-BR-3: 13.5;U-2 OS: 11.1" "Low region specificity" "Detected in all" "HPA029422, CAB033624" Enhanced NA NA "CAB033624: AB_784835, HPA029422: AB_10600863" "unprognostic (3.43e-2)" "unprognostic (8.44e-2)" "unprognostic (2.02e-1)" "unprognostic (4.61e-4)" "unprognostic (6.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.14e-2)" "unprognostic (5.08e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-2)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (2.40e-2)" "unprognostic (4.36e-3)" "unprognostic (5.44e-2)" "unprognostic (7.41e-3)" "unprognostic (2.43e-1)" 0.8 12.9 4.4 1.5 3.4 2.3 2.0 0.9 8.4 1.1 12.2 1.0 1.1 7.9 1.4 0.8 0.8 0.7 4.6 1.2 2.5 5.6 0.9 0.4 1.2 2.0 3.8 2.7 2.9 4.9 1.8 2.0 0.4 11.8 2.2 4.0 11.7 2.1 1.2 0.8 0.7 27.2 0.9 3.1 5.2 11.2 5.1 0.6 0.1 4.3 0.9 1.4 3.1 2.0 0.3 1.2 3.1 1.1 1.8 0.7 0.4 0.0 1.4 2.3 6.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 2.9 0.0 0.0 0.0 1.8 0.4 0.0 1.9 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.0 0.2 0.0 0.2 0.0 0.2 1.1 3.5 0.0 0.0 3.8 0.2 0.2 12.2 0.5 6.9 0.2 13.5 0.0 0.7 0.0 0.0 0.7 0.0 11.1 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.5 1.1 3.1 0.7 0.4 0.2 0.3 0.4 0.1 1.2 0.2 0.2 0.3 0.7 1.8 0.6 0.7 0.5 0.4 4.4 3.4 0.9 8.4 2.5 5.6 3.8 2.7 11.8 0.6 0.0 0.0 0.0 2.2 0.2 1.7 1.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 7.1 0.0 2.2 0.0 0.0 0.5 1.1 0.0 0.1 15.9 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 0.0 1.5 1.1 0.0 0.0 0.0 0.0 0.4 0.2 7.9 0.0 0.0 0.0 1.5 0.9 CHRNA9 NACHRA9 ENSG00000174343 "Cholinergic receptor nicotinic alpha 9 subunit" Q9UGM1 4 40335329-40355217 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 3.5" "Region enhanced" "Detected in some" "pons and medulla: 2.6" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 4 "T-cells: 1.5" "Cell line enriched" "Detected in some" 7 "U-87 MG: 19.2" "Region enriched" "Detected in single" 6 "basal ganglia: 1.0" "Low region specificity" "Detected in single" NA NA "unprognostic (6.20e-3)" "unprognostic (9.18e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "unprognostic (3.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "unprognostic (7.30e-2)" "unprognostic (1.94e-1)" "unprognostic (8.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.76e-1)" "unprognostic (5.01e-2)" "unprognostic (9.18e-3)" 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.2 4.6 0.7 2.6 0.0 0.0 0.0 2.7 0.0 0.0 2.7 0.0 0.0 3.3 0.1 0.0 0.4 0.0 0.0 0.4 0.0 0.4 0.7 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.1 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.4 0.5 0.0 0.3 1.5 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 1.4 0.2 0.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNB1 CHRNB ENSG00000170175 "Cholinergic receptor nicotinic beta 1 subunit" P11230 17 7445061-7457707 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6;tongue: 33.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 18.4;RH-30: 38.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005822, CAB011200" Approved NA NA "CAB011200: AB_262151, HPA005822: AB_1079484" "unprognostic (2.89e-2)" "unprognostic (3.43e-1)" "unprognostic (1.08e-1)" "unprognostic (2.67e-2)" "unprognostic (4.19e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "unprognostic (3.56e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" "unprognostic (2.49e-1)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" 4.5 11.5 5.7 1.9 5.1 6.1 3.7 2.3 4.4 3.4 2.0 4.5 3.7 2.3 2.4 5.5 3.6 2.9 1.6 5.0 4.8 3.9 3.9 5.5 2.4 2.6 6.0 3.5 2.9 18.2 8.3 2.5 5.8 4.0 2.6 2.1 4.5 4.5 2.6 81.6 4.0 2.2 2.6 5.1 3.1 2.0 1.2 4.4 4.5 6.0 33.9 3.2 2.4 2.5 7.8 8.2 15.2 11.1 12.3 11.7 7.1 0.8 1.2 2.0 2.5 3.3 2.2 4.6 0.6 2.0 3.0 2.5 0.8 1.1 3.2 2.2 1.3 1.1 7.3 0.7 13.3 1.1 3.9 2.5 1.8 1.2 4.2 1.4 1.1 4.7 4.9 3.7 1.8 6.0 5.1 2.0 6.4 2.3 1.8 18.4 0.5 3.4 2.1 1.5 0.8 0.6 2.2 38.4 8.1 8.3 0.7 0.3 6.0 1.3 2.2 2.5 3.3 2.1 1.6 1.9 1.3 3.5 0.9 2.6 4.4 4.8 0.9 1.1 2.5 1.1 10.6 6.6 15.2 9.9 7.2 7.7 7.8 11.0 10.0 8.2 7.6 9.0 11.7 2.2 12.3 11.1 6.3 8.9 7.1 5.7 5.1 2.3 4.1 4.8 3.9 6.0 3.5 4.0 4.4 0.0 3.7 9.9 2.9 5.7 3.9 7.5 2.5 9.4 5.7 8.7 2.0 34.2 19.9 14.8 1.2 10.3 6.8 0.0 11.8 7.3 8.0 3.5 12.7 8.3 11.1 14.3 2.4 8.0 6.5 1.5 20.1 8.4 11.8 19.8 4.8 11.2 14.5 6.5 15.9 11.9 7.2 0.0 10.3 2.8 2.1 5.6 25.4 14.6 4.8 3.1 CHRNB2 ENSG00000160716 "Cholinergic receptor nicotinic beta 2 subunit" P17787 1 154567781-154580026 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 28.4" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 12.2;Cone photoreceptor cells: 13.7;Horizontal cells: 39.7;Late spermatids: 8.0;Rod photoreceptor cells: 7.6" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Group enriched" "Detected in some" 6 "SCLC-21H: 20.7;SH-SY5Y: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.13e-1)" "unprognostic (6.33e-2)" "unprognostic (8.15e-3)" "unprognostic (3.32e-1)" "unprognostic (4.37e-3)" "unprognostic (2.25e-1)" "unprognostic (3.51e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (4.36e-1)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (5.65e-2)" "unprognostic (1.84e-1)" 0.9 3.2 7.8 1.2 16.4 1.0 1.8 8.1 28.4 0.9 1.1 1.6 0.0 1.4 1.0 0.9 1.1 1.0 0.9 0.9 9.4 8.9 0.9 0.9 0.9 0.9 7.9 9.8 1.0 2.1 0.9 3.3 0.9 15.4 0.9 1.2 3.1 1.0 0.9 0.9 1.3 1.2 1.1 1.4 0.9 1.6 2.0 1.7 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 20.7 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.8 16.4 8.1 22.1 9.4 8.9 7.9 9.8 15.4 1.7 0.0 0.0 0.0 0.0 0.1 12.2 1.6 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 39.7 3.5 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.9 0.3 0.3 0.0 0.0 0.0 0.0 CHRNB3 ENSG00000147432 "Cholinergic receptor nicotinic beta 3 subunit" Q05901 8 42697376-42737407 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.6;pancreas: 6.8;testis: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.6" "Group enriched" "Detected in many" 5 "cerebellum: 19.6;midbrain: 8.2" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.5;T-reg: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Group enriched" "Detected in some" 6 "NTERA-2: 3.3;U-266/84: 7.3" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 32 "cerebellum: 21.0;midbrain: 30.4" HPA045555 Enhanced NA NA "HPA045555: AB_10960891" "unprognostic (8.63e-2)" "unprognostic (4.12e-1)" "unprognostic (7.29e-2)" "unprognostic (1.62e-1)" 0.1 0.1 0.3 0.1 0.8 0.1 0.1 19.6 2.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.4 0.1 0.1 0.1 0.8 8.2 2.3 0.1 6.8 0.1 0.9 0.1 1.1 0.1 0.1 3.4 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.8 19.6 2.7 0.4 0.4 8.2 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624119-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7" "Group enriched" "Detected in some" 21 "Early spermatids: 41.7;Late spermatids: 39.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "SCLC-21H: 20.7;SH-SY5Y: 26.9" "Group enriched" "Detected in some" 5 "olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6" "Low region specificity" "Detected in many" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" NA NA "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.2 6.6 2.7 3.9 0.8 0.7 0.2 0.5 0.4 0.6 2.3 0.2 0.0 0.2 0.8 0.7 1.4 0.1 0.1 0.8 1.0 0.3 0.5 0.1 0.1 2.9 0.2 0.0 0.3 0.2 0.0 1.6 0.0 1.3 0.2 1.1 10.6 2.2 2.4 0.6 0.3 1.0 0.9 1.0 1.0 0.8 10.7 0.1 18.5 0.4 0.3 1.1 0.5 0.5 1.5 0.4 1.4 0.8 1.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 26.9 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.3 0.5 0.2 0.6 0.9 0.5 0.6 0.2 1.5 0.8 0.8 1.4 1.0 0.4 0.4 0.3 0.0 2.7 0.8 0.5 0.4 1.0 0.3 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 1.6 1.9 0.0 0.0 0.0 0.0 0.1 CHRND ACHRD ENSG00000135902 "Cholinergic receptor nicotinic delta subunit" Q07001 2 232525993-232536667 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 49.1" "Cell type enriched" "Detected in single" 11 "Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 72 "RH-30: 43.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "olfactory region: 1.4" "HPA056404, HPA065404" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA056404: AB_2732603, HPA065404: AB_2732734" "unprognostic (1.69e-2)" "unprognostic (7.93e-2)" "unprognostic (3.28e-3)" "unprognostic (7.75e-3)" "unprognostic (6.04e-2)" "unprognostic (1.10e-1)" "unprognostic (7.25e-2)" "unprognostic (1.90e-1)" "unprognostic (4.97e-8)" "unprognostic (7.52e-2)" "unprognostic (2.86e-1)" "unprognostic (2.46e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 49.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRNE ACHRE ENSG00000108556 "Cholinergic receptor nicotinic epsilon subunit" Q04844 17 4897774-4903074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 53.3;pituitary gland: 19.0" "Cell type enriched" "Detected in many" 5 "Late spermatids: 132.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "gdT-cell: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "HEL: 6.0;HMC-1: 15.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 13 "basal ganglia: 5.7" NA NA "unprognostic (2.00e-3)" "unprognostic (1.56e-1)" "unprognostic (3.94e-2)" "unprognostic (4.35e-3)" "unprognostic (6.55e-2)" "unprognostic (2.27e-3)" "unprognostic (7.80e-4)" "unprognostic (7.75e-2)" "unprognostic (3.24e-1)" "unprognostic (1.34e-1)" "unprognostic (3.69e-2)" "unprognostic (6.58e-2)" "unprognostic (8.42e-4)" "unprognostic (1.39e-3)" "unprognostic (1.26e-1)" "unprognostic (5.83e-2)" "unprognostic (5.70e-2)" 0.3 0.1 0.1 0.4 0.1 0.4 0.1 0.3 0.4 0.1 0.2 0.1 0.1 0.3 0.4 0.8 0.2 0.1 0.4 53.3 0.1 0.0 0.1 1.3 0.3 0.2 0.3 0.1 0.3 0.6 0.3 19.0 0.4 0.2 0.1 0.0 0.5 0.5 0.1 1.0 0.8 0.1 0.2 0.1 0.7 0.1 0.2 0.1 0.1 0.1 1.4 0.2 0.1 0.1 1.0 0.3 1.0 0.4 1.6 5.9 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 6.0 0.0 0.7 0.5 0.0 15.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.0 5.9 0.2 0.0 0.0 0.0 2.1 0.2 1.0 0.1 1.6 0.2 1.6 0.4 0.3 0.0 1.5 0.1 0.1 0.3 0.4 0.1 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 1.1 1.4 0.8 6.3 2.5 0.0 0.0 1.8 3.9 0.4 1.7 0.1 27.7 1.4 0.0 0.0 0.8 6.2 2.6 0.9 8.1 5.9 3.1 3.2 0.0 3.7 1.8 132.7 0.9 5.7 0.0 8.2 0.0 1.2 0.8 0.0 0.4 1.1 10.0 0.0 0.5 4.3 3.0 1.0 9.3 3.2 0.1 0.6 CHRNG ACHRG ENSG00000196811 "Cholinergic receptor nicotinic gamma subunit" P07510 2 232539727-232546403 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "epididymis: 16.7;skeletal muscle: 40.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 18 "HSkMC: 5.1;RH-30: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.26e-1)" "unprognostic (8.97e-2)" "unprognostic (5.61e-2)" "unprognostic (1.92e-2)" "unprognostic (4.38e-1)" "unprognostic (4.86e-3)" "unprognostic (2.32e-1)" "unprognostic (1.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (4.18e-2)" "unprognostic (4.32e-1)" "unprognostic (4.19e-6)" "unprognostic (6.13e-2)" "unprognostic (8.66e-2)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 40.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 0.6 0.3 0.5 0.5 1.1 0.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.1 0.2 0.1 0.0 0.1 0.1 14.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.2 0.2 0.2 0.7 0.2 0.4 0.5 0.2 0.6 0.8 0.8 0.2 1.1 0.2 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHST1 "C6ST, KSGal6ST" ENSG00000175264 "Carbohydrate sulfotransferase 1" O43916 11 45648877-45665622 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.5" "Group enriched" "Detected in some" 4 "Early spermatids: 50.9;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 10.3;TIME: 9.8;WM-115: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.77e-2)" "unprognostic (1.67e-1)" "unprognostic (6.37e-3)" "unprognostic (1.32e-1)" "unprognostic (2.18e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (6.22e-2)" "unprognostic (1.64e-1)" "unprognostic (1.39e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.64e-7)" "unprognostic (5.37e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" 2.2 8.6 21.2 2.0 21.5 1.2 4.8 2.3 42.5 2.2 1.6 5.0 0.0 1.9 2.5 1.2 1.3 6.5 2.1 2.8 18.6 15.5 2.6 1.5 2.5 2.0 13.6 17.0 4.4 2.5 17.7 4.9 1.7 10.6 1.4 1.2 1.3 14.8 1.6 3.6 1.7 1.7 2.0 2.5 4.7 1.9 3.2 5.5 0.1 9.0 0.4 1.7 2.3 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.3 0.0 0.0 0.3 0.3 10.3 0.1 0.0 0.0 0.9 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.5 0.8 0.2 0.0 9.8 2.0 2.9 0.0 0.0 0.0 0.0 0.0 4.2 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 21.5 2.3 35.8 18.6 15.5 13.6 17.0 10.6 5.5 0.0 0.0 0.0 2.4 0.1 8.6 1.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 50.9 4.8 0.0 0.0 0.2 0.0 1.9 0.7 0.0 0.0 0.2 0.0 0.0 4.9 0.0 7.6 5.2 0.0 0.0 0.0 0.0 3.7 0.4 0.0 4.6 0.0 0.2 25.8 0.8 6.2 1.4 0.0 0.0 0.0 0.0 0.9 CHST10 HNK-1ST ENSG00000115526 "Carbohydrate sulfotransferase 10" O43529 2 100391860-100417656 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 14.9;Bipolar cells: 11.4;Muller glia cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "B-cells: 2.3;dendritic cells: 3.1;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012884, HPA051545" Approved Approved Cytosol "Intracellular and membrane" NA NA 290000 Cytosol "HPA012884: AB_1846710, HPA051545: AB_2681529" "unprognostic (5.40e-3)" "unprognostic (3.62e-2)" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (3.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.89e-2)" "unprognostic (1.44e-1)" "unprognostic (1.78e-1)" "unprognostic (4.54e-2)" "prognostic favorable (4.05e-4)" "unprognostic (8.02e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-2)" "unprognostic (3.73e-2)" "unprognostic (3.06e-2)" "unprognostic (3.27e-1)" 4.1 6.7 14.6 3.9 18.7 2.6 5.0 12.6 28.2 6.2 4.1 12.1 2.4 2.2 11.4 13.5 4.1 9.7 5.3 10.1 12.4 9.5 4.4 1.2 7.8 4.0 9.8 12.2 12.9 5.3 8.8 8.6 7.8 9.3 8.1 2.4 7.3 5.5 5.4 5.1 1.6 2.5 11.7 8.9 3.7 3.4 5.8 7.6 3.1 9.8 1.6 5.1 5.8 4.9 2.3 3.1 0.0 0.0 0.1 3.5 1.0 0.1 7.7 15.3 7.8 4.7 6.6 7.7 8.8 6.3 12.1 7.8 0.1 4.5 10.6 7.7 5.3 21.5 0.0 10.7 1.1 7.8 15.0 11.3 5.4 4.2 11.9 5.6 10.9 14.3 4.8 1.5 5.7 1.0 5.8 9.5 10.3 15.7 0.0 5.1 2.4 9.7 8.7 22.5 0.1 9.4 7.0 9.4 0.1 3.3 3.4 16.5 13.5 0.6 0.0 12.2 11.3 4.1 15.1 8.6 8.4 13.4 6.3 8.1 0.0 0.0 10.9 10.3 9.8 9.9 0.0 0.0 0.0 3.5 0.0 1.3 2.3 0.6 2.9 0.6 1.8 0.8 2.3 0.0 0.1 0.0 3.1 0.0 1.0 14.6 18.7 12.6 24.8 12.4 9.5 9.8 12.2 9.3 7.6 14.9 1.9 0.8 1.0 0.8 11.4 4.7 0.0 1.4 7.9 1.8 0.0 4.2 3.3 3.0 0.4 3.3 0.0 0.0 2.5 8.4 3.1 1.0 0.0 0.0 4.8 6.4 1.7 0.0 1.2 0.0 2.0 1.1 0.0 5.4 0.0 17.6 1.9 0.0 4.9 1.0 4.3 0.0 2.5 1.1 4.5 0.5 1.1 2.5 0.0 0.1 CHST13 C4ST3 ENSG00000180767 "Carbohydrate sulfotransferase 13" Q8NET6 3 126524283-126543291 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 46.8;liver: 42.5" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 56.2;Hepatocytes: 33.7;Spermatocytes: 29.3" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "eosinophil: 46.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 46.8" "Group enriched" "Detected in some" 8 "CACO-2: 12.5;Hep G2: 22.4;NB-4: 14.9;THP-1: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA067960 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA067960: " "unprognostic (5.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (6.42e-4)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (8.45e-3)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (5.75e-2)" "unprognostic (5.16e-2)" "unprognostic (6.68e-2)" "unprognostic (2.26e-1)" "unprognostic (1.59e-2)" 0.5 0.2 0.2 0.5 0.3 0.9 0.0 0.2 0.6 0.1 0.9 0.1 0.0 0.8 0.0 1.1 0.1 0.1 0.2 1.1 0.2 0.1 2.6 42.5 0.6 0.6 0.3 0.2 0.4 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.6 0.5 0.1 0.3 0.0 1.8 0.0 0.3 2.9 0.6 9.7 0.1 0.5 0.1 0.0 0.2 0.1 0.0 0.0 7.0 46.8 10.6 0.0 0.0 3.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 22.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.7 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 10.6 46.8 0.0 6.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 9.8 0.0 5.2 0.0 0.0 3.6 0.2 0.3 0.2 0.6 0.2 0.1 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 12.3 0.0 1.2 1.3 7.6 3.8 1.4 3.2 0.0 0.0 0.9 0.0 0.0 2.9 1.1 7.9 0.0 0.0 0.0 29.3 2.7 0.0 0.2 0.0 1.6 0.0 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119331-143124014 "Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 106.5;Sertoli cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.4" "Group enriched" "Detected in many" 4 "monocytes: 11.4;NK-cells: 4.8" "Cell line enhanced" "Detected in many" "ASC diff: 20.5;ASC TERT1: 21.0;HEL: 16.2;HHSteC: 42.2;HMC-1: 19.4;HSkMC: 22.1;U-266/70: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 6.5 2.6 8.2 11.6 16.6 20.0 4.1 9.8 15.1 4.6 3.1 6.5 2.6 3.6 6.4 2.7 2.0 1.6 3.1 2.6 7.3 10.4 4.8 1.6 5.1 10.2 10.6 5.8 3.6 2.0 1.5 5.5 15.3 14.0 7.6 2.3 5.9 4.0 15.9 2.7 3.0 4.9 6.0 32.9 17.0 5.4 2.3 4.8 24.7 5.4 0.1 8.1 7.4 5.4 1.4 1.8 0.8 11.4 4.8 0.8 0.9 0.0 0.1 1.0 0.9 20.5 21.0 0.0 1.1 3.2 0.8 0.7 0.0 0.0 0.2 0.7 0.7 1.1 0.0 0.7 2.7 0.4 0.2 0.5 16.2 0.0 0.0 42.2 0.4 19.4 22.1 3.4 1.0 3.5 1.2 1.2 2.5 1.8 1.0 5.3 0.0 3.0 4.1 5.8 0.0 2.7 0.1 0.3 0.0 0.6 0.7 1.3 0.0 0.2 0.0 1.8 1.0 0.0 0.6 4.2 2.5 1.4 3.3 4.7 18.6 0.2 1.1 4.8 3.1 12.8 0.7 0.6 0.8 0.4 4.5 0.0 1.4 0.1 0.2 1.8 1.0 0.8 0.6 0.3 4.8 11.4 0.1 0.5 0.9 8.2 16.6 9.8 15.1 7.3 10.4 10.6 5.8 14.0 4.8 0.0 0.0 14.2 7.0 2.2 20.1 1.2 0.0 0.0 2.3 3.5 2.0 0.4 0.0 0.3 0.1 6.4 0.0 23.3 0.2 0.3 7.1 9.4 11.5 0.0 2.8 1.6 0.0 4.3 6.4 0.4 11.8 13.0 16.9 9.0 0.0 106.5 3.5 0.0 2.1 0.0 19.2 90.5 5.5 0.0 1.9 0.5 0.8 8.7 0.0 15.6 CHST4 "HEC-GLCNAC-6-ST, LSST" ENSG00000140835 "Carbohydrate sulfotransferase 4" Q8NCG5 16 71525233-71538746 "Predicted intracellular proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "gallbladder: 46.9" "Cell type enriched" "Detected in some" 40 "Cholangiocytes: 152.8" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.2;HL-60: 3.4;NB-4: 6.3;NTERA-2: 9.7;SCLC-21H: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021955 Enhanced "Intracellular and membrane" NA NA "HPA021955: AB_1846723" "unprognostic (2.22e-3)" "unprognostic (1.41e-1)" "unprognostic (8.87e-2)" "unprognostic (3.35e-2)" "unprognostic (4.76e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (9.24e-4)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-6)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" 0.6 1.7 0.0 0.7 0.1 0.0 0.1 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 2.9 46.9 0.0 0.3 0.0 0.0 5.9 0.3 0.5 0.0 0.2 0.7 9.6 0.0 0.6 0.0 0.4 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.3 0.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.5 0.1 0.0 0.4 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.9 0.1 1.9 0.0 0.1 2.2 0.0 0.1 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 152.8 1.4 1.2 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CHST5 "FLJ22167, I-GLCNAC-6-ST" ENSG00000135702 "Carbohydrate sulfotransferase 5" Q9GZS9 16 75528535-75535247 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 32.9" "Group enriched" "Detected in some" 18 "Ciliated cells: 2.7;Enterocytes: 5.7;Intestinal endocrine cells: 2.4;Mucus-secreting cells: 3.0;Paneth cells: 5.9;Undifferentiated cells: 2.2" "Group enriched" "Detected in some" 6 "colorectal cancer: 1.4;stomach cancer: 1.5" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 4.6" "HPA043804, HPA068029" Enhanced "Intracellular and membrane" NA NA "HPA043804: AB_10960563, HPA068029: " "unprognostic (6.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.99e-3)" "unprognostic (1.03e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-2)" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (2.09e-2)" "unprognostic (9.03e-3)" "unprognostic (4.27e-2)" "unprognostic (2.05e-3)" "unprognostic (3.56e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.42e-2)" 0.4 0.0 0.7 0.4 1.7 0.0 0.4 2.4 1.1 0.4 17.5 0.4 0.4 32.9 0.4 0.4 0.4 1.1 0.4 0.4 0.8 0.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.4 0.4 0.4 21.6 0.4 0.4 0.4 2.1 0.0 28.5 0.4 0.4 0.4 1.7 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.1 3.0 1.3 1.1 1.1 0.4 0.4 1.0 1.4 1.6 0.4 1.0 0.8 0.0 0.3 0.6 0.5 0.6 1.9 1.2 0.6 0.3 0.2 1.1 0.1 0.7 0.0 0.4 1.4 0.2 0.5 1.9 0.3 0.7 0.8 1.1 0.1 0.0 0.4 0.5 0.2 1.1 0.4 1.3 0.0 2.7 0.7 3.8 0.9 0.1 4.6 0.5 0.4 2.6 1.6 0.5 2.2 3.7 1.9 1.4 0.2 0.2 1.0 0.3 0.3 1.6 1.1 2.7 0.3 0.8 1.9 0.2 1.0 0.4 0.9 3.0 1.0 1.0 0.9 1.0 0.8 1.0 0.8 0.7 0.5 1.3 1.1 1.1 2.6 1.1 1.3 1.1 0.7 0.4 0.7 1.7 2.4 1.1 0.8 0.8 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 5.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 CHST6 MCDC1 ENSG00000183196 "Carbohydrate sulfotransferase 6" Q9GZX3 16 75472052-75495384 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 7.2;brain: 22.6;cervix, uterine: 18.6;intestine: 16.8;salivary gland: 20.1" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 26.8;Club cells: 7.9;Paneth cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.3;CAPAN-2: 13.6;NTERA-2: 6.5;SK-MEL-30: 5.5;U-2 OS: 8.2;WM-115: 7.1" HPA068029 Approved "Intracellular and membrane" NA NA "HPA068029: " "unprognostic (2.28e-2)" "unprognostic (2.25e-2)" "unprognostic (1.07e-1)" "unprognostic (3.93e-3)" "unprognostic (3.30e-2)" "unprognostic (4.02e-2)" "unprognostic (7.15e-2)" "unprognostic (1.73e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (3.16e-2)" "unprognostic (1.07e-1)" "unprognostic (1.10e-7)" "unprognostic (1.23e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (2.80e-4)" 0.8 7.2 10.1 1.1 17.4 0.8 0.7 8.3 11.6 18.6 5.9 22.6 0.0 16.8 1.4 1.1 2.5 2.9 0.8 2.3 9.4 5.5 1.1 0.6 1.4 0.8 17.6 4.9 0.7 0.7 1.1 1.4 0.8 18.5 1.3 5.9 0.4 20.1 1.0 0.9 0.9 15.5 1.3 19.5 0.9 1.3 1.3 13.6 0.0 0.8 0.0 0.8 0.9 0.5 1.2 0.8 2.5 0.5 1.4 0.7 0.2 0.2 0.6 0.8 12.3 0.2 0.6 0.2 0.1 0.0 0.0 0.1 0.2 13.6 0.1 1.8 0.1 0.1 0.2 1.2 0.2 0.1 0.0 0.3 0.0 0.2 1.2 0.0 0.0 0.2 0.4 0.0 0.2 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 6.5 0.0 0.2 0.0 0.0 0.1 1.1 0.1 0.3 0.1 0.0 0.1 5.5 1.9 0.1 0.4 0.2 0.1 8.2 0.1 0.0 0.3 0.2 3.1 0.4 0.0 7.1 2.5 0.5 0.4 0.6 0.3 0.5 0.8 0.4 0.4 0.1 1.2 0.5 0.7 2.0 1.4 0.3 0.8 0.3 0.2 10.1 17.4 8.3 11.6 9.4 5.5 17.6 4.9 18.5 13.6 0.0 3.7 0.0 1.9 0.0 0.7 0.8 0.0 26.8 7.9 3.5 0.0 1.7 0.0 0.0 1.1 0.0 5.0 0.0 0.0 0.1 0.3 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.7 0.6 0.1 10.5 0.0 0.0 0.4 0.0 0.7 0.3 0.1 0.0 0.6 0.0 1.5 3.1 CHST8 GALNAC-4-ST1 ENSG00000124302 "Carbohydrate sulfotransferase 8" Q9H2A9 19 33621955-33773509 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 27.1;pituitary gland: 36.7" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 12.0;Late spermatids: 40.2;Smooth muscle cells: 7.8" "Cancer enhanced" "Detected in many" "glioma: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 18.8;SCLC-21H: 11.0;SH-SY5Y: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016004 Enhanced "Intracellular and membrane" NA NA "HPA016004: AB_1846731" "unprognostic (1.00e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (9.44e-2)" "unprognostic (2.96e-2)" "unprognostic (1.15e-2)" "unprognostic (5.75e-2)" "unprognostic (8.41e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (6.98e-8)" "unprognostic (9.37e-3)" "unprognostic (2.61e-1)" "unprognostic (3.28e-1)" "unprognostic (3.87e-2)" 2.0 3.8 3.6 1.7 2.8 0.4 7.0 16.6 9.2 3.4 1.1 1.0 0.0 0.5 1.3 0.4 0.7 2.0 4.0 0.8 9.2 7.9 0.5 0.7 0.6 2.0 5.3 1.5 1.4 3.4 0.4 36.7 0.4 27.1 1.8 0.5 1.4 0.7 0.8 0.6 0.9 0.8 0.8 7.2 3.3 0.9 2.9 0.9 0.0 0.6 0.3 1.4 0.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 0.0 0.0 0.0 0.1 18.8 0.0 0.3 11.0 19.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.6 2.8 16.6 9.2 9.2 7.9 5.3 1.5 27.1 0.9 0.0 0.0 0.0 0.4 0.7 2.7 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 4.8 0.0 7.8 0.5 0.6 0.1 0.0 0.0 0.0 0.7 CHST9 "GALNAC-4-ST2, GALNAC4ST-2" ENSG00000154080 "Carbohydrate sulfotransferase 9" Q7L1S5 18 26906481-27185317 "Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.4" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 422.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.4;Hep G2: 9.5;RPTEC TERT1: 30.0;SCLC-21H: 6.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA011393 Uncertain "Intracellular and membrane" NA NA "HPA011393: AB_1846733" "unprognostic (9.24e-3)" "unprognostic (1.13e-2)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (4.53e-3)" "unprognostic (9.98e-3)" "unprognostic (9.21e-3)" "unprognostic (7.92e-2)" "unprognostic (1.61e-1)" "unprognostic (2.04e-2)" "unprognostic (3.54e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-2)" "unprognostic (1.38e-1)" "unprognostic (3.93e-3)" 0.3 0.4 1.7 0.3 2.4 0.2 3.7 1.0 2.6 4.0 2.1 4.5 0.7 0.4 0.3 0.9 2.2 13.6 4.5 3.4 3.7 2.7 2.4 12.1 8.6 0.1 2.6 0.8 1.2 11.9 0.1 4.3 0.1 4.9 4.8 0.4 5.3 23.4 2.7 0.4 0.4 0.7 0.3 5.3 7.1 1.0 8.5 4.2 0.0 0.3 3.9 7.0 2.6 10.5 0.5 0.1 0.8 0.1 0.3 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 30.0 0.0 6.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.5 0.2 0.3 0.5 0.3 0.0 0.1 0.1 0.0 1.7 2.4 1.0 2.6 3.7 2.7 2.6 0.8 4.9 4.2 0.0 2.4 0.0 29.8 0.6 1.3 7.7 38.2 422.9 93.3 5.2 0.0 0.2 10.0 8.9 6.1 0.0 0.0 0.0 0.5 0.1 1.1 6.5 4.7 8.9 0.3 0.0 3.4 0.0 0.0 2.4 0.6 0.0 6.8 0.0 0.0 72.3 2.1 0.0 0.4 0.1 1.8 0.0 0.5 0.7 0.7 0.0 0.2 0.0 0.0 37.1 CHSY1 "CSS1, KIAA0990" ENSG00000131873 "Chondroitin sulfate synthase 1" Q86X52 15 101175723-101251932 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 72.5" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 69.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (7.28e-2)" "unprognostic (6.39e-2)" "unprognostic (9.24e-2)" "unprognostic (1.55e-1)" "unprognostic (7.60e-2)" "unprognostic (9.51e-3)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (1.77e-1)" "unprognostic (1.32e-2)" "unprognostic (5.97e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.33e-5)" "unprognostic (3.44e-2)" "unprognostic (1.02e-1)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" 23.2 15.6 14.4 14.6 13.7 15.7 17.7 8.5 11.1 17.7 6.5 9.6 8.6 4.9 15.6 11.6 9.1 14.1 19.0 19.0 11.4 7.5 9.0 8.1 20.6 12.4 15.3 5.5 21.9 6.0 5.9 8.7 72.5 12.9 13.6 7.0 12.1 9.8 10.1 7.3 13.7 6.8 16.4 11.9 18.4 9.3 10.8 13.5 8.3 9.7 9.2 8.7 14.3 20.0 1.9 1.5 8.7 2.4 1.2 3.2 1.0 2.8 3.5 11.9 6.0 6.2 8.4 7.9 6.9 6.1 8.4 8.6 3.0 2.3 6.8 4.1 11.5 5.5 7.9 7.9 8.8 9.3 7.6 3.9 13.5 4.0 3.5 7.7 20.5 14.0 7.7 7.4 7.2 6.6 9.6 9.9 3.1 4.9 69.8 6.3 2.4 2.8 14.1 13.7 5.5 2.5 6.4 12.0 10.1 5.8 5.6 2.1 11.3 7.3 3.6 12.5 10.2 4.1 25.5 8.3 13.8 7.9 6.5 14.5 12.4 28.6 4.0 10.7 19.5 10.2 0.0 2.4 5.1 2.9 1.5 3.1 1.7 1.8 3.1 1.5 1.9 1.0 1.9 8.7 1.2 1.6 0.9 3.2 1.0 14.4 13.7 8.5 11.1 11.4 7.5 15.3 5.5 12.9 13.5 0.0 17.8 6.2 17.2 51.4 9.0 7.1 2.5 10.7 11.4 15.7 5.9 5.6 1.7 4.4 0.7 37.9 0.9 23.3 1.9 19.4 44.1 15.0 24.4 4.9 14.0 36.5 2.9 57.7 14.0 1.3 50.9 17.6 25.3 1.0 3.4 9.1 4.6 3.4 44.2 1.9 7.3 45.3 68.0 3.9 7.2 54.6 11.6 8.7 3.1 8.5 CIB2 "DFNB48, KIP2, USH1J" ENSG00000136425 "Calcium and integrin binding family member 2" O75838 15 78104606-78131544 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.5;intestine: 48.5" "Group enriched" "Detected in many" 6 "Early spermatids: 72.8;Late spermatids: 196.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 51 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in single" 51 "dendritic cells: 16.1" "Cell line enhanced" "Detected in many" "AN3-CA: 19.9;GAMG: 18.0;HAP1: 17.4;SCLC-21H: 18.0;SH-SY5Y: 18.8;SuSa: 23.8" "Low region specificity" "Detected in all" HPA036697 Approved NA NA "HPA036697: AB_10672475" "unprognostic (5.77e-2)" "unprognostic (1.83e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.46e-1)" "unprognostic (2.57e-1)" "unprognostic (1.11e-2)" "unprognostic (6.73e-3)" "unprognostic (1.66e-1)" "unprognostic (9.94e-3)" "unprognostic (3.18e-1)" "unprognostic (7.49e-2)" "prognostic favorable (6.16e-4)" "unprognostic (9.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 5.8 8.8 9.7 3.4 6.7 1.2 6.0 5.1 8.2 9.6 11.0 3.5 2.8 16.0 6.1 3.2 4.2 4.3 3.2 45.5 7.2 6.8 7.0 0.8 1.9 3.3 6.9 4.9 6.9 13.0 9.2 7.1 4.8 9.1 7.9 6.3 4.2 6.8 8.2 6.3 4.2 48.5 7.5 4.1 3.7 2.7 13.4 2.0 35.0 3.0 1.9 5.4 6.0 7.9 0.0 16.1 0.1 0.0 0.0 0.3 0.1 1.7 3.9 11.1 19.9 0.5 0.7 8.5 1.1 0.4 0.9 2.0 0.0 4.4 0.2 2.3 5.0 18.0 0.9 17.4 3.4 0.3 9.8 12.5 1.1 0.7 0.6 2.0 0.0 1.6 1.0 1.5 1.6 1.0 2.4 2.0 5.9 4.0 0.1 1.8 0.3 0.5 0.2 14.5 0.6 0.1 7.4 0.0 0.4 1.3 0.3 18.0 18.8 2.9 1.4 1.5 23.8 0.3 1.1 0.1 0.0 9.6 1.0 0.1 0.2 0.2 3.2 0.4 0.0 2.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 16.1 0.0 0.1 9.7 6.7 5.1 8.2 7.2 6.8 6.9 4.9 9.1 2.0 0.0 0.0 0.8 16.1 4.8 1.6 8.5 2.5 0.0 0.0 1.8 5.9 15.9 8.3 2.9 72.8 1.1 18.0 0.0 0.9 13.5 3.3 10.3 0.0 0.5 2.4 4.8 2.9 1.3 0.6 196.3 3.1 0.6 6.8 0.0 22.5 8.7 1.8 14.4 2.5 6.5 2.2 6.5 2.3 10.0 16.2 2.8 7.8 0.0 11.2 8.8 CIB3 KIP3 ENSG00000141977 "Calcium and integrin binding family member 3" Q96Q77 19 16161368-16173525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 5.4;bone marrow: 4.8;testis: 3.8" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 22.7;Late spermatids: 6.6" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.9" "Cell type enhanced" "Detected in some" "eosinophil: 5.4" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HMC-1: 9.2;MCF7: 4.4;NB-4: 2.8;THP-1: 2.6;U-937: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043553, HPA043995" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043553: AB_10964566, HPA043995: " "unprognostic (8.43e-2)" "unprognostic (7.26e-5)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.25e-1)" "unprognostic (3.14e-1)" "unprognostic (2.93e-2)" "unprognostic (3.05e-1)" "unprognostic (5.68e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.8 0.0 4.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 3.8 0.0 0.7 0.1 0.0 0.1 0.6 5.4 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 9.2 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 2.8 0.4 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.1 0.0 1.9 0.1 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 CIB4 ENSG00000157884 "Calcium and integrin binding family member 4" A0PJX0 2 26581202-26641368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 22.5" "Cell type enriched" "Detected in some" 7 "Early spermatids: 115.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.0;EFO-21: 1.6;SCLC-21H: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036130, HPA036131" Uncertain NA NA "HPA036130: AB_10670709, HPA036131: AB_2674959" "unprognostic (3.63e-3)" "unprognostic (1.78e-1)" "unprognostic (2.61e-4)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (4.29e-4)" "unprognostic (1.57e-1)" "unprognostic (3.19e-5)" "unprognostic (1.20e-2)" "unprognostic (3.63e-1)" "unprognostic (1.76e-3)" "unprognostic (3.50e-1)" 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.5 1.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 22.5 0.1 0.1 3.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 5.2 2.0 0.0 0.0 0.0 115.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 14.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 1.7 0.2 0.0 0.7 0.0 0.0 0.0 CIDEA CIDE-A ENSG00000176194 "Cell death-inducing DFFA-like effector a" O60543 18 12254319-12277595 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 79.9;breast: 32.6" "Cell type enhanced" "Detected in some" 15 "Late spermatids: 2.7;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basal ganglia: 1.7;cerebral cortex: 1.9;olfactory region: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "hTEC/SVTERT24-B: 5.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 12.2" NA NA "unprognostic (2.96e-2)" "unprognostic (2.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (8.93e-3)" "unprognostic (3.20e-2)" "unprognostic (7.00e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-3)" "unprognostic (3.17e-2)" "unprognostic (7.67e-3)" "unprognostic (1.96e-1)" 79.9 1.5 0.1 5.8 1.7 0.2 32.6 0.0 1.9 1.1 8.0 0.0 0.6 0.2 0.2 0.2 2.1 0.2 4.9 2.4 0.2 0.0 0.2 0.3 0.2 0.3 0.1 1.5 0.2 0.5 0.2 0.0 0.2 0.3 0.3 0.5 0.0 2.1 0.3 1.0 3.0 0.8 0.3 0.0 0.2 0.2 0.3 0.0 0.0 0.3 3.4 0.3 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 1.9 0.2 0.0 0.1 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.9 0.0 0.0 0.0 0.4 CIDEB ENSG00000136305 "Cell death-inducing DFFA-like effector b" Q9UHD4 14 24305096-24311430 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "intestine: 123.9;liver: 215.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 219.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 15.2;HEL: 7.8;Hep G2: 17.0;HL-60: 10.9;Karpas-707: 7.8;U-266/84: 10.1;U-937: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA001272 Approved NA NA "HPA001272: AB_2666255" "unprognostic (2.62e-2)" "unprognostic (6.55e-2)" "unprognostic (2.62e-3)" "unprognostic (9.35e-2)" "unprognostic (2.38e-3)" "unprognostic (1.83e-2)" "unprognostic (1.57e-1)" "unprognostic (8.48e-4)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (3.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.43e-2)" "unprognostic (6.04e-2)" "unprognostic (5.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.64e-1)" 2.3 5.6 0.9 1.9 1.2 3.9 2.2 3.1 0.9 2.7 43.4 1.1 1.9 26.0 2.2 2.7 7.1 2.5 3.1 1.2 1.0 0.6 24.2 215.9 2.0 3.3 1.2 0.9 5.5 3.9 0.5 2.5 0.8 1.3 3.1 1.3 2.4 2.8 2.2 0.6 4.0 123.9 1.5 1.0 19.5 1.4 0.9 0.9 0.8 1.4 3.2 4.5 1.3 3.8 0.7 7.1 8.7 7.1 6.3 4.9 2.5 0.0 0.0 0.0 0.0 1.0 0.5 0.2 0.3 0.1 0.1 0.0 1.0 0.4 0.0 0.0 0.4 0.0 1.4 0.0 0.1 0.0 15.2 0.0 7.8 0.0 17.0 0.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 7.8 0.0 0.0 0.0 5.1 0.0 4.0 0.0 1.2 0.1 3.9 0.0 0.5 3.3 0.0 4.3 0.1 0.0 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 6.2 10.1 0.1 0.0 12.8 0.0 0.9 7.1 8.7 4.9 2.4 4.5 0.7 3.2 3.1 7.1 0.6 2.0 2.6 4.1 6.3 1.2 1.7 1.6 2.5 0.9 1.2 3.1 0.9 1.0 0.6 1.2 0.9 1.3 0.9 0.0 1.7 9.5 5.0 6.3 0.2 0.0 7.6 13.4 4.5 1.8 2.0 0.0 8.3 1.4 0.1 2.8 20.6 23.3 8.5 0.2 2.5 0.9 8.1 219.7 6.4 0.0 1.7 13.5 28.5 0.0 5.8 5.6 5.0 0.0 2.5 0.5 10.4 20.1 2.8 43.4 0.6 0.0 1.7 0.2 1.3 5.4 0.2 8.7 1.6 0.9 CIDEC "CIDE-3, FLJ20871, Fsp27" ENSG00000187288 "Cell death inducing DFFA like effector c" Q96AQ7 3 9866711-9880254 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 16 "adipose tissue: 129.9;breast: 63.7;intestine: 60.5" "Cell type enriched" "Detected in some" 6 "Enterocytes: 107.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.2;plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "ASC diff: 197.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018837, HPA020553" Approved NA NA "HPA018837: AB_1846767, HPA020553: AB_1846769" "unprognostic (1.83e-2)" "unprognostic (3.08e-2)" "unprognostic (2.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.19e-1)" "unprognostic (7.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-5)" "unprognostic (9.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.48e-3)" "unprognostic (8.14e-2)" "unprognostic (5.37e-5)" "unprognostic (9.47e-3)" "unprognostic (2.02e-1)" "unprognostic (7.46e-3)" "unprognostic (2.94e-2)" 129.9 1.1 0.1 5.3 0.1 0.0 63.7 0.1 0.1 0.4 44.3 0.1 0.9 13.5 0.5 0.6 0.1 0.2 5.3 2.3 0.1 0.0 0.6 2.6 0.1 2.7 0.1 0.1 0.1 1.4 0.0 0.1 0.1 0.1 0.4 0.8 0.1 2.9 0.8 1.7 2.4 60.5 0.8 0.1 0.1 0.8 0.4 0.1 0.1 0.4 1.9 0.2 2.4 1.1 2.2 1.8 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 197.1 44.5 0.1 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.5 0.0 2.2 0.1 0.0 0.5 0.6 0.0 0.2 0.0 0.2 0.4 1.8 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 107.8 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 2.3 0.0 1.7 0.0 1.7 0.0 0.6 17.3 0.4 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.3 0.1 CIITA "C2TA, MHC2TA, NLRA" ENSG00000179583 "Class II major histocompatibility complex transactivator" P33076 16 10866222-10943021 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, Kinase, Transferase" "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 17.9;Macrophages: 36.9;monocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 23.3;REH: 40.9;U-266/70: 8.6;U-698: 12.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016084, HPA054757" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016084: AB_627261, HPA054757: " "unprognostic (1.45e-3)" "unprognostic (1.38e-2)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" "unprognostic (5.66e-2)" "unprognostic (2.88e-3)" "unprognostic (2.92e-2)" "unprognostic (1.55e-2)" "unprognostic (1.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.23e-1)" "unprognostic (3.72e-1)" "unprognostic (1.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.33e-3)" "unprognostic (2.74e-1)" "unprognostic (1.05e-2)" 8.0 5.9 4.6 47.7 7.1 4.3 6.8 1.5 5.5 6.3 3.7 10.6 4.2 10.4 8.1 10.4 4.8 5.2 8.1 4.9 4.7 3.5 8.8 2.9 15.0 27.0 9.4 1.1 2.5 3.5 1.9 4.0 1.2 6.6 5.5 4.3 5.5 13.3 4.3 2.9 4.4 17.4 3.7 15.6 25.9 6.2 1.5 7.4 12.6 6.1 5.2 67.2 6.3 6.8 27.3 19.0 6.5 11.9 0.7 0.5 1.7 0.1 0.2 0.3 0.3 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.3 5.6 5.1 0.8 0.0 0.9 0.9 0.0 0.0 0.1 23.3 0.3 2.9 1.1 0.6 0.0 0.5 0.4 1.0 0.0 0.1 0.0 0.9 0.0 0.3 0.3 2.0 0.1 0.3 0.2 0.4 0.1 0.2 0.1 40.9 0.3 3.6 0.0 1.7 0.9 0.1 0.9 0.3 0.9 0.3 0.5 1.7 0.3 2.1 0.3 0.6 0.2 8.6 0.6 12.1 7.7 0.5 6.9 0.2 11.9 6.5 0.3 9.5 0.1 17.9 0.1 0.5 17.7 27.3 0.1 0.2 2.8 0.7 10.0 19.0 0.4 1.7 4.6 7.1 1.5 5.5 4.7 3.5 9.4 1.1 6.6 7.4 6.0 17.9 12.3 0.3 2.1 0.6 2.8 2.5 2.7 1.2 3.5 0.0 0.1 0.0 2.5 0.6 4.2 3.4 0.0 1.7 0.2 1.0 0.3 10.4 1.0 9.1 0.0 2.4 2.5 15.6 0.0 0.6 36.9 6.8 58.7 0.7 0.4 1.7 0.0 0.0 3.3 0.9 0.0 0.9 0.0 0.0 2.5 0.1 1.0 0.4 0.3 CILP2 MGC45771 ENSG00000160161 "Cartilage intermediate layer protein 2" Q8IUL8 19 19538248-19546659 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 9.4;testis: 10.1" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 20.5;Late spermatids: 15.9;Sertoli cells: 6.5;Spermatogonia: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC diff: 8.9;HEK 293: 5.2;NB-4: 3.9;THP-1: 5.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA041847 Uncertain "Secreted to extracellular matrix" NA NA 11000000 "HPA041847: AB_10795599" "unprognostic (6.51e-2)" "unprognostic (2.54e-2)" "unprognostic (5.42e-4)" "prognostic unfavorable (3.22e-6)" "unprognostic (4.81e-2)" "unprognostic (1.73e-1)" "unprognostic (4.31e-2)" "unprognostic (4.13e-3)" "unprognostic (4.48e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.09e-2)" "unprognostic (1.41e-2)" "unprognostic (0.00e+0)" "unprognostic (1.59e-2)" "unprognostic (3.19e-2)" "unprognostic (3.12e-3)" "unprognostic (1.36e-2)" 2.8 0.1 0.9 1.1 1.0 3.1 3.6 0.3 1.1 3.1 0.7 0.0 0.8 0.1 0.7 1.1 0.8 0.9 5.6 1.0 0.8 1.4 0.2 0.7 0.9 2.5 0.3 0.0 9.4 0.2 1.4 0.9 2.4 0.4 1.2 0.2 3.0 2.8 0.9 4.0 0.7 0.3 0.5 0.1 0.7 0.2 10.1 0.0 0.0 7.8 0.4 1.8 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.3 0.2 8.9 0.3 1.2 1.1 0.0 0.5 0.1 2.4 0.9 0.1 2.3 0.4 0.1 1.0 0.2 0.0 0.1 0.6 5.2 0.0 0.2 0.3 0.3 0.0 0.6 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.0 3.9 3.3 2.7 1.6 0.6 0.0 0.0 0.1 0.0 0.1 2.2 0.5 2.8 0.3 0.5 0.5 5.0 0.0 0.1 1.1 0.4 0.2 0.7 2.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.3 1.1 0.8 1.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.5 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.3 3.7 4.5 0.5 0.0 0.0 0.0 0.4 CIP2A KIAA1524 ENSG00000163507 "Cell proliferation regulating inhibitor of protein phosphatase 2A" Q8TCG1 3 108549869-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 2.1 2.3 2.5 8.5 6.3 10.4 3.6 6.3 6.2 3.2 3.1 2.6 0.8 2.0 3.2 1.8 4.0 1.8 2.0 2.7 2.9 2.1 2.2 1.6 2.2 10.2 2.0 3.2 3.8 1.8 1.8 3.0 3.3 2.4 3.0 4.4 2.2 2.3 1.4 2.0 1.9 2.7 2.5 2.4 5.5 2.0 8.5 1.5 21.5 1.9 1.5 8.0 4.0 2.7 1.9 0.3 0.7 1.1 0.0 1.6 0.6 18.9 5.6 15.9 10.2 0.7 1.5 6.5 14.4 6.8 17.1 20.1 6.8 8.5 12.8 5.0 5.2 13.0 9.7 5.4 5.1 31.2 4.0 5.3 15.3 7.8 5.1 0.2 9.8 11.0 0.6 1.0 13.3 5.5 2.8 7.6 5.9 9.4 20.7 16.7 3.9 11.8 8.8 16.4 7.1 9.8 13.6 14.8 7.0 5.2 5.3 7.7 10.2 10.6 4.2 5.9 9.7 7.1 7.0 5.5 17.6 19.9 5.3 17.3 4.8 5.3 21.2 7.8 10.7 17.9 0.6 0.3 0.7 0.0 0.5 1.3 1.2 0.7 0.3 0.0 1.9 0.7 1.6 0.0 0.0 1.1 0.3 0.8 0.6 2.5 6.3 6.3 6.2 2.9 2.1 2.0 3.2 2.4 1.5 8.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 3.5 0.0 2.5 1.7 2.4 0.0 0.0 0.0 0.0 6.4 10.7 0.0 0.0 3.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 CIPC KIAA1737 ENSG00000198894 "CLOCK interacting pacemaker" Q9C0C6 14 77098097-77117287 "Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA000644 Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Cytosol" Nucleoli "HPA000644: AB_1079206" "unprognostic (3.93e-2)" "unprognostic (6.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (6.67e-3)" "unprognostic (3.73e-2)" "unprognostic (1.74e-1)" "unprognostic (2.31e-2)" "unprognostic (3.20e-1)" "prognostic favorable (1.77e-10)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "unprognostic (1.13e-1)" "unprognostic (1.21e-1)" 8.9 7.3 20.8 5.9 20.7 3.1 11.4 29.0 24.2 12.8 14.1 27.9 9.9 7.5 10.7 10.0 15.5 21.2 6.7 26.1 21.6 17.5 10.4 10.9 7.9 5.8 22.2 14.9 7.1 7.1 15.8 9.4 6.6 20.5 18.3 14.1 10.6 13.3 18.2 77.7 8.6 7.9 11.8 21.6 6.3 7.1 8.0 23.4 3.4 14.4 13.1 7.1 11.4 8.8 11.4 7.2 7.7 6.7 7.6 5.8 4.2 6.2 8.3 17.6 11.8 7.2 5.7 10.9 4.2 6.5 7.4 6.8 6.6 13.4 15.3 4.0 6.6 6.9 9.5 16.4 6.3 10.2 7.9 4.4 10.2 6.3 6.1 6.8 5.6 7.5 6.6 12.6 7.3 4.6 10.0 8.6 12.4 8.8 6.2 5.6 13.5 13.2 6.8 7.4 14.3 7.2 13.3 7.7 9.2 7.6 10.5 25.1 9.3 7.4 12.1 9.7 7.8 18.9 5.7 10.3 4.9 10.5 6.9 5.0 5.5 3.8 7.4 9.3 4.8 10.3 5.8 5.8 2.1 3.7 6.7 5.8 11.4 5.2 3.9 7.2 9.4 5.6 3.9 7.7 7.6 4.8 2.7 5.3 4.2 20.8 20.7 29.0 22.4 21.6 17.5 22.2 14.9 20.5 23.4 14.9 13.6 0.8 7.0 8.0 24.6 44.8 7.6 14.7 14.8 10.4 55.0 5.6 8.3 4.2 8.7 5.8 18.6 0.0 4.7 3.7 6.0 7.5 1.1 23.6 12.8 11.1 16.7 6.7 14.3 9.9 3.7 5.8 8.5 3.6 15.6 18.9 3.9 10.5 13.4 4.9 36.3 12.9 9.5 14.9 6.1 8.5 11.3 3.9 9.5 5.8 CISD1 "C10orf70, MDS029, mitoNEET, ZCD1" ENSG00000122873 "CDGSH iron sulfur domain 1" Q9NZ45 10 58269058-58289586 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 63.1" "Cell type enhanced" "Detected in all" 6 "Distal tubular cells: 606.8;Proximal tubular cells: 437.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074383 Supported Supported Mitochondria NA NA Mitochondria "HPA074383: AB_2686684" "prognostic unfavorable (1.11e-4)" "unprognostic (8.60e-3)" "unprognostic (1.07e-1)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.87e-2)" "unprognostic (2.35e-1)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "unprognostic (7.23e-2)" "unprognostic (1.34e-3)" "unprognostic (4.19e-2)" "unprognostic (7.20e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (6.69e-4)" 4.7 8.9 14.0 5.4 21.6 1.4 5.4 14.8 24.9 6.2 10.3 3.7 3.6 17.8 5.2 3.9 9.5 5.7 6.4 32.1 16.2 17.6 20.8 13.2 4.1 4.9 14.7 19.5 6.4 4.8 63.1 10.5 5.0 16.6 6.9 7.7 5.8 8.0 6.7 43.9 7.2 16.7 8.9 9.0 4.2 6.4 3.0 6.0 3.5 8.7 20.4 5.1 8.3 4.4 7.6 9.5 3.0 5.8 6.1 8.3 5.1 12.1 6.2 4.9 9.0 6.7 7.5 2.9 10.3 11.9 10.3 14.2 14.5 11.5 21.7 8.7 10.6 6.0 8.0 13.4 9.2 9.3 9.7 18.2 5.7 10.3 11.7 7.6 10.0 4.5 9.3 7.6 9.8 15.1 8.8 12.0 11.0 12.5 10.2 7.1 4.1 8.5 10.8 5.3 9.3 19.5 6.6 18.3 11.4 13.9 4.3 15.7 5.6 7.9 21.2 7.3 4.5 14.1 5.4 11.8 4.4 8.0 12.8 12.2 10.4 16.9 16.3 11.9 10.0 4.3 0.0 5.8 0.3 5.7 4.2 6.7 7.6 6.6 6.6 9.5 6.0 7.7 7.5 3.0 6.1 2.6 6.2 8.3 5.1 14.0 21.6 14.8 24.9 16.2 17.6 14.7 19.5 16.6 6.0 56.6 40.8 43.2 69.2 114.4 85.6 290.3 127.4 66.9 55.7 127.4 41.2 139.3 606.8 85.2 163.9 59.9 102.8 23.3 70.7 53.7 53.8 54.1 34.5 218.9 59.2 39.7 216.5 78.0 41.4 266.7 39.1 30.5 173.7 19.8 105.2 33.6 75.5 104.0 37.8 437.6 44.2 32.3 59.0 46.8 59.2 99.9 60.8 26.6 102.8 57.1 CIT "CITK, CRIK, KIAA0949, STK21" ENSG00000122966 "Citron rho-interacting serine/threonine kinase" O14578 12 119685790-119877291 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3;brain: 35.0" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 82.5;Early spermatids: 63.4;Late spermatids: 28.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019082, HPA048812, HPA075506" Uncertain Approved Cytosol NA NA Cytosol "HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752" "unprognostic (5.64e-2)" "unprognostic (5.00e-2)" "unprognostic (8.16e-2)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (3.61e-6)" "unprognostic (6.02e-2)" "unprognostic (7.78e-2)" "unprognostic (4.42e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-2)" "unprognostic (2.55e-3)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (1.70e-1)" "unprognostic (3.30e-1)" 1.4 4.4 14.7 3.3 14.0 15.3 1.6 12.7 35.0 1.6 4.6 2.9 0.0 4.0 1.3 1.5 3.2 0.9 1.6 1.0 9.8 5.7 5.7 1.4 3.0 3.4 3.2 21.9 0.7 0.7 1.2 2.9 2.6 7.4 1.0 5.3 0.6 1.3 1.0 1.3 5.1 3.5 2.6 5.0 5.6 3.5 8.3 9.5 5.9 1.5 0.1 4.9 1.7 1.7 0.4 0.0 0.0 0.1 0.0 1.2 0.8 15.1 13.7 12.0 11.3 1.1 3.3 7.1 11.7 9.7 12.2 9.2 8.7 6.3 11.0 6.3 9.0 6.0 9.5 8.2 6.8 16.9 7.8 6.0 13.9 8.8 5.4 0.1 7.3 12.8 0.7 0.8 14.6 9.0 4.4 9.3 12.2 8.8 9.3 11.5 7.6 13.2 11.1 6.5 5.7 9.3 12.1 21.9 3.6 2.4 6.7 8.6 4.7 19.4 3.8 9.2 6.3 13.7 5.3 7.1 15.3 14.1 10.4 12.7 6.3 7.1 7.5 10.1 8.1 23.6 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 14.7 14.0 12.7 35.0 9.8 5.7 3.2 21.9 7.4 9.5 6.0 8.8 0.8 0.6 3.0 7.4 1.6 0.0 1.4 9.1 8.7 82.5 0.9 0.0 0.2 63.4 1.1 0.4 0.0 0.7 4.0 1.1 0.3 1.1 0.8 2.9 0.0 1.7 1.3 1.9 28.5 1.1 1.0 3.3 0.0 1.1 15.4 0.1 0.0 1.1 5.7 15.0 0.0 0.4 11.5 3.5 1.1 0.8 2.5 1.6 1.0 CITED1 MSG1 ENSG00000125931 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1" Q99966 X 72301638-72307187 "Predicted intracellular proteins" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 247.1;pituitary gland: 62.8;testis: 89.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 13.8;Late spermatids: 28.3;Sertoli cells: 12.9" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 134.9" "Region enriched" "Detected in many" 5 "hypothalamus: 18.9" "Cell type enhanced" "Detected in some" "eosinophil: 2.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 17.9;SK-MEL-30: 71.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049051 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA049051: AB_2680612" "unprognostic (7.04e-2)" "unprognostic (3.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" "unprognostic (8.81e-2)" "unprognostic (5.67e-4)" "unprognostic (3.40e-1)" "unprognostic (9.55e-2)" "unprognostic (4.60e-3)" "unprognostic (4.38e-2)" "unprognostic (6.33e-3)" "unprognostic (1.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.62e-1)" "prognostic favorable (6.10e-4)" "prognostic favorable (3.95e-4)" "unprognostic (2.99e-2)" 0.5 0.6 3.5 0.5 2.2 0.4 6.0 0.9 2.8 1.3 0.5 0.3 5.3 0.5 1.0 247.1 0.4 0.5 0.4 0.4 2.4 18.9 0.6 0.4 0.5 0.4 1.1 0.9 0.5 0.6 0.4 62.8 0.4 2.7 2.1 0.4 27.8 0.4 1.2 0.4 0.4 0.5 1.7 0.5 0.4 0.4 89.9 0.0 0.0 1.7 0.0 0.4 0.4 0.0 0.0 0.8 2.2 0.5 0.0 1.1 1.1 0.1 0.1 0.7 17.9 0.8 0.0 0.6 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 6.4 0.4 0.0 1.8 2.5 0.3 0.2 0.0 0.0 0.1 3.5 0.3 0.2 0.2 0.3 0.0 0.0 0.1 0.7 0.1 0.1 0.2 0.0 1.4 1.0 0.1 1.2 0.0 1.2 0.9 0.0 0.2 8.1 4.2 0.1 1.6 71.3 0.1 0.5 0.4 0.0 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 0.2 1.7 0.0 0.5 2.2 0.4 0.0 1.1 0.0 0.2 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 3.5 2.2 0.9 2.8 2.4 18.9 1.1 0.9 2.7 0.0 0.0 0.0 0.0 1.0 0.1 3.2 0.3 2.5 0.0 0.0 3.5 5.9 0.1 0.0 0.0 13.8 0.2 0.1 0.0 0.7 0.0 0.2 8.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 28.3 6.9 0.0 3.3 0.0 0.1 0.8 0.4 7.2 2.8 0.3 3.5 12.9 0.3 6.8 3.7 0.0 0.0 0.0 0.1 0.9 CKAP2 "FLJ10749, LB1, se20-10, TMAP" ENSG00000136108 "Cytoskeleton associated protein 2" Q8WWK9 13 52455429-52476628 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 42.3;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 140.2;Spermatocytes: 150.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA008410, HPA027821" Enhanced Enhanced Microtubules,Cytosol No Yes Microtubules Cytosol "HPA008410: AB_1846832, HPA027821: AB_10602208" "unprognostic (1.85e-1)" "unprognostic (2.09e-3)" "unprognostic (2.44e-2)" "unprognostic (4.07e-3)" "unprognostic (1.39e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (3.26e-5)" "unprognostic (3.38e-2)" "unprognostic (4.24e-2)" "unprognostic (1.69e-2)" "unprognostic (8.30e-2)" "unprognostic (6.60e-3)" "prognostic unfavorable (1.90e-5)" "unprognostic (2.01e-2)" "unprognostic (5.20e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" 4.6 9.2 7.1 12.1 12.2 42.3 4.4 16.4 9.9 4.3 6.7 1.9 2.3 9.0 4.2 5.2 14.7 3.0 4.1 5.3 5.8 7.8 5.0 3.2 5.0 13.5 5.9 5.8 3.5 2.4 3.4 10.9 10.2 16.1 4.6 7.4 1.4 6.7 3.6 5.8 10.4 7.0 6.5 5.5 12.4 4.2 22.1 5.2 49.2 5.0 10.3 14.8 8.1 6.6 15.2 16.1 30.4 12.8 2.5 15.7 4.2 19.5 10.6 42.5 21.0 5.5 5.5 10.7 32.3 19.1 37.7 24.3 15.2 24.8 37.6 5.2 24.0 17.6 23.0 29.2 16.4 52.6 25.4 24.1 33.9 11.9 10.8 2.3 33.6 13.8 4.0 6.8 17.6 23.2 11.2 22.8 16.1 14.2 15.6 41.5 9.2 23.1 16.6 25.1 30.5 11.2 22.2 24.4 16.4 11.5 10.7 13.0 16.9 18.2 13.4 9.9 22.5 14.7 16.2 15.0 10.9 16.8 17.0 32.3 9.2 13.5 46.3 7.6 17.6 28.7 30.4 7.2 10.4 5.4 10.4 4.8 12.2 8.2 6.4 7.5 15.2 6.5 5.5 2.2 2.5 12.8 16.1 15.7 4.2 7.1 12.2 16.4 9.9 5.8 7.8 5.9 5.8 16.1 5.2 6.0 3.2 36.9 3.9 13.4 9.9 7.3 0.0 2.7 9.1 1.8 5.9 24.3 8.3 5.2 32.6 9.8 4.5 140.2 5.2 34.8 11.3 2.6 16.1 4.3 26.4 1.6 6.9 16.5 20.7 39.9 6.9 16.4 0.0 14.4 7.9 12.3 2.8 3.5 15.9 6.7 5.8 6.5 6.2 150.2 65.4 13.4 8.4 11.7 11.3 2.4 CKAP2L "FLJ40629, radmis" ENSG00000169607 "Cytoskeleton associated protein 2 like" Q8IYA6 2 112736607-112764677 "Disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.4;lymphoid tissue: 38.3" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 8.9;Spermatocytes: 31.7;Spermatogonia: 32.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA039407, HPA040057, HPA070737" Uncertain Supported "Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" Cytosol "HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303" "unprognostic (2.29e-1)" "unprognostic (1.54e-1)" "unprognostic (4.69e-3)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.59e-2)" "unprognostic (5.75e-5)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (9.57e-6)" "unprognostic (2.42e-1)" "unprognostic (0.00e+0)" "unprognostic (7.37e-2)" "unprognostic (1.24e-1)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" 1.5 0.7 0.6 9.2 0.6 13.4 1.3 0.7 0.6 0.6 1.8 0.0 0.3 1.5 0.5 1.4 3.8 0.7 0.1 2.3 0.6 0.5 0.7 0.7 1.2 5.3 0.6 0.2 0.6 0.6 0.0 0.5 3.2 0.2 0.6 2.4 0.0 1.0 0.0 0.6 1.5 2.4 0.9 0.6 2.2 0.9 9.0 0.1 38.3 0.6 5.9 6.0 0.9 0.7 1.0 0.8 1.8 0.7 1.6 1.8 0.4 20.1 4.0 15.9 7.2 0.9 1.5 3.2 16.7 13.9 17.4 16.6 3.8 5.9 13.8 6.9 6.5 21.7 7.8 9.1 8.8 29.3 19.2 4.0 23.0 5.6 3.2 0.0 10.8 13.8 0.4 0.8 21.8 12.4 4.5 7.9 10.1 6.1 20.2 14.1 2.9 13.1 4.1 6.8 8.6 13.2 9.5 16.7 3.6 2.9 7.9 8.8 5.5 6.8 5.6 5.8 6.2 5.5 5.0 5.6 19.3 15.0 15.3 12.2 4.3 8.4 11.8 8.3 7.8 30.2 0.8 0.5 0.7 0.5 0.7 0.4 0.9 1.2 1.1 0.5 1.0 0.5 0.7 1.8 1.6 0.7 0.8 1.8 0.4 0.6 0.6 0.7 0.6 0.6 0.5 0.6 0.2 0.2 0.1 3.0 1.1 0.8 1.6 3.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 8.9 0.4 0.3 0.0 0.0 5.4 0.0 0.0 1.8 2.1 0.8 0.0 1.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 31.7 32.2 1.5 0.8 1.5 1.0 0.9 CKB CKBB ENSG00000166165 "Creatine kinase B" P12277 14 103519659-103523111 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 158.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 2313.9;Horizontal cells: 4762.4;Muller glia cells: 3352.8;Rod photoreceptor cells: 2841.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "non-classical monocyte: 50.0" "Lineage enriched" "Detected in many" 17 "monocytes: 50.0" "Cell line enhanced" "Detected in many" "CACO-2: 54.3;HEK 293: 138.1;SCLC-21H: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001254, CAB047313" Enhanced Supported Cytosol No No 50000000 Cytosol "CAB047313: , HPA001254: AB_1078528" "unprognostic (9.97e-2)" "unprognostic (1.33e-3)" "unprognostic (4.25e-3)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (3.62e-2)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (4.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.68e-3)" "unprognostic (9.89e-3)" "prognostic favorable (4.02e-8)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-2)" "unprognostic (2.13e-1)" 32.4 27.3 75.4 10.4 114.6 3.1 5.3 94.3 158.5 29.1 121.5 51.4 23.8 17.6 37.3 8.9 28.6 35.7 17.8 36.4 60.7 43.2 26.7 3.4 12.8 3.6 63.4 93.3 15.8 10.2 20.3 9.7 3.7 63.3 107.5 55.0 43.9 18.3 92.1 19.1 14.4 17.5 53.2 31.9 3.6 66.7 22.1 50.9 0.0 19.8 7.8 3.9 43.0 13.0 0.0 2.9 1.4 50.0 0.0 0.1 0.9 0.3 6.8 27.5 1.4 0.2 0.2 0.5 2.9 0.0 0.3 0.1 54.3 0.8 0.0 3.3 2.1 1.1 6.0 7.9 0.1 0.0 1.2 138.1 10.2 30.3 18.6 1.2 0.0 8.4 1.1 0.0 0.2 0.1 0.4 0.0 0.6 17.8 0.4 0.4 2.3 0.2 0.3 10.7 4.6 21.4 1.8 0.5 28.2 5.0 0.2 78.6 32.3 5.8 1.0 2.1 2.0 2.5 4.2 0.1 0.1 5.3 0.5 12.9 1.3 0.3 0.9 0.7 0.2 1.0 0.3 0.1 1.4 0.0 5.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.1 0.0 50.0 0.0 0.1 0.9 75.4 114.6 94.3 152.7 60.7 43.2 63.4 93.3 63.3 50.9 181.7 96.3 15.9 251.5 136.6 2313.9 490.2 117.2 301.2 83.0 108.2 1798.5 3.2 1933.1 99.3 397.5 36.5 717.3 0.0 37.5 9.9 100.2 316.9 28.8 6.8 6.9 4762.4 449.5 67.5 3.0 120.4 281.6 32.2 172.1 122.6 614.3 3352.8 99.2 2059.7 1024.0 69.5 2841.9 58.2 193.9 161.4 92.5 153.2 34.8 12.1 562.9 194.5 CKLF "C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1" ENSG00000217555 "Chemokine like factor" Q9UBR5 16 66552563-66566251 "Predicted membrane proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 142.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA062779 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA062779: AB_2684867" "unprognostic (1.64e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (4.97e-2)" "unprognostic (3.06e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.79e-2)" "unprognostic (8.05e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.06e-9)" "unprognostic (2.36e-1)" "unprognostic (2.65e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.07e-1)" 18.8 21.1 16.1 27.7 16.9 29.9 18.8 19.0 14.9 14.8 20.6 11.0 9.1 15.7 14.8 15.2 12.5 16.4 22.8 11.0 14.9 13.4 15.0 14.6 28.9 41.2 23.1 11.0 14.5 12.0 11.4 13.5 14.6 15.0 14.6 22.0 10.9 13.0 9.7 6.8 9.0 26.5 16.9 20.8 44.4 12.2 42.5 18.6 40.2 12.3 11.7 24.6 17.6 13.0 9.4 32.2 142.0 39.6 17.7 25.6 34.2 35.7 31.9 6.7 19.3 18.1 14.8 4.9 17.9 13.6 19.6 29.3 29.7 43.9 14.1 22.7 15.3 20.5 19.3 13.3 10.7 27.6 17.4 6.7 10.3 28.4 36.3 10.9 32.0 27.8 10.1 8.7 24.4 8.7 23.5 23.3 43.6 16.4 40.7 24.4 11.9 30.9 31.8 2.2 21.1 51.8 53.1 35.4 39.2 65.4 19.9 9.4 11.4 54.8 3.6 16.6 4.7 10.6 21.7 14.2 28.4 25.7 9.8 21.0 19.3 39.7 71.8 23.9 28.2 22.9 64.6 39.6 74.8 20.6 19.8 25.6 9.4 19.2 20.0 32.2 8.8 10.2 14.1 142.0 17.7 18.6 16.3 22.9 34.2 16.1 16.9 19.0 14.9 14.9 13.4 23.1 11.0 15.0 18.6 17.9 66.2 46.2 20.8 24.3 8.2 0.8 101.9 65.6 35.2 54.1 0.0 40.5 14.9 120.7 24.7 44.8 58.0 23.3 113.2 92.3 41.3 13.1 334.0 34.2 227.1 1.6 31.7 66.9 154.7 20.5 45.8 289.2 38.8 30.7 61.5 19.0 153.7 40.3 28.3 75.1 6.4 32.3 33.5 349.8 69.4 20.1 14.5 215.8 65.0 23.3 CKM CKMM ENSG00000104879 "Creatine kinase, M-type" P06732 19 45306414-45322977 "Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 1374.7;tongue: 354.9" "Cell type enriched" "Detected in some" 137 "Cardiomyocytes: 5083.5" "Group enriched" "Detected in many" 33 "head and neck cancer: 64.4;prostate cancer: 14.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 2.8;intermediate monocyte: 1.1;myeloid DC: 2.1" "Group enriched" "Detected in many" 25 "dendritic cells: 2.1;monocytes: 2.8" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047859 Enhanced NA NA 190000000 "HPA047859: AB_2680186" "unprognostic (3.51e-1)" "unprognostic (7.63e-2)" "unprognostic (2.61e-2)" "unprognostic (4.14e-1)" "unprognostic (7.68e-3)" "unprognostic (4.04e-3)" "unprognostic (1.85e-2)" "unprognostic (4.23e-2)" "unprognostic (5.19e-2)" "unprognostic (1.81e-1)" "unprognostic (5.00e-1)" "unprognostic (9.46e-3)" "unprognostic (9.67e-8)" "unprognostic (3.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.33e-1)" "unprognostic (1.95e-1)" 13.9 0.1 0.2 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 23.5 21.1 0.1 0.1 187.9 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 2.8 0.1 0.8 17.6 0.2 1374.7 0.2 0.2 0.2 0.3 0.1 0.5 0.3 0.0 0.0 11.1 354.9 24.8 0.2 0.1 0.0 2.1 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 3.0 0.0 0.1 8.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 3.3 0.1 0.1 0.0 0.0 37.6 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5083.5 0.0 0.0 0.0 0.0 0.0 0.3 10.0 0.0 12.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.0 5.5 0.0 0.0 0.6 1.9 37.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 15.2 1.8 0.1 0.2 0.0 0.0 0.1 CKMT1A CKMT1 ENSG00000223572 "Creatine kinase, mitochondrial 1A" P12532 15 43692886-43699222 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.2;esophagus: 19.9;intestine: 25.5" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 64.4;Enterocytes: 82.9;Paneth cells: 55.7;Syncytiotrophoblasts: 78.6;Undifferentiated cells: 74.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 39.8;hTCEpi: 18.1;OE19: 43.7;SK-BR-3: 31.3;T-47d: 27.9" HPA043491 Uncertain "Intracellular and membrane" NA NA 2100000 "HPA043491: AB_2678510" "unprognostic (2.04e-2)" "unprognostic (2.53e-2)" "unprognostic (1.17e-1)" "unprognostic (4.02e-3)" "unprognostic (3.80e-1)" "unprognostic (7.44e-2)" "unprognostic (2.21e-1)" "unprognostic (3.10e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.51e-2)" "unprognostic (3.78e-9)" "unprognostic (3.52e-2)" "unprognostic (1.03e-1)" "unprognostic (7.37e-2)" "unprognostic (1.73e-3)" 0.0 0.7 4.8 1.9 6.3 0.0 2.1 17.2 12.6 1.8 25.5 24.7 0.0 0.0 19.9 0.4 3.0 0.0 5.6 7.9 0.9 0.0 0.0 0.0 5.0 0.0 0.1 2.1 1.4 2.5 0.5 24.1 7.2 0.0 0.0 13.0 21.7 0.9 1.1 0.0 7.8 0.0 0.6 4.4 1.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.3 0.0 9.9 0.0 0.0 0.0 0.0 2.1 6.9 0.0 0.4 0.0 0.6 39.8 5.7 11.7 0.0 0.0 4.3 0.0 0.6 0.1 0.0 0.0 1.8 0.0 18.1 0.0 3.1 0.0 0.0 1.4 1.7 0.0 0.0 9.2 0.0 0.0 2.8 43.7 2.1 0.0 0.0 1.8 1.9 1.4 14.1 5.5 0.0 31.3 2.0 0.8 27.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 15.8 5.9 0.4 12.7 1.4 5.7 1.8 19.6 64.4 23.2 3.4 0.0 0.1 82.9 0.0 18.3 17.8 0.6 2.2 9.2 0.0 4.0 6.4 17.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 34.6 1.5 9.9 55.7 0.0 0.3 8.7 0.0 0.3 0.0 0.0 16.2 78.6 0.0 74.1 11.5 CKMT1B "CKMT, CKMT1, UMTCK" ENSG00000237289 "Creatine kinase, mitochondrial 1B" P12532 15 43593054-43604901 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.7;intestine: 28.1" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 111.7;Enterocytes: 108.3;Paneth cells: 69.6;Syncytiotrophoblasts: 115.3;Undifferentiated cells: 90.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 38.6;hTCEpi: 19.9;OE19: 42.8;SK-BR-3: 47.5;T-47d: 27.7" HPA043491 Uncertain "Intracellular and membrane" NA NA 2100000 "HPA043491: AB_2678510" "unprognostic (3.47e-2)" "unprognostic (9.73e-3)" "unprognostic (3.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.29e-1)" "unprognostic (1.96e-1)" "unprognostic (5.19e-2)" "unprognostic (2.84e-1)" "unprognostic (3.64e-1)" "unprognostic (5.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (2.26e-8)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.43e-2)" "unprognostic (4.36e-2)" 0.0 0.3 5.4 1.6 8.8 0.0 1.6 52.7 13.6 0.7 28.1 22.4 0.0 0.0 13.8 0.2 2.8 0.0 6.8 7.4 0.9 0.0 0.0 0.0 5.4 0.0 0.2 1.4 1.3 3.7 0.6 23.1 4.8 0.0 0.0 7.6 16.2 1.2 1.8 0.0 10.0 0.0 1.7 4.1 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 9.4 0.0 0.0 0.0 0.0 2.2 6.6 0.0 0.3 0.0 1.9 38.6 7.7 14.8 0.0 0.1 4.5 0.0 0.9 0.9 0.0 0.0 2.2 0.0 19.9 0.0 1.7 0.0 0.0 1.5 2.5 0.0 0.0 9.4 0.0 0.0 3.1 42.8 4.1 0.0 0.0 0.2 0.7 1.0 14.9 5.3 0.2 47.5 2.8 0.6 27.7 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 22.2 7.6 0.3 7.6 4.0 1.2 5.2 17.7 111.7 18.3 3.4 0.0 0.1 108.3 0.0 25.5 16.9 0.5 1.7 0.0 0.0 8.1 6.4 20.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 49.2 2.3 12.5 69.6 0.0 0.5 7.5 0.0 0.2 0.0 0.0 21.7 115.3 0.0 90.6 15.9 CKMT2 SMTCK ENSG00000131730 "Creatine kinase, mitochondrial 2" P17540 5 81233285-81266397 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6" "Cell type enriched" "Detected in some" 25 "Cardiomyocytes: 792.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "NK-cell: 3.8" "Lineage enriched" "Detected in single" 9 "NK-cells: 3.8" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;BEWO: 6.0;Hep G2: 5.2;HHSteC: 4.0;T-47d: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051880 Enhanced NA NA 3200000 "HPA051880: AB_2681650" "unprognostic (3.64e-3)" "unprognostic (1.15e-1)" "unprognostic (2.82e-3)" "unprognostic (1.88e-2)" "unprognostic (1.21e-2)" "unprognostic (2.41e-2)" "unprognostic (1.73e-2)" "unprognostic (3.57e-2)" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (5.34e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (2.75e-3)" 2.5 5.0 1.3 0.3 1.9 0.2 0.8 0.4 1.2 1.2 0.5 1.2 2.5 0.3 1.3 11.5 3.0 1.2 1.5 153.2 1.5 0.9 2.7 0.3 0.4 0.3 2.3 1.4 1.6 1.3 1.1 0.7 0.3 4.1 2.0 0.3 2.5 9.1 2.1 182.4 0.5 0.6 1.4 2.8 0.4 2.1 0.9 1.5 0.0 3.3 103.6 2.9 1.0 0.6 0.4 0.1 0.0 0.4 3.8 0.3 0.0 0.1 0.9 0.0 0.9 3.7 0.8 6.0 0.1 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.0 0.9 0.1 0.0 0.0 0.0 0.5 3.2 0.0 0.7 5.2 4.0 0.5 0.2 1.4 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.6 0.0 0.7 0.2 0.1 0.8 0.0 0.4 0.8 0.9 0.0 0.0 0.1 0.7 0.7 0.5 0.4 0.9 2.3 9.7 0.4 0.8 0.5 0.9 0.5 0.3 0.1 0.1 0.8 0.4 0.5 0.9 0.0 0.2 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.4 0.1 0.2 0.0 3.8 0.0 0.1 0.2 0.0 1.3 1.9 0.4 1.2 1.5 0.9 2.3 1.4 4.1 1.5 0.0 0.3 0.0 0.4 0.1 0.7 792.8 7.6 1.4 1.2 12.2 0.0 0.1 31.5 1.6 16.2 5.3 0.0 0.0 0.5 0.4 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 6.6 0.0 3.3 0.0 0.0 1.3 0.2 0.0 14.2 0.6 0.9 0.0 5.9 0.2 0.4 0.1 0.2 0.0 0.2 0.1 CKS2 ENSG00000123975 "CDC28 protein kinase regulatory subunit 2" P33552 9 89311198-89316703 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.6;testis: 103.2" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 581.2;Spermatogonia: 464.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 54.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003424, HPA030762" Approved Approved Nucleoplasm,Vesicles,Mitochondria,Cytosol NA Yes "Mitochondria, Cytosol" "Nucleoplasm, Vesicles" "HPA003424: AB_2666948, HPA030762: AB_10670044" "unprognostic (8.30e-2)" "unprognostic (3.00e-1)" "unprognostic (1.50e-2)" "unprognostic (2.80e-2)" "unprognostic (2.96e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (3.57e-3)" "unprognostic (7.04e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (2.13e-3)" "unprognostic (1.44e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" 4.8 22.4 4.2 22.7 6.1 38.1 10.7 4.0 7.5 3.6 10.8 3.0 16.7 10.8 4.6 4.4 20.4 2.8 4.7 3.3 6.1 3.2 11.0 10.2 9.5 24.6 5.2 4.3 3.9 2.6 7.0 2.2 12.4 5.0 4.8 10.7 3.2 4.4 7.6 3.6 6.1 9.3 4.1 5.4 12.6 6.8 103.2 3.6 41.6 4.6 13.5 20.8 8.1 16.7 18.3 54.6 12.4 7.5 11.6 17.9 6.5 84.0 72.1 44.1 29.5 13.0 11.9 32.2 50.1 27.0 55.5 44.5 29.6 41.8 63.0 29.7 18.7 98.8 59.2 52.9 38.6 63.9 49.1 42.8 31.9 52.8 78.5 5.6 65.0 36.4 4.3 8.9 39.7 35.1 21.2 51.3 51.9 38.0 55.2 71.1 63.1 51.0 114.6 64.4 99.0 66.6 44.2 48.5 37.6 43.5 19.3 37.4 22.3 41.6 40.4 40.4 43.2 48.6 37.8 29.1 24.0 45.6 58.0 72.8 44.8 90.7 50.8 35.4 37.7 34.1 10.5 5.9 12.4 7.0 7.5 7.9 18.3 9.6 6.7 6.5 13.5 5.2 6.8 4.2 11.6 4.1 54.6 17.9 6.5 4.2 6.1 4.0 7.5 6.1 3.2 5.2 4.3 5.0 3.6 35.7 93.0 97.3 70.9 248.9 4.2 55.0 5.1 12.0 17.0 14.0 0.0 149.0 19.9 15.2 25.4 26.7 39.1 350.4 9.7 329.6 72.5 59.4 147.1 19.5 152.7 0.0 117.0 28.3 40.0 59.4 23.9 84.8 133.3 33.3 56.8 24.6 23.3 46.9 15.6 148.6 6.0 45.3 99.9 581.2 464.7 261.3 166.8 40.1 104.9 59.3 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 95.1;Cone photoreceptor cells: 147.3;Horizontal cells: 87.4;Rod photoreceptor cells: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA067071: AB_2685775" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favorable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 7.9 14.5 20.6 6.5 31.6 6.0 9.0 45.4 67.1 13.0 8.9 50.7 3.4 5.6 11.7 6.7 10.2 9.4 10.0 22.0 19.1 16.8 10.4 6.1 8.6 7.9 33.4 22.1 16.1 6.5 11.6 16.1 8.7 44.7 9.8 7.7 13.4 6.5 12.4 31.7 7.3 6.7 11.2 29.7 7.7 6.8 6.5 37.3 4.1 8.1 4.9 8.6 8.0 7.5 8.4 8.7 4.7 8.4 12.3 7.2 5.6 7.2 16.2 18.5 15.6 12.1 11.9 13.4 13.7 13.0 16.2 17.5 9.4 7.6 24.1 8.0 10.7 10.4 6.4 24.0 10.9 19.7 19.4 17.0 23.7 14.3 8.3 5.8 23.3 20.3 7.3 10.9 17.4 16.7 9.4 15.6 15.0 23.1 13.8 17.4 4.0 17.2 10.0 13.8 7.3 10.3 18.6 17.5 13.1 10.3 8.3 15.6 26.4 15.9 12.4 13.7 15.7 11.7 20.8 14.9 12.7 11.1 9.5 15.1 9.8 18.3 20.0 11.5 16.2 16.1 4.7 5.9 3.3 4.8 6.3 7.2 8.4 4.2 4.5 8.7 5.6 5.7 5.2 1.2 12.3 8.4 8.3 4.5 5.6 20.6 31.6 45.4 38.7 19.1 16.8 33.4 22.1 44.7 37.3 6.0 9.4 14.3 7.0 18.7 95.1 34.3 17.8 9.4 12.5 14.0 147.3 10.5 1.7 5.7 2.3 12.1 7.3 0.0 5.9 6.5 12.4 12.6 11.5 12.2 13.1 87.4 13.8 14.7 32.0 2.6 13.3 16.7 15.1 9.0 10.0 36.3 7.3 7.0 12.7 9.9 124.9 6.5 18.9 10.8 13.8 26.8 10.8 17.0 10.1 7.8 CLC "Gal-10, LGALS10, MGC149659" ENSG00000105205 "Charcot-Leyden crystal galectin" Q05315 19 39731250-39738028 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 489.7" "Cell type enhanced" "Detected in single" 29 "Late spermatids: 1.9" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 256 "basophil: 489.7;eosinophil: 448.3" "Lineage enriched" "Detected in single" 1987 "granulocytes: 489.7" "Cell line enriched" "Detected in some" 13 "HMC-1: 418.2" HPA041751 Enhanced NA NA 240000 "HPA041751: AB_10793973" "unprognostic (4.53e-2)" "unprognostic (3.04e-2)" "unprognostic (4.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-1)" "unprognostic (1.34e-2)" "unprognostic (6.60e-2)" "unprognostic (2.21e-1)" "unprognostic (4.28e-2)" "unprognostic (5.74e-2)" "unprognostic (1.24e-1)" 1.0 0.3 1.1 5.0 0.7 80.4 0.3 0.3 1.3 0.7 1.6 1.9 0.3 4.8 0.3 1.3 0.3 0.2 2.9 0.6 0.3 2.3 0.3 1.2 6.3 0.3 0.4 1.2 0.3 0.7 0.0 0.6 1.5 0.7 0.3 1.2 0.3 2.6 0.3 1.5 0.2 8.1 4.4 0.4 13.8 2.8 0.6 0.3 6.4 0.4 0.3 0.3 9.2 0.3 0.1 0.1 489.7 0.2 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 418.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 489.7 0.1 448.3 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 1.8 0.0 0.2 0.1 0.0 1.6 1.1 0.7 0.3 1.3 0.3 2.3 0.4 1.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 CLCA1 "CaCC, CLCRG1" ENSG00000016490 "Chloride channel accessory 1" A8K7I4 1 86468368-86500289 "Predicted secreted proteins, Transporters" "Calcium transport, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 242.9" "Cell type enriched" "Detected in some" 56 "Mucus-secreting cells: 1736.8" "Group enriched" "Detected in some" 9 "colorectal cancer: 86.8;pancreatic cancer: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.6;K-562: 1.7;NB-4: 5.3;RPMI-8226: 5.7;SH-SY5Y: 4.1;U-2197: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052787, HPA059301" Enhanced "Secreted to digestive system" NA NA 70000 "HPA052787: AB_2681947, HPA059301: AB_2683971" "prognostic favorable (2.98e-4)" "unprognostic (3.42e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-1)" 0.2 0.2 0.2 41.7 0.2 0.0 0.2 0.2 0.2 0.2 100.0 0.1 0.1 80.7 0.2 0.1 0.2 0.3 4.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.2 98.0 0.2 0.2 0.1 0.2 0.2 242.9 1.1 0.2 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1736.8 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.9 0.0 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "hTCEpi: 68.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: AB_2679977" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 12.6 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 68.6 0.3 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 6.0 42.1 0.0 0.3 0.0 10.7 22.7 0.0 0.0 0.2 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 47.9 0.1 0.0 0.0 35.8 CLCA4 CaCC2 ENSG00000016602 "Chloride channel accessory 4" Q14CN2 1 86547078-86580754 "Predicted membrane proteins" Transport "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 182.1;intestine: 64.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 115.2" "Cancer enhanced" "Detected in many" "cervical cancer: 21.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 988 "RT4: 98.7" "HPA017045, HPA064770" Uncertain Approved "Nucleoplasm,Plasma membrane,Aggresome" "Intracellular and membrane" NA NA 210000 "Plasma membrane" "Nucleoplasm, Aggresome" "HPA017045: AB_2291679, HPA064770: " "unprognostic (1.38e-4)" "unprognostic (1.52e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.73e-2)" "unprognostic (7.03e-2)" "prognostic favorable (8.63e-4)" "unprognostic (7.59e-2)" "unprognostic (3.35e-1)" "unprognostic (1.26e-1)" "unprognostic (6.01e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-2)" "unprognostic (2.29e-1)" "unprognostic (5.69e-2)" "unprognostic (3.43e-2)" 0.2 0.1 2.2 8.8 3.0 0.1 0.6 0.0 2.0 12.3 64.2 2.0 0.0 0.1 0.3 0.1 182.1 0.1 0.1 0.1 2.2 0.6 0.1 0.1 0.1 0.1 3.2 1.6 0.1 0.0 0.1 0.0 0.1 3.0 1.8 38.4 0.0 5.9 0.1 0.1 4.5 6.1 0.8 2.4 0.1 0.1 0.1 5.0 0.0 0.1 8.6 21.5 9.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 2.0 2.2 0.6 3.2 1.6 3.0 5.0 0.0 0.0 0.0 13.3 3.0 0.0 0.2 0.0 2.7 5.7 1.8 0.0 0.0 0.0 0.0 0.3 0.0 18.6 0.0 0.0 0.0 0.0 3.9 9.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 4.1 115.2 CLCN1 "ClC-1, CLC1" ENSG00000188037 "Chloride voltage-gated channel 1" P35523 7 143316126-143352083 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "skeletal muscle: 38.9;tongue: 21.1" "Group enriched" "Detected in some" 13 "Early spermatids: 20.5;Late spermatids: 67.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 2.4;intermediate monocyte: 2.6;myeloid DC: 1.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;monocytes: 3.8" "Cell line enhanced" "Detected in some" "CACO-2: 1.5;HSkMC: 5.5;NTERA-2: 1.2;PC-3: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.16e-2)" "unprognostic (4.99e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" "unprognostic (9.53e-2)" "unprognostic (8.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.56e-4)" "unprognostic (8.71e-3)" "unprognostic (2.35e-1)" "unprognostic (2.90e-3)" "unprognostic (3.12e-1)" "unprognostic (2.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.47e-1)" "unprognostic (3.55e-3)" "unprognostic (3.57e-2)" 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 38.9 0.0 0.8 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.7 21.1 0.9 0.1 0.0 0.0 1.8 0.5 3.8 0.0 0.2 0.9 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 2.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 3.8 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 2.1 CLCN2 "ClC-2, CLC2, EJM6" ENSG00000114859 "Chloride voltage-gated channel 2" P51788 3 184346185-184361651 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 21.0;intestine: 20.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 10.2;Enterocytes: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009397, HPA014545, HPA024108" Approved Approved Cytosol NA NA Cytosol "CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883" "unprognostic (1.13e-1)" "unprognostic (4.01e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (4.67e-8)" "unprognostic (1.72e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.19e-1)" "unprognostic (4.40e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (1.35e-1)" 1.6 5.4 4.9 2.6 8.3 1.3 1.6 8.8 6.3 2.8 20.2 16.9 5.1 11.6 4.5 5.0 1.7 2.8 21.0 1.5 6.3 3.1 3.7 1.8 1.3 1.0 15.3 4.1 6.1 5.9 4.4 4.0 1.5 8.9 2.6 14.0 15.6 3.7 9.0 1.2 2.2 11.8 2.4 10.8 1.6 2.7 11.9 9.8 0.1 3.2 1.3 1.3 2.2 2.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 8.0 2.8 2.3 6.2 2.1 1.8 5.4 2.9 1.6 2.9 1.8 15.1 2.7 2.8 8.0 1.4 7.5 14.0 3.3 3.1 0.9 2.5 4.0 2.5 5.8 6.4 1.3 1.0 2.5 3.4 2.5 2.5 2.9 1.3 2.7 3.0 1.0 1.4 1.0 4.4 0.8 1.3 3.5 6.7 4.4 5.0 2.2 9.6 3.5 6.1 3.9 2.3 3.0 10.5 4.7 1.6 8.5 1.1 1.3 1.5 4.4 7.1 7.0 3.8 4.8 1.7 2.6 4.8 6.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 8.3 8.8 6.3 6.3 3.1 15.3 4.1 8.9 9.8 3.0 2.6 0.0 0.7 0.9 2.2 1.1 10.2 4.0 1.2 0.0 0.0 0.9 0.0 3.5 2.4 0.5 30.8 0.0 1.8 0.4 1.0 0.6 1.1 0.4 0.5 1.6 2.9 1.8 0.0 1.3 4.9 0.4 0.0 1.0 3.6 1.8 1.8 7.8 4.6 2.2 2.6 0.0 0.8 3.3 1.6 0.4 1.3 0.0 6.5 0.3 CLCN4 "ClC-4, CLC4" ENSG00000073464 "Chloride voltage-gated channel 4" P51793 X 10156945-10237660 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 75.3;Cone photoreceptor cells: 96.2;Horizontal cells: 49.3;Rod photoreceptor cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4" "Group enriched" "Detected in many" 9 "B-cells: 6.8;granulocytes: 4.4" "Cell line enhanced" "Detected in many" "GAMG: 17.5;HEL: 16.2;SCLC-21H: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031313, HPA063637" Enhanced Approved Approved Vesicles NA NA Vesicles "HPA031313: AB_10601358, HPA063637: AB_2685069" "unprognostic (1.01e-1)" "unprognostic (1.20e-2)" "unprognostic (5.07e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (2.96e-1)" "unprognostic (3.75e-1)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (1.75e-1)" "unprognostic (5.99e-2)" "prognostic favorable (9.55e-4)" "unprognostic (9.70e-2)" "unprognostic (9.78e-3)" "unprognostic (1.68e-1)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" 3.1 3.4 9.7 2.0 21.3 2.1 1.6 18.6 29.1 2.0 1.4 15.7 0.0 1.2 1.3 22.8 2.3 3.0 2.8 11.4 13.0 10.5 3.4 3.5 3.4 2.9 23.5 10.4 2.2 2.4 8.9 3.9 1.7 18.2 2.1 1.1 6.0 2.3 1.7 34.6 1.2 1.2 1.4 15.2 3.2 2.1 2.2 17.9 0.0 6.8 2.0 2.2 2.3 0.8 6.8 0.6 4.4 0.5 0.0 0.0 0.6 4.8 3.0 2.2 0.0 1.1 2.0 0.0 0.1 0.0 0.0 0.0 5.9 3.3 3.6 8.7 0.9 17.5 1.0 1.4 3.2 0.1 0.0 3.4 16.2 1.6 2.4 5.4 0.0 0.0 9.7 2.6 4.2 1.0 3.4 6.2 0.0 1.2 0.0 2.2 0.5 0.0 0.1 2.8 5.2 10.5 0.0 3.6 0.0 1.5 0.5 16.8 6.3 6.9 0.7 0.0 2.0 1.8 2.0 6.1 2.6 4.4 11.4 0.4 0.4 8.1 1.3 8.3 0.0 3.3 2.3 0.5 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.6 6.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.6 9.7 21.3 18.6 26.7 13.0 10.5 23.5 10.4 18.2 17.9 8.9 1.9 3.7 0.7 0.5 75.3 26.7 12.7 5.3 1.2 7.0 96.2 0.1 0.0 2.2 0.0 1.4 0.0 0.0 3.1 0.2 1.0 0.7 1.1 4.2 2.5 49.3 14.5 17.2 4.7 0.0 0.9 0.5 0.0 0.0 0.0 12.8 2.9 0.0 3.5 2.6 37.1 0.0 0.8 0.0 0.2 0.1 0.2 0.0 0.0 0.8 CLCN5 "ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN" ENSG00000171365 "Chloride voltage-gated channel 5" P51795 X 49922615-50099235 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.1" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 8 "dendritic cells: 6.6;monocytes: 1.8" "Cell line enhanced" "Detected in many" "CACO-2: 25.4;RH-30: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000401, HPA003213" Uncertain Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane" Cytosol "HPA000401: AB_1078531, HPA003213: AB_2666843" "unprognostic (3.33e-2)" "unprognostic (6.15e-2)" "unprognostic (3.13e-1)" "unprognostic (1.57e-1)" "unprognostic (7.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.54e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-1)" "unprognostic (5.21e-2)" "prognostic favorable (5.20e-4)" "unprognostic (3.59e-2)" "prognostic favorable (2.05e-8)" "unprognostic (7.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" 4.4 4.1 2.5 2.4 2.9 2.1 3.4 9.4 3.4 2.3 3.1 2.6 4.7 5.0 9.8 26.7 3.7 4.6 7.6 2.2 3.1 2.8 46.1 15.8 4.7 3.0 2.6 2.5 10.8 6.7 2.6 8.3 7.3 5.9 2.7 3.7 7.6 4.0 3.5 5.6 6.2 6.4 3.8 4.3 3.0 4.0 5.9 2.3 1.2 3.6 4.0 2.3 2.4 3.1 0.2 6.6 0.5 1.8 0.3 0.4 0.5 1.8 2.8 2.2 3.3 8.4 5.3 4.7 1.5 0.8 1.0 1.2 25.4 1.7 1.8 0.8 1.7 5.6 1.5 6.8 0.8 1.6 0.7 4.6 1.8 1.4 6.6 4.0 2.3 3.4 3.1 1.1 2.6 3.8 0.8 3.6 2.4 2.7 2.7 2.9 1.8 0.8 0.7 3.2 4.2 1.4 1.1 39.3 2.8 3.8 2.9 3.8 2.7 2.2 2.2 3.1 8.7 1.9 1.1 1.8 1.0 2.1 7.8 0.9 2.3 6.9 4.1 1.7 3.8 5.1 0.1 1.8 0.0 0.2 1.5 0.3 0.2 0.4 0.4 3.8 0.2 0.1 0.1 0.5 0.3 0.3 6.6 0.0 0.5 2.5 2.9 9.4 3.4 3.1 2.8 2.6 2.5 5.9 2.3 8.9 5.9 1.5 1.6 6.4 19.5 1.6 5.1 5.3 0.0 12.2 2.0 5.2 10.0 3.7 1.1 3.8 10.9 0.0 2.9 2.2 5.7 3.1 2.3 21.7 8.9 7.9 0.0 0.6 9.5 0.0 4.9 8.9 3.3 5.4 5.7 2.8 5.8 6.2 12.4 32.4 4.3 0.0 3.3 1.0 0.7 8.3 4.2 0.0 6.4 4.6 CLCNKA hClC-Ka ENSG00000186510 "Chloride voltage-gated channel Ka" P51800 1 16018875-16034050 "Disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 46.9;parathyroid gland: 15.4" "Cell type enriched" "Detected in some" 4 "Late spermatids: 171.7" "Group enriched" "Detected in some" 7 "renal cancer: 4.4;thyroid cancer: 1.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 13.0" HPA057717 Approved NA NA "HPA057717: AB_2683509" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (4.02e-1)" "unprognostic (2.76e-3)" "unprognostic (8.20e-2)" "unprognostic (6.16e-2)" "unprognostic (1.18e-2)" "unprognostic (6.92e-3)" "unprognostic (3.49e-2)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (8.13e-3)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (4.37e-3)" "unprognostic (1.28e-1)" 0.2 0.7 0.2 0.2 0.2 0.0 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 46.9 0.2 0.2 0.2 0.2 0.2 0.2 1.2 15.4 5.8 0.2 0.2 0.2 0.0 0.2 4.4 0.2 0.2 0.0 0.2 0.2 0.2 0.2 1.6 1.1 0.2 0.2 6.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.4 3.1 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.2 0.5 0.0 0.0 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.3 0.0 0.0 0.1 0.6 3.5 0.0 0.0 1.2 24.4 0.0 0.4 21.6 0.1 38.8 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.1 12.7 1.2 0.0 0.0 171.7 0.3 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.7 0.7 0.0 0.6 0.0 0.0 0.1 CLCNKB hClC-Kb ENSG00000184908 "Chloride voltage-gated channel Kb" P51801 1 16043736-16057308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 58.4;salivary gland: 25.7" "Group enriched" "Detected in some" 10 "Collecting duct cells: 22.7;Distal tubular cells: 49.7;Early spermatids: 20.7;Late spermatids: 76.4" "Cancer enriched" "Detected in some" 9 "renal cancer: 24.9" "Region enriched" "Detected in single" 7 "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;CAPAN-2: 2.2;EFO-21: 5.1;HeLa: 3.1;K-562: 2.0;SuSa: 2.1" HPA057717 Approved NA NA "HPA057717: AB_2683509" "unprognostic (9.05e-4)" "unprognostic (1.72e-1)" "unprognostic (2.41e-2)" "unprognostic (2.68e-3)" "unprognostic (1.44e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-4)" "unprognostic (1.87e-1)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (4.57e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.27e-7)" "unprognostic (2.04e-2)" "unprognostic (4.62e-1)" "unprognostic (1.78e-2)" "unprognostic (5.14e-2)" 0.1 0.5 0.2 0.1 0.2 0.0 0.1 2.8 0.2 0.7 0.1 0.1 2.2 0.0 0.5 0.5 0.1 0.1 0.4 1.2 0.1 0.1 58.4 0.1 0.3 0.1 0.1 0.1 0.5 0.4 0.9 0.8 0.4 0.3 0.5 0.0 1.2 25.7 0.7 0.1 0.0 0.2 0.3 0.5 0.1 0.1 0.7 0.1 0.1 11.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 2.2 0.0 5.1 0.7 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 3.1 0.1 0.6 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.2 2.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.1 2.1 0.4 0.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.8 0.2 0.1 0.1 0.1 0.1 0.3 0.1 3.0 1.1 0.0 0.0 0.0 0.5 4.3 0.0 1.4 2.3 22.7 0.0 0.3 49.7 0.5 20.7 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 76.4 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.1 0.2 0.0 0.0 0.1 1.4 0.6 0.0 0.5 0.0 0.6 0.0 CLDN1 "ILVASC, SEMP1" ENSG00000163347 "Claudin 1" O95832 3 190305701-190322475 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 134.3;skin 1: 73.9" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 390.9;Suprabasal keratinocytes: 730.8;Urothelial cells: 538.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "EFO-21: 107.5;HaCaT: 37.6;hTCEpi: 46.9;RPTEC TERT1: 67.3;RT4: 42.1" "Low region specificity" "Detected in many" "CAB002602, HPA048319" Enhanced NA NA "CAB002602: , HPA048319: AB_2680355" "unprognostic (5.89e-2)" "unprognostic (4.58e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (7.92e-3)" "unprognostic (2.43e-1)" "unprognostic (3.54e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (3.06e-1)" "unprognostic (1.13e-1)" "unprognostic (4.43e-2)" "unprognostic (9.20e-2)" "unprognostic (1.09e-3)" "unprognostic (1.22e-1)" 11.4 14.7 1.0 4.9 0.5 0.0 5.8 0.2 0.7 10.1 7.2 1.2 11.4 0.1 46.5 18.8 13.8 18.8 9.2 3.2 0.7 0.6 7.2 134.3 5.5 0.0 1.0 0.4 13.3 18.0 0.0 1.3 30.5 2.0 13.0 0.3 0.5 10.6 18.2 0.6 73.9 0.4 31.1 1.3 1.2 0.4 7.1 0.1 6.7 8.5 12.2 19.8 9.7 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.7 0.0 0.0 0.0 0.0 0.0 0.4 8.4 0.1 0.3 2.7 11.0 0.0 107.5 0.0 9.5 37.6 0.2 12.3 1.0 0.1 0.2 0.0 1.6 6.4 8.2 0.0 0.0 0.0 46.9 0.9 14.2 0.4 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.3 0.8 0.0 0.1 0.0 67.3 42.1 0.0 0.0 4.9 0.9 2.8 0.6 8.6 0.0 2.0 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.2 0.7 0.7 0.6 1.0 0.4 2.0 0.1 11.9 29.6 0.0 214.2 390.9 0.0 0.4 173.3 195.4 155.8 29.6 0.0 1.3 0.0 178.6 0.0 0.8 0.0 0.0 49.1 0.2 10.7 75.9 1.1 165.2 1.0 0.0 1.7 1.8 2.7 0.9 14.4 13.7 30.4 10.0 0.2 0.0 113.1 0.0 33.2 1.9 0.0 0.0 9.2 0.2 0.3 730.8 28.3 0.5 0.0 538.7 CLDN10 "CPETRL3, OSP-L" ENSG00000134873 "Claudin 10" P78369 13 95433604-95579759 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0" "Group enriched" "Detected in many" 7 "Cholangiocytes: 247.1;Collecting duct cells: 94.2;Distal tubular cells: 114.4;Ductal cells: 224.8;Exocrine glandular cells: 70.7;Melanocytes: 65.8;Muller glia cells: 75.5;Pancreatic endocrine cells: 89.7;Proximal tubular cells: 232.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 7.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.8" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 19.7;SuSa: 64.9" "Low region specificity" "Detected in all" "CAB012969, HPA042348" Enhanced NA NA "CAB012969: AB_2533386, HPA042348: AB_2677955" "unprognostic (6.45e-2)" "unprognostic (5.72e-2)" "unprognostic (3.35e-1)" "unprognostic (4.60e-2)" "unprognostic (4.73e-2)" "unprognostic (2.46e-3)" "unprognostic (6.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.91e-3)" "unprognostic (2.59e-3)" "unprognostic (7.93e-2)" "prognostic favorable (7.46e-5)" "unprognostic (1.11e-2)" "unprognostic (9.94e-2)" "prognostic favorable (2.13e-4)" "unprognostic (4.75e-3)" 0.8 0.5 28.3 0.5 17.1 1.9 2.6 5.9 17.7 26.0 0.6 4.3 0.0 1.4 8.1 15.4 2.6 16.0 23.1 0.6 18.1 6.2 50.5 1.7 0.8 0.5 10.8 12.0 1.1 97.3 0.8 1.1 0.7 5.7 1.4 0.6 3.4 70.0 0.6 0.5 4.5 0.5 0.7 2.8 0.7 1.0 0.9 6.3 0.0 0.5 2.1 49.4 0.6 0.2 1.2 0.6 7.8 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.1 0.0 0.0 0.0 0.0 19.7 0.0 0.1 0.1 0.0 0.0 0.0 64.9 0.2 1.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.6 0.0 0.1 28.3 17.1 5.9 17.7 18.1 6.2 10.8 12.0 5.7 6.3 0.0 0.0 0.5 5.8 0.2 0.1 0.4 247.1 9.4 6.8 94.2 0.0 13.8 114.4 224.8 2.4 2.7 0.0 0.0 70.7 5.3 0.5 10.6 0.0 0.0 1.7 0.0 0.0 1.3 0.0 1.7 0.0 0.1 65.8 2.8 0.0 75.5 89.7 0.0 0.4 232.4 3.9 6.5 1.4 6.7 11.3 0.5 19.3 0.0 0.0 3.0 CLDN11 "OSP, OTM" ENSG00000013297 "Claudin 11" O75508 3 170418865-170454733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.9;ovary: 47.7;testis: 86.1" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 37.5;Ito cells: 49.1;Leydig cells: 97.5;Peritubular cells: 63.6" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 57.6;ASC TERT1: 72.7;EFO-21: 43.2;HSkMC: 26.6;HUVEC TERT2: 62.3;TIME: 98.4" "CAB009789, HPA013166, HPA013657" Enhanced Supported "Lipid droplets,Cell Junctions" NA NA "Cell Junctions" "Lipid droplets" "CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: " "prognostic favorable (6.31e-4)" "unprognostic (3.18e-1)" "unprognostic (2.32e-2)" "unprognostic (5.28e-4)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" "unprognostic (5.48e-2)" "unprognostic (8.70e-11)" "unprognostic (2.50e-3)" "unprognostic (1.93e-1)" "unprognostic (6.68e-3)" "unprognostic (2.29e-1)" 8.2 1.9 14.1 2.0 40.6 1.7 6.3 3.5 50.3 1.9 3.4 85.9 0.5 2.2 2.7 4.6 4.6 4.2 18.9 4.0 28.7 13.0 3.2 2.8 2.8 2.1 59.5 17.1 47.7 2.1 1.8 5.5 4.2 37.3 5.1 2.5 0.6 4.7 4.2 1.7 3.6 2.6 2.8 80.6 2.6 2.5 86.1 47.9 0.0 2.0 0.9 2.0 6.3 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 57.6 72.7 0.0 0.7 3.7 4.7 7.9 0.0 9.7 0.0 43.2 5.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.3 17.8 0.0 0.0 26.6 0.0 25.9 0.0 0.2 62.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.1 40.6 3.5 25.0 28.7 13.0 59.5 17.1 37.3 47.9 0.0 1.1 0.0 12.0 12.8 0.4 1.4 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 6.5 21.9 0.0 0.0 0.0 1.7 37.5 1.3 0.0 0.8 0.8 0.0 0.0 49.1 0.0 16.0 97.5 1.7 13.5 0.0 0.0 0.3 0.5 0.0 63.6 0.0 0.0 0.0 5.9 7.2 2.6 8.9 0.7 0.0 0.0 1.0 CLDN14 DFNB29 ENSG00000159261 "Claudin 14" O95500 21 36460621-36576569 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 7.4;liver: 25.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 7.6;Distal tubular cells: 16.6;Ductal cells: 10.3;Exocrine glandular cells: 7.3;Hepatocytes: 19.8;Pancreatic endocrine cells: 13.1" "Cancer enriched" "Detected in many" 6 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Cell line enriched" "Detected in some" 14 "HDLM-2: 70.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054707 Uncertain Vesicles NA NA Vesicles "HPA054707: " "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "prognostic favorable (1.53e-4)" "unprognostic (3.50e-4)" "unprognostic (2.28e-1)" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (4.87e-1)" "unprognostic (7.44e-4)" "unprognostic (2.77e-2)" "unprognostic (7.65e-2)" "unprognostic (2.45e-2)" "unprognostic (9.71e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.1 0.3 0.0 7.4 25.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.8 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.4 0.0 0.5 1.4 0.1 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.2 2.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.3 1.4 0.0 0.2 0.1 1.9 3.7 0.0 0.3 0.1 0.0 0.7 0.2 2.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 1.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 1.0 0.3 0.0 0.8 7.6 0.0 0.0 1.8 0.0 0.1 16.6 10.3 0.4 0.0 0.0 0.0 7.3 0.9 0.0 0.7 0.0 19.8 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 3.3 1.0 0.0 0.0 13.1 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.7 0.0 0.0 1.4 CLDN15 ENSG00000106404 "Claudin 15" P56746 7 101232092-101238820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 194.8" "Cell type enhanced" "Detected in many" 6 "Undifferentiated cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.85e-2)" "unprognostic (1.48e-1)" "unprognostic (4.93e-2)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (1.03e-1)" "unprognostic (6.56e-2)" "unprognostic (1.79e-1)" "prognostic favorable (2.56e-4)" "unprognostic (2.02e-2)" "prognostic unfavorable (5.31e-5)" "unprognostic (9.98e-2)" "unprognostic (2.89e-2)" "unprognostic (9.64e-2)" "prognostic favorable (3.30e-4)" 15.4 0.7 1.0 5.2 1.0 3.9 12.5 1.3 1.1 2.5 172.9 1.1 1.2 76.6 2.4 4.4 1.8 3.2 7.2 2.1 1.7 0.8 3.7 7.0 2.2 2.9 1.7 0.8 4.4 1.3 1.1 1.3 2.0 1.7 2.2 2.4 0.8 1.4 1.2 1.1 2.1 194.8 1.6 2.3 5.7 1.7 2.4 1.4 1.0 1.8 1.3 2.3 2.7 3.0 1.0 1.8 1.7 1.2 0.8 1.9 1.4 2.2 6.9 3.7 5.8 5.8 4.7 2.5 2.2 2.8 2.7 4.0 4.6 2.6 7.4 3.9 1.4 4.5 4.2 6.1 1.3 2.7 9.2 12.9 3.4 3.9 5.9 5.1 3.8 7.5 4.5 6.1 3.6 4.7 5.9 2.2 7.5 16.0 12.1 2.1 7.7 6.0 21.9 2.9 3.3 4.8 8.2 3.2 6.1 1.6 2.8 3.6 12.7 2.0 3.8 10.6 5.3 3.5 7.7 3.2 9.0 7.8 13.6 2.6 12.8 16.0 7.9 2.5 10.0 5.2 0.2 1.2 0.1 1.9 0.7 0.6 0.4 1.9 0.2 0.8 1.0 1.3 1.4 1.7 0.8 0.9 1.8 0.8 1.4 1.0 1.0 1.3 1.0 1.7 0.8 1.7 0.8 1.7 1.4 3.0 1.4 5.2 5.3 6.1 17.9 0.8 12.7 5.3 7.9 21.0 29.5 4.1 11.6 4.4 13.8 6.7 24.5 0.0 5.8 3.2 6.0 5.3 0.0 8.1 2.4 14.3 11.6 4.9 1.9 3.0 14.1 2.9 6.8 3.6 27.6 4.1 4.8 25.4 2.1 2.2 21.1 6.5 2.5 6.0 6.3 4.5 4.2 8.2 51.4 2.7 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412143 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "kidney: 55.9" "Cell type enriched" "Detected in many" 7 "Distal tubular cells: 159.2" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 131 "EFO-21: 101.3;RPTEC TERT1: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced NA NA "HPA056020: AB_2683011" "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.2 0.8 0.4 0.2 0.3 0.0 0.2 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.6 0.2 0.2 0.3 0.4 55.9 1.2 0.2 0.7 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.5 0.2 1.8 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 3.4 0.2 0.4 0.3 0.2 0.5 0.4 1.4 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 1.4 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 1.2 0.3 0.2 0.4 0.1 0.0 0.4 0.3 0.2 0.5 0.3 0.4 0.3 0.2 0.2 0.2 0.0 0.0 0.0 4.8 6.3 0.2 0.3 5.1 22.7 1.2 8.7 0.0 0.2 159.2 2.2 0.6 0.0 0.0 0.0 0.3 0.1 0.3 1.2 1.1 1.5 0.1 3.2 0.0 0.0 0.3 0.0 0.0 1.0 5.0 0.0 0.0 0.0 0.4 0.0 0.4 0.6 0.1 0.0 0.0 0.1 0.1 11.0 5.1 0.0 0.0 3.1 CLDN17 "MGC126552, MGC126554" ENSG00000156282 "Claudin 17" P56750 21 30165564-30166756 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0" "Cell type enriched" "Detected in single" 6 "Early spermatids: 3.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "HaCaT: 2.2;hTCEpi: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA045903 Enhanced NA NA "HPA045903: AB_2679491" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 24.4 2.8 0.0 9.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN18 SFTPJ ENSG00000066405 "Claudin 18" P56856 3 137998735-138033655 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "gallbladder: 37.4;lung: 91.9;stomach 1: 126.9" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 1488.8" "Group enriched" "Detected in some" 11 "pancreatic cancer: 113.7;stomach cancer: 186.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "OE19: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013010, CAB013243, HPA018446" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (2.93e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (5.14e-4)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" "unprognostic (2.60e-1)" "unprognostic (9.54e-2)" "unprognostic (1.38e-2)" "unprognostic (4.42e-5)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (8.26e-2)" "unprognostic (2.95e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.1 0.1 0.1 0.3 0.1 37.4 2.0 0.1 0.0 0.1 0.1 91.9 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 126.9 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.9 0.3 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.6 18.9 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.5 0.3 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 1488.8 318.5 0.0 0.0 0.0 0.8 18.9 0.0 1.4 20.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 9.9 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 257.5 0.0 0.0 0.0 1.4 0.0 0.0 6.6 3.8 0.0 0.0 0.0 0.0 0.0 CLDN19 ENSG00000164007 "Claudin 19" Q8N6F1 1 42733093-42740254 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0" "Cell type enriched" "Detected in some" 7 "Extravillous trophoblasts: 192.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Group enriched" "Detected in some" 54 "midbrain: 13.8;pons and medulla: 9.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4" "Region enhanced" "Detected in some" "olfactory region: 6.7" "Low region specificity" "Detected in all" NA NA "unprognostic (6.23e-4)" "unprognostic (1.80e-1)" "unprognostic (1.85e-6)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-1)" "unprognostic (9.45e-2)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (7.22e-2)" "unprognostic (8.76e-3)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.29e-3)" 1.0 0.2 0.1 0.1 0.2 0.2 1.6 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.9 0.6 0.3 0.1 0.4 0.2 0.1 22.5 0.2 0.2 0.1 13.8 0.0 0.2 0.2 0.1 0.2 20.9 9.5 0.4 0.1 37.0 1.2 2.7 0.4 0.8 0.3 1.0 6.2 0.1 0.5 0.2 0.0 1.3 0.1 2.6 0.1 0.8 1.0 0.5 0.4 1.4 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.5 0.5 1.4 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 13.8 0.0 9.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 1.2 12.2 0.0 9.1 28.2 0.0 0.0 0.0 0.0 0.0 0.0 192.3 0.2 0.1 0.0 0.0 4.4 0.0 0.0 0.6 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 10.4 0.0 0.0 0.0 CLDN2 ENSG00000165376 "Claudin 2" P57739 X 106900164-106930861 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7" "Cell type enhanced" "Detected in some" 21 "Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0" "Group enriched" "Detected in many" 5 "colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5" "Region enriched" "Detected in some" 6 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 81.0" "Group enriched" "Detected in many" 5 "basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5" "Not detected" "Not detected" "CAB002609, HPA051548" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB002609: , HPA051548: AB_2681530" "unprognostic (2.31e-1)" "unprognostic (2.62e-1)" "unprognostic (3.99e-1)" "unprognostic (1.73e-1)" "unprognostic (1.30e-2)" "unprognostic (1.42e-2)" "unprognostic (6.07e-2)" "unprognostic (7.47e-3)" "unprognostic (2.24e-1)" "unprognostic (8.67e-2)" "unprognostic (8.83e-2)" "unprognostic (8.15e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "prognostic favorable (1.70e-4)" "unprognostic (9.76e-2)" 0.4 1.2 0.4 0.4 0.6 0.0 0.4 0.4 3.4 0.4 0.4 19.4 0.4 5.3 0.4 9.6 0.4 0.1 28.4 0.4 5.0 0.1 46.1 25.2 0.4 0.4 0.4 0.4 0.4 7.8 0.0 0.4 0.4 31.7 0.6 1.0 11.0 0.4 27.7 0.4 0.2 11.3 0.4 0.4 0.4 2.1 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.4 3.4 5.0 0.1 0.4 0.4 31.7 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 15.3 0.0 0.0 1.8 0.0 0.0 13.3 67.3 0.0 0.0 1.0 0.0 42.5 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 2.8 0.1 0.9 28.7 2.9 0.0 138.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 CLDN22 CLDN21 ENSG00000177300 "Claudin 22" Q8N7P3 4 183318194-183320774 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "fallopian tube: 4.2;salivary gland: 7.2" "Group enriched" "Detected in some" 18 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0;Club cells: 3.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 1.0;MCF7: 1.0;RT4: 1.3;SCLC-21H: 1.5;THP-1: 1.1" NA NA 0.0 0.4 0.2 0.0 0.4 0.2 0.0 0.3 0.5 0.1 0.1 0.0 1.0 0.0 0.9 4.2 0.0 0.0 0.5 0.2 1.1 1.3 0.1 0.0 0.1 0.0 0.2 0.1 0.4 0.0 0.4 0.0 7.2 0.1 0.5 0.4 0.0 0.1 0.2 0.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN24 CLDN21 ENSG00000185758 "Claudin 24" A6NM45 4 183321764-183322426 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 4.6;salivary gland: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.9;fHDF/TERT166: 3.6;HSkMC: 1.5;SCLC-21H: 1.5;SK-BR-3: 3.1" NA NA "unprognostic (1.49e-1)" "unprognostic (9.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.93e-3)" 0.1 0.3 0.0 0.5 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.0 0.1 0.0 0.2 0.0 0.0 4.6 0.4 0.6 0.0 0.0 0.2 0.3 0.5 0.1 0.0 0.1 0.0 2.1 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.3 1.9 0.7 0.0 0.3 0.0 0.4 3.6 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN25 ENSG00000228607 "Claudin 25" C9JDP6 11 113779747-113780500 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.5;skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 34 "T-47d: 3.3" "Not detected" "Not detected" HPA053555 Uncertain NA NA "HPA053555: AB_2682186" "unprognostic (1.02e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDN3 "C7orf1, CPE-R2, CPETR2, HRVP1, RVP1" ENSG00000165215 "Claudin 3" O15551 7 73768997-73770270 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.4;thyroid gland: 91.6" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 2133.6;Mucus-secreting cells: 1109.4;Paneth cells: 1932.3;Undifferentiated cells: 955.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 7 "cerebellum: 3.1;pons and medulla: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.6;MCF7: 66.5;PC-3: 14.2;RPMI-8226: 11.4;SCLC-21H: 17.6;T-47d: 31.6" "Not detected" "Not detected" HPA014361 Enhanced Supported "Cell Junctions" NA NA 15000 "Cell Junctions" "HPA014361: AB_2668982" "unprognostic (1.84e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-1)" "unprognostic (5.27e-2)" "unprognostic (2.61e-1)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (8.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.28e-3)" "unprognostic (1.42e-1)" "prognostic favorable (3.39e-5)" "unprognostic (1.46e-2)" "unprognostic (1.87e-1)" "unprognostic (5.18e-2)" "unprognostic (6.72e-2)" 0.3 0.1 0.1 11.5 0.1 0.2 7.1 3.1 0.2 3.8 77.9 1.6 21.8 24.3 2.8 8.8 0.3 9.4 11.3 0.1 0.2 0.4 20.7 16.0 6.0 0.2 0.0 0.0 4.3 38.0 0.2 7.4 3.1 3.0 14.6 8.0 1.9 31.1 32.1 0.1 2.1 100.4 0.5 0.0 0.1 0.7 1.2 0.0 2.2 91.6 0.9 3.6 0.8 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.5 0.7 1.0 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.2 10.6 0.0 3.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.1 0.3 0.6 2.6 14.2 0.0 0.0 11.4 0.6 0.0 17.6 0.2 0.0 10.1 0.0 0.0 31.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 3.1 0.2 0.2 0.4 0.0 0.0 3.0 0.0 35.7 34.4 4.2 34.2 0.1 0.7 0.5 206.4 104.4 48.9 120.4 3.9 47.1 8.3 212.5 0.0 0.0 2133.6 23.3 15.9 8.6 0.5 498.9 28.7 32.7 4.3 0.0 581.8 0.0 0.0 0.0 2.3 0.9 10.1 3.6 1109.4 10.8 59.3 1932.3 0.0 42.3 8.5 0.0 0.4 0.0 0.0 0.0 60.5 2.9 955.0 455.4 CLDN34 ENSG00000234469 "Claudin 34" H7C241 X 9967358-9968352 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "testis: 5.4" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 5.9;Early spermatids: 9.7;Late spermatids: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.2;RT4: 4.2;SuSa: 2.2;U-138 MG: 1.7" NA NA "unprognostic (1.54e-2)" "unprognostic (6.73e-5)" "unprognostic (1.25e-1)" "unprognostic (2.80e-1)" "unprognostic (5.43e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "unprognostic (6.82e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-3)" "unprognostic (5.39e-1)" "unprognostic (8.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.89e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.4 0.3 0.0 0.0 0.6 0.5 0.0 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.5 4.2 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.8 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 5.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 CLDN4 "CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8" ENSG00000189143 "Claudin 4" O14493 7 73799542-73832693 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 141.0" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 2545.0;Glandular cells: 2415.4;Urothelial cells: 7943.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 43.3;BEWO: 51.0;CAPAN-2: 95.4;MCF7: 48.6;OE19: 49.3;PC-3: 62.1;RT4: 42.0;SK-BR-3: 80.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB002610 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB002610: " "unprognostic (1.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-1)" "unprognostic (1.23e-2)" "unprognostic (1.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.16e-3)" "unprognostic (5.11e-1)" "prognostic favorable (3.46e-10)" "unprognostic (5.77e-2)" "unprognostic (1.37e-1)" "unprognostic (9.38e-2)" "unprognostic (4.63e-2)" 0.7 0.2 0.4 17.1 0.4 0.0 17.1 0.4 0.5 17.5 53.7 0.7 23.2 25.0 5.1 15.9 62.3 15.4 15.4 0.5 0.4 0.3 30.2 2.0 28.8 0.4 0.4 0.4 5.5 32.4 2.7 3.5 78.1 1.3 31.8 24.7 0.7 52.0 25.7 0.6 35.3 93.3 2.7 0.4 0.4 2.7 2.5 0.4 3.8 141.0 60.9 55.7 38.5 21.0 0.1 0.1 0.2 0.1 0.1 0.6 0.0 43.3 0.5 0.0 0.2 0.0 0.0 51.0 0.4 0.0 0.0 0.0 22.7 95.4 0.0 3.5 0.0 0.3 24.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 15.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.6 0.0 0.2 0.0 49.3 62.1 0.0 0.8 1.0 11.6 42.0 10.1 0.2 0.0 80.9 0.1 2.9 31.6 0.1 0.0 0.1 1.8 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.3 0.4 0.4 1.3 0.4 256.1 182.2 2.2 2545.0 14.3 0.2 0.6 242.0 323.9 224.1 207.6 0.0 586.9 11.6 821.2 0.0 2.9 1686.2 0.0 388.8 629.5 21.8 2415.4 27.6 0.8 67.0 0.0 648.6 0.0 0.3 0.0 2.3 10.6 13.5 27.1 955.9 0.9 781.5 1557.1 0.0 10.2 0.0 0.0 2.1 0.0 0.2 47.2 799.6 1.7 627.6 7943.2 CLDN5 "AWAL, BEC1, CPETRL1, TMVCF" ENSG00000184113 "Claudin 5" O00501 22 19523024-19527545 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 101.1" "Group enriched" "Detected in many" 22 "Endothelial cells: 667.5;Ito cells: 611.4" "Cancer enhanced" "Detected in all" "glioma: 32.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 18 "basophil: 7.4;naive CD4 T-cell: 3.4;neutrophil: 4.1" "Group enriched" "Detected in many" 20 "granulocytes: 7.4;T-cells: 3.4" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 41.0;SCLC-21H: 25.8" "Low region specificity" "Detected in all" CAB002607 Approved NA NA 730000 "CAB002607: " "unprognostic (1.26e-1)" "unprognostic (2.05e-3)" "unprognostic (1.77e-2)" "unprognostic (2.07e-1)" "unprognostic (3.05e-3)" "unprognostic (6.00e-2)" "unprognostic (4.98e-2)" "unprognostic (3.24e-3)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (2.29e-3)" "unprognostic (1.15e-1)" "unprognostic (7.31e-2)" "unprognostic (2.01e-2)" "unprognostic (2.47e-2)" "unprognostic (2.22e-1)" "unprognostic (2.96e-2)" 101.1 4.9 13.9 6.8 17.9 1.9 45.5 7.1 20.0 10.6 19.4 10.2 3.0 9.9 10.2 5.1 7.8 9.5 11.7 14.1 16.9 15.0 7.6 6.0 43.6 9.2 19.8 4.5 8.6 5.5 2.4 1.5 13.1 20.0 8.2 5.0 5.4 4.1 5.1 26.2 10.2 10.3 7.6 18.9 13.5 8.8 6.5 11.9 0.3 20.1 7.3 3.7 7.6 34.7 0.1 0.2 7.4 0.2 0.0 3.4 20.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 41.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.0 25.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 3.4 0.1 4.1 0.0 0.0 0.1 0.0 20.9 13.9 17.9 7.1 15.8 16.9 15.0 19.8 4.5 20.0 11.9 3.0 10.6 2.2 1.1 28.7 0.6 15.4 2.5 0.0 1.2 7.0 0.0 0.2 0.0 0.0 3.6 667.5 0.0 0.0 0.7 0.2 7.1 3.4 1.1 1.0 0.7 0.0 2.4 611.4 25.1 2.3 4.9 2.8 13.5 0.0 0.0 2.5 0.0 0.0 0.7 0.0 4.4 0.0 16.5 0.7 0.9 26.7 0.0 5.7 0.0 6.3 CLDN6 ENSG00000184697 "Claudin 6" P56747 16 3014712-3020071 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 9.5;testis: 4.8" "Cell type enhanced" "Detected in some" 28 "Cytotrophoblasts: 21.7;Ductal cells: 18.1;Extravillous trophoblasts: 119.4;Syncytiotrophoblasts: 36.8" "Group enriched" "Detected in many" 8 "endometrial cancer: 25.8;ovarian cancer: 73.6;testis cancer: 112.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Group enriched" "Detected in some" 6 "BEWO: 85.2;CACO-2: 23.1;NTERA-2: 78.4;SuSa: 61.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.59e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.42e-6)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (6.08e-2)" "unprognostic (1.92e-1)" "unprognostic (5.50e-4)" "unprognostic (1.02e-2)" "unprognostic (5.88e-1)" "unprognostic (1.98e-2)" "unprognostic (7.66e-4)" "unprognostic (1.79e-3)" "unprognostic (1.02e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.78e-4)" 0.1 0.9 0.5 0.1 3.7 0.5 0.1 2.5 1.0 0.1 0.6 0.1 0.1 0.5 0.4 0.1 0.1 0.4 0.7 0.2 0.7 0.8 0.2 0.1 0.9 0.1 0.7 0.1 0.1 3.3 0.0 1.2 9.5 1.5 0.1 0.4 0.1 0.1 0.1 0.6 0.0 0.4 0.1 0.3 0.2 0.4 4.8 0.1 1.3 0.2 0.1 0.1 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 85.2 0.0 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 78.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 3.7 2.5 1.0 0.7 0.8 0.7 0.1 1.5 0.1 3.0 0.0 0.0 1.2 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.7 0.0 18.1 0.1 0.0 0.0 0.0 0.0 119.4 0.2 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.4 0.4 36.8 0.0 0.0 0.1 CLDN7 "CEPTRL2, CPETRL2, Hs.84359" ENSG00000181885 "Claudin 7" O95471 17 7259903-7263983 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 166.7" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 1175.0;Paneth cells: 985.5;Urothelial cells: 711.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 26.8;CACO-2: 27.9;CAPAN-2: 54.3;HaCaT: 114.0;MCF7: 39.7;OE19: 42.8;SK-BR-3: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013063, HPA014703, HPA073662" Enhanced Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "CAB013063: , HPA014703: AB_1846873, HPA073662: " "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (4.12e-2)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (3.41e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-3)" "unprognostic (8.34e-2)" "unprognostic (4.89e-3)" "unprognostic (1.62e-2)" "prognostic favorable (8.96e-11)" "prognostic favorable (4.09e-4)" "unprognostic (1.87e-1)" "prognostic favorable (1.85e-4)" "unprognostic (1.62e-1)" 1.6 2.0 0.4 28.0 0.4 0.0 9.5 0.4 0.4 9.9 71.4 0.4 47.6 47.2 2.4 49.3 73.4 13.4 47.2 0.7 0.4 0.3 30.0 12.1 32.3 0.8 0.4 0.4 3.4 70.9 12.3 7.3 25.0 0.4 9.8 42.5 0.7 40.9 42.2 0.9 2.9 166.7 1.8 0.5 1.4 1.2 1.8 0.4 1.5 40.5 28.3 45.6 12.2 19.3 3.8 1.6 0.0 3.0 2.2 6.7 2.3 3.2 0.3 0.0 0.0 0.0 0.2 26.8 0.0 0.1 0.0 0.0 27.9 54.3 0.0 1.0 0.1 0.1 114.0 0.0 3.5 0.0 0.0 0.6 0.0 0.7 0.0 2.1 0.0 0.2 0.5 5.4 0.0 0.2 0.0 2.5 0.0 0.3 0.1 0.0 39.7 0.0 0.3 0.2 42.8 1.0 0.0 0.0 0.7 0.0 0.0 6.5 0.1 0.3 47.5 0.0 2.2 17.3 0.4 5.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 2.2 3.0 4.8 0.5 1.5 3.3 1.6 3.8 3.7 6.7 0.0 2.2 0.1 0.2 0.9 2.3 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 104.2 43.9 5.4 188.2 1.8 0.8 0.5 226.7 123.1 91.0 305.4 7.9 231.4 33.2 701.7 0.0 3.8 1175.0 0.0 684.7 284.5 5.1 310.2 5.7 34.7 29.8 0.0 313.6 3.7 3.1 0.0 1.1 9.1 23.6 18.0 591.9 0.4 632.6 985.5 0.0 47.8 6.8 0.0 2.1 0.2 3.0 2.3 492.5 5.9 501.5 711.9 CLDN8 ENSG00000156284 "Claudin 8" P56748 21 30214006-30216073 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 26.2;kidney: 48.4" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 212.9" "Cancer enhanced" "Detected in many" "prostate cancer: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "HaCaT: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA060605 Supported NA NA "HPA060605: AB_2684331" "unprognostic (3.74e-2)" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (1.62e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.32e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.6 0.6 0.1 0.6 0.0 26.2 0.7 0.6 2.5 10.0 0.0 6.9 0.0 0.7 14.0 4.2 0.8 0.0 0.7 0.6 0.6 48.4 0.9 1.7 0.0 0.6 0.0 0.6 1.5 0.0 1.3 5.9 0.0 4.6 19.5 0.0 14.2 8.7 0.6 2.2 0.8 0.0 0.6 0.6 0.7 1.0 0.0 0.0 12.2 1.2 1.8 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 0.0 0.0 26.8 4.5 212.9 0.0 0.0 10.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 13.5 0.0 0.0 17.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 6.6 18.2 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012456-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2" "Cell type enhanced" "Detected in some" 12 "Cholangiocytes: 10.2;Ductal cells: 8.3;Pancreatic endocrine cells: 5.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.7;MCF7: 19.5;SCLC-21H: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076613 Supported "Vesicles,Cell Junctions" NA NA "Cell Junctions" Vesicles "HPA076613: AB_2686808" "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.4 0.4 0.5 2.1 5.2 0.3 16.5 1.4 0.6 1.0 0.3 0.3 1.8 0.3 0.9 0.3 2.3 1.1 0.4 0.8 0.8 0.6 2.6 1.5 0.3 1.4 0.3 0.3 9.6 4.8 15.9 10.2 0.5 0.3 0.1 0.3 1.7 0.3 1.5 0.4 1.2 0.3 2.2 1.0 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.3 0.1 0.0 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 5.7 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 19.5 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.1 15.3 0.1 0.8 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.1 16.5 1.4 0.8 0.8 1.4 0.3 0.5 0.3 0.0 0.0 0.0 1.8 0.1 1.4 0.3 10.2 2.7 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 1.6 0.7 0.0 0.7 0.0 0.0 0.1 0.0 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 5.9 1.1 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.4 0.9 0.0 0.2 1.7 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 22.9 14.0 27.7 21.6 12.5 14.2 19.6 20.0 27.7 14.8 18.3 9.0 19.2 13.6 38.0 24.3 17.6 10.8 35.1 21.2 7.5 18.7 5.2 13.2 22.2 16.8 18.7 25.2 58.3 15.6 16.8 21.5 21.7 17.9 9.3 27.7 28.1 9.4 12.3 11.1 19.9 7.8 15.6 8.3 30.8 11.4 18.7 8.1 8.3 22.8 19.6 6.6 28.1 32.1 6.6 14.3 20.1 26.1 24.1 17.7 18.4 36.7 15.7 14.5 43.6 16.2 33.3 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 32.8 39.6 30.5 103.2 128.0 19.7 48.0 12.7 16.0 23.9 26.2 23.6 44.0 24.9 18.4 58.8 63.1 19.7 46.7 14.2 132.7 70.7 85.5 35.8 18.7 31.6 14.3 27.5 54.0 25.9 62.2 47.8 38.0 108.0 43.3 18.8 28.6 24.0 11.5 43.9 18.2 31.4 51.8 126.4 168.0 50.6 171.8 80.1 103.6 17.1 110.7 CLDND2 MGC33839 ENSG00000160318 "Claudin domain containing 2" Q8NHS1 19 51367098-51369003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 31.4" "Cell type enriched" "Detected in many" 15 "Early spermatids: 230.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 11.7" HPA056971 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA056971: AB_2683294" "unprognostic (2.86e-1)" "unprognostic (4.29e-5)" "unprognostic (2.29e-2)" "unprognostic (3.40e-2)" "unprognostic (1.19e-1)" "unprognostic (9.42e-2)" "unprognostic (5.74e-3)" "unprognostic (1.79e-1)" "unprognostic (2.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.25e-3)" "unprognostic (1.13e-2)" "unprognostic (1.94e-9)" "unprognostic (4.00e-2)" "unprognostic (3.95e-1)" "unprognostic (1.85e-1)" "unprognostic (8.70e-2)" 7.7 7.8 6.8 3.2 11.1 13.3 3.3 10.9 16.5 2.6 3.6 1.4 8.4 7.7 3.0 2.5 2.9 2.8 4.5 2.5 9.9 4.7 2.8 3.5 4.0 3.2 19.6 5.2 6.7 9.1 1.5 2.9 1.8 7.4 3.8 2.4 1.7 7.5 6.0 11.9 1.5 7.1 3.8 10.2 7.3 3.3 31.4 10.6 0.0 2.9 2.2 1.2 3.2 3.0 1.7 3.0 5.8 2.0 5.3 4.5 0.7 2.1 6.0 2.2 3.0 3.3 2.9 1.2 1.0 0.5 1.0 1.3 0.7 7.1 5.6 1.2 0.6 0.7 2.7 0.7 0.3 0.2 3.9 9.7 4.9 9.4 11.7 1.3 1.4 1.4 2.2 1.0 0.2 0.6 1.5 0.7 2.8 3.1 4.1 0.9 1.3 1.2 8.1 0.9 6.1 7.6 1.1 5.1 2.2 1.6 1.6 1.3 1.5 2.6 0.5 2.1 1.1 1.5 0.4 1.4 2.2 4.4 2.3 0.9 3.8 4.0 2.0 5.4 5.6 1.3 5.8 0.9 4.1 3.5 2.0 2.0 1.7 0.8 4.5 1.4 1.1 0.6 1.5 0.5 5.3 0.7 3.0 1.2 0.7 6.8 11.1 10.9 16.5 9.9 4.7 19.6 5.2 7.4 10.6 0.0 5.9 7.8 5.0 1.4 5.5 3.6 12.7 9.4 1.2 15.7 0.0 1.9 3.3 0.7 230.3 1.7 6.6 0.0 0.6 1.1 2.3 4.4 15.1 13.4 2.3 3.2 9.9 7.4 2.4 9.1 5.8 4.6 1.7 1.8 14.5 2.3 0.8 5.8 6.0 3.0 1.9 0.0 2.7 2.3 1.3 2.4 0.7 4.5 10.5 4.6 CLEC10A "CD301, CLECSF13, CLECSF14, HML, HML2" ENSG00000132514 "C-type lectin domain containing 10A" Q8IUN9 17 7074537-7080307 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;lymphoid tissue: 49.3" "Group enriched" "Detected in some" 6 "Kupffer cells: 53.6;Macrophages: 176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 12 "myeloid DC: 81.1" "Lineage enriched" "Detected in many" 12 "dendritic cells: 81.1" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 1.6;NB-4: 4.0" HPA021937 Approved NA NA "HPA021937: AB_1846905" "unprognostic (3.96e-3)" "unprognostic (1.71e-3)" "unprognostic (2.95e-2)" "unprognostic (2.04e-3)" "unprognostic (4.54e-2)" "prognostic favorable (1.26e-5)" "unprognostic (1.07e-1)" "prognostic favorable (9.24e-4)" "unprognostic (2.70e-2)" "unprognostic (1.41e-1)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.12e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (3.23e-1)" "unprognostic (3.65e-1)" 12.7 4.0 0.4 14.3 0.5 0.6 6.6 0.4 0.6 4.9 9.7 0.8 1.7 7.9 6.4 31.3 6.9 6.1 12.2 17.5 0.4 0.4 4.4 6.2 22.0 49.3 0.6 0.6 4.1 3.3 0.4 2.0 1.3 2.0 7.2 9.7 3.8 5.0 5.9 6.1 5.1 14.3 9.6 0.9 10.2 4.4 3.7 0.5 5.4 4.7 9.9 10.4 9.8 4.6 0.0 81.1 0.3 6.6 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.0 5.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.3 0.3 0.0 1.6 0.0 3.3 0.4 0.5 0.4 0.6 0.4 0.4 0.6 0.6 2.0 0.5 3.0 3.8 2.2 0.0 11.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.1 0.9 17.9 0.0 0.0 0.6 53.6 0.7 0.3 176.8 20.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 6.5 3.9 0.0 2.1 10.3 0.1 0.0 0.0 0.0 CLEC11A "CLECSF3, LSLCL, P47, SCGF" ENSG00000105472 "C-type lectin domain containing 11A" Q9Y240 19 50723329-50725718 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.1" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 101.2;Fibroblasts: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 17.2" "Group enriched" "Detected in many" 4 "dendritic cells: 12.0;monocytes: 17.2" "Group enriched" "Detected in many" 4 "HEL: 45.4;HMC-1: 84.1;NB-4: 111.7;THP-1: 90.3;U-937: 46.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042690 Approved Approved Centrosome "Secreted in other tissues" NA NA 45000 Centrosome "HPA042690: AB_10795511" "unprognostic (9.33e-2)" "unprognostic (6.66e-2)" "unprognostic (2.40e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.33e-1)" "unprognostic (8.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.29e-2)" "unprognostic (5.26e-2)" "unprognostic (4.99e-2)" "unprognostic (2.79e-2)" "unprognostic (8.30e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (6.09e-2)" "unprognostic (8.66e-3)" "unprognostic (4.00e-2)" "unprognostic (1.57e-2)" 5.5 5.4 3.0 5.6 3.1 77.1 4.5 4.5 3.6 33.6 6.5 1.2 6.7 3.9 26.6 27.8 6.7 13.5 10.7 5.6 2.6 3.4 7.4 5.4 7.5 3.5 2.9 1.3 16.1 2.6 2.0 7.5 6.9 4.0 18.9 2.1 8.9 2.9 10.2 3.4 5.0 5.2 8.5 3.4 4.9 3.1 4.9 0.8 4.0 3.8 4.5 2.6 8.4 10.1 0.3 12.0 1.2 17.2 3.4 3.2 6.7 0.3 0.4 0.0 0.3 4.4 6.0 10.3 17.7 4.8 2.0 2.0 0.0 0.0 0.0 0.2 8.8 0.1 0.2 0.0 0.0 1.4 0.0 2.9 45.4 0.0 0.0 2.8 0.0 84.1 4.4 0.0 0.2 0.2 0.0 2.2 2.0 0.5 0.3 3.7 0.3 0.3 111.7 0.2 0.0 0.5 3.8 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 6.8 0.0 0.1 90.3 12.7 0.1 5.5 0.0 0.1 0.2 0.2 0.0 6.4 46.9 5.8 1.0 17.2 0.2 0.6 7.2 0.0 0.3 0.2 0.1 12.0 0.3 1.5 3.2 1.2 3.4 3.3 3.2 0.1 6.7 3.0 3.1 4.5 3.6 2.6 3.4 2.9 1.3 4.0 0.8 3.0 4.8 1.4 26.8 28.4 18.8 2.8 10.2 5.3 3.4 27.9 9.8 8.6 101.2 10.9 4.6 14.5 0.7 0.0 2.6 36.0 98.6 20.9 5.7 4.4 44.2 20.6 25.4 62.6 21.5 13.3 65.6 36.7 74.2 4.6 3.4 42.6 5.0 1.4 63.3 6.3 17.5 64.7 31.1 20.5 10.0 40.1 15.3 4.3 3.4 13.1 CLEC12A "CD371, CLL-1, DCAL-2, MICL" ENSG00000172322 "C-type lectin domain family 12 member A" Q5QGZ9 12 9951316-9995694 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4" "Cell type enhanced" "Detected in some" 18 "granulocytes: 27.9;Kupffer cells: 91.2;Macrophages: 86.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 46.5" "Group enriched" "Detected in many" 38 "dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8" "Group enriched" "Detected in some" 6 "HL-60: 12.1;U-937: 37.8" HPA048515 Enhanced NA NA "HPA048515: AB_2680425" "unprognostic (4.74e-2)" "unprognostic (6.06e-3)" "unprognostic (7.76e-2)" "unprognostic (6.88e-2)" "unprognostic (2.00e-2)" "unprognostic (6.66e-2)" "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (3.29e-1)" "unprognostic (1.44e-2)" "unprognostic (1.70e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-3)" "unprognostic (9.67e-3)" "unprognostic (7.43e-2)" "unprognostic (3.78e-2)" "prognostic favorable (9.33e-4)" 4.2 1.2 0.3 6.4 1.2 35.4 1.2 0.6 1.1 0.9 1.5 0.3 0.1 0.2 1.9 3.7 0.9 1.3 2.8 3.5 0.3 0.3 1.9 3.4 36.2 9.6 0.5 0.8 1.0 1.4 0.0 0.6 3.4 1.2 1.3 1.3 1.4 1.5 0.1 0.7 1.1 1.9 3.5 1.5 22.4 1.3 0.9 0.3 2.8 0.7 0.1 1.2 2.1 1.0 0.0 17.1 46.5 32.8 0.8 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 37.8 0.0 4.1 32.8 46.5 0.0 26.4 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.1 10.2 0.8 28.4 1.5 0.0 12.5 0.3 1.2 0.6 1.1 0.3 0.3 0.5 0.8 1.2 0.3 3.0 5.3 4.2 0.0 0.3 0.0 0.4 0.0 2.7 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 27.9 0.8 20.0 0.0 0.0 1.3 91.2 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 1.1 3.2 0.0 0.0 CLEC12B ENSG00000256660 "C-type lectin domain family 12 member B" Q2HXU8 12 10010627-10018619 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 30.9" "Cell type enriched" "Detected in some" 6 "Melanocytes: 75.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "GAMG: 5.7;U-937: 12.0" "Region enhanced" "Detected in single" "pons and medulla: 0.8" "Not detected" "Not detected" NA NA "unprognostic (2.08e-2)" "unprognostic (4.81e-2)" "unprognostic (3.60e-1)" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (3.36e-3)" "unprognostic (4.14e-4)" "unprognostic (7.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-5)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" "unprognostic (5.48e-1)" "unprognostic (8.95e-4)" 0.4 0.0 0.2 0.5 0.2 5.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 1.3 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.2 0.2 5.4 0.2 0.2 0.2 2.7 0.1 30.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.5 1.3 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 12.0 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.6 7.2 0.3 0.4 75.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.6 0.0 0.0 0.0 0.0 CLEC14A C14orf27 ENSG00000176435 "C-type lectin domain containing 14A" Q86T13 14 38254103-38256369 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 63.2" "Group enriched" "Detected in some" 45 "Endothelial cells: 217.3;Ito cells: 286.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 17.4;HUVEC TERT2: 94.4;TIME: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039468, HPA048119" Uncertain Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 3600000 "Endoplasmic reticulum, Golgi apparatus" "HPA039468: AB_2676524, HPA048119: AB_2680270" "unprognostic (4.02e-1)" "unprognostic (4.26e-2)" "unprognostic (4.20e-3)" "unprognostic (9.44e-2)" "unprognostic (1.35e-1)" "prognostic favorable (4.13e-6)" "unprognostic (2.55e-3)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (6.90e-2)" "unprognostic (5.41e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-2)" "unprognostic (1.75e-2)" "unprognostic (1.55e-1)" "unprognostic (4.97e-2)" "unprognostic (5.28e-2)" 32.2 3.9 3.2 6.8 4.3 0.0 47.8 2.3 3.9 14.5 9.3 3.4 5.9 5.9 18.4 13.3 9.3 9.9 13.6 23.7 3.8 3.4 6.8 11.4 63.2 7.9 4.9 2.2 7.6 3.3 5.0 2.8 15.0 4.4 11.8 4.4 10.8 5.5 6.5 36.5 6.5 7.4 12.1 3.9 9.0 5.9 6.8 2.2 1.4 14.0 21.1 3.8 9.4 14.8 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.3 2.3 3.9 3.8 3.4 4.9 2.2 4.4 2.2 0.0 5.6 2.9 0.3 3.1 0.0 5.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 217.3 0.0 0.0 0.2 0.1 2.7 0.2 1.1 0.8 0.3 0.0 0.0 286.7 5.6 1.0 0.6 0.7 5.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.0 4.1 0.6 0.2 2.8 0.1 0.0 0.0 0.0 CLEC17A FLJ45910 ENSG00000187912 "C-type lectin domain containing 17A" Q6ZS10 19 14583084-14611157 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 30.9;intestine: 8.5;lymphoid tissue: 25.1" "Group enriched" "Detected in some" 31 "B-cells: 2.2;Early spermatids: 5.2;Late spermatids: 8.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "memory B-cell: 14.7;naive B-cell: 30.9" "Lineage enriched" "Detected in many" 16 "B-cells: 30.9" "Group enriched" "Detected in some" 10 "Daudi: 10.1;U-698: 18.7" "Low region specificity" "Detected in some" NA NA "unprognostic (4.71e-5)" "unprognostic (1.34e-2)" "unprognostic (9.64e-4)" "unprognostic (5.02e-3)" "unprognostic (3.90e-1)" "unprognostic (9.00e-4)" "unprognostic (3.18e-3)" "unprognostic (1.60e-3)" "unprognostic (1.32e-2)" "unprognostic (7.11e-2)" "unprognostic (3.78e-2)" "unprognostic (4.43e-2)" "unprognostic (9.13e-3)" "unprognostic (1.65e-1)" "unprognostic (5.91e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" 0.4 0.3 0.8 23.2 2.2 1.3 0.3 0.3 1.3 0.3 0.6 3.3 0.0 0.4 0.3 0.0 0.4 0.3 0.6 0.3 2.2 1.1 0.6 0.3 0.4 18.7 1.3 0.0 0.3 0.3 0.1 0.5 0.1 1.7 0.4 0.6 0.4 4.7 0.0 0.3 0.3 8.5 0.0 3.7 17.0 0.7 1.4 2.0 1.0 0.5 0.0 25.1 1.5 0.3 30.9 1.8 0.7 0.3 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 14.7 0.0 0.0 1.8 30.9 0.0 0.0 0.7 0.1 0.1 0.2 0.0 1.3 0.8 2.2 0.3 1.3 2.2 1.1 1.3 0.0 1.7 2.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC18A MRCL ENSG00000157322 "C-type lectin domain family 18 member A" A5D8T8 16 69950705-69964452 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 19.6" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 57.3" "Cancer enriched" "Detected in single" 7 "renal cancer: 1.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.8;BEWO: 3.6" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (1.68e-1)" "unprognostic (3.06e-2)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (3.14e-2)" "unprognostic (4.62e-2)" "unprognostic (1.36e-1)" "unprognostic (4.14e-2)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-4)" "unprognostic (6.73e-2)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (9.03e-4)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" 0.1 1.3 0.3 0.0 0.8 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.5 19.6 0.1 0.1 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.5 0.0 1.0 0.7 0.5 3.4 0.1 0.1 0.4 0.0 0.9 0.3 1.6 0.0 0.5 0.1 0.0 0.3 0.3 2.8 0.2 0.0 0.8 3.6 0.0 0.0 0.6 0.2 0.6 0.1 0.5 0.3 0.0 0.5 0.0 0.0 0.4 0.3 0.6 0.9 0.0 0.0 1.5 0.0 0.7 1.8 0.0 1.4 1.4 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.4 0.0 0.0 1.0 1.6 0.1 0.8 0.0 0.1 0.5 0.7 1.6 0.0 0.7 1.9 0.2 0.0 0.7 0.8 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.1 1.2 0.4 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.2 0.2 0.2 1.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.3 3.2 0.0 1.3 0.0 0.6 0.3 0.1 0.0 0.0 0.9 1.5 0.5 0.0 0.0 57.3 1.1 0.0 0.2 0.5 0.1 0.0 0.2 0.0 1.6 0.1 CLEC18B MRCL2 ENSG00000140839 "C-type lectin domain family 18 member B" Q6UXF7 16 74408270-74421953 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 28.1" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 18.2" "Group enriched" "Detected in some" 12 "glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;JURKAT: 4.1;K-562: 7.3;U-266/70: 2.7" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (5.69e-2)" "unprognostic (1.46e-1)" "unprognostic (5.30e-3)" "unprognostic (9.37e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (7.15e-2)" "unprognostic (7.51e-2)" "unprognostic (4.49e-3)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (9.91e-2)" "unprognostic (3.58e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-2)" "unprognostic (5.87e-2)" "unprognostic (5.43e-2)" "unprognostic (4.27e-2)" 0.1 1.1 1.1 0.3 1.4 0.1 0.1 2.5 1.2 0.1 0.1 0.4 0.1 0.6 1.2 0.1 0.3 0.0 1.0 1.0 28.1 0.1 0.0 0.1 1.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.0 0.2 0.1 2.0 0.1 0.1 6.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 1.6 2.9 1.8 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.2 1.1 0.5 0.5 1.0 0.9 0.0 0.1 0.3 0.2 0.4 0.3 0.1 0.7 0.0 0.3 1.7 0.4 0.1 0.1 0.7 0.0 4.1 7.3 0.0 0.3 0.0 0.0 0.0 1.2 0.3 0.8 0.4 0.0 1.6 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.2 0.9 2.7 1.6 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.3 0.6 0.4 0.0 0.0 18.2 1.1 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 CLEC18C "MGC34761, MRCL3" ENSG00000157335 "C-type lectin domain family 18 member C" Q8NCF0 16 70173322-70187361 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "kidney: 16.5;testis: 4.6" "Cell type enriched" "Detected in single" 48 "Proximal tubular cells: 18.8" "Cancer enriched" "Detected in single" 9 "renal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;RT4: 1.3;TIME: 3.0" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (3.90e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-4)" "unprognostic (5.55e-2)" "unprognostic (5.72e-3)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (6.98e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 16.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 4.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.3 1.3 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.6 3.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CLEC19A ENSG00000261210 "C-type lectin domain containing 19A" Q6UXS0 16 19285739-19322145 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "brain: 7.2;retina: 24.4" "Group enriched" "Detected in some" 16 "Ciliated cells: 2.7;Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;EFO-21: 1.2;MCF7: 1.6;NTERA-2: 1.0;OE19: 2.5;RPMI-8226: 1.8;U-2 OS: 1.5" "Secreted - unknown location" NA NA "unprognostic (3.19e-1)" "unprognostic (3.72e-1)" "unprognostic (1.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" 0.1 0.0 2.6 0.0 0.2 0.0 0.0 0.8 7.2 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 4.5 1.3 0.0 0.1 0.5 0.3 0.3 0.2 0.0 0.1 0.0 0.3 0.1 1.2 0.8 0.1 24.4 0.4 0.0 0.3 1.2 0.1 0.0 0.1 0.0 0.8 0.5 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 1.0 2.5 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.6 0.2 0.8 5.0 4.5 1.3 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CLEC1A "CLEC1, MGC34328" ENSG00000150048 "C-type lectin domain family 1 member A" Q8NC01 12 10069554-10111627 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.8" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 45.1;Endothelial cells: 22.2;Extravillous trophoblasts: 51.1;Ito cells: 14.7;Syncytiotrophoblasts: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.2;intermediate monocyte: 1.3;myeloid DC: 5.2;neutrophil: 2.8" "Group enriched" "Detected in many" 14 "dendritic cells: 5.2;granulocytes: 2.8;monocytes: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 18.8;HUVEC TERT2: 15.9;SuSa: 5.1;U-266/70: 4.3;U-266/84: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (5.96e-2)" "unprognostic (2.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-2)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (7.15e-2)" "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.94e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" 27.4 2.1 1.6 4.9 3.0 0.5 14.0 1.2 1.9 9.7 3.1 1.2 2.4 1.4 16.1 6.0 4.3 4.2 4.9 4.8 2.0 1.8 3.6 2.5 19.9 4.5 3.1 0.6 4.9 4.1 1.0 2.6 40.8 3.4 5.2 2.0 2.3 2.0 2.3 4.8 2.9 3.0 7.6 3.5 5.8 2.6 3.3 1.7 20.4 5.6 3.6 3.0 6.4 12.3 0.2 5.2 2.8 2.2 0.2 0.1 0.5 0.0 0.0 0.3 0.2 0.2 0.1 18.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.0 1.6 0.0 0.0 0.0 0.4 2.6 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.2 0.0 5.1 0.0 0.0 1.2 0.0 0.2 0.2 0.0 4.3 9.5 0.0 0.2 0.0 0.0 0.2 2.2 0.1 0.0 1.3 0.1 0.1 0.0 0.0 5.2 0.2 0.1 0.0 2.8 0.2 0.5 0.2 0.0 0.5 1.6 3.0 1.2 1.9 2.0 1.8 3.1 0.6 3.4 1.7 0.0 0.3 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.3 22.2 0.0 0.0 0.0 51.1 1.7 0.2 0.0 0.0 4.4 0.0 0.0 14.7 6.5 0.0 6.9 1.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 2.4 1.4 43.6 0.0 0.0 0.4 CLEC1B CLEC2 ENSG00000165682 "C-type lectin domain family 1 member B" Q9P126 12 9985642-10013424 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 12.5;liver: 44.1" "Cell type enriched" "Detected in some" 10 "Ito cells: 718.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 7.8" "Group enriched" "Detected in many" 37 "dendritic cells: 2.1;granulocytes: 7.8;monocytes: 4.9" "Group enriched" "Detected in some" 6 "Karpas-707: 10.1;U-266/84: 23.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA 1500000 "unprognostic (2.03e-1)" "unprognostic (2.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.15e-3)" "unprognostic (1.26e-2)" "unprognostic (7.71e-2)" "unprognostic (4.98e-2)" "unprognostic (1.58e-1)" "unprognostic (8.13e-2)" "unprognostic (1.49e-3)" "unprognostic (1.46e-2)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (2.91e-2)" 0.1 0.3 0.0 0.4 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.0 0.0 0.0 0.1 44.1 2.1 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.2 0.0 4.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.1 7.8 4.9 0.1 0.1 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 2.9 0.0 7.8 4.9 6.7 0.0 4.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 3.3 0.1 3.7 1.2 0.0 12.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.1 0.0 0.0 718.7 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 CLEC20A "FLJ44005, LINC00083, NCRNA00083, RP4-593C16.2" ENSG00000188585 "C-type lectin domain containing 20A" 1 178479247-178499634 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 12.9;testis: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.5;naive B-cell: 12.9" "Lineage enriched" "Detected in many" 8 "B-cells: 12.9" "Cell line enriched" "Detected in single" 5 "REH: 4.8" NA NA 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.5 5.3 0.0 1.9 0.0 12.9 0.5 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.3 12.9 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932381 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 37.0" "Group enriched" "Detected in some" 199 "Basal keratinocytes: 16.7;Suprabasal keratinocytes: 32.4" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 13.5;U-937: 33.7" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA048530: AB_2680429, HPA072407: AB_2686518" "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.1 CLEC2B "AICL, CLECSF2, HP10085" ENSG00000110852 "C-type lectin domain family 2 member B" Q92478 12 9852984-9870136 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 179.2;Macrophages: 186.4;Suprabasal keratinocytes: 210.5;T-cells: 224.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 58.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;ASC TERT1: 27.2;HSkMC: 14.9;U-937: 62.1" HPA008194 Enhanced "Intracellular and membrane" NA NA "HPA008194: AB_1078533" "unprognostic (3.14e-2)" "unprognostic (4.27e-2)" "unprognostic (2.14e-2)" "unprognostic (9.69e-3)" "unprognostic (4.83e-2)" "unprognostic (2.51e-1)" "unprognostic (5.99e-2)" "unprognostic (4.45e-1)" "unprognostic (1.79e-1)" "unprognostic (3.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.50e-1)" "prognostic unfavorable (5.64e-13)" "unprognostic (8.09e-2)" "unprognostic (7.12e-3)" "unprognostic (5.70e-2)" "unprognostic (2.79e-1)" 10.8 1.8 2.0 9.1 2.8 29.8 8.2 2.4 3.0 6.3 3.9 2.7 3.4 1.5 7.2 4.4 6.1 3.6 6.0 4.8 2.0 1.3 2.7 4.5 13.1 8.9 3.0 2.0 12.9 2.0 0.2 2.0 4.8 3.2 4.9 3.7 3.4 4.5 2.0 5.7 24.5 4.9 4.0 3.3 12.6 2.2 3.6 2.4 56.6 3.4 3.6 7.6 5.3 7.9 5.6 9.3 58.7 17.3 17.1 19.1 18.6 0.0 0.8 0.0 0.0 17.2 27.2 0.1 0.4 3.3 0.2 0.9 0.0 0.6 0.3 0.2 13.7 10.3 5.1 2.8 0.0 0.1 0.7 0.0 0.9 0.0 0.0 5.7 0.6 0.1 14.9 5.1 0.6 0.1 0.8 8.6 3.6 0.0 2.3 4.0 0.0 5.3 1.2 0.1 0.0 0.5 7.9 0.1 0.0 0.0 5.5 0.0 0.0 0.2 0.0 3.5 0.0 1.3 0.1 11.4 0.1 3.2 0.4 1.6 4.1 0.3 0.6 3.5 62.1 5.0 9.6 10.3 3.7 18.4 14.7 14.6 3.1 11.6 19.1 9.3 5.6 11.1 16.8 58.7 17.1 17.3 3.5 9.3 18.6 2.0 2.8 2.4 3.0 2.0 1.3 3.0 2.0 3.2 2.4 3.0 33.4 35.1 68.5 179.2 0.0 3.1 12.7 4.0 26.1 0.0 0.0 0.7 0.0 3.8 0.2 130.0 0.2 23.3 0.7 1.4 28.8 14.5 52.1 2.6 77.5 0.0 1.7 145.5 124.7 0.7 46.1 186.4 75.9 10.8 0.0 0.4 1.8 0.0 16.6 0.7 0.2 6.5 37.7 0.2 0.5 210.5 1.6 224.3 0.0 126.6 CLEC2D "CLAX, LLT1, OCIL" ENSG00000069493 "C-type lectin domain family 2 member D" Q9UHP7 12 9664969-9699555 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 45.6;lymphoid tissue: 47.5" "Group enriched" "Detected in many" 5 "B-cells: 129.2;Early spermatids: 83.6;monocytes: 115.4;T-cells: 223.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "gdT-cell: 37.8;MAIT T-cell: 23.0;memory B-cell: 15.9;memory CD4 T-cell: 37.3;memory CD8 T-cell: 41.3;naive B-cell: 24.6;naive CD4 T-cell: 39.4;naive CD8 T-cell: 45.6;T-reg: 31.5" "Group enriched" "Detected in many" 11 "B-cells: 24.6;T-cells: 45.6" "Group enriched" "Detected in many" 4 "Daudi: 27.8;HDLM-2: 21.7;Karpas-707: 13.2;U-698: 42.8" "HPA017649, HPA047584" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA017649: AB_1846912, HPA047584: " "unprognostic (1.09e-3)" "prognostic favorable (1.37e-4)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (1.29e-1)" "unprognostic (2.77e-4)" "unprognostic (4.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (5.85e-11)" "unprognostic (1.17e-1)" "unprognostic (2.70e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.68e-7)" 3.8 1.0 1.1 47.5 1.1 7.8 3.7 0.8 1.0 2.9 6.0 0.6 1.4 1.7 3.0 7.0 3.6 3.2 3.0 3.3 1.2 1.1 2.6 1.3 10.4 28.3 1.7 1.2 4.0 1.5 0.2 1.3 1.7 1.1 4.5 2.1 2.5 9.8 3.2 1.2 2.4 11.2 3.2 2.5 21.3 2.7 5.7 1.0 44.7 2.8 2.7 29.4 8.2 2.5 24.6 0.4 1.1 0.4 3.1 45.6 19.2 0.5 1.0 1.5 0.1 0.2 0.6 1.7 0.7 1.0 0.3 0.9 0.8 0.9 27.8 0.1 0.7 0.4 0.3 0.5 0.1 0.5 21.7 0.4 0.8 0.7 1.2 2.5 0.7 0.7 1.0 0.7 0.2 0.9 3.4 0.0 0.5 0.2 13.2 0.6 1.8 0.3 2.4 1.4 0.1 0.2 6.0 0.6 0.8 1.4 1.5 0.3 0.5 0.4 1.2 1.2 2.9 0.2 0.7 0.2 0.5 0.7 0.4 0.5 1.8 0.4 42.8 1.2 1.3 0.8 1.1 0.4 0.2 37.8 0.2 23.0 15.9 37.3 41.3 0.4 24.6 39.4 45.6 1.1 3.1 0.2 0.3 31.5 19.2 1.1 1.1 0.8 1.0 1.2 1.1 1.7 1.2 1.1 1.0 6.0 26.8 129.2 29.8 3.7 0.6 6.9 2.5 10.7 11.4 1.8 3.9 9.1 6.6 2.1 83.6 9.8 0.4 0.0 1.7 5.4 7.0 13.2 18.6 2.1 8.0 4.8 0.0 12.3 20.8 15.6 7.8 18.9 1.7 115.4 2.5 3.7 2.3 2.0 9.2 1.9 2.1 19.4 6.6 4.7 5.1 4.3 4.0 223.7 3.0 25.3 CLEC2L FLJ32986 ENSG00000236279 "C-type lectin domain family 2 member L" P0C7M8 7 139523856-139544984 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.8;parathyroid gland: 15.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 2.2;Extravillous trophoblasts: 2.6;Horizontal cells: 4.8;Muller glia cells: 1.7;Rod photoreceptor cells: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 15.3;U-266/70: 3.7;U-266/84: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045050 Enhanced NA NA "HPA045050: AB_10965839" "unprognostic (1.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.20e-4)" "unprognostic (1.24e-2)" "unprognostic (1.33e-2)" "unprognostic (6.17e-2)" "unprognostic (2.29e-6)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (6.73e-2)" "unprognostic (2.68e-1)" "unprognostic (8.31e-2)" "unprognostic (7.94e-4)" "unprognostic (3.57e-3)" "unprognostic (4.03e-2)" "unprognostic (8.42e-3)" "unprognostic (3.02e-2)" 1.1 0.9 9.8 1.0 9.4 1.1 0.8 14.0 24.1 2.3 0.9 1.4 0.0 0.9 2.5 0.5 1.6 0.8 1.9 0.5 13.8 9.2 0.7 0.6 0.7 0.8 15.1 7.2 0.7 0.7 15.5 0.1 0.7 26.8 0.6 0.9 2.2 0.7 0.6 5.5 0.7 1.2 2.2 3.8 0.7 0.6 1.3 0.5 1.8 0.8 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.6 0.0 1.5 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.8 9.4 14.0 24.1 13.8 9.2 15.1 7.2 26.8 0.5 0.0 0.0 0.0 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.7 1.7 0.0 0.3 0.0 0.0 0.0 CLEC3A CLECSF1 ENSG00000166509 "C-type lectin domain family 3 member A" 16 78022515-78066761 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2" "Cell type enhanced" "Detected in single" 26 "Glandular cells: 1.4" "Cancer enriched" "Detected in some" 102 "breast cancer: 78.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SK-BR-3: 7.5;T-47d: 21.4" "Region enhanced" "Detected in single" "midbrain: 0.5" "Not detected" "Not detected" HPA051511 Uncertain "Secreted to extracellular matrix" NA NA "HPA051511: AB_2681514" "prognostic unfavorable (1.61e-4)" "unprognostic (1.60e-1)" "unprognostic (2.42e-1)" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-2)" 0.1 0.1 0.1 1.8 0.3 0.0 14.6 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 4.6 0.3 0.1 1.1 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 8.6 0.0 3.3 0.1 0.0 0.1 0.1 0.1 17.1 0.1 0.1 0.8 0.1 0.0 0.0 0.1 1.9 0.0 17.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.8 0.1 1.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC3B "TN, TNA" ENSG00000163815 "C-type lectin domain family 3 member B" P05452 3 45001548-45036071 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 185.2;lung: 216.5" "Cell type enhanced" "Detected in some" 15 "Fibroblasts: 14.4;Ito cells: 43.0;Late spermatids: 15.2;Leydig cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 51.1;ASC TERT1: 101.9;U-2197: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002582, HPA034794" Approved "Secreted to blood" NA NA 6540000000 46000000000 "CAB002582: AB_564027, HPA034794: AB_2674332" "unprognostic (2.04e-1)" "unprognostic (1.80e-3)" "unprognostic (2.58e-1)" "unprognostic (4.57e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.53e-4)" "prognostic favorable (9.99e-9)" "unprognostic (1.75e-2)" "unprognostic (2.25e-1)" "unprognostic (4.02e-1)" "prognostic favorable (5.68e-4)" "unprognostic (9.33e-2)" "unprognostic (2.39e-2)" "unprognostic (7.46e-2)" "unprognostic (1.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.21e-2)" 70.8 11.5 6.6 16.9 8.9 0.5 185.2 5.9 10.2 17.4 20.3 4.8 39.0 8.4 15.7 54.2 17.2 6.9 38.8 72.8 8.1 6.8 20.6 7.0 216.5 8.3 8.8 7.4 5.1 6.1 2.1 5.0 37.7 13.2 7.4 10.1 17.7 9.7 19.2 26.5 27.6 16.3 90.3 10.0 65.5 8.3 24.9 1.5 2.3 15.8 40.8 5.4 28.0 24.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 51.1 101.9 0.0 6.7 10.5 0.2 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 20.5 0.0 0.2 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.6 8.9 5.9 10.2 8.1 6.8 8.8 7.4 13.2 1.5 0.0 0.0 0.0 0.0 3.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.8 10.5 0.0 0.0 0.2 0.0 14.4 0.0 0.0 0.0 0.8 0.0 0.0 43.0 1.2 15.2 27.9 0.8 3.3 1.0 0.0 0.0 0.1 0.0 6.0 0.0 0.1 0.0 4.2 0.0 0.0 3.3 0.1 0.0 0.0 0.0 CLEC4A "CD367, CLECSF6, DCIR, DDB27" ENSG00000111729 "C-type lectin domain family 4 member A" Q9UMR7 12 8123632-8138607 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lung: 30.0" "Cell type enhanced" "Detected in many" 18 "Hofbauer cells: 22.3;Kupffer cells: 81.7;Macrophages: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.2;classical monocyte: 54.6;intermediate monocyte: 31.2;myeloid DC: 53.2;neutrophil: 48.8;non-classical monocyte: 19.6" "Group enriched" "Detected in many" 12 "dendritic cells: 53.2;granulocytes: 48.8;monocytes: 54.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.4" HPA007842 Uncertain NA NA "HPA007842: AB_1078534" "unprognostic (9.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.41e-2)" "unprognostic (3.13e-2)" "unprognostic (2.69e-1)" "unprognostic (9.34e-2)" "unprognostic (5.49e-2)" "unprognostic (8.22e-2)" "unprognostic (1.62e-1)" "unprognostic (7.84e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.42e-3)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (3.05e-1)" "unprognostic (9.79e-2)" 8.3 2.0 2.7 20.1 4.0 14.6 3.3 2.2 2.6 3.7 3.1 3.5 0.6 3.6 2.7 5.2 2.1 2.9 5.6 3.4 2.5 2.5 5.4 4.1 30.0 25.1 2.8 2.4 5.5 2.5 0.5 3.3 6.0 3.2 4.1 4.6 4.0 2.6 2.2 2.2 3.8 4.7 3.3 8.1 16.3 2.0 2.8 3.7 5.7 2.8 3.2 7.4 6.0 3.1 4.5 53.2 48.8 54.6 0.5 0.2 23.7 0.3 0.0 0.7 1.8 3.3 8.4 1.1 2.2 0.9 1.8 2.5 3.0 1.4 1.3 0.3 1.2 0.7 0.4 1.9 0.4 1.1 2.2 2.2 1.4 1.5 0.8 4.1 4.2 5.6 4.2 1.9 0.7 2.3 5.2 0.4 3.0 0.7 1.2 2.3 1.0 1.2 3.1 1.3 1.1 0.8 0.8 1.4 2.1 1.2 2.0 0.3 0.7 0.5 1.6 0.0 2.9 0.2 0.3 0.5 3.1 1.9 1.2 1.4 1.4 0.2 1.7 0.4 1.6 0.1 29.2 54.6 0.1 0.1 31.2 0.1 2.0 0.1 0.2 53.2 4.5 0.1 0.1 48.8 0.5 19.6 7.3 0.1 23.7 2.7 4.0 2.2 2.6 2.5 2.5 2.8 2.4 3.2 3.7 0.0 5.8 5.0 0.6 3.8 0.5 0.8 0.0 4.0 3.4 0.0 3.9 0.2 1.7 0.1 4.1 1.4 0.0 0.0 0.4 0.2 2.2 0.8 2.3 0.9 22.3 0.0 1.7 1.3 81.7 0.9 2.3 93.5 6.8 1.0 0.0 0.4 0.5 0.3 1.4 0.2 0.6 0.0 1.2 0.2 0.5 2.9 0.2 0.5 0.0 0.7 CLEC4C "BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL" ENSG00000198178 "C-type lectin domain family 4 member C" Q8WTT0 12 7729415-7751605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "blood: 80.0" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 16 "plasmacytoid DC: 80.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 80.0" "Cell line enriched" "Detected in some" 4 "HDLM-2: 6.6" HPA029432 Approved NA NA "HPA029432: AB_10601259" "unprognostic (3.55e-3)" "unprognostic (3.01e-2)" "unprognostic (1.03e-1)" "unprognostic (3.70e-2)" "unprognostic (7.37e-5)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-2)" "unprognostic (6.98e-2)" "unprognostic (1.39e-1)" "unprognostic (1.88e-3)" "unprognostic (2.82e-2)" "unprognostic (3.18e-3)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" 0.3 0.2 0.2 1.6 0.2 1.8 2.0 0.2 0.6 0.2 0.2 0.1 0.1 0.0 0.2 0.1 0.3 0.5 1.2 0.3 0.2 0.2 0.5 0.3 1.5 7.0 0.2 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.4 0.3 2.0 0.2 0.3 0.3 0.1 0.2 4.6 0.3 9.9 0.1 6.7 0.3 0.1 7.1 1.9 0.3 0.5 80.0 4.9 0.1 0.5 0.0 0.5 0.2 0.0 0.3 0.3 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 6.6 0.2 0.3 0.7 0.2 0.0 0.6 1.3 0.4 0.3 0.0 0.0 0.1 0.1 0.0 0.2 1.0 0.0 0.1 0.1 0.8 1.5 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.2 0.2 0.1 0.2 0.0 0.4 0.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.2 1.4 0.1 0.3 0.3 0.9 0.1 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 2.6 0.5 0.0 80.0 0.0 0.5 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.3 0.0 0.0 0.0 0.0 CLEC4D "CD368, CLECSF8, Dectin-3, MCL, Mpcl" ENSG00000166527 "C-type lectin domain family 4 member D" Q8WXI8 12 8509475-8522366 "Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 35.0;bone marrow: 38.4;lymphoid tissue: 15.0" "Cell type enriched" "Detected in some" 5 "Kupffer cells: 13.9" "Cancer enriched" "Detected in single" 50 "testis cancer: 11.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 18 "classical monocyte: 20.9;neutrophil: 35.0" "Group enriched" "Detected in many" 32 "granulocytes: 35.0;monocytes: 20.9" "Cell line enhanced" "Detected in some" "NB-4: 2.9;NTERA-2: 11.6;SuSa: 12.4;U-937: 6.6" "Not detected" "Not detected" HPA004906 Approved NA NA "HPA004906: AB_1078535" "unprognostic (1.10e-1)" "unprognostic (4.94e-2)" "unprognostic (4.78e-2)" "unprognostic (1.27e-1)" "unprognostic (4.39e-1)" "unprognostic (3.84e-2)" "unprognostic (7.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.70e-1)" "unprognostic (3.81e-1)" "unprognostic (7.91e-5)" "unprognostic (1.12e-2)" "unprognostic (8.57e-2)" "unprognostic (7.89e-2)" "unprognostic (2.18e-1)" 1.7 0.2 0.1 4.8 0.6 38.4 0.4 0.1 1.8 2.2 0.3 0.1 0.0 0.0 0.2 0.3 0.3 1.4 0.3 3.6 1.1 0.2 0.4 0.7 6.7 10.4 0.6 0.0 0.4 0.3 0.0 0.4 0.4 0.7 0.2 0.0 0.1 0.3 0.0 1.3 0.1 0.5 0.5 0.5 15.0 0.5 0.5 0.4 0.1 0.7 0.4 0.4 0.5 4.2 0.1 0.8 35.0 20.9 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 11.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.3 20.9 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 35.0 0.0 0.3 0.2 0.0 4.4 0.1 0.6 0.1 1.8 1.1 0.2 0.6 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 13.9 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CLEC4E "CLECSF9, mincle" ENSG00000166523 "C-type lectin domain family 4 member E" Q9ULY5 12 8533305-8540963 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2" "Group enriched" "Detected in some" 8 "Kupffer cells: 144.8;Macrophages: 65.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 22.8;neutrophil: 81.7" "Group enriched" "Detected in many" 17 "granulocytes: 81.7;monocytes: 22.8" "Group enriched" "Detected in some" 4 "NB-4: 5.8;RPTEC TERT1: 16.3" "Not detected" "Not detected" HPA004935 Uncertain Uncertain Cytosol NA NA Cytosol "HPA004935: AB_2667299" "unprognostic (3.05e-2)" "unprognostic (2.01e-2)" "unprognostic (8.91e-2)" "unprognostic (3.76e-1)" "unprognostic (1.76e-1)" "unprognostic (9.71e-3)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (9.29e-2)" "unprognostic (1.83e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.62e-1)" "unprognostic (1.51e-1)" "unprognostic (8.44e-2)" "unprognostic (2.29e-1)" 8.4 3.0 1.1 20.9 2.4 37.7 17.5 1.2 2.2 3.4 1.4 0.0 1.1 0.1 1.2 1.6 1.7 4.2 6.7 5.9 1.3 1.2 6.2 3.5 25.6 41.2 2.8 0.6 1.0 3.3 0.0 1.7 1.7 9.0 1.6 0.5 1.1 1.2 0.6 2.7 0.7 1.9 3.2 5.3 34.2 1.8 3.3 0.8 0.7 12.8 0.9 1.1 2.2 2.2 0.0 2.9 81.7 22.8 0.0 0.0 4.5 0.1 0.6 0.4 0.0 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1 2.0 0.1 0.2 2.6 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.3 0.3 0.0 0.7 0.1 0.0 1.7 0.1 0.6 0.7 0.1 0.2 0.1 0.0 0.1 0.0 5.8 0.5 0.0 0.1 0.1 0.2 0.1 16.3 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.0 0.5 1.3 0.6 0.1 1.1 0.1 0.2 0.1 0.1 1.6 0.5 0.1 0.0 22.8 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 81.7 0.0 0.1 0.1 0.0 4.5 1.1 2.4 1.2 2.2 1.3 1.2 2.8 0.6 9.0 0.8 0.0 6.6 1.4 0.0 0.0 0.0 0.3 7.6 1.4 3.4 1.8 0.0 0.0 0.0 4.5 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 5.8 0.0 0.0 11.6 144.8 1.1 0.9 65.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 12.9 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 CLEC4G "LSECtin, UNQ431" ENSG00000182566 "C-type lectin domain family 4 member G" Q6UXB4 19 7728957-7733906 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 63.1;lymphoid tissue: 53.5" "Cell type enriched" "Detected in some" 13 "Ito cells: 979.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 11.8" "Cell type enhanced" "Detected in some" "classical monocyte: 13.9;myeloid DC: 11.9" "Group enriched" "Detected in many" 19 "B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.3;RT4: 1.2;TIME: 2.7;U-937: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB003789, HPA014044" Enhanced NA NA "CAB003789: , HPA014044: AB_1846916" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.64e-1)" "unprognostic (4.47e-2)" "unprognostic (1.35e-1)" "unprognostic (7.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.23e-1)" "unprognostic (3.29e-2)" "unprognostic (7.45e-2)" "unprognostic (3.04e-1)" "unprognostic (2.13e-8)" "unprognostic (5.21e-2)" "unprognostic (1.27e-1)" "unprognostic (1.77e-1)" "unprognostic (6.65e-2)" 11.2 0.1 0.9 1.5 1.2 0.9 2.6 11.8 1.6 0.2 1.5 0.2 0.2 0.4 0.2 1.3 5.2 2.7 1.0 7.3 2.6 1.0 0.3 63.1 0.5 53.5 0.8 0.2 0.5 0.8 0.0 0.2 0.8 0.2 0.8 0.7 0.3 4.9 0.5 0.2 0.4 0.7 0.7 0.2 1.3 0.3 0.7 0.2 0.3 0.5 0.6 0.2 2.0 0.6 4.1 11.9 0.5 13.9 0.4 0.1 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.7 2.7 0.0 0.1 0.7 0.0 0.1 0.0 0.3 0.0 2.2 0.1 0.0 13.9 0.0 0.0 3.3 0.0 0.3 0.0 0.0 11.9 4.1 0.1 0.0 0.5 0.4 0.4 0.6 0.0 2.8 0.9 1.2 11.8 1.6 2.6 1.0 0.8 0.2 0.2 0.2 0.0 0.0 9.3 0.0 0.1 0.0 0.4 7.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 979.0 76.3 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.2 0.0 0.0 0.0 CLEC4M "CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN" ENSG00000104938 "C-type lectin domain family 4 member M" Q9H2X3 19 7763149-7769605 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "liver: 38.5;lymphoid tissue: 30.1" "Cell type enriched" "Detected in some" 17 "Ito cells: 378.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Group enriched" "Detected in some" 7 "GAMG: 3.5;HUVEC TERT2: 2.3;K-562: 3.1;Karpas-707: 1.2;RPMI-8226: 1.6" "CAB033689, CAB033691, HPA042661" Supported "Intracellular and membrane" NA NA 890000 "CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101" "unprognostic (1.56e-1)" "unprognostic (3.03e-1)" "unprognostic (1.00e-1)" "unprognostic (1.71e-2)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (6.58e-2)" "unprognostic (1.27e-1)" "unprognostic (4.58e-3)" "unprognostic (4.60e-2)" "unprognostic (5.15e-2)" "unprognostic (1.43e-1)" 0.9 0.9 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.3 0.1 1.2 0.6 0.1 0.1 0.1 0.0 0.1 38.5 2.5 30.1 0.1 0.1 2.7 0.1 0.0 0.1 4.8 0.2 0.1 0.0 0.1 0.8 0.1 0.1 0.0 0.5 0.1 0.1 0.2 0.0 1.4 0.1 0.1 0.2 0.1 0.2 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 3.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.0 378.7 22.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.1 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.8" "Group enriched" "Detected in some" 4 "Hofbauer cells: 18.6;Macrophages: 57.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "classical monocyte: 11.5" "Lineage enriched" "Detected in many" 8 "monocytes: 11.5" "Group enriched" "Detected in some" 23 "HL-60: 15.2;U-937: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054137: AB_2732582" "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.4 3.2 1.8 7.3 2.4 35.8 0.8 0.8 2.5 1.7 0.4 1.9 0.6 0.4 0.8 0.5 1.4 1.2 2.0 3.8 7.6 3.1 2.9 2.1 13.9 0.3 2.4 0.5 2.7 2.6 1.4 1.1 2.7 8.2 0.9 0.5 0.8 2.7 0.8 0.3 2.7 0.3 1.5 4.8 2.1 0.4 0.9 4.8 1.1 1.4 4.9 1.4 1.9 1.1 0.0 0.5 1.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.0 11.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 1.9 1.8 2.4 0.8 2.5 7.6 3.1 2.4 0.5 8.2 4.8 0.0 7.4 0.0 0.0 1.6 0.0 0.3 2.5 5.3 9.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 2.3 0.0 18.6 0.0 0.0 0.0 3.8 0.2 0.0 57.4 1.7 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.3 0.2 0.0 0.0 0.0 CLEC6A "CLECSF10, dectin-2" ENSG00000205846 "C-type lectin domain containing 6A" Q6EIG7 12 8455926-8478330 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.4;heart muscle: 2.3;lung: 6.2;lymphoid tissue: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 8.4;myeloid DC: 3.5" "Group enriched" "Detected in many" 11 "dendritic cells: 3.5;monocytes: 8.4" "Cell line enriched" "Detected in some" 4 "NTERA-2: 8.6" "Low region specificity" "Detected in many" NA NA "unprognostic (1.44e-1)" "unprognostic (9.07e-3)" "unprognostic (5.32e-3)" "unprognostic (1.27e-2)" "unprognostic (2.54e-1)" "unprognostic (4.27e-4)" "unprognostic (6.06e-2)" "unprognostic (2.17e-1)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (7.30e-4)" "unprognostic (8.89e-2)" "unprognostic (3.29e-1)" "unprognostic (2.43e-1)" "unprognostic (2.60e-2)" 0.2 0.2 0.1 4.9 0.2 0.5 0.2 0.1 0.1 0.8 0.2 0.0 0.0 0.0 0.2 0.8 0.2 0.3 0.2 2.3 0.5 0.2 0.4 0.8 6.2 5.0 0.2 0.0 0.1 0.3 0.0 0.2 0.9 0.4 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.4 0.9 0.1 0.5 0.0 0.7 0.2 0.0 1.7 1.1 0.2 0.0 3.5 0.5 8.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.2 0.1 0.1 0.5 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLEC7A "CD369, CLECSF12, dectin-1, hDectin-1, SCARE2" ENSG00000172243 "C-type lectin domain containing 7A" Q9BXN2 12 10116777-10130258 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8" "Group enriched" "Detected in many" 11 "Hofbauer cells: 84.0;Kupffer cells: 334.2;Macrophages: 240.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 53.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "Karpas-707: 60.8;U-266/84: 47.3" "Low region specificity" "Detected in many" NA NA "unprognostic (1.79e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" "unprognostic (3.64e-1)" "unprognostic (3.03e-2)" "unprognostic (5.49e-2)" "unprognostic (5.19e-2)" "unprognostic (5.88e-3)" "unprognostic (2.10e-1)" "unprognostic (9.87e-2)" "unprognostic (7.46e-2)" "unprognostic (4.40e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.83e-2)" "unprognostic (3.89e-2)" "unprognostic (5.13e-2)" "unprognostic (1.14e-1)" 7.1 5.0 6.3 27.7 7.4 43.9 3.7 0.9 3.4 3.9 4.5 9.5 0.5 3.7 3.2 8.9 8.7 5.3 7.4 5.2 6.2 4.2 8.7 6.9 32.8 24.2 8.9 4.3 2.4 2.8 1.6 2.6 7.8 8.6 2.7 5.0 6.4 6.5 2.4 1.2 3.2 6.5 5.7 18.7 28.8 3.1 1.6 7.3 5.1 2.3 3.2 9.1 5.5 3.8 0.1 13.1 53.9 30.1 0.1 0.1 7.4 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 0.1 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.4 47.3 0.0 0.1 0.3 0.0 0.2 26.4 0.4 0.0 29.5 0.1 0.0 0.0 0.0 13.1 0.1 0.0 0.0 53.9 0.1 30.1 0.2 0.0 7.4 6.3 7.4 0.9 3.4 6.2 4.2 8.9 4.3 8.6 7.3 11.9 20.4 11.3 0.2 3.3 0.0 0.6 0.0 4.0 13.6 0.0 0.0 1.2 0.0 0.0 1.4 3.1 0.0 0.0 0.0 10.7 2.6 0.1 5.8 2.1 84.0 0.0 0.0 8.0 334.2 1.5 0.3 240.6 3.3 8.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 12.9 0.1 0.0 0.5 2.6 4.5 1.3 0.0 0.4 CLEC9A "CD370, DNGR-1, HEEE9341, UNQ9341" ENSG00000197992 "C-type lectin domain containing 9A" Q6UXN8 12 10030677-10066027 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 17.3;brain: 7.8;lymphoid tissue: 8.9;testis: 21.1" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 2.2;Macrophages: 9.3;Spermatocytes: 7.0" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 103 "myeloid DC: 17.3;neutrophil: 6.1" "Group enriched" "Detected in many" 103 "dendritic cells: 17.3;granulocytes: 6.1" "Group enriched" "Detected in some" 5 "GAMG: 2.1;Karpas-707: 1.2;U-266/84: 3.7" "Not detected" "Not detected" NA NA "unprognostic (1.13e-3)" "unprognostic (1.21e-2)" "unprognostic (5.00e-3)" "unprognostic (7.85e-3)" "unprognostic (1.28e-2)" "unprognostic (1.56e-5)" "unprognostic (6.58e-4)" "unprognostic (4.73e-3)" "unprognostic (9.65e-2)" "unprognostic (7.45e-3)" "unprognostic (8.15e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (7.93e-2)" "unprognostic (3.45e-5)" "unprognostic (2.17e-1)" 0.6 0.0 3.3 1.7 2.5 0.3 0.6 0.6 1.1 0.6 0.6 0.6 0.6 0.9 0.6 0.6 0.6 0.0 1.0 0.6 3.2 3.1 0.6 0.8 0.6 8.9 5.0 0.6 0.8 0.6 0.0 0.6 1.0 0.6 0.6 0.6 0.6 1.2 0.6 0.6 0.0 1.8 0.8 7.8 6.4 0.2 21.1 0.6 0.6 0.6 0.6 2.8 0.8 0.6 0.0 17.3 6.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 6.1 0.1 0.0 0.0 0.0 0.3 3.3 2.5 0.6 1.0 3.2 3.1 5.0 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.9 0.0 0.0 0.0 0.0 0.0 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6" "Group enriched" "Detected in some" 4 "B-cells: 69.2;Hofbauer cells: 21.8;Kupffer cells: 84.7;Macrophages: 31.4;monocytes: 69.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 42.4" "Lineage enriched" "Detected in many" 5 "B-cells: 42.4" "Group enriched" "Detected in some" 5 "HEL: 16.0;Karpas-707: 22.2;U-698: 56.8;U-937: 31.2" HPA063928 Supported "Plasma membrane,Centriolar satellite" NA NA "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 2.7 1.0 0.8 9.8 1.1 0.9 1.1 0.3 0.9 0.6 1.7 1.3 0.1 1.6 0.7 1.3 2.6 0.9 1.5 2.7 1.0 0.9 1.6 1.4 1.9 15.5 1.3 0.7 0.5 1.7 0.0 0.9 0.5 0.9 0.8 2.8 0.8 1.5 0.1 0.5 0.5 11.5 0.9 2.5 20.5 2.6 0.6 0.3 2.2 0.9 0.5 20.6 2.8 2.4 42.4 8.6 0.7 4.6 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 56.8 0.0 31.2 0.0 0.7 2.6 0.1 1.7 4.6 0.0 42.4 1.4 3.5 6.1 14.5 0.0 0.5 0.1 0.0 4.6 8.6 0.1 2.1 0.8 1.1 0.3 0.9 1.0 0.9 1.3 0.7 0.9 0.3 0.0 0.0 69.2 0.1 1.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.4 0.0 4.7 0.2 21.8 0.0 0.0 0.6 84.7 1.1 0.3 31.4 11.8 69.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.2 0.0 0.0 1.6 0.2 12.5 0.0 0.1 CLGN ENSG00000153132 Calmegin O14967 4 140388455-140427968 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 243.4;Early spermatids: 78.2;Muller glia cells: 200.1;Spermatocytes: 280.7" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 21.7;U-251 MG: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020709, HPA048761, HPA058627" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782" "unprognostic (6.74e-2)" "unprognostic (8.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" "unprognostic (3.73e-3)" "unprognostic (6.14e-2)" "unprognostic (4.80e-2)" "unprognostic (3.11e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-2)" "unprognostic (2.45e-3)" "unprognostic (3.00e-3)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.01e-1)" 0.4 3.6 2.1 0.7 3.7 1.2 1.6 5.9 3.5 0.8 1.4 0.5 0.0 0.4 1.0 1.6 0.9 7.0 0.4 40.3 0.9 3.4 0.4 3.7 0.5 0.5 1.4 1.6 1.8 1.6 0.2 23.6 0.3 8.6 11.9 0.8 2.4 0.6 0.6 0.4 0.3 0.8 0.9 0.8 0.3 1.6 52.6 0.3 3.1 1.5 0.0 0.8 0.6 0.4 0.5 1.0 3.4 1.1 0.0 0.0 0.1 0.0 4.0 4.2 2.7 1.7 8.8 1.0 0.0 3.7 4.0 7.5 0.1 0.3 0.0 11.5 0.4 3.5 0.1 2.9 0.0 6.6 0.2 3.4 1.1 4.0 2.9 17.5 14.6 0.2 1.0 16.1 0.4 0.4 21.7 0.1 3.9 0.7 0.0 0.0 0.2 18.3 0.2 4.8 0.1 11.4 12.2 0.0 0.1 0.0 0.1 6.8 12.3 2.5 1.6 0.7 1.6 0.8 2.2 0.0 11.0 2.0 4.0 28.9 5.8 12.6 7.9 17.7 0.6 1.2 3.4 1.1 1.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 3.7 5.9 3.5 0.9 3.4 1.4 1.6 8.6 0.3 0.0 2.1 0.0 1.0 0.0 8.5 243.4 0.0 28.1 4.5 0.0 3.9 0.3 0.0 0.9 78.2 1.1 0.0 23.3 3.7 0.1 0.5 35.3 0.0 2.6 0.1 23.8 5.1 0.0 0.0 42.6 4.6 0.0 1.7 0.0 0.0 200.1 1.4 0.0 4.2 0.0 11.8 0.0 0.3 280.7 9.8 0.1 0.2 0.0 0.4 0.9 CLIC2 XAP121 ENSG00000155962 "Chloride intracellular channel 2" O15247 X 155276211-155334657 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 62.3;vagina: 66.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 83.4;Alveolar cells type 2: 48.6;Endothelial cells: 49.6;Kupffer cells: 47.8;monocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 14 "dendritic cells: 24.5;monocytes: 9.5" "Group enriched" "Detected in some" 5 "HDLM-2: 37.3;K-562: 20.2;Karpas-707: 18.6;RPMI-8226: 31.8" "Low region specificity" "Detected in all" "HPA047381, HPA060101" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 290000 "Plasma membrane, Cytosol" Nucleoplasm "HPA047381: AB_2680022, HPA060101: AB_2684204" "unprognostic (3.27e-2)" "unprognostic (5.21e-3)" "unprognostic (9.70e-2)" "unprognostic (7.25e-2)" "unprognostic (9.71e-2)" "unprognostic (3.78e-2)" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.95e-1)" "unprognostic (1.74e-1)" "unprognostic (1.97e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (1.97e-2)" "unprognostic (2.97e-2)" "unprognostic (6.63e-2)" "unprognostic (1.54e-1)" 26.5 3.7 3.8 7.5 6.1 3.4 24.1 2.6 4.8 15.5 6.8 0.6 3.3 4.0 11.3 10.5 10.4 6.5 9.8 9.4 3.7 3.4 5.4 6.3 31.0 15.6 7.5 1.4 12.5 2.6 2.0 7.8 4.5 6.8 9.1 6.9 3.0 5.4 3.2 10.3 5.2 7.3 10.2 5.2 32.1 4.7 5.6 4.3 6.9 62.3 8.7 12.4 14.0 66.1 0.0 24.5 0.6 9.5 1.1 0.1 1.0 0.2 0.0 0.4 0.3 0.3 2.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 37.3 0.2 5.2 0.1 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 20.2 18.6 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 31.8 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.7 0.6 0.7 0.3 1.2 1.6 0.0 0.9 1.1 0.6 0.0 1.8 0.1 0.0 9.5 0.1 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.6 1.1 6.5 2.5 0.0 1.0 3.8 6.1 2.6 4.8 3.7 3.4 7.5 1.4 6.8 4.3 83.4 48.6 0.8 0.7 11.7 1.1 2.8 0.0 2.7 10.3 0.0 0.0 0.0 0.0 0.0 0.1 49.6 0.0 23.3 0.2 0.1 22.3 0.4 3.5 1.0 4.8 0.0 1.2 19.0 47.8 0.4 12.7 29.8 16.9 118.2 0.0 0.0 0.1 0.0 8.9 0.2 0.3 6.5 4.8 0.0 0.0 12.0 0.0 2.2 0.0 1.4 CLIC3 ENSG00000169583 "Chloride intracellular channel 3" O95833 9 136994635-136996803 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.5;esophagus: 74.1;placenta: 103.5" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 778.7;Extravillous trophoblasts: 921.9;Syncytiotrophoblasts: 1705.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 130.8" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 10 "plasmacytoid DC: 163.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 163.5" "Cell line enhanced" "Detected in some" "BEWO: 68.1;MCF7: 31.0;SK-BR-3: 13.0;T-47d: 29.6;TIME: 23.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA005963 Enhanced Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA005963: AB_1078536" "unprognostic (4.30e-2)" "unprognostic (2.53e-1)" "unprognostic (3.54e-1)" "unprognostic (1.55e-2)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-3)" "unprognostic (1.39e-1)" "unprognostic (3.26e-3)" "unprognostic (7.73e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.74e-4)" 1.9 0.2 0.1 1.6 0.2 1.2 1.1 0.0 0.5 17.6 0.5 0.1 0.0 0.2 1.3 6.8 74.1 0.6 0.8 1.8 0.2 0.1 0.4 0.2 27.3 1.4 0.2 0.2 0.4 0.2 0.1 0.5 103.5 0.8 1.0 0.1 1.3 8.2 0.6 0.2 25.0 0.8 0.3 0.6 2.2 2.9 0.6 0.0 15.7 55.5 53.4 43.1 0.8 28.1 0.2 163.5 0.6 0.1 17.1 15.8 10.2 5.5 0.0 0.0 0.0 0.1 0.3 68.1 0.5 0.2 0.1 0.0 0.3 2.7 0.0 4.5 4.8 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.7 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 11.7 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 9.3 13.0 0.0 0.0 29.6 0.0 23.5 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 15.8 0.1 6.9 0.1 2.2 9.6 0.6 0.2 0.5 8.6 0.6 17.1 0.1 163.5 0.7 10.2 0.1 0.2 0.0 0.5 0.2 0.1 0.2 0.2 0.8 0.0 199.5 37.7 10.4 3.5 3.4 0.0 1.6 0.0 1.4 30.7 1.8 0.0 778.7 8.3 2.3 0.7 5.8 6.5 0.0 5.8 921.9 16.8 2.3 1.1 0.8 81.9 0.0 4.7 4.3 1.0 5.3 116.2 0.2 10.1 3.6 3.8 0.0 49.2 9.9 39.3 0.3 0.0 0.0 1.7 0.0 0.2 16.9 1705.4 70.8 2.9 18.2 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9" "Cell type enhanced" "Detected in many" 20 "Alveolar cells type 1: 473.4;Cardiomyocytes: 276.0;Enterocytes: 100.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 8.8" "Lineage enriched" "Detected in single" 23 "T-cells: 8.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.6;EFO-21: 9.6;HDLM-2: 5.0;REH: 11.7;U-266/70: 12.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA074371 Supported "Nuclear speckles,Plasma membrane" NA NA 1000000 "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 7.4 0.6 0.8 3.2 1.5 0.0 2.3 0.6 1.1 6.0 10.2 0.3 0.4 5.6 0.8 2.5 2.2 1.2 2.1 65.6 0.9 1.2 17.5 0.5 32.8 0.4 1.1 1.4 0.7 0.7 0.4 1.3 22.0 0.8 0.9 7.5 7.8 2.0 0.4 99.9 0.7 46.2 1.4 0.9 16.1 0.9 1.0 0.0 0.2 4.8 18.8 1.5 1.0 4.3 0.3 0.0 0.0 0.0 0.3 8.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.6 0.0 9.6 0.0 0.0 0.3 0.0 0.1 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.3 1.5 0.0 11.7 0.3 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 8.8 0.3 3.6 2.2 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 1.6 0.8 0.8 1.5 0.6 1.1 0.9 1.2 1.1 1.4 0.8 0.0 473.4 23.0 0.5 0.0 0.1 0.1 276.0 0.0 20.1 48.9 14.0 0.0 0.1 0.0 1.4 38.1 3.8 100.0 0.0 0.2 0.0 0.2 1.5 1.1 0.0 0.0 0.0 12.5 0.6 0.0 75.0 0.9 0.0 0.0 1.0 16.3 47.6 1.9 24.6 0.7 2.1 1.1 0.0 2.1 0.6 0.1 0.1 1.8 2.9 9.8 0.8 CLIC6 "CLIC1L, CLIC5" ENSG00000159212 "Chloride intracellular channel 6" Q96NY7 21 34669389-34718227 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.3;retina: 85.1;stomach 1: 45.1" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 30.6;Ciliated cells: 72.3;Club cells: 52.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 12 "pons and medulla: 63.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.4;NTERA-2: 5.9;T-47d: 12.0;THP-1: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065285 Enhanced NA NA "HPA065285: AB_2685454" "prognostic favorable (6.11e-5)" "unprognostic (2.17e-2)" "unprognostic (1.65e-2)" "unprognostic (4.27e-2)" "unprognostic (2.93e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-2)" "prognostic favorable (3.15e-5)" "unprognostic (4.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.43e-3)" 7.7 0.0 0.8 3.0 1.7 0.0 5.7 0.6 2.3 8.7 1.8 12.4 0.6 0.9 1.0 5.2 1.2 6.1 4.5 6.3 5.4 1.0 0.9 0.6 6.4 0.4 0.4 0.5 2.3 1.2 0.0 1.3 0.6 63.3 4.0 1.3 85.1 10.9 3.8 1.9 2.3 1.1 1.9 0.6 0.7 45.1 1.1 0.6 2.4 8.2 0.9 1.8 7.5 2.0 0.3 0.1 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.4 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 1.7 12.0 5.3 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.1 0.8 1.7 0.6 2.3 5.4 1.0 0.4 0.5 63.3 0.6 6.0 20.2 0.0 4.6 0.6 0.0 5.3 30.6 72.3 52.4 8.7 0.0 0.0 1.7 6.3 0.0 0.0 0.2 0.0 0.8 0.0 3.8 9.0 1.1 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.3 0.0 6.8 1.0 1.0 0.0 15.9 0.0 2.8 0.0 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 3.3 13.7 CLIP1 "CLIP, CLIP-170, CLIP170, CYLN1, RSN" ENSG00000130779 "CAP-Gly domain containing linker protein 1" P30622 12 122271432-122422632 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.5" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 400.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004399, HPA026678" Approved Supported "Microtubule ends,Cytosol" NA NA 7700 "Microtubule ends, Cytosol" "CAB004399: AB_671001, HPA026678: AB_1846954" "unprognostic (1.18e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (2.51e-1)" "unprognostic (7.62e-2)" "unprognostic (2.31e-2)" "unprognostic (8.97e-2)" "unprognostic (3.26e-2)" "unprognostic (5.50e-2)" "unprognostic (2.63e-1)" "unprognostic (3.37e-1)" "unprognostic (2.52e-3)" 14.4 12.6 9.8 9.1 10.9 6.4 11.7 44.5 11.5 11.6 19.5 4.3 13.9 5.7 14.3 10.1 24.8 7.5 7.7 11.8 9.3 7.5 10.0 15.2 10.0 5.8 6.5 9.5 6.3 9.1 37.8 10.9 36.5 8.7 13.2 7.1 6.7 11.8 15.1 96.5 16.8 9.1 31.1 7.2 5.9 9.6 6.1 6.9 3.7 24.1 25.9 10.1 22.2 16.6 5.3 5.4 18.2 10.6 3.9 7.2 3.7 15.5 19.7 12.2 12.3 10.4 16.1 21.3 22.3 21.2 15.1 9.5 9.1 7.7 7.0 15.0 28.8 19.4 20.0 7.7 9.1 17.1 29.3 5.6 2.3 13.1 9.6 20.8 8.1 12.9 10.6 31.5 17.4 26.3 20.2 15.1 6.2 8.7 4.8 15.1 9.0 5.0 2.8 4.6 6.7 17.5 4.6 9.4 3.5 13.6 17.9 4.7 3.0 47.7 11.7 19.5 11.0 10.1 4.8 29.2 11.5 12.4 26.9 14.5 5.3 4.2 4.2 19.7 4.1 7.9 3.6 6.5 5.2 7.2 10.6 5.4 5.3 6.7 6.5 5.4 3.6 5.0 3.7 18.2 3.9 8.6 3.5 5.8 3.7 9.8 10.9 44.5 11.5 9.3 7.5 6.5 9.5 8.7 6.9 125.0 126.6 21.9 132.8 59.6 59.4 113.6 43.3 131.2 134.2 41.8 41.2 101.8 6.6 54.0 137.2 49.6 24.3 0.0 56.4 29.4 46.1 121.3 69.5 39.3 33.9 125.5 13.4 48.5 34.8 68.2 33.1 51.6 52.3 30.7 18.9 36.4 75.0 24.6 58.4 10.5 41.9 71.1 40.1 21.2 29.5 125.3 400.9 27.1 21.5 189.8 CLIP2 "CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4" ENSG00000106665 "CAP-Gly domain containing linker protein 2" Q9UDT6 7 74289475-74405943 "Plasma proteins, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.0" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 26.9;Enterocytes: 28.7" "Cancer enhanced" "Detected in all" "glioma: 43.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 31.4" "Low region specificity" "Detected in all" "HPA020430, CAB020767" Enhanced NA NA 960000 "CAB020767: , HPA020430: AB_1846958" "unprognostic (7.46e-2)" "unprognostic (2.49e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (5.35e-4)" "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" "unprognostic (5.94e-2)" "unprognostic (2.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-3)" "unprognostic (3.18e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.22e-1)" "unprognostic (6.96e-2)" "unprognostic (4.89e-2)" "unprognostic (1.38e-1)" 6.3 7.1 27.8 9.3 24.1 3.7 2.9 16.0 44.0 8.6 15.3 28.2 3.3 10.5 8.9 2.6 6.3 4.8 10.3 4.7 28.3 24.9 4.9 2.3 6.0 4.8 30.9 17.9 16.7 11.9 6.3 5.6 8.3 19.3 5.4 9.5 4.0 3.7 9.5 2.2 9.0 12.7 8.0 34.7 6.0 11.1 3.0 18.3 2.0 1.9 1.0 6.8 7.4 10.5 2.8 0.7 2.9 2.1 0.1 0.6 0.9 3.1 11.0 8.6 9.3 10.2 11.5 0.1 8.1 16.1 4.7 5.1 2.4 14.4 0.5 1.6 14.3 31.4 11.8 1.6 8.8 2.0 21.3 0.8 2.5 1.5 6.1 9.9 0.5 3.0 12.8 4.0 14.2 11.8 12.3 6.8 0.3 0.6 0.1 8.9 1.0 0.3 16.4 3.9 14.3 10.8 16.8 3.3 0.7 6.1 11.1 1.8 9.8 4.5 1.3 15.9 6.9 1.0 1.9 8.1 12.7 7.8 17.4 4.9 0.4 0.1 0.0 14.7 4.6 10.7 2.9 1.2 0.0 0.1 2.1 0.6 2.8 0.0 0.0 0.7 0.9 0.0 0.4 0.8 0.1 0.9 0.0 0.0 0.9 27.8 24.1 16.0 27.6 28.3 24.9 30.9 17.9 19.3 18.3 0.0 0.0 1.3 4.6 26.9 8.9 1.6 10.2 1.4 1.2 3.5 0.0 0.2 0.0 8.8 0.2 7.1 28.7 0.0 5.4 0.3 8.4 1.9 1.1 1.1 4.8 17.5 9.9 4.9 3.3 0.0 2.6 7.0 11.8 7.2 12.0 4.0 8.7 16.9 7.4 0.3 3.3 12.9 11.5 0.0 1.7 5.9 0.8 4.3 8.7 1.0 CLIP3 "CLIPR-59, RSNL1" ENSG00000105270 "CAP-Gly domain containing linker protein 3" Q96DZ5 19 36014660-36033343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 108.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 31.5;Horizontal cells: 39.7;Leydig cells: 20.4;Muller glia cells: 27.8;Peritubular cells: 23.0" "Cancer enhanced" "Detected in all" "glioma: 65.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.6;ASC TERT1: 30.7;fHDF/TERT166: 21.4;HHSteC: 19.8;HSkMC: 34.0;hTERT-RPE1: 29.1" HPA079430 Uncertain NA NA "HPA079430: " "unprognostic (1.91e-2)" "unprognostic (8.70e-2)" "unprognostic (1.16e-2)" "unprognostic (5.01e-2)" "unprognostic (1.19e-1)" "unprognostic (1.38e-1)" "unprognostic (3.60e-2)" "unprognostic (2.92e-2)" "unprognostic (2.55e-2)" "unprognostic (3.26e-2)" "prognostic favorable (2.80e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (1.56e-10)" "unprognostic (6.31e-3)" "unprognostic (1.52e-1)" "unprognostic (9.63e-2)" "unprognostic (1.09e-2)" 6.4 10.9 38.4 7.5 35.2 1.6 4.1 52.9 108.3 17.6 15.1 14.9 2.8 5.7 24.0 10.4 12.7 10.6 17.0 5.1 33.3 37.6 4.8 2.3 4.2 5.5 30.6 37.8 28.2 3.6 2.1 10.9 7.5 30.2 16.7 7.4 4.9 3.9 25.4 2.4 3.7 5.8 27.7 20.3 6.3 6.7 6.6 16.9 2.9 2.2 0.1 5.4 17.4 7.4 1.2 0.7 1.7 0.9 2.6 1.8 0.8 0.4 1.3 11.7 0.5 19.6 30.7 0.4 6.6 16.2 5.6 8.5 1.4 0.4 0.6 2.8 21.4 0.4 0.5 0.2 0.0 4.0 0.8 0.4 0.3 1.2 0.2 19.8 0.3 0.3 34.0 0.3 4.8 0.1 29.1 6.2 4.5 0.6 1.2 12.4 1.0 6.2 0.4 1.4 0.4 0.3 0.8 0.2 0.3 0.2 0.4 11.5 13.4 0.7 0.3 0.3 5.1 0.4 0.1 1.7 9.6 8.1 0.4 0.4 1.0 0.8 0.5 14.8 0.6 3.5 0.0 0.6 1.7 1.1 0.9 0.3 1.2 1.7 0.6 0.2 1.0 1.8 1.2 0.5 2.6 0.4 0.7 1.1 0.8 38.4 35.2 52.9 50.6 33.3 37.6 30.6 37.8 30.2 16.9 0.0 0.0 0.0 0.7 0.6 31.5 1.7 0.0 1.4 0.0 1.8 2.0 0.5 0.0 0.1 9.4 3.1 0.2 0.0 0.2 0.4 8.7 0.2 0.0 0.0 0.7 39.7 2.4 4.3 0.0 15.7 20.4 0.6 3.3 0.0 0.7 27.8 0.4 0.0 23.0 0.0 9.4 6.5 9.5 2.2 2.9 1.1 1.0 0.0 0.2 0.0 CLLU1OS ENSG00000205057 "Chronic lymphocytic leukemia up-regulated 1 opposite strand" Q5K130 12 92420094-92428148 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.0;lymphoid tissue: 2.9;salivary gland: 4.0" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 1.9;monocytes: 1.8;Pancreatic endocrine cells: 1.5" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 31 "memory B-cell: 4.0;naive B-cell: 3.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 27 "B-cells: 4.0;dendritic cells: 1.3" "Cell line enriched" "Detected in some" 8 "U-698: 12.0" NA NA "unprognostic (9.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.12e-1)" "unprognostic (2.68e-1)" "unprognostic (8.52e-3)" "unprognostic (2.41e-1)" "unprognostic (1.75e-2)" "unprognostic (2.58e-1)" "unprognostic (7.07e-2)" "unprognostic (3.72e-1)" "unprognostic (1.69e-2)" "unprognostic (6.61e-2)" "unprognostic (2.88e-1)" "unprognostic (2.51e-1)" 0.4 0.0 0.0 0.7 0.0 1.4 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.0 0.3 0.5 0.0 0.0 0.4 0.2 0.5 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.3 0.2 0.6 0.0 0.1 2.9 0.2 0.1 0.0 2.9 2.4 0.3 4.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.5 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319906 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 38.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 153.5;Late spermatids: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 11.9;SK-BR-3: 13.7;T-47d: 11.5;WM-115: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favorable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 14.1 2.3 11.0 5.9 36.3 2.0 13.0 3.1 20.1 7.8 15.3 31.6 5.6 4.6 5.6 11.0 4.3 8.2 8.3 3.7 13.0 5.6 18.9 18.8 5.2 2.3 38.1 8.0 3.5 18.1 4.7 3.4 9.2 17.2 8.0 17.6 7.1 9.4 7.9 4.6 3.5 6.9 4.5 14.5 3.6 10.0 33.4 34.0 0.0 6.6 1.8 2.9 7.3 7.1 3.8 3.0 7.2 8.4 0.0 0.1 2.1 5.2 7.0 1.1 0.2 4.3 1.9 0.4 0.1 0.0 0.3 0.2 0.6 8.8 0.0 0.8 0.0 11.9 4.6 0.5 3.1 0.0 3.5 1.3 0.1 0.2 4.1 0.4 0.0 0.1 2.1 3.1 1.4 5.0 1.7 3.6 1.9 0.0 1.0 2.6 4.5 0.2 0.4 0.4 6.3 1.7 3.9 3.8 2.3 3.4 8.6 1.4 1.4 1.8 13.7 7.0 1.1 11.5 0.3 1.0 0.1 3.2 0.0 0.2 1.4 0.1 4.8 2.5 2.1 13.1 6.0 8.4 0.7 0.0 3.0 0.0 3.8 0.0 0.0 1.8 2.2 0.0 0.1 7.2 0.0 1.8 3.0 0.0 2.1 11.0 36.3 3.1 20.1 13.0 5.6 38.1 8.0 17.2 34.0 14.9 4.3 9.8 28.6 5.6 59.5 42.8 43.3 50.9 12.5 55.8 13.7 1.6 23.2 46.5 153.5 5.6 41.0 0.0 41.2 1.5 4.6 50.7 4.6 61.4 7.5 36.5 22.4 1.8 17.1 245.4 20.8 7.6 3.3 6.4 64.0 3.2 40.2 35.1 10.3 17.9 25.8 103.5 91.4 4.1 16.6 2.3 2.4 2.2 48.8 39.4 CLN8 "C8orf61, EPMR, FLJ39417" ENSG00000182372 "CLN8, transmembrane ER and ERGIC protein" Q9UBY8 8 1755778-1801711 "Disease related genes, Predicted membrane proteins" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.5" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "plasmacytoid DC: 35.5" "Lineage enriched" "Detected in all" 5 "dendritic cells: 35.5" "Low cell line specificity" "Detected in many" NA NA "unprognostic (5.86e-2)" "unprognostic (1.95e-2)" "unprognostic (6.40e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (4.05e-3)" "unprognostic (1.21e-1)" "unprognostic (3.45e-1)" "unprognostic (3.03e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-3)" "unprognostic (1.83e-1)" "prognostic favorable (4.36e-8)" "unprognostic (1.36e-1)" "unprognostic (1.70e-1)" "unprognostic (6.24e-2)" "unprognostic (8.38e-2)" 6.4 4.6 10.3 5.2 11.5 12.8 4.2 5.5 11.4 4.2 6.1 22.8 5.1 8.3 5.0 7.7 14.6 5.6 13.3 8.1 12.2 8.7 6.2 12.0 7.5 8.2 21.3 6.1 3.3 11.5 2.2 4.0 8.9 12.1 4.2 5.2 3.0 6.1 7.2 4.8 10.3 6.2 6.8 24.1 8.9 7.3 7.3 14.6 3.9 6.1 6.4 7.6 11.3 4.5 6.8 35.5 2.6 6.0 2.1 3.4 2.7 3.1 7.0 1.7 3.1 3.5 3.4 8.2 5.4 4.3 3.5 5.0 5.1 8.4 4.3 2.5 2.9 3.2 5.9 3.4 6.1 7.0 2.0 1.6 3.5 2.4 1.7 1.4 2.0 11.8 2.0 3.5 3.8 2.0 0.6 6.9 5.5 4.0 2.1 6.9 3.1 6.2 1.9 3.4 8.7 6.6 4.2 2.5 2.4 4.4 5.6 1.0 1.6 2.2 1.7 2.3 4.7 13.3 2.9 9.7 7.4 2.8 0.8 4.0 0.8 4.1 6.1 3.8 4.6 8.5 2.6 4.7 1.9 3.2 6.0 3.4 4.8 3.3 2.1 4.7 6.8 3.3 2.2 1.3 2.1 5.0 35.5 3.2 2.7 10.3 11.5 5.5 11.4 12.2 8.7 21.3 6.1 12.1 14.6 8.9 17.4 41.7 67.0 48.5 25.6 7.1 17.8 17.4 20.5 29.6 29.5 28.5 13.3 22.8 3.3 40.5 18.2 23.3 16.7 15.9 22.8 74.2 27.6 23.7 40.5 38.1 18.9 29.4 36.1 4.9 7.5 56.8 20.3 11.8 14.0 14.7 16.6 18.2 11.3 7.6 25.5 12.9 16.5 14.9 10.9 55.6 110.1 17.3 14.4 48.1 CLNK MIST ENSG00000109684 "Cytokine dependent hematopoietic cell linker" Q7Z7G1 4 10486395-10684865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 10.9;lymphoid tissue: 10.8" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 11.6;granulocytes: 11.5" "Cancer enriched" "Detected in single" 13 "renal cancer: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 9.2;U-937: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035671, HPA035672" Uncertain Uncertain Vesicles NA NA Vesicles "HPA035671: AB_10669673, HPA035672: AB_10669775" "unprognostic (2.47e-3)" "unprognostic (4.74e-4)" "unprognostic (1.99e-4)" "unprognostic (2.24e-3)" "unprognostic (1.17e-1)" "unprognostic (2.23e-6)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" "unprognostic (9.87e-2)" "unprognostic (3.75e-2)" "unprognostic (2.55e-1)" "unprognostic (7.74e-3)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (6.65e-3)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" 0.4 0.5 0.3 5.7 0.3 0.5 0.7 0.4 0.3 1.9 1.8 0.1 0.1 0.7 0.8 1.7 2.0 0.4 1.4 0.3 0.3 0.3 10.9 1.2 3.2 5.0 0.3 0.1 0.5 0.7 0.0 3.2 1.5 0.5 0.5 0.4 1.6 2.5 0.1 0.3 1.2 2.3 1.7 0.3 6.3 1.6 1.1 0.1 8.4 0.5 1.5 10.8 0.4 0.4 3.4 5.5 1.6 0.4 4.3 3.6 0.5 0.1 0.6 0.5 0.3 0.8 0.2 0.6 0.4 0.0 0.1 0.2 0.0 0.4 0.3 0.1 0.4 0.1 0.4 0.0 0.0 0.1 9.2 0.4 0.4 0.5 0.1 0.1 0.3 0.3 0.4 0.1 0.0 0.3 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.2 0.1 1.1 0.1 0.6 0.8 0.1 0.3 0.5 0.3 0.3 0.3 0.0 1.0 0.2 0.3 0.6 0.3 0.5 0.1 0.4 0.5 4.8 0.2 1.0 0.4 0.6 0.7 0.3 0.3 3.4 1.2 0.4 5.5 2.9 0.5 0.5 1.6 4.3 0.2 1.4 3.6 0.5 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.1 0.5 0.1 3.0 4.8 0.8 0.8 0.7 1.1 0.6 0.0 0.0 1.2 0.0 2.0 0.3 11.6 0.0 4.9 0.3 0.0 0.0 0.0 1.6 0.4 0.4 11.5 0.2 0.2 0.0 0.0 0.6 0.3 3.1 0.3 1.3 1.7 0.0 0.0 0.2 0.2 0.0 2.1 0.0 0.8 0.0 0.4 1.1 0.5 0.4 0.1 2.5 0.0 0.6 CLPB "ANKCLB, FLJ13152, HSP78, SKD3" ENSG00000162129 "ClpB homolog, mitochondrial AAA ATPase chaperonin" Q9H078 11 72285495-72434680 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 87.9" "Cell type enriched" "Detected in many" 4 "Late spermatids: 4145.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 18.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039005, HPA039006, HPA064571" Enhanced NA NA "HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290" "unprognostic (9.36e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-1)" "unprognostic (1.23e-1)" "unprognostic (2.99e-1)" "unprognostic (2.05e-2)" "unprognostic (8.22e-2)" "unprognostic (8.37e-2)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "prognostic favorable (8.36e-8)" "unprognostic (9.29e-2)" "unprognostic (1.25e-1)" "unprognostic (5.83e-2)" "unprognostic (3.28e-2)" 4.4 6.1 5.7 4.8 7.2 7.9 3.4 5.6 10.5 3.1 3.1 6.7 2.5 3.2 3.8 3.1 3.7 2.9 2.9 4.1 4.9 4.1 6.7 8.5 3.7 3.0 5.7 5.9 3.2 5.5 8.6 3.4 6.5 7.9 2.7 3.1 3.1 4.2 3.3 6.5 2.8 2.9 4.5 3.9 3.9 3.7 87.9 6.4 2.7 4.7 1.8 2.9 3.7 3.0 1.6 18.3 4.0 11.7 1.8 2.4 5.2 6.4 18.3 5.7 11.8 7.8 5.8 14.8 6.9 4.2 10.4 7.8 24.4 9.7 16.5 16.0 6.5 18.2 13.7 15.3 15.1 12.8 14.9 11.5 13.9 19.0 14.5 6.7 14.0 24.8 7.6 5.0 18.4 18.6 4.1 11.6 14.6 18.9 11.7 7.4 16.9 12.5 13.3 6.0 21.9 18.3 11.4 8.6 7.1 6.0 11.0 14.4 11.0 9.4 21.7 16.1 7.9 11.2 12.1 9.1 14.8 9.6 15.0 13.3 5.6 8.0 9.4 7.9 11.9 11.3 4.0 11.7 0.6 2.4 9.3 2.4 1.5 1.4 2.1 18.3 1.6 1.8 1.4 1.0 1.8 5.2 3.3 0.8 5.2 5.7 7.2 5.6 10.5 4.9 4.1 5.7 5.9 7.9 6.4 14.9 8.9 9.0 3.7 0.3 2.5 3.1 5.1 6.7 9.1 8.7 3.9 12.5 5.0 12.7 991.0 7.2 4.0 0.0 14.2 13.7 3.1 2.7 3.5 9.7 19.2 3.2 0.0 1.3 10.6 4145.4 23.3 12.7 1.7 7.2 1.0 1.3 10.6 0.8 17.3 17.4 5.7 12.9 2.1 35.9 21.3 1.0 27.7 2.5 1.9 5.1 CLPS ENSG00000137392 Colipase P04118 6 35794982-35797344 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Digestion, Lipid degradation, Lipid metabolism" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1551 "pancreas: 4260.9" "Cell type enriched" "Detected in some" 9 "Exocrine glandular cells: 19853.4" "Cancer enriched" "Detected in many" 188 "pancreatic cancer: 1726.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.4;U-2 OS: 3.0;U-266/84: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA010512 Enhanced "Secreted to digestive system" NA NA 1100000 "HPA010512: AB_1846979" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.12e-3)" "unprognostic (2.47e-1)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 4260.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.4 2.7 0.4 1.3 1.1 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 3.0 0.0 1.0 0.0 2.4 1.0 0.0 0.9 0.0 0.5 0.4 1.3 0.1 0.2 0.0 0.3 1.1 0.1 0.4 0.5 0.3 0.0 2.7 1.3 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.4 0.0 0.0 0.0 0.0 19853.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 228.2 0.0 0.0 2154.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 CLPSL1 "C6orf127, dJ510O8.6" ENSG00000204140 "Colipase like 1" A2RUU4 6 35781017-35793675 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "epididymis: 123.5;pancreas: 103.6" "Group enriched" "Detected in some" 40 "Exocrine glandular cells: 32.7;Pancreatic endocrine cells: 14.1" "Group enriched" "Detected in some" 6 "breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "T-47d: 13.9" HPA073155 Enhanced "Secreted in male reproductive system" NA NA "HPA073155: AB_2686576" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (4.75e-1)" "unprognostic (2.54e-1)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.60e-2)" "unprognostic (7.06e-3)" 0.1 0.1 1.6 0.0 0.2 0.0 0.8 0.1 0.9 0.1 0.1 0.0 9.6 0.0 0.1 123.5 0.1 0.1 0.0 0.1 1.8 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 103.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 13.9 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.1 0.9 1.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 CLPSL2 "C6orf126, dJ510O8.5, UNQ3045" ENSG00000196748 "Colipase like 2" Q6UWE3 6 35776594-35779552 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "epididymis: 124.8" "Group enriched" "Detected in some" 6 "Exocrine glandular cells: 3.5;Intestinal endocrine cells: 1.7;Pancreatic endocrine cells: 3.5;Spermatogonia: 1.5" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Cell line enriched" "Detected in some" 6 "T-47d: 12.6" HPA051655 Approved "Secreted in male reproductive system" NA NA "HPA051655: " "unprognostic (2.38e-1)" "unprognostic (3.65e-1)" "unprognostic (6.39e-3)" "unprognostic (9.38e-2)" "unprognostic (4.03e-2)" "unprognostic (2.47e-1)" "unprognostic (4.85e-3)" "unprognostic (8.69e-2)" "unprognostic (3.17e-2)" "unprognostic (3.95e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.7 0.0 1.1 0.0 0.0 0.0 2.3 0.0 0.0 124.8 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 9.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.0 0.4 0.5 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.3 1.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.6 0.0 0.3 12.6 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.4 0.2 0.0 1.1 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.0 0.0 0.0 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.3 9.1 8.0 10.1 8.5 11.0 8.6 6.1 6.9 6.8 7.1 9.1 7.5 16.6 5.2 8.2 5.0 11.5 29.3 8.1 7.3 6.5 5.3 12.5 8.9 11.5 12.2 15.9 7.3 13.1 11.2 6.2 11.9 7.8 8.6 9.0 11.4 5.9 7.9 6.8 7.5 14.1 9.0 10.6 4.1 14.8 9.5 17.1 12.7 12.4 7.0 5.7 8.3 13.3 9.0 11.0 6.1 13.5 7.5 6.9 6.0 5.5 5.7 6.3 9.6 8.7 6.7 20.2 5.3 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 32.8 28.6 14.9 17.9 17.1 27.3 62.7 28.1 33.5 33.0 31.4 13.7 35.1 18.3 32.5 87.1 17.9 15.6 0.0 27.4 27.2 19.7 20.0 15.1 79.9 19.8 30.2 9.9 22.1 23.9 189.0 26.7 16.0 16.9 26.2 22.4 24.3 27.3 17.5 28.0 28.4 24.1 25.8 16.0 33.9 29.6 26.3 74.6 19.1 23.3 18.4 CLRN1 "RP61, USH3, USH3A" ENSG00000163646 "Clarin 1" P58418 3 150926163-150972999 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 11.2;retina: 16.2" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 150.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 32 "NTERA-2: 8.9" NA NA "unprognostic (1.00e-3)" "unprognostic (1.26e-1)" "unprognostic (5.54e-1)" "unprognostic (9.68e-2)" 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.1 0.0 1.6 0.0 2.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 150.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN2 ENSG00000249581 "Clarin 2" A0PK11 4 17515165-17527104 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 1.2;salivary gland: 1.1;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042407 Uncertain NA NA "HPA042407: AB_10806237" 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN3 "MGC32871, TMEM12, USH3AL1" ENSG00000180745 "Clarin 3" Q8NCR9 10 127877841-127892947 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 69.3;kidney: 14.7;liver: 25.6" "Group enriched" "Detected in some" 5 "Enterocytes: 118.1;Hepatocytes: 34.8;Intestinal endocrine cells: 39.9;Mucus-secreting cells: 70.4;Paneth cells: 98.2;Proximal tubular cells: 59.1;Undifferentiated cells: 39.3" "Group enriched" "Detected in many" 10 "colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 40 "OE19: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014482 Approved NA NA "HPA014482: AB_2082885" "unprognostic (7.34e-3)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (1.46e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (6.22e-2)" "unprognostic (4.67e-1)" "unprognostic (8.86e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.74e-1)" "unprognostic (2.89e-3)" "unprognostic (3.00e-2)" 0.4 0.2 0.3 3.1 0.2 0.0 0.2 0.2 0.3 0.2 27.5 0.3 0.2 23.7 0.2 1.3 0.2 0.1 9.5 0.2 0.3 0.2 14.7 25.6 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 23.5 0.2 0.2 0.2 0.2 0.1 69.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 1.4 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.1 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 118.1 0.0 0.5 0.0 0.0 0.0 0.0 34.8 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 0.0 0.2 98.2 0.0 59.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 0.0 CLSPN ENSG00000092853 Claspin Q9HAW4 1 35720218-35769967 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in single" 12 "basal ganglia: 7.0" "Low region specificity" "Detected in all" "HPA026305, HPA026312" Enhanced "Nucleoplasm,Golgi apparatus" Yes Yes "Nucleoplasm, Golgi apparatus" "HPA026305: AB_2671833, HPA026312: AB_2671837" "unprognostic (4.75e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-3)" "unprognostic (3.54e-2)" "unprognostic (6.82e-2)" "unprognostic (1.62e-2)" "unprognostic (1.18e-6)" "unprognostic (3.99e-3)" "unprognostic (2.08e-3)" "unprognostic (1.63e-2)" "unprognostic (8.71e-6)" "unprognostic (3.23e-2)" "unprognostic (7.61e-6)" "prognostic favorable (4.92e-4)" "unprognostic (5.12e-1)" "unprognostic (1.73e-1)" "unprognostic (1.29e-1)" 1.5 0.8 0.9 11.5 1.0 12.6 1.7 0.3 3.6 0.9 2.1 0.1 0.0 1.0 0.5 0.9 2.9 0.5 2.8 0.6 1.1 0.6 1.0 0.7 1.9 6.0 0.6 0.1 0.5 0.5 0.3 0.4 4.3 0.7 0.5 2.7 1.9 1.0 0.0 0.4 1.2 3.4 1.0 0.8 4.4 1.1 10.0 0.5 30.4 0.5 4.2 6.6 0.9 1.2 0.9 0.9 3.4 1.1 1.3 1.6 1.1 8.7 7.3 15.9 8.4 1.1 2.1 5.9 18.0 5.0 13.2 17.7 11.5 8.2 18.7 5.8 4.8 9.6 8.8 15.5 6.2 20.7 12.8 7.0 26.3 15.9 5.1 0.0 21.5 15.5 0.4 0.2 22.7 1.6 1.5 7.1 11.2 17.7 13.0 12.6 5.7 22.6 4.9 15.0 6.0 5.2 14.4 24.1 5.6 2.7 14.5 5.9 6.9 15.6 4.8 3.1 11.2 4.1 8.5 5.1 19.0 14.4 11.6 20.0 4.7 11.4 19.7 6.0 15.4 15.3 1.6 1.1 1.1 1.6 0.5 0.5 0.4 1.0 0.8 0.9 0.9 0.4 0.8 3.4 1.3 0.7 0.8 1.3 1.1 0.9 1.0 0.3 3.6 1.1 0.6 0.6 0.1 0.7 0.5 0.0 0.3 1.5 4.6 4.9 7.9 1.1 2.5 0.0 3.4 0.0 11.8 5.5 0.0 1.3 6.2 1.9 0.4 0.0 0.6 33.9 3.9 1.4 1.1 0.0 14.0 1.6 1.2 3.7 3.2 4.9 2.3 6.5 3.3 15.4 1.6 6.6 0.9 1.9 0.4 0.0 96.1 6.5 2.5 71.5 133.3 1.8 8.7 5.1 4.1 2.6 CLSTN1 "CDHR12, CSTN1, KIAA0911" ENSG00000171603 "Calsyntenin 1" O94985 1 9729026-9824526 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.0" "Cell type enhanced" "Detected in all" 8 "Cone photoreceptor cells: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012412, HPA077705" Enhanced NA NA 70000000 "HPA012412: AB_1846981, HPA077705: " "unprognostic (4.63e-2)" "unprognostic (2.89e-1)" "unprognostic (9.76e-2)" "unprognostic (1.43e-1)" "unprognostic (9.79e-2)" "unprognostic (1.63e-1)" "unprognostic (2.44e-3)" "unprognostic (3.07e-2)" "unprognostic (2.54e-1)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (1.25e-1)" "prognostic favorable (4.10e-7)" "unprognostic (1.12e-1)" "unprognostic (2.65e-1)" "unprognostic (4.05e-2)" "unprognostic (4.72e-2)" 13.6 20.1 38.2 15.0 51.2 5.2 15.4 90.5 102.0 24.2 28.6 25.1 11.7 16.7 35.9 14.2 21.0 35.1 25.6 16.3 32.1 31.2 23.3 4.7 16.0 16.4 25.8 53.8 33.6 31.1 27.8 21.0 22.8 32.3 33.6 26.1 29.8 30.0 24.9 10.3 45.6 18.6 28.8 22.0 14.4 15.1 8.1 21.6 15.3 20.9 12.9 16.1 18.0 23.6 2.5 2.7 8.5 1.7 0.9 6.3 2.5 27.7 16.5 23.9 22.1 25.5 16.9 7.9 17.7 19.9 22.7 20.8 11.6 66.9 21.9 46.4 34.9 21.6 39.7 14.0 62.6 18.2 24.8 17.0 6.5 20.7 12.2 35.4 12.2 10.6 17.2 43.2 29.3 19.9 33.3 31.6 12.7 3.0 17.1 11.1 12.9 13.5 6.4 10.0 16.7 13.3 20.4 8.7 10.5 28.1 8.1 25.4 16.0 25.6 49.2 19.8 15.1 10.0 20.9 47.1 26.9 21.4 17.9 29.3 17.4 16.0 31.7 23.0 19.7 30.3 8.5 1.4 4.3 6.3 1.7 3.3 2.3 4.0 4.7 2.7 2.5 2.9 2.6 0.8 0.9 1.7 1.7 3.6 2.5 38.2 51.2 90.5 99.9 32.1 31.2 25.8 53.8 32.3 21.6 26.8 14.9 18.6 53.3 38.9 198.8 10.5 58.6 40.2 38.7 48.8 412.3 27.6 1.7 25.3 3.7 30.8 111.5 23.3 34.1 12.2 32.6 55.8 11.5 2.0 24.2 170.0 29.6 34.4 22.3 3.2 42.8 12.3 30.4 20.8 86.8 156.4 43.0 51.5 47.4 25.6 134.9 84.1 20.6 13.5 37.1 22.8 16.0 25.3 48.3 36.5 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;ovary: 59.4" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 17.1;Late spermatids: 10.8;Leydig cells: 25.9" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 21.0;SCLC-21H: 9.3;SuSa: 28.6;THP-1: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" Yes No 9100 Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: AB_2684615" "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 14.2 5.0 4.9 1.0 9.8 0.8 8.5 1.5 19.7 4.1 1.8 2.4 0.3 1.2 5.2 1.8 1.6 3.6 2.6 5.9 15.4 4.0 4.5 1.5 1.7 2.8 4.1 14.3 59.4 2.0 1.5 1.3 1.5 23.7 5.4 1.4 3.0 1.6 1.8 1.9 2.1 1.5 6.6 1.4 0.8 1.4 1.9 0.5 0.0 2.9 0.5 1.0 1.9 4.7 0.3 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 3.3 0.0 1.4 0.4 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 1.3 0.0 0.0 0.0 28.6 1.4 5.8 0.0 0.7 0.3 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 4.9 9.8 1.5 19.7 15.4 4.0 4.1 14.3 23.7 0.5 0.0 0.0 0.0 0.2 0.5 0.7 5.3 0.0 5.3 1.2 3.5 0.0 0.2 1.7 0.0 17.1 0.7 0.0 0.0 0.2 0.0 1.6 5.3 0.0 0.0 0.1 0.0 0.0 3.1 0.8 10.8 25.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 7.9 3.7 0.0 6.1 0.7 0.7 0.0 0.0 0.0 0.0 0.1 CLSTN3 "CDHR14, CSTN3, KIAA0726" ENSG00000139182 "Calsyntenin 3" Q9BQT9 12 7129698-7158945 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 150.4;Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 12.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 50000 "prognostic favorable (5.08e-4)" "unprognostic (2.84e-2)" "unprognostic (1.06e-3)" "unprognostic (1.33e-2)" "unprognostic (6.73e-3)" "unprognostic (6.35e-2)" "unprognostic (9.52e-2)" "unprognostic (2.58e-1)" "unprognostic (2.94e-1)" "unprognostic (1.85e-1)" "prognostic favorable (1.19e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (2.19e-2)" "unprognostic (6.14e-2)" "unprognostic (1.91e-1)" "prognostic favorable (8.07e-4)" 11.0 16.2 22.1 14.9 37.1 14.4 6.8 51.4 64.0 5.9 6.0 5.7 1.7 8.1 8.1 4.2 4.9 7.2 12.2 4.1 19.2 33.3 14.1 14.6 7.8 15.4 13.3 31.6 13.2 6.9 14.4 15.0 4.1 37.6 5.8 6.0 7.6 8.1 5.7 1.4 11.1 7.1 8.9 6.0 14.1 6.1 3.5 4.0 6.7 6.5 1.0 11.3 12.0 5.6 0.3 0.2 2.6 0.0 12.4 7.2 1.9 6.6 11.1 3.8 9.2 4.6 6.7 17.2 3.9 9.2 6.8 11.2 16.1 10.5 10.7 2.9 7.7 7.9 8.7 6.9 7.6 4.0 10.8 6.6 17.7 17.4 15.1 6.3 2.7 32.2 20.1 7.6 8.7 10.7 32.6 8.2 10.2 16.5 6.6 1.6 2.0 6.9 2.9 10.9 0.4 0.7 4.6 0.0 3.1 10.4 12.4 5.0 8.2 9.4 2.3 1.5 9.8 4.5 6.4 4.9 4.3 13.0 9.8 2.1 8.1 1.9 1.4 7.6 3.7 2.6 2.6 0.0 0.0 7.2 0.0 4.1 0.3 3.2 6.1 0.2 0.3 1.1 2.5 0.5 12.4 0.0 0.1 3.3 1.9 22.1 37.1 51.4 64.0 19.2 33.3 13.3 31.6 37.6 4.0 0.0 3.8 0.0 2.3 3.7 150.4 1.2 7.6 0.0 1.2 14.0 58.9 4.9 0.0 8.1 0.8 7.7 1.7 0.0 6.4 6.3 4.3 1.9 5.7 23.1 1.0 25.4 28.2 4.3 3.5 0.6 11.8 1.7 5.0 1.0 3.4 9.5 6.3 2.9 6.0 28.2 36.4 6.5 2.5 0.7 1.1 5.0 2.7 13.6 2.8 1.6 CLTCL1 "CHC22, CLH22, CLTCL, CLTD" ENSG00000070371 "Clathrin heavy chain like 1" P53675 22 19179473-19291716 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.0" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 11.2;Cone photoreceptor cells: 13.7;Early spermatids: 15.7;Late spermatids: 12.9;Spermatocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 3.3;neutrophil: 8.4" "Group enriched" "Detected in many" 15 "granulocytes: 8.4;monocytes: 3.3" "Cell line enhanced" "Detected in many" "HMC-1: 34.9;K-562: 16.3" "HPA075327, HPA075795" Enhanced Approved Vesicles NA NA Vesicles "HPA075327: , HPA075795: AB_2686764" "unprognostic (1.29e-2)" "unprognostic (3.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.16e-3)" "unprognostic (8.20e-2)" "unprognostic (6.93e-3)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (4.42e-2)" "unprognostic (2.93e-3)" "unprognostic (3.14e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "unprognostic (8.71e-4)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" "unprognostic (1.06e-1)" 2.9 3.3 1.1 0.9 2.0 9.7 1.6 3.4 1.8 1.3 1.0 3.7 1.2 0.4 2.3 3.1 2.2 1.4 0.9 5.6 1.3 1.7 1.0 1.7 1.2 0.6 2.7 1.4 1.4 0.9 2.1 14.9 1.1 4.1 1.8 0.8 4.2 1.5 1.1 53.0 2.1 0.9 2.4 3.6 0.9 1.0 17.2 1.2 1.3 2.7 10.4 0.7 1.2 1.3 0.2 0.3 8.4 3.3 0.0 0.3 0.6 2.3 2.4 1.6 2.6 5.9 3.2 0.7 1.6 1.7 2.3 3.4 0.8 0.7 0.9 0.2 3.6 1.7 0.8 2.5 4.6 1.9 0.1 2.4 0.1 2.2 2.7 3.0 3.3 34.9 13.9 3.7 4.2 5.9 6.7 1.4 1.3 16.3 0.9 5.3 1.8 0.4 11.6 2.0 9.4 2.0 1.2 13.3 0.0 1.8 0.9 3.8 0.6 3.5 2.2 0.2 2.0 4.7 14.1 0.4 4.1 8.7 2.3 2.7 1.8 4.2 0.4 2.4 9.0 0.8 0.0 3.3 0.3 0.1 0.7 0.0 0.0 0.1 0.3 0.3 0.2 0.3 0.0 8.4 0.0 0.0 0.1 0.0 0.6 1.1 2.0 3.4 1.8 1.3 1.7 2.7 1.4 4.1 1.2 3.0 0.3 0.0 0.5 0.6 1.6 11.2 2.5 0.0 2.3 0.0 13.7 0.3 0.0 0.7 15.7 0.4 0.0 0.0 0.0 0.1 0.9 1.4 0.0 1.5 0.3 0.0 0.0 1.3 1.5 12.9 2.3 0.0 0.0 0.0 1.2 1.7 1.0 0.0 3.9 0.6 2.1 0.0 2.1 13.4 5.3 0.6 0.9 0.0 0.9 0.0 CLTRN "NX17, TMEM27" ENSG00000147003 "Collectrin, amino acid transport regulator" Q9HBJ8 X 15627318-15665031 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "kidney: 204.4" "Cell type enriched" "Detected in some" 15 "Proximal tubular cells: 679.1" "Cancer enriched" "Detected in many" 35 "renal cancer: 106.2" "Region enriched" "Detected in single" 9 "pons and medulla: 5.0" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048543 Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum, Vesicles" "HPA048543: AB_2680436" "unprognostic (1.27e-1)" "unprognostic (4.77e-2)" "unprognostic (2.45e-2)" "unprognostic (2.66e-2)" "unprognostic (5.20e-2)" "unprognostic (5.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-2)" "prognostic favorable (5.65e-4)" "unprognostic (1.05e-2)" "unprognostic (3.03e-1)" "prognostic favorable (6.78e-9)" "unprognostic (1.77e-1)" "unprognostic (2.60e-2)" "unprognostic (2.58e-1)" "unprognostic (1.33e-2)" 0.1 0.2 0.3 0.1 0.4 0.0 0.3 0.1 0.2 0.2 0.2 0.5 0.1 0.1 0.2 1.6 0.2 0.4 0.6 0.2 0.5 0.4 204.4 11.5 0.6 0.1 0.3 0.1 0.8 1.2 4.0 0.2 0.7 5.0 0.3 0.0 11.3 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 2.4 0.3 0.1 0.2 0.7 0.1 0.1 0.4 0.2 0.9 0.6 0.0 0.5 0.0 3.0 0.4 3.0 2.1 1.5 0.6 0.8 1.2 1.0 0.1 0.0 0.1 0.1 0.2 0.5 0.3 2.1 0.1 0.2 10.6 0.9 2.5 0.0 0.4 1.4 0.3 0.0 1.0 1.6 0.0 0.0 0.2 2.4 0.4 6.1 0.7 0.0 2.4 0.7 0.6 0.3 3.5 0.2 0.4 3.5 0.9 3.1 0.3 0.5 1.3 9.8 0.2 1.4 1.3 0.8 0.2 2.0 6.5 1.0 0.3 0.1 0.2 0.5 0.4 0.0 0.5 0.3 0.4 0.9 0.1 0.1 0.0 0.5 0.0 0.6 0.2 1.3 0.4 0.8 0.5 0.6 0.9 3.0 0.9 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.4 0.1 0.2 0.5 0.4 0.3 0.1 5.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 26.2 0.0 1.9 46.4 19.8 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 679.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 CLU "APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2" ENSG00000120885 Clusterin P10909 8 27596917-27615031 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Complement pathway, Immunity, Innate immunity" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 580.4;liver: 590.5" "Group enriched" "Detected in all" 5 "Cholangiocytes: 2112.1;Collecting duct cells: 3344.6;Hepatocytes: 3521.2;Muller glia cells: 8189.5" "Cancer enhanced" "Detected in all" "glioma: 1485.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "basophil: 69.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 69.2" "Cell line enhanced" "Detected in many" "HeLa: 238.1;SK-BR-3: 208.2;T-47d: 151.9;U-2 OS: 135.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000572, CAB016253" Enhanced "Secreted to blood" NA NA 169000000000 36000000000 "CAB016253: AB_673562, HPA000572: AB_1078539" "unprognostic (1.10e-2)" "unprognostic (1.81e-2)" "unprognostic (1.14e-3)" "unprognostic (2.74e-2)" "unprognostic (5.59e-2)" "unprognostic (4.13e-2)" "unprognostic (1.76e-2)" "unprognostic (2.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-2)" "unprognostic (1.41e-1)" "unprognostic (1.80e-2)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "prognostic favorable (7.66e-5)" "unprognostic (5.29e-2)" 82.5 217.4 233.5 50.2 280.3 3.4 90.4 141.2 414.7 78.3 47.9 139.5 184.6 19.9 55.4 580.4 48.3 217.2 172.7 24.6 176.2 154.7 69.8 590.5 30.5 127.3 209.0 173.1 49.6 134.8 220.4 34.3 8.5 189.0 63.4 18.0 125.4 62.2 359.2 7.7 12.8 24.0 87.9 255.2 17.2 56.6 161.5 113.5 5.3 106.6 11.8 134.8 72.2 54.7 0.1 1.3 69.2 2.1 0.9 2.7 110.6 0.7 98.0 4.3 5.1 24.3 33.5 13.7 17.4 34.3 4.6 2.4 18.8 15.5 0.3 69.8 15.5 55.6 32.9 18.6 2.8 3.0 72.3 18.0 42.5 238.1 23.1 21.2 1.0 113.5 56.1 11.2 19.8 5.7 43.1 60.4 0.6 0.5 50.1 1.6 16.4 0.3 3.2 35.8 29.0 11.6 0.3 16.4 13.5 45.4 70.8 4.0 2.5 24.1 208.2 1.0 21.9 151.9 0.6 8.9 1.4 135.9 7.8 5.8 6.4 22.9 0.8 109.3 7.0 0.6 69.2 2.1 0.9 2.3 0.6 0.8 0.0 2.7 2.5 0.7 0.1 0.3 0.8 9.6 0.9 0.1 1.3 0.7 110.6 233.5 280.3 141.2 223.1 176.2 154.7 209.0 173.1 189.0 113.5 29.8 96.4 52.8 642.1 72.2 63.1 87.3 2112.1 730.8 804.1 3344.6 72.6 73.8 34.9 312.8 239.8 477.4 8.7 46.7 557.4 25.4 414.6 130.8 770.5 3521.2 11.3 28.6 9.1 491.7 164.5 655.4 105.9 31.6 195.7 27.9 9.3 8189.5 192.6 14.0 53.7 270.7 191.3 12.9 236.7 107.2 16.3 48.3 71.6 54.8 14.0 337.2 CLUH "CLU1, KIAA0664" ENSG00000132361 "Clustered mitochondria homolog" O75153 17 2689386-2712663 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 75.2" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CACO-2: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031505, HPA044346" Uncertain Supported "Nuclear bodies,Vesicles" NA NA Vesicles "Nuclear bodies" "HPA031505: AB_2673912, HPA044346: AB_10962153" "unprognostic (3.48e-2)" "unprognostic (3.97e-2)" "unprognostic (9.02e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (2.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.84e-1)" "unprognostic (2.69e-2)" "unprognostic (5.64e-2)" "unprognostic (5.11e-2)" "prognostic favorable (1.92e-5)" "unprognostic (4.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-2)" "unprognostic (6.26e-2)" 14.1 21.0 9.6 10.4 12.4 7.8 10.2 16.0 20.9 7.6 17.5 10.6 7.4 29.4 8.4 6.9 28.7 7.6 11.2 31.8 8.5 6.9 28.6 75.2 7.4 8.2 7.0 9.7 8.3 20.3 7.0 8.2 6.2 12.5 9.4 8.1 9.9 18.9 8.4 65.6 20.0 20.9 9.9 6.5 9.9 13.6 11.4 7.5 6.8 10.1 22.1 15.9 12.4 10.0 4.5 5.0 0.4 5.9 1.1 4.7 1.5 18.8 33.6 2.4 8.5 5.0 3.7 28.1 10.1 3.6 11.0 7.9 67.8 7.7 34.5 12.2 4.8 6.7 34.5 11.2 13.2 3.6 12.3 24.9 18.9 26.1 23.4 4.7 15.0 12.3 6.1 7.9 12.3 6.4 2.4 5.5 11.4 23.1 10.4 3.2 20.3 16.8 14.6 7.6 8.8 19.4 27.4 10.5 18.2 6.8 29.2 11.4 9.0 11.5 31.8 11.8 1.7 19.1 7.8 10.6 9.1 12.5 24.8 22.1 5.3 5.9 13.0 9.4 20.0 10.7 0.0 4.3 0.0 3.4 5.9 2.6 4.1 2.0 1.8 4.4 4.5 4.7 4.1 0.4 1.1 3.6 5.0 2.6 1.5 9.6 12.4 16.0 20.9 8.5 6.9 7.0 9.7 12.5 7.5 6.0 18.1 8.5 8.5 27.1 17.5 35.8 43.3 8.1 15.9 17.4 21.6 8.2 10.0 15.3 1.5 8.3 36.2 23.3 15.5 6.0 8.2 12.0 1.1 92.0 11.5 7.9 24.8 9.8 7.8 2.5 4.6 6.3 20.3 6.4 32.3 6.2 17.5 10.5 5.6 26.8 15.7 6.5 11.0 5.0 16.6 31.0 6.9 5.7 49.3 18.7 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 335.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 24.6" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: AB_2732286" "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.6 3.9 7.5 5.1 0.0 0.0 4.5 2.9 0.2 0.0 0.0 3.1 1.5 3.1 0.7 0.0 2.7 1.1 0.0 0.4 0.0 2.5 7.0 5.2 2.1 24.6 0.0 1.7 1.0 0.2 0.0 0.0 0.0 1.3 0.3 7.7 7.3 9.1 0.0 0.8 3.1 5.6 0.5 3.2 1.8 6.3 3.5 11.0 0.8 0.8 6.6 4.6 2.9 1.8 2.2 6.3 2.4 0.8 0.6 3.0 4.4 2.1 1.4 5.2 9.1 6.5 2.4 3.4 2.6 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 0.0 1.6 0.0 3.4 0.0 23.9 0.1 0.0 4.0 2.3 0.0 19.6 0.4 1.7 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.1 8.5 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 46.9 0.0 0.0 1.1 0.3 335.8 6.5 0.0 8.4 4.5 0.1 0.3 0.0 0.0 1.4 CLVS1 "C6orf212L, CRALBPL, MGC34646, RLBP1L1" ENSG00000177182 "Clavesin 1" Q8IUQ0 8 61057158-61501645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.8;pituitary gland: 10.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.0;Muller glia cells: 9.0" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 3.2;SCLC-21H: 8.4;SH-SY5Y: 3.7;U-266/70: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076650 Approved NA NA "HPA076650: " "unprognostic (1.86e-2)" "unprognostic (3.09e-4)" "unprognostic (2.79e-1)" "unprognostic (2.96e-7)" "unprognostic (1.11e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-1)" "unprognostic (8.02e-4)" "unprognostic (2.23e-1)" "unprognostic (8.44e-3)" "unprognostic (7.25e-3)" "unprognostic (2.94e-1)" "unprognostic (5.79e-8)" "unprognostic (2.49e-1)" "unprognostic (3.19e-2)" "unprognostic (9.71e-2)" "unprognostic (1.14e-2)" 4.0 1.1 9.7 1.3 20.5 1.1 1.9 33.8 16.8 0.7 1.0 2.3 0.0 0.9 0.6 0.7 4.4 1.8 1.3 1.4 5.9 7.7 0.7 0.8 1.0 1.6 4.4 8.0 0.7 0.5 0.5 10.3 0.8 10.2 1.1 0.8 0.5 3.3 0.6 1.6 4.1 1.2 0.6 2.3 1.5 0.8 5.3 3.7 0.0 3.7 0.0 2.6 0.7 0.4 2.2 1.2 4.3 1.2 2.6 1.4 0.7 0.4 0.9 0.4 1.3 0.4 0.1 0.1 0.4 0.0 0.0 0.3 0.4 0.3 3.2 0.0 0.0 0.0 0.6 0.0 0.6 0.2 0.4 0.9 0.2 0.6 0.2 0.0 0.3 0.9 0.0 0.0 0.5 0.3 0.8 0.2 0.1 0.0 0.9 0.0 0.2 0.3 1.1 1.7 0.5 0.6 2.7 2.3 0.3 0.9 0.1 8.4 3.7 0.3 0.4 0.0 0.6 0.6 1.1 0.7 0.6 0.5 0.3 0.4 3.7 1.7 0.6 2.1 0.2 0.1 2.7 1.2 0.8 1.0 0.9 0.6 1.3 1.1 0.7 0.2 2.2 0.7 1.4 4.3 2.6 0.6 1.2 0.3 0.7 9.7 20.5 33.8 13.7 5.9 7.7 4.4 8.0 10.2 3.7 6.0 0.3 0.0 0.1 0.0 1.7 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.6 0.1 0.7 0.0 0.0 0.1 CLVS2 "bA160A10.4, C6orf212, C6orf213, RLBP1L2" ENSG00000146352 "Clavesin 2" Q5SYC1 6 122995971-123072927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 71.4" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 14.7;SCLC-21H: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043764 Uncertain NA NA "HPA043764: AB_10960281" "unprognostic (1.35e-1)" "unprognostic (3.28e-2)" "unprognostic (4.68e-2)" "unprognostic (3.60e-1)" "unprognostic (2.38e-1)" "unprognostic (7.04e-2)" "unprognostic (1.43e-2)" "unprognostic (5.72e-3)" "unprognostic (9.60e-2)" "unprognostic (8.71e-2)" 0.7 2.8 5.0 0.9 9.6 0.7 0.8 39.9 22.6 2.1 1.1 0.6 0.0 0.9 3.1 0.7 0.8 0.7 0.8 0.7 5.8 3.9 0.7 0.8 0.7 0.8 3.0 10.2 0.7 0.7 0.7 6.3 0.7 8.5 7.9 1.1 0.1 0.8 1.1 0.7 0.8 0.9 2.8 1.3 0.7 0.8 1.0 1.8 0.0 0.7 0.0 0.7 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 9.6 39.9 22.6 5.8 3.9 3.0 10.2 8.5 1.8 0.0 0.0 0.0 13.8 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 71.4 0.0 0.0 0.4 0.0 4.5 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 1.8 CLYBL CLB ENSG00000125246 "Citrate lyase beta like" Q8N0X4 13 99606669-99897134 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.7" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 117.7;Hepatocytes: 75.9;Proximal tubular cells: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 29.2;SCLC-21H: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039959, HPA040691" Enhanced NA NA "HPA039959: AB_10793857, HPA040691: AB_10794746" "unprognostic (1.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.30e-3)" "unprognostic (7.57e-3)" "unprognostic (3.69e-1)" "unprognostic (2.90e-2)" "unprognostic (1.57e-3)" "unprognostic (2.91e-1)" "unprognostic (2.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.49e-2)" "unprognostic (2.85e-1)" "prognostic favorable (6.66e-16)" "unprognostic (3.74e-2)" "unprognostic (5.41e-2)" "unprognostic (4.78e-2)" "unprognostic (7.82e-2)" 4.2 11.6 6.2 10.4 9.4 2.6 6.0 6.7 6.4 4.6 11.2 3.8 4.8 13.6 5.2 7.6 6.4 4.7 8.3 12.3 5.1 6.3 35.0 57.7 4.7 9.6 7.9 8.6 3.5 15.0 6.1 5.7 2.2 12.5 4.2 12.3 8.9 8.7 5.5 22.2 5.7 12.5 8.6 4.5 5.5 4.8 10.7 4.3 4.6 7.0 13.3 8.2 4.9 4.4 11.0 7.5 1.2 6.7 9.2 16.7 5.5 0.2 1.2 9.0 4.0 4.2 3.9 1.9 0.4 0.8 0.7 1.4 0.2 6.6 1.5 2.6 0.5 1.7 2.0 0.8 1.5 1.0 7.9 1.3 9.9 2.4 6.1 2.9 5.3 0.7 2.1 4.4 0.1 3.4 0.9 1.1 8.3 1.4 5.2 0.8 2.2 2.4 7.4 5.8 29.2 1.8 3.1 0.3 3.6 8.8 0.6 28.8 4.4 1.8 2.0 1.7 3.3 4.3 6.9 0.1 0.4 1.0 0.7 1.4 12.1 2.4 0.3 6.1 7.8 1.2 1.2 3.3 0.3 7.5 6.7 9.0 10.9 13.3 10.6 6.7 11.0 10.3 12.1 0.5 9.2 3.2 7.5 16.7 5.5 6.2 9.4 6.7 6.4 5.1 6.3 7.9 8.6 12.5 4.3 6.0 5.3 4.4 8.9 4.8 1.8 30.3 20.4 4.0 11.4 14.0 2.0 11.2 117.7 9.6 1.2 6.3 18.6 0.0 7.0 2.5 2.6 3.4 5.8 75.9 6.9 0.0 1.2 6.2 7.5 4.0 2.0 7.7 15.1 4.6 8.4 4.5 3.8 14.0 3.9 93.6 4.3 0.0 9.2 3.1 9.1 5.5 6.2 6.9 16.4 5.1 CMBL FLJ23617 ENSG00000164237 "Carboxymethylenebutenolidase homolog" Q96DG6 5 10275875-10308026 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "gallbladder: 21.6;intestine: 71.4;kidney: 81.7;liver: 83.7;skeletal muscle: 70.6" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 182.4;Enterocytes: 265.0;Hepatocytes: 151.5;Proximal tubular cells: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 27.9;HSkMC: 30.8;K-562: 31.3;PC-3: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036571 Uncertain NA NA 590000 "HPA036571: AB_10670114" "unprognostic (1.81e-2)" "unprognostic (2.55e-1)" "unprognostic (8.10e-3)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.20e-1)" "unprognostic (8.64e-2)" "prognostic favorable (1.99e-4)" "unprognostic (1.76e-1)" "unprognostic (4.44e-2)" "unprognostic (1.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.44e-1)" 5.7 13.9 8.1 6.1 7.7 2.0 13.1 4.1 7.8 5.6 38.3 2.9 5.2 47.0 4.3 6.1 3.0 5.1 21.6 11.4 7.8 5.1 81.7 83.7 5.5 2.1 5.8 7.6 10.6 6.5 13.9 6.0 1.3 5.1 8.6 17.8 4.8 3.5 8.4 70.6 1.4 71.4 5.0 7.0 1.4 14.4 3.9 4.1 1.3 7.3 10.5 1.6 6.4 4.8 0.8 0.6 3.0 1.2 0.7 2.1 0.8 3.7 4.3 5.1 12.8 20.5 23.5 27.9 6.3 6.8 2.0 2.9 1.8 19.1 0.1 10.6 4.6 9.4 0.1 12.0 8.1 2.5 0.2 9.0 16.7 20.1 14.3 6.3 0.1 0.1 30.8 5.3 4.2 3.8 7.6 6.1 0.0 31.3 0.2 7.1 0.7 0.1 0.6 7.8 0.0 30.2 3.7 0.0 0.4 18.8 2.4 4.1 6.3 15.1 1.4 0.4 6.4 10.5 0.6 1.8 3.0 4.0 4.8 0.0 0.1 0.0 0.0 5.0 0.0 0.0 2.1 1.2 0.5 1.5 0.5 2.1 0.3 1.7 0.7 0.6 0.8 0.8 1.6 3.0 0.7 0.3 0.5 0.2 0.8 8.1 7.7 4.1 7.8 7.8 5.1 5.8 7.6 5.1 4.1 23.8 12.1 3.2 13.6 3.3 2.0 76.4 50.9 18.7 22.7 22.7 3.9 12.7 182.4 9.2 2.2 11.3 265.0 23.3 13.7 8.1 16.4 25.4 12.7 151.5 10.5 0.0 18.5 12.3 5.4 2.2 44.3 3.5 1.7 0.0 82.6 15.4 13.3 100.8 38.9 326.1 2.8 0.0 8.6 0.7 6.4 3.3 4.1 2.5 128.4 10.7 CMKLR1 RVER1 ENSG00000174600 "Chemerin chemokine-like receptor 1" Q99788 12 108288044-108339341 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.6" "Cell type enhanced" "Detected in some" 20 "Hofbauer cells: 25.9;Kupffer cells: 51.2;Macrophages: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 11.9;plasmacytoid DC: 15.2" "Group enriched" "Detected in many" 31 "dendritic cells: 15.2;monocytes: 11.9;T-cells: 6.3" "Cell line enhanced" "Detected in some" "ASC diff: 7.9;ASC TERT1: 33.3;BJ hTERT+: 23.7;hTERT-RPE1: 8.0;LHCN-M2: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047865 Uncertain NA NA "HPA047865: AB_2680191" "unprognostic (1.78e-1)" "unprognostic (2.61e-2)" "unprognostic (8.83e-3)" "unprognostic (7.39e-2)" "unprognostic (2.44e-1)" "unprognostic (3.49e-3)" "unprognostic (1.69e-1)" "unprognostic (2.94e-2)" "unprognostic (1.69e-1)" "unprognostic (6.83e-2)" "unprognostic (1.06e-1)" "unprognostic (8.72e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "unprognostic (1.83e-2)" "unprognostic (5.19e-2)" "unprognostic (1.14e-1)" 11.3 6.3 2.5 8.5 3.5 0.3 5.1 0.9 3.6 6.7 5.2 5.1 1.7 3.1 9.6 12.0 4.1 5.4 6.4 9.3 2.9 2.3 4.3 7.1 10.5 17.2 5.6 1.5 3.9 3.2 1.6 4.1 18.9 4.0 5.3 6.5 10.7 5.6 3.7 2.9 4.6 5.4 12.1 5.1 42.6 3.4 4.6 4.8 3.2 9.9 5.9 5.8 6.9 3.2 0.0 15.2 0.2 11.9 0.3 6.3 3.1 0.0 0.0 0.1 0.0 7.9 33.3 0.1 0.0 23.7 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 8.0 0.4 0.0 0.0 0.0 7.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 3.2 0.0 6.3 11.9 0.0 0.0 1.0 4.2 0.8 0.0 0.4 3.4 0.2 0.3 2.0 15.2 0.3 3.1 2.5 3.5 0.9 2.6 2.9 2.3 5.6 1.5 4.0 4.8 0.0 0.0 0.9 0.0 0.8 0.0 1.2 0.0 1.4 1.2 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 6.2 0.0 0.0 0.0 25.9 0.0 0.0 5.5 51.2 0.0 0.3 10.6 3.3 1.8 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.5 5.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 CMTM1 "CKLFH, CKLFH1a, CKLFSF1" ENSG00000089505 "CKLF like MARVEL transmembrane domain containing 1" Q8IZ96 16 66566393-66579137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 80.7" "Group enriched" "Detected in some" 13 "Early spermatids: 60.6;Late spermatids: 113.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.7" "Cell line enhanced" "Detected in many" "REH: 16.8" "HPA013801, HPA017136" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA013801: AB_1846990, HPA017136: AB_1846992" "unprognostic (2.37e-2)" "unprognostic (7.48e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.32e-2)" "unprognostic (2.97e-3)" "unprognostic (5.12e-3)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (2.47e-2)" "unprognostic (1.56e-4)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (3.49e-1)" 0.9 0.8 0.8 1.9 1.2 0.0 0.5 2.2 1.3 0.7 0.9 0.5 0.5 1.7 1.3 1.1 0.6 0.8 1.5 0.7 0.8 1.1 0.8 0.5 0.9 1.2 0.8 0.6 1.7 0.5 0.3 1.1 0.9 0.7 0.7 0.2 0.5 0.6 0.5 0.6 0.6 1.2 0.5 0.9 2.8 0.9 80.7 0.7 0.8 0.7 0.5 0.6 0.9 0.6 0.3 1.9 8.7 2.1 1.3 1.9 1.1 4.2 6.7 1.2 5.6 2.4 2.3 1.2 5.6 2.7 4.5 4.7 1.4 2.9 2.0 3.0 1.6 1.4 3.4 1.9 0.3 2.4 7.4 1.3 0.7 3.0 1.4 1.1 3.9 4.9 1.9 0.5 4.0 0.5 6.9 2.3 4.0 3.5 2.8 1.9 1.6 7.4 3.8 1.0 0.6 2.5 16.8 14.4 4.6 4.0 2.0 3.2 4.3 7.8 0.6 2.0 0.2 2.0 2.8 5.7 8.0 12.7 4.8 2.4 2.8 6.7 7.3 3.8 5.3 9.3 8.7 2.1 7.1 1.9 0.6 1.6 0.2 0.6 0.9 1.9 0.3 0.5 0.6 8.4 1.3 1.2 0.5 0.6 1.1 0.8 1.2 2.2 1.0 0.8 1.1 0.8 0.6 0.7 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 113.2 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 6.5 0.0 4.8 0.4 0.3 0.1 0.0 0.0 0.0 CMTM2 "CKLFSF2, FLJ25732, MGC39436" ENSG00000140932 "CKLF like MARVEL transmembrane domain containing 2" Q8TAZ6 16 66579448-66588275 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 165.2" "Group enriched" "Detected in some" 7 "Early spermatids: 2945.7;Late spermatids: 2467.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.8" "Cell line enriched" "Detected in some" 20 "REH: 26.7" "Low region specificity" "Detected in many" NA NA "unprognostic (2.81e-1)" "unprognostic (3.75e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (8.71e-2)" "unprognostic (3.31e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (1.91e-2)" "unprognostic (3.27e-2)" "unprognostic (1.02e-4)" "unprognostic (1.80e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 165.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.7 2.8 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.4 0.0 0.1 1.3 0.4 0.1 0.0 0.0 26.7 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.6 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.9 34.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 9.1 0.0 0.0 0.0 0.0 0.0 2945.7 0.0 0.0 0.0 0.2 0.1 0.1 0.0 17.4 0.0 1.1 0.0 0.0 1.3 0.3 2467.7 33.6 1.5 0.0 0.0 0.0 0.0 0.4 0.0 28.7 0.1 0.6 19.4 0.0 398.0 14.3 0.0 0.1 0.0 0.0 0.0 CMTM4 CKLFSF4 ENSG00000183723 "CKLF like MARVEL transmembrane domain containing 4" Q8IZR5 16 66614750-66696707 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 39.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014704, HPA023890" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA014704: AB_1847005, HPA023890: AB_1847007" "unprognostic (2.65e-3)" "unprognostic (1.16e-1)" "unprognostic (6.17e-3)" "unprognostic (3.43e-1)" "unprognostic (5.13e-1)" "unprognostic (8.30e-2)" "unprognostic (2.88e-2)" "unprognostic (2.65e-1)" "unprognostic (3.35e-3)" "unprognostic (6.06e-3)" "unprognostic (2.07e-2)" "unprognostic (3.08e-1)" "prognostic favorable (4.72e-9)" "unprognostic (1.41e-1)" "unprognostic (2.31e-1)" "unprognostic (4.94e-2)" "unprognostic (1.00e-1)" 2.7 4.8 18.9 3.3 18.2 2.9 6.6 8.3 22.1 4.8 16.1 13.5 8.7 12.6 3.2 21.8 4.5 11.5 4.8 3.3 20.0 16.2 18.3 2.5 6.5 1.3 17.0 13.0 2.5 15.1 31.7 9.4 4.3 12.5 6.8 13.4 5.2 10.7 6.9 2.7 7.2 15.8 4.2 13.3 1.8 18.5 6.3 10.3 0.0 39.3 0.5 2.1 4.3 2.6 0.2 1.3 0.1 1.2 0.2 0.9 0.2 9.6 8.3 4.8 11.9 1.6 2.4 20.2 4.1 3.5 2.2 3.6 14.6 11.0 0.4 7.1 2.4 3.0 12.3 11.8 4.6 3.3 0.8 10.8 0.9 3.0 8.8 3.5 0.8 1.9 4.0 8.2 2.5 5.2 7.5 1.2 1.3 4.9 2.7 3.2 10.6 0.1 1.9 5.7 17.1 5.4 2.1 6.4 2.9 9.5 8.7 11.5 4.4 16.6 9.2 5.7 3.6 9.8 2.0 2.5 4.0 4.7 1.1 4.1 0.9 1.9 0.5 5.0 2.0 4.9 0.0 1.2 0.0 0.3 0.3 0.0 0.0 0.1 0.9 1.3 0.2 0.1 0.2 0.1 0.2 0.7 1.3 0.7 0.2 18.9 18.2 8.3 22.1 20.0 16.2 17.0 13.0 12.5 10.3 20.8 12.0 0.0 6.0 4.6 10.9 5.9 25.5 21.4 7.9 22.7 7.9 4.2 11.6 14.5 1.6 3.0 26.2 0.0 20.6 27.7 3.1 19.1 4.6 5.0 2.0 28.6 37.5 1.3 3.0 2.1 2.3 1.5 3.3 0.0 24.3 22.6 24.1 11.5 2.8 20.3 9.2 6.5 4.7 4.7 6.8 4.8 2.4 0.0 32.7 12.7 CMTM5 "CKLFSF5, FLJ37521" ENSG00000166091 "CKLF like MARVEL transmembrane domain containing 5" Q96DZ9 14 23376808-23379772 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 19.4;brain: 67.3" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 28.7" "Group enriched" "Detected in some" 37 "glioma: 8.4;melanoma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 7.6;neutrophil: 2.8" "Lineage enriched" "Detected in single" 11 "granulocytes: 7.6" "Cell line enriched" "Detected in some" 6 "HEL: 42.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052338 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA052338: AB_2681793" "unprognostic (2.73e-3)" "unprognostic (1.51e-1)" "unprognostic (5.24e-1)" "unprognostic (2.43e-3)" "unprognostic (2.63e-1)" "unprognostic (6.40e-2)" "unprognostic (8.34e-3)" "unprognostic (1.78e-1)" "unprognostic (2.27e-2)" "unprognostic (8.40e-2)" "unprognostic (6.24e-4)" "unprognostic (3.03e-3)" "unprognostic (1.97e-3)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.11e-2)" 1.7 1.8 14.1 1.3 19.4 6.6 1.3 4.8 55.4 2.6 1.9 47.0 0.0 1.3 1.6 1.6 2.1 1.7 2.5 5.8 19.6 12.1 1.1 1.0 1.7 1.1 26.9 10.3 1.7 1.1 0.9 0.1 1.5 18.4 1.9 1.6 0.6 3.1 4.2 1.4 1.5 2.0 1.7 67.3 1.9 1.1 1.1 12.7 0.0 1.0 0.0 1.0 1.3 0.7 0.1 0.7 7.6 0.4 0.0 0.3 19.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 7.6 0.4 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.3 19.4 14.1 19.4 4.8 24.8 19.6 12.1 26.9 10.3 18.4 12.7 0.0 0.0 0.0 0.1 0.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.2 0.0 0.0 0.0 5.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 1.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 CMTM6 "CKLFSF6, FLJ20396" ENSG00000091317 "CKLF like MARVEL transmembrane domain containing 6" Q9NX76 3 32481312-32503408 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.5" "Cell type enhanced" "Detected in many" 6 "monocytes: 520.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026980, HPA063491" Enhanced Supported Vesicles NA NA 390000 Vesicles "HPA026980: AB_10602801, HPA063491: " "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.34e-2)" "unprognostic (1.81e-2)" "unprognostic (7.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.99e-1)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (1.04e-3)" "unprognostic (6.79e-2)" "unprognostic (2.27e-1)" "unprognostic (7.23e-2)" "unprognostic (6.58e-2)" "unprognostic (3.74e-2)" "unprognostic (1.55e-3)" 5.5 6.4 2.8 8.2 2.6 10.4 6.7 1.4 1.4 6.6 5.5 2.5 6.7 4.9 9.8 24.4 6.1 4.2 2.4 2.4 5.1 21.6 9.0 5.6 2.8 4.1 6.0 4.0 3.0 8.6 6.0 7.3 9.0 5.0 0.7 12.6 5.9 4.7 3.9 10.5 6.3 5.7 7.7 9.5 9.3 6.1 10.0 12.8 55.5 35.4 11.2 8.1 16.3 22.9 7.4 14.8 11.1 25.7 25.6 65.6 17.0 24.4 17.9 20.7 7.9 38.4 13.7 19.4 22.7 12.1 14.9 10.3 28.2 24.5 61.1 12.6 17.3 5.4 11.7 18.3 28.8 34.5 25.3 18.2 20.6 15.5 28.9 28.7 13.4 8.4 25.8 22.8 7.1 17.3 15.0 13.2 19.2 11.0 14.7 11.6 10.6 24.8 32.2 3.4 10.0 15.5 8.8 16.3 15.7 12.9 28.9 25.7 19.9 13.2 19.4 20.3 13.4 13.3 12.8 13.9 25.3 24.8 24.6 15.1 35.2 5.6 23.3 6.2 10.0 7.5 5.3 12.8 7.1 4.4 4.9 55.5 11.2 35.4 6.9 8.1 16.3 32.8 47.1 95.1 72.5 85.3 9.9 5.1 81.5 112.4 53.4 90.7 11.8 219.6 28.2 87.5 4.6 59.7 40.2 0.0 72.9 81.3 109.6 119.8 124.6 218.5 140.7 47.7 126.8 122.2 288.9 5.4 36.5 262.8 77.6 520.2 93.6 137.9 99.4 49.1 40.3 54.3 17.2 38.8 75.2 34.5 20.2 110.7 218.9 111.7 53.2 91.4 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370325 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 81.9;Syncytiotrophoblasts: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.2;memory CD4 T-cell: 2.8" "Group enriched" "Detected in many" 7 "granulocytes: 4.2;T-cells: 2.8" "Group enriched" "Detected in many" 4 "BEWO: 68.3;SK-BR-3: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 9.7 9.9 4.3 4.1 3.5 0.9 27.0 1.5 3.4 4.7 6.8 1.3 10.8 5.2 3.4 13.4 4.2 6.3 5.7 8.2 3.6 3.2 8.8 40.0 19.9 12.6 3.9 3.3 2.1 79.8 2.8 3.1 12.4 2.5 8.8 5.5 4.4 13.5 19.2 4.3 6.2 8.1 2.0 3.1 1.5 10.0 1.1 1.6 5.5 20.7 6.0 11.2 4.7 5.6 0.1 0.0 4.2 0.1 0.4 2.8 0.3 3.3 3.5 0.6 4.3 3.1 4.9 68.3 0.0 0.1 0.3 0.4 4.7 4.8 0.0 7.1 0.0 0.0 1.8 5.5 1.1 0.3 0.0 10.1 2.1 0.7 7.9 0.2 0.8 1.7 9.6 3.5 0.4 3.4 1.7 2.7 3.6 0.0 0.0 3.4 2.4 2.7 0.3 1.4 5.1 3.2 3.9 0.8 0.6 4.2 3.8 1.2 1.0 0.5 19.3 1.7 0.8 5.5 0.4 2.4 0.0 5.2 0.0 1.0 0.1 0.1 0.0 0.0 1.5 1.1 0.0 0.1 4.2 0.3 0.0 0.4 0.0 2.8 0.8 0.0 0.1 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.3 4.3 3.5 1.5 3.4 3.6 3.2 3.9 3.3 2.5 1.6 35.7 27.6 0.8 29.9 10.3 0.0 1.7 12.7 6.7 19.4 0.0 0.0 81.9 10.0 16.6 7.5 35.8 13.1 23.3 32.2 59.6 6.9 51.8 0.0 67.6 8.5 0.0 21.4 46.1 6.0 1.8 2.3 4.1 5.0 1.0 41.2 30.7 28.4 10.5 1.1 21.6 1.7 0.0 4.7 3.4 2.1 5.6 97.1 15.0 21.1 38.8 CMYA5 "C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76" ENSG00000164309 "Cardiomyopathy associated 5" Q8N3K9 5 79689877-79800240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 119.1;skeletal muscle: 329.3" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 3073.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.6;RT4: 3.1;THP-1: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA074081, HPA077831" Enhanced Approved "Nuclear speckles,Vesicles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Cytosol" "Vesicles, Plasma membrane" "HPA074081: , HPA077831: " "unprognostic (5.53e-2)" "unprognostic (9.91e-3)" "unprognostic (1.21e-2)" "unprognostic (1.49e-2)" "unprognostic (9.01e-4)" "unprognostic (7.00e-2)" "unprognostic (7.39e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.75e-1)" "unprognostic (5.04e-1)" "unprognostic (1.93e-1)" "unprognostic (1.93e-2)" "unprognostic (6.30e-3)" "unprognostic (3.88e-2)" "unprognostic (7.69e-2)" "unprognostic (9.74e-2)" 2.4 0.2 0.3 0.0 0.3 0.0 0.9 0.3 0.4 0.4 0.4 0.0 0.0 0.0 1.4 2.6 2.0 0.5 0.2 119.1 0.3 0.3 0.6 0.3 0.3 0.0 0.3 0.0 3.6 0.2 2.2 1.1 0.3 0.3 1.4 0.0 0.0 2.4 0.5 329.3 0.5 0.2 1.1 0.4 0.2 0.3 0.2 0.1 0.0 2.3 54.0 2.5 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 1.0 1.3 0.4 0.1 0.1 0.2 0.2 0.4 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.2 0.0 0.1 1.6 0.4 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 2.6 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 3.1 0.1 0.0 0.1 0.0 0.2 0.2 2.0 10.7 0.0 0.1 0.4 0.0 0.3 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.1 8.9 3.2 0.0 15.7 1.1 1.4 3073.8 2.5 8.1 15.9 24.4 0.0 14.8 14.9 0.5 0.1 0.7 0.0 0.0 0.4 2.5 3.7 5.2 1.1 2.0 1.8 205.0 1.7 0.6 0.3 1.1 13.8 1.1 0.0 0.0 0.0 10.8 0.4 0.0 12.7 11.5 2.6 0.0 0.9 0.2 1.1 4.6 27.5 0.5 0.0 12.0 CNBD1 FLJ35802 ENSG00000176571 "Cyclic nucleotide binding domain containing 1" Q8NA66 8 86866442-87615219 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 16.9" "Group enriched" "Detected in some" 49 "Early spermatids: 118.7;Late spermatids: 73.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "Karpas-707: 9.3;U-266/70: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025037, HPA027469, HPA027786" Uncertain "Secreted in male reproductive system" NA NA "HPA025037: AB_10794318, HPA027469: AB_10599492, HPA027786: AB_10600231" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 118.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 CNBD2 "C20orf152, CNMPD1, dJ954P9.1" ENSG00000149646 "Cyclic nucleotide binding domain containing 2" Q96M20 20 35954564-36030700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 141.3;Late spermatids: 79.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA043182 Uncertain NA NA "HPA043182: AB_10794389" "unprognostic (1.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.58e-1)" "unprognostic (3.27e-2)" "unprognostic (2.81e-2)" "unprognostic (6.59e-3)" "unprognostic (2.77e-2)" "unprognostic (6.71e-2)" "unprognostic (2.22e-1)" "unprognostic (1.44e-1)" "unprognostic (4.82e-4)" "unprognostic (1.63e-1)" "unprognostic (1.29e-1)" "unprognostic (2.05e-1)" "unprognostic (2.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" 1.7 1.7 1.8 2.4 3.2 4.9 2.5 3.3 4.6 1.7 3.3 0.5 1.8 2.4 1.7 9.6 1.7 1.6 3.3 2.2 2.0 1.8 5.2 3.2 1.7 2.2 1.8 1.1 1.7 2.5 2.4 1.8 0.7 2.6 1.7 1.6 2.6 3.8 1.9 10.0 1.9 2.7 1.3 1.7 2.0 1.7 31.1 2.5 2.0 2.7 6.5 1.9 1.6 1.6 0.8 0.2 2.5 2.2 3.3 2.6 0.2 1.9 2.8 4.5 4.1 3.3 1.7 2.8 0.4 1.6 3.1 2.8 7.1 4.0 3.2 1.4 2.3 2.4 1.6 2.9 5.1 3.2 1.2 4.6 4.8 8.4 14.2 2.7 2.7 0.7 3.1 4.7 2.3 2.6 1.5 4.7 5.3 1.4 16.3 1.9 4.7 3.1 7.5 0.7 2.8 4.6 1.8 2.8 11.3 4.3 1.9 8.3 3.7 1.7 4.7 2.2 1.1 2.7 4.4 1.9 2.1 2.2 0.8 0.5 13.9 8.0 8.0 2.1 4.6 0.9 2.5 0.5 0.3 2.6 2.2 0.3 0.5 0.5 1.2 0.2 0.8 0.4 0.6 2.1 3.3 0.7 0.2 2.1 0.2 1.8 3.2 3.3 4.6 2.0 1.8 1.8 1.1 2.6 2.5 0.0 6.2 11.5 9.1 0.2 10.5 0.4 17.8 4.0 5.7 10.4 21.6 6.1 24.9 3.7 141.3 0.6 14.2 0.0 4.7 5.7 0.9 6.2 1.1 10.4 6.9 22.3 12.2 8.6 12.0 79.9 6.1 4.1 0.0 2.8 12.5 18.2 3.0 8.0 2.8 14.6 36.8 19.4 1.0 21.1 15.2 0.1 4.1 12.9 9.5 6.5 CNDP1 "CN1, CPGL2, HsT2308, MGC10825" ENSG00000150656 "Carnosine dipeptidase 1" Q96KN2 18 74534440-74587212 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 60.3;liver: 41.4" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 6.1;Hepatocytes: 26.1;Proximal tubular cells: 14.6" "Group enriched" "Detected in some" 10 "glioma: 4.4;liver cancer: 1.0;melanoma: 1.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 69 "U-266/84: 42.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA008933, HPA073283" Enhanced "Secreted in brain" NA NA 1900000000 "HPA008933: AB_1847033, HPA073283: " "unprognostic (7.43e-3)" "unprognostic (6.00e-2)" "unprognostic (8.55e-3)" "unprognostic (3.93e-1)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-3)" "unprognostic (1.12e-2)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.16e-1)" "unprognostic (1.66e-1)" "unprognostic (6.90e-3)" "unprognostic (1.14e-1)" "unprognostic (3.30e-2)" "unprognostic (1.33e-1)" "unprognostic (1.28e-1)" 1.1 1.2 14.9 1.2 28.2 1.3 1.1 4.5 60.3 1.1 1.1 54.9 0.0 5.7 1.1 2.1 1.1 1.1 1.3 1.1 28.9 15.1 1.9 41.4 1.1 1.2 44.1 12.9 1.1 1.2 1.1 0.1 1.1 50.0 1.2 1.1 0.5 1.1 1.3 2.2 1.1 1.9 1.1 51.1 1.1 1.2 1.4 28.8 0.0 1.3 0.0 1.1 1.1 0.0 0.7 0.7 1.9 0.5 1.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 42.2 0.0 0.0 0.0 0.0 1.3 0.5 0.4 0.4 0.2 0.2 0.3 0.3 0.2 0.1 0.7 0.4 0.4 1.9 1.0 0.2 0.7 0.2 0.2 14.9 28.2 4.5 22.5 28.9 15.1 44.1 12.9 50.0 28.8 0.0 0.0 0.0 0.2 0.1 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.1 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 26.1 0.1 0.0 0.0 0.6 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 14.6 0.6 0.0 0.0 0.9 0.5 0.3 0.0 0.5 0.0 0.2 CNFN PLAC8L2 ENSG00000105427 Cornifelin Q9BYD5 19 42387019-42390287 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4;Enterocytes: 33.5;Intestinal endocrine cells: 31.2;Paneth cells: 38.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 367.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "memory B-cell: 25.1;naive B-cell: 27.5" "Lineage enriched" "Detected in many" 11 "B-cells: 27.5" "Cell line enhanced" "Detected in many" "A549: 14.7;HEK 293: 21.0;MCF7: 10.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA049073, HPA053997" Enhanced Approved "Microtubules,Cytokinetic bridge" Yes No Microtubules "Cytokinetic bridge" "HPA049073: AB_2680620, HPA053997: AB_2682337" "unprognostic (5.08e-2)" "unprognostic (4.21e-3)" "unprognostic (2.52e-1)" "unprognostic (7.22e-2)" "unprognostic (3.15e-2)" "unprognostic (8.35e-3)" "unprognostic (6.04e-2)" "unprognostic (2.06e-3)" "unprognostic (3.52e-1)" "unprognostic (9.44e-2)" "unprognostic (1.39e-1)" "unprognostic (8.37e-2)" "unprognostic (8.42e-2)" "unprognostic (4.83e-2)" "unprognostic (7.77e-3)" "prognostic favorable (4.02e-5)" "unprognostic (2.45e-1)" 0.4 0.3 0.2 0.2 0.8 0.2 2.5 0.2 0.2 58.9 0.5 0.2 0.2 0.2 4.4 1.4 268.7 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.6 0.3 0.2 39.0 0.3 0.5 37.3 0.4 0.2 0.2 0.3 0.2 0.2 0.2 0.9 0.2 323.6 276.3 0.2 85.7 27.5 2.4 0.5 2.0 0.0 0.7 1.0 4.7 14.7 0.3 1.3 0.7 0.7 0.2 0.8 0.3 0.3 0.3 0.8 1.3 4.1 6.6 0.2 1.0 1.9 1.2 1.8 0.1 0.0 21.0 0.3 5.5 1.5 0.0 0.0 0.0 1.5 3.3 0.8 0.0 0.1 0.0 3.8 0.8 0.2 0.0 10.0 0.0 0.1 5.4 6.4 4.4 1.7 0.3 2.2 1.4 1.8 2.2 6.4 2.7 4.1 1.9 2.3 5.0 2.1 0.0 0.0 4.5 0.1 0.0 4.8 5.7 2.7 0.0 1.7 0.2 0.0 2.0 0.0 0.7 1.5 0.2 25.1 0.5 0.5 2.4 27.5 0.2 0.4 0.5 0.0 0.3 0.5 0.0 1.0 0.2 0.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 2.1 11.5 15.0 4.0 0.0 0.8 2.5 6.7 9.1 31.4 0.0 0.2 6.6 7.5 0.6 5.2 33.5 0.0 2.2 0.2 1.0 15.2 4.6 0.8 4.7 0.0 31.2 3.7 4.5 3.2 4.9 5.5 3.3 4.6 21.3 0.1 3.6 38.6 4.2 9.0 0.0 0.0 4.8 0.5 14.2 11.3 0.2 0.0 28.2 20.4 CNGA1 "CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49" ENSG00000198515 "Cyclic nucleotide gated channel alpha 1" P29973 4 47935977-48016672 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.7" "Cell type enriched" "Detected in many" 9 "Rod photoreceptor cells: 880.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076168 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA076168: AB_2686781" "unprognostic (2.68e-2)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (8.59e-2)" "unprognostic (2.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.48e-6)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.66e-2)" "unprognostic (8.23e-2)" 4.9 1.1 0.6 2.7 1.0 0.1 2.9 0.3 0.5 5.7 6.1 0.2 1.6 2.1 0.6 12.1 13.7 3.9 1.5 1.0 0.6 0.6 4.9 23.7 0.5 0.0 1.3 0.0 1.6 2.1 5.2 4.2 21.3 0.4 6.2 2.3 14.7 4.9 1.7 4.2 5.3 12.7 0.5 0.9 8.2 2.5 1.4 0.2 0.1 2.2 3.6 2.7 8.2 8.8 0.7 2.7 1.2 0.4 1.9 1.6 0.1 3.2 1.2 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 13.4 0.1 0.7 0.0 3.6 2.1 0.3 0.4 0.1 0.0 0.9 0.0 0.3 1.0 0.0 0.1 0.3 0.1 0.6 0.0 0.1 1.6 0.0 1.1 0.9 0.7 0.2 1.3 0.1 0.2 0.6 2.0 3.1 0.1 0.0 0.1 0.6 10.7 0.3 0.1 0.2 0.6 0.2 0.3 1.2 0.0 0.6 0.3 4.2 0.1 0.1 0.9 1.0 0.1 0.1 0.1 2.4 0.2 0.4 0.0 0.5 0.4 0.1 0.3 0.2 1.6 0.3 0.7 0.3 0.6 1.2 1.9 0.2 2.7 0.1 0.1 0.6 1.0 0.3 0.5 0.6 0.6 1.3 0.0 0.4 0.2 0.0 0.0 0.0 1.4 0.1 78.5 0.4 2.5 0.0 0.0 59.3 86.4 0.0 0.0 7.8 0.4 0.1 8.4 0.0 5.9 0.0 0.2 4.0 0.0 30.0 1.3 42.9 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 3.2 100.9 1.6 10.5 0.0 0.3 880.8 0.0 3.1 0.3 1.3 2.4 0.2 0.0 2.9 15.6 CNGA2 "CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA" ENSG00000183862 "Cyclic nucleotide gated channel alpha 2" Q16280 X 151738451-151745304 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Calmodulin-binding, Ion channel, Ligand-gated ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 26 "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Region enriched" "Detected in single" 4 "olfactory region: 0.6" "Not detected" "Not detected" HPA015065 Uncertain NA NA "HPA015065: AB_1847034" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNGA3 "ACHM2, CCNC1, CCNCa, CNCG3, CNG3" ENSG00000144191 "Cyclic nucleotide gated channel alpha 3" Q16281 2 98346155-98398601 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pituitary gland: 32.0" "Cell type enriched" "Detected in some" 39 "Cone photoreceptor cells: 41.2" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "U-87 MG: 12.8" "Group enriched" "Detected in some" 6 "basal ganglia: 1.9;hypothalamus: 2.2" "Not detected" "Not detected" "HPA049378, CAB079025" Approved Approved NA NA "CAB079025: , HPA049378: AB_2732551" "unprognostic (2.34e-2)" "unprognostic (1.83e-2)" "unprognostic (4.96e-2)" "unprognostic (4.81e-2)" "unprognostic (1.13e-1)" "unprognostic (2.18e-1)" "unprognostic (4.17e-4)" "unprognostic (4.65e-2)" "unprognostic (1.86e-3)" "unprognostic (2.88e-1)" "unprognostic (3.85e-3)" "unprognostic (8.98e-2)" "unprognostic (5.90e-2)" "unprognostic (3.71e-2)" 0.1 0.0 0.3 1.4 0.7 0.0 0.7 0.1 2.9 0.1 6.1 2.4 0.1 2.8 0.1 0.1 4.6 0.8 0.4 0.1 1.2 4.0 0.1 0.1 0.2 0.1 0.8 0.4 0.1 1.5 0.0 32.0 0.1 4.9 0.1 3.2 1.2 0.2 0.5 0.1 0.0 4.0 2.2 4.3 0.1 3.0 1.1 0.3 0.1 0.1 0.1 0.1 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 1.5 1.2 4.0 0.8 0.4 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CNGA4 "CNCA2, CNG5, CNGB2, OCNC2, OCNCb" ENSG00000132259 "Cyclic nucleotide gated channel alpha 4" Q8IV77 11 6234765-6244429 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Olfaction, Sensory transduction, Transport" "Ion channel, Ligand-gated ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 8.0;fallopian tube: 22.5;ovary: 9.1" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Early spermatids: 3.5;Late spermatids: 2.4" "Cancer enriched" "Detected in single" 6 "endometrial cancer: 2.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 21 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.5;CAPAN-2: 2.6;HaCaT: 2.3;HMC-1: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (1.11e-2)" "unprognostic (4.32e-2)" "unprognostic (2.69e-3)" "prognostic favorable (1.48e-4)" "unprognostic (4.96e-2)" "unprognostic (1.09e-1)" "unprognostic (2.01e-3)" "unprognostic (1.89e-1)" "unprognostic (8.51e-2)" "unprognostic (5.51e-2)" "unprognostic (1.83e-2)" "unprognostic (8.70e-2)" "unprognostic (1.03e-3)" "unprognostic (3.84e-2)" "unprognostic (3.47e-2)" "unprognostic (8.11e-2)" "unprognostic (3.55e-3)" 0.2 0.3 1.5 0.3 2.0 0.6 0.2 0.6 1.1 1.0 0.4 1.9 0.1 0.5 1.2 8.0 0.4 22.5 0.3 0.1 1.7 1.4 0.3 0.2 6.6 0.4 1.0 0.1 9.1 0.3 0.3 2.3 0.2 3.3 0.3 0.2 0.3 0.2 0.8 0.1 0.4 0.3 0.3 1.3 0.3 0.3 7.4 1.4 0.1 0.3 0.1 0.3 0.2 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.7 2.5 0.1 0.1 0.1 0.0 0.1 0.0 0.0 2.6 0.7 0.3 0.0 0.3 2.3 0.1 0.5 0.0 1.6 0.3 0.0 0.4 0.1 0.1 0.2 3.4 1.6 1.2 0.2 0.1 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.0 0.1 1.1 0.4 0.0 0.0 0.0 0.4 0.2 0.5 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.3 0.4 0.2 0.6 0.0 1.1 0.6 0.0 0.7 0.3 1.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.0 0.6 1.1 1.7 1.4 1.0 0.1 3.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 CNGB1 "CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45" ENSG00000070729 "Cyclic nucleotide gated channel beta 1" Q14028 16 57882340-57971116 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Olfaction, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 79.8" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 312.2;Rod photoreceptor cells: 1014.1" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "EFO-21: 3.0;RPMI-8226: 3.4;SCLC-21H: 9.6;SiHa: 5.6;SK-BR-3: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039159, HPA060355" Approved Vesicles,Cytosol No NA Cytosol Vesicles "HPA039159: AB_10795579, HPA060355: " "unprognostic (5.52e-3)" "unprognostic (4.51e-3)" "unprognostic (1.06e-1)" "unprognostic (2.73e-3)" "unprognostic (6.20e-2)" "unprognostic (1.76e-1)" "unprognostic (8.56e-4)" "unprognostic (3.08e-1)" "unprognostic (9.84e-2)" "unprognostic (2.83e-1)" "unprognostic (2.14e-4)" "unprognostic (5.42e-2)" "unprognostic (1.01e-3)" "unprognostic (5.20e-2)" "unprognostic (1.88e-1)" "unprognostic (4.57e-2)" "unprognostic (9.07e-2)" 0.2 7.2 13.1 3.0 3.0 0.7 0.2 0.2 6.3 0.2 1.7 0.0 0.0 0.5 0.2 0.5 0.2 0.4 0.8 0.2 7.1 11.0 0.2 0.2 0.4 0.7 1.3 4.0 0.1 1.5 0.0 0.5 1.2 4.2 0.2 1.2 79.8 0.3 0.4 0.1 0.5 1.8 0.2 0.7 0.2 0.2 1.3 0.0 0.0 0.2 0.0 0.4 0.3 0.2 0.4 0.3 2.6 0.3 0.3 0.4 0.0 0.6 1.2 0.0 0.2 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.2 0.2 3.0 0.0 1.0 0.0 0.0 2.5 0.0 0.2 0.0 0.6 1.8 1.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.6 0.1 0.2 0.0 0.2 0.1 0.0 3.4 0.0 1.2 9.6 0.1 5.6 2.8 0.0 0.2 0.1 0.1 0.7 0.3 0.5 0.4 0.1 0.2 0.6 0.1 0.1 0.3 0.1 0.6 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.4 0.4 0.2 2.6 0.3 0.3 0.3 0.0 0.0 13.1 3.0 0.2 6.3 7.1 11.0 1.3 4.0 4.2 0.0 0.0 0.0 0.0 0.5 0.0 44.0 0.8 0.0 0.0 0.0 0.0 312.2 4.7 0.0 0.2 1.5 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.4 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.3 0.0 0.0 0.0 1014.1 0.0 0.0 0.4 0.6 0.0 1.1 0.0 0.0 0.1 CNGB3 "ACHM1, ACHM3, RMCH" ENSG00000170289 "Cyclic nucleotide gated channel beta 3" Q9NQW8 8 86553977-86743675 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 68.9" "Cell type enriched" "Detected in some" 21 "Cone photoreceptor cells: 149.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA057244 Enhanced NA NA "HPA057244: AB_2683380" "unprognostic (5.35e-1)" "unprognostic (1.68e-3)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (3.62e-2)" "unprognostic (2.58e-1)" "unprognostic (6.25e-2)" "unprognostic (1.18e-1)" "unprognostic (2.91e-1)" "unprognostic (2.17e-1)" "unprognostic (3.82e-1)" "unprognostic (9.28e-2)" "unprognostic (2.77e-4)" "unprognostic (1.40e-4)" "unprognostic (1.66e-2)" "unprognostic (8.76e-2)" "unprognostic (1.84e-1)" 0.2 0.1 0.4 0.4 0.2 7.9 0.2 0.2 1.0 0.9 0.1 0.1 0.1 0.9 0.7 0.4 0.2 2.8 0.1 0.3 0.2 0.2 0.2 0.1 0.1 0.3 0.6 0.1 1.0 1.5 0.0 0.6 0.1 1.8 0.1 0.0 68.9 0.3 0.1 0.1 2.4 0.4 0.1 0.8 0.1 0.6 5.4 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 1.4 0.1 0.0 0.0 3.1 0.3 0.0 0.0 0.4 0.0 1.6 21.6 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.2 1.0 0.2 0.2 0.6 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 149.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.2 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.0 0.0 CNIH2 "CNIH-2, Cnil, MGC50896" ENSG00000174871 "Cornichon family AMPA receptor auxiliary protein 2" Q6PI25 11 66278190-66285301 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 74.5" "Group enriched" "Detected in some" 9 "Early spermatids: 56.3;Horizontal cells: 15.9;Intestinal endocrine cells: 47.6;Late spermatids: 18.6" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.1;AN3-CA: 7.8;MCF7: 7.7;NTERA-2: 8.5;SCLC-21H: 35.5;SH-SY5Y: 16.4;T-47d: 7.7" "Low region specificity" "Detected in all" NA NA "unprognostic (1.84e-2)" "unprognostic (3.53e-3)" "unprognostic (3.40e-3)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.18e-4)" "unprognostic (1.81e-1)" "unprognostic (1.74e-2)" "unprognostic (3.29e-1)" "unprognostic (3.25e-1)" "unprognostic (3.80e-2)" "unprognostic (7.66e-3)" "unprognostic (4.16e-2)" "unprognostic (6.95e-8)" "unprognostic (3.53e-1)" "unprognostic (3.19e-2)" "unprognostic (3.17e-2)" "unprognostic (3.55e-2)" 1.5 6.5 33.9 1.5 37.6 3.2 1.4 8.4 49.5 1.2 1.4 6.2 0.0 2.1 1.5 1.3 1.3 2.0 1.5 1.2 74.5 17.3 1.2 1.2 1.4 1.4 9.6 15.5 1.2 4.2 1.6 8.8 2.0 4.6 1.4 1.6 0.0 1.3 1.2 1.2 3.1 1.6 1.6 2.4 1.6 2.8 2.6 4.7 0.5 1.3 0.0 1.3 1.3 0.0 0.8 0.3 0.0 0.0 0.0 0.8 0.0 0.2 0.4 9.1 7.8 0.1 0.2 1.1 0.5 0.6 1.1 0.1 0.2 0.0 0.0 0.1 0.1 0.5 0.1 2.0 0.0 0.1 0.8 0.7 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.1 1.2 0.5 7.7 1.2 0.1 8.5 0.0 0.6 3.7 0.0 0.0 0.1 0.4 35.5 16.4 0.0 4.4 0.3 0.4 7.7 0.1 0.0 1.0 0.4 0.3 0.3 0.2 0.2 0.3 2.4 0.2 5.9 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.1 0.8 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 33.9 37.6 8.4 36.5 74.5 17.3 9.6 15.5 4.6 4.7 0.0 0.3 0.0 0.2 0.6 1.7 0.8 2.5 4.0 0.0 0.0 0.0 0.6 0.0 0.0 56.3 0.3 0.0 0.0 0.2 1.7 0.2 0.2 0.0 0.0 0.2 15.9 47.6 0.6 0.0 18.6 0.6 0.0 0.0 0.0 1.2 0.5 0.7 0.0 0.4 0.0 2.8 0.0 0.0 0.5 0.7 0.4 1.0 0.8 0.3 0.3 CNIH3 "CNIH-3, FLJ38993" ENSG00000143786 "Cornichon family AMPA receptor auxiliary protein 3" Q8TBE1 1 224434660-224740549 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 16.1;pancreas: 21.7" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 26.6;Early spermatids: 14.0;Late spermatids: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.8;hTEC/SVTERT24-B: 24.9;hTERT-RPE1: 14.1;NTERA-2: 9.2;U-266/70: 13.3;U-87 MG: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (4.90e-2)" "unprognostic (5.18e-2)" "unprognostic (2.88e-1)" "unprognostic (7.18e-2)" "unprognostic (4.96e-2)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (4.63e-2)" "unprognostic (3.15e-1)" "unprognostic (2.30e-1)" "unprognostic (5.23e-5)" "unprognostic (1.03e-1)" "unprognostic (3.66e-1)" "unprognostic (5.87e-2)" "unprognostic (2.63e-1)" 2.0 0.8 7.0 0.5 5.1 0.2 1.3 1.0 16.1 1.7 0.6 0.6 0.0 0.8 1.5 0.9 0.6 1.9 1.2 0.6 9.8 5.0 1.5 0.6 0.9 0.9 5.4 8.0 3.6 21.7 0.3 0.7 0.4 3.5 0.9 0.7 0.2 0.6 1.1 0.7 0.4 0.6 1.0 1.4 0.6 0.6 3.9 0.1 0.2 1.0 0.0 0.9 0.7 0.9 0.9 0.3 0.0 0.0 1.8 0.9 0.1 0.2 0.2 0.3 0.3 0.3 0.5 0.1 1.8 9.8 0.2 0.5 0.0 2.2 0.0 0.9 4.2 0.7 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.7 0.3 0.0 24.9 0.3 14.1 0.0 0.1 0.0 0.0 1.4 0.0 0.0 3.0 9.2 0.1 1.1 0.0 0.5 0.0 1.5 0.9 0.3 0.2 0.0 0.0 6.1 1.0 0.0 0.2 0.0 0.0 2.3 0.0 0.2 13.3 0.5 0.0 29.6 0.1 3.7 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.3 0.3 0.0 0.6 0.0 1.8 0.0 0.0 0.9 0.1 7.0 5.1 1.0 11.1 9.8 5.0 5.4 8.0 3.5 0.1 0.0 1.3 0.5 2.4 2.5 3.3 1.2 2.5 13.4 0.0 1.8 0.0 1.5 26.6 0.6 14.0 2.7 0.4 0.0 2.6 0.4 3.2 2.0 2.3 1.7 5.2 0.0 1.2 1.8 0.0 26.2 2.6 1.9 0.0 1.0 2.3 9.2 0.7 0.0 1.1 9.0 0.5 0.0 0.9 2.3 9.6 1.9 4.2 1.8 1.7 1.3 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 38.4" "Cell type enhanced" "Detected in many" 21 "Cone photoreceptor cells: 19.6;Horizontal cells: 22.3;Rod photoreceptor cells: 86.9" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.9;naive CD4 T-cell: 3.0" "Group enriched" "Detected in many" 5 "B-cells: 2.9;T-cells: 3.0" "Cell line enhanced" "Detected in some" "A549: 6.8;AF22: 4.8;NTERA-2: 11.1;PC-3: 5.7;RH-30: 10.3;U-251 MG: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 2.0 5.2 23.5 1.4 29.6 1.3 2.1 31.3 38.4 1.4 1.2 1.7 0.0 1.1 1.4 1.8 1.1 2.3 1.2 1.7 26.4 4.4 1.0 2.0 2.8 2.4 3.1 20.8 1.9 4.9 1.0 1.0 1.1 1.8 2.2 1.1 3.5 1.7 1.2 7.4 1.1 1.2 1.2 1.7 1.8 1.3 1.8 5.0 0.6 1.2 0.0 2.6 1.3 0.7 2.9 0.1 0.6 0.0 0.0 3.0 0.3 0.0 6.8 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.1 11.1 0.0 5.7 0.0 10.3 0.0 0.0 0.0 4.7 1.9 0.0 0.1 0.2 2.9 0.0 0.6 0.0 0.1 2.2 0.0 6.8 3.6 0.0 3.6 1.0 0.0 2.7 0.1 0.0 0.6 0.1 0.0 0.4 1.1 0.6 0.0 0.0 2.9 3.0 1.0 0.0 0.0 0.0 0.1 0.8 0.3 23.5 29.6 31.3 24.4 26.4 4.4 3.1 20.8 1.8 5.0 14.9 2.2 0.5 0.5 1.1 11.3 5.6 0.0 0.0 10.3 0.0 19.6 0.0 0.0 0.4 0.2 0.0 0.4 0.0 1.9 0.0 1.4 2.1 1.1 2.4 0.1 22.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 12.8 0.8 0.0 1.4 0.0 86.9 0.0 0.8 0.9 8.7 1.6 0.0 0.0 0.1 0.0 CNMD "BRICD3, CHM-I, CHM1, LECT1, MYETS1" ENSG00000136110 Chondromodulin O75829 13 52703264-52739812 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 33 "NTERA-2: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010510 Uncertain "Secreted to extracellular matrix" NA NA "HPA010510: AB_10602021" "unprognostic (7.52e-3)" "unprognostic (1.34e-1)" "unprognostic (7.36e-2)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (3.22e-1)" "unprognostic (2.84e-2)" "unprognostic (2.63e-2)" "unprognostic (1.42e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-1)" 0.3 0.3 3.1 0.3 11.1 0.3 0.4 0.9 2.5 0.3 0.5 4.3 0.0 0.3 0.3 0.3 0.6 0.4 0.3 0.4 3.0 2.6 0.3 0.3 3.9 0.3 3.7 0.9 0.4 1.1 0.3 2.5 0.5 3.1 1.6 0.5 6.1 15.1 0.4 0.5 0.5 0.4 0.3 4.4 1.0 0.4 4.2 4.1 0.0 8.0 0.0 0.6 0.3 0.0 0.0 0.6 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 3.1 11.1 0.9 2.3 3.0 2.6 3.7 0.9 3.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CNN1 "Sm-Calp, SMCC" ENSG00000130176 "Calponin 1" P51911 19 11538717-11550323 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 489.2;urinary bladder: 357.9" "Group enriched" "Detected in many" 7 "Early spermatids: 328.5;Late spermatids: 430.5;Peritubular cells: 207.9;Smooth muscle cells: 159.5" "Cancer enhanced" "Detected in all" "prostate cancer: 142.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 33.7;BJ hTERT+: 12.9;BJ hTERT+ SV40 Large T+: 17.6;BJ hTERT+ SV40 Large T+ RasG12V: 24.5;HBF TERT88: 27.2;SuSa: 28.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB000007, HPA014263" Enhanced Approved "Actin filaments" No No "Actin filaments" "CAB000007: AB_2082148, HPA014263: AB_1847039" "unprognostic (4.98e-3)" "unprognostic (1.01e-1)" "unprognostic (3.04e-3)" "unprognostic (1.95e-1)" "unprognostic (2.47e-1)" "unprognostic (4.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.76e-1)" "unprognostic (1.35e-1)" "unprognostic (7.06e-2)" "unprognostic (2.19e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (5.43e-6)" "unprognostic (1.70e-2)" "unprognostic (1.07e-1)" "unprognostic (2.78e-3)" "unprognostic (6.11e-3)" 9.3 4.1 0.5 34.9 0.9 0.0 7.9 0.5 1.2 90.5 193.4 1.3 78.1 9.4 182.6 50.6 140.5 52.2 105.7 22.2 0.6 0.6 6.2 1.0 9.5 2.2 0.7 1.8 36.5 1.3 0.0 0.7 4.0 2.2 120.1 26.4 8.8 9.1 125.2 4.8 4.5 37.1 489.2 1.0 1.2 66.5 16.4 0.5 0.4 3.2 4.5 3.3 357.9 26.8 0.0 0.4 0.0 0.1 0.0 0.0 5.2 0.0 0.5 2.2 0.4 0.2 0.0 1.3 33.7 12.9 17.6 24.5 9.5 0.0 0.1 1.0 9.5 1.6 0.1 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.1 1.1 0.0 10.8 0.0 0.5 0.0 0.0 12.5 0.0 0.0 0.0 0.1 1.7 1.1 0.0 0.2 0.1 0.4 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.1 28.8 0.0 0.0 0.1 0.1 12.7 0.5 0.4 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.5 0.9 0.5 1.2 0.6 0.6 0.7 1.8 2.2 0.5 0.0 0.0 0.0 5.1 4.2 0.0 35.3 0.0 0.0 0.0 1.8 0.0 0.4 0.0 2.8 328.5 2.4 0.0 0.0 0.3 0.9 9.3 2.2 0.0 0.0 2.0 0.0 0.0 9.2 0.0 430.5 7.8 0.0 3.3 1.0 0.0 0.2 1.4 0.0 207.9 0.0 0.0 38.8 159.5 2.5 4.9 6.1 0.6 0.0 0.0 0.9 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329099-99394330 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 16.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 30.2;Early spermatids: 76.6;Horizontal cells: 47.7;Late spermatids: 66.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 17.4;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.1;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8;OE19: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.6 2.5 3.4 0.7 15.5 0.5 1.3 8.1 12.7 2.0 1.0 0.3 1.1 1.2 2.1 3.7 1.4 2.4 1.0 0.5 2.8 5.0 2.4 0.8 0.6 0.5 2.1 7.1 5.4 1.7 0.4 4.2 0.5 4.8 3.6 1.2 0.7 1.0 2.1 0.5 2.5 1.2 1.5 1.0 0.5 1.6 16.8 2.3 0.0 0.5 0.2 0.6 2.2 1.2 0.1 0.1 0.2 0.0 0.1 1.3 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 2.5 6.6 6.1 10.4 0.0 4.0 0.0 0.0 1.2 0.1 1.6 7.8 0.0 4.4 0.0 0.8 1.7 2.6 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.3 2.3 0.2 0.0 0.8 6.7 0.7 0.0 0.0 0.0 0.8 0.0 2.0 5.6 1.8 0.4 0.8 0.5 0.0 0.0 0.0 0.6 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.4 15.5 8.1 12.4 2.8 5.0 2.1 7.1 4.8 2.3 0.0 0.0 0.0 3.4 2.1 30.2 1.1 0.0 0.0 0.0 1.8 13.7 0.0 0.0 0.4 76.6 0.7 0.0 0.0 1.3 0.0 0.5 2.4 0.0 0.0 0.0 47.7 0.0 2.5 0.0 66.1 2.0 0.0 1.7 0.0 0.0 0.8 1.8 0.0 2.5 0.5 3.3 0.0 0.3 1.1 1.4 0.9 0.0 0.0 0.0 2.2 CNNM2 ACDP2 ENSG00000148842 "Cyclin and CBS domain divalent metal cation transport mediator 2" Q9H8M5 10 102918293-103090221 "Disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Disease mutation, Epilepsy, Mental retardation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 30.2;Syncytiotrophoblasts: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059954, HPA071631" Enhanced Vesicles NA NA Vesicles "HPA059954: AB_2684177, HPA071631: AB_2686427" "unprognostic (2.18e-1)" "unprognostic (6.46e-2)" "unprognostic (1.24e-1)" "unprognostic (2.65e-3)" "unprognostic (3.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.93e-1)" "unprognostic (4.80e-2)" "unprognostic (4.51e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.39e-8)" "unprognostic (2.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.65e-3)" "unprognostic (1.56e-1)" 5.7 19.8 9.5 6.6 13.8 13.3 5.0 16.8 15.1 6.0 11.8 12.5 8.0 6.9 6.6 5.8 3.3 8.9 9.4 4.1 7.8 10.9 15.6 7.9 6.4 4.1 10.4 8.6 8.8 6.8 35.6 10.6 14.3 9.6 5.0 11.2 7.7 5.2 7.1 3.0 7.2 7.7 6.9 9.3 4.1 5.4 8.0 12.7 3.3 10.0 1.9 3.0 6.2 5.4 1.3 1.3 2.8 0.8 4.5 1.1 0.4 4.7 7.8 3.1 8.2 7.9 3.2 8.4 2.3 9.4 3.1 3.8 5.5 4.2 1.8 3.5 3.3 5.9 6.3 6.6 4.4 2.3 3.1 11.6 2.6 4.3 11.1 4.6 1.8 3.6 4.2 6.4 3.1 10.5 7.8 1.9 5.4 4.5 10.6 1.7 8.0 2.1 2.1 4.9 4.6 4.9 5.2 3.9 2.2 2.4 2.8 4.4 5.7 5.6 1.4 5.9 9.3 10.1 3.5 1.5 4.2 6.3 2.9 4.0 11.6 12.8 3.3 7.4 6.3 1.7 1.9 0.8 0.7 1.0 0.8 0.8 1.3 0.7 0.5 0.6 0.7 0.8 0.7 2.8 4.5 0.4 1.3 1.1 0.4 9.5 13.8 16.8 15.1 7.8 10.9 10.4 8.6 9.6 12.7 6.0 6.7 7.5 2.1 2.2 15.8 3.5 0.0 8.1 7.9 5.2 11.8 13.9 1.7 1.8 8.4 3.8 24.6 0.0 4.8 2.7 2.9 2.2 3.5 5.4 3.3 30.2 6.4 3.1 1.5 10.4 3.1 2.7 6.8 1.0 4.2 6.5 2.7 11.5 3.2 4.4 15.7 12.9 7.8 15.0 5.4 3.6 33.3 3.1 7.4 1.8 CNOT6L "Ccr4b, DKFZp434K098" ENSG00000138767 "CCR4-NOT transcription complex subunit 6 like" Q96LI5 4 77713387-77819615 "Enzymes, Predicted intracellular proteins" "mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 51.3" "Cell type enhanced" "Detected in many" 5 "T-cells: 121.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042688 Uncertain Supported Cytosol NA NA Cytosol "HPA042688: AB_10794384" "unprognostic (3.91e-1)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.10e-2)" "unprognostic (2.56e-1)" "unprognostic (3.72e-2)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (5.06e-2)" "unprognostic (6.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (4.51e-2)" "unprognostic (7.95e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-3)" 13.6 7.8 8.6 21.5 8.2 15.3 11.0 11.1 9.2 7.8 7.3 7.0 4.6 7.5 11.4 6.3 10.2 7.1 8.3 7.5 6.0 5.7 7.7 10.8 12.7 19.2 7.6 7.3 8.8 10.8 14.6 10.0 12.3 6.7 8.4 8.9 10.3 9.9 7.4 9.1 12.2 11.5 8.4 6.9 23.4 7.9 7.3 5.6 51.3 9.1 6.2 21.1 10.7 10.3 7.5 6.1 20.2 9.3 7.4 10.0 4.4 8.8 5.7 7.2 4.8 8.5 7.4 7.1 7.0 9.3 6.3 8.6 2.2 9.9 15.3 8.9 9.8 5.0 5.7 9.3 9.7 8.5 15.3 5.2 14.3 7.9 6.4 5.4 14.2 12.6 4.8 12.6 7.1 13.0 6.0 20.0 11.1 11.9 20.5 7.3 6.0 26.2 7.2 3.3 7.0 1.8 6.5 20.4 10.9 7.2 10.0 8.9 4.3 12.1 11.1 4.9 8.8 3.5 7.3 21.7 6.1 6.8 11.5 3.8 26.3 11.2 19.0 6.6 6.2 4.5 20.2 4.7 10.2 10.0 7.0 10.0 5.3 7.5 7.8 4.5 7.5 7.3 8.5 6.7 7.4 9.3 6.1 6.0 4.4 8.6 8.2 11.1 9.2 6.0 5.7 7.6 7.3 6.7 5.6 20.8 16.0 29.6 11.9 51.4 38.1 14.5 22.9 14.7 28.4 34.9 37.3 22.8 51.4 5.9 3.4 42.7 16.9 0.0 10.5 7.4 21.1 30.3 36.9 27.0 14.9 30.2 25.2 41.7 40.3 2.8 17.3 33.5 23.6 14.4 31.3 20.1 8.9 14.0 12.0 17.0 40.7 32.3 31.7 19.1 30.9 57.7 20.4 121.5 23.0 16.3 CNP ENSG00000173786 "2',3'-cyclic nucleotide 3' phosphodiesterase" P09543 17 41966741-41977731 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 211.7" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 49.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002672, HPA023266, HPA023278, HPA023280, HPA023338" Enhanced Supported Supported "Plasma membrane" NA NA 730000 "Plasma membrane" "CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062" "unprognostic (2.17e-1)" "unprognostic (4.48e-2)" "unprognostic (3.85e-3)" "unprognostic (1.41e-1)" "unprognostic (3.09e-1)" "unprognostic (9.71e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.87e-1)" "unprognostic (2.99e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (8.86e-2)" "unprognostic (1.10e-3)" 9.1 8.9 51.4 9.5 72.8 6.7 8.1 13.4 125.3 10.3 7.5 211.7 2.3 7.1 8.0 12.7 15.0 9.3 10.8 7.6 78.4 40.7 14.7 9.6 6.7 10.5 86.7 49.0 11.2 9.2 5.8 4.4 7.8 66.7 11.7 6.4 3.6 15.1 13.2 7.6 11.1 6.4 10.1 160.2 7.1 7.4 4.6 63.5 2.1 7.2 2.2 11.2 9.8 5.7 9.9 49.1 7.3 13.1 7.3 7.5 9.1 13.9 23.9 22.7 27.9 19.4 18.3 9.7 17.5 26.9 45.5 51.4 18.7 12.8 14.9 14.1 22.8 23.4 24.1 15.3 11.6 15.8 14.7 19.3 14.4 16.4 32.4 20.9 14.0 13.1 30.1 8.3 24.9 6.1 16.5 20.7 14.9 10.2 12.1 15.8 8.9 35.9 12.7 5.3 7.6 17.0 22.4 33.3 14.5 12.1 14.3 13.3 18.0 22.2 33.4 38.9 11.6 14.9 21.0 20.8 17.7 19.5 24.1 20.6 13.7 15.6 11.8 17.6 10.9 69.2 4.9 12.1 7.3 7.5 13.1 5.9 9.9 6.5 6.0 11.1 7.0 5.9 6.9 2.6 7.3 10.3 49.1 7.2 9.1 51.4 72.8 13.4 93.8 78.4 40.7 86.7 49.0 66.7 63.5 14.9 10.1 20.1 16.4 14.8 20.3 11.3 20.4 13.4 22.7 33.2 5.9 26.2 106.1 40.0 1.0 17.9 18.3 0.0 37.1 41.6 27.2 18.5 9.2 25.9 34.6 47.7 18.9 18.4 13.2 2.8 35.9 14.9 52.3 31.5 12.9 73.9 30.9 17.3 33.9 48.5 23.1 32.3 36.5 3.9 13.0 16.6 10.9 18.7 18.8 16.6 CNPY1 ENSG00000146910 "Canopy FGF signaling regulator 1" Q3B7I2 7 155474206-155555450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "brain: 21.1;pancreas: 8.5" "Cell type enriched" "Detected in single" 17 "Spermatogonia: 4.9" "Cancer enriched" "Detected in single" 10 "glioma: 1.6" "Region enriched" "Detected in some" 17 "cerebellum: 21.1" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "AF22: 26.6" "Region enriched" "Detected in single" 29 "cerebellum: 215.6" HPA047400 Uncertain NA NA "HPA047400: AB_10960413" "unprognostic (4.28e-3)" "unprognostic (2.12e-1)" "unprognostic (4.18e-2)" "unprognostic (8.27e-12)" "unprognostic (1.44e-1)" "unprognostic (2.16e-1)" 0.1 0.0 0.2 0.1 0.3 0.7 0.1 21.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.9 0.1 0.2 8.5 0.0 0.2 0.1 1.2 0.1 0.1 0.5 0.2 0.1 0.1 1.2 0.5 0.1 0.5 0.1 0.2 2.1 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 2.3 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.1 0.1 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.3 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 21.1 0.5 0.2 0.2 0.9 0.1 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.0 0.0 0.0 0.0 CNPY3 "CAG4A, TNRC5" ENSG00000137161 "Canopy FGF signaling regulator 3" Q9BT09 6 42929192-42939287 "Predicted intracellular proteins" "Immunity, Innate immunity" Chaperone "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 96.6" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 217.2;Kupffer cells: 210.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016560 Uncertain "Intracellular and membrane" NA NA 530000 "HPA016560: AB_1858173" "unprognostic (5.26e-3)" "unprognostic (6.63e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (8.15e-2)" "unprognostic (3.12e-1)" "unprognostic (1.79e-1)" "unprognostic (5.70e-3)" "unprognostic (5.11e-2)" "unprognostic (4.77e-2)" "unprognostic (1.94e-2)" "unprognostic (2.26e-3)" "unprognostic (4.54e-2)" "prognostic unfavorable (9.85e-6)" "unprognostic (2.34e-1)" "unprognostic (1.93e-2)" "unprognostic (2.21e-2)" "unprognostic (2.98e-3)" 14.6 13.5 16.3 24.8 17.8 51.4 20.4 12.1 21.8 17.5 12.8 21.6 14.3 12.6 17.4 14.0 10.8 21.1 18.0 12.8 16.3 18.3 14.8 27.2 19.7 31.5 23.4 14.7 21.2 60.5 9.6 19.3 19.3 14.6 19.3 12.5 17.8 14.3 15.1 6.4 9.2 20.9 17.5 25.8 48.5 15.0 19.3 15.1 45.2 23.8 6.9 27.5 17.0 13.6 30.3 77.8 96.6 54.3 14.1 15.1 38.3 14.6 14.7 14.7 31.1 24.3 9.2 14.4 11.7 15.6 15.9 18.4 16.3 11.2 15.7 18.2 20.0 34.8 12.3 10.7 13.4 9.8 15.4 11.5 17.1 12.9 25.3 14.3 29.6 35.2 11.1 8.2 12.3 13.6 23.1 14.2 15.3 13.6 31.4 10.2 27.7 26.8 35.9 11.6 70.8 8.1 18.6 10.0 22.9 15.8 11.3 15.3 13.6 7.3 7.6 25.3 19.7 9.7 64.8 10.5 16.6 16.9 6.1 12.5 21.6 14.5 22.1 6.8 34.5 13.9 18.6 54.3 26.9 13.8 36.7 13.2 30.3 12.2 15.1 46.2 27.5 13.8 14.1 96.6 14.1 33.9 77.8 11.1 38.3 16.3 17.8 12.1 21.8 16.3 18.3 23.4 14.7 14.6 15.1 11.9 12.0 91.0 29.7 20.3 42.9 14.4 28.1 30.8 15.9 22.7 13.7 52.2 6.6 39.5 40.4 26.8 23.4 0.0 29.7 135.2 27.2 40.7 45.1 48.2 217.2 1.6 53.2 39.3 210.8 51.6 31.1 105.5 28.7 83.8 26.6 20.0 32.7 29.1 28.3 15.7 9.5 19.4 21.7 26.5 29.2 14.9 30.2 65.5 30.8 31.1 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell type enriched" "Detected in some" 14 "Sertoli cells: 97.0" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 6 "B-cells: 2.9" "Group enriched" "Detected in some" 7 "ASC diff: 40.3;HSkMC: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA042256: AB_2677917, HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 19.4 6.4 18.0 5.2 15.8 1.5 14.9 13.8 30.5 3.9 5.5 0.8 0.8 2.3 3.1 4.7 3.7 5.5 3.6 1.4 17.6 7.7 0.9 0.7 6.4 6.5 2.3 14.7 4.1 1.8 1.3 18.3 5.2 4.2 1.5 5.1 0.0 4.3 4.0 1.7 2.4 4.2 5.8 3.2 2.3 2.3 2.7 2.8 0.0 2.6 0.0 9.9 2.7 3.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 40.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.9 1.4 0.0 2.6 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 18.0 15.8 13.8 21.4 17.6 7.7 2.3 14.7 4.2 2.8 0.0 7.2 2.7 0.4 0.6 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 97.0 2.3 0.0 0.1 0.1 0.1 0.0 0.0 0.7 CNR2 CB2 ENSG00000188822 "Cannabinoid receptor 2" P34972 1 23870526-23913362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 19.2;lymphoid tissue: 31.1" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 4.6;B-cells: 16.4;T-cells: 5.7" "Cancer enriched" "Detected in single" 6 "testis cancer: 2.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basophil: 19.2;eosinophil: 16.2;memory B-cell: 14.9;naive B-cell: 15.1;NK-cell: 8.7" "Group enriched" "Detected in many" 7 "B-cells: 15.1;granulocytes: 19.2;NK-cells: 8.7" "Cell line enhanced" "Detected in some" "Daudi: 5.0;HEL: 4.2;HMC-1: 19.4;U-698: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB009719 Uncertain NA NA "CAB009719: AB_2082784" "unprognostic (9.45e-4)" "unprognostic (5.40e-3)" "unprognostic (8.50e-3)" "unprognostic (8.19e-3)" "unprognostic (3.55e-3)" "unprognostic (9.34e-6)" "unprognostic (5.58e-3)" "unprognostic (6.96e-3)" "unprognostic (1.74e-1)" "unprognostic (7.87e-2)" "unprognostic (1.53e-1)" "unprognostic (4.93e-2)" "unprognostic (1.04e-3)" "unprognostic (3.67e-1)" "unprognostic (1.80e-1)" "unprognostic (3.75e-2)" "unprognostic (4.91e-2)" 0.3 0.2 0.2 18.5 0.2 1.8 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.1 0.2 0.1 1.8 0.2 0.3 0.3 0.2 0.2 0.4 0.3 0.6 27.7 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.4 0.3 0.3 3.1 0.0 1.8 0.2 5.5 0.0 0.2 29.7 0.4 0.4 0.0 3.0 0.6 0.6 31.1 1.5 0.3 15.1 0.8 19.2 0.1 8.7 2.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.1 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 13.0 0.0 0.1 0.0 19.2 0.1 16.2 1.7 0.0 2.0 14.9 0.1 1.5 0.2 15.1 0.1 0.9 0.6 8.7 0.1 0.8 0.1 0.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 4.6 16.4 0.7 0.6 0.7 0.3 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 3.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.8 0.0 0.3 0.3 0.2 0.3 0.2 5.7 0.0 0.6 CNRIP1 "C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924" ENSG00000119865 "Cannabinoid receptor interacting protein 1" Q96F85 2 68284171-68320051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 71.9;granulocytes: 120.1" "Cancer enhanced" "Detected in all" "glioma: 14.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 79 "basophil: 11.1" "Lineage enriched" "Detected in single" 79 "granulocytes: 11.1" "Cell line enhanced" "Detected in many" "HEL: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035337 Approved Cytosol NA NA 50000 Cytosol "HPA035337: AB_10601359" "unprognostic (1.23e-1)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.20e-1)" "unprognostic (6.51e-2)" "unprognostic (3.52e-2)" "unprognostic (2.86e-2)" "unprognostic (4.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.04e-2)" "unprognostic (3.63e-2)" "unprognostic (1.69e-1)" "unprognostic (3.38e-3)" 26.6 8.6 26.9 7.1 21.9 6.4 11.8 28.3 42.2 15.3 7.3 7.5 2.0 4.9 15.7 8.0 6.3 9.3 10.3 8.8 26.9 22.4 5.0 3.8 10.0 5.7 16.0 22.9 24.5 2.6 2.7 7.2 14.7 12.7 10.1 6.3 10.9 3.3 11.6 7.8 3.6 7.0 11.8 10.8 10.8 5.7 4.0 6.5 0.1 4.1 3.0 4.1 9.3 13.6 0.1 0.0 11.1 0.1 0.0 0.1 0.1 0.0 0.3 3.0 0.0 11.5 8.5 0.0 11.5 8.9 10.4 7.5 0.0 0.0 0.0 0.4 11.0 7.9 0.0 0.2 0.1 11.0 0.0 2.8 53.5 0.8 0.0 12.1 0.0 7.6 7.9 0.0 6.9 4.0 6.4 16.0 0.0 0.0 0.0 7.5 0.0 0.0 0.1 5.2 0.0 5.3 0.0 4.7 0.0 0.0 0.0 15.8 16.0 0.8 0.0 8.8 0.0 0.0 0.5 17.0 7.3 4.7 6.4 16.7 0.0 0.0 0.0 5.8 0.0 5.3 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 26.9 21.9 28.3 31.9 26.9 22.4 16.0 22.9 12.7 6.5 0.0 7.0 0.0 0.4 11.4 71.9 1.9 0.0 0.0 1.2 0.0 21.6 1.3 0.0 0.3 0.6 60.8 0.0 23.3 0.2 8.9 42.3 0.7 120.1 0.5 43.9 27.0 0.0 30.1 16.8 1.5 42.0 12.4 35.4 3.6 0.0 23.6 0.9 0.0 40.0 0.0 41.8 45.3 56.7 0.4 0.2 9.4 1.7 2.2 0.0 0.9 CNTD1 "CNTD, FLJ40137" ENSG00000176563 "Cyclin N-terminal domain containing 1" Q8N815 17 42798792-42811587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 31.0" "Group enriched" "Detected in many" 12 "Ciliated cells: 80.3;Early spermatids: 53.3;Late spermatids: 75.8;Spermatocytes: 135.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 6.3;ASC diff: 4.3;SiHa: 3.3;T-47d: 2.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023324 Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA023324: AB_1848931" "unprognostic (5.92e-2)" "unprognostic (1.99e-3)" "unprognostic (3.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.25e-1)" "unprognostic (6.29e-3)" "unprognostic (6.61e-2)" "unprognostic (1.09e-2)" "unprognostic (7.82e-2)" "unprognostic (6.18e-2)" "unprognostic (1.36e-2)" "unprognostic (2.07e-1)" "unprognostic (5.89e-7)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.81e-4)" 0.2 0.1 0.7 0.0 1.4 0.0 1.6 0.2 1.7 0.2 0.6 0.4 0.0 0.0 0.1 0.9 0.1 0.5 0.0 0.1 1.5 0.3 1.2 0.1 0.3 0.0 0.5 0.8 0.3 0.8 0.0 0.1 0.0 0.9 1.1 1.5 0.1 0.5 0.0 0.2 0.1 0.2 0.7 0.8 0.1 2.3 31.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.9 0.1 2.7 0.3 0.1 0.3 0.3 6.3 0.7 0.5 1.3 4.3 1.5 0.0 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.4 0.6 1.3 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.0 3.3 0.3 0.8 0.1 2.4 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.3 0.1 0.1 0.5 0.4 0.0 0.3 0.0 0.3 0.2 0.3 0.4 0.1 0.0 0.1 0.9 0.0 0.0 2.7 0.1 0.1 0.0 0.0 0.3 0.7 1.4 0.2 1.7 1.5 0.3 0.5 0.8 0.9 1.6 3.0 2.9 0.0 0.4 0.3 1.6 0.8 0.0 80.3 3.4 0.0 0.0 0.2 5.0 0.2 53.3 0.3 0.5 0.0 0.3 0.3 0.6 7.4 5.8 0.9 0.3 6.4 0.0 0.0 1.0 75.8 2.3 0.7 0.0 0.0 4.6 1.2 0.3 0.0 1.1 0.3 0.4 6.5 0.9 135.1 2.7 0.5 0.2 0.5 2.1 0.9 CNTD2 "CCNP, FLJ13265" ENSG00000105219 "Cyclin N-terminal domain containing 2" Q9H8S5 19 40222208-40226697 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 8.0;brain: 12.0;liver: 7.9" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 8.7;Early spermatids: 3.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 12.0" "Cell type enriched" "Detected in single" 81 "basophil: 8.0" "Lineage enriched" "Detected in single" 81 "granulocytes: 8.0" "Cell line enhanced" "Detected in some" "Hep G2: 1.8;Karpas-707: 1.4;SCLC-21H: 6.7;T-47d: 1.5" "Low region specificity" "Detected in single" HPA045615 Uncertain NA NA "HPA045615: AB_2679390" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (4.41e-2)" "unprognostic (1.07e-2)" "unprognostic (9.79e-4)" "unprognostic (5.27e-2)" "unprognostic (3.10e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (1.23e-1)" "unprognostic (2.23e-1)" "unprognostic (9.43e-3)" "unprognostic (1.97e-2)" "unprognostic (3.10e-1)" "unprognostic (7.65e-2)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" 3.9 1.0 0.7 0.1 1.2 0.3 1.4 12.0 1.8 1.0 0.2 0.4 0.0 0.4 0.3 2.1 0.1 1.9 0.7 1.5 1.1 0.8 5.6 7.9 0.3 0.2 0.5 0.0 0.4 0.1 0.1 3.5 2.8 1.3 1.5 0.5 0.4 0.4 0.3 0.7 0.6 0.6 0.4 0.8 0.6 0.7 1.0 0.0 0.0 1.4 0.7 0.1 0.2 0.1 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.9 0.7 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 1.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.2 1.1 0.4 0.1 0.0 0.2 0.1 0.0 6.7 0.4 0.6 0.0 0.7 0.3 1.5 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.4 0.0 0.3 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 12.0 1.8 1.1 0.8 0.5 0.0 1.3 0.0 0.0 0.0 0.5 0.1 2.1 1.9 1.4 0.0 1.4 0.0 8.7 0.0 0.5 0.0 0.1 3.9 0.4 0.9 0.0 0.5 0.0 0.2 0.3 1.1 0.8 0.2 1.6 0.0 0.6 0.3 1.0 0.9 0.0 1.7 0.0 0.1 2.4 0.3 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 2.5 3.2 0.0 0.5 0.1 CNTF HCNTF ENSG00000242689 "Ciliary neurotrophic factor" P26441 11 58622673-58625733 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "midbrain: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 12.9" "Low region specificity" "Detected in many" HPA019654 Approved Approved Vesicles NA NA 69200 Vesicles "HPA019654: AB_1859050" "unprognostic (1.88e-1)" "unprognostic (2.64e-3)" "unprognostic (1.01e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-1)" "unprognostic (5.91e-2)" "unprognostic (1.63e-1)" "unprognostic (9.24e-2)" "unprognostic (5.87e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-4)" "unprognostic (5.42e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" 2.0 0.7 1.4 0.9 4.8 10.0 0.8 1.2 1.6 0.3 0.9 2.5 1.1 1.4 0.3 1.4 0.9 8.3 0.8 2.5 1.8 1.6 0.9 0.9 0.8 0.6 47.5 0.9 0.3 0.5 1.2 0.5 0.6 9.3 0.6 1.3 3.1 1.3 0.4 3.7 0.9 0.9 0.6 22.8 0.6 0.5 0.7 1.2 0.2 1.0 3.7 0.6 0.6 0.3 0.4 0.0 0.0 0.3 0.0 0.7 0.2 2.1 0.8 3.4 3.6 1.1 0.3 1.7 1.6 2.2 1.6 1.2 3.0 3.0 4.4 1.2 2.2 1.8 3.9 3.7 3.9 3.3 3.1 2.1 2.3 4.4 1.6 0.4 3.4 4.3 1.0 1.4 5.3 1.7 0.7 1.7 3.1 3.4 1.0 2.0 0.9 3.3 3.2 2.1 1.5 1.6 2.2 2.4 3.0 1.9 2.5 1.6 4.3 2.3 2.4 5.9 2.6 3.0 2.5 1.2 2.5 2.0 12.9 4.0 2.4 5.0 3.8 6.7 1.7 2.9 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 1.2 1.4 1.8 1.6 47.5 0.9 9.3 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CNTFR ENSG00000122756 "Ciliary neurotrophic factor receptor" P26992 9 34551432-34590140 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 44.7;skeletal muscle: 33.6" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 23.9;Muller glia cells: 80.1;Paneth cells: 23.0" "Cancer enhanced" "Detected in many" "glioma: 22.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 47.9;SH-SY5Y: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025310 Approved NA NA 36000000 "CAB025310: " "unprognostic (1.39e-1)" "unprognostic (9.40e-2)" "unprognostic (1.93e-2)" "unprognostic (1.90e-2)" "unprognostic (2.59e-1)" "unprognostic (1.22e-1)" "unprognostic (2.18e-1)" "unprognostic (2.94e-2)" "unprognostic (1.28e-1)" "unprognostic (9.70e-2)" "unprognostic (4.45e-3)" "unprognostic (1.72e-2)" "unprognostic (6.32e-2)" "unprognostic (4.99e-3)" "unprognostic (7.37e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" 44.7 9.4 17.0 2.2 27.9 0.7 17.3 30.6 28.7 11.1 5.8 8.2 1.1 3.4 2.6 2.9 3.9 5.6 5.7 10.1 18.6 11.7 1.9 6.5 2.2 1.5 15.5 9.8 4.5 2.4 0.8 2.5 4.8 12.0 5.3 2.5 7.5 9.0 7.6 33.6 4.4 6.0 1.8 6.3 16.1 3.0 4.9 10.9 0.2 3.2 3.8 1.0 1.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.9 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 23.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 27.9 30.6 22.0 18.6 11.7 15.5 9.8 12.0 10.9 0.0 0.0 0.0 1.1 3.2 8.3 0.7 2.5 0.0 0.0 0.0 5.9 0.5 1.7 0.0 3.9 0.2 6.5 0.0 0.0 0.4 23.9 0.2 0.0 0.9 1.2 3.2 0.0 4.3 0.0 1.7 9.2 0.0 3.3 0.0 0.3 80.1 0.0 23.0 2.1 0.0 2.8 0.0 2.3 1.6 15.8 2.0 1.9 0.0 0.2 0.3 CNTN1 "F3, GP135" ENSG00000018236 "Contactin 1" Q12860 12 40692442-41072418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.2" "Cell type enhanced" "Detected in many" 14 "Late spermatids: 116.1;Leydig cells: 58.1;Peritubular cells: 56.6" "Cancer enhanced" "Detected in many" "glioma: 17.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 71.9;HaCaT: 13.0;SCLC-21H: 22.1;SH-SY5Y: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025200, HPA070467" Enhanced Approved "Intracellular and membrane" NA NA 490000000 "CAB025200: , HPA070467: AB_2732156" "unprognostic (3.18e-2)" "unprognostic (5.96e-3)" "unprognostic (3.66e-2)" "unprognostic (7.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (9.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.32e-2)" "unprognostic (8.15e-4)" "unprognostic (6.98e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (3.75e-4)" 2.9 21.0 27.8 2.1 21.5 0.8 5.7 47.1 81.2 9.9 2.5 14.3 0.7 1.8 7.9 2.2 6.5 2.1 8.2 1.1 27.5 22.1 8.2 1.4 3.3 3.1 23.0 27.7 32.3 4.5 0.8 7.7 0.8 27.0 18.4 3.0 6.9 3.8 18.1 1.1 8.3 2.5 14.4 32.2 5.3 3.0 5.9 17.8 0.0 1.4 0.5 2.9 11.8 3.6 1.6 2.2 6.4 1.4 1.9 1.3 0.2 0.0 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 13.0 1.9 3.4 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 22.1 13.4 0.0 0.7 0.8 0.3 0.0 0.2 0.0 0.0 1.4 0.0 2.9 1.0 0.0 0.0 0.1 0.0 0.2 6.4 1.4 1.9 1.1 0.8 1.0 1.3 0.9 0.6 0.2 1.6 1.3 0.9 4.1 1.9 0.9 2.2 0.7 0.2 27.8 21.5 47.1 32.6 27.5 22.1 23.0 27.7 27.0 17.8 0.0 5.1 0.0 0.5 4.6 26.9 0.6 0.0 0.0 6.8 5.2 27.5 0.0 1.7 0.0 29.3 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.1 11.1 0.0 0.0 0.0 116.1 58.1 0.0 10.1 0.0 0.0 31.8 0.7 0.0 56.6 0.0 5.7 0.0 1.9 0.7 0.9 11.8 0.0 0.0 0.0 0.1 CNTN2 "AXT, TAG-1, TAX, TAX1" ENSG00000184144 "Contactin 2" Q02246 1 205042937-205078284 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cell adhesion" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 78.5" "Group enriched" "Detected in some" 4 "Early spermatids: 10.8;Late spermatids: 18.2" "Cancer enriched" "Detected in some" 9 "glioma: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 5.7;SCLC-21H: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001397, HPA012497" Approved "Secreted in brain" NA NA 13000 "HPA001397: AB_1847146, HPA012497: AB_1847147" "unprognostic (1.90e-1)" "unprognostic (1.86e-1)" "unprognostic (2.87e-2)" "unprognostic (4.52e-3)" "unprognostic (2.98e-2)" "unprognostic (5.96e-2)" "unprognostic (3.25e-1)" "unprognostic (1.43e-2)" "unprognostic (8.56e-2)" "unprognostic (2.40e-1)" "unprognostic (3.44e-3)" "unprognostic (5.62e-2)" "unprognostic (1.73e-7)" "unprognostic (9.82e-3)" "unprognostic (1.19e-1)" "unprognostic (3.35e-2)" "unprognostic (3.07e-2)" 2.0 2.4 15.6 2.1 52.5 1.6 1.6 11.0 68.8 1.8 2.3 78.5 0.0 1.7 1.6 1.7 1.9 1.7 1.8 1.7 27.4 15.9 1.6 1.6 1.6 1.7 59.8 22.0 1.6 1.6 1.6 2.7 1.6 41.9 1.8 2.3 0.0 2.2 2.4 1.6 2.3 2.2 1.8 55.4 1.7 1.7 9.1 48.3 0.0 1.6 0.0 2.0 1.6 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 15.6 52.5 11.0 28.4 27.4 15.9 59.8 22.0 41.9 48.3 0.0 1.1 0.0 0.0 0.0 0.2 3.4 0.0 2.7 1.2 1.8 0.0 0.0 0.0 0.4 10.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 18.2 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.1 CNTN3 "BIG-1, PANG" ENSG00000113805 "Contactin 3" Q9P232 3 74262568-74521140 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.9;fallopian tube: 8.7" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ: 7.5;fHDF/TERT166: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003341 Approved "Intracellular and membrane" NA NA 54000000 "HPA003341: AB_1078556" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (2.35e-3)" "unprognostic (9.86e-2)" "unprognostic (1.82e-2)" "unprognostic (1.94e-5)" "unprognostic (4.25e-2)" "unprognostic (2.13e-3)" "unprognostic (8.42e-2)" "unprognostic (3.85e-2)" "unprognostic (1.50e-1)" "unprognostic (7.25e-2)" "unprognostic (9.30e-7)" "unprognostic (4.23e-2)" "unprognostic (1.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" 2.2 3.3 5.3 0.0 3.0 0.0 1.2 1.2 8.9 2.6 3.3 0.1 0.7 1.7 0.1 8.7 2.1 1.7 4.4 3.9 4.1 3.2 0.6 0.0 1.4 0.9 1.6 0.0 3.7 0.0 6.9 3.0 0.3 5.1 0.0 0.3 0.2 0.1 0.5 1.7 1.0 0.4 1.5 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 7.5 0.0 1.2 0.4 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 2.6 0.0 1.5 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 1.0 0.6 4.9 3.0 7.6 6.7 6.8 8.7 0.0 0.0 1.7 1.1 2.2 0.3 0.9 0.0 0.5 0.0 1.1 4.2 0.0 5.6 0.1 20.6 1.2 1.3 0.0 1.1 0.0 0.0 0.0 0.0 6.0 0.1 0.6 3.5 0.0 6.5 0.4 0.0 1.4 0.1 0.2 0.3 0.0 0.0 5.7 1.0 CNTN4 BIG-2 ENSG00000144619 "Contactin 4" Q8IWV2 3 2098813-3057956 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 29.2" "Cell type enhanced" "Detected in many" 22 "Bipolar cells: 65.3;Early spermatids: 291.2;Horizontal cells: 95.3;Late spermatids: 104.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "BEWO: 8.7;CACO-2: 9.2;HEK 293: 5.7;SH-SY5Y: 17.6;WM-115: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 89000000 "unprognostic (1.64e-1)" "unprognostic (7.17e-3)" "unprognostic (9.85e-2)" "unprognostic (5.75e-2)" "unprognostic (9.94e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (2.60e-2)" "unprognostic (7.38e-3)" "unprognostic (2.41e-2)" "prognostic favorable (1.00e-4)" "unprognostic (1.22e-2)" "unprognostic (2.88e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" 3.7 1.2 5.8 1.5 8.6 0.1 2.9 20.6 14.6 9.2 4.3 0.7 2.0 1.7 7.9 3.1 3.0 4.1 4.8 3.1 2.4 3.2 4.2 2.6 3.4 3.1 3.4 6.8 1.9 1.9 29.2 16.6 7.4 3.1 4.4 3.2 7.6 2.1 5.7 1.4 1.6 3.9 4.4 2.1 0.9 3.2 15.7 0.4 0.4 21.6 1.3 2.4 3.7 4.1 1.0 0.6 1.8 0.5 0.4 0.6 0.1 0.0 0.0 1.2 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 17.6 0.0 0.0 0.1 1.5 0.1 0.2 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.7 1.8 0.5 0.6 0.5 0.2 0.4 0.7 0.5 0.5 0.0 1.0 0.6 0.6 1.0 0.4 0.3 0.6 0.3 0.1 5.8 8.6 20.6 14.6 2.4 3.2 3.4 6.8 3.1 0.4 8.9 2.2 0.0 1.1 0.7 65.3 1.1 2.5 0.0 10.3 0.0 0.0 0.0 0.0 2.5 291.2 0.6 2.6 0.0 0.0 0.1 4.1 0.3 0.0 0.0 0.2 95.3 7.5 0.0 0.3 104.8 4.6 0.6 1.7 0.0 1.9 29.1 0.0 1.4 4.9 3.9 4.9 6.5 8.2 3.9 4.0 0.0 0.2 0.0 2.2 0.1 CNTN5 "hNB-2, NB-2" ENSG00000149972 "Contactin 5" O94779 11 99020953-100358885 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9;pituitary gland: 12.0;salivary gland: 28.4" "Group enriched" "Detected in some" 6 "Bipolar cells: 7.6;Ciliated cells: 20.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.2;TIME: 2.1;U-138 MG: 1.0;U-266/70: 3.4" "Low region specificity" "Detected in many" "HPA039492, HPA041223" Approved "Intracellular and membrane" NA NA 100000 "HPA039492: AB_10795108, HPA041223: AB_10794549" "unprognostic (2.09e-2)" "unprognostic (3.40e-1)" "unprognostic (8.99e-3)" "unprognostic (4.20e-2)" "unprognostic (6.51e-5)" "unprognostic (3.85e-2)" "unprognostic (9.25e-2)" "unprognostic (6.13e-2)" "unprognostic (3.02e-2)" "unprognostic (8.72e-2)" "unprognostic (5.48e-3)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" 0.3 0.5 6.5 0.3 4.0 0.2 0.2 0.6 10.9 0.7 0.4 0.5 0.0 0.3 0.6 0.3 0.3 3.8 0.3 0.4 5.0 3.4 1.4 0.5 0.7 0.3 1.4 2.0 0.4 0.9 0.2 12.0 7.4 3.9 0.5 0.3 0.0 28.4 1.1 0.2 0.2 0.3 0.4 0.5 0.2 0.5 0.8 0.3 0.0 5.9 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.1 0.0 0.0 0.9 0.2 2.1 1.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.0 0.6 10.9 5.0 3.4 1.4 2.0 3.9 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.6 0.0 20.1 2.3 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.7 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 CNTN6 NB-3 ENSG00000134115 "Contactin 6" Q9UQ52 3 1092576-1404217 "Predicted membrane proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 41.4;thyroid gland: 18.9" "Cell type enriched" "Detected in some" 6 "Alveolar cells type 1: 32.8" "Group enriched" "Detected in some" 15 "renal cancer: 2.7;thyroid cancer: 3.2" "Region enriched" "Detected in many" 5 "cerebellum: 41.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 45 "AF22: 5.1;GAMG: 2.4;SH-SY5Y: 5.9;SuSa: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016645 Uncertain NA NA 2100000 "HPA016645: AB_1847149" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-1)" "unprognostic (1.05e-4)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (3.80e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.26e-3)" "unprognostic (5.45e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.46e-2)" 0.2 4.7 1.6 0.2 2.2 0.2 0.4 41.4 6.3 0.3 0.3 0.1 0.0 0.2 0.3 0.8 0.3 0.4 0.2 0.4 1.5 3.0 0.5 0.2 5.6 0.2 2.4 2.6 0.2 0.3 0.2 0.5 3.4 7.8 0.2 0.3 0.4 0.3 0.3 0.2 0.2 0.2 0.3 1.7 0.2 0.2 0.4 0.3 0.0 18.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 41.4 6.3 1.5 3.0 2.4 2.6 7.8 0.3 32.8 2.2 0.0 0.0 0.0 2.6 0.4 0.0 1.4 5.7 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 CNTNAP1 "Caspr, CNTNAP, NRXN4, p190" ENSG00000108797 "Contactin associated protein 1" P78357 17 42682613-42699814 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;smooth muscle: 26.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 12.8;Sertoli cells: 6.5;Smooth muscle cells: 4.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "TIME: 30.0;U-138 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011772 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011772: AB_1079541" "unprognostic (4.04e-2)" "unprognostic (3.69e-1)" "unprognostic (2.37e-3)" "unprognostic (1.89e-1)" "unprognostic (5.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.59e-1)" "unprognostic (9.76e-3)" "unprognostic (1.99e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.16e-14)" "unprognostic (9.52e-3)" "unprognostic (2.27e-2)" "unprognostic (3.11e-2)" "unprognostic (7.37e-3)" 6.1 2.5 35.5 5.9 18.8 1.1 1.7 31.7 48.7 4.7 8.5 2.9 1.4 2.3 12.1 7.1 2.9 7.0 7.1 4.0 29.2 14.8 1.7 0.9 3.9 2.8 10.5 23.9 8.7 6.5 1.7 7.2 5.0 18.4 4.2 4.7 2.1 2.0 7.6 3.5 2.5 2.7 26.7 11.5 3.2 3.9 2.3 13.3 0.0 1.7 0.2 2.9 5.8 3.3 0.0 0.7 0.1 0.0 0.1 1.4 0.0 1.8 2.6 5.8 1.9 9.0 18.4 0.4 10.9 19.1 8.1 7.3 0.3 0.4 0.0 0.6 11.9 8.1 2.1 2.8 0.9 6.3 4.2 0.9 0.0 10.8 2.7 4.4 0.0 0.1 17.9 0.0 7.7 1.5 12.9 10.1 0.1 0.5 3.3 3.1 0.3 0.0 1.6 2.0 0.1 2.6 0.3 0.7 1.0 2.1 0.0 1.1 3.4 3.2 0.0 2.1 5.5 2.1 0.9 30.0 34.8 5.9 8.0 3.0 4.0 2.4 0.1 9.6 0.7 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.0 35.5 18.8 31.7 48.7 29.2 14.8 10.5 23.9 18.4 13.3 0.0 2.6 0.0 0.1 0.5 12.8 1.1 0.0 1.4 1.2 0.0 3.9 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.1 1.6 0.0 2.5 0.0 0.0 1.4 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.7 0.0 2.8 6.5 4.4 0.2 0.2 0.3 0.2 0.0 0.0 0.1 CNTNAP2 "Caspr2, KIAA0868, NRXN4" ENSG00000174469 "Contactin associated protein like 2" Q9UHC6 7 146116002-148420998 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Autism, Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enriched" "Detected in many" 32 "Horizontal cells: 974.1" "Cancer enhanced" "Detected in many" "prostate cancer: 10.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 31 "memory B-cell: 1.8;naive B-cell: 6.1" "Lineage enriched" "Detected in single" 48 "B-cells: 6.1" "Group enriched" "Detected in some" 4 "AF22: 7.5;CACO-2: 6.3;NTERA-2: 11.2;SCLC-21H: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002739 Enhanced NA NA "HPA002739: AB_1078545" "unprognostic (2.49e-2)" "unprognostic (1.49e-2)" "unprognostic (4.05e-1)" "unprognostic (3.08e-3)" "unprognostic (1.77e-1)" "unprognostic (2.29e-1)" "unprognostic (2.51e-2)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-1)" "unprognostic (3.67e-2)" "unprognostic (2.68e-1)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.00e-3)" 0.9 2.0 14.0 1.2 16.6 0.9 2.2 4.4 25.8 0.7 2.3 1.2 0.0 0.7 0.9 0.7 1.4 2.2 0.8 1.0 9.6 6.4 1.0 3.5 0.8 1.6 7.5 16.2 1.7 1.1 0.7 2.7 1.9 17.0 8.7 1.6 2.5 0.9 1.0 0.7 0.8 2.0 0.8 18.1 1.7 1.2 1.4 0.5 2.4 1.5 0.0 1.3 0.8 0.5 6.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 7.5 1.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.2 0.0 1.8 1.6 0.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 1.3 0.0 0.0 0.0 2.1 0.0 0.0 20.2 1.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 14.0 16.6 4.4 25.8 9.6 6.4 7.5 16.2 17.0 0.5 0.0 0.0 2.0 0.2 0.1 29.8 1.1 12.7 0.0 0.0 0.0 2.0 30.0 0.0 0.9 5.7 0.0 1.3 0.0 0.6 2.5 0.6 7.2 0.0 8.9 2.7 974.1 2.4 0.0 1.2 2.1 1.1 0.4 0.0 0.0 3.6 7.0 3.6 2.5 0.0 0.5 13.9 0.0 0.2 1.9 1.5 0.0 5.3 0.0 6.5 0.1 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein like 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;esophagus: 9.5" "Cell type enhanced" "Detected in many" 11 "Ito cells: 22.1;Muller glia cells: 11.5" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 22 "neutrophil: 10.6" "Lineage enriched" "Detected in single" 107 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 12.7;AF22: 15.4;TIME: 9.7;WM-115: 25.7" HPA047731 Uncertain "Intracellular and membrane" NA NA "HPA047731: AB_2680137" "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.9 0.1 1.2 0.3 4.8 1.0 2.6 0.4 2.5 0.8 2.4 0.6 0.2 0.2 9.5 1.6 1.1 4.1 1.2 1.3 1.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.3 1.7 1.6 1.4 2.8 1.7 0.0 8.3 1.0 2.5 1.1 2.4 0.1 1.9 1.3 0.3 0.5 1.9 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.7 12.7 15.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.9 3.2 1.3 2.9 0.0 0.0 1.1 0.0 3.4 0.3 0.1 0.2 0.0 0.4 2.8 0.0 1.1 6.5 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 3.9 0.0 0.4 3.5 0.3 0.5 1.4 0.5 4.5 0.0 2.5 1.7 0.0 2.1 9.7 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 3.4 5.6 0.8 2.5 7.6 2.7 0.0 1.8 2.0 0.7 0.0 0.3 1.3 5.8 0.0 0.0 0.2 0.6 0.9 0.8 0.0 1.8 0.1 0.0 3.4 22.1 1.3 0.8 0.3 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.5 0.4 0.0 0.5 0.9 5.8 6.8 0.6 0.0 0.0 2.5 CNTNAP4 "CASPR4, KIAA1763" ENSG00000152910 "Contactin associated protein like 4" Q9C0A0 16 76277278-76559238 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 36.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 20.9;Early spermatids: 11.3;Late spermatids: 7.8;Muller glia cells: 4.3" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Daudi: 14.0;HSkMC: 5.6;Karpas-707: 4.8;RPMI-8226: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031859 Enhanced NA NA 73000 "HPA031859: AB_10601360" "unprognostic (7.88e-2)" "unprognostic (7.19e-2)" "unprognostic (6.58e-2)" "unprognostic (2.46e-1)" "unprognostic (1.55e-2)" "unprognostic (1.50e-3)" "unprognostic (9.42e-3)" "unprognostic (1.91e-2)" "unprognostic (5.26e-4)" "unprognostic (1.83e-2)" "unprognostic (2.00e-2)" "unprognostic (4.56e-1)" "unprognostic (1.09e-1)" 0.9 2.4 10.2 0.9 19.1 0.9 0.9 13.2 36.9 1.3 0.9 27.6 0.0 1.2 0.9 0.9 0.9 0.9 0.9 0.9 9.9 2.2 1.0 0.9 0.9 1.0 23.1 15.1 1.0 0.9 0.9 0.8 0.9 25.0 1.3 0.9 0.0 0.9 1.4 0.9 0.9 1.1 1.0 30.9 0.9 0.9 2.2 21.4 0.0 0.9 0.0 1.0 0.9 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.2 19.1 13.2 14.4 9.9 2.2 23.1 15.1 25.0 21.4 0.0 0.0 0.0 0.0 0.0 20.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 CNTNAP5 "caspr5, FLJ31966" ENSG00000155052 "Contactin associated protein like 5" Q8WYK1 2 124025287-124915287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 22.4" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 5.6;Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.4" "Low region specificity" "Detected in all" "HPA069095, HPA069356" Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Vesicles" "HPA069095: AB_2686083, HPA069356: AB_2686127" "unprognostic (6.32e-3)" "unprognostic (6.38e-2)" "unprognostic (1.23e-1)" "unprognostic (2.25e-1)" "unprognostic (1.68e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (3.11e-2)" "unprognostic (2.62e-6)" "unprognostic (3.65e-3)" "unprognostic (5.32e-2)" "unprognostic (9.58e-2)" 0.7 2.8 12.9 0.7 7.9 1.0 0.7 3.3 22.4 0.6 0.8 1.5 0.0 1.0 0.7 0.7 0.7 0.6 4.2 0.7 14.0 4.0 1.2 0.7 0.7 0.7 2.2 8.4 0.6 1.1 0.7 0.8 0.7 15.2 0.8 0.8 0.4 0.6 1.0 0.7 0.8 0.9 0.8 1.9 0.7 0.7 0.9 2.8 0.0 0.7 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 7.9 3.3 22.4 14.0 4.0 2.2 8.4 15.2 2.8 0.0 0.0 0.0 0.0 0.0 5.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 CNTROB "LIP8, PP1221" ENSG00000170037 "Centrobin, centriole duplication and spindle assembly protein" Q8N137 17 7932101-7949918 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023319, HPA023320, HPA023321, HPA023325" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "HPA023319: AB_1852886, HPA023320: AB_1852888, HPA023321: AB_1852890, HPA023325: AB_1852892" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.26e-2)" "unprognostic (4.21e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (9.88e-4)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (3.47e-3)" "unprognostic (1.48e-2)" "unprognostic (8.63e-2)" "unprognostic (4.47e-2)" "unprognostic (1.54e-1)" "unprognostic (4.79e-1)" "unprognostic (2.16e-2)" 9.0 7.4 7.5 9.2 10.1 18.4 9.3 11.2 12.7 13.0 10.9 9.8 9.9 6.8 21.3 12.6 11.0 10.4 9.0 7.1 9.5 8.0 9.2 8.7 15.0 8.4 9.3 9.9 11.4 11.0 16.5 9.6 9.9 9.9 9.9 12.5 10.3 9.6 8.6 6.8 16.9 9.1 16.3 7.0 9.9 8.4 51.2 6.4 16.0 10.4 6.2 11.2 9.3 10.0 2.1 7.6 9.4 3.4 3.4 3.5 2.6 22.3 14.7 21.9 12.1 9.3 12.8 7.1 19.5 18.3 27.3 20.9 12.4 8.3 23.0 10.3 17.0 12.2 18.0 17.0 13.6 30.6 22.6 13.3 15.2 24.0 9.8 13.7 14.1 23.6 11.7 10.1 19.2 19.4 13.2 16.8 23.1 11.0 11.3 18.9 7.2 21.4 13.6 4.9 8.1 11.5 22.8 15.1 8.6 12.6 6.9 7.2 12.9 15.8 8.1 6.2 12.2 11.0 9.0 13.7 15.3 13.0 20.6 26.8 17.3 11.6 15.9 13.1 18.1 21.7 9.4 2.5 1.0 2.9 3.4 2.6 2.1 2.2 3.5 1.7 1.5 1.4 2.4 0.4 3.4 1.4 7.6 2.9 2.6 7.5 10.1 11.2 12.7 9.5 8.0 9.3 9.9 9.9 6.4 6.0 15.8 4.5 6.8 7.0 5.8 3.0 5.1 4.0 7.9 12.2 7.9 3.3 1.7 4.4 2.1 5.8 3.6 0.0 6.0 3.6 5.0 5.0 18.4 3.4 5.7 3.2 2.9 5.5 5.9 3.4 4.9 7.2 3.3 0.0 5.6 5.3 5.0 3.5 7.4 2.6 6.5 0.0 3.5 40.6 8.3 7.5 2.1 4.9 7.3 4.1 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.7" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 114.1;Rod photoreceptor cells: 71.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "BEWO: 15.1;HeLa: 27.0;OE19: 23.9;RPMI-8226: 20.7;SuSa: 16.0;U-266/84: 15.3" "Low region specificity" "Detected in many" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 1.8 1.3 27.5 1.8 26.1 0.7 9.5 12.5 23.8 3.9 11.6 27.9 2.2 11.6 2.0 4.4 9.5 12.7 5.8 32.8 27.7 14.5 8.3 12.3 8.8 0.7 23.8 13.8 2.6 11.4 24.7 5.2 3.4 10.8 9.4 7.3 2.8 26.9 3.7 68.7 10.7 20.7 2.2 25.0 0.8 7.4 2.5 16.8 0.0 5.5 12.2 3.1 1.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 5.5 4.1 0.0 0.1 0.0 0.0 15.1 0.0 0.0 0.0 0.0 9.9 8.9 0.0 0.4 0.0 0.6 10.4 5.7 0.0 0.0 0.0 4.4 0.0 27.0 2.1 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.8 2.8 0.1 0.0 3.5 0.0 0.0 4.0 23.9 3.4 0.0 0.2 20.7 8.1 0.0 5.4 0.1 1.9 12.1 1.7 16.0 8.7 0.0 0.0 0.0 4.9 0.1 0.4 0.0 15.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 27.5 26.1 12.5 19.0 27.7 14.5 23.8 13.8 10.8 16.8 35.7 15.8 2.2 2.5 15.9 1.6 66.3 17.8 37.5 19.4 8.7 55.0 16.7 0.0 19.8 2.6 1.4 61.6 0.0 8.3 8.0 1.8 28.8 9.3 24.7 1.8 0.0 17.9 0.6 0.6 2.7 0.6 1.8 15.1 1.8 27.0 114.1 19.3 28.1 0.4 14.7 71.8 0.0 1.0 0.5 5.5 31.1 33.6 1.3 11.7 6.4 COBLL1 KIAA0977 ENSG00000082438 "Cordon-bleu WH2 repeat protein like 1" Q53SF7 2 164653624-164843679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 154.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 207.6;Cone photoreceptor cells: 235.6;Rod photoreceptor cells: 204.2;Syncytiotrophoblasts: 277.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "memory B-cell: 15.5;naive B-cell: 9.2;plasmacytoid DC: 5.5" "Group enriched" "Detected in many" 18 "B-cells: 15.5;dendritic cells: 5.5" "Cell line enhanced" "Detected in many" "Karpas-707: 29.3;RPTEC TERT1: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044933, HPA053344" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA044933: AB_2679148, HPA053344: AB_2682123" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.38e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-1)" "unprognostic (4.49e-3)" "unprognostic (1.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.27e-13)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (2.47e-1)" "unprognostic (1.42e-1)" 14.3 35.7 3.3 4.1 4.0 1.1 9.3 1.4 4.0 8.1 7.0 3.3 17.7 4.3 5.3 11.2 16.3 2.9 9.7 3.7 4.1 3.2 35.6 43.4 10.8 4.7 4.5 2.9 7.1 23.4 4.9 8.9 154.2 5.2 11.9 3.1 8.8 8.0 22.6 2.6 8.2 5.8 9.7 3.9 4.6 12.6 3.0 2.6 1.2 7.6 9.6 6.9 13.0 11.1 15.5 5.5 0.0 0.0 0.5 0.0 0.3 4.7 1.1 3.0 0.0 3.4 0.6 5.4 16.1 6.5 2.8 2.6 3.9 2.0 0.4 3.1 1.5 2.4 17.3 12.0 10.0 2.9 1.3 4.6 4.5 4.7 16.2 4.9 0.0 0.0 0.8 9.4 0.4 13.2 2.8 10.0 0.6 0.0 29.3 3.5 5.3 0.1 0.0 1.4 11.7 5.4 0.6 11.6 4.8 29.5 16.3 6.6 2.5 7.0 6.8 2.2 5.7 5.1 0.0 4.3 5.2 4.4 2.0 3.7 11.0 4.1 1.5 2.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.5 0.0 5.5 0.0 0.3 3.3 4.0 1.4 4.0 4.1 3.2 4.5 2.9 5.2 2.6 65.5 51.4 43.3 40.0 86.4 11.5 10.1 22.9 12.0 29.6 207.6 235.6 40.1 53.0 22.3 0.0 41.7 10.7 0.0 28.9 56.5 18.0 52.9 32.4 126.9 7.6 3.2 21.4 6.2 3.7 0.4 13.6 3.0 18.6 0.0 10.3 171.4 30.8 3.5 7.4 27.0 204.2 45.3 41.9 0.5 0.9 61.5 277.1 1.9 9.2 67.1 COCH "COCH-5B2, DFNA31, DFNA9" ENSG00000100473 Cochlin O43405 14 30874514-30895065 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 63.0;pancreas: 136.8" "Cell type enhanced" "Detected in many" 12 "Exocrine glandular cells: 52.5;Horizontal cells: 79.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 63.0" "Group enriched" "Detected in some" 13 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in many" 20 "B-cells: 24.0" "Cell line enhanced" "Detected in many" "HEK 293: 30.6;Hep G2: 20.0;K-562: 39.4;NB-4: 32.7;SCLC-21H: 36.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6" HPA065086 Supported Vesicles "Secreted to extracellular matrix" NA NA 88000 Vesicles "HPA065086: " "unprognostic (8.36e-3)" "unprognostic (2.51e-2)" "unprognostic (8.61e-2)" "unprognostic (1.64e-2)" "unprognostic (6.48e-2)" "unprognostic (6.53e-2)" "unprognostic (9.61e-2)" "unprognostic (4.03e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.27e-2)" "unprognostic (2.91e-3)" "unprognostic (5.42e-3)" "unprognostic (3.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" 1.1 1.4 2.1 1.1 63.0 1.3 0.9 1.1 2.3 4.0 0.8 1.4 1.6 0.6 0.6 1.0 0.6 2.2 1.2 0.9 1.2 2.9 1.8 0.5 0.5 3.1 0.8 1.9 0.6 136.8 0.4 3.3 0.9 2.1 14.7 1.0 0.8 1.8 21.8 0.6 4.6 0.7 0.7 1.4 0.8 0.8 1.8 7.9 0.0 0.6 0.7 2.4 1.1 7.8 24.0 0.0 0.1 0.3 0.0 1.1 0.6 0.0 11.2 1.0 0.0 0.2 0.0 7.0 0.0 0.0 2.1 5.6 6.6 0.4 0.1 0.5 0.0 0.4 0.0 7.1 0.0 3.5 0.0 30.6 5.6 2.6 20.0 0.0 0.5 2.3 0.4 0.0 0.2 0.0 0.0 0.1 12.7 39.4 1.6 0.5 0.2 2.8 32.7 3.8 0.0 1.2 8.3 0.0 0.2 0.3 1.0 36.3 9.8 0.8 0.1 0.0 4.1 0.0 15.3 0.2 0.0 0.0 0.1 0.0 1.8 4.8 3.5 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.6 2.1 63.0 1.1 2.3 1.2 2.9 0.8 1.9 2.1 7.9 0.0 0.3 11.3 1.6 16.9 1.9 0.4 2.5 0.0 1.2 0.0 3.9 3.9 1.7 0.4 1.3 2.1 0.2 0.0 52.5 9.8 3.8 3.0 1.1 3.9 3.1 79.4 16.4 4.3 8.6 1.3 1.4 1.5 18.6 4.6 0.0 14.5 5.7 0.0 5.6 7.9 3.9 0.0 15.6 3.9 6.6 11.8 5.5 2.9 0.4 1.0 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938187-56961054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.8" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 199.1;Late spermatids: 405.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA057480, CAB069400" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli fibrillar center,Nuclear bodies" NA NA "Nuclear bodies" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 8.7 5.6 7.3 5.5 8.1 10.9 8.2 12.6 8.9 8.9 6.4 7.6 4.9 6.7 8.1 8.1 8.5 6.8 4.9 5.3 5.8 5.7 7.0 8.5 5.3 7.7 7.1 6.5 8.6 9.1 8.5 9.7 9.5 8.2 7.8 7.3 5.8 7.5 9.1 7.9 7.8 7.0 5.9 7.2 8.1 6.4 58.8 6.0 12.3 8.7 5.3 8.5 7.7 7.3 22.5 13.7 14.0 13.4 12.7 17.8 8.6 13.2 10.1 20.8 8.0 7.1 8.6 14.4 9.5 9.0 14.6 15.6 13.8 11.5 16.0 19.4 7.6 10.9 7.8 14.1 11.0 20.9 19.2 17.8 26.1 9.7 15.6 7.7 21.9 16.0 7.9 13.8 11.0 11.9 8.7 12.4 9.5 22.5 13.4 13.7 16.8 17.2 14.0 12.2 14.7 10.2 8.2 25.6 12.8 10.0 13.4 17.7 17.5 6.4 6.4 16.0 12.5 23.1 21.5 8.7 17.0 12.9 8.2 12.3 19.9 24.8 18.8 8.9 12.2 10.3 14.0 11.5 13.9 13.9 10.4 15.6 22.5 15.4 14.6 11.3 21.6 17.8 17.2 6.8 12.7 13.4 13.7 15.2 8.6 7.3 8.1 12.6 8.9 5.8 5.7 7.1 6.5 8.2 6.0 11.9 15.2 21.2 34.1 16.7 35.0 13.4 17.8 20.1 25.0 14.0 35.3 36.2 11.6 24.9 199.1 26.3 12.6 0.0 24.1 27.5 24.2 25.8 21.9 21.5 19.3 23.8 23.0 21.5 14.0 405.7 39.1 13.9 3.3 14.4 16.2 26.1 21.4 17.5 28.7 18.7 47.6 12.9 18.4 95.4 43.3 19.8 24.4 22.3 20.7 27.1 COL10A1 ENSG00000123500 "Collagen type X alpha 1 chain" Q03692 6 116118923-116158747 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.2;retina: 32.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.1;Club cells: 1.2;Horizontal cells: 1.6;Muller glia cells: 2.0" "Cancer enhanced" "Detected in many" "pancreatic cancer: 51.9" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.7" "Cell line enriched" "Detected in some" 6 "hTEC/SVTERT24-B: 30.1" "Region enhanced" "Detected in single" "amygdala: 1.0" "Low region specificity" "Detected in single" HPA053268 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 21000 "Endoplasmic reticulum" "HPA053268: " "unprognostic (3.83e-2)" "unprognostic (6.81e-2)" "unprognostic (7.20e-2)" "unprognostic (7.45e-3)" "unprognostic (2.33e-2)" "unprognostic (1.28e-1)" "unprognostic (3.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (4.37e-2)" "unprognostic (7.03e-2)" "unprognostic (1.38e-11)" "unprognostic (2.16e-3)" "unprognostic (7.22e-2)" "unprognostic (3.60e-1)" "unprognostic (2.06e-3)" 0.9 0.1 0.4 0.8 0.7 0.1 0.3 0.3 1.4 1.4 0.3 0.9 0.3 0.0 0.6 0.3 0.5 0.0 12.2 0.3 0.6 0.2 0.8 0.7 3.5 0.4 0.3 0.6 5.4 4.2 0.5 0.9 0.3 3.2 2.6 0.0 32.7 6.5 0.9 0.3 0.7 0.3 0.5 0.3 2.9 0.2 0.5 0.3 0.8 1.4 0.3 2.0 0.3 0.3 0.6 0.3 2.7 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 2.2 0.3 4.6 0.0 0.0 0.1 0.0 0.7 0.0 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 30.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 4.9 0.1 0.3 0.4 0.0 0.0 0.1 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.3 1.4 0.6 0.2 0.3 0.6 3.2 0.3 0.0 1.1 0.0 0.0 0.1 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 COL11A1 "CO11A1, COLL6, STL2" ENSG00000060718 "Collagen type XI alpha 1 chain" P12107 1 102876467-103108872 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 33.3" "Group enriched" "Detected in some" 7 "Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA058335 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" No No 270000 "Endoplasmic reticulum" "HPA058335: AB_2683682" "unprognostic (2.60e-3)" "unprognostic (6.61e-4)" "unprognostic (9.58e-2)" "unprognostic (5.06e-5)" "unprognostic (2.83e-1)" "unprognostic (2.85e-2)" "unprognostic (6.03e-3)" "unprognostic (2.23e-3)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (1.94e-2)" "unprognostic (3.01e-12)" "unprognostic (1.27e-2)" "unprognostic (3.53e-1)" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" 1.2 1.8 8.6 1.3 9.1 0.8 1.5 2.0 7.9 2.3 1.1 4.1 0.0 1.0 1.8 1.0 0.8 0.8 5.9 0.8 8.3 8.6 1.0 0.8 1.2 0.9 8.1 5.9 1.2 1.9 1.0 5.5 33.3 11.1 1.1 1.4 5.9 3.3 2.2 0.9 2.4 0.9 1.3 9.0 2.2 0.9 4.7 5.8 0.0 0.9 0.6 0.8 1.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 38.5 0.0 1.5 2.1 0.0 13.5 5.2 7.8 28.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 48.5 0.0 0.3 0.0 5.9 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.2 9.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.6 9.1 2.0 7.9 8.3 8.6 8.1 5.9 11.1 5.8 0.0 2.1 0.0 0.0 1.5 0.6 0.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.5 2.1 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.9 1.1 0.6 10.1 0.0 0.0 27.8 0.1 0.0 0.0 0.0 1.7 0.0 1.9 0.5 0.4 1.0 0.2 0.0 0.0 0.0 COL11A2 "DFNA13, DFNB53, HKE5" ENSG00000204248 "Collagen type XI alpha 2 chain" P13942 6 33162681-33192499 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pituitary gland: 28.8" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 3.9;Early spermatids: 11.3;Ito cells: 6.7;Muller glia cells: 6.7" "Cancer enriched" "Detected in many" 8 "melanoma: 13.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.4;U-698: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA 720000 "unprognostic (4.62e-1)" "unprognostic (8.69e-2)" "unprognostic (1.65e-4)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (1.69e-1)" "unprognostic (1.04e-2)" "unprognostic (9.67e-2)" "unprognostic (2.05e-2)" "unprognostic (4.47e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-3)" "unprognostic (2.26e-6)" "unprognostic (8.27e-2)" "unprognostic (2.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.96e-2)" 1.6 0.7 0.8 0.6 1.5 0.2 0.4 6.6 2.8 1.2 0.4 2.5 0.1 1.2 0.6 1.2 0.4 0.3 0.5 1.6 1.1 0.9 0.4 0.8 0.7 0.3 2.7 0.1 0.5 1.7 0.2 28.8 0.5 1.7 0.8 0.2 2.6 2.2 0.6 2.5 1.6 1.5 0.9 2.2 0.8 3.5 4.5 1.8 1.1 2.1 0.9 0.6 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.1 0.2 0.1 2.0 0.3 1.6 1.0 0.2 0.7 0.2 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.3 2.1 0.3 0.0 0.1 0.1 0.0 0.1 1.5 0.5 0.8 0.2 0.3 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.4 0.2 1.2 0.4 0.2 0.8 1.5 0.0 0.1 2.4 1.7 2.9 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.4 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.5 6.6 1.2 1.1 0.9 2.7 0.1 1.7 1.8 0.0 0.0 0.0 0.1 1.3 1.9 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 11.3 0.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 6.7 1.2 1.0 0.0 0.0 1.7 0.0 0.0 6.7 0.1 0.0 0.4 0.0 1.1 0.0 1.0 0.9 1.5 1.0 0.0 0.0 0.0 0.0 COL12A1 COL12A1L ENSG00000111799 "Collagen type XII alpha 1 chain" Q99715 6 75084326-75206051 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 136.8" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 71.5;Leydig cells: 55.8;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 164.5;SiHa: 97.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA009143, HPA010021" Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 4300000 Vesicles Cytosol "HPA009143: AB_1847095, HPA010021: " "unprognostic (2.60e-2)" "unprognostic (2.80e-3)" "unprognostic (7.92e-2)" "unprognostic (8.27e-3)" "unprognostic (1.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" "unprognostic (3.47e-3)" "unprognostic (1.38e-1)" "unprognostic (4.30e-1)" "unprognostic (1.18e-3)" "unprognostic (3.04e-1)" "prognostic unfavorable (1.69e-9)" "unprognostic (1.03e-3)" "unprognostic (1.81e-1)" "unprognostic (3.16e-3)" "unprognostic (1.92e-2)" 53.1 5.6 0.9 33.1 1.3 0.0 136.8 0.4 2.0 65.0 23.0 0.5 14.8 4.2 64.6 18.1 29.2 14.9 16.3 17.1 1.1 1.1 7.6 1.5 22.2 23.5 2.0 1.5 52.0 4.1 1.5 1.9 2.6 1.6 12.3 8.7 2.4 5.9 21.4 21.6 16.8 14.1 32.4 1.4 5.0 6.9 10.6 0.4 1.0 8.2 15.0 4.4 24.8 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 35.2 19.7 3.3 32.0 26.7 22.0 30.7 3.2 0.0 0.0 3.3 164.5 0.4 7.0 0.0 3.3 20.8 0.0 0.1 0.0 11.9 0.0 13.1 0.0 0.0 29.6 0.6 4.9 6.0 21.3 3.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.8 0.0 1.8 0.0 2.7 0.0 1.1 1.6 0.0 0.0 97.7 2.5 0.0 1.9 15.5 0.0 0.0 9.5 11.8 5.0 10.6 0.0 0.0 0.0 3.2 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.4 2.0 1.1 1.1 2.0 1.5 1.6 0.4 71.5 6.1 0.0 0.6 18.3 0.2 2.8 0.0 2.7 7.9 3.5 0.0 0.4 0.0 0.8 19.1 3.6 0.0 0.0 3.8 0.6 25.9 1.3 1.1 0.0 0.7 0.0 0.0 5.5 0.0 9.7 55.8 1.7 20.3 0.0 0.0 0.0 4.6 0.0 12.4 0.8 0.0 45.3 24.5 0.2 0.6 11.4 0.6 0.0 0.0 0.3 COL13A1 ENSG00000197467 "Collagen type XIII alpha 1 chain" Q5TAT6 10 69801867-69964275 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Osteogenesis" "Developmental protein, Heparin-binding" "Congenital myasthenic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.6;epididymis: 22.3" "Cell type enhanced" "Detected in some" 21 "Fibroblasts: 4.1;granulocytes: 19.7;Melanocytes: 5.0;Smooth muscle cells: 5.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 18 "cerebellum: 54.6" "Group enriched" "Detected in some" 18 "gdT-cell: 1.9;NK-cell: 1.9" "Group enriched" "Detected in many" 18 "NK-cells: 1.9;T-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 19.6;BJ hTERT+: 18.2;hTERT-RPE1: 25.5;HUVEC TERT2: 31.8;PC-3: 29.2;TIME: 45.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050392 Approved NA NA "HPA050392: AB_2681110" "unprognostic (2.79e-2)" "unprognostic (2.82e-3)" "unprognostic (1.38e-1)" "unprognostic (3.86e-1)" "unprognostic (4.67e-4)" "unprognostic (3.13e-1)" "unprognostic (1.69e-1)" "unprognostic (7.43e-2)" "unprognostic (6.16e-3)" "unprognostic (1.22e-1)" "unprognostic (2.60e-1)" "unprognostic (2.53e-2)" "unprognostic (1.36e-5)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.52e-2)" "unprognostic (3.93e-2)" 0.7 1.2 0.5 3.3 1.0 0.0 1.3 54.6 1.3 3.5 3.1 0.6 4.3 1.8 1.4 22.3 1.3 2.0 2.7 2.7 0.6 0.5 1.3 0.5 8.2 0.7 0.9 0.7 1.1 1.2 0.9 2.7 0.9 3.0 10.7 2.3 3.8 1.0 6.2 2.7 3.1 2.9 2.0 1.7 5.0 3.9 0.9 0.7 0.3 1.0 1.1 0.6 2.2 1.2 0.0 0.0 0.1 0.0 1.9 1.9 0.4 0.4 0.1 7.0 0.0 0.0 1.3 0.0 19.6 18.2 3.3 1.6 0.0 0.4 0.0 3.3 8.7 0.3 0.7 0.0 0.0 5.6 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 2.8 0.0 8.3 2.6 25.5 31.8 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.3 0.0 29.2 0.0 0.0 3.5 0.1 0.0 0.7 0.0 0.0 0.0 0.9 0.2 0.0 0.0 45.4 0.1 5.4 1.7 14.9 4.3 0.0 0.0 11.6 0.0 16.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.4 0.5 1.0 54.6 1.3 0.6 0.5 0.9 0.7 3.0 0.7 0.0 1.1 0.0 0.3 3.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.0 0.0 0.0 0.0 4.1 0.3 19.7 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 5.2 0.5 0.5 2.6 0.1 0.0 0.0 0.1 COL14A1 UND ENSG00000187955 "Collagen type XIV alpha 1 chain" Q05707 8 120059780-120372036 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 87.4" "Cell type enhanced" "Detected in many" 21 "Cytotrophoblasts: 32.7;Fibroblasts: 157.1;Smooth muscle cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 18.3;hTERT-RPE1: 9.3;RH-30: 48.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023781 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 2000000 Vesicles "HPA023781: AB_1847098" "unprognostic (1.10e-1)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-3)" "unprognostic (5.96e-2)" "unprognostic (4.29e-2)" "unprognostic (7.61e-2)" "unprognostic (3.77e-2)" "unprognostic (4.36e-1)" "unprognostic (5.07e-2)" "prognostic unfavorable (5.79e-5)" "unprognostic (1.07e-2)" "unprognostic (8.21e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.01e-4)" 20.0 3.3 0.8 20.8 0.9 0.0 21.6 0.7 0.9 87.4 13.9 1.0 9.6 1.3 64.6 39.2 20.0 15.6 38.6 27.8 0.8 1.0 8.3 5.0 8.8 4.5 1.1 1.1 62.1 4.4 1.1 1.8 30.8 3.0 41.7 10.5 4.2 21.8 5.8 7.6 5.4 12.2 45.2 6.5 15.4 10.1 13.3 0.4 1.1 15.7 32.5 9.9 30.4 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 18.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.6 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 5.3 0.1 0.0 4.7 0.1 1.0 0.0 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 48.7 0.1 2.1 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.1 1.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.7 0.9 0.8 1.0 1.1 1.1 3.0 0.4 0.0 1.4 0.0 0.2 10.1 0.0 7.8 0.0 0.0 7.9 1.8 0.0 32.7 0.0 0.0 0.8 2.9 0.0 0.0 0.0 2.9 157.1 0.4 3.5 0.0 5.4 0.0 0.0 25.8 0.0 0.4 13.6 0.8 5.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.2 0.0 54.7 3.5 2.9 8.4 21.2 0.0 0.0 0.4 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104086002 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 85.8;skin 1: 123.2;tongue: 64.0" "Cell type enriched" "Detected in many" 4 "Basal keratinocytes: 520.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 227.4" "Region enriched" "Detected in single" 4 "basal ganglia: 1.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Not detected" "Not detected" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 0.2 0.0 0.2 4.4 1.2 7.5 8.1 0.2 0.2 15.2 9.3 0.2 0.9 2.0 0.6 2.6 31.5 0.1 1.2 0.2 0.2 0.1 0.4 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.6 85.8 0.2 5.0 5.4 0.2 15.5 7.3 0.5 123.2 23.2 0.8 0.2 0.3 3.9 4.0 0.2 18.1 2.0 64.0 24.7 3.0 17.3 0.0 0.0 3.7 0.2 0.0 0.0 0.8 3.1 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.7 0.0 0.5 56.6 0.1 90.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.8 0.0 100.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 5.1 3.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.8 0.2 1.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.6 0.0 12.4 520.3 0.6 0.8 0.0 2.7 20.5 0.0 0.0 3.5 0.0 0.7 8.5 1.0 105.8 0.0 0.8 8.3 2.1 0.6 0.0 0.0 1.2 0.0 2.4 0.0 0.0 2.6 0.3 1.0 32.1 0.0 5.9 0.4 45.8 16.1 0.7 0.0 0.4 0.0 1.7 8.3 1.1 121.8 4.7 0.0 14.5 8.0 COL18A1 "KNO, KNO1, KS" ENSG00000182871 "Collagen type XVIII alpha 1 chain" P39060 21 45405137-45513720 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 273.2" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 362.6;Sertoli cells: 219.9;Smooth muscle cells: 163.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 31.8;EFO-21: 71.6;NTERA-2: 39.8;TIME: 42.1" "Region enriched" "Detected in many" 6 "cerebellum: 24.8" "Low region specificity" "Detected in all" "HPA030933, HPA036104" Supported Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 250000000 "Golgi apparatus" "HPA030933: , HPA036104: AB_2674943" "unprognostic (4.32e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (3.47e-2)" "unprognostic (3.25e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.23e-3)" "unprognostic (9.93e-2)" "unprognostic (3.48e-1)" "unprognostic (2.77e-1)" "unprognostic (5.50e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-2)" "unprognostic (9.44e-2)" "unprognostic (9.10e-3)" "unprognostic (2.25e-3)" 25.5 14.4 2.2 12.7 13.0 5.6 17.7 3.4 8.5 40.4 12.7 26.0 19.6 12.6 22.2 72.5 12.0 18.8 25.3 18.5 3.5 5.3 36.2 273.2 11.9 7.6 35.5 3.5 43.3 21.8 2.6 17.8 16.5 20.8 13.9 2.3 17.3 8.8 20.2 8.1 23.1 10.6 33.4 31.9 14.5 7.1 11.0 23.6 2.3 16.0 12.0 6.7 28.7 18.2 0.4 0.4 7.3 0.4 0.0 1.2 0.2 2.5 19.5 4.8 4.4 9.1 7.6 1.0 18.7 31.8 9.0 2.4 12.1 6.9 0.5 71.6 18.5 5.2 8.8 1.0 1.1 1.7 0.2 5.4 11.2 0.3 16.5 8.8 0.4 1.1 8.8 0.7 0.8 1.0 2.1 27.6 0.2 11.3 0.1 3.2 4.5 0.4 1.1 39.8 0.8 7.2 0.5 3.1 1.1 30.2 0.4 5.5 4.2 1.8 2.0 5.9 17.9 1.8 3.0 42.1 0.2 2.8 0.1 4.4 0.1 0.2 0.3 0.1 0.9 7.7 1.0 0.4 1.5 0.1 0.4 0.2 0.4 0.4 0.0 0.1 0.1 1.2 0.6 7.3 0.0 0.3 0.4 0.0 0.2 2.2 13.0 3.4 8.5 3.5 5.3 35.5 3.5 20.8 23.6 0.0 5.5 7.0 15.2 60.1 7.9 13.7 53.5 0.0 4.5 106.4 3.9 1.4 8.3 111.6 1.1 54.0 0.0 0.0 4.9 1.1 50.8 5.3 58.6 362.6 2.2 0.0 0.0 84.7 7.3 4.5 73.9 8.3 47.2 2.8 0.0 116.0 10.0 0.0 118.5 54.9 3.8 219.9 163.2 2.6 4.5 25.0 2.1 7.5 0.0 2.2 COL19A1 ENSG00000082293 "Collagen type XIX alpha 1 chain" Q14993 6 69866571-70209976 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4" "Cell type enriched" "Detected in some" 5 "B-cells: 16.7" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Region enhanced" "Detected in many" "cerebellum: 14.4" "Group enriched" "Detected in some" 156 "memory B-cell: 7.9;naive B-cell: 23.1" "Lineage enriched" "Detected in single" 232 "B-cells: 23.1" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;RH-30: 14.5;SCLC-21H: 4.1;SK-MEL-30: 12.2;WM-115: 10.2" "Low region specificity" "Detected in many" HPA042422 Uncertain "Secreted to extracellular matrix" NA NA "HPA042422: AB_10794798" "unprognostic (2.65e-2)" "unprognostic (2.55e-1)" "unprognostic (2.71e-1)" "unprognostic (9.24e-2)" "unprognostic (2.26e-2)" "unprognostic (6.20e-2)" "unprognostic (3.17e-1)" "unprognostic (1.10e-3)" "unprognostic (3.41e-1)" "unprognostic (1.28e-1)" "unprognostic (2.76e-1)" "unprognostic (1.62e-2)" "unprognostic (1.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.20e-1)" "unprognostic (3.35e-1)" "unprognostic (8.91e-2)" 4.2 0.7 1.1 18.8 2.7 1.1 0.5 14.4 4.1 0.5 1.6 0.0 0.0 0.8 0.5 0.2 0.6 0.7 0.6 2.6 6.0 1.0 4.5 0.6 0.6 7.3 0.7 1.1 0.5 0.9 0.2 4.2 0.4 0.7 5.2 2.2 0.0 0.8 0.4 3.7 0.5 2.3 37.8 0.6 4.2 4.4 1.5 0.0 1.3 0.6 0.0 8.8 12.4 2.3 23.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 14.5 0.0 0.0 0.0 4.1 3.0 0.0 0.0 12.2 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 2.7 14.4 4.1 6.0 1.0 0.7 1.1 0.7 0.0 0.0 0.0 16.7 0.2 0.1 2.8 2.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.9 1.7 0.9 0.0 0.0 0.0 0.0 0.1 COL1A1 OI4 ENSG00000108821 "Collagen type I alpha 1 chain" P02452 17 50183289-50201632 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 415.7" "Cell type enhanced" "Detected in many" 22 "Fibroblasts: 2038.6;Ito cells: 615.0;Leydig cells: 514.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 91.8;BJ: 176.2;fHDF/TERT166: 266.1;HHSteC: 71.8;HSkMC: 134.8;U-138 MG: 143.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA011795, HPA012111" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 58000000 "Endoplasmic reticulum, Vesicles" "HPA011795: AB_1847088, HPA012111: " "unprognostic (1.61e-1)" "unprognostic (3.60e-3)" "unprognostic (8.29e-2)" "unprognostic (5.52e-2)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.01e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-2)" "unprognostic (8.53e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (7.19e-12)" "unprognostic (2.74e-2)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (3.87e-3)" 30.2 5.7 0.7 28.2 4.0 0.1 31.7 0.6 0.9 415.7 25.7 1.6 23.9 3.0 121.8 70.9 17.4 33.0 110.3 43.9 0.7 0.1 7.5 4.6 18.8 38.5 0.7 1.2 73.6 10.5 1.0 10.7 89.1 2.2 31.5 4.0 9.2 9.1 21.0 11.0 35.5 10.6 88.0 1.3 13.7 15.0 44.6 0.7 7.7 6.7 15.5 8.7 67.3 49.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.2 0.9 0.1 37.7 91.8 1.6 176.2 47.9 43.9 27.6 3.5 0.8 0.0 0.4 266.1 0.3 0.5 0.4 0.1 7.9 0.2 0.3 0.0 4.4 0.2 71.8 0.0 0.0 134.8 2.6 53.7 0.2 7.3 0.0 0.2 0.1 0.0 22.1 0.4 0.0 0.0 0.9 0.6 0.5 0.3 0.1 0.1 0.2 0.0 0.1 0.5 0.3 0.2 0.0 13.7 2.2 0.0 0.0 143.2 31.3 21.4 0.8 0.1 0.3 0.0 10.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.0 0.6 0.9 0.7 0.1 0.7 1.2 2.2 0.7 8.9 14.4 0.5 11.0 166.9 0.0 4.8 0.0 5.3 12.5 7.0 0.0 29.5 0.0 11.2 0.9 5.1 0.0 0.0 3.7 26.1 2038.6 12.1 2.3 1.9 59.9 0.0 2.9 615.0 0.8 4.5 514.8 7.7 178.8 0.0 2.2 2.8 25.7 0.0 252.1 0.5 0.1 77.6 273.4 4.2 1.7 142.9 93.5 0.5 1.3 7.5 COL1A2 OI4 ENSG00000164692 "Collagen type I alpha 2 chain" P08123 7 94394561-94431232 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 244.6" "Cell type enhanced" "Detected in many" 15 "Fibroblasts: 1445.8;Ito cells: 427.2;Leydig cells: 918.4;Peritubular cells: 470.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 154.3;ASC TERT1: 185.1;BJ: 151.4;BJ hTERT+: 111.2;fHDF/TERT166: 512.4;HSkMC: 160.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB032650, HPA059738" Approved Supported "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 21000000 "Endoplasmic reticulum" "CAB032650: AB_2082039, HPA059738: AB_2684116" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.32e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-2)" "unprognostic (2.81e-1)" "unprognostic (5.15e-2)" "unprognostic (7.38e-3)" "unprognostic (2.01e-2)" "unprognostic (1.40e-2)" "unprognostic (5.83e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.35e-2)" "unprognostic (5.25e-2)" "unprognostic (1.15e-1)" "unprognostic (3.31e-3)" 44.7 9.8 1.2 34.9 4.3 0.0 33.4 1.7 2.4 244.6 26.5 2.1 54.1 3.8 166.9 139.1 28.2 36.6 101.4 45.1 1.3 0.8 10.2 4.1 37.1 20.4 1.8 2.8 68.3 10.9 1.8 6.0 70.6 3.8 40.3 10.1 23.0 17.5 28.0 12.1 35.6 15.2 100.7 3.2 16.4 16.1 49.7 1.1 5.6 14.7 42.7 12.6 62.4 55.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 57.1 154.3 185.1 0.0 151.4 111.2 24.9 33.3 0.0 0.1 0.0 0.1 512.4 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 160.7 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.5 63.6 0.0 39.4 4.2 0.0 0.0 0.0 15.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.3 1.7 2.4 1.3 0.8 1.8 2.8 3.8 1.1 3.0 17.5 0.0 0.5 198.1 0.1 13.3 0.0 1.4 5.7 1.8 0.0 23.0 0.0 2.8 7.1 30.1 0.0 0.0 0.2 19.3 1445.8 1.2 9.3 1.1 95.1 0.0 0.0 427.2 1.0 22.0 918.4 12.0 226.0 4.6 0.0 3.0 8.5 0.0 470.9 0.3 0.3 297.5 291.6 5.1 3.2 163.7 59.2 0.0 0.0 0.7 COL20A1 KIAA1510 ENSG00000101203 "Collagen type XX alpha 1 chain" Q9P218 20 63293186-63334851 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.6" "Cell type enhanced" "Detected in some" 18 "Horizontal cells: 3.2;Late spermatids: 1.8;Spermatocytes: 8.1;Spermatogonia: 3.6" "Cancer enriched" "Detected in single" 19 "glioma: 8.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.6;SK-MEL-30: 3.3;SuSa: 1.5;U-266/70: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA "unprognostic (6.34e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "unprognostic (2.01e-1)" "unprognostic (5.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (2.89e-1)" "unprognostic (8.41e-7)" "unprognostic (7.85e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-2)" "unprognostic (1.16e-1)" 0.6 0.9 6.9 0.6 3.9 0.6 0.5 2.2 21.6 1.0 0.6 14.0 0.0 0.5 0.5 1.2 0.5 0.6 0.5 0.6 5.6 3.0 0.6 0.6 0.5 0.5 4.7 4.5 0.7 0.5 0.5 1.1 0.6 3.5 0.6 0.5 0.7 0.8 0.6 0.5 0.5 0.6 0.5 4.3 2.0 0.5 3.0 5.0 0.0 0.5 0.2 0.5 0.5 0.1 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 1.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.5 0.0 0.0 0.0 0.0 0.6 0.7 0.1 2.5 0.5 0.3 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 6.9 3.9 2.2 6.3 5.6 3.0 4.7 4.5 3.5 5.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 1.4 0.0 0.0 8.1 3.6 0.0 0.0 0.0 0.0 0.0 COL22A1 ENSG00000169436 "Collagen type XXII alpha 1 chain" Q8NFW1 8 138588235-138914006 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 46.5" "Group enriched" "Detected in some" 4 "Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024830 Enhanced Supported "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA Vesicles "Endoplasmic reticulum" "HPA024830: AB_1847102" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (2.88e-2)" "unprognostic (4.19e-6)" "prognostic unfavorable (4.15e-4)" "unprognostic (1.05e-2)" "unprognostic (5.57e-3)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.01e-1)" "unprognostic (9.24e-2)" "unprognostic (5.74e-2)" "unprognostic (3.62e-2)" "unprognostic (3.66e-15)" "unprognostic (2.38e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (1.09e-1)" 0.1 12.0 0.2 1.3 1.1 0.0 0.1 6.8 1.1 1.3 0.7 1.4 10.8 0.3 2.4 1.9 0.2 0.5 0.4 0.2 0.3 0.8 2.8 0.1 0.1 0.5 0.3 0.0 0.3 0.2 1.7 46.5 0.0 1.9 4.7 0.1 1.6 0.8 5.1 0.5 0.1 0.4 2.2 1.8 0.3 3.7 0.8 0.1 1.4 0.3 0.7 1.7 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.2 6.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.8 0.3 0.3 0.8 0.3 0.0 1.9 0.1 0.0 0.0 0.0 2.8 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 30.8 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 25.2 0.3 0.0 0.0 1.0 0.0 26.2 2.1 0.0 0.0 0.0 1.1 0.0 0.3 1.1 0.8 0.0 0.0 0.0 0.0 1.3 COL23A1 DKFZp434K0621 ENSG00000050767 "Collagen type XXIII alpha 1 chain" Q86Y22 5 178237618-178590555 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 42.3" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 56.2" "Cancer enhanced" "Detected in many" "renal cancer: 41.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.1" "Group enriched" "Detected in some" 4 "K-562: 8.1;NB-4: 23.1;THP-1: 23.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067824 Uncertain NA NA "HPA067824: AB_2685907" "unprognostic (5.24e-2)" "unprognostic (2.65e-1)" "unprognostic (6.65e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (3.04e-1)" "unprognostic (8.67e-3)" "unprognostic (1.14e-1)" "unprognostic (3.62e-1)" "unprognostic (2.12e-1)" "unprognostic (3.52e-2)" "unprognostic (3.96e-2)" "unprognostic (5.93e-3)" "unprognostic (8.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.90e-2)" "unprognostic (2.11e-3)" "unprognostic (2.37e-1)" 0.6 0.5 1.6 1.9 1.3 6.9 1.5 8.8 3.4 2.2 2.2 0.1 7.6 3.1 1.2 3.6 0.7 2.0 0.9 11.4 1.5 1.0 2.2 1.5 1.4 0.6 0.7 2.3 0.2 1.9 3.0 0.8 0.1 2.9 4.1 0.1 3.7 1.7 12.6 1.3 6.3 3.8 1.1 2.6 1.5 2.2 2.3 0.1 0.3 42.3 2.2 1.6 1.0 1.5 0.0 3.1 0.0 0.5 0.5 0.0 0.2 0.0 0.0 4.0 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 8.1 0.4 0.0 1.0 0.0 23.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.9 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 3.1 0.0 0.2 1.6 1.3 8.8 3.4 1.5 1.0 0.7 2.3 2.9 0.1 0.0 0.0 0.0 2.5 1.9 0.7 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.2 1.3 0.4 0.0 0.0 0.5 0.0 0.0 1.8 1.6 0.0 0.3 0.9 0.0 0.0 0.0 56.2 0.1 0.0 2.5 0.5 2.5 6.5 4.7 1.1 2.0 4.1 0.1 0.0 0.0 0.1 COL24A1 ENSG00000171502 "Collagen type XXIV alpha 1 chain" Q17RW2 1 85729233-86156943 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 59.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.2" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;HSkMC: 3.2;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;SuSa: 4.6;U-266/70: 11.2" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA 12000 "unprognostic (3.00e-1)" "unprognostic (6.19e-2)" "unprognostic (2.21e-2)" "unprognostic (6.76e-3)" "unprognostic (1.82e-3)" "unprognostic (2.45e-2)" "unprognostic (2.44e-5)" "unprognostic (1.37e-1)" "unprognostic (4.08e-2)" "unprognostic (6.59e-2)" "unprognostic (3.89e-2)" "unprognostic (1.46e-1)" "unprognostic (3.48e-6)" "unprognostic (2.79e-5)" "unprognostic (5.07e-1)" "unprognostic (1.19e-1)" "unprognostic (9.90e-2)" 1.1 0.4 6.2 3.4 7.1 2.3 1.1 1.7 18.0 7.0 9.5 0.3 0.0 4.1 3.6 2.4 2.2 0.6 4.4 4.1 12.1 1.2 1.5 0.3 1.7 1.0 1.1 5.2 6.9 0.3 0.2 2.0 0.3 1.7 2.3 2.4 2.4 1.2 4.3 1.4 1.6 3.7 2.8 1.0 0.8 3.4 1.9 2.9 0.0 0.8 2.6 0.8 8.3 4.9 0.0 6.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 3.4 0.6 0.0 0.6 0.1 0.2 0.5 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.9 0.0 1.4 0.0 0.8 0.0 1.0 0.1 0.1 0.0 0.0 3.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 6.0 0.9 0.0 0.0 0.2 3.1 0.0 0.0 0.0 4.4 0.5 0.6 1.1 0.1 0.0 0.0 0.2 0.5 4.6 0.0 0.9 0.0 2.0 0.2 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 6.2 0.0 0.0 6.2 7.1 1.7 18.0 12.1 1.2 1.1 5.2 1.7 2.9 0.0 1.1 1.9 0.0 0.3 2.2 1.6 0.0 2.7 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 10.1 0.0 0.0 59.8 0.0 0.0 0.7 0.0 1.1 0.0 0.0 1.1 0.4 0.1 0.0 0.0 0.0 0.0 COL25A1 ENSG00000188517 "Collagen type XXV alpha 1 chain" Q9BXS0 4 108808725-109302752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.4;retina: 22.1;testis: 23.6" "Group enriched" "Detected in some" 16 "Early spermatids: 89.3;Late spermatids: 22.6;Rod photoreceptor cells: 75.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HeLa: 31.5" "Low region specificity" "Detected in many" HPA029107 Approved "Endoplasmic reticulum,Vesicles,Cytosol" NA NA "Vesicles, Cytosol" "Endoplasmic reticulum" "HPA029107: AB_10600802" "unprognostic (1.77e-1)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "unprognostic (8.87e-5)" "unprognostic (2.43e-2)" "unprognostic (3.20e-1)" "unprognostic (7.62e-3)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (3.53e-1)" "unprognostic (1.50e-2)" "unprognostic (1.17e-1)" "unprognostic (5.30e-3)" "unprognostic (2.82e-3)" "unprognostic (9.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" 9.0 0.8 6.7 0.2 4.4 0.0 5.1 0.8 3.4 1.6 0.9 0.4 0.9 4.0 2.1 3.5 0.8 1.4 3.1 2.0 4.7 2.1 2.9 3.2 0.9 0.1 0.8 0.0 1.6 0.9 3.9 17.4 0.4 2.5 0.9 0.4 22.1 6.7 1.4 1.4 1.1 3.1 1.5 0.9 1.0 0.9 23.6 1.5 0.0 3.7 0.1 0.0 1.6 3.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.9 0.0 0.1 0.0 2.3 4.2 31.5 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.2 4.0 0.0 0.5 0.0 1.2 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 4.4 0.8 3.4 4.7 2.1 0.8 0.0 2.5 1.5 0.0 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 1.2 1.8 3.9 0.0 0.0 0.0 89.3 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.6 0.0 1.3 0.0 22.6 0.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 75.2 0.0 3.4 3.2 1.5 0.1 0.0 0.0 0.0 0.0 COL26A1 "EMI6, EMID2, Emu2" ENSG00000160963 "Collagen type XXVI alpha 1 chain" Q96A83 7 101362820-101559024 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.4;brain: 18.3" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 5.2;Hepatocytes: 2.6;Late spermatids: 2.2;Spermatogonia: 2.2" "Group enriched" "Detected in many" 6 "endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 63 "dendritic cells: 11.4" "Cell line enhanced" "Detected in some" "AF22: 20.3;BEWO: 16.3;HAP1: 7.2;NTERA-2: 17.1;SuSa: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027059 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA027059: AB_1848142" "unprognostic (5.94e-3)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.66e-1)" "unprognostic (3.35e-1)" "prognostic favorable (2.32e-5)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.26e-3)" "unprognostic (1.78e-1)" "unprognostic (4.24e-3)" "unprognostic (3.60e-1)" "unprognostic (1.50e-1)" "unprognostic (7.48e-4)" "unprognostic (2.83e-3)" 0.0 4.1 2.5 0.3 7.0 0.3 0.2 0.4 18.3 0.1 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.2 0.3 0.1 3.3 3.1 4.8 0.6 0.9 0.0 8.1 0.2 3.1 6.7 0.0 0.5 0.6 3.7 0.0 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.3 0.4 0.2 0.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 20.3 1.2 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.2 0.0 0.0 0.0 7.2 0.0 0.0 0.7 0.8 0.0 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.1 13.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 2.6 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.3 0.0 0.0 0.5 COL27A1 "FLJ11895, KIAA1870, MGC11337" ENSG00000196739 "Collagen type XXVII alpha 1 chain" Q8IZC6 9 114155560-114312511 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9;cervix, uterine: 41.9" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 73.9;Extravillous trophoblasts: 60.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 56.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 30.2;Hep G2: 25.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 23 "cerebellum: 141.7" "HPA021884, HPA048471" Uncertain "Secreted to extracellular matrix" NA NA "HPA021884: AB_2670857, HPA048471: AB_2680407" "unprognostic (4.45e-2)" "unprognostic (3.27e-1)" "unprognostic (1.32e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (7.11e-4)" "unprognostic (4.13e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (6.25e-2)" "unprognostic (1.71e-1)" "unprognostic (1.09e-3)" "unprognostic (3.31e-1)" "unprognostic (3.41e-2)" "unprognostic (2.97e-2)" "unprognostic (9.48e-2)" "unprognostic (6.21e-3)" "unprognostic (3.50e-3)" 4.7 4.2 6.0 4.2 4.6 0.1 4.1 56.9 5.7 41.9 4.4 2.6 5.7 2.9 25.9 17.0 3.6 6.4 6.3 3.3 4.9 1.7 11.0 16.5 4.4 2.9 5.8 1.8 13.1 12.9 0.7 2.2 9.0 8.6 9.8 1.0 9.6 4.1 11.3 4.0 11.9 3.5 8.4 7.3 3.0 9.7 2.7 5.1 2.8 6.1 5.2 3.2 5.7 17.9 0.9 0.4 2.0 0.2 0.5 0.3 0.1 2.0 4.1 9.8 3.5 0.7 1.1 30.2 4.7 3.2 3.4 2.9 4.3 0.1 0.0 1.2 2.3 2.6 4.9 3.3 4.4 1.9 0.0 0.4 0.0 3.4 25.5 1.0 0.0 10.9 2.7 1.2 4.2 1.9 1.9 5.1 4.0 0.0 1.0 1.9 0.9 0.0 1.8 3.5 8.0 1.1 13.6 9.9 1.9 8.1 2.2 0.1 0.1 0.2 0.1 0.5 3.9 0.9 3.1 4.7 3.0 6.1 0.4 7.3 0.5 0.0 0.0 2.5 0.0 4.6 0.6 0.2 0.4 0.2 0.2 0.2 0.3 0.3 0.2 0.1 0.9 0.3 0.2 2.0 0.5 0.1 0.4 0.2 0.1 6.0 4.6 56.9 5.7 4.9 1.7 5.8 1.8 8.6 5.1 3.0 16.5 1.5 4.6 24.2 0.6 24.9 73.9 0.0 6.8 8.7 5.9 0.7 3.3 9.2 1.1 3.6 0.0 0.0 4.3 60.6 14.4 5.3 0.0 35.8 5.2 1.6 4.6 6.2 1.0 0.9 17.8 0.6 21.9 0.0 1.6 6.1 5.4 0.8 4.2 5.7 1.0 25.8 35.4 0.2 1.9 19.6 1.9 0.0 2.2 1.6 COL2A1 "AOM, SEDC, STL1" ENSG00000139219 "Collagen type II alpha 1 chain" P02458 12 47972965-48004554 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 12.7;Intestinal endocrine cells: 42.2;Muller glia cells: 19.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 55.2;HAP1: 34.6;HEK 293: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002214, HPA055753" Approved Approved Nucleoplasm "Secreted to extracellular matrix" No NA Nucleoplasm "CAB002214: AB_563666, HPA055753: AB_2682908" "unprognostic (7.25e-2)" "unprognostic (1.20e-1)" "unprognostic (2.58e-1)" "unprognostic (3.44e-1)" "unprognostic (2.88e-2)" "unprognostic (3.08e-2)" "unprognostic (8.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (3.12e-2)" "unprognostic (1.31e-4)" "unprognostic (2.64e-1)" "unprognostic (3.44e-3)" "unprognostic (1.89e-1)" "unprognostic (2.93e-1)" "unprognostic (2.07e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.1 2.2 0.3 0.0 0.7 0.9 0.9 0.0 0.2 0.3 0.0 0.0 0.3 22.7 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.7 1.3 0.0 0.0 11.0 0.4 1.9 2.6 0.4 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 11.3 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 34.6 0.0 0.0 0.0 12.8 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.9 0.9 0.5 1.3 0.0 0.7 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.0 42.2 0.0 0.0 7.1 0.9 0.0 0.0 0.0 0.3 19.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.7 0.0 0.7 0.0 0.9 0.1 COL3A1 EDS4A ENSG00000168542 "Collagen type III alpha 1 chain" P02461 2 188974320-189012746 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 304.2;endometrium 1: 208.0" "Cell type enriched" "Detected in many" 4 "Fibroblasts: 1855.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 81.7;ASC diff: 151.5;ASC TERT1: 263.7;fHDF/TERT166: 106.1;HHSteC: 104.2;HSkMC: 196.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA007583, CAB016766, CAB059993" Approved Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 16000000 "Endoplasmic reticulum" "CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548" "unprognostic (1.12e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-1)" "unprognostic (2.04e-1)" "unprognostic (6.94e-2)" "unprognostic (6.77e-3)" "unprognostic (3.57e-3)" "unprognostic (2.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (3.59e-10)" "unprognostic (1.70e-3)" "unprognostic (3.76e-2)" "unprognostic (7.61e-2)" "unprognostic (6.17e-3)" 41.7 9.7 0.7 34.1 3.4 0.0 29.7 0.8 1.2 304.2 41.3 1.3 23.8 3.9 208.0 82.0 31.3 32.3 116.3 41.0 1.0 0.3 14.4 12.1 32.9 39.3 1.3 1.1 54.9 14.4 1.7 2.3 161.2 3.2 27.4 18.3 32.0 15.1 22.4 14.5 28.3 24.2 114.1 1.7 29.5 25.3 45.5 0.7 9.5 12.8 44.8 15.4 64.8 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.7 3.1 151.5 263.7 0.0 32.9 29.3 14.4 12.9 0.4 0.0 0.0 0.0 106.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 13.9 0.0 104.2 0.1 0.0 196.1 0.0 17.5 2.8 0.0 0.7 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.4 0.0 1.2 0.8 0.0 0.0 60.2 0.0 0.0 0.0 0.1 1.7 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.4 0.8 1.2 1.0 0.3 1.3 1.1 3.2 0.7 3.0 20.2 0.0 0.4 152.4 0.0 9.8 0.0 2.7 2.3 0.0 0.0 40.3 0.0 2.5 21.6 52.5 0.0 0.0 0.0 34.9 1855.8 0.5 5.8 0.9 81.7 0.0 5.8 358.5 0.8 11.8 299.1 3.8 163.6 0.0 0.0 0.0 6.1 0.0 221.7 0.0 0.0 446.3 215.4 1.1 1.0 136.1 105.6 0.0 0.0 0.3 COL4A1 ENSG00000187498 "Collagen type IV alpha 1 chain" P02462 13 110148963-110307149 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 163.4" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 577.1;Ito cells: 181.7;Sertoli cells: 498.0;Smooth muscle cells: 250.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Lineage enhanced" "Detected in single" "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 74.0;EFO-21: 126.5;TIME: 45.0" "Low region specificity" "Detected in many" CAB001695 Approved "Secreted to extracellular matrix" NA NA 55000 "CAB001695: " "unprognostic (3.82e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (2.27e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-1)" "unprognostic (6.51e-3)" "unprognostic (1.06e-2)" "unprognostic (9.79e-2)" "unprognostic (1.73e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.47e-3)" "unprognostic (1.72e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-2)" 86.0 10.0 1.6 23.5 3.0 0.2 65.2 1.5 2.0 20.5 27.7 1.6 14.3 4.4 52.3 21.8 20.6 18.8 38.8 29.2 2.5 1.5 21.1 5.7 37.3 28.9 2.6 1.0 20.0 8.5 9.1 3.9 163.4 5.0 24.6 5.9 7.6 5.9 17.3 24.6 6.9 11.6 58.1 4.1 60.5 16.0 8.7 1.1 3.1 16.5 9.0 3.8 47.0 24.5 0.0 0.4 1.1 0.1 0.0 0.0 0.0 5.1 2.0 26.7 0.0 74.0 19.9 37.6 33.7 8.0 18.6 9.2 0.5 0.0 0.0 126.5 6.2 8.1 3.5 0.0 7.6 4.2 0.1 3.9 0.0 4.0 0.0 20.8 0.0 0.0 7.2 1.1 18.4 8.4 29.2 28.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 3.7 0.0 0.4 0.0 7.9 0.0 39.8 0.0 0.1 3.6 0.0 0.0 7.4 28.5 0.0 1.7 45.0 5.5 16.6 0.1 12.8 0.0 0.1 0.2 0.0 0.0 40.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 3.0 1.5 2.0 2.5 1.5 2.6 1.0 5.0 1.1 38.7 12.8 3.4 7.1 12.5 0.7 31.3 7.6 4.0 1.2 22.7 0.0 40.0 1.7 11.1 0.5 125.5 0.0 0.0 0.2 577.1 125.0 3.3 1.1 0.8 24.5 0.0 0.0 181.7 6.3 0.7 35.6 3.9 28.7 1.0 0.3 2.8 0.5 0.0 102.9 11.3 0.3 498.0 250.4 1.2 5.1 13.2 37.6 0.0 0.2 0.9 COL4A2 "DKFZp686I14213, FLJ22259" ENSG00000134871 "Collagen type IV alpha 2 chain" P08572 13 110305812-110513027 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 125.7" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 463.3;Peritubular cells: 165.5;Sertoli cells: 368.7;Smooth muscle cells: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 145.1;WM-115: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010751, HPA029118, HPA069337" Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA 1900000 Vesicles "CAB010751: AB_476828, HPA029118: , HPA069337: " "unprognostic (2.43e-1)" "unprognostic (4.13e-3)" "unprognostic (8.04e-2)" "unprognostic (6.03e-3)" "unprognostic (2.20e-1)" "unprognostic (2.64e-2)" "unprognostic (3.45e-2)" "unprognostic (1.15e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.33e-2)" "unprognostic (1.57e-2)" "unprognostic (6.95e-2)" "prognostic unfavorable (9.25e-4)" 87.2 9.5 4.6 26.1 3.3 0.1 50.1 2.0 3.0 37.2 53.1 1.9 30.3 7.6 48.4 25.5 23.0 26.3 52.4 26.6 3.6 1.4 18.4 5.7 35.9 17.5 3.8 1.7 25.7 8.3 7.3 3.8 125.7 5.0 26.9 5.5 12.2 7.6 29.3 26.3 9.2 16.9 84.1 2.8 58.5 23.4 11.0 1.9 4.2 16.0 8.0 5.7 65.3 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.6 6.6 30.1 0.0 39.2 16.3 47.4 40.8 14.8 24.3 11.4 0.7 0.0 0.0 145.1 9.5 10.7 11.4 0.0 12.2 4.7 1.5 6.3 0.0 11.2 0.3 28.9 0.0 0.1 7.3 0.7 17.0 11.7 31.1 25.4 0.0 0.0 0.1 4.0 0.2 0.0 1.0 4.7 0.2 2.3 0.0 12.4 0.0 26.8 0.2 0.9 4.9 0.0 0.1 12.8 13.5 0.0 0.5 43.7 13.4 34.1 0.3 22.1 0.0 0.2 0.6 0.3 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 3.3 2.0 3.0 3.6 1.4 3.8 1.7 5.0 1.9 77.4 8.0 1.4 6.5 8.5 2.0 27.9 25.5 2.7 2.3 50.6 0.0 67.8 1.7 25.5 1.6 98.7 13.4 0.0 3.7 463.3 94.4 2.1 1.1 1.6 26.8 0.0 0.0 139.3 5.4 1.5 56.1 5.8 37.1 3.6 5.1 9.5 2.8 0.0 165.5 16.1 0.2 368.7 174.9 0.2 8.1 6.0 56.2 0.0 3.7 1.2 COL4A3 ENSG00000169031 "Collagen type IV alpha 3 chain" Q01955 2 227164565-227314792 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 27.9" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 157.8;Cone photoreceptor cells: 375.0;Muller glia cells: 214.6" "Group enriched" "Detected in some" 6 "lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory B-cell: 3.8;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 7 "B-cells: 3.8" "Cell line enhanced" "Detected in some" "HeLa: 15.4;hTERT-RPE1: 13.4;Karpas-707: 9.0;RPTEC TERT1: 10.1;U-266/70: 8.3" "Not detected" "Not detected" HPA042064 Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA Vesicles "Endoplasmic reticulum" "HPA042064: AB_10794410" "unprognostic (4.81e-2)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (9.28e-6)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.84e-2)" "unprognostic (7.07e-3)" "unprognostic (2.30e-1)" "unprognostic (9.09e-3)" "unprognostic (9.30e-2)" "unprognostic (3.02e-2)" "prognostic favorable (2.51e-7)" "unprognostic (1.78e-1)" "unprognostic (3.10e-2)" "unprognostic (2.49e-2)" "unprognostic (1.26e-1)" 0.7 9.5 0.9 5.4 2.9 0.3 0.9 1.4 2.9 0.7 0.7 1.7 12.0 0.7 1.5 15.3 1.1 1.5 5.3 6.7 1.6 1.2 27.9 0.7 15.0 3.6 2.4 0.0 3.6 4.4 0.2 16.7 0.2 7.5 4.9 1.0 20.9 1.1 11.2 17.8 0.6 5.0 2.9 3.1 6.1 1.5 1.5 3.4 0.0 16.2 9.4 5.8 1.8 1.2 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.2 1.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 1.1 0.0 9.0 0.0 0.4 0.0 0.1 1.3 0.0 0.0 0.0 0.0 2.8 10.1 2.0 0.4 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 8.3 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 3.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.9 1.4 2.9 1.6 1.2 2.4 0.0 7.5 3.4 157.8 24.8 4.7 0.0 0.1 58.0 1.7 0.0 0.0 17.0 40.1 375.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.8 0.0 1.7 0.0 0.0 214.6 0.9 0.0 11.3 1.0 11.5 12.9 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 COL4A4 CA44 ENSG00000081052 "Collagen type IV alpha 4 chain" P53420 2 227002711-227164453 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.7" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 68.5;Collecting duct cells: 43.6;Cone photoreceptor cells: 53.0;Muller glia cells: 117.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "memory B-cell: 8.0" "Lineage enriched" "Detected in many" 7 "B-cells: 8.0" "Cell line enhanced" "Detected in some" "HeLa: 23.1;hTERT-RPE1: 19.7;Karpas-707: 6.3;RPTEC TERT1: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (7.31e-2)" "unprognostic (7.56e-2)" "unprognostic (6.65e-2)" "unprognostic (4.88e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (8.50e-3)" "unprognostic (5.14e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "prognostic favorable (2.30e-13)" "unprognostic (1.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.30e-1)" "unprognostic (4.15e-2)" 1.6 8.8 1.2 7.2 2.4 0.2 1.3 1.0 1.8 1.0 1.1 0.7 16.1 1.2 4.8 12.7 2.4 3.0 13.7 11.5 1.4 1.5 28.7 1.9 15.8 13.0 2.4 0.0 3.2 6.6 0.5 15.3 0.7 7.4 7.2 1.2 8.3 1.4 10.9 7.5 0.9 3.3 12.0 4.6 3.7 1.9 1.9 1.5 0.9 12.1 6.6 6.2 3.9 3.7 8.0 0.0 0.1 0.0 1.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.4 0.0 0.5 0.0 1.2 0.0 0.5 0.0 2.2 0.7 0.2 0.0 2.4 0.0 23.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 19.7 0.0 0.7 0.0 6.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.9 10.6 3.9 0.6 0.0 1.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.9 0.0 0.2 4.8 3.5 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.5 0.0 0.0 8.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 2.4 1.0 1.8 1.4 1.5 2.4 0.0 7.4 1.5 68.5 17.9 2.2 0.4 0.5 29.8 2.6 15.3 0.0 11.4 43.6 53.0 0.0 1.7 0.2 0.7 0.3 0.0 0.0 3.2 0.0 0.7 0.1 0.0 0.5 0.1 0.0 1.2 2.5 0.3 2.1 23.3 0.7 0.0 0.0 0.0 117.3 3.3 0.0 25.5 2.2 7.4 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 COL4A5 "ASLN, ATS" ENSG00000188153 "Collagen type IV alpha 5 chain" P29400 X 108439844-108697545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 25.8;Basal keratinocytes: 23.9;Peritubular cells: 34.6;Urothelial cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 28.5;HHSteC: 32.8;HUVEC TERT2: 30.8;TIME: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077177 Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA077177: " "unprognostic (2.58e-2)" "unprognostic (2.57e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.97e-2)" "unprognostic (7.27e-2)" "unprognostic (2.70e-1)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.61e-2)" "unprognostic (1.06e-1)" 3.3 2.7 13.1 1.7 27.7 0.3 5.8 1.8 16.1 16.9 3.7 47.2 9.5 2.7 31.4 18.2 6.9 19.3 12.6 5.9 13.9 6.2 5.9 1.7 5.9 0.9 46.6 15.7 11.5 2.8 22.3 10.2 9.7 19.5 18.0 4.1 5.8 3.7 23.9 4.8 17.5 3.1 32.8 20.5 2.8 17.7 2.8 40.5 0.0 5.4 0.9 0.9 23.9 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.8 15.8 5.0 6.2 3.6 0.1 0.9 3.9 4.8 7.9 7.9 0.6 1.3 0.0 0.6 2.9 7.1 4.4 14.9 6.1 2.1 3.8 1.1 28.5 0.9 32.8 0.0 4.5 17.0 18.1 5.9 12.7 15.4 30.8 0.0 0.0 0.0 4.6 0.6 0.0 0.1 4.7 0.0 5.3 0.0 0.0 0.0 12.0 8.8 0.0 0.0 23.0 0.7 1.9 23.3 4.3 0.0 29.1 3.2 1.0 2.1 1.3 0.6 0.0 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 27.7 1.8 16.1 13.9 6.2 46.6 15.7 19.5 40.5 6.0 5.3 0.0 25.8 23.9 0.3 8.9 0.0 4.0 11.4 19.2 0.0 0.6 0.0 0.2 0.1 2.9 0.0 0.0 0.8 0.3 8.5 8.2 1.1 0.4 0.4 0.0 0.0 4.9 0.3 1.2 18.7 0.8 1.7 0.0 0.0 13.0 0.5 0.0 34.6 0.0 0.4 6.5 18.6 0.3 0.7 13.9 0.6 0.0 0.0 22.6 COL4A6 ENSG00000197565 "Collagen type IV alpha 6 chain" Q14031 X 108155607-108439497 "Disease related genes, Predicted secreted proteins" "Cell adhesion" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 60.9" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 19.4;Cardiomyocytes: 9.2;Muller glia cells: 7.7;Peritubular cells: 8.5;Smooth muscle cells: 8.0;Urothelial cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.4;HeLa: 16.2;HHSteC: 24.9;hTERT-HME1: 18.2;HUVEC TERT2: 16.8;TIME: 37.6" "Low region specificity" "Detected in single" HPA065393 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum" "HPA065393: AB_2685483" "unprognostic (8.47e-3)" "unprognostic (4.50e-3)" "unprognostic (9.75e-3)" "unprognostic (9.80e-3)" "unprognostic (1.18e-1)" "unprognostic (5.99e-2)" "unprognostic (1.78e-2)" "unprognostic (3.78e-2)" "unprognostic (1.72e-1)" "unprognostic (9.84e-2)" "unprognostic (1.40e-2)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (1.32e-2)" "unprognostic (2.06e-1)" "unprognostic (8.54e-3)" "unprognostic (3.51e-1)" 2.1 0.4 0.4 0.8 0.5 0.0 1.7 0.2 0.4 12.1 1.0 1.3 8.0 0.7 22.9 17.1 25.0 11.3 35.8 3.6 0.6 0.6 3.0 0.3 2.1 0.0 1.0 0.9 6.4 0.3 7.6 11.3 1.9 0.9 16.5 1.3 8.3 1.4 15.6 1.0 4.1 1.8 60.9 1.4 1.1 10.4 2.1 0.7 0.2 0.6 1.4 0.5 24.7 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 12.4 4.0 0.0 10.1 0.7 0.0 0.0 0.7 0.1 0.1 7.1 0.0 0.0 0.0 0.0 1.6 2.3 4.1 18.4 0.3 0.1 3.5 0.3 16.2 0.1 24.9 0.0 0.0 1.0 11.4 2.6 18.2 0.0 16.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.6 0.0 1.5 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.9 0.0 0.0 7.8 0.3 0.0 37.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.4 0.6 0.6 1.0 0.9 0.9 0.7 0.0 0.0 0.0 19.4 5.7 0.0 9.2 0.0 2.7 2.3 1.8 0.0 0.1 1.7 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.9 3.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 7.7 0.1 0.0 8.5 0.0 0.2 0.0 8.0 0.3 0.2 3.1 0.0 0.0 0.0 10.6 COL5A1 ENSG00000130635 "Collagen type V alpha 1 chain" P20908 9 134641774-134844843 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Cancer-related genes, Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 110.7" "Cell type enhanced" "Detected in many" 15 "Fibroblasts: 127.8;Leydig cells: 56.7;Peritubular cells: 36.4;Sertoli cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Cell line enhanced" "Detected in many" "BJ: 72.5;fHDF/TERT166: 67.3;HeLa: 48.1;HHSteC: 45.8;SiHa: 47.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA030769 Approved Approved Vesicles "Secreted to extracellular matrix" No No 12000000 Vesicles "HPA030769: AB_2673603" "unprognostic (7.77e-2)" "unprognostic (4.55e-3)" "unprognostic (2.22e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (8.07e-2)" "unprognostic (8.09e-2)" "unprognostic (2.38e-3)" "unprognostic (1.54e-2)" "unprognostic (5.03e-3)" "unprognostic (5.05e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.07e-12)" "unprognostic (2.02e-2)" "unprognostic (4.73e-2)" "unprognostic (1.65e-2)" "unprognostic (2.50e-3)" 11.5 4.2 1.5 13.7 1.4 0.0 9.5 3.0 1.2 110.7 20.9 1.4 11.8 3.6 42.1 24.1 12.3 20.5 31.8 12.2 1.8 0.9 4.3 3.4 13.4 7.8 3.0 1.3 19.5 3.7 3.7 2.6 53.8 2.2 23.3 4.7 9.1 5.1 9.9 5.0 6.9 8.7 26.7 1.5 6.5 12.5 9.5 1.1 2.7 4.1 10.1 4.0 21.8 22.9 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 2.7 2.1 3.4 32.6 35.1 1.3 72.5 14.6 12.4 13.3 0.0 0.0 0.0 16.1 67.3 6.6 0.9 0.0 0.0 3.5 0.0 0.1 0.0 48.1 0.0 45.8 0.0 0.4 34.4 0.0 11.9 0.9 0.0 14.7 0.0 0.0 0.2 6.5 0.6 0.0 0.1 1.2 0.0 1.4 2.5 8.4 0.3 0.0 0.0 0.9 0.4 47.8 0.3 0.0 30.7 0.1 0.0 25.1 26.0 10.8 31.9 15.1 0.0 0.0 0.0 20.6 0.0 4.4 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 3.0 1.2 1.8 0.9 3.0 1.3 2.2 1.1 0.0 2.6 0.0 3.4 12.9 0.3 5.6 0.0 0.0 0.0 1.8 2.0 4.0 1.7 1.3 5.2 6.8 0.0 0.0 0.0 10.7 127.8 0.4 0.0 0.0 8.0 0.0 0.0 32.5 0.3 11.4 56.7 0.5 6.8 0.0 0.0 6.9 1.9 0.0 36.4 0.1 0.6 51.8 23.2 0.5 0.6 6.8 8.7 0.0 0.0 0.3 COL5A3 ENSG00000080573 "Collagen type V alpha 3 chain" P25940 19 9959561-10010471 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.9" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 63.5;Sertoli cells: 90.5;Smooth muscle cells: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 23.9;BJ: 13.8;BJ hTERT+: 15.5;BJ hTERT+ SV40 Large T+: 8.6;HSkMC: 17.2;WM-115: 15.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA048256 Approved "Secreted to extracellular matrix" NA NA 210000 "HPA048256: AB_2680330" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" "unprognostic (4.63e-2)" "unprognostic (3.24e-2)" "unprognostic (6.84e-3)" "unprognostic (3.01e-1)" "unprognostic (7.47e-2)" "unprognostic (1.79e-2)" "unprognostic (2.36e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.17e-8)" "unprognostic (3.25e-2)" "unprognostic (7.31e-3)" "unprognostic (6.00e-2)" "prognostic unfavorable (6.87e-5)" 48.9 2.6 11.6 10.8 15.9 0.4 27.0 3.2 11.9 24.5 7.8 3.2 3.1 3.6 17.5 9.8 11.3 8.1 10.7 9.5 10.1 3.0 1.9 4.1 6.4 9.2 5.2 3.5 3.4 3.8 3.2 0.9 30.2 4.5 6.8 2.2 9.7 5.1 9.1 15.4 19.0 3.9 9.6 2.5 1.3 3.4 5.3 2.6 1.6 4.5 11.5 4.7 7.3 10.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 7.6 23.9 0.0 13.8 15.5 8.6 3.4 0.0 0.0 0.0 0.1 2.5 0.2 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 17.2 0.3 3.1 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.1 0.0 0.0 0.0 7.0 3.2 0.3 0.0 0.0 0.0 0.0 0.9 0.0 15.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.6 15.9 3.2 11.9 10.1 3.0 5.2 3.5 4.5 2.6 0.0 0.0 0.0 0.1 3.8 63.5 3.1 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.1 5.8 3.8 0.0 0.0 0.0 0.2 13.8 0.3 0.0 17.3 0.5 3.2 0.0 6.7 0.0 0.9 16.1 0.0 13.5 0.0 0.0 1.6 0.3 0.0 7.8 0.0 22.9 90.5 30.6 0.2 0.1 6.1 0.1 0.0 0.0 0.3 COL6A5 "COL29A1, FLJ35880, VWA4" ENSG00000172752 "Collagen type VI alpha 5 chain" 3 130345516-130484844 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lung: 9.6;skin 1: 11.1" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 3.1;Club cells: 1.2;Early spermatids: 4.1;Late spermatids: 2.4;Suprabasal keratinocytes: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 63 "HDLM-2: 18.8" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected" "Not detected" HPA043138 Uncertain "Secreted in other tissues" NA NA "HPA043138: AB_10796687" "unprognostic (3.45e-2)" "unprognostic (4.08e-2)" "unprognostic (6.01e-3)" "unprognostic (2.32e-1)" "unprognostic (3.42e-2)" "unprognostic (1.46e-6)" "unprognostic (8.44e-2)" "unprognostic (2.07e-3)" "unprognostic (2.47e-1)" "unprognostic (1.71e-1)" "unprognostic (7.58e-8)" "unprognostic (3.85e-2)" "unprognostic (4.51e-1)" "unprognostic (1.54e-1)" "unprognostic (2.79e-2)" 0.2 0.0 0.2 0.2 0.5 0.1 1.0 0.2 0.2 0.2 0.4 0.2 0.2 1.5 0.2 0.2 2.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 9.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 11.1 1.8 0.2 0.2 0.2 1.5 1.1 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.0 0.0 0.0 0.0 0.0 COL6A6 ENSG00000206384 "Collagen type VI alpha 6 chain" A6NMZ7 3 130560334-130678155 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7" "Cell type enriched" "Detected in some" 4 "Fibroblasts: 7.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SuSa: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA045239 Uncertain "Secreted to extracellular matrix" NA NA 490000 "HPA045239: AB_2679268" "unprognostic (4.86e-3)" "unprognostic (2.16e-2)" "unprognostic (9.91e-2)" "unprognostic (2.08e-4)" "unprognostic (2.79e-1)" "unprognostic (1.11e-5)" "unprognostic (3.74e-3)" "unprognostic (5.59e-2)" "unprognostic (1.42e-1)" "unprognostic (3.50e-2)" "unprognostic (8.90e-2)" "unprognostic (2.70e-1)" "unprognostic (2.96e-4)" "unprognostic (5.82e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (1.07e-1)" 2.3 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.7 0.3 1.2 0.3 0.0 5.6 0.0 0.0 0.0 0.9 11.1 0.0 0.0 0.2 0.0 0.0 5.7 0.8 0.0 0.0 2.2 0.0 0.0 0.4 0.0 0.5 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 5.5 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.8 1.2 1.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.4 0.6 0.1 0.0 0.0 0.0 COL7A1 "EBD1, EBDCT, EBR1" ENSG00000114270 "Collagen type VII alpha 1 chain" Q02388 3 48564073-48595267 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 59.2" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 22.7;Basal keratinocytes: 64.5;Suprabasal keratinocytes: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "basophil: 1.9" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ: 20.8;HaCaT: 20.0;HBEC3-KT: 31.9;HDLM-2: 30.1;HeLa: 39.2;SiHa: 26.2" "Region enhanced" "Detected in single" "cerebellum: 0.7" "Not detected" "Not detected" "CAB016357, HPA018877, HPA042420" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum" Vesicles "CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990" "unprognostic (2.69e-2)" "unprognostic (4.11e-1)" "unprognostic (1.35e-1)" "unprognostic (3.47e-1)" "unprognostic (4.93e-2)" "prognostic favorable (6.31e-4)" "unprognostic (7.56e-2)" "unprognostic (1.25e-2)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.74e-2)" "unprognostic (0.00e+0)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (3.86e-2)" 1.3 1.0 0.6 2.6 3.3 0.4 2.5 8.2 3.6 11.7 1.3 0.8 5.2 1.4 8.0 11.9 11.3 2.5 4.5 1.6 2.3 4.4 3.4 1.2 0.9 1.0 1.5 1.0 1.8 0.5 0.4 1.1 2.2 4.8 17.1 0.9 2.6 7.3 10.8 2.3 59.2 1.8 2.9 3.2 4.3 1.2 1.6 0.7 0.5 0.4 13.5 4.8 3.3 14.2 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 8.0 0.3 0.1 3.0 4.1 10.0 20.8 13.1 5.5 3.3 0.1 0.1 0.0 0.6 4.7 5.0 20.0 0.0 31.9 1.0 30.1 0.1 0.0 39.2 1.3 8.4 0.0 0.1 6.6 19.1 11.1 8.7 7.5 0.0 0.2 0.1 0.2 0.6 0.1 0.0 0.2 1.0 0.4 0.4 0.1 0.7 0.0 3.0 0.0 0.0 0.0 26.2 0.0 0.2 1.2 0.4 0.1 0.0 1.8 1.0 1.0 15.5 0.6 0.5 0.0 16.0 0.1 0.9 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 8.2 3.6 2.3 4.4 1.5 1.0 4.8 0.7 0.0 0.0 0.5 22.7 64.5 15.5 5.3 0.0 0.0 13.6 10.4 9.8 1.0 0.0 0.6 11.6 0.8 0.2 0.0 0.6 0.8 2.6 2.0 0.0 0.4 1.5 7.9 1.7 0.0 0.3 3.8 4.6 0.7 8.5 0.0 0.2 2.3 9.3 0.0 5.3 0.0 11.7 0.0 8.5 2.8 0.9 21.1 1.0 0.0 0.0 4.6 COL8A1 "C3orf7, MGC9568" ENSG00000144810 "Collagen type VIII alpha 1 chain" P27658 3 99638475-99799226 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 56.0" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 229.3;Ito cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.3;fHDF/TERT166: 149.2;hTERT-RPE1: 63.4;LHCN-M2: 43.8;TIME: 64.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA053107 Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA053107: AB_2682046" "unprognostic (3.13e-2)" "unprognostic (2.92e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-3)" "unprognostic (2.49e-1)" "unprognostic (2.31e-2)" "unprognostic (4.83e-2)" "unprognostic (2.62e-2)" "unprognostic (4.79e-2)" "unprognostic (3.58e-2)" "unprognostic (3.71e-1)" "prognostic unfavorable (9.39e-8)" "unprognostic (2.98e-3)" "unprognostic (1.72e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-3)" 20.5 4.7 1.0 6.1 3.0 0.1 7.5 2.4 0.9 5.8 16.9 1.8 11.8 0.6 5.9 16.8 15.3 6.4 6.8 26.7 1.2 1.4 9.4 1.9 36.5 0.5 1.8 2.1 7.7 0.9 32.3 9.4 5.5 2.9 13.1 4.8 38.7 5.2 8.8 5.0 2.3 2.7 18.8 3.0 0.9 4.2 6.4 0.6 0.0 56.0 6.4 0.8 21.3 12.1 0.4 0.1 0.9 0.2 0.3 0.4 0.1 0.0 0.0 0.4 0.0 22.0 36.3 0.0 8.9 5.8 9.0 18.1 0.0 0.0 0.0 0.8 149.2 0.2 0.0 0.0 11.6 23.4 0.0 0.0 0.0 1.2 0.0 4.0 0.0 0.0 20.7 0.4 7.0 11.8 63.4 17.4 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 64.9 4.2 3.3 0.2 4.7 0.0 0.0 0.0 8.2 0.0 32.0 0.9 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.4 0.4 0.7 0.3 0.1 0.1 0.1 0.1 1.0 3.0 2.4 0.9 1.2 1.4 1.8 2.1 2.9 0.6 229.3 23.2 0.0 0.4 0.7 0.4 4.2 0.0 1.4 6.8 8.7 0.0 0.1 0.0 0.2 0.7 1.5 0.0 0.0 0.0 0.2 2.4 0.1 4.7 0.8 0.1 0.0 0.0 85.3 1.9 0.4 2.0 0.9 1.7 0.0 0.0 0.5 0.1 0.0 8.9 0.8 0.5 0.0 8.3 0.3 0.2 0.5 0.3 1.0 0.0 0.2 COL8A2 "FECD, FECD1, PPCD, PPCD2" ENSG00000171812 "Collagen type VIII alpha 2 chain" P25067 1 36095236-36125220 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.4" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 9.8;Fibroblasts: 13.4;Hofbauer cells: 6.5;Melanocytes: 6.8;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 15 "dendritic cells: 2.8;monocytes: 1.2" "Cell line enhanced" "Detected in some" "BJ: 5.6;fHDF/TERT166: 4.1;HHSteC: 14.2;hTERT-RPE1: 18.1;THP-1: 4.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA049788 Uncertain Uncertain "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA049788: AB_2680882" "unprognostic (9.98e-2)" "unprognostic (3.26e-2)" "unprognostic (2.51e-2)" "unprognostic (8.41e-3)" "unprognostic (8.76e-2)" "prognostic favorable (9.44e-4)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (3.50e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.35e-5)" "unprognostic (1.08e-2)" "unprognostic (6.77e-2)" "unprognostic (2.24e-2)" "unprognostic (1.16e-3)" 4.4 1.2 1.7 8.1 3.4 0.3 7.2 6.0 1.3 9.6 4.8 4.5 1.0 1.4 5.2 3.1 6.4 3.4 6.3 11.1 1.7 1.4 1.1 0.4 4.8 2.9 3.8 0.9 4.2 1.8 0.1 3.7 13.7 7.6 5.5 2.1 39.4 6.5 13.4 1.4 4.6 1.8 16.3 4.8 7.5 9.6 1.9 2.5 1.9 7.7 4.7 3.5 10.1 5.5 0.0 2.8 0.1 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 1.0 0.1 5.6 1.6 1.5 0.9 0.2 0.1 0.0 0.8 4.1 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.1 14.2 0.0 0.0 1.7 0.1 0.7 0.0 18.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.5 0.5 0.0 0.2 0.4 0.0 4.5 0.1 2.3 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 0.2 2.4 0.0 0.2 1.7 3.4 6.0 1.3 1.7 1.4 3.8 0.9 7.6 2.5 0.0 2.6 0.0 1.6 1.9 0.0 9.8 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.2 13.4 0.7 2.3 0.0 6.5 0.0 0.0 0.6 1.9 0.0 2.8 5.1 6.8 0.0 0.0 0.3 0.4 0.0 5.6 0.0 0.0 6.5 2.3 0.0 0.1 1.1 0.7 0.0 0.0 0.4 COL9A1 ENSG00000112280 "Collagen type IX alpha 1 chain" P20849 6 70215061-70303083 "Disease related genes, Predicted secreted proteins" "Deafness, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 29.6;retina: 52.6" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 18.1;Horizontal cells: 33.4;Muller glia cells: 88.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 23.7;NTERA-2: 8.0" "Not detected" "Not detected" HPA074749 Enhanced "Secreted to extracellular matrix" NA NA "HPA074749: AB_2732266" "unprognostic (2.18e-2)" "unprognostic (2.16e-1)" "unprognostic (2.25e-2)" "unprognostic (3.48e-3)" "unprognostic (5.72e-2)" "unprognostic (5.32e-4)" "unprognostic (3.24e-3)" "unprognostic (8.79e-2)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "unprognostic (1.54e-1)" "unprognostic (2.09e-1)" "unprognostic (2.78e-1)" "unprognostic (3.62e-2)" 0.7 0.6 8.5 0.7 7.5 0.5 0.6 3.6 4.7 0.6 1.1 7.2 0.0 1.8 1.1 0.8 0.8 0.7 1.1 5.6 8.4 9.4 1.1 0.5 0.6 0.6 10.3 1.7 0.6 0.5 0.9 3.3 0.6 5.6 29.6 1.4 52.6 3.0 1.1 0.6 0.6 2.0 0.9 5.3 0.6 2.6 4.1 6.9 0.0 1.0 0.2 0.7 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 7.5 3.6 4.7 8.4 9.4 10.3 1.7 5.6 6.9 0.0 0.0 0.0 0.1 0.0 0.2 3.5 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 18.1 0.0 0.2 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.1 33.4 1.2 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.4 88.9 0.0 0.0 0.4 0.0 1.8 0.0 1.4 0.6 0.7 0.0 0.0 0.0 1.1 0.1 COL9A2 "EDM2, MED" ENSG00000049089 "Collagen type IX alpha 2 chain" Q14055 1 40300487-40317813 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Dwarfism, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.3;pituitary gland: 32.1;retina: 40.8" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 280.3" "Cancer enhanced" "Detected in all" "prostate cancer: 68.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 6.4;myeloid DC: 2.7" "Group enriched" "Detected in many" 6 "dendritic cells: 2.7;granulocytes: 6.4" "Cell line enhanced" "Detected in some" "HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3" "Low region specificity" "Detected in all" "HPA056316, HPA075286" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA Vesicles Nucleoplasm "HPA056316: AB_2683099, HPA075286: AB_2732288" "unprognostic (1.42e-2)" "unprognostic (3.54e-2)" "unprognostic (8.94e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.46e-2)" "unprognostic (1.83e-3)" "unprognostic (2.06e-2)" "unprognostic (9.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.56e-3)" "unprognostic (2.26e-1)" "unprognostic (1.16e-3)" "unprognostic (4.28e-2)" "unprognostic (2.56e-1)" "unprognostic (5.89e-2)" "unprognostic (1.71e-2)" 0.7 2.3 17.2 2.6 19.5 7.6 3.1 2.3 12.1 10.0 3.6 32.0 17.4 4.6 3.9 1.5 0.7 3.7 6.5 1.0 20.8 14.5 4.3 0.6 2.8 4.2 29.8 10.5 0.6 1.7 28.3 32.1 0.9 16.3 8.8 2.6 40.8 13.7 21.3 0.3 2.0 3.3 1.3 35.3 3.2 12.8 0.8 19.7 0.2 4.3 0.9 2.5 4.0 0.5 0.7 2.7 6.4 0.7 0.4 0.3 0.1 4.3 0.1 0.7 0.3 1.0 0.5 2.9 0.0 0.0 0.2 0.5 0.1 2.5 1.2 3.8 0.1 0.0 0.7 0.0 0.0 0.1 35.4 0.5 0.7 0.3 9.9 0.6 0.3 34.1 1.8 0.0 0.0 0.0 0.2 0.0 0.5 0.0 7.4 0.0 0.9 0.4 0.7 0.8 0.0 0.4 0.8 0.0 2.4 0.0 5.2 0.5 0.8 0.0 4.4 0.4 2.6 5.6 38.3 0.0 0.0 4.5 0.0 0.1 0.5 0.0 1.2 0.3 4.5 0.2 0.0 0.2 6.4 0.0 0.5 0.0 0.5 0.2 0.0 2.7 0.7 0.1 0.0 1.1 0.4 0.7 0.3 0.3 0.1 17.2 19.5 2.3 10.8 20.8 14.5 29.8 10.5 16.3 19.7 0.0 3.5 4.5 2.6 0.9 1.8 0.8 7.6 1.4 3.4 24.4 0.0 2.3 0.0 6.3 0.0 0.0 3.3 0.0 0.7 0.4 1.4 7.8 26.4 0.0 3.3 0.0 12.2 1.3 0.3 0.8 2.0 6.5 1.7 30.7 5.5 280.3 3.6 7.0 0.0 0.1 7.8 0.0 0.9 2.6 2.6 0.5 1.1 2.2 12.2 11.1 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 37.2;salivary gland: 38.9;thyroid gland: 18.1" "Group enriched" "Detected in many" 5 "Early spermatids: 120.8;Late spermatids: 311.3;Muller glia cells: 91.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 53.7;Hep G2: 21.2;SK-MEL-30: 17.6;WM-115: 21.3" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" NA NA Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: AB_2683679" "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 2.2 2.0 11.2 2.3 16.3 1.2 1.5 1.5 8.9 1.7 3.4 26.4 1.6 2.3 1.8 1.5 1.6 1.2 1.4 2.1 14.9 9.8 1.4 1.3 1.3 1.4 18.4 8.1 1.6 5.4 1.1 5.3 1.9 12.4 1.7 1.3 37.2 38.9 3.4 1.5 1.8 2.5 1.4 25.0 1.2 1.8 6.4 15.2 0.0 18.1 1.4 1.2 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.3 53.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.5 21.2 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 2.4 2.9 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 17.6 1.8 0.1 1.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 16.3 1.5 8.0 14.9 9.8 18.4 8.1 12.4 15.2 3.0 0.0 13.7 1.7 2.9 1.0 1.2 0.0 0.0 0.0 5.2 9.8 4.0 1.7 1.3 120.8 3.1 0.9 0.0 0.0 35.4 10.4 0.9 0.0 2.4 2.1 0.0 4.1 3.1 2.7 311.3 3.7 1.3 3.3 0.0 2.6 91.3 0.1 6.2 1.4 9.5 2.5 0.0 1.1 2.5 4.1 6.0 3.3 0.0 1.5 0.8 COLEC10 CL-L1 ENSG00000184374 "Collectin subfamily member 10" Q9Y6Z7 8 118995452-119106582 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 47.4" "Cell type enriched" "Detected in single" 42 "Ito cells: 16.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.4;HHSteC: 3.5;SK-BR-3: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 5700000 "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (3.79e-4)" "unprognostic (6.25e-3)" "unprognostic (1.80e-3)" "unprognostic (7.73e-2)" "prognostic favorable (5.79e-4)" "unprognostic (1.05e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.25e-2)" "unprognostic (9.02e-5)" "unprognostic (2.47e-1)" "unprognostic (1.82e-1)" "unprognostic (5.85e-5)" "unprognostic (7.12e-2)" 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.1 0.1 0.3 47.4 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.5 0.1 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.7 8.4 0.1 0.1 0.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 15.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 COLEC11 "CL-K1, MGC3279" ENSG00000118004 "Collectin subfamily member 11" Q9BWP8 2 3594832-3644644 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.9;liver: 57.4" "Group enriched" "Detected in many" 6 "Ito cells: 128.3;Peritubular cells: 49.1;Proximal tubular cells: 111.2;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HHSteC: 53.7;SH-SY5Y: 48.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035241 Uncertain "Secreted to blood" NA NA 30000000 "HPA035241: AB_10600701" "unprognostic (3.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" "unprognostic (1.53e-2)" "unprognostic (1.40e-2)" "unprognostic (7.95e-3)" "unprognostic (5.85e-3)" "unprognostic (6.96e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-1)" "unprognostic (6.96e-2)" "unprognostic (2.26e-1)" "unprognostic (9.27e-3)" "unprognostic (7.54e-2)" "unprognostic (1.46e-1)" "unprognostic (1.60e-1)" 3.7 13.2 0.5 0.5 1.2 0.6 1.7 0.7 1.4 0.5 1.7 1.3 0.8 1.7 0.7 1.0 1.2 1.4 61.9 14.8 0.9 0.1 7.9 57.4 0.9 1.8 0.6 0.5 15.8 6.5 0.2 2.0 2.8 3.6 1.6 0.1 1.0 0.8 0.5 1.0 0.4 3.0 1.6 0.7 1.4 0.7 2.5 0.5 0.7 5.5 0.6 0.5 1.8 1.5 1.2 0.8 4.0 0.8 1.2 1.8 0.2 0.0 0.4 0.2 0.8 0.0 0.0 4.5 0.2 0.0 0.1 0.0 0.3 0.0 0.1 1.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.4 1.5 53.7 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.2 3.8 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.6 48.5 0.5 0.3 0.2 0.1 0.1 0.3 0.0 0.0 0.2 0.2 0.1 1.0 7.8 0.4 0.1 0.4 0.2 1.9 0.8 1.2 0.6 0.2 0.5 0.6 0.3 0.3 0.3 1.2 1.8 1.0 4.0 1.2 0.4 0.8 0.3 0.2 0.5 1.2 0.7 1.4 0.9 0.1 0.6 0.5 3.6 0.5 0.0 0.0 0.5 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 14.9 0.0 0.3 1.8 0.0 0.0 0.0 0.9 12.4 0.1 0.0 6.8 2.3 0.0 0.0 128.3 3.5 0.4 6.9 0.0 3.3 0.0 0.0 0.3 0.1 0.0 49.1 111.2 0.0 71.1 4.0 0.4 11.1 0.6 1.0 0.0 0.0 0.0 COLEC12 "CL-P1, SCARA4, SRCL" ENSG00000158270 "Collectin subfamily member 12" Q5KU26 18 316740-500722 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 40.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 109.4;Cytotrophoblasts: 115.8;Hofbauer cells: 118.9;Syncytiotrophoblasts: 93.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.7;BJ: 8.6;HSkMC: 14.6;U-2197: 22.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047917, HPA071056" Enhanced Approved "Golgi apparatus,Vesicles,Cell Junctions" NA NA 550000 "Golgi apparatus, Vesicles" "Cell Junctions" "HPA047917: AB_2680208, HPA071056: AB_2686338" "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (3.60e-2)" "unprognostic (6.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.14e-4)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "unprognostic (4.86e-2)" "unprognostic (1.32e-2)" "unprognostic (1.53e-1)" "unprognostic (2.61e-1)" "unprognostic (2.24e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.01e-3)" 14.2 3.7 6.9 4.6 9.7 1.2 9.4 3.5 6.4 40.8 8.0 7.7 5.1 3.4 13.1 9.9 7.5 6.6 8.1 13.5 7.0 6.3 2.7 1.4 18.7 13.9 8.1 5.8 6.8 2.4 1.5 1.5 32.0 10.5 9.6 5.0 23.5 4.8 3.5 6.3 4.4 5.0 14.3 5.2 1.2 5.0 5.0 4.7 0.7 7.6 3.8 4.9 15.0 7.3 0.9 0.9 3.3 0.8 0.7 0.5 0.3 0.0 0.0 1.5 0.0 1.7 17.7 0.6 8.6 3.0 1.2 2.2 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.8 0.0 0.5 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.1 2.2 0.3 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.8 0.4 0.5 0.3 0.3 0.5 0.5 0.4 0.2 0.9 0.4 0.4 3.3 0.7 0.5 0.9 0.3 0.3 6.9 9.7 3.5 6.4 7.0 6.3 8.1 5.8 10.5 4.7 3.0 109.4 0.0 2.9 3.7 6.1 3.6 0.0 2.7 19.4 3.5 9.8 115.8 0.0 0.1 7.2 3.1 0.0 0.0 0.0 4.3 47.7 8.6 12.8 0.2 118.9 6.4 15.1 1.8 4.1 16.7 57.0 17.9 1.7 27.1 0.2 63.6 0.3 0.0 6.7 0.0 10.8 0.0 1.9 1.1 1.2 3.3 93.0 1.3 0.7 1.6 COLGALT2 "C1orf17, GLT25D2, KIAA0584" ENSG00000198756 "Collagen beta(1-O)galactosyltransferase 2" Q8IYK4 1 183929854-184037729 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 38.2;Late spermatids: 52.3;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "glioma: 11.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "basophil: 8.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 8.1" "Cell line enhanced" "Detected in many" "Hep G2: 12.7;OE19: 10.2;SK-MEL-30: 13.7;U-251 MG: 13.1;WM-115: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031749, HPA031750" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "HPA031749: AB_10599298, HPA031750: AB_10611252" "unprognostic (5.44e-3)" "unprognostic (3.08e-1)" "unprognostic (6.29e-5)" "unprognostic (2.08e-1)" "unprognostic (4.41e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-1)" "unprognostic (2.00e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (5.13e-9)" "unprognostic (1.53e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (3.80e-2)" 2.1 9.4 10.8 1.7 16.6 1.9 2.8 10.6 39.0 2.0 3.0 31.3 0.0 1.4 3.0 5.2 1.7 3.5 3.7 11.7 15.3 7.9 1.8 1.0 4.5 1.1 20.2 12.9 2.3 3.5 1.0 1.9 0.8 17.4 8.1 2.0 3.5 4.4 3.7 11.0 1.1 1.4 3.0 21.8 1.3 3.4 5.0 22.5 0.0 5.1 1.8 1.5 2.4 1.4 0.0 0.0 8.1 0.0 0.7 0.6 0.1 0.1 0.0 4.4 0.2 2.3 3.4 0.1 1.2 0.5 0.6 0.7 2.1 0.2 0.0 0.3 3.3 0.8 0.0 4.2 0.0 1.1 4.6 2.3 0.3 0.0 12.7 0.1 4.1 0.0 2.0 0.0 0.6 0.1 6.4 0.0 0.1 4.1 5.4 4.6 0.1 0.2 0.2 3.0 10.2 0.0 0.4 0.0 0.0 0.0 0.9 1.7 2.7 0.2 0.0 13.7 2.9 0.0 0.2 0.0 0.5 0.4 0.0 13.1 8.0 0.0 0.0 0.4 2.0 16.9 8.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 10.8 16.6 10.6 17.2 15.3 7.9 20.2 12.9 17.4 22.5 0.0 0.0 0.0 0.4 0.3 0.8 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 38.2 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 52.3 2.0 1.5 1.7 0.0 0.0 4.8 1.0 0.0 3.9 0.2 0.2 12.9 0.5 0.3 0.4 0.4 0.0 3.5 0.0 0.3 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.8;lymphoid tissue: 19.6" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 11.4" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 31.8" "Lineage enriched" "Detected in single" 35 "T-cells: 31.8" "Group enriched" "Detected in some" 5 "BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA "Plasma membrane" "Cell Junctions" "HPA045876: AB_2679479" "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.7 0.7 0.9 0.7 1.1 1.3 0.9 11.4 2.1 2.4 2.3 0.4 0.2 0.8 3.2 2.7 1.3 8.8 1.8 15.9 1.5 1.2 0.5 0.9 2.1 19.6 0.9 1.1 2.3 0.6 10.0 1.1 0.5 2.1 2.0 0.5 2.0 1.1 1.4 14.3 0.9 1.4 1.1 1.5 3.8 1.5 2.0 0.4 3.8 1.0 0.6 3.3 1.3 1.4 0.0 0.2 0.0 0.4 0.9 31.8 1.7 0.1 0.5 2.0 1.2 1.5 1.0 17.3 0.3 0.5 0.4 0.6 0.0 0.3 0.1 0.7 0.3 0.1 0.2 0.3 0.4 0.5 5.6 1.2 0.6 0.7 0.2 0.2 0.4 1.2 0.8 0.4 0.8 0.3 0.8 0.3 1.5 0.0 0.6 0.8 0.3 0.6 1.8 0.2 0.0 0.6 0.8 0.2 0.4 0.4 0.4 0.6 1.8 0.2 0.1 0.4 1.9 1.2 0.8 0.1 0.2 1.1 1.9 0.6 1.7 1.5 0.1 0.1 8.7 0.1 0.0 0.4 0.0 5.5 0.0 31.8 0.0 2.7 3.9 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.2 0.1 1.7 0.9 1.1 11.4 2.1 1.5 1.2 0.9 1.1 2.1 0.4 0.0 1.1 0.0 0.1 0.2 0.3 0.7 0.0 6.7 2.3 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.8 0.2 6.4 1.2 2.5 0.0 11.3 1.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 4.2 0.0 0.6 0.0 0.2 0.7 0.2 0.1 1.9 1.3 0.0 0.0 COMP "EDM1, EPD1, MED, PSACH, THBS5" ENSG00000105664 "Cartilage oligomeric matrix protein" P49747 19 18782773-18791314 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cell adhesion" Heparin-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 39.1;skeletal muscle: 59.6" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 32.0;Fibroblasts: 20.3;Late spermatids: 53.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 138.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA077555 Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 1100000000 "Golgi apparatus" "HPA077555: " "unprognostic (1.26e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (9.08e-5)" "prognostic unfavorable (2.04e-4)" "unprognostic (8.05e-2)" "unprognostic (8.45e-2)" "unprognostic (3.62e-2)" "unprognostic (5.12e-2)" "unprognostic (1.65e-1)" "unprognostic (1.55e-2)" "unprognostic (2.18e-2)" "unprognostic (3.85e-1)" "prognostic unfavorable (1.52e-6)" "unprognostic (5.96e-3)" "unprognostic (1.44e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (6.95e-4)" 39.1 0.2 0.0 1.0 0.0 0.0 4.1 1.8 0.2 2.7 2.0 0.1 2.5 0.0 3.0 24.2 4.7 0.4 16.2 21.6 0.2 0.0 4.5 0.4 2.9 2.7 0.0 0.6 0.9 3.3 0.1 0.1 8.2 0.2 8.7 0.0 0.1 6.0 7.4 59.6 31.8 0.3 13.0 0.2 0.1 0.9 11.5 0.0 0.3 8.9 27.6 0.9 10.8 11.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 138.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.2 0.0 0.0 0.6 0.2 0.0 3.0 0.3 0.0 0.5 10.2 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 32.0 0.7 0.0 0.0 0.2 0.2 20.3 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 53.4 0.9 0.0 10.1 0.0 0.0 1.8 0.1 0.0 0.7 0.0 0.3 6.5 6.4 3.1 1.5 6.1 0.5 0.0 0.0 0.3 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941607-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 139.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 779.9;Syncytiotrophoblasts: 542.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 118.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" NA NA 560000 Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favorable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favorable (5.67e-4)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 18.6 49.0 29.4 14.3 28.8 24.3 27.8 19.6 32.9 22.4 23.4 42.4 36.1 21.0 19.8 33.8 58.1 19.4 36.8 28.1 28.9 22.3 31.1 139.3 30.9 17.0 29.0 18.4 36.3 27.2 14.1 12.7 59.0 23.3 25.7 8.9 24.9 67.3 30.9 21.5 27.7 28.6 15.5 41.0 17.8 24.8 18.2 23.7 11.5 19.2 44.0 32.0 36.3 28.0 11.2 55.1 10.9 60.0 12.9 15.6 28.0 19.1 19.7 2.3 19.5 22.2 19.8 0.8 21.8 27.4 18.7 21.4 16.7 22.4 7.7 9.7 31.1 7.4 26.3 3.7 23.3 5.0 16.7 24.9 13.8 10.5 39.0 41.5 23.0 5.5 25.2 28.9 16.2 16.1 18.0 17.5 12.5 55.7 16.5 15.0 118.8 9.0 41.3 4.8 52.7 6.7 13.6 19.5 10.6 19.7 60.8 9.5 8.4 7.2 61.7 18.0 1.3 13.3 64.7 20.9 33.4 12.8 10.9 16.3 6.1 2.6 6.3 36.0 31.0 23.0 10.2 60.0 10.9 15.6 39.9 12.8 11.2 10.8 12.6 47.7 10.7 9.6 10.6 2.4 12.9 26.6 55.1 13.3 28.0 29.4 28.8 19.6 32.9 28.9 22.3 29.0 18.4 23.3 23.7 116.1 64.8 45.5 189.7 90.7 68.3 29.9 109.5 88.3 85.3 144.8 9.8 779.9 271.9 173.4 3.6 68.7 98.5 0.0 167.1 75.3 99.4 123.4 70.4 231.9 281.1 23.8 81.1 74.9 149.0 7.4 124.3 142.1 227.7 154.1 89.3 151.7 163.3 110.1 169.0 60.7 34.5 135.8 91.5 4.4 5.3 107.9 542.4 36.6 110.1 180.5 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233969-75236030 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 57.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 363.3;Exocrine glandular cells: 216.7;Paneth cells: 207.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 14.9;HEK 293: 22.9;PC-3: 31.9;RPMI-8226: 17.8;U-266/70: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 2.5 5.2 1.3 5.8 1.4 2.9 5.7 3.6 2.2 4.8 14.1 0.5 9.7 17.9 2.0 5.9 20.0 1.6 6.4 8.0 1.2 1.6 12.6 14.9 4.4 4.1 1.9 1.7 2.2 57.2 3.2 5.3 7.8 2.2 3.1 2.1 3.2 21.2 9.1 19.6 7.3 22.9 1.9 1.0 3.4 16.1 1.5 0.6 2.7 7.0 14.4 6.0 2.4 7.5 6.6 15.7 3.8 9.3 7.3 12.5 7.1 4.9 0.9 0.2 0.9 0.2 0.4 14.9 1.4 0.4 0.1 0.3 1.2 4.4 14.0 2.8 0.3 0.7 7.1 0.4 1.2 0.0 2.1 22.9 0.5 1.3 2.4 0.7 2.7 2.4 0.3 1.9 0.0 1.2 0.3 0.0 1.8 5.6 2.7 0.0 3.3 3.9 8.3 0.7 3.9 31.9 7.3 0.7 17.8 1.0 0.2 5.4 1.3 1.5 11.5 3.0 0.1 6.7 0.3 1.2 0.3 4.3 0.5 1.6 15.3 3.2 6.8 0.3 2.3 0.3 0.0 8.9 3.8 12.1 9.3 12.5 6.6 11.7 12.2 10.1 4.7 3.8 6.7 1.8 7.3 8.9 15.7 9.0 7.1 1.3 1.4 3.6 1.7 1.2 1.6 1.9 1.7 2.2 0.6 17.9 14.4 22.9 33.2 26.2 5.2 26.2 48.4 2.7 4.5 50.6 9.8 24.6 122.7 126.7 1.3 10.8 363.3 0.0 216.7 64.2 12.7 34.1 12.7 75.5 32.8 1.6 38.7 19.0 24.7 2.2 8.9 19.4 35.4 37.9 104.6 5.8 134.6 207.0 6.7 96.3 26.7 32.3 19.1 2.1 2.3 33.4 25.4 25.5 104.0 43.9 COQ10A FLJ32452 ENSG00000135469 "Coenzyme Q10A" Q96MF6 12 56266858-56270966 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 43.5;skeletal muscle: 103.7;tongue: 46.1" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068931 Approved "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Golgi apparatus" "HPA068931: AB_2686061" "unprognostic (4.55e-2)" "unprognostic (4.88e-3)" "prognostic unfavorable (5.46e-4)" "unprognostic (8.99e-3)" "unprognostic (2.77e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-1)" "unprognostic (2.86e-3)" "unprognostic (6.09e-2)" "unprognostic (8.57e-2)" "prognostic favorable (2.06e-4)" "unprognostic (5.03e-2)" "prognostic favorable (3.44e-4)" "unprognostic (1.67e-1)" "unprognostic (8.07e-2)" "unprognostic (7.20e-2)" "unprognostic (1.15e-1)" 2.9 12.4 5.0 2.3 6.8 2.2 3.1 7.6 7.3 3.7 2.9 4.8 5.9 1.9 3.6 7.7 4.3 5.2 3.2 43.5 4.5 5.4 7.2 12.8 3.5 3.4 5.6 3.9 4.5 5.5 6.0 9.9 1.7 4.8 4.1 2.7 14.0 6.5 5.6 103.7 2.2 2.9 3.7 3.6 3.8 2.6 2.4 3.0 4.9 5.4 46.1 6.2 2.7 3.3 11.7 6.8 8.0 1.1 5.0 8.6 3.6 2.5 10.3 10.0 6.5 5.7 5.8 4.2 3.6 8.6 12.7 12.7 8.0 3.8 14.7 8.2 9.0 3.6 2.4 11.5 2.0 7.6 2.3 12.8 6.8 9.4 8.3 7.8 5.4 4.2 6.0 3.4 9.4 3.7 8.0 6.6 10.4 4.5 6.1 11.8 3.3 7.7 19.3 8.5 1.8 6.0 16.6 10.9 9.7 7.0 1.5 14.5 15.6 12.3 2.6 3.8 7.7 4.0 6.0 4.7 2.4 7.1 6.7 3.6 12.8 13.7 7.2 7.1 5.1 1.8 8.0 1.0 0.9 7.7 1.1 7.9 11.7 7.1 8.2 1.7 6.7 8.6 8.4 0.4 5.0 0.8 6.8 4.6 3.6 5.0 6.8 7.6 7.3 4.5 5.4 5.6 3.9 4.8 3.0 3.0 7.4 6.1 12.1 11.8 17.4 115.4 7.6 12.0 4.5 10.4 15.7 5.0 44.7 2.4 0.1 9.6 2.1 0.0 4.0 5.9 8.0 4.7 4.6 14.0 4.4 30.2 15.5 2.5 1.6 1.4 7.8 2.5 11.8 1.8 2.8 21.7 2.5 3.4 15.9 11.0 30.0 38.8 18.9 1.7 17.7 9.3 2.5 13.4 4.5 4.3 COQ8A "ADCK3, CABC1, COQ8, SCAR9" ENSG00000163050 "Coenzyme Q8A" Q8NI60 1 226897536-226987545 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Kinase, Transferase" "Disease mutation, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 216.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 18.7;Collecting duct cells: 31.4;Exocrine glandular cells: 28.2;monocytes: 19.8;Proximal tubular cells: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 32.8;RPMI-8226: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061662 Supported Mitochondria NA NA Mitochondria "HPA061662: AB_2684578" "unprognostic (6.37e-3)" "unprognostic (2.09e-2)" "unprognostic (2.29e-1)" "unprognostic (9.06e-2)" "unprognostic (8.94e-2)" "unprognostic (2.49e-1)" "unprognostic (4.42e-2)" "unprognostic (3.50e-3)" "unprognostic (1.81e-1)" "unprognostic (4.02e-1)" "unprognostic (4.15e-3)" "unprognostic (8.67e-2)" "unprognostic (2.40e-2)" "unprognostic (9.24e-2)" "unprognostic (2.82e-1)" "unprognostic (8.88e-2)" "unprognostic (2.62e-1)" 13.3 25.4 2.8 2.7 4.5 5.3 8.5 14.5 3.9 3.2 7.3 4.1 4.2 6.9 3.6 5.5 7.3 5.0 6.1 41.0 2.7 1.8 3.8 17.7 2.7 4.1 5.0 2.4 7.2 20.3 1.6 1.6 2.0 3.8 6.5 2.0 1.9 7.2 5.0 216.5 4.4 4.4 7.8 2.9 3.5 8.8 3.0 4.7 2.7 4.6 50.2 5.8 10.2 3.5 15.2 9.3 32.3 11.5 9.9 11.8 11.6 3.1 5.8 1.5 4.4 4.7 3.0 23.4 1.5 1.3 2.1 2.8 9.1 5.1 9.4 7.2 1.0 1.2 3.7 2.9 3.3 0.5 9.9 32.8 6.6 4.8 15.0 1.0 9.9 4.0 5.9 5.0 1.7 2.3 2.1 1.0 9.7 11.3 7.8 0.3 4.3 5.7 14.6 6.4 24.3 11.9 5.7 7.0 29.9 0.7 2.4 24.1 9.9 2.9 11.7 8.5 1.7 6.2 13.5 1.2 2.5 2.3 3.4 5.4 17.5 15.3 4.9 2.3 11.3 2.4 19.7 11.5 32.3 8.7 8.6 8.3 12.1 8.5 7.7 9.3 15.2 11.8 9.0 21.9 9.9 6.5 4.1 10.6 11.6 2.8 4.5 14.5 3.9 2.7 1.8 5.0 2.4 3.8 4.7 3.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 7.9 31.4 0.0 10.4 13.3 14.2 0.0 0.0 0.0 0.0 28.2 7.8 0.0 0.0 12.8 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 19.8 0.0 0.0 14.5 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 COQ9 "C16orf49, DKFZP434K046" ENSG00000088682 "Coenzyme Q9" O75208 16 57447425-57461275 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 86.0" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 184.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040918 Supported Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA040918: AB_10794154" "unprognostic (9.18e-2)" "unprognostic (3.60e-2)" "unprognostic (2.34e-2)" "unprognostic (1.29e-2)" "unprognostic (2.14e-3)" "unprognostic (2.57e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-1)" "unprognostic (2.59e-1)" "unprognostic (9.78e-2)" "unprognostic (2.34e-2)" "unprognostic (1.46e-1)" "prognostic favorable (9.03e-11)" "unprognostic (7.40e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.23e-2)" 8.8 19.3 11.5 7.8 12.4 3.7 9.3 11.2 13.8 7.9 17.9 9.4 14.7 17.6 7.2 9.9 16.6 9.5 11.3 46.1 9.5 8.8 28.8 29.1 5.8 6.4 9.7 8.6 6.9 12.6 23.6 8.9 8.1 8.8 10.4 14.5 12.2 17.7 14.5 86.0 9.4 23.7 22.1 6.9 5.3 13.6 8.9 8.5 5.4 11.8 31.1 9.4 16.3 8.4 13.6 23.3 14.7 24.1 15.2 18.7 14.1 11.9 24.4 6.6 16.6 13.3 10.3 7.9 11.6 9.1 16.4 9.2 14.8 15.6 14.5 22.4 10.1 12.6 25.6 19.1 20.3 10.3 7.8 16.5 10.0 16.7 22.7 14.7 12.7 16.4 17.1 26.6 13.0 25.4 10.9 18.2 12.8 19.2 6.6 9.8 17.0 10.5 9.2 10.9 25.9 32.2 21.4 21.8 37.3 25.5 13.3 20.9 21.1 39.3 37.9 19.2 6.1 21.8 14.2 12.5 11.9 14.7 12.9 14.6 16.1 9.9 17.3 16.6 18.3 13.5 11.5 19.3 14.7 13.9 24.1 14.4 13.6 12.0 12.2 23.3 12.0 13.0 18.7 6.0 15.2 23.5 14.5 16.8 14.1 11.5 12.4 11.2 13.8 9.5 8.8 9.7 8.6 8.8 8.5 11.9 17.6 19.3 15.0 7.4 15.8 75.0 50.9 26.8 17.0 24.4 15.7 61.9 184.1 42.5 28.2 16.5 72.4 0.0 25.5 19.3 14.4 15.7 6.9 45.9 33.9 19.1 26.5 16.5 14.0 20.8 19.5 12.8 27.0 30.7 42.6 24.6 24.1 37.4 19.1 80.1 22.7 12.9 16.7 66.0 31.1 9.8 65.8 15.2 58.3 17.0 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593998-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 11.6;heart muscle: 39.5" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 50.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "pons and medulla: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 32.6" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Low region specificity" "Detected in single" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.3 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.1 3.1 0.1 0.1 2.6 0.0 3.4 11.6 0.7 1.2 4.5 39.5 0.0 0.2 2.0 0.0 1.3 0.0 0.2 0.0 0.6 0.1 0.0 1.5 0.6 1.6 1.7 0.0 0.4 0.3 4.6 0.2 5.3 0.4 0.5 0.0 3.5 0.3 3.7 0.0 0.2 0.1 1.7 0.4 0.8 3.2 0.2 0.0 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.2 7.5 32.6 0.0 1.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.6 0.0 0.0 6.9 0.0 0.2 3.4 0.8 50.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 9.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.8 4.4 0.0 5.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.1 0.0 4.2 3.0 4.6 2.4 0.0 0.0 0.0 0.2 CORO1A "coronin-1, HCORO1, p57" ENSG00000102879 "Coronin 1A" P31146 16 30182827-30189076 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8" "Group enriched" "Detected in many" 5 "B-cells: 445.3;Hofbauer cells: 429.4;Kupffer cells: 429.2;Macrophages: 313.3;monocytes: 310.2;T-cells: 809.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 86.3;HL-60: 60.2;HMC-1: 104.2;JURKAT: 54.9;MOLT-4: 58.2;NB-4: 68.9;RPMI-8226: 90.9;U-698: 56.3;U-937: 76.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046473, HPA051132" Enhanced Approved Cytosol NA NA 130000000 Cytosol "CAB046473: AB_10602363, HPA051132: AB_2681355" "unprognostic (4.17e-3)" "unprognostic (3.64e-3)" "unprognostic (3.86e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.41e-1)" "prognostic favorable (4.42e-4)" "unprognostic (1.99e-2)" "unprognostic (8.27e-3)" "unprognostic (8.26e-3)" "unprognostic (4.30e-1)" "unprognostic (1.54e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.74e-7)" "unprognostic (2.55e-1)" "unprognostic (2.37e-2)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" 6.4 4.9 12.7 58.9 10.8 94.9 4.4 7.8 13.6 2.9 5.0 6.0 0.2 8.3 3.0 3.0 4.7 5.9 8.6 4.8 10.4 7.8 4.9 3.8 13.7 99.8 9.6 8.2 2.2 2.7 0.6 3.0 4.8 7.3 3.3 2.9 2.2 12.3 1.6 1.3 3.4 28.7 4.1 9.0 92.0 8.5 1.1 7.5 86.0 3.6 3.2 64.8 15.8 3.1 41.6 67.7 204.4 67.5 39.1 66.4 101.2 0.2 0.3 1.0 2.1 0.0 0.0 0.5 0.2 0.0 0.5 0.2 0.0 0.6 86.3 0.5 0.0 0.1 0.4 0.4 1.0 0.1 27.6 0.2 9.1 0.0 1.3 0.1 60.2 104.2 0.3 0.0 0.4 0.0 0.0 0.1 54.9 0.1 44.4 0.3 7.3 58.2 68.9 0.4 0.2 0.6 31.7 1.6 90.9 0.1 0.4 1.6 1.2 0.2 10.4 0.2 0.0 0.1 35.0 0.1 0.4 0.8 0.2 0.2 34.5 45.5 56.3 0.3 76.3 0.6 52.5 58.3 204.4 53.7 67.5 50.5 41.6 48.4 52.2 67.7 41.6 46.6 48.1 105.8 39.1 66.3 38.2 66.4 101.2 12.7 10.8 7.8 13.6 10.4 7.8 9.6 8.2 7.3 7.5 20.8 52.4 445.3 1.0 10.1 1.2 1.2 17.8 5.3 7.9 1.8 0.0 4.1 0.0 3.5 0.4 3.6 1.1 0.0 0.8 13.9 9.4 0.7 83.0 2.1 429.4 0.0 5.8 20.9 429.2 0.4 0.6 313.3 30.4 310.2 1.7 0.8 6.6 28.8 0.0 3.7 0.7 6.5 7.2 0.0 0.9 8.0 4.1 809.5 1.3 1.0 CORO2A "IR10, WDR2" ENSG00000106789 "Coronin 2A" Q92828 9 98120975-98192640 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 36.1" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 38.2;Enterocytes: 69.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1" "Cell line enhanced" "Detected in many" "BEWO: 32.3;OE19: 26.3;SK-BR-3: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041161, HPA041302" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041161: AB_10795537, HPA041302: AB_10794195" "unprognostic (4.49e-3)" "unprognostic (3.44e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.39e-3)" "unprognostic (1.64e-1)" "unprognostic (3.73e-2)" "unprognostic (5.73e-2)" "unprognostic (2.79e-1)" "unprognostic (1.52e-1)" "unprognostic (4.50e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" "unprognostic (6.40e-3)" 1.6 0.8 1.2 6.9 1.8 8.1 2.9 9.3 2.4 3.9 22.0 0.7 1.3 20.8 2.0 2.2 13.6 2.7 27.7 1.5 1.3 3.0 1.4 2.9 7.5 1.6 2.6 1.3 1.5 1.4 2.8 5.2 3.5 3.3 9.0 7.9 1.2 5.4 1.9 0.9 6.3 36.1 1.9 0.6 3.8 6.6 11.4 0.6 5.6 1.1 3.6 6.6 7.7 6.2 0.6 0.7 10.9 7.0 1.5 11.1 1.4 3.9 1.4 0.3 0.9 0.6 0.6 32.3 0.3 0.3 1.0 1.6 8.9 0.6 0.0 4.5 0.6 1.5 11.0 3.7 6.0 0.6 3.2 0.8 0.1 5.6 7.9 1.3 3.6 0.3 0.2 7.4 0.5 9.1 0.3 0.3 4.7 3.1 1.8 0.1 2.9 0.7 3.6 4.1 26.3 1.0 2.8 0.0 0.1 0.6 11.1 0.8 1.1 2.0 21.8 0.7 7.6 2.5 6.0 0.3 0.1 4.8 0.1 1.1 0.3 1.8 0.3 0.2 1.2 1.3 7.7 1.5 10.9 2.4 3.0 5.5 0.6 4.1 3.8 0.5 0.6 2.7 3.5 1.1 1.5 7.0 0.7 11.1 1.4 1.2 1.8 9.3 2.4 1.3 3.0 2.6 1.3 3.3 0.6 11.9 23.8 0.9 17.5 6.0 1.5 1.2 38.2 20.1 35.2 0.0 3.9 8.5 0.0 3.0 2.2 1.9 69.1 0.0 4.5 31.7 3.1 14.5 0.0 3.2 5.8 1.6 6.9 1.3 11.0 3.0 0.0 4.9 0.0 0.0 14.0 0.5 13.8 17.3 0.4 1.4 1.5 0.0 1.9 0.5 3.2 8.7 13.3 8.7 25.7 26.0 CORO2B "ClipinC, KIAA0925" ENSG00000103647 "Coronin 2B" Q9UQ03 15 68578969-68727806 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.5;fallopian tube: 27.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 32.6;Ciliated cells: 14.7;Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 20.9" "Group enriched" "Detected in many" 8 "glioma: 34.7;melanoma: 21.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.2;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 21 "B-cells: 4.5" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;ASC TERT1: 27.8;HSkMC: 20.0;hTEC/SVTERT24-B: 16.3;U-87 MG: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017960 Enhanced Supported Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA017960: AB_1847167" "unprognostic (1.35e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-3)" "unprognostic (4.71e-3)" "unprognostic (3.28e-1)" "unprognostic (8.11e-5)" "unprognostic (4.77e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (1.81e-1)" "unprognostic (1.33e-3)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" "unprognostic (1.10e-2)" "unprognostic (5.83e-2)" "unprognostic (3.59e-2)" "unprognostic (1.87e-2)" 10.9 4.4 15.7 3.2 30.1 1.9 4.8 33.7 53.5 6.5 3.4 27.3 0.8 2.4 7.5 3.9 2.7 27.4 6.3 7.2 23.0 15.1 5.5 2.0 5.8 3.5 20.9 18.8 18.4 2.9 1.6 1.5 4.7 23.6 3.2 2.9 11.8 3.4 6.9 3.8 5.6 3.3 8.4 35.0 3.6 2.0 2.2 17.5 0.0 4.6 0.6 1.9 3.0 1.6 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 12.3 1.0 12.9 27.8 0.0 6.2 6.9 1.1 1.5 0.1 1.4 1.5 0.7 1.0 1.7 0.0 0.4 0.1 4.5 0.0 0.5 0.0 0.0 0.6 4.7 0.0 0.1 20.0 0.1 16.3 1.0 9.7 0.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 3.0 0.0 0.0 1.0 0.0 0.5 1.7 0.0 7.1 0.1 0.1 0.0 3.6 2.4 0.0 1.4 0.1 3.7 4.1 0.7 8.2 0.0 0.0 1.5 27.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 30.1 33.7 29.3 23.0 15.1 20.9 18.8 23.6 17.5 0.0 0.0 0.0 0.3 0.9 32.6 1.1 0.0 14.7 0.0 7.0 35.3 0.0 0.0 3.8 0.2 1.5 0.0 0.0 0.5 0.0 2.6 0.1 0.0 0.0 0.2 0.0 3.5 5.5 0.3 0.0 7.2 0.0 6.8 0.0 0.0 9.5 0.4 0.0 0.4 0.0 20.9 6.5 2.3 0.2 0.4 0.6 0.0 0.0 0.0 0.1 CORO6 FLJ14871 ENSG00000167549 "Coronin 6" Q6QEF8 17 29614756-29622907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 130.9" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 30.8;Extravillous trophoblasts: 17.0;Horizontal cells: 28.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 19 "basophil: 3.9;eosinophil: 2.4" "Lineage enriched" "Detected in single" 23 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "REH: 12.5;RH-30: 14.1;SH-SY5Y: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021556 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA021556: " "unprognostic (7.12e-3)" "unprognostic (2.68e-2)" "unprognostic (2.60e-4)" "unprognostic (9.25e-4)" "unprognostic (1.45e-2)" "unprognostic (1.15e-1)" "unprognostic (1.11e-2)" "unprognostic (1.62e-1)" "unprognostic (3.00e-4)" "unprognostic (6.70e-2)" "unprognostic (6.61e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.61e-7)" "unprognostic (8.48e-2)" "unprognostic (4.09e-1)" "unprognostic (1.92e-1)" "unprognostic (1.13e-2)" 2.7 1.6 5.7 1.2 17.7 0.9 2.2 4.5 12.4 1.4 4.4 0.7 1.6 1.3 3.3 3.4 6.9 3.5 2.4 28.4 5.2 3.3 0.9 0.8 2.1 1.0 1.8 8.7 1.2 1.0 11.7 1.0 25.7 8.1 4.0 1.7 1.2 3.8 2.7 130.9 2.0 2.4 5.6 1.3 1.1 2.1 1.0 3.6 0.0 21.3 18.3 1.1 4.9 1.9 0.0 0.0 3.9 0.0 0.0 0.1 0.1 7.7 3.4 3.0 0.0 4.7 2.6 4.7 2.6 0.9 1.6 0.7 0.2 0.0 0.1 0.6 4.1 0.2 8.2 2.3 0.5 0.8 0.1 3.9 0.0 6.4 1.0 7.6 0.0 0.4 9.3 0.7 0.8 0.0 4.3 1.7 0.0 0.5 0.1 5.5 0.0 5.1 0.2 1.0 0.0 0.1 12.5 14.1 0.3 0.4 0.0 0.0 17.5 0.7 2.3 0.0 2.3 0.0 1.1 0.5 1.1 0.0 1.4 1.1 6.6 3.4 0.9 2.4 0.0 0.0 3.9 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 17.7 4.5 12.4 5.2 3.3 1.8 8.7 8.1 3.6 0.0 0.0 0.0 2.8 1.3 0.5 30.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.0 0.0 17.0 1.9 0.8 0.0 0.0 1.2 28.6 0.0 3.1 2.2 0.0 6.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.0 0.9 6.5 3.4 0.2 0.7 0.4 2.1 0.7 0.0 0.1 CORO7 FLJ22021 ENSG00000262246 "Coronin 7" P57737 16 4354542-4425705 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 19.9;RPMI-8226: 37.0" "HPA041657, HPA053586" Uncertain NA NA 17000 "HPA041657: AB_10796351, HPA053586: AB_2682201" "unprognostic (4.75e-3)" "prognostic favorable (8.68e-4)" "unprognostic (2.18e-1)" "prognostic favorable (4.25e-4)" "unprognostic (3.80e-2)" "unprognostic (1.05e-1)" "unprognostic (7.54e-4)" "unprognostic (3.32e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-3)" "unprognostic (1.20e-2)" "unprognostic (6.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.04e-1)" "unprognostic (9.55e-2)" "unprognostic (4.06e-3)" 9.7 8.4 14.8 15.7 19.2 53.9 6.8 7.0 16.1 5.9 9.3 25.2 4.0 14.7 7.7 7.9 5.6 8.9 9.5 5.8 13.5 7.4 8.7 4.8 14.1 27.9 27.3 9.7 4.3 8.4 6.5 7.3 9.6 11.9 9.0 6.4 5.0 7.1 7.8 4.0 5.8 15.8 7.1 12.2 30.9 10.7 13.2 24.9 13.1 7.6 5.3 11.8 7.8 5.9 5.6 9.3 17.3 16.3 4.1 9.4 9.7 2.4 3.8 2.2 2.3 0.5 0.8 4.5 1.7 1.5 2.4 2.5 2.1 5.2 5.9 2.0 1.8 1.7 3.8 1.6 2.8 1.0 5.5 10.5 2.0 5.5 3.1 2.0 5.9 12.1 2.2 0.8 1.7 0.4 0.8 4.0 4.2 5.7 19.9 1.0 7.8 4.0 14.9 2.5 1.6 1.4 13.4 8.0 37.0 1.3 4.1 4.3 5.2 1.7 1.7 4.2 1.2 1.2 8.2 5.0 1.8 3.0 5.0 2.1 10.7 5.4 13.1 1.4 8.0 1.8 8.9 12.4 17.3 8.7 16.3 9.4 5.6 7.3 9.2 9.3 2.7 3.8 5.4 12.4 4.1 13.2 3.7 8.4 9.7 14.8 19.2 7.0 16.1 13.5 7.4 27.3 9.7 11.9 24.9 3.0 9.6 19.9 4.7 8.4 13.9 2.3 7.6 5.3 5.7 5.2 41.2 10.3 3.3 11.1 3.6 10.5 13.5 0.0 13.9 10.3 6.2 4.9 11.5 2.0 33.1 27.0 7.5 22.1 41.3 3.6 4.6 22.2 16.9 19.0 8.5 6.8 14.7 14.4 3.2 2.4 18.9 6.5 4.7 10.9 7.1 10.5 7.7 30.2 11.5 7.6 CORT MGC32686 ENSG00000241563 Cortistatin O00230 1 10449719-10451902 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 28.8" "Group enriched" "Detected in some" 4 "Early spermatids: 4.5;Late spermatids: 3.6;Spermatocytes: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in many" 33 "amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "unprognostic (1.25e-2)" "unprognostic (1.79e-2)" "unprognostic (1.65e-1)" "unprognostic (3.70e-3)" "unprognostic (8.87e-2)" "unprognostic (1.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.05e-1)" "unprognostic (7.94e-3)" "unprognostic (7.08e-7)" "unprognostic (2.01e-1)" "unprognostic (9.01e-4)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.02e-1)" "unprognostic (2.14e-4)" 1.0 0.7 3.3 0.9 28.8 0.9 0.6 3.2 26.6 0.7 1.0 0.1 0.0 1.3 0.8 1.0 0.5 0.7 1.0 0.6 2.3 2.5 1.2 0.8 0.7 0.7 1.0 6.2 1.0 0.9 1.0 3.2 1.7 0.0 1.1 0.8 0.0 0.7 0.8 0.8 1.1 1.2 0.7 0.7 0.8 0.9 2.1 20.3 0.0 1.1 0.0 0.5 0.8 0.5 0.2 0.4 0.0 0.1 1.2 0.3 0.3 1.2 3.7 1.8 2.3 0.2 0.2 0.8 1.1 0.2 0.4 0.4 3.2 0.5 1.2 0.9 0.0 0.3 1.0 1.1 0.0 0.0 2.1 3.2 1.7 2.8 3.0 0.4 2.4 1.1 0.0 0.3 0.5 0.0 0.2 0.0 1.6 1.1 1.0 0.3 2.5 0.5 2.3 0.3 0.2 4.5 0.9 1.6 0.5 0.2 0.9 1.6 0.8 0.9 1.1 0.7 0.9 0.7 0.0 1.7 0.3 1.8 2.2 0.6 0.9 2.8 1.1 0.7 1.8 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.3 3.3 28.8 3.2 21.5 2.3 2.5 1.0 6.2 0.0 20.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.1 0.4 0.3 0.0 0.0 0.0 0.1 COTL1 CLP ENSG00000103187 "Coactosin like F-actin binding protein 1" Q14019 16 84565594-84618077 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Chaperone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 206.6;lymphoid tissue: 103.0" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 1310.7;Hofbauer cells: 547.8;Kupffer cells: 920.9;Macrophages: 713.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6" "Group enriched" "Detected in all" 5 "dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6" "Cell line enhanced" "Detected in many" "WM-115: 130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008918, CAB062328" Enhanced Supported Cytosol NA NA 28000000 Cytosol "CAB062328: AB_2084785, HPA008918: AB_2668176" "unprognostic (2.93e-2)" "unprognostic (1.11e-1)" "unprognostic (3.27e-2)" "unprognostic (2.38e-1)" "unprognostic (3.21e-3)" "unprognostic (8.95e-2)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (7.70e-2)" "unprognostic (5.99e-2)" "unprognostic (5.43e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (5.48e-2)" "unprognostic (7.73e-2)" "unprognostic (3.35e-3)" 28.6 9.9 20.4 68.1 19.5 57.7 13.7 12.4 18.1 7.6 16.5 25.3 2.4 22.0 13.2 8.4 8.2 13.2 18.7 7.2 19.6 24.9 34.3 12.4 26.6 103.0 28.9 8.1 10.8 7.5 5.1 13.1 29.4 23.2 11.8 16.7 30.8 7.7 7.6 5.1 5.1 26.1 16.2 27.8 92.3 29.6 8.0 13.4 33.0 10.1 5.2 62.0 29.3 7.6 28.5 117.3 160.2 206.6 30.8 32.5 108.3 53.9 45.1 103.2 108.9 11.8 32.7 31.1 47.0 30.4 37.1 14.4 61.2 83.8 15.0 14.4 35.3 22.1 27.2 6.3 37.0 37.4 0.1 7.9 28.1 9.5 16.1 33.5 31.5 111.6 26.1 5.9 35.7 32.0 23.3 17.6 33.3 2.6 6.2 22.0 8.7 9.7 19.0 12.7 17.8 46.1 1.0 3.5 0.9 54.4 23.0 16.3 0.8 43.8 10.5 23.4 12.7 7.9 25.7 45.3 53.5 30.4 17.1 34.2 1.2 5.6 12.2 41.8 15.4 130.2 29.6 110.8 160.2 3.6 190.1 4.8 28.5 23.0 21.7 117.3 13.2 10.3 12.1 86.8 30.8 206.6 6.0 32.5 108.3 20.4 19.5 12.4 18.1 19.6 24.9 28.9 8.1 23.2 13.4 3.0 13.5 259.5 72.9 56.3 9.5 4.4 17.8 2.7 6.8 73.3 229.7 114.0 33.2 49.7 5.6 83.4 40.6 0.0 29.3 1310.7 47.3 43.2 143.7 4.2 547.8 23.8 139.8 242.5 920.9 6.9 7.5 713.2 91.1 125.4 65.3 16.9 70.8 14.4 15.2 238.6 41.0 6.5 62.8 2.9 18.1 33.4 144.5 177.7 122.8 153.6 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 COX4I2 "COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2" ENSG00000131055 "Cytochrome c oxidase subunit 4I2" Q96KJ9 20 31637888-31645006 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.7" "Group enriched" "Detected in some" 34 "Sertoli cells: 407.4;Smooth muscle cells: 177.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 11 "B-cells: 2.6" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.64e-1)" "unprognostic (2.09e-2)" "unprognostic (2.76e-3)" "unprognostic (2.18e-2)" "unprognostic (4.51e-2)" "prognostic favorable (6.04e-5)" "unprognostic (5.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.51e-1)" "unprognostic (7.45e-2)" "unprognostic (1.04e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.11e-1)" "unprognostic (3.30e-3)" "unprognostic (1.43e-1)" "unprognostic (5.59e-2)" 9.9 0.7 1.6 1.7 1.9 0.1 7.9 0.7 2.5 4.7 2.2 1.5 0.9 1.1 5.9 3.5 7.1 2.6 5.4 15.5 1.7 1.4 2.0 0.5 24.6 4.9 2.4 1.0 1.9 1.9 2.1 1.1 60.7 2.7 5.2 1.6 4.1 2.4 2.8 12.8 2.5 2.7 3.9 1.2 0.8 2.0 1.5 2.1 0.5 8.0 7.5 2.3 3.7 3.7 2.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.7 2.5 1.7 1.4 2.4 1.0 2.7 2.1 0.0 0.0 0.0 0.2 5.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.2 4.3 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 3.4 1.1 8.5 0.0 0.0 1.1 0.1 0.0 0.7 0.0 0.4 407.4 177.5 0.0 0.1 5.8 2.1 0.0 0.0 0.3 COX5A ENSG00000178741 "Cytochrome c oxidase subunit 5A" P20674 15 74919791-74938168 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 209.7;skeletal muscle: 222.8" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 1647.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027526 Supported NA NA 5400000 "HPA027526: AB_10602802" "unprognostic (7.32e-2)" "prognostic favorable (2.15e-4)" "unprognostic (4.06e-2)" "unprognostic (9.85e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (3.79e-2)" "unprognostic (9.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.77e-1)" "unprognostic (8.62e-2)" "prognostic favorable (6.06e-7)" "unprognostic (9.78e-2)" "unprognostic (2.22e-1)" "unprognostic (1.30e-1)" "unprognostic (3.81e-3)" 22.4 20.1 30.4 25.9 29.1 20.6 36.1 22.4 57.9 15.0 70.8 12.1 21.6 51.5 11.6 19.3 31.6 14.6 22.7 209.7 26.7 25.4 42.6 49.4 17.7 29.0 32.7 27.3 8.7 41.1 27.7 16.4 15.0 26.7 15.6 65.7 13.7 32.2 23.1 222.8 17.2 49.4 15.9 20.9 17.3 31.7 26.2 12.2 21.9 19.9 86.5 30.6 17.9 15.1 52.2 81.2 47.3 80.6 58.8 64.1 65.7 35.1 39.1 48.5 42.3 29.9 34.6 53.4 32.0 28.3 41.1 38.4 43.6 44.6 80.7 39.5 27.6 50.0 69.6 114.5 46.5 34.4 45.6 106.8 66.9 40.8 54.0 37.5 76.4 42.1 35.0 50.6 25.6 58.1 28.2 48.0 55.9 61.4 54.9 41.0 27.7 63.7 58.8 51.5 71.5 58.0 59.4 46.5 93.7 60.0 59.5 71.1 30.5 48.5 72.9 100.2 55.3 36.5 62.4 32.4 31.1 29.4 38.8 50.8 62.9 115.4 89.4 33.4 101.4 28.3 47.3 65.5 36.1 37.6 80.6 44.9 52.2 46.7 44.2 81.2 37.8 33.2 38.5 15.8 58.8 72.1 64.7 64.1 65.7 30.4 29.1 22.4 57.9 26.7 25.4 32.7 27.3 26.7 12.2 92.3 98.3 157.9 175.6 140.6 98.6 1647.0 242.0 117.8 108.1 162.3 37.3 430.9 1250.1 355.7 826.5 138.1 1074.0 93.5 379.0 409.1 121.0 226.5 102.6 381.0 504.7 87.4 443.2 110.5 242.1 581.7 92.9 227.7 237.8 426.6 815.4 91.5 365.2 768.6 80.6 703.8 110.5 90.5 143.5 367.8 236.9 139.0 427.4 165.8 1016.3 341.5 COX5B ENSG00000135940 "Cytochrome c oxidase subunit 5B" P10606 2 97646040-97648383 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 336.2" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034517 Supported Enhanced Mitochondria NA NA 2200000 Mitochondria "HPA034517: AB_10603561" "unprognostic (4.61e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-1)" "unprognostic (2.72e-2)" "unprognostic (1.79e-2)" "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.73e-4)" 39.8 25.3 54.5 20.8 46.1 27.6 23.9 22.6 46.4 19.5 58.6 16.0 27.6 44.5 13.1 22.3 31.9 19.4 24.0 160.6 39.9 36.0 44.8 52.5 13.8 16.1 48.1 32.5 17.7 24.6 19.9 17.5 18.1 39.0 21.5 31.5 14.3 36.5 29.2 336.2 18.9 38.6 19.9 30.8 17.9 40.4 13.4 23.0 14.2 25.8 65.4 15.3 19.4 16.7 85.1 111.2 115.8 122.5 48.1 83.6 145.2 19.9 23.3 14.4 23.9 17.0 15.5 62.3 25.7 14.4 17.1 19.1 64.4 20.9 33.7 55.3 16.4 27.0 30.5 16.6 25.8 7.8 26.2 70.6 45.4 25.8 76.9 32.7 43.0 33.3 28.7 22.9 16.4 12.8 17.5 14.6 27.0 33.3 14.9 13.2 49.4 27.1 62.4 28.4 34.1 122.6 26.7 24.8 50.4 23.0 30.7 28.6 30.6 25.0 30.2 48.2 20.0 16.1 45.1 26.5 15.6 26.6 25.0 16.5 38.9 36.8 25.7 28.3 37.0 16.1 96.9 122.5 99.8 54.7 114.1 52.6 85.1 66.3 57.1 111.2 68.8 64.5 57.5 115.8 48.1 95.9 75.8 83.6 145.2 54.5 46.1 22.6 46.4 39.9 36.0 48.1 32.5 39.0 23.0 205.4 224.6 375.1 495.2 343.3 204.5 3263.7 647.1 369.4 268.4 759.0 214.0 640.2 3068.8 479.5 156.4 370.1 2132.4 140.2 527.3 778.4 340.5 424.2 320.2 1125.6 767.8 133.5 711.5 338.8 489.5 270.1 325.7 488.5 865.4 798.1 1204.0 259.4 460.5 1508.0 286.4 1849.4 303.9 439.8 473.4 213.2 290.0 419.6 512.8 265.9 1320.1 744.1 COX6A2 ENSG00000156885 "Cytochrome c oxidase subunit 6A2" Q02221 16 31427731-31428428 "Predicted intracellular proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8" "Cell type enriched" "Detected in some" 64 "Cardiomyocytes: 3924.5" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 125 "NK-cell: 12.5" "Lineage enriched" "Detected in single" 125 "NK-cells: 12.5" "Cell line enriched" "Detected in some" 4 "U-266/84: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.66e-1)" "unprognostic (1.73e-3)" "unprognostic (2.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.68e-2)" "unprognostic (3.88e-1)" "unprognostic (5.61e-2)" "unprognostic (7.20e-2)" "unprognostic (8.71e-2)" "unprognostic (6.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.65e-1)" 3.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 9.3 5.6 0.1 0.1 398.6 0.1 0.3 0.2 0.9 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.8 0.1 0.0 2.3 0.1 0.9 8.4 0.1 421.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 5.5 230.8 11.4 0.1 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3924.5 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 61.4 2.1 3.2 0.0 0.6 2.1 0.8 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.7 20.3 3.9 19.4 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 COX6B2 "COXVIB2, CT59, FLJ32865" ENSG00000160471 "Cytochrome c oxidase subunit 6B2" Q6YFQ2 19 55349306-55354814 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 66.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 22.6;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA035014 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA035014: AB_10601261" "unprognostic (7.43e-3)" "unprognostic (8.72e-2)" "unprognostic (1.42e-1)" "unprognostic (5.75e-2)" "unprognostic (2.59e-2)" "unprognostic (9.23e-3)" "unprognostic (1.88e-2)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (6.82e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (8.11e-2)" "unprognostic (1.81e-6)" "unprognostic (9.91e-2)" "unprognostic (1.47e-1)" "unprognostic (1.02e-2)" "unprognostic (2.02e-1)" 0.3 0.0 0.4 0.6 0.6 0.7 0.5 0.3 0.6 0.2 3.3 0.2 0.2 0.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.5 0.5 0.2 0.2 0.6 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.6 0.2 3.5 0.7 0.6 0.2 0.2 1.8 0.2 0.2 0.7 0.2 0.0 66.5 0.3 0.2 0.2 0.2 1.2 0.2 0.4 1.3 1.4 5.7 1.0 1.6 0.9 0.8 2.7 0.4 0.1 0.1 0.0 0.0 0.2 0.4 0.1 0.3 0.5 0.1 22.6 0.1 0.2 0.2 0.3 1.8 0.7 0.2 0.2 0.8 0.7 0.0 1.7 0.1 0.3 0.2 1.8 0.2 2.5 0.4 0.5 1.7 0.0 0.1 0.4 0.2 0.0 0.5 0.1 0.2 0.6 2.3 0.5 0.1 0.0 0.2 0.0 0.4 9.7 0.3 0.3 0.1 0.0 0.6 0.4 0.0 0.4 0.3 0.5 0.1 0.2 1.5 1.2 0.1 0.1 0.3 0.2 1.9 1.0 1.0 0.8 0.5 0.5 0.7 0.7 0.6 0.3 1.3 0.7 0.9 5.7 1.6 0.7 1.4 0.6 0.8 0.4 0.6 0.3 0.6 0.2 0.5 0.4 0.2 0.6 0.3 0.0 0.3 0.0 0.6 0.5 2.1 0.4 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.6 23.6 0.0 3.2 0.0 0.6 0.2 0.4 0.2 0.0 0.0 0.1 3.2 1.2 0.0 0.0 19.1 0.6 0.0 0.0 0.0 1.3 0.9 5.6 3.5 0.0 0.0 4.1 0.0 0.0 77.8 1.3 0.4 0.3 0.0 4.4 2.5 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99894062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Supported Mitochondria NA NA 53000 Mitochondria "CAB016244: AB_2085703, HPA014295: AB_2668966" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 20.5 43.1 66.1 21.6 56.2 44.4 23.3 28.5 63.8 18.7 46.0 14.3 29.4 113.7 38.8 64.1 31.6 27.4 23.5 113.0 54.8 46.9 38.7 66.8 18.2 23.2 58.8 36.7 32.7 26.5 12.1 24.0 30.7 38.8 23.3 38.1 20.6 32.4 30.1 232.1 31.2 55.8 38.7 40.4 23.7 35.1 29.6 23.5 17.9 19.5 80.6 17.8 31.0 21.3 45.9 62.3 55.7 50.6 37.2 73.5 48.0 17.0 6.9 8.0 32.8 18.3 13.3 13.4 5.6 5.3 3.8 4.3 6.9 36.5 41.4 42.4 8.7 6.1 22.7 4.5 46.4 6.4 7.5 11.6 85.9 8.2 20.1 11.9 39.6 26.6 12.3 61.8 3.2 7.1 17.0 5.7 13.0 6.0 74.4 6.4 16.3 41.1 36.5 15.4 25.7 15.9 47.8 2.6 40.5 58.2 90.8 24.9 15.2 3.9 85.1 41.6 8.6 60.0 25.4 4.9 29.1 37.9 30.7 7.9 18.5 14.9 24.6 40.9 16.1 25.7 55.7 29.3 22.1 40.1 42.3 41.8 45.9 61.0 42.5 43.8 41.7 73.5 65.7 3.5 37.2 50.6 62.3 56.9 48.0 66.1 56.2 28.5 63.8 54.8 46.9 58.8 36.7 38.8 23.5 375.2 414.8 374.3 402.8 435.9 194.1 2063.7 626.8 575.5 377.6 574.0 96.2 831.0 1886.7 571.0 645.5 416.6 1532.5 303.7 739.7 730.3 697.7 423.0 347.2 1528.6 904.1 147.8 776.1 376.3 443.5 180.9 615.6 499.6 695.0 943.2 982.6 392.7 687.3 1094.2 552.3 1121.0 205.6 485.0 628.5 756.0 487.0 560.0 1492.7 393.7 1121.0 582.7 COX7A1 "COX7A, COX7AH" ENSG00000161281 "Cytochrome c oxidase subunit 7A1" P24310 19 36150922-36152869 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 114.9;skeletal muscle: 404.3" "Cell type enriched" "Detected in many" 28 "Cardiomyocytes: 19391.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9" "Group enriched" "Detected in many" 8 "dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9" "Cell line enhanced" "Detected in some" "ASC diff: 24.5;ASC TERT1: 18.0;BJ: 16.5;BJ hTERT+: 13.7;fHDF/TERT166: 25.1;HHSteC: 16.3;HSkMC: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.48e-2)" "unprognostic (1.19e-1)" "unprognostic (6.13e-3)" "unprognostic (6.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.87e-2)" "unprognostic (3.77e-2)" "unprognostic (9.93e-2)" "unprognostic (1.92e-1)" "unprognostic (1.41e-1)" "unprognostic (9.49e-2)" "unprognostic (1.46e-1)" "unprognostic (7.84e-3)" "unprognostic (7.27e-3)" "unprognostic (9.44e-2)" "unprognostic (6.23e-2)" "unprognostic (1.54e-2)" 15.7 8.1 5.3 2.5 3.6 1.2 8.8 2.1 13.1 4.1 8.0 0.8 2.6 2.0 3.9 6.1 6.6 3.1 5.0 114.9 3.3 2.4 5.0 1.6 4.0 2.7 2.6 4.6 4.2 3.5 6.0 7.9 2.6 1.7 5.9 2.3 5.9 6.2 7.1 404.3 2.0 2.2 12.3 1.4 3.1 3.6 1.6 1.5 1.6 5.1 59.7 2.6 7.0 4.7 0.0 1.3 1.4 1.9 0.0 0.1 0.3 0.1 2.6 0.2 0.0 24.5 18.0 0.1 16.5 13.7 0.5 0.0 0.0 0.8 0.6 6.9 25.1 0.0 0.3 0.0 0.0 0.1 0.1 0.9 0.1 0.9 0.1 16.3 0.0 0.2 16.9 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.3 0.0 0.1 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 3.7 0.0 0.6 0.2 0.1 0.4 0.4 0.3 0.1 0.3 0.5 0.0 1.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.4 0.0 0.5 0.4 0.1 0.3 5.3 3.6 2.1 13.1 3.3 2.4 2.6 4.6 1.7 1.5 0.0 9.0 5.9 1.3 23.5 71.7 19391.7 25.5 1.4 3.4 21.0 43.2 1.0 693.0 10.8 13.4 160.8 0.0 0.0 12.2 0.9 86.2 2.4 43.9 4.4 18.4 63.5 0.0 239.4 11.6 76.0 207.9 6.0 269.9 0.0 0.0 16.2 9.2 0.0 264.5 128.7 56.3 181.1 233.8 1.5 3.2 16.7 1.6 2.5 0.0 0.6 COX7A2 "COX7AL, COXVIIa-L" ENSG00000112695 "Cytochrome c oxidase subunit 7A2" 6 75237675-75250323 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 157.6" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 3729.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.49e-2)" "unprognostic (2.56e-1)" "unprognostic (1.98e-2)" "unprognostic (2.15e-2)" "unprognostic (1.34e-1)" "unprognostic (5.67e-3)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (7.70e-2)" "unprognostic (2.73e-3)" "unprognostic (7.44e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" 26.9 25.3 49.7 18.8 55.3 26.5 30.2 27.0 54.9 19.5 55.9 12.3 37.0 35.3 16.9 41.5 29.7 20.3 23.4 76.3 38.0 32.9 44.8 51.7 17.8 23.9 48.9 34.6 12.6 46.9 19.4 27.2 18.3 36.8 24.0 61.5 18.3 35.7 27.1 38.2 19.1 35.6 29.0 39.4 18.1 36.4 62.8 27.5 17.4 22.4 47.1 27.1 23.4 16.7 109.1 130.5 94.1 108.8 76.9 110.3 157.6 15.3 35.2 46.2 37.9 27.6 31.4 33.5 37.5 34.5 37.5 40.7 63.3 23.5 25.1 33.3 33.8 50.5 33.4 32.1 40.5 47.0 45.8 65.9 37.6 110.1 83.1 28.4 40.0 44.4 33.9 54.3 34.6 22.7 39.5 43.4 57.2 33.2 36.5 50.6 71.4 17.0 43.6 29.0 75.8 64.5 27.8 23.3 66.0 59.7 100.2 31.6 38.3 23.3 42.8 37.6 39.6 26.1 113.0 21.1 16.6 30.3 13.2 42.5 51.7 56.3 27.8 18.9 45.8 32.3 92.9 100.0 94.1 78.3 107.7 83.0 109.1 102.4 93.5 103.6 90.2 101.1 93.4 74.7 76.9 108.8 130.5 110.3 157.6 49.7 55.3 27.0 54.9 38.0 32.9 48.9 34.6 36.8 27.5 282.9 318.7 403.4 476.4 491.8 218.2 2259.4 751.6 480.5 353.8 478.1 113.9 585.5 2205.0 700.7 3729.3 440.0 1510.8 210.2 878.7 682.4 432.2 710.6 290.2 1241.2 769.2 146.2 637.2 364.0 458.4 2761.1 329.4 416.4 803.1 743.0 1103.4 253.8 951.9 1195.4 318.9 1303.8 241.1 401.0 739.2 2380.3 194.6 547.7 684.3 381.3 1038.8 776.7 COX7B ENSG00000131174 "Cytochrome c oxidase subunit 7B" P24311 X 77899438-77907373 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 81.4" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 2170.2;Distal tubular cells: 1934.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058041 Uncertain NA NA "HPA058041: AB_2683587" "unprognostic (1.24e-2)" "unprognostic (1.76e-3)" "unprognostic (8.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (2.11e-2)" "unprognostic (1.06e-1)" "unprognostic (2.26e-1)" "unprognostic (8.10e-2)" "prognostic favorable (6.80e-6)" "unprognostic (8.58e-2)" "unprognostic (4.62e-1)" "unprognostic (6.38e-2)" "prognostic favorable (2.43e-4)" 9.4 11.5 23.7 9.2 26.8 18.0 18.2 15.4 32.3 13.1 22.5 4.1 19.8 18.0 8.1 16.4 17.1 10.4 10.7 81.4 21.9 20.6 34.6 28.8 9.7 9.9 24.0 22.9 7.2 15.1 11.1 11.7 8.6 21.3 9.6 22.9 6.9 14.5 18.1 69.4 9.2 19.7 15.9 19.0 8.1 14.5 3.0 12.9 4.8 12.2 62.7 10.8 11.3 9.7 16.5 23.0 19.4 25.9 17.2 22.2 19.1 8.0 20.5 11.8 12.0 13.3 11.3 8.0 6.6 10.3 13.1 15.3 23.9 13.7 12.5 10.1 10.9 12.6 13.2 31.7 18.3 15.5 5.6 31.1 13.6 29.1 22.7 11.1 21.2 8.6 14.4 15.5 15.7 13.9 8.4 13.9 8.2 15.6 22.6 14.0 23.8 12.7 20.5 12.0 38.5 55.9 11.5 17.4 34.5 35.6 26.1 11.4 7.4 17.2 22.3 10.5 10.0 8.6 11.5 9.2 5.9 8.7 12.9 5.8 5.0 13.0 15.6 13.8 28.3 7.6 19.4 20.8 14.0 15.6 25.9 21.1 16.5 20.1 19.0 23.0 13.4 20.7 22.2 15.5 17.2 24.5 17.1 18.4 19.1 23.7 26.8 15.4 32.3 21.9 20.6 24.0 22.9 21.3 12.9 125.0 164.5 253.2 284.4 264.2 96.9 2170.2 624.2 230.2 216.1 350.7 33.4 385.6 1934.8 387.0 16.0 214.7 1219.2 420.4 345.1 332.3 226.1 262.9 221.6 970.7 631.3 44.5 495.8 200.1 437.7 23.1 184.6 371.7 511.2 421.2 729.5 113.4 365.0 764.5 165.9 1221.3 122.9 207.0 327.3 45.0 113.1 302.1 494.9 208.8 796.8 406.4 COX7B2 ENSG00000170516 "Cytochrome c oxidase subunit 7B2" Q8TF08 4 46734827-46909235 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 43.9" "Group enriched" "Detected in some" 7 "Early spermatids: 328.3;Late spermatids: 134.7;Spermatocytes: 292.2" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Cell line enriched" "Detected in some" 15 "Karpas-707: 28.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (2.82e-1)" "unprognostic (2.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 3.4 0.2 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.1 0.0 0.4 0.1 0.0 3.4 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 328.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.7 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 292.2 34.5 0.0 0.0 0.0 0.0 0.0 COX7C ENSG00000127184 "Cytochrome c oxidase subunit 7C" P15954 5 86617904-86620962 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 298.4" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 4397.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046647 Approved NA NA "HPA046647: AB_2679736" "unprognostic (1.45e-1)" "unprognostic (1.74e-2)" "unprognostic (9.10e-2)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (1.04e-1)" "unprognostic (3.70e-1)" "unprognostic (4.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.23e-5)" "unprognostic (4.56e-2)" "unprognostic (2.06e-1)" "unprognostic (1.46e-1)" "unprognostic (4.46e-2)" 43.3 60.4 76.4 35.7 68.1 36.8 49.6 41.1 65.0 35.0 74.8 22.7 44.0 76.0 50.7 55.5 53.7 32.6 44.4 150.2 61.8 57.6 91.6 83.1 36.0 66.1 72.0 44.2 51.9 88.8 39.3 47.3 26.5 51.5 42.7 53.9 36.2 127.6 46.1 298.4 28.0 73.3 71.5 39.7 35.5 54.2 31.2 32.1 39.7 56.3 84.9 40.1 53.9 58.0 92.8 91.6 54.1 73.4 51.2 96.5 113.9 55.5 64.2 57.7 107.6 53.9 54.3 64.7 43.2 34.7 28.7 40.6 74.5 101.3 75.7 47.3 31.9 78.1 60.6 51.0 82.1 47.1 56.1 78.3 60.5 99.2 76.9 45.1 71.9 72.2 63.5 70.8 36.5 50.2 82.4 45.8 66.0 36.6 89.1 41.9 110.9 74.5 90.7 61.3 55.5 185.9 72.5 67.3 139.2 85.7 106.5 72.0 52.6 41.5 97.8 91.1 65.6 99.3 98.1 45.3 26.7 49.0 45.7 82.5 86.4 99.9 87.4 68.5 84.2 50.4 38.0 72.1 54.1 58.1 73.4 72.5 92.8 91.1 71.8 91.6 79.4 96.5 84.2 7.3 51.2 68.2 85.2 80.2 113.9 76.4 68.1 41.1 65.0 61.8 57.6 72.0 44.2 51.5 32.1 476.4 561.1 1097.3 719.7 642.7 245.3 4397.0 1722.3 686.6 645.0 1151.5 147.3 1042.4 4003.9 1050.4 765.0 580.9 1905.7 373.8 1318.7 727.2 613.8 874.5 590.4 2267.2 1206.0 217.7 881.2 710.8 1215.4 325.7 912.7 888.1 1057.8 1208.3 1577.3 394.4 1159.8 1813.1 677.5 3328.8 216.7 588.6 707.6 958.9 346.1 817.7 1104.6 792.5 1997.9 1118.8 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974607-63976543 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 275.5" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 1984.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055942 Supported NA NA "HPA055942: AB_2682979" "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 41.4 42.8 54.0 32.8 53.4 50.4 47.4 40.9 60.3 30.2 76.6 18.2 35.5 69.0 23.3 31.2 63.3 35.9 43.9 154.9 41.5 41.0 78.8 61.1 38.1 50.8 54.5 34.0 24.7 43.0 38.7 37.6 32.2 35.7 37.9 51.6 35.9 54.4 50.2 275.5 31.2 66.7 29.9 37.0 31.0 50.8 18.7 24.3 44.6 42.4 121.7 34.8 38.8 29.8 52.7 114.8 87.8 108.6 51.0 75.7 80.3 60.3 80.6 52.0 51.6 22.3 27.3 37.7 32.0 35.9 63.6 49.5 53.8 49.6 28.8 70.9 44.5 60.2 60.3 40.0 55.1 21.8 42.3 69.5 41.9 65.4 63.1 35.8 42.2 54.6 35.2 41.9 50.9 41.1 28.4 39.4 68.6 48.7 62.8 39.9 157.1 59.7 143.7 47.3 72.0 141.6 46.8 41.8 121.1 51.4 51.0 47.2 66.8 38.1 55.4 78.5 23.2 81.4 45.9 24.2 37.0 50.2 79.2 37.3 78.9 61.8 44.4 48.1 41.7 44.3 78.3 101.8 87.8 57.5 108.6 42.4 52.7 63.2 56.4 114.8 46.4 49.0 53.4 71.3 51.0 97.9 113.0 75.7 80.3 54.0 53.4 40.9 60.3 41.5 41.0 54.5 34.0 35.7 24.3 208.4 199.1 288.8 299.8 261.7 169.3 1162.0 458.6 376.1 244.5 415.2 68.7 392.2 1984.5 389.4 7.0 198.9 1123.7 140.2 421.4 448.5 223.4 381.0 221.4 677.3 801.9 101.7 693.6 209.3 461.0 13.2 221.8 429.5 595.5 445.4 846.8 231.3 439.3 874.7 207.9 1094.8 128.1 155.2 347.5 51.9 59.0 324.2 306.9 320.7 910.0 526.5 COX8C COX8-3 ENSG00000187581 "Cytochrome c oxidase subunit 8C" Q7Z4L0 14 93347191-93348356 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 72 "testis: 72.8" "Group enriched" "Detected in some" 11 "Early spermatids: 811.2;Late spermatids: 1407.4;Spermatocytes: 393.6" "Group enriched" "Detected in some" 8 "ovarian cancer: 2.9;testis cancer: 6.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "U-937: 18.0" "Not detected" "Not detected" HPA003127 Approved NA NA "HPA003127: AB_1078560" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (3.76e-3)" "unprognostic (2.11e-1)" "unprognostic (2.77e-2)" "unprognostic (7.71e-2)" "unprognostic (3.83e-1)" "unprognostic (1.99e-2)" "unprognostic (8.28e-2)" "unprognostic (6.33e-2)" "unprognostic (2.64e-2)" "unprognostic (9.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 72.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 811.2 0.0 0.0 0.0 0.0 10.6 0.2 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1407.4 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 19.4 0.0 393.6 80.8 0.1 2.9 0.0 0.0 0.1 CP ENSG00000047457 Ceruloplasmin P00450 3 149162410-149222055 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Copper transport, Ion transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "liver: 311.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 505.9;Club cells: 754.1;Hepatocytes: 1101.0;Muller glia cells: 606.4" "Cancer enhanced" "Detected in many" "liver cancer: 98.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "EFO-21: 82.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA001834, CAB008591" Supported "Secreted to blood" NA NA 160000000000 830000000000 "CAB008591: AB_1613734, HPA001834: AB_1078502" "unprognostic (3.58e-1)" "unprognostic (4.24e-1)" "unprognostic (9.61e-2)" "unprognostic (1.80e-2)" "unprognostic (4.14e-2)" "unprognostic (1.02e-2)" "unprognostic (1.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "unprognostic (6.03e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.68e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (2.70e-1)" 1.8 0.7 2.6 0.6 5.7 0.4 3.5 2.6 3.5 10.5 2.0 2.5 0.0 1.7 2.3 0.3 1.1 1.5 0.5 6.6 3.6 1.7 1.6 311.1 2.1 2.4 4.2 0.9 0.4 1.2 1.4 5.3 1.9 9.4 2.1 2.7 15.5 6.9 0.4 1.2 2.0 2.6 0.7 4.8 3.5 0.7 0.5 4.4 0.0 2.8 0.4 3.0 3.2 2.9 1.3 0.8 0.6 1.0 0.3 1.3 0.4 0.0 4.9 4.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.2 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.1 1.8 4.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 1.0 0.5 0.8 0.6 0.8 0.9 0.4 0.5 0.6 1.3 0.4 1.3 0.4 0.3 0.4 0.8 0.4 0.4 2.6 5.7 2.6 3.5 3.6 1.7 4.2 0.9 9.4 4.4 17.9 59.9 35.0 6.7 3.0 6.0 0.4 86.6 505.9 754.1 8.7 5.9 0.0 0.0 26.9 0.5 5.3 0.0 93.5 17.8 0.2 12.7 23.8 2.3 1101.0 0.6 4.8 0.0 42.4 37.9 0.4 0.3 3.4 0.0 2.8 0.0 606.4 111.7 0.0 0.4 0.1 13.8 0.0 2.6 0.0 0.0 2.3 0.2 4.3 0.0 44.8 CPA1 CPA ENSG00000091704 "Carboxypeptidase A1" P15085 7 130380339-130388114 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 3231 "pancreas: 3541.6" "Cell type enriched" "Detected in some" 10 "Exocrine glandular cells: 8426.3" "Cancer enriched" "Detected in some" 639 "pancreatic cancer: 1377.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AN3-CA: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021836, CAB025197, HPA052215" Enhanced "Secreted to digestive system" NA NA 17000000 "CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764" "unprognostic (8.41e-2)" "unprognostic (9.24e-4)" "unprognostic (5.22e-2)" "unprognostic (1.76e-1)" "unprognostic (3.97e-1)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.34e-6)" "unprognostic (4.99e-1)" "unprognostic (1.67e-1)" "unprognostic (2.16e-1)" "unprognostic (4.37e-2)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.0 3541.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.3 0.0 0.3 0.0 1.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 5.0 13.2 1.2 0.0 0.0 0.0 8426.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 5.9 0.9 0.0 0.0 77.5 0.0 2.3 847.8 0.0 0.7 0.0 0.0 0.0 0.0 0.5 2.4 0.0 1.4 0.0 0.0 0.0 CPA2 ENSG00000158516 "Carboxypeptidase A2" P48052 7 130266827-130289798 "Enzymes, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 529 "pancreas: 1357.9" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 4303.0" "Cancer enriched" "Detected in many" 60 "pancreatic cancer: 411.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA020342, HPA021317" Enhanced Approved "Golgi apparatus" "Secreted to digestive system" NA NA 1500000 "Golgi apparatus" "HPA020342: AB_1846007, HPA021317: AB_1846008" "unprognostic (1.12e-1)" "unprognostic (3.97e-1)" "unprognostic (4.21e-2)" "unprognostic (1.82e-2)" "unprognostic (1.38e-1)" "unprognostic (6.76e-2)" "unprognostic (4.65e-2)" "unprognostic (1.08e-1)" "unprognostic (1.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.66e-1)" "unprognostic (3.84e-5)" "unprognostic (7.52e-2)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (8.48e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1357.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.1 0.2 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.5 0.0 0.1 0.0 0.0 0.0 0.7 0.0 7.5 0.0 0.0 1.0 0.0 0.6 0.0 1.4 0.0 0.1 1.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.4 0.0 6.2 0.1 0.1 0.7 3.4 0.0 0.2 0.0 2.1 0.3 0.0 0.2 0.0 0.0 1.1 0.8 0.6 0.0 0.7 0.2 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.7 6.6 3.8 0.0 0.8 0.0 4303.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 24.4 0.0 2.8 764.8 8.6 0.0 0.0 0.3 0.0 0.0 0.3 1.5 0.1 0.2 0.0 0.2 0.1 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865256-148897196 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 111.7" "Cell type enriched" "Detected in some" 15 "granulocytes: 4120.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1118 "basophil: 111.7" "Lineage enriched" "Detected in single" 1118 "granulocytes: 111.7" "Cell line enriched" "Detected in some" 43 "HEL: 81.5" "Low region specificity" "Detected in single" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 12.4 0.6 0.4 12.0 0.4 5.6 6.2 0.4 0.5 25.4 14.1 0.8 4.4 7.1 14.1 21.2 16.5 3.7 50.9 4.5 0.4 0.2 5.8 2.8 37.3 15.2 0.4 0.4 2.0 7.2 0.7 0.8 1.3 0.5 37.3 16.4 8.5 8.8 5.8 1.4 12.7 20.2 24.3 0.4 1.0 13.7 7.1 0.4 3.6 1.4 9.9 7.1 14.0 8.9 0.0 0.0 111.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 81.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.5 0.4 29.8 269.3 0.0 0.2 1.4 0.0 0.2 0.0 16.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.1 4120.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.3 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 19.4 1.0 0.0 0.0 0.1 0.3 0.0 15.6 29.6 15.9 3.9 0.1 1.7 0.0 3.0 6.6 16.1 1.1 0.0 8.6 16.5 0.0 0.0 0.0 6.3 0.4 0.4 0.0 0.0 0.2 13.9 1.4 2.0 55.9 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.1 0.1 2.3 0.0 16.1 0.0 7.5 0.8 0.0 0.0 10.3 4.9 0.1 6.3 0.1 0.0 11.9 3.9 32.8 1.3 1.5 0.0 0.0 0.0 59.0 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 3.0 0.3 0.0 0.5 15.8 0.0 0.3 0.0 2.7 2.3 0.0 0.0 3.7 0.0 0.5 0.3 0.1 0.0 0.0 45.1 1.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 27.0 7.9 0.0 0.0 0.9 CPA5 ENSG00000158525 "Carboxypeptidase A5" Q8WXQ8 7 130344816-130368730 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "blood: 25.2;testis: 30.4" "Group enriched" "Detected in some" 20 "Early spermatids: 46.3;Late spermatids: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 8.0;naive CD8 T-cell: 20.3;T-reg: 25.2" "Lineage enriched" "Detected in single" 114 "T-cells: 25.2" "Cell line enhanced" "Detected in some" "RH-30: 11.2;RT4: 5.1;U-266/84: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020322 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA020322: AB_10960562" "unprognostic (2.44e-1)" "unprognostic (3.76e-1)" "unprognostic (1.50e-1)" "unprognostic (5.94e-2)" "unprognostic (4.96e-2)" "unprognostic (7.10e-3)" "unprognostic (1.64e-2)" "unprognostic (1.41e-2)" "unprognostic (3.26e-1)" "unprognostic (5.02e-2)" "unprognostic (5.83e-4)" "unprognostic (1.43e-1)" "unprognostic (8.88e-13)" "unprognostic (5.16e-2)" "unprognostic (1.32e-1)" "unprognostic (8.81e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.4 0.0 1.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.4 0.1 0.1 1.6 0.0 30.4 0.1 0.1 0.1 0.1 0.7 0.8 0.1 0.0 0.0 0.2 0.0 0.0 25.2 3.1 0.8 0.0 0.1 0.6 0.0 0.0 0.0 0.4 3.3 0.2 0.4 2.4 0.0 0.0 0.0 0.0 1.1 0.1 0.4 0.7 0.0 0.0 1.9 0.7 0.7 1.2 0.5 0.0 0.0 0.0 1.1 0.0 1.2 1.4 0.0 0.9 0.0 1.6 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 11.2 0.4 1.5 5.1 1.4 0.2 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 8.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 8.0 4.1 0.0 0.0 2.1 20.3 0.0 0.0 0.0 0.0 25.2 3.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 2.8 0.0 0.0 46.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 106.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 1.9 0.0 3.9 0.0 0.0 0.0 CPA6 CPAH ENSG00000165078 "Carboxypeptidase A6" Q8N4T0 8 67422038-67746385 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 16.2;prostate: 10.6;retina: 13.0" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 26.9;Early spermatids: 15.2;Muller glia cells: 22.3;Pancreatic endocrine cells: 12.5;Urothelial cells: 26.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5;OE19: 4.2" "Region enriched" "Detected in single" 10 "olfactory region: 15.5" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (2.85e-2)" "unprognostic (1.95e-1)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (2.58e-1)" "unprognostic (2.24e-1)" "unprognostic (2.08e-1)" "unprognostic (2.88e-1)" "unprognostic (9.35e-2)" "unprognostic (1.65e-1)" "unprognostic (5.23e-2)" "unprognostic (6.99e-2)" "unprognostic (3.57e-4)" "unprognostic (9.61e-5)" "unprognostic (1.75e-1)" "unprognostic (9.09e-2)" "unprognostic (1.41e-2)" 0.2 0.1 0.1 9.8 0.1 0.2 0.2 0.1 0.1 9.4 16.2 0.7 0.8 0.2 8.3 1.7 3.7 0.2 0.3 0.1 0.2 0.1 0.3 0.1 0.7 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.3 0.3 10.6 7.2 13.0 0.1 0.7 0.1 0.2 1.3 3.4 0.7 0.3 0.5 1.3 0.0 0.0 0.2 1.5 0.6 4.1 5.5 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 6.2 0.0 0.0 3.5 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.8 0.0 4.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 26.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.3 0.0 0.0 5.6 0.0 0.0 0.1 1.6 2.4 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.7 22.3 12.5 2.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 26.0 CPAMD8 "K-CAP, KIAA1283, VIP" ENSG00000160111 "C3 and PZP like, alpha-2-macroglobulin domain containing 8" Q8IZJ3 19 16892947-17026815 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 19.3;retina: 23.7;seminal vesicle: 30.5" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 21.4;Collecting duct cells: 26.2;Glandular cells: 18.0;Leydig cells: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "BEWO: 14.7;EFO-21: 9.5;T-47d: 25.8" "Not detected" "Not detected" "HPA031327, HPA031328, HPA031329, HPA031330" Uncertain Uncertain "Focal adhesion sites" "Secreted to blood" NA NA 180000 "Focal adhesion sites" "HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788" "unprognostic (4.71e-3)" "unprognostic (1.07e-2)" "unprognostic (4.20e-2)" "unprognostic (2.76e-2)" "unprognostic (4.32e-2)" "unprognostic (4.06e-3)" "unprognostic (7.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-2)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" "unprognostic (8.69e-2)" "unprognostic (1.01e-3)" "unprognostic (2.08e-1)" "unprognostic (8.45e-2)" "unprognostic (1.80e-2)" 3.1 1.3 1.0 0.4 2.3 0.2 3.6 0.6 2.3 5.3 0.4 2.9 6.5 0.2 1.5 8.2 0.6 0.6 0.4 7.0 1.2 1.3 8.9 0.5 11.5 1.5 4.9 0.4 0.6 0.4 3.5 2.0 3.1 5.1 19.3 0.0 23.7 1.1 30.5 1.7 0.4 0.4 0.4 5.6 1.1 0.1 0.9 2.8 0.9 11.6 1.4 0.4 1.2 1.4 0.2 0.0 0.6 1.5 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 9.5 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.2 0.5 0.0 0.0 1.4 0.0 0.1 0.4 2.0 0.0 0.0 0.0 0.4 0.0 0.1 25.8 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 2.3 0.6 2.3 1.2 1.3 4.9 0.4 5.1 2.8 20.8 21.4 0.0 10.1 0.8 0.4 4.8 2.5 1.4 12.5 26.2 0.0 6.4 0.0 0.6 1.5 8.6 0.0 0.0 0.0 5.0 2.4 18.0 2.3 0.0 2.6 0.0 0.0 12.9 6.6 3.6 29.1 1.5 0.0 0.0 0.4 0.0 0.9 0.8 6.0 0.0 0.0 0.0 2.8 5.4 1.0 0.5 5.0 0.0 0.0 3.4 CPB1 ENSG00000153002 "Carboxypeptidase B1" P15086 3 148791102-148860187 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 590 "pancreas: 3628.4" "Cell type enriched" "Detected in some" 7 "Exocrine glandular cells: 6332.0" "Group enriched" "Detected in some" 312 "breast cancer: 293.8;pancreatic cancer: 641.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 2.8;EFO-21: 2.9;HDLM-2: 3.1;U-2 OS: 5.2;U-251 MG: 1.5;U-266/84: 2.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB026158, HPA038069, HPA046340" Enhanced "Secreted to digestive system" NA NA 6600000 "CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628" "unprognostic (6.90e-2)" "unprognostic (3.79e-2)" "unprognostic (3.34e-2)" "unprognostic (2.64e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (6.26e-4)" "unprognostic (1.90e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (7.59e-2)" "unprognostic (4.51e-2)" "unprognostic (5.50e-8)" "unprognostic (3.08e-1)" "unprognostic (1.60e-1)" "unprognostic (4.93e-2)" 0.2 1.7 0.1 0.1 0.2 0.0 0.7 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 3628.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.2 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 1.8 1.1 6.1 1.0 3.1 3.5 0.9 0.0 0.0 0.0 0.0 2.8 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 2.9 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.2 0.0 1.5 0.0 2.4 0.6 0.0 0.0 0.0 6.1 0.7 1.1 3.0 0.9 2.2 0.9 1.3 2.6 0.3 1.8 0.9 3.5 4.5 3.1 1.0 1.1 0.6 0.9 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 9.9 0.1 0.0 0.0 6332.0 0.0 1.4 6.8 0.0 0.0 0.8 0.0 158.6 0.0 0.0 1.9 0.6 0.0 0.0 31.5 0.0 0.0 954.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.1 CPB2 "CPU, PCPB, TAFI" ENSG00000080618 "Carboxypeptidase B2" Q96IY4 13 46053195-46105033 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 82 "liver: 246.8" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 1070.7" "Cancer enriched" "Detected in some" 112 "liver cancer: 268.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 76 "Hep G2: 62.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA004146 Approved "Secreted to blood" NA NA 14000000000 "HPA004146: AB_1078397" "unprognostic (3.44e-2)" "unprognostic (1.25e-1)" "unprognostic (2.94e-2)" "unprognostic (1.89e-2)" "unprognostic (7.69e-2)" "unprognostic (1.17e-2)" "prognostic favorable (2.06e-4)" "unprognostic (1.89e-1)" "unprognostic (2.74e-1)" "unprognostic (2.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.83e-2)" "unprognostic (3.20e-3)" "unprognostic (1.34e-1)" "unprognostic (7.10e-2)" "unprognostic (3.34e-2)" "unprognostic (9.61e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 246.8 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.5 0.5 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 62.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.2 0.5 0.4 0.5 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 24.8 0.0 0.0 0.0 0.0 0.0 127.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1070.7 0.1 0.0 0.0 16.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 CPE ENSG00000109472 "Carboxypeptidase E" P16870 4 165361194-165498320 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 203.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 533.2;Cone photoreceptor cells: 585.1;Glandular cells: 402.2;Intestinal endocrine cells: 564.2;Leydig cells: 463.7;Muller glia cells: 511.1;Peritubular cells: 583.8;Rod photoreceptor cells: 443.0;Sertoli cells: 840.8;Smooth muscle cells: 614.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in many" "Hep G2: 49.0;SCLC-21H: 69.0;SiHa: 101.3;SuSa: 59.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003819, CAB024907" Supported Approved Nucleoplasm,Vesicles,Centrosome "Intracellular and membrane" NA NA 470000 Centrosome "Nucleoplasm, Vesicles" "CAB024907: , HPA003819: AB_2667054" "unprognostic (1.84e-1)" "unprognostic (5.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.70e-2)" "unprognostic (2.51e-1)" "unprognostic (1.44e-2)" "unprognostic (1.65e-1)" "unprognostic (9.52e-2)" "unprognostic (2.91e-3)" "unprognostic (9.01e-2)" "unprognostic (4.84e-3)" "unprognostic (5.56e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (4.35e-3)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (2.12e-4)" 27.7 33.8 123.1 4.4 135.5 0.9 21.5 82.9 203.7 10.7 9.6 31.6 5.3 5.0 13.3 94.3 16.4 15.7 14.0 19.6 116.9 56.3 12.0 6.3 11.0 7.6 56.9 70.7 23.4 35.5 33.9 40.0 2.2 53.0 66.5 8.8 13.2 12.0 20.1 11.0 5.5 6.2 18.5 40.5 2.8 19.2 30.4 53.3 0.9 40.7 4.3 7.7 6.3 9.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.3 8.9 1.7 7.1 0.7 0.4 0.0 3.6 1.3 2.9 0.0 0.0 0.0 2.6 0.0 0.3 0.2 3.4 0.7 0.7 0.0 13.0 0.0 3.6 49.0 0.5 0.0 0.0 17.3 3.6 0.0 0.0 17.2 0.0 0.0 0.0 0.3 1.8 2.4 0.0 0.4 5.6 0.0 2.0 0.0 0.0 0.1 0.1 0.5 69.0 22.8 101.3 12.7 0.0 59.1 7.6 0.3 0.0 2.7 7.0 0.2 0.2 3.9 0.0 0.3 2.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 123.1 135.5 82.9 82.2 116.9 56.3 56.9 70.7 53.0 53.3 0.0 9.3 0.0 67.8 23.2 533.2 32.3 40.8 0.0 3.4 21.0 585.1 0.4 0.0 15.1 5.5 57.1 1.6 0.0 1.5 0.1 129.4 402.2 0.0 7.9 0.8 66.7 564.2 115.4 9.2 11.5 463.7 12.5 82.7 1.8 12.7 511.1 19.3 2.9 583.8 9.6 443.0 840.8 614.9 17.7 9.6 18.2 0.7 1.9 3.7 11.3 CPEB1 "CPEB, FLJ13203" ENSG00000214575 "Cytoplasmic polyadenylation element binding protein 1" Q9BZB8 15 82543201-82648861 "Predicted intracellular proteins" "mRNA processing, Translation regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.0" "Cell type enhanced" "Detected in many" 15 "Late spermatids: 16.0;Spermatocytes: 18.2;Spermatogonia: 47.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 14.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 27 "B-cells: 1.8;T-cells: 3.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 16.1;U-2197: 46.5;U-87 MG: 17.0" HPA040396 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040396: AB_2676960" "unprognostic (3.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-2)" "unprognostic (7.51e-3)" "unprognostic (1.97e-3)" "unprognostic (9.50e-3)" "unprognostic (8.17e-2)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" 2.1 5.6 7.5 1.6 10.8 0.5 2.1 11.9 15.7 5.2 5.3 9.4 0.2 1.6 4.2 8.7 4.0 9.2 4.3 2.9 6.2 6.2 1.6 0.8 1.9 0.8 12.4 9.0 15.4 1.6 1.4 8.3 0.6 13.0 2.7 2.9 3.9 1.4 4.4 2.2 1.5 2.2 3.9 7.7 0.9 2.6 32.0 8.1 0.0 2.7 0.0 0.8 5.5 3.8 1.8 0.0 0.0 0.0 0.0 3.5 0.6 0.0 1.5 0.1 0.1 1.1 0.1 0.0 1.2 0.1 0.8 0.6 0.0 0.0 0.0 2.8 0.4 8.7 0.0 2.2 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.8 0.0 1.0 0.6 0.0 1.5 0.0 0.1 0.0 3.3 3.7 0.0 0.5 0.0 0.2 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.6 1.0 4.0 0.2 16.1 5.2 0.0 0.5 0.0 8.4 3.4 46.5 2.5 2.3 5.9 0.6 17.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.7 1.8 0.3 1.8 0.0 0.5 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.6 7.5 10.8 11.9 15.7 6.2 6.2 12.4 9.0 13.0 8.1 0.0 0.0 0.0 0.3 0.7 10.3 1.2 0.0 4.0 0.0 0.0 9.8 0.0 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.0 2.1 0.1 1.1 0.0 0.2 11.1 0.0 0.0 0.0 16.0 3.7 0.2 5.0 0.0 0.0 4.5 0.2 0.0 2.1 0.3 3.5 6.5 2.3 18.2 47.3 0.5 0.1 0.0 0.0 0.1 CPEB3 KIAA0940 ENSG00000107864 "Cytoplasmic polyadenylation element binding protein 3" Q8NE35 10 92046692-92291087 "Predicted intracellular proteins" "Translation regulation" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4;liver: 39.5" "Group enriched" "Detected in many" 4 "Early spermatids: 216.8;Late spermatids: 321.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.1;U-266/70: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070942 Approved "Nucleoplasm,Plasma membrane,Midbody,Cytosol" NA No Cytosol "Nucleoplasm, Plasma membrane, Midbody" "HPA070942: " "unprognostic (4.90e-2)" "unprognostic (2.12e-2)" "unprognostic (3.00e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-1)" "unprognostic (2.95e-5)" "prognostic favorable (5.06e-5)" "unprognostic (4.09e-4)" "unprognostic (2.73e-1)" "unprognostic (2.40e-1)" "unprognostic (1.47e-2)" "unprognostic (2.42e-2)" "prognostic favorable (3.84e-9)" "unprognostic (3.33e-2)" "unprognostic (7.42e-2)" "unprognostic (1.36e-2)" "unprognostic (1.40e-1)" 3.1 6.1 11.9 3.0 10.9 2.9 5.0 33.4 24.6 4.0 3.8 4.4 5.5 4.8 3.3 6.8 6.0 3.3 3.4 7.0 10.7 11.5 7.0 39.5 3.6 3.0 10.3 15.1 5.8 5.4 6.6 8.6 2.8 16.4 6.5 4.2 3.0 10.2 8.0 23.4 5.3 4.6 3.4 4.6 4.1 4.5 20.5 7.0 0.3 9.3 5.4 3.4 3.3 4.5 1.8 0.9 6.5 1.5 0.5 0.7 0.5 1.2 0.3 0.4 2.7 0.7 0.7 1.1 1.2 0.9 1.7 1.4 0.9 2.7 1.4 1.3 0.5 0.8 3.4 1.1 0.9 0.9 1.6 1.4 1.9 1.8 1.0 2.0 0.9 2.0 0.7 2.1 1.0 3.1 1.5 1.5 1.9 1.3 16.1 0.7 0.9 1.2 1.1 0.2 1.8 1.3 1.6 2.3 2.8 1.6 0.5 2.0 0.7 1.1 3.1 2.0 1.4 3.9 2.0 1.2 0.8 0.9 0.6 1.0 9.0 2.4 1.5 0.4 3.0 0.2 6.5 1.1 2.2 0.7 1.4 0.5 1.8 0.4 0.7 0.9 0.5 0.4 0.4 1.3 0.5 1.5 0.6 0.3 0.5 11.9 10.9 33.4 24.6 10.7 11.5 10.3 15.1 16.4 7.0 6.0 6.5 0.8 3.2 7.8 25.2 21.8 5.1 2.7 3.4 12.2 47.1 1.8 5.0 2.1 216.8 6.0 7.5 0.0 2.3 1.3 3.9 15.1 3.5 66.1 4.2 28.6 19.0 11.6 22.6 321.1 5.5 7.7 5.0 6.4 9.1 2.5 3.1 3.5 7.4 2.5 21.8 0.0 3.1 11.2 6.8 12.2 1.0 2.5 5.2 5.3 CPEB4 KIAA1673 ENSG00000113742 "Cytoplasmic polyadenylation element binding protein 4" Q17RY0 5 173888280-173961976 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.6" "Cell line enhanced" "Detected in many" "U-266/70: 39.1;U-266/84: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038394 Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA038394: AB_10671226" "unprognostic (2.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.12e-1)" "unprognostic (3.99e-1)" "unprognostic (8.80e-2)" "unprognostic (2.91e-1)" "unprognostic (4.58e-1)" "unprognostic (8.75e-2)" "unprognostic (2.54e-1)" "unprognostic (9.37e-3)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "prognostic favorable (4.99e-8)" "unprognostic (2.66e-1)" "unprognostic (4.73e-2)" "unprognostic (1.42e-2)" "unprognostic (3.83e-2)" 11.9 42.2 25.9 10.3 21.0 39.7 11.5 29.7 30.9 11.3 7.5 10.5 9.8 8.1 8.6 6.0 18.6 6.4 12.1 26.4 22.3 14.7 30.3 44.6 12.5 6.9 15.1 20.7 6.6 21.1 45.7 20.5 17.8 33.3 7.7 8.0 14.4 17.3 13.5 106.1 10.8 8.8 12.5 38.4 9.7 11.3 8.4 18.9 1.5 20.0 16.9 9.3 11.6 15.8 1.6 0.8 9.6 2.3 0.8 1.3 0.6 4.0 5.5 2.7 1.5 5.0 2.9 5.5 7.2 6.7 2.5 3.0 5.2 2.7 5.0 5.2 4.0 8.0 0.3 2.4 3.8 4.1 10.0 2.8 3.3 13.3 3.0 10.7 1.1 6.6 4.5 8.7 6.5 10.0 11.3 2.4 1.8 10.9 12.3 5.7 2.9 0.9 1.0 1.5 1.7 5.5 0.9 2.2 16.6 3.6 7.3 3.1 3.5 0.8 10.1 13.0 4.9 7.0 2.3 7.1 4.1 2.0 2.0 4.6 39.1 56.1 2.6 10.1 2.3 5.2 0.5 1.8 2.0 1.0 1.7 1.0 1.6 1.1 0.8 0.6 1.2 1.3 0.7 9.6 0.8 2.3 0.8 1.0 0.6 25.9 21.0 29.7 30.9 22.3 14.7 15.1 20.7 33.3 18.9 71.5 29.3 27.4 12.7 37.7 148.4 204.8 101.9 49.5 43.3 50.6 127.6 9.5 19.9 29.9 46.6 42.1 41.8 303.7 22.7 4.8 24.4 44.9 87.8 135.7 55.5 138.2 60.1 69.3 106.0 36.0 8.1 47.3 70.9 28.9 21.7 91.5 33.7 35.1 20.1 36.6 121.5 0.0 63.5 43.8 7.5 44.8 51.8 22.9 14.9 35.9 CPHXL ENSG00000283755 "Cytoplasmic polyadenylated homeobox like" 16 75714224-75726442 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "testis: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 2.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPLX1 CPX-I ENSG00000168993 "Complexin 1" O14810 4 784957-826198 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 98.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 30.5;Horizontal cells: 17.5;Intestinal endocrine cells: 20.6;Rod photoreceptor cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (9.21e-3)" "prognostic unfavorable (4.20e-4)" "unprognostic (3.45e-2)" "unprognostic (4.68e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" "unprognostic (2.26e-2)" "unprognostic (9.52e-3)" "unprognostic (2.01e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.10e-3)" "unprognostic (3.32e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (7.77e-2)" 7.8 6.5 13.1 2.9 40.7 1.5 2.4 26.3 98.8 2.2 2.5 3.9 0.0 2.8 4.2 1.5 1.6 2.3 1.9 3.0 16.9 7.6 2.4 2.4 2.8 2.4 16.3 18.3 2.4 3.0 3.4 1.7 1.8 52.8 4.4 1.7 3.8 4.4 2.5 4.5 3.0 2.8 2.0 5.4 5.6 3.2 4.9 4.2 0.0 1.8 0.0 1.6 1.7 1.7 0.2 2.3 0.1 0.0 0.0 0.8 0.0 2.7 0.2 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.2 0.9 2.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.1 0.0 1.2 1.1 0.0 1.3 2.2 1.3 0.0 0.0 0.8 0.0 0.2 43.0 6.0 0.2 2.8 0.0 0.1 4.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 13.1 40.7 26.3 98.8 16.9 7.6 16.3 18.3 52.8 4.2 0.0 0.0 0.0 3.4 0.9 30.5 3.0 0.0 0.0 3.4 0.0 3.9 0.0 1.7 0.4 1.2 10.8 0.5 0.0 0.7 2.6 0.7 2.0 0.0 3.8 0.2 17.5 20.6 8.0 0.3 1.9 1.7 0.0 1.7 0.0 1.7 13.7 0.7 2.9 0.0 0.8 15.0 0.0 1.4 4.7 8.2 1.0 0.8 1.0 1.5 1.1 CPLX2 "CPX-2, DKFZp547D155" ENSG00000145920 "Complexin 2" Q6PUV4 5 175796310-175884020 "Predicted intracellular proteins" "Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.3;epididymis: 80.1" "Cell type enhanced" "Detected in some" 29 "Horizontal cells: 90.6;Intestinal endocrine cells: 35.2;Late spermatids: 18.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Group enriched" "Detected in some" 22 "A549: 106.1;Hep G2: 64.0;SCLC-21H: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (1.36e-1)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (8.98e-2)" "unprognostic (1.23e-2)" "unprognostic (5.73e-2)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (6.22e-2)" "unprognostic (1.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.90e-5)" "unprognostic (6.88e-2)" "unprognostic (2.20e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" 1.7 23.3 72.6 2.0 32.7 1.4 1.3 79.0 95.3 1.3 2.6 2.6 0.3 2.7 1.3 80.1 1.4 1.4 1.4 1.3 68.3 16.3 1.4 1.3 2.1 1.3 37.2 26.3 1.3 7.9 1.3 11.3 1.3 17.9 1.4 2.2 0.2 1.3 1.4 1.3 1.4 2.5 1.6 4.0 1.3 5.1 3.1 3.7 0.0 1.4 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 106.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 45.2 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 72.6 32.7 79.0 66.6 68.3 16.3 37.2 26.3 17.9 3.7 0.0 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.6 35.2 0.0 0.0 18.1 0.9 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 3.8 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 CPLX3 CPX-III ENSG00000213578 "Complexin 3" Q8WVH0 15 74826547-74831802 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 506.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 5.6;Karpas-707: 4.9;SCLC-21H: 2.2;SK-BR-3: 2.8;U-266/84: 3.2;U-698: 2.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB079003 Supported NA NA "CAB079003: " 0.4 2.5 6.4 0.5 7.4 0.4 0.4 20.8 19.6 0.5 0.5 3.3 0.0 0.4 0.4 0.5 0.5 0.4 0.4 13.4 6.4 0.8 0.4 0.4 0.4 0.5 0.6 7.9 0.4 0.4 0.4 1.7 0.4 8.2 56.4 0.4 32.8 9.8 0.4 0.4 0.5 0.6 0.4 1.0 31.8 4.6 2.2 1.2 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.0 0.1 0.2 0.1 0.0 5.6 0.1 0.0 0.0 0.2 0.1 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.1 0.0 0.9 0.1 0.0 0.3 0.2 0.0 0.4 0.0 0.1 2.2 0.1 0.0 2.8 1.2 0.3 1.7 0.0 0.0 0.1 0.1 0.5 0.0 1.4 3.2 2.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 7.4 20.8 19.6 6.4 0.8 0.6 7.9 8.2 1.2 0.0 0.0 0.0 0.2 0.0 506.7 0.0 0.0 0.0 0.0 0.0 72.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 14.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 54.1 0.0 0.0 8.1 1.7 0.0 0.0 0.0 0.0 0.1 CPLX4 CPX-IV ENSG00000166569 "Complexin 4" Q7Z7G2 18 59275156-59318649 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 61.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 55.6;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 128.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "cerebellum: 6.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047627 Enhanced NA NA "HPA047627: " "unprognostic (1.85e-1)" "unprognostic (4.46e-1)" "unprognostic (4.20e-2)" "unprognostic (4.05e-2)" "unprognostic (9.90e-3)" 0.1 0.3 0.2 0.0 0.1 2.8 0.1 6.3 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.2 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.1 0.0 61.9 0.3 0.0 0.3 1.9 0.1 0.0 0.2 0.3 0.1 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.6 0.7 1.7 0.3 0.8 0.7 0.1 0.2 0.8 0.5 0.8 0.7 0.2 0.9 0.9 0.0 0.1 0.0 0.3 0.6 0.5 0.1 0.2 0.2 1.1 0.2 0.0 1.2 0.3 0.0 0.2 1.6 0.9 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.7 0.7 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.2 0.0 0.9 0.0 0.6 0.1 0.3 0.6 0.6 0.2 0.9 0.0 0.8 0.4 0.4 0.1 0.2 0.7 0.4 0.3 0.1 0.3 0.0 0.3 0.1 0.4 0.3 0.0 0.6 0.2 0.7 1.7 0.8 0.1 0.7 0.2 0.1 0.2 0.1 6.3 0.1 0.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 55.6 0.3 0.0 0.0 0.0 0.0 106.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPM ENSG00000135678 "Carboxypeptidase M" P14384 12 68842197-68971570 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 333.5;Sertoli cells: 750.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.5;myeloid DC: 11.9" "Group enriched" "Detected in many" 5 "dendritic cells: 11.9;monocytes: 15.5" "Cell line enhanced" "Detected in many" "ASC diff: 29.5;ASC TERT1: 21.0;HSkMC: 37.8;SiHa: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002657, HPA077243" Enhanced Uncertain Vesicles NA NA 5000000 Vesicles "HPA002657: AB_1078398, HPA077243: " "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.00e-4)" "unprognostic (4.58e-2)" "unprognostic (8.61e-2)" "unprognostic (1.57e-2)" "unprognostic (2.01e-1)" "unprognostic (8.42e-2)" "unprognostic (1.40e-1)" "unprognostic (1.35e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-3)" "unprognostic (8.58e-2)" "unprognostic (6.85e-2)" "unprognostic (2.59e-2)" "unprognostic (1.06e-1)" 56.1 6.6 3.8 5.4 7.0 1.1 37.2 1.2 4.9 6.5 12.9 13.2 0.9 1.6 10.7 6.1 4.1 6.4 6.5 2.9 5.3 3.0 22.1 11.6 24.1 13.0 10.9 4.3 7.5 7.8 3.2 1.0 27.9 5.5 6.2 10.8 2.7 3.2 1.7 8.2 13.0 3.7 2.5 6.7 11.4 5.9 5.8 9.3 1.1 5.1 3.5 4.5 4.4 4.4 2.8 11.9 1.3 15.5 0.3 1.3 4.7 0.0 1.5 0.0 0.0 29.5 21.0 0.3 3.9 0.4 0.7 0.9 1.2 1.6 0.2 3.9 0.5 1.7 0.0 0.5 1.0 1.7 0.0 1.0 0.0 6.4 0.1 0.1 0.4 0.7 37.8 0.2 0.4 0.8 3.5 0.0 0.1 0.0 0.0 3.0 0.6 0.0 0.2 0.6 0.0 2.1 1.2 0.2 0.0 2.9 2.3 0.1 0.0 27.7 4.3 3.3 2.3 0.4 10.3 0.1 0.5 3.2 0.2 0.0 0.1 0.1 5.1 1.7 5.2 2.3 0.3 15.5 0.1 0.1 10.2 0.0 1.4 1.2 0.0 11.9 2.8 0.7 0.1 1.3 0.3 4.7 0.8 1.3 4.7 3.8 7.0 1.2 4.9 5.3 3.0 10.9 4.3 5.5 9.3 333.5 253.0 5.4 2.5 11.0 2.5 1.6 147.7 26.8 114.9 48.8 0.0 22.1 24.9 48.5 13.5 7.1 69.0 0.0 179.6 47.4 3.8 40.7 105.6 33.4 132.7 0.0 10.4 90.2 236.7 12.1 97.2 57.6 10.1 10.8 28.4 65.4 68.6 50.7 74.3 67.7 4.3 750.3 107.2 0.5 1.9 8.7 144.2 7.9 29.3 2.4 CPN1 ENSG00000120054 "Carboxypeptidase N subunit 1" P15169 10 100042193-100081877 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "liver: 76.8" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 24.6" "Group enriched" "Detected in some" 12 "liver cancer: 26.6;melanoma: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "SK-MEL-30: 56.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 22000000000 "unprognostic (2.97e-2)" "unprognostic (2.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (6.75e-2)" "unprognostic (2.93e-2)" "unprognostic (5.26e-2)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 2.1 0.0 0.1 0.0 0.1 0.0 CPN2 ACBP ENSG00000178772 "Carboxypeptidase N subunit 2" P22792 3 194339765-194351328 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "liver: 225.5" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 157.2" "Cancer enriched" "Detected in some" 32 "liver cancer: 72.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 25 "Hep G2: 37.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA004732 Uncertain "Secreted to blood" NA NA 42000000000 "HPA004732: AB_1078561" "unprognostic (4.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.42e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.05e-4)" "unprognostic (1.27e-1)" "unprognostic (8.65e-2)" "unprognostic (8.56e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.91e-2)" "unprognostic (2.40e-1)" "unprognostic (6.90e-5)" "unprognostic (8.42e-2)" 0.2 1.1 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 8.5 225.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 2.5 0.3 0.2 0.6 0.0 0.1 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.3 37.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.4 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.9 1.1 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.3 0.5 0.5 0.2 0.4 0.2 0.5 0.4 0.0 0.6 0.3 0.6 2.5 0.2 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 157.2 0.2 0.0 0.0 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Cell type enhanced" "Detected in many" 8 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: AB_2677316" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.4 16.3 25.2 13.9 4.5 4.4 4.2 9.2 14.6 21.1 14.8 4.5 9.8 5.0 8.5 13.9 11.7 13.3 9.9 5.5 11.5 6.2 5.8 2.1 6.5 3.8 8.2 1.7 0.2 4.2 6.2 8.2 4.0 15.8 31.0 2.8 5.6 0.1 5.3 3.9 2.5 24.7 5.7 4.1 3.5 31.5 7.9 4.2 14.0 3.2 0.5 10.2 11.7 2.5 7.0 11.9 2.7 33.7 21.8 19.3 10.5 4.8 11.9 1.2 1.0 11.3 12.5 7.4 13.5 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 17.9 6.1 2.9 13.5 2.1 0.0 2.2 2.5 1.4 2.3 5.2 0.0 0.6 5.0 3.9 14.0 20.4 28.0 0.0 3.4 2.1 10.4 9.0 0.0 1.6 20.0 0.0 3.5 72.4 21.2 4.7 6.4 6.9 6.8 3.6 15.7 3.3 5.9 21.0 7.1 1.6 0.0 32.3 14.4 0.5 1.7 3.8 0.7 4.4 15.9 9.9 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2;prostate: 35.7" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 17.1;Glandular cells: 18.5;Intestinal endocrine cells: 4.7" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "A549: 9.9;AF22: 9.3;Karpas-707: 2.8;RT4: 3.1" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: AB_2732377" "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 1.4 1.4 7.0 0.8 11.6 0.8 0.7 0.4 27.2 1.0 1.1 2.5 0.7 1.6 0.9 1.6 1.1 1.2 0.7 1.9 17.5 5.3 2.1 0.8 1.2 0.7 1.3 11.8 0.7 0.8 3.8 9.5 0.7 3.1 35.7 1.0 0.1 1.1 6.0 0.6 1.0 1.4 1.2 4.6 1.8 1.4 2.3 3.6 0.0 1.1 0.0 0.7 0.7 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 9.9 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 2.8 1.3 0.6 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.6 3.1 1.4 0.6 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.2 2.3 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 7.0 11.6 0.4 27.2 17.5 5.3 1.3 11.8 3.1 3.6 0.0 0.0 0.0 0.4 0.2 0.8 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 0.1 1.6 4.7 0.0 0.0 3.6 0.3 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 1.2 0.5 0.0 0.8 1.2 1.1 0.1 0.0 0.0 0.0 0.8 CPNE5 "COPN5, CPN5, KIAA1599" ENSG00000124772 "Copine 5" Q9HCH3 6 36740775-36840002 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.1;brain: 50.3;heart muscle: 28.6" "Cell type enhanced" "Detected in many" 16 "B-cells: 43.6;Cardiomyocytes: 20.4;granulocytes: 11.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 50.3" "Group enriched" "Detected in some" 82 "memory B-cell: 27.1;naive B-cell: 12.9" "Lineage enriched" "Detected in single" 111 "B-cells: 27.1" "Group enriched" "Detected in some" 4 "Daudi: 33.0;HUVEC TERT2: 13.6;U-266/70: 11.4;U-266/84: 9.1;U-698: 15.5" "Region enhanced" "Detected in many" "basal ganglia: 100.1" "Region enhanced" "Detected in many" "basal ganglia: 166.9" HPA031369 Enhanced Approved Cytosol NA NA Cytosol "HPA031369: AB_10601801" "unprognostic (5.71e-3)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.73e-2)" "unprognostic (1.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (1.07e-1)" "unprognostic (3.07e-2)" "unprognostic (9.57e-2)" "unprognostic (1.21e-3)" "unprognostic (2.45e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.68e-2)" "unprognostic (3.80e-1)" "unprognostic (2.00e-1)" "unprognostic (3.57e-1)" 1.8 1.1 8.1 12.5 50.3 1.1 1.7 1.9 49.4 1.8 4.2 1.3 0.0 3.9 3.7 1.0 1.8 11.3 1.7 28.6 3.7 4.9 1.3 0.5 1.5 14.3 3.6 12.8 2.3 1.0 0.8 3.6 1.3 3.3 2.9 3.6 4.1 2.0 2.2 0.5 1.0 2.9 3.6 3.0 7.1 3.4 11.8 6.2 0.1 1.4 0.0 20.3 5.5 1.9 27.1 0.1 0.2 0.1 0.0 0.1 2.2 0.5 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.0 0.1 33.0 0.3 0.4 1.6 0.3 0.1 0.2 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 2.4 13.6 0.1 0.1 0.9 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.6 0.1 0.0 0.5 3.1 0.2 0.4 0.0 1.3 11.4 9.1 15.5 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.1 0.1 0.0 0.0 12.9 0.0 0.0 0.2 0.0 0.1 0.1 0.0 2.2 8.1 50.3 1.9 20.4 3.7 4.9 3.6 12.8 3.3 6.2 0.0 5.1 43.6 0.1 0.6 9.8 20.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.9 2.8 5.1 0.0 0.2 0.0 0.6 0.2 11.6 0.4 0.4 0.0 4.1 3.7 1.5 3.5 0.0 0.2 3.3 0.0 0.8 1.0 0.2 10.5 0.4 0.0 1.1 0.0 0.3 0.6 1.4 0.1 0.0 0.5 1.5 0.1 CPNE6 ENSG00000100884 "Copine 6" O95741 14 24070837-24078100 "Plasma proteins, Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;seminal vesicle: 20.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 22.1;Horizontal cells: 30.2;Late spermatids: 9.6" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.5;SK-MEL-30: 1.1;U-266/84: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031636, HPA076665" Enhanced NA NA "HPA031636: AB_10601203, HPA076665: " "unprognostic (1.02e-2)" "unprognostic (3.26e-4)" "unprognostic (1.64e-1)" "unprognostic (5.66e-5)" "unprognostic (3.51e-3)" "unprognostic (2.53e-2)" "unprognostic (2.49e-2)" "unprognostic (1.09e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-2)" "unprognostic (2.71e-1)" 1.3 1.5 36.3 1.4 25.1 1.4 1.1 19.1 41.8 1.2 1.5 8.6 1.2 4.8 1.2 2.6 3.7 1.3 1.2 1.4 34.8 16.0 7.9 4.7 1.2 1.2 11.4 20.5 1.3 1.1 1.1 2.7 1.1 20.1 3.5 1.9 2.4 1.2 20.8 1.1 1.2 5.8 1.6 5.1 1.2 1.2 1.3 5.6 0.0 1.2 0.0 1.1 1.5 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 36.3 25.1 19.1 33.2 34.8 16.0 11.4 20.5 20.1 5.6 0.0 0.0 0.0 0.0 0.1 22.1 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 30.2 0.0 0.0 0.0 9.6 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPNE7 ENSG00000178773 "Copine 7" Q9UBL6 16 89575768-89597246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 34.5;epididymis: 26.2;seminal vesicle: 21.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 12.4;Collecting duct cells: 19.2;Spermatogonia: 7.5;T-cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 8.5" "Lineage enriched" "Detected in many" 7 "T-cells: 8.5" "Cell line enhanced" "Detected in many" "HHSteC: 42.8;TIME: 23.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043359 Uncertain NA NA "HPA043359: AB_10794884" "unprognostic (6.77e-2)" "unprognostic (1.30e-2)" "unprognostic (1.43e-1)" "unprognostic (1.97e-1)" "unprognostic (3.08e-2)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.28e-3)" "unprognostic (2.55e-1)" "unprognostic (6.47e-2)" "unprognostic (5.88e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.87e-2)" "unprognostic (1.17e-1)" "unprognostic (3.08e-1)" "prognostic favorable (7.22e-4)" 0.4 0.9 9.5 1.4 6.4 1.3 1.6 0.0 14.2 1.7 0.8 3.3 34.5 4.8 0.9 26.2 1.6 1.6 4.4 0.7 8.0 14.6 3.3 0.9 1.4 0.9 4.0 9.3 0.7 1.1 0.8 11.0 0.6 4.1 1.9 0.4 0.7 2.0 21.9 0.2 2.3 2.8 0.5 0.7 1.0 4.5 2.7 1.0 1.7 0.6 0.0 0.8 1.4 0.8 0.0 0.0 0.2 0.0 1.2 8.5 0.4 0.0 9.8 0.1 0.1 16.8 17.4 0.1 4.2 1.8 6.0 4.6 9.8 8.2 0.0 3.8 1.6 0.2 6.6 6.2 0.2 2.0 2.3 4.8 0.1 7.3 0.1 42.8 0.0 1.6 6.8 0.4 3.1 11.8 20.0 0.1 6.9 10.3 0.1 14.1 1.4 3.0 1.8 6.4 6.0 7.6 0.1 0.0 6.7 0.8 0.0 5.5 0.0 1.4 2.0 0.4 0.1 1.8 1.2 23.2 11.6 0.0 7.1 0.0 0.0 0.0 1.8 11.4 6.7 4.7 0.0 0.0 0.2 1.1 0.0 8.5 0.0 2.0 3.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.3 0.4 9.5 6.4 0.0 14.2 8.0 14.6 4.0 9.3 4.1 1.0 0.0 1.1 0.0 0.8 2.1 12.4 0.8 2.5 0.0 1.2 19.2 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.7 1.3 0.9 0.0 0.5 0.2 7.5 1.0 0.0 5.7 0.1 1.3 CPNE9 KIAA4217 ENSG00000144550 "Copine family member 9" Q8IYJ1 3 9703807-9729908 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 46.9" "Group enriched" "Detected in some" 15 "Early spermatids: 13.5;Late spermatids: 33.6" "Cancer enhanced" "Detected in single" "testis cancer: 1.6" "Group enriched" "Detected in all" 4 "cerebellum: 26.6;cerebral cortex: 17.0;pons and medulla: 46.9" "Group enriched" "Detected in some" 7 "classical monocyte: 1.2;intermediate monocyte: 3.5;non-classical monocyte: 2.4;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 25 "dendritic cells: 1.4;monocytes: 3.5" "Cell line enhanced" "Detected in some" "Daudi: 5.9;U-937: 5.3" "Low region specificity" "Detected in many" NA NA "unprognostic (2.96e-1)" "unprognostic (4.75e-2)" "unprognostic (1.34e-1)" "unprognostic (5.04e-3)" "unprognostic (1.10e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (1.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-4)" "unprognostic (2.67e-2)" "unprognostic (5.44e-4)" "unprognostic (1.47e-2)" "unprognostic (8.59e-2)" "unprognostic (3.45e-1)" "unprognostic (7.48e-2)" 0.7 1.4 1.7 0.8 3.1 2.8 0.6 26.6 18.2 0.7 0.8 2.3 0.0 1.1 0.7 0.5 0.6 0.6 0.8 0.4 1.9 7.2 0.8 0.6 1.1 1.0 7.0 5.1 0.6 0.5 0.4 3.4 0.7 46.9 0.5 0.8 0.3 0.8 1.0 0.4 4.2 1.1 0.8 2.3 0.9 0.7 3.0 1.4 0.0 0.4 0.0 0.7 0.8 0.1 0.0 1.4 0.0 3.5 0.0 0.0 0.4 0.1 0.9 0.2 0.0 0.9 0.2 1.0 0.3 0.3 0.1 0.0 0.1 0.3 5.9 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.5 1.8 0.6 0.1 0.0 0.7 0.8 0.9 0.0 0.7 0.3 0.0 0.3 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.7 0.1 0.1 0.0 0.5 0.0 0.7 1.6 1.3 0.1 0.0 0.6 1.2 2.0 2.4 0.0 0.0 0.2 0.8 0.1 0.3 1.8 1.2 0.8 5.3 0.4 0.0 1.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.4 1.4 0.0 0.4 1.7 3.1 26.6 17.0 1.9 7.2 7.0 5.1 46.9 1.4 0.0 0.0 0.0 0.0 0.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.3 33.6 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.9 0.4 0.0 0.0 0.0 0.0 CPO ENSG00000144410 "Carboxypeptidase O" Q8IVL8 2 206939554-206969474 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 71.1" "Cell type enriched" "Detected in single" 6 "Early spermatids: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "basophil: 10.3" "Lineage enriched" "Detected in single" 42 "granulocytes: 10.3" "Cell line enhanced" "Detected in some" "ASC diff: 2.8;hTCEpi: 2.1;hTERT-RPE1: 2.4;NB-4: 3.9;SuSa: 2.5" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (9.39e-2)" "unprognostic (2.64e-1)" "unprognostic (2.95e-2)" "unprognostic (5.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.16e-1)" "unprognostic (9.06e-2)" "unprognostic (4.03e-1)" "unprognostic (1.33e-1)" "unprognostic (3.75e-3)" "unprognostic (1.22e-1)" "unprognostic (3.60e-2)" "unprognostic (2.52e-1)" "unprognostic (6.56e-2)" "unprognostic (4.03e-2)" "unprognostic (4.89e-2)" 0.2 0.4 0.2 0.1 0.9 0.0 0.3 0.1 0.4 0.2 0.6 0.1 1.1 0.1 0.1 9.4 0.1 0.1 0.1 0.1 0.2 0.5 0.5 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.6 0.5 0.1 0.1 0.3 0.1 0.1 0.3 0.3 0.2 0.1 71.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 10.3 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.0 2.8 1.0 1.6 0.4 0.0 0.0 0.1 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.5 0.0 0.0 0.2 0.0 0.7 0.2 0.8 2.1 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.2 0.0 0.1 3.9 0.2 0.3 0.6 0.1 0.0 0.2 1.4 0.1 0.3 0.0 0.0 0.3 0.0 2.5 0.2 0.5 0.0 0.0 1.0 0.6 0.3 0.1 0.9 0.0 0.0 0.2 0.5 10.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.4 0.2 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98521132-98593723 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.9" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 140.2;Extravillous trophoblasts: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Enhanced Mitochondria No No 140000 Mitochondria "HPA015736: AB_1847194, HPA054448: AB_2682490" "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 6.6 8.9 12.6 9.0 29.9 30.2 6.6 10.1 21.1 7.5 8.2 29.6 5.7 17.7 8.8 6.4 14.1 6.4 7.2 6.9 17.5 11.7 5.6 29.3 6.3 9.1 42.9 16.2 9.5 6.9 9.9 5.5 14.8 23.7 7.4 10.3 3.4 7.2 7.2 8.5 10.8 12.3 7.7 32.8 9.1 7.7 3.9 36.0 7.7 6.2 7.0 9.8 8.5 10.4 1.7 1.7 0.0 2.1 2.1 3.0 0.7 16.6 8.1 7.2 12.7 13.5 10.0 20.7 10.8 7.8 11.1 12.7 13.4 5.2 1.7 12.1 5.7 12.3 12.1 8.9 11.6 19.0 5.3 7.8 58.1 4.6 17.3 6.9 12.2 13.8 7.8 9.8 10.5 4.4 13.1 10.6 7.2 11.1 7.5 10.4 5.1 12.3 10.5 8.5 9.3 14.8 8.8 16.4 7.7 9.4 6.9 4.8 4.7 11.4 3.9 32.3 8.4 6.1 7.9 8.8 16.6 16.3 9.5 7.8 11.6 9.1 9.4 16.5 13.5 12.1 0.0 2.1 0.0 1.4 1.0 2.5 1.7 2.4 2.9 1.7 1.5 0.8 3.0 0.0 2.1 0.7 1.1 1.1 0.7 12.6 29.9 10.1 21.1 17.5 11.7 42.9 16.2 23.7 36.0 3.0 8.3 6.9 4.0 6.5 3.4 7.1 2.5 1.4 0.0 3.5 7.9 21.7 1.7 3.0 0.0 5.8 6.4 140.2 1.6 67.8 9.9 4.4 1.1 30.1 11.2 0.0 8.1 11.6 10.8 0.0 6.9 8.9 11.8 10.8 8.6 6.0 2.8 0.0 7.4 5.1 5.3 12.9 9.0 0.0 3.2 8.9 8.9 10.7 9.7 3.7 CPPED1 "CSTP1, FLJ11151" ENSG00000103381 "Calcineurin like phosphoesterase domain containing 1" Q9BRF8 16 12659799-12804017 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 85.5;Syncytiotrophoblasts: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 93.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 45.3;HMC-1: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040938, HPA041970" Uncertain Supported "Plasma membrane,Cytosol" No No 380000 Cytosol "Plasma membrane" "HPA040938: AB_10673443, HPA041970: AB_2677774" "prognostic unfavorable (9.72e-4)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (1.13e-3)" "unprognostic (3.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.67e-2)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (6.26e-2)" "unprognostic (3.64e-1)" "prognostic favorable (1.62e-9)" "unprognostic (5.05e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-3)" "unprognostic (2.40e-2)" 10.9 11.5 8.3 14.3 14.3 9.5 8.5 2.7 11.8 9.2 13.8 20.8 7.4 16.3 8.2 6.2 23.1 7.2 8.9 10.7 11.2 9.5 26.2 31.4 10.4 21.2 20.7 7.7 6.4 4.1 4.3 6.5 36.6 17.6 9.1 11.9 10.2 15.1 7.3 6.4 6.8 20.5 10.0 22.1 27.4 8.1 18.2 13.1 5.8 11.1 8.4 16.9 9.8 9.6 1.5 23.1 93.6 43.7 1.9 1.8 14.6 1.5 9.5 1.0 2.5 4.0 8.5 0.1 17.4 4.7 9.3 7.6 4.6 4.9 2.3 18.0 12.6 4.1 0.1 0.0 4.3 9.7 5.3 2.6 19.7 1.4 45.3 2.5 0.0 42.8 8.5 0.9 0.8 6.7 0.0 13.9 3.2 6.8 1.4 22.8 1.9 1.7 9.1 2.8 0.7 1.3 3.7 6.1 4.9 14.1 3.0 5.0 3.3 0.0 15.8 6.2 5.2 3.4 4.3 20.8 13.5 2.8 0.0 0.0 0.0 0.3 3.6 3.0 10.0 2.8 6.1 30.6 19.3 1.3 43.7 1.1 1.5 1.1 1.4 23.1 1.0 0.3 0.8 93.6 1.9 40.6 5.6 1.8 14.6 8.3 14.3 2.7 11.8 11.2 9.5 20.7 7.7 17.6 13.1 8.9 18.4 13.0 2.9 4.0 3.6 8.2 7.6 10.7 6.8 14.0 7.9 85.5 51.4 33.8 2.3 11.3 13.5 0.0 10.9 10.0 9.3 3.3 52.1 38.5 44.3 9.5 5.8 7.4 74.6 2.3 14.4 42.4 6.8 27.9 7.5 12.5 30.7 13.6 22.6 51.8 5.5 25.8 4.2 1.6 11.5 4.0 110.3 7.4 10.6 1.4 CPQ "LDP, PGCP" ENSG00000104324 "Carboxypeptidase Q" Q9Y646 8 96645227-97149654 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 94.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 62.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 37.0;ASC TERT1: 42.5;hTERT-RPE1: 34.7;Karpas-707: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023235, HPA024490" Enhanced Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 51000000 "Golgi apparatus, Vesicles" "HPA023235: AB_1855257, HPA024490: AB_1855258" "unprognostic (4.04e-2)" "unprognostic (5.46e-2)" "unprognostic (4.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "unprognostic (3.98e-3)" "unprognostic (5.24e-2)" "unprognostic (2.92e-2)" "unprognostic (2.67e-2)" "unprognostic (9.19e-2)" "unprognostic (2.38e-3)" "unprognostic (6.16e-3)" "prognostic favorable (5.40e-5)" "unprognostic (6.74e-3)" "unprognostic (8.71e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" 17.4 12.6 12.5 10.1 18.3 9.5 15.4 8.3 11.3 26.3 16.5 19.4 21.1 9.4 24.5 19.5 9.1 16.8 20.0 24.1 14.0 9.2 26.4 22.1 13.9 12.3 27.6 8.8 35.3 18.8 20.7 14.2 12.4 16.6 18.1 10.9 19.8 10.9 18.6 5.0 9.1 14.1 30.8 15.3 12.9 14.5 7.3 24.5 1.3 94.4 8.1 7.2 16.9 19.3 1.8 12.8 62.6 17.5 6.3 7.3 8.4 0.6 1.9 1.6 0.4 37.0 42.5 0.5 11.3 17.1 4.0 8.4 1.3 0.7 1.0 9.2 17.8 5.8 0.6 0.7 0.8 3.9 10.2 1.5 9.6 1.8 5.6 8.2 2.3 12.5 22.2 2.0 4.6 1.1 34.7 1.8 0.6 9.3 30.9 9.1 0.6 0.3 4.7 1.2 0.8 1.9 2.1 0.3 0.5 8.3 4.3 1.2 0.8 4.0 0.4 8.7 10.1 4.3 9.3 8.1 17.7 2.1 0.8 4.2 3.1 0.7 0.4 11.2 7.7 11.7 5.4 17.5 10.8 7.3 12.0 7.3 1.5 5.5 6.3 12.8 1.8 5.0 6.7 62.6 6.3 11.0 3.7 5.7 8.4 12.5 18.3 8.3 11.3 14.0 9.2 27.6 8.8 16.6 24.5 11.9 12.2 10.4 23.2 17.2 13.3 24.2 48.4 5.3 9.1 45.4 27.5 10.3 14.9 15.7 4.0 23.3 10.7 0.0 9.4 1.2 64.4 11.1 36.9 37.7 48.7 9.5 13.3 50.3 56.8 5.7 67.0 38.8 74.2 14.4 6.1 41.4 11.7 8.6 68.6 42.8 14.9 51.8 32.1 4.7 3.6 11.4 5.0 17.9 10.9 12.0 CPS1 ENSG00000021826 "Carbamoyl-phosphate synthase 1" P31327 2 210477682-210679107 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Urea cycle" "Allosteric enzyme, Ligase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 298.3" "Cell type enriched" "Detected in many" 72 "Hepatocytes: 1670.2" "Cancer enriched" "Detected in many" 8 "liver cancer: 136.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 90.5;SK-BR-3: 27.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB003781, HPA021400" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA 2100000 "Nucleoli, Nucleoli rim" "CAB003781: , HPA021400: AB_1847197" "unprognostic (1.67e-2)" "unprognostic (3.72e-2)" "unprognostic (4.02e-2)" "unprognostic (7.21e-7)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "prognostic favorable (6.93e-5)" "unprognostic (1.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.35e-2)" "unprognostic (5.38e-2)" "unprognostic (1.94e-3)" "unprognostic (2.38e-4)" "unprognostic (5.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.14e-2)" "unprognostic (3.74e-2)" 0.4 0.1 0.5 0.3 1.6 0.0 0.8 0.3 0.7 0.4 0.2 0.7 0.3 31.5 0.3 0.7 0.5 0.2 0.4 0.3 0.5 0.4 0.6 298.3 0.2 0.3 1.5 0.8 0.7 0.2 0.0 0.4 1.1 1.4 0.3 0.0 0.6 0.2 0.2 0.3 0.3 17.2 0.4 2.3 0.3 0.2 1.3 0.5 0.0 0.4 0.4 0.1 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.4 6.3 4.3 4.2 7.4 6.7 2.3 2.7 2.7 4.2 0.6 0.0 1.0 0.1 2.5 3.8 1.1 0.2 3.8 6.8 0.0 1.9 4.0 90.5 5.6 1.4 2.1 0.0 3.8 2.8 5.3 5.4 6.9 0.3 1.7 4.0 0.3 4.4 1.1 0.1 0.2 2.4 0.0 0.6 0.2 5.8 0.5 5.7 0.0 0.1 0.4 15.8 27.3 3.0 8.5 0.0 0.7 3.0 7.0 2.1 2.1 4.9 0.0 0.3 0.0 4.6 4.4 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.3 0.7 0.5 0.4 1.5 0.8 1.4 0.5 11.9 9.6 20.7 0.5 1.9 1.1 0.7 15.3 1.4 6.8 1.8 7.9 0.3 0.0 0.1 23.2 1.4 0.3 23.3 0.2 0.4 2.5 1.2 3.5 1670.2 0.2 0.0 0.0 16.5 22.7 3.6 2.3 1.8 1.7 0.0 0.1 1.4 0.0 0.0 1.1 0.7 2.2 0.0 2.5 0.3 1.1 1.6 17.4 5.0 0.1 0.4 CPT1B "CPT1-M, M-CPT1" ENSG00000205560 "Carnitine palmitoyltransferase 1B" Q92523 22 50568861-50578465 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 162.2;skeletal muscle: 59.8" "Group enriched" "Detected in many" 6 "Early spermatids: 35.8;Late spermatids: 93.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA079265 Enhanced NA NA "HPA079265: " "unprognostic (1.66e-1)" "unprognostic (2.99e-1)" "unprognostic (6.71e-3)" "unprognostic (2.53e-2)" "unprognostic (1.36e-1)" "unprognostic (1.18e-3)" "unprognostic (8.89e-2)" "unprognostic (7.16e-2)" "unprognostic (5.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.10e-3)" "unprognostic (9.76e-3)" "unprognostic (7.37e-2)" "unprognostic (4.98e-3)" "unprognostic (1.14e-1)" "unprognostic (8.43e-2)" "unprognostic (3.15e-5)" 4.3 1.5 1.7 2.9 2.7 3.3 2.8 9.1 2.0 1.7 3.1 1.8 1.6 3.8 1.6 2.9 3.7 0.9 1.6 162.2 2.1 1.9 4.0 4.2 1.9 3.5 2.5 1.6 1.6 3.1 17.2 4.5 2.3 2.2 2.5 2.9 5.2 4.3 1.6 59.8 3.8 3.7 1.6 2.2 5.0 3.8 19.7 2.3 1.9 5.2 39.6 4.5 2.0 1.6 0.5 2.3 0.7 0.4 2.3 1.6 0.3 5.3 4.9 15.7 5.8 3.6 2.1 12.4 0.6 2.0 2.6 3.0 2.3 4.7 10.6 1.8 1.2 4.1 8.8 8.3 1.9 2.4 4.3 9.2 5.3 14.3 2.4 0.9 5.5 15.4 1.2 14.3 1.9 3.1 9.9 0.5 7.5 1.8 17.9 2.5 7.5 2.1 10.7 3.4 2.7 3.3 9.7 5.1 2.3 6.7 12.6 4.4 8.5 4.0 6.4 6.5 10.1 7.0 11.6 1.1 7.7 8.2 5.1 1.8 15.3 3.5 5.5 3.6 9.8 5.2 0.0 0.4 0.5 1.0 0.1 0.0 0.5 1.6 0.3 2.3 0.2 0.4 0.2 0.7 2.3 0.2 0.3 0.1 0.3 1.7 2.7 9.1 2.0 2.1 1.9 2.5 1.6 2.2 2.3 0.0 11.2 0.0 0.0 0.2 1.8 2.8 2.5 0.0 1.2 3.5 2.0 0.4 0.0 1.6 35.8 0.4 3.9 0.0 1.8 0.5 0.6 0.0 6.9 1.9 0.5 3.2 0.0 0.6 0.0 93.5 0.3 0.7 1.7 10.8 4.9 0.2 1.1 2.5 0.7 0.3 1.6 0.0 0.3 6.9 1.7 0.3 0.3 1.3 3.7 0.0 CPT1C "CPT1P, CPTIC, FLJ23809" ENSG00000169169 "Carnitine palmitoyltransferase 1C" Q8TCG5 19 49690898-49713731 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 39.6;Horizontal cells: 30.2;Late spermatids: 17.8;Rod photoreceptor cells: 18.1" "Cancer enhanced" "Detected in many" "glioma: 9.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.8;AN3-CA: 15.8;SCLC-21H: 13.1;SH-SY5Y: 33.9;U-87 MG: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014529, HPA063621" Approved Approved Centrosome NA NA Centrosome "HPA014529: AB_1847206, HPA063621: AB_2732706" "unprognostic (1.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.03e-2)" "unprognostic (5.18e-3)" "unprognostic (1.73e-1)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "prognostic favorable (1.84e-4)" "unprognostic (4.36e-1)" "unprognostic (1.92e-10)" "unprognostic (9.44e-4)" "unprognostic (3.35e-2)" "unprognostic (3.91e-1)" "unprognostic (4.72e-3)" 3.4 9.3 11.2 3.1 18.9 0.8 1.1 16.3 34.0 4.1 1.9 8.9 0.2 2.7 6.4 5.3 1.8 4.1 7.6 2.8 11.9 12.8 1.6 1.6 2.5 2.6 8.0 13.4 3.8 1.2 0.7 15.6 1.9 11.4 2.8 1.7 7.4 1.5 4.8 1.7 1.5 2.4 7.8 6.6 4.2 1.4 4.1 6.3 0.0 1.7 0.2 1.7 4.4 1.9 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 18.8 15.8 6.8 5.4 0.0 6.0 11.9 7.7 10.8 0.3 0.0 0.3 0.0 5.9 0.9 1.4 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 11.1 0.0 0.0 6.2 0.0 6.2 0.0 2.0 10.6 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.8 1.2 3.9 0.0 0.0 0.0 0.4 0.0 13.1 33.9 0.0 0.0 0.0 0.3 0.0 0.0 8.6 0.4 0.1 3.6 3.0 0.1 1.4 0.1 14.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.2 18.9 16.3 23.4 11.9 12.8 8.0 13.4 11.4 6.3 0.0 0.0 0.0 3.3 1.9 39.6 1.2 2.5 0.0 0.0 0.0 15.7 0.8 0.0 0.0 7.9 4.5 0.0 0.0 0.0 3.6 3.1 1.5 0.0 0.0 0.3 30.2 0.0 3.1 1.2 17.8 3.1 0.0 0.0 0.0 0.0 14.9 0.5 0.0 12.4 0.0 18.1 0.0 5.3 2.7 6.9 1.6 0.9 0.0 0.0 0.9 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CPVL ENSG00000106066 "Carboxypeptidase, vitellogenic like" Q9H3G5 7 28995231-29195451 "Enzymes, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 111.9;lymphoid tissue: 84.0" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 263.6;Kupffer cells: 230.2;Macrophages: 292.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9" "Group enriched" "Detected in many" 52 "dendritic cells: 111.9;monocytes: 95.8" "Cell line enriched" "Detected in many" 4 "RPTEC TERT1: 131.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB003697, HPA045715, HPA056466" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 510000 "Endoplasmic reticulum" "CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140" "unprognostic (4.72e-2)" "unprognostic (7.08e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (8.56e-6)" "unprognostic (1.63e-1)" "unprognostic (2.49e-2)" "unprognostic (6.85e-3)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (4.98e-2)" "unprognostic (3.07e-1)" "unprognostic (4.25e-2)" "unprognostic (1.56e-2)" "unprognostic (1.79e-3)" "unprognostic (2.21e-1)" "unprognostic (7.46e-3)" "prognostic unfavorable (4.99e-4)" 19.0 6.2 4.0 15.0 9.1 11.9 7.7 11.6 3.4 9.1 10.0 7.7 4.2 7.6 6.9 20.4 6.4 7.2 10.2 30.2 6.1 4.4 39.1 12.3 13.5 30.5 6.6 2.3 10.1 8.5 0.2 6.1 31.3 20.1 8.4 6.0 15.8 3.5 5.2 7.9 5.1 13.3 8.1 9.7 84.0 4.7 10.6 4.2 29.7 51.9 5.0 8.1 11.0 15.7 0.1 111.9 1.9 95.8 0.5 0.3 74.4 0.2 0.0 3.3 0.0 0.0 0.0 31.5 0.0 0.0 0.3 0.0 9.5 0.0 0.0 15.0 0.1 15.6 0.5 8.4 0.6 0.1 0.0 7.8 10.6 0.1 22.8 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 0.1 4.4 7.1 0.0 0.2 0.0 9.8 0.0 5.2 0.0 2.6 0.0 0.0 0.0 131.9 3.6 1.9 1.5 8.6 20.6 15.9 16.8 2.4 7.9 0.0 0.0 0.1 0.0 1.9 2.9 31.7 0.1 0.0 3.9 3.3 1.0 95.8 0.4 0.2 81.6 0.3 0.1 0.1 0.1 111.9 0.1 0.1 0.1 1.9 0.5 26.0 2.9 0.1 74.4 4.0 9.1 11.6 3.4 6.1 4.4 6.6 2.3 20.1 4.2 6.0 20.2 17.9 1.1 11.1 0.0 63.1 7.6 2.7 4.5 68.0 0.0 103.1 29.9 0.5 15.2 12.6 0.0 0.0 14.2 103.4 14.2 0.2 4.7 0.5 263.6 0.0 1.7 6.7 230.2 6.4 8.6 292.5 10.1 4.6 0.8 0.2 1.2 0.0 2.8 23.9 0.3 0.0 5.7 15.2 103.9 7.8 99.1 0.9 0.9 0.9 CPXCR1 CT77 ENSG00000147183 "CPX chromosome region, candidate 1" Q8N123 X 88747225-88754785 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 12.1" "Cell type enriched" "Detected in some" 10 "Early spermatids: 56.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;Karpas-707: 3.5;U-266/70: 1.9" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 CPXM1 "CPX-1, CPX1, CPXM" ENSG00000088882 "Carboxypeptidase X, M14 family member 1" Q96SM3 20 2794069-2800637 "Enzymes, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.3" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 29.4;Leydig cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 22 "memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 26 "B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9" "Cell line enhanced" "Detected in some" "AF22: 45.9;HSkMC: 25.0;NB-4: 40.3;REH: 41.1;SH-SY5Y: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.48e-2)" "unprognostic (3.61e-1)" "unprognostic (6.70e-2)" "unprognostic (1.47e-2)" "unprognostic (3.41e-1)" "unprognostic (5.24e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (9.32e-2)" "unprognostic (7.02e-2)" "unprognostic (3.23e-2)" "prognostic unfavorable (4.62e-10)" "unprognostic (1.30e-1)" "unprognostic (1.49e-1)" "unprognostic (5.55e-3)" "unprognostic (1.27e-2)" 24.0 2.4 0.5 4.6 1.1 5.6 14.9 0.9 3.7 32.2 7.4 1.3 7.6 0.2 43.6 41.4 1.4 13.6 31.1 14.4 0.5 0.2 4.3 0.6 2.7 1.9 2.1 0.6 20.7 1.7 0.6 2.7 60.3 2.4 8.5 0.2 16.2 2.7 5.3 2.2 5.8 1.4 14.5 1.4 0.5 1.0 10.1 0.3 15.2 8.8 0.7 1.5 23.0 15.2 2.3 1.4 0.0 0.0 3.9 0.0 0.7 0.0 0.0 45.9 0.0 0.0 1.4 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.1 0.2 2.3 6.0 0.0 0.0 0.6 0.0 0.9 25.0 0.0 2.1 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.1 40.3 9.7 0.0 0.0 41.1 0.0 1.1 0.0 0.0 0.0 30.9 0.0 0.0 0.0 7.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.0 1.1 0.0 0.7 0.5 1.1 0.9 1.1 0.5 0.2 2.1 0.6 2.4 0.3 0.0 0.3 0.5 2.6 2.4 0.0 0.5 0.0 5.3 1.2 3.5 0.0 2.4 0.0 1.9 2.1 0.5 0.0 0.0 0.0 2.1 29.4 0.8 2.3 0.0 6.0 0.0 0.0 1.3 0.0 1.8 16.1 0.3 1.7 1.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.9 0.0 1.7 1.8 2.7 0.0 0.0 0.9 CPZ ENSG00000109625 "Carboxypeptidase Z" Q66K79 4 8592660-8619759 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 63.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA078608 Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "HPA078608: " "unprognostic (2.58e-1)" "unprognostic (7.16e-2)" "unprognostic (4.83e-2)" "unprognostic (1.42e-1)" "unprognostic (7.77e-2)" "unprognostic (2.20e-2)" "unprognostic (2.98e-1)" "unprognostic (7.77e-2)" "unprognostic (2.30e-1)" "unprognostic (1.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (7.23e-8)" "unprognostic (4.30e-3)" "unprognostic (3.58e-2)" "unprognostic (6.13e-4)" "unprognostic (5.51e-2)" 4.3 0.9 0.3 2.8 1.1 0.0 5.4 1.1 1.6 15.7 1.8 1.5 27.1 0.1 7.9 24.1 3.0 7.4 12.9 2.4 0.4 0.3 1.5 0.8 2.9 0.7 1.5 0.4 63.2 1.1 0.3 2.3 18.9 2.3 4.1 0.5 4.4 0.8 20.6 0.3 5.5 1.2 10.3 1.3 0.7 1.7 4.4 0.1 1.6 3.5 0.1 2.2 9.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.0 0.7 2.2 0.2 29.5 17.0 22.9 6.4 2.6 0.7 0.3 0.0 1.6 9.3 0.1 0.0 0.0 0.0 2.4 0.0 1.2 0.0 0.1 0.3 2.0 0.0 0.0 4.2 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.0 0.4 2.5 0.0 0.0 3.9 0.1 9.3 0.0 25.1 0.0 0.0 0.5 0.0 0.0 0.6 0.2 0.0 3.8 0.1 0.0 0.0 0.9 1.2 18.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.1 1.6 0.4 0.3 1.5 0.4 2.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CR1 "CD35, KN" ENSG00000203710 "Complement C3b/C4b receptor 1 (Knops blood group)" P17927 1 207496147-207641765 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.2;lymphoid tissue: 42.3" "Group enriched" "Detected in some" 4 "B-cells: 23.8;Erythroid cells: 46.7;Kupffer cells: 50.8;Macrophages: 12.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.2" "Group enriched" "Detected in some" 9 "HL-60: 9.0;HMC-1: 21.1;NB-4: 8.4" "CAB002491, CAB016271, HPA042455, HPA043579, HPA049348" Enhanced NA NA 27000000 "CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723" "unprognostic (1.74e-1)" "unprognostic (3.16e-2)" "unprognostic (2.75e-2)" "unprognostic (6.12e-2)" "unprognostic (1.58e-2)" "unprognostic (7.14e-2)" "unprognostic (2.84e-1)" "unprognostic (3.86e-2)" "unprognostic (2.02e-1)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "unprognostic (1.84e-1)" "unprognostic (2.29e-3)" "unprognostic (4.38e-2)" "unprognostic (3.32e-2)" "unprognostic (6.45e-2)" "unprognostic (3.50e-3)" 9.0 1.1 0.6 17.0 0.6 5.8 1.5 0.4 0.5 0.6 1.7 0.2 0.0 0.5 0.7 5.6 1.4 2.2 1.1 8.0 0.6 0.5 2.3 3.8 4.0 42.3 0.6 0.0 1.7 1.2 0.0 0.6 5.5 1.0 1.7 0.7 0.5 1.9 0.0 0.8 0.5 5.1 3.6 0.7 42.0 1.1 0.9 0.1 1.3 0.7 0.0 11.1 3.2 1.3 2.8 0.2 23.2 2.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 9.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.2 2.3 9.4 0.0 1.4 0.4 2.8 0.6 0.3 0.2 1.4 0.1 0.1 9.1 0.0 1.2 0.0 0.0 0.6 0.6 0.6 0.4 0.5 0.6 0.5 0.6 0.0 1.0 0.1 0.0 6.2 23.8 0.0 0.0 0.0 0.8 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 46.7 0.0 0.1 0.2 0.0 1.1 0.0 8.0 0.0 0.0 0.0 50.8 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CR1L ENSG00000197721 "Complement C3b/C4b receptor 1 like" Q2VPA4 1 207645113-207738416 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.1;brain: 4.3" "Cell type enriched" "Detected in some" 19 "Erythroid cells: 93.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 3.1;HMC-1: 7.8;K-562: 3.8" HPA049348 Approved "Intracellular and membrane" NA NA "HPA049348: AB_2680723" "unprognostic (2.35e-2)" "unprognostic (8.27e-2)" "unprognostic (1.99e-1)" "unprognostic (8.89e-2)" "unprognostic (1.31e-2)" "unprognostic (5.50e-2)" "unprognostic (2.01e-1)" "unprognostic (7.45e-2)" "unprognostic (5.27e-2)" "unprognostic (8.21e-3)" "unprognostic (7.94e-2)" "unprognostic (3.02e-1)" "unprognostic (6.33e-2)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (9.68e-2)" 0.4 0.3 0.2 1.3 2.5 6.1 0.2 0.2 4.0 0.7 0.3 0.9 0.9 0.1 0.2 0.1 0.2 1.3 0.1 0.2 0.8 0.2 3.2 0.8 2.8 1.3 1.0 1.7 0.9 0.2 0.1 0.2 2.6 1.1 0.3 0.2 0.0 0.9 1.0 0.2 0.2 0.6 0.1 4.3 1.0 0.2 0.2 3.3 0.0 0.3 0.0 0.8 0.2 0.2 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.2 4.0 0.8 0.2 1.0 1.7 1.1 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 5.0 0.4 0.0 0.1 0.0 93.5 0.0 0.2 0.0 0.3 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 CR2 "C3DR, CD21" ENSG00000117322 "Complement C3d receptor 2" P20023 1 207454230-207489895 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 97.2" "Cell type enriched" "Detected in some" 15 "B-cells: 25.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 13.3;naive B-cell: 16.2" "Lineage enriched" "Detected in many" 9 "B-cells: 16.2" "Cell line enhanced" "Detected in some" "Daudi: 21.5;JURKAT: 3.7;MOLT-4: 11.8;RPMI-8226: 4.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB002659, HPA052942, HPA060715" Enhanced NA NA 150000000 "CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349" "prognostic favorable (6.90e-4)" "unprognostic (1.22e-1)" "unprognostic (9.95e-2)" "unprognostic (3.64e-2)" "unprognostic (2.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-1)" "unprognostic (6.62e-3)" "unprognostic (1.91e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (7.95e-2)" "unprognostic (2.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.19e-1)" "unprognostic (2.09e-2)" "unprognostic (3.35e-2)" 0.5 0.3 0.4 97.2 0.3 0.0 0.4 0.3 0.3 0.3 1.2 0.0 0.0 0.0 0.3 0.0 2.8 0.3 0.3 0.3 0.4 0.4 1.4 0.4 2.0 72.8 0.4 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.5 0.9 0.0 6.0 0.0 0.4 0.3 11.5 0.0 0.4 63.4 1.4 0.5 0.0 6.5 0.7 0.3 56.3 0.6 0.3 16.2 0.0 0.2 0.0 0.0 1.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.1 11.8 0.0 1.9 0.0 0.2 0.0 0.2 4.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 13.3 0.7 0.5 0.0 16.2 1.8 1.6 0.2 0.0 0.0 0.0 0.0 1.1 0.4 0.3 0.3 0.3 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 CRABP1 "CRABP, CRABP-I, CRABPI, RBP5" ENSG00000166426 "Cellular retinoic acid binding protein 1" P29762 15 78340324-78348230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.1;retina: 73.2;thyroid gland: 80.6" "Cell type enriched" "Detected in some" 23 "Muller glia cells: 4142.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 117.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.2" "Group enriched" "Detected in some" 8 "AF22: 146.8;NTERA-2: 43.9" "Group enriched" "Detected in many" 5 "amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8" "Low region specificity" "Detected in many" HPA017203 Enhanced Supported NA NA "HPA017203: AB_1846512" "unprognostic (1.23e-1)" "unprognostic (3.76e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.01e-1)" "unprognostic (4.35e-2)" "unprognostic (1.05e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-2)" "unprognostic (9.79e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (9.37e-2)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (2.69e-1)" 0.7 1.3 6.3 1.8 25.6 0.6 24.8 2.8 12.4 1.2 1.9 3.3 0.3 0.9 1.5 1.9 0.7 0.5 1.2 0.7 1.1 21.9 4.2 0.5 0.8 0.6 16.9 4.5 0.7 0.7 0.5 6.3 7.0 40.1 1.0 1.3 73.2 0.6 24.8 0.5 12.3 2.3 1.3 7.3 21.1 1.9 0.6 2.4 0.4 80.6 2.4 1.0 0.7 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 146.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.1 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 7.8 0.0 43.9 0.1 0.1 0.0 0.0 0.0 0.0 0.2 12.3 8.3 0.0 0.0 0.0 3.7 0.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 25.6 2.8 12.4 1.1 21.9 16.9 4.5 40.1 2.4 0.0 0.0 0.0 0.0 8.7 31.5 0.0 0.0 0.0 0.0 0.0 31.4 0.7 59.7 0.0 0.0 0.0 0.2 0.0 0.0 0.4 7.4 0.3 0.0 0.0 1.3 9.5 0.0 0.0 0.0 0.0 0.0 0.0 182.2 0.0 0.0 4142.9 0.0 0.0 0.0 0.5 73.8 0.0 0.0 0.0 1.5 2.3 1.1 0.0 0.0 0.0 CRABP2 CRABP-II ENSG00000143320 "Cellular retinoic acid binding protein 2" P29373 1 156699606-156705816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 154.2;tongue: 80.5" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 286.6;Glandular cells: 140.0;Suprabasal keratinocytes: 166.6;Urothelial cells: 412.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 163.8;MCF7: 62.5;T-47d: 126.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004135 Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA004135: AB_1846516" "unprognostic (1.17e-2)" "unprognostic (9.30e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (1.75e-2)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" "unprognostic (6.45e-2)" "unprognostic (7.79e-2)" "unprognostic (7.23e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.19e-13)" "unprognostic (3.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" 4.9 1.1 1.0 1.7 3.2 0.7 16.8 1.3 2.1 66.8 1.3 1.2 38.5 0.0 13.9 2.8 154.2 13.1 2.8 1.2 0.9 2.1 1.4 0.2 0.7 0.4 0.8 2.9 5.9 0.8 2.7 5.0 7.0 3.7 6.7 0.7 7.9 10.6 28.0 0.5 25.7 0.9 8.8 1.1 0.8 0.5 1.1 0.9 2.1 2.2 80.5 33.5 10.0 66.6 0.1 0.0 0.4 0.0 0.0 1.3 0.5 10.4 0.5 12.0 0.1 15.6 23.4 0.0 22.2 163.8 1.8 2.2 18.6 38.6 0.1 11.0 23.6 0.2 13.6 2.9 0.0 0.5 0.2 0.8 0.0 1.4 0.1 3.1 0.0 0.2 7.4 1.1 2.6 0.0 1.4 0.0 0.2 0.1 0.2 0.2 62.5 0.1 0.1 14.4 1.2 5.9 0.1 0.0 0.3 0.2 0.4 29.8 2.1 0.3 38.7 0.1 23.5 126.9 0.0 0.0 0.4 6.8 3.7 1.3 1.0 2.2 0.1 3.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.2 0.0 0.1 1.3 1.2 0.4 0.0 0.0 0.0 0.0 0.5 1.0 3.2 1.3 2.1 0.9 2.1 0.8 2.9 3.7 0.9 0.0 1.6 0.0 100.3 57.8 1.7 0.6 0.0 4.0 10.3 15.7 2.0 42.7 0.0 12.0 2.0 4.3 0.4 0.0 4.5 5.4 286.6 140.0 0.0 0.0 8.9 0.0 0.0 10.4 0.0 0.7 18.4 1.0 59.1 0.0 0.5 0.8 11.9 0.0 35.3 0.0 0.5 0.0 22.7 1.4 6.6 166.6 15.1 2.9 0.6 412.9 CRACR2A "EFCAB4B, MGC4266" ENSG00000130038 "Calcium release activated channel regulator 2A" Q9BSW2 12 3606633-3764819 "Predicted intracellular proteins" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 37.6" "Group enriched" "Detected in many" 5 "Mucus-secreting cells: 48.4;T-cells: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "basophil: 12.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.3" "Not detected" "Not detected" HPA038686 Enhanced NA NA "HPA038686: AB_10671748" "unprognostic (6.78e-2)" "unprognostic (3.82e-2)" "unprognostic (3.96e-2)" "unprognostic (9.15e-2)" "unprognostic (1.40e-3)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-2)" "unprognostic (2.17e-2)" "unprognostic (5.47e-2)" "unprognostic (5.11e-2)" "prognostic favorable (2.85e-6)" "unprognostic (4.94e-3)" "unprognostic (2.01e-2)" "unprognostic (3.43e-2)" "unprognostic (1.21e-1)" "unprognostic (5.04e-2)" 1.4 0.7 0.7 6.3 1.2 10.3 3.1 0.6 0.7 1.3 5.9 0.5 1.6 2.8 0.9 1.8 0.8 0.9 2.5 2.1 0.8 0.7 0.9 1.4 1.9 4.2 0.9 0.1 1.1 10.1 0.0 0.8 0.3 0.4 6.3 9.3 0.6 37.6 0.8 0.8 2.0 5.5 2.0 0.7 4.9 2.2 1.4 0.4 13.8 1.3 2.5 8.3 1.7 1.2 2.7 0.9 12.3 1.3 3.8 6.0 2.0 7.7 2.7 0.5 0.1 1.0 3.2 6.2 0.8 0.7 2.3 3.2 5.3 1.5 11.6 0.3 3.0 0.1 0.0 9.0 0.0 3.2 17.3 2.0 10.2 0.0 0.0 1.8 14.0 0.2 2.4 0.9 7.1 0.0 0.0 6.5 11.2 7.0 5.2 2.9 6.3 12.8 6.9 3.2 14.7 0.0 6.9 7.4 2.3 0.0 10.0 5.9 1.3 1.8 1.9 0.0 0.6 0.3 8.0 9.5 0.0 9.6 7.8 0.0 0.0 0.0 15.0 0.0 6.6 0.0 12.3 1.1 2.6 6.0 1.3 5.9 2.7 3.2 4.8 0.9 1.2 1.8 3.1 1.2 3.8 0.3 0.3 1.2 2.0 0.7 1.2 0.6 0.7 0.8 0.7 0.9 0.1 0.4 0.4 0.0 1.1 0.0 1.1 0.0 0.2 3.3 0.0 5.3 5.7 0.0 2.0 0.0 0.0 1.4 1.1 0.0 1.6 0.0 2.6 0.4 0.3 6.8 0.0 0.4 1.8 0.0 0.0 2.5 2.4 1.6 1.7 0.8 0.0 0.0 48.4 0.1 1.5 0.0 4.2 0.2 0.2 0.0 0.5 0.7 0.8 0.0 0.0 12.5 3.7 1.6 CRACR2B "EFCAB4A, MGC45840" ENSG00000177685 "Calcium release activated channel regulator 2B" Q8N4Y2 11 826144-831991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "pancreas: 71.2;salivary gland: 149.6" "Cell type enhanced" "Detected in many" 8 "Mucus-secreting cells: 107.4;Urothelial cells: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "memory B-cell: 8.3" "Group enriched" "Detected in many" 4 "B-cells: 8.3;granulocytes: 6.6;NK-cells: 3.0" "Cell line enhanced" "Detected in many" "HDLM-2: 12.9;NB-4: 14.2;OE19: 14.0;SK-BR-3: 50.4;U-266/70: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046217 Approved NA NA "HPA046217: AB_10960833" "unprognostic (8.87e-2)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.81e-5)" "unprognostic (4.47e-3)" "unprognostic (8.20e-3)" "unprognostic (5.27e-3)" "unprognostic (7.31e-2)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (5.61e-3)" "unprognostic (3.49e-3)" "unprognostic (9.25e-3)" "unprognostic (5.28e-2)" "unprognostic (4.29e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-1)" "unprognostic (5.15e-3)" 1.8 1.5 0.7 4.9 0.8 3.7 15.6 0.7 0.8 2.8 7.2 0.9 10.0 6.3 1.2 2.1 2.1 1.2 9.6 3.5 0.9 0.0 3.1 0.9 4.8 1.3 0.6 0.6 0.7 71.2 3.1 5.1 0.8 1.4 9.5 4.4 1.1 149.6 21.4 1.1 4.5 9.7 1.3 0.8 2.8 15.7 1.2 0.6 0.7 1.1 4.7 9.3 7.4 2.6 8.3 1.0 6.6 1.3 3.0 0.6 0.5 1.8 1.2 0.2 0.5 0.2 0.1 5.5 0.1 0.0 0.0 0.0 1.6 6.1 0.0 2.3 0.0 0.0 1.2 0.9 0.1 0.0 12.9 0.5 6.4 1.4 3.9 0.0 4.7 0.1 0.1 0.2 0.0 0.0 0.8 0.2 0.6 7.9 4.5 0.0 3.1 0.1 14.2 0.3 14.0 0.1 1.1 0.3 11.3 4.2 1.2 1.1 0.7 0.1 50.4 0.0 0.3 7.9 4.3 0.1 0.6 0.2 0.1 0.1 12.7 1.1 1.7 2.3 6.4 0.0 4.8 1.3 6.6 0.4 0.0 0.0 8.3 0.0 0.6 0.0 2.9 0.0 0.0 0.3 3.0 0.5 1.0 0.0 0.5 0.7 0.8 0.7 0.8 0.9 0.0 0.6 0.6 1.4 0.6 6.0 16.6 8.9 4.8 0.0 1.3 7.6 25.5 24.1 50.0 12.2 0.0 3.0 13.3 12.8 2.0 18.3 22.7 0.0 32.6 0.9 0.5 40.3 1.1 0.9 3.0 0.0 11.7 46.6 4.0 3.8 2.3 1.1 0.0 1.0 107.4 10.8 21.9 42.1 1.8 3.3 6.8 12.9 1.5 0.1 5.1 0.0 1.5 2.9 38.9 58.3 CRAT CAT1 ENSG00000095321 "Carnitine O-acetyltransferase" P43155 9 129094810-129111189 "Enzymes, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6;testis: 71.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 149.6;Late spermatids: 410.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019230, HPA020260, HPA022815" Enhanced Approved "Nucleoplasm,Nuclear membrane" NA NA 13000 "Nucleoplasm, Nuclear membrane" "HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427" "unprognostic (5.13e-2)" "unprognostic (9.79e-3)" "unprognostic (1.99e-2)" "prognostic favorable (2.36e-4)" "unprognostic (2.19e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" "unprognostic (5.11e-2)" "unprognostic (3.24e-2)" "unprognostic (3.13e-3)" "unprognostic (2.03e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.38e-1)" "unprognostic (9.27e-2)" "unprognostic (1.26e-2)" "unprognostic (7.65e-2)" 11.6 13.4 8.4 4.6 9.2 5.9 10.7 7.5 15.9 8.3 15.4 8.6 6.2 24.3 6.5 9.5 9.4 5.4 10.0 17.3 7.7 7.9 12.9 50.0 4.2 3.1 8.3 9.1 7.3 33.1 16.8 3.2 7.9 9.3 10.5 4.4 8.1 14.7 7.9 98.6 7.0 22.8 8.3 5.2 4.6 8.1 71.7 4.4 2.4 8.0 20.2 4.4 9.3 6.8 2.6 11.3 6.0 11.3 6.0 10.0 8.1 0.1 18.3 6.4 13.1 12.0 16.1 9.3 7.8 8.7 9.5 6.0 3.8 7.4 0.7 4.7 13.1 12.7 3.3 1.7 2.8 3.4 11.8 0.4 3.6 9.2 14.7 17.1 0.1 14.0 14.7 0.0 8.0 0.2 12.1 12.4 3.5 1.6 3.8 9.7 3.6 0.3 8.1 1.5 19.8 8.2 9.1 12.3 6.0 9.2 0.3 2.1 6.6 0.0 4.1 2.7 2.1 26.6 4.0 11.1 14.3 1.0 17.9 7.7 13.0 11.0 0.0 16.9 2.2 9.1 2.5 11.3 6.0 5.0 7.4 10.0 2.4 6.9 6.6 11.3 2.6 4.3 4.7 2.9 6.0 7.3 5.3 6.4 8.1 8.4 9.2 7.5 15.9 7.7 7.9 8.3 9.1 9.3 4.4 6.0 3.0 5.4 4.5 2.9 1.4 52.0 20.4 1.4 3.4 3.5 2.0 38.4 14.9 16.6 149.6 12.6 94.4 0.0 19.6 46.4 21.8 14.9 6.9 58.6 18.0 1.6 14.9 14.1 8.1 410.0 20.4 8.8 5.0 9.0 16.9 13.4 12.1 38.6 23.0 41.0 1.4 6.5 14.6 94.3 6.9 4.0 42.1 10.7 22.1 9.9 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 155.1;Muller glia cells: 100.9;Rod photoreceptor cells: 136.0" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA061250: AB_2684458, HPA063127: AB_2684944" "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 0.0 0.0 0.0 0.2 0.2 12.7 1.2 0.0 0.0 0.0 0.0 155.1 0.0 0.0 0.0 1.4 0.0 0.0 23.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 100.9 0.0 0.0 0.4 0.0 136.0 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 CRB2 "FLJ16786, FLJ38464" ENSG00000148204 "Crumbs 2, cell polarity complex component" Q5IJ48 9 123356170-123380324 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Gastrulation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.9;Cone photoreceptor cells: 111.9;Rod photoreceptor cells: 97.1" "Group enriched" "Detected in some" 7 "glioma: 9.4;ovarian cancer: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043674 Approved Supported "Intracellular and membrane" NA NA 240000 "HPA043674: AB_10962974" "unprognostic (1.38e-2)" "unprognostic (2.39e-2)" "unprognostic (1.26e-1)" "unprognostic (2.83e-4)" "unprognostic (2.85e-2)" "unprognostic (1.14e-2)" "unprognostic (2.31e-1)" "unprognostic (3.69e-4)" "unprognostic (1.20e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-3)" "unprognostic (3.09e-1)" "unprognostic (5.56e-5)" "unprognostic (1.31e-1)" "unprognostic (1.55e-1)" "unprognostic (4.38e-2)" "unprognostic (3.38e-1)" 1.3 0.6 6.8 1.9 8.7 1.3 1.0 3.0 16.2 0.5 2.4 21.5 0.0 0.9 2.4 0.9 0.7 3.4 0.5 0.6 9.7 3.7 5.7 0.5 0.6 2.4 7.3 17.4 0.9 0.5 0.5 1.3 0.7 7.4 0.6 1.7 5.1 0.6 0.6 0.5 1.0 1.0 1.3 9.5 1.8 1.1 1.1 7.7 0.0 0.6 0.0 2.3 0.7 0.2 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 27.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 0.0 3.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.8 8.7 3.0 8.2 9.7 3.7 7.3 17.4 7.4 7.7 0.0 0.0 0.0 0.0 0.2 30.9 2.2 0.0 0.0 0.0 1.8 111.9 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 2.3 0.0 1.1 0.0 0.2 3.2 2.9 0.0 0.0 6.2 1.7 0.0 0.0 0.0 2.8 4.9 0.0 0.0 0.0 0.0 97.1 0.0 0.4 0.1 0.1 0.5 0.2 0.0 3.1 0.1 CRCT1 "C1orf42, NICE-1" ENSG00000169509 "Cysteine rich C-terminal 1" Q9UGL9 1 152514502-152516010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 212.8;lymphoid tissue: 82.6;tongue: 126.1;vagina: 69.4" "Group enriched" "Detected in some" 5 "Pancreatic endocrine cells: 88.8;Suprabasal keratinocytes: 32.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 68.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 10.8" NA NA "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (2.86e-2)" "unprognostic (3.30e-1)" "prognostic unfavorable (7.03e-4)" "unprognostic (1.56e-2)" "unprognostic (1.46e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 2.7 0.1 0.1 46.9 0.1 0.1 0.1 0.2 2.3 0.1 212.8 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.1 22.9 0.1 0.7 38.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 126.1 82.6 0.1 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 32.4 0.0 0.0 0.0 2.1 CREB3L1 OASIS ENSG00000157613 "CAMP responsive element binding protein 3 like 1" Q96BA8 11 46277661-46321422 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 60.7" "Cell type enhanced" "Detected in many" 14 "Mucus-secreting cells: 277.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 30.1;BJ hTERT+: 29.5;BJ hTERT+ SV40 Large T+: 27.6;fHDF/TERT166: 71.5;OE19: 28.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA024069, CAB026151" Enhanced NA NA "CAB026151: , HPA024069: AB_1854750" "unprognostic (2.46e-2)" "unprognostic (2.80e-1)" "unprognostic (1.34e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.66e-3)" "unprognostic (2.93e-1)" "unprognostic (5.41e-2)" "unprognostic (2.75e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (1.54e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.97e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (1.12e-2)" 2.5 3.6 3.7 3.1 2.3 0.0 3.0 1.6 2.9 17.2 13.1 0.9 9.5 8.6 9.7 9.2 2.2 1.7 37.6 4.8 3.3 3.5 1.4 1.5 10.4 0.5 3.4 1.7 9.7 60.7 0.0 3.3 8.2 0.6 17.6 14.1 1.8 28.3 14.3 1.6 2.3 12.9 12.8 1.8 2.2 22.1 3.8 0.2 0.4 1.8 2.2 13.0 15.1 3.4 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.3 5.9 19.1 18.3 0.1 30.1 29.5 27.6 19.2 3.0 0.0 0.0 0.1 71.5 1.9 0.0 0.3 0.0 15.4 0.0 0.3 0.4 0.1 0.0 26.6 0.0 0.4 17.6 0.0 15.6 0.5 25.1 0.2 0.1 2.4 0.0 23.1 0.0 0.0 0.0 3.8 28.4 3.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 5.6 0.0 1.0 0.0 14.5 4.3 11.1 18.3 0.0 0.0 0.0 17.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 3.7 2.3 1.6 2.9 3.3 3.5 3.4 1.7 0.6 0.2 0.0 39.0 0.0 35.2 1.3 0.0 14.6 15.3 5.3 4.5 27.9 0.0 0.7 3.3 38.7 1.0 1.3 18.0 0.0 79.2 1.7 61.0 50.4 4.6 0.0 1.7 0.0 8.7 5.5 0.0 3.9 77.3 1.8 10.1 3.6 277.8 0.0 45.1 42.1 41.8 0.5 0.0 0.0 3.6 0.9 1.1 1.9 2.9 0.0 48.7 36.7 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002067 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 120.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: AB_2669210" "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 14.9 19.8 4.7 17.1 9.8 10.8 15.7 1.9 6.0 25.4 16.7 11.4 18.7 11.6 28.2 25.5 12.8 16.2 16.2 20.4 5.6 4.3 17.0 11.7 14.6 15.2 11.8 3.7 25.9 16.0 38.4 28.8 81.6 9.8 15.9 9.5 24.9 26.5 23.3 5.0 6.9 17.5 17.7 6.2 12.1 14.1 9.8 9.1 7.0 35.8 10.9 18.1 21.3 15.7 4.6 12.4 7.4 5.6 6.5 11.8 3.2 4.0 6.3 12.0 0.2 20.5 20.4 9.0 20.4 33.0 14.3 14.5 8.6 3.7 0.8 5.5 22.1 7.8 2.2 7.0 14.9 28.0 5.9 3.5 25.7 8.6 20.5 13.6 7.7 36.9 8.4 9.5 18.0 21.1 14.7 18.8 2.1 13.2 12.0 16.7 7.3 2.4 9.5 4.3 5.6 4.5 5.4 6.5 6.8 11.2 4.2 3.1 7.2 6.6 17.1 9.1 7.3 2.5 5.8 20.0 19.2 2.9 23.1 7.4 14.2 4.9 5.3 23.0 21.8 42.5 7.4 5.6 5.9 8.2 2.9 10.6 4.0 6.0 8.6 5.8 4.6 2.2 3.8 2.1 6.5 1.5 12.4 11.8 3.2 4.7 9.8 1.9 6.0 5.6 4.3 11.8 3.7 9.8 9.1 6.0 20.4 20.6 8.1 10.9 7.2 14.1 20.4 10.7 18.2 22.7 9.8 50.6 11.6 9.3 48.0 20.2 32.0 0.0 15.3 76.5 40.4 27.0 48.5 24.5 49.4 14.3 15.1 30.1 33.2 14.1 57.2 25.1 25.3 10.0 17.0 6.7 15.1 17.3 96.9 9.1 12.4 38.8 42.4 1.1 4.3 6.1 120.8 27.3 14.9 17.2 CREB3L3 CREB-H ENSG00000060566 "CAMP responsive element binding protein 3 like 3" Q68CJ9 19 4153601-4173054 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 95 "intestine: 117.4;liver: 179.5" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 100.8" "Cancer enriched" "Detected in many" 18 "liver cancer: 91.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 1.0;T-reg: 1.5" "Group enriched" "Detected in many" 13 "granulocytes: 1.0;T-cells: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 4.6;HDLM-2: 31.5;Hep G2: 10.0;HMC-1: 5.8;U-266/70: 6.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA040671, HPA056228" Enhanced NA NA "HPA040671: AB_2677072, HPA056228: AB_2683072" "unprognostic (1.86e-2)" "unprognostic (2.13e-1)" "unprognostic (2.81e-1)" "unprognostic (1.66e-2)" "unprognostic (8.41e-4)" "unprognostic (1.79e-4)" "unprognostic (1.88e-1)" "unprognostic (5.28e-4)" "unprognostic (3.01e-1)" "unprognostic (3.61e-2)" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.53e-6)" "unprognostic (3.18e-3)" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (3.35e-2)" 0.1 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 38.6 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.5 179.5 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.4 0.0 0.1 0.1 0.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 10.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 2.6 0.3 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 6.9 2.8 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.2 0.0 0.0 0.0 100.8 0.0 0.0 0.0 2.5 3.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 8.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 54.0;Mucus-secreting cells: 48.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favorable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.3 3.3 3.1 3.4 2.2 3.3 7.8 1.9 2.2 2.6 2.3 1.5 9.7 4.2 10.1 0.8 2.0 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.6 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.4 2.3 5.1 2.4 5.3 1.2 24.9 2.7 1.1 2.1 25.3 4.0 6.2 3.2 7.8 2.8 1.6 5.9 6.3 2.0 55.0 5.2 4.2 44.1 4.5 1.4 0.8 2.4 1.6 1.5 10.0 5.1 3.1 1.7 2.6 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 6.0 12.5 2.0 15.5 2.6 4.7 1.7 10.2 18.7 12.5 1.8 2.0 11.1 8.3 11.1 0.0 4.9 3.2 0.0 11.8 13.3 3.3 54.0 5.7 12.3 4.8 0.0 8.6 3.1 7.9 0.0 6.6 2.2 5.0 1.8 48.0 6.0 7.4 3.5 2.1 3.6 7.5 19.4 3.3 3.6 8.7 2.6 3.5 4.4 11.8 3.5 CREB5 "CRE-BPA, H_GS165L15.1" ENSG00000146592 "CAMP responsive element binding protein 5" Q02930 7 28299321-28825894 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.3;brain: 38.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 53.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA050020, HPA061622" Approved "Nucleoplasm,Vesicles,Plasma membrane" NA Yes Nucleoplasm "Vesicles, Plasma membrane" "HPA050020: AB_2680993, HPA061622: AB_2684569" "unprognostic (3.59e-2)" "unprognostic (3.80e-1)" "unprognostic (1.06e-1)" "unprognostic (6.46e-2)" "unprognostic (1.01e-1)" "unprognostic (4.90e-3)" "unprognostic (2.01e-3)" "unprognostic (2.87e-1)" "unprognostic (3.31e-1)" "unprognostic (1.04e-1)" "unprognostic (3.49e-1)" "unprognostic (2.67e-1)" "unprognostic (4.91e-3)" "unprognostic (6.61e-2)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" 20.0 3.6 12.1 15.4 19.5 11.5 9.0 10.4 17.8 4.6 5.6 38.0 0.9 2.8 16.3 6.9 7.7 4.7 23.1 10.4 16.7 8.7 6.6 4.6 9.5 6.1 17.9 12.1 2.4 7.0 1.5 2.8 19.5 18.3 3.1 4.3 1.1 6.5 3.0 6.2 5.5 4.2 9.8 14.6 12.6 3.2 2.3 22.7 0.0 3.8 7.0 2.5 5.5 5.0 0.3 4.8 53.3 7.8 0.0 0.0 1.5 0.0 0.3 3.9 0.2 0.2 5.7 0.1 0.3 0.8 2.4 3.6 2.2 1.4 9.9 0.7 0.9 2.4 0.4 0.1 3.4 7.6 0.0 2.7 10.7 2.1 0.2 0.2 32.2 0.4 0.7 0.7 10.2 11.0 0.5 1.6 0.0 1.2 13.5 0.8 0.0 0.0 0.0 4.9 0.0 3.9 0.2 3.7 0.2 4.9 1.0 0.4 2.8 0.1 0.2 1.1 5.7 0.1 0.7 0.4 4.7 14.2 15.5 4.5 0.8 2.2 0.1 5.2 0.2 8.0 0.0 7.8 0.0 0.0 2.7 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 53.3 0.0 0.8 0.0 0.0 1.5 12.1 19.5 10.4 15.6 16.7 8.7 17.9 12.1 18.3 22.7 6.0 11.1 4.5 116.6 19.5 0.0 14.1 22.9 5.3 6.8 12.2 0.0 2.5 1.7 61.9 0.4 14.9 0.0 0.0 23.7 9.2 31.3 32.4 13.9 0.5 8.1 4.8 0.0 7.4 46.4 1.1 5.5 74.2 28.7 74.9 0.0 16.6 30.3 0.0 0.4 18.3 0.6 19.4 10.7 12.5 3.3 11.5 20.7 1.3 0.0 28.7 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 21.9 77.6 24.3 16.5 31.9 3.0 18.9 21.4 24.6 16.4 13.4 14.6 13.5 13.2 11.4 17.5 10.4 14.9 16.4 14.3 19.8 23.0 28.7 28.2 18.5 18.8 20.2 19.8 22.6 14.2 31.7 31.5 13.8 19.7 17.1 14.2 20.5 15.4 14.4 6.6 14.1 13.3 12.0 20.0 20.2 14.1 17.1 18.3 8.6 25.9 6.7 16.6 17.7 14.0 2.0 4.2 3.6 8.7 1.6 8.1 2.2 5.5 7.2 6.3 7.1 22.3 22.6 12.2 10.9 18.4 8.0 11.1 5.2 8.1 4.8 4.2 13.2 12.2 4.7 9.5 8.3 13.7 26.8 5.7 3.8 7.2 6.3 14.6 5.3 7.1 14.6 15.0 9.4 15.5 27.5 11.7 3.8 3.8 7.6 13.5 8.9 2.8 4.4 18.9 5.3 6.6 3.8 10.9 3.0 15.4 16.1 7.4 8.5 11.0 5.4 19.0 28.5 3.0 6.1 9.4 11.1 7.1 10.9 10.7 6.4 8.5 1.2 13.2 4.6 11.4 1.7 3.8 3.6 2.8 8.7 5.0 1.5 5.5 4.4 4.2 2.0 5.5 4.5 0.7 1.6 3.6 2.1 8.1 2.2 24.3 31.9 21.4 24.6 19.8 23.0 20.2 19.8 19.7 18.3 23.8 21.6 14.3 16.0 19.7 16.9 12.3 22.9 16.0 12.5 31.4 2.0 14.7 34.9 16.6 23.6 20.4 18.6 0.0 19.2 14.9 18.4 35.5 10.3 38.9 36.4 35.0 28.8 22.7 83.1 5.0 33.4 54.7 32.1 45.9 18.1 28.7 18.7 10.5 33.2 48.0 11.0 38.8 9.1 30.0 17.4 25.5 23.0 15.3 15.1 19.2 CREG2 ENSG00000175874 "Cellular repressor of E1A stimulated genes 2" Q8IUH2 2 101345551-101387595 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 56.0" "Cell type enhanced" "Detected in some" 13 "Collecting duct cells: 1.8;Early spermatids: 4.9;Late spermatids: 3.0;Pancreatic endocrine cells: 1.7;Spermatogonia: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "T-reg: 2.6" "Lineage enriched" "Detected in single" 5 "T-cells: 2.6" "Cell line enhanced" "Detected in some" "CACO-2: 3.6;HaCaT: 9.5;HeLa: 3.7;OE19: 10.4;PC-3: 3.8;RT4: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038224 Enhanced "Secreted in brain" NA NA "HPA038224: AB_10673167" "unprognostic (5.09e-2)" "unprognostic (3.78e-3)" "unprognostic (4.10e-3)" "unprognostic (8.15e-3)" "unprognostic (5.63e-3)" "unprognostic (9.68e-3)" "unprognostic (4.52e-8)" "unprognostic (3.86e-4)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (7.69e-2)" "unprognostic (5.41e-3)" "unprognostic (4.44e-2)" "unprognostic (2.91e-1)" "unprognostic (8.26e-3)" "unprognostic (7.77e-2)" 0.8 0.9 12.6 0.8 13.8 0.9 0.8 0.2 56.0 0.9 0.8 1.0 0.0 0.9 0.8 0.8 0.8 1.1 0.9 0.9 17.2 4.4 0.9 0.8 0.8 0.8 3.3 16.6 0.9 0.8 0.8 0.2 0.9 7.2 0.8 0.9 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.2 0.8 0.8 0.9 0.5 0.0 0.8 0.0 0.8 0.8 0.6 0.2 0.3 0.5 0.0 0.0 2.6 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.1 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 10.4 3.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.3 2.6 0.0 12.6 13.8 0.2 29.7 17.2 4.4 3.3 16.6 7.2 0.5 0.0 0.0 0.0 0.2 0.0 0.8 0.6 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.5 2.1 0.0 0.1 0.0 0.0 1.3 CRELD2 MGC11256 ENSG00000184164 "Cysteine rich with EGF like domains 2" Q6UXH1 22 49918167-49927540 "Predicted secreted proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 98.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000603, CAB025604" Approved "Secreted to blood" NA NA 270000 "CAB025604: , HPA000603: AB_1078565" "unprognostic (1.12e-1)" "unprognostic (7.35e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.42e-7)" "unprognostic (5.04e-2)" "unprognostic (5.43e-2)" "unprognostic (3.21e-3)" "unprognostic (2.71e-1)" "unprognostic (3.60e-1)" "unprognostic (1.24e-1)" "unprognostic (2.57e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (1.34e-9)" "unprognostic (6.13e-2)" "unprognostic (3.01e-1)" "unprognostic (7.30e-2)" "unprognostic (4.02e-1)" 10.2 10.1 8.1 14.1 11.5 8.6 17.2 7.2 7.9 11.1 12.5 7.7 18.0 15.0 10.8 26.1 8.5 10.0 13.2 11.3 7.5 9.6 10.5 39.3 15.7 24.3 9.5 6.6 9.5 98.1 4.8 23.1 8.1 10.9 10.8 9.5 6.9 24.9 17.6 7.3 5.4 10.9 10.0 8.1 13.8 17.6 12.8 7.5 7.4 31.1 7.8 10.5 11.6 7.1 15.8 29.4 13.0 8.2 18.8 13.7 6.8 12.9 9.1 10.5 35.0 11.4 13.0 14.5 26.8 16.6 15.3 13.1 15.5 16.0 7.0 21.7 23.3 15.4 13.0 13.3 13.6 6.6 3.8 20.7 3.8 13.6 19.3 47.3 15.1 15.1 11.8 12.2 13.2 11.1 10.8 15.5 7.9 5.5 29.6 11.4 41.1 5.9 16.0 7.6 25.7 18.6 14.0 18.8 16.7 7.3 11.9 7.1 20.0 23.0 27.5 10.7 7.3 11.3 18.5 11.3 13.3 21.9 12.1 8.4 23.7 5.6 6.1 19.5 11.4 20.7 13.0 6.8 8.9 10.4 8.2 10.6 15.8 8.9 13.7 7.6 11.5 7.3 6.1 3.5 18.8 4.6 29.4 5.9 6.8 8.1 11.5 7.2 7.9 7.5 9.6 9.5 6.6 10.9 7.5 6.0 17.3 30.4 27.9 29.1 34.1 14.8 20.4 20.1 23.9 8.7 23.6 26.3 6.6 36.6 77.4 28.6 31.5 23.3 54.9 90.3 53.6 71.5 35.7 52.1 67.2 23.8 38.2 45.4 27.6 20.1 40.9 33.7 91.1 24.4 37.3 35.9 49.0 25.4 38.9 14.0 28.3 12.9 36.2 131.8 131.6 26.8 46.1 46.8 32.5 34.2 CREM hCREM-2 ENSG00000095794 "CAMP responsive element modulator" Q03060 10 35126791-35212958 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.9" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 1553.0;Late spermatids: 579.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001818, CAB018352" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB018352: AB_673599, HPA001818: AB_1078566" "unprognostic (1.78e-1)" "unprognostic (6.26e-3)" "unprognostic (7.09e-2)" "unprognostic (2.51e-2)" "unprognostic (6.22e-3)" "unprognostic (9.27e-3)" "unprognostic (1.16e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" "unprognostic (8.98e-2)" "unprognostic (3.42e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (4.44e-2)" "unprognostic (4.19e-1)" "unprognostic (1.66e-2)" "unprognostic (1.52e-1)" 21.9 61.4 14.3 21.3 15.1 8.1 15.4 6.2 13.8 10.6 8.0 8.4 10.2 4.1 13.3 10.8 8.2 9.9 19.7 19.5 14.5 15.2 15.4 26.1 19.6 7.1 12.7 8.3 21.4 8.2 8.3 24.2 42.0 20.1 12.2 6.4 9.6 5.7 19.2 10.0 3.2 7.0 11.0 15.5 21.8 7.5 74.9 7.7 8.1 10.8 6.8 7.3 18.1 11.7 6.4 11.2 10.1 4.9 8.6 14.6 8.2 9.1 14.8 12.5 12.8 8.8 9.2 12.5 12.1 9.5 7.6 10.6 1.7 3.9 15.7 11.8 7.0 8.3 2.1 10.7 7.9 11.2 38.5 7.9 5.6 10.2 6.9 10.5 1.3 5.9 8.1 10.0 14.9 4.6 6.7 21.2 11.9 16.2 6.5 11.7 7.4 9.5 4.0 3.7 3.4 34.1 5.9 6.5 2.9 13.4 3.6 2.9 8.0 5.7 5.0 32.0 14.9 2.8 4.1 28.1 5.8 7.5 16.0 7.9 2.9 3.9 5.4 13.9 12.4 5.0 4.7 3.3 10.1 11.5 4.9 14.2 6.4 12.7 10.1 3.8 5.5 9.0 10.4 9.0 8.6 3.6 11.2 14.6 8.2 14.3 15.1 6.2 13.8 14.5 15.2 12.7 8.3 20.1 7.7 17.9 64.8 33.0 45.1 127.4 16.5 58.9 20.4 53.5 31.8 157.1 5.9 87.7 82.9 30.2 1553.0 61.6 13.0 0.0 38.6 102.1 73.7 43.8 344.6 37.7 100.7 9.5 66.1 14.1 50.2 579.8 24.2 113.1 234.5 315.6 10.3 26.0 26.6 17.5 30.8 49.4 18.2 45.3 183.3 211.4 136.9 94.7 192.3 100.1 11.0 45.0 CRH "CRF, CRH1" ENSG00000147571 "Corticotropin releasing hormone" P06850 8 66176382-66178725 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 209.9" "Cell type enriched" "Detected in some" 6 "Syncytiotrophoblasts: 134.3" "Cancer enriched" "Detected in some" 28 "urothelial cancer: 34.5" "Region enhanced" "Detected in many" "hypothalamus: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 1.4;SuSa: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 10000 "unprognostic (1.62e-1)" "unprognostic (9.68e-2)" "unprognostic (1.00e-1)" "unprognostic (9.55e-2)" "unprognostic (7.22e-3)" 2.7 0.2 4.1 0.2 2.1 0.3 0.2 0.0 6.7 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 2.7 28.4 0.2 0.2 0.3 0.2 0.4 1.1 0.2 1.3 0.2 0.1 209.9 13.8 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.5 0.1 0.2 0.4 0.9 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.0 5.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.1 0.0 6.7 2.7 28.4 0.4 1.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 134.3 0.0 0.0 0.1 CRHBP "CRF-BP, CRFBP" ENSG00000145708 "Corticotropin releasing hormone binding protein" P24387 5 76952713-76981158 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;liver: 99.9" "Cell type enriched" "Detected in some" 15 "Ito cells: 1768.4" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Region enhanced" "Detected in many" "hypothalamus: 24.9" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 5.0;BJ hTERT+ SV40 Large T+ RasG12V: 4.9;HBF TERT88: 8.9;RPMI-8226: 3.0;U-698: 9.7;U-87 MG: 5.4;WM-115: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036234, HPA046120" Approved Supported "Secreted to blood" NA NA 43000000 "HPA036234: , HPA046120: AB_10959760" "unprognostic (1.41e-1)" "unprognostic (2.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.36e-3)" "unprognostic (4.44e-5)" "unprognostic (2.16e-1)" "unprognostic (7.08e-2)" "unprognostic (4.98e-4)" "unprognostic (1.09e-1)" "unprognostic (6.63e-5)" "unprognostic (2.76e-2)" "unprognostic (4.64e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-2)" 8.4 5.6 3.5 0.4 5.4 1.2 2.6 0.0 7.8 1.6 0.3 3.2 1.8 0.4 1.2 0.7 0.2 0.9 0.5 3.2 4.0 24.9 16.1 99.9 0.3 0.4 2.7 5.4 0.8 0.2 0.4 0.0 18.1 1.8 0.6 0.3 1.5 0.6 1.9 0.5 0.2 0.3 0.8 2.2 13.9 0.3 0.5 1.2 0.0 1.9 0.9 0.4 0.5 0.2 0.0 0.0 1.2 0.1 0.0 0.2 0.8 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 5.0 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 2.6 0.0 0.1 0.0 9.7 5.4 0.0 4.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 3.5 5.4 0.0 7.8 4.0 24.9 2.7 5.4 1.8 1.2 0.0 0.0 23.4 0.0 0.3 0.0 0.6 22.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 18.4 0.0 0.0 0.2 0.3 0.4 0.0 0.0 4.9 1.6 0.0 0.0 1768.4 116.1 0.6 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.3 0.0 0.0 CRHR1 "CRF-R, CRF1, CRHR" ENSG00000120088 "Corticotropin releasing hormone receptor 1" P34998 17 45784280-45835828 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 23.2;pituitary gland: 16.5" "Group enriched" "Detected in some" 13 "Early spermatids: 37.9;Late spermatids: 37.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RT4: 8.1;SH-SY5Y: 5.0" CAB025251 Enhanced "Intracellular and membrane" NA NA "CAB025251: " "unprognostic (4.59e-2)" "unprognostic (1.43e-2)" "unprognostic (2.59e-7)" "unprognostic (1.76e-1)" "unprognostic (2.71e-1)" "unprognostic (3.94e-2)" "unprognostic (2.48e-1)" "unprognostic (4.55e-4)" "unprognostic (1.65e-2)" "unprognostic (2.21e-1)" "unprognostic (3.33e-4)" "unprognostic (2.07e-5)" "unprognostic (3.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.59e-1)" 0.8 0.6 14.7 0.5 5.1 0.5 1.5 23.2 11.5 1.4 0.6 1.1 0.0 0.8 2.7 1.1 0.5 1.6 0.7 0.5 3.2 2.2 0.6 0.5 0.6 0.5 1.8 5.2 0.6 0.5 0.6 16.5 0.6 2.9 1.3 0.6 1.9 1.2 2.5 0.6 1.4 1.0 1.2 1.0 0.5 0.5 1.0 2.8 0.0 0.9 0.0 0.5 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.6 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 5.1 23.2 11.5 3.2 2.2 1.8 5.2 2.9 2.8 0.0 0.0 0.0 1.1 1.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.5 0.0 0.1 2.3 1.5 2.9 0.0 0.0 0.0 0.5 CRHR2 "CRF-RB, CRF2, HM-CRF" ENSG00000106113 "Corticotropin releasing hormone receptor 2" Q13324 7 30651943-30700129 "G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell type enriched" "Detected in single" 13 "Horizontal cells: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (7.14e-2)" "unprognostic (4.20e-1)" "unprognostic (1.68e-1)" "unprognostic (1.24e-3)" "unprognostic (5.69e-2)" "unprognostic (8.58e-2)" "unprognostic (6.00e-2)" "unprognostic (1.86e-4)" "unprognostic (2.01e-1)" "unprognostic (3.07e-1)" "unprognostic (5.90e-4)" "unprognostic (4.02e-2)" "unprognostic (8.29e-4)" "unprognostic (3.73e-3)" "unprognostic (2.84e-3)" "unprognostic (1.81e-1)" "unprognostic (3.84e-1)" 1.4 0.7 0.9 0.5 4.1 0.4 1.6 0.5 11.7 0.8 0.6 0.0 3.6 2.1 1.1 0.5 1.7 2.1 1.0 3.2 4.3 3.2 0.8 0.4 0.6 0.6 0.9 3.2 1.0 3.9 0.9 8.0 0.4 3.1 0.9 0.9 1.7 0.7 6.2 5.5 0.8 1.2 1.1 0.8 0.3 1.0 1.8 1.0 0.0 1.7 3.2 0.6 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.3 0.0 1.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.2 0.2 3.0 0.0 0.4 0.0 0.0 0.6 0.0 0.9 1.7 0.1 0.2 0.0 0.2 0.6 0.1 0.0 0.5 0.4 1.0 0.3 0.2 0.8 0.3 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 0.5 11.7 4.3 3.2 0.9 3.2 3.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CRIM1 S52 ENSG00000150938 "Cysteine rich transmembrane BMP regulator 1" Q9NZV1 2 36355926-36551135 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 116.2" "Cell type enhanced" "Detected in many" 5 "Ito cells: 170.0;Syncytiotrophoblasts: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 68.0;fHDF/TERT166: 67.0;TIME: 94.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000556 Enhanced "Intracellular and membrane" NA NA 120000 "HPA000556: AB_1078567" "unprognostic (2.15e-1)" "unprognostic (5.41e-2)" "unprognostic (6.39e-2)" "unprognostic (3.17e-3)" "unprognostic (3.88e-2)" "unprognostic (3.44e-2)" "unprognostic (1.88e-1)" "unprognostic (6.25e-2)" "unprognostic (2.32e-1)" "unprognostic (4.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.51e-4)" "unprognostic (1.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (6.67e-2)" 42.4 6.0 9.1 8.7 11.0 1.1 44.6 6.1 9.0 13.8 13.1 6.4 10.2 5.7 14.9 9.8 12.4 14.2 17.3 32.2 8.6 8.7 28.6 6.2 24.7 13.2 7.6 10.2 15.5 9.2 18.0 4.3 116.2 12.0 14.9 9.4 24.7 13.1 13.8 25.9 13.7 9.0 23.1 10.8 17.5 10.2 8.1 6.2 3.0 18.1 7.9 4.5 16.9 22.3 0.8 5.5 3.4 1.4 1.1 1.6 0.2 14.2 10.9 2.2 2.5 10.5 12.0 18.6 68.0 36.1 38.1 20.1 13.7 4.9 0.0 44.4 67.0 24.8 6.2 1.6 11.0 31.3 0.1 1.2 0.4 14.6 7.9 34.0 0.3 0.1 16.8 8.2 15.2 27.5 35.9 53.3 0.2 0.6 0.1 40.0 1.3 0.0 0.1 1.7 0.7 3.2 0.7 2.9 2.2 24.0 5.9 0.2 0.0 11.8 3.9 0.5 8.8 10.6 0.2 94.6 48.2 17.4 5.9 32.8 3.7 0.0 0.1 14.2 0.0 14.8 3.4 0.4 1.2 1.6 0.2 1.2 0.6 0.7 0.9 0.3 0.8 0.2 1.0 0.5 1.1 1.4 5.5 0.5 0.2 9.1 11.0 6.1 9.0 8.6 8.7 7.6 10.2 12.0 6.2 11.9 46.6 5.2 34.8 58.6 7.1 35.8 48.4 26.8 35.2 125.6 2.0 107.1 3.3 29.4 0.9 118.8 18.6 0.0 2.2 34.1 49.4 51.6 1.1 0.9 22.4 0.0 30.5 170.0 6.5 1.3 17.5 10.5 37.1 10.8 41.0 15.6 17.1 31.7 18.7 36.6 37.9 45.3 115.4 2.1 8.7 26.3 145.1 13.8 31.6 40.7 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 702.6;Endothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Cell line enhanced" "Detected in many" "A549: 38.5;EFO-21: 39.4;HUVEC TERT2: 36.8;MCF7: 56.5;SK-BR-3: 44.3;T-47d: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 38.5 5.6 15.3 0.9 4.0 1.6 1.7 0.4 0.5 0.1 1.2 7.1 0.0 39.4 12.6 0.8 22.0 0.7 9.3 0.0 0.2 0.2 0.0 24.2 14.6 4.1 0.0 3.3 1.9 0.8 0.9 5.3 7.2 36.8 0.0 0.0 0.3 5.5 56.5 0.1 0.1 1.5 7.8 23.1 0.0 0.7 1.6 25.9 0.1 8.5 21.4 2.5 44.3 0.3 0.9 37.9 0.0 14.3 12.8 6.0 0.3 7.1 0.1 0.1 0.1 3.7 0.0 25.7 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 145.9 41.3 6.5 66.0 136.0 2.2 702.6 96.8 105.7 131.9 179.7 3.9 0.9 131.0 90.2 30.6 478.7 0.0 0.0 80.2 15.4 145.8 41.0 7.0 27.0 2.6 89.0 24.2 229.6 13.7 62.0 25.9 11.3 148.5 2.8 0.0 55.2 33.3 0.0 13.8 9.8 3.7 271.7 208.1 5.9 44.5 172.0 26.8 6.4 0.0 77.0 CRIP3 "bA480N24.2, TLP, TLP-A" ENSG00000146215 "Cysteine rich protein 3" Q6Q6R5 6 43299710-43308797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;heart muscle: 24.8;liver: 29.0" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Distal tubular cells: 8.3;Late spermatids: 6.8;Spermatocytes: 5.9" "Cancer enhanced" "Detected in some" "liver cancer: 3.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 14 "myeloid DC: 25.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 25.5" "Cell line enhanced" "Detected in some" "HAP1: 4.1;HEK 293: 4.9;HeLa: 5.1;Hep G2: 9.2;NTERA-2: 8.4;RPMI-8226: 6.8;THP-1: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036198 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036198: AB_10670791" "unprognostic (8.35e-3)" "unprognostic (4.14e-3)" "unprognostic (6.37e-2)" "unprognostic (5.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.07e-2)" "unprognostic (1.18e-1)" "unprognostic (2.30e-2)" "unprognostic (4.34e-2)" "unprognostic (1.46e-2)" "unprognostic (8.49e-4)" "unprognostic (1.86e-2)" "unprognostic (7.30e-3)" "unprognostic (5.02e-2)" "unprognostic (4.89e-2)" "unprognostic (4.46e-2)" "unprognostic (2.80e-4)" 0.4 0.5 4.2 5.6 5.8 2.5 2.1 9.4 3.0 0.8 0.8 0.6 3.1 2.2 0.8 2.7 0.9 1.0 4.6 24.8 3.5 3.5 10.4 29.0 0.6 5.3 2.3 2.2 1.0 2.4 0.8 1.1 0.7 2.1 4.1 0.5 1.0 0.7 9.5 0.5 1.8 4.5 1.0 1.7 4.4 0.3 13.5 0.4 0.6 1.1 0.4 6.1 1.8 0.5 1.7 25.5 0.5 1.5 0.2 0.0 0.9 0.0 1.2 0.3 0.1 0.4 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.4 0.0 0.2 0.9 4.1 0.1 0.0 0.0 4.9 0.0 5.1 9.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 6.8 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.9 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.5 0.5 0.0 1.0 0.0 1.4 0.0 0.0 25.5 1.7 0.0 0.0 0.4 0.2 1.3 0.2 0.0 0.9 4.2 5.8 9.4 3.0 3.5 3.5 2.3 2.2 2.1 0.4 0.0 0.0 2.2 0.2 0.6 0.4 1.8 5.1 0.0 0.0 0.0 0.0 0.0 8.3 0.8 3.1 0.0 0.3 0.0 0.2 0.0 0.2 0.1 0.0 2.9 0.2 0.0 0.0 0.0 0.8 6.8 1.1 0.0 0.0 1.0 0.0 0.3 0.4 0.0 0.0 2.4 0.7 0.0 0.0 5.9 0.9 0.0 0.0 0.0 0.1 0.1 CRISP1 "AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP" ENSG00000124812 "Cysteine rich secretory protein 1" P54107 6 49834257-49877096 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "epididymis: 203.0" "Group enriched" "Detected in some" 45 "Early spermatids: 33.8;Late spermatids: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;NB-4: 7.3;RPMI-8226: 2.1;SH-SY5Y: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028445, HPA030534" Enhanced "Secreted in male reproductive system" NA NA "HPA028445: AB_10670428, HPA030534: AB_2732459" 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.0 48.8 0.0 0.2 203.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.4 8.8 0.2 0.2 0.6 0.0 0.2 0.2 0.2 7.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 CRISP2 "CRISP-2, CT36, GAPDL5, TPX1" ENSG00000124490 "Cysteine rich secretory protein 2" P16562 6 49692358-49713590 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 135.5" "Group enriched" "Detected in some" 81 "Early spermatids: 4897.0;Late spermatids: 16112.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.9;U-2 OS: 1.8" "Not detected" "Not detected" HPA031248 Enhanced "Secreted in male reproductive system" NA NA "HPA031248: AB_10602211" "unprognostic (1.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (7.38e-2)" "unprognostic (2.35e-2)" "unprognostic (9.23e-3)" "unprognostic (4.05e-2)" 0.0 0.0 0.0 0.0 0.3 3.5 0.0 0.0 0.1 0.3 0.0 0.1 3.2 0.0 0.0 7.0 0.7 4.4 1.7 0.0 0.2 0.1 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.1 0.1 0.0 0.1 3.4 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 135.5 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 38.8 7.9 0.0 0.0 0.0 0.0 0.1 4897.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16112.2 124.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 78.8 0.0 0.0 64.7 0.0 130.2 60.3 0.0 0.0 0.0 0.0 0.4 CRISP3 "Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28" ENSG00000096006 "Cysteine rich secretory protein 3" P54108 6 49727384-49744437 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3" "Group enriched" "Detected in some" 8 "Cholangiocytes: 38.2;Club cells: 23.9;Melanocytes: 21.9" "Group enriched" "Detected in many" 7 "breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 45 "neutrophil: 6.0;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 45 "granulocytes: 6.0;monocytes: 2.9" "Group enriched" "Detected in some" 20 "HEL: 14.5;RT4: 4.9;SK-BR-3: 11.0;T-47d: 5.4" "Not detected" "Not detected" HPA054392 Supported "Secreted in other tissues" NA NA 390000000 "HPA054392: AB_2682472" "unprognostic (1.28e-2)" "unprognostic (7.01e-2)" "unprognostic (8.93e-2)" "unprognostic (5.56e-2)" "unprognostic (1.02e-1)" "unprognostic (2.22e-4)" "unprognostic (5.30e-2)" "unprognostic (6.70e-2)" "unprognostic (9.16e-2)" "unprognostic (4.34e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-1)" 0.2 0.2 0.2 0.0 0.2 33.5 0.2 0.2 0.2 11.1 0.2 0.0 156.3 0.0 0.7 0.0 45.3 117.6 2.0 0.2 0.2 0.2 0.2 0.2 0.6 0.0 0.2 0.0 15.9 1.7 0.0 0.2 0.0 0.0 3.0 0.0 0.0 233.3 17.7 0.2 0.6 0.2 0.0 0.2 0.4 0.2 0.2 0.0 0.0 0.2 56.7 14.8 1.2 14.4 0.0 0.0 6.0 2.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 11.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 2.9 0.0 0.0 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 38.2 2.7 23.9 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.4 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 CRISPLD1 "Cocoacrisp, DKFZp762F133, LCRISP1" ENSG00000121005 "Cysteine rich secretory protein LCCL domain containing 1" Q9H336 8 74984515-75034558 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 22.7;Cytotrophoblasts: 18.0;Glandular cells: 13.7;Ito cells: 28.3" "Cancer enhanced" "Detected in many" "glioma: 30.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 32 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 32 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "AF22: 51.9;SH-SY5Y: 28.1;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024725 Uncertain "Secreted - unknown location" NA NA "HPA024725: AB_1847238" "unprognostic (2.16e-1)" "unprognostic (5.88e-2)" "unprognostic (4.01e-2)" "unprognostic (3.78e-2)" "unprognostic (3.85e-2)" "unprognostic (1.65e-1)" "unprognostic (2.09e-4)" "unprognostic (6.81e-2)" "unprognostic (1.58e-2)" "unprognostic (5.96e-2)" "unprognostic (2.35e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (7.39e-3)" "unprognostic (2.38e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" 3.2 1.0 5.3 1.7 24.7 1.0 22.4 0.7 8.2 5.4 3.8 15.9 0.0 0.5 7.1 4.0 4.0 5.9 7.8 8.4 10.2 6.4 1.6 1.6 2.2 1.8 7.8 4.7 4.7 1.8 12.1 1.9 5.7 34.4 20.0 1.2 3.1 15.1 2.2 0.7 3.2 1.7 5.4 29.6 1.4 1.7 3.2 9.3 6.0 12.9 1.6 1.1 2.4 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 51.9 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.7 0.3 0.0 0.0 7.4 0.0 0.8 0.0 4.3 0.0 0.0 0.0 1.9 0.0 1.9 0.0 1.1 0.0 0.4 2.8 0.1 0.0 0.4 6.5 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 5.3 0.0 1.9 0.0 7.1 0.0 0.0 0.0 0.3 28.1 0.0 0.0 2.9 11.2 3.9 2.4 0.0 1.4 7.8 0.0 0.2 0.9 0.3 0.0 1.8 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.3 24.7 0.7 8.2 10.2 6.4 7.8 4.7 34.4 9.3 3.0 0.0 0.0 7.5 0.7 1.0 0.4 0.0 22.7 9.1 1.8 0.0 18.0 0.0 0.0 10.9 0.7 0.0 0.0 0.0 1.0 4.8 13.7 3.5 0.0 1.6 0.0 0.0 28.3 2.4 1.1 3.7 0.0 6.8 0.0 0.0 9.7 0.0 0.0 1.4 0.0 0.7 0.0 1.0 1.4 4.1 0.9 10.1 0.0 0.0 0.4 CRLF2 "CRL2, TSLPR" ENSG00000205755 "Cytokine receptor like factor 2" Q9HC73 X 1187549-1212750 "Cancer-related genes, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 7.8" "Cell type enriched" "Detected in some" 9 "monocytes: 174.9" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 43 "plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 43 "dendritic cells: 4.3" "Cell line enhanced" "Detected in some" "GAMG: 2.4;HMC-1: 18.5;RPMI-8226: 4.7;U-698: 4.0" "Intracellular and membrane" NA NA "unprognostic (7.84e-2)" "unprognostic (7.99e-4)" "unprognostic (6.02e-3)" "unprognostic (2.01e-2)" "unprognostic (1.15e-3)" "unprognostic (2.31e-6)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "unprognostic (4.59e-3)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (9.72e-3)" "unprognostic (6.88e-5)" "unprognostic (7.09e-3)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.62e-1)" 0.8 0.0 0.2 4.1 0.2 4.1 0.6 0.2 0.2 3.0 0.7 0.2 0.2 0.2 7.8 0.2 0.9 0.2 3.7 0.2 0.2 0.1 0.9 0.2 1.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 1.0 0.2 0.6 0.9 0.2 0.8 0.2 0.2 0.7 1.5 0.3 0.2 0.6 1.0 0.2 0.2 0.2 0.2 0.2 1.4 1.3 0.6 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.6 1.0 0.2 0.3 2.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.5 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.7 1.0 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 3.0 3.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 174.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRLF3 "CREME9, CYTOR4" ENSG00000176390 "Cytokine receptor like factor 3" Q8IUI8 17 30769388-30824776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 43.6" "Cell type enhanced" "Detected in many" 4 "T-cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007596 Enhanced Approved "Plasma membrane,Cytosol" NA NA 830000 "Plasma membrane, Cytosol" "HPA007596: AB_1847241" "unprognostic (1.02e-1)" "unprognostic (9.79e-2)" "unprognostic (7.12e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-2)" "unprognostic (9.22e-2)" "unprognostic (1.00e-2)" "unprognostic (3.10e-2)" "unprognostic (5.81e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.31e-7)" "unprognostic (3.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (6.51e-2)" 8.7 4.8 8.8 22.7 8.3 16.7 7.3 12.4 9.4 6.9 7.0 5.9 3.9 5.5 6.3 3.6 15.4 6.1 7.0 5.8 7.5 6.6 5.3 5.4 9.7 28.6 6.6 9.3 5.8 5.5 5.1 6.9 12.3 7.3 6.6 7.4 4.4 7.5 3.9 3.8 10.7 11.3 6.1 8.7 22.0 5.9 9.6 6.7 26.7 5.7 4.5 27.8 10.3 9.3 15.9 13.9 43.6 21.8 12.9 35.7 25.2 6.2 6.9 4.3 9.0 7.9 6.2 6.5 5.9 5.8 11.5 12.1 9.2 4.3 20.9 8.9 7.3 11.2 11.0 7.3 4.9 13.9 9.8 13.4 8.8 6.1 6.0 4.4 11.5 6.5 3.7 6.9 9.3 7.9 4.5 11.2 18.8 22.1 22.2 7.2 3.8 25.5 12.7 8.6 10.5 4.6 11.3 14.0 12.3 7.6 5.3 3.1 7.3 6.3 9.5 6.5 9.5 7.2 5.8 5.9 6.7 8.3 10.8 14.4 9.3 7.7 14.0 6.4 9.5 7.4 15.5 18.8 43.6 13.0 19.2 13.7 15.9 18.3 14.6 13.9 14.9 35.7 26.4 38.3 12.9 21.8 7.2 20.1 25.2 8.8 8.3 12.4 9.4 7.5 6.6 6.6 9.3 7.3 6.7 0.0 8.4 28.2 5.7 20.0 17.5 3.7 2.5 9.4 3.4 7.0 13.7 16.5 5.0 4.9 13.2 9.0 6.3 0.0 4.6 15.0 7.1 4.7 22.0 3.0 15.6 6.4 3.5 6.2 19.7 16.0 6.1 21.7 5.0 16.2 2.9 3.5 6.7 3.5 3.9 3.7 22.3 12.9 8.2 10.9 22.3 24.3 38.3 45.7 3.5 7.0 CRLS1 "C20orf155, CLS1, dJ967N21.6, GCD10" ENSG00000088766 "Cardiolipin synthase 1" Q9UJA2 20 6006090-6040053 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 84.2" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 167.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.88e-1)" "unprognostic (8.56e-2)" "unprognostic (9.64e-3)" "unprognostic (1.89e-1)" "unprognostic (1.41e-2)" "unprognostic (2.65e-2)" "unprognostic (1.42e-1)" "unprognostic (2.00e-1)" "unprognostic (9.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.52e-2)" "unprognostic (1.83e-2)" "unprognostic (1.85e-1)" "unprognostic (9.54e-2)" "prognostic favorable (8.02e-4)" 23.0 30.4 9.1 13.2 9.2 9.9 15.0 6.8 9.9 11.5 30.4 8.2 18.5 24.0 11.6 10.8 11.7 10.5 17.2 84.2 7.9 7.5 32.9 67.4 16.4 8.3 7.9 7.7 12.6 27.0 10.2 10.1 13.3 9.5 14.4 14.8 9.1 18.3 13.4 48.5 7.2 33.1 10.5 6.8 11.0 19.3 12.3 7.1 13.1 17.2 23.7 9.6 11.7 8.6 4.9 3.7 1.1 2.4 3.6 5.2 1.1 19.7 14.9 9.6 12.3 26.7 24.3 10.3 12.5 16.2 12.9 15.4 19.7 13.6 21.5 9.1 16.1 22.4 12.9 18.3 22.5 19.4 6.1 10.8 29.4 6.0 72.0 18.1 28.0 9.7 14.2 18.0 13.5 23.0 12.0 17.3 12.4 20.5 9.8 14.4 7.9 18.5 24.9 16.8 45.6 11.7 12.2 14.0 22.9 19.3 7.7 15.5 13.2 12.6 31.9 21.3 10.6 10.8 17.9 11.1 14.1 9.9 14.3 16.7 9.7 21.2 22.3 5.7 23.7 13.0 0.0 2.4 1.1 2.6 2.0 5.2 4.9 1.7 2.2 2.6 1.9 3.6 1.9 0.1 3.6 1.0 3.7 1.5 1.1 9.1 9.2 6.8 9.9 7.9 7.5 7.9 7.7 9.5 7.1 20.8 47.1 26.8 35.6 30.0 10.8 90.4 68.8 2.7 11.4 34.9 3.9 40.1 54.7 25.2 142.9 23.9 44.6 0.0 24.8 50.7 32.7 86.4 14.9 167.1 31.2 11.1 27.4 25.2 33.0 73.4 28.1 27.8 25.3 10.8 46.4 39.8 24.6 45.6 23.0 104.4 12.9 12.9 24.5 18.2 18.6 24.3 30.3 22.3 71.8 34.1 CRMP1 "DPYSL1, DRP-1" ENSG00000072832 "Collapsin response mediator protein 1" Q14194 4 5748084-5893058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.1;pituitary gland: 23.0" "Group enriched" "Detected in some" 6 "Bipolar cells: 117.0;Horizontal cells: 198.6;Muller glia cells: 68.8" "Cancer enhanced" "Detected in all" "glioma: 37.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "naive B-cell: 2.5" "Lineage enriched" "Detected in single" 25 "B-cells: 2.5" "Cell line enhanced" "Detected in some" "AF22: 20.8;HAP1: 29.8;NTERA-2: 21.6;REH: 56.6;RH-30: 33.4;SCLC-21H: 43.3;SH-SY5Y: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035640, CAB037313" Approved Supported Centrosome,Cytosol NA NA Centrosome Cytosol "CAB037313: AB_1078571, HPA035640: AB_10670838" "unprognostic (1.56e-1)" "unprognostic (7.22e-2)" "unprognostic (5.14e-2)" "unprognostic (8.08e-3)" "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (1.84e-2)" "unprognostic (1.20e-1)" "unprognostic (2.79e-1)" "unprognostic (9.71e-2)" "prognostic favorable (4.54e-4)" "unprognostic (2.26e-1)" "unprognostic (8.52e-3)" "unprognostic (1.21e-2)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.60e-3)" 1.8 8.2 24.2 2.5 21.7 0.7 1.0 32.0 63.1 3.3 2.0 5.9 0.1 1.5 11.7 0.7 2.7 4.3 4.3 2.6 22.2 23.9 2.4 0.9 4.2 1.8 9.9 18.1 6.9 4.8 0.9 23.0 4.6 12.3 3.0 1.9 4.6 2.6 3.1 1.0 3.3 2.5 11.6 4.7 1.4 3.5 2.8 4.5 0.0 2.4 0.9 1.3 2.9 1.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 20.8 0.7 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 7.0 0.5 29.8 0.0 0.0 0.5 0.2 0.0 1.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 21.6 0.0 0.6 56.6 33.4 5.0 0.0 0.0 43.3 27.4 0.0 0.1 0.3 14.6 0.2 0.0 1.7 1.0 7.2 0.6 0.6 3.8 0.5 0.0 2.5 0.2 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 21.7 32.0 34.2 22.2 23.9 9.9 18.1 12.3 4.5 0.0 1.4 0.0 0.0 0.3 117.0 0.8 0.0 0.0 0.0 0.0 17.7 0.1 0.0 0.0 1.0 2.7 0.0 0.0 0.0 0.1 3.1 0.4 0.0 0.0 0.4 198.6 2.4 0.0 0.0 3.8 0.6 0.0 1.7 0.0 0.0 68.8 0.7 0.0 0.4 0.0 20.1 6.5 2.5 0.6 9.8 0.1 0.2 0.0 0.0 0.0 CRNN "C1orf10, SEP53" ENSG00000143536 Cornulin Q9UBG3 1 152409243-152414263 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 459.6;lymphoid tissue: 187.9;tongue: 139.6" "Cell type enriched" "Detected in single" 6 "Late spermatids: 2.2" "Group enriched" "Detected in many" 18 "cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.9;HaCaT: 1.1;HL-60: 1.2;hTCEpi: 1.0;K-562: 2.1;TIME: 1.2;U-266/84: 1.1;U-698: 1.5;U-937: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA024343, CAB026182" Enhanced NA NA 36000 "CAB026182: , HPA024343: AB_1847162" "unprognostic (1.96e-2)" "unprognostic (1.74e-6)" "unprognostic (4.20e-2)" "unprognostic (3.43e-1)" "unprognostic (6.43e-3)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 57.1 0.2 0.0 0.0 0.2 6.2 0.2 459.6 0.2 0.3 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 49.6 0.2 0.2 0.6 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.2 139.6 187.9 0.3 81.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 1.1 1.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CROCC "ROLT, rootletin" ENSG00000058453 "Ciliary rootlet coiled-coil, rootletin" Q5TZA2 1 16740273-16972979 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 135.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021191, HPA021762" Enhanced Supported "Plasma membrane,Centrosome" NA NA "Plasma membrane, Centrosome" "HPA021191: AB_1856395, HPA021762: AB_1856396" "unprognostic (9.07e-3)" "unprognostic (9.03e-2)" "unprognostic (6.04e-2)" "prognostic favorable (8.34e-5)" "unprognostic (3.27e-1)" "unprognostic (1.25e-3)" "unprognostic (1.42e-3)" "prognostic favorable (7.92e-4)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (3.36e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (1.58e-1)" "unprognostic (9.83e-2)" "unprognostic (6.05e-2)" "unprognostic (1.76e-3)" 5.0 3.8 3.2 3.2 7.0 2.1 2.5 12.9 3.0 3.9 2.8 5.4 2.2 2.4 5.1 2.4 3.2 9.9 2.3 2.1 4.6 3.5 2.4 1.8 3.9 3.2 2.1 2.5 5.0 4.2 3.0 3.6 2.2 11.3 3.3 0.6 30.6 135.2 2.9 8.2 14.4 3.1 1.8 2.3 6.4 3.5 1.9 4.3 2.1 2.5 2.3 1.8 2.9 3.8 1.1 0.6 1.7 0.8 1.3 2.8 0.6 4.1 1.7 3.2 3.2 2.3 2.1 1.3 3.0 1.0 1.0 1.1 0.2 1.9 10.9 2.8 1.2 0.3 5.0 0.8 2.2 0.1 0.9 5.8 5.0 5.3 0.8 3.9 0.3 5.1 1.8 5.2 0.9 0.9 1.7 1.6 7.9 0.7 2.8 0.3 3.5 3.3 1.2 11.6 0.9 2.7 3.1 4.2 3.7 0.7 1.2 9.9 10.6 3.2 2.1 9.7 1.0 4.2 1.4 4.4 2.8 3.7 7.0 2.3 5.0 3.6 2.2 2.8 0.7 3.3 0.0 0.4 1.7 1.6 0.8 2.8 0.7 1.3 1.3 0.2 1.1 1.1 0.9 0.1 1.3 0.3 0.6 1.3 0.6 3.2 7.0 12.9 3.0 4.6 3.5 2.1 2.5 11.3 4.3 0.0 5.8 0.5 4.2 5.6 20.9 3.2 2.5 14.7 3.4 5.2 25.5 1.1 0.0 4.8 3.5 6.8 0.7 0.0 2.0 5.8 4.5 2.1 1.1 2.4 2.0 3.2 3.5 6.7 2.2 1.9 17.8 2.2 5.0 2.8 3.7 11.9 3.2 2.3 12.0 1.3 111.2 0.0 9.2 1.4 13.2 4.4 0.9 3.8 2.5 1.4 CROCC2 ENSG00000226321 "Ciliary rootlet coiled-coil, rootletin family member 2" H7BZ55 2 240906330-240993311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;epididymis: 19.4;fallopian tube: 14.9" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 6.5;Ciliated cells: 24.1" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.5" "Group enriched" "Detected in many" 4 "basal ganglia: 5.0;hippocampal formation: 4.2;pons and medulla: 9.5" "Group enriched" "Detected in some" 18 "intermediate monocyte: 1.1;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 26 "monocytes: 3.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;HDLM-2: 2.3;Hep G2: 1.2;HSkMC: 2.8;Karpas-707: 1.0;RPMI-8226: 7.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA048678 Enhanced NA NA "HPA048678: AB_2680491" "unprognostic (4.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.24e-2)" "unprognostic (1.68e-3)" "unprognostic (7.92e-2)" "unprognostic (1.75e-4)" "unprognostic (2.84e-3)" "unprognostic (3.10e-2)" "unprognostic (8.28e-2)" "unprognostic (3.45e-2)" "unprognostic (6.56e-3)" "unprognostic (2.28e-2)" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-2)" "unprognostic (9.90e-3)" "unprognostic (7.19e-2)" 0.2 0.1 0.6 0.3 5.0 0.2 0.0 0.0 0.1 2.4 0.1 3.8 0.0 0.5 0.4 19.4 0.0 14.9 0.1 0.0 4.2 1.4 0.1 0.5 2.3 1.4 0.0 0.0 3.2 0.1 0.0 2.1 0.1 9.5 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.8 0.1 0.0 4.7 0.3 0.4 0.5 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.6 5.0 0.0 0.1 4.2 1.4 0.0 0.0 9.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.0 24.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.6 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRP PTX1 ENSG00000132693 "C-reactive protein" P02741 1 159712289-159714589 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "liver: 1139.7" "Cell type enriched" "Detected in some" 14 "Hepatocytes: 2991.5" "Cancer enriched" "Detected in some" 13 "liver cancer: 1010.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005036, HPA027367, HPA027396" Supported Approved "Nucleoplasm,Vesicles,Intermediate filaments" "Secreted to blood" NA NA 2920000000 5400000000 "Nucleoplasm, Vesicles" "Intermediate filaments" "CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217" "unprognostic (3.74e-1)" "unprognostic (5.31e-2)" "unprognostic (2.97e-2)" "unprognostic (1.27e-1)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (4.17e-10)" "unprognostic (3.39e-2)" "unprognostic (3.48e-1)" "unprognostic (5.60e-2)" "unprognostic (6.61e-2)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 17.2 0.1 0.1 0.0 0.1 1139.7 0.1 0.1 0.1 0.1 0.1 7.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.3 0.0 0.0 0.0 7.8 0.0 0.3 0.0 0.0 0.0 0.3 0.1 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.1 0.9 0.0 13.1 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 55.9 0.0 0.0 0.0 0.0 109.5 0.0 0.0 0.0 0.0 0.0 0.0 220.4 1.2 0.0 0.0 23.3 52.3 0.0 0.0 0.0 0.0 2991.5 0.1 0.0 0.0 82.9 72.1 0.0 0.0 0.0 0.0 17.2 0.0 0.0 97.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRTAC1 "ASPIC1, CEP-68, FLJ10320" ENSG00000095713 "Cartilage acidic protein 1" Q9NQ79 10 97865000-98030828 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 90.9;Club cells: 66.0" "Cancer enhanced" "Detected in many" "melanoma: 43.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.6;HMC-1: 3.3;HUVEC TERT2: 8.9;SCLC-21H: 5.9;SK-MEL-30: 9.8;TIME: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008175 Enhanced "Secreted to extracellular matrix" NA NA 360000000 "HPA008175: AB_1847254" "unprognostic (2.55e-1)" "unprognostic (6.41e-3)" "unprognostic (4.90e-3)" "prognostic unfavorable (5.01e-6)" "unprognostic (2.54e-1)" "unprognostic (6.96e-3)" "unprognostic (9.30e-2)" "unprognostic (9.13e-2)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (7.66e-2)" "unprognostic (1.69e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.70e-4)" "unprognostic (1.05e-2)" "unprognostic (3.29e-3)" "prognostic favorable (1.51e-4)" 4.5 1.4 6.2 1.6 7.2 0.8 2.0 7.2 27.3 3.9 6.0 3.8 4.5 1.2 1.2 4.8 7.9 34.0 1.1 6.2 5.5 7.0 3.1 1.1 42.1 1.1 9.2 5.8 2.2 1.8 1.4 3.2 0.8 27.5 3.3 1.1 31.6 3.4 31.1 1.4 2.9 1.2 3.6 6.8 0.8 1.0 4.0 2.7 0.0 4.4 0.7 1.0 25.5 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.8 0.0 3.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 5.9 1.3 0.7 0.0 9.8 0.4 0.1 0.0 11.9 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 7.2 7.2 18.7 5.5 7.0 9.2 5.8 27.5 2.7 20.8 90.9 0.0 2.0 1.3 5.7 3.9 2.5 1.4 66.0 8.7 0.0 0.0 0.0 4.3 0.0 1.6 0.0 0.0 0.6 0.0 1.7 0.4 4.7 0.0 0.0 0.0 1.7 5.5 0.3 0.2 0.0 0.3 8.5 0.0 0.0 14.5 0.8 0.0 0.4 0.0 3.6 0.0 0.5 0.9 1.7 0.4 0.0 0.0 0.0 1.1 CRTAM CD355 ENSG00000109943 "Cytotoxic and regulatory T cell molecule" O95727 11 122838500-122872639 "CD markers, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 140.8" "Cell type enhanced" "Detected in some" 25 "Hofbauer cells: 6.2;Kupffer cells: 9.1;Macrophages: 7.2;T-cells: 34.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 24 "cerebellum: 140.8" "Cell type enhanced" "Detected in many" "NK-cell: 25.7" "Group enriched" "Detected in many" 5 "NK-cells: 25.7;T-cells: 16.7" "Cell line enriched" "Detected in single" 34 "SCLC-21H: 17.4" "Region enriched" "Detected in single" 44 "cerebellum: 115.2" "Low region specificity" "Detected in all" NA NA 3200000 "unprognostic (3.51e-3)" "unprognostic (6.73e-4)" "unprognostic (1.33e-2)" "unprognostic (3.73e-3)" "unprognostic (2.40e-2)" "unprognostic (5.25e-4)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (5.27e-2)" "unprognostic (1.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.32e-1)" "unprognostic (1.83e-4)" "unprognostic (6.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.87e-2)" "unprognostic (6.59e-2)" 0.4 0.3 0.3 2.7 0.4 1.9 0.4 140.8 0.4 0.3 0.4 0.2 0.1 0.4 0.8 0.4 0.3 0.3 1.8 0.3 0.3 0.3 0.3 1.0 2.2 10.6 0.4 0.1 0.3 0.3 0.0 0.3 0.2 5.8 0.3 0.5 0.3 0.7 0.1 0.3 0.3 1.3 0.2 1.2 4.4 0.7 0.3 0.1 3.3 0.3 0.2 4.3 1.1 0.3 0.1 1.7 0.6 4.4 25.7 16.7 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.2 0.2 6.7 2.7 6.5 0.0 0.7 13.5 1.7 0.1 2.2 16.7 0.6 25.7 4.4 0.1 0.0 2.8 0.3 0.4 140.8 0.4 0.3 0.3 0.4 0.1 5.8 0.1 0.0 1.4 0.0 0.4 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 1.1 0.0 6.2 0.0 0.0 0.6 9.1 0.6 0.0 7.2 3.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.6 0.1 34.1 0.0 0.3 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683677-18782333 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.7" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022035, HPA063619" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255, HPA063619: " "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favorable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favorable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.6 7.7 26.0 7.4 38.8 3.2 3.8 40.7 30.1 5.0 4.4 6.5 4.3 6.5 6.8 5.6 3.1 10.5 5.5 5.6 17.7 7.8 6.6 4.5 5.7 6.3 6.4 18.1 6.7 10.0 8.4 11.3 6.4 6.0 7.0 2.6 5.1 8.8 9.4 12.4 5.5 6.2 4.3 4.8 8.1 8.0 7.5 10.2 1.9 7.4 1.1 3.7 4.6 3.5 4.1 3.8 1.8 3.4 1.1 3.0 1.3 4.4 8.1 5.9 9.4 5.5 4.6 16.7 4.9 3.3 4.7 4.5 5.4 5.8 6.2 10.4 4.6 3.3 4.8 1.8 3.0 1.1 2.7 14.1 5.2 7.2 8.9 5.3 7.1 14.6 7.5 2.9 4.0 1.2 6.2 2.6 6.4 4.1 5.7 2.6 16.1 4.6 8.1 7.6 2.3 11.9 7.3 2.6 6.8 2.9 7.9 10.8 9.7 5.5 5.2 5.8 2.0 5.8 4.3 4.7 5.3 8.2 9.7 5.6 3.8 3.0 4.1 6.2 7.7 4.0 1.5 3.4 1.8 1.7 1.3 1.8 2.3 2.7 3.0 3.0 4.1 2.3 1.8 1.7 1.1 1.9 3.8 1.8 1.3 26.0 38.8 40.7 30.1 17.7 7.8 6.4 18.1 6.0 10.2 0.0 4.0 4.2 9.5 2.4 24.9 14.0 5.1 2.7 2.3 17.4 25.5 8.5 10.0 3.6 0.7 4.5 5.1 0.0 5.3 2.1 5.4 3.0 2.3 3.4 7.8 41.3 18.4 1.3 5.4 1.7 8.6 3.7 3.3 1.8 6.9 8.9 2.6 8.6 4.6 4.3 14.1 0.0 8.2 2.9 7.2 1.8 8.7 5.1 4.8 2.5 CRX "CORD2, CRD, LCA7, OTX3" ENSG00000105392 "Cone-rod homeobox" O43186 19 47819779-47843330 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Cone-rod dystrophy, Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "retina: 125.2" "Group enriched" "Detected in many" 7 "Bipolar cells: 121.9;Cone photoreceptor cells: 269.0;Rod photoreceptor cells: 472.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036762, HPA036763" Enhanced NA NA "HPA036762: AB_10673663, HPA036763: AB_10670922" "unprognostic (1.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.95e-10)" "unprognostic (9.27e-2)" "unprognostic (1.82e-2)" "unprognostic (8.94e-2)" "unprognostic (1.78e-3)" 0.1 0.1 0.1 0.3 0.1 1.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.4 0.1 0.5 0.3 0.3 0.2 0.1 1.8 0.1 0.2 0.2 0.0 0.4 0.7 0.0 0.1 0.0 0.9 0.1 0.0 125.2 0.4 0.0 2.9 0.9 0.3 0.0 0.1 0.1 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 1.3 1.0 2.9 0.6 0.9 0.6 0.3 0.2 0.6 0.3 0.2 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.3 0.5 0.4 0.3 0.0 0.3 0.5 0.2 0.0 0.1 0.2 0.3 0.6 0.7 0.6 0.0 0.7 0.5 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.9 0.0 0.4 0.2 0.8 3.1 0.0 0.0 0.4 0.3 0.0 0.0 0.7 0.4 0.3 0.6 0.7 0.0 0.8 0.3 0.5 0.0 1.1 0.3 0.3 0.9 0.6 0.2 0.4 0.1 0.3 0.3 2.1 0.6 0.5 0.4 0.3 0.5 0.6 0.4 0.4 0.2 1.3 0.6 0.5 2.9 0.9 0.4 1.0 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.9 0.0 6.0 17.6 0.0 1.9 0.8 121.9 0.5 2.5 17.4 25.0 0.0 269.0 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.1 0.6 1.2 9.3 0.5 0.2 30.2 0.0 1.8 0.6 0.0 4.4 1.6 0.0 0.0 0.0 42.1 0.0 0.0 0.7 0.0 472.4 0.0 0.0 0.1 0.4 1.0 0.0 0.0 0.0 1.7 CRYAA "CRYA1, HSPB4" ENSG00000160202 "Crystallin alpha A" P02489 21 43169008-43172805 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Chaperone, Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 45.5" "Cell type enhanced" "Detected in single" 35 "Muller glia cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 140 "Hep G2: 28.9" "HPA037737, HPA038430" Supported Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" "unprognostic (3.68e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYAA2 ENSG00000276076 "Crystallin alpha A2" 21 6560714-6564489 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "kidney: 34.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 200 "Hep G2: 28.9" "HPA037737, HPA038430" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA037737: AB_2675639, HPA038430: AB_2732478" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908565-111923722 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 743.1;skeletal muscle: 581.1" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 1730.9;Cardiomyocytes: 6792.5;Proximal tubular cells: 5845.1" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 235.7;fHDF/TERT166: 76.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 12000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337" "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.70e-5)" 107.4 11.5 47.8 16.7 82.3 2.1 69.5 24.8 153.7 22.4 23.6 132.9 7.2 5.5 14.8 25.9 41.9 13.5 14.0 743.1 65.9 44.0 151.8 3.8 8.4 3.9 139.2 29.7 8.8 6.6 3.3 8.6 16.1 80.7 30.3 12.9 23.3 30.6 75.1 581.1 18.1 6.2 45.2 168.0 5.5 11.6 3.9 101.8 0.0 40.7 94.1 9.2 16.2 53.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.4 235.7 10.3 1.6 6.5 0.2 0.1 0.2 0.1 0.0 0.0 3.9 76.9 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 1.2 0.6 2.0 0.0 0.0 8.2 1.0 0.0 0.5 5.1 0.0 0.0 0.5 0.2 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.8 3.5 5.8 0.5 0.0 0.1 30.5 10.9 0.8 0.3 0.1 0.0 0.0 0.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 82.3 24.8 48.5 65.9 44.0 139.2 29.7 80.7 101.8 77.4 5.5 0.9 1730.9 155.3 11.4 6792.5 86.6 2.7 1.2 1270.1 17.7 2.9 573.6 165.7 20.3 23.3 0.0 0.0 10.0 5.8 309.0 1331.1 0.0 0.8 5.4 9.5 6.8 56.4 0.3 11.1 211.7 26.8 458.9 6.4 0.0 1097.1 19.7 0.0 176.4 5845.1 41.9 135.8 899.5 10.0 0.7 135.6 27.9 0.5 0.0 203.0 CRYBA1 CRYB1 ENSG00000108255 "Crystallin beta A1" P05813 17 29246863-29254494 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;bone marrow: 1.4;brain: 2.8;lymphoid tissue: 1.5" "Cell type enhanced" "Detected in single" 33 "Syncytiotrophoblasts: 2.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebral cortex: 2.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AF22: 6.8;BEWO: 8.8;SuSa: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA022016 Supported NA NA "HPA022016: AB_2732426" "unprognostic (2.89e-2)" "unprognostic (1.57e-1)" "unprognostic (8.75e-2)" "unprognostic (1.37e-1)" "unprognostic (9.62e-2)" "unprognostic (4.27e-3)" "unprognostic (2.08e-1)" "unprognostic (5.60e-2)" "unprognostic (2.52e-2)" "unprognostic (9.90e-2)" "unprognostic (5.85e-3)" "unprognostic (2.83e-1)" "unprognostic (2.09e-6)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.31e-2)" "unprognostic (6.84e-3)" 0.0 0.0 0.2 1.5 0.3 1.4 0.0 0.0 2.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.6 0.0 0.0 0.0 1.3 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.4 1.4 0.0 0.7 0.1 0.0 0.0 6.8 0.1 0.0 0.0 8.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.3 1.4 0.4 0.4 0.7 0.1 0.8 1.0 0.3 0.1 0.4 0.0 0.0 0.4 0.0 0.1 0.2 0.3 0.0 2.8 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 CRYBA2 ENSG00000163499 "Crystallin beta A2" P53672 2 218990189-218993421 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 4.6;intestine: 5.8;pancreas: 16.2;pituitary gland: 12.2;stomach 1: 6.1" "Cell type enriched" "Detected in some" 69 "Intestinal endocrine cells: 827.9" "Cancer enriched" "Detected in some" 15 "pancreatic cancer: 16.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "BEWO: 40.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA062293 Supported NA NA "HPA062293: AB_2732680" "unprognostic (5.29e-2)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (4.19e-1)" "unprognostic (6.19e-2)" "unprognostic (1.77e-1)" "unprognostic (2.72e-1)" "unprognostic (1.66e-2)" "unprognostic (3.75e-1)" "prognostic favorable (7.62e-4)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.19e-1)" 0.3 4.6 0.3 0.3 2.0 0.0 0.3 0.3 0.8 0.3 5.8 0.3 0.3 3.5 0.3 0.3 0.3 0.0 0.3 0.3 0.6 0.5 0.3 0.3 0.3 0.3 0.6 0.3 0.3 16.2 0.1 12.2 0.3 0.7 0.5 2.8 0.8 0.3 0.3 0.3 0.1 4.7 0.3 0.3 0.3 6.1 1.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.9 1.4 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.3 0.8 0.6 0.5 0.6 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 2.7 0.0 1.1 3.3 0.0 1.3 0.0 0.0 0.2 0.0 827.9 0.0 0.0 6.2 0.0 0.0 1.7 0.0 3.6 0.0 11.9 8.6 0.0 0.0 0.8 0.0 0.0 0.5 3.0 0.3 0.2 0.0 1.5 0.0 CRYBA4 ENSG00000196431 "Crystallin beta A4" P53673 22 26621964-26630672 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.2;epididymis: 6.0;retina: 2.0;testis: 4.1" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 1.1;Spermatogonia: 1.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.2" "Lineage enhanced" "Detected in single" "T-cells: 2.2" "Cell line enriched" "Detected in some" 4 "HEL: 12.6" "Not detected" "Not detected" HPA071178 Supported NA NA "HPA071178: AB_2686354" "unprognostic (6.69e-2)" "unprognostic (3.94e-3)" "unprognostic (5.61e-5)" "unprognostic (1.74e-2)" "unprognostic (5.57e-2)" "unprognostic (2.32e-2)" "unprognostic (2.71e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-6)" "unprognostic (2.86e-1)" "unprognostic (1.20e-6)" "unprognostic (1.87e-2)" "unprognostic (7.23e-2)" "unprognostic (7.71e-2)" "unprognostic (3.70e-1)" 0.1 0.0 0.5 0.3 0.5 0.4 0.1 0.1 0.5 0.2 0.5 0.1 0.1 0.8 0.1 6.0 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 2.0 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.8 0.1 4.1 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.5 0.2 0.4 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.0 0.0 0.0 CRYBB1 ENSG00000100122 "Crystallin beta B1" P53674 22 26599278-26618088 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;epididymis: 17.4" "Cell type enriched" "Detected in some" 36 "Hofbauer cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 10.6;non-classical monocyte: 7.5" "Lineage enriched" "Detected in many" 6 "monocytes: 10.6" "Group enriched" "Detected in some" 5 "Karpas-707: 21.5;RPMI-8226: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003448, CAB010058" Supported NA NA 93000 "CAB010058: AB_668166, HPA003448: AB_2732396" "unprognostic (1.31e-1)" "unprognostic (5.56e-3)" "unprognostic (1.39e-2)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (7.89e-3)" "unprognostic (1.51e-1)" "unprognostic (9.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (3.88e-4)" "unprognostic (2.62e-2)" "unprognostic (1.23e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-2)" 3.0 3.0 2.5 2.1 2.2 1.1 2.0 0.3 4.4 1.2 1.1 5.6 0.0 1.1 1.1 17.4 1.4 1.5 2.3 2.8 2.4 1.9 1.1 1.0 2.9 3.1 3.8 0.3 1.2 2.6 0.7 1.7 8.3 1.9 2.7 0.8 1.7 1.3 1.1 1.1 0.4 0.9 1.6 3.6 5.7 1.0 1.0 1.0 0.8 0.6 0.0 1.0 2.3 0.7 0.3 1.7 0.5 10.6 0.4 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.7 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.4 0.0 38.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.8 0.0 1.1 0.0 0.0 1.0 0.0 0.0 10.6 0.0 0.3 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.4 7.5 0.0 0.0 0.6 2.5 2.2 0.3 4.4 2.4 1.9 3.8 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.4 0.0 1.1 0.0 64.7 0.0 0.0 0.0 1.3 0.0 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 CRYBB2 "CCA2, CRYB2, CRYB2A" ENSG00000244752 "Crystallin beta B2" P43320 22 25219522-25231869 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 26.9" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 23.2;Melanocytes: 11.8;Peritubular cells: 7.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 5.2;THP-1: 1.7;U-138 MG: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043749 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA043749: AB_2678652" "unprognostic (1.28e-1)" "unprognostic (2.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.95e-1)" "unprognostic (5.06e-2)" "unprognostic (7.04e-2)" "unprognostic (8.57e-3)" "unprognostic (9.51e-3)" "unprognostic (8.55e-2)" "unprognostic (2.46e-2)" "unprognostic (4.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.73e-5)" "unprognostic (1.44e-2)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-3)" 0.8 0.7 2.0 0.5 3.7 0.1 1.7 0.5 1.8 1.0 1.3 0.5 0.5 0.8 0.5 1.8 1.1 0.4 0.5 0.6 2.9 1.5 0.5 0.5 1.4 0.5 0.8 0.5 0.5 0.5 0.0 2.6 0.5 0.9 0.9 1.5 26.9 1.2 0.5 0.6 0.4 1.0 1.0 0.5 0.5 0.2 4.0 0.5 0.5 1.7 0.5 0.5 0.5 0.5 1.4 1.3 0.5 1.1 1.7 1.4 0.7 0.2 0.5 0.1 0.7 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.2 0.0 1.1 0.6 5.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.3 1.2 0.3 0.6 0.0 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.9 1.7 0.0 3.0 0.7 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.5 0.8 0.4 1.4 0.6 0.6 1.4 1.2 0.7 1.1 1.0 1.1 1.2 0.1 1.7 1.1 1.3 0.4 0.7 2.0 3.7 0.5 1.8 2.9 1.5 0.8 0.5 0.9 0.5 0.0 0.0 0.0 0.4 4.7 0.1 0.8 0.0 0.0 0.0 1.8 0.0 0.1 23.2 0.0 2.5 2.4 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.4 0.2 0.0 0.0 0.6 0.3 4.0 2.3 0.7 11.8 0.0 0.1 0.7 0.4 0.0 7.8 0.7 0.0 0.0 4.2 2.1 2.6 3.3 0.1 0.0 0.0 0.6 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Group enriched" "Detected in many" 11 "Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Low region specificity" "Detected in single" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.6 0.0 0.0 0.0 9.0 32.1 3.3 1.5 11.8 3.4 3.2 0.7 3.8 16.7 0.7 7.3 4.8 17.2 0.1 40.2 1.7 22.7 0.7 0.0 0.5 5.2 4.2 10.1 0.0 16.0 23.5 6.5 31.1 0.0 14.7 13.2 0.5 2.4 9.2 1.2 2.9 4.0 0.1 0.0 7.1 5.0 0.1 0.1 5.4 25.3 0.7 0.0 6.5 11.1 0.1 1.0 5.5 7.7 4.2 3.9 0.5 0.0 10.6 1.8 1.4 18.2 18.4 12.8 8.3 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 11.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 23.9 31.4 0.0 184.0 3.3 8.8 0.0 0.0 0.0 0.0 10.8 7.2 0.0 0.0 1.1 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 16.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 501.8 0.0 0.0 0.0 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.9;placenta: 55.0" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 40.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm NA NA Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 8.0 4.4 0.0 0.0 4.9 0.9 0.6 43.9 0.2 2.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.0 0.0 0.8 1.4 0.1 5.1 0.0 0.0 13.8 10.4 0.0 0.0 0.0 0.9 1.2 0.0 0.1 0.0 22.0 19.8 4.9 16.1 0.7 0.0 2.4 0.1 0.2 1.7 0.3 7.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 25.1 16.9 0.1 5.1 0.0 0.1 6.3 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.0 0.0 3.0 0.0 1.2 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.5 0.7 1.7 0.7 0.0 0.6 0.5 0.5 2.4 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.9 1.7 1.8 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 CRYGA "CRY-g-A, CRYG1, CRYG5" ENSG00000168582 "Crystallin gamma A" P11844 2 208160740-208163576 "Predicted intracellular proteins" "Eye lens protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-138 MG: 1.3" "Not detected" "Not detected" HPA043386 Supported Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.49e-1)" 0.1 0.0 1.0 0.1 1.8 0.0 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.1 0.1 0.9 1.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 0.1 1.5 0.9 1.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGB CRYG2 ENSG00000182187 "Crystallin gamma B" P07316 2 208142573-208146168 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "ovarian cancer: 1.1;testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.1;NTERA-2: 2.8;SuSa: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (6.73e-2)" "unprognostic (1.31e-1)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.5 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRYGC CRYG3 ENSG00000163254 "Crystallin gamma C" P07315 2 208128137-208129830 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 5.4" "Group enriched" "Detected in some" 4 "Early spermatids: 1.6;Late spermatids: 2.9;Spermatocytes: 1.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8;ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;CACO-2: 1.0;EFO-21: 2.0;U-2 OS: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043386 Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043386: " "unprognostic (1.89e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 CRYGD CRYG4 ENSG00000118231 "Crystallin gamma D" P07320 2 208121607-208124501 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "ovary: 17.7" "Group enriched" "Detected in some" 8 "Early spermatids: 10.1;Muller glia cells: 30.9" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "HEL: 15.4" "Not detected" "Not detected" "HPA041269, HPA043386" Supported Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA041269: AB_2732491, HPA043386: " "unprognostic (4.49e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" 0.2 0.2 4.2 0.2 2.0 2.3 0.2 0.0 2.5 0.2 0.2 0.3 0.0 0.4 0.2 0.2 0.3 0.3 0.2 0.6 2.1 4.3 0.2 0.2 0.2 0.2 4.0 1.6 17.7 0.2 0.2 0.4 0.5 1.9 2.0 0.2 2.1 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.2 0.5 1.4 0.5 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.2 2.0 0.0 2.5 2.1 4.3 4.0 1.6 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 CRYGN ENSG00000127377 "Crystallin gamma N" Q8WXF5 7 151428835-151440813 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "seminal vesicle: 4.3;thyroid gland: 16.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 25 "thyroid cancer: 15.7" "Group enriched" "Detected in some" 31 "memory CD4 T-cell: 3.4;naive CD4 T-cell: 3.4;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 35 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 1.7;CAPAN-2: 2.7;MOLT-4: 2.0;SCLC-21H: 3.6" "Region enriched" "Detected in single" 4 "basal ganglia: 9.3" "Not detected" "Not detected" HPA050788 Uncertain NA NA "HPA050788: AB_2681239" "unprognostic (1.69e-1)" "unprognostic (1.91e-1)" "unprognostic (1.55e-3)" "unprognostic (5.50e-2)" "unprognostic (2.94e-5)" "unprognostic (2.49e-3)" "unprognostic (1.55e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (3.67e-2)" "unprognostic (1.39e-1)" "unprognostic (8.48e-2)" "unprognostic (8.93e-10)" "unprognostic (2.55e-4)" "unprognostic (2.71e-1)" "unprognostic (2.36e-2)" "unprognostic (3.36e-1)" 0.3 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.4 1.1 0.3 0.0 0.9 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 2.6 0.8 0.3 0.3 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 16.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.3 0.0 0.8 1.0 2.7 0.3 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.3 0.4 0.0 2.0 0.5 1.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.4 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 15.1;cervix, uterine: 21.8" "Cell type enhanced" "Detected in some" 5 "Rod photoreceptor cells: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.6 1.9 3.6 1.8 2.7 4.0 3.4 15.1 3.3 21.8 1.8 3.5 1.6 1.7 2.7 3.8 1.6 1.3 1.6 1.6 4.1 4.1 2.2 1.8 2.6 4.2 4.2 1.6 2.2 1.8 1.9 1.6 1.6 3.0 1.6 3.7 5.8 1.8 2.9 1.6 3.0 1.8 2.3 3.2 3.6 2.4 1.8 1.6 6.0 1.6 3.2 3.3 1.6 1.6 0.3 0.6 0.2 0.2 0.0 2.1 0.1 1.0 2.0 3.7 3.1 3.6 5.6 0.5 0.5 1.2 1.3 2.5 0.4 1.5 3.8 4.1 2.7 1.6 3.2 1.7 2.8 5.5 3.2 4.9 5.0 1.4 1.9 1.4 2.9 3.4 5.9 3.8 1.2 2.1 5.4 4.2 4.2 1.0 2.2 3.0 1.2 2.6 1.5 0.2 1.7 1.6 4.3 0.8 1.8 1.5 2.3 1.7 1.6 2.6 2.5 1.0 3.0 2.0 1.7 4.5 1.4 1.1 1.6 2.7 4.6 2.3 5.3 1.9 1.9 2.7 0.0 0.2 0.0 1.4 0.0 2.1 0.3 1.9 0.8 0.4 0.1 0.2 0.4 0.2 0.0 0.0 0.6 0.2 0.1 3.6 2.7 15.1 3.3 4.1 4.1 4.2 1.6 3.0 1.6 0.0 1.7 0.5 0.2 0.2 1.0 2.2 2.5 0.0 1.2 0.0 2.0 0.1 0.0 0.4 0.1 0.7 0.4 0.0 0.2 0.1 0.5 0.2 1.1 1.1 0.3 1.6 0.0 1.8 0.0 1.0 0.3 1.6 0.0 0.0 0.9 0.5 0.3 0.0 0.7 0.0 3.0 0.0 0.6 1.4 0.7 0.1 0.2 1.3 1.0 0.1 CRYL1 "GDH, lambda-CRY, MGC149525, MGC149526" ENSG00000165475 "Crystallin lambda 1" Q9Y2S2 13 20403666-20525873 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 104.0;liver: 80.8" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 411.1;Hepatocytes: 272.9;Proximal tubular cells: 848.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040403 Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA 210000 "Nucleoplasm, Nucleoli" "Golgi apparatus, Plasma membrane" "HPA040403: AB_10795632" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (3.25e-2)" "prognostic favorable (1.76e-5)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-3)" "unprognostic (4.75e-3)" "unprognostic (1.19e-1)" "unprognostic (4.09e-2)" "unprognostic (2.12e-2)" "unprognostic (8.80e-2)" "prognostic favorable (2.30e-9)" "unprognostic (9.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (3.11e-1)" 9.8 8.9 21.5 8.8 22.9 3.5 7.0 10.4 17.4 11.8 35.1 26.7 18.9 61.0 9.2 18.0 7.4 9.3 16.1 9.3 18.8 19.8 104.0 80.8 6.8 5.9 24.5 12.3 7.3 15.4 5.3 10.4 5.6 16.8 11.2 16.5 17.2 13.1 20.1 5.4 4.1 45.7 8.0 32.0 6.5 12.0 2.7 16.4 3.2 11.9 5.6 5.5 8.6 5.9 9.3 25.7 1.8 24.3 6.0 15.6 17.5 3.3 2.9 2.5 18.4 14.1 16.3 2.5 4.7 8.5 2.1 1.7 1.1 3.1 0.0 9.1 6.5 4.8 0.8 2.5 4.2 2.1 8.1 2.0 5.9 0.3 23.0 8.1 1.9 5.4 9.6 2.7 1.5 9.7 7.6 22.3 8.7 0.4 2.3 5.5 12.1 5.1 3.0 0.1 28.9 4.5 2.6 1.6 0.4 17.8 7.1 1.8 2.2 2.8 1.3 21.2 1.3 9.1 7.6 21.3 2.6 1.2 6.3 2.9 3.3 0.6 0.0 4.9 3.3 10.5 1.8 21.8 1.4 10.5 24.3 8.5 9.3 14.0 10.0 25.7 9.1 11.0 10.2 0.7 6.0 20.1 2.8 15.6 17.5 21.5 22.9 10.4 17.4 18.8 19.8 24.5 12.3 16.8 16.4 6.0 6.4 19.9 13.2 9.2 5.0 9.8 48.4 10.7 6.8 73.3 11.8 18.1 411.1 21.5 2.6 23.7 181.3 0.0 27.8 9.4 16.4 23.5 24.3 272.9 59.4 1.6 8.7 49.1 76.7 2.9 24.2 36.1 35.4 11.8 69.9 93.7 32.1 152.6 22.6 848.9 10.8 19.4 12.3 0.9 0.2 8.2 17.4 15.3 78.8 12.2 CRYM DFNA40 ENSG00000103316 "Crystallin mu" Q14894 16 21238874-21303083 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.7;brain: 61.3;heart muscle: 45.9" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 521.3" "Cancer enhanced" "Detected in many" "prostate cancer: 14.6" "Region enhanced" "Detected in many" "basal ganglia: 61.3" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 23.7" "Lineage enriched" "Detected in single" 26 "dendritic cells: 23.7" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 31.2" "Group enriched" "Detected in many" 12 "amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0" "Low region specificity" "Detected in all" "HPA019086, HPA030619" Enhanced Supported Cytosol NA NA 110000 Cytosol "HPA019086: AB_1847260, HPA030619: AB_2673551" "unprognostic (1.32e-1)" "unprognostic (2.93e-3)" "unprognostic (8.96e-2)" "unprognostic (1.44e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.88e-1)" "unprognostic (5.75e-3)" "unprognostic (2.81e-1)" "unprognostic (7.37e-2)" "unprognostic (2.05e-2)" "unprognostic (5.95e-2)" "unprognostic (2.11e-3)" "unprognostic (7.79e-3)" "unprognostic (2.49e-2)" "unprognostic (1.87e-3)" "unprognostic (1.31e-1)" 1.4 0.5 7.6 0.5 61.3 0.5 1.0 15.6 21.2 1.8 2.2 0.0 0.0 0.7 0.8 0.3 2.3 0.5 2.3 45.9 6.5 2.1 17.8 4.2 2.7 0.5 1.0 15.5 0.5 0.8 0.6 3.3 0.3 0.1 10.5 2.6 1.0 4.8 0.3 4.0 1.4 1.0 2.0 0.9 0.5 0.6 1.6 1.2 0.0 0.5 0.0 1.5 8.3 0.8 0.9 23.7 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.2 1.6 0.0 0.0 0.0 0.4 7.2 0.0 0.7 0.0 0.0 0.7 0.3 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 3.2 0.5 0.1 0.0 0.0 0.2 31.2 0.0 1.2 1.7 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.2 0.2 2.7 0.0 0.0 0.0 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.3 7.6 61.3 15.6 20.7 6.5 2.1 1.0 15.5 0.1 1.2 0.0 15.3 1.5 24.8 2.1 5.8 124.1 5.1 20.1 22.7 14.0 3.9 0.0 14.9 0.1 17.0 1.0 5.3 0.0 0.0 0.0 2.2 17.1 1.1 6.0 0.1 1.6 12.6 0.6 0.0 9.6 0.0 0.9 32.1 1.0 19.3 521.3 0.2 0.0 0.0 111.6 17.7 0.0 1.0 4.4 6.3 1.1 0.1 0.0 7.9 58.9 CRYZ ENSG00000116791 "Crystallin zeta" Q08257 1 74705482-74733408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.0;liver: 79.8" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 151.8;Distal tubular cells: 192.3;Hepatocytes: 184.9;Proximal tubular cells: 384.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 98.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021921, HPA023290" Approved Supported Cytosol NA NA 7200000 Cytosol "HPA021921: AB_1847262, HPA023290: AB_1847263" "unprognostic (3.64e-2)" "unprognostic (3.38e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.32e-3)" "unprognostic (5.79e-2)" "unprognostic (6.29e-2)" "unprognostic (1.04e-1)" "unprognostic (4.56e-2)" "unprognostic (1.06e-1)" "unprognostic (6.38e-3)" "unprognostic (2.19e-1)" "unprognostic (1.35e-3)" "unprognostic (3.12e-1)" "unprognostic (7.50e-2)" "unprognostic (2.94e-1)" "unprognostic (7.32e-2)" 6.0 13.4 7.5 4.6 5.4 0.2 8.8 4.2 5.9 19.8 12.6 3.9 27.1 11.3 11.9 29.1 9.7 11.5 15.7 10.4 6.0 9.0 100.0 79.8 7.1 4.8 6.5 3.5 9.4 26.1 13.2 17.2 3.7 11.1 13.8 4.9 9.4 5.9 21.9 5.6 5.6 19.8 14.1 6.8 5.4 9.5 4.9 5.9 7.1 17.1 7.9 5.8 14.8 15.8 18.2 8.9 4.7 8.6 14.4 21.7 9.0 2.5 24.8 12.8 3.6 14.8 16.2 8.7 8.0 12.7 11.6 13.1 19.4 10.3 13.9 14.1 15.5 20.4 6.9 10.4 10.1 19.0 16.0 4.2 5.8 7.7 38.8 7.8 4.9 11.9 7.5 9.0 18.6 3.4 10.9 9.7 7.7 18.2 5.0 24.2 5.8 8.9 8.3 9.6 20.2 16.2 5.7 12.1 5.1 98.3 7.9 3.5 6.3 1.8 13.5 8.7 15.0 12.1 1.6 4.7 2.8 7.0 8.7 12.0 3.6 6.9 6.8 22.8 1.9 7.9 4.7 5.2 0.9 18.2 7.7 14.7 18.2 17.9 16.7 8.9 13.7 15.7 16.7 0.8 14.4 8.6 7.5 21.7 9.0 7.5 5.4 4.2 5.9 6.0 9.0 6.5 3.5 11.1 5.9 26.8 16.9 14.3 23.5 15.9 2.5 25.7 89.2 16.0 12.5 151.8 2.0 12.7 192.3 42.4 0.3 8.0 12.3 0.0 28.1 14.2 21.7 10.3 13.9 184.9 15.3 0.0 6.4 11.6 12.5 1.1 19.2 10.6 10.1 10.0 13.2 6.8 30.1 9.1 19.4 384.2 2.6 0.0 15.9 1.4 6.8 18.4 6.1 15.2 13.3 12.7 CS ENSG00000062485 "Citrate synthase" O75390 12 56271699-56300392 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tricarboxylic acid cycle" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 125.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 207.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754" Enhanced Enhanced Mitochondria NA NA 4400000 Mitochondria "CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024" "unprognostic (7.67e-3)" "unprognostic (3.80e-1)" "unprognostic (2.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (6.09e-3)" "unprognostic (3.34e-2)" "unprognostic (2.43e-1)" "unprognostic (5.58e-2)" "unprognostic (2.56e-1)" "unprognostic (1.97e-2)" "prognostic favorable (1.17e-4)" "unprognostic (1.20e-1)" "unprognostic (2.09e-1)" "unprognostic (1.30e-2)" "unprognostic (2.02e-1)" 37.1 35.5 11.9 16.3 20.4 19.3 55.6 28.5 43.8 17.2 27.4 14.1 11.3 25.3 19.9 10.8 31.7 16.5 14.0 79.2 11.2 14.5 26.7 12.3 17.3 30.8 12.3 14.2 16.9 20.7 28.1 14.3 11.9 24.8 16.2 32.7 19.8 23.1 17.5 125.9 22.8 27.0 21.2 15.0 18.4 21.4 7.9 11.1 20.7 17.9 48.2 26.1 22.9 19.1 19.5 37.1 59.6 27.8 15.9 19.7 18.2 35.8 38.8 31.7 41.1 42.1 39.2 20.6 29.9 29.4 52.7 36.8 54.7 35.2 70.1 29.4 37.7 22.6 38.9 87.5 45.0 50.4 24.3 44.5 48.1 28.2 39.4 23.6 58.8 34.6 43.1 43.0 41.3 50.1 43.4 59.1 36.6 49.8 42.1 45.9 28.8 48.7 18.1 25.2 27.2 56.1 47.5 37.2 52.9 32.6 36.4 41.6 27.3 38.7 46.1 30.3 30.8 64.1 34.3 39.2 26.6 37.3 37.5 31.5 27.8 42.3 45.6 24.5 43.4 24.9 14.5 22.0 59.6 15.2 27.8 19.7 19.5 18.3 14.3 37.1 16.7 19.4 15.4 9.8 15.9 27.0 20.5 19.3 18.2 11.9 20.4 28.5 43.8 11.2 14.5 12.3 14.2 24.8 11.1 14.9 33.2 16.0 18.6 34.7 21.7 207.5 22.9 10.7 19.4 12.2 58.9 15.6 29.9 31.3 5.1 27.0 51.5 0.0 38.6 26.0 18.2 26.3 27.6 26.2 31.0 9.5 16.3 17.2 29.2 3.6 18.7 33.5 10.1 27.1 43.6 15.1 37.2 23.0 18.7 17.3 36.0 12.9 25.9 18.4 24.7 45.7 14.1 18.1 64.8 26.5 CSAG1 "CSAGE, CT24.1" ENSG00000198930 "Chondrosarcoma associated gene 1" Q6PB30 X 152727484-152733735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.2;lymphoid tissue: 3.3;testis: 6.3" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 38.2;HMC-1: 21.2;K-562: 13.5;OE19: 44.1;PC-3: 19.1;U-266/70: 33.6" NA NA "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" "unprognostic (8.96e-3)" "unprognostic (4.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.83e-3)" "unprognostic (5.96e-2)" "unprognostic (4.21e-1)" "unprognostic (6.68e-3)" "unprognostic (3.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-6)" "unprognostic (5.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-3)" "unprognostic (8.70e-3)" 0.2 0.2 3.3 1.1 4.2 0.2 0.2 1.6 4.1 0.2 0.3 1.5 0.0 0.2 0.8 0.2 0.2 0.4 0.2 0.2 3.2 1.8 0.3 0.4 0.3 3.3 3.0 0.9 0.2 0.2 0.2 0.0 0.3 2.0 0.4 0.3 0.0 0.5 0.5 0.2 0.5 0.6 0.7 1.3 0.5 0.4 6.3 2.7 0.1 0.9 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.0 21.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.5 0.1 0.0 0.0 0.0 0.0 0.0 44.1 19.1 0.0 0.0 0.1 0.0 0.0 2.1 11.9 0.0 7.1 5.6 0.0 0.3 0.0 0.1 1.3 0.3 6.9 2.2 33.6 0.5 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.2 1.6 4.1 3.2 1.8 3.0 0.9 2.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 10.7 0.0 0.1 0.0 0.0 0.6 CSAG2 "CSAG3B, CT24.2, TRAG3" ENSG00000268902 "CSAG family member 2" X 152708261-152714549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.1;skin 1: 2.7;testis: 1.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 17.2;SK-BR-3: 7.1;U-266/70: 5.7;U-266/84: 7.1" NA NA "unprognostic (5.87e-2)" "unprognostic (3.82e-2)" "unprognostic (1.44e-1)" "unprognostic (2.48e-1)" "unprognostic (2.81e-2)" "unprognostic (3.35e-2)" "unprognostic (1.55e-1)" "unprognostic (1.50e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 1.0 0.0 1.9 0.0 0.2 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.5 0.0 0.0 0.0 0.0 0.4 2.1 2.1 0.0 0.0 2.4 0.0 0.0 1.4 3.1 0.0 7.1 3.0 0.0 0.0 0.3 0.1 0.1 2.4 0.6 0.2 5.7 7.1 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSAG3 CSAG3A ENSG00000268916 "CSAG family member 3" Q9Y5P2 X 152753921-152760222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 3.4;skin 1: 2.4;testis: 5.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 18.9;HMC-1: 11.1;OE19: 26.9;SH-SY5Y: 14.4;SK-BR-3: 13.3;U-266/70: 34.4;U-266/84: 17.4" NA NA "unprognostic (1.56e-1)" "unprognostic (9.48e-2)" "unprognostic (1.41e-1)" "unprognostic (7.12e-3)" "unprognostic (4.99e-2)" "unprognostic (2.88e-1)" "unprognostic (1.02e-2)" "unprognostic (7.06e-2)" "unprognostic (7.06e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-2)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.3 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 8.9 0.0 0.0 0.0 0.0 0.0 26.9 0.1 0.0 0.0 1.1 0.0 0.0 2.9 14.4 0.0 13.3 0.5 0.0 0.0 0.5 0.0 0.0 10.5 0.0 0.0 34.4 17.4 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSDC2 PIPPin ENSG00000172346 "Cold shock domain containing C2" Q9Y534 22 41560763-41577741 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 84.8;ovary: 48.5" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 64.6;Muller glia cells: 39.5;Proximal tubular cells: 29.3;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HeLa: 8.1;U-2 OS: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003073, HPA076549" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003073: AB_1078578, HPA076549: AB_2686807" "unprognostic (9.42e-2)" "unprognostic (5.52e-2)" "unprognostic (3.66e-3)" "unprognostic (1.36e-1)" "unprognostic (2.06e-1)" "unprognostic (3.52e-1)" "unprognostic (3.93e-2)" "unprognostic (1.60e-1)" "unprognostic (2.70e-3)" "unprognostic (2.35e-2)" "unprognostic (1.93e-1)" "unprognostic (3.72e-1)" "prognostic favorable (6.42e-4)" "unprognostic (8.86e-3)" "unprognostic (6.08e-2)" "unprognostic (1.02e-1)" "unprognostic (9.09e-3)" 2.5 39.0 4.7 2.1 9.6 1.1 1.2 30.5 15.3 16.8 2.6 2.7 5.5 1.6 18.4 2.0 2.2 4.1 2.6 84.8 6.0 8.5 9.9 1.2 2.8 1.1 9.0 6.0 48.5 25.5 1.1 4.1 1.3 17.7 5.3 1.4 5.6 1.4 11.7 1.5 1.1 1.5 9.1 10.5 1.2 1.6 11.1 3.4 0.0 1.1 0.3 1.0 5.8 6.2 1.0 1.0 1.7 1.1 0.4 1.6 0.7 0.0 0.1 1.0 0.1 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.3 3.1 0.3 0.1 0.0 0.0 0.0 0.0 2.1 0.0 8.1 0.9 2.4 0.0 0.0 1.3 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.7 0.1 0.0 0.0 0.1 0.7 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.1 29.6 0.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 1.0 1.0 1.7 1.3 1.1 0.5 1.0 0.8 0.7 1.0 1.0 1.5 0.7 1.0 0.4 0.9 0.2 1.6 0.7 4.7 9.6 30.5 14.7 6.0 8.5 9.0 6.0 17.7 3.4 0.0 0.0 0.0 0.2 0.2 8.1 64.6 0.0 1.4 0.0 7.0 2.0 0.1 16.6 0.3 1.1 0.1 0.0 0.0 9.2 0.1 1.9 0.1 0.0 0.0 0.2 6.4 0.0 0.6 0.0 3.6 4.9 0.0 1.7 0.0 0.0 39.5 2.3 0.0 2.5 29.3 3.1 71.1 22.6 0.2 0.2 0.1 0.2 0.0 0.0 0.0 CSDE1 "D1S155E, UNR" ENSG00000009307 "Cold shock domain containing E1" O75534 1 114716913-114758676 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 266.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 226.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018846, HPA052221" Supported Enhanced "Plasma membrane,Cytosol" NA NA 13000 "Plasma membrane, Cytosol" "HPA018846: AB_1847266, HPA052221: AB_2681767" "unprognostic (2.84e-1)" "unprognostic (9.18e-3)" "unprognostic (4.86e-3)" "unprognostic (3.30e-3)" "unprognostic (2.83e-2)" "unprognostic (4.51e-2)" "unprognostic (5.32e-3)" "unprognostic (5.16e-2)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.69e-2)" "unprognostic (4.67e-2)" "unprognostic (1.18e-1)" "unprognostic (5.17e-3)" "unprognostic (2.54e-2)" 71.2 31.4 33.5 25.8 33.2 37.9 42.1 29.6 35.4 39.0 64.7 29.6 35.9 29.5 46.4 38.9 58.8 30.3 29.4 64.2 33.2 31.7 37.4 39.5 34.2 31.4 41.6 31.4 43.9 37.2 50.3 38.4 38.8 44.4 52.6 32.9 32.0 43.2 42.0 266.5 33.8 46.5 88.3 42.4 32.2 39.9 41.5 35.1 39.6 55.7 73.9 31.9 75.4 45.5 43.9 59.0 57.9 65.2 48.1 62.3 80.5 61.7 21.8 38.8 38.7 44.3 57.6 54.3 54.6 40.8 36.8 29.9 31.9 18.7 48.7 46.1 52.0 21.5 26.3 43.0 42.4 53.7 59.5 29.4 47.8 39.7 28.2 39.2 35.5 28.5 41.8 46.2 44.0 58.1 50.0 42.0 41.2 48.4 32.0 44.9 226.5 47.5 22.7 73.9 26.0 29.4 35.6 120.2 22.9 29.2 48.7 48.0 31.8 53.4 44.6 41.3 42.8 22.9 56.7 50.6 43.5 60.0 57.0 59.9 48.9 53.2 54.6 56.2 40.3 132.6 46.4 57.7 57.9 40.9 60.8 55.5 43.9 52.2 49.7 59.0 34.7 62.3 52.3 40.9 48.1 65.2 23.0 56.7 80.5 33.5 33.2 29.6 35.4 33.2 31.7 41.6 31.4 44.4 35.1 184.6 166.5 131.5 180.2 192.1 123.0 534.2 132.5 139.2 159.3 122.1 55.0 150.1 192.3 174.5 301.0 172.2 163.0 93.5 175.1 175.9 149.1 211.7 211.6 144.5 141.9 93.8 210.9 124.6 242.4 459.7 149.8 180.0 209.2 170.5 206.0 141.9 193.9 122.8 212.2 179.3 91.0 161.7 255.2 219.6 163.8 204.6 228.3 138.0 172.8 220.6 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.5;lymphoid tissue: 82.6" "Group enriched" "Detected in many" 8 "Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 60.7;non-classical monocyte: 82.5" "Lineage enriched" "Detected in many" 4 "monocytes: 82.5" "Group enriched" "Detected in some" 5 "BEWO: 51.8;SK-BR-3: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1500000000 "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 20.9 12.4 18.2 28.1 18.9 1.8 7.7 2.8 13.5 9.3 8.3 25.4 1.1 9.2 5.9 13.1 8.4 7.9 16.1 8.7 16.4 13.7 7.8 15.1 13.7 25.4 21.3 6.0 5.3 5.2 5.9 6.4 52.1 17.1 8.5 8.4 16.8 8.0 8.7 3.0 5.8 14.5 16.2 25.8 82.6 9.0 4.9 23.0 3.1 4.2 2.9 8.2 16.4 4.7 0.0 19.1 2.9 82.5 0.0 0.1 13.9 1.7 0.0 0.0 0.0 0.8 0.2 51.8 0.1 0.0 0.0 0.0 1.5 0.0 2.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.8 0.0 7.4 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.0 2.6 0.9 0.0 0.4 18.1 0.5 0.1 60.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 2.9 0.0 82.5 1.4 0.0 13.9 18.2 18.9 2.8 13.4 16.4 13.7 21.3 6.0 17.1 23.0 0.0 6.7 0.5 0.0 2.5 0.0 2.8 5.1 1.4 0.0 0.0 0.0 2.9 0.0 0.0 3.7 2.2 0.0 0.0 0.0 97.9 3.3 0.0 2.3 0.8 277.3 0.0 0.0 4.9 200.7 3.5 1.7 125.7 3.3 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.4 12.9 1.3 0.5 0.2 1.1 22.1 2.2 0.0 0.0 CSF2 "GM-CSF, GMCSF" ENSG00000164400 "Colony stimulating factor 2" P04141 5 132073790-132076170 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;lung: 6.8;pancreas: 4.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Ductal cells: 12.3;granulocytes: 5.7;Pancreatic endocrine cells: 14.6;T-cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "NK-cell: 9.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 9.5" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 45.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA057404, HPA062006" Enhanced Vesicles "Secreted to blood" NA NA 23900 Vesicles "HPA057404: AB_2683428, HPA062006: AB_2684654" "unprognostic (7.29e-2)" "unprognostic (2.49e-3)" "unprognostic (8.77e-2)" "unprognostic (2.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (1.47e-2)" "unprognostic (2.64e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-8)" "unprognostic (4.81e-2)" "unprognostic (1.22e-1)" "unprognostic (9.07e-2)" "unprognostic (2.06e-2)" 0.2 0.1 0.1 3.9 0.1 1.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.7 0.0 1.5 0.1 1.1 0.2 0.1 0.1 0.3 0.9 6.8 0.3 0.1 0.0 0.1 4.5 0.0 0.1 0.5 0.0 0.2 0.7 0.0 1.9 0.0 0.1 0.4 1.0 0.6 0.1 1.0 0.2 0.2 0.0 0.4 0.2 0.0 1.8 2.3 0.1 0.0 0.0 0.0 0.0 9.5 0.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 2.6 0.0 3.6 0.0 0.7 0.0 2.7 0.1 0.0 3.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.4 7.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 10.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.5 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 4.9 0.0 1.3 CSF2RA "alphaGMR, CD116, CSF2R" ENSG00000198223 "Colony stimulating factor 2 receptor alpha subunit" P15509 X 1268800-1310381 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.2;placenta: 79.5" "Cell type enhanced" "Detected in many" 26 "Cytotrophoblasts: 215.8;monocytes: 954.0;Syncytiotrophoblasts: 261.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5" "Group enriched" "Detected in many" 28 "dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0" "Group enriched" "Detected in some" 7 "BEWO: 60.4;HMC-1: 18.2;SK-MEL-30: 42.3" CAB016148 Uncertain "Secreted to blood" NA NA 9400000 "CAB016148: AB_626868" "unprognostic (4.19e-2)" "prognostic favorable (2.38e-5)" "unprognostic (5.47e-2)" "unprognostic (4.33e-2)" "unprognostic (4.88e-2)" "prognostic favorable (2.81e-4)" "unprognostic (8.24e-2)" "unprognostic (2.17e-1)" "unprognostic (5.55e-2)" "unprognostic (8.48e-2)" "unprognostic (8.89e-2)" "unprognostic (3.80e-1)" "unprognostic (2.89e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (5.53e-4)" "unprognostic (3.60e-1)" "unprognostic (9.44e-2)" 8.7 2.3 11.8 11.1 11.1 8.9 17.7 3.4 9.6 3.1 2.2 0.6 0.6 2.2 4.4 0.6 2.1 2.2 5.7 3.7 15.0 4.7 2.4 1.7 11.2 8.3 18.8 6.5 3.5 1.0 0.2 2.1 79.5 13.2 1.5 3.3 0.6 3.1 1.0 0.6 1.8 3.3 2.9 25.5 12.6 1.7 0.6 16.3 0.6 2.5 0.6 10.4 4.2 1.5 0.3 31.9 60.2 30.0 1.4 0.2 10.1 0.1 3.5 0.2 0.0 0.0 0.0 60.4 0.0 0.1 0.1 0.0 1.2 0.3 0.0 3.9 0.0 3.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.4 0.0 0.0 1.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 5.6 0.5 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 42.3 5.0 2.8 5.0 0.0 0.0 1.7 0.3 0.0 0.1 0.1 0.1 0.0 5.5 0.0 2.4 30.0 36.0 0.0 17.7 0.2 0.3 0.0 0.0 31.9 0.1 0.0 0.0 60.2 1.4 8.4 30.5 0.1 10.1 11.8 11.1 3.4 9.6 15.0 4.7 18.8 6.5 13.2 16.3 0.0 8.2 11.1 1.0 6.9 0.6 1.1 5.1 4.0 5.7 1.8 0.0 215.8 0.0 0.2 0.5 1.4 0.0 0.0 1.5 101.6 5.3 0.5 9.3 0.0 66.0 0.0 0.0 1.3 66.8 0.0 0.9 146.7 8.5 954.0 0.0 0.5 0.3 0.0 0.4 0.0 1.1 6.5 2.1 0.2 0.4 4.5 261.3 0.0 0.0 2.1 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor beta common subunit" P32927 22 36913628-36940449 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.1;placenta: 73.6" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 32.6;granulocytes: 87.9;Macrophages: 41.6;monocytes: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 53.1;neutrophil: 20.1" "Lineage enriched" "Detected in many" 14 "granulocytes: 53.1" "Group enriched" "Detected in some" 6 "HEL: 27.0;HMC-1: 84.6" "Low region specificity" "Detected in all" HPA078677 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA078677: AB_2732389" "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 8.5 1.8 1.5 28.9 1.5 21.7 6.0 0.6 1.0 3.0 5.9 2.0 0.4 4.5 2.2 2.8 4.0 3.6 5.5 4.2 1.4 1.4 2.4 3.5 12.6 34.1 2.9 0.2 2.5 1.9 0.3 1.2 73.6 2.4 3.5 3.8 2.8 9.7 1.0 2.6 3.8 10.2 3.0 2.9 25.2 3.9 2.1 1.9 8.2 3.4 4.8 30.5 8.2 4.3 0.4 3.8 53.1 2.1 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 27.0 0.0 0.0 0.0 0.4 84.6 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 3.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.7 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.1 0.2 0.0 0.0 0.0 0.4 0.2 1.7 0.0 3.9 0.0 53.1 1.9 5.8 0.0 2.1 0.0 0.4 0.0 0.0 1.2 0.3 0.0 0.0 20.1 0.0 1.7 3.8 0.6 1.8 1.5 1.5 0.6 1.0 1.4 1.4 2.9 0.2 2.4 1.9 0.0 14.5 8.2 0.0 6.4 0.0 0.8 5.1 5.3 3.4 0.0 0.0 2.2 0.0 0.0 11.1 9.0 0.0 0.0 0.2 32.6 4.1 0.0 87.9 0.0 16.8 0.0 0.0 4.3 26.0 26.5 0.0 41.6 11.8 29.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 5.5 13.8 1.3 0.0 0.0 CSF3 "C17orf33, G-CSF, GCSF, MGC45931" ENSG00000108342 "Colony stimulating factor 3" P09919 17 40015361-40017813 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 27.9;lung: 60.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 122.0;Basal keratinocytes: 30.7;Club cells: 33.0;Melanocytes: 37.1;Suprabasal keratinocytes: 29.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 19.9;U-87 MG: 78.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 6170 "unprognostic (3.59e-3)" "unprognostic (1.57e-2)" "unprognostic (1.73e-1)" "prognostic favorable (8.45e-4)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (1.10e-1)" "unprognostic (1.16e-2)" "unprognostic (1.74e-1)" "unprognostic (2.26e-1)" "unprognostic (2.82e-2)" "unprognostic (7.40e-4)" "unprognostic (1.21e-1)" "unprognostic (1.96e-1)" "unprognostic (4.10e-2)" "unprognostic (4.80e-3)" 12.4 1.5 1.0 13.8 1.3 3.0 2.8 0.8 1.6 27.9 3.0 1.4 0.0 0.2 2.3 2.2 5.9 2.9 2.1 6.9 1.1 1.0 0.2 0.5 60.9 0.5 1.2 0.1 3.3 4.1 0.2 3.8 2.6 7.4 4.3 0.7 1.6 0.6 0.3 20.6 0.4 1.4 1.6 2.6 1.0 2.0 1.1 1.2 0.1 0.7 8.8 7.0 7.2 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 3.2 0.0 2.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.3 0.8 1.6 1.1 1.0 1.2 0.1 7.4 1.2 20.8 122.0 0.0 4.6 30.7 0.0 0.1 0.0 14.7 33.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.0 8.9 8.7 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 37.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.7 29.4 0.0 0.0 0.1 5.4 CSF3R "CD114, GCSFR" ENSG00000119535 "Colony stimulating factor 3 receptor" Q99062 1 36466043-36483278 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7" "Cell type enhanced" "Detected in many" 27 "Alveolar cells type 2: 228.0;Cytotrophoblasts: 271.6;Syncytiotrophoblasts: 999.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 167.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 167.3" "Group enriched" "Detected in some" 18 "BEWO: 34.9;NB-4: 9.4;THP-1: 22.9;U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017116, HPA048086" Enhanced "Intracellular and membrane" NA NA "CAB017116: , HPA048086: AB_2680257" "unprognostic (5.57e-3)" "unprognostic (8.05e-2)" "unprognostic (7.23e-2)" "unprognostic (3.87e-2)" "unprognostic (2.88e-1)" "unprognostic (2.92e-2)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (5.65e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (6.33e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (2.03e-1)" "unprognostic (2.31e-2)" 8.5 1.5 2.9 39.5 3.2 88.9 2.4 0.7 2.9 1.1 1.1 4.2 0.4 0.6 0.7 1.1 1.2 6.9 4.3 5.6 2.6 2.0 1.7 4.5 26.9 27.5 7.2 1.1 1.1 1.3 0.3 1.1 152.7 3.8 1.3 0.5 2.1 1.6 0.5 0.6 0.3 1.6 3.1 7.1 71.4 2.2 1.4 3.3 1.1 1.0 0.4 0.9 4.6 3.9 0.0 8.2 167.3 22.1 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.1 0.0 0.0 22.1 0.6 0.0 4.8 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 167.3 0.2 1.8 0.2 0.0 10.3 2.9 3.2 0.7 2.9 2.6 2.0 7.2 1.1 3.8 3.3 23.8 228.0 2.4 0.6 0.9 0.0 1.4 0.0 12.0 18.2 0.0 0.0 271.6 0.0 0.0 0.4 1.9 0.0 0.0 0.0 49.1 3.0 0.2 17.4 0.8 60.8 0.0 0.0 3.7 146.3 0.4 0.3 62.6 0.0 3.6 0.0 0.2 0.1 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.2 0.1 999.2 0.5 0.0 2.2 CSGALNACT1 "ChGn, CSGalNAcT-1, FLJ11264" ENSG00000147408 "Chondroitin sulfate N-acetylgalactosaminyltransferase 1" Q8TDX6 8 19404161-19758029 "Enzymes, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 57.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 41.5;Endothelial cells: 33.7;Glandular cells: 33.6" "Cancer enhanced" "Detected in all" "prostate cancer: 22.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 20.1;granulocytes: 10.3;T-cells: 25.5" "Cell line enhanced" "Detected in some" "A549: 29.0;BJ hTERT+: 16.3;GAMG: 11.7;RPTEC TERT1: 20.3;U-2197: 18.5;U-87 MG: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068462 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA068462: " "unprognostic (8.90e-2)" "unprognostic (1.57e-2)" "unprognostic (4.66e-2)" "unprognostic (2.58e-1)" "unprognostic (6.03e-2)" "unprognostic (3.17e-3)" "unprognostic (9.78e-2)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (1.22e-2)" "unprognostic (1.89e-1)" "unprognostic (2.38e-2)" "unprognostic (1.46e-3)" "unprognostic (1.02e-2)" 13.8 8.7 22.7 6.0 15.4 6.8 7.2 3.8 21.4 13.0 3.8 9.2 4.0 2.8 7.1 5.9 21.2 8.7 10.8 23.8 17.7 8.2 5.3 2.3 7.9 10.5 9.1 18.7 38.6 10.9 4.2 5.9 25.1 7.0 21.7 2.1 2.6 5.8 7.3 3.9 4.2 4.2 17.2 8.6 6.3 5.4 2.7 10.3 4.0 57.7 4.5 6.1 18.9 9.7 20.1 1.7 10.3 1.2 3.2 25.5 4.8 0.7 29.0 0.2 0.0 4.8 1.1 3.7 0.6 16.3 0.1 0.1 1.4 0.3 0.0 0.0 0.0 11.7 0.3 0.0 0.0 0.1 3.6 0.2 0.0 8.3 0.7 2.1 0.0 0.0 0.4 0.7 0.1 0.1 0.0 5.5 0.0 0.0 0.0 0.0 1.2 1.1 0.1 0.0 3.6 0.9 0.1 0.0 0.0 20.3 0.7 0.1 0.1 8.5 3.4 1.1 0.6 0.0 0.0 0.3 0.4 0.4 18.5 0.2 0.1 0.0 0.0 13.4 1.6 5.6 0.0 1.2 10.3 2.5 0.0 0.3 20.1 11.5 3.9 1.1 6.2 20.6 5.2 7.1 3.2 0.1 1.7 25.5 4.8 22.7 15.4 3.8 21.4 17.7 8.2 9.1 18.7 7.0 10.3 3.0 1.4 8.2 8.2 3.9 0.4 41.5 0.0 2.7 1.2 12.2 9.8 1.4 1.7 3.7 5.5 33.7 0.0 0.0 1.5 13.5 20.0 33.6 0.0 0.0 12.0 17.5 2.9 20.3 21.2 5.9 4.9 5.1 11.8 0.0 0.0 0.9 3.0 0.0 11.3 0.0 1.0 6.5 7.2 0.1 0.0 2.8 7.0 2.2 0.0 2.1 CSGALNACT2 "GALNACT-2, GALNACT2, MGC40204, PRO0082" ENSG00000169826 "Chondroitin sulfate N-acetylgalactosaminyltransferase 2" Q8N6G5 10 43138486-43185308 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.6" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 62.0;Macrophages: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031540 Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA031540: AB_10599943" "unprognostic (1.65e-1)" "unprognostic (2.70e-2)" "unprognostic (9.10e-2)" "unprognostic (6.41e-2)" "unprognostic (1.95e-1)" "unprognostic (8.28e-3)" "unprognostic (2.85e-3)" "unprognostic (4.95e-2)" "unprognostic (2.96e-1)" "unprognostic (3.43e-3)" "unprognostic (7.65e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (3.53e-7)" "unprognostic (2.68e-2)" "unprognostic (1.40e-1)" "unprognostic (2.47e-1)" "unprognostic (4.05e-3)" 18.3 8.2 9.0 16.4 13.0 80.6 11.5 10.0 10.9 11.4 12.5 17.6 4.8 6.8 14.7 7.5 9.8 12.8 18.4 11.5 10.0 9.0 8.2 11.3 24.0 25.7 11.0 6.2 16.2 6.3 7.8 15.0 18.3 11.5 10.4 8.9 19.8 7.9 8.6 12.5 8.1 9.6 15.7 14.4 21.1 8.7 6.7 9.6 24.3 9.2 6.6 12.2 17.8 11.0 2.5 11.6 15.2 16.3 8.7 6.3 5.1 4.9 3.3 6.2 5.9 9.7 16.4 1.5 18.1 24.4 8.0 12.5 1.1 5.1 8.2 4.5 16.3 3.8 4.6 5.1 6.8 13.1 9.8 3.8 4.3 3.1 3.4 21.2 9.9 9.0 16.3 7.5 17.8 37.3 10.1 10.2 12.5 1.8 24.7 16.3 2.6 7.5 5.9 2.7 1.7 4.3 4.7 6.2 3.4 7.1 2.6 5.6 11.1 4.7 4.8 11.3 5.6 6.4 8.2 15.0 6.9 10.9 21.5 12.1 6.4 8.9 4.4 14.6 24.3 3.2 10.7 9.8 15.2 6.3 11.4 5.5 2.5 4.9 4.9 11.6 2.2 5.8 4.8 9.0 8.7 16.3 3.4 5.6 5.1 9.0 13.0 10.0 10.9 10.0 9.0 11.0 6.2 11.5 9.6 14.9 16.0 7.2 10.1 15.8 11.9 9.2 2.5 6.7 14.8 10.4 9.8 1.9 0.0 5.4 2.1 14.0 1.4 0.0 6.0 5.6 26.7 10.2 46.2 10.4 15.8 7.9 8.6 14.1 62.0 0.4 15.8 59.7 8.5 7.2 2.1 4.4 9.8 1.7 11.7 3.4 8.3 25.8 25.1 11.7 17.2 10.7 1.3 32.8 1.6 6.0 CSH1 "CSA, CSMT, FLJ75407, hCS-A, PL" ENSG00000136488 "Chorionic somatomammotropin hormone 1" P0DML2 17 63894909-63896661 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 450.4" "Group enriched" "Detected in some" 22 "Extravillous trophoblasts: 439.3;Syncytiotrophoblasts: 913.5" "Cancer enriched" "Detected in single" 8 "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 12.0;SuSa: 18.9" "CAB026374, HPA043715" Enhanced "Secreted to blood" NA NA "CAB026374: , HPA043715: AB_2678632" "unprognostic (6.99e-2)" 2.6 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 15.7 450.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.9 0.1 1.0 0.9 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 439.3 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 913.5 0.0 0.0 0.0 CSH2 "CS-2, CSB, hCS-B" ENSG00000213218 "Chorionic somatomammotropin hormone 2" P0DML3 17 63872012-63873766 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "placenta: 246.2" "Cell type enriched" "Detected in some" 25 "Syncytiotrophoblasts: 230.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "BEWO: 10.2;SuSa: 15.3" HPA043715 Supported "Secreted to blood" NA NA "HPA043715: AB_2678632" "unprognostic (1.68e-1)" "unprognostic (1.85e-1)" "unprognostic (1.86e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 246.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 230.4 0.0 0.0 0.0 CSHL1 "CS-5, CSHP1, CSL, hCS-L, MGC149868" ENSG00000204414 "Chorionic somatomammotropin hormone like 1" Q14406 17 63909597-63918838 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 864 "pituitary gland: 334.1;placenta: 293.7" "Cell type enriched" "Detected in some" 16 "Syncytiotrophoblasts: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.2;SCLC-21H: 1.3;SuSa: 1.7" "CAB025646, HPA043715" Enhanced "Secreted to blood" NA NA "CAB025646: , HPA043715: AB_2678632" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 334.1 293.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 18.1 0.0 0.0 0.0 CSK ENSG00000103653 "C-terminal Src kinase" P41240 15 74782057-74803198 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 91.8;Kupffer cells: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011203, HPA026488, HPA028425" Approved Approved Enhanced Vesicles,Cytosol No No 1500000 "Vesicles, Cytosol" "CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899" "unprognostic (1.05e-1)" "prognostic favorable (5.14e-5)" "unprognostic (2.59e-3)" "prognostic favorable (8.22e-4)" "unprognostic (4.15e-2)" "unprognostic (4.11e-2)" "unprognostic (1.87e-1)" "unprognostic (2.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-1)" "unprognostic (4.12e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.74e-4)" "prognostic favorable (1.07e-4)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" 9.3 8.0 9.5 39.3 11.0 19.9 12.6 18.7 13.4 12.1 13.5 11.8 7.3 16.1 13.9 6.4 33.3 10.6 11.2 14.0 9.8 8.5 8.0 20.9 15.6 67.2 11.1 7.4 10.5 6.7 6.6 10.4 8.8 12.2 9.8 8.9 9.8 13.2 7.0 8.7 14.9 26.2 8.5 10.9 62.7 13.1 8.1 10.6 62.7 8.1 9.5 47.4 17.4 13.2 35.6 22.8 49.6 46.8 16.3 30.7 19.9 12.9 18.3 9.0 14.7 8.6 6.6 7.7 8.7 8.4 16.6 11.8 16.7 12.0 58.0 11.5 7.8 15.4 13.5 18.8 17.5 4.7 28.1 23.2 49.1 6.7 16.7 11.9 25.6 62.6 9.3 8.7 11.8 10.6 8.3 12.5 27.4 14.1 20.2 9.8 21.9 18.4 15.1 11.1 11.7 13.1 20.5 7.7 42.3 7.6 28.8 14.9 10.3 11.3 23.7 15.1 6.0 16.3 37.8 10.8 20.1 10.6 15.7 15.0 10.8 21.8 59.2 10.4 49.0 13.6 20.7 19.7 49.6 23.4 42.4 20.0 29.4 20.3 23.1 22.8 35.6 15.7 18.4 39.1 16.3 46.8 13.2 30.7 19.9 9.5 11.0 18.7 13.4 9.8 8.5 11.1 7.4 12.2 10.6 3.0 11.6 91.8 7.2 8.2 16.5 8.1 12.7 5.3 6.8 8.7 5.9 6.3 1.7 8.5 10.0 11.5 27.7 0.0 12.0 11.0 7.6 9.3 25.5 25.0 46.4 27.0 9.1 12.3 77.9 2.1 8.3 44.5 8.5 36.9 25.3 6.5 15.2 17.3 7.8 6.8 4.1 6.5 8.5 3.8 11.3 8.0 4.7 60.9 22.8 10.5 CSKMT "CS-KMT, METTL12, U99HG" ENSG00000214756 "Citrate synthase lysine methyltransferase" A8MUP2 11 62665309-62668496 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 17.3" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 52.8;Club cells: 38.7;Cytotrophoblasts: 24.1;granulocytes: 25.6;Syncytiotrophoblasts: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 5.8" "Low region specificity" "Detected in many" HPA038533 Approved NA NA "HPA038533: AB_10697392" "prognostic favorable (8.73e-4)" "unprognostic (2.59e-1)" "unprognostic (3.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.48e-2)" "unprognostic (3.17e-1)" "unprognostic (9.43e-5)" "unprognostic (1.55e-2)" "unprognostic (7.62e-2)" "unprognostic (2.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (4.98e-3)" "unprognostic (2.72e-3)" "unprognostic (1.85e-1)" "unprognostic (1.57e-2)" "unprognostic (3.28e-1)" 2.3 2.5 3.4 3.1 4.1 1.2 3.8 7.1 4.1 3.8 3.1 0.9 2.8 3.9 3.2 1.9 3.5 4.3 2.2 2.2 3.3 2.2 2.6 2.4 3.0 6.1 5.9 2.7 4.4 17.3 1.9 1.9 3.8 6.0 2.9 3.5 1.1 3.0 4.2 5.2 2.2 2.0 1.5 3.7 2.3 2.5 4.7 2.3 2.9 2.1 8.9 4.7 3.2 5.9 5.2 2.5 1.3 3.3 0.8 6.1 2.9 1.8 1.9 0.6 0.8 5.6 2.3 1.0 0.7 1.4 1.7 2.0 1.4 1.9 3.5 0.8 2.5 0.4 3.5 3.3 1.7 3.0 1.0 0.0 1.1 0.0 2.1 0.0 0.0 1.3 2.0 5.8 0.4 2.2 1.5 0.5 0.6 1.5 0.0 2.0 1.6 0.9 1.3 3.4 0.1 1.7 1.6 0.9 0.5 0.8 0.3 0.0 0.1 1.7 2.1 1.8 0.7 4.1 0.4 0.0 0.4 1.9 5.0 0.1 0.3 0.0 0.0 0.5 0.8 0.9 1.3 2.2 0.3 1.8 3.3 3.6 5.2 5.0 2.2 2.1 3.2 6.1 5.1 0.0 0.8 2.3 2.5 2.5 2.9 3.4 4.1 7.1 4.1 3.3 2.2 5.9 2.7 6.0 2.3 11.9 52.8 0.0 0.0 0.0 0.0 0.0 0.0 12.0 38.7 17.4 0.0 24.1 5.0 5.9 0.0 0.0 0.0 0.0 4.9 17.7 0.0 0.0 25.6 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 3.6 0.0 0.0 5.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" 8 2935353-4994972 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;testis: 9.0" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 8.4;Ciliated cells: 17.4;Early spermatids: 38.6" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 9.0;U-2 OS: 4.4;U-266/70: 4.3;U-266/84: 3.9;U-698: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles NA NA Vesicles "HPA074707: AB_2686707" "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 1.0 1.1 20.4 0.8 21.1 0.8 1.4 6.3 29.5 2.5 0.8 1.7 0.0 1.0 1.2 0.9 0.8 3.2 0.8 0.7 12.9 4.5 2.7 0.7 1.4 0.9 3.9 18.2 0.9 0.9 0.7 0.7 2.8 3.4 1.1 0.8 0.0 0.7 1.5 1.1 1.0 1.0 1.7 2.4 2.8 0.8 9.0 2.4 0.0 1.1 0.0 0.9 1.1 0.5 0.0 0.9 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.4 0.0 0.0 4.3 3.9 3.7 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 20.4 21.1 6.3 29.5 12.9 4.5 3.9 18.2 3.4 2.4 0.0 0.3 0.0 0.0 0.2 8.4 1.6 0.0 17.4 1.2 1.8 0.0 2.4 0.0 0.0 38.6 0.4 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.7 0.5 0.0 0.0 7.1 5.4 0.1 3.0 0.0 0.0 0.0 CSMD2 KIAA1884 ENSG00000121904 "CUB and Sushi multiple domains 2" Q7Z408 1 33513999-34165842 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 4.8;Bipolar cells: 10.5" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 4.9;fHDF/TERT166: 6.0;HEL: 9.0;NTERA-2: 7.2;PC-3: 7.4;U-87 MG: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008622 Uncertain NA NA "HPA008622: AB_1078579" "unprognostic (1.33e-2)" "unprognostic (2.98e-1)" "unprognostic (6.47e-2)" "unprognostic (2.14e-1)" "unprognostic (7.03e-2)" "unprognostic (2.77e-1)" "unprognostic (1.31e-3)" "unprognostic (5.90e-2)" "unprognostic (7.44e-2)" "unprognostic (5.36e-2)" "unprognostic (2.32e-2)" "unprognostic (2.97e-1)" "unprognostic (1.25e-5)" "unprognostic (1.03e-3)" "unprognostic (1.46e-1)" "unprognostic (8.04e-2)" "unprognostic (1.38e-2)" 2.1 2.3 9.0 2.0 10.6 0.7 0.9 5.9 15.8 1.2 1.1 6.2 1.6 1.7 1.4 1.3 1.1 0.9 6.6 1.5 10.4 7.5 1.0 0.9 1.0 1.9 4.7 9.3 0.9 1.9 0.8 0.8 0.9 10.4 1.4 1.4 2.7 0.9 1.8 0.8 1.6 1.4 2.5 7.4 1.5 1.2 3.4 5.2 0.0 1.3 0.0 2.9 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.1 1.3 0.0 2.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 10.6 5.9 15.8 10.4 7.5 4.7 9.3 10.4 5.2 6.0 4.8 0.0 0.3 0.2 10.5 4.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 3.6 2.8 1.2 0.0 0.0 2.5 0.1 0.6 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.0 1.4 0.4 0.0 0.0 0.0 0.2 0.9 0.0 3.5 0.0 1.6 0.0 0.5 0.3 1.8 0.4 0.0 0.0 0.0 0.2 CSMD3 ENSG00000164796 "CUB and Sushi multiple domains 3" Q7Z407 8 112222928-113437099 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 26.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 4.8;Bipolar cells: 6.4;Early spermatids: 10.2;Spermatocytes: 15.3;Spermatogonia: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 2.4;hTCEpi: 2.4;hTERT-HME1: 1.7;LHCN-M2: 3.4;RH-30: 2.1;SCLC-21H: 1.5;U-2 OS: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029007 Uncertain NA NA "HPA029007: AB_10601802" "unprognostic (2.26e-1)" "unprognostic (2.16e-2)" "unprognostic (2.83e-2)" "unprognostic (5.97e-2)" "unprognostic (3.44e-2)" "unprognostic (1.26e-2)" "unprognostic (3.54e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (2.89e-2)" "unprognostic (2.33e-2)" "unprognostic (5.03e-10)" "unprognostic (1.95e-1)" "unprognostic (4.14e-3)" "unprognostic (1.91e-2)" "unprognostic (1.74e-3)" 1.0 1.0 26.6 1.0 21.9 1.0 1.0 6.0 18.3 1.6 1.1 2.2 0.0 1.1 1.1 1.1 1.0 2.3 1.0 1.0 14.2 6.7 1.1 1.0 1.1 1.0 3.0 15.8 1.0 1.0 1.0 5.7 1.0 10.9 2.1 1.2 0.0 1.0 2.1 1.0 1.0 1.2 1.1 3.6 2.4 1.3 5.0 7.0 0.0 1.0 0.0 1.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.4 0.0 1.7 0.6 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 21.9 6.0 18.3 14.2 6.7 3.0 15.8 10.9 7.0 0.0 4.8 0.0 0.1 0.2 6.4 1.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 10.2 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 15.3 5.6 0.5 0.0 0.0 0.0 0.2 CSN1S1 "CASA, CSN1" ENSG00000126545 "Casein alpha s1" P47710 4 69931081-69946574 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Milk protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "breast: 184.8" "Cell type enriched" "Detected in single" 11 "Cardiomyocytes: 1.6" "Cancer enriched" "Detected in some" 10 "breast cancer: 17.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NK-cell: 1.6;plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 11 "dendritic cells: 3.2;NK-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;HL-60: 1.4;U-266/70: 1.5" "HPA035659, HPA057031" Enhanced "Secreted in female reproductive system" NA NA "HPA035659: AB_10696356, HPA057031: AB_2683315" "unprognostic (1.52e-2)" "unprognostic (1.01e-1)" 44.7 0.0 0.0 0.0 0.1 0.0 184.8 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 1.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.2 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.6 0.0 3.2 0.0 0.2 0.0 0.1 0.0 0.9 0.1 1.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CSN2 CASB ENSG00000135222 "Casein beta" P05814 4 69955256-69961007 "Predicted secreted proteins" "Milk protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "breast: 82.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 156 "breast cancer: 75.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-266/70: 1.4" "Not detected" "Not detected" HPA041036 Supported "Secreted in female reproductive system" NA NA "HPA041036: AB_10793865" 0.0 0.0 0.0 0.0 0.0 0.0 82.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSN3 CSN10 ENSG00000171209 "Casein kappa" P07498 4 70242588-70251428 "Predicted secreted proteins" "Milk protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 96 "breast: 91.1;salivary gland: 31.2" "Group enriched" "Detected in some" 9 "Early spermatids: 3.2;Late spermatids: 1.1;Spermatocytes: 1.0" "Group enriched" "Detected in some" 15 "breast cancer: 35.3;lung cancer: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.4;U-266/70: 1.6" "Not detected" "Not detected" "HPA035953, HPA035954" Enhanced "Secreted in female reproductive system" NA NA "HPA035953: AB_10673226, HPA035954: AB_2674884" 0.1 0.0 0.1 0.1 0.1 0.0 91.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 31.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 CSNK1A1L MGC33182 ENSG00000180138 "Casein kinase 1 alpha 1 like" Q8N752 13 37103259-37105664 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 10.5;testis: 9.0" "Group enriched" "Detected in some" 8 "Early spermatids: 23.1;Late spermatids: 19.5;Spermatocytes: 11.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 40 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 42 "granulocytes: 10.5" "Not detected" "Not detected" HPA051334 Uncertain Cytosol NA NA Cytosol "HPA051334: AB_2681446" "unprognostic (1.23e-2)" "unprognostic (1.59e-1)" "unprognostic (3.19e-2)" "unprognostic (3.54e-2)" "unprognostic (2.40e-2)" "unprognostic (5.40e-2)" "unprognostic (8.90e-2)" "unprognostic (3.47e-1)" "unprognostic (1.47e-3)" "unprognostic (4.50e-1)" "unprognostic (2.02e-1)" "unprognostic (2.28e-3)" "unprognostic (3.45e-1)" "unprognostic (2.38e-1)" 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.0 0.0 0.0 0.0 0.0 0.1 0.2 10.5 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 10.5 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 1.5 1.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 23.1 0.5 0.0 0.0 0.0 0.1 0.4 0.9 0.0 0.0 0.1 0.0 0.0 1.8 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.4 1.1 2.4 0.2 0.0 0.0 1.0 CSNKA2IP ENSG00000283434 "Casein kinase 2 subunit alpha' interacting protein" 3 88338413-88467562 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 24 "testis: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562239-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 81.1" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 28.1;Muller glia cells: 86.9;Rod photoreceptor cells: 19.5;Spermatocytes: 17.2" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.8;HEK 293: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446" "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favorable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 1.8 1.8 30.6 1.3 25.8 1.1 1.6 7.2 81.1 1.3 1.4 6.7 0.0 1.1 1.3 1.2 1.3 1.4 1.2 1.3 20.2 17.1 1.2 1.2 1.7 1.3 12.9 12.6 1.1 1.4 1.1 0.2 1.8 5.6 1.5 1.3 8.0 1.1 1.1 1.5 1.6 1.3 1.4 6.2 1.1 1.2 2.2 4.1 0.0 1.3 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 26.8 4.7 0.5 0.0 0.7 0.5 0.1 1.0 0.3 0.2 1.6 0.1 2.1 0.0 2.0 0.4 2.2 0.2 0.2 0.0 7.4 0.4 1.1 0.0 0.0 0.3 1.2 0.0 0.9 0.1 0.0 0.7 0.0 0.9 5.2 0.2 0.1 1.2 0.2 0.3 2.6 1.9 2.7 0.4 0.2 0.6 1.1 0.9 2.8 1.3 1.7 3.4 0.1 0.7 1.3 2.4 0.2 0.0 5.6 0.1 1.5 0.6 0.6 0.0 0.4 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 25.8 7.2 22.4 20.2 17.1 12.9 12.6 5.6 4.1 3.0 1.3 0.0 0.1 0.7 28.1 1.2 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.5 0.2 6.4 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 86.9 0.2 0.0 0.0 0.0 19.5 0.0 0.2 17.2 1.0 0.5 0.1 0.0 0.2 0.1 CSRNP3 "FAM130A2, FLJ32093, PPP1R73, TAIP-2" ENSG00000178662 "Cysteine and serine rich nuclear protein 3" Q8WYN3 2 165469647-165689407 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.7;pituitary gland: 21.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 49.8;Cone photoreceptor cells: 66.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;PC-3: 3.1;SCLC-21H: 9.5;SH-SY5Y: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017905 Approved Uncertain "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "HPA017905: AB_1857757" "unprognostic (2.85e-1)" "unprognostic (1.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.61e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-3)" "unprognostic (7.41e-2)" "unprognostic (5.36e-2)" "unprognostic (3.17e-1)" "unprognostic (1.08e-2)" 2.1 5.5 9.3 1.4 24.9 0.7 6.7 8.8 31.7 5.7 2.0 3.2 0.4 2.1 6.3 2.3 2.0 2.5 2.5 3.4 9.3 10.2 3.7 1.8 1.4 1.1 5.3 13.2 7.8 8.0 6.0 21.1 1.1 7.8 3.9 2.5 4.0 4.9 5.1 0.9 2.1 1.7 5.7 2.9 2.1 2.0 1.9 4.8 0.0 5.3 0.0 1.0 1.9 2.5 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.6 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.9 0.6 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 3.1 0.0 0.1 0.8 0.7 0.0 9.5 7.7 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.8 0.3 0.0 0.3 0.6 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.3 24.9 8.8 31.7 9.3 10.2 5.3 13.2 7.8 4.8 3.0 3.2 0.0 2.6 4.6 49.8 6.7 10.2 0.0 1.2 10.4 66.8 0.3 3.3 1.8 2.5 2.9 0.5 0.0 2.1 0.1 4.7 0.3 0.0 2.9 2.0 11.1 7.5 1.3 0.3 1.3 6.9 0.0 6.8 0.0 2.6 18.3 1.0 1.9 7.8 5.0 17.9 6.5 14.6 0.7 0.7 4.0 0.2 0.0 2.9 1.4 CSRP1 "CSRP, CYRP, D1S181E" ENSG00000159176 "Cysteine and glycine rich protein 1" P21291 1 201483530-201509456 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 338.6" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 327.5;Smooth muscle cells: 369.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045617 Uncertain NA NA 25000000 "HPA045617: AB_2679391" "unprognostic (7.08e-2)" "unprognostic (1.59e-2)" "unprognostic (4.86e-2)" "unprognostic (9.89e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (2.87e-1)" "unprognostic (1.45e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (9.24e-2)" "unprognostic (2.58e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.96e-3)" 33.9 17.1 39.0 27.3 53.5 5.1 39.6 12.0 56.6 75.6 200.1 92.2 63.2 23.2 159.3 48.5 116.7 81.5 49.4 15.5 41.9 29.6 15.5 14.4 31.1 7.8 55.6 29.8 46.1 14.0 30.9 10.1 26.8 42.2 123.0 56.5 13.9 30.9 338.6 6.7 17.0 41.2 247.1 41.7 15.0 73.6 17.1 62.2 1.6 20.7 8.9 8.5 214.4 40.4 11.0 27.0 26.2 20.9 12.6 21.8 16.4 10.0 26.9 6.8 15.2 11.2 14.4 35.7 76.0 66.7 59.9 47.8 28.4 7.5 9.7 4.7 41.4 12.8 18.4 4.3 15.6 44.8 21.2 3.9 11.1 32.3 3.9 52.0 8.8 1.5 13.2 13.7 48.5 22.1 33.4 65.9 4.5 0.5 9.7 39.2 29.1 5.9 1.4 0.1 12.5 9.3 2.3 39.5 33.5 27.7 17.5 3.6 3.1 30.5 66.1 20.7 3.5 11.3 9.4 76.4 40.4 25.6 27.3 31.4 5.3 10.1 3.9 40.5 17.4 26.4 25.5 19.8 26.2 16.2 19.8 16.2 11.0 15.9 15.2 27.0 7.3 9.2 11.3 2.2 12.6 20.9 2.1 21.8 16.4 39.0 53.5 12.0 56.6 41.9 29.6 55.6 29.8 42.2 62.2 35.7 48.7 12.3 252.2 43.7 3.6 21.5 15.3 34.8 54.6 45.4 0.0 68.5 41.4 149.4 19.4 56.7 80.6 0.0 151.8 327.5 64.0 87.3 27.6 22.4 61.2 0.0 55.6 90.2 24.3 32.7 38.0 44.7 119.8 111.8 58.6 112.9 109.7 63.1 274.8 18.6 3.3 142.3 369.1 0.7 3.0 30.6 134.6 27.7 55.0 93.5 CSRP3 "CLP, CMD1M, MLP" ENSG00000129170 "Cysteine and glycine rich protein 3" P50461 11 19182030-19210573 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Actin-binding, Developmental protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "heart muscle: 223.9;skeletal muscle: 156.7" "Cell type enriched" "Detected in some" 655 "Cardiomyocytes: 3256.5" "Cancer enriched" "Detected in some" 6 "head and neck cancer: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 3.6;RH-30: 1.5;U-2 OS: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA042581 Enhanced NA NA 240000 "HPA042581: AB_2678061" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.55e-2)" "unprognostic (4.72e-2)" "unprognostic (5.99e-2)" "unprognostic (1.08e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 3.4 0.0 0.0 223.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 4.5 0.0 156.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 46.9 2.3 0.0 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.0 0.1 0.6 3.6 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.2 2.8 0.6 0.7 0.0 0.2 0.4 0.9 0.9 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3256.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST1 ENSG00000170373 "Cystatin SN" P01037 20 23747553-23751268 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "salivary gland: 704.2" "Group enriched" "Detected in some" 118 "Cholangiocytes: 25.5;Collecting duct cells: 75.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 157.4" "CAB026769, HPA043706, HPA044763" Enhanced "Secreted to digestive system" NA NA 6600000 "CAB026769: , HPA043706: AB_2678627, HPA044763: AB_2679080" "prognostic favorable (4.00e-4)" "unprognostic (2.47e-1)" "unprognostic (3.11e-1)" "unprognostic (3.62e-2)" "unprognostic (1.99e-1)" "unprognostic (5.27e-2)" "unprognostic (1.99e-1)" "unprognostic (1.56e-1)" "unprognostic (1.83e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.39e-1)" "unprognostic (8.26e-2)" "unprognostic (9.58e-2)" "unprognostic (2.58e-1)" "unprognostic (9.00e-2)" "unprognostic (9.91e-3)" 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 4.8 0.1 0.1 0.3 7.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.1 0.1 0.1 15.2 0.0 0.1 704.2 0.1 0.1 4.0 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 1.6 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.6 157.4 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.2 25.5 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 CST11 "CST8L, CTES2, dJ322G13.6" ENSG00000125831 "Cystatin 11" Q9H112 20 23450403-23452857 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "epididymis: 76.3" "Cell type enriched" "Detected in single" 10 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA053399 Enhanced "Secreted in male reproductive system" NA NA "HPA053399: AB_2682136" "unprognostic (9.42e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 76.3 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST2 ENSG00000170369 "Cystatin SA" P09228 20 23823769-23826731 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 230 "salivary gland: 1538.3" "Cell type enriched" "Detected in single" 16 "Melanocytes: 15.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "RT4: 39.1" "CAB024963, HPA043706, HPA044763" Enhanced "Secreted to digestive system" NA NA 110000 "CAB024963: , HPA043706: AB_2678627, HPA044763: AB_2679080" "unprognostic (1.57e-2)" "unprognostic (3.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.10e-1)" "unprognostic (1.64e-2)" "unprognostic (5.17e-3)" "unprognostic (1.28e-2)" "unprognostic (2.75e-3)" "unprognostic (2.73e-1)" "unprognostic (4.82e-3)" "unprognostic (6.43e-3)" "unprognostic (2.51e-1)" "unprognostic (4.58e-11)" "unprognostic (1.29e-3)" "unprognostic (3.22e-1)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" 1.6 6.6 0.1 0.1 0.1 0.0 0.1 0.3 0.1 3.8 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.7 0.0 5.9 0.7 0.1 2.6 0.0 0.1 1538.3 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.8 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.0 39.1 0.0 0.0 0.0 0.0 3.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.1 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CST4 ENSG00000101441 "Cystatin S" P01036 20 23685640-23689040 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 94 "salivary gland: 705.3" "Cell type enriched" "Detected in single" 9 "Collecting duct cells: 8.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 6.8;RT4: 16.7" "HPA043706, HPA044763" Supported "Secreted to digestive system" NA NA 2700000 "HPA043706: AB_2678627, HPA044763: AB_2679080" "unprognostic (2.80e-1)" "unprognostic (7.88e-2)" "unprognostic (2.48e-1)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (4.98e-5)" "unprognostic (1.00e-2)" "unprognostic (9.52e-2)" "unprognostic (2.11e-2)" "unprognostic (2.31e-1)" "unprognostic (7.95e-2)" "prognostic favorable (2.88e-4)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.5 0.1 0.1 0.0 1.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.0 0.1 0.1 0.1 7.5 0.0 0.1 705.3 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 4.7 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 6.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 16.7 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 CST5 ENSG00000170367 "Cystatin D" P28325 20 23875935-23879750 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 268 "salivary gland: 1065.3" "Cell type enriched" "Detected in single" 22 "Alveolar cells type 1: 8.9" "Cancer enriched" "Detected in many" 5 "breast cancer: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;RPTEC TERT1: 3.6;RT4: 1.9;SuSa: 2.3;U-2 OS: 1.6" "CAB024944, HPA061449" Enhanced "Secreted to digestive system" NA NA "CAB024944: , HPA061449: AB_2684523" "unprognostic (2.43e-1)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (4.73e-1)" "unprognostic (4.31e-2)" "unprognostic (1.76e-2)" "unprognostic (2.32e-1)" "unprognostic (1.35e-1)" "unprognostic (4.83e-3)" "unprognostic (5.14e-2)" "unprognostic (2.31e-1)" 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.8 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1065.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.9 0.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.8 0.0 0.6 0.9 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66011841-66013505 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 124.5" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 86.4;Ciliated cells: 56.2;Collecting duct cells: 55.8;Pancreatic endocrine cells: 216.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 171.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A-431: 26.8;CAPAN-2: 74.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 110000000 "Plasma membrane" Cytosol "CAB019316: , HPA044963: AB_2679158" "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 0.6 0.2 0.1 1.5 0.1 0.2 8.7 0.4 0.2 5.5 0.2 0.0 1.4 0.1 0.3 0.8 11.3 4.3 0.7 2.4 0.1 0.2 1.0 0.1 27.2 1.2 0.1 0.0 1.3 0.2 0.5 0.4 26.5 0.2 0.9 0.1 1.1 1.3 26.5 0.7 124.5 0.2 0.2 0.2 0.2 0.2 1.0 0.0 2.8 14.6 13.6 4.4 0.5 3.7 0.4 0.9 0.0 1.6 0.0 0.2 0.7 26.8 0.0 0.0 0.1 0.0 0.0 8.0 0.2 0.0 0.0 0.0 0.1 74.8 0.0 0.4 0.9 0.0 0.9 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.0 86.4 6.7 0.0 1.2 1.0 0.0 1.0 0.0 56.2 26.1 55.8 0.0 5.9 0.0 14.5 0.1 0.1 0.0 0.0 19.3 11.2 1.9 1.4 21.8 0.0 43.3 0.0 0.0 0.0 0.3 0.5 0.0 6.5 5.0 1.8 0.0 0.8 216.2 0.0 0.4 0.2 0.0 0.0 0.4 1.4 16.7 24.1 53.7 0.0 0.0 5.4 CST7 ENSG00000077984 "Cystatin F" O76096 20 24949230-24959928 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 120.9;bone marrow: 160.2;lymphoid tissue: 51.3" "Group enriched" "Detected in many" 14 "monocytes: 1133.5;T-cells: 425.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "gdT-cell: 120.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 16.1;HMC-1: 45.1;NB-4: 44.2;U-937: 79.4" "Region enriched" "Detected in single" 5 "olfactory region: 2.3" "Low region specificity" "Detected in all" HPA040442 Enhanced "Secreted to blood" NA NA 12000 "HPA040442: AB_2676988" "prognostic favorable (6.55e-4)" "prognostic favorable (7.90e-4)" "unprognostic (9.37e-2)" "prognostic favorable (9.17e-6)" "unprognostic (2.38e-2)" "prognostic favorable (5.85e-5)" "unprognostic (1.00e-2)" "unprognostic (8.66e-2)" "unprognostic (2.84e-3)" "unprognostic (7.93e-2)" "unprognostic (5.05e-2)" "unprognostic (7.42e-2)" "prognostic unfavorable (4.37e-6)" "unprognostic (7.64e-2)" "unprognostic (3.38e-1)" "unprognostic (4.45e-1)" "unprognostic (7.62e-2)" 4.9 0.9 0.8 9.7 0.9 160.2 1.4 0.9 1.0 2.5 1.9 0.1 0.5 1.1 2.2 1.8 2.4 4.6 10.7 6.2 0.9 0.8 1.6 3.5 23.0 30.4 4.0 0.0 2.2 1.1 0.2 0.9 1.6 0.7 3.5 1.0 3.2 1.3 0.7 1.9 1.2 3.7 1.0 1.2 51.3 1.6 1.7 0.2 6.6 1.6 2.5 15.4 6.0 11.8 0.3 2.5 29.8 0.2 53.9 120.9 42.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 16.1 45.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.6 0.0 0.0 0.4 44.2 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 79.4 0.0 5.0 0.2 0.8 120.9 0.2 67.5 0.3 18.3 84.3 2.5 0.3 4.0 52.3 29.8 53.9 0.2 0.6 10.5 42.2 0.8 0.9 0.9 1.0 0.9 0.8 4.0 0.0 0.7 0.2 8.9 22.7 14.7 0.3 20.3 0.0 0.8 2.5 4.0 1.2 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 3.0 0.0 6.1 0.1 55.7 2.1 1.4 0.0 0.0 8.6 13.8 0.0 0.0 51.5 23.6 1133.5 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 2.3 0.0 0.1 20.8 0.9 425.3 0.0 0.3 CST8 "CRES, CTES5" ENSG00000125815 "Cystatin 8" O60676 20 23491101-23496018 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 31.8" "Group enriched" "Detected in some" 122 "Early spermatids: 188.8;Late spermatids: 79.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 CST9 "CLM, CTES7A" ENSG00000173335 "Cystatin 9" Q5W186 20 23602410-23605876 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "breast: 6.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 37 "breast cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA029190 Uncertain "Secreted - unknown location" NA NA "HPA029190: AB_10602804" "unprognostic (2.06e-2)" "unprognostic (2.21e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CST9L "bA218C14.1, CTES7B" ENSG00000101435 "Cystatin 9 like" Q9H4G1 20 23564732-23568749 "Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 49.8" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 2.4;Late spermatids: 7.3;Leydig cells: 2.3;Peritubular cells: 1.4;Spermatocytes: 1.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "HEL: 5.6" "Secreted in male reproductive system" NA NA "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325244-122341972 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 312.4;tongue: 421.9" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 712.6;monocytes: 1063.2;Syncytiotrophoblasts: 279.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 405.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6" "Group enriched" "Detected in many" 193 "dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 33.8;hTCEpi: 149.9;THP-1: 93.6;U-698: 59.6;U-937: 29.8" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol No No 39000000 "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favorable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 2.0 0.2 0.3 4.4 0.8 19.8 4.5 0.2 0.5 55.4 0.4 0.2 1.1 0.0 4.7 1.7 312.4 0.2 0.7 1.0 0.3 0.0 0.4 3.4 6.8 4.8 1.1 0.2 1.8 0.2 0.0 0.3 1.3 0.5 1.3 0.1 0.3 57.4 0.7 0.7 28.2 0.3 0.4 0.7 2.0 2.2 0.3 0.6 2.2 0.3 421.9 99.0 1.5 93.5 0.1 54.6 36.0 74.6 0.2 0.2 32.0 1.7 0.1 0.0 0.4 3.9 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.7 0.0 10.5 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.8 0.8 13.6 0.2 3.8 149.9 0.3 14.7 0.0 0.0 0.1 0.1 3.6 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.8 0.0 0.0 1.6 0.9 1.2 0.0 0.1 93.6 0.0 0.2 2.4 0.0 0.1 0.0 0.2 59.6 3.2 29.8 0.0 0.7 74.6 2.2 0.0 37.5 0.2 0.1 0.1 0.1 54.6 0.0 0.0 0.1 36.0 0.2 21.6 1.0 0.1 32.0 0.3 0.8 0.2 0.5 0.3 0.0 1.1 0.2 0.5 0.6 6.0 27.0 9.0 93.6 74.1 0.0 0.0 2.5 30.8 34.2 0.0 0.0 203.1 0.0 2.0 0.2 3.5 1.3 0.0 19.8 10.9 5.6 14.2 12.8 90.0 136.3 0.0 0.0 8.0 712.6 0.6 9.5 248.7 8.5 1063.2 0.5 0.0 27.6 1.1 3.5 0.5 0.0 32.3 4.2 0.1 0.1 179.2 279.5 4.3 0.8 83.6 CSTB "CST6, EPM1, PME, STFB" ENSG00000160213 "Cystatin B" P04080 21 43772511-43776445 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8" "Cell type enhanced" "Detected in all" 7 "Hofbauer cells: 2667.6;Urothelial cells: 2153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 68.7;RT4: 87.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017380, CAB047320, HPA058557" Enhanced Supported Nucleoli,Cytosol NA NA 6100000 Cytosol Nucleoli "CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755" "unprognostic (1.69e-1)" "unprognostic (3.35e-1)" "unprognostic (2.09e-1)" "unprognostic (3.05e-2)" "unprognostic (3.05e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (6.66e-5)" "unprognostic (1.90e-1)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (3.63e-1)" "unprognostic (4.88e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" 21.1 7.5 5.6 6.1 5.9 3.2 13.6 3.0 5.3 57.8 8.8 4.4 3.9 5.6 6.1 6.4 365.3 6.0 7.2 6.5 4.6 5.0 9.6 17.3 17.2 11.2 5.3 4.9 7.8 5.0 3.2 7.6 5.2 5.8 7.1 7.2 7.8 65.2 6.2 4.8 9.4 7.5 6.3 5.1 7.4 10.4 4.1 4.1 8.6 11.6 138.8 130.6 14.0 81.5 11.4 43.2 25.4 69.1 7.7 22.3 21.3 55.9 16.9 5.6 7.1 29.8 24.5 13.9 12.1 14.1 7.7 7.6 13.0 31.4 4.5 9.4 18.8 68.7 10.0 12.9 13.5 4.8 18.8 15.3 12.6 13.0 15.0 26.7 3.1 10.6 26.0 14.1 21.0 10.5 14.4 10.6 4.3 9.3 25.0 11.2 14.1 3.9 9.7 13.5 37.6 29.2 6.5 3.1 51.3 22.0 87.3 5.3 4.8 15.9 8.5 34.0 2.8 7.9 7.8 16.3 12.7 6.6 11.9 7.6 6.1 10.8 8.4 55.4 14.7 8.9 16.8 28.2 16.9 14.5 45.9 13.3 11.4 18.6 15.0 43.2 9.7 13.2 13.0 25.4 7.7 69.1 5.3 22.3 21.3 5.6 5.9 3.0 5.3 4.6 5.0 5.3 4.9 5.8 4.1 163.8 245.7 187.7 333.5 342.3 67.2 88.0 305.8 447.0 218.4 394.3 33.4 255.6 455.9 484.2 8.1 312.8 471.8 23.3 431.0 773.3 255.1 459.8 223.9 313.1 2667.6 63.5 229.7 229.6 443.8 23.5 353.0 857.1 447.1 1223.7 177.1 98.3 684.5 378.7 310.4 313.1 54.5 116.4 179.2 37.0 105.4 520.9 336.5 191.8 261.7 2153.8 CSTL1 "CTES1, dJ322G13.4" ENSG00000125823 "Cystatin like 1" Q9H114 20 23439685-23444930 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 20 "testis: 7.5" "Group enriched" "Detected in some" 434 "Early spermatids: 55.2;Late spermatids: 53.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 4.3;OE19: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.14e-1)" "unprognostic (1.54e-1)" "unprognostic (3.25e-3)" "unprognostic (2.04e-1)" "unprognostic (6.58e-2)" "unprognostic (2.68e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (3.63e-1)" "unprognostic (2.97e-1)" "unprognostic (6.87e-2)" "unprognostic (2.35e-1)" "unprognostic (5.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 7.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 70.1;Karpas-707: 32.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 32.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.0 0.0 0.5 6.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 5.5 0.0 0.0 0.0 0.0 0.0 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell type enriched" "Detected in some" 16 "Spermatogonia: 57.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 33.3;K-562: 9.9;Karpas-707: 36.9;U-266/84: 31.0" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 7.3 31.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 57.9 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HMC-1: 32.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 29.9;T-47d: 17.5;U-266/84: 90.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 90.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 10.5" "Group enriched" "Detected in some" 18 "Alveolar cells type 2: 2.2;Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 18.3;Karpas-707: 12.8;RPMI-8226: 6.8;U-266/84: 66.2" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 2.5 0.0 0.0 0.9 66.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794706-135802656 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/84: 47.3" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846499-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 16 "testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 14.2;HMC-1: 30.1" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863776-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HMC-1: 55.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A1 CT47.1 ENSG00000236371 "Cancer/testis antigen family 47, member A1" Q5JQC4 X 120982476-120985788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "U-266/70: 7.3" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A10 CT47.10 ENSG00000224089 "Cancer/testis antigen family 47, member A10" Q5JQC4 X 120938701-120942023 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A11 CT47.11 ENSG00000226929 "Cancer/testis antigen family 47, member A11" Q5JQC4 X 120933840-120937158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "EFO-21: 1.6;U-87 MG: 1.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CT47A12 CT47.12 ENSG00000226685 "Cancer/testis antigen family 47, member A12" Q5JQC4 X 120930250-120932301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;U-2197: 1.1;U-266/70: 3.0" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 3.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 CT47A2 CT47.2 ENSG00000242362 "Cancer/testis antigen family 47, member A2" Q5JQC4 X 120977606-120980928 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A3 CT47.3 ENSG00000236126 "Cancer/testis antigen family 47, member A3" Q5JQC4 X 120972746-120976068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A4 CT47.4 ENSG00000230594 "Cancer/testis antigen family 47, member A4" Q5JQC4 X 120967886-120971208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A5 CT47.5 ENSG00000237957 "Cancer/testis antigen family 47, member A5" Q5JQC4 X 120963026-120966348 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A6 CT47.6 ENSG00000226023 "Cancer/testis antigen family 47, member A6" Q5JQC4 X 120958165-120961487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "U-266/70: 4.2;U-266/84: 1.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 CT47A7 CT47.7 ENSG00000228517 "Cancer/testis antigen family 47, member A7" Q5JQC4 X 120953288-120956600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A8 CT47.8 ENSG00000230347 "Cancer/testis antigen family 47, member A8" Q5JQC4 X 120948422-120951744 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47A9 CT47.9 ENSG00000226600 "Cancer/testis antigen family 47, member A9" Q5JQC4 X 120943561-120946883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 3.1" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT47B1 CT47.13 ENSG00000236446 "Cancer/testis antigen family 47, member B1" P0C2W7 X 120872603-120875929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 61 "testis: 10.7" "Group enriched" "Detected in some" 20 "Spermatocytes: 28.7;Spermatogonia: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.0;U-266/84: 1.4" HPA042483 Supported NA NA "HPA042483: AB_2678017" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 28.7 27.9 0.0 0.0 0.0 0.0 0.0 CT55 "CXorf48, FLJ20527" ENSG00000169551 "Cancer/testis antigen 55" Q8WUE5 X 135156536-135171398 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 9.2" "Group enriched" "Detected in some" 35 "Spermatocytes: 8.1;Spermatogonia: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "K-562: 12.8" HPA059575 Approved Vesicles "Secreted in male reproductive system" NA NA Vesicles "HPA059575: " "unprognostic (6.20e-2)" "unprognostic (1.39e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.47e-1)" "unprognostic (2.67e-1)" "unprognostic (4.44e-2)" "unprognostic (1.49e-1)" 0.1 0.2 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.2 0.6 0.8 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.1 23.4 0.0 0.0 0.0 0.0 0.0 CT62 ENSG00000225362 "Cancer/testis antigen 62" P0C5K7 15 71110244-71115494 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 50 "testis: 31.2" "Group enriched" "Detected in some" 57 "Early spermatids: 181.5;Late spermatids: 60.0" "Group enriched" "Detected in some" 8 "breast cancer: 2.3;prostate cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;HaCaT: 3.4;T-47d: 7.6;U-2197: 6.0" HPA045306 Uncertain NA NA "HPA045306: AB_10960632" "unprognostic (1.55e-1)" "unprognostic (3.53e-3)" "unprognostic (9.17e-2)" "unprognostic (3.55e-1)" "unprognostic (5.49e-2)" "unprognostic (2.16e-2)" "unprognostic (9.27e-3)" "unprognostic (1.02e-1)" "unprognostic (1.46e-1)" "unprognostic (1.45e-1)" "unprognostic (2.95e-5)" "unprognostic (2.89e-2)" "unprognostic (2.03e-1)" "unprognostic (1.01e-2)" "unprognostic (1.52e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 31.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.2 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 1.5 0.0 0.2 7.6 0.0 0.9 0.0 0.0 6.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 181.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.1 0.0 0.0 0.0 CT83 "CXorf61, FLJ20611, FLJ22913, KK-LC-1" ENSG00000204019 "Cancer/testis antigen 83" Q5H943 X 116461682-116463003 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 46.8" "Group enriched" "Detected in some" 113 "Early spermatids: 613.3;Late spermatids: 1930.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 28.4;OE19: 26.9;RPMI-8226: 8.7;U-266/70: 40.1;U-266/84: 20.2" "Not detected" "Not detected" NA NA "unprognostic (1.59e-2)" "unprognostic (1.69e-2)" "unprognostic (8.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.3 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 40.1 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 613.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1930.3 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 9.3 5.2 0.0 0.0 0.0 0.0 0.0 CTAG1A "ESO1, LAGE2A" ENSG00000268651 "Cancer/testis antigen 1A" P78358 X 154585143-154586821 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "heart muscle: 3.0;testis: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 123.7" CAB013061 Enhanced NA NA "CAB013061: " 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.7 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 CTAG1B "CT6.1, CTAG, CTAG1, ESO1, LAGE2A, LAGE2B, NY-ESO-1" ENSG00000184033 "Cancer/testis antigen 1B" P78358 X 154617609-154619282 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 56 "testis: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-266/70: 131.6" CAB015453 Enhanced NA NA "CAB015453: AB_784921" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 131.6 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 72.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 22.0;K-562: 27.8;OE19: 41.0;RPMI-8226: 61.9;SK-BR-3: 40.5;U-266/84: 70.1" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: AB_2686402, HPA076586: " "prognostic unfavorable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.2 1.0 0.4 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.2 0.0 0.0 0.0 1.0 2.9 0.0 8.5 0.0 0.0 0.1 0.8 0.2 0.0 0.2 0.8 3.6 0.0 0.4 4.4 0.2 0.0 0.1 0.0 5.7 0.2 0.0 0.0 0.0 0.3 0.6 11.9 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.6 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.5 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.3 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.8 72.0 0.0 0.9 0.0 0.0 0.0 CTAGE1 "CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2" ENSG00000212710 "Cutaneous T cell lymphoma-associated antigen 1" "Q96RT6, Q9HC47" 18 22413601-22417915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 12.9" "Cell type enriched" "Detected in some" 11 "Early spermatids: 62.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 2.3;U-2 OS: 1.8" "HPA000387, HPA000922, CAB016204" Uncertain NA NA "CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.41e-1)" "unprognostic (5.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.52e-1)" "unprognostic (1.70e-2)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 4.9 0.5 0.3 0.1 0.0 0.0 0.3 CTAGE15 CTAGE15P ENSG00000271079 "CTAGE family member 15" A4D2H0 7 143571801-143574387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 8.1" "Cell type enhanced" "Detected in single" 34 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (2.82e-1)" "unprognostic (8.64e-2)" "unprognostic (3.23e-1)" "unprognostic (3.32e-1)" "unprognostic (2.44e-1)" "unprognostic (2.23e-1)" "unprognostic (4.52e-2)" "unprognostic (9.94e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-2)" "unprognostic (3.72e-1)" "unprognostic (2.47e-1)" "unprognostic (2.33e-1)" "unprognostic (2.91e-2)" "unprognostic (2.39e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTAGE4 "cTAGE-4, FLJ43692" ENSG00000225932 "CTAGE family member 4" Q8IX94 7 144183466-144186053 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 9.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.3;T-reg: 2.0" "Lineage enriched" "Detected in single" 5 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "A-431: 13.8;hTCEpi: 12.2;RPTEC TERT1: 10.9;T-47d: 7.7;WM-115: 7.4" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.76e-1)" "unprognostic (3.24e-3)" "unprognostic (2.89e-1)" "unprognostic (5.17e-2)" "unprognostic (2.80e-1)" "unprognostic (3.65e-3)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (4.69e-2)" "unprognostic (1.91e-2)" "unprognostic (9.50e-3)" "unprognostic (1.07e-1)" "unprognostic (2.30e-1)" "unprognostic (8.36e-2)" "unprognostic (2.68e-1)" 1.3 0.9 0.2 0.0 0.7 0.0 3.8 0.1 0.2 0.7 1.2 3.7 1.4 2.5 1.3 1.1 1.9 1.4 0.2 0.4 1.3 1.6 2.0 0.0 0.7 1.9 4.1 0.0 2.1 0.8 1.3 3.5 2.0 0.3 0.3 9.1 1.0 0.0 0.4 1.3 2.4 4.9 7.5 0.0 0.8 1.3 0.4 0.0 0.0 0.0 0.0 2.0 0.0 13.8 0.1 0.0 0.0 0.0 0.0 5.8 0.4 0.2 0.0 0.2 1.3 4.4 0.0 0.0 0.5 0.3 0.4 0.0 2.5 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.3 12.2 0.4 3.8 0.6 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.5 3.9 0.0 0.0 0.0 0.0 10.9 3.6 0.0 0.0 5.0 5.1 0.4 2.3 7.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.0 3.5 0.0 0.1 0.6 0.0 0.4 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 CTAGE6 "CTAGE6P, MGC41943" ENSG00000271321 "CTAGE family member 6" Q86UF2 7 143755089-143757696 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 40 "testis: 15.0" "Cell type enhanced" "Detected in single" 27 "Early spermatids: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;HeLa: 1.6;U-266/70: 1.0" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (1.51e-2)" "unprognostic (8.90e-12)" "unprognostic (1.73e-2)" "unprognostic (2.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.8 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 CTAGE8 ENSG00000244693 "CTAGE family member 8" P0CG41 7 144266701-144269288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.6;Ciliated cells: 1.4;Club cells: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.5;CAPAN-2: 3.1;HaCaT: 2.9;HBEC3-KT: 2.9;OE19: 6.4;RT4: 4.1" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (4.80e-2)" "unprognostic (2.54e-1)" "unprognostic (1.93e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (9.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.92e-3)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (1.33e-2)" "unprognostic (8.73e-2)" "unprognostic (6.23e-3)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" 0.3 0.0 0.0 0.4 0.0 0.2 1.5 0.0 0.0 0.6 1.4 1.8 0.6 0.3 3.9 0.5 0.8 0.0 0.0 0.0 3.3 2.3 1.2 0.2 0.0 0.9 2.5 6.2 1.1 0.4 2.1 1.0 2.4 0.5 0.0 6.9 2.4 0.1 0.0 0.5 2.0 7.7 6.0 0.4 0.6 1.4 0.5 0.6 0.1 0.0 0.1 0.3 0.2 8.5 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.1 0.2 2.5 3.1 0.0 0.0 0.0 0.0 2.9 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.9 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.2 6.4 0.0 0.0 0.0 0.0 0.9 4.1 0.0 0.0 1.2 1.9 1.5 0.5 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.6 0.2 0.2 6.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CTAGE9 ENSG00000236761 "CTAGE family member 9" A4FU28 6 131708684-131711017 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 29 "testis: 11.6" "Cell type enhanced" "Detected in some" 17 "Club cells: 2.3;Early spermatids: 1.9;Suprabasal keratinocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A-431: 1.3" "HPA000387, HPA000922" Uncertain NA NA "HPA000387: AB_1078582, HPA000922: AB_1078581" "unprognostic (3.92e-2)" "unprognostic (6.84e-2)" "unprognostic (3.48e-2)" "unprognostic (1.92e-1)" "unprognostic (9.89e-3)" "unprognostic (2.36e-1)" "unprognostic (5.55e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-2)" "unprognostic (5.74e-4)" "unprognostic (3.15e-2)" "unprognostic (9.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 11.6 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.2 0.2 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.4 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 114.6" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 33 "HMC-1: 33.3;K-562: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.2 0.1 0.1 0.1 0.4 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.5 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.1 35.4 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.1 1.0 4.3 0.8 0.8 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 1.2 0.1 0.1 0.2 1.8 0.7 1.2 0.6 0.7 0.5 1.3 0.4 0.5 0.3 2.1 0.7 0.8 4.3 0.8 0.8 1.0 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.4 18.5 114.6 0.0 0.0 0.0 0.0 0.1 CTDNEP1 "DULLARD, HSA011916, NET56" ENSG00000175826 "CTD nuclear envelope phosphatase 1" O95476 17 7243591-7252491 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 140.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037439, HPA066466" Uncertain Approved "Lipid droplets" NA NA "Lipid droplets" "HPA037439: AB_10601264, HPA066466: AB_2732745" "unprognostic (7.11e-2)" "unprognostic (7.78e-2)" "unprognostic (1.33e-2)" "prognostic favorable (6.45e-4)" "unprognostic (3.12e-1)" "unprognostic (2.13e-1)" "unprognostic (4.61e-2)" "unprognostic (1.50e-2)" "unprognostic (2.98e-1)" "unprognostic (9.90e-2)" "prognostic favorable (1.81e-4)" "unprognostic (3.37e-1)" "unprognostic (2.77e-3)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (9.97e-2)" "unprognostic (2.02e-2)" 27.1 23.1 21.4 22.4 21.0 24.2 38.8 21.8 26.6 25.3 24.8 26.6 16.7 20.8 31.2 22.8 26.6 27.3 18.8 29.0 21.5 12.9 23.8 20.6 26.5 39.4 24.7 17.1 31.1 27.9 30.7 26.1 30.4 20.5 25.2 27.9 20.4 23.0 23.8 140.1 35.5 30.9 26.7 25.6 38.3 24.3 26.6 24.3 43.8 26.0 31.5 34.1 22.4 26.7 13.0 17.3 18.3 11.8 7.2 11.2 3.8 38.9 58.3 32.8 35.2 51.4 63.3 24.9 29.2 48.9 47.1 40.6 27.8 27.3 36.1 31.1 52.1 32.9 32.7 43.0 45.0 52.7 53.6 36.5 25.2 39.2 47.9 47.7 28.6 47.7 51.0 54.8 53.9 57.6 48.5 50.1 35.8 22.5 26.8 44.2 24.6 31.9 30.7 22.8 34.9 24.8 38.9 29.2 28.8 37.4 20.5 12.6 36.2 23.2 23.3 31.1 33.9 22.0 23.6 28.5 34.4 29.6 27.4 54.8 23.2 20.2 18.5 44.2 39.6 35.5 6.3 11.8 18.3 10.5 11.7 8.5 13.0 10.1 11.0 8.4 12.4 7.8 11.2 15.6 7.2 7.7 17.3 9.6 3.8 21.4 21.0 21.8 26.6 21.5 12.9 24.7 17.1 20.5 24.3 23.8 21.0 48.6 41.4 41.9 42.6 10.8 30.6 9.4 25.0 38.4 21.6 54.3 10.0 54.2 3.7 44.4 63.2 0.0 73.6 98.0 42.3 51.3 19.7 33.8 80.8 28.6 70.8 40.5 83.4 5.0 53.5 53.1 27.0 36.9 73.9 45.9 67.9 46.0 44.2 29.3 28.2 25.8 33.0 14.6 35.6 58.6 69.6 36.2 58.8 56.2 CTH ENSG00000116761 "Cystathionine gamma-lyase" P32929 1 70411218-70439851 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Calmodulin-binding, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 104.5" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 130.7" "Group enriched" "Detected in all" 5 "liver cancer: 30.0;testis cancer: 8.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.5;T-cells: 6.4" "Cell line enhanced" "Detected in many" "HHSteC: 20.2;Karpas-707: 31.3;SK-MEL-30: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021591, HPA023300" Enhanced NA NA 25000 "HPA021591: AB_1847321, HPA023300: AB_1847322" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (2.76e-1)" "unprognostic (7.66e-2)" "unprognostic (2.45e-3)" "prognostic favorable (8.69e-4)" "unprognostic (1.71e-1)" "unprognostic (1.95e-1)" "unprognostic (1.00e-1)" "unprognostic (1.43e-3)" "unprognostic (5.05e-3)" "unprognostic (3.25e-2)" "unprognostic (1.03e-1)" "unprognostic (8.97e-2)" "unprognostic (3.05e-3)" "unprognostic (1.26e-1)" 2.2 8.3 2.3 1.0 3.2 2.2 2.0 3.7 3.6 1.9 3.3 2.2 1.8 3.3 1.7 1.4 2.7 2.3 1.5 1.6 2.1 2.7 8.2 104.5 2.2 1.0 2.4 2.2 18.3 11.6 1.5 1.7 1.0 3.2 2.9 4.1 11.2 4.8 2.8 2.1 1.0 3.2 1.2 2.4 0.8 3.7 5.4 1.3 0.0 11.4 1.2 1.5 2.7 1.2 4.5 1.3 1.1 0.6 0.6 6.4 1.1 5.1 0.7 3.5 4.9 4.3 2.4 7.8 2.1 1.9 1.8 7.8 1.4 3.2 2.8 1.6 1.5 4.6 2.4 13.5 1.4 3.6 8.6 3.0 3.3 2.6 4.4 20.2 3.7 0.8 3.7 12.2 3.7 4.3 0.7 1.6 5.6 6.5 31.3 1.1 1.4 1.3 0.8 3.6 1.9 2.7 1.3 1.9 7.8 3.6 0.0 1.9 1.6 3.2 3.8 40.8 6.9 1.3 2.1 0.5 0.6 4.0 2.8 1.9 12.1 7.1 1.5 4.8 7.7 1.4 1.1 0.6 0.2 2.5 0.4 4.6 4.5 2.3 3.5 1.0 2.9 6.4 3.1 0.9 0.6 0.5 1.3 0.7 1.1 2.3 3.2 3.7 3.6 2.1 2.7 2.4 2.2 3.2 1.3 6.0 3.5 5.6 6.2 2.3 6.8 1.6 5.1 0.0 1.2 5.2 9.8 0.6 10.0 1.6 14.9 2.0 11.9 0.0 3.5 1.3 2.8 5.2 0.0 130.7 1.0 0.0 2.9 4.3 2.9 3.4 1.1 1.3 18.6 0.0 5.9 4.3 6.4 11.0 3.9 22.0 10.1 0.0 5.5 1.6 0.5 1.8 0.7 4.3 4.3 2.8 CTLA4 "CD, CD152, CELIAC3, GSE, IDDM12" ENSG00000163599 "Cytotoxic T-lymphocyte associated protein 4" P16410 2 203867786-203873960 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Diabetes mellitus, Disease mutation, FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.8;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 5.6;granulocytes: 1.1;T-cells: 1.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 6 "T-reg: 24.8" "Lineage enriched" "Detected in single" 248 "T-cells: 24.8" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.9;U-266/70: 5.9;U-266/84: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.92e-2)" "unprognostic (9.13e-3)" "unprognostic (1.47e-3)" "unprognostic (9.89e-6)" "unprognostic (1.86e-1)" "prognostic favorable (4.48e-5)" "unprognostic (1.02e-1)" "unprognostic (1.75e-2)" "unprognostic (1.84e-3)" "unprognostic (2.65e-3)" "unprognostic (2.77e-1)" "unprognostic (3.76e-1)" "unprognostic (9.86e-10)" "unprognostic (4.13e-2)" "unprognostic (7.45e-2)" "unprognostic (4.94e-2)" "unprognostic (1.19e-2)" 1.6 0.2 0.2 24.1 0.3 2.9 1.3 0.2 0.6 0.8 1.6 0.1 0.6 0.2 1.1 0.1 2.0 1.2 3.6 0.5 0.3 0.5 1.6 0.6 5.8 27.9 0.3 0.3 0.7 0.3 0.1 0.6 0.1 1.7 1.1 1.7 0.8 1.4 0.6 0.2 1.0 10.3 0.3 1.5 6.7 1.2 1.7 0.1 14.2 1.9 3.3 31.2 4.6 1.3 0.0 0.0 0.0 0.0 0.0 24.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 5.9 16.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 24.8 0.4 0.2 0.3 0.2 0.6 0.3 0.5 0.3 0.3 1.7 0.1 0.0 5.6 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.6 0.1 1.9 0.0 0.0 CTNNA2 "CAP-R, CT114" ENSG00000066032 "Catenin alpha 2" P26232 2 79185231-80648861 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Differentiation" "Developmental protein" "Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.1;brain: 58.4;epididymis: 58.1" "Cell type enhanced" "Detected in some" 32 "Early spermatids: 437.5;Late spermatids: 110.5;Muller glia cells: 106.1" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.9;glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 66 "basophil: 25.1" "Lineage enriched" "Detected in single" 252 "granulocytes: 25.1" "Cell line enhanced" "Detected in some" "AF22: 8.4;Karpas-707: 9.6;NTERA-2: 7.9;SCLC-21H: 4.5;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" CAB037175 Enhanced NA NA "CAB037175: AB_476883" "unprognostic (9.15e-2)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (4.04e-1)" "unprognostic (3.17e-2)" "unprognostic (5.62e-2)" "unprognostic (7.96e-3)" "unprognostic (8.76e-2)" "unprognostic (2.27e-4)" "unprognostic (7.80e-2)" "unprognostic (8.44e-4)" "unprognostic (1.73e-4)" "unprognostic (2.83e-1)" 1.2 5.1 34.7 1.6 24.1 1.2 1.2 10.1 58.4 1.2 1.9 8.7 0.0 1.4 3.8 58.1 1.3 2.7 1.3 1.1 23.6 16.1 1.2 1.2 1.1 1.1 12.5 28.3 1.1 1.7 1.1 9.3 1.1 12.7 1.9 1.8 5.1 1.3 1.8 1.3 1.2 1.7 1.5 4.3 1.1 2.1 14.4 10.4 0.0 1.1 0.0 1.1 1.1 0.3 0.0 0.0 25.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.6 0.0 0.0 0.0 0.1 7.9 0.3 0.0 0.0 0.0 0.0 0.8 0.0 4.5 12.7 0.0 0.0 0.5 1.2 0.1 0.7 0.0 0.5 0.9 0.2 0.0 2.7 0.0 0.0 3.3 0.0 2.3 25.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 34.7 24.1 10.1 35.8 23.6 16.1 12.5 28.3 12.7 10.4 0.0 0.0 0.0 0.0 0.0 16.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 437.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 110.5 2.3 0.0 0.0 0.0 0.0 106.1 0.4 0.0 2.8 0.1 3.8 0.0 0.0 3.7 2.8 0.0 0.0 0.0 0.0 0.0 CTNNA3 "MGC26194, VR22" ENSG00000183230 "Catenin alpha 3" Q9UI47 10 65912518-67696169 "Disease related genes, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.8;heart muscle: 27.5;liver: 12.9;skeletal muscle: 16.2;tongue: 7.9" "Group enriched" "Detected in some" 23 "Cardiomyocytes: 70.8;Early spermatids: 163.6;Late spermatids: 166.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.2;plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 4.1;Karpas-707: 2.6;NTERA-2: 3.0;RPMI-8226: 4.0;SCLC-21H: 2.6;SuSa: 2.5;U-266/70: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061818 Enhanced NA NA "HPA061818: AB_2684618" "unprognostic (2.19e-1)" "unprognostic (1.57e-1)" "unprognostic (8.64e-4)" "unprognostic (8.13e-3)" "unprognostic (6.43e-3)" "unprognostic (9.90e-2)" "unprognostic (2.60e-4)" "unprognostic (8.27e-2)" "unprognostic (5.10e-2)" "unprognostic (2.55e-1)" "unprognostic (9.09e-3)" "unprognostic (1.15e-1)" "unprognostic (2.67e-3)" "unprognostic (7.93e-5)" "unprognostic (6.43e-2)" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" 1.8 1.4 6.3 3.6 19.3 0.8 1.5 6.6 10.3 2.1 2.5 26.0 0.0 1.1 2.5 0.8 2.9 1.7 1.6 27.5 7.6 2.3 1.1 12.9 1.1 0.9 25.9 5.8 3.4 1.1 1.2 1.1 1.2 16.2 1.2 1.6 0.0 1.2 1.0 16.2 1.2 1.9 4.5 26.8 1.1 1.8 3.6 28.8 0.0 1.4 7.9 1.1 1.3 1.9 0.7 1.4 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 4.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.1 0.0 3.0 1.0 1.3 0.2 0.0 4.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 2.5 0.2 0.0 0.0 0.3 0.8 0.0 0.0 11.3 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.2 6.3 19.3 6.6 10.3 7.6 2.3 25.9 5.8 16.2 28.8 0.0 0.0 0.0 0.0 0.1 0.0 70.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.9 0.0 0.0 0.0 0.6 0.3 166.8 4.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.2 0.0 0.0 0.0 4.1 3.2 1.8 0.1 0.0 0.0 0.0 0.0 CTNNAL1 "alpha-CATU, CLLP" ENSG00000119326 "Catenin alpha like 1" Q9UBT7 9 108942569-109013529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 92.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 8.6" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;NK-cells: 5.8;T-cells: 8.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.93e-1)" "unprognostic (1.45e-1)" "unprognostic (2.10e-2)" "unprognostic (6.07e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-3)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.05e-1)" "unprognostic (4.72e-2)" "unprognostic (3.55e-2)" "unprognostic (7.45e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.53e-1)" "unprognostic (5.79e-3)" "unprognostic (1.67e-1)" 9.9 92.9 5.5 8.0 4.4 10.3 16.5 3.5 8.5 9.1 11.8 1.6 18.0 3.8 11.1 13.6 13.8 9.2 9.4 38.1 4.4 3.8 16.0 15.4 20.9 5.8 5.1 4.7 44.1 10.6 8.3 7.9 14.1 15.1 10.5 5.7 17.2 6.4 17.1 16.2 7.5 6.2 24.9 7.1 9.3 13.1 17.7 2.4 8.0 53.7 6.1 4.4 15.9 12.0 1.4 0.2 4.8 0.3 5.8 8.6 3.0 33.4 11.8 13.2 10.7 9.1 24.1 23.9 44.7 20.1 44.4 29.0 36.8 52.8 10.3 14.0 22.6 34.6 25.2 17.2 39.6 54.5 14.4 10.9 5.4 12.3 24.8 12.6 13.1 1.3 18.6 2.8 23.4 32.4 37.5 21.5 8.6 12.6 10.5 20.2 3.4 9.0 9.5 14.9 31.1 25.3 18.0 35.1 9.1 46.1 7.3 10.3 7.0 14.2 1.4 10.2 13.4 10.6 5.0 24.0 17.7 25.8 15.8 25.0 8.1 7.7 9.6 24.8 10.1 19.7 0.0 0.3 1.3 0.9 0.0 3.0 1.4 1.3 2.4 0.2 0.3 2.1 0.6 4.8 5.8 0.0 0.1 8.6 3.0 5.5 4.4 3.5 8.5 4.4 3.8 5.1 4.7 15.1 2.4 17.9 37.0 11.5 67.2 97.7 6.9 105.5 15.3 76.3 36.4 27.9 27.5 183.1 111.0 70.2 50.4 118.9 3.8 46.7 91.2 85.9 56.1 64.4 4.7 18.7 21.1 31.8 20.2 112.3 5.4 14.5 50.9 14.7 52.3 8.2 16.7 75.9 141.6 11.5 42.5 13.5 14.8 12.9 40.5 93.9 10.4 21.0 72.5 18.7 18.5 18.6 CTNNBIP1 "ICAT, MGC15093" ENSG00000178585 "Catenin beta interacting protein 1" Q9NSA3 1 9848276-9910336 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 116.5" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 254.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042617, HPA067089" Enhanced Approved "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane, Cell Junctions, Mitochondria" "HPA042617: AB_2678081, HPA067089: " "unprognostic (2.71e-1)" "unprognostic (4.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.68e-6)" "unprognostic (3.08e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" "unprognostic (2.23e-2)" "unprognostic (2.62e-1)" "unprognostic (2.17e-2)" "unprognostic (1.77e-1)" "unprognostic (1.24e-3)" "unprognostic (3.62e-2)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (4.37e-2)" 12.6 4.0 10.1 4.3 8.1 7.7 18.3 21.4 14.8 16.6 5.8 10.1 10.9 7.4 4.8 31.3 49.0 5.2 4.8 13.7 10.1 9.5 5.6 4.8 15.2 4.0 8.4 11.3 5.5 14.1 4.0 6.6 11.0 13.7 9.9 4.2 13.3 15.5 16.5 13.1 116.5 5.8 4.5 9.2 3.3 8.8 11.8 6.5 4.8 7.9 33.9 13.5 5.6 21.7 1.9 6.8 12.9 5.4 8.8 2.9 2.3 26.2 3.9 24.2 18.4 3.6 6.1 7.7 5.2 9.2 7.7 4.9 1.9 33.5 8.1 15.1 6.7 7.9 13.4 2.8 30.9 3.5 20.4 4.3 5.2 1.2 24.4 7.6 3.9 3.1 6.8 30.6 9.8 10.0 6.6 20.7 15.3 9.2 3.8 4.7 16.1 8.7 14.6 12.8 21.2 6.8 10.0 7.1 5.2 3.9 9.0 26.6 16.8 11.8 10.8 15.7 8.6 13.2 9.7 13.5 5.0 6.1 7.5 11.4 8.4 10.9 9.5 1.8 20.0 19.7 2.7 5.4 12.9 2.9 1.9 1.7 1.9 1.5 2.4 6.8 1.6 1.4 1.4 4.0 8.8 1.2 2.1 1.2 2.3 10.1 8.1 21.4 14.8 10.1 9.5 8.4 11.3 13.7 6.5 26.8 11.5 11.8 34.8 91.7 8.4 11.6 22.9 1.4 7.9 17.4 7.9 61.2 28.2 16.0 101.0 18.1 20.6 23.3 16.2 34.6 26.7 52.4 0.0 22.9 49.6 15.9 47.1 16.0 32.6 19.5 13.8 30.5 45.5 5.4 34.9 106.1 27.9 25.8 21.5 23.0 12.2 45.3 22.1 72.3 36.2 254.8 40.5 18.1 24.3 54.7 CTNND2 "GT24, NPRAP" ENSG00000169862 "Catenin delta 2" Q9UQB3 5 10971840-11904043 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein" "Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 74.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 18.0;Cholangiocytes: 38.2;Early spermatids: 21.0;Late spermatids: 23.3;Muller glia cells: 39.5" "Cancer enriched" "Detected in many" 16 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.1;MCF7: 8.2;SK-BR-3: 5.4;U-266/84: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015077, CAB037339, HPA071124" Enhanced Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cell Junctions" Cytosol "CAB037339: , HPA015077: AB_2669150, HPA071124: " "unprognostic (7.32e-2)" "unprognostic (1.51e-3)" "unprognostic (2.23e-1)" "unprognostic (5.16e-2)" "unprognostic (5.66e-2)" "unprognostic (2.06e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-2)" "unprognostic (9.13e-2)" "unprognostic (9.86e-2)" "unprognostic (8.95e-3)" "unprognostic (2.66e-1)" "unprognostic (9.55e-4)" "unprognostic (5.87e-2)" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (4.76e-2)" 1.7 2.4 30.9 1.8 26.3 1.4 2.8 21.6 74.3 1.7 1.8 16.6 0.0 1.7 1.6 1.9 1.6 1.7 4.8 6.0 26.0 17.7 1.5 1.7 2.4 1.6 22.8 20.2 2.1 12.5 1.5 5.7 1.9 11.0 2.6 1.9 2.6 1.7 1.7 1.6 1.5 2.0 1.6 13.3 5.7 1.9 4.2 14.7 0.0 1.7 0.0 1.5 1.6 0.1 0.0 0.0 0.8 0.4 0.0 0.3 0.6 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 15.4 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.6 30.9 26.3 21.6 29.1 26.0 17.7 22.8 20.2 11.0 14.7 0.0 0.0 0.0 0.0 0.0 18.0 8.4 38.2 0.0 0.0 1.8 0.0 0.0 3.3 5.4 21.0 0.3 0.0 0.0 5.4 0.0 0.0 3.6 0.0 0.0 0.1 7.9 4.7 0.0 0.0 23.3 1.4 0.0 0.0 0.0 0.0 39.5 3.5 0.0 0.0 0.3 2.6 0.0 0.0 1.4 3.1 0.0 0.0 0.0 0.0 0.1 CTRB1 CTRB ENSG00000168925 "Chymotrypsinogen B1" P17538 16 75219000-75226338 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2272 "pancreas: 1908.8" "Cell type enriched" "Detected in some" 12 "Exocrine glandular cells: 26371.2" "Cancer enriched" "Detected in some" 1905 "pancreatic cancer: 962.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 5.0;U-2 OS: 2.5;U-251 MG: 1.6" "Secreted to digestive system" NA NA "unprognostic (1.76e-1)" "unprognostic (2.62e-1)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (5.22e-2)" "unprognostic (4.43e-3)" "unprognostic (2.96e-1)" "unprognostic (1.17e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 1908.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.0 0.4 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.2 1.6 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 0.0 0.0 26371.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.1 0.0 0.0 2264.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTRB2 ENSG00000168928 "Chymotrypsinogen B2" Q6GPI1 16 75204096-75207185 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5240 "pancreas: 3761.5" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 45669.7" "Cancer enriched" "Detected in single" 1696 "pancreatic cancer: 540.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.1;HDLM-2: 1.9;U-2 OS: 9.3;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4" "Secreted to digestive system" NA NA "unprognostic (9.41e-4)" "unprognostic (2.20e-1)" "unprognostic (1.28e-2)" "unprognostic (2.10e-1)" "unprognostic (2.92e-2)" "unprognostic (2.77e-1)" "unprognostic (5.95e-2)" "unprognostic (9.56e-2)" "unprognostic (3.54e-3)" "unprognostic (7.06e-2)" "unprognostic (2.17e-1)" "unprognostic (7.57e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 3761.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 9.3 0.0 1.9 0.1 2.6 2.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 1.0 0.0 0.0 0.0 45669.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.3 0.3 0.0 0.0 376.1 0.0 0.0 8606.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTRC "CLCR, ELA4" ENSG00000162438 "Chymotrypsin C" Q99895 1 15438439-15449242 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 417 "pancreas: 1443.7" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 5617.8" "Cancer enriched" "Detected in some" 168 "pancreatic cancer: 236.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA046920 Enhanced "Secreted to digestive system" NA NA "HPA046920: AB_2679865" "unprognostic (2.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (8.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (2.94e-2)" "unprognostic (7.60e-2)" "unprognostic (3.34e-1)" "unprognostic (2.00e-1)" "unprognostic (9.55e-11)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "unprognostic (1.50e-1)" "unprognostic (5.99e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1443.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.4 3.4 0.7 1.5 0.6 0.1 3.6 0.6 0.5 0.7 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 1.7 0.5 1.1 0.0 0.5 0.5 0.0 0.1 0.2 1.1 0.6 0.4 0.3 0.1 0.9 0.2 1.7 0.3 0.0 0.0 0.0 0.6 0.0 0.7 0.1 1.8 0.2 0.5 1.1 1.7 0.5 0.0 0.0 0.5 0.1 0.3 0.0 0.1 0.4 1.0 0.4 0.2 0.2 0.2 0.3 0.1 0.9 0.4 1.4 0.9 0.3 0.8 1.6 0.3 0.8 0.8 0.3 3.4 0.4 0.4 0.4 0.2 0.2 0.3 0.3 0.6 0.1 1.1 0.3 0.4 1.7 1.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.1 0.0 0.0 5617.8 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 41.5 0.0 0.0 1090.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 CTRL ENSG00000141086 "Chymotrypsin like" P40313 16 67927640-67932414 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 281 "pancreas: 639.8" "Group enriched" "Detected in some" 39 "Exocrine glandular cells: 185.6;Pancreatic endocrine cells: 95.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034504, HPA034505" Enhanced "Secreted to digestive system" NA NA "HPA034504: AB_2674196, HPA034505: AB_10602212" "unprognostic (3.03e-5)" "unprognostic (3.53e-3)" "unprognostic (3.46e-2)" "unprognostic (1.37e-1)" "unprognostic (9.66e-2)" "unprognostic (2.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (6.83e-3)" "unprognostic (6.41e-2)" "unprognostic (1.88e-1)" "unprognostic (3.20e-4)" "unprognostic (6.69e-2)" "unprognostic (2.79e-1)" "unprognostic (2.63e-1)" "unprognostic (1.29e-3)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 639.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 1.1 1.1 0.7 0.0 2.2 0.5 0.5 3.7 1.1 0.3 0.2 0.1 1.8 0.3 0.7 1.2 1.3 2.3 1.4 0.7 0.4 0.7 1.2 1.0 5.7 0.7 3.1 1.4 6.4 0.8 1.1 1.4 0.3 0.9 2.5 1.2 0.2 3.9 1.0 0.5 0.0 1.9 1.6 1.0 0.6 1.1 0.7 2.8 6.3 1.3 2.3 2.9 0.5 4.6 0.0 0.9 2.7 1.4 1.3 0.7 0.6 0.9 1.2 4.4 1.7 0.1 2.1 0.5 1.6 6.6 2.8 3.6 0.2 0.8 0.8 0.6 0.7 0.3 1.5 0.7 0.2 0.3 1.1 0.5 0.9 0.6 0.5 2.2 1.1 0.0 0.7 1.1 0.0 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 185.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.6 0.4 0.0 95.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 CTSA "GSL, PPGB" ENSG00000064601 "Cathepsin A" P10619 20 45890144-45898820 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 125.7" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 113.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024930, HPA031068, HPA072487" Enhanced Enhanced Vesicles "Intracellular and membrane" NA NA 18000000 Vesicles "CAB024930: , HPA031068: AB_10601205, HPA072487: " "unprognostic (8.61e-2)" "unprognostic (3.37e-1)" "unprognostic (4.30e-2)" "unprognostic (2.13e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (6.33e-2)" "unprognostic (9.53e-3)" "unprognostic (7.19e-2)" "unprognostic (1.83e-1)" "unprognostic (6.85e-2)" "unprognostic (7.57e-2)" "unprognostic (1.09e-1)" "unprognostic (6.05e-2)" "unprognostic (1.71e-1)" "unprognostic (8.40e-2)" 29.0 125.7 12.0 22.8 19.5 22.1 35.3 11.4 30.0 14.1 50.6 17.4 16.2 29.4 18.2 19.3 20.7 12.7 28.0 32.6 11.5 11.6 88.2 43.8 28.4 38.9 12.3 16.1 23.9 19.2 28.3 16.5 47.7 15.7 18.2 50.5 30.1 20.5 15.1 19.3 28.2 40.6 19.6 11.9 38.8 19.7 14.3 11.2 8.0 18.1 24.9 22.4 23.3 18.7 7.0 16.6 81.1 46.1 12.0 31.2 50.0 14.1 14.5 2.7 12.4 113.6 58.9 6.3 20.3 54.2 22.3 29.1 27.3 38.1 3.0 23.6 38.1 84.2 22.6 7.3 13.7 14.0 5.9 6.8 8.0 10.2 47.5 25.3 12.7 33.2 46.7 16.5 14.4 3.2 55.8 24.2 3.9 7.9 46.7 24.1 29.1 3.2 11.8 2.8 21.6 34.6 5.1 14.1 16.8 17.8 12.5 5.5 5.2 33.9 59.3 56.7 7.3 14.5 18.3 22.3 44.8 10.5 25.3 15.9 23.1 29.1 2.1 80.6 16.9 18.4 60.6 46.1 81.1 7.5 26.6 31.2 7.0 12.9 13.2 16.6 3.6 4.7 6.9 24.7 12.0 17.7 6.6 23.9 50.0 12.0 19.5 11.4 30.0 11.5 11.6 12.3 16.1 15.7 11.2 32.8 24.6 40.4 31.0 21.5 54.2 10.9 58.6 22.7 26.1 68.0 56.9 86.8 33.2 172.8 2.3 41.6 257.8 0.0 146.8 91.1 44.1 21.0 9.2 53.3 279.4 44.5 51.9 105.0 166.6 3.6 30.5 81.3 106.3 136.1 70.2 92.8 127.7 92.2 25.8 168.1 30.9 25.8 46.4 6.2 32.4 19.9 120.5 54.2 85.6 31.9 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869448 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 297.0" "Cell type enhanced" "Detected in all" 11 "Hofbauer cells: 2617.6;Kupffer cells: 1392.4" "Cancer enhanced" "Detected in all" "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4" "Group enriched" "Detected in all" 5 "dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 239.8;fHDF/TERT166: 139.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" NA NA 130000000 Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favorable (5.76e-4)" "prognostic unfavorable (9.02e-4)" 227.9 42.1 19.6 67.2 24.4 14.7 67.6 14.9 31.4 76.7 49.1 30.1 22.7 29.9 53.2 44.8 54.2 52.4 43.6 120.7 18.3 23.7 95.6 167.8 94.3 175.1 29.1 16.5 44.2 31.6 13.8 21.6 68.7 24.8 42.6 27.9 33.8 63.7 33.6 41.3 22.8 51.2 51.1 35.9 116.4 26.7 21.5 20.4 18.1 297.0 25.9 38.4 56.8 62.2 7.9 95.4 53.1 127.4 5.3 17.1 108.5 6.4 29.5 3.8 16.2 66.6 74.9 11.8 122.8 239.8 43.0 51.0 14.0 38.4 0.1 17.8 139.3 57.7 35.8 5.2 33.9 27.2 3.2 5.0 9.5 3.4 34.5 67.8 2.1 7.1 82.1 46.2 38.9 34.8 74.9 84.1 2.8 7.9 21.7 35.7 5.2 0.8 3.5 3.2 75.8 9.9 3.4 3.8 16.6 13.1 10.2 1.6 9.6 14.2 7.7 64.0 11.7 12.5 6.4 116.4 73.1 24.8 23.4 22.8 21.6 15.7 0.6 83.9 8.2 34.2 53.1 127.4 16.3 5.2 97.0 7.2 7.9 17.1 5.8 68.0 6.1 9.6 4.1 18.5 5.3 54.7 95.4 13.4 108.5 19.6 24.4 14.9 28.0 18.3 23.7 29.1 16.5 24.8 20.4 101.3 205.9 73.7 364.9 48.5 44.4 251.7 175.8 137.9 227.5 108.2 39.3 224.9 23.2 276.8 13.3 119.6 152.5 210.2 211.7 280.5 149.9 239.1 169.3 203.7 2617.6 55.6 148.7 214.9 1392.4 12.2 70.8 859.7 153.5 399.5 80.9 115.8 264.9 108.7 87.4 331.7 35.7 38.8 121.0 4.8 18.5 35.4 543.3 50.7 114.7 284.4 CTSC "DPP1, PALS, PLS" ENSG00000109861 "Cathepsin C" P53634 11 88293592-88337787 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 218.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 362.7;Hofbauer cells: 897.2;Macrophages: 364.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 111.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025364, HPA066610, HPA068434" Enhanced Supported Vesicles "Intracellular and membrane" No No 19000000 Vesicles "CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989" "unprognostic (4.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (1.10e-1)" "unprognostic (3.70e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (9.30e-5)" "unprognostic (1.62e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (3.11e-2)" "unprognostic (3.35e-1)" "prognostic favorable (4.80e-4)" "unprognostic (2.93e-1)" "unprognostic (4.35e-2)" "unprognostic (8.10e-2)" "unprognostic (4.07e-2)" 40.7 20.5 6.7 44.5 10.6 12.0 35.3 1.5 5.6 14.0 25.3 7.1 6.2 20.4 16.1 24.0 21.8 16.7 36.6 53.3 6.8 6.5 62.7 18.1 110.1 218.6 12.5 3.6 11.0 24.8 3.8 17.3 43.4 9.4 13.8 33.1 27.0 35.1 5.8 10.0 11.7 28.5 14.2 14.6 86.6 13.5 10.8 9.2 19.5 17.7 25.3 30.0 30.2 16.9 8.5 75.9 52.5 92.6 34.7 42.4 31.2 11.1 11.5 4.5 9.4 12.1 32.9 30.1 76.8 111.7 43.9 31.7 31.1 51.7 17.4 40.9 41.7 10.1 18.1 7.0 32.5 35.0 30.7 12.7 22.7 31.8 35.0 16.2 28.9 15.4 45.8 23.0 33.8 69.4 37.0 43.1 16.9 20.6 21.1 5.3 2.1 13.0 39.9 23.5 75.5 35.6 17.0 4.7 30.9 56.4 18.8 1.2 9.4 12.9 17.1 10.0 27.9 3.8 19.8 20.9 3.0 27.2 20.9 48.8 8.9 12.8 17.7 7.9 60.9 16.6 12.5 32.5 52.5 42.4 69.3 36.5 8.5 19.5 37.8 35.1 4.6 9.9 23.8 37.2 34.7 92.6 75.9 28.4 31.2 6.7 10.6 1.5 5.6 6.8 6.5 12.5 3.6 9.4 9.2 20.8 83.9 64.9 5.0 26.8 1.0 2.5 56.0 80.3 93.3 38.4 0.0 362.7 24.9 14.0 1.2 41.8 29.0 0.0 79.6 130.7 85.3 3.1 72.8 14.0 897.2 0.0 10.9 24.5 290.2 4.0 183.8 364.2 45.5 139.7 15.7 0.6 35.1 69.1 24.1 150.6 0.6 58.2 183.3 3.0 11.5 23.7 190.1 167.5 36.3 14.2 CTSE ENSG00000196188 "Cathepsin E" P14091 1 206009264-206023909 "Enzymes, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 57.9;intestine: 47.3;stomach 1: 153.0" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 98.3;Club cells: 77.3;Exocrine glandular cells: 240.3;Pancreatic endocrine cells: 151.8;Paneth cells: 175.6" "Group enriched" "Detected in many" 8 "lung cancer: 68.8;pancreatic cancer: 297.4;stomach cancer: 200.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "OE19: 201.7" "Not detected" "Not detected" "HPA012940, CAB032687" Enhanced "Intracellular and membrane" NA NA "CAB032687: AB_637901, HPA012940: AB_2668773" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-2)" "unprognostic (2.72e-2)" "unprognostic (1.35e-2)" "unprognostic (2.52e-3)" "unprognostic (1.45e-1)" "unprognostic (3.29e-2)" "unprognostic (2.87e-2)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "unprognostic (6.37e-3)" "unprognostic (1.42e-1)" "unprognostic (5.45e-2)" "unprognostic (2.61e-2)" "prognostic favorable (5.26e-5)" 0.2 0.1 0.1 3.7 0.1 3.0 0.1 0.1 0.1 0.1 47.3 0.3 0.8 29.3 0.1 0.7 0.6 0.5 57.9 0.3 0.1 0.1 0.2 0.2 24.9 0.0 0.1 0.0 0.1 2.2 0.0 0.5 0.0 0.1 1.3 3.2 0.0 0.1 0.0 0.1 0.1 29.7 0.0 0.1 0.2 153.0 0.1 0.0 0.3 4.2 0.0 1.1 1.8 0.4 0.2 0.7 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 201.7 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 98.3 20.9 0.0 0.1 0.0 0.0 0.4 17.8 13.4 77.3 0.0 0.0 0.0 0.0 44.2 0.0 0.0 5.1 23.3 240.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 2.8 8.1 0.0 151.8 175.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.2 CTSG CG ENSG00000100448 "Cathepsin G" P08311 14 24573522-24576260 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "bone marrow: 450.3" "Cell type enriched" "Detected in some" 9 "granulocytes: 500.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.5;memory CD8 T-cell: 3.5;myeloid DC: 5.1;naive CD8 T-cell: 1.8;neutrophil: 7.1;NK-cell: 5.2;plasmacytoid DC: 5.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "THP-1: 448.1" "Not detected" "Not detected" "CAB000110, HPA047737" Enhanced "Intracellular and membrane" NA NA 67000 "CAB000110: , HPA047737: AB_2680140" "unprognostic (1.67e-1)" "unprognostic (2.57e-2)" "unprognostic (6.92e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.57e-4)" "unprognostic (4.05e-2)" "unprognostic (4.13e-2)" "unprognostic (3.06e-1)" "unprognostic (2.42e-1)" "unprognostic (2.60e-2)" "unprognostic (2.05e-2)" "unprognostic (1.63e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.91e-4)" 15.1 0.5 0.0 6.0 0.0 450.3 6.0 0.0 0.6 10.0 5.1 0.0 2.8 1.1 6.2 19.7 6.4 0.8 16.7 23.4 0.0 0.0 2.1 2.0 9.2 3.7 0.0 0.0 1.5 3.4 0.8 0.5 3.0 0.0 8.2 3.2 2.6 6.3 6.9 1.1 19.5 8.9 14.9 0.0 10.7 3.2 2.8 0.0 15.6 0.5 12.0 5.1 2.9 3.3 0.0 5.7 7.1 6.5 5.2 3.5 12.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 448.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 66.4 0.0 0.0 6.5 0.0 1.1 1.0 0.0 0.0 1.0 3.5 5.1 0.0 0.0 1.8 7.1 5.2 0.0 5.7 0.0 12.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 11.9 58.0 0.0 0.0 5.7 0.0 0.6 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 1.0 0.0 500.2 0.0 0.2 0.0 0.0 0.0 0.0 4.7 0.0 4.7 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.0 CTSH "ACC-4, ACC-5, ACC4, ACC5, CPSB" ENSG00000103811 "Cathepsin H" P09668 15 78921058-78949574 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 82.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 1152.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 42.8" "Group enriched" "Detected in all" 5 "B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.1;HaCaT: 31.5;OE19: 31.0;RT4: 119.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000458, HPA003524" Enhanced Supported "Vesicles,Cytosol,Cytoplasmic bodies" "Intracellular and membrane" NA NA 10000000 "Vesicles, Cytosol, Cytoplasmic bodies" "CAB000458: , HPA003524: AB_1846075" "unprognostic (6.47e-2)" "unprognostic (4.65e-3)" "unprognostic (1.05e-1)" "prognostic favorable (6.90e-4)" "unprognostic (4.37e-2)" "unprognostic (1.93e-1)" "unprognostic (7.18e-2)" "unprognostic (3.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.96e-2)" "unprognostic (4.10e-2)" "unprognostic (3.89e-2)" "unprognostic (6.63e-3)" "unprognostic (3.83e-1)" "unprognostic (4.42e-2)" "unprognostic (2.70e-3)" "unprognostic (1.79e-3)" 16.7 10.6 9.5 24.2 7.0 5.4 23.9 4.5 9.8 25.1 11.4 17.7 14.7 10.6 10.3 17.1 7.8 13.1 29.2 16.5 14.8 6.7 66.7 18.7 82.6 65.4 12.1 11.6 14.6 25.8 12.3 6.5 7.7 9.4 18.6 6.6 6.7 15.4 15.9 7.0 13.5 16.6 9.8 10.8 20.3 15.6 6.7 15.7 6.6 8.5 4.8 34.8 39.6 13.5 20.6 41.2 1.4 42.8 1.3 7.6 27.3 16.2 1.1 0.4 4.8 1.1 0.0 5.3 1.6 0.6 2.8 1.5 7.1 43.1 5.7 1.8 0.1 3.1 31.5 2.0 7.8 2.3 24.0 0.1 0.1 0.2 16.5 1.7 0.0 1.1 0.8 2.2 0.0 0.0 11.8 0.2 0.7 11.6 0.0 3.9 1.7 3.7 10.0 1.2 31.0 0.3 0.0 0.3 0.9 9.9 119.7 0.5 1.2 7.0 3.9 9.7 2.3 1.6 5.4 2.2 0.0 1.0 0.0 0.7 0.1 12.4 3.1 0.0 10.5 1.7 0.0 42.8 0.4 1.4 28.3 7.6 20.6 4.1 2.1 41.2 12.0 0.4 0.7 1.4 1.3 17.0 4.2 3.1 27.3 9.5 7.0 4.5 9.8 14.8 6.7 12.1 11.6 9.4 15.7 220.3 1152.3 144.6 210.0 21.5 0.8 25.2 351.6 270.4 197.9 349.0 3.9 16.6 71.3 153.3 17.1 109.7 15.8 0.0 128.8 33.6 30.0 89.1 30.2 82.9 261.0 0.0 8.7 15.4 160.1 15.9 67.6 392.5 75.9 476.1 19.5 21.1 69.6 11.5 5.6 352.9 5.6 19.4 17.8 5.0 52.9 16.3 19.6 25.4 37.0 308.4 CTSK "CTSO, CTSO2, PKND, PYCD" ENSG00000143387 "Cathepsin K" P43235 1 150796208-150808323 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.1" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 61.1;Leydig cells: 110.1;Melanocytes: 92.8;Peritubular cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 6.7" "Lineage enriched" "Detected in many" 6 "monocytes: 6.7" "Group enriched" "Detected in some" 8 "ASC diff: 205.0;ASC TERT1: 75.1;BJ hTERT+: 165.6" "Low region specificity" "Detected in all" HPA050346 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA050346: AB_2681101" "unprognostic (1.48e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (7.61e-3)" "unprognostic (5.08e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (6.60e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.54e-2)" "prognostic unfavorable (7.12e-5)" "unprognostic (6.07e-3)" "unprognostic (2.98e-2)" "unprognostic (5.93e-3)" "unprognostic (6.41e-2)" 104.1 2.4 1.2 6.5 1.6 1.3 79.3 2.4 2.3 70.6 23.6 2.2 10.1 2.7 72.5 25.9 26.5 12.5 53.4 14.7 1.1 1.1 3.4 1.8 8.7 10.4 1.1 1.7 25.4 2.9 0.3 3.0 30.6 2.6 24.2 11.5 56.0 10.9 6.8 19.9 44.0 11.0 26.9 2.0 5.6 8.6 24.1 0.9 1.1 7.1 13.2 10.7 38.0 48.2 0.1 1.0 1.0 6.7 0.5 1.2 1.8 0.1 0.1 0.4 0.3 205.0 75.1 0.2 5.8 165.6 0.4 0.9 0.0 0.1 0.1 0.2 11.4 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 1.1 0.1 0.4 14.9 0.5 4.6 0.1 13.1 0.6 0.1 0.0 0.5 0.4 0.3 0.0 0.7 1.1 0.2 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.7 0.3 0.0 3.1 0.9 0.2 0.2 0.4 0.2 0.1 0.2 0.3 0.7 0.5 1.1 17.4 0.0 1.0 0.0 6.7 1.0 0.7 3.4 0.2 0.0 0.6 0.2 0.4 0.1 0.3 0.5 0.6 0.5 2.0 1.0 1.2 1.8 1.2 1.6 2.4 2.3 1.1 1.1 1.1 1.7 2.6 0.9 3.0 5.8 0.0 0.5 61.1 8.4 1.2 2.5 2.7 5.7 3.5 3.9 1.0 0.0 1.1 0.8 5.2 1.1 0.0 0.2 1.9 31.5 0.9 0.0 0.0 19.2 3.2 1.2 9.8 3.7 1.7 110.1 6.6 92.8 2.8 1.9 2.4 1.3 0.6 140.7 0.0 7.8 12.9 47.6 1.4 0.7 51.7 0.8 0.0 0.9 0.5 CTSL "CTSL1, FLJ31037" ENSG00000135047 "Cathepsin L" P07711 9 87725519-87731393 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 237.0" "Cell type enhanced" "Detected in all" 8 "Cytotrophoblasts: 935.7;Extravillous trophoblasts: 843.2;Hofbauer cells: 1004.8;Ito cells: 672.8;Syncytiotrophoblasts: 1290.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "intermediate monocyte: 31.0;non-classical monocyte: 44.3" "Lineage enriched" "Detected in many" 10 "monocytes: 44.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 201.6;HSkMC: 93.2" "CAB000459, HPA070413" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 17000000 "Golgi apparatus, Vesicles" "CAB000459: AB_2292484, HPA070413: " "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.19e-3)" "unprognostic (8.12e-3)" "prognostic unfavorable (5.15e-5)" "unprognostic (2.09e-1)" "unprognostic (3.15e-1)" "unprognostic (6.80e-2)" "unprognostic (3.21e-1)" "prognostic favorable (4.34e-4)" "unprognostic (5.64e-3)" "unprognostic (2.26e-2)" "unprognostic (1.72e-1)" "unprognostic (7.11e-3)" 60.3 21.5 10.4 27.2 24.6 18.4 23.3 6.9 12.3 14.8 23.2 14.1 13.7 9.0 24.1 22.3 11.4 25.7 20.7 37.7 10.7 11.4 65.4 98.0 53.1 80.5 18.9 7.7 25.0 14.3 18.8 18.0 237.0 18.4 19.4 13.0 23.2 22.0 23.5 29.3 9.1 12.0 36.6 16.1 108.1 17.5 14.1 15.7 6.8 19.2 9.4 10.1 41.3 26.5 0.0 1.7 0.1 44.3 0.0 4.3 2.4 6.4 37.4 2.6 4.4 47.1 201.6 15.7 20.8 60.7 17.9 22.4 3.6 5.9 0.0 9.8 26.9 56.7 5.5 3.4 6.8 14.8 0.1 3.3 1.1 10.6 8.7 30.5 0.0 4.5 93.2 11.4 29.2 11.4 15.6 14.1 0.0 12.1 0.0 25.7 10.8 0.0 0.7 4.9 10.1 7.1 1.5 1.5 0.0 12.5 3.4 3.7 4.6 4.3 9.8 23.9 15.6 1.1 7.4 22.0 16.0 8.7 58.4 8.8 1.6 6.0 0.0 58.7 0.0 5.2 0.1 3.5 0.1 0.0 31.0 0.0 0.0 1.8 0.0 1.7 0.0 4.3 0.3 0.1 0.0 44.3 0.1 0.3 2.4 10.4 24.6 6.9 11.7 10.7 11.4 18.9 7.7 18.4 15.7 38.7 60.6 38.5 79.1 33.5 37.4 87.3 84.1 56.2 38.7 71.5 17.7 935.7 23.2 77.5 3.5 75.9 8.6 46.7 82.1 843.2 226.1 43.7 27.8 100.7 1004.8 12.7 11.1 672.8 182.1 10.4 145.3 481.4 60.8 19.8 7.7 78.6 55.2 2.9 176.0 107.8 35.6 90.5 103.2 144.4 46.2 29.6 1290.9 15.3 8.8 43.0 CTSS ENSG00000163131 "Cathepsin S" P25774 1 150730196-150765957 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 171.4;lymphoid tissue: 111.4" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 672.3;Kupffer cells: 1992.4;Macrophages: 1161.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5" "Group enriched" "Detected in all" 9 "dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.6;HMC-1: 51.4;U-698: 109.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000460, HPA002988" Supported Approved Vesicles "Intracellular and membrane" NA NA 19000000 Vesicles "CAB000460: , HPA002988: AB_1078409" "unprognostic (7.81e-2)" "unprognostic (9.04e-2)" "unprognostic (3.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (6.00e-3)" "unprognostic (1.46e-1)" "unprognostic (3.89e-1)" "unprognostic (6.24e-2)" "unprognostic (7.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.13e-1)" "unprognostic (2.47e-3)" 41.6 9.3 6.8 32.3 10.3 30.3 9.7 1.9 6.2 4.7 32.9 6.6 5.6 19.6 3.7 12.9 8.8 10.7 15.9 17.3 6.4 5.1 9.6 21.5 55.8 99.5 12.6 2.3 7.6 6.4 0.4 3.4 14.4 9.3 7.5 33.4 6.5 12.9 3.3 3.5 3.8 38.0 6.8 17.1 111.4 13.8 3.8 9.5 12.9 7.6 4.6 22.8 21.5 5.3 11.1 43.5 94.5 171.4 3.3 5.6 145.4 1.0 3.3 0.0 0.0 0.4 0.3 0.3 0.0 3.3 0.2 0.6 0.0 21.6 14.9 1.6 0.1 6.1 0.4 0.0 0.1 0.0 8.3 0.0 6.5 0.1 0.0 0.0 8.9 51.4 0.6 0.0 1.9 0.1 0.1 1.2 0.0 0.6 13.0 0.4 0.0 0.0 6.3 0.0 0.0 0.0 3.7 1.2 18.2 4.0 3.2 0.0 0.1 0.2 0.9 0.3 0.0 0.0 18.2 1.8 1.3 0.2 0.0 0.3 9.0 0.8 109.3 7.6 9.6 0.8 1.2 171.4 16.5 3.2 151.2 3.9 11.1 3.9 3.8 43.5 10.2 3.9 3.6 94.5 3.3 138.5 9.4 5.6 145.4 6.8 10.3 1.9 6.2 6.4 5.1 12.6 2.3 9.3 9.5 101.3 167.2 252.8 20.8 15.0 2.0 3.0 84.1 518.0 134.2 40.1 11.8 3.1 0.0 145.4 5.3 35.1 277.5 0.0 157.6 3.9 26.3 16.7 100.8 19.5 672.3 0.0 40.9 64.4 1992.4 1.7 4.9 1161.7 54.0 251.5 198.9 0.3 150.7 378.7 2.1 4.2 4.1 19.4 7.6 0.2 0.4 13.6 5.1 117.4 149.8 109.8 CTSV "CTSL2, CTSU" ENSG00000136943 "Cathepsin V" O60911 9 97029679-97039643 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 154.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 42 "dendritic cells: 15.7;NK-cells: 4.2" "Group enriched" "Detected in many" 9 "BEWO: 92.0;SuSa: 118.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017112 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 260000 "Nucleoli fibrillar center, Cytosol" "Nucleoplasm, Plasma membrane" "CAB017112: " "unprognostic (2.40e-1)" "unprognostic (2.74e-2)" "unprognostic (1.50e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.29e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (2.83e-5)" "unprognostic (7.04e-3)" "unprognostic (6.06e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.86e-2)" "unprognostic (1.78e-1)" "unprognostic (2.41e-2)" "unprognostic (1.33e-1)" "unprognostic (3.04e-3)" "prognostic unfavorable (2.39e-4)" 0.7 0.0 0.4 0.6 0.7 0.0 3.5 0.4 1.0 23.0 1.4 2.0 0.4 0.5 1.5 1.5 9.8 0.6 0.5 0.2 0.8 0.6 9.7 0.4 0.6 0.2 1.5 0.7 0.4 1.1 1.1 0.9 8.7 1.6 0.5 1.6 4.3 5.0 0.6 0.5 25.0 0.6 0.2 3.0 0.2 1.1 32.4 1.0 154.7 0.7 6.3 2.7 0.2 9.9 0.2 15.7 0.2 0.0 4.2 0.0 0.1 5.9 1.8 2.0 5.3 0.1 0.0 92.0 0.0 0.0 1.3 1.0 12.1 5.9 0.0 0.5 0.0 8.8 11.4 9.8 7.2 1.9 0.0 1.3 0.2 0.6 1.8 0.0 0.0 0.8 0.0 2.4 0.3 0.3 0.1 0.4 1.7 0.2 0.0 2.3 2.2 0.1 0.0 12.2 12.0 1.7 0.0 4.4 0.1 1.8 0.7 0.5 0.9 6.0 2.1 2.1 118.9 3.8 0.7 0.0 0.3 6.0 0.0 0.6 1.2 3.2 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.2 4.2 0.0 15.7 0.0 0.1 0.4 0.7 0.4 1.0 0.8 0.6 1.5 0.7 1.6 1.0 0.0 0.6 1.5 13.2 27.0 4.4 0.8 0.0 0.0 3.4 1.8 9.8 114.1 1.7 1.2 1.5 1.5 1.2 0.0 0.7 136.0 2.6 7.1 0.0 0.0 11.8 0.0 1.7 0.6 0.0 9.6 3.7 1.6 0.0 0.0 0.9 4.5 0.6 1.7 1.1 11.1 26.0 6.5 0.8 34.6 32.6 10.5 56.3 0.0 3.7 6.4 CTSW ENSG00000172543 "Cathepsin W" P56202 11 65879809-65883741 "Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.2;bone marrow: 41.4" "Group enriched" "Detected in many" 10 "granulocytes: 70.4;T-cells: 273.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 106.6;MAIT T-cell: 67.7;memory CD8 T-cell: 68.3;naive CD8 T-cell: 51.4;NK-cell: 157.2" "Group enriched" "Detected in many" 48 "NK-cells: 157.2;T-cells: 106.6" "Group enriched" "Detected in some" 23 "HEL: 38.8;NB-4: 88.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" CAB016345 Enhanced "Secreted to blood" NA NA 340000 "CAB016345: AB_626813" "prognostic favorable (3.06e-4)" "unprognostic (2.06e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.36e-6)" "unprognostic (1.21e-1)" "prognostic favorable (9.89e-4)" "unprognostic (5.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (5.14e-3)" "unprognostic (2.83e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (8.84e-6)" "unprognostic (3.86e-2)" "unprognostic (3.78e-1)" "unprognostic (1.26e-1)" "unprognostic (4.01e-3)" 5.2 1.2 0.9 4.9 1.0 41.4 2.3 0.6 0.7 3.9 4.9 0.8 0.5 2.4 8.4 4.0 2.1 2.1 2.5 9.0 0.9 1.0 2.5 6.8 12.7 36.0 1.1 0.6 3.0 1.1 0.0 1.4 10.7 1.4 7.4 2.5 6.3 10.9 1.5 1.9 1.5 5.9 1.7 2.1 33.1 3.3 3.4 0.4 11.1 3.1 1.3 18.2 4.5 2.6 0.4 2.7 2.3 0.3 157.2 106.6 45.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 38.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.2 0.0 0.0 0.4 88.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 2.4 0.0 2.3 0.2 0.3 106.6 0.2 67.7 0.4 11.7 68.3 2.7 0.3 7.0 51.4 2.0 157.2 0.3 1.7 1.6 45.7 0.9 1.0 0.6 0.7 0.9 1.0 1.1 0.6 1.4 0.4 0.0 6.2 3.7 0.4 4.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.2 1.8 0.6 0.0 0.0 0.0 0.1 3.2 0.3 70.4 1.7 1.9 0.0 0.0 5.5 5.3 8.8 0.0 7.3 16.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.8 0.2 0.9 5.5 0.2 273.8 0.0 0.3 CTXN1 FLJ25968 ENSG00000178531 "Cortexin 1" P60606 19 7924485-7926166 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 91.1" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4" "Cancer enhanced" "Detected in all" "ovarian cancer: 138.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016669 Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA Nucleoplasm "Plasma membrane, Cell Junctions" "HPA016669: AB_1847330" "unprognostic (1.49e-2)" "unprognostic (3.52e-2)" "unprognostic (1.79e-2)" "unprognostic (2.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.82e-2)" "unprognostic (5.42e-2)" "unprognostic (2.17e-1)" "unprognostic (2.58e-1)" "unprognostic (2.28e-2)" "unprognostic (1.69e-3)" "unprognostic (3.31e-2)" "unprognostic (1.56e-3)" "unprognostic (4.84e-2)" "unprognostic (3.09e-2)" "unprognostic (3.76e-2)" "unprognostic (9.41e-2)" 2.1 4.8 47.7 2.5 91.1 1.6 2.1 0.0 74.2 5.2 6.1 5.0 3.6 2.6 17.5 5.1 2.4 16.4 1.8 1.6 49.4 16.8 3.1 1.5 3.0 1.6 15.7 20.1 2.7 2.1 2.3 6.5 2.0 4.0 5.5 2.1 0.0 2.1 16.5 1.6 2.8 2.1 7.1 1.5 2.0 2.2 6.1 8.3 0.0 1.8 0.0 1.6 2.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 2.8 7.3 33.9 0.0 0.1 1.7 2.9 0.8 1.4 0.8 0.8 1.7 0.0 5.8 0.7 0.8 12.3 1.6 0.3 0.0 1.0 23.6 0.2 1.9 0.5 0.3 0.6 0.6 0.0 0.9 0.5 0.3 3.5 1.9 3.2 7.1 0.1 0.1 13.7 6.2 4.6 25.7 0.8 11.9 19.5 0.0 2.2 5.2 0.5 20.0 33.6 1.8 0.9 3.1 0.6 7.4 0.2 2.8 0.7 11.9 1.3 1.6 0.2 0.3 1.6 2.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 91.1 0.0 63.8 49.4 16.8 15.7 20.1 4.0 8.3 0.0 0.0 0.0 3.6 1.0 0.2 0.2 0.0 0.0 0.0 8.7 3.9 0.1 3.3 5.0 7.3 0.5 0.0 0.0 0.3 0.4 0.9 14.7 0.0 0.0 0.2 0.0 8.7 0.6 0.0 13.4 1.1 0.1 1.7 0.0 0.0 0.1 2.0 0.2 1.8 7.2 0.4 0.0 4.2 3.6 10.4 1.8 0.2 0.0 0.0 5.9 CTXN2 ENSG00000233932 "Cortexin 2" P0C2S0 15 48178122-48203756 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 11.3;pituitary gland: 5.7;testis: 4.9" "Group enriched" "Detected in some" 6 "Early spermatids: 29.9;Late spermatids: 26.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 1.0;SCLC-21H: 3.6;SH-SY5Y: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053168 Uncertain NA NA "HPA053168: AB_2682066" "unprognostic (1.90e-1)" "unprognostic (3.85e-3)" "unprognostic (7.43e-2)" "unprognostic (2.18e-4)" "unprognostic (6.81e-3)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" "unprognostic (4.61e-2)" 0.5 1.2 6.4 0.7 6.7 0.5 0.6 8.4 9.0 0.5 0.8 0.0 0.0 0.7 0.5 0.6 0.6 1.3 0.7 0.5 4.0 11.3 0.9 0.5 0.6 0.6 7.3 2.9 0.5 1.4 0.6 5.7 0.5 8.8 0.6 0.9 0.0 0.5 0.6 0.6 0.5 1.1 0.6 1.9 0.5 0.6 4.9 1.2 0.0 0.6 0.0 0.6 0.5 0.0 0.0 0.1 0.3 1.5 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.6 1.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 0.1 0.0 0.0 6.4 6.7 8.4 9.0 4.0 11.3 7.3 2.9 8.8 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 26.0 0.9 0.0 0.0 0.0 0.0 1.7 0.2 2.9 0.0 0.3 0.3 0.0 0.0 1.4 1.6 0.0 0.0 0.0 0.1 0.0 CTXN3 ENSG00000205279 "Cortexin 3" Q4LDR2 5 127649044-127658630 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 21.9;kidney: 58.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 121.0" "Cancer enriched" "Detected in single" 8 "renal cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 4.5;NTERA-2: 1.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 4 "olfactory region: 50.2" NA NA "unprognostic (7.32e-2)" "unprognostic (9.88e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-1)" "unprognostic (6.20e-3)" 0.6 0.6 2.2 0.5 9.4 0.5 0.6 0.2 19.1 0.6 0.6 0.7 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 7.9 4.8 58.1 0.6 0.6 0.6 12.6 4.6 0.5 0.5 0.5 5.9 0.5 21.9 0.9 0.6 0.0 0.7 0.6 9.1 0.5 0.5 0.5 0.5 0.5 0.6 0.6 1.0 0.0 0.5 0.3 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.2 19.1 7.9 4.8 12.6 4.6 21.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 19.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 CTXND1 LINC01314 ENSG00000259417 "Cortexin domain containing 1" 15 80195484-80252213 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 20.8;epididymis: 9.1;liver: 14.7" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 4.6;Ciliated cells: 1.4;Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 5.6" "Group enriched" "Detected in many" 7 "glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.7;SK-MEL-30: 3.4;WM-115: 10.2" "Region enriched" "Detected in many" 4 "hippocampal formation: 38.5" NA NA "unprognostic (4.15e-5)" "unprognostic (8.42e-2)" "unprognostic (6.08e-2)" "unprognostic (1.86e-3)" "unprognostic (5.59e-2)" "unprognostic (3.48e-1)" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (2.41e-1)" "unprognostic (7.04e-2)" "unprognostic (3.90e-4)" "unprognostic (2.43e-1)" "unprognostic (1.72e-2)" "unprognostic (1.92e-3)" "unprognostic (1.06e-1)" "unprognostic (5.14e-3)" "unprognostic (1.34e-1)" 0.3 4.2 12.8 0.3 5.7 0.1 0.2 4.4 8.2 0.2 0.5 2.2 0.0 0.7 0.2 9.1 0.2 0.4 0.2 6.6 20.8 3.5 14.7 2.6 0.4 1.9 1.9 0.4 0.7 0.0 0.0 0.1 4.5 0.2 0.5 1.1 0.2 0.3 0.6 1.3 0.8 0.2 3.3 2.0 3.3 0.3 7.1 0.0 0.8 0.0 0.5 0.2 0.0 0.4 0.1 0.5 0.1 0.3 0.6 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 1.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.1 0.2 0.2 10.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.6 0.1 0.5 0.3 0.0 0.1 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTXND2 ENSG00000283324 "Cortexin domain containing 2" 1 150887136-150913292 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "fallopian tube: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BEWO: 5.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CUBN "gp280, IFCR, MGA1" ENSG00000107611 Cubilin O60494 10 16823964-17129831 "Disease related genes, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 28.9;kidney: 79.7" "Cell type enriched" "Detected in many" 12 "Proximal tubular cells: 301.3" "Cancer enriched" "Detected in some" 15 "renal cancer: 24.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 18.2;ASC TERT1: 4.6;SK-MEL-30: 3.4;WM-115: 6.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004133, HPA043854" Enhanced "Intracellular and membrane" NA NA 240000 "HPA004133: AB_2732398, HPA043854: AB_2732510" "unprognostic (1.75e-1)" "unprognostic (2.35e-1)" "unprognostic (2.12e-3)" "unprognostic (8.61e-4)" "unprognostic (9.54e-2)" "unprognostic (2.78e-2)" "unprognostic (2.88e-2)" "unprognostic (7.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.47e-1)" "prognostic favorable (1.12e-4)" "unprognostic (6.24e-3)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (1.93e-1)" 0.3 0.3 0.3 0.3 0.6 0.1 0.4 0.4 0.3 0.5 0.3 0.3 0.3 0.0 0.4 11.5 0.3 1.6 0.3 0.3 0.3 0.3 79.7 0.3 0.3 0.4 0.3 0.3 2.0 0.3 0.6 1.7 1.1 0.3 0.6 0.1 0.3 0.3 0.3 0.3 0.3 28.9 0.3 0.3 0.5 0.1 1.2 0.3 0.3 3.1 0.3 0.3 0.3 0.3 0.8 1.2 0.9 0.2 0.6 1.4 0.0 0.0 0.1 1.8 18.2 0.6 4.6 0.1 0.1 0.1 0.1 0.1 2.1 0.0 0.0 0.1 0.9 1.2 0.0 0.0 0.2 0.1 0.4 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.6 0.0 0.6 0.2 0.7 1.8 1.0 0.2 0.3 0.2 0.0 0.3 0.3 0.3 0.0 0.2 0.1 0.4 0.0 0.6 0.0 0.0 0.5 0.0 0.0 3.4 0.1 0.0 0.1 1.8 0.2 0.2 0.3 0.2 0.6 0.1 0.0 0.5 0.1 6.9 0.9 0.2 0.0 0.8 0.0 1.0 0.4 0.4 0.2 0.0 0.8 0.8 1.4 0.6 0.6 0.0 1.2 0.7 0.0 0.3 0.6 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 1.0 0.0 0.4 0.5 0.9 1.1 0.0 2.7 5.7 5.2 2.0 0.0 11.6 0.0 25.3 2.7 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.8 25.4 2.6 0.4 6.8 0.0 0.3 8.7 0.1 0.0 1.1 301.3 3.7 0.0 1.2 0.7 0.2 0.6 0.1 0.5 0.0 0.1 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038619, HPA058231" Enhanced Enhanced Nucleoplasm,Nucleoli,Cytosol No No "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649, HPA058231: " "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.5 20.5 7.2 21.9 26.8 12.3 3.9 7.8 10.1 7.9 8.9 9.4 7.3 34.7 7.0 13.3 3.9 8.2 14.7 13.0 8.8 10.2 14.0 11.5 9.2 14.8 12.4 21.3 5.6 12.7 8.1 12.6 26.2 9.8 13.5 20.2 10.1 7.7 5.9 6.6 19.1 22.0 7.2 9.7 7.7 13.0 8.5 13.3 8.3 3.9 2.4 5.4 3.6 5.7 9.8 10.4 9.1 12.2 7.5 3.3 4.4 3.6 10.3 12.7 16.5 24.3 10.8 45.8 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 8.9 12.2 21.9 13.0 10.8 16.5 35.8 10.2 20.1 10.3 5.2 7.9 15.9 18.3 14.6 8.1 21.5 4.9 0.0 15.0 10.7 15.3 11.4 30.0 20.2 18.3 11.1 11.6 22.7 17.8 6.8 12.0 15.9 28.7 27.9 7.8 17.8 10.1 10.1 15.2 24.5 27.1 19.4 15.6 105.8 35.1 9.5 11.3 20.1 9.7 10.7 CUX2 "CDP2, CUTL2, KIAA0293" ENSG00000111249 "Cut like homeobox 2" O14529 12 111034024-111350554 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.9;brain: 13.2;liver: 21.5;prostate: 13.6" "Group enriched" "Detected in some" 4 "Hepatocytes: 40.4;Horizontal cells: 25.4" "Cancer enhanced" "Detected in some" "prostate cancer: 11.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 100 "plasmacytoid DC: 9.9" "Lineage enriched" "Detected in single" 100 "dendritic cells: 9.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 7.5;HDLM-2: 3.2;hTERT-HME1: 4.1;SCLC-21H: 7.5;SH-SY5Y: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (6.98e-3)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.78e-2)" "unprognostic (1.22e-2)" "unprognostic (9.44e-2)" "unprognostic (2.33e-1)" "unprognostic (3.30e-2)" "unprognostic (7.83e-5)" "unprognostic (2.67e-1)" "unprognostic (3.54e-3)" "unprognostic (4.31e-2)" "unprognostic (9.03e-2)" "unprognostic (4.64e-2)" "unprognostic (1.90e-2)" 0.2 0.2 2.9 0.4 4.8 0.3 2.3 1.2 13.2 1.1 0.3 0.3 2.8 0.3 0.3 0.5 0.3 0.2 0.2 0.2 1.9 2.1 0.2 21.5 0.2 0.6 2.7 3.1 0.1 0.2 0.1 1.9 0.2 1.0 13.6 0.2 0.6 0.1 5.4 0.2 0.2 0.3 0.1 0.4 0.4 1.2 0.6 0.4 0.0 4.9 0.0 0.7 0.3 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 7.5 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 7.5 16.2 0.0 0.0 0.0 0.5 0.3 0.2 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 2.9 4.8 1.2 13.2 1.9 2.1 2.7 3.1 1.0 0.4 0.0 0.0 0.0 2.9 0.0 7.7 0.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 40.4 0.5 25.4 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.6 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832149-122850793 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 200 "pancreas: 650.6" "Group enriched" "Detected in some" 23 "Exocrine glandular cells: 224.1;Pancreatic endocrine cells: 71.0" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 6 "B-cells: 1.1;T-cells: 3.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 7.2;LHCN-M2: 8.0" "Low region specificity" "Detected in single" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 650.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.2 0.0 3.2 0.2 1.6 1.7 1.7 0.0 0.5 0.8 1.0 2.5 0.7 0.3 1.7 1.8 3.7 0.9 0.7 1.1 0.0 1.7 0.0 1.5 2.6 2.3 2.2 3.6 4.7 0.8 0.3 0.0 3.8 1.2 0.3 1.5 7.2 0.2 1.8 1.5 1.3 1.5 8.0 0.4 2.0 2.7 1.7 0.9 1.3 0.0 4.0 0.6 1.4 1.3 1.9 0.7 0.9 0.4 1.1 2.0 1.3 1.9 3.6 0.0 2.4 0.9 0.0 1.9 1.4 3.2 1.3 5.9 0.0 0.0 0.1 0.3 0.8 0.1 1.3 0.6 0.9 1.1 0.1 1.1 1.4 0.7 0.0 0.0 0.2 0.2 3.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.1 0.0 0.0 0.0 224.1 0.0 0.1 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 4.5 0.3 0.0 0.0 6.4 0.0 0.0 71.0 0.0 0.4 0.0 0.5 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.0 0.0 CWC25 "CCDC49, FLJ20291" ENSG00000273559 "CWC25 spliceosome associated protein homolog" Q9NXE8 17 38800434-38825481 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 29.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014874, HPA062997" Supported Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB014874: , HPA062997: AB_2684917" "unprognostic (2.21e-1)" "unprognostic (4.30e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (4.75e-2)" "unprognostic (3.69e-2)" "unprognostic (1.01e-2)" "unprognostic (3.24e-2)" "unprognostic (3.43e-3)" "unprognostic (8.79e-3)" "unprognostic (4.17e-3)" "unprognostic (4.98e-2)" "unprognostic (1.32e-1)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (8.68e-3)" 6.0 4.4 5.1 5.5 5.8 29.7 4.6 6.6 6.2 5.5 4.8 4.4 5.4 5.4 6.0 3.6 3.9 3.1 4.5 3.0 4.3 4.6 4.8 4.6 6.5 5.0 3.7 5.0 4.3 4.0 7.8 7.5 4.4 5.1 4.1 4.4 4.5 6.3 7.6 8.6 5.6 4.3 6.5 5.2 4.0 10.4 5.8 7.8 4.6 4.4 6.4 5.4 5.6 4.5 4.8 18.0 5.2 3.4 4.4 2.5 5.9 7.4 5.3 7.4 6.5 5.3 4.6 6.2 4.8 8.8 6.7 6.2 6.2 8.0 4.5 5.9 5.9 13.6 5.9 4.7 9.5 7.0 8.3 5.6 7.5 6.5 6.4 13.8 9.1 5.5 7.5 7.1 6.2 7.6 5.4 8.6 8.7 8.1 5.7 3.9 14.3 14.5 4.7 5.0 4.5 10.5 7.2 6.3 7.7 6.0 5.1 4.7 6.1 4.1 7.4 7.6 6.3 11.0 5.8 6.1 5.3 7.9 10.0 7.3 5.8 10.3 6.6 7.4 6.0 7.6 5.2 5.8 3.9 3.0 3.3 4.2 3.6 3.7 3.6 4.5 4.4 3.3 18.0 3.4 4.1 4.8 3.1 2.5 53.6 65.8 41.0 55.5 56.7 36.2 16.5 20.4 42.8 40.9 22.7 78.5 31.2 24.9 23.9 91.6 38.3 59.9 0.0 20.6 29.6 30.9 43.3 57.7 21.2 25.2 25.4 40.1 33.7 24.5 18.9 34.5 34.1 25.3 34.3 24.6 32.1 24.1 42.1 32.5 21.6 45.5 38.8 31.1 88.3 31.3 67.0 66.1 52.2 22.8 57.6 CWH43 "CWH43-C, FLJ21511" ENSG00000109182 "Cell wall biogenesis 43 C-terminal homolog" Q9H720 4 48986247-49062081 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 26.1;seminal vesicle: 22.9" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 22.7;Collecting duct cells: 7.0;Glandular cells: 8.2;Paneth cells: 11.5;Suprabasal keratinocytes: 8.0;Undifferentiated cells: 8.9" "Cancer enhanced" "Detected in many" "prostate cancer: 20.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;NB-4: 1.4;SH-SY5Y: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA042814, HPA048140" Uncertain NA NA "HPA042814: AB_2678182, HPA048140: AB_2680280" "unprognostic (9.38e-3)" "unprognostic (6.23e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.32e-4)" "unprognostic (2.14e-1)" "unprognostic (5.00e-2)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-1)" "unprognostic (2.49e-4)" "unprognostic (1.24e-1)" "prognostic favorable (2.29e-11)" "unprognostic (5.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.82e-2)" "unprognostic (2.51e-2)" 0.1 0.0 0.1 9.3 0.1 0.0 1.0 0.1 0.2 5.1 9.7 0.2 11.1 0.0 2.0 2.2 19.8 8.6 0.4 0.1 0.1 0.1 7.6 1.1 0.8 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 26.1 9.1 0.4 2.7 22.9 0.1 16.9 0.1 1.9 0.1 0.1 5.2 0.7 0.1 0.3 10.6 12.6 3.6 3.7 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 1.6 0.0 0.3 0.0 22.7 2.3 7.0 0.0 0.0 1.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 11.5 0.0 3.4 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 8.9 0.3 CX3CR1 "CCRL1, CMKBRL1, CMKDR1, GPR13, V28" ENSG00000168329 "C-X3-C motif chemokine receptor 1" P49238 3 39263494-39281735 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 69.2;brain: 51.6" "Cell type enhanced" "Detected in some" 17 "Kupffer cells: 14.4;Macrophages: 26.4;Sertoli cells: 6.5;T-cells: 15.2" "Cancer enhanced" "Detected in many" "glioma: 21.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 69.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 20 "RPMI-8226: 114.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032478, HPA046587" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "CAB032478: AB_638830, HPA046587: AB_2679708" "unprognostic (2.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.65e-1)" "unprognostic (2.42e-2)" "unprognostic (6.52e-2)" "unprognostic (3.01e-3)" "unprognostic (2.64e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.57e-3)" "unprognostic (1.13e-2)" "unprognostic (1.04e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (8.59e-2)" "unprognostic (7.71e-3)" "unprognostic (1.12e-1)" 2.3 3.8 14.9 6.0 17.3 0.9 4.8 2.5 34.1 2.7 1.2 51.6 0.0 1.2 2.7 4.2 1.4 5.9 2.5 2.2 12.4 11.9 2.5 1.9 9.0 1.8 21.8 7.4 1.8 1.8 5.2 2.5 4.3 21.8 3.7 1.2 3.5 6.4 7.0 5.2 2.4 1.2 3.3 33.5 10.3 1.5 1.8 16.3 0.8 2.4 0.7 4.7 2.8 1.3 0.1 15.7 3.5 69.2 6.5 46.5 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.6 0.0 1.2 15.9 0.2 46.5 43.3 0.5 0.1 10.4 25.2 15.7 0.1 3.7 22.7 3.5 6.5 69.2 1.1 0.2 29.8 14.9 17.3 2.5 19.9 12.4 11.9 21.8 7.4 21.8 16.3 0.0 0.3 0.0 0.0 0.5 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.7 0.0 3.5 0.0 0.0 0.6 14.4 0.0 0.3 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.5 0.0 0.7 0.2 0.5 0.0 15.2 0.0 0.0 CXADR CAR ENSG00000154639 "CXADR, Ig-like cell adhesion molecule" P78310 21 17512382-17593579 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 287.2;Suprabasal keratinocytes: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;Hep G2: 20.8;NTERA-2: 37.3;RT4: 36.0" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 11000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 4.0 3.1 6.4 3.2 9.4 1.3 5.8 2.0 15.4 6.3 27.1 12.5 9.0 24.9 3.3 9.3 15.0 6.5 17.2 10.8 7.9 5.5 5.1 28.6 9.9 4.2 9.2 5.6 1.1 12.0 5.2 11.1 0.3 11.6 9.2 15.4 3.7 16.3 15.8 0.6 30.0 41.4 2.1 13.0 1.4 17.6 8.5 6.9 0.9 13.1 4.9 3.8 14.7 10.0 0.8 0.4 2.6 0.5 0.9 2.7 0.9 5.6 3.1 15.4 0.0 0.0 0.0 9.3 0.0 0.0 0.2 0.9 32.2 4.9 2.0 6.9 0.0 4.6 9.8 7.8 2.0 0.3 3.1 6.6 0.0 9.2 20.8 1.0 0.6 0.0 0.0 8.5 0.4 0.1 3.7 3.0 1.9 0.1 0.1 0.0 0.3 1.2 0.0 37.3 5.0 0.0 0.0 5.2 4.0 12.9 36.0 6.2 4.2 3.6 4.1 2.1 16.5 8.6 0.1 0.1 0.0 9.3 0.1 2.2 1.5 2.5 0.1 1.2 0.0 0.2 2.6 0.5 0.4 0.5 0.2 1.0 0.3 2.6 0.6 0.1 0.8 2.7 0.8 1.4 0.9 0.2 0.4 0.5 0.9 6.4 9.4 2.0 15.4 7.9 5.5 9.2 5.6 11.6 6.9 131.0 63.6 1.5 156.7 287.2 15.2 27.4 137.6 50.9 55.7 97.7 25.5 1.0 5.0 109.2 4.3 2.0 199.0 0.0 81.3 0.2 6.8 133.1 5.7 114.1 0.6 0.0 77.6 70.6 23.6 4.0 2.0 5.3 21.9 1.0 96.0 11.6 81.7 112.0 0.0 4.4 10.0 6.5 3.8 4.2 22.3 300.5 0.6 3.8 81.0 165.3 CXCL1 "FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1" ENSG00000163739 "C-X-C motif chemokine ligand 1" P09341 4 73869393-73871242 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Inflammatory response" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 124.8" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 990.8;Club cells: 598.3;Ductal cells: 654.4;Glandular cells: 1080.1;Intestinal endocrine cells: 612.7;Urothelial cells: 1138.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 253 "neutrophil: 25.3" "Lineage enriched" "Detected in single" 253 "granulocytes: 25.3" "Group enriched" "Detected in some" 6 "BJ hTERT+: 80.8;EFO-21: 206.4;RPTEC TERT1: 74.5" "Secreted to blood" NA NA 384000 "prognostic favorable (7.83e-4)" "prognostic unfavorable (7.23e-4)" "unprognostic (5.24e-3)" "unprognostic (1.27e-1)" "unprognostic (1.33e-2)" "unprognostic (4.23e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (5.45e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.17e-1)" "unprognostic (5.30e-2)" "unprognostic (7.41e-2)" "unprognostic (9.41e-2)" 12.0 0.8 1.3 22.5 2.2 14.8 4.1 0.8 1.4 49.2 7.7 1.0 0.7 4.3 0.9 2.1 27.8 6.1 11.2 12.1 1.7 1.3 8.9 4.2 23.0 10.9 3.1 1.0 3.8 13.0 0.0 0.7 26.1 3.9 8.7 7.1 2.1 8.1 4.1 3.2 0.8 10.8 1.2 3.8 124.8 3.1 2.1 1.7 1.7 0.7 7.9 22.6 29.9 6.6 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 1.3 0.0 2.2 80.8 1.9 2.0 0.0 1.4 0.0 206.4 0.1 7.9 4.1 0.0 0.3 10.5 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.0 0.1 14.5 1.1 0.1 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 74.5 1.7 0.0 0.0 0.1 0.0 4.0 0.2 0.0 0.1 18.6 0.0 0.7 4.0 0.1 0.0 0.1 0.3 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 1.3 2.2 0.8 1.4 1.7 1.3 3.1 1.0 3.9 1.7 41.7 227.2 0.5 990.8 112.5 0.0 3.2 298.1 463.1 598.3 5.2 0.0 0.2 0.0 654.4 0.0 47.2 8.0 0.0 37.1 0.6 117.2 1080.1 15.1 1.3 22.0 0.0 612.7 4.3 11.7 0.0 0.0 126.7 118.1 99.2 4.2 0.0 202.8 8.2 0.0 0.8 0.0 0.0 77.8 0.2 0.1 92.0 0.3 6.9 15.1 1138.8 CXCL10 "C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10" ENSG00000169245 "C-X-C motif chemokine ligand 10" P02778 4 76021117-76023497 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9" "Lineage enriched" "Detected in many" 15 "monocytes: 25.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 253000 "unprognostic (1.94e-1)" "unprognostic (5.32e-2)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-1)" "unprognostic (7.59e-2)" "prognostic favorable (1.12e-5)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.75e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.03e-1)" "unprognostic (4.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.66e-2)" 4.3 2.1 2.7 34.8 2.5 0.0 7.3 1.8 4.8 8.1 3.5 0.9 0.2 3.8 2.3 6.7 4.7 1.2 3.8 7.6 1.2 1.2 7.5 10.6 36.2 21.7 3.2 1.6 3.9 1.2 0.0 2.3 5.6 3.0 34.6 6.0 2.6 9.1 2.1 7.3 2.1 4.1 5.5 11.3 15.8 6.4 1.3 0.9 15.0 25.7 5.4 9.2 9.2 2.2 0.5 1.6 0.6 25.5 0.0 0.1 3.7 0.7 0.0 0.0 0.3 0.0 0.2 0.0 0.0 9.2 3.4 3.4 0.3 0.1 3.0 0.3 0.0 7.9 0.0 0.0 0.2 0.2 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 6.3 0.1 3.6 0.0 0.0 0.0 0.7 2.0 0.0 0.2 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.8 0.0 0.0 10.6 0.0 0.0 25.5 0.0 0.5 0.1 0.0 1.6 0.0 0.0 0.0 0.6 0.0 15.9 0.0 0.0 3.7 2.7 2.5 1.8 4.8 1.2 1.2 3.2 1.6 3.0 0.9 0.0 2.1 0.5 9.7 0.8 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 1.1 0.0 0.0 0.0 0.8 10.1 1.1 0.0 18.2 0.0 0.0 0.0 5.6 3.5 0.3 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 CXCL11 "b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B" ENSG00000169248 "C-X-C motif chemokine ligand 11" O14625 4 76033682-76041415 "Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 20.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 3.0;Basal glandular cells: 2.5;Cholangiocytes: 2.5;Exocrine glandular cells: 3.0;Kupffer cells: 4.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+: 8.3;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;GAMG: 2.3" "Not detected" "Not detected" CAB009921 Uncertain "Secreted to blood" NA NA 187000 "CAB009921: AB_2088137" "unprognostic (2.00e-1)" "unprognostic (3.62e-1)" "unprognostic (6.94e-3)" "unprognostic (1.87e-2)" "unprognostic (9.95e-2)" "unprognostic (5.85e-2)" "unprognostic (1.89e-1)" "unprognostic (1.04e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.31e-7)" "prognostic unfavorable (8.18e-5)" "unprognostic (2.90e-1)" "prognostic unfavorable (3.29e-6)" "unprognostic (1.53e-1)" "unprognostic (4.17e-2)" "unprognostic (4.48e-2)" "unprognostic (5.32e-2)" 3.6 0.3 3.8 10.5 3.1 0.0 3.4 1.3 2.0 3.3 1.4 0.6 0.1 0.6 1.3 2.0 2.3 1.4 2.0 3.3 2.2 2.8 2.5 2.1 13.7 10.0 3.1 1.5 1.3 8.9 0.0 0.7 3.5 2.8 8.5 4.5 0.3 2.9 1.1 6.4 0.6 1.0 1.4 9.8 7.0 5.6 0.6 1.5 4.3 20.1 3.6 1.4 3.2 0.7 0.0 0.9 0.0 2.1 0.0 0.1 0.6 1.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 5.3 8.3 8.8 0.0 0.2 1.0 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 3.8 3.1 1.3 2.0 2.2 2.8 3.1 1.5 2.8 1.5 3.0 0.0 0.0 2.5 0.1 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 3.0 0.0 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.6 4.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 CXCL13 "ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13" ENSG00000156234 "C-X-C motif chemokine ligand 13" O43927 4 77511753-77611834 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 82.5" "Cell type enriched" "Detected in some" 6 "monocytes: 67.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Lineage enhanced" "Detected in single" "T-cells: 1.0" "Cell line enhanced" "Detected in some" "HL-60: 1.4;RH-30: 1.2;U-266/70: 5.4" HPA052613 Uncertain "Secreted to blood" NA NA 93700 "HPA052613: AB_2681885" "unprognostic (5.25e-3)" "unprognostic (1.19e-2)" "prognostic favorable (9.12e-4)" "prognostic favorable (5.52e-4)" "unprognostic (1.53e-2)" "unprognostic (1.17e-3)" "unprognostic (1.49e-1)" "unprognostic (6.41e-3)" "unprognostic (9.82e-3)" "prognostic favorable (5.41e-4)" "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.16e-10)" "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (6.68e-3)" 0.2 0.1 0.0 15.3 0.2 0.0 1.5 0.3 0.0 0.1 1.1 0.0 0.8 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.3 4.3 0.2 65.1 0.0 0.2 0.0 0.0 0.8 0.0 3.8 1.8 0.8 0.0 0.0 0.1 15.5 0.0 0.0 82.5 3.7 0.3 0.5 57.5 6.2 0.2 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 5.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 10.4 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 2.8 1.1 8.6 10.5 0.0 0.0 0.6 2.2 0.0 0.0 0.0 0.0 67.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 2.8 CXCL14 "BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14" ENSG00000145824 "C-X-C motif chemokine ligand 14" O95715 5 135570679-135579279 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 140.1" "Group enriched" "Detected in many" 6 "Basal keratinocytes: 3051.6;Fibroblasts: 4090.0;Proximal tubular cells: 2046.8;Suprabasal keratinocytes: 1848.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.2" "Group enriched" "Detected in many" 6 "dendritic cells: 3.2;granulocytes: 1.1" "Group enriched" "Detected in some" 12 "HAP1: 17.2;hTCEpi: 22.8;RPTEC TERT1: 61.9;SuSa: 34.3;U-2 OS: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB029996 Uncertain "Secreted to blood" NA NA 800000 "CAB029996: AB_2086070" "unprognostic (1.82e-3)" "prognostic favorable (1.71e-4)" "prognostic favorable (4.52e-4)" "unprognostic (2.75e-2)" "unprognostic (2.71e-3)" "unprognostic (2.94e-2)" "unprognostic (1.33e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" "unprognostic (5.34e-2)" "unprognostic (1.26e-1)" "unprognostic (9.89e-2)" "unprognostic (2.09e-1)" "unprognostic (3.48e-1)" "unprognostic (1.85e-1)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" 59.5 0.9 19.4 25.8 14.9 0.2 44.1 0.6 20.7 40.7 30.0 1.5 4.5 38.8 6.8 26.1 16.7 5.2 3.8 11.2 10.8 4.6 79.2 10.3 1.7 13.9 6.3 9.3 2.1 2.8 0.3 25.4 30.5 7.6 7.0 34.3 14.3 44.2 3.7 17.2 140.1 59.2 8.6 1.0 15.1 18.7 5.1 2.4 1.5 10.0 30.2 22.9 12.7 17.0 0.2 3.2 1.1 0.3 0.3 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 2.6 0.0 0.8 0.0 1.1 0.0 17.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 61.9 0.0 0.3 0.2 0.1 0.0 0.0 34.3 0.0 0.0 0.0 0.0 25.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.9 0.3 0.2 0.2 0.1 0.3 0.1 0.2 0.1 3.2 0.2 0.3 0.2 1.1 0.3 0.2 0.2 0.2 0.1 19.4 14.9 0.6 20.7 10.8 4.6 6.3 9.3 7.6 2.4 0.0 0.6 0.9 12.3 3051.6 249.2 2.0 0.0 0.0 0.0 268.7 0.0 28.7 477.5 0.0 0.6 4.8 0.0 0.0 0.0 24.5 4090.0 8.5 0.0 0.0 56.4 6.4 0.0 74.3 0.0 1.1 19.2 3.2 416.7 0.0 0.0 3.7 0.1 0.0 0.4 2046.8 14.0 0.0 20.0 0.5 4.1 1848.7 64.5 0.0 0.0 8.1 CXCL17 "Dcip1, DMC, UNQ473, VCC1" ENSG00000189377 "C-X-C motif chemokine ligand 17" Q6UXB2 19 42428288-42443048 "Predicted secreted proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 68.0;lung: 83.0;stomach 1: 79.9" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 380.6;Ciliated cells: 365.4;Club cells: 424.2;Pancreatic endocrine cells: 272.5;Urothelial cells: 1358.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Group enriched" "Detected in some" 7 "OE19: 13.0;RT4: 3.9" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.74e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.03e-2)" "unprognostic (4.46e-3)" "unprognostic (3.77e-1)" "prognostic favorable (4.92e-5)" "unprognostic (6.68e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.70e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-1)" "unprognostic (1.88e-1)" "unprognostic (8.13e-3)" "unprognostic (2.29e-1)" 0.1 0.0 0.1 0.2 0.2 0.0 0.7 0.1 0.1 17.4 0.1 0.4 0.1 0.0 1.0 5.1 68.0 6.3 1.3 0.1 0.1 0.0 0.7 0.4 83.0 0.1 0.1 0.1 2.8 11.4 0.0 2.3 0.1 0.3 6.8 0.0 0.3 39.2 0.5 0.1 0.0 0.1 0.3 0.1 0.1 79.9 0.3 0.1 0.5 1.2 8.8 40.1 5.5 10.0 0.0 0.0 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.3 13.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 32.8 380.6 0.0 160.7 0.0 0.2 0.0 2.5 365.4 424.2 5.2 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 159.6 0.0 0.0 167.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.6 0.0 0.0 272.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1358.9 CXCL2 "CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2" ENSG00000081041 "C-X-C motif chemokine ligand 2" P19875 4 74097035-74099293 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 113.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 1610.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.0;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 25 "granulocytes: 1.4;monocytes: 3.5" "Cell line enriched" "Detected in some" 8 "GAMG: 95.1" "Secreted to blood" NA NA "prognostic favorable (5.93e-5)" "prognostic unfavorable (1.41e-4)" "unprognostic (5.28e-3)" "unprognostic (1.36e-1)" "unprognostic (2.64e-3)" "unprognostic (1.27e-1)" "unprognostic (7.14e-3)" "unprognostic (3.00e-1)" "unprognostic (1.72e-1)" "unprognostic (1.49e-1)" "unprognostic (6.72e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.07e-6)" "unprognostic (1.05e-2)" "unprognostic (2.33e-1)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" 22.8 3.8 2.4 19.9 4.3 20.7 10.9 0.8 1.7 20.4 5.7 2.3 0.9 0.9 4.4 3.8 6.2 5.8 15.2 14.2 1.7 2.0 3.2 113.1 22.4 35.0 2.8 0.5 5.8 24.9 0.6 2.3 1.4 4.3 5.1 6.4 5.1 4.8 3.6 30.9 1.3 3.8 4.1 4.6 3.7 7.5 3.1 1.6 0.0 2.1 18.5 1.8 11.7 4.1 0.0 0.0 1.4 3.5 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.2 0.9 0.0 0.9 11.3 0.4 1.3 0.0 1.7 0.0 1.5 0.0 95.1 0.0 0.0 2.4 1.8 0.0 0.0 0.7 0.9 0.0 7.9 0.3 0.0 0.9 8.3 6.0 8.1 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 1.0 0.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.5 0.4 0.1 1.7 0.8 0.0 0.0 0.0 6.9 1.8 0.0 1.4 0.6 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.5 0.0 0.0 0.1 2.4 4.3 0.8 1.7 1.7 2.0 2.8 0.5 4.3 1.6 443.7 1610.2 15.2 162.7 369.1 0.0 20.4 257.4 125.8 325.3 8.7 0.0 1.9 0.0 632.5 1.0 297.5 87.8 0.0 520.6 3.2 166.5 200.8 79.0 270.4 117.3 0.0 126.9 134.4 220.1 0.6 14.7 392.1 263.2 87.4 36.2 0.5 376.8 15.8 0.0 0.5 0.0 71.1 657.8 1.2 3.4 199.1 1.8 7.9 38.9 91.4 CXCL3 "CINC-2b, GRO3, GROg, MIP-2b, SCYB3" ENSG00000163734 "C-X-C motif chemokine ligand 3" P19876 4 74036589-74038807 "Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 28.5" "Cell type enhanced" "Detected in many" 12 "Macrophages: 757.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 23.2;hTEC/SVTERT24-B: 36.5;RPTEC TERT1: 21.0" "Secreted to blood" NA NA 28700 "unprognostic (2.12e-3)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.08e-3)" "unprognostic (6.97e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-1)" "unprognostic (5.80e-4)" "unprognostic (2.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.81e-1)" "unprognostic (2.89e-6)" "unprognostic (2.61e-3)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (1.20e-1)" 18.8 0.6 1.7 16.5 1.2 10.3 4.3 0.2 1.2 19.6 3.3 1.0 0.4 0.5 0.7 2.2 1.3 1.7 9.2 7.2 1.3 0.8 1.7 3.2 28.5 1.8 2.0 1.0 4.9 3.1 0.0 0.6 1.5 3.0 2.3 7.9 0.8 4.4 0.9 2.3 0.6 2.8 1.2 2.2 5.3 10.3 1.6 0.6 2.7 0.8 2.7 1.9 11.7 0.5 0.0 0.5 0.4 1.0 0.0 0.4 2.4 0.2 1.7 0.7 0.0 0.4 0.7 0.0 2.5 23.2 0.6 1.4 0.0 2.8 0.0 2.5 0.0 8.6 0.1 0.1 0.8 5.1 0.0 0.0 1.9 0.2 0.0 2.8 0.2 0.0 0.5 0.6 36.5 3.6 0.6 0.5 0.4 0.4 0.0 1.0 0.0 0.5 0.1 0.3 3.3 0.7 0.0 0.8 0.0 21.0 0.6 0.0 0.0 0.2 0.0 0.5 0.3 0.1 0.0 0.9 5.2 0.2 2.6 6.4 0.0 0.0 0.0 5.8 0.1 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.0 0.5 0.0 2.4 1.7 1.2 0.2 1.2 1.3 0.8 2.0 1.0 3.0 0.6 92.3 203.1 5.1 105.8 203.0 0.0 6.1 33.1 87.0 40.9 5.2 0.0 0.5 0.0 138.2 0.4 32.1 49.7 0.0 85.9 1.0 32.9 154.6 26.5 1.1 74.4 0.0 50.8 10.4 119.3 0.9 13.0 757.6 178.8 48.7 41.4 0.0 148.4 28.8 0.4 0.0 0.0 38.8 169.7 0.7 3.1 129.9 6.8 2.5 59.8 50.3 CXCL5 "ENA-78, SCYB5" ENSG00000163735 "C-X-C motif chemokine ligand 5" P42830 4 73995642-73998779 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2" "Group enriched" "Detected in some" 8 "Ductal cells: 71.4;Pancreatic endocrine cells: 163.7" "Cancer enhanced" "Detected in many" "stomach cancer: 74.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "A549: 34.5;EFO-21: 29.1;HSkMC: 20.9;hTEC/SVTERT24-B: 15.0;RPTEC TERT1: 111.3" HPA065474 Approved "Secreted to blood" NA NA 1110000 "HPA065474: AB_2685494" "unprognostic (5.56e-3)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.80e-2)" "unprognostic (1.43e-2)" "unprognostic (2.04e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.06e-2)" "unprognostic (3.04e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (7.99e-2)" "prognostic unfavorable (2.45e-5)" "unprognostic (3.72e-1)" "unprognostic (3.07e-1)" "unprognostic (2.72e-2)" "unprognostic (9.30e-2)" 1.7 0.3 1.6 28.0 6.0 0.7 2.4 0.4 1.4 10.5 0.7 1.5 0.2 0.6 0.3 0.0 0.6 0.4 3.9 1.4 4.3 2.8 0.4 2.1 20.0 13.6 1.2 0.1 0.3 0.8 0.0 0.3 1.5 7.4 1.5 0.2 0.0 31.2 0.5 0.3 0.3 1.8 0.1 2.6 5.2 6.4 5.4 0.2 1.0 0.3 10.8 0.8 10.9 0.3 0.0 0.0 1.1 0.1 0.0 0.2 5.5 0.0 34.5 0.1 0.0 0.0 1.3 0.0 0.6 0.5 0.2 0.5 0.1 0.3 0.0 29.1 0.0 6.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 20.9 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 5.5 1.6 6.0 0.4 1.0 4.3 2.8 1.2 0.1 7.4 0.2 3.0 0.0 0.0 0.8 0.8 0.0 1.3 15.3 1.4 3.4 0.0 0.0 0.0 0.0 71.4 0.2 0.7 0.0 0.0 1.2 0.0 0.5 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 9.3 0.0 2.8 0.0 0.0 163.7 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 0.0 0.0 0.0 0.3 CXCL6 "CKA-3, GCP-2, SCYB6" ENSG00000124875 "C-X-C motif chemokine ligand 6" P80162 4 73836497-73849064 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 59.6" "Cell type enhanced" "Detected in some" 13 "Cholangiocytes: 280.2;Ductal cells: 403.7;Glandular cells: 173.8;Urothelial cells: 356.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 107 "neutrophil: 10.7" "Lineage enriched" "Detected in single" 107 "granulocytes: 10.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 17.2;EFO-21: 41.4;HUVEC TERT2: 27.0;RPTEC TERT1: 32.1" "Secreted to blood" NA NA 108000 "unprognostic (4.35e-4)" "unprognostic (4.47e-2)" "unprognostic (6.09e-2)" "unprognostic (4.60e-2)" "unprognostic (1.98e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-3)" "unprognostic (2.62e-1)" "unprognostic (2.05e-1)" "unprognostic (2.02e-2)" "unprognostic (3.75e-2)" "unprognostic (9.02e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.47e-1)" "unprognostic (4.88e-1)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" 3.5 0.1 0.1 5.7 0.2 0.5 0.3 0.1 0.2 7.4 3.7 0.0 1.7 3.1 0.1 0.9 1.6 1.7 16.3 2.7 0.5 0.1 4.4 4.6 8.9 0.9 0.3 0.3 0.7 9.4 0.0 0.2 0.0 1.3 3.5 0.1 0.3 2.4 4.7 0.1 0.1 5.2 0.0 0.5 59.6 0.3 1.4 0.0 1.4 0.1 0.6 2.2 13.7 3.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 5.5 0.0 0.9 17.2 0.1 0.2 0.0 0.0 0.0 41.4 0.0 1.3 3.4 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.1 8.7 0.0 0.1 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 32.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.3 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.5 0.1 0.3 0.3 1.3 0.0 3.0 1.3 0.0 76.4 0.3 0.0 0.2 280.2 68.3 72.8 0.0 0.0 0.0 0.0 403.7 0.0 0.0 0.0 0.0 3.2 0.0 2.3 173.8 0.0 0.0 0.2 0.0 75.3 0.0 0.8 0.0 0.0 1.1 0.0 13.6 0.0 0.0 55.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 356.0 CXCL8 "3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1" ENSG00000169429 "C-X-C motif chemokine ligand 8" P10145 4 73740506-73743716 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 79.4;bone marrow: 300.7;lung: 106.1" "Group enriched" "Detected in many" 4 "Basal glandular cells: 9866.5;Glandular cells: 5032.8;Urothelial cells: 12569.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 428 "neutrophil: 79.4" "Lineage enriched" "Detected in single" 794 "granulocytes: 79.4" "Group enriched" "Detected in many" 4 "BJ hTERT+: 291.3;GAMG: 80.6" "Not detected" "Not detected" HPA057179 Supported "Secreted to blood" NA NA 7260 "HPA057179: AB_2683362" "unprognostic (3.42e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (3.91e-3)" "unprognostic (8.49e-2)" "unprognostic (3.29e-2)" "unprognostic (3.03e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.37e-3)" "unprognostic (3.19e-1)" "unprognostic (4.46e-1)" "unprognostic (7.19e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.13e-6)" "unprognostic (4.73e-2)" "unprognostic (8.57e-2)" "unprognostic (1.64e-2)" "unprognostic (6.15e-2)" 13.4 1.6 1.8 21.9 1.9 300.7 1.7 0.4 1.5 6.5 1.4 0.8 0.0 0.5 4.5 0.9 6.7 3.9 18.9 17.7 1.3 1.1 2.4 8.4 106.1 2.3 2.4 0.9 4.4 4.3 0.3 1.1 9.6 7.8 4.3 1.0 1.9 7.4 0.3 2.9 0.5 1.6 1.4 5.5 1.6 2.8 13.5 1.1 1.0 1.1 9.3 7.7 27.9 1.5 0.0 0.0 79.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.4 0.0 1.8 291.3 2.6 8.6 0.0 0.9 0.0 39.9 0.0 80.6 3.4 0.0 0.0 41.6 0.1 0.0 0.0 0.0 0.4 0.5 2.6 0.1 0.9 0.1 8.7 0.2 0.9 9.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.0 1.4 0.0 0.0 0.0 23.1 1.2 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.3 22.4 4.2 0.3 1.1 3.8 0.0 0.0 0.1 18.8 2.1 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 0.0 0.0 0.0 0.0 0.0 1.8 1.9 0.4 1.5 1.3 1.1 2.4 0.9 7.8 1.1 47.6 287.8 4.2 9866.5 0.0 0.2 22.2 150.3 327.9 783.7 0.0 0.0 3.4 0.0 1020.3 1.4 16.9 1.6 0.0 220.3 4.9 10.8 5032.8 48.7 2.5 332.1 0.0 18.3 23.9 507.0 0.5 0.6 391.0 0.0 2049.7 1.0 0.4 645.9 0.0 0.4 0.4 1.1 38.8 17.7 0.0 1.2 0.0 17.8 4.3 1.6 12569.9 CXCL9 "CMK, crg-10, Humig, MIG, SCYB9" ENSG00000138755 "C-X-C motif chemokine ligand 9" Q07325 4 76001275-76007488 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 70.6;thyroid gland: 28.6" "Cell type enhanced" "Detected in some" 15 "Hofbauer cells: 6.6;Kupffer cells: 11.9;Macrophages: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.2;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 27 "monocytes: 2.6" "Cell line enriched" "Detected in single" 8 "RPMI-8226: 4.9" "Region enhanced" "Detected in single" "olfactory region: 0.6" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 902000 "prognostic favorable (6.36e-4)" "unprognostic (6.86e-3)" "unprognostic (1.25e-2)" "prognostic favorable (2.07e-4)" "unprognostic (2.97e-1)" "unprognostic (3.78e-3)" "unprognostic (8.79e-2)" "unprognostic (4.93e-2)" "unprognostic (1.46e-2)" "prognostic favorable (8.06e-4)" "unprognostic (2.18e-3)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.15e-6)" "unprognostic (4.76e-2)" "unprognostic (4.14e-2)" "unprognostic (1.57e-2)" "unprognostic (6.54e-2)" 6.3 0.4 0.5 30.8 0.8 0.0 4.4 0.4 0.4 6.0 2.4 0.4 1.0 0.5 1.1 3.6 2.5 0.5 2.1 5.3 0.5 0.4 9.9 5.9 16.4 70.6 0.3 0.5 4.5 1.0 0.0 1.5 2.1 1.3 5.0 7.3 2.9 4.9 0.6 7.0 2.2 6.6 3.4 2.6 18.6 4.1 1.9 0.4 17.3 28.6 3.5 15.7 4.3 1.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.5 0.8 0.4 0.4 0.5 0.4 0.3 0.5 1.3 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.8 6.6 0.0 0.0 0.0 11.9 1.4 0.6 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 2.7 0.3 0.1 0.0 0.0 0.1 CXCR1 "CD181, CDw128a, CKR-1, CMKAR1, IL8RA" ENSG00000163464 "C-X-C motif chemokine receptor 1" P25024 2 218162845-218166995 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 144.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 9.0;granulocytes: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 16 "neutrophil: 144.6" "Lineage enriched" "Detected in many" 59 "granulocytes: 144.6" "Cell line enriched" "Detected in single" 26 "HMC-1: 11.6" "Not detected" "Not detected" HPA031991 Uncertain NA NA "HPA031991: AB_2674103" "unprognostic (2.80e-1)" "unprognostic (2.91e-2)" "unprognostic (3.53e-2)" "unprognostic (5.74e-2)" "unprognostic (1.19e-1)" "unprognostic (1.68e-1)" "unprognostic (2.14e-2)" "unprognostic (3.36e-2)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (8.27e-2)" "unprognostic (2.15e-2)" "unprognostic (2.88e-1)" "unprognostic (5.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-1)" "unprognostic (8.85e-2)" 11.5 0.4 0.8 21.1 0.7 7.3 0.6 0.9 2.6 0.6 0.6 0.2 0.0 0.0 0.5 0.1 1.3 2.8 3.6 3.8 0.9 0.6 0.7 2.9 20.3 33.4 5.9 0.0 1.7 1.2 0.0 0.8 2.1 2.3 0.9 0.1 1.4 0.6 0.0 1.0 0.5 0.6 1.4 3.4 33.7 1.0 1.4 0.7 0.1 0.9 0.6 0.4 4.5 4.1 0.0 0.0 144.6 0.2 0.1 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.2 2.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.9 144.6 0.1 0.2 0.0 0.0 0.7 0.8 0.7 0.9 2.6 0.9 0.6 5.9 0.0 2.3 0.7 0.0 9.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 CXCR2 "CD182, CMKAR2, IL8RB" ENSG00000180871 "C-X-C motif chemokine receptor 2" P25025 2 218125289-218137253 "Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 216.1" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 17.5;Club cells: 3.4;granulocytes: 5.8;Kupffer cells: 5.0;Macrophages: 4.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 59 "neutrophil: 216.1" "Lineage enriched" "Detected in many" 109 "granulocytes: 216.1" "Group enriched" "Detected in some" 11 "BEWO: 12.4;HL-60: 6.9;HMC-1: 14.4;THP-1: 13.1;U-937: 12.9" "Low region specificity" "Detected in single" "CAB016268, HPA031999, HPA032017" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle" NA NA "Plasma membrane" "Nucleoplasm, Microtubules, Mitotic spindle" "CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112" "unprognostic (4.89e-2)" "unprognostic (2.01e-1)" "unprognostic (5.63e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (3.13e-1)" "unprognostic (1.33e-1)" "unprognostic (2.13e-1)" "unprognostic (5.96e-2)" "unprognostic (1.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-1)" "unprognostic (7.54e-2)" "unprognostic (1.04e-1)" "unprognostic (7.23e-2)" "unprognostic (8.18e-2)" "unprognostic (5.48e-2)" 9.3 0.9 1.3 25.6 1.5 4.0 0.6 1.2 1.3 5.2 0.6 0.5 2.5 0.0 0.8 1.1 18.1 3.3 5.2 4.3 1.5 0.6 0.7 4.6 16.7 40.5 6.6 0.0 1.2 1.7 0.0 0.7 4.5 1.7 1.9 0.3 1.8 3.3 2.6 0.6 3.0 0.7 1.4 4.1 30.6 1.0 1.1 0.7 0.6 0.6 4.8 10.1 5.4 6.4 0.0 1.6 216.1 1.9 0.4 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 14.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.1 0.2 0.0 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 13.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 0.0 3.6 1.9 3.2 1.9 0.5 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.7 216.1 0.4 0.2 1.6 0.0 1.0 1.3 1.5 1.2 1.3 1.5 0.6 6.6 0.0 1.7 0.7 0.0 17.5 0.0 0.9 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.2 5.8 0.0 1.6 0.0 0.0 0.0 5.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 1.8 CXCR3 "CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR" ENSG00000186810 "C-X-C motif chemokine receptor 3" P49682 X 71615916-71618517 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Angiogenesis, Apoptosis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 61.7;lymphoid tissue: 24.5" "Cell type enriched" "Detected in some" 4 "T-cells: 31.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 61.7" "Group enriched" "Detected in many" 4 "dendritic cells: 61.7;NK-cells: 38.1;T-cells: 26.6" "Cell line enriched" "Detected in some" 15 "RPMI-8226: 32.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045942 Enhanced NA NA "HPA045942: AB_2679507" "unprognostic (4.84e-3)" "unprognostic (3.05e-3)" "unprognostic (1.61e-1)" "prognostic favorable (3.44e-6)" "unprognostic (3.93e-2)" "prognostic favorable (3.35e-4)" "unprognostic (1.01e-2)" "unprognostic (5.24e-2)" "prognostic favorable (2.90e-4)" "unprognostic (6.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.67e-6)" "unprognostic (4.67e-2)" "unprognostic (2.18e-1)" "unprognostic (2.91e-2)" "unprognostic (5.76e-2)" 0.9 0.9 0.4 9.0 0.4 6.0 0.6 0.3 0.3 1.9 2.4 0.4 0.5 5.4 3.3 1.4 1.3 1.1 2.6 2.4 0.3 0.4 1.9 0.8 4.5 19.0 0.4 0.1 1.6 0.8 0.0 0.6 0.7 0.5 2.9 0.8 1.5 3.9 1.0 0.4 0.5 9.1 0.3 0.7 13.9 2.6 0.6 0.0 14.0 1.9 1.7 24.5 1.7 1.8 9.8 61.7 0.4 0.0 38.1 26.6 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 17.3 0.0 8.9 9.8 19.6 26.6 1.6 1.8 1.2 11.1 0.4 38.1 0.0 61.7 17.8 6.3 0.4 0.4 0.3 0.3 0.3 0.4 0.4 0.1 0.5 0.0 0.0 0.0 7.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.7 1.8 1.1 0.0 0.1 5.8 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 0.1 31.9 1.7 0.0 CXCR4 "CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R" ENSG00000121966 "C-X-C motif chemokine receptor 4" P61073 2 136114349-136118165 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 149.9;lymphoid tissue: 186.3" "Cell type enhanced" "Detected in many" 14 "B-cells: 772.9;Macrophages: 299.5;monocytes: 255.1;T-cells: 588.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 76.4;JURKAT: 43.5;Karpas-707: 41.0;MOLT-4: 69.2;REH: 36.7;U-266/70: 88.9;U-698: 89.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (1.46e-2)" "unprognostic (2.69e-1)" "unprognostic (5.97e-2)" "unprognostic (1.29e-2)" "unprognostic (1.12e-2)" "unprognostic (4.99e-2)" "unprognostic (9.25e-2)" "unprognostic (6.06e-2)" "prognostic favorable (2.05e-4)" "unprognostic (1.23e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.41e-7)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.57e-1)" "unprognostic (3.47e-2)" "unprognostic (9.33e-2)" 15.4 26.5 3.0 39.1 3.4 149.9 9.7 0.8 2.1 7.7 8.7 6.8 1.5 1.6 8.3 3.8 16.4 9.1 12.0 5.4 4.1 4.7 8.2 7.1 29.3 94.5 6.5 1.3 6.3 3.1 0.7 8.1 7.8 6.1 6.8 7.0 10.0 10.6 2.2 3.2 2.3 57.8 3.8 22.9 82.4 8.0 7.2 3.4 186.3 9.2 4.6 97.5 50.0 6.6 47.3 16.8 37.8 7.2 4.0 32.0 11.9 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 76.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.9 4.6 12.1 0.0 0.0 10.5 8.3 0.0 0.0 0.0 0.0 0.0 7.3 43.5 0.1 41.0 0.0 0.2 69.2 9.4 1.2 5.9 0.4 36.7 8.5 13.3 0.6 0.0 4.2 3.5 0.0 0.2 0.0 0.4 0.0 20.7 1.0 0.0 0.2 0.0 0.0 88.9 15.0 89.4 0.0 17.4 0.0 17.9 7.2 29.6 22.9 3.8 18.7 30.1 21.1 21.7 6.6 47.3 32.0 30.1 37.8 4.0 2.1 16.8 18.9 11.9 3.0 3.4 0.8 2.1 4.1 4.7 6.5 1.3 6.1 3.4 14.9 64.2 772.9 4.0 36.5 4.4 3.6 2.5 4.0 6.8 3.5 0.0 1.4 11.6 3.6 0.9 19.0 0.0 46.7 0.8 2.2 30.2 4.8 11.6 5.5 168.4 0.0 1.7 22.7 175.5 1.7 1.4 299.5 108.0 255.1 0.1 1.0 1.6 0.0 2.5 2.1 0.6 45.3 16.3 0.5 5.5 31.1 5.3 588.4 0.4 3.2 CXCR5 "BLR1, CD185, MDR15" ENSG00000160683 "C-X-C motif chemokine receptor 5" P32302 11 118883766-118897799 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "B-cell activation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 35.5;lymphoid tissue: 45.6" "Cell type enriched" "Detected in some" 26 "B-cells: 71.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 4.0" "Group enriched" "Detected in some" 8 "memory B-cell: 24.2;naive B-cell: 35.5" "Lineage enriched" "Detected in many" 9 "B-cells: 35.5" "Group enriched" "Detected in some" 10 "Daudi: 10.6;U-698: 37.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026149, HPA042432" Enhanced NA NA "CAB026149: , HPA042432: AB_2677995" "unprognostic (8.51e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-1)" "unprognostic (4.02e-5)" "unprognostic (2.08e-2)" "unprognostic (3.23e-3)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-5)" "unprognostic (4.21e-1)" "unprognostic (2.03e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" 0.4 0.8 0.6 31.8 0.6 7.3 0.1 4.0 0.9 0.1 3.6 0.2 0.1 0.1 0.2 0.1 2.6 0.0 0.5 0.9 0.7 0.5 0.8 1.0 0.9 31.5 0.3 0.1 0.3 0.5 0.0 0.9 0.1 0.2 2.9 0.3 0.3 3.6 0.1 1.3 0.9 8.6 0.1 0.3 45.6 1.3 0.1 0.1 1.9 0.7 1.3 41.8 3.9 0.9 35.5 0.0 0.0 0.0 0.0 3.9 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 10.6 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.5 0.4 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.1 0.1 0.5 0.0 0.2 0.5 0.0 0.0 0.2 0.0 37.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.3 24.2 3.9 1.0 0.0 35.5 0.4 0.3 0.0 0.0 0.0 0.0 0.5 1.9 0.6 0.6 4.0 0.9 0.7 0.5 0.3 0.1 0.2 0.1 0.0 2.6 71.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.5 0.0 0.0 CXCR6 "BONZO, CD186, STRL33, TYMSTR" ENSG00000172215 "C-X-C motif chemokine receptor 6" O00574 3 45940933-45948353 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.3" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 66.4;T-cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 4 "MAIT T-cell: 81.3" "Lineage enriched" "Detected in many" 6 "T-cells: 81.3" "Cell line enhanced" "Detected in some" "BEWO: 4.1;CAPAN-2: 15.7;JURKAT: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-3)" "prognostic favorable (4.92e-4)" "unprognostic (1.77e-3)" "prognostic favorable (6.74e-6)" "unprognostic (6.67e-2)" "prognostic favorable (2.16e-4)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.93e-2)" "unprognostic (3.65e-4)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (3.46e-2)" "unprognostic (1.57e-2)" 2.5 1.1 0.5 7.6 0.5 0.5 2.1 0.4 0.5 2.3 9.9 1.1 1.5 3.0 2.7 3.2 3.0 2.4 5.2 1.7 0.6 0.6 2.5 2.5 9.2 10.4 0.6 0.2 3.7 1.6 0.0 0.9 18.9 1.0 2.6 2.6 3.0 3.3 0.2 7.7 1.1 10.8 1.0 1.3 22.3 6.0 2.3 0.2 5.2 4.1 5.3 14.6 5.2 2.6 0.0 0.1 0.1 0.0 13.4 81.3 3.8 0.3 0.1 0.0 0.3 0.0 0.0 4.1 0.2 0.0 0.0 0.0 1.1 15.7 0.3 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.2 0.5 0.0 0.2 0.8 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.3 0.9 0.0 2.1 0.2 0.8 0.4 1.5 0.7 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.0 17.3 0.0 81.3 0.0 4.9 20.3 0.0 0.0 0.2 3.1 0.1 13.4 0.0 0.1 14.5 3.8 0.5 0.5 0.4 0.5 0.6 0.6 0.6 0.2 1.0 0.2 0.0 0.0 0.0 0.0 0.9 0.7 0.7 0.0 0.0 0.0 0.0 2.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.5 0.1 1.1 0.8 0.7 0.0 0.0 1.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.6 0.0 0.0 1.0 8.6 54.5 0.0 0.0 CXorf21 FLJ11577 ENSG00000120280 "Chromosome X open reading frame 21" Q9HAI6 X 30558824-30577844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7" "Cell type enhanced" "Detected in some" 13 "B-cells: 25.2;granulocytes: 15.0;Hofbauer cells: 20.5;Kupffer cells: 21.1;Macrophages: 39.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "THP-1: 59.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001185 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA001185: AB_1078591" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (4.37e-2)" "unprognostic (2.27e-2)" "unprognostic (3.47e-2)" "unprognostic (5.25e-3)" "unprognostic (9.07e-3)" "unprognostic (5.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (3.43e-1)" "unprognostic (3.60e-1)" "unprognostic (1.66e-3)" "unprognostic (8.99e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-2)" "unprognostic (3.23e-2)" 6.5 2.1 4.6 9.8 4.0 16.0 2.0 0.8 4.4 1.4 3.0 2.3 0.2 4.3 1.2 2.4 1.4 1.5 3.6 1.5 5.0 2.1 1.9 2.8 6.1 12.9 6.3 0.0 1.0 2.0 0.7 1.5 2.7 5.1 1.5 3.1 1.1 3.3 0.5 0.8 1.1 5.3 1.8 9.9 16.7 3.1 0.8 5.2 9.1 1.4 1.2 9.3 4.8 1.4 11.1 21.9 14.9 18.9 3.2 1.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 4.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 7.2 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.1 0.0 0.0 0.0 0.0 0.0 5.6 0.5 2.7 0.0 8.5 0.0 3.4 10.3 11.4 0.8 9.6 0.1 11.1 1.0 0.5 12.0 10.8 1.0 0.7 14.9 3.2 18.9 21.9 1.6 3.5 4.6 4.0 0.8 4.4 5.0 2.1 6.3 0.0 5.1 5.2 0.0 2.2 25.2 0.2 0.5 0.0 0.2 0.0 2.7 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 15.0 0.0 20.5 0.0 0.0 0.6 21.1 0.0 0.0 39.3 8.5 5.4 0.0 2.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.2 1.3 0.0 0.1 CXorf49 ENSG00000215115 "Chromosome X open reading frame 49" A8MYA2 X 71714371-71718151 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 5.8" "Cell type enriched" "Detected in single" 12 "Alveolar cells type 1: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "A-431: 14.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 CXorf49B ENSG00000215113 "Chromosome X open reading frame 49B" A8MYA2 X 71763424-71767204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "A-431: 14.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 CXorf51B ENSG00000235699 "Chromosome X open reading frame 51B" X 146809784-146810409 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 37 "testis: 36.8" "Group enriched" "Detected in some" 43 "Early spermatids: 13.4;Late spermatids: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 37 "RPMI-8226: 2.6;U-138 MG: 4.8" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CXorf57 "FLJ10178, FLJ14191" ENSG00000147231 "Chromosome X open reading frame 57" Q6NSI4 X 106611930-106679442 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;pituitary gland: 32.3" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 26.8;Intestinal endocrine cells: 14.9;Syncytiotrophoblasts: 18.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 3.5;MAIT T-cell: 2.6;memory B-cell: 3.9;memory CD4 T-cell: 3.0;memory CD8 T-cell: 2.4;naive B-cell: 2.9;naive CD4 T-cell: 3.7;naive CD8 T-cell: 3.0;NK-cell: 2.1;T-reg: 1.1" "Group enriched" "Detected in many" 11 "B-cells: 3.9;NK-cells: 2.1;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HEK 293: 22.6;RT4: 23.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000896, HPA001010, HPA001374" Uncertain Supported "Nuclear speckles" NA No "Nuclear speckles" "HPA000896: AB_1078880, HPA001010: , HPA001374: AB_2666288" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (4.85e-2)" "unprognostic (8.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.89e-1)" "unprognostic (3.02e-1)" "unprognostic (5.49e-2)" "unprognostic (3.81e-3)" "unprognostic (1.17e-1)" "unprognostic (4.20e-3)" "unprognostic (1.63e-1)" "unprognostic (2.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.23e-3)" 1.4 12.0 5.2 2.1 23.0 0.8 2.3 0.9 8.5 2.9 1.3 6.8 1.0 1.8 5.1 3.7 1.3 6.3 1.0 1.5 5.9 25.8 4.2 2.2 3.8 4.8 4.7 5.3 11.3 2.5 0.1 32.3 5.7 6.3 2.3 1.3 2.6 1.1 2.2 2.2 4.0 2.0 1.5 4.5 2.9 4.2 6.0 5.4 1.9 5.2 0.4 3.3 5.9 2.0 3.9 0.2 0.2 0.0 2.1 3.7 1.2 4.2 0.0 4.4 6.1 2.5 2.1 6.6 0.1 0.8 0.0 0.0 0.9 0.9 8.8 0.0 0.5 4.7 1.2 11.2 1.9 0.0 0.0 22.6 2.9 0.0 0.2 0.1 0.0 2.0 1.2 1.3 0.3 0.8 1.2 0.0 7.9 0.1 11.6 1.0 0.0 8.0 0.0 4.0 2.8 0.7 0.0 4.0 0.0 1.9 23.8 7.2 0.0 0.4 0.1 2.5 3.5 1.0 0.1 0.0 1.9 1.6 0.0 2.6 4.2 1.7 10.9 3.4 0.0 3.1 0.0 0.0 0.0 3.5 0.0 2.6 3.9 3.0 2.4 0.0 2.9 3.7 3.0 0.2 2.1 0.0 0.2 1.1 1.2 5.2 23.0 0.9 6.8 5.9 25.8 4.7 5.3 6.3 5.4 8.9 2.6 0.0 0.8 2.3 3.2 0.8 2.5 26.8 7.9 1.8 0.0 10.7 3.3 0.3 1.0 0.0 0.3 0.0 0.5 3.6 0.7 0.2 0.0 1.9 1.1 0.0 14.9 0.0 0.0 0.9 0.6 0.0 5.0 0.0 0.0 2.3 0.3 0.0 0.4 0.8 0.2 6.5 0.6 2.9 11.5 1.4 18.9 2.5 0.1 0.5 CXorf58 FLJ25444 ENSG00000165182 "Chromosome X open reading frame 58" Q96LI9 X 23907801-23939507 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 18.3;Spermatocytes: 20.0;Spermatogonia: 5.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "monocytes: 1.0;T-cells: 1.8" "Cell line enhanced" "Detected in some" "GAMG: 4.4;PC-3: 2.0;U-266/70: 1.9" "HPA031542, HPA031543, HPA031544" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031542: AB_2673927, HPA031543: AB_10603789, HPA031544: AB_2673929" "unprognostic (9.74e-2)" "unprognostic (9.17e-3)" "unprognostic (2.52e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-2)" "unprognostic (1.24e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-2)" "unprognostic (1.43e-1)" "unprognostic (4.14e-3)" "unprognostic (8.19e-2)" "unprognostic (3.82e-2)" "unprognostic (1.10e-1)" "unprognostic (3.21e-2)" "unprognostic (7.39e-2)" "unprognostic (5.06e-3)" 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.2 0.2 0.3 0.6 0.2 0.1 0.0 0.2 0.0 0.4 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 8.4 0.6 0.0 0.2 0.0 0.1 0.2 0.1 1.0 0.0 1.8 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.1 0.0 0.8 1.0 0.2 0.0 4.4 0.5 0.1 0.7 0.0 0.4 0.5 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.7 0.6 0.5 0.0 0.0 1.6 0.3 0.2 0.1 0.1 0.1 0.8 0.0 0.1 2.0 0.4 0.0 0.1 1.0 0.0 0.9 0.1 0.5 0.1 0.4 0.1 1.1 0.1 0.4 0.0 0.0 0.2 0.3 1.9 0.9 0.2 0.2 0.1 0.3 0.0 0.0 0.1 0.3 1.0 1.4 0.1 1.3 1.0 0.0 0.1 1.0 0.7 0.0 0.0 0.2 0.2 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 4.0 0.0 0.0 0.0 0.1 1.7 0.0 18.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.0 0.0 0.5 0.1 0.0 0.0 0.0 2.3 0.0 0.0 20.0 5.2 0.0 0.1 0.0 0.0 0.0 CXorf65 ENSG00000204165 "Chromosome X open reading frame 65" A6NEN9 X 71103889-71106788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 47.7" "Group enriched" "Detected in some" 123 "Early spermatids: 438.7;Late spermatids: 952.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 23 "B-cells: 2.2" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;HEL: 2.7;JURKAT: 2.1;K-562: 2.6;MOLT-4: 2.4;NB-4: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047396 Uncertain NA NA "HPA047396: AB_2680028" "unprognostic (7.81e-3)" "unprognostic (8.43e-4)" "unprognostic (1.08e-2)" "unprognostic (1.87e-2)" "unprognostic (6.14e-2)" "unprognostic (3.06e-3)" "unprognostic (6.20e-2)" "unprognostic (2.62e-2)" "unprognostic (6.72e-2)" "unprognostic (1.84e-4)" "unprognostic (9.53e-2)" "unprognostic (1.36e-1)" "unprognostic (1.44e-8)" "unprognostic (1.12e-1)" "unprognostic (3.49e-2)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 0.1 0.0 0.1 0.6 0.1 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 1.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.9 0.1 0.1 2.0 0.0 47.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.1 2.6 0.7 0.0 0.0 2.4 4.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 438.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.6 0.0 0.0 0.0 0.0 952.5 4.0 0.8 1.7 0.0 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 4.3 1.7 0.0 0.9 5.0 0.0 0.0 CXorf66 "RP11-35F15.2, SGPX" ENSG00000203933 "Chromosome X open reading frame 66" Q5JRM2 X 139955725-139965520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 17.8" "Cell type enriched" "Detected in some" 12 "Early spermatids: 95.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.87e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 CXorf67 ENSG00000187690 "Chromosome X open reading frame 67" Q86X51 X 51406915-51408843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 14.3;testis: 21.4" "Group enriched" "Detected in some" 5 "Sertoli cells: 6.5;Spermatocytes: 4.9;Spermatogonia: 15.6" "Cancer enriched" "Detected in some" 6 "testis cancer: 11.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.8" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 11 "B-cells: 1.1;T-cells: 1.2" "Cell line enriched" "Detected in single" 46 "U-2 OS: 27.7" "HPA004003, HPA006128" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004003: AB_2667113, HPA006128: AB_2667517" "unprognostic (4.21e-2)" "unprognostic (6.36e-2)" "unprognostic (3.37e-2)" "unprognostic (8.58e-3)" "unprognostic (3.57e-4)" "unprognostic (1.47e-6)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (4.26e-1)" 0.1 0.2 0.3 0.2 0.6 0.1 0.1 2.8 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.7 0.1 0.0 1.5 14.3 0.1 0.4 0.1 0.1 0.9 0.2 0.1 0.2 0.2 0.1 0.4 0.7 0.1 21.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.7 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 2.8 0.4 0.3 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 6.5 0.0 4.9 15.6 0.0 1.6 0.0 0.0 0.0 CXXC4 IDAX ENSG00000168772 "CXXC finger protein 4" 4 104468312-104494901 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.4;pituitary gland: 17.2" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036600, HPA036925" Uncertain Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036600: AB_10673659, HPA036925: " "unprognostic (1.37e-2)" "unprognostic (1.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.86e-2)" "unprognostic (9.07e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (9.69e-3)" "unprognostic (2.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.82e-1)" "unprognostic (4.52e-3)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (2.38e-1)" "unprognostic (4.42e-3)" 2.2 4.3 10.3 0.9 12.0 0.6 4.3 17.5 19.4 2.4 2.5 7.4 0.8 5.4 1.9 5.3 1.0 6.7 1.5 5.3 9.9 14.4 1.7 2.7 2.3 0.7 7.9 9.9 5.6 5.8 3.2 17.2 1.4 10.2 2.1 2.9 7.9 7.5 2.1 1.3 0.8 5.5 1.8 5.3 1.4 4.3 4.9 13.3 0.0 7.1 0.1 0.7 1.6 1.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 7.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.6 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 9.3 0.0 0.0 2.7 0.0 2.6 0.1 0.1 0.0 0.0 5.4 0.0 0.1 12.5 2.3 0.0 0.6 0.0 3.1 0.3 0.0 0.0 0.0 1.7 0.0 0.1 10.2 2.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.0 17.5 19.4 9.9 14.4 7.9 9.9 10.2 13.3 0.0 5.4 0.0 0.8 0.2 41.0 12.8 0.0 14.7 2.3 0.0 29.5 0.1 0.0 0.1 0.2 1.6 0.9 0.0 2.9 0.0 0.4 0.5 0.0 2.4 0.1 42.9 98.1 1.3 0.3 0.4 0.3 0.0 1.7 0.0 4.3 13.3 2.1 0.0 10.3 0.7 25.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.8 0.4 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 68.2" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 594.9;Horizontal cells: 511.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 10.2;memory B-cell: 27.7;naive B-cell: 29.3;NK-cell: 21.8;plasmacytoid DC: 19.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 57.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: AB_2683621" "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favorable (2.40e-4)" "prognostic unfavorable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 12.3 9.5 22.4 9.3 19.9 22.2 9.2 68.2 38.8 17.5 10.2 39.3 5.1 6.0 9.9 18.0 10.1 18.1 11.4 15.8 23.9 16.7 25.6 33.8 9.0 15.5 30.9 21.7 5.4 24.9 18.2 18.6 10.4 25.4 8.1 7.9 14.2 30.0 11.7 39.7 9.8 9.1 8.4 36.7 18.1 11.4 19.0 27.5 20.5 12.5 7.7 13.5 9.6 9.9 29.3 19.1 0.7 2.1 21.8 10.2 3.4 9.4 8.0 8.8 3.3 12.4 17.0 3.4 6.2 9.5 2.7 5.4 17.6 9.6 12.5 27.6 16.5 16.3 10.9 1.8 4.8 1.3 1.3 3.1 18.6 7.1 12.3 5.3 4.1 0.6 6.1 1.1 4.5 1.3 26.2 0.7 0.4 17.4 2.0 19.5 24.7 4.4 13.2 10.7 10.3 2.2 8.0 18.1 19.1 20.3 6.9 28.2 29.1 2.2 57.1 4.6 20.4 31.2 19.5 3.9 22.2 4.4 10.5 5.5 7.5 15.6 23.6 33.4 1.4 12.2 0.3 2.1 0.1 3.2 0.4 10.2 27.7 0.3 2.3 1.8 29.3 0.2 0.9 0.7 21.8 0.1 19.1 0.4 3.4 22.4 19.9 68.2 38.8 23.9 16.7 30.9 21.7 25.4 27.5 44.7 16.8 79.0 14.3 23.4 189.2 39.2 91.7 25.4 18.2 139.6 23.6 2.7 268.5 104.4 594.9 41.3 10.1 23.3 127.1 18.5 63.9 34.4 20.8 98.7 39.4 511.7 17.9 26.4 25.4 156.4 36.2 34.8 57.3 50.5 49.6 220.2 83.9 5.8 28.7 146.6 42.7 12.9 77.3 5.4 7.8 18.2 31.5 24.5 24.3 15.8 CYB561 "CYB561A1, FRRS2" ENSG00000008283 "Cytochrome b561" P49447 17 63432304-63446378 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 86.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 90.7;SK-BR-3: 43.4;T-47d: 35.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014753 Enhanced NA NA "HPA014753: AB_1847364" "prognostic unfavorable (8.89e-5)" "unprognostic (2.90e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-5)" "unprognostic (1.81e-3)" "unprognostic (3.82e-1)" "unprognostic (1.37e-2)" "unprognostic (8.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.91e-2)" "unprognostic (8.97e-2)" "unprognostic (6.38e-2)" "unprognostic (8.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.89e-1)" 4.7 46.3 7.0 5.6 12.4 1.0 16.6 2.4 12.3 16.6 11.8 3.7 43.7 12.4 5.2 20.9 16.8 19.8 13.2 9.9 7.1 14.5 10.1 12.0 14.6 9.1 4.7 7.8 8.8 86.9 21.8 26.3 12.2 9.9 22.8 7.3 6.2 26.0 32.0 2.7 11.9 13.7 3.4 3.7 2.8 16.9 4.7 1.8 1.2 17.1 8.3 8.3 5.3 8.6 0.4 1.2 3.4 4.4 12.6 16.2 3.1 19.6 6.7 0.5 4.2 2.4 11.3 8.9 1.9 2.4 2.5 1.0 6.0 19.9 0.0 4.6 15.3 0.7 17.2 4.2 1.6 1.0 5.0 1.6 2.5 4.2 0.4 4.6 0.2 0.8 1.8 17.4 2.3 0.3 3.7 4.9 0.0 7.7 3.7 0.8 28.1 0.0 0.9 4.1 16.2 9.9 0.0 0.0 6.2 8.2 10.1 15.4 90.7 5.1 43.4 2.0 1.6 35.0 1.2 0.7 5.5 6.0 12.8 0.6 0.0 0.1 0.0 4.8 1.0 2.9 0.1 1.1 0.1 12.6 3.4 16.2 0.4 9.6 8.5 1.2 0.4 0.8 2.8 3.4 12.6 4.4 0.0 0.0 3.1 7.0 12.4 2.4 12.3 7.1 14.5 4.7 7.8 9.9 1.8 26.8 31.5 1.9 20.2 14.5 3.6 9.6 22.9 60.2 43.3 22.7 0.0 20.6 3.3 36.2 4.3 10.0 21.5 0.0 44.2 24.7 8.9 51.0 16.1 9.6 4.4 0.0 20.7 8.0 4.0 4.1 3.4 4.5 3.3 6.4 26.8 5.6 29.3 5.8 3.2 10.5 26.5 6.5 4.1 8.4 5.8 24.3 20.7 11.7 23.3 15.7 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Cell type enhanced" "Detected in many" 10 "Melanocytes: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.2 30.8 4.9 14.2 23.4 15.5 4.2 9.2 14.0 11.1 11.1 8.3 20.4 35.5 16.6 16.2 9.0 25.5 4.7 25.6 6.8 23.7 10.5 6.1 20.8 5.6 11.0 8.4 15.9 21.8 36.2 24.1 11.1 9.2 16.5 16.1 20.0 21.3 18.6 19.6 15.8 3.6 9.2 16.3 17.7 19.2 4.8 26.5 12.8 18.1 6.1 10.1 18.8 27.1 21.2 3.4 22.0 9.8 10.9 13.1 6.8 12.7 13.2 13.3 17.6 19.9 18.0 14.7 16.4 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 6.0 28.1 119.0 16.1 25.1 15.4 1.4 7.6 29.4 25.0 12.2 29.5 43.5 10.0 22.6 55.7 11.9 46.6 0.0 34.2 35.0 17.5 17.4 8.1 18.7 49.1 17.5 18.5 11.6 20.3 10.6 19.2 29.8 303.7 77.5 27.1 16.9 21.9 38.6 19.4 12.9 51.6 12.9 12.3 5.4 11.1 21.0 33.1 21.8 26.6 12.9 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350695-50358460 "Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA071862 Approved NA NA "HPA071862: " "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favorable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favorable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 8.7 16.6 9.8 11.9 11.6 14.8 12.0 10.9 12.2 8.5 14.6 11.5 12.8 16.4 6.3 20.5 11.1 7.8 16.0 7.6 8.8 6.9 15.2 42.2 11.2 16.6 12.2 10.0 5.9 27.3 13.6 14.8 12.2 8.0 12.6 13.9 8.9 15.2 18.2 7.1 6.9 19.0 6.2 11.5 19.7 16.4 7.4 12.4 12.3 16.1 6.5 11.2 9.7 6.9 29.9 31.0 58.3 46.9 34.4 53.2 33.8 7.4 16.6 4.2 7.9 8.9 7.7 9.9 13.4 10.0 12.4 14.2 11.6 12.3 11.9 14.2 16.7 15.3 8.1 6.2 12.4 5.4 17.9 15.5 11.0 19.5 10.5 12.8 12.1 25.9 11.6 5.6 14.9 7.1 6.4 10.3 9.4 4.8 15.8 9.8 14.2 7.7 10.9 6.7 11.9 26.2 5.5 2.9 23.7 12.9 12.8 4.2 11.8 6.6 27.3 8.2 4.6 9.7 14.4 11.1 11.2 9.6 18.7 16.5 12.1 11.3 7.6 15.5 15.2 12.0 42.4 41.1 58.3 53.2 46.9 34.8 29.9 36.1 42.0 30.0 27.4 25.6 38.0 39.0 34.4 44.1 31.0 37.1 33.8 9.8 11.6 10.9 12.2 8.8 6.9 12.2 10.0 8.0 12.4 6.0 23.7 4.5 12.5 4.4 5.8 0.0 0.0 9.4 5.7 24.4 5.9 30.2 10.0 36.4 10.5 4.1 40.7 0.0 59.2 35.9 11.9 18.5 20.8 0.0 51.2 7.9 30.5 0.0 0.0 5.2 8.1 24.4 18.6 37.9 39.9 23.0 38.7 49.1 7.4 20.3 5.2 12.9 4.1 5.0 13.0 6.5 46.1 13.1 23.6 13.9 CYB5A CYB5 ENSG00000166347 "Cytochrome b5 type A" P00167 18 74250847-74292016 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 266.8" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 1827.0;Hepatocytes: 3445.7;Proximal tubular cells: 3021.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 154.8;RT4: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006333, HPA047548, HPA058547" Enhanced Enhanced Vesicles,Cytosol No No 780000 "Vesicles, Cytosol" "CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750" "unprognostic (1.88e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.23e-4)" "unprognostic (1.08e-2)" "unprognostic (1.41e-1)" "unprognostic (9.14e-2)" "prognostic favorable (4.15e-4)" "unprognostic (7.79e-3)" "unprognostic (1.11e-1)" "unprognostic (3.33e-2)" "unprognostic (2.68e-2)" "unprognostic (1.65e-2)" "unprognostic (1.17e-1)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (4.64e-2)" "unprognostic (8.54e-2)" 25.0 13.2 4.3 11.0 5.8 1.5 39.4 6.9 5.9 7.5 68.2 4.3 38.5 37.7 4.9 16.0 8.3 7.0 34.8 14.5 4.1 3.7 76.2 266.8 67.0 9.2 6.5 3.4 25.1 75.3 10.1 6.5 7.2 5.2 13.5 9.0 6.2 7.6 54.9 4.3 11.4 70.7 21.2 11.5 10.3 18.0 12.2 5.5 4.6 4.6 7.9 4.3 21.6 18.8 34.9 16.9 2.1 12.9 10.2 38.0 13.5 10.0 17.2 9.0 0.0 154.8 27.5 12.0 6.9 15.1 14.8 22.3 20.3 11.0 12.3 4.9 12.7 7.3 22.5 0.0 9.5 11.8 22.9 11.9 4.5 9.4 53.8 24.0 8.6 5.9 46.1 7.6 8.4 4.3 8.9 8.1 11.0 7.3 4.6 12.4 18.1 4.8 10.3 4.0 14.2 11.2 12.0 2.9 0.2 14.8 67.5 25.7 10.7 6.7 18.4 8.2 8.0 36.4 8.2 7.6 0.0 11.6 3.5 8.8 3.2 13.3 3.8 9.1 2.4 8.5 1.1 9.6 2.1 16.7 10.8 38.0 28.5 18.7 19.6 16.9 34.9 18.4 23.1 1.1 10.2 12.9 14.8 14.4 13.5 4.3 5.8 6.9 5.9 4.1 3.7 6.5 3.4 5.2 5.5 592.6 899.4 80.0 70.0 87.0 10.0 73.8 919.7 746.8 1341.0 799.1 3.9 200.0 1827.0 177.8 6.0 109.5 224.5 0.0 443.4 144.1 156.3 120.6 38.2 3445.7 88.8 7.9 157.7 172.5 116.8 12.6 146.4 67.3 86.0 370.7 201.7 22.6 370.4 256.3 140.7 3021.0 12.1 51.8 70.7 13.6 36.0 195.7 37.2 60.9 256.7 159.2 CYB5B CYB5-M ENSG00000103018 "Cytochrome b5 type B" O43169 16 69424525-69466266 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 130.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007893 Approved Approved "Endoplasmic reticulum,Centriolar satellite,Cytosol" NA NA 1600000 "Endoplasmic reticulum" "Centriolar satellite, Cytosol" "HPA007893: AB_1847369" "unprognostic (1.13e-1)" "unprognostic (4.47e-2)" "unprognostic (9.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (2.87e-3)" "unprognostic (4.35e-3)" "unprognostic (3.87e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-2)" "unprognostic (3.10e-1)" "prognostic favorable (6.38e-5)" "unprognostic (9.69e-3)" "unprognostic (4.66e-2)" "unprognostic (3.78e-2)" "unprognostic (1.30e-2)" 21.3 130.7 29.6 15.4 33.1 5.9 17.1 12.0 37.9 16.6 29.0 22.8 12.6 21.9 20.5 24.6 21.4 19.2 14.7 18.0 23.1 22.0 26.9 26.5 18.3 20.1 21.6 24.4 19.9 12.8 26.3 16.2 24.6 34.3 17.1 38.2 20.2 14.8 16.7 19.9 16.0 31.2 19.9 20.8 20.7 15.4 14.0 16.0 26.0 19.9 17.6 23.5 24.3 16.0 24.8 44.2 35.8 28.3 32.3 46.0 32.4 29.6 94.4 38.9 24.0 18.0 24.0 16.6 26.6 37.1 44.6 42.2 65.8 36.4 27.1 26.8 25.7 36.3 35.3 37.0 38.5 50.8 14.4 14.1 13.0 17.0 76.7 26.6 26.8 29.0 20.6 19.4 52.8 25.3 18.9 42.0 31.3 21.0 13.1 27.3 38.6 43.9 32.6 28.8 27.6 12.9 41.6 21.5 29.7 59.5 34.0 22.8 11.7 70.8 13.6 22.5 20.9 26.3 21.5 18.9 25.7 21.2 17.0 23.4 15.9 35.1 82.9 26.5 22.3 29.7 35.8 20.3 24.3 39.3 28.3 32.2 24.8 29.6 30.8 24.8 22.6 24.6 29.2 6.1 32.3 20.1 44.2 46.0 32.4 29.6 33.1 12.0 37.9 23.1 22.0 21.6 24.4 34.3 16.0 41.7 38.5 39.4 44.1 44.3 21.6 21.7 25.5 52.2 42.1 59.3 5.9 140.9 66.3 51.1 13.9 49.6 69.8 23.3 62.0 75.3 41.2 33.1 58.9 43.3 55.7 28.6 22.5 36.2 27.6 17.2 41.1 44.4 59.1 64.9 68.4 45.7 54.3 63.1 41.8 46.7 30.4 45.3 42.2 31.1 48.5 36.9 50.0 71.0 55.0 45.3 CYB5R1 "humb5R2, NQO3A2" ENSG00000159348 "Cytochrome b5 reductase 1" Q9UHQ9 1 202961869-202967280 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.2" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010641, HPA014147" Enhanced Approved Mitochondria,Cytosol NA NA 860000 Mitochondria Cytosol "HPA010641: AB_1078600, HPA014147: AB_1847370" "unprognostic (6.36e-2)" "unprognostic (8.51e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.14e-4)" "unprognostic (1.86e-2)" "unprognostic (4.34e-2)" "unprognostic (8.46e-2)" "unprognostic (1.28e-1)" "unprognostic (4.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.73e-2)" "unprognostic (2.33e-1)" "unprognostic (6.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.69e-1)" 9.6 14.5 7.8 5.0 8.4 3.9 16.9 6.2 11.0 11.6 7.5 8.7 10.6 4.4 10.1 32.3 13.7 16.4 9.2 33.9 7.3 9.2 15.5 18.4 10.1 11.7 10.0 9.1 10.8 11.1 16.3 11.1 63.8 11.9 10.5 5.0 15.7 14.4 10.1 119.2 28.5 6.9 10.6 7.4 10.8 18.6 20.1 6.7 11.7 13.5 26.4 10.0 13.6 10.1 20.2 21.9 25.7 33.3 17.2 26.5 28.8 8.5 5.3 4.7 9.6 43.9 10.1 46.1 17.1 16.2 11.2 10.0 4.4 10.1 5.3 14.6 17.1 6.2 47.3 3.8 14.7 7.4 7.6 9.7 3.0 6.5 5.0 15.8 2.6 7.6 16.2 48.7 12.3 6.7 9.5 7.3 6.6 8.9 9.6 40.2 10.0 3.2 2.3 3.1 7.7 10.3 5.4 22.7 11.3 10.6 10.2 4.0 5.0 9.6 32.0 13.9 10.7 14.8 5.8 7.1 12.8 5.4 4.8 9.5 9.0 10.6 2.5 14.1 4.0 9.5 11.6 33.3 25.6 16.7 24.2 22.2 13.6 19.3 17.8 21.9 20.2 26.5 18.8 25.7 17.2 15.7 15.1 19.1 28.8 7.8 8.4 6.2 11.0 7.3 9.2 10.0 9.1 11.9 6.7 20.8 24.3 13.0 30.5 166.3 19.6 98.7 33.1 58.9 20.5 27.9 27.5 100.3 6.6 35.7 4.3 29.5 11.9 23.3 41.7 159.6 29.6 19.2 27.7 36.0 54.2 9.5 18.4 23.4 39.9 5.4 27.6 33.5 60.8 9.0 10.9 56.4 53.6 10.5 29.4 32.1 25.9 12.9 34.0 24.6 2.7 137.6 245.4 17.5 14.2 47.8 CYB5R2 ENSG00000166394 "Cytochrome b5 reductase 2" Q6BCY4 11 7665100-7677222 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 58.8" "Group enriched" "Detected in many" 5 "Early spermatids: 205.4;Late spermatids: 439.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 5.9;memory B-cell: 12.2" "Group enriched" "Detected in many" 9 "B-cells: 12.2;granulocytes: 5.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 42.5;BJ hTERT+ SV40 Large T+: 22.7;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 18.2;NTERA-2: 23.9;WM-115: 32.7" "Low region specificity" "Detected in many" "HPA038962, HPA061707" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA038962: AB_10675954, HPA061707: AB_2732668" "unprognostic (1.47e-1)" "unprognostic (2.56e-2)" "unprognostic (8.90e-3)" "unprognostic (4.41e-2)" "unprognostic (4.13e-3)" "unprognostic (1.60e-2)" "unprognostic (4.02e-2)" "unprognostic (2.48e-1)" "unprognostic (3.41e-2)" "unprognostic (1.30e-2)" "unprognostic (2.64e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.40e-1)" "unprognostic (8.16e-2)" "unprognostic (1.70e-1)" "unprognostic (7.01e-2)" 3.3 1.9 9.3 2.8 12.1 1.9 7.7 3.1 12.3 6.6 2.3 26.1 4.2 1.3 10.0 13.1 8.0 5.2 3.4 2.0 11.2 5.3 2.4 2.5 4.6 3.8 22.3 7.3 14.9 2.2 23.1 0.6 6.7 11.6 7.8 2.7 12.2 12.8 11.6 0.8 23.4 1.7 6.8 12.4 2.0 2.2 58.8 14.5 0.2 2.6 6.7 4.9 5.9 7.1 12.2 0.0 5.9 1.0 0.0 0.2 0.7 2.3 1.2 0.5 0.0 0.1 0.6 7.9 14.8 42.5 22.7 20.7 0.2 3.2 0.0 3.5 7.6 7.0 0.2 0.0 0.1 18.2 0.0 0.0 0.0 1.3 0.3 12.3 0.1 2.3 6.2 0.5 0.1 1.2 0.0 1.9 0.0 2.2 0.0 0.1 0.0 0.0 0.0 23.9 2.4 1.1 11.2 0.0 0.0 0.0 1.5 0.0 0.2 0.1 9.5 0.6 4.0 1.6 3.1 0.0 2.1 0.0 0.1 1.1 0.0 0.0 3.5 0.1 0.0 32.7 0.0 1.0 5.9 0.0 0.5 0.0 12.2 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.7 9.3 12.1 3.1 12.3 11.2 5.3 22.3 7.3 11.6 14.5 20.8 3.2 0.0 7.4 6.3 0.8 1.9 0.0 8.1 2.3 3.5 19.6 4.6 0.0 1.4 205.4 1.0 0.0 0.0 4.2 16.5 7.1 4.8 2.3 1.1 2.3 0.0 0.0 0.0 0.0 439.8 4.4 1.4 5.0 0.0 1.4 0.8 4.6 0.9 5.6 0.0 37.7 12.9 12.6 63.0 5.9 8.8 3.8 0.0 1.4 10.5 CYB5R4 "b5+b5R, dJ676J13.1, NCB5OR" ENSG00000065615 "Cytochrome b5 reductase 4" Q7L1T6 6 83859643-83967424 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 49.6" "Group enriched" "Detected in many" 4 "Early spermatids: 150.1;Late spermatids: 277.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 49.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018992 Approved NA NA "HPA018992: AB_1847371" "unprognostic (4.86e-3)" "unprognostic (1.16e-1)" "unprognostic (1.80e-3)" "unprognostic (1.21e-2)" "unprognostic (1.72e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-2)" "unprognostic (7.94e-2)" "unprognostic (4.77e-1)" "unprognostic (6.77e-2)" "unprognostic (1.39e-2)" "unprognostic (5.44e-1)" "unprognostic (6.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.15e-1)" "unprognostic (8.15e-2)" 9.3 8.2 4.5 17.9 9.1 23.1 9.6 11.5 8.4 6.3 10.5 8.0 6.2 10.0 7.2 7.6 11.1 6.1 5.3 10.8 4.9 5.0 8.7 8.6 12.3 23.4 10.2 3.4 6.0 8.5 3.6 10.5 12.6 7.3 6.5 8.2 4.3 9.3 4.3 11.9 6.6 11.0 8.8 12.2 18.8 10.8 21.6 9.7 14.2 5.6 6.6 11.9 10.9 7.6 6.9 11.4 49.6 14.6 3.3 5.6 6.3 5.1 4.5 3.2 4.1 1.8 2.4 6.0 3.5 5.2 5.2 7.6 5.8 3.5 9.4 5.5 2.1 14.3 4.3 2.9 4.8 4.0 36.1 6.5 22.7 2.7 3.2 3.4 13.5 20.5 3.0 1.3 3.5 3.7 2.1 2.6 8.5 8.1 7.2 3.7 2.0 3.6 3.8 1.8 4.1 4.2 6.0 11.8 3.4 2.3 5.4 8.5 4.7 4.2 4.2 4.8 2.1 2.4 8.1 3.4 5.3 4.4 10.8 11.0 8.3 12.7 5.2 6.1 9.4 5.8 20.8 14.6 42.2 4.4 12.1 3.5 6.9 3.8 3.9 11.4 6.6 2.5 3.9 49.6 3.3 13.1 4.8 5.6 6.3 4.5 9.1 11.5 8.4 4.9 5.0 10.2 3.4 7.3 9.7 6.0 15.2 26.7 12.4 9.8 12.6 13.4 10.2 13.4 10.3 7.0 15.7 4.8 10.0 22.8 150.1 8.3 13.5 0.0 22.1 16.9 8.2 11.7 24.3 10.5 42.4 12.7 15.5 4.3 52.6 277.8 7.8 46.0 15.1 45.9 13.5 5.7 21.9 14.0 7.1 16.1 19.3 6.5 11.4 23.0 27.4 12.9 9.6 25.4 14.0 17.7 CYBA p22-PHOX ENSG00000051523 "Cytochrome b-245 alpha chain" P13498 16 88643283-88651152 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Transport" Oxidoreductase "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 116.7;lymphoid tissue: 129.2" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 1995.7;Kupffer cells: 1785.0;Macrophages: 1690.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 94.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 141.2;THP-1: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009492 Enhanced NA NA "CAB009492: AB_2090309" "prognostic favorable (8.19e-4)" "unprognostic (1.05e-1)" "unprognostic (8.32e-2)" "prognostic favorable (4.75e-5)" "unprognostic (2.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.88e-2)" "unprognostic (9.16e-2)" "unprognostic (1.72e-1)" "unprognostic (1.11e-1)" "unprognostic (3.08e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.91e-1)" "unprognostic (5.22e-2)" "unprognostic (2.57e-2)" "unprognostic (1.63e-2)" 31.4 12.6 9.7 60.1 14.9 116.7 16.5 2.0 8.6 16.1 40.5 11.5 25.8 35.7 11.4 20.0 19.6 19.2 43.6 18.0 7.8 8.0 49.3 19.8 46.7 120.1 15.7 3.4 14.8 37.4 0.9 8.2 19.3 11.8 14.7 15.2 15.1 21.7 22.5 6.7 7.1 41.0 9.0 16.7 129.2 41.1 7.4 12.7 31.0 25.6 14.0 60.4 27.0 13.6 15.3 28.4 94.1 20.7 5.2 11.9 5.7 0.2 55.2 0.2 0.1 0.1 0.0 29.8 13.5 7.4 3.9 2.2 36.8 78.7 42.3 40.1 5.6 0.0 23.0 2.1 0.0 0.5 13.4 45.6 8.3 20.7 58.7 7.4 14.0 37.5 7.8 0.0 0.1 0.0 0.1 2.1 9.6 23.7 57.8 0.3 85.6 13.6 66.7 10.1 23.9 0.1 39.7 0.1 141.2 32.1 46.3 7.9 7.0 40.4 7.9 12.7 6.4 0.1 117.9 11.2 0.1 0.5 0.1 0.2 34.5 41.4 46.5 19.2 40.2 5.1 15.9 14.7 94.1 11.9 20.7 8.7 14.5 5.8 11.0 15.7 15.3 4.6 5.7 28.5 5.2 19.3 28.4 5.8 5.7 9.7 14.9 2.0 8.6 7.8 8.0 15.7 3.4 11.8 12.7 14.9 14.3 1206.4 193.9 106.1 0.0 11.3 382.1 38.8 34.2 270.4 2.0 56.0 107.8 589.8 3.5 108.2 700.4 256.9 138.1 250.5 228.6 131.9 281.8 17.4 1995.7 0.0 221.3 360.3 1785.0 7.4 46.3 1690.4 1093.2 1012.7 382.5 1.5 573.4 1045.1 20.1 714.0 2.1 58.2 83.9 0.6 17.7 74.9 98.9 597.7 722.2 321.4 CYBB "CGD, GP91-PHOX, NOX2" ENSG00000165168 "Cytochrome b-245 beta chain" P04839 X 37780011-37813461 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.3;lung: 49.4;lymphoid tissue: 74.5" "Group enriched" "Detected in many" 6 "Hofbauer cells: 133.2;Kupffer cells: 479.9;Macrophages: 227.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 50.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 16.5;NB-4: 19.8;REH: 16.9;RPMI-8226: 65.1" "Not detected" "Not detected" HPA051227 Enhanced NA NA 640000 "HPA051227: AB_2681395" "unprognostic (5.83e-2)" "unprognostic (1.77e-2)" "unprognostic (2.15e-3)" "unprognostic (1.48e-2)" "unprognostic (1.27e-1)" "unprognostic (5.65e-2)" "unprognostic (2.29e-2)" "unprognostic (4.45e-2)" "unprognostic (9.14e-2)" "unprognostic (2.32e-2)" "unprognostic (5.73e-2)" "unprognostic (5.18e-2)" "unprognostic (5.92e-2)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (1.32e-1)" "unprognostic (9.72e-2)" 16.4 11.0 9.7 44.2 13.2 42.6 8.1 2.5 6.7 3.7 6.0 10.4 0.2 5.2 3.4 6.3 3.2 6.0 7.5 10.1 6.8 6.5 6.2 11.8 49.4 74.5 12.6 2.9 5.3 4.5 1.4 4.9 16.1 10.3 4.8 8.9 4.5 6.0 2.7 2.5 2.2 16.1 15.3 20.3 49.9 4.9 2.3 10.3 5.4 3.4 3.5 20.2 13.9 3.1 8.1 17.5 20.0 50.3 0.1 0.1 22.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.1 16.9 0.0 65.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.0 0.0 2.8 0.0 0.3 45.5 20.0 0.0 50.3 0.1 8.1 0.0 0.0 12.1 7.2 0.0 0.0 3.7 0.1 42.7 17.5 0.1 22.0 9.7 13.2 2.5 6.7 6.8 6.5 12.6 2.9 10.3 10.3 23.8 33.4 47.7 0.1 0.9 0.0 9.6 2.5 13.4 23.9 1.8 0.0 0.9 0.0 0.0 0.1 1.6 0.9 0.0 0.3 0.9 4.3 0.0 7.0 2.1 133.2 1.6 0.0 7.4 479.9 0.4 0.6 227.9 1.7 3.6 0.7 0.1 0.2 0.0 0.0 0.5 0.5 12.9 0.9 0.0 0.3 1.1 1.5 2.5 1.2 0.0 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095027-144097525 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 145.2" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 693.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 151.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Approved "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA 110000 Mitochondria "Nucleoplasm, Nuclear bodies, Cytosol" "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favorable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 16.0 31.3 16.2 13.2 20.1 19.5 12.1 19.1 32.1 13.0 33.3 13.4 14.4 38.1 13.9 10.1 36.2 15.5 13.1 92.1 16.6 14.1 44.8 55.9 11.2 16.5 18.0 18.6 15.0 21.4 17.9 10.6 16.0 17.7 16.5 25.3 13.3 23.3 17.2 145.2 17.7 42.6 16.3 11.8 18.3 22.4 13.9 11.5 21.5 21.7 43.8 18.5 19.9 14.4 34.9 76.7 22.1 60.0 30.2 26.1 58.5 22.2 50.5 13.4 28.0 11.1 12.4 25.9 12.8 15.7 32.7 21.5 35.3 27.9 31.6 29.0 17.1 15.9 33.0 29.3 25.4 12.3 19.3 38.8 33.9 42.7 32.3 20.0 20.0 22.1 18.0 31.9 20.8 41.4 11.0 19.0 21.9 30.8 28.2 17.1 80.0 37.4 18.5 15.6 62.7 151.5 33.0 18.0 55.3 26.9 35.9 36.1 15.9 35.8 49.5 26.3 7.7 40.7 30.7 14.4 20.9 44.6 23.0 39.0 31.4 22.8 23.4 26.6 34.1 26.6 22.1 59.7 15.9 24.1 60.0 25.4 34.9 20.1 25.8 76.7 29.4 19.7 25.4 5.8 30.2 44.8 42.9 26.1 58.5 16.2 20.1 19.1 32.1 16.6 14.1 18.0 18.6 17.7 11.5 17.9 24.8 104.2 137.8 138.6 109.2 340.1 175.8 33.5 25.0 75.0 76.6 235.5 693.0 191.2 55.0 98.8 477.2 70.0 250.0 197.5 112.8 124.7 59.9 203.6 217.6 82.6 140.6 55.3 91.9 71.2 82.3 127.4 170.4 267.9 288.6 98.9 227.1 319.6 85.2 391.4 75.4 71.1 158.3 73.6 93.6 143.2 198.1 79.6 481.1 207.2 CYCS "CYC, HCS" ENSG00000172115 "Cytochrome c, somatic" P99999 7 25120091-25125361 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Electron transport, Respiratory chain, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 109.6;skeletal muscle: 103.7" "Cell type enhanced" "Detected in all" 5 "Distal tubular cells: 1409.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004222, CAB005126, CAB018597" Enhanced Supported Mitochondria NA NA 190000000 Mitochondria "CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383" "unprognostic (3.06e-2)" "unprognostic (3.39e-1)" "unprognostic (3.32e-2)" "unprognostic (4.11e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.81e-4)" "unprognostic (4.44e-2)" "unprognostic (7.04e-3)" "unprognostic (5.67e-2)" "unprognostic (6.22e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "prognostic favorable (1.30e-5)" "unprognostic (1.18e-1)" "unprognostic (4.94e-2)" "unprognostic (8.75e-3)" "unprognostic (7.04e-2)" 20.3 29.3 29.8 20.0 44.8 17.1 14.7 25.1 41.1 12.1 62.1 13.3 9.6 35.4 11.4 10.7 26.6 11.0 13.1 109.6 30.2 26.4 39.8 37.0 13.4 13.8 30.7 34.7 12.2 9.3 24.8 18.6 10.3 29.9 13.7 58.5 13.5 14.9 15.7 103.7 11.3 30.2 21.8 28.0 15.6 24.3 23.5 18.1 17.3 18.3 41.2 20.0 15.9 14.3 35.5 38.0 17.1 38.3 25.2 31.0 25.2 41.7 23.4 25.3 35.2 14.6 11.2 26.1 40.3 16.6 30.2 35.1 38.7 28.6 48.1 19.8 17.6 89.2 49.7 51.4 37.9 53.3 14.2 23.0 40.0 27.8 27.4 22.9 91.5 35.7 14.9 34.0 30.1 65.4 13.1 27.0 29.5 73.3 51.0 32.0 19.3 49.9 35.6 47.4 94.1 44.3 35.2 30.4 46.0 47.0 41.0 51.4 24.4 21.0 89.6 32.4 46.5 46.4 54.8 19.4 27.8 50.5 42.8 74.3 52.8 61.1 107.5 37.0 66.7 76.8 17.1 20.0 14.0 25.3 38.3 31.0 35.5 23.4 26.8 38.0 26.0 22.4 26.8 3.0 25.2 33.6 27.8 29.5 25.2 29.8 44.8 25.1 41.1 30.2 26.4 30.7 34.7 29.9 18.1 77.4 123.3 298.1 610.6 612.7 158.0 675.3 165.6 120.5 170.6 174.5 72.6 180.3 1409.2 260.2 374.4 142.6 539.3 116.8 187.6 286.9 225.4 312.0 210.9 174.2 320.2 125.5 369.3 82.3 121.9 99.1 83.4 292.4 560.1 339.0 300.1 181.9 228.9 349.1 88.1 469.8 154.2 135.8 467.2 297.7 184.8 625.2 292.1 228.4 388.1 691.0 CYFIP2 PIR121 ENSG00000055163 "Cytoplasmic FMR1 interacting protein 2" Q96F07 5 157266079-157395595 "Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.8;brain: 44.2;kidney: 69.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 150.1;Distal tubular cells: 147.6;Horizontal cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 52.0;JURKAT: 35.9;MOLT-4: 49.3;U-266/70: 38.4;U-698: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB055519, HPA068106, HPA071459" Uncertain Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum" "Plasma membrane, Cytosol" "CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (7.07e-2)" "prognostic unfavorable (2.42e-6)" "unprognostic (3.76e-1)" "unprognostic (4.58e-2)" "unprognostic (1.14e-1)" "unprognostic (6.91e-3)" "unprognostic (3.97e-2)" "unprognostic (5.25e-2)" "prognostic favorable (1.18e-4)" "unprognostic (3.81e-2)" "prognostic favorable (3.21e-12)" "unprognostic (2.90e-1)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.49e-2)" 1.9 6.6 28.6 13.4 31.7 22.8 1.7 39.1 44.2 1.8 4.3 7.7 1.6 3.1 3.5 12.3 2.1 4.9 4.7 5.1 28.7 20.4 69.7 8.2 5.9 25.9 16.2 27.2 2.7 3.6 30.6 13.2 4.4 15.8 3.2 5.0 4.7 2.2 3.5 3.1 1.8 6.4 2.9 7.9 15.8 9.5 2.6 8.9 28.5 5.4 0.0 25.7 6.0 1.7 13.7 15.6 30.1 42.8 17.4 32.1 22.9 0.0 8.1 12.5 7.0 0.2 0.3 20.0 1.4 2.5 0.6 1.8 1.5 0.1 52.0 3.6 0.8 1.8 0.1 9.9 6.7 1.5 11.8 15.6 6.6 10.6 6.0 1.0 6.9 18.4 1.4 2.7 2.0 0.1 4.9 2.1 35.9 0.1 20.9 1.7 1.9 49.3 1.3 5.5 0.1 2.1 12.2 0.3 24.8 6.6 7.4 18.1 7.2 0.1 7.1 1.1 12.7 4.8 0.2 2.9 0.4 5.3 1.7 1.3 38.4 9.6 36.6 5.5 8.3 2.9 17.4 4.3 30.1 32.1 20.0 22.9 13.7 23.3 27.7 6.2 13.4 24.7 28.1 14.4 17.4 42.8 15.6 18.4 22.9 28.6 31.7 39.1 38.3 28.7 20.4 16.2 27.2 15.8 8.9 3.0 24.0 31.6 2.0 1.0 56.1 15.1 10.2 6.7 11.4 150.1 15.7 28.2 147.6 8.4 15.2 2.7 5.3 0.0 1.4 38.9 2.1 1.2 2.3 30.8 4.7 85.8 13.8 7.4 5.4 14.9 1.7 6.2 6.8 13.6 5.6 10.9 2.5 9.9 6.3 46.6 33.3 0.0 7.1 2.3 11.5 1.3 17.6 48.4 8.8 1.4 CYLC1 ENSG00000183035 "Cylicin 1" P35663 X 83861126-83886699 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 24.4" "Group enriched" "Detected in some" 197 "Early spermatids: 395.0;Late spermatids: 1009.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070355 Enhanced NA NA "HPA070355: AB_2686261" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 395.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1009.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 CYLC2 ENSG00000155833 "Cylicin 2" Q14093 9 102995311-103018488 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 61 "testis: 34.0" "Group enriched" "Detected in some" 177 "Early spermatids: 1820.7;Late spermatids: 2014.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.1" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 1.1 0.4 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.4 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.9 0.5 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1820.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2014.1 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 10.8 4.2 0.0 0.0 0.0 0.0 0.0 CYP11A1 "CYP11A, P450SCC" ENSG00000140459 "Cytochrome P450 family 11 subfamily A member 1" P05108 15 74337759-74367740 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 145.3;placenta: 157.2" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 305.6;Syncytiotrophoblasts: 1214.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 36 "basal ganglia: 14.8" "Cell type enriched" "Detected in single" 37 "basophil: 15.8" "Lineage enriched" "Detected in single" 37 "granulocytes: 15.8" "Group enriched" "Detected in some" 4 "BEWO: 44.0;HEL: 35.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA016436 Enhanced NA NA "HPA016436: AB_1847423" "unprognostic (8.89e-2)" "unprognostic (6.96e-2)" "unprognostic (4.95e-3)" "unprognostic (9.31e-2)" "unprognostic (9.42e-4)" "unprognostic (1.90e-1)" "unprognostic (1.55e-3)" "unprognostic (8.06e-2)" "unprognostic (3.04e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-2)" "unprognostic (5.45e-2)" "unprognostic (9.66e-4)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (3.04e-2)" "unprognostic (7.95e-2)" 0.4 145.3 0.4 0.1 14.8 0.0 0.4 0.3 0.3 0.2 0.2 7.6 0.1 0.0 0.3 0.5 1.5 0.3 0.0 0.3 0.3 0.2 0.1 0.7 0.1 0.0 0.3 0.2 9.2 0.1 0.0 0.4 157.2 0.2 0.2 0.0 0.3 0.1 0.6 0.3 0.1 0.1 0.3 0.3 5.7 0.1 20.4 0.1 0.0 0.1 0.3 0.7 0.2 0.2 0.0 0.0 15.8 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 44.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 35.0 1.0 0.3 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 8.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 14.8 0.3 0.3 0.3 0.2 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 139.8 1.7 0.0 1.4 0.0 0.0 0.0 0.0 305.6 0.6 0.1 0.0 3.4 19.4 0.0 0.0 0.0 0.0 2.9 45.1 0.0 0.0 1.0 0.0 5.1 0.2 0.0 163.4 0.0 0.0 0.0 0.0 3.2 3.1 0.0 1214.3 0.0 0.0 0.0 CYP11B1 "CPN1, CYP11B, FHI, P450C11" ENSG00000160882 "Cytochrome P450 family 11 subfamily B member 1" P15538 8 142872356-142879846 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 781 "adrenal gland: 224.9" "Group enriched" "Detected in some" 119 "Early spermatids: 41.1;Late spermatids: 67.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 3.1;SH-SY5Y: 1.3" "HPA049171, HPA056348, HPA057752" Supported NA NA "HPA049171: AB_2680661, HPA056348: AB_2683104, HPA057752: AB_2683516" 0.0 224.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 CYP11B2 "ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo" ENSG00000179142 "Cytochrome P450 family 11 subfamily B member 2" P19099 8 142910559-142917843 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 259 "adrenal gland: 51.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049171, HPA056348, HPA057752" Supported NA NA "HPA049171: AB_2680661, HPA056348: AB_2683104, HPA057752: AB_2683516" 0.0 51.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP17A1 "CPT7, CYP17, P450C17, S17AH" ENSG00000148795 "Cytochrome P450 family 17 subfamily A member 1" P05093 10 102830531-102837533 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Steroidogenesis "Lyase, Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 425.4" "Cell type enhanced" "Detected in some" 17 "Distal tubular cells: 18.3;Early spermatids: 40.8;Proximal tubular cells: 39.5" "Cancer enriched" "Detected in many" 5 "liver cancer: 22.7" "Region enriched" "Detected in single" 103 "basal ganglia: 19.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Group enriched" "Detected in some" 4 "HMC-1: 8.0;SCLC-21H: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA048533 Enhanced "Intracellular and membrane" NA NA "HPA048533: AB_2680432" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (3.01e-2)" "unprognostic (9.08e-2)" "unprognostic (1.91e-1)" "unprognostic (6.29e-2)" "unprognostic (2.92e-3)" "unprognostic (2.39e-4)" "unprognostic (8.26e-2)" "unprognostic (2.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.07e-1)" "unprognostic (5.56e-2)" "unprognostic (1.66e-2)" "unprognostic (2.94e-4)" 0.0 425.4 0.0 0.1 19.7 0.0 0.0 0.1 0.1 0.1 0.0 78.5 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 6.4 1.7 0.1 0.0 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 82.3 0.0 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 3.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 19.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.1 0.6 0.6 0.0 0.0 0.0 1.8 0.0 0.3 18.3 0.0 40.8 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 3.2 0.1 1.6 0.0 0.0 0.0 8.3 1.7 0.2 0.0 0.0 0.0 0.2 1.2 0.0 0.0 39.5 1.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell type enriched" "Detected in some" 36 "Syncytiotrophoblasts: 1678.9" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 45.7 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.3 0.1 3.7 0.3 0.0 0.0 15.3 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 8.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.0 0.0 13.4 0.0 0.0 0.0 1.6 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.3 7.7 0.2 0.0 1678.9 0.0 0.0 0.0 CYP1A1 "CP11, CYP1, P1-450, P450-C, P450DX" ENSG00000140465 "Cytochrome P450 family 1 subfamily A member 1" P04798 15 74719542-74725610 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 38.3;lung: 144.1;urinary bladder: 40.0" "Cell type enhanced" "Detected in some" 21 "Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2" "Group enriched" "Detected in some" 24 "liver cancer: 18.6;urothelial cancer: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB018654 Uncertain NA NA "CAB018654: AB_2088699" "unprognostic (1.71e-2)" "unprognostic (7.86e-2)" "unprognostic (2.57e-2)" "unprognostic (2.89e-1)" "unprognostic (5.45e-3)" "unprognostic (6.34e-2)" "unprognostic (3.08e-1)" "unprognostic (6.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (4.21e-2)" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (4.77e-1)" "unprognostic (1.28e-1)" 9.3 0.4 0.1 0.4 0.2 0.2 7.7 0.2 0.5 2.3 0.7 0.4 3.9 0.5 3.8 4.4 1.2 0.2 11.3 3.0 0.1 0.0 0.7 38.3 144.1 0.2 0.1 0.1 0.5 0.5 0.2 0.1 3.5 0.3 0.2 0.2 0.8 2.1 0.5 1.5 8.1 10.7 5.9 0.2 0.2 0.4 0.3 0.1 0.1 0.8 0.8 8.0 40.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.3 0.1 0.0 0.3 0.0 7.2 0.0 0.0 0.4 0.2 22.0 0.9 0.2 5.9 0.0 5.4 6.9 0.4 4.4 0.2 0.0 0.6 0.3 1.5 3.2 0.1 0.2 7.1 0.0 12.0 0.1 0.9 0.2 11.5 0.2 1.3 0.2 0.0 0.4 0.0 0.2 0.1 7.2 1.8 0.7 0.0 0.2 0.0 1.4 0.3 0.1 1.0 9.0 2.3 23.3 0.3 0.1 0.6 1.0 0.3 3.2 0.0 0.4 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 3.2 CYP1A2 "CP12, P3-450" ENSG00000140505 "Cytochrome P450 family 1 subfamily A member 2" P05177 15 74748844-74756202 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 143.0" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 44.0" "Group enriched" "Detected in some" 22 "liver cancer: 25.3;urothelial cancer: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB016531 Enhanced NA NA "CAB016531: AB_629359" "unprognostic (1.54e-4)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-2)" "unprognostic (5.48e-2)" "unprognostic (2.33e-2)" "unprognostic (7.41e-2)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 1.1 4.5 1.2 1.1 0.7 0.3 1.1 0.9 2.7 2.1 0.2 0.0 1.6 0.7 0.0 0.0 0.2 0.6 1.3 2.2 0.5 0.0 1.8 1.2 0.1 0.2 0.1 0.5 1.2 2.8 1.6 0.8 0.1 1.9 1.1 0.4 0.3 0.1 0.0 0.7 0.2 3.9 1.9 4.0 0.0 0.8 2.5 1.3 1.7 0.9 0.6 2.6 2.4 0.9 0.0 2.2 2.2 1.1 2.1 6.0 0.4 2.3 1.6 1.0 0.4 1.1 1.4 1.1 1.2 1.0 0.7 1.6 1.1 2.4 1.2 3.2 1.2 1.2 0.6 0.6 0.5 0.8 0.7 0.5 0.4 1.7 0.7 0.7 4.5 1.1 0.8 1.1 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell type enhanced" "Detected in many" 11 "Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria NA NA Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.2 0.4 0.0 24.6 26.4 0.0 0.1 0.8 0.2 2.3 0.0 5.5 0.0 3.6 3.2 0.5 10.8 0.0 0.7 0.4 1.0 0.7 0.0 4.0 0.0 6.8 0.0 0.0 105.7 10.3 5.7 0.2 24.4 0.0 0.0 0.1 0.0 0.1 5.2 0.0 4.0 1.4 1.8 2.5 0.0 0.0 0.0 2.5 0.1 0.1 0.4 49.2 7.2 0.0 1.4 9.1 1.9 0.0 0.2 0.0 20.2 0.0 0.0 0.0 0.0 26.8 0.0 2.2 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 17.9 50.6 0.5 98.2 15.8 0.9 2.7 0.0 12.0 35.2 43.6 0.0 0.4 13.3 5.0 11.7 36.8 0.0 0.0 0.5 0.7 41.1 345.6 3.5 9.7 12.6 0.0 1.7 5.5 116.2 8.6 147.9 28.1 16.9 39.7 0.3 0.5 0.4 0.0 160.5 0.8 0.3 19.4 20.8 1.0 1.8 12.4 0.2 0.0 0.8 295.9 CYP21A2 "CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B" ENSG00000231852 "Cytochrome P450 family 21 subfamily A member 2" P08686 6 32038265-32041670 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Steroidogenesis "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "adrenal gland: 170.9" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 14.4" "Cancer enhanced" "Detected in some" "liver cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 11.8;Hep G2: 1.9;Karpas-707: 3.2" "Not detected" "Not detected" "HPA048979, HPA053371" Enhanced "Intracellular and membrane" NA NA "HPA048979: AB_2680584, HPA053371: AB_2682131" "unprognostic (1.03e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-4)" "unprognostic (2.58e-1)" "unprognostic (2.97e-1)" "unprognostic (2.93e-2)" "unprognostic (2.76e-2)" "unprognostic (8.75e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (6.67e-7)" "unprognostic (7.39e-2)" "unprognostic (5.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.82e-1)" 0.1 170.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 6.7 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.3 7.4 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 3.6 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.3 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.1 14.4 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.0 1.7 0.4 0.0 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 CYP26A1 "CP26, CYP26, P450RAI, P450RAI1" ENSG00000095596 "Cytochrome P450 family 26 subfamily A member 1" O43174 10 93073475-93077890 "Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "liver: 23.2;retina: 7.3" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 70.3" "Cancer enhanced" "Detected in many" "testis cancer: 5.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 37.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 6.8" NA NA "unprognostic (2.80e-1)" "unprognostic (4.21e-3)" "unprognostic (5.65e-2)" "unprognostic (2.94e-1)" "unprognostic (2.16e-1)" "unprognostic (4.90e-1)" "unprognostic (4.17e-2)" "unprognostic (6.22e-2)" "unprognostic (3.35e-1)" "unprognostic (4.89e-1)" "unprognostic (1.11e-2)" "unprognostic (6.24e-2)" "unprognostic (2.04e-11)" "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (4.11e-1)" 0.1 0.3 0.3 0.0 0.6 0.1 0.3 0.4 1.8 0.3 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 23.2 0.1 0.0 0.2 1.4 0.1 0.0 0.0 0.2 0.8 0.3 0.1 0.0 7.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 1.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 37.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.4 1.8 0.6 0.3 0.2 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 8.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.5 1.1 0.0 6.4 0.0 0.0 0.0 CYP26B1 P450RAI-2 ENSG00000003137 "Cytochrome P450 family 26 subfamily B member 1" Q9NR63 2 72129238-72148038 "Disease related genes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4" "Group enriched" "Detected in many" 8 "Leydig cells: 70.2;Peritubular cells: 216.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 8.2;HaCaT: 12.1;RH-30: 15.6;U-2 OS: 17.3;U-2197: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012567 Uncertain Approved Cytosol "Intracellular and membrane" No No Cytosol "HPA012567: AB_1847429" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (8.76e-2)" "unprognostic (2.19e-4)" "unprognostic (3.46e-2)" "unprognostic (4.40e-1)" "unprognostic (2.17e-4)" "unprognostic (8.41e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (7.55e-3)" "unprognostic (1.52e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.55e-1)" "unprognostic (9.44e-3)" "unprognostic (2.04e-2)" 16.6 2.6 8.3 2.1 7.8 0.1 7.7 25.0 23.9 5.8 2.4 1.2 1.6 3.6 1.5 1.6 3.4 2.7 1.2 6.0 2.5 1.5 4.2 0.7 2.7 4.4 3.4 10.0 4.9 0.2 0.9 5.2 3.2 35.4 1.3 1.2 1.2 5.1 7.5 7.6 20.5 2.4 1.5 0.6 1.9 0.5 13.8 1.1 4.9 9.2 2.2 2.8 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.1 8.2 3.1 4.9 0.7 0.1 0.2 0.2 1.5 0.4 0.0 0.4 0.6 2.4 12.1 6.9 0.0 0.1 0.0 2.2 0.0 4.9 0.6 0.1 0.0 0.2 0.0 0.4 0.0 0.2 2.5 0.9 3.3 0.4 0.1 0.7 2.3 0.0 0.1 0.0 0.1 0.8 0.0 15.6 0.0 0.0 1.2 0.5 0.1 2.7 0.0 2.9 1.0 0.2 0.7 0.0 1.3 17.3 7.6 2.6 0.0 0.9 0.0 5.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 7.8 25.0 23.9 2.5 1.5 3.4 10.0 35.4 1.1 0.0 0.0 2.9 1.1 13.1 0.1 1.1 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 1.6 0.0 0.0 0.0 0.7 3.7 0.3 0.0 0.2 0.1 0.0 1.7 17.2 4.5 4.9 70.2 0.0 6.8 0.0 0.0 5.4 0.2 0.0 216.0 0.0 0.0 0.0 5.6 1.4 3.0 8.4 0.1 0.0 0.0 0.1 CYP26C1 ENSG00000187553 "Cytochrome P450 family 26 subfamily C member 1" Q6V0L0 10 93060808-93069536 "Disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 1.3;lymphoid tissue: 2.0;testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;SiHa: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.39e-2)" "unprognostic (3.41e-2)" "unprognostic (3.88e-1)" "unprognostic (5.05e-2)" "unprognostic (3.25e-2)" "unprognostic (3.43e-2)" "unprognostic (4.97e-2)" "unprognostic (1.70e-1)" "unprognostic (8.85e-2)" "unprognostic (5.29e-2)" "unprognostic (2.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.02e-2)" "unprognostic (1.74e-4)" "unprognostic (8.59e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" 0.1 1.3 0.2 0.1 0.1 0.0 0.1 0.1 0.8 0.3 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 2.0 0.1 1.8 0.1 1.7 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.3 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 CYP27A1 "CP27, CTX, CYP27" ENSG00000135929 "Cytochrome P450 family 27 subfamily A member 1" Q02318 2 218781749-218815293 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 149.0" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 367.9;Hofbauer cells: 155.3;monocytes: 143.3" "Cancer enhanced" "Detected in all" "liver cancer: 176.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 38.2;neutrophil: 30.6" "Group enriched" "Detected in many" 20 "granulocytes: 30.6;monocytes: 38.2" "Cell line enhanced" "Detected in some" "Hep G2: 74.3;HSkMC: 14.2;RPTEC TERT1: 18.9;SK-MEL-30: 30.5;WM-115: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059155 Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA059155: AB_2683933" "prognostic favorable (1.05e-4)" "unprognostic (4.21e-2)" "unprognostic (2.34e-1)" "unprognostic (1.83e-3)" "unprognostic (3.71e-3)" "unprognostic (1.31e-2)" "prognostic favorable (8.62e-6)" "unprognostic (6.04e-2)" "unprognostic (1.73e-1)" "unprognostic (4.04e-1)" "unprognostic (1.25e-3)" "unprognostic (8.76e-3)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (7.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 14.4 12.3 6.3 4.7 13.4 0.7 5.5 2.4 7.5 6.5 21.9 16.9 24.9 21.0 5.0 5.4 3.5 9.2 5.1 6.9 8.3 6.2 12.6 149.0 22.4 5.6 19.9 5.7 9.5 2.4 6.3 7.1 2.0 12.1 11.6 6.0 15.1 10.0 21.5 10.0 3.9 36.8 5.0 18.8 3.1 3.5 3.7 15.7 3.7 3.1 4.0 7.6 5.5 5.7 0.1 1.7 30.6 38.2 0.0 0.1 10.0 0.0 0.0 0.7 0.0 1.3 0.9 0.1 0.8 3.0 1.0 2.1 3.7 0.1 0.0 1.5 2.1 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.0 0.1 74.3 4.3 0.1 0.0 14.2 0.1 0.0 0.0 3.5 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.7 0.1 18.9 0.0 0.0 0.0 0.0 0.0 30.5 0.7 0.5 0.7 1.7 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.9 0.0 38.2 0.1 0.0 4.3 0.0 0.1 0.0 0.1 1.7 0.0 0.0 0.0 30.6 0.0 0.3 0.2 0.0 10.0 6.3 13.4 2.4 7.5 8.3 6.2 19.9 5.7 12.1 15.7 3.0 28.2 0.9 44.4 4.6 13.8 5.0 17.8 14.7 12.5 3.5 25.5 0.9 8.3 9.2 0.9 7.1 46.1 0.0 10.8 0.5 20.2 45.1 2.3 367.9 155.3 9.5 23.5 19.6 15.9 0.6 44.0 31.1 47.2 143.3 9.0 29.6 6.6 19.3 25.1 66.2 13.7 0.0 8.5 0.3 0.0 2.8 1.0 2.5 18.7 20.0 CYP27B1 "CYP1, P450c1, PDDR, VDD1" ENSG00000111012 "Cytochrome P450 family 27 subfamily B member 1" O15528 12 57762334-57768986 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 45.7" "Group enriched" "Detected in many" 4 "Exocrine glandular cells: 18.7;monocytes: 39.7;Proximal tubular cells: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in many" 6 "RH-30: 34.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.59e-2)" "unprognostic (1.42e-1)" "unprognostic (8.89e-2)" "unprognostic (2.77e-2)" "unprognostic (4.16e-2)" "unprognostic (1.03e-2)" "unprognostic (1.28e-2)" "unprognostic (1.44e-1)" "unprognostic (2.10e-2)" "unprognostic (4.72e-2)" "unprognostic (2.51e-1)" "unprognostic (1.17e-2)" "unprognostic (1.75e-3)" "unprognostic (4.10e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.67e-3)" 0.5 1.1 0.3 1.4 0.3 1.5 0.6 0.3 0.4 0.4 0.3 0.3 0.9 0.3 0.8 1.0 0.6 0.2 0.8 0.3 0.3 0.1 45.7 0.8 0.8 1.4 0.3 0.3 0.3 3.6 0.7 0.6 0.5 0.3 0.5 0.8 1.1 0.7 0.3 0.3 0.8 0.4 0.3 0.3 0.3 0.7 0.5 0.3 1.0 4.4 0.3 0.8 0.6 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.1 1.1 0.2 0.6 1.7 0.0 0.3 1.9 0.0 1.7 0.2 0.9 2.0 0.5 2.5 0.2 0.3 0.2 1.7 0.9 2.9 1.1 0.5 0.8 1.6 0.3 0.0 0.1 2.6 2.6 0.0 1.1 1.1 0.1 0.8 0.0 1.7 1.6 5.4 0.0 0.5 0.5 1.1 1.6 0.4 1.6 1.3 34.0 1.3 0.0 0.9 0.7 0.7 1.3 0.0 0.2 0.1 1.3 1.8 0.0 1.4 2.4 1.3 0.9 2.4 2.2 1.3 0.8 3.3 0.8 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.7 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 1.3 1.1 4.6 0.2 0.6 0.0 0.0 2.3 0.0 2.0 0.1 1.7 1.6 0.7 0.5 0.4 0.0 18.7 0.4 0.3 0.9 4.6 0.5 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 39.7 0.5 0.7 7.0 0.0 0.4 25.9 4.9 0.0 1.6 0.2 0.7 2.4 0.1 0.0 0.6 0.4 CYP27C1 FLJ16008 ENSG00000186684 "Cytochrome P450 family 27 subfamily C member 1" Q4G0S4 2 127184120-127220078 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 10.6" "Cell type enhanced" "Detected in some" 10 "Club cells: 7.9;Collecting duct cells: 3.5;Leydig cells: 6.9;Pancreatic endocrine cells: 4.4;Suprabasal keratinocytes: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 8.4;HDLM-2: 12.1;hTERT-RPE1: 12.8;TIME: 12.1;U-138 MG: 12.4;U-251 MG: 8.1" "Low region specificity" "Detected in many" "HPA062460, HPA068731" Enhanced Vesicles NA NA Vesicles "HPA062460: AB_2732683, HPA068731: AB_2686023" "unprognostic (1.90e-1)" "unprognostic (4.07e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-2)" "unprognostic (3.03e-1)" "unprognostic (7.75e-3)" "unprognostic (3.48e-1)" "unprognostic (2.31e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.81e-3)" "unprognostic (1.11e-1)" "unprognostic (6.29e-4)" "unprognostic (3.49e-4)" "unprognostic (1.83e-1)" "unprognostic (4.27e-2)" "unprognostic (8.64e-2)" 2.7 1.0 0.6 2.4 2.4 0.8 0.6 0.4 1.8 5.2 1.9 1.5 0.4 0.5 1.3 0.8 4.4 1.0 1.5 2.0 0.4 0.9 0.4 0.4 0.4 0.6 2.9 0.4 0.4 0.4 0.0 0.4 0.4 0.7 2.2 0.7 4.2 0.4 1.5 0.8 10.6 1.0 0.4 0.4 0.4 0.5 0.7 3.6 0.4 0.4 2.2 1.6 2.7 4.5 1.5 1.3 3.6 1.0 1.8 1.4 0.2 1.3 3.8 1.9 0.1 0.1 0.0 0.2 0.5 3.6 2.0 0.8 0.1 3.0 0.2 0.1 2.2 1.4 8.4 3.1 1.8 0.6 12.1 1.4 0.0 2.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 1.2 12.8 0.5 0.3 0.1 0.5 2.3 0.1 0.3 0.1 4.3 0.0 1.0 0.1 0.2 0.0 6.3 1.1 0.1 0.7 5.3 0.0 0.0 1.5 0.2 0.1 12.1 12.4 2.2 6.0 8.1 0.2 0.1 0.1 0.1 0.1 0.9 2.4 1.0 0.7 1.2 0.7 1.0 0.9 1.0 0.8 0.3 1.5 1.1 1.4 3.6 1.8 0.7 1.3 0.8 0.2 0.6 2.4 0.4 1.3 0.4 0.9 2.9 0.4 0.7 3.6 0.0 1.1 0.0 1.2 1.5 0.0 0.3 0.0 0.0 7.9 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.4 0.0 0.0 0.0 0.9 0.1 0.1 6.4 0.0 0.0 0.0 3.0 CYP2A13 "CPAD, CYP2A" ENSG00000197838 "Cytochrome P450 family 2 subfamily A member 13" Q16696 19 41088472-41096195 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 30.7" "Cell type enriched" "Detected in single" 7 "Early spermatids: 3.0" "Cancer enriched" "Detected in single" 5 "liver cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;NTERA-2: 1.6" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (9.79e-2)" "unprognostic (1.00e-1)" "unprognostic (4.51e-3)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 30.7 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 CYP2A6 "CPA6, CYP2A, CYP2A3" ENSG00000255974 "Cytochrome P450 family 2 subfamily A member 6" P11509 19 40843538-40850447 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 165 "liver: 199.5" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 161.7" "Cancer enriched" "Detected in some" 12 "liver cancer: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (1.21e-1)" "unprognostic (4.10e-1)" "unprognostic (5.05e-2)" "unprognostic (2.64e-2)" "prognostic favorable (5.38e-5)" "unprognostic (4.98e-3)" "unprognostic (4.86e-2)" "unprognostic (6.23e-2)" "unprognostic (5.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.25e-2)" "unprognostic (8.83e-3)" "unprognostic (2.46e-1)" "unprognostic (3.07e-2)" "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 199.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.1 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 161.7 0.0 0.0 0.0 12.9 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 CYP2A7 CYP2A ENSG00000198077 "Cytochrome P450 family 2 subfamily A member 7" P20853 19 40875439-40882752 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "liver: 53.7" "Cell type enhanced" "Detected in some" 29 "Hepatocytes: 29.0;Ito cells: 12.3;Kupffer cells: 5.7" "Group enriched" "Detected in some" 238 "breast cancer: 9.2;liver cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 2.0" "CAB033510, HPA046713, HPA047262" Enhanced "Intracellular and membrane" NA NA "CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (2.65e-3)" "unprognostic (8.89e-2)" "unprognostic (1.39e-2)" "unprognostic (3.95e-1)" "unprognostic (9.21e-2)" "unprognostic (8.71e-2)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 29.0 0.0 0.0 0.0 12.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 326.3" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;OE19: 4.9" "Not detected" "Not detected" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.0 0.1 1.5 0.0 0.3 0.3 0.2 0.1 7.0 0.4 0.1 0.1 0.3 0.6 0.4 0.7 0.4 0.4 0.4 0.4 0.0 0.4 0.3 0.1 0.3 0.5 0.7 0.4 0.1 0.2 0.1 0.8 1.8 0.6 4.9 0.4 0.2 0.5 0.4 1.7 0.1 0.9 0.2 0.3 0.1 0.5 0.3 0.7 1.1 0.8 0.6 0.3 0.7 0.5 0.3 0.7 0.9 0.2 1.1 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.2 2.5 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 46.7 0.2 0.0 0.0 0.1 0.0 326.3 0.0 0.0 0.0 10.4 11.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.6 CYP2C18 "CPCI, CYP2C, CYP2C17, P450IIC17" ENSG00000108242 "Cytochrome P450 family 2 subfamily C member 18" P33260 10 94683621-94736190 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 62.9;liver: 56.1" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 113.1" "Cancer enhanced" "Detected in many" "liver cancer: 18.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 1.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4" "Intracellular and membrane" NA NA "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-1)" "unprognostic (9.78e-2)" "unprognostic (2.28e-1)" "unprognostic (4.22e-3)" "unprognostic (1.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (6.81e-3)" 0.2 0.0 0.2 0.8 0.2 0.0 0.2 0.2 0.2 2.4 29.2 0.3 0.2 30.2 0.2 0.2 13.5 0.0 6.7 0.2 0.2 0.0 0.2 56.1 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.5 0.2 0.2 0.5 0.2 2.4 0.2 0.2 1.7 62.9 0.2 0.2 0.2 19.0 0.2 0.2 0.3 0.2 5.0 3.8 0.2 3.7 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.3 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 4.4 0.0 0.0 0.0 0.9 0.5 0.2 0.3 0.6 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 3.5 0.0 0.0 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 14.7 0.0 6.4 0.1 0.0 0.0 0.0 113.1 0.0 0.0 0.0 1.8 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.3 0.0 1.5 0.0 CYP2C19 "CPCJ, CYP2C, P450IIC19" ENSG00000165841 "Cytochrome P450 family 2 subfamily C member 19" P33261 10 94762681-94853205 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 47.7;liver: 76.4" "Cell type enriched" "Detected in single" 31 "Hepatocytes: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;RPMI-8226: 1.6" HPA015066 Supported "Intracellular and membrane" NA NA "HPA015066: AB_1847433" "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 30.0 0.0 0.0 14.7 0.0 0.0 1.0 0.0 3.7 0.0 0.0 0.0 0.0 76.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 47.7 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP2C8 CPC8 ENSG00000138115 "Cytochrome P450 family 2 subfamily C member 8" P10632 10 95036772-95069497 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 131 "liver: 247.5" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 1616.5" "Cancer enriched" "Detected in some" 82 "liver cancer: 102.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "gdT-cell: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3" "HPA013547, HPA013970, HPA015066" Enhanced "Intracellular and membrane" NA NA "HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433" "unprognostic (3.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-2)" "unprognostic (1.80e-3)" "unprognostic (4.29e-2)" "unprognostic (1.03e-1)" "unprognostic (3.38e-1)" "prognostic favorable (9.82e-4)" "unprognostic (2.85e-1)" "unprognostic (1.44e-3)" "unprognostic (2.63e-1)" "unprognostic (7.88e-2)" "unprognostic (1.39e-1)" "unprognostic (4.05e-4)" 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.3 247.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.1 1.1 0.2 0.0 0.2 0.0 0.7 1.0 0.0 1.0 0.5 2.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.3 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 2.3 1.2 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 21.0 0.0 0.0 0.9 0.2 155.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 70.0 0.2 0.0 0.0 0.1 0.0 1616.5 0.0 4.8 1.7 61.4 65.7 5.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.1 CYP2C9 "CYP2C10, P450IIC9" ENSG00000138109 "Cytochrome P450 family 2 subfamily C member 9" P11712 10 94938658-94989391 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 233.0" "Cell type enriched" "Detected in some" 48 "Hepatocytes: 1765.4" "Cancer enriched" "Detected in some" 41 "liver cancer: 118.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6" "HPA015066, CAB016123" Enhanced "Intracellular and membrane" NA NA "CAB016123: AB_629363, HPA015066: AB_1847433" "unprognostic (3.37e-1)" "unprognostic (5.68e-2)" "unprognostic (9.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "prognostic favorable (2.83e-6)" "unprognostic (2.37e-1)" "unprognostic (2.05e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-4)" "unprognostic (7.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.45e-2)" "unprognostic (1.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 45.8 0.0 0.0 13.6 0.0 0.6 1.1 0.0 1.0 0.0 0.0 0.0 0.5 233.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 43.8 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.4 0.9 0.0 0.0 0.3 2.5 0.4 0.0 0.1 0.1 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 1.8 0.0 0.0 0.0 4.7 0.0 0.0 4.2 23.3 0.6 0.0 0.0 0.0 0.0 1765.4 0.0 0.0 0.0 36.8 31.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 78.0" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 435.9" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3" HPA045223 Enhanced Approved "Golgi apparatus" No No "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.1 3.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 78.0 0.1 0.1 0.1 0.1 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 11.2 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.3 0.2 0.0 0.6 0.0 0.2 3.6 0.0 1.1 0.0 0.0 0.1 0.3 1.2 0.1 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.3 4.3 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.5 0.5 6.5 0.3 2.5 1.4 0.0 1.8 2.0 0.1 1.7 0.6 2.9 0.3 3.9 0.0 0.5 0.1 0.2 0.5 0.0 435.9 0.1 11.1 1.2 6.7 6.2 11.4 0.0 0.0 0.0 0.0 1.0 0.9 0.5 2.9 1.4 0.5 2.0 0.0 0.2 0.7 0.3 1.0 0.3 0.5 0.8 0.2 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "liver: 802.4" "Cell type enriched" "Detected in many" 65 "Hepatocytes: 5979.1" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.9;myeloid DC: 9.1" "Group enriched" "Detected in many" 17 "dendritic cells: 9.1;T-cells: 3.9" "Cell line enhanced" "Detected in many" "HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009128, HPA029564" Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Mitochondria" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.6 0.3 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.8 0.2 1.3 0.1 0.1 0.1 0.3 802.4 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 1.5 0.1 0.1 0.0 9.1 0.0 0.3 0.2 3.9 0.3 0.1 0.0 0.3 0.9 3.2 1.8 0.7 1.4 4.0 0.0 0.3 0.0 2.4 1.3 0.2 0.4 0.0 9.8 0.0 0.2 0.3 0.2 1.4 1.5 0.1 1.1 0.5 7.6 8.1 0.9 0.2 0.0 0.6 1.7 0.0 2.8 0.5 0.4 0.9 0.6 0.5 20.6 5.6 3.7 0.4 0.3 5.5 0.0 1.8 0.0 0.0 0.0 3.7 0.0 0.6 0.1 0.2 0.8 0.0 1.3 0.4 2.0 0.9 2.0 0.8 2.8 1.3 6.4 0.1 0.0 0.0 0.0 0.1 0.0 3.9 0.0 1.7 1.0 9.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.6 21.0 0.2 2.1 4.5 2.2 50.9 2.7 2.3 0.0 2.0 0.0 0.0 0.3 1.3 0.4 0.0 23.3 1.2 0.1 0.4 0.5 1.1 5979.1 0.0 7.9 0.0 68.2 91.8 1.9 1.4 0.0 0.0 0.0 0.0 1.0 2.6 0.0 2.5 0.0 5.2 0.0 0.5 3.6 2.2 6.6 0.1 8.7 0.0 0.0 CYP2F1 CYP2F ENSG00000197446 "Cytochrome P450 family 2 subfamily F member 1" P24903 19 41114432-41128366 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "basophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 7 "HMC-1: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (2.04e-1)" "unprognostic (8.79e-2)" "unprognostic (4.63e-1)" "unprognostic (4.60e-2)" "unprognostic (2.54e-1)" "unprognostic (7.29e-3)" "unprognostic (6.23e-3)" "unprognostic (2.87e-2)" "unprognostic (3.91e-2)" "unprognostic (1.58e-6)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 3.1 6.1 0.0 2.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 22.7 48.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 4.8 0.0 0.0 0.0 0.0 0.0 CYP2J2 ENSG00000134716 "Cytochrome P450 family 2 subfamily J member 2" P51589 1 59893308-59926790 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.9;intestine: 46.6;liver: 74.6" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 84.7;Cytotrophoblasts: 107.4;Syncytiotrophoblasts: 201.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "OE19: 9.9;RT4: 36.0;SK-BR-3: 9.7" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.53e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-2)" "unprognostic (1.99e-2)" "unprognostic (2.51e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.84e-2)" "unprognostic (7.29e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (5.54e-7)" "unprognostic (4.96e-1)" "unprognostic (8.45e-2)" "unprognostic (4.25e-1)" "unprognostic (9.70e-2)" 0.8 0.9 8.8 1.2 12.0 0.7 5.8 7.9 8.5 1.2 13.1 22.1 0.0 17.9 1.2 1.1 7.2 1.1 1.7 44.9 9.1 6.9 2.2 74.6 1.4 0.8 13.2 6.3 0.7 1.8 0.6 0.7 11.9 12.3 2.4 12.0 0.5 7.2 1.0 12.2 5.3 46.6 1.6 10.1 0.7 3.0 0.9 15.5 0.0 0.7 0.5 2.3 5.8 1.8 1.8 1.2 0.0 0.0 0.7 6.0 1.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.7 0.2 1.6 0.0 0.5 0.0 2.1 0.5 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 1.8 0.0 0.0 0.9 9.9 1.6 0.0 3.8 0.0 2.0 36.0 0.5 2.3 0.0 9.7 0.3 0.1 2.4 0.0 0.0 1.2 1.5 0.0 0.5 1.1 0.1 0.0 0.4 0.0 4.0 0.0 0.0 0.0 0.2 0.0 1.2 1.8 0.7 0.4 0.1 0.9 6.0 5.2 0.0 0.7 0.0 1.2 0.0 1.0 8.8 12.0 7.9 8.5 9.1 6.9 13.2 6.3 12.3 15.5 3.0 2.6 0.5 1.2 0.3 0.0 84.7 12.7 29.4 35.2 0.0 0.0 107.4 0.0 9.1 16.8 0.0 23.8 0.0 0.8 7.3 1.0 0.8 0.0 44.3 6.1 0.0 8.6 0.0 0.6 19.0 0.0 0.0 0.0 1.0 21.4 11.9 1.8 21.0 0.0 2.9 1.0 0.0 0.0 0.3 0.1 1.9 201.5 0.0 23.6 0.9 CYP2S1 ENSG00000167600 "Cytochrome P450 family 2 subfamily S member 1" Q96SQ9 19 41193049-41207539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 9.5;myeloid DC: 33.1" "Group enriched" "Detected in many" 121 "dendritic cells: 33.1;monocytes: 9.5" "Cell line enhanced" "Detected in many" "A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA049227, HPA069248" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049227: AB_2680681, HPA069248: AB_2732128" "unprognostic (1.49e-2)" "unprognostic (7.45e-2)" "unprognostic (2.45e-2)" "unprognostic (6.03e-2)" "unprognostic (3.93e-2)" "unprognostic (7.46e-2)" "unprognostic (1.27e-2)" "unprognostic (4.85e-2)" "unprognostic (2.18e-1)" "unprognostic (1.54e-2)" "unprognostic (6.25e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.60e-6)" "unprognostic (1.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.02e-1)" "unprognostic (7.66e-2)" 1.2 0.8 0.8 2.3 1.0 0.5 0.6 0.1 1.0 1.7 18.3 1.2 0.5 37.6 0.3 0.9 10.1 2.4 29.1 1.0 1.4 1.6 0.9 2.1 3.8 3.3 5.6 0.4 0.8 0.6 0.0 0.9 1.6 4.5 0.9 7.2 1.1 3.8 0.3 0.1 2.0 62.7 0.6 1.1 4.0 45.9 0.5 1.2 2.6 0.4 15.8 21.0 3.2 2.7 0.0 33.1 0.0 9.5 0.0 0.1 3.9 1.2 31.3 0.0 0.0 0.0 0.0 1.5 0.2 0.2 0.3 0.0 16.1 4.5 0.0 3.7 0.2 0.0 16.8 5.5 8.5 0.1 0.0 0.1 4.2 1.7 5.8 6.6 0.0 0.1 0.2 0.4 0.4 0.2 0.0 0.2 1.4 1.9 0.1 0.0 0.6 0.1 0.0 23.7 51.4 4.1 0.0 0.0 0.3 0.5 6.7 0.0 0.2 3.1 0.0 0.0 9.7 4.1 1.6 3.6 0.0 1.3 0.6 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 9.5 0.0 0.0 2.3 0.1 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 3.9 0.8 1.0 0.1 1.0 1.4 1.6 5.6 0.4 4.5 1.2 0.0 8.6 0.0 1.6 2.3 0.0 0.8 0.0 8.1 7.9 1.8 0.0 16.5 0.0 0.8 0.3 0.0 23.2 0.0 0.9 0.6 1.3 0.4 1.1 0.0 12.8 0.0 0.0 0.6 4.7 0.0 0.0 11.5 0.0 8.2 29.0 0.0 13.8 14.8 0.0 0.0 0.0 0.0 0.3 0.1 0.4 2.5 8.6 0.0 13.9 0.1 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 18.6;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 5.2 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 13.5 2.5 7.8 0.1 3.3 5.5 1.8 7.4 0.0 3.5 0.2 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 3.0 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 3.0 3.8 3.2 3.2 1.0 4.3 3.4 2.5 13.4 3.4 8.7 3.9 0.4 0.0 0.9 9.6 5.8 2.6 0.0 1.7 0.3 5.1 1.7 4.6 6.8 1.9 1.6 2.9 6.7 6.1 6.1 16.4 4.6 18.6 3.6 1.1 9.9 0.4 0.0 16.6 2.4 3.3 0.0 5.2 0.9 4.3 1.3 0.2 1.3 1.6 0.7 CYP2W1 "FLJ20359, MGC34287" ENSG00000073067 "Cytochrome P450 family 2 subfamily W member 1" Q8TAV3 7 983199-989640 "Predicted intracellular proteins" "Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 18.0;intestine: 9.1;skin 1: 12.1" "Cell type enriched" "Detected in many" 8 "Intestinal endocrine cells: 94.6" "Group enriched" "Detected in many" 5 "colorectal cancer: 25.3;stomach cancer: 15.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CACO-2: 9.0;Hep G2: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA012753 Uncertain "Intracellular and membrane" NA NA "HPA012753: AB_1847444" "unprognostic (7.09e-3)" "unprognostic (1.94e-2)" "unprognostic (2.75e-2)" "unprognostic (1.51e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (1.41e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (6.26e-2)" "unprognostic (2.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.34e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.85e-4)" 0.8 18.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.8 1.4 0.0 0.0 9.1 0.0 0.0 3.6 0.2 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 2.4 0.3 0.0 0.3 6.1 0.3 1.9 0.7 1.7 0.3 2.2 0.0 12.1 5.0 0.0 0.7 0.4 0.9 2.4 0.0 0.0 0.0 2.3 0.7 1.1 3.2 0.4 0.1 1.5 0.2 0.1 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.5 0.2 0.3 0.1 0.2 0.2 0.1 0.4 0.2 0.3 1.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.3 0.0 3.0 0.0 0.0 1.8 3.5 0.0 0.3 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.4 1.4 0.7 0.0 0.0 1.0 0.0 94.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 5.7 12.1 0.1 2.9 0.0 0.0 0.6 0.0 0.0 0.1 0.0 3.9 1.6 0.0 4.2 3.1 CYP39A1 ENSG00000146233 "Cytochrome P450 family 39 subfamily A member 1" Q9NYL5 6 46549580-46652830 "Enzymes, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 52.2" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 58.9" "Cancer enhanced" "Detected in many" "prostate cancer: 11.9" "Region enriched" "Detected in many" 8 "cerebellum: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 6.9;hTCEpi: 15.5;OE19: 6.7;SiHa: 9.3;U-698: 10.9" "Region enhanced" "Detected in many" "olfactory region: 24.1" "Low region specificity" "Detected in all" NA NA "unprognostic (1.33e-1)" "unprognostic (1.62e-2)" "unprognostic (8.46e-3)" "unprognostic (5.89e-2)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (4.99e-2)" "unprognostic (7.33e-2)" "unprognostic (6.11e-2)" "prognostic favorable (1.86e-4)" "unprognostic (1.54e-1)" "unprognostic (5.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" 2.6 2.0 1.7 2.9 1.9 0.0 2.9 19.3 1.9 3.6 1.9 1.5 6.4 0.4 1.9 12.0 4.9 2.3 3.4 4.8 1.6 1.1 3.3 52.2 2.6 0.2 2.3 0.9 6.5 8.7 8.6 8.3 0.2 2.3 8.2 1.9 8.0 21.0 1.8 0.5 8.5 1.4 1.7 2.2 0.6 2.7 3.3 0.9 0.0 9.4 2.3 2.1 2.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 2.0 0.3 0.0 0.0 0.0 1.2 0.4 0.1 0.0 0.6 6.9 5.0 0.0 1.0 1.9 0.9 1.6 0.0 0.0 3.0 0.0 1.8 2.0 4.7 0.0 0.0 0.5 15.5 0.0 1.8 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.7 1.7 0.5 1.3 0.1 3.3 4.4 0.8 0.0 9.3 0.0 0.2 0.5 1.7 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.9 19.3 1.9 1.6 1.1 2.3 0.9 2.3 0.9 14.9 1.0 0.0 7.1 3.5 0.2 4.6 10.2 8.1 4.5 3.5 2.0 0.0 5.0 1.6 11.8 2.3 0.5 0.0 0.3 0.9 1.7 12.3 0.0 58.9 0.2 0.0 0.0 0.0 1.9 15.3 5.8 0.2 3.3 0.0 3.1 8.0 0.9 2.9 8.9 4.1 1.5 0.0 2.1 0.7 0.1 13.4 0.0 0.0 2.3 6.0 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784265 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 45 "intestine: 145.3;liver: 464.6" "Cell type enriched" "Detected in some" 45 "Hepatocytes: 2276.5" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 145.3 0.1 0.1 56.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 464.6 0.1 0.1 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 126.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.6 0.2 0.6 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 1.9 0.4 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.1 4.5 0.3 0.0 0.0 0.0 2.2 6.7 0.0 0.5 2.6 5.0 0.5 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.4 0.0 0.7 0.1 0.7 0.1 0.7 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.6 0.6 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.3 1.0 0.3 0.0 0.3 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.6 46.7 0.8 0.0 0.0 0.5 0.0 2276.5 0.0 0.0 0.0 39.3 50.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.9 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 32.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "HPA066463, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA066463: AB_2685670, HPA072245: , HPA075539: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.2 32.5 0.1 0.1 0.1 0.1 0.1 8.0 0.0 2.2 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.5 1.6 0.6 0.3 0.6 0.2 0.1 0.0 0.9 0.3 1.1 0.2 0.2 0.0 0.2 0.2 0.2 1.2 0.7 1.5 0.3 0.3 0.1 1.3 0.2 0.0 0.7 0.2 0.5 0.9 1.5 1.3 0.3 0.9 1.3 0.0 0.7 0.0 0.0 0.6 0.5 0.1 1.0 1.0 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.9 0.0 0.2 0.8 1.6 0.5 0.4 0.6 1.7 0.0 0.7 0.5 0.0 1.6 0.5 0.2 1.1 0.7 1.1 1.2 0.1 0.8 0.4 0.2 1.5 0.6 0.4 0.6 0.2 0.3 0.3 0.3 0.2 0.1 0.6 0.5 0.5 1.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 6.8 0.1 1.6 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.2 0.3 0.0 0.0 0.0 0.0 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99680026 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 72.9;liver: 73.4;stomach 1: 21.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favorable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 1.0 3.3 0.4 2.0 0.5 0.0 1.3 0.6 0.6 1.9 32.6 0.6 1.0 30.3 0.7 0.5 5.2 0.5 8.2 0.4 0.4 0.0 6.8 73.4 2.4 0.8 0.4 0.4 0.6 12.1 0.0 1.8 0.6 0.8 4.9 5.1 0.4 0.6 1.3 0.4 4.3 72.9 0.6 0.5 0.4 21.3 0.7 0.4 0.5 0.4 2.2 4.0 3.0 2.7 0.0 0.2 0.1 0.6 0.0 0.7 0.2 0.0 2.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 8.3 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.3 0.2 23.6 0.0 0.1 0.0 0.6 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.5 0.6 0.6 0.4 0.0 0.4 0.4 0.8 0.4 11.9 11.3 11.2 107.3 41.0 13.1 1.0 346.5 14.7 12.5 3.5 11.8 1.3 0.0 58.0 1.7 2.5 640.5 46.7 44.6 1.0 3.8 166.5 9.3 330.1 0.6 7.9 52.5 9.8 8.3 0.0 2.3 4.6 3.3 7.2 117.1 6.0 69.5 210.5 2.5 4.2 20.2 0.0 3.5 6.8 4.2 51.6 1.3 12.9 85.2 352.8 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99684957-99735196 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 82.6" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 135.0" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.4 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.2 0.0 3.9 0.0 0.1 0.0 2.8 82.6 0.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.4 3.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 135.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.4 0.1 0.0 0.0 4.9 3.7 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" P24462 7 99685226-99735093 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 73.9" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 7.6" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.3;U-87 MG: 2.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 73.9 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.5 0.0 0.3 0.5 1.6 0.5 0.2 4.3 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.9 1.4 1.9 0.0 0.0 0.5 0.3 0.4 0.4 0.0 0.4 0.5 0.0 0.8 0.5 1.1 0.1 0.2 1.2 0.5 0.2 0.5 0.2 0.1 0.4 1.5 0.0 0.0 0.4 0.2 0.0 0.5 0.6 0.6 0.0 0.1 0.4 0.3 0.5 0.5 0.6 0.9 0.7 0.1 2.6 0.7 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP46A1 CYP46 ENSG00000036530 "Cytochrome P450 family 46 subfamily A member 1" Q9Y6A2 14 99684304-99727301 "Enzymes, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 49.2" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 62.8;Muller glia cells: 24.1;Rod photoreceptor cells: 25.1" "Cancer enriched" "Detected in single" 5 "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "plasmacytoid DC: 7.0" "Lineage enriched" "Detected in single" 23 "dendritic cells: 7.0" "Group enriched" "Detected in some" 4 "AF22: 4.4;U-937: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.16e-1)" "unprognostic (4.30e-1)" "unprognostic (2.50e-5)" "unprognostic (9.48e-5)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (5.37e-2)" "unprognostic (4.01e-2)" "unprognostic (1.32e-5)" "unprognostic (5.21e-2)" "unprognostic (2.44e-4)" "unprognostic (5.97e-4)" "unprognostic (1.59e-1)" "unprognostic (1.15e-2)" "unprognostic (3.88e-3)" 3.0 3.3 13.8 1.3 47.3 1.0 1.2 2.6 49.2 1.4 1.1 3.7 0.0 1.2 1.9 2.0 1.1 1.6 1.4 6.2 15.7 9.9 2.0 1.5 1.3 1.6 7.1 10.0 2.1 2.3 2.7 5.3 1.0 3.8 1.8 1.1 0.6 2.5 1.7 2.0 1.1 1.0 1.9 3.1 1.0 1.0 2.1 6.1 0.4 1.8 0.0 1.1 1.1 0.1 0.0 7.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 1.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.5 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 1.4 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 1.5 0.1 1.9 0.0 0.1 0.0 1.0 0.0 0.3 0.0 0.0 0.2 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.0 13.8 47.3 2.6 21.5 15.7 9.9 7.1 10.0 3.8 6.1 3.0 5.9 0.0 6.3 1.4 10.6 6.1 2.5 1.4 3.4 1.8 62.8 0.1 1.7 0.1 0.5 4.1 0.0 0.0 1.0 0.2 2.6 3.1 1.1 2.9 0.4 7.9 0.0 3.7 2.2 0.4 4.4 1.4 3.3 1.8 0.0 24.1 0.1 0.0 3.9 3.7 25.1 0.0 2.7 8.0 3.7 1.3 0.1 0.5 0.0 2.3 CYP4A11 "CYP4A2, CYP4AII" ENSG00000187048 "Cytochrome P450 family 4 subfamily A member 11" Q02928 1 46929177-46941484 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 78 "kidney: 36.5;liver: 141.0" "Group enriched" "Detected in some" 6 "Hepatocytes: 433.3;Proximal tubular cells: 109.9" "Cancer enriched" "Detected in some" 5 "liver cancer: 73.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.4;HL-60: 1.2;RH-30: 1.3;SiHa: 1.6;U-698: 2.3;U-937: 1.6" NA NA "unprognostic (9.05e-2)" "unprognostic (4.98e-2)" "unprognostic (4.43e-2)" "unprognostic (4.11e-1)" "unprognostic (7.81e-5)" "unprognostic (5.10e-3)" "unprognostic (1.16e-2)" "unprognostic (1.83e-2)" "unprognostic (1.92e-2)" "unprognostic (1.90e-1)" "unprognostic (1.12e-1)" "unprognostic (4.59e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-3)" "unprognostic (1.68e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.3 0.1 0.1 0.0 36.5 141.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 0.0 0.3 0.4 0.0 0.2 0.1 1.1 0.0 1.4 0.0 0.4 0.0 1.2 0.5 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.5 1.3 0.6 0.0 0.0 0.0 0.4 1.6 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.0 1.6 0.1 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.2 0.0 0.2 0.8 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 7.0 0.0 0.0 14.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.3 0.0 0.0 0.0 6.2 6.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4A22 ENSG00000162365 "Cytochrome P450 family 4 subfamily A member 22" Q5TCH4 1 47137435-47149741 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 71.0" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 99.2" "Cancer enriched" "Detected in some" 13 "liver cancer: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 5.1;SuSa: 2.6" NA NA "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-2)" "unprognostic (2.88e-3)" "unprognostic (2.76e-3)" "unprognostic (1.50e-3)" "unprognostic (2.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-2)" "unprognostic (5.29e-3)" "unprognostic (1.02e-1)" "unprognostic (1.71e-1)" "unprognostic (8.59e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.0 14.4 71.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.4 0.2 0.1 0.6 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.4 0.5 0.5 0.2 0.1 0.0 0.2 0.3 0.0 0.1 0.2 0.2 0.1 0.5 0.0 0.0 0.6 0.6 0.2 0.0 0.1 0.2 0.0 0.1 0.3 0.2 0.5 0.1 0.1 0.4 0.4 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.4 0.5 0.2 0.3 0.1 0.0 2.6 0.4 0.6 0.7 0.2 0.1 0.2 0.0 0.0 0.5 0.6 0.2 1.1 0.0 0.0 0.2 0.4 0.5 0.0 0.4 0.5 0.5 0.6 0.1 0.6 0.5 0.6 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.2 0.0 0.0 0.0 1.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enhanced" "Detected in single" "midbrain: 1.7" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enriched" "Detected in some" 8 "RT4: 81.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles NA NA Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favorable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 41.6 2.2 0.0 0.6 0.1 0.3 45.5 0.1 0.3 9.5 6.7 0.1 7.2 0.7 2.1 2.8 17.9 18.5 0.8 13.5 0.0 0.0 1.4 0.2 92.0 1.5 1.7 0.1 3.3 0.9 0.5 4.8 0.9 0.8 15.4 0.5 2.8 5.0 6.9 14.4 10.4 3.4 6.8 3.5 0.5 3.0 1.7 0.1 0.7 12.7 4.5 5.7 36.5 18.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.5 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 1.7 0.1 0.8 0.1 1140.4 70.0 0.0 114.6 0.5 0.0 4.8 0.0 602.3 304.8 0.0 0.0 0.9 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.2 4.7 3.9 5.8 0.0 0.6 0.0 0.0 2.5 0.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.6 0.7 0.0 0.0 142.5 CYP4F11 ENSG00000171903 "Cytochrome P450 family 4 subfamily F member 11" Q9HBI6 19 15912367-15934867 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 88.6" "Cell type enhanced" "Detected in many" 17 "Ductal cells: 13.3;Hepatocytes: 48.8;Urothelial cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.6;CAPAN-2: 30.3;EFO-21: 11.4;Hep G2: 14.7;RPMI-8226: 7.9;RT4: 9.1" "HPA017265, CAB033648, HPA058960" Enhanced "Intracellular and membrane" NA NA "CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862" "prognostic favorable (4.05e-4)" "unprognostic (4.12e-2)" "unprognostic (1.79e-1)" "unprognostic (5.99e-2)" "unprognostic (5.92e-3)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (2.33e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (9.28e-4)" "unprognostic (4.44e-2)" "unprognostic (9.50e-3)" "unprognostic (2.14e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-2)" "unprognostic (4.64e-2)" 0.4 2.2 3.6 0.5 4.4 0.5 1.7 1.8 5.4 1.1 2.5 4.4 0.0 7.5 0.5 11.8 7.9 2.2 12.9 0.4 3.9 1.4 4.9 88.6 2.4 0.4 2.1 3.8 0.3 3.5 0.2 0.6 0.2 8.3 2.4 1.9 0.6 2.6 3.4 0.5 0.8 15.7 0.2 9.7 0.9 2.7 1.0 3.0 0.0 2.2 2.8 1.8 4.8 2.0 0.1 0.1 0.8 1.2 0.0 0.2 0.1 7.6 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.1 11.4 0.0 6.5 0.9 0.0 3.9 0.0 0.0 0.0 0.0 2.3 14.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 1.1 0.0 0.1 0.0 6.7 0.0 0.0 0.1 7.9 2.1 9.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 0.1 0.1 0.1 0.3 0.1 0.2 0.9 0.0 0.8 0.5 0.0 0.1 1.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.7 0.1 0.0 0.1 3.6 4.4 1.8 5.4 3.9 1.4 2.1 3.8 8.3 3.0 0.0 0.0 0.0 7.8 0.1 0.0 0.3 0.0 4.0 1.2 8.7 0.0 0.0 1.7 13.3 0.0 0.0 5.3 0.0 9.9 0.0 0.0 7.8 0.0 48.8 0.0 0.0 1.2 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.0 2.5 7.5 2.9 0.0 5.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.7 13.3 CYP4F12 ENSG00000186204 "Cytochrome P450 family 4 subfamily F member 12" 19 15672757-15697174 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 53.0;liver: 24.2" "Cell type enhanced" "Detected in many" 16 "Enterocytes: 95.3;Paneth cells: 35.4;Undifferentiated cells: 26.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 39 "basophil: 5.3;eosinophil: 13.2" "Lineage enriched" "Detected in single" 76 "granulocytes: 13.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.6;HaCaT: 18.7;Hep G2: 5.2;Karpas-707: 12.6;OE19: 27.1" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (4.30e-4)" "prognostic favorable (1.21e-4)" "unprognostic (1.86e-1)" "unprognostic (1.48e-2)" "unprognostic (1.37e-2)" "unprognostic (5.32e-3)" "unprognostic (1.84e-3)" "unprognostic (9.13e-2)" "unprognostic (9.11e-2)" "unprognostic (2.50e-1)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-3)" "unprognostic (6.20e-2)" "unprognostic (5.45e-2)" "unprognostic (3.17e-1)" "prognostic favorable (2.33e-4)" 1.9 0.7 1.6 6.1 0.9 0.6 3.5 0.0 1.9 3.9 24.6 5.6 1.4 24.6 1.4 1.8 11.5 2.1 10.8 1.7 1.9 0.3 1.1 24.2 0.9 0.3 3.0 3.5 1.9 0.2 0.1 0.3 0.4 2.7 4.4 5.1 1.4 3.0 1.5 0.4 12.9 53.0 5.1 0.8 0.7 8.0 0.4 4.8 0.2 0.6 8.9 6.3 10.1 6.5 0.0 0.0 13.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.3 0.0 0.0 0.1 18.7 0.0 0.0 0.0 1.0 0.0 0.0 0.7 5.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 13.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 1.9 1.9 0.3 3.0 3.5 2.7 4.8 0.0 2.6 0.8 10.1 12.5 0.0 1.0 5.1 2.7 0.0 0.0 0.0 0.1 0.0 0.3 1.1 1.5 95.3 0.0 0.0 0.1 3.0 2.8 0.0 24.2 0.4 0.0 7.5 0.6 0.3 2.2 3.7 0.0 1.7 0.0 24.4 2.7 1.1 35.4 1.1 2.1 0.0 0.0 0.8 0.1 0.0 18.4 0.2 0.7 26.0 18.3 CYP4F2 ENSG00000186115 "Cytochrome P450 family 4 subfamily F member 2" P78329 19 15878023-15898120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 69.1;liver: 102.9" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 132.0" "Cancer enriched" "Detected in some" 9 "liver cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 8.5" "Lineage enriched" "Detected in single" 86 "granulocytes: 8.5" "Cell line enriched" "Detected in some" 4 "Hep G2: 9.0" "HPA014048, HPA017265, HPA058960" Supported "Intracellular and membrane" NA NA "HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862" "unprognostic (7.46e-3)" "unprognostic (3.58e-1)" "unprognostic (3.01e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" "unprognostic (2.87e-2)" "unprognostic (4.55e-3)" "unprognostic (6.52e-2)" "unprognostic (2.05e-1)" "unprognostic (4.64e-2)" "unprognostic (9.82e-2)" "unprognostic (2.92e-1)" "unprognostic (8.69e-4)" "unprognostic (3.24e-1)" "unprognostic (1.89e-1)" "unprognostic (7.79e-3)" 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.1 0.2 0.2 10.1 0.2 0.1 24.5 0.1 8.8 0.2 0.1 1.8 0.1 0.2 0.1 11.9 102.9 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.2 1.9 0.0 0.1 0.1 0.2 0.1 0.5 69.1 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.7 0.1 0.3 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.2 9.0 0.0 1.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 1.6 0.1 0.0 0.1 0.3 0.6 0.8 0.1 0.4 0.4 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.5 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 6.2 0.0 16.2 0.0 0.3 0.0 0.0 0.6 0.0 132.0 0.0 0.0 1.7 0.6 3.9 11.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 5.8 0.0 14.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.0 0.1 CYP4F22 FLJ39501 ENSG00000171954 "Cytochrome P450 family 4 subfamily F member 22" Q6NT55 19 15508493-15552317 "Disease related genes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" Ichthyosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 44.6;skin 1: 29.0" "Cell type enhanced" "Detected in some" 21 "Glandular cells: 1.9;granulocytes: 6.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 2.6" "Group enriched" "Detected in many" 7 "breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "intermediate monocyte: 6.1;MAIT T-cell: 4.6;non-classical monocyte: 13.2" "Group enriched" "Detected in many" 9 "monocytes: 13.2;T-cells: 4.6" "Cell line enhanced" "Detected in some" "HEL: 1.3;JURKAT: 2.8;MCF7: 5.1;RT4: 2.5;T-47d: 3.1;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA058960 Uncertain NA NA "HPA058960: AB_2683862" "unprognostic (2.32e-3)" "unprognostic (1.17e-2)" "unprognostic (6.81e-2)" "unprognostic (2.47e-2)" "unprognostic (1.03e-1)" "unprognostic (7.02e-2)" "unprognostic (1.30e-1)" "unprognostic (2.43e-1)" "unprognostic (3.33e-1)" "unprognostic (1.89e-2)" "unprognostic (9.33e-2)" "unprognostic (3.00e-2)" "unprognostic (2.21e-5)" "unprognostic (8.10e-2)" "unprognostic (3.16e-1)" "unprognostic (7.25e-3)" "unprognostic (2.03e-2)" 0.5 0.0 0.0 0.1 0.0 0.1 3.6 0.0 0.0 5.4 0.1 0.0 10.3 0.2 0.6 0.2 12.1 0.1 0.6 0.0 0.0 0.0 0.0 19.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.2 0.0 0.0 1.6 44.6 1.2 29.0 0.1 1.0 0.0 0.3 0.5 0.7 0.0 0.4 0.0 14.7 6.7 5.5 10.3 0.0 0.2 0.0 13.2 1.0 4.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.8 0.0 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.8 6.1 4.6 0.0 0.6 1.5 0.2 0.0 0.0 0.4 0.0 1.0 13.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.9 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 0.0 0.9 0.0 0.2 CYP4F3 "CYP4F, LTB4H" ENSG00000186529 "Cytochrome P450 family 4 subfamily F member 3" Q08477 19 15640897-15662825 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 159.2" "Cell type enriched" "Detected in many" 6 "Hepatocytes: 506.3" "Cancer enhanced" "Detected in many" "liver cancer: 30.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 68 "neutrophil: 33.1" "Lineage enriched" "Detected in single" 166 "granulocytes: 33.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (1.73e-2)" "unprognostic (9.70e-3)" "unprognostic (1.21e-1)" "unprognostic (1.16e-3)" "unprognostic (5.40e-1)" "unprognostic (1.57e-1)" "unprognostic (7.15e-3)" "unprognostic (5.19e-2)" "unprognostic (2.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.32e-1)" "unprognostic (1.59e-3)" "unprognostic (2.36e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-2)" "unprognostic (2.07e-1)" 0.4 0.1 0.3 0.3 1.5 24.8 0.1 0.1 2.2 2.1 3.4 6.5 0.0 3.1 0.1 0.4 8.6 0.3 19.8 0.2 0.8 0.2 23.7 159.2 0.7 0.0 0.4 1.9 0.1 0.2 0.0 0.2 0.0 1.6 0.3 0.5 0.0 1.3 0.1 0.1 1.2 13.4 0.1 1.0 2.6 1.7 0.2 1.8 0.0 0.1 1.1 0.8 1.8 2.7 0.0 0.0 33.1 0.1 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.0 0.0 0.1 0.0 0.0 9.1 0.0 0.1 0.0 0.3 0.0 0.1 1.9 10.9 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.1 2.2 0.8 0.2 0.4 1.9 1.6 1.8 8.9 5.9 5.1 2.3 0.9 0.0 0.8 91.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 13.5 23.3 0.2 0.1 0.3 1.7 1.1 506.3 0.0 0.0 50.9 6.2 10.2 0.4 0.0 0.4 0.0 0.0 5.6 0.0 2.5 7.0 0.0 31.2 0.0 0.0 0.2 0.0 0.1 5.6 0.0 0.8 8.3 10.8 CYP4F8 ENSG00000186526 "Cytochrome P450 family 4 subfamily F member 8" P98187 19 15615218-15630638 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 155 "ductus deferens: 265.6;seminal vesicle: 360.6" "Cell type enhanced" "Detected in some" 14 "Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4" "Group enriched" "Detected in some" 31 "breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (1.70e-2)" "unprognostic (5.46e-3)" "unprognostic (3.21e-2)" "unprognostic (3.97e-6)" "unprognostic (3.51e-3)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-2)" "unprognostic (1.15e-2)" "unprognostic (1.02e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 265.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 360.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.4 CYP4V2 CYP4AH1 ENSG00000145476 "Cytochrome P450 family 4 subfamily V member 2" Q6ZWL3 4 186191520-186213456 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sensory transduction, Vision" "Monooxygenase, Oxidoreductase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Muller glia cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 13.1;SK-MEL-30: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029122 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA029122: AB_10601806" "unprognostic (1.65e-1)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.05e-1)" "unprognostic (6.49e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.49e-7)" "unprognostic (3.25e-2)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" 6.6 16.6 7.8 5.0 12.4 1.6 5.5 8.9 7.5 6.7 8.0 8.9 4.9 11.4 5.7 4.2 5.2 6.2 13.7 7.4 7.7 4.6 21.6 64.7 7.3 4.1 7.7 9.0 6.3 12.1 30.8 16.1 3.0 6.7 5.6 8.2 19.1 6.2 9.1 3.3 2.8 14.7 6.4 7.0 7.5 5.2 3.2 7.4 4.4 11.9 2.1 3.8 8.0 5.1 2.3 2.5 0.0 6.2 1.3 4.0 1.5 2.6 1.8 0.6 0.0 11.3 4.6 0.1 3.8 8.1 1.4 2.0 0.0 10.9 1.0 0.5 2.5 5.7 1.3 1.3 1.2 0.4 6.5 1.3 4.1 0.4 0.5 3.4 2.2 2.0 4.2 0.5 1.4 0.7 4.7 0.1 4.2 1.6 13.1 4.7 2.3 2.5 0.6 1.4 1.1 0.0 2.1 0.5 1.1 4.6 5.2 2.8 4.1 0.9 0.0 19.4 0.2 1.9 3.5 4.2 3.0 0.7 3.3 1.6 0.0 0.0 0.5 9.0 8.3 3.6 0.0 1.2 0.0 4.0 4.1 2.5 1.0 2.5 3.4 1.5 2.3 2.7 2.3 0.0 1.3 6.2 2.5 2.1 1.5 7.8 12.4 8.9 7.5 7.7 4.6 7.7 9.0 6.7 7.4 6.0 7.8 8.3 3.1 2.3 31.1 15.3 45.9 12.0 10.3 14.0 29.5 1.8 8.3 16.1 2.4 5.5 19.2 0.0 19.5 1.7 8.4 5.5 6.9 92.7 11.5 4.8 16.3 9.2 11.2 1.7 4.6 7.1 3.3 0.0 19.1 64.2 11.0 10.5 6.0 31.8 27.1 0.0 10.2 8.1 5.4 2.8 0.8 10.7 8.9 5.0 CYP4X1 MGC40051 ENSG00000186377 "Cytochrome P450 family 4 subfamily X member 1" Q8N118 1 47023568-47050751 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 38.1" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5" "Low region specificity" "Detected in all" HPA017661 Approved NA NA "HPA017661: AB_2669633" "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (1.78e-2)" "unprognostic (9.88e-2)" "unprognostic (1.56e-3)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (2.76e-2)" "unprognostic (3.03e-2)" "unprognostic (1.79e-3)" "unprognostic (3.65e-2)" "unprognostic (8.56e-2)" "unprognostic (5.03e-2)" 7.9 3.6 9.0 1.1 14.9 0.5 16.0 7.1 16.9 38.1 2.0 1.6 2.5 2.1 3.6 3.2 12.0 9.7 2.0 6.7 4.8 10.6 6.3 10.0 8.9 2.0 3.3 13.5 1.7 2.0 2.0 4.1 1.5 7.8 8.0 2.3 17.6 23.7 3.4 4.5 5.0 1.8 2.4 2.0 1.0 14.3 4.2 0.9 0.0 4.0 6.9 8.8 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.9 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.9 1.0 0.0 0.0 0.5 0.0 0.6 0.2 3.8 0.0 0.0 0.3 0.0 0.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 14.9 7.1 16.9 4.8 10.6 3.3 13.5 7.8 0.9 20.8 10.5 0.0 23.5 2.3 0.9 1.0 0.0 156.6 27.3 0.0 0.0 0.0 0.0 0.3 6.0 2.3 0.0 0.0 0.6 0.0 1.9 10.7 0.0 2.5 2.9 0.0 0.0 0.6 0.3 5.6 9.8 0.6 5.0 0.0 0.0 0.0 0.2 0.0 19.4 1.3 0.7 0.0 14.5 0.0 1.5 1.3 0.1 0.0 0.6 26.2 CYP4Z1 CYP4A20 ENSG00000186160 "Cytochrome P450 family 4 subfamily Z member 1" Q86W10 1 47067488-47118319 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "breast: 23.1" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9" "Cancer enriched" "Detected in some" 50 "breast cancer: 42.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 39 "HDLM-2: 13.7;SK-BR-3: 5.9" NA NA "unprognostic (4.11e-2)" "unprognostic (2.57e-2)" "unprognostic (2.46e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (4.33e-4)" "unprognostic (1.10e-1)" "unprognostic (3.53e-3)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (6.82e-3)" "unprognostic (5.09e-3)" "unprognostic (3.88e-2)" "unprognostic (6.46e-2)" "unprognostic (3.49e-3)" 2.5 0.2 0.4 0.4 0.9 0.0 23.1 0.4 2.0 1.0 0.4 0.4 0.4 0.0 0.4 0.8 0.8 0.7 0.4 0.4 0.4 1.8 0.4 1.5 2.1 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.7 1.3 0.0 0.4 1.5 0.8 0.5 2.2 0.4 0.4 0.4 0.4 0.2 1.0 0.4 0.6 0.4 0.4 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 2.0 0.4 1.8 0.4 0.4 0.7 0.4 8.9 0.6 0.0 0.4 0.1 0.0 0.2 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 CYP51A1 "CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1" ENSG00000001630 "Cytochrome P450 family 51 subfamily A member 1" Q16850 7 92112151-92142952 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 96.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041325, HPA043508" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA041325: AB_2677411, HPA043508: AB_2678520" "unprognostic (6.68e-2)" "prognostic unfavorable (6.12e-4)" "unprognostic (3.48e-2)" "unprognostic (1.18e-2)" "unprognostic (7.82e-2)" "unprognostic (3.60e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.84e-2)" "unprognostic (1.36e-1)" "unprognostic (9.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.59e-9)" "unprognostic (1.82e-1)" "unprognostic (2.73e-1)" "unprognostic (5.13e-2)" "unprognostic (1.09e-3)" 10.3 27.0 16.7 8.1 22.1 10.5 15.5 13.3 32.0 11.8 21.1 32.9 6.3 33.1 9.1 15.3 23.4 7.1 10.3 9.9 18.6 20.8 18.6 80.9 22.2 5.0 17.2 13.7 21.0 20.2 32.4 11.9 8.8 47.1 18.2 16.9 17.1 11.0 7.7 4.3 12.8 28.8 8.3 43.7 7.3 18.1 35.7 19.5 2.3 14.1 18.7 10.0 9.0 13.2 14.2 14.1 3.5 13.9 6.7 10.7 7.1 21.4 10.5 26.6 17.0 18.7 30.7 3.8 7.3 22.1 9.5 26.0 25.3 39.3 18.7 11.6 12.6 96.2 18.8 23.1 46.1 11.1 7.8 16.4 5.4 11.2 19.0 25.6 11.0 8.1 22.2 21.0 37.1 39.0 8.4 9.7 3.8 20.2 43.2 11.1 22.0 2.3 10.2 19.8 8.8 10.5 7.6 5.5 42.2 43.0 36.4 18.7 12.5 15.5 30.9 22.6 12.6 11.2 13.2 11.5 13.0 14.6 18.8 9.5 14.7 13.1 17.1 10.0 14.6 16.6 1.8 9.7 3.5 10.7 13.9 7.1 14.2 7.6 8.4 14.1 10.7 7.2 9.2 1.5 6.7 8.3 12.4 5.8 7.1 16.7 22.1 13.3 32.0 18.6 20.8 17.2 13.7 47.1 19.5 62.5 133.7 7.5 1.0 2.3 2.1 1.2 7.6 28.1 77.3 1.8 2.0 1.3 1.7 9.2 70.7 2.1 14.4 23.3 17.0 0.8 1.8 1.3 27.7 4.2 1.3 0.0 10.4 8.6 6.6 27.7 3.4 2.1 0.0 1.0 12.0 1.9 12.3 10.4 1.4 1.7 1.8 0.0 2.8 3.2 1.5 4.6 3.7 1.0 11.5 2.1 CYP7A1 CYP7 ENSG00000167910 "Cytochrome P450 family 7 subfamily A member 1" P22680 8 58490178-58500236 "Enzymes, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "liver: 50.4" "Cell type enriched" "Detected in single" 12 "Hepatocytes: 4.7" "Cancer enriched" "Detected in single" 96 "liver cancer: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (5.20e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-2)" "prognostic favorable (3.19e-4)" "unprognostic (7.60e-2)" "unprognostic (5.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (8.43e-3)" "unprognostic (3.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.5 0.0 0.0 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.2 0.5 0.0 0.4 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 CYP8B1 CYP12 ENSG00000180432 "Cytochrome P450 family 8 subfamily B member 1" Q9UNU6 3 42856005-42876165 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 132.7" "Cell type enriched" "Detected in some" 57 "Hepatocytes: 737.2" "Cancer enriched" "Detected in some" 46 "liver cancer: 69.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Group enriched" "Detected in some" 5 "BEWO: 6.8;HEL: 1.7;Hep G2: 2.6;SK-BR-3: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.58e-2)" "unprognostic (5.41e-2)" "unprognostic (6.38e-2)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (1.42e-3)" "unprognostic (4.47e-3)" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (4.04e-3)" "unprognostic (5.86e-3)" "unprognostic (2.74e-1)" "unprognostic (3.37e-1)" "unprognostic (1.03e-1)" "unprognostic (3.63e-1)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 6.7 132.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.2 0.1 0.2 0.1 0.4 0.7 0.3 0.2 0.0 0.0 6.8 0.1 0.0 0.0 0.0 0.5 0.3 0.2 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 1.7 0.2 2.6 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.2 0.0 0.4 0.2 0.0 0.3 0.1 0.4 0.5 0.6 0.3 0.3 0.5 0.1 0.0 0.6 3.1 0.3 0.4 0.3 0.1 0.3 0.3 0.6 0.3 0.2 0.4 0.1 0.3 0.3 0.4 0.1 1.4 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 737.2 0.1 0.0 0.0 10.4 10.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 CYS1 ENSG00000205795 "Cystin 1" Q717R9 2 10056780-10080944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 75.1" "Group enriched" "Detected in some" 5 "Cholangiocytes: 17.8;Collecting duct cells: 48.8;Distal tubular cells: 59.7;Muller glia cells: 31.8;Proximal tubular cells: 43.8" "Cancer enhanced" "Detected in many" "renal cancer: 46.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RPTEC TERT1: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.48e-2)" "unprognostic (8.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.00e-2)" "unprognostic (2.80e-1)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (1.94e-2)" "unprognostic (9.53e-2)" "unprognostic (7.05e-2)" "unprognostic (7.03e-2)" "prognostic favorable (1.27e-5)" "unprognostic (2.19e-3)" "unprognostic (1.47e-1)" "unprognostic (8.93e-2)" "unprognostic (1.20e-2)" 1.4 0.8 3.2 3.2 1.6 0.0 0.9 2.8 2.6 8.1 4.5 2.1 2.7 1.2 5.5 6.6 3.3 3.4 14.9 2.8 2.0 1.9 75.1 0.4 3.1 0.5 1.4 3.1 6.9 17.1 0.2 3.2 0.0 2.4 2.6 0.9 5.9 1.4 3.9 0.5 0.7 1.7 3.1 1.5 1.3 1.9 1.4 0.9 0.1 7.8 2.4 1.0 2.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.0 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.2 1.9 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.9 0.1 0.0 2.7 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.6 2.8 2.6 2.0 1.9 1.4 3.1 2.4 0.9 6.0 0.6 0.0 0.0 0.5 8.9 7.1 17.8 0.0 0.0 48.8 0.0 0.0 59.7 5.8 0.0 0.0 0.0 0.0 1.0 0.3 3.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 31.8 0.5 0.0 4.2 43.8 1.3 0.0 2.3 0.0 1.2 0.1 0.0 0.0 0.0 0.0 CYSLTR1 "CysLT(1), CysLT1, CYSLT1R" ENSG00000173198 "Cysteinyl leukotriene receptor 1" Q9Y271 X 78271464-78327691 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.9;esophagus: 24.6" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 54.8;Ciliated cells: 65.6;Club cells: 67.1;granulocytes: 76.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 11.6;Karpas-707: 7.5;NB-4: 16.2;RPMI-8226: 24.7;THP-1: 15.2;U-937: 16.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010546 Approved NA NA "HPA010546: AB_1078268" "unprognostic (9.48e-2)" "unprognostic (6.01e-5)" "unprognostic (4.72e-3)" "unprognostic (3.04e-1)" "unprognostic (6.30e-2)" "unprognostic (2.80e-3)" "unprognostic (2.52e-1)" "unprognostic (8.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.53e-2)" "unprognostic (4.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.41e-4)" "unprognostic (5.82e-2)" "unprognostic (3.56e-2)" "unprognostic (9.87e-2)" "unprognostic (8.94e-2)" 7.3 2.0 1.7 7.8 1.7 2.8 5.4 0.8 2.2 3.0 3.3 1.7 2.9 2.2 2.3 4.4 24.6 2.3 5.6 3.1 2.3 1.9 4.8 2.7 6.9 19.5 3.8 0.8 1.7 2.0 1.7 1.5 3.3 2.9 3.7 4.8 3.1 5.4 0.8 1.7 3.1 7.1 4.2 5.1 22.8 5.2 2.3 4.0 4.7 4.5 4.8 11.3 9.8 3.5 8.1 7.4 33.9 11.9 4.1 3.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 11.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 16.2 0.0 0.0 0.0 3.3 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 16.8 0.0 5.8 6.3 33.9 0.0 10.9 0.0 8.1 2.4 0.1 4.8 5.8 3.7 0.0 18.4 4.1 11.9 7.4 0.5 2.8 1.7 1.7 0.8 2.2 2.3 1.9 3.8 0.8 2.9 4.0 62.5 54.8 40.4 3.9 3.3 2.9 0.6 0.0 65.6 67.1 0.0 5.9 0.3 0.0 0.1 0.0 9.0 0.0 0.0 0.2 0.2 1.4 1.2 76.2 0.0 23.3 0.0 0.0 3.7 30.2 0.0 0.6 32.2 6.8 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.2 3.1 0.7 17.5 0.5 1.4 CYSLTR2 "CysLT(2), CYSLT2R" ENSG00000152207 "Cysteinyl leukotriene receptor 2" Q9NS75 13 48653711-48711226 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4" "Cell type enhanced" "Detected in some" 12 "Macrophages: 4.3;Melanocytes: 5.0;Sertoli cells: 12.9;Smooth muscle cells: 5.1" "Group enriched" "Detected in many" 6 "melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 12 "eosinophil: 37.2" "Lineage enriched" "Detected in many" 12 "granulocytes: 37.2" "Cell line enriched" "Detected in some" 43 "HDLM-2: 44.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA046528 Approved NA NA "HPA046528: AB_2679687" "unprognostic (9.83e-3)" "unprognostic (2.72e-3)" "unprognostic (1.05e-2)" "unprognostic (6.81e-2)" "unprognostic (2.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.11e-1)" "unprognostic (7.41e-3)" "unprognostic (8.33e-2)" "unprognostic (1.83e-1)" "unprognostic (5.44e-2)" "unprognostic (5.93e-2)" "unprognostic (1.88e-3)" "unprognostic (3.79e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-2)" "unprognostic (1.18e-2)" 2.0 11.4 3.4 3.9 4.2 0.7 1.0 1.6 8.0 0.9 1.0 1.1 25.1 2.1 1.3 1.7 0.7 3.4 1.6 11.5 4.1 3.4 1.8 1.0 1.5 4.4 3.3 1.5 5.4 0.5 0.7 2.3 22.6 3.7 3.4 1.1 2.9 0.7 22.4 0.5 1.3 2.5 0.7 2.3 6.9 1.1 1.0 2.9 1.0 1.1 0.5 1.5 1.0 1.2 0.0 0.9 37.2 3.2 0.4 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 1.0 37.2 0.2 3.2 0.0 0.0 0.4 0.0 0.9 0.0 0.5 0.1 0.1 0.4 2.0 0.0 0.3 0.4 3.4 4.2 1.6 8.0 4.1 3.4 3.3 1.5 3.7 2.9 0.0 1.4 0.5 0.1 0.5 0.0 0.8 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 1.0 4.1 0.0 1.1 0.0 0.6 0.0 0.0 3.1 2.1 0.0 0.3 4.3 5.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 5.1 0.0 0.1 0.0 2.4 1.9 0.0 0.0 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" 9 137224635-137226311 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "esophagus: 33.4" "Cell type enriched" "Detected in some" 6 "Pancreatic endocrine cells: 33.8" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 10.0;CAPAN-2: 12.7;HaCaT: 14.1;HeLa: 12.5;MCF7: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" Yes No "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.7 0.4 1.0 0.7 0.9 0.2 0.8 0.7 1.7 1.4 0.7 0.7 0.7 0.3 0.7 0.7 33.4 1.0 0.7 0.7 1.4 1.3 1.4 0.7 0.7 0.7 0.8 0.7 0.7 0.7 0.3 3.5 0.7 0.7 1.1 0.0 0.7 2.2 0.7 0.7 8.1 0.7 0.7 0.7 0.7 0.8 2.2 0.7 0.7 1.3 0.7 5.3 0.7 2.1 0.9 0.6 0.9 3.0 0.9 0.3 0.1 10.0 1.2 1.0 2.1 0.0 0.1 2.8 0.3 0.3 0.4 0.2 0.7 12.7 0.7 0.8 0.2 0.4 14.1 0.3 3.2 0.0 1.3 1.0 0.2 12.5 6.6 0.7 0.1 0.6 0.3 1.5 0.4 0.1 0.7 0.1 1.0 0.4 2.2 0.8 19.6 0.4 0.7 0.5 2.0 1.5 1.5 1.3 1.7 0.5 0.7 0.3 1.0 2.1 1.8 0.5 0.7 4.0 0.2 0.5 0.8 0.5 1.8 0.3 1.2 0.9 0.7 0.8 0.6 0.8 0.9 0.2 0.2 0.3 1.7 0.1 0.9 0.3 0.2 0.6 0.8 0.2 0.3 0.7 0.9 3.0 0.4 0.2 0.1 1.0 0.9 0.7 1.7 1.4 1.3 0.8 0.7 0.7 0.7 0.0 0.6 0.0 0.2 0.0 0.1 0.2 0.0 0.0 4.5 5.2 0.0 0.4 0.0 1.1 0.5 0.0 0.4 0.0 5.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 33.8 0.0 0.4 0.5 0.5 0.0 0.2 1.9 0.3 0.0 0.0 0.0 0.2 1.1 CYSTM1 "C5orf32, ORF1-FL49" ENSG00000120306 "Cysteine rich transmembrane module containing 1" Q9H1C7 5 140174642-140282052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 171.2" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 2176.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 54.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 54.8" "Cell line enhanced" "Detected in many" "OE19: 72.4;RPTEC TERT1: 42.2" "Low region specificity" "Detected in all" HPA050930 Enhanced NA NA "HPA050930: AB_2681278" "unprognostic (7.39e-2)" "unprognostic (3.68e-2)" "unprognostic (4.46e-2)" "prognostic favorable (1.31e-4)" "unprognostic (5.38e-2)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.26e-1)" "unprognostic (1.12e-1)" "unprognostic (2.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.69e-5)" "unprognostic (7.63e-2)" "unprognostic (2.23e-1)" "unprognostic (4.67e-2)" "unprognostic (1.14e-2)" 22.0 30.2 18.0 9.4 19.8 23.1 43.1 6.2 20.9 9.6 25.0 8.9 8.5 47.2 9.2 14.1 8.3 24.0 56.9 19.9 16.4 14.2 48.8 11.8 23.0 13.4 17.3 13.6 9.1 31.5 12.4 15.0 10.8 23.1 7.5 22.2 21.1 13.9 8.4 46.8 6.2 36.5 10.5 18.6 8.9 171.2 12.0 12.2 2.8 20.1 21.2 4.0 14.0 16.6 2.5 9.5 54.8 5.3 0.5 2.2 2.4 6.5 14.4 1.2 7.3 20.3 16.9 5.7 2.8 10.2 4.7 9.6 16.2 11.9 2.8 10.0 6.5 23.5 4.4 6.2 7.4 3.0 6.2 10.6 0.4 5.8 10.9 16.3 0.8 7.3 4.7 10.0 5.7 9.0 8.1 9.0 11.5 5.0 8.4 1.1 7.2 3.5 2.1 1.8 72.4 6.5 1.0 1.4 5.3 42.2 31.8 2.7 2.2 4.3 2.9 34.6 3.8 10.3 2.7 1.9 2.1 2.1 1.7 3.5 6.9 4.3 2.7 11.2 1.0 4.3 1.9 5.3 3.0 0.7 5.2 1.1 2.5 1.5 1.0 6.3 1.6 0.4 0.6 54.8 0.5 5.2 9.5 2.2 2.4 18.0 19.8 6.2 20.9 16.4 14.2 17.3 13.6 23.1 12.2 294.8 102.9 70.3 392.9 150.7 4.8 94.0 394.9 426.9 161.5 544.3 2.0 332.6 2176.8 534.5 379.9 108.8 797.8 0.0 749.4 21.2 132.9 299.0 117.6 78.1 176.9 11.1 418.4 86.5 34.6 908.1 94.0 93.9 374.5 157.9 230.8 109.5 936.6 768.0 109.6 936.2 14.3 142.3 215.9 202.3 36.6 99.4 328.7 57.5 263.6 550.9 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 38.8" "Cancer enhanced" "Detected in all" "melanoma: 47.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9" "Cell line enhanced" "Detected in many" "WM-115: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (2.63e-5)" 24.0 9.1 10.9 6.6 14.4 6.1 22.0 14.2 17.6 10.4 16.4 7.0 5.7 15.1 13.0 8.1 13.4 12.6 13.9 21.1 11.4 7.2 8.8 3.0 14.0 5.4 9.4 10.7 11.0 6.6 9.4 7.1 66.6 9.4 6.8 6.7 17.8 8.6 8.7 12.3 15.6 18.5 15.2 8.5 7.5 9.2 26.0 6.5 2.9 20.4 10.8 5.0 7.7 16.5 0.6 1.8 0.7 0.4 3.3 5.9 0.4 21.6 5.5 5.2 3.6 24.5 29.0 7.4 12.8 11.2 12.7 12.1 8.4 10.8 2.9 7.8 25.8 16.4 20.4 3.6 9.3 8.5 0.2 5.1 0.8 6.5 1.0 11.6 0.9 1.4 20.5 4.2 6.7 9.8 5.7 2.2 4.3 3.4 0.4 9.2 3.5 0.7 3.8 3.6 2.9 7.4 3.8 14.0 1.6 9.8 2.6 3.4 6.5 7.9 27.8 22.5 4.7 1.7 6.1 8.0 8.7 23.2 9.4 7.8 1.0 0.3 3.0 2.8 2.3 35.5 0.7 0.4 0.0 2.2 0.2 5.9 0.3 1.0 2.4 0.4 0.6 0.1 1.5 0.3 3.3 0.4 1.8 0.8 0.4 10.9 14.4 14.2 17.6 11.4 7.2 9.4 10.7 9.4 6.5 14.9 8.0 2.4 1.7 13.5 4.8 16.5 2.5 2.7 3.4 3.5 7.9 12.6 5.0 3.3 9.9 14.7 7.5 0.0 2.4 7.4 14.4 3.0 12.7 1.5 9.9 14.3 2.9 16.0 2.7 12.1 15.3 4.6 30.4 1.0 5.8 8.8 6.4 5.3 12.4 1.0 1.8 38.8 24.0 19.5 10.5 9.9 12.7 5.0 6.9 1.6 CYTH4 "CYT4, cytohesin-4, PSCD4" ENSG00000100055 "Cytohesin 4" Q9UIA0 22 37282027-37315345 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.3;lymphoid tissue: 53.9" "Cell type enhanced" "Detected in some" 11 "granulocytes: 55.4;Hofbauer cells: 64.0;Kupffer cells: 57.8;Macrophages: 83.4;T-cells: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 12.1;HMC-1: 50.8;THP-1: 33.3;U-266/70: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004065, HPA071573" Approved Supported "Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol" NA NA "Plasma membrane" "Cytokinetic bridge, Centriolar satellite, Cytosol" "HPA004065: , HPA071573: AB_2686418" "unprognostic (4.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" "unprognostic (9.28e-3)" "unprognostic (9.25e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (5.84e-2)" "unprognostic (3.30e-3)" "unprognostic (1.23e-1)" "unprognostic (3.31e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (2.41e-8)" "unprognostic (3.70e-2)" "unprognostic (1.92e-2)" "unprognostic (5.56e-2)" "unprognostic (2.07e-1)" 13.6 6.6 7.0 32.0 9.2 24.2 7.6 1.5 4.2 2.9 5.0 7.0 0.9 4.1 3.9 6.5 3.2 5.5 8.3 9.2 4.7 3.7 5.1 4.5 14.8 27.4 10.3 2.6 2.5 3.1 1.1 3.7 13.5 6.9 4.0 4.8 4.6 10.3 2.1 2.1 3.0 13.2 6.0 9.9 53.9 5.4 2.3 7.5 12.9 3.6 2.9 22.9 12.0 3.2 8.0 27.2 52.3 31.4 11.4 15.1 16.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.1 0.0 0.8 0.0 0.0 0.2 0.0 1.8 0.0 3.5 0.0 0.0 0.0 12.1 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 4.5 0.0 0.0 0.3 0.4 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 0.0 10.3 1.3 1.6 6.9 4.1 0.1 3.7 15.6 21.6 15.1 26.4 10.6 7.8 8.3 11.9 12.4 8.0 8.0 10.6 52.3 11.4 31.4 27.2 7.5 16.1 7.0 9.2 1.5 4.2 4.7 3.7 10.3 2.6 6.9 7.5 3.0 12.5 18.1 0.7 2.2 0.0 1.6 0.0 0.0 3.4 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.6 2.1 0.3 55.4 0.8 64.0 0.0 0.0 2.5 57.8 0.0 0.6 83.4 6.8 1.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.1 1.9 0.8 48.9 0.0 0.6 CYTIP "B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP" ENSG00000115165 "Cytohesin 1 interacting protein" O60759 2 157414619-157488961 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.4;lymphoid tissue: 92.9" "Cell type enriched" "Detected in many" 4 "monocytes: 788.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.6;HDLM-2: 11.7;Karpas-707: 39.9;RPMI-8226: 12.2;U-266/70: 68.0;U-266/84: 25.5" "Region enhanced" "Detected in single" "basal ganglia: 0.4" "Not detected" "Not detected" HPA007191 Approved Approved Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA007191: AB_1855801" "unprognostic (3.61e-3)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "prognostic favorable (9.12e-4)" "unprognostic (5.71e-2)" "unprognostic (1.36e-3)" "unprognostic (9.13e-2)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.41e-2)" "unprognostic (1.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (5.49e-2)" "unprognostic (5.43e-2)" "unprognostic (3.78e-2)" 9.4 1.4 1.4 33.3 1.6 32.3 3.9 0.8 1.0 4.4 9.7 1.6 0.8 9.3 3.1 4.2 6.6 2.8 5.8 3.8 1.5 1.5 4.1 3.9 26.8 92.9 3.1 0.6 2.9 3.1 0.0 1.5 1.3 2.0 2.4 5.0 3.1 11.5 3.1 1.4 2.1 17.4 2.1 4.3 48.3 14.4 3.3 1.3 40.5 3.2 3.8 61.8 24.1 3.2 21.9 13.0 48.5 53.3 19.9 53.4 31.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 39.9 0.2 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 12.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 68.0 25.5 6.6 0.6 1.8 0.0 48.5 8.4 24.5 30.6 27.8 30.9 21.9 32.4 28.9 13.0 21.1 53.4 40.7 48.2 19.9 53.3 6.7 31.3 31.6 1.4 1.6 0.8 1.0 1.5 1.5 3.1 0.6 2.0 1.3 3.0 16.4 102.3 1.0 18.5 0.0 2.0 5.1 0.0 2.3 1.8 0.0 0.5 13.3 0.2 1.2 1.2 0.5 23.3 1.7 9.8 8.5 0.5 6.9 1.0 24.4 0.0 1.7 4.9 80.4 1.7 0.0 153.9 79.2 788.1 1.9 0.0 0.2 0.0 0.0 0.8 0.0 0.0 3.2 0.0 0.2 15.6 2.5 190.7 1.5 0.1 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.2" "Cell type enhanced" "Detected in some" 12 "Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5" "Cancer enhanced" "Detected in many" "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "NK-cell: 18.8" "Lineage enriched" "Detected in many" 10 "NK-cells: 18.8" "Cell line enhanced" "Detected in some" "HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA067201: AB_2732760" "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (7.43e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.25e-4)" 5.2 2.3 6.5 2.0 6.0 10.8 6.4 0.7 4.2 11.0 4.9 9.2 4.9 1.0 10.1 2.8 5.3 7.3 4.6 4.4 5.4 4.4 1.2 0.8 17.1 9.4 6.2 2.1 2.5 1.1 1.7 1.6 42.2 4.7 10.5 1.8 4.5 4.0 14.2 0.8 3.3 2.1 4.2 11.0 1.1 4.9 2.2 8.4 0.5 5.7 3.6 4.8 13.2 7.4 0.0 0.3 1.9 1.0 18.8 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 34.2 0.0 0.0 1.7 0.0 0.0 0.0 83.4 0.1 0.0 0.0 1.2 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 5.2 0.0 0.0 0.0 11.7 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 20.2 1.9 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.1 18.8 0.0 0.3 0.0 0.6 6.5 6.0 0.7 4.2 5.4 4.4 6.2 2.1 4.7 8.4 0.0 0.3 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.1 15.8 0.5 9.2 0.0 12.7 0.0 0.0 1.3 0.0 0.0 0.0 5.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.5 0.0 0.0 0.6 CYYR1 C21orf95 ENSG00000166265 "Cysteine and tyrosine rich 1" Q96J86 21 26466209-26573284 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "breast: 59.8" "Group enriched" "Detected in many" 6 "Endothelial cells: 113.7;Ito cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 38 "plasmacytoid DC: 21.1" "Lineage enriched" "Detected in single" 73 "dendritic cells: 21.1" "Cell line enhanced" "Detected in some" "AF22: 9.0;NTERA-2: 25.2;PC-3: 6.9;RH-30: 10.7;SCLC-21H: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034921, HPA067685" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB034921: AB_2089315, HPA067685: AB_2685887" "unprognostic (5.64e-2)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-2)" "unprognostic (2.88e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.46e-1)" "unprognostic (2.44e-3)" "unprognostic (9.29e-3)" "unprognostic (2.26e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" 30.9 28.9 3.8 7.7 4.4 4.0 59.8 2.1 4.3 19.0 8.4 2.7 13.4 3.5 15.1 14.7 13.1 8.6 10.8 29.1 4.7 3.9 10.6 7.1 23.8 13.4 5.6 2.5 9.8 4.5 5.1 3.5 21.7 3.9 11.7 4.0 11.6 5.4 10.5 14.5 4.8 6.8 14.6 5.0 34.1 5.9 9.2 2.5 3.6 11.2 9.1 2.7 11.2 23.9 0.0 21.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.2 0.0 3.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 25.2 0.0 6.9 0.0 10.7 0.0 1.0 0.0 21.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 21.1 0.0 0.0 3.8 4.4 2.1 4.3 4.7 3.9 5.6 2.5 3.9 2.5 0.0 1.1 0.9 1.1 10.4 0.0 5.6 0.0 1.4 2.3 14.0 0.0 0.1 3.3 0.0 0.6 113.7 0.0 0.0 0.0 0.2 6.1 0.4 0.0 0.0 0.3 0.0 0.0 60.8 2.7 0.9 2.0 1.2 6.8 1.0 0.0 0.5 0.1 0.0 0.0 2.6 0.0 0.0 3.3 0.2 1.1 4.6 0.2 0.0 0.0 0.7 DAAM2 KIAA0381 ENSG00000146122 "Dishevelled associated activator of morphogenesis 2" Q86T65 6 39792298-39904877 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 83.3" "Cell type enriched" "Detected in many" 5 "Sertoli cells: 148.8" "Cancer enhanced" "Detected in all" "melanoma: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051300, HPA054630" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA051300: AB_2681430, HPA054630: AB_2682549" "unprognostic (7.53e-2)" "unprognostic (6.02e-3)" "unprognostic (4.49e-2)" "unprognostic (7.93e-2)" "unprognostic (8.24e-2)" "unprognostic (4.28e-2)" "unprognostic (2.43e-2)" "unprognostic (1.05e-3)" "unprognostic (1.33e-1)" "unprognostic (5.89e-2)" "unprognostic (2.17e-1)" "unprognostic (5.24e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.67e-2)" "unprognostic (8.54e-2)" "unprognostic (7.94e-2)" "unprognostic (8.54e-4)" 21.5 17.8 34.8 6.7 43.0 1.7 7.8 4.4 52.2 9.3 6.4 83.3 8.0 7.6 7.5 8.5 28.3 8.9 5.9 6.1 40.4 25.2 5.9 4.0 8.4 2.8 42.8 24.8 7.3 5.2 3.5 2.1 9.4 41.3 8.7 7.1 5.1 4.3 17.6 23.8 4.4 8.9 13.7 48.8 15.5 7.0 8.7 51.9 0.0 5.0 2.1 2.2 4.6 4.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.7 0.1 0.1 4.4 5.9 1.0 0.5 0.4 0.0 0.0 0.2 6.6 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 4.1 0.0 0.0 25.8 0.0 0.1 0.0 7.2 0.0 13.8 0.0 0.0 25.3 0.0 0.6 0.0 0.7 1.3 0.0 0.0 4.6 3.5 0.0 0.0 0.9 1.0 0.0 0.3 31.3 5.6 0.0 0.0 0.2 9.6 2.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 34.8 43.0 4.4 28.9 40.4 25.2 42.8 24.8 41.3 51.9 8.9 9.8 0.0 0.8 1.5 1.7 2.1 0.0 2.7 6.8 0.0 0.0 0.4 0.0 0.4 3.6 2.0 0.0 0.0 3.0 0.4 11.3 0.8 0.0 1.0 0.2 0.0 0.0 3.1 15.2 4.2 21.9 3.1 8.5 0.0 0.0 8.2 0.4 0.0 20.8 0.0 1.5 148.8 28.3 0.7 1.1 1.0 0.2 0.0 0.0 1.0 DAB1 ENSG00000173406 "DAB1, reelin adaptor protein" O75553 1 56994778-58546734 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4;intestine: 20.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 20.8;Early spermatids: 6.5;Horizontal cells: 20.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 31.4" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.5" "Group enriched" "Detected in many" 16 "granulocytes: 1.4;T-cells: 5.5" "Cell line enhanced" "Detected in some" "AF22: 6.0;fHDF/TERT166: 30.0;HeLa: 10.8;NTERA-2: 13.3;RT4: 17.7;WM-115: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032329, HPA052033, HPA067495" Enhanced Enhanced Vesicles NA NA Vesicles "CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (8.54e-2)" "unprognostic (2.09e-4)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (7.30e-4)" "unprognostic (3.90e-1)" "unprognostic (3.07e-2)" "unprognostic (1.47e-2)" "unprognostic (2.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.00e-3)" "unprognostic (1.78e-1)" "unprognostic (2.01e-1)" "unprognostic (1.44e-2)" "unprognostic (5.67e-2)" 1.8 1.7 5.8 0.3 3.8 0.0 0.7 31.4 6.2 1.7 1.0 1.8 0.5 15.0 1.0 1.0 0.6 1.6 0.8 1.8 5.3 1.4 0.7 7.5 0.8 0.2 1.1 4.2 1.2 0.7 0.0 0.7 0.0 2.0 4.0 0.3 2.9 5.2 10.2 0.6 0.6 20.8 0.3 1.1 0.6 1.0 0.9 0.7 0.0 0.8 0.0 0.1 1.9 1.0 0.0 0.0 1.4 0.0 0.2 5.5 0.1 0.0 0.0 6.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 13.3 0.0 0.0 3.2 0.0 0.1 0.0 17.7 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 1.4 0.5 0.0 5.5 0.0 2.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 5.8 3.8 31.4 6.2 5.3 1.4 1.1 4.2 2.0 0.7 0.0 0.0 0.0 0.0 0.0 20.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.1 20.6 0.0 1.3 0.0 4.3 3.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.5 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.6 0.7 0.0 0.0 DAB2 DOC-2 ENSG00000153071 "DAB2, clathrin adaptor protein" P98082 5 39371675-39462300 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 194.4" "Group enriched" "Detected in many" 5 "Hofbauer cells: 1338.9;Proximal tubular cells: 964.6;Syncytiotrophoblasts: 1107.7" "Cancer enhanced" "Detected in all" "renal cancer: 52.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "plasmacytoid DC: 26.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 26.6" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;ASC TERT1: 46.3;fHDF/TERT166: 67.0;TIME: 40.3;U-138 MG: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009314, HPA028888" Enhanced Enhanced "Nucleoli fibrillar center,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "Nucleoli fibrillar center" "CAB009314: AB_638976, HPA028888: AB_2672814" "unprognostic (1.24e-1)" "unprognostic (7.28e-2)" "unprognostic (2.16e-1)" "unprognostic (1.25e-1)" "unprognostic (5.37e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.38e-6)" "unprognostic (3.11e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (3.16e-2)" "prognostic unfavorable (9.67e-4)" "unprognostic (1.27e-2)" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" 51.6 44.2 2.6 12.2 3.5 0.6 21.8 6.1 2.6 16.6 14.0 4.1 4.5 3.3 16.6 34.8 10.8 9.6 13.3 25.1 2.9 3.0 75.2 6.9 22.4 31.8 4.0 2.1 12.7 11.3 3.2 3.9 194.4 4.7 11.6 14.6 14.6 12.9 5.3 12.7 9.3 10.4 16.0 5.2 21.1 7.2 8.7 2.5 7.3 10.9 8.4 7.4 17.8 14.7 0.1 26.6 2.2 2.5 0.9 1.3 7.0 0.0 1.6 2.5 5.4 43.0 46.3 3.1 27.8 28.4 11.0 18.1 20.3 0.1 0.0 1.7 67.0 10.8 0.0 0.3 1.0 15.4 0.0 0.8 3.7 36.9 6.6 10.4 0.0 4.8 28.8 0.0 17.8 3.2 17.0 32.9 1.9 0.0 0.9 18.1 0.1 0.3 0.0 1.7 0.7 3.0 1.0 6.3 0.0 7.3 0.6 0.0 0.0 3.3 1.8 15.5 4.1 0.1 0.9 40.3 46.9 5.2 5.4 2.2 0.0 0.0 0.0 16.3 3.4 6.1 2.2 1.2 0.2 1.3 2.5 0.0 0.1 0.2 0.7 3.4 0.1 0.1 1.0 1.8 0.9 0.6 26.6 0.2 7.0 2.6 3.5 6.1 2.6 2.9 3.0 4.0 2.1 4.7 2.5 35.7 35.6 25.8 1.3 12.9 0.7 50.4 61.1 9.4 7.9 90.7 66.8 112.4 167.5 58.4 0.6 97.7 30.4 23.3 1.6 14.9 120.5 7.2 24.3 2.1 1338.9 7.9 9.4 214.9 131.6 1.1 113.4 176.8 11.8 7.2 5.6 72.3 7.0 12.7 60.5 964.6 2.1 6.5 26.7 0.5 4.7 11.7 1107.7 10.8 19.2 0.7 DAB2IP "AF9Q34, AIP1, DIP1/2, KIAA1743" ENSG00000136848 "DAB2 interacting protein" Q5VWQ8 9 121567057-121785530 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell cycle, Growth regulation, Immunity, Inflammatory response, Innate immunity, Stress response, Unfolded protein response" "Developmental protein, GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 81.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 81.4" "Cell type enriched" "Detected in single" 16 "MAIT T-cell: 2.8" "Lineage enriched" "Detected in single" 22 "T-cells: 2.8" "Cell line enhanced" "Detected in many" "HaCaT: 34.2;HDLM-2: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.82e-2)" "unprognostic (2.79e-1)" "unprognostic (2.62e-2)" "unprognostic (4.99e-3)" "unprognostic (1.52e-1)" "unprognostic (1.90e-1)" "unprognostic (2.31e-1)" "unprognostic (1.07e-1)" "unprognostic (1.08e-1)" "unprognostic (1.49e-2)" "unprognostic (3.09e-1)" "unprognostic (1.87e-1)" "prognostic favorable (4.00e-15)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.81e-2)" 13.0 8.1 17.4 6.9 18.1 0.2 12.2 81.4 24.5 11.2 15.8 6.0 23.0 12.7 15.9 9.0 14.1 12.2 10.4 17.6 13.6 8.5 12.1 4.7 13.1 2.4 7.6 13.6 11.4 8.8 8.9 6.0 9.8 8.4 9.9 10.5 6.0 26.4 21.3 29.5 9.8 14.2 15.5 5.5 10.2 12.1 12.8 6.6 1.8 8.0 8.9 4.2 12.6 10.7 0.0 0.0 0.0 0.0 0.1 2.8 0.0 5.6 6.7 7.4 6.5 1.6 0.8 9.7 4.6 12.0 4.4 2.2 4.8 6.1 0.0 7.3 4.7 6.2 34.2 6.9 19.3 1.1 25.1 3.9 0.1 9.3 9.7 1.8 1.1 0.0 0.6 13.8 1.5 3.0 3.6 6.6 0.4 0.1 0.1 1.1 7.4 5.3 1.5 7.9 20.9 2.6 2.5 5.1 11.2 4.5 11.2 7.6 13.8 3.0 18.0 9.9 4.5 21.4 0.9 5.8 5.4 6.2 1.0 4.5 0.1 0.1 0.3 0.6 0.2 5.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 17.4 18.1 81.4 24.5 13.6 8.5 7.6 13.6 8.4 6.6 41.7 9.4 2.0 14.7 4.4 17.9 19.2 30.6 1.4 9.1 10.4 0.0 4.8 8.3 32.4 5.1 19.6 18.4 0.0 27.7 8.5 9.9 17.4 0.0 9.0 1.0 14.3 5.8 12.9 0.0 5.8 11.8 0.8 13.5 1.0 17.4 42.0 31.4 5.8 9.2 6.8 2.4 6.5 16.5 3.9 10.0 2.5 22.2 1.7 20.8 15.3 DACH2 ENSG00000126733 "Dachshund family transcription factor 2" Q96NX9 X 86148458-86832604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;epididymis: 9.3;fallopian tube: 8.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.3;Horizontal cells: 3.2;Muller glia cells: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HAP1: 11.5" "Low region specificity" "Detected in some" "HPA000258, HPA001367" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA000258: AB_1078618, HPA001367: " "unprognostic (5.73e-3)" "unprognostic (3.22e-1)" "unprognostic (1.54e-6)" "unprognostic (3.66e-1)" "unprognostic (1.98e-1)" "unprognostic (3.34e-1)" "unprognostic (7.71e-2)" "unprognostic (6.48e-1)" "unprognostic (3.17e-2)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.28e-1)" "unprognostic (5.74e-3)" "unprognostic (5.01e-3)" "unprognostic (2.63e-2)" 0.9 0.9 7.9 0.6 29.5 0.6 0.6 0.2 17.8 1.0 0.8 0.3 0.0 1.2 1.2 9.3 0.7 8.0 0.6 0.6 13.5 10.8 2.4 0.6 0.9 0.6 3.4 10.4 1.4 1.1 0.7 1.3 0.6 11.8 1.5 0.7 1.6 0.7 0.8 0.6 0.7 1.3 0.8 0.7 0.6 1.4 0.7 1.7 0.0 0.7 0.0 0.6 1.4 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 29.5 0.2 16.8 13.5 10.8 3.4 10.4 11.8 1.7 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DACT2 "bA503C24.7, C6orf116, DAPPER2" ENSG00000164488 "Dishevelled binding antagonist of beta catenin 2" Q5SW24 6 168292830-168319754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 14.2;placenta: 54.8" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 180.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Region enriched" "Detected in many" 8 "basal ganglia: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.5;CACO-2: 3.6;hTCEpi: 2.5;NTERA-2: 3.2;OE19: 15.1;SCLC-21H: 3.5" "Low region specificity" "Detected in many" HPA030251 Enhanced Supported NA NA "HPA030251: AB_10611108" "unprognostic (5.22e-6)" "unprognostic (3.13e-2)" "unprognostic (1.04e-2)" "prognostic favorable (1.07e-5)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (4.04e-1)" "unprognostic (1.31e-1)" "unprognostic (7.05e-3)" "unprognostic (2.48e-1)" "prognostic favorable (5.76e-5)" "unprognostic (1.51e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-4)" "unprognostic (4.23e-2)" 1.0 1.3 0.5 0.4 14.2 0.0 0.4 1.5 1.4 2.3 1.1 1.2 1.0 0.9 3.7 2.2 0.7 2.2 2.9 2.7 0.9 0.5 2.2 2.4 2.0 0.4 1.1 0.9 0.9 1.6 0.0 0.4 54.8 1.7 6.1 0.4 1.6 5.3 0.5 0.4 5.6 0.8 0.8 0.7 0.4 0.5 1.0 0.7 0.9 0.4 0.4 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 15.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 14.2 1.5 1.4 0.9 0.5 1.1 0.9 1.7 0.7 0.0 1.3 0.0 1.8 2.7 9.8 0.5 2.5 0.0 2.3 1.8 0.0 38.3 0.0 1.5 0.0 0.1 0.0 0.0 0.2 4.7 1.1 0.8 0.0 0.0 4.6 0.0 5.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 1.1 22.6 0.4 0.0 0.0 4.9 0.7 0.0 0.0 0.0 0.0 1.3 180.9 0.0 1.8 0.0 DAGLA "C11orf11, DAGLALPHA, KIAA0659, NSDDR" ENSG00000134780 "Diacylglycerol lipase alpha" Q9Y4D2 11 61680433-61747001 "Disease related genes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell type enhanced" "Detected in many" 5 "Mucus-secreting cells: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.2;T-47d: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062497, CAB078793" Approved Supported NA NA "CAB078793: , HPA062497: AB_2684784" "unprognostic (2.53e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.13e-7)" "unprognostic (1.23e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-4)" "unprognostic (2.22e-2)" "unprognostic (2.29e-3)" "unprognostic (3.99e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.14e-2)" 3.7 2.5 7.2 2.8 13.3 1.1 3.0 12.0 22.0 3.1 6.0 3.6 3.1 4.4 2.7 3.8 4.7 3.8 2.9 3.8 8.6 6.0 2.3 0.5 3.2 1.3 3.7 7.4 1.2 8.8 1.7 3.3 1.7 4.5 3.5 3.7 2.5 7.9 4.0 3.1 1.1 5.2 3.2 1.4 3.4 2.9 3.3 2.7 0.0 1.6 2.0 1.0 1.7 1.4 0.0 0.8 0.0 1.9 0.0 0.1 0.3 5.4 6.2 4.8 1.0 1.1 1.8 0.8 2.6 0.7 2.9 3.1 3.6 11.2 0.0 2.6 2.3 4.5 3.2 0.8 0.0 1.2 0.0 3.2 0.0 4.6 5.5 1.8 0.0 1.0 0.9 0.3 3.7 0.0 1.7 0.8 0.4 0.0 0.0 1.3 2.6 0.0 0.0 9.9 1.9 6.0 0.0 0.7 0.0 1.0 1.3 10.0 5.5 1.4 2.4 1.7 1.2 12.3 3.1 3.4 1.9 8.7 5.2 3.0 0.0 0.0 0.0 5.2 1.4 3.0 0.0 1.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.3 7.2 13.3 12.0 21.5 8.6 6.0 3.7 7.4 4.5 2.7 3.0 0.3 0.0 0.3 0.3 1.1 0.7 0.0 0.0 2.3 3.5 0.0 0.0 0.0 1.5 0.0 0.6 3.1 0.0 1.9 0.1 0.5 0.7 0.0 0.0 2.2 0.0 4.1 2.5 3.3 0.0 1.7 2.7 0.0 0.0 5.6 1.7 2.4 0.0 3.9 0.4 0.3 0.0 0.4 1.2 2.9 0.3 0.0 0.0 4.5 0.0 DAND5 "CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3" ENSG00000179284 "DAN domain BMP antagonist family member 5" Q8N907 19 12965159-12974762 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;heart muscle: 13.7" "Cell type enriched" "Detected in single" 29 "Cardiomyocytes: 13.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "HPA043493, HPA049472" Uncertain Approved Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA043493: AB_2732505, HPA049472: AB_2680781" "unprognostic (1.18e-2)" "unprognostic (4.63e-2)" "unprognostic (7.51e-2)" "unprognostic (4.63e-2)" "unprognostic (3.82e-2)" "unprognostic (8.71e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-1)" "unprognostic (5.95e-3)" "unprognostic (7.27e-3)" "unprognostic (8.17e-2)" "unprognostic (2.15e-1)" "unprognostic (2.48e-10)" "unprognostic (4.43e-1)" "unprognostic (2.48e-2)" "unprognostic (6.77e-2)" "unprognostic (1.37e-1)" 0.2 2.0 0.9 0.9 2.5 3.0 0.4 1.4 1.4 0.2 3.6 2.1 0.0 0.4 0.4 0.4 0.3 0.1 0.7 13.7 0.4 0.3 0.1 0.1 0.2 0.3 0.5 0.0 0.4 0.4 0.4 0.2 0.0 3.8 0.2 0.5 3.6 2.6 0.0 0.2 0.7 2.5 0.4 1.6 0.1 0.7 0.8 0.3 0.0 0.5 0.0 0.0 0.3 0.2 1.6 1.4 5.3 0.6 1.4 1.2 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.7 0.3 0.0 0.1 0.2 0.2 0.0 0.3 0.0 0.2 0.1 0.8 0.4 1.3 0.0 0.5 0.3 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.2 0.1 1.1 21.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.1 0.1 0.0 0.3 0.1 2.7 0.6 1.3 0.7 0.4 0.6 0.9 0.4 0.4 0.2 1.6 0.7 1.2 5.3 1.4 0.3 1.4 0.2 0.3 0.9 2.5 1.4 0.8 0.4 0.3 0.5 0.0 3.8 0.3 0.0 0.0 0.0 0.2 0.1 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 DAO DAMOX ENSG00000110887 "D-amino acid oxidase" P14920 12 108858932-108901043 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 39 "brain: 37.0;kidney: 39.0;liver: 64.2" "Group enriched" "Detected in some" 11 "Hepatocytes: 41.2;Proximal tubular cells: 75.6" "Cancer enriched" "Detected in some" 9 "liver cancer: 13.2" "Group enriched" "Detected in many" 5 "cerebellum: 37.0;pons and medulla: 31.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.5;HL-60: 1.8;HMC-1: 1.3;RH-30: 1.2" "Group enriched" "Detected in some" 10 "cerebellum: 74.4;pons and medulla: 21.1" "Group enriched" "Detected in many" 4 "cerebellum: 54.0;midbrain: 31.9;pons and medulla: 55.4;thalamus: 16.3" "HPA038653, HPA038654" Enhanced "Intracellular and membrane" NA NA "HPA038653: AB_10673016, HPA038654: AB_10673285" "unprognostic (1.50e-1)" "unprognostic (5.61e-2)" "unprognostic (1.43e-1)" "unprognostic (2.91e-1)" "unprognostic (2.18e-1)" "unprognostic (2.99e-2)" "unprognostic (2.31e-3)" "unprognostic (8.02e-2)" "unprognostic (2.88e-2)" "unprognostic (9.59e-2)" "unprognostic (9.07e-2)" "unprognostic (7.13e-2)" "prognostic favorable (4.11e-4)" "unprognostic (3.44e-3)" "unprognostic (8.96e-2)" "unprognostic (2.67e-1)" "unprognostic (2.17e-1)" 0.3 0.2 0.0 0.2 2.7 0.2 0.2 37.0 0.7 0.2 0.9 11.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.9 39.0 64.2 0.3 0.2 6.4 0.5 0.2 0.3 0.2 0.0 0.2 31.2 0.2 1.1 0.0 0.2 0.2 0.2 0.2 0.2 0.3 35.9 0.2 0.2 0.2 0.4 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 37.0 0.5 0.8 0.9 6.4 0.5 31.2 0.4 0.0 0.0 0.9 0.0 0.0 0.5 0.4 0.0 0.0 0.0 1.8 0.0 0.6 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.2 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 75.6 5.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761272 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 17.4 36.6 13.7 17.9 12.7 10.6 23.1 3.9 11.6 23.5 25.4 11.4 63.4 26.5 21.1 34.7 14.3 18.6 44.0 22.9 13.4 9.1 40.1 78.2 21.6 22.6 10.2 10.1 26.1 178.8 30.0 28.4 26.4 21.8 24.8 20.2 22.7 71.1 76.0 5.9 15.2 42.6 18.3 10.8 23.8 31.6 23.2 9.8 15.5 31.2 12.8 18.6 25.9 16.9 18.1 32.8 27.3 33.2 13.1 17.6 22.5 19.2 14.1 17.5 16.1 32.8 39.7 19.4 47.4 73.7 35.9 41.7 10.0 16.5 8.4 31.2 58.5 22.7 3.8 10.8 28.1 40.0 44.3 7.9 11.3 27.3 24.6 31.0 21.1 8.4 20.4 9.8 23.5 42.7 20.8 66.9 9.5 13.1 28.6 35.1 15.3 11.3 13.5 6.3 26.2 32.3 15.5 7.7 13.9 47.3 35.9 11.9 16.0 48.3 19.7 12.6 14.0 15.6 31.0 32.7 22.3 24.2 14.7 25.1 16.1 20.8 12.4 22.0 41.2 33.4 14.9 33.2 18.6 14.8 29.4 17.6 18.1 15.3 13.0 32.8 12.0 11.3 11.2 27.3 13.1 28.5 26.9 16.1 22.5 13.7 12.7 3.9 11.6 13.4 9.1 10.2 10.1 21.8 9.8 14.9 40.1 32.0 53.6 17.1 8.1 11.0 56.0 12.0 30.7 50.6 5.9 59.1 112.7 83.0 10.9 31.6 98.3 0.0 168.9 84.1 36.6 77.8 35.6 106.2 46.0 4.8 42.5 36.2 35.6 22.8 27.6 32.0 27.0 38.7 87.4 19.0 105.6 63.3 32.2 50.2 7.2 0.0 21.7 33.1 6.1 15.8 84.4 24.1 65.2 69.2 DAPK1 "DAPK, ROCO3" ENSG00000196730 "Death associated protein kinase 1" P53355 9 87497228-87708633 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Apoptosis, Translation regulation" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 94.7" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 65.3;Ito cells: 79.2;Kupffer cells: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 55 "dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9" "Cell line enhanced" "Detected in many" "HMC-1: 38.8;HUVEC TERT2: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB037302, HPA040472, HPA048436" Approved Approved Centrosome NA NA Centrosome "CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390" "unprognostic (2.55e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.75e-1)" "unprognostic (1.88e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-2)" "unprognostic (2.77e-3)" "unprognostic (8.31e-3)" "unprognostic (8.76e-2)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (1.09e-3)" 14.6 4.9 10.4 8.8 25.5 3.8 4.1 2.9 17.6 8.1 16.6 6.5 8.1 7.8 8.7 16.1 4.5 12.2 21.6 4.1 12.4 8.1 14.7 21.3 28.6 8.5 4.6 10.4 32.7 21.2 4.8 16.6 94.7 6.6 5.1 7.5 5.9 9.3 7.3 1.5 3.7 11.0 8.1 4.8 16.4 15.0 6.3 7.3 34.5 7.2 1.5 5.2 13.2 10.5 0.1 5.3 6.9 11.9 0.1 0.1 2.1 0.0 18.3 8.8 6.2 0.2 0.1 14.0 1.2 1.7 7.2 8.2 2.6 0.1 0.1 1.8 0.3 0.1 17.1 5.4 0.4 3.1 0.1 4.4 8.8 2.5 8.9 7.9 0.0 38.8 0.5 2.9 1.3 0.5 11.3 22.0 2.5 6.6 3.7 6.0 0.5 2.6 0.0 10.0 16.9 0.0 0.7 7.8 0.0 20.1 18.3 4.0 4.5 0.0 1.8 7.7 13.5 0.0 5.8 0.1 0.0 0.1 0.0 0.0 14.6 3.0 0.0 0.1 2.4 1.2 1.3 5.3 6.9 0.0 11.9 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 1.6 0.1 11.7 5.3 0.0 2.1 10.4 25.5 2.9 17.6 12.4 8.1 4.6 10.4 6.6 7.3 47.6 65.3 5.9 0.6 3.2 19.8 1.9 40.8 16.0 40.9 21.0 2.0 5.6 1.7 27.2 1.2 13.0 2.1 0.0 20.1 14.4 11.4 3.9 23.1 16.3 21.3 17.5 0.0 79.2 64.1 2.2 13.8 42.1 11.8 30.7 7.7 14.5 31.5 1.7 12.7 5.9 2.9 0.0 2.3 3.9 4.1 2.8 11.9 0.7 2.8 9.3 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;skeletal muscle: 46.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 80.4;Enterocytes: 44.6;Late spermatids: 59.2" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4" "Lineage enriched" "Detected in many" 23 "granulocytes: 51.8" "Cell line enhanced" "Detected in many" "ASC diff: 10.1;HaCaT: 8.4;HMC-1: 17.2;MCF7: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA071581: AB_2686421" "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 8.2 1.6 2.6 6.8 5.0 10.3 5.2 1.4 3.9 3.6 16.6 12.0 8.3 14.2 1.7 1.5 2.1 1.2 1.7 17.6 3.6 2.0 2.2 1.4 14.0 2.5 6.8 3.0 0.7 1.7 1.1 1.1 0.3 4.7 3.1 4.7 1.9 4.8 4.8 46.1 4.6 25.8 1.2 3.4 4.7 6.9 2.0 6.5 1.1 22.3 8.7 3.3 2.1 9.6 0.3 2.2 51.8 0.0 0.7 0.6 0.3 2.8 2.0 5.7 1.4 10.1 0.4 0.1 1.9 6.1 1.0 1.1 0.9 1.4 0.2 0.6 6.1 3.4 8.4 3.5 0.1 0.6 0.2 0.1 1.1 3.9 0.1 0.1 0.1 17.2 1.1 7.3 0.4 0.2 6.6 0.6 0.1 0.4 0.1 0.7 8.7 0.0 0.3 0.6 2.8 2.0 2.6 0.0 0.3 0.0 2.8 0.4 0.3 0.4 1.1 0.0 1.4 4.8 0.4 0.4 0.8 1.0 1.3 1.6 0.6 0.2 0.0 0.0 2.7 0.2 19.1 0.0 51.8 0.6 0.0 0.2 0.3 0.1 0.5 0.0 0.1 0.0 0.4 16.4 0.7 0.0 2.2 0.0 0.3 2.6 5.0 1.4 3.9 3.6 2.0 6.8 3.0 4.7 6.5 80.4 21.1 2.7 6.6 10.3 0.0 34.6 2.5 2.7 19.4 0.0 0.0 0.1 1.7 7.8 19.1 2.8 44.6 0.0 30.2 0.1 3.1 14.5 15.0 0.8 0.4 4.8 8.1 8.6 1.2 59.2 2.8 1.4 0.0 0.0 13.0 1.6 13.0 28.8 5.3 0.3 0.1 12.9 2.1 0.9 3.4 3.6 0.1 14.9 16.9 10.7 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 522.1" "Group enriched" "Detected in all" 7 "cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1" "Not detected" "Not detected" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 0.3 14.7 1.4 0.4 1.3 0.0 7.4 0.4 1.0 11.7 1.0 0.8 1.6 0.0 2.1 53.5 75.6 21.1 0.6 0.2 1.5 3.6 1.3 0.2 0.8 0.4 2.8 0.3 3.8 5.7 0.0 5.6 0.2 1.5 2.3 0.0 63.9 6.8 0.4 0.2 61.3 0.5 1.1 0.4 0.2 0.2 2.1 0.8 0.8 21.5 37.3 16.9 2.0 21.1 1.4 4.0 2.9 2.6 2.8 1.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.2 22.1 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.3 5.7 0.0 0.0 0.0 0.6 0.0 0.6 1.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 2.9 2.6 1.6 0.5 1.9 1.0 1.2 0.8 0.4 1.0 1.4 0.4 0.5 2.2 2.8 0.6 4.0 1.3 0.5 1.4 1.3 0.4 1.0 1.5 3.6 2.8 0.3 1.5 0.8 0.0 0.0 14.6 31.4 94.9 6.8 0.0 5.1 1.4 17.0 8.7 5.9 5.5 3.3 8.0 10.6 0.5 2.5 0.0 5.1 10.7 4.1 10.8 4.6 12.1 12.9 3.2 2.9 0.6 7.9 43.8 3.7 5.5 11.8 2.8 1.6 522.1 5.7 3.5 2.1 5.8 16.3 0.0 5.1 9.8 4.1 110.7 3.8 1.9 2.5 25.5 DAPP1 BAM32 ENSG00000070190 "Dual adaptor of phosphotyrosine and 3-phosphoinositides 1" Q9UN19 4 99816833-99870154 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.0;lymphoid tissue: 45.6" "Cell type enhanced" "Detected in many" 17 "monocytes: 322.0;Urothelial cells: 169.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HBEC3-KT: 14.0;HDLM-2: 32.3;RPMI-8226: 35.0;SK-BR-3: 15.1;U-698: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033822, HPA046074" Approved NA NA 29000 "CAB033822: AB_2245677, HPA046074: AB_2679525" "unprognostic (9.30e-2)" "unprognostic (1.36e-1)" "unprognostic (1.77e-2)" "unprognostic (9.96e-2)" "unprognostic (3.48e-1)" "unprognostic (1.14e-1)" "unprognostic (1.68e-1)" "unprognostic (9.09e-2)" "unprognostic (4.71e-1)" "unprognostic (5.13e-2)" "unprognostic (4.01e-3)" "unprognostic (2.24e-1)" "unprognostic (8.45e-5)" "unprognostic (2.88e-1)" "unprognostic (3.91e-2)" "unprognostic (9.32e-2)" "unprognostic (4.60e-2)" 3.1 1.0 1.3 22.0 2.8 8.8 2.1 0.6 1.7 7.1 3.0 1.8 0.0 0.8 9.7 2.9 29.3 3.4 8.7 1.0 1.0 1.0 1.6 1.1 6.4 20.3 3.1 0.5 1.5 0.9 0.0 1.0 13.4 1.9 3.6 1.9 1.0 9.5 0.3 1.2 10.0 6.4 9.7 5.6 20.3 3.7 0.7 2.4 12.9 1.1 17.4 45.6 8.9 12.0 36.4 29.0 51.0 27.0 6.3 8.7 21.6 11.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 11.8 12.4 0.1 0.0 0.0 6.6 0.0 14.0 0.0 32.3 0.0 12.1 0.0 0.0 0.0 4.7 0.5 0.0 6.0 0.0 4.6 0.0 0.0 0.6 0.6 11.7 0.0 0.1 0.0 2.8 0.0 0.0 0.2 0.1 0.0 35.0 2.3 9.7 0.0 0.0 0.0 15.1 0.0 0.1 0.2 4.7 0.0 0.0 0.2 0.0 0.0 4.2 1.7 24.8 0.0 3.1 0.0 6.8 27.0 24.8 0.9 22.4 0.9 33.9 4.4 1.5 29.0 36.4 4.9 1.7 51.0 6.3 20.2 12.6 8.7 21.6 1.3 2.8 0.6 1.7 1.0 1.0 3.1 0.5 1.9 2.4 3.0 4.8 61.4 19.8 55.0 0.0 0.4 2.5 46.8 10.3 8.7 0.0 0.8 0.0 4.3 0.1 0.1 1.3 0.0 2.7 11.9 1.4 20.7 8.1 0.2 22.3 0.0 1.2 0.6 36.9 0.4 0.0 39.3 11.8 322.0 2.2 0.0 12.0 3.1 0.0 0.0 0.1 0.0 1.6 0.0 0.4 61.5 2.9 7.5 1.4 169.6 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 14.9;fallopian tube: 24.4;testis: 49.9" "Group enriched" "Detected in some" 12 "Ciliated cells: 69.6;Early spermatids: 83.7;Late spermatids: 157.9;Spermatocytes: 115.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 6.2;HUVEC TERT2: 15.2;U-2197: 28.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 25.4" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.4 0.1 2.5 0.3 14.9 0.4 0.5 0.0 1.8 0.7 0.3 3.1 0.0 0.1 0.3 3.1 0.6 24.4 0.4 0.4 3.9 3.0 0.3 0.5 2.4 0.3 0.3 2.7 1.3 0.1 0.7 0.2 0.8 14.3 0.2 0.2 0.0 0.3 0.2 2.6 0.3 0.2 0.2 0.3 0.3 0.2 49.9 1.1 0.0 0.2 0.0 0.3 0.3 0.0 0.5 0.5 1.2 0.5 0.2 0.8 0.0 0.6 0.0 0.1 0.0 0.2 0.9 0.4 0.6 0.3 0.6 0.4 3.7 0.3 0.2 0.0 0.1 6.2 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.3 0.0 0.7 0.5 4.1 15.2 0.0 0.1 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.2 0.1 0.3 1.5 0.1 1.4 28.5 0.0 0.0 0.1 0.2 2.7 0.0 0.2 1.2 0.0 0.2 0.2 0.5 0.8 0.3 0.4 0.4 0.0 0.5 0.6 0.3 0.0 0.2 0.5 0.5 0.6 0.0 2.5 14.9 0.0 1.8 3.9 3.0 0.3 2.7 14.3 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 69.6 9.1 0.0 3.9 0.0 0.0 0.0 83.7 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 157.9 3.1 0.0 0.0 0.0 0.0 0.2 1.7 0.0 2.5 0.0 0.2 0.0 0.0 115.4 1.4 0.1 0.2 0.0 0.0 0.0 DAZ1 "DAZ, SPGY" ENSG00000188120 "Deleted in azoospermia 1" Q9NQZ3 Y 23129355-23199094 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "stomach 1: 3.7;testis: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "U-266/70: 14.1;U-266/84: 21.1" HPA047113 Supported NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 6.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 DAZ2 "MGC126442, pDP1678" ENSG00000205944 "Deleted in azoospermia 2" Q13117 Y 23219434-23291356 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "stomach 1: 19.3;testis: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SK-MEL-30: 6.4" HPA047113 Approved NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 19.3 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DAZ3 ENSG00000187191 "Deleted in azoospermia 3" Q9NR90 Y 24763069-24813492 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "stomach 1: 2.4;testis: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 2.2" HPA047113 Approved NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DAZ4 ENSG00000205916 "Deleted in azoospermia 4" Q86SG3 Y 24833843-24907040 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "stomach 1: 21.9;testis: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 128 "U-266/70: 51.5;U-266/84: 47.8" HPA047113 Approved NA NA "HPA047113: AB_2679936" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 21.9 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.5 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DAZL "DAZH, DAZL1, DAZLA, MGC26406, SPGYLA" ENSG00000092345 "Deleted in azoospermia like" Q92904 3 16586792-16670306 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 68.6" "Group enriched" "Detected in some" 4 "Spermatocytes: 242.1;Spermatogonia: 122.2" "Cancer enriched" "Detected in single" 51 "testis cancer: 13.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 27 "B-cells: 2.7" "Cell line enriched" "Detected in some" 8 "HAP1: 20.5" "Region enhanced" "Detected in many" "basal ganglia: 8.7" "Not detected" "Not detected" "HPA019777, HPA047113" Enhanced NA NA "HPA019777: AB_1847495, HPA047113: AB_2679936" "unprognostic (5.61e-2)" "unprognostic (5.27e-3)" "unprognostic (2.80e-1)" "unprognostic (5.85e-2)" "unprognostic (2.32e-3)" "unprognostic (2.60e-2)" "unprognostic (6.34e-2)" "unprognostic (4.91e-2)" "unprognostic (9.69e-2)" "unprognostic (7.79e-2)" "unprognostic (2.04e-1)" "unprognostic (3.47e-1)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 68.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 37.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 6.5 0.0 242.1 122.2 0.0 0.1 0.0 0.0 0.0 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909541 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 11.8;testis: 34.2" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 250.0;Spermatocytes: 291.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA042923 Supported "Nucleoplasm,Nuclear bodies" Yes Yes "Nucleoplasm, Nuclear bodies" "HPA042923: AB_2678222" "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavorable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 1.1 1.2 1.4 5.9 2.0 1.8 3.0 1.9 1.9 1.4 2.1 0.0 0.6 1.2 1.2 1.4 1.7 1.1 1.5 1.0 1.5 1.4 1.2 1.1 2.4 5.0 1.3 1.0 3.4 1.3 1.2 1.8 1.4 0.8 1.2 1.2 0.0 1.2 1.1 1.9 1.3 1.5 0.9 1.2 4.6 1.1 34.2 0.7 11.8 1.4 1.9 2.7 1.6 1.1 1.3 0.9 4.0 0.4 0.9 1.6 0.5 1.3 1.4 3.0 3.8 0.7 0.6 0.9 1.4 0.3 1.5 3.0 2.3 0.9 3.1 1.1 0.9 2.6 1.3 3.1 0.8 1.6 2.3 2.1 2.0 1.7 0.5 0.2 2.4 1.6 0.7 0.8 1.7 1.6 0.5 1.3 2.9 1.7 6.5 2.0 2.4 4.2 3.0 3.0 3.1 2.9 1.1 4.7 3.7 1.2 0.2 4.4 2.8 1.9 3.3 1.5 2.5 1.4 2.5 0.6 1.8 2.2 4.7 3.0 3.7 7.7 3.1 1.3 4.4 3.9 4.0 0.4 0.4 1.2 0.3 0.3 0.8 1.1 0.6 0.2 1.3 1.1 1.3 1.1 0.9 0.4 0.9 1.6 0.5 1.4 2.0 1.9 1.9 1.5 1.4 1.3 1.0 0.8 0.7 3.0 13.0 34.9 16.3 13.9 5.8 3.6 0.0 14.7 5.7 8.7 11.8 12.2 3.3 5.4 250.0 8.5 4.5 46.7 12.9 31.0 7.6 10.6 30.1 5.4 13.9 3.2 14.3 7.4 8.8 57.4 14.4 14.2 11.8 9.0 18.6 1.9 10.7 7.0 8.9 4.4 15.5 12.9 8.2 291.4 77.1 11.0 8.0 21.5 15.8 11.4 DBH DBM ENSG00000123454 "Dopamine beta-hydroxylase" P09172 9 133636360-133659344 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 86.6;brain: 36.2;liver: 35.6" "Cell type enriched" "Detected in single" 43 "Ito cells: 17.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 45 "pons and medulla: 36.2" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in single" 340 "SH-SY5Y: 206.1" "Region enriched" "Detected in some" 6 "pons and medulla: 23.2" "Region enriched" "Detected in single" 38 "pons and medulla: 25.1" "HPA002130, HPA005960, HPA070789" Enhanced Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA 2000000000 Vesicles "Endoplasmic reticulum" "HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312" "unprognostic (1.93e-3)" "unprognostic (7.52e-3)" "unprognostic (8.53e-2)" "unprognostic (2.10e-2)" "unprognostic (2.18e-3)" "unprognostic (3.38e-3)" "unprognostic (3.39e-3)" "unprognostic (3.97e-2)" "unprognostic (1.71e-1)" "unprognostic (8.99e-2)" "unprognostic (5.80e-2)" "unprognostic (7.69e-2)" "unprognostic (2.81e-7)" "unprognostic (9.31e-2)" "unprognostic (6.77e-2)" "unprognostic (1.49e-2)" "unprognostic (5.06e-3)" 0.7 86.6 0.1 0.3 0.1 0.0 0.0 0.1 0.8 0.3 0.0 1.9 0.7 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.5 35.6 0.3 0.6 0.0 0.0 0.1 1.3 0.0 0.6 0.4 36.2 0.8 0.0 1.0 0.2 5.9 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.2 206.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004865-90020128 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.6;skeletal muscle: 39.7" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 13.8;Exocrine glandular cells: 16.0;Horizontal cells: 28.6;Pancreatic endocrine cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 14.4" "Lineage enriched" "Detected in many" 6 "B-cells: 14.4" "Cell line enhanced" "Detected in many" "MCF7: 47.7" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" No No "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favorable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 2.1 6.9 21.5 2.3 13.7 0.8 4.7 16.1 31.6 2.6 2.0 6.5 1.9 1.9 1.4 9.6 13.9 3.9 3.9 3.4 15.7 14.6 6.9 6.2 3.0 3.9 17.6 9.4 3.1 14.1 6.3 3.0 0.6 19.2 3.7 1.8 3.9 11.9 3.8 39.7 3.9 1.2 1.6 6.8 1.6 4.3 1.1 4.5 0.0 3.6 2.3 4.7 2.0 2.3 14.4 0.1 0.6 0.0 0.0 2.5 0.8 7.8 12.0 1.1 14.5 0.3 0.1 8.6 1.7 2.2 3.5 1.7 11.7 6.4 0.0 1.0 0.3 3.3 8.2 12.7 0.3 3.4 0.0 23.1 0.0 1.7 19.1 0.5 0.1 1.3 0.3 1.0 6.1 0.0 8.1 15.2 0.2 2.2 0.1 1.2 47.7 0.0 9.9 20.3 5.7 5.1 4.8 11.0 0.2 19.8 1.5 17.5 18.7 1.9 1.7 14.9 3.3 11.3 1.3 12.2 2.8 5.5 0.1 7.8 0.0 0.1 0.0 1.2 0.9 6.9 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.6 0.4 0.0 14.4 2.5 0.4 0.0 0.0 0.0 0.1 0.0 0.8 21.5 13.7 16.1 31.6 15.7 14.6 17.6 9.4 19.2 4.5 3.0 1.3 0.8 0.5 0.3 1.3 2.2 7.6 1.4 2.3 8.7 0.0 0.1 8.3 13.8 0.0 0.6 0.3 0.0 16.0 0.2 0.2 4.5 0.0 2.0 0.3 28.6 5.8 1.8 0.0 0.0 1.1 0.0 3.3 0.0 2.1 5.1 15.0 2.9 0.4 7.3 1.2 0.0 0.7 0.0 1.9 0.9 0.0 0.0 0.6 1.0 DBNDD2 "C20orf35, HSMNP1" ENSG00000244274 "Dysbindin domain containing 2" Q9BQY9 20 45406057-45410610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 160.5;skeletal muscle: 84.2" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Ciliated cells: 9.4;Club cells: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 16 "dendritic cells: 15.0;monocytes: 9.3;T-cells: 7.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043991 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043991: AB_10966212" "unprognostic (6.33e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.79e-3)" "unprognostic (2.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.31e-3)" "unprognostic (8.24e-2)" "unprognostic (5.44e-2)" "unprognostic (3.06e-1)" "unprognostic (3.71e-2)" "unprognostic (2.47e-1)" "unprognostic (1.41e-3)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (2.52e-2)" "unprognostic (3.48e-1)" 12.2 7.8 56.5 9.9 64.9 2.1 15.3 21.3 88.8 11.0 26.4 132.3 5.0 16.6 14.9 13.6 18.3 17.7 10.2 68.4 85.1 47.3 5.9 2.5 13.9 5.8 98.2 31.5 6.5 6.7 18.4 5.0 13.2 51.8 14.2 28.4 3.1 9.0 29.1 84.2 10.4 19.4 31.0 160.5 5.0 13.3 3.0 70.7 2.7 4.8 10.5 8.2 16.8 8.2 0.3 15.0 0.3 9.3 0.6 7.9 3.5 21.7 3.9 3.1 22.0 2.0 0.9 4.4 12.8 13.9 10.7 7.3 10.5 29.8 0.3 2.2 12.6 4.0 32.2 21.5 1.1 6.6 0.1 12.6 18.1 16.8 9.5 12.9 0.9 27.6 0.3 3.7 4.0 3.8 18.7 7.3 18.6 1.3 0.4 0.8 27.6 1.5 1.3 4.1 14.3 23.2 0.0 0.3 0.2 30.6 0.4 7.2 3.7 4.4 2.4 27.5 2.3 30.1 5.6 11.7 0.4 21.3 14.2 13.9 0.3 0.4 0.1 1.5 0.1 3.1 0.0 8.4 0.0 7.9 9.3 2.9 0.1 6.9 5.8 6.0 0.3 6.4 6.0 0.3 0.6 5.0 15.0 5.8 3.5 56.5 64.9 21.3 62.5 85.1 47.3 98.2 31.5 51.8 70.7 3.0 0.3 0.0 0.1 0.0 0.0 1.0 0.0 9.4 4.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.2 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 DBX1 ENSG00000109851 "Developing brain homeobox 1" A6NMT0 11 20156155-20160613 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NTERA-2: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039802 Uncertain NA NA "HPA039802: AB_10795256" "unprognostic (3.76e-1)" "unprognostic (5.64e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DBX2 FLJ16139 ENSG00000185610 "Developing brain homeobox 2" Q6ZNG2 12 45014672-45051099 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 32 "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 1.2;HeLa: 1.7;SCLC-21H: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066053 Uncertain NA NA "HPA066053: AB_2685605" "unprognostic (1.13e-4)" "unprognostic (9.99e-2)" "unprognostic (7.82e-3)" "unprognostic (5.24e-2)" "unprognostic (5.62e-2)" "unprognostic (1.51e-1)" "unprognostic (9.22e-2)" "unprognostic (4.76e-2)" "unprognostic (1.64e-1)" "unprognostic (5.19e-1)" 2.0 0.5 4.4 0.5 3.6 0.5 1.8 1.2 10.7 0.9 0.5 5.1 0.2 0.4 0.5 0.4 0.6 0.6 0.7 0.9 4.4 4.6 1.1 0.4 0.5 0.5 5.9 3.1 0.4 0.4 0.5 0.0 0.4 10.3 0.7 0.5 0.0 0.8 0.7 0.7 2.1 0.4 0.5 10.3 0.4 0.5 2.9 1.8 0.0 0.7 1.3 0.6 0.6 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 3.6 1.2 4.6 4.4 4.6 5.9 3.1 10.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 22.6;testis: 30.9" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 15.4;Late spermatids: 30.6;Spermatogonia: 12.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "EFO-21: 17.6;U-2 OS: 9.8" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.2 0.1 0.2 0.0 0.1 0.0 0.7 0.1 0.1 0.5 0.1 0.0 6.2 0.0 0.6 22.6 0.1 4.3 4.3 0.1 0.1 0.4 3.3 0.1 0.1 0.0 0.1 0.0 1.5 0.1 0.0 0.6 0.0 0.3 1.0 0.0 0.5 0.1 3.9 0.1 0.1 0.1 2.5 0.1 1.5 1.6 30.9 0.0 0.3 0.9 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.8 0.0 0.0 0.0 3.4 12.5 0.0 0.0 0.0 0.0 0.0 DCAF12L2 WDR40C ENSG00000198354 "DDB1 and CUL4 associated factor 12 like 2" Q5VW00 X 126163499-126166097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 15.7;epididymis: 53.6;testis: 15.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HAP1: 5.9;NTERA-2: 4.9;U-2 OS: 8.1" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (1.16e-4)" "unprognostic (8.83e-3)" "unprognostic (2.93e-1)" "unprognostic (2.52e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-1)" "unprognostic (3.34e-3)" "unprognostic (1.16e-1)" "unprognostic (8.47e-4)" "unprognostic (1.56e-2)" "unprognostic (4.05e-2)" "unprognostic (3.86e-2)" "unprognostic (2.51e-1)" 1.1 1.2 1.1 0.1 1.9 0.1 2.3 0.5 2.1 1.9 0.9 0.0 15.7 0.1 2.4 53.6 0.5 3.0 0.2 0.4 1.0 3.9 0.4 0.1 0.2 0.2 1.0 1.7 1.9 0.2 2.4 1.3 0.1 1.3 2.0 0.2 0.2 0.6 5.6 0.4 0.5 0.5 2.0 0.8 0.2 0.7 15.8 0.1 0.0 0.4 0.0 0.3 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.5 2.1 1.0 3.9 1.0 1.7 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCAF4L1 WDR21B ENSG00000182308 "DDB1 and CUL4 associated factor 4 like 1" Q3SXM0 4 41981696-41986467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 37.5" "Group enriched" "Detected in some" 5 "Spermatocytes: 81.2;Spermatogonia: 91.3" "Cancer enriched" "Detected in single" 49 "testis cancer: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "REH: 3.6" CAB073535 Enhanced NA NA "CAB073535: " "unprognostic (6.24e-2)" "unprognostic (7.52e-3)" "unprognostic (8.11e-3)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (9.63e-3)" "unprognostic (4.64e-4)" "unprognostic (1.62e-1)" "unprognostic (1.42e-2)" "unprognostic (3.11e-2)" "unprognostic (2.83e-2)" "unprognostic (4.03e-1)" "unprognostic (3.76e-3)" "unprognostic (4.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.49e-2)" "unprognostic (1.36e-4)" 0.1 0.1 0.1 0.2 0.2 0.1 1.1 0.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.9 0.3 0.1 0.1 0.1 0.5 0.0 37.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 1.4 0.3 0.0 0.4 0.0 0.1 0.2 0.3 2.4 0.1 0.1 1.5 0.4 0.1 0.3 0.2 0.3 0.8 0.6 0.3 0.1 0.3 0.8 2.0 0.2 0.6 0.2 0.8 2.1 2.0 0.4 0.2 2.3 1.3 0.1 2.2 0.6 0.3 0.0 0.0 0.7 1.0 0.0 0.2 0.1 0.8 2.9 0.3 0.4 0.6 3.6 0.4 0.6 0.2 0.4 0.7 0.7 0.2 0.1 0.3 0.4 0.2 0.2 0.4 0.3 2.1 0.6 2.1 0.9 2.8 0.3 0.3 2.0 1.0 0.9 0.3 0.1 0.3 0.2 0.0 0.3 0.4 0.2 0.1 0.6 0.0 0.4 1.4 0.0 0.3 0.3 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.3 1.3 0.9 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 17.6 0.7 0.0 0.0 0.5 0.2 0.4 1.2 0.0 0.8 0.3 0.0 0.0 0.0 2.6 5.4 1.1 0.1 3.3 1.0 0.0 0.0 0.6 0.0 0.4 0.0 1.3 0.0 0.0 81.2 91.3 0.6 0.5 0.0 0.4 0.1 DCAF4L2 WDR21C ENSG00000176566 "DDB1 and CUL4 associated factor 4 like 2" Q8NA75 8 87870743-87874068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 26.6" "Group enriched" "Detected in some" 7 "Spermatocytes: 54.4;Spermatogonia: 72.8" "Cancer enriched" "Detected in some" 6 "testis cancer: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "U-266/84: 12.7" HPA067584 Uncertain NA NA "HPA067584: AB_2685868" "unprognostic (4.25e-1)" "unprognostic (4.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 54.4 72.8 0.0 0.0 0.0 0.0 0.0 DCAF6 "IQWD1, PC326" ENSG00000143164 "DDB1 and CUL4 associated factor 6" Q58WW2 1 167935783-168075843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 155.9" "Group enriched" "Detected in all" 4 "Cardiomyocytes: 200.2;Early spermatids: 375.8;Late spermatids: 573.8;monocytes: 176.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054305 Supported "Nucleoplasm,Focal adhesion sites" NA NA "Nucleoplasm, Focal adhesion sites" "HPA054305: AB_2682444" "unprognostic (1.54e-1)" "unprognostic (2.11e-1)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (2.20e-1)" "unprognostic (1.19e-1)" "unprognostic (5.42e-2)" "unprognostic (1.81e-1)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.74e-1)" "unprognostic (3.20e-2)" "unprognostic (9.21e-2)" "unprognostic (7.06e-2)" "unprognostic (6.00e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 10.6 17.0 10.9 7.8 12.2 6.2 8.8 10.5 17.8 10.2 11.5 3.9 8.4 6.2 9.5 11.4 9.3 7.7 8.2 43.8 7.6 5.5 9.5 26.2 7.3 4.8 5.2 11.5 8.3 6.1 10.8 11.3 7.8 6.5 10.5 8.7 5.7 10.3 11.9 155.9 6.4 7.8 10.2 4.8 5.9 9.8 21.5 4.8 7.8 8.2 27.3 7.3 9.1 7.3 6.2 7.7 12.5 13.9 4.4 7.2 5.0 23.0 11.0 6.1 9.9 20.3 28.9 21.6 23.6 35.4 16.8 25.1 18.3 19.5 19.1 13.8 30.5 8.0 17.4 9.6 17.7 23.8 10.8 10.2 20.3 16.8 13.1 16.4 9.1 9.7 20.5 17.9 15.9 13.3 25.6 18.3 6.1 22.9 15.8 24.7 5.3 10.1 8.3 3.9 12.9 12.3 7.8 12.7 14.8 41.9 11.3 9.0 7.2 18.9 17.4 12.9 13.4 29.7 11.2 25.8 16.8 10.5 16.2 9.7 17.0 13.8 14.9 22.4 7.8 6.8 6.0 7.0 12.5 6.7 9.6 7.2 6.2 5.4 5.8 7.7 4.5 5.0 6.4 7.2 4.4 13.9 4.6 6.1 5.0 10.9 12.2 10.5 17.8 7.6 5.5 5.2 11.5 6.5 4.8 53.6 33.4 19.8 24.8 51.4 13.4 200.2 45.9 60.2 53.4 24.4 21.6 61.0 14.9 25.7 375.8 29.8 24.8 46.7 16.9 26.6 39.2 32.0 18.5 81.0 17.8 4.8 20.3 25.8 28.6 573.8 53.2 22.6 35.4 176.7 27.3 14.6 18.0 28.1 45.6 26.9 16.7 32.3 37.1 78.4 58.9 34.8 68.0 20.8 28.8 23.7 DCAF8L1 WDR42B ENSG00000226372 "DDB1 and CUL4 associated factor 8 like 1" A6NGE4 X 27977993-27981449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 8.4" "Group enriched" "Detected in some" 14 "Spermatocytes: 2.8;Spermatogonia: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "Karpas-707: 20.8" HPA043787 Enhanced NA NA "HPA043787: AB_10961430" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 5.3 0.0 0.0 0.0 0.0 0.0 DCAF8L2 WDR42C ENSG00000189186 "DDB1 and CUL4 associated factor 8 like 2" P0C7V8 X 27590382-27748821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 35.0" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2 OS: 14.9" NA NA "unprognostic (2.88e-1)" "unprognostic (1.13e-1)" "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 DCANP1 "C5orf20, DCNP1" ENSG00000251380 "Dendritic cell associated nuclear protein" Q8TF63 5 135444214-135447348 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.9;intestine: 2.0;lymphoid tissue: 3.0;skin 1: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.9;plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "THP-1: 6.7" HPA048308 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA048308: AB_2680349" 0.2 0.0 0.1 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.2 0.2 0.5 3.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.1 2.2 2.0 0.0 0.2 2.7 0.1 0.0 0.2 1.6 0.1 0.2 0.0 1.0 0.1 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCC "IGDCC1, NTN1R1" ENSG00000187323 "DCC netrin 1 receptor" P43146 18 52340172-53535903 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 22.0;testis: 16.5" "Group enriched" "Detected in some" 27 "Early spermatids: 183.2;Late spermatids: 131.3" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 15.4;U-266/70: 47.9;U-266/84: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055376, HPA069552" Enhanced Approved "Golgi apparatus" NA NA 25000 "Golgi apparatus" "HPA055376: AB_2682798, HPA069552: AB_2686151" "unprognostic (1.96e-3)" "unprognostic (1.69e-2)" "unprognostic (3.13e-1)" "unprognostic (3.90e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-3)" "unprognostic (2.59e-1)" "unprognostic (5.59e-2)" "unprognostic (2.00e-1)" "unprognostic (2.58e-1)" "unprognostic (8.22e-4)" "unprognostic (4.14e-2)" "unprognostic (1.27e-4)" "unprognostic (7.21e-2)" "unprognostic (1.84e-2)" "unprognostic (1.42e-1)" "unprognostic (2.69e-3)" 0.5 1.9 6.3 0.8 22.0 0.4 0.6 0.7 10.1 0.8 0.9 1.3 0.0 0.5 0.4 1.0 0.7 0.7 0.5 0.5 18.4 2.0 0.9 0.5 3.8 0.4 1.5 9.9 0.7 1.2 0.6 1.1 0.4 5.3 1.3 0.8 0.0 0.8 3.5 0.4 0.8 0.7 0.5 2.4 0.8 0.8 16.5 6.5 0.7 0.5 0.0 1.1 0.8 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 47.9 22.5 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 22.0 0.7 10.1 18.4 2.0 1.5 9.9 5.3 6.5 0.0 5.9 0.0 0.1 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 183.2 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 131.3 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 1.4 1.9 0.0 0.1 0.0 0.0 0.0 DCD "AIDD, DCD-1, DSEP, HCAP, PIF" ENSG00000161634 Dermcidin P81605 12 54644591-54648493 "Plasma proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "breast: 84.3;skin 1: 197.7" "Cell type enriched" "Detected in some" 386 "Melanocytes: 7747.1" "Cancer enriched" "Detected in some" 9 "breast cancer: 91.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 3.9" HPA063967 Enhanced "Secreted in other tissues" NA NA 370000000 "HPA063967: AB_2685163" "unprognostic (3.55e-2)" "unprognostic (1.61e-1)" 7.3 0.0 0.1 0.1 0.1 0.2 84.3 0.1 0.1 0.1 0.1 0.1 4.4 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 4.6 0.1 2.7 197.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 1.8 1.8 5.2 2.2 3.2 2.5 0.8 0.7 0.9 1.6 1.4 0.8 1.2 1.7 1.9 0.3 0.0 1.1 0.0 1.8 0.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.6 2.4 2.1 0.8 0.5 0.0 0.4 1.4 0.7 0.4 0.0 0.0 0.2 0.4 0.2 1.1 3.9 0.0 0.0 0.0 1.5 0.6 0.0 0.7 1.0 0.7 0.3 0.0 0.8 1.6 1.1 0.0 1.4 0.4 1.3 0.5 0.6 0.0 1.1 0.9 0.9 0.1 0.0 0.6 0.3 0.3 1.0 0.2 5.2 1.6 2.0 1.4 1.2 2.5 1.8 1.7 1.4 1.0 1.7 2.1 2.3 3.6 3.2 2.2 1.8 1.9 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7747.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 20.1 0.0 0.0 0.0 0.0 DCDC1 ENSG00000170959 "Doublecortin domain containing 1" P59894 11 30830369-31369810 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.2;pituitary gland: 26.7" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 56.2;Cone photoreceptor cells: 19.6;Early spermatids: 31.2;Rod photoreceptor cells: 20.7;Spermatocytes: 15.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "basal ganglia: 5.6;pons and medulla: 19.2" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.8;U-266/70: 5.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.01e-2)" "unprognostic (1.57e-1)" "unprognostic (8.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.87e-2)" "unprognostic (1.06e-2)" "unprognostic (5.68e-2)" "unprognostic (4.73e-1)" "unprognostic (3.17e-1)" "unprognostic (4.47e-3)" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-3)" "unprognostic (2.61e-1)" 0.6 0.6 1.0 0.1 5.6 0.2 1.0 0.4 1.0 1.3 0.5 2.7 3.3 0.1 1.3 13.3 0.4 9.9 4.3 0.5 1.9 1.6 3.4 6.4 4.8 0.2 0.6 0.2 4.2 2.4 3.9 26.7 0.2 19.2 0.6 0.2 2.8 0.7 2.0 0.4 0.5 0.4 0.2 0.6 0.4 0.5 11.5 1.1 0.0 2.8 0.0 0.2 0.5 1.3 0.0 0.0 1.4 0.0 0.0 0.9 0.0 0.2 1.1 0.8 0.6 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.1 0.0 1.0 0.4 0.1 0.1 1.0 0.4 0.6 0.0 0.1 1.5 0.0 0.2 0.3 0.7 0.0 0.3 0.3 0.3 0.0 1.0 0.3 0.1 0.2 0.1 0.2 0.0 1.4 0.4 0.0 0.0 0.3 0.0 2.8 0.0 0.8 0.1 1.4 0.0 0.1 0.2 0.2 0.0 0.1 0.5 0.8 1.1 0.2 5.5 0.3 0.2 1.2 0.0 0.3 1.4 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 5.6 0.4 1.0 1.9 1.6 0.6 0.2 19.2 1.1 0.0 1.0 0.0 0.1 0.2 1.9 0.8 0.0 56.2 6.8 0.0 19.6 0.0 0.0 0.6 31.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.4 0.1 0.0 0.0 0.0 0.6 13.2 1.4 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.4 1.0 20.7 0.0 0.0 15.2 3.7 0.0 0.0 0.0 0.0 0.0 DCDC2 "DCDC2A, DFNB66, KIAA1154, NPHP19, RU2" ENSG00000146038 "Doublecortin domain containing 2" Q9UHG0 6 24171756-24358052 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Neurogenesis" "Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 37.0;kidney: 46.4;pancreas: 22.7" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 61.1;Ciliated cells: 60.2;Collecting duct cells: 75.0;Distal tubular cells: 48.0;Ductal cells: 106.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 20.2;EFO-21: 14.1;Hep G2: 22.9;RPTEC TERT1: 74.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031582, HPA031583, HPA031584" Enhanced Enhanced "Microtubules,Mitotic spindle,Centriolar satellite,Cytosol" NA NA "Mitotic spindle, Cytosol" "Microtubules, Centriolar satellite" "HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-2)" "unprognostic (1.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.09e-1)" "unprognostic (2.67e-2)" "unprognostic (5.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.99e-2)" 0.1 0.9 1.1 0.2 1.5 0.0 3.5 0.3 0.9 1.6 0.3 0.2 1.0 0.3 3.4 37.0 0.2 5.8 7.7 0.2 1.3 1.7 46.4 1.8 3.9 0.0 0.6 0.5 2.1 22.7 7.6 4.3 1.7 1.8 1.5 0.3 2.8 0.9 3.7 0.5 0.2 0.2 0.4 0.5 0.1 1.1 3.7 0.2 0.2 8.4 0.0 0.2 1.0 0.1 1.2 0.5 1.3 0.4 1.0 0.5 0.2 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.2 0.0 1.5 0.1 0.0 0.4 0.0 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.4 0.3 0.5 0.2 0.2 0.5 0.5 0.3 0.3 1.2 0.4 0.4 1.3 1.0 0.2 0.5 0.2 0.2 1.1 1.5 0.3 0.9 1.3 1.7 0.6 0.5 1.8 0.2 17.9 11.8 0.0 0.6 0.1 0.0 0.3 61.1 60.2 10.3 75.0 0.0 0.3 48.0 106.8 23.9 0.0 0.0 0.0 7.2 0.0 0.3 1.1 0.0 1.0 0.5 0.0 3.5 0.0 0.0 11.0 0.3 0.0 0.0 3.6 3.4 1.9 20.8 2.9 0.4 39.0 0.0 0.0 0.3 7.7 2.2 0.1 0.1 0.0 1.2 0.5 DCDC2B ENSG00000222046 "Doublecortin domain containing 2B" A2VCK2 1 32209094-32216196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 11.1;fallopian tube: 26.6;lung: 10.1" "Cell type enriched" "Detected in some" 13 "Ciliated cells: 115.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 1.6;hTERT-RPE1: 2.9;TIME: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045832 Uncertain NA NA "HPA045832: AB_10962048" "unprognostic (6.45e-3)" "unprognostic (3.71e-2)" "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (2.18e-1)" "unprognostic (1.87e-3)" "unprognostic (7.66e-3)" "unprognostic (6.35e-2)" "unprognostic (4.84e-2)" "unprognostic (3.33e-1)" "unprognostic (2.71e-3)" "unprognostic (8.73e-2)" "unprognostic (6.18e-4)" "unprognostic (8.53e-2)" "unprognostic (2.00e-1)" "unprognostic (4.76e-2)" "unprognostic (4.39e-3)" 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 11.1 0.0 26.6 0.2 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 5.5 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 1.0 0.6 0.1 0.2 0.3 0.0 0.1 0.8 1.6 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 2.9 0.0 0.9 0.1 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 1.2 0.4 0.0 0.0 0.6 0.2 0.5 0.8 0.1 3.6 0.1 0.7 1.0 0.7 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 1.0 0.1 0.0 0.0 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 115.1 9.1 1.8 3.9 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 3.2 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 DCDC2C ENSG00000214866 "Doublecortin domain containing 2C" A8MYV0 2 3703592-3847411 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 9.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 180.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045848 Uncertain NA NA "HPA045848: AB_10961120" "unprognostic (2.63e-2)" "unprognostic (1.81e-1)" "unprognostic (3.81e-3)" "unprognostic (6.98e-2)" 0.2 0.2 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.6 0.1 0.1 0.5 0.0 0.5 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 9.0 0.1 0.1 0.6 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 180.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 5.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.6 0.0 0.0 0.0 0.3 0.7 0.7 0.0 0.0 0.0 0.0 0.0 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" 4 154231742-154495570 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 8.6" "Group enriched" "Detected in some" 7 "Early spermatids: 20.6;Horizontal cells: 23.8;Intestinal endocrine cells: 6.4;Late spermatids: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2 OS: 8.0" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA064159: AB_2685201" "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.9 1.6 3.4 1.3 7.0 1.1 1.0 0.6 4.8 2.6 4.0 1.9 1.1 1.3 8.6 1.5 1.0 2.0 1.6 0.8 3.5 2.6 0.9 0.7 1.1 0.8 3.0 2.3 1.9 0.6 1.1 1.7 0.8 4.6 1.6 1.5 2.7 0.8 3.6 1.0 2.1 1.0 3.0 7.0 0.8 4.9 2.6 2.9 0.0 1.0 0.0 0.9 2.3 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.4 7.0 0.6 4.8 3.5 2.6 3.0 2.3 4.6 2.9 0.0 0.0 0.0 0.2 0.3 0.0 1.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 23.8 6.4 0.0 0.0 14.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.3 0.0 0.0 0.0 0.0 DCK ENSG00000156136 "Deoxycytidine kinase" P27707 4 70992538-71030914 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 60.9;U-698: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059609, HPA062773" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA059609: AB_2684082, HPA062773: AB_2684865" "unprognostic (9.16e-2)" "unprognostic (2.44e-1)" "unprognostic (5.24e-3)" "unprognostic (4.77e-2)" "unprognostic (3.95e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (6.90e-7)" "unprognostic (3.04e-2)" "unprognostic (7.19e-2)" "unprognostic (8.28e-2)" "unprognostic (4.51e-1)" "unprognostic (1.33e-1)" "unprognostic (3.37e-2)" "unprognostic (4.47e-2)" "unprognostic (6.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.27e-2)" 8.0 8.3 11.9 30.9 16.8 17.2 6.9 11.4 14.8 5.6 8.6 10.4 2.6 7.6 7.5 4.4 8.8 5.5 6.1 5.5 12.3 13.1 5.8 4.8 9.7 42.8 11.7 10.3 6.0 5.0 3.6 4.2 7.9 11.1 5.9 10.4 6.4 6.3 4.0 6.8 7.9 12.4 7.5 17.6 17.5 8.2 5.6 8.6 80.9 8.3 3.8 39.9 9.5 6.5 27.9 34.2 17.5 12.7 18.5 24.9 25.1 6.7 4.5 9.9 5.9 3.1 5.5 5.7 17.5 6.5 13.9 11.6 2.9 14.8 60.9 7.6 7.2 8.1 3.9 8.8 5.5 18.8 12.9 5.4 12.6 5.2 4.6 3.2 25.1 16.3 2.7 6.7 8.4 5.1 6.8 7.9 17.3 5.0 23.2 15.8 3.9 31.0 9.9 4.7 11.5 5.5 26.4 20.1 4.8 6.9 4.7 8.8 9.4 6.6 12.9 7.7 4.7 5.8 13.2 6.3 15.7 11.8 13.1 9.4 8.8 5.8 49.4 10.9 15.7 11.6 13.1 10.7 17.5 16.2 12.7 20.3 27.9 21.8 20.0 14.3 26.4 23.4 23.5 5.4 18.5 12.1 34.2 24.9 25.1 11.9 16.8 11.4 14.8 12.3 13.1 11.7 10.3 11.1 8.6 0.0 11.3 75.5 8.0 38.1 13.6 4.6 7.6 1.4 3.4 12.2 5.9 9.8 24.9 17.7 0.4 14.3 9.0 186.9 5.6 16.0 12.9 9.5 23.0 5.3 33.7 17.5 20.2 21.5 48.3 1.1 7.8 41.6 43.9 68.5 17.2 14.3 8.9 7.0 9.6 6.1 8.2 6.5 20.6 34.4 28.8 37.9 3.8 61.7 14.3 6.2 DCLK1 "DCAMKL1, DCDC3A, DCLK, KIAA0369" ENSG00000133083 "Doublecortin like kinase 1" O15075 13 35768652-36131306 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 76.5" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 84.2" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012405, HPA015040, HPA015655" Enhanced Approved Nucleoplasm,Cytosol NA NA 11000 Nucleoplasm Cytosol "CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265" "unprognostic (2.29e-1)" "unprognostic (2.56e-1)" "unprognostic (7.45e-2)" "unprognostic (1.30e-2)" "unprognostic (1.99e-1)" "unprognostic (2.35e-2)" "unprognostic (1.48e-1)" "unprognostic (3.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-1)" "unprognostic (7.72e-2)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (1.93e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-4)" 13.9 3.3 14.3 4.2 25.0 1.1 8.6 8.6 76.5 12.2 3.5 8.6 0.5 2.0 6.4 5.8 5.8 3.3 7.1 5.8 21.9 21.9 1.9 1.2 3.0 4.3 11.9 22.5 6.4 2.1 1.5 7.4 1.1 13.9 4.7 4.4 0.5 2.5 4.7 1.9 4.7 2.7 17.0 10.4 4.6 2.5 2.2 8.5 0.0 2.1 1.4 2.9 5.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 16.7 15.8 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 12.9 19.8 0.0 10.0 0.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 0.0 14.6 7.3 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.7 0.0 0.2 0.0 1.1 0.0 0.5 0.0 4.1 2.5 0.0 0.0 1.2 6.1 0.0 0.0 0.0 0.0 3.4 4.3 0.7 0.1 0.0 0.0 1.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 25.0 8.6 45.8 21.9 21.9 11.9 22.5 13.9 8.5 8.9 1.1 0.0 1.0 13.5 2.2 5.1 0.0 4.0 4.5 3.5 3.9 0.0 0.0 0.0 1.3 2.9 0.0 0.0 0.0 0.0 9.3 0.5 0.0 0.0 0.1 9.5 0.0 0.6 0.3 0.9 19.2 0.0 13.5 0.0 0.0 84.2 0.3 0.0 3.9 0.2 2.1 6.5 16.8 1.6 0.7 8.4 0.0 0.0 0.0 1.3 DCLK2 "DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428" ENSG00000170390 "Doublecortin like kinase 2" Q8N568 4 150078274-150257457 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 60.5" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 18.2;Cone photoreceptor cells: 15.7;Horizontal cells: 33.4;Muller glia cells: 39.2" "Cancer enriched" "Detected in many" 17 "glioma: 53.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.5;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 18.6;BJ: 8.4;BJ hTERT+: 19.4;fHDF/TERT166: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015770 Enhanced Approved NA NA "HPA015770: AB_1847509" "unprognostic (7.37e-2)" "unprognostic (1.56e-3)" "unprognostic (9.30e-2)" "unprognostic (1.49e-2)" "unprognostic (4.06e-1)" "unprognostic (6.24e-3)" "unprognostic (1.90e-1)" "unprognostic (7.38e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.25e-4)" "prognostic favorable (2.48e-4)" "unprognostic (6.87e-2)" "unprognostic (3.93e-3)" "unprognostic (3.74e-3)" "unprognostic (4.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.45e-2)" 2.9 3.9 23.3 2.1 23.5 1.6 2.0 9.3 60.5 3.1 2.8 16.5 0.8 2.8 4.3 3.5 3.0 2.8 4.0 14.4 23.5 17.5 2.9 1.8 2.7 1.6 14.9 14.5 4.3 3.5 1.4 4.7 2.9 20.2 3.9 3.5 2.1 2.0 3.6 2.3 2.1 2.7 6.4 23.4 2.1 2.2 4.2 15.9 0.0 4.1 0.0 1.5 3.3 2.0 2.5 1.5 0.0 0.5 0.0 0.0 0.0 0.8 3.2 18.6 2.9 0.0 0.9 0.3 8.4 19.4 2.8 0.6 0.1 0.0 0.0 0.3 8.5 2.8 0.0 2.7 0.0 3.5 3.8 1.6 0.0 4.9 0.0 4.0 0.5 0.5 0.5 0.0 1.7 0.2 1.7 0.9 0.5 0.0 0.0 1.9 0.1 0.3 0.0 0.4 0.2 1.0 0.0 2.1 0.7 0.0 0.8 7.1 6.8 3.5 2.6 0.8 1.6 0.0 0.0 1.6 2.6 1.0 1.7 0.9 0.8 0.0 0.0 2.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 23.3 23.5 9.3 19.3 23.5 17.5 14.9 14.5 20.2 15.9 0.0 0.0 0.0 0.1 0.5 18.2 9.1 2.5 0.0 1.2 3.5 15.7 0.0 0.0 0.3 0.0 5.6 0.0 0.0 0.6 0.0 2.2 0.9 4.6 0.0 1.3 33.4 2.9 8.6 0.0 0.0 1.7 1.0 5.0 0.0 0.2 39.2 0.2 0.0 3.5 0.3 8.9 12.9 4.1 0.1 0.2 0.5 0.2 0.0 1.3 0.1 DCLK3 "DCAMKL3, DCDC3C, KIAA1765" ENSG00000163673 "Doublecortin like kinase 3" Q9C098 3 36712422-36764349 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.0;testis: 8.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 24.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.4;SCLC-21H: 3.3;SH-SY5Y: 2.7;U-2 OS: 1.9;U-2197: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040685 Approved NA NA "HPA040685: AB_2732487" "unprognostic (9.09e-3)" "unprognostic (1.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.66e-2)" "unprognostic (2.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.96e-2)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" "unprognostic (7.07e-2)" "unprognostic (6.11e-5)" "unprognostic (7.94e-3)" "unprognostic (5.80e-2)" "unprognostic (3.25e-3)" "unprognostic (1.36e-2)" 1.1 0.4 2.6 1.4 10.0 0.3 0.1 0.1 2.3 0.5 0.2 0.3 0.0 0.5 0.3 0.1 0.1 0.2 0.6 0.9 1.4 0.9 0.0 0.1 0.3 0.2 0.6 0.0 0.0 0.2 0.4 1.8 1.1 0.4 0.3 0.3 1.3 1.7 0.2 2.7 0.4 0.4 0.9 0.7 0.1 0.0 8.0 3.2 0.0 0.9 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 2.7 0.1 0.3 0.0 0.2 0.0 0.4 0.3 0.0 1.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 10.0 0.1 2.3 1.4 0.9 0.6 0.0 0.4 3.2 0.0 0.0 0.0 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 DCP1A "HSA275986, SMAD4IP1, SMIF" ENSG00000272886 "Decapping mRNA 1A" Q9NPI6 3 53283428-53347610 "Plasma proteins, Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 30.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013202 Approved Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA013202: AB_1857287" "unprognostic (2.10e-1)" "unprognostic (7.61e-2)" "prognostic favorable (9.01e-4)" "unprognostic (9.79e-3)" "unprognostic (7.68e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (3.24e-2)" "unprognostic (1.86e-1)" "unprognostic (8.37e-2)" "unprognostic (7.33e-3)" "unprognostic (9.14e-2)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.95e-1)" 8.0 5.7 4.8 5.4 6.9 18.5 6.1 11.1 8.8 7.2 4.7 6.8 2.1 3.9 8.4 5.8 5.5 6.5 5.5 5.4 4.3 4.6 4.9 5.1 6.3 5.1 3.7 11.2 6.9 8.5 10.0 9.9 5.8 5.8 5.8 7.0 3.8 5.0 5.0 4.9 6.4 7.6 5.8 6.5 4.1 4.9 6.0 11.4 6.1 4.0 10.0 8.2 5.8 26.7 17.4 23.6 25.8 29.4 30.3 19.0 5.8 6.1 14.4 11.6 9.9 10.4 19.3 6.9 9.2 15.4 14.5 17.9 10.7 13.6 2.8 8.7 9.0 5.0 18.7 7.1 13.4 12.1 8.3 13.3 8.4 9.2 8.7 15.7 18.2 8.1 6.9 13.8 11.3 9.4 11.1 9.6 11.1 14.8 7.4 3.6 21.6 7.9 9.1 6.1 8.9 10.0 9.7 9.4 6.4 13.3 7.6 12.3 12.0 7.9 10.3 11.2 5.1 12.2 11.9 7.4 10.6 7.5 10.3 9.3 8.0 15.7 9.0 9.1 13.1 23.6 13.6 22.4 24.3 14.4 30.1 21.7 24.8 28.1 15.0 26.7 30.3 28.1 13.9 29.4 25.8 17.4 16.9 19.0 26.8 30.7 38.9 43.4 51.1 29.0 23.8 15.3 8.1 19.4 7.0 45.2 35.0 3.3 24.3 8.2 29.2 20.6 0.0 30.3 45.7 31.6 39.2 36.8 11.0 17.6 27.0 49.6 26.4 22.2 19.1 23.0 23.0 10.1 34.3 24.7 17.5 34.8 14.0 24.4 13.1 28.3 12.9 30.9 12.2 16.6 36.0 53.5 27.4 26.1 50.6 DCP2 NUDT20 ENSG00000172795 "Decapping mRNA 2" Q8IU60 5 112976702-113020970 "Enzymes, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 52.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011677, HPA057676" Approved Approved "Nucleoplasm,Cell Junctions,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "Cell Junctions" "CAB011677: AB_731858, HPA057676: AB_2683500" "unprognostic (2.76e-1)" "unprognostic (3.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-1)" "unprognostic (3.86e-3)" "prognostic unfavorable (4.84e-4)" "unprognostic (1.87e-1)" "unprognostic (3.64e-2)" "unprognostic (6.26e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (8.39e-2)" "unprognostic (2.84e-1)" "unprognostic (3.25e-2)" "unprognostic (5.75e-2)" 8.0 7.5 8.1 16.3 9.5 22.9 15.0 16.8 10.9 9.1 6.6 6.4 6.6 6.3 10.5 6.8 7.4 8.0 6.5 6.1 8.1 8.9 8.1 8.1 13.2 19.8 6.9 6.1 12.8 6.2 7.0 12.2 40.2 8.3 8.1 7.3 6.5 9.6 8.6 8.3 9.8 8.7 7.3 7.4 19.9 6.7 6.8 6.5 52.9 7.0 4.1 20.0 8.7 9.1 5.1 6.5 16.3 8.3 3.9 5.9 3.2 3.6 3.1 14.1 11.3 2.8 3.1 22.8 3.3 2.7 4.2 6.1 14.6 7.8 19.1 5.3 1.9 3.4 4.5 16.2 4.5 5.1 5.1 7.0 17.9 2.7 5.8 3.2 10.9 9.3 2.9 3.1 5.1 5.1 4.0 7.1 14.7 13.2 7.5 3.8 4.6 16.0 11.6 12.2 2.2 1.9 15.7 13.4 7.1 6.5 9.3 3.3 7.0 4.6 5.2 6.7 15.3 15.4 14.6 4.6 4.7 8.4 2.4 5.0 5.1 11.2 14.6 2.7 15.3 3.6 12.2 7.2 5.5 4.0 7.1 5.5 5.1 4.9 4.2 6.5 3.6 4.6 4.7 16.3 3.9 8.3 3.5 5.9 3.2 8.1 9.5 16.8 10.9 8.1 8.9 6.9 6.1 8.3 6.5 17.9 15.6 38.9 16.7 24.6 21.6 11.4 5.1 18.7 22.7 19.2 74.6 53.4 16.6 8.9 23.5 21.8 10.0 0.0 10.3 41.1 27.2 25.6 18.5 5.9 27.7 27.0 15.5 27.6 71.2 42.2 17.5 46.5 25.3 36.9 9.1 34.4 12.8 10.5 10.3 11.2 35.2 6.5 17.9 29.3 19.0 23.2 53.9 38.8 11.3 37.6 DCST1 FLJ32785 ENSG00000163357 "DC-STAMP domain containing 1" Q5T197 1 155033824-155050930 "Enzymes, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "retina: 18.2;skin 1: 6.8;testis: 10.7" "Cell type enhanced" "Detected in some" 19 "Cone photoreceptor cells: 11.8;Early spermatids: 23.4;Late spermatids: 15.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.9;HeLa: 4.1;RPMI-8226: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA060314 Uncertain NA NA "HPA060314: AB_2684250" "unprognostic (1.44e-1)" "unprognostic (7.66e-2)" "unprognostic (3.77e-2)" "unprognostic (1.05e-4)" "unprognostic (3.58e-2)" "unprognostic (8.75e-4)" "unprognostic (1.46e-2)" "unprognostic (2.66e-1)" "unprognostic (6.01e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.89e-2)" "unprognostic (8.33e-15)" "unprognostic (7.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.38e-1)" "unprognostic (1.23e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 1.7 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 18.2 0.7 0.1 0.1 6.8 1.6 0.1 0.1 0.2 0.4 10.7 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.8 0.8 0.9 1.2 0.0 1.0 0.1 1.5 0.7 2.7 1.5 0.1 0.0 1.0 0.6 0.0 0.0 0.0 0.7 3.3 1.6 0.5 0.0 0.7 4.9 0.0 0.0 0.0 1.2 0.4 0.4 4.1 0.3 0.0 1.2 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.1 2.3 0.0 1.0 0.0 0.3 0.2 0.2 2.2 0.0 1.1 5.6 0.0 0.8 0.9 1.8 0.6 1.8 0.2 1.1 3.5 0.1 0.0 0.4 0.2 0.8 0.4 1.0 0.8 0.3 0.7 1.6 0.0 0.0 0.2 0.9 0.1 0.0 0.0 0.8 0.4 0.2 0.3 0.0 1.0 0.2 0.2 0.0 1.2 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 1.2 0.6 0.0 1.4 2.3 0.0 11.8 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 DCST2 FLJ32934 ENSG00000163354 "DC-STAMP domain containing 2" Q5T1A1 1 155018520-155033781 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.6;testis: 20.8" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 15.7;Early spermatids: 43.0;Late spermatids: 21.0;Rod photoreceptor cells: 17.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;Karpas-707: 3.7;U-266/70: 4.9" "Low region specificity" "Detected in some" NA NA "unprognostic (8.08e-2)" "unprognostic (5.67e-2)" "unprognostic (6.04e-4)" "unprognostic (1.63e-2)" "unprognostic (3.34e-2)" "unprognostic (1.88e-3)" "unprognostic (8.25e-2)" "unprognostic (2.65e-2)" "unprognostic (2.94e-1)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (8.92e-2)" "unprognostic (2.78e-10)" "unprognostic (6.95e-3)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-3)" 0.8 0.2 0.5 0.5 0.5 0.1 2.2 0.7 0.5 1.8 0.6 0.5 0.5 2.5 0.7 0.5 1.2 1.5 0.5 0.5 0.5 0.1 0.5 0.8 0.5 0.5 0.5 0.5 0.8 0.5 0.0 0.5 0.5 0.5 1.9 0.7 5.3 3.0 1.2 0.5 8.6 1.5 0.5 0.5 0.5 0.6 20.8 0.5 0.5 0.7 0.5 0.5 0.5 2.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.4 1.2 1.6 0.9 0.8 0.9 0.1 0.5 0.3 0.0 0.0 1.2 0.2 1.0 0.2 0.3 3.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.2 0.1 0.9 2.2 0.1 0.4 0.5 0.0 0.1 0.1 3.7 0.0 1.1 0.0 0.1 0.2 1.3 0.2 0.3 0.1 1.3 0.4 0.1 0.6 0.3 1.1 0.6 0.8 0.8 0.7 0.0 0.0 0.0 1.0 0.0 0.0 4.9 1.9 0.0 0.0 0.4 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.7 0.5 0.5 0.1 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.8 0.8 1.1 0.4 0.0 0.0 0.0 0.0 15.7 0.3 0.0 0.0 43.0 0.1 1.1 0.0 0.2 9.8 0.2 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.7 0.5 17.6 0.0 0.8 2.6 1.6 1.1 0.7 0.0 0.6 0.4 DCSTAMP "DC-STAMP, FIND, TM7SF4" ENSG00000164935 "Dendrocyte expressed seven transmembrane protein" Q9H295 8 104339087-104356689 "Predicted membrane proteins, Transporters" "Differentiation, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adipose tissue: 28.8;lung: 18.2" "Group enriched" "Detected in some" 4 "Hofbauer cells: 7.5;Macrophages: 2.5" "Cancer enriched" "Detected in some" 46 "thyroid cancer: 45.3" "Region enriched" "Detected in single" 4 "amygdala: 3.5" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 1.5" "Lineage enriched" "Detected in single" 16 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.1;RPMI-8226: 1.2;SuSa: 1.4;U-87 MG: 4.5;U-937: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.11e-2)" "unprognostic (1.22e-2)" "unprognostic (8.41e-2)" "unprognostic (2.96e-2)" "unprognostic (8.48e-4)" "unprognostic (2.14e-1)" "unprognostic (5.40e-2)" "unprognostic (1.51e-2)" "unprognostic (3.08e-2)" "unprognostic (1.18e-2)" "unprognostic (5.26e-2)" "unprognostic (2.45e-1)" "unprognostic (1.61e-3)" "unprognostic (8.84e-2)" "unprognostic (1.36e-1)" "unprognostic (8.05e-2)" "unprognostic (8.34e-3)" 28.8 0.1 3.5 0.3 0.2 0.4 1.2 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.3 0.0 0.8 0.2 0.1 1.0 18.2 0.8 0.2 0.0 0.8 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.5 1.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 3.5 0.2 0.0 0.6 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 7.5 0.0 0.0 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436808-94479682 "Enzymes, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 58 "retina: 151.5;skin 1: 54.2" "Cell type enriched" "Detected in some" 25 "Melanocytes: 3369.1" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 259 "SK-MEL-30: 76.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.2 0.2 0.5 0.1 1.5 0.1 1.7 0.2 0.6 0.2 0.1 0.3 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.1 0.3 0.2 0.0 151.5 1.4 0.2 0.2 54.2 0.2 0.1 0.8 0.1 0.0 0.3 0.4 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 76.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 0.2 0.6 0.4 0.5 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.1 135.3 0.7 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.9 0.0 3369.1 0.0 0.0 2.4 0.0 0.0 0.7 0.0 0.2 0.0 0.9 0.5 0.2 29.2 0.0 0.0 0.0 0.0 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 95.0" "Cell type enriched" "Detected in all" 4 "Late spermatids: 9862.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol NA NA 70000 Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 5.0 5.2 7.9 5.0 7.1 6.9 4.8 9.3 8.3 4.5 4.9 4.1 2.7 4.9 5.4 4.9 6.7 4.3 4.6 5.5 7.4 5.0 7.2 11.2 4.3 5.0 9.3 6.8 4.7 3.6 4.6 14.6 4.5 8.0 6.1 4.8 2.8 4.9 5.4 14.7 5.2 6.5 8.1 9.2 5.2 4.2 95.0 7.6 7.2 6.7 5.2 6.0 8.4 4.9 7.4 10.7 17.3 9.8 11.2 8.0 5.7 23.3 10.4 13.9 6.0 14.7 14.5 11.8 15.0 16.9 16.9 16.6 15.3 17.4 27.4 33.0 14.0 25.5 13.1 11.6 12.0 22.5 22.4 6.3 26.4 8.1 6.4 9.3 15.5 19.9 10.3 14.7 9.4 8.9 12.5 11.6 16.8 8.8 14.4 12.3 12.5 15.2 8.3 11.3 17.6 9.5 12.0 14.7 18.1 12.2 16.5 10.1 10.1 26.3 18.9 14.1 15.3 38.7 12.6 11.2 10.5 10.1 14.3 17.6 11.9 22.0 27.8 13.2 14.7 15.1 9.4 9.1 17.3 7.8 9.8 7.5 7.4 6.4 7.7 10.7 4.7 7.5 7.9 15.0 11.2 6.3 8.2 8.0 5.7 7.9 7.1 9.3 8.3 7.4 5.0 9.3 6.8 8.0 7.6 20.8 25.6 17.1 21.7 38.5 14.2 28.2 17.8 20.1 27.3 45.4 9.8 16.2 31.5 26.1 2225.5 18.8 26.6 46.7 26.5 15.7 27.7 32.3 28.9 42.3 24.9 17.5 25.8 17.8 32.1 9862.3 80.3 36.4 11.8 45.1 19.9 16.6 27.2 23.4 60.5 33.6 20.5 77.6 25.5 86.4 52.0 37.1 16.7 25.3 19.6 34.8 DCUN1D2 "C13orf17, FLJ10704, FLJ20092" ENSG00000150401 "Defective in cullin neddylation 1 domain containing 2" Q6PH85 13 113455819-113490952 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039349 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039349: AB_10673240" "unprognostic (3.09e-1)" "unprognostic (1.35e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (7.43e-2)" "unprognostic (7.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (2.02e-2)" "prognostic favorable (5.65e-5)" "unprognostic (1.21e-2)" "unprognostic (7.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.69e-2)" "unprognostic (1.25e-2)" 4.9 4.5 6.2 6.0 7.0 7.8 4.6 24.0 13.3 4.1 4.3 6.5 3.4 3.1 6.2 6.6 4.7 4.0 4.9 59.1 5.9 7.2 4.3 4.0 3.8 4.6 7.2 5.9 5.5 4.5 3.5 7.1 5.2 9.7 3.9 4.5 6.2 4.5 4.5 65.6 9.1 5.4 5.2 8.5 4.9 4.3 5.6 6.1 5.3 3.3 7.5 4.9 3.8 3.7 3.5 2.7 10.9 2.2 2.8 4.1 1.8 6.9 4.3 7.2 5.5 5.3 4.7 5.6 5.4 6.6 5.1 5.8 15.3 4.2 5.0 1.7 6.2 8.0 10.0 7.8 4.1 7.3 3.2 13.1 8.4 19.6 4.1 2.8 12.9 6.3 6.9 6.8 5.7 4.6 3.5 4.3 6.9 4.7 4.8 4.9 4.9 8.7 21.2 4.6 5.0 6.8 9.2 12.0 6.6 3.8 4.5 32.2 7.2 4.1 14.5 4.0 5.3 8.3 6.1 7.1 6.7 9.1 5.1 7.7 14.2 6.0 10.0 15.3 5.7 4.5 10.9 1.9 3.6 3.1 1.7 4.1 3.5 2.8 1.9 2.7 1.9 3.0 1.6 1.5 2.8 2.2 0.3 2.9 1.8 6.2 7.0 24.0 13.3 5.9 7.2 7.2 5.9 9.7 6.1 14.9 17.0 2.7 1.7 5.3 7.7 67.8 0.0 5.3 13.6 3.5 15.7 2.0 1.7 1.6 5.2 4.6 3.6 0.0 1.2 1.1 4.5 2.6 4.7 3.9 1.2 17.5 6.3 6.2 4.0 4.5 6.6 3.5 5.0 0.0 4.3 4.4 1.8 0.0 5.3 2.1 9.9 0.0 3.3 3.4 4.8 6.5 2.2 2.6 3.7 2.5 DCUN1D3 "DKFZp686O0290, FLJ41725, MGC48972, SCCRO3" ENSG00000188215 "Defective in cullin neddylation 1 domain containing 3" Q8IWE4 16 20854925-20900384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 38.4" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 30.6;ASC TERT1: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041983, HPA043511" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041983: , HPA043511: AB_2678521" "unprognostic (9.34e-2)" "unprognostic (4.56e-2)" "unprognostic (3.47e-2)" "unprognostic (1.33e-2)" "unprognostic (4.24e-2)" "unprognostic (8.71e-2)" "unprognostic (5.90e-2)" "unprognostic (1.73e-1)" "unprognostic (1.81e-1)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.31e-2)" "prognostic unfavorable (5.41e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-1)" "unprognostic (5.31e-2)" "unprognostic (2.42e-1)" 19.2 9.9 4.3 6.0 4.6 2.7 17.2 7.9 5.6 7.5 6.0 5.5 3.2 3.4 7.7 5.9 8.5 6.6 9.6 8.9 2.5 2.8 10.0 17.4 9.7 3.1 5.2 3.0 5.3 6.6 6.4 9.5 9.4 6.7 6.6 4.1 6.3 3.9 4.5 38.4 7.1 4.9 11.9 3.9 4.5 6.4 7.9 3.8 1.5 4.8 11.5 4.5 6.7 15.8 1.4 1.6 4.8 2.5 2.6 2.7 1.0 2.7 4.8 2.4 5.2 30.6 23.1 3.3 9.1 7.9 4.6 6.3 6.0 5.2 1.7 7.4 8.9 2.8 3.7 2.8 3.8 6.2 2.3 1.9 1.4 3.8 8.7 8.0 2.2 13.9 15.2 5.2 8.7 4.9 4.9 12.6 1.7 1.6 4.7 9.3 3.7 2.0 3.2 5.7 2.3 1.6 3.4 2.7 1.7 4.0 2.8 2.2 3.0 3.5 3.9 2.1 3.0 2.6 1.0 6.2 9.8 3.4 4.1 2.4 4.0 2.3 1.2 10.4 2.3 5.0 4.8 1.4 1.2 1.7 2.5 1.7 1.0 1.2 2.7 1.6 1.4 1.5 2.7 1.9 2.6 2.2 1.2 1.0 1.0 4.3 4.6 7.9 5.6 2.5 2.8 5.2 3.0 6.7 3.8 11.9 17.1 0.0 12.6 27.8 12.1 4.0 5.1 0.0 6.8 8.7 33.4 3.0 0.0 3.5 50.8 14.3 4.3 0.0 4.4 1.7 12.7 8.1 0.0 12.9 2.1 12.7 19.4 10.4 7.1 34.5 10.0 8.0 11.8 0.0 4.7 5.2 3.9 0.0 9.2 4.0 23.2 6.5 12.2 4.6 3.5 19.7 4.2 4.3 3.8 16.9 DCX "DBCN, DC, LISX, SCLH, XLIS" ENSG00000077279 Doublecortin O43602 X 111293779-111412429 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.1;testis: 6.4" "Cell type enriched" "Detected in some" 12 "Rod photoreceptor cells: 22.7" "Cancer enriched" "Detected in some" 5 "glioma: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 34.6;SH-SY5Y: 14.2" "Region enriched" "Detected in many" 9 "olfactory region: 90.9" "Region enriched" "Detected in all" 5 "olfactory region: 130.1" HPA036121 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA036121: AB_2674950" "unprognostic (1.36e-2)" "unprognostic (1.99e-1)" "unprognostic (7.36e-2)" "unprognostic (4.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.00e-2)" "unprognostic (7.18e-2)" "unprognostic (3.24e-2)" "unprognostic (2.33e-3)" "unprognostic (3.67e-1)" "unprognostic (4.90e-4)" "unprognostic (5.02e-3)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" 0.8 1.1 7.0 0.7 9.2 0.7 3.2 0.7 17.1 0.7 0.6 0.9 0.0 0.7 4.1 3.6 0.6 0.6 0.8 0.7 4.2 5.4 0.5 0.5 0.6 0.7 2.5 6.7 0.6 0.8 0.5 1.0 0.6 3.7 0.5 0.8 0.0 2.2 0.6 0.5 0.7 0.7 0.6 3.0 0.6 1.2 6.4 2.3 0.0 0.6 0.0 0.5 0.6 0.3 0.3 0.4 0.6 0.2 0.7 0.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 34.6 14.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.2 0.1 0.3 0.3 0.3 0.6 0.7 0.0 0.4 0.1 0.0 7.0 9.2 0.7 10.8 4.2 5.4 2.5 6.7 3.7 2.3 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.2 0.0 1.4 0.0 22.7 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DCXR "DCR, KIDCR, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037732 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 293.8" "Group enriched" "Detected in all" 5 "Distal tubular cells: 688.1;Hepatocytes: 2593.4;Proximal tubular cells: 1817.7" "Cancer enhanced" "Detected in all" "liver cancer: 305.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 65.1;MCF7: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules NA NA 2700000 "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 12.7 6.1 12.8 4.3 12.1 5.7 12.2 9.0 15.1 9.9 9.5 8.4 18.1 7.8 4.4 62.7 11.7 6.1 4.8 11.8 9.8 9.7 50.8 293.8 10.5 5.3 14.4 7.3 8.1 13.0 6.7 7.2 9.0 13.4 22.3 5.4 7.8 19.3 14.0 22.5 8.6 6.8 3.6 8.4 4.4 14.9 8.7 9.7 8.3 15.6 12.6 9.1 7.5 6.4 32.8 52.7 25.3 33.1 35.2 43.7 35.8 8.9 12.4 5.7 10.3 23.1 5.8 15.2 4.6 6.0 12.7 8.7 21.8 3.9 18.6 9.0 6.4 1.6 10.6 10.4 9.3 4.4 3.9 26.8 17.8 9.3 65.1 24.7 13.7 21.9 8.4 11.5 4.0 14.6 2.7 7.1 11.1 20.2 13.6 6.7 80.0 11.4 32.8 6.6 40.3 13.1 10.5 7.7 24.2 9.4 12.8 16.0 9.4 6.5 55.1 8.0 3.6 41.3 13.5 3.6 6.7 8.4 9.1 8.6 13.9 10.2 8.8 5.8 15.0 4.9 13.9 33.1 25.3 24.7 30.6 23.6 28.6 30.8 23.6 52.7 32.8 43.7 31.9 16.5 35.2 28.0 42.5 33.1 35.8 12.8 12.1 9.0 15.1 9.8 9.7 14.4 7.3 13.4 9.7 47.6 155.8 118.2 185.0 52.0 15.8 102.4 124.9 20.1 28.4 169.3 17.7 343.4 688.1 41.9 5.1 35.2 135.9 23.3 37.0 376.5 68.0 203.5 64.5 2593.4 145.3 20.6 52.6 88.4 114.9 15.1 65.6 57.1 170.4 47.7 117.0 81.8 32.4 105.2 44.6 1817.7 18.5 19.4 66.5 6.6 48.3 64.0 286.5 126.9 129.4 155.9 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 36.9;SH-SY5Y: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006308, HPA071064" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532, HPA071064: " "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favorable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favorable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.3 2.3 6.5 1.2 10.9 9.2 0.8 21.7 13.2 7.7 8.2 26.1 4.9 0.0 9.1 24.6 7.6 5.3 23.5 4.5 9.9 0.0 9.0 0.0 6.2 9.1 3.9 16.7 1.0 7.7 0.4 6.5 4.1 9.8 12.3 0.0 0.0 1.8 19.8 1.5 0.8 0.0 7.8 36.9 6.8 0.0 15.2 0.2 33.0 13.7 18.3 35.6 2.8 16.5 2.6 9.7 8.9 1.2 24.0 6.8 5.5 1.6 15.1 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 32.8 31.3 4.2 4.0 12.2 2.7 11.4 68.8 30.8 13.6 66.3 3.9 1.7 106.1 15.6 17.1 4.5 78.7 0.0 26.7 0.8 23.5 37.8 0.0 94.3 0.9 0.0 32.8 9.2 2.2 18.4 14.7 1.5 11.8 1.0 77.8 59.7 34.2 73.6 70.4 219.6 8.0 12.9 18.9 5.0 5.6 12.5 0.7 3.3 85.4 6.5 DDC AADC ENSG00000132437 "Dopa decarboxylase" P20711 7 50458436-50565457 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 90.1;kidney: 68.1" "Group enriched" "Detected in many" 5 "Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "midbrain: 7.9;pons and medulla: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "midbrain: 90.4;pons and medulla: 40.7" HPA017742 Enhanced Approved "Actin filaments" NA NA 380000 "Actin filaments" "HPA017742: AB_1847832" "unprognostic (1.04e-1)" "unprognostic (3.68e-2)" "unprognostic (2.57e-2)" "unprognostic (3.49e-5)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (1.28e-1)" "unprognostic (5.15e-2)" "unprognostic (4.69e-2)" "unprognostic (5.44e-2)" "unprognostic (9.36e-3)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-1)" "unprognostic (3.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.16e-1)" 0.3 10.9 0.3 3.0 0.7 0.0 0.3 0.3 0.4 0.3 36.7 0.4 0.3 33.5 0.3 1.8 0.3 0.0 0.7 0.3 0.3 1.3 68.1 11.7 0.7 0.3 7.9 0.3 0.4 9.8 0.0 0.3 0.3 3.4 0.4 8.1 0.4 0.3 0.3 0.3 0.1 90.1 0.3 0.3 0.3 4.3 0.6 0.5 0.3 0.3 0.4 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.4 0.0 0.0 0.0 0.2 0.4 0.0 43.6 45.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.3 0.4 0.3 1.3 7.9 0.3 3.4 0.5 0.0 9.8 0.8 0.0 0.0 81.1 0.4 5.1 0.0 1.2 3.5 39.3 0.0 21.6 0.0 3.6 0.0 72.8 0.0 0.7 0.1 0.0 0.4 0.0 58.7 0.1 3.2 394.4 1.3 1.3 4.3 0.0 0.0 0.0 0.0 30.4 24.1 0.2 26.6 0.0 366.2 456.4 0.0 0.0 3.6 0.4 0.0 0.1 0.0 46.0 0.0 DDI1 FLJ36017 ENSG00000170967 "DNA damage inducible 1 homolog 1" Q8WTU0 11 104036580-104039188 "Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "testis: 53.2" "Group enriched" "Detected in some" 79 "Early spermatids: 338.2;Late spermatids: 769.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079511 Enhanced NA NA "HPA079511: " "unprognostic (2.98e-1)" "unprognostic (2.14e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 338.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 769.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 7.0 2.7 0.0 0.0 0.0 0.0 0.0 DDI2 MGC14844 ENSG00000197312 "DNA damage inducible 1 homolog 2" Q5TDH0 1 15617500-15669044 "Plasma proteins, Predicted intracellular proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA043119, HPA043225" Approved Enhanced Nucleoplasm,Cytosol NA NA 170000 "Nucleoplasm, Cytosol" "HPA043119: AB_2678326, HPA043225: AB_2678369" "unprognostic (1.93e-1)" "unprognostic (8.03e-2)" "unprognostic (1.26e-1)" "unprognostic (3.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-3)" "unprognostic (3.04e-2)" "unprognostic (1.63e-2)" "unprognostic (3.31e-3)" "unprognostic (8.31e-3)" "unprognostic (1.02e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-3)" "unprognostic (7.56e-2)" "unprognostic (1.84e-1)" "unprognostic (7.63e-2)" "unprognostic (3.77e-2)" 14.8 8.1 5.1 10.5 7.1 10.5 15.0 8.7 8.4 8.7 10.8 8.2 9.8 9.0 12.3 9.6 19.4 7.7 8.3 12.5 5.8 4.7 10.4 24.9 10.2 9.1 6.7 5.2 8.3 9.4 14.8 8.0 11.5 7.5 12.1 7.9 11.5 13.5 13.8 54.8 13.3 9.2 8.0 6.5 9.9 6.9 4.3 6.0 11.1 7.6 11.7 16.4 12.1 12.3 3.8 5.4 0.8 2.3 2.0 3.5 1.4 7.5 4.4 8.0 8.3 11.0 8.7 7.8 4.7 3.6 4.2 3.6 10.7 6.9 19.0 5.6 5.2 3.1 8.0 17.4 7.6 7.1 8.7 11.6 14.8 7.4 10.5 4.7 19.6 7.5 8.6 9.1 7.8 8.4 5.2 8.5 12.4 23.8 7.0 5.1 5.1 11.3 6.5 7.6 11.2 3.6 10.7 11.3 11.2 5.9 6.3 9.8 5.4 8.8 14.4 13.1 9.4 7.5 5.1 7.4 6.0 5.2 6.8 5.8 6.6 8.0 15.4 4.7 14.3 4.7 0.7 2.3 0.4 3.3 2.1 2.9 2.6 2.5 2.6 2.3 3.8 2.8 3.5 0.8 2.0 1.6 5.4 2.3 1.4 5.1 7.1 8.7 8.4 5.8 4.7 6.7 5.2 7.5 6.0 8.9 15.2 11.9 12.2 13.6 23.7 23.0 12.7 29.4 22.7 3.5 13.7 17.5 1.7 6.8 1.5 12.1 15.1 46.7 6.6 16.1 13.9 22.6 1.1 54.8 13.2 33.4 14.5 16.0 21.2 0.4 11.8 12.5 15.1 6.4 22.4 8.0 12.5 3.5 6.3 16.5 36.7 6.5 12.3 10.0 7.8 17.7 33.6 12.7 20.1 12.7 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.6;testis: 16.3" "Cell type enhanced" "Detected in some" 12 "Kupffer cells: 5.3;Spermatocytes: 12.0;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: AB_2676071" "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 1.3 1.0 0.8 6.1 0.8 7.0 1.7 0.8 1.2 1.9 2.3 1.2 0.2 1.3 1.5 2.6 5.5 1.0 0.4 2.6 0.9 0.7 1.0 2.3 3.1 5.0 0.8 0.6 1.3 0.9 0.0 0.5 2.5 1.0 0.9 2.0 0.2 2.1 0.2 10.1 2.3 1.9 1.5 0.9 5.5 1.1 16.3 0.9 17.6 0.8 9.5 5.9 1.8 1.8 2.0 4.5 5.8 10.7 1.9 0.7 3.2 6.0 9.6 9.9 7.2 1.0 1.5 7.3 11.5 4.9 12.8 14.9 9.4 7.6 7.4 17.3 2.6 10.1 11.6 16.7 7.2 17.7 13.4 9.0 10.5 4.9 4.2 0.1 12.9 9.3 0.3 0.7 16.1 7.4 1.1 6.0 9.2 10.6 12.8 11.3 8.8 12.1 10.5 11.8 16.7 11.0 9.0 19.2 9.5 2.7 10.1 7.4 10.0 7.1 7.2 2.7 10.1 7.8 5.4 2.8 12.8 17.4 33.7 14.0 7.3 19.1 25.7 4.0 9.3 12.1 0.6 10.7 3.9 0.5 8.3 0.3 1.1 0.3 0.7 4.5 2.0 0.7 0.4 5.8 1.9 7.8 1.4 0.5 3.2 0.8 0.8 0.8 1.2 0.9 0.7 0.8 0.6 1.0 0.9 0.0 0.0 4.6 0.8 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 1.4 0.0 0.5 2.7 0.0 0.0 0.0 0.5 4.3 0.0 0.3 0.0 0.5 2.2 0.0 0.0 1.3 5.3 1.6 0.3 1.6 0.0 0.0 0.2 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.3 12.0 15.1 0.0 0.2 0.0 0.6 0.9 DDIT4 "Dig2, FLJ20500, REDD-1, REDD1, RTP801" ENSG00000168209 "DNA damage inducible transcript 4" Q9NX09 10 72273920-72276036 "Predicted intracellular proteins" "Antiviral defense, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 159.3" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 589.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 66.5;hTCEpi: 225.6;hTERT-HME1: 82.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034507, HPA034508" Approved Supported Cytosol NA NA Cytosol "HPA034507: AB_2674199, HPA034508: AB_10601206" "unprognostic (2.84e-3)" "unprognostic (1.05e-3)" "unprognostic (1.06e-1)" "unprognostic (2.59e-1)" "unprognostic (7.91e-3)" "prognostic unfavorable (5.42e-4)" "unprognostic (7.65e-2)" "unprognostic (1.62e-3)" "unprognostic (2.90e-1)" "unprognostic (4.96e-3)" "prognostic unfavorable (2.78e-4)" "unprognostic (9.72e-2)" "prognostic unfavorable (2.54e-6)" "unprognostic (8.52e-2)" "unprognostic (1.12e-1)" "unprognostic (5.92e-2)" "unprognostic (1.66e-1)" 29.0 43.9 27.3 28.0 28.0 35.5 88.2 23.1 27.1 38.7 18.7 6.4 14.4 7.5 16.3 13.5 37.0 14.5 21.7 23.0 28.2 8.4 13.6 27.5 33.7 26.5 45.5 11.6 73.4 159.3 5.4 16.4 16.2 34.4 15.8 5.1 10.2 41.2 29.2 29.5 21.0 13.0 11.7 22.8 17.5 19.6 8.1 34.9 30.8 13.4 11.1 34.5 37.8 47.7 25.9 40.5 9.7 2.5 70.6 57.1 40.9 12.8 9.3 1.9 17.3 12.5 7.2 5.6 3.9 4.3 1.4 5.8 1.0 27.8 1.4 11.8 0.6 1.8 15.1 2.6 66.5 3.2 20.8 3.4 1.5 21.0 6.9 49.5 4.3 6.3 30.4 225.6 6.0 82.9 13.2 5.5 3.3 12.4 34.6 5.0 5.3 2.6 6.0 0.4 6.2 2.1 1.5 2.1 24.6 11.9 3.0 3.4 4.8 9.2 14.6 52.1 4.5 2.0 9.7 11.4 0.4 3.7 0.8 2.1 24.6 13.6 3.8 24.8 9.8 2.9 9.2 1.6 9.7 50.4 2.5 48.6 17.9 32.8 27.8 7.2 25.9 57.1 42.9 5.3 70.6 2.0 40.5 24.0 40.9 27.3 28.0 23.1 27.1 28.2 8.4 45.5 11.6 34.4 34.9 11.9 40.9 153.5 238.2 203.1 78.2 12.9 58.6 36.1 63.7 57.6 74.6 7.9 51.4 226.4 2.3 154.0 50.8 23.3 146.9 35.2 109.4 154.5 397.0 55.0 80.1 28.6 71.9 166.3 61.3 4.7 81.7 238.1 376.2 53.3 48.9 589.5 133.5 28.1 120.6 9.0 131.0 71.1 402.1 1.9 4.3 219.8 15.9 277.0 34.0 244.9 DDIT4L "REDD2, Rtp801L" ENSG00000145358 "DNA damage inducible transcript 4 like" Q96D03 4 100185870-100190782 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 106.4" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 21.0;Distal tubular cells: 18.3;Extravillous trophoblasts: 14.7;Sertoli cells: 19.4;Smooth muscle cells: 16.0" "Cancer enhanced" "Detected in many" "testis cancer: 19.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.9;BJ: 18.8;fHDF/TERT166: 10.2;HSkMC: 9.8;hTERT-RPE1: 21.5;RPTEC TERT1: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050903 Uncertain "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA050903: " "unprognostic (2.21e-1)" "unprognostic (1.92e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.77e-4)" "unprognostic (1.66e-3)" "unprognostic (5.92e-2)" "unprognostic (2.72e-2)" "unprognostic (3.12e-1)" "unprognostic (3.21e-1)" "unprognostic (7.18e-2)" "unprognostic (2.59e-1)" "unprognostic (1.41e-1)" "unprognostic (4.47e-2)" "unprognostic (4.82e-3)" "unprognostic (2.09e-2)" "unprognostic (7.53e-5)" "unprognostic (4.99e-3)" 1.4 0.5 1.5 0.3 6.3 0.3 0.6 2.0 1.6 7.9 0.6 1.7 0.0 0.2 0.9 3.0 2.6 0.9 0.3 3.5 2.1 0.7 6.2 0.2 0.4 0.3 1.5 1.6 2.8 0.2 0.3 1.2 1.3 2.7 3.8 0.5 5.2 6.3 2.6 106.4 0.4 0.3 0.8 2.4 0.5 0.2 1.1 1.7 0.0 0.6 18.6 1.2 0.5 0.9 0.2 0.0 0.0 0.2 0.0 2.0 0.2 0.0 1.4 5.5 0.0 2.5 12.9 0.8 18.8 1.6 0.3 0.1 0.1 0.5 0.0 0.4 10.2 0.4 0.0 3.9 0.3 0.3 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 9.8 0.1 0.2 1.0 21.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 6.2 0.0 0.0 0.3 0.0 0.0 13.4 0.0 0.0 0.0 0.3 0.7 2.5 1.4 0.0 0.0 0.1 0.0 0.0 0.0 1.4 2.5 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.1 2.0 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 1.0 0.2 1.5 6.3 2.0 1.6 2.1 0.7 1.5 1.6 2.7 1.7 0.0 0.0 0.0 0.1 2.4 0.0 4.7 0.0 0.0 0.0 21.0 0.0 1.7 18.3 0.1 0.6 1.5 0.0 0.0 0.0 14.7 5.0 0.8 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 6.8 0.0 0.0 8.3 0.5 0.0 2.1 1.3 0.0 19.4 16.0 0.7 0.1 1.3 3.3 0.0 0.0 0.1 DDN KIAA0749 ENSG00000181418 Dendrin O94850 12 48995149-48999309 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 40.8;skeletal muscle: 73.8" "Group enriched" "Detected in some" 4 "Collecting duct cells: 3.5;Ito cells: 1.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 10.6;RPMI-8226: 20.1;SCLC-21H: 10.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "amygdala: 228.1;basal ganglia: 257.7;cerebral cortex: 232.0;hippocampal formation: 236.4;olfactory region: 128.1" HPA060952 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060952: AB_2684396" "unprognostic (2.80e-2)" "unprognostic (3.19e-3)" "unprognostic (4.56e-2)" "unprognostic (8.10e-3)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (6.20e-5)" "unprognostic (8.61e-4)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (5.08e-2)" "unprognostic (1.37e-6)" "unprognostic (1.72e-2)" "unprognostic (5.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.53e-2)" 0.7 0.7 40.5 0.8 40.8 1.3 0.7 0.0 38.5 0.7 0.7 0.2 0.0 0.7 0.7 3.8 1.0 0.7 0.7 0.9 30.5 2.0 4.8 0.7 0.7 0.9 2.9 9.3 0.7 0.8 0.8 0.0 0.7 0.0 1.6 0.7 0.0 0.7 0.7 73.8 0.8 0.8 0.7 0.0 0.8 0.8 0.8 1.2 0.0 0.7 0.0 0.8 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.3 0.3 0.2 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.2 4.5 0.4 0.0 0.2 0.0 0.0 1.6 10.6 0.0 0.1 0.5 4.8 2.3 0.5 1.0 0.0 5.5 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 3.5 0.2 0.1 5.3 6.0 0.1 0.8 1.4 4.9 0.3 20.1 0.0 0.1 10.6 1.0 0.2 0.5 0.2 0.1 0.3 0.7 0.1 0.2 0.5 0.2 0.0 1.2 2.3 4.7 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 40.5 40.8 0.0 31.9 30.5 2.0 2.9 9.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 DDT DDCT ENSG00000099977 "D-dopachrome tautomerase" P30046 22 23971365-23980469 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Melanin biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.8;liver: 58.4" "Cell type enriched" "Detected in all" 5 "Hepatocytes: 4710.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 68.5" "HPA049871, HPA074115" Enhanced Approved Mitochondria NA NA Mitochondria "HPA049871: AB_2680926, HPA074115: " "unprognostic (1.77e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (8.09e-2)" "unprognostic (4.00e-3)" "unprognostic (2.02e-3)" "unprognostic (6.58e-2)" "unprognostic (4.66e-2)" "unprognostic (2.23e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (7.34e-2)" "unprognostic (3.30e-1)" "unprognostic (3.81e-1)" "unprognostic (2.61e-3)" 9.7 6.6 5.4 3.4 4.8 8.8 4.5 2.1 4.4 3.0 9.8 11.8 2.7 4.3 5.8 2.8 1.4 7.7 4.2 4.0 11.3 58.4 3.2 2.9 5.4 4.1 14.4 1.3 1.8 2.5 5.8 6.4 7.1 4.4 10.4 3.7 11.6 2.0 4.6 3.2 8.2 1.2 3.7 2.7 4.3 3.2 30.4 52.8 27.8 38.0 23.8 29.0 28.6 27.1 11.6 4.0 9.4 7.7 6.8 24.5 7.9 5.3 6.9 7.2 10.2 7.9 26.0 7.4 4.1 10.2 22.5 10.0 9.8 4.5 11.0 68.5 15.6 15.8 22.2 7.8 34.2 15.7 6.8 7.5 6.9 6.1 8.0 7.4 4.1 14.1 10.5 6.9 13.3 7.5 31.0 12.1 24.0 35.0 16.5 7.5 37.1 12.3 10.0 13.7 13.2 16.3 30.9 23.2 5.7 7.8 10.8 8.5 7.2 16.0 7.3 8.2 32.4 10.7 16.3 14.1 12.7 13.8 20.7 38.0 27.8 19.9 32.4 20.3 30.4 24.1 21.1 35.7 28.4 21.9 21.3 24.2 23.8 29.6 52.8 29.0 28.6 77.4 62.3 170.5 177.4 123.4 46.7 20.4 580.9 78.9 76.2 230.3 84.4 209.3 608.5 198.5 156.1 122.0 650.8 116.8 322.3 247.0 92.9 222.4 128.0 4710.9 242.3 41.3 249.4 161.4 217.6 261.8 108.4 147.1 150.1 220.0 322.2 63.3 238.6 309.5 104.0 969.7 70.4 77.6 140.0 72.1 40.3 164.4 250.7 154.1 488.9 247.4 DDTL ENSG00000099974 "D-dopachrome tautomerase like" A6NHG4 22 23966901-23972532 "Predicted intracellular proteins" Lyase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 36.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 6.0;Cardiomyocytes: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA074115 Approved NA NA "HPA074115: " "unprognostic (6.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.91e-1)" "unprognostic (6.34e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "prognostic favorable (5.98e-4)" "unprognostic (2.65e-2)" "unprognostic (2.26e-2)" "unprognostic (1.60e-1)" "unprognostic (1.77e-2)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (3.70e-2)" "unprognostic (3.58e-3)" 3.1 4.7 2.3 5.9 6.8 6.6 6.3 3.3 4.3 2.7 7.8 2.6 4.3 8.3 3.5 4.6 4.7 2.8 5.9 10.7 2.7 2.2 7.0 36.5 3.4 6.5 2.6 4.6 5.0 22.6 0.6 3.3 3.7 4.5 6.1 4.3 2.9 9.0 6.1 10.1 7.0 11.0 3.9 3.0 5.4 6.1 4.4 1.7 3.2 4.6 7.2 3.5 4.6 3.5 2.0 1.6 6.4 2.0 2.5 2.9 0.9 3.0 2.1 2.4 2.6 1.5 0.5 3.1 1.6 0.0 0.0 0.0 4.6 3.0 5.2 1.1 0.2 2.1 7.8 2.5 0.6 0.1 1.9 10.1 2.9 7.7 4.4 1.9 7.3 3.2 0.9 1.1 0.5 0.0 3.3 0.5 1.7 2.9 3.8 0.0 2.2 1.3 4.3 0.9 2.3 1.8 4.3 2.5 1.6 1.4 4.3 2.6 1.3 2.3 4.5 7.6 3.0 3.7 1.4 1.1 4.6 3.6 1.4 1.2 2.9 0.8 2.2 1.1 3.6 2.7 6.4 1.4 2.2 2.0 2.0 2.1 1.9 1.4 2.9 1.2 2.0 1.1 1.7 0.6 2.5 0.4 1.6 1.4 0.9 2.3 6.8 3.3 4.3 2.7 2.2 2.6 4.6 4.5 1.7 6.0 1.9 0.0 1.1 0.9 0.8 10.4 0.0 0.0 2.3 0.0 3.9 1.1 5.0 0.8 0.8 1.1 2.9 0.0 0.4 1.1 0.6 0.8 1.1 4.7 0.8 0.0 1.2 1.8 1.9 0.4 0.6 1.2 0.0 1.0 1.1 0.5 1.2 2.6 1.1 3.6 0.7 0.0 0.4 0.2 0.6 0.6 2.1 0.0 2.7 0.7 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111755245-111768016 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 81.7" "Group enriched" "Detected in many" 13 "Early spermatids: 570.4;Late spermatids: 538.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favorable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 3.1 2.8 2.9 2.7 4.3 5.9 9.8 5.8 5.1 2.7 2.6 1.8 2.6 2.0 4.0 2.9 2.6 3.7 1.7 2.0 4.3 1.6 2.7 2.4 4.1 3.8 2.4 1.9 3.9 2.9 4.0 3.9 2.7 3.4 2.9 2.6 1.2 2.6 2.7 5.1 2.5 3.5 2.9 5.6 4.5 2.8 81.7 3.3 5.1 3.2 1.7 4.1 2.9 5.0 11.9 7.4 12.7 7.4 10.5 14.1 7.8 11.4 4.7 12.2 11.0 8.8 7.0 11.4 11.2 8.7 16.1 15.7 7.0 4.0 26.8 8.8 7.6 5.7 9.2 14.4 11.3 18.0 12.2 13.0 13.0 9.2 7.2 8.8 12.8 9.6 7.0 9.9 13.7 13.9 4.5 11.1 10.5 12.4 9.8 12.2 10.8 15.7 13.0 15.3 6.9 9.6 15.4 20.1 6.7 10.5 9.0 12.7 11.5 10.8 13.5 18.0 10.6 8.4 13.6 9.8 9.8 14.5 17.5 13.0 4.9 6.9 20.5 10.2 13.2 22.1 12.7 7.0 6.9 10.0 7.3 13.3 11.9 11.7 11.8 7.4 10.1 14.1 12.3 5.0 10.5 7.4 5.2 11.7 7.8 2.9 4.3 5.8 5.1 4.3 1.6 2.4 1.9 3.4 3.3 11.9 6.5 3.7 7.8 9.6 12.2 5.9 2.5 13.4 12.5 5.2 2.0 8.6 3.3 8.9 570.4 7.1 2.4 0.0 6.0 6.8 4.8 3.0 7.0 4.9 8.0 6.4 4.1 3.7 9.1 538.8 15.3 8.7 1.7 3.6 5.7 6.3 6.3 2.9 12.4 6.9 8.9 6.5 10.3 41.2 25.6 6.4 4.2 7.0 5.8 5.5 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048291-94081245 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 103.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favorable (3.06e-9)" "prognostic unfavorable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 18.0 45.5 19.7 13.7 41.3 53.3 18.5 31.4 40.8 17.4 20.9 21.9 14.3 13.6 23.2 103.0 20.1 18.9 21.3 28.6 25.0 31.3 36.3 30.1 16.4 27.4 22.0 29.0 21.4 12.5 8.3 32.0 11.2 38.7 16.0 14.6 17.4 15.9 17.7 28.5 23.4 12.6 17.9 21.8 18.1 15.0 38.5 17.4 14.3 25.3 11.8 25.8 21.7 14.9 4.1 3.1 10.6 3.3 6.2 5.3 5.0 3.8 1.1 7.2 4.6 4.3 5.7 1.7 10.8 9.1 14.1 12.7 1.4 2.5 17.9 4.1 2.4 4.2 2.5 7.4 0.6 15.4 7.8 0.4 9.5 2.1 5.8 3.6 13.7 4.2 0.9 4.1 2.6 2.5 4.7 2.3 3.4 4.9 5.3 6.0 10.8 4.1 11.7 4.8 1.2 0.1 5.5 16.7 2.1 10.2 1.4 5.7 5.3 10.6 2.6 5.0 1.3 4.2 4.9 6.9 4.0 2.7 5.1 3.3 2.1 13.8 19.3 5.8 7.5 3.1 10.6 3.3 2.5 5.0 2.6 1.4 2.9 2.9 3.0 2.0 4.1 5.3 5.3 2.6 6.2 2.5 3.1 3.3 5.0 19.7 41.3 31.4 40.8 25.0 31.3 22.0 29.0 38.7 17.4 157.8 151.6 175.7 121.2 162.3 169.0 198.2 58.6 192.7 154.7 139.6 123.7 76.5 230.5 124.3 63.9 107.4 65.5 116.8 86.3 59.9 133.4 81.0 147.1 96.2 75.0 219.3 93.7 105.0 83.4 46.7 214.3 119.2 94.5 181.3 57.7 131.2 82.3 69.1 230.2 135.3 189.8 161.7 156.5 383.4 396.2 127.2 131.4 217.1 54.9 94.1 DDX25 GRTH ENSG00000109832 "DEAD-box helicase 25" Q9UHL0 11 125903348-125943702 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport" "Developmental protein, Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.3;testis: 64.2" "Group enriched" "Detected in some" 5 "Early spermatids: 250.3;Spermatocytes: 190.6" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "JURKAT: 16.8;NTERA-2: 11.4;SCLC-21H: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020137 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA020137: AB_1847552" "unprognostic (5.78e-3)" "unprognostic (9.75e-3)" "unprognostic (7.93e-2)" "unprognostic (5.09e-3)" "unprognostic (1.11e-2)" "unprognostic (1.78e-2)" "unprognostic (1.54e-1)" "unprognostic (2.91e-3)" "unprognostic (6.24e-5)" "unprognostic (2.57e-1)" "unprognostic (2.44e-3)" "unprognostic (3.89e-1)" "unprognostic (3.44e-3)" "unprognostic (1.44e-1)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.69e-1)" 0.7 2.8 8.7 0.8 13.2 0.9 0.8 7.9 17.3 0.8 0.8 2.0 0.0 1.0 0.9 0.9 0.8 0.9 0.8 0.7 8.4 7.1 2.7 0.8 0.8 0.8 4.8 8.9 1.2 1.8 2.6 7.1 0.9 5.9 0.9 0.8 2.3 0.8 1.0 0.8 1.6 0.8 0.7 3.4 0.9 1.0 64.2 3.0 0.0 4.3 0.0 0.8 0.7 0.2 0.6 0.5 3.3 0.3 1.3 0.5 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.2 1.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.8 0.0 0.3 0.0 0.5 1.6 0.0 11.4 0.5 0.0 0.4 0.0 0.0 0.0 0.1 9.2 2.1 0.1 0.0 1.6 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 2.1 0.3 0.6 0.3 0.2 0.2 0.4 0.5 0.2 0.1 0.6 0.4 0.3 3.3 1.3 0.2 0.5 0.1 0.1 8.7 13.2 7.9 12.5 8.4 7.1 4.8 8.9 5.9 3.0 0.0 0.3 0.0 0.7 0.1 18.2 0.8 0.0 0.0 0.0 0.0 15.7 0.0 3.3 0.1 250.3 0.9 0.0 0.0 0.2 0.1 0.3 0.5 0.0 0.5 0.1 15.9 0.0 0.6 0.0 41.7 3.4 0.1 0.0 0.0 0.0 16.0 0.1 0.0 4.6 1.8 16.0 0.0 0.1 190.6 24.5 0.0 0.0 0.0 0.0 0.1 DDX39A "BAT1L, DDX39, DDXL, URH49" ENSG00000123136 "DExD-box helicase 39A" O00148 19 14408819-14419383 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 238.8;Late spermatids: 232.5;Spermatocytes: 336.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055334 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055334: AB_2682787" "unprognostic (1.31e-1)" "prognostic favorable (6.86e-4)" "unprognostic (2.41e-1)" "unprognostic (1.10e-1)" "unprognostic (1.12e-1)" "unprognostic (5.20e-2)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.87e-1)" "unprognostic (8.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.50e-10)" "unprognostic (1.55e-3)" "unprognostic (8.57e-2)" "unprognostic (3.92e-1)" "unprognostic (7.38e-3)" 10.9 8.5 7.2 20.6 11.4 41.4 10.5 9.1 7.9 8.2 10.9 11.0 4.4 13.0 9.4 7.2 15.9 7.0 8.1 7.8 6.6 6.1 9.7 12.1 10.3 31.2 12.6 5.0 7.4 8.8 3.0 7.4 10.5 10.0 7.3 8.9 5.2 7.9 4.4 7.9 10.6 12.8 6.8 9.4 23.4 10.4 60.7 10.3 39.9 8.4 16.3 26.1 10.3 8.8 36.7 36.6 7.7 28.5 21.5 39.7 33.6 32.9 27.1 13.9 26.9 5.7 4.2 13.6 14.7 8.1 30.6 18.9 27.5 17.9 63.7 15.6 12.1 16.4 20.4 34.2 23.8 12.5 22.3 17.9 68.4 31.6 19.7 10.1 37.2 30.6 5.8 5.4 19.8 8.1 4.5 16.0 23.4 42.0 28.1 17.0 39.9 63.7 55.2 26.6 32.2 41.5 44.2 24.6 37.3 10.9 27.1 32.4 17.9 10.9 22.8 16.5 9.5 25.2 36.3 14.9 27.1 16.9 44.5 32.8 29.2 51.2 65.6 30.4 40.6 27.0 6.8 25.9 7.7 35.6 28.5 30.5 36.7 28.4 28.2 36.6 33.2 24.9 26.7 7.7 21.5 23.4 22.6 39.7 33.6 7.2 11.4 9.1 7.9 6.6 6.1 12.6 5.0 10.0 10.3 14.9 27.9 70.7 37.1 67.5 10.3 9.4 17.8 21.4 18.2 5.2 0.0 37.6 31.5 37.9 238.8 33.8 44.6 23.3 57.3 97.5 36.2 30.0 89.1 10.6 78.7 11.1 24.6 27.6 51.6 232.5 24.5 64.4 47.2 70.3 24.3 13.8 42.5 28.1 17.7 22.6 3.9 19.4 54.6 336.3 94.8 62.0 50.1 65.4 35.5 32.5 DDX4 VASA ENSG00000152670 "DEAD-box helicase 4" Q9NQI0 5 55738017-55817157 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 171 "testis: 60.4" "Group enriched" "Detected in some" 4 "Early spermatids: 435.1;Late spermatids: 140.2;Spermatocytes: 312.4" "Cancer enriched" "Detected in single" 37 "testis cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.1;HEK 293: 1.6;NB-4: 1.0;PC-3: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB026170, HPA037763, HPA037764" Enhanced NA NA "CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.54e-1)" "unprognostic (2.58e-1)" "unprognostic (3.80e-2)" "unprognostic (3.03e-1)" "unprognostic (5.35e-2)" "unprognostic (3.91e-1)" "unprognostic (3.77e-2)" "unprognostic (3.28e-1)" "unprognostic (5.73e-2)" "unprognostic (5.43e-7)" "unprognostic (4.84e-2)" "unprognostic (1.12e-1)" "unprognostic (5.60e-2)" "unprognostic (1.55e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 60.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.4 0.0 0.1 0.0 0.7 0.4 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 435.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.2 5.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.0 312.4 73.7 0.0 0.0 0.0 0.0 0.0 DDX43 "CT13, DKFZp434H2114, HAGE" ENSG00000080007 "DEAD-box helicase 43" Q9NXZ2 6 73394748-73417569 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 35.2" "Group enriched" "Detected in many" 6 "Spermatocytes: 50.6;Spermatogonia: 31.3" "Cancer enriched" "Detected in many" 15 "testis cancer: 13.0" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 9.0;CAPAN-2: 15.1;HHSteC: 4.2;MCF7: 2.8;U-2 OS: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA031381 Enhanced NA NA "HPA031381: AB_10601885" "unprognostic (4.03e-3)" "unprognostic (8.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (3.59e-4)" "unprognostic (1.64e-2)" "unprognostic (3.11e-2)" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (3.08e-1)" "unprognostic (1.19e-3)" "unprognostic (1.02e-1)" "unprognostic (2.68e-1)" "unprognostic (1.58e-1)" "unprognostic (8.78e-2)" 1.3 0.7 0.6 1.0 0.7 0.7 1.9 0.4 0.8 0.8 2.6 1.2 2.1 1.4 1.0 0.4 1.1 0.7 6.1 1.2 0.7 0.6 0.8 1.0 1.6 0.9 1.0 0.0 2.9 1.9 0.1 0.7 5.7 3.3 1.8 0.7 1.5 4.3 2.2 0.4 1.4 1.7 3.0 1.9 1.2 2.4 35.2 0.7 0.4 1.8 1.3 1.9 1.7 0.7 2.3 0.8 2.9 0.9 1.6 3.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.0 0.0 0.1 15.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 2.9 3.3 0.9 2.6 2.3 2.5 2.8 0.8 2.3 1.3 0.4 0.6 1.6 0.8 0.2 1.4 0.7 0.6 0.7 0.4 0.8 0.7 0.6 1.0 0.0 3.3 0.7 3.0 4.8 0.5 1.1 2.4 0.3 0.4 0.0 1.4 3.4 0.0 0.0 6.5 0.0 0.4 2.2 2.2 0.0 0.0 0.8 2.9 1.1 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.3 2.0 1.8 3.3 1.0 0.0 0.4 1.3 0.0 1.1 1.4 0.9 0.0 0.4 50.6 31.3 1.3 5.0 2.5 0.0 0.7 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 47.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.0 8.8 0.0 0.0 0.0 0.0 0.0 DEAF1 "NUDR, SPN, ZMYND5" ENSG00000177030 "DEAF1, transcription factor" O75398 11 644233-706715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030302 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA030302: AB_2673421" "unprognostic (1.32e-2)" "unprognostic (3.32e-2)" "unprognostic (3.58e-3)" "unprognostic (5.90e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (2.42e-2)" "unprognostic (2.65e-1)" "unprognostic (2.48e-1)" "unprognostic (2.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.39e-2)" "unprognostic (2.79e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-1)" "unprognostic (5.15e-2)" 4.8 5.9 36.1 6.5 19.9 4.5 16.9 19.4 26.2 5.4 4.3 5.3 5.2 4.8 7.5 6.3 6.8 9.8 6.0 8.3 30.2 15.7 4.5 2.8 5.3 4.4 18.3 3.4 6.0 13.2 5.9 14.5 5.2 9.7 6.7 2.2 3.6 11.8 4.7 7.8 6.6 4.0 7.2 8.1 4.0 7.2 5.7 9.8 15.2 12.0 2.7 5.3 7.0 20.3 1.2 4.4 3.3 3.0 3.5 5.9 1.6 7.5 4.6 7.4 3.9 7.3 9.5 5.8 5.6 7.2 11.9 8.7 4.9 6.5 2.1 6.1 5.5 3.2 5.0 7.1 5.1 1.7 9.1 42.1 5.0 2.6 3.7 13.2 11.0 8.2 8.0 7.0 2.1 6.0 7.6 9.4 5.8 11.1 8.8 4.4 3.8 4.1 10.1 17.4 7.8 9.7 10.1 2.6 8.2 8.4 0.9 10.6 11.1 4.0 6.0 4.0 1.9 3.7 3.2 10.8 3.9 2.2 1.6 4.8 9.8 3.6 3.9 4.4 7.3 7.7 0.0 3.0 3.3 2.4 1.7 2.6 1.2 4.7 2.7 4.4 0.8 5.9 3.2 1.8 3.5 1.9 0.5 1.7 1.6 36.1 19.9 19.4 26.2 30.2 15.7 18.3 3.4 9.7 9.8 0.0 3.8 9.0 22.8 11.7 18.3 6.1 10.2 5.3 4.5 33.2 9.8 11.6 44.7 17.9 3.0 13.5 11.1 0.0 9.7 5.1 14.9 30.4 0.0 10.4 8.8 57.2 10.5 4.9 7.0 5.1 18.4 9.0 16.9 12.6 8.6 20.4 12.8 10.7 28.3 22.3 17.1 12.9 15.5 6.7 11.7 13.6 12.9 8.7 8.9 26.8 DEC1 CTS9 ENSG00000173077 "Deleted in esophageal cancer 1" Q9P2X7 9 115141818-115402644 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 1.4;testis: 2.3" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 4.3;Intestinal endocrine cells: 1.7;Late spermatids: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.3;HeLa: 4.7;SuSa: 1.5;WM-115: 1.8" NA NA "unprognostic (9.06e-2)" "unprognostic (1.40e-1)" "unprognostic (3.28e-2)" "unprognostic (2.18e-2)" "unprognostic (4.06e-2)" "unprognostic (4.03e-2)" "unprognostic (2.86e-1)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (4.77e-1)" "unprognostic (1.12e-1)" "unprognostic (1.66e-2)" "unprognostic (1.78e-5)" "unprognostic (1.75e-1)" "unprognostic (2.88e-2)" "unprognostic (3.74e-1)" "unprognostic (3.18e-3)" 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.1 0.0 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 1.4 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.3 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90052092 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 338.2;Proximal tubular cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 740000 Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 26.9 45.7 13.2 18.1 17.6 9.2 15.6 10.3 14.5 13.0 29.0 10.4 11.8 32.4 11.9 13.7 16.2 8.5 12.6 70.0 15.4 9.0 44.8 120.2 12.9 14.0 12.5 12.8 12.7 14.4 22.2 16.8 5.8 13.6 11.0 22.9 9.5 15.7 9.9 37.9 12.5 42.7 11.5 11.9 20.1 12.7 17.0 14.5 20.3 15.0 32.1 15.3 11.6 10.6 23.4 52.3 37.2 42.8 19.8 31.3 27.8 10.5 6.0 17.8 20.1 12.5 20.3 3.8 9.3 16.1 6.1 9.5 2.4 10.5 8.1 7.4 11.1 5.5 8.0 6.6 9.4 10.2 12.2 0.7 19.3 5.4 9.6 15.6 4.2 4.0 16.0 7.3 4.8 8.1 15.1 18.0 12.9 20.1 16.0 29.0 12.1 12.0 6.2 1.1 22.4 18.2 10.2 4.7 14.4 29.8 26.6 0.8 6.7 14.0 132.5 11.1 0.5 17.0 10.9 16.3 10.3 4.9 13.5 5.5 8.1 6.1 9.5 9.8 9.6 13.1 15.0 31.5 10.2 21.4 42.8 22.6 23.4 20.1 21.8 52.3 19.2 21.3 21.0 37.2 19.8 37.2 20.4 31.3 27.8 13.2 17.6 10.3 14.5 15.4 9.0 12.5 12.8 13.6 14.5 71.5 50.7 52.5 52.8 36.7 12.7 229.8 79.0 71.0 51.2 68.0 2.0 44.0 338.2 106.7 118.9 49.7 161.9 0.0 82.2 42.9 47.8 37.6 48.5 196.2 104.2 30.2 100.6 52.2 85.9 33.7 79.1 96.9 81.0 80.2 84.9 41.0 80.5 101.7 48.4 333.3 6.5 71.1 40.1 118.4 23.4 35.9 34.3 71.9 118.0 55.4 DECR2 "PDCR, SDR17C1" ENSG00000242612 "2,4-dienoyl-CoA reductase 2" Q9NUI1 16 401826-412487 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 68.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 103.3;Proximal tubular cells: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047631 Approved Peroxisomes,Microtubules NA NA Peroxisomes Microtubules "HPA047631: " "unprognostic (2.74e-2)" "unprognostic (3.84e-1)" "unprognostic (1.83e-1)" "unprognostic (4.44e-3)" "unprognostic (1.77e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (3.02e-2)" "unprognostic (3.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-1)" "unprognostic (2.21e-1)" "unprognostic (1.94e-1)" "unprognostic (4.22e-3)" 5.7 10.8 3.2 4.3 4.0 3.5 4.0 3.8 5.0 2.9 10.2 2.7 5.0 14.2 4.0 7.3 4.1 2.5 7.8 4.4 2.8 2.3 16.9 68.2 4.3 3.9 2.0 3.0 2.6 9.7 1.8 2.6 2.3 2.0 4.1 2.4 3.0 6.2 5.6 15.9 2.9 14.4 5.1 1.9 1.9 5.9 4.1 1.8 1.2 1.7 4.3 2.9 2.7 2.2 3.3 9.5 0.4 6.1 2.7 5.1 3.9 1.1 11.1 1.4 6.6 1.3 3.0 4.2 3.4 2.5 2.9 3.0 7.0 7.6 3.8 7.3 4.2 1.7 2.5 1.1 2.8 0.4 8.4 3.6 0.9 5.4 16.6 8.7 3.4 5.4 4.3 2.1 1.9 2.4 3.3 3.6 4.4 2.3 3.5 2.4 11.6 1.9 4.7 4.1 4.2 5.8 4.5 0.5 6.9 2.9 2.9 2.9 4.5 6.4 7.2 3.7 0.5 10.3 4.2 7.5 2.5 2.7 3.5 2.6 5.0 3.9 1.6 3.4 5.1 8.1 0.0 6.1 0.4 3.6 5.6 2.5 2.8 2.2 2.4 6.5 3.3 5.1 3.0 0.3 2.7 4.5 9.5 1.7 3.9 3.2 4.0 3.8 5.0 2.8 2.3 2.0 3.0 2.0 1.8 11.9 14.4 4.2 8.0 3.4 2.0 7.0 17.8 12.0 9.1 19.2 0.0 28.2 33.2 28.8 1.8 5.8 56.4 46.7 34.2 4.7 8.9 4.3 12.7 103.3 11.0 3.2 12.0 6.7 6.7 5.5 6.1 5.3 5.0 15.4 26.4 5.8 28.8 35.1 6.3 98.2 2.7 0.0 6.2 1.8 5.7 5.3 10.5 2.2 34.3 2.7 DEDD2 FLAME-3 ENSG00000160570 "Death effector domain containing 2" Q8WXF8 19 42198598-42220140 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 58.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043419 Approved Nucleoplasm NA NA Nucleoplasm "HPA043419: AB_10960747" "unprognostic (1.59e-1)" "unprognostic (5.90e-2)" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (5.57e-2)" "unprognostic (6.48e-2)" "unprognostic (1.03e-1)" "unprognostic (7.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (6.39e-2)" "unprognostic (2.46e-1)" "unprognostic (3.59e-2)" "unprognostic (1.24e-1)" "unprognostic (5.80e-2)" "unprognostic (3.70e-2)" "prognostic favorable (3.26e-6)" 8.7 12.5 9.9 13.5 13.1 22.2 12.3 17.6 14.9 7.8 13.8 6.0 11.5 14.5 7.2 7.9 11.6 9.6 6.4 6.3 9.4 15.4 11.5 11.1 12.9 12.7 14.5 5.7 9.7 11.6 7.1 17.0 10.5 10.4 13.8 5.7 6.3 11.6 8.2 13.6 11.4 13.2 5.8 8.2 17.8 19.7 9.6 10.5 17.2 24.1 6.3 13.2 10.4 58.6 16.9 19.0 49.2 29.1 14.3 21.9 24.2 10.1 22.9 1.5 1.8 3.5 0.8 6.8 4.1 3.6 3.3 2.3 6.4 6.6 6.6 8.0 1.2 3.6 4.0 6.9 1.5 1.5 5.5 18.3 3.2 5.4 9.8 4.3 3.7 6.8 0.5 3.8 2.5 3.5 6.0 1.9 2.8 15.9 7.4 0.9 4.4 3.9 11.8 3.6 9.4 13.8 4.6 2.9 5.7 2.6 3.7 11.8 4.6 3.7 10.9 2.1 2.2 2.0 4.3 3.3 2.5 7.9 1.0 7.4 13.9 6.3 2.1 3.8 5.8 2.6 27.5 21.5 34.5 20.1 27.0 21.9 16.9 18.6 19.2 13.5 16.4 16.8 17.3 49.2 14.3 29.1 19.0 17.4 24.2 9.9 13.1 17.6 14.9 9.4 15.4 14.5 5.7 10.4 10.5 6.0 6.9 42.9 43.3 41.2 27.1 5.5 5.1 21.4 3.4 14.0 11.8 24.7 10.0 21.5 27.8 12.7 56.1 0.0 21.3 35.2 14.6 62.6 72.3 7.4 33.6 14.3 88.4 6.2 27.4 2.8 12.4 48.4 37.1 35.1 33.2 17.2 32.9 38.6 12.0 13.6 18.4 6.5 24.7 15.9 12.6 46.9 135.5 55.4 23.8 77.9 DEF6 "IBP, SLAT, SWAP70L" ENSG00000023892 "DEF6, guanine nucleotide exchange factor" Q9H4E7 6 35297852-35321771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 51.7" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 76.8;Late spermatids: 127.4;T-cells: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 27.3;MOLT-4: 23.7;NB-4: 31.6;REH: 21.9;THP-1: 25.3;U-937: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038975, HPA038976" Enhanced Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA038975: AB_10697544, HPA038976: AB_10673409" "prognostic favorable (3.02e-6)" "prognostic favorable (1.08e-4)" "prognostic unfavorable (1.71e-4)" "prognostic favorable (2.37e-4)" "unprognostic (1.93e-1)" "unprognostic (3.63e-3)" "unprognostic (2.24e-1)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (2.12e-1)" "unprognostic (2.14e-1)" "unprognostic (6.21e-3)" "prognostic unfavorable (1.02e-8)" "unprognostic (1.78e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.45e-3)" 2.9 2.0 4.5 34.8 4.6 30.3 3.4 0.9 3.1 4.3 4.7 6.9 4.7 5.3 3.1 11.1 15.3 2.7 6.8 2.6 3.8 2.7 3.1 2.5 7.5 42.7 5.3 1.0 2.0 16.5 0.7 5.1 4.2 4.8 10.6 4.0 2.9 14.1 6.7 0.9 14.4 15.2 2.4 7.1 32.6 8.3 6.7 5.0 42.6 4.7 9.3 51.7 6.7 8.6 13.9 21.0 43.5 13.8 25.9 31.5 20.7 7.5 0.0 0.2 0.2 0.0 0.1 9.6 0.8 1.2 0.2 0.2 0.4 3.2 9.0 2.7 0.4 0.0 5.0 0.0 6.4 0.1 0.3 0.3 10.1 0.1 4.0 0.2 18.2 13.3 1.5 8.2 0.1 7.4 0.0 0.0 27.3 4.5 21.7 0.0 3.9 23.7 31.6 0.4 0.9 0.9 21.9 0.2 12.1 0.8 5.7 0.1 0.0 0.6 1.9 1.7 0.4 5.2 25.3 1.2 0.1 0.2 0.0 0.1 12.4 11.4 7.5 0.0 37.9 0.0 16.3 13.8 43.5 31.5 11.0 25.8 13.9 25.7 31.0 21.0 12.5 27.1 26.1 26.7 25.9 9.9 13.9 26.9 20.7 4.5 4.6 0.9 3.1 3.8 2.7 5.3 1.0 4.8 5.0 6.0 10.1 30.6 16.6 10.5 2.3 0.5 5.1 2.7 6.8 5.2 0.0 20.5 0.0 0.7 44.9 1.7 2.9 0.0 8.6 14.6 1.5 5.8 17.3 0.5 76.8 3.2 4.1 3.7 28.3 127.4 2.6 28.4 6.8 7.2 8.5 0.8 5.8 10.5 1.8 0.2 1.6 0.0 1.2 4.2 0.7 10.3 10.5 75.9 7.2 12.7 DEFA1 "DEF1, DEFA2, HNP-1, MRS" ENSG00000206047 "Defensin alpha 1" P59665 8 6977649-6980080 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 825.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 17 "NB-4: 6.8" "CAB032548, HPA052517" Enhanced "Intracellular and membrane" NA NA "CAB032548: AB_2277258, HPA052517: AB_2681860" 1.3 0.1 0.2 0.1 0.6 825.5 0.6 0.0 0.4 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.3 0.2 0.2 0.2 6.0 41.9 0.3 0.3 0.1 0.1 0.1 1.0 0.6 0.1 0.1 0.6 0.1 0.5 1.8 0.1 0.1 0.0 115.5 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.3 0.5 0.7 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFA1B ENSG00000240247 "Defensin alpha 1B" P59665 8 6996766-6999195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 734.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 1.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA052517 Supported "Intracellular and membrane" NA NA "HPA052517: AB_2681860" 0.4 0.0 0.0 0.0 0.0 734.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 16.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 49.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 1.2 0.8 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.8 0.5 1.1 1.2 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFA3 "DEF3, HNP-3" ENSG00000239839 "Defensin alpha 3" P59666 8 7015869-7018301 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 235.0;bone marrow: 924.7" "Group enriched" "Detected in some" 7 "Cholangiocytes: 2.5;Hepatocytes: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 18 "neutrophil: 51.5" "Lineage enriched" "Detected in many" 18 "granulocytes: 51.5" "Cell line enriched" "Detected in single" 8 "NB-4: 5.8" HPA052517 Supported "Intracellular and membrane" NA NA "HPA052517: AB_2681860" "unprognostic (8.21e-2)" 0.7 0.0 0.3 0.3 1.0 924.7 0.3 0.3 0.9 0.3 0.3 0.3 0.3 0.0 0.6 0.3 0.3 0.0 0.3 10.1 0.3 0.2 0.3 3.4 25.6 0.3 0.3 0.3 0.3 0.3 0.0 0.8 2.5 2.3 0.3 0.0 0.6 0.7 0.3 0.3 1.2 0.3 0.3 0.3 81.5 0.0 0.3 0.3 2.0 0.7 0.3 0.3 0.3 0.3 0.1 0.0 51.5 1.6 0.0 2.7 235.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 2.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 51.5 0.0 0.1 0.0 0.0 235.0 0.3 1.0 0.3 0.9 0.3 0.2 0.3 0.3 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFA4 "DEF4, HP-4" ENSG00000164821 "Defensin alpha 4" P12838 8 6935822-6938338 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 245.5" "Cell type enhanced" "Detected in single" 23 "Hepatocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 9.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 9.8" "Cell line enriched" "Detected in some" 8 "THP-1: 11.9" HPA051266 Enhanced "Secreted to blood" NA NA "HPA051266: AB_2681414" 0.3 0.0 0.1 0.1 0.2 245.5 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 35.0 0.1 0.1 0.1 1.5 8.9 0.5 0.1 0.0 0.4 0.0 0.0 0.4 3.5 0.4 0.0 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.2 0.0 26.5 0.0 0.0 0.0 8.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.3 0.0 0.7 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 16.8 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFA5 "DEF5, HD-5" ENSG00000164816 "Defensin alpha 5" Q01523 8 7055304-7056734 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 231 "intestine: 574.2" "Group enriched" "Detected in some" 4 "Enterocytes: 16.2;granulocytes: 4.6;Intestinal endocrine cells: 13.6;Mucus-secreting cells: 13.7;Paneth cells: 11.5" "Cancer enhanced" "Detected in many" "cervical cancer: 181.1;colorectal cancer: 147.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 19.9;NB-4: 16.4;RPMI-8226: 17.2;SH-SY5Y: 14.0;U-2197: 6.0" "HPA015309, HPA015775, CAB069919" Enhanced Approved Vesicles,Midbody "Secreted to digestive system" NA NA Vesicles Midbody "CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594" "prognostic favorable (9.44e-5)" "unprognostic (3.91e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 408.9 0.0 0.0 249.9 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 574.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 1.8 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.8 0.1 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.0 DEFA6 "DEF6, HD-6" ENSG00000164822 "Defensin alpha 6" Q01524 8 6924693-6926076 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 189 "intestine: 316.3" "Cell type enriched" "Detected in some" 5 "Mucus-secreting cells: 29.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 75.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" "Group enriched" "Detected in some" 12 "BEWO: 12.8;NB-4: 13.4;RPMI-8226: 15.7;SH-SY5Y: 10.8;U-2197: 5.0" HPA019462 Enhanced "Secreted to digestive system" NA NA "HPA019462: AB_1847595" "unprognostic (7.48e-3)" "unprognostic (1.63e-1)" "unprognostic (1.34e-1)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 262.3 0.0 0.0 181.7 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 316.3 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.9 10.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 DEFB1 "BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822" ENSG00000164825 "Defensin beta 1" P60022 8 6870575-6878022 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 121.1;pancreas: 219.9;salivary gland: 173.0" "Cell type enriched" "Detected in many" 5 "Distal tubular cells: 11270.5" "Cancer enhanced" "Detected in many" "renal cancer: 522.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 1.4;intermediate monocyte: 1.6" "Lineage enriched" "Detected in single" 9 "monocytes: 1.6" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 27.8" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.31e-2)" "unprognostic (8.35e-3)" "unprognostic (1.24e-1)" "unprognostic (1.75e-1)" "unprognostic (1.89e-1)" "unprognostic (2.16e-3)" "unprognostic (4.41e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (2.77e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (5.94e-4)" "unprognostic (3.24e-1)" "prognostic favorable (1.90e-5)" "unprognostic (9.62e-2)" "unprognostic (2.86e-2)" "unprognostic (2.21e-2)" "unprognostic (1.16e-1)" 1.1 0.0 0.2 0.5 0.3 0.5 10.5 0.6 0.3 38.7 2.3 0.3 1.6 0.6 2.6 3.1 14.9 2.7 6.5 0.7 0.3 0.0 121.1 22.3 0.7 0.2 0.4 0.3 0.8 219.9 0.0 1.6 4.3 0.8 3.8 1.5 0.5 173.0 3.2 0.8 14.6 0.7 0.5 0.7 0.3 4.0 0.7 0.3 0.3 0.8 10.4 8.8 1.8 10.6 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.3 0.0 1.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.1 0.2 0.0 1.3 0.6 27.8 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.3 0.3 0.0 0.4 0.3 0.8 0.3 3.0 5.0 2.9 372.3 80.0 0.3 0.0 2435.7 5.3 4.5 931.7 0.0 6.7 11270.5 1231.2 0.0 0.6 52.3 0.0 250.8 0.3 5.0 291.3 0.0 169.8 3.4 0.0 15.1 4.9 6.0 0.0 16.1 5.3 6.8 26.2 10.3 0.5 226.2 20.7 0.0 94.9 0.6 0.0 4.1 0.0 0.0 470.0 3.1 3.8 11.3 236.2 DEFB103A "DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3" ENSG00000176797 "Defensin beta 103A" P81534 8 7881204-7882664 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2" "Secreted in other tissues" NA NA 0.3 0.0 0.1 0.1 0.1 0.0 1.0 0.1 0.1 2.2 0.1 0.1 0.1 0.0 0.1 0.5 3.3 0.0 0.1 0.1 0.1 0.0 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 3.5 0.1 0.1 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 16.7 6.6 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB103B ENSG00000177243 "Defensin beta 103B" P81534 8 7428888-7430348 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 4.1;lymphoid tissue: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2" "Secreted in other tissues" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.1 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB104A "DEFB-4, DEFB104, DEFB4" ENSG00000176782 "Defensin beta 104A" Q8WTQ1 8 7836471-7841242 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "epididymis: 110.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "GAMG: 1.9;SH-SY5Y: 1.1" HPA045292 Supported "Secreted in male reproductive system" NA NA "HPA045292: AB_2679288" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 110.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB104B ENSG00000177023 "Defensin beta 104B" Q8WTQ1 8 7470308-7475082 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "epididymis: 108.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "GAMG: 1.9;SH-SY5Y: 1.1" HPA045292 Supported "Secreted in male reproductive system" NA NA "HPA045292: AB_2679288" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 108.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB105A "DEFB-5, DEFB105" ENSG00000186562 "Defensin beta 105A" Q8NG35 8 7821966-7823889 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 438 "epididymis: 227.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;GAMG: 1.3;NB-4: 12.8;SH-SY5Y: 2.6" "Secreted in male reproductive system" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 227.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB105B ENSG00000186599 "Defensin beta 105B" Q8NG35 8 7487669-7489593 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 396 "epididymis: 150.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "NB-4: 2.2" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.1 150.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB106A "DEFB-6, DEFB106" ENSG00000186579 "Defensin beta 106A" Q8N104 8 7825172-7829053 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "epididymis: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "BEWO: 3.0;RPMI-8226: 1.9;SH-SY5Y: 4.6" HPA045592 Supported "Secreted in male reproductive system" NA NA "HPA045592: AB_2679378" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 22.0 0.1 1.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB106B ENSG00000187082 "Defensin beta 106B" Q8N104 8 7482504-7486400 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 362 "epididymis: 164.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "NB-4: 5.6" HPA045592 Supported "Secreted in male reproductive system" NA NA "HPA045592: AB_2679378" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107A "DEFB-7, DEFB107" ENSG00000186572 "Defensin beta 107A" Q8IZN7 8 7811720-7815716 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 100 "epididymis: 77.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.8" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.3 77.2 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB107B HsT21816 ENSG00000198129 "Defensin beta 107B" Q8IZN7 8 7495846-7509311 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 95 "epididymis: 78.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.1;NB-4: 1.8" HPA045626 Approved "Secreted in male reproductive system" NA NA "HPA045626: AB_2679396" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.3 78.7 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB110 "DEFB-10, DEFB-11, DEFB111" ENSG00000203970 "Defensin beta 110" Q30KQ9 6 50009138-50021981 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 158 "epididymis: 149.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NB-4: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.9 0.0 0.1 149.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB112 DEFB-12 ENSG00000180872 "Defensin beta 112" Q30KQ8 6 50043575-50048651 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 54 "epididymis: 58.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "NB-4: 2.9" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 58.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB113 DEFB-13 ENSG00000214642 "Defensin beta 113" Q30KQ7 6 49968677-49969625 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 139 "epididymis: 34.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB114 DEFB-14 ENSG00000177684 "Defensin beta 114" Q30KQ6 6 49960249-49964105 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "epididymis: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 39.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB115 DEFB-15 ENSG00000215547 "Defensin beta 115" Q30KQ5 20 31257664-31259632 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 22 "epididymis: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "U-2 OS: 6.0" HPA053160 Uncertain "Secreted in male reproductive system" NA NA "HPA053160: AB_2682062" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB116 DEFB-16 ENSG00000215545 "Defensin beta 116" Q30KQ4 20 31303212-31308585 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "epididymis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047430 Uncertain "Secreted in male reproductive system" NA NA "HPA047430: AB_10964749" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB118 "C20orf63, DEFB-18, dJ1018D12.3, ESC42" ENSG00000131068 "Defensin beta 118" Q96PH6 20 31368618-31373923 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 147 "epididymis: 167.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.9;NB-4: 4.5;RPMI-8226: 1.6" HPA042634 Enhanced "Secreted in male reproductive system" NA NA "HPA042634: AB_10797505" "unprognostic (3.24e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 167.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB119 "DEFB-19, DEFB-20, DEFB120" ENSG00000180483 "Defensin beta 119" Q8N690 20 31377164-31390603 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 61 "epididymis: 218.6;testis: 126.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 32.4;Cone photoreceptor cells: 37.3;Early spermatids: 56.5;Late spermatids: 59.1;Rod photoreceptor cells: 148.5" "Cancer enriched" "Detected in single" 67 "testis cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 5.1;RPMI-8226: 3.2;SCLC-21H: 1.2;SH-SY5Y: 2.4" HPA043059 Supported "Secreted in male reproductive system" NA NA "HPA043059: AB_10797025" "unprognostic (2.03e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 218.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 126.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 1.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 56.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 59.1 11.5 0.0 0.0 0.0 0.0 16.4 0.0 0.0 6.0 0.0 148.5 12.9 0.0 7.7 7.7 0.0 0.0 0.0 0.0 0.0 DEFB121 DEFB-21 ENSG00000204548 "Defensin beta 121" Q5J5C9 20 31404845-31412838 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "epididymis: 201.9" "Group enriched" "Detected in some" 13 "Early spermatids: 9.2;Late spermatids: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 81 "NB-4: 8.0" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 201.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 DEFB123 DEFB-23 ENSG00000180424 "Defensin beta 123" Q8N688 20 31440519-31450257 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 403 "epididymis: 39.9;testis: 75.3" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 12.5;Late spermatids: 37.8;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 17 "testis cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;U-2197: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (9.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 3.6 3.9 0.0 0.0 0.0 0.0 0.0 DEFB124 DEFB-24 ENSG00000180383 "Defensin beta 124" Q8NES8 20 31465506-31476757 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "fallopian tube: 9.1;testis: 7.7" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 6.7;Club cells: 2.3;Smooth muscle cells: 1.4;Spermatocytes: 1.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 4.9;HMC-1: 2.8;U-2 OS: 2.1;WM-115: 10.8" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "midbrain: 2.6;pons and medulla: 1.6;thalamus: 3.4" "Secreted in other tissues" NA NA "unprognostic (1.24e-2)" "unprognostic (9.76e-3)" "unprognostic (1.27e-1)" "unprognostic (3.23e-3)" "unprognostic (6.92e-3)" "unprognostic (3.69e-2)" "unprognostic (3.37e-2)" "unprognostic (1.78e-1)" "unprognostic (9.07e-2)" "unprognostic (4.43e-1)" "unprognostic (3.32e-7)" "unprognostic (1.56e-2)" "unprognostic (1.29e-1)" "unprognostic (4.42e-2)" "unprognostic (4.28e-1)" 3.5 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.7 1.9 0.0 5.3 4.6 0.4 9.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.4 0.0 1.3 0.9 0.0 1.0 0.9 0.5 5.0 0.9 0.2 0.9 0.6 0.0 0.6 0.9 7.7 0.8 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 1.0 0.5 0.0 0.0 0.0 0.0 0.0 DEFB125 DEFB-25 ENSG00000178591 "Defensin beta 125" Q8N687 20 87250-97094 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 13.6 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 DEFB126 "bA530N10.1, C20orf8, DEFB-26" ENSG00000125788 "Defensin beta 126" Q9BYW3 20 142369-145751 "Disease related genes, Predicted secreted proteins" Fertilization "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "epididymis: 255.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;OE19: 5.9;RPMI-8226: 1.1;SH-SY5Y: 1.0;SK-BR-3: 1.2" "Secreted in male reproductive system" NA NA "unprognostic (1.16e-1)" "unprognostic (1.21e-1)" "unprognostic (3.16e-2)" "unprognostic (2.41e-2)" "unprognostic (2.32e-1)" "unprognostic (1.47e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 18.2 0.0 0.1 255.5 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 5.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 1.2 0.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 DEFB127 "bA530N10.2, C20orf73, DEF-27" ENSG00000088782 "Defensin beta 127" Q9H1M4 20 157470-159163 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 56 "epididymis: 170.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "BEWO: 3.1;NB-4: 3.0;SH-SY5Y: 2.0" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 3.0 0.0 0.1 170.3 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB128 DEFB-28 ENSG00000185982 "Defensin beta 128" Q7Z7B8 20 187853-189681 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 239 "epididymis: 186.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "BEWO: 2.9;NB-4: 3.2;RPMI-8226: 1.8" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 186.7 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB129 "bA530N10.3, C20orf87, DEFB-29" ENSG00000125903 "Defensin beta 129" Q9H1M3 20 227258-229886 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "epididymis: 223.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;NB-4: 7.1;RPMI-8226: 1.6;SH-SY5Y: 3.5" "Not detected" "Not detected" HPA014581 Enhanced "Secreted in male reproductive system" NA NA "HPA014581: AB_2732410" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 14.0 0.0 0.2 223.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB130A "DEFB-30, DEFB130, DEFB30" ENSG00000232948 "Defensin beta 130A" P0DP74 8 12310962-12318316 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "epididymis: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB130B ENSG00000233050 "Defensin beta 130B" P0DP73 8 12064389-12071747 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "epididymis: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB131A "DEFB-31, DEFB131" ENSG00000186146 "Defensin beta 131A" P59861 4 9444534-9450514 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "ductus deferens: 31.3;epididymis: 65.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 18 "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "TIME: 6.8" "Secreted in other tissues" NA NA "unprognostic (2.11e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 9.0 0.0 31.3 5.5 0.1 65.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 10.9 0.1 0.1 10.3 0.0 0.1 0.1 0.2 0.3 0.0 0.0 8.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB131B ENSG00000225805 "Defensin beta 131B" A0A096LNP1 11 71878453-71884561 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "epididymis: 36.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 17.5" "Secreted in male reproductive system" NA NA "unprognostic (5.87e-2)" "unprognostic (1.44e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" "unprognostic (3.57e-2)" "unprognostic (3.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (7.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.43e-1)" "unprognostic (5.21e-2)" "unprognostic (3.39e-1)" "unprognostic (1.05e-2)" "unprognostic (3.62e-1)" 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 36.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.9 0.3 3.0 0.8 0.7 1.4 1.2 0.0 0.6 0.0 3.6 1.4 0.0 0.0 0.4 3.7 0.0 0.0 0.0 4.4 4.1 3.5 1.3 0.0 1.6 3.8 0.0 0.0 0.0 2.8 2.9 3.7 2.2 2.5 0.0 4.7 1.7 0.0 0.0 0.0 0.0 1.7 0.0 8.0 8.5 6.1 0.0 3.3 2.0 1.2 1.1 4.0 5.7 3.9 17.5 1.1 0.0 1.1 4.1 1.6 3.5 2.0 3.4 3.2 3.5 0.4 2.1 1.3 3.6 2.5 0.3 3.0 1.0 4.7 2.1 4.1 0.8 0.8 0.7 0.0 1.2 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.4 0.6 0.0 1.4 0.5 3.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB132 "DEFB32, RP5-1103G7.6" ENSG00000186458 "Defensin beta 132" Q7Z7B7 20 257736-261096 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 37.1;epididymis: 119.7" "Cell type enriched" "Detected in some" 10 "Collecting duct cells: 10.4" "Cancer enhanced" "Detected in some" "liver cancer: 0.8;prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 1.1;NB-4: 3.3;RPMI-8226: 1.8;SH-SY5Y: 1.7" HPA046399 Approved "Secreted in male reproductive system" NA NA "HPA046399: AB_10960992" "unprognostic (9.27e-3)" "unprognostic (1.61e-2)" "unprognostic (2.54e-2)" 17.2 0.1 0.1 0.0 0.1 0.0 4.4 0.1 0.1 0.1 0.1 0.0 37.1 0.0 0.1 119.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.9 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.1 6.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.3 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DEFB133 ENSG00000214643 "Defensin beta 133" Q30KQ1 6 49946021-49950265 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 30 "epididymis: 18.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 43 "K-562: 4.2" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB134 ENSG00000205882 "Defensin beta 134" Q4QY38 8 11993174-11996312 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "epididymis: 24.4" "Group enriched" "Detected in some" 43 "Early spermatids: 38.2;Late spermatids: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.6;NTERA-2: 1.3;U-87 MG: 1.2;WM-115: 1.3" "Secreted in male reproductive system" NA NA "unprognostic (3.80e-2)" "unprognostic (2.20e-1)" 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.6 0.3 0.0 24.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 DEFB135 ENSG00000205883 "Defensin beta 135" Q30KP9 8 11982321-11984590 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "epididymis: 30.8" "Cell type enriched" "Detected in single" 6 "Early spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 1.8;MCF7: 7.0" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.5 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB136 DEFB137 ENSG00000205884 "Defensin beta 136" Q30KP8 8 11973937-11974599 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "epididymis: 5.8;prostate: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HAP1: 2.8;WM-115: 1.4" "Not detected" "Not detected" HPA068255 Enhanced "Secreted in male reproductive system" NA NA "HPA068255: AB_2732780" 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 5.8 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEFB4A "DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1" ENSG00000171711 "Defensin beta 4A" O15263 8 7894629-7896711 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4" "Group enriched" "Detected in some" 32 "Exocrine glandular cells: 31.8;Pancreatic endocrine cells: 27.9" "Group enriched" "Detected in many" 6 "head and neck cancer: 32.2;melanoma: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "EFO-21: 6.9;NTERA-2: 2.6" "Secreted in other tissues" NA NA "unprognostic (6.96e-2)" "unprognostic (1.17e-2)" "unprognostic (2.72e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.75e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.0 0.2 0.2 0.2 0.0 0.3 0.2 44.1 0.0 8.6 0.2 0.2 0.0 0.2 0.2 2.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 7.3 0.2 0.2 1.3 0.2 0.2 0.2 0.2 2.9 0.2 0.2 0.2 0.2 50.4 15.7 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 DEFB4B DEFB4P ENSG00000177257 "Defensin beta 4B" O15263 8 7414860-7416863 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 14.3;lymphoid tissue: 8.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CAPAN-2: 1.4;JURKAT: 1.2" "Secreted in other tissues" NA NA "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEGS1 "DEGS-1, Des-1, DES1, FADS7, MLD" ENSG00000143753 "Delta 4-desaturase, sphingolipid 1" O15121 1 224175756-224193441 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 164.4" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 218.5;Cytotrophoblasts: 229.8;Suprabasal keratinocytes: 280.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076422 Supported Mitochondria NA NA Mitochondria "HPA076422: AB_2686799" "unprognostic (2.34e-2)" "unprognostic (6.91e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (7.74e-5)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.29e-5)" "unprognostic (7.70e-2)" "unprognostic (2.31e-1)" "unprognostic (3.20e-1)" "unprognostic (3.63e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.83e-7)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (3.86e-2)" "prognostic unfavorable (2.53e-4)" 19.2 10.7 14.7 14.1 15.7 20.0 28.6 11.9 17.8 17.8 17.0 19.9 15.8 15.0 17.2 13.4 16.1 13.1 13.5 16.6 15.1 16.4 12.8 17.3 16.1 24.5 22.0 17.4 14.4 9.3 11.8 15.1 40.1 17.9 27.6 9.4 15.9 14.8 20.1 7.6 164.4 12.1 23.3 22.1 13.0 14.6 9.2 19.3 7.7 19.7 12.3 15.7 15.5 24.9 31.7 39.5 43.6 25.7 16.1 24.4 16.8 14.9 10.6 14.0 10.4 61.0 39.4 10.9 42.0 47.3 29.5 35.5 9.8 11.5 11.9 54.6 38.0 17.9 15.9 16.3 14.3 32.8 17.4 29.1 8.6 11.7 5.9 37.1 17.2 18.7 39.2 32.0 27.1 15.3 30.9 29.1 6.6 12.6 13.2 37.8 5.5 8.7 9.3 17.4 8.2 15.7 8.0 19.8 7.7 37.5 4.1 9.1 14.7 22.3 35.2 22.2 26.8 11.9 25.1 26.5 28.4 9.0 32.6 40.9 9.4 11.1 11.0 30.6 8.6 31.8 32.3 22.3 43.6 12.7 25.7 24.4 23.9 21.5 17.5 39.5 31.7 17.1 15.0 26.1 16.1 17.4 13.2 22.0 16.8 14.7 15.7 11.9 17.8 15.1 16.4 22.0 17.4 17.9 19.3 77.4 27.7 37.9 37.6 218.5 30.5 15.7 12.7 22.7 20.5 10.4 13.7 229.8 11.6 30.3 15.3 49.6 4.2 23.3 38.8 36.5 83.9 44.4 103.9 18.1 85.9 17.5 14.3 60.2 49.3 8.5 58.4 80.4 65.8 75.7 5.0 21.7 25.8 5.8 74.6 25.8 15.9 103.5 85.6 67.0 42.8 280.0 166.4 61.0 5.6 12.9 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100160163 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.5;skin 1: 30.6" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 22.9" "Cell type enhanced" "Detected in many" "memory B-cell: 11.9" "Group enriched" "Detected in many" 5 "B-cells: 11.9;granulocytes: 6.4" "Group enriched" "Detected in some" 16 "OE19: 29.1;T-47d: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.3 2.0 2.3 4.6 0.5 5.8 22.9 6.4 5.3 20.2 1.8 0.6 20.8 3.4 4.6 20.9 1.9 13.3 0.3 2.0 1.5 8.7 17.2 2.6 0.8 2.4 1.4 0.8 13.0 0.3 1.6 0.6 2.7 2.5 4.2 0.8 4.5 2.3 0.5 30.6 44.5 0.7 1.9 0.5 17.9 0.7 0.7 0.0 2.4 7.3 11.1 7.1 5.2 11.9 0.7 6.4 0.5 0.2 1.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.7 0.1 0.1 0.0 29.1 0.0 0.1 0.0 1.5 0.0 0.7 2.2 0.0 0.0 1.3 0.0 0.0 45.3 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.5 6.4 1.8 0.0 0.0 11.9 0.1 0.8 0.7 5.9 0.0 1.2 0.2 0.2 0.0 0.1 0.0 0.8 2.0 4.6 22.9 6.4 2.0 1.5 2.4 1.4 2.7 0.7 3.0 5.3 0.0 2.8 1.5 4.4 0.4 38.2 77.6 11.4 78.5 0.0 5.9 1.7 13.4 1.0 0.9 31.3 0.0 1.3 1.5 0.3 1.1 9.2 0.2 1.6 0.0 53.2 0.6 1.9 1.5 0.3 1.0 0.0 0.0 43.3 1.2 2.8 43.8 0.0 0.1 24.4 0.0 0.2 0.9 1.9 13.4 31.2 1.3 46.7 17.4 DENND1C "FAM31C, FLJ22757" ENSG00000205744 "DENN domain containing 1C" Q8IV53 19 6467207-6482557 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 32.9" "Cell type enhanced" "Detected in many" 10 "B-cells: 28.3;Erythroid cells: 23.3;granulocytes: 16.1;T-cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HEL: 8.8;HMC-1: 27.4;MOLT-4: 8.4;THP-1: 8.1;U-937: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA042758, HPA042839" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042758: AB_10962357, HPA042839: AB_10959898" "unprognostic (5.94e-2)" "unprognostic (1.41e-3)" "unprognostic (4.26e-2)" "unprognostic (1.93e-3)" "unprognostic (1.21e-1)" "unprognostic (1.72e-3)" "unprognostic (3.91e-2)" "prognostic favorable (1.23e-4)" "unprognostic (7.76e-3)" "unprognostic (4.45e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.95e-4)" "prognostic favorable (7.51e-14)" "unprognostic (1.37e-3)" "unprognostic (1.27e-1)" "unprognostic (4.53e-2)" "prognostic favorable (5.62e-4)" 2.1 1.3 1.5 22.0 2.5 14.1 2.0 0.5 1.6 1.0 2.8 2.5 0.0 3.4 1.0 1.5 1.7 1.7 3.4 1.0 1.3 1.3 2.2 2.0 5.2 30.1 3.1 0.6 0.8 1.0 0.0 1.1 1.3 2.2 1.7 0.8 1.4 5.4 0.8 0.6 1.0 12.1 0.8 2.7 31.3 3.5 0.5 2.7 32.9 1.8 1.2 25.2 3.0 1.5 16.3 12.2 19.0 20.6 14.1 26.7 20.2 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 13.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 8.8 0.0 0.9 0.0 4.3 27.4 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 5.7 0.1 0.0 8.4 6.7 0.0 0.3 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 6.1 0.0 18.3 0.0 10.4 11.6 19.0 26.7 20.6 23.4 16.3 19.1 22.9 12.2 13.7 24.8 21.6 17.6 14.1 20.0 7.1 21.9 20.2 1.5 2.5 0.5 1.6 1.3 1.3 3.1 0.6 2.2 2.7 3.0 4.8 28.3 0.0 0.3 0.0 0.9 2.5 2.7 0.0 1.8 0.0 0.1 1.7 0.4 0.6 0.0 1.1 23.3 0.0 0.2 0.2 0.0 16.1 0.0 12.9 0.0 0.0 1.8 9.9 0.4 0.0 9.2 3.3 3.6 0.6 0.0 0.4 0.0 0.0 3.4 0.0 0.0 0.3 0.2 0.7 0.1 0.2 32.3 0.8 0.1 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.7;skeletal muscle: 31.1" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 99.0;Basal keratinocytes: 97.0;Suprabasal keratinocytes: 150.2;Urothelial cells: 270.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 6.1;eosinophil: 2.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "U-2197: 10.3;U-266/70: 22.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA029935, HPA054955" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029935: AB_10601208, HPA054955: AB_2682648" "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 1.9 0.7 1.5 0.7 1.5 0.8 1.7 1.4 1.1 8.6 1.1 0.5 0.8 0.6 4.2 1.7 28.7 1.0 1.1 1.5 1.3 0.5 0.8 2.1 1.7 1.7 0.6 0.3 1.1 4.0 2.4 3.6 0.3 1.9 2.5 0.6 1.6 3.0 1.4 31.1 10.6 0.6 2.4 0.6 0.5 0.8 4.5 0.2 0.0 1.3 16.0 10.4 6.2 6.6 0.6 0.1 6.1 0.2 0.3 0.5 0.3 1.7 0.0 0.1 1.2 1.5 1.7 0.3 0.5 0.9 0.6 0.9 0.2 0.0 0.0 0.8 3.5 1.2 6.5 1.2 4.0 0.6 0.0 1.6 1.0 0.4 0.1 0.5 0.0 1.6 1.7 3.9 2.4 2.0 0.1 0.2 0.4 0.1 0.3 2.1 5.1 0.2 0.1 0.8 0.0 0.9 0.0 5.5 0.1 0.1 4.9 0.0 0.0 3.9 0.1 0.4 1.1 0.8 0.3 0.2 0.9 1.3 10.3 0.1 22.5 4.0 0.0 0.9 0.0 0.7 6.1 0.2 2.1 0.5 0.0 0.5 0.6 0.1 0.4 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.1 0.2 0.3 1.5 1.5 1.4 1.1 1.3 0.5 0.6 0.3 1.9 0.2 26.8 2.1 0.0 99.0 97.0 21.6 6.9 12.7 20.1 4.5 7.0 19.6 0.1 0.0 5.6 23.7 8.7 0.0 0.0 6.4 0.0 5.3 46.7 2.3 11.0 0.2 0.0 0.0 13.5 3.4 9.1 4.6 1.6 6.8 1.0 0.8 2.0 20.3 0.0 2.1 0.6 8.7 0.0 8.5 23.4 49.0 150.2 0.0 0.7 0.5 270.3 DENND2D "FLJ22457, RP5-1180E21.2" ENSG00000162777 "DENN domain containing 2D" Q9H6A0 1 111187174-111204535 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 51.0;lymphoid tissue: 67.6" "Cell type enhanced" "Detected in many" 8 "T-cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 44.8;MAIT T-cell: 38.2;memory CD4 T-cell: 32.5;memory CD8 T-cell: 45.6;naive CD4 T-cell: 51.0;naive CD8 T-cell: 48.4;NK-cell: 45.1;T-reg: 13.7" "Group enriched" "Detected in all" 6 "NK-cells: 45.1;T-cells: 51.0" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;MOLT-4: 52.9;SK-BR-3: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043630, HPA048642" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043630: AB_2678589, HPA048642: AB_2680474" "unprognostic (1.72e-3)" "prognostic favorable (1.67e-4)" "unprognostic (2.60e-2)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic favorable (2.70e-4)" "unprognostic (5.09e-2)" "unprognostic (8.10e-2)" "unprognostic (1.35e-1)" "unprognostic (4.66e-3)" "unprognostic (3.09e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-2)" "unprognostic (3.80e-3)" "unprognostic (5.45e-2)" "unprognostic (2.75e-2)" "prognostic favorable (8.66e-5)" 8.9 11.1 0.9 42.9 2.6 3.5 6.5 0.8 1.6 4.9 10.4 1.4 4.9 6.4 2.4 5.9 19.5 6.4 9.9 2.5 1.0 1.0 11.4 9.3 11.5 42.0 2.6 0.8 3.0 7.5 8.8 8.0 20.2 1.9 9.2 6.9 3.7 21.1 4.7 1.3 7.9 13.8 1.3 3.2 33.8 9.0 5.1 1.8 39.2 8.0 7.0 67.6 15.7 8.2 8.2 3.2 3.5 3.5 45.1 51.0 29.6 10.4 0.4 0.0 0.0 2.6 1.0 0.1 0.6 0.0 1.1 0.2 3.1 5.1 11.1 3.7 1.6 0.0 3.3 0.0 0.5 1.1 21.0 0.0 3.3 0.7 0.0 3.9 0.0 3.4 3.1 2.3 0.3 0.0 3.5 0.1 4.2 0.0 3.5 0.3 8.9 52.9 0.3 0.0 13.2 1.4 1.3 0.0 16.1 3.7 11.3 3.7 0.0 3.7 34.3 1.2 0.0 10.1 10.5 0.0 0.0 0.0 0.0 0.0 3.2 1.3 8.3 0.0 9.3 0.0 0.8 3.5 2.3 44.8 2.5 38.2 7.2 32.5 45.6 3.2 8.2 51.0 48.4 3.5 45.1 1.8 2.4 13.7 29.6 0.9 2.6 0.8 1.6 1.0 1.0 2.6 0.8 1.9 1.8 6.0 15.6 29.2 15.0 4.4 0.0 0.9 7.6 18.7 18.2 19.2 0.0 1.2 16.6 23.6 26.8 2.9 16.1 0.0 14.1 2.1 4.1 21.1 17.3 4.9 46.9 0.0 5.8 9.2 28.5 38.6 1.1 9.9 6.8 1.0 23.6 0.0 13.8 14.0 0.4 21.0 0.5 0.0 0.7 13.0 0.7 3.4 9.6 105.1 20.4 26.5 DENND3 KIAA0870 ENSG00000105339 "DENN domain containing 3" A2RUS2 8 141117278-141195808 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.9" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 145.9;Kupffer cells: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.0;neutrophil: 22.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 22.2" "Cell line enhanced" "Detected in many" "HDLM-2: 27.4;HeLa: 33.9;U-937: 24.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024491, HPA041668" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA024491: AB_2671581, HPA041668: " "unprognostic (2.27e-1)" "unprognostic (9.62e-2)" "unprognostic (9.47e-3)" "unprognostic (1.66e-1)" "unprognostic (6.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (7.07e-3)" "unprognostic (2.71e-2)" "unprognostic (2.25e-2)" "unprognostic (7.74e-2)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (4.51e-2)" "unprognostic (5.42e-2)" 21.8 6.2 12.2 21.7 15.2 75.9 17.6 1.7 12.3 10.4 17.0 11.5 2.3 5.5 10.3 6.1 6.8 8.3 12.0 8.8 12.1 8.5 12.2 3.9 30.1 27.8 15.9 7.7 8.9 4.7 4.5 5.8 13.0 13.7 9.0 7.4 7.1 10.2 8.3 12.9 8.3 12.7 7.8 21.9 24.7 9.1 4.6 11.8 3.4 11.4 3.5 20.6 9.5 9.8 2.4 2.2 22.2 5.4 1.4 0.4 1.6 6.9 6.3 0.4 1.3 1.9 2.9 1.1 4.0 11.7 1.6 1.3 1.9 6.6 1.8 10.4 7.4 3.3 3.5 1.8 4.3 1.2 27.4 1.6 7.2 33.9 0.6 1.7 7.2 1.1 0.2 2.2 1.8 2.3 4.0 9.2 3.4 0.0 17.7 1.2 2.1 1.0 10.0 0.4 1.3 8.3 1.2 0.3 6.9 6.6 2.4 2.0 1.3 0.8 0.5 0.5 3.3 2.9 11.6 7.3 0.3 3.2 4.6 0.1 3.6 15.7 0.5 1.1 24.9 0.4 9.3 2.9 18.0 0.4 4.5 0.4 2.4 0.3 0.1 2.2 2.3 0.0 0.1 22.2 1.4 5.4 0.0 0.1 1.6 12.2 15.2 1.7 12.3 12.1 8.5 15.9 7.7 13.7 11.8 145.9 32.8 17.6 6.5 14.0 4.7 7.8 12.7 9.4 19.4 21.0 3.9 0.6 1.7 2.8 4.9 20.2 7.4 0.0 3.1 0.5 4.2 8.9 10.4 0.0 19.6 1.6 4.6 19.6 50.4 1.5 1.4 26.4 8.5 21.6 7.6 0.6 7.1 3.1 0.7 2.1 0.3 38.8 16.5 7.0 7.2 8.0 0.5 10.2 3.6 4.9 DENND6B "AFI1B, FAM116B, MGC33692" ENSG00000205593 "DENN domain containing 6B" Q8NEG7 22 50309030-50327060 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 24.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 8.3;RPMI-8226: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018934, HPA021653, HPA029570" Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131" "unprognostic (2.50e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.41e-4)" "prognostic favorable (5.93e-5)" "unprognostic (9.39e-2)" "unprognostic (3.17e-1)" "unprognostic (1.89e-3)" "unprognostic (1.16e-1)" "unprognostic (5.10e-2)" "unprognostic (4.50e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (8.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" 2.7 5.5 11.6 4.3 17.0 2.0 3.2 21.1 22.8 5.7 2.8 7.5 5.5 2.5 5.2 5.3 3.4 24.7 6.2 2.3 8.4 10.2 5.7 1.3 7.3 5.2 4.9 14.4 4.3 6.4 6.8 15.1 2.3 10.4 4.7 2.3 4.1 5.9 7.4 1.1 5.0 3.0 3.6 3.2 4.4 4.2 9.0 4.5 0.0 6.0 1.0 3.5 4.4 2.7 0.7 1.8 0.5 3.9 1.0 0.7 0.9 0.6 2.3 5.0 5.4 1.2 4.8 0.0 1.0 2.4 0.6 0.4 0.1 3.5 8.3 2.1 2.3 0.3 4.2 0.1 0.1 0.2 2.0 1.2 1.4 4.0 0.2 1.1 0.2 3.7 4.1 5.3 0.1 0.7 4.9 1.0 0.1 1.8 1.5 1.2 3.6 0.0 0.8 0.3 2.5 0.2 1.2 0.0 12.0 6.2 2.0 2.1 4.0 2.7 3.4 0.4 0.2 5.5 1.2 1.1 0.9 0.8 0.8 0.1 1.3 0.3 1.2 2.2 0.9 1.0 0.5 2.6 0.1 0.4 3.2 0.6 0.6 0.6 0.7 1.8 0.7 0.6 0.7 0.5 1.0 3.9 1.4 0.6 0.9 11.6 17.0 21.1 22.8 8.4 10.2 4.9 14.4 10.4 4.5 3.0 2.6 18.2 2.8 1.0 4.9 1.1 7.6 30.8 7.9 5.2 21.6 0.2 3.3 4.8 20.6 3.4 4.9 23.3 1.6 0.6 4.0 3.3 5.7 0.8 12.8 1.6 9.8 3.7 21.8 47.0 2.3 13.7 5.0 26.2 3.4 6.4 2.6 2.3 2.5 14.1 15.4 0.0 1.2 23.6 17.9 0.5 0.8 7.2 3.3 2.3 DEPDC1 "DEP.8, DEPDC1A, FLJ20354, SDP35" ENSG00000024526 "DEP domain containing 1" Q5TB30 1 68474152-68497221 "Predicted intracellular proteins" "Transcription, Transcription regulation" "GTPase activation, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6;testis: 19.5" "Group enriched" "Detected in many" 7 "Early spermatids: 29.0;Erythroid cells: 70.0;Extravillous trophoblasts: 29.4;Late spermatids: 57.0;Spermatocytes: 71.4;Spermatogonia: 20.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB017845 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA Yes Nucleoplasm "Nucleoli fibrillar center" "CAB017845: " "unprognostic (2.73e-1)" "unprognostic (7.40e-2)" "prognostic favorable (8.70e-5)" "unprognostic (1.23e-3)" "unprognostic (3.06e-1)" "unprognostic (7.73e-3)" "unprognostic (4.37e-6)" "unprognostic (3.39e-3)" "unprognostic (1.57e-3)" "unprognostic (8.59e-2)" "unprognostic (9.04e-6)" "unprognostic (2.18e-1)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (2.27e-1)" "unprognostic (2.83e-2)" "unprognostic (1.11e-1)" 1.3 0.8 0.7 12.1 0.5 5.1 1.9 0.3 0.7 1.2 3.3 0.1 0.5 2.9 0.5 0.7 6.5 0.6 0.3 1.3 2.1 0.6 0.7 0.8 2.0 5.5 0.5 0.2 0.6 0.5 0.3 0.4 7.4 0.3 2.5 4.3 0.5 1.3 0.0 0.4 1.7 3.7 1.5 0.4 3.1 1.4 19.5 0.0 28.6 0.5 5.4 5.7 1.5 2.0 0.3 0.0 0.0 0.0 0.8 2.6 0.3 15.5 7.2 13.8 6.3 0.9 2.0 10.8 20.0 9.2 17.1 14.8 6.0 6.5 0.0 14.9 8.2 27.4 10.5 20.0 10.4 29.0 13.6 13.1 12.7 12.8 3.4 0.2 10.9 0.0 0.7 0.5 19.5 10.9 3.5 12.3 5.6 8.7 12.4 30.3 3.5 0.0 4.1 11.9 6.5 9.9 0.0 41.2 5.1 6.9 4.2 15.5 7.2 20.0 8.5 10.4 9.3 7.7 5.5 7.2 11.0 12.6 19.4 23.1 7.8 16.7 0.1 10.4 3.8 22.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.6 0.3 0.7 0.5 0.3 0.7 2.1 0.6 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.2 3.0 0.4 0.5 0.0 0.0 0.0 1.8 0.0 3.1 0.0 0.1 29.0 0.0 0.7 70.0 0.0 29.4 1.9 1.8 0.0 0.0 6.9 0.0 0.0 0.6 1.9 57.0 0.3 1.3 0.0 0.0 1.9 0.0 0.1 0.0 0.4 0.0 0.2 0.0 1.0 71.4 20.2 1.1 2.4 1.3 2.5 1.4 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 17.8;Extravillous trophoblasts: 18.7;Spermatocytes: 32.0;Syncytiotrophoblasts: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 24.0 8.2 25.0 15.2 0.5 0.8 27.4 6.5 4.4 11.5 15.0 13.6 15.3 13.7 16.1 2.0 14.9 8.0 20.0 14.6 15.5 19.5 14.5 17.1 9.4 16.9 0.4 14.4 16.7 0.5 1.5 3.7 5.4 2.2 10.6 14.7 12.2 18.8 10.1 15.1 23.2 12.6 18.4 5.2 13.3 25.8 20.3 11.7 9.3 12.0 13.9 6.4 15.3 5.5 7.2 11.7 10.2 11.5 4.9 4.9 14.4 3.9 16.5 9.5 16.6 27.1 6.1 21.2 13.6 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 0.0 2.6 0.8 0.8 4.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 1.9 0.0 0.3 1.4 0.1 1.7 0.0 0.2 18.7 0.4 0.5 3.5 0.0 5.2 0.0 0.0 0.0 1.2 1.8 0.3 2.2 0.0 0.0 1.0 0.2 0.7 2.0 0.0 0.5 0.0 6.5 0.4 32.0 8.7 1.8 39.2 0.0 6.3 0.3 DEPDC4 "DEP.4, FLJ33505" ENSG00000166153 "DEP domain containing 4" Q8N2C3 12 100203669-100267079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.5" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 9.9;Late spermatids: 14.1" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 7 "naive B-cell: 2.8;naive CD4 T-cell: 2.1;naive CD8 T-cell: 1.8" "Group enriched" "Detected in many" 8 "B-cells: 2.8;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039323 Uncertain Approved Microtubules NA NA Microtubules "HPA039323: AB_10674283" "unprognostic (8.89e-2)" "unprognostic (2.29e-1)" "unprognostic (1.09e-1)" "unprognostic (4.33e-2)" "unprognostic (3.62e-1)" "unprognostic (7.96e-2)" "unprognostic (1.59e-1)" "unprognostic (1.53e-1)" "unprognostic (9.09e-4)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (3.35e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-2)" 0.2 0.6 1.3 0.2 1.0 0.7 1.4 0.2 1.3 0.4 1.0 2.1 0.5 0.7 1.1 0.6 0.6 0.6 1.0 1.2 3.3 2.2 0.3 0.3 1.1 1.3 1.8 1.0 1.2 1.1 1.3 1.4 0.9 1.9 0.3 0.6 0.6 0.2 1.6 0.1 0.9 7.5 0.8 0.2 1.0 0.5 2.8 0.0 0.0 0.3 0.0 2.1 0.0 2.1 3.1 5.7 1.6 0.3 0.7 3.6 2.9 2.1 6.3 3.7 4.8 1.2 2.2 1.9 1.6 1.8 3.3 4.9 2.5 6.9 2.5 5.4 7.9 1.5 5.4 0.7 2.6 3.2 0.6 1.5 2.2 0.5 1.3 1.6 4.1 4.7 1.0 2.8 2.2 1.6 4.7 2.7 2.7 3.2 3.3 5.8 5.3 2.9 1.3 1.6 3.5 1.7 2.3 1.8 3.5 4.7 2.8 0.3 4.3 1.7 1.7 2.3 2.6 2.6 5.0 1.3 2.0 3.5 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 2.8 2.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 1.0 0.8 1.8 0.8 0.0 2.7 3.4 5.2 3.9 2.9 5.0 0.4 9.9 0.6 0.5 0.0 1.1 1.7 0.9 0.6 0.0 0.4 0.9 0.0 0.0 0.0 0.3 14.1 1.1 0.0 1.7 0.0 0.6 1.0 0.4 0.0 0.0 3.4 3.9 0.0 0.5 4.7 6.6 0.3 1.0 0.0 1.6 0.9 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 30.9;Early spermatids: 98.0;Extravillous trophoblasts: 40.1;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 27.2;RH-30: 20.6;SiHa: 18.8;U-2197: 17.5" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Yes No Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 2.0 1.9 2.5 8.2 2.7 5.0 6.8 6.7 0.4 0.0 1.9 8.1 2.3 4.7 5.4 1.9 6.0 0.0 7.5 1.3 7.9 9.4 1.6 4.4 5.6 2.4 2.9 2.9 2.1 2.7 0.0 0.0 3.0 0.0 27.2 0.5 0.0 7.1 2.4 3.8 0.0 0.0 20.6 0.0 1.6 0.6 0.8 2.1 18.8 3.3 16.3 2.7 0.8 2.3 0.0 3.2 5.4 17.5 5.2 0.0 0.0 0.0 1.2 0.0 15.9 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 0.0 0.0 0.0 8.3 30.9 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.3 3.3 0.4 98.0 0.1 8.6 0.0 0.5 40.1 1.6 0.8 2.3 19.4 2.7 0.0 3.4 2.5 0.3 6.3 1.4 2.4 1.7 1.8 1.0 0.0 1.0 0.0 1.1 11.2 0.0 0.0 1.4 27.7 7.6 6.5 1.3 0.0 2.1 0.7 DEPP1 "C10orf10, DEPP, FIG, Fseg" ENSG00000165507 "DEPP1, autophagy regulator" Q9NTK1 10 44970981-44978810 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 204.9;breast: 227.9" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 96.0;Exocrine glandular cells: 99.5;Pancreatic endocrine cells: 71.2;Syncytiotrophoblasts: 251.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 35.2;HDLM-2: 24.4;HHSteC: 63.6;HSkMC: 49.5;HUVEC TERT2: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013687, HPA037818, HPA037819" Uncertain Supported Vesicles,Mitochondria "Intracellular and membrane" NA NA Mitochondria Vesicles "CAB013687: , HPA037818: , HPA037819: AB_2675685" "unprognostic (3.99e-2)" "unprognostic (4.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-1)" "unprognostic (1.88e-2)" "unprognostic (5.66e-3)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (4.25e-1)" "unprognostic (5.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.89e-2)" "prognostic unfavorable (2.29e-6)" "unprognostic (2.30e-3)" "unprognostic (2.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.74e-1)" 204.9 14.6 8.7 14.1 16.8 2.4 227.9 10.8 19.7 14.1 36.5 2.9 10.0 7.4 25.0 14.9 23.5 25.5 28.0 37.0 8.5 6.0 13.0 48.2 70.7 20.6 9.4 3.3 51.2 107.1 4.7 12.2 33.4 21.6 25.8 5.7 12.1 16.2 13.0 81.0 19.6 9.9 30.2 39.0 9.5 12.7 31.9 11.0 0.8 33.3 13.4 19.1 52.1 27.6 0.0 3.7 1.2 0.3 0.0 0.7 1.4 6.9 0.0 0.1 0.0 35.2 17.2 1.7 0.0 2.4 0.1 0.4 0.2 2.6 0.0 0.4 3.1 1.7 0.3 0.3 2.1 0.1 24.4 0.9 0.0 0.0 2.5 63.6 0.0 0.0 49.5 0.1 0.0 0.3 6.0 39.2 0.0 0.0 15.1 0.1 0.0 0.0 0.3 0.0 0.1 0.2 1.1 0.4 5.8 0.1 2.5 1.3 0.0 0.0 0.3 1.3 4.2 0.0 1.6 0.3 1.9 1.3 0.1 1.6 0.4 0.6 0.0 10.7 0.6 1.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.5 0.0 0.1 3.7 0.0 1.4 8.7 16.8 10.8 19.7 8.5 6.0 9.4 3.3 21.6 11.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 10.7 11.4 29.6 0.0 39.6 31.5 96.0 0.0 0.0 0.0 0.0 99.5 11.6 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 71.2 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 251.0 0.0 0.0 0.0 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050913 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 67.6;skeletal muscle: 65.0" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "myeloid DC: 17.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 17.1" "Cell line enhanced" "Detected in many" "Daudi: 30.3;RPMI-8226: 54.0;RPTEC TERT1: 44.7;U-698: 15.9" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 8.1 30.2 6.4 5.2 11.0 1.1 9.7 5.1 9.2 18.9 12.7 17.8 5.7 7.8 16.0 5.7 7.2 12.7 6.1 4.3 7.3 6.3 22.7 7.5 2.7 8.5 9.5 6.1 12.5 5.6 13.3 13.6 4.4 7.5 6.4 4.8 0.7 67.6 7.9 65.0 4.3 7.4 7.7 8.2 5.3 20.0 2.1 11.5 0.7 45.0 20.7 2.7 4.8 5.7 0.1 17.1 0.3 1.5 0.3 0.8 0.8 0.0 1.0 0.1 0.3 6.4 1.9 0.1 0.0 0.1 0.1 0.1 0.7 0.1 30.3 0.7 0.3 0.0 0.1 1.6 0.0 0.1 0.6 0.8 4.1 0.2 0.1 3.9 0.8 7.1 1.7 2.9 0.2 0.1 0.0 0.0 0.5 0.0 5.0 0.1 2.0 0.0 0.7 0.4 13.2 1.0 0.1 1.4 54.0 44.7 1.2 0.9 0.2 0.5 3.3 0.9 0.9 2.9 0.1 0.0 0.1 0.2 6.4 0.1 13.4 3.1 15.9 1.9 1.1 0.2 0.0 0.8 0.0 0.2 1.5 0.7 0.1 0.3 0.6 17.1 0.1 0.8 0.5 0.3 0.3 0.1 0.8 0.3 0.8 6.4 11.0 5.1 9.2 7.3 6.3 9.5 6.1 7.5 11.5 6.0 9.4 4.5 12.1 4.6 2.2 2.2 15.3 0.0 5.7 24.4 0.0 0.5 72.9 3.3 1.3 3.6 3.9 0.0 10.6 1.5 8.2 11.1 11.5 10.5 2.8 0.0 16.0 4.3 11.8 1.1 10.9 7.6 13.5 1.8 2.9 0.9 1.3 20.9 3.2 24.6 0.4 0.0 1.7 3.2 3.2 4.8 0.3 0.0 14.7 16.9 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;pancreas: 80.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 88.6;Late spermatids: 121.3;Melanocytes: 212.6;Spermatocytes: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 77.7" "Lineage enriched" "Detected in many" 9 "dendritic cells: 77.7" "Cell line enhanced" "Detected in some" "Karpas-707: 33.9;RPMI-8226: 19.9;U-266/70: 36.4;U-698: 8.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB037234, HPA049306" Approved Uncertain Vesicles NA NA Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favorable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favorable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 1.3 1.8 1.2 27.3 2.1 4.1 2.8 1.7 1.6 3.7 21.5 1.1 20.2 18.7 1.9 2.9 4.1 3.4 5.7 3.9 1.2 1.9 2.9 4.7 7.2 25.5 1.3 1.2 1.1 80.8 0.6 4.0 7.9 2.4 1.6 6.9 1.9 44.8 29.3 1.3 0.4 14.9 0.3 1.0 28.5 21.8 12.6 1.6 1.0 9.5 3.4 36.1 15.5 1.2 8.4 77.7 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 3.5 0.6 0.0 0.6 0.0 0.3 0.6 0.0 0.7 1.8 0.1 2.0 0.0 0.4 3.8 0.9 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.5 33.9 0.0 0.0 0.5 2.0 0.5 1.4 0.1 2.6 0.0 19.9 0.7 0.1 0.3 0.0 0.1 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 36.4 4.4 8.6 0.4 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 77.7 0.0 1.3 1.2 2.1 1.7 1.6 1.2 1.9 1.3 1.2 2.4 1.6 0.0 1.4 39.4 1.5 1.5 1.1 2.8 2.5 14.7 3.4 0.0 2.0 0.7 0.0 0.3 88.6 0.5 1.3 0.0 5.0 4.3 1.1 2.3 2.3 3.2 2.9 0.0 1.7 6.7 2.4 121.3 2.3 1.7 212.6 0.0 4.0 0.8 1.6 0.0 3.9 0.3 0.5 0.0 1.2 55.6 36.8 1.8 12.9 5.7 4.3 0.9 DES "CMD1I, CSM1, CSM2" ENSG00000175084 Desmin P17661 2 219418377-219426739 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 2379.6" "Cancer enhanced" "Detected in all" "prostate cancer: 562.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 6 "monocytes: 2.7" "Cell line enhanced" "Detected in some" "HSkMC: 18.1;LHCN-M2: 36.0;NB-4: 9.4;RH-30: 83.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 45.7" "CAB000034, HPA018803" Enhanced Supported "Intermediate filaments" NA NA 1300000 "Intermediate filaments" "CAB000034: , HPA018803: AB_1847616" "unprognostic (1.75e-1)" "unprognostic (1.95e-3)" "unprognostic (3.43e-2)" "unprognostic (8.76e-2)" "unprognostic (7.75e-3)" "unprognostic (6.61e-3)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (4.67e-1)" "unprognostic (3.84e-2)" "unprognostic (2.57e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (3.49e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (9.25e-3)" 9.1 2.5 0.1 35.1 0.2 0.1 1.9 0.1 0.3 41.3 238.3 0.4 69.1 12.6 95.6 80.2 209.7 33.0 149.8 531.0 0.1 0.1 2.1 0.3 4.8 3.0 0.3 0.8 20.3 0.7 0.0 0.1 2.4 0.8 101.0 11.2 3.8 11.9 104.2 600.8 4.2 43.2 439.9 0.3 0.6 72.6 10.9 0.0 0.0 9.4 161.2 12.5 343.7 34.4 0.0 0.2 0.4 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.3 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 36.0 0.0 0.0 9.4 0.1 0.0 0.0 0.0 83.8 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.7 0.1 0.2 0.1 0.3 0.1 0.1 0.3 0.8 0.8 0.0 0.0 0.0 0.0 2.4 3.7 0.0 2379.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 70.8 4.5 0.0 0.0 0.0 3.6 31.7 3.6 0.0 0.0 4.8 0.0 0.0 0.6 0.0 43.3 26.7 0.4 11.8 0.0 0.5 0.0 0.8 0.0 47.4 0.0 0.0 45.3 204.9 1.8 1.7 8.5 7.1 0.0 0.0 0.4 DESI1 "D15Wsu75e, FAM152B, PPPDE2" ENSG00000100418 "Desumoylating isopeptidase 1" Q6ICB0 22 41598028-41621096 "Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Group enriched" "Detected in many" 5 "Early spermatids: 685.0;Late spermatids: 303.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053415 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA053415: AB_2682141" "unprognostic (1.07e-1)" "unprognostic (2.07e-1)" "unprognostic (1.83e-2)" "prognostic favorable (7.70e-4)" "unprognostic (2.31e-2)" "unprognostic (6.16e-3)" "unprognostic (8.75e-3)" "unprognostic (9.27e-2)" "unprognostic (3.97e-2)" "unprognostic (6.27e-2)" "unprognostic (1.80e-2)" "unprognostic (1.42e-1)" "unprognostic (2.31e-3)" "unprognostic (2.65e-2)" "unprognostic (1.55e-1)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" 12.9 14.5 24.6 12.6 25.4 8.4 13.4 17.0 33.3 11.7 11.9 22.8 9.5 14.5 10.4 15.1 19.7 11.3 11.5 30.3 24.3 19.7 19.5 69.2 14.0 13.2 23.5 16.3 12.7 13.2 15.7 10.0 11.8 18.3 13.4 14.0 9.7 13.2 14.4 14.6 15.9 16.1 14.5 22.4 11.3 12.6 29.2 19.0 9.7 9.7 14.6 16.8 10.8 9.2 6.2 7.4 10.6 12.5 2.8 7.3 5.5 7.0 7.6 7.6 10.4 10.7 12.9 4.3 14.4 9.3 13.4 9.9 10.0 4.5 27.2 10.0 16.6 7.1 10.4 20.1 16.1 14.1 12.2 15.3 6.1 14.1 8.4 13.2 23.9 8.3 11.0 18.8 16.4 15.4 11.0 20.2 9.5 17.7 30.9 10.6 9.0 5.4 7.3 7.5 26.7 11.5 7.4 3.2 27.8 16.8 4.6 5.4 2.8 13.9 15.3 9.8 9.0 5.0 7.8 20.4 9.9 7.2 10.4 7.0 11.4 8.8 13.0 24.6 10.6 13.1 9.5 9.3 10.6 5.0 12.5 6.4 6.2 6.2 5.9 7.4 5.4 5.6 6.5 5.5 2.8 8.2 4.4 7.3 5.5 24.6 25.4 17.0 33.3 24.3 19.7 23.5 16.3 18.3 19.0 8.9 13.9 25.3 26.2 7.7 21.3 44.5 10.2 6.7 9.1 8.7 5.9 24.8 33.2 44.8 685.0 20.4 35.5 0.0 26.0 35.1 19.1 35.6 10.4 60.6 45.6 20.6 18.9 16.0 22.9 303.8 17.5 21.6 13.5 65.9 16.1 16.2 45.9 21.8 9.9 43.5 8.8 25.8 18.2 109.0 21.3 11.5 69.9 20.8 23.8 53.6 DEUP1 "CCDC67, FLJ25393" ENSG00000165325 "Deuterosome assembly protein 1" Q05D60 11 93329971-93438487 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 6.0;pituitary gland: 13.0;testis: 19.9" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 40.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;Karpas-707: 1.0;NTERA-2: 4.0;SCLC-21H: 1.6;SuSa: 1.2;U-2 OS: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (4.68e-1)" "unprognostic (3.25e-1)" "unprognostic (3.93e-1)" "unprognostic (7.24e-3)" "unprognostic (2.09e-1)" "unprognostic (4.13e-1)" "unprognostic (2.29e-1)" "unprognostic (1.79e-2)" "unprognostic (1.16e-1)" "unprognostic (1.84e-1)" "unprognostic (1.25e-1)" "unprognostic (1.41e-3)" "unprognostic (1.33e-1)" "unprognostic (6.03e-3)" "unprognostic (8.59e-2)" "unprognostic (2.25e-1)" 0.0 0.7 0.2 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.1 0.8 0.8 0.0 0.2 1.5 0.2 6.0 0.1 0.0 0.3 1.0 1.0 0.0 0.6 0.0 0.3 0.0 1.6 0.9 0.1 13.0 0.0 0.7 1.1 0.1 0.1 1.6 1.8 1.3 0.2 0.1 0.1 1.0 0.0 0.1 19.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.2 4.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 2.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.3 1.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 3.4 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DEXI MYLE ENSG00000182108 "Dexi homolog" O95424 16 10928891-10942460 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041511 Approved Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA041511: AB_10796675" "unprognostic (4.14e-1)" "unprognostic (8.52e-2)" "unprognostic (1.29e-1)" "unprognostic (9.70e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (1.19e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "unprognostic (1.47e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.21e-2)" "unprognostic (1.33e-3)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.75e-2)" "unprognostic (1.83e-2)" 15.0 25.2 15.7 8.0 20.8 4.1 10.7 14.0 27.5 12.2 13.9 9.8 12.7 11.1 11.7 18.5 12.9 14.5 11.6 32.2 13.1 13.6 13.3 26.3 9.5 9.9 18.8 12.3 15.9 18.0 22.1 12.9 13.3 21.3 13.6 6.6 13.7 15.4 16.6 81.6 10.3 11.1 12.1 9.4 12.7 10.6 8.9 11.9 13.7 18.4 10.6 8.1 10.9 10.5 4.0 2.4 8.2 0.7 3.9 7.0 1.2 9.5 13.9 7.5 13.2 30.6 16.9 6.9 14.7 15.4 9.7 9.2 6.5 10.0 11.3 22.2 16.6 10.5 12.4 8.8 15.8 8.3 26.6 19.8 5.6 9.1 27.5 17.6 9.6 10.7 17.1 18.3 9.4 11.0 15.7 13.9 16.2 12.8 11.4 10.7 16.8 11.9 10.5 10.5 11.8 14.5 11.1 9.9 17.3 11.9 7.1 15.5 13.6 14.0 15.5 11.7 6.6 12.3 16.8 15.2 9.8 10.5 23.0 9.6 15.1 11.6 3.3 8.6 20.7 11.0 1.7 0.6 8.2 6.0 0.7 5.6 0.6 5.2 7.0 0.4 4.0 6.4 6.0 0.7 3.9 0.3 2.4 3.9 1.2 15.7 20.8 14.0 27.5 13.1 13.6 18.8 12.3 21.3 11.9 6.0 8.9 13.4 27.4 29.7 18.1 0.0 48.4 8.1 2.3 26.2 11.8 20.0 64.6 22.3 6.3 18.5 9.7 0.0 31.5 17.9 28.6 35.2 1.1 87.3 33.0 22.3 14.3 38.1 12.3 11.5 69.6 8.7 15.1 16.2 13.5 38.1 25.7 13.9 80.6 56.2 12.9 19.4 35.5 2.4 2.7 28.4 9.7 18.1 16.8 37.0 DGAT1 "ARGP1, DGAT" ENSG00000185000 "Diacylglycerol O-acyltransferase 1" O75907 8 144314584-144326910 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "intestine: 161.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 291.1;Paneth cells: 112.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 15.8;PC-3: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB032853 Enhanced Approved "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "CAB032853: AB_2090798" "unprognostic (9.24e-3)" "unprognostic (1.61e-1)" "unprognostic (1.75e-2)" "unprognostic (2.23e-1)" "unprognostic (3.49e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (5.10e-2)" "unprognostic (2.78e-2)" "unprognostic (6.88e-2)" "unprognostic (3.52e-1)" "unprognostic (2.65e-3)" "unprognostic (3.83e-2)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.67e-3)" 11.8 18.5 3.6 5.7 4.7 6.4 6.8 6.6 5.6 3.3 60.2 4.0 6.4 44.7 3.9 3.6 5.5 3.1 7.9 6.3 3.7 2.7 6.7 14.4 3.8 3.1 4.1 2.7 3.3 3.9 5.0 4.0 4.3 3.6 3.4 6.3 4.1 5.9 4.3 10.0 4.8 161.0 3.6 2.6 5.3 5.7 10.7 4.2 5.1 3.8 6.2 5.0 4.7 3.4 0.7 2.2 2.8 2.0 0.3 1.7 0.8 3.8 4.2 2.0 3.6 3.2 1.3 2.3 2.8 2.7 2.6 1.8 9.7 2.6 1.5 10.7 1.7 1.3 3.3 1.6 3.8 0.6 2.8 4.0 2.8 3.4 15.8 2.3 0.7 2.9 1.8 2.9 1.7 1.9 1.8 2.0 4.9 2.2 3.6 1.7 3.2 4.8 3.1 0.9 9.2 17.6 6.3 0.8 2.5 2.4 2.1 2.0 3.4 3.6 4.4 1.8 0.8 2.5 2.7 1.6 1.4 4.9 2.8 2.2 2.1 0.4 0.6 1.5 4.9 2.3 0.0 2.0 2.8 1.2 1.3 1.7 0.7 0.9 1.1 2.2 0.5 0.7 0.3 2.3 0.3 1.7 1.1 0.7 0.8 3.6 4.7 6.6 5.6 3.7 2.7 4.1 2.7 3.6 4.2 14.9 21.3 6.5 9.8 7.1 24.2 17.9 15.3 4.0 7.9 17.4 27.5 10.2 1.7 6.8 13.4 13.5 291.1 0.0 10.4 8.3 7.1 8.8 6.9 49.5 16.5 17.5 22.4 10.4 25.4 16.4 6.4 15.0 5.0 1.0 70.1 18.1 11.4 112.2 6.3 6.8 21.9 0.0 10.5 25.1 15.9 8.2 13.7 8.5 84.8 18.4 DGAT2 ENSG00000062282 "Diacylglycerol O-acyltransferase 2" Q96PD7 11 75759512-75801535 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.3;blood: 68.9;liver: 81.3" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4" "Cancer enhanced" "Detected in many" "liver cancer: 19.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "eosinophil: 26.3;neutrophil: 68.9" "Lineage enriched" "Detected in many" 16 "granulocytes: 68.9" "Cell line enhanced" "Detected in many" "ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2" "Low region specificity" "Detected in all" HPA013351 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA013351: AB_1847630" "unprognostic (2.28e-1)" "unprognostic (3.69e-1)" "unprognostic (9.38e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.63e-1)" "unprognostic (4.99e-2)" "unprognostic (1.10e-2)" "unprognostic (7.59e-2)" "unprognostic (4.46e-1)" "unprognostic (4.12e-3)" "unprognostic (2.87e-1)" "unprognostic (2.99e-1)" "unprognostic (1.49e-7)" "unprognostic (2.03e-1)" "unprognostic (2.85e-1)" "unprognostic (2.74e-2)" "unprognostic (5.60e-2)" 104.3 1.3 1.9 12.5 6.8 1.7 30.4 0.1 4.2 1.0 11.8 0.6 0.4 3.6 0.5 0.6 6.3 0.7 6.3 6.0 1.0 1.2 1.0 81.3 1.8 16.1 0.6 1.2 0.6 1.3 0.4 0.6 0.5 1.0 1.0 1.4 1.2 9.9 0.6 1.3 34.1 8.1 0.9 0.6 3.7 3.3 13.6 0.5 1.0 2.4 3.9 4.5 4.0 2.7 1.5 1.1 68.9 4.2 0.0 0.0 0.9 4.6 2.3 0.1 4.0 30.3 2.4 0.3 0.4 0.5 0.6 0.3 16.7 4.9 7.4 6.2 0.1 4.4 0.1 0.6 2.3 1.6 22.0 0.4 0.5 1.6 22.9 0.3 2.6 2.6 10.1 12.4 2.7 3.9 1.6 0.4 7.5 0.4 10.1 0.2 3.0 1.7 5.7 1.3 44.2 10.9 0.0 0.0 8.7 0.4 12.9 8.3 0.5 4.2 0.7 1.0 1.0 1.6 9.3 0.5 5.3 2.6 0.1 3.2 5.9 13.2 9.9 3.8 8.4 9.0 3.0 4.2 26.3 0.0 0.8 0.0 1.5 0.0 0.0 1.1 1.2 0.0 0.0 68.9 0.0 0.8 0.3 0.0 0.9 1.9 6.8 0.1 4.2 1.0 1.2 0.6 1.2 1.0 0.5 6.0 4.8 3.4 0.8 1.0 0.6 3.4 0.0 1.4 1.2 0.0 2.0 0.5 0.0 1.4 192.0 0.3 0.4 0.0 0.4 0.1 0.8 2.0 0.0 104.6 2.3 1.6 1.2 1.3 5.6 49.3 2.0 1.7 1.7 0.0 5.0 0.5 2.1 2.6 0.7 1.7 0.0 6.5 0.3 45.4 49.4 6.9 0.7 0.0 3.4 4.2 DGAT2L6 "DC3, FLJ25989" ENSG00000184210 "Diacylglycerol O-acyltransferase 2 like 6" Q6ZPD8 X 70177483-70205545 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "breast: 6.9;skin 1: 10.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NB-4: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.90e-2)" "unprognostic (3.08e-1)" "unprognostic (1.43e-3)" "unprognostic (3.47e-3)" "unprognostic (8.60e-2)" "unprognostic (5.82e-2)" "unprognostic (1.63e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DGCR6 ENSG00000183628 "DiGeorge syndrome critical region gene 6" Q14129 22 18906028-18914238 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 49.2" "Group enriched" "Detected in many" 6 "Early spermatids: 233.3;Late spermatids: 675.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 9.5;myeloid DC: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 2.4;granulocytes: 9.5" "Cell line enriched" "Detected in many" 11 "OE19: 32.6" NA NA "unprognostic (9.80e-3)" "unprognostic (2.12e-3)" "unprognostic (1.51e-1)" "unprognostic (3.93e-3)" "unprognostic (2.41e-1)" "unprognostic (3.14e-1)" "unprognostic (1.60e-1)" "unprognostic (1.45e-2)" "unprognostic (1.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.42e-2)" "unprognostic (5.77e-2)" "unprognostic (2.23e-2)" "unprognostic (3.38e-2)" "unprognostic (8.08e-2)" "unprognostic (3.11e-1)" "unprognostic (1.28e-1)" 4.5 5.6 13.5 2.3 14.4 4.7 6.2 12.2 17.7 4.2 2.2 5.6 0.5 4.0 4.6 6.4 3.2 3.8 3.4 20.7 12.2 12.5 3.0 7.4 4.5 4.5 13.4 11.9 6.2 7.5 7.3 6.4 3.8 11.3 4.9 3.1 5.0 8.9 4.4 49.2 8.6 2.8 2.8 6.6 4.1 2.4 9.0 8.6 2.7 7.7 18.3 3.9 2.4 2.1 0.4 2.4 9.5 1.2 0.7 1.3 1.4 0.5 1.7 2.7 2.1 1.2 1.1 0.6 0.6 0.5 1.0 0.6 0.4 1.1 0.2 0.9 1.0 0.6 1.2 2.0 1.1 0.8 0.8 2.9 0.4 1.8 0.4 0.9 1.0 0.4 0.7 1.5 0.8 0.3 0.9 0.4 1.3 2.6 1.3 0.9 1.2 0.9 1.5 1.1 32.6 0.9 1.5 2.4 0.1 0.5 0.2 2.5 1.2 0.8 0.3 0.3 2.1 0.9 0.2 0.2 1.8 1.5 0.5 0.5 1.3 0.2 0.3 1.2 1.8 1.3 9.5 1.0 1.4 0.4 1.2 0.7 0.4 0.9 1.1 2.4 0.3 1.3 0.8 0.6 0.7 0.5 0.3 0.9 1.4 13.5 14.4 12.2 13.1 12.2 12.5 13.4 11.9 11.3 8.6 8.9 3.2 1.9 9.0 14.5 5.9 54.5 5.1 12.0 4.5 7.0 3.9 1.9 19.9 1.4 233.3 3.6 3.5 0.0 2.3 2.3 3.1 3.2 9.2 7.2 2.4 28.6 1.7 1.3 4.3 675.1 4.0 3.8 75.9 2.8 2.3 8.0 2.0 0.0 7.8 3.5 1.8 6.5 28.3 5.2 2.1 27.7 1.9 2.2 1.1 7.6 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.1" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.2;hTERT-HME1: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Vesicles "Nucleoplasm, Mitochondria" "HPA041645: AB_2677595, HPA045462: AB_2679335" "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 4.9 4.7 7.1 31.8 8.2 9.7 4.8 6.0 10.8 8.4 13.4 3.6 3.1 20.5 6.9 4.1 42.0 4.9 7.9 3.8 4.6 2.4 3.9 1.5 7.6 28.6 2.1 4.1 4.9 6.4 6.2 3.1 10.2 3.3 10.6 11.0 4.1 16.2 5.3 1.0 33.0 27.2 5.7 3.7 23.1 4.8 4.4 2.6 117.1 4.5 9.6 57.0 13.0 15.1 7.6 4.0 5.4 2.8 5.2 30.2 10.9 6.7 4.3 3.0 4.0 7.5 9.8 0.9 15.2 15.6 6.0 4.4 2.0 11.5 3.8 3.6 10.1 2.0 12.4 3.2 42.2 7.2 3.2 0.7 6.1 9.1 1.1 6.5 1.9 6.0 8.4 22.8 8.3 44.8 20.0 12.2 22.7 0.7 5.9 16.1 0.7 12.5 2.4 0.6 5.6 5.1 5.8 1.0 0.6 14.2 19.5 0.5 1.7 5.0 0.2 0.5 8.2 2.7 2.0 10.9 3.9 2.8 0.8 0.5 0.7 0.3 9.2 4.7 5.2 1.1 5.2 2.8 5.4 6.5 2.0 11.7 7.6 24.3 11.7 4.0 6.4 30.2 18.1 5.2 5.2 1.2 4.0 26.7 10.9 7.1 8.2 6.0 10.8 4.6 2.4 2.1 4.1 3.3 2.6 3.0 6.2 15.6 8.5 13.4 0.8 2.0 0.0 0.0 11.4 5.2 0.0 13.4 0.0 4.1 6.5 3.3 38.4 0.0 8.4 4.0 3.8 8.2 6.9 0.0 3.7 0.0 2.4 4.9 4.1 4.7 3.4 10.2 0.0 16.2 7.5 4.9 15.8 6.2 2.8 0.1 0.4 6.5 3.1 3.8 2.7 12.2 22.1 20.6 5.2 18.0 DGKB "DAGK2, DGK, DGK-BETA, KIAA0718" ENSG00000136267 "Diacylglycerol kinase beta" Q9Y6T7 7 14145049-14974777 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 37.7" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 16.8;Club cells: 3.4;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 11 "glioma: 1.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.8;fHDF/TERT166: 5.7;hTEC/SVTERT24-B: 2.2;SCLC-21H: 2.9;SH-SY5Y: 2.1;U-266/70: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020321 Supported NA NA "HPA020321: " "unprognostic (9.89e-2)" "unprognostic (9.72e-5)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.32e-2)" "unprognostic (3.37e-1)" "unprognostic (7.34e-2)" "unprognostic (5.91e-2)" "unprognostic (6.19e-2)" "unprognostic (8.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (5.98e-2)" "unprognostic (2.37e-3)" "unprognostic (6.13e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-4)" 1.1 5.2 11.5 1.1 37.7 0.8 0.8 1.3 34.0 4.9 1.6 1.4 0.0 0.9 6.1 0.9 1.6 2.7 1.3 1.4 10.5 4.3 2.6 1.1 0.8 0.8 2.2 11.3 0.8 0.9 0.8 1.8 0.7 4.8 1.1 1.7 0.0 0.9 0.9 1.2 0.9 1.2 3.1 3.5 0.8 0.8 0.9 7.9 0.0 0.9 0.0 0.8 1.5 0.6 0.7 0.6 1.3 0.3 0.6 0.5 0.1 0.1 0.0 2.8 0.1 0.0 0.2 0.1 0.0 1.2 0.0 0.3 0.2 0.0 0.1 0.0 5.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.9 2.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.0 0.0 0.0 7.6 0.0 0.0 0.1 0.1 0.1 0.7 0.3 0.3 0.5 0.2 0.4 0.3 0.5 0.2 0.1 0.7 0.5 0.4 1.3 0.6 0.2 0.6 0.2 0.1 11.5 37.7 1.3 19.1 10.5 4.3 2.2 11.3 4.8 7.9 0.0 0.0 0.0 0.2 0.1 16.8 1.2 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.2 6.5 1.4 0.2 0.2 0.4 0.0 0.0 0.0 0.3 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362237 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.4" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2" "Cell line enhanced" "Detected in some" "HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 3.1 6.9 13.4 3.1 7.1 14.5 1.9 53.4 23.1 2.7 3.5 6.2 1.1 3.0 1.9 14.6 8.5 7.7 2.2 15.0 15.3 7.4 3.1 2.1 4.3 2.1 7.4 11.3 2.0 1.6 4.7 7.5 13.5 25.2 3.1 2.1 7.8 1.9 4.0 2.4 1.4 2.7 5.3 5.6 2.0 3.3 1.2 7.1 0.0 2.5 0.0 2.1 4.8 2.4 0.6 2.9 5.3 4.2 0.0 0.0 1.3 2.7 4.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.4 0.0 2.9 0.2 0.0 0.0 0.0 20.2 0.0 2.7 0.0 2.9 0.0 6.4 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.1 0.1 2.2 0.4 0.0 1.2 1.4 0.0 2.3 0.0 0.0 0.5 0.0 0.8 0.0 1.7 0.0 0.1 4.2 0.0 0.0 0.7 2.1 2.4 0.0 7.7 0.0 12.8 6.0 2.3 0.0 4.2 2.4 0.0 2.4 0.0 0.6 0.0 0.0 2.9 0.3 0.0 0.0 5.3 0.0 2.8 0.5 0.0 1.3 13.4 7.1 53.4 14.7 15.3 7.4 7.4 11.3 25.2 7.1 0.0 1.7 1.5 0.1 0.3 0.0 16.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.2 2.4 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.0 1.9 1.6 0.0 27.6 2.7 2.0 1.7 2.3 0.0 1.0 0.0 7.5 0.7 0.0 0.4 0.8 0.0 12.9 16.7 0.0 0.0 0.4 0.1 0.0 0.0 0.4 DGKI DGK-IOTA ENSG00000157680 "Diacylglycerol kinase iota" O75912 7 137381037-137847092 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;thyroid gland: 32.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 40.2;Horizontal cells: 42.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 4.0;GAMG: 4.5;hTEC/SVTERT24-B: 4.2;SCLC-21H: 6.8;U-2197: 18.8;U-87 MG: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-3)" "unprognostic (1.76e-1)" "unprognostic (6.08e-2)" "unprognostic (1.42e-1)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (1.09e-1)" "unprognostic (9.01e-2)" "unprognostic (8.74e-2)" "unprognostic (4.46e-2)" "unprognostic (5.98e-5)" "unprognostic (2.85e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "unprognostic (1.73e-3)" 1.5 1.3 5.0 1.1 19.8 0.7 1.1 11.4 12.7 0.8 0.9 2.6 0.0 0.9 1.4 0.9 0.9 0.9 1.9 5.0 4.6 3.3 1.7 0.7 0.8 0.8 2.8 9.0 0.8 0.7 0.8 6.0 0.8 6.6 1.0 0.9 10.8 1.0 1.1 0.7 0.9 0.9 2.7 2.5 0.8 0.8 1.9 5.8 0.0 32.1 0.0 0.8 1.1 0.3 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.0 0.9 0.0 4.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 1.3 4.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 1.0 0.0 0.1 0.2 0.0 4.2 0.1 0.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 2.9 0.0 0.0 0.5 0.3 0.0 0.0 0.3 1.6 0.6 18.8 0.9 0.1 0.0 0.0 7.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 5.0 19.8 11.4 12.7 4.6 3.3 2.8 9.0 6.6 5.8 0.0 0.0 0.0 0.2 1.0 40.2 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 42.9 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.4 0.3 3.0 0.0 1.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 DGKK ENSG00000274588 "Diacylglycerol kinase kappa" Q5KSL6 X 50365409-50470738 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "adrenal gland: 9.8;brain: 29.6;pituitary gland: 33.5" "Cell type enhanced" "Detected in single" 20 "Late spermatids: 1.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 2.4;memory CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in some" 19 "Hep G2: 27.9" "Region enhanced" "Detected in some" "hypothalamus: 12.9" "Group enriched" "Detected in many" 6 "basal ganglia: 3.5;hypothalamus: 1.8;midbrain: 4.3;pons and medulla: 1.1" NA NA "unprognostic (3.99e-1)" "unprognostic (1.18e-1)" "unprognostic (4.18e-3)" "unprognostic (1.23e-1)" "unprognostic (5.83e-3)" "unprognostic (9.58e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-2)" "unprognostic (2.06e-1)" "unprognostic (4.28e-3)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.49e-2)" "unprognostic (4.64e-3)" 0.1 9.8 0.0 0.0 29.6 0.2 0.3 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 DGKZ "DAGK5, DAGK6, DGK-ZETA, hDGKzeta" ENSG00000149091 "Diacylglycerol kinase zeta" Q13574 11 46332905-46380554 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.7" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 84.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051336 Enhanced Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA051336: AB_2681448" "unprognostic (2.85e-2)" "unprognostic (3.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.40e-1)" "unprognostic (4.12e-2)" "unprognostic (3.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (2.49e-2)" "unprognostic (3.66e-3)" "unprognostic (8.18e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.48e-3)" "unprognostic (7.75e-2)" "unprognostic (3.61e-2)" "unprognostic (7.84e-3)" 8.6 6.7 34.5 11.8 27.4 28.0 6.8 22.6 50.7 7.5 7.4 8.5 2.5 21.0 6.1 4.3 7.1 6.3 6.7 16.0 48.0 9.2 5.3 3.3 8.3 20.7 9.4 26.7 5.0 17.3 7.0 18.6 8.4 7.5 5.9 4.2 4.8 24.1 7.0 42.8 8.3 23.2 5.6 7.2 15.6 9.9 5.0 7.5 14.2 4.1 9.1 9.9 7.6 5.0 0.9 12.3 11.2 11.8 7.7 7.5 8.1 11.9 10.7 7.2 10.8 3.8 4.3 33.7 9.3 7.0 9.9 8.7 12.7 5.5 15.4 6.8 9.7 10.9 14.0 8.7 13.5 3.5 15.4 20.3 10.0 7.8 9.3 6.9 18.9 20.3 5.8 6.4 5.4 7.4 5.1 10.9 12.8 14.0 9.5 7.0 31.5 18.2 29.7 21.1 17.3 16.4 21.8 12.6 6.5 3.0 11.7 49.8 8.5 10.7 35.9 7.3 4.8 25.8 23.9 12.2 13.1 14.2 20.6 16.8 6.3 7.1 12.6 17.9 17.2 12.1 11.2 11.8 5.8 7.5 6.1 4.5 0.4 4.7 6.3 12.3 0.9 4.9 5.0 9.8 7.7 5.9 5.9 4.5 8.1 34.5 27.4 22.6 50.7 48.0 9.2 9.4 26.7 7.5 7.5 3.0 10.0 17.1 20.8 11.7 19.2 20.9 10.2 1.4 4.5 8.7 19.6 12.7 8.3 11.4 5.4 22.4 36.9 0.0 41.8 84.0 10.8 14.0 20.7 7.8 43.9 15.9 49.4 57.1 44.7 5.4 12.0 18.5 11.8 19.8 18.9 5.8 26.8 45.6 7.8 15.4 9.2 32.3 11.3 7.0 13.2 8.2 22.9 57.3 18.0 14.7 DGLUCY "C14orf159, FLJ39975" ENSG00000133943 "D-glutamate cyclase" Q7Z3D6 14 91060333-91225632 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 26.8;Collecting duct cells: 27.9;Cytotrophoblasts: 25.8;Hofbauer cells: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 57.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041423, HPA052932" Approved Supported Cytosol NA NA Cytosol "HPA041423: AB_10795540, HPA052932: AB_2681991" "unprognostic (5.02e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (4.28e-4)" "unprognostic (1.28e-1)" "unprognostic (2.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (9.48e-5)" "unprognostic (3.56e-1)" "prognostic favorable (7.28e-4)" "unprognostic (2.30e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.77e-15)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.75e-2)" "unprognostic (2.57e-3)" 12.5 18.7 23.4 15.9 23.1 10.7 9.3 27.3 22.6 14.6 16.7 18.1 16.0 13.8 16.8 13.1 16.0 21.9 12.5 63.9 18.8 16.6 20.1 13.1 13.7 11.2 20.1 19.2 13.4 9.3 29.3 14.2 9.2 19.0 13.3 17.0 11.3 17.4 22.3 82.9 13.9 12.3 20.0 18.5 17.3 18.9 12.2 21.6 11.2 16.8 29.1 14.1 19.4 11.4 9.4 19.8 57.9 19.3 5.6 12.0 7.0 2.7 7.5 3.8 9.2 15.7 14.9 10.0 2.9 8.1 9.0 9.3 4.8 21.6 18.7 21.7 8.6 11.8 8.3 10.5 11.4 3.7 10.3 4.4 12.5 3.8 6.2 23.0 12.8 18.3 22.9 4.9 4.9 1.9 11.9 16.0 10.5 6.2 25.5 8.5 0.7 10.0 12.1 7.7 0.3 0.7 17.2 7.4 13.6 15.3 11.8 10.6 5.4 4.8 8.4 3.5 4.1 14.9 10.8 11.4 2.7 2.4 8.0 2.7 14.7 10.4 6.3 14.0 16.7 1.8 13.7 13.6 8.1 8.8 19.3 9.0 9.4 5.9 7.2 19.8 7.0 4.9 6.0 57.9 5.6 15.5 6.2 12.0 7.0 23.4 23.1 27.3 22.6 18.8 16.6 20.1 19.2 19.0 21.6 26.8 16.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 10.3 27.9 0.0 25.8 18.3 11.9 0.0 0.0 0.0 0.0 5.1 13.7 0.0 0.0 7.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 12.6 0.0 0.0 7.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 DHCR24 "DCE, KIAA0018, seladin-1" ENSG00000116133 "24-dehydrocholesterol reductase" Q15392 1 54849633-54887218 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 164.5;liver: 119.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 733.4;Hepatocytes: 888.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 132.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017981, CAB037247, HPA063005" Enhanced NA NA "CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919" "unprognostic (2.88e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (1.69e-1)" "unprognostic (2.61e-1)" "unprognostic (1.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.68e-1)" "unprognostic (1.86e-1)" "unprognostic (6.18e-3)" "unprognostic (3.35e-1)" "unprognostic (7.82e-3)" "unprognostic (5.48e-2)" "unprognostic (1.83e-1)" "unprognostic (1.70e-1)" "unprognostic (3.97e-2)" 10.6 164.5 6.6 3.9 22.1 0.7 22.0 6.5 27.5 7.7 11.1 43.8 1.2 11.9 2.2 1.1 40.8 12.3 8.6 3.7 12.0 9.2 6.4 119.6 40.9 2.0 36.2 13.0 7.8 4.6 28.4 2.6 4.4 47.9 26.1 8.3 4.8 20.2 2.1 24.6 47.6 7.3 2.7 71.7 24.3 17.6 14.1 31.1 1.7 4.3 17.1 14.3 2.5 13.0 5.4 7.0 7.3 3.1 3.7 9.0 5.5 40.5 7.5 26.5 32.0 132.8 28.6 6.2 11.7 20.3 16.9 34.9 41.6 25.7 6.5 23.6 10.2 53.9 39.0 31.7 61.7 15.1 0.9 19.9 36.1 17.7 49.7 21.6 15.0 8.4 20.8 53.9 52.2 9.7 8.3 8.3 15.3 26.3 0.0 6.2 17.0 3.2 13.2 73.3 11.0 20.5 0.0 6.7 19.9 92.9 32.9 18.3 6.7 22.2 42.0 15.3 29.3 54.7 17.5 7.6 5.6 16.5 8.1 22.1 2.8 6.4 11.2 4.1 25.9 7.3 7.3 2.4 1.1 9.0 3.1 0.5 5.4 4.0 4.2 7.0 2.4 3.9 4.7 0.1 3.7 1.0 4.2 0.7 5.5 6.6 22.1 6.5 27.5 12.0 9.2 36.2 13.0 47.9 31.1 276.9 733.4 19.9 13.4 27.9 4.4 9.0 165.6 95.0 154.7 64.6 0.0 33.0 3.3 46.7 12.8 10.6 64.2 93.5 65.4 27.5 19.8 70.0 30.2 888.0 22.6 4.8 23.1 154.7 70.4 40.3 13.0 6.1 13.5 10.8 30.6 3.7 38.4 26.0 7.4 11.2 4.4 0.0 4.7 1.7 14.0 70.3 25.6 7.0 24.8 34.0 DHCR7 SLOS ENSG00000172893 "7-dehydrocholesterol reductase" Q9UBM7 11 71428193-71452868 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.8" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 43.9;Hepatocytes: 67.2;Syncytiotrophoblasts: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044280 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044280: AB_10794893" "unprognostic (1.76e-1)" "unprognostic (1.50e-3)" "unprognostic (1.32e-2)" "unprognostic (7.16e-3)" "unprognostic (2.69e-1)" "unprognostic (2.18e-3)" "unprognostic (8.57e-3)" "unprognostic (3.02e-2)" "unprognostic (4.91e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-2)" "unprognostic (5.45e-2)" "prognostic favorable (6.93e-7)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (8.15e-2)" "prognostic unfavorable (5.67e-4)" 8.0 40.1 12.1 5.6 14.5 19.0 16.8 5.3 22.8 5.5 9.3 27.9 8.8 20.8 4.0 27.3 14.6 5.2 5.8 10.7 13.7 13.2 7.1 64.8 12.0 2.7 20.6 12.3 21.5 7.3 14.0 7.0 3.7 23.4 10.0 6.6 16.6 10.0 3.9 5.4 22.9 15.8 4.5 20.5 5.9 8.5 17.7 15.5 2.8 5.4 12.1 7.7 4.3 7.4 6.3 6.2 3.5 1.9 4.6 12.1 5.7 21.2 19.3 18.9 20.9 8.9 13.8 5.9 8.8 23.5 7.5 20.5 71.9 70.0 14.9 14.0 8.4 67.3 41.0 22.5 47.6 7.9 5.6 16.9 5.7 16.3 30.7 22.8 10.6 2.7 15.9 21.1 28.2 19.4 6.2 11.1 19.5 26.6 31.8 7.5 57.2 8.7 12.0 27.1 21.1 11.5 7.9 26.6 64.0 28.2 32.2 25.7 9.6 8.4 27.8 20.0 9.6 26.9 5.8 10.4 2.0 11.4 0.6 10.5 10.5 12.7 15.9 6.0 18.9 8.5 3.5 1.9 1.7 9.7 1.2 11.8 6.3 8.2 9.0 2.5 5.4 10.5 12.1 1.0 4.6 1.2 6.2 5.1 5.7 12.1 14.5 5.3 22.8 13.7 13.2 20.6 12.3 23.4 15.5 3.0 12.6 6.7 7.1 0.7 6.8 11.3 10.2 5.3 9.1 21.0 11.8 13.8 6.6 29.1 0.1 6.6 7.8 0.0 43.9 21.8 9.3 14.2 0.0 67.2 9.8 0.0 9.1 6.2 3.7 0.0 7.8 3.0 5.0 9.0 11.8 20.9 19.8 7.0 4.6 2.9 8.0 12.9 2.5 0.6 5.9 1.0 45.3 10.2 14.5 7.1 DHDH HUM2DD ENSG00000104808 "Dihydrodiol dehydrogenase" Q9UQ10 19 48933682-48944969 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 32.4;kidney: 18.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.8;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 31 "granulocytes: 5.8;T-cells: 4.8" "Cell line enhanced" "Detected in many" "JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0" "Low region specificity" "Detected in all" HPA044131 Approved Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA044131: AB_10966968" "unprognostic (1.54e-1)" "unprognostic (2.72e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.91e-4)" "unprognostic (3.33e-3)" "unprognostic (1.45e-1)" "unprognostic (5.81e-6)" "unprognostic (1.56e-2)" "unprognostic (5.88e-2)" "unprognostic (4.96e-2)" "unprognostic (3.30e-2)" "unprognostic (5.08e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.54e-1)" 0.3 0.5 1.5 0.1 2.1 0.1 0.2 1.8 1.5 0.1 8.2 0.2 0.1 10.6 0.2 0.4 0.8 0.3 0.8 0.1 2.7 2.0 18.0 0.7 1.9 0.2 0.4 0.4 0.5 0.4 0.2 2.1 1.3 0.6 3.5 0.1 1.2 0.8 0.2 0.3 0.2 32.4 0.1 0.9 1.8 0.7 2.8 0.1 0.4 0.1 0.5 0.7 1.1 0.3 0.1 0.0 5.8 0.0 0.0 4.8 0.5 2.8 0.0 0.2 1.4 0.8 0.6 1.1 0.0 0.4 0.5 1.4 2.7 2.2 0.0 0.5 0.0 1.8 0.8 0.9 2.0 0.9 1.0 2.2 3.9 0.9 1.0 0.0 0.0 0.9 0.5 0.2 1.1 0.0 0.7 0.0 6.3 1.2 0.4 0.0 0.6 0.0 0.2 0.6 4.0 1.8 1.4 0.2 1.9 0.3 0.9 4.2 2.3 0.5 0.3 0.9 0.3 1.9 0.1 0.0 0.0 1.7 0.6 0.1 6.4 5.0 1.6 1.3 0.0 0.4 5.8 0.0 0.9 1.6 0.0 0.8 0.0 1.6 0.7 0.0 0.1 4.8 3.1 0.1 0.0 0.0 0.0 1.2 0.5 1.5 2.1 1.8 1.5 2.7 2.0 0.4 0.4 0.6 0.1 3.0 5.4 0.0 2.6 0.7 1.3 0.4 0.0 0.0 4.5 3.5 0.0 0.1 8.3 1.3 0.5 0.6 1.7 0.0 0.3 0.1 0.5 5.2 1.1 0.0 10.9 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.7 1.5 1.2 2.9 0.0 56.2 4.3 0.0 0.1 0.0 0.6 0.1 0.1 0.0 0.6 2.6 DHH "HHG-3, MGC35145" ENSG00000139549 "Desert hedgehog" O43323 12 49089421-49094819 "Disease related genes, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 35.7" "Cell type enhanced" "Detected in single" 17 "Endothelial cells: 1.1" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 4 "midbrain: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;EFO-21: 7.3;HUVEC TERT2: 2.9;K-562: 12.2;TIME: 6.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "midbrain: 2.1" "Secreted in male reproductive system" NA NA "unprognostic (7.56e-2)" "unprognostic (2.05e-3)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (2.36e-4)" "unprognostic (1.29e-1)" "unprognostic (7.22e-3)" "unprognostic (8.21e-2)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" 0.9 0.4 0.2 1.2 0.6 0.1 1.4 0.3 0.6 0.6 0.5 0.2 0.3 0.3 1.0 0.9 0.5 0.6 1.7 0.9 0.2 0.2 0.6 0.2 0.9 0.2 5.2 0.0 0.4 0.2 0.2 0.8 1.5 1.2 0.7 0.2 1.3 0.7 0.8 0.6 0.3 0.5 1.0 1.2 0.3 0.3 35.7 0.0 0.0 0.4 1.3 0.2 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.9 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.6 0.2 0.2 5.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.4 15.5 4.5 7.5 2.4 3.2 8.6 6.4 2.6 9.7 7.5 12.2 6.8 16.8 8.7 3.5 5.4 7.9 8.9 6.9 11.5 3.8 8.4 9.2 7.5 12.0 6.8 12.7 6.8 3.1 7.1 11.7 12.3 3.1 7.0 11.4 14.0 3.1 5.9 19.8 12.0 12.2 10.2 12.7 6.1 15.2 5.9 17.7 5.8 4.9 5.4 6.3 8.6 9.2 4.2 5.8 8.2 6.4 3.0 8.9 5.5 8.4 9.3 5.9 10.9 28.4 4.6 14.0 8.1 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 3.0 9.6 9.5 6.4 4.9 5.7 12.1 7.6 9.4 1.2 7.0 3.9 12.0 5.0 6.6 2.1 6.7 0.7 0.0 4.4 9.6 6.0 5.0 8.1 106.1 6.9 3.2 1.2 2.5 5.3 2.3 2.6 3.4 11.8 3.6 4.4 4.8 5.2 2.9 2.1 20.1 4.2 0.0 9.9 7.9 8.0 3.3 2.4 5.0 6.2 4.1 DHRS1 "FLJ25430, MGC20204, SDR19C1" ENSG00000157379 "Dehydrogenase/reductase 1" Q96LJ7 14 24290598-24299833 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000599, HPA076886" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA000599: AB_1078655, HPA076886: " "unprognostic (2.08e-3)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (2.75e-1)" "unprognostic (3.57e-1)" "unprognostic (6.57e-2)" "prognostic favorable (1.18e-5)" "prognostic favorable (6.83e-4)" "unprognostic (3.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (9.88e-2)" "unprognostic (2.25e-3)" "unprognostic (1.32e-2)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-1)" 6.5 8.9 3.0 6.1 5.0 3.3 7.4 6.3 6.0 8.6 12.0 9.8 8.4 16.1 6.7 8.9 35.7 5.4 10.2 3.7 2.7 3.1 8.5 47.1 6.7 4.8 3.6 5.3 4.2 10.7 11.5 5.2 4.1 6.0 5.5 5.4 7.1 14.0 15.6 1.8 20.8 25.7 4.8 4.4 6.3 6.1 2.8 3.7 5.6 6.6 25.6 16.5 6.0 13.0 10.4 10.7 17.3 9.5 4.2 11.7 4.7 11.1 2.7 2.9 1.1 6.8 7.2 0.7 4.0 8.8 9.5 10.3 1.0 10.9 5.2 1.7 6.2 1.5 9.1 2.2 18.5 4.6 3.5 2.3 1.6 6.5 17.6 3.2 3.1 1.2 6.5 10.9 2.3 1.7 7.7 7.1 4.3 3.2 5.0 7.7 4.5 1.2 1.1 0.5 8.9 4.0 4.0 2.0 7.2 7.3 4.2 2.5 1.9 5.7 7.7 1.9 2.1 3.9 0.9 2.7 0.7 1.8 1.1 1.3 2.8 2.2 2.5 3.4 2.7 0.9 10.0 8.7 17.3 6.9 9.5 7.5 10.4 7.5 6.3 10.7 7.0 7.6 4.2 5.7 4.2 5.9 6.4 11.7 4.7 3.0 5.0 6.3 6.0 2.7 3.1 3.6 5.3 6.0 3.7 20.8 17.9 18.2 23.9 29.2 10.8 13.9 45.9 16.0 18.2 33.2 17.7 40.2 33.2 24.7 15.1 15.7 74.2 0.0 26.8 7.7 17.9 21.4 5.8 70.1 24.0 14.3 18.5 14.1 11.6 27.0 18.7 16.2 43.9 11.8 37.9 14.1 42.2 46.0 19.4 44.2 44.1 25.8 21.7 26.2 9.3 40.0 21.9 26.1 38.6 36.3 DHRS11 "MGC4172, SDR24C1" ENSG00000278535 "Dehydrogenase/reductase 11" Q6UWP2 17 36591798-36600806 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "intestine: 88.0" "Cell type enhanced" "Detected in many" 16 "Cone photoreceptor cells: 121.7;Enterocytes: 380.9;Paneth cells: 114.5;Undifferentiated cells: 112.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041226, HPA048236, HPA053623" Enhanced Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 11000 Cytosol "Golgi apparatus" "HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209" "unprognostic (2.00e-3)" "unprognostic (1.22e-2)" "unprognostic (1.06e-2)" "unprognostic (3.74e-1)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (1.80e-2)" "unprognostic (3.67e-1)" "unprognostic (5.94e-2)" "unprognostic (1.33e-2)" "unprognostic (4.11e-2)" "prognostic favorable (3.24e-4)" "unprognostic (1.45e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-2)" "unprognostic (9.35e-2)" 1.3 0.6 1.2 4.1 2.4 0.4 0.7 0.5 5.7 0.4 38.7 0.4 0.4 42.7 0.4 0.1 1.2 1.1 1.4 2.0 0.5 2.5 1.7 0.1 0.0 0.0 2.4 0.1 2.8 1.5 0.2 0.0 1.6 0.5 12.4 2.8 2.1 0.8 2.0 0.8 88.0 0.9 0.1 0.0 1.1 2.2 0.3 0.0 1.3 1.3 1.0 0.4 0.0 0.9 0.2 0.9 0.7 0.1 2.7 0.1 6.7 6.0 2.9 7.6 0.6 1.8 5.6 2.0 1.4 6.5 5.9 9.8 5.4 0.7 1.4 2.0 2.7 7.0 6.1 4.2 6.6 3.5 11.6 1.7 5.8 18.9 3.1 2.0 0.6 0.9 3.9 4.5 3.3 1.4 5.0 6.9 15.8 5.9 3.5 5.9 6.5 3.6 2.2 7.9 2.3 8.1 7.1 11.2 6.6 5.7 6.1 2.6 7.2 7.4 16.6 4.7 10.2 1.8 1.8 0.9 9.3 4.9 5.1 9.7 8.1 2.3 3.3 4.8 2.9 0.4 0.5 0.9 1.0 0.7 0.1 0.4 1.0 0.6 0.1 0.9 1.3 0.9 0.5 0.1 0.1 0.2 2.7 0.1 0.0 1.0 1.9 6.8 3.8 17.5 8.4 0.0 1.4 0.0 7.0 121.7 6.4 49.7 8.1 18.9 4.8 380.9 23.3 9.9 3.7 2.7 10.9 0.0 11.5 3.0 15.9 11.6 3.1 2.2 23.8 3.7 2.3 18.6 4.6 59.2 11.6 6.1 114.5 4.9 26.7 62.6 0.0 3.5 26.3 5.2 5.3 5.8 1.3 112.5 13.2 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8" "Region enriched" "Detected in single" 4 "cerebellum: 2.7" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 0.1 0.3 0.3 0.0 0.2 0.0 79.9 0.1 0.2 0.5 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.8 1.8 5.0 0.2 0.0 0.2 0.0 9.0 5.9 0.3 0.5 5.0 0.1 40.2 0.0 0.1 20.1 0.6 0.1 0.7 0.1 23.1 0.3 3.7 0.8 0.9 0.0 0.0 0.1 0.0 0.0 120.7 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.4 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 20.1 1.5 0.1 0.0 49.9 0.0 0.2 1.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.4 2.2 0.1 0.4 0.1 0.0 59.8 0.2 0.3 0.4 292.6 0.3 0.0 0.2 0.0 0.0 0.1 95.8 0.5 0.3 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 5.9 6.6 0.0 3.4 0.0 0.0 0.0 0.2 10.3 0.3 0.2 0.0 0.8 1.6 0.0 3.4 0.0 0.8 3.0 0.0 0.0 0.0 1.0 0.0 0.0 6.7 0.0 1.1 0.1 1.0 6.5 0.0 0.0 8.5 0.1 20.7 0.0 0.5 11.9 DHRS7 "retDSR4, SDR34C1" ENSG00000100612 "Dehydrogenase/reductase 7" Q9Y394 14 60144120-60169856 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 123.5" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "prostate cancer: 199.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031121, HPA078401" Enhanced Approved Nucleoplasm,Mitochondria No No 63000 "Nucleoplasm, Mitochondria" "HPA031121: AB_10600803, HPA078401: " "prognostic favorable (6.42e-4)" "unprognostic (5.20e-2)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (2.51e-4)" "unprognostic (4.65e-2)" "unprognostic (4.31e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (7.99e-4)" "unprognostic (1.73e-1)" "unprognostic (1.59e-1)" "prognostic favorable (1.92e-10)" "unprognostic (8.35e-3)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" 15.0 24.6 12.3 10.1 10.9 10.5 17.9 10.6 12.4 11.1 30.6 10.7 57.3 20.7 11.7 19.4 12.3 9.9 15.3 17.4 11.0 11.4 22.6 27.9 13.1 13.9 14.1 8.8 13.4 17.2 40.2 17.2 6.1 17.8 83.4 13.4 9.1 113.7 93.0 123.5 9.8 48.7 9.6 15.5 11.1 32.6 4.9 11.0 6.4 24.8 16.7 10.1 12.4 15.6 26.0 56.6 121.4 32.2 37.3 50.8 54.0 52.6 15.9 9.2 20.2 47.7 18.7 11.7 17.0 43.8 6.2 13.8 8.8 35.7 5.5 10.2 15.9 15.8 22.7 12.0 23.9 9.1 38.3 11.2 13.6 7.8 14.4 25.1 16.1 0.4 13.9 28.8 9.8 33.3 11.1 11.9 14.0 4.1 11.9 15.5 15.9 9.3 15.3 4.3 31.1 16.1 9.7 12.4 6.4 27.7 18.0 19.8 24.8 17.2 26.1 37.7 11.8 18.3 7.1 8.3 30.9 10.5 8.4 9.7 4.2 1.9 9.8 16.8 15.6 21.2 80.1 32.2 71.6 50.8 22.6 49.9 26.0 36.0 43.9 27.1 21.8 20.2 38.9 121.4 37.3 29.0 56.6 29.0 54.0 12.3 10.9 10.6 12.4 11.0 11.4 14.1 8.8 17.8 11.0 50.6 96.5 40.4 57.0 30.2 23.6 16.5 147.7 46.8 59.1 82.0 78.5 22.0 16.6 184.7 1.5 65.9 155.6 0.0 145.2 76.8 60.2 242.6 172.3 147.5 88.2 39.7 44.6 30.1 58.9 2.0 76.2 101.1 102.9 178.5 77.9 88.0 174.5 89.2 79.2 41.6 54.4 84.1 70.6 1.1 3.1 22.2 17.4 135.7 66.0 41.6 DHRS7C SDR32C2 ENSG00000184544 "Dehydrogenase/reductase 7C" A6NNS2 17 9771434-9791297 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 62.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "BJ hTERT+: 4.5;HeLa: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (6.83e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 44.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 2.7 0.0 87.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 DHRS9 "3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4" ENSG00000073737 "Dehydrogenase/reductase 9" Q9BPW9 2 169064789-169096167 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 118.1;granulocytes: 85.8;Syncytiotrophoblasts: 223.7;Urothelial cells: 225.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 16.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 53.1" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 10.1;HUVEC TERT2: 8.9;NB-4: 14.7;THP-1: 42.9;TIME: 19.1;U-2197: 14.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA036491, HPA036667" Approved "Intracellular and membrane" NA NA "HPA036491: AB_10673498, HPA036667: AB_10670237" "unprognostic (1.15e-1)" "unprognostic (3.82e-3)" "unprognostic (1.15e-1)" "unprognostic (1.85e-1)" "unprognostic (4.80e-2)" "unprognostic (2.35e-1)" "unprognostic (3.24e-2)" "unprognostic (1.40e-1)" "unprognostic (3.18e-1)" "unprognostic (3.62e-4)" "prognostic unfavorable (2.73e-4)" "unprognostic (2.72e-1)" "unprognostic (3.23e-1)" "unprognostic (1.85e-2)" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.41e-1)" 40.0 0.1 1.3 14.9 1.0 3.3 2.2 0.3 1.9 4.0 30.9 1.1 0.8 0.6 1.3 0.9 12.8 0.6 2.3 32.2 1.2 0.8 0.4 1.0 9.6 8.0 2.5 1.1 1.2 1.4 0.0 0.3 4.9 1.1 3.5 20.9 0.6 2.9 0.3 1.0 1.5 2.7 3.5 2.4 4.0 4.6 12.3 0.6 0.9 0.5 23.2 12.0 3.7 4.6 1.7 5.4 53.1 6.1 0.0 0.1 1.3 0.0 0.3 0.0 0.0 1.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.4 0.2 0.2 0.6 2.7 10.1 8.9 0.0 0.4 0.0 0.0 0.0 0.0 14.7 0.0 0.1 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 19.1 0.0 0.1 14.1 0.1 0.0 0.0 0.0 0.3 7.7 0.0 53.1 5.4 23.9 0.0 6.1 0.1 1.7 0.0 0.0 5.4 1.0 0.0 0.0 19.5 0.0 1.2 0.4 0.0 1.3 1.3 1.0 0.3 0.7 1.2 0.8 2.5 1.1 1.1 0.6 0.0 2.2 0.9 6.8 1.4 0.0 26.4 0.0 57.6 10.3 0.0 0.0 1.7 0.0 0.3 118.1 0.6 34.9 0.0 21.0 1.1 1.1 5.5 85.8 0.5 25.7 0.0 1.7 0.0 5.7 33.8 1.1 6.4 0.0 0.0 38.5 3.5 40.1 9.5 0.4 0.0 0.0 6.5 0.1 0.7 0.6 1.3 223.7 0.0 1.3 225.8 DHTKD1 "CMT2Q, DKFZP762M115, KIAA1630, MGC3090" ENSG00000181192 "Dehydrogenase E1 and transketolase domain containing 1" Q96HY7 10 12068972-12123225 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Oxidoreductase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.5" "Group enriched" "Detected in many" 4 "Hepatocytes: 213.4;Proximal tubular cells: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037949, HPA037950, HPA066098" Enhanced Supported Mitochondria NA NA Mitochondria "HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617" "unprognostic (3.76e-2)" "unprognostic (8.08e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (3.04e-3)" "unprognostic (3.83e-3)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (3.02e-3)" "unprognostic (3.46e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.43e-4)" "unprognostic (2.12e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-2)" "unprognostic (2.88e-3)" 5.7 6.3 6.5 4.7 6.6 2.2 5.0 5.7 7.2 5.5 5.7 9.8 5.0 4.5 4.7 5.0 5.1 4.2 4.5 7.7 5.3 4.8 23.8 69.5 4.2 6.9 7.5 5.2 7.1 16.6 5.4 4.1 4.7 6.2 7.6 6.3 7.2 9.7 7.1 10.5 3.6 4.3 3.5 6.1 5.1 6.1 4.4 6.6 10.1 6.8 6.7 8.0 5.2 4.1 9.5 12.5 16.8 11.0 10.2 4.1 3.3 11.4 8.8 13.2 10.5 8.2 4.9 16.0 5.8 3.7 10.4 9.2 5.6 6.9 8.3 1.9 3.6 4.8 16.3 13.8 4.5 11.9 4.6 6.2 4.5 3.5 4.3 8.1 1.8 1.7 6.0 3.5 6.0 2.4 4.1 5.6 10.1 7.0 6.7 2.8 22.2 6.0 3.2 7.3 10.6 2.1 10.3 4.3 7.0 6.7 2.7 3.4 15.5 11.4 20.4 6.8 14.8 45.0 6.5 2.5 3.4 2.5 7.0 4.2 6.0 4.2 5.3 4.3 3.2 5.6 16.8 4.8 10.7 3.2 6.8 3.4 9.5 2.5 2.1 8.6 7.8 2.5 3.3 14.0 10.2 11.0 12.5 4.1 3.3 6.5 6.6 5.7 7.2 5.3 4.8 7.5 5.2 6.2 6.6 11.9 32.1 21.6 5.5 4.6 11.5 26.6 25.5 5.3 6.8 15.7 9.8 22.3 16.6 9.3 2.6 7.4 10.3 0.0 9.7 18.5 6.6 11.2 8.1 213.4 8.4 25.4 10.9 11.6 11.9 3.1 11.5 11.3 5.0 13.6 19.6 10.8 9.7 10.5 11.3 55.4 18.7 12.9 5.0 5.6 3.6 5.3 11.3 7.1 15.0 6.2 DIABLO "DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC" ENSG00000284934 "Diablo IAP-binding mitochondrial protein" Q9NR28 12 122207662-122227534 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 17.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 21.4" HPA001825 Uncertain Approved Mitochondria NA NA 21000 Mitochondria "HPA001825: AB_1857247" 0.1 8.7 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.2 5.3 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 2.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.9 2.4 0.0 1.2 0.6 1.1 0.6 0.6 2.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.4 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.7 0.0 0.4 1.9 21.4 0.4 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.7 0.5 0.3 1.4 0.6 1.0 0.3 1.0 2.3 0.6 1.2 0.3 1.3 1.1 0.6 0.2 0.4 2.2 0.5 0.0 1.1 2.9 4.0 4.4 7.1 0.0 10.2 0.0 1.2 0.0 3.9 0.0 0.0 0.2 4.3 1.9 8.8 0.0 0.0 0.0 2.4 3.1 4.6 2.8 0.0 3.2 7.0 4.3 1.9 3.9 5.2 0.8 3.3 0.0 7.8 7.2 0.2 9.7 3.2 0.0 9.1 6.5 4.1 17.0 15.2 4.3 0.0 5.0 9.3 3.3 DIAPH1 "DFNA1, hDIA1, LFHL1" ENSG00000131504 "Diaphanous related formin 1" O60610 5 141515016-141619055 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing Actin-binding "Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 106.8" "Low region specificity" "Detected in all" "HPA004916, HPA076913" Approved Approved "Plasma membrane" NA NA 10000000 "Plasma membrane" "HPA004916: AB_1847668, HPA076913: " "unprognostic (6.79e-2)" "unprognostic (2.99e-1)" "unprognostic (2.12e-3)" "unprognostic (3.73e-2)" "unprognostic (4.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (4.54e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (7.81e-5)" "unprognostic (2.88e-3)" "prognostic favorable (1.29e-5)" "unprognostic (1.64e-2)" "unprognostic (1.84e-2)" "unprognostic (7.00e-2)" "unprognostic (1.65e-1)" 14.5 10.0 5.2 22.3 10.4 27.9 10.6 8.8 7.8 11.6 17.1 3.9 11.4 14.2 9.9 16.8 26.5 9.1 15.7 21.3 5.1 6.3 30.1 48.7 22.4 21.7 3.8 4.3 9.7 20.2 17.6 22.1 28.2 7.2 7.8 11.0 8.8 18.0 13.8 79.8 19.1 24.1 9.6 3.4 20.2 15.5 12.1 2.9 44.2 14.9 23.8 34.1 12.3 13.3 5.9 8.6 19.2 9.3 8.2 22.7 9.3 25.7 16.7 9.7 12.8 7.8 10.5 13.4 10.6 11.3 12.4 13.0 57.1 24.7 28.8 16.3 15.6 19.7 28.8 21.6 36.1 15.7 15.5 12.0 49.8 22.1 18.6 7.4 34.6 106.8 6.7 19.2 17.8 18.0 5.7 16.2 44.1 17.5 20.3 12.2 25.2 38.4 45.2 9.6 13.6 11.1 43.2 16.0 15.9 23.8 28.5 12.9 6.9 26.3 35.0 10.5 9.1 14.6 16.8 9.4 17.5 9.3 9.6 21.5 10.2 16.2 20.0 9.5 27.8 10.8 12.7 8.6 19.2 22.7 9.2 15.2 5.9 14.4 17.6 8.6 5.0 10.5 17.3 9.4 8.2 9.3 6.6 11.9 9.3 5.2 10.4 8.8 7.8 5.1 6.3 3.8 4.3 7.2 2.9 44.7 41.4 32.0 39.1 46.8 17.7 17.9 22.9 24.1 60.3 41.8 51.1 15.3 5.0 57.1 16.9 35.0 40.0 0.0 84.2 26.5 20.2 67.6 45.1 77.8 16.2 6.4 5.2 9.2 34.1 6.8 10.9 53.5 18.6 17.2 18.0 10.9 93.8 28.1 10.3 13.0 72.6 12.9 19.6 15.4 23.7 52.1 43.6 55.8 23.9 92.4 DIAPH3 "AN, AUNA1, DRF3, FLJ34705, NSDAN" ENSG00000139734 "Diaphanous related formin 3" Q9NSV4 13 59665583-60163987 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.2;testis: 19.6" "Cell type enriched" "Detected in many" 6 "Early spermatids: 290.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HBF TERT88: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA032151 Supported "Plasma membrane,Microtubules" NA Yes "Plasma membrane, Microtubules" "HPA032151: AB_2674181" "unprognostic (3.78e-2)" "unprognostic (1.28e-2)" "prognostic favorable (9.04e-4)" "prognostic unfavorable (4.18e-4)" "unprognostic (2.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.27e-4)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.74e-2)" "unprognostic (2.19e-1)" "unprognostic (5.22e-5)" "unprognostic (3.59e-3)" "unprognostic (5.31e-5)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "unprognostic (2.74e-3)" 1.8 0.4 1.7 11.5 1.8 6.7 1.6 0.1 1.4 0.9 4.7 0.2 0.4 2.0 1.4 1.1 7.1 0.3 2.5 1.1 1.0 1.6 1.7 0.4 4.1 2.9 1.0 0.0 0.4 0.4 0.5 0.2 9.4 0.2 0.4 2.3 0.0 1.6 0.0 0.1 1.8 4.3 2.7 0.3 2.5 3.1 19.6 0.0 35.2 0.2 5.3 5.9 0.8 1.5 0.4 2.0 0.4 0.2 0.0 0.5 0.2 18.3 6.1 6.4 3.6 1.1 2.9 10.8 25.7 11.4 26.0 22.7 16.2 12.5 6.1 2.1 13.1 6.8 12.6 10.3 10.1 39.7 6.9 7.1 8.8 15.7 3.6 1.7 11.9 7.0 1.1 0.2 15.8 10.7 6.6 11.6 5.6 6.7 8.8 24.7 2.6 10.6 5.1 5.9 8.7 3.5 7.2 15.7 5.0 8.5 3.8 3.3 5.8 13.1 9.1 3.9 14.3 6.6 6.5 11.5 16.5 10.6 5.5 21.2 5.9 6.5 9.6 4.4 5.9 12.4 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 2.0 0.5 0.2 1.7 1.8 0.1 1.4 1.0 1.6 1.0 0.0 0.2 0.0 50.6 4.3 0.8 0.3 3.3 0.0 0.4 2.5 0.0 2.3 0.0 0.0 8.7 5.0 0.6 290.3 0.7 1.3 23.3 3.7 26.7 3.3 0.3 0.0 0.4 5.2 0.0 0.0 2.5 0.6 34.3 0.6 1.2 0.0 0.0 1.1 2.3 1.3 0.0 0.0 3.1 0.0 0.0 0.0 34.2 17.3 1.0 6.1 0.9 1.7 0.6 DIO1 TXDI1 ENSG00000211452 "Iodothyronine deiodinase 1" P49895 1 53891239-53911086 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "kidney: 36.1;liver: 50.8;thyroid gland: 67.7" "Cell type enhanced" "Detected in some" 22 "Cholangiocytes: 17.8;Hepatocytes: 52.9;Proximal tubular cells: 83.0" "Group enriched" "Detected in many" 8 "liver cancer: 44.7;thyroid cancer: 43.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 26 "Hep G2: 17.0;SK-BR-3: 41.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.89e-2)" "unprognostic (4.86e-2)" "unprognostic (1.81e-2)" "unprognostic (1.21e-2)" "unprognostic (1.06e-1)" "unprognostic (2.68e-2)" "unprognostic (3.91e-3)" "unprognostic (6.96e-4)" "unprognostic (6.94e-2)" "unprognostic (4.83e-2)" "unprognostic (8.81e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-3)" "unprognostic (9.99e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (3.59e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 36.1 50.8 0.4 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 67.7 0.1 0.1 0.1 0.1 0.0 1.5 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.0 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 41.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 13.7 17.8 0.0 0.0 0.0 0.0 0.2 10.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 52.9 0.4 0.0 0.0 0.6 2.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 DIO2 "SelY, TXDI2" ENSG00000211448 "Iodothyronine deiodinase 2" Q92813 14 80197527-80387757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 67.7;thyroid gland: 128.7" "Group enriched" "Detected in many" 14 "Extravillous trophoblasts: 495.6;Muller glia cells: 220.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 26.7;fHDF/TERT166: 14.7;HeLa: 30.6;HHSteC: 15.2;SiHa: 55.9;SK-BR-3: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048002 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA048002: AB_2680230" "unprognostic (1.22e-1)" "unprognostic (1.69e-1)" "prognostic favorable (1.67e-4)" "prognostic favorable (4.62e-6)" "unprognostic (2.76e-1)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.17e-1)" "unprognostic (2.07e-1)" "unprognostic (8.78e-2)" "unprognostic (3.68e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-3)" "unprognostic (5.08e-2)" "unprognostic (3.43e-1)" "unprognostic (8.40e-2)" "unprognostic (7.15e-2)" 1.3 1.8 13.0 0.9 12.3 0.7 6.1 1.0 19.7 67.7 1.2 1.6 1.9 1.2 15.6 1.1 36.1 0.9 2.5 4.7 14.2 2.7 2.4 0.7 1.2 1.0 4.1 7.6 0.7 1.3 0.9 35.9 5.9 13.2 5.0 1.3 13.1 17.7 12.4 3.0 3.3 1.2 2.4 1.2 0.9 2.5 2.5 1.4 0.0 128.7 15.8 12.0 2.6 13.7 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.4 0.0 26.7 5.7 2.4 0.3 0.0 0.1 0.0 0.1 14.7 0.1 0.5 0.9 0.0 1.9 0.0 0.0 0.0 30.6 0.0 15.2 0.0 0.0 1.7 0.0 0.5 0.0 1.3 0.5 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.5 0.0 0.1 0.2 1.2 0.0 0.0 0.2 0.0 0.0 55.9 11.7 0.1 2.5 0.0 0.0 0.3 0.1 2.4 5.6 6.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 13.0 12.3 1.0 19.7 14.2 2.7 4.1 7.6 13.2 1.4 0.0 0.3 0.0 0.1 2.6 2.9 1.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 18.5 1.4 0.0 0.0 0.0 495.6 26.0 0.2 0.0 0.0 8.2 1.6 0.0 0.6 1.0 9.6 3.1 0.3 5.0 0.0 0.0 220.7 0.6 0.0 3.9 0.0 6.2 0.0 8.2 3.3 0.6 2.6 23.6 0.0 0.0 0.0 DIO3 TXDI3 ENSG00000197406 "Iodothyronine deiodinase 3" P55073 14 101561351-101563452 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 40.9;placenta: 17.6" "Group enriched" "Detected in some" 4 "Fibroblasts: 8.0;Leydig cells: 10.0;Muller glia cells: 6.6;Peritubular cells: 7.1;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "AF22: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073684 Supported Vesicles NA NA Vesicles "HPA073684: " "unprognostic (4.52e-3)" "unprognostic (1.80e-1)" "unprognostic (3.04e-3)" "unprognostic (3.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.24e-2)" "unprognostic (8.11e-2)" "unprognostic (2.58e-1)" "unprognostic (6.24e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-1)" "unprognostic (7.46e-5)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (1.11e-4)" "unprognostic (9.80e-3)" 4.5 0.2 0.2 1.7 1.8 0.0 3.5 0.1 0.8 40.9 1.6 0.1 1.0 0.0 3.4 2.2 1.9 3.5 2.9 1.6 0.7 0.0 0.9 2.7 1.4 7.1 0.1 0.1 9.2 4.1 0.0 0.6 17.6 0.3 1.6 0.4 12.6 0.8 2.5 2.2 1.9 0.7 0.9 0.1 2.5 0.7 1.0 0.1 0.1 3.6 1.1 0.4 6.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.1 0.6 0.7 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.1 0.0 0.9 0.0 0.0 2.1 8.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 1.0 0.0 6.6 0.6 0.0 7.1 0.0 0.1 0.0 1.2 0.0 0.0 0.1 23.7 0.0 0.0 0.1 DIRAS1 "Di-Ras1, GBTS1, RIG" ENSG00000176490 "DIRAS family GTPase 1" O95057 19 2714567-2721418 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 48.0;heart muscle: 52.0;parathyroid gland: 13.5" "Cell type enhanced" "Detected in some" 27 "Cardiomyocytes: 15.7;Distal tubular cells: 26.6;Horizontal cells: 84.2" "Cancer enhanced" "Detected in many" "glioma: 17.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 14 "memory B-cell: 1.2;naive B-cell: 1.4" "Lineage enriched" "Detected in single" 15 "B-cells: 1.4" "Cell line enhanced" "Detected in many" "HMC-1: 22.8;REH: 24.7;SH-SY5Y: 14.6;THP-1: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.43e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (4.19e-3)" "unprognostic (8.01e-3)" "unprognostic (2.68e-1)" "unprognostic (5.62e-2)" "unprognostic (3.60e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.00e-1)" "unprognostic (1.79e-3)" "unprognostic (5.47e-3)" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (6.91e-4)" 1.3 2.9 12.8 1.7 20.1 1.2 2.0 20.6 48.0 3.4 1.7 3.0 0.1 1.7 6.9 2.8 5.2 2.8 1.3 52.0 14.8 8.5 2.5 0.7 1.0 1.2 10.0 16.2 1.8 6.1 13.5 8.2 1.0 19.1 3.1 1.6 2.4 6.0 2.3 1.4 1.6 1.8 6.8 2.9 2.2 2.6 4.2 1.3 0.0 1.0 1.8 1.3 1.6 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.6 12.5 0.4 1.7 0.0 4.2 1.4 0.2 0.0 0.7 0.2 0.0 0.5 11.1 6.4 0.0 5.2 0.0 0.0 0.0 8.1 0.3 0.4 0.4 0.5 0.0 22.8 0.7 2.6 0.0 0.1 2.4 0.0 0.1 7.4 3.7 1.4 1.8 0.1 0.2 7.9 0.0 1.7 24.7 0.0 5.9 0.0 0.0 1.6 14.6 0.1 0.5 7.9 0.6 0.6 17.2 0.0 2.8 3.5 0.1 1.3 8.7 6.0 4.5 6.2 0.2 12.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 20.1 20.6 48.0 14.8 8.5 10.0 16.2 19.1 1.3 0.0 0.0 0.0 0.5 1.0 2.0 15.7 0.0 0.0 0.0 1.8 0.0 0.0 26.6 1.3 0.3 0.0 0.0 0.0 1.6 0.2 0.7 0.8 0.0 0.0 4.6 84.2 0.0 0.0 0.0 0.5 1.1 0.3 3.3 0.0 0.0 4.3 1.8 0.0 0.0 0.0 4.3 0.0 1.9 0.5 0.2 0.4 0.2 0.0 0.0 0.1 DIRAS2 "Di-Ras2, DKFZp761C07121" ENSG00000165023 "DIRAS family GTPase 2" Q96HU8 9 90609832-90643105 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 65.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 58.2;Horizontal cells: 66.7;Rod photoreceptor cells: 20.4" "Cancer enhanced" "Detected in many" "glioma: 5.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 12.5;EFO-21: 3.6;SCLC-21H: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.70e-1)" "unprognostic (6.02e-2)" "unprognostic (1.20e-3)" "unprognostic (4.39e-2)" "unprognostic (1.35e-1)" "unprognostic (6.57e-2)" "unprognostic (4.27e-5)" "unprognostic (3.94e-2)" "unprognostic (4.37e-2)" "unprognostic (9.75e-3)" "unprognostic (9.85e-3)" "unprognostic (1.86e-1)" "unprognostic (5.70e-2)" "unprognostic (2.14e-1)" "unprognostic (5.39e-1)" "unprognostic (2.64e-3)" "unprognostic (2.05e-1)" 0.9 2.8 6.1 0.9 24.5 1.1 1.4 64.5 65.3 8.5 1.1 2.1 0.0 2.4 1.1 1.1 0.9 1.2 4.6 0.8 13.6 5.4 1.4 1.0 0.9 1.0 4.3 23.0 0.8 1.8 3.3 0.6 1.3 3.9 0.9 0.9 2.2 2.1 1.1 0.8 1.5 2.7 0.9 6.2 1.0 1.7 1.0 0.9 0.0 2.9 0.0 0.8 0.8 0.3 1.9 1.0 1.9 1.6 1.6 0.9 0.4 0.1 1.4 12.5 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.1 0.6 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.3 0.2 0.4 0.0 0.2 2.3 0.3 0.0 0.1 0.0 0.4 0.1 0.1 1.0 0.1 0.6 0.3 0.1 0.3 0.1 0.2 0.2 0.2 0.2 1.8 1.6 1.6 0.7 0.3 0.4 0.8 0.8 0.6 0.2 1.9 0.9 0.9 1.9 1.6 0.6 1.0 0.2 0.4 6.1 24.5 64.5 41.4 13.6 5.4 4.3 23.0 3.9 0.9 0.0 0.0 0.0 0.0 0.1 58.2 0.4 5.1 0.0 0.0 3.5 2.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 66.7 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 8.5 0.0 0.0 0.0 0.6 20.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 DIRAS3 "ARHI, NOEY2" ENSG00000162595 "DIRAS family GTPase 3" O95661 1 68045896-68051631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9;ovary: 33.2;pituitary gland: 35.2" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 16.7;Distal tubular cells: 54.7;Exocrine glandular cells: 17.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 49.9" "Group enriched" "Detected in some" 18 "plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 20 "dendritic cells: 2.1;T-cells: 1.8" "Cell line enhanced" "Detected in some" "HHSteC: 7.5;HSkMC: 15.7;TIME: 9.7;U-251 MG: 7.9;U-87 MG: 15.2" "Low region specificity" "Detected in all" "HPA028483, HPA028557, HPA029384" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343" "prognostic favorable (9.21e-4)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (1.69e-2)" "unprognostic (1.15e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (2.31e-2)" "unprognostic (1.13e-1)" "unprognostic (7.86e-2)" "unprognostic (8.35e-2)" "unprognostic (4.33e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.34e-1)" "unprognostic (4.99e-1)" "unprognostic (1.24e-2)" "unprognostic (5.07e-3)" 1.0 10.2 2.0 0.2 49.9 0.0 2.4 0.9 2.9 2.3 1.6 1.0 0.0 3.4 1.2 5.4 1.3 1.3 5.9 5.7 1.3 8.7 3.2 4.5 2.3 0.0 1.3 1.1 33.2 9.9 8.8 35.2 0.0 17.3 2.3 0.1 2.4 1.3 1.1 1.0 1.1 1.2 0.3 1.7 1.2 1.9 2.4 0.5 0.0 1.6 0.3 0.1 1.2 1.9 0.0 2.1 0.0 0.0 0.0 1.8 0.0 0.0 1.3 1.4 0.0 4.8 3.6 0.5 4.0 1.4 0.3 1.1 0.0 0.7 0.0 0.2 4.2 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 7.5 0.0 0.0 15.7 0.1 0.6 0.0 0.0 0.9 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.0 0.1 0.5 0.1 0.0 9.7 0.0 0.4 0.2 7.9 2.5 0.0 0.0 15.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.8 0.0 2.0 49.9 0.9 2.9 1.3 8.7 1.3 1.1 17.3 0.5 0.0 2.6 0.0 16.7 2.9 0.6 4.8 10.2 1.4 3.4 3.5 9.8 0.7 54.7 2.0 0.0 0.6 0.0 0.0 17.0 0.1 10.6 3.2 0.0 2.6 0.1 0.0 15.5 1.8 0.0 0.0 6.4 0.2 5.0 0.0 0.3 0.7 3.6 0.0 1.4 5.0 5.6 0.0 2.6 0.0 0.2 2.5 0.3 0.0 0.6 2.1 DIRC1 ENSG00000174325 "Disrupted in renal carcinoma 1" Q969H9 2 188734155-188790104 "Disease related genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 5.9;gallbladder: 2.1" "Group enriched" "Detected in some" 7 "Early spermatids: 1.8;Late spermatids: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 24.7;HSkMC: 9.0" HPA068508 Approved Nucleoplasm NA NA Nucleoplasm "HPA068508: AB_2732783" "unprognostic (3.11e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (2.77e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (7.39e-4)" "unprognostic (6.95e-2)" 1.4 0.0 0.0 0.4 0.0 0.0 5.9 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 24.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 DIRC3 FLJ14199 ENSG00000231672 "Disrupted in renal carcinoma 3" 2 217284019-217756593 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.2;parathyroid gland: 5.2" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 6.3;Late spermatids: 7.6;Muller glia cells: 4.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.6;JURKAT: 2.4" NA NA "unprognostic (1.29e-2)" "unprognostic (2.16e-1)" "unprognostic (3.15e-1)" "unprognostic (5.44e-6)" "unprognostic (3.39e-2)" "unprognostic (2.72e-1)" "unprognostic (9.31e-4)" "unprognostic (9.87e-2)" "unprognostic (2.14e-1)" "unprognostic (5.36e-3)" "unprognostic (2.95e-1)" "unprognostic (3.20e-2)" "unprognostic (4.88e-6)" "unprognostic (8.05e-3)" "unprognostic (1.51e-1)" "unprognostic (8.99e-2)" "unprognostic (4.83e-1)" 0.6 0.9 5.2 1.4 4.8 0.2 0.6 0.5 7.2 1.1 0.6 1.4 0.0 0.2 0.6 2.1 0.6 0.5 1.5 0.9 4.0 0.9 0.5 0.5 0.5 0.7 0.7 5.4 0.9 0.5 5.2 3.9 0.7 1.7 0.6 0.2 0.3 0.5 0.6 0.5 0.6 0.5 0.4 1.4 0.5 0.5 2.4 1.7 0.0 0.9 0.0 0.4 0.7 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.8 0.5 7.2 4.0 0.9 0.7 5.4 1.7 1.7 0.0 0.0 0.0 0.0 0.1 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 1.0 6.3 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.2 7.6 1.7 0.0 0.0 0.0 0.0 4.2 0.1 0.0 1.4 0.2 0.2 0.0 1.4 0.9 0.7 0.1 0.1 0.0 0.0 0.0 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358235-40378639 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 37.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 15.6;Enterocytes: 12.9;Horizontal cells: 17.5;Mucus-secreting cells: 14.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 5.2;HaCaT: 8.1;SCLC-21H: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059903: AB_2684156" "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.8 2.5 9.0 1.5 7.6 1.3 0.6 37.2 14.5 0.7 4.0 1.0 0.0 3.4 0.9 0.9 0.7 1.1 1.1 0.8 9.0 7.0 0.5 0.7 0.9 1.5 2.9 14.0 1.3 1.4 0.6 2.8 1.0 11.4 0.8 3.9 0.3 1.2 1.8 0.8 1.3 3.0 1.4 2.0 1.1 3.9 2.4 1.8 0.0 3.4 0.0 0.6 1.2 0.4 0.9 1.1 2.9 0.4 1.1 0.6 0.2 1.5 0.6 0.4 2.5 0.1 0.1 0.9 0.2 0.1 1.0 1.5 2.3 0.7 0.2 1.7 0.9 5.2 8.1 0.3 1.3 0.6 0.2 0.5 0.4 0.5 0.1 0.0 0.5 1.5 1.8 0.0 0.3 0.2 0.3 0.5 0.9 0.6 1.0 1.3 0.3 0.2 0.4 0.4 2.0 1.1 0.2 0.4 0.5 0.3 2.1 16.7 2.4 0.3 0.2 0.2 0.5 0.4 0.2 0.5 1.2 0.9 0.2 0.2 0.3 0.2 0.3 0.4 0.7 2.3 2.1 0.4 0.5 0.6 0.3 0.4 0.5 0.4 0.4 0.2 0.9 0.5 0.6 2.9 1.1 0.4 1.1 0.4 0.2 9.0 7.6 37.2 14.5 9.0 7.0 2.9 14.0 11.4 1.8 3.0 5.1 0.0 2.0 0.0 15.6 1.4 2.5 4.0 7.9 3.5 9.8 0.2 0.0 0.3 0.9 1.0 12.9 0.0 0.3 0.2 0.8 1.1 8.1 0.0 0.8 17.5 9.2 0.6 0.0 1.5 1.1 0.9 0.0 0.0 14.1 1.7 0.2 2.9 0.0 0.0 7.2 0.0 0.4 4.2 6.6 0.0 0.2 0.0 4.8 1.0 DISP3 "KIAA1337, PTCHD2" ENSG00000204624 "Dispatched RND transporter family member 3" Q9P2K9 1 11479166-11537584 "Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Differentiation, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;testis: 7.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;NTERA-2: 3.4;SCLC-21H: 3.2;SH-SY5Y: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054579 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054579: AB_2682529" "unprognostic (4.93e-2)" "unprognostic (2.23e-2)" "unprognostic (1.61e-1)" "unprognostic (9.55e-3)" "unprognostic (1.80e-1)" "unprognostic (2.73e-1)" "unprognostic (6.12e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.08e-1)" "unprognostic (4.34e-3)" "unprognostic (4.86e-2)" "unprognostic (3.80e-2)" "unprognostic (3.88e-1)" "unprognostic (7.06e-2)" "unprognostic (1.79e-4)" "unprognostic (1.34e-1)" 0.9 1.9 7.3 1.1 10.0 0.9 0.9 4.1 17.4 0.9 1.0 9.0 0.0 1.3 1.1 0.9 0.8 1.0 0.8 0.8 7.3 5.7 0.9 0.8 0.9 1.2 4.0 6.5 0.9 1.6 0.8 4.2 0.8 5.1 1.6 0.9 5.4 0.9 0.8 0.8 0.8 1.3 1.0 2.1 1.1 1.2 7.5 6.8 0.0 0.9 0.0 1.0 0.9 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 7.9 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.8 0.0 2.0 0.0 0.2 3.2 11.0 2.4 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 10.0 4.1 12.9 7.3 5.7 4.0 6.5 5.1 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DIXDC1 "Dixin, KIAA1735" ENSG00000150764 "DIX domain containing 1" Q155Q3 11 111927144-112022584 "Predicted intracellular proteins" "Wnt signaling pathway" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.2" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 98.2;Horizontal cells: 114.4;Spermatocytes: 82.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "eosinophil: 8.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 23.4;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039658 Supported Cytosol NA NA Cytosol "HPA039658: AB_2676611" "unprognostic (1.93e-1)" "unprognostic (2.90e-2)" "unprognostic (8.93e-3)" "unprognostic (2.84e-1)" "unprognostic (2.98e-2)" "unprognostic (1.44e-1)" "unprognostic (2.37e-1)" "unprognostic (1.41e-1)" "unprognostic (7.23e-2)" "unprognostic (1.59e-1)" "unprognostic (7.85e-2)" "unprognostic (5.11e-2)" "prognostic favorable (6.89e-5)" "unprognostic (4.10e-2)" "unprognostic (2.11e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (4.19e-5)" 9.7 10.4 8.8 4.5 16.1 0.0 8.6 52.2 15.7 11.5 7.4 20.2 4.9 2.9 14.3 11.0 8.4 12.3 7.0 12.7 8.7 9.9 6.4 4.7 5.1 1.0 16.1 10.2 9.5 3.9 10.2 8.9 5.9 10.8 14.1 5.7 6.8 4.7 22.0 6.6 4.2 3.9 24.9 9.2 3.1 4.8 10.1 16.2 0.0 6.5 1.7 1.0 17.4 18.0 0.1 0.1 8.6 0.2 0.1 0.9 0.2 0.4 2.0 5.3 10.0 16.7 9.7 1.1 4.1 2.8 1.6 2.8 0.3 1.1 0.8 1.1 11.3 1.8 0.5 2.3 1.2 1.6 3.2 2.0 0.4 3.0 5.3 2.5 2.7 0.3 7.9 10.5 3.4 23.4 11.7 16.3 2.1 2.6 0.3 6.4 0.4 1.7 2.4 3.2 0.4 3.6 0.8 1.5 3.2 6.6 0.1 4.4 9.1 3.0 2.5 1.4 2.4 3.7 1.0 26.5 7.2 3.1 1.3 6.7 0.6 2.8 0.4 3.9 7.0 2.5 0.0 0.2 8.6 0.6 0.0 0.1 0.1 0.5 0.6 0.0 0.1 0.9 0.8 0.7 0.1 0.1 0.1 0.0 0.2 8.8 16.1 52.2 12.4 8.7 9.9 16.1 10.2 10.8 16.2 14.9 10.1 0.0 13.7 5.7 18.5 26.9 10.2 25.4 13.6 17.4 98.2 1.3 13.3 5.7 16.4 14.3 2.3 0.0 6.7 4.7 25.2 9.8 1.1 19.4 1.7 114.4 2.4 56.4 3.4 12.0 36.8 2.6 11.8 1.8 13.3 32.0 6.9 6.6 34.6 10.7 68.4 12.9 30.8 82.9 14.2 3.6 1.1 0.9 4.8 2.7 DKK1 "DKK-1, SK" ENSG00000107984 "Dickkopf WNT signaling pathway inhibitor 1" O94907 10 52314296-52318042 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 153.6" "Cell type enhanced" "Detected in many" 19 "Basal glandular cells: 400.3;Glandular cells: 95.5;Pancreatic endocrine cells: 113.3;Urothelial cells: 308.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "pons and medulla: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 113.4;BJ hTERT+: 62.2;CACO-2: 99.0;fHDF/TERT166: 156.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in female reproductive system" NA NA "unprognostic (5.65e-2)" "unprognostic (4.21e-2)" "unprognostic (7.09e-2)" "unprognostic (7.99e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.35e-8)" "unprognostic (7.93e-2)" "prognostic unfavorable (7.80e-6)" "unprognostic (1.54e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.81e-1)" "unprognostic (1.68e-1)" "unprognostic (7.47e-3)" "unprognostic (4.05e-1)" "unprognostic (1.19e-1)" "unprognostic (2.06e-2)" 15.6 0.1 0.5 0.3 0.4 0.0 4.0 0.4 0.6 26.2 0.3 0.6 1.8 0.1 2.1 0.5 5.3 0.1 2.8 0.6 0.8 1.7 0.5 0.2 0.6 0.3 0.7 0.3 0.9 0.1 0.1 0.2 153.6 15.2 4.2 0.1 0.7 1.6 1.3 0.6 11.7 0.2 1.2 0.2 0.4 0.8 1.6 0.4 0.1 0.2 0.1 0.5 10.6 7.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 30.3 21.3 0.0 3.2 15.5 3.1 0.0 113.4 62.2 39.0 20.8 99.0 6.4 0.0 0.1 156.8 9.5 24.3 0.0 12.9 37.1 0.0 0.0 0.0 0.4 2.5 3.3 0.0 0.0 3.1 1.6 8.4 50.0 2.0 3.5 0.0 0.0 0.0 25.6 13.1 0.0 0.0 0.0 1.3 54.5 0.0 3.5 0.0 14.9 2.5 0.0 34.8 10.2 0.1 1.6 0.0 0.1 0.0 7.8 0.0 0.0 34.2 20.6 0.0 0.0 0.0 0.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.6 0.8 1.7 0.7 0.3 15.2 0.4 23.8 0.0 0.0 400.3 4.7 0.1 0.4 0.0 1.4 1.2 0.0 0.0 3.4 0.0 3.5 1.1 0.3 0.4 0.0 3.6 4.7 77.0 95.5 4.6 0.0 8.5 0.0 0.0 1.8 0.0 0.4 0.0 0.8 0.0 0.0 0.3 5.8 113.3 0.0 0.0 0.0 0.3 0.0 1.4 0.2 0.9 2.8 7.0 0.0 0.4 308.8 DKK2 ENSG00000155011 "Dickkopf WNT signaling pathway inhibitor 2" Q9UBU2 4 106921802-107283806 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 21.7" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 6.8;Fibroblasts: 6.3;Hofbauer cells: 12.7;Ito cells: 4.9;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 3.0" "Lineage enriched" "Detected in single" 13 "T-cells: 3.0" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009727, HPA052611" Uncertain Supported "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "CAB009727: AB_2091492, HPA052611: AB_2732576" "unprognostic (3.14e-3)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (3.21e-2)" "unprognostic (9.75e-2)" "unprognostic (3.68e-1)" "unprognostic (1.04e-3)" "unprognostic (2.47e-2)" "unprognostic (5.11e-1)" "unprognostic (5.21e-2)" "unprognostic (3.21e-1)" "unprognostic (3.52e-1)" "unprognostic (1.32e-1)" "unprognostic (1.42e-1)" "unprognostic (6.86e-2)" "unprognostic (3.22e-1)" "unprognostic (4.58e-2)" 6.6 1.2 3.0 1.5 2.5 0.0 4.8 1.8 3.6 21.7 3.6 0.2 0.0 0.1 1.4 2.4 2.0 0.9 1.6 3.1 2.9 2.2 0.4 0.3 7.9 0.9 2.0 1.5 6.3 0.3 0.9 3.4 3.4 2.5 2.9 0.7 6.8 2.7 2.4 2.4 6.1 0.5 0.9 2.3 1.7 0.4 0.5 0.2 0.1 1.3 4.4 3.7 1.1 2.6 0.0 0.2 0.0 0.1 0.0 3.0 0.0 0.0 0.0 3.7 0.0 0.7 0.4 0.0 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.1 0.1 3.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.5 1.8 3.6 2.9 2.2 2.0 1.5 2.5 0.2 0.0 0.0 0.0 0.0 6.8 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 6.3 0.0 0.0 0.0 12.7 0.0 0.0 4.9 0.3 0.0 3.7 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 6.5 0.0 0.0 0.0 0.0 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11963106-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 94.7;heart muscle: 297.4" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 489.8;Muller glia cells: 1823.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 90 "T-cells: 8.9" "Cell line enhanced" "Detected in many" "BJ: 60.1;BJ hTERT+: 93.0;fHDF/TERT166: 87.0;hTERT-RPE1: 54.3;TIME: 49.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 15000000 Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 4.8 21.7 44.9 3.5 94.7 1.3 6.8 32.5 60.3 25.8 7.3 12.1 4.1 4.9 7.8 5.6 8.8 4.9 17.9 297.4 49.6 23.5 5.1 2.7 17.8 3.1 19.1 45.8 10.8 5.7 10.9 6.6 7.5 24.7 16.8 4.6 10.7 9.1 22.3 2.7 8.3 7.3 12.0 32.9 9.0 7.0 8.9 25.5 0.0 4.7 2.5 2.6 10.5 7.8 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.2 1.8 2.6 0.0 2.2 4.4 0.0 60.1 93.0 26.6 30.3 1.3 0.4 0.0 6.6 87.0 14.2 9.2 0.2 25.9 10.2 0.0 0.0 0.0 0.2 0.0 17.0 0.0 0.0 6.7 8.7 9.0 22.3 54.3 28.2 0.0 0.0 0.0 36.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 7.8 0.2 0.0 0.0 7.3 0.0 0.0 49.9 15.8 12.4 1.6 15.5 0.0 0.0 0.0 2.6 0.0 14.8 0.0 0.0 0.0 0.8 0.0 8.9 0.0 0.8 5.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 44.9 94.7 32.5 46.5 49.6 23.5 19.1 45.8 24.7 25.5 3.0 4.8 0.0 55.5 40.5 22.0 489.8 0.0 4.0 20.5 0.0 11.8 0.4 0.0 0.6 98.7 37.6 0.0 0.0 0.2 0.6 30.9 9.6 1.1 0.0 15.3 12.7 1.7 47.3 1.0 66.1 19.0 2.3 60.8 0.0 0.0 1823.0 1.0 0.0 54.1 0.0 52.9 187.5 74.5 0.5 1.3 12.9 0.7 4.9 0.1 2.6 DKK4 ENSG00000104371 "Dickkopf WNT signaling pathway inhibitor 4" Q9UBT3 8 42374068-42377232 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.6;gallbladder: 9.9" "Group enriched" "Detected in some" 10 "Basal glandular cells: 3.4;Early spermatids: 1.1;Glandular cells: 1.4;Pancreatic endocrine cells: 2.5;Spermatocytes: 1.2;Urothelial cells: 4.3" "Cancer enriched" "Detected in many" 20 "endometrial cancer: 174.4" "Region enhanced" "Detected in some" "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "OE19: 21.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052916 Uncertain "Secreted in other tissues" NA NA "HPA052916: AB_2681987" "unprognostic (1.64e-1)" "unprognostic (5.84e-2)" "unprognostic (1.97e-1)" "unprognostic (5.37e-3)" "unprognostic (3.23e-1)" "unprognostic (2.91e-2)" "unprognostic (2.13e-2)" "unprognostic (1.99e-1)" "unprognostic (6.80e-2)" "unprognostic (2.71e-2)" "unprognostic (1.63e-2)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (8.11e-2)" 0.2 0.0 0.1 0.1 0.1 0.2 1.6 2.8 0.1 2.3 0.1 0.1 0.1 5.1 1.6 2.3 10.6 0.7 9.9 0.1 0.1 1.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.5 1.4 0.0 0.1 1.7 1.9 0.2 0.2 0.9 0.5 0.1 0.1 2.2 2.9 0.1 1.8 0.1 5.9 1.6 2.5 4.3 0.7 0.7 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.1 0.1 2.8 0.1 0.1 1.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.3 DKKL1 "CT34, SGY-1" ENSG00000104901 "Dickkopf like acrosomal protein 1" Q9UK85 19 49361783-49375116 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 91.5" "Group enriched" "Detected in some" 39 "Early spermatids: 1802.9;Late spermatids: 1817.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.1" "Lineage enriched" "Detected in single" 42 "B-cells: 4.1" "Cell line enhanced" "Detected in many" "AF22: 7.3;AN3-CA: 13.8" "Group enriched" "Detected in many" 17 "amygdala: 27.1;basal ganglia: 15.6;cerebral cortex: 50.1;hippocampal formation: 25.1;olfactory region: 20.8" "Low region specificity" "Detected in all" "CAB025410, HPA047194" Enhanced Approved Vesicles "Secreted in male reproductive system" NA NA Vesicles "CAB025410: , HPA047194: AB_2679979" "unprognostic (1.64e-1)" "unprognostic (5.30e-1)" "unprognostic (5.39e-4)" "unprognostic (1.85e-4)" "unprognostic (3.79e-2)" "unprognostic (4.30e-2)" "unprognostic (5.52e-4)" "unprognostic (1.00e-1)" "unprognostic (6.76e-2)" "unprognostic (4.08e-1)" "unprognostic (1.90e-1)" "unprognostic (5.65e-2)" "unprognostic (2.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.13e-1)" "unprognostic (1.18e-1)" "unprognostic (5.57e-2)" 0.2 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.4 0.5 0.3 0.4 0.2 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 91.5 0.0 0.0 0.0 0.2 0.1 0.3 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.3 13.8 0.1 0.5 0.6 1.4 0.0 0.2 0.4 0.0 0.6 0.0 1.0 0.3 0.5 0.1 0.2 0.0 0.0 0.0 2.6 0.0 3.5 0.3 0.0 0.0 1.2 1.0 0.4 0.2 0.5 1.3 1.2 0.0 1.4 0.6 0.1 0.6 0.0 0.1 2.9 0.7 1.5 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.2 0.0 0.7 1.5 1.4 2.7 1.7 1.6 0.9 1.0 0.0 0.6 0.8 0.3 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 1802.9 1.0 0.0 0.0 0.5 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1817.6 15.5 0.0 1.7 0.0 0.1 2.2 0.4 0.0 11.3 0.0 0.1 6.5 0.3 46.8 10.9 0.0 0.0 0.0 0.0 0.1 DLAT "DLTA, PDC-E2" ENSG00000150768 "Dihydrolipoamide S-acetyltransferase" P10515 11 112024814-112064390 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 55.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 95.8;Distal tubular cells: 63.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003782, HPA040786, HPA062766" Supported Supported Mitochondria NA NA Mitochondria "CAB003782: , HPA040786: AB_2677136, HPA062766: AB_2684864" "unprognostic (4.57e-3)" "unprognostic (1.75e-1)" "prognostic favorable (6.19e-6)" "unprognostic (7.68e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (8.68e-2)" "unprognostic (5.36e-2)" "unprognostic (2.93e-1)" "unprognostic (2.23e-3)" "unprognostic (6.25e-2)" "prognostic favorable (1.95e-14)" "unprognostic (5.82e-2)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (6.15e-2)" 14.1 10.7 10.6 8.8 11.9 4.8 10.9 10.5 14.2 6.7 13.3 6.3 7.8 12.4 6.3 8.1 12.2 7.2 6.4 55.4 10.4 13.5 19.1 12.0 6.6 8.7 11.2 9.7 7.9 6.0 15.8 7.8 8.3 13.0 8.3 13.5 7.6 10.4 9.9 41.0 7.2 13.0 6.6 7.3 6.9 8.1 7.3 4.2 12.7 10.7 22.1 8.8 7.5 6.7 9.2 9.1 7.9 8.9 7.2 10.3 8.0 6.1 6.2 8.3 11.0 11.6 8.7 9.9 8.5 4.9 9.4 10.7 19.7 18.2 25.3 16.7 7.7 12.8 13.3 17.2 9.1 10.7 9.1 10.8 16.1 6.6 12.1 8.3 20.3 9.2 10.5 10.0 9.4 9.5 7.2 8.5 12.5 26.2 12.1 11.0 4.8 9.2 24.3 9.7 15.8 12.1 14.3 11.2 28.5 17.2 6.5 15.9 9.7 10.2 28.9 6.4 9.9 21.4 12.6 5.7 9.4 10.2 9.4 10.9 4.0 6.3 38.4 2.6 22.2 7.3 7.9 6.6 4.7 8.3 8.9 9.5 9.2 8.2 8.9 9.1 7.5 10.3 8.3 0.5 7.2 8.9 7.4 8.8 8.0 10.6 11.9 10.5 14.2 10.4 13.5 11.2 9.7 13.0 4.2 11.9 12.6 16.4 7.1 10.0 7.6 95.8 12.7 32.1 7.9 10.4 0.0 17.8 63.0 16.0 3.0 8.3 19.1 0.0 10.1 34.1 8.5 6.3 3.5 14.3 16.4 7.9 16.6 5.5 12.3 2.3 5.8 7.9 16.9 18.0 18.5 8.6 12.5 3.5 10.3 29.2 10.5 0.0 11.3 21.6 15.8 8.5 14.5 8.6 24.8 9.1 DLEC1 "CFAP81, DLC1" ENSG00000008226 "Deleted in lung and esophageal cancer 1" Q9Y238 3 38039205-38124025 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.1;fallopian tube: 23.2;testis: 28.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 68.3;Club cells: 21.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019077 Enhanced Supported Cytosol NA NA Cytosol "HPA019077: AB_1847724" "unprognostic (1.24e-4)" "unprognostic (3.60e-3)" "unprognostic (2.11e-1)" "unprognostic (1.09e-3)" "unprognostic (2.32e-1)" "unprognostic (1.76e-3)" "unprognostic (2.50e-3)" "unprognostic (8.54e-3)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (9.53e-2)" "unprognostic (7.62e-2)" "unprognostic (8.70e-4)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.94e-4)" 0.8 0.3 1.3 0.7 8.3 1.1 0.5 0.0 0.6 3.3 0.6 6.1 3.5 0.7 1.1 21.1 0.3 23.2 1.3 0.3 1.7 2.5 0.3 0.3 10.0 1.7 0.5 0.2 6.3 0.2 0.6 14.2 0.3 9.8 0.8 0.6 0.8 0.6 1.8 0.2 0.7 0.7 0.3 0.6 0.7 0.6 28.9 1.7 0.0 0.8 0.0 0.6 0.4 0.1 0.2 0.1 0.9 0.4 0.1 1.1 0.1 0.1 0.0 1.1 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.3 0.0 0.4 0.2 0.1 3.4 0.5 0.0 0.0 0.0 0.2 0.1 2.8 0.5 0.2 0.3 1.7 0.5 0.2 0.1 0.3 0.0 0.0 0.5 0.3 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.8 0.2 0.4 0.2 1.1 0.0 0.1 0.1 0.2 0.0 0.9 0.1 0.1 0.1 0.2 0.1 1.3 8.3 0.0 0.6 1.7 2.5 0.5 0.2 9.8 1.7 3.0 4.8 0.0 0.6 0.5 1.1 0.6 0.0 68.3 21.6 0.0 0.0 0.1 0.0 0.1 2.7 0.3 0.7 0.0 0.2 0.1 0.6 0.5 2.3 0.2 0.4 0.0 1.2 0.0 0.0 4.3 0.9 0.9 0.0 1.0 0.4 0.1 0.1 0.8 0.0 0.0 0.5 0.0 0.2 8.4 1.0 0.3 0.1 0.5 0.0 0.4 DLEU7 FLJ44882 ENSG00000186047 "Deleted in lymphocytic leukemia, 7" Q6UYE1 13 50711008-50843939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 13.2" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 13.2;Hofbauer cells: 6.2;Kupffer cells: 30.1;Macrophages: 7.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "intermediate monocyte: 1.5;naive B-cell: 1.3;neutrophil: 1.2;T-reg: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "NTERA-2: 15.4;U-698: 6.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA053750 Uncertain NA NA "HPA053750: AB_2682249" "unprognostic (3.97e-2)" "unprognostic (2.53e-1)" "unprognostic (7.03e-2)" "unprognostic (9.31e-2)" "unprognostic (3.08e-1)" "unprognostic (1.08e-1)" "unprognostic (4.47e-3)" "unprognostic (1.09e-1)" "unprognostic (1.24e-1)" "unprognostic (8.75e-3)" "unprognostic (1.23e-1)" "unprognostic (1.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.59e-1)" "unprognostic (4.52e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" 0.7 1.0 4.8 0.8 7.8 0.5 0.5 5.8 13.2 0.6 0.7 0.5 0.0 0.6 0.8 3.0 0.5 0.5 0.4 0.5 4.6 5.7 1.4 0.5 0.5 0.4 3.7 4.2 0.6 0.7 0.4 0.1 0.5 4.1 0.7 0.8 0.0 0.4 0.5 0.5 1.0 0.8 0.5 1.2 0.8 0.5 0.9 0.8 1.3 1.9 0.0 0.5 0.4 0.1 1.3 0.0 1.2 1.5 0.0 1.4 0.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 15.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 1.2 0.0 0.0 0.0 1.4 0.7 4.8 7.8 5.8 9.9 4.6 5.7 3.7 4.2 4.1 0.8 0.0 0.3 0.0 0.0 0.0 13.2 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 30.1 0.0 0.0 7.8 0.0 1.8 0.0 0.2 0.0 0.0 1.4 0.5 1.8 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 223.8;Cone photoreceptor cells: 259.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 7.5;CACO-2: 4.7;NTERA-2: 5.2;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.7;SuSa: 6.6;T-47d: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353" "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.4 11.0 20.0 1.4 30.7 0.7 2.5 9.3 44.7 2.4 1.7 39.5 0.6 1.5 3.3 4.4 7.8 6.0 2.3 2.8 19.9 9.9 3.7 2.8 1.9 1.3 28.7 21.2 6.2 3.3 14.6 7.9 2.7 25.7 4.3 1.5 2.9 3.1 5.4 1.2 19.5 1.5 2.6 19.7 2.6 1.5 6.6 37.3 0.0 15.6 0.0 2.9 1.5 2.1 1.3 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.1 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 5.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 5.2 7.8 0.0 4.7 0.0 6.6 19.3 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 20.0 30.7 9.3 34.9 19.9 9.9 28.7 21.2 25.7 37.3 3.0 7.2 0.0 3.1 3.0 223.8 7.2 0.0 1.4 3.4 7.0 259.2 6.2 8.3 0.7 16.5 2.8 0.9 0.0 0.4 0.4 3.3 2.5 0.0 3.8 3.0 22.3 4.1 0.6 0.3 12.1 7.2 0.0 1.7 1.0 0.1 17.1 0.3 0.0 6.0 2.3 52.8 6.5 1.9 8.1 3.3 7.4 1.7 1.0 0.4 0.9 DLG4 "PSD-95, PSD95, SAP-90, SAP90" ENSG00000132535 "Discs large MAGUK scaffold protein 4" P78352 17 7189890-7219702 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 83.2" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 35.6;Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 30.9;hTERT-RPE1: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001999, CAB002000, HPA010122" Enhanced "Intracellular and membrane" NA NA "CAB001999: , CAB002000: , HPA010122: AB_1855169" "unprognostic (7.08e-2)" "unprognostic (1.06e-2)" "unprognostic (3.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.23e-2)" "unprognostic (1.80e-1)" "unprognostic (7.18e-3)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (2.72e-2)" "prognostic favorable (8.82e-6)" "unprognostic (3.45e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.12e-2)" "unprognostic (2.83e-2)" "unprognostic (3.68e-2)" "unprognostic (4.77e-3)" 5.5 16.0 58.3 7.5 73.3 4.1 4.5 47.4 83.2 9.7 4.1 5.4 4.3 4.7 13.8 5.0 5.0 9.2 10.7 8.9 58.7 24.2 3.3 3.1 6.0 4.2 14.4 53.9 12.8 4.6 11.5 15.1 8.7 14.8 7.3 3.8 3.1 6.3 12.5 3.6 4.0 4.4 10.7 11.3 7.8 5.7 10.1 17.0 1.7 5.8 0.0 3.5 7.0 4.2 0.0 1.6 0.0 0.9 0.0 1.6 0.6 0.2 7.4 18.5 6.2 7.1 10.5 0.5 9.7 8.5 7.3 7.0 0.3 3.0 1.3 4.3 8.4 0.9 0.7 1.0 3.9 3.6 9.6 1.9 5.5 13.3 0.9 6.0 0.1 30.9 11.6 0.4 6.2 6.3 28.1 8.6 7.7 2.2 4.9 10.9 0.2 4.2 3.3 2.6 0.2 0.5 7.6 0.7 0.7 5.3 0.2 7.6 6.0 0.2 0.4 1.1 3.3 4.4 3.5 10.5 17.6 8.5 3.5 5.1 0.8 0.5 0.7 13.2 3.5 5.4 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.3 0.1 0.0 0.0 0.1 1.6 0.0 0.6 58.3 73.3 47.4 71.2 58.7 24.2 14.4 53.9 14.8 17.0 0.0 1.0 3.7 1.7 2.4 35.6 3.1 2.5 1.4 2.3 3.5 96.2 0.4 0.0 0.7 1.5 5.0 0.3 0.0 0.2 0.4 6.2 1.4 6.9 1.5 3.3 19.1 14.5 5.5 10.2 0.9 6.6 5.5 3.3 1.8 0.7 6.0 0.3 0.0 9.6 0.0 58.6 0.0 2.3 6.5 1.9 1.6 0.5 0.5 0.6 0.7 DLGAP1 "DAP-1, GKAP, SAPAP1" ENSG00000170579 "DLG associated protein 1" O14490 18 3496032-4455335 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 16.0;Early spermatids: 8.3;Late spermatids: 10.7;Melanocytes: 11.8;Spermatocytes: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.0" "Lineage enhanced" "Detected in single" "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "Daudi: 14.6;HAP1: 5.2;U-2197: 4.6;U-87 MG: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.50e-3)" "unprognostic (7.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.98e-1)" "unprognostic (1.07e-2)" "unprognostic (3.63e-3)" "unprognostic (2.73e-2)" "unprognostic (1.97e-2)" "unprognostic (2.93e-3)" "unprognostic (5.49e-3)" "unprognostic (5.87e-4)" "unprognostic (2.18e-1)" "unprognostic (2.78e-3)" "unprognostic (3.10e-2)" "unprognostic (4.93e-3)" "unprognostic (8.93e-2)" "unprognostic (9.68e-2)" 1.0 5.1 18.3 1.0 22.6 0.8 2.4 25.9 55.9 1.4 1.0 1.3 4.1 0.9 1.6 9.0 1.0 7.1 4.8 1.2 17.2 4.7 1.4 0.9 1.4 1.0 4.2 20.8 2.7 1.0 0.8 2.0 1.4 6.1 3.8 1.0 0.0 2.4 11.4 0.9 1.0 0.9 1.1 2.2 1.3 0.9 4.3 1.6 0.0 1.3 0.0 0.9 0.9 0.7 0.5 0.0 2.0 0.0 0.0 0.1 0.2 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 14.6 0.0 0.3 1.5 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.4 0.0 1.3 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.7 0.0 2.0 1.2 1.7 0.0 0.2 0.0 1.1 0.2 0.0 0.0 0.0 0.0 1.4 4.6 0.0 0.4 0.0 0.2 3.4 0.0 1.3 0.9 0.0 2.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 18.3 22.6 25.9 40.3 17.2 4.7 4.2 20.8 6.1 1.6 0.0 2.9 0.0 0.2 0.7 16.0 2.2 5.1 5.3 0.0 1.8 0.0 0.1 0.0 0.0 8.3 0.7 0.0 0.0 0.2 0.0 1.5 3.3 0.0 0.0 0.2 0.0 2.9 1.3 0.0 10.7 0.6 0.0 11.8 0.0 1.2 0.2 0.3 0.0 0.4 2.9 1.2 0.0 0.4 9.3 4.3 0.1 0.2 0.0 0.0 0.0 DLGAP2 "C8orf68, DAP-2, ERICH1-AS1" ENSG00000198010 "DLG associated protein 2" Q9P1A6 8 737596-1708474 "Nuclear receptors, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.3;testis: 12.5" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 15.7;Early spermatids: 52.5;Horizontal cells: 38.1;Late spermatids: 20.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "NTERA-2: 2.0;REH: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030320 Uncertain NA NA "HPA030320: AB_10600904" "unprognostic (8.86e-2)" "unprognostic (2.32e-1)" "unprognostic (5.32e-1)" "unprognostic (1.33e-1)" "unprognostic (5.42e-2)" "unprognostic (1.23e-3)" "unprognostic (1.07e-1)" "unprognostic (2.71e-2)" "unprognostic (5.01e-2)" "unprognostic (2.16e-2)" "unprognostic (1.90e-3)" "unprognostic (2.53e-1)" "unprognostic (1.04e-1)" "unprognostic (2.05e-3)" "unprognostic (1.96e-1)" "unprognostic (3.85e-1)" "unprognostic (3.81e-1)" 0.8 1.0 7.5 0.8 14.9 0.9 0.8 0.4 15.3 1.3 0.7 0.0 0.3 0.7 0.7 1.5 0.7 0.7 0.6 0.7 8.0 3.1 2.0 0.8 0.7 0.9 1.1 8.9 0.7 0.6 0.6 3.4 0.8 0.7 0.8 0.6 0.0 0.8 0.9 0.6 1.5 0.7 0.7 0.6 0.9 0.6 12.5 1.2 0.0 1.6 0.0 0.8 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 14.9 0.4 15.3 8.0 3.1 1.1 8.9 0.7 1.2 0.0 0.0 0.0 0.2 0.3 3.5 0.8 0.0 1.4 3.4 0.0 15.7 0.0 1.7 0.1 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 38.1 0.0 0.0 0.0 20.9 0.9 0.0 1.7 0.0 0.0 1.5 0.0 0.0 0.0 2.4 2.6 0.0 0.0 3.2 5.8 0.1 0.0 0.0 0.0 0.0 DLGAP3 "DAP3, SAPAP3" ENSG00000116544 "DLG associated protein 3" O95886 1 34865436-34929585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.7" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.5;Hofbauer cells: 7.8;Horizontal cells: 20.6;Late spermatids: 13.7" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 9.6;NTERA-2: 5.2;SCLC-21H: 15.5;SH-SY5Y: 3.0" "Group enriched" "Detected in all" 4 "amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9" "Low region specificity" "Detected in all" "HPA026445, HPA027304" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Midbody" NA NA "Endoplasmic reticulum" "Plasma membrane, Midbody" "HPA026445: AB_1847733, HPA027304: " "unprognostic (8.63e-2)" "unprognostic (8.58e-2)" "unprognostic (1.48e-1)" "unprognostic (5.77e-7)" "unprognostic (4.01e-2)" "unprognostic (5.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.69e-1)" "unprognostic (1.27e-4)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (6.12e-2)" "unprognostic (1.47e-1)" "unprognostic (2.26e-1)" "unprognostic (2.21e-1)" 1.3 1.5 17.4 1.8 20.0 2.8 1.1 14.6 28.7 0.9 1.2 3.3 0.0 1.4 1.0 1.0 0.9 1.0 1.1 1.0 17.7 5.5 1.3 1.0 1.1 1.4 5.4 9.6 1.0 2.2 1.0 1.9 1.0 2.3 1.0 1.0 0.7 1.1 1.5 1.0 1.1 1.3 1.0 1.1 2.5 1.3 6.7 5.0 0.0 1.0 0.0 1.2 1.0 0.0 0.3 3.2 0.4 2.3 0.1 0.8 0.9 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 9.6 0.2 0.0 1.2 0.0 1.6 0.0 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.6 0.0 0.0 5.2 0.0 0.0 0.5 0.0 0.2 0.0 0.5 15.5 3.0 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 1.7 0.0 0.0 0.2 0.3 1.9 0.1 0.1 0.1 0.4 2.3 0.0 0.2 1.4 0.8 0.3 0.5 0.5 3.2 0.3 0.2 0.8 0.0 0.1 0.1 0.9 0.7 0.9 17.4 20.0 14.6 22.4 17.7 5.5 5.4 9.6 2.3 5.0 0.0 0.0 0.0 0.6 0.2 4.0 1.1 0.0 0.0 0.0 1.8 3.9 0.1 3.3 0.4 11.5 0.1 0.8 0.0 0.5 0.2 0.2 0.2 0.0 0.0 7.8 20.6 1.2 0.0 7.3 13.7 0.9 1.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.7 2.2 0.0 0.1 2.7 3.4 0.3 0.0 0.8 0.7 0.1 DLGAP5 "DLG1, DLG7, HURP, KIAA0008" ENSG00000126787 "DLG associated protein 5" Q15398 14 55148112-55191678 "Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.1" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 140.2;Spermatocytes: 61.2;Spermatogonia: 32.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 8.3" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005546 Enhanced Supported "Centriolar satellite,Cytosol" Yes Yes "Centriolar satellite, Cytosol" "HPA005546: AB_1078677" "unprognostic (2.24e-1)" "unprognostic (1.77e-1)" "unprognostic (1.19e-3)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.42e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.52e-6)" "prognostic unfavorable (7.85e-4)" "unprognostic (6.15e-3)" "unprognostic (3.55e-1)" "prognostic unfavorable (9.94e-6)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.06e-2)" "unprognostic (3.64e-1)" "unprognostic (1.29e-1)" "unprognostic (1.93e-2)" 1.4 0.9 0.3 11.4 0.4 16.2 0.5 0.3 0.5 1.3 3.3 0.2 0.2 2.9 0.9 1.0 8.7 0.3 1.3 0.7 0.2 0.3 1.1 0.8 2.1 10.6 0.3 0.2 0.7 0.4 0.0 0.3 3.3 0.3 0.5 4.1 0.3 1.5 0.2 0.5 1.9 4.1 1.3 0.3 6.6 2.2 13.0 0.2 65.1 0.4 6.4 11.4 1.7 2.4 1.1 0.4 0.4 0.0 1.3 8.3 1.2 37.6 15.0 39.4 17.7 0.9 3.9 12.2 21.9 14.5 32.4 30.9 12.2 20.8 21.9 12.1 12.7 13.0 23.4 25.2 17.5 42.6 26.4 12.4 22.5 14.1 10.5 0.1 22.0 13.8 0.8 0.6 15.2 7.3 5.2 35.6 22.5 18.2 22.0 30.1 18.1 27.7 11.2 20.3 16.8 15.6 21.7 38.1 10.1 10.6 12.2 20.1 11.3 23.3 8.8 8.6 17.5 19.6 8.2 13.8 14.5 38.0 14.0 25.1 5.4 11.7 29.1 10.1 15.7 23.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.1 2.3 0.4 0.1 0.5 0.2 0.4 1.3 0.0 0.0 8.3 1.2 0.3 0.4 0.3 0.5 0.2 0.3 0.3 0.2 0.3 0.2 0.0 0.3 8.5 0.2 1.0 0.0 0.3 0.0 1.4 1.2 0.0 0.0 1.3 0.0 0.4 10.7 0.0 0.2 140.2 0.0 19.8 1.0 0.2 0.0 0.8 8.6 0.0 0.0 1.8 4.5 4.6 0.9 2.2 0.0 0.0 1.3 0.0 0.1 0.0 1.1 0.0 0.0 6.5 0.0 61.2 32.3 0.4 1.6 1.5 2.5 1.1 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9" "Group enriched" "Detected in many" 5 "Exocrine glandular cells: 527.9;Leydig cells: 1256.4" "Cancer enhanced" "Detected in many" "liver cancer: 28.1" "Group enriched" "Detected in some" 5 "hypothalamus: 2.6;pons and medulla: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 23.1;Hep G2: 77.0;SH-SY5Y: 91.7" "Region enhanced" "Detected in some" "hypothalamus: 65.4" "Region enhanced" "Detected in many" "midbrain: 159.6" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" NA NA 160000 "Golgi apparatus" "CAB005872: AB_731965, HPA062262: AB_2684729" "unprognostic (2.16e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 0.3 157.6 0.2 0.7 0.8 0.0 0.9 0.0 0.1 0.5 0.0 1.8 0.2 0.2 0.2 4.4 0.3 0.3 0.8 2.7 0.1 2.6 0.1 0.1 0.1 0.1 0.8 0.0 34.9 4.6 0.0 143.1 244.9 6.0 0.2 0.0 0.2 8.2 0.0 2.0 0.1 0.2 0.2 0.3 0.2 0.2 14.2 0.0 0.5 0.0 10.0 1.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 77.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.5 91.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.8 0.0 0.0 0.1 2.6 0.8 0.0 6.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 52.1 0.0 2.9 4.0 0.0 0.0 0.0 527.9 35.4 1.3 0.5 0.0 0.0 73.1 0.0 0.0 0.0 0.0 11.5 1256.4 0.0 0.0 0.0 0.0 0.0 6.5 0.0 162.3 0.0 0.0 58.2 0.0 6.5 56.6 0.4 88.4 0.0 0.0 0.1 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell type enriched" "Detected in some" 7 "Basal glandular cells: 79.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles No No Nucleoplasm "Nucleoli, Vesicles" "HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.2 1.9 0.5 7.9 0.0 0.4 1.8 1.9 2.1 2.2 1.0 1.8 0.2 1.0 1.2 0.4 2.7 16.5 5.6 9.0 0.5 1.0 2.1 0.4 0.9 2.8 0.6 0.3 1.1 0.9 27.2 0.6 5.1 0.7 0.0 3.1 0.4 0.8 0.8 2.0 0.4 0.4 0.7 2.0 2.0 1.1 1.0 0.5 0.3 1.8 5.9 0.6 0.6 0.2 0.3 0.4 0.5 1.6 0.5 0.8 2.5 0.6 3.8 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 0.0 0.3 0.0 79.5 9.0 0.6 0.5 0.0 0.0 7.9 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.0 0.0 0.0 2.1 0.2 4.3 0.0 0.0 0.1 11.1 1.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.9 0.0 0.3 1.2 5.5 2.3 0.2 0.0 0.0 3.9 DLL1 ENSG00000198719 "Delta like canonical Notch ligand 1" O00548 6 170282206-170306565 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 59.4;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 7.3" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;HBEC3-KT: 10.8;NB-4: 17.8;THP-1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078298 Uncertain Nucleoplasm NA NA 210000 Nucleoplasm "HPA078298: " "unprognostic (1.03e-1)" "unprognostic (9.22e-2)" "unprognostic (2.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.89e-2)" "unprognostic (6.35e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-1)" "unprognostic (9.22e-2)" "unprognostic (1.14e-2)" "unprognostic (1.39e-2)" "unprognostic (2.64e-2)" "unprognostic (5.23e-3)" "unprognostic (3.50e-1)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.66e-1)" 8.9 5.7 4.1 5.5 9.0 3.2 8.6 2.5 13.8 7.4 10.3 18.5 2.6 8.1 6.0 3.0 11.1 5.7 11.4 7.2 5.2 4.0 5.8 13.5 6.8 5.6 5.5 5.2 2.5 13.8 2.2 3.1 5.0 10.0 14.5 5.2 14.3 8.9 7.1 3.8 14.3 13.1 3.9 4.6 36.9 5.9 1.6 7.3 0.9 6.1 5.3 6.3 4.5 11.0 0.0 0.0 0.1 0.9 7.3 0.5 0.2 0.9 0.1 4.3 2.7 0.3 0.2 2.3 0.2 0.6 0.3 0.5 1.1 0.1 0.0 0.2 0.1 0.7 7.0 2.7 10.8 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 3.1 0.1 2.0 0.0 1.1 0.2 1.1 0.1 0.0 0.0 0.4 3.0 0.0 17.8 0.6 0.4 0.0 0.8 4.3 0.1 0.0 1.3 1.9 0.1 0.3 0.0 0.0 1.6 0.7 14.7 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.3 0.1 7.3 0.9 0.0 0.0 0.2 4.1 9.0 2.5 11.2 5.2 4.0 5.5 5.2 10.0 7.3 0.0 0.3 0.0 15.5 59.4 0.7 4.6 0.0 10.7 10.3 1.8 21.6 2.4 0.0 0.3 0.3 18.9 1.6 0.0 1.5 5.2 8.9 3.8 5.7 0.0 1.0 0.0 49.7 20.9 3.9 1.2 0.3 2.5 6.8 0.0 76.5 1.0 0.9 2.9 1.1 0.0 0.6 12.9 9.0 0.5 1.9 11.2 3.1 0.0 2.6 0.9 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 37.2" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 42.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA056533 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 2.0 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 2.0 0.0 0.8 0.0 1.2 0.5 0.1 0.6 3.1 0.1 0.0 0.2 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.0 3.2 0.3 0.1 0.1 0.1 0.1 7.4 7.6 1.5 0.0 42.1 0.1 0.0 0.1 0.0 0.0 1.4 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 2.9 0.0 0.0 1.6 1.1 0.0 1.7 0.0 0.0 0.5 0.2 0.0 1.4 0.0 0.6 6.5 0.0 5.4 37.2 0.1 0.2 0.0 0.0 0.0 DLX1 ENSG00000144355 "Distal-less homeobox 1" P56177 2 172084740-172089677 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 4.7;brain: 17.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "prostate cancer: 11.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in many" "AN3-CA: 48.7;U-138 MG: 13.0;WM-115: 14.4" "Group enriched" "Detected in many" 5 "basal ganglia: 29.8;olfactory region: 101.7" "Region enriched" "Detected in many" 5 "olfactory region: 106.7" HPA045884 Approved NA NA "HPA045884: AB_10960361" "unprognostic (2.14e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (7.92e-3)" "unprognostic (8.86e-2)" "unprognostic (2.80e-2)" "unprognostic (2.03e-1)" "unprognostic (5.74e-2)" "unprognostic (2.04e-1)" "unprognostic (7.40e-9)" "unprognostic (2.22e-1)" "unprognostic (9.19e-2)" "unprognostic (1.25e-1)" "unprognostic (5.91e-3)" 0.6 4.7 8.9 1.0 7.4 0.4 0.9 0.1 15.5 0.4 1.2 0.5 0.0 0.4 0.4 0.4 0.6 0.4 0.8 0.6 5.5 17.3 0.4 0.5 0.4 0.5 0.8 9.5 0.6 0.5 0.6 0.1 0.4 0.0 2.2 1.3 0.1 0.9 0.7 0.4 0.6 0.8 0.8 0.2 0.4 0.5 0.6 1.4 0.0 1.6 0.4 1.3 0.5 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.2 48.7 0.7 1.5 0.1 1.3 2.2 2.5 1.3 0.4 0.1 0.0 2.9 2.4 2.7 3.6 2.7 0.5 1.9 0.1 12.2 7.3 5.4 1.9 0.0 3.0 6.0 0.0 0.9 0.6 1.0 1.9 0.0 2.4 4.2 0.0 2.1 2.6 0.0 0.8 0.0 0.0 8.5 0.1 6.2 0.0 0.4 1.6 4.2 0.0 2.2 0.2 6.2 0.2 1.9 3.6 2.6 13.0 0.0 6.3 6.1 0.0 0.0 0.0 5.5 7.5 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 8.9 7.4 0.1 15.5 5.5 17.3 0.8 9.5 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DLX2 TES-1 ENSG00000115844 "Distal-less homeobox 2" Q07687 2 172099439-172102900 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.9" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 1.5;Early spermatids: 4.3;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AN3-CA: 39.6;HEK 293: 25.2" "Group enriched" "Detected in many" 4 "basal ganglia: 13.8;olfactory region: 36.1" "Region enriched" "Detected in many" 5 "olfactory region: 43.5" HPA056965 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056965: AB_2683291" "unprognostic (8.12e-2)" "unprognostic (3.56e-1)" "unprognostic (2.48e-2)" "unprognostic (1.28e-2)" "unprognostic (4.07e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (3.03e-2)" "unprognostic (2.41e-1)" "unprognostic (8.74e-2)" "unprognostic (3.53e-2)" "unprognostic (3.01e-1)" "unprognostic (6.69e-10)" "unprognostic (9.38e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-1)" "unprognostic (7.95e-3)" 0.7 3.2 4.5 0.7 5.4 1.2 1.2 0.1 10.9 0.4 0.7 1.1 0.0 0.6 0.5 0.4 0.4 0.5 0.7 0.7 4.3 7.5 0.5 0.6 0.5 0.4 0.4 4.1 0.4 0.4 0.4 0.2 0.6 0.0 1.0 0.6 0.0 1.7 0.7 0.4 1.9 1.2 0.5 0.1 0.4 0.5 2.5 3.4 1.4 1.5 1.5 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.6 0.2 0.2 1.1 2.1 0.5 0.3 0.1 0.2 0.1 0.0 1.2 0.9 1.9 2.0 1.3 0.1 0.1 0.0 25.2 0.6 4.1 0.9 0.1 0.2 0.1 0.0 1.8 0.0 0.2 0.1 0.0 1.0 0.2 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.6 2.3 0.6 0.3 0.1 0.1 2.8 0.0 1.5 0.2 0.0 0.0 0.2 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 5.4 0.1 10.9 4.3 7.5 0.4 4.1 0.0 3.4 0.0 0.0 0.0 0.1 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.7 0.0 0.3 0.0 0.2 0.0 DLX3 ENSG00000064195 "Distal-less homeobox 3" O60479 17 49990005-49995224 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "placenta: 47.6;skin 1: 32.4;tongue: 11.9" "Group enriched" "Detected in some" 13 "Cytotrophoblasts: 28.7;Extravillous trophoblasts: 58.3;Syncytiotrophoblasts: 80.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 54.8;SK-BR-3: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.20e-1)" "unprognostic (1.75e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (1.95e-1)" "unprognostic (2.63e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (1.77e-2)" "unprognostic (7.98e-2)" "unprognostic (1.44e-5)" "unprognostic (3.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.49e-1)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" 0.5 0.2 0.1 0.0 0.1 0.0 1.5 0.0 0.2 2.2 0.3 0.1 0.0 0.0 0.1 0.6 2.8 0.1 0.2 0.1 0.1 0.1 0.5 0.0 0.4 0.0 0.0 0.0 1.4 0.8 0.0 0.2 47.6 0.3 0.7 0.0 0.5 1.1 1.1 0.1 32.4 0.4 0.0 0.1 0.0 0.1 0.4 0.0 0.4 3.6 11.9 3.4 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 1.0 0.3 0.2 54.8 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.6 0.6 0.0 6.8 2.8 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.2 0.0 5.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.6 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.7 6.1 0.0 0.6 17.6 0.0 3.8 7.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.4 4.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 58.3 0.5 0.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 4.4 80.3 0.0 0.0 0.3 DLX4 "BP1, DLX7, DLX8, DLX9" ENSG00000108813 "Distal-less homeobox 4" Q92988 17 49968970-49974959 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 14.7;skin 1: 6.0" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.6;CACO-2: 13.1;GAMG: 12.4;HAP1: 9.0;K-562: 10.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059933 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059933: AB_2684169" "unprognostic (8.12e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" "unprognostic (2.29e-3)" "unprognostic (7.49e-2)" "unprognostic (2.71e-1)" "unprognostic (9.35e-3)" "unprognostic (2.85e-2)" "unprognostic (8.73e-2)" "unprognostic (5.93e-2)" "unprognostic (1.29e-2)" "unprognostic (4.34e-2)" "unprognostic (2.88e-13)" "unprognostic (8.79e-3)" "unprognostic (2.77e-1)" "unprognostic (5.00e-2)" "unprognostic (6.86e-2)" 0.4 0.3 0.2 1.2 0.7 0.4 0.7 0.3 0.8 0.8 0.6 0.8 0.2 0.2 0.2 0.6 1.5 0.5 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.5 0.2 0.2 0.2 0.7 0.1 0.2 14.7 1.4 0.5 0.3 0.5 2.7 0.6 0.2 6.0 1.5 0.2 0.2 0.8 0.3 0.5 0.2 0.2 0.6 3.8 1.2 0.4 0.8 0.1 0.9 0.0 1.3 1.0 0.8 0.3 0.4 1.1 0.0 0.1 0.1 0.0 18.6 0.1 0.1 0.0 0.3 13.1 0.8 0.5 2.7 0.2 12.4 1.8 9.0 0.3 0.0 3.5 4.7 0.3 4.5 1.3 0.0 0.7 3.1 0.0 2.3 0.1 0.0 0.1 0.0 2.7 10.3 0.0 0.0 2.2 0.3 4.7 0.2 2.4 0.0 0.0 4.2 0.4 0.1 0.6 1.5 0.0 0.3 1.6 0.8 2.9 3.3 3.1 0.0 0.0 0.9 0.2 0.0 0.7 0.1 0.0 0.3 2.4 0.0 0.0 0.3 0.0 0.8 1.3 0.0 0.0 0.0 0.4 0.7 0.1 0.2 0.0 0.0 1.0 1.3 0.9 0.0 0.3 0.2 0.7 0.3 0.8 0.2 0.2 0.2 0.2 1.4 0.2 6.0 0.0 0.0 0.3 2.3 0.0 2.0 0.0 2.7 0.0 0.0 0.0 10.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 67.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.5 14.1 0.0 0.0 0.3 DLX5 ENSG00000105880 "Distal-less homeobox 5" P56178 7 97020392-97024950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 128.5;Extravillous trophoblasts: 203.8;Sertoli cells: 58.2;Syncytiotrophoblasts: 263.3" "Cancer enriched" "Detected in many" 11 "endometrial cancer: 81.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 32.9;HAP1: 16.5;SuSa: 8.6" "Group enriched" "Detected in many" 4 "basal ganglia: 13.5;olfactory region: 36.5" "Region enhanced" "Detected in many" "olfactory region: 24.3" HPA005670 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005670: AB_1078681" "unprognostic (3.99e-1)" "unprognostic (1.05e-1)" "unprognostic (2.96e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (2.86e-2)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (5.89e-2)" "unprognostic (6.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-2)" "unprognostic (7.43e-8)" "unprognostic (1.39e-2)" "unprognostic (3.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" 1.5 0.6 2.7 0.5 11.5 0.3 1.5 0.1 3.9 10.0 0.6 0.3 1.4 0.7 17.7 1.7 5.8 2.0 0.8 1.2 2.2 4.5 0.4 0.2 0.4 1.9 0.5 2.5 2.1 0.2 0.4 1.9 44.5 0.0 1.8 0.3 0.1 3.6 3.9 0.6 20.6 0.3 1.4 0.2 0.3 0.3 1.2 3.1 2.5 1.6 6.5 2.7 1.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 3.7 16.5 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 2.1 0.9 1.3 0.1 0.0 0.0 8.6 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 2.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.5 0.1 3.9 2.2 4.5 0.5 2.5 0.0 3.1 0.0 0.0 0.0 0.7 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 128.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 203.8 2.2 1.1 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 58.2 7.1 1.8 6.0 18.1 263.3 0.0 0.0 1.4 DLX6 ENSG00000006377 "Distal-less homeobox 6" P56179 7 97005548-97011039 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.2;placenta: 11.3;testis: 10.4" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 24.7;Extravillous trophoblasts: 48.9;Sertoli cells: 12.9;Syncytiotrophoblasts: 14.5" "Cancer enriched" "Detected in many" 8 "endometrial cancer: 12.5" "Region enhanced" "Detected in many" "basal ganglia: 23.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.3;BEWO: 24.3;HAP1: 10.9;SH-SY5Y: 8.0;SuSa: 14.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory region: 44.2" "HPA030608, HPA061460" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA030608: AB_10600867, HPA061460: AB_2684529" "unprognostic (7.50e-2)" "unprognostic (1.91e-1)" "unprognostic (5.19e-2)" "unprognostic (8.06e-2)" "unprognostic (8.16e-2)" "unprognostic (3.05e-1)" "unprognostic (4.32e-2)" "unprognostic (2.51e-1)" "unprognostic (2.86e-1)" "unprognostic (6.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.12e-7)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (5.58e-2)" "unprognostic (8.12e-2)" 0.9 0.4 1.8 0.3 23.2 0.9 0.4 0.3 6.1 5.7 0.6 0.5 0.0 0.4 7.0 2.4 0.3 1.5 0.3 0.5 3.9 2.6 0.4 0.3 0.3 1.0 0.5 2.8 0.9 0.3 0.4 0.4 11.3 0.0 0.7 0.3 0.0 1.7 2.5 0.5 1.6 0.3 0.9 0.3 0.5 0.4 10.4 4.2 0.1 0.7 0.0 0.8 0.9 0.6 0.4 0.6 1.5 0.7 0.5 0.7 0.3 0.0 0.0 0.0 7.3 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 0.0 1.3 10.9 0.0 0.0 0.0 2.8 0.0 4.1 4.9 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 1.1 0.0 0.0 0.0 0.0 1.5 5.3 8.0 0.7 0.0 0.2 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.8 0.6 1.1 0.5 0.6 0.2 0.3 0.5 0.4 0.4 0.3 0.3 0.4 0.7 0.6 1.5 0.5 0.7 0.6 0.5 0.3 1.8 23.2 0.3 6.1 3.9 2.6 0.5 2.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 9.5 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 1.7 7.1 0.0 14.5 0.0 0.0 0.1 DMBT1 "Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin" ENSG00000187908 "Deleted in malignant brain tumors 1" Q9UGM3 10 122560665-122643736 "Disease related genes, Predicted secreted proteins" "Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 122.3;salivary gland: 130.0" "Group enriched" "Detected in many" 12 "Alveolar cells type 2: 221.3;Paneth cells: 136.4" "Group enriched" "Detected in many" 10 "colorectal cancer: 47.6;lung cancer: 18.0;pancreatic cancer: 33.3;stomach cancer: 76.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 4.6;LHCN-M2: 9.2;RH-30: 21.4" HPA040778 Enhanced Approved "Centriolar satellite" "Secreted in other tissues" NA NA 7500000 "Centriolar satellite" "HPA040778: AB_2677132" "unprognostic (3.32e-2)" "unprognostic (2.17e-2)" "unprognostic (3.47e-2)" "prognostic favorable (1.43e-4)" "unprognostic (8.77e-2)" "unprognostic (2.56e-2)" "unprognostic (3.70e-1)" "unprognostic (7.97e-2)" "unprognostic (1.31e-1)" "unprognostic (4.51e-1)" "unprognostic (2.22e-1)" "unprognostic (2.20e-1)" "unprognostic (1.08e-9)" "unprognostic (2.26e-1)" "unprognostic (2.92e-4)" "unprognostic (2.00e-3)" "unprognostic (2.22e-1)" 0.1 0.1 0.2 2.4 0.2 0.0 0.1 0.1 0.2 1.1 34.8 0.1 0.1 122.3 0.2 0.1 0.3 0.3 2.7 0.1 0.3 0.2 0.1 0.1 13.1 0.1 0.6 0.1 0.2 1.2 0.0 0.1 0.1 0.1 0.5 1.5 0.1 130.0 0.1 0.2 0.2 68.3 0.9 1.1 0.1 0.2 0.3 0.1 0.1 0.1 19.7 14.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.3 0.2 4.6 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 21.4 2.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.6 2.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.3 0.2 0.6 0.1 0.1 0.1 6.0 221.3 0.0 3.3 0.0 0.0 0.4 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.4 2.3 0.0 14.7 0.0 13.8 0.0 0.0 0.8 9.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 8.4 0.0 1.0 136.4 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.0 0.0 0.0 4.5 12.8 DMBX1 "OTX3, PAXB" ENSG00000197587 "Diencephalon/mesencephalon homeobox 1" Q8NFW5 1 46506996-46514226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.7;testis: 3.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 1.5;Cone photoreceptor cells: 2.0;Spermatogonia: 1.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 7 "hypothalamus: 1.2;midbrain: 1.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 15.7;CAPAN-2: 5.0;GAMG: 4.0;K-562: 5.1;SiHa: 5.1;T-47d: 4.4" "Group enriched" "Detected in some" 7 "midbrain: 1.8;pons and medulla: 1.0" "Region enhanced" "Detected in some" "thalamus: 5.1" HPA026811 Uncertain NA NA "HPA026811: AB_10603660" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (7.13e-5)" "unprognostic (2.33e-2)" "unprognostic (8.92e-3)" "unprognostic (1.07e-1)" "unprognostic (5.90e-2)" "unprognostic (2.63e-2)" "unprognostic (1.89e-1)" "unprognostic (2.00e-4)" "unprognostic (1.19e-2)" "unprognostic (2.12e-12)" "unprognostic (7.91e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (3.35e-2)" 0.3 1.8 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.0 2.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 3.5 0.1 0.1 1.4 0.1 0.1 0.9 0.1 0.6 0.3 1.9 0.2 0.0 0.1 0.0 2.2 1.5 0.0 15.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.8 0.0 4.0 1.4 3.0 0.0 0.0 1.1 1.8 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 1.7 0.0 0.1 0.1 2.9 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 5.1 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.2 1.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.0 0.1 DMC1 LIM15 ENSG00000100206 "DNA meiotic recombinase 1" Q14565 22 38518949-38570286 "Predicted intracellular proteins" "Cell cycle, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.1" "Cell type enhanced" "Detected in many" 21 "Erythroid cells: 23.3;Sertoli cells: 12.9;Spermatocytes: 61.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.7;hTEC/SVTERT24-B: 12.6;U-266/84: 14.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA001232, CAB015397" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB015397: AB_629406, HPA001232: AB_1078683" "unprognostic (1.29e-2)" "unprognostic (3.11e-3)" "unprognostic (4.48e-3)" "unprognostic (5.71e-2)" "unprognostic (6.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.22e-2)" "unprognostic (2.61e-2)" "unprognostic (4.23e-2)" "unprognostic (3.99e-3)" "unprognostic (7.40e-3)" "unprognostic (1.00e-2)" "unprognostic (2.16e-4)" "unprognostic (3.94e-1)" "unprognostic (2.79e-1)" "unprognostic (7.27e-2)" "unprognostic (2.99e-1)" 1.7 0.6 1.6 4.7 2.0 3.1 4.4 2.2 2.0 2.5 1.3 0.7 1.2 0.4 3.7 2.6 1.5 1.6 1.8 3.3 2.5 1.1 1.0 0.5 1.1 3.9 2.8 1.5 1.8 0.8 0.8 1.1 1.0 3.2 2.9 1.6 2.7 1.0 1.3 1.8 2.5 1.1 3.4 4.4 0.9 1.0 24.1 2.3 8.2 0.8 3.2 4.5 2.0 3.8 1.2 0.8 3.3 1.0 2.5 1.5 0.4 4.9 1.9 3.7 0.1 0.3 1.5 0.2 5.3 0.7 8.5 5.9 0.2 0.6 2.5 0.2 1.4 0.0 0.9 1.4 0.2 9.7 17.7 0.3 9.5 1.4 0.1 0.1 0.8 2.1 0.4 0.0 12.6 0.0 0.0 0.7 8.0 7.1 2.6 3.0 2.8 1.9 7.2 6.5 2.4 0.1 4.2 0.0 3.6 1.1 0.7 7.2 0.4 8.9 0.8 0.1 0.9 1.6 2.1 0.2 0.1 0.5 0.1 0.1 7.1 14.7 4.5 1.5 2.0 0.7 2.2 1.0 0.5 1.5 0.3 0.3 0.5 1.3 0.6 0.8 1.2 1.2 0.5 3.3 2.5 0.6 0.7 0.7 0.4 1.6 2.0 2.2 2.0 2.5 1.1 2.8 1.5 3.2 2.3 0.0 2.9 0.0 0.7 2.1 0.6 2.0 0.0 1.4 4.5 3.5 0.0 0.8 1.7 0.2 1.9 0.6 0.0 23.3 0.0 1.3 1.2 0.2 1.1 0.0 0.8 0.0 0.0 0.6 0.0 1.6 1.4 0.8 0.0 0.0 0.8 2.3 0.1 0.0 1.4 0.0 0.3 12.9 0.8 61.6 8.3 0.5 0.7 1.0 2.1 0.0 DMGDH ENSG00000132837 "Dimethylglycine dehydrogenase" Q9UI17 5 78997606-79236038 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "kidney: 50.2;liver: 81.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.2;Hepatocytes: 84.9;Late spermatids: 27.1;Proximal tubular cells: 59.0" "Group enriched" "Detected in some" 12 "liver cancer: 15.6;renal cancer: 12.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.7;Hep G2: 11.5;hTEC/SVTERT24-B: 3.6;Karpas-707: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036441, HPA036442, HPA077849" Enhanced Supported Mitochondria NA NA 440000 Mitochondria "HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859" "unprognostic (3.11e-2)" "unprognostic (3.36e-1)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (3.15e-1)" "unprognostic (2.52e-3)" "prognostic favorable (5.32e-5)" "unprognostic (2.21e-1)" "unprognostic (3.05e-2)" "unprognostic (3.19e-2)" "unprognostic (1.07e-4)" "unprognostic (1.89e-1)" "prognostic favorable (1.17e-5)" "unprognostic (2.03e-2)" "unprognostic (9.75e-4)" "unprognostic (1.46e-1)" "unprognostic (2.26e-1)" 2.8 2.2 0.8 0.8 1.3 0.0 1.5 0.4 0.6 0.5 0.5 0.7 1.9 0.1 0.9 5.9 0.4 0.4 0.6 1.3 0.8 0.8 50.2 81.8 0.1 0.1 0.8 0.3 1.0 0.5 0.3 2.1 0.0 1.1 0.9 0.1 2.7 0.4 1.1 0.6 0.2 0.3 2.0 1.7 0.0 0.4 1.2 0.2 0.0 1.5 0.8 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.5 0.5 1.4 0.4 0.3 5.7 1.3 2.3 0.0 0.1 0.0 0.4 1.8 0.0 0.0 0.1 0.0 1.9 0.3 0.0 0.0 0.0 11.5 3.2 0.0 0.0 2.7 3.3 3.6 2.6 2.5 0.0 1.3 0.0 3.6 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.3 0.4 0.6 0.8 0.8 0.8 0.3 1.1 0.2 0.0 0.6 1.4 0.4 0.1 1.5 0.8 2.5 2.7 0.0 8.7 2.0 0.2 16.6 0.4 25.2 0.6 0.5 0.0 0.6 0.1 0.8 0.9 0.0 84.9 0.1 0.0 1.2 1.3 2.4 27.1 2.3 0.4 0.0 0.0 1.1 3.5 0.7 0.6 2.5 59.0 4.1 0.0 0.1 3.4 5.2 0.3 0.2 0.5 0.6 0.7 DMKN ZD52F10 ENSG00000161249 Dermokine Q6E0U4 19 35497220-35513658 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 365.3" "Cell type enriched" "Detected in many" 5 "Suprabasal keratinocytes: 7442.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Cell type enhanced" "Detected in many" "NK-cell: 11.1" "Group enriched" "Detected in many" 5 "NK-cells: 11.1;T-cells: 7.0" "Cell line enhanced" "Detected in many" "A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3" HPA029406 Enhanced Approved Nucleoplasm,Cytosol "Secreted in other tissues" NA NA 29000000 "Nucleoplasm, Cytosol" "HPA029406: AB_10603661" "unprognostic (5.70e-2)" "unprognostic (2.36e-2)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.28e-2)" "unprognostic (2.48e-2)" "unprognostic (3.82e-2)" "unprognostic (3.23e-1)" "unprognostic (1.03e-1)" "unprognostic (8.82e-2)" "unprognostic (2.54e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.37e-6)" "unprognostic (3.50e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (2.08e-1)" 1.4 1.1 0.6 0.5 4.7 0.6 23.9 0.7 2.0 54.8 1.2 1.1 2.5 1.0 5.6 9.2 25.3 8.7 0.6 1.4 0.7 1.1 11.3 0.8 8.8 0.5 0.9 0.6 11.7 29.5 4.7 13.3 1.7 9.5 5.0 1.0 9.5 8.2 9.1 2.4 365.3 1.2 0.9 0.9 0.6 1.8 0.8 2.3 3.1 25.9 62.9 16.9 3.5 27.5 1.7 0.2 0.0 0.0 11.1 7.0 1.2 32.0 5.2 0.0 0.0 1.3 2.0 9.0 0.1 4.3 0.2 0.3 39.6 34.0 0.0 13.0 0.3 1.6 18.0 9.8 51.9 0.4 0.1 9.5 0.0 0.0 8.8 1.5 0.0 0.1 17.8 14.0 0.9 30.2 3.0 0.0 0.0 0.1 0.0 0.1 28.0 0.0 0.0 28.8 23.3 2.1 0.0 0.0 1.3 51.3 21.2 0.1 0.0 7.8 0.0 3.1 8.6 13.0 0.0 0.0 5.0 15.2 0.1 0.1 0.2 0.0 0.2 4.2 0.0 0.3 0.0 0.0 0.0 7.0 0.0 6.1 1.7 0.6 3.4 0.0 0.2 0.1 2.4 0.0 11.1 0.0 0.2 0.0 1.2 0.6 4.7 0.7 2.0 0.7 1.1 0.9 0.6 9.5 2.3 98.3 94.2 3.7 121.7 1442.2 1.4 15.2 94.3 261.0 92.1 193.7 0.0 0.7 195.6 125.9 15.0 6.0 1.3 0.0 120.1 1.1 57.3 55.5 7.0 2.0 1.0 0.0 47.4 5.5 0.8 67.8 12.0 5.1 290.1 4.6 4.2 9.3 137.6 5.8 14.9 4.4 0.7 0.0 14.2 7.1 16.4 7442.2 1.9 5.3 11.0 72.7 DMP1 ENSG00000152592 "Dentin matrix acidic phosphoprotein 1" Q13316 4 87650307-87664361 "Disease related genes, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.9;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 1.4;SuSa: 1.1;U-266/70: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037465 Approved "Secreted to extracellular matrix" NA NA "HPA037465: AB_10672492" "unprognostic (6.77e-2)" "unprognostic (1.55e-1)" "unprognostic (1.42e-3)" "unprognostic (1.80e-1)" "unprognostic (4.96e-3)" "unprognostic (7.73e-2)" "unprognostic (3.88e-1)" "unprognostic (1.11e-1)" "unprognostic (1.35e-2)" "unprognostic (8.50e-9)" "unprognostic (5.82e-2)" "unprognostic (1.49e-2)" "unprognostic (2.77e-1)" "unprognostic (1.74e-3)" 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMPK "DM, DM1, DM1PK, DMK, MDPK, MT-PK" ENSG00000104936 "DM1 protein kinase" Q09013 19 45769717-45782552 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.6" "Cell type enhanced" "Detected in many" 9 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 44.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007164, HPA008905" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA007164: AB_1078687, HPA008905: AB_1078685" "unprognostic (7.44e-2)" "unprognostic (2.66e-1)" "unprognostic (1.76e-3)" "unprognostic (2.61e-3)" "unprognostic (1.29e-1)" "unprognostic (5.46e-2)" "unprognostic (8.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-1)" "prognostic favorable (9.39e-5)" "unprognostic (1.93e-1)" "unprognostic (1.60e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (4.24e-3)" 9.0 18.7 5.1 9.7 6.3 1.7 4.9 8.8 6.2 16.5 23.4 4.4 15.6 8.7 21.2 15.0 31.2 13.7 20.3 56.7 5.0 5.3 4.9 2.2 6.5 4.1 4.8 6.5 8.4 33.3 3.1 10.7 6.8 5.6 16.3 3.8 22.0 6.1 19.7 79.6 5.1 11.3 65.1 4.2 5.3 12.0 5.9 4.0 1.1 6.1 36.6 5.0 44.9 8.2 1.5 0.0 0.0 0.8 0.3 2.2 0.0 7.2 10.2 12.1 7.5 8.2 11.5 7.3 16.4 12.1 6.6 6.4 1.2 3.9 2.3 2.5 18.7 5.3 10.7 3.5 1.6 2.5 11.4 10.7 0.9 12.7 1.7 8.0 0.1 4.1 16.6 5.7 5.7 2.8 16.3 3.0 1.2 7.2 5.9 9.5 8.1 1.1 2.8 7.2 3.2 2.2 3.7 44.7 3.8 3.5 8.4 6.5 10.5 8.9 18.8 5.3 6.9 15.4 3.6 9.2 7.7 7.6 7.2 12.0 11.4 9.7 2.3 7.0 1.0 10.7 0.0 0.0 0.0 2.2 0.8 0.5 0.3 0.7 0.2 0.0 1.5 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.1 6.3 8.8 6.2 5.0 5.3 4.8 6.5 5.6 4.0 0.0 2.1 0.9 7.0 7.1 4.9 3.1 2.5 0.0 2.3 3.5 7.9 2.3 1.7 2.4 1.4 6.0 3.6 0.0 15.0 1.5 12.7 3.3 0.0 0.9 0.7 4.8 9.7 10.4 1.2 1.4 6.6 0.5 6.8 0.0 5.5 2.2 5.0 3.5 21.9 22.0 7.6 58.2 23.7 6.3 6.0 5.9 1.4 5.0 3.6 3.7 DMRT1 "CT154, DMT1" ENSG00000137090 "Doublesex and mab-3 related transcription factor 1" Q9Y5R6 9 841690-969090 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "testis: 44.1" "Group enriched" "Detected in some" 5 "Early spermatids: 31.6;Spermatogonia: 103.9" "Cancer enriched" "Detected in some" 9 "testis cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 8.5;SuSa: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA027850 Enhanced NA NA "HPA027850: AB_10600868" "unprognostic (3.23e-1)" "unprognostic (1.91e-1)" "unprognostic (9.75e-4)" "unprognostic (1.34e-1)" "unprognostic (2.50e-1)" "unprognostic (3.08e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (5.60e-2)" "unprognostic (3.06e-2)" "unprognostic (1.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.3 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 8.5 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.2 103.9 0.0 0.0 0.0 0.0 0.0 DMRT2 ENSG00000173253 "Doublesex and mab-3 related transcription factor 2" Q9Y5R5 9 1049858-1057552 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 97.8" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.9;RH-30: 5.3;RPMI-8226: 19.8;SCLC-21H: 3.1;SK-MEL-30: 5.4;THP-1: 3.8;WM-115: 3.8" "Region enhanced" "Detected in some" "cerebral cortex: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" HPA029297 Uncertain NA NA "HPA029297: AB_10600905" "unprognostic (5.67e-2)" "unprognostic (2.20e-3)" "unprognostic (3.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.32e-1)" "unprognostic (7.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (1.74e-1)" "unprognostic (1.43e-3)" "unprognostic (8.93e-2)" "unprognostic (8.62e-2)" "unprognostic (4.93e-2)" "unprognostic (1.27e-3)" 3.8 0.5 1.9 0.5 6.5 0.4 4.5 0.5 4.5 0.5 1.6 11.0 2.6 0.4 0.5 1.3 0.6 0.6 0.4 0.5 3.2 1.3 27.3 0.4 2.4 0.6 7.0 2.5 0.4 0.4 52.9 0.7 0.6 3.6 0.6 1.1 0.0 1.4 1.5 9.0 0.6 0.4 0.5 3.0 0.4 0.4 0.9 6.2 18.4 0.4 6.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.9 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.3 19.8 0.0 0.9 3.1 0.0 0.0 0.0 5.4 0.3 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.5 0.5 4.5 3.2 1.3 7.0 2.5 3.6 6.2 0.0 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 97.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.7 0.3 0.0 2.3 0.0 0.0 1.7 0.0 0.0 4.2 1.5 0.1 0.1 0.0 1.5 0.1 DMRT3 DMRTA3 ENSG00000064218 "Doublesex and mab-3 related transcription factor 3" Q9NQL9 9 976964-991731 "Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 34.2;testis: 11.7;thyroid gland: 11.5" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 3.0;Spermatocytes: 14.4;Spermatogonia: 5.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.6" "Region enriched" "Detected in some" 7 "hippocampal formation: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.9;HEK 293: 3.8;hTERT-RPE1: 5.7;SCLC-21H: 2.3;SuSa: 2.2;THP-1: 6.1" "Region enhanced" "Detected in single" "hippocampal formation: 0.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.3" HPA077685 Approved NA NA "HPA077685: AB_2732357" "unprognostic (2.42e-1)" "unprognostic (2.26e-1)" "unprognostic (1.51e-2)" "unprognostic (2.13e-4)" "unprognostic (1.73e-2)" "unprognostic (3.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (3.84e-1)" "unprognostic (2.12e-3)" "unprognostic (2.91e-2)" "unprognostic (5.84e-1)" "unprognostic (1.05e-2)" "unprognostic (1.11e-1)" 4.0 0.0 0.4 0.0 0.2 0.0 6.4 0.0 1.1 0.2 0.0 1.8 0.0 0.0 0.1 1.0 0.6 0.7 0.0 1.4 8.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.5 0.7 0.0 0.2 0.4 0.0 0.0 11.7 0.0 0.2 11.5 0.6 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.7 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 6.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.1 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.4 5.1 0.0 0.0 0.0 0.0 0.0 DMRTA1 ENSG00000176399 "DMRT like family A1" Q5VZB9 9 22446841-22455740 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 12.2;salivary gland: 16.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 13.3;Hepatocytes: 25.3;Proximal tubular cells: 21.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.0;hTERT-RPE1: 11.0;LHCN-M2: 4.2;RPTEC TERT1: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 2.5" "HPA044764, HPA062253" Uncertain Approved Vesicles NA NA Vesicles "HPA044764: AB_10959788, HPA062253: AB_2684726" "unprognostic (1.47e-1)" "unprognostic (2.48e-2)" "unprognostic (2.86e-1)" "unprognostic (7.74e-4)" "unprognostic (3.81e-2)" "unprognostic (2.67e-3)" "unprognostic (4.36e-2)" "unprognostic (2.36e-2)" "unprognostic (1.28e-1)" "unprognostic (9.64e-2)" "unprognostic (3.65e-3)" "unprognostic (2.92e-1)" "prognostic favorable (1.14e-6)" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (8.53e-3)" 2.1 0.2 0.7 1.4 0.7 0.0 5.6 0.8 0.7 2.4 1.0 0.7 1.1 0.7 1.2 1.8 5.5 0.3 1.2 0.6 0.6 0.5 5.5 12.2 1.1 1.4 0.8 0.4 0.6 2.7 6.1 2.9 0.0 0.9 2.4 0.4 1.9 16.3 0.5 0.9 0.5 0.8 0.7 0.7 0.4 2.8 0.6 0.0 1.1 5.0 0.6 2.0 0.9 1.7 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.5 0.1 0.0 0.4 0.1 0.2 0.0 9.0 0.3 0.3 0.1 0.1 0.0 2.0 0.0 0.2 0.3 1.8 2.4 0.3 0.0 0.6 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.7 11.0 0.6 0.0 0.0 3.3 4.2 0.9 0.0 0.0 1.8 0.4 3.0 0.0 0.2 1.2 4.3 0.0 0.1 0.0 1.1 0.7 2.0 2.2 0.0 0.0 3.1 0.0 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.8 0.7 0.6 0.5 0.8 0.4 0.9 0.0 0.0 2.4 0.0 4.7 0.0 0.5 1.1 2.5 4.0 4.5 5.2 0.0 0.0 13.3 5.4 0.0 0.0 2.6 0.0 6.0 0.0 1.3 5.6 0.0 25.3 0.3 0.0 2.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 4.8 5.6 0.0 0.0 21.4 0.0 0.0 0.4 0.0 0.6 0.4 0.1 0.0 1.9 6.2 DMRTA2 ENSG00000142700 "DMRT like family A2" Q96SC8 1 50417550-50423500 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 3.7;Intestinal endocrine cells: 1.2" "Cancer enhanced" "Detected in many" "glioma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HBEC3-KT: 4.3;RH-30: 15.6;SH-SY5Y: 3.3;SiHa: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043098, HPA062958" Uncertain Approved Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA Mitochondria Nucleoplasm "HPA043098: AB_10796684, HPA062958: AB_2684911" "unprognostic (1.60e-1)" "unprognostic (4.56e-3)" "unprognostic (2.62e-1)" "unprognostic (3.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.75e-2)" "unprognostic (1.15e-2)" "unprognostic (3.29e-1)" "unprognostic (6.89e-2)" "unprognostic (4.79e-1)" "unprognostic (7.47e-2)" "unprognostic (1.21e-3)" "unprognostic (7.08e-3)" "unprognostic (4.16e-2)" "unprognostic (7.85e-2)" "unprognostic (2.68e-3)" 0.2 0.1 0.4 0.1 1.5 0.2 0.2 0.4 2.1 0.3 0.3 8.5 0.0 0.4 0.2 0.1 3.8 0.2 0.1 0.1 1.2 0.7 0.2 0.2 0.2 0.2 1.2 0.0 0.2 0.1 0.4 5.4 0.2 2.1 0.2 0.3 0.0 0.5 0.2 0.3 0.1 0.2 0.1 2.0 0.3 0.2 4.0 3.7 0.3 0.2 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 1.9 0.0 1.3 4.3 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 3.3 3.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.4 1.8 1.2 0.7 1.2 0.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 DMRTB1 ENSG00000143006 "DMRT like family B with proline rich C-terminal 1" Q96MA1 1 53459399-53467488 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 104 "testis: 78.1" "Group enriched" "Detected in some" 17 "Early spermatids: 42.1;Late spermatids: 90.9;Spermatocytes: 144.5;Spermatogonia: 150.6" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.3" "Low region specificity" "Detected in single" "HPA036490, HPA058553" Enhanced NA NA "HPA036490: AB_10671844, HPA058553: AB_2683753" "unprognostic (2.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.5 0.0 144.5 150.6 0.0 0.0 0.0 0.0 0.0 DMRTC1 ENSG00000269502 "DMRT like family C1" Q5HYR2 X 72872025-72943814 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Group enriched" "Detected in many" 17 "B-cells: 2.2;T-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;Daudi: 3.6;JURKAT: 2.6;NTERA-2: 1.2;U-266/70: 1.2;U-266/84: 1.4;U-698: 2.0" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (1.83e-1)" 0.0 1.3 0.0 0.0 0.0 4.0 0.6 0.1 0.0 1.1 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.6 0.7 0.0 1.1 2.0 0.8 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.0 2.2 0.7 1.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTC1B ENSG00000184911 "DMRT like family C1B" Q5HYR2 X 72777009-72848802 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.1;ovary: 12.1;pituitary gland: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 12 "B-cells: 2.1;T-cells: 2.8" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;SK-BR-3: 1.0;SuSa: 2.2;U-266/70: 1.5" "HPA046874, HPA046992" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA046874: AB_2679850, HPA046992: AB_2679894" "unprognostic (2.00e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-1)" "unprognostic (6.52e-2)" 0.3 4.6 11.0 1.7 15.1 0.1 0.7 4.5 14.3 1.7 0.6 2.2 1.4 0.5 2.2 9.6 0.3 3.3 0.6 0.2 8.6 14.2 1.6 0.2 1.1 1.4 4.9 9.1 12.1 5.2 1.5 12.1 0.2 2.2 3.8 0.8 2.4 1.0 1.9 0.2 0.5 0.5 0.6 2.2 1.3 1.2 7.1 2.9 0.7 3.9 0.2 2.1 0.3 0.2 2.1 0.0 0.0 0.0 0.2 2.8 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.8 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.4 0.0 2.1 2.1 2.8 0.0 0.2 0.0 0.0 0.0 0.2 11.0 15.1 4.5 11.4 8.6 14.2 4.9 9.1 2.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DMRTC2 ENSG00000142025 "DMRT like family C2" Q8IXT2 19 41844743-41852333 "Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 53.5" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 176.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.3" "Group enriched" "Detected in many" 4 "granulocytes: 1.3;monocytes: 1.1" "Cell line enhanced" "Detected in some" "HMC-1: 1.6" "Not detected" "Not detected" HPA045016 Uncertain NA NA "HPA045016: AB_10960404" "unprognostic (6.80e-3)" "unprognostic (4.38e-2)" "unprognostic (5.36e-2)" "unprognostic (2.69e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.3 1.1 0.2 0.2 0.0 0.2 0.0 0.5 1.0 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.7 1.1 0.1 0.1 0.2 0.2 0.6 0.0 0.0 0.0 1.2 0.6 0.0 0.8 0.2 0.0 0.6 1.6 0.3 0.0 0.2 0.0 1.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.5 1.1 0.7 1.3 0.9 0.1 0.3 0.3 0.4 0.2 0.2 0.9 0.1 1.0 1.2 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.2 1.3 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 176.3 24.5 0.0 0.0 0.0 0.0 0.0 DMTN "DMT, EPB49" ENSG00000158856 "Dematin actin binding protein" Q08495 8 22048995-22082527 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 88.6" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 140.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.1;MAIT T-cell: 2.1;memory CD4 T-cell: 4.7;memory CD8 T-cell: 2.0;naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.0;neutrophil: 1.5;T-reg: 3.8" "Group enriched" "Detected in many" 7 "granulocytes: 1.5;T-cells: 4.7" "Cell line enhanced" "Detected in many" "A549: 20.2;HEL: 65.2;HMC-1: 19.8;OE19: 19.4;RPTEC TERT1: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024290, HPA058487" Uncertain NA NA 6700000 "HPA024290: AB_1847601, HPA058487: " "unprognostic (6.74e-2)" "unprognostic (1.51e-1)" "unprognostic (3.48e-2)" "unprognostic (1.24e-3)" "prognostic unfavorable (7.92e-5)" "unprognostic (2.88e-1)" "unprognostic (3.85e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-2)" "unprognostic (2.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.97e-1)" "prognostic favorable (3.85e-9)" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "unprognostic (8.07e-2)" 15.0 14.7 49.7 2.8 60.0 51.1 5.8 24.9 88.6 5.2 9.6 5.2 4.3 4.5 5.9 7.3 9.1 14.8 6.5 31.7 36.6 28.0 18.4 5.8 8.5 1.7 19.2 39.9 1.8 13.4 20.4 23.5 3.7 31.8 9.4 7.4 6.0 10.2 10.4 27.2 10.2 5.4 6.9 6.0 4.5 8.0 3.1 9.0 0.0 16.1 3.1 1.9 3.9 3.0 0.0 0.4 1.5 0.1 0.0 4.7 11.4 12.5 20.2 0.1 0.4 0.3 0.1 1.6 1.3 1.2 4.3 1.3 8.7 7.8 0.1 13.2 0.2 0.2 4.3 0.6 0.8 1.9 0.1 3.8 65.2 1.5 18.2 0.4 0.0 19.8 0.2 8.8 0.0 0.0 2.5 4.3 0.6 6.1 0.6 0.0 5.4 1.6 0.1 0.5 19.4 1.8 0.0 0.1 0.9 26.1 3.6 4.7 6.5 2.1 0.2 0.9 1.1 3.3 0.6 7.6 0.0 6.7 0.1 6.9 0.0 0.0 0.2 0.1 0.0 4.5 0.0 0.1 0.2 2.1 0.0 2.1 0.0 4.7 2.0 0.1 0.0 2.0 2.0 1.5 0.0 0.0 0.4 3.8 11.4 49.7 60.0 24.9 88.6 36.6 28.0 19.2 39.9 31.8 9.0 3.0 12.5 1.7 3.4 2.1 30.2 35.3 0.0 8.1 5.7 7.0 11.8 0.1 16.6 9.4 11.0 7.0 4.9 140.2 10.0 1.6 0.9 3.8 0.0 14.9 0.4 27.0 19.8 3.1 0.8 5.8 0.3 0.0 13.5 0.0 8.9 2.0 13.8 5.8 2.5 23.0 4.9 0.0 5.0 1.1 2.3 5.0 0.1 4.9 8.2 4.0 DNA2 "DNA2L, KIAA0083" ENSG00000138346 "DNA replication helicase/nuclease 2" P51530 10 68414064-68472121 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease" "Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 49.1" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.5" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA037487, HPA057526" Approved Supported Mitochondria No No Mitochondria "HPA037487: AB_10672493, HPA057526: AB_2683456" "unprognostic (1.79e-1)" "unprognostic (1.35e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-2)" "unprognostic (4.50e-5)" "unprognostic (3.36e-2)" "unprognostic (4.70e-2)" "unprognostic (3.72e-2)" "unprognostic (1.30e-2)" "unprognostic (3.29e-4)" "unprognostic (1.09e-10)" "unprognostic (3.43e-2)" "unprognostic (1.98e-1)" "unprognostic (9.36e-2)" "unprognostic (1.23e-2)" 1.6 1.2 2.0 13.7 2.4 7.0 3.0 6.2 3.8 1.6 4.5 1.1 0.8 3.5 3.0 1.8 3.2 1.0 2.4 2.0 2.5 2.2 3.4 6.2 3.3 8.4 2.9 5.0 1.9 2.4 1.1 2.3 4.0 1.7 3.0 5.0 0.9 2.3 0.8 2.3 2.9 5.2 1.9 3.0 5.2 2.6 7.0 1.4 49.1 1.5 5.1 10.8 2.3 2.0 0.4 0.1 0.9 0.1 5.5 0.6 0.1 13.9 7.2 16.5 11.6 1.9 1.3 11.6 6.9 5.8 9.9 12.2 17.2 9.1 14.3 2.6 2.1 3.8 8.6 9.4 3.6 12.0 8.8 7.1 8.7 4.5 6.6 0.5 14.9 9.4 1.0 1.5 7.0 2.1 2.5 4.4 9.5 12.7 13.0 5.7 4.9 23.0 10.8 11.6 5.9 13.6 18.0 11.4 4.6 4.2 6.5 7.5 9.0 9.5 12.1 2.3 12.2 9.3 6.3 1.8 3.8 11.9 4.8 13.1 6.6 7.4 21.4 3.2 14.3 5.0 0.0 0.0 0.9 0.2 0.0 0.2 0.4 0.2 0.6 0.1 0.4 0.3 0.3 0.1 5.5 0.1 0.0 0.4 0.1 2.0 2.4 6.2 3.8 2.5 2.2 2.9 5.0 1.7 1.4 6.0 0.6 0.0 0.7 2.1 2.2 7.3 2.5 0.0 1.2 1.8 5.9 2.0 0.0 0.5 1.6 0.7 1.3 70.0 0.8 3.8 1.9 3.2 0.0 4.4 1.8 0.0 1.2 1.3 2.2 3.1 0.6 0.0 0.0 0.0 1.3 0.2 0.7 0.0 0.7 0.4 3.6 0.0 1.0 5.0 14.2 1.5 1.0 1.5 2.3 0.9 DNAAF1 "CILD13, FLJ25330, LRRC50, ODA7, swt" ENSG00000154099 "Dynein axonemal assembly factor 1" Q8NEP3 16 84145287-84178767 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.3;testis: 49.6" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 520.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.1" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1" "Cell type enhanced" "Detected in some" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.5;Karpas-707: 8.8;PC-3: 2.7;SK-BR-3: 2.5;U-266/70: 7.4;U-266/84: 4.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA041166, HPA074239" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nuclear speckles" "HPA041166: AB_10794190, HPA074239: AB_2732250" "unprognostic (5.25e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-2)" "prognostic favorable (2.14e-4)" "unprognostic (1.42e-1)" "unprognostic (9.99e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (7.71e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-5)" "unprognostic (2.70e-2)" "unprognostic (4.61e-3)" "unprognostic (1.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-4)" "unprognostic (7.51e-4)" 0.8 1.2 3.5 0.6 9.4 1.5 0.5 0.1 1.5 2.1 0.6 5.3 1.5 0.4 1.0 13.3 0.9 21.3 0.5 0.4 4.6 6.5 0.7 2.0 3.7 0.9 0.5 1.5 4.2 0.4 0.7 6.1 1.5 11.1 0.4 0.4 0.9 0.5 0.6 0.6 0.5 0.6 0.4 1.0 7.2 0.5 49.6 1.2 0.0 1.2 0.0 0.4 0.8 0.0 0.5 1.0 5.5 0.8 0.9 2.1 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.1 1.3 0.2 0.0 0.0 2.5 0.1 0.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 7.4 4.8 0.7 0.2 0.4 0.0 3.6 0.8 0.4 0.4 0.6 0.1 0.0 0.2 0.1 0.4 0.5 0.8 0.8 5.5 0.9 0.4 1.0 2.1 0.9 3.5 9.4 0.1 1.5 4.6 6.5 0.5 1.5 11.1 1.2 0.0 17.2 2.2 1.6 0.6 1.4 0.6 2.5 520.6 108.1 3.5 51.1 0.2 0.0 1.0 67.6 1.4 0.0 0.0 0.3 0.4 0.9 0.8 3.5 0.4 1.9 0.0 0.0 3.1 2.7 16.2 1.1 4.8 82.7 1.0 0.0 2.1 1.3 0.0 0.4 0.7 53.5 0.0 0.4 118.6 19.6 0.3 0.3 0.0 0.0 0.7 DNAAF2 "C14orf104, CILD10, FLJ10563, KTU, PF13" ENSG00000165506 "Dynein axonemal assembly factor 2" Q9NVR5 14 49625174-49635230 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002894, HPA004113" Enhanced Supported Cytosol NA NA Cytosol "HPA002894: AB_1078316, HPA004113: AB_1078315" "unprognostic (3.88e-2)" "unprognostic (2.11e-1)" "unprognostic (7.57e-2)" "unprognostic (5.85e-2)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-2)" "unprognostic (2.53e-2)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "unprognostic (2.25e-2)" "prognostic favorable (6.74e-7)" "unprognostic (6.72e-2)" "unprognostic (2.54e-1)" "unprognostic (5.04e-2)" "unprognostic (3.44e-2)" 3.4 5.7 4.3 3.9 9.1 2.5 5.8 5.9 4.9 4.6 7.1 4.8 2.3 7.6 4.2 13.8 5.3 9.2 6.1 4.1 5.5 5.2 7.0 9.5 9.7 4.9 4.0 3.8 14.6 7.0 3.6 7.3 3.7 10.7 4.0 4.7 2.9 5.3 3.0 5.4 2.9 6.8 3.0 3.8 3.9 4.8 48.1 3.2 4.8 5.4 8.5 4.3 4.3 3.5 12.6 6.2 7.2 5.8 13.7 11.5 5.3 10.3 6.2 13.7 10.6 6.7 7.8 13.0 5.6 6.2 6.2 6.9 6.0 10.0 15.2 8.9 3.7 5.1 11.4 11.2 7.8 7.8 10.5 6.7 7.7 4.6 10.3 5.2 12.4 6.5 5.1 8.5 5.3 7.3 6.4 6.4 8.4 11.5 10.4 6.1 12.8 8.1 12.9 14.9 10.8 11.3 10.2 10.6 5.1 8.8 8.7 20.9 15.6 8.3 9.1 9.9 9.0 10.3 5.0 5.2 5.9 16.6 6.0 6.9 20.9 13.0 12.5 2.2 7.7 6.4 6.7 5.5 7.2 8.7 4.7 10.4 12.6 9.8 11.5 6.2 9.7 9.5 9.3 2.1 13.7 5.8 5.6 9.1 5.3 4.3 9.1 5.9 4.9 5.5 5.2 4.0 3.8 10.7 3.2 3.0 3.5 17.3 19.1 36.5 7.1 7.3 5.1 22.7 2.3 12.2 0.0 18.3 26.6 23.9 17.8 15.2 14.4 0.0 21.0 26.5 18.1 14.8 11.5 20.2 12.2 3.2 9.2 20.3 9.1 5.0 17.0 10.4 18.6 9.0 15.1 8.0 21.7 14.0 15.6 29.9 11.8 6.5 13.8 17.7 14.3 38.5 10.4 17.3 20.2 14.2 DNAAF3 "C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22" ENSG00000167646 "Dynein axonemal assembly factor 3" 19 55158661-55166722 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 12 "fallopian tube: 29.7;testis: 60.1" "Group enriched" "Detected in many" 6 "Early spermatids: 336.2;Late spermatids: 540.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 17.3;HEL: 20.1;K-562: 15.7;U-937: 11.4" HPA056220 Approved "Nuclear bodies,Mitochondria" No No Mitochondria "Nuclear bodies" "HPA056220: AB_2683071" "unprognostic (1.71e-2)" "unprognostic (2.67e-2)" "unprognostic (6.10e-2)" "unprognostic (9.93e-3)" "unprognostic (1.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.22e-2)" "unprognostic (1.82e-1)" "unprognostic (5.36e-2)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (2.35e-2)" "unprognostic (8.03e-2)" 0.2 1.0 0.7 0.1 1.7 0.0 0.4 0.1 0.5 1.9 0.3 2.5 1.8 0.0 0.9 3.8 0.3 29.7 0.6 2.9 1.2 1.5 2.5 1.7 3.3 0.1 0.5 0.1 3.1 0.8 1.0 0.3 0.1 2.7 0.2 0.0 0.4 0.8 0.6 0.2 0.3 0.1 0.1 0.2 0.2 0.2 60.1 0.8 0.2 1.5 0.1 0.4 0.1 0.1 0.0 0.9 0.5 0.4 0.0 0.0 1.6 5.5 4.6 0.4 4.5 0.0 0.0 0.5 0.1 0.0 0.6 0.5 0.2 2.6 6.7 1.7 0.2 1.3 6.7 0.9 1.9 0.2 0.0 17.3 20.1 0.2 0.3 0.1 8.5 2.0 0.1 2.8 1.1 1.5 0.6 0.3 3.0 15.7 9.1 0.2 3.6 0.2 0.2 0.3 6.0 10.0 10.4 0.6 2.0 3.5 0.1 0.6 1.8 0.7 0.7 1.0 0.1 5.6 0.3 0.7 0.5 2.6 2.6 0.1 0.2 1.5 0.3 3.2 11.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.7 1.7 0.1 0.5 1.2 1.5 0.5 0.1 2.7 0.8 0.0 0.3 0.0 0.0 2.9 0.0 3.3 2.5 49.5 6.8 7.0 0.0 0.0 6.6 2.0 336.2 0.3 0.0 0.0 0.9 0.1 1.1 0.2 0.0 0.2 0.2 0.0 0.0 0.6 0.0 540.3 4.0 0.2 0.0 0.0 0.0 1.9 0.2 0.0 2.8 4.3 0.0 0.0 0.0 70.4 14.7 1.1 0.0 0.0 0.0 0.1 DNAAF4 "CILD25, DYX1C1, EKN1, FLJ37882" ENSG00000256061 "Dynein axonemal assembly factor 4" Q8WXU2 15 55410525-55508234 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.6" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 187.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.1" "Low region specificity" "Detected in all" HPA051048 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051048: AB_2681325" "unprognostic (5.97e-4)" "unprognostic (3.60e-2)" "unprognostic (1.69e-1)" "unprognostic (7.45e-4)" "unprognostic (1.74e-1)" "unprognostic (5.30e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-2)" "unprognostic (8.24e-2)" "unprognostic (2.91e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (5.29e-2)" "unprognostic (3.85e-2)" "unprognostic (3.06e-2)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" 1.8 3.0 11.4 1.8 14.7 1.6 4.9 1.8 8.0 4.3 2.1 3.2 5.9 1.1 7.0 15.3 1.8 15.7 3.4 1.6 9.2 7.8 7.2 1.0 6.2 1.5 4.2 8.9 4.8 3.5 13.6 26.6 1.2 9.1 3.2 1.5 6.9 2.4 3.2 1.3 2.4 1.3 3.1 3.7 2.0 1.7 14.6 4.5 0.1 14.3 0.9 1.3 2.8 2.0 2.9 4.2 4.3 1.8 0.7 1.1 0.4 6.5 4.4 4.7 10.1 1.9 3.3 1.5 0.9 2.4 3.1 3.6 0.9 2.6 0.5 4.2 2.0 5.0 1.8 1.8 2.6 3.7 2.0 2.1 2.3 2.8 1.5 1.8 5.0 4.1 2.0 5.5 7.5 2.8 4.9 7.0 2.1 0.7 0.3 4.6 2.3 0.9 4.3 2.6 10.1 3.6 0.8 2.3 0.8 17.1 2.3 4.8 10.5 4.3 1.1 5.8 4.4 6.0 1.2 2.3 5.0 2.5 4.1 4.8 1.8 4.8 1.4 8.2 1.0 1.1 0.0 1.8 1.3 0.6 1.2 0.4 2.9 0.9 0.7 1.2 2.6 1.1 0.8 4.3 0.7 1.2 4.2 0.9 0.4 11.4 14.7 1.8 8.0 9.2 7.8 4.2 8.9 9.1 4.5 11.9 15.9 0.0 0.0 0.0 0.0 0.0 0.0 187.4 28.4 12.2 0.0 1.6 5.0 11.3 0.0 0.0 0.0 0.0 4.4 1.1 0.0 0.0 2.3 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 DNAH10 FLJ43808 ENSG00000197653 "Dynein axonemal heavy chain 10" Q8IVF4 12 123762188-123936206 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 104.4;Club cells: 20.5;Early spermatids: 27.9;Late spermatids: 49.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 4.8;pons and medulla: 10.0" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 13 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;ASC diff: 3.9;SuSa: 2.4" HPA039066 Enhanced NA NA "HPA039066: AB_10673237" "unprognostic (1.37e-1)" "unprognostic (1.78e-1)" "unprognostic (6.08e-3)" "unprognostic (9.90e-3)" "unprognostic (2.16e-1)" "unprognostic (8.91e-2)" "unprognostic (3.39e-2)" "unprognostic (1.86e-1)" "unprognostic (5.59e-2)" "unprognostic (1.08e-2)" "unprognostic (7.28e-3)" "unprognostic (5.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.33e-1)" "unprognostic (7.23e-2)" "unprognostic (1.22e-2)" "unprognostic (9.11e-3)" 0.4 0.2 0.7 0.2 4.8 3.1 0.3 1.2 0.6 1.9 0.7 3.9 0.5 0.5 0.6 10.1 0.2 9.5 0.2 0.2 1.4 1.7 0.4 0.2 11.8 0.2 0.5 0.0 6.2 0.2 0.1 0.2 0.4 10.0 1.1 0.2 0.0 0.2 0.2 0.1 0.2 1.1 0.2 1.5 0.3 0.2 16.4 0.3 0.0 0.5 0.0 0.2 0.4 0.9 0.1 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.0 0.1 2.3 3.9 1.7 0.6 1.0 0.3 0.0 0.2 0.0 0.4 0.1 0.2 1.2 0.4 0.4 0.0 0.0 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 1.1 1.3 0.0 0.3 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.8 2.4 0.0 0.2 0.3 1.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 4.8 1.2 0.5 1.4 1.7 0.5 0.0 10.0 0.3 0.0 5.6 0.0 0.0 0.0 0.2 2.0 0.0 104.4 20.5 0.0 0.0 0.0 1.7 0.0 27.9 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.4 0.8 12.9 0.0 7.6 1.9 0.0 0.0 0.0 0.0 0.1 DNAH10OS FLJ45278 ENSG00000250091 "Dynein axonemal heavy chain 10 opposite strand" P0CZ25 12 123926424-123934984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 3.3;Cone photoreceptor cells: 3.9;Horizontal cells: 1.6;Rod photoreceptor cells: 1.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 9.0" HPA039786 Enhanced NA NA "HPA039786: AB_10795115" "unprognostic (1.62e-2)" "unprognostic (1.97e-2)" "unprognostic (8.74e-3)" "unprognostic (1.04e-2)" "unprognostic (7.76e-2)" "unprognostic (2.73e-1)" "unprognostic (8.78e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-1)" "unprognostic (3.52e-2)" "unprognostic (3.12e-3)" "unprognostic (3.45e-1)" "unprognostic (8.63e-3)" "unprognostic (3.20e-2)" "unprognostic (4.49e-2)" "unprognostic (1.16e-2)" "unprognostic (1.15e-2)" 0.9 0.3 3.6 0.4 5.2 0.8 1.2 7.6 6.3 0.4 0.7 0.3 0.8 0.8 0.5 0.5 0.6 1.0 3.7 1.5 3.7 0.5 1.5 0.4 1.4 1.6 2.7 2.1 1.1 0.6 1.1 0.4 0.9 1.8 1.7 0.6 0.4 1.3 1.0 0.8 1.4 0.9 1.8 0.4 0.4 0.3 0.6 0.3 3.3 0.7 0.3 1.0 0.3 0.5 3.8 3.1 4.2 2.0 1.9 1.1 0.6 3.3 0.5 0.5 0.3 0.3 0.4 1.3 1.6 0.5 0.3 0.9 0.2 0.2 1.8 0.5 0.7 0.3 0.2 0.7 0.3 2.8 0.3 1.1 0.8 0.2 9.0 0.7 3.1 0.2 0.7 0.7 2.5 0.3 0.6 0.3 0.1 0.4 0.2 0.2 0.1 3.2 1.2 0.7 3.1 0.3 0.3 0.7 3.1 0.7 0.3 1.2 4.4 0.2 1.0 0.4 2.0 0.8 0.2 2.7 0.4 1.6 1.1 0.7 0.3 1.0 0.4 0.8 0.6 0.3 0.8 0.1 0.6 0.4 0.5 3.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 1.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 DNAH11 "CILD7, DNAHBL, Dnahc11, DNHBL, DPL11" ENSG00000105877 "Dynein axonemal heavy chain 11" Q96DT5 7 21543215-21901839 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 22.2;parathyroid gland: 62.2" "Cell type enriched" "Detected in some" 9 "Ciliated cells: 111.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "basal ganglia: 5.5;pons and medulla: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.6;HUVEC TERT2: 2.4;U-2 OS: 2.7;U-2197: 3.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA045880, HPA056474" Approved NA NA "HPA045880: AB_10962003, HPA056474: AB_2683145" "unprognostic (2.24e-2)" "unprognostic (2.28e-1)" "unprognostic (1.01e-2)" "unprognostic (5.17e-3)" "unprognostic (4.15e-2)" "unprognostic (1.51e-1)" "unprognostic (9.01e-2)" "unprognostic (6.32e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.79e-2)" "unprognostic (3.10e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (3.86e-3)" "unprognostic (4.79e-3)" 3.2 4.6 0.8 0.5 5.5 0.4 0.4 0.2 1.0 1.6 0.9 6.7 3.0 0.4 0.8 22.2 2.5 9.3 0.5 1.1 2.5 1.2 0.5 0.8 7.7 0.4 0.2 0.6 7.2 0.5 62.2 0.8 2.9 15.5 1.1 0.5 0.0 0.4 1.0 1.5 0.9 0.6 0.4 0.3 0.4 0.5 0.9 2.1 0.7 5.2 0.3 0.5 0.4 3.4 0.6 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.7 0.0 0.6 0.9 0.0 0.1 0.1 0.0 0.4 0.0 0.1 7.6 0.1 0.0 0.7 1.5 0.0 1.7 0.0 0.5 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.4 0.7 0.2 0.3 0.0 0.0 0.6 0.0 0.1 0.7 0.0 1.4 0.0 0.0 1.7 0.7 2.7 3.4 0.4 0.2 0.1 0.3 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 5.5 0.2 1.0 2.5 1.2 0.2 0.6 15.5 2.1 6.0 3.8 0.0 3.5 2.2 0.0 3.3 0.0 111.1 12.5 0.0 0.0 0.0 0.0 0.1 2.5 0.3 0.0 0.0 0.0 1.3 0.2 2.3 0.0 0.2 0.1 6.4 0.0 0.0 0.0 1.5 0.3 0.0 1.7 1.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.7 0.4 0.3 1.4 0.0 0.0 0.7 DNAH12 "DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19" ENSG00000174844 "Dynein axonemal heavy chain 12" Q6ZR08 3 57293699-57544344 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 439.0" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enriched" "Detected in many" 8 "pons and medulla: 23.0" "Cell type enhanced" "Detected in single" "NK-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 3.1;GAMG: 1.9;LHCN-M2: 2.1" "HPA037493, HPA058203, HPA061365" Enhanced NA NA "HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493" "unprognostic (4.85e-2)" "unprognostic (1.29e-2)" "unprognostic (2.23e-1)" "unprognostic (2.18e-3)" "unprognostic (2.96e-2)" "unprognostic (2.17e-1)" "unprognostic (2.80e-2)" "unprognostic (1.51e-3)" "unprognostic (3.06e-2)" "unprognostic (3.21e-1)" "unprognostic (4.40e-2)" "unprognostic (5.90e-2)" "unprognostic (3.43e-5)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (2.53e-2)" "unprognostic (5.47e-2)" 0.2 0.3 0.6 0.1 3.0 0.1 0.4 0.2 0.5 1.3 0.2 5.3 0.0 0.1 1.4 11.6 0.2 16.7 0.5 0.1 2.9 0.8 0.2 0.3 17.5 0.2 0.4 0.0 7.6 3.1 0.1 8.9 0.1 23.0 0.2 0.2 0.0 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.2 0.2 17.6 1.0 0.0 0.3 0.0 0.1 0.2 0.2 0.5 0.5 0.0 0.0 1.2 0.9 0.1 0.3 0.7 0.0 0.0 0.9 0.3 0.1 0.0 0.2 0.3 0.0 3.1 0.3 0.1 0.0 0.4 1.9 0.4 0.0 0.3 0.2 0.7 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.6 0.1 0.4 0.4 0.2 0.6 0.2 0.1 2.1 0.0 0.0 0.4 0.0 0.4 0.5 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.9 0.1 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.2 0.0 0.0 1.2 0.0 0.5 0.0 0.1 0.6 3.0 0.2 0.3 2.9 0.8 0.4 0.0 23.0 1.0 3.0 1.4 0.0 0.2 0.0 0.2 0.8 0.0 439.0 70.5 0.0 0.0 0.1 0.0 0.1 38.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.1 0.0 0.1 0.0 1.7 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.4 0.4 0.0 0.0 0.0 24.4 2.6 0.0 0.0 0.0 0.0 0.0 DNAH14 "C1orf67, DKFZp781B1548, Dnahc14, HL-18, HL18, MGC27277" ENSG00000185842 "Dynein axonemal heavy chain 14" Q0VDD8 1 224896262-225399292 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 32.4;testis: 29.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 102.3;Spermatocytes: 58.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 3.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "K-562: 25.5" "HPA027718, HPA028545, HPA031379" Uncertain Supported Centrosome NA NA Centrosome "HPA027718: AB_10601210, HPA028545: AB_2672665, HPA031379: AB_2673851" "unprognostic (1.16e-1)" "unprognostic (1.77e-2)" "unprognostic (2.95e-1)" "unprognostic (1.86e-2)" "unprognostic (5.92e-2)" "unprognostic (1.09e-3)" "unprognostic (9.94e-4)" "unprognostic (4.23e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (2.12e-1)" "unprognostic (2.51e-1)" "unprognostic (2.33e-9)" "unprognostic (6.76e-2)" "unprognostic (7.39e-2)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" 1.6 5.2 6.3 2.7 2.5 2.5 5.2 0.9 3.4 3.1 2.9 0.2 3.8 1.7 3.3 6.5 2.0 2.6 5.3 3.7 7.0 5.5 4.2 6.8 5.4 0.6 2.9 4.6 5.5 11.2 3.4 32.4 2.6 7.2 4.3 3.7 3.6 3.4 7.8 0.6 1.0 1.1 4.6 8.5 1.0 3.8 29.9 0.8 3.2 7.1 0.9 0.4 2.5 1.9 0.6 0.2 0.4 0.2 3.5 0.9 0.0 10.4 5.4 4.9 5.4 2.0 4.1 11.8 2.2 2.0 4.0 3.5 8.4 11.5 0.0 5.4 2.2 0.0 0.1 7.6 2.1 6.8 0.0 12.6 5.0 3.6 1.8 2.4 10.3 1.7 3.9 4.6 5.5 3.9 4.3 1.3 7.3 25.5 0.0 6.8 2.8 1.8 10.8 13.9 11.8 6.6 0.0 18.8 9.5 3.7 4.8 8.3 9.4 8.4 6.3 16.9 8.6 11.6 9.0 0.2 0.0 8.0 0.2 0.1 11.6 7.2 0.1 0.0 0.0 7.5 0.0 0.1 0.3 0.1 0.2 0.0 0.6 0.3 0.7 0.2 0.3 0.4 0.5 0.4 3.5 0.1 0.0 0.9 0.0 6.3 2.5 0.9 3.4 7.0 5.5 2.9 4.6 7.2 0.8 11.9 11.5 0.0 10.9 1.8 29.3 4.4 10.2 5.3 4.5 19.2 31.4 8.6 6.6 11.0 102.3 2.9 1.1 0.0 8.7 10.5 3.0 8.7 13.9 7.6 3.0 27.0 7.9 2.5 0.0 31.3 2.6 1.6 3.3 1.0 4.3 11.2 8.0 0.0 3.2 6.4 3.4 6.5 0.9 58.5 19.2 0.6 9.6 0.0 4.1 6.8 DNAH17 "DNAHL1, DNEL2, FLJ40457" ENSG00000187775 "Dynein axonemal heavy chain 17" Q9UFH2 17 78423697-78577394 "Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 45 "testis: 39.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 44.2;Cone photoreceptor cells: 82.5;Early spermatids: 36.7;Late spermatids: 24.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.0;MOLT-4: 4.8" "Not detected" "Not detected" "HPA024354, HPA076261" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA024354: AB_1847911, HPA076261: AB_2732305" "unprognostic (4.98e-4)" "unprognostic (2.26e-1)" "unprognostic (2.30e-3)" "unprognostic (8.70e-3)" "unprognostic (6.66e-2)" "unprognostic (9.23e-2)" "unprognostic (3.72e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.20e-3)" "unprognostic (8.35e-3)" "unprognostic (1.58e-10)" "unprognostic (5.25e-2)" "unprognostic (1.54e-1)" "unprognostic (5.12e-1)" "unprognostic (6.04e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.1 0.0 39.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 1.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 6.0 0.3 0.5 0.2 0.6 44.2 2.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 36.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 24.9 0.6 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 7.2 0.0 0.2 16.2 0.5 0.1 0.0 0.0 0.0 0.1 DNAH2 "DNHD3, FLJ46675, KIAA1503" ENSG00000183914 "Dynein axonemal heavy chain 2" Q9P225 17 7717354-7833744 "Predicted intracellular proteins, Predicted membrane proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 14.3;parathyroid gland: 20.0;testis: 21.0" "Group enriched" "Detected in some" 7 "Ciliated cells: 33.5;Rod photoreceptor cells: 127.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 4.8;CACO-2: 7.5;CAPAN-2: 4.8;OE19: 3.5;SCLC-21H: 4.6;SiHa: 4.5" "Low region specificity" "Detected in many" HPA067103 Enhanced Approved Microtubules NA NA Microtubules "HPA067103: AB_2685778" "unprognostic (2.03e-2)" "unprognostic (1.79e-2)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (3.92e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-1)" "unprognostic (7.50e-3)" "unprognostic (1.29e-2)" "unprognostic (8.28e-2)" "unprognostic (2.51e-3)" "unprognostic (1.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (8.74e-3)" "unprognostic (4.60e-2)" 0.2 0.1 1.5 0.2 4.8 0.5 0.5 1.8 0.9 1.3 0.2 7.9 1.1 0.2 0.7 5.7 0.2 14.3 0.4 0.2 2.1 1.9 0.2 0.3 5.5 0.2 0.2 0.6 3.0 0.5 20.0 1.2 1.8 7.0 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 21.0 0.7 0.2 0.3 0.2 0.2 0.2 0.2 1.2 0.6 3.2 0.7 0.6 0.7 0.1 4.8 0.2 0.3 0.3 0.1 0.0 0.8 0.2 0.1 0.0 0.1 7.5 4.8 0.2 2.3 0.1 0.1 0.4 0.0 1.1 0.1 0.1 0.2 0.1 0.5 0.2 1.2 0.3 0.2 0.4 0.0 0.8 0.1 0.7 0.0 0.3 0.2 0.4 0.0 0.9 0.1 0.4 0.4 3.5 1.6 0.2 0.5 0.1 0.0 1.4 4.6 0.3 4.5 0.1 2.3 0.4 0.4 0.3 0.2 0.4 0.9 0.1 0.0 0.4 0.1 0.2 0.1 0.1 0.8 0.7 0.7 0.4 0.7 0.3 0.5 0.5 0.4 0.6 0.2 1.2 0.5 0.7 3.2 0.6 0.3 0.6 0.3 0.1 1.5 4.8 1.8 0.9 2.1 1.9 0.2 0.6 7.0 0.7 0.0 1.4 0.0 0.8 0.2 2.1 1.7 0.0 33.5 4.5 0.0 2.0 0.0 0.0 0.1 5.0 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 1.6 6.4 0.6 0.3 1.7 0.3 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 127.6 0.0 0.4 11.6 2.3 0.1 0.0 0.0 0.0 0.7 DNAH3 "DKFZp434N074, DLP3, Dnahc3b, Hsadhc3" ENSG00000158486 "Dynein axonemal heavy chain 3" Q8TD57 16 20933111-21159441 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 10.4;testis: 6.2" "Group enriched" "Detected in some" 5 "Ciliated cells: 87.0;Early spermatids: 28.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.2;hTEC/SVTERT24-B: 1.4;U-698: 1.2" HPA062493 Approved "Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane" "Intermediate filaments" "HPA062493: " "unprognostic (1.68e-1)" "unprognostic (9.84e-2)" "unprognostic (1.32e-1)" "unprognostic (2.11e-3)" "unprognostic (1.25e-2)" "unprognostic (5.23e-2)" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (7.50e-2)" "unprognostic (1.75e-1)" "unprognostic (2.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.57e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 10.4 0.0 0.0 0.5 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.0 1.2 0.1 0.4 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.6 0.2 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.0 1.6 0.0 87.0 9.1 0.0 0.0 0.2 0.0 0.0 28.8 0.3 0.9 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 5.3 0.5 0.0 0.0 1.9 0.1 DNAH5 "CILD3, Dnahc5, HL1, KTGNR, PCD" ENSG00000039139 "Dynein axonemal heavy chain 5" Q8TE73 5 13690331-13944543 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.9" "Group enriched" "Detected in many" 11 "Ciliated cells: 321.2;Club cells: 100.1" "Cancer enhanced" "Detected in many" "prostate cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.2;LHCN-M2: 2.8;PC-3: 6.7;RPTEC TERT1: 3.7;TIME: 2.6" "HPA037469, HPA037470" Enhanced NA NA "HPA037469: AB_10672791, HPA037470: AB_10672348" "unprognostic (3.85e-1)" "unprognostic (8.17e-2)" "unprognostic (5.94e-2)" "unprognostic (1.12e-1)" "unprognostic (4.58e-3)" "unprognostic (6.23e-2)" "unprognostic (3.33e-3)" "unprognostic (2.86e-2)" "unprognostic (9.94e-2)" "unprognostic (4.39e-2)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (9.97e-3)" "unprognostic (8.87e-2)" "unprognostic (8.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" 0.0 0.1 0.5 0.0 1.1 0.0 3.7 0.0 0.4 0.7 0.0 0.0 0.3 0.2 0.0 8.9 0.2 0.0 0.8 1.1 1.9 1.6 3.8 0.0 0.2 0.0 1.7 0.0 3.3 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 2.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 0.2 0.1 0.0 0.2 0.1 0.9 4.2 0.2 0.3 0.0 1.4 0.0 1.4 0.6 1.1 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.7 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.5 6.7 0.0 0.0 0.0 3.7 1.0 0.8 0.0 0.1 0.2 0.0 0.8 0.1 0.0 2.6 0.2 0.5 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 19.5 0.0 1.5 0.0 0.0 1.2 15.3 321.2 100.1 5.2 0.0 0.0 0.0 5.5 6.0 0.3 0.0 0.0 3.1 0.1 0.2 10.1 2.3 8.9 0.0 0.0 1.7 0.0 0.0 3.1 0.0 0.7 0.0 0.0 0.0 0.5 3.2 0.0 0.0 1.4 0.0 0.0 0.4 0.4 3.6 0.0 0.0 0.0 0.0 1.5 DNAH6 "Dnahc6, DNHL1, FLJ37357, HL-2" ENSG00000115423 "Dynein axonemal heavy chain 6" Q9C0G6 2 84516455-84819589 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;fallopian tube: 15.3;pituitary gland: 17.4" "Group enriched" "Detected in many" 6 "Ciliated cells: 149.9;Early spermatids: 61.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "naive CD4 T-cell: 3.8;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 16 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "GAMG: 3.1;OE19: 5.9;SK-MEL-30: 1.8" "Low region specificity" "Detected in many" "HPA036391, HPA061401" Enhanced NA NA "HPA036391: AB_10672220, HPA061401: " "unprognostic (4.87e-2)" "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.72e-2)" "unprognostic (1.67e-1)" "unprognostic (6.43e-2)" "unprognostic (6.06e-2)" "unprognostic (3.46e-1)" "unprognostic (8.11e-8)" "unprognostic (2.04e-1)" "unprognostic (2.33e-1)" "unprognostic (2.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.80e-2)" "unprognostic (5.97e-2)" 1.4 1.2 7.7 0.8 17.7 0.7 1.7 0.6 10.0 1.8 1.0 3.2 0.7 0.7 2.0 11.0 0.6 15.3 0.8 0.6 7.9 3.5 1.9 3.6 4.8 1.0 0.9 7.2 5.1 1.2 6.2 17.4 0.7 23.7 1.1 1.1 0.5 0.6 1.3 0.5 0.7 0.8 0.8 1.6 0.8 2.0 7.2 3.0 0.0 3.9 0.0 0.8 0.7 0.6 0.0 0.2 0.1 0.0 0.0 3.8 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.5 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.3 0.5 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 1.8 0.1 0.0 0.3 0.0 0.3 0.3 0.2 0.1 1.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 3.8 1.2 0.0 0.0 0.0 0.2 0.0 0.4 7.7 17.7 0.6 10.0 7.9 3.5 0.9 7.2 23.7 3.0 6.0 2.6 0.0 1.6 0.1 0.3 1.2 2.5 149.9 17.0 0.0 2.0 1.0 0.0 0.3 61.0 0.7 0.0 0.0 0.8 0.1 0.4 1.3 0.0 3.9 0.1 0.0 0.0 0.0 0.3 10.6 0.6 0.6 1.7 0.0 0.7 1.5 0.2 0.0 0.7 0.8 3.5 0.0 0.0 8.6 4.9 0.0 0.2 0.5 1.6 0.4 DNAH7 KIAA0944 ENSG00000118997 "Dynein axonemal heavy chain 7" Q8WXX0 2 195737703-196068812 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 127.2;Cone photoreceptor cells: 66.8;Early spermatids: 40.0;Rod photoreceptor cells: 42.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "neutrophil: 2.0;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;granulocytes: 2.0" "Cell line enhanced" "Detected in some" "PC-3: 10.6;RPTEC TERT1: 5.0" "Low region specificity" "Detected in many" "HPA034724, HPA044070" Enhanced Supported Cytosol NA NA Cytosol "HPA034724: AB_10670977, HPA044070: AB_2678798" "unprognostic (1.71e-1)" "unprognostic (2.81e-2)" "unprognostic (2.65e-2)" "unprognostic (1.04e-2)" "unprognostic (3.56e-1)" "unprognostic (1.58e-2)" "unprognostic (6.74e-3)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.24e-1)" "unprognostic (7.76e-2)" "unprognostic (2.52e-3)" "unprognostic (3.98e-2)" 1.0 2.6 6.8 1.4 9.9 0.7 1.9 0.6 6.4 3.3 1.9 4.6 4.3 0.9 2.2 12.9 1.1 19.4 1.9 1.4 7.1 5.8 4.5 1.2 9.5 0.9 3.4 3.5 3.9 4.2 3.6 25.2 0.9 21.7 1.9 1.6 1.8 1.8 2.5 0.6 0.9 1.9 1.2 2.1 0.8 1.5 18.3 2.3 0.0 5.9 0.0 1.0 1.3 0.5 0.3 2.0 2.0 0.0 0.1 0.2 0.2 0.6 2.4 0.5 0.2 1.4 0.9 0.2 0.2 1.4 0.5 0.6 0.5 1.7 0.0 0.7 0.5 1.8 0.1 0.0 0.3 0.4 0.0 1.4 0.0 3.0 0.7 0.2 0.1 0.2 0.3 0.4 2.1 0.4 3.2 0.0 0.0 0.6 3.3 0.9 2.4 0.0 0.1 0.5 1.2 10.6 0.1 0.6 0.8 5.0 0.3 1.1 1.9 0.6 0.4 0.2 0.2 1.0 0.2 0.0 1.3 0.4 2.1 0.6 2.6 2.4 0.0 2.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 2.0 0.1 0.0 2.0 0.0 0.2 6.8 9.9 0.6 6.4 7.1 5.8 3.4 3.5 21.7 2.3 0.0 6.7 0.0 1.1 0.8 1.7 1.2 0.0 127.2 17.0 1.8 66.8 0.0 0.0 1.9 40.0 0.7 2.1 0.0 0.6 0.0 0.9 2.2 0.0 0.0 0.1 1.6 0.0 0.6 0.0 20.2 0.6 0.5 1.7 0.0 0.6 2.7 0.8 0.0 1.4 2.2 42.3 0.0 0.5 26.9 4.3 1.1 0.1 0.0 0.4 0.6 DNAH8 hdhc9 ENSG00000124721 "Dynein axonemal heavy chain 8" Q96JB1 6 38715341-39030529 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 36.0" "Group enriched" "Detected in some" 4 "Early spermatids: 21.1;Late spermatids: 6.9;Spermatocytes: 22.6" "Cancer enriched" "Detected in single" 7 "prostate cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "basophil: 5.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.4" "Cell line enriched" "Detected in some" 8 "HMC-1: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA028447 Uncertain NA NA "HPA028447: AB_10599600" "unprognostic (2.83e-1)" "unprognostic (4.46e-4)" "unprognostic (1.27e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "unprognostic (1.22e-2)" "unprognostic (1.41e-1)" "unprognostic (3.47e-3)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.17e-9)" "unprognostic (1.46e-3)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-3)" 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 3.5 0.0 0.0 0.0 0.1 0.0 2.6 0.2 0.0 0.1 5.0 0.0 36.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.7 0.0 5.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 3.8 0.0 0.0 0.0 0.0 0.0 DNAH9 "DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357" ENSG00000007174 "Dynein axonemal heavy chain 9" Q9NYC9 17 11598431-11969748 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.8;fallopian tube: 41.2" "Group enriched" "Detected in many" 8 "Ciliated cells: 84.3;Early spermatids: 42.5;Late spermatids: 41.7" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.4;Karpas-707: 1.6;NTERA-2: 2.3;SH-SY5Y: 2.0;WM-115: 4.6" "Low region specificity" "Detected in some" HPA052641 Enhanced NA NA "HPA052641: AB_2681895" "unprognostic (4.16e-3)" "unprognostic (3.67e-2)" "unprognostic (9.31e-2)" "prognostic favorable (6.79e-5)" "unprognostic (8.37e-3)" "unprognostic (3.17e-2)" "unprognostic (2.43e-1)" "unprognostic (1.68e-1)" "unprognostic (1.26e-1)" "unprognostic (7.35e-2)" "unprognostic (1.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-3)" "unprognostic (5.31e-2)" 2.8 1.4 8.1 0.9 8.3 0.6 1.1 0.8 5.2 2.0 0.7 13.1 2.1 0.6 2.3 9.6 0.8 41.2 1.0 0.6 11.4 10.4 1.7 0.7 5.5 0.6 8.4 2.2 8.2 2.7 2.8 3.0 1.0 18.8 1.5 0.7 0.8 0.6 3.1 0.9 1.0 0.6 1.2 8.5 0.7 0.7 7.1 3.6 0.0 1.5 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.1 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 8.3 0.8 5.2 11.4 10.4 8.4 2.2 18.8 3.6 3.0 0.6 0.0 0.7 0.7 1.8 1.4 0.0 84.3 5.7 3.5 2.0 0.0 1.7 0.8 42.5 0.0 0.0 0.0 0.2 0.0 0.9 1.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.6 0.0 0.0 0.0 0.0 0.9 0.2 0.0 2.8 0.1 7.4 0.0 0.3 6.1 3.6 1.0 0.1 0.0 0.0 0.6 DNAI1 "CILD1, DIC1, PCD" ENSG00000122735 "Dynein axonemal intermediate chain 1" Q9UI46 9 34457414-34520989 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 14.6;fallopian tube: 32.2;pituitary gland: 36.4;testis: 47.0" "Cell type enhanced" "Detected in some" 25 "Ciliated cells: 109.7;Late spermatids: 23.8;Spermatocytes: 48.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 3.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;BEWO: 5.8;HDLM-2: 4.1;RPTEC TERT1: 2.2;SK-BR-3: 3.0;T-47d: 1.9" "Low region specificity" "Detected in many" "HPA021649, HPA021843" Enhanced NA NA "HPA021649: AB_1847913, HPA021843: AB_1847914" "unprognostic (9.61e-2)" "unprognostic (5.16e-2)" "unprognostic (4.59e-2)" "unprognostic (1.44e-3)" "unprognostic (3.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (6.39e-2)" "unprognostic (4.38e-1)" "unprognostic (1.51e-1)" "unprognostic (8.16e-3)" "unprognostic (8.14e-2)" "unprognostic (2.74e-2)" "unprognostic (3.77e-2)" "unprognostic (2.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" 0.4 0.4 2.3 0.4 8.0 0.4 0.9 0.3 3.1 2.2 0.4 3.6 0.0 0.4 1.3 6.8 0.4 32.2 0.5 0.4 2.7 3.3 0.9 0.5 4.3 0.4 1.0 0.2 3.5 1.2 1.9 36.4 0.4 14.6 0.5 0.4 1.3 0.4 0.5 0.4 0.4 0.4 0.4 0.6 0.4 0.6 47.0 1.5 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 1.8 0.7 0.2 0.0 5.8 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.4 0.3 0.0 3.0 0.8 1.2 1.9 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 8.0 0.3 3.1 2.7 3.3 1.0 0.2 14.6 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 109.7 13.6 0.0 3.9 0.1 1.7 0.0 16.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 1.2 0.0 0.0 48.1 2.7 0.0 0.2 0.0 0.0 0.0 DNAI2 "CILD9, DIC2" ENSG00000171595 "Dynein axonemal intermediate chain 2" Q9GZS0 17 74274247-74314884 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 28.1;testis: 47.2" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 60.2;Early spermatids: 11.0;Late spermatids: 10.6;Spermatocytes: 22.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "NK-cell: 7.9" "Lineage enriched" "Detected in single" 8 "NK-cells: 7.9" "Cell line enriched" "Detected in some" 4 "HMC-1: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB006245, HPA050565" Enhanced NA NA "CAB006245: AB_426059, HPA050565: AB_2681177" "unprognostic (6.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.36e-1)" "unprognostic (3.04e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (1.16e-3)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (3.14e-2)" "unprognostic (1.61e-3)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "unprognostic (2.89e-2)" "unprognostic (1.96e-1)" "unprognostic (1.46e-1)" "unprognostic (4.62e-3)" 0.1 0.0 0.8 0.2 1.3 0.1 0.0 0.0 0.1 2.5 0.0 3.1 0.0 0.0 0.9 2.9 0.0 28.1 0.0 0.0 1.6 1.7 0.0 0.0 3.8 0.1 0.0 0.0 3.7 0.0 0.0 1.9 0.1 3.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 47.2 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.9 0.7 0.0 0.0 0.1 0.1 0.0 7.9 0.0 0.0 0.6 0.1 0.8 1.3 0.0 0.1 1.6 1.7 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 60.2 3.4 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 22.1 0.5 0.0 0.0 0.0 0.0 0.0 DNAJA1 "dj-2, hdj-2, HSJ2, HSPF4, NEDD7" ENSG00000086061 "DnaJ heat shock protein family (Hsp40) member A1" P31689 9 33025211-33039907 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 189.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001306, CAB033665" Approved Supported Microtubules,Cytosol NA NA Cytosol Microtubules "CAB033665: AB_2094242, HPA001306: AB_1079043" "unprognostic (3.11e-2)" "unprognostic (5.05e-2)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (3.17e-2)" "unprognostic (2.88e-2)" "unprognostic (5.58e-2)" "prognostic favorable (5.39e-4)" "unprognostic (1.69e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.40e-4)" "unprognostic (3.27e-1)" "unprognostic (2.65e-1)" "unprognostic (1.25e-1)" "unprognostic (4.70e-2)" 29.0 46.7 46.5 26.1 47.2 42.7 57.2 31.6 53.3 30.4 18.7 20.7 25.5 14.4 27.6 27.9 17.1 34.8 28.2 22.2 42.5 51.7 36.0 71.9 30.7 23.8 56.5 30.8 30.7 19.5 47.3 40.2 35.0 49.6 29.8 21.7 9.0 18.9 23.0 14.5 13.1 15.9 29.0 42.4 22.3 20.8 42.2 51.5 24.1 47.0 15.3 28.1 27.9 189.5 36.6 60.0 50.0 69.0 31.6 37.2 49.5 38.7 69.6 56.4 19.5 39.2 25.5 32.3 40.1 32.4 72.2 56.2 46.1 18.0 39.8 30.8 27.2 40.9 17.7 81.1 24.1 62.3 56.0 23.6 31.9 85.7 58.4 18.8 36.6 37.5 15.6 24.9 27.1 8.7 35.1 43.0 17.4 49.6 17.4 41.3 31.7 61.1 80.7 54.8 39.1 48.6 45.0 20.2 20.4 40.4 23.0 35.8 39.1 53.9 34.9 17.9 44.0 16.3 35.6 36.8 25.8 44.1 29.3 53.2 11.2 34.7 42.1 33.8 32.0 22.1 33.3 40.1 43.3 28.5 56.0 33.3 36.6 35.6 31.4 35.7 32.7 37.2 34.7 50.0 31.6 69.0 60.0 30.1 49.5 46.5 47.2 31.6 53.3 42.5 51.7 56.5 30.8 49.6 51.5 199.5 144.3 123.6 875.9 235.0 170.2 172.5 48.4 514.0 273.0 78.5 196.3 237.2 145.9 218.2 352.5 305.0 136.1 70.0 158.2 280.3 289.7 362.1 422.8 118.0 203.3 114.4 374.9 98.8 133.8 169.3 91.7 282.9 269.9 316.6 116.6 133.1 170.5 185.9 89.1 138.6 144.4 103.5 321.4 400.4 214.4 232.0 388.8 169.6 115.9 335.9 DNAJA4 PRO1472 ENSG00000140403 "DnaJ heat shock protein family (Hsp40) member A4" Q8WW22 15 78264086-78282196 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 63.2;skeletal muscle: 69.0" "Group enriched" "Detected in many" 5 "Early spermatids: 661.6;Late spermatids: 1220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.7;HeLa: 18.6;RT4: 34.6;SCLC-21H: 22.3;SiHa: 17.4;THP-1: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004646, HPA041790" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004646: AB_426011, HPA041790: AB_2677674" "unprognostic (8.41e-2)" "unprognostic (2.48e-1)" "unprognostic (3.00e-2)" "unprognostic (8.20e-3)" "unprognostic (1.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.86e-2)" "unprognostic (7.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.08e-7)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (9.01e-2)" "unprognostic (2.93e-2)" 7.3 10.1 29.6 7.6 33.7 28.6 7.6 20.1 25.8 8.6 8.7 10.5 10.4 7.8 5.1 25.3 9.1 21.7 6.6 63.2 22.3 33.8 7.7 1.9 7.0 6.0 26.0 28.1 3.6 3.2 9.5 11.9 5.5 29.2 15.4 10.6 7.2 6.8 9.6 69.0 15.5 9.0 10.7 16.0 5.1 10.8 26.8 14.9 2.0 6.3 15.2 6.9 12.6 62.3 1.9 1.1 2.7 1.0 0.4 4.7 1.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.2 0.0 17.7 0.0 0.1 1.3 0.0 12.8 0.0 0.0 0.0 0.0 0.0 7.9 18.6 0.0 4.0 0.0 8.6 1.5 1.7 1.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.0 0.0 34.6 22.3 0.0 17.4 3.5 1.5 1.0 13.4 16.0 0.2 0.0 3.7 1.6 0.1 0.2 0.9 0.0 0.0 1.7 0.0 0.0 0.8 2.7 1.8 0.9 2.6 1.9 2.5 2.5 1.1 0.4 4.7 3.9 0.0 0.4 1.0 0.6 1.4 1.6 29.6 33.7 20.1 25.8 22.3 33.8 26.0 28.1 29.2 14.9 6.0 4.5 10.8 119.2 25.5 16.8 36.3 2.5 131.2 36.4 7.0 76.6 1.2 1.7 1.2 661.6 9.0 34.2 93.5 2.1 3.7 10.3 173.0 37.9 0.2 13.8 6.4 96.0 7.4 7.3 1220.8 9.5 17.6 49.0 1.8 23.3 9.8 3.7 22.8 10.6 5.0 21.2 6.5 7.7 27.5 21.6 40.8 5.7 8.5 16.9 141.9 DNAJB1 "Hsp40, HSPF1, RSPH16B, Sis1" ENSG00000132002 "DnaJ heat shock protein family (Hsp40) member B1" P25685 19 14514770-14529770 "Cancer-related genes, Predicted intracellular proteins" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 291.1" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017450, HPA063247" Enhanced Supported Nucleoplasm NA Yes 9600 Nucleoplasm "CAB017450: AB_10631418, HPA063247: AB_2684971" "unprognostic (3.75e-2)" "unprognostic (2.23e-1)" "unprognostic (1.46e-1)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.74e-2)" "unprognostic (3.83e-1)" "unprognostic (1.85e-1)" "unprognostic (7.91e-3)" "unprognostic (2.17e-1)" "prognostic favorable (5.96e-4)" "unprognostic (2.20e-2)" "unprognostic (4.44e-2)" "unprognostic (2.00e-2)" "unprognostic (6.77e-2)" 29.2 76.9 28.5 13.2 30.0 36.2 67.0 41.4 29.4 19.3 15.5 21.5 14.5 10.5 20.4 11.8 72.3 21.7 56.4 23.5 28.2 31.6 23.4 37.7 35.7 10.7 53.4 12.0 32.3 22.6 18.3 25.0 33.5 45.8 29.6 13.1 12.2 18.4 40.8 16.1 25.3 9.5 24.0 40.2 9.4 19.1 37.5 37.9 15.0 28.9 18.0 31.1 19.2 291.1 19.7 15.2 28.2 31.6 23.0 61.6 56.7 36.9 39.3 14.2 15.1 26.2 21.1 8.9 24.6 18.3 39.0 29.5 23.2 20.9 10.2 28.2 20.9 25.5 28.1 29.1 17.7 27.7 10.7 14.4 16.3 26.0 48.6 17.9 11.5 15.5 11.7 42.4 15.1 13.2 20.4 12.8 6.9 24.1 110.7 21.4 23.4 18.5 10.7 15.1 48.9 42.4 14.2 20.0 23.0 17.7 12.7 13.1 9.7 22.3 44.2 24.2 16.6 12.1 11.2 13.3 31.7 19.1 36.5 51.6 49.3 30.2 13.4 22.6 19.9 28.2 11.5 18.9 22.3 36.6 31.1 38.9 19.4 52.5 45.4 15.2 19.7 61.6 47.6 28.2 23.0 31.6 9.1 51.8 56.7 28.5 30.0 41.4 29.4 28.2 31.6 53.4 12.0 45.8 37.9 145.9 105.3 114.6 695.7 378.2 47.1 335.7 48.4 87.0 71.7 22.7 111.9 123.3 34.9 105.0 377.6 275.7 133.0 0.0 143.2 142.5 617.3 678.1 342.8 50.4 134.5 49.3 390.0 73.1 71.9 368.9 58.7 232.5 477.5 35.1 126.4 109.5 97.8 108.7 34.6 43.9 149.2 25.8 802.9 139.1 31.8 418.7 229.9 251.4 123.6 238.8 DNAJB13 "RSPH16A, TSARG6" ENSG00000187726 "DnaJ heat shock protein family (Hsp40) member B13" P59910 11 73950319-73970366 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Chaperone "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 30.4;testis: 10.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 66.9;Early spermatids: 65.2;Late spermatids: 44.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 8.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA052465, HPA061330" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA052465: AB_2681842, HPA061330: AB_2732659" "unprognostic (1.07e-1)" "unprognostic (3.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.56e-2)" "unprognostic (1.03e-1)" "unprognostic (1.20e-4)" "unprognostic (1.30e-2)" "unprognostic (1.72e-4)" "unprognostic (5.00e-2)" "unprognostic (4.73e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (2.10e-6)" "unprognostic (3.32e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-2)" "unprognostic (2.40e-2)" 0.0 0.0 1.2 0.4 1.4 2.1 0.0 0.0 0.1 4.7 0.0 0.1 1.0 3.2 0.0 30.4 1.1 0.0 1.6 1.5 0.6 0.0 1.9 1.0 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.4 1.6 0.0 0.2 1.4 0.0 0.2 0.5 0.0 10.8 0.1 0.0 0.0 0.0 1.6 3.4 3.1 0.8 0.6 1.7 0.4 0.4 0.9 1.4 1.7 0.1 0.4 0.8 0.3 0.0 0.4 0.1 1.8 0.7 1.8 4.0 0.7 0.8 1.3 0.3 0.0 0.1 5.1 0.8 2.1 1.9 0.7 0.0 1.1 1.6 0.0 0.8 0.4 0.0 1.1 0.0 2.6 0.7 5.2 1.0 0.8 1.3 1.8 0.6 0.5 2.9 0.8 2.8 1.8 8.3 1.6 0.8 2.1 1.0 4.3 0.4 0.9 0.8 1.5 0.3 0.6 1.3 1.9 0.7 4.3 3.5 3.5 0.6 0.5 0.5 3.1 0.8 1.1 1.2 0.2 0.4 1.6 1.2 0.7 0.7 1.5 1.0 1.7 1.4 0.6 0.3 3.4 1.1 0.4 3.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 66.9 3.4 1.8 0.0 0.0 0.0 1.1 65.2 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.5 1.1 0.0 1.7 0.0 0.0 0.2 0.1 0.0 1.1 0.1 0.5 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 0.6 DNAJB4 HLJ1 ENSG00000162616 "DnaJ heat shock protein family (Hsp40) member B4" Q9UDY4 1 77979175-78017964 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 89.8" "Cell type enhanced" "Detected in all" 4 "Syncytiotrophoblasts: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 28.6;HUVEC TERT2: 43.5;LHCN-M2: 73.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004995, HPA028383, HPA028385" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944" "unprognostic (1.21e-1)" "unprognostic (4.36e-2)" "unprognostic (2.19e-1)" "unprognostic (5.50e-3)" "unprognostic (3.40e-2)" "unprognostic (4.76e-3)" "unprognostic (4.32e-3)" "unprognostic (3.93e-3)" "unprognostic (1.53e-1)" "unprognostic (2.16e-1)" "unprognostic (2.00e-1)" "unprognostic (3.22e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (7.12e-3)" "unprognostic (1.01e-2)" 23.3 39.0 19.2 8.4 20.7 4.9 16.6 22.7 24.1 21.3 12.7 7.2 9.3 5.4 20.8 10.1 25.0 11.7 25.2 42.0 18.0 16.8 16.0 15.5 21.7 7.0 25.7 9.1 15.3 18.5 16.4 19.1 19.5 23.8 19.4 9.4 5.1 7.0 12.2 33.3 7.6 8.8 23.0 29.5 30.3 11.9 7.8 22.5 2.8 35.1 29.4 5.1 22.1 89.8 3.6 5.0 4.5 1.9 3.1 7.2 2.6 1.4 2.8 3.5 2.1 15.3 28.6 1.6 27.8 7.1 12.4 14.0 0.9 1.8 2.1 4.7 13.2 5.1 2.1 4.5 2.4 21.2 2.3 1.2 1.0 8.3 6.7 20.8 0.5 0.5 11.8 6.7 16.0 4.6 6.9 43.5 0.7 4.5 1.5 73.8 0.1 0.6 1.5 2.2 0.4 1.3 1.1 6.2 1.3 2.9 0.7 2.5 0.8 3.2 2.3 2.6 3.8 0.9 0.9 20.7 17.5 4.3 12.4 3.6 1.3 0.4 1.8 2.3 1.2 3.0 4.5 1.7 2.7 2.6 1.7 4.4 3.6 3.2 3.1 1.7 3.0 7.2 5.1 0.4 3.1 1.9 5.0 4.2 2.6 19.2 20.7 22.7 24.1 18.0 16.8 25.7 9.1 23.8 22.5 56.6 4.6 13.3 77.1 37.1 28.0 82.6 10.2 30.8 20.5 17.4 64.8 46.9 31.5 10.5 126.4 66.1 19.8 23.3 12.8 18.9 83.6 23.4 57.5 18.1 15.9 28.6 20.5 33.2 21.3 48.4 22.7 19.0 62.4 6.4 4.0 35.7 14.8 17.5 32.9 22.8 56.8 25.8 119.1 21.1 13.2 34.4 151.4 15.2 6.5 27.1 DNAJB5 Hsc40 ENSG00000137094 "DnaJ heat shock protein family (Hsp40) member B5" O75953 9 34989641-34998900 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 99.4" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 37.5;Smooth muscle cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "myeloid DC: 7.7;neutrophil: 7.6" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023818, HPA050794" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA023818: AB_1847793, HPA050794: AB_2681241" "unprognostic (1.41e-2)" "unprognostic (3.87e-1)" "unprognostic (2.53e-3)" "unprognostic (5.21e-2)" "unprognostic (1.86e-1)" "unprognostic (3.54e-2)" "unprognostic (7.31e-2)" "unprognostic (2.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-2)" "unprognostic (1.89e-1)" "unprognostic (1.17e-1)" "unprognostic (4.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.00e-3)" 7.2 6.3 5.9 5.1 7.2 0.9 2.6 8.6 13.0 6.5 19.1 6.2 9.2 3.8 18.5 9.7 15.7 9.6 8.7 29.3 6.6 6.3 3.7 2.0 3.7 2.2 4.7 3.4 6.5 3.1 2.2 8.6 1.4 6.0 13.8 6.2 5.7 3.7 26.2 99.4 1.5 6.1 29.9 4.5 5.6 11.3 8.1 3.5 1.6 4.4 38.0 2.9 23.0 3.6 0.7 7.7 7.6 1.5 0.5 1.3 0.7 2.5 2.1 13.4 7.1 7.9 6.1 1.5 11.2 8.2 17.3 15.4 1.5 0.6 2.4 2.8 12.3 18.2 0.3 5.1 8.8 14.7 3.5 1.6 0.9 3.1 0.7 9.1 0.3 8.1 8.9 0.6 10.2 5.1 7.7 11.0 4.6 0.2 5.2 13.9 1.8 4.2 3.6 6.3 1.1 4.5 3.2 13.9 1.3 2.4 0.2 5.7 9.3 6.0 0.3 1.3 12.1 2.2 0.8 4.9 8.3 18.2 4.3 3.4 1.9 1.3 1.7 9.5 1.0 8.9 0.1 1.5 0.0 0.4 0.4 1.3 0.7 0.3 0.1 7.7 0.3 0.5 1.1 7.6 0.5 0.1 0.2 1.3 0.7 5.9 7.2 8.6 8.5 6.6 6.3 4.7 3.4 6.0 3.5 6.0 1.0 0.9 1.9 1.8 4.1 37.5 2.5 1.4 1.2 0.0 5.9 0.1 0.0 2.1 5.3 5.2 0.7 0.0 3.0 0.5 3.1 1.5 0.0 1.1 4.7 1.6 0.0 2.5 1.5 5.1 1.4 2.8 5.0 1.0 0.0 12.0 4.2 0.0 7.4 3.7 2.5 6.5 19.4 8.0 0.9 2.6 0.7 0.8 0.0 0.6 DNAJB7 HSC3 ENSG00000172404 "DnaJ heat shock protein family (Hsp40) member B7" Q7Z6W7 22 40859549-40862126 "Predicted intracellular proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 24.9" "Cell type enriched" "Detected in some" 8 "Early spermatids: 549.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA000534 Approved NA NA "HPA000534: AB_1078693" "unprognostic (3.89e-2)" "unprognostic (1.12e-2)" "unprognostic (9.61e-2)" "unprognostic (1.27e-1)" "unprognostic (5.45e-2)" "unprognostic (2.66e-2)" "unprognostic (1.16e-2)" "unprognostic (5.56e-3)" "unprognostic (1.62e-1)" "unprognostic (7.42e-2)" "unprognostic (1.22e-3)" "unprognostic (2.81e-2)" "unprognostic (4.46e-4)" "unprognostic (3.32e-3)" "unprognostic (3.06e-2)" "unprognostic (7.05e-2)" "unprognostic (2.45e-2)" 0.1 0.1 0.1 0.2 0.2 0.9 0.1 1.1 0.3 0.2 0.1 0.1 0.1 0.9 0.2 1.3 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.3 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.6 0.3 0.9 0.1 0.1 0.2 0.3 24.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.9 0.5 2.4 0.6 0.5 1.6 0.1 0.4 0.1 1.0 1.5 0.0 0.0 1.7 1.0 0.0 0.0 0.0 0.3 0.3 1.6 0.2 0.1 0.8 0.6 0.0 0.0 0.0 0.1 0.8 0.6 2.3 0.6 0.0 1.5 0.5 0.0 0.0 0.2 0.0 0.4 0.0 0.6 1.1 1.8 0.1 0.6 1.9 1.9 1.3 0.5 0.3 1.1 1.1 0.7 0.0 0.6 1.7 0.4 0.5 0.7 0.3 1.0 0.3 1.0 0.0 1.1 1.6 1.4 0.5 1.7 0.9 1.0 0.1 0.5 1.3 1.9 0.5 0.3 0.7 0.4 0.7 0.3 0.6 0.6 0.3 0.9 1.6 0.9 2.4 0.5 0.6 0.5 0.2 0.1 0.1 0.2 1.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 549.9 0.0 0.9 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.1 1.6 0.0 0.0 0.0 68.8 2.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.5 0.0 9.9 0.0 0.0 2.7 1.4 0.0 0.2 0.0 0.8 0.0 DNAJB8 "CT156, MGC33884" ENSG00000179407 "DnaJ heat shock protein family (Hsp40) member B8" Q8NHS0 3 128462439-128467248 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 286 "testis: 28.6" "Group enriched" "Detected in some" 114 "Early spermatids: 999.2;Late spermatids: 3374.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SH-SY5Y: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 999.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3374.7 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 6.5 0.0 19.3 7.5 0.0 0.0 0.0 0.0 0.0 DNAJC10 "ERdj5, PDIA19" ENSG00000077232 "DnaJ heat shock protein family (Hsp40) member C10" Q8IXB1 2 182716041-182794464 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 74.8" "Cell type enhanced" "Detected in all" 4 "Ciliated cells: 156.6;Early spermatids: 164.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031111 Approved NA NA "HPA031111: AB_10601211" "unprognostic (3.29e-2)" "unprognostic (5.20e-3)" "unprognostic (3.10e-3)" "prognostic favorable (6.42e-5)" "unprognostic (1.89e-1)" "unprognostic (1.18e-1)" "unprognostic (4.34e-3)" "unprognostic (1.82e-2)" "unprognostic (1.54e-2)" "unprognostic (4.34e-2)" "unprognostic (2.29e-1)" "unprognostic (9.76e-2)" "prognostic unfavorable (2.19e-7)" "unprognostic (2.91e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.87e-2)" 10.4 8.6 10.2 21.2 12.1 2.8 14.8 11.2 14.5 17.2 10.9 7.4 28.9 8.3 18.5 74.8 8.1 18.8 17.0 17.7 10.8 12.8 14.5 14.0 12.2 17.3 10.7 8.9 14.4 21.9 16.1 17.7 11.5 10.5 12.4 11.8 9.0 19.7 31.5 7.6 6.6 11.7 11.8 11.4 16.3 15.1 14.5 7.7 13.5 17.8 8.2 15.0 10.9 10.3 22.0 13.1 2.1 12.2 6.6 7.3 6.9 10.6 8.2 14.0 7.2 23.0 30.6 14.5 23.3 30.3 14.7 16.5 14.9 20.2 32.2 22.8 21.7 18.0 11.7 12.1 18.5 26.9 15.6 10.9 11.3 12.3 12.1 19.9 25.3 21.8 16.0 20.4 18.1 30.2 23.8 32.7 6.8 10.9 16.7 15.4 4.6 8.9 7.0 22.7 14.2 20.3 10.0 14.2 38.6 24.4 12.2 12.6 11.9 14.7 13.8 14.0 22.1 6.6 8.5 30.0 25.9 18.8 14.6 16.9 11.7 24.1 18.0 35.9 16.9 22.3 2.1 12.2 0.9 5.8 10.8 7.3 22.0 6.3 6.3 13.1 20.2 6.1 6.3 1.2 6.6 7.7 7.7 5.9 6.9 10.2 12.1 11.2 14.5 10.8 12.8 10.7 8.9 10.5 7.7 41.7 19.5 54.5 15.2 15.2 33.5 38.3 38.2 156.6 45.5 54.1 17.7 9.8 5.0 42.2 164.5 36.8 7.7 23.3 54.2 34.9 31.0 39.6 29.0 22.1 32.9 22.3 31.2 39.3 29.9 40.9 33.6 30.3 18.6 10.0 110.7 20.3 38.0 14.8 41.8 19.0 26.1 45.3 35.3 87.4 41.1 12.9 9.0 20.8 19.8 17.3 DNAJC12 JDP1 ENSG00000108176 "DnaJ heat shock protein family (Hsp40) member C12" Q9UKB3 10 67796665-67838166 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.7;liver: 46.2" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 77.6;Intestinal endocrine cells: 159.7;Pancreatic endocrine cells: 67.5;Proximal tubular cells: 98.7" "Cancer enhanced" "Detected in many" "breast cancer: 22.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in single" 21 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "Daudi: 33.0;NB-4: 27.2;SCLC-21H: 27.2;U-698: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036289 Enhanced NA NA "HPA036289: AB_10670794" "unprognostic (1.52e-2)" "unprognostic (3.65e-3)" "unprognostic (4.12e-2)" "unprognostic (2.28e-2)" "unprognostic (5.28e-2)" "unprognostic (6.59e-3)" "unprognostic (6.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (5.05e-2)" "unprognostic (3.97e-2)" "unprognostic (7.31e-3)" "prognostic unfavorable (1.97e-10)" "unprognostic (7.35e-3)" "unprognostic (1.37e-1)" "unprognostic (5.81e-3)" "unprognostic (7.99e-2)" 1.3 31.4 14.7 1.9 21.6 1.3 22.3 34.7 16.8 4.9 6.5 6.6 1.9 2.6 5.5 4.6 1.2 2.5 4.1 3.4 11.3 18.6 19.7 46.2 1.5 0.8 13.4 10.1 11.2 14.7 9.3 22.5 0.5 13.7 3.0 10.2 1.0 6.4 4.9 6.9 0.5 3.6 4.5 10.4 1.1 5.5 5.1 12.6 0.6 0.9 1.1 0.9 1.9 1.2 0.2 10.5 0.0 0.0 0.0 0.4 0.0 0.0 11.8 1.9 0.3 2.7 2.2 0.0 0.0 0.7 0.4 2.5 0.2 0.0 33.0 5.0 0.0 0.1 0.0 0.3 0.3 0.1 1.5 13.5 7.7 10.4 3.0 2.9 14.7 0.1 7.3 2.8 1.2 0.7 0.0 4.2 0.9 14.3 0.4 1.1 0.6 0.7 27.2 0.5 0.1 13.4 0.3 1.1 17.2 0.3 0.0 27.2 15.4 0.1 5.3 0.4 0.1 0.2 0.1 0.0 1.3 0.3 0.3 0.3 3.1 0.3 24.6 2.5 17.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.2 0.2 0.4 0.0 0.0 0.0 10.5 0.0 0.0 14.7 21.6 34.7 13.6 11.3 18.6 13.4 10.1 13.7 12.6 0.0 1.4 1.3 1.0 0.2 28.8 6.1 0.0 36.1 19.4 5.2 5.9 0.0 8.3 1.1 4.5 1.1 2.1 0.0 47.7 0.2 2.3 19.0 0.0 77.6 0.7 36.5 159.7 1.3 1.6 3.1 15.0 4.1 0.0 6.4 52.0 13.5 67.5 4.3 20.1 98.7 4.9 0.0 4.1 1.8 0.7 0.1 0.0 0.0 4.1 1.0 DNAJC18 MGC29463 ENSG00000170464 "DnaJ heat shock protein family (Hsp40) member C18" Q9H819 5 139408588-139444491 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.4" "Group enriched" "Detected in many" 20 "Early spermatids: 425.4;Late spermatids: 1065.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036538, HPA060154" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA036538: AB_10670802, HPA060154: AB_2684212" "unprognostic (2.03e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (2.73e-3)" "unprognostic (8.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "prognostic favorable (5.89e-4)" "unprognostic (8.09e-2)" "unprognostic (1.69e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (6.96e-2)" "unprognostic (1.97e-2)" 4.1 4.0 8.2 2.9 15.7 1.9 4.3 10.7 19.5 4.7 3.3 12.4 0.7 1.8 7.6 4.9 3.9 4.9 4.2 6.3 8.7 8.7 4.5 1.2 4.5 3.3 8.8 11.7 10.7 2.3 6.5 7.1 4.1 16.2 4.9 3.0 3.4 2.1 5.9 8.4 2.2 2.4 6.8 9.0 2.9 2.4 51.4 7.5 1.2 5.1 1.7 2.6 3.4 3.3 3.5 2.0 2.1 2.0 6.0 6.7 1.4 1.6 1.8 11.3 10.4 6.3 6.7 1.2 3.4 7.5 6.0 11.0 4.0 1.3 7.5 9.3 5.3 13.3 2.9 6.3 10.2 6.3 17.0 8.4 5.1 3.8 1.9 5.0 0.6 2.5 9.0 1.3 10.0 6.1 10.2 8.2 2.9 2.2 7.3 8.9 0.9 2.2 2.4 7.8 0.6 2.5 6.2 12.3 1.2 3.6 1.8 10.5 11.0 3.5 1.4 7.7 15.2 1.6 3.8 10.5 8.0 0.0 2.4 7.2 8.7 11.4 4.0 4.3 3.8 3.4 1.9 2.0 2.1 2.2 1.3 3.2 3.5 3.2 4.1 1.5 3.5 3.2 2.0 0.6 6.0 0.7 2.0 6.7 1.4 8.2 15.7 10.7 19.5 8.7 8.7 8.8 11.7 16.2 7.5 3.0 4.6 2.2 8.0 1.3 29.0 8.8 0.0 2.7 7.9 1.8 9.8 3.8 1.7 4.8 425.4 11.3 0.5 0.0 0.9 3.3 5.4 2.7 9.2 0.0 2.4 15.9 12.1 12.9 3.1 1065.4 13.0 2.6 5.0 4.6 2.5 14.5 2.5 1.4 17.7 2.9 18.4 19.4 8.5 37.2 4.9 1.0 3.9 3.2 1.2 2.6 DNAJC22 "FLJ13236, wus" ENSG00000178401 "DnaJ heat shock protein family (Hsp40) member C22" Q8N4W6 12 49346917-49357546 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 10.0;intestine: 10.0;liver: 18.9" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 40.8;Enterocytes: 38.0;Exocrine glandular cells: 37.8;Hepatocytes: 39.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 15.7;EFO-21: 16.9;MCF7: 13.8;OE19: 28.8;T-47d: 12.5" "Region enhanced" "Detected in single" "midbrain: 1.4" "Not detected" "Not detected" HPA039953 Approved Vesicles NA NA Vesicles "HPA039953: AB_2676770" "unprognostic (5.23e-2)" "unprognostic (1.24e-1)" "unprognostic (9.01e-2)" "prognostic favorable (4.56e-5)" "unprognostic (4.77e-3)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (4.05e-2)" "prognostic unfavorable (7.54e-4)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-2)" "unprognostic (9.35e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-2)" 1.1 0.3 0.5 0.4 1.0 0.0 0.4 0.4 2.2 1.5 5.4 0.8 0.4 10.0 2.2 1.3 0.4 0.8 10.0 0.4 0.7 0.5 5.2 18.9 0.4 0.4 1.0 1.2 0.4 5.2 2.7 0.4 0.9 4.6 0.4 5.2 0.8 1.2 0.4 0.4 0.2 8.3 0.4 0.8 0.4 4.4 0.6 0.4 0.4 6.6 0.4 0.4 0.4 0.7 0.7 0.8 2.7 0.5 0.5 0.5 0.4 1.4 9.4 0.0 10.0 0.0 0.0 3.3 0.3 3.0 1.0 2.2 15.7 9.9 0.0 16.9 0.3 0.9 0.1 1.4 0.0 1.7 0.1 2.3 0.3 0.2 7.8 2.4 0.0 1.7 0.1 0.0 1.5 0.3 4.0 1.4 0.0 0.1 0.3 0.7 13.8 0.0 0.0 0.0 28.8 4.8 0.0 4.8 0.0 0.2 0.0 1.6 0.8 0.3 0.5 3.1 0.2 12.5 0.2 0.2 1.0 3.1 0.1 1.3 0.0 0.0 0.0 2.3 0.0 2.0 2.3 0.5 0.5 0.5 0.3 0.3 0.4 0.4 0.3 0.1 0.7 0.3 0.3 2.7 0.5 0.4 0.8 0.2 0.4 0.5 1.0 0.4 2.2 0.7 0.5 1.0 1.2 4.6 0.4 0.0 0.6 0.0 1.8 0.6 0.1 0.3 40.8 8.1 1.2 1.8 0.0 0.1 0.0 13.9 3.9 0.3 38.0 0.0 37.8 0.2 1.3 0.5 1.1 39.4 0.1 3.2 20.2 1.3 0.3 1.3 0.0 0.0 3.3 1.0 24.6 0.6 20.2 23.0 0.7 18.0 0.3 0.0 0.3 0.0 0.4 0.3 0.3 0.0 23.4 0.1 DNAJC25 bA16L21.2.1 ENSG00000059769 "DnaJ heat shock protein family (Hsp40) member C25" Q9H1X3 9 111631352-111654351 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 41.9" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019122 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019122: AB_1853155" "unprognostic (3.07e-1)" "unprognostic (7.42e-2)" "unprognostic (8.94e-3)" "prognostic favorable (3.73e-4)" "unprognostic (2.08e-2)" "unprognostic (5.66e-2)" "unprognostic (1.60e-2)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (9.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.09e-2)" "unprognostic (2.52e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-1)" "unprognostic (8.30e-2)" "unprognostic (5.19e-2)" 5.1 10.2 3.3 3.9 4.6 1.9 5.8 4.5 4.2 3.4 5.1 2.5 5.7 4.6 4.1 7.7 3.4 3.8 3.6 6.7 4.3 3.8 7.8 41.9 3.5 4.1 2.7 2.3 5.7 7.0 7.4 9.0 4.4 3.3 5.9 3.0 3.6 9.7 4.0 3.6 2.4 6.9 5.0 2.9 2.9 3.7 4.2 1.9 1.4 4.3 2.4 2.2 6.4 4.5 0.6 1.1 1.2 1.9 0.4 0.8 0.3 2.6 2.0 1.4 2.4 14.7 6.6 5.4 10.2 4.9 4.0 4.0 3.9 1.7 2.3 4.0 7.0 6.3 8.6 1.5 2.9 3.9 1.9 2.0 2.3 0.0 7.9 4.8 4.3 3.4 5.7 8.3 3.1 5.9 3.2 3.3 1.3 4.6 2.0 5.1 2.9 1.3 0.2 2.5 5.1 4.8 2.2 7.5 2.1 8.4 2.9 2.4 1.3 5.7 8.0 3.6 2.6 4.2 1.1 6.4 4.9 2.2 13.1 5.8 3.7 5.6 1.3 8.4 2.1 4.3 0.0 0.1 1.2 0.6 1.9 0.2 0.3 0.5 0.0 0.5 0.6 0.5 0.2 0.8 0.4 1.0 1.1 0.8 0.3 3.3 4.6 4.5 4.2 4.3 3.8 2.7 2.3 3.3 1.9 6.0 11.0 14.5 13.2 9.4 7.7 9.0 7.6 13.4 12.5 10.4 19.6 11.8 11.6 13.6 7.8 4.9 17.6 0.0 14.1 18.7 13.1 26.6 1.1 75.4 10.9 12.7 16.6 6.7 5.0 1.4 9.5 7.9 11.8 4.6 14.9 3.9 11.0 7.4 9.6 10.7 20.2 12.9 11.3 29.8 11.9 8.2 11.6 7.9 10.9 17.1 DNAJC27 "RabJS, RBJ" ENSG00000115137 "DnaJ heat shock protein family (Hsp40) member C27" Q9NZQ0 2 24943636-24972094 "Predicted intracellular proteins" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 30.4" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 74.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036815, HPA036816" Uncertain Approved Cytosol NA NA Cytosol "HPA036815: , HPA036816: AB_10673506" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (4.53e-2)" "unprognostic (3.09e-1)" "unprognostic (5.17e-3)" "unprognostic (5.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.13e-1)" "unprognostic (4.60e-2)" "unprognostic (7.44e-4)" "unprognostic (8.84e-2)" "prognostic favorable (8.48e-5)" "unprognostic (3.35e-1)" "unprognostic (3.66e-1)" "unprognostic (3.05e-2)" "unprognostic (1.78e-3)" 6.0 5.6 6.7 3.4 13.8 5.3 5.9 9.4 15.7 5.6 4.1 6.8 1.9 3.2 6.6 8.1 3.7 5.7 4.8 7.3 6.7 8.0 6.1 3.1 4.4 4.1 9.5 6.5 10.9 3.6 7.6 10.2 4.6 19.0 5.5 4.6 4.9 3.2 5.2 6.5 4.5 3.3 5.0 8.3 4.1 3.7 30.4 8.2 3.6 5.3 2.4 3.9 4.1 6.1 1.4 0.8 2.9 1.2 4.5 1.9 0.9 4.6 2.0 4.3 4.4 6.2 5.2 3.3 3.6 5.3 3.8 3.3 2.1 2.1 4.3 0.8 2.5 3.2 3.7 3.3 2.2 3.9 1.9 2.6 2.7 2.4 1.9 3.9 2.4 3.8 3.9 3.8 3.0 5.9 4.3 1.5 5.2 1.8 4.0 4.1 1.7 4.3 4.2 2.8 1.6 1.8 2.7 8.7 2.4 3.6 2.5 1.6 5.6 3.3 2.6 4.9 4.8 2.3 1.8 1.4 5.0 3.6 2.6 3.2 10.4 3.7 5.2 2.5 4.0 2.1 0.0 0.8 2.9 1.0 0.5 1.9 1.4 1.2 0.8 0.8 1.1 1.6 1.8 0.2 4.5 1.2 0.4 1.1 0.9 6.7 13.8 9.4 15.7 6.7 8.0 9.5 6.5 19.0 8.2 8.9 7.7 4.2 5.9 1.8 22.7 19.8 5.1 22.7 2.3 7.0 35.3 3.3 3.3 2.4 37.0 4.1 3.2 0.0 2.2 1.6 4.0 4.1 10.4 2.5 2.9 35.0 14.9 5.5 2.4 25.8 8.1 4.3 1.7 3.6 4.6 11.7 1.3 0.0 6.0 2.2 22.5 0.0 12.8 74.8 19.0 2.9 3.5 5.7 4.3 3.0 DNAJC5B "CSP-beta, MGC26226" ENSG00000147570 "DnaJ heat shock protein family (Hsp40) member C5 beta" Q9UF47 8 66021560-66100526 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 52.6" "Group enriched" "Detected in some" 54 "Early spermatids: 825.6;Late spermatids: 1955.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 9.6" "Lineage enriched" "Detected in many" 5 "B-cells: 9.6" "Group enriched" "Detected in some" 5 "HDLM-2: 15.0;RPTEC TERT1: 17.4;THP-1: 10.6;U-266/70: 9.6;U-937: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.01e-1)" "unprognostic (7.29e-3)" "unprognostic (7.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.76e-2)" "unprognostic (4.92e-2)" "unprognostic (7.85e-2)" "unprognostic (7.78e-2)" "unprognostic (2.53e-3)" "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (8.38e-2)" "unprognostic (1.65e-2)" "unprognostic (2.80e-1)" "unprognostic (4.42e-2)" "unprognostic (1.88e-1)" "unprognostic (8.84e-2)" 0.2 0.1 0.2 1.3 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.2 0.6 0.4 0.2 0.7 0.3 0.1 0.2 0.2 0.2 0.1 0.2 0.7 3.2 3.6 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.5 0.2 0.2 0.2 1.2 0.1 0.9 0.2 0.3 0.8 0.1 52.6 0.2 0.2 0.2 1.6 1.8 0.6 0.2 9.6 1.8 0.0 0.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.6 0.0 0.4 0.0 0.0 0.0 9.6 0.0 0.3 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.7 0.0 9.6 0.0 0.0 1.8 2.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.0 0.0 9.3 0.8 0.1 0.0 0.2 0.0 4.0 1.2 0.0 0.0 0.1 0.0 0.0 825.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 7.3 0.0 0.0 0.0 5.6 1955.3 12.4 4.6 1.7 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 25.8 0.2 10.2 5.0 0.1 0.0 0.0 0.0 0.5 DNAJC5G "CSP-gamma, FLJ40417" ENSG00000163793 "DnaJ heat shock protein family (Hsp40) member C5 gamma" Q8N7S2 2 27275421-27281499 "Predicted membrane proteins" Chaperone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "epididymis: 35.8;testis: 58.0" "Group enriched" "Detected in some" 6 "Early spermatids: 52.3;Late spermatids: 63.1;Spermatocytes: 116.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 2.8;HAP1: 3.6;JURKAT: 3.7;SH-SY5Y: 1.9" "Not detected" "Not detected" HPA041445 Approved NA NA "HPA041445: AB_2677485" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (2.61e-2)" "unprognostic (2.26e-1)" "unprognostic (3.99e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-2)" "unprognostic (1.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.06e-1)" "unprognostic (1.75e-4)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" "unprognostic (7.67e-2)" "unprognostic (1.97e-2)" 0.1 0.7 0.5 0.1 0.1 0.0 0.1 0.1 2.1 0.4 0.1 0.1 0.1 0.0 0.3 35.8 0.1 0.2 0.1 1.3 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 58.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.9 2.4 0.9 0.4 0.7 0.8 2.8 1.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 1.0 0.3 0.0 1.4 0.1 0.9 1.6 0.0 0.0 0.0 0.6 0.5 0.5 3.7 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 1.5 1.5 0.4 0.0 0.4 0.2 1.9 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 1.6 0.9 0.6 0.3 0.5 0.2 0.2 0.3 0.3 0.1 0.5 0.7 0.3 2.4 0.4 0.6 0.9 0.2 0.8 0.5 0.1 0.1 2.1 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 116.2 14.0 0.0 0.0 0.0 0.0 0.0 DNAJC6 "KIAA0473, PARK19" ENSG00000116675 "DnaJ heat shock protein family (Hsp40) member C6" O75061 1 65248219-65415869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Chaperone, Hydrolase, Protein phosphatase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 91.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 29.6;Cardiomyocytes: 26.1;Erythroid cells: 23.3;Horizontal cells: 49.3;Rod photoreceptor cells: 21.6" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 21.2;HEL: 56.7;K-562: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031182, HPA054917" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA031182: AB_10611957, HPA054917: AB_2682641" "unprognostic (6.99e-2)" "unprognostic (2.00e-3)" "unprognostic (3.19e-1)" "unprognostic (7.94e-7)" "unprognostic (1.59e-1)" "unprognostic (7.61e-3)" "unprognostic (1.87e-4)" "unprognostic (2.98e-1)" "unprognostic (1.89e-1)" "unprognostic (4.14e-1)" "unprognostic (4.22e-3)" "unprognostic (1.53e-1)" "prognostic favorable (2.81e-4)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.36e-1)" "unprognostic (8.67e-3)" 2.1 12.1 18.6 2.2 28.5 5.0 2.0 24.2 91.4 2.2 2.8 26.9 0.0 2.3 1.9 1.8 1.7 2.4 2.3 9.0 25.0 26.7 8.5 1.6 2.7 1.6 28.8 23.8 1.9 3.4 2.1 7.5 8.0 40.5 2.5 3.0 2.2 1.7 2.1 1.6 2.1 2.3 2.2 28.7 3.2 2.9 3.2 21.1 0.0 3.0 0.0 1.7 1.8 0.6 0.5 0.5 0.0 0.0 0.6 1.5 0.3 3.5 1.0 0.0 1.6 0.8 0.2 8.4 7.1 11.6 11.7 11.5 0.9 0.1 3.4 0.6 2.9 2.9 0.9 5.1 1.1 9.2 21.2 2.4 56.7 1.9 0.2 0.0 1.9 1.4 1.0 0.8 1.1 5.0 2.2 0.2 2.8 22.0 0.4 2.4 0.6 0.7 0.0 2.3 0.0 0.8 0.0 1.7 0.1 8.9 0.0 14.2 9.7 4.1 5.6 1.9 14.1 2.7 0.1 2.2 1.7 1.2 0.2 2.0 2.1 1.4 1.0 4.8 1.4 2.9 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.5 0.9 0.0 0.0 0.4 0.6 0.0 0.6 0.0 0.5 0.0 0.3 18.6 28.5 24.2 37.4 25.0 26.7 28.8 23.8 40.5 21.1 0.0 0.3 0.0 0.2 1.1 29.6 26.1 0.0 0.0 0.0 0.0 13.7 4.8 1.7 0.8 1.8 0.7 0.0 23.3 0.6 1.9 1.7 1.3 0.0 0.0 1.1 49.3 6.9 0.0 0.0 1.4 0.0 0.8 6.8 1.8 1.3 3.1 0.4 0.0 0.0 5.9 21.6 0.0 2.3 1.0 2.3 0.3 6.2 0.0 0.5 0.1 DNAJC9 "JDD1, SB73" ENSG00000213551 "DnaJ heat shock protein family (Hsp40) member C9" Q8WXX5 10 73183362-73248862 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.2" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 140.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035215, HPA035216" Supported Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA035215: AB_10603663, HPA035216: AB_2674522" "unprognostic (4.18e-2)" "unprognostic (1.61e-2)" "unprognostic (7.63e-2)" "unprognostic (2.67e-3)" "unprognostic (3.45e-1)" "unprognostic (6.83e-3)" "unprognostic (2.43e-3)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.20e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (7.07e-5)" "unprognostic (5.61e-2)" "unprognostic (3.08e-3)" "unprognostic (6.49e-2)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" 3.1 4.0 4.0 5.0 4.3 24.2 4.6 12.9 5.8 3.0 4.6 4.2 4.0 3.9 6.8 2.9 1.7 2.7 4.2 5.2 2.8 3.5 2.9 7.7 3.5 5.2 2.6 3.6 4.3 5.4 3.6 5.8 3.6 3.9 3.4 5.3 4.1 3.8 3.1 5.9 3.4 4.3 2.9 9.9 3.1 4.4 15.6 9.4 13.2 4.9 10.6 16.5 8.8 26.5 16.4 21.3 17.6 5.1 5.0 9.4 21.6 12.8 21.7 22.7 28.1 18.7 18.4 7.1 9.5 9.3 18.1 21.3 14.3 24.6 21.3 14.7 39.1 16.8 18.6 3.5 34.3 15.8 4.0 7.9 22.8 20.0 10.6 14.3 23.4 34.9 21.4 17.1 24.6 33.2 26.0 7.8 12.6 46.0 24.7 18.6 10.1 10.8 12.9 10.2 17.2 15.8 26.0 11.3 10.2 13.6 16.1 10.4 14.5 25.7 15.5 32.9 10.0 15.1 29.6 14.6 34.2 9.3 7.3 1.8 13.2 13.0 4.9 14.4 15.6 15.9 14.1 3.0 12.7 15.6 13.8 2.1 10.6 4.7 9.4 16.5 8.8 8.9 10.5 40.2 29.5 42.4 24.8 2.4 25.5 29.4 27.3 8.7 7.9 69.3 18.3 29.2 74.3 18.0 13.1 140.2 27.2 89.2 17.4 20.5 39.5 8.2 51.9 14.3 11.5 9.8 11.3 30.7 13.0 16.8 30.4 31.5 17.2 26.4 30.7 17.3 19.1 11.3 38.3 25.8 22.7 21.1 59.5 38.0 48.5 45.3 32.2 33.3 DNAL1 "1700010H15RiK, C14orf168, CILD16, MGC12435" ENSG00000119661 "Dynein axonemal light chain 1" Q4LDG9 14 73644875-73703732 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 42.4" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 129.8;Early spermatids: 234.2;Spermatocytes: 109.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053129, HPA060974" Approved Approved "Nucleoplasm,Centriolar satellite" NA NA "Nucleoplasm, Centriolar satellite" "HPA053129: AB_2682051, HPA060974: " "unprognostic (1.11e-1)" "unprognostic (1.13e-2)" "unprognostic (2.27e-2)" "unprognostic (4.31e-2)" "unprognostic (1.66e-1)" "unprognostic (4.34e-1)" "unprognostic (4.25e-3)" "unprognostic (2.80e-1)" "unprognostic (2.91e-1)" "unprognostic (2.36e-2)" "unprognostic (3.16e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.17e-8)" "unprognostic (9.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 6.2 6.3 9.9 5.2 15.0 5.2 4.7 9.2 15.6 5.6 4.7 10.6 7.2 2.4 9.8 11.2 4.1 20.2 8.6 7.6 16.0 9.6 9.9 3.9 6.7 4.3 7.3 14.2 7.1 5.7 11.8 15.0 4.2 18.8 5.5 5.0 7.6 5.5 7.7 4.4 2.9 3.1 8.2 8.5 4.1 5.0 42.4 7.6 3.5 14.2 2.9 3.9 4.8 4.4 6.8 10.9 6.3 4.7 3.8 7.5 2.4 9.2 6.8 8.4 7.6 6.0 7.6 6.9 9.3 7.2 12.3 12.7 7.1 14.7 3.7 7.0 9.8 11.6 5.6 7.9 7.2 17.7 5.5 3.3 3.0 10.1 2.5 6.2 3.5 3.8 5.7 5.8 13.3 9.6 9.3 7.8 5.9 3.4 8.5 14.7 15.1 9.0 4.3 3.9 7.7 6.8 6.5 12.7 1.5 10.1 9.8 13.1 6.1 15.5 3.0 7.2 6.9 16.6 2.4 7.4 15.3 27.6 11.4 8.6 5.0 10.4 7.9 12.5 1.8 10.6 6.3 4.3 4.5 5.2 4.7 7.5 4.9 5.1 5.3 3.9 6.8 4.8 5.2 4.1 3.8 3.7 10.9 4.3 2.4 9.9 15.0 9.2 15.6 16.0 9.6 7.3 14.2 18.8 7.6 17.9 12.2 5.6 6.2 2.9 13.9 11.5 20.4 129.8 26.1 17.4 56.9 4.4 8.3 13.8 234.2 10.5 2.6 0.0 12.4 7.6 10.5 6.3 9.3 5.5 7.5 14.3 9.8 8.0 7.5 33.5 16.1 6.3 11.8 8.2 6.0 18.8 9.5 5.1 15.6 18.2 38.1 12.9 8.2 109.4 22.6 1.8 2.1 5.7 5.4 4.1 DNALI1 "dJ423B22.5, hp28, P28" ENSG00000163879 "Dynein axonemal light intermediate chain 1" O14645 1 37556919-37566857 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 50.5;testis: 59.5" "Group enriched" "Detected in many" 7 "Ciliated cells: 307.9;Early spermatids: 530.7;Late spermatids: 878.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.1;ASC TERT1: 9.0;hTERT-RPE1: 13.5;RPTEC TERT1: 12.1;SH-SY5Y: 8.4;T-47d: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028305, HPA031633" Enhanced NA NA "HPA028305: AB_10601807, HPA031633: " "unprognostic (1.21e-2)" "unprognostic (9.04e-2)" "unprognostic (2.58e-2)" "unprognostic (6.09e-3)" "unprognostic (2.33e-1)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "prognostic favorable (6.02e-4)" "unprognostic (1.52e-1)" "unprognostic (5.50e-3)" "unprognostic (8.00e-3)" "unprognostic (3.52e-2)" "unprognostic (1.74e-2)" "unprognostic (1.19e-1)" "unprognostic (2.78e-2)" "unprognostic (1.47e-1)" "unprognostic (5.52e-2)" 2.4 6.3 9.7 1.3 10.8 0.6 7.7 2.6 7.2 9.2 3.9 17.2 10.5 1.7 8.4 20.6 3.2 50.5 8.8 2.9 10.1 13.2 11.9 11.3 9.9 1.3 8.5 6.2 13.9 8.7 8.5 19.2 2.1 23.9 6.9 2.8 7.5 4.1 8.7 1.5 0.9 1.9 5.2 9.1 1.5 6.0 59.5 8.1 0.0 12.1 1.1 1.2 3.3 1.8 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.1 0.9 2.1 9.0 0.1 1.3 2.8 0.1 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 6.8 0.0 0.0 4.0 0.0 6.6 0.0 13.5 1.1 0.0 0.7 0.0 5.4 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.7 0.0 12.1 0.0 1.2 8.4 0.0 0.0 0.0 1.7 21.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 10.8 2.6 7.2 10.1 13.2 8.5 6.2 23.9 8.1 17.9 25.9 0.0 16.8 0.8 2.6 3.9 17.8 307.9 42.1 19.2 7.9 2.6 24.9 24.8 530.7 3.4 0.0 0.0 8.9 6.5 7.1 30.3 2.3 8.5 2.2 3.2 20.1 4.3 0.3 878.1 12.7 1.8 0.0 0.0 9.8 15.1 16.1 0.0 11.3 26.7 18.7 6.5 4.8 82.2 15.6 0.5 2.9 1.3 3.7 7.4 DNASE1 DNL1 ENSG00000213918 "Deoxyribonuclease 1" P24855 16 3611728-3680143 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Actin-binding, Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 26.7" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010703 Enhanced Supported Vesicles "Secreted in other tissues" NA NA 160000 Vesicles "HPA010703: AB_10600806" "unprognostic (5.18e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (2.38e-1)" "unprognostic (1.90e-2)" "unprognostic (3.73e-2)" "unprognostic (3.82e-1)" "unprognostic (3.20e-1)" "unprognostic (9.91e-2)" "unprognostic (1.69e-3)" "unprognostic (5.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.14e-4)" 1.5 1.4 1.5 2.6 1.6 1.7 1.5 3.8 2.5 2.2 12.2 1.8 1.5 14.9 1.5 2.2 3.4 1.2 2.5 1.5 1.5 1.2 11.4 1.5 1.5 4.4 1.5 1.5 2.0 13.7 1.6 12.2 1.9 3.1 5.1 2.1 1.5 3.3 1.5 1.5 3.9 26.7 1.5 1.5 2.3 6.0 2.7 1.5 1.5 1.6 2.6 3.8 1.9 2.3 4.5 2.2 9.2 2.0 1.9 3.4 1.0 2.5 5.8 10.2 5.3 3.0 2.6 4.8 4.0 0.7 3.3 4.8 6.9 6.1 10.7 3.3 0.6 7.0 4.2 3.6 1.1 3.5 4.6 5.6 3.7 8.6 4.5 1.5 2.6 8.7 2.1 4.3 4.4 1.1 5.2 2.2 9.0 9.3 4.7 2.8 10.4 5.3 11.5 6.2 7.4 3.1 12.6 4.6 5.2 2.8 2.2 7.2 6.7 3.0 9.2 1.7 5.3 9.1 6.6 3.0 6.1 4.5 3.8 2.3 4.3 6.1 18.5 1.7 4.9 5.8 4.3 2.0 5.3 3.0 1.3 1.9 2.5 2.3 2.4 1.0 4.5 2.7 3.4 9.2 1.9 1.2 2.2 2.4 1.0 1.5 1.6 3.8 2.5 1.5 1.2 1.5 1.5 3.1 1.5 8.9 10.1 2.4 8.5 2.4 27.4 4.8 5.1 9.4 11.4 15.7 21.6 6.6 48.0 4.5 16.1 4.5 12.7 0.0 9.7 3.3 5.1 9.8 2.3 1.5 3.2 23.8 13.7 4.9 2.7 34.9 7.8 3.8 1.7 11.8 11.3 12.8 4.3 11.2 7.4 1.4 18.3 0.0 4.2 15.1 17.5 3.3 5.1 10.5 15.3 5.3 DNASE1L1 "DNAS1L1, DNASEX, DNL1L, XIB" ENSG00000013563 "Deoxyribonuclease 1 like 1" P49184 X 154401238-154412112 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA072635 Approved "Intracellular and membrane" NA NA 60000 "HPA072635: AB_2686542" "unprognostic (5.27e-2)" "unprognostic (1.95e-1)" "unprognostic (4.57e-3)" "unprognostic (2.97e-1)" "unprognostic (1.27e-2)" "unprognostic (1.59e-3)" "unprognostic (3.82e-2)" "unprognostic (3.08e-2)" "unprognostic (2.88e-1)" "unprognostic (1.96e-1)" "unprognostic (1.32e-1)" "unprognostic (4.98e-1)" "prognostic favorable (2.19e-4)" "unprognostic (7.02e-2)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "unprognostic (6.75e-2)" 12.3 11.8 5.6 6.9 7.4 10.1 9.9 3.3 7.7 7.5 7.7 4.5 7.8 7.5 6.9 15.5 9.6 6.8 10.2 16.3 5.5 6.5 11.4 9.0 10.5 11.7 5.6 5.8 6.1 9.7 9.0 8.7 13.0 4.6 6.2 6.0 12.9 9.1 6.1 76.7 4.5 10.2 5.5 4.7 12.7 7.0 3.8 4.1 3.9 10.2 24.3 9.0 6.7 6.8 4.5 10.7 12.8 16.1 3.0 3.6 4.2 6.7 7.1 2.2 4.2 21.0 27.7 2.9 19.5 30.0 6.2 12.4 1.9 10.1 11.1 24.9 35.9 25.2 3.2 2.6 10.8 4.6 3.1 4.8 1.6 7.4 2.4 14.5 2.9 11.9 20.6 12.6 13.9 14.5 17.9 26.4 1.8 2.2 11.6 21.6 11.4 1.1 1.4 1.7 12.7 8.3 2.3 10.4 17.5 10.6 3.4 7.1 4.1 5.9 10.5 7.8 5.5 4.0 2.8 38.9 6.3 7.4 9.2 3.8 22.0 4.8 11.3 9.6 5.0 7.8 10.1 8.8 12.8 2.7 16.1 3.1 4.5 2.5 2.4 10.7 3.4 1.9 1.6 5.2 3.0 15.4 6.1 3.6 4.2 5.6 7.4 3.3 7.7 5.5 6.5 5.6 5.8 4.6 4.1 6.0 6.2 8.2 5.7 1.1 1.6 1.6 7.6 4.0 1.2 5.2 0.0 4.0 8.3 5.3 0.1 12.6 16.7 0.0 9.0 20.2 4.6 5.7 12.7 6.6 26.3 0.0 5.8 18.4 27.9 0.2 3.1 15.3 15.1 15.4 9.5 7.1 10.1 13.3 2.5 8.1 1.1 0.0 5.7 0.2 0.5 1.5 7.4 4.5 10.9 9.2 DNASE1L2 DNAS1L2 ENSG00000167968 "Deoxyribonuclease 1 like 2" Q92874 16 2235816-2238711 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 11.7;skin 1: 20.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.1;Horizontal cells: 1.6;Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 1.4;neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044714 Uncertain Mitochondria "Secreted in other tissues" NA NA Mitochondria "HPA044714: AB_10962870" "unprognostic (9.88e-2)" "unprognostic (1.11e-3)" "unprognostic (6.80e-4)" "unprognostic (4.29e-2)" "unprognostic (2.35e-1)" "unprognostic (1.55e-1)" "unprognostic (2.72e-2)" "unprognostic (2.50e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-3)" "unprognostic (2.17e-2)" "unprognostic (4.67e-4)" "unprognostic (1.40e-4)" "unprognostic (3.51e-1)" "unprognostic (2.28e-1)" "unprognostic (2.94e-4)" 0.6 1.3 1.3 0.6 2.1 0.8 2.1 8.8 2.8 0.6 0.6 0.6 0.6 0.8 1.2 3.5 0.6 0.4 0.6 0.6 1.6 2.1 0.9 1.6 0.6 0.6 1.5 0.6 0.7 1.9 0.2 2.1 1.3 1.3 0.8 0.2 0.6 11.7 0.6 0.7 20.6 0.8 0.6 1.3 1.0 0.9 1.9 0.6 2.4 2.7 7.1 3.4 0.6 0.6 0.0 0.0 1.6 0.0 0.0 0.2 0.0 1.9 4.0 1.7 1.8 1.4 0.8 6.9 0.6 0.5 1.6 0.8 4.4 4.1 2.6 2.1 0.2 0.5 0.6 0.6 0.2 0.2 5.1 3.8 1.1 6.2 1.0 0.2 1.2 4.2 0.9 1.4 1.2 0.3 1.6 0.3 3.0 3.5 3.9 0.6 4.5 3.6 7.5 1.7 0.5 2.7 6.7 2.0 3.5 0.9 0.9 3.5 1.8 0.9 1.5 2.8 0.4 6.1 2.7 0.2 3.4 4.4 1.9 1.4 9.5 4.5 2.4 1.1 2.5 1.7 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 2.1 8.8 2.8 1.6 2.1 1.5 0.6 1.3 0.6 0.0 1.1 0.0 0.0 0.1 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 DNASE1L3 "DNAS1L3, LSD" ENSG00000163687 "Deoxyribonuclease 1 like 3" Q13609 3 58192257-58214697 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Necrosis" "Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 78.1;liver: 72.3;lymphoid tissue: 46.9" "Cell type enriched" "Detected in many" 11 "Ito cells: 2006.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "plasmacytoid DC: 78.1" "Lineage enriched" "Detected in many" 20 "dendritic cells: 78.1" "Cell line enhanced" "Detected in some" "BEWO: 5.4;Karpas-707: 3.2;RPMI-8226: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA019955 Approved "Secreted to blood" NA NA "HPA019955: AB_1847805" "unprognostic (7.49e-3)" "unprognostic (3.08e-3)" "unprognostic (9.75e-3)" "unprognostic (3.92e-3)" "unprognostic (2.93e-3)" "unprognostic (1.01e-2)" "prognostic favorable (1.20e-6)" "unprognostic (4.74e-4)" "unprognostic (2.10e-1)" "unprognostic (9.71e-2)" "unprognostic (1.91e-3)" "unprognostic (6.95e-2)" "prognostic favorable (1.06e-7)" "unprognostic (7.57e-2)" "unprognostic (2.47e-1)" "unprognostic (1.57e-1)" "unprognostic (5.64e-3)" 3.5 7.2 0.5 27.8 0.5 0.1 3.8 0.6 0.5 2.7 6.1 0.5 1.1 6.1 0.9 1.1 4.2 0.8 1.7 3.4 0.5 0.5 14.3 72.3 5.7 38.5 0.5 0.1 1.5 0.8 0.0 6.0 2.0 0.4 1.4 9.2 12.0 3.3 1.2 0.9 1.8 14.0 0.4 1.3 46.9 0.8 1.5 0.0 11.0 3.9 20.1 17.0 3.6 3.2 3.8 78.1 0.1 0.0 0.1 0.0 0.6 0.2 0.8 0.5 0.3 0.1 0.1 5.4 0.3 0.2 0.3 0.1 1.0 0.3 0.5 0.4 0.0 1.3 1.6 0.2 0.0 0.1 0.2 0.1 0.5 0.8 2.1 0.2 1.1 1.2 0.2 1.1 0.5 0.7 0.2 1.1 0.1 0.5 3.2 0.0 0.7 0.3 1.3 0.5 0.1 0.4 0.6 0.7 5.6 0.2 0.3 0.8 0.5 0.4 0.4 0.6 0.5 0.4 0.6 0.9 0.7 0.3 0.4 0.3 0.9 0.5 0.8 0.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 6.1 3.8 0.0 0.0 0.1 0.1 0.0 78.1 0.0 0.6 0.5 0.5 0.6 0.5 0.5 0.5 0.5 0.1 0.4 0.0 0.0 15.6 31.8 0.3 8.1 0.0 0.6 48.4 0.0 2.3 0.0 0.0 0.1 3.3 0.0 1.3 29.5 0.0 46.7 0.3 0.7 3.1 0.4 1.1 21.7 0.4 1.6 0.0 2006.5 176.2 3.1 3.7 12.8 3.3 55.1 0.0 0.0 0.0 0.0 24.1 1.8 0.1 0.0 1.3 0.1 0.0 14.3 0.2 13.8 0.0 0.9 DNASE2B DLAD ENSG00000137976 "Deoxyribonuclease 2 beta" Q8WZ79 1 84398532-84415018 "Enzymes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "salivary gland: 98.7" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 1.4;Early spermatids: 1.6;Glandular cells: 2.3;Hofbauer cells: 5.7;Late spermatids: 2.4;Paneth cells: 1.7" "Cancer enhanced" "Detected in some" "prostate cancer: 9.3" "Region enhanced" "Detected in single" "basal ganglia: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.6;U-266/70: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (2.24e-1)" "unprognostic (3.57e-2)" "unprognostic (2.77e-1)" "unprognostic (1.22e-1)" "unprognostic (4.70e-2)" "unprognostic (3.70e-1)" "unprognostic (2.86e-1)" "unprognostic (1.62e-2)" "unprognostic (9.87e-2)" "unprognostic (7.90e-2)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (3.82e-5)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" 16.2 0.1 0.2 0.1 2.2 0.1 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.6 0.1 0.2 13.0 1.2 0.3 0.0 0.3 0.4 0.0 0.4 0.1 0.2 2.9 0.3 0.0 98.7 0.1 1.8 0.0 0.1 0.1 1.7 0.5 0.6 0.3 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.3 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 5.7 0.0 1.2 0.0 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 DND1 "MGC34750, RBMS4" ENSG00000256453 "DND microRNA-mediated repression inhibitor 1" Q8IYX4 5 140670794-140673586 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.2;testis: 12.0" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 44.0;Horizontal cells: 19.1;Spermatogonia: 26.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059723 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA059723: " 0.5 0.2 1.7 0.4 0.8 0.4 0.7 3.2 0.4 0.6 0.6 0.4 0.4 0.3 0.4 0.5 0.4 0.7 0.4 0.4 0.4 0.4 0.4 0.8 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.1 0.4 0.4 0.6 0.9 0.4 0.4 0.6 0.4 0.3 0.4 0.5 0.5 0.7 0.4 12.0 0.4 0.4 0.4 0.4 1.4 0.4 0.4 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.5 0.8 0.6 0.9 0.4 2.1 0.2 0.9 3.5 3.2 1.0 0.7 0.8 0.3 0.6 0.4 0.8 2.2 1.1 1.4 0.7 2.0 0.3 1.4 0.3 1.4 0.5 1.0 0.7 3.4 2.9 1.8 0.4 1.2 1.1 0.7 0.1 1.2 0.2 0.2 2.6 0.6 0.0 2.2 2.1 0.5 0.4 1.8 0.4 1.4 1.2 0.2 0.1 0.8 0.7 0.3 0.5 0.0 0.8 1.6 0.6 0.1 4.0 1.1 0.4 0.0 0.5 0.8 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 3.2 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.0 1.4 1.3 0.8 0.5 10.3 0.0 0.0 0.0 1.2 3.5 3.9 0.2 0.0 0.2 44.0 0.7 0.4 0.0 0.3 0.3 0.7 1.6 0.0 0.9 0.5 19.1 1.2 0.0 1.0 5.6 0.6 1.1 0.0 0.0 0.1 3.9 0.2 0.0 0.4 0.0 3.8 0.0 0.3 6.9 26.2 0.9 0.2 3.2 0.6 1.2 DNER "bet, UNQ26" ENSG00000187957 "Delta/notch like EGF repeat containing" Q8NFT8 2 229357629-229714558 "Cancer-related genes, Predicted membrane proteins" "Notch signaling pathway" "Activator, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 45.6;brain: 85.2;salivary gland: 46.1" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 121.0;Intestinal endocrine cells: 27.5;Muller glia cells: 53.3;Rod photoreceptor cells: 35.9" "Cancer enriched" "Detected in many" 32 "glioma: 73.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Group enriched" "Detected in some" 7 "GAMG: 71.3;hTERT-HME1: 29.1;hTERT-RPE1: 79.5;U-138 MG: 49.2;U-87 MG: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017320 Enhanced NA NA 2700000 "HPA017320: AB_1847808" "unprognostic (4.39e-2)" "unprognostic (1.83e-1)" "unprognostic (3.25e-1)" "unprognostic (1.00e-3)" "unprognostic (8.73e-2)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.23e-3)" "unprognostic (2.97e-1)" "unprognostic (1.17e-1)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.42e-4)" "unprognostic (2.59e-2)" "unprognostic (7.32e-2)" "unprognostic (5.63e-2)" "unprognostic (5.13e-3)" 1.7 45.6 25.4 2.2 26.8 1.3 3.1 19.5 85.2 2.2 2.3 38.4 0.0 1.6 2.1 5.7 1.5 4.1 1.5 6.8 23.9 36.8 9.7 1.3 2.0 1.5 39.8 15.2 1.6 1.9 1.7 9.6 1.5 30.0 2.8 2.2 2.5 46.1 1.6 1.3 2.5 1.9 2.2 26.4 1.3 8.3 2.0 30.4 0.0 1.4 0.0 2.1 1.4 0.2 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.1 0.1 0.0 0.0 0.2 1.6 0.5 0.0 0.2 0.0 0.0 0.0 71.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.5 1.7 1.2 29.1 79.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.3 0.0 2.8 0.0 5.8 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 49.2 0.0 1.6 7.3 0.0 0.0 0.0 29.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 25.4 26.8 19.5 26.6 23.9 36.8 39.8 15.2 30.0 30.4 0.0 0.0 0.0 5.8 0.3 121.0 10.3 0.0 14.7 0.0 3.5 13.7 0.0 1.7 0.2 6.8 0.0 0.0 0.0 1.2 0.1 0.8 3.8 0.0 0.0 0.1 11.1 27.5 0.0 0.0 1.3 5.5 1.0 18.6 0.0 0.0 53.3 0.5 0.0 5.6 0.8 35.9 0.0 0.5 0.7 1.1 0.0 0.1 0.0 0.0 0.4 DNHD1 "C11orf47, CCDC35, DHCD1, DKFZp686J0796, DNHD1L, FLJ32752, FLJ35709, FLJ46184" ENSG00000179532 "Dynein heavy chain domain 1" Q96M86 11 6497260-6593758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 58.7" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 46.7;Spermatocytes: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039698, HPA040267, HPA057639" Uncertain Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Nucleoplasm, Cytokinetic bridge" "HPA039698: AB_10795111, HPA040267: AB_2676913, HPA057639: AB_2683486" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (5.87e-2)" "unprognostic (2.18e-2)" "unprognostic (9.96e-2)" "unprognostic (2.00e-3)" "unprognostic (1.43e-1)" "unprognostic (3.11e-1)" "unprognostic (5.38e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-2)" "unprognostic (9.25e-3)" "unprognostic (5.45e-9)" "unprognostic (2.33e-1)" "unprognostic (2.50e-1)" "unprognostic (4.56e-4)" "unprognostic (8.15e-2)" 1.9 2.1 3.6 1.9 5.9 6.8 2.1 6.8 3.4 2.6 2.9 1.6 2.2 2.2 2.8 3.5 1.3 2.0 3.1 1.8 2.3 1.9 1.5 3.1 3.1 3.4 1.5 1.6 3.3 1.6 1.3 2.0 1.3 2.0 2.3 2.0 2.0 2.3 3.2 1.9 3.4 3.6 6.4 2.2 3.5 1.8 58.7 1.3 1.3 2.5 1.3 2.8 2.2 11.0 1.8 1.5 3.0 0.4 0.1 2.2 0.5 4.3 4.6 4.3 4.0 3.5 5.1 4.3 2.0 2.0 2.3 1.5 3.5 3.9 3.7 0.9 1.6 3.2 7.4 2.1 1.7 2.7 2.3 3.9 3.1 6.0 2.7 2.2 4.3 1.9 3.5 2.9 4.2 6.2 2.2 1.0 5.2 3.7 4.4 1.6 0.9 1.4 4.8 4.3 1.2 3.4 2.2 1.8 2.8 2.4 2.5 2.3 4.4 1.3 4.2 3.1 3.4 2.2 4.6 1.9 2.3 2.5 5.1 2.9 10.7 8.4 5.7 2.2 4.8 2.7 0.0 0.4 3.0 1.3 0.0 1.4 0.3 1.3 0.5 0.6 1.8 1.9 2.2 1.3 0.1 0.3 1.5 1.3 0.5 3.6 5.9 6.8 3.4 2.3 1.9 1.5 1.6 2.0 1.3 0.0 4.3 3.0 1.1 0.8 9.3 3.6 0.0 4.0 5.7 0.0 3.9 0.3 0.0 0.2 8.7 2.2 2.0 46.7 0.3 0.2 1.1 1.8 1.1 4.9 0.7 9.5 0.0 3.1 1.5 9.6 0.9 1.2 0.0 1.0 1.7 5.6 0.3 1.5 1.1 0.3 9.1 0.0 1.2 17.5 1.7 3.3 0.6 0.5 1.7 1.6 DNM1 DNM ENSG00000106976 "Dynamin 1" Q05193 9 128191655-128255248 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 133.5" "Group enriched" "Detected in many" 10 "Bipolar cells: 113.1;Cone photoreceptor cells: 84.4;Horizontal cells: 47.7;Rod photoreceptor cells: 70.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 49.8;U-87 MG: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005920, HPA049910, HPA061801" Enhanced Supported Nucleoplasm NA NA 440000 Nucleoplasm "CAB005920: , HPA049910: AB_2680948, HPA061801: AB_2797266" "unprognostic (3.25e-2)" "unprognostic (5.49e-2)" "unprognostic (1.34e-3)" "unprognostic (3.95e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (5.53e-2)" "unprognostic (6.53e-2)" "unprognostic (6.62e-3)" "unprognostic (6.30e-1)" "unprognostic (9.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.10e-3)" 5.9 6.1 31.5 3.3 36.9 2.3 4.6 57.7 133.5 11.7 3.0 2.5 0.0 2.4 4.6 2.7 3.3 6.3 9.0 2.7 33.4 24.0 2.9 1.8 2.5 2.5 18.3 33.0 1.6 4.7 3.2 5.5 2.7 33.0 2.9 2.9 4.3 2.6 3.1 2.3 4.6 3.3 4.4 5.1 1.6 2.6 4.0 1.8 0.0 1.9 0.4 2.3 3.6 3.7 0.3 0.4 0.5 0.3 0.0 0.3 0.7 3.3 49.8 4.5 1.1 1.4 15.2 0.2 3.1 7.5 6.3 2.6 0.6 1.0 0.0 4.3 6.5 0.2 6.0 0.7 0.3 3.5 0.0 4.8 3.1 7.1 0.2 1.0 0.4 2.2 4.0 0.1 4.9 0.0 6.1 0.0 2.9 1.1 0.2 0.0 1.4 0.2 1.0 4.8 0.8 9.1 5.9 0.1 1.5 0.9 0.0 6.5 10.9 10.6 0.3 0.4 0.6 0.1 4.3 0.2 0.2 14.4 14.5 6.3 0.4 0.1 0.3 19.0 0.1 1.0 0.0 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.4 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.7 31.5 36.9 57.7 71.8 33.4 24.0 18.3 33.0 33.0 1.8 0.0 0.0 0.0 1.6 7.0 113.1 2.0 7.6 1.4 1.2 0.0 84.4 0.2 1.7 0.7 0.5 1.5 0.6 0.0 0.7 0.2 3.9 0.7 1.1 0.5 8.0 47.7 0.0 0.0 0.8 0.4 2.6 1.9 3.3 1.0 0.1 8.1 1.0 2.9 1.4 3.4 70.6 0.0 4.1 0.3 1.3 6.6 0.7 0.7 0.6 0.5 DNM3 KIAA0820 ENSG00000197959 "Dynamin 3" Q9UQ16 1 171841498-172418466 "Enzymes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 19.5;Cone photoreceptor cells: 27.5;Endothelial cells: 14.6;Rod photoreceptor cells: 28.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.2;HMC-1: 8.5;RPTEC TERT1: 15.7;U-251 MG: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064121 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA064121: AB_2685193" "unprognostic (8.21e-2)" "unprognostic (6.80e-3)" "unprognostic (1.68e-1)" "unprognostic (1.41e-2)" "unprognostic (8.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.52e-3)" "unprognostic (6.46e-2)" "unprognostic (5.52e-2)" "unprognostic (2.96e-2)" "unprognostic (2.45e-2)" "unprognostic (3.37e-1)" "unprognostic (6.10e-4)" "unprognostic (1.60e-3)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (2.70e-3)" 5.0 19.3 14.1 2.3 28.3 2.6 3.4 41.4 39.7 6.8 2.7 26.8 0.0 1.9 5.9 3.1 3.0 6.0 5.1 3.0 14.3 16.3 5.8 1.4 7.5 2.5 19.6 17.7 4.6 2.6 3.5 10.3 1.6 47.3 3.6 2.7 2.9 3.7 3.6 2.5 4.0 2.4 5.7 16.4 3.6 5.3 5.4 22.1 0.0 3.4 0.0 2.2 4.3 3.6 0.7 0.7 1.1 0.4 1.0 4.0 3.8 0.6 2.0 1.6 0.3 1.2 0.8 0.0 0.4 1.0 0.8 1.0 0.0 3.0 0.0 6.3 0.9 1.0 0.2 1.2 2.3 0.7 0.8 2.4 18.2 3.0 0.0 0.1 0.3 8.5 0.6 0.4 1.0 0.5 0.9 0.4 1.6 0.0 0.3 0.3 0.0 1.1 0.1 4.7 7.5 1.4 1.2 8.2 0.0 15.7 0.1 3.2 0.6 2.2 0.6 0.2 0.6 0.0 0.7 0.2 2.3 3.2 1.9 11.3 3.1 0.5 0.1 2.2 0.9 0.8 0.0 0.4 0.0 0.7 0.0 0.9 0.7 1.0 0.5 0.7 0.0 1.2 1.5 1.1 1.0 0.3 0.0 4.0 3.8 14.1 28.3 41.4 31.6 14.3 16.3 19.6 17.7 47.3 22.1 0.0 5.0 0.0 1.2 2.2 19.5 2.1 0.0 1.4 0.0 0.0 27.5 0.0 3.3 0.3 6.5 14.6 0.0 0.0 0.3 0.1 3.3 0.4 1.1 0.0 0.7 7.9 0.0 4.3 0.0 2.3 1.7 1.3 0.0 0.0 0.4 3.1 1.6 0.0 2.5 0.5 28.5 0.0 1.4 5.0 0.3 1.5 0.2 0.0 0.5 0.9 DNMT3B ENSG00000088305 "DNA methyltransferase 3 beta" Q9UBC3 20 32762385-32809356 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Activator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7;testis: 23.3" "Cell type enhanced" "Detected in some" 7 "Cytotrophoblasts: 3.7;Extravillous trophoblasts: 3.8;Horizontal cells: 4.8;Sertoli cells: 6.5;Syncytiotrophoblasts: 4.0" "Cancer enriched" "Detected in all" 25 "testis cancer: 111.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 55.3;CACO-2: 20.8;HEL: 21.7;K-562: 20.8;NTERA-2: 74.7;SuSa: 41.2" "Low region specificity" "Detected in some" "HPA001595, HPA001803, CAB069896" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB069896: AB_2094115, HPA001595: AB_1847814, HPA001803: " "unprognostic (7.65e-3)" "unprognostic (3.52e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (5.04e-4)" "unprognostic (3.42e-1)" "unprognostic (7.27e-2)" "unprognostic (4.39e-4)" "unprognostic (4.18e-3)" "unprognostic (8.60e-3)" "unprognostic (8.48e-2)" "unprognostic (6.79e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (6.62e-2)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (6.55e-2)" 1.1 0.8 0.9 2.5 0.9 4.7 2.4 4.5 1.4 1.6 2.1 0.7 0.5 0.9 1.3 4.7 1.6 1.1 1.6 1.8 0.8 0.7 2.7 1.2 1.2 1.9 0.9 0.5 1.2 7.5 2.5 1.1 2.8 0.8 1.1 0.8 1.2 3.5 1.6 0.5 5.5 0.8 1.0 0.5 1.3 1.1 23.3 0.8 17.7 2.6 1.7 2.5 2.7 2.2 0.7 1.0 0.0 0.2 0.9 1.3 0.1 0.8 1.1 6.0 1.4 0.1 0.5 55.3 0.7 0.5 0.8 0.8 20.8 0.9 2.1 2.2 0.3 0.9 0.5 3.9 0.3 0.6 0.2 3.1 21.7 0.7 3.9 0.2 0.9 2.2 0.5 0.4 1.2 0.2 0.4 1.4 1.3 20.8 0.6 0.3 3.3 3.3 18.4 74.7 1.9 0.7 3.3 1.0 0.5 2.0 0.9 1.9 1.2 1.3 1.9 0.5 41.2 1.2 1.1 0.3 1.2 2.8 0.6 0.5 1.3 0.6 0.8 0.5 5.9 0.5 0.0 0.2 0.0 0.1 0.1 0.1 0.7 0.2 0.0 1.0 0.0 1.3 0.0 0.0 0.9 0.1 0.9 0.0 0.1 0.9 0.9 4.5 1.4 0.8 0.7 0.9 0.5 0.8 0.8 0.0 1.0 0.0 0.1 0.8 1.4 1.1 0.0 0.0 1.2 0.0 2.0 3.7 0.0 0.9 0.0 0.4 0.0 0.0 0.5 3.8 0.9 0.6 0.0 0.0 0.6 4.8 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.8 1.1 0.0 0.4 0.6 2.1 6.5 0.4 0.0 2.5 1.1 4.0 0.0 0.8 0.0 DNMT3L MGC1090 ENSG00000142182 "DNA methyltransferase 3 like" Q9UJW3 21 44246339-44262216 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "kidney: 7.8;liver: 20.5" "Group enriched" "Detected in some" 4 "Hepatocytes: 17.3;Proximal tubular cells: 13.5" "Cancer enriched" "Detected in some" 90 "testis cancer: 46.3" "Region enriched" "Detected in single" 13 "cerebellum: 2.5" "Group enriched" "Detected in some" 16 "memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 19 "B-cells: 3.2;dendritic cells: 1.1" "Cell line enriched" "Detected in some" 7 "BEWO: 31.2" "HPA055234, HPA066780" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055234: AB_2682750, HPA066780: AB_2685719" "unprognostic (1.05e-4)" "unprognostic (1.91e-1)" "unprognostic (2.73e-9)" "unprognostic (2.77e-1)" "unprognostic (5.28e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 7.8 20.5 0.1 1.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 4.6 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 DNTT TDT ENSG00000107447 "DNA nucleotidylexotransferase" P04053 10 96304396-96338564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Terminal addition" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 171.0" "Group enriched" "Detected in some" 4 "Early spermatids: 10.3;Late spermatids: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "naive B-cell: 1.2;naive CD4 T-cell: 4.5" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 4.5" "Group enriched" "Detected in some" 5 "MOLT-4: 49.7;REH: 172.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036532, HPA044194" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036532: , HPA044194: AB_10960525" "unprognostic (4.24e-1)" "unprognostic (1.00e-1)" "unprognostic (2.60e-2)" "unprognostic (1.86e-2)" 0.0 0.0 0.1 0.1 0.3 24.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.7 0.0 171.0 0.6 0.0 2.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 49.7 0.0 0.0 0.0 0.0 172.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" NA NA "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: AB_2685528" "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.1 0.8 0.3 0.0 9.8 0.4 0.7 0.5 0.3 4.0 2.7 0.0 0.9 0.4 1.4 0.2 5.0 2.0 0.2 0.1 0.5 0.8 0.5 0.3 0.7 0.9 2.9 1.2 0.8 0.1 1.1 5.0 0.0 3.3 0.3 0.0 0.0 7.8 2.1 3.6 1.5 3.1 4.2 8.0 0.1 0.4 0.5 0.8 26.6 2.1 0.6 2.8 0.2 2.4 2.7 1.7 0.8 0.3 1.5 0.3 0.3 0.5 0.1 0.1 0.3 12.8 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 0.0 5.8 0.5 3.1 0.6 1.2 0.6 2.5 72.3 12.5 1.8 21.6 0.3 1.7 0.0 196.5 0.7 0.9 0.0 0.0 0.9 0.7 1.8 0.0 0.0 0.4 0.0 1.2 1.8 1.3 146.0 0.6 1.3 1.7 0.0 2.2 3.1 0.0 0.0 1.8 0.0 1.8 0.0 0.3 1.7 4.1 0.6 0.1 0.0 4.1 0.7 DOC2B DOC2BL ENSG00000272636 "Double C2 domain beta" 17 142789-181636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Group enriched" "Detected in many" 9 "Cone photoreceptor cells: 164.9;Muller glia cells: 138.9;Rod photoreceptor cells: 101.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "HAP1: 7.4;SH-SY5Y: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043168 Uncertain NA NA "HPA043168: AB_2678349" "prognostic favorable (3.45e-4)" "unprognostic (2.28e-3)" "unprognostic (3.17e-1)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "prognostic favorable (8.68e-4)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (2.62e-1)" "unprognostic (8.78e-3)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (2.27e-3)" "unprognostic (2.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-3)" "unprognostic (4.87e-3)" 11.1 7.7 9.1 4.6 10.6 11.0 4.5 23.1 12.6 2.6 1.9 0.2 0.2 1.0 2.8 1.1 8.1 4.8 2.2 2.8 15.5 2.8 0.3 2.6 2.8 0.4 9.9 0.5 6.7 0.9 1.1 3.2 6.6 2.2 2.3 7.6 0.4 2.4 2.1 2.2 2.3 4.1 4.2 2.8 1.7 0.2 2.1 0.0 0.7 5.7 8.4 2.2 10.5 0.8 1.1 1.8 1.1 0.7 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.3 0.5 0.7 0.4 0.5 0.3 0.3 0.2 0.8 0.3 0.3 1.6 0.7 1.1 1.1 0.3 0.1 0.0 2.9 0.0 0.5 0.0 8.2 2.0 0.0 2.7 0.0 8.7 164.9 0.0 0.0 0.2 0.9 5.2 0.0 0.0 3.5 0.0 1.5 0.5 0.0 0.0 0.1 1.6 0.0 14.7 0.8 1.5 0.0 0.0 0.0 1.0 0.0 138.9 3.8 0.0 0.0 0.0 101.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 3.3 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042445 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;lymphoid tissue: 27.6" "Cell type enhanced" "Detected in many" 11 "granulocytes: 34.8;Horizontal cells: 92.2;Kupffer cells: 46.3;Macrophages: 38.8;monocytes: 40.5;T-cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 31.6;HDLM-2: 21.5;TIME: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058106: AB_2683606" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.2 7.6 17.1 16.7 28.8 8.8 4.0 3.0 18.4 9.5 5.9 27.6 0.0 4.1 3.4 1.4 3.4 2.5 6.4 1.8 24.3 14.7 2.9 5.4 7.3 23.9 33.3 9.6 15.9 1.8 1.9 1.4 2.5 23.2 2.0 6.7 1.1 4.1 2.0 1.3 5.0 8.5 4.4 37.7 26.5 6.1 2.3 35.5 27.6 2.7 1.3 18.4 6.6 3.7 6.8 6.2 2.6 9.6 12.8 10.5 4.0 0.0 8.9 2.8 0.0 3.7 7.9 0.0 19.0 15.5 9.1 6.8 0.0 0.0 0.2 0.0 12.0 31.6 0.2 0.0 0.0 7.3 21.5 0.0 0.2 1.9 0.0 0.1 1.8 0.9 1.8 0.2 13.2 5.2 3.6 9.0 2.9 0.0 17.9 15.3 0.8 3.2 2.5 1.1 0.0 2.1 4.3 4.1 2.6 0.4 0.0 0.1 2.3 0.0 0.0 1.9 0.5 0.6 8.2 20.1 9.9 2.4 4.7 6.4 0.0 0.0 0.0 14.0 12.2 4.2 2.6 2.8 0.2 6.2 8.2 6.4 6.8 10.5 8.8 6.2 3.8 10.4 9.0 0.1 12.8 9.6 2.6 7.5 4.0 17.1 28.8 3.0 18.4 24.3 14.7 33.3 9.6 23.2 35.5 3.0 10.8 18.5 0.5 4.1 5.6 0.8 0.0 4.0 4.5 5.2 0.0 0.2 1.7 0.1 1.7 2.2 0.0 0.0 0.0 0.1 2.3 0.5 34.8 0.9 29.1 92.2 2.4 2.5 46.3 2.2 0.6 38.8 8.5 40.5 2.7 1.3 0.3 0.0 0.0 0.2 2.0 12.9 8.6 0.1 0.2 3.6 0.7 37.4 3.3 0.6 DOCK2 KIAA0209 ENSG00000134516 "Dedicator of cytokinesis 2" Q92608 5 169637247-170083382 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.0;bone marrow: 29.8;lymphoid tissue: 50.3" "Group enriched" "Detected in many" 4 "B-cells: 35.0;granulocytes: 32.4;Hofbauer cells: 37.5;Kupffer cells: 86.2;Macrophages: 45.8;T-cells: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 32.4;HDLM-2: 40.7;HL-60: 32.3;HMC-1: 37.5;MOLT-4: 24.6;U-698: 28.6;U-937: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036469 Enhanced NA NA "HPA036469: AB_2675140" "unprognostic (3.45e-2)" "unprognostic (1.84e-2)" "unprognostic (3.90e-3)" "unprognostic (2.04e-2)" "unprognostic (1.03e-1)" "unprognostic (5.92e-3)" "unprognostic (3.47e-1)" "unprognostic (1.61e-2)" "unprognostic (1.34e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-1)" "unprognostic (1.31e-1)" "unprognostic (2.03e-3)" "unprognostic (1.47e-1)" "unprognostic (2.22e-2)" "unprognostic (6.95e-2)" "unprognostic (7.24e-2)" 7.3 3.1 2.9 30.7 4.8 29.8 4.1 1.0 2.7 2.2 3.5 5.8 1.2 2.6 2.9 2.7 2.4 2.9 4.9 2.7 3.4 2.5 3.1 2.9 12.6 22.6 4.8 1.3 1.9 1.9 0.7 2.2 3.8 4.1 3.3 4.5 2.6 6.6 1.2 1.3 2.0 13.7 3.6 8.5 28.0 3.6 1.8 3.7 50.3 2.8 1.7 31.5 6.2 2.5 6.4 14.0 12.7 31.0 6.6 6.6 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 3.3 0.0 0.0 32.4 0.6 2.5 0.3 0.0 0.0 0.0 4.1 40.7 0.0 18.0 0.3 0.0 0.0 32.3 37.5 0.0 0.0 0.7 0.0 0.7 0.0 17.3 0.3 16.3 0.8 0.0 24.6 8.3 0.0 0.0 0.0 15.3 0.5 12.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.1 0.3 1.0 0.4 0.7 5.1 7.9 28.6 0.6 22.5 0.0 6.2 12.7 10.0 6.4 23.0 6.6 6.4 5.9 6.3 14.0 5.3 4.3 5.0 12.7 6.6 31.0 4.8 5.3 9.4 2.9 4.8 1.0 2.7 3.4 2.5 4.8 1.3 4.1 3.7 0.0 3.8 35.0 0.2 0.8 0.0 1.2 0.0 1.4 4.5 0.0 0.0 0.3 0.0 0.0 4.2 0.5 0.0 0.0 0.0 0.4 0.9 0.0 32.4 0.9 37.5 0.0 0.0 1.3 86.2 4.1 0.3 45.8 5.0 10.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.5 0.3 1.7 1.5 1.8 0.7 34.6 0.0 0.1 DOCK3 "KIAA0299, MOCA, PBP" ENSG00000088538 "Dedicator of cytokinesis 3" Q8IZD9 3 50675241-51384198 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 20.8;Early spermatids: 10.4;Horizontal cells: 31.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 7.6;GAMG: 7.5;HMC-1: 6.1;JURKAT: 7.2;U-87 MG: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037543, HPA037544" Enhanced Supported Enhanced Cytosol NA NA Cytosol "HPA037543: AB_10672495, HPA037544: AB_10670383" "unprognostic (1.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-3)" "unprognostic (6.35e-8)" "unprognostic (2.63e-1)" "unprognostic (3.02e-2)" "unprognostic (4.64e-2)" "unprognostic (3.67e-1)" "unprognostic (1.91e-1)" "unprognostic (7.99e-2)" "unprognostic (2.36e-3)" "unprognostic (1.34e-2)" "unprognostic (1.45e-2)" "unprognostic (5.83e-5)" "unprognostic (7.96e-2)" "unprognostic (6.19e-2)" "unprognostic (1.24e-1)" 1.6 5.5 15.3 1.7 19.8 1.6 1.7 24.2 38.9 1.7 2.3 11.6 1.9 1.7 2.1 2.7 4.2 2.2 1.9 4.6 11.5 9.8 1.9 1.3 1.8 1.8 9.1 17.6 1.7 2.0 15.8 9.2 1.5 13.1 3.8 1.9 1.8 3.2 5.0 4.3 4.0 1.7 3.1 8.5 1.8 1.7 9.0 10.7 0.0 17.4 0.0 1.9 2.0 0.7 0.7 0.7 0.2 2.0 0.6 1.3 0.0 0.1 0.2 0.2 7.6 0.0 0.0 3.3 0.1 0.2 0.4 0.3 0.2 0.5 0.0 0.6 2.4 7.5 0.5 5.1 0.0 0.1 4.3 5.3 0.1 1.3 0.1 0.1 0.2 6.1 0.1 0.1 0.2 0.0 0.4 0.0 7.2 0.0 0.1 0.6 0.2 0.0 0.0 2.5 0.3 2.4 0.0 0.7 0.0 0.4 0.7 4.7 0.0 0.3 4.3 0.1 5.5 0.1 0.0 0.5 0.2 2.1 0.2 2.7 0.3 0.0 0.0 10.1 1.0 0.1 0.0 0.1 0.2 0.5 0.4 0.5 0.4 0.4 0.2 0.1 0.7 1.3 0.5 0.2 0.6 2.0 0.7 0.1 0.0 15.3 19.8 24.2 25.3 11.5 9.8 9.1 17.6 13.1 10.7 0.0 1.1 0.0 0.1 0.0 20.8 6.7 0.0 0.0 1.2 0.0 2.0 0.0 1.7 0.0 10.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 31.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 4.9 0.0 1.4 3.5 2.9 0.1 0.0 0.0 0.0 0.0 DOCK8 "FLJ00026, FLJ00152, FLJ00346, ZIR8" ENSG00000107099 "Dedicator of cytokinesis 8" Q8NF50 9 214854-465259 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.5;lymphoid tissue: 61.0" "Cell type enhanced" "Detected in many" 6 "B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003218, HPA073349" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria,Cytosol NA NA Centrosome "Nucleoplasm, Mitochondria, Cytosol" "HPA003218: AB_1078695, HPA073349: " "unprognostic (1.56e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-2)" "unprognostic (7.55e-3)" "unprognostic (3.31e-1)" "unprognostic (6.28e-3)" "unprognostic (1.79e-1)" "unprognostic (8.12e-2)" "unprognostic (2.72e-2)" "unprognostic (6.72e-2)" "unprognostic (1.90e-1)" "unprognostic (3.89e-2)" "prognostic favorable (9.21e-6)" "unprognostic (2.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.91e-1)" "prognostic favorable (6.89e-6)" 6.7 12.9 5.6 27.4 8.4 20.8 6.1 1.2 4.1 3.1 3.9 9.2 0.9 3.9 3.0 4.3 6.0 4.1 8.2 2.9 6.3 3.3 7.5 3.9 16.8 35.3 10.2 2.3 2.5 6.4 7.6 3.5 10.4 8.1 4.9 4.1 4.4 10.5 2.4 1.7 3.3 15.0 3.4 13.6 43.5 4.9 7.2 8.9 61.0 5.1 3.0 27.1 10.5 4.0 7.3 15.4 40.5 21.5 6.6 5.5 6.4 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.5 0.4 17.3 1.2 0.0 0.0 0.7 0.2 0.1 0.0 5.9 0.6 0.0 0.0 0.0 0.0 17.2 2.3 0.1 3.2 0.0 0.0 0.0 0.0 0.0 3.7 8.7 0.0 1.0 16.1 27.2 0.1 0.0 0.2 20.2 0.0 6.7 0.0 17.9 0.0 0.0 0.0 0.2 1.2 0.3 0.4 51.7 3.4 0.0 0.1 0.2 0.0 3.5 0.0 0.0 0.0 10.9 0.3 14.2 14.7 16.7 4.6 15.1 3.8 7.3 5.5 4.8 15.4 6.8 4.4 4.2 40.5 6.6 21.5 4.4 5.3 6.4 5.6 8.4 1.2 4.1 6.3 3.3 10.2 2.3 8.1 8.9 8.9 31.0 83.1 1.5 5.7 0.2 2.0 22.9 1.4 3.4 7.0 72.6 44.4 1.7 0.8 24.2 4.8 0.5 0.0 5.9 3.1 2.9 1.1 23.2 2.5 50.8 0.0 8.1 3.1 113.9 11.5 2.8 79.1 8.5 79.4 8.9 1.0 1.4 17.5 0.4 8.7 3.8 12.9 14.4 15.4 4.1 3.3 35.7 76.2 1.0 3.0 DOK2 "Dok-2, p56dok-2" ENSG00000147443 "Docking protein 2" O60496 8 21908873-21913860 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 138.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 113.3;Kupffer cells: 141.8;Macrophages: 166.3;T-cells: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "eosinophil: 138.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 10.1;HEL: 21.6;HMC-1: 46.4;JURKAT: 8.4;THP-1: 16.7;U-937: 16.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB004379, HPA005507, HPA066571" Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 1200000 Cytosol "Nucleoplasm, Nuclear bodies, Golgi apparatus" "CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749" "unprognostic (5.39e-2)" "unprognostic (8.84e-3)" "unprognostic (8.72e-3)" "unprognostic (1.74e-3)" "unprognostic (2.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.34e-1)" "unprognostic (7.22e-2)" "prognostic favorable (4.31e-4)" "unprognostic (2.22e-1)" "unprognostic (4.19e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.88e-1)" "unprognostic (1.24e-2)" "unprognostic (3.19e-1)" "unprognostic (2.80e-1)" 13.6 3.3 0.6 14.2 0.6 8.4 3.5 0.5 0.6 2.4 4.4 0.4 2.1 3.5 2.0 5.9 3.8 2.8 4.8 3.8 0.6 0.7 2.7 4.6 14.0 12.3 1.5 0.2 2.4 2.3 0.0 1.5 5.3 1.4 3.9 1.6 2.6 2.9 0.6 1.4 1.8 5.9 3.4 2.2 28.6 3.2 1.9 0.7 17.9 1.8 2.7 13.5 4.4 9.8 1.4 38.9 138.5 55.9 27.1 52.8 60.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 21.6 0.0 0.0 0.0 0.1 46.4 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.3 1.9 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 16.2 0.0 44.9 45.1 138.5 39.0 55.9 18.0 1.4 27.4 29.5 38.9 0.6 15.4 19.1 3.4 27.1 49.3 0.7 52.8 60.8 0.6 0.6 0.5 0.6 0.6 0.7 1.5 0.2 1.4 0.7 3.0 27.3 13.0 0.5 10.2 0.0 1.7 0.0 2.7 2.3 3.5 0.0 0.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.9 5.1 0.2 36.8 0.9 113.3 0.0 0.0 4.3 141.8 0.0 0.3 166.3 18.6 8.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.1 0.3 1.7 7.4 0.8 159.2 0.0 0.9 DOK3 FLJ22570 ENSG00000146094 "Docking protein 3" Q7L591 5 177501907-177511274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0" "Cell type enhanced" "Detected in some" 14 "granulocytes: 17.4;Hofbauer cells: 49.3;Kupffer cells: 45.9;Macrophages: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 47.5" "Group enriched" "Detected in many" 6 "B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2" "Cell line enhanced" "Detected in many" "Daudi: 41.4;HMC-1: 33.7;REH: 51.0;U-698: 40.9;U-937: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA077312 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" NA NA 750000 "Plasma membrane" "Nucleoplasm, Cytokinetic bridge, Cytosol" "HPA077312: AB_2732339" "unprognostic (2.21e-2)" "unprognostic (1.14e-2)" "unprognostic (2.05e-2)" "unprognostic (5.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.34e-3)" "unprognostic (4.17e-2)" "unprognostic (2.20e-1)" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (1.21e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.82e-11)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (1.55e-1)" "unprognostic (3.78e-2)" 6.9 2.4 2.7 22.6 7.1 51.8 4.7 2.7 3.3 1.4 2.4 1.5 0.4 3.6 1.4 2.5 2.4 3.3 2.4 2.2 3.6 2.2 2.3 4.0 10.9 26.3 6.1 0.7 2.0 1.8 0.4 1.4 4.0 4.1 2.1 1.8 2.3 4.1 1.0 1.3 1.0 10.8 2.4 7.6 50.0 2.9 3.1 2.9 1.9 1.7 0.6 21.7 4.8 1.5 12.7 4.8 47.5 23.2 0.1 0.1 7.8 1.4 2.2 1.5 1.8 0.9 0.1 4.0 1.2 0.2 4.0 3.7 3.3 0.6 41.4 0.9 1.0 2.0 2.5 3.4 2.1 1.9 7.5 4.5 6.7 5.2 0.6 0.3 15.6 33.7 0.5 1.3 4.5 0.4 0.4 0.7 3.3 4.6 18.2 1.4 3.8 0.7 19.7 3.8 0.4 3.9 51.0 3.1 0.3 1.2 1.5 2.2 1.4 0.5 0.6 1.8 1.4 3.5 22.1 0.9 3.8 3.6 1.9 1.4 3.7 4.0 40.9 0.8 29.5 0.7 4.7 20.6 19.9 0.1 20.4 0.1 12.7 0.0 0.1 4.8 6.7 0.0 0.0 47.5 0.1 23.2 0.3 0.0 7.8 2.7 7.1 2.7 3.3 3.6 2.2 6.1 0.7 4.1 2.9 0.0 9.3 13.0 0.1 0.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.5 0.4 0.1 17.4 0.0 49.3 0.0 0.0 8.0 45.9 0.0 0.6 19.8 1.7 1.0 0.1 0.5 0.0 0.0 1.1 0.0 0.6 0.0 0.4 3.0 1.9 0.3 0.8 0.0 0.6 0.1 DOK5 "C20orf180, dJ805C22.1" ENSG00000101134 "Docking protein 5" Q9P104 20 54475597-54651171 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 41.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 33.2;Horizontal cells: 36.5;monocytes: 25.2;Muller glia cells: 60.0" "Group enriched" "Detected in many" 6 "glioma: 18.0;ovarian cancer: 29.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 19.7;ASC diff: 8.0;ASC TERT1: 6.8;hTEC/SVTERT24-B: 8.2;U-138 MG: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054460, HPA065235" Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA054460: AB_2682495, HPA065235: AB_2685441" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (8.90e-2)" "prognostic unfavorable (8.99e-7)" "unprognostic (1.02e-1)" "unprognostic (1.72e-2)" "unprognostic (5.88e-4)" "unprognostic (5.12e-2)" "unprognostic (4.51e-3)" "unprognostic (2.97e-1)" "unprognostic (2.69e-2)" "unprognostic (1.49e-1)" "unprognostic (6.49e-2)" "unprognostic (4.23e-3)" "unprognostic (3.08e-1)" "unprognostic (4.56e-2)" "unprognostic (1.99e-2)" 3.5 2.7 15.5 2.3 11.0 0.6 2.0 1.4 14.8 1.8 1.3 6.6 0.4 1.0 2.1 1.0 2.4 13.6 10.6 18.1 11.0 12.5 3.6 3.2 1.0 1.2 8.4 6.2 2.4 1.9 0.9 1.2 2.4 7.3 1.6 1.4 7.6 1.7 1.5 41.3 0.6 1.1 3.5 5.4 0.9 0.9 2.2 6.4 0.0 5.9 6.4 1.0 3.6 3.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 19.7 0.0 8.0 6.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 2.6 0.0 8.2 0.0 0.3 1.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 2.0 4.2 0.0 5.2 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 31.2 2.0 0.9 0.0 0.0 0.0 0.1 1.4 0.0 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 11.0 1.4 12.6 11.0 12.5 8.4 6.2 7.3 6.4 0.0 0.0 0.0 1.0 0.2 9.7 5.9 17.8 0.0 0.0 10.4 5.9 0.2 33.2 16.2 1.9 2.3 0.0 0.0 1.0 0.5 11.2 0.9 0.0 0.0 21.8 36.5 0.0 9.8 0.3 3.1 2.3 1.1 0.0 25.2 0.0 60.0 3.5 0.0 1.1 0.0 7.4 0.0 2.0 0.6 0.4 0.4 0.7 0.0 0.0 0.4 DOK6 "DOK5L, HsT3226, MGC20785" ENSG00000206052 "Docking protein 6" Q6PKX4 18 69401055-69849087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 239.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.5;SCLC-21H: 4.8;SH-SY5Y: 10.9;SuSa: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041099, HPA063534" Approved Approved "Focal adhesion sites,Cytosol" NA NA "Focal adhesion sites, Cytosol" "HPA041099: AB_2677299, HPA063534: AB_2685032" "unprognostic (5.83e-2)" "unprognostic (1.39e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (2.77e-2)" "unprognostic (2.59e-1)" "unprognostic (1.55e-1)" "unprognostic (1.90e-2)" "unprognostic (8.62e-2)" "unprognostic (5.99e-2)" "unprognostic (1.04e-2)" "unprognostic (4.60e-3)" "unprognostic (2.13e-4)" "unprognostic (2.30e-3)" "unprognostic (2.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.09e-3)" 2.1 1.6 21.3 1.6 11.3 0.6 1.3 6.8 22.1 3.8 1.5 0.9 0.3 1.0 3.0 1.4 1.7 1.7 5.8 10.2 19.2 9.2 8.7 4.4 4.2 1.2 13.7 13.1 4.2 0.7 3.4 1.1 9.9 14.0 3.5 1.3 5.5 1.7 4.2 0.6 1.2 1.3 6.6 2.7 1.8 1.3 2.8 2.7 0.0 4.1 0.0 1.2 5.2 6.6 0.0 0.0 0.0 0.0 0.9 0.9 0.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 10.9 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.5 0.0 0.0 4.8 10.9 0.0 0.0 0.0 8.1 0.0 0.0 0.0 4.1 0.6 0.0 1.5 0.3 0.0 0.0 3.1 0.0 3.2 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.0 0.9 0.0 0.0 0.3 0.4 21.3 11.3 6.8 17.1 19.2 9.2 13.7 13.1 14.0 2.7 0.0 0.0 0.0 0.1 0.2 239.6 6.5 0.0 0.0 2.3 0.0 13.7 0.0 1.7 0.0 32.5 0.7 0.0 0.0 0.0 0.0 5.3 0.1 0.0 1.0 0.0 9.5 0.0 0.0 0.3 23.0 1.4 0.3 0.0 0.0 0.0 4.1 0.0 0.0 6.3 7.8 12.7 0.0 2.7 0.7 0.1 0.5 0.0 0.0 0.0 0.1 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463311-3501473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 19.1;skeletal muscle: 17.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Group enriched" "Detected in some" 8 "cerebellum: 8.7;pons and medulla: 2.5" "Group enriched" "Detected in some" 14 "memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2" "Group enriched" "Detected in many" 15 "B-cells: 6.3;NK-cells: 3.2" "Cell line enriched" "Detected in some" 4 "MCF7: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA059449: AB_2684023, HPA062780: AB_2732688" "prognostic favorable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favorable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favorable (1.28e-4)" 1.2 0.5 0.1 0.2 0.2 0.2 0.5 8.7 0.7 1.5 0.3 1.4 0.1 0.1 1.3 4.7 1.1 5.0 3.7 19.1 0.4 0.6 1.4 0.4 1.7 0.7 0.1 0.1 1.3 4.3 0.0 9.7 0.1 2.5 0.7 0.1 2.4 2.0 6.4 17.0 0.3 0.1 0.7 0.1 0.6 2.2 5.3 0.4 0.1 0.6 1.8 0.6 0.6 0.1 6.3 0.0 0.0 0.0 3.2 0.3 0.2 2.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.9 0.0 0.1 1.0 0.0 3.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 27.8 0.0 1.1 0.2 1.2 0.1 0.0 5.4 0.2 1.8 2.4 0.5 0.1 2.3 0.0 0.0 0.0 6.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.3 0.0 3.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.2 0.1 0.2 8.7 0.7 0.4 0.6 0.1 0.1 2.5 0.4 0.0 1.0 0.0 3.2 0.0 0.2 11.9 0.0 1.4 4.5 5.2 0.0 0.0 0.0 1.9 5.5 0.0 0.0 0.0 3.8 0.0 0.3 1.8 0.0 0.0 0.1 0.0 5.8 0.0 0.0 4.8 0.9 0.0 0.0 0.0 2.1 0.0 1.3 0.0 0.0 0.4 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 DOPEY2 "C21orf5, KIAA0933" ENSG00000142197 "Dopey family member 2" Q9Y3R5 21 36156782-36294274 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 43.1" "Cell type enhanced" "Detected in many" 7 "Mucus-secreting cells: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072065 Enhanced Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA072065: AB_2686486" "prognostic unfavorable (7.08e-4)" "unprognostic (7.68e-2)" "unprognostic (2.50e-2)" "unprognostic (1.99e-1)" "unprognostic (1.84e-1)" "unprognostic (1.66e-2)" "unprognostic (1.04e-2)" "unprognostic (1.01e-1)" "unprognostic (2.38e-1)" "unprognostic (1.36e-1)" "unprognostic (3.13e-2)" "unprognostic (4.35e-2)" "unprognostic (3.01e-2)" "unprognostic (2.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-1)" 4.6 2.3 5.5 7.5 9.5 17.1 4.9 28.7 11.6 5.1 11.8 3.8 6.8 9.7 2.8 3.3 13.5 3.6 6.5 4.3 4.6 4.0 3.5 7.2 7.2 5.8 3.1 5.8 2.3 3.8 43.1 3.1 4.7 9.5 9.8 12.0 2.8 15.2 9.1 11.1 7.4 13.9 3.8 3.7 5.2 15.8 3.3 3.3 9.3 3.6 7.5 10.6 5.4 6.5 12.0 6.4 6.3 3.2 1.1 3.1 1.3 14.9 3.2 2.4 4.0 2.7 5.2 23.2 7.1 8.5 10.1 6.3 2.2 1.2 2.8 1.1 5.3 7.7 3.1 4.6 1.6 8.2 5.1 4.2 6.4 0.7 0.8 2.4 6.2 3.3 1.8 3.3 6.6 1.7 6.1 4.2 6.7 2.0 4.6 2.9 16.8 4.9 6.4 2.0 17.7 3.3 8.9 1.4 13.6 5.4 6.0 6.5 3.7 4.7 21.5 6.1 3.4 7.8 7.7 7.2 3.9 1.1 5.1 5.7 3.4 8.4 1.3 5.6 13.5 2.2 1.0 3.2 6.3 3.1 3.1 1.7 8.6 2.0 1.8 2.1 12.0 1.3 1.1 5.5 1.1 2.6 6.4 1.5 1.3 5.5 9.5 28.7 11.6 4.6 4.0 3.1 5.8 9.5 3.3 0.0 5.8 31.4 6.9 2.7 5.3 4.0 10.2 6.7 3.4 8.7 3.9 1.5 3.3 8.1 0.7 3.3 17.3 0.0 2.8 9.8 2.8 21.2 8.1 8.5 15.7 0.0 28.2 6.2 15.4 0.0 2.3 12.0 5.0 7.2 56.5 1.5 7.5 24.6 2.8 1.3 3.0 0.0 2.5 4.4 13.0 4.5 6.8 7.5 19.5 10.1 DOT1L "DOT1, KIAA1814, KMT4" ENSG00000104885 "DOT1 like histone lysine methyltransferase" Q8TEK3 19 2164149-2232578 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011875, HPA071217, HPA074977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: " "unprognostic (1.41e-2)" "unprognostic (1.44e-1)" "unprognostic (2.26e-1)" "prognostic favorable (1.69e-4)" "unprognostic (1.08e-1)" "prognostic favorable (6.00e-4)" "unprognostic (2.53e-3)" "unprognostic (2.21e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (5.25e-3)" "unprognostic (8.18e-3)" "unprognostic (2.56e-1)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" 7.3 8.8 7.0 10.7 11.7 20.1 5.1 20.6 11.7 4.5 7.9 9.8 6.0 13.5 6.4 4.9 8.3 5.4 6.9 5.7 7.0 3.6 9.5 8.5 10.0 8.4 11.9 5.3 6.5 10.8 3.6 8.3 11.6 7.1 5.7 4.9 9.5 6.1 7.4 9.8 9.9 13.0 4.2 6.7 10.4 13.3 64.7 9.7 10.5 9.2 7.0 9.1 4.8 5.3 0.7 1.0 3.0 0.9 2.8 1.4 0.6 12.2 6.6 22.4 12.2 1.7 2.5 29.5 7.0 1.5 3.8 3.1 8.4 4.6 14.4 3.4 4.5 3.3 11.0 7.4 3.9 1.8 7.3 9.3 13.2 10.8 8.2 2.7 18.9 24.4 2.4 2.9 7.4 3.8 3.1 3.1 8.2 16.0 15.1 3.0 7.0 15.1 20.9 17.3 7.8 11.8 15.6 6.3 9.9 2.1 5.8 15.0 11.6 4.9 14.6 9.2 6.2 6.7 14.5 4.4 10.7 9.8 15.8 13.4 14.0 18.3 10.0 10.6 13.1 6.2 0.5 0.7 3.0 0.9 0.3 1.4 0.7 0.8 0.2 0.9 0.7 0.5 0.3 0.3 2.8 0.9 1.0 0.1 0.6 7.0 11.7 20.6 11.7 7.0 3.6 11.9 5.3 7.1 9.7 29.8 18.9 9.9 9.3 15.8 25.0 5.2 20.4 6.7 6.8 8.7 62.8 5.3 3.3 10.1 25.8 7.1 25.4 0.0 10.4 11.3 11.0 12.4 5.8 13.1 9.3 12.7 20.0 6.7 11.9 11.9 2.8 14.6 11.8 5.4 10.8 7.3 14.1 14.0 3.2 2.2 26.6 0.0 8.1 28.3 23.5 17.3 13.6 4.9 11.7 14.2 DPCD "DKFZP566F084, RP11-529I10.4" ENSG00000166171 "Deleted in primary ciliary dyskinesia homolog (mouse)" Q9BVM2 10 101570560-101609668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 56.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 438.7;Late spermatids: 828.3;Spermatocytes: 210.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 11.9;intermediate monocyte: 13.2;myeloid DC: 17.4;non-classical monocyte: 5.3" "Group enriched" "Detected in many" 13 "dendritic cells: 17.4;monocytes: 13.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036603, HPA036604" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA036603: AB_2675212, HPA036604: AB_10673503" "unprognostic (1.22e-2)" "unprognostic (1.73e-3)" "unprognostic (4.66e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.90e-1)" "unprognostic (9.13e-2)" "unprognostic (4.00e-3)" "unprognostic (1.71e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (1.64e-1)" "unprognostic (4.55e-2)" "unprognostic (2.70e-1)" "unprognostic (5.04e-2)" "unprognostic (3.83e-2)" "unprognostic (7.54e-2)" 4.6 8.1 21.9 4.0 19.9 4.4 9.3 3.4 14.0 10.7 7.1 6.0 4.6 3.1 8.4 20.6 8.3 35.0 7.2 13.0 15.6 16.6 14.7 4.9 6.7 3.8 16.1 18.6 10.8 9.0 17.9 23.6 4.8 16.0 7.9 6.5 9.6 10.0 10.2 9.5 5.8 2.8 8.5 8.1 1.7 6.1 56.2 7.5 1.1 15.5 5.1 3.6 5.2 5.5 0.8 17.4 0.6 13.2 0.9 1.2 4.6 29.4 16.4 11.9 24.4 11.2 18.8 5.1 14.0 15.8 17.7 16.9 11.6 16.0 2.7 23.5 12.5 7.3 16.8 16.5 19.5 18.9 6.9 16.3 3.4 16.1 17.3 6.0 18.0 2.6 13.4 16.8 21.7 17.4 46.7 15.2 3.8 9.2 3.8 13.4 36.7 0.0 14.2 8.8 7.9 12.6 0.0 16.3 6.2 28.6 8.0 11.8 20.3 11.3 7.5 9.3 11.0 22.6 7.2 11.0 8.6 8.1 17.6 18.5 11.0 12.7 5.0 30.5 4.1 3.7 0.0 11.9 0.5 1.1 13.2 1.0 0.8 0.9 0.9 17.4 0.5 1.0 1.2 0.6 0.9 5.3 2.4 0.3 4.6 21.9 19.9 3.4 14.0 15.6 16.6 16.1 18.6 16.0 7.5 32.8 7.7 2.2 25.6 8.7 11.8 24.6 35.7 158.0 35.2 47.1 17.7 19.9 81.2 52.5 438.7 13.1 5.2 0.0 23.9 15.9 26.0 24.1 1.1 10.2 20.8 11.1 23.0 11.6 6.2 828.3 21.9 11.0 15.1 4.6 10.7 17.5 29.9 10.5 26.2 91.2 37.4 0.0 27.0 210.7 59.6 12.4 8.9 2.2 21.5 16.5 DPCR1 "bCX105N19.6, C6orf37, PBLT" ENSG00000168631 "Diffuse panbronchiolitis critical region 1" Q3MIW9 6 30934523-30954221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "gallbladder: 53.4;stomach 1: 70.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 42.0;Cholangiocytes: 48.4" "Group enriched" "Detected in some" 9 "pancreatic cancer: 56.8;stomach cancer: 55.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;OE19: 4.7;RPTEC TERT1: 1.3" HPA014036 Enhanced NA NA "HPA014036: AB_1847841" "unprognostic (2.81e-1)" "unprognostic (4.49e-2)" "unprognostic (9.13e-4)" "unprognostic (6.74e-2)" "unprognostic (4.29e-2)" "unprognostic (8.06e-2)" "unprognostic (3.08e-1)" "unprognostic (1.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.79e-1)" "prognostic unfavorable (6.58e-4)" "unprognostic (1.13e-1)" "unprognostic (5.97e-2)" "unprognostic (4.76e-2)" "unprognostic (9.80e-2)" "unprognostic (3.20e-2)" "unprognostic (3.58e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.9 0.0 0.0 0.0 0.0 4.8 0.0 53.4 0.0 0.0 0.0 0.0 2.5 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 4.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.9 42.0 0.0 0.2 0.0 0.0 0.0 48.4 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 DPEP1 ENSG00000015413 "Dipeptidase 1" P16444 16 89613308-89638456 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 161.7;kidney: 52.2;pancreas: 100.5" "Cell type enhanced" "Detected in many" 26 "Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6" "Cancer enriched" "Detected in many" 8 "colorectal cancer: 107.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009426, HPA012783" Enhanced Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 270000 "Nucleoplasm, Cell Junctions" "HPA009426: AB_1847842, HPA012783: AB_1847843" "unprognostic (3.31e-2)" "unprognostic (3.86e-1)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (3.45e-2)" "unprognostic (5.18e-1)" "unprognostic (8.68e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.84e-4)" "unprognostic (6.12e-3)" "unprognostic (1.92e-1)" "unprognostic (5.23e-2)" "unprognostic (3.93e-2)" 0.1 0.4 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 53.6 0.1 0.4 16.1 0.2 3.4 0.3 0.1 0.9 0.1 0.1 0.1 52.2 0.1 0.3 0.9 0.1 0.1 0.2 100.5 0.0 0.2 0.1 0.2 0.1 0.0 0.2 0.3 0.4 0.1 0.4 161.7 0.1 0.1 0.9 0.2 9.8 0.1 0.2 0.1 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.1 2.8 0.0 0.0 0.0 0.0 5.2 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 20.3 9.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.6 0.7 2.1 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.1 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 3.0 2.6 14.9 0.0 0.5 3.3 0.3 0.0 0.0 1.2 22.7 0.0 0.1 48.0 0.3 10.3 0.1 4.2 0.0 171.7 0.3 4.5 0.0 1.1 0.0 0.5 0.0 8.5 1.8 0.0 29.1 268.4 1.7 5.0 1.8 1.9 0.0 43.8 11.5 1144.5 391.6 0.1 6.5 0.3 15.6 2.9 0.3 0.3 0.5 1.2 0.0 DPEP2 ENSG00000167261 "Dipeptidase 2" Q9H4A9 16 67987394-68000586 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 105.1" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 29.3;Kupffer cells: 40.0;Macrophages: 33.7;Syncytiotrophoblasts: 45.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 105.1" "Cell line enhanced" "Detected in some" "HEL: 4.4;HMC-1: 19.9;NB-4: 4.3;U-937: 6.6" "Low region specificity" "Detected in many" HPA035644 Approved NA NA 260000000 "HPA035644: AB_10670164" "unprognostic (8.81e-2)" "unprognostic (7.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.42e-2)" "unprognostic (1.92e-1)" "unprognostic (6.66e-3)" "unprognostic (1.03e-1)" "unprognostic (5.47e-2)" "unprognostic (3.69e-2)" "unprognostic (1.68e-1)" "unprognostic (6.01e-2)" "unprognostic (1.46e-1)" "unprognostic (3.91e-2)" "unprognostic (5.75e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (7.78e-3)" "unprognostic (3.91e-2)" 7.8 0.9 1.3 7.1 2.4 13.0 3.5 0.7 2.5 1.5 2.6 2.4 1.1 1.7 4.1 4.1 1.8 2.0 6.8 2.4 1.6 1.3 2.0 2.0 11.4 10.4 2.1 2.0 0.7 0.9 0.1 0.9 19.4 2.7 2.4 2.4 5.1 2.8 0.4 1.6 1.2 10.1 2.3 3.3 26.4 1.6 2.5 1.6 3.5 2.5 3.8 11.1 6.3 1.5 5.0 4.3 105.1 15.3 5.6 4.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.4 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 4.4 0.0 0.1 0.0 0.1 19.9 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.3 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.6 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 6.6 0.0 43.5 10.7 105.1 2.3 13.0 2.7 4.1 4.0 1.9 4.3 5.0 4.9 2.5 47.3 5.6 15.3 0.6 4.0 5.7 1.3 2.4 0.7 2.5 1.6 1.3 2.1 2.0 2.7 1.6 0.0 12.2 15.6 0.0 1.8 0.0 1.1 0.0 2.7 2.3 0.0 0.0 7.7 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.6 1.6 0.0 2.3 0.0 29.3 0.0 0.0 17.2 40.0 0.9 0.0 33.7 3.3 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 6.5 6.1 1.1 45.2 13.8 0.0 0.1 DPEP2NB ENSG00000263201 "DPEP2 neighbor" 16 68013436-68015911 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.6;placenta: 2.8;testis: 5.7" "Cell type enriched" "Detected in some" 46 "Syncytiotrophoblasts: 54.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "eosinophil: 3.6;neutrophil: 2.1" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;SuSa: 1.4;U-2197: 1.5" "Not detected" "Not detected" NA NA "unprognostic (1.91e-1)" "unprognostic (3.22e-2)" 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 0.0 0.0 0.0 DPEP3 ENSG00000141096 "Dipeptidase 3" Q9H4B8 16 67975663-67980829 "Enzymes, Predicted intracellular proteins" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 56.7" "Group enriched" "Detected in some" 7 "Spermatocytes: 154.2;Spermatogonia: 290.0" "Group enriched" "Detected in many" 10 "melanoma: 3.7;ovarian cancer: 16.9;testis cancer: 5.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "neutrophil: 9.2;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 9.2;NK-cells: 2.3" "Cell line enriched" "Detected in single" 11 "U-266/70: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA031870, HPA058607" Enhanced "Intracellular and membrane" NA NA 16000000 "HPA031870: AB_2674079, HPA058607: AB_2683775" "unprognostic (9.93e-2)" "unprognostic (2.81e-3)" "unprognostic (1.86e-1)" "unprognostic (9.52e-2)" "unprognostic (3.61e-2)" "unprognostic (1.37e-2)" "unprognostic (1.55e-1)" "unprognostic (6.52e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.49e-3)" "unprognostic (9.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-3)" "unprognostic (1.13e-1)" "unprognostic (3.98e-2)" "unprognostic (1.51e-1)" 0.2 0.0 0.1 0.4 0.4 1.0 0.6 0.1 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.5 0.0 0.4 1.4 0.2 56.7 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.8 0.1 9.2 0.5 2.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.5 0.3 0.4 0.0 0.0 0.1 0.8 0.8 0.3 9.2 2.3 0.1 0.0 0.0 0.3 0.1 0.4 0.1 0.3 0.3 0.1 0.1 0.0 0.9 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 30.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 25.8 0.0 154.2 290.0 0.0 0.2 0.0 0.0 0.0 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 18.4;Early spermatids: 23.8;Horizontal cells: 42.9;Late spermatids: 17.6" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.7;SCLC-21H: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA049148: AB_2680653" "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.5 3.0 12.8 9.3 0.9 0.6 1.3 3.8 2.2 6.5 5.5 2.1 0.3 5.8 2.6 2.9 2.6 2.3 15.7 2.1 2.9 5.5 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 0.8 1.2 4.4 4.3 0.3 6.1 4.9 3.1 0.3 2.3 1.0 3.5 5.8 6.5 1.2 0.6 1.1 18.5 6.4 4.2 0.4 0.8 1.6 1.9 0.3 1.4 9.4 3.0 2.2 3.4 2.3 7.7 7.7 4.9 2.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 0.0 0.0 0.0 0.0 2.1 18.4 1.1 0.0 1.4 0.0 0.0 7.9 0.1 0.0 0.0 23.8 0.3 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.2 42.9 0.0 0.0 0.0 17.6 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 2.5 0.0 2.9 0.0 1.3 4.9 6.8 1.0 0.1 0.0 0.0 0.0 DPF3 "BAF45c, cer-d4, Cerd4, FLJ14079" ENSG00000205683 "Double PHD fingers 3" Q92784 14 72619296-72894116 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.3;skeletal muscle: 28.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 33.3;Cone photoreceptor cells: 102.1;Early spermatids: 36.1;Rod photoreceptor cells: 86.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 5 "cerebellum: 56.3" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 13.7;BJ hTERT+ SV40 Large T+: 9.4;HEL: 23.3;Karpas-707: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA066790, HPA070601" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA066790: AB_2685724, HPA070601: AB_2686284" "unprognostic (2.38e-2)" "unprognostic (2.96e-1)" "unprognostic (3.25e-1)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (9.98e-2)" "unprognostic (4.80e-2)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (3.54e-2)" "unprognostic (9.71e-3)" "unprognostic (1.02e-1)" "unprognostic (2.02e-1)" "unprognostic (3.85e-3)" "unprognostic (4.08e-2)" "unprognostic (4.80e-2)" "unprognostic (1.96e-1)" 0.7 2.2 6.2 1.1 10.3 3.2 0.8 56.3 7.6 0.9 2.7 8.4 0.0 0.8 0.8 0.5 1.2 0.7 1.0 16.8 6.4 2.5 2.2 4.3 0.8 1.5 8.9 4.5 17.8 0.7 8.4 0.9 0.9 10.4 0.7 2.4 3.4 0.8 0.7 28.4 1.1 1.7 1.2 10.1 1.4 1.1 6.6 10.7 0.0 0.8 6.3 1.8 0.8 0.7 1.9 0.0 0.0 0.3 0.4 0.8 0.2 1.5 0.0 1.2 0.1 0.2 2.3 13.7 4.1 3.9 9.4 3.6 0.0 0.1 0.2 0.2 1.2 0.2 0.1 1.3 0.6 5.8 0.2 0.5 23.3 0.1 0.0 0.3 0.1 0.4 0.6 0.2 2.2 1.6 1.6 3.0 2.5 2.0 9.5 3.0 0.1 1.9 0.2 0.0 0.0 1.3 5.1 0.6 0.3 1.6 0.0 0.9 0.5 0.0 0.1 0.0 0.4 0.0 0.0 6.5 4.6 0.0 1.7 0.5 3.4 0.9 0.3 0.4 0.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.2 6.2 10.3 56.3 7.6 6.4 2.5 8.9 4.5 10.4 10.7 0.0 0.0 0.9 0.0 0.6 4.7 33.3 0.0 0.0 0.0 0.0 102.1 2.2 1.7 0.0 36.1 1.8 3.9 23.3 0.3 1.2 0.8 0.1 4.6 4.2 0.4 6.4 0.0 0.6 1.5 22.2 0.3 0.9 0.0 0.0 3.3 8.1 0.5 4.0 4.6 9.9 86.0 0.0 0.8 1.7 0.7 0.3 0.1 2.5 6.3 0.0 DPP10 "DPL2, DPPY, DPRP3" ENSG00000175497 "Dipeptidyl peptidase like 10" Q8N608 2 114442299-115845752 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 15.6;brain: 30.3;pancreas: 23.4" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 5.1;Early spermatids: 10.4;Extravillous trophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.1;HAP1: 7.6;HMC-1: 5.4;JURKAT: 4.1;NTERA-2: 4.6;RT4: 8.1;SCLC-21H: 12.0;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048767 Uncertain NA NA "HPA048767: AB_2680515" "unprognostic (1.19e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (2.03e-2)" "unprognostic (6.59e-2)" "unprognostic (2.92e-1)" "unprognostic (5.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (8.33e-2)" "unprognostic (7.61e-2)" "unprognostic (4.22e-2)" 0.7 15.6 13.4 1.1 15.9 0.9 0.9 1.9 30.3 1.3 3.6 7.9 0.0 2.4 1.4 0.8 0.8 0.9 1.9 0.8 17.5 9.9 1.1 0.9 1.0 0.7 7.1 21.3 0.9 23.4 0.7 1.5 1.8 10.8 0.8 4.6 0.0 1.0 0.8 0.7 0.9 2.4 1.9 12.7 0.7 1.5 2.1 10.3 0.0 1.6 0.0 0.8 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 12.0 4.8 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.9 1.9 30.3 17.5 9.9 7.1 21.3 10.8 10.3 0.0 0.0 0.0 0.0 0.0 2.7 1.4 5.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 10.4 0.0 0.4 0.0 2.3 7.3 0.2 0.0 0.0 0.0 0.3 4.8 4.1 0.6 0.0 4.3 0.3 0.0 1.7 0.0 1.3 1.4 1.2 0.0 0.0 0.0 0.5 0.0 0.0 1.7 1.1 0.0 3.7 0.0 2.9 0.0 DPP4 "ADCP2, CD26, DPPIV" ENSG00000197635 "Dipeptidyl peptidase 4" P27487 2 161992241-162074542 "CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 133.1;parathyroid gland: 75.5" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 134.1;Proximal tubular cells: 80.1;Syncytiotrophoblasts: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 26.7" "Lineage enriched" "Detected in many" 10 "T-cells: 26.7" "Cell line enhanced" "Detected in many" "ASC diff: 42.8;ASC TERT1: 43.4;BJ hTERT+: 39.8;RPTEC TERT1: 58.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB045970, HPA068778, HPA071236" Enhanced "Secreted in other tissues" NA NA 170000000 "CAB045970: AB_11140529, HPA068778: , HPA071236: " "unprognostic (4.47e-2)" "unprognostic (4.47e-2)" "unprognostic (8.89e-2)" "unprognostic (3.36e-1)" "unprognostic (7.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.78e-1)" "unprognostic (3.54e-2)" "unprognostic (3.58e-1)" "unprognostic (4.73e-1)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.98e-4)" "prognostic favorable (1.35e-6)" "unprognostic (4.68e-2)" "unprognostic (6.33e-2)" "prognostic favorable (4.99e-4)" "unprognostic (1.21e-2)" 9.5 2.9 0.3 3.2 0.5 0.0 5.0 0.3 1.4 2.2 50.0 0.2 36.9 19.1 2.2 3.5 1.2 1.2 5.2 2.1 0.4 0.3 29.1 12.2 5.4 2.1 0.4 0.2 2.7 1.8 75.5 0.3 24.0 0.2 21.1 2.8 0.6 46.9 38.8 2.4 4.4 133.1 0.9 0.8 5.0 1.2 0.6 0.1 6.2 1.0 1.4 1.1 1.0 2.6 0.1 2.1 0.3 0.0 2.6 26.7 2.5 0.0 0.0 0.1 0.0 42.8 43.4 0.1 7.9 39.8 2.2 7.7 8.0 0.2 0.0 3.0 13.7 7.4 0.2 0.1 0.0 1.3 2.5 0.1 0.0 0.0 11.9 17.4 0.0 0.0 4.9 0.0 13.4 0.1 2.0 1.3 0.1 0.0 0.0 0.7 0.0 0.7 0.1 0.4 0.3 16.4 0.0 0.0 0.1 58.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 7.1 4.6 0.2 0.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 3.2 0.0 26.7 0.1 8.3 5.2 0.6 0.0 8.3 3.3 0.3 2.6 0.0 2.1 0.9 2.5 0.3 0.5 0.3 1.4 0.4 0.3 0.4 0.2 0.2 0.1 6.0 17.5 0.0 0.3 3.7 1.7 4.0 12.7 4.0 4.5 14.0 9.8 134.1 1.7 3.1 13.0 3.9 21.3 0.0 0.0 52.7 45.7 38.3 12.8 39.9 12.7 0.0 53.0 12.3 1.6 6.2 0.0 4.6 5.0 1.0 11.0 0.0 0.9 11.4 0.0 80.1 0.0 0.0 1.0 2.1 0.8 3.6 143.8 11.4 12.8 0.3 DPP6 "DPL1, DPPX" ENSG00000130226 "Dipeptidyl peptidase like 6" P42658 7 153887097-154894285 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 13.3;Horizontal cells: 30.2;Late spermatids: 16.0;Melanocytes: 15.1;Muller glia cells: 18.7" "Cancer enriched" "Detected in some" 11 "glioma: 12.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "NTERA-2: 11.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050509 Enhanced Supported NA NA "HPA050509: AB_2681150" "unprognostic (1.29e-1)" "unprognostic (3.55e-2)" "unprognostic (5.68e-2)" "unprognostic (5.86e-2)" "unprognostic (1.53e-2)" "unprognostic (2.28e-1)" "unprognostic (2.73e-1)" "unprognostic (5.83e-4)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (7.45e-3)" "unprognostic (4.04e-3)" "unprognostic (2.94e-3)" "unprognostic (1.85e-4)" "unprognostic (1.05e-1)" "unprognostic (4.61e-3)" "unprognostic (6.11e-2)" 1.6 7.2 15.4 1.4 32.5 1.3 1.5 26.6 45.7 2.3 6.8 8.7 0.0 1.6 24.5 3.1 1.5 4.6 1.3 1.4 26.6 15.2 3.6 1.2 2.2 1.3 14.0 22.7 1.3 4.0 1.2 4.9 1.3 18.8 1.5 2.4 0.4 1.3 8.1 4.6 3.7 2.0 15.8 7.2 4.2 3.5 7.9 10.0 0.0 24.1 0.0 1.2 1.3 0.4 0.6 0.6 1.9 0.9 0.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 1.2 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.9 0.4 0.7 0.4 0.6 0.7 0.6 0.6 0.4 0.4 0.6 0.7 0.7 1.6 0.9 0.9 0.6 0.5 0.3 15.4 32.5 26.6 32.4 26.6 15.2 14.0 22.7 18.8 10.0 0.0 0.0 0.0 0.4 3.0 9.3 5.9 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.1 13.3 0.0 0.0 0.0 3.6 0.0 0.3 0.1 0.0 0.0 0.2 30.2 9.9 0.0 0.0 16.0 1.1 0.0 15.1 0.0 0.2 18.7 0.5 0.0 3.5 0.3 6.0 0.0 0.3 0.9 1.7 1.4 0.0 0.0 0.0 0.1 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 4.9;testis: 9.0" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 2.7;Extravillous trophoblasts: 9.2" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "BEWO: 7.6;EFO-21: 14.5;SuSa: 8.7" HPA036134 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.5 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 8.7 0.5 0.1 0.1 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 DPPA3 "Pgc7, Stella" ENSG00000187569 "Developmental pluripotency associated 3" Q6W0C5 12 7711454-7717559 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.3;lung: 2.1;ovary: 1.8;testis: 3.6" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 1.1;Spermatocytes: 1.2;Spermatogonia: 1.6;Syncytiotrophoblasts: 1.1" "Cancer enriched" "Detected in single" 779 "testis cancer: 339.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 17 "dendritic cells: 2.3;granulocytes: 1.7" "Group enriched" "Detected in some" 5 "BEWO: 86.3;NTERA-2: 36.2" NA NA "unprognostic (2.52e-1)" "unprognostic (9.49e-2)" 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.4 3.6 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.3 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 1.1 0.0 0.0 0.0 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 18.3;Extravillous trophoblasts: 16.9;Syncytiotrophoblasts: 5.1" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "Group enriched" "Detected in some" 4 "HAP1: 22.5;NTERA-2: 83.0;SuSa: 32.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Cytosol" "CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536" "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.3 0.2 1.1 1.0 1.4 0.0 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 2.1 0.0 5.1 0.7 0.0 0.3 DPPA5 Esg1 ENSG00000203909 "Developmental pluripotency associated 5" A6NC42 6 73353062-73354295 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lung: 2.0;testis: 6.8" "Cell type enhanced" "Detected in single" 35 "Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 2209 "testis cancer: 347.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 49 "SuSa: 12.7" "Not detected" "Not detected" "HPA055016, HPA064505" Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055016: , HPA064505: AB_2685275" "unprognostic (1.85e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 6.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 DPRX ENSG00000204595 "Divergent-paired related homeobox" A6NFQ7 19 53632056-53637009 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "placenta: 4.9;skeletal muscle: 4.2" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 20 "thyroid cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;SuSa: 3.3" HPA043682 Uncertain NA NA "HPA043682: AB_10963073" "unprognostic (2.47e-1)" "unprognostic (1.89e-1)" 2.0 0.0 0.1 0.0 0.1 0.0 1.3 0.1 0.0 0.2 0.1 0.0 0.1 1.8 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.7 0.0 0.0 0.1 4.2 0.5 0.0 0.1 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 DPT ENSG00000143196 Dermatopontin Q07507 1 168695459-168729264 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.1" "Group enriched" "Detected in some" 4 "Fibroblasts: 155.7;Leydig cells: 214.6;Peritubular cells: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 55.3;fHDF/TERT166: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065548 Approved Vesicles "Secreted to extracellular matrix" NA NA 25000 Vesicles "HPA065548: AB_2685511" "unprognostic (1.49e-1)" "unprognostic (7.62e-2)" "unprognostic (5.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.64e-2)" "unprognostic (3.78e-3)" "unprognostic (4.09e-2)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" "unprognostic (1.03e-2)" "unprognostic (8.88e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.12e-3)" "unprognostic (2.89e-2)" "unprognostic (1.09e-1)" "unprognostic (8.98e-3)" 128.1 6.1 0.8 22.6 0.8 0.0 99.3 0.8 2.4 51.0 81.7 0.9 19.8 2.4 20.4 38.8 33.1 23.0 52.3 48.8 0.8 0.3 2.4 6.0 9.6 7.7 0.8 0.8 12.8 13.4 0.0 0.9 7.8 0.9 24.0 9.4 1.8 14.4 10.2 13.0 8.6 23.1 76.1 0.8 1.0 23.6 8.7 0.8 2.3 16.3 55.7 22.8 48.7 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.3 0.2 0.0 0.0 2.4 2.7 2.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 2.4 0.8 0.3 0.8 0.8 0.9 0.8 3.0 1.7 0.0 0.1 28.3 0.0 5.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.6 0.4 0.0 0.0 0.2 0.3 155.7 0.2 0.0 0.0 0.6 0.0 0.0 12.9 0.0 0.7 214.6 0.0 37.1 0.0 0.0 0.0 0.3 0.0 116.3 0.0 0.0 0.0 15.0 0.3 0.3 28.0 0.3 0.0 0.0 0.5 DPY19L2 "FLJ32949, SPATA34" ENSG00000177990 "Dpy-19 like 2" Q6NUT2 12 63558913-63668939 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 44.0" "Group enriched" "Detected in many" 6 "Early spermatids: 300.2;Late spermatids: 304.6;Spermatocytes: 171.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.4;naive CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "U-266/84: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA071264, HPA078305" Enhanced Approved Nucleoplasm,Mitochondria Yes No Mitochondria Nucleoplasm "HPA071264: AB_2686375, HPA078305: " "unprognostic (1.97e-1)" "unprognostic (4.08e-1)" "unprognostic (4.46e-3)" "unprognostic (2.50e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-4)" "unprognostic (2.28e-2)" "unprognostic (2.14e-3)" "unprognostic (1.53e-1)" "unprognostic (3.64e-1)" "unprognostic (3.99e-3)" "unprognostic (1.97e-1)" "unprognostic (6.31e-3)" "unprognostic (4.22e-3)" "unprognostic (5.88e-2)" "unprognostic (8.90e-3)" "unprognostic (1.79e-1)" 5.7 4.3 2.6 1.6 5.2 2.1 2.4 5.2 4.5 5.6 2.6 1.4 3.1 0.7 7.8 3.4 1.3 3.7 2.4 12.9 1.8 2.4 6.0 0.3 1.1 0.8 1.7 3.1 7.3 2.3 7.4 10.9 1.2 3.0 5.7 1.2 5.1 2.3 6.3 0.5 1.4 0.9 4.3 0.7 1.1 1.5 44.0 0.9 0.5 8.4 1.4 0.7 2.7 3.1 0.1 0.0 0.1 0.0 0.1 3.4 0.4 1.2 3.1 2.8 6.6 0.7 0.0 0.3 2.1 2.2 2.9 3.8 0.4 1.0 3.4 2.2 0.9 3.6 0.5 3.3 0.3 4.4 1.7 2.0 5.4 1.4 2.0 0.6 3.9 1.7 1.5 0.1 1.4 0.0 7.4 0.8 2.6 2.2 3.4 4.7 2.1 0.2 1.6 2.5 0.5 2.5 0.1 2.3 0.0 5.6 0.5 8.5 0.9 0.8 0.3 1.2 1.2 2.4 1.1 0.6 4.0 5.2 0.6 5.4 9.1 10.4 0.0 4.3 1.9 3.6 0.1 0.0 0.0 0.6 0.0 3.4 0.0 0.1 0.6 0.0 0.1 1.0 2.7 0.0 0.1 0.0 0.0 0.0 0.4 2.6 5.2 5.2 4.5 1.8 2.4 1.7 3.1 3.0 0.9 3.0 0.0 0.0 2.9 0.5 41.9 24.2 2.5 16.0 6.8 12.2 13.7 1.1 5.0 0.4 300.2 2.3 0.0 0.0 0.0 1.1 1.0 3.0 2.3 0.0 0.3 3.2 0.0 0.0 0.0 304.6 6.6 0.0 6.8 0.0 0.0 11.1 0.2 0.0 8.1 5.6 6.2 25.8 15.6 171.9 4.1 0.4 1.1 0.0 0.0 0.9 DPYS DHPase ENSG00000147647 Dihydropyrimidinase Q14117 8 104330324-104467053 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "kidney: 42.2;liver: 103.6" "Group enriched" "Detected in some" 15 "Hepatocytes: 429.9;Proximal tubular cells: 408.7" "Group enriched" "Detected in some" 21 "liver cancer: 57.6;renal cancer: 11.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 13 "monocytes: 1.2" "Cell line enhanced" "Detected in some" "HDLM-2: 2.7;HSkMC: 2.4;U-266/84: 2.0;U-698: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA024785 Enhanced NA NA 89000 "HPA024785: AB_1847856" "unprognostic (1.54e-3)" "unprognostic (2.33e-1)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-1)" "unprognostic (2.38e-3)" "unprognostic (4.16e-4)" "unprognostic (1.56e-1)" "unprognostic (3.53e-2)" "unprognostic (3.85e-3)" "unprognostic (2.43e-1)" "unprognostic (4.81e-2)" "unprognostic (9.56e-3)" "unprognostic (2.72e-1)" "unprognostic (2.02e-1)" "unprognostic (1.86e-1)" 2.5 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.2 2.1 0.1 0.0 0.0 0.0 1.6 0.1 0.2 1.3 0.0 0.0 0.1 42.2 103.6 0.2 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.1 0.9 0.0 0.2 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.7 0.7 0.0 0.0 0.0 1.2 0.0 0.0 2.7 0.0 0.1 0.0 0.2 0.0 1.3 1.1 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.4 0.0 0.7 0.0 0.1 0.6 1.3 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.0 1.5 0.0 0.7 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.4 28.1 0.0 0.0 19.2 0.0 0.0 23.2 0.0 9.9 0.0 0.0 23.3 0.0 0.0 0.6 2.5 0.0 429.9 1.3 0.0 0.0 6.2 6.2 9.7 0.9 0.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 408.7 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 DPYSL2 "CRMP2, DHPRP2, DRP-2, DRP2" ENSG00000092964 "Dihydropyrimidinase like 2" Q16555 8 26514022-26658178 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.0" "Cell type enhanced" "Detected in many" 5 "Ito cells: 240.0" "Cancer enhanced" "Detected in all" "glioma: 89.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1" "Group enriched" "Detected in many" 6 "dendritic cells: 25.5;monocytes: 26.7" "Cell line enhanced" "Detected in many" "ASC diff: 61.4;Karpas-707: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002381, CAB018719" Supported Supported "Plasma membrane,Cytosol" NA NA 3900000 Cytosol "Plasma membrane" "CAB018719: AB_2085366, HPA002381: AB_1847244" "unprognostic (2.88e-2)" "unprognostic (1.01e-2)" "unprognostic (9.51e-2)" "unprognostic (3.16e-3)" "unprognostic (8.23e-2)" "unprognostic (1.68e-2)" "unprognostic (1.51e-1)" "unprognostic (9.95e-3)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-2)" "unprognostic (4.13e-2)" "unprognostic (5.58e-2)" "unprognostic (9.32e-3)" "unprognostic (1.23e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (5.41e-5)" 31.6 21.7 53.5 13.4 48.1 3.0 21.3 51.8 137.0 14.6 12.2 54.7 3.9 7.1 14.2 8.1 12.0 14.7 18.0 27.2 52.9 48.6 12.1 11.2 45.3 9.9 56.5 45.4 25.8 7.5 5.1 7.2 25.6 46.9 9.8 12.4 8.2 6.5 10.3 10.9 10.2 9.7 19.9 70.1 19.0 8.5 7.5 44.9 5.8 7.7 5.2 12.3 14.0 13.1 3.2 25.5 0.6 26.7 4.0 4.6 8.8 4.7 23.1 22.8 12.1 61.4 28.3 2.2 9.3 21.8 8.9 11.6 9.0 6.9 7.1 6.8 29.2 18.0 4.6 23.9 9.3 8.5 16.1 2.0 8.1 8.8 12.6 39.4 1.7 3.3 35.1 13.5 24.4 14.2 28.8 17.9 5.6 0.2 63.2 8.9 3.0 13.7 1.7 17.8 15.3 4.5 18.3 9.1 4.7 15.0 5.5 10.4 21.9 11.3 0.1 6.1 15.7 1.7 3.2 32.2 20.3 8.2 16.8 4.0 8.9 9.1 5.6 29.4 10.6 10.3 0.4 24.0 0.2 3.5 26.7 1.2 3.2 3.1 2.3 25.5 1.7 1.6 2.1 0.6 4.0 16.2 15.1 4.6 8.8 53.5 48.1 51.8 68.4 52.9 48.6 56.5 45.4 46.9 44.9 122.1 67.9 17.3 0.8 35.8 104.6 86.8 104.4 17.4 31.8 21.0 29.5 12.9 3.3 17.3 2.6 134.9 3.1 0.0 1.6 9.2 59.6 1.1 19.7 13.4 46.2 133.5 58.3 240.0 207.1 6.4 100.9 92.1 114.7 101.8 73.9 141.1 9.7 3.6 84.1 17.3 36.8 135.8 60.8 3.1 8.5 29.5 3.8 8.7 6.6 1.1 DPYSL3 "CRMP4, DRP-3, ULIP" ENSG00000113657 "Dihydropyrimidinase like 3" Q14195 5 147390811-147510056 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 91.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 312.2;Peritubular cells: 193.4;Rod photoreceptor cells: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 119.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010948 Approved Approved Cytosol NA NA 170000 Cytosol "HPA010948: AB_1847245" "unprognostic (3.92e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-3)" "unprognostic (1.39e-1)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "unprognostic (5.99e-2)" "unprognostic (6.92e-2)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.87e-9)" "unprognostic (1.14e-2)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.23e-4)" 21.7 7.2 22.9 18.9 20.4 0.5 14.1 6.7 31.0 26.8 39.7 20.9 31.4 6.8 38.8 28.0 28.8 20.1 33.9 18.5 23.7 24.7 2.5 1.8 16.2 6.1 16.7 15.2 33.0 2.2 1.0 4.2 7.1 27.0 40.0 14.3 32.3 7.1 61.4 22.1 7.3 12.9 91.4 24.7 9.1 15.0 12.1 15.9 0.3 7.2 15.5 9.6 45.6 18.9 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 6.1 11.0 0.0 0.4 11.3 0.2 5.8 27.8 12.4 16.5 19.1 0.5 0.0 1.6 16.8 6.5 0.6 2.2 0.2 13.8 2.6 5.0 0.0 5.3 0.0 11.2 0.0 0.0 2.1 0.1 26.6 10.5 31.2 35.3 0.0 0.0 0.2 7.0 0.0 0.0 0.1 23.4 0.0 9.1 0.0 23.4 0.0 10.9 2.4 8.2 119.4 0.0 0.0 1.9 15.9 0.1 0.1 15.4 9.0 6.8 22.0 21.3 19.8 3.5 0.0 8.3 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 22.9 20.4 6.7 12.5 23.7 24.7 16.7 15.2 27.0 15.9 0.0 3.2 0.0 2.8 8.4 12.5 5.2 2.5 4.0 5.7 0.0 312.2 0.1 0.0 3.6 14.1 50.5 0.0 0.0 7.4 0.2 38.0 9.9 1.1 0.2 1.5 4.8 6.3 29.4 0.6 13.2 39.7 1.1 18.6 0.0 0.0 22.9 10.7 0.0 193.4 0.0 109.3 0.0 35.1 1.4 2.6 7.2 0.3 0.0 0.0 3.4 DPYSL4 "DRP-4, ULIP4" ENSG00000151640 "Dihydropyrimidinase like 4" O14531 10 132186900-132205776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;heart muscle: 19.0" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 33.5;Cone photoreceptor cells: 55.0;Horizontal cells: 31.8" "Cancer enhanced" "Detected in many" "glioma: 13.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 23.7;AN3-CA: 31.1;SH-SY5Y: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049066 Approved Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA049066: AB_2680619" "unprognostic (6.27e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "unprognostic (1.81e-1)" "unprognostic (3.95e-1)" "unprognostic (5.99e-2)" "unprognostic (8.36e-5)" "unprognostic (1.72e-1)" "unprognostic (8.91e-2)" "unprognostic (1.08e-2)" "unprognostic (3.81e-2)" "unprognostic (6.36e-2)" "unprognostic (7.47e-6)" "unprognostic (3.04e-3)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.11e-4)" 1.5 4.4 11.8 2.0 12.3 1.1 1.5 8.9 32.0 1.7 1.4 6.5 0.2 1.1 6.4 2.2 1.4 1.4 2.1 19.0 13.6 9.6 1.0 1.0 1.5 1.4 9.0 9.1 3.0 1.9 1.0 5.0 1.3 6.0 4.8 1.0 4.6 1.5 4.2 2.5 1.6 1.2 2.7 8.1 2.5 1.8 6.7 4.8 0.0 1.0 0.0 1.3 1.4 0.4 0.7 0.0 0.0 0.6 1.1 2.5 0.8 0.0 6.7 23.7 31.1 0.0 0.2 0.0 2.0 0.2 1.3 0.3 0.0 0.2 0.0 0.8 1.0 2.3 0.0 4.6 4.5 0.1 0.0 0.9 0.0 0.0 2.4 4.2 0.0 4.7 2.1 2.2 0.7 0.1 0.4 2.4 0.0 0.0 0.2 3.4 1.9 0.0 0.0 4.1 0.3 2.3 0.0 0.0 3.7 0.0 0.4 3.7 32.3 0.7 0.0 4.1 1.4 0.1 0.0 3.9 5.9 9.9 0.0 5.6 0.0 1.6 0.0 9.9 0.0 0.6 0.0 0.1 0.0 1.4 0.6 0.0 0.0 1.1 0.1 0.0 0.7 2.5 0.7 0.0 1.1 0.5 0.0 0.0 0.8 11.8 12.3 8.9 18.7 13.6 9.6 9.0 9.1 6.0 4.8 0.0 0.0 0.0 0.2 0.5 33.5 14.2 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.2 4.3 0.9 0.0 0.0 0.0 0.1 2.4 0.4 0.0 0.0 0.2 31.8 1.7 0.0 0.0 7.1 3.7 0.0 1.7 0.0 0.0 7.5 0.8 0.0 4.2 0.0 12.3 0.0 4.7 4.4 2.7 0.1 0.0 0.0 0.0 0.0 DPYSL5 "CRAM, CRMP-5, CRMP5, Ulip6" ENSG00000157851 "Dihydropyrimidinase like 5" Q9BPU6 2 26847747-26950351 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.1" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 80.5;Early spermatids: 30.8;Late spermatids: 97.8" "Group enriched" "Detected in some" 15 "glioma: 17.7;testis cancer: 8.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 41.9;HAP1: 34.9;SCLC-21H: 50.0;SH-SY5Y: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034544, HPA072387" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034544: AB_10671228, HPA072387: AB_2686516" "unprognostic (1.07e-4)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (3.64e-6)" "unprognostic (3.94e-1)" "unprognostic (6.21e-2)" "unprognostic (6.12e-2)" "unprognostic (2.66e-1)" "unprognostic (1.54e-1)" "unprognostic (3.54e-2)" "unprognostic (1.35e-1)" "unprognostic (1.77e-2)" "unprognostic (5.67e-3)" "unprognostic (3.62e-2)" "unprognostic (1.08e-1)" "unprognostic (2.43e-1)" 1.2 4.7 6.1 1.6 18.4 1.1 1.1 7.8 36.6 1.4 1.6 43.5 0.0 1.7 1.2 1.1 1.3 1.2 1.1 1.1 10.3 11.3 1.2 1.1 1.1 1.1 24.3 8.8 1.1 1.1 1.1 2.8 1.2 21.9 1.3 1.5 1.6 1.1 1.1 1.2 1.2 1.7 1.6 47.1 1.1 1.1 10.3 19.7 0.0 1.1 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 41.9 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 1.1 0.0 34.9 0.0 0.0 0.0 7.6 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.0 29.6 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.2 0.0 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 18.4 7.8 11.8 10.3 11.3 24.3 8.8 21.9 19.7 0.0 0.0 0.0 0.3 0.0 9.2 5.3 0.0 0.0 0.0 0.0 80.5 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.3 0.0 0.1 7.9 0.0 0.0 0.0 97.8 1.4 0.2 1.7 0.0 0.0 15.6 0.0 0.0 1.1 0.0 12.4 0.0 0.0 3.2 2.3 0.3 0.0 0.0 0.0 0.1 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526336 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 41.0" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 21.9;Mucus-secreting cells: 12.7;Paneth cells: 11.8;Undifferentiated cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.9;Hep G2: 16.6;hTCEpi: 6.1;OE19: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039158 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039158: AB_10960125" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.1 0.0 0.1 2.1 0.2 0.0 0.1 0.1 0.1 0.8 13.3 0.2 0.1 14.7 0.1 0.1 3.7 0.2 3.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.2 5.1 0.1 0.6 0.1 0.1 1.5 41.0 0.3 0.1 0.2 2.9 0.1 0.1 0.2 0.1 0.7 1.5 1.1 1.4 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.6 0.1 5.9 0.0 0.0 0.3 0.4 0.1 16.6 0.0 0.2 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.3 14.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 0.0 2.3 0.0 1.1 0.6 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 5.3 1.2 0.0 2.0 1.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.5 0.1 11.8 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.9 0.0 10.6 0.2 DRAM1 "DRAM, FLJ11259" ENSG00000136048 "DNA damage regulated autophagy modulator 1" Q8N682 12 101877351-102012130 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.5;lung: 73.9" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 271.2;Early spermatids: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "BJ hTERT+: 103.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.82e-2)" "unprognostic (1.80e-1)" "unprognostic (7.19e-2)" "prognostic favorable (6.52e-8)" "unprognostic (1.15e-2)" "unprognostic (2.35e-3)" "unprognostic (1.29e-3)" "unprognostic (1.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (6.17e-3)" "unprognostic (5.02e-2)" "prognostic unfavorable (3.91e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (3.58e-2)" "unprognostic (2.07e-2)" 13.1 11.0 3.6 9.9 3.8 16.7 52.5 1.2 2.6 9.2 8.3 2.3 3.6 3.4 8.0 9.2 8.1 6.9 11.2 13.8 3.6 3.6 16.7 7.2 73.9 20.9 4.3 2.3 10.9 13.7 4.3 6.6 15.2 4.4 13.2 4.8 5.4 8.8 5.4 6.6 4.6 6.4 10.8 4.4 14.8 10.0 8.6 2.2 4.9 10.4 4.3 6.4 12.4 22.1 2.6 3.0 9.2 9.8 3.5 2.2 2.5 2.0 4.0 1.4 0.4 18.8 4.3 8.0 15.0 103.6 15.1 23.6 1.3 3.9 0.3 1.7 24.6 5.8 3.0 0.3 6.2 21.0 2.1 1.3 0.5 3.5 5.1 8.7 0.6 1.1 5.1 2.7 5.2 5.7 13.0 8.0 0.5 1.8 0.7 3.9 1.6 0.3 1.7 1.0 5.0 0.9 0.7 1.0 0.3 16.0 9.5 0.3 0.3 8.3 0.9 3.8 4.2 2.9 2.2 4.9 10.6 1.9 1.8 2.7 2.2 1.0 0.2 3.6 5.1 2.8 9.2 8.8 5.8 1.9 9.8 2.2 2.6 1.4 2.0 3.0 1.7 1.1 1.3 8.8 3.5 5.6 0.8 1.9 2.5 3.6 3.8 1.2 2.4 3.6 3.6 4.3 2.3 4.4 2.2 50.6 271.2 17.1 18.3 18.5 1.0 4.5 5.1 6.7 36.4 27.9 0.0 23.3 1.7 10.2 116.0 15.0 0.2 0.0 18.2 25.9 19.4 16.1 23.1 1.3 54.5 0.0 0.0 8.6 37.3 53.8 13.0 40.8 8.5 26.2 1.0 2.5 22.0 0.0 9.9 19.6 0.0 12.9 8.0 0.9 2.5 5.4 18.4 6.5 1.0 16.9 DRAXIN "C1orf187, Draxin, FLJ34999, Neucrin" ENSG00000162490 "Dorsal inhibitory axon guidance protein" Q8NBI3 1 11691729-11725857 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.6;brain: 9.5" "Cell type enhanced" "Detected in some" 6 "Basal glandular cells: 2.5;T-cells: 3.5" "Group enriched" "Detected in some" 6 "glioma: 5.1;testis cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 25.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA014302 Uncertain "Secreted in brain" NA NA "HPA014302: AB_1853084" "unprognostic (5.28e-2)" "unprognostic (2.73e-1)" "unprognostic (6.58e-2)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.85e-1)" "unprognostic (1.37e-2)" "unprognostic (1.84e-2)" "unprognostic (1.49e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-2)" "unprognostic (7.47e-2)" "unprognostic (5.16e-6)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (8.52e-2)" "unprognostic (5.08e-1)" 0.7 0.4 9.5 1.0 4.4 2.8 1.4 4.1 4.7 0.3 0.4 4.9 0.0 0.6 1.0 0.8 0.6 0.7 0.6 0.4 8.9 0.9 0.5 0.2 1.2 1.0 2.7 3.0 0.5 0.7 0.4 0.2 0.4 2.4 0.4 0.5 0.0 3.6 0.7 0.6 1.3 0.7 0.3 1.9 0.9 0.4 1.5 2.5 0.0 0.7 0.8 0.5 0.4 0.2 1.2 0.6 5.6 1.1 0.9 1.9 0.5 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.4 0.0 0.9 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 5.1 0.0 0.2 0.0 0.1 0.0 0.1 1.8 0.3 25.0 0.0 0.0 5.5 0.2 0.0 0.0 0.0 1.7 0.7 0.0 0.0 0.1 4.3 0.0 0.1 0.2 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 5.6 1.1 0.7 1.9 0.6 0.7 0.6 0.5 1.1 0.3 1.2 0.8 1.0 2.9 0.9 0.7 0.6 0.8 0.5 9.5 4.4 4.1 4.2 8.9 0.9 2.7 3.0 2.4 2.5 0.0 0.3 0.9 2.5 0.5 0.8 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.6 0.9 0.0 0.0 0.2 0.1 0.7 1.6 1.1 0.0 0.4 0.0 0.0 0.0 0.3 1.8 0.6 1.5 1.7 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.9 0.6 1.9 0.3 0.0 3.5 0.0 2.0 DRC1 "C2orf39, CCDC164, CILD21, FLJ32660, MGC16372" ENSG00000157856 "Dynein regulatory complex subunit 1" Q96MC2 2 26401916-26456711 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.5;fallopian tube: 36.8;testis: 29.6" "Group enriched" "Detected in some" 7 "Ciliated cells: 339.9;Early spermatids: 110.1;Late spermatids: 214.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.3" "Region enriched" "Detected in many" 4 "pons and medulla: 20.5" "Cell type enriched" "Detected in single" 64 "neutrophil: 11.2" "Lineage enriched" "Detected in single" 64 "granulocytes: 11.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.7;SCLC-21H: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-3)" "unprognostic (2.68e-2)" "unprognostic (5.36e-2)" "unprognostic (5.27e-3)" "unprognostic (3.41e-3)" "unprognostic (8.56e-3)" "unprognostic (7.02e-4)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (7.26e-2)" "unprognostic (1.97e-3)" "unprognostic (2.99e-1)" "unprognostic (3.06e-3)" "unprognostic (8.19e-2)" "unprognostic (9.91e-3)" "unprognostic (2.16e-1)" "unprognostic (1.30e-2)" 0.3 0.4 2.4 0.3 3.6 1.0 0.3 0.1 2.1 2.0 0.3 7.7 0.0 0.3 1.3 11.3 0.3 36.8 0.3 0.3 3.6 4.8 0.4 0.3 6.0 0.3 1.3 1.8 5.2 0.3 0.3 4.8 0.3 20.5 0.4 0.3 0.0 0.3 0.7 0.3 0.3 0.3 0.3 1.0 0.3 0.4 29.6 2.9 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 11.2 0.1 0.0 0.0 0.0 0.2 0.6 0.6 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.8 4.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 2.4 3.6 0.1 2.1 3.6 4.8 1.3 1.8 20.5 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 339.9 21.6 1.8 0.0 0.0 0.0 0.0 110.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 214.9 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 33.5 1.1 0.0 0.0 0.0 0.0 0.0 DRC3 "CFAP134, DKFZP586M1120, LRRC48" ENSG00000171962 "Dynein regulatory complex subunit 3" Q9H069 17 17972813-18016889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 46.9" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 239.6;Cone photoreceptor cells: 117.8;Rod photoreceptor cells: 86.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 7.2;U-87 MG: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036040, HPA036041" Approved NA NA "HPA036040: AB_10602349, HPA036041: AB_2674915" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-3)" "unprognostic (9.48e-2)" "prognostic favorable (4.05e-5)" "unprognostic (1.06e-1)" "unprognostic (7.64e-5)" "unprognostic (6.11e-2)" "unprognostic (5.47e-3)" "unprognostic (8.59e-2)" "unprognostic (3.67e-1)" "unprognostic (1.33e-4)" "unprognostic (1.62e-1)" "unprognostic (1.15e-2)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.56e-2)" 0.7 1.1 3.3 0.4 5.9 0.3 2.2 1.2 3.1 5.0 0.7 8.2 7.2 0.9 5.3 15.9 0.7 46.9 2.3 1.1 5.1 5.1 3.7 1.1 6.5 0.7 0.8 2.3 8.2 3.3 6.8 18.5 0.6 13.4 2.2 0.7 6.1 1.6 2.1 1.3 1.2 0.5 1.9 1.2 0.9 0.8 15.4 2.6 0.0 7.0 0.3 0.5 0.6 1.0 0.4 0.4 3.1 0.7 0.0 1.0 0.2 1.0 3.9 0.6 2.3 0.5 1.5 0.3 1.0 0.5 1.9 2.0 0.6 4.2 0.0 3.4 0.6 1.2 3.4 1.3 0.5 1.1 0.2 2.8 0.1 0.3 0.0 1.4 0.6 0.2 1.3 1.1 3.0 0.4 2.4 0.6 0.5 0.0 0.3 2.3 1.2 0.2 0.1 0.7 0.3 0.8 0.2 1.2 0.0 7.2 1.5 1.2 3.5 1.4 0.1 3.7 2.7 3.9 0.0 1.1 1.1 0.9 0.2 0.5 0.5 0.2 0.1 5.8 0.0 3.3 0.0 0.7 2.0 0.3 0.2 0.2 0.4 0.1 1.0 0.4 0.3 0.3 0.6 3.1 0.0 0.2 0.2 0.0 0.2 3.3 5.9 1.2 3.1 5.1 5.1 0.8 2.3 13.4 2.6 3.0 1.9 0.0 3.5 0.0 8.7 0.0 0.0 239.6 25.0 10.4 117.8 0.4 5.0 2.5 24.3 0.6 0.0 0.0 0.7 2.1 0.0 2.0 0.0 0.0 0.4 19.1 0.0 5.5 1.6 6.6 4.6 0.3 0.0 0.0 0.1 9.7 0.9 0.0 4.2 8.7 86.1 0.0 0.0 42.6 12.5 0.0 0.7 4.3 0.3 1.1 DRC7 "C16orf50, CCDC135, CFAP50, DKFZp434I099, FAP50" ENSG00000159625 "Dynein regulatory complex subunit 7" Q8IY82 16 57694793-57731805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 16.0;testis: 60.2" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 40.2;Early spermatids: 92.8;Late spermatids: 98.4;Spermatocytes: 22.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 8.9;neutrophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 8.9" "Cell line enhanced" "Detected in some" "BEWO: 3.1;Hep G2: 6.8;HMC-1: 3.1;JURKAT: 4.1;NB-4: 3.1" "Group enriched" "Detected in many" 5 "basal ganglia: 7.9;hippocampal formation: 7.4;hypothalamus: 3.9;pons and medulla: 7.0;thalamus: 6.2" "Low region specificity" "Detected in many" NA NA "unprognostic (4.04e-3)" "unprognostic (1.54e-1)" "unprognostic (4.11e-2)" "prognostic favorable (3.61e-4)" "unprognostic (9.96e-2)" "unprognostic (5.14e-2)" "unprognostic (1.80e-1)" "unprognostic (3.04e-1)" "unprognostic (2.18e-1)" "unprognostic (3.21e-2)" "unprognostic (1.04e-2)" "unprognostic (1.09e-1)" "unprognostic (5.34e-4)" "unprognostic (2.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.80e-2)" "unprognostic (5.53e-2)" 0.0 0.0 1.0 0.2 3.5 0.7 0.0 0.2 1.3 1.1 0.0 2.4 0.2 0.0 0.4 2.3 0.0 16.0 0.5 0.0 1.4 1.6 0.7 0.2 1.5 0.1 0.3 1.1 1.6 0.9 1.6 0.8 0.1 2.5 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.1 0.1 0.4 0.1 0.2 60.2 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 8.9 0.3 0.0 0.0 0.3 0.0 1.6 0.7 0.4 0.0 0.1 3.1 0.0 0.0 0.0 0.0 1.0 2.4 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.8 0.9 0.7 3.1 1.5 0.0 0.4 0.0 1.5 0.4 4.1 1.6 0.0 0.0 0.0 0.8 3.1 0.2 0.0 0.0 1.9 0.0 0.0 1.3 0.0 1.6 1.9 0.0 0.0 0.1 0.2 0.2 1.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.0 1.1 0.6 8.9 0.3 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.3 1.0 3.5 0.2 1.3 1.4 1.6 0.3 1.1 2.5 0.8 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 40.2 3.4 0.0 0.0 0.1 0.0 0.4 92.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 98.4 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 22.2 0.9 0.0 0.0 0.0 0.0 0.0 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 40.8;Horizontal cells: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 24.2" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" "HPA013393, HPA017304" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA013393: AB_1847833, HPA017304: " "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 24.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 0.0 0.0 0.0 0.0 0.1 40.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 31.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRD2 ENSG00000149295 "Dopamine receptor D2" P14416 11 113409615-113475691 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6" "Cell type enriched" "Detected in some" 12 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 52.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 45.2" "Region enriched" "Detected in many" 10 "basal ganglia: 183.8" "Group enriched" "Detected in many" 8 "basal ganglia: 126.7;midbrain: 41.7" "HPA015139, HPA015691" Supported Supported NA NA "HPA015139: , HPA015691: AB_1847834" "unprognostic (8.49e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-4)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (1.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.40e-2)" "unprognostic (8.33e-4)" "unprognostic (1.10e-1)" "unprognostic (6.65e-3)" "unprognostic (2.29e-1)" "unprognostic (1.71e-1)" "unprognostic (4.82e-2)" "unprognostic (8.49e-3)" 0.6 17.3 0.9 0.5 52.0 0.2 2.1 0.2 3.3 1.3 0.6 1.5 0.0 0.3 2.3 0.4 0.9 2.1 0.6 0.5 0.3 4.1 0.3 0.2 0.6 0.2 9.9 0.2 0.3 0.4 0.3 51.6 0.2 2.4 1.5 0.9 3.9 5.1 1.7 1.7 0.3 0.5 3.2 0.2 0.2 0.5 1.6 9.5 0.0 0.2 0.0 0.3 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 45.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.9 52.0 0.2 3.3 0.3 4.1 9.9 0.2 2.4 9.5 0.0 0.0 0.0 0.0 0.0 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRD3 ENSG00000151577 "Dopamine receptor D3" P35462 3 114128652-114199407 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 8.3;testis: 4.2" "Group enriched" "Detected in some" 39 "Early spermatids: 5.5;Late spermatids: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.0" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Region enriched" "Detected in some" 5 "basal ganglia: 7.5" "Region enriched" "Detected in many" 12 "basal ganglia: 25.2" NA NA "unprognostic (2.32e-1)" 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 2.0 0.6 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 DRD4 ENSG00000069696 "Dopamine receptor D4" P21917 11 637293-640706 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 86.1" "Group enriched" "Detected in some" 7 "Bipolar cells: 115.9;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 193.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;Hep G2: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.83e-2)" "unprognostic (2.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.81e-2)" "unprognostic (7.52e-2)" "unprognostic (7.89e-3)" "unprognostic (3.14e-2)" "unprognostic (2.96e-1)" "unprognostic (8.45e-2)" "unprognostic (5.07e-2)" "unprognostic (3.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.05e-4)" "unprognostic (1.26e-2)" "unprognostic (8.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-1)" 0.9 0.6 1.8 0.5 1.9 1.2 0.7 3.5 1.6 1.2 1.4 4.3 0.5 1.5 1.5 0.5 0.5 1.5 0.6 0.7 2.3 2.0 1.0 0.7 1.1 1.4 1.0 1.1 3.4 1.4 0.5 4.2 1.1 7.3 1.6 0.5 86.1 1.6 0.5 10.2 3.5 2.8 0.8 1.2 1.0 0.6 1.8 0.7 0.7 1.3 0.5 1.0 0.5 1.2 0.0 3.2 0.2 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 2.7 0.0 0.1 0.0 0.3 1.3 0.2 0.4 2.7 0.0 0.7 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.1 1.0 0.0 0.0 0.8 0.6 0.1 0.6 0.2 0.0 0.2 0.3 0.0 0.0 0.3 0.0 1.0 0.5 0.3 0.1 0.0 0.3 1.0 0.0 0.7 0.7 0.1 0.9 1.0 0.9 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.8 1.9 3.5 1.6 2.3 2.0 1.0 1.1 7.3 0.7 0.0 0.3 0.0 0.3 0.0 115.9 1.1 0.0 0.0 0.0 1.8 82.5 0.4 0.0 0.1 0.4 0.0 1.3 0.0 0.3 0.2 0.4 0.7 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 1.1 19.0 0.3 0.0 0.7 1.2 193.4 0.0 0.3 0.2 1.0 0.4 0.1 0.0 1.1 0.3 DRD5 "DRD1B, DRD1L2" ENSG00000169676 "Dopamine receptor D5" P21918 4 9781680-9784009 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Dystonia, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 8.4;lymphoid tissue: 3.5;stomach 1: 10.9" "Cell type enhanced" "Detected in single" 41 "Horizontal cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 3.6;THP-1: 2.0;U-2 OS: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048930 Supported NA NA "HPA048930: AB_2680562" "unprognostic (2.03e-2)" "unprognostic (2.63e-1)" "unprognostic (9.73e-2)" "unprognostic (4.27e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (1.32e-4)" "unprognostic (5.09e-4)" "unprognostic (6.51e-2)" "unprognostic (1.46e-1)" "unprognostic (7.36e-3)" 0.2 0.2 2.8 3.5 4.1 0.1 0.2 0.0 8.4 0.1 0.9 0.0 0.0 0.9 0.1 0.1 0.3 0.3 0.1 0.1 3.2 3.2 0.2 0.1 0.4 0.2 1.9 0.8 0.1 0.2 0.1 1.0 0.1 7.4 0.6 0.2 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.6 0.1 10.9 1.3 1.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.0 2.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.1 0.0 8.4 3.2 3.2 1.9 0.8 7.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRG1 NEDD3 ENSG00000185721 "Developmentally regulated GTP binding protein 1" Q9Y295 22 31399523-31530634 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 86.8" "Group enriched" "Detected in all" 4 "Early spermatids: 642.5;Late spermatids: 488.7;Spermatocytes: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001218 Enhanced Supported "Nuclear bodies,Cytosol" No No "Nuclear bodies, Cytosol" "HPA001218: AB_1078704" "unprognostic (4.94e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (5.26e-2)" "unprognostic (4.66e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (7.71e-4)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" "unprognostic (2.32e-3)" "unprognostic (8.69e-3)" "unprognostic (1.55e-3)" "unprognostic (4.80e-2)" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (2.25e-1)" 14.5 18.1 12.3 10.6 18.1 11.9 15.3 14.1 20.9 12.7 10.5 13.3 11.7 9.3 13.6 17.6 13.4 14.7 8.4 18.5 11.2 12.7 15.3 15.7 9.4 11.1 12.6 14.9 15.7 16.4 14.2 11.9 19.6 17.2 13.5 13.3 14.3 17.0 13.3 47.0 11.9 10.1 14.9 10.9 11.7 12.4 86.8 9.9 23.6 17.8 12.1 15.7 15.0 10.5 29.4 25.2 25.1 27.1 25.0 27.6 24.8 22.3 18.5 22.9 18.9 20.6 24.3 18.3 20.9 25.5 39.5 33.2 30.1 11.5 32.9 11.4 26.3 18.8 19.1 39.4 25.5 43.1 15.3 47.9 21.2 21.2 30.4 29.6 51.0 20.0 20.7 19.0 32.0 48.5 20.2 27.3 18.6 27.3 14.2 30.2 26.2 20.3 26.1 18.2 34.3 20.6 28.1 36.5 28.8 25.8 20.5 24.5 15.3 23.5 23.5 29.9 22.9 17.6 22.6 15.2 17.8 23.6 17.8 23.5 19.3 21.7 31.7 17.3 22.5 22.8 13.7 23.9 25.1 20.5 27.1 23.8 29.4 22.1 25.2 25.2 21.7 24.7 23.9 5.4 25.0 19.9 22.1 27.6 24.8 12.3 18.1 14.1 20.9 11.2 12.7 12.6 14.9 17.2 9.9 17.9 12.5 30.5 35.8 34.3 19.4 44.6 22.9 17.4 14.8 26.2 23.6 110.4 54.7 49.0 642.5 35.9 23.9 23.3 39.8 84.2 28.3 31.7 33.4 30.9 52.4 14.3 10.9 31.9 29.8 488.7 33.1 24.0 16.9 36.9 29.8 16.4 39.9 28.1 35.0 47.3 15.4 58.2 31.1 203.2 83.0 28.1 97.9 27.4 38.4 40.9 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 68.5" "Group enriched" "Detected in some" 100 "Early spermatids: 369.6;Late spermatids: 442.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 5 "CACO-2: 15.6" HPA020446 Approved Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.5 0.5 0.5 0.5 0.5 1.3 0.8 1.0 0.5 0.5 0.5 0.5 0.5 0.1 1.3 9.7 0.5 0.6 0.5 0.5 0.5 0.3 1.2 0.5 0.5 0.7 0.5 0.5 1.3 0.9 8.3 0.8 0.5 0.5 0.7 0.2 0.5 0.5 0.6 0.5 1.3 0.6 0.5 0.5 0.8 0.4 68.5 0.5 0.5 1.0 0.5 0.5 0.5 0.5 0.0 0.0 0.4 0.6 0.0 1.0 0.0 0.7 0.9 2.2 0.6 2.7 0.6 2.0 0.0 0.0 0.1 0.1 15.6 0.6 1.0 0.1 0.6 0.5 1.5 3.0 0.1 0.4 0.2 1.5 0.5 1.2 0.7 1.0 0.4 2.4 1.2 1.3 0.5 0.0 0.9 0.4 0.4 1.2 0.3 0.2 0.8 0.3 0.7 0.2 0.7 0.8 1.6 0.1 0.0 0.4 1.7 1.0 0.7 0.0 1.3 1.1 0.5 0.3 0.1 0.4 0.0 2.8 2.5 0.2 1.0 1.4 0.1 2.6 0.6 0.2 0.0 0.3 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.0 0.5 0.5 0.3 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 369.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 442.6 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.3 0.0 0.0 0.0 4.1 1.5 0.0 0.1 0.0 0.0 0.0 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.3;Intestinal endocrine cells: 1.7;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 11.3;TIME: 19.0;U-87 MG: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 2.4 0.1 0.1 0.2 0.1 0.5 0.1 0.4 1.0 0.0 0.4 0.3 0.3 0.1 0.7 0.0 0.3 0.0 0.8 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.5 1.5 0.0 0.8 0.0 0.1 1.4 0.5 0.0 1.0 1.6 0.0 1.3 0.5 0.1 0.1 0.1 0.3 11.3 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.5 0.0 0.1 19.0 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 0.0 0.0 0.0 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSC1 CDHF1 ENSG00000134765 "Desmocollin 1" Q08554 18 31129236-31162856 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 78.4" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 145.5" "Group enriched" "Detected in some" 17 "head and neck cancer: 7.3;melanoma: 4.1" "Region enriched" "Detected in single" 13 "cerebral cortex: 7.0" "Group enriched" "Detected in some" 8 "naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in single" 8 "T-cells: 5.7" "Cell line enriched" "Detected in single" 4 "hTERT-RPE1: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075379 Enhanced NA NA 18000000 "HPA075379: AB_2732290" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.48e-2)" "unprognostic (3.71e-2)" "unprognostic (8.19e-3)" "unprognostic (1.56e-1)" "unprognostic (1.89e-1)" "unprognostic (1.27e-1)" "unprognostic (1.78e-1)" "unprognostic (5.65e-6)" "unprognostic (5.08e-2)" "unprognostic (2.91e-1)" "unprognostic (6.99e-2)" "unprognostic (4.74e-5)" 0.2 0.1 0.1 0.3 0.5 0.0 3.5 0.1 7.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 2.8 0.1 0.0 9.1 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.1 0.0 1.3 1.2 0.0 0.2 78.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.1 0.1 16.6 1.5 0.1 0.2 0.0 0.0 0.7 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 5.7 5.2 0.7 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.1 7.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.4 29.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 145.5 0.3 0.0 0.0 0.1 DSC2 "CDHF2, DSC3" ENSG00000134755 "Desmocollin 2" Q02487 18 31058840-31102415 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 156.0;Extravillous trophoblasts: 157.3;Paneth cells: 155.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 48.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "eosinophil: 20.4;neutrophil: 5.7" "Lineage enriched" "Detected in many" 14 "granulocytes: 20.4" "Cell line enhanced" "Detected in many" "BEWO: 15.3;CAPAN-2: 19.8;HaCaT: 28.6;hTCEpi: 30.9;OE19: 24.0;SK-BR-3: 18.1;SuSa: 18.6" "Not detected" "Not detected" "HPA011911, HPA012615" Enhanced NA NA 14000000 "HPA011911: AB_1847618, HPA012615: AB_1847619" "unprognostic (3.28e-2)" "unprognostic (3.20e-1)" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (1.90e-1)" "unprognostic (3.04e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (7.66e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-3)" "unprognostic (2.10e-1)" "unprognostic (1.43e-3)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (3.01e-4)" 3.3 1.1 1.1 9.8 1.1 0.0 6.3 0.7 0.9 38.1 23.6 0.6 0.2 12.1 3.0 2.4 127.5 1.5 1.1 9.5 1.0 0.9 4.7 4.3 3.3 6.3 1.1 0.6 1.0 3.8 11.8 0.7 20.0 1.1 4.5 13.3 1.3 22.4 0.0 0.7 4.4 33.5 0.8 1.7 6.1 12.6 0.9 0.7 4.8 2.5 163.9 68.2 1.0 39.6 0.0 0.0 20.4 1.5 0.0 0.0 0.3 7.1 0.7 1.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 3.6 19.8 0.0 0.3 0.0 0.3 28.6 4.8 2.0 0.0 0.0 2.8 10.6 3.4 6.3 0.1 0.0 0.2 0.1 30.9 0.0 3.0 2.5 0.0 0.0 5.1 0.0 0.0 5.7 0.0 0.4 4.6 24.0 7.1 5.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 18.1 0.0 18.6 4.9 7.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 20.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.3 1.1 1.1 0.7 0.9 1.0 0.9 1.1 0.6 1.1 0.7 26.8 6.4 0.9 29.2 74.4 0.7 29.9 22.9 0.0 3.4 7.0 0.0 77.6 0.0 76.8 0.1 5.3 156.0 0.0 28.7 157.3 3.7 131.3 0.0 14.0 21.2 0.0 66.7 9.8 50.9 0.0 0.3 31.7 13.5 34.3 68.2 7.3 108.4 155.6 0.7 8.6 0.6 0.0 3.3 0.1 0.6 48.1 70.1 3.2 63.7 69.4 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30990008-31042815 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 444.8;Suprabasal keratinocytes: 602.1" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 71.0;HBEC3-KT: 16.3;hTCEpi: 42.0;hTERT-HME1: 30.9;REH: 11.9" "Group enriched" "Detected in some" 4 "basal ganglia: 1.3;hippocampal formation: 3.6" "Low region specificity" "Detected in some" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 2700000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645" "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.04e-5)" 1.5 0.0 0.0 0.6 0.0 0.0 10.4 0.0 0.0 11.9 1.0 0.0 0.4 0.1 2.1 1.4 73.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 2.4 0.1 16.0 0.1 4.5 0.0 0.0 7.2 0.3 0.2 99.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 2.2 0.0 92.4 28.4 1.0 14.4 0.7 0.2 1.0 0.5 0.4 0.4 0.1 4.5 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 71.0 0.0 16.3 0.0 0.0 3.9 0.2 1.4 0.1 2.7 0.0 0.0 2.8 42.0 0.0 30.9 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 5.8 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.2 0.4 0.3 0.2 0.0 0.7 0.3 0.4 1.0 0.4 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 1.4 0.0 43.5 444.8 0.0 1.2 0.0 2.7 19.4 0.0 0.0 62.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.1 7.5 19.6 0.0 0.0 4.6 0.0 2.4 0.0 0.0 0.0 0.0 0.6 37.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 602.1 20.9 0.0 0.0 96.7 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847139 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.2;pituitary gland: 9.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 15.0;Horizontal cells: 15.9" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.6;MCF7: 12.3;NTERA-2: 3.4;SCLC-21H: 5.1;T-47d: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019324, HPA057493" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA019324: AB_2670118, HPA057493: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.9 1.1 12.7 0.9 10.3 0.9 1.2 3.0 22.2 0.9 1.0 8.2 0.0 1.0 0.9 2.8 0.9 1.1 1.0 0.9 10.1 8.6 0.9 1.4 1.0 0.9 6.8 10.1 0.9 1.2 0.9 9.1 2.9 9.5 1.0 1.0 0.7 0.9 1.0 0.9 0.9 1.0 0.9 3.7 2.9 0.9 2.0 6.9 0.0 0.9 0.0 0.9 1.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.5 3.4 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.7 10.3 3.0 14.7 10.1 8.6 6.8 10.1 9.5 6.9 0.0 0.0 0.0 0.0 0.0 15.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 15.9 0.0 0.6 1.0 3.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.8 1.5 0.0 0.7 0.0 0.0 0.0 DSCAML1 KIAA1132 ENSG00000177103 "DS cell adhesion molecule like 1" Q8TD84 11 117427773-117817525 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 78.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 127.6" "Group enriched" "Detected in some" 5 "glioma: 1.9;ovarian cancer: 0.9;pancreatic cancer: 0.6;renal cancer: 2.5;thyroid cancer: 0.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 1.7;naive B-cell: 2.0;T-reg: 2.4" "Group enriched" "Detected in many" 22 "B-cells: 2.0;T-cells: 2.4" "Group enriched" "Detected in some" 4 "EFO-21: 9.2;RPTEC TERT1: 6.8;T-47d: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035230 Uncertain NA NA "HPA035230: AB_2674527" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.07e-2)" "unprognostic (6.27e-5)" "unprognostic (8.48e-2)" "unprognostic (1.56e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (7.96e-2)" "unprognostic (2.89e-2)" "unprognostic (2.39e-3)" "unprognostic (8.37e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-2)" 1.5 1.7 10.4 1.3 14.5 1.1 1.3 3.4 19.5 1.7 2.2 26.0 0.0 1.8 4.2 2.2 1.3 4.3 3.5 2.1 12.0 5.8 5.6 1.2 2.0 1.4 14.9 11.1 9.9 2.6 1.0 5.0 1.0 12.1 1.7 2.3 10.8 3.6 1.5 2.1 1.0 1.9 2.9 12.2 3.3 1.9 4.2 17.4 0.0 1.5 0.0 1.7 1.7 0.9 2.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.2 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.1 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.3 6.8 0.0 1.2 0.2 0.0 0.0 0.0 0.4 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 10.4 14.5 3.4 14.4 12.0 5.8 14.9 11.1 12.1 17.4 0.0 0.0 0.0 0.0 0.1 78.3 2.8 0.0 5.3 0.0 0.0 39.3 0.0 0.0 0.4 5.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 3.2 6.4 0.6 0.0 8.6 1.1 0.0 0.0 0.0 2.5 2.5 0.0 0.0 1.8 2.1 127.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 DSCC1 "DCC1, hDCC1, MGC5528" ENSG00000136982 "DNA replication and sister chromatid cohesion 1" Q9BVC3 8 119833976-119856010 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.2" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 15.8;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA023780, HPA024401" Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA023780: AB_2671311, HPA024401: AB_2671557" "unprognostic (7.36e-3)" "unprognostic (8.24e-2)" "unprognostic (1.56e-1)" "unprognostic (4.71e-3)" "unprognostic (9.91e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.92e-6)" "prognostic unfavorable (3.93e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (3.24e-3)" "unprognostic (8.12e-3)" "unprognostic (2.72e-2)" "unprognostic (2.32e-9)" "unprognostic (2.75e-2)" "unprognostic (5.01e-1)" "unprognostic (4.40e-2)" "unprognostic (8.18e-2)" 4.3 4.7 3.6 8.5 3.9 9.2 5.4 9.4 5.0 5.1 4.6 3.3 3.5 4.1 6.2 2.4 5.8 3.0 4.7 3.4 3.9 2.6 2.1 2.5 3.3 11.5 4.0 2.0 4.1 7.0 1.3 1.6 4.0 5.3 4.1 6.4 2.1 11.4 4.3 3.9 4.5 4.0 4.9 4.2 4.1 4.0 4.8 5.1 34.2 2.4 5.7 9.5 3.4 5.1 1.4 0.8 0.2 0.2 2.4 3.3 0.9 11.9 5.9 11.7 10.6 1.7 3.1 5.0 8.2 1.7 5.9 6.2 5.3 7.3 21.6 7.2 2.4 3.7 8.8 13.2 5.1 6.4 14.6 11.9 27.5 6.0 6.2 0.5 10.7 9.7 1.4 0.8 7.3 3.5 1.4 1.7 14.5 9.3 9.7 7.1 11.7 28.2 6.7 17.1 31.7 14.6 10.1 11.1 10.3 4.6 7.5 10.5 6.4 4.4 35.1 5.5 9.5 6.5 5.9 1.1 6.5 17.7 6.2 11.9 13.3 19.8 22.9 3.3 17.3 9.4 0.0 0.2 0.2 3.3 0.0 2.5 1.4 0.7 1.6 0.2 0.6 0.4 1.4 0.0 2.4 0.0 0.8 1.1 0.9 3.6 3.9 9.4 5.0 3.9 2.6 4.0 2.0 5.3 5.1 0.0 0.3 0.0 1.9 3.1 0.4 0.7 0.0 2.7 0.0 0.0 0.0 1.8 0.0 1.6 0.1 2.4 0.1 0.0 2.1 15.8 3.5 1.4 4.6 0.0 4.1 0.0 0.0 6.2 1.3 0.0 1.1 0.0 3.3 0.0 0.4 1.3 0.5 0.0 2.5 1.1 0.2 0.0 2.8 1.1 22.6 2.9 1.1 1.3 1.5 0.9 DSG1 "CDHF4, DSG" ENSG00000134760 "Desmoglein 1" Q02413 18 31318089-31357029 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 124.8;tongue: 117.4" "Group enriched" "Detected in some" 28 "Basal keratinocytes: 104.3;Suprabasal keratinocytes: 276.0" "Group enriched" "Detected in many" 10 "head and neck cancer: 57.0;melanoma: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "hTCEpi: 14.6" "Not detected" "Not detected" "HPA022128, HPA074188" Enhanced NA NA 140000000 "HPA022128: AB_1847620, HPA074188: " "unprognostic (2.55e-2)" "unprognostic (8.87e-2)" "unprognostic (2.00e-1)" "unprognostic (4.13e-1)" "unprognostic (5.22e-1)" "unprognostic (1.81e-2)" "unprognostic (1.57e-2)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (2.19e-1)" "unprognostic (6.15e-2)" "unprognostic (4.24e-3)" "unprognostic (2.87e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.99e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 30.9 0.0 0.0 0.0 0.0 1.3 0.0 18.5 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 4.2 0.0 0.3 124.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.0 0.0 117.4 2.3 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.1 276.0 0.0 0.0 0.0 0.0 DSG2 CDHF5 ENSG00000046604 "Desmoglein 2" Q14126 18 31498043-31549008 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 208.8;Mucus-secreting cells: 176.4;Pancreatic endocrine cells: 177.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 7 "pons and medulla: 6.9" "Cell type enriched" "Detected in single" 10 "basophil: 9.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 9.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 36.3;HaCaT: 56.6;HBEC3-KT: 42.0;hTERT-HME1: 45.7;OE19: 47.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA004896, CAB025122" Enhanced Supported "Cell Junctions" NA NA 94000000 "Cell Junctions" "CAB025122: , HPA004896: AB_1078643" "unprognostic (1.56e-3)" "prognostic unfavorable (8.22e-4)" "prognostic favorable (7.81e-4)" "unprognostic (8.77e-3)" "unprognostic (3.53e-4)" "prognostic unfavorable (5.63e-4)" "unprognostic (2.86e-3)" "prognostic unfavorable (2.43e-4)" "unprognostic (5.21e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (4.94e-5)" "unprognostic (3.40e-1)" "prognostic favorable (3.14e-10)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (3.72e-1)" "unprognostic (8.57e-3)" 17.3 1.1 0.6 11.6 0.7 0.0 21.1 0.7 0.7 3.9 50.2 1.3 4.0 18.1 3.8 5.6 6.3 4.9 14.2 15.7 0.7 0.6 22.4 10.8 7.0 2.4 0.6 0.9 8.8 15.5 39.9 2.7 39.8 6.9 10.4 23.8 4.5 27.3 1.5 2.2 5.3 70.7 3.1 0.5 0.6 17.3 2.3 0.5 13.6 20.8 3.2 5.8 18.5 7.7 0.1 0.9 9.5 0.0 0.0 0.3 0.0 24.2 9.4 0.8 0.0 0.1 1.5 30.5 0.0 0.0 0.0 0.0 6.5 36.3 0.0 13.8 0.0 11.6 56.6 11.5 42.0 0.0 0.0 7.1 0.0 10.8 7.3 4.4 3.0 0.0 2.1 29.2 0.9 45.7 22.0 0.0 7.2 9.6 0.0 0.0 6.4 6.4 0.4 11.7 47.1 4.8 10.8 0.0 15.5 14.1 12.1 5.1 0.0 18.4 13.1 0.0 26.3 9.3 2.6 0.0 0.0 5.4 0.0 6.0 1.2 0.0 0.0 4.3 0.0 5.3 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.6 0.7 0.7 0.7 0.7 0.6 0.6 0.9 6.9 0.5 50.6 38.4 0.5 64.3 11.9 0.2 51.1 89.2 42.8 50.0 12.2 0.0 70.4 3.3 82.4 0.6 8.7 208.8 23.3 65.2 91.9 9.5 96.7 4.6 22.1 9.0 1.6 76.9 2.5 1.5 1.6 1.4 1.8 16.9 10.8 176.4 4.2 177.3 149.7 0.4 10.0 0.2 0.0 9.5 3.0 8.1 5.3 50.1 1.3 168.5 163.4 DSG3 CDHF6 ENSG00000134757 "Desmoglein 3" P32926 18 31447795-31478702 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 156.7;lymphoid tissue: 50.7;tongue: 158.9" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 175.5;Suprabasal keratinocytes: 180.4;Urothelial cells: 67.6" "Group enriched" "Detected in many" 5 "cervical cancer: 104.0;head and neck cancer: 183.9;lung cancer: 36.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 26 "basophil: 9.0" "Lineage enriched" "Detected in single" 42 "granulocytes: 9.0" "Group enriched" "Detected in some" 7 "HaCaT: 42.1;hTCEpi: 104.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA046864, HPA056863, CAB069880" Enhanced NA NA "CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260" "unprognostic (5.76e-3)" "unprognostic (6.99e-2)" "unprognostic (7.67e-2)" "unprognostic (7.79e-2)" "unprognostic (1.00e-2)" "unprognostic (4.08e-3)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "prognostic unfavorable (1.43e-5)" "unprognostic (8.26e-2)" "unprognostic (8.35e-7)" "unprognostic (8.85e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (9.90e-4)" 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.1 35.9 1.1 0.0 0.0 1.6 2.3 0.0 156.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.0 10.6 0.0 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.1 0.0 3.2 0.0 158.9 50.7 0.4 24.8 0.2 0.1 9.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.2 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 21.0 0.0 12.2 175.5 0.0 0.3 0.0 24.1 22.7 0.0 0.0 0.3 0.0 0.3 0.4 0.1 0.9 0.0 0.3 0.3 0.8 3.0 11.6 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 2.5 6.8 1.0 0.0 0.2 0.7 2.9 0.7 0.0 0.6 6.5 2.2 3.1 2.6 180.4 0.2 0.0 0.2 67.6 DSG4 "CDHF13, LAH" ENSG00000175065 "Desmoglein 4" Q86SJ6 18 31376777-31414912 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 7.3;testis: 2.6" "Group enriched" "Detected in some" 4 "Early spermatids: 1.0;Urothelial cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 143 "HaCaT: 31.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA059456 Enhanced NA NA 300000 "HPA059456: AB_2684025" "unprognostic (9.86e-2)" "unprognostic (8.61e-2)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "unprognostic (5.55e-2)" "unprognostic (5.61e-2)" "unprognostic (2.11e-2)" "unprognostic (6.00e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "unprognostic (2.14e-1)" "unprognostic (1.79e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 0.0 7.3 0.7 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 DSP "DPI, DPII, KPPS2, PPKS2" ENSG00000096696 Desmoplakin P15924 6 7541575-7586717 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 138.3;skin 1: 136.5;tongue: 189.6" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 801.2;Cardiomyocytes: 699.5;Suprabasal keratinocytes: 1763.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 314.1" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 19 "naive B-cell: 5.8" "Lineage enriched" "Detected in single" 59 "B-cells: 5.8" "Cell line enhanced" "Detected in many" "BEWO: 46.0;HaCaT: 49.6;HBEC3-KT: 35.7;hTCEpi: 112.8;SuSa: 35.9" "Region enriched" "Detected in single" 23 "hippocampal formation: 12.8" "Low region specificity" "Detected in all" "CAB037324, HPA045840, HPA054950" Enhanced Supported "Cell Junctions" NA NA 110000000 "Cell Junctions" "CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645" "unprognostic (1.65e-1)" "unprognostic (3.09e-1)" "unprognostic (6.13e-2)" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.82e-2)" "unprognostic (7.03e-3)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (5.02e-2)" "unprognostic (2.94e-2)" "prognostic favorable (1.53e-9)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.82e-4)" 1.3 2.7 0.9 9.6 0.7 0.0 12.5 0.6 0.8 27.5 19.4 0.2 9.1 8.1 2.8 11.2 138.3 2.5 8.7 71.8 0.7 0.6 8.7 21.9 8.0 1.4 0.6 0.9 1.4 23.0 8.1 2.7 25.7 2.5 9.0 7.0 3.4 25.6 8.5 0.6 136.5 28.2 1.1 1.4 1.0 7.4 0.8 0.1 15.0 17.1 189.6 48.7 3.1 46.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 20.8 6.3 0.0 0.0 0.9 1.4 46.0 4.1 3.6 2.0 2.0 18.0 5.5 0.0 5.9 6.6 1.6 49.6 7.6 35.7 0.3 0.0 8.8 0.0 3.6 24.1 0.0 0.1 0.1 0.3 112.8 1.8 20.6 5.0 0.0 0.1 0.0 0.0 3.6 9.8 0.0 0.1 0.9 10.1 3.1 0.0 0.0 5.3 7.6 5.6 2.1 0.0 4.6 9.9 0.0 35.9 11.7 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.6 0.8 0.7 0.6 0.6 0.9 2.5 0.1 47.6 14.2 5.1 114.0 801.2 2.1 699.5 132.5 179.3 220.6 57.6 13.7 231.6 1.7 136.3 1.3 28.8 238.5 0.0 97.9 229.6 43.4 178.6 3.5 162.5 23.9 0.0 167.6 3.1 1.6 0.5 0.9 5.6 96.2 4.6 145.6 14.8 137.3 200.0 0.0 11.0 27.9 0.0 22.7 1.4 2.5 1763.9 322.6 2.9 145.6 184.4 DTHD1 FLJ16686 ENSG00000197057 "Death domain containing 1" Q6ZMT9 4 36281622-36345756 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;fallopian tube: 20.6;lung: 18.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 286.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (9.79e-6)" "unprognostic (4.04e-2)" "unprognostic (1.15e-2)" "unprognostic (5.54e-3)" "unprognostic (2.85e-1)" "unprognostic (5.45e-5)" "unprognostic (5.12e-3)" "unprognostic (9.11e-2)" "unprognostic (1.82e-2)" "unprognostic (7.59e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.05e-5)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.65e-2)" "unprognostic (7.12e-3)" 0.7 0.5 1.9 5.8 14.8 0.9 0.4 0.3 0.3 2.1 1.1 2.8 1.4 0.7 1.1 11.9 0.7 20.6 3.5 0.4 3.1 2.9 0.4 0.7 18.5 5.4 0.4 0.0 8.1 0.3 0.2 0.8 0.2 16.6 0.5 0.7 0.1 0.6 0.3 0.2 0.2 1.3 0.4 0.7 8.0 0.8 2.2 4.5 0.0 0.6 1.2 4.0 3.1 0.5 0.0 0.0 0.1 0.0 1.1 6.8 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.1 6.8 0.0 1.2 0.0 0.6 2.1 0.0 0.0 0.0 2.6 0.0 1.1 0.0 0.0 0.0 0.7 1.9 14.8 0.3 0.2 3.1 2.9 0.4 0.0 16.6 4.5 3.0 2.6 0.0 0.0 0.0 0.0 0.4 0.0 286.4 40.9 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.6 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 20.1 0.0 0.0 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 17.8;Erythroid cells: 23.3;Extravillous trophoblasts: 13.2;Spermatocytes: 35.9;Spermatogonia: 19.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Yes Yes Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: AB_2674119" "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.6 10.8 18.5 9.2 1.1 2.3 9.1 15.9 9.9 15.1 22.5 6.7 11.2 9.6 6.0 6.1 9.7 9.9 24.4 13.4 21.8 11.6 11.7 15.3 14.3 8.1 0.0 20.1 9.6 1.0 0.4 24.4 13.0 2.7 6.9 17.0 18.2 19.6 17.4 5.1 26.8 9.2 21.4 9.6 12.5 21.3 32.7 18.5 4.3 8.8 11.6 18.2 15.1 14.5 6.5 19.7 12.4 9.2 3.7 15.1 11.3 15.6 17.9 7.2 11.2 22.2 7.6 13.3 14.6 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 7.8 0.4 2.1 0.0 6.1 2.5 0.0 1.2 0.0 0.0 7.5 0.0 0.2 17.8 1.8 0.5 23.3 0.0 13.2 1.2 0.2 0.0 0.0 3.9 0.0 0.0 1.3 0.3 7.9 1.1 1.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 35.9 19.1 1.5 1.3 1.9 2.9 0.0 DTNA "D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3" ENSG00000134769 "Dystrobrevin alpha" Q9Y4J8 18 34493290-34891844 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 121.0;Muller glia cells: 42.7" "Cancer enriched" "Detected in many" 9 "glioma: 28.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;T-cells: 6.7" "Cell line enhanced" "Detected in many" "MCF7: 17.7;NTERA-2: 19.8;SCLC-21H: 27.8;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015196, HPA071177" Enhanced Approved "Nucleoplasm,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" Nucleoplasm "CAB015196: AB_2261797, HPA071177: " "unprognostic (1.57e-1)" "unprognostic (4.57e-2)" "unprognostic (3.13e-3)" "unprognostic (7.82e-6)" "unprognostic (5.03e-1)" "unprognostic (2.43e-3)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (1.23e-1)" "unprognostic (6.27e-2)" "unprognostic (1.35e-4)" "unprognostic (6.89e-2)" "prognostic favorable (2.64e-7)" "unprognostic (6.08e-3)" "unprognostic (3.93e-2)" "unprognostic (1.12e-1)" "unprognostic (7.27e-5)" 9.3 5.3 51.5 4.0 47.6 1.6 7.3 37.7 69.1 4.5 5.4 38.7 0.9 3.4 4.3 13.9 13.9 7.6 7.1 82.8 42.3 46.5 2.7 2.5 4.8 2.3 44.7 21.0 5.4 12.3 1.4 6.1 3.6 51.0 14.6 5.6 3.4 5.7 15.9 90.2 1.8 3.9 15.2 106.3 3.9 3.6 4.7 39.5 0.0 9.3 6.5 2.4 12.8 1.7 1.4 7.0 0.4 1.3 1.0 6.7 1.7 0.3 0.1 7.6 0.0 4.9 13.6 1.2 2.0 7.4 0.3 0.9 1.7 0.0 0.0 4.5 0.8 7.0 0.6 0.9 3.9 0.7 0.0 5.3 0.0 0.4 3.5 3.9 0.1 0.1 10.3 0.8 6.4 2.2 7.3 3.3 0.0 1.1 1.0 2.1 17.7 0.1 0.0 19.8 0.3 4.0 0.0 3.7 12.1 0.3 0.1 27.8 3.2 0.0 0.7 2.0 12.5 10.9 2.6 0.1 8.8 4.8 0.1 2.7 0.6 0.9 0.4 28.4 0.0 3.8 0.4 1.3 0.0 1.4 0.0 1.9 1.4 2.7 1.9 7.0 1.1 2.8 2.0 0.1 1.0 0.0 0.2 6.7 1.7 51.5 47.6 37.7 35.7 42.3 46.5 44.7 21.0 51.0 39.5 0.0 1.4 0.0 0.0 1.3 10.2 121.0 22.9 4.0 1.2 0.0 5.9 0.0 5.0 9.9 3.1 0.7 0.0 0.0 21.8 0.1 2.8 0.9 0.0 0.0 7.1 1.6 0.0 0.0 4.1 1.9 5.5 8.8 5.0 0.0 0.0 42.7 12.5 0.0 0.4 1.5 4.2 12.9 22.8 0.5 1.5 0.9 0.0 0.0 0.0 0.1 DTNB ENSG00000138101 "Dystrobrevin beta" O60941 2 25377198-25673647 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 49.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061357 Uncertain Approved Mitochondria NA NA Mitochondria "HPA061357: AB_2684489" "unprognostic (1.14e-1)" "unprognostic (1.39e-2)" "unprognostic (3.17e-2)" "unprognostic (7.40e-2)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.78e-2)" "unprognostic (3.67e-3)" "unprognostic (3.98e-2)" "unprognostic (9.45e-2)" "unprognostic (4.67e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-2)" "unprognostic (6.49e-2)" 3.6 3.5 19.1 5.2 21.3 4.7 13.9 14.5 24.6 7.7 2.7 9.5 13.6 2.2 4.7 14.0 4.6 7.3 5.9 3.4 20.6 12.6 6.3 5.1 6.6 4.6 12.4 11.7 7.2 10.3 12.2 9.6 5.4 13.2 10.5 2.4 4.2 49.4 13.9 2.7 4.6 2.3 3.1 13.1 4.4 7.7 9.0 7.3 6.3 15.7 1.0 5.4 5.2 4.3 7.4 1.1 7.2 2.2 5.1 7.4 2.8 8.9 7.6 6.2 6.9 3.6 4.6 0.2 2.7 3.7 3.4 4.9 2.9 2.3 4.7 1.1 2.2 4.4 3.2 4.3 11.7 1.9 7.2 10.0 3.7 2.3 8.9 2.6 4.7 3.7 3.7 10.1 3.6 6.3 4.3 4.7 9.7 0.3 7.2 2.6 9.0 7.7 3.9 7.1 2.4 5.2 6.2 10.1 8.9 6.4 8.4 8.2 11.9 8.9 15.8 10.9 3.4 8.3 2.8 1.9 1.4 6.4 2.0 4.8 12.7 5.6 8.5 4.0 8.6 5.1 0.5 2.2 7.2 5.8 1.1 6.6 5.7 7.4 5.2 0.7 7.4 7.3 5.0 4.3 5.1 0.6 1.1 6.4 2.8 19.1 21.3 14.5 24.6 20.6 12.6 12.4 11.7 13.2 7.3 8.9 10.9 3.7 21.9 7.1 8.6 2.2 12.7 0.0 5.7 14.0 5.9 3.1 10.0 3.9 2.3 3.8 0.0 0.0 10.2 1.2 2.1 14.7 1.1 5.0 26.1 20.6 2.9 2.5 4.7 4.5 1.4 3.1 11.8 2.8 2.3 15.1 6.9 0.3 2.5 7.1 7.8 6.5 1.4 9.4 12.4 1.8 1.7 8.6 1.0 16.0 DTNBP1 "BLOC1S8, DBND, Dysbindin, HPS7, My031" ENSG00000047579 "Dystrobrevin binding protein 1" Q96EV8 6 15522801-15663058 "Disease related genes, Predicted intracellular proteins" "Sensory transduction" "Albinism, Hermansky-Pudlak syndrome, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.0" "Cell type enhanced" "Detected in many" 6 "Rod photoreceptor cells: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028053, HPA029615, HPA029616" Approved Enhanced Microtubules,Midbody Yes No Microtubules Midbody "HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413" "unprognostic (2.83e-1)" "prognostic favorable (2.82e-4)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (4.93e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.72e-4)" "prognostic favorable (6.34e-5)" "unprognostic (1.36e-1)" "unprognostic (4.28e-3)" "unprognostic (2.21e-3)" "unprognostic (2.08e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.81e-3)" "unprognostic (1.09e-2)" 7.2 5.0 22.8 10.5 91.0 9.3 7.7 6.7 18.4 6.8 10.5 7.8 4.5 7.2 8.0 12.5 7.2 6.9 7.9 12.0 15.0 18.0 11.3 5.0 8.4 16.9 18.5 10.3 7.3 6.7 13.1 8.5 9.3 13.7 8.1 10.9 13.4 6.7 10.1 15.4 7.1 7.6 11.9 9.4 10.2 7.6 5.5 17.2 9.3 7.8 2.7 19.4 8.6 8.1 17.8 17.9 8.1 7.1 26.9 12.1 6.6 15.8 6.9 5.9 12.7 8.7 9.9 9.1 8.2 10.7 19.7 17.9 9.1 7.4 22.5 22.1 11.6 16.3 5.5 11.6 8.7 18.0 14.4 15.5 15.8 9.0 13.5 15.2 15.9 13.5 9.4 13.4 10.0 14.9 9.0 17.3 15.5 14.9 5.6 11.8 18.6 16.5 25.3 4.1 13.5 10.0 19.6 11.6 17.5 18.4 16.6 12.1 5.1 6.4 15.4 19.3 14.3 11.1 10.2 7.9 11.2 7.3 11.5 15.0 15.1 28.9 15.8 5.2 14.1 21.1 5.9 5.9 8.1 12.1 7.1 8.0 13.7 10.3 10.4 6.4 17.8 9.8 7.9 6.8 26.9 4.9 17.9 6.9 6.6 22.8 91.0 6.7 18.4 15.0 18.0 18.5 10.3 13.7 17.2 11.9 9.9 44.3 12.8 25.8 42.2 26.6 17.8 9.4 6.8 14.0 55.0 37.3 31.5 32.0 38.0 30.8 18.0 0.0 31.0 15.5 19.0 10.2 54.2 4.5 46.0 23.8 13.3 16.0 15.1 14.5 9.5 25.1 35.4 33.3 15.2 31.7 24.9 8.6 14.5 53.8 136.7 6.5 24.2 17.4 12.7 19.3 14.0 27.9 17.5 9.3 DTX1 "hDx-1, RNF140" ENSG00000135144 "Deltex E3 ubiquitin ligase 1" Q86Y01 12 113056709-113098028 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 9.7;lymphoid tissue: 13.3" "Cell type enriched" "Detected in many" 15 "Horizontal cells: 162.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "Daudi: 40.9;REH: 16.8;U-698: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051249, HPA055275" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA051249: , HPA055275: AB_2682769" "unprognostic (2.13e-3)" "unprognostic (3.20e-3)" "unprognostic (4.24e-4)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.59e-3)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (9.55e-2)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.41e-2)" "unprognostic (4.70e-1)" "unprognostic (1.63e-1)" "unprognostic (4.78e-3)" 9.7 2.3 6.1 8.9 7.0 3.2 3.9 7.3 8.3 0.8 0.7 1.1 0.5 1.6 2.0 0.5 1.2 1.7 1.0 2.7 5.4 5.9 1.7 6.4 0.5 13.3 3.7 4.2 0.5 2.0 0.0 2.2 0.9 4.6 0.8 0.2 1.4 3.2 0.5 0.5 0.5 2.2 0.5 1.1 9.8 1.0 4.9 0.5 0.5 1.3 0.5 8.1 0.5 0.5 2.3 0.0 0.0 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 1.7 0.0 0.8 0.0 0.0 16.8 0.0 1.0 0.0 0.0 1.0 2.7 0.1 0.1 1.0 0.0 0.0 0.1 0.4 0.0 1.6 0.0 0.0 0.2 0.0 41.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.0 0.0 2.3 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.2 6.1 7.0 7.3 7.1 5.4 5.9 3.7 4.2 4.6 0.5 0.0 0.0 2.9 0.0 0.9 1.5 0.7 0.0 0.0 0.0 1.8 7.9 0.0 6.6 1.6 0.6 0.7 0.0 0.0 0.0 0.0 0.8 0.1 6.9 10.5 0.6 162.1 0.0 0.0 0.0 1.1 7.2 0.0 3.3 0.0 0.0 10.3 0.2 0.0 7.1 0.0 2.1 0.0 0.9 0.7 1.2 0.4 0.0 0.0 0.0 0.0 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.1;esophagus: 19.2" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 28.3;CAPAN-2: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 2.9 1.3 0.4 4.8 0.5 1.5 3.2 0.4 0.2 4.8 5.7 4.1 3.0 0.0 19.2 3.2 3.8 1.8 0.5 0.5 1.6 2.8 3.2 3.9 0.7 2.7 4.3 3.8 2.1 1.8 4.6 3.2 10.5 1.3 2.8 11.6 5.5 1.3 1.1 4.9 6.1 8.3 2.7 4.0 4.6 8.8 7.0 14.7 19.1 14.1 3.3 9.0 6.4 12.9 28.3 4.2 6.2 2.4 2.3 9.1 2.8 2.4 3.1 4.3 7.9 46.8 4.0 2.0 2.8 16.4 9.7 2.2 13.4 1.9 9.0 4.8 2.3 5.8 6.9 3.2 3.3 5.8 4.2 8.2 8.0 4.3 2.4 2.3 7.2 7.0 6.1 3.7 6.3 5.1 11.6 6.1 9.8 4.3 5.6 3.9 7.2 1.4 10.1 1.7 3.5 4.5 7.8 3.8 3.9 7.8 8.9 2.4 17.5 8.4 5.9 11.2 4.6 5.4 4.6 3.8 3.6 9.0 12.4 9.2 13.3 7.6 10.9 5.5 6.0 6.4 7.5 8.4 7.0 6.6 6.9 19.1 3.3 14.1 14.7 9.0 6.4 6.0 5.3 7.3 17.3 30.1 2.6 1.7 5.1 29.4 18.2 7.0 7.9 16.0 3.3 16.6 13.7 4.7 27.5 0.0 9.5 11.1 6.0 16.5 3.5 3.2 18.8 3.2 8.7 9.2 11.1 6.7 5.2 11.6 6.8 9.0 26.8 5.0 19.5 35.3 4.6 2.9 8.7 6.5 4.1 9.2 10.1 30.9 31.5 8.3 21.7 51.5 DTX4 "KIAA0937, RNF155" ENSG00000110042 "Deltex E3 ubiquitin ligase 4" Q9Y2E6 11 59171430-59208587 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.8" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 33.1;Muller glia cells: 28.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 63.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 27.3;CACO-2: 14.8;CAPAN-2: 15.7;OE19: 15.1;RT4: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056760, HPA059294" Approved Approved Vesicles NA NA Vesicles "HPA056760: AB_2683228, HPA059294: AB_2683969" "unprognostic (3.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (4.97e-2)" "unprognostic (5.03e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (5.51e-2)" "unprognostic (2.51e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.57e-3)" 7.0 2.2 8.9 7.6 12.8 8.2 7.9 14.0 16.5 8.9 17.7 29.8 1.4 16.7 4.3 2.3 3.7 6.5 9.5 2.1 10.7 10.9 6.5 23.9 17.7 5.2 15.3 8.8 16.3 5.9 1.7 3.3 15.3 24.8 5.6 18.4 7.7 16.0 3.7 1.5 4.2 14.3 3.6 42.8 5.0 12.2 1.9 9.1 0.8 12.4 2.3 6.7 19.8 14.7 3.3 6.1 3.1 1.0 0.1 0.1 0.2 2.0 2.3 13.5 0.2 3.8 0.2 27.3 0.2 1.1 0.1 0.1 14.8 15.7 4.8 0.9 0.3 0.5 7.0 4.1 5.1 0.0 0.3 0.2 0.0 2.7 4.7 1.0 0.4 0.9 0.6 8.5 0.0 0.2 0.9 0.0 0.9 0.0 0.5 0.6 1.1 0.2 0.0 6.9 15.1 0.6 1.6 11.9 0.5 1.1 41.0 0.0 0.0 10.4 2.7 0.3 3.6 2.0 0.2 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 1.1 1.5 1.0 0.7 0.1 1.0 0.0 2.2 0.1 0.0 1.4 3.3 0.0 0.0 3.1 0.1 0.5 6.1 0.0 0.2 8.9 12.8 14.0 16.5 10.7 10.9 15.3 8.8 24.8 9.1 17.9 15.6 2.4 2.4 1.4 1.4 1.1 33.1 12.0 18.2 7.0 0.0 12.2 0.0 6.5 0.3 2.0 19.7 0.0 4.4 16.4 5.2 2.1 1.1 17.4 3.2 0.0 4.7 3.7 2.6 0.0 3.7 1.6 5.0 1.0 10.0 28.1 8.4 17.3 3.2 9.1 1.1 0.0 0.4 0.2 1.5 1.1 4.6 0.8 13.7 22.1 DUOX1 "LNOX1, NOXEF1, THOX1" ENSG00000137857 "Dual oxidase 1" Q9NRD9 15 45129933-45165576 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 48.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 77.4;Alveolar cells type 2: 116.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HaCaT: 34.6;hTCEpi: 16.8;RT4: 19.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.5" HPA023544 Approved NA NA "HPA023544: AB_1847878" "unprognostic (2.85e-2)" "prognostic favorable (4.31e-6)" "unprognostic (2.49e-2)" "unprognostic (8.84e-3)" "unprognostic (1.44e-2)" "unprognostic (3.27e-2)" "unprognostic (1.23e-1)" "unprognostic (2.57e-2)" "unprognostic (5.87e-2)" "unprognostic (6.02e-3)" "unprognostic (5.13e-2)" "unprognostic (1.19e-1)" "unprognostic (8.91e-3)" "unprognostic (2.23e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (3.03e-1)" 0.4 5.2 0.5 0.4 0.8 0.0 2.0 1.2 0.9 18.9 0.6 2.4 43.3 0.1 2.2 37.8 38.3 6.0 6.2 1.1 0.6 0.1 0.2 0.1 48.7 0.1 1.0 0.5 1.2 0.1 1.8 0.9 2.5 0.9 4.8 0.0 4.3 9.8 19.2 0.8 34.2 0.3 1.6 0.5 0.1 18.0 1.0 1.1 0.7 31.9 35.9 31.9 6.2 13.1 0.2 1.5 0.5 0.5 0.1 0.4 0.0 4.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.6 0.0 3.2 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 16.8 0.0 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 19.3 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.0 0.1 0.3 0.0 1.1 0.2 0.2 0.0 0.0 0.1 0.1 1.5 0.2 0.0 0.5 0.8 1.2 0.9 0.6 0.1 1.0 0.5 0.9 1.1 77.4 116.2 6.7 13.0 9.8 20.8 2.0 10.2 38.8 34.2 3.5 7.9 3.8 0.0 3.4 0.5 2.9 2.7 0.0 4.8 0.6 5.2 5.8 8.1 1.7 1.1 6.4 20.8 8.6 5.1 0.0 3.1 5.8 15.1 1.8 3.4 4.1 3.3 4.2 3.5 0.3 2.6 0.0 2.7 2.8 2.3 15.7 3.1 10.1 2.3 23.7 DUOX2 "LNOX2, P138-TOX, P138(TOX), THOX2" ENSG00000140279 "Dual oxidase 2" Q9NRD8 15 45092650-45114344 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 151.5;gallbladder: 80.4" "Cell type enhanced" "Detected in many" 18 "Ductal cells: 151.4;Exocrine glandular cells: 106.5;Pancreatic endocrine cells: 346.5;Urothelial cells: 98.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 60.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Cell line enriched" "Detected in some" 8 "HaCaT: 11.8" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Not detected" "Not detected" NA NA "unprognostic (3.19e-1)" "unprognostic (7.51e-2)" "unprognostic (3.77e-2)" "unprognostic (5.99e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (7.93e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.49e-2)" "unprognostic (9.59e-3)" "unprognostic (7.11e-2)" "unprognostic (5.32e-5)" "unprognostic (1.71e-1)" "unprognostic (1.62e-2)" "unprognostic (4.12e-2)" "unprognostic (1.63e-2)" 0.1 0.6 0.1 8.4 0.3 0.0 0.1 0.1 0.2 5.1 3.2 0.2 151.5 0.3 0.4 0.8 10.9 0.0 80.4 0.3 0.1 0.0 0.3 0.8 1.2 0.1 0.1 0.1 0.2 0.8 0.0 0.1 0.2 0.2 3.4 1.4 0.4 7.3 1.2 0.6 2.1 3.5 0.6 0.1 0.1 14.9 0.5 0.1 0.1 29.0 6.1 6.6 20.4 9.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 11.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.3 0.2 0.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 44.7 41.2 0.0 1.9 1.6 0.4 1.6 68.8 21.4 37.5 0.0 0.0 0.0 0.0 151.4 0.5 0.0 4.3 0.0 106.5 0.0 0.5 3.8 30.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.3 0.9 0.0 9.0 4.1 0.1 346.5 4.2 0.0 0.0 0.3 0.0 3.1 0.7 0.3 1.6 0.0 0.0 2.1 98.5 DUOXA1 "FLJ32334, mol, NIP, NUMBIP" ENSG00000140254 "Dual oxidase maturation factor 1" Q1HG43 15 45117367-45129938 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 48.0" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 90.0;Ciliated cells: 38.8;Club cells: 36.4;Urothelial cells: 33.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "MAIT T-cell: 2.1" "Lineage enriched" "Detected in single" 12 "T-cells: 2.1" "Cell line enriched" "Detected in some" 7 "HaCaT: 48.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041578 Approved NA NA "HPA041578: AB_10795691" "unprognostic (1.28e-1)" "unprognostic (1.32e-3)" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (2.71e-1)" "unprognostic (6.87e-3)" "unprognostic (1.03e-1)" "unprognostic (4.45e-2)" "unprognostic (6.69e-2)" "unprognostic (3.68e-2)" "unprognostic (5.82e-2)" "unprognostic (1.86e-1)" "unprognostic (2.17e-5)" "unprognostic (8.11e-2)" "unprognostic (1.12e-2)" "unprognostic (4.69e-2)" "unprognostic (5.36e-2)" 0.5 1.2 0.4 0.9 0.5 0.0 1.4 0.4 0.6 8.5 0.4 0.7 18.8 0.1 2.0 18.9 48.0 1.9 1.8 0.4 0.4 0.0 0.6 0.4 23.7 0.4 0.4 0.4 0.4 0.4 1.0 0.4 1.0 0.5 5.7 0.0 1.6 7.5 9.5 0.4 32.8 0.5 1.7 0.4 0.4 9.1 0.6 0.4 0.4 30.3 34.1 26.2 10.0 17.9 0.1 0.0 0.0 0.1 0.1 2.1 0.3 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.5 0.4 0.6 0.4 0.0 0.4 0.4 0.5 0.4 56.6 90.0 0.0 16.5 8.4 0.4 0.4 0.0 38.8 36.4 0.0 2.0 1.6 0.0 1.1 0.1 0.6 0.0 0.0 2.7 0.1 1.5 6.6 1.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.3 1.1 0.0 1.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 19.2 2.5 0.0 0.0 33.5 DUOXA2 ENSG00000140274 "Dual oxidase maturation factor 2" Q1HG44 15 45114321-45118421 "Disease related genes, Predicted membrane proteins" "Protein transport, Transport" "Congenital hypothyroidism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 78.3;gallbladder: 38.9" "Group enriched" "Detected in some" 4 "Ductal cells: 452.7;Pancreatic endocrine cells: 814.2;Urothelial cells: 638.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;EFO-21: 1.9;HDLM-2: 1.1;U-2 OS: 3.9;U-266/84: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA063548 Enhanced NA NA "HPA063548: AB_2685037" "unprognostic (1.87e-1)" "unprognostic (9.88e-2)" "unprognostic (7.37e-2)" "unprognostic (6.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-3)" "unprognostic (6.73e-2)" "unprognostic (2.03e-1)" "unprognostic (2.10e-1)" "unprognostic (3.15e-2)" "unprognostic (1.26e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-4)" "unprognostic (9.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.54e-2)" 0.0 0.3 0.0 3.2 0.0 0.0 0.4 0.0 0.0 3.6 1.9 0.0 78.3 0.2 0.1 0.2 5.6 0.0 38.9 0.5 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.4 0.0 0.0 0.0 1.5 0.2 0.0 0.0 16.5 0.1 0.0 0.0 20.2 3.9 2.9 12.9 7.8 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.6 0.6 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.6 0.0 4.2 0.0 0.0 0.6 17.8 0.0 2.3 0.0 0.0 0.0 0.0 452.7 0.0 0.0 1.7 0.0 151.7 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 1.7 0.0 814.2 0.8 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 638.1 DUPD1 DUSP27 ENSG00000188716 "Dual specificity phosphatase and pro isomerase domain containing 1" Q68J44 10 75037836-75058514 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "skeletal muscle: 38.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042964 Uncertain NA NA "HPA042964: AB_10795764" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (2.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUSP10 "MKP-5, MKP5" ENSG00000143507 "Dual specificity phosphatase 10" Q9Y6W6 1 221701424-221742176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 35.4" "Cell type enhanced" "Detected in many" 9 "granulocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;HaCaT: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016758 Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No Nucleoplasm "Golgi apparatus, Cytosol" "HPA016758: AB_1847880" "unprognostic (1.55e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-1)" "unprognostic (6.65e-2)" "unprognostic (3.83e-2)" "unprognostic (2.85e-3)" "prognostic favorable (5.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.89e-2)" "unprognostic (9.68e-2)" "unprognostic (2.38e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (3.69e-4)" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (8.88e-3)" "unprognostic (1.97e-2)" 7.4 4.7 6.0 7.1 11.2 23.2 8.2 5.9 11.1 5.7 10.8 21.1 0.3 2.1 4.9 2.7 7.0 8.5 7.6 3.8 7.2 4.0 2.8 35.4 8.0 9.0 14.0 5.6 2.8 18.3 1.8 2.5 4.5 8.4 3.6 4.9 8.5 9.5 1.7 21.0 8.0 6.2 9.7 10.1 6.4 4.5 3.9 14.1 5.6 5.3 10.6 8.6 8.5 4.1 0.8 5.4 4.6 4.2 15.1 12.7 1.6 6.1 2.6 0.2 0.2 19.2 9.9 0.2 4.1 10.8 6.9 5.3 0.1 1.7 4.8 1.4 10.7 5.0 42.3 0.9 4.0 6.0 12.3 0.5 8.2 1.2 0.7 4.5 3.6 5.6 13.8 2.9 7.4 7.5 3.2 0.2 1.2 0.8 1.7 6.5 0.1 0.7 2.8 0.6 1.3 0.3 0.4 11.7 0.3 2.3 3.7 15.8 1.2 0.5 0.5 17.5 2.5 0.9 2.1 1.5 3.5 0.9 5.3 5.1 2.9 2.0 2.6 5.4 1.6 3.6 4.6 4.2 0.2 3.6 3.7 3.3 0.7 2.5 2.5 5.4 0.8 0.8 1.5 0.3 15.1 1.4 0.2 12.7 1.6 6.0 11.2 5.9 11.1 7.2 4.0 14.0 5.6 8.4 14.1 0.0 1.7 1.9 12.6 45.2 4.5 3.3 10.2 8.1 6.8 3.5 19.6 2.2 0.0 27.3 29.1 6.3 1.0 0.0 7.8 2.7 8.3 10.9 135.7 50.4 22.0 1.6 42.1 1.8 11.0 2.7 23.0 23.9 21.9 13.6 9.9 13.5 21.9 0.0 12.0 0.7 32.3 0.0 5.1 3.8 2.0 36.1 2.9 29.9 2.2 14.4 DUSP13 "BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP" ENSG00000079393 "Dual specificity phosphatase 13" "Q6B8I1, Q9UII6" 10 75094432-75109221 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 75.2;testis: 18.6;tongue: 26.0" "Cell type enriched" "Detected in some" 6 "Early spermatids: 345.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 39 "neutrophil: 3.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 3.9" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 5.9;Hep G2: 12.2;K-562: 4.7;LHCN-M2: 10.9;RH-30: 9.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (1.79e-1)" "unprognostic (2.39e-2)" "unprognostic (2.39e-1)" "unprognostic (7.07e-2)" "unprognostic (1.66e-3)" "unprognostic (2.47e-3)" "unprognostic (8.63e-2)" "unprognostic (1.97e-1)" "unprognostic (2.63e-2)" "unprognostic (1.27e-1)" "unprognostic (3.92e-1)" "unprognostic (2.22e-7)" "unprognostic (1.93e-2)" "unprognostic (1.54e-1)" "unprognostic (4.81e-1)" "unprognostic (2.09e-2)" 0.8 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 1.2 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 2.3 0.0 75.2 0.1 0.0 0.0 0.0 0.1 0.0 18.6 0.0 0.0 1.0 26.0 1.9 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 12.2 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 10.9 0.6 0.0 0.0 0.7 0.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.4 0.0 10.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 345.5 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 54.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.0 0.0 2.6 2.7 1.8 2.5 0.0 0.0 0.1 DUSP15 "bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY" ENSG00000149599 "Dual specificity phosphatase 15" Q9H1R2 20 31847637-31870747 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 75.1" "Group enriched" "Detected in many" 5 "Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.6" "Lineage enriched" "Detected in single" 14 "B-cells: 1.6" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3" "Low region specificity" "Detected in all" HPA076649 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076649: AB_2686811" "unprognostic (3.84e-2)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (9.01e-3)" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (1.48e-5)" "unprognostic (7.31e-2)" "prognostic favorable (5.40e-7)" "unprognostic (2.79e-2)" "unprognostic (1.93e-1)" "unprognostic (3.11e-3)" "unprognostic (2.55e-1)" 1.1 2.1 2.8 0.6 4.0 0.5 1.3 1.2 3.7 1.6 0.8 4.2 6.9 0.9 1.4 10.4 0.6 0.7 1.1 2.7 2.8 3.1 15.4 0.6 0.8 1.0 4.9 2.3 2.1 1.8 10.6 2.7 1.1 5.9 1.9 0.5 5.3 2.1 9.3 2.4 0.7 1.0 2.3 5.2 1.0 1.1 75.1 1.4 0.0 3.5 0.1 0.6 0.7 0.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 5.4 0.1 1.1 2.2 0.3 3.0 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 3.8 0.7 0.0 0.0 17.7 2.1 0.1 0.0 0.0 2.5 5.1 2.9 0.0 4.4 0.2 1.3 1.1 0.0 0.0 4.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.0 1.2 3.7 2.8 3.1 4.9 2.3 5.9 1.4 0.0 0.0 0.0 1.0 0.6 0.5 2.0 2.5 0.0 0.0 17.4 3.9 0.0 232.1 1.7 237.5 0.7 0.0 0.0 0.9 0.1 2.4 0.7 0.0 0.0 0.5 6.4 1.7 3.1 0.0 743.6 8.1 0.8 6.8 1.0 0.0 2.7 0.9 0.0 10.3 33.5 0.2 0.0 1.0 85.0 5.2 0.1 0.1 0.0 0.0 0.1 DUSP2 PAC-1 ENSG00000158050 "Dual specificity phosphatase 2" Q05923 2 96143166-96145440 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 151.1" "Cell type enhanced" "Detected in many" 12 "Melanocytes: 136.7;T-cells: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 46.1" "Group enriched" "Detected in all" 10 "NK-cells: 29.6;T-cells: 46.1" "Cell line enhanced" "Detected in many" "Daudi: 15.3;HeLa: 13.9;JURKAT: 14.2;Karpas-707: 17.5;NB-4: 14.5;RT4: 17.4;SCLC-21H: 15.5;U-698: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071920 Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA071920: AB_2686472" "unprognostic (2.69e-3)" "unprognostic (6.70e-3)" "unprognostic (1.15e-1)" "unprognostic (5.46e-3)" "unprognostic (3.32e-2)" "unprognostic (8.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.15e-1)" "unprognostic (2.86e-1)" "unprognostic (3.66e-2)" "unprognostic (3.10e-1)" "unprognostic (6.30e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (1.82e-1)" "unprognostic (2.41e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-3)" 6.4 3.1 2.0 13.1 4.3 51.3 2.9 1.3 4.3 4.8 3.9 1.9 7.9 0.8 4.3 18.3 4.1 3.0 8.8 7.4 3.0 1.4 5.5 3.4 15.9 19.0 1.8 0.8 3.0 1.7 0.4 14.6 0.6 2.0 10.7 1.1 2.8 2.0 151.1 1.8 9.8 4.7 3.7 1.6 16.4 2.1 3.3 0.7 43.4 2.4 2.6 12.2 24.6 14.1 3.9 2.3 1.4 2.2 29.6 46.1 7.5 1.5 0.0 0.1 0.1 0.2 0.3 2.3 1.9 0.0 2.8 2.7 4.4 0.3 15.3 5.6 2.1 0.0 1.1 3.8 0.0 0.5 0.2 0.0 0.3 13.9 0.0 1.0 6.3 1.3 0.5 1.0 0.4 0.0 0.0 0.0 14.2 0.0 17.5 0.1 2.6 12.5 14.5 3.4 0.4 5.4 0.0 0.2 12.1 0.1 17.4 15.5 0.8 0.7 0.2 2.8 0.0 1.0 7.2 0.0 0.0 4.1 0.0 0.9 1.2 1.8 21.0 0.0 6.9 0.1 0.5 0.9 0.2 46.1 2.2 22.6 3.9 11.4 41.4 2.3 2.6 7.8 23.9 1.4 29.6 1.8 0.6 3.4 7.5 2.0 4.3 1.3 4.3 3.0 1.4 1.8 0.8 2.0 0.7 0.0 10.6 47.7 90.1 86.0 22.1 33.5 2.5 0.0 1.2 8.7 21.6 0.8 1.7 0.9 0.7 8.2 3.3 0.0 1.2 1.1 24.2 63.5 105.8 2.8 75.6 0.0 84.2 8.6 27.5 0.7 1.7 90.7 136.7 0.0 12.3 1.3 0.9 2.9 1.8 1.0 2.5 0.0 35.3 0.5 4.3 95.9 1.4 346.4 21.8 28.5 DUSP21 ENSG00000189037 "Dual specificity phosphatase 21" Q9H596 X 44844004-44844888 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 15.9" "Group enriched" "Detected in some" 54 "Early spermatids: 58.8;Late spermatids: 167.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 1.7;K-562: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 167.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.0 DUSP23 "DUSP25, FLJ20442" ENSG00000158716 "Dual specificity phosphatase 23" Q9BVJ7 1 159780932-159782543 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 88.0" "Cell type enhanced" "Detected in many" 8 "Exocrine glandular cells: 394.0;Proximal tubular cells: 620.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028211, HPA045792" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028211: AB_2672522, HPA045792: AB_10961133" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-2)" "unprognostic (4.36e-2)" "unprognostic (3.22e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (3.16e-1)" "unprognostic (4.62e-1)" "unprognostic (3.33e-3)" "unprognostic (4.72e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (8.58e-2)" "unprognostic (2.84e-2)" "unprognostic (7.47e-2)" "unprognostic (1.39e-1)" 25.0 28.0 7.6 9.3 10.5 11.2 27.3 4.4 9.0 15.5 15.9 5.9 6.6 17.2 12.2 15.0 21.2 10.9 12.6 14.9 7.8 5.2 88.0 80.8 12.1 15.4 8.5 4.6 12.3 21.5 12.5 4.3 7.4 9.6 18.0 9.1 9.5 37.8 10.9 32.8 15.8 16.1 7.7 9.6 8.7 11.0 9.7 7.3 5.7 27.0 17.4 11.4 10.5 19.1 13.6 59.7 49.9 43.2 21.3 24.0 24.0 12.2 13.2 0.1 0.0 12.9 11.1 0.1 5.0 4.1 5.9 4.6 5.4 14.1 0.0 30.0 5.5 1.3 0.5 3.4 4.5 3.2 3.0 1.5 16.9 4.8 0.0 19.3 10.2 13.0 46.8 12.3 3.8 13.9 4.3 22.6 0.0 7.7 6.2 8.3 22.2 1.0 0.4 22.9 22.1 18.9 0.0 0.0 5.8 7.2 2.1 5.8 12.8 9.1 20.0 23.4 2.4 12.9 16.0 16.5 4.9 0.2 0.6 0.0 4.4 10.3 0.1 8.3 8.2 3.7 20.0 43.2 49.9 24.0 33.4 13.3 13.6 18.1 22.5 59.7 9.8 11.0 16.4 43.2 21.3 22.1 13.6 15.7 24.0 7.6 10.5 4.4 9.0 7.8 5.2 8.5 4.6 9.6 7.3 38.7 65.7 25.0 97.5 66.2 8.4 26.4 94.3 38.8 83.0 48.8 5.9 13.5 222.2 148.8 39.6 154.1 106.2 0.0 394.0 20.1 31.9 94.9 53.1 219.9 155.2 1.6 34.0 66.3 86.6 5.5 24.5 94.8 40.5 32.5 101.6 59.7 258.6 101.7 14.9 620.9 7.1 12.9 32.0 3.2 13.0 65.1 4.8 43.7 91.6 102.1 DUSP26 "DUSP24, MGC1136" ENSG00000133878 "Dual specificity phosphatase 26" Q9BV47 8 33591332-33600106 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 147.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 76.1;Cardiomyocytes: 54.3;Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 58.5" "Cancer enhanced" "Detected in some" "glioma: 6.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 16 "B-cells: 1.5" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018221 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA018221: AB_2669813" "unprognostic (2.77e-4)" "unprognostic (2.70e-2)" "unprognostic (2.70e-3)" "unprognostic (5.47e-3)" "unprognostic (2.01e-1)" "unprognostic (1.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.53e-2)" "unprognostic (2.81e-1)" "unprognostic (1.39e-1)" "unprognostic (4.10e-3)" "unprognostic (1.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (8.15e-2)" "unprognostic (5.80e-2)" 1.3 9.3 11.5 1.4 13.1 1.1 1.2 18.2 14.8 1.1 1.7 4.2 0.0 2.4 1.5 3.4 3.0 2.3 1.5 20.1 9.1 15.9 1.6 1.0 1.7 1.1 10.6 8.8 15.1 2.2 1.0 14.0 1.0 7.6 2.6 1.5 4.4 1.5 1.3 147.1 1.0 1.9 2.0 10.0 1.2 2.6 1.6 3.8 0.0 1.1 27.0 1.3 1.4 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 46.2 11.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 13.1 18.2 14.8 9.1 15.9 10.6 8.8 7.6 3.8 0.0 0.0 0.0 0.2 0.0 76.1 54.3 0.0 0.0 0.0 0.0 39.3 0.0 18.3 0.3 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 23.8 24.6 0.0 0.0 4.4 0.0 0.0 1.7 0.0 0.0 13.3 1.6 0.0 5.6 0.8 58.5 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 DUSP27 ENSG00000198842 "Dual specificity phosphatase 27, atypical" Q5VZP5 1 167094045-167129165 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 131.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 12.8;stomach cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RH-30: 18.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA012912 Approved Nucleoplasm NA NA Nucleoplasm "HPA012912: AB_2668767" "unprognostic (1.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.44e-3)" "unprognostic (1.22e-1)" "unprognostic (2.10e-3)" "unprognostic (4.65e-2)" "unprognostic (1.53e-1)" "unprognostic (8.19e-2)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.72e-1)" "unprognostic (7.65e-2)" "unprognostic (8.23e-2)" "unprognostic (3.39e-1)" 2.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.1 46.8 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.0 0.0 0.9 0.0 64.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.5 18.2 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 131.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 DUSP3 VHR ENSG00000108861 "Dual specificity phosphatase 3" P51452 17 43766121-43778988 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 242.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063616 Supported Nucleoplasm,Cytosol NA NA 1300000 Nucleoplasm Cytosol "HPA063616: AB_2685061" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-1)" "unprognostic (8.54e-2)" "unprognostic (1.04e-3)" "prognostic unfavorable (3.00e-4)" "unprognostic (4.83e-2)" "unprognostic (8.98e-2)" "unprognostic (5.13e-1)" "unprognostic (6.01e-2)" "unprognostic (1.78e-1)" "unprognostic (8.40e-3)" "prognostic favorable (5.49e-5)" "unprognostic (2.67e-3)" "unprognostic (5.45e-2)" "unprognostic (1.94e-1)" "unprognostic (1.37e-2)" 17.1 17.8 23.1 10.2 20.8 4.6 22.0 14.3 28.6 12.8 28.4 11.1 16.7 13.4 17.5 18.7 23.6 10.6 19.3 64.0 21.5 18.1 27.1 39.9 17.2 9.0 17.6 19.1 9.1 19.2 27.5 11.4 15.0 17.1 22.6 13.1 14.3 11.1 36.6 106.9 8.9 15.2 31.1 12.7 14.5 19.6 8.0 10.8 1.2 13.9 22.8 6.5 20.7 24.1 1.7 19.5 5.2 17.0 0.9 1.7 5.8 10.5 19.2 7.4 7.9 21.6 11.6 6.3 8.0 19.2 18.8 22.8 18.4 7.1 1.6 12.7 15.0 39.0 9.2 11.4 9.8 19.9 3.6 8.7 5.3 8.8 15.0 26.4 0.6 5.6 10.7 17.8 14.5 12.6 20.6 13.1 5.4 4.8 1.8 21.9 7.6 2.7 2.7 3.4 15.1 14.0 3.4 22.3 4.0 26.1 11.2 4.1 7.5 9.4 6.3 23.6 21.3 28.1 14.9 13.6 21.3 14.5 30.2 13.2 9.8 13.0 0.4 25.3 7.5 7.1 5.2 17.0 3.5 1.0 8.9 1.7 1.7 1.5 1.2 19.5 1.6 1.2 1.1 4.1 0.9 10.8 8.2 0.9 5.8 23.1 20.8 14.3 28.6 21.5 18.1 17.6 19.1 17.1 10.8 23.8 16.8 7.2 42.9 19.9 16.3 242.3 48.4 14.7 9.1 40.1 23.6 14.4 34.9 42.9 73.8 32.1 42.0 0.0 50.5 17.5 18.4 41.2 38.1 99.4 73.0 19.1 34.9 27.6 34.5 128.1 13.6 40.3 10.1 32.5 17.6 14.8 50.2 28.1 24.8 69.4 16.6 32.3 35.5 2.4 2.9 25.2 37.6 6.4 14.6 32.8 DUSP4 "HVH2, MKP-2, TYP" ENSG00000120875 "Dual specificity phosphatase 4" Q13115 8 29333064-29350668 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 94.6;monocytes: 131.7;Pancreatic endocrine cells: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "T-reg: 9.6" "Lineage enriched" "Detected in single" 18 "T-cells: 9.6" "Cell line enhanced" "Detected in many" "A549: 29.9;OE19: 27.1;SK-MEL-30: 46.1;WM-115: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061967 Supported Nucleoplasm NA NA Nucleoplasm "HPA061967: AB_2684648" "unprognostic (1.92e-1)" "unprognostic (5.97e-3)" "unprognostic (3.24e-1)" "unprognostic (6.54e-2)" "unprognostic (2.18e-2)" "unprognostic (7.66e-3)" "unprognostic (7.30e-2)" "unprognostic (7.08e-2)" "unprognostic (1.83e-2)" "unprognostic (9.73e-3)" "unprognostic (9.60e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (4.19e-4)" "unprognostic (6.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-2)" "unprognostic (6.07e-2)" 10.9 3.4 1.2 3.6 1.1 3.4 17.1 4.8 2.7 4.6 1.7 1.0 46.7 0.8 3.2 0.7 1.6 1.3 13.1 1.5 4.6 0.8 0.7 0.4 3.7 1.8 0.8 0.8 1.2 78.6 0.1 3.7 17.7 0.7 4.3 0.9 17.1 8.9 63.5 2.7 3.5 1.3 1.5 1.1 0.6 20.6 1.7 0.2 3.9 1.2 2.0 4.7 7.4 3.0 0.0 0.5 0.0 0.0 0.2 9.6 0.1 11.1 29.9 17.8 0.8 2.2 0.0 1.5 2.3 12.7 7.0 3.1 0.3 5.7 0.0 6.3 1.0 4.9 3.6 0.2 7.7 4.2 0.3 0.6 0.0 1.0 0.2 0.0 0.1 14.6 1.4 5.1 2.1 13.1 15.4 5.7 0.1 0.1 1.3 14.0 12.6 0.0 2.0 3.1 27.1 18.4 0.3 0.5 2.3 16.1 5.9 0.1 9.8 3.2 15.2 46.1 0.3 3.2 0.3 16.0 5.1 0.0 0.0 1.6 3.5 0.4 0.0 15.6 2.6 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 9.6 0.1 1.2 1.1 4.8 2.7 4.6 0.8 0.8 0.8 0.7 0.2 0.0 3.2 1.4 94.6 10.8 34.2 1.9 28.1 29.4 15.9 0.0 11.8 2.7 0.0 64.0 3.5 10.8 0.4 0.0 66.9 37.5 8.4 20.9 5.8 0.0 19.5 41.3 93.8 19.6 5.0 19.7 0.3 25.0 62.4 131.7 7.6 0.9 166.3 0.0 0.0 0.0 2.8 12.9 12.2 0.6 0.4 10.5 14.9 8.5 2.2 92.0 DUSP6 "MKP-3, PYST1" ENSG00000139318 "Dual specificity phosphatase 6" Q16828 12 89347232-89353271 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 125.0" "Group enriched" "Detected in many" 11 "granulocytes: 125.0;monocytes: 79.7" "Cell line enhanced" "Detected in many" "AN3-CA: 82.0;NB-4: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017566, HPA053188, HPA064692" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017566: AB_647991, HPA053188: , HPA064692: " "unprognostic (7.35e-2)" "unprognostic (1.50e-2)" "unprognostic (5.77e-2)" "prognostic favorable (7.21e-4)" "unprognostic (2.35e-3)" "unprognostic (2.10e-3)" "unprognostic (3.76e-2)" "unprognostic (1.42e-1)" "unprognostic (8.63e-2)" "unprognostic (1.67e-2)" "unprognostic (3.15e-3)" "unprognostic (2.09e-1)" "unprognostic (5.91e-3)" "unprognostic (1.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-2)" "unprognostic (2.84e-1)" 37.7 7.5 7.2 15.9 11.7 41.3 24.1 3.4 14.7 11.6 12.4 6.2 5.8 6.1 9.8 8.7 12.0 15.4 25.1 16.2 10.5 6.5 17.1 38.4 28.2 13.3 6.9 7.4 7.5 12.2 15.0 13.7 19.7 7.9 17.4 15.3 44.4 64.3 6.3 12.0 8.5 14.6 11.3 7.1 28.4 10.3 4.8 6.4 6.1 21.0 13.3 17.8 15.2 6.9 1.2 9.2 125.0 79.7 1.2 0.9 32.4 1.1 1.1 24.4 82.0 21.1 18.0 0.0 8.8 11.2 1.8 1.3 7.2 1.3 0.0 2.1 3.7 3.4 9.4 0.1 22.0 2.5 0.1 0.1 3.6 0.2 11.4 15.0 15.7 40.2 3.5 7.7 15.5 14.5 18.4 40.7 0.4 0.0 3.8 5.6 0.5 0.5 58.8 14.8 28.0 20.0 40.0 3.0 1.5 25.2 23.7 0.4 17.4 0.2 0.1 46.7 8.7 1.2 8.8 10.9 6.0 0.1 1.1 4.2 0.6 3.2 0.1 24.9 11.1 38.0 125.0 49.5 22.4 0.9 79.7 0.4 0.2 0.2 0.3 9.2 1.2 0.1 0.3 22.5 1.2 74.4 1.2 0.6 32.4 7.2 11.7 3.4 14.7 10.5 6.5 6.9 7.4 7.9 6.4 95.3 270.1 20.5 66.1 80.7 1.2 8.1 53.5 22.7 111.5 171.0 31.4 63.9 14.9 10.9 1.1 97.2 31.9 0.0 11.9 2.9 29.6 20.6 438.5 128.2 43.3 1.6 18.4 173.1 216.2 1.4 1.4 140.4 11.8 1.8 11.0 9.0 12.3 7.4 3.2 23.5 2.0 25.8 8.5 1.2 1.1 21.7 41.2 18.5 12.8 23.4 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554044-1571920 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 101.5;Cone photoreceptor cells: 45.2;Horizontal cells: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;MCF7: 6.2;SH-SY5Y: 5.5;U-251 MG: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol NA NA Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favorable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 6.3 2.2 18.8 3.2 18.8 7.5 3.5 20.0 30.2 1.9 4.3 4.2 1.4 1.7 5.9 4.8 3.5 4.0 5.4 5.7 16.6 9.3 2.6 3.7 3.6 3.5 5.5 11.2 2.2 12.7 1.7 10.8 2.8 5.1 3.0 4.1 2.7 5.1 2.7 6.1 3.2 6.3 9.3 3.6 6.3 4.3 2.4 5.1 0.0 2.6 2.2 2.3 2.7 1.6 0.1 0.1 0.0 0.0 0.0 0.7 0.0 1.8 0.8 1.0 0.1 0.0 0.1 2.2 0.1 1.2 0.4 1.2 0.0 0.0 0.1 0.0 0.3 0.0 1.2 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.2 0.4 0.0 0.1 0.1 0.0 1.8 0.0 6.2 0.0 0.4 0.0 0.0 1.9 0.1 0.1 0.7 0.0 0.2 0.0 5.5 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.0 2.3 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 18.8 18.8 20.0 30.2 16.6 9.3 5.5 11.2 5.1 5.1 3.0 0.6 0.0 5.6 8.8 101.5 5.2 5.1 0.0 0.0 12.2 45.2 0.1 1.7 6.9 0.2 2.2 22.7 0.0 9.6 0.4 4.5 12.8 0.0 0.4 0.4 85.8 40.5 1.3 0.0 0.0 0.6 0.3 5.0 1.8 20.2 16.0 9.8 17.5 0.4 1.1 36.7 6.5 5.1 0.2 0.4 4.3 4.9 1.3 16.8 9.8 DUSP9 "MKP-4, MKP4" ENSG00000130829 "Dual specificity phosphatase 9" Q99956 X 153642492-153651326 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 23.0;placenta: 63.1" "Group enriched" "Detected in some" 14 "Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Hep G2: 90.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6" HPA003336 Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003336: AB_1078709" "unprognostic (4.64e-2)" "unprognostic (6.48e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.52e-2)" "unprognostic (2.74e-3)" "unprognostic (9.36e-3)" "unprognostic (6.15e-2)" "unprognostic (2.81e-1)" "unprognostic (3.03e-1)" "unprognostic (1.29e-2)" "unprognostic (1.38e-2)" "unprognostic (2.68e-7)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (5.52e-2)" 0.2 0.1 3.2 0.2 4.4 0.1 0.3 0.2 2.0 0.2 0.1 0.7 0.0 0.2 0.1 0.3 0.3 0.2 0.1 0.2 2.5 0.6 23.0 0.7 0.2 0.2 1.1 0.6 1.9 0.5 0.1 0.0 63.1 0.9 0.2 0.1 0.0 0.8 1.5 0.1 0.2 0.2 0.1 0.5 0.2 0.2 1.1 0.8 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 8.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.6 0.5 0.0 4.0 0.0 0.3 1.8 10.1 0.2 0.0 0.2 1.8 0.0 0.7 90.8 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.2 0.2 0.4 3.7 0.0 0.0 0.0 0.0 2.3 0.1 0.3 0.6 0.7 0.3 0.2 0.1 0.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 4.4 0.2 2.0 2.5 0.6 1.1 0.6 0.9 0.8 0.0 0.0 0.0 0.6 0.6 0.0 1.8 0.0 0.0 0.0 10.4 0.0 876.9 616.8 0.1 0.0 0.0 0.0 0.0 0.0 57.4 0.2 0.3 0.0 0.8 72.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 0.0 0.0 0.0 0.7 8.3 0.0 1451.1 0.0 0.0 0.9 DUX4 ENSG00000260596 "Double homeobox 4" Q9UBX2 4 190173774-190185942 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 3.4" "Group enriched" "Detected in some" 21 "Early spermatids: 4.1;Late spermatids: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4" HPA058451 Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Nucleoli" "Golgi apparatus, Cytosol" "HPA058451: AB_2683722" 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.5 0.3 0.0 1.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 2.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 3.7 0.7 0.0 8.0 10.4 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUXA ENSG00000258873 "Double homeobox A" A6NLW8 19 57154021-57167443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;Daudi: 1.5;HMC-1: 1.5;TIME: 2.1" HPA059358 Uncertain NA NA "HPA059358: AB_2683989" "unprognostic (2.34e-1)" 1.0 0.1 0.1 1.1 0.1 0.5 0.3 0.1 0.4 0.3 0.2 1.0 0.6 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.4 1.0 0.8 0.1 0.4 0.1 0.0 0.1 0.3 0.2 0.0 0.5 0.0 0.6 0.9 0.1 0.0 0.1 0.9 0.1 1.4 0.2 0.5 0.1 0.1 1.0 0.6 2.5 0.2 1.1 0.8 0.0 0.4 0.0 0.7 1.6 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 1.1 1.5 0.2 0.0 0.0 0.5 0.3 0.0 0.3 0.2 0.4 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.1 0.0 0.4 0.4 0.0 0.3 0.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.5 0.1 1.1 0.0 2.1 0.2 0.2 0.8 0.2 1.2 1.1 0.1 0.8 0.9 1.0 0.5 0.2 0.2 0.3 0.2 0.2 0.6 0.1 0.6 0.0 1.0 0.3 0.8 2.5 1.1 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUXB ENSG00000282757 "Double homeobox B" 16 75693929-75701459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.3;retina: 1.8;testis: 1.2;thyroid gland: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.1;MCF7: 1.8;NTERA-2: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DVL1 ENSG00000107404 "Dishevelled segment polarity protein 1" O14640 1 1335276-1349350 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 120.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "PC-3: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011538, HPA073607" Approved NA NA "CAB011538: AB_2093326, HPA073607: " "unprognostic (2.67e-1)" "unprognostic (4.34e-3)" "unprognostic (2.13e-3)" "unprognostic (2.05e-2)" "unprognostic (9.58e-2)" "unprognostic (1.51e-1)" "unprognostic (2.81e-3)" "unprognostic (5.03e-3)" "unprognostic (1.78e-2)" "unprognostic (2.96e-2)" "unprognostic (1.62e-3)" "unprognostic (5.35e-2)" "unprognostic (4.03e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.33e-4)" "unprognostic (2.34e-2)" "unprognostic (2.55e-2)" 13.2 14.1 18.8 7.7 17.1 5.9 12.5 13.9 25.7 8.4 10.4 13.3 12.2 17.9 9.4 8.0 15.4 11.6 8.0 21.4 18.1 11.9 8.0 12.2 9.6 6.2 12.7 17.3 12.5 34.3 10.3 10.6 10.0 13.5 10.8 4.7 7.3 36.5 10.4 120.4 17.0 16.1 12.7 11.8 9.3 18.3 15.0 12.2 2.8 9.0 13.9 6.8 9.8 17.5 2.1 2.0 0.9 2.1 0.8 1.6 0.6 25.7 13.4 5.5 11.7 5.3 6.6 13.6 15.9 7.6 12.6 6.3 10.3 32.7 8.3 24.0 7.0 6.9 16.0 4.3 16.1 1.9 10.0 25.2 4.6 23.9 18.6 11.5 7.1 7.3 5.6 9.9 16.8 11.5 10.7 4.3 11.1 17.9 5.8 5.1 10.4 6.9 11.9 8.7 9.3 51.3 11.8 4.3 14.2 9.2 4.1 21.5 14.7 7.6 20.8 21.0 2.1 11.5 12.1 8.4 7.2 18.5 27.5 26.4 9.3 3.7 10.0 21.1 10.1 4.5 0.9 2.1 0.1 1.6 1.8 1.5 2.1 1.3 1.3 0.7 0.3 1.4 0.7 0.8 0.8 1.2 2.0 0.9 0.6 18.8 17.1 13.9 25.7 18.1 11.9 12.7 17.3 13.5 12.2 17.9 11.3 3.2 4.5 12.2 32.0 19.1 10.2 6.7 7.9 7.0 5.9 9.1 3.3 9.5 0.8 10.3 19.1 0.0 17.4 11.3 7.6 12.8 1.1 17.4 4.4 30.2 11.6 6.7 4.1 1.1 12.0 4.0 6.8 1.8 16.9 20.4 34.3 16.9 9.9 4.4 20.9 12.9 7.8 16.2 12.2 13.6 9.5 3.1 18.7 8.9 DWORF ENSG00000240045 "DWARF open reading frame" 3 155290229-155293775 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 173.0" "Cell type enriched" "Detected in some" 4 "Proximal tubular cells: 7.9" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Region enriched" "Detected in some" 8 "basal ganglia: 19.5" NA NA "unprognostic (6.77e-4)" "unprognostic (1.60e-2)" "unprognostic (6.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.82e-3)" "unprognostic (1.33e-2)" 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.2 2.9 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 173.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.7 23.7 0.9 0.0 0.0 0.5 0.4 2.9 0.2 0.4 0.2 0.0 0.2 0.0 0.6 0.0 0.0 2.3 0.7 0.3 0.0 0.0 0.6 0.0 1.3 0.0 0.4 0.0 0.4 0.5 0.3 0.5 0.0 0.3 0.6 0.4 0.5 0.5 0.0 1.8 0.4 2.1 0.0 0.0 0.5 0.4 0.8 0.0 0.6 1.3 1.2 0.4 0.2 1.7 1.2 0.7 0.6 0.3 0.2 0.3 0.0 0.0 1.0 0.9 0.0 0.7 0.1 1.0 0.9 1.1 1.9 1.8 1.3 0.8 0.2 0.2 0.3 0.8 0.8 0.3 0.0 2.9 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.5 0.2 0.2 0.8 0.4 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DXO DOM3Z ENSG00000204348 "Decapping exoribonuclease" O77932 6 31969810-31972292 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Group enriched" "Detected in many" 5 "Early spermatids: 374.6;Late spermatids: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046708 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA046708: AB_2679764" "unprognostic (4.56e-2)" "unprognostic (2.21e-1)" "unprognostic (1.80e-1)" "unprognostic (4.07e-3)" "unprognostic (1.93e-1)" "unprognostic (2.00e-3)" "unprognostic (3.43e-3)" "unprognostic (4.18e-3)" "unprognostic (3.10e-2)" "unprognostic (2.64e-3)" "prognostic favorable (5.87e-4)" "unprognostic (4.29e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (9.17e-2)" "unprognostic (7.24e-2)" "unprognostic (2.01e-1)" "unprognostic (2.23e-3)" 4.3 18.4 8.3 8.0 11.0 4.2 7.0 15.5 12.4 7.1 5.0 6.5 8.6 7.8 6.4 6.4 4.0 7.9 6.0 8.4 7.7 6.5 8.5 8.7 5.1 4.3 9.0 6.5 10.5 12.3 9.4 12.4 4.7 7.4 7.6 4.2 5.8 5.5 6.8 5.6 3.4 4.1 6.3 4.9 7.2 7.6 32.8 7.3 3.4 8.8 4.7 4.3 6.4 5.5 2.2 3.2 1.5 1.9 3.0 3.3 1.5 3.0 1.3 0.5 14.3 1.7 1.0 1.5 1.7 2.7 4.5 3.7 2.2 2.9 1.0 3.2 5.8 0.8 4.1 1.5 3.2 1.6 1.9 4.4 2.0 2.9 2.9 3.9 0.0 2.7 2.2 2.9 1.8 3.0 2.2 6.6 1.1 2.5 3.2 1.8 4.4 0.1 2.4 0.7 1.9 0.1 0.1 2.0 1.8 5.3 0.8 7.4 5.6 3.3 1.4 3.7 0.5 0.0 4.5 0.9 0.8 4.9 2.8 3.7 1.9 3.4 2.4 2.6 4.6 2.2 0.0 1.0 1.5 1.1 1.9 3.3 1.4 1.4 1.8 3.2 2.2 1.3 1.6 0.6 3.0 1.2 1.2 0.6 1.5 8.3 11.0 15.5 9.4 7.7 6.5 9.0 6.5 7.4 7.3 6.0 11.1 11.2 13.5 7.6 12.9 6.5 7.6 8.1 6.8 3.5 15.7 12.3 16.6 7.5 374.6 6.3 6.1 0.0 10.8 7.9 10.8 9.4 5.8 9.7 5.9 4.8 15.5 6.7 4.9 209.7 16.4 6.7 11.8 4.6 7.0 16.2 6.4 8.6 11.7 11.7 14.7 12.9 10.8 58.1 11.8 4.8 16.8 13.1 6.8 7.3 DYDC1 "bA36D19.5, DPY30D1" ENSG00000170788 "DPY30 domain containing 1" Q8WWB3 10 80336105-80356755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 50.4" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 52.2;Early spermatids: 129.6;Late spermatids: 49.2;Spermatocytes: 233.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 2.6;RH-30: 1.2;SCLC-21H: 1.4;SH-SY5Y: 1.7;U-266/70: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037790, HPA037791" Uncertain NA NA "HPA037790: AB_10805351, HPA037791: AB_10796215" "unprognostic (8.95e-2)" "unprognostic (8.28e-3)" "unprognostic (7.11e-2)" "unprognostic (3.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.90e-1)" "unprognostic (9.96e-2)" "unprognostic (7.95e-2)" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.1 4.8 0.7 1.4 0.3 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.6 1.2 0.0 0.4 0.0 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.7 0.3 0.0 0.0 0.3 0.4 4.8 0.7 0.5 0.3 0.1 0.0 0.7 0.2 0.2 0.1 1.0 0.2 0.2 1.4 1.4 0.2 1.1 0.1 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.2 10.3 0.0 0.0 0.0 0.0 0.0 129.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 49.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 233.3 4.1 0.0 0.0 0.0 0.0 0.0 DYDC2 "bA36D19.6, MGC16186" ENSG00000133665 "DPY30 domain containing 2" Q96IM9 10 80344745-80368073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 56.4" "Cell type enriched" "Detected in some" 9 "Ciliated cells: 337.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Group enriched" "Detected in many" 5 "amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 4.4;NTERA-2: 7.0;SCLC-21H: 6.0;SH-SY5Y: 4.0;U-2197: 4.4" "Low region specificity" "Detected in all" "HPA038006, HPA038007" Enhanced NA NA "HPA038006: AB_10672734, HPA038007: AB_2675783" "unprognostic (1.60e-3)" "unprognostic (7.35e-2)" "unprognostic (1.89e-2)" "unprognostic (9.26e-3)" "unprognostic (8.85e-2)" "unprognostic (3.26e-1)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.54e-4)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (2.34e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-4)" "unprognostic (9.86e-2)" "unprognostic (5.40e-2)" 0.2 0.2 6.3 0.2 9.1 0.6 0.4 0.1 1.7 1.6 0.3 3.0 0.1 0.3 1.3 10.0 0.5 56.4 0.4 0.2 7.7 6.8 0.3 0.3 3.6 0.2 0.2 0.4 4.3 0.6 0.2 0.1 0.4 16.3 0.3 0.2 0.1 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.2 0.4 5.2 0.7 0.1 0.3 0.1 0.2 0.2 0.1 0.6 0.6 2.4 0.3 1.2 0.4 0.0 0.2 0.1 4.4 0.1 0.5 0.0 0.1 0.0 0.6 0.4 0.1 0.4 0.7 0.1 0.9 0.1 1.0 0.2 0.3 0.1 0.1 0.2 0.6 0.3 0.2 1.5 0.0 0.0 0.4 0.2 1.1 0.0 0.1 0.0 0.0 1.4 0.2 0.3 0.3 0.3 0.7 0.0 7.0 0.0 0.0 1.8 0.5 1.6 0.0 0.1 6.0 4.0 0.2 0.0 0.7 1.7 0.0 2.7 0.1 0.1 0.3 4.4 0.0 0.1 0.1 0.3 0.4 0.0 0.0 2.4 0.3 0.1 0.3 0.1 0.4 0.3 0.3 0.2 0.0 0.6 0.3 0.4 0.5 1.2 0.2 0.6 0.0 0.0 6.3 9.1 0.1 1.6 7.7 6.8 0.2 0.4 16.3 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 337.3 30.7 0.0 0.0 0.0 1.7 0.4 35.5 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.0 0.0 24.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.9 2.2 0.0 0.0 0.0 0.0 0.1 DYNAP "C18orf26, FLJ39106" ENSG00000178690 "Dynactin associated protein" Q8N1N2 18 54587757-54599493 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 23.9;tongue: 50.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 16.9" HPA011148 Uncertain NA NA "HPA011148: AB_1845609" "unprognostic (9.88e-2)" "unprognostic (2.51e-2)" "unprognostic (1.75e-3)" "unprognostic (1.45e-1)" "unprognostic (8.09e-3)" 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.8 0.1 0.1 0.1 0.1 0.5 1.4 23.9 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.1 0.4 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.1 2.1 0.1 0.2 0.5 0.2 0.3 0.1 1.4 0.2 0.4 0.1 0.2 0.1 50.3 6.7 0.1 0.3 1.8 1.0 3.1 2.9 0.7 1.0 0.0 1.0 0.3 1.8 0.8 0.9 2.1 1.8 0.4 0.7 1.3 1.4 0.9 0.7 0.9 0.6 0.9 1.4 0.6 1.2 0.0 0.7 0.3 0.3 0.3 1.1 0.6 0.7 0.8 0.8 0.9 0.2 1.3 0.4 0.5 0.3 0.8 1.3 16.9 0.2 0.3 0.6 0.5 2.7 0.3 0.5 0.6 2.0 0.8 0.5 0.9 0.7 1.0 0.3 0.3 2.9 1.3 0.5 1.1 2.9 0.6 3.3 0.7 0.5 0.6 0.5 1.3 0.9 0.4 0.4 1.2 1.3 2.1 1.0 1.1 0.7 1.0 0.6 0.4 0.4 1.8 0.7 0.7 3.1 0.7 2.9 1.0 0.3 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DYNC1I1 "DNCI1, DNCIC1" ENSG00000158560 "Dynein cytoplasmic 1 intermediate chain 1" O14576 7 95772506-96110322 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 40.0;Cardiomyocytes: 28.5;Cone photoreceptor cells: 47.1;Muller glia cells: 109.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 14.2;SH-SY5Y: 10.5;SuSa: 8.1;U-266/84: 8.9;WM-115: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061689 Enhanced Supported NA NA "HPA061689: AB_2684586" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" "unprognostic (3.83e-2)" "prognostic favorable (3.79e-4)" "unprognostic (6.27e-2)" "unprognostic (2.11e-4)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (2.18e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.86e-2)" "unprognostic (2.24e-4)" "unprognostic (2.25e-4)" "unprognostic (1.63e-1)" "unprognostic (7.81e-4)" "unprognostic (1.10e-2)" 3.1 16.5 15.6 2.9 20.3 2.3 3.6 34.3 62.0 3.1 7.9 5.2 1.2 2.8 3.8 7.3 5.3 2.6 3.5 21.6 29.2 23.1 3.6 1.6 2.3 2.1 25.8 26.5 10.7 3.6 2.0 17.2 2.2 27.3 10.3 4.9 9.5 2.7 11.3 4.2 4.0 2.5 17.1 18.8 2.8 3.3 3.9 7.4 0.0 3.6 0.0 1.9 10.5 3.6 0.8 2.7 4.7 1.1 2.1 1.0 0.6 0.4 0.3 0.2 1.3 0.2 0.1 0.5 0.2 0.0 0.7 0.2 1.7 1.1 0.5 14.2 1.9 1.1 0.6 4.9 0.3 0.3 0.1 1.1 3.4 0.5 0.0 0.2 0.4 4.6 0.2 0.3 0.3 0.6 0.6 0.3 2.0 0.6 0.5 2.2 3.1 0.4 0.6 0.9 0.3 2.9 0.8 0.4 1.9 1.8 1.6 1.9 10.5 0.1 0.2 2.2 8.1 1.0 0.8 0.4 4.1 2.9 2.2 2.2 7.3 8.9 0.4 4.7 0.5 9.1 1.5 1.1 0.6 1.0 0.6 0.5 0.7 0.5 0.4 0.2 0.8 0.7 0.6 4.7 2.1 0.3 2.7 0.6 0.6 15.6 20.3 34.3 30.4 29.2 23.1 25.8 26.5 27.3 7.4 0.0 0.0 0.0 1.0 0.7 40.0 28.5 0.0 0.0 0.0 0.0 47.1 1.2 0.0 0.3 4.6 2.9 0.0 0.0 0.9 0.1 1.0 0.6 0.0 0.6 0.5 1.6 1.7 9.2 0.3 3.6 17.5 0.2 20.3 0.0 0.0 109.5 0.6 0.0 11.0 0.0 22.8 6.5 10.8 0.5 3.1 1.0 0.1 0.0 0.0 0.5 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.2 5.7 2.8 8.0 18.0 0.3 3.2 5.2 5.4 5.8 1.2 1.1 0.0 4.5 6.2 2.5 4.3 4.4 6.0 4.3 0.0 4.1 0.8 3.7 0.1 7.7 1.7 1.0 11.2 2.3 12.1 13.9 8.4 2.1 1.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 0.0 6.1 0.0 4.7 0.1 5.8 0.7 4.1 2.9 5.1 1.4 2.4 1.4 5.3 1.1 5.1 6.5 2.6 6.1 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 0.0 12.5 0.0 11.5 6.0 22.2 9.4 2.5 167.3 23.9 26.2 106.0 0.3 1.7 5.6 13.4 9.0 0.0 0.0 3.1 0.4 14.8 5.9 3.5 0.8 2.0 30.2 16.6 6.7 1.5 6.5 19.2 3.8 8.5 0.0 0.8 17.7 6.8 1.1 17.3 14.8 86.1 19.4 11.3 64.2 10.4 4.8 0.5 2.5 0.9 5.7 DYNLRB2 "DNCL2B, DNLC2B, ROBLD2" ENSG00000168589 "Dynein light chain roadblock-type 2" Q8TF09 16 80540734-80550760 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 34.2;testis: 76.1" "Cell type enhanced" "Detected in many" 27 "Ciliated cells: 563.5;Early spermatids: 1943.2;Late spermatids: 560.3;Spermatocytes: 347.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.7;MCF7: 9.7;RPTEC TERT1: 6.5;SCLC-21H: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.41e-2)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.91e-5)" "unprognostic (2.29e-2)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (1.17e-1)" "unprognostic (1.05e-3)" "unprognostic (1.41e-1)" "unprognostic (8.82e-3)" "unprognostic (1.73e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-4)" "unprognostic (1.55e-4)" 0.4 1.0 3.4 0.3 4.1 0.1 2.0 1.5 1.8 1.1 0.2 4.4 2.2 0.3 0.8 9.6 0.5 34.2 1.1 0.3 4.1 3.9 2.9 0.5 3.4 0.2 1.6 2.1 2.6 0.9 2.1 2.8 0.6 12.8 1.0 0.2 0.9 0.4 1.6 0.1 1.0 0.2 0.6 1.8 0.1 0.3 76.1 2.6 0.2 1.9 0.0 0.4 0.4 0.2 0.8 3.7 4.7 0.5 1.4 4.0 0.7 0.1 0.0 0.6 0.0 1.6 0.9 0.3 0.0 0.3 0.8 0.0 0.0 3.7 0.0 0.2 0.0 0.1 2.7 0.0 0.0 0.0 2.9 0.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.8 9.7 0.0 0.0 0.2 0.3 2.1 0.2 0.0 0.0 6.5 1.3 3.3 0.7 1.4 2.6 0.0 0.4 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.2 1.4 0.5 0.9 0.8 1.3 1.0 0.2 0.3 1.7 4.0 4.7 1.4 0.3 3.7 3.8 0.7 3.4 4.1 1.5 1.8 4.1 3.9 1.6 2.1 12.8 2.6 3.0 9.0 0.0 3.1 4.5 1.0 0.2 5.1 563.5 30.7 1.8 0.0 2.0 29.9 3.5 1943.2 0.6 0.0 0.0 1.3 0.6 1.9 3.6 7.0 0.8 0.5 0.0 2.9 1.3 1.2 560.3 18.1 1.3 0.0 5.4 1.2 11.7 1.7 0.0 14.5 29.8 2.7 12.9 1.4 347.0 18.3 2.5 2.9 0.8 0.0 2.2 DYRK1B MIRK ENSG00000105204 "Dual specificity tyrosine phosphorylation regulated kinase 1B" Q9Y463 19 39825350-39834201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.1" "Group enriched" "Detected in many" 14 "Early spermatids: 145.5;Late spermatids: 469.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028522, HPA028786" Uncertain Supported "Nucleoplasm,Mitotic chromosome" Yes No Nucleoplasm "Mitotic chromosome" "HPA028522: AB_2672656, HPA028786: AB_10670831" "unprognostic (2.22e-2)" "unprognostic (9.86e-2)" "unprognostic (4.55e-2)" "unprognostic (3.45e-3)" "unprognostic (1.96e-1)" "unprognostic (1.13e-2)" "unprognostic (2.25e-1)" "unprognostic (2.39e-1)" "unprognostic (6.02e-2)" "unprognostic (3.67e-2)" "unprognostic (8.93e-2)" "unprognostic (4.22e-2)" "prognostic favorable (8.83e-4)" "unprognostic (9.73e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-2)" "unprognostic (3.88e-2)" 4.8 7.9 7.4 3.7 10.2 5.0 4.0 10.1 13.1 4.5 4.2 7.4 6.1 6.2 6.4 12.3 6.7 8.0 4.6 9.0 6.6 6.1 6.1 3.2 5.4 5.1 4.4 6.7 6.1 5.2 7.1 12.3 3.8 6.4 5.5 3.4 6.7 5.5 5.8 89.1 6.3 5.1 3.9 3.4 5.9 5.2 28.8 4.6 11.2 6.4 25.3 5.3 5.6 4.1 4.7 8.3 4.8 3.2 6.2 7.0 2.6 0.4 8.6 8.4 5.9 4.8 4.5 0.7 2.7 1.7 2.5 2.3 0.8 3.3 1.3 10.6 3.2 0.1 2.9 1.2 1.9 2.2 4.9 7.3 0.6 5.4 0.8 4.0 0.3 1.8 6.1 1.2 0.8 2.8 8.2 0.6 3.3 1.4 1.9 0.4 4.3 1.9 0.8 2.0 2.5 2.0 0.9 0.1 0.6 5.4 2.1 12.2 13.8 4.2 4.2 0.2 4.7 4.1 0.5 4.2 1.1 1.9 0.9 0.8 3.1 1.0 0.9 7.1 0.8 0.4 1.2 3.1 3.2 5.9 3.2 7.0 4.7 4.0 5.9 3.5 3.5 2.2 3.5 4.8 6.2 2.9 8.3 4.2 2.6 7.4 10.2 10.1 13.1 6.6 6.1 4.4 6.7 6.4 4.6 0.0 1.1 13.7 3.6 3.1 14.9 5.3 5.1 1.4 0.0 15.7 19.6 1.8 8.3 11.7 145.5 5.7 9.1 0.0 3.7 1.5 4.0 5.4 1.1 3.0 4.9 9.5 19.5 6.2 9.2 469.8 6.6 2.7 5.0 3.6 9.4 8.1 8.6 8.6 4.9 11.2 13.0 0.0 2.3 22.4 14.0 2.5 1.1 6.9 8.5 3.2 DYRK3 "hYAK3-2, RED, REDK" ENSG00000143479 "Dual specificity tyrosine phosphorylation regulated kinase 3" O43781 1 206635536-206684419 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.2" "Cell type enriched" "Detected in many" 6 "Early spermatids: 160.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA075041 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA075041: AB_2686730" "unprognostic (6.51e-2)" "unprognostic (1.24e-2)" "unprognostic (3.36e-2)" "unprognostic (2.03e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-4)" "unprognostic (2.69e-1)" "unprognostic (3.91e-1)" "unprognostic (2.71e-1)" "unprognostic (2.79e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (9.41e-7)" "unprognostic (2.38e-1)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (7.62e-3)" 7.1 2.7 4.2 4.2 3.5 6.2 7.7 1.3 2.7 5.6 2.7 2.6 3.7 1.2 7.6 5.1 2.7 6.2 12.8 16.3 6.0 3.4 3.4 7.4 5.0 1.6 2.6 2.0 7.6 5.2 2.8 11.2 1.2 4.6 4.5 1.5 4.1 5.5 3.0 2.1 2.0 2.1 7.5 2.7 1.8 3.7 38.2 3.1 5.1 11.9 3.0 1.7 5.4 7.6 0.0 6.1 0.0 0.1 0.0 0.3 0.0 2.5 3.5 0.8 4.9 8.7 7.8 0.1 8.2 18.1 7.5 9.7 0.2 1.3 3.7 1.2 9.6 13.2 0.7 4.2 6.6 8.0 0.0 2.8 5.4 4.4 0.8 13.8 3.7 3.5 5.5 4.3 12.9 35.7 7.7 5.8 5.7 10.4 0.7 11.5 0.9 8.2 2.1 6.9 0.2 6.5 20.4 2.6 0.0 2.4 0.1 5.0 3.7 7.3 0.3 10.0 1.0 0.9 0.9 4.3 15.7 5.9 7.6 6.8 2.9 1.1 4.4 9.3 4.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 4.2 3.5 1.3 2.7 6.0 3.4 2.6 2.0 4.6 3.1 3.0 5.1 0.5 10.3 5.8 0.1 10.3 2.5 13.4 5.7 1.8 9.8 0.0 0.0 3.0 160.9 4.2 0.0 0.0 1.9 0.1 7.3 3.2 0.0 1.1 0.9 0.0 2.4 2.5 1.5 27.7 3.7 1.9 8.5 1.8 0.3 3.0 1.4 0.0 1.8 1.0 7.4 6.5 10.3 17.6 3.4 3.1 0.3 0.0 0.2 3.5 DYRK4 ENSG00000010219 "Dual specificity tyrosine phosphorylation regulated kinase 4" Q9NR20 12 4562204-4615302 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "testis: 85.9" "Group enriched" "Detected in many" 7 "Early spermatids: 369.7;Late spermatids: 289.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028065, HPA056073" Enhanced Enhanced Vesicles No No Vesicles "HPA028065: AB_10601212, HPA056073: AB_2683028" "unprognostic (2.50e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (3.56e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-3)" "unprognostic (2.03e-2)" "unprognostic (4.69e-2)" "unprognostic (1.29e-1)" "unprognostic (7.13e-2)" "unprognostic (1.22e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (1.86e-1)" "unprognostic (9.71e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" 1.6 2.1 2.3 2.1 1.8 1.6 2.8 1.9 2.3 2.6 2.1 2.2 2.3 1.7 2.5 9.1 1.6 2.0 1.7 1.7 1.8 1.8 1.9 2.0 2.2 2.5 1.9 2.5 2.2 2.3 2.9 2.7 2.9 2.3 2.3 2.7 2.4 2.3 3.4 1.6 1.9 2.4 2.1 2.7 4.3 1.7 85.9 2.1 1.6 4.3 1.6 2.0 2.4 1.6 7.6 2.7 1.3 5.2 1.1 1.6 1.6 1.9 3.0 3.8 4.1 5.8 7.2 4.6 2.3 4.6 5.3 5.8 0.6 3.1 5.7 0.3 6.5 3.6 4.0 2.9 4.3 4.2 4.3 6.6 4.0 0.8 3.3 16.4 3.4 3.2 4.9 9.2 3.7 12.2 9.9 7.4 6.3 1.6 6.5 4.7 4.0 3.2 8.5 5.2 1.0 1.7 0.7 2.7 2.4 6.4 1.8 0.0 1.5 0.4 2.3 3.3 8.7 1.8 3.1 0.5 6.2 4.9 0.6 2.9 1.9 2.3 3.4 3.3 5.4 3.2 0.6 2.8 1.3 1.0 2.2 1.1 7.6 1.5 1.6 2.7 5.8 1.6 1.6 0.1 1.1 5.2 1.4 1.1 1.6 2.3 1.8 1.9 2.3 1.8 1.8 1.9 2.5 2.3 2.1 11.9 14.4 11.1 13.1 7.9 20.7 19.4 5.1 12.0 13.6 15.7 9.8 12.9 26.6 22.0 369.7 9.3 4.0 0.0 23.8 10.1 17.5 12.6 17.3 9.2 41.7 12.7 5.2 9.2 15.7 289.4 14.1 15.9 15.1 18.0 47.3 16.6 22.1 15.8 29.7 28.1 17.0 6.5 15.6 20.0 31.5 6.6 8.2 17.3 15.6 9.8 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" Yes No "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.9 0.6 0.1 0.3 0.0 4.9 0.0 1.3 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 12.8 32.9 0.0 3.1 0.0 29.9 0.0 0.0 2.2 3.2 0.0 0.3 0.0 31.6 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 3.3 0.1 0.3 21.5 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.2 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 3.0 13.8 0.5 0.0 2.2 0.8 20.1 0.0 1.4 2.3 0.0 0.0 5.4 0.0 0.4 4.4 22.1 0.0 0.0 0.2 2.8 1.4 0.2 2.3 9.9 11.0 0.0 0.0 34.4 20.6 4.1 0.6 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.7 0.1 6.5 3.1 0.5 0.0 1.4 55.4 0.9 0.0 0.0 DYTN ENSG00000232125 Dystrotelin A2CJ06 2 206651621-206718396 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.5;bone marrow: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HEL: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.23e-3)" "unprognostic (8.52e-2)" 0.0 0.0 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589682-108694846 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.4" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 183.4;Cone photoreceptor cells: 308.3;Spermatocytes: 314.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles No No Vesicles "HPA035066: AB_10601549, HPA049232: AB_2680684" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favorable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 4.6 9.3 14.1 4.5 25.7 3.1 5.0 14.5 23.7 5.2 4.4 5.8 2.1 2.8 7.4 9.7 3.8 17.4 5.4 10.8 13.2 18.5 10.5 3.9 6.0 8.4 10.3 16.0 10.3 4.9 10.3 57.4 4.5 20.3 9.2 4.5 4.0 3.3 7.0 10.1 3.4 3.6 7.9 9.2 7.0 6.0 29.9 8.0 10.4 12.0 2.8 7.0 5.0 3.5 6.8 1.8 5.2 1.6 11.7 6.5 1.8 6.5 6.0 17.0 10.2 7.6 7.9 5.8 4.1 8.2 6.9 9.4 8.3 4.5 11.8 8.9 4.4 14.9 2.4 9.7 3.5 14.7 4.3 4.1 5.4 2.2 5.7 4.5 2.1 3.1 8.2 1.9 6.4 8.0 7.1 4.3 7.6 5.1 5.8 13.1 5.9 5.3 2.3 10.4 3.4 4.3 6.8 14.0 1.1 5.8 3.2 11.5 11.0 6.9 0.7 7.4 16.0 10.2 1.8 4.9 6.2 9.5 1.2 3.6 6.7 3.8 23.0 4.7 1.7 7.5 5.2 0.7 1.4 5.0 1.0 6.0 6.8 5.1 6.1 0.6 6.0 4.5 6.0 0.1 11.7 1.6 1.8 6.5 1.8 14.1 25.7 14.5 23.7 13.2 18.5 10.3 16.0 20.3 8.0 11.9 13.8 8.3 8.5 6.6 67.2 33.6 2.5 183.4 29.6 31.4 308.3 19.8 11.6 8.1 23.6 8.2 3.9 0.0 8.1 7.3 13.9 8.8 8.1 3.6 7.8 73.1 50.7 6.7 7.3 46.6 16.1 6.2 6.8 14.4 6.1 33.9 8.4 3.5 16.6 15.3 32.1 19.4 9.2 314.4 93.7 6.5 12.4 18.5 6.3 4.3 E2F1 "RBBP3, RBP3" ENSG00000101412 "E2F transcription factor 1" Q01094 20 33675683-33686404 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.5;lymphoid tissue: 21.9" "Cell type enriched" "Detected in many" 5 "Spermatogonia: 37.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 3.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000329, HPA008003, CAB019308, HPA029735" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176" "unprognostic (7.46e-2)" "prognostic favorable (9.22e-6)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.33e-5)" "unprognostic (1.51e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (1.25e-2)" "unprognostic (8.23e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (4.18e-4)" "unprognostic (3.15e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (1.05e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.62e-4)" "unprognostic (1.91e-1)" 2.4 5.3 6.8 12.7 9.7 32.5 2.1 1.1 6.4 1.2 4.4 5.1 0.7 3.9 1.4 0.8 5.1 1.5 4.1 2.0 7.1 3.6 0.9 1.7 8.1 9.3 6.2 2.9 3.4 1.2 2.3 0.3 3.3 5.9 1.7 4.8 0.3 1.6 1.4 1.4 5.4 4.9 3.3 6.2 4.8 3.4 12.1 6.0 21.9 1.0 4.9 7.7 1.9 3.1 2.2 0.6 0.7 3.7 1.4 1.2 0.6 16.0 15.6 18.1 14.1 1.8 1.3 13.8 15.4 7.5 19.7 16.6 27.6 16.6 29.6 15.6 6.9 23.9 12.1 8.8 8.2 8.8 8.9 12.6 24.2 23.2 16.0 0.1 11.3 15.3 1.0 0.5 10.8 1.9 2.0 5.0 18.6 6.4 20.9 12.1 14.2 24.0 24.0 5.4 16.2 22.5 23.9 49.4 12.2 3.3 9.8 27.1 19.1 18.8 13.1 7.6 5.4 16.4 14.3 2.7 23.0 13.5 15.9 21.8 20.5 13.8 24.4 19.2 6.7 13.6 0.0 0.0 0.7 0.1 0.9 0.0 2.2 0.6 0.4 0.2 0.2 0.2 1.2 0.3 1.4 3.7 0.6 0.8 0.6 6.8 9.7 1.1 6.4 7.1 3.6 6.2 2.9 5.9 6.0 0.0 0.6 2.9 0.7 2.6 2.2 0.4 0.0 0.0 2.3 0.0 0.0 2.6 0.0 0.9 0.7 0.1 0.5 0.0 0.2 7.9 1.1 0.6 0.0 0.8 3.8 0.0 0.0 0.6 0.0 2.3 2.0 0.9 1.7 0.0 2.9 1.2 0.5 0.0 1.1 0.0 2.0 0.0 0.9 3.8 37.5 1.5 1.5 0.7 4.6 0.9 E2F2 E2F-2 ENSG00000007968 "E2F transcription factor 2" Q14209 1 23506430-23531220 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 22.8;lymphoid tissue: 69.7" "Group enriched" "Detected in some" 9 "Early spermatids: 45.0;Late spermatids: 84.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.9;Karpas-707: 20.5;U-266/84: 18.3;U-698: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" CAB016313 Uncertain NA Yes "CAB016313: AB_2096794" "unprognostic (3.14e-2)" "unprognostic (5.74e-3)" "unprognostic (1.31e-3)" "unprognostic (4.18e-2)" "unprognostic (8.54e-2)" "unprognostic (1.70e-3)" "unprognostic (6.43e-6)" "unprognostic (7.83e-3)" "unprognostic (1.53e-2)" "unprognostic (7.33e-2)" "unprognostic (1.51e-3)" "unprognostic (1.86e-2)" "unprognostic (0.00e+0)" "unprognostic (1.00e-3)" "unprognostic (2.82e-1)" "unprognostic (8.67e-3)" "unprognostic (1.84e-1)" 0.4 0.2 0.1 6.1 0.2 22.8 1.0 0.1 0.2 1.1 3.5 0.2 0.0 1.6 0.1 0.2 11.2 0.1 0.2 1.5 0.0 0.0 0.4 0.7 1.2 3.3 0.2 0.0 0.2 0.6 0.0 0.0 2.2 0.2 0.3 2.3 0.3 1.2 0.0 0.0 4.4 3.4 0.4 0.2 6.8 0.9 4.4 0.1 69.7 0.3 3.9 6.1 0.5 2.3 0.9 1.1 6.7 2.0 0.2 2.8 0.4 2.7 2.0 3.4 5.4 0.1 0.1 2.4 1.3 0.6 1.2 1.6 1.2 1.6 23.9 1.6 0.6 0.6 5.5 6.8 0.3 1.1 6.0 2.2 3.8 5.1 1.4 0.0 2.7 5.0 0.0 0.0 0.9 0.1 0.2 0.4 11.2 2.9 20.5 0.6 1.6 12.2 2.5 0.7 2.9 1.0 13.4 7.3 8.1 0.5 0.7 4.4 6.2 2.2 2.8 0.6 0.4 2.1 2.0 0.2 1.2 3.3 3.7 1.8 15.2 18.3 19.8 1.1 3.0 2.2 6.7 0.6 1.7 0.2 1.5 0.1 0.9 0.7 0.5 1.1 0.6 0.1 0.2 0.4 0.2 2.0 0.9 2.8 0.4 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 7.0 0.1 0.7 0.0 0.5 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 45.0 0.0 2.0 0.0 0.0 4.0 0.2 0.4 0.0 0.0 2.0 0.0 1.2 0.6 4.4 84.0 0.3 0.9 0.0 0.0 5.6 0.0 0.1 7.0 0.4 0.0 0.0 0.0 0.0 1.1 3.3 0.9 0.5 0.0 7.4 1.0 E2F7 ENSG00000165891 "E2F transcription factor 7" Q96AV8 12 77021247-77065580 "Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 42.0" "Group enriched" "Detected in some" 7 "Early spermatids: 38.5;Late spermatids: 53.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 5.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "midbrain: 7.6;pons and medulla: 7.4;thalamus: 12.1" HPA064866 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA064866: AB_2685374" "unprognostic (1.21e-1)" "unprognostic (8.92e-2)" "unprognostic (7.39e-2)" "unprognostic (7.27e-2)" "unprognostic (1.54e-1)" "unprognostic (3.80e-2)" "unprognostic (6.14e-5)" "unprognostic (1.05e-3)" "unprognostic (1.72e-1)" "unprognostic (3.57e-2)" "unprognostic (5.67e-5)" "unprognostic (1.42e-1)" "unprognostic (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.00e-1)" "unprognostic (2.51e-1)" 1.3 0.4 0.6 4.7 0.7 8.4 0.4 0.5 0.8 1.1 1.7 1.2 0.5 1.3 1.2 1.4 5.0 1.2 1.3 0.8 0.7 0.6 0.5 0.5 1.4 2.7 0.5 0.0 0.7 0.7 0.5 1.8 2.1 0.6 0.7 3.0 0.4 0.9 1.0 0.3 2.1 2.3 0.9 0.6 2.4 1.2 6.1 0.2 42.0 0.4 2.3 6.3 1.4 1.7 0.6 5.0 1.2 0.0 0.2 1.0 0.0 9.6 4.6 13.0 5.0 0.4 1.3 15.7 13.6 14.8 7.2 8.7 6.2 3.3 5.4 2.7 2.7 15.0 7.5 7.7 14.7 13.8 2.1 5.1 4.7 13.3 3.5 3.1 4.0 4.4 0.4 3.9 18.9 11.7 4.2 7.0 9.4 4.9 4.4 14.7 4.9 15.2 0.0 9.1 3.2 11.0 11.1 11.2 3.0 1.8 8.2 8.2 5.4 11.3 3.9 3.2 5.7 6.3 4.2 19.4 27.3 13.7 11.6 17.8 4.8 2.7 3.5 9.8 1.8 17.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 5.0 1.0 0.0 0.6 0.7 0.5 0.8 0.7 0.6 0.5 0.0 0.6 0.2 0.0 0.3 0.0 1.0 0.2 0.0 1.6 0.0 1.4 3.4 0.0 0.0 0.4 0.0 0.4 38.5 0.0 0.0 0.0 0.9 2.6 0.2 0.3 4.6 0.0 0.8 0.0 0.0 0.0 0.3 53.3 0.3 0.3 0.0 0.0 0.5 1.5 7.0 0.0 0.7 0.0 0.0 0.0 0.3 1.0 1.9 0.5 0.2 0.7 0.4 4.4 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol No No Nucleoli "Nucleoplasm, Cytosol" "HPA064882: AB_2685381, HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.2 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 5.5 12.6 10.7 1.0 8.4 9.5 8.7 4.9 2.4 4.0 0.0 7.4 11.8 0.2 0.0 1.9 0.6 0.5 13.0 10.1 10.3 13.7 3.7 6.9 14.6 9.3 4.0 16.1 6.0 15.9 8.2 9.5 4.0 9.6 3.8 4.3 3.5 7.0 0.8 2.4 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 1.0 0.0 2.0 0.0 8.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 23.3 0.0 1.4 0.6 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.1 0.3 0.2 0.0 2.6 0.6 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427355-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.7" "Group enriched" "Detected in many" 6 "Early spermatids: 229.6;Late spermatids: 321.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 56.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 15.6 11.5 13.9 12.2 20.0 55.7 11.4 18.1 19.1 9.8 11.7 13.3 11.5 12.7 10.1 9.9 13.1 9.4 12.9 7.6 14.3 18.1 13.7 22.2 12.0 12.4 14.7 13.0 8.0 11.8 13.0 17.6 18.9 18.6 12.7 12.4 9.6 9.5 15.4 8.6 15.9 12.5 10.4 13.7 15.1 13.7 9.7 10.1 14.0 13.0 9.1 12.9 11.9 9.0 5.1 9.9 7.1 7.4 8.1 15.4 4.3 4.0 6.6 7.0 7.1 4.1 3.5 56.2 5.9 4.2 6.8 6.7 9.0 4.5 11.3 3.8 4.3 4.5 3.4 9.0 5.2 7.9 9.2 6.5 9.7 6.0 8.1 9.2 9.1 7.9 4.6 9.3 9.9 6.7 5.2 6.8 9.3 10.3 8.3 5.6 8.3 9.0 5.1 12.4 7.6 6.8 8.3 5.8 6.2 5.9 7.1 7.2 12.6 7.2 6.8 6.9 9.4 10.1 7.3 6.6 7.2 5.3 6.3 8.5 11.0 22.1 11.9 7.0 10.9 8.5 7.1 7.4 4.5 12.0 5.4 15.4 5.1 10.1 9.3 4.3 3.8 6.0 9.8 6.7 8.1 6.5 9.9 10.5 4.3 13.9 20.0 18.1 19.1 14.3 18.1 14.7 13.0 18.6 10.1 8.9 12.9 2.9 7.7 41.7 6.8 4.5 7.6 6.7 10.3 12.2 5.9 7.2 8.3 7.8 229.6 11.7 13.6 0.0 7.0 11.7 16.0 15.1 10.3 27.0 14.1 20.6 33.0 11.6 21.8 321.2 10.6 14.6 21.9 5.4 11.2 4.8 11.8 10.5 11.3 18.9 6.0 25.8 11.3 18.6 11.5 47.4 30.0 20.4 10.9 14.5 EAF2 "BM040, TRAITS, U19" ENSG00000145088 "ELL associated factor 2" Q96CJ1 3 121835183-121886526 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 40.1" "Cell type enhanced" "Detected in many" 11 "B-cells: 44.6;Proximal tubular cells: 115.5;Spermatocytes: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 32.1;naive B-cell: 30.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 25.7;HL-60: 39.5;THP-1: 21.0;U-698: 32.6;U-937: 22.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA008411 Enhanced NA NA "HPA008411: AB_1847950" "unprognostic (3.43e-1)" "prognostic favorable (2.25e-9)" "unprognostic (1.48e-1)" "prognostic favorable (2.66e-4)" "unprognostic (1.00e-1)" "unprognostic (3.18e-2)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "unprognostic (2.04e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "unprognostic (2.08e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (9.04e-2)" "unprognostic (8.34e-2)" 3.4 3.7 7.2 21.3 6.1 40.1 6.5 9.3 5.7 3.8 6.4 1.7 20.7 5.5 2.0 3.4 4.1 3.3 3.3 3.0 8.2 3.9 18.4 4.1 4.5 30.7 4.5 4.7 1.9 6.9 2.8 19.8 2.0 4.6 13.6 7.6 1.9 8.3 29.7 1.9 1.8 8.2 2.4 7.8 26.0 5.0 5.7 6.5 6.1 2.6 1.0 25.5 7.9 3.6 32.1 9.8 13.1 16.1 0.5 1.0 4.3 1.2 1.0 0.7 0.9 0.2 0.6 2.2 0.4 0.2 0.8 1.6 2.1 0.7 25.7 0.5 0.1 2.7 1.9 1.8 0.9 2.2 12.5 1.0 14.8 1.1 3.9 0.3 39.5 16.4 0.3 2.5 1.0 0.9 0.0 0.8 3.5 1.6 5.1 0.4 0.3 5.6 5.2 1.0 4.7 0.9 5.9 2.3 3.8 0.9 1.5 0.8 0.2 0.7 0.7 2.0 2.1 0.6 21.0 0.2 0.5 0.9 0.5 1.2 9.3 4.1 32.6 1.0 22.6 1.7 3.2 6.2 13.1 0.4 12.8 0.9 32.1 0.7 0.5 6.9 30.8 1.0 0.5 1.1 0.5 16.1 9.8 0.8 4.3 7.2 6.1 9.3 5.7 8.2 3.9 4.5 4.7 4.6 6.5 3.0 3.4 44.6 7.2 2.2 1.0 4.1 0.0 8.1 5.7 1.8 3.9 12.6 14.9 3.8 14.3 2.8 2.1 0.0 15.6 1.6 2.5 12.3 9.3 1.1 15.0 0.0 1.2 1.8 23.2 1.1 4.6 27.6 15.1 32.5 3.4 7.2 4.3 3.5 2.8 115.5 4.6 0.0 4.4 40.5 4.5 2.0 6.4 5.9 2.5 5.0 EBF2 "COE2, FLJ11500" ENSG00000221818 "Early B cell factor 2" Q9HAK2 8 25841730-26045397 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.8" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;ASC TERT1: 25.5;HSkMC: 25.9;hTEC/SVTERT24-B: 14.4;U-138 MG: 9.3;U-2197: 12.2;U-87 MG: 10.4" "Group enriched" "Detected in many" 4 "basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9" "Low region specificity" "Detected in some" "HPA003954, HPA055101" Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003954: , HPA055101: " "unprognostic (3.70e-1)" "unprognostic (3.88e-3)" "unprognostic (2.69e-2)" "unprognostic (2.47e-3)" "unprognostic (1.03e-1)" "unprognostic (6.10e-2)" "unprognostic (5.92e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-2)" "unprognostic (6.13e-3)" "unprognostic (1.58e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (7.41e-4)" "unprognostic (2.28e-1)" "unprognostic (3.80e-2)" "unprognostic (1.82e-2)" 25.8 1.1 0.2 3.2 0.9 0.1 14.5 0.2 0.2 3.0 4.2 0.0 2.9 0.2 3.0 14.1 5.2 5.1 3.8 16.4 0.2 0.5 0.9 0.2 1.3 4.4 0.9 0.0 3.9 4.0 3.1 0.6 0.8 2.8 3.7 0.7 0.1 1.7 0.8 11.1 1.8 1.0 5.4 10.1 0.2 1.2 4.2 0.0 0.4 7.4 11.6 0.5 6.2 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 12.5 25.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 14.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.3 0.1 12.2 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.2 0.2 0.5 0.9 0.0 2.8 0.0 0.0 0.3 0.0 0.1 0.1 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.2 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 38.8 9.5 0.2 0.2 0.3 0.0 0.0 0.0 0.0 EBF3 "COE3, DKFZp667B0210" ENSG00000108001 "Early B cell factor 3" Q9H4W6 10 129835283-129963841 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 25.8;lymphoid tissue: 29.9" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 2.4;Endothelial cells: 3.5;Smooth muscle cells: 11.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.1;HAP1: 11.8;LHCN-M2: 18.9;NB-4: 23.8;RH-30: 10.3;SCLC-21H: 24.4;THP-1: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061169 Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA061169: AB_2684441" "unprognostic (2.96e-1)" "unprognostic (3.78e-2)" "unprognostic (8.63e-3)" "unprognostic (2.60e-2)" "unprognostic (7.68e-2)" "unprognostic (4.50e-3)" "unprognostic (8.53e-6)" "unprognostic (2.93e-2)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.63e-1)" "unprognostic (4.16e-3)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (9.49e-2)" "unprognostic (4.58e-2)" 20.0 0.9 0.3 3.4 0.4 0.1 25.8 0.7 0.5 7.3 3.6 0.2 2.5 0.2 5.4 4.9 4.3 3.8 4.3 10.5 0.3 2.5 0.6 0.4 1.0 29.9 5.0 0.3 1.0 1.2 3.6 0.9 3.8 4.8 4.6 0.8 2.0 3.6 2.2 10.9 2.8 1.0 6.3 9.3 0.2 1.6 4.6 0.1 0.5 6.7 6.3 2.4 4.7 16.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 10.1 7.8 0.1 0.7 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.3 0.0 0.0 11.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 2.3 0.0 0.0 0.0 0.7 0.0 0.0 18.9 0.1 0.0 23.8 0.1 0.0 0.0 0.3 10.3 0.0 0.0 0.1 24.4 0.3 0.0 0.0 0.0 0.2 0.0 10.0 0.0 0.0 1.2 6.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.5 0.3 2.5 5.0 0.3 4.8 0.1 0.0 0.0 0.0 0.0 1.6 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.6 0.0 11.8 0.0 0.9 0.6 0.0 0.0 0.0 0.0 EBI3 "IL27B, IL35B" ENSG00000105246 "Epstein-Barr virus induced 3" Q14213 19 4229498-4237531 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "placenta: 411.9" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 389.3;monocytes: 881.9;Syncytiotrophoblasts: 281.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 15.5;naive B-cell: 8.5" "Group enriched" "Detected in many" 15 "B-cells: 15.5;monocytes: 4.5" "Cell line enriched" "Detected in some" 13 "HDLM-2: 68.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046635 Enhanced "Secreted to blood" NA NA 1200000 "HPA046635: AB_2679729" "unprognostic (7.26e-2)" "unprognostic (1.49e-2)" "unprognostic (9.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.59e-1)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.10e-2)" "unprognostic (7.78e-2)" "unprognostic (4.87e-2)" "unprognostic (4.25e-3)" "unprognostic (8.27e-2)" "prognostic unfavorable (1.04e-8)" "unprognostic (1.97e-1)" "unprognostic (2.78e-2)" "unprognostic (9.29e-2)" "unprognostic (4.67e-2)" 2.1 2.5 1.9 5.7 1.5 0.4 1.4 0.3 1.0 0.8 1.3 1.1 0.3 1.7 0.6 0.8 0.5 1.7 2.3 0.7 1.7 1.4 2.1 1.9 1.8 18.5 2.5 0.7 0.6 1.0 0.1 1.1 411.9 1.1 1.0 0.7 0.7 1.1 0.6 0.4 0.2 5.1 0.8 3.8 24.6 1.5 0.9 1.3 4.9 0.5 0.3 2.9 2.0 0.5 15.5 0.6 0.1 4.5 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.2 1.3 0.1 0.0 0.4 0.3 1.3 5.4 0.0 0.6 0.0 0.0 0.0 0.0 68.8 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.1 0.0 0.7 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 3.7 0.0 15.5 0.0 0.0 0.6 8.5 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.4 1.9 1.5 0.3 1.0 1.7 1.4 2.5 0.7 1.1 1.3 0.0 0.3 0.9 0.0 0.3 0.0 0.1 2.5 0.0 1.2 0.0 0.0 2.4 0.0 2.3 0.0 0.3 0.0 0.0 0.8 389.3 0.0 0.1 11.5 0.0 9.0 0.0 0.0 1.3 69.8 0.0 0.0 8.1 0.0 881.9 0.0 0.0 0.8 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 281.4 0.0 0.0 0.0 EBLN1 ENSG00000223601 "Endogenous Bornavirus like nucleoprotein 1" P0CF75 10 22208814-22210021 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 7.4" "Group enriched" "Detected in some" 26 "Early spermatids: 14.7;Late spermatids: 4.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "myeloid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "GAMG: 4.8;U-2 OS: 1.6" NA NA "unprognostic (1.39e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA062510: AB_2684787, HPA068795: AB_2686038" "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.2 1.2 0.0 2.1 0.0 15.3 2.6 0.5 0.3 2.4 1.5 1.0 2.6 2.5 1.8 3.1 1.1 2.1 0.1 0.0 0.8 1.8 3.1 1.7 0.1 5.1 2.6 1.2 1.2 1.9 1.6 2.4 3.1 0.5 1.3 2.2 2.1 1.4 1.0 2.1 1.8 0.9 2.4 1.5 2.4 2.9 2.6 2.2 6.3 1.5 1.1 3.8 0.2 1.3 0.9 5.3 4.7 1.4 3.0 4.0 2.1 0.4 1.3 1.0 2.6 4.3 3.3 0.8 2.8 1.3 1.8 2.0 2.2 2.7 1.3 1.2 2.2 5.0 2.3 0.8 4.2 4.9 2.9 1.6 2.7 2.6 2.6 1.8 2.9 1.6 5.1 1.5 2.8 2.0 5.9 3.3 1.1 1.4 5.3 1.3 2.0 1.4 5.5 1.2 2.6 1.3 2.3 0.7 3.9 3.5 1.6 3.4 1.5 2.9 4.0 3.2 5.1 2.4 2.6 1.5 4.6 2.6 0.3 1.5 6.3 3.6 0.5 3.0 1.5 3.2 3.1 0.5 2.6 2.7 3.8 3.3 1.1 0.6 2.2 3.7 0.2 0.0 2.1 5.0 11.6 5.0 4.7 0.8 15.3 2.7 2.3 3.5 7.9 7.1 0.0 3.1 1.5 4.5 4.5 23.3 1.4 5.4 6.2 7.7 1.1 4.4 2.5 3.2 4.1 7.4 3.3 0.2 7.8 3.9 1.7 1.8 3.3 2.8 3.5 3.5 3.5 0.1 5.0 6.5 3.1 3.7 4.8 5.5 12.2 7.5 3.3 11.2 EBP "CDPX2, CHO2, CPX, CPXD" ENSG00000147155 "Emopamil binding protein (sterol isomerase)" Q15125 X 48521158-48528716 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Cataract, Disease mutation, Dwarfism, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.1" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 389.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003130 Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003130: AB_1078717" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (2.80e-1)" "unprognostic (6.27e-2)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.47e-1)" "unprognostic (5.14e-2)" "unprognostic (4.04e-2)" "unprognostic (5.39e-2)" "unprognostic (4.13e-1)" "unprognostic (1.36e-1)" 3.7 33.2 5.3 4.3 5.7 10.5 10.5 10.1 6.3 8.6 19.6 2.8 3.4 17.2 4.0 3.7 20.6 3.9 4.5 21.7 4.7 4.3 12.8 74.1 14.9 13.0 3.5 8.0 4.8 11.7 6.0 3.7 4.2 8.8 8.6 15.7 5.2 8.7 4.8 3.5 9.1 30.0 5.6 7.0 7.9 8.1 5.4 2.8 9.0 4.6 9.8 10.4 5.0 10.0 17.1 22.9 21.5 12.6 13.3 29.9 18.1 33.6 7.1 18.9 11.3 10.5 7.8 6.1 8.6 7.2 11.5 16.6 14.1 56.2 18.2 6.1 6.0 11.3 37.9 31.6 46.7 8.7 14.0 15.8 9.2 9.5 12.1 7.7 33.8 22.8 7.6 17.0 15.3 11.4 2.9 7.6 12.9 11.7 17.3 9.4 14.7 18.8 20.7 19.0 9.7 23.4 13.0 1.9 51.6 28.1 6.0 16.1 8.1 31.8 16.4 4.5 12.6 18.0 8.1 8.0 5.9 10.0 22.7 9.4 7.4 11.6 18.4 13.7 34.1 5.6 17.4 8.9 21.5 29.9 11.7 25.1 17.1 22.2 27.5 12.3 12.6 20.1 25.5 1.8 13.3 12.6 22.9 22.4 18.1 5.3 5.7 10.1 6.3 4.7 4.3 3.5 8.0 8.8 2.8 29.8 39.6 41.7 45.2 33.0 23.7 36.3 81.5 22.7 21.6 50.6 7.9 40.6 33.2 80.2 5.4 24.3 135.6 46.7 207.1 93.9 32.6 42.4 40.3 389.0 57.0 7.9 28.8 28.8 26.6 7.8 12.4 34.4 35.4 47.7 72.4 13.4 126.3 129.8 13.8 76.4 15.9 12.9 20.6 8.6 20.0 39.6 31.4 74.7 134.2 61.7 ECE1 ECE ENSG00000117298 "Endothelin converting enzyme 1" P42892 1 21217247-21345504 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 114.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 21.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 103.3;TIME: 91.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001490, HPA013616" Enhanced NA NA 2100000 "HPA001490: AB_1078718, HPA013616: AB_1847963" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (1.49e-2)" "unprognostic (1.46e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (6.20e-2)" "unprognostic (1.92e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (7.70e-2)" "unprognostic (3.55e-2)" "unprognostic (9.10e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-2)" 44.0 49.9 10.3 18.7 14.5 17.3 33.7 3.6 15.6 29.5 27.5 19.2 11.2 12.4 24.0 10.5 15.6 19.1 23.0 30.9 12.4 8.0 14.9 41.8 30.1 14.4 13.9 13.4 34.2 42.1 114.4 21.6 27.0 14.6 27.9 14.6 26.5 14.7 11.4 15.2 14.8 23.2 24.1 13.2 23.5 18.9 19.1 14.7 9.5 23.2 10.7 19.1 34.2 37.0 4.6 2.0 21.5 7.5 1.0 6.1 4.2 13.8 9.3 12.0 6.0 17.4 18.6 6.9 20.7 36.1 11.3 10.4 6.7 42.8 5.0 52.1 20.8 24.4 5.9 4.9 9.9 9.9 12.6 4.1 7.2 14.4 5.4 23.2 1.0 1.8 9.7 11.6 17.4 8.7 30.9 103.3 4.1 1.4 2.7 9.5 2.9 2.1 1.6 3.6 3.9 7.3 2.5 6.9 7.2 17.6 2.5 4.1 10.0 20.5 12.1 8.9 6.8 8.7 3.0 91.7 25.5 12.4 11.2 11.9 4.1 7.0 5.8 52.9 2.4 30.7 0.1 5.8 2.2 2.2 7.5 3.3 4.6 4.6 3.5 0.5 3.1 3.1 1.9 21.5 1.0 5.2 2.0 6.1 4.2 10.3 14.5 3.6 15.6 12.4 8.0 13.9 13.4 14.6 14.7 17.9 9.8 18.9 17.1 18.0 1.9 16.1 7.6 10.7 28.4 22.7 0.0 3.6 5.0 21.9 1.1 83.9 51.8 23.3 49.4 26.8 34.3 33.0 18.4 32.5 3.1 0.0 24.2 95.8 8.2 1.7 40.3 5.1 6.8 27.9 10.9 57.2 80.7 84.2 51.9 7.4 4.7 38.8 42.9 1.1 4.7 14.1 8.8 10.7 20.9 38.3 ECE2 "KIAA0604, MGC2408" ENSG00000145194 "Endothelin converting enzyme 2" O60344 3 184276011-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 14.4;brain: 25.1;pancreas: 29.0;pituitary gland: 7.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 60.4;Late spermatids: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "REH: 14.3" NA NA "unprognostic (2.70e-2)" "unprognostic (1.44e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (8.41e-5)" "unprognostic (1.37e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.47e-2)" "unprognostic (3.69e-1)" "unprognostic (2.65e-3)" "unprognostic (1.70e-2)" "unprognostic (5.95e-2)" "unprognostic (1.63e-9)" "unprognostic (3.66e-2)" "unprognostic (6.16e-2)" "unprognostic (2.19e-1)" "unprognostic (1.25e-2)" 0.7 14.4 9.1 0.9 17.1 0.7 0.7 17.6 10.5 0.7 1.1 2.2 0.0 0.8 0.7 1.6 0.8 0.9 0.7 1.5 4.6 25.1 0.7 0.7 0.7 0.7 10.3 3.0 0.7 29.0 0.7 7.6 0.7 7.5 1.6 0.9 1.4 1.1 1.1 0.7 0.7 0.8 0.9 2.9 0.7 1.0 0.8 3.3 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 17.1 17.6 5.2 4.6 25.1 10.3 3.0 7.5 3.3 0.0 0.0 2.2 6.7 34.0 1.3 1.7 7.6 0.0 0.0 0.0 2.0 18.6 0.0 0.0 60.4 2.8 7.7 0.0 0.0 41.9 6.7 11.2 0.0 31.4 15.8 25.4 11.7 4.3 4.8 84.4 2.8 0.8 8.5 0.0 11.8 2.3 0.0 3.5 2.1 0.0 0.7 6.5 3.1 38.6 9.8 34.3 18.0 0.0 13.4 15.3 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 19 "Muller glia cells: 76.3;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 30.1;HeLa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.7 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 76.3 0.2 0.0 19.8 0.0 1.7 0.0 2.1 0.2 1.7 0.0 0.0 0.0 0.0 0.0 ECHDC2 FLJ10948 ENSG00000121310 "Enoyl-CoA hydratase domain containing 2" Q86YB7 1 52895910-52927212 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.9" "Cell type enhanced" "Detected in all" 8 "Hepatocytes: 663.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 15.4;HHSteC: 11.1;THP-1: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026731, HPA026768" Enhanced Approved Mitochondria NA NA 410000 Mitochondria "HPA026731: AB_1847969, HPA026768: AB_1847970" "unprognostic (2.73e-3)" "unprognostic (1.52e-2)" "unprognostic (4.08e-2)" "unprognostic (3.76e-1)" "unprognostic (7.67e-2)" "prognostic favorable (6.65e-4)" "unprognostic (1.51e-3)" "unprognostic (1.40e-3)" "unprognostic (6.11e-2)" "unprognostic (7.16e-2)" "unprognostic (2.98e-3)" "unprognostic (4.40e-2)" "unprognostic (5.47e-2)" "unprognostic (5.12e-2)" "unprognostic (2.93e-1)" "unprognostic (3.62e-1)" "prognostic favorable (2.70e-4)" 10.2 13.3 4.8 9.3 7.4 3.1 10.3 12.3 2.9 10.0 11.2 2.6 20.3 14.5 10.4 20.5 10.2 9.1 20.7 11.1 4.8 2.6 21.3 74.9 9.2 2.5 2.9 3.6 11.8 9.9 8.4 18.1 4.4 5.3 10.9 3.8 15.9 11.2 25.6 22.2 6.0 13.3 16.2 4.6 3.8 10.2 3.8 4.2 1.8 16.4 11.1 8.1 8.0 10.7 5.2 8.2 1.7 1.8 4.8 11.0 3.8 0.0 1.5 0.0 0.0 1.1 0.5 15.4 1.2 7.1 1.5 2.4 0.0 1.1 0.0 7.1 1.2 0.0 0.8 0.0 1.2 0.3 0.0 7.2 0.0 2.6 3.2 11.1 0.0 2.1 1.6 3.2 1.0 1.1 2.1 4.4 0.0 1.1 0.2 0.0 3.8 0.0 0.8 0.1 6.2 1.6 0.0 0.1 0.6 4.9 6.0 0.7 0.3 2.1 5.6 0.1 0.8 1.1 9.3 1.7 0.0 0.0 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.3 0.0 1.8 1.7 11.0 1.4 8.2 5.2 9.0 10.3 8.2 2.6 10.2 6.2 0.4 4.8 0.7 2.0 10.8 3.8 4.8 7.4 12.3 2.9 4.8 2.6 2.9 3.6 5.3 4.2 50.6 72.4 17.1 77.5 27.2 30.8 55.4 119.8 60.2 70.5 82.0 308.3 162.8 150.9 46.2 111.4 19.6 107.0 46.7 52.0 12.3 46.8 90.9 28.9 663.7 26.8 39.7 50.1 25.8 25.9 134.0 142.6 17.0 38.8 10.0 59.3 58.0 41.0 123.8 105.7 257.8 155.8 19.4 46.6 14.2 12.8 25.7 103.7 39.2 56.8 67.7 ECHDC3 FLJ20909 ENSG00000134463 "Enoyl-CoA hydratase domain containing 3" Q96DC8 10 11742366-11764070 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.1;skeletal muscle: 77.7" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 122.7;Hepatocytes: 134.4;Proximal tubular cells: 172.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "pons and medulla: 7.5" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 14.3" "Cell line enhanced" "Detected in many" "A-431: 28.6;BEWO: 16.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038306 Enhanced NA NA 93000 "HPA038306: AB_10672586" "unprognostic (8.74e-2)" "unprognostic (1.69e-1)" "unprognostic (2.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.92e-1)" "unprognostic (2.37e-2)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (5.07e-1)" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (3.53e-1)" "prognostic favorable (3.43e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (3.91e-4)" 29.9 9.9 0.7 4.7 1.3 2.5 53.8 1.2 1.3 5.1 5.9 1.5 4.4 0.6 3.3 4.9 14.0 3.5 2.3 47.7 0.6 0.5 26.4 64.1 9.8 8.2 0.8 0.4 4.6 23.6 0.8 4.4 6.8 7.5 6.9 1.4 7.7 16.0 6.4 77.7 5.7 3.2 2.5 1.0 6.1 6.7 6.7 0.8 1.4 11.2 10.8 6.2 3.4 4.6 1.2 1.8 14.3 1.8 0.5 0.5 0.3 28.6 4.2 0.0 0.0 0.0 0.0 16.3 3.6 0.0 2.6 2.3 10.6 0.2 0.0 3.3 7.8 0.7 7.0 6.7 1.0 1.1 0.0 0.3 0.0 4.4 0.0 11.9 0.0 4.2 8.1 6.7 2.7 0.0 0.2 5.2 0.0 10.5 0.0 0.8 3.9 0.0 0.1 7.6 0.1 0.0 8.8 0.0 0.0 2.0 0.0 3.1 4.8 0.0 7.4 0.0 9.9 11.5 1.4 1.5 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.9 1.8 14.3 0.0 0.6 0.1 0.2 0.2 0.5 1.8 1.2 0.3 0.1 3.6 0.5 0.6 0.6 0.0 0.3 0.7 1.3 1.2 1.3 0.6 0.5 0.8 0.4 7.5 0.8 17.9 7.3 4.3 13.8 3.9 0.9 32.5 20.4 0.0 10.3 15.7 2.0 55.7 122.7 29.3 3.7 3.1 0.5 0.0 26.3 26.3 3.1 15.0 0.0 134.4 11.9 0.0 0.0 8.0 12.9 4.4 2.6 7.8 8.5 8.2 0.0 12.9 17.3 0.0 3.2 172.5 2.2 19.4 8.2 13.5 8.7 5.0 24.1 0.5 0.4 4.7 ECHS1 SCEH ENSG00000127884 "Enoyl-CoA hydratase, short chain 1" P30084 10 133362480-133373689 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.2" "Cell type enhanced" "Detected in all" 11 "Hepatocytes: 1338.6;Proximal tubular cells: 2021.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003783, HPA021995, HPA022476" Enhanced Enhanced Mitochondria NA NA 1500000 Mitochondria "CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975" "unprognostic (3.68e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (2.51e-3)" "unprognostic (2.30e-1)" "unprognostic (1.82e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (1.27e-1)" "prognostic favorable (8.57e-5)" "unprognostic (2.84e-2)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" 36.5 18.7 16.6 9.1 16.6 5.0 15.2 8.2 18.3 8.8 21.8 13.0 34.7 22.8 9.5 14.1 16.5 12.2 17.4 29.8 14.6 11.5 62.1 148.2 6.3 7.8 14.8 10.3 11.6 16.3 9.2 11.0 12.8 11.1 13.9 14.0 11.0 40.2 38.4 35.7 8.8 32.1 9.9 11.9 7.3 11.0 10.2 10.2 3.9 16.2 17.5 13.0 11.2 7.8 39.4 53.7 18.3 45.7 33.5 32.1 44.5 28.9 36.3 19.8 49.3 28.7 18.6 18.1 21.3 28.2 29.8 25.2 79.7 28.1 21.8 18.5 23.9 15.6 27.2 25.7 21.6 21.6 16.7 45.0 21.8 22.0 56.6 24.2 28.1 15.5 20.7 18.7 19.7 25.2 26.5 26.3 15.9 19.6 19.2 28.9 68.6 14.0 55.0 13.8 45.9 43.6 24.2 24.0 11.6 36.8 37.1 12.8 20.3 22.0 36.6 27.7 11.9 28.5 27.2 21.1 13.4 19.5 27.9 28.0 14.4 8.8 24.8 31.9 15.4 11.1 17.0 41.7 18.3 24.9 45.7 32.1 39.4 28.1 27.1 53.7 32.2 28.9 27.9 4.4 33.5 34.3 23.2 26.0 44.5 16.6 16.6 8.2 18.3 14.6 11.5 14.8 10.3 11.1 10.2 41.7 72.4 78.2 79.8 60.7 58.8 224.4 180.9 62.9 56.9 165.7 5.9 406.8 479.1 144.4 24.0 65.0 374.4 46.7 88.5 126.6 74.8 83.9 89.0 1338.6 193.8 42.9 126.4 78.5 88.6 29.7 71.9 72.7 128.2 149.7 152.5 112.9 99.9 252.6 86.3 2021.6 42.1 84.1 76.9 50.6 40.1 66.7 250.1 49.0 276.7 103.8 ECI1 DCI ENSG00000167969 "Enoyl-CoA delta isomerase 1" P42126 16 2239395-2252300 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 90.3" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 255.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041746, HPA043227" Enhanced Enhanced Mitochondria NA NA 11000000 Mitochondria "HPA041746: AB_10960693, HPA043227: AB_10960273" "unprognostic (4.99e-2)" "prognostic favorable (3.04e-5)" "unprognostic (3.75e-1)" "unprognostic (2.92e-3)" "unprognostic (8.90e-2)" "unprognostic (2.85e-2)" "prognostic favorable (1.07e-4)" "unprognostic (1.98e-1)" "unprognostic (2.17e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-2)" "unprognostic (2.66e-2)" "prognostic favorable (8.99e-8)" "unprognostic (2.61e-2)" "unprognostic (3.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.08e-3)" 15.7 12.5 12.5 9.8 10.8 9.1 16.8 12.8 11.3 10.9 27.6 9.7 20.3 30.9 10.6 16.7 15.5 13.4 17.3 56.4 10.1 10.3 36.5 57.4 10.3 10.7 12.4 8.8 10.8 30.4 11.1 11.9 10.6 13.0 13.4 8.4 16.3 40.9 19.1 90.3 10.4 31.2 14.1 10.1 8.0 17.2 8.4 9.6 10.4 38.7 25.4 10.5 14.4 11.5 7.6 6.5 3.9 7.1 5.8 6.7 1.7 7.3 17.7 6.8 27.8 2.6 3.7 25.5 7.4 5.2 6.2 9.1 31.1 22.7 10.7 18.7 4.6 4.4 18.3 7.9 7.1 0.8 18.5 40.7 3.3 16.5 38.4 23.8 9.6 1.5 6.8 16.8 5.1 11.1 4.4 6.1 0.2 17.7 22.7 2.1 30.4 0.9 14.4 15.7 11.9 17.9 33.6 7.3 51.4 11.7 8.4 23.4 14.8 18.1 34.1 22.5 3.5 22.0 17.1 5.0 4.8 18.1 5.2 8.3 25.2 14.8 17.4 6.3 8.9 6.8 3.2 6.8 2.7 3.8 7.1 6.0 7.6 5.5 2.9 5.5 7.4 6.7 5.6 3.9 5.8 4.2 6.5 6.7 1.7 12.5 10.8 12.8 11.3 10.1 10.3 12.4 8.8 13.0 9.6 3.0 23.3 31.8 94.0 18.9 51.2 90.1 94.3 9.4 14.8 73.3 41.2 151.4 255.4 28.6 6.2 23.5 150.2 0.0 31.7 67.6 25.6 72.7 5.7 199.4 41.4 20.6 43.7 26.4 26.7 4.2 22.7 23.7 37.1 14.4 73.5 52.4 28.1 70.2 22.6 187.7 57.7 0.0 30.2 2.5 15.8 19.4 91.9 17.5 89.4 98.4 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115689-4135597 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.3" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 363.1;Proximal tubular cells: 504.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria NA NA "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favorable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 17.9 29.2 13.2 7.3 17.4 4.5 17.0 8.9 9.5 15.7 18.0 10.7 14.9 16.2 15.2 26.2 10.6 12.7 12.4 32.1 10.3 11.1 56.8 102.3 7.4 8.9 13.3 7.2 19.0 59.2 8.9 17.2 11.1 10.3 14.6 14.0 13.3 9.0 10.5 45.7 5.6 22.7 10.3 11.9 10.1 23.2 11.9 9.3 13.3 17.7 26.6 7.5 12.6 8.9 20.6 25.1 7.0 16.2 25.5 27.7 16.7 17.8 9.7 16.3 35.3 20.5 30.5 2.0 25.3 25.9 27.6 24.7 7.3 2.7 0.7 31.9 27.5 25.1 9.4 18.4 14.7 40.2 6.7 21.1 9.4 13.7 39.3 11.9 8.5 4.7 20.9 9.0 23.5 13.2 37.6 57.5 30.4 30.8 6.9 26.1 7.1 24.0 21.2 11.0 1.7 34.8 23.3 20.2 0.3 14.9 3.6 0.3 7.6 1.5 10.6 22.3 30.8 24.5 4.0 58.0 20.8 11.4 18.4 15.0 10.5 18.8 1.8 10.7 7.5 16.1 6.9 15.5 7.0 18.9 11.5 25.9 19.9 22.3 26.4 25.1 20.6 27.7 27.1 0.4 25.5 16.2 19.2 23.6 16.7 13.2 17.4 8.9 9.5 10.3 11.1 13.3 7.2 10.3 9.3 26.8 25.1 23.1 44.0 16.3 13.3 158.2 86.6 121.8 59.1 34.9 11.8 242.5 363.1 46.4 49.2 44.3 33.7 46.7 154.5 15.1 57.4 23.5 22.0 167.8 55.4 17.5 50.1 41.7 22.4 39.8 58.7 24.7 33.7 36.1 38.2 54.7 71.1 41.2 47.7 504.9 43.8 25.8 23.7 25.7 33.2 11.2 85.2 49.0 60.0 20.4 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA027241, HPA076029" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 12000000000 Cytosol Nucleoplasm "HPA027241: AB_1847976, HPA076029: " "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.20e-5)" 16.1 2.5 0.9 1.8 1.3 0.1 11.0 0.9 4.2 37.9 2.8 0.1 7.4 1.5 10.5 133.2 257.1 3.3 30.7 11.6 0.9 1.0 2.5 16.7 3.8 0.2 1.0 1.7 3.0 0.8 0.3 2.0 20.2 4.2 2.6 3.1 1.6 28.7 2.9 3.5 11.5 2.0 5.3 0.8 3.6 2.1 5.9 0.0 0.0 1.8 45.5 107.2 6.0 46.6 0.0 1.8 0.0 1.2 0.0 0.4 1.3 6.2 0.6 2.3 0.0 14.0 77.4 2.1 22.7 53.9 14.2 18.6 0.3 3.5 0.1 0.2 50.8 1.6 13.1 0.0 2.7 14.9 0.1 0.1 0.9 0.8 0.1 3.9 0.0 23.5 6.8 0.1 36.5 1.3 20.9 3.9 0.1 4.8 0.1 39.5 0.0 0.0 0.7 0.2 26.5 0.7 0.3 17.0 0.1 0.5 0.0 0.1 0.0 5.2 0.1 19.4 1.1 0.0 6.0 1.0 30.1 4.5 3.4 4.9 0.1 0.2 0.2 15.8 2.1 4.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 1.3 0.9 4.2 0.9 1.0 1.0 1.7 4.2 0.0 0.0 0.6 1.4 1.8 13.1 0.7 1.1 12.7 0.0 2.3 3.5 0.0 1.3 0.0 4.8 0.2 4.4 0.2 0.0 3.7 26.0 80.6 1.0 10.3 0.6 16.0 1.6 0.0 56.4 2.1 0.0 9.2 4.8 70.9 0.0 0.3 0.8 42.0 0.0 20.8 0.0 1.1 12.9 16.1 0.5 0.4 16.7 9.2 0.0 0.2 5.8 ECPAS "ECM29, FLJ22036, KIAA0368" ENSG00000136813 "Ecm29 proteasome adaptor and scaffold" Q5VYK3 9 111360692-111484745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 92.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 52.8;Ciliated cells: 44.2;Club cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021646, HPA059795" Uncertain Approved Nucleoplasm Yes No Nucleoplasm "HPA021646: AB_2670788, HPA059795: AB_2684127" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (7.42e-2)" "unprognostic (5.72e-2)" "unprognostic (3.81e-1)" "unprognostic (1.79e-1)" "unprognostic (1.80e-2)" "unprognostic (5.12e-2)" "unprognostic (2.02e-1)" "unprognostic (2.17e-1)" "unprognostic (9.99e-2)" "unprognostic (1.67e-1)" "unprognostic (3.72e-3)" "unprognostic (2.67e-1)" "unprognostic (1.34e-1)" "unprognostic (2.09e-1)" "unprognostic (1.05e-1)" 21.0 17.2 16.4 12.9 29.0 13.2 19.4 18.4 18.1 16.6 16.6 14.1 20.8 17.1 18.9 17.2 13.6 14.3 13.2 19.9 27.4 13.7 16.0 16.6 12.7 13.8 15.1 12.8 17.9 19.2 28.5 20.8 12.8 15.7 19.2 16.4 13.7 14.9 23.3 92.6 15.3 17.8 19.5 11.5 13.9 15.7 18.3 11.5 8.7 17.7 23.7 14.5 17.8 18.5 5.6 11.6 4.0 8.6 6.6 8.2 3.6 20.7 19.2 12.9 13.8 30.8 30.9 21.2 25.6 22.0 21.1 14.6 17.8 12.9 21.0 12.1 22.4 17.3 30.3 16.4 17.1 19.7 23.1 10.3 12.9 23.2 25.5 22.9 24.1 14.2 28.0 18.0 21.1 31.5 24.0 21.4 5.3 29.7 29.8 17.2 17.6 0.1 14.1 25.2 26.6 16.1 11.8 39.6 12.6 17.9 18.7 24.7 11.8 21.9 23.6 16.0 14.6 18.5 12.9 23.3 14.2 16.3 21.2 23.4 26.4 49.2 25.8 20.8 10.0 13.1 4.0 8.2 2.7 6.9 8.6 8.2 5.6 7.4 8.0 11.6 5.3 4.5 7.6 2.6 6.6 6.2 5.3 5.8 3.6 16.4 29.0 18.4 18.1 27.4 13.7 15.1 12.8 15.7 11.5 53.6 52.8 0.0 0.0 0.0 0.0 0.0 0.0 44.2 60.3 12.2 0.0 13.8 8.3 18.8 0.0 0.0 0.0 0.0 18.6 9.6 0.0 0.0 22.1 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 19.0 0.0 0.0 20.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 6.4 6.0 5.4 9.9 7.2 16.3 7.4 11.1 7.6 9.0 11.0 2.6 2.1 9.1 4.6 2.8 14.9 3.2 6.6 4.2 5.4 5.0 10.1 4.3 8.9 9.6 6.7 5.8 3.2 4.1 4.0 6.1 11.1 10.2 4.1 16.1 2.4 9.0 2.7 2.9 7.0 7.6 7.2 8.4 8.7 9.2 14.7 6.8 50.8 5.7 9.3 10.8 8.0 6.5 2.8 2.6 10.4 3.2 1.3 3.6 1.0 46.2 33.0 26.1 13.5 2.7 5.6 13.0 20.5 16.8 30.8 30.0 18.3 49.1 11.5 31.2 12.0 29.5 20.4 21.0 13.1 42.1 16.4 11.6 7.2 18.1 9.3 1.2 11.1 8.3 1.8 2.2 18.3 18.7 8.7 13.2 17.1 7.4 16.9 24.3 16.3 11.3 8.3 21.2 38.3 18.0 8.1 25.6 14.8 23.4 10.8 17.4 11.2 25.9 29.5 10.4 13.7 49.1 8.3 11.4 15.0 14.4 20.1 42.6 8.3 11.1 21.7 13.2 9.7 19.5 6.8 3.2 1.3 1.8 2.8 1.9 2.2 2.4 1.6 2.4 2.8 1.2 1.8 10.4 1.3 1.2 2.6 3.6 1.0 5.4 7.2 11.1 7.6 5.4 5.0 6.7 5.8 10.2 6.8 6.0 2.7 9.0 4.3 17.3 3.4 3.1 7.6 10.7 4.5 3.5 60.9 4.9 0.0 9.0 2.7 6.4 3.2 70.0 7.9 13.0 7.0 8.8 0.0 1.5 6.1 0.0 4.6 5.5 3.1 2.3 0.9 5.1 6.8 1.8 10.8 2.9 14.3 3.5 1.4 1.9 13.4 0.0 3.3 33.1 37.4 11.2 3.2 1.5 6.2 7.8 ECT2L "ARHGEF32, C6orf91, FBXO49, LFDH" ENSG00000203734 "Epithelial cell transforming 2 like" Q008S8 6 138795926-138904070 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 133.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "pons and medulla: 8.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 2.8;SCLC-21H: 2.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA035488 Uncertain NA NA "HPA035488: AB_10672865" "unprognostic (2.88e-2)" "unprognostic (7.88e-2)" "unprognostic (2.52e-2)" "unprognostic (5.53e-3)" "unprognostic (3.48e-2)" "unprognostic (8.45e-3)" "unprognostic (9.42e-2)" "unprognostic (2.44e-2)" "unprognostic (1.18e-1)" "unprognostic (7.03e-2)" "unprognostic (5.90e-4)" "unprognostic (2.32e-1)" "unprognostic (5.21e-2)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (7.07e-3)" "unprognostic (2.65e-3)" 0.5 0.3 0.7 0.2 1.1 0.5 0.4 0.8 0.7 1.1 0.3 4.2 0.0 0.2 0.6 7.7 1.0 18.5 1.7 2.7 1.1 1.1 0.1 0.2 12.2 0.2 0.3 0.0 9.4 0.1 0.3 1.8 0.2 8.1 0.3 0.1 0.8 0.6 0.2 0.5 0.7 0.6 1.6 0.3 0.3 0.3 1.2 0.8 0.0 0.4 0.0 0.1 0.8 0.3 0.6 0.3 1.7 0.6 0.7 0.8 0.0 0.2 0.1 0.2 0.8 0.0 0.5 1.2 0.0 0.0 0.1 0.1 0.8 0.8 0.8 0.3 0.0 0.3 0.3 0.0 0.0 0.9 0.2 0.5 2.8 0.2 0.0 0.1 0.9 0.4 1.3 1.0 0.0 0.0 0.6 0.0 0.2 0.2 0.9 0.0 0.3 0.6 1.0 0.6 0.2 0.6 0.5 0.3 0.2 0.0 0.7 2.9 0.7 0.2 0.8 0.4 0.5 0.3 1.2 0.0 0.6 0.3 0.8 0.3 0.4 0.2 0.3 0.4 0.8 0.2 1.7 0.3 0.6 0.3 0.3 0.4 0.3 0.2 0.7 0.1 0.6 0.7 0.8 0.6 0.7 0.6 0.3 0.2 0.0 0.7 1.1 0.8 0.7 1.1 1.1 0.3 0.0 8.1 0.8 0.0 0.6 0.0 0.5 0.5 2.2 1.2 0.0 133.8 21.6 0.0 2.0 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.3 EDAR "DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar" ENSG00000135960 "Ectodysplasin A receptor" Q9UNE0 2 108894471-108989372 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 1.4;Club cells: 1.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8" "Lineage enriched" "Detected in single" 102 "T-cells: 10.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.6;HaCaT: 14.2;OE19: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042292 Approved NA NA "HPA042292: AB_10794648" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (2.22e-2)" "unprognostic (1.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.21e-2)" "unprognostic (2.30e-1)" "unprognostic (2.53e-2)" "unprognostic (3.70e-1)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (8.83e-7)" "unprognostic (9.21e-2)" "unprognostic (5.61e-2)" "unprognostic (2.29e-1)" "unprognostic (5.03e-3)" 0.3 0.2 0.3 1.9 0.4 0.5 1.8 0.4 0.3 2.8 2.9 0.1 0.0 2.2 1.1 2.6 9.2 0.4 6.8 0.5 0.3 0.4 1.9 1.9 2.4 6.6 0.3 0.0 0.3 0.5 0.0 0.2 0.2 0.3 1.6 4.5 0.1 3.2 0.1 0.3 3.5 2.5 1.3 1.2 0.5 1.8 0.6 0.2 3.2 0.3 1.7 11.3 4.6 3.5 0.0 0.0 0.0 0.0 0.0 10.2 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 6.6 0.0 0.5 0.0 0.0 14.2 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.2 4.8 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.4 0.4 0.3 0.3 0.4 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 EDARADD ENSG00000186197 "EDAR associated death domain" Q8WWZ3 1 236348257-236502915 "Disease related genes, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 22.7;granulocytes: 20.9;Syncytiotrophoblasts: 18.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 6 "basophil: 24.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 24.6" "Group enriched" "Detected in some" 4 "HMC-1: 37.6;RT4: 30.4" "Group enriched" "Detected in some" 5 "olfactory region: 0.7;thalamus: 0.8" "Low region specificity" "Detected in many" HPA018836 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA018836: AB_1847984" "unprognostic (3.74e-1)" "unprognostic (3.10e-2)" "unprognostic (2.92e-1)" "unprognostic (2.12e-2)" "unprognostic (2.06e-3)" "unprognostic (3.12e-3)" "unprognostic (9.94e-2)" "unprognostic (2.96e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (2.57e-2)" "unprognostic (5.72e-2)" "unprognostic (3.00e-1)" "unprognostic (2.47e-1)" "unprognostic (1.90e-2)" "unprognostic (9.62e-3)" 0.9 0.4 0.5 2.4 0.5 0.2 5.8 0.3 0.4 1.1 1.1 0.1 13.7 0.2 0.9 13.0 7.2 1.0 1.3 2.2 0.4 0.4 2.5 0.6 1.7 1.2 0.5 0.0 0.7 5.5 0.0 0.4 6.4 0.1 11.3 0.2 1.7 3.6 16.6 0.3 5.7 0.7 3.6 0.4 2.9 6.4 4.0 0.2 4.5 6.4 5.3 6.8 15.6 9.9 0.1 0.3 24.6 0.2 2.9 4.0 1.1 0.0 1.8 0.1 0.0 0.0 0.0 7.7 0.0 0.0 0.7 0.4 0.4 0.0 0.0 0.0 0.1 2.0 4.2 3.0 4.5 0.7 6.0 3.6 0.0 0.0 0.6 0.0 0.1 37.6 0.0 1.3 0.5 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.3 0.1 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 30.4 0.2 0.1 0.0 0.6 0.1 0.2 7.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.6 0.2 0.0 2.1 0.2 2.7 0.1 3.2 4.0 0.3 0.1 0.3 2.1 0.2 2.9 0.1 0.0 2.9 1.1 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.0 0.1 0.2 0.0 2.2 0.8 6.8 6.2 0.0 2.8 5.1 1.4 6.8 0.0 0.0 22.7 3.3 1.2 4.8 1.8 0.0 0.0 0.8 12.0 2.0 3.1 20.9 0.0 3.1 0.0 0.0 4.3 2.7 5.8 0.3 0.7 11.8 6.4 0.0 0.4 1.0 0.0 0.4 0.2 0.0 0.0 1.7 3.1 3.4 4.5 18.9 5.0 0.0 5.8 EDDM3A "FAM12A, HE3-ALPHA" ENSG00000181562 "Epididymal protein 3A" Q14507 14 20745892-20748380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "ductus deferens: 61.8;epididymis: 129.9" "Cell type enriched" "Detected in some" 22 "Collecting duct cells: 27.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 13 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 2.9;NB-4: 3.4;SH-SY5Y: 1.5" HPA049952 Approved "Secreted in male reproductive system" NA NA "HPA049952: AB_2680970" "unprognostic (1.42e-1)" "unprognostic (9.88e-2)" "unprognostic (8.56e-3)" "unprognostic (2.10e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 61.8 0.0 0.1 129.9 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.2 14.7 0.1 0.1 0.1 0.0 0.1 0.4 0.4 4.7 0.0 0.0 0.1 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 EDDM3B "FAM12B, HE3-BETA" ENSG00000181552 "Epididymal protein 3B" P56851 14 20768427-20770948 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "epididymis: 261.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.8;NB-4: 7.2;RPMI-8226: 1.7;SH-SY5Y: 2.1" HPA001323 Enhanced "Secreted in male reproductive system" NA NA "HPA001323: AB_1848377" "unprognostic (2.40e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.1 0.1 0.2 0.1 0.0 12.9 0.0 0.2 261.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.8 0.9 0.2 0.4 0.1 0.0 0.2 0.1 0.1 3.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219957 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 57.5;lymphoid tissue: 89.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" NA NA "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 6.5 7.6 5.3 13.1 6.7 26.3 7.0 4.8 6.3 6.7 7.6 4.5 5.1 5.9 8.4 6.4 10.5 7.0 6.2 4.8 4.3 3.1 6.6 57.5 14.2 16.9 3.9 5.0 8.6 20.3 10.2 6.5 14.2 4.2 6.6 7.6 5.5 9.7 5.7 3.7 10.1 11.8 5.4 3.7 15.4 7.8 7.8 4.0 89.4 7.8 5.5 23.5 8.8 8.1 9.9 10.3 4.3 5.8 2.9 8.9 2.8 4.7 4.8 3.0 3.0 4.0 9.0 9.7 7.8 10.6 5.4 7.1 2.2 6.3 25.5 4.2 7.7 11.8 3.7 3.3 10.7 8.3 48.9 1.9 8.7 4.5 4.9 18.8 10.2 25.5 8.1 13.1 11.5 12.7 7.3 10.7 33.3 2.2 35.3 6.6 2.8 20.5 3.9 1.5 2.2 3.6 29.9 5.4 23.4 6.2 10.0 0.4 4.0 5.6 8.1 11.5 2.8 4.1 32.9 10.4 10.4 7.3 8.8 8.9 20.8 12.6 43.9 17.3 9.9 8.6 3.5 3.8 4.0 5.8 5.0 8.4 9.9 8.8 6.5 4.6 6.8 7.9 6.2 4.3 2.9 5.8 10.3 8.9 2.8 5.3 6.7 4.8 6.3 4.3 3.1 3.9 5.0 4.2 4.0 56.6 96.8 35.0 6.3 18.3 4.1 2.8 17.8 6.7 20.5 15.7 9.8 8.0 0.0 6.0 9.1 11.3 14.8 0.0 10.5 26.0 8.7 10.9 23.1 65.7 15.8 1.6 8.1 14.7 33.3 37.6 7.8 35.8 15.1 47.7 22.7 3.5 14.0 0.0 8.5 7.0 3.5 0.0 12.2 6.7 2.0 23.8 34.2 21.4 10.1 16.1 EDIL3 DEL1 ENSG00000164176 "EGF like repeats and discoidin domains 3" O43854 5 83940554-84384793 "Predicted secreted proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.3" "Cell type enriched" "Detected in many" 6 "Bipolar cells: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 105.9;LHCN-M2: 32.2;TIME: 38.1;U-2 OS: 32.4;U-87 MG: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020415 Approved "Secreted to blood" NA NA "HPA020415: AB_2670434" "unprognostic (9.93e-3)" "unprognostic (2.38e-1)" "unprognostic (2.71e-2)" "unprognostic (8.63e-2)" "unprognostic (2.22e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (9.19e-2)" "unprognostic (6.64e-3)" "unprognostic (2.98e-1)" "unprognostic (1.56e-1)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.28e-3)" 7.9 12.6 29.3 7.2 45.3 0.2 3.6 5.5 46.2 10.9 20.1 77.0 0.3 9.3 15.6 26.2 9.9 4.9 19.2 10.8 42.6 24.7 6.5 1.1 11.7 0.5 67.3 22.5 6.1 2.0 0.9 2.1 2.6 37.1 8.1 21.8 5.0 2.5 13.5 1.2 5.5 14.3 14.4 85.3 1.8 10.6 1.4 61.6 0.0 2.4 0.1 2.1 7.7 5.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.0 0.9 0.0 2.4 3.2 0.0 4.0 0.0 0.0 0.0 1.7 3.7 0.0 0.1 1.8 0.0 1.7 0.0 11.5 0.0 19.7 0.1 0.0 5.0 0.5 11.7 1.6 105.9 4.1 0.0 0.0 0.0 32.2 0.0 0.0 0.0 1.6 0.0 7.5 0.0 7.9 0.0 5.4 0.0 0.8 0.1 0.0 0.0 0.0 5.2 0.0 0.0 38.1 11.8 32.4 0.4 10.5 0.3 0.0 0.0 21.8 0.0 3.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 29.3 45.3 5.5 30.1 42.6 24.7 67.3 22.5 37.1 61.6 8.9 5.9 0.0 1.5 10.8 147.4 10.0 0.0 1.4 2.3 3.5 2.0 0.2 0.0 0.1 25.1 3.5 0.0 0.0 0.0 0.0 17.5 0.7 5.7 0.0 0.2 4.8 22.0 2.5 0.0 12.5 2.3 0.0 3.3 0.0 8.3 4.1 0.7 5.8 3.5 0.7 9.6 6.5 24.5 1.1 0.6 14.1 0.3 0.0 9.7 0.4 EDN2 ET2 ENSG00000127129 "Endothelin 2" P20800 1 41478775-41484673 "Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 27.8" "Cell type enhanced" "Detected in many" 18 "Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5" "Cancer enhanced" "Detected in many" "cervical cancer: 24.0" "Region enriched" "Detected in single" 12 "pons and medulla: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA028459 Uncertain Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA028459: AB_10602490" "unprognostic (2.71e-2)" "unprognostic (5.64e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" "unprognostic (5.44e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.81e-4)" "unprognostic (5.59e-2)" "unprognostic (1.28e-2)" "unprognostic (8.47e-2)" "unprognostic (1.76e-1)" "unprognostic (6.14e-2)" "unprognostic (3.85e-1)" 0.5 0.2 0.0 0.9 0.2 0.3 2.2 0.0 0.1 15.1 13.6 0.4 1.4 4.5 1.8 6.3 17.4 2.3 0.4 1.9 0.0 0.0 4.0 0.8 18.4 0.1 0.0 0.0 0.8 3.2 0.1 1.1 0.4 2.6 9.7 1.3 1.4 4.3 1.0 0.9 8.9 27.8 0.2 0.0 0.1 0.9 0.7 0.1 0.0 1.3 4.0 13.7 1.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 8.6 0.0 21.7 0.0 0.0 1.1 0.0 0.1 0.0 2.4 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.2 0.0 0.0 0.8 5.1 5.8 0.4 10.4 0.0 0.2 25.8 0.0 0.5 0.5 0.0 0.0 0.0 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.1 6.0 1.0 0.0 145.6 27.0 0.0 0.4 5.1 1.4 0.0 66.3 0.0 0.0 0.0 6.2 0.0 0.0 10.9 0.0 0.9 0.0 0.5 63.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.5 6.7 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.5 0.0 0.0 3.3 23.3 EDN3 ET3 ENSG00000124205 "Endothelin 3" P14138 20 59300427-59325992 "Disease related genes, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Deafness, Disease mutation, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.8;retina: 86.8;salivary gland: 37.0;vagina: 37.8" "Group enriched" "Detected in some" 4 "Enterocytes: 53.9;Paneth cells: 70.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "memory CD4 T-cell: 2.1;T-reg: 1.2" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enriched" "Detected in single" 5 "SH-SY5Y: 4.0" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 30900 "unprognostic (4.64e-3)" "unprognostic (7.87e-2)" "unprognostic (7.49e-2)" "unprognostic (2.88e-3)" "prognostic favorable (1.73e-4)" "unprognostic (1.58e-1)" "unprognostic (1.78e-2)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (4.01e-2)" "unprognostic (4.08e-2)" "unprognostic (4.48e-1)" "unprognostic (6.11e-2)" "unprognostic (1.55e-1)" "unprognostic (6.40e-2)" 0.0 1.2 1.1 0.7 2.5 0.0 3.7 0.8 3.3 22.7 21.7 2.1 0.2 20.7 2.6 3.2 9.2 0.0 1.3 0.0 2.3 1.6 0.2 0.0 0.2 0.0 1.8 1.7 0.6 5.1 0.0 20.8 0.2 3.2 3.2 8.9 86.8 37.0 0.4 0.6 0.8 35.8 1.3 1.7 3.6 0.8 1.1 0.4 0.1 33.2 1.3 0.6 0.2 37.8 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 1.1 2.5 0.8 3.3 2.3 1.6 1.8 1.7 3.2 0.4 8.9 0.3 0.0 3.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 53.9 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.3 70.2 1.8 0.0 0.2 0.0 0.3 0.0 0.1 0.3 0.0 0.0 14.4 0.1 EDNRA ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 62.6;seminal vesicle: 52.3" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 7.6 2.6 1.3 1.4 1.8 0.0 7.2 0.6 2.4 62.6 2.6 1.0 21.7 1.5 37.3 14.2 4.7 13.3 7.3 15.1 1.3 1.3 3.1 1.4 12.7 2.0 1.8 1.0 23.5 0.9 1.9 2.2 5.9 2.7 21.5 1.5 10.3 4.1 52.3 4.8 3.2 1.8 19.4 1.6 11.5 4.4 9.1 1.4 2.9 5.0 6.0 2.6 14.7 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.2 0.0 7.3 14.5 0.0 2.2 2.9 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.5 0.0 0.3 0.6 0.2 0.0 1.5 0.0 2.5 0.0 7.4 0.0 0.0 5.6 0.5 0.4 0.0 2.7 0.0 0.0 0.0 1.1 17.2 0.2 0.0 0.1 1.2 0.0 0.9 0.0 0.7 0.1 1.1 0.8 0.0 13.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.6 2.4 1.3 1.3 1.8 1.0 2.7 1.4 3.0 4.0 0.0 0.6 2.7 0.0 17.1 0.0 0.0 7.9 0.0 0.0 0.2 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.1 11.8 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 40.6 0.3 3.3 0.0 0.0 0.0 0.2 0.0 64.0 0.0 0.0 51.8 84.6 0.6 0.6 2.4 0.1 0.0 0.0 0.2 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 2.0 0.0 25.2 0.0 19.2 0.7 0.3 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 23.1 3.4 0.0 0.1 0.1 0.2 0.0 0.0 0.1 15.1 8.5 0.0 0.4 0.0 48.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 11.9 38.2 0.0 1.0 13.2 3.2 7.3 0.0 2.7 4.5 0.0 5.9 14.3 0.0 0.0 2.4 97.7 0.0 0.0 0.0 10.2 27.8 2.5 5.8 0.5 10.9 0.0 0.0 106.8 21.3 1.8 73.9 9.2 104.6 0.0 0.0 142.7 0.1 0.0 2.5 0.0 3.4 213.4 110.2 0.3 1.4 6.4 4.8 0.0 0.0 1.4 EEF1A2 "EEF1AL, HS1, STN, STNL" ENSG00000101210 "Eukaryotic translation elongation factor 1 alpha 2" Q05639 20 63488012-63499322 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 298.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 100.4;Cardiomyocytes: 108.0;Horizontal cells: 254.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 56.2;HBF TERT88: 28.3;MCF7: 46.5;SCLC-21H: 29.6;T-47d: 24.1;U-2 OS: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034019, HPA051759, HPA053862, HPA056990" Approved Approved Nucleoli,Cytosol NA NA 55000000 Cytosol Nucleoli "CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (1.40e-2)" "unprognostic (6.82e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (5.17e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.85e-1)" "unprognostic (1.68e-1)" "unprognostic (3.02e-2)" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (2.30e-1)" "unprognostic (1.86e-1)" "unprognostic (8.29e-3)" "unprognostic (1.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" 2.2 8.0 21.3 2.3 23.5 1.9 2.2 41.1 51.3 1.9 2.3 2.3 0.1 2.2 2.0 2.3 4.1 2.1 2.6 51.9 23.0 21.0 2.0 2.0 2.0 2.1 13.9 31.0 2.0 3.5 6.1 16.6 2.0 23.1 3.7 2.1 1.8 3.4 2.2 298.6 2.2 2.3 2.1 4.8 2.0 3.6 2.3 3.6 0.0 2.0 23.9 2.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.3 0.1 10.8 0.2 2.6 0.0 0.1 1.3 2.1 0.3 10.7 3.6 1.4 7.1 0.0 18.9 0.1 2.9 5.1 56.2 0.1 28.3 0.1 2.6 0.0 4.0 0.4 0.6 0.0 2.5 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.1 46.5 0.1 0.1 1.9 19.3 18.1 1.3 0.0 1.7 0.4 0.5 29.6 18.0 17.1 1.9 0.1 0.5 24.1 0.6 0.0 0.0 32.9 0.1 0.3 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 21.3 23.5 41.1 51.3 23.0 21.0 13.9 31.0 23.1 3.6 0.0 0.0 0.0 0.5 0.3 100.4 108.0 0.0 0.0 1.2 0.0 11.8 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.2 0.1 0.2 2.9 5.7 0.0 0.0 254.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 10.8 0.3 0.0 0.0 0.3 33.6 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.0 0.9 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 39.7" "Cell type enhanced" "Detected in some" 10 "Exocrine glandular cells: 10.8;Hofbauer cells: 6.6;monocytes: 15.4;Proximal tubular cells: 12.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 7 "RH-30: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" NA NA Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 9.3 6.1 3.1 3.8 3.0 1.6 10.1 3.7 3.8 8.9 5.4 2.5 8.7 2.8 10.1 8.1 6.4 7.2 8.3 3.9 2.5 1.6 10.8 6.1 7.2 5.5 2.1 2.7 10.7 34.4 6.0 3.6 4.5 3.5 7.7 3.7 6.1 39.7 14.6 2.8 6.2 3.3 7.0 2.9 3.8 6.0 4.3 1.4 1.5 8.4 5.1 6.2 7.7 6.9 0.7 3.9 1.2 5.4 1.8 10.6 2.6 1.9 3.5 1.8 2.2 5.3 5.0 1.5 2.2 4.4 3.7 3.7 2.1 3.3 1.1 2.5 3.0 2.6 1.9 1.4 1.3 3.7 1.2 2.1 5.6 1.9 3.5 4.7 1.4 2.4 5.3 3.5 3.8 4.0 6.0 3.9 5.2 3.3 8.9 2.2 1.5 1.6 3.9 1.3 1.4 3.2 3.3 59.3 3.8 2.5 2.2 1.7 2.4 3.9 2.8 2.4 1.7 4.7 3.7 3.7 5.5 3.1 2.2 2.3 1.9 0.8 1.5 4.2 6.0 3.7 0.5 3.9 0.1 2.5 1.5 10.6 0.7 4.9 2.9 3.9 0.7 2.5 1.9 1.2 1.8 5.4 2.0 3.0 2.6 3.1 3.0 3.7 3.8 2.5 1.6 2.1 2.7 3.5 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 2.7 5.0 4.7 0.0 0.0 0.0 0.0 10.8 4.0 0.0 0.0 2.3 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.4 0.0 0.0 6.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" O60344 3 184249650-184259585 "Predicted intracellular proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 29.5" "Group enriched" "Detected in some" 4 "Club cells: 5.7;Collecting duct cells: 7.0;Distal tubular cells: 13.3;Ductal cells: 14.2;Exocrine glandular cells: 13.1;Pancreatic endocrine cells: 10.0;Proximal tubular cells: 17.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.1 1.7 0.2 3.3 0.8 1.8 1.9 0.3 0.5 1.3 4.2 0.0 2.5 2.5 0.6 0.5 4.1 0.4 1.4 2.4 0.4 4.2 29.5 2.3 2.5 0.2 0.0 1.7 8.3 1.0 3.1 8.4 0.8 1.6 2.3 0.8 5.7 2.7 5.4 2.4 4.3 1.1 0.1 3.7 1.6 13.0 0.6 4.8 6.9 4.5 3.7 1.3 1.6 4.9 10.1 1.2 12.0 3.4 7.6 5.6 13.1 6.9 1.6 4.4 2.4 1.6 10.1 1.5 2.9 2.3 2.2 12.9 2.0 15.6 10.3 1.7 12.2 4.9 7.4 7.5 1.3 6.1 8.7 4.1 4.4 8.2 2.9 10.8 3.5 2.0 9.1 2.6 4.5 1.0 1.9 5.2 7.4 14.5 1.1 20.6 4.4 13.1 3.3 17.2 13.1 9.2 2.2 12.6 2.7 3.2 8.0 2.7 3.0 23.7 5.8 2.4 19.9 5.0 1.4 2.6 3.5 6.1 7.6 8.7 17.5 15.4 2.1 17.9 2.7 0.0 12.0 1.2 4.3 9.7 4.8 4.9 4.6 4.2 10.1 3.2 3.3 5.2 0.2 3.4 6.2 9.0 7.6 5.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 5.7 7.0 0.0 0.0 13.3 14.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.8 0.0 0.0 10.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" O60344 3 184249695-184293031 "Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "REH: 5.1" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 1.2 6.6 0.0 2.1 0.1 0.3 0.3 0.0 1.5 0.6 2.9 0.0 1.5 0.9 0.3 0.3 2.8 0.5 0.6 2.1 0.0 2.8 22.6 1.3 1.5 0.0 0.0 0.9 6.0 1.5 2.0 6.1 0.2 1.4 0.6 0.2 4.0 1.6 3.8 0.3 2.9 0.4 0.0 2.4 0.3 9.7 0.0 3.3 4.9 3.1 2.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EEF1G EF1G ENSG00000254772 "Eukaryotic translation elongation factor 1 gamma" P26641 11 62559601-62574086 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 334.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 310.9;Ciliated cells: 275.7;Club cells: 547.1;granulocytes: 349.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040688, HPA055316" Enhanced Approved Mitochondria NA NA 4600000 Mitochondria "HPA040688: AB_10961632, HPA055316: AB_2732593" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (2.44e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-1)" "unprognostic (9.22e-4)" "unprognostic (1.14e-1)" "unprognostic (5.14e-2)" "unprognostic (5.07e-3)" "unprognostic (1.86e-1)" "unprognostic (8.59e-2)" "unprognostic (8.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (6.04e-2)" 46.5 38.1 33.0 41.3 40.0 60.6 84.9 30.4 56.5 53.8 45.4 30.6 29.7 40.9 48.6 43.0 71.1 61.0 35.1 62.2 34.6 24.7 49.4 64.5 41.7 98.8 29.1 31.8 105.3 103.9 29.9 31.7 41.4 51.4 50.4 49.2 29.0 58.9 35.5 207.2 88.5 45.0 38.2 39.6 48.4 45.8 236.9 28.8 43.9 41.1 118.6 70.9 47.7 66.1 203.5 136.9 27.4 83.9 114.5 251.4 334.5 88.9 94.8 99.1 140.2 149.4 193.7 99.4 77.9 141.5 97.8 75.0 105.3 113.3 264.8 124.4 123.9 56.2 105.5 117.1 114.8 89.6 85.1 108.9 69.0 106.6 107.7 162.6 139.0 81.5 221.3 208.1 96.7 237.9 162.2 134.5 93.4 138.1 127.9 115.1 183.7 151.0 248.8 119.4 79.5 83.0 126.5 127.4 251.8 130.4 117.8 85.9 107.0 46.9 159.4 211.8 66.0 182.6 155.2 90.6 56.9 79.8 109.8 67.3 89.6 86.7 132.4 64.6 103.1 79.6 27.4 83.9 21.0 87.3 78.5 173.5 203.5 167.7 112.9 136.9 187.5 251.4 169.1 12.3 114.5 64.0 108.5 119.2 334.5 33.0 40.0 30.4 56.5 34.6 24.7 29.1 31.8 51.4 28.8 140.0 310.9 21.7 1.8 7.0 0.2 0.0 15.3 275.7 547.1 1.8 2.0 15.0 3.3 107.6 3.5 4.3 75.4 0.0 165.8 22.5 5.1 2.5 349.5 4.3 11.2 0.0 142.8 8.6 9.7 16.1 2.8 8.0 1.7 204.6 135.2 0.7 121.7 69.1 2.1 8.2 0.3 0.0 5.1 1.4 0.5 5.4 17.6 20.3 189.4 2.0 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Group enriched" "Detected in many" 21 "Ciliated cells: 342.6;Early spermatids: 456.6;Late spermatids: 332.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.1;ASC diff: 4.0;ASC TERT1: 9.3;CAPAN-2: 4.5;hTEC/SVTERT24-B: 3.8;SCLC-21H: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: AB_2686220" "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.6 1.5 5.4 0.5 9.5 0.9 2.5 0.2 4.1 8.1 0.8 14.0 10.3 0.9 8.6 19.0 0.9 61.9 0.9 0.6 9.1 8.4 0.6 0.9 16.5 0.5 2.7 3.9 13.7 1.8 0.4 2.0 0.8 23.9 4.2 0.7 1.9 1.8 4.6 0.5 3.5 1.1 2.7 1.4 0.6 0.8 19.7 3.0 0.0 0.5 0.3 0.6 1.4 2.1 1.0 0.0 4.1 0.0 1.1 1.1 0.3 9.1 0.0 1.2 0.0 4.0 9.3 0.0 0.1 0.9 0.0 0.3 0.0 4.5 0.0 0.0 0.2 0.0 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.3 0.3 3.8 1.6 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 2.1 7.2 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.1 1.0 0.7 0.8 0.0 0.8 0.5 0.3 4.1 1.1 0.0 0.0 0.7 0.3 5.4 9.5 0.2 4.1 9.1 8.4 2.7 3.9 23.9 3.0 0.0 5.1 0.0 6.6 6.1 0.0 0.4 0.0 342.6 18.2 0.0 0.0 0.3 0.0 0.1 456.6 0.1 0.0 0.0 1.3 0.1 1.9 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 332.2 4.4 1.2 1.7 0.0 0.0 0.0 2.0 0.0 5.3 0.0 0.0 0.0 0.8 5.7 4.4 1.6 0.2 0.0 0.0 1.8 EFCAB10 ENSG00000185055 "EF-hand calcium binding domain 10" A6NFE3 7 105565120-105600875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.0;testis: 34.9" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 275.7;Early spermatids: 163.2;Late spermatids: 68.5;Spermatocytes: 62.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA019751 Uncertain NA NA "HPA019751: AB_1848011" "unprognostic (1.20e-1)" "unprognostic (2.24e-3)" "unprognostic (8.96e-2)" "unprognostic (4.76e-3)" "unprognostic (4.11e-2)" "unprognostic (3.58e-2)" "unprognostic (3.58e-2)" "unprognostic (6.07e-3)" "unprognostic (1.47e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-3)" "unprognostic (6.87e-2)" "unprognostic (3.07e-9)" "unprognostic (2.13e-2)" "unprognostic (3.37e-1)" "unprognostic (1.15e-1)" "unprognostic (5.67e-2)" 0.4 0.8 2.0 0.9 9.6 2.2 0.3 0.7 3.7 1.5 0.7 4.2 0.0 0.7 1.3 6.2 0.9 29.0 0.5 0.5 2.9 3.5 0.7 0.7 6.4 1.0 0.7 3.5 6.9 1.6 0.2 2.0 0.4 11.8 0.7 0.5 0.0 1.0 0.2 1.3 1.4 0.8 0.2 1.1 0.9 0.8 34.9 2.3 0.0 0.7 0.0 0.3 0.8 0.4 2.9 1.7 3.7 1.2 1.4 3.0 0.6 2.1 6.0 3.2 2.1 0.6 0.3 1.4 2.9 0.0 0.0 0.1 1.1 1.4 2.9 2.6 0.1 0.6 0.8 0.1 0.0 0.0 1.1 5.4 1.5 4.1 3.3 0.4 1.9 1.9 0.2 0.0 0.2 0.0 2.0 0.0 1.4 4.4 2.4 0.1 4.5 2.1 4.1 5.3 1.4 2.2 1.4 3.3 6.3 0.3 1.3 3.1 4.2 1.7 6.2 1.0 4.4 1.2 2.2 1.6 3.1 2.1 6.4 1.9 3.4 4.0 2.7 1.8 3.0 1.5 3.7 1.2 1.0 1.9 0.9 1.7 1.6 1.9 1.6 0.7 2.9 3.0 2.2 1.4 1.4 0.9 1.7 1.2 0.6 2.0 9.6 0.7 3.7 2.9 3.5 0.7 3.5 11.8 2.3 0.0 4.1 0.0 0.1 0.0 0.7 0.3 0.0 275.7 12.5 0.0 0.0 0.0 0.0 0.0 163.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 68.5 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.3 0.1 0.0 0.0 62.1 1.9 0.0 0.1 0.0 0.0 0.0 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.9" "Group enriched" "Detected in many" 7 "Early spermatids: 451.2;Late spermatids: 287.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA051209: AB_2681389" "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 4.7 5.8 10.2 6.2 8.1 5.3 9.3 5.7 7.6 5.6 5.2 10.4 6.7 5.1 4.9 6.9 6.2 11.0 4.9 3.7 7.8 6.6 7.6 5.8 3.2 3.3 8.6 5.7 5.2 4.8 8.3 8.2 8.4 7.7 5.4 5.6 6.1 5.6 5.4 2.4 3.7 3.6 6.3 8.4 6.7 4.4 36.9 6.2 2.5 7.9 3.3 6.3 5.2 4.1 2.6 2.1 12.8 5.3 3.3 1.6 0.8 4.8 7.5 6.5 8.2 4.0 4.4 18.5 7.2 6.5 9.8 6.9 8.8 17.4 7.6 13.7 4.8 7.0 10.7 5.6 14.3 14.2 8.6 3.6 5.5 6.4 14.3 0.9 7.0 13.3 3.0 3.5 6.4 7.3 5.6 8.1 8.2 5.7 7.6 11.6 25.3 5.2 9.4 2.8 19.9 13.6 6.0 10.4 5.5 9.0 13.6 2.8 4.6 9.1 16.9 8.4 14.2 13.7 5.0 6.9 5.3 7.4 5.6 7.0 4.5 13.0 13.2 7.7 3.3 9.7 12.8 1.3 3.4 0.6 3.0 0.3 2.6 1.0 1.0 2.1 2.6 1.6 1.4 4.0 3.3 5.3 1.8 1.3 0.8 10.2 8.1 5.7 7.6 7.8 6.6 8.6 5.7 7.7 6.2 0.0 0.6 12.8 5.3 4.5 8.4 3.5 17.8 49.5 6.8 17.4 2.0 13.9 8.3 10.8 451.2 6.0 2.7 0.0 14.8 23.8 8.0 3.2 4.7 5.8 10.3 3.2 0.0 4.3 3.7 287.7 5.2 6.4 3.3 12.6 3.3 4.2 5.4 6.2 7.1 13.3 10.8 0.0 3.1 26.2 12.8 2.9 6.4 2.9 9.5 4.6 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;fallopian tube: 29.9;testis: 24.8" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 58.9;Early spermatids: 23.2;Late spermatids: 14.5" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "basal ganglia: 14.9;pons and medulla: 24.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 4.7;RPTEC TERT1: 3.8;SCLC-21H: 2.9" "Region enhanced" "Detected in many" "midbrain: 14.2" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" NA NA Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.7 0.6 2.2 0.7 14.9 1.5 0.9 1.7 3.0 2.0 0.6 7.8 0.0 0.5 1.8 10.1 0.6 29.9 1.5 0.7 4.2 4.3 1.2 2.1 3.6 0.8 0.5 3.5 6.1 1.0 3.1 15.2 0.7 24.4 4.1 0.6 1.5 0.6 0.9 0.5 0.5 0.5 0.6 1.0 0.7 1.0 24.8 1.6 0.0 2.4 0.0 0.9 0.5 0.1 1.4 0.0 1.3 0.4 0.3 0.6 0.0 0.4 2.2 0.7 2.2 0.4 0.1 0.4 0.0 0.2 0.3 0.1 0.8 1.2 0.5 0.4 0.0 0.0 0.3 0.0 0.4 0.3 0.6 0.5 0.6 0.6 4.7 0.3 0.3 0.9 0.5 0.0 0.5 0.0 0.4 0.0 1.3 1.4 0.9 0.0 0.3 0.1 1.7 0.3 0.2 0.1 0.8 0.0 0.5 3.8 0.0 2.9 0.1 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.0 0.5 1.1 0.2 1.4 1.8 2.2 0.5 0.8 0.2 0.0 0.4 0.8 0.1 0.0 0.3 0.3 0.0 0.6 0.0 1.4 0.3 0.2 1.3 0.3 0.0 0.0 0.2 0.0 2.2 14.9 1.7 3.0 4.2 4.3 0.5 3.5 24.4 1.6 3.0 1.7 0.0 0.1 0.5 0.2 1.1 2.5 58.9 2.3 0.0 2.0 0.0 0.0 0.1 23.2 0.3 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.8 0.1 4.8 0.0 0.0 0.0 14.5 0.3 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 5.2 0.0 0.0 8.2 2.5 0.3 0.0 0.0 0.0 0.1 EFCAB13 "C17orf57, FLJ40342" ENSG00000178852 "EF-hand calcium binding domain 13" Q8IY85 17 47323290-47441312 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 29.9" "Group enriched" "Detected in many" 4 "Early spermatids: 161.3;Late spermatids: 143.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "CAB002501, HPA021633, HPA023249, HPA026561" Uncertain Enhanced "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nuclear speckles" "CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596" "unprognostic (1.66e-1)" "unprognostic (3.48e-1)" "unprognostic (1.24e-2)" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.40e-1)" "unprognostic (7.43e-2)" "unprognostic (8.79e-3)" "unprognostic (8.75e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-5)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (8.10e-2)" "unprognostic (1.90e-3)" 4.1 2.8 2.9 12.2 3.4 3.4 6.5 2.8 3.8 6.5 4.7 2.3 3.5 4.8 8.9 4.4 2.4 4.2 4.1 3.5 2.3 1.5 7.5 4.0 3.1 4.3 3.6 0.4 5.5 2.8 8.4 7.6 5.4 3.2 9.3 3.4 2.6 5.4 2.0 1.3 2.2 6.3 9.9 3.5 4.6 3.5 20.0 2.7 2.4 14.9 0.7 4.3 5.5 29.9 5.6 1.0 5.3 2.1 0.8 2.6 0.8 0.9 4.0 1.7 0.2 2.1 7.3 3.1 2.2 0.5 0.7 1.2 1.7 5.6 0.3 6.6 0.8 0.0 1.1 0.0 0.4 4.0 0.2 0.6 5.2 3.3 0.5 2.1 4.0 0.6 1.3 1.9 2.7 0.0 5.0 4.5 4.1 1.5 9.9 2.4 0.1 1.7 2.3 0.9 2.8 3.2 4.7 1.3 1.8 9.2 3.2 1.2 0.6 1.2 0.1 2.6 1.3 6.6 4.7 1.6 0.3 1.3 0.4 1.1 10.2 7.0 0.9 6.3 7.8 4.3 5.3 2.1 0.6 1.1 1.2 0.9 4.3 0.9 0.6 1.0 5.6 2.6 1.2 0.0 0.8 0.7 0.4 0.1 0.8 2.9 3.4 2.8 3.8 2.3 1.5 3.6 0.4 3.2 2.7 8.9 2.1 2.0 1.7 0.7 2.3 3.8 0.0 5.3 1.2 0.0 0.0 0.2 0.0 0.7 161.3 6.3 0.5 0.0 0.7 0.2 1.3 1.0 5.8 0.8 1.7 3.2 2.9 3.7 2.1 143.2 1.7 1.3 0.0 1.8 0.2 1.1 1.2 0.0 3.5 0.8 2.6 0.0 2.3 34.1 7.9 0.5 0.0 0.0 0.6 1.0 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.5 8.3 7.1 11.2 34.0 21.4 16.3 15.8 23.3 17.5 18.1 9.9 9.9 11.7 16.5 21.4 23.7 17.6 12.1 17.4 23.8 22.2 7.8 14.6 9.2 4.0 11.7 18.8 28.8 18.9 29.2 13.9 11.6 16.8 21.3 11.4 9.0 16.7 18.0 5.7 12.4 8.5 10.1 17.2 9.4 9.5 19.9 10.2 18.5 29.6 3.7 5.1 19.5 27.6 14.8 20.1 12.3 16.5 19.6 15.0 7.3 17.4 16.0 17.2 23.8 9.4 19.2 16.2 11.0 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 68.5 69.2 34.6 40.1 28.2 30.1 33.2 45.9 45.5 45.5 108.2 29.5 31.8 26.6 31.3 50.1 52.8 51.8 0.0 33.7 27.6 35.0 57.4 96.2 51.2 37.0 44.5 36.2 46.1 67.7 14.4 43.7 41.1 25.3 34.3 62.6 50.2 37.9 57.5 46.7 30.6 17.7 25.8 28.8 37.2 23.3 38.0 49.3 41.5 41.9 98.2 EFCAB3 FLJ25818 ENSG00000172421 "EF-hand calcium binding domain 3" Q8N7B9 17 62343941-62416479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 11.3" "Cell type enriched" "Detected in some" 8 "Early spermatids: 41.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 2.1;T-47d: 2.2" "Not detected" "Not detected" HPA046862 Uncertain NA NA "HPA046862: AB_2679844" "unprognostic (2.99e-6)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.2 1.9 0.3 0.5 1.3 0.4 0.0 0.1 0.3 0.0 0.4 0.8 0.1 0.0 0.1 0.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.8 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.7 0.1 0.6 0.2 0.9 0.6 1.5 1.4 0.1 0.0 1.5 0.0 1.1 0.5 0.6 0.7 2.1 0.0 1.9 0.3 0.5 2.2 0.0 0.5 0.2 0.4 0.5 0.1 0.0 0.5 0.2 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 41.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.6 0.0 4.9 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 EFCAB5 FLJ46247 ENSG00000176927 "EF-hand calcium binding domain 5" A4FU69 17 29929200-30108452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.2;testis: 16.3" "Group enriched" "Detected in some" 12 "Early spermatids: 108.9;Late spermatids: 82.2;Spermatocytes: 53.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 4.7;eosinophil: 6.2;naive B-cell: 1.6" "Group enriched" "Detected in many" 4 "B-cells: 1.6;granulocytes: 6.2" "Cell line enhanced" "Detected in many" "MOLT-4: 4.6;RPTEC TERT1: 6.6;SK-MEL-30: 5.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (2.30e-1)" "unprognostic (3.74e-1)" "unprognostic (8.52e-2)" "unprognostic (2.40e-1)" "unprognostic (5.08e-4)" "unprognostic (3.13e-1)" "unprognostic (3.22e-2)" "unprognostic (6.77e-3)" "unprognostic (9.86e-4)" "unprognostic (7.93e-2)" "unprognostic (2.11e-1)" "unprognostic (6.74e-2)" "unprognostic (3.11e-5)" 0.5 0.5 3.2 2.6 2.0 2.5 0.5 5.9 5.4 0.5 1.9 0.5 0.0 0.4 0.5 0.5 0.5 0.5 0.5 0.9 4.3 0.9 1.1 0.4 0.6 1.2 1.7 2.8 0.4 2.6 0.2 0.5 0.4 2.7 0.5 2.6 0.4 0.5 0.2 0.6 0.8 1.1 0.7 2.0 0.6 0.8 16.3 1.8 2.6 0.7 0.0 0.9 0.7 1.7 1.6 0.0 6.2 0.2 0.3 0.9 0.0 0.7 1.0 0.8 0.0 0.8 1.3 0.0 1.3 0.3 0.1 1.0 0.0 2.0 1.1 0.7 2.0 0.8 1.0 0.3 1.3 1.3 0.4 3.8 0.0 2.4 0.9 0.6 1.2 0.8 0.0 0.0 0.2 0.1 1.7 0.4 1.7 0.1 0.3 0.0 0.0 4.6 2.1 0.4 1.0 0.0 1.6 1.8 1.7 6.6 2.7 3.1 0.6 1.9 1.1 5.3 0.8 0.0 0.4 1.2 0.2 0.8 1.0 0.0 0.1 0.2 2.0 0.4 0.5 2.4 4.7 0.0 6.2 0.2 0.2 0.2 0.8 0.3 0.6 0.0 1.6 0.6 0.2 0.2 0.3 0.0 0.0 0.9 0.0 3.2 2.0 5.9 5.4 4.3 0.9 1.7 2.8 2.7 1.8 0.0 1.3 0.8 0.2 0.2 0.4 0.6 2.5 0.0 0.0 3.5 0.0 0.3 1.7 0.0 108.9 0.1 1.0 0.0 0.2 0.1 0.0 0.2 4.7 0.2 0.2 0.0 0.0 0.6 0.0 82.2 1.7 0.9 6.8 0.0 1.0 0.0 0.3 0.0 0.7 1.0 0.2 0.0 0.0 53.1 3.8 0.0 0.0 0.0 1.0 0.3 EFCAB6 "dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672" ENSG00000186976 "EF-hand calcium binding domain 6" Q5THR3 22 43528744-43812337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.2;testis: 32.2" "Group enriched" "Detected in many" 13 "Early spermatids: 263.3;Late spermatids: 334.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.6;RPTEC TERT1: 3.8" "Low region specificity" "Detected in some" HPA003098 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003098: AB_1079087" "unprognostic (1.85e-1)" "unprognostic (8.85e-3)" "unprognostic (4.45e-2)" "unprognostic (1.04e-5)" "unprognostic (1.00e-1)" "unprognostic (4.25e-2)" "unprognostic (4.96e-2)" "unprognostic (8.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-3)" "unprognostic (3.66e-2)" "unprognostic (1.71e-3)" "unprognostic (4.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.65e-3)" "unprognostic (1.33e-2)" 1.2 1.8 3.3 0.8 4.8 0.6 2.1 1.2 4.7 2.2 1.3 3.0 8.9 1.0 2.3 9.3 1.2 11.5 2.2 1.3 2.3 2.6 2.7 1.1 2.6 0.8 1.4 2.4 4.0 2.3 5.2 17.2 0.8 5.7 1.9 0.9 5.2 1.7 4.8 1.0 1.2 0.9 1.3 1.3 0.8 1.8 32.2 1.3 0.0 5.0 0.5 0.8 1.3 1.2 0.3 0.0 0.0 1.3 0.0 0.6 0.1 0.3 0.8 1.2 1.7 1.5 5.6 0.0 1.3 1.0 0.3 0.6 0.0 0.3 0.0 0.8 0.6 2.3 1.6 0.0 0.4 1.2 0.0 0.4 0.0 0.0 0.0 3.3 0.1 0.0 1.9 2.0 1.4 0.4 1.3 0.4 0.5 0.1 0.1 0.9 3.5 0.1 0.3 1.5 1.0 0.5 0.1 0.0 0.1 3.8 0.7 2.3 0.9 3.3 0.1 1.8 1.0 0.6 0.0 0.4 1.0 0.3 1.3 0.3 0.2 0.2 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.2 0.0 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 3.3 4.8 1.2 4.7 2.3 2.6 1.4 2.4 5.7 1.3 3.0 2.6 0.0 0.8 0.2 4.0 1.4 0.0 22.7 3.4 0.0 5.9 0.0 0.0 0.5 263.3 0.0 0.0 0.0 0.6 0.1 0.3 0.5 1.1 0.0 0.2 6.4 0.0 0.6 0.0 334.9 2.8 0.0 0.0 1.0 0.4 2.0 1.1 0.0 1.4 1.0 12.9 6.5 1.0 23.2 4.7 0.1 0.1 0.0 0.2 0.1 EFCAB8 ENSG00000215529 "EF-hand calcium binding domain 8" A8MWE9 20 32858923-32961609 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "testis: 5.3" "Cell type enhanced" "Detected in single" 33 "Early spermatids: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 2.1;BJ hTERT+: 2.6;HMC-1: 2.6;Karpas-707: 1.5;U-937: 1.9" "CAB034246, HPA042751" Uncertain NA NA "CAB034246: AB_1565078, HPA042751: AB_2678145" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (7.35e-2)" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (2.16e-4)" "unprognostic (2.35e-2)" "unprognostic (1.50e-1)" "unprognostic (3.26e-1)" "unprognostic (9.35e-2)" "unprognostic (2.10e-4)" "unprognostic (4.48e-2)" "unprognostic (4.44e-10)" "unprognostic (1.66e-1)" "unprognostic (6.57e-2)" "unprognostic (2.31e-1)" "unprognostic (3.74e-3)" 0.1 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.4 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.5 1.1 0.0 0.0 0.3 0.1 5.3 0.8 0.7 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.2 0.0 2.6 0.1 0.0 0.6 0.0 0.1 0.5 0.1 0.0 0.4 0.0 0.0 0.1 0.7 0.2 0.4 0.0 0.0 0.0 0.1 2.6 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 1.5 0.0 0.1 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.3 0.7 0.1 0.0 0.7 0.2 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 EFCAB9 ENSG00000214360 "EF-hand calcium binding domain 9" A8MZ26 5 172194172-172203452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 14.2" "Group enriched" "Detected in some" 28 "Early spermatids: 69.4;Late spermatids: 23.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 1.6;NB-4: 2.4;PC-3: 1.7;WM-115: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.32e-1)" "unprognostic (6.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.42e-1)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.6 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 1.6 0.0 2.4 0.7 0.0 1.7 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 1.3 0.7 0.2 0.0 0.4 0.3 0.0 0.1 0.0 0.5 0.1 0.0 1.1 5.5 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 EFCC1 "C3orf73, CCDC48, FLJ12057" ENSG00000114654 "EF-hand and coiled-coil domain containing 1" Q9HA90 3 129001629-129040742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 34.1" "Cell type enhanced" "Detected in some" 9 "Endothelial cells: 4.6;Intestinal endocrine cells: 9.1;Leydig cells: 4.4;Peritubular cells: 7.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 3.3;HL-60: 8.7;U-266/84: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042798, HPA050888" Uncertain NA NA "HPA042798: AB_2678173, HPA050888: AB_2681263" "unprognostic (1.74e-1)" "unprognostic (5.16e-3)" "unprognostic (1.65e-1)" "unprognostic (1.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.54e-2)" "unprognostic (1.66e-3)" "unprognostic (7.23e-3)" "unprognostic (1.57e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.70e-4)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.82e-1)" "unprognostic (2.20e-1)" 3.7 0.5 0.9 4.7 0.5 0.3 1.9 1.7 1.0 2.3 4.6 0.5 2.2 4.8 5.1 2.3 1.6 0.8 34.1 1.9 1.5 0.8 1.8 0.7 12.9 0.4 0.4 0.2 6.1 0.5 0.3 1.5 1.0 2.3 2.7 1.2 1.4 1.8 1.6 2.3 1.1 3.8 5.0 0.4 6.2 4.5 0.6 0.0 0.3 2.6 3.6 0.7 2.0 2.5 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.5 1.7 1.0 1.5 0.8 0.4 0.2 2.3 0.0 0.0 1.4 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 4.6 0.0 0.0 0.5 0.0 1.6 0.1 0.0 0.0 0.1 0.0 9.1 3.1 0.3 3.9 4.4 0.0 1.7 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.0 6.5 1.7 0.2 0.5 0.4 0.1 0.0 0.0 0.1 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.3;testis: 19.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 129.8;Early spermatids: 43.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 33 "RPTEC TERT1: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078067 Approved Nucleoli NA NA Nucleoli "HPA078067: AB_2732370" "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 1.1 1.5 3.9 0.7 6.0 0.7 1.8 0.7 4.3 2.0 0.7 6.5 0.0 0.6 2.0 7.8 1.0 23.3 1.3 0.8 6.3 4.7 1.8 0.7 3.9 0.7 4.4 2.2 5.5 0.5 0.5 1.6 1.0 9.5 1.0 1.0 2.3 0.6 1.3 0.7 1.1 0.6 1.6 3.1 1.2 0.6 19.2 6.0 0.0 1.2 0.0 0.8 0.7 0.6 1.3 0.6 1.1 0.8 0.4 2.2 0.4 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 21.5 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 2.2 0.1 0.1 0.8 0.3 0.4 0.0 1.3 0.5 0.3 1.1 0.4 0.3 0.6 0.0 0.4 3.9 6.0 0.7 3.8 6.3 4.7 4.4 2.2 9.5 6.0 0.0 0.6 0.0 0.4 0.1 0.5 0.3 7.6 129.8 20.5 3.5 2.0 0.8 5.0 0.3 43.0 0.2 0.5 0.0 0.2 0.4 1.1 0.3 3.5 0.4 0.4 1.6 1.2 0.6 1.3 16.0 2.3 0.7 0.0 0.0 0.0 3.6 0.4 0.0 2.1 4.5 0.7 0.0 0.3 18.4 3.3 0.1 0.7 0.0 0.3 0.1 EFHC1 "EJM, EJM1, FLJ10466" ENSG00000096093 "EF-hand domain containing 1" Q5JVL4 6 52362123-52529886 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 49.3" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 243.6;Early spermatids: 178.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 20.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035307 Approved NA NA "HPA035307: AB_2674561" "unprognostic (2.11e-1)" "unprognostic (5.22e-2)" "unprognostic (3.31e-1)" "unprognostic (3.43e-2)" "unprognostic (2.51e-1)" "unprognostic (4.03e-3)" "unprognostic (1.60e-4)" "unprognostic (2.53e-2)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.33e-4)" "unprognostic (3.04e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (5.83e-2)" "unprognostic (3.14e-1)" "unprognostic (6.53e-2)" "unprognostic (3.27e-1)" 4.1 5.2 12.5 4.1 25.5 5.2 8.7 12.6 18.3 10.1 10.2 29.4 12.5 4.0 10.6 10.9 4.1 49.3 6.1 4.3 16.7 9.7 6.8 2.9 8.5 4.1 37.8 13.4 10.9 6.0 8.1 18.8 6.1 23.0 6.5 5.9 3.5 5.5 22.4 3.7 8.9 14.9 6.2 21.3 4.9 5.9 23.1 29.3 2.9 13.3 0.8 3.7 5.2 6.0 5.6 8.6 2.8 0.8 1.9 1.2 0.6 2.7 3.0 7.3 5.1 7.1 12.4 1.4 3.1 8.2 4.3 6.9 1.9 3.1 1.1 7.4 5.2 8.2 2.7 2.1 5.8 5.6 0.6 2.6 1.0 7.5 2.4 5.0 1.0 1.3 5.8 3.3 6.1 5.7 20.6 9.0 1.3 2.3 1.9 6.5 2.2 1.1 1.8 2.2 2.0 1.3 1.6 3.9 1.3 5.9 1.0 15.1 4.1 0.8 1.4 6.3 9.6 5.2 1.3 2.9 3.1 4.3 1.2 2.3 1.6 2.2 1.9 8.6 0.4 5.6 0.8 0.8 2.0 1.2 0.3 0.6 5.2 0.5 1.0 1.9 5.6 0.6 1.0 2.8 1.9 0.5 8.6 0.4 0.6 12.5 25.5 12.6 18.3 16.7 9.7 37.8 13.4 23.0 29.3 6.0 12.2 17.9 27.6 16.1 22.9 3.1 5.1 243.6 38.7 40.1 56.9 10.3 0.0 14.7 178.6 12.1 12.3 0.0 7.1 14.4 23.0 22.5 8.1 4.9 7.0 12.7 24.0 11.6 9.2 47.8 26.2 11.0 15.1 8.2 9.6 15.2 9.0 16.9 20.8 3.1 40.4 32.3 18.9 79.6 24.7 10.7 3.8 12.8 10.0 20.5 EFHC2 "FLJ22843, MRX74" ENSG00000183690 "EF-hand domain containing 2" Q5JST6 X 44147882-44343672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;fallopian tube: 20.8" "Group enriched" "Detected in many" 4 "Ciliated cells: 64.3;Early spermatids: 62.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "pons and medulla: 20.6" "Group enriched" "Detected in some" 5 "basophil: 14.1;NK-cell: 6.6" "Group enriched" "Detected in many" 5 "granulocytes: 14.1;NK-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.2;HEL: 5.4;HMC-1: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034492 Approved Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Plasma membrane" "HPA034492: AB_10671227" "unprognostic (1.93e-1)" "unprognostic (7.80e-3)" "unprognostic (7.35e-2)" "unprognostic (2.75e-1)" "unprognostic (6.83e-3)" "unprognostic (5.07e-2)" "unprognostic (4.29e-2)" "unprognostic (1.75e-2)" "unprognostic (3.50e-2)" "unprognostic (2.90e-2)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (7.89e-2)" "unprognostic (1.06e-1)" "unprognostic (6.13e-4)" "unprognostic (1.64e-3)" "unprognostic (4.97e-2)" 0.7 0.6 4.0 0.8 6.2 1.9 1.2 1.6 3.1 4.6 1.6 6.5 3.7 0.6 5.4 12.6 2.9 20.8 3.0 6.0 4.8 3.9 2.0 0.1 4.5 0.5 1.5 2.0 5.2 0.3 0.9 6.9 1.3 20.6 2.9 0.6 0.6 9.6 5.8 0.1 4.7 0.8 2.6 1.4 0.6 1.6 10.1 3.1 0.4 3.7 1.4 0.9 1.7 1.4 0.1 0.4 14.1 0.0 6.6 2.1 1.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.2 0.0 0.1 0.0 1.7 0.0 0.4 0.0 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 18.0 0.3 0.3 0.3 0.0 0.2 0.0 0.8 1.5 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.1 0.3 0.0 0.0 1.5 0.0 0.3 0.6 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 14.1 0.0 0.0 2.1 0.0 0.8 0.1 0.8 0.1 0.4 0.1 0.7 1.0 1.9 6.6 0.0 0.0 0.0 1.4 4.0 6.2 1.6 3.1 4.8 3.9 1.5 2.0 20.6 3.1 0.0 4.6 0.0 5.2 2.7 0.1 12.2 5.1 64.3 2.3 0.0 2.0 0.0 1.7 0.5 62.9 0.0 1.3 0.0 5.3 0.0 1.0 0.7 15.1 0.0 0.2 0.0 0.0 0.0 0.0 12.0 6.4 0.2 0.0 0.0 1.3 4.9 0.7 0.0 6.7 0.0 0.0 6.5 2.1 8.6 10.4 2.5 0.2 0.5 3.5 6.5 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.0;breast: 83.4;kidney: 75.9" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 333.2;Sertoli cells: 194.1;Smooth muscle cells: 137.2;Syncytiotrophoblasts: 220.7" "Cancer enhanced" "Detected in all" "breast cancer: 100.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.1" "Group enriched" "Detected in many" 5 "granulocytes: 6.1;T-cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 30.4;RPTEC TERT1: 16.4;SK-BR-3: 72.5;T-47d: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" No NA "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: AB_2680716, HPA056959: AB_2683288" "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 16.1 4.0 32.0 2.3 71.3 1.1 83.4 4.1 39.1 37.2 3.9 85.0 0.8 2.7 22.2 16.5 5.1 16.7 6.0 13.5 42.0 24.5 75.9 24.2 4.0 2.3 85.0 25.2 32.1 39.3 4.8 3.5 55.2 43.2 8.0 3.4 12.9 10.1 13.8 13.5 5.9 3.8 10.3 66.0 20.7 3.7 7.3 80.1 0.0 6.8 3.6 1.8 5.0 9.3 0.8 0.7 6.1 0.7 0.3 1.6 0.3 0.0 0.8 1.4 0.3 0.5 0.0 30.4 6.3 0.5 0.5 0.4 0.2 0.1 0.0 0.4 2.7 0.7 0.0 4.5 0.0 0.0 0.1 2.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 1.3 0.9 0.1 0.1 0.5 0.1 0.0 1.9 0.0 0.0 0.1 1.7 0.1 16.4 0.1 0.0 0.7 2.1 72.5 4.2 10.7 56.7 0.6 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.2 1.9 0.7 0.4 0.7 0.3 1.2 0.8 1.0 1.0 0.3 0.3 1.6 1.6 6.1 0.3 0.2 0.7 0.3 0.3 32.0 71.3 4.1 35.5 42.0 24.5 85.0 25.2 43.2 80.1 0.0 0.0 0.9 2.3 3.2 0.2 5.5 2.5 1.4 1.2 33.2 0.0 88.3 333.2 0.0 5.5 3.6 0.0 0.0 0.0 19.0 12.5 5.1 0.0 67.8 7.6 0.0 0.0 4.9 1.0 4.7 41.1 1.8 8.5 0.0 0.0 41.8 0.0 0.0 53.7 77.7 1.1 194.1 137.2 1.4 9.8 2.8 220.7 0.0 0.1 1.8 EFNA1 "ECKLG, EPLG1, LERK1, TNFAIP4" ENSG00000169242 "Ephrin A1" P20827 1 155127460-155134857 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 123.2" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 660.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "naive CD4 T-cell: 12.1;naive CD8 T-cell: 6.0" "Lineage enriched" "Detected in single" 26 "T-cells: 12.1" "Cell line enhanced" "Detected in many" "BEWO: 58.2;HaCaT: 20.4;SiHa: 33.5;SK-BR-3: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069549 Approved "Secreted to blood" NA NA 2100000 "HPA069549: " "unprognostic (5.14e-2)" "unprognostic (3.04e-3)" "unprognostic (5.03e-2)" "unprognostic (2.01e-1)" "unprognostic (1.59e-1)" "unprognostic (2.47e-2)" "unprognostic (1.78e-2)" "unprognostic (5.80e-3)" "unprognostic (1.53e-1)" "unprognostic (4.56e-2)" "unprognostic (2.00e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (1.32e-1)" 16.2 6.1 6.8 2.9 14.5 0.4 29.5 4.4 10.9 7.1 27.6 11.8 10.7 21.7 7.2 11.7 12.6 8.0 8.7 13.3 6.4 4.6 16.1 123.2 27.0 2.7 15.7 4.3 5.7 14.0 4.9 5.3 38.2 13.8 18.6 20.2 5.0 17.7 17.2 10.4 27.5 27.5 5.1 9.6 2.3 13.1 3.3 14.8 3.7 30.2 7.8 4.1 10.7 12.7 0.3 0.0 0.4 0.0 0.3 12.1 2.0 3.1 1.3 0.1 2.5 0.4 0.0 58.2 0.0 0.0 0.0 0.0 3.2 7.1 0.0 5.9 0.0 1.9 20.4 1.3 7.1 0.0 2.0 0.4 0.0 4.5 17.6 0.1 0.0 0.3 0.9 17.3 0.0 6.0 1.5 10.9 0.2 0.5 0.1 0.0 11.6 0.0 0.2 0.4 10.9 4.2 1.2 0.3 2.0 13.7 5.0 2.0 3.1 33.5 51.5 1.2 11.3 10.8 0.0 1.3 0.0 2.0 0.1 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 1.0 0.7 0.0 0.3 12.1 6.0 0.4 0.3 0.0 0.0 0.0 2.0 6.8 14.5 4.4 10.9 6.4 4.6 15.7 4.3 13.8 14.8 184.6 95.0 4.2 57.3 113.4 3.4 35.5 84.1 53.5 91.0 17.4 0.0 130.6 11.6 117.4 0.2 123.9 167.8 0.0 55.8 660.1 20.2 202.8 5.8 108.3 24.7 4.8 17.9 76.1 6.4 0.0 4.4 7.0 59.1 1.0 105.2 4.9 63.4 143.2 0.4 26.7 0.9 0.0 30.9 0.2 0.1 190.3 212.6 5.0 70.3 74.6 EFNA2 "ELF-1, EPLG6, LERK6" ENSG00000099617 "Ephrin A2" O43921 19 1286154-1300237 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.0;intestine: 30.3;liver: 14.2" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 1.3;Cardiomyocytes: 4.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;BEWO: 5.1;Hep G2: 9.5;NTERA-2: 5.5;REH: 7.3;SH-SY5Y: 17.2;U-2 OS: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067567 Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA067567: AB_2732771" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (2.87e-3)" "unprognostic (1.96e-2)" "unprognostic (4.04e-2)" "unprognostic (3.90e-1)" "unprognostic (7.19e-2)" "unprognostic (2.34e-3)" "unprognostic (3.58e-2)" "unprognostic (6.82e-2)" "unprognostic (8.48e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (1.17e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-4)" "unprognostic (1.94e-1)" 0.2 0.1 1.5 3.4 2.2 0.2 0.1 1.5 2.0 0.1 10.7 2.0 0.0 12.0 0.2 0.1 0.4 0.1 10.0 0.1 1.0 1.6 0.3 14.2 0.1 0.1 1.2 0.5 0.1 0.1 0.1 0.3 0.2 1.1 0.1 2.3 1.9 0.1 0.2 0.2 0.1 30.3 0.2 0.9 0.2 0.6 0.6 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 1.7 0.0 0.0 5.1 0.2 0.0 0.0 0.0 3.6 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.0 0.0 0.1 2.2 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 5.5 2.4 0.0 7.3 0.6 0.1 0.0 0.1 0.0 17.2 0.2 0.0 0.1 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.2 1.5 2.0 1.0 1.6 1.2 0.5 1.1 0.7 0.0 0.0 0.0 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 EFNA3 "Ehk1-L, EPLG3, LERK3" ENSG00000143590 "Ephrin A3" P52797 1 155078872-155087538 "Predicted membrane proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3;skin 1: 41.3" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 56.1;Suprabasal keratinocytes: 95.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 27.8;SCLC-21H: 16.8;T-47d: 15.7" "Low region specificity" "Detected in all" CAB010494 Uncertain NA NA "CAB010494: AB_2097783" "unprognostic (3.75e-2)" "unprognostic (1.53e-2)" "unprognostic (1.56e-2)" "unprognostic (1.51e-2)" "unprognostic (3.88e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.86e-2)" "unprognostic (3.56e-1)" "unprognostic (1.57e-1)" "unprognostic (5.14e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (9.66e-10)" "unprognostic (2.83e-3)" "unprognostic (6.38e-2)" "unprognostic (1.07e-1)" "unprognostic (1.90e-3)" 1.0 1.3 5.9 1.1 15.5 0.7 5.8 1.7 17.3 4.7 3.9 0.8 0.0 1.5 1.3 4.4 13.3 1.3 1.1 0.8 6.4 5.6 0.7 1.1 1.0 1.0 2.2 8.6 1.5 1.3 1.6 5.6 1.2 12.2 1.8 4.1 0.4 4.0 1.0 1.1 41.3 1.5 1.2 1.3 1.1 1.3 2.2 1.7 0.0 0.9 8.9 3.8 1.1 9.0 3.1 3.4 2.0 1.8 6.5 3.5 1.1 3.6 0.9 1.6 10.3 1.8 0.9 1.2 0.2 0.3 0.4 0.6 0.6 1.6 2.8 1.7 0.4 0.9 6.2 11.3 2.3 0.4 1.6 2.5 0.3 0.4 0.8 0.2 0.4 2.1 0.5 2.8 0.2 0.6 4.9 0.9 1.8 1.7 1.8 0.4 4.8 0.5 1.5 1.1 27.8 3.0 3.6 0.9 9.3 1.2 0.1 16.8 5.1 0.6 11.0 0.3 1.5 15.7 0.6 0.3 1.1 3.3 0.5 0.3 3.5 1.5 0.7 2.0 1.4 0.1 0.0 1.4 2.0 2.1 1.8 2.1 2.6 1.7 1.1 3.4 3.1 2.5 1.2 0.1 6.5 0.8 2.6 3.5 1.1 5.9 15.5 1.7 17.3 6.4 5.6 2.2 8.6 12.2 1.7 0.0 1.1 0.5 4.0 56.1 1.3 0.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 3.3 0.5 2.4 1.1 0.0 2.6 18.7 1.9 6.6 0.0 0.8 1.9 3.2 1.2 0.0 1.5 0.2 1.1 1.6 8.5 1.0 6.0 8.6 2.8 7.0 0.4 0.8 1.1 0.0 1.7 4.7 6.8 95.1 2.4 1.0 5.3 3.7 EFNB3 "EPLG8, LERK-8" ENSG00000108947 "Ephrin B3" Q15768 17 7705202-7711378 "Cancer-related genes, Predicted membrane proteins" "Differentiation, Host-virus interaction, Neurogenesis" "Developmental protein, Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.6" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 6.7;Early spermatids: 6.8;Intestinal endocrine cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 30.0;AN3-CA: 17.8;hTERT-RPE1: 18.3;SH-SY5Y: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001623 Approved NA NA "HPA001623: AB_1848026" "unprognostic (5.17e-2)" "unprognostic (7.15e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (3.27e-1)" "unprognostic (1.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.61e-1)" "unprognostic (2.64e-2)" "unprognostic (1.14e-1)" "prognostic favorable (8.21e-4)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.00e-1)" "unprognostic (8.56e-2)" "unprognostic (2.20e-2)" 1.7 2.8 10.6 1.1 26.5 0.4 4.3 1.1 34.6 4.8 1.0 4.0 0.0 0.8 12.3 1.0 2.2 6.7 1.8 1.1 10.9 19.0 1.4 2.3 1.5 0.7 3.0 11.8 3.2 1.8 1.1 3.0 1.8 4.3 2.7 1.1 1.4 1.7 1.0 0.8 6.9 1.0 4.7 1.3 0.5 1.3 2.1 2.1 0.0 1.2 0.1 1.4 2.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 30.0 17.8 0.5 0.4 0.2 0.3 3.9 2.6 1.7 1.1 1.8 0.0 0.6 1.1 0.2 0.2 7.6 3.7 1.5 0.0 3.7 0.1 0.0 0.0 0.8 0.0 0.0 1.7 0.7 0.8 0.6 18.3 0.2 0.3 0.0 0.0 0.5 2.8 0.0 0.0 2.7 0.0 0.5 0.1 0.1 0.0 4.1 0.4 1.9 15.7 0.0 0.0 0.6 5.5 1.6 0.0 0.0 1.8 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.6 26.5 1.1 26.3 10.9 19.0 3.0 11.8 4.3 2.1 0.0 0.0 0.0 4.1 3.7 0.4 1.6 0.0 6.7 1.2 0.0 0.0 0.2 0.0 0.8 6.8 0.1 0.0 0.0 0.2 0.8 2.7 1.3 1.1 0.0 0.4 4.8 6.4 3.7 0.0 4.2 4.4 0.0 0.0 0.0 0.0 1.3 0.3 0.0 3.2 0.0 0.6 0.0 0.8 0.2 0.2 2.5 0.2 0.0 0.0 0.6 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042130-25159137 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;retina: 21.1;skeletal muscle: 25.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 26.8;Cone photoreceptor cells: 21.6;Early spermatids: 15.3;Late spermatids: 37.7;Muller glia cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "AN3-CA: 9.0;BEWO: 10.6;SH-SY5Y: 9.4;SK-BR-3: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 1.9 3.2 13.1 1.7 22.9 1.3 1.3 15.5 30.5 1.4 1.7 9.4 0.0 1.4 1.8 8.4 1.3 1.8 1.5 6.9 11.4 8.7 1.4 1.1 4.4 1.3 8.7 13.5 1.4 1.3 2.4 4.1 3.2 29.9 1.5 1.8 21.1 1.1 2.0 25.1 1.7 1.3 2.6 7.8 4.3 2.2 3.5 9.0 0.0 4.5 0.2 1.1 1.4 0.7 1.0 0.6 4.4 0.5 1.0 0.7 0.1 0.1 7.1 8.4 9.0 0.5 0.1 10.6 0.9 0.2 0.4 0.1 5.7 0.3 0.1 0.5 1.2 2.9 0.5 6.6 0.0 0.1 1.3 1.6 1.4 0.3 0.5 0.0 0.1 0.7 0.1 0.0 2.0 0.1 0.6 0.2 0.2 0.1 0.4 0.2 0.8 0.2 0.4 1.7 0.1 5.7 0.6 8.0 0.2 0.1 0.2 3.5 9.4 1.0 15.8 5.1 4.9 0.8 0.1 0.5 0.5 2.4 3.6 1.7 0.6 0.7 0.1 6.5 0.1 1.7 4.4 0.4 1.1 0.7 0.3 0.5 0.6 0.4 0.6 0.3 1.0 0.4 0.7 1.7 1.0 0.5 0.6 0.2 0.1 13.1 22.9 15.5 22.7 11.4 8.7 8.7 13.5 29.9 9.0 26.8 0.6 0.0 0.6 0.0 8.6 7.4 0.0 0.0 0.0 8.7 21.6 0.0 0.0 0.2 15.3 2.0 0.4 0.0 0.7 0.1 1.0 0.7 0.0 0.0 0.8 4.8 3.5 3.7 0.0 37.7 1.1 0.0 0.0 0.0 0.0 20.0 0.5 0.0 2.5 0.1 10.3 0.0 1.4 2.1 1.9 0.1 0.1 0.0 0.3 0.4 EGF ENSG00000138798 "Epidermal growth factor" P01133 4 109912884-110012266 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 38.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;SK-BR-3: 14.9;U-251 MG: 4.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 209000 25000 "unprognostic (2.83e-2)" "unprognostic (1.02e-2)" "unprognostic (8.50e-3)" "unprognostic (1.88e-3)" "unprognostic (4.24e-2)" "unprognostic (1.64e-3)" "unprognostic (5.06e-4)" "unprognostic (8.30e-2)" "unprognostic (2.21e-3)" "unprognostic (4.25e-2)" "unprognostic (1.80e-2)" "unprognostic (2.95e-1)" "unprognostic (7.72e-3)" "unprognostic (4.64e-5)" "unprognostic (2.63e-1)" "unprognostic (9.80e-5)" "unprognostic (3.92e-3)" 0.8 0.1 0.4 0.0 0.4 0.0 5.9 0.1 0.9 0.2 0.2 0.3 0.3 0.0 0.3 2.6 0.9 0.2 0.3 2.3 0.8 0.3 48.4 0.0 0.6 0.0 1.2 0.7 0.0 41.2 0.0 0.4 0.0 1.4 0.6 0.4 3.9 8.4 0.1 19.8 0.5 0.2 1.9 0.6 0.2 0.0 0.2 0.2 0.0 1.2 4.5 0.4 0.4 0.5 0.0 0.4 1.7 0.0 0.0 0.0 2.6 0.2 0.3 2.4 0.1 0.0 0.1 0.0 0.6 1.5 0.8 0.5 0.1 0.1 0.0 8.2 0.8 2.1 0.0 0.3 0.0 0.6 0.1 0.4 0.1 0.9 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.2 0.8 0.1 0.0 0.0 2.9 0.0 0.6 0.2 0.1 0.7 0.7 0.2 0.0 0.0 0.0 14.9 0.5 1.8 3.5 0.0 0.0 1.3 2.0 0.0 4.7 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 2.6 0.4 0.4 0.1 0.9 0.8 0.3 1.2 0.7 1.4 0.2 0.0 0.0 0.0 0.1 0.9 0.6 6.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 2.2 0.0 0.4 0.0 4.9 0.0 0.0 1.5 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 38.3 1.6 0.0 0.0 1.2 1.1 0.0 0.0 0.5 0.3 1.3 0.0 0.0 1.6 0.1 EGFL6 MAEG ENSG00000198759 "EGF like domain multiple 6" Q8IUX8 X 13569605-13633575 "Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 137.5" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 17.4;Cytotrophoblasts: 12.5;Fibroblasts: 9.4;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 9.6;NTERA-2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001838 Enhanced "Secreted to extracellular matrix" NA NA "HPA001838: AB_2666457" "unprognostic (1.66e-1)" "unprognostic (1.32e-2)" "unprognostic (9.15e-3)" "unprognostic (3.76e-3)" "unprognostic (1.77e-2)" "prognostic favorable (9.73e-4)" "unprognostic (4.13e-3)" "unprognostic (1.37e-1)" "unprognostic (5.19e-3)" "prognostic favorable (4.95e-4)" "unprognostic (2.39e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-9)" "unprognostic (7.10e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.82e-3)" 16.1 0.1 0.3 0.2 0.2 0.1 2.3 0.0 0.2 0.4 4.1 0.0 0.1 0.2 0.5 0.4 3.3 0.6 1.5 0.6 0.1 0.7 0.2 0.1 18.6 0.2 0.1 0.1 0.2 0.3 0.1 1.7 137.5 0.9 0.6 0.2 27.1 0.2 0.1 0.1 0.4 0.2 2.0 0.6 0.2 0.4 0.2 0.0 0.0 0.2 0.2 0.4 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.1 0.7 0.1 0.1 0.9 0.0 0.0 1.3 0.0 1.3 0.9 4.9 0.3 0.0 17.4 6.8 0.0 0.0 12.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 8.1 9.4 0.1 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 7.3 0.0 0.2 0.4 22.1 0.0 0.0 3.8 EGFL7 ZNEU1 ENSG00000172889 "EGF like domain multiple 7" Q9UHF1 9 136658856-136672678 "Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 112.4" "Group enriched" "Detected in many" 7 "Endothelial cells: 251.2;Hofbauer cells: 218.0;Ito cells: 521.1;Spermatogonia: 179.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 2.6;eosinophil: 4.2;intermediate monocyte: 7.7;non-classical monocyte: 6.2;plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 20 "dendritic cells: 7.1;granulocytes: 4.2;monocytes: 7.7" "Cell line enhanced" "Detected in many" "EFO-21: 39.9;HUVEC TERT2: 70.6;RPMI-8226: 27.7;TIME: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050716 Approved "Secreted to extracellular matrix" NA NA "HPA050716: AB_2732562" "unprognostic (1.72e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (9.76e-3)" "unprognostic (5.03e-1)" "unprognostic (1.03e-1)" "unprognostic (4.31e-3)" "unprognostic (4.39e-2)" "unprognostic (1.14e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (4.09e-2)" "unprognostic (4.49e-2)" 54.8 11.2 17.7 9.0 23.7 8.7 34.2 8.5 23.6 19.7 10.3 7.2 17.4 9.3 28.9 19.7 9.5 14.6 17.5 31.0 18.0 12.7 24.3 10.6 46.9 12.0 21.5 8.1 7.5 9.7 5.7 10.5 112.4 27.5 13.7 3.5 19.9 21.3 16.1 29.3 14.1 9.9 10.9 10.4 41.1 7.4 11.4 17.6 0.2 20.7 16.2 4.9 10.7 55.3 0.1 7.1 4.2 7.7 0.2 0.3 3.4 0.0 9.6 3.1 11.2 0.2 0.2 7.2 2.7 0.5 1.6 0.5 3.3 9.0 0.0 39.9 0.9 2.5 1.3 0.8 1.7 0.0 15.9 3.0 5.9 0.7 0.2 2.5 0.0 8.7 0.3 0.7 0.8 0.0 0.5 70.6 0.4 21.3 0.0 0.5 17.2 0.1 0.1 4.5 13.3 0.5 18.9 1.2 27.7 1.0 0.2 2.0 6.7 1.3 1.2 2.5 0.9 3.3 9.1 65.9 0.4 8.2 0.9 0.5 0.0 0.0 0.1 0.0 0.0 8.1 0.0 2.6 4.2 0.1 7.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 1.1 0.2 6.2 7.1 0.0 3.4 17.7 23.7 8.5 23.6 18.0 12.7 21.5 8.1 27.5 17.6 0.0 40.6 8.9 4.8 10.5 1.1 15.4 5.1 0.0 2.3 3.5 0.0 2.9 6.6 21.4 2.1 251.2 1.7 0.0 1.6 13.3 17.6 15.2 19.7 15.3 218.0 3.2 1.2 521.1 30.4 6.8 8.1 8.2 18.6 0.0 2.8 1.3 8.5 1.1 5.6 16.8 1.6 12.9 13.3 3.6 179.3 8.3 5.0 2.5 0.0 3.1 EGFL8 "C6orf8, NG3" ENSG00000241404 "EGF like domain multiple 8" Q99944 6 32164583-32168281 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;Hep G2: 3.6;NB-4: 3.0;SK-MEL-30: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061173 Uncertain Approved "Nuclear speckles,Vesicles" "Secreted - unknown location" NA NA Vesicles "Nuclear speckles" "HPA061173: AB_2684443" "unprognostic (7.13e-2)" "unprognostic (1.86e-1)" "unprognostic (6.79e-3)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (7.60e-4)" "unprognostic (3.42e-2)" "unprognostic (2.49e-1)" "unprognostic (6.42e-3)" "unprognostic (1.97e-1)" "unprognostic (7.60e-3)" "unprognostic (8.11e-3)" "unprognostic (1.07e-4)" "unprognostic (1.11e-1)" "unprognostic (6.79e-2)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" 4.5 6.3 7.3 2.6 7.6 4.5 5.0 6.3 9.4 7.1 6.7 8.4 8.7 4.7 6.4 5.5 4.3 4.8 8.4 4.8 8.2 4.4 4.3 1.8 4.3 2.0 25.7 3.9 14.4 2.9 1.3 2.9 9.2 14.1 6.0 2.7 14.7 3.9 5.3 3.8 12.9 5.8 3.0 11.9 3.5 3.9 2.3 7.0 0.2 3.1 8.3 2.0 5.2 6.8 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.3 1.3 3.2 0.4 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.2 0.0 0.0 2.0 1.3 0.4 0.0 0.0 1.9 0.0 1.0 3.6 1.1 0.0 0.7 0.0 0.3 0.3 0.0 0.1 0.7 2.2 0.3 0.0 0.0 1.7 1.0 3.0 0.0 0.3 0.0 1.1 0.1 0.0 0.2 0.6 0.5 1.2 0.0 0.1 3.7 0.0 1.4 2.2 0.0 0.8 1.7 0.0 0.1 0.0 0.1 0.1 0.1 1.1 1.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 7.6 6.3 9.4 8.2 4.4 25.7 3.9 14.1 7.0 6.0 5.5 0.0 0.6 1.3 1.4 0.1 0.0 2.7 2.3 1.8 2.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.2 0.3 0.8 0.6 0.0 0.0 0.2 0.0 0.0 2.5 0.3 0.0 3.4 0.0 0.0 0.0 1.0 1.1 0.2 0.0 1.1 0.0 1.1 0.0 1.2 0.4 0.4 1.9 0.7 0.0 1.2 0.4 EGFLAM "AGRINL, AGRNL, FLJ39155, PIKA" ENSG00000164318 "EGF like, fibronectin type III and laminin G domains" Q63HQ2 5 38258409-38465021 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.7" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 113.9;Leydig cells: 143.8;Sertoli cells: 84.1;Smooth muscle cells: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 7.2;HBEC3-KT: 8.7;hTERT-HME1: 11.6;HUVEC TERT2: 11.1;LHCN-M2: 25.6;U-2 OS: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066577 Approved "Secreted - unknown location" NA NA "HPA066577: " "unprognostic (2.05e-1)" "unprognostic (4.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-3)" "unprognostic (1.08e-2)" "unprognostic (3.63e-3)" "unprognostic (6.31e-2)" "unprognostic (2.83e-1)" "unprognostic (2.08e-2)" "unprognostic (1.71e-3)" "unprognostic (1.12e-1)" "unprognostic (5.80e-2)" "prognostic unfavorable (4.47e-5)" "unprognostic (7.02e-6)" "unprognostic (2.60e-1)" "unprognostic (9.90e-2)" "unprognostic (1.04e-2)" 18.6 10.4 0.8 3.1 2.6 0.0 25.9 1.5 0.7 7.8 4.0 1.5 5.1 0.8 9.3 9.2 6.3 3.9 4.0 7.8 0.6 1.1 4.8 3.5 1.5 11.0 1.3 0.6 16.6 1.4 2.1 3.0 25.7 3.5 9.9 1.5 19.8 6.6 11.1 54.7 2.9 2.3 3.5 2.2 8.1 1.8 9.1 1.3 4.9 4.6 19.4 4.2 6.0 6.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 4.6 0.1 0.5 0.1 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.1 7.2 0.0 0.1 0.0 0.0 8.7 0.0 0.0 1.1 0.0 4.1 0.0 2.0 0.0 0.0 3.9 0.0 0.0 11.6 0.0 11.1 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.7 0.0 2.6 0.1 1.0 0.0 0.1 0.0 0.1 11.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.6 1.5 0.7 0.6 1.1 1.3 0.6 3.5 1.3 0.0 0.0 0.0 0.2 2.4 1.0 2.0 0.0 0.0 0.0 0.0 113.9 0.4 3.3 0.4 41.7 3.3 0.0 0.0 0.9 0.4 12.7 0.2 0.0 0.0 0.6 0.0 0.0 1.3 0.0 39.1 143.8 0.6 5.0 0.0 0.0 1.5 0.9 0.0 29.0 2.9 30.1 84.1 78.8 8.1 3.1 1.8 0.5 0.0 0.0 0.3 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "A-431: 345.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 4740000 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 4.4 1.1 1.5 7.1 4.4 1.2 3.4 4.6 2.1 1.6 0.8 3.7 0.2 0.8 2.9 9.0 13.9 0.0 15.3 2.5 0.1 0.2 0.0 1.9 0.2 1.8 0.0 0.0 2.1 14.0 5.3 28.6 3.1 0.2 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.3 1.3 2.2 0.0 0.6 0.0 2.6 3.7 0.0 1.3 2.9 3.5 0.7 1.2 0.3 0.8 1.0 1.9 0.5 14.9 3.2 0.0 0.3 0.2 2.6 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 89.3 37.5 4.2 67.7 76.2 1.5 7.3 53.5 16.0 59.1 21.0 5.9 207.2 0.0 30.6 4.6 10.9 15.9 23.3 21.0 36.6 45.3 37.8 0.0 77.4 24.2 0.0 4.1 6.7 7.0 2.2 118.8 1.3 16.9 2.8 25.3 106.1 41.7 17.3 125.5 14.0 2.3 77.6 23.1 1.6 2.7 78.5 315.1 0.0 20.0 46.4 EGLN1 "C1orf12, HIFPH2, PHD2, SM-20, ZMYND6" ENSG00000135766 "Egl-9 family hypoxia inducible factor 1" Q9GZT9 1 231363751-231425044 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 14.9;skeletal muscle: 46.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 14.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 14.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022129 Approved NA NA "HPA022129: AB_1848046" "unprognostic (4.20e-1)" "prognostic unfavorable (2.99e-7)" "unprognostic (8.86e-2)" "unprognostic (1.26e-1)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.20e-1)" "unprognostic (3.87e-3)" "unprognostic (1.91e-1)" "unprognostic (3.99e-1)" "unprognostic (6.63e-2)" "unprognostic (9.71e-2)" "unprognostic (3.82e-2)" "unprognostic (1.23e-1)" "unprognostic (1.55e-1)" "unprognostic (5.65e-2)" "unprognostic (1.81e-2)" 4.9 4.2 4.4 1.4 4.5 0.8 3.5 3.6 4.3 3.0 3.3 3.9 3.1 2.6 3.5 2.3 2.9 7.0 4.4 3.5 5.2 7.2 1.6 1.6 4.1 4.1 4.4 5.5 2.1 4.4 2.6 2.8 2.3 3.5 46.9 5.6 3.9 2.8 4.1 3.0 2.0 1.3 2.8 1.8 2.5 2.7 0.6 0.7 14.9 1.4 0.7 1.1 0.3 13.5 13.0 4.2 8.0 11.0 7.6 4.6 6.7 9.8 9.3 12.8 9.5 10.8 4.1 11.7 9.5 7.1 6.8 5.9 7.8 16.5 5.8 14.8 2.0 5.4 8.1 7.8 9.6 2.7 6.0 7.2 6.3 7.8 13.6 12.1 4.4 9.2 7.7 8.8 2.6 2.3 3.6 5.0 8.2 7.3 5.0 5.8 5.0 11.8 4.8 4.2 11.3 8.3 10.9 22.0 2.8 5.8 27.5 14.3 10.9 6.0 10.9 12.5 19.1 11.6 3.7 15.2 3.6 15.2 4.1 0.6 2.5 0.7 0.9 0.5 0.6 0.8 0.6 0.7 0.6 0.9 1.1 14.9 0.7 1.4 0.6 0.6 0.3 17.9 21.0 17.1 13.9 52.0 29.6 107.6 71.4 9.4 10.3 17.4 35.3 14.4 29.9 33.2 0.9 34.6 39.6 0.0 31.0 19.9 31.2 15.1 9.3 63.5 14.7 58.8 12.2 28.8 20.9 3.4 15.0 24.1 25.3 8.2 24.3 55.9 37.0 28.6 21.5 37.2 42.8 19.4 30.9 8.6 21.6 50.3 8.7 18.1 19.3 17.0 EGLN3 "HIFPH3, PHD3" ENSG00000129521 "Egl-9 family hypoxia inducible factor 3" Q9H6Z9 14 33924231-34462774 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 49.6;skin 1: 44.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 189.9;Cardiomyocytes: 91.5;Suprabasal keratinocytes: 202.4;Syncytiotrophoblasts: 86.2" "Cancer enhanced" "Detected in all" "renal cancer: 50.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 19.0" "Lineage enriched" "Detected in many" 16 "dendritic cells: 19.0" "Cell line enhanced" "Detected in many" "RH-30: 18.1;RPTEC TERT1: 15.5;RT4: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064895 Supported Cytosol NA NA Cytosol "HPA064895: AB_2685384" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" "unprognostic (1.75e-1)" "unprognostic (8.87e-2)" "unprognostic (6.88e-2)" "unprognostic (1.38e-2)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.39e-3)" "unprognostic (3.44e-2)" "unprognostic (1.79e-1)" "unprognostic (2.93e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.37e-1)" "unprognostic (5.21e-2)" "unprognostic (4.71e-2)" "unprognostic (6.30e-2)" 6.3 0.8 12.9 4.8 10.6 0.4 6.0 3.0 11.9 7.3 14.3 13.4 4.9 19.3 5.9 2.8 10.4 5.4 7.8 49.6 10.9 7.3 6.1 2.4 3.0 3.0 10.7 8.1 2.5 6.5 0.4 1.5 19.6 9.9 9.9 11.3 3.5 4.2 11.3 9.7 44.1 21.7 11.7 9.7 2.8 19.9 1.0 12.5 3.4 1.2 1.3 5.3 25.6 16.1 0.0 19.0 1.2 0.0 0.8 1.0 0.6 12.0 3.1 0.3 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.3 0.0 4.1 0.0 0.3 0.3 6.0 11.7 0.0 1.2 3.2 3.2 8.9 0.4 0.0 0.0 0.1 1.6 5.9 0.0 0.0 0.0 0.0 0.9 6.4 0.0 0.1 1.0 0.2 0.0 9.8 10.4 1.1 0.0 18.1 4.3 15.5 48.6 2.5 2.8 0.8 4.7 1.3 7.7 4.8 0.0 0.0 0.1 1.3 0.0 0.7 0.1 2.6 0.0 2.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.8 1.9 0.0 0.1 0.0 0.1 0.8 0.0 19.0 0.0 0.6 12.9 10.6 3.0 9.8 10.9 7.3 10.7 8.1 9.9 12.5 0.0 1.1 0.5 43.6 189.9 4.5 91.5 5.1 22.7 1.2 8.7 2.0 4.2 8.3 14.2 1.1 18.4 46.6 0.0 6.0 63.3 14.3 12.5 1.1 0.0 2.7 1.6 15.5 12.9 1.0 4.7 2.3 3.8 38.8 1.0 24.2 10.5 32.3 25.2 0.7 14.0 2.0 0.0 7.2 0.5 0.3 202.4 86.2 1.5 10.0 11.9 EGR2 KROX20 ENSG00000122877 "Early growth response 2" P11161 10 62811996-62919900 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 57.1" "Cell type enhanced" "Detected in many" 10 "Intestinal endocrine cells: 70.2;Macrophages: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5;non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "U-87 MG: 22.9" "Group enriched" "Detected in many" 10 "amygdala: 2.5;basal ganglia: 3.8;cerebral cortex: 4.9;hippocampal formation: 4.1;olfactory region: 3.0" "Group enriched" "Detected in many" 4 "basal ganglia: 3.7;cerebral cortex: 6.6;hippocampal formation: 5.1;midbrain: 3.0;olfactory region: 9.8" HPA031165 Supported Nucleoplasm NA NA Nucleoplasm "HPA031165: AB_2673768" "prognostic favorable (7.30e-5)" "unprognostic (1.86e-3)" "unprognostic (1.45e-2)" "unprognostic (8.72e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (2.70e-1)" "unprognostic (1.75e-1)" "unprognostic (9.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (2.47e-3)" "unprognostic (6.54e-2)" "unprognostic (1.74e-2)" "unprognostic (3.46e-1)" "unprognostic (1.11e-3)" 9.4 4.7 1.8 8.3 9.2 2.7 7.8 1.2 9.9 8.5 2.9 18.7 0.5 0.7 5.8 25.5 3.5 6.1 13.1 16.1 3.3 1.6 3.0 5.2 15.7 5.3 6.0 1.2 7.6 2.2 3.9 10.6 4.9 7.5 7.6 1.5 7.8 3.1 1.3 1.2 15.9 3.1 6.7 3.1 3.6 3.0 4.3 0.7 22.7 57.1 5.0 11.5 8.2 2.4 1.2 1.1 1.5 5.5 0.5 0.4 0.6 0.0 0.2 2.5 1.0 1.8 2.5 0.4 0.5 0.2 0.6 0.8 0.0 0.3 0.6 0.0 0.6 0.7 0.3 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.6 3.9 0.3 0.6 1.3 0.2 0.8 0.1 0.3 0.2 0.8 0.1 1.2 0.0 1.7 0.2 0.1 1.3 0.1 0.3 0.4 0.0 0.2 0.1 0.3 0.2 0.8 4.0 0.5 0.0 0.5 0.1 0.6 0.4 0.2 0.3 1.4 0.6 0.3 22.9 0.5 0.4 0.0 1.1 0.4 0.4 5.5 0.0 1.0 0.0 0.2 1.1 1.2 0.0 0.4 1.5 0.5 5.3 0.0 0.0 0.6 1.8 9.2 1.2 9.9 3.3 1.6 6.0 1.2 7.5 0.7 0.0 18.8 0.5 8.5 18.9 0.9 4.8 0.0 4.0 0.0 0.0 0.0 1.3 0.0 0.9 6.3 2.1 6.9 0.0 0.6 1.1 14.4 7.8 19.7 1.5 22.6 0.0 70.2 5.5 12.4 3.1 1.7 30.3 8.5 1.0 16.6 1.7 0.8 5.8 6.7 0.0 0.5 6.5 4.4 0.1 1.1 10.9 0.9 4.4 14.3 0.8 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693302 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 102.0;Intestinal endocrine cells: 272.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6;HMC-1: 7.5;MCF7: 24.5;SK-MEL-30: 16.4" "Group enriched" "Detected in many" 10 "amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2" "Group enriched" "Detected in many" 9 "amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 20.7 17.7 11.5 12.3 33.6 5.6 7.1 0.8 35.0 7.4 3.3 11.1 0.2 0.9 3.8 1.0 4.0 14.6 20.6 8.5 13.7 2.0 3.0 2.0 4.1 7.3 1.9 12.8 10.6 2.9 12.8 5.0 1.2 3.6 10.3 2.2 2.6 2.3 4.0 1.6 28.4 3.6 8.3 1.6 2.8 5.3 4.1 2.1 5.5 5.8 1.3 5.8 12.3 2.5 0.8 0.0 2.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 1.5 4.6 0.1 0.4 0.5 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.3 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.5 0.4 0.2 0.2 0.0 0.6 0.1 0.1 0.2 0.1 0.0 24.5 0.0 0.2 0.1 1.7 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.4 0.0 16.4 0.2 1.1 0.0 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.0 0.7 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 11.5 33.6 0.8 35.0 13.7 2.0 1.9 12.8 3.6 2.1 6.0 18.6 7.5 26.7 20.5 1.6 35.5 0.0 2.7 3.4 0.0 0.0 1.2 0.0 2.5 19.0 17.5 0.9 0.0 3.9 1.1 23.9 18.9 102.0 0.4 3.7 0.0 272.8 20.9 12.3 6.2 2.8 11.0 20.3 0.0 12.8 3.0 2.6 2.9 0.4 0.0 1.1 0.0 23.7 0.0 0.2 43.7 8.1 0.0 4.3 3.1 EGR4 "NGFI-C, PAT133" ENSG00000135625 "Early growth response 4" Q05215 2 73290929-73293705 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 20.0" "Cell type enriched" "Detected in some" 10 "Intestinal endocrine cells: 95.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028983 Enhanced NA NA "HPA028983: AB_10603665" "unprognostic (7.75e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-4)" "unprognostic (2.43e-3)" "unprognostic (2.68e-2)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (5.20e-2)" "unprognostic (4.00e-1)" "unprognostic (2.29e-4)" "unprognostic (2.41e-1)" "unprognostic (1.75e-2)" "unprognostic (3.20e-2)" "unprognostic (1.77e-1)" "unprognostic (1.21e-2)" "unprognostic (4.07e-3)" 1.1 0.8 4.9 1.0 15.9 0.9 0.6 17.2 20.0 0.6 0.6 1.2 0.0 0.5 0.6 0.5 0.6 0.6 0.6 0.6 8.8 1.9 0.6 0.6 0.6 0.6 0.3 4.4 0.6 0.5 0.6 2.3 0.6 0.0 0.7 0.6 0.0 0.5 0.5 0.6 0.6 0.6 0.6 0.3 0.6 0.7 4.9 2.6 0.0 0.5 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 15.9 17.2 20.0 8.8 1.9 0.3 4.4 0.0 2.6 0.0 0.0 0.5 1.6 2.4 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.2 2.0 9.2 0.0 0.2 0.0 95.4 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.4 0.0 3.0 1.9 0.7 0.0 0.1 0.1 EHBP1L1 "DKFZp762C186, TANGERIN" ENSG00000173442 "EH domain binding protein 1 like 1" Q8N3D4 11 65576038-65592650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.8" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 70.0;Kupffer cells: 72.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039479, HPA073476" Enhanced NA NA 25000 "HPA039479: AB_10795678, HPA073476: " "unprognostic (1.87e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.84e-1)" "unprognostic (2.41e-3)" "unprognostic (2.35e-1)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.36e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.10e-3)" "unprognostic (5.02e-2)" "unprognostic (3.50e-2)" "unprognostic (1.10e-1)" 11.7 3.3 3.7 21.1 5.7 19.9 7.9 2.4 2.9 17.5 30.7 3.6 15.5 10.1 20.9 16.6 22.5 15.1 29.7 14.3 3.9 2.3 5.4 3.6 12.0 17.9 5.9 2.1 9.7 2.7 2.6 3.3 8.1 6.1 17.7 5.1 11.2 7.2 16.9 87.8 6.8 17.6 50.3 4.5 32.4 14.6 3.7 4.2 7.9 4.2 36.2 19.4 27.8 19.7 0.3 0.6 2.8 1.9 0.1 0.4 0.2 14.9 15.6 0.5 8.4 4.2 10.6 3.1 11.9 8.8 5.7 3.0 5.2 13.3 5.2 20.0 17.3 16.0 21.1 2.9 11.3 1.3 14.2 0.4 12.1 18.2 4.4 4.0 2.6 11.4 9.0 7.7 14.4 2.6 10.5 5.8 8.0 18.4 21.6 5.2 12.9 4.5 10.2 0.7 5.6 13.0 12.2 0.1 17.3 5.3 7.6 0.3 6.6 6.6 5.9 12.0 1.2 8.4 12.7 9.9 15.8 16.8 22.1 0.2 37.4 23.4 2.7 23.6 7.1 9.2 0.3 1.5 0.1 0.4 1.9 0.2 0.3 0.2 0.1 0.5 0.1 0.1 0.2 2.8 0.1 0.8 0.6 0.1 0.2 3.7 5.7 2.4 2.9 3.9 2.3 5.9 2.1 6.1 4.2 0.0 8.6 17.0 7.5 9.0 1.5 16.9 5.1 9.4 9.1 1.8 0.0 3.0 0.0 3.3 0.1 21.2 32.9 70.0 4.5 1.0 11.3 8.3 2.3 3.4 28.2 0.0 4.1 15.4 72.0 0.2 10.6 28.8 6.8 15.4 14.6 0.9 17.2 25.1 35.7 0.5 0.8 25.8 27.4 1.0 5.7 12.9 2.2 15.3 11.5 13.3 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234337-31269447 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.4;esophagus: 29.1" "Cell type enriched" "Detected in many" 5 "Ito cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 17.8;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 9 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "BJ: 25.6;BJ hTERT+: 63.5;HEL: 24.6;U-266/70: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" NA NA 41000000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.7 7.1 15.0 5.6 16.3 2.0 3.3 10.6 37.4 5.6 2.2 7.3 0.0 1.9 3.9 3.4 29.1 4.9 3.6 14.8 16.7 8.9 15.0 10.8 4.8 6.3 9.6 21.6 2.9 1.4 8.7 6.0 11.3 13.3 5.7 2.1 2.8 4.8 4.9 2.3 3.0 2.9 4.8 9.4 5.8 1.9 1.6 6.6 1.2 2.5 1.5 10.4 7.8 4.2 17.8 0.4 1.0 1.9 0.6 1.7 7.8 0.5 2.7 1.5 1.3 2.5 3.9 0.2 25.6 63.5 2.5 2.3 0.0 0.3 0.2 0.9 8.4 2.2 0.2 0.0 1.7 1.8 1.0 2.3 24.6 0.1 0.0 8.8 0.0 0.0 6.2 0.7 2.4 1.0 6.7 0.0 0.0 0.0 0.1 1.8 4.0 0.3 0.0 5.8 0.0 1.3 0.8 0.1 0.5 1.9 2.9 0.7 3.9 0.2 0.4 0.0 4.9 0.3 0.0 0.0 1.9 1.8 0.1 2.0 15.9 2.0 0.0 4.9 0.0 4.0 0.4 0.4 0.3 1.7 0.8 0.9 17.8 0.9 1.1 0.4 4.4 0.8 0.4 1.0 0.6 1.9 0.0 0.4 7.8 15.0 16.3 10.6 32.7 16.7 8.9 9.6 21.6 13.3 6.6 0.0 0.0 23.6 1.4 0.7 9.2 18.9 2.5 0.0 1.2 0.0 0.0 3.5 0.0 0.3 0.0 5.2 0.0 0.0 0.2 7.3 2.3 0.8 0.0 0.8 1.4 0.0 1.7 172.5 21.8 0.0 1.1 0.2 0.0 1.0 0.0 8.1 0.2 0.0 2.8 0.2 5.4 19.4 3.3 0.2 2.1 0.6 36.7 2.5 0.0 3.2 EHF "ESE3, ESEJ" ENSG00000135373 "ETS homologous factor" Q9NZC4 11 34621093-34661057 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 340.0;Ciliated cells: 235.5;Club cells: 254.8;Urothelial cells: 370.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "myeloid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 34.8;HaCaT: 23.9;HBEC3-KT: 26.3;OE19: 29.4;RT4: 53.2;T-47d: 53.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050923, HPA060734" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" No NA Nucleoplasm "Golgi apparatus" "HPA050923: AB_2681275, HPA060734: AB_2684351" "unprognostic (1.06e-2)" "unprognostic (1.06e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.82e-1)" "unprognostic (5.62e-2)" "unprognostic (1.22e-3)" "unprognostic (2.44e-1)" "unprognostic (2.04e-1)" "unprognostic (1.38e-1)" "unprognostic (6.79e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.24e-1)" "unprognostic (2.89e-1)" "unprognostic (7.08e-2)" 0.8 1.0 0.8 9.3 0.9 0.0 32.1 0.7 0.7 19.3 16.0 0.5 152.4 6.9 4.5 21.4 69.0 23.0 22.1 0.7 0.9 0.9 11.6 1.6 9.9 0.1 1.5 0.3 4.7 10.5 0.2 0.9 0.5 1.4 20.7 22.3 0.2 118.0 161.8 0.7 12.8 10.1 1.7 3.3 0.7 10.1 1.4 0.5 0.4 1.2 50.3 59.7 13.7 30.3 0.0 4.9 0.0 0.4 0.0 0.0 0.2 11.4 6.7 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.1 34.8 0.0 4.4 0.0 0.0 23.9 0.0 26.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 29.4 0.2 0.0 0.0 0.2 4.7 53.2 0.0 0.0 0.1 3.6 0.0 0.0 53.9 0.1 0.0 0.0 0.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.9 0.7 0.7 0.9 0.9 1.5 0.3 1.4 0.5 44.7 66.1 0.0 340.0 97.3 0.0 0.4 43.3 235.5 254.8 52.4 0.0 0.0 13.3 55.4 8.4 0.2 36.0 0.0 76.2 0.0 1.9 138.5 1.1 0.6 0.1 0.0 22.3 0.0 0.0 0.0 0.0 5.3 11.8 9.0 45.3 3.9 68.8 28.8 0.0 0.1 0.0 0.0 2.3 0.1 0.0 148.7 1.1 0.0 33.6 370.0 EHHADH ECHD ENSG00000113790 "Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase" Q08426 3 185190624-185281990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 37.1;liver: 91.2" "Group enriched" "Detected in many" 7 "Hepatocytes: 227.5;Proximal tubular cells: 124.0" "Group enriched" "Detected in all" 7 "liver cancer: 42.2;renal cancer: 25.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036401, HPA042021" Enhanced NA NA "HPA036401: AB_10670165, HPA042021: AB_2677801" "unprognostic (1.20e-1)" "unprognostic (5.99e-2)" "unprognostic (2.17e-3)" "unprognostic (2.69e-2)" "unprognostic (6.82e-2)" "unprognostic (1.48e-1)" "unprognostic (4.79e-3)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (3.89e-2)" "unprognostic (3.19e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-5)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.96e-2)" "unprognostic (2.80e-1)" 4.1 1.2 1.2 1.7 1.4 0.1 1.5 0.5 1.2 1.7 6.4 0.8 0.4 5.2 1.0 2.0 2.9 0.8 3.0 3.2 1.2 0.9 37.1 91.2 1.9 1.0 1.7 0.7 0.8 2.5 2.7 0.9 1.3 2.1 1.7 2.6 8.3 2.7 0.4 0.7 1.1 9.9 1.0 1.4 1.7 2.4 0.9 0.9 1.4 2.1 1.7 1.2 1.8 1.0 1.5 6.0 0.2 2.2 2.7 2.7 1.1 8.3 3.5 1.0 0.0 5.3 4.5 1.1 4.0 1.2 2.6 3.0 15.2 5.3 0.0 15.9 4.0 1.0 4.1 0.0 3.3 5.5 11.1 3.7 5.9 0.9 15.4 3.5 0.7 0.1 6.4 4.3 2.7 2.4 3.6 3.8 0.0 3.8 4.3 5.0 4.3 0.1 3.5 2.1 3.0 4.4 0.0 7.1 0.3 11.0 4.7 3.2 4.6 7.8 4.6 7.3 9.1 16.8 6.9 1.8 1.7 2.6 1.3 0.3 1.2 3.8 0.3 0.6 2.6 2.8 0.2 2.2 0.0 1.6 2.1 1.0 1.5 1.1 2.4 6.0 0.2 1.6 2.7 0.1 2.7 2.0 2.4 1.4 1.1 1.2 1.4 0.5 1.2 1.2 0.9 1.7 0.7 2.1 0.9 14.9 7.5 13.7 1.5 1.3 0.2 17.9 25.5 4.0 4.5 19.2 3.9 7.2 16.6 2.0 0.1 2.8 13.8 0.0 5.9 2.1 1.5 1.8 0.0 227.5 3.7 0.0 7.5 12.3 12.4 0.0 0.6 1.3 3.3 15.4 11.6 1.7 3.3 8.6 0.4 124.0 0.9 0.0 2.0 3.9 4.1 0.4 1.1 3.2 10.6 1.6 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24, autophagy associated transmembrane protein" O14681 11 125569216-125584687 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 164.6" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 494.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 13.4 10.2 13.3 8.9 16.2 4.6 16.7 11.2 22.1 12.7 17.0 14.4 13.8 11.3 13.6 12.9 22.7 12.1 15.8 16.4 10.6 10.7 14.6 55.5 12.1 11.2 12.0 11.1 13.1 34.2 164.6 9.2 11.9 11.0 13.7 18.9 13.2 20.9 14.3 26.5 17.2 16.1 15.9 9.2 10.5 17.7 10.4 10.5 9.9 12.0 14.2 13.0 16.2 12.9 8.5 15.5 5.4 7.3 6.5 10.0 4.9 24.5 18.7 21.4 25.8 35.2 26.8 26.8 25.2 19.1 17.4 15.7 28.4 49.7 24.7 42.9 23.7 18.5 28.4 32.5 53.0 22.6 6.5 20.6 117.9 13.4 26.6 26.2 26.6 12.8 25.0 48.6 26.1 38.7 17.2 36.7 13.5 53.5 10.1 24.4 17.3 12.1 13.6 28.2 63.6 20.5 17.8 25.3 21.0 29.0 44.0 20.0 19.2 29.5 35.2 9.5 37.0 71.9 26.5 30.5 22.4 15.2 15.7 20.4 6.3 12.7 32.2 9.8 40.8 29.8 4.1 7.3 5.4 8.2 7.0 8.1 8.5 6.5 10.0 11.6 7.3 9.4 7.6 0.9 6.5 5.1 15.5 9.0 4.9 13.3 16.2 11.2 22.1 10.6 10.7 12.0 11.1 11.0 10.5 29.8 34.7 29.8 114.2 107.2 57.4 55.7 129.9 9.4 27.3 104.7 35.3 140.6 122.7 154.4 19.7 84.2 53.8 0.0 158.4 174.0 83.1 141.9 27.6 494.9 92.4 77.9 94.5 65.1 44.4 33.9 66.2 50.8 86.0 34.3 100.9 68.5 153.1 52.6 67.8 102.8 30.5 45.3 89.6 92.8 109.0 158.6 117.2 35.1 116.3 136.4 EID2B "EID-3, FLJ38944" ENSG00000176401 "EP300 interacting inhibitor of differentiation 2B" Q96D98 19 39530990-39532854 "Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.7" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 29.5;Horizontal cells: 30.2;Rod photoreceptor cells: 28.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064185 Approved NA NA "HPA064185: AB_2685207" "unprognostic (1.15e-1)" "unprognostic (8.53e-3)" "unprognostic (6.41e-3)" "unprognostic (1.08e-3)" "unprognostic (4.00e-1)" "unprognostic (7.08e-2)" "unprognostic (9.92e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.57e-4)" "unprognostic (6.80e-2)" "unprognostic (1.77e-1)" "unprognostic (1.02e-2)" "unprognostic (1.78e-1)" "unprognostic (2.77e-1)" "unprognostic (4.20e-2)" 3.7 7.9 9.6 4.1 20.7 2.5 3.4 17.3 16.3 3.7 3.4 4.5 2.1 2.9 7.1 6.2 2.8 6.3 2.9 6.2 8.6 14.6 3.7 1.3 3.7 6.1 6.6 12.6 11.4 3.2 3.4 10.4 2.6 9.1 4.4 2.4 5.6 3.1 4.7 3.9 2.1 2.7 3.6 4.9 5.4 3.1 7.7 5.1 3.6 7.7 1.2 3.3 2.9 2.7 5.2 3.5 5.4 3.0 6.8 10.3 3.1 2.4 5.1 5.8 6.4 3.8 3.6 1.3 3.8 3.0 6.4 5.9 0.8 1.6 5.0 2.2 2.4 3.2 0.8 2.9 2.6 4.7 7.6 7.9 2.2 5.7 3.0 3.3 2.2 4.0 3.5 1.9 3.6 1.9 2.4 2.8 11.2 2.4 7.1 3.1 2.2 4.3 3.9 1.5 0.9 2.8 5.7 5.5 2.4 3.1 0.8 8.1 5.0 7.7 0.3 3.0 2.5 0.7 1.2 1.9 4.8 8.5 4.6 4.9 5.2 7.3 3.5 2.6 5.2 2.5 0.6 2.7 5.4 4.5 2.8 4.2 5.2 5.3 6.4 3.5 5.2 10.3 6.7 0.9 6.8 3.0 3.4 3.3 3.1 9.6 20.7 17.3 14.3 8.6 14.6 6.6 12.6 9.1 5.1 6.0 0.6 9.9 0.8 1.3 29.5 3.5 0.0 10.7 10.3 8.7 23.6 2.6 10.0 3.4 1.5 2.8 0.0 0.0 2.6 0.9 4.5 0.5 4.6 1.0 3.2 30.2 5.8 1.8 4.3 0.4 14.1 4.0 8.5 3.6 0.0 20.1 1.8 0.2 10.6 3.7 28.8 12.9 4.8 22.4 8.6 0.5 0.7 8.7 0.0 0.3 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 69.1" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 291.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5" "Cell line enhanced" "Detected in many" "A549: 10.2;BJ: 9.5;BJ hTERT+: 7.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.8;HeLa: 8.6" "Low region specificity" "Detected in single" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA059367: AB_2683992" "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 1.7 1.7 2.0 2.9 2.7 3.0 1.7 4.0 2.6 1.6 1.8 1.5 0.2 0.6 2.1 1.9 1.3 1.8 1.8 1.2 1.9 1.9 1.2 0.9 1.8 3.7 1.2 2.3 3.4 1.7 0.9 5.3 1.1 2.2 2.7 0.6 1.7 1.3 4.1 1.5 1.6 1.6 1.6 1.2 1.9 1.4 69.1 1.6 2.3 1.0 0.4 2.5 1.5 1.3 2.9 0.5 0.7 1.5 6.6 9.5 2.6 0.3 10.2 0.3 1.0 2.3 2.4 2.0 9.5 7.8 4.6 7.8 0.2 0.5 0.1 0.1 2.1 2.1 0.2 0.3 0.8 6.8 0.6 0.1 1.9 8.6 1.5 3.4 0.2 0.5 3.2 0.0 2.9 0.6 0.4 0.7 0.4 0.1 0.6 2.8 0.1 3.4 1.4 0.5 0.2 2.0 0.3 0.0 0.1 2.5 0.3 0.1 0.0 6.3 0.4 0.2 0.2 0.0 0.0 1.4 0.1 0.3 2.3 0.4 0.5 0.2 0.1 0.2 0.0 1.0 0.0 0.3 0.5 5.2 1.5 5.5 2.7 6.6 6.2 0.3 2.9 9.5 5.7 0.7 6.6 0.9 0.5 7.6 2.6 2.0 2.7 4.0 2.6 1.9 1.9 1.2 2.3 2.2 1.6 0.0 5.9 2.9 50.8 11.8 3.4 1.1 0.0 4.0 1.2 1.8 25.5 2.0 0.0 2.4 44.2 5.2 1.3 0.0 1.2 1.1 8.0 25.2 1.1 1.7 1.7 11.1 0.0 6.2 4.0 12.9 8.1 6.1 1.7 5.4 0.0 7.6 5.0 0.2 4.2 1.0 17.5 6.5 8.2 291.8 33.6 6.8 2.1 10.2 0.7 39.4 EIF1 "A121, EIF-1, EIF1A, ISO1, SUI1" ENSG00000173812 "Eukaryotic translation initiation factor 1" P41567 17 41688885-41692668 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 310.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 245.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (1.62e-1)" "unprognostic (7.13e-2)" "unprognostic (4.45e-2)" "unprognostic (1.50e-2)" "unprognostic (1.39e-1)" "unprognostic (5.01e-2)" "unprognostic (1.09e-1)" "unprognostic (4.23e-3)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.45e-4)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (2.62e-1)" "unprognostic (3.63e-3)" 82.5 56.0 51.7 44.2 59.6 197.5 80.3 43.2 63.7 53.0 55.1 54.5 43.6 54.6 54.7 33.1 55.5 46.0 46.9 86.0 48.2 41.8 51.4 70.8 51.3 72.4 87.8 55.0 68.1 104.6 35.3 51.6 44.0 67.8 44.8 32.3 43.7 92.7 45.9 310.6 54.2 47.2 67.3 63.5 52.8 61.2 54.7 68.3 44.4 46.2 78.7 41.4 60.3 80.6 48.0 42.4 138.7 61.5 30.3 60.0 68.8 29.0 15.3 17.7 16.7 35.8 33.3 17.1 38.9 27.9 21.4 21.1 8.9 21.0 39.5 31.0 29.4 22.3 36.9 23.7 26.4 20.8 41.8 20.2 20.7 7.9 13.1 74.5 32.7 41.2 40.0 51.3 29.1 71.8 31.6 21.0 31.8 32.8 61.0 20.1 8.1 38.4 20.9 15.2 245.2 29.4 19.5 38.1 39.0 18.8 13.9 21.9 28.1 23.5 43.9 85.0 17.7 30.8 23.8 32.8 21.1 32.4 43.9 38.6 90.6 75.0 31.9 30.0 20.6 26.5 138.7 50.8 63.8 38.9 61.4 48.1 48.0 52.9 45.3 42.4 45.2 55.7 47.7 52.8 30.3 61.5 42.3 60.0 68.8 51.7 59.6 43.2 63.7 48.2 41.8 87.8 55.0 67.8 68.3 753.4 886.8 1390.4 4108.6 2734.6 854.2 990.2 1113.4 793.7 881.5 736.2 292.6 1250.0 3549.6 1767.3 2008.3 1676.7 1511.8 1097.9 2683.6 1846.9 1569.0 2512.5 1233.6 1181.4 2190.1 759.6 925.2 1234.4 2588.9 4341.4 1258.2 2516.3 2314.7 2944.2 1211.8 969.4 2095.4 1742.9 903.7 2154.1 766.2 944.3 2181.7 1140.5 702.9 2563.8 3307.9 1614.3 1237.8 4568.8 EIF1AY ENSG00000198692 "Eukaryotic translation initiation factor 1A, Y-linked" O14602 Y 20575725-20593154 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 78.3;skeletal muscle: 124.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 345.1;Erythroid cells: 467.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.9;HEL: 46.5;U-266/84: 32.9;U-698: 74.6" HPA002561 Uncertain Supported Approved Cytosol NA NA Cytosol "HPA002561: AB_1078724" "unprognostic (4.31e-2)" "unprognostic (3.74e-1)" "unprognostic (2.14e-3)" "unprognostic (2.68e-2)" "unprognostic (1.12e-2)" "unprognostic (2.89e-2)" "unprognostic (4.18e-2)" "unprognostic (2.17e-2)" "unprognostic (4.10e-2)" "unprognostic (8.53e-3)" "unprognostic (2.89e-1)" "unprognostic (6.03e-2)" 5.9 8.3 7.0 18.6 8.3 29.2 5.0 4.5 10.9 0.0 12.6 10.0 22.2 9.0 0.1 20.2 9.9 0.0 10.5 78.3 6.5 10.4 9.1 23.0 13.3 22.8 8.2 0.0 0.1 15.0 0.2 11.4 10.3 13.4 17.4 16.1 8.8 13.1 22.9 124.6 4.2 17.9 28.2 9.2 45.8 6.5 13.1 0.0 28.7 6.2 48.9 15.9 8.9 0.0 22.1 23.0 44.5 8.0 7.8 11.9 5.0 0.1 5.5 0.0 0.0 0.0 0.0 11.6 12.3 8.3 8.6 8.5 0.0 0.0 37.9 0.0 6.5 0.0 0.0 0.0 0.0 11.8 20.4 0.0 46.5 0.0 13.8 8.5 0.0 0.0 4.6 9.4 0.0 0.0 0.0 0.0 12.8 0.0 0.0 13.7 0.0 30.0 0.0 8.2 0.0 0.0 0.0 15.5 15.1 12.0 14.4 11.0 0.0 0.0 0.0 8.4 16.5 0.0 6.5 12.2 6.6 0.1 0.0 13.3 22.9 32.9 74.6 2.5 0.0 0.0 10.0 6.7 9.3 5.2 7.7 7.3 19.2 9.5 6.1 5.7 22.1 11.9 9.0 44.5 7.8 8.0 23.0 10.9 5.0 7.0 8.3 4.5 10.9 6.5 10.4 8.2 0.0 13.4 0.0 29.8 47.1 119.4 60.3 48.5 15.1 345.1 22.9 49.5 51.2 50.6 9.8 109.0 74.6 30.4 26.6 37.2 2.6 467.2 0.3 42.0 36.5 59.3 86.9 0.9 30.7 6.4 17.0 39.3 60.3 8.8 39.7 51.5 64.1 79.4 12.1 66.9 34.6 8.6 41.1 80.0 20.6 38.8 56.6 53.4 88.1 44.3 77.6 62.3 1.0 56.7 EIF1B GC20 ENSG00000114784 "Eukaryotic translation initiation factor 1B" O60739 3 40309684-40312424 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 156.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.54e-1)" "unprognostic (1.06e-2)" "unprognostic (1.31e-2)" "unprognostic (3.20e-3)" "unprognostic (7.64e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.02e-2)" "unprognostic (1.13e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.33e-1)" "unprognostic (1.23e-1)" "unprognostic (1.82e-1)" "unprognostic (8.87e-2)" 21.9 35.7 36.1 17.3 39.2 70.4 36.2 42.4 57.5 20.5 21.8 20.1 11.9 15.6 24.9 23.8 16.3 24.4 23.3 156.7 39.4 40.5 36.5 34.3 21.6 22.7 35.1 43.0 38.0 22.7 28.9 43.7 19.8 58.6 19.9 16.6 17.0 17.5 22.9 52.1 14.3 17.9 23.9 53.7 20.0 21.1 31.7 24.7 12.7 22.7 16.0 21.6 23.4 21.0 31.3 24.3 44.7 18.7 12.9 19.0 12.9 10.3 8.5 29.1 16.5 35.2 34.6 17.4 21.3 28.1 21.1 27.6 13.3 14.1 21.4 11.9 14.5 12.7 7.1 19.8 10.4 21.6 32.3 20.1 34.4 9.1 30.4 56.0 20.7 17.8 25.1 32.2 18.6 31.9 30.0 22.2 14.5 28.7 26.5 24.4 6.6 16.6 22.5 39.4 9.2 22.7 11.5 16.2 17.2 20.6 13.3 12.4 20.4 15.4 9.0 57.1 28.8 11.4 21.1 17.0 12.2 12.7 24.7 14.8 24.6 43.4 31.0 15.3 22.8 17.4 24.3 16.4 43.7 13.0 18.7 15.5 31.3 16.0 16.5 15.0 29.2 19.0 16.4 44.7 12.9 17.2 24.3 18.8 12.9 36.1 39.2 42.4 57.5 39.4 40.5 35.1 43.0 58.6 24.7 86.4 63.3 142.5 178.7 168.9 98.3 402.0 73.9 78.9 54.6 83.7 51.1 96.0 248.7 84.2 121.0 94.4 91.5 210.2 99.3 99.2 140.4 90.8 128.0 63.6 111.8 141.4 112.7 92.1 138.5 56.3 100.9 134.4 141.7 129.0 77.2 134.9 73.1 164.9 86.3 216.1 189.9 90.5 167.9 467.4 251.4 129.2 96.7 111.5 78.2 186.4 EIF2S3B "eIF-2-gamma2, eIF2gA" ENSG00000180574 "Eukaryotic translation initiation factor 2 subunit gamma B" Q2VIR3 12 10505602-10523135 "Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 8.1" "Cell type enhanced" "Detected in some" 23 "Club cells: 2.3;granulocytes: 1.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.4;Hep G2: 3.5;HL-60: 7.9;MOLT-4: 6.8;RH-30: 5.1;U-251 MG: 4.1" NA NA "unprognostic (2.23e-1)" "unprognostic (6.09e-2)" "unprognostic (1.03e-2)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (9.02e-2)" "unprognostic (7.67e-2)" "unprognostic (2.56e-1)" "unprognostic (2.58e-4)" "unprognostic (4.95e-2)" "unprognostic (2.29e-1)" "unprognostic (3.24e-2)" "unprognostic (9.45e-3)" "unprognostic (2.73e-1)" "unprognostic (4.39e-1)" 0.9 1.0 0.0 0.9 0.1 0.6 0.8 0.4 0.3 1.7 0.9 3.8 2.2 0.1 1.8 0.8 0.7 0.6 0.0 0.0 0.9 0.6 0.8 0.4 0.0 2.3 2.0 0.1 0.1 0.3 0.3 0.1 1.0 0.2 1.6 0.9 1.9 0.4 0.2 0.6 2.0 8.1 0.6 0.1 2.5 1.2 0.8 1.2 0.4 1.0 0.7 1.7 0.7 0.2 0.0 0.1 2.4 0.5 1.2 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 7.9 2.1 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.1 0.0 5.1 0.2 0.0 0.2 1.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 4.1 0.2 3.1 0.4 2.9 0.0 0.0 0.3 0.6 0.1 0.5 0.9 1.7 0.8 0.9 0.7 1.2 0.3 1.1 1.4 0.4 0.7 1.0 0.1 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 EIF3J "eIF3-alpha, eIF3-p35, eIF3j, EIF3S1" ENSG00000104131 "Eukaryotic translation initiation factor 3 subunit J" O75822 15 44537057-44563029 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050977 Approved Approved Cytosol NA NA 8600 Cytosol "HPA050977: AB_2681297" "unprognostic (4.47e-2)" "unprognostic (1.28e-1)" "unprognostic (7.68e-2)" "unprognostic (3.76e-2)" "unprognostic (1.72e-3)" "unprognostic (1.47e-3)" "unprognostic (2.33e-2)" "unprognostic (1.41e-2)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "unprognostic (3.43e-3)" "unprognostic (1.39e-2)" "unprognostic (1.97e-1)" "unprognostic (4.76e-1)" "prognostic unfavorable (4.96e-5)" 23.7 17.8 24.7 21.0 21.9 16.4 22.8 16.6 23.1 15.6 18.4 13.2 20.5 17.7 15.8 17.2 28.0 11.9 14.8 36.8 22.8 23.7 23.3 46.3 14.7 18.3 26.3 19.2 15.0 35.1 17.3 22.9 22.9 31.6 17.1 20.0 6.9 27.0 25.4 134.3 18.9 16.6 18.6 29.0 20.9 18.4 14.7 20.9 17.0 19.2 27.3 24.9 23.0 20.6 26.7 33.2 22.6 19.2 28.2 23.9 6.4 22.5 12.0 19.7 12.3 14.1 14.2 24.2 35.8 10.6 24.9 17.0 38.1 13.8 20.9 42.2 15.0 23.7 42.8 31.6 22.8 30.6 23.4 16.0 47.6 29.7 24.1 26.4 51.0 21.2 12.6 30.6 17.2 33.7 15.3 26.8 23.7 61.8 27.5 22.3 15.9 25.6 34.8 12.0 42.9 19.7 29.9 33.9 31.1 28.4 27.0 26.7 16.4 33.0 31.4 19.8 17.3 26.3 42.3 31.6 27.1 32.2 29.1 48.0 32.8 61.7 52.8 18.9 55.7 25.6 22.6 19.2 16.8 17.4 18.3 21.0 26.7 23.2 22.3 22.2 24.7 22.8 23.9 7.7 28.2 16.3 33.2 23.6 6.4 24.7 21.9 16.6 23.1 22.8 23.7 26.3 19.2 31.6 20.9 56.6 49.9 94.2 75.5 155.6 53.4 84.7 117.2 50.9 87.6 137.9 19.6 122.2 164.2 124.7 123.5 94.8 95.5 23.3 127.9 138.5 81.8 61.2 124.7 370.0 99.0 41.3 112.5 102.5 88.2 85.7 84.3 75.4 57.3 96.4 107.9 41.1 136.6 97.1 66.8 158.9 63.2 45.3 85.9 219.1 126.3 150.4 206.6 73.5 113.9 75.3 EIF4E1B FLJ36951 ENSG00000175766 "Eukaryotic translation initiation factor 4E family member 1B" A6NMX2 5 176630682-176646641 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 8.9;epididymis: 5.6" "Group enriched" "Detected in some" 9 "Bipolar cells: 4.4;Cardiomyocytes: 12.4;Cone photoreceptor cells: 15.7;Horizontal cells: 11.1;Rod photoreceptor cells: 17.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "T-47d: 8.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA045045 Approved NA NA "HPA045045: AB_2679197" "unprognostic (6.54e-2)" "unprognostic (1.53e-2)" "unprognostic (7.44e-2)" "unprognostic (5.26e-2)" "unprognostic (1.86e-1)" 0.2 1.0 3.4 0.2 1.4 0.5 0.3 4.0 8.9 0.2 0.2 0.0 0.0 0.2 0.2 5.6 0.2 0.4 0.2 0.3 3.6 2.3 0.3 0.2 0.2 0.2 2.3 2.4 0.2 0.2 0.2 0.8 0.3 0.7 0.2 0.2 1.0 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.2 1.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.4 4.0 8.9 3.6 2.3 2.3 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 12.4 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 EIF4EBP1 "4E-BP1, PHAS-I" ENSG00000187840 "Eukaryotic translation initiation factor 4E binding protein 1" Q13541 8 38030341-38060365 "Cancer-related genes, Predicted intracellular proteins" "Translation regulation" "Protein synthesis inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7;salivary gland: 109.8" "Cell type enhanced" "Detected in many" 10 "Exocrine glandular cells: 638.8;Pancreatic endocrine cells: 291.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005032, CAB005039, HPA023501" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095" "unprognostic (1.55e-2)" "unprognostic (2.45e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (8.86e-4)" "unprognostic (6.94e-2)" "unprognostic (2.69e-1)" "unprognostic (1.94e-2)" "unprognostic (3.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.16e-2)" "unprognostic (3.18e-3)" "unprognostic (7.21e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.98e-2)" "unprognostic (3.01e-1)" "unprognostic (4.57e-2)" "unprognostic (5.72e-3)" 17.7 3.4 2.5 4.9 3.6 9.2 21.7 1.8 3.2 5.5 15.4 2.0 7.7 6.2 5.3 2.1 22.2 5.0 7.0 9.4 2.2 1.8 6.0 39.6 6.9 7.4 4.3 1.4 9.3 94.7 1.7 2.2 8.7 2.8 7.4 4.6 2.8 109.8 8.0 38.4 4.9 9.0 7.1 4.2 9.3 10.6 3.0 2.7 2.7 3.7 12.6 9.2 11.3 11.1 16.3 41.3 31.3 53.5 4.0 7.6 28.0 20.5 10.6 3.1 18.5 4.0 3.5 13.7 22.8 10.7 12.4 19.8 7.0 5.3 8.0 15.9 11.3 7.5 11.0 10.4 18.6 7.4 6.2 33.7 47.1 4.8 9.7 42.0 15.2 7.6 9.8 30.4 13.7 25.7 3.9 19.8 5.5 25.7 21.5 5.2 12.9 13.3 37.0 23.1 10.4 42.9 11.7 13.1 28.4 4.6 2.0 43.4 33.0 4.6 7.5 53.8 2.0 10.1 17.9 18.6 7.4 24.5 22.0 17.3 31.0 16.8 9.2 17.4 27.0 16.1 5.1 53.5 31.3 3.9 41.2 3.5 16.3 4.5 4.0 41.3 13.5 3.6 3.6 4.7 4.0 31.4 31.3 7.6 28.0 2.5 3.6 1.8 3.2 2.2 1.8 4.3 1.4 2.8 2.7 8.9 8.8 22.0 33.9 66.1 3.6 36.7 76.5 18.7 7.9 19.2 2.0 28.3 24.9 210.7 13.0 33.7 22.3 46.7 638.8 158.3 47.3 50.3 18.4 91.8 194.5 0.0 38.6 74.3 87.1 71.0 40.3 79.1 69.2 40.5 88.6 11.9 291.0 56.1 18.0 71.9 1.8 12.9 44.1 1.1 21.0 74.5 32.3 24.2 76.7 54.2 EIF5A2 ENSG00000163577 "Eukaryotic translation initiation factor 5A2" Q9GZV4 3 170888415-170908693 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.2" "Group enriched" "Detected in many" 11 "Early spermatids: 309.4;Late spermatids: 705.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029090 Approved Supported Vesicles NA NA Vesicles "HPA029090: AB_10671359" "unprognostic (2.41e-1)" "unprognostic (2.42e-1)" "unprognostic (4.05e-1)" "unprognostic (5.75e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (1.11e-3)" "unprognostic (1.47e-1)" "unprognostic (3.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (2.66e-2)" "unprognostic (3.45e-2)" "unprognostic (5.92e-2)" "unprognostic (1.64e-2)" "unprognostic (4.29e-3)" 5.6 3.9 3.6 4.1 8.4 4.9 4.2 1.9 14.4 4.4 4.6 4.3 2.0 2.5 6.2 2.0 4.1 3.6 4.9 5.4 4.3 5.8 6.8 3.4 3.2 3.6 6.7 6.2 6.4 4.5 2.2 5.2 2.5 21.6 4.8 3.8 3.4 2.7 4.2 1.9 3.0 2.6 9.6 5.1 3.0 11.0 31.2 2.5 6.1 3.1 2.6 4.2 6.3 6.2 2.6 0.9 10.2 1.3 6.9 11.2 4.3 11.6 6.1 2.2 3.1 12.0 7.9 5.3 8.8 11.5 9.4 13.2 12.4 7.7 7.4 16.6 12.3 21.1 3.9 7.1 3.2 12.0 8.1 3.1 3.4 2.5 3.9 8.1 9.1 10.7 8.6 4.7 14.1 11.7 13.1 4.6 1.9 2.8 0.0 15.3 3.7 4.1 4.1 4.2 9.1 3.9 0.0 6.5 0.0 3.9 2.1 1.8 3.4 9.4 2.4 7.4 3.7 5.4 6.2 6.4 11.6 8.2 23.8 20.2 11.6 0.1 16.8 3.9 3.2 8.2 10.2 1.2 1.2 11.2 1.3 7.7 2.0 7.7 10.6 0.9 2.6 4.6 7.6 0.6 6.9 1.2 0.8 9.2 4.3 3.6 8.4 1.9 14.4 4.3 5.8 6.7 6.2 21.6 2.5 0.0 0.3 3.2 5.2 15.1 2.8 8.1 0.0 4.0 1.2 1.8 0.0 0.8 1.7 6.4 309.4 7.1 1.0 0.0 6.6 1.7 11.3 4.4 2.3 2.4 7.4 0.0 4.7 2.5 4.1 705.4 11.8 4.9 10.1 11.8 1.1 7.5 12.5 4.2 10.6 18.0 2.6 45.3 14.5 25.1 9.3 18.9 0.6 16.6 1.6 5.0 EIF5AL1 "bA342M3.3, EIF5AP1" ENSG00000253626 "Eukaryotic translation initiation factor 5A-like 1" Q6IS14 10 79512601-79516440 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 19.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-251 MG: 5.7" NA NA "unprognostic (2.16e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.55e-1)" "unprognostic (4.14e-3)" "unprognostic (1.50e-1)" "unprognostic (3.48e-2)" "unprognostic (4.25e-2)" "unprognostic (2.50e-3)" "unprognostic (2.04e-2)" "unprognostic (3.57e-1)" "unprognostic (1.01e-1)" "unprognostic (8.79e-3)" "unprognostic (1.56e-1)" "unprognostic (8.63e-2)" "unprognostic (1.87e-1)" "unprognostic (6.68e-2)" "unprognostic (1.81e-1)" 0.8 1.0 0.6 0.8 1.0 0.7 0.7 0.6 1.0 1.2 1.1 0.5 1.6 0.7 0.6 0.7 2.5 0.5 0.8 2.5 0.5 0.5 1.0 8.4 1.0 1.0 0.5 0.0 0.7 3.7 1.4 0.9 0.5 0.8 1.5 0.8 0.0 1.7 0.5 2.6 1.4 2.7 0.4 0.3 1.6 0.8 19.5 0.4 3.3 1.1 2.8 1.1 1.6 0.7 3.9 6.5 2.3 4.9 4.0 3.7 1.3 1.2 2.1 0.9 4.7 0.1 0.6 0.9 0.7 0.5 0.8 0.5 1.6 0.9 2.3 0.8 0.2 0.5 1.4 0.5 0.1 0.5 0.7 1.8 0.6 2.8 0.9 0.5 0.7 1.8 0.1 0.1 0.3 0.4 0.1 0.6 0.2 0.5 0.9 0.3 1.6 2.5 2.3 3.4 0.3 0.3 0.8 2.1 1.5 1.4 2.2 0.6 1.4 1.4 1.3 1.5 0.3 2.2 1.9 0.7 1.3 2.8 3.1 5.7 1.2 1.3 2.1 2.1 0.6 1.8 2.3 2.1 1.5 3.3 4.9 3.7 3.6 3.1 3.7 3.8 3.9 2.4 3.5 2.0 4.0 2.9 6.5 2.5 1.3 0.6 1.0 0.6 1.0 0.5 0.5 0.5 0.0 0.8 0.4 14.9 35.4 7.2 2.5 30.0 0.6 38.6 2.5 9.4 25.0 0.0 0.0 18.6 10.0 58.5 11.5 13.8 60.4 0.0 41.0 29.8 19.2 2.9 47.3 4.9 15.9 1.6 57.6 2.5 8.1 4.4 4.6 16.8 18.6 64.1 60.4 1.3 56.7 66.6 2.8 3.6 0.5 0.0 27.6 84.1 3.8 30.2 23.1 7.5 80.1 2.7 ELANE "ELA2, HLE, HNE, NE" ENSG00000197561 "Elastase, neutrophil expressed" P08246 19 851014-856247 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "bone marrow: 244.3" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 7.7;Fibroblasts: 5.7;Kupffer cells: 5.6;Leydig cells: 5.8;Melanocytes: 6.8;Suprabasal keratinocytes: 6.5" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "classical monocyte: 3.2;neutrophil: 6.9" "Group enriched" "Detected in many" 9 "granulocytes: 6.9;monocytes: 3.2" "Cell line enriched" "Detected in some" 65 "THP-1: 197.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB015409, HPA066836" Enhanced "Secreted to blood" NA NA 59000 "CAB015409: AB_831596, HPA066836: AB_2685733" "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-3)" "unprognostic (2.09e-2)" "unprognostic (1.80e-3)" "unprognostic (3.43e-2)" "unprognostic (3.92e-1)" "unprognostic (6.38e-3)" "unprognostic (5.80e-1)" "unprognostic (2.54e-2)" "unprognostic (4.06e-2)" "unprognostic (3.48e-2)" "unprognostic (1.19e-10)" "unprognostic (6.27e-3)" "unprognostic (4.00e-2)" "unprognostic (2.76e-2)" "unprognostic (4.75e-3)" 1.5 0.3 0.1 0.3 0.1 244.3 1.6 0.2 0.6 0.3 0.6 0.7 0.0 0.3 0.3 0.7 0.5 0.6 0.8 31.2 0.0 0.0 0.3 1.5 17.8 1.6 0.0 0.0 0.3 1.8 0.3 0.4 4.7 0.5 1.4 0.3 1.0 0.7 0.3 1.1 2.1 0.5 0.5 0.0 22.5 0.5 0.3 0.0 23.0 2.3 0.9 0.3 1.0 0.2 0.0 0.0 6.9 3.2 0.0 0.5 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 11.2 0.1 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 5.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 5.6 0.0 5.8 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.7 0.2 0.0 6.5 0.0 0.0 0.0 0.0 ELAVL2 "HEL-N1, HuB" ENSG00000107105 "ELAV like RNA binding protein 2" Q12926 9 23690104-23826337 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 30.7;testis: 45.3" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 154.0" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.1;AF22: 15.6;SCLC-21H: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022222, HPA063001" Enhanced Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB022222: , HPA063001: AB_2684918" "unprognostic (3.51e-1)" "unprognostic (4.18e-2)" "unprognostic (2.05e-1)" "unprognostic (1.47e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-1)" "unprognostic (4.26e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.74e-4)" "unprognostic (3.98e-1)" "unprognostic (9.08e-4)" "unprognostic (8.30e-2)" "unprognostic (1.91e-2)" "unprognostic (2.12e-1)" "unprognostic (2.65e-1)" 1.0 2.4 8.7 1.0 13.4 1.4 1.1 18.3 27.5 1.0 1.3 0.7 0.0 1.0 1.5 1.4 1.1 1.0 1.1 1.0 8.1 19.2 1.4 0.8 1.1 1.0 16.3 18.9 2.1 0.8 1.2 2.5 0.9 30.7 1.2 1.5 0.5 1.0 1.0 1.0 1.5 1.1 1.1 5.0 1.0 1.0 45.3 1.1 0.0 1.2 0.0 1.0 1.6 0.3 1.8 1.1 5.1 0.9 1.4 1.3 0.1 10.1 0.1 15.6 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 4.2 6.5 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 4.0 0.0 4.7 0.0 0.1 0.0 0.3 0.5 2.2 0.0 0.0 0.0 4.1 0.0 4.9 0.0 5.6 0.1 0.0 0.0 52.1 4.9 0.1 0.1 0.1 4.2 0.2 0.7 0.0 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.6 2.7 0.9 1.6 0.5 0.6 0.6 1.0 0.5 0.4 0.4 1.8 1.1 1.3 5.1 1.4 0.5 1.1 0.6 0.1 8.7 13.4 18.3 27.5 8.1 19.2 16.3 18.9 30.7 1.1 0.0 0.0 0.0 0.3 0.9 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 34.9 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.9 4.1 0.0 0.0 30.7 2.8 0.0 0.0 0.0 0.7 2.7 0.0 0.0 1.4 0.0 9.6 0.0 0.3 12.2 154.0 0.6 0.0 0.0 0.8 0.8 ELAVL3 "DKFZp547J036, HUC, HUCL, MGC20653, PLE21" ENSG00000196361 "ELAV like RNA binding protein 3" Q14576 19 11451326-11481046 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 53.8" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 7.3;Cone photoreceptor cells: 3.9;Horizontal cells: 4.8;Rod photoreceptor cells: 7.7" "Cancer enriched" "Detected in some" 10 "glioma: 11.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9;naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Group enriched" "Detected in some" 8 "SCLC-21H: 40.6;SH-SY5Y: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013066 Enhanced NA NA "CAB013066: AB_221448" "unprognostic (1.47e-2)" "unprognostic (2.29e-2)" "unprognostic (1.70e-1)" "unprognostic (7.78e-3)" "unprognostic (8.76e-2)" "unprognostic (2.95e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-2)" "unprognostic (2.44e-1)" "unprognostic (5.93e-3)" "unprognostic (1.86e-2)" "unprognostic (2.15e-3)" "unprognostic (2.26e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (9.60e-3)" 1.0 2.4 14.0 1.5 13.2 1.0 1.0 45.2 53.8 1.0 1.3 12.2 0.0 1.2 1.1 1.6 1.2 1.0 1.0 1.1 17.3 13.0 1.1 1.1 1.1 1.0 14.3 18.3 1.0 1.0 1.0 1.3 1.0 9.5 1.6 1.2 0.1 1.0 1.2 4.0 1.0 1.2 1.2 21.9 1.1 1.2 1.5 5.1 0.0 1.0 0.0 1.0 1.0 0.0 1.9 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 1.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 14.0 13.2 45.2 35.2 17.3 13.0 14.3 18.3 9.5 5.1 0.0 0.0 0.0 0.6 0.6 2.8 7.3 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 7.7 0.0 1.9 1.8 2.5 0.1 0.0 0.0 0.0 0.3 ELAVL4 "HUD, PNEM" ENSG00000162374 "ELAV like RNA binding protein 4" P26378 1 50048014-50203786 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1" "Group enriched" "Detected in some" 11 "Early spermatids: 111.8;Intestinal endocrine cells: 31.6;Late spermatids: 117.9" "Group enriched" "Detected in some" 10 "glioma: 2.6;pancreatic cancer: 0.6;testis cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 5 "monocytes: 3.1" "Cell line enriched" "Detected in some" 19 "SH-SY5Y: 53.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004442, HPA043047" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004442: AB_627765, HPA043047: AB_2732502" "unprognostic (1.25e-1)" "unprognostic (6.63e-3)" "unprognostic (4.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.28e-2)" "unprognostic (3.83e-4)" "unprognostic (4.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.75e-1)" "unprognostic (3.75e-3)" "unprognostic (7.91e-2)" "unprognostic (2.39e-3)" "unprognostic (7.83e-2)" "unprognostic (2.81e-2)" "unprognostic (4.13e-2)" "unprognostic (7.43e-2)" 0.9 11.4 11.5 3.3 12.8 0.8 1.0 11.6 43.1 0.9 3.0 0.9 0.0 2.3 0.9 0.8 1.1 0.9 1.0 1.0 12.3 16.5 0.9 1.0 1.0 0.9 10.6 30.7 0.8 2.8 0.8 7.1 0.9 37.0 1.0 3.8 0.0 0.9 0.9 0.8 1.2 3.1 2.0 8.5 1.0 1.9 7.8 1.4 0.1 0.8 0.0 1.0 0.9 0.5 0.0 0.6 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.6 0.0 0.0 11.5 12.8 11.6 40.4 12.3 16.5 10.6 30.7 37.0 1.4 0.0 0.0 0.0 0.0 0.7 0.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 31.6 0.0 4.5 117.9 1.4 2.3 1.7 0.0 0.0 1.0 0.5 0.0 0.4 0.0 3.0 0.0 0.0 7.5 7.9 0.6 0.1 0.0 0.0 0.0 ELF1 ENSG00000120690 "E74 like ETS transcription factor 1" P32519 13 40932028-41061440 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 129.5" "Cell type enhanced" "Detected in all" 5 "granulocytes: 307.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001755, CAB005172" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB005172: AB_631428, HPA001755: AB_1078732" "unprognostic (1.21e-1)" "unprognostic (8.73e-3)" "unprognostic (4.20e-2)" "unprognostic (8.45e-2)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.11e-2)" "unprognostic (5.78e-2)" "unprognostic (3.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.02e-3)" "unprognostic (2.96e-1)" "unprognostic (4.11e-2)" "unprognostic (8.98e-2)" "unprognostic (3.72e-2)" 27.7 11.5 6.0 37.9 12.5 51.4 22.6 3.4 7.7 19.9 23.4 9.0 12.0 14.5 20.9 15.6 25.1 17.0 19.3 15.8 7.0 4.5 16.6 13.8 28.0 34.8 14.9 3.4 16.7 20.0 12.7 13.9 15.9 11.1 17.4 14.0 10.9 22.0 16.8 13.0 23.8 34.6 14.8 15.1 44.8 15.2 8.5 11.1 129.5 19.4 18.6 44.4 26.7 23.4 20.1 17.1 64.6 26.3 20.7 27.2 20.6 8.0 4.7 3.7 3.6 16.8 17.8 13.7 8.3 20.3 11.6 13.5 12.0 21.4 46.5 5.3 14.0 8.7 18.5 0.7 10.6 7.4 10.2 5.6 41.6 3.9 8.1 12.6 23.6 65.4 18.4 18.6 7.9 15.2 7.7 16.4 22.2 10.1 12.3 7.7 7.3 30.7 13.7 2.8 27.2 3.7 41.3 6.0 13.2 12.1 12.7 1.4 5.0 7.2 7.2 14.7 5.3 5.1 30.6 14.6 5.0 3.0 4.1 2.9 5.7 3.2 30.6 7.0 15.1 10.7 64.6 17.7 38.1 21.9 19.5 23.1 19.1 25.1 24.2 17.1 20.1 27.2 24.0 28.8 20.7 26.3 11.3 24.7 20.6 6.0 12.5 3.4 7.7 7.0 4.5 14.9 3.4 11.1 11.1 71.5 71.4 100.3 182.5 96.7 2.4 28.3 40.8 78.9 75.1 54.1 9.8 29.1 16.6 56.5 37.6 98.4 56.1 46.7 60.7 47.9 62.5 133.5 307.0 22.1 83.5 3.2 55.8 63.3 93.8 11.4 39.7 135.9 114.7 64.1 49.8 7.5 56.2 45.6 40.7 23.7 3.6 38.8 56.7 7.6 8.5 100.4 44.7 171.1 49.4 185.4 ELF3 "EPR-1, ERT, ESE-1, ESX" ENSG00000163435 "E74 like ETS transcription factor 3" P78545 1 202007945-202017188 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Inflammatory response, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 100.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 1511.9;Glandular cells: 1015.6;Paneth cells: 1043.9;Urothelial cells: 1629.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 40.5;CAPAN-2: 57.8;OE19: 37.3;RT4: 41.5;SK-BR-3: 80.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003316, HPA003479" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA003316: AB_1078757, HPA003479: AB_1078756" "unprognostic (9.90e-3)" "unprognostic (1.72e-1)" "unprognostic (7.50e-2)" "unprognostic (1.12e-1)" "unprognostic (2.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (1.69e-1)" "unprognostic (5.05e-3)" "unprognostic (7.67e-3)" "unprognostic (7.07e-2)" "unprognostic (9.92e-3)" "unprognostic (4.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-1)" "unprognostic (3.37e-3)" 0.3 0.1 0.1 16.0 0.2 0.0 34.0 0.2 0.2 13.2 80.7 0.2 12.5 34.4 3.8 8.9 59.3 8.6 67.7 1.1 0.1 0.1 38.1 33.3 24.6 0.1 0.1 0.1 5.8 38.4 1.1 1.7 16.7 0.3 39.9 31.3 0.7 37.9 11.3 0.7 3.5 100.8 9.5 0.3 0.2 29.9 1.9 0.1 0.6 5.7 25.5 43.5 44.7 22.7 0.3 0.8 2.0 0.3 0.2 0.3 0.0 10.6 40.5 0.0 0.0 0.0 0.0 12.6 0.0 1.5 0.0 0.0 9.0 57.8 0.0 4.8 0.0 0.3 10.5 0.0 0.0 0.0 1.2 0.0 0.0 7.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 0.6 37.3 3.4 0.0 0.0 0.5 15.4 41.5 0.0 0.0 0.4 80.2 0.0 1.9 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.8 0.3 0.2 0.1 2.0 0.2 0.3 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.1 273.9 377.1 5.4 575.3 4.5 1.7 1.2 448.4 586.2 343.5 312.3 17.7 60.7 34.9 553.5 0.0 1.1 1511.9 0.0 565.5 107.5 4.2 1015.6 40.3 30.4 7.8 0.0 434.4 0.6 1.3 0.0 0.0 12.0 8.5 25.2 963.0 2.0 453.3 1043.9 0.0 114.1 63.9 0.0 0.4 0.0 0.2 7.3 215.1 2.2 773.6 1629.9 ELF5 ENSG00000135374 "E74 like ETS transcription factor 5" Q9UKW6 11 34478793-34513805 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "breast: 48.8;ductus deferens: 72.2;salivary gland: 85.1;seminal vesicle: 86.9" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 2: 29.3;Collecting duct cells: 96.0;Cytotrophoblasts: 17.5;Melanocytes: 16.9" "Cancer enhanced" "Detected in many" "breast cancer: 8.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "RT4: 17.8;T-47d: 34.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062706 Approved Nucleoplasm NA NA Nucleoplasm "HPA062706: AB_2684841" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (7.55e-2)" "unprognostic (3.31e-2)" "unprognostic (2.41e-4)" "unprognostic (6.90e-2)" "unprognostic (3.93e-1)" "prognostic favorable (3.64e-4)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (8.15e-2)" "unprognostic (3.15e-2)" "unprognostic (1.78e-3)" "unprognostic (3.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (2.86e-1)" 0.1 0.0 0.0 0.0 0.1 0.0 48.8 0.0 0.0 0.5 0.0 0.0 72.2 0.6 0.0 0.1 0.6 0.0 1.1 0.0 0.0 0.0 6.5 0.0 2.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.8 0.0 1.4 0.0 0.0 85.1 86.9 0.0 3.5 0.0 1.0 0.0 0.3 0.1 0.1 0.0 0.2 0.0 3.5 1.0 5.8 1.2 0.5 0.5 2.0 1.8 0.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 17.8 0.0 0.0 0.0 3.1 0.0 0.1 34.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.0 0.3 0.2 0.5 1.8 0.3 0.2 0.3 0.4 0.3 0.5 0.4 0.4 0.9 0.7 1.8 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 29.3 0.0 2.5 0.2 0.0 0.3 0.0 5.3 9.1 96.0 0.0 17.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 1.9 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 9.6 0.0 0.0 5.8 ELFN1 PPP1R28 ENSG00000225968 "Extracellular leucine rich repeat and fibronectin type III domain containing 1" P0C7U0 7 1688119-1747954 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.3" "Cell type enhanced" "Detected in some" 10 "Cone photoreceptor cells: 5.9;Hepatocytes: 7.8;Ito cells: 9.8;Rod photoreceptor cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 19.5;U-138 MG: 12.3;U-2 OS: 18.0;U-2197: 20.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066382 Approved "Nucleoplasm,Cell Junctions" NA NA 11000 "Nucleoplasm, Cell Junctions" "HPA066382: AB_2732744" "unprognostic (8.45e-2)" "unprognostic (3.39e-3)" "unprognostic (6.54e-4)" "unprognostic (1.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "prognostic favorable (9.68e-4)" "unprognostic (4.60e-3)" "unprognostic (1.63e-3)" "unprognostic (6.60e-2)" "unprognostic (4.14e-3)" "unprognostic (1.11e-2)" "unprognostic (2.31e-2)" "unprognostic (7.47e-3)" "unprognostic (8.63e-2)" "unprognostic (2.78e-1)" "unprognostic (4.07e-1)" 1.8 0.8 2.2 0.6 1.4 0.0 0.6 0.0 4.2 3.2 0.3 0.2 2.2 0.3 0.3 0.8 0.8 3.3 1.8 2.2 2.8 13.3 0.3 0.1 2.7 0.0 0.2 0.2 0.2 0.7 0.6 0.0 0.5 0.2 1.2 0.6 0.3 0.5 1.7 1.7 0.2 0.7 0.2 0.0 0.5 0.9 0.5 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 3.0 6.3 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.1 0.3 0.0 3.0 1.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.5 0.0 2.9 1.2 0.0 0.7 19.5 0.0 1.9 0.0 0.0 2.8 1.3 0.1 0.1 0.0 0.3 0.0 0.2 0.0 12.3 18.0 20.9 0.0 0.0 0.2 5.3 0.0 0.0 1.5 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.4 0.1 1.0 1.6 0.0 0.0 0.0 0.0 5.9 0.0 3.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.8 0.1 0.0 0.0 9.8 0.6 0.0 0.9 0.0 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.7 0.0 0.9 0.0 2.7 0.0 0.0 0.0 0.0 0.0 ELFN2 "dJ63G5.3, KIAA1904, LRRC62, PPP1R29" ENSG00000166897 "Extracellular leucine rich repeat and fibronectin type III domain containing 2" Q5R3F8 22 37367960-37427470 "Predicted membrane proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.0" "Cell type enriched" "Detected in some" 11 "Bipolar cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.7;CAPAN-2: 8.4;GAMG: 9.4;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000781 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA000781: AB_1079280" "unprognostic (2.74e-1)" "unprognostic (6.81e-2)" "unprognostic (2.80e-2)" "unprognostic (1.31e-5)" "unprognostic (3.28e-1)" "unprognostic (2.51e-2)" "unprognostic (7.76e-2)" "unprognostic (4.25e-2)" "unprognostic (6.05e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (4.51e-1)" "prognostic unfavorable (7.21e-4)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" 1.0 2.1 26.8 0.9 10.9 0.9 0.9 0.7 30.0 0.9 0.9 1.9 0.0 0.9 0.9 0.9 0.9 1.0 1.9 0.8 16.2 8.7 1.2 0.8 2.0 1.0 6.7 15.0 0.8 1.1 0.8 0.1 0.8 5.8 2.2 0.9 0.9 0.9 0.9 0.9 1.5 0.9 0.8 3.8 0.9 1.1 4.2 3.9 0.1 0.8 0.0 0.9 0.9 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 8.7 3.7 0.0 0.0 0.0 0.7 0.0 4.0 2.1 0.9 0.0 1.4 8.4 0.2 5.2 2.8 9.4 6.1 0.4 0.8 0.1 0.2 0.0 0.0 3.9 0.0 0.2 0.0 0.1 0.7 0.1 0.3 1.2 3.5 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.2 5.2 8.0 0.1 0.0 8.4 16.4 0.0 0.7 0.0 3.6 4.6 0.0 0.0 0.0 0.1 0.4 0.0 18.7 0.1 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 10.9 0.7 16.8 16.2 8.7 6.7 15.0 5.8 3.9 0.0 3.2 0.0 0.0 0.1 43.2 0.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.3 1.6 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772600-43777543 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.3;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 5.3;Early spermatids: 1.5;Enterocytes: 1.7;Late spermatids: 1.8;Mucus-secreting cells: 2.0;Undifferentiated cells: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory B-cell: 5.3;naive B-cell: 8.5" "Lineage enriched" "Detected in many" 7 "B-cells: 8.5" "Cell line enhanced" "Detected in some" "Daudi: 7.9;U-698: 19.2" "Region enriched" "Detected in single" 11 "olfactory region: 2.4" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" NA NA "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.7 1.1 1.0 24.2 0.6 0.4 2.5 4.7 0.6 2.3 10.6 0.5 1.6 4.8 1.0 1.0 5.5 1.3 0.9 0.6 1.0 0.6 1.8 0.5 0.9 7.5 1.3 0.0 1.3 0.7 0.6 1.2 0.8 2.6 2.1 1.8 0.8 2.0 0.7 1.0 7.0 13.3 0.9 0.6 1.5 1.1 12.3 0.5 0.8 1.1 2.8 16.7 1.3 1.7 8.5 1.0 0.1 0.1 0.1 1.2 0.6 0.6 0.1 0.6 0.2 1.6 0.1 0.1 0.2 0.5 0.8 1.3 0.1 0.5 7.9 0.1 0.7 0.1 2.9 0.3 0.0 0.5 0.7 3.4 0.3 2.6 0.8 0.5 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.1 1.2 0.3 0.9 0.0 1.1 0.8 0.8 0.1 0.1 0.2 0.0 3.6 0.2 0.3 1.5 0.3 0.1 3.6 0.2 0.1 0.2 0.0 0.3 0.2 0.0 0.0 19.2 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.2 5.3 0.5 0.2 0.0 8.5 1.2 0.3 0.1 0.1 0.0 1.0 0.3 0.6 1.0 0.6 4.7 0.6 1.0 0.6 1.3 0.0 2.6 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 1.7 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 2.0 0.1 ELMO1 "CED-12, CED12, ELMO-1, KIAA0281" ENSG00000155849 "Engulfment and cell motility 1" Q92556 7 36854361-37449249 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.3" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 37.9;Ito cells: 37.4;Kupffer cells: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 28.8;JURKAT: 31.3;Karpas-707: 27.9;U-266/70: 24.0;U-698: 34.5;U-937: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.77e-2)" "unprognostic (8.29e-3)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (3.69e-1)" "unprognostic (4.09e-2)" "unprognostic (3.01e-2)" "unprognostic (3.53e-3)" "unprognostic (1.34e-1)" "unprognostic (1.71e-1)" "prognostic favorable (4.62e-4)" "unprognostic (3.59e-1)" "prognostic unfavorable (3.27e-5)" "unprognostic (1.65e-2)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (3.16e-3)" 13.5 9.5 33.7 16.8 39.9 28.5 7.7 39.7 58.3 7.7 7.0 34.9 1.4 4.3 5.0 3.6 6.8 5.4 11.7 7.5 33.6 21.1 3.4 15.8 14.6 24.0 30.5 17.2 8.5 8.4 2.9 5.6 21.8 37.0 4.5 7.9 4.0 4.3 6.7 3.1 4.5 6.6 8.9 36.4 28.4 5.3 4.5 29.7 9.3 47.4 2.1 26.0 11.3 6.5 14.3 20.4 41.4 13.7 10.8 15.3 13.4 0.0 1.1 1.9 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.5 0.0 0.3 0.1 0.0 0.0 0.0 15.9 1.0 20.4 0.1 0.0 0.0 13.2 8.9 0.4 0.0 0.0 0.0 0.0 10.9 31.3 0.3 27.9 0.0 0.2 16.6 20.1 4.5 0.0 0.0 17.8 2.1 16.1 0.0 0.0 2.5 10.2 0.0 5.7 0.1 7.5 0.0 9.5 2.8 0.0 0.3 0.0 0.1 24.0 22.5 34.5 5.6 27.8 1.2 10.9 13.7 41.4 9.0 11.7 9.8 14.3 15.3 10.5 20.4 12.8 14.4 10.6 32.4 10.8 9.9 11.6 14.7 13.4 33.7 39.9 39.7 52.8 33.6 21.1 30.5 17.2 37.0 29.7 0.0 7.4 19.0 3.6 4.4 16.7 2.2 10.2 0.0 1.2 0.0 0.0 1.2 0.0 0.2 0.9 37.9 0.0 0.0 1.0 20.6 12.0 1.7 34.6 10.6 17.5 0.0 3.5 37.4 44.8 0.9 5.8 32.7 6.8 24.4 0.7 1.2 0.8 0.0 23.3 1.6 1.6 12.9 3.1 1.4 3.2 3.8 16.5 28.0 0.1 1.3 ELMOD1 DKFZp547C176 ENSG00000110675 "ELMO domain containing 1" Q8N336 11 107591091-107666779 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 51.1;pituitary gland: 20.8;skin 1: 34.7" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 30.4;Cone photoreceptor cells: 15.7;Horizontal cells: 35.0;Late spermatids: 14.0;Rod photoreceptor cells: 17.8" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 11.9;RH-30: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038435, HPA066479" Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038435: AB_10795575, HPA066479: " "unprognostic (2.74e-1)" "unprognostic (1.72e-4)" "unprognostic (2.58e-2)" "unprognostic (9.13e-2)" "unprognostic (3.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.34e-1)" "unprognostic (6.59e-3)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (6.29e-2)" "unprognostic (9.44e-2)" "unprognostic (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (3.15e-1)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" 1.5 4.2 10.7 1.5 41.1 1.3 4.1 12.8 51.1 1.5 1.4 1.7 0.0 1.4 1.6 1.3 1.2 3.6 1.2 4.8 13.8 14.3 4.7 1.3 1.6 1.3 8.7 15.2 1.2 1.2 1.2 20.8 1.2 14.8 2.1 1.3 1.4 1.3 1.2 2.8 34.7 1.3 1.4 6.6 1.2 1.2 2.9 3.9 0.0 1.3 0.0 1.2 1.1 0.1 0.9 0.7 2.4 0.9 1.8 0.5 0.2 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.2 3.5 0.4 2.2 0.3 0.4 0.0 1.8 0.1 0.0 0.1 1.2 0.1 0.0 0.4 0.1 0.0 0.0 0.1 11.9 1.5 0.0 0.1 0.8 0.1 0.0 0.1 0.5 0.0 1.8 0.0 27.1 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.3 0.0 0.7 0.1 0.0 0.0 3.6 0.0 2.1 1.6 0.9 0.6 0.4 0.6 0.4 0.5 0.5 0.2 0.2 0.9 0.4 0.5 2.4 1.8 0.6 0.7 0.4 0.2 10.7 41.1 12.8 26.9 13.8 14.3 8.7 15.2 14.8 3.9 0.0 3.8 0.0 0.4 0.0 30.4 3.6 0.0 8.1 2.3 0.0 15.7 0.1 0.0 0.0 8.5 0.7 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.8 0.1 35.0 0.0 0.6 0.3 14.0 0.3 1.4 0.0 0.0 0.0 6.5 0.0 0.0 0.4 3.6 17.8 0.0 0.5 0.9 0.4 2.8 0.0 0.0 0.0 0.3 ELOA2 "HsT832, TCEB3B, TCEB3L" ENSG00000206181 "Elongin A2" Q8IYF1 18 47032572-47035621 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.8;WM-115: 1.2" "HPA041009, HPA043501, HPA048971, HPA049178, HPA050086, HPA053158" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041009: AB_10959881, HPA043501: AB_10960403, HPA048971: AB_2680578, HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " "unprognostic (2.38e-1)" "unprognostic (4.47e-1)" "unprognostic (2.54e-4)" "unprognostic (2.39e-1)" "unprognostic (8.75e-2)" "unprognostic (5.34e-2)" "unprognostic (3.64e-1)" "unprognostic (5.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.38e-2)" "unprognostic (3.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOA3C ENSG00000275553 "Elongin A3 family member C" 18 46968695-46969912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049178, HPA050086, HPA053158" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA049178: AB_2680664, HPA050086: AB_2681009, HPA053158: " 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363397-43368074 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 101.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Enhanced Supported "Endoplasmic reticulum" NA Yes "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: AB_2683173" "unprognostic (5.23e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 21.2 15.6 16.2 15.3 25.3 18.3 24.1 6.8 32.5 16.1 23.6 101.5 11.7 20.7 14.1 13.0 46.6 15.1 17.3 11.5 30.3 18.3 26.6 23.8 22.9 22.7 51.4 14.1 9.3 18.3 16.7 8.4 20.9 45.6 21.6 20.1 8.6 20.6 21.6 6.8 54.0 21.7 20.7 99.5 17.2 22.8 8.4 37.2 7.2 23.9 15.6 21.7 20.4 22.6 30.9 61.1 46.9 54.8 30.5 32.3 48.8 23.8 26.9 5.2 10.3 35.6 33.5 16.3 28.3 35.7 36.1 29.1 23.8 41.9 16.5 22.0 44.3 31.2 27.5 18.4 34.8 22.2 21.2 12.4 21.4 18.6 17.2 30.9 18.4 22.9 25.6 39.6 42.6 47.1 27.1 36.1 6.5 14.8 12.6 41.3 17.6 4.3 15.5 7.6 31.1 27.9 9.7 13.9 20.1 45.5 29.1 6.4 6.7 16.7 59.7 23.8 16.2 28.1 18.4 29.8 30.6 19.4 37.0 35.8 6.3 6.8 7.9 29.8 18.9 27.5 29.0 54.8 46.9 32.3 50.6 28.6 30.9 30.7 31.4 61.1 25.5 20.1 28.1 38.2 30.5 48.1 42.9 31.4 48.8 16.2 25.3 6.8 32.5 30.3 18.3 51.4 14.1 45.6 37.2 17.9 8.4 18.1 20.4 13.9 5.4 3.6 45.9 5.3 7.9 38.4 9.8 79.2 6.6 86.7 2.5 28.7 74.3 70.0 86.6 103.3 20.2 33.0 20.7 13.7 66.2 3.2 18.4 23.4 47.0 3.4 18.7 37.1 11.8 129.8 30.5 12.4 99.9 40.7 24.1 21.3 8.4 19.4 15.3 6.7 8.6 27.0 80.2 24.6 36.9 43.7 ELOVL2 Ssc2 ENSG00000197977 "ELOVL fatty acid elongase 2" Q9NXB9 6 10980759-11044314 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4" "Group enriched" "Detected in many" 8 "breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic favorable (6.73e-5)" "unprognostic (4.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.28e-5)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.89e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (6.92e-3)" "unprognostic (1.78e-2)" "unprognostic (1.04e-12)" "unprognostic (9.98e-4)" "unprognostic (8.86e-2)" "unprognostic (3.41e-1)" "unprognostic (9.47e-2)" 1.4 1.3 10.7 1.7 11.5 0.6 4.7 5.8 12.2 0.6 0.6 8.8 0.0 0.7 0.9 2.5 0.8 0.6 1.1 3.1 6.4 4.8 0.7 43.1 0.7 0.9 7.1 7.1 0.7 2.6 19.9 2.8 28.4 8.0 5.0 0.6 5.9 1.1 0.9 1.3 0.7 0.8 1.1 18.6 0.5 0.6 9.3 4.0 0.0 2.0 0.0 1.3 1.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 11.2 0.0 0.0 0.0 6.4 0.2 0.5 9.9 17.0 0.0 0.0 0.0 0.0 0.6 17.5 0.0 11.7 0.0 16.4 0.0 10.1 0.1 0.2 12.5 0.5 0.2 2.7 0.1 0.0 7.6 0.0 0.6 0.0 0.5 0.6 0.0 0.2 0.0 6.4 0.1 2.1 0.0 9.6 8.9 17.8 0.0 0.0 0.1 4.5 5.1 0.0 0.0 4.1 9.5 2.0 5.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.7 11.5 5.8 10.9 6.4 4.8 7.1 7.1 8.0 4.0 0.0 0.0 0.0 0.0 0.1 1.8 0.6 5.1 0.0 0.0 0.0 27.5 1.6 0.0 4.8 8.6 0.7 0.0 0.0 0.8 17.8 7.2 2.1 0.0 13.2 1.1 0.0 0.0 0.0 0.0 12.4 0.9 0.0 0.0 0.0 0.0 3.9 1.1 0.0 0.4 0.0 10.2 19.4 0.3 12.1 7.9 0.0 1.4 0.0 0.0 0.0 ELOVL3 CIG-30 ENSG00000119915 "ELOVL fatty acid elongase 3" Q9HB03 10 102226328-102229589 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.6" "Cell type enhanced" "Detected in some" 11 "Ito cells: 1.3;Kupffer cells: 2.4;Smooth muscle cells: 2.0;Spermatogonia: 2.7" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 11 "classical monocyte: 9.4;intermediate monocyte: 3.1;myeloid DC: 2.6;non-classical monocyte: 6.6" "Group enriched" "Detected in many" 12 "dendritic cells: 2.6;monocytes: 9.4" "Cell line enhanced" "Detected in some" "ASC diff: 8.3;ASC TERT1: 8.3;HSkMC: 12.2;NB-4: 9.4;SiHa: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036236 Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA036236: AB_10601550" "unprognostic (1.52e-2)" "unprognostic (6.76e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (6.25e-5)" "unprognostic (8.23e-3)" "unprognostic (9.82e-2)" "unprognostic (2.17e-4)" "unprognostic (4.27e-2)" "unprognostic (2.28e-1)" "unprognostic (5.56e-2)" "unprognostic (1.84e-2)" "unprognostic (5.36e-3)" "unprognostic (2.66e-9)" "unprognostic (1.04e-1)" "unprognostic (2.81e-1)" "unprognostic (1.97e-1)" "unprognostic (1.79e-1)" 6.3 1.1 1.2 2.1 2.4 3.6 7.3 0.4 0.9 0.2 0.2 0.0 0.0 0.0 0.9 0.3 0.3 0.3 2.5 2.5 0.6 0.2 0.5 0.2 1.8 0.1 0.7 0.0 0.2 0.2 0.0 1.8 2.4 1.1 0.3 0.2 1.6 3.4 1.7 1.7 24.6 0.3 0.0 0.2 0.8 0.2 6.8 0.0 0.0 0.2 2.8 0.0 0.6 2.6 0.0 2.6 0.5 9.4 0.0 0.0 1.9 2.6 0.2 0.1 6.6 8.3 8.3 2.4 0.1 0.2 0.3 0.4 0.4 2.5 0.0 0.3 0.0 0.0 0.0 5.0 0.1 0.4 0.0 0.0 0.1 0.3 0.6 0.3 0.0 0.1 12.2 1.4 3.0 0.0 0.0 0.0 0.8 0.1 3.0 0.7 0.0 0.0 9.4 0.1 0.9 0.9 0.0 4.3 0.0 1.7 0.0 0.0 0.3 18.9 0.8 0.6 0.5 6.9 2.2 0.0 1.3 0.0 0.3 0.2 0.4 5.8 0.0 3.0 5.4 0.0 0.0 9.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.5 0.0 6.6 0.0 0.0 1.9 1.2 2.4 0.4 0.9 0.6 0.2 0.7 0.0 1.1 0.0 0.0 0.6 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.0 0.0 1.3 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.7 0.1 0.2 0.0 0.0 0.0 ELOVL4 "CT118, SCA34, STGD2, STGD3" ENSG00000118402 "ELOVL fatty acid elongase 4" Q9GZR5 6 79914812-79947580 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 92.6;skin 1: 41.9" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 139.4;Rod photoreceptor cells: 278.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 19.1" "Lineage enriched" "Detected in single" 191 "T-cells: 19.1" "Cell line enhanced" "Detected in many" "JURKAT: 25.2;MOLT-4: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-2)" "unprognostic (8.58e-3)" "unprognostic (2.38e-2)" "unprognostic (3.08e-6)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.27e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (3.46e-1)" "unprognostic (6.91e-3)" "unprognostic (3.39e-1)" "unprognostic (1.38e-2)" "unprognostic (3.45e-3)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.27e-4)" 1.2 2.6 6.0 1.6 8.8 0.6 4.7 16.0 15.5 2.2 1.4 2.3 0.2 1.1 2.8 1.6 11.0 0.9 2.2 0.9 8.4 10.4 1.9 0.6 0.7 0.9 6.3 4.8 2.3 1.0 10.7 7.6 2.2 19.3 4.7 1.6 15.5 3.0 2.3 0.7 41.9 1.3 3.2 3.5 1.0 1.0 5.8 2.3 92.6 2.0 4.4 2.2 1.8 2.6 0.0 0.0 0.0 0.0 0.0 19.1 0.6 0.0 0.5 6.7 7.4 5.6 5.4 1.0 3.4 3.8 2.9 6.4 0.9 0.0 0.0 0.6 4.7 12.1 0.7 8.6 4.8 2.2 0.0 11.2 0.2 1.4 0.0 5.2 2.6 1.0 4.4 1.8 3.0 3.1 4.2 4.8 25.2 0.0 0.0 6.1 1.1 19.2 0.0 6.4 0.0 3.5 0.0 9.6 0.0 0.1 0.0 8.9 2.6 3.7 5.9 1.0 4.8 2.3 0.2 0.4 1.3 2.6 2.0 2.6 4.5 8.9 0.0 3.1 0.0 2.0 0.0 0.0 0.0 1.8 0.0 19.1 0.0 2.6 3.1 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.2 0.6 6.0 8.8 16.0 13.5 8.4 10.4 6.3 4.8 19.3 2.3 0.0 0.0 0.0 2.3 10.1 47.3 0.4 0.0 0.0 4.5 0.0 139.4 0.8 0.0 0.1 4.5 0.8 0.0 0.0 0.0 1.6 3.2 2.0 0.0 0.0 0.2 39.7 8.5 0.0 0.0 1.8 1.1 0.0 3.3 0.0 0.0 35.8 0.0 0.0 3.2 2.3 278.2 0.0 5.3 13.5 7.8 33.1 0.8 0.5 0.0 0.7 ELOVL6 "FLJ23378, LCE, MGC5487" ENSG00000170522 "ELOVL fatty acid elongase 6" Q9H5J4 4 110045846-110199199 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.9" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 35.3;Hepatocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 4.8;MAIT T-cell: 4.9;memory CD4 T-cell: 2.1;memory CD8 T-cell: 3.2;naive CD8 T-cell: 2.3;NK-cell: 5.6" "Group enriched" "Detected in many" 20 "NK-cells: 5.6;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042355 Uncertain NA NA "HPA042355: AB_10796577" "unprognostic (3.92e-2)" "unprognostic (9.47e-2)" "prognostic favorable (6.74e-4)" "unprognostic (8.09e-2)" "unprognostic (2.06e-2)" "unprognostic (1.08e-3)" "unprognostic (4.16e-1)" "unprognostic (3.01e-3)" "unprognostic (4.03e-1)" "unprognostic (1.47e-1)" "unprognostic (2.33e-1)" "unprognostic (1.90e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (5.32e-2)" 7.6 9.8 7.7 7.9 9.4 3.7 7.9 10.9 12.3 4.0 14.5 8.6 0.9 11.8 3.4 2.7 16.6 2.9 11.1 8.1 6.6 5.9 6.4 43.9 3.3 2.2 7.5 9.4 2.0 2.5 10.6 7.1 2.6 15.7 3.0 14.1 4.3 6.9 3.2 1.4 12.3 10.2 5.7 20.0 1.9 16.9 1.3 7.3 1.1 2.3 7.9 4.0 6.0 5.0 0.1 0.0 0.2 0.1 5.6 4.9 0.8 13.4 8.0 29.3 7.3 19.7 20.7 15.0 9.4 4.6 3.3 7.4 3.9 23.7 1.1 0.8 7.2 11.3 12.6 22.2 27.5 7.7 4.6 6.4 15.2 8.7 10.2 12.2 14.8 9.9 18.0 6.4 16.8 8.0 10.9 6.5 1.6 18.1 31.5 7.3 7.1 3.4 1.5 13.4 8.2 4.8 2.3 11.5 3.9 21.4 10.1 5.2 11.2 4.8 32.0 4.1 13.9 5.4 0.1 2.4 6.7 7.9 11.2 11.4 1.5 4.9 24.9 10.2 0.0 1.7 0.2 0.1 0.1 4.8 0.0 4.9 0.1 2.1 3.2 0.0 0.1 0.7 2.3 0.2 5.6 0.0 0.0 0.2 0.8 7.7 9.4 10.9 12.3 6.6 5.9 7.5 9.4 15.7 7.3 0.0 5.6 0.0 2.3 1.5 22.3 2.4 7.6 1.4 6.8 10.4 35.3 1.2 5.0 6.1 3.7 1.1 16.0 0.0 7.3 21.6 3.9 2.4 5.8 43.3 1.6 25.4 2.9 4.3 2.7 2.7 1.1 0.7 0.0 0.0 12.4 4.4 12.1 24.6 1.1 5.6 15.9 6.5 3.8 0.2 1.2 6.0 1.7 12.8 12.4 4.4 ELP5 "C17orf81, DERP6" ENSG00000170291 "Elongator acetyltransferase complex subunit 5" Q8TE02 17 7251416-7259940 "Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 320.1;Late spermatids: 402.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023279, HPA052411" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023279: AB_1847613, HPA052411: " "unprognostic (3.73e-2)" "unprognostic (9.21e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-3)" "unprognostic (7.72e-2)" "unprognostic (1.22e-1)" "unprognostic (7.70e-2)" "unprognostic (1.53e-1)" "unprognostic (7.83e-3)" "unprognostic (1.60e-2)" "prognostic favorable (2.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.83e-1)" "unprognostic (8.07e-2)" "unprognostic (2.71e-1)" "unprognostic (1.62e-1)" "unprognostic (2.30e-2)" 12.4 18.2 14.0 13.6 14.0 11.8 10.4 14.1 17.8 11.1 15.5 12.2 13.3 11.4 13.1 13.5 10.9 12.6 11.9 23.0 13.2 12.0 16.5 21.3 9.1 15.0 13.6 12.8 15.2 10.6 9.6 15.9 12.6 12.5 14.0 11.0 16.4 20.9 12.7 28.3 7.8 14.6 18.0 11.2 14.1 10.7 103.3 12.4 23.6 15.7 17.2 16.1 11.6 11.0 31.1 36.7 16.3 29.3 27.6 34.7 21.5 12.4 35.3 15.9 14.4 28.0 22.2 6.9 11.2 13.3 18.0 16.7 35.2 8.2 24.8 12.4 17.8 31.6 9.4 40.2 26.4 13.0 15.3 56.6 22.8 11.9 32.0 13.9 16.2 9.0 15.6 19.9 12.2 24.3 11.4 15.3 31.6 15.7 6.7 27.9 21.1 41.0 31.0 13.1 13.1 24.5 35.3 17.9 13.4 20.0 11.8 7.8 15.5 21.8 6.6 17.2 16.6 9.4 11.8 17.3 10.4 12.2 19.9 17.8 7.8 10.4 28.8 18.9 15.8 13.4 16.3 25.3 12.4 27.9 29.3 34.7 31.1 24.9 25.5 30.0 31.0 26.4 31.2 4.4 27.6 19.3 36.7 33.8 21.5 14.0 14.0 14.1 17.8 13.2 12.0 13.6 12.8 12.5 12.4 8.9 9.4 30.5 41.1 19.6 21.3 59.0 10.2 6.7 18.2 43.6 19.6 35.0 82.9 28.6 320.1 27.1 27.3 0.0 11.8 67.2 24.2 62.2 6.9 20.8 36.0 27.0 40.0 14.1 10.8 402.6 31.7 24.4 20.3 27.1 33.9 22.3 22.6 35.1 31.1 76.9 29.6 38.8 32.4 100.6 36.9 19.1 48.4 32.0 48.2 43.2 ELSPBP1 "E12, EDDM12, HE12" ENSG00000169393 "Epididymal sperm binding protein 1" Q96BH3 19 47994651-48025153 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "epididymis: 279.8" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 15.7;Early spermatids: 23.3;Horizontal cells: 17.5;Late spermatids: 14.5;Muller glia cells: 16.0;Rod photoreceptor cells: 68.3" "Cancer enhanced" "Detected in single" "melanoma: 0.9" "Region enriched" "Detected in single" 11 "hypothalamus: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 14.6;NB-4: 7.9" "Not detected" "Not detected" "HPA044256, HPA050341" Enhanced "Secreted in male reproductive system" NA NA "HPA044256: AB_2678879, HPA050341: AB_2681097" "unprognostic (1.51e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.1 279.8 0.0 0.0 0.0 0.0 0.1 1.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 17.5 0.0 0.0 0.0 14.5 0.6 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.4 0.0 68.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 EMB MGC71745 ENSG00000170571 Embigin Q6PCB8 5 50396192-50443248 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;intestine: 42.2;lymphoid tissue: 44.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 62.5;Cone photoreceptor cells: 102.1;T-cells: 112.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "THP-1: 70.3;U-937: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.01e-3)" "unprognostic (8.65e-2)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-2)" "unprognostic (8.31e-2)" "unprognostic (2.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (2.76e-5)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (1.22e-2)" "unprognostic (8.86e-3)" 15.0 16.4 1.7 21.7 2.0 43.3 8.4 1.1 2.9 2.7 18.9 1.4 0.5 21.7 1.6 5.6 6.5 4.7 6.1 16.7 2.2 4.7 4.2 1.9 10.6 44.1 3.8 1.4 2.7 1.8 15.2 8.0 6.6 4.5 9.5 3.6 4.0 7.4 6.9 2.7 15.9 42.2 2.5 3.3 20.6 3.7 10.5 1.8 15.9 13.7 3.6 17.0 5.3 2.9 9.9 11.4 16.4 14.7 16.4 26.1 16.1 8.6 0.7 1.7 0.0 0.7 2.3 0.1 0.4 0.0 0.7 0.0 0.0 22.7 17.3 0.4 0.8 0.0 13.1 3.9 11.1 0.1 5.3 8.8 8.2 2.8 0.0 0.1 16.4 0.0 0.1 6.1 1.8 7.5 11.8 0.0 6.9 0.0 23.1 13.5 10.0 10.1 9.7 6.6 0.0 4.4 16.1 0.0 22.6 0.0 7.7 5.2 4.7 0.0 2.6 0.2 3.6 1.0 70.3 0.0 0.0 8.3 0.0 0.0 0.2 0.0 14.3 0.0 30.5 2.1 3.7 14.7 16.4 21.5 1.9 26.1 9.9 19.4 19.3 9.7 6.5 11.5 15.5 13.7 16.4 0.6 11.4 23.4 16.1 1.7 2.0 1.1 2.9 2.2 4.7 3.8 1.4 4.5 1.8 62.5 15.9 38.9 1.7 16.3 3.3 1.5 2.5 32.1 40.9 0.0 102.1 10.9 0.0 0.8 0.4 3.6 2.6 46.7 0.8 7.9 5.8 13.2 18.5 1.3 19.1 1.6 7.0 24.5 40.6 0.5 2.6 44.9 10.1 18.0 6.4 0.9 9.3 2.9 6.3 0.2 9.0 0.0 5.9 0.9 1.9 11.0 7.1 112.1 9.7 1.6 EMC10 "C19orf63, HSM1, HSS1, INM02" ENSG00000161671 "ER membrane protein complex subunit 10" Q5UCC4 19 50476400-50490870 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 147.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 52.1;PC-3: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053905 Uncertain "Secreted to blood" NA NA "HPA053905: AB_2682303" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (9.86e-3)" "unprognostic (1.65e-1)" "unprognostic (6.94e-2)" "unprognostic (8.38e-3)" "unprognostic (3.23e-2)" "unprognostic (9.87e-2)" "unprognostic (2.77e-1)" "unprognostic (2.99e-1)" "prognostic favorable (4.39e-4)" "unprognostic (5.01e-2)" "prognostic favorable (6.64e-6)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" 17.8 24.4 21.9 12.4 21.2 17.2 11.1 10.8 32.1 14.5 22.4 41.1 23.1 23.4 17.4 24.9 14.4 22.7 24.9 21.9 21.8 19.2 33.8 43.2 15.3 19.8 23.0 20.0 22.4 25.6 32.5 48.2 21.1 22.2 20.5 8.7 29.8 29.4 19.0 147.8 13.9 28.7 8.5 31.4 14.6 33.1 24.3 19.1 15.4 34.0 13.7 16.4 12.6 11.7 12.2 10.8 11.2 10.5 4.7 10.3 6.8 17.2 21.4 0.8 8.3 2.4 3.0 0.2 16.8 3.1 1.5 1.6 0.2 11.9 5.7 0.2 3.0 2.7 14.5 1.0 2.7 0.5 22.0 52.1 1.2 9.5 0.0 4.1 4.9 33.5 3.7 3.1 1.5 1.2 1.4 3.6 5.0 11.0 12.2 3.0 12.1 7.8 0.1 0.0 6.8 37.2 13.5 2.6 18.4 6.8 15.8 13.3 29.6 24.8 8.0 8.8 1.0 8.4 9.1 6.9 1.0 23.0 6.3 9.1 13.6 33.8 4.7 6.8 3.5 8.3 7.8 10.5 11.2 8.1 8.0 6.9 9.4 8.6 8.6 7.7 12.2 10.3 10.0 4.5 4.7 5.9 10.8 6.8 6.8 21.9 21.2 10.8 32.1 21.8 19.2 23.0 20.0 22.2 19.1 59.6 135.5 78.7 47.6 26.4 78.3 8.1 86.6 29.4 64.8 66.3 76.6 114.1 19.9 150.7 157.7 33.8 118.0 0.0 98.3 126.3 46.9 69.4 51.9 61.8 121.6 35.0 203.6 53.4 97.1 29.5 63.9 74.5 79.2 85.6 93.3 93.2 107.1 129.8 108.2 56.1 61.3 6.5 41.2 14.0 52.6 27.4 126.3 73.4 108.6 54.5 EMC6 "MGC2963, TMEM93" ENSG00000127774 "ER membrane protein complex subunit 6" Q9BV81 17 3668815-3669668 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062681 Uncertain Approved Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA062681: AB_2684831" "unprognostic (2.21e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.21e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (6.20e-3)" "unprognostic (4.03e-2)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.86e-1)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (7.58e-3)" "unprognostic (4.17e-2)" "unprognostic (1.94e-1)" "unprognostic (6.37e-2)" "unprognostic (3.27e-1)" "unprognostic (6.32e-2)" 14.6 18.5 15.5 12.2 15.5 21.4 12.5 9.9 21.2 8.9 15.9 14.9 10.0 16.9 9.8 10.8 15.6 9.5 12.1 26.2 14.5 12.3 19.8 42.1 10.2 10.7 14.2 11.0 8.7 24.5 7.6 9.3 16.6 12.2 12.9 9.7 14.6 17.8 10.5 100.1 10.6 16.8 10.1 13.6 12.5 18.8 27.4 11.1 14.3 14.9 31.5 14.3 9.7 9.1 34.5 56.1 40.7 42.0 25.2 43.4 38.5 31.2 30.8 13.5 14.1 9.7 7.8 26.0 22.5 11.0 18.5 17.1 18.6 11.8 19.7 32.8 10.5 16.3 30.2 15.6 15.8 13.4 19.0 58.3 14.3 21.6 25.8 14.1 9.9 14.7 9.8 18.0 17.0 11.9 14.6 14.0 23.7 17.9 14.3 13.5 19.0 20.2 29.2 19.4 19.1 34.8 18.9 12.6 18.6 25.9 8.9 11.1 20.2 18.4 14.5 23.9 14.1 16.9 10.7 15.3 15.5 19.2 23.3 32.8 14.0 15.4 12.9 24.3 13.0 18.6 34.5 42.0 40.7 34.9 39.7 32.0 34.5 39.0 38.3 35.8 32.3 40.6 36.7 31.6 25.2 27.9 56.1 43.4 38.5 15.5 15.5 9.9 21.2 14.5 12.3 14.2 11.0 12.2 11.1 14.9 23.4 62.6 99.3 79.0 40.5 0.3 94.3 53.5 23.9 55.8 33.4 102.2 140.9 117.4 202.1 52.2 55.0 23.3 123.7 126.4 43.1 113.2 54.3 108.8 90.3 31.8 49.3 39.3 53.3 121.5 35.6 54.6 64.1 101.0 61.0 85.4 129.4 63.1 32.2 149.9 38.8 38.8 51.5 146.4 87.0 89.1 107.9 52.2 68.0 156.9 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.3;epididymis: 10.6;testis: 21.9" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 4.0;Spermatocytes: 10.5;Spermatogonia: 8.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 29 "basophil: 15.3" "Lineage enriched" "Detected in single" 29 "granulocytes: 15.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 1.0 0.9 1.6 2.5 2.0 6.0 0.8 0.8 1.8 1.3 1.9 3.0 0.0 1.1 0.9 10.6 2.6 0.7 1.6 0.7 0.9 0.6 0.7 0.8 1.1 3.3 1.4 0.9 1.3 0.6 0.2 0.5 2.4 1.5 0.7 2.0 1.0 1.6 0.1 1.4 1.5 2.1 0.8 1.9 2.2 1.1 21.9 2.8 5.7 0.5 0.9 3.9 1.0 1.2 0.1 0.5 15.3 0.0 0.0 0.1 0.2 7.4 11.0 14.7 7.7 0.7 1.5 10.6 7.8 3.0 10.9 10.1 17.3 6.1 6.0 10.4 3.1 6.8 5.9 13.6 6.2 15.6 11.7 10.7 14.3 12.7 8.0 0.0 5.8 4.7 0.3 0.4 12.6 5.2 1.4 2.5 17.3 8.6 14.4 6.4 8.2 13.3 7.5 8.5 7.7 7.6 13.8 28.5 8.3 2.4 3.0 5.7 11.4 4.8 2.6 4.5 12.3 9.4 6.7 1.7 14.2 8.5 9.3 10.7 9.0 9.1 5.8 4.5 6.6 8.7 15.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 1.6 2.0 0.8 1.8 0.9 0.6 1.4 0.9 1.5 2.8 0.0 1.4 0.0 0.2 0.1 1.5 0.4 0.0 1.4 1.2 0.0 0.0 1.9 0.0 0.2 0.4 0.0 0.0 0.0 0.0 4.0 0.5 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.0 1.8 0.4 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.4 10.5 8.0 0.1 0.9 0.0 0.6 0.1 EME2 "FLJ00151, SLX2B" ENSG00000197774 "Essential meiotic structure-specific endonuclease subunit 2" A4GXA9 16 1773207-1781708 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.9" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 12.7;REH: 5.3;SCLC-21H: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045770 Uncertain NA NA "HPA045770: AB_2679447" "unprognostic (2.67e-2)" "unprognostic (1.77e-1)" "unprognostic (2.07e-1)" "unprognostic (2.94e-1)" "unprognostic (5.83e-2)" "prognostic favorable (2.86e-4)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (2.42e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (6.76e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "prognostic favorable (6.32e-5)" 2.7 1.8 1.4 2.0 9.9 1.1 1.1 3.4 2.5 1.9 1.9 0.6 0.3 3.0 1.6 2.5 6.4 1.5 0.4 1.2 2.7 0.8 1.3 0.5 1.8 1.0 0.4 1.7 0.7 1.6 0.4 6.3 0.8 2.9 3.7 0.2 0.3 2.1 4.0 1.1 1.0 1.5 0.4 0.3 1.9 5.1 1.1 0.3 2.0 2.6 2.3 2.7 2.3 0.9 0.5 0.8 0.4 0.3 0.0 0.5 0.1 0.5 0.1 0.0 0.5 0.2 0.0 1.3 2.2 0.0 0.2 0.0 0.2 1.0 3.8 1.8 0.1 0.0 3.5 0.0 0.1 0.0 4.7 12.7 1.1 0.5 0.2 0.0 1.4 3.0 0.1 0.2 0.0 0.0 0.1 0.2 0.7 3.5 0.1 0.1 0.4 0.9 0.5 1.7 0.2 1.7 5.3 0.5 2.3 0.1 0.1 5.3 1.4 2.3 0.9 0.1 0.0 1.5 0.5 1.8 0.3 1.1 0.4 0.9 3.4 1.3 3.0 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.5 0.5 0.5 0.4 0.1 0.4 0.0 0.2 0.8 0.0 0.1 1.4 9.9 3.4 2.5 2.7 0.8 0.4 1.7 2.9 0.3 3.0 10.9 5.1 1.0 2.4 12.6 0.8 0.0 0.0 6.8 3.5 7.9 1.7 0.0 1.6 1.5 1.4 5.8 0.0 1.9 1.0 1.6 2.4 0.0 2.5 3.2 4.8 6.4 3.1 3.8 0.4 1.1 3.1 3.3 3.6 3.9 3.2 2.9 0.0 1.4 1.2 7.6 0.0 2.1 1.8 1.9 2.5 2.1 2.9 5.6 1.1 EMID1 "EMI5, EMU1, hEmu1" ENSG00000186998 "EMI domain containing 1" Q96A84 22 29205851-29259597 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.0" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 23.3;granulocytes: 11.5;Ito cells: 14.7" "Cancer enhanced" "Detected in all" "endometrial cancer: 23.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "NK-cell: 2.3" "Lineage enriched" "Detected in single" 8 "NK-cells: 2.3" "Group enriched" "Detected in some" 4 "HEL: 13.2;NB-4: 45.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000592 Uncertain "Secreted in other tissues" NA NA "HPA000592: AB_1078737" "unprognostic (2.20e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-2)" "unprognostic (7.80e-3)" "unprognostic (2.40e-2)" "unprognostic (1.42e-1)" "unprognostic (3.46e-1)" "unprognostic (6.25e-3)" "unprognostic (3.75e-2)" "unprognostic (2.33e-1)" "unprognostic (5.24e-3)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.59e-1)" "unprognostic (1.76e-1)" "unprognostic (3.09e-2)" "unprognostic (1.08e-1)" 2.6 19.3 17.8 3.6 12.7 11.7 2.4 3.5 17.9 2.9 5.4 14.2 2.2 4.8 10.5 2.5 0.9 10.4 4.8 1.3 12.6 6.1 7.7 2.1 7.0 13.3 5.6 14.7 4.8 12.7 4.5 1.2 4.7 3.8 5.2 3.4 2.9 4.7 4.2 0.7 3.6 7.4 2.3 2.6 31.0 7.0 2.1 6.9 4.6 8.4 0.5 2.2 5.0 1.4 0.1 0.0 0.0 0.0 2.3 0.3 0.1 0.0 0.1 2.3 4.9 0.0 0.0 0.3 0.0 0.0 0.2 0.1 2.6 0.3 0.0 2.2 0.0 0.0 0.0 1.2 0.0 0.0 5.2 4.1 13.2 0.0 0.5 0.3 1.8 1.0 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.1 0.0 0.0 3.6 0.1 45.9 0.5 0.0 0.2 0.0 0.1 5.0 0.0 0.0 6.3 3.0 0.2 0.0 0.0 0.4 1.9 2.4 0.0 0.0 3.9 0.0 0.0 0.2 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 17.8 12.7 3.5 17.9 12.6 6.1 5.6 14.7 3.8 6.9 0.0 4.5 0.0 0.8 2.5 0.1 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.1 2.2 0.0 23.3 1.2 0.1 3.1 2.4 11.5 0.2 0.3 0.0 0.0 14.7 0.8 0.2 2.8 0.0 0.0 1.0 0.0 1.2 0.7 0.0 1.8 1.4 0.5 0.0 2.8 0.0 1.5 1.8 0.2 0.5 0.0 0.4 EMILIN2 "FLJ33200, FOAP-10" ENSG00000132205 "Elastin microfibril interfacer 2" Q9BXX0 18 2847030-2915993 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 83.7" "Cell type enhanced" "Detected in many" 8 "granulocytes: 45.1;Hofbauer cells: 53.4;Kupffer cells: 51.7;Macrophages: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 22.6;BEWO: 17.4;HL-60: 16.4;HMC-1: 27.9;HSkMC: 12.3;SuSa: 12.3;THP-1: 16.3;U-2197: 21.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "midbrain: 9.1;pons and medulla: 16.9;thalamus: 6.3" HPA064576 Supported "Secreted to extracellular matrix" NA NA 600000 "HPA064576: AB_2732717" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (7.91e-3)" "unprognostic (1.11e-2)" "unprognostic (3.98e-3)" "unprognostic (9.91e-3)" "prognostic unfavorable (6.30e-4)" "unprognostic (2.01e-1)" "unprognostic (1.15e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.49e-1)" "unprognostic (3.15e-3)" "unprognostic (3.72e-2)" "unprognostic (2.96e-1)" 32.3 1.4 0.9 8.4 0.7 4.9 14.5 0.3 0.8 5.8 3.9 1.1 2.2 1.1 6.8 6.7 3.9 5.2 4.3 9.6 1.0 1.1 2.0 1.3 10.9 24.4 3.1 0.0 11.0 1.8 83.7 0.6 34.9 3.7 4.6 2.0 2.4 2.9 1.0 3.9 3.0 2.4 5.7 16.4 6.9 1.9 2.8 0.3 2.8 3.0 4.1 1.8 7.9 6.6 0.5 2.1 8.0 2.3 3.1 0.9 0.6 0.1 0.1 1.3 0.0 22.6 9.4 17.4 3.5 0.0 0.6 1.1 2.5 0.0 0.0 0.2 8.6 0.2 0.0 0.4 0.0 1.2 0.0 1.2 0.2 0.1 0.1 0.8 16.4 27.9 12.3 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.5 2.2 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.6 12.3 0.0 16.3 0.2 0.0 2.4 21.4 0.2 0.0 0.0 0.0 1.4 4.1 0.4 8.0 2.3 0.6 0.9 1.6 0.7 0.4 0.9 0.6 2.1 0.5 0.5 0.9 2.3 3.1 1.4 1.4 0.6 0.6 0.9 0.7 0.3 0.8 1.0 1.1 3.1 0.0 3.7 0.3 3.0 7.9 13.7 4.1 5.0 0.0 14.9 2.5 6.7 9.1 3.5 0.0 3.6 1.7 2.4 1.6 8.0 1.1 0.0 1.0 8.1 19.7 2.5 45.1 0.0 53.4 0.0 2.9 3.1 51.7 2.1 14.1 73.7 5.0 24.4 3.9 0.0 1.8 8.0 1.1 1.1 0.3 0.0 8.5 4.7 3.5 3.4 2.4 4.9 4.5 1.7 EMILIN3 "C20orf130, dJ620E11.4, EMILIN5" ENSG00000183798 "Elastin microfibril interfacer 3" Q9NT22 20 41359966-41366827 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 49.9" "Cell type enhanced" "Detected in some" 25 "Leydig cells: 1.7;Peritubular cells: 4.6" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.9;HAP1: 12.1;NTERA-2: 7.7;SCLC-21H: 14.4" "Region enriched" "Detected in single" 29 "cerebellum: 3.7" "Low region specificity" "Detected in single" "HPA044034, HPA059912, HPA078559" Enhanced Approved "Golgi apparatus,Microtubules,Cytokinetic bridge" "Secreted to extracellular matrix" NA NA 650000 "Golgi apparatus" "Microtubules, Cytokinetic bridge" "HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: " "unprognostic (1.66e-4)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.14e-1)" "unprognostic (2.65e-1)" "unprognostic (2.15e-2)" "unprognostic (1.71e-1)" "unprognostic (7.66e-2)" "unprognostic (2.18e-3)" "unprognostic (2.57e-1)" "unprognostic (6.54e-2)" "unprognostic (7.66e-2)" "unprognostic (3.13e-7)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (9.62e-2)" 0.9 1.9 2.9 1.6 2.0 0.5 3.5 0.7 8.2 7.1 4.1 1.9 8.5 1.1 2.7 49.9 1.1 3.2 0.9 6.0 3.0 2.9 0.8 0.6 0.7 0.6 3.8 0.7 9.2 0.6 0.5 1.6 0.6 2.7 8.1 0.8 5.8 1.5 10.0 1.3 3.4 1.4 1.6 2.2 0.6 1.9 4.3 2.3 0.3 0.7 2.9 0.8 2.4 5.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 12.1 0.0 0.3 0.0 1.4 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.4 1.4 0.0 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.9 2.0 0.7 8.2 3.0 2.9 3.8 0.7 2.7 2.3 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 EML5 "EMAP-2, HuEMAP-2" ENSG00000165521 "Echinoderm microtubule associated protein like 5" Q05BV3 14 88612431-88792752 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;ovary: 26.8" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 29.6;Cone photoreceptor cells: 56.9;Horizontal cells: 19.1;Rod photoreceptor cells: 32.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 10.6;SH-SY5Y: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054019, HPA055379" Uncertain NA NA "HPA054019: AB_2682345, HPA055379: AB_2682799" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (2.49e-1)" "unprognostic (8.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.67e-4)" "unprognostic (3.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.63e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.36e-1)" "unprognostic (1.11e-4)" "unprognostic (1.21e-2)" "unprognostic (1.05e-1)" "unprognostic (3.82e-1)" "unprognostic (1.53e-3)" 0.8 9.1 5.1 1.5 9.0 0.8 1.4 23.0 5.0 0.8 1.6 1.9 0.1 1.2 1.7 0.7 1.6 1.7 1.1 0.9 5.8 2.6 1.9 1.1 1.2 1.5 1.6 4.7 26.8 2.2 6.0 13.7 0.7 3.8 7.6 0.7 4.5 1.6 0.7 0.6 1.3 1.4 1.8 1.6 1.5 1.6 4.9 2.1 0.9 3.9 0.8 1.1 1.2 0.9 0.9 0.3 0.0 0.2 0.0 2.4 0.4 2.0 1.4 2.0 1.9 0.0 0.0 4.0 2.0 0.3 0.2 0.1 0.6 1.7 1.0 0.8 0.0 1.1 4.7 3.7 0.1 0.1 3.2 2.9 1.4 1.3 1.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 1.9 0.0 5.0 1.5 10.6 0.0 2.6 3.6 1.2 1.6 1.8 2.2 2.4 2.1 1.0 0.1 4.1 5.4 22.8 2.6 4.6 1.5 1.5 2.0 1.5 0.8 2.2 0.4 0.3 2.7 4.9 1.3 4.4 0.9 1.3 0.9 0.0 0.0 0.0 0.2 0.2 2.4 0.9 0.5 0.2 0.3 0.5 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.4 5.1 9.0 23.0 5.0 5.8 2.6 1.6 4.7 3.8 2.1 0.0 4.3 0.8 0.6 0.5 29.6 1.0 0.0 8.1 2.3 0.0 56.9 0.1 0.0 0.7 2.6 0.1 0.0 0.0 0.3 0.1 0.4 5.4 1.1 0.0 0.0 19.1 10.3 0.0 0.0 2.3 0.6 0.0 3.3 0.0 0.1 3.3 0.2 0.0 1.1 0.3 32.2 0.0 0.9 7.4 8.3 0.4 0.1 0.5 0.0 0.6 EML6 FLJ42562 ENSG00000214595 "Echinoderm microtubule associated protein like 6" Q6ZMW3 2 54723499-54972025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.2;lymphoid tissue: 11.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 25.5;Cone photoreceptor cells: 53.0;Horizontal cells: 36.5;Rod photoreceptor cells: 32.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory B-cell: 2.5" "Lineage enriched" "Detected in single" 26 "B-cells: 2.5" "Cell line enhanced" "Detected in some" "Daudi: 7.3;SCLC-21H: 20.5;U-698: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062808, HPA068759" Uncertain Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA062808: AB_2684872, HPA068759: AB_2686027" "unprognostic (1.06e-1)" "unprognostic (6.89e-4)" "unprognostic (7.83e-2)" "unprognostic (9.96e-2)" "unprognostic (6.24e-2)" "unprognostic (3.26e-4)" "unprognostic (5.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (6.27e-2)" "unprognostic (6.85e-6)" "unprognostic (5.00e-1)" "unprognostic (5.81e-2)" "unprognostic (6.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (5.13e-3)" 0.1 3.3 1.8 4.0 2.8 0.0 0.2 7.2 4.2 0.0 0.6 0.6 0.0 1.3 0.3 0.4 0.1 0.0 1.9 2.1 1.3 0.2 0.1 7.9 1.5 0.0 0.5 3.0 3.4 1.4 0.4 0.8 0.1 0.4 0.6 0.8 1.8 0.3 0.5 2.7 0.4 1.5 3.1 11.9 0.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 1.1 0.7 0.2 1.5 0.1 0.2 0.2 0.2 0.6 0.2 7.3 0.1 0.4 0.3 0.2 1.0 0.3 0.3 0.7 0.3 0.4 0.6 2.8 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.1 4.0 0.0 1.2 0.0 0.7 1.4 0.2 0.3 0.1 1.2 0.6 0.5 0.6 0.0 0.7 20.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.6 0.4 0.4 5.0 1.3 23.3 1.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.2 1.6 3.3 25.5 1.4 0.0 5.3 5.7 3.5 53.0 0.4 0.0 0.1 12.7 1.7 0.4 0.0 0.4 0.4 0.7 1.5 0.0 0.8 1.0 36.5 2.4 1.8 1.3 9.6 0.6 1.0 0.0 0.0 1.7 19.3 0.1 0.0 0.7 0.5 32.8 0.0 2.1 3.9 1.9 3.9 0.1 0.0 0.2 2.3 EMP1 "CL-20, TMP" ENSG00000134531 "Epithelial membrane protein 1" P54849 12 13196716-13219939 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 240.9;lymphoid tissue: 129.3" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 28.6" "Cell type enriched" "Detected in some" 7 "myeloid DC: 7.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 7.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051931, HPA056250" Approved Nucleoplasm NA NA Nucleoplasm "HPA051931: , HPA056250: " "unprognostic (1.40e-2)" "unprognostic (7.30e-2)" "unprognostic (8.01e-2)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (8.41e-3)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (7.46e-4)" "unprognostic (2.98e-1)" "unprognostic (4.84e-2)" "unprognostic (3.05e-2)" "unprognostic (3.45e-2)" "unprognostic (3.25e-1)" "prognostic unfavorable (9.69e-8)" 63.3 5.0 2.7 8.0 10.4 2.1 20.8 0.8 3.9 51.3 11.6 5.5 4.0 4.6 14.0 10.4 240.9 9.9 25.2 16.1 7.3 2.8 8.9 4.4 18.1 5.9 5.3 0.9 5.7 10.2 2.9 2.8 10.6 28.6 6.3 6.9 17.8 45.4 2.8 12.0 16.8 10.7 17.6 9.7 8.5 6.0 5.2 3.0 0.6 22.5 99.1 129.3 14.1 80.6 0.0 7.0 0.0 0.5 0.1 0.1 0.0 38.9 2.0 1.0 0.2 63.1 132.0 0.1 28.8 52.9 14.9 19.0 0.2 66.0 0.2 20.6 91.8 6.5 82.1 1.1 3.8 20.2 0.7 0.0 0.1 6.9 0.0 15.2 0.2 0.2 41.4 5.6 47.3 13.9 11.8 34.0 0.0 0.2 0.6 35.0 0.1 0.0 0.8 0.7 7.3 6.7 0.1 4.0 0.3 43.5 0.4 0.0 0.0 12.9 1.9 21.5 7.7 0.3 0.2 37.2 33.5 11.8 31.4 15.5 0.1 0.4 0.2 48.8 0.2 39.3 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 2.7 10.4 0.8 3.9 7.3 2.8 5.3 0.9 28.6 3.0 190.6 90.0 2.7 198.6 616.6 0.0 9.5 2.5 87.0 247.9 17.4 0.0 0.8 13.3 17.9 0.7 293.7 59.6 0.0 3.9 1.5 489.5 352.1 46.5 2.0 41.5 0.0 45.6 127.7 32.1 0.5 64.5 93.9 448.7 7.2 4.0 2.5 37.6 27.1 102.9 0.2 0.0 6.5 173.1 0.7 0.5 601.1 0.9 5.1 5.6 926.6 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580698 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 118.7" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 3868.0;Suprabasal keratinocytes: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;RT4: 40.9;SK-BR-3: 58.8;T-47d: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 16.5 2.0 5.0 7.9 5.1 0.0 26.2 3.4 4.7 14.8 10.4 3.4 6.1 4.2 7.3 13.8 35.7 7.4 7.3 14.0 5.5 3.0 3.1 47.5 118.7 5.7 5.4 2.5 14.0 3.2 19.9 3.2 23.5 5.3 11.1 10.0 10.8 9.9 5.8 7.7 40.2 6.6 12.8 3.4 5.3 9.3 5.6 4.1 2.2 7.5 26.4 18.4 10.6 16.3 1.3 1.1 4.1 1.1 1.4 1.0 0.4 6.3 8.8 3.6 4.3 8.2 7.1 7.2 9.1 8.4 5.5 8.3 28.8 22.3 0.0 2.9 10.9 4.0 28.3 9.3 11.2 7.3 0.0 5.9 0.0 18.5 15.7 1.4 0.0 0.1 4.3 3.0 7.3 0.7 1.2 2.3 0.0 2.1 0.6 15.2 59.5 0.1 0.1 4.2 10.3 2.1 1.6 4.2 13.8 1.2 40.9 5.1 5.8 11.2 58.8 3.3 11.0 35.9 1.4 1.2 17.6 7.6 5.9 5.0 0.1 0.2 0.0 7.7 0.1 17.2 3.4 1.0 1.0 0.8 0.8 1.0 1.0 0.8 0.7 0.5 1.3 0.9 0.9 4.1 1.4 1.1 1.1 0.8 0.4 5.0 5.1 3.4 4.7 5.5 3.0 5.4 2.5 5.3 4.1 3868.0 343.3 4.5 123.1 317.0 1.8 48.0 109.5 153.9 326.4 40.1 0.0 59.0 0.0 2.5 4.2 191.2 51.9 0.0 60.2 16.3 121.0 91.1 34.8 181.1 8.8 0.0 100.6 112.3 14.0 5.0 176.6 42.0 82.7 58.7 141.3 5.2 27.3 172.1 259.6 0.0 1.1 51.8 141.5 2.3 13.2 1026.6 40.2 4.3 139.9 220.6 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 165.9" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 530.6;Hofbauer cells: 548.3;Kupffer cells: 540.8;Macrophages: 782.1;Melanocytes: 1059.5" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 116.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.31e-7)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 27.6 23.4 10.4 26.5 12.6 66.2 28.7 7.2 8.4 50.6 40.3 9.2 14.6 8.4 45.9 22.6 26.9 26.1 21.1 37.9 10.8 6.9 15.6 7.0 36.1 48.0 15.2 6.7 41.4 6.4 2.2 6.1 29.9 12.7 30.7 15.4 24.7 11.3 23.1 13.2 16.3 20.8 46.7 19.1 27.8 19.2 18.2 8.2 16.2 11.6 13.4 25.6 36.8 30.6 44.9 54.8 165.9 91.0 59.7 119.1 124.8 5.6 63.2 3.5 10.1 56.2 87.8 0.1 39.0 71.1 51.7 45.8 6.1 20.4 0.7 8.8 86.6 26.7 1.0 3.7 4.2 31.8 18.6 1.6 27.0 16.6 3.7 47.2 13.3 28.3 47.6 0.8 53.0 36.6 38.4 22.1 6.1 17.8 46.4 79.0 0.9 2.0 116.0 4.7 1.2 16.0 1.6 12.2 27.4 44.3 0.0 0.1 0.2 17.7 0.1 10.1 6.8 0.2 20.4 36.4 46.8 20.3 36.9 30.6 24.5 30.4 1.7 27.7 17.6 31.7 165.9 77.2 105.6 109.2 91.0 90.4 44.9 114.8 106.6 54.8 35.4 65.7 78.2 85.7 59.7 86.6 40.8 119.1 124.8 10.4 12.6 7.2 8.4 10.8 6.9 15.2 6.7 12.7 8.2 0.0 5.0 254.5 67.7 246.9 2.2 3.9 15.3 5.3 11.4 31.4 0.0 10.5 5.0 62.4 5.0 137.6 1.3 0.0 9.8 19.7 530.6 38.3 254.8 4.7 548.3 0.0 5.8 114.8 540.8 9.1 310.7 782.1 1059.5 206.4 2.9 65.0 72.6 17.3 204.0 6.5 3.3 103.5 237.6 9.8 4.5 166.0 16.9 200.3 2.6 22.6 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;kidney: 27.4" "Group enriched" "Detected in some" 8 "Collecting duct cells: 52.4;Proximal tubular cells: 31.6" "Cancer enhanced" "Detected in some" "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6" "HPA006230, HPA006421" Approved Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA006230: AB_2667542, HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.3 5.2 0.2 3.1 0.1 0.1 0.1 14.8 0.1 0.5 0.0 0.8 1.4 0.1 6.0 0.2 0.1 0.1 0.2 5.0 0.4 27.4 0.2 0.1 0.2 0.4 1.5 0.2 0.4 4.8 0.2 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.2 0.2 1.1 0.1 0.1 0.1 0.3 2.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.8 0.0 0.0 1.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.1 0.1 14.8 5.0 0.4 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 52.4 0.0 0.0 5.0 0.0 0.8 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 EMX2 ENSG00000170370 "Empty spiracles homeobox 2" Q04743 10 117542444-117549546 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3" "Cell type enhanced" "Detected in many" 17 "Collecting duct cells: 226.8;Distal tubular cells: 76.3;Leydig cells: 55.8;Proximal tubular cells: 156.2" "Group enriched" "Detected in many" 13 "endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 17.2;fHDF/TERT166: 19.0;RPTEC TERT1: 19.2;RT4: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003497, HPA065294" Enhanced Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA003497: , HPA065294: AB_2685455" "unprognostic (1.53e-1)" "prognostic favorable (2.80e-4)" "unprognostic (7.21e-3)" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (3.53e-2)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (7.33e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "prognostic favorable (2.28e-13)" "unprognostic (3.65e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.88e-2)" 4.6 0.5 11.5 0.6 10.3 0.5 1.4 0.5 12.5 23.5 0.7 7.3 46.8 0.5 40.5 53.9 0.7 25.4 1.2 0.6 14.7 2.1 25.5 0.5 0.5 0.7 1.8 10.4 5.7 0.5 0.6 1.1 0.6 2.5 1.9 0.5 3.4 1.3 76.3 5.1 4.7 0.5 22.6 0.6 0.5 0.5 3.6 6.2 0.0 0.5 1.2 0.7 4.2 2.4 0.7 0.5 2.4 0.9 1.0 0.7 0.1 0.0 0.0 0.0 1.9 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 17.2 19.0 0.0 0.1 0.4 0.0 0.0 0.0 1.8 0.5 0.1 0.1 0.0 0.1 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.1 19.2 6.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.4 0.7 0.6 0.5 1.1 1.0 0.9 0.5 0.6 0.1 11.5 10.3 0.5 12.5 14.7 2.1 1.8 10.4 2.5 6.2 0.0 0.0 0.0 1.9 9.5 0.0 1.1 0.0 0.0 0.0 226.8 0.0 0.0 76.3 0.0 1.2 0.8 0.0 0.0 0.0 0.3 13.4 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 55.8 1.8 20.3 0.0 0.0 0.0 0.0 0.0 38.5 156.2 0.0 51.8 12.2 0.1 0.2 6.6 0.1 0.0 0.0 1.1 EN1 ENSG00000163064 "Engrailed homeobox 1" Q05925 2 118842171-118847678 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0" "Cell type enriched" "Detected in some" 5 "Melanocytes: 11.8" "Cancer enhanced" "Detected in many" "breast cancer: 5.6" "Group enriched" "Detected in some" 10 "midbrain: 11.4;pons and medulla: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8" "Region enriched" "Detected in single" 5 "midbrain: 5.9" "Region enriched" "Detected in some" 5 "midbrain: 23.9" "CAB014884, HPA073141" Enhanced Approved "Nucleoplasm,Nucleoli rim" NA NA "Nucleoli rim" Nucleoplasm "CAB014884: , HPA073141: AB_2686573" "unprognostic (5.20e-2)" "unprognostic (1.61e-1)" "unprognostic (5.78e-2)" "unprognostic (4.84e-7)" "unprognostic (1.87e-3)" "unprognostic (1.90e-1)" "unprognostic (1.95e-3)" "unprognostic (1.16e-1)" "unprognostic (2.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.46e-1)" "unprognostic (3.38e-9)" "unprognostic (2.15e-2)" "unprognostic (1.88e-1)" "unprognostic (1.70e-1)" "unprognostic (9.30e-3)" 5.6 0.1 0.0 0.1 0.4 0.0 2.7 0.9 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 11.4 0.0 0.1 0.0 0.1 0.0 0.0 8.8 0.1 0.1 0.2 0.7 0.1 20.1 10.0 0.1 0.1 2.7 0.1 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.5 0.2 14.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 4.2 0.4 0.5 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 8.8 0.9 9.8 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.2 0.1 11.4 0.0 8.8 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 2.3 0.0 0.0 0.0 0.0 EN2 ENSG00000164778 "Engrailed homeobox 2" P19622 7 155458129-155464831 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 26.5" "Cell type enhanced" "Detected in single" 16 "Spermatocytes: 1.2" "Cancer enhanced" "Detected in many" "melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 27.5;AN3-CA: 10.1;HAP1: 5.9;HEK 293: 16.7;SK-MEL-30: 8.1" "Region enriched" "Detected in some" 8 "cerebellum: 31.1" "Region enriched" "Detected in some" 6 "cerebellum: 71.6" "HPA045646, HPA069809" Supported "Nucleoplasm,Nucleoli fibrillar center" No No Nucleoplasm "Nucleoli fibrillar center" "HPA045646: AB_2679404, HPA069809: AB_2686205" "unprognostic (2.44e-3)" "unprognostic (1.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.99e-3)" "prognostic unfavorable (1.74e-6)" "unprognostic (2.54e-1)" "unprognostic (8.02e-2)" "unprognostic (7.00e-2)" "unprognostic (1.15e-1)" "unprognostic (9.87e-3)" "unprognostic (1.07e-1)" "unprognostic (1.94e-1)" "unprognostic (1.03e-13)" "unprognostic (4.91e-3)" "unprognostic (2.72e-1)" "unprognostic (2.24e-1)" "unprognostic (5.64e-3)" 0.3 0.2 0.1 0.0 0.1 0.0 0.1 26.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 1.3 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.5 27.5 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.9 0.0 5.9 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 3.5 0.0 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 8.1 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.1 0.0 0.0 0.0 0.0 ENAM AIH2 ENSG00000132464 Enamelin Q9NRM1 4 70628744-70686816 "Disease related genes, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 10.1;heart muscle: 5.0;kidney: 7.9" "Cell type enriched" "Detected in some" 7 "Melanocytes: 32.1" "Cancer enhanced" "Detected in some" "renal cancer: 1.7" "Group enriched" "Detected in some" 18 "memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 20 "B-cells: 1.7;dendritic cells: 2.2" "Group enriched" "Detected in some" 4 "Daudi: 2.4;RPTEC TERT1: 1.5;U-266/70: 2.5;U-266/84: 3.4;U-698: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (1.52e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.02e-2)" "unprognostic (2.78e-2)" "unprognostic (1.02e-1)" "unprognostic (7.94e-3)" "unprognostic (4.73e-2)" "unprognostic (2.06e-1)" "unprognostic (9.06e-4)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.81e-14)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.1 1.5 5.0 0.0 0.0 7.9 0.5 0.0 0.0 0.0 0.0 2.5 0.8 0.5 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 1.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 3.4 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.5 0.0 0.0 3.5 0.0 0.0 3.3 0.7 4.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 32.1 0.0 0.0 0.0 0.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 106.8" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 54.5;Ito cells: 49.7;Pancreatic endocrine cells: 54.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 7 "amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9" "Group enriched" "Detected in many" 6 "classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078061 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA078061: " "prognostic unfavorable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 2.2 1.1 39.7 4.7 42.7 5.4 1.8 1.3 106.8 4.2 5.2 2.4 2.1 6.4 2.9 1.6 2.5 1.3 7.5 3.2 44.1 7.7 2.2 6.4 4.8 2.2 4.6 43.9 6.0 12.3 1.0 2.4 4.2 4.9 4.3 8.1 0.8 5.4 7.4 1.7 1.7 8.1 3.0 2.3 4.0 9.8 4.5 1.5 0.5 1.3 0.3 2.0 6.5 1.3 0.4 2.4 3.4 5.4 2.8 3.0 1.4 11.8 14.7 14.6 6.9 6.3 1.5 31.5 7.9 9.0 9.1 6.7 23.6 19.9 0.0 9.9 6.8 14.9 9.6 0.2 15.3 19.8 0.2 1.1 13.0 2.8 10.3 0.6 1.2 0.1 2.4 1.0 24.1 2.3 31.0 7.4 3.0 2.8 7.6 23.7 2.8 1.2 1.7 15.3 10.9 13.2 1.4 9.6 1.2 4.9 9.0 19.7 8.0 1.3 6.5 0.7 18.8 3.1 1.6 17.6 15.4 25.8 9.1 25.5 0.1 0.0 0.2 17.8 1.1 23.5 0.0 5.4 3.4 2.3 4.8 0.0 0.1 0.5 3.0 2.4 0.4 0.2 2.5 1.4 2.8 1.3 0.0 0.0 1.4 39.7 42.7 1.3 86.4 44.1 7.7 4.6 43.9 4.9 1.5 0.0 13.4 5.7 13.3 2.3 0.4 1.1 17.8 5.3 7.9 10.4 2.0 12.1 3.3 54.5 16.1 6.0 12.3 0.0 27.4 3.5 12.2 16.4 20.8 16.3 21.6 0.0 14.9 49.7 10.4 13.6 34.8 5.3 0.0 1.8 18.9 0.5 54.2 10.5 31.5 3.3 1.1 6.5 8.2 0.6 0.4 1.0 2.2 4.4 26.4 13.6 ENDOG ENSG00000167136 "Endonuclease G" Q14249 9 128818474-128822677 "Plasma proteins, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 91.2" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021335, HPA021830" Approved "Intracellular and membrane" NA NA "HPA021335: AB_1848151, HPA021830: AB_1848152" "unprognostic (1.35e-1)" "unprognostic (3.41e-1)" "unprognostic (4.86e-2)" "prognostic favorable (5.12e-4)" "unprognostic (2.51e-1)" "unprognostic (3.95e-1)" "unprognostic (6.56e-2)" "unprognostic (2.64e-2)" "unprognostic (4.90e-1)" "unprognostic (6.97e-2)" "unprognostic (8.35e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.06e-7)" "unprognostic (1.69e-2)" "unprognostic (1.81e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" 5.8 6.4 8.6 3.2 9.1 3.9 8.1 8.1 15.0 4.4 8.4 5.3 8.8 10.3 3.1 2.6 5.7 7.7 4.3 19.9 8.0 8.3 9.9 18.5 3.8 5.7 7.2 7.2 3.5 8.4 8.0 4.8 3.9 6.0 6.9 5.5 4.8 5.9 7.0 91.2 5.2 7.6 3.4 4.1 3.4 7.6 6.1 6.5 5.2 8.1 18.1 3.7 4.3 7.1 3.9 6.9 1.5 3.8 2.3 3.1 1.3 6.7 7.3 1.9 10.1 5.1 4.3 8.7 6.5 3.4 6.2 4.3 4.4 5.4 2.2 5.9 4.2 3.8 19.0 6.1 5.7 1.1 4.2 10.9 3.8 7.1 7.8 2.3 11.6 14.5 4.5 7.0 3.7 2.5 3.7 4.7 7.4 11.8 3.4 3.8 9.8 9.0 24.0 4.8 11.7 27.5 10.9 2.2 22.6 9.2 2.4 16.8 16.8 14.5 13.3 3.3 1.3 12.8 5.8 4.7 4.3 2.6 6.1 4.8 11.0 1.5 4.1 8.7 8.4 4.4 0.0 2.3 1.5 2.8 3.8 2.5 3.2 2.8 1.3 3.6 3.9 2.7 3.1 0.0 2.3 1.7 6.9 1.1 1.3 8.6 9.1 8.1 15.0 8.0 8.3 7.2 7.2 6.0 6.5 8.9 5.6 7.4 19.5 7.8 12.7 0.6 22.9 57.6 14.8 22.7 3.9 26.8 86.2 4.1 68.9 6.3 48.0 0.0 6.7 25.6 14.1 19.2 1.1 66.2 17.1 11.1 13.8 7.4 15.1 101.7 17.3 7.0 10.1 2.8 22.6 31.6 6.8 21.6 17.7 68.6 11.9 6.5 10.3 83.7 5.7 12.7 8.5 8.7 25.5 25.2 ENDOU "P11, PP11, PRSS26" ENSG00000111405 "Endonuclease, poly(U) specific" P21128 12 47709734-47725567 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 42.1;placenta: 86.0;tongue: 28.8" "Group enriched" "Detected in some" 6 "Suprabasal keratinocytes: 8.0;Syncytiotrophoblasts: 28.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.9;SK-BR-3: 8.7;SuSa: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012388, HPA067448" Enhanced "Secreted in other tissues" NA NA "HPA012388: AB_1854860, HPA067448: AB_2685843" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.44e-2)" "unprognostic (1.25e-2)" "unprognostic (1.09e-1)" "prognostic favorable (6.29e-4)" "unprognostic (6.50e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" 0.6 0.1 1.3 0.2 1.4 0.2 1.2 0.2 1.1 7.5 0.2 0.2 0.2 0.1 0.3 0.8 42.1 0.6 0.4 0.4 0.7 0.1 0.2 0.2 0.2 0.2 0.4 0.3 0.9 0.2 0.1 0.2 86.0 0.5 0.2 0.1 0.2 9.3 0.2 0.2 13.5 0.2 0.4 0.3 0.2 0.1 0.2 0.2 0.5 0.4 28.8 21.6 0.2 10.9 0.2 0.2 0.8 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.5 2.1 1.4 0.3 1.7 1.4 1.2 0.2 0.1 3.9 0.9 0.1 0.0 0.2 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.2 1.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 8.7 0.1 8.7 0.2 0.0 0.2 0.4 0.1 1.1 0.2 2.2 2.1 0.8 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 1.3 1.4 0.2 0.7 0.7 0.1 0.4 0.3 0.5 0.2 0.0 0.0 0.0 0.2 1.4 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 8.0 28.7 0.0 0.0 0.1 ENGASE FLJ21865 ENSG00000167280 Endo-beta-N-acetylglucosaminidase Q8NFI3 17 79074939-79088599 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 51.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021551 Enhanced Approved Centrosome,Cytosol No No Cytosol Centrosome "HPA021551: AB_1848156" "unprognostic (7.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (6.16e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-3)" "unprognostic (9.62e-2)" "unprognostic (4.09e-2)" "unprognostic (9.07e-2)" "unprognostic (7.00e-3)" "prognostic favorable (2.60e-4)" "unprognostic (4.79e-2)" "prognostic unfavorable (8.97e-6)" "unprognostic (8.38e-3)" "unprognostic (6.03e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.73e-5)" 10.0 10.1 9.5 20.7 18.4 8.9 11.4 7.0 13.9 10.9 15.1 12.4 8.8 20.3 11.4 6.8 6.5 10.6 8.6 10.3 9.3 5.8 9.2 10.2 10.1 10.7 16.8 8.5 16.3 9.3 11.3 9.8 8.1 13.6 12.3 12.5 10.7 12.1 9.6 35.4 11.9 17.3 7.3 11.9 24.9 11.4 3.9 14.0 8.1 13.6 7.0 9.1 17.5 51.4 0.2 0.7 0.0 1.1 0.0 2.1 0.6 4.5 9.8 3.4 6.3 3.6 1.5 6.6 3.5 1.8 2.9 2.0 5.2 5.0 0.0 4.2 3.5 4.8 6.8 5.4 3.8 1.6 2.7 7.3 4.1 10.0 3.1 2.7 4.7 7.8 4.1 5.3 2.5 2.8 5.6 3.0 8.9 5.9 2.9 1.8 3.9 0.4 4.5 1.5 9.5 8.8 8.6 11.7 3.0 1.5 12.9 2.9 5.7 5.6 25.9 2.6 5.3 9.1 4.4 3.9 5.6 4.2 4.8 3.4 6.9 1.2 2.0 2.3 8.7 4.0 0.0 0.7 0.0 0.0 1.1 0.9 0.0 0.1 0.4 0.7 0.2 0.0 0.0 0.0 0.0 0.5 0.6 2.1 0.6 9.5 18.4 7.0 13.9 9.3 5.8 16.8 8.5 13.6 14.0 0.0 13.6 6.4 3.8 3.9 10.7 4.8 7.6 0.0 6.8 10.4 33.4 4.2 0.0 3.5 1.5 6.5 16.4 0.0 3.6 3.8 4.8 7.4 4.7 10.6 7.5 7.9 25.1 9.8 10.8 1.0 3.1 8.2 0.0 5.4 15.9 5.6 2.5 11.5 1.8 1.7 24.7 12.9 6.0 2.2 1.4 5.1 5.6 5.7 18.8 4.1 ENHO "C9orf165, UNQ470" ENSG00000168913 "Energy homeostasis associated" Q6UWT2 9 34521040-34523041 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 79.6" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 53.5" "Cancer enhanced" "Detected in many" "glioma: 44.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "myeloid DC: 19.4" "Lineage enriched" "Detected in many" 7 "dendritic cells: 19.4" "Cell line enhanced" "Detected in many" "AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042575 Approved "Secreted to blood" NA NA 4240000 "HPA042575: AB_10794914" "unprognostic (2.63e-2)" "unprognostic (9.53e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.30e-1)" "unprognostic (7.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.34e-2)" "unprognostic (5.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.78e-4)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.47e-2)" "unprognostic (1.87e-1)" "unprognostic (5.50e-2)" "unprognostic (8.76e-2)" 1.5 1.9 58.0 1.9 59.3 1.7 3.7 15.5 79.6 2.9 3.9 13.9 0.0 3.0 1.4 1.4 1.5 3.6 1.8 1.8 36.3 37.5 1.5 12.0 2.0 1.4 52.0 27.1 1.5 2.6 1.2 1.0 1.3 13.7 5.2 3.2 0.1 1.8 1.7 1.6 3.8 3.6 1.3 17.1 1.6 5.3 6.4 13.4 0.0 1.4 0.0 1.4 1.5 0.0 0.0 19.4 0.0 2.5 2.7 0.0 0.4 0.1 1.0 5.3 13.4 0.1 0.0 0.3 0.0 0.0 2.1 2.2 0.5 0.2 2.2 3.7 0.0 4.3 0.2 6.1 0.4 0.4 0.3 5.9 0.0 0.1 1.2 0.2 0.0 3.0 0.0 0.1 0.0 0.2 0.0 0.0 4.3 0.0 1.9 0.5 0.3 0.0 0.0 18.5 1.0 3.7 0.1 0.0 0.3 0.5 0.0 9.4 8.9 0.7 4.1 0.4 0.7 0.3 1.7 0.0 0.4 2.1 0.1 0.1 1.1 1.3 0.1 0.5 0.0 3.1 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 2.7 0.7 1.0 0.0 0.4 58.0 59.3 15.5 37.0 36.3 37.5 52.0 27.1 13.7 13.4 0.0 0.3 0.0 2.5 2.5 4.3 0.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.2 1.0 10.2 0.0 2.6 2.6 4.8 1.7 1.3 0.3 2.7 0.3 3.2 1.7 1.0 0.0 53.5 0.0 0.0 0.4 0.3 2.8 0.0 0.1 0.5 5.9 2.8 0.0 0.0 0.0 0.5 ENKUR "C10orf63, CFAP106, enkurin, MGC26778" ENSG00000151023 "Enkurin, TRPC channel interacting protein" Q8TC29 10 24981979-25062279 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7;fallopian tube: 46.2" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 400.2" "Cancer enhanced" "Detected in some" "glioma: 4.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "AN3-CA: 4.1;CAPAN-2: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037593, HPA037594, HPA061503" Enhanced NA NA "HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543" "unprognostic (2.33e-3)" "unprognostic (4.86e-2)" "unprognostic (1.13e-2)" "unprognostic (6.52e-3)" "unprognostic (3.31e-2)" "unprognostic (2.91e-2)" "unprognostic (1.38e-2)" "unprognostic (7.35e-2)" "unprognostic (1.18e-1)" "unprognostic (8.69e-2)" "unprognostic (6.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-6)" "unprognostic (3.94e-1)" "unprognostic (3.35e-2)" "unprognostic (3.45e-3)" "unprognostic (8.43e-3)" 0.7 1.1 8.4 1.2 13.4 1.0 0.7 1.1 10.6 2.2 0.9 6.2 0.0 2.0 2.5 7.0 0.7 46.2 1.0 0.8 8.8 10.8 1.2 2.4 6.7 0.7 9.2 3.5 6.5 0.6 0.8 10.4 1.4 18.7 0.7 0.8 0.0 0.8 0.7 0.9 0.8 4.6 0.9 6.5 1.0 0.9 8.4 8.6 0.0 1.2 0.0 0.8 0.7 0.0 0.0 0.4 4.1 0.3 0.0 0.0 9.9 0.4 1.2 1.2 4.1 0.2 0.3 0.1 0.4 0.0 0.0 0.0 0.7 7.1 0.7 1.0 0.2 1.2 0.6 0.0 0.7 0.1 0.4 0.5 0.8 1.0 0.4 0.1 0.0 0.2 0.0 0.0 0.4 0.6 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 1.1 0.3 1.0 2.3 0.4 0.2 0.2 0.3 0.6 0.0 0.2 0.4 1.2 0.6 1.0 0.0 0.1 0.0 2.1 0.2 0.1 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.1 0.0 0.1 0.4 0.0 9.9 8.4 13.4 1.1 5.2 8.8 10.8 9.2 3.5 18.7 8.6 0.0 0.6 0.0 0.5 0.0 0.3 0.3 0.0 400.2 38.7 1.8 0.0 0.2 0.0 2.0 50.2 0.3 1.3 0.0 4.5 1.5 0.4 0.5 1.1 0.0 0.0 0.0 2.4 0.0 0.0 6.6 1.1 0.0 0.0 1.0 0.1 17.6 8.5 0.0 0.7 0.7 1.8 0.0 0.1 10.8 4.8 0.1 0.2 0.0 0.2 0.1 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 119.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 242.1;Cone photoreceptor cells: 294.5;Horizontal cells: 405.2;Rod photoreceptor cells: 613.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5" "Group enriched" "Detected in many" 7 "B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 94.8;U-87 MG: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 89000000 "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119" "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 4.2 20.7 31.2 8.3 48.0 4.0 4.9 115.2 119.2 7.6 7.9 10.9 2.6 4.9 11.7 6.3 5.9 9.4 8.0 10.3 30.2 39.2 3.5 2.0 10.1 10.5 29.6 47.4 3.7 4.1 19.1 15.5 4.8 47.7 8.0 7.4 28.6 3.1 15.3 2.1 5.8 6.0 15.2 15.7 5.8 6.4 3.2 13.3 1.7 14.2 0.3 10.3 7.1 5.0 5.6 1.0 6.2 0.2 0.4 10.8 4.5 12.2 7.7 2.8 0.1 4.2 4.5 0.2 9.5 6.1 14.1 21.7 1.4 1.0 17.2 1.5 4.1 18.6 1.8 29.3 2.6 21.4 34.4 2.7 23.8 7.9 10.3 3.0 1.3 28.6 2.3 0.1 10.4 2.1 94.8 2.9 22.5 1.5 0.2 9.4 1.6 11.1 1.5 14.9 5.3 4.4 12.4 2.3 3.8 6.9 1.6 22.5 15.8 2.5 0.1 16.2 14.3 0.7 0.7 3.7 12.3 13.0 16.6 12.2 12.6 12.6 2.5 70.7 0.0 2.5 1.3 0.0 0.1 8.2 0.0 9.7 5.6 10.8 9.6 0.0 3.3 7.1 7.4 6.2 0.4 0.2 1.0 5.5 4.5 31.2 48.0 115.2 91.3 30.2 39.2 29.6 47.4 47.7 13.3 32.8 30.1 5.4 2.3 5.6 242.1 12.0 0.0 21.4 10.3 12.2 294.5 0.2 0.0 16.0 0.3 7.1 0.0 0.0 1.5 0.3 6.6 1.7 65.8 0.0 1.7 405.2 23.0 6.2 0.0 0.0 5.2 2.5 11.8 5.4 0.0 91.6 10.4 0.2 9.2 0.0 613.6 12.9 21.7 1.8 1.3 1.9 0.2 11.4 0.4 1.6 ENO3 ENSG00000108515 "Enolase 3" P13929 17 4948092-4957131 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 638.2;tongue: 320.3" "Group enriched" "Detected in many" 8 "Cardiomyocytes: 511.6;monocytes: 134.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HDLM-2: 71.7;HeLa: 30.7;HMC-1: 30.3;RH-30: 49.3;RPMI-8226: 25.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA000793, HPA068284, HPA068721" Enhanced Supported "Plasma membrane,Cytosol" Yes No 100000000 "Plasma membrane, Cytosol" "HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119" "unprognostic (7.35e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (2.08e-2)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.04e-3)" "unprognostic (2.21e-2)" "unprognostic (4.63e-2)" "unprognostic (5.34e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "unprognostic (4.50e-2)" 7.6 0.3 0.2 0.6 0.2 0.7 0.5 0.6 0.2 0.2 0.4 0.0 0.1 0.8 0.4 8.5 8.6 0.4 0.1 38.3 0.2 0.1 0.5 5.0 0.4 0.5 0.2 0.0 0.4 0.3 0.3 0.5 0.2 0.1 2.1 0.1 1.2 11.8 0.1 638.2 0.3 0.7 0.4 0.2 0.8 0.4 0.5 0.0 0.6 4.8 320.3 10.5 0.3 0.3 13.3 21.0 27.1 24.8 18.5 23.3 36.0 2.9 6.3 2.9 2.7 2.5 0.7 6.9 5.1 0.7 0.3 0.3 3.0 2.0 5.4 7.0 0.4 0.9 3.7 1.0 0.4 0.3 71.7 5.8 5.2 30.7 4.5 0.9 1.6 30.3 4.2 1.0 0.5 1.0 2.6 0.3 6.2 2.4 9.9 1.5 1.6 1.9 6.3 3.7 0.8 2.6 8.5 49.3 25.8 0.7 1.9 1.8 6.9 3.3 2.8 3.7 2.0 2.6 1.7 1.6 3.0 5.7 1.3 3.8 7.0 3.9 4.4 1.7 5.1 3.0 13.5 15.6 27.1 21.8 22.5 14.7 13.3 18.7 20.3 21.0 11.1 12.3 19.7 19.7 18.5 24.8 16.6 23.3 36.0 0.2 0.2 0.6 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.0 2.6 2.9 1.0 1.8 3.2 511.6 0.0 0.0 2.3 5.2 3.9 4.3 0.0 1.4 1.3 2.2 4.3 0.0 0.7 3.1 3.6 1.0 8.1 38.1 4.4 3.2 0.0 3.1 3.8 2.7 0.3 4.5 1.7 134.3 2.3 1.5 1.3 1.7 0.4 5.4 2.4 6.5 0.9 8.6 3.9 1.6 2.7 4.3 2.1 0.6 ENO4 "AC023283.3, C10orf134" ENSG00000188316 "Enolase family member 4" A6NNW6 10 116849512-116911788 "Enzymes, Predicted intracellular proteins" Glycolysis Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1;epididymis: 12.6;fallopian tube: 13.6" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 36.1;Cone photoreceptor cells: 21.6;Early spermatids: 11.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;MCF7: 8.3;T-47d: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037937, HPA037938" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA037937: AB_10697089, HPA037938: AB_2675746" "unprognostic (2.92e-3)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (6.55e-4)" "unprognostic (8.38e-5)" "unprognostic (1.88e-1)" "unprognostic (2.21e-1)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (3.74e-3)" "unprognostic (2.06e-1)" "unprognostic (2.20e-3)" "unprognostic (1.18e-1)" "unprognostic (9.77e-3)" "unprognostic (9.87e-5)" "unprognostic (1.08e-2)" 0.7 2.1 4.3 0.6 4.3 0.2 2.2 2.6 3.6 1.7 1.0 8.0 0.9 0.3 4.3 12.6 1.4 13.6 1.3 0.5 6.4 4.7 2.3 2.7 3.9 1.2 4.1 4.8 4.2 3.2 3.7 3.4 0.5 12.1 2.1 0.8 3.0 1.6 1.2 0.2 1.1 0.5 0.9 4.4 0.5 0.8 8.8 1.9 0.2 4.2 0.0 0.6 1.8 0.5 1.8 1.0 0.0 0.6 0.0 1.2 0.1 1.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.3 1.1 0.0 0.9 2.1 0.2 2.7 0.0 0.7 0.8 0.0 1.5 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.9 0.1 1.1 0.1 0.0 0.7 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 1.2 0.6 0.9 0.0 2.2 0.1 0.0 1.8 5.2 0.0 0.5 0.0 0.8 0.4 1.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 1.6 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.0 0.2 1.0 1.2 0.1 4.3 4.3 2.6 3.6 6.4 4.7 4.1 4.8 12.1 1.9 0.0 0.0 0.0 0.2 0.1 4.4 0.2 0.0 36.1 0.0 0.0 21.6 0.2 0.0 0.3 11.9 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 4.8 1.7 0.0 0.0 8.8 1.1 0.1 0.0 1.0 0.0 1.3 0.2 0.0 0.7 0.6 9.0 0.0 0.2 7.6 2.7 0.0 0.1 0.0 0.1 0.0 ENOPH1 "E1, MASA, mtnC" ENSG00000145293 "Enolase-phosphatase 1" Q9UHY7 4 82430562-82461091 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004985, HPA044607" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA 140000 Nucleoplasm "Nuclear bodies" "CAB004985: AB_426046, HPA044607: AB_2679019" "unprognostic (6.64e-3)" "unprognostic (3.05e-1)" "unprognostic (6.77e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.68e-3)" "prognostic unfavorable (1.74e-5)" "unprognostic (9.99e-3)" "unprognostic (1.18e-1)" "unprognostic (2.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (9.30e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.52e-3)" "unprognostic (3.52e-2)" 10.2 15.4 43.4 12.1 37.1 14.3 16.3 22.9 38.8 13.8 12.7 34.7 5.1 12.2 10.5 23.3 13.5 10.4 9.0 11.1 44.2 34.9 20.8 13.3 11.1 16.0 47.5 26.4 12.9 14.6 17.8 11.7 17.7 31.0 17.2 15.3 8.9 11.4 11.9 9.8 13.1 11.0 11.1 66.2 12.8 13.2 6.1 29.4 14.2 18.0 8.2 18.6 10.7 9.5 13.0 14.1 4.3 10.4 14.4 20.2 12.2 18.5 12.3 22.1 13.7 13.5 13.3 24.2 21.6 14.5 19.8 17.7 22.4 20.8 37.0 22.7 16.4 21.7 10.0 29.2 27.4 35.9 22.2 13.6 22.4 12.0 29.8 21.9 37.0 19.4 12.8 29.1 20.7 24.6 14.3 20.0 23.5 28.9 20.4 25.8 23.9 40.8 22.0 20.3 47.0 10.0 29.1 33.9 20.1 32.3 18.4 31.3 19.1 12.3 37.3 27.5 20.7 16.8 17.9 14.7 24.6 18.3 24.3 28.5 23.5 20.1 46.1 15.9 23.1 33.0 3.4 8.7 4.3 14.4 10.4 18.0 13.0 17.3 16.5 12.7 11.0 20.2 16.2 0.7 14.4 8.8 14.1 18.4 12.2 43.4 37.1 22.9 38.4 44.2 34.9 47.5 26.4 31.0 29.4 14.9 8.0 28.1 32.4 60.9 36.5 11.3 12.7 12.0 15.9 12.2 15.7 71.0 74.6 41.8 4.1 24.5 12.6 0.0 22.6 47.0 29.3 32.2 38.0 10.2 49.6 27.0 28.2 13.5 22.1 4.1 24.5 27.7 37.1 45.1 21.1 46.8 34.7 8.6 22.6 42.5 27.7 12.9 30.9 6.8 22.6 56.0 39.0 34.8 25.8 31.0 ENPEP "CD249, gp160" ENSG00000138792 "Glutamyl aminopeptidase" Q07075 4 110365733-110565285 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 165.1;kidney: 63.8" "Cell type enhanced" "Detected in many" 14 "Proximal tubular cells: 153.4;Sertoli cells: 155.2;Smooth muscle cells: 60.8;Syncytiotrophoblasts: 49.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 41.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;HEK 293: 11.4;MOLT-4: 2.7;SuSa: 8.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005128 Enhanced NA NA 37000000 "HPA005128: AB_1844795" "unprognostic (2.73e-3)" "unprognostic (2.84e-3)" "unprognostic (5.16e-3)" "unprognostic (3.48e-1)" "unprognostic (2.90e-1)" "unprognostic (8.74e-2)" "unprognostic (3.34e-2)" "unprognostic (1.03e-1)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.93e-1)" "unprognostic (9.47e-2)" "unprognostic (4.49e-3)" "unprognostic (3.43e-3)" "unprognostic (1.52e-2)" "unprognostic (8.46e-2)" "unprognostic (2.49e-3)" 5.8 1.0 0.4 0.4 0.6 0.0 2.8 0.3 1.0 1.1 54.4 0.4 0.7 11.1 5.3 2.4 0.8 1.4 1.1 2.3 0.5 0.3 63.8 14.5 2.7 0.5 0.4 0.3 1.0 1.0 33.3 0.8 4.4 0.5 1.4 0.0 0.8 0.6 0.5 2.3 0.4 165.1 3.1 0.5 4.7 0.7 0.4 0.4 1.4 2.4 2.0 0.4 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 0.0 0.1 0.2 4.2 0.6 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.5 2.7 0.5 0.5 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.1 0.2 0.0 2.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.3 1.0 0.5 0.3 0.4 0.3 0.5 0.4 0.0 1.3 0.0 0.1 1.4 0.0 3.3 0.0 0.0 0.0 10.4 0.0 33.0 14.9 0.0 0.4 1.4 2.6 0.0 0.0 2.7 19.7 0.1 0.0 24.1 2.4 0.0 1.7 1.8 0.3 0.0 0.6 0.6 0.0 0.0 0.8 0.0 0.0 0.8 0.4 153.4 0.0 155.2 60.8 0.0 0.2 0.9 49.0 1.3 1.1 0.1 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" NA NA 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: AB_2682218" "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favorable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 25.2 0.0 34.5 73.7 0.0 23.2 42.4 10.0 9.6 0.0 0.0 0.0 0.3 27.3 0.0 0.0 0.5 0.0 7.1 1.8 0.7 0.0 0.0 0.6 15.4 0.0 0.1 33.8 0.2 20.4 1.0 0.1 0.1 0.0 0.0 4.1 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 20.3 0.4 24.4 0.1 0.2 0.0 0.0 17.1 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 11.9 5.1 3.2 0.5 9.4 1.1 1.2 38.2 6.7 1.2 1.8 0.0 3.4 1.7 0.0 34.3 16.3 0.9 0.0 0.0 1.5 51.0 0.1 5.8 0.4 50.0 0.0 51.9 19.0 12.5 3.6 2.8 8.9 43.9 0.0 0.6 3.3 1.2 0.3 3.2 45.6 1.2 0.0 5.1 1.1 0.4 4.5 5.4 0.5 0.6 0.9 ENPP3 "B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3" ENSG00000154269 "Ectonucleotide pyrophosphatase/phosphodiesterase 3" O14638 6 131628442-131747418 "CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7" "Cell type enhanced" "Detected in many" 20 "Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2" "Cancer enriched" "Detected in many" 8 "renal cancer: 49.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 74 "basophil: 18.2" "Lineage enriched" "Detected in single" 74 "granulocytes: 18.2" "Group enriched" "Detected in some" 18 "HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6" "Low region specificity" "Detected in some" HPA043772 Enhanced "Secreted - unknown location" NA NA 480000 "HPA043772: AB_10795616" "unprognostic (2.74e-1)" "unprognostic (1.99e-2)" "unprognostic (1.84e-1)" "unprognostic (5.41e-3)" "unprognostic (6.07e-2)" "unprognostic (4.86e-5)" "unprognostic (1.13e-1)" "unprognostic (7.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.80e-2)" "unprognostic (7.85e-2)" "unprognostic (2.29e-1)" "unprognostic (1.31e-3)" 0.8 7.9 0.5 2.0 0.5 0.0 4.0 2.1 0.4 19.0 18.5 0.2 29.0 9.3 6.2 7.2 0.5 2.3 1.8 0.2 0.4 0.7 11.9 2.7 1.7 0.2 0.5 0.2 0.9 0.2 0.0 0.5 0.4 0.2 3.7 4.8 0.6 14.9 70.7 0.2 0.8 45.4 1.9 0.4 0.5 0.7 1.0 0.2 4.1 0.5 1.2 0.5 0.9 1.2 0.0 0.0 18.2 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 5.2 0.0 17.0 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.5 2.1 0.4 0.4 0.7 0.5 0.2 0.2 0.2 0.0 1.4 0.0 2.8 0.0 0.0 0.2 0.0 2.7 1.2 0.0 0.0 0.0 1.7 0.0 1.3 0.3 9.0 0.0 0.0 0.0 0.5 4.6 33.7 1.7 0.1 0.0 0.0 0.6 0.6 0.0 1.1 0.2 1.7 0.0 1.1 0.0 0.0 2.3 0.7 8.2 0.0 0.0 0.0 1.8 0.8 0.5 0.1 0.5 5.2 1.1 ENPP5 ENSG00000112796 "Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)" Q9UJA9 6 46159187-46170971 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 116.5" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 68.3;Muller glia cells: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 13.4" "Lineage enriched" "Detected in many" 6 "T-cells: 13.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.7;HSkMC: 7.8;SuSa: 6.9;T-47d: 9.2;U-266/84: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016902 Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 300000 Cytosol Nucleoplasm "HPA016902: AB_1848172" "unprognostic (1.12e-1)" "unprognostic (5.19e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-1)" "unprognostic (7.61e-2)" "unprognostic (1.63e-1)" "unprognostic (5.01e-2)" "prognostic favorable (4.57e-4)" "unprognostic (1.96e-1)" "unprognostic (9.89e-2)" "prognostic favorable (4.04e-4)" "unprognostic (7.00e-2)" "prognostic favorable (4.44e-13)" "unprognostic (4.40e-2)" "unprognostic (2.78e-2)" "unprognostic (1.61e-1)" "unprognostic (1.60e-1)" 1.5 4.8 6.5 1.3 10.3 0.8 7.1 9.2 16.1 6.9 2.0 3.3 28.7 1.5 1.6 116.5 1.6 7.9 3.9 3.9 6.6 9.4 12.1 1.0 4.7 1.2 14.2 10.5 5.4 6.2 21.8 23.3 1.5 14.4 14.6 2.3 11.8 6.9 27.5 6.9 1.3 1.6 5.1 5.5 3.2 3.5 16.2 3.5 1.0 24.3 0.9 1.4 5.7 1.7 0.4 0.0 1.0 0.1 2.2 13.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.6 0.1 0.3 11.7 1.9 3.9 0.2 4.0 0.0 0.6 1.6 0.1 0.0 2.6 0.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 1.9 0.0 0.5 2.5 5.5 0.0 0.0 0.3 0.2 4.9 0.6 5.1 0.2 0.0 4.9 0.0 6.9 9.2 0.0 0.0 0.0 1.3 0.0 0.1 5.8 7.9 0.0 3.1 0.0 0.1 0.0 0.0 0.0 13.4 0.1 7.2 0.4 2.7 8.6 0.0 0.4 0.8 8.2 1.0 2.2 0.0 0.0 0.0 2.6 6.5 10.3 9.2 16.1 6.6 9.4 14.2 10.5 14.4 3.5 11.9 9.8 0.0 4.7 0.8 11.0 8.1 7.6 68.3 9.1 22.7 3.9 4.2 1.7 6.9 0.8 0.1 1.4 0.0 6.5 2.4 3.3 16.0 4.6 0.0 0.3 9.5 7.9 0.6 0.0 1.5 2.6 0.7 0.0 1.0 3.4 94.1 2.7 2.9 11.3 16.2 2.9 6.5 0.7 0.2 2.3 0.5 0.2 3.8 2.5 2.6 ENPP6 MGC33971 ENSG00000164303 "Ectonucleotide pyrophosphatase/phosphodiesterase 6" Q6UWR7 4 184088706-184221230 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;kidney: 30.8" "Group enriched" "Detected in some" 5 "Peritubular cells: 33.2;Proximal tubular cells: 21.8" "Cancer enriched" "Detected in some" 5 "glioma: 3.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HDLM-2: 1.9;Karpas-707: 6.4;SH-SY5Y: 7.3;U-266/70: 6.0;U-266/84: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042740, HPA069197" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA 68000 "Golgi apparatus" "HPA042740: AB_10793984, HPA069197: " "unprognostic (4.81e-4)" "unprognostic (1.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.69e-3)" "unprognostic (3.07e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.60e-3)" "unprognostic (3.04e-2)" "unprognostic (1.72e-1)" "unprognostic (2.98e-2)" "unprognostic (2.82e-1)" "unprognostic (3.93e-3)" "unprognostic (2.01e-1)" 0.5 0.6 2.0 1.1 8.0 1.1 1.0 1.7 6.7 0.5 1.3 35.2 0.4 2.0 0.5 6.9 1.3 0.5 0.8 0.5 5.4 3.5 30.8 0.4 0.6 1.1 26.1 3.3 13.7 0.3 0.3 4.1 0.4 19.5 2.7 1.3 7.7 0.9 6.9 0.4 0.5 2.5 0.4 28.2 1.2 1.5 2.7 14.0 0.0 0.5 0.0 3.1 0.9 0.7 0.9 0.8 2.2 0.9 1.5 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 1.9 0.0 0.7 0.3 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 6.4 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.4 0.0 0.2 7.3 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.1 0.0 0.1 6.0 3.2 0.1 0.1 0.1 0.0 2.2 0.9 0.6 0.5 0.5 0.6 0.7 0.4 0.3 0.1 0.9 0.4 0.5 1.7 1.5 0.3 0.8 0.5 0.1 2.0 8.0 1.7 6.7 5.4 3.5 26.1 3.3 19.5 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 1.8 0.0 0.0 3.3 0.9 0.8 0.2 0.0 0.0 0.2 0.0 0.2 0.1 5.7 0.0 0.2 0.0 0.0 0.0 0.6 0.0 3.7 0.0 1.7 1.8 0.0 0.0 0.0 0.0 33.2 21.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 ENPP7 "alk-SMase, NPP7" ENSG00000182156 "Ectonucleotide pyrophosphatase/phosphodiesterase 7" Q6UWV6 17 79730919-79742222 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 71.1" "Group enriched" "Detected in some" 5 "Hepatocytes: 8.5;Proximal tubular cells: 7.3" "Cancer enriched" "Detected in some" 6 "liver cancer: 6.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 2.9;Karpas-707: 5.2;U-266/70: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024603 Approved "Intracellular and membrane" NA NA 440000 "HPA024603: AB_1848174" "unprognostic (4.00e-2)" "unprognostic (1.16e-2)" "unprognostic (6.49e-2)" "unprognostic (4.83e-2)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (1.24e-1)" "unprognostic (1.01e-1)" "unprognostic (8.45e-4)" "unprognostic (4.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (5.21e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.3 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ENTHD1 FLJ25421 ENSG00000176177 "ENTH domain containing 1" Q8IYW4 22 39743044-39893864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 15.8" "Group enriched" "Detected in some" 5 "Early spermatids: 12.8;granulocytes: 9.2;Late spermatids: 12.4;Spermatocytes: 26.1" "Cancer enriched" "Detected in single" 30 "melanoma: 7.0" "Region enriched" "Detected in single" 20 "basal ganglia: 2.0" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 7.0" "Not detected" "Not detected" HPA019800 Uncertain NA NA "HPA019800: AB_1848842" "unprognostic (5.28e-3)" "unprognostic (1.27e-1)" "unprognostic (8.04e-2)" "unprognostic (9.84e-3)" "unprognostic (2.97e-4)" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (2.17e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-4)" "unprognostic (3.60e-2)" "unprognostic (7.75e-10)" "unprognostic (3.68e-2)" "unprognostic (8.56e-2)" "unprognostic (4.99e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 15.8 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.2 0.0 0.1 0.0 0.0 0.0 0.0 12.4 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 26.1 3.0 0.0 0.0 0.0 0.0 0.0 ENTPD1 "ATPDase, CD39, NTPDase-1, SPG64" ENSG00000138185 "Ectonucleoside triphosphate diphosphohydrolase 1" P49961 10 95711779-95869695 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Hydrolase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 59.4" "Cell type enhanced" "Detected in many" 8 "B-cells: 45.3;Endothelial cells: 46.6;Kupffer cells: 77.1;Macrophages: 80.4;monocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 37.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HDLM-2: 57.3;Karpas-707: 47.1" "CAB002494, HPA014067" Enhanced Uncertain Microtubules NA NA Microtubules "CAB002494: AB_563557, HPA014067: AB_1848178" "unprognostic (1.14e-1)" "unprognostic (1.01e-2)" "unprognostic (3.11e-1)" "unprognostic (5.67e-2)" "unprognostic (9.68e-3)" "unprognostic (3.45e-3)" "unprognostic (6.31e-2)" "unprognostic (5.26e-3)" "unprognostic (2.73e-1)" "unprognostic (1.28e-2)" "unprognostic (6.40e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.33e-5)" "unprognostic (9.79e-2)" "unprognostic (2.30e-1)" "prognostic favorable (7.89e-4)" "unprognostic (5.09e-2)" 10.4 7.5 7.4 16.2 8.4 15.6 8.8 7.6 6.9 18.9 12.7 13.1 8.7 5.8 59.4 12.8 13.2 15.6 22.2 6.8 7.4 7.4 6.2 3.9 14.8 14.5 8.5 4.9 10.3 2.8 3.0 4.3 24.0 9.9 14.7 9.1 10.8 6.7 12.7 3.3 5.5 12.2 37.2 17.9 25.3 7.5 5.4 7.2 3.5 13.4 12.5 21.1 25.2 12.4 6.0 11.8 37.4 15.2 0.5 5.1 4.6 0.1 0.3 0.9 0.8 0.0 0.0 0.5 0.5 0.4 0.0 0.0 0.5 0.1 1.0 0.6 0.0 1.4 0.3 0.0 0.0 0.0 57.3 0.7 0.6 0.4 0.7 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.3 7.5 0.3 0.6 47.1 0.0 0.6 0.4 1.5 0.6 0.6 0.2 2.4 0.4 0.7 0.5 0.2 0.7 1.1 0.3 1.1 0.8 0.6 0.5 1.6 0.8 0.4 0.2 0.6 0.6 6.7 0.9 0.0 0.6 3.1 0.2 0.1 15.2 37.4 0.1 10.7 0.3 6.0 0.6 0.3 11.8 4.6 0.1 0.1 26.7 0.5 2.4 0.7 5.1 4.6 7.4 8.4 7.6 6.9 7.4 7.4 8.5 4.9 9.9 7.2 0.0 1.4 45.3 0.3 7.9 1.4 8.5 0.0 1.4 1.2 1.8 2.0 0.4 1.7 0.0 5.9 46.6 0.0 0.0 1.8 1.7 8.7 0.4 3.5 0.0 23.2 0.0 0.0 11.6 77.1 6.1 0.6 80.4 15.1 46.9 0.0 0.7 0.2 0.2 2.8 0.3 0.7 6.5 32.0 6.2 4.3 9.8 13.2 14.6 0.4 0.2 ENTPD2 "CD39L1, NTPDase-2" ENSG00000054179 "Ectonucleoside triphosphate diphosphohydrolase 2" Q9Y5L3 9 137048098-137054045 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Group enriched" "Detected in many" 4 "Leydig cells: 178.1;Peritubular cells: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 2.6" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "Hep G2: 15.9;hTCEpi: 8.8;MCF7: 11.0;OE19: 17.7;SK-BR-3: 14.8;T-47d: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017676 Approved NA NA "HPA017676: AB_1848179" "unprognostic (1.64e-1)" "unprognostic (3.35e-2)" "unprognostic (1.76e-1)" "unprognostic (3.33e-2)" "unprognostic (2.15e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.71e-2)" "unprognostic (4.97e-2)" "unprognostic (3.23e-1)" "unprognostic (2.99e-1)" "unprognostic (1.89e-1)" "prognostic favorable (3.51e-6)" "prognostic favorable (1.38e-4)" "unprognostic (2.51e-1)" "unprognostic (8.43e-2)" "unprognostic (1.12e-3)" 1.7 1.6 18.8 1.5 10.1 0.6 7.0 4.0 10.4 9.8 9.1 21.9 1.7 17.6 2.8 4.4 3.3 9.4 10.7 2.7 22.6 9.6 4.5 1.0 1.0 0.5 6.1 12.8 0.8 2.6 1.2 3.1 3.9 11.9 11.2 5.8 2.5 6.2 2.9 3.0 9.3 11.1 1.9 7.5 0.5 9.5 6.8 11.7 0.0 0.7 2.6 1.0 0.9 3.5 0.0 0.0 2.6 0.1 0.0 0.0 0.0 4.2 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.9 0.0 0.0 3.4 0.3 2.5 0.0 0.0 0.1 0.0 0.4 15.9 0.0 0.0 0.2 0.0 8.8 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 17.7 2.4 0.0 0.7 1.6 1.9 0.4 2.4 0.0 0.2 14.8 0.0 0.1 16.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.8 10.1 4.0 9.8 22.6 9.6 6.1 12.8 11.9 11.7 0.0 0.0 0.0 1.1 1.4 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.3 0.0 6.1 1.1 0.7 31.6 0.0 3.9 0.9 1.7 5.9 0.0 0.9 0.2 0.0 24.2 0.6 0.0 2.1 178.1 0.0 5.0 1.0 8.1 7.2 4.5 31.7 90.9 8.4 0.0 0.0 0.4 1.2 4.3 1.3 0.8 0.0 12.8 1.0 ENTPD3 "CD39L3, HB6, NTPDase-3" ENSG00000168032 "Ectonucleoside triphosphate diphosphohydrolase 3" O75355 3 40387156-40428619 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 26.2;pancreas: 37.3" "Group enriched" "Detected in many" 4 "Exocrine glandular cells: 19.8;Pancreatic endocrine cells: 5.7;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 7.4" "Lineage enriched" "Detected in many" 5 "dendritic cells: 7.4" "Cell line enhanced" "Detected in some" "HaCaT: 3.8;HBEC3-KT: 12.7;hTCEpi: 8.6;RT4: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.00e-1)" "unprognostic (1.54e-2)" "unprognostic (2.75e-2)" "unprognostic (9.84e-3)" "unprognostic (2.27e-2)" "unprognostic (2.04e-1)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (8.40e-2)" "unprognostic (9.88e-3)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (3.25e-1)" "unprognostic (6.53e-2)" "unprognostic (5.99e-2)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" 4.6 2.2 5.7 1.7 25.9 0.5 2.1 5.4 15.8 26.2 3.3 0.6 1.9 1.7 4.0 4.4 7.5 1.3 3.6 1.4 4.9 6.3 3.6 0.5 4.8 0.9 4.0 6.3 2.6 37.3 1.7 4.2 2.9 14.5 5.3 3.6 2.8 21.2 5.1 1.7 3.2 1.6 2.5 1.7 5.1 8.8 1.3 4.8 0.0 7.0 5.6 4.8 13.7 2.9 0.5 7.4 1.4 0.3 0.9 0.8 0.1 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.1 3.8 0.0 12.7 0.3 0.7 0.4 0.7 0.5 0.2 0.0 0.0 0.0 0.1 8.6 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.5 0.0 0.1 0.1 0.3 1.1 0.1 0.0 0.3 1.6 18.3 1.9 0.4 0.8 1.4 0.3 0.4 0.7 0.0 0.4 0.2 0.1 0.0 0.0 0.2 0.4 0.0 1.1 0.1 0.1 1.4 0.2 0.0 0.2 0.3 0.8 0.3 0.2 0.3 0.0 0.5 0.6 0.6 0.0 0.9 0.2 7.4 0.6 0.1 5.7 25.9 5.4 15.8 4.9 6.3 4.0 6.3 14.5 4.8 3.0 3.4 0.0 1.0 2.1 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 19.8 0.0 0.2 2.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.3 5.7 0.0 0.7 0.0 0.6 19.4 3.1 0.3 0.1 1.9 0.0 0.0 0.0 3.7 ENTPD5 "CD39L4, NTPDase-5, PCPH" ENSG00000187097 "Ectonucleoside triphosphate diphosphohydrolase 5" O75356 14 73958010-74019399 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 52.0;kidney: 43.1;liver: 71.4" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 99.9;Hepatocytes: 120.9;Mucus-secreting cells: 67.4" "Cancer enhanced" "Detected in all" "prostate cancer: 39.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 15.0;eosinophil: 8.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in all" "RT4: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002927 Enhanced "Secreted to blood" NA NA 5000000 "HPA002927: AB_1078744" "unprognostic (4.19e-1)" "unprognostic (9.63e-3)" "unprognostic (3.11e-2)" "unprognostic (2.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.19e-1)" "unprognostic (3.34e-1)" "unprognostic (6.01e-2)" "unprognostic (6.20e-2)" "unprognostic (2.55e-1)" "prognostic favorable (3.95e-5)" "unprognostic (1.25e-1)" "unprognostic (5.06e-2)" "unprognostic (1.76e-1)" "unprognostic (6.92e-3)" 3.0 3.6 2.8 9.4 3.8 1.7 3.5 3.0 4.0 2.4 25.8 5.8 3.1 19.3 3.0 2.7 4.5 2.4 6.6 2.6 2.8 2.3 43.1 71.4 2.3 1.3 3.5 2.3 3.3 5.9 1.8 2.7 2.2 5.5 10.2 29.6 3.2 4.7 1.5 3.8 2.7 52.0 3.9 5.5 3.2 11.8 4.5 2.5 2.1 2.7 3.0 3.3 9.5 3.0 1.6 1.6 15.0 2.1 0.6 2.5 1.2 5.4 4.4 5.0 9.3 10.0 9.5 5.8 5.7 4.7 3.8 4.4 3.3 6.6 6.2 2.9 7.8 3.7 6.5 5.0 8.3 4.3 5.2 2.4 4.6 3.2 18.1 9.7 2.7 5.4 7.7 8.4 5.4 11.2 5.4 7.6 10.2 5.1 9.4 5.6 7.7 3.1 3.3 1.5 4.9 9.6 3.5 4.8 3.0 6.7 34.5 3.6 3.7 9.7 7.7 5.5 4.0 11.1 2.5 6.4 7.7 8.0 4.6 4.2 6.1 9.5 5.0 4.9 5.1 6.9 15.0 1.2 8.3 2.5 2.1 1.3 1.3 1.3 1.7 1.6 1.6 2.1 2.1 0.2 0.6 1.3 0.8 1.4 1.2 2.8 3.8 3.0 4.0 2.8 2.3 3.5 2.3 5.5 2.5 14.9 7.9 6.7 4.8 3.3 6.1 4.8 12.7 5.3 10.3 7.0 3.9 6.4 21.6 5.1 13.9 5.4 99.9 0.0 11.3 5.7 4.9 39.5 1.1 120.9 5.5 9.5 15.5 11.6 7.0 8.7 2.6 5.1 5.0 6.4 67.4 4.8 7.4 54.7 5.3 50.1 12.0 12.9 4.1 20.1 18.3 3.0 2.7 4.9 41.0 12.3 ENTPD7 "FLJ30978, LALP1" ENSG00000198018 "Ectonucleoside triphosphate diphosphohydrolase 7" Q9NQZ7 10 99659506-99706240 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 46.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 14.1;Urothelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014351 Uncertain Approved Nucleoplasm NA NA 24000 Nucleoplasm "HPA014351: AB_1848183" "unprognostic (1.82e-1)" "unprognostic (7.26e-2)" "unprognostic (1.11e-2)" "unprognostic (6.01e-3)" "unprognostic (6.22e-2)" "unprognostic (3.32e-3)" "unprognostic (9.35e-2)" "unprognostic (3.77e-3)" "unprognostic (3.83e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-2)" "unprognostic (1.39e-1)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "unprognostic (1.22e-1)" "unprognostic (2.99e-2)" "unprognostic (3.39e-1)" 3.1 5.6 2.2 5.1 2.1 6.4 2.7 2.4 3.3 4.4 15.7 1.3 11.3 18.6 3.9 5.7 9.1 3.1 9.1 3.2 2.0 1.7 6.0 14.5 4.2 7.1 1.4 1.9 3.2 23.9 3.6 8.6 8.5 1.5 5.6 4.9 3.4 9.0 13.2 1.6 4.4 46.1 5.6 1.4 5.4 5.1 3.5 0.5 2.5 3.5 6.0 6.3 11.4 5.0 0.9 7.7 3.7 2.2 2.7 2.2 1.3 5.2 6.0 8.0 14.8 4.0 4.0 9.7 9.9 20.6 12.9 10.8 11.0 5.9 4.5 5.8 13.3 3.9 13.9 6.7 4.0 10.6 1.9 5.3 3.4 4.7 10.1 6.0 12.0 7.8 3.7 6.9 16.2 15.4 15.0 13.0 4.8 6.4 4.4 5.1 4.7 2.4 2.5 4.7 6.5 2.6 0.0 6.2 2.4 14.1 17.0 3.3 6.4 6.9 2.6 8.6 5.7 7.2 6.1 8.2 11.2 7.2 7.2 8.3 4.5 7.5 4.1 10.9 3.7 3.0 0.3 2.2 3.7 2.2 2.2 2.0 0.9 0.8 1.8 5.0 0.3 1.4 0.9 2.0 2.7 1.2 7.7 0.6 1.3 2.2 2.1 2.4 3.3 2.0 1.7 1.4 1.9 1.5 0.5 0.0 0.0 0.0 14.1 7.2 0.4 0.6 0.0 4.0 2.3 5.2 2.0 4.5 0.0 1.9 1.4 1.0 6.5 0.0 4.3 4.4 1.5 1.8 0.0 3.4 1.7 0.0 5.2 0.6 1.2 2.2 0.9 1.3 0.0 6.4 2.7 0.7 3.4 2.9 0.7 1.3 1.8 0.0 1.4 1.4 0.7 6.5 4.2 0.0 1.4 22.1 ENTPD8 "NTPDase-8, UNQ2492" ENSG00000188833 "Ectonucleoside triphosphate diphosphohydrolase 8" Q5MY95 9 137434364-137441816 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 48.1" "Group enriched" "Detected in some" 6 "Enterocytes: 107.0;Mucus-secreting cells: 160.6;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.1;OE19: 3.0;RPMI-8226: 8.8;T-47d: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021509 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA021509: AB_1848185" "unprognostic (3.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "unprognostic (1.40e-1)" "unprognostic (6.46e-3)" "unprognostic (8.70e-2)" "unprognostic (3.87e-2)" "unprognostic (8.48e-2)" "unprognostic (1.69e-1)" "unprognostic (2.34e-2)" "unprognostic (1.08e-5)" "prognostic favorable (7.17e-4)" "unprognostic (2.17e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-1)" 0.4 0.0 0.4 2.6 0.4 0.0 0.4 0.4 0.4 0.4 19.2 0.4 0.4 18.5 0.4 0.4 0.4 0.3 2.2 0.4 0.5 0.0 2.1 9.8 0.8 0.4 0.4 0.4 0.4 1.8 0.0 4.2 0.5 0.4 0.4 7.5 0.8 4.1 0.4 0.4 0.0 48.1 0.4 0.4 0.4 6.1 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.0 9.1 0.0 0.6 0.0 0.7 0.1 0.0 0.0 0.0 1.5 0.2 0.0 0.6 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 1.6 0.0 0.2 0.1 3.0 0.4 0.0 0.0 8.8 1.4 0.0 0.3 0.9 0.2 0.0 0.1 0.7 4.8 0.2 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 12.7 0.0 0.0 19.2 0.0 0.0 0.0 0.8 0.0 0.0 107.0 0.0 6.8 0.1 0.0 1.0 0.0 8.2 0.1 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 160.6 0.0 0.5 49.1 0.0 4.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 12.7 0.6 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.9;brain: 22.6;lymphoid tissue: 21.4" "Group enriched" "Detected in some" 8 "Erythroid cells: 23.3;T-cells: 32.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in some" 20 "cerebellum: 22.6" "Group enriched" "Detected in many" 7 "gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9" "Group enriched" "Detected in many" 102 "NK-cells: 17.9;T-cells: 16.5" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7" "Region enriched" "Detected in some" 8 "olfactory region: 95.2" "Group enriched" "Detected in many" 13 "cerebellum: 44.2;olfactory region: 21.9" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.4 0.7 0.5 6.8 0.4 1.6 1.6 22.6 0.4 1.8 0.8 0.0 0.0 0.3 3.2 0.9 1.4 0.6 5.0 0.7 0.4 0.7 1.0 4.9 10.1 15.6 0.5 0.3 1.3 0.9 0.0 0.6 1.6 1.1 2.1 0.9 3.3 2.2 0.1 0.4 0.4 1.8 0.7 0.9 21.4 1.4 0.5 0.0 1.8 1.1 0.9 11.2 3.3 0.8 0.0 0.0 0.1 0.0 17.9 16.5 1.4 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 2.6 2.0 0.0 10.2 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.1 1.2 0.0 1.4 0.5 0.0 12.3 0.3 0.0 0.0 3.0 2.7 0.0 0.3 0.2 1.2 1.9 0.0 0.0 1.0 0.0 5.7 0.0 0.0 0.0 1.2 0.5 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 10.0 0.0 16.5 0.0 1.9 12.0 0.0 0.0 0.1 7.5 0.1 17.9 0.0 0.0 0.0 1.4 0.5 0.4 22.6 0.4 0.4 0.7 0.5 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 3.7 3.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 1.6 0.1 0.0 32.6 0.0 0.0 EPAS1 "bHLHe73, HIF2A, HLF, MOP2, PASD2" ENSG00000116016 "Endothelial PAS domain protein 1" Q99814 2 46293667-46386703 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 200.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "basophil: 14.9;eosinophil: 7.1" "Lineage enriched" "Detected in single" 21 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031200, HPA069697" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031200: AB_2673785, HPA069697: AB_2732139" "unprognostic (1.74e-1)" "unprognostic (9.47e-2)" "unprognostic (1.29e-2)" "unprognostic (2.74e-1)" "unprognostic (5.25e-2)" "unprognostic (1.75e-1)" "unprognostic (2.22e-2)" "unprognostic (8.67e-2)" "unprognostic (6.00e-2)" "unprognostic (9.72e-2)" "unprognostic (1.55e-2)" "unprognostic (9.29e-2)" "prognostic favorable (2.63e-4)" "unprognostic (6.66e-3)" "unprognostic (7.75e-2)" "unprognostic (7.56e-2)" "unprognostic (1.36e-1)" 71.2 14.2 12.5 17.1 15.7 0.8 101.7 5.3 13.9 24.9 20.9 8.9 11.3 12.0 28.8 13.0 21.6 24.8 35.2 40.0 12.8 11.0 35.2 31.2 200.8 27.2 14.3 11.1 20.2 15.5 18.1 9.4 119.6 18.4 20.7 11.5 41.2 13.3 18.7 25.2 13.0 15.6 19.2 12.5 20.5 12.8 13.8 8.0 1.1 43.8 15.2 10.3 32.2 39.3 0.0 0.0 14.9 0.1 0.7 0.1 0.1 5.3 5.7 0.3 0.4 27.6 17.8 46.9 16.9 46.2 9.7 10.6 1.0 0.9 0.0 4.2 32.2 9.7 2.6 0.1 13.5 7.3 0.1 0.2 0.0 1.8 12.0 58.7 0.0 3.4 26.0 18.7 19.0 13.4 7.2 33.4 0.1 0.5 0.0 5.9 4.6 0.1 0.1 0.2 3.7 3.2 0.1 0.6 1.7 6.0 58.1 0.2 12.0 13.3 30.6 3.6 12.5 2.0 2.3 58.0 50.4 1.4 6.7 1.4 0.0 0.0 0.0 36.7 0.9 1.2 14.9 0.1 7.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 12.5 15.7 5.3 12.6 12.8 11.0 14.3 11.1 18.4 8.0 71.5 137.9 8.1 61.5 42.7 3.5 58.5 50.9 30.8 96.7 3.5 9.8 93.6 1.7 15.5 12.6 341.0 66.4 0.0 45.9 256.0 104.5 46.7 40.4 77.4 47.9 0.0 4.1 438.9 58.4 41.8 11.5 23.9 27.0 0.0 13.6 89.1 25.9 40.4 6.0 24.0 57.7 278.1 281.4 1.2 1.7 29.1 292.5 9.6 11.6 58.0 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 11 "cerebellum: 375.3" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 3400000 "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 9.2 9.6 3.3 19.4 10.2 28.0 9.6 59.7 11.6 8.2 12.4 2.0 9.8 9.3 10.5 5.7 10.8 5.5 7.9 7.5 3.3 4.8 10.0 13.2 11.0 25.4 3.9 3.0 12.3 10.4 9.1 9.0 8.7 10.3 8.3 12.5 14.6 10.1 10.8 15.0 8.9 14.6 9.2 5.8 13.5 14.0 7.9 6.9 42.2 8.1 8.8 19.8 11.3 12.4 9.9 3.0 30.1 2.1 5.7 15.9 7.7 7.4 1.8 18.6 8.8 1.5 0.2 6.2 1.9 2.8 2.3 2.9 4.9 9.0 13.8 5.0 2.5 3.8 3.4 23.2 1.8 2.5 24.8 7.1 39.5 5.6 8.0 2.9 13.4 26.4 0.5 5.4 2.2 4.0 5.7 4.1 22.1 37.2 11.0 0.0 2.5 21.7 8.8 19.5 12.3 2.9 33.4 8.2 19.8 2.2 9.5 25.1 18.6 5.8 5.5 12.6 6.6 4.2 5.2 0.4 0.1 3.9 3.6 3.8 16.5 21.4 24.7 3.5 13.8 2.1 17.2 2.1 12.6 8.5 0.7 9.6 9.9 12.4 9.3 2.4 9.3 14.8 8.9 30.1 5.7 0.8 3.0 15.9 7.7 3.3 10.2 59.7 11.6 3.3 4.8 3.9 3.0 10.3 6.9 17.9 64.9 30.6 6.3 9.3 105.3 20.1 30.6 22.7 21.6 15.7 129.6 2.3 14.9 15.8 13.9 14.5 25.2 116.8 16.1 3.2 3.3 11.2 23.1 28.8 6.5 20.6 40.0 20.3 22.1 13.3 2.0 11.5 0.0 11.8 25.9 13.2 25.6 22.4 2.1 10.5 166.4 12.9 4.7 8.6 53.0 14.6 3.4 42.8 28.3 11.5 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.9;Late spermatids: 207.6;Syncytiotrophoblasts: 179.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 4 "monocytes: 11.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.9;HUVEC TERT2: 18.9;SCLC-21H: 21.2;TIME: 51.8;U-2 OS: 18.9;U-2197: 18.4;U-251 MG: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 140000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 17.1 19.4 12.0 16.4 32.1 2.5 8.9 35.9 36.3 5.1 10.6 36.2 1.4 29.8 5.8 7.1 6.8 8.8 6.0 6.0 11.3 16.6 21.0 3.1 8.8 8.8 46.4 15.9 7.8 4.4 14.7 9.0 12.7 46.8 4.0 8.4 3.8 3.6 5.0 4.6 3.5 27.9 8.3 27.2 10.5 3.2 35.9 36.6 0.9 4.0 1.5 2.6 5.6 5.8 0.0 2.5 0.7 11.6 0.0 0.6 0.7 0.1 0.3 1.2 0.0 17.9 20.9 14.1 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.4 7.5 0.0 12.2 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 1.4 10.9 0.0 3.9 0.0 5.2 18.9 0.0 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 4.0 0.0 0.0 0.0 0.1 1.5 21.2 0.1 0.0 0.1 8.3 10.5 0.2 1.5 51.8 0.1 18.9 18.4 22.2 0.0 0.0 0.0 0.0 1.7 2.1 0.0 4.5 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.7 0.0 11.6 0.0 0.0 0.7 12.0 32.1 35.9 27.7 11.3 16.6 46.4 15.9 46.8 36.6 17.9 8.3 0.0 3.7 14.2 75.0 2.0 5.1 2.7 3.4 7.0 72.6 84.0 13.3 0.3 163.9 11.1 47.9 0.0 0.6 44.2 10.4 3.0 0.0 0.5 50.4 3.2 8.7 3.7 66.5 207.6 20.8 56.6 10.1 55.9 6.1 2.9 1.2 7.0 7.4 56.6 13.2 0.0 5.0 1.9 3.0 7.3 179.0 2.2 7.2 1.3 EPB41L4B EHM2 ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171975-109320964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.1;pancreas: 59.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 67.5;Hepatocytes: 107.1;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 52.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 16.0;hTCEpi: 25.1;OE19: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavorable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 6.5 4.2 7.3 1.2 14.6 0.0 4.8 4.9 11.4 1.1 18.4 1.5 7.1 15.1 0.7 5.9 0.7 3.2 1.8 3.5 2.9 3.5 1.9 28.1 1.7 0.2 1.6 6.8 4.7 59.8 3.3 0.9 1.1 2.7 2.2 18.7 2.4 8.0 3.5 2.2 5.6 16.1 0.3 2.2 0.2 9.4 2.7 1.3 0.4 14.6 1.3 1.2 1.2 1.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 4.2 5.3 0.3 0.4 0.4 0.0 16.0 0.5 0.2 1.8 0.9 9.0 4.2 0.0 1.1 0.5 4.5 6.9 10.6 5.6 2.0 4.4 2.5 0.0 1.7 12.8 1.1 0.2 0.0 0.1 25.1 0.7 8.6 0.5 0.1 3.9 0.1 0.0 2.6 10.7 0.1 0.1 6.9 30.4 7.8 0.0 0.0 0.2 6.4 6.4 6.6 0.7 1.7 11.1 0.0 3.3 2.6 0.0 0.2 3.8 3.9 1.2 1.5 0.0 0.0 0.0 2.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.6 4.9 11.4 2.9 3.5 1.6 6.8 2.7 1.3 6.0 3.2 0.8 4.6 10.2 8.3 14.9 22.9 16.0 5.7 7.0 0.0 3.3 0.0 3.2 8.7 0.7 67.5 0.0 18.0 1.6 2.2 9.9 0.0 107.1 0.5 36.5 49.7 4.3 1.6 1.5 12.4 0.2 1.7 0.0 52.8 1.8 12.8 37.4 2.5 0.6 1.0 0.0 0.4 1.4 14.8 21.0 1.6 0.0 34.5 5.7 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 54.8;placenta: 16.1" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 186.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 92 "HEL: 43.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 7500000 "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 7.5 0.4 0.4 0.4 0.9 54.8 1.3 4.3 1.0 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.6 1.9 0.4 0.9 0.5 0.9 5.5 0.3 0.5 0.3 0.8 0.3 0.3 0.3 16.1 0.7 0.5 0.3 0.3 0.3 0.3 1.3 1.1 1.0 0.3 0.3 5.3 0.5 2.4 0.3 0.5 1.2 0.3 0.5 1.6 4.5 0.0 0.3 0.2 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 4.2 0.4 0.9 4.3 1.0 0.4 0.9 0.5 0.3 0.7 0.3 0.0 0.0 0.5 1.2 1.6 3.7 0.3 2.5 0.0 0.0 0.0 5.9 3.3 0.0 0.0 7.7 0.6 1.1 186.9 0.0 1.9 1.7 1.0 4.6 0.5 1.0 6.4 0.0 1.3 0.3 8.0 2.6 0.8 1.7 0.0 0.8 2.8 0.0 1.7 0.7 0.0 7.8 6.5 1.2 12.1 3.8 2.5 5.6 4.4 0.6 1.6 EPCAM "17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1" ENSG00000119888 "Epithelial cell adhesion molecule" P16422 2 47345158-47387601 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 303.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 1952.6;Mucus-secreting cells: 1256.8;Paneth cells: 2168.3;Undifferentiated cells: 1330.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "A-431: 55.5;CACO-2: 71.9;CAPAN-2: 101.2;OE19: 96.3;RPTEC TERT1: 43.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB003809, HPA026761, CAB030012, CAB055098, HPA067463" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846" "unprognostic (6.79e-2)" "unprognostic (2.28e-1)" "unprognostic (1.59e-2)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (3.49e-2)" "unprognostic (2.01e-1)" "unprognostic (3.61e-2)" "unprognostic (3.40e-1)" "prognostic favorable (3.30e-4)" "unprognostic (5.27e-2)" "unprognostic (3.28e-2)" "prognostic favorable (1.04e-6)" "unprognostic (6.38e-3)" "unprognostic (1.28e-1)" "unprognostic (6.45e-3)" "unprognostic (6.08e-2)" 0.4 2.1 1.8 49.8 3.0 0.2 8.9 0.6 1.0 10.8 155.8 0.7 31.5 66.8 4.4 35.2 2.8 10.2 41.6 0.4 1.7 2.7 60.2 1.2 22.6 0.4 1.2 0.4 3.8 54.1 19.8 38.7 2.2 0.9 9.0 70.5 0.7 47.2 25.0 0.5 2.0 303.2 1.7 1.4 0.5 15.3 5.5 0.9 1.7 83.6 4.2 4.1 4.1 2.1 0.2 1.9 0.4 0.2 0.0 0.0 0.6 55.5 0.6 0.0 0.1 0.0 0.0 35.2 0.0 0.0 0.0 0.0 71.9 101.2 0.0 15.6 0.1 0.0 26.2 0.5 6.6 0.2 0.0 6.4 0.0 0.3 28.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 16.6 0.0 0.0 28.3 0.0 2.6 18.2 96.3 3.6 0.0 0.0 14.1 43.2 24.5 39.1 0.3 0.4 20.7 0.0 15.5 17.4 0.1 0.0 0.0 0.7 0.2 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.6 1.8 3.0 0.6 1.0 1.7 2.7 1.2 0.4 0.9 0.9 288.8 113.7 7.2 161.4 8.2 0.1 1.7 236.9 180.7 188.8 425.7 0.0 14.0 64.6 814.0 5.0 2.3 1952.6 0.0 356.0 2.6 1.9 182.8 33.3 0.4 2.4 0.0 478.4 0.0 0.0 3.2 19.0 5.0 33.7 19.8 1256.8 11.8 505.0 2168.3 17.7 160.0 0.7 12.9 0.4 67.3 135.0 9.2 5.0 2.5 1330.8 202.8 EPDR1 "EPDR, MERP-1, MERP1, UCC1" ENSG00000086289 "Ependymin related 1" Q9UM22 7 37683843-37951941 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6;skeletal muscle: 55.8" "Cell type enhanced" "Detected in many" 10 "Peritubular cells: 93.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 9 "dendritic cells: 5.4;NK-cells: 1.9;T-cells: 1.9" "Cell line enhanced" "Detected in many" "U-937: 36.5;WM-115: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026298, HPA072321" Enhanced "Intracellular and membrane" NA NA "CAB026298: AB_425991, HPA072321: " "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (4.44e-3)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic unfavorable (6.97e-4)" "unprognostic (2.53e-2)" "unprognostic (2.75e-1)" "unprognostic (3.13e-1)" "unprognostic (7.23e-2)" "unprognostic (1.85e-1)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (4.13e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.00e-4)" 11.2 23.3 21.9 2.2 16.0 2.1 4.8 30.5 30.5 21.5 4.9 7.5 1.6 7.0 22.4 7.4 4.6 15.5 5.3 13.9 20.3 34.3 8.6 6.0 13.8 2.9 25.3 18.8 18.6 5.7 5.8 4.6 2.8 57.6 18.5 4.7 8.0 7.3 22.6 55.8 1.5 6.8 16.4 13.9 8.3 3.4 6.7 5.2 5.2 16.1 7.7 1.7 4.7 8.5 0.0 5.4 0.2 0.3 1.9 1.9 0.4 0.0 23.8 2.0 0.0 18.8 6.8 0.0 1.8 0.0 0.9 2.9 2.3 1.5 0.0 27.0 26.5 28.2 0.0 0.5 0.2 0.0 0.0 3.0 10.4 3.2 14.5 0.1 8.6 0.0 11.4 0.0 6.7 0.1 6.4 0.0 10.6 0.0 7.9 15.9 1.5 3.3 7.3 7.4 0.0 3.5 10.6 6.9 9.1 14.7 5.8 2.6 9.2 0.0 1.2 8.3 5.1 0.0 6.1 0.0 5.2 8.9 14.4 11.0 10.6 4.5 0.1 24.1 36.5 35.6 0.0 0.3 0.2 1.7 0.3 0.0 0.0 0.0 1.9 1.0 0.0 0.1 1.1 0.2 1.9 0.0 5.4 0.0 0.4 21.9 16.0 30.5 30.5 20.3 34.3 25.3 18.8 57.6 5.2 29.8 37.4 1.3 9.3 1.1 5.1 16.9 7.6 5.3 20.5 1.8 0.0 0.5 14.9 8.1 0.2 1.4 6.8 0.0 7.1 0.1 8.4 9.6 2.3 11.9 3.1 11.1 3.5 6.7 1.3 0.9 26.2 2.2 27.0 24.4 4.7 10.5 13.6 5.3 93.0 11.3 5.3 6.5 12.8 0.0 0.6 0.3 0.1 0.5 4.7 2.0 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "hTCEpi: 62.6;U-2197: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.1 0.0 62.6 1.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 2.2 EPHA1 "EPH, EPHT, EPHT1" ENSG00000146904 "EPH receptor A1" P21709 7 143390289-143408892 "Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 104.4" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1" "Lineage enriched" "Detected in single" 9 "T-cells: 6.9" "Cell line enhanced" "Detected in some" "CACO-2: 10.5;HaCaT: 9.8;HBEC3-KT: 8.0;MCF7: 8.7;NTERA-2: 32.7" "Not detected" "Not detected" CAB026144 Uncertain NA NA 24000000 "CAB026144: " "unprognostic (1.54e-2)" "unprognostic (3.04e-2)" "unprognostic (2.07e-1)" "unprognostic (4.58e-3)" "unprognostic (5.82e-3)" "unprognostic (2.45e-2)" "unprognostic (9.56e-2)" "unprognostic (1.81e-2)" "unprognostic (5.09e-1)" "unprognostic (7.59e-3)" "unprognostic (6.54e-2)" "unprognostic (3.24e-3)" "prognostic favorable (1.14e-6)" "unprognostic (3.73e-2)" "unprognostic (3.28e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" 0.4 0.4 0.0 2.0 0.1 0.5 1.2 0.9 0.3 5.7 7.9 0.0 3.3 3.3 0.9 1.4 29.3 1.6 7.9 0.4 0.0 0.0 2.8 10.6 2.9 5.8 0.0 0.0 1.2 2.9 104.4 1.3 5.5 1.1 2.1 0.9 1.3 5.8 3.9 0.3 9.5 12.3 0.4 0.2 0.5 1.8 0.8 0.0 5.1 6.0 16.4 17.2 1.6 11.8 0.0 0.7 0.2 0.1 0.2 6.9 1.6 5.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 10.5 4.2 0.0 0.0 0.0 0.0 9.8 0.0 8.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 8.7 0.0 1.1 32.7 5.1 0.0 0.0 0.0 0.0 0.7 4.0 0.1 0.0 0.0 4.9 0.0 2.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 3.4 0.9 0.4 0.0 6.9 5.1 0.2 0.2 0.0 0.7 0.2 1.6 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.1 0.0 5.0 1.8 0.0 0.8 2.5 0.0 3.4 7.0 0.0 1.5 0.0 3.9 16.5 0.0 6.5 0.0 3.7 2.0 0.4 2.1 0.0 7.6 0.4 0.0 1.2 0.0 0.0 7.5 0.6 0.0 0.0 0.0 3.7 0.3 5.1 6.8 0.0 1.1 0.0 0.0 0.0 0.2 1.2 3.1 0.8 0.0 6.0 5.0 EPHA10 "FLJ16103, FLJ33655" ENSG00000183317 "EPH receptor A10" Q5JZY3 1 37713880-37765133 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.6;intestine: 12.6;testis: 24.8" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 86.4;Early spermatids: 49.4;Late spermatids: 147.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 5.2;HDLM-2: 19.6;SCLC-21H: 9.1" HPA027497 Uncertain "Intracellular and membrane" NA NA "HPA027497: AB_10601158" "unprognostic (9.27e-2)" "unprognostic (1.21e-1)" "unprognostic (2.94e-2)" "unprognostic (1.24e-6)" "unprognostic (1.06e-1)" "unprognostic (1.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.40e-1)" "unprognostic (7.06e-3)" "unprognostic (1.50e-1)" "unprognostic (8.81e-5)" "unprognostic (2.55e-2)" "unprognostic (2.97e-2)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 0.4 1.1 5.8 1.7 15.6 0.7 1.9 1.3 10.5 0.6 12.6 3.6 0.2 5.8 0.5 6.8 0.8 1.8 2.1 0.4 4.6 7.4 0.5 0.4 0.5 0.6 3.5 5.0 0.4 5.1 1.1 10.8 0.4 6.4 1.4 10.3 1.6 2.4 0.7 0.4 0.6 7.3 1.0 2.3 0.5 5.3 24.8 2.1 0.0 1.0 0.0 0.5 0.6 0.3 0.4 0.3 1.5 0.3 0.8 0.7 0.1 1.5 1.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.7 2.8 0.0 0.4 0.0 0.3 0.1 0.1 0.0 0.0 19.6 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.7 0.0 1.1 0.0 0.2 0.7 2.1 0.6 0.0 0.0 0.4 0.3 1.7 9.1 0.4 1.1 0.0 0.0 0.2 2.9 0.1 0.0 0.0 1.0 0.1 0.0 1.8 1.2 0.0 0.0 0.0 0.1 1.4 0.2 0.1 0.7 0.1 0.4 0.4 0.3 0.3 0.1 0.4 0.6 0.7 1.5 0.8 0.3 0.3 0.2 0.1 5.8 15.6 1.3 10.5 4.6 7.4 3.5 5.0 6.4 2.1 0.0 0.3 0.0 0.0 0.1 5.0 1.4 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.4 49.4 0.0 9.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 11.1 18.0 0.0 0.0 147.5 1.7 0.0 0.0 0.0 9.3 0.3 2.1 23.5 0.4 0.0 3.0 0.0 0.0 8.2 2.5 0.0 0.0 0.0 8.3 0.1 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156087 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.2" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 115 "dendritic cells: 11.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 6.7 3.4 1.3 3.1 2.6 0.0 5.2 0.5 2.1 12.1 4.9 1.6 1.9 4.3 7.8 3.8 51.2 4.6 16.7 6.4 1.1 0.8 5.7 8.2 6.6 4.7 2.7 1.3 4.5 10.2 2.2 2.8 8.9 3.4 5.8 2.6 5.4 31.0 2.8 3.4 12.7 13.1 2.7 3.0 2.8 6.8 2.4 1.2 1.2 5.7 21.8 25.5 15.2 18.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 15.6 31.7 8.8 4.2 0.6 0.7 5.2 9.5 13.4 17.2 10.9 13.2 42.4 0.0 40.9 5.4 21.3 6.4 2.1 21.9 6.0 0.0 1.4 0.0 9.2 8.4 11.3 0.0 0.0 1.0 8.2 9.3 20.7 27.0 18.3 0.0 0.0 0.0 10.9 5.0 0.0 0.0 4.2 11.8 48.6 0.0 8.0 0.0 18.2 8.1 0.0 1.3 18.4 4.5 1.2 4.8 0.6 0.1 22.6 6.1 16.5 0.4 49.8 0.0 0.1 0.1 4.7 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 1.3 2.6 0.5 2.1 1.1 0.8 2.7 1.3 3.4 1.2 50.6 28.9 0.5 100.5 179.7 0.6 5.8 40.8 37.5 33.0 8.7 3.9 8.1 0.0 31.3 5.4 17.5 57.1 0.0 12.5 0.9 7.0 56.8 5.7 19.8 1.6 0.0 2.9 32.5 2.8 0.0 3.1 4.6 25.3 1.8 19.6 5.8 62.9 20.1 0.0 1.4 2.0 32.3 17.6 0.0 0.7 217.2 6.3 0.0 17.7 155.0 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107524-89482134 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 39.0" "Group enriched" "Detected in some" 5 "Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 66.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 9.7 1.1 2.3 1.7 4.5 0.2 5.1 1.3 8.7 12.3 5.8 0.6 1.4 2.2 13.9 1.3 6.3 2.6 17.2 10.0 2.2 2.5 1.5 4.4 2.7 3.0 2.5 3.4 4.2 2.8 1.2 3.4 17.5 11.9 39.0 5.9 5.4 3.8 6.8 1.7 1.7 3.5 17.3 2.9 1.2 3.7 1.3 2.0 0.0 16.3 6.0 3.0 11.8 12.2 0.3 0.1 0.5 0.1 0.3 0.2 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.8 0.0 0.2 0.0 0.8 0.0 0.0 4.1 0.0 0.0 0.6 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.6 0.0 0.5 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 2.3 4.5 1.3 8.7 2.2 2.5 2.5 3.4 11.9 2.0 0.0 0.0 0.0 0.3 0.5 1.5 2.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.1 12.2 0.1 0.0 0.0 0.1 19.1 0.0 0.6 0.0 1.3 2.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 7.8 0.0 16.9 6.5 20.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 EPHA4 "Hek8, TYRO1" ENSG00000116106 "EPH receptor A4" P54764 2 221418027-221574202 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 25.0;Pancreatic endocrine cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 35.8;ASC diff: 15.8;CACO-2: 26.2;U-2197: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB028368 Enhanced NA NA 8400000 "CAB028368: AB_2099353" "unprognostic (1.28e-1)" "unprognostic (5.87e-2)" "unprognostic (2.28e-1)" "unprognostic (2.46e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (7.05e-4)" "unprognostic (1.80e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (1.12e-1)" "unprognostic (2.85e-2)" "prognostic favorable (5.67e-4)" "unprognostic (3.12e-2)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (8.66e-2)" 7.1 1.8 8.1 1.9 18.3 3.5 5.2 14.7 29.6 4.9 5.9 3.1 3.2 1.1 6.5 3.1 5.0 6.6 3.3 16.7 19.9 4.4 5.2 0.9 3.7 2.5 2.4 16.4 11.7 1.2 2.0 1.2 1.7 4.9 5.9 4.7 0.8 3.7 6.7 3.1 12.8 4.1 8.2 2.1 3.3 4.0 11.4 2.6 0.5 9.8 3.7 3.2 4.6 4.9 2.5 0.2 3.0 0.0 6.0 5.0 0.7 1.1 1.1 35.8 0.0 15.8 9.8 0.0 8.5 3.7 7.7 2.8 26.2 0.4 0.0 0.0 11.8 0.0 3.1 5.5 0.0 3.2 4.2 3.0 0.0 0.3 0.0 0.4 0.0 0.6 3.9 1.9 2.4 0.0 4.8 7.2 0.0 0.0 0.0 2.0 4.2 0.1 0.0 2.5 2.6 0.8 0.0 3.9 0.0 12.0 1.9 6.3 0.0 2.8 0.6 0.6 3.0 1.3 0.0 0.0 0.8 1.5 17.5 0.4 0.0 0.0 0.0 3.2 0.0 1.6 3.0 0.0 0.0 3.4 0.0 3.4 2.5 5.0 3.3 0.0 1.8 1.9 0.3 0.2 6.0 0.0 0.2 2.1 0.7 8.1 18.3 14.7 29.6 19.9 4.4 2.4 16.4 4.9 2.6 0.0 5.4 0.8 0.4 5.5 10.2 25.0 7.6 1.4 3.4 8.7 0.0 0.0 6.6 0.2 2.0 11.7 0.1 0.0 0.2 0.0 3.9 1.2 1.1 0.0 0.3 1.6 3.4 12.3 0.0 4.3 1.1 0.2 6.8 0.0 14.0 6.3 18.0 0.0 8.1 1.5 2.7 0.0 7.2 6.7 1.3 10.9 0.0 1.0 6.8 1.8 EPHA5 "CEK7, EHK1, Hek7, TYRO4" ENSG00000145242 "EPH receptor A5" P54756 4 65319563-65670495 "Enzymes, Predicted membrane proteins" Neurogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.5" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 12.1;Late spermatids: 12.5;Muller glia cells: 6.4" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 7.8;PC-3: 7.1;TIME: 9.5;U-138 MG: 19.9;U-2197: 12.1;U-251 MG: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.02e-2)" "unprognostic (4.22e-2)" "unprognostic (2.38e-1)" "unprognostic (4.89e-4)" "unprognostic (7.43e-4)" "unprognostic (1.60e-1)" "unprognostic (6.68e-3)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (9.25e-2)" "unprognostic (5.88e-3)" "unprognostic (2.55e-2)" "unprognostic (5.97e-4)" "unprognostic (3.81e-3)" 0.9 2.7 17.6 1.0 9.0 0.8 0.8 1.9 25.5 5.9 1.2 1.5 1.8 0.9 1.9 0.9 1.1 1.0 0.9 2.7 17.3 6.8 0.9 0.8 1.1 0.9 5.4 13.2 6.2 0.8 0.8 6.5 2.7 10.2 4.2 1.1 2.6 1.2 4.1 0.8 1.2 0.9 1.4 17.7 1.5 1.1 2.2 0.7 0.0 3.0 0.0 0.8 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.6 0.3 0.0 0.3 0.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 3.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.8 0.2 0.0 0.0 1.2 1.9 0.0 0.0 0.0 0.0 0.0 7.1 0.0 2.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 9.5 19.9 2.5 12.1 15.3 0.0 0.0 0.0 2.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 9.0 1.9 24.7 17.3 6.8 5.4 13.2 10.2 0.7 0.0 0.0 0.0 0.0 0.5 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 1.6 0.0 0.0 0.0 12.5 0.9 0.0 3.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.0 0.2 0.1 0.0 0.0 0.0 0.0 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;ovary: 13.2;testis: 15.5" "Group enriched" "Detected in some" 67 "Early spermatids: 305.1;Late spermatids: 156.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 8.2;U-266/70: 24.9" "Low region specificity" "Detected in many" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.8 0.5 8.7 0.5 9.8 0.3 0.8 27.9 9.9 2.2 5.8 1.1 0.3 0.6 2.2 1.0 2.1 4.2 2.1 1.1 15.4 1.3 1.3 0.5 0.5 0.4 1.1 6.8 13.2 1.4 0.7 0.6 0.5 5.7 2.5 1.8 0.2 0.6 1.7 0.4 0.5 1.1 3.2 0.8 0.4 1.7 15.5 2.8 0.0 4.3 0.0 0.5 2.1 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 8.2 0.0 2.1 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.1 0.0 0.8 24.9 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 9.8 27.9 9.9 15.4 1.3 1.1 6.8 5.7 2.8 0.0 0.0 0.0 0.1 0.2 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 156.3 2.8 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.6 0.2 0.0 0.1 3.4 2.3 0.0 0.1 0.0 0.0 0.0 EPHA7 Hek11 ENSG00000135333 "EPH receptor A7" Q15375 6 93240020-93419547 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "parathyroid gland: 110.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 14.1;Cardiomyocytes: 10.8;Early spermatids: 3.7;Horizontal cells: 11.1;Proximal tubular cells: 11.5" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.9;HEK 293: 25.5;RH-30: 24.4;THP-1: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010496 Approved "Intracellular and membrane" NA NA 340000 "CAB010496: AB_2099673" "unprognostic (3.34e-1)" "unprognostic (7.82e-2)" "unprognostic (1.41e-1)" "unprognostic (9.32e-2)" "unprognostic (1.19e-1)" "unprognostic (3.56e-2)" "unprognostic (1.62e-2)" "unprognostic (4.07e-1)" "unprognostic (4.16e-2)" "unprognostic (3.19e-2)" "unprognostic (5.69e-2)" "unprognostic (1.69e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-1)" "unprognostic (1.56e-2)" "unprognostic (4.82e-2)" 1.3 1.3 6.0 1.7 24.6 1.2 2.2 21.6 8.6 2.4 24.6 0.0 0.1 2.5 2.0 7.5 14.7 1.7 3.1 4.2 13.8 2.9 6.9 1.3 1.5 1.3 2.4 5.8 3.0 1.3 110.4 5.6 1.6 6.7 17.9 3.6 0.4 8.2 1.9 1.3 1.4 6.5 20.2 4.8 4.7 14.9 2.1 4.4 0.0 1.3 0.0 1.3 9.7 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 25.5 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.5 0.0 0.6 4.5 24.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 20.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 24.6 21.6 8.6 13.8 2.9 2.4 5.8 6.7 4.4 0.0 0.0 0.0 0.4 0.3 14.1 10.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.7 0.7 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.1 11.1 0.0 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 11.5 0.9 0.0 0.8 0.2 0.7 0.9 0.0 0.0 0.0 0.0 EPHA8 "EEK, Hek3" ENSG00000070886 "EPH receptor A8" P29322 1 22563564-22603594 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 5.2;Early spermatids: 2.5;Horizontal cells: 3.2;Late spermatids: 3.9;Rod photoreceptor cells: 8.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "SCLC-21H: 37.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 25.0" "CAB009660, HPA031433" Uncertain "Intracellular and membrane" NA NA "CAB009660: AB_2099696, HPA031433: AB_10601371" "unprognostic (8.58e-2)" "unprognostic (8.59e-2)" "unprognostic (3.72e-1)" "unprognostic (1.15e-2)" "unprognostic (4.69e-4)" "unprognostic (3.58e-1)" "unprognostic (7.14e-2)" "unprognostic (1.52e-1)" "unprognostic (4.75e-2)" "unprognostic (9.80e-2)" "unprognostic (2.10e-1)" "unprognostic (9.84e-14)" "unprognostic (2.14e-3)" "unprognostic (1.69e-1)" "unprognostic (2.76e-1)" "unprognostic (8.68e-2)" 0.2 9.4 1.6 0.2 3.1 0.2 0.1 1.8 3.9 0.2 0.2 2.2 0.0 1.7 0.1 0.3 0.2 0.1 0.2 0.2 2.0 2.6 0.1 0.1 0.2 0.2 2.1 4.1 0.1 8.3 0.2 1.7 0.1 5.3 0.2 0.2 1.6 0.8 0.2 0.3 0.4 0.2 0.1 1.3 10.3 0.2 3.5 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 3.1 1.8 3.9 2.0 2.6 2.1 4.1 5.3 0.6 0.0 0.0 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.0 8.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 74.7" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Region enhanced" "Detected in all" "cerebellum: 74.7" "Group enriched" "Detected in some" 33 "neutrophil: 15.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 33 "dendritic cells: 15.4;granulocytes: 15.9" "Group enriched" "Detected in some" 4 "HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: AB_2685895" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 2.0 1.5 9.0 1.8 16.6 1.5 5.5 74.7 23.6 3.6 3.4 3.4 3.1 2.8 4.1 2.0 3.8 2.8 3.3 1.1 9.4 5.3 2.3 2.9 1.0 3.3 2.8 7.0 1.7 1.1 0.6 3.8 0.9 7.1 3.3 1.4 1.9 3.9 5.1 7.4 6.0 1.7 1.7 6.0 3.4 1.3 16.7 6.0 0.0 11.6 2.9 3.3 4.5 2.6 0.0 15.4 15.9 0.0 0.0 0.4 0.1 0.0 0.0 4.8 0.0 0.1 0.0 0.1 3.6 0.0 0.2 0.0 0.0 0.0 0.6 1.0 1.9 0.3 0.0 3.2 0.0 0.7 34.7 0.4 2.6 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.2 2.6 0.1 0.1 0.1 1.4 0.6 0.0 0.0 0.5 0.1 9.4 0.0 0.6 0.1 0.0 0.0 0.0 0.7 0.1 0.4 0.2 0.6 2.0 0.3 4.3 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 15.4 0.0 0.1 9.0 16.6 74.7 19.0 9.4 5.3 2.8 7.0 7.1 6.0 0.0 0.0 0.9 0.0 3.3 1.2 1.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.8 30.2 0.6 0.0 0.0 0.3 0.0 0.2 0.1 0.0 5.8 0.4 0.0 0.0 0.0 0.0 26.8 0.6 0.0 1.7 0.0 0.0 16.2 0.6 0.0 0.0 0.0 0.9 0.0 0.8 0.4 0.9 5.1 0.0 0.0 0.0 0.1 EPHB2 "DRT, EPHT3, ERK, Hek5, Tyro5" ENSG00000133216 "EPH receptor B2" P29323 1 22710839-22921500 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0" "Cell type enhanced" "Detected in many" 11 "Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013647, HPA071200" Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" No No 290000 "Plasma membrane" Nucleoplasm "CAB013647: , HPA071200: AB_2686360" "unprognostic (2.47e-2)" "unprognostic (2.43e-2)" "prognostic favorable (4.98e-4)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.99e-2)" "unprognostic (8.91e-3)" "unprognostic (1.23e-1)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "unprognostic (7.73e-2)" "unprognostic (1.23e-2)" "unprognostic (2.15e-2)" "unprognostic (2.16e-4)" "unprognostic (1.45e-1)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (3.46e-2)" 3.7 2.9 3.4 15.4 5.4 0.9 2.5 1.9 8.2 3.8 23.9 16.2 4.6 21.6 2.5 3.2 1.1 5.4 4.4 5.4 5.6 6.5 3.5 1.1 3.0 5.5 12.7 3.8 17.9 5.4 6.1 5.4 12.0 8.2 3.3 25.0 2.2 6.6 4.0 0.7 1.8 22.6 4.0 12.1 3.3 2.3 2.9 9.3 0.1 8.4 1.0 2.1 5.3 3.3 0.1 0.6 0.3 2.5 0.1 0.1 0.4 15.9 6.7 6.5 10.4 0.6 0.6 0.0 3.7 0.2 11.3 2.4 2.3 6.4 0.2 8.0 1.6 34.4 15.1 4.4 21.7 3.0 0.0 1.6 0.0 0.7 0.0 6.8 0.0 1.6 2.2 7.0 20.2 0.1 10.0 29.7 0.9 0.6 0.0 2.2 2.3 0.3 0.1 1.5 17.8 4.4 1.9 6.7 0.3 5.5 1.5 7.1 7.4 6.5 0.2 0.0 0.6 0.4 0.2 29.4 4.5 11.8 11.4 25.5 0.0 0.1 0.0 8.4 0.3 0.1 0.3 2.5 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 3.4 5.4 1.9 8.2 5.6 6.5 12.7 3.8 8.2 9.3 3.0 0.0 0.0 1.5 0.7 11.6 1.2 12.7 1.4 3.4 0.0 0.0 0.4 0.0 42.3 2.3 0.5 6.8 0.0 6.8 2.2 1.5 1.4 0.0 0.5 9.1 6.4 46.8 0.6 7.5 0.4 0.9 3.7 0.0 0.0 53.6 20.9 38.4 3.5 0.7 0.0 1.7 0.0 1.7 0.5 2.6 0.4 0.9 0.0 82.9 1.0 EPHB3 "ETK2, Hek2, Tyro6" ENSG00000182580 "EPH receptor B3" P54753 3 184561784-184582409 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Angiogenesis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 49.3" "Cell type enhanced" "Detected in many" 10 "Intestinal endocrine cells: 68.8;Mucus-secreting cells: 39.5;Suprabasal keratinocytes: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 1.1;myeloid DC: 3.1" "Group enriched" "Detected in many" 5 "dendritic cells: 3.1;monocytes: 1.1" "Cell line enhanced" "Detected in many" "BEWO: 17.0;HaCaT: 23.4;OE19: 16.1;SK-BR-3: 18.1;T-47d: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007698, HPA008184, CAB034350" Enhanced NA NA 20000 "CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.17e-2)" "unprognostic (7.80e-2)" "unprognostic (1.52e-1)" "unprognostic (9.19e-2)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (5.51e-2)" "unprognostic (1.76e-1)" "unprognostic (7.42e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (7.88e-5)" "unprognostic (8.83e-3)" "unprognostic (3.03e-2)" "unprognostic (9.59e-3)" "unprognostic (2.10e-3)" 1.4 0.9 4.5 5.0 2.6 0.5 9.0 9.7 5.7 22.7 8.8 2.3 1.7 5.7 10.0 1.9 19.9 3.0 9.7 1.6 4.7 1.8 1.7 1.0 4.7 1.0 3.3 3.7 9.0 49.3 1.1 1.7 6.3 7.2 7.7 9.7 3.8 27.7 3.5 0.7 32.3 5.6 3.5 1.3 1.2 16.0 1.1 4.0 0.2 1.0 15.7 8.4 4.0 13.6 0.0 3.1 0.3 1.1 0.0 0.4 0.4 3.7 1.3 8.8 0.9 2.7 0.2 17.0 0.6 1.1 1.3 0.7 1.2 0.1 0.0 1.7 3.6 0.6 23.4 3.1 1.1 0.3 0.1 0.7 0.0 0.2 0.0 0.2 0.0 0.2 0.7 7.7 1.0 0.1 0.4 0.0 0.0 0.0 0.0 0.6 9.9 0.0 3.8 0.9 16.1 1.4 0.8 5.3 0.0 0.0 3.4 1.1 1.3 0.7 18.1 0.8 4.8 12.0 0.1 0.0 2.1 3.1 1.1 1.4 0.0 0.0 0.1 0.2 0.0 8.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.4 4.5 2.6 9.7 5.7 4.7 1.8 3.3 3.7 7.2 4.0 3.0 2.4 0.0 6.9 21.4 0.0 1.4 2.5 1.4 2.3 0.0 0.0 8.1 1.7 0.3 0.4 0.6 3.5 0.0 1.4 14.8 8.4 5.5 4.6 0.0 17.9 14.3 68.8 3.1 0.3 0.0 2.6 1.0 0.0 1.0 39.5 0.1 2.4 7.0 5.6 0.1 0.8 0.0 2.1 0.5 0.6 31.2 13.6 0.0 27.1 19.5 EPHB6 HEP ENSG00000106123 "EPH receptor B6" 7 142855061-142871094 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1" "Cell type enhanced" "Detected in many" 16 "Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MOLT-4: 18.2;RT4: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035784 Uncertain "Nuclear speckles" "Intracellular and membrane" NA NA "Nuclear speckles" "HPA035784: AB_2674781" "unprognostic (1.90e-2)" "prognostic favorable (1.80e-4)" "unprognostic (7.08e-3)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (2.53e-3)" "unprognostic (3.15e-2)" "unprognostic (4.39e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.06e-3)" "unprognostic (3.18e-1)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.16e-1)" "prognostic favorable (4.68e-5)" 3.3 1.7 7.4 3.0 30.1 3.3 2.6 3.1 29.3 9.0 1.5 0.8 3.4 0.9 3.0 4.5 7.5 6.4 2.8 1.4 5.4 4.2 1.7 1.3 2.4 3.6 3.3 14.4 3.9 7.8 0.8 1.1 2.9 1.7 6.8 0.9 1.5 4.7 8.1 1.8 32.1 1.6 2.0 1.4 2.6 3.3 3.8 3.6 26.7 6.6 2.5 3.3 5.1 6.5 4.1 0.9 1.0 1.3 0.0 3.1 1.4 0.1 0.0 0.0 0.4 2.0 1.0 0.0 0.2 0.4 0.1 0.0 0.6 1.3 0.0 0.0 0.1 0.0 4.5 0.2 0.0 0.0 1.0 0.1 0.3 0.0 0.2 0.6 4.3 0.2 0.3 0.0 1.2 0.0 0.0 0.2 3.0 0.6 0.0 0.0 0.0 18.2 3.3 3.1 0.7 1.3 0.4 0.0 0.0 0.0 34.6 0.0 0.0 1.2 0.9 0.0 0.4 2.9 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 1.3 0.5 0.1 1.0 0.6 4.1 2.5 1.4 0.9 1.0 3.1 1.5 1.0 0.0 0.4 0.1 1.9 1.4 7.4 30.1 3.1 29.3 5.4 4.2 3.3 14.4 1.7 3.6 3.0 1.7 4.5 25.1 48.3 4.3 2.0 38.2 6.7 10.3 7.0 2.0 0.2 5.0 25.0 0.7 1.4 0.0 0.0 5.7 0.0 12.3 11.7 0.0 1.8 4.3 0.0 1.7 1.3 11.5 4.0 27.9 5.3 11.8 0.0 0.0 270.3 19.6 0.0 9.2 0.4 5.0 103.5 18.4 0.2 8.3 103.5 0.2 8.3 0.0 23.4 EPHX1 EPHX ENSG00000143819 "Epoxide hydrolase 1" P07099 1 225810092-225845563 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aromatic hydrocarbons catabolism, Detoxification" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 156.4;liver: 265.0" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 721.1;Leydig cells: 288.2" "Cancer enriched" "Detected in all" 6 "liver cancer: 1047.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 157.2;SiHa: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020593, HPA048847" Enhanced NA NA 83000 "HPA020593: AB_10601373, HPA048847: AB_2680538" "unprognostic (2.85e-2)" "unprognostic (2.52e-2)" "unprognostic (2.00e-2)" "unprognostic (2.53e-3)" "unprognostic (2.50e-1)" "unprognostic (6.60e-2)" "unprognostic (3.92e-2)" "prognostic favorable (7.02e-5)" "unprognostic (1.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.32e-4)" "unprognostic (8.10e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (5.15e-2)" "unprognostic (1.88e-2)" 39.5 156.4 16.8 5.7 20.1 3.4 31.3 8.3 25.1 31.3 12.6 28.7 15.3 16.6 21.8 15.7 24.9 26.2 17.8 11.5 16.3 11.2 36.8 265.0 24.1 6.9 17.1 14.5 45.6 85.0 39.5 14.0 5.4 23.6 25.9 8.4 27.3 26.3 21.3 16.4 8.8 9.6 18.6 10.7 8.3 12.1 22.7 12.6 3.6 24.9 15.6 14.9 20.9 32.3 0.5 2.2 0.5 6.6 1.4 1.3 2.3 4.5 43.3 1.7 15.9 157.2 16.4 3.4 5.2 6.6 3.8 5.3 8.9 46.0 0.1 19.7 19.6 4.3 5.0 4.7 2.5 1.5 1.0 8.2 3.2 18.3 49.9 17.1 2.0 1.9 15.3 5.7 10.7 1.0 14.9 2.8 1.9 2.2 4.0 6.7 5.3 1.9 3.7 9.3 21.7 12.2 4.2 2.0 13.1 11.4 28.5 14.9 1.9 74.7 26.8 6.9 4.3 19.9 5.8 8.2 6.5 5.2 8.7 8.3 1.3 6.8 0.6 9.7 2.1 8.5 0.0 6.6 0.2 0.5 1.9 0.9 0.3 0.9 0.5 1.5 0.5 1.3 1.0 0.5 1.4 0.8 2.2 0.7 2.3 16.8 20.1 8.3 25.1 16.3 11.2 17.1 14.5 23.6 12.6 0.0 12.3 2.9 88.1 17.4 7.0 1.4 96.8 16.0 12.5 48.8 27.5 40.2 14.9 84.0 9.3 77.9 28.9 23.3 63.2 4.5 52.6 51.6 5.7 721.1 118.3 1.6 10.4 74.9 24.4 15.1 288.2 14.5 40.5 8.2 13.8 96.3 71.3 21.0 149.6 79.4 10.3 219.9 78.5 3.1 3.6 15.4 19.1 10.2 31.9 79.3 EPHX2 ENSG00000120915 "Epoxide hydrolase 2" P34913 8 27490779-27545564 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism" "Hydrolase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.9;liver: 87.6" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 152.5;Proximal tubular cells: 198.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 39.2" "Lineage enriched" "Detected in many" 24 "T-cells: 39.2" "Group enriched" "Detected in many" 4 "JURKAT: 50.5;K-562: 17.8;OE19: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023094, HPA023660" Enhanced Enhanced Cytosol NA NA 720000 Cytosol "HPA023094: AB_1848214, HPA023660: AB_1848215" "unprognostic (1.30e-1)" "prognostic favorable (2.45e-4)" "unprognostic (2.99e-2)" "unprognostic (3.62e-2)" "unprognostic (1.76e-2)" "unprognostic (3.30e-3)" "unprognostic (1.26e-3)" "unprognostic (3.31e-3)" "unprognostic (1.46e-1)" "unprognostic (3.55e-2)" "unprognostic (4.14e-3)" "unprognostic (1.98e-1)" "prognostic favorable (1.98e-10)" "unprognostic (9.82e-2)" "unprognostic (1.73e-1)" "unprognostic (8.12e-2)" "unprognostic (2.26e-1)" 4.8 25.1 4.8 14.3 6.0 0.4 8.3 5.6 3.3 7.6 56.2 6.1 21.8 29.8 10.3 15.1 15.2 11.3 9.4 7.8 4.1 4.8 44.2 87.6 4.6 5.0 5.8 3.2 11.4 25.3 11.6 14.6 2.9 10.5 17.9 15.6 13.3 18.0 22.7 8.5 11.5 83.9 13.1 4.5 3.5 6.7 5.4 3.9 45.7 7.5 13.2 11.7 7.0 7.4 1.6 0.0 0.0 0.0 1.4 39.2 7.6 5.3 3.6 2.3 2.9 0.1 0.0 1.7 0.4 0.3 0.2 0.0 2.8 3.6 0.0 2.1 1.3 1.2 3.8 0.4 0.9 0.1 0.0 1.7 7.9 0.4 8.7 1.3 0.0 1.6 3.2 3.9 0.0 0.4 0.9 0.1 50.5 17.8 0.0 0.0 1.6 5.1 0.2 3.7 36.3 6.2 0.0 0.0 0.1 3.2 0.8 1.9 5.9 4.3 5.2 5.2 1.8 7.9 1.5 0.0 0.0 1.4 0.6 0.0 4.6 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 4.0 1.6 12.5 4.5 0.0 0.9 39.2 18.0 0.0 1.4 0.0 0.0 9.4 7.6 4.8 6.0 5.6 3.3 4.1 4.8 5.8 3.2 10.5 3.9 6.0 13.4 4.7 14.5 10.5 33.3 21.0 15.3 24.1 10.3 26.2 74.6 18.1 152.5 4.7 6.3 6.0 93.2 0.0 5.7 2.6 7.2 27.0 5.7 98.6 1.8 31.8 22.4 10.4 3.5 2.4 27.6 0.8 5.0 2.8 54.7 84.9 4.3 74.7 17.7 198.6 56.3 0.0 12.0 1.5 7.0 15.9 6.9 5.7 88.0 6.7 EPHX3 "ABHD9, FLJ22408" ENSG00000105131 "Epoxide hydrolase 3" Q9H6B9 19 15226919-15233435 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6" "Group enriched" "Detected in many" 4 "Suprabasal keratinocytes: 37.9;Urothelial cells: 18.6" "Cancer enhanced" "Detected in many" "cervical cancer: 30.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 18 "dendritic cells: 2.8;monocytes: 4.9" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;NTERA-2: 3.7;OE19: 12.9;SuSa: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012842 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA012842: AB_10601648" "unprognostic (1.39e-1)" "unprognostic (1.16e-2)" "unprognostic (1.54e-2)" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "prognostic favorable (2.27e-5)" "unprognostic (8.83e-3)" "unprognostic (1.50e-1)" "unprognostic (3.90e-1)" "unprognostic (4.36e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-1)" "unprognostic (3.68e-2)" "unprognostic (1.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.01e-2)" 0.2 0.1 0.1 0.2 0.3 0.1 1.0 0.1 0.3 12.5 0.2 0.2 0.4 0.1 0.9 0.3 34.8 1.1 1.7 0.1 0.5 0.1 1.6 0.2 1.6 0.0 0.2 0.0 0.6 0.0 2.2 2.4 0.2 0.4 1.5 0.1 0.6 3.4 0.6 0.2 33.1 0.2 0.2 0.2 1.2 0.5 2.7 0.2 2.4 0.2 39.6 29.6 2.8 13.6 0.0 2.8 0.2 4.9 0.0 0.0 0.5 0.1 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.5 0.3 4.0 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.6 0.0 0.5 3.7 12.9 0.5 0.0 0.0 0.0 0.1 0.8 1.6 0.2 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.0 1.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 4.9 2.8 0.0 0.5 0.1 0.3 0.1 0.3 0.5 0.1 0.2 0.0 0.4 0.2 0.0 0.6 0.0 1.5 6.3 0.2 0.3 2.5 1.4 0.0 5.2 0.0 1.5 1.7 0.5 0.3 0.1 0.0 0.0 0.0 2.5 0.7 2.0 0.0 0.0 0.6 0.0 0.0 1.3 1.3 0.0 0.0 1.4 0.0 1.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 2.1 2.1 37.9 2.2 0.0 0.0 18.6 EPHX4 "ABHD7, EPHXRP, FLJ90341" ENSG00000172031 "Epoxide hydrolase 4" Q8IUS5 1 92029982-92063536 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 13.3;brain: 20.7" "Cell type enhanced" "Detected in some" 11 "Endothelial cells: 2.9;Melanocytes: 3.3;Muller glia cells: 8.1;Pancreatic endocrine cells: 3.0;Spermatocytes: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 13.3" "Lineage enriched" "Detected in single" 24 "T-cells: 13.3" "Cell line enhanced" "Detected in some" "A-431: 10.0;CAPAN-2: 8.8;EFO-21: 17.9;RPTEC TERT1: 24.8;U-251 MG: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035067 Uncertain Approved Vesicles NA NA Vesicles "HPA035067: AB_10601465" "unprognostic (1.27e-1)" "unprognostic (4.17e-2)" "unprognostic (6.76e-3)" "unprognostic (6.10e-8)" "prognostic unfavorable (9.43e-4)" "unprognostic (5.36e-3)" "unprognostic (2.72e-4)" "unprognostic (4.85e-2)" "unprognostic (9.44e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (2.53e-1)" "unprognostic (6.36e-6)" "unprognostic (6.93e-3)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" 1.0 1.3 5.8 1.3 14.1 0.3 3.2 1.7 20.7 2.4 1.0 0.3 0.1 1.6 1.7 1.3 2.1 1.3 1.2 1.2 3.3 2.4 0.9 0.4 1.5 0.7 3.1 9.8 0.6 0.3 0.5 1.3 1.9 4.4 2.2 1.4 1.5 0.4 4.1 0.4 0.6 0.9 2.5 1.1 0.4 0.5 2.6 2.1 0.0 3.9 0.0 0.7 1.9 0.4 0.1 0.0 0.0 0.0 0.5 13.3 1.4 10.0 0.3 2.0 0.0 0.0 0.0 0.5 0.2 3.7 0.3 0.2 0.0 8.8 0.0 17.9 0.0 2.7 0.1 0.3 0.8 0.3 0.0 5.4 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.4 0.0 0.0 6.5 3.1 0.0 0.0 0.0 0.3 0.6 1.4 0.3 1.9 0.0 3.5 0.3 0.2 0.0 24.8 2.0 1.2 1.5 6.1 0.0 1.8 0.1 0.0 1.4 0.1 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 2.3 0.1 1.7 3.3 0.0 0.0 0.4 3.4 0.0 0.5 0.0 0.0 0.0 1.4 5.8 14.1 1.7 20.7 3.3 2.4 3.1 9.8 4.4 2.1 0.0 0.0 0.0 0.1 0.1 0.8 1.2 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.3 1.3 2.9 0.0 0.0 0.7 0.6 0.5 0.2 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 8.1 3.0 0.0 0.0 0.0 1.8 0.0 0.8 3.8 0.7 0.4 0.0 0.0 0.0 0.3 EPM2A "LD, LDE" ENSG00000112425 "EPM2A, laforin glucan phosphatase" O95278 6 145382535-145736023 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Hydrolase, Protein phosphatase" "Disease mutation, Epilepsy, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.9" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 20.3" "Low region specificity" "Detected in all" "HPA053643, HPA055468" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053643: AB_2797247, HPA055468: AB_2797252" "unprognostic (2.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (3.34e-3)" "unprognostic (2.92e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (1.52e-4)" "unprognostic (2.28e-1)" "prognostic favorable (4.08e-7)" "unprognostic (4.12e-4)" "unprognostic (2.17e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" 5.4 6.0 8.8 1.9 9.0 2.2 3.6 4.0 8.9 3.9 11.1 8.6 2.5 3.4 4.8 4.8 8.9 4.3 3.9 19.4 9.6 8.7 8.0 5.7 3.5 3.4 11.9 5.5 5.9 2.9 5.5 3.3 2.0 9.6 6.2 3.4 5.6 3.1 9.2 60.9 2.4 3.3 13.9 13.6 2.5 4.6 3.3 7.1 3.7 4.2 15.7 2.9 10.4 6.0 1.4 1.0 0.3 1.4 5.4 2.4 1.0 1.1 1.7 3.3 6.3 8.2 2.5 1.4 3.0 3.5 2.8 3.4 1.5 1.7 20.3 2.5 3.5 3.4 1.8 1.2 1.3 2.5 7.9 1.7 3.3 2.4 2.5 5.0 11.3 2.0 2.1 6.8 1.7 0.6 3.7 2.0 4.8 1.4 5.2 3.5 2.6 7.5 2.4 3.4 3.0 1.7 4.3 3.0 5.9 2.5 1.7 6.1 6.1 5.3 3.2 7.0 3.1 1.8 6.5 4.3 2.8 1.4 2.6 2.3 3.8 3.8 8.2 2.4 2.7 4.4 0.0 0.1 0.1 0.4 1.4 1.1 1.3 1.1 0.9 1.0 1.4 1.2 2.4 0.3 5.4 0.3 0.9 0.2 1.0 8.8 9.0 4.0 8.9 9.6 8.7 11.9 5.5 9.6 7.1 6.0 1.0 3.2 0.8 0.8 7.9 23.5 5.1 2.7 3.4 1.8 5.9 0.7 10.0 0.9 28.2 1.5 0.3 0.0 2.0 0.6 1.2 1.3 2.3 5.8 2.0 28.6 1.2 1.3 1.5 14.1 2.8 3.1 6.8 0.0 1.5 7.5 1.1 1.1 2.1 6.3 6.7 0.0 2.0 1.6 1.3 0.4 0.3 0.0 1.0 0.3 EPN2 "EHB21, KIAA1065" ENSG00000072134 "Epsin 2" O95208 17 19215615-19336715 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 19.9" "Cell line enhanced" "Detected in many" "SuSa: 53.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049809, HPA053360" Approved Supported Vesicles NA NA Vesicles "HPA049809: AB_2680893, HPA053360: AB_2682126" "unprognostic (1.38e-2)" "unprognostic (2.54e-2)" "unprognostic (2.58e-2)" "unprognostic (2.09e-1)" "unprognostic (1.94e-1)" "unprognostic (8.12e-3)" "unprognostic (6.73e-3)" "unprognostic (1.43e-1)" "unprognostic (8.89e-2)" "unprognostic (4.58e-3)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.32e-1)" "unprognostic (9.40e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (8.15e-5)" 6.5 5.1 16.3 6.2 11.8 3.4 4.4 9.9 34.8 7.0 5.2 4.3 3.6 2.9 9.9 7.0 13.9 7.7 4.8 10.7 16.7 10.5 4.5 3.6 6.1 3.6 14.9 13.1 7.2 4.3 8.4 3.6 7.7 8.5 7.3 3.0 5.6 5.0 9.2 9.8 18.4 3.6 8.7 14.7 4.5 3.2 6.7 10.6 3.6 4.4 8.1 3.6 5.4 6.9 2.9 0.7 19.9 1.1 0.6 1.5 0.4 11.8 11.9 17.4 7.6 9.2 14.8 13.7 11.4 7.4 7.1 6.2 7.7 3.6 1.8 11.2 11.3 6.6 11.2 7.7 8.5 8.7 8.8 8.6 1.2 7.5 3.8 9.6 0.5 5.2 8.3 7.7 11.2 9.1 9.4 15.1 2.6 3.3 1.6 6.2 8.6 0.5 0.8 4.5 15.8 7.8 2.7 7.4 3.1 8.3 3.3 5.1 11.6 8.1 5.4 5.9 53.3 8.2 1.5 13.8 7.9 9.1 12.3 4.9 2.6 1.6 1.5 21.5 0.2 12.1 7.1 1.1 19.9 1.5 0.7 1.0 2.3 1.1 1.2 0.5 2.9 1.3 1.2 7.3 0.6 0.8 0.7 0.9 0.4 16.3 11.8 9.9 34.8 16.7 10.5 14.9 13.1 8.5 10.6 50.6 24.8 8.0 24.9 21.4 65.7 28.8 28.1 48.2 27.3 36.6 45.2 23.3 23.2 18.4 30.4 27.0 5.3 0.0 7.3 34.8 19.7 26.8 13.9 7.3 7.0 33.4 5.8 14.7 4.7 54.7 43.1 5.7 5.0 1.0 14.8 42.7 16.8 14.0 37.1 7.8 80.3 25.8 29.9 37.7 38.9 42.8 18.3 5.0 8.3 28.7 EPO EP ENSG00000130427 Erythropoietin P01588 7 100720800-100723700 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins" "Erythrocyte maturation" Hormone "Cancer-related genes, Congenital erythrocytosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3" "Cell type enhanced" "Detected in some" 16 "Exocrine glandular cells: 3.6;Extravillous trophoblasts: 12.2;Hepatocytes: 8.5;Pancreatic endocrine cells: 6.1" "Group enriched" "Detected in many" 5 "liver cancer: 2.7;renal cancer: 5.4" "Region enriched" "Detected in single" 9 "cerebral cortex: 4.4" "Cell type enriched" "Detected in single" 13 "non-classical monocyte: 1.2" "Lineage enriched" "Detected in single" 13 "monocytes: 1.2" "Group enriched" "Detected in some" 7 "BEWO: 3.6;Hep G2: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB010336 Supported "Secreted to blood" NA NA 12300 "CAB010336: AB_2098408" "unprognostic (2.93e-1)" "unprognostic (1.57e-2)" "unprognostic (1.08e-3)" "unprognostic (7.30e-2)" "unprognostic (1.09e-1)" "unprognostic (1.78e-3)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.52e-2)" "unprognostic (5.16e-2)" "unprognostic (9.70e-2)" "unprognostic (2.44e-3)" "unprognostic (3.31e-1)" "prognostic unfavorable (2.18e-6)" "unprognostic (4.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.59e-2)" "unprognostic (3.34e-1)" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.4 10.9 0.0 0.0 0.0 0.0 8.7 0.6 0.4 0.0 0.0 0.1 0.0 0.0 2.8 29.3 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.7 0.0 1.6 0.0 0.7 0.9 1.6 0.0 0.7 0.0 0.6 0.0 0.0 0.0 2.4 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.2 0.0 0.0 13.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.4 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.4 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 12.2 0.0 0.1 0.0 8.5 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 2.4 0.0 0.0 0.0 EPOP "C17orf96, LOC100170841, PRR28" ENSG00000273604 "Elongin BC and polycomb repressive complex 2 associated protein" A6NHQ4 17 38671703-38675421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 3.3;Exocrine glandular cells: 3.4;monocytes: 4.6;Pancreatic endocrine cells: 3.5;Syncytiotrophoblasts: 11.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 8 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 16.1;Hep G2: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA055190, HPA056555" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA055190: AB_2682731, HPA056555: AB_2683172" "unprognostic (9.08e-2)" "unprognostic (3.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.75e-3)" "unprognostic (1.83e-1)" "unprognostic (1.84e-2)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (2.17e-2)" "unprognostic (2.63e-2)" "unprognostic (1.78e-10)" "unprognostic (8.97e-2)" "unprognostic (2.51e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" 1.2 2.0 2.5 1.5 5.1 0.4 1.1 0.0 13.5 0.3 0.2 0.0 2.5 0.2 0.7 0.7 0.7 0.4 0.8 0.4 1.1 0.3 3.4 0.4 2.4 0.3 3.2 0.1 3.6 3.0 0.0 1.2 0.4 0.7 0.3 0.2 0.5 1.2 0.1 1.0 0.2 0.5 0.8 0.6 0.5 5.8 0.8 1.7 0.1 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 2.9 3.5 2.3 16.1 0.5 0.1 3.9 0.6 0.2 0.7 1.1 3.5 1.1 5.6 3.9 0.4 2.0 2.4 7.5 1.5 1.2 5.8 5.7 1.2 0.6 18.4 1.0 0.6 3.0 0.3 2.6 0.7 1.5 1.5 0.5 6.3 3.8 8.7 0.4 4.7 5.0 1.6 0.5 1.9 3.2 12.0 1.3 12.2 0.4 0.7 3.5 5.4 1.9 2.6 0.6 3.9 3.8 2.3 0.8 0.6 0.7 0.7 0.6 4.6 5.0 7.1 1.3 8.3 2.3 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.8 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.0 3.4 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 EPPIN "CT71, dJ461P17.2, EPPIN1, EPPIN2, EPPIN3, SPINLW1, WAP7, WFDC7" ENSG00000101448 "Epididymal peptidase inhibitor" O95925 20 45540626-45547752 "Predicted intracellular proteins, Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "epididymis: 89.0;testis: 72.2" "Group enriched" "Detected in some" 5 "Ciliated cells: 41.5;Late spermatids: 17.4;Sertoli cells: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 5.5;U-87 MG: 6.8" HPA067335 Supported "Secreted in male reproductive system" NA NA "HPA067335: " "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.08e-3)" "unprognostic (1.06e-2)" "unprognostic (3.75e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-2)" "unprognostic (2.00e-2)" 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.5 89.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 72.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.5 0.4 3.1 0.7 0.5 0.8 0.1 1.9 0.2 1.0 1.0 1.0 1.7 1.4 2.3 0.1 0.3 0.1 1.4 0.7 1.6 1.0 0.2 2.1 0.8 0.3 0.0 0.1 1.5 0.4 1.1 1.3 1.1 0.3 0.6 2.2 0.5 0.5 0.4 0.3 0.4 0.2 1.3 1.6 5.5 0.5 1.2 0.6 2.1 2.2 0.5 0.5 1.8 0.6 1.3 0.2 0.7 1.1 1.4 0.7 0.4 1.1 1.2 1.2 1.5 1.8 2.0 1.7 2.4 1.3 1.8 2.0 0.9 6.8 0.7 2.2 3.1 0.7 0.4 0.8 0.1 0.5 0.5 0.3 0.4 0.2 1.5 0.5 0.4 1.4 0.5 0.4 0.4 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 41.5 2.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 3.5 2.4 0.0 0.0 0.0 0.0 0.0 EPPIN-WFDC6 SPINLW1-WFDC6 ENSG00000249139 "EPPIN-WFDC6 readthrough" O95925 20 45536986-45547426 "Predicted secreted proteins" "Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 48 "epididymis: 25.8;testis: 68.0" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 2.7" HPA067335 Supported "Secreted in male reproductive system" NA NA "HPA067335: " "unprognostic (1.46e-3)" "unprognostic (6.38e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.9 25.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 68.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 EPPK1 EPIPL1 ENSG00000261150 "Epiplakin 1" 8 143857324-143878464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 121.8;Suprabasal keratinocytes: 239.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "BEWO: 11.1;EFO-21: 10.4;HaCaT: 10.3;HeLa: 17.3;MCF7: 14.9;SK-BR-3: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA066808, HPA067357, HPA069333" Approved Enhanced "Intermediate filaments" NA NA "Intermediate filaments" "HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123" "unprognostic (1.42e-1)" "unprognostic (9.30e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (5.52e-5)" "unprognostic (2.85e-2)" "unprognostic (5.86e-3)" "unprognostic (4.90e-2)" "unprognostic (8.73e-2)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.35e-1)" "unprognostic (1.97e-3)" "unprognostic (5.94e-3)" "unprognostic (4.35e-1)" "unprognostic (3.68e-3)" "unprognostic (5.08e-3)" 0.0 0.0 0.0 3.0 0.0 0.0 1.1 0.7 0.0 0.4 7.8 0.0 7.2 3.1 3.4 2.4 6.0 1.4 2.3 0.0 0.0 0.8 0.0 4.2 0.9 0.0 0.0 1.0 1.9 0.6 0.0 2.8 0.5 2.9 0.8 0.0 14.8 4.9 0.1 14.1 12.1 15.7 0.1 1.5 1.2 2.3 0.0 0.0 0.0 7.2 4.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.8 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 5.6 0.4 0.0 10.4 0.0 0.0 10.3 1.1 0.1 0.0 0.0 2.6 0.0 17.3 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.9 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 3.7 1.8 0.0 1.6 7.1 0.0 0.9 5.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.0 0.2 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 17.9 8.6 0.0 14.7 121.8 0.8 15.4 17.8 9.4 2.3 14.0 0.0 1.6 0.0 10.2 0.3 1.1 29.4 0.0 12.8 0.1 1.9 5.7 0.0 3.0 0.3 0.0 5.8 0.6 0.0 0.0 0.0 0.6 15.1 0.0 11.2 0.5 21.7 23.0 0.0 3.5 0.1 0.0 4.1 1.6 0.4 239.8 5.1 0.0 21.5 36.3 EPS8L1 "DRC3, FLJ20258, MGC23164, MGC4642" ENSG00000131037 "EPS8 like 1" Q8TE68 19 55072020-55087923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.9;placenta: 45.0" "Group enriched" "Detected in many" 4 "Syncytiotrophoblasts: 357.9;Urothelial cells: 188.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.3;BEWO: 32.6;SK-BR-3: 10.0;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041851, HPA043545" Uncertain Supported Cytosol NA NA Cytosol "HPA041851: AB_2677706, HPA043545: AB_2678544" "unprognostic (1.91e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (7.18e-2)" "unprognostic (9.33e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.43e-2)" "unprognostic (5.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.85e-3)" "unprognostic (5.04e-3)" "unprognostic (3.02e-1)" "unprognostic (5.41e-3)" "unprognostic (2.63e-1)" 1.2 0.0 0.2 2.1 0.3 0.0 1.7 0.3 0.4 7.6 2.1 0.2 1.5 2.0 1.3 1.8 40.9 6.2 6.9 0.2 0.2 0.0 4.1 0.2 1.8 0.2 0.2 0.2 1.6 4.0 1.1 1.1 45.0 0.3 2.9 0.5 0.3 6.6 2.5 0.4 18.7 1.5 0.7 0.2 0.4 23.2 0.9 0.2 1.0 6.2 12.1 16.9 1.9 12.1 0.1 3.5 5.1 0.4 1.7 0.8 0.5 9.3 0.4 0.3 0.2 0.0 0.0 32.6 0.9 0.0 0.0 0.0 2.9 7.7 0.1 1.9 0.0 0.0 4.7 0.2 0.5 0.0 0.2 0.9 0.7 0.3 0.2 0.1 1.5 6.5 0.0 1.5 0.0 0.0 0.0 0.0 0.7 3.5 0.0 0.0 4.3 0.5 1.5 0.5 4.8 0.0 0.1 0.0 3.1 0.7 0.7 0.1 2.3 0.6 10.0 0.4 0.3 15.8 1.8 0.7 0.0 0.4 0.0 0.0 1.4 1.7 0.9 2.0 0.5 1.2 2.6 0.4 5.1 0.8 0.1 0.7 0.0 0.4 0.8 0.0 0.1 0.1 0.0 0.0 1.7 0.0 3.5 0.7 0.5 0.2 0.3 0.3 0.4 0.2 0.0 0.2 0.2 0.3 0.2 8.9 6.7 0.9 18.5 1.8 0.0 2.0 5.1 5.3 11.4 29.6 0.0 28.7 11.6 18.5 1.3 3.8 22.2 0.0 9.1 18.2 2.6 37.2 10.3 0.0 7.9 0.0 2.9 8.0 1.2 3.6 1.1 2.6 20.3 8.2 28.9 0.2 62.1 35.1 0.7 0.8 0.0 25.8 14.1 0.6 2.6 3.4 357.9 2.5 9.9 188.1 EPS8L2 "FLJ21935, FLJ22171, MGC3088" ENSG00000177106 "EPS8 like 2" Q9H6S3 11 694438-727727 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 73.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 131.0;Enterocytes: 200.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 6.4" "Cell line enhanced" "Detected in many" "A-431: 46.7;BEWO: 46.2;CAPAN-2: 44.0;SK-BR-3: 54.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 13.6" HPA041143 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041143: AB_10794985" "unprognostic (1.39e-2)" "unprognostic (1.07e-1)" "unprognostic (7.58e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.87e-2)" "unprognostic (3.27e-2)" "unprognostic (1.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.92e-1)" "unprognostic (3.25e-2)" "unprognostic (2.51e-2)" "unprognostic (4.19e-1)" "unprognostic (2.79e-1)" "unprognostic (5.03e-2)" 1.7 3.0 2.0 6.4 3.3 0.0 12.4 6.9 2.5 11.6 31.5 1.2 23.9 38.7 4.6 10.1 53.3 5.3 21.7 1.0 1.3 1.6 30.4 38.3 18.0 0.4 1.7 0.5 3.9 11.6 1.8 4.3 39.6 3.6 8.4 6.0 2.7 26.2 17.6 0.7 22.8 73.3 2.4 2.4 0.5 18.0 7.2 1.5 0.9 29.5 29.4 33.7 6.9 19.2 0.2 6.4 0.7 0.1 0.1 0.1 0.1 46.7 14.3 0.0 0.3 0.5 3.2 46.2 4.1 4.2 6.1 2.6 10.7 44.0 0.1 17.1 4.3 1.1 24.8 0.1 24.8 1.4 0.1 0.9 0.0 5.3 19.2 3.5 0.0 0.0 1.7 16.6 1.8 4.3 2.5 0.0 0.0 0.3 0.2 0.7 15.0 0.1 0.2 0.5 14.6 4.6 0.1 0.1 0.3 21.7 11.7 0.1 0.1 14.6 54.0 0.1 3.2 20.4 0.0 0.3 2.5 5.8 1.5 0.3 0.1 0.2 0.1 1.3 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 6.4 0.0 0.1 2.0 3.3 6.9 2.5 1.3 1.6 1.7 0.5 3.6 1.5 131.0 60.0 7.3 23.9 17.5 0.8 3.6 53.5 33.5 51.2 85.5 0.0 43.8 23.2 45.5 1.0 3.0 200.0 0.0 70.5 25.8 7.1 28.6 6.9 55.5 4.3 0.0 42.1 0.6 1.3 1.7 16.7 3.2 13.5 3.6 61.8 8.9 66.1 98.2 11.0 84.7 0.7 0.0 5.1 0.7 4.1 21.3 77.3 21.0 62.0 26.8 EPS8L3 "FLJ21522, MGC16817" ENSG00000198758 "EPS8 like 3" Q8TE67 1 109750080-109764027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 30.0;intestine: 115.1" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 255.7;Late spermatids: 82.4;Mucus-secreting cells: 88.8;Paneth cells: 126.3;Undifferentiated cells: 82.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 22 "NK-cells: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 8.6;CAPAN-2: 8.2;Hep G2: 19.4;OE19: 36.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030998 Approved Approved Vesicles NA NA Vesicles "HPA030998: AB_2673691" "unprognostic (1.73e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.13e-5)" "unprognostic (5.55e-3)" "unprognostic (3.71e-2)" "unprognostic (2.09e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (5.87e-3)" "unprognostic (3.89e-1)" "prognostic favorable (1.82e-4)" 0.2 0.1 0.2 11.0 0.2 0.0 0.2 0.2 0.2 0.5 88.2 0.2 0.2 41.3 0.2 0.2 0.3 0.2 30.0 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.3 22.1 0.2 0.2 0.3 0.2 0.1 115.1 0.5 0.2 0.2 15.1 1.2 0.2 0.2 0.2 0.2 0.2 0.5 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 8.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 36.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 28.5 0.0 255.7 0.0 21.7 0.0 0.0 0.0 4.6 0.0 0.0 0.0 49.3 0.0 0.0 82.4 0.6 0.0 0.0 0.0 88.8 0.0 26.8 126.3 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 82.1 0.5 EPSTI1 "BRESI1, MGC29634" ENSG00000133106 "Epithelial stromal interaction 1" Q96J88 13 42886388-42992271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 146.8;monocytes: 201.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 36.9;BJ hTERT+ SV40 Large T+ RasG12V: 38.7;HDLM-2: 27.2;RPMI-8226: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017362 Approved NA NA "HPA017362: AB_1848226" "unprognostic (2.06e-1)" "unprognostic (3.51e-1)" "unprognostic (1.80e-1)" "unprognostic (3.59e-2)" "unprognostic (2.35e-1)" "unprognostic (9.55e-2)" "unprognostic (2.31e-1)" "unprognostic (2.49e-2)" "unprognostic (1.02e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (7.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.05e-3)" "unprognostic (8.13e-2)" 22.4 11.9 3.9 42.2 5.5 18.2 7.1 1.4 3.7 6.5 14.1 5.1 5.9 20.3 7.0 9.7 6.8 5.4 11.2 7.5 3.8 3.9 14.8 7.9 14.6 18.7 5.4 3.9 5.4 2.9 5.1 4.7 18.1 6.4 6.5 6.8 6.6 10.5 16.8 3.0 2.7 22.2 5.8 7.4 28.3 9.2 5.8 4.0 28.5 7.6 4.3 18.0 10.1 5.4 12.7 14.4 19.3 26.8 10.2 26.4 9.7 1.0 0.0 0.0 0.0 0.0 2.0 1.1 0.9 9.8 36.9 38.7 8.6 2.1 1.3 0.3 1.2 3.9 4.3 0.0 1.4 4.7 27.2 0.0 4.3 0.0 0.0 9.0 0.0 0.7 6.8 2.0 2.9 0.2 0.5 0.5 2.1 0.0 6.8 0.9 0.0 6.8 1.0 0.2 0.7 0.0 0.0 0.0 13.0 6.1 0.2 0.7 0.0 0.1 0.0 0.7 0.1 0.2 0.7 1.4 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.7 0.0 0.4 19.3 16.2 13.0 5.5 26.8 5.7 12.7 11.1 6.0 14.4 10.9 5.3 4.0 7.8 10.2 16.6 1.7 26.4 9.7 3.9 5.5 1.4 3.7 3.8 3.9 5.4 3.9 6.4 4.0 17.9 10.4 22.5 1.3 3.8 0.0 2.4 12.7 4.0 9.1 5.2 0.0 8.1 1.7 29.5 48.9 12.4 65.2 0.0 34.8 146.8 15.4 3.9 10.4 5.9 77.7 0.0 23.6 15.4 21.0 17.6 13.8 49.5 10.1 201.0 13.5 0.2 43.1 16.5 4.6 28.0 0.0 0.0 4.2 2.1 1.9 3.3 12.1 22.4 16.6 3.1 EPX "EPO, EPP, EPX-PEN" ENSG00000121053 "Eosinophil peroxidase" P11678 17 58192737-58205174 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 27.2;lymphoid tissue: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 41 "eosinophil: 5.5" "Lineage enriched" "Detected in single" 41 "granulocytes: 5.5" "Cell line enriched" "Detected in some" 69 "NB-4: 74.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076792 Enhanced NA NA "HPA076792: " "unprognostic (5.67e-2)" "unprognostic (1.73e-2)" "unprognostic (3.36e-2)" "unprognostic (3.30e-1)" "unprognostic (2.18e-1)" "unprognostic (1.34e-3)" "unprognostic (4.83e-1)" "unprognostic (3.16e-2)" "unprognostic (1.41e-1)" "unprognostic (1.52e-2)" "unprognostic (1.71e-4)" "unprognostic (7.38e-2)" "unprognostic (1.64e-1)" "unprognostic (2.02e-1)" "unprognostic (5.43e-2)" "unprognostic (1.02e-2)" "unprognostic (1.73e-1)" 0.1 0.1 0.3 0.2 0.8 27.2 0.1 2.0 0.6 0.1 0.1 0.5 0.1 0.1 0.4 0.1 0.1 0.2 0.1 1.4 0.3 0.3 0.1 0.2 4.2 0.4 0.2 0.1 0.2 0.1 0.0 0.3 0.2 0.6 0.1 0.0 0.1 0.3 0.1 0.1 0.5 0.1 0.1 0.2 4.5 0.1 0.1 0.1 15.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 74.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 2.0 0.6 0.3 0.3 0.2 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPYC "DSPG3, Pg-Lb, SLRR3B" ENSG00000083782 Epiphycan Q99645 12 90963679-91005026 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "placenta: 67.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTERT-RPE1: 8.2;U-266/70: 2.0" "Region enhanced" "Detected in single" "midbrain: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4" "HPA038212, HPA045455" Approved "Secreted to extracellular matrix" NA NA "HPA038212: AB_10672739, HPA045455: AB_2679330" "unprognostic (2.25e-1)" "unprognostic (2.08e-1)" "unprognostic (2.79e-1)" "unprognostic (4.28e-2)" "unprognostic (1.81e-2)" "unprognostic (4.07e-2)" "unprognostic (9.20e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.77e-2)" "unprognostic (6.44e-9)" "unprognostic (2.83e-2)" "unprognostic (3.08e-1)" "unprognostic (8.68e-2)" "unprognostic (1.20e-1)" 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.0 0.0 0.0 67.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EQTN "AFAF, C9orf11, equatorin, SPACA8" ENSG00000120160 Equatorin Q9NQ60 9 27284659-27297139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 39.9" "Cell type enriched" "Detected in some" 26 "Early spermatids: 558.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1" "HPA015089, HPA015504" Enhanced "Intracellular and membrane" NA NA "HPA015089: AB_1845795, HPA015504: AB_2067598" "unprognostic (7.83e-2)" "unprognostic (1.55e-1)" "unprognostic (5.64e-2)" "unprognostic (8.12e-3)" "unprognostic (1.34e-3)" "unprognostic (4.41e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.32e-1)" "unprognostic (1.89e-1)" "unprognostic (5.67e-2)" "unprognostic (1.14e-1)" "unprognostic (4.59e-2)" "unprognostic (8.46e-2)" "unprognostic (3.90e-2)" "unprognostic (1.42e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.1 39.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 1.3 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.6 1.1 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 558.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.1 1.9 0.3 0.1 0.0 0.2 0.1 ERAS "HRAS2, HRASP" ENSG00000187682 "ES cell expressed Ras" Q7Z444 X 48826513-48830138 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5" "Cell type enhanced" "Detected in some" 18 "Spermatocytes: 1.9;Spermatogonia: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;NB-4: 2.3;THP-1: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.47e-2)" "unprognostic (1.28e-2)" "unprognostic (4.50e-2)" "unprognostic (3.93e-2)" "unprognostic (3.61e-1)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (1.87e-2)" "unprognostic (2.72e-4)" "unprognostic (9.40e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (1.98e-1)" "unprognostic (1.08e-1)" "unprognostic (2.25e-2)" 0.1 0.2 1.7 0.0 1.7 0.7 0.0 4.2 2.7 0.2 0.2 0.0 1.0 0.3 0.1 0.4 0.1 0.0 1.1 5.5 0.5 1.1 0.4 0.0 1.2 0.7 0.0 0.9 1.4 0.2 0.2 0.0 0.7 1.1 0.6 1.0 0.4 0.6 1.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.2 0.3 0.2 0.0 0.5 0.5 0.0 0.0 0.3 0.0 2.8 0.6 0.0 0.1 0.0 0.0 0.2 0.5 1.7 0.4 0.0 0.5 0.0 0.8 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.5 0.1 0.5 0.0 0.0 0.0 2.3 0.8 0.0 1.0 0.4 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.3 0.6 0.2 0.0 2.1 0.0 0.0 0.8 0.5 0.0 0.6 0.6 0.4 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 ERBB4 "ALS19, HER4" ENSG00000178568 "Erb-b2 receptor tyrosine kinase 4" Q15303 2 211375717-212538841 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Lactation, Transcription, Transcription regulation" "Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.5" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 11.2;Cardiomyocytes: 15.3;Ciliated cells: 26.8;Club cells: 17.0;Collecting duct cells: 12.2;Muller glia cells: 12.4" "Cancer enhanced" "Detected in many" "breast cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;EFO-21: 7.2;HEK 293: 5.3;RPTEC TERT1: 7.8;SCLC-21H: 4.4;T-47d: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000276, HPA012016, CAB025522" Enhanced NA NA 140000 "CAB000276: , CAB025522: , HPA012016: AB_1846541" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (4.31e-3)" "unprognostic (1.76e-3)" "unprognostic (3.59e-1)" "unprognostic (2.75e-1)" "unprognostic (2.88e-1)" "unprognostic (9.56e-2)" "unprognostic (2.07e-1)" "unprognostic (4.67e-3)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (7.14e-3)" "unprognostic (1.49e-3)" "unprognostic (1.41e-1)" "unprognostic (1.14e-1)" "unprognostic (4.11e-2)" 1.6 1.9 15.1 1.2 15.0 1.0 13.4 18.6 14.1 7.8 1.1 7.6 8.8 1.1 1.5 1.2 1.3 24.5 1.2 7.0 14.3 6.5 11.9 1.1 2.9 1.2 7.8 10.7 1.3 2.4 10.8 5.1 1.3 8.8 1.7 1.1 2.0 9.7 18.1 3.8 1.8 1.2 1.1 7.3 1.2 1.5 7.6 12.0 0.0 4.5 1.1 1.2 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.6 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 7.2 1.0 0.0 0.4 0.2 0.0 0.0 0.1 5.3 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 7.8 0.4 4.4 0.2 0.0 0.1 0.1 0.1 7.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 15.0 18.6 14.1 14.3 6.5 7.8 10.7 8.8 12.0 0.0 9.3 0.0 0.8 0.6 11.2 15.3 0.0 26.8 17.0 12.2 0.0 0.0 5.0 0.4 4.1 0.1 0.0 0.0 0.4 0.1 0.2 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.7 0.0 3.3 0.0 0.0 12.4 0.0 0.0 0.4 0.0 1.4 6.5 3.1 1.9 1.5 1.1 0.0 0.0 0.0 1.0 ERC2 "CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110" ENSG00000187672 "ELKS/RAB6-interacting/CAST family member 2" O15083 3 55508308-56468363 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 30.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 11.9;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 12.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HUVEC TERT2: 3.7;Karpas-707: 12.3;SH-SY5Y: 3.0;U-266/70: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073739 Enhanced NA NA "HPA073739: AB_2732240" "unprognostic (2.13e-2)" "unprognostic (1.39e-1)" "unprognostic (9.10e-2)" "unprognostic (1.93e-2)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (4.50e-2)" "unprognostic (2.95e-2)" "unprognostic (1.22e-1)" "unprognostic (3.06e-2)" "unprognostic (2.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.24e-2)" "unprognostic (4.49e-2)" "unprognostic (9.09e-2)" 0.9 1.6 13.4 1.0 9.5 0.9 1.1 11.5 30.5 1.0 1.0 0.7 1.3 1.0 1.2 0.9 1.0 1.0 1.1 2.2 9.4 5.3 1.4 0.9 1.1 0.9 3.8 12.6 2.9 1.3 0.9 7.4 1.3 8.8 1.5 1.0 1.1 1.0 3.1 0.9 0.9 1.1 1.1 2.3 0.9 1.2 1.5 1.5 0.0 1.3 0.0 0.9 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 3.7 0.0 0.0 12.3 0.0 1.5 0.0 0.0 2.7 0.0 0.3 0.0 0.2 0.0 2.8 0.0 1.5 3.0 0.0 0.0 0.0 2.1 0.0 0.0 0.5 0.0 1.3 0.0 0.3 8.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 9.5 11.5 16.8 9.4 5.3 3.8 12.6 8.8 1.5 3.0 0.3 0.0 0.2 0.1 11.9 2.7 0.0 2.7 2.3 0.0 23.6 0.0 0.0 0.4 4.7 0.3 0.0 0.0 0.5 0.1 0.2 0.8 0.0 0.0 0.5 4.8 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.7 0.3 12.0 0.0 0.0 1.4 2.7 0.1 0.0 0.0 0.0 0.1 ERCC6L "FLJ20105, PICH, RAD26L" ENSG00000186871 "ERCC excision repair 6 like, spindle assembly checkpoint helicase" Q2NKX8 X 72204657-72239047 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 2.5;Extravillous trophoblasts: 1.5;Spermatocytes: 1.7;Spermatogonia: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "NK-cell: 5.3" "Lineage enriched" "Detected in many" 5 "NK-cells: 5.3" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA050492 Approved Uncertain Nucleoplasm,Centrosome,Cytosol No No Centrosome "Nucleoplasm, Cytosol" "HPA050492: AB_2681145" "prognostic unfavorable (1.80e-4)" "unprognostic (2.93e-1)" "unprognostic (1.95e-2)" "unprognostic (5.76e-3)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (9.23e-6)" "unprognostic (8.63e-3)" "unprognostic (1.57e-2)" "unprognostic (1.99e-2)" "unprognostic (3.68e-5)" "unprognostic (4.61e-2)" "unprognostic (0.00e+0)" "unprognostic (2.97e-3)" "unprognostic (9.56e-2)" "unprognostic (1.17e-1)" "unprognostic (6.41e-2)" 0.4 0.5 0.2 3.1 0.2 6.0 3.0 0.9 0.8 1.5 2.2 0.2 0.2 1.5 0.9 0.8 4.6 0.6 1.0 0.2 0.2 0.3 0.5 0.5 0.8 4.7 0.7 0.2 1.2 0.5 0.0 0.6 0.9 0.9 0.7 2.5 0.2 1.1 0.2 2.6 1.3 2.1 0.5 1.3 4.0 1.5 2.0 0.2 13.1 0.5 2.8 5.6 0.7 1.6 0.5 0.3 0.5 0.2 5.3 1.1 0.4 11.0 9.7 8.9 5.6 0.6 1.1 4.9 11.9 5.5 10.4 11.0 7.9 6.9 17.9 4.5 4.2 14.1 9.2 16.8 8.8 18.6 10.2 12.2 6.2 3.4 4.6 0.0 12.0 8.7 0.1 0.5 14.5 2.7 1.7 5.8 9.1 8.1 4.4 10.6 8.7 11.4 7.0 16.2 10.8 15.0 9.6 16.0 3.2 2.6 6.9 7.4 5.3 8.8 5.9 2.2 7.6 4.5 2.7 3.5 7.1 11.4 13.3 7.7 3.5 5.3 15.5 5.0 8.3 7.0 0.0 0.2 0.5 0.1 0.1 0.6 0.2 0.5 0.1 0.1 0.5 0.4 1.1 0.3 5.3 0.2 0.3 1.1 0.4 0.2 0.2 0.9 0.8 0.2 0.3 0.7 0.2 0.9 0.2 0.0 0.0 0.8 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.1 0.3 0.0 0.1 0.1 EREG ER ENSG00000124882 Epiregulin O14944 4 74365143-74388751 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;tongue: 44.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054373 Approved Vesicles "Secreted to blood" NA NA 46000 Vesicles "HPA054373: " "unprognostic (1.26e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (4.56e-3)" "unprognostic (3.94e-2)" "unprognostic (2.24e-3)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.57e-5)" "unprognostic (2.94e-1)" "unprognostic (1.70e-6)" "unprognostic (2.42e-2)" "unprognostic (1.13e-2)" "unprognostic (6.59e-3)" "unprognostic (3.16e-3)" 2.2 0.0 0.1 4.6 0.3 52.1 1.2 0.0 0.1 5.0 1.2 0.1 0.0 0.0 0.1 0.5 15.3 1.2 7.3 0.8 0.0 0.0 0.4 0.2 6.7 1.1 0.0 0.2 0.5 0.1 0.0 0.0 2.0 0.3 0.2 1.6 0.1 1.6 0.0 0.5 10.7 1.0 1.3 0.1 1.9 0.3 0.3 0.0 0.2 0.0 44.0 7.2 4.1 4.6 0.6 1.3 2.6 1.2 0.4 0.3 0.3 0.3 9.1 0.0 0.0 0.9 1.5 0.0 2.0 60.3 0.6 0.3 7.1 17.1 0.0 10.1 0.0 4.6 0.5 0.0 13.1 0.6 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.9 4.6 19.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 41.1 0.0 0.0 0.0 0.0 70.5 0.0 0.0 1.9 1.2 2.6 0.3 1.0 0.2 0.2 0.2 0.2 1.3 0.6 0.3 0.2 1.0 0.4 0.2 0.4 0.2 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 6.0 11.1 1.9 4.9 4.7 0.0 15.7 2.5 4.0 29.6 0.0 0.0 0.5 0.0 0.0 3.1 2.2 44.2 0.0 0.2 0.7 6.1 2.0 6.9 0.0 28.2 0.0 3.5 0.6 56.9 0.4 0.3 122.8 6.8 29.7 24.7 0.0 0.4 17.5 0.0 0.1 0.0 0.0 2.2 0.5 0.2 8.2 0.6 1.0 27.7 6.7 ERFE "C1QTNF15, CTRP15, FAM132B, FLJ37034" ENSG00000178752 Erythroferrone Q4G0M1 2 238158982-238168900 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 12.4;testis: 13.8;thyroid gland: 25.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 7.5;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 3.3;granulocytes: 4.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.2" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 14.1;hTEC/SVTERT24-B: 13.7;REH: 14.0;RH-30: 17.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 277000 "unprognostic (1.66e-1)" "unprognostic (9.14e-2)" "unprognostic (3.64e-4)" "prognostic unfavorable (3.75e-4)" "unprognostic (2.84e-1)" "unprognostic (9.61e-4)" "unprognostic (4.68e-3)" "unprognostic (3.16e-3)" "unprognostic (9.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.31e-4)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (4.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.33e-2)" 1.6 0.0 2.4 2.5 1.0 3.5 0.1 9.2 2.5 2.1 0.5 0.4 0.1 0.6 0.9 3.0 0.8 0.1 0.3 3.2 1.9 0.1 3.3 0.3 0.5 0.1 0.1 0.7 0.4 0.3 0.2 0.1 3.5 0.5 0.4 0.3 0.4 1.5 1.6 12.4 0.0 1.1 0.5 0.1 0.5 0.7 13.8 0.1 0.4 25.6 4.8 0.4 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 2.1 0.6 0.9 1.9 0.1 3.4 0.2 1.4 2.0 3.5 5.8 0.1 5.2 0.0 4.0 0.3 6.9 0.2 9.3 0.4 3.1 0.0 14.1 0.0 0.2 0.1 1.2 0.0 1.0 7.3 1.0 13.7 9.8 0.4 0.1 4.5 3.0 0.0 9.0 2.8 0.0 5.8 1.5 0.6 0.9 14.0 17.9 0.6 7.3 0.0 0.3 5.4 2.1 0.4 7.9 1.8 0.3 10.5 0.8 5.5 5.1 2.1 7.2 0.0 0.0 0.6 9.3 2.9 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 1.0 9.2 2.5 1.9 0.1 0.1 0.7 0.5 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 1.8 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ERICH2 ENSG00000204334 "Glutamate rich 2" A1L162 2 170783786-170798971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 61.2" "Cell type enriched" "Detected in many" 8 "Early spermatids: 1704.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enriched" "Detected in many" 4 "hTCEpi: 36.9" "Low region specificity" "Detected in all" HPA061010 Approved "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center" Vesicles "HPA061010: " "unprognostic (1.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.26e-1)" "prognostic favorable (9.49e-4)" "unprognostic (7.57e-3)" "unprognostic (6.61e-2)" "unprognostic (9.62e-3)" "unprognostic (6.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.27e-2)" "unprognostic (1.12e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (8.98e-7)" "unprognostic (1.03e-1)" "unprognostic (5.28e-3)" "unprognostic (7.35e-2)" "unprognostic (2.76e-1)" 0.6 0.3 1.4 0.6 1.1 0.0 1.3 0.6 0.8 2.1 0.6 0.6 0.6 0.0 1.5 1.0 0.6 3.3 0.6 0.9 1.0 1.5 0.9 1.6 4.2 0.6 1.1 0.6 0.6 0.7 0.8 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.1 0.6 0.6 0.6 0.6 1.0 61.2 0.6 0.6 6.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.4 0.0 0.0 4.6 0.0 0.0 0.2 0.0 0.0 0.9 1.9 4.6 1.1 0.0 0.2 0.0 2.0 0.1 1.1 0.4 0.0 0.7 1.2 2.3 0.0 0.1 4.8 0.2 0.3 0.7 36.9 0.0 8.5 0.1 0.0 0.9 5.1 0.0 0.0 1.9 0.0 0.4 5.7 6.5 0.9 0.0 0.9 0.0 2.6 0.1 0.6 1.2 3.3 0.0 1.3 1.1 0.8 0.7 0.0 1.2 1.0 0.0 0.5 0.0 0.0 0.0 4.6 2.2 3.5 0.0 0.0 0.0 2.7 0.0 0.9 0.0 0.5 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.6 0.8 1.0 1.5 1.1 0.6 0.6 0.6 6.0 19.5 0.0 0.6 0.2 1.3 1.7 5.1 20.1 2.3 1.8 0.0 0.0 11.6 0.7 1704.8 0.0 0.0 0.0 1.5 0.2 1.0 0.2 0.0 2.1 0.0 0.0 7.5 0.0 0.0 202.2 8.9 0.0 0.0 0.0 0.6 1.1 1.9 0.0 7.1 0.3 0.2 6.5 0.3 12.1 9.1 0.1 0.0 0.0 0.1 0.0 ERICH3 "C1orf173, DKFZp547I048, RP11-653A5.1" ENSG00000178965 "Glutamate rich 3" Q5RHP9 1 74568111-74673738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.5;fallopian tube: 21.1;testis: 26.4" "Group enriched" "Detected in some" 6 "Ciliated cells: 431.0;Early spermatids: 257.5;Late spermatids: 256.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.2;SCLC-21H: 3.3" "HPA028655, HPA072916" Approved NA NA "HPA028655: AB_10961002, HPA072916: " "unprognostic (4.49e-4)" "unprognostic (1.02e-2)" "prognostic favorable (1.56e-5)" "unprognostic (1.71e-2)" "unprognostic (5.94e-2)" "unprognostic (6.83e-2)" "unprognostic (6.53e-2)" "unprognostic (4.76e-2)" "unprognostic (8.84e-2)" "unprognostic (1.49e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-4)" "unprognostic (9.21e-3)" "unprognostic (2.25e-1)" "unprognostic (2.02e-1)" "unprognostic (8.90e-2)" 0.4 3.5 12.7 0.5 10.7 0.4 1.4 7.0 14.5 7.6 0.5 0.5 0.0 0.5 1.7 3.0 0.4 21.1 0.5 0.5 12.0 4.2 0.5 0.6 3.7 0.7 1.0 10.3 1.2 0.4 0.4 6.3 0.5 2.4 0.5 0.6 0.0 0.7 0.5 0.4 0.5 0.5 0.5 0.7 0.6 0.6 26.4 1.6 0.0 0.5 0.0 0.7 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.5 0.0 3.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 10.7 7.0 12.0 12.0 4.2 1.0 10.3 2.4 1.6 3.0 1.9 0.0 0.0 0.0 4.0 0.5 0.0 431.0 52.4 0.0 0.0 0.0 0.0 0.0 257.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 3.4 0.0 0.0 256.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.3 6.5 0.0 35.8 1.4 0.0 0.1 0.0 0.0 0.3 ERICH4 "C19orf69, LOC100170765" ENSG00000204978 "Glutamate rich 4" A6NGS2 19 41443158-41444765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 78.1" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 73.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "CACO-2: 4.8;Hep G2: 11.1;THP-1: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA042632, HPA048484" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042632: AB_2678090, HPA048484: AB_2680415" "unprognostic (1.41e-1)" "unprognostic (3.05e-1)" "unprognostic (9.52e-2)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" "unprognostic (4.03e-5)" "unprognostic (8.53e-2)" "unprognostic (7.54e-2)" "unprognostic (1.97e-1)" "unprognostic (3.09e-2)" "unprognostic (1.04e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-1)" "unprognostic (1.16e-1)" 0.6 0.0 0.2 0.2 0.3 0.0 0.6 0.2 0.3 0.4 21.0 0.2 0.2 27.1 0.4 0.4 0.2 0.4 0.5 1.3 0.2 0.0 10.0 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.9 0.0 78.1 0.2 0.3 0.2 0.1 0.8 0.2 0.2 0.3 0.2 0.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 73.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 ERICH5 "C8orf47, FLJ39553" ENSG00000177459 "Glutamate rich 5" Q6P6B1 8 98064311-98093610 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 27.9;retina: 26.7" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 84.1;Ciliated cells: 72.3;Ductal cells: 42.6" "Cancer enhanced" "Detected in many" "liver cancer: 23.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.3" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.3" "Cell line enhanced" "Detected in some" "A549: 6.5;HAP1: 6.0;HEK 293: 8.8;JURKAT: 11.6;RPTEC TERT1: 5.8;RT4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA025070, HPA025293, HPA027233" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780" "unprognostic (2.88e-3)" "unprognostic (1.49e-1)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (6.86e-2)" "unprognostic (2.39e-1)" "unprognostic (8.66e-2)" "unprognostic (1.57e-1)" "unprognostic (4.66e-1)" "unprognostic (2.84e-2)" "unprognostic (1.16e-1)" "unprognostic (5.73e-1)" "prognostic favorable (3.76e-4)" "unprognostic (4.36e-2)" "unprognostic (9.22e-2)" "unprognostic (3.17e-2)" "prognostic favorable (9.38e-4)" 0.5 0.2 2.3 0.2 6.7 0.0 0.8 0.4 2.2 2.0 3.3 0.1 3.6 4.3 1.1 0.6 0.7 8.8 13.1 5.4 0.7 2.6 8.7 8.1 1.7 0.7 1.0 2.2 1.6 27.9 0.6 1.7 4.1 1.9 2.2 3.0 26.7 1.3 1.9 0.1 0.6 1.3 0.4 1.0 0.2 9.5 3.4 0.5 0.3 0.6 0.0 0.5 3.1 0.5 0.0 5.3 0.0 0.0 0.0 0.5 0.0 0.0 6.5 0.0 0.0 0.1 0.0 3.8 3.4 1.3 1.8 1.4 0.1 2.0 0.0 5.0 0.9 2.8 0.3 6.0 0.1 2.2 0.0 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 11.6 0.0 0.0 0.1 0.1 0.0 0.7 1.4 0.1 2.6 0.0 0.0 0.1 5.8 15.3 3.5 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.3 6.7 0.4 2.2 0.7 2.6 1.0 2.2 1.9 0.5 3.0 0.0 0.0 1.1 0.0 0.0 5.9 84.1 72.3 5.7 7.0 0.0 0.3 0.0 42.6 0.3 0.0 0.7 0.0 16.3 1.5 0.0 3.1 0.0 3.9 0.1 0.0 17.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 2.3 5.8 17.1 0.0 0.0 19.3 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 3.3 1.3 ERICH6 "C3orf44, ERICH6A, FAM194A, MGC39662" ENSG00000163645 "Glutamate rich 6" Q7L0X2 3 150659885-150703971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 35.4" "Group enriched" "Detected in some" 6 "Early spermatids: 72.0;Late spermatids: 42.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 3.7;SH-SY5Y: 3.9;U-266/70: 4.1;U-266/84: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA048373 Enhanced NA NA "HPA048373: AB_2680375" "unprognostic (7.38e-2)" "unprognostic (3.89e-3)" "unprognostic (7.02e-3)" "unprognostic (2.52e-2)" "unprognostic (7.38e-3)" "unprognostic (1.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (1.96e-1)" "unprognostic (8.44e-2)" "unprognostic (1.71e-2)" "unprognostic (1.80e-2)" "unprognostic (7.27e-2)" "unprognostic (2.21e-1)" "unprognostic (1.49e-2)" "unprognostic (3.16e-2)" 0.4 0.4 0.4 0.2 1.8 0.3 0.3 0.4 1.5 0.3 0.3 0.4 0.1 0.6 0.5 1.9 0.3 0.4 0.8 0.4 0.7 0.4 0.8 0.3 0.3 0.6 0.3 0.6 0.5 0.5 0.0 3.9 0.4 0.5 0.5 0.1 0.3 0.3 0.5 0.2 0.3 0.4 0.4 0.3 0.4 0.4 35.4 0.6 0.0 1.3 0.0 0.2 0.4 0.3 2.6 3.5 0.1 0.1 5.9 8.0 2.0 0.2 3.7 0.2 1.5 0.0 0.0 0.0 0.3 0.0 0.3 0.6 1.7 1.5 0.0 2.2 0.0 1.4 0.2 0.0 0.0 0.2 1.6 1.2 1.0 0.6 0.1 0.0 0.0 0.1 0.2 0.0 1.0 0.0 0.0 0.0 1.2 0.0 2.5 0.0 0.6 0.9 0.0 0.9 0.0 0.0 1.0 0.9 0.0 0.1 0.8 1.8 3.9 0.0 0.3 0.0 0.0 0.9 1.3 0.1 0.6 1.4 1.5 0.2 4.1 6.3 0.8 0.7 0.1 0.0 0.0 0.1 0.1 4.1 0.0 8.0 2.6 2.6 3.1 0.1 2.3 3.5 3.6 0.1 5.9 0.1 3.5 2.5 2.0 0.4 1.8 0.4 1.5 0.7 0.4 0.3 0.6 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 9.1 1.0 0.0 0.0 0.0 0.0 0.0 ERICH6B "FAM194B, FLJ32682" ENSG00000165837 "Glutamate rich 6B" Q5W0A0 13 45534522-45615739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "testis: 6.7" "Group enriched" "Detected in some" 13 "Early spermatids: 27.8;Late spermatids: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043559 Uncertain NA NA "HPA043559: AB_2678552" "unprognostic (6.77e-3)" "unprognostic (3.52e-3)" "unprognostic (3.80e-2)" "unprognostic (2.06e-2)" "unprognostic (2.05e-1)" "unprognostic (7.08e-2)" "unprognostic (1.25e-1)" "unprognostic (7.98e-3)" "unprognostic (7.27e-3)" "unprognostic (9.81e-2)" "unprognostic (3.05e-3)" "unprognostic (3.37e-3)" "unprognostic (5.70e-8)" "unprognostic (4.42e-2)" "unprognostic (1.88e-1)" "unprognostic (9.74e-2)" "unprognostic (7.89e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.9 0.0 0.0 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.1 0.0 0.0 0.0 ERLIN1 "C10orf69, Erlin-1, KE04, SPFH1, SPG62" ENSG00000107566 "ER lipid raft associated 1" O75477 10 100150094-100188334 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 81.4" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011252 Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011252: AB_1853965" "unprognostic (3.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (6.98e-3)" "unprognostic (2.69e-1)" "unprognostic (1.70e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (7.63e-4)" "unprognostic (1.26e-1)" "unprognostic (9.68e-2)" "unprognostic (1.99e-3)" "unprognostic (9.09e-2)" "unprognostic (1.32e-3)" "unprognostic (6.10e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" 12.9 8.0 5.4 6.9 10.1 23.2 13.9 6.7 6.1 11.3 18.6 5.7 7.0 13.8 11.9 6.6 17.9 11.2 6.8 6.8 6.2 3.7 12.3 81.4 8.7 10.1 7.3 3.8 13.9 17.7 5.9 8.8 24.2 4.7 9.2 13.5 8.2 9.8 5.7 5.5 10.8 18.9 7.7 4.1 9.7 12.7 17.4 5.4 8.6 11.8 10.3 14.3 14.7 14.6 6.2 12.6 18.2 16.0 7.5 9.0 7.0 23.5 23.4 12.0 21.8 28.9 28.4 24.5 37.5 34.8 31.0 35.8 15.7 27.5 10.5 15.2 34.7 25.4 24.6 10.7 22.1 43.0 6.3 9.5 9.0 10.5 19.8 12.0 31.5 10.0 16.1 13.4 27.1 32.9 29.2 22.4 10.8 8.9 6.4 32.6 9.5 8.1 11.5 8.5 15.8 9.8 6.9 19.7 7.6 13.3 9.4 4.9 7.9 21.3 6.0 13.2 14.4 15.0 26.1 25.3 31.1 23.9 18.5 39.4 5.0 8.4 14.3 27.3 49.9 15.3 4.3 16.0 18.2 8.5 11.7 7.6 6.2 6.6 7.0 12.6 5.5 6.8 9.0 11.6 7.5 8.6 2.9 3.8 7.0 5.4 10.1 6.7 6.1 6.2 3.7 7.3 3.8 4.7 5.4 0.0 8.6 8.0 9.7 14.1 4.7 3.7 2.5 34.8 12.5 14.0 5.9 17.0 0.0 8.5 15.7 14.3 24.4 23.3 9.6 54.3 14.0 10.1 8.1 68.9 12.5 3.2 12.7 11.1 15.9 10.0 14.1 7.2 10.1 10.0 23.4 5.6 8.4 17.5 7.4 10.3 5.3 0.0 6.6 35.7 16.8 17.8 20.7 5.0 23.6 11.9 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 2.2;Early spermatids: 1.2;Kupffer cells: 1.2;Macrophages: 1.1;T-cells: 1.9" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "HAP1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favorable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 2.0 0.0 0.3 21.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 0.4 0.2 0.8 2.3 0.3 0.1 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.3 0.7 1.3 0.0 0.2 0.1 0.2 0.6 3.5 2.0 0.6 1.8 1.0 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 ERMP1 "FLJ23309, FXNA, KIAA1815" ENSG00000099219 "Endoplasmic reticulum metallopeptidase 1" Q7Z2K6 9 5765076-5833117 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 57.6" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 69.8;Urothelial cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.5;RT4: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055582 Approved NA NA "HPA055582: " "unprognostic (1.93e-2)" "unprognostic (3.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.93e-2)" "unprognostic (2.97e-1)" "unprognostic (8.59e-2)" "unprognostic (4.30e-3)" "unprognostic (2.81e-1)" "unprognostic (5.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.14e-2)" "unprognostic (2.88e-2)" "prognostic favorable (5.83e-10)" "unprognostic (1.41e-1)" "unprognostic (4.00e-1)" "unprognostic (5.77e-2)" "unprognostic (1.36e-1)" 4.0 12.0 5.3 3.6 13.8 1.6 4.8 7.3 12.3 8.5 8.2 20.5 1.5 3.4 4.9 2.9 12.7 4.9 8.8 7.1 6.8 5.8 18.8 3.5 4.7 2.7 18.3 7.0 5.6 4.4 57.6 3.3 5.7 17.0 4.8 8.4 6.9 12.8 3.4 5.2 6.8 4.8 3.2 15.9 2.5 9.1 5.9 11.5 4.6 19.1 4.6 7.2 18.7 8.1 0.2 0.3 0.9 0.5 4.7 2.0 0.3 15.3 15.0 0.6 1.8 7.8 7.5 8.0 1.7 3.9 0.8 0.7 3.6 9.4 3.6 6.8 2.9 9.2 11.0 3.2 10.2 1.2 18.9 2.6 19.1 7.9 7.0 1.7 5.4 7.5 3.8 4.5 0.7 4.5 10.3 10.6 1.6 2.3 3.4 0.9 7.0 0.2 2.1 2.3 9.6 2.9 0.5 1.9 4.8 27.5 53.7 3.5 1.1 2.5 18.1 2.8 9.0 12.0 6.9 6.3 0.5 1.8 1.1 5.5 3.2 4.5 1.8 2.3 4.5 1.4 0.6 0.3 0.9 1.3 0.5 2.0 0.2 0.6 0.3 0.0 0.0 0.5 0.5 0.0 4.7 0.2 0.3 0.5 0.3 5.3 13.8 7.3 12.3 6.8 5.8 18.3 7.0 17.0 11.5 6.0 0.6 0.0 11.5 2.6 3.5 12.6 20.4 5.3 4.5 69.8 9.8 5.8 0.0 3.6 19.1 5.0 9.1 0.0 2.6 5.6 2.6 6.9 9.2 5.1 5.4 3.2 10.9 3.1 1.3 31.7 2.8 3.3 1.7 1.0 10.0 3.5 3.4 27.9 4.6 2.8 2.1 6.5 1.9 7.2 4.1 4.0 3.4 4.4 10.3 55.0 ERN2 IRE1b ENSG00000134398 "Endoplasmic reticulum to nucleus signaling 2" Q76MJ5 16 23690326-23713500 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 64.5;stomach 1: 30.0" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 28.1;Enterocytes: 26.1;Mucus-secreting cells: 126.1;Paneth cells: 28.8;Undifferentiated cells: 53.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 30.5" "Region enhanced" "Detected in single" "hypothalamus: 0.7" "Not detected" "Not detected" HPA076875 Approved "Intracellular and membrane" NA NA "HPA076875: " "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (3.45e-1)" "unprognostic (2.98e-2)" "unprognostic (3.83e-2)" "unprognostic (1.13e-2)" "unprognostic (7.67e-4)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (4.93e-2)" "unprognostic (7.34e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-9)" "unprognostic (1.48e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-3)" 0.1 0.3 0.1 8.1 0.2 0.0 0.1 0.1 0.2 11.4 17.3 0.2 0.1 7.0 1.1 0.1 0.9 0.1 64.5 0.1 0.1 0.0 0.2 0.1 1.0 0.5 0.1 0.1 0.1 0.5 0.0 0.8 0.1 0.1 2.6 12.6 0.2 14.0 0.1 0.1 0.1 11.8 0.9 0.1 0.1 30.0 0.1 0.1 0.2 0.1 2.2 7.6 6.3 3.9 0.9 0.6 3.6 0.4 1.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.4 0.5 0.3 0.3 0.2 0.3 0.3 0.3 0.1 0.9 0.3 0.4 2.1 1.5 0.2 0.6 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 1.0 0.0 0.0 0.4 28.1 4.0 6.8 0.0 0.0 0.2 0.0 0.6 0.1 0.0 26.1 0.0 1.8 0.0 0.0 1.0 4.6 0.0 0.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 126.1 0.0 19.2 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 53.3 10.4 ERO1A "ERO1-alpha, Ero1alpha, ERO1L" ENSG00000197930 "Endoplasmic reticulum oxidoreductase 1 alpha" Q96HE7 14 52639916-52695900 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 98.4" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 166.6;Pancreatic endocrine cells: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026653, HPA030053, CAB034294" Enhanced "Intracellular and membrane" NA NA 75000 "CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467" "unprognostic (8.64e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.86e-2)" "unprognostic (5.89e-2)" "unprognostic (5.69e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (7.59e-4)" "prognostic unfavorable (1.10e-5)" "unprognostic (4.98e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.54e-9)" "unprognostic (9.19e-2)" "unprognostic (2.78e-2)" "unprognostic (4.58e-1)" "unprognostic (5.03e-2)" 12.4 3.9 4.7 8.2 5.7 18.1 6.8 6.3 7.4 27.8 8.1 3.6 8.2 7.6 5.3 6.9 98.4 4.4 8.3 6.9 4.3 5.8 6.6 16.2 8.3 8.9 4.0 5.5 7.0 9.0 6.1 5.8 20.0 5.8 7.1 7.9 7.0 20.3 7.3 4.1 7.1 10.0 5.9 5.4 8.2 12.2 3.3 3.7 4.4 6.7 31.0 28.2 27.5 28.3 4.5 4.2 14.9 7.5 6.1 10.5 2.1 32.5 7.6 6.5 7.1 18.1 21.0 12.0 14.2 16.9 11.2 18.8 10.6 51.0 8.6 17.5 9.0 13.8 20.3 8.6 26.9 28.2 7.2 4.3 1.1 7.7 13.2 15.7 19.2 23.6 18.2 18.0 14.3 14.7 26.3 15.4 10.5 5.3 16.6 14.8 4.9 11.4 11.7 3.7 14.6 5.3 7.0 20.4 11.5 17.2 31.2 5.8 15.6 9.5 5.8 12.7 8.8 8.0 7.1 13.3 20.3 10.1 16.5 12.3 8.5 9.1 7.3 29.5 9.9 9.3 14.9 5.5 9.6 4.8 6.1 10.4 4.5 9.2 6.1 4.2 3.1 5.5 5.4 13.4 6.1 7.5 3.3 10.5 2.1 4.7 5.7 6.3 7.4 4.3 5.8 4.0 5.5 5.8 3.7 14.9 31.8 9.3 59.0 0.0 22.2 0.0 35.7 24.1 28.4 36.6 15.7 17.2 3.3 166.6 0.4 13.1 15.8 0.0 112.4 116.8 9.3 107.5 5.8 47.8 39.8 39.7 10.5 22.7 38.1 1.4 5.8 33.6 0.0 36.9 16.0 11.6 235.4 24.6 12.0 13.0 24.5 19.4 0.0 0.5 1.0 0.0 76.4 24.9 24.7 102.5 ERO1B "ERO1-L(beta), Ero1beta, ERO1LB" ENSG00000086619 "Endoplasmic reticulum oxidoreductase 1 beta" Q86YB8 1 236215555-236281985 "Predicted intracellular proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pancreas: 160.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 96.2;Spermatocytes: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 12.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028085 Enhanced "Intracellular and membrane" NA NA "HPA028085: AB_10601214" "unprognostic (1.16e-1)" "unprognostic (1.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-1)" "unprognostic (9.80e-2)" "unprognostic (2.49e-2)" "prognostic favorable (7.53e-5)" "unprognostic (1.73e-2)" "unprognostic (2.85e-2)" "unprognostic (4.65e-2)" "unprognostic (5.90e-2)" "unprognostic (8.26e-3)" "unprognostic (7.87e-2)" "unprognostic (3.37e-1)" "unprognostic (2.22e-3)" "unprognostic (8.09e-3)" 2.7 2.5 3.2 4.3 4.8 2.6 6.9 7.4 4.0 2.4 3.3 2.0 5.7 4.4 2.5 10.1 1.4 2.1 4.1 2.9 3.3 2.7 3.7 11.6 2.5 3.5 4.0 1.7 3.4 160.4 5.4 8.5 2.2 3.9 2.7 1.4 1.4 9.0 3.2 1.9 1.7 2.7 2.2 3.0 4.1 17.7 10.9 4.1 4.1 12.5 0.8 2.7 2.4 2.3 2.9 7.2 12.9 1.9 1.3 2.8 0.9 1.9 2.3 3.8 3.3 3.1 2.0 4.6 2.9 2.8 2.1 1.8 0.6 2.1 5.2 8.1 4.6 7.9 0.9 1.8 2.6 3.0 5.3 11.4 1.5 0.3 2.0 8.2 2.1 0.9 3.6 5.7 3.7 7.1 4.6 2.5 4.9 0.8 13.3 2.8 1.0 0.9 0.9 1.5 0.2 0.7 10.9 2.7 1.3 4.2 4.5 8.0 4.7 9.5 3.3 7.7 2.1 7.7 9.5 2.3 3.2 2.7 3.2 3.9 9.3 0.6 3.0 4.4 3.1 4.9 12.9 1.9 3.2 2.8 1.9 2.5 1.9 1.5 1.9 1.9 2.9 2.3 2.2 3.9 1.3 0.8 7.2 1.4 0.9 3.2 4.8 7.4 4.0 3.3 2.7 4.0 1.7 3.9 4.1 8.9 10.3 14.8 16.9 0.0 17.4 0.0 30.6 2.7 5.7 15.7 13.7 11.3 1.7 4.0 96.2 5.8 0.3 0.0 14.8 3.6 2.8 16.1 4.7 24.1 5.9 23.8 14.0 13.5 15.6 13.2 17.8 7.4 0.0 3.6 1.5 10.4 15.9 0.0 10.6 7.1 50.0 0.0 0.0 84.9 13.2 0.0 18.9 11.5 0.4 8.4 ERP27 "C12orf46, ERp27, FLJ32115, PDIA8" ENSG00000139055 "Endoplasmic reticulum protein 27" Q96DN0 12 14914035-14939082 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 182.8" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 38.7;Collecting duct cells: 38.4;Distal tubular cells: 139.3;Exocrine glandular cells: 34.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "RT4: 45.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039636, HPA052851" Enhanced "Intracellular and membrane" NA NA "HPA039636: AB_10795403, HPA052851: AB_2681972" "unprognostic (9.02e-3)" "unprognostic (2.53e-1)" "unprognostic (1.41e-1)" "unprognostic (4.69e-2)" "unprognostic (8.70e-2)" "unprognostic (3.92e-3)" "unprognostic (2.70e-1)" "unprognostic (1.48e-2)" "unprognostic (2.37e-3)" "unprognostic (5.33e-2)" "unprognostic (2.34e-2)" "unprognostic (1.88e-1)" "unprognostic (7.89e-2)" "unprognostic (4.55e-2)" "unprognostic (8.98e-2)" "unprognostic (1.76e-3)" "unprognostic (3.45e-2)" 0.1 0.1 0.0 0.6 0.4 0.4 0.8 0.0 0.2 0.7 0.1 0.1 1.0 0.0 0.1 7.2 1.1 9.1 0.0 0.6 0.0 0.0 11.6 0.1 5.7 0.4 0.0 0.0 1.8 182.8 0.1 1.3 7.7 0.3 4.2 0.1 1.0 5.1 0.5 0.0 0.4 0.5 0.0 0.5 0.9 0.5 0.4 0.0 0.1 36.0 1.9 1.0 3.6 0.1 2.1 2.9 4.7 5.2 1.4 8.1 3.1 1.5 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.3 9.1 0.6 0.9 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 1.8 0.0 7.1 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.4 0.0 3.2 1.4 2.2 0.0 0.1 0.0 0.7 0.0 0.1 0.3 45.3 0.0 0.0 0.0 7.5 0.0 0.8 0.3 1.7 1.2 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 3.4 4.2 4.7 6.3 4.8 8.1 2.1 5.6 4.2 2.9 2.0 7.2 7.6 2.0 1.4 5.2 0.3 6.8 3.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 38.7 14.4 0.0 2.4 0.3 0.0 0.2 0.0 30.8 30.7 38.4 0.0 3.7 139.3 6.7 0.0 0.0 0.0 0.0 34.4 9.6 0.3 0.8 1.1 0.0 1.3 0.0 1.7 0.0 1.5 0.0 1.7 1.2 0.0 1.8 0.0 2.1 31.0 3.6 0.0 4.8 0.0 0.0 0.7 0.0 0.0 0.4 0.7 3.3 0.2 13.1 ERRFI1 "GENE-33, MIG-6, RALT" ENSG00000116285 "ERBB receptor feedback inhibitor 1" Q9UJM3 1 8004404-8026308 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 141.1;pancreas: 133.6" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1158.6;Basal keratinocytes: 1103.5;Hepatocytes: 716.0;Suprabasal keratinocytes: 640.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.9" "Group enriched" "Detected in many" 7 "monocytes: 4.9;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 94.3;LHCN-M2: 72.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076543 Supported Cytosol NA NA Cytosol "HPA076543: " "unprognostic (2.13e-3)" "unprognostic (1.01e-2)" "unprognostic (2.34e-1)" "unprognostic (1.71e-2)" "unprognostic (2.50e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.47e-1)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (1.19e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.34e-1)" "unprognostic (8.03e-3)" 38.6 8.8 4.4 6.3 6.3 0.6 27.8 9.6 7.0 17.5 13.6 5.4 8.4 6.8 15.9 9.6 13.6 12.2 27.3 8.8 4.7 2.5 32.6 141.1 15.5 7.7 7.5 3.7 29.7 133.6 7.7 41.9 33.7 8.1 9.3 5.1 12.0 14.5 5.9 68.3 20.2 26.5 22.9 12.5 2.1 22.3 7.4 5.2 0.6 19.4 4.7 3.8 20.0 19.5 0.4 0.3 0.2 4.9 0.0 1.3 0.2 13.4 7.9 3.4 4.6 32.4 24.3 35.5 13.2 3.8 2.4 2.9 3.5 35.4 0.2 7.9 4.4 16.9 2.9 0.9 23.3 11.3 0.4 2.6 0.2 2.3 41.0 94.3 0.1 0.5 32.9 23.5 8.1 19.7 34.6 6.2 0.5 0.9 0.1 72.0 5.7 0.0 0.8 8.1 10.5 19.8 1.1 38.4 0.2 11.4 4.3 2.3 1.4 2.6 6.0 4.1 25.1 4.1 0.3 8.7 9.6 5.6 8.0 18.5 0.2 0.1 0.2 36.9 0.6 8.8 0.0 0.4 0.0 1.3 0.1 0.2 0.3 1.2 1.3 0.2 0.4 0.9 1.2 0.2 0.0 4.9 0.3 0.6 0.2 4.4 6.3 9.6 7.0 4.7 2.5 7.5 3.7 8.1 5.2 205.4 106.1 3.4 1158.6 1103.5 8.8 38.3 122.3 92.3 168.4 26.2 13.7 65.0 26.6 64.8 18.3 16.0 90.3 0.0 96.3 48.0 90.0 430.0 13.9 716.0 8.9 3.2 104.9 36.8 11.3 51.0 48.1 13.8 67.4 1.0 17.1 35.7 105.2 28.1 36.0 45.8 9.2 6.5 58.9 10.4 22.8 640.6 216.6 5.7 21.0 466.7 ERVFRD-1 "envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2" ENSG00000244476 "Endogenous retrovirus group FRD member 1, envelope" P60508 6 11102489-11111732 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 66.9" "Cell type enriched" "Detected in some" 52 "Syncytiotrophoblasts: 481.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SuSa: 30.4" NA NA "unprognostic (1.99e-1)" "unprognostic (3.29e-4)" "unprognostic (4.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (2.19e-3)" "unprognostic (3.35e-1)" "unprognostic (6.44e-2)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-2)" "unprognostic (2.78e-3)" "unprognostic (5.80e-4)" "unprognostic (3.40e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" 1.4 2.0 0.1 0.1 0.1 0.1 0.8 0.2 0.2 0.5 0.8 0.1 0.1 0.3 1.3 0.8 0.7 0.2 0.5 0.5 0.1 0.0 1.5 0.7 1.5 1.0 0.1 0.1 0.1 0.1 15.8 0.1 66.9 0.1 1.2 0.2 0.7 0.9 0.5 0.1 0.9 1.9 0.8 0.1 0.1 1.0 0.3 0.1 0.6 0.2 0.9 0.3 1.5 2.2 0.5 0.0 0.3 0.1 2.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.7 0.4 0.3 2.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 9.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 481.3 0.0 0.0 0.0 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 5000000 Nucleoplasm Cytosol "HPA011423: AB_2668510, HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.5 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 28.2 6.0 0.0 0.6 0.1 0.4 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 20.3 0.0 3.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 1.9 1.8 0.8 0.0 0.0 0.0 15.1 0.4 1.2 0.3 1.9 0.8 0.0 3.0 2.5 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 0.0 0.0 0.0 1.1 0.5 0.0 2.4 0.0 0.0 0.0 7.0 0.0 66.3 0.0 2.3 3.2 0.1 0.0 0.0 0.7 80.6 1.3 1.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.3 0.2 0.4 0.1 14.5 0.0 0.4 1.1 ERVV-1 "ENVV1, FLJ32214, HERV-V1" ENSG00000269526 "Endogenous retrovirus group V member 1, envelope" B6SEH8 19 53013921-53016122 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 19.7" "Cell type enriched" "Detected in some" 31 "Syncytiotrophoblasts: 218.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 11.7;SuSa: 9.8" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (1.04e-3)" "unprognostic (7.32e-3)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.67e-2)" "unprognostic (9.92e-2)" "unprognostic (6.75e-2)" "unprognostic (4.34e-5)" "unprognostic (3.48e-2)" "unprognostic (5.80e-2)" "unprognostic (3.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.2 0.0 0.0 0.0 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044738-53051076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 105 "placenta: 85.9" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 19.1;SuSa: 12.9;T-47d: 5.4" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 ERVW-1 "envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW" ENSG00000242950 "Endogenous retrovirus group W member 1, envelope" Q9UQF0 7 92468380-92477986 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 83.4" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 179.3;Syncytiotrophoblasts: 714.1" "Cancer enriched" "Detected in single" 143 "testis cancer: 31.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "BEWO: 43.6;SuSa: 13.9" NA NA "unprognostic (2.85e-1)" "unprognostic (1.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (1.48e-4)" "unprognostic (4.80e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-2)" "unprognostic (8.02e-2)" 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 83.4 0.2 0.2 0.1 0.2 0.4 0.2 0.4 0.4 0.2 0.2 0.3 0.3 0.5 10.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 2.2 0.8 0.1 0.2 0.0 0.1 0.2 0.3 0.2 0.0 0.3 43.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.6 0.3 0.2 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.7 0.0 0.2 0.2 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.0 0.6 0.0 13.9 0.1 0.2 0.1 0.0 0.8 0.2 0.1 0.7 0.3 0.1 0.1 0.2 0.0 0.0 0.4 2.2 0.2 0.8 0.1 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.6 0.0 0.1 0.0 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 3.0 1.9 0.0 0.5 0.7 2.2 0.2 0.0 9.4 2.3 0.0 0.0 179.3 0.0 0.0 28.9 0.1 0.0 0.0 0.0 79.7 2.8 0.2 2.3 0.0 23.6 0.0 0.0 0.0 1.0 5.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 1.4 0.0 0.0 0.5 0.4 1.8 714.1 0.0 0.0 0.5 ESAM W117m ENSG00000149564 "Endothelial cell adhesion molecule" Q96AP7 11 124752583-124762290 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 93.0" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 198.2;Ito cells: 127.7;Sertoli cells: 148.8;Smooth muscle cells: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7;neutrophil: 5.5" "Group enriched" "Detected in many" 9 "B-cells: 6.7;granulocytes: 5.5;T-cells: 1.8" "Group enriched" "Detected in some" 10 "HEL: 53.4;HUVEC TERT2: 69.5;TIME: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051043, HPA056293" Uncertain Approved Microtubules NA NA 64000000 Microtubules "HPA051043: AB_2681323, HPA056293: AB_2683089" "unprognostic (1.52e-1)" "unprognostic (2.03e-1)" "unprognostic (1.05e-2)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.49e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (9.05e-2)" "unprognostic (2.99e-2)" "unprognostic (3.08e-1)" "unprognostic (3.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.24e-2)" "unprognostic (5.10e-2)" "unprognostic (2.29e-1)" "unprognostic (5.06e-2)" 37.1 6.0 6.6 5.3 9.6 1.3 44.6 3.8 8.2 11.8 6.1 5.4 3.7 4.3 14.5 9.5 10.7 10.3 11.5 20.1 7.5 6.6 15.5 10.2 38.4 6.9 9.1 3.9 8.4 6.4 5.4 5.5 93.0 9.0 10.9 5.0 12.4 5.1 9.8 14.6 5.9 6.4 17.2 7.2 8.2 7.6 5.4 5.9 0.9 44.9 10.9 5.0 11.4 25.4 6.7 0.3 5.5 0.5 0.0 1.8 19.4 0.2 0.4 0.1 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 3.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.3 53.4 0.0 1.9 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 69.5 0.0 0.0 1.5 0.1 0.4 0.0 0.0 0.1 5.0 0.5 0.0 0.2 0.2 0.0 0.5 0.0 0.2 0.0 4.0 0.0 2.0 0.8 0.2 34.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.5 0.0 0.1 0.2 0.0 1.4 1.3 0.1 0.3 6.7 1.8 0.6 5.5 0.0 0.0 0.3 0.4 19.4 6.6 9.6 3.8 8.2 7.5 6.6 9.1 3.9 9.0 5.9 35.7 59.6 0.8 0.6 13.5 1.3 10.6 0.0 2.7 4.5 14.0 3.9 0.9 5.0 3.3 4.0 198.2 0.0 0.0 2.1 13.5 8.5 1.1 3.5 0.8 0.9 0.0 0.0 127.7 5.6 13.6 0.9 2.6 11.8 1.0 0.2 0.8 27.0 2.6 0.4 0.0 1.0 148.8 94.7 0.0 0.3 9.5 31.0 0.0 1.7 1.7 ESCO2 "EFO2, RBS" ENSG00000171320 "Establishment of sister chromatid cohesion N-acetyltransferase 2" Q56NI9 8 27771949-27812640 "Disease related genes, Predicted intracellular proteins" "Cell cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3" "Group enriched" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027243, HPA053679" Supported "Nucleoplasm,Golgi apparatus,Cell Junctions" Yes Yes "Nucleoplasm, Golgi apparatus" "Cell Junctions" "HPA027243: AB_2672175, HPA053679: AB_2682227" "unprognostic (7.86e-2)" "unprognostic (1.50e-2)" "prognostic favorable (1.04e-4)" "unprognostic (5.13e-3)" "unprognostic (9.50e-2)" "unprognostic (8.67e-3)" "unprognostic (7.30e-4)" "unprognostic (5.24e-3)" "unprognostic (2.24e-2)" "unprognostic (2.54e-2)" "unprognostic (7.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.65e-14)" "unprognostic (6.65e-3)" "unprognostic (5.32e-1)" "unprognostic (5.85e-2)" "unprognostic (4.06e-1)" 1.0 1.7 0.5 7.1 0.5 5.5 1.0 0.4 0.6 1.2 9.6 0.1 0.5 11.9 0.6 1.0 5.0 0.3 1.8 1.1 0.7 0.5 1.6 1.4 1.1 4.2 0.5 0.6 0.6 1.0 0.3 0.3 1.5 0.5 0.5 4.5 0.1 1.4 1.4 0.4 1.1 23.2 0.4 0.8 4.7 2.4 10.3 0.2 39.8 0.5 5.3 5.7 1.0 1.8 1.3 1.9 0.8 1.5 0.9 4.6 0.8 25.1 19.1 8.6 10.4 1.1 1.8 4.8 15.1 6.4 14.1 16.1 6.7 5.0 9.3 8.0 3.9 11.8 13.9 10.4 4.1 21.4 7.2 4.4 11.0 8.6 7.1 0.1 5.6 10.3 0.3 0.4 8.2 2.1 1.4 5.2 7.2 8.8 14.2 8.1 4.9 22.6 2.5 5.8 13.8 6.4 10.0 25.7 6.8 4.6 15.2 3.7 5.5 7.6 9.2 3.8 3.3 6.3 6.2 2.3 8.7 18.0 17.5 11.8 1.9 5.0 11.5 4.8 9.4 12.0 0.1 0.7 0.4 0.3 1.5 0.1 1.3 0.7 1.0 1.9 0.1 0.5 0.4 0.8 0.9 0.4 0.2 4.6 0.8 0.5 0.5 0.4 0.6 0.7 0.5 0.5 0.6 0.5 0.2 0.0 6.6 2.2 0.7 2.1 1.5 1.1 0.0 2.7 5.7 0.0 3.9 1.0 0.0 0.3 3.9 0.1 5.3 70.0 0.0 5.5 0.9 0.2 1.1 1.1 4.5 0.0 1.2 0.6 4.1 0.4 1.7 3.5 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 1.8 6.5 0.3 30.1 77.3 0.5 0.8 2.9 4.0 0.9 ESM1 ENSG00000164283 "Endothelial cell specific molecule 1" Q9NQ30 5 54977864-55022671 "Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 31.4;thyroid gland: 14.8" "Cell type enhanced" "Detected in some" 21 "Ductal cells: 8.7;Endothelial cells: 4.9;Ito cells: 1.8;Pancreatic endocrine cells: 1.9" "Cancer enriched" "Detected in all" 8 "renal cancer: 65.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.6;memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.7;naive CD8 T-cell: 1.6;NK-cell: 3.7" "Group enriched" "Detected in many" 32 "NK-cells: 3.7;T-cells: 2.7" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 55.5;TIME: 103.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB047364 Approved "Secreted to blood" NA NA 1540000 400000 "CAB047364: " "unprognostic (4.70e-2)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.63e-3)" "unprognostic (2.31e-3)" "unprognostic (4.68e-2)" "unprognostic (1.55e-1)" "unprognostic (6.85e-3)" "unprognostic (1.59e-2)" "unprognostic (1.05e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (4.00e-4)" "unprognostic (7.77e-2)" "unprognostic (1.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.94e-1)" 1.5 3.5 0.3 0.4 0.6 0.2 0.6 0.2 0.7 1.5 1.1 0.8 4.2 0.3 3.0 1.1 0.3 0.2 0.9 2.4 0.9 3.7 31.4 2.2 12.9 0.9 0.5 0.3 2.3 1.8 1.7 9.0 0.5 1.3 4.8 0.0 1.5 5.6 3.2 0.7 0.3 2.4 0.4 1.1 4.0 0.5 0.6 0.5 0.6 14.8 0.8 0.4 1.4 1.0 0.0 0.0 0.0 0.0 3.7 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 1.7 0.7 0.1 0.0 0.0 0.0 1.3 1.0 0.4 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 55.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.7 0.9 2.5 7.2 3.8 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 1.6 0.0 2.7 1.7 0.0 0.0 0.0 1.6 0.0 3.7 0.0 0.0 0.0 0.5 0.3 0.6 0.2 0.7 0.9 3.7 0.5 0.3 1.3 0.5 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 4.9 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.9;lymphoid tissue: 30.3" "Cell type enhanced" "Detected in some" 6 "Enterocytes: 4.1;Hepatocytes: 4.9;Proximal tubular cells: 5.6;Spermatocytes: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.01e-5)" "prognostic unfavorable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favorable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.7 0.4 0.2 7.1 0.4 7.2 0.3 0.2 0.5 3.9 2.3 0.4 0.8 4.2 0.6 0.7 17.9 0.2 0.5 1.0 1.1 0.1 1.0 0.9 0.7 4.1 0.2 0.2 0.3 0.2 0.0 0.2 3.0 0.6 0.4 1.5 0.6 2.6 0.2 0.2 2.7 4.4 0.5 0.2 3.0 0.8 10.9 0.3 30.3 0.3 2.5 7.8 0.7 6.2 0.0 0.0 0.4 0.1 0.0 1.8 0.0 12.6 12.9 13.8 11.3 0.3 1.2 8.5 8.3 4.2 14.3 9.1 7.0 11.1 22.8 4.6 3.4 8.4 10.5 16.0 4.9 7.5 7.1 16.2 15.3 11.7 5.3 0.0 9.6 12.7 0.4 0.3 8.3 4.1 1.4 7.3 11.3 20.5 20.6 4.2 13.1 15.0 8.2 11.2 7.5 7.0 14.1 14.8 9.5 2.0 5.3 10.0 7.7 7.0 10.3 5.4 6.8 17.0 6.4 3.3 7.2 14.0 6.0 11.4 15.3 14.2 15.4 4.1 9.1 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.8 0.0 0.2 0.4 0.2 0.5 1.1 0.1 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 3.5 0.0 0.7 0.0 0.2 0.6 0.4 4.1 0.0 0.0 1.9 1.0 0.3 0.0 4.9 2.1 0.0 3.4 1.3 0.6 1.1 0.0 1.3 0.0 0.0 1.2 0.0 1.0 0.2 0.4 5.6 0.0 0.0 0.4 6.5 2.7 0.5 0.2 0.0 3.1 0.5 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.4;liver: 54.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 302.8;Late spermatids: 360.4;Muller glia cells: 292.0;Paneth cells: 221.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 6.0" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.6;memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 37 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "BEWO: 17.0;Hep G2: 27.1;SK-BR-3: 55.6;T-47d: 18.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA028674, HPA060220" Enhanced Approved Vesicles NA NA Vesicles "HPA028674: AB_10601316, HPA060220: AB_2684224" "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 1.4 0.6 2.5 0.8 6.7 2.9 6.0 0.7 13.3 44.8 0.6 9.2 27.1 1.2 19.7 9.9 6.3 1.2 0.6 1.0 0.1 14.3 54.9 1.6 0.6 0.6 0.6 2.4 0.6 12.9 12.1 1.3 0.6 2.6 1.7 19.5 2.9 4.7 0.6 27.1 70.4 1.0 0.6 0.6 0.4 37.7 0.6 1.2 0.7 2.4 3.2 0.8 5.9 0.0 0.0 0.0 0.0 0.0 3.6 0.3 4.6 0.2 0.2 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 10.1 0.5 0.1 2.3 0.0 0.0 11.1 0.8 0.0 0.0 0.6 0.2 0.1 0.2 27.1 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 5.7 0.0 0.0 9.4 0.0 0.3 0.2 1.2 4.2 0.0 0.1 3.6 0.0 0.0 7.3 0.3 1.3 55.6 1.7 0.1 18.5 2.4 5.3 0.0 0.2 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.6 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.6 0.8 6.0 0.7 1.0 0.1 0.6 0.6 0.6 0.6 0.0 1.1 1.4 1.7 6.9 5.5 1.1 5.1 1.4 1.2 8.7 64.8 2.2 11.6 0.3 114.4 0.6 302.8 23.3 2.9 0.4 0.4 1.4 0.0 99.9 0.2 0.0 5.8 3.1 2.9 360.4 3.4 0.3 0.0 0.0 16.1 292.0 0.1 221.0 2.1 91.6 68.8 0.0 0.0 2.6 2.5 19.8 5.5 0.8 19.0 3.2 ESPNL FLJ42568 ENSG00000144488 "Espin like" Q6ZVH7 2 238100157-238133287 "Predicted intracellular proteins" Hearing Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.9;pituitary gland: 8.2" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.7;Muller glia cells: 1.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 5 "cerebellum: 9.9" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 16 "B-cells: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 3.6;Daudi: 5.1;fHDF/TERT166: 4.7;HHSteC: 5.4;THP-1: 3.7;U-87 MG: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA055103 Uncertain NA NA "HPA055103: AB_2682694" "unprognostic (8.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.34e-2)" "unprognostic (1.18e-3)" "unprognostic (1.51e-2)" "unprognostic (2.12e-1)" "unprognostic (2.01e-2)" "unprognostic (3.20e-1)" "unprognostic (1.79e-1)" "unprognostic (2.18e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (3.94e-6)" "unprognostic (3.49e-2)" "unprognostic (8.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.67e-2)" 0.6 0.5 0.3 6.0 0.3 0.0 0.6 9.9 0.6 1.2 1.1 0.6 0.3 1.4 1.5 0.3 0.8 2.8 0.3 1.3 0.3 0.0 1.1 3.5 0.7 2.6 0.3 0.3 4.0 1.3 0.0 8.2 0.3 2.0 1.5 0.2 0.6 2.0 3.5 0.3 0.1 4.9 1.6 0.3 3.8 0.8 0.4 0.8 0.3 2.0 0.3 2.8 0.4 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 1.4 0.6 2.0 1.0 1.7 1.8 0.0 0.0 5.1 2.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.9 1.8 5.4 0.0 1.1 1.9 0.0 0.2 0.0 0.0 0.0 1.6 1.7 0.0 2.0 0.0 0.0 2.3 0.4 0.0 0.0 1.6 0.2 0.7 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.2 4.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 9.9 0.6 0.3 0.0 0.3 0.3 2.0 0.8 0.0 0.0 0.8 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ESR1 "ER-alpha, Era, ESR, NR3A1" ENSG00000091831 "Estrogen receptor 1" P03372 6 151656691-152129619 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 64.5;endometrium 1: 68.9" "Group enriched" "Detected in many" 6 "Early spermatids: 36.0;Hepatocytes: 48.4;Horizontal cells: 58.8" "Group enriched" "Detected in many" 9 "breast cancer: 40.2;endometrial cancer: 24.3;ovarian cancer: 8.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "MCF7: 24.9;T-47d: 32.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB000037, HPA000449, HPA000450, CAB055099, CAB072858" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754" "unprognostic (8.28e-2)" "unprognostic (3.02e-2)" "unprognostic (1.43e-2)" "prognostic favorable (5.47e-7)" "unprognostic (4.79e-1)" "unprognostic (2.43e-3)" "unprognostic (4.10e-5)" "unprognostic (9.92e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (7.35e-2)" "unprognostic (3.45e-1)" "unprognostic (1.20e-2)" "unprognostic (7.91e-3)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.52e-1)" 3.0 0.9 0.5 1.6 0.5 0.2 16.2 0.8 0.4 64.5 1.5 0.2 2.2 0.1 68.9 27.7 1.1 26.7 1.9 1.1 0.5 0.8 1.5 6.6 3.6 1.6 0.4 0.1 14.2 0.4 0.0 9.3 0.9 0.6 3.6 0.1 2.6 1.6 4.1 2.0 0.6 0.5 20.8 0.4 1.6 0.3 1.9 0.4 1.9 1.3 2.2 2.5 3.8 23.7 0.6 1.0 0.0 0.8 0.3 2.5 1.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.0 0.0 0.6 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.1 32.2 0.0 0.0 0.1 0.1 0.3 0.0 3.0 0.5 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.3 0.2 1.0 0.6 1.3 0.4 1.0 0.4 2.5 0.9 0.0 0.3 0.0 0.0 0.3 1.0 0.5 0.5 0.8 0.4 0.5 0.8 0.4 0.1 0.6 0.4 0.0 0.6 0.0 1.4 0.9 3.8 4.5 0.0 1.4 1.2 0.0 7.9 0.1 1.7 0.0 36.0 0.6 0.0 0.0 0.2 0.1 4.7 0.6 2.3 48.4 0.9 58.8 1.7 6.7 4.7 6.9 3.7 2.4 1.7 0.0 0.0 2.7 0.2 0.0 2.1 3.3 4.0 0.0 1.4 1.6 1.2 1.5 0.1 0.0 0.0 8.4 ESR2 "ER-beta, Erb, NR3A2" ENSG00000140009 "Estrogen receptor 2" Q92731 14 64084232-64338112 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 19.1;testis: 30.2;vagina: 14.3" "Group enriched" "Detected in many" 9 "Early spermatids: 48.9;Late spermatids: 62.8;Rod photoreceptor cells: 41.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;U-266/70: 10.8;U-698: 17.6" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 17.8" CAB079300 Enhanced NA NA "CAB079300: " "unprognostic (7.63e-3)" "unprognostic (2.28e-3)" "unprognostic (8.27e-3)" "unprognostic (5.41e-2)" "unprognostic (2.91e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (1.95e-1)" "unprognostic (8.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.65e-1)" "unprognostic (3.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.66e-1)" "unprognostic (4.21e-2)" "unprognostic (5.89e-2)" 2.1 9.4 0.2 2.3 0.8 1.0 3.7 0.8 0.6 1.3 2.9 0.6 0.2 1.4 1.7 0.7 1.7 1.1 0.6 1.0 1.1 0.4 1.4 0.7 1.3 2.8 0.2 0.2 19.1 2.5 0.0 1.6 0.7 1.4 2.2 1.5 0.5 1.5 0.9 1.4 1.2 1.5 0.6 1.0 3.0 1.3 30.2 0.6 5.0 0.6 0.2 2.9 1.8 14.3 2.4 4.0 1.1 0.3 0.4 1.3 0.2 0.7 0.3 0.7 0.7 0.0 0.1 1.3 0.1 0.0 0.1 0.1 0.2 0.8 2.9 0.1 0.0 0.3 1.0 0.9 0.0 0.1 0.7 0.3 0.3 0.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.3 1.2 0.6 4.1 0.2 0.7 0.4 0.2 0.7 0.6 0.4 0.5 0.4 0.3 0.1 1.4 2.5 0.7 0.5 0.2 1.1 0.4 0.8 0.0 0.4 0.5 1.0 0.2 0.1 10.8 3.2 17.6 0.2 0.1 0.7 0.3 0.3 1.0 0.8 0.2 0.6 1.7 0.6 1.1 0.1 2.4 1.3 1.0 1.1 0.4 0.2 4.0 0.5 0.2 0.2 0.8 0.8 0.6 1.1 0.4 0.2 0.2 1.4 0.6 6.0 0.0 2.7 2.5 0.2 1.4 0.8 0.0 2.7 1.2 0.0 5.9 0.6 0.0 0.1 48.9 0.6 0.0 0.0 0.6 0.4 0.3 0.9 1.1 0.0 0.1 0.0 0.0 0.0 0.0 62.8 0.9 0.0 1.7 0.0 0.6 1.6 0.4 0.0 1.1 0.0 41.7 0.0 0.8 6.0 0.8 0.1 0.9 0.5 0.4 1.7 ESRP1 "FLJ20171, RBM35A" ENSG00000104413 "Epithelial splicing regulatory protein 1" Q6NXG1 8 94641074-94707466 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 65.1" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 101.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A-431: 33.3;BEWO: 25.6;CAPAN-2: 35.1;HaCaT: 20.4;hTCEpi: 57.4;OE19: 34.8;RT4: 24.4;T-47d: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA023719, HPA023720, HPA067104" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" Nucleoplasm "HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779" "prognostic unfavorable (9.28e-4)" "unprognostic (7.12e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.12e-1)" "unprognostic (6.99e-3)" "unprognostic (2.70e-1)" "unprognostic (2.61e-2)" "unprognostic (5.19e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (4.48e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.96e-2)" "unprognostic (1.29e-1)" 0.6 0.5 0.5 15.1 0.5 0.0 7.6 0.5 0.6 9.7 18.1 0.2 18.7 7.7 3.3 21.3 43.1 6.6 14.5 0.6 0.5 0.5 6.4 0.7 15.5 0.8 0.5 0.2 1.8 65.1 11.8 10.1 18.5 0.3 8.9 20.8 0.2 38.2 15.1 0.5 24.8 12.7 1.9 0.5 0.5 12.1 1.0 0.2 1.4 20.2 30.4 28.9 9.0 16.8 0.0 0.0 0.0 0.0 0.0 1.9 0.0 33.3 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 10.9 35.1 0.0 0.9 0.0 0.0 20.4 0.9 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.4 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 16.2 0.4 0.1 3.1 34.8 0.8 0.0 0.0 4.4 4.4 24.4 8.9 0.0 0.0 5.2 3.3 5.6 27.1 0.2 0.0 0.0 0.0 0.0 0.0 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.2 0.3 0.2 35.7 23.4 0.5 19.5 39.6 0.0 0.7 20.4 30.8 22.7 26.2 0.0 45.8 11.6 18.7 5.9 0.0 53.4 0.0 24.0 54.1 2.0 25.5 1.1 0.0 5.1 0.0 31.9 0.0 0.0 6.8 0.0 0.6 23.6 1.0 101.9 0.0 21.5 42.1 0.7 0.3 0.0 0.0 0.9 0.2 0.7 69.3 51.9 0.0 68.9 33.0 ESRP2 "FLJ21918, RBM35B" ENSG00000103067 "Epithelial splicing regulatory protein 2" Q9H6T0 16 68229111-68238102 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.2;pancreas: 41.5" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 63.6;Syncytiotrophoblasts: 48.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 18.4;MCF7: 36.1;RT4: 19.4;SK-BR-3: 19.4;T-47d: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040751, HPA048597, HPA048618" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463" "unprognostic (3.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.19e-1)" "unprognostic (3.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.62e-2)" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (1.50e-1)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "unprognostic (8.80e-2)" "prognostic favorable (1.30e-6)" "unprognostic (1.24e-1)" "unprognostic (3.16e-1)" "unprognostic (9.04e-3)" "unprognostic (8.75e-3)" 0.4 0.2 0.2 7.6 0.5 0.0 3.9 0.6 0.3 4.7 8.0 0.6 4.1 4.6 1.2 10.2 30.1 2.1 12.4 0.6 0.3 0.1 13.4 45.2 15.6 0.2 0.2 0.2 1.3 41.5 7.0 2.5 11.3 0.7 6.6 5.6 0.8 17.3 5.0 0.3 17.6 8.5 0.6 0.2 0.2 12.8 7.0 0.3 3.0 18.4 25.7 17.1 6.4 9.4 0.0 0.0 0.0 0.8 0.0 0.8 0.0 12.4 0.0 0.0 0.0 0.0 0.0 18.4 0.1 0.0 0.0 0.1 11.7 6.2 0.0 0.5 0.0 0.0 12.9 0.0 9.6 0.0 0.0 8.5 0.0 3.5 9.3 0.2 0.0 0.1 0.0 13.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 1.3 9.3 4.2 0.0 0.0 0.0 4.8 19.4 1.3 0.0 6.2 19.4 0.0 1.6 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.6 0.3 0.3 0.1 0.2 0.2 0.7 0.3 17.9 12.1 0.0 4.0 5.7 0.5 1.0 15.3 2.7 10.3 22.7 0.0 27.4 0.0 10.0 23.1 0.4 10.3 0.0 12.2 3.2 0.8 6.9 0.0 28.2 2.4 0.0 8.1 0.0 1.5 63.6 0.9 0.0 1.7 1.0 23.1 0.2 11.0 7.0 0.0 3.5 0.2 0.0 0.3 5.7 1.5 7.4 48.9 0.0 15.1 7.1 ESRRA "ERR1, ERRa, ERRalpha, ESRL1, NR3B1" ENSG00000173153 "Estrogen related receptor alpha" P11474 11 64305572-64316743 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053785, HPA077297" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Nucleoli fibrillar center, Microtubules" "Cytokinetic bridge" "HPA053785: AB_2682260, HPA077297: " "unprognostic (7.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (3.08e-1)" "unprognostic (7.24e-2)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.98e-1)" "unprognostic (3.52e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.34e-7)" "unprognostic (3.43e-3)" "unprognostic (3.19e-2)" "unprognostic (2.38e-2)" "unprognostic (7.20e-2)" 8.2 9.6 6.0 8.9 7.7 7.9 17.8 9.8 9.4 4.3 32.4 4.9 18.3 43.1 4.6 6.2 17.1 4.1 15.7 45.2 6.8 5.0 21.4 26.9 8.7 9.2 10.4 5.2 2.5 20.5 10.1 4.6 11.0 8.0 7.5 12.6 6.0 28.7 14.9 78.3 10.5 46.4 7.1 7.4 9.3 14.1 2.2 6.0 6.0 8.2 27.1 10.0 8.5 12.0 4.1 4.2 8.5 8.4 2.6 5.4 2.4 9.8 15.8 3.9 9.5 5.3 5.2 21.5 9.7 4.7 3.6 3.6 14.5 12.0 13.5 18.2 5.1 9.6 25.4 6.6 13.1 1.4 9.1 8.5 8.7 18.7 11.4 7.4 14.8 22.0 7.2 20.0 8.2 10.8 5.1 5.1 7.2 14.7 7.5 6.0 22.2 7.2 21.0 10.9 11.9 30.1 7.7 7.7 30.3 12.1 20.8 8.3 10.2 4.9 33.0 31.2 2.3 10.2 14.7 11.0 6.7 8.0 18.7 9.8 11.6 9.5 8.9 10.9 14.5 5.2 0.3 4.7 7.1 4.4 8.4 4.4 2.9 3.8 3.1 4.2 4.1 4.1 5.4 8.5 2.6 7.5 3.2 5.1 2.4 6.0 7.7 9.8 9.4 6.8 5.0 10.4 5.2 8.0 6.0 8.9 27.2 29.9 28.0 16.6 29.0 7.9 132.5 5.3 12.5 19.2 31.4 79.6 46.4 50.0 2.6 9.0 143.7 46.7 68.6 49.1 11.9 19.0 7.0 154.8 29.6 31.8 36.4 44.2 93.5 0.2 6.1 20.2 16.9 19.8 71.8 17.3 67.0 94.7 11.3 48.1 19.0 12.9 10.3 2.8 8.0 16.2 112.2 15.3 83.1 49.8 ESRRB "DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2" ENSG00000119715 "Estrogen related receptor beta" O95718 14 76310712-76501837 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 14.5;retina: 50.2" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 14.7;Horizontal cells: 52.4;Late spermatids: 27.9;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.8;K-562: 9.7;U-266/70: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA074772 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074772: " "unprognostic (1.12e-1)" "unprognostic (1.34e-2)" "unprognostic (6.28e-2)" "unprognostic (3.92e-5)" "unprognostic (5.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.14e-1)" "unprognostic (1.48e-1)" "unprognostic (2.28e-2)" "unprognostic (2.24e-2)" "unprognostic (2.16e-2)" "unprognostic (4.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.46e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-4)" "unprognostic (4.40e-2)" 0.2 0.1 0.3 0.0 1.0 0.0 0.6 0.3 0.6 0.1 0.0 0.8 0.3 0.0 0.1 0.4 0.1 0.1 0.0 7.8 0.3 0.4 14.5 0.1 0.1 0.9 0.5 0.4 0.0 0.2 0.0 0.3 0.1 1.3 0.2 0.0 50.2 0.1 0.4 9.5 0.0 0.1 0.0 0.5 1.2 5.1 2.0 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.5 0.5 0.0 0.1 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.7 0.4 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.0 1.0 0.1 0.5 4.9 1.4 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 1.0 0.3 0.6 0.3 0.4 0.5 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 1.6 5.5 0.0 0.0 0.0 0.0 2.0 0.0 11.6 0.0 14.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.3 40.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ESRRG NR3B3 ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;parathyroid gland: 37.2;placenta: 40.8" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 55.0;Syncytiotrophoblasts: 179.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "pons and medulla: 49.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RPMI-8226: 15.4;SH-SY5Y: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favorable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.5 5.1 2.8 0.4 3.3 0.2 2.9 6.9 10.3 1.4 0.7 0.7 2.2 4.0 0.5 1.5 1.4 2.1 0.8 8.3 3.2 2.6 22.0 0.8 0.7 0.4 6.8 1.7 0.8 4.4 37.2 9.9 40.8 49.5 2.6 0.4 10.7 11.0 2.4 6.3 1.5 3.7 0.9 2.6 1.0 22.2 1.0 1.5 0.0 4.6 7.2 0.4 1.0 0.7 0.4 0.2 1.5 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 15.4 2.4 1.7 5.5 29.5 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.0 2.8 3.3 6.9 10.3 3.2 2.6 6.8 1.7 49.5 1.5 0.0 2.6 0.0 3.3 0.2 26.3 45.0 7.6 18.7 1.2 22.7 55.0 29.1 46.4 3.1 4.5 0.3 0.0 0.0 2.1 3.1 1.5 8.3 0.0 0.8 3.8 46.1 7.9 0.6 0.8 4.6 0.3 0.0 8.5 0.0 0.7 12.3 0.6 0.2 0.7 23.0 34.7 0.0 1.0 1.4 0.1 0.3 179.8 0.0 0.2 1.4 ESX1 "ESX1L, ESXR1" ENSG00000123576 "ESX homeobox 1" Q8N693 X 104250038-104254933 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 25.4" "Cell type enriched" "Detected in some" 37 "Spermatogonia: 71.7" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "TIME: 23.7" HPA051992 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA051992: AB_2681684" "unprognostic (1.87e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 71.7 0.0 0.0 0.0 0.0 0.0 ESYT3 "CHR3SYT, FAM62C" ENSG00000158220 "Extended synaptotagmin 3" A0FGR9 3 138434586-138481686 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;skin 1: 13.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.7;Alveolar cells type 2: 30.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.3;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0;SuSa: 3.7" "Region enhanced" "Detected in many" "hypothalamus: 8.5" "Low region specificity" "Detected in all" HPA039200 Approved NA NA "HPA039200: AB_10805356" "unprognostic (4.48e-2)" "unprognostic (3.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-4)" "unprognostic (2.23e-1)" "unprognostic (8.22e-2)" "unprognostic (3.55e-3)" "prognostic favorable (8.30e-4)" "unprognostic (3.38e-1)" "unprognostic (5.57e-2)" "unprognostic (6.19e-3)" "unprognostic (4.88e-3)" "unprognostic (3.16e-5)" "unprognostic (3.46e-1)" "unprognostic (1.12e-1)" "unprognostic (2.13e-1)" "unprognostic (6.43e-2)" 0.6 0.8 5.7 0.6 5.8 0.5 2.6 28.5 5.9 1.3 4.9 0.6 0.2 0.7 5.3 0.8 0.9 1.0 2.8 1.1 5.3 3.0 1.8 0.5 12.4 0.5 1.9 4.0 0.9 2.0 3.5 3.0 1.5 4.2 1.0 1.1 0.7 0.8 0.7 0.8 13.7 0.7 4.8 1.2 0.5 2.7 1.4 1.2 0.0 11.5 1.8 1.6 2.5 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.2 0.4 0.0 2.0 1.8 0.2 0.6 3.0 0.2 0.0 0.5 0.1 0.2 1.0 1.1 0.3 0.1 0.3 0.1 1.3 0.1 0.1 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.2 0.7 7.5 0.0 0.5 0.0 0.1 0.0 0.8 0.2 8.1 0.0 3.3 0.4 4.0 3.7 0.8 0.3 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.7 5.8 28.5 5.9 5.3 3.0 1.9 4.0 4.2 1.2 35.7 30.7 0.0 0.7 0.7 1.8 2.0 2.5 1.4 7.9 1.8 3.9 0.8 0.0 0.6 0.2 0.0 0.0 0.0 0.8 0.4 1.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.0 0.2 2.3 0.0 0.5 2.1 0.5 1.4 0.6 0.0 0.1 0.0 ETDA ENSG00000238210 "Embryonic testis differentiation homolog A" X 135252061-135253583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;Daudi: 1.2;hTERT-RPE1: 3.0;PC-3: 1.2" NA NA "unprognostic (5.34e-1)" 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETDB LINC00633 ENSG00000224107 "Embryonic testis differentiation homolog B" X 135118955-135120526 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 29 "testis: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SH-SY5Y: 1.4" NA NA 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETDC ENSG00000283644 "Embryonic testis differentiation homolog C" X 135309480-135309659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.2;seminal vesicle: 2.9;skin 1: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "HeLa: 3.4;JURKAT: 3.1;SK-MEL-30: 3.4;U-937: 1.6" NA NA 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 3.9 0.0 0.0 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ETFB ENSG00000105379 "Electron transfer flavoprotein beta subunit" P38117 19 51345169-51366418 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.6;liver: 106.6" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 1022.8;Proximal tubular cells: 1001.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 183.6;OE19: 84.6" "Low region specificity" "Detected in all" "HPA018910, HPA018921, HPA018923" Supported Enhanced Mitochondria NA NA 640000 Mitochondria "HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282" "unprognostic (1.44e-1)" "prognostic favorable (6.45e-4)" "unprognostic (8.66e-2)" "unprognostic (3.08e-1)" "unprognostic (1.77e-1)" "unprognostic (3.94e-2)" "unprognostic (3.20e-1)" "unprognostic (6.93e-3)" "unprognostic (2.63e-2)" "unprognostic (7.79e-2)" "unprognostic (1.23e-1)" "unprognostic (4.75e-1)" "prognostic favorable (6.45e-5)" "unprognostic (2.19e-1)" "unprognostic (2.54e-1)" "unprognostic (4.83e-1)" "unprognostic (1.99e-1)" 35.8 28.7 26.1 12.0 30.7 14.3 16.7 9.4 19.5 9.1 27.2 17.7 11.3 33.2 9.8 10.1 24.2 13.2 31.5 108.6 22.2 19.2 32.1 106.6 10.2 12.3 27.9 17.1 11.1 23.0 12.8 11.7 10.5 18.1 12.9 10.1 18.4 46.7 10.2 72.9 13.6 30.6 16.6 22.2 10.6 19.1 7.7 15.9 17.7 14.2 47.7 14.6 11.4 9.9 66.0 62.5 27.0 49.3 46.2 50.7 31.9 13.0 33.8 4.7 12.9 15.0 17.6 7.5 8.9 6.9 7.2 7.2 28.4 21.5 13.1 9.1 14.3 3.8 11.6 9.3 19.0 2.2 19.5 36.2 10.3 20.7 183.6 16.5 9.8 7.7 27.3 5.7 9.8 10.1 9.1 6.1 12.9 15.4 14.7 9.3 26.5 10.2 9.3 3.0 84.6 41.9 11.4 12.6 24.5 9.9 15.0 10.5 5.1 19.7 5.6 10.1 3.5 14.7 9.5 8.6 7.6 7.9 8.1 8.1 22.6 13.7 11.6 38.5 14.6 19.4 26.7 46.9 27.0 26.4 49.3 34.4 63.9 39.6 33.7 53.5 66.0 42.2 35.0 23.6 46.2 36.6 62.5 50.7 31.9 26.1 30.7 9.4 19.5 22.2 19.2 27.9 17.1 18.1 15.9 74.5 84.5 90.8 84.9 57.8 71.3 216.3 254.8 84.3 67.1 115.1 29.5 201.1 484.1 142.6 109.5 67.1 494.9 140.2 122.3 163.1 89.1 73.5 87.6 1022.8 188.0 41.3 161.8 136.9 151.1 228.9 99.5 69.4 271.7 69.5 259.6 93.2 146.4 263.1 107.5 1001.5 53.3 97.0 80.2 54.2 48.9 55.7 133.9 91.6 302.4 92.8 ETFDH ETFQO ENSG00000171503 "Electron transfer flavoprotein dehydrogenase" Q16134 4 158672125-158709623 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 72.8" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 138.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041978 Enhanced NA NA "HPA041978: AB_10795605" "unprognostic (7.19e-2)" "unprognostic (2.28e-1)" "unprognostic (2.90e-2)" "unprognostic (5.92e-3)" "unprognostic (1.91e-1)" "unprognostic (8.45e-2)" "unprognostic (1.23e-3)" "unprognostic (7.17e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-2)" "prognostic favorable (5.76e-10)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.85e-3)" "unprognostic (1.74e-1)" 11.3 20.1 7.0 3.9 8.6 2.8 12.9 10.3 8.2 5.1 12.5 6.5 6.1 23.0 5.7 6.4 10.9 4.3 5.2 47.8 7.2 5.0 17.3 72.8 4.3 2.9 8.0 5.3 5.0 8.9 11.4 8.8 9.0 8.5 5.2 10.5 7.4 7.2 5.6 33.7 7.7 20.4 8.5 4.8 4.8 9.2 4.1 8.4 4.9 6.0 17.5 5.4 5.8 6.1 5.8 11.0 24.5 13.5 6.2 9.2 5.4 5.7 3.6 6.0 10.8 25.9 15.5 2.9 10.1 10.2 7.5 7.3 2.0 12.7 14.0 2.2 12.2 7.8 6.7 11.5 10.1 10.6 22.2 8.4 12.8 8.2 3.4 11.3 11.0 12.3 14.3 12.7 8.1 6.9 11.5 14.6 9.5 7.1 26.5 12.0 5.9 10.7 5.5 2.3 16.9 8.8 8.6 2.0 9.8 11.2 5.0 9.1 3.5 10.1 20.2 9.6 5.7 13.7 8.5 6.5 6.1 3.1 8.9 5.2 14.9 18.5 9.5 12.6 9.3 6.5 2.5 13.5 24.5 6.7 13.3 8.1 5.8 6.3 6.8 11.0 5.4 7.8 6.6 4.6 6.2 11.7 8.4 9.2 5.4 7.0 8.6 10.3 8.2 7.2 5.0 8.0 5.3 8.5 8.4 11.9 9.3 20.1 42.9 29.3 26.0 138.5 12.7 10.7 12.5 17.4 60.9 18.8 24.9 11.1 2.6 18.0 45.5 46.7 10.2 7.3 20.8 16.4 4.7 70.6 11.7 23.8 17.2 12.3 7.8 3.6 21.3 13.7 8.5 7.2 18.2 11.7 10.7 23.7 22.3 23.7 43.8 32.3 23.1 37.2 33.4 32.2 35.9 18.3 21.5 33.8 ETHE1 "HSCO, YF13H12" ENSG00000105755 "ETHE1, persulfide dioxygenase" O95571 19 43506719-43527244 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.7" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 485.2;Paneth cells: 571.2;Undifferentiated cells: 334.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 49.1;OE19: 77.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028360, HPA029028, HPA029029" Enhanced Enhanced Mitochondria No No 13000 Mitochondria "HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998" "unprognostic (8.04e-2)" "unprognostic (3.33e-1)" "unprognostic (1.50e-2)" "unprognostic (2.45e-1)" "unprognostic (8.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.58e-4)" "unprognostic (7.75e-2)" "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.72e-3)" "unprognostic (2.73e-2)" 7.7 10.5 5.2 28.3 6.3 13.1 8.8 4.5 6.7 10.9 80.7 4.6 9.6 27.4 7.1 12.2 28.2 7.1 18.4 8.9 4.4 4.1 19.0 21.3 11.4 15.5 5.6 4.9 7.4 12.7 3.0 7.2 16.7 5.1 12.0 72.1 5.6 18.5 6.7 9.4 9.1 40.3 11.8 4.5 11.0 13.2 3.3 4.7 12.0 26.2 23.3 24.4 10.9 13.3 7.9 35.8 7.4 24.3 9.9 20.2 15.1 11.5 15.3 3.1 10.9 17.1 11.6 1.2 18.0 49.1 15.5 15.9 4.5 11.8 0.0 13.5 17.2 4.9 9.4 4.5 27.1 4.1 5.8 1.4 2.9 6.6 12.7 7.7 4.3 4.1 11.9 21.3 6.0 16.8 20.5 11.5 11.2 1.9 19.5 7.6 7.8 5.0 4.0 0.8 77.6 7.4 5.7 1.3 2.5 33.7 24.1 0.0 3.9 4.6 16.5 10.8 5.3 5.0 7.2 9.6 2.5 10.7 3.0 3.3 5.5 4.3 0.3 10.9 17.9 12.9 7.4 24.3 0.6 17.2 12.7 20.0 7.9 20.2 16.3 35.8 3.4 15.6 14.8 0.7 9.9 8.5 7.1 19.4 15.1 5.2 6.3 4.5 6.7 4.4 4.1 5.6 4.9 5.1 4.7 20.8 18.9 42.5 70.4 30.7 9.5 8.3 53.5 14.7 17.0 52.4 0.0 162.0 46.4 62.5 0.4 49.6 485.2 0.0 56.4 70.8 54.7 70.7 36.9 78.8 100.9 4.8 61.2 36.8 100.2 1.6 16.4 79.3 75.9 58.7 224.1 9.4 73.6 571.2 15.2 90.3 4.6 19.4 61.2 1.8 5.5 20.3 77.3 53.3 334.8 123.3 ETNK2 "EKI2, FLJ10761" ENSG00000143845 "Ethanolamine kinase 2" Q9NVF9 1 204131062-204152003 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 65.9;liver: 80.5;testis: 45.0" "Group enriched" "Detected in many" 5 "Early spermatids: 370.3;Late spermatids: 1080.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 4.8;MAIT T-cell: 4.6;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.9;naive CD4 T-cell: 2.9;naive CD8 T-cell: 3.6;NK-cell: 1.5" "Group enriched" "Detected in many" 11 "NK-cells: 1.5;T-cells: 4.8" "Cell line enhanced" "Detected in many" "hTCEpi: 26.4;MCF7: 25.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 8 "basal ganglia: 24.7" HPA057167 Enhanced NA NA "HPA057167: AB_2683358" "unprognostic (1.64e-1)" "unprognostic (4.17e-2)" "unprognostic (2.56e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-3)" "unprognostic (4.28e-2)" "unprognostic (6.54e-2)" "unprognostic (4.35e-2)" "prognostic favorable (6.50e-4)" "unprognostic (5.50e-3)" "unprognostic (4.69e-2)" "unprognostic (2.00e-2)" "unprognostic (1.20e-1)" 3.3 2.3 4.0 0.8 4.7 0.9 6.3 0.9 4.0 5.1 1.6 1.9 6.5 0.8 3.1 11.0 8.3 4.9 1.9 2.6 2.6 2.5 65.9 80.5 1.2 2.0 2.7 1.9 13.1 4.3 6.2 8.8 2.3 2.7 3.8 0.9 4.8 7.6 7.8 0.6 5.1 0.8 2.4 1.5 2.4 1.1 45.0 1.9 1.1 4.0 3.9 12.9 3.8 6.2 0.2 0.0 0.2 0.2 1.5 4.8 1.0 5.2 1.8 5.3 10.1 2.0 0.6 5.3 5.4 12.0 7.5 3.3 9.0 2.6 0.2 9.1 1.3 8.8 4.7 9.4 7.6 5.2 0.2 8.4 0.1 1.0 13.8 8.0 0.2 0.3 2.7 26.4 1.6 0.3 3.9 5.4 5.7 0.7 0.2 0.9 25.5 1.5 0.1 11.1 0.2 4.0 0.4 6.3 0.2 6.5 2.0 1.4 7.6 3.4 16.1 2.5 17.6 15.6 0.3 0.3 2.1 11.7 0.4 3.9 0.2 0.1 0.2 0.1 0.2 3.0 0.1 0.2 0.0 4.8 0.0 4.6 0.0 1.3 2.9 0.0 0.2 2.9 3.6 0.2 1.5 0.1 0.0 0.7 1.0 4.0 4.7 0.9 4.0 2.6 2.5 2.7 1.9 2.7 1.9 0.0 0.0 0.5 9.8 3.7 1.8 0.9 5.1 2.7 0.0 3.5 3.9 4.8 33.2 8.0 370.3 1.0 0.0 0.0 5.6 7.9 5.7 10.1 9.2 156.9 0.7 0.0 1.2 1.8 5.1 1080.2 27.0 0.6 10.1 0.0 0.0 2.6 4.6 0.0 39.6 120.8 0.8 0.0 3.8 9.3 5.9 2.0 7.9 0.9 0.0 8.3 ETNPPL AGXT2L1 ENSG00000164089 "Ethanolamine-phosphate phospho-lyase" Q8TBG4 4 108742040-108763054 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 53.5;liver: 111.0" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 9.4;Hepatocytes: 22.6;Muller glia cells: 6.4" "Group enriched" "Detected in some" 23 "glioma: 7.9;liver cancer: 21.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 11.0;Hep G2: 4.3;NTERA-2: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044546, HPA072938" Approved Approved Nucleoplasm Yes NA Nucleoplasm "HPA044546: AB_10962867, HPA072938: AB_2686560" "unprognostic (5.20e-3)" "unprognostic (1.33e-1)" "unprognostic (3.93e-1)" "prognostic favorable (9.52e-5)" "unprognostic (5.93e-3)" "unprognostic (3.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.32e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (1.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (9.48e-2)" 1.2 1.9 50.8 1.3 51.3 1.2 1.3 7.9 53.5 1.3 1.2 13.4 0.0 1.3 1.4 1.2 1.3 1.2 1.4 3.2 37.5 20.1 6.2 111.0 1.2 1.2 26.0 28.7 1.3 1.2 1.4 0.1 1.2 15.7 1.2 1.2 0.5 19.9 1.3 1.6 1.2 1.2 1.2 7.3 1.6 10.4 1.5 18.7 0.0 1.9 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.1 11.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 2.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.9 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 51.3 7.9 24.9 37.5 20.1 26.0 28.7 15.7 18.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.6 1.0 1.3 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ETS1 "ETS-1, EWSR2, FLJ10768" ENSG00000134954 "ETS proto-oncogene 1, transcription factor" P14921 11 128458761-128587558 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Immunity, Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 122.5" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 159.3;Ito cells: 228.3;T-cells: 181.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 59.4;JURKAT: 62.5;U-698: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002575, HPA063230" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002575: AB_563721, HPA063230: AB_2684965" "unprognostic (1.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.18e-3)" "unprognostic (6.22e-2)" "unprognostic (3.07e-1)" "unprognostic (2.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.57e-1)" "unprognostic (1.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (2.02e-1)" "unprognostic (3.08e-2)" "unprognostic (1.38e-1)" "unprognostic (5.48e-3)" 33.2 6.3 4.1 45.9 4.7 6.4 24.0 1.6 3.3 13.3 15.0 3.1 4.9 5.3 18.0 9.3 12.6 8.1 13.6 19.1 4.2 3.7 12.4 9.9 36.7 53.9 4.7 2.9 14.1 6.2 6.7 4.1 11.6 4.2 11.7 6.6 12.7 11.7 5.7 12.9 7.5 19.1 7.9 4.3 68.0 8.8 6.0 2.3 122.5 16.7 9.2 51.4 17.5 18.8 6.0 3.0 20.5 0.4 12.5 17.3 4.7 14.5 2.6 12.7 0.0 5.5 8.9 0.0 11.3 24.2 14.2 13.7 0.8 15.8 52.7 11.6 18.6 32.6 5.1 1.2 32.6 30.0 11.1 0.2 59.4 1.1 0.0 14.8 6.1 0.7 17.4 2.6 12.2 44.7 8.1 11.7 62.5 0.1 11.0 17.0 0.0 30.6 4.5 4.7 1.3 9.5 8.4 20.8 4.1 11.2 16.3 0.1 0.8 5.9 0.1 12.5 8.9 0.0 3.0 21.5 32.0 10.0 6.2 18.5 8.2 1.4 79.5 5.7 11.5 28.0 20.5 0.0 3.0 10.4 0.1 14.6 6.0 14.0 12.6 0.1 4.9 17.3 13.5 0.5 12.5 0.4 3.0 15.5 4.7 4.1 4.7 1.6 3.3 4.2 3.7 4.7 2.9 4.2 2.3 23.8 31.1 40.2 29.1 102.1 0.0 6.2 2.5 2.7 35.2 10.4 0.0 0.2 0.0 33.5 2.0 159.3 6.7 0.0 19.5 0.3 45.7 17.2 18.5 3.8 5.6 0.0 14.9 228.3 20.9 0.9 13.0 5.0 65.8 10.0 13.3 0.1 65.1 5.8 14.5 2.9 0.0 103.5 62.6 0.9 1.5 55.3 0.3 181.5 4.0 30.3 ETV1 ER81 ENSG00000006468 "ETS variant 1" P50549 7 13891228-13991425 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 90.0;salivary gland: 45.8" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 2: 112.4;Cardiomyocytes: 72.8;Intestinal endocrine cells: 190.4" "Cancer enhanced" "Detected in all" "glioma: 22.5" "Region enriched" "Detected in all" 8 "cerebellum: 90.0" "Cell type enriched" "Detected in single" 5 "T-reg: 3.1" "Lineage enriched" "Detected in single" 5 "T-cells: 3.1" "Cell line enhanced" "Detected in many" "AN3-CA: 22.2;hTERT-RPE1: 25.6;SCLC-21H: 26.3;U-87 MG: 51.8;WM-115: 25.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 418.9" "HPA068389, HPA077249" Supported Approved Nucleoplasm No No Nucleoplasm "HPA068389: , HPA077249: AB_2686829" "unprognostic (2.45e-1)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-2)" "unprognostic (2.13e-2)" "unprognostic (1.64e-7)" "unprognostic (7.08e-3)" "unprognostic (7.21e-2)" "unprognostic (2.36e-1)" "unprognostic (2.01e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-3)" "unprognostic (2.21e-2)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" 2.5 12.4 8.1 1.1 11.7 0.2 4.4 90.0 35.2 1.4 2.4 3.1 0.1 1.2 2.4 1.3 1.5 1.1 9.2 18.0 7.0 4.5 2.1 2.0 14.9 0.7 4.5 6.9 1.0 1.6 11.4 7.4 1.9 8.3 3.1 2.4 0.9 45.8 7.1 0.9 1.5 1.9 2.0 3.5 4.5 1.7 4.5 2.9 0.3 6.5 0.9 4.7 1.8 1.3 0.0 0.0 0.0 0.6 0.0 3.1 0.2 0.0 1.6 11.6 22.2 4.1 12.2 0.0 1.0 3.9 0.6 2.6 0.0 5.3 0.0 1.2 1.8 3.2 0.1 0.4 1.2 1.4 0.3 0.5 0.6 1.0 0.0 2.4 3.8 1.5 3.6 0.0 7.6 0.6 25.6 5.0 0.3 3.4 0.1 4.7 0.0 0.0 0.0 17.5 0.6 11.8 0.0 7.1 0.9 7.9 0.1 26.3 5.1 0.0 0.4 6.3 4.2 0.4 0.1 2.7 2.3 0.7 4.5 4.3 4.0 1.2 0.0 51.8 0.2 25.6 0.0 0.2 0.0 0.1 0.6 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 8.1 11.7 90.0 10.9 7.0 4.5 4.5 6.9 8.3 2.9 17.9 112.4 0.0 2.5 0.9 4.2 72.8 38.2 1.4 1.2 3.5 0.0 0.4 5.0 2.7 18.7 5.2 0.0 0.0 0.8 0.3 4.2 0.2 2.3 11.0 2.6 4.8 190.4 1.8 6.0 6.6 1.4 0.8 11.8 0.0 0.7 12.2 0.9 0.0 32.5 2.7 0.4 19.4 8.2 0.5 1.0 1.1 0.2 0.7 1.1 0.3 ETV2 ER71 ENSG00000105672 "ETS variant 2" O00321 19 35641745-35644871 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.2;testis: 40.3" "Group enriched" "Detected in many" 13 "Early spermatids: 128.4;Late spermatids: 360.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 19.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 19.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.14e-1)" "unprognostic (3.24e-2)" "unprognostic (1.73e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "unprognostic (2.53e-3)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (2.83e-1)" "unprognostic (2.69e-3)" "unprognostic (8.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-4)" "unprognostic (2.48e-1)" "unprognostic (1.41e-1)" "unprognostic (2.74e-1)" 1.8 2.2 0.9 1.5 1.2 0.9 1.4 1.5 0.9 2.3 3.0 0.5 3.9 4.4 2.0 2.1 3.5 1.1 2.2 0.8 0.8 0.9 3.0 3.5 1.2 1.0 0.8 1.0 2.2 6.6 0.8 1.5 0.7 1.0 3.1 0.8 1.8 5.0 8.1 0.6 3.5 4.3 1.2 1.3 1.4 1.6 40.3 0.9 2.3 2.2 1.7 2.4 1.6 2.4 2.0 19.2 0.8 2.8 0.7 3.3 1.5 2.3 3.2 2.1 2.6 2.5 4.9 0.5 0.9 1.4 2.5 3.9 1.1 1.3 0.3 3.5 1.7 0.5 0.8 0.2 1.8 0.3 3.7 4.0 4.4 1.8 2.2 4.3 1.2 5.8 4.3 3.5 1.2 1.9 1.4 0.8 1.3 1.3 1.8 1.3 2.9 2.0 1.2 0.3 3.8 1.0 2.8 5.3 3.4 3.6 2.2 2.7 1.9 3.3 0.6 5.0 0.5 2.1 5.0 0.7 7.3 3.7 3.9 2.8 2.0 3.8 0.7 3.5 1.4 7.0 0.0 1.8 0.8 2.6 2.6 3.0 2.0 3.3 3.3 2.1 1.1 1.8 2.4 0.6 0.7 2.8 19.2 2.5 1.5 0.9 1.2 1.5 0.9 0.8 0.9 0.8 1.0 1.0 0.9 0.0 0.6 3.0 2.6 5.0 3.7 1.2 5.1 1.4 0.0 5.2 0.0 1.6 6.6 1.9 128.4 2.9 12.9 0.0 4.6 2.5 3.8 3.3 1.1 19.0 2.0 0.0 7.5 3.1 0.0 360.8 8.3 2.7 1.7 0.0 6.0 2.4 2.2 3.5 2.5 14.0 2.7 0.0 1.8 4.3 2.6 11.3 1.6 2.2 7.8 3.7 ETV3L FLJ16478 ENSG00000253831 "ETS variant 3 like" Q6ZN32 1 157092044-157099808 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.8;breast: 4.4;lymphoid tissue: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.8;pons and medulla: 7.8" "Group enriched" "Detected in some" 13 "classical monocyte: 1.5;intermediate monocyte: 1.0" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Cell line enriched" "Detected in some" 17 "HDLM-2: 27.7" "Not detected" "Not detected" NA NA "unprognostic (7.39e-4)" "unprognostic (1.53e-1)" "unprognostic (3.22e-2)" "unprognostic (1.79e-5)" "unprognostic (2.25e-1)" "unprognostic (5.91e-2)" "unprognostic (1.57e-2)" "unprognostic (3.09e-4)" "unprognostic (1.88e-1)" "unprognostic (5.37e-2)" "unprognostic (3.37e-1)" 0.1 0.0 0.9 2.0 3.8 0.1 4.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.3 0.3 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.0 1.8 0.1 7.8 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.1 0.0 5.0 0.1 0.1 0.1 0.0 5.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.8 0.0 0.7 0.5 0.3 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ETV4 "E1A-F, E1AF, PEA3" ENSG00000175832 "ETS variant 4" P43268 17 43527844-43579620 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.4" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 10.2;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.2;Intestinal endocrine cells: 14.3;Syncytiotrophoblasts: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 45.2;Hep G2: 42.4;SK-MEL-30: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005768 Approved Supported "Nucleoli rim,Mitotic chromosome" Yes No "Nucleoli rim" "Mitotic chromosome" "HPA005768: AB_1848294" "unprognostic (2.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.14e-1)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.58e-2)" "unprognostic (5.34e-2)" "unprognostic (8.13e-2)" "unprognostic (7.05e-2)" "unprognostic (3.01e-1)" "unprognostic (7.79e-2)" "unprognostic (2.03e-1)" "unprognostic (7.08e-2)" "prognostic favorable (7.60e-4)" "unprognostic (1.69e-1)" 0.6 2.4 1.4 0.9 1.4 0.0 6.8 1.6 8.3 3.6 3.3 0.4 1.3 5.7 3.4 2.2 9.9 2.4 38.4 2.6 1.8 1.3 7.8 1.4 2.5 0.4 2.3 1.1 1.2 23.8 19.3 19.7 11.6 2.7 4.7 1.6 1.7 4.9 4.5 1.3 6.7 3.8 1.2 1.8 0.5 3.6 1.3 0.5 0.3 6.6 15.0 12.1 3.1 5.3 0.2 0.0 1.3 0.2 0.0 0.6 0.1 5.9 16.8 20.6 45.2 0.8 5.3 4.6 1.9 5.3 3.8 3.9 9.4 8.6 0.0 1.1 1.0 9.4 10.9 0.7 10.1 3.4 0.2 0.1 0.5 2.7 42.4 1.1 11.4 5.4 0.9 0.3 14.6 9.1 4.3 8.1 0.0 11.8 0.0 7.8 2.4 0.0 20.3 29.8 30.4 28.2 24.5 2.5 14.4 8.5 4.3 0.0 18.4 0.5 1.1 48.9 11.8 0.2 3.4 3.7 2.7 13.5 4.0 5.4 1.8 11.3 0.0 4.9 2.2 15.9 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.6 1.3 0.0 0.0 0.0 0.0 0.1 1.4 1.4 1.6 3.6 1.8 1.3 2.3 1.1 2.7 0.5 0.0 0.0 0.0 2.1 1.6 1.1 0.6 10.2 1.4 3.4 0.0 0.0 2.2 14.9 6.8 2.8 0.6 0.9 0.0 0.9 11.2 1.7 0.4 0.0 0.0 0.7 0.0 14.3 0.6 0.0 3.9 0.3 0.0 3.3 0.0 0.8 7.7 2.7 2.3 0.4 0.0 0.3 0.0 0.8 0.0 0.0 1.0 12.5 0.0 2.5 3.1 ETV5 ERM ENSG00000244405 "ETS variant 5" P41161 3 186046308-186110318 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 55.3" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 62.8;Syncytiotrophoblasts: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009590, HPA063065, HPA073889" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: " "unprognostic (3.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.54e-2)" "unprognostic (3.30e-1)" "unprognostic (9.00e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (7.85e-9)" "unprognostic (3.52e-3)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (4.18e-2)" "unprognostic (1.48e-1)" "unprognostic (1.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.57e-1)" "unprognostic (3.58e-2)" "unprognostic (3.84e-3)" 5.8 30.3 13.2 5.5 21.7 1.6 11.3 12.1 35.2 4.7 3.0 15.7 1.3 5.1 6.8 6.2 3.8 4.6 4.8 8.8 13.6 9.4 7.1 6.2 21.9 8.9 9.9 11.0 2.5 25.4 55.3 28.1 24.3 11.5 6.3 3.1 7.4 5.5 5.1 9.8 5.3 2.8 6.1 9.6 10.0 11.9 7.2 6.1 2.0 16.6 1.7 3.6 3.6 3.6 0.6 1.8 0.9 3.1 0.1 0.3 0.5 13.0 9.0 11.6 25.3 7.2 7.4 0.8 11.2 12.6 8.9 9.6 9.9 8.0 0.3 15.1 10.8 13.4 2.2 0.2 8.5 13.2 2.8 0.3 3.8 0.3 11.1 11.9 9.5 7.1 6.5 1.4 14.2 17.4 10.6 13.0 1.3 3.5 4.7 15.1 6.0 1.2 14.5 17.3 3.7 10.2 26.7 11.6 8.7 7.3 3.1 0.5 14.9 2.7 0.1 56.7 4.8 0.0 5.3 12.6 4.9 8.0 12.3 21.9 3.6 14.7 0.1 14.9 7.6 29.1 0.0 0.3 0.1 0.3 3.1 0.0 0.6 0.0 0.0 1.8 0.1 0.0 0.0 0.9 0.1 1.5 1.6 0.0 0.5 13.2 21.7 12.1 31.7 13.6 9.4 9.9 11.0 11.5 6.1 3.0 55.6 4.2 10.8 14.0 15.6 4.7 20.4 1.4 2.3 0.0 11.8 53.9 3.3 8.2 19.2 8.3 1.0 0.0 8.0 16.2 11.4 2.6 8.1 8.5 45.7 4.8 10.3 14.7 47.8 37.8 8.3 13.5 15.1 2.8 0.3 62.8 9.4 0.0 14.5 11.8 15.8 0.0 15.7 17.4 9.3 4.5 74.3 0.9 0.4 1.6 ETV7 "TEL-2, TEL2" ENSG00000010030 "ETS variant 7" Q9Y603 6 36354091-36387800 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.9;Cytotrophoblasts: 25.0;Exocrine glandular cells: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 15.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.1;BJ hTERT+ SV40 Large T+: 8.4;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;HDLM-2: 33.3" "Low region specificity" "Detected in all" HPA029033 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA029033: AB_10601375" "unprognostic (1.67e-2)" "prognostic favorable (5.16e-4)" "unprognostic (9.48e-2)" "unprognostic (1.57e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-3)" "unprognostic (9.08e-2)" "unprognostic (4.11e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.32e-4)" "unprognostic (6.81e-3)" "unprognostic (1.11e-1)" "unprognostic (1.69e-3)" "unprognostic (5.54e-2)" "unprognostic (4.93e-1)" "unprognostic (1.27e-2)" "prognostic favorable (2.95e-6)" 2.3 2.5 1.7 7.9 1.7 0.9 1.8 0.9 1.5 2.3 15.1 0.9 2.1 14.4 2.0 2.1 4.7 1.9 7.5 0.9 0.9 1.0 3.0 3.6 7.5 4.2 1.1 1.7 3.7 2.4 3.1 9.9 7.2 3.0 5.3 2.2 3.0 8.1 1.5 0.8 15.1 22.2 4.5 1.5 3.3 5.5 1.1 1.3 3.7 5.3 5.5 8.0 4.3 9.8 2.8 0.7 15.4 4.4 0.4 12.0 1.8 2.1 0.3 0.5 1.3 0.0 0.1 16.1 0.2 5.3 8.4 16.0 1.1 4.7 0.7 0.8 0.1 1.4 2.7 0.2 0.9 0.4 33.3 0.6 1.1 0.3 1.2 1.1 0.5 0.6 0.7 1.4 0.4 0.1 0.4 0.2 0.4 0.3 1.0 0.2 0.4 0.7 0.6 1.2 0.7 0.1 3.5 0.3 0.3 0.1 1.3 0.8 0.5 0.8 1.8 0.5 0.8 2.9 1.0 0.7 0.8 0.9 0.4 0.5 0.3 0.5 0.7 0.3 1.9 0.9 0.0 2.9 0.2 1.4 4.4 3.3 2.8 4.5 1.8 0.7 1.1 0.9 1.2 15.4 0.4 1.4 0.0 12.0 1.8 1.7 1.7 0.9 1.5 0.9 1.0 1.1 1.7 3.0 1.3 17.9 17.9 0.0 1.9 1.8 0.2 0.3 0.0 1.4 7.9 0.0 0.0 25.0 0.0 12.2 0.4 0.7 9.3 0.0 20.9 4.3 2.4 3.4 2.3 0.2 2.5 0.0 3.5 0.0 0.8 0.0 1.4 0.5 3.3 10.0 4.6 2.2 12.8 5.8 1.1 0.8 0.6 0.0 8.2 0.9 16.6 3.1 7.1 0.0 4.5 4.3 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.4;pancreas: 32.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.2;U-138 MG: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 0.6 0.3 0.3 0.7 0.5 0.0 1.2 0.3 0.2 3.7 0.6 0.1 11.4 0.5 1.6 5.1 0.5 1.3 0.4 0.6 0.3 0.3 23.6 69.4 15.2 0.1 0.8 0.0 0.8 32.3 0.8 0.8 26.6 0.5 0.6 0.2 5.7 14.3 13.5 0.9 1.5 1.1 0.7 0.4 5.9 0.4 2.2 0.3 3.3 1.2 0.8 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 1.1 0.7 0.3 4.6 0.5 0.1 1.0 7.1 0.5 21.7 14.6 19.4 9.9 0.1 0.4 0.0 2.0 27.2 17.8 3.0 0.5 4.6 12.2 0.0 0.3 0.0 0.8 14.4 0.7 0.0 0.0 5.0 2.7 23.9 11.0 19.5 12.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.0 0.0 7.5 2.4 0.0 0.0 10.7 0.1 0.3 0.5 2.0 0.1 16.6 0.7 0.0 0.1 9.8 36.5 15.3 0.6 22.6 0.2 0.0 0.0 20.7 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.3 0.2 0.3 0.3 0.8 0.0 0.5 0.3 38.7 30.7 2.7 9.2 2.5 0.8 0.2 0.0 1.4 36.4 10.4 0.0 33.7 23.2 27.0 11.0 1.3 0.0 0.0 14.2 17.5 2.1 5.2 0.0 71.0 3.2 0.0 1.7 3.7 0.6 8.2 0.3 0.8 27.0 0.0 0.0 0.0 15.1 0.0 0.7 53.7 0.0 0.0 1.0 1.7 0.4 0.6 104.4 0.0 0.0 10.0 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31317560-31321884 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.7;brain: 74.0" "Group enriched" "Detected in many" 4 "granulocytes: 75.5;Hofbauer cells: 100.8;Kupffer cells: 231.8;Macrophages: 127.6;T-cells: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 20.2;Karpas-707: 33.4;RPMI-8226: 51.6" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA045033: AB_2679191, HPA057051: AB_2683321" "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 6.4 4.7 26.8 25.8 36.0 15.1 4.7 3.8 30.0 5.2 6.2 16.5 0.0 6.3 2.2 1.6 3.5 2.1 10.6 2.6 42.5 21.8 2.2 5.3 12.5 27.4 64.7 13.9 1.6 1.6 1.0 1.6 11.6 33.7 2.4 8.2 0.0 3.0 2.0 1.2 1.5 6.8 4.1 74.0 20.4 6.9 1.2 59.7 32.1 2.0 0.6 22.6 14.2 2.2 8.6 17.9 51.7 26.5 8.9 19.2 23.9 0.0 0.0 0.0 0.0 1.7 10.6 0.0 1.3 2.2 1.7 6.1 0.0 0.5 9.0 0.0 1.7 9.9 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 20.2 10.4 11.4 13.1 0.0 2.4 7.0 2.6 0.6 8.3 0.3 33.4 13.2 0.1 7.4 11.4 0.0 0.0 0.0 7.8 1.3 51.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.4 4.3 7.3 0.2 0.3 4.8 15.0 0.0 10.1 5.9 7.6 6.0 1.3 26.5 1.0 11.3 12.7 13.7 8.6 16.1 13.1 17.9 4.2 19.2 16.8 51.7 8.9 9.6 5.9 17.1 23.9 26.8 36.0 3.8 24.0 42.5 21.8 64.7 13.9 33.7 59.7 0.0 6.4 31.5 0.3 3.5 0.2 0.3 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.0 2.0 1.3 0.0 0.0 0.0 0.5 2.6 0.2 75.5 0.8 100.8 0.0 0.0 7.4 231.8 0.0 0.3 127.6 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.7 0.0 1.6 0.1 0.2 2.8 1.1 130.3 0.0 0.3 EVI2B "CD361, D17S376, EVDB" ENSG00000185862 "Ecotropic viral integration site 2B" P34910 17 31303766-31314112 "CD markers, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 133.6;lymphoid tissue: 72.8" "Cell type enhanced" "Detected in many" 16 "B-cells: 217.4;Kupffer cells: 447.5;Macrophages: 274.7;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 133.6" "Group enriched" "Detected in all" 4 "granulocytes: 133.6;monocytes: 34.3" "Cell line enhanced" "Detected in many" "Daudi: 24.2;HHSteC: 19.9;HL-60: 27.3;HMC-1: 38.5;Karpas-707: 27.3;NB-4: 21.6;RPMI-8226: 39.9;THP-1: 34.4" "Low region specificity" "Detected in all" HPA007436 Enhanced Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA Nucleoplasm "Plasma membrane, Focal adhesion sites" "HPA007436: AB_1848307" "unprognostic (1.07e-2)" "unprognostic (1.20e-2)" "unprognostic (5.97e-2)" "unprognostic (4.09e-3)" "unprognostic (2.99e-2)" "unprognostic (1.41e-2)" "unprognostic (3.06e-1)" "unprognostic (3.36e-2)" "unprognostic (1.93e-2)" "unprognostic (1.48e-1)" "unprognostic (1.78e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.56e-2)" "unprognostic (3.32e-2)" "unprognostic (8.64e-2)" "unprognostic (2.73e-2)" 15.0 3.6 4.4 37.7 5.8 44.0 4.2 1.7 4.4 3.7 10.7 6.5 0.3 6.0 2.8 4.8 7.1 4.7 8.1 6.7 6.4 4.4 7.8 7.1 38.5 37.5 10.2 2.6 3.8 2.7 0.4 2.1 4.8 7.8 5.3 8.1 2.5 6.6 1.5 2.3 2.4 23.3 4.2 22.0 72.8 8.0 3.7 6.7 26.1 4.0 3.0 43.0 13.0 7.6 18.6 14.6 133.6 34.3 4.1 16.4 19.8 0.1 0.1 0.0 0.0 1.9 2.5 0.0 0.2 1.7 2.0 3.7 0.0 0.9 24.2 0.0 1.5 7.5 0.1 0.0 0.3 2.2 0.0 0.0 0.5 0.0 0.0 19.9 27.3 38.5 4.6 0.0 1.1 1.5 0.6 1.9 2.0 0.3 27.3 5.7 0.0 7.9 21.6 0.0 0.0 0.0 13.9 0.1 39.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.4 2.1 0.5 0.0 0.2 1.9 5.3 0.2 5.3 2.5 9.4 0.6 78.9 30.5 74.5 8.2 23.2 7.9 18.6 12.6 10.6 14.6 14.3 9.7 9.1 133.6 4.1 34.3 8.4 16.4 19.8 4.4 5.8 1.7 4.4 6.4 4.4 10.2 2.6 7.8 6.7 0.0 17.9 217.4 0.6 4.7 0.2 0.4 2.5 4.0 11.4 1.8 0.0 0.5 0.0 0.0 5.3 2.7 0.2 0.0 0.0 0.5 2.8 0.3 78.7 1.7 88.8 0.0 0.0 9.8 447.5 4.7 0.0 274.7 35.4 10.8 0.0 0.0 0.7 0.0 0.4 0.7 0.8 19.4 4.1 0.3 0.5 3.1 0.2 178.5 0.0 1.1 EVI5 NB4S ENSG00000067208 "Ecotropic viral integration site 5" O60447 1 92508696-92792404 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027339 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027339: AB_1848308" "unprognostic (1.23e-1)" "unprognostic (2.84e-1)" "unprognostic (4.29e-3)" "unprognostic (1.65e-1)" "unprognostic (4.94e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-3)" "unprognostic (7.43e-2)" "unprognostic (1.12e-1)" "unprognostic (9.11e-2)" "unprognostic (9.04e-3)" "unprognostic (2.25e-1)" "unprognostic (6.15e-2)" "unprognostic (8.30e-2)" "unprognostic (5.40e-1)" "unprognostic (6.38e-2)" "unprognostic (2.35e-2)" 4.5 8.5 27.5 3.4 13.4 1.6 3.6 5.1 35.7 5.4 4.1 2.3 1.7 3.4 5.6 3.9 3.2 4.4 5.0 6.0 12.5 5.5 4.2 14.5 5.9 2.1 5.6 23.1 3.5 4.4 8.8 4.5 10.4 3.7 4.6 4.6 1.7 4.2 5.0 3.1 4.0 3.3 6.1 5.7 3.3 5.3 8.0 2.4 1.7 5.6 1.7 2.4 4.2 3.9 2.3 2.2 6.0 4.8 0.2 0.2 0.7 3.7 4.1 6.5 6.3 10.7 13.5 6.2 8.6 13.1 5.9 6.8 7.2 1.0 1.6 12.2 9.8 11.0 4.3 6.1 6.3 10.6 0.1 2.4 3.0 4.2 4.3 10.5 2.1 3.5 8.4 5.2 10.2 6.2 17.3 12.7 0.1 5.2 2.7 9.8 1.8 0.2 2.5 1.9 2.4 3.4 1.5 15.6 2.1 4.5 10.8 2.4 5.1 10.1 5.3 11.5 7.4 2.6 4.9 8.3 6.6 4.9 8.7 5.6 3.9 2.3 2.7 4.3 3.5 5.4 1.3 4.8 4.4 0.2 3.3 0.1 2.0 0.2 0.0 2.2 2.3 0.1 0.1 6.0 0.2 4.7 1.5 0.1 0.7 27.5 13.4 5.1 35.7 12.5 5.5 5.6 23.1 3.7 2.4 56.6 25.1 12.7 21.7 38.6 23.4 46.0 22.9 36.1 35.2 15.7 23.6 42.6 14.9 25.8 2.6 27.4 18.8 23.3 25.8 20.4 35.1 27.0 12.7 46.1 26.8 28.6 21.2 46.1 51.1 3.1 26.2 36.2 25.3 13.6 24.7 27.6 47.1 17.3 50.9 15.5 24.8 12.9 30.0 35.6 42.8 43.7 54.8 3.2 18.7 31.6 EVL RNB6 ENSG00000196405 Enah/Vasp-like Q9UI08 14 99971449-100144236 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 98.2" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 421.2;T-cells: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 71.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018849, HPA019536, CAB033987" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180" "unprognostic (1.12e-3)" "unprognostic (5.03e-3)" "unprognostic (6.46e-3)" "unprognostic (2.70e-1)" "unprognostic (2.65e-1)" "unprognostic (2.27e-3)" "unprognostic (3.65e-2)" "unprognostic (2.35e-1)" "unprognostic (2.06e-1)" "unprognostic (6.35e-3)" "prognostic favorable (4.07e-6)" "unprognostic (3.50e-3)" "prognostic unfavorable (4.14e-6)" "unprognostic (7.97e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-3)" "unprognostic (2.43e-1)" 14.5 15.0 50.9 37.0 57.8 19.9 28.5 57.4 66.2 11.8 12.4 20.7 10.7 12.7 23.6 25.1 11.2 18.0 20.1 19.7 42.4 43.3 12.4 24.4 28.4 63.5 34.8 31.4 23.3 17.1 9.8 28.6 13.5 26.2 16.4 12.0 24.2 20.0 16.5 12.8 15.6 18.7 29.4 23.1 44.2 15.2 13.2 20.3 98.2 11.0 7.5 55.8 18.3 9.3 7.8 2.5 14.2 8.7 9.3 20.6 5.4 4.1 3.6 27.6 8.3 5.6 16.0 16.0 5.4 6.9 3.5 4.9 0.2 2.8 7.8 7.2 4.9 3.0 0.1 13.0 9.4 4.4 8.4 8.2 12.8 2.9 2.2 4.6 3.8 30.4 8.5 4.8 2.4 9.4 7.8 9.6 29.8 6.4 0.5 3.9 5.6 71.4 20.5 5.8 3.6 5.4 17.2 14.3 1.3 4.5 0.1 33.5 19.7 3.8 5.9 1.6 6.8 4.6 11.3 5.9 2.9 4.6 18.0 3.0 14.6 11.0 21.9 3.9 6.5 4.7 1.5 1.5 14.2 11.6 7.6 8.9 6.2 13.6 11.0 2.5 7.8 16.5 14.6 0.3 9.3 8.7 0.4 20.6 5.4 50.9 57.8 57.4 66.2 42.4 43.3 34.8 31.4 26.2 20.3 26.8 48.9 156.1 17.2 18.4 110.7 4.1 20.4 32.1 12.5 12.2 379.0 17.5 26.6 12.5 2.9 40.5 1.7 0.0 11.9 10.1 19.8 14.8 16.2 95.1 134.9 73.1 8.1 33.2 56.1 8.6 23.0 74.9 25.3 0.0 0.9 52.0 14.3 1.1 46.7 11.5 421.2 6.5 20.8 13.4 26.7 27.5 12.2 371.9 1.5 13.9 EVPL EVPK ENSG00000167880 Envoplakin Q92817 17 76004502-76027452 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 21.6;Intestinal endocrine cells: 19.7;Suprabasal keratinocytes: 22.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 24.7;MCF7: 16.1;RT4: 35.7;SK-BR-3: 17.8;T-47d: 22.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002220, HPA053969" Enhanced Supported "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "CAB002220: AB_563701, HPA053969: AB_2682326" "unprognostic (2.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (4.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-2)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-1)" "unprognostic (7.40e-3)" "unprognostic (2.64e-1)" "unprognostic (2.40e-2)" "unprognostic (2.31e-1)" "unprognostic (3.47e-1)" "unprognostic (7.93e-2)" "unprognostic (3.09e-2)" 0.2 0.0 0.0 2.3 0.1 1.1 1.2 0.0 0.3 11.6 5.7 0.1 2.8 4.8 1.9 1.3 69.9 0.9 4.1 0.0 0.0 0.0 4.8 0.0 5.7 0.2 0.0 0.0 0.4 2.4 1.8 1.1 2.3 0.1 3.2 0.7 0.7 10.9 4.5 0.5 43.7 7.8 2.1 0.2 0.1 1.9 0.3 0.1 0.4 6.3 43.1 46.1 5.0 21.6 0.4 1.7 1.9 0.3 1.6 1.4 0.0 11.2 9.5 0.0 0.1 0.1 0.0 4.0 0.1 0.0 0.0 0.0 1.2 6.8 0.0 0.0 0.0 0.0 24.7 0.0 3.1 0.0 0.0 0.0 0.2 7.0 7.1 0.0 0.0 1.8 0.0 5.1 0.1 0.0 0.0 0.0 1.6 0.0 0.5 0.0 16.1 0.4 1.5 0.0 5.1 4.3 4.6 0.0 0.1 7.4 35.7 0.4 0.0 4.7 17.8 0.0 0.0 22.5 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.0 1.0 0.3 0.7 0.6 0.3 0.7 0.2 0.2 0.5 0.1 0.4 1.4 0.6 1.9 1.6 0.2 1.7 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 17.9 21.6 0.0 4.0 10.4 0.0 2.2 5.1 6.7 11.4 5.2 0.0 0.1 1.7 3.7 0.0 0.0 12.7 0.0 0.5 0.1 0.7 3.8 11.6 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.9 0.6 1.7 0.0 3.7 0.0 5.7 6.8 1.8 2.9 0.0 0.0 0.5 0.1 1.1 22.6 0.0 0.0 9.3 10.3 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377662-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.2;lymphoid tissue: 10.4" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.9;Basal glandular cells: 1.7;Club cells: 2.3;Collecting duct cells: 1.8;Spermatogonia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.9;HaCaT: 1.9;HeLa: 3.3;hTCEpi: 11.5;RT4: 4.0;SiHa: 2.1;T-47d: 3.5" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 3.3 0.5 0.0 0.7 0.4 0.8 0.9 22.2 0.4 0.8 0.0 0.0 0.0 0.9 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.7 0.2 0.0 2.1 3.1 0.1 7.8 0.4 1.4 0.0 0.1 1.7 2.5 0.0 0.1 2.2 9.5 10.4 3.5 7.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 2.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.5 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 3.4 1.1 0.0 0.0 0.0 1.0 EVX1 ENSG00000106038 "Even-skipped homeobox 1" P49640 7 27242700-27250493 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9" "Group enriched" "Detected in some" 29 "Early spermatids: 49.8;Late spermatids: 47.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 26 "pons and medulla: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "OE19: 21.4;RT4: 13.3" "Group enriched" "Detected in some" 15 "midbrain: 1.0;pons and medulla: 1.0" "Not detected" "Not detected" HPA055132 Approved Nucleoplasm NA NA Nucleoplasm "HPA055132: AB_2682707" "unprognostic (2.73e-2)" "unprognostic (3.59e-1)" "unprognostic (4.31e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-3)" "unprognostic (2.08e-2)" "unprognostic (8.48e-3)" "unprognostic (5.94e-2)" "unprognostic (1.26e-8)" "unprognostic (2.94e-1)" "unprognostic (1.39e-1)" "unprognostic (9.12e-2)" "unprognostic (1.83e-2)" 0.1 6.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.2 0.6 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 3.0 6.4 0.7 0.1 0.1 6.7 0.1 0.0 0.1 1.9 0.1 0.1 0.0 1.7 0.1 0.1 0.1 0.1 0.1 8.9 5.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.2 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 3.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 47.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 EVX2 ENSG00000174279 "Even-skipped homeobox 2" Q03828 2 176077472-176083913 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 3.4;prostate: 3.8;seminal vesicle: 5.0;testis: 6.1;vagina: 2.9" "Group enriched" "Detected in some" 5 "Early spermatids: 8.2;Intestinal endocrine cells: 2.4;Late spermatids: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;SCLC-21H: 1.5;SH-SY5Y: 1.8" "Group enriched" "Detected in some" 15 "midbrain: 1.6;pons and medulla: 1.2" "Not detected" "Not detected" HPA041576 Uncertain NA NA "HPA041576: AB_10796347" "unprognostic (2.27e-1)" "unprognostic (1.68e-3)" "unprognostic (1.83e-1)" "unprognostic (3.41e-1)" "unprognostic (5.75e-1)" "unprognostic (3.13e-2)" "unprognostic (2.15e-3)" "unprognostic (2.32e-1)" "unprognostic (4.93e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.8 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.3 EXD1 "EXDL1, MGC33637" ENSG00000178997 "Exonuclease 3'-5' domain containing 1" Q8NHP7 15 41182725-41230743 "Predicted intracellular proteins" "Meiosis, RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 30.2" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 8.5;Late spermatids: 5.6;Spermatocytes: 26.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 1.8;HeLa: 2.0;HHSteC: 2.1;MCF7: 2.1;U-266/70: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-1)" "unprognostic (6.33e-3)" "unprognostic (2.51e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-2)" "unprognostic (6.50e-2)" "unprognostic (4.57e-2)" "unprognostic (4.54e-2)" "unprognostic (2.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.92e-1)" "unprognostic (2.11e-6)" "unprognostic (2.15e-1)" "unprognostic (2.29e-1)" "unprognostic (2.72e-1)" "unprognostic (2.71e-2)" 0.4 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 30.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.3 0.0 1.0 1.7 0.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 1.8 0.0 1.5 0.1 0.0 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.1 1.5 0.9 0.0 0.1 0.4 0.0 0.0 0.2 1.0 0.0 2.1 0.0 0.0 0.7 0.7 1.1 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.2 0.1 0.2 0.9 0.4 0.4 0.0 0.0 0.6 0.0 0.0 2.2 0.2 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.0 0.3 0.3 0.1 0.2 0.0 1.0 0.5 0.0 0.6 0.0 0.1 0.2 0.0 0.4 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 26.0 2.5 0.1 0.0 0.0 0.0 0.0 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA053079: AB_2682037, HPA069738: AB_2732140" "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavorable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 2.1 1.0 0.9 10.3 1.0 15.6 1.0 0.3 1.3 1.3 3.1 0.3 0.1 2.9 0.7 0.8 6.2 0.4 1.3 1.5 0.7 0.6 0.9 1.3 1.5 5.6 0.6 0.3 1.3 1.3 1.8 0.4 4.6 0.7 0.7 3.9 0.3 1.4 0.1 1.0 1.7 4.2 1.0 0.6 5.7 1.5 14.8 0.1 31.3 0.6 4.0 8.1 1.6 2.0 1.4 0.6 2.9 0.7 0.9 3.3 1.0 15.1 10.1 16.7 11.0 1.0 2.7 14.1 20.2 6.8 18.1 19.8 12.6 8.6 16.6 9.9 4.7 9.5 15.1 21.1 8.4 21.5 25.6 18.5 15.4 10.8 6.4 0.3 21.9 11.5 0.6 0.4 18.0 4.9 2.2 5.6 16.3 30.8 21.9 14.4 7.0 23.6 12.4 22.8 18.5 10.0 17.1 15.6 17.7 3.7 9.6 18.7 23.7 13.2 10.7 7.1 8.2 9.9 13.6 2.0 17.6 15.5 16.5 27.2 16.1 21.3 26.7 6.1 17.9 20.9 2.9 0.7 0.0 1.1 0.0 0.0 1.4 1.1 1.1 0.6 1.3 0.6 0.2 0.3 0.9 0.0 0.1 3.3 1.0 0.9 1.0 0.3 1.3 0.7 0.6 0.6 0.3 0.7 0.1 0.0 0.0 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 0.0 0.0 0.0 14.1 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 9.8 6.9 0.1 3.3 0.7 0.6 0.1 EXOC1L ENSG00000250821 "Exocyst complex component 1 like" 4 55819819-55837487 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.7;blood: 5.2;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 52 "NK-cell: 5.2" "Lineage enriched" "Detected in single" 52 "NK-cells: 5.2" "Group enriched" "Detected in some" 6 "HEK 293: 5.8;HSkMC: 2.3" "Region enriched" "Detected in single" 4 "pons and medulla: 3.0" "Not detected" "Not detected" NA NA 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 5.8 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184366-67190204 "Predicted intracellular proteins" Exocytosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 11.7;Ito cells: 32.5;Leydig cells: 14.4;Peritubular cells: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.1;SuSa: 3.8;TIME: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 4.5 2.4 0.3 1.8 0.9 0.0 2.4 0.4 1.2 1.4 0.6 0.3 0.3 0.8 3.6 0.8 1.2 0.9 1.5 4.5 1.3 0.2 3.3 1.4 8.7 1.8 0.3 0.8 2.0 1.0 0.4 1.1 6.0 1.0 1.6 0.3 2.4 1.1 0.5 1.8 0.7 1.0 0.8 1.0 26.6 0.7 1.0 0.3 0.3 4.1 1.0 0.5 1.0 0.5 0.0 0.7 1.8 2.0 0.0 0.0 0.3 0.2 0.1 1.2 0.4 0.0 0.1 3.1 0.4 0.0 0.0 0.0 1.4 0.3 0.1 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 5.8 0.6 0.5 0.0 0.1 0.2 0.3 0.1 0.5 0.1 0.6 1.3 1.2 0.2 0.0 0.2 11.1 1.3 1.5 0.3 0.1 3.8 1.0 0.1 4.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.8 0.0 0.3 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.3 0.3 0.9 0.4 1.2 1.3 0.2 0.3 0.8 1.0 0.3 0.0 0.0 0.0 1.6 0.8 1.7 0.8 0.0 0.0 0.0 3.5 0.0 0.4 6.6 0.7 1.6 11.7 4.2 0.0 3.3 2.5 0.2 0.3 0.0 0.8 0.8 3.2 1.2 32.5 1.5 3.1 14.4 0.3 0.0 1.0 3.3 0.2 0.5 1.7 17.3 0.1 0.8 0.0 0.1 0.4 0.9 1.8 0.7 0.0 2.3 1.3 EXOC3L4 C14orf73 ENSG00000205436 "Exocyst complex component 3 like 4" Q17RC7 14 103100144-103110559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 15.3;liver: 26.4" "Cell type enhanced" "Detected in some" 13 "Cholangiocytes: 7.6;Enterocytes: 6.7;Hepatocytes: 19.1;Proximal tubular cells: 10.2" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.9;HEL: 7.1;Hep G2: 5.0;RPMI-8226: 4.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043661 Approved NA NA "HPA043661: AB_10965693" "unprognostic (8.71e-2)" "unprognostic (7.42e-3)" "prognostic unfavorable (1.43e-5)" "unprognostic (8.20e-2)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (9.53e-3)" "unprognostic (6.64e-2)" "unprognostic (1.49e-1)" "unprognostic (6.98e-2)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.22e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.81e-4)" 0.4 0.2 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.4 1.5 15.3 0.1 0.0 0.3 0.2 2.0 0.4 0.0 0.0 2.4 26.4 1.1 4.4 0.0 0.2 0.8 0.0 0.1 0.3 0.8 0.7 0.2 0.0 0.0 0.1 7.4 0.0 0.0 3.5 3.2 0.1 0.1 1.9 0.2 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.0 1.2 0.3 0.3 0.0 0.0 0.3 0.0 0.0 0.0 6.9 0.0 7.1 0.1 5.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.1 0.0 4.8 0.0 0.1 0.2 0.0 0.0 1.7 0.0 0.0 0.3 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 6.7 0.0 3.7 2.6 1.2 0.2 0.0 19.1 0.2 0.0 1.2 0.6 0.6 0.0 1.4 0.0 0.0 0.0 2.8 0.0 0.6 3.5 1.4 10.2 0.0 0.0 0.0 0.1 0.9 0.4 0.2 0.0 4.0 0.5 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 51.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: AB_2674218, HPA063991: AB_2685168" "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 12.1 14.2 17.9 5.7 23.0 1.9 9.5 19.8 23.3 10.2 7.2 18.0 6.0 8.4 11.8 7.5 16.5 8.7 7.8 51.7 18.3 14.4 8.8 4.8 7.9 3.8 18.5 17.0 17.4 6.0 18.6 11.2 34.7 19.8 9.7 7.0 7.3 7.6 10.9 11.2 27.5 10.7 11.6 15.0 6.0 8.0 7.7 20.4 3.1 11.7 7.8 7.3 9.5 12.6 3.0 1.7 3.2 2.0 1.6 3.4 1.2 11.0 8.4 7.8 9.4 22.4 9.3 13.5 8.1 11.5 7.0 4.6 11.4 1.7 2.9 5.1 13.5 10.5 18.5 6.5 13.4 10.2 2.1 5.3 8.5 5.9 6.5 12.1 1.2 2.9 7.9 19.5 7.9 12.4 11.1 11.4 4.5 0.9 0.0 9.2 3.8 3.2 1.5 8.1 7.6 4.7 1.7 14.0 1.1 6.8 26.0 3.9 3.4 13.9 4.3 5.6 9.0 3.0 1.1 12.6 8.2 7.0 6.9 4.9 2.9 2.9 0.0 9.5 0.6 6.5 3.2 1.9 0.2 2.7 1.7 2.1 2.4 2.1 1.7 1.7 3.0 2.4 3.4 0.0 1.6 2.0 0.6 2.6 1.2 17.9 23.0 19.8 22.8 18.3 14.4 18.5 17.0 19.8 20.4 0.0 5.5 0.0 9.0 23.2 16.7 77.2 15.3 8.1 2.3 8.7 23.6 12.0 5.0 7.6 41.6 13.1 12.8 0.0 10.1 10.9 6.2 6.3 8.1 4.9 4.0 15.9 2.9 9.2 9.1 4.0 7.8 4.5 5.0 1.0 4.1 9.1 8.3 8.6 7.1 4.1 9.9 0.0 8.9 8.7 4.8 32.6 20.6 2.5 3.8 7.8 EXPH5 SLAC2-B ENSG00000110723 "Exophilin 5" Q8NEV8 11 108505431-108593738 "Disease related genes, Predicted intracellular proteins" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.9;placenta: 45.1;skin 1: 23.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 137.0;Basal keratinocytes: 95.7;Ciliated cells: 87.0;Club cells: 88.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 14 "cerebellum: 74.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.4;hTERT-HME1: 10.6;RT4: 18.5;SK-BR-3: 9.0" "Group enriched" "Detected in many" 4 "cerebellum: 23.5;cerebral cortex: 6.7" "Region enriched" "Detected in many" 10 "cerebellum: 64.1" NA NA "unprognostic (1.34e-3)" "unprognostic (8.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (3.42e-6)" "unprognostic (2.91e-1)" "prognostic favorable (1.46e-4)" "unprognostic (4.57e-3)" "prognostic favorable (5.12e-4)" "unprognostic (1.26e-1)" "unprognostic (3.03e-1)" "unprognostic (5.56e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.18e-2)" "unprognostic (2.57e-1)" "unprognostic (3.36e-1)" "unprognostic (4.51e-1)" 0.7 0.6 0.8 1.2 2.7 0.1 2.6 74.9 1.1 3.3 3.3 1.4 0.0 0.5 0.9 2.5 9.8 1.5 0.3 0.7 1.1 0.8 3.4 6.7 4.7 0.0 1.6 1.0 0.8 1.4 9.3 2.2 45.1 5.4 1.6 3.8 0.7 6.2 0.1 0.6 23.1 1.1 0.6 2.6 0.6 2.8 1.7 2.4 0.6 1.9 7.1 5.2 1.7 1.9 0.7 0.9 3.0 0.6 3.2 2.2 0.5 3.5 0.4 0.2 0.1 0.0 0.0 3.0 0.2 0.1 0.0 0.6 0.9 5.5 0.0 0.2 0.2 0.8 7.4 5.2 1.9 0.2 0.1 1.6 1.5 0.7 0.0 0.5 0.7 0.1 0.1 3.1 0.0 10.6 0.5 0.0 1.2 2.6 0.0 2.9 0.6 0.9 0.0 0.2 5.8 2.2 0.0 0.1 0.0 0.6 18.5 1.3 0.8 0.9 9.0 0.2 1.1 6.0 0.1 0.1 0.0 2.2 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 2.0 0.6 0.5 0.7 0.3 0.3 0.7 1.1 0.4 0.5 0.7 2.1 2.2 3.0 3.2 0.4 0.9 0.3 0.5 0.8 2.7 74.9 1.1 1.1 0.8 1.6 1.0 5.4 2.4 137.0 48.9 0.0 11.5 95.7 0.5 3.3 5.1 87.0 88.7 19.2 13.7 31.0 3.3 4.4 6.2 2.9 12.0 0.0 4.2 3.9 6.1 19.8 1.1 21.3 3.5 0.0 4.7 1.3 0.6 1.6 0.6 3.3 5.0 1.8 33.3 0.5 3.9 11.5 0.0 3.7 1.6 0.0 1.6 1.1 0.2 63.1 45.7 1.8 19.9 16.0 EXT1 "LGCR, LGS, ttv" ENSG00000182197 "Exostosin glycosyltransferase 1" Q16394 8 117794490-118111853 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation, Hereditary multiple exostoses, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 55.5;fHDF/TERT166: 56.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044394 Uncertain NA Yes 9600000 "HPA044394: AB_10963838" "unprognostic (1.29e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (2.73e-2)" "unprognostic (2.02e-3)" "unprognostic (2.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.70e-1)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (6.58e-2)" "unprognostic (1.27e-2)" "unprognostic (9.84e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (1.85e-1)" 13.8 11.9 5.8 20.5 4.6 2.1 16.5 7.3 7.4 13.3 17.1 4.1 8.7 23.2 11.5 12.5 11.2 8.8 19.3 14.4 4.6 3.1 8.8 66.4 19.9 8.3 3.0 6.8 10.4 17.9 7.1 6.4 15.6 4.8 9.8 16.0 13.2 9.8 13.3 4.2 12.3 32.0 16.8 4.3 20.1 11.5 5.0 2.7 8.7 12.0 10.3 7.2 11.0 18.5 0.8 1.7 1.2 4.5 0.7 2.4 1.0 17.3 5.0 7.6 3.0 13.7 11.1 3.5 32.5 55.5 24.0 22.1 5.2 1.7 0.3 14.6 56.1 17.9 11.0 3.3 19.1 33.8 6.5 5.6 0.7 4.7 4.1 6.4 0.0 1.2 6.9 5.1 29.1 26.8 30.1 14.7 1.6 0.4 4.8 11.1 1.4 0.8 0.0 2.4 9.2 6.5 0.0 2.8 0.5 9.4 6.3 2.4 2.2 5.0 2.3 4.8 20.2 3.2 0.2 19.5 20.2 18.6 18.6 9.5 2.8 2.7 1.6 18.8 0.0 5.4 0.3 4.4 0.2 0.2 4.5 1.3 0.8 0.5 0.6 1.0 0.1 0.5 0.9 1.2 0.7 2.2 1.7 2.4 1.0 5.8 4.6 7.3 7.4 4.6 3.1 3.0 6.8 4.8 2.7 17.9 5.9 1.4 18.7 48.7 21.1 6.2 28.1 5.3 6.8 7.0 13.7 5.2 0.0 34.9 1.3 16.6 42.3 0.0 17.2 3.2 32.1 10.0 6.9 22.6 2.2 9.5 4.6 17.8 28.9 1.6 16.1 5.4 18.6 5.4 20.7 6.0 21.6 14.0 33.9 5.0 24.5 0.0 28.1 0.5 4.3 41.4 10.2 2.2 21.2 17.9 EXTL1 "EXTL, MGC70794" ENSG00000158008 "Exostosin like glycosyltransferase 1" Q92935 1 26019884-26036464 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.1;heart muscle: 6.0;skeletal muscle: 20.5" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 6.2;Cardiomyocytes: 2.9;Horizontal cells: 9.5;Melanocytes: 6.8" "Cancer enriched" "Detected in some" 13 "melanoma: 21.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "WM-115: 58.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA010726, HPA037749" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 68000 Centrosome Vesicles "HPA010726: , HPA037749: AB_10805350" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (8.16e-3)" "unprognostic (1.47e-2)" "unprognostic (2.47e-2)" "unprognostic (6.14e-3)" "unprognostic (3.78e-2)" "unprognostic (1.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (1.44e-2)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-3)" "unprognostic (2.27e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-2)" 0.6 2.1 15.3 0.6 9.5 0.5 2.0 1.1 21.1 1.3 0.6 1.4 0.0 0.7 2.5 0.7 1.5 1.7 1.2 6.0 12.7 3.7 0.7 0.5 0.7 0.8 3.7 7.9 2.3 1.0 0.5 0.5 1.0 2.9 1.2 0.6 2.7 0.8 0.9 20.5 1.6 0.7 2.9 2.7 2.2 0.6 1.0 0.8 0.0 0.9 3.2 0.6 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 15.3 9.5 1.1 21.1 12.7 3.7 3.7 7.9 2.9 0.8 0.0 0.0 0.0 0.0 0.1 6.2 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.4 1.4 0.0 6.8 0.0 0.0 0.6 0.0 0.0 2.5 0.0 1.4 0.0 0.3 0.2 0.2 0.0 0.8 0.0 0.0 0.0 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 45.5;pituitary gland: 30.8" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 7.5;Ciliated cells: 12.0;Club cells: 9.1;Early spermatids: 3.9;Late spermatids: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "NK-cell: 9.8" "Lineage enriched" "Detected in many" 4 "NK-cells: 9.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;RH-30: 13.0;SH-SY5Y: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028917 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA028917: AB_2672826" "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 1.0 1.1 2.8 0.6 16.8 0.5 0.6 0.2 6.8 4.0 0.6 1.9 0.0 0.7 0.6 2.2 1.0 2.5 0.8 4.6 2.8 2.2 0.6 0.5 1.0 0.6 2.9 2.8 0.8 0.6 45.5 30.8 0.6 4.2 12.4 0.7 15.3 1.2 4.6 3.2 0.6 0.7 3.9 0.4 0.7 0.9 1.3 5.1 4.4 0.9 2.9 0.6 3.5 5.7 0.8 1.9 1.8 2.3 9.8 2.3 0.2 0.1 0.0 3.8 16.8 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 2.7 0.0 1.2 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 1.2 0.0 0.9 0.0 13.0 5.5 0.0 0.0 1.3 31.6 0.0 0.0 1.0 3.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.2 1.8 0.3 0.6 0.9 0.9 1.9 0.8 0.7 1.9 0.7 0.8 1.3 1.4 1.6 9.8 2.3 1.9 2.3 0.2 2.8 16.8 0.2 2.8 2.8 2.2 2.9 2.8 4.2 5.1 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.0 12.0 9.1 0.0 0.0 0.6 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 1.0 0.1 0.5 0.0 0.0 0.0 EYA2 EAB1 ENSG00000064655 "EYA transcriptional coactivator and phosphatase 2" O00167 20 46894624-47188844 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 47.4" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 40.0;Club cells: 18.2;Cytotrophoblasts: 21.2;Urothelial cells: 36.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 69.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "memory B-cell: 2.4" "Lineage enriched" "Detected in single" 16 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "HBEC3-KT: 13.7;SCLC-21H: 20.9;SK-BR-3: 9.3;U-266/70: 38.9;U-266/84: 47.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027024, HPA059291" Uncertain Supported Cytosol NA NA Cytosol "HPA027024: AB_1848334, HPA059291: AB_2683967" "unprognostic (1.08e-1)" "unprognostic (5.71e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.30e-5)" "unprognostic (3.32e-2)" "unprognostic (1.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (2.54e-1)" "unprognostic (2.65e-1)" "unprognostic (7.06e-2)" "unprognostic (2.15e-1)" "unprognostic (2.78e-1)" "unprognostic (4.17e-3)" "unprognostic (1.56e-1)" 10.5 2.0 6.5 2.6 7.4 0.8 13.4 2.4 6.5 47.4 6.4 3.8 21.0 1.0 15.7 10.7 25.9 28.2 2.2 4.3 7.0 4.1 5.2 1.8 2.3 1.3 6.3 4.9 5.2 2.4 11.5 4.7 5.9 9.1 18.5 3.2 15.4 28.6 27.3 2.1 4.2 1.1 2.3 7.2 1.1 8.2 4.9 5.1 14.3 21.4 3.6 14.0 5.5 17.3 2.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.7 0.1 13.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 20.9 0.0 0.0 9.3 0.0 1.1 1.8 0.1 0.0 0.0 1.7 0.1 3.1 38.9 47.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.5 7.4 2.4 6.5 7.0 4.1 6.3 4.9 9.1 5.1 0.0 0.0 0.0 40.0 0.6 0.2 0.5 0.0 6.7 18.2 0.0 5.9 21.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.8 4.7 9.2 1.1 2.4 5.8 0.0 1.2 0.6 0.0 0.0 0.0 0.2 3.3 4.6 0.2 0.0 0.7 1.7 0.7 4.4 0.3 0.0 1.4 0.2 0.7 0.3 9.0 0.0 1.5 36.7 EYA4 "CMD1J, DFNA10" ENSG00000112319 "EYA transcriptional coactivator and phosphatase 4" O95677 6 133240598-133532120 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 65.6" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 11.9;Cardiomyocytes: 13.7;Collecting duct cells: 43.6;monocytes: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 12.7;GAMG: 13.2;HeLa: 35.6;RH-30: 12.1;U-87 MG: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA004805, HPA038771, HPA038772" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.27e-1)" "unprognostic (2.04e-9)" "unprognostic (1.64e-1)" "unprognostic (3.08e-2)" "unprognostic (3.44e-2)" "unprognostic (7.21e-2)" "unprognostic (9.07e-2)" "unprognostic (2.04e-2)" "unprognostic (2.80e-1)" "unprognostic (2.29e-1)" "unprognostic (8.27e-4)" "unprognostic (1.82e-3)" "unprognostic (6.67e-2)" "unprognostic (9.55e-2)" "unprognostic (2.51e-2)" 1.6 3.0 1.2 0.2 1.3 0.1 2.4 0.4 1.2 9.7 0.6 2.5 11.1 0.4 2.6 1.9 0.7 8.3 0.7 6.2 1.5 1.2 6.1 0.4 2.0 0.2 2.1 0.8 1.6 0.4 0.2 7.2 0.2 3.5 6.6 0.4 2.7 0.8 13.9 65.6 0.4 0.5 1.9 3.5 0.6 0.7 7.4 1.4 1.8 2.5 5.5 0.7 2.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 1.2 0.0 0.0 0.0 0.0 0.0 10.2 0.2 1.5 0.0 0.0 0.0 10.0 0.0 13.2 0.0 7.7 3.3 0.0 0.0 10.0 1.3 35.6 0.0 0.3 0.0 3.5 2.6 0.0 7.3 2.3 1.7 0.0 0.0 0.0 5.4 4.1 0.0 0.0 0.0 0.0 0.1 0.7 0.1 12.1 0.0 0.0 1.9 1.9 2.0 0.1 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 3.7 1.6 0.0 12.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.4 1.2 1.5 1.2 2.1 0.8 3.5 1.4 11.9 2.6 0.0 0.1 0.1 0.0 13.7 0.0 0.0 3.4 43.6 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.7 0.6 1.3 2.0 0.6 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.6 6.6 0.0 0.0 0.0 0.0 0.1 EYS "bA166P24.2, bA307F22.3, bA74E24.1, C6orf178, C6orf179, C6orf180, dJ1018A4.2, dJ303F19.1, EGFL10, EGFL11, RP25, SPAM" ENSG00000188107 "Eyes shut homolog (Drosophila)" Q5T1H1 6 63719980-65707225 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 40.7" "Cell type enhanced" "Detected in some" 26 "Cone photoreceptor cells: 298.4;Early spermatids: 59.0;Rod photoreceptor cells: 144.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.7;neutrophil: 3.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "Karpas-707: 5.5;SCLC-21H: 3.9" "Secreted in other tissues" NA NA "unprognostic (2.92e-2)" "unprognostic (1.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.47e-2)" "unprognostic (2.16e-3)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (6.38e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (2.04e-1)" "unprognostic (2.18e-1)" "unprognostic (2.61e-4)" "unprognostic (1.89e-1)" "unprognostic (8.41e-2)" "unprognostic (6.38e-3)" "unprognostic (1.11e-1)" 2.8 0.4 0.4 0.6 0.2 1.1 1.1 1.2 0.8 0.2 0.7 0.2 0.2 0.4 0.3 0.2 0.2 0.3 0.4 0.4 0.4 0.2 0.2 1.7 0.3 0.6 0.2 0.5 0.4 0.6 0.0 2.2 0.3 0.5 0.6 2.6 40.7 0.5 0.2 0.6 1.3 0.6 0.2 0.3 0.3 0.3 2.9 0.2 0.6 0.5 0.2 0.2 0.4 0.3 0.3 0.3 3.7 0.8 0.3 0.4 0.9 0.5 0.3 0.7 0.5 0.0 0.6 0.2 0.4 0.3 0.0 0.0 0.4 0.3 0.8 0.5 0.1 0.2 0.2 0.9 0.4 0.0 0.5 0.7 0.5 1.3 1.1 0.1 0.8 0.3 0.3 0.9 0.3 0.1 1.0 0.0 0.4 0.6 5.5 0.5 0.0 0.3 0.3 0.2 1.2 0.6 0.3 0.1 0.4 1.2 0.2 3.9 0.3 0.2 0.1 0.2 0.8 0.0 0.8 0.3 0.5 0.6 0.3 0.5 1.6 0.8 0.4 0.6 1.1 0.2 3.7 0.8 0.2 0.3 0.2 0.2 0.2 0.1 0.1 0.3 0.3 0.3 0.4 3.2 0.3 0.3 0.2 0.1 0.9 0.4 0.2 1.2 0.7 0.4 0.2 0.2 0.5 0.5 0.2 0.0 2.6 0.0 0.5 0.2 7.4 1.5 0.0 0.0 1.2 1.8 298.4 0.6 0.0 0.2 59.0 0.3 0.0 0.0 0.4 0.2 0.2 0.2 2.3 0.0 0.1 9.5 19.4 0.0 0.0 34.1 0.9 0.2 0.0 0.0 0.1 4.0 0.4 0.0 0.7 0.1 144.8 0.0 0.3 1.8 0.7 0.1 0.9 0.0 0.2 0.1 EZH2 "ENX-1, EZH1, KMT6, KMT6A" ENSG00000106462 "Enhancer of zeste 2 polycomb repressive complex 2 subunit" Q15910 7 148807383-148884321 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.5;lymphoid tissue: 44.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 72.2;Spermatocytes: 126.7;Spermatogonia: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009589 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009589: " "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.57e-1)" "unprognostic (3.30e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "prognostic unfavorable (2.11e-6)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.32e-3)" "unprognostic (1.58e-3)" "unprognostic (1.69e-3)" "prognostic unfavorable (8.18e-12)" "prognostic favorable (6.97e-4)" "unprognostic (1.83e-1)" "unprognostic (2.12e-1)" "unprognostic (6.67e-2)" 2.0 1.7 1.8 10.6 1.6 25.5 1.4 4.9 2.7 2.6 4.8 1.1 0.1 3.8 1.7 2.8 11.0 0.9 3.0 0.9 0.8 0.6 1.7 3.3 2.3 12.6 1.3 0.3 2.2 3.8 0.6 1.7 3.4 1.4 1.4 5.1 1.8 3.2 1.6 3.7 6.4 4.8 1.5 1.2 5.8 2.7 19.6 1.3 44.1 0.9 5.5 12.4 2.6 3.5 1.5 4.7 1.3 3.9 8.5 10.3 1.7 17.0 8.0 27.3 18.2 0.8 1.4 14.9 13.3 5.4 11.0 11.1 12.0 19.7 30.2 6.5 5.0 10.0 10.5 14.0 4.6 14.0 43.2 14.0 12.9 9.9 9.3 2.2 28.6 10.6 1.2 2.6 8.2 4.4 3.3 6.4 29.3 27.3 20.1 9.8 19.3 55.6 23.9 21.7 15.0 10.8 34.4 15.3 18.7 5.1 8.2 26.1 16.6 16.7 12.7 4.4 7.3 9.3 12.3 3.9 11.7 5.4 23.3 23.8 18.0 19.6 30.4 10.7 19.6 22.9 0.5 2.2 1.3 1.7 1.5 1.3 1.5 3.4 2.9 4.7 0.8 1.9 1.2 0.2 8.5 3.9 1.0 10.3 1.7 1.8 1.6 4.9 2.7 0.8 0.6 1.3 0.3 1.4 1.3 0.0 7.9 6.7 5.7 23.6 4.8 6.5 2.5 14.7 7.9 7.0 33.4 13.6 3.3 9.1 72.2 7.1 6.7 23.3 7.4 29.5 10.8 4.4 21.8 1.3 10.4 14.3 8.6 4.3 8.9 19.2 2.8 10.9 13.5 19.0 10.2 2.0 10.1 9.3 0.7 1.0 21.1 6.5 9.9 126.7 62.4 25.3 25.5 18.7 18.6 4.0 F10 ENSG00000126218 "Coagulation factor X" P00742 13 113122814-113149529 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 116.7" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 174.9;Leydig cells: 199.9;Peritubular cells: 222.0" "Cancer enriched" "Detected in many" 11 "liver cancer: 95.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 8.5;BJ hTERT+: 6.8;CACO-2: 7.2;fHDF/TERT166: 7.6;Hep G2: 33.5;HHSteC: 7.0;SH-SY5Y: 16.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 16000000000 "unprognostic (4.18e-2)" "unprognostic (1.07e-1)" "unprognostic (7.62e-2)" "unprognostic (9.88e-2)" "unprognostic (9.44e-2)" "unprognostic (1.15e-2)" "unprognostic (4.90e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.24e-1)" "prognostic favorable (1.82e-5)" "unprognostic (6.39e-2)" "prognostic unfavorable (5.14e-5)" "unprognostic (6.60e-2)" "unprognostic (1.21e-1)" "unprognostic (3.87e-2)" "unprognostic (2.23e-3)" 8.1 3.7 0.3 2.9 0.7 0.0 5.4 0.4 0.8 20.3 5.9 0.6 7.6 4.5 12.6 21.4 4.5 9.9 10.0 18.4 0.5 0.5 2.3 116.7 4.9 1.6 0.5 0.7 18.2 3.0 0.0 1.7 3.6 1.0 18.1 0.7 6.9 2.0 6.1 2.6 7.8 7.6 11.7 0.6 1.3 3.2 9.5 0.6 0.6 3.1 5.6 1.8 7.8 10.3 0.0 0.0 0.0 0.0 0.9 1.0 0.3 0.0 0.0 1.5 0.2 4.9 5.0 0.0 8.5 6.8 0.5 0.2 7.2 0.0 0.0 0.3 7.6 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 33.5 7.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.6 16.6 0.0 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.8 0.5 0.5 0.5 0.7 1.0 0.6 0.0 0.0 0.0 0.0 14.0 1.0 4.8 7.6 0.0 0.0 1.8 0.0 0.6 0.0 0.0 2.6 2.1 0.3 0.0 0.0 0.6 66.0 0.1 1.1 174.9 1.2 6.4 17.1 9.8 4.5 5.6 199.9 0.3 18.6 1.0 1.4 3.8 0.5 2.9 222.0 5.6 1.1 51.8 54.2 2.1 1.1 13.4 0.9 2.5 0.9 0.2 F11 FXI ENSG00000088926 "Coagulation factor XI" P03951 4 186265945-186288806 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 88.9" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 2: 19.3;Distal tubular cells: 10.0;Hepatocytes: 59.9" "Cancer enriched" "Detected in some" 13 "liver cancer: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "Hep G2: 14.0" "Not detected" "Not detected" HPA039808 Approved Vesicles "Secreted to blood" NA NA 4400000000 Vesicles "HPA039808: AB_2676693" "unprognostic (1.28e-1)" "unprognostic (3.15e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.88e-1)" "unprognostic (2.08e-1)" "unprognostic (2.11e-1)" "unprognostic (1.85e-3)" "unprognostic (2.91e-2)" "unprognostic (7.65e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 2.7 0.1 0.1 5.5 0.2 0.3 0.1 0.1 4.8 0.1 0.1 0.1 10.2 88.9 2.8 0.1 0.1 0.1 0.1 19.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.1 0.1 0.1 0.1 6.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.0 19.3 0.0 0.0 0.0 0.0 0.3 2.5 0.0 4.5 1.8 0.0 0.0 10.0 0.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 59.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F12 ENSG00000131187 "Coagulation factor XII" P00748 5 177402140-177409576 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "liver: 180.1" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 391.6" "Cancer enriched" "Detected in many" 21 "liver cancer: 171.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 2.5;eosinophil: 6.9" "Group enriched" "Detected in many" 5 "granulocytes: 6.9;monocytes: 2.5" "Cell line enhanced" "Detected in some" "HDLM-2: 8.7;MCF7: 11.1;PC-3: 8.2;SH-SY5Y: 5.6;U-937: 5.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA003825 Approved "Secreted to blood" NA NA 1040000 6600000000 "HPA003825: AB_1078790" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (2.93e-1)" "unprognostic (4.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "prognostic favorable (4.63e-5)" "unprognostic (6.97e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (4.41e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (4.11e-2)" "unprognostic (3.69e-1)" "unprognostic (3.40e-6)" "unprognostic (6.48e-2)" 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.2 180.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.0 6.9 2.5 0.7 0.3 1.0 0.8 2.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.3 1.4 0.0 0.4 0.0 0.3 1.4 0.7 0.4 0.0 8.7 1.9 1.4 0.3 0.9 0.2 0.7 3.1 0.2 1.3 0.1 0.4 0.1 0.2 2.1 0.4 3.3 0.0 11.1 0.1 2.6 0.0 2.6 8.2 0.6 0.2 1.9 1.1 0.0 2.6 5.6 0.3 1.0 0.7 0.0 0.4 0.0 0.0 0.2 1.1 0.0 0.3 0.5 0.0 0.1 0.1 5.8 0.6 0.0 2.5 6.9 0.3 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.0 0.1 0.9 0.7 0.9 1.0 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 8.5 7.4 29.5 0.4 0.8 17.8 0.0 0.0 1.8 3.9 0.0 0.0 6.1 19.4 0.7 34.8 0.0 3.5 0.2 0.9 2.0 0.0 391.6 0.5 0.0 9.9 17.8 13.2 32.7 0.6 1.8 8.5 1.0 5.5 0.2 9.4 20.1 0.0 9.1 0.5 0.0 0.7 13.0 12.8 47.4 0.1 0.7 30.8 5.8 F13A1 F13A ENSG00000124491 "Coagulation factor XIII A chain" P00488 6 6144085-6321013 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 110.1" "Cell type enriched" "Detected in many" 6 "Hofbauer cells: 646.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 27.6;myeloid DC: 33.7" "Group enriched" "Detected in many" 5 "dendritic cells: 33.7;monocytes: 27.6" "Cell line enhanced" "Detected in some" "AF22: 15.7;LHCN-M2: 5.8;RH-30: 29.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA001804, CAB002155" Enhanced "Secreted to blood" NA NA 1400000000 "CAB002155: AB_564077, HPA001804: AB_1078792" "unprognostic (4.44e-1)" "unprognostic (5.90e-2)" "unprognostic (2.65e-2)" "unprognostic (3.93e-2)" "unprognostic (5.02e-2)" "unprognostic (3.75e-2)" "unprognostic (5.27e-2)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (6.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.61e-6)" "unprognostic (2.79e-2)" "unprognostic (1.52e-1)" "unprognostic (1.57e-1)" "unprognostic (2.54e-3)" 56.6 19.4 2.2 11.4 6.5 3.1 57.9 2.2 1.8 13.3 21.8 2.6 2.5 2.2 4.7 35.6 13.4 16.8 12.6 55.4 2.0 2.2 17.5 1.3 14.5 52.7 5.8 1.4 10.2 8.9 5.3 9.3 110.1 7.5 16.4 15.1 11.6 11.5 3.3 18.5 10.4 10.6 20.1 5.0 5.1 11.5 16.7 2.5 2.7 22.4 8.3 6.1 23.7 6.5 0.0 33.7 6.6 27.6 0.0 0.1 63.5 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 29.5 0.5 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 27.6 0.2 0.1 4.9 0.1 0.0 0.0 0.0 33.7 0.0 0.0 0.0 6.6 0.0 0.1 2.4 0.0 63.5 2.2 6.5 2.2 1.8 2.0 2.2 5.8 1.4 7.5 2.5 0.0 3.4 0.8 0.0 16.7 0.0 7.5 10.2 4.0 0.0 0.0 0.0 4.0 0.0 0.0 3.8 4.7 0.0 0.0 0.0 3.4 16.5 0.0 1.1 0.8 646.4 0.0 0.0 4.3 113.2 4.2 4.0 57.6 18.6 1.0 0.0 0.7 0.1 0.0 0.7 3.1 4.1 58.2 9.2 1.4 1.0 13.2 8.5 0.0 0.0 0.0 F13B FXIIIB ENSG00000143278 "Coagulation factor XIII B chain" P05160 1 197039191-197067267 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "liver: 76.3" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 49.0" "Cancer enriched" "Detected in single" 816 "liver cancer: 46.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;Hep G2: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003827, HPA052139" Supported "Secreted to blood" NA NA 3400000000 "HPA003827: AB_1078794, HPA052139: AB_2681744" "unprognostic (1.46e-1)" "prognostic favorable (6.78e-5)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 F2 ENSG00000180210 "Coagulation factor II, thrombin" P00734 11 46719180-46739506 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 593 "liver: 324.8" "Cell type enriched" "Detected in some" 37 "Hepatocytes: 904.6" "Cancer enriched" "Detected in some" 110 "liver cancer: 508.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "Hep G2: 78.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016780, HPA051476, HPA054698" Enhanced "Secreted to blood" NA NA 108000000000 43000000000 "CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578" "unprognostic (1.98e-1)" "unprognostic (2.52e-1)" "unprognostic (2.64e-2)" "unprognostic (1.85e-1)" "unprognostic (2.29e-1)" "unprognostic (2.81e-1)" "unprognostic (2.23e-2)" "unprognostic (3.94e-2)" "unprognostic (5.79e-2)" "unprognostic (8.29e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.75e-12)" "unprognostic (5.65e-3)" "unprognostic (5.80e-2)" "unprognostic (1.54e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 324.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 78.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.6 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 904.6 0.0 0.0 0.0 24.5 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 F2R "CF2R, PAR-1, PAR1, TR" ENSG00000181104 "Coagulation factor II thrombin receptor" P25116 5 76716043-76735781 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.5" "Cell type enriched" "Detected in many" 9 "Ito cells: 323.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 17.6" "Lineage enriched" "Detected in many" 4 "T-cells: 17.6" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 39.1;HUVEC TERT2: 71.3;WM-115: 67.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008973, CAB012962" Approved NA NA "CAB008973: , CAB012962: AB_2533198" "unprognostic (3.03e-1)" "unprognostic (7.76e-2)" "unprognostic (5.55e-2)" "unprognostic (7.76e-2)" "unprognostic (7.14e-2)" "unprognostic (3.46e-1)" "unprognostic (2.51e-1)" "unprognostic (3.75e-2)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" "unprognostic (1.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (2.21e-7)" "unprognostic (2.72e-3)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (6.74e-3)" 12.3 11.2 1.5 7.5 2.2 1.1 8.9 0.8 3.5 11.7 14.0 3.3 20.1 5.9 17.6 8.6 9.3 3.5 20.8 19.2 1.4 1.7 19.5 22.6 24.4 10.4 1.5 1.8 6.2 4.0 1.6 4.7 32.0 2.5 9.6 5.1 9.6 26.4 14.0 7.2 23.7 15.5 8.4 3.5 67.5 4.5 16.6 1.4 4.0 9.1 11.4 13.5 10.7 4.7 0.4 0.2 0.8 0.3 4.2 17.6 6.4 1.0 3.3 10.5 1.7 19.8 34.7 0.5 5.8 20.0 3.8 13.9 0.7 9.1 0.0 9.9 2.5 17.4 2.5 4.5 3.5 7.3 0.8 3.7 22.8 0.7 2.8 29.9 0.1 0.9 19.5 11.9 7.3 2.0 39.1 71.3 4.1 4.2 4.3 7.8 0.4 1.7 0.0 3.3 0.0 18.2 3.2 6.3 0.8 18.1 0.1 1.2 5.7 1.7 0.0 8.5 9.9 0.1 0.2 32.6 24.3 5.4 0.2 10.8 11.7 3.4 0.0 6.4 0.4 67.2 0.5 0.2 0.3 17.6 0.3 4.4 0.4 4.1 12.1 0.0 0.1 0.7 9.1 0.8 4.2 0.1 0.2 0.4 6.4 1.5 2.2 0.8 2.1 1.4 1.7 1.5 1.8 2.5 1.4 0.0 11.6 1.5 0.5 15.2 2.5 2.0 10.2 4.0 3.4 7.0 0.0 0.1 0.0 1.9 8.8 22.6 0.2 0.0 1.9 0.3 28.8 1.2 5.8 2.5 1.6 0.0 6.3 323.5 25.7 3.6 0.9 1.3 11.8 0.0 3.2 0.0 6.7 0.0 9.9 2.2 1.6 0.0 17.5 6.7 4.1 35.0 0.2 30.2 1.0 0.4 F2RL1 "GPR11, PAR2" ENSG00000164251 "F2R like trypsin receptor 1" P55085 5 76818933-76835315 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 7.8" "Cell type enriched" "Detected in many" 4 "neutrophil: 24.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.9" "Cell line enhanced" "Detected in many" "PC-3: 34.7;RPTEC TERT1: 57.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012989, HPA014091" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "CAB012989: AB_2533199, HPA014091: AB_2668939" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (3.88e-4)" "unprognostic (1.98e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (8.92e-4)" "unprognostic (6.13e-2)" "unprognostic (4.07e-1)" "unprognostic (2.16e-3)" "unprognostic (1.52e-2)" "prognostic favorable (5.86e-7)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-2)" "unprognostic (9.73e-2)" 0.6 1.1 1.0 7.2 1.4 0.1 2.9 0.4 0.8 2.4 34.0 1.1 25.3 17.4 1.0 2.2 6.4 2.9 13.6 3.6 1.1 0.9 28.9 7.4 2.8 3.7 0.8 0.4 1.2 16.6 1.3 3.2 2.8 7.8 6.0 21.4 1.1 7.1 23.7 0.3 24.8 64.1 0.7 1.5 3.5 16.8 0.8 0.5 0.6 9.6 5.8 3.1 5.3 3.9 0.3 2.7 24.9 5.7 0.3 2.3 2.0 8.7 14.4 1.2 0.0 0.4 1.1 9.3 0.4 4.8 0.2 0.7 12.4 22.6 0.0 19.5 1.0 22.3 15.0 7.6 6.7 0.4 0.0 7.1 0.2 0.3 8.8 3.1 0.0 0.0 1.6 19.2 2.2 14.4 2.3 23.9 2.2 0.1 0.0 0.0 4.7 1.0 0.0 1.6 4.9 34.7 0.0 0.0 0.2 57.6 16.2 0.6 0.1 3.4 3.5 0.0 14.5 1.5 0.0 15.7 0.0 9.1 0.0 0.0 1.3 0.2 0.0 5.1 0.0 0.4 4.6 5.7 1.0 0.3 1.9 1.2 0.3 2.3 1.2 2.7 0.1 2.2 1.3 24.9 0.3 0.3 0.3 0.6 2.0 1.0 1.4 0.4 0.8 1.1 0.9 0.8 0.4 7.8 0.5 8.9 3.0 2.0 18.2 97.5 0.0 0.3 35.7 18.7 11.4 29.6 0.0 4.8 1.7 20.1 0.0 0.6 75.9 0.0 13.1 6.2 3.7 19.6 2.3 8.5 0.7 0.0 12.6 1.8 2.4 0.0 0.0 1.1 1.7 0.0 43.8 0.0 29.3 35.1 0.0 20.2 1.6 0.0 1.0 0.0 1.4 147.0 1.7 0.0 39.6 93.4 F2RL2 PAR3 ENSG00000164220 "Coagulation factor II thrombin receptor like 2" O00254 5 76615482-76623434 "G-protein coupled receptors, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 34.2" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Ito cells: 9.2;Kupffer cells: 2.7;Rod photoreceptor cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "basophil: 10.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 20.8;HBF TERT88: 13.4;HEL: 28.0;hTEC/SVTERT24-B: 13.7;hTERT-RPE1: 29.0;U-138 MG: 21.5;WM-115: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.35e-3)" "unprognostic (5.71e-3)" "prognostic favorable (4.69e-4)" "unprognostic (6.71e-2)" "unprognostic (4.16e-3)" "unprognostic (3.56e-2)" "unprognostic (9.71e-2)" "unprognostic (8.49e-2)" "unprognostic (3.78e-2)" "unprognostic (1.43e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-1)" "unprognostic (2.24e-8)" "unprognostic (7.64e-2)" "unprognostic (8.98e-2)" "unprognostic (1.29e-1)" "unprognostic (1.73e-2)" 0.7 0.7 0.4 2.7 1.3 0.3 6.1 0.1 0.8 2.3 6.7 0.5 0.0 2.5 5.9 0.5 5.9 0.6 11.4 2.6 0.9 3.8 1.0 5.1 1.1 0.1 4.7 0.7 0.3 4.2 0.2 1.5 0.4 7.0 0.9 2.9 34.2 7.4 0.2 0.3 4.6 6.3 6.3 1.1 0.5 2.9 0.4 0.1 4.1 0.6 10.2 3.1 2.1 0.8 0.3 1.6 10.2 0.7 1.8 1.2 0.1 0.0 0.8 0.0 0.0 0.9 4.9 0.0 12.0 20.8 3.3 12.0 0.0 0.0 0.0 0.7 0.0 9.7 0.0 0.0 0.0 13.4 0.0 0.0 28.0 0.2 0.1 1.9 0.0 0.0 2.6 0.0 13.7 0.0 29.0 1.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 21.5 6.5 0.9 0.1 1.0 0.0 0.0 2.5 0.0 26.8 10.2 0.7 0.2 1.2 0.3 1.0 0.1 1.1 0.6 0.2 0.3 0.5 1.2 1.4 1.8 0.2 1.6 1.2 0.1 0.4 1.3 0.1 0.8 0.9 3.8 4.7 0.7 7.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 9.2 2.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 F2RL3 PAR4 ENSG00000127533 "F2R like thrombin or trypsin receptor 3" Q96RI0 19 16888860-16892606 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.4;breast: 30.7;lung: 33.0" "Group enriched" "Detected in some" 5 "Endothelial cells: 5.8;granulocytes: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HEL: 24.9;HMC-1: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031401, HPA042340" Supported "Plasma membrane" NA NA "Plasma membrane" "HPA031401: , HPA042340: " "unprognostic (6.17e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-2)" "unprognostic (3.83e-1)" "unprognostic (3.27e-1)" "unprognostic (8.31e-3)" "unprognostic (2.97e-1)" "unprognostic (3.28e-2)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (6.30e-2)" "unprognostic (3.00e-3)" "prognostic favorable (6.25e-4)" "unprognostic (2.37e-2)" "unprognostic (1.43e-1)" "unprognostic (3.53e-1)" "unprognostic (2.11e-2)" 69.4 3.3 0.2 2.6 0.4 1.3 30.7 0.2 0.6 1.3 16.9 0.4 0.5 1.9 1.3 1.9 4.3 1.0 4.5 9.7 0.5 0.2 5.0 0.8 33.0 2.6 0.2 0.3 3.9 12.3 0.5 2.3 1.1 1.4 1.4 1.5 1.3 1.0 0.8 6.5 2.2 4.4 1.1 0.2 3.0 5.4 2.5 0.2 0.3 27.1 2.3 1.5 3.4 1.9 5.3 4.3 5.8 2.5 3.9 3.3 3.2 0.2 0.2 0.7 0.3 0.1 0.2 0.7 0.4 0.1 0.2 0.1 0.4 0.7 0.5 0.5 0.2 0.3 0.7 0.1 0.2 0.2 0.3 0.4 24.9 0.9 0.4 0.2 0.3 10.0 0.0 0.1 0.3 0.2 0.3 0.8 0.5 2.0 1.0 0.1 0.3 0.3 2.4 0.3 0.3 0.2 0.2 0.2 0.8 0.2 0.5 0.4 0.2 0.2 0.2 0.1 0.6 0.5 1.7 1.0 0.6 0.5 0.3 0.3 0.5 0.3 0.5 0.2 0.4 0.4 5.8 2.5 1.6 2.2 1.4 2.1 3.9 2.4 1.9 0.8 5.3 3.3 3.1 5.3 3.9 1.8 4.3 1.7 3.2 0.2 0.4 0.2 0.6 0.5 0.2 0.2 0.3 1.4 0.2 0.0 0.6 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.5 0.0 0.5 0.3 6.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.3 F5 ENSG00000198734 "Coagulation factor V" P12259 1 169514166-169586588 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;liver: 88.8;placenta: 32.2" "Cell type enhanced" "Detected in many" 22 "Cholangiocytes: 79.0;Cytotrophoblasts: 65.0;Hepatocytes: 221.3;Syncytiotrophoblasts: 49.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 69.6" "Region enriched" "Detected in many" 11 "pons and medulla: 27.9" "Cell type enhanced" "Detected in some" "eosinophil: 8.7;neutrophil: 8.0" "Group enriched" "Detected in many" 13 "granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0" "Group enriched" "Detected in some" 23 "Hep G2: 13.8;OE19: 52.9" "Group enriched" "Detected in many" 5 "basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8" "Group enriched" "Detected in many" 7 "amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9" HPA002036 Approved "Golgi apparatus" "Secreted to blood" NA NA 7670000000 13000000000 "Golgi apparatus" "HPA002036: AB_1078787" "unprognostic (3.67e-2)" "unprognostic (2.77e-4)" "unprognostic (5.42e-2)" "unprognostic (2.56e-4)" "unprognostic (2.03e-1)" "unprognostic (2.39e-4)" "unprognostic (3.46e-3)" "unprognostic (9.25e-3)" "unprognostic (2.02e-1)" "unprognostic (8.99e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.15e-2)" "unprognostic (3.41e-1)" "unprognostic (4.31e-1)" 1.1 0.4 0.4 1.4 0.5 1.5 0.8 1.0 0.4 0.4 0.4 6.7 0.0 0.5 0.4 2.2 0.4 1.6 14.1 13.9 2.5 0.5 1.2 88.8 1.1 1.1 1.4 0.1 0.4 1.3 0.1 2.0 32.2 27.9 1.0 0.4 17.8 4.4 0.1 0.4 1.3 0.5 0.5 2.6 1.9 2.2 0.7 1.1 0.0 0.7 0.2 2.6 1.5 0.4 0.0 0.5 8.7 4.2 0.0 7.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.2 8.7 0.0 0.2 0.0 0.0 1.7 0.2 0.5 0.0 0.3 0.0 8.0 0.0 0.0 0.0 7.0 1.1 0.4 0.5 1.0 0.4 2.5 0.5 1.4 0.1 27.9 1.1 3.0 1.1 0.0 4.4 0.1 0.1 8.6 79.0 5.3 3.4 0.0 2.0 65.0 0.0 1.6 0.7 1.0 0.0 0.0 0.2 1.6 7.7 0.3 0.0 221.3 4.7 0.0 24.2 3.1 18.7 0.0 0.0 0.2 3.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 49.8 1.3 0.0 9.0 F7 ENSG00000057593 "Coagulation factor VII" P08709 13 113105788-113120681 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "liver: 68.0" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 131.2" "Cancer enriched" "Detected in some" 17 "liver cancer: 41.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Group enriched" "Detected in some" 9 "CACO-2: 16.6;Hep G2: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA004826 Approved Mitochondria "Secreted to blood" NA NA 351000000 1500000000 Mitochondria "HPA004826: AB_10602805" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-3)" "unprognostic (3.81e-1)" "unprognostic (4.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.19e-3)" "unprognostic (1.15e-1)" "unprognostic (1.35e-3)" "unprognostic (3.36e-3)" "unprognostic (1.09e-1)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 68.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.6 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.2 0.0 0.5 0.0 0.0 131.2 0.1 0.0 0.0 3.7 3.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.5 0.0 0.0 F8A3 ENSG00000277150 "Coagulation factor VIII associated 3" P23610 X 155456914-155458672 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 6.3;parathyroid gland: 10.5" "Cell type enhanced" "Detected in some" 5 "Hepatocytes: 2.4;Hofbauer cells: 2.0;Syncytiotrophoblasts: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 18.4;U-266/70: 22.7;U-266/84: 21.2" NA NA "unprognostic (1.83e-1)" "unprognostic (9.94e-2)" "unprognostic (3.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.94e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (7.03e-2)" "unprognostic (2.03e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-1)" "unprognostic (7.96e-2)" 2.3 1.4 1.4 2.1 1.2 2.5 0.9 1.7 1.1 0.0 1.6 0.0 0.6 0.9 0.3 1.8 1.8 0.4 0.8 1.0 0.0 10.5 0.4 0.0 0.3 0.1 0.6 4.2 0.0 1.9 0.0 0.7 1.5 0.0 0.0 0.1 2.9 1.0 1.0 6.3 0.7 0.4 1.8 0.3 0.5 0.0 1.1 0.0 4.7 3.4 0.0 0.2 0.0 0.0 0.0 2.2 0.0 6.3 0.6 7.8 0.0 6.1 1.3 0.0 0.0 0.9 3.0 8.1 5.2 0.1 5.4 10.8 3.9 0.0 0.0 4.9 3.8 0.0 3.1 0.0 0.0 0.0 8.0 0.0 11.2 0.0 2.2 18.4 0.4 0.5 0.0 5.9 4.8 3.8 0.0 2.2 4.5 0.0 0.1 11.1 0.0 6.8 2.7 11.1 0.1 7.9 12.9 22.7 21.2 0.3 3.3 0.1 0.0 0.0 0.6 6.3 1.8 0.4 1.1 0.8 1.6 1.5 0.9 1.0 0.9 1.0 1.5 0.4 0.7 1.0 0.3 0.3 0.0 0.0 0.0 0.3 0.0 1.8 0.2 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.6 0.0 0.1 0.5 0.0 1.4 0.6 0.0 0.3 0.0 2.4 2.0 0.0 0.0 1.3 1.6 0.0 0.0 0.0 0.0 0.0 1.8 0.5 1.0 0.0 0.0 1.7 1.1 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.6 0.1 F9 FIX ENSG00000101981 "Coagulation factor IX" P00740 X 139530758-139563458 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2334 "liver: 233.6" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 475.1" "Cancer enriched" "Detected in single" 1354 "liver cancer: 67.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.8;RH-30: 2.0;SiHa: 1.6;U-698: 1.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted to blood" NA NA 11000000000 "prognostic favorable (6.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.2 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 475.1 0.0 0.0 0.0 15.4 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FA2H "FAAH, FAXDC1, FLJ25287, SPG35" ENSG00000103089 "Fatty acid 2-hydroxylase" Q7L5A8 16 74712955-74774831 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism" Oxidoreductase "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.2;stomach 1: 45.5" "Cell type enhanced" "Detected in many" 20 "Mucus-secreting cells: 34.0;Paneth cells: 56.1;Urothelial cells: 163.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "memory B-cell: 3.0" "Lineage enriched" "Detected in single" 24 "B-cells: 3.0" "Cell line enhanced" "Detected in some" "A549: 16.0;HAP1: 20.7;JURKAT: 38.1;OE19: 25.5;SK-BR-3: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056614, HPA077840" Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA056614: AB_2683191, HPA077840: AB_2686858" "unprognostic (1.33e-1)" "unprognostic (4.97e-2)" "unprognostic (9.19e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.85e-2)" "unprognostic (1.48e-2)" "unprognostic (2.47e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (3.74e-4)" "unprognostic (6.01e-2)" "prognostic favorable (5.01e-6)" "unprognostic (1.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.83e-2)" "unprognostic (2.11e-3)" 0.7 0.7 11.8 3.4 27.7 0.7 2.6 2.8 25.3 2.0 16.2 62.4 0.0 8.1 0.7 2.2 3.7 1.8 14.3 0.7 22.3 11.0 3.7 0.7 1.5 0.9 40.5 16.5 0.6 6.8 7.1 0.8 1.0 28.5 1.9 15.4 0.0 8.4 1.0 0.6 3.5 11.3 1.4 78.2 0.8 45.5 2.4 44.6 2.6 2.0 0.0 4.7 3.8 1.2 3.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 16.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 8.7 8.9 0.0 0.0 0.0 0.9 1.5 20.7 0.2 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 6.3 0.3 0.0 0.4 25.5 1.0 0.0 0.0 0.7 10.1 6.5 2.8 0.0 0.0 12.3 0.0 0.5 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.8 27.7 2.8 16.1 22.3 11.0 40.5 16.5 28.5 44.6 0.0 2.2 0.0 4.2 0.5 0.0 0.3 10.2 4.0 2.3 0.0 0.0 0.2 6.6 11.5 6.3 0.0 25.4 0.0 12.9 0.1 0.0 20.7 0.0 0.0 0.1 0.0 6.4 0.0 0.0 2.7 0.0 0.0 3.3 0.0 34.0 0.0 26.4 56.1 0.4 0.0 0.0 0.0 0.1 0.5 2.1 0.6 0.1 0.0 16.8 163.9 FAAH2 "AMDD, FAAH-2, FLJ31204, RP11-479E16.1" ENSG00000165591 "Fatty acid amide hydrolase 2" Q6GMR7 X 57286706-57489196 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.6;pituitary gland: 42.8" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 24.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 18.0" "Cell type enhanced" "Detected in many" "T-reg: 13.6" "Lineage enriched" "Detected in many" 8 "T-cells: 13.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.7;HDLM-2: 9.6;RPMI-8226: 19.4;U-266/70: 16.3;U-266/84: 8.3" NA NA "unprognostic (1.37e-1)" "unprognostic (1.78e-2)" "unprognostic (7.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.02e-1)" "unprognostic (4.51e-2)" "unprognostic (7.93e-3)" "unprognostic (4.47e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.99e-4)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.47e-13)" "unprognostic (9.16e-3)" "unprognostic (2.27e-1)" "prognostic favorable (2.66e-4)" "prognostic favorable (6.83e-5)" 1.0 1.4 1.0 6.8 1.5 0.0 6.7 18.0 1.0 3.5 3.9 0.2 3.8 2.6 1.4 4.7 5.5 5.8 2.4 0.6 1.2 2.3 9.7 20.1 3.5 5.7 1.1 0.5 1.9 43.6 12.7 42.8 1.4 1.8 9.3 3.6 3.8 9.1 5.3 0.3 10.0 6.4 0.6 1.1 2.3 4.1 0.6 0.3 8.5 15.3 2.7 11.0 3.0 3.6 1.8 1.0 0.3 0.0 0.7 13.6 1.5 2.5 0.2 0.0 0.1 0.1 0.1 2.4 0.0 0.0 0.0 0.0 1.8 10.7 0.1 3.1 0.0 0.0 0.4 0.8 1.9 0.0 9.6 5.2 0.3 2.5 0.7 0.0 1.1 0.0 0.0 3.2 0.0 0.0 0.1 0.0 1.0 1.2 4.8 0.0 1.0 0.5 0.0 1.8 2.2 0.0 0.0 1.8 19.4 6.3 3.4 1.8 0.1 0.1 3.0 0.0 4.6 3.0 0.0 0.0 0.0 0.2 0.0 0.1 16.3 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 4.7 1.8 7.7 3.2 0.0 0.6 7.5 0.9 0.3 0.7 0.0 1.0 13.6 1.5 1.0 1.5 18.0 1.0 1.2 2.3 1.1 0.5 1.8 0.3 3.0 5.6 0.0 11.2 2.4 3.1 0.3 2.5 24.1 6.8 5.2 17.7 4.4 8.3 8.3 0.0 0.0 3.9 0.0 12.2 2.1 0.5 10.4 0.0 9.0 0.6 1.6 12.7 0.6 0.0 0.0 0.6 0.0 3.3 1.0 5.6 1.2 11.6 3.4 0.4 4.5 12.2 0.0 0.1 0.0 0.0 5.8 4.7 2.5 4.7 9.0 FABP1 L-FABP ENSG00000163586 "Fatty acid binding protein 1" P07148 2 88122982-88128116 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 453.2;liver: 370.7" "Group enriched" "Detected in many" 5 "Enterocytes: 8164.5;Hepatocytes: 5503.1;Paneth cells: 3221.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 175.1;liver cancer: 437.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "neutrophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Group enriched" "Detected in some" 7 "CACO-2: 26.2;Hep G2: 83.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002305, HPA028275" Enhanced Approved Nucleoplasm,Cytosol NA NA 32000000 "Nucleoplasm, Cytosol" "CAB002305: AB_563728, HPA028275: AB_10600909" "unprognostic (1.91e-1)" "unprognostic (7.91e-3)" "unprognostic (5.47e-2)" "unprognostic (1.96e-1)" "unprognostic (2.03e-2)" "unprognostic (2.35e-1)" "unprognostic (7.99e-2)" "unprognostic (8.92e-2)" "unprognostic (2.29e-1)" 0.4 0.1 0.4 33.9 0.4 0.0 0.4 0.4 0.5 0.4 153.5 0.4 0.4 137.9 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.2 57.6 370.7 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 97.7 0.4 0.5 0.4 0.4 0.1 453.2 6.7 0.4 0.4 0.2 0.5 0.4 0.4 0.5 0.5 0.4 0.4 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 26.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 83.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.0 1.4 7.7 0.0 0.1 0.8 5.7 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.7 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.4 0.0 0.0 173.3 0.0 0.0 0.0 0.4 119.8 0.0 0.0 57.6 0.0 0.1 132.6 0.0 0.0 0.0 8164.5 140.2 0.0 0.1 0.0 0.3 133.2 5503.1 1.4 0.0 251.5 124.0 159.5 0.0 0.0 0.0 0.0 0.0 830.4 0.0 0.1 3221.0 0.0 668.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 51.0 1046.9 0.0 FABP12 ENSG00000197416 "Fatty acid binding protein 12" A6NFH5 8 81524981-81531378 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 6.7;testis: 13.2" "Group enriched" "Detected in some" 5 "Early spermatids: 65.5;Late spermatids: 133.2" "Cancer enhanced" "Detected in single" "cervical cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.3;RT4: 1.1" "Not detected" "Not detected" HPA044041 Enhanced NA NA "HPA044041: AB_10962213" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 65.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.2 0.6 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 20.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 FABP2 I-FABP ENSG00000145384 "Fatty acid binding protein 2" P12104 4 119317250-119322390 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "intestine: 358.6" "Group enriched" "Detected in some" 5 "Enterocytes: 422.5;Mucus-secreting cells: 344.1;Paneth cells: 175.6" "Group enriched" "Detected in some" 9 "colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.1;neutrophil: 7.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.6" "Cell line enhanced" "Detected in some" "BEWO: 2.9;Hep G2: 2.5;NB-4: 3.9;RPMI-8226: 3.3;SH-SY5Y: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034607, CAB047325, CAB047326" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 46000 "Actin filaments, Cytosol" "Plasma membrane" "CAB047325: , CAB047326: , HPA034607: AB_10601317" "unprognostic (3.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (4.58e-1)" "unprognostic (1.51e-2)" "unprognostic (2.61e-2)" "unprognostic (1.69e-4)" "unprognostic (1.93e-1)" "unprognostic (1.02e-1)" 0.1 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 47.0 0.0 0.0 50.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.9 0.1 0.1 0.0 0.1 0.1 358.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.5 7.6 0.7 0.9 0.5 0.0 0.2 0.3 0.2 0.4 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.4 0.4 0.4 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.1 0.3 0.1 0.5 2.5 0.0 0.5 0.4 0.2 0.0 0.2 0.1 0.1 0.0 0.2 0.3 0.5 0.0 0.1 0.4 3.9 0.2 0.2 0.5 0.3 0.3 3.3 0.0 0.5 1.0 2.6 0.1 0.4 0.0 0.2 0.3 0.1 0.9 0.4 0.4 1.5 0.2 0.7 0.3 0.6 0.3 0.3 0.1 2.1 0.7 0.7 0.4 0.3 0.4 0.2 0.4 0.3 0.2 0.5 0.5 0.5 7.6 0.9 0.2 0.5 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 422.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 344.1 0.0 0.0 175.6 0.0 18.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 64.7 0.0 FABP3 "FABP11, H-FABP, MDGI, O-FABP" ENSG00000121769 "Fatty acid binding protein 3" P05413 1 31365625-31376850 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "heart muscle: 420.9;skeletal muscle: 129.4" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 2447.6" "Cancer enhanced" "Detected in all" "renal cancer: 92.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "ASC TERT1: 120.7" "Low region specificity" "Detected in all" "CAB017830, HPA055754" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Focal adhesion sites" NA NA 1640000 4400000 "Focal adhesion sites" "Golgi apparatus, Plasma membrane" "CAB017830: , HPA055754: AB_2682909" "unprognostic (2.07e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.73e-2)" "unprognostic (2.05e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-3)" "unprognostic (1.04e-1)" "unprognostic (6.86e-2)" "unprognostic (1.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-7)" "unprognostic (5.80e-3)" "unprognostic (3.45e-1)" "unprognostic (7.38e-3)" "unprognostic (9.76e-3)" 2.3 5.2 8.1 0.7 6.0 0.5 22.7 1.4 14.6 3.9 1.3 0.8 3.4 0.7 6.8 5.3 3.1 2.8 1.1 420.9 11.0 5.3 21.3 1.9 4.3 1.3 9.8 6.0 2.2 0.4 0.3 0.7 1.1 13.7 5.0 1.5 3.0 4.4 14.0 129.4 0.9 0.6 13.0 3.4 3.9 3.6 2.0 1.3 0.1 1.7 31.6 2.2 2.5 2.5 1.4 0.5 0.0 0.9 0.2 0.9 0.6 0.1 0.0 3.3 0.2 23.1 120.7 1.1 0.9 8.9 0.1 3.2 0.2 0.9 0.2 12.8 2.5 0.0 0.3 0.9 0.0 0.1 0.1 0.5 0.4 1.1 2.4 1.5 0.2 0.0 10.7 0.0 2.4 0.0 0.3 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.2 6.1 0.0 0.4 0.1 1.2 0.0 2.9 0.0 0.3 0.0 0.5 0.0 13.9 7.1 0.1 1.4 0.3 0.2 0.1 2.1 0.2 0.1 0.4 0.1 0.5 0.1 0.3 0.0 0.4 0.0 0.9 0.9 0.6 0.2 0.5 0.5 0.5 1.4 0.0 0.9 0.0 0.2 0.1 0.4 0.6 0.6 8.1 6.0 1.4 13.3 11.0 5.3 9.8 6.0 13.7 1.3 0.0 1.7 0.8 1.0 3.2 3.1 2447.6 5.1 2.7 2.3 26.2 2.0 2.1 383.0 0.3 2.1 0.8 0.0 0.0 0.3 1.3 14.9 3.8 1.1 0.0 96.1 7.9 0.0 3.7 20.0 4.2 6.4 17.6 8.5 0.0 0.0 2.7 0.5 3.6 7.4 399.5 8.1 0.0 32.3 0.3 0.1 2.6 1.4 1.0 0.1 5.2 FABP4 "A-FABP, aP2" ENSG00000170323 "Fatty acid binding protein 4" P15090 8 81478419-81483263 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "adipose tissue: 492.7;breast: 545.8" "Cell type enriched" "Detected in many" 4 "Sertoli cells: 705.0" "Group enriched" "Detected in all" 7 "breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 145 "ASC diff: 282.1;RT4: 139.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002188, CAB024961" Enhanced NA NA 30000000 "CAB024961: , HPA002188: AB_1078822" "unprognostic (4.81e-2)" "unprognostic (2.30e-3)" "unprognostic (1.64e-3)" "unprognostic (2.63e-2)" "unprognostic (2.58e-1)" "unprognostic (8.70e-3)" "unprognostic (1.78e-3)" "unprognostic (1.67e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-1)" "unprognostic (8.76e-2)" "unprognostic (1.13e-3)" "unprognostic (4.48e-2)" "unprognostic (2.26e-2)" "unprognostic (1.39e-1)" 492.7 3.5 0.3 16.1 0.3 0.1 545.8 0.2 0.2 0.9 42.2 0.0 1.8 0.2 0.6 2.9 4.8 1.0 7.6 15.6 0.3 0.3 1.2 0.4 9.3 4.7 0.3 0.0 0.7 1.3 2.2 0.3 15.9 0.3 7.7 2.9 0.1 7.6 1.7 13.0 5.5 4.5 3.3 0.3 0.7 2.2 6.1 0.0 0.7 7.4 7.3 0.1 15.4 60.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 282.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 139.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.3 0.3 0.3 0.0 0.3 0.0 32.8 75.0 1.5 0.4 12.8 0.2 16.2 0.0 40.2 48.9 0.0 0.0 0.3 0.0 0.1 0.9 172.1 0.0 0.0 4.6 0.6 7.6 0.4 25.6 0.0 120.8 0.0 0.0 12.9 57.0 0.6 1.4 13.8 15.1 1.0 0.0 0.7 0.1 0.0 1.1 0.0 1.7 705.0 59.7 0.0 0.1 12.2 0.6 0.0 0.0 61.1 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280363-81284777 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0;tongue: 204.1;vagina: 141.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2" "Cancer enhanced" "Detected in all" "cervical cancer: 268.3;head and neck cancer: 288.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 93.8;MOLT-4: 91.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: AB_2681654" "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 41.4 1.5 8.5 11.8 13.2 8.5 37.3 5.5 8.9 78.7 20.6 7.9 2.2 8.0 5.7 3.1 237.0 2.1 8.5 27.1 8.5 9.8 1.6 2.7 24.8 15.1 7.6 5.0 2.0 8.7 0.7 1.9 30.0 19.1 4.4 18.2 4.2 32.9 1.6 9.4 42.9 9.7 4.5 23.0 14.9 15.6 3.8 10.6 6.6 4.4 204.1 25.7 19.5 141.9 6.8 20.3 2.5 5.9 8.2 5.2 4.3 5.8 16.7 10.2 0.0 48.8 4.6 0.0 11.9 0.6 9.3 11.8 0.2 8.0 93.8 6.8 2.9 0.1 5.4 24.8 19.1 8.0 47.6 53.9 33.8 11.9 25.2 4.3 32.3 8.8 3.5 39.3 11.5 23.7 9.4 53.4 24.9 9.7 10.2 5.6 5.6 91.6 16.5 13.5 57.9 64.9 40.9 0.0 9.9 15.0 72.5 42.4 16.1 5.8 1.9 4.4 18.5 0.1 16.6 7.6 0.0 26.5 0.1 0.1 12.6 4.9 66.8 4.3 31.0 14.9 2.5 5.0 0.3 2.3 5.9 3.7 6.8 2.7 5.2 20.3 3.3 1.3 4.5 2.0 8.2 2.0 20.1 3.5 4.3 8.5 13.2 5.5 8.9 8.5 9.8 7.6 5.0 19.1 10.6 268.0 1256.0 87.2 58.7 107.4 21.2 2.8 2.5 100.4 708.6 21.0 43.2 16.9 3.3 27.1 23.0 313.1 94.4 0.0 20.3 209.8 84.3 44.5 54.3 0.8 2357.3 20.6 189.4 31.9 161.8 37.2 5.8 624.3 195.7 1172.2 116.5 252.2 31.0 459.1 4.9 0.8 41.8 355.7 66.0 131.8 169.3 147.4 22.5 71.0 321.9 172.7 FABP6 "I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP" ENSG00000170231 "Fatty acid binding protein 6" P51161 5 160187367-160238735 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "intestine: 299.2" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 208.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "Daudi: 20.6;EFO-21: 19.8;HDLM-2: 8.7;NB-4: 8.1;RPMI-8226: 9.5;RT4: 9.1;U-2197: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA012601, CAB024713" Enhanced "Intracellular and membrane" NA NA 650000 "CAB024713: , HPA012601: AB_1848435" "unprognostic (3.03e-2)" "unprognostic (7.55e-2)" "unprognostic (1.27e-1)" "unprognostic (5.00e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (5.35e-7)" "unprognostic (3.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.41e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.35e-9)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (2.48e-1)" "unprognostic (1.85e-3)" 0.1 0.9 0.2 0.1 0.4 0.0 0.1 0.1 0.1 0.5 0.1 0.3 0.1 0.2 0.3 0.1 0.1 4.3 0.1 0.1 0.4 0.5 0.1 0.1 1.3 0.1 0.4 0.1 0.5 0.1 0.0 0.2 0.1 1.0 0.1 0.0 0.1 0.4 0.1 0.1 0.0 299.2 0.1 0.2 0.1 0.0 0.1 0.2 1.2 0.1 0.5 0.2 0.2 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 3.4 0.6 20.6 19.8 0.0 0.1 0.0 0.0 0.0 0.0 8.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 1.5 0.8 0.2 0.0 0.0 0.0 8.1 0.0 0.0 1.8 0.0 0.6 9.5 0.0 9.1 1.8 0.4 0.0 5.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 8.6 1.0 1.1 4.5 2.3 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.1 0.4 0.5 0.4 0.1 1.0 0.2 0.0 1.0 0.0 0.2 0.5 0.0 2.0 0.0 208.8 34.2 0.0 0.0 0.0 0.0 0.9 0.3 0.0 2.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.3 0.5 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.6 1.4 FABP7 "B-FABP, BLBP" ENSG00000164434 "Fatty acid binding protein 7" O15540 6 122779475-122784074 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 62.7;breast: 26.8" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 827.1" "Group enriched" "Detected in many" 6 "glioma: 139.3;renal cancer: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1" "Group enriched" "Detected in some" 8 "AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3" "Region enriched" "Detected in all" 6 "olfactory region: 1471.1" "Low region specificity" "Detected in all" "CAB025488, HPA028825, CAB058697" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130" "prognostic favorable (2.49e-4)" "unprognostic (1.56e-2)" "unprognostic (2.53e-3)" "unprognostic (5.80e-2)" "unprognostic (2.29e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (2.09e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (1.65e-6)" "unprognostic (9.83e-2)" "unprognostic (1.30e-2)" "unprognostic (2.50e-1)" "unprognostic (8.66e-2)" 2.1 1.3 34.8 1.1 15.5 1.3 26.8 51.6 62.7 1.1 1.5 13.0 0.0 1.2 1.2 1.3 1.6 1.2 1.2 1.2 32.0 16.4 1.6 1.4 1.1 1.1 11.4 30.3 1.1 1.1 1.0 2.1 1.3 11.2 1.3 1.2 5.7 7.0 3.7 6.7 10.5 1.1 1.1 8.1 1.1 1.3 1.2 6.9 0.0 1.1 0.0 1.1 1.4 0.0 0.4 0.2 3.1 0.3 1.1 0.4 0.0 0.0 0.0 38.7 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.4 0.0 23.3 3.1 0.3 0.1 0.3 0.1 0.3 0.2 0.3 0.4 0.1 0.4 0.3 0.3 0.5 1.1 0.2 0.2 0.1 0.0 34.8 15.5 51.6 27.3 32.0 16.4 11.4 30.3 11.2 6.9 0.0 0.0 0.0 0.1 10.9 6.8 0.4 0.0 0.0 0.0 0.0 11.8 4.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 162.7 1.1 0.0 0.0 0.0 2.5 4.8 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 827.1 0.0 0.0 0.0 0.2 37.4 0.0 0.8 0.0 0.0 16.6 5.9 0.0 0.0 0.0 FABP9 "PERF, PERF15, T-FABP" ENSG00000205186 "Fatty acid binding protein 9" Q0Z7S8 8 81458341-81461579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 28.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.1;PC-3: 2.2" "Not detected" "Not detected" HPA073619 Enhanced NA NA "HPA073619: AB_2732229" "unprognostic (2.99e-1)" 2.3 0.0 0.1 0.1 0.1 0.0 5.3 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 0.2 28.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FADS2 "D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13" ENSG00000134824 "Fatty acid desaturase 2" O95864 11 61792980-61867354 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 204.5;seminal vesicle: 98.8" "Cell type enhanced" "Detected in many" 5 "monocytes: 34.3;Muller glia cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 151.3;HBEC3-KT: 90.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006741 Approved NA NA "HPA006741: AB_1078796" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" "unprognostic (4.33e-3)" "unprognostic (4.63e-2)" "unprognostic (2.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.35e-3)" "unprognostic (2.01e-1)" "unprognostic (4.21e-2)" "unprognostic (8.95e-3)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (6.19e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-2)" "prognostic unfavorable (3.42e-4)" 7.1 85.9 34.3 10.0 31.7 7.5 20.2 10.1 48.5 23.7 4.9 28.6 204.5 9.3 19.9 10.3 3.2 8.9 6.6 8.2 24.4 29.9 3.8 38.0 9.7 6.7 28.1 20.1 8.6 3.1 41.5 11.8 12.8 26.4 32.0 4.3 16.7 5.0 98.8 3.0 26.1 3.6 39.3 17.9 3.3 3.6 10.4 24.0 8.4 2.5 3.2 9.2 10.6 6.5 3.5 13.3 6.9 9.0 6.3 9.4 3.8 1.4 53.2 79.1 43.7 72.0 151.3 20.6 8.9 80.5 13.1 35.8 3.3 17.8 0.3 1.2 19.6 19.9 1.5 51.7 90.4 5.6 0.6 1.1 30.2 10.6 7.8 56.8 1.8 1.7 56.8 2.7 47.6 4.3 19.6 38.7 28.4 1.7 24.5 6.0 1.3 17.0 10.0 34.5 0.0 14.0 23.0 1.4 74.4 52.0 0.4 23.5 28.6 5.8 0.1 2.3 19.5 2.2 22.3 15.6 1.4 14.2 0.9 1.2 11.4 10.0 4.0 1.4 10.1 16.0 4.5 5.7 6.9 9.4 9.0 2.2 1.6 3.5 5.0 10.5 3.5 2.0 4.4 3.1 6.3 7.5 13.3 3.0 3.8 34.3 31.7 10.1 25.2 24.4 29.9 28.1 20.1 26.4 24.0 8.9 13.1 0.0 1.0 1.4 6.9 3.6 2.5 0.0 6.8 3.5 3.9 1.6 0.0 5.8 1.5 2.9 0.0 0.0 15.7 18.4 8.5 18.5 4.7 12.9 16.1 4.8 5.2 3.1 3.2 3.5 23.9 3.8 8.5 34.3 0.0 29.9 4.9 0.0 22.3 0.2 13.0 0.0 10.8 0.9 0.5 0.5 2.6 4.4 0.6 0.7 FADS3 "CYB5RP, LLCDL3" ENSG00000221968 "Fatty acid desaturase 3" Q9Y5Q0 11 61873519-61892051 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 63.1" "Cell type enhanced" "Detected in all" 5 "Extravillous trophoblasts: 109.7;Rod photoreceptor cells: 109.4;Smooth muscle cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.9;naive B-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 63.4;HHSteC: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045224 Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA045224: AB_10967570" "unprognostic (4.69e-3)" "unprognostic (1.31e-2)" "unprognostic (5.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.91e-2)" "prognostic unfavorable (9.54e-5)" "unprognostic (1.76e-3)" "unprognostic (3.46e-1)" "unprognostic (6.45e-2)" "unprognostic (1.49e-1)" "unprognostic (1.28e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.50e-9)" "unprognostic (1.14e-1)" "unprognostic (3.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.37e-1)" 63.1 25.9 15.7 17.5 17.9 4.1 23.5 8.7 16.5 9.3 8.3 13.8 5.9 4.3 9.8 25.4 7.4 9.0 9.9 22.7 14.4 11.6 16.6 8.5 16.3 15.4 16.9 10.0 12.7 12.1 12.4 5.0 48.2 15.1 7.1 4.4 16.8 5.5 11.3 15.7 4.2 9.0 14.9 13.3 9.7 8.3 6.0 15.6 1.1 6.1 7.3 15.7 10.4 9.9 10.6 0.7 5.7 1.2 0.6 2.4 0.7 7.7 2.4 0.7 4.9 63.4 12.8 15.8 15.8 38.6 16.9 16.4 3.4 2.8 5.8 10.3 31.4 13.2 4.3 2.9 42.9 9.0 1.6 1.6 4.8 10.3 6.9 54.9 0.4 0.9 14.0 18.7 20.3 38.8 10.3 19.5 3.1 4.6 11.0 28.7 9.0 1.7 2.4 2.3 0.8 6.4 9.7 31.3 16.1 18.9 2.7 1.2 1.6 18.0 2.4 16.0 6.8 3.5 1.0 13.2 16.5 11.5 4.8 6.9 3.4 1.6 7.0 13.8 2.3 11.9 0.0 0.7 5.7 1.8 1.2 1.6 8.9 1.6 2.4 0.7 10.6 0.1 0.6 0.3 0.6 0.8 0.0 0.4 0.7 15.7 17.9 8.7 15.4 14.4 11.6 16.9 10.0 15.1 15.6 29.8 6.9 31.8 7.1 6.1 10.3 18.6 7.6 2.7 1.2 5.2 7.9 34.9 1.7 39.5 16.2 27.8 7.0 23.3 17.7 109.7 19.7 8.5 6.9 8.5 17.2 1.6 6.4 18.4 3.7 8.3 26.4 14.0 33.7 12.6 3.6 57.1 21.1 3.5 16.6 9.1 109.4 19.4 106.1 2.1 3.8 4.8 56.9 4.3 4.8 3.3 FADS6 ENSG00000172782 "Fatty acid desaturase 6" 17 74877299-74893781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.2;epididymis: 22.6;intestine: 20.0" "Cell type enhanced" "Detected in some" 8 "Cytotrophoblasts: 1.7;Hepatocytes: 3.4;Spermatogonia: 2.2;Syncytiotrophoblasts: 3.2" "Cancer enhanced" "Detected in some" "liver cancer: 2.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016802 Uncertain NA NA "HPA016802: AB_2669448" "unprognostic (2.41e-2)" "unprognostic (6.80e-3)" "unprognostic (2.64e-1)" "unprognostic (4.68e-3)" "unprognostic (4.73e-2)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (1.07e-1)" "unprognostic (6.41e-2)" "unprognostic (6.98e-4)" "unprognostic (3.38e-2)" "unprognostic (7.53e-2)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (2.27e-1)" "unprognostic (8.45e-2)" "unprognostic (1.79e-1)" 0.4 6.3 1.7 0.7 3.3 1.7 0.7 13.2 5.9 0.5 9.7 0.4 1.2 9.2 0.4 22.6 2.7 0.3 0.2 0.4 1.7 3.4 1.4 5.2 0.3 0.7 4.5 1.9 0.4 0.6 0.6 0.1 0.4 12.5 0.6 1.0 0.6 2.3 0.5 0.7 6.5 20.0 0.3 0.8 4.7 0.4 1.0 0.4 0.3 0.6 2.2 1.1 1.7 0.9 1.1 0.8 5.3 2.9 1.3 0.5 0.0 0.7 0.7 1.8 1.7 0.0 2.7 3.0 3.3 0.2 0.4 0.8 2.3 1.3 1.2 0.5 1.5 1.4 1.0 2.5 0.0 0.4 0.4 0.1 1.4 3.9 1.7 0.9 1.3 1.5 1.0 0.2 3.4 1.2 0.8 0.0 1.2 1.5 4.3 2.0 2.2 0.9 3.0 1.1 1.1 1.5 0.8 1.0 1.5 1.0 0.7 1.6 1.3 2.5 1.0 0.5 2.1 1.0 2.0 1.0 1.7 2.5 1.9 1.7 1.7 0.7 1.3 3.3 1.1 2.2 2.1 1.3 1.0 0.4 1.2 0.2 0.4 0.3 0.4 0.2 1.1 0.4 0.5 5.3 1.3 2.9 0.8 0.3 0.0 1.7 3.3 13.2 5.9 1.7 3.4 4.5 1.9 12.5 0.4 0.0 0.0 0.0 1.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.2 1.0 0.0 3.4 0.3 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.3 0.0 0.0 0.0 2.2 0.5 3.2 0.0 0.1 1.4 FAH ENSG00000103876 "Fumarylacetoacetate hydrolase" P16930 15 80152490-80186946 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 109.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 250.1;Hofbauer cells: 63.7;Proximal tubular cells: 236.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 76.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041370, HPA044093" Enhanced Approved Nucleoplasm,Cytosol NA NA 230000000 Cytosol Nucleoplasm "HPA041370: AB_2677438, HPA044093: AB_2678806" "unprognostic (3.15e-1)" "unprognostic (5.65e-2)" "unprognostic (1.64e-1)" "unprognostic (6.16e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.19e-2)" "unprognostic (5.83e-2)" "unprognostic (2.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "unprognostic (2.93e-1)" "unprognostic (8.98e-2)" 32.1 17.8 4.6 6.1 3.6 4.7 22.8 2.3 3.3 4.7 8.6 3.1 8.3 4.1 5.1 14.8 4.4 6.8 7.1 6.8 4.1 2.8 18.9 109.4 7.9 6.2 4.0 2.1 7.2 6.5 4.8 4.4 2.3 3.5 4.9 3.4 2.4 5.3 5.4 7.7 2.4 7.6 4.4 5.9 6.0 3.3 9.7 3.0 2.3 4.2 4.9 3.9 4.1 6.1 0.1 16.0 16.9 11.7 3.6 5.8 6.1 4.5 7.6 3.1 3.9 14.7 15.1 7.8 5.8 13.3 6.2 5.3 4.6 8.4 0.0 9.6 12.2 8.6 6.7 11.2 13.9 6.0 2.9 6.3 38.8 4.5 23.8 76.6 18.3 21.5 26.1 8.6 5.3 9.6 20.3 8.6 8.9 16.2 8.3 11.5 6.9 5.0 9.1 2.2 3.5 8.7 2.8 4.5 29.1 17.8 5.5 0.1 1.9 6.5 18.0 18.2 5.3 13.7 12.5 29.9 11.3 7.1 6.0 9.8 7.6 15.5 3.1 23.5 42.9 6.3 16.9 11.7 1.9 5.8 4.9 1.5 0.1 1.6 3.9 16.0 0.0 2.0 1.8 0.7 3.6 4.8 1.2 1.5 6.1 4.6 3.6 2.3 3.3 4.1 2.8 4.0 2.1 3.5 3.0 3.0 14.4 5.2 13.1 6.1 0.4 12.0 10.2 5.3 4.5 31.4 0.0 32.5 44.7 8.5 6.3 2.5 15.8 23.3 3.1 9.0 17.2 8.6 42.5 250.1 63.7 0.0 4.1 11.1 20.0 10.6 9.2 23.1 18.6 3.6 11.8 3.5 4.6 14.4 7.4 236.8 0.3 0.0 8.1 1.5 2.1 5.0 18.4 8.7 22.4 12.8 FAHD2A CGI-105 ENSG00000115042 "Fumarylacetoacetate hydrolase domain containing 2A" Q96GK7 2 95402721-95416616 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 59.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042145, HPA044987, CAB045971, CAB045972" Enhanced NA NA "CAB045971: AB_11126570, CAB045972: AB_11140511, HPA042145: AB_2677873, HPA044987: AB_2679170" "unprognostic (6.52e-2)" "unprognostic (1.25e-3)" "unprognostic (9.36e-2)" "unprognostic (1.27e-2)" "unprognostic (7.77e-3)" "unprognostic (6.82e-2)" "unprognostic (2.80e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (4.58e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-2)" "unprognostic (1.17e-2)" "unprognostic (1.95e-1)" "unprognostic (1.88e-2)" "unprognostic (1.55e-2)" 11.2 10.1 12.7 5.4 14.2 7.8 12.2 12.9 14.3 7.3 22.0 12.1 7.3 19.1 8.8 6.8 5.7 8.9 8.7 14.9 11.6 8.1 11.4 59.2 6.5 6.0 11.8 13.1 11.7 17.7 7.4 5.6 6.6 11.2 7.3 8.6 11.7 51.3 8.1 18.2 8.2 22.1 9.5 12.2 6.6 10.0 11.7 10.8 8.6 21.2 11.6 7.2 5.8 6.8 11.0 19.8 5.6 12.7 7.8 15.5 10.3 14.6 14.3 15.8 10.1 17.5 16.0 11.4 13.8 23.4 16.4 26.1 8.5 6.4 8.9 6.2 14.1 20.7 8.0 11.2 12.8 16.3 7.9 14.4 7.3 6.3 14.0 22.9 10.8 4.1 15.3 14.3 14.9 19.1 26.0 21.5 18.3 10.2 20.4 20.5 17.9 19.4 14.8 5.0 8.5 13.9 14.5 10.0 24.9 18.2 6.0 9.6 4.8 8.3 13.5 16.0 20.7 8.5 4.3 10.2 20.8 14.6 8.8 9.5 22.3 9.7 9.0 14.4 10.1 10.3 1.5 11.5 5.6 14.1 12.7 15.5 11.0 12.9 13.4 16.7 7.1 13.4 10.8 0.7 7.8 6.0 19.8 13.9 10.3 12.7 14.2 12.9 14.3 11.6 8.1 11.8 13.1 11.2 10.8 8.9 8.4 13.7 11.9 8.8 15.6 30.5 33.1 14.7 14.8 27.9 9.8 25.3 59.7 25.7 84.6 12.6 16.8 0.0 20.0 11.8 16.4 13.5 4.6 76.4 22.5 15.9 4.7 16.0 11.3 63.5 34.2 10.9 16.9 26.2 17.6 20.6 19.9 16.9 49.1 26.9 16.9 12.9 19.6 44.0 14.1 6.8 14.3 8.7 23.3 9.7 FAHD2B DKFZp434N062 ENSG00000144199 "Fumarylacetoacetate hydrolase domain containing 2B" Q6P2I3 2 97083583-97094882 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.1" "Group enriched" "Detected in many" 5 "Early spermatids: 176.4;Late spermatids: 175.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 6.9;NK-cells: 11.5;T-cells: 12.2" "Low cell line specificity" "Detected in many" "HPA042145, HPA044987" Approved NA NA "HPA042145: AB_2677873, HPA044987: AB_2679170" "unprognostic (6.55e-3)" "unprognostic (5.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (9.03e-3)" "unprognostic (4.13e-3)" "unprognostic (8.84e-3)" "unprognostic (1.59e-1)" "unprognostic (1.41e-1)" "unprognostic (8.65e-3)" "unprognostic (1.94e-1)" "unprognostic (7.67e-2)" "unprognostic (1.48e-1)" "unprognostic (5.03e-2)" "unprognostic (6.26e-3)" "unprognostic (2.04e-1)" 3.6 2.6 5.5 0.9 7.4 0.9 5.9 7.6 6.8 3.8 2.9 0.7 5.9 21.1 2.8 5.0 1.6 8.9 5.7 6.2 3.0 1.1 2.2 2.1 7.1 10.3 4.0 6.8 2.1 0.3 3.5 2.4 4.1 3.3 10.2 4.3 1.3 5.5 7.6 1.6 10.1 11.4 0.1 3.3 3.9 2.7 6.9 2.1 0.1 0.2 11.5 12.2 3.6 2.8 3.5 4.7 9.7 4.7 5.7 7.7 2.5 2.8 4.3 4.0 3.2 4.4 5.4 2.1 0.9 8.1 2.9 6.9 5.5 2.5 6.9 12.6 5.9 4.6 2.5 15.3 6.6 3.8 7.6 5.8 0.5 9.2 1.9 4.6 21.3 10.1 13.5 0.3 0.0 8.0 19.6 4.6 1.2 9.4 7.8 1.3 19.2 4.7 4.7 1.1 4.1 8.4 2.2 11.8 9.4 9.3 5.3 0.8 0.5 8.1 0.5 2.4 8.8 11.5 14.3 0.7 17.3 5.8 0.0 0.1 0.1 9.0 0.2 12.2 6.9 8.7 8.8 1.3 2.9 6.1 7.8 0.1 11.5 0.1 2.1 10.8 3.6 6.0 12.0 0.8 9.3 5.8 5.7 37.5 2.5 6.7 10.3 5.2 2.0 1.6 23.2 7.2 176.4 7.5 0.0 0.0 3.8 0.7 9.1 5.4 5.7 2.4 2.9 4.8 1.7 3.7 2.2 175.9 15.8 2.1 28.7 1.8 2.4 17.2 7.9 0.0 15.9 2.1 4.9 0.0 10.3 19.1 7.0 6.1 0.8 7.4 3.5 7.4 FAIM "FAIM1, FLJ10582" ENSG00000158234 "Fas apoptotic inhibitory molecule" Q9NVQ4 3 138608606-138633376 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 61.9" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 189.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 45.4" "Low region specificity" "Detected in all" "HPA042440, HPA052209" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042440: AB_2677999, HPA052209: AB_2681761" "unprognostic (6.45e-2)" "unprognostic (8.21e-3)" "unprognostic (5.97e-2)" "unprognostic (1.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.96e-5)" "unprognostic (4.84e-2)" "unprognostic (4.15e-2)" "unprognostic (9.23e-3)" "unprognostic (2.29e-1)" "unprognostic (2.63e-2)" "prognostic favorable (6.63e-4)" "unprognostic (4.76e-2)" "unprognostic (3.51e-1)" "unprognostic (3.43e-1)" "unprognostic (6.98e-2)" 13.7 6.6 12.3 6.7 11.6 2.6 19.0 7.8 9.9 24.5 6.8 10.2 38.5 4.7 9.6 15.1 8.8 28.5 9.0 4.7 12.2 12.5 15.4 6.0 7.6 7.2 13.9 7.1 8.4 27.5 7.2 15.4 6.1 10.7 11.4 6.0 9.1 7.2 61.9 6.1 6.2 4.2 7.2 19.6 3.7 6.7 5.4 9.1 13.2 15.2 9.3 9.6 10.3 13.2 13.9 5.0 11.1 2.6 13.9 9.1 3.4 26.9 5.3 0.5 4.8 5.2 9.8 19.4 8.3 5.0 8.8 7.6 9.1 7.9 0.0 7.4 10.9 10.2 7.1 23.1 4.7 10.0 22.1 24.1 5.1 14.6 13.1 5.8 0.0 1.6 13.7 9.3 3.3 5.1 5.4 9.5 1.9 3.3 6.9 5.4 10.2 0.1 22.8 10.5 0.8 5.3 27.2 6.3 0.7 14.0 13.4 9.1 7.7 14.8 8.2 20.8 6.0 13.9 6.7 5.8 1.8 4.2 9.0 4.0 0.0 0.1 45.4 7.3 0.0 7.2 11.1 2.4 1.7 9.1 2.6 8.5 13.9 5.0 7.2 5.0 7.9 3.4 8.5 0.3 13.9 1.7 3.5 5.4 3.4 12.3 11.6 7.8 8.2 12.2 12.5 13.9 7.1 10.7 9.1 17.9 15.6 9.3 23.8 9.6 27.4 4.5 63.7 87.0 36.4 24.4 62.8 37.0 26.6 49.3 9.6 10.8 2.0 0.0 43.5 25.4 17.6 19.1 40.4 10.2 24.6 14.3 20.3 8.6 3.5 11.1 16.1 5.5 15.1 23.4 8.3 34.0 31.2 0.0 18.7 19.0 189.9 0.0 19.6 16.8 2.2 11.4 12.2 9.6 11.5 23.3 FAIM2 "KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2" ENSG00000135472 "Fas apoptotic inhibitory molecule 2" Q9BWQ8 12 49866896-49904217 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 136.4;Early spermatids: 135.6;Horizontal cells: 219.3" "Cancer enriched" "Detected in many" 8 "glioma: 21.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 1.7;T-reg: 6.2" "Lineage enriched" "Detected in single" 9 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "HHSteC: 9.1;OE19: 11.7;SH-SY5Y: 4.9;U-87 MG: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018790, HPA048800" Enhanced Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA018790: AB_1852822, HPA048800: AB_2680526" "unprognostic (1.74e-1)" "unprognostic (5.98e-4)" "unprognostic (2.22e-1)" "unprognostic (9.75e-3)" "unprognostic (3.36e-2)" "unprognostic (2.61e-4)" "unprognostic (2.62e-1)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (1.75e-2)" "unprognostic (5.66e-2)" "unprognostic (1.30e-2)" "unprognostic (3.28e-6)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.47e-1)" "unprognostic (6.78e-4)" 3.9 27.2 35.6 4.1 57.5 1.4 2.5 42.4 138.5 3.2 4.7 29.1 0.2 2.7 4.2 6.4 3.9 5.8 7.5 7.4 38.8 51.0 2.0 1.5 2.5 3.5 35.9 33.7 2.6 2.8 14.7 7.8 1.5 65.6 8.8 3.5 3.9 3.0 7.1 2.0 1.8 4.0 8.7 36.9 2.5 2.6 12.1 20.5 0.0 1.7 0.0 3.1 4.7 2.0 0.0 0.0 0.0 0.4 0.6 6.2 0.2 0.0 0.3 0.4 0.5 2.0 1.3 0.1 0.5 2.6 0.5 0.3 0.3 0.0 0.0 0.1 3.6 0.2 0.2 1.2 0.0 0.3 0.0 0.0 2.0 0.0 0.0 9.1 0.1 0.0 0.8 0.2 1.9 0.0 0.0 0.0 0.2 1.1 0.3 0.5 0.0 0.1 0.0 0.0 11.7 0.0 0.0 0.1 0.0 0.0 0.0 3.2 4.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 28.4 0.0 0.2 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 6.2 0.2 35.6 57.5 42.4 99.5 38.8 51.0 35.9 33.7 65.6 20.5 0.0 0.0 0.0 0.1 0.2 136.4 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 135.6 0.0 0.0 0.0 0.2 0.0 1.4 0.6 26.4 0.0 0.4 219.3 0.0 0.0 0.0 31.4 4.6 0.0 0.0 0.0 2.0 34.2 0.1 0.0 4.9 0.1 14.5 0.0 0.9 1.2 2.1 0.3 0.1 0.0 0.2 0.1 FAM104A FLJ14775 ENSG00000133193 "Family with sequence similarity 104 member A" Q969W3 17 73207353-73236753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.8" "Group enriched" "Detected in all" 4 "Early spermatids: 1144.0;Late spermatids: 1283.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021459, HPA079514" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021459: AB_1848361, HPA079514: " "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (5.02e-3)" "unprognostic (3.23e-2)" "unprognostic (2.28e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (2.12e-7)" "unprognostic (5.19e-2)" "unprognostic (2.31e-2)" "unprognostic (4.88e-2)" "unprognostic (4.20e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.26e-10)" "unprognostic (6.70e-2)" "unprognostic (1.81e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" 9.3 7.2 8.7 9.1 9.0 23.2 12.4 10.8 7.9 9.9 9.1 6.9 7.4 7.8 8.4 8.4 10.4 6.6 8.5 11.6 8.1 7.0 6.4 10.0 8.2 10.1 6.9 8.3 8.2 11.4 8.4 11.2 14.2 6.4 9.3 8.1 8.4 8.3 8.0 11.9 11.7 10.1 7.3 7.1 11.8 13.3 74.8 6.5 14.6 9.2 7.1 11.2 9.9 11.6 21.3 19.7 34.3 20.3 26.7 49.5 29.9 23.0 19.0 9.5 17.7 14.7 13.8 31.4 18.9 19.9 20.9 21.6 15.9 14.9 13.5 15.6 18.1 20.3 14.7 12.3 13.8 22.7 15.8 16.5 19.6 16.3 24.0 19.5 17.1 33.8 14.6 18.3 18.5 13.6 13.7 24.4 16.4 15.2 22.6 25.0 15.7 30.4 11.8 13.2 17.0 24.3 16.7 26.7 13.0 15.9 19.0 15.8 21.0 11.0 16.1 20.2 18.7 22.6 17.7 16.9 24.7 28.6 16.8 22.0 22.4 22.1 16.4 22.1 18.8 18.2 24.5 20.3 34.3 24.7 17.6 23.7 21.3 30.3 28.1 19.7 20.2 22.2 26.7 33.3 26.7 18.6 12.8 49.5 29.9 8.7 9.0 10.8 7.9 8.1 7.0 6.9 8.3 6.4 6.5 8.9 12.2 25.3 20.2 50.6 15.0 5.0 20.4 16.0 12.5 21.0 5.9 95.7 26.6 29.8 1144.0 18.8 18.8 23.3 22.0 52.3 27.1 25.6 28.8 17.8 31.7 25.4 19.0 11.1 20.2 1283.3 32.5 21.6 23.6 33.3 24.5 18.6 28.1 24.3 22.6 15.4 19.4 6.5 17.5 121.4 59.8 57.5 271.7 30.5 18.4 48.7 FAM105A "FLJ11127, NET20" ENSG00000145569 "Family with sequence similarity 105 member A" Q9NUU6 5 14581775-14615007 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 89.3;Hofbauer cells: 83.6;Intestinal endocrine cells: 59.1;Kupffer cells: 69.4;Spermatogonia: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.0;HMC-1: 44.0;OE19: 12.3;THP-1: 12.2;U-937: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 5.1 3.5 4.0 7.9 4.9 35.4 5.2 3.1 5.1 6.3 15.4 9.0 4.5 8.3 3.0 5.6 2.9 3.1 4.1 3.0 3.9 4.3 5.2 1.9 28.8 16.7 6.1 3.8 4.0 13.3 1.9 8.7 6.7 7.9 12.6 17.3 10.3 3.1 13.5 1.3 2.6 13.7 3.3 10.8 13.2 5.4 4.4 4.1 3.5 27.2 3.0 6.2 7.1 5.8 0.1 26.7 6.9 26.2 14.1 9.6 16.2 0.0 0.6 1.2 0.0 0.2 0.0 5.3 1.5 1.4 0.4 0.7 1.9 1.4 0.0 0.8 0.7 2.2 0.1 2.6 1.2 0.6 0.8 3.6 3.4 14.0 0.3 1.3 0.0 44.0 0.1 0.3 0.2 0.0 0.0 0.0 2.2 0.0 5.5 0.1 1.1 0.0 1.2 1.9 12.3 9.4 0.4 0.5 1.6 0.0 10.5 4.6 5.1 0.7 0.5 0.0 1.3 0.5 12.2 0.0 0.6 3.4 0.2 1.1 0.0 0.0 0.0 0.8 20.8 0.2 0.0 26.2 0.1 4.5 12.4 6.0 0.1 5.7 6.1 26.7 0.1 7.8 7.5 6.9 14.1 9.4 19.7 9.6 16.2 4.0 4.9 3.1 5.1 3.9 4.3 6.1 3.8 7.9 4.1 89.3 8.2 0.9 4.4 7.4 0.7 0.0 2.5 0.0 3.4 0.0 0.0 0.7 0.0 0.0 1.1 6.3 22.2 0.0 0.0 1.5 5.9 7.8 49.6 0.2 83.6 0.0 59.1 4.3 69.4 2.0 4.0 37.7 11.8 0.0 39.6 2.5 0.0 37.1 3.2 0.0 0.9 0.0 3.8 20.5 57.7 5.9 1.1 30.5 41.5 2.7 FAM107A "DRR1, TU3A" ENSG00000168309 "Family with sequence similarity 107 member A" O95990 3 58564117-58627610 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Stress response" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.7" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 151.7;Ito cells: 84.7;Muller glia cells: 82.8" "Cancer enriched" "Detected in many" 6 "glioma: 110.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "ASC diff: 11.7;HUVEC TERT2: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055888 Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA055888: AB_2682957" "unprognostic (1.20e-2)" "unprognostic (1.19e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.11e-1)" "unprognostic (7.80e-3)" "prognostic favorable (3.38e-4)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (5.73e-2)" "unprognostic (7.82e-3)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (7.95e-3)" 22.4 4.6 119.4 4.7 86.5 1.3 8.4 32.4 149.7 17.0 7.6 68.6 1.7 3.6 9.4 25.1 13.9 39.6 8.4 15.8 91.5 52.0 12.4 3.5 18.1 2.4 66.6 44.3 4.3 11.1 4.1 12.0 13.8 33.5 16.3 8.4 10.7 17.5 19.4 7.5 3.5 5.8 19.8 77.5 12.0 5.8 2.5 87.2 1.2 9.9 1.4 4.8 6.5 10.2 0.3 0.3 1.3 0.9 0.7 0.6 0.1 0.0 0.0 0.5 0.0 11.7 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 1.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.4 0.5 0.3 0.4 0.6 0.2 0.3 0.2 0.2 0.3 0.2 0.3 0.6 0.7 0.9 0.3 0.3 0.1 119.4 86.5 32.4 80.7 91.5 52.0 66.6 44.3 33.5 87.2 6.0 8.5 0.0 39.0 1.9 4.2 23.8 5.1 4.0 5.7 36.6 49.1 0.0 8.3 0.9 13.1 151.7 0.0 0.0 0.2 0.0 9.4 6.0 1.1 0.8 0.0 3.2 3.5 84.7 1.3 25.6 30.5 1.9 5.0 0.0 0.0 82.8 0.5 0.0 11.0 1.9 41.9 6.5 14.4 0.7 0.2 2.4 0.0 0.0 0.0 0.9 FAM109A "FLJ32356, IPIP27A, SES1" ENSG00000198324 "Family with sequence similarity 109 member A" Q8N4B1 12 111360651-111369121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 37.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 44.6;Enterocytes: 38.0;Paneth cells: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 6.1" "Group enriched" "Detected in many" 4 "B-cells: 2.5;dendritic cells: 6.1;monocytes: 3.9" "Cell line enhanced" "Detected in many" "Hep G2: 27.2;OE19: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.26e-1)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.05e-1)" "unprognostic (6.02e-2)" "unprognostic (1.15e-3)" "unprognostic (6.18e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (5.51e-2)" "unprognostic (9.42e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.95e-1)" "unprognostic (1.31e-1)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" 5.3 8.5 4.3 6.3 4.4 1.2 11.0 4.6 4.9 7.8 14.4 4.7 5.2 23.8 6.9 3.0 6.7 4.8 12.2 7.3 2.4 2.9 5.4 8.1 6.7 6.1 4.1 2.0 9.0 25.9 2.4 2.7 11.3 4.5 5.4 4.6 3.9 5.1 3.4 5.4 9.9 37.6 3.7 3.5 12.7 14.8 6.3 3.6 1.7 4.4 5.3 3.4 4.1 4.7 2.5 6.1 0.4 3.9 0.8 0.9 1.4 5.3 4.8 4.0 6.2 5.7 5.0 10.8 3.5 3.1 2.7 1.5 7.4 3.7 0.1 7.6 5.2 3.9 2.9 2.2 2.2 1.2 2.1 4.9 3.6 1.6 27.2 3.3 0.7 4.9 4.1 5.8 4.1 1.3 5.5 4.1 1.8 8.3 0.4 3.4 5.0 0.9 4.3 6.3 21.7 11.4 3.5 2.7 1.5 2.8 3.0 0.9 12.2 5.4 8.4 2.3 3.6 5.6 1.3 4.9 4.1 8.3 4.7 2.6 3.5 3.0 0.6 4.1 2.4 4.6 0.1 2.3 0.4 0.6 3.9 0.9 0.5 0.2 0.2 6.1 2.5 0.1 0.8 0.0 0.8 3.7 0.7 0.0 1.4 4.3 4.4 4.6 4.9 2.4 2.9 4.1 2.0 4.5 3.6 6.0 1.3 0.8 1.6 4.2 1.5 0.0 2.5 1.4 0.0 0.0 0.0 1.0 0.0 0.0 44.6 2.2 38.0 0.0 0.0 3.8 2.7 2.9 0.0 3.4 8.8 3.2 6.9 10.4 4.1 3.2 7.2 4.4 1.7 0.0 14.6 1.7 0.0 21.0 6.7 0.0 2.7 0.0 3.4 1.5 3.2 2.8 1.0 0.5 17.4 2.0 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 83.4;eosinophil: 24.8;intermediate monocyte: 25.1;non-classical monocyte: 37.7" "Group enriched" "Detected in all" 9 "granulocytes: 83.4;monocytes: 37.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 5.2 3.6 1.7 17.7 4.2 7.4 7.7 1.9 3.9 6.5 8.8 2.0 7.7 10.0 4.0 6.1 22.1 1.9 6.9 4.8 1.7 2.5 4.8 3.9 15.2 18.7 2.1 1.9 2.6 3.5 9.3 5.1 11.1 3.6 11.1 3.4 3.1 12.7 10.5 3.7 39.9 9.2 1.3 1.6 15.1 5.5 2.8 1.3 22.9 7.7 8.0 18.9 7.8 9.7 1.9 5.8 83.4 37.7 1.0 6.4 3.2 12.7 3.4 1.9 3.6 2.2 0.9 13.4 4.0 2.2 2.6 2.3 7.5 8.0 4.1 1.8 2.5 3.6 20.7 1.6 10.5 2.1 3.3 1.1 8.6 2.2 1.9 1.0 2.3 3.0 0.6 13.1 3.5 3.5 0.8 1.7 3.8 4.6 10.3 2.3 7.6 6.5 6.4 2.5 8.2 5.9 6.5 3.4 5.4 1.9 9.2 3.7 4.4 3.4 40.4 1.8 0.8 16.7 3.5 2.2 6.1 4.5 5.5 4.4 3.8 3.2 1.7 0.9 6.1 4.4 83.4 4.4 24.8 2.2 25.1 2.0 1.1 4.0 4.6 5.8 1.9 4.9 4.7 2.5 1.0 37.7 0.6 6.4 3.2 1.7 4.2 1.9 3.9 1.7 2.5 2.1 1.9 3.6 1.3 0.0 6.5 19.9 14.7 29.0 0.2 2.4 5.1 4.0 0.0 10.4 0.0 36.4 1.7 8.3 6.0 5.8 6.9 46.7 5.2 131.1 4.7 17.7 52.8 0.8 17.4 4.8 10.4 18.4 36.5 13.5 3.1 27.8 6.8 6.4 7.5 0.2 10.7 8.0 1.8 2.1 2.5 6.5 5.2 1.9 5.3 32.1 26.2 26.2 7.8 20.9 FAM110C ENSG00000184731 "Family with sequence similarity 110 member C" Q1W6H9 2 38814-46870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 41.1" "Group enriched" "Detected in many" 5 "Basal glandular cells: 169.4;Urothelial cells: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 10.1;HBEC3-KT: 8.0;hTCEpi: 8.1;RPTEC TERT1: 13.9;RT4: 19.0;SK-BR-3: 8.6" "Low region specificity" "Detected in some" "HPA036144, HPA036145" Uncertain NA NA "HPA036144: AB_10670710, HPA036145: AB_2674968" "unprognostic (4.29e-2)" "unprognostic (1.96e-1)" "unprognostic (8.47e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (7.64e-4)" "unprognostic (3.07e-2)" "unprognostic (2.08e-1)" "unprognostic (1.94e-1)" "unprognostic (3.94e-1)" "unprognostic (1.73e-1)" "unprognostic (8.36e-2)" "unprognostic (1.90e-1)" "unprognostic (5.02e-2)" "unprognostic (3.64e-2)" "unprognostic (1.41e-2)" "unprognostic (4.82e-3)" "unprognostic (2.68e-1)" 7.6 2.5 1.7 5.2 1.6 0.0 3.7 0.7 2.1 6.1 9.8 2.4 41.1 7.3 3.2 24.7 31.7 6.1 8.5 2.8 1.5 0.9 13.1 11.6 2.5 0.9 0.8 1.3 5.3 16.4 4.5 3.0 0.8 2.3 6.4 7.1 2.7 4.5 18.9 1.0 6.7 10.7 1.0 2.2 1.1 5.0 4.9 1.3 1.2 4.5 9.0 9.5 7.4 10.0 0.3 0.2 1.0 0.2 0.4 2.4 0.0 3.9 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 6.3 0.0 4.9 0.0 0.2 10.1 0.0 8.0 0.0 0.6 0.3 0.0 1.3 0.9 0.0 0.0 0.0 0.0 8.1 0.0 1.4 0.0 0.0 7.0 0.0 0.0 0.0 6.7 4.3 0.0 1.0 4.7 2.5 0.0 0.0 0.0 13.9 19.0 0.5 0.0 0.0 8.6 0.0 0.8 3.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.3 0.2 0.2 1.0 0.4 0.1 0.2 2.4 0.0 1.7 1.6 0.7 2.1 1.5 0.9 0.8 1.3 2.3 1.3 0.0 4.3 0.0 169.4 20.4 0.0 4.9 28.1 1.4 23.9 33.2 0.0 0.0 16.6 9.3 0.2 0.6 18.4 0.0 4.6 0.0 1.1 15.5 0.0 11.9 0.1 3.2 28.5 0.6 0.0 0.4 2.0 0.2 0.0 0.0 36.3 1.9 9.3 20.3 1.8 10.2 0.0 0.0 1.0 0.0 0.1 26.3 0.0 1.0 9.7 194.1 FAM111A "FLJ22794, KIAA1895" ENSG00000166801 "Family with sequence similarity 111 member A" Q96PZ2 11 59142748-59155039 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, DNA replication, Host-virus interaction" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 73.4" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039529, HPA040176" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Nucleoplasm, Nucleoli fibrillar center" "HPA039529: AB_10795149, HPA040176: AB_10793958" "unprognostic (4.12e-3)" "unprognostic (8.47e-2)" "unprognostic (7.80e-3)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (5.83e-3)" "unprognostic (1.81e-1)" "unprognostic (9.88e-2)" "unprognostic (5.96e-2)" "unprognostic (2.74e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.15e-5)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (1.76e-2)" "prognostic favorable (4.39e-4)" 16.3 13.7 4.8 28.1 6.7 9.9 14.5 3.3 4.8 14.7 14.2 8.3 13.2 12.8 18.1 16.8 10.2 11.3 15.9 6.7 5.5 3.9 14.5 11.7 17.5 19.6 7.4 3.8 11.2 10.7 17.8 17.4 10.8 8.1 22.5 11.7 13.2 13.4 13.0 5.6 11.0 19.3 14.0 12.3 29.5 12.9 5.9 6.5 73.4 19.5 12.9 21.3 10.9 13.2 4.6 6.5 7.7 6.3 6.9 8.6 2.4 21.2 5.5 2.7 2.6 6.1 7.4 1.8 30.4 16.6 13.1 19.3 8.3 20.0 31.2 12.8 9.8 17.9 7.4 9.0 13.3 16.6 27.7 0.4 11.7 7.0 2.5 6.3 18.6 15.9 5.1 3.4 12.2 3.9 7.6 12.1 19.3 1.4 25.8 14.1 6.0 28.1 12.5 1.2 6.6 6.0 19.4 9.8 7.3 8.8 19.0 0.0 0.7 15.6 13.1 5.9 1.5 26.9 8.4 11.7 21.4 19.3 14.6 14.2 13.2 13.7 5.1 11.7 13.3 25.7 6.2 6.3 6.7 6.6 5.4 8.6 4.2 4.5 4.8 6.5 4.6 4.4 3.7 7.7 6.9 2.6 1.8 4.6 2.4 4.8 6.7 3.3 4.8 5.5 3.9 7.4 3.8 8.1 6.5 59.6 39.5 24.4 9.7 7.6 2.2 3.9 12.7 46.8 26.1 15.7 0.0 8.9 8.3 10.1 0.0 17.5 12.9 0.0 6.6 1.2 14.9 15.7 26.6 7.9 24.4 0.0 5.8 27.6 31.6 1.1 12.0 25.0 6.8 12.6 19.1 29.9 8.0 15.8 6.3 7.6 6.5 0.0 10.7 0.4 1.9 7.8 3.7 21.8 15.3 10.9 FAM111B CANP ENSG00000189057 "Family with sequence similarity 111 member B" Q6SJ93 11 59107185-59127410 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 43.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory B-cell: 5.7;naive B-cell: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038637 Uncertain Approved Nucleoplasm,Cytosol No Yes Nucleoplasm Cytosol "HPA038637: AB_10672522" "unprognostic (2.31e-1)" "unprognostic (2.68e-2)" "unprognostic (1.80e-3)" "unprognostic (6.94e-2)" "unprognostic (1.89e-1)" "unprognostic (1.96e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.49e-3)" "unprognostic (1.40e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.01e-2)" "unprognostic (1.24e-5)" "unprognostic (2.94e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-3)" "unprognostic (1.24e-1)" 1.3 1.3 0.4 8.9 0.8 3.5 1.9 0.3 1.1 1.8 4.7 0.4 0.3 2.5 0.8 2.0 9.3 0.7 1.8 1.0 0.4 0.4 1.8 2.6 2.1 9.9 0.5 0.3 1.0 0.8 1.4 0.9 2.8 0.8 1.2 5.0 0.3 2.6 0.3 0.5 3.5 4.1 1.3 0.6 5.4 2.8 1.0 0.6 43.9 0.7 9.2 11.1 1.5 2.6 5.7 0.3 3.1 0.2 0.1 1.4 0.3 24.4 6.3 9.4 0.1 1.0 1.8 0.1 18.6 9.3 11.1 16.5 13.3 9.7 30.5 12.6 5.4 9.3 19.0 13.7 12.6 19.8 15.8 3.3 3.3 12.0 5.8 0.0 0.1 3.9 0.4 0.4 10.7 0.8 2.1 5.9 8.3 0.9 28.8 13.0 9.2 19.2 0.2 0.1 14.8 7.4 20.3 14.0 11.9 5.9 21.1 1.8 6.0 15.4 17.8 3.0 3.6 19.7 1.7 3.2 8.6 18.8 26.0 16.9 22.2 16.0 0.2 12.5 0.1 12.3 0.5 0.2 0.2 0.3 0.1 0.2 5.7 0.4 0.7 0.3 5.7 0.2 0.2 3.1 0.1 0.2 0.3 1.4 0.3 0.4 0.8 0.3 1.1 0.4 0.4 0.5 0.3 0.8 0.6 0.0 0.0 4.8 2.0 3.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.3 2.4 0.1 0.5 6.3 0.9 FAM124A FLJ30707 ENSG00000150510 "Family with sequence similarity 124 member A" Q86V42 13 51222334-51284241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.3" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 43.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HAP1: 13.3;HUVEC TERT2: 7.9;NTERA-2: 26.1;SH-SY5Y: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048182 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA048182: AB_2680301" "unprognostic (3.94e-3)" "unprognostic (8.76e-2)" "unprognostic (8.05e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-1)" "unprognostic (8.37e-2)" "unprognostic (2.59e-2)" "unprognostic (2.08e-3)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (7.38e-3)" "unprognostic (4.51e-2)" "unprognostic (4.54e-3)" "unprognostic (1.05e-2)" 5.3 3.5 7.7 4.7 19.6 0.7 2.6 2.6 15.0 3.3 7.2 40.3 0.3 1.4 3.8 8.4 2.4 3.6 4.3 7.1 13.5 7.4 6.7 1.5 3.3 1.5 29.1 7.7 1.3 2.7 1.2 1.5 6.2 18.8 6.5 2.6 3.8 12.4 8.1 1.8 1.9 2.1 8.9 25.3 13.2 4.1 2.3 26.7 0.3 2.8 0.6 1.1 4.1 1.8 0.8 1.0 2.7 0.9 1.2 0.8 0.3 0.0 1.2 0.9 0.8 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.4 0.0 0.0 1.6 0.1 13.3 0.1 0.1 0.0 2.0 0.0 0.3 0.0 1.0 0.6 0.8 0.3 0.1 0.4 0.0 0.0 7.9 3.5 0.1 0.0 0.0 0.2 3.2 0.2 26.1 0.2 2.0 0.7 0.0 1.9 0.0 0.1 1.9 10.0 0.4 1.6 1.5 2.0 0.2 0.7 0.1 0.0 0.9 0.7 0.9 0.2 0.0 0.0 1.2 2.3 1.1 2.7 0.8 0.8 0.8 0.6 0.8 0.6 0.5 0.6 0.4 0.8 0.7 0.7 2.4 1.2 0.9 1.0 0.6 0.3 7.7 19.6 2.6 11.8 13.5 7.4 29.1 7.7 18.8 26.7 0.0 0.0 0.0 2.1 0.7 7.7 8.9 0.0 2.7 0.0 1.8 47.1 0.0 3.3 1.9 3.5 6.8 0.0 0.0 0.7 0.0 0.9 1.6 1.1 0.0 0.2 6.4 0.0 6.7 0.3 3.3 0.6 0.5 3.3 0.0 0.0 3.4 0.8 0.0 0.4 8.4 43.8 0.0 2.1 0.0 1.4 0.1 0.0 0.0 0.0 0.4 FAM124B FLJ22746 ENSG00000124019 "Family with sequence similarity 124 member B" Q9H5Z6 2 224378698-224402085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.8;blood: 18.0" "Group enriched" "Detected in some" 4 "Endothelial cells: 4.4;granulocytes: 4.6;Ito cells: 1.3;Kupffer cells: 1.9" "Cancer enriched" "Detected in many" 10 "testis cancer: 7.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 18.0;eosinophil: 11.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "HUVEC TERT2: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA070240 Approved Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA070240: AB_2686238" "unprognostic (2.01e-1)" "unprognostic (1.83e-1)" "unprognostic (6.87e-3)" "unprognostic (2.49e-1)" "unprognostic (7.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.28e-2)" "unprognostic (5.78e-2)" "unprognostic (3.19e-1)" "unprognostic (1.85e-1)" "unprognostic (1.57e-1)" "unprognostic (3.36e-1)" "unprognostic (7.61e-3)" "unprognostic (1.36e-2)" "unprognostic (4.30e-1)" "unprognostic (2.25e-1)" "unprognostic (5.80e-3)" 28.8 0.6 1.6 1.4 1.9 5.9 16.0 0.6 1.8 4.2 2.1 1.6 0.7 1.3 2.4 2.5 2.6 1.8 1.7 2.4 2.2 2.2 1.4 2.6 5.8 0.8 2.0 0.6 2.5 0.5 9.4 0.8 12.5 1.8 3.9 1.5 4.0 1.7 0.6 4.3 2.6 1.5 3.5 2.1 0.8 1.2 2.3 0.2 1.0 2.9 0.8 1.0 3.4 2.6 0.0 5.6 18.0 2.1 3.8 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 49.2 0.0 2.2 0.1 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 2.1 11.6 0.1 1.6 0.0 0.0 0.5 0.0 5.6 0.0 0.0 0.0 0.1 3.8 0.5 0.0 1.7 0.7 1.6 1.9 0.6 1.8 2.2 2.2 2.0 0.6 1.8 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.1 0.2 0.0 4.6 0.2 0.4 0.0 0.0 1.3 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 FAM129A "C1orf24, GIG39, NIBAN" ENSG00000135842 "Family with sequence similarity 129 member A" Q9BZQ8 1 184790724-184974550 "Cancer-related genes, Predicted intracellular proteins" "Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 129.1;urinary bladder: 90.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 641.6;monocytes: 234.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "neutrophil: 32.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 32.7" "Cell line enhanced" "Detected in many" "Karpas-707: 29.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA028172, HPA028231, HPA028657" Approved Supported "Plasma membrane,Cytosol" NA NA 40000 "Plasma membrane, Cytosol" "HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680" "unprognostic (4.61e-3)" "unprognostic (3.45e-2)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (2.77e-1)" "unprognostic (3.87e-1)" "unprognostic (3.23e-2)" "unprognostic (1.30e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (4.12e-1)" "unprognostic (1.32e-1)" "unprognostic (2.94e-3)" "unprognostic (9.01e-3)" "unprognostic (4.38e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (4.52e-4)" 10.1 3.5 1.1 16.9 1.8 2.3 7.8 0.8 1.3 13.0 39.3 1.0 14.9 2.5 14.6 11.0 32.3 10.7 30.4 52.2 1.1 1.1 1.8 1.2 6.1 10.7 3.0 0.5 8.0 27.3 0.8 1.9 2.9 1.7 34.6 5.1 13.8 59.3 14.7 21.4 4.1 8.3 129.1 2.1 6.5 30.0 4.1 1.3 4.9 4.7 14.7 8.7 90.3 20.3 0.5 2.3 32.7 1.5 2.6 5.3 0.8 13.8 0.1 0.0 0.0 9.9 15.1 0.5 7.1 14.7 6.2 7.8 0.0 5.9 0.0 4.7 18.3 1.6 15.7 0.8 0.5 10.0 27.6 1.1 5.8 2.9 0.0 23.2 18.8 6.6 13.8 22.7 18.0 21.9 4.4 0.0 2.1 1.3 29.4 0.2 0.0 0.6 3.3 3.8 0.0 1.5 4.4 3.4 0.2 8.5 0.2 0.8 0.7 0.1 0.0 10.2 2.5 3.1 6.0 1.1 12.3 0.0 2.2 14.6 24.7 9.7 2.9 24.1 7.9 12.0 7.1 1.5 4.7 2.5 0.9 2.1 0.5 2.2 2.3 2.3 0.1 0.2 0.9 32.7 2.6 0.3 0.2 5.3 0.8 1.1 1.8 0.8 1.3 1.1 1.1 3.0 0.5 1.7 1.3 8.9 24.2 6.6 12.3 11.2 0.1 641.6 7.6 9.4 48.9 1.8 0.0 0.2 0.0 2.5 0.0 17.7 0.0 0.0 61.8 0.9 15.1 45.2 2.3 0.0 13.2 4.8 1.7 11.6 31.3 0.2 10.0 78.8 13.5 234.4 0.1 0.0 33.4 0.0 6.7 0.3 0.0 84.1 72.3 0.0 0.1 7.3 0.3 29.8 0.6 15.6 FAM129B "bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Family with sequence similarity 129 member B" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 95.6;placenta: 103.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 7.8 17.9 4.5 8.4 5.6 5.1 6.7 6.5 4.2 19.1 13.9 4.2 12.3 11.9 9.6 7.3 95.6 8.9 22.9 8.2 4.8 4.1 9.9 5.5 24.0 5.1 6.9 3.1 9.3 24.8 6.8 5.7 103.7 9.1 12.8 7.2 9.4 23.6 11.7 4.1 17.3 17.1 10.5 7.0 6.8 13.8 5.4 4.2 1.3 39.8 44.6 48.8 11.8 28.3 0.0 2.4 0.5 3.7 0.0 0.5 1.7 22.1 25.3 5.1 6.7 15.6 30.4 24.0 44.1 41.0 24.4 15.1 8.0 24.5 0.0 17.5 49.8 30.1 37.0 4.4 32.6 8.1 4.2 4.7 3.8 37.5 8.3 30.8 0.1 10.8 33.2 20.5 40.1 14.1 44.9 36.6 1.4 7.1 0.2 46.1 26.1 0.2 6.2 5.3 38.1 33.3 2.6 17.3 11.6 20.9 17.8 8.2 3.8 36.0 25.7 15.6 7.6 16.9 1.2 47.3 25.1 10.9 31.5 36.4 0.4 0.8 0.0 70.6 3.6 46.3 0.5 3.7 0.0 0.2 1.3 0.0 0.0 0.5 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.7 4.5 5.6 6.5 4.2 4.8 4.1 6.9 3.1 9.1 4.2 65.5 43.5 0.0 30.8 28.7 0.4 4.2 38.2 10.7 36.4 36.6 0.0 59.0 3.3 72.5 1.0 28.6 94.2 0.0 92.9 33.5 19.8 56.7 28.9 1.0 21.5 0.0 21.4 28.8 11.8 1.8 29.7 23.3 21.9 2.8 41.6 12.6 107.3 42.4 47.4 1.5 1.5 12.9 32.0 0.3 1.1 32.6 101.1 2.2 37.3 104.7 FAM129C "BCNP1, FLJ39802" ENSG00000167483 "Family with sequence similarity 129 member C" Q86XR2 19 17523301-17553839 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9" "Cell type enriched" "Detected in some" 37 "B-cells: 63.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 226 "memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2" "Group enriched" "Detected in many" 284 "B-cells: 19.5;dendritic cells: 37.2" "Group enriched" "Detected in some" 22 "Daudi: 29.8;REH: 15.0;U-698: 18.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043277 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043277: AB_10794391" "unprognostic (6.55e-5)" "unprognostic (3.03e-7)" "unprognostic (3.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-4)" "unprognostic (3.79e-3)" "unprognostic (1.69e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-1)" "unprognostic (9.47e-4)" "unprognostic (8.42e-2)" "unprognostic (5.51e-5)" "unprognostic (3.39e-1)" "unprognostic (9.03e-3)" "unprognostic (6.08e-2)" "unprognostic (7.56e-3)" 0.5 0.2 0.2 37.9 0.2 12.1 0.2 0.3 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 2.2 0.2 0.5 0.6 0.2 0.2 0.5 0.3 0.9 17.4 0.2 0.0 0.3 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.4 9.9 0.2 0.1 0.2 12.3 0.0 0.3 28.5 0.4 0.5 0.0 2.5 0.5 0.4 35.4 3.0 0.4 19.5 37.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.7 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.1 63.2 0.7 0.1 0.1 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.1 0.0 0.1 0.0 0.0 1.3 0.3 0.4 0.0 0.4 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.9 0.3 0.1 0.0 0.0 0.3 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5" HPA042800 Uncertain Approved "Nucleoli rim,Mitotic chromosome" "Secreted - unknown location" Yes No "Nucleoli rim" "Mitotic chromosome" "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 8.1 14.9 18.8 4.6 26.4 2.5 5.0 21.9 54.7 5.4 6.4 8.0 4.8 6.3 7.5 4.9 7.5 7.7 8.4 11.9 28.1 13.0 4.1 3.0 6.0 3.4 9.1 25.9 8.8 11.3 9.2 16.4 5.0 7.8 6.7 3.5 3.3 7.1 11.7 9.3 10.5 5.8 8.7 5.9 5.3 5.5 7.0 7.0 0.8 3.5 3.9 2.7 5.5 4.1 2.1 5.5 11.1 6.5 1.6 2.2 2.5 8.2 3.4 5.5 9.7 7.5 6.2 5.2 3.7 8.4 5.9 4.6 2.6 2.9 1.2 15.5 3.6 12.6 7.8 0.0 6.7 3.8 8.8 9.3 0.0 5.2 5.6 7.6 0.1 6.5 4.6 1.1 5.0 11.6 5.5 11.8 5.7 1.8 1.3 2.2 6.4 3.2 0.2 9.4 5.1 6.9 5.8 2.2 7.9 5.9 0.2 16.9 17.6 2.3 6.5 8.6 3.7 19.1 2.1 11.9 7.2 5.6 5.8 11.6 14.0 8.4 0.8 23.2 1.2 5.1 2.0 4.8 6.0 1.5 6.5 1.6 2.0 1.2 1.6 5.5 2.1 1.2 1.5 11.1 1.6 3.4 2.3 2.2 2.5 18.8 26.4 21.9 54.7 28.1 13.0 9.1 25.9 7.8 7.0 6.0 5.3 6.7 16.9 9.8 21.2 5.1 10.2 16.0 1.2 14.0 13.7 8.2 1.7 5.6 3.9 8.8 13.1 23.3 2.9 2.7 5.4 12.7 6.9 1.5 6.8 22.3 9.2 15.4 5.4 0.7 17.3 8.3 1.7 9.0 6.4 14.1 7.4 8.6 19.4 3.0 16.3 6.5 10.3 11.6 6.8 12.8 27.8 4.4 8.1 13.1 FAM131B KIAA0773 ENSG00000159784 "Family with sequence similarity 131 member B" Q86XD5 7 143353400-143362770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell type enhanced" "Detected in some" 13 "Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9" "Cancer enriched" "Detected in many" 11 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021371, HPA029992" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021371: AB_1852341, HPA029992: " "unprognostic (1.70e-1)" "unprognostic (7.26e-2)" "unprognostic (1.29e-1)" "unprognostic (5.61e-2)" "unprognostic (5.97e-2)" "unprognostic (2.54e-2)" "unprognostic (9.99e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.00e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (3.53e-2)" 1.5 2.1 10.0 2.0 12.4 0.9 1.2 37.2 47.1 2.7 2.0 15.1 0.0 1.7 4.4 1.0 1.7 1.6 1.4 1.1 9.1 6.8 1.1 0.9 1.5 1.3 14.6 12.3 1.0 0.9 6.4 0.4 0.9 13.8 1.0 2.2 0.0 0.9 1.0 7.7 0.8 2.1 5.6 18.6 1.1 1.4 1.2 11.3 0.0 0.9 0.0 1.1 1.2 0.5 0.0 0.2 0.0 0.5 0.1 2.1 0.2 0.0 0.1 5.0 0.0 4.1 5.2 0.0 0.2 1.2 0.8 0.2 10.3 0.0 0.0 0.0 0.3 0.0 0.2 2.0 0.4 0.7 2.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 6.5 0.9 0.1 0.0 0.0 0.7 0.0 0.0 0.3 16.8 0.0 16.1 0.0 0.0 0.0 0.0 0.0 16.4 0.5 0.2 1.2 0.0 1.1 0.0 0.0 0.7 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.1 3.3 0.1 0.0 0.3 0.0 2.1 0.5 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.2 0.0 0.0 0.2 10.0 12.4 37.2 25.0 9.1 6.8 14.6 12.3 13.8 11.3 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 2.4 0.6 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 10.8;HEK 293: 7.0;PC-3: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" NA NA "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: AB_2673711" "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favorable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.3 10.8 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.4 0.0 0.4 0.5 2.7 1.2 1.4 0.3 0.4 0.0 7.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 3.8 0.7 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.5 2.2 8.0 0.0 0.0 4.6 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.0 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 0.0 0.0 0.0 0.3 0.2 3.5 1.6 2.5 0.0 0.0 8.7 3.9 0.0 16.6 2.6 1.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 36.5 3.4 0.6 0.0 1.3 0.0 0.0 0.0 4.6 0.0 32.7 0.4 0.0 0.0 0.3 2.0 0.0 0.3 0.6 1.9 1.0 0.0 0.0 0.0 0.4 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.8;pituitary gland: 8.2;testis: 16.1" "Group enriched" "Detected in some" 9 "Bipolar cells: 12.3;Early spermatids: 14.0;Horizontal cells: 19.1;Late spermatids: 18.2;Spermatocytes: 21.3;Spermatogonia: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.1;Karpas-707: 22.2;U-2197: 11.6;U-266/70: 17.4;U-266/84: 37.7" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.5 3.0 4.7 0.4 14.8 0.3 0.8 2.3 7.7 1.7 0.5 0.5 0.0 0.4 1.0 0.8 0.4 1.1 0.7 2.2 2.5 4.5 0.4 0.4 0.5 0.4 2.3 4.4 1.4 0.4 0.4 8.2 0.4 3.7 0.4 0.5 0.2 0.4 0.5 0.3 0.6 0.5 0.8 4.5 0.5 0.4 16.1 2.6 0.0 0.9 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 22.2 0.0 0.0 0.0 0.0 0.5 0.0 5.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.5 11.6 0.5 17.4 37.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 14.8 2.3 7.3 2.5 4.5 2.3 4.4 3.7 2.6 0.0 0.0 0.0 0.0 0.6 12.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 1.3 0.0 18.2 1.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 1.1 0.0 0.2 21.3 34.9 0.1 0.0 0.0 0.0 0.0 FAM135B C8ORFK32 ENSG00000147724 "Family with sequence similarity 135 member B" Q49AJ0 8 138130023-138496822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.1;brain: 14.3;testis: 10.3" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 27.7;Cone photoreceptor cells: 27.5;Early spermatids: 96.5;Late spermatids: 22.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "RH-30: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023911, HPA023950, HPA024815" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA023911: AB_1845791, HPA023950: AB_1845792, HPA024815: AB_10601376" "unprognostic (3.78e-1)" "unprognostic (4.80e-1)" "unprognostic (1.71e-2)" "unprognostic (6.64e-2)" "unprognostic (1.03e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.36e-3)" "unprognostic (4.54e-2)" "unprognostic (6.85e-4)" "unprognostic (9.92e-3)" "unprognostic (9.82e-3)" "unprognostic (4.47e-1)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (1.30e-1)" 0.6 8.1 12.1 0.9 6.8 0.6 0.7 13.9 14.3 0.7 2.7 1.3 0.0 1.4 0.6 0.9 0.7 0.7 0.7 0.8 9.3 4.5 1.4 0.8 0.7 0.6 4.6 5.6 0.6 1.9 0.6 3.6 0.6 5.2 1.3 2.3 0.7 0.7 1.4 0.6 0.6 1.4 0.8 2.5 0.6 2.5 10.3 3.5 0.0 0.6 0.0 0.6 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 14.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 6.8 13.9 12.3 9.3 4.5 4.6 5.6 5.2 3.5 0.0 0.0 0.0 0.0 0.0 27.7 1.1 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 96.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 22.0 1.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 FAM149A "DKFZP564J102, MST119, MSTP119" ENSG00000109794 "Family with sequence similarity 149 member A" A5PLN7 4 186104419-186172667 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.7" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 34.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 11.3;JURKAT: 8.1;MOLT-4: 8.0;RT4: 9.3;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "HPA044019, HPA055004" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA044019: AB_2732513, HPA055004: AB_2682667" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (4.64e-2)" "prognostic favorable (2.67e-6)" "unprognostic (7.08e-2)" "unprognostic (9.12e-2)" "unprognostic (1.41e-3)" "unprognostic (1.06e-1)" "unprognostic (2.52e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.81e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-1)" "unprognostic (2.36e-1)" 8.7 4.3 17.6 3.7 22.7 0.3 8.6 5.1 12.4 6.1 7.3 8.2 4.7 4.6 6.0 9.8 9.1 11.1 12.8 7.3 15.4 10.0 27.3 37.7 4.3 1.1 8.9 5.8 6.2 19.6 8.8 3.7 1.9 7.4 7.5 6.2 12.2 12.2 13.3 7.0 1.7 3.9 13.8 12.4 1.9 8.4 3.6 5.7 1.0 2.7 3.2 1.5 8.4 4.9 1.0 0.7 0.2 0.0 0.0 4.0 0.0 0.0 3.2 2.9 0.1 11.3 4.6 0.1 0.0 0.0 0.3 0.3 0.0 1.9 0.0 1.6 1.5 2.9 0.0 5.1 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.7 0.1 0.2 2.1 0.3 0.2 0.0 1.1 0.0 8.1 0.0 2.5 1.3 1.6 8.0 0.3 5.1 0.0 0.0 0.3 0.0 2.0 1.7 9.3 14.2 3.9 0.1 0.0 4.4 0.9 1.0 0.0 0.8 0.2 1.7 0.0 1.6 0.0 0.0 0.0 0.8 0.0 1.3 0.2 0.0 0.0 0.1 0.0 0.1 1.0 0.1 1.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.7 4.0 0.0 17.6 22.7 5.1 12.4 15.4 10.0 8.9 5.8 7.4 5.7 0.0 1.0 0.0 2.3 0.5 11.0 6.9 17.8 10.7 6.8 5.2 43.2 0.6 5.0 8.6 10.0 0.3 0.8 0.0 4.8 0.7 2.0 2.4 0.0 11.4 0.2 1.6 9.1 1.3 1.5 3.2 3.1 1.6 3.3 0.0 2.7 20.8 4.0 3.5 3.9 7.7 34.6 6.5 2.2 1.0 2.8 0.3 0.7 0.0 3.0 1.8 FAM151A "C1orf179, MGC27169" ENSG00000162391 "Family with sequence similarity 151 member A" Q8WW52 1 54609182-54623556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 45.8;kidney: 59.3" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 116.1" "Group enriched" "Detected in many" 5 "liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Cell line enriched" "Detected in single" 45 "CACO-2: 41.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA016840 Approved NA NA "HPA016840: AB_2669461" "unprognostic (1.89e-1)" "unprognostic (6.90e-3)" "unprognostic (3.73e-2)" "unprognostic (1.97e-6)" "unprognostic (1.71e-2)" "unprognostic (4.84e-3)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.05e-2)" "unprognostic (4.91e-3)" "unprognostic (9.99e-2)" "prognostic favorable (4.09e-5)" "unprognostic (5.85e-2)" "unprognostic (8.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-3)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.6 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.0 59.3 5.6 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 45.8 0.1 0.1 0.5 0.0 0.3 0.1 0.3 0.1 0.1 0.9 0.1 0.1 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 41.7 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.0 11.6 0.0 4.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 9.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.8 0.0 116.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 FAM153A NY-REN-7 ENSG00000170074 "Family with sequence similarity 153 member A" Q9UHL3 5 177707981-177783398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.6;lymphoid tissue: 8.9;testis: 15.2" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 55.5;Late spermatids: 14.2;Peritubular cells: 20.8;Sertoli cells: 38.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 5.1;naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 13 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "A549: 2.6;Daudi: 1.1;K-562: 1.3" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain NA NA "HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836" "unprognostic (5.92e-5)" "unprognostic (1.41e-1)" "unprognostic (5.94e-2)" "unprognostic (4.20e-3)" "unprognostic (1.58e-2)" "unprognostic (5.55e-3)" "unprognostic (1.70e-2)" "unprognostic (3.41e-2)" "unprognostic (1.44e-1)" "unprognostic (1.77e-2)" "unprognostic (4.75e-2)" "unprognostic (4.33e-2)" "unprognostic (1.30e-1)" "unprognostic (5.33e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" 0.5 0.3 1.3 0.5 3.5 1.1 0.2 10.6 4.3 1.3 0.2 0.6 0.4 0.4 0.4 1.2 0.5 0.3 2.0 1.5 0.3 0.3 0.5 1.2 0.0 5.3 0.5 0.3 5.2 0.2 3.9 0.3 0.3 0.5 0.5 1.5 0.5 0.2 0.0 8.9 0.3 15.2 1.3 1.4 0.2 0.6 0.3 0.1 0.0 0.0 0.0 5.1 0.2 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.3 5.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.9 0.0 2.6 0.6 1.0 1.6 0.0 1.4 2.3 0.0 3.9 0.0 0.0 0.5 55.5 0.7 0.0 0.0 0.0 0.3 0.2 0.9 2.3 0.0 0.1 0.0 0.0 0.6 0.0 14.2 13.0 0.3 0.0 0.0 0.0 0.5 1.0 0.0 20.8 0.0 0.6 38.8 0.6 0.7 0.4 0.5 0.0 0.0 0.0 0.3 FAM153B ENSG00000182230 "Family with sequence similarity 153 member B" P0C7A2 5 176060689-176116015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.2;ovary: 15.3;testis: 14.7" "Group enriched" "Detected in many" 4 "Early spermatids: 211.9;Leydig cells: 93.7;Sertoli cells: 304.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-2 OS: 4.9" "HPA042585, HPA044022, HPA046691, HPA052337, HPA055498" Uncertain NA NA "HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: AB_2681792, HPA055498: AB_2682836" "unprognostic (1.08e-2)" "unprognostic (4.15e-2)" "unprognostic (1.92e-1)" "unprognostic (2.66e-2)" "unprognostic (2.45e-1)" "unprognostic (1.09e-3)" "unprognostic (1.66e-2)" "unprognostic (3.62e-3)" "unprognostic (3.59e-1)" "unprognostic (4.47e-2)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (5.66e-2)" "unprognostic (2.62e-2)" "unprognostic (3.06e-1)" 2.1 2.1 8.1 1.7 5.6 1.4 0.4 16.2 11.1 1.5 0.4 0.4 0.4 0.3 0.7 2.8 0.4 4.5 2.6 1.5 7.9 2.6 0.6 0.4 1.3 3.5 0.4 2.6 15.3 1.2 0.3 7.1 0.4 1.4 2.7 0.6 0.6 0.6 0.9 0.5 0.7 0.6 0.4 1.0 8.5 0.5 14.7 1.8 0.4 1.2 0.4 1.9 0.4 0.4 0.5 2.6 0.7 0.3 0.3 3.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.3 0.1 0.3 0.0 0.5 0.5 0.4 0.4 0.0 0.4 3.1 3.0 0.5 0.3 0.1 2.6 0.0 0.3 8.1 5.6 16.2 11.1 7.9 2.6 0.4 2.6 1.4 1.8 0.0 0.3 0.0 2.6 1.8 3.5 1.1 2.5 1.4 0.0 0.0 2.0 0.0 0.0 0.6 211.9 0.7 0.0 0.0 0.2 0.1 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 21.2 93.7 1.0 1.7 0.0 0.0 2.3 0.3 0.0 48.4 0.0 0.7 304.0 0.9 3.9 1.6 2.4 0.0 0.0 0.0 1.1 FAM153C NY-REN-7-like ENSG00000204677 "Family with sequence similarity 153 member C" Q494X1 5 178006405-178055559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;pituitary gland: 11.8;testis: 21.9" "Group enriched" "Detected in some" 4 "Ciliated cells: 4.0;Early spermatids: 11.8;Late spermatids: 4.5;Leydig cells: 9.5;Peritubular cells: 4.6;Sertoli cells: 12.9" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 2.4;Karpas-707: 3.1;MCF7: 2.7;THP-1: 2.3;U-2 OS: 4.0" "HPA042585, HPA046691, HPA052337" Uncertain NA NA "HPA042585: AB_2678063, HPA046691: AB_2679754, HPA052337: AB_2681792" "unprognostic (5.81e-2)" "unprognostic (3.95e-1)" "unprognostic (1.38e-1)" "unprognostic (8.15e-2)" "unprognostic (2.14e-3)" "unprognostic (5.54e-2)" "unprognostic (1.99e-2)" "unprognostic (3.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.07e-1)" "unprognostic (3.86e-3)" "unprognostic (3.23e-1)" "unprognostic (6.05e-2)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" 0.9 1.1 1.2 0.5 3.9 0.7 0.0 22.5 5.1 0.0 0.0 0.1 0.3 2.0 0.5 0.4 0.1 0.0 2.3 0.7 0.0 0.1 1.0 1.2 0.0 2.0 3.6 0.0 11.8 0.0 2.8 0.0 0.6 1.1 0.1 2.1 0.3 0.0 0.0 1.4 0.0 21.9 1.9 0.5 0.0 0.1 1.1 3.0 0.7 0.0 1.8 3.2 0.7 0.0 1.1 0.0 0.0 0.1 0.0 0.4 0.0 0.9 0.3 0.0 0.0 0.4 2.4 0.4 0.0 0.1 0.3 0.5 0.0 0.0 0.6 1.4 0.0 0.3 0.0 1.0 0.0 0.5 0.0 0.0 0.1 1.0 0.0 0.2 0.9 0.4 3.1 0.3 2.7 0.3 0.0 0.3 0.1 0.0 1.2 2.1 0.5 0.0 0.8 2.0 0.0 0.2 0.3 0.0 0.4 0.5 2.3 0.0 0.0 4.0 0.3 0.0 1.7 0.0 1.4 0.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.1 0.9 0.3 0.1 0.0 1.1 3.2 1.9 0.0 1.8 0.0 3.0 2.2 0.7 0.0 0.3 0.0 1.9 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 9.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 4.6 0.0 0.0 12.9 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.3 FAM155A ENSG00000204442 "Family with sequence similarity 155 member A" B1AL88 13 107163510-107866735 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0;pituitary gland: 10.3" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 18.2;Bipolar cells: 15.9;Early spermatids: 42.2;Horizontal cells: 35.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.4;RPTEC TERT1: 11.7;SCLC-21H: 7.2;SH-SY5Y: 16.3;U-87 MG: 10.4" "Low region specificity" "Detected in all" "HPA039453, HPA058768" Enhanced Approved Nucleoplasm,Vesicles,Centrosome NA NA "Nucleoplasm, Vesicles" Centrosome "HPA039453: AB_10795290, HPA058768: AB_2683813" "unprognostic (8.40e-2)" "unprognostic (9.98e-3)" "unprognostic (1.48e-1)" "unprognostic (3.38e-3)" "unprognostic (2.69e-1)" "unprognostic (5.88e-2)" "unprognostic (1.40e-1)" "unprognostic (5.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.26e-1)" "unprognostic (9.06e-2)" "unprognostic (1.02e-5)" "unprognostic (5.56e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-2)" "unprognostic (3.69e-3)" 0.9 2.7 10.7 0.6 4.3 0.4 0.6 6.9 19.0 1.5 0.7 0.6 0.0 0.5 1.7 4.0 0.7 0.7 1.3 0.7 8.8 10.8 0.7 0.4 1.2 0.5 6.4 4.9 0.7 0.5 0.4 10.3 1.2 2.0 2.7 0.7 0.7 0.3 3.8 0.4 0.5 0.7 1.2 2.7 0.6 0.7 2.3 0.5 0.0 1.3 0.0 0.9 1.4 0.2 0.2 0.0 0.4 0.1 0.8 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 2.5 0.1 5.4 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 4.4 0.0 0.0 0.2 0.0 11.7 1.9 7.2 16.3 0.0 0.0 0.0 0.2 4.1 0.0 0.2 5.0 2.0 1.7 0.2 0.0 0.0 0.0 10.4 0.0 3.5 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.4 0.8 0.0 0.0 0.0 0.0 10.7 4.3 6.9 12.3 8.8 10.8 6.4 4.9 2.0 0.5 3.0 18.2 0.0 0.4 0.1 15.9 0.7 0.0 0.0 3.4 3.5 0.0 0.0 0.0 1.4 42.2 2.9 0.0 0.0 0.0 0.1 1.8 0.8 0.0 0.0 0.2 35.0 0.0 1.8 0.0 14.6 1.7 0.0 0.0 0.0 0.0 7.0 0.3 0.0 1.1 0.0 1.5 6.5 0.2 1.1 0.9 0.0 0.0 0.0 0.0 0.1 FAM155B "CXorf63, TED, TMEM28" ENSG00000130054 "Family with sequence similarity 155 member B" O75949 X 69505241-69532508 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 18.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.9;HAP1: 15.4;Hep G2: 5.6;NTERA-2: 21.3;OE19: 6.0;SCLC-21H: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036093 Uncertain NA NA "HPA036093: AB_10673613" "prognostic unfavorable (4.61e-5)" "unprognostic (1.17e-1)" "unprognostic (2.14e-1)" "unprognostic (5.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.49e-2)" "unprognostic (3.09e-4)" "unprognostic (7.07e-2)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (4.94e-3)" "prognostic unfavorable (1.83e-4)" "prognostic favorable (6.63e-4)" "unprognostic (1.46e-2)" "unprognostic (3.50e-2)" "unprognostic (2.21e-1)" "unprognostic (8.21e-2)" 0.0 0.5 1.4 0.0 1.1 0.0 0.1 3.5 1.4 0.1 0.0 0.0 0.2 0.3 0.0 0.7 0.1 25.0 1.1 2.1 0.5 0.0 0.0 0.0 1.3 0.0 1.8 0.9 1.1 0.0 0.9 0.0 1.1 6.7 0.0 0.0 0.0 0.0 0.4 0.6 0.5 0.8 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 4.3 0.0 0.0 0.0 15.4 0.6 0.0 0.0 4.2 0.0 0.0 5.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.8 0.0 0.0 21.3 6.0 0.0 0.0 0.0 0.0 0.2 0.0 10.2 0.7 0.1 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 18.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.4 0.8 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.2 FAM156B TMEM29B ENSG00000179304 "Family with sequence similarity 156 member B" Q8NDB6 X 52891306-52908560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 34.3" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056640, HPA056643" Uncertain NA NA "HPA056640: AB_2683200, HPA056643: AB_2683201" "unprognostic (2.91e-1)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (3.24e-5)" "unprognostic (2.97e-1)" 6.4 7.4 6.5 10.9 6.9 5.2 7.9 13.7 12.3 4.6 5.0 5.6 13.9 5.0 8.8 9.3 4.6 8.7 5.4 6.4 10.1 5.7 5.9 4.9 5.3 3.8 4.7 11.4 7.7 5.0 3.9 13.9 34.3 5.6 6.2 4.4 7.2 6.1 9.8 5.1 20.6 4.8 7.0 5.5 7.6 4.5 4.6 2.4 3.5 7.0 3.0 4.7 5.9 5.1 1.1 8.0 1.2 7.3 3.1 2.6 3.3 3.7 7.0 4.6 6.6 5.0 4.2 13.5 3.9 6.1 5.9 4.2 3.5 3.7 3.3 2.8 11.6 4.9 4.8 7.9 6.2 1.7 1.0 8.8 2.4 13.6 14.1 17.0 2.2 2.2 9.8 6.5 6.7 5.4 8.8 5.1 9.0 2.6 2.1 7.7 8.5 5.2 12.5 5.0 6.1 12.0 3.5 4.8 5.6 7.1 4.8 4.4 5.2 3.3 8.9 4.3 10.8 5.0 5.8 4.3 3.1 3.5 6.0 4.2 4.7 6.7 6.2 4.4 9.6 1.9 0.0 4.6 1.2 1.2 7.3 1.8 1.1 0.7 1.2 8.0 1.0 2.6 0.6 1.1 3.1 6.8 4.5 2.4 3.3 6.5 6.9 13.7 12.3 10.1 5.7 4.7 11.4 5.6 2.4 0.0 0.6 0.0 0.1 0.1 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 FAM160A1 FLJ43373 ENSG00000164142 "Family with sequence similarity 160 member A1" Q05DH4 4 151409216-151663632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 10.5;Horizontal cells: 7.9;Suprabasal keratinocytes: 12.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 5.8" "Lineage enriched" "Detected in single" 13 "dendritic cells: 5.8" "Cell line enhanced" "Detected in many" "A-431: 8.3;HeLa: 10.1;hTERT-HME1: 9.5;SiHa: 9.0;SK-BR-3: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046348 Enhanced Approved Cytosol NA NA Cytosol "HPA046348: AB_10966145" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.21e-3)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" "unprognostic (1.38e-1)" "unprognostic (5.33e-2)" "unprognostic (4.55e-2)" "unprognostic (1.52e-1)" "unprognostic (7.21e-3)" "unprognostic (1.30e-3)" "unprognostic (2.39e-1)" "unprognostic (1.51e-12)" "unprognostic (2.41e-2)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (1.28e-1)" 1.4 1.2 3.0 3.4 0.8 1.5 3.8 7.5 0.9 6.3 5.2 0.6 10.4 1.7 6.1 5.9 13.1 2.8 4.9 6.5 0.7 0.7 7.0 1.6 5.4 0.1 0.6 0.0 3.7 23.7 11.1 9.4 1.8 4.8 4.5 3.3 10.0 11.1 12.5 33.6 12.6 9.0 1.8 0.7 0.7 2.3 3.5 0.0 0.9 11.4 22.0 10.0 6.2 5.0 0.0 5.8 0.4 0.0 0.1 0.1 0.0 8.3 0.7 0.0 0.2 0.0 0.0 3.1 0.4 2.0 0.8 0.2 3.6 3.1 0.0 0.9 0.1 2.8 7.6 2.2 6.3 1.3 0.0 3.6 0.0 10.1 0.8 0.0 0.0 0.1 0.1 6.3 0.0 9.5 1.9 0.1 0.7 0.0 0.0 0.5 1.2 0.0 0.0 2.9 2.6 0.8 0.0 2.1 0.3 4.4 5.7 1.4 0.4 9.0 7.9 0.0 2.5 3.4 0.0 0.0 0.6 3.7 0.2 1.4 0.0 0.0 0.0 2.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 3.0 0.8 7.5 0.9 0.7 0.7 0.6 0.0 4.8 0.0 3.0 1.3 0.0 6.2 10.5 0.0 1.6 0.0 0.0 6.8 0.0 0.0 0.3 0.0 1.3 1.8 0.3 3.4 0.0 1.5 0.5 0.3 5.9 1.1 0.5 0.2 7.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.0 3.7 1.2 0.0 0.0 0.3 4.5 0.0 0.3 2.1 4.1 12.7 1.4 0.0 1.4 6.8 FAM162B "bA86F4.2, C6orf189" ENSG00000183807 "Family with sequence similarity 162 member B" Q5T6X4 6 116752197-116765723 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.6" "Group enriched" "Detected in some" 4 "Sertoli cells: 64.7;Smooth muscle cells: 58.7" "Cancer enriched" "Detected in many" 18 "testis cancer: 32.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.0;BJ hTERT+: 19.0;BJ hTERT+ SV40 Large T+ RasG12V: 18.3;HHSteC: 5.3;HSkMC: 6.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 6.9" "HPA036112, HPA060342" Enhanced NA NA "HPA036112: AB_10696649, HPA060342: AB_2684258" "unprognostic (1.81e-1)" "unprognostic (5.65e-3)" "unprognostic (1.54e-1)" "unprognostic (3.38e-1)" "unprognostic (5.45e-2)" "unprognostic (1.86e-5)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-2)" "unprognostic (2.44e-2)" "unprognostic (7.32e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.22e-2)" "unprognostic (1.72e-1)" "unprognostic (2.73e-3)" "unprognostic (4.34e-2)" 11.4 12.5 2.2 1.0 4.0 0.5 11.2 0.5 8.6 13.0 3.8 1.1 4.8 1.1 7.8 7.0 6.5 6.7 4.9 7.7 2.0 1.8 4.3 1.0 14.6 2.4 2.7 5.8 7.7 1.5 2.5 6.1 51.6 1.9 9.7 2.2 6.0 6.5 11.8 7.3 2.5 1.9 3.7 1.3 0.5 3.0 2.9 0.5 0.0 8.7 5.2 1.4 5.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 7.0 19.0 3.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.0 0.5 8.6 2.0 1.8 2.7 5.8 1.9 0.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.9 4.5 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 2.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 64.7 58.7 3.5 6.0 0.6 0.5 0.0 0.0 0.0 FAM163A "C1orf76, MGC16664, NDSP" ENSG00000143340 "Family with sequence similarity 163 member A" Q96GL9 1 179743163-179816198 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2" "Group enriched" "Detected in some" 12 "Early spermatids: 27.4;Late spermatids: 35.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 9 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 51.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.74e-3)" "unprognostic (3.42e-2)" "unprognostic (1.32e-2)" "unprognostic (3.24e-1)" "unprognostic (2.62e-1)" "unprognostic (1.66e-1)" "unprognostic (5.67e-6)" "unprognostic (5.56e-2)" "unprognostic (1.52e-1)" "unprognostic (2.40e-2)" "unprognostic (3.81e-3)" "unprognostic (9.14e-2)" "unprognostic (7.75e-5)" "unprognostic (1.67e-2)" "unprognostic (2.83e-1)" "unprognostic (1.60e-1)" "unprognostic (4.98e-2)" 0.2 10.9 0.7 2.1 1.5 0.0 0.0 0.4 2.1 0.0 1.3 0.7 0.0 1.9 0.1 1.7 0.0 0.6 5.5 0.3 0.4 0.8 0.1 0.4 0.0 1.0 1.2 1.0 0.4 0.6 0.0 24.2 0.4 19.2 0.4 0.9 0.2 0.0 0.1 0.1 0.1 1.3 0.6 0.2 0.4 1.7 9.0 0.0 25.5 1.5 0.0 1.2 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 51.2 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.7 1.5 0.4 2.1 0.4 0.8 1.2 1.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133578415-133586197 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 41.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 15.1" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "SH-SY5Y: 40.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 8.2 10.0 0.0 2.7 0.0 0.0 3.2 41.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 1.2 6.1 3.9 0.1 2.7 0.0 1.3 3.3 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.8 40.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM166A ENSG00000188163 "Family with sequence similarity 166 member A" Q6J272 9 137243584-137247770 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 53 "testis: 54.2" "Group enriched" "Detected in some" 96 "Early spermatids: 561.7;Late spermatids: 950.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "T-47d: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA023307 Enhanced NA NA "HPA023307: AB_1848930" "unprognostic (2.22e-1)" "unprognostic (8.39e-2)" "unprognostic (1.01e-3)" "unprognostic (1.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (9.83e-2)" "unprognostic (2.18e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (2.67e-4)" "unprognostic (7.81e-2)" "unprognostic (1.77e-3)" "unprognostic (1.83e-1)" "unprognostic (2.02e-2)" "unprognostic (2.09e-1)" "unprognostic (4.18e-3)" 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 54.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 1.4 0.5 1.2 0.8 0.0 0.7 0.0 0.5 0.0 0.0 0.5 2.0 0.6 0.1 0.0 0.3 1.0 0.0 0.0 0.0 1.1 0.7 0.5 1.2 1.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.2 0.9 0.0 0.3 0.3 1.9 0.3 0.3 0.1 0.6 0.1 0.8 0.8 0.8 0.3 1.0 0.8 0.4 3.2 0.9 0.7 0.8 1.0 0.3 0.1 0.8 1.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.4 0.3 0.0 0.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 561.7 0.0 0.0 0.0 0.0 0.1 0.2 0.1 3.5 0.8 0.1 0.0 0.0 0.6 0.3 950.4 5.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 6.0 0.0 0.5 0.0 0.0 7.9 3.0 0.3 0.2 0.0 0.0 0.1 FAM166B ENSG00000215187 "Family with sequence similarity 166 member B" A8MTA8 9 35561831-35563899 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 77.3;fallopian tube: 26.1;skeletal muscle: 102.9" "Group enriched" "Detected in some" 4 "Ciliated cells: 26.8;Club cells: 6.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 11.7;ovarian cancer: 4.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.5;Hep G2: 5.6" "Low region specificity" "Detected in many" HPA045540 Enhanced NA NA "HPA045540: AB_10962627" "unprognostic (4.18e-5)" "unprognostic (7.56e-3)" "unprognostic (1.65e-1)" "prognostic favorable (2.61e-5)" "unprognostic (5.66e-3)" "unprognostic (3.48e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (2.21e-1)" "prognostic favorable (6.20e-6)" "unprognostic (3.69e-3)" "unprognostic (9.09e-2)" "unprognostic (4.37e-3)" "unprognostic (5.82e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (3.52e-5)" 2.8 77.3 0.9 0.7 1.2 0.0 0.7 0.1 0.5 1.3 0.6 3.1 0.3 0.0 0.5 9.4 0.8 26.1 0.9 0.1 1.3 1.5 0.4 0.1 2.7 0.1 0.1 0.2 2.5 0.1 0.0 0.2 0.1 3.8 0.1 0.0 0.7 0.6 0.6 102.9 0.2 0.3 0.3 0.4 0.2 0.0 0.5 0.6 0.1 0.3 1.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 2.5 0.7 0.6 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.3 1.3 0.0 1.3 0.2 1.4 0.5 0.9 0.0 0.3 0.0 0.0 5.6 0.0 0.4 0.4 0.0 0.5 0.0 0.5 0.2 0.4 1.9 0.0 0.6 0.0 0.1 0.0 0.4 0.5 0.5 0.6 0.0 0.2 0.0 2.0 0.3 0.8 0.0 0.0 0.0 0.0 1.8 0.6 0.0 1.1 0.7 0.4 0.8 0.0 1.3 0.8 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.2 0.1 0.5 1.3 1.5 0.1 0.2 3.8 0.6 0.0 0.3 0.0 1.1 4.1 0.0 0.2 0.0 26.8 6.8 0.0 2.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 1.3 0.1 0.0 0.2 0.2 0.0 1.8 0.0 0.0 0.0 0.3 FAM167A C8orf13 ENSG00000154319 "Family with sequence similarity 167 member A" Q96KS9 8 11421463-11474715 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.0;thyroid gland: 51.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 14.9;Distal tubular cells: 11.6;Early spermatids: 17.1;Intestinal endocrine cells: 18.3;Late spermatids: 27.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 24.6;RPMI-8226: 26.0;SH-SY5Y: 19.7;U-698: 19.7;U-87 MG: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023915, HPA030426" Approved Approved Mitochondria NA NA Mitochondria "HPA023915: AB_1845768, HPA030426: AB_10601318" "unprognostic (8.51e-3)" "unprognostic (2.43e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (5.96e-4)" "unprognostic (3.08e-2)" "unprognostic (4.62e-3)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (4.06e-2)" "unprognostic (7.17e-2)" "unprognostic (1.77e-2)" "unprognostic (7.13e-2)" "unprognostic (1.56e-1)" "unprognostic (4.30e-2)" "unprognostic (2.21e-2)" 0.8 1.6 13.8 1.8 11.2 1.3 2.0 7.1 20.0 1.1 1.4 12.6 0.0 1.1 0.9 1.3 1.4 2.0 1.8 0.9 13.8 7.6 6.6 0.8 10.5 2.8 8.6 11.8 0.8 2.8 0.8 12.3 2.5 12.2 2.1 1.4 0.5 3.3 5.7 0.8 11.8 1.3 0.8 7.0 1.9 2.7 3.2 7.6 0.8 51.1 0.3 3.5 1.3 1.0 4.0 1.3 0.1 1.8 0.9 0.1 0.1 2.0 1.3 2.7 0.2 0.2 1.1 0.0 7.4 7.0 4.5 1.9 0.0 0.6 24.6 0.4 7.9 2.1 0.7 0.0 1.7 5.3 10.6 0.3 0.0 0.0 0.0 9.3 0.0 0.0 1.3 1.1 2.3 14.5 14.5 0.0 0.0 0.1 1.0 2.6 0.7 0.0 0.0 0.7 0.0 0.0 0.1 0.0 26.0 2.3 0.2 11.7 19.7 0.3 2.1 0.9 0.3 0.8 0.0 12.5 0.4 0.7 11.4 0.1 7.9 5.7 19.7 16.3 0.0 0.7 0.1 0.2 0.0 0.0 1.8 0.1 4.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.9 1.7 1.3 0.0 0.1 13.8 11.2 7.1 12.5 13.8 7.6 8.6 11.8 12.2 7.6 14.9 2.6 0.0 0.4 5.3 0.0 0.6 2.5 1.4 0.0 5.2 9.8 0.0 11.6 1.8 17.1 0.0 0.0 0.0 1.7 0.0 0.5 1.1 0.0 0.0 0.1 0.0 18.3 0.0 0.3 27.3 0.3 0.0 0.0 0.0 1.3 1.8 0.9 2.9 0.4 0.0 1.7 0.0 0.0 1.2 2.5 3.0 0.0 0.0 0.0 0.1 FAM167B "C1orf90, MGC10820" ENSG00000183615 "Family with sequence similarity 167 member B" Q9BTA0 1 32247233-32248856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "vagina: 91.1" "Cell type enriched" "Detected in some" 10 "Ito cells: 188.4" "Cancer enhanced" "Detected in all" "melanoma: 46.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.5" "Lineage enriched" "Detected in many" 4 "T-cells: 4.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 7.0;EFO-21: 8.9;SK-MEL-30: 21.5;U-2197: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029398, HPA062074" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA029398: AB_10602807, HPA062074: AB_2684677" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.03e-2)" "unprognostic (1.74e-2)" "unprognostic (3.36e-3)" "unprognostic (7.44e-3)" "unprognostic (3.64e-1)" "unprognostic (3.00e-3)" "unprognostic (1.02e-2)" "unprognostic (1.30e-2)" "unprognostic (8.89e-2)" "unprognostic (4.80e-2)" "unprognostic (2.69e-2)" "unprognostic (1.60e-1)" "unprognostic (8.04e-2)" "unprognostic (5.08e-2)" 17.2 10.5 1.4 5.0 1.7 0.1 20.1 1.7 1.9 6.1 3.1 1.1 7.4 3.6 7.8 2.2 4.5 3.4 5.5 11.3 1.8 1.7 20.3 18.4 22.4 6.2 3.2 0.6 3.8 6.6 5.2 8.5 5.8 3.3 9.2 2.7 5.2 2.6 8.2 3.3 1.1 4.1 7.5 2.6 1.4 4.0 1.8 2.7 1.2 11.8 1.5 1.9 7.2 91.1 1.0 0.0 0.8 0.0 0.3 4.5 0.7 0.6 1.3 0.4 0.0 0.9 0.8 0.0 3.1 7.0 1.4 1.9 0.0 0.6 0.1 8.9 5.2 1.6 1.0 0.2 0.0 0.4 0.1 0.0 0.0 2.8 0.4 0.3 0.0 0.1 0.8 0.5 1.0 0.3 1.8 2.6 0.4 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.1 3.0 0.6 0.0 0.8 0.9 0.3 1.3 0.3 2.0 0.1 21.5 0.5 0.3 0.0 2.3 0.6 0.7 22.0 0.0 0.1 0.2 0.5 0.2 0.1 0.3 0.0 0.0 0.8 2.6 0.0 0.7 0.5 0.8 0.8 0.0 1.0 0.5 1.6 0.0 0.3 0.0 0.0 4.5 0.7 1.4 1.7 1.7 1.9 1.8 1.7 3.2 0.6 3.3 2.7 0.0 1.4 3.9 0.4 0.2 0.2 0.4 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.4 0.0 19.1 0.0 0.0 0.7 0.3 0.9 0.6 0.0 1.0 0.5 0.0 0.0 188.4 11.9 0.0 2.6 0.4 1.7 0.0 1.0 0.0 0.2 0.2 1.1 0.0 0.6 0.0 1.2 0.0 0.2 0.9 0.2 3.3 0.4 0.3 FAM168A "KIAA0280, TCRP1" ENSG00000054965 "Family with sequence similarity 168 member A" Q92567 11 73400487-73598189 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037580 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA037580: AB_10672906" "unprognostic (2.65e-1)" "unprognostic (2.10e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (5.51e-4)" "unprognostic (4.60e-2)" "unprognostic (3.24e-2)" "unprognostic (3.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.64e-1)" "unprognostic (2.18e-2)" "unprognostic (3.07e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.41e-5)" "unprognostic (2.10e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.70e-4)" 12.4 10.3 32.0 9.7 28.5 9.9 12.3 29.1 54.7 15.3 10.1 28.2 7.9 7.9 14.6 16.3 9.3 14.0 13.6 11.8 30.3 22.5 11.8 7.9 9.9 7.8 30.1 29.2 16.9 10.3 34.0 9.2 9.5 34.3 12.7 9.4 9.6 11.3 16.2 16.1 8.0 9.8 17.4 35.3 8.5 8.2 6.4 22.4 5.5 14.5 4.3 7.6 9.9 8.5 1.1 2.6 7.5 4.1 0.9 1.5 0.6 8.3 9.3 20.1 11.5 14.3 16.5 3.2 12.0 14.0 14.1 13.3 9.9 10.4 8.9 11.0 22.1 12.6 7.2 12.5 12.5 16.6 7.0 8.4 10.3 9.6 4.9 5.6 5.7 19.4 16.0 7.9 14.7 7.5 17.2 8.5 14.3 2.7 7.0 13.1 11.7 13.4 4.8 7.1 14.9 12.0 18.4 33.5 4.7 7.3 7.2 13.9 20.7 14.2 10.2 21.3 7.4 17.3 6.3 10.9 15.8 13.5 19.7 9.6 15.6 11.0 16.0 7.8 6.6 14.1 7.5 2.7 1.5 1.5 4.1 0.8 1.0 0.8 1.3 2.1 1.1 1.1 1.3 6.3 0.9 2.9 2.6 1.2 0.6 32.0 28.5 29.1 42.4 30.3 22.5 30.1 29.2 34.3 22.4 3.0 10.9 4.5 1.7 3.4 21.0 18.2 20.4 5.3 11.4 7.0 43.2 1.8 0.0 3.1 18.3 6.3 4.9 0.0 2.3 3.2 6.1 2.6 23.0 15.5 8.6 3.2 12.2 9.8 15.1 18.1 6.9 6.9 5.0 2.8 7.8 24.9 3.6 3.5 12.0 3.1 22.1 6.5 13.3 3.7 4.1 3.3 2.3 2.5 6.6 1.4 FAM169A "KIAA0888, SLAP75" ENSG00000198780 "Family with sequence similarity 169 member A" Q9Y6X4 5 74777574-74866951 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;epididymis: 23.6" "Group enriched" "Detected in many" 5 "Bipolar cells: 120.0;Collecting duct cells: 47.1;Cone photoreceptor cells: 133.5;Horizontal cells: 81.0;Muller glia cells: 163.2;Rod photoreceptor cells: 163.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.8;Hep G2: 15.5;SuSa: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041574 Enhanced Supported "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA041574: AB_10794382" "unprognostic (3.39e-1)" "unprognostic (2.25e-2)" "unprognostic (1.75e-4)" "unprognostic (5.87e-2)" "unprognostic (2.28e-2)" "unprognostic (1.46e-3)" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-2)" "unprognostic (2.72e-2)" "unprognostic (8.02e-2)" "unprognostic (3.51e-3)" "unprognostic (4.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" 0.7 4.2 9.9 1.4 13.5 1.5 1.1 11.0 21.8 1.7 1.9 5.2 2.9 0.7 3.8 23.6 0.9 3.8 3.0 2.2 9.4 14.2 6.7 3.1 0.8 2.5 9.6 10.3 3.4 2.0 10.7 8.3 1.2 10.4 6.4 3.0 11.3 1.9 7.0 0.8 0.7 1.0 1.0 11.1 2.5 2.1 15.5 4.6 3.7 9.6 0.0 2.5 4.1 1.1 1.4 0.5 0.0 0.0 0.8 4.0 1.2 5.1 4.6 3.3 4.4 0.0 0.0 22.8 0.7 1.7 3.5 3.5 2.1 3.4 0.0 2.3 0.0 9.4 3.7 6.8 10.3 3.6 3.8 7.8 1.4 0.8 15.5 0.1 0.0 0.0 0.1 10.9 0.8 5.1 0.5 0.0 5.0 0.0 0.0 2.0 1.5 4.9 0.0 8.2 1.4 2.5 7.1 2.1 0.3 3.2 8.2 2.0 2.7 8.6 3.9 0.6 15.6 3.7 1.0 0.0 0.2 3.3 0.0 3.7 12.6 11.7 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.7 0.0 4.0 0.8 1.6 2.5 0.0 1.4 3.5 3.4 0.0 0.8 0.0 0.5 0.9 1.2 9.9 13.5 11.0 17.1 9.4 14.2 9.6 10.3 10.4 4.6 0.0 0.0 0.9 4.9 0.2 120.0 1.2 0.0 2.7 3.4 47.1 133.5 4.4 3.3 1.6 12.3 0.6 1.3 0.0 0.0 0.4 0.4 6.7 1.1 2.9 0.4 81.0 3.4 0.0 0.6 22.2 4.6 0.0 1.7 1.0 1.2 163.2 2.0 0.0 3.9 2.0 163.5 0.0 0.3 18.9 10.7 0.1 0.2 5.1 0.6 3.4 FAM169B ENSG00000283597 "Family with sequence similarity 169 member B" Q8N8A8 15 98437162-98547728 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "stomach 1: 1.0" "Cell type enhanced" "Detected in single" 19 "Early spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 FAM170A ZNFD ENSG00000164334 "Family with sequence similarity 170 member A" A1A519 5 119629559-119635822 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 37.0" "Group enriched" "Detected in some" 17 "Early spermatids: 12.9;Late spermatids: 7.4;Sertoli cells: 6.5;Spermatocytes: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037900, HPA037902" Enhanced NA NA "HPA037900: AB_2675728, HPA037902: AB_2675730" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (9.70e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-4)" "unprognostic (2.12e-1)" "unprognostic (2.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.6 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 11.4 0.3 0.0 0.0 0.0 0.0 0.0 FAM170B "C10orf73, Em:AC084727.4" ENSG00000172538 "Family with sequence similarity 170 member B" A6NMN3 10 49131154-49134008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 51 "blood: 5.3;testis: 10.0" "Cell type enriched" "Detected in some" 7 "Early spermatids: 79.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 40 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 40 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "Daudi: 3.2;HDLM-2: 2.4;U-266/84: 1.1;U-87 MG: 1.1" "Not detected" "Not detected" "HPA043899, HPA050610" Uncertain NA NA "HPA043899: AB_2678721, HPA050610: AB_2681189" "unprognostic (8.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.6 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 104.4;Ito cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "TIME: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 96000 "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.3 13.0 5.0 5.3 10.1 0.1 7.9 1.5 4.0 3.5 1.1 7.4 0.0 9.6 20.5 9.1 0.6 9.3 0.1 4.5 2.6 14.6 18.4 2.0 18.2 5.8 0.0 14.9 7.9 1.9 10.9 1.6 14.6 20.0 2.7 7.2 0.0 12.7 0.5 3.1 0.0 12.5 3.5 3.5 12.4 6.9 1.9 5.0 0.0 9.0 11.5 4.4 0.1 0.0 14.5 0.0 0.2 42.6 5.5 23.2 19.9 8.3 2.7 0.7 0.0 12.2 0.0 4.2 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 0.0 0.0 0.0 3.3 1.1 3.8 5.1 104.4 2.7 2.3 14.0 0.0 0.1 3.3 17.1 0.6 18.9 12.0 0.0 10.5 0.1 8.9 13.8 1.1 18.3 0.3 6.4 20.2 41.1 4.4 1.0 4.9 0.0 1.7 1.0 25.9 1.5 15.9 8.6 5.3 4.1 1.1 0.0 6.2 2.3 3.5 1.6 0.1 1.3 31.1 2.1 FAM171A2 MGC34829 ENSG00000161682 "Family with sequence similarity 171 member A2" A8MVW0 17 44353215-44363875 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Group enriched" "Detected in some" 7 "Bipolar cells: 39.1;Horizontal cells: 41.3;Muller glia cells: 149.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 10.6;REH: 18.4;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019770 Uncertain NA NA "HPA019770: AB_1848383" "unprognostic (1.28e-2)" "unprognostic (2.07e-2)" "unprognostic (4.14e-3)" "unprognostic (8.47e-2)" "unprognostic (9.98e-2)" "unprognostic (1.92e-1)" "unprognostic (1.62e-4)" "unprognostic (5.76e-2)" "unprognostic (1.98e-2)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (3.00e-1)" "unprognostic (2.43e-3)" "unprognostic (1.06e-1)" "unprognostic (1.38e-1)" "unprognostic (2.36e-2)" "unprognostic (4.76e-2)" 3.1 3.3 10.3 1.2 12.8 1.0 1.0 13.9 26.5 6.4 1.2 1.7 1.1 1.1 4.1 7.9 2.1 5.4 2.6 1.3 8.6 8.8 1.7 1.0 1.4 1.3 3.7 13.2 5.5 1.1 2.3 7.3 1.8 4.6 2.2 0.9 3.1 1.5 3.2 1.1 2.0 1.2 1.6 1.7 1.4 1.2 1.3 2.2 0.0 2.6 0.0 1.2 1.5 1.9 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 1.8 5.6 7.7 0.9 1.1 3.9 2.1 0.3 1.8 2.2 0.2 0.1 2.5 4.9 0.6 1.0 0.1 2.0 0.5 0.2 2.0 10.6 0.7 0.1 1.0 0.6 0.1 0.4 1.3 0.2 0.7 0.0 3.1 2.7 5.7 1.7 0.0 0.6 6.3 5.7 1.0 8.3 0.0 4.0 18.4 3.6 1.5 0.3 0.4 13.2 9.9 0.7 0.1 0.9 1.4 2.1 1.3 1.7 2.6 5.0 4.3 0.7 0.8 0.2 0.9 0.2 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.8 13.9 26.5 8.6 8.8 3.7 13.2 4.6 2.2 0.0 0.0 0.0 0.0 0.0 39.1 1.1 0.0 0.0 0.0 3.5 11.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.2 41.3 0.0 0.6 0.3 0.0 1.7 0.0 0.0 0.0 0.0 149.9 0.4 0.0 0.7 0.0 7.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 FAM171B "FLJ34104, KIAA1946" ENSG00000144369 "Family with sequence similarity 171 member B" Q6P995 2 186693971-186765965 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.0" "Cell type enriched" "Detected in many" 6 "Bipolar cells: 137.0" "Cancer enriched" "Detected in many" 5 "glioma: 15.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 25.4;U-138 MG: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010639, HPA013434" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA010639: AB_1852447, HPA013434: AB_2262499" "unprognostic (2.52e-1)" "unprognostic (7.75e-3)" "unprognostic (1.27e-1)" "unprognostic (1.04e-2)" "unprognostic (4.03e-2)" "unprognostic (9.43e-2)" "unprognostic (6.78e-3)" "unprognostic (2.68e-1)" "unprognostic (1.88e-2)" "unprognostic (1.52e-1)" "unprognostic (4.24e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (9.51e-7)" "unprognostic (4.63e-3)" "unprognostic (1.52e-1)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.03e-4)" 3.1 13.1 32.0 2.0 32.6 1.1 3.7 12.7 62.0 6.7 2.1 5.8 0.1 1.6 7.1 2.6 2.4 3.2 4.9 1.9 25.5 13.1 1.8 1.1 2.0 1.6 9.1 23.0 9.7 1.6 11.4 13.4 3.5 9.7 3.2 2.5 1.4 17.8 2.8 1.3 3.8 1.9 4.5 8.4 2.0 2.4 1.6 10.4 0.0 2.7 0.0 1.7 2.9 1.8 0.3 1.3 1.1 1.7 2.4 1.1 0.5 2.3 2.8 4.2 13.1 12.5 9.5 0.1 2.6 4.6 3.2 4.6 7.7 12.6 0.0 0.9 7.3 5.5 0.3 5.7 2.5 4.6 0.0 3.3 2.8 1.3 0.0 1.0 0.8 1.0 12.1 1.0 2.5 2.0 4.2 7.0 2.2 0.0 25.4 6.1 1.6 1.6 0.0 5.6 0.0 2.8 0.0 8.1 0.6 5.0 9.0 13.2 7.2 1.3 0.8 3.5 2.6 1.0 0.6 4.1 17.6 2.3 0.3 1.6 6.8 6.5 0.0 5.4 0.0 2.4 1.1 0.7 0.3 0.8 1.7 0.7 0.3 1.0 0.9 0.6 0.2 0.6 1.1 0.4 2.4 1.6 1.3 0.1 0.5 32.0 32.6 12.7 30.4 25.5 13.1 9.1 23.0 9.7 10.4 0.0 0.0 0.0 2.1 7.9 137.0 0.8 10.2 0.0 2.3 0.0 13.7 7.9 0.0 0.7 1.4 10.5 0.0 0.0 0.3 0.8 6.6 1.2 0.0 0.0 1.7 22.3 4.6 8.0 0.3 2.5 7.2 1.1 3.3 1.0 0.0 16.5 0.5 0.0 13.1 0.1 15.5 0.0 4.1 0.1 1.4 4.5 6.9 0.0 0.0 0.5 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617443-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 98.3;Mucus-secreting cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;MCF7: 25.6;OE19: 21.5;RPMI-8226: 30.0;RT4: 63.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" No No "Intermediate filaments" "HPA015306: AB_2669182" "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favorable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 6.1 3.5 5.9 3.3 6.3 0.7 17.9 3.9 8.6 10.9 6.2 2.9 21.5 3.6 5.1 4.9 5.2 14.6 6.4 4.2 7.4 8.3 3.3 4.0 16.3 5.5 6.5 6.2 10.2 57.6 2.5 15.9 4.6 6.7 19.4 9.2 7.7 47.7 10.8 16.3 4.9 5.0 4.6 4.9 3.2 17.3 9.7 3.6 4.2 28.9 3.9 4.8 24.4 15.3 0.4 4.5 3.7 0.9 0.7 10.9 0.7 0.0 3.6 2.3 0.7 0.0 0.0 0.3 1.3 6.3 0.0 0.0 21.3 2.4 0.3 6.1 0.1 1.7 0.1 4.0 0.1 0.0 0.1 1.8 0.2 0.4 0.2 0.4 0.3 0.9 0.3 0.1 0.0 0.0 0.1 3.0 2.0 0.3 15.8 3.5 25.6 0.7 0.0 11.5 21.5 0.0 2.4 6.6 30.0 1.5 63.4 1.4 1.1 1.8 12.2 3.9 7.0 9.8 2.2 0.0 0.0 0.5 0.1 2.9 0.5 4.7 0.7 0.0 0.2 1.5 1.1 0.8 0.9 0.2 0.9 0.4 0.4 2.5 0.0 0.6 0.3 2.8 3.3 3.7 0.7 0.0 4.5 10.9 0.7 5.9 6.3 3.9 8.6 7.4 8.3 6.5 6.2 6.7 3.6 98.3 20.3 0.0 14.7 2.1 5.3 4.1 10.2 14.7 18.2 7.0 7.9 1.1 6.6 4.4 19.8 5.8 2.3 0.0 12.4 15.9 4.1 29.2 18.4 5.8 4.2 11.1 40.5 30.7 4.3 39.0 5.5 1.8 11.8 0.0 61.2 3.5 17.4 0.0 1.8 1.1 2.7 0.0 5.3 1.0 3.4 2.6 0.6 2.1 4.7 23.7 FAM177B "FLJ43505, RP11-452F19.2" ENSG00000197520 "Family with sequence similarity 177 member B" A6PVY3 1 222737207-222750805 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 26.5;stomach 1: 34.2" "Group enriched" "Detected in some" 8 "B-cells: 12.3;Cardiomyocytes: 15.7;Cholangiocytes: 15.3;Early spermatids: 7.0;Late spermatids: 7.7;Mucus-secreting cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 21 "memory B-cell: 17.9;naive B-cell: 26.5" "Lineage enriched" "Detected in many" 25 "B-cells: 26.5" "Cell line enhanced" "Detected in some" "Daudi: 1.6;fHDF/TERT166: 1.2;HUVEC TERT2: 2.4;RPMI-8226: 2.4" "Low region specificity" "Detected in some" HPA063059 Uncertain NA NA "HPA063059: AB_2684933" "unprognostic (8.19e-2)" "unprognostic (1.72e-1)" "unprognostic (4.88e-3)" "unprognostic (3.09e-2)" "unprognostic (7.70e-3)" "unprognostic (1.57e-3)" "unprognostic (2.65e-2)" "unprognostic (1.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.56e-6)" "unprognostic (5.13e-1)" "unprognostic (1.09e-1)" "unprognostic (1.79e-2)" "unprognostic (4.29e-2)" 0.6 1.1 1.1 6.4 5.5 0.0 0.5 0.4 2.3 0.4 4.6 0.2 2.0 3.3 0.5 0.1 0.8 0.4 12.6 0.4 1.8 0.7 0.6 0.5 1.6 10.3 1.8 0.0 0.4 0.6 0.2 1.3 2.0 2.0 0.8 6.5 0.6 8.3 0.3 0.4 0.4 14.2 0.6 4.9 5.6 34.2 1.2 1.5 0.3 0.5 1.4 14.6 1.0 0.6 26.5 1.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 1.6 0.2 1.2 0.0 0.7 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 1.0 1.1 0.0 0.0 2.4 0.5 1.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 17.9 0.0 0.0 0.0 26.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.6 1.1 5.5 0.4 2.3 1.8 0.7 1.8 0.0 2.0 1.5 0.0 0.0 12.3 0.6 0.3 0.0 15.7 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.0 1.3 0.0 0.3 0.0 0.5 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.3 7.7 0.0 0.0 0.0 0.0 27.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.4 0.4 FAM178B LOC51252 ENSG00000168754 "Family with sequence similarity 178 member B" Q8IXR5 2 96875882-96986592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 6.9;Late spermatids: 5.1;Spermatogonia: 19.4" "Cancer enriched" "Detected in many" 5 "melanoma: 8.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD4 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Cell line enhanced" "Detected in some" "K-562: 17.5;OE19: 4.8;RH-30: 4.8;RPMI-8226: 19.1;WM-115: 19.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042516, HPA062110" Uncertain Uncertain "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA042516: AB_10806241, HPA062110: " "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (1.08e-2)" "unprognostic (8.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.28e-2)" "unprognostic (9.02e-4)" "unprognostic (4.70e-2)" "unprognostic (8.55e-2)" "unprognostic (6.49e-3)" "unprognostic (1.49e-1)" "unprognostic (5.13e-2)" "unprognostic (9.82e-11)" "unprognostic (6.93e-2)" "unprognostic (1.57e-1)" "unprognostic (9.63e-3)" "unprognostic (1.08e-1)" 0.8 0.0 2.4 0.6 3.8 18.2 0.6 1.0 1.5 0.6 1.0 0.6 0.6 0.1 0.7 6.8 0.6 1.5 0.6 0.6 3.4 1.9 0.6 0.6 0.6 0.6 5.3 0.6 0.6 0.6 0.0 0.6 1.1 0.6 0.6 0.2 1.0 0.6 1.0 0.6 1.2 0.6 0.6 8.5 13.3 0.0 29.5 0.6 0.6 0.6 0.6 0.6 1.0 0.6 0.0 0.8 0.0 0.0 0.1 2.6 0.6 4.2 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.4 1.7 0.0 0.0 0.1 4.8 0.0 0.0 4.8 19.1 0.0 0.0 0.6 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 19.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 1.7 0.0 0.1 0.0 0.8 0.0 0.6 2.4 3.8 1.0 1.5 3.4 1.9 5.3 0.6 0.6 0.6 0.0 0.0 0.8 0.6 0.7 0.1 0.3 0.0 0.0 0.0 0.0 2.0 2.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 6.9 1.4 0.2 0.0 0.0 1.1 1.6 0.0 0.6 0.0 5.1 0.9 0.3 3.3 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 1.7 19.4 1.5 2.1 0.0 0.0 0.1 FAM180A "HWKM1940, UNQ1940" ENSG00000189320 "Family with sequence similarity 180 member A" Q6UWF9 7 135728348-135748846 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.0" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 6.6;Cardiomyocytes: 5.2;Fibroblasts: 5.8;Ito cells: 8.0;Leydig cells: 2.6;Melanocytes: 6.8;Peritubular cells: 3.9;Smooth muscle cells: 2.8;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "basophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "U-2197: 74.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021224 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA Nucleoplasm "HPA021224: AB_1851352" "unprognostic (3.85e-2)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.27e-1)" "unprognostic (5.05e-2)" "unprognostic (1.97e-3)" "unprognostic (5.62e-2)" "unprognostic (7.55e-2)" "unprognostic (8.88e-4)" "unprognostic (3.14e-3)" "unprognostic (1.82e-1)" "unprognostic (4.35e-4)" "unprognostic (6.62e-4)" 9.3 2.6 0.1 1.7 0.5 0.0 5.6 0.1 1.0 7.8 5.7 0.3 0.5 0.7 9.4 2.0 5.1 3.0 21.2 14.7 0.1 0.1 8.7 23.0 4.6 0.0 0.1 0.0 8.1 1.1 0.0 0.3 1.4 0.5 6.1 1.8 1.9 2.2 0.1 3.5 5.5 3.2 8.1 0.4 0.9 1.6 3.9 0.1 0.0 4.6 4.8 0.9 6.6 8.3 0.6 0.2 2.0 0.3 0.4 0.5 0.1 0.0 0.0 0.0 0.0 8.1 8.4 0.0 4.2 16.1 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 10.3 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 16.7 0.0 74.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.0 0.1 0.1 0.3 0.1 0.2 0.2 0.3 0.2 0.0 0.6 0.4 0.5 0.8 0.4 0.3 0.2 0.2 0.1 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 6.6 0.0 5.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 2.6 0.0 6.8 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.0 2.8 0.0 0.0 4.3 0.6 0.0 0.0 0.0 FAM180B LOC399888 ENSG00000196666 "Family with sequence similarity 180 member B" 11 47586693-47589194 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 4.6;breast: 6.9;skin 1: 5.2;thyroid gland: 3.9" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 6.5;Leydig cells: 2.3;Melanocytes: 5.0;Peritubular cells: 3.9;Suprabasal keratinocytes: 5.5" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Cell type enriched" "Detected in single" 5 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HEL: 2.2;MCF7: 2.0;NB-4: 2.1;SK-MEL-30: 4.2;U-937: 3.1" "Not detected" "Not detected" HPA029408 Uncertain NA NA "HPA029408: AB_10601319" "unprognostic (1.28e-2)" "unprognostic (4.99e-3)" "unprognostic (7.48e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.64e-2)" "unprognostic (1.21e-3)" "unprognostic (1.04e-1)" "unprognostic (2.69e-1)" "unprognostic (3.87e-2)" "unprognostic (3.16e-2)" "unprognostic (1.03e-5)" "unprognostic (5.65e-2)" "unprognostic (1.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" 4.6 0.4 0.2 0.0 1.4 0.3 6.9 0.7 1.2 0.5 0.4 0.1 0.1 0.3 0.0 0.7 0.8 0.6 0.2 0.9 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 1.1 5.2 0.0 0.1 1.2 0.0 0.3 0.7 3.9 0.2 0.5 0.1 0.0 0.0 0.0 0.2 0.1 1.2 0.0 0.1 0.0 1.9 0.0 1.3 1.3 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.3 2.2 0.4 0.7 0.1 0.4 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.2 2.0 0.1 2.1 0.3 0.1 0.2 0.6 0.4 0.0 0.0 0.1 0.0 0.3 0.3 0.0 4.2 0.4 0.2 0.7 1.2 0.5 0.3 0.2 0.0 0.3 0.2 0.1 0.0 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 2.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.1 0.0 0.0 0.0 FAM181A C14orf152 ENSG00000140067 "Family with sequence similarity 181 member A" Q8N9Y4 14 93918894-93929608 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;testis: 19.2" "Group enriched" "Detected in some" 6 "Early spermatids: 37.0;Spermatocytes: 48.6" "Group enriched" "Detected in some" 6 "endometrial cancer: 3.1;glioma: 9.7;ovarian cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AF22: 10.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 31.1" HPA001603 Enhanced NA NA "HPA001603: AB_1078326" "unprognostic (8.19e-2)" "unprognostic (6.78e-2)" "unprognostic (1.28e-2)" "unprognostic (1.31e-1)" "unprognostic (2.05e-2)" "unprognostic (1.84e-2)" "unprognostic (6.27e-2)" "unprognostic (4.44e-2)" "unprognostic (5.37e-2)" 0.6 0.6 9.3 0.6 8.3 0.6 0.6 2.1 6.0 0.8 0.6 7.6 0.0 0.6 0.8 0.6 0.7 5.2 0.7 0.7 6.4 6.6 0.6 0.6 1.4 0.6 5.3 6.0 0.6 0.6 0.6 1.5 0.6 6.8 0.6 0.6 0.0 0.7 0.7 3.7 0.6 0.6 0.6 6.4 0.6 0.7 19.2 3.8 0.0 2.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 8.3 2.1 5.7 6.4 6.6 5.3 6.0 6.8 3.8 3.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 6.7 4.5 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.2 0.0 0.0 48.6 0.6 0.0 0.0 0.0 0.0 0.0 FAM181B "LOC220382, MGC33846" ENSG00000182103 "Family with sequence similarity 181 member B" A6NEQ2 11 82729941-82733864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 29.6" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 5.2;Distal tubular cells: 3.3;Muller glia cells: 18.0;Smooth muscle cells: 3.1" "Cancer enriched" "Detected in many" 19 "glioma: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 6.7;SH-SY5Y: 3.6;U-2 OS: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066861 Enhanced Approved "Nuclear membrane,Mitochondria" NA NA Mitochondria "Nuclear membrane" "HPA066861: AB_2685738" "unprognostic (2.84e-4)" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "prognostic favorable (8.07e-4)" "unprognostic (6.71e-3)" "unprognostic (3.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (1.90e-1)" "unprognostic (5.50e-2)" "unprognostic (6.27e-4)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (1.53e-2)" "unprognostic (2.56e-1)" "unprognostic (7.20e-3)" "unprognostic (7.20e-2)" 1.9 2.9 18.3 1.8 13.3 1.5 1.6 16.9 29.6 2.0 1.7 18.6 0.0 1.9 2.2 1.8 1.5 2.6 1.4 2.0 19.6 11.3 2.0 1.3 1.3 1.4 17.1 13.0 2.7 1.5 1.5 1.1 1.4 17.2 1.9 1.5 0.7 3.2 2.7 1.7 1.7 2.3 1.6 16.9 1.3 1.8 1.7 16.7 0.0 2.1 0.0 1.7 2.2 0.5 0.2 0.0 0.6 0.3 0.3 0.4 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.1 0.3 0.1 0.4 0.0 0.1 0.1 0.5 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.1 0.1 1.2 0.0 0.2 0.1 0.0 0.0 0.2 6.7 1.0 3.6 0.0 0.0 0.1 0.3 0.1 0.4 0.0 0.1 3.5 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.4 0.0 0.6 0.3 0.3 0.0 0.1 0.0 18.3 13.3 16.9 11.4 19.6 11.3 17.1 13.0 17.2 16.7 0.0 0.0 0.0 0.2 0.2 0.2 2.7 0.0 0.0 0.0 5.2 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 18.0 0.0 0.0 0.4 0.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 FAM182B ENSG00000175170 "Family with sequence similarity 182 member B" Q5T319 20 25763466-25868225 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.6;testis: 9.9" "Group enriched" "Detected in some" 37 "Early spermatids: 201.1;Late spermatids: 281.2" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "SCLC-21H: 17.4" HPA050100 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA050100: AB_2681014" "unprognostic (8.05e-2)" "unprognostic (1.48e-2)" "unprognostic (1.29e-2)" "unprognostic (3.63e-1)" "unprognostic (2.68e-1)" "unprognostic (1.50e-2)" "unprognostic (1.88e-4)" "unprognostic (1.61e-1)" "unprognostic (3.15e-2)" "unprognostic (1.33e-1)" "unprognostic (4.58e-2)" "unprognostic (3.30e-1)" "unprognostic (2.47e-9)" "unprognostic (2.36e-1)" "unprognostic (4.40e-2)" "unprognostic (6.54e-2)" "unprognostic (3.18e-1)" 0.4 0.9 2.9 0.2 3.8 0.0 0.8 7.6 5.9 0.6 0.2 0.1 1.2 0.3 0.6 6.4 0.2 0.3 3.0 3.7 0.4 0.0 1.2 0.2 2.0 1.7 0.8 0.5 2.7 4.4 1.7 0.1 0.8 0.5 1.2 5.2 0.7 0.4 1.2 0.8 0.6 9.9 1.4 0.0 0.0 0.4 0.2 0.2 2.1 0.1 0.7 1.2 0.4 2.2 1.0 1.2 1.2 0.6 0.1 0.5 0.3 0.0 0.1 0.4 0.0 3.0 0.2 1.3 1.5 1.0 4.1 0.0 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.3 0.2 1.1 0.9 0.1 0.0 1.1 0.0 0.1 1.4 1.0 2.8 0.0 0.1 1.4 0.7 0.1 1.7 1.6 0.1 0.1 0.6 0.4 0.0 17.4 1.1 0.7 0.2 1.2 1.2 0.5 0.6 0.3 0.2 3.7 0.8 0.5 1.8 0.3 0.8 0.2 0.5 1.5 0.0 0.1 1.7 0.6 0.0 0.6 0.1 1.0 0.3 0.2 0.2 0.9 1.2 2.1 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 3.0 0.6 0.4 0.0 0.0 0.0 1.8 5.9 0.5 1.7 0.0 201.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.4 0.0 0.0 0.0 281.2 2.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 6.5 1.4 5.1 1.3 2.5 0.0 0.0 0.0 0.0 FAM183A "hCG23177, LOC440585" ENSG00000186973 "Family with sequence similarity 183 member A" A6NL82 1 43145153-43156396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 25.5;fallopian tube: 55.8" "Cell type enriched" "Detected in many" 7 "Ciliated cells: 1011.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 19.3" "Region enhanced" "Detected in many" "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.9;hTCEpi: 4.4;NTERA-2: 5.4;SCLC-21H: 4.6;SuSa: 9.1" "Low region specificity" "Detected in many" "HPA043382, HPA049120" Approved NA NA "HPA043382: AB_2678456, HPA049120: AB_2680640" "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (9.56e-2)" "unprognostic (1.42e-3)" "unprognostic (6.79e-2)" "unprognostic (3.79e-2)" "unprognostic (1.44e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-2)" "unprognostic (1.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (4.30e-2)" "unprognostic (1.27e-2)" "unprognostic (7.88e-2)" "unprognostic (1.18e-3)" "unprognostic (1.73e-2)" 0.1 0.1 3.6 0.1 9.8 0.1 0.8 0.0 0.5 2.6 0.3 6.5 0.0 0.2 1.3 16.5 0.5 55.8 0.2 0.1 4.6 4.7 0.3 0.2 14.5 0.2 0.1 0.2 10.1 0.3 1.0 5.5 0.5 25.5 1.4 0.3 0.0 0.9 0.3 0.1 5.5 0.1 0.3 0.6 0.2 0.2 6.7 1.7 0.0 0.2 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.6 0.6 0.6 1.0 5.9 0.0 0.8 0.4 0.6 0.7 0.0 0.4 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 5.4 0.2 0.0 0.0 0.0 0.0 2.3 1.1 4.6 0.0 0.0 0.3 0.0 9.1 1.3 0.0 0.9 0.0 0.7 0.2 0.1 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 9.8 0.0 0.5 4.6 4.7 0.1 0.2 25.5 1.7 0.0 6.1 0.0 12.9 1.6 0.0 0.1 0.0 1011.8 135.4 3.5 0.0 1.5 3.3 0.0 89.9 0.1 0.0 0.0 0.0 0.2 0.4 3.8 3.5 0.0 0.1 0.0 4.1 0.0 0.0 153.7 1.7 0.0 3.3 0.0 0.1 0.4 0.2 0.0 0.7 1.3 0.0 0.0 0.0 1.9 2.8 2.3 1.7 0.0 0.4 10.2 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.2 15.9 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.2 1.1 0.0 0.2 6.0 0.0 4.9 0.0 0.2 1.2 9.4 0.5 1.4 7.0 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.3 0.0 13.4 13.0 0.5 0.2 0.3 0.3 0.0 5.3 0.6 1.2 0.0 0.0 0.0 0.1 0.1 10.4 7.7 0.5 0.5 1.5 3.0 2.1 1.8 0.2 0.8 0.4 0.1 4.0 4.0 4.3 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 44.7 90.2 0.0 6.1 2.2 36.7 3.9 5.1 60.2 31.8 3.5 27.5 45.2 14.9 0.8 12.9 1.9 0.1 0.0 1.0 13.5 5.0 0.9 5.8 3.4 4.9 12.7 5.8 3.1 0.3 5.4 3.4 0.8 0.0 0.0 0.0 12.5 0.5 0.0 6.7 1.3 27.8 6.5 2.3 64.6 15.4 3.0 222.8 4.1 0.4 1.0 FAM184B KIAA1276 ENSG00000047662 "Family with sequence similarity 184 member B" Q9ULE4 4 17629306-17781512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.1;skeletal muscle: 11.1" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 30.0;Erythroid cells: 23.3;Horizontal cells: 30.2;Muller glia cells: 22.9;Rod photoreceptor cells: 27.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 6.9;T-47d: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044119, HPA048458" Enhanced NA NA "HPA044119: AB_2678817, HPA048458: AB_2680401" "unprognostic (1.20e-2)" "unprognostic (4.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (9.64e-2)" "unprognostic (1.71e-2)" "unprognostic (5.13e-4)" "unprognostic (2.04e-2)" "unprognostic (7.46e-2)" "unprognostic (2.54e-4)" "unprognostic (1.01e-1)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-1)" "unprognostic (1.54e-4)" 1.5 0.6 3.2 0.5 5.0 0.8 0.6 2.0 5.1 0.3 1.1 2.5 0.0 0.3 0.4 0.8 0.4 0.3 0.4 0.3 3.6 2.7 1.2 0.3 0.4 0.5 3.3 1.2 0.5 0.3 0.8 0.4 0.3 3.7 0.5 0.8 0.1 0.9 0.3 11.1 1.1 0.4 0.3 2.0 0.5 0.5 0.6 2.9 0.0 0.4 0.4 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.9 0.0 0.0 0.2 0.4 0.8 0.0 0.1 0.2 0.7 0.0 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.5 0.1 0.2 1.0 0.1 0.1 0.1 0.0 0.1 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.8 1.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 6.9 0.2 0.0 0.0 1.0 0.2 1.8 0.2 0.3 0.0 0.0 0.1 0.3 0.2 0.2 0.1 0.1 0.3 0.6 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.3 0.9 0.2 0.0 0.1 0.0 0.0 0.0 3.2 5.0 2.0 3.1 3.6 2.7 3.3 1.2 3.7 2.9 0.0 1.3 5.2 5.5 3.9 30.0 0.6 5.1 0.0 1.2 0.0 13.7 3.9 0.0 0.0 0.7 1.4 0.3 23.3 0.9 2.9 3.1 3.5 13.8 1.7 1.1 30.2 4.1 0.6 2.7 0.9 10.6 3.1 3.3 0.0 0.1 22.9 0.8 0.0 7.1 0.5 27.9 0.0 1.9 6.9 8.7 8.4 4.5 2.5 0.2 4.7 FAM186A LOC121006 ENSG00000185958 "Family with sequence similarity 186 member A" A6NE01 12 50326230-50396622 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 19.3" "Cell type enriched" "Detected in some" 16 "Early spermatids: 388.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA047128 Uncertain NA NA "HPA047128: AB_10967726" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" "unprognostic (1.25e-1)" "unprognostic (2.31e-1)" "unprognostic (1.88e-1)" "unprognostic (3.69e-2)" "unprognostic (3.48e-3)" "unprognostic (1.43e-2)" "unprognostic (1.30e-2)" "unprognostic (6.96e-2)" "unprognostic (4.65e-5)" "unprognostic (1.93e-1)" "unprognostic (2.42e-5)" "unprognostic (1.65e-1)" "unprognostic (1.32e-1)" "unprognostic (7.51e-2)" "unprognostic (3.22e-3)" 0.2 0.2 0.4 0.3 0.8 0.9 0.2 0.9 0.8 0.2 0.2 0.2 0.2 0.1 0.2 1.2 0.2 0.1 0.2 0.3 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 2.0 0.8 0.3 0.2 0.2 0.3 0.0 19.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.9 3.1 1.5 1.8 1.4 0.3 0.6 0.3 0.2 2.1 0.0 0.0 1.0 0.3 0.0 0.1 0.0 0.2 1.0 0.8 0.7 0.6 0.7 0.3 0.1 0.2 0.0 1.2 0.8 0.4 1.0 1.0 0.4 0.6 0.9 1.0 0.3 0.0 0.2 0.5 0.0 0.7 0.9 1.6 1.0 1.7 0.2 0.8 0.9 0.3 0.2 0.7 0.5 0.2 0.1 1.3 0.4 0.2 0.4 0.4 0.2 0.2 1.1 0.3 0.0 0.6 0.9 0.5 0.5 1.2 0.5 0.8 0.9 0.1 0.2 2.4 1.5 1.2 1.4 0.7 0.8 0.5 0.8 0.5 0.2 0.8 0.9 1.2 3.1 1.8 0.6 0.9 0.4 0.3 0.4 0.8 0.9 0.8 0.4 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 388.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.6 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 FAM186B "C12orf25, DKFZP434J0113" ENSG00000135436 "Family with sequence similarity 186 member B" Q8IYM0 12 49582885-49605639 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 58.0" "Group enriched" "Detected in some" 9 "Early spermatids: 62.4;Late spermatids: 75.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Group enriched" "Detected in many" 7 "B-cells: 2.3;T-cells: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039736, HPA040028" Uncertain NA NA "HPA039736: AB_10795295, HPA040028: AB_10795684" "unprognostic (2.96e-1)" "unprognostic (1.25e-1)" "unprognostic (2.86e-1)" "unprognostic (1.94e-1)" "unprognostic (3.00e-1)" "unprognostic (5.55e-2)" "unprognostic (1.53e-1)" "unprognostic (3.37e-3)" "unprognostic (1.44e-1)" "unprognostic (4.11e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-1)" "unprognostic (4.42e-5)" "unprognostic (1.56e-1)" "unprognostic (6.18e-2)" "unprognostic (2.10e-5)" "unprognostic (7.23e-2)" 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.4 0.2 0.2 0.2 0.2 0.5 1.0 0.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 58.0 0.2 0.2 0.6 0.2 0.2 0.2 0.2 2.3 0.2 0.0 0.2 0.2 1.4 0.0 0.8 3.7 0.4 1.3 0.4 0.2 2.0 0.0 0.5 0.2 0.4 4.8 1.5 2.8 0.9 0.3 0.9 1.4 0.7 0.7 0.4 0.9 1.1 1.6 2.1 0.7 0.4 3.1 0.8 0.2 1.1 0.7 2.1 0.4 0.3 1.2 2.5 2.2 0.7 2.6 0.3 0.3 0.6 1.3 1.4 1.0 0.3 1.3 1.4 1.3 3.3 0.8 1.6 0.7 2.4 0.9 1.6 1.4 1.5 0.3 1.6 1.3 0.8 1.5 1.1 4.9 0.6 1.3 0.7 0.0 0.2 0.0 0.1 0.1 1.4 0.1 0.4 0.1 0.2 2.3 1.0 0.4 0.0 0.2 0.1 0.2 1.3 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 62.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 75.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.1 7.5 1.1 0.0 0.0 0.0 0.0 0.0 FAM187A ENSG00000214447 "Family with sequence similarity 187 member A" A6NFU0 17 44899712-44905390 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.2;testis: 37.0" "Cell type enriched" "Detected in single" 67 "Ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 12.4;U-87 MG: 14.1" HPA043131 Approved Cytosol NA NA Cytosol "HPA043131: AB_10796686" 0.7 1.3 5.8 0.6 8.9 0.7 1.4 1.0 5.0 2.5 0.9 3.1 1.7 0.3 1.9 2.7 0.5 21.2 3.0 0.6 5.4 6.7 3.7 0.5 2.0 0.7 5.3 4.1 3.7 1.6 2.2 2.2 0.3 4.5 1.1 1.0 1.7 1.3 1.9 0.4 0.6 0.6 1.1 4.2 0.4 0.6 37.0 1.1 0.3 4.5 0.2 0.6 0.9 0.3 0.8 1.8 1.9 2.9 0.2 0.8 2.0 1.7 8.8 2.2 1.8 2.7 3.1 1.4 0.5 4.3 2.5 3.1 2.6 4.7 0.2 1.4 1.6 5.9 5.2 0.5 2.3 1.1 5.2 2.1 0.7 3.7 0.7 1.1 1.0 0.7 0.4 3.0 4.7 1.0 4.2 1.1 1.1 1.6 0.1 0.9 1.2 0.1 1.3 0.7 3.0 1.2 0.8 0.3 0.4 12.4 0.8 5.9 1.4 0.5 0.1 0.7 1.7 6.3 1.0 0.6 1.0 2.2 1.2 1.0 0.2 0.2 0.4 14.1 0.8 1.1 0.0 2.9 1.9 0.2 0.8 0.0 0.0 0.0 0.8 1.8 0.8 0.0 0.1 0.0 0.2 0.3 0.0 0.6 2.0 5.8 8.9 1.0 5.0 5.4 6.7 5.3 4.1 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM187B "FLJ25660, TMEM162" ENSG00000177558 "Family with sequence similarity 187 member B" Q17R55 19 35224800-35228729 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 108 "testis: 56.0" "Group enriched" "Detected in some" 117 "Early spermatids: 555.2;Late spermatids: 1683.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079535 Enhanced NA NA "HPA079535: " "unprognostic (3.34e-1)" "unprognostic (4.96e-1)" "unprognostic (2.40e-1)" "unprognostic (2.84e-1)" "unprognostic (2.72e-1)" "unprognostic (2.12e-1)" "unprognostic (1.25e-3)" "unprognostic (2.71e-1)" "unprognostic (2.49e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 56.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 555.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1683.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 7.6 4.2 0.0 0.0 0.0 0.0 0.0 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;parathyroid gland: 6.5" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.1;Ductal cells: 3.7;Enterocytes: 2.3;Intestinal endocrine cells: 2.9;Paneth cells: 3.5;Undifferentiated cells: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HDLM-2: 15.6;Karpas-707: 2.0;REH: 3.7" "Low region specificity" "Detected in many" "HPA009410, HPA010637" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.8 1.5 12.8 0.6 7.9 0.4 0.6 4.2 9.5 0.4 4.0 1.5 0.0 1.0 1.1 0.8 0.6 1.5 0.5 0.7 15.3 4.7 1.7 0.5 1.5 0.5 3.5 3.4 0.4 3.3 6.5 0.0 0.7 4.0 0.8 3.0 0.0 1.1 0.5 0.4 0.8 3.2 1.0 0.7 1.3 0.6 2.3 0.3 0.0 1.9 0.0 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.3 0.0 0.0 0.0 0.2 15.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 2.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 12.8 7.9 4.2 9.5 15.3 4.7 3.5 3.4 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.7 0.0 2.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 1.7 0.1 0.2 3.5 1.4 0.8 0.3 0.0 0.2 0.5 1.2 0.0 0.0 0.0 2.9 0.5 FAM189A2 "C9orf61, X123" ENSG00000135063 "Family with sequence similarity 189 member A2" Q15884 9 69324567-69392558 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.1;thyroid gland: 38.0" "Cell type enhanced" "Detected in many" 23 "Alveolar cells type 1: 145.9;Club cells: 48.9;Muller glia cells: 40.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.4;NTERA-2: 8.4;RPTEC TERT1: 3.1;RT4: 3.7;SK-MEL-30: 8.1;SuSa: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029411, HPA057207" Approved NA NA "HPA029411: AB_10602338, HPA057207: AB_2683369" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.16e-6)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (2.09e-1)" "unprognostic (2.71e-3)" "unprognostic (7.84e-2)" "unprognostic (1.07e-2)" "prognostic favorable (1.75e-5)" "unprognostic (3.42e-1)" "unprognostic (2.41e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-1)" 3.2 3.1 9.2 1.5 11.6 0.8 13.2 4.5 12.2 25.6 3.9 11.4 8.3 1.8 5.6 2.5 5.3 6.0 2.9 11.5 10.3 4.1 2.0 0.8 21.4 1.3 7.2 4.9 15.0 5.2 8.5 4.7 2.2 20.0 8.9 1.9 6.7 6.4 5.0 40.1 6.7 2.3 6.0 17.1 1.1 9.0 1.5 9.3 3.7 38.0 6.0 1.6 4.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.4 1.1 1.1 0.0 0.0 1.0 2.7 0.1 2.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 8.4 0.5 0.0 0.0 0.2 0.0 3.1 3.7 0.0 0.1 0.0 0.0 8.1 3.4 0.2 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.6 4.5 12.2 10.3 4.1 7.2 4.9 20.0 9.3 145.9 21.8 0.0 5.1 3.0 0.6 11.3 0.0 4.0 48.9 1.8 0.0 0.9 0.0 0.8 0.1 6.8 0.1 0.0 0.6 0.1 0.8 4.4 0.0 0.0 0.3 0.0 0.0 1.8 0.3 0.0 0.0 0.0 18.6 0.0 0.3 40.4 2.8 0.3 0.0 0.1 0.8 0.0 2.1 0.1 0.4 2.0 0.2 0.0 0.6 1.3 FAM196A "C10orf141, FLJ45557, INSYN2" ENSG00000188916 "Family with sequence similarity 196 member A" Q6ZSG2 10 127135426-127196158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 11 "Bipolar cells: 10.9;Leydig cells: 14.4;Peritubular cells: 12.4" "Group enriched" "Detected in some" 13 "breast cancer: 3.4;glioma: 3.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 30 "dendritic cells: 3.0" "Group enriched" "Detected in some" 5 "SCLC-21H: 5.4;U-87 MG: 10.6" "Low region specificity" "Detected in many" "HPA035898, HPA035899" Uncertain NA NA "HPA035898: AB_10964352, HPA035899: AB_10961723" "unprognostic (4.00e-2)" "unprognostic (9.28e-2)" "unprognostic (5.39e-2)" "unprognostic (1.66e-3)" "unprognostic (2.18e-1)" "unprognostic (4.70e-2)" "unprognostic (7.30e-2)" "unprognostic (3.62e-1)" "unprognostic (2.18e-2)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (5.47e-2)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (2.45e-1)" 0.6 0.4 3.7 1.0 11.7 0.4 3.0 2.3 8.3 0.3 1.7 0.9 0.0 0.8 0.4 1.7 0.6 0.4 1.0 1.0 2.8 5.0 1.2 0.3 0.5 0.5 4.4 3.0 3.4 0.9 0.3 0.8 0.4 4.7 3.6 0.7 0.3 3.4 0.7 0.4 0.8 1.4 0.8 1.9 1.5 0.9 3.0 2.9 2.2 0.5 0.0 0.7 1.6 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 1.7 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.2 0.8 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.5 0.0 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.7 11.7 2.3 3.6 2.8 5.0 4.4 3.0 4.7 2.9 0.0 0.0 0.0 0.0 0.0 10.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 14.4 0.0 0.0 1.0 0.0 0.4 0.0 0.0 12.4 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 FAM196B C5orf57 ENSG00000204767 "Family with sequence similarity 196 member B" A6NMK8 5 169864264-169980740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;breast: 14.4;salivary gland: 10.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.1;HUVEC TERT2: 12.9;U-138 MG: 33.5;U-251 MG: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047227 Uncertain NA NA "HPA047227: AB_2679992" "unprognostic (5.30e-2)" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (1.26e-3)" "unprognostic (2.31e-2)" "unprognostic (1.98e-2)" "unprognostic (3.31e-5)" "unprognostic (5.16e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-2)" "unprognostic (2.37e-1)" "unprognostic (6.38e-2)" "unprognostic (3.73e-3)" 1.4 1.5 3.8 1.3 8.8 1.1 14.4 2.3 10.4 0.6 0.6 13.5 0.0 0.5 0.8 0.5 0.6 0.6 1.1 0.8 4.9 3.6 1.4 0.7 0.7 0.6 6.7 3.5 4.6 0.6 0.5 3.3 0.6 5.2 2.1 0.6 6.7 10.6 0.6 0.5 1.0 0.5 1.1 7.9 3.0 0.5 0.7 5.9 0.0 2.3 0.0 0.5 0.8 0.4 0.3 0.1 0.9 0.4 0.0 0.4 0.0 0.1 0.2 0.7 0.0 5.3 1.9 0.0 3.6 1.8 3.0 2.4 0.0 0.0 0.0 8.0 20.1 5.8 0.0 0.1 6.2 5.9 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 0.7 0.0 4.2 3.7 5.8 12.9 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 33.5 0.3 0.9 11.3 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.4 0.9 0.0 0.2 0.0 0.0 0.0 3.8 8.8 2.3 8.3 4.9 3.6 6.7 3.5 5.2 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM198B "C4orf18, DKFZp434L142, ENED, FLJ38155" ENSG00000164125 "Family with sequence similarity 198 member B" Q6UWH4 4 158124474-158173318 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 83.8" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 51.3;Hofbauer cells: 56.1;Ito cells: 49.7;Kupffer cells: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 23.8;intermediate monocyte: 14.8;myeloid DC: 7.6;non-classical monocyte: 6.8" "Group enriched" "Detected in many" 37 "dendritic cells: 7.6;monocytes: 23.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.5;ASC TERT1: 40.6;HSkMC: 46.6;HUVEC TERT2: 52.0;WM-115: 20.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007227 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA007227: AB_1847689" "unprognostic (4.87e-2)" "unprognostic (7.79e-2)" "unprognostic (6.60e-3)" "unprognostic (9.42e-3)" "unprognostic (2.37e-2)" "unprognostic (7.47e-2)" "unprognostic (2.13e-2)" "unprognostic (7.49e-2)" "unprognostic (9.20e-3)" "unprognostic (1.71e-1)" "unprognostic (1.60e-1)" "unprognostic (1.89e-1)" "unprognostic (3.25e-3)" "unprognostic (3.74e-3)" "unprognostic (3.85e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-2)" 24.1 83.8 13.9 12.9 12.6 0.9 15.9 22.9 16.0 16.7 8.9 12.1 6.2 4.5 27.5 13.2 6.0 10.6 12.6 25.8 24.2 9.0 4.2 2.9 6.9 7.1 18.6 20.2 50.1 4.8 4.4 2.7 9.5 12.4 8.3 8.1 4.2 7.9 10.8 3.8 3.5 6.3 23.9 25.9 15.7 7.5 7.0 17.5 0.0 8.2 3.1 2.3 14.2 7.3 0.0 7.6 0.4 23.8 0.0 0.0 7.3 3.2 2.6 1.6 0.3 21.5 40.6 3.1 0.8 0.6 0.1 1.0 3.5 1.3 0.0 0.1 1.3 1.4 0.0 19.0 5.0 0.5 0.0 0.0 0.2 0.0 9.7 14.4 0.1 0.0 46.6 1.2 6.6 0.7 2.2 52.0 0.0 3.3 0.0 9.6 0.2 0.0 0.0 0.1 11.3 0.0 0.0 0.1 0.0 0.0 7.3 0.1 0.0 0.0 7.5 2.1 9.6 1.4 0.0 2.5 4.4 4.8 2.6 1.6 0.0 0.0 11.8 0.6 0.0 20.0 0.0 23.8 0.0 0.0 14.8 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.4 0.0 6.8 0.3 0.0 7.3 13.9 12.6 22.9 16.0 24.2 9.0 18.6 20.2 12.4 17.5 8.9 3.8 1.7 1.7 8.1 0.0 30.3 0.0 2.7 2.3 3.5 0.0 3.6 0.0 0.5 2.4 51.3 2.6 0.0 5.0 0.9 14.8 2.4 1.1 0.8 56.1 6.4 1.7 49.7 140.4 4.3 32.5 27.2 8.5 0.0 6.5 0.0 3.2 1.9 39.6 0.0 0.0 6.5 10.3 4.4 0.5 6.5 4.9 2.2 2.9 1.0 FAM19A1 "TAFA-1, TAFA1" ENSG00000183662 "Family with sequence similarity 19 member A1, C-C motif chemokine like" Q7Z5A9 3 68004216-68545625 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.9;brain: 28.0" "Cell type enriched" "Detected in some" 12 "Early spermatids: 14.9" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 13.9;MAIT T-cell: 10.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 7.5;naive CD4 T-cell: 8.2;naive CD8 T-cell: 11.5;T-reg: 5.0" "Lineage enriched" "Detected in many" 6 "T-cells: 13.9" "Cell line enriched" "Detected in single" 9 "REH: 6.1" "Low region specificity" "Detected in many" HPA013407 Approved "Secreted in brain" NA NA "HPA013407: AB_1848386" "unprognostic (5.19e-2)" "unprognostic (4.64e-3)" "unprognostic (1.97e-2)" "unprognostic (1.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.40e-2)" "unprognostic (3.42e-3)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-1)" "unprognostic (1.41e-2)" "unprognostic (7.87e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.99e-1)" "unprognostic (3.50e-4)" "unprognostic (5.77e-2)" 0.7 2.0 10.6 0.8 9.0 0.4 0.5 0.4 28.0 0.5 0.7 0.1 0.3 2.3 0.8 2.0 0.5 0.5 1.4 0.5 18.4 4.8 0.8 0.8 0.5 1.2 4.4 10.4 0.4 0.4 0.4 0.6 0.4 25.2 2.6 0.6 0.0 0.6 6.2 0.6 0.4 0.5 0.9 1.3 0.9 0.5 0.7 0.2 0.0 0.6 0.0 0.7 0.7 0.3 0.0 0.0 0.2 0.1 2.1 13.9 2.6 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.9 0.0 10.7 0.0 11.5 7.5 0.0 0.0 8.2 11.5 0.2 2.1 0.0 0.0 5.0 2.6 10.6 9.0 0.4 24.4 18.4 4.8 4.4 10.4 25.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 FAM19A2 "TAFA-2, TAFA2" ENSG00000198673 "Family with sequence similarity 19 member A2, C-C motif chemokine like" Q8N3H0 12 61708259-62279150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;brain: 25.8" "Group enriched" "Detected in many" 7 "Early spermatids: 155.9;Late spermatids: 77.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 17.7;neutrophil: 9.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.7" "Cell line enhanced" "Detected in some" "hTCEpi: 9.8;SCLC-21H: 3.7;WM-115: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.89e-3)" "unprognostic (9.33e-2)" "unprognostic (1.02e-1)" "unprognostic (1.37e-2)" "unprognostic (2.78e-1)" "unprognostic (4.83e-1)" "unprognostic (6.62e-2)" "unprognostic (4.16e-3)" "unprognostic (4.08e-1)" "unprognostic (1.80e-1)" "unprognostic (3.22e-5)" "unprognostic (1.05e-1)" "unprognostic (2.22e-2)" "unprognostic (3.31e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.28e-1)" 1.7 1.7 16.7 1.3 10.1 3.8 1.5 1.3 25.8 3.1 1.7 1.1 0.0 1.8 1.9 1.0 0.9 1.3 1.2 0.7 13.1 7.0 0.9 0.8 0.9 1.4 5.8 12.7 4.3 1.8 0.9 5.7 4.9 9.9 2.4 1.5 0.2 1.2 11.1 0.6 1.3 1.3 1.0 2.1 1.8 1.2 5.3 0.0 0.0 1.0 0.0 0.7 1.5 2.5 0.4 0.4 17.7 1.9 0.4 2.8 0.4 0.2 0.0 1.9 0.4 1.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.8 0.1 0.0 0.3 0.3 0.3 0.7 0.4 1.3 3.0 0.0 0.3 1.4 2.2 0.1 9.8 0.0 0.0 0.3 0.0 2.7 1.9 1.1 0.0 0.0 2.5 0.5 0.8 0.3 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.3 0.8 0.0 0.6 0.7 0.4 0.4 0.1 0.4 1.1 0.2 0.5 0.8 0.9 0.5 0.0 0.6 8.1 17.7 1.9 3.8 0.3 0.6 0.1 0.4 0.8 0.4 0.2 0.2 0.7 0.2 9.2 0.4 0.2 0.4 2.8 0.4 16.7 10.1 1.3 25.8 13.1 7.0 5.8 12.7 9.9 0.0 0.0 0.0 3.7 1.0 1.6 1.7 2.5 0.0 4.0 0.0 0.0 2.0 1.3 5.0 0.5 155.9 1.6 1.5 0.0 1.0 1.1 3.2 0.6 1.1 2.4 1.6 0.0 2.4 0.6 10.4 77.3 3.7 1.2 1.7 0.0 1.5 2.5 0.9 1.9 0.4 1.3 1.7 6.5 0.8 17.3 5.6 0.5 2.2 2.5 1.7 1.4 FAM19A3 "TAFA-3, TAFA3" ENSG00000184599 "Family with sequence similarity 19 member A3, C-C motif chemokine like" Q7Z5A8 1 112720419-112727235 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 12 "adrenal gland: 19.6;brain: 5.2;testis: 8.8" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 44.6;Cone photoreceptor cells: 64.8;Muller glia cells: 15.8;Rod photoreceptor cells: 17.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.7;BJ hTERT+: 9.5;HEL: 3.7;U-87 MG: 3.8" HPA055927 Approved "Secreted in other tissues" NA NA "HPA055927: AB_2682972" "unprognostic (9.96e-2)" "unprognostic (4.30e-1)" "unprognostic (3.36e-2)" "unprognostic (5.63e-4)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.66e-1)" "unprognostic (3.40e-2)" "unprognostic (1.13e-1)" "unprognostic (6.43e-2)" "unprognostic (1.32e-1)" "unprognostic (9.82e-2)" "unprognostic (2.51e-1)" "unprognostic (5.14e-6)" "unprognostic (2.10e-4)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-1)" 0.1 19.6 0.4 0.1 0.0 0.0 0.3 5.2 0.4 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.4 3.9 0.6 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.2 0.0 0.0 0.6 0.8 0.2 9.5 0.7 0.6 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.1 0.5 0.4 1.6 0.3 3.7 0.0 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.5 0.0 0.2 0.0 0.4 0.4 0.4 0.1 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.3 0.6 0.1 0.0 1.1 0.0 1.4 1.3 0.2 0.5 0.1 0.0 0.0 3.8 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.6 0.4 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.3 8.1 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.6 0.9 0.0 0.1 0.0 0.0 0.0 FAM19A4 TAFA-4 ENSG00000163377 "Family with sequence similarity 19 member A4, C-C motif chemokine like" Q96LR4 3 68731766-68953297 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.0;brain: 10.9" "Cell type enriched" "Detected in some" 7 "Cone photoreceptor cells: 31.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.7;NTERA-2: 13.9;SuSa: 4.1" "Region enriched" "Detected in some" 5 "thalamus: 14.7" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (1.92e-1)" "unprognostic (9.97e-3)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (8.78e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-2)" "unprognostic (1.22e-1)" "unprognostic (3.66e-2)" "unprognostic (8.06e-2)" "unprognostic (2.50e-1)" 0.5 26.0 2.3 0.9 7.3 0.5 0.6 0.4 7.5 0.5 0.7 10.8 0.0 0.6 0.5 0.5 1.1 0.6 2.7 0.5 2.9 4.2 0.7 0.5 0.6 0.6 10.9 1.8 1.0 0.5 0.5 1.8 1.8 8.7 2.2 0.6 5.0 0.7 1.1 0.5 0.5 0.5 1.0 10.4 0.6 8.3 2.1 8.2 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.3 0.4 7.5 2.9 4.2 10.9 1.8 8.7 8.2 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 FAM19A5 TAFA-5 ENSG00000219438 "Family with sequence similarity 19 member A5, C-C motif chemokine like" Q7Z5A7 22 48489460-48850912 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.2" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 15.0;Muller glia cells: 37.6;Peritubular cells: 8.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 13.8;HEK 293: 9.3;Hep G2: 21.3;NTERA-2: 12.0;SCLC-21H: 6.1;U-2 OS: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025629 Approved "Secreted in brain" NA NA "CAB025629: " "unprognostic (2.86e-1)" "unprognostic (2.98e-1)" "unprognostic (3.42e-2)" "unprognostic (2.19e-1)" "unprognostic (3.57e-1)" "unprognostic (1.80e-1)" "unprognostic (2.82e-3)" "unprognostic (2.41e-2)" "unprognostic (6.80e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-2)" "unprognostic (1.26e-1)" "unprognostic (9.31e-3)" "unprognostic (2.64e-2)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.94e-2)" 1.9 2.5 22.7 1.7 18.7 0.7 2.7 19.1 40.2 12.2 1.8 8.5 0.1 2.0 8.1 6.9 1.1 3.4 3.4 1.4 23.6 22.8 1.9 3.0 2.2 1.2 18.1 12.9 8.3 2.4 0.8 1.9 0.8 8.7 4.0 1.0 0.7 7.3 5.7 1.5 1.9 2.6 1.8 9.9 1.1 3.7 2.5 7.3 1.3 1.1 0.0 1.0 2.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.8 0.1 0.0 0.9 0.0 0.0 0.0 9.3 0.0 0.1 21.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.2 12.0 0.4 0.0 0.5 0.0 5.1 0.0 0.0 6.1 0.1 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.7 19.1 21.9 23.6 22.8 18.1 12.9 8.7 7.3 3.0 2.9 0.0 0.0 1.6 15.0 1.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.6 0.0 0.0 0.3 0.0 5.6 1.0 0.0 0.0 0.2 3.2 0.0 0.6 0.0 0.0 6.4 0.2 5.0 0.0 0.0 37.6 0.7 0.0 8.9 1.8 1.5 0.0 0.9 0.5 3.4 1.4 0.0 0.0 0.0 0.0 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723055-34729467 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 24.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 99.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;THP-1: 2.3" HPA071267 Enhanced Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA071267: AB_2686376" "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 FAM205C FAM205CP ENSG00000187791 "Family with sequence similarity 205 member C" A6NFA0 9 34889064-34895778 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 23.2" "Group enriched" "Detected in some" 80 "Early spermatids: 294.6;Late spermatids: 336.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 97 "THP-1: 18.1" NA NA "unprognostic (1.29e-1)" "unprognostic (1.90e-1)" "unprognostic (3.64e-2)" "unprognostic (8.64e-2)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-4)" "unprognostic (1.48e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 294.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 336.5 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.6 0.5 0.0 0.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 FAM209A "C20orf106, dJ1153D9.3" ENSG00000124103 "Family with sequence similarity 209 member A" Q5JX71 20 56517187-56526142 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 40.3" "Cell type enriched" "Detected in some" 15 "Early spermatids: 1951.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.9;neutrophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 5.5;Karpas-707: 3.0;U-266/84: 3.9" NA NA "unprognostic (1.03e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (8.58e-3)" "unprognostic (1.06e-2)" "unprognostic (2.12e-1)" "unprognostic (2.10e-1)" "unprognostic (9.83e-2)" "unprognostic (5.56e-3)" "unprognostic (7.68e-2)" "unprognostic (1.86e-9)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-2)" 0.2 0.0 0.0 0.3 0.0 8.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.1 40.3 0.0 0.5 0.0 0.1 0.6 0.3 2.3 0.2 0.0 1.9 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.3 0.3 0.2 1.9 0.3 0.5 0.2 0.2 0.5 0.2 0.2 0.3 0.3 0.6 0.4 0.0 0.2 1.5 5.5 0.3 1.6 0.0 0.2 0.2 0.0 1.7 0.0 3.0 0.0 1.3 0.2 1.9 0.2 0.1 0.2 1.0 0.9 1.2 0.0 0.7 0.5 0.0 0.0 2.1 0.5 0.0 0.4 0.9 0.0 0.5 0.3 0.8 0.3 1.4 3.9 2.0 0.0 0.2 0.1 0.0 0.2 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 2.3 0.0 0.2 0.3 0.0 0.0 0.0 2.9 0.0 0.1 0.1 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1951.2 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.1 0.0 0.1 0.0 1.2 1.8 0.3 132.6 8.1 0.8 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 0.0 7.5 4.1 0.0 0.2 0.0 0.1 0.1 FAM209B "C20orf107, dJ1153D9.4" ENSG00000213714 "Family with sequence similarity 209 member B" Q5JX69 20 56533246-56536520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 40.8" "Cell type enriched" "Detected in some" 10 "Early spermatids: 1427.6" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 5.0" HPA042144 Enhanced NA NA "HPA042144: AB_10794414" "unprognostic (2.93e-1)" "unprognostic (6.90e-2)" "unprognostic (9.49e-3)" "unprognostic (4.96e-3)" "unprognostic (1.72e-1)" "unprognostic (3.77e-1)" "unprognostic (1.72e-1)" "unprognostic (7.77e-2)" "unprognostic (3.63e-2)" "unprognostic (1.43e-1)" "unprognostic (4.59e-4)" "unprognostic (3.47e-1)" "unprognostic (2.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.55e-1)" "unprognostic (7.13e-2)" "unprognostic (1.48e-4)" 0.2 0.0 0.0 0.2 0.1 4.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.9 0.1 40.8 0.0 0.3 0.0 0.0 1.0 0.8 3.4 1.1 0.0 2.1 0.4 0.0 2.7 0.7 0.0 0.0 0.3 0.4 1.1 1.9 2.4 0.9 1.7 0.1 0.3 1.8 1.2 0.6 1.4 1.2 0.7 2.1 0.4 1.1 1.2 0.0 1.1 0.0 2.2 4.2 1.3 2.0 0.2 1.5 0.0 0.0 1.9 0.2 1.9 0.0 2.6 0.8 2.0 0.5 0.2 1.5 0.7 0.8 0.2 1.5 0.9 1.7 0.4 0.9 3.4 0.6 0.8 1.5 0.6 0.0 0.3 0.7 1.7 0.1 5.0 4.5 0.9 0.4 1.0 0.3 0.0 1.1 3.4 2.1 0.4 0.3 0.0 0.1 1.3 0.8 1.0 0.7 0.0 1.8 0.0 0.7 0.0 0.0 0.4 0.0 3.4 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1427.6 0.0 0.0 0.0 1.4 0.4 0.0 0.3 1.1 0.0 0.5 0.0 1.2 0.0 0.3 148.4 10.6 0.7 0.0 1.0 0.0 0.0 0.6 0.0 7.8 0.5 0.0 0.0 0.5 6.9 6.8 0.0 0.0 0.0 0.0 0.6 FAM20A DKFZp434F2322 ENSG00000108950 "FAM20A, golgi associated secretory pathway pseudokinase" Q96MK3 17 68535113-68601389 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.2;salivary gland: 50.4" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 68.0;Early spermatids: 61.3;Hepatocytes: 58.2;Hofbauer cells: 72.2;Late spermatids: 140.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 3.8" "Cell type enhanced" "Detected in some" "non-classical monocyte: 2.1" "Group enriched" "Detected in many" 4 "dendritic cells: 1.0;granulocytes: 1.8;monocytes: 2.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.8;BJ hTERT+: 27.3;HSkMC: 22.8;U-2197: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA048964 Approved "Secreted in other tissues" NA NA 10000000 "HPA048964: AB_2680575" "unprognostic (3.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.35e-2)" "unprognostic (4.49e-3)" "unprognostic (6.56e-2)" "unprognostic (5.29e-2)" "unprognostic (3.90e-3)" "unprognostic (2.39e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (9.16e-10)" "unprognostic (1.25e-3)" "unprognostic (1.06e-1)" "unprognostic (4.55e-2)" "unprognostic (2.39e-2)" 4.9 1.1 0.2 4.7 0.4 1.0 3.7 0.2 1.5 12.1 3.2 0.7 0.7 1.4 7.6 9.9 2.2 4.1 2.3 6.5 0.3 0.4 19.6 59.2 17.6 14.7 0.3 0.8 6.8 1.0 0.6 4.8 4.2 3.8 3.5 1.0 8.7 50.4 1.7 2.8 1.5 1.2 4.7 2.4 7.3 9.5 9.1 0.2 0.9 8.2 4.0 2.5 3.7 3.4 0.2 1.0 1.8 2.1 0.1 0.3 0.0 0.0 0.1 0.0 0.1 1.3 11.8 0.0 0.5 27.3 0.0 0.0 0.0 0.0 0.0 2.4 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 22.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.9 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.1 1.8 0.1 2.1 1.0 0.0 0.0 0.2 0.4 0.2 1.5 0.3 0.4 0.3 0.8 3.8 0.2 14.9 68.0 0.0 0.1 2.1 3.1 4.8 7.6 1.4 37.5 41.8 0.0 0.5 0.0 0.3 61.3 1.3 0.0 0.0 0.4 2.0 5.8 0.0 1.1 58.2 72.2 39.7 0.0 7.4 20.3 140.0 10.3 11.6 1.7 1.8 0.0 0.2 0.6 0.0 13.8 13.0 2.9 6.5 0.7 1.2 0.2 1.6 2.3 0.0 0.0 0.0 FAM20C "DKFZp547D065, DMP4, G-CK, IMAGE:4942737" ENSG00000177706 "FAM20C, golgi associated secretory pathway kinase" Q8IXL6 7 192969-260745 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" Biomineralization "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 80.6" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019823 Approved "Nucleoplasm,Golgi apparatus" "Secreted in other tissues" NA NA 160000000 "Golgi apparatus" Nucleoplasm "HPA019823: AB_1848389" "unprognostic (1.94e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (3.15e-2)" "unprognostic (1.03e-2)" "unprognostic (3.33e-3)" "unprognostic (2.47e-2)" "unprognostic (7.86e-2)" "unprognostic (2.45e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (9.40e-6)" "unprognostic (1.97e-3)" "unprognostic (2.49e-1)" "unprognostic (3.08e-3)" "unprognostic (1.94e-2)" "unprognostic (3.92e-2)" "unprognostic (2.16e-2)" "unprognostic (3.83e-3)" 27.5 10.2 10.8 19.3 16.6 3.3 25.6 7.4 14.9 8.3 20.1 13.5 15.1 12.9 9.5 6.9 11.1 9.7 15.0 15.0 8.8 7.2 31.8 31.6 12.7 5.1 16.9 5.6 11.8 14.8 2.6 9.2 7.2 15.8 15.0 4.6 8.8 80.6 11.8 20.4 6.8 16.5 17.0 17.0 6.9 20.0 5.9 14.8 0.4 9.6 8.4 4.4 20.5 17.5 0.0 0.6 0.0 1.6 0.2 0.0 0.0 13.3 6.5 0.2 9.3 11.9 19.7 0.0 11.9 20.2 6.5 5.2 0.7 8.2 0.0 6.6 17.8 8.8 11.6 1.0 0.5 1.6 2.8 0.6 0.0 3.1 3.5 9.0 0.0 0.9 50.3 1.5 0.2 0.7 39.1 4.5 0.0 0.0 0.1 1.7 1.8 0.0 0.7 6.3 0.1 0.4 1.5 0.3 0.0 4.8 0.0 3.1 0.1 12.4 0.0 1.8 1.2 8.8 6.1 12.5 8.1 4.0 6.9 3.6 0.0 0.0 0.0 31.0 0.8 23.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.8 16.6 7.4 14.9 8.8 7.2 16.9 5.6 15.8 14.8 6.0 3.2 2.4 1.9 9.0 20.6 8.1 33.1 5.3 0.0 52.4 0.0 0.5 5.0 1.3 0.0 2.4 3.5 0.0 4.1 0.6 13.5 6.8 3.5 80.0 49.0 1.6 11.3 9.8 15.6 1.1 15.0 14.7 1.7 11.8 4.2 16.6 6.5 3.5 53.0 46.8 8.0 12.9 15.3 0.2 0.7 7.0 0.5 0.0 7.3 1.4 FAM212A "C3orf54, INKA1" ENSG00000185614 "Family with sequence similarity 212 member A" Q96EL1 3 49803254-49805030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.8;skin 1: 30.0" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 22.2;granulocytes: 19.8;Hofbauer cells: 41.3;Ito cells: 39.3;Suprabasal keratinocytes: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 19.0;memory B-cell: 25.8;naive B-cell: 23.4" "Group enriched" "Detected in many" 6 "B-cells: 25.8;granulocytes: 19.0" "Cell line enhanced" "Detected in many" "HEL: 31.9;HMC-1: 21.9;NB-4: 17.7;THP-1: 19.7;U-937: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041879 Uncertain Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 6.0 4.1 5.8 3.2 4.7 5.0 3.5 8.0 6.3 6.8 2.6 4.9 1.4 1.7 5.5 2.8 16.3 2.9 4.8 7.6 4.4 4.3 3.4 1.2 7.3 5.9 6.3 4.8 3.6 2.3 0.8 2.0 5.2 5.6 5.4 1.4 3.2 4.5 3.9 15.3 30.0 3.5 5.3 8.3 6.9 2.2 2.4 4.3 1.8 1.9 10.4 8.4 4.8 8.5 25.8 3.6 19.0 2.9 0.0 1.5 2.8 0.6 0.5 0.7 0.5 0.9 2.0 0.0 1.4 0.9 0.7 0.8 0.0 0.0 6.9 0.2 1.0 0.7 4.1 0.2 4.9 0.0 1.2 0.0 31.9 0.3 0.1 1.3 4.8 21.9 2.7 7.0 1.4 1.3 0.4 2.9 0.5 2.1 0.6 0.6 0.3 0.4 17.7 0.5 0.0 2.8 6.5 0.4 1.5 0.0 7.9 0.3 2.5 1.3 0.2 0.7 0.2 0.1 19.7 1.8 3.6 0.4 1.6 0.6 0.8 0.7 0.5 1.5 16.4 0.8 19.0 0.9 4.3 0.6 2.2 0.1 25.8 0.6 0.7 0.2 23.4 0.9 1.5 0.5 0.0 2.9 3.6 0.6 2.8 5.8 4.7 8.0 6.3 4.4 4.3 6.3 4.8 5.6 4.3 3.0 1.1 0.0 11.6 22.2 1.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 1.6 7.5 0.0 0.0 0.0 0.4 7.5 1.1 19.8 0.0 41.3 0.0 0.0 39.3 2.2 7.4 1.7 0.0 11.8 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.4 12.9 0.5 1.7 3.2 24.1 0.9 0.0 0.0 4.7 FAM212B "C1orf183, FLJ31105, INKA2" ENSG00000284755 "Family with sequence similarity 212 member B" 1 111722064-111755824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in many" 5 "Early spermatids: 52.0;Late spermatids: 39.5;Sertoli cells: 32.3" "Cell type enriched" "Detected in single" 5 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 5 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 2.5;HHSteC: 3.7;HSkMC: 2.9;LHCN-M2: 3.5;SuSa: 3.5;THP-1: 2.5;U-87 MG: 2.5" "HPA027810, HPA027811" Uncertain Uncertain Nucleoplasm,Nucleoli,Vesicles NA NA "Nucleoplasm, Vesicles" Nucleoli "HPA027810: , HPA027811: AB_10600872" 0.1 0.3 0.1 0.4 2.8 0.2 0.1 0.1 1.7 0.1 0.2 1.5 0.1 0.3 1.7 2.0 0.1 0.0 0.3 0.4 0.1 0.7 0.1 0.5 0.2 0.1 0.1 0.1 1.0 0.0 0.1 1.0 1.6 0.8 1.3 0.1 0.1 1.2 0.1 0.0 1.0 2.5 2.6 2.2 0.0 0.7 1.2 2.6 0.8 0.1 0.1 1.9 0.1 0.1 0.2 0.7 0.1 3.4 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 3.7 1.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 3.5 1.3 0.5 1.9 1.8 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 3.5 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 2.5 2.2 0.0 0.7 0.0 0.0 0.2 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.3 0.3 0.0 3.4 0.1 0.2 0.2 0.0 0.0 0.0 0.5 3.1 6.2 6.2 0.0 0.0 2.7 0.0 0.0 7.9 0.0 0.0 0.0 52.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 6.9 1.3 2.8 39.5 2.0 2.0 6.8 0.0 4.6 1.2 0.0 1.1 5.3 0.0 5.9 32.3 6.1 4.2 2.1 3.4 0.0 0.0 0.9 0.6 FAM213A "Adrx, C10orf58, MGC4248, PAMM" ENSG00000122378 "Family with sequence similarity 213 member A" Q9BRX8 10 80407829-80437115 "Predicted intracellular proteins, Predicted membrane proteins" Antioxidant "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 120.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "plasmacytoid DC: 48.5" "Lineage enriched" "Detected in all" 10 "dendritic cells: 48.5" "Cell line enhanced" "Detected in many" "ASC diff: 140.5;HaCaT: 39.5;HUVEC TERT2: 62.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009025, HPA024565" Enhanced "Intracellular and membrane" NA NA "HPA009025: AB_1078312, HPA024565: AB_1845519" "unprognostic (1.73e-2)" "unprognostic (2.96e-2)" "unprognostic (6.96e-3)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (4.31e-2)" "unprognostic (3.14e-1)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (7.01e-2)" "unprognostic (3.54e-2)" "unprognostic (2.83e-3)" "unprognostic (3.32e-3)" "unprognostic (3.55e-1)" "unprognostic (6.78e-2)" "unprognostic (1.80e-1)" "prognostic favorable (6.11e-4)" 120.6 9.3 42.3 6.5 47.7 1.7 64.1 9.8 44.0 33.0 21.1 17.8 11.2 28.0 18.4 75.3 22.5 11.3 10.8 22.5 36.2 33.7 38.2 65.6 7.4 7.6 36.6 26.2 11.4 22.3 34.6 23.3 15.5 26.5 25.0 15.1 31.7 17.4 16.6 15.4 27.1 25.4 7.9 29.6 4.4 7.3 17.1 16.3 5.0 19.2 24.3 11.4 19.1 13.0 4.6 48.5 3.3 1.0 1.9 4.4 1.5 3.5 8.9 15.2 0.0 140.5 0.0 1.0 0.5 3.1 0.2 0.0 8.4 10.9 2.3 11.9 0.0 6.8 39.5 1.3 1.5 0.0 0.1 2.5 4.6 3.4 12.3 13.6 0.0 1.3 10.5 2.9 0.9 0.0 36.5 62.5 13.5 3.6 0.0 0.0 12.4 5.7 0.6 7.3 5.4 0.0 16.3 7.0 0.1 32.2 14.9 15.7 11.1 1.5 21.4 23.0 12.0 9.5 6.4 16.8 0.1 0.1 0.0 0.0 1.3 2.9 0.0 9.6 0.0 1.0 0.2 1.0 3.3 2.1 0.2 1.7 4.6 1.1 1.7 1.0 3.5 4.4 4.4 0.7 1.9 0.0 48.5 0.0 1.5 42.3 47.7 9.8 44.0 36.2 33.7 36.6 26.2 26.5 16.3 11.9 50.5 16.1 75.8 154.2 6.5 138.5 66.2 64.3 94.4 97.7 188.5 13.2 134.3 70.7 6.8 96.0 160.8 23.3 57.1 4.9 53.1 76.2 34.7 150.8 61.4 60.4 146.2 122.8 34.6 11.5 196.2 17.8 30.4 14.4 55.9 89.2 48.7 48.9 115.6 124.6 24.9 291.1 47.4 18.8 66.6 118.3 3.1 6.9 70.5 111.2 FAM216A "C12orf24, HSU79274" ENSG00000204856 "Family with sequence similarity 216 member A" Q8WUB2 12 110468364-110490385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.9" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 244.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038286 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA038286: AB_2675931" "unprognostic (7.91e-2)" "unprognostic (3.73e-2)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (3.04e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (8.49e-2)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (4.18e-10)" "unprognostic (7.60e-2)" "unprognostic (4.35e-2)" "unprognostic (6.66e-2)" "unprognostic (1.05e-1)" 3.3 6.6 8.6 6.1 11.7 3.7 3.9 15.8 19.7 4.6 2.5 3.8 0.7 1.8 4.9 1.5 2.6 3.9 4.2 7.0 11.6 13.0 3.0 3.2 2.1 6.3 8.3 11.9 6.5 2.3 4.4 4.0 3.7 12.5 4.1 2.5 1.2 2.2 5.1 6.0 1.9 2.3 5.6 6.6 4.3 2.2 43.9 6.2 5.0 3.0 1.4 4.4 3.8 2.5 9.9 5.5 3.2 4.9 2.5 12.3 5.4 8.0 7.0 5.1 6.6 3.8 7.0 1.3 14.3 3.9 16.5 7.6 6.9 2.3 29.2 3.8 6.6 4.3 5.9 9.5 8.6 18.8 9.3 23.0 15.0 4.4 5.0 5.6 17.8 11.8 6.4 2.2 8.4 18.5 9.9 5.5 12.6 16.0 7.6 10.9 2.7 14.3 22.9 17.6 3.2 13.0 7.2 7.7 20.5 5.8 0.1 25.3 8.3 7.0 4.4 3.5 1.6 11.6 10.4 4.8 5.5 2.4 4.8 13.8 14.1 10.2 22.8 9.0 16.6 10.1 1.4 4.9 1.9 3.1 3.3 4.4 9.2 4.8 5.0 5.5 9.9 12.3 7.3 3.2 2.5 3.1 2.9 3.3 5.4 8.6 11.7 15.8 19.7 11.6 13.0 8.3 11.9 12.5 6.2 0.0 1.0 8.5 4.7 1.4 10.2 15.3 0.0 5.3 4.5 3.5 2.0 0.6 0.0 3.2 29.5 5.8 0.0 0.0 0.8 1.9 5.1 1.6 10.3 3.9 6.7 12.7 1.2 4.9 4.5 44.3 8.9 2.1 3.3 1.8 0.0 4.6 2.5 0.0 5.3 2.9 4.1 12.9 5.1 244.4 20.0 1.8 0.5 3.2 0.2 1.3 FAM216B "C13orf30, FLJ40919" ENSG00000179813 "Family with sequence similarity 216 member B" Q8N7L0 13 42781550-42791549 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 348.0" "Group enriched" "Detected in some" 10 "endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9" "Group enriched" "Detected in many" 5 "basal ganglia: 9.5;pons and medulla: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-87 MG: 6.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040118 Uncertain NA NA "HPA040118: AB_10674429" "unprognostic (1.03e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.77e-4)" "unprognostic (4.35e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (2.54e-2)" "unprognostic (5.44e-3)" "unprognostic (1.32e-1)" "unprognostic (2.27e-1)" "unprognostic (8.14e-3)" "unprognostic (1.37e-1)" "unprognostic (1.30e-2)" 0.3 0.2 1.7 0.9 9.5 0.2 0.2 0.1 0.6 3.0 0.3 8.0 0.0 0.3 1.3 18.2 0.2 51.3 0.4 10.0 3.1 3.2 0.2 0.2 28.5 2.2 0.1 0.0 18.3 0.3 0.2 2.0 0.2 21.0 0.2 0.5 0.0 0.7 0.2 0.2 0.2 1.5 0.2 0.5 0.3 0.3 1.0 1.7 0.0 0.2 0.0 3.9 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 9.5 0.1 0.6 3.1 3.2 0.1 0.0 21.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 7.7 0.0 348.0 42.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FAM217A "C6orf146, MGC43581" ENSG00000145975 "Family with sequence similarity 217 member A" Q8IXS0 6 4049434-4087344 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 16.9" "Group enriched" "Detected in some" 23 "Early spermatids: 174.7;Late spermatids: 307.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "HeLa: 1.2" "Low region specificity" "Detected in many" HPA035455 Uncertain NA NA "HPA035455: AB_10669905" "unprognostic (5.93e-2)" "unprognostic (3.70e-2)" "unprognostic (1.24e-1)" "unprognostic (8.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.53e-2)" "unprognostic (2.99e-2)" "unprognostic (1.08e-2)" "unprognostic (2.09e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (4.54e-1)" "unprognostic (6.55e-2)" "unprognostic (2.86e-1)" "unprognostic (1.85e-1)" "unprognostic (1.53e-2)" "unprognostic (5.51e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.3 0.1 0.3 0.4 0.5 1.3 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 10.6 2.7 0.0 0.0 0.0 0.0 0.0 FAM219A "bA573M23.5, C9orf25, FLJ39031" ENSG00000164970 "Family with sequence similarity 219 member A" Q8IW50 9 34398184-34458570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.9" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019338, HPA052909" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA019338: AB_1845819, HPA052909: AB_2681986" "unprognostic (9.96e-3)" "unprognostic (2.16e-1)" "unprognostic (1.50e-2)" "unprognostic (1.23e-2)" "unprognostic (6.81e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.71e-2)" "unprognostic (2.50e-1)" "unprognostic (2.95e-1)" "prognostic favorable (2.46e-4)" "unprognostic (3.46e-3)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.34e-1)" "unprognostic (2.76e-1)" 13.6 10.3 27.8 10.9 27.0 4.9 7.1 26.3 56.9 7.5 6.3 23.3 3.7 7.2 13.2 8.6 6.3 6.5 7.6 17.5 25.4 27.6 6.1 5.0 11.0 7.8 30.8 31.0 10.7 8.4 9.4 10.6 16.3 34.0 9.2 6.6 5.4 7.1 9.7 28.6 12.3 6.7 15.0 25.2 9.8 7.2 6.9 25.6 2.9 7.2 4.0 6.6 6.5 6.4 0.5 0.6 3.8 0.7 0.7 1.5 0.3 12.6 4.9 11.6 6.6 10.8 4.1 11.3 7.7 5.8 6.7 8.5 3.4 2.9 2.8 8.0 7.4 13.3 5.3 9.2 4.9 6.7 43.6 5.2 1.1 6.3 3.6 6.1 2.7 6.5 4.3 5.0 10.0 5.6 8.3 11.0 5.0 2.7 14.0 5.2 2.5 4.2 3.8 7.5 1.7 7.3 5.5 1.9 2.4 4.8 2.7 3.7 11.8 6.6 4.8 3.8 11.1 2.4 2.8 13.0 7.4 5.8 15.3 10.6 3.7 5.3 2.4 21.2 6.4 13.0 2.3 0.6 3.8 1.5 0.4 0.8 0.5 0.8 0.4 0.5 0.4 0.6 0.8 2.0 0.7 0.7 0.6 1.4 0.3 27.8 27.0 26.3 40.8 25.4 27.6 30.8 31.0 34.0 25.6 6.0 3.5 2.2 2.9 5.6 18.4 10.5 0.0 1.4 1.2 3.5 3.9 8.2 0.0 5.2 12.0 14.3 0.9 0.0 4.2 12.1 5.6 5.6 2.3 2.4 5.2 50.9 10.4 5.5 4.6 25.8 3.4 2.3 8.5 3.6 1.6 8.5 5.6 1.4 5.3 2.1 10.5 6.5 8.2 10.3 2.4 5.6 17.3 4.4 0.8 2.6 FAM220A "ACPIN1, C7orf70, MGC12966, SIPAR" ENSG00000178397 "Family with sequence similarity 220 member A" Q7Z4H9 7 6329409-6348981 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.7;testis: 40.9" "Group enriched" "Detected in many" 14 "Early spermatids: 230.4;Late spermatids: 278.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055050 Approved Vesicles NA NA Vesicles "HPA055050: AB_2682684" "unprognostic (3.49e-2)" "unprognostic (3.53e-1)" "unprognostic (2.69e-2)" "unprognostic (9.79e-2)" "unprognostic (3.26e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (5.17e-6)" "unprognostic (2.78e-1)" "unprognostic (1.43e-2)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (8.84e-3)" "unprognostic (1.14e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (3.71e-2)" 5.8 6.9 10.5 5.1 9.3 2.3 7.7 14.0 16.6 7.5 6.1 6.8 3.8 4.3 8.1 6.1 8.9 6.2 5.9 12.6 10.3 9.7 6.5 5.1 4.9 6.8 8.3 11.6 8.7 10.5 15.3 7.2 6.0 7.9 6.6 4.4 5.6 7.2 6.9 56.7 7.7 4.6 7.3 7.9 5.8 5.3 40.9 5.4 9.7 9.1 11.8 7.7 7.5 6.3 11.1 9.6 9.5 5.5 16.2 10.2 3.8 15.9 10.1 7.4 17.3 17.2 14.6 8.2 8.2 10.2 9.9 11.7 6.7 8.9 13.3 9.5 9.7 19.9 11.8 11.2 6.9 13.0 9.2 7.2 4.4 8.1 7.5 18.7 8.0 6.7 8.1 23.4 7.4 18.0 9.6 9.2 10.1 8.6 12.8 8.5 12.5 4.9 14.7 17.3 8.4 13.2 12.8 11.1 11.1 9.1 5.8 7.6 13.1 11.5 14.2 17.1 15.6 13.6 21.0 6.9 7.9 18.1 15.3 10.4 13.8 21.3 14.5 9.2 14.5 24.1 6.7 5.5 9.5 5.5 4.5 5.7 11.1 6.6 8.5 9.6 10.6 10.2 8.4 2.4 16.2 4.7 7.7 8.3 3.8 10.5 9.3 14.0 16.6 10.3 9.7 8.3 11.6 7.9 5.4 3.0 1.4 4.4 4.7 6.9 2.7 8.5 0.0 1.4 9.1 1.8 5.9 5.4 1.7 4.8 230.4 3.3 2.5 0.0 4.1 6.2 5.2 3.7 1.1 3.4 5.7 0.0 5.8 5.5 5.9 278.7 7.8 5.7 3.3 6.4 4.0 3.7 5.0 2.3 12.4 2.2 1.8 0.0 4.2 17.9 10.4 8.8 6.9 3.3 3.2 5.9 FAM221B C9orf128 ENSG00000204930 "Family with sequence similarity 221 member B" A6H8Z2 9 35816391-35828747 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.9;testis: 27.3" "Group enriched" "Detected in some" 27 "Early spermatids: 217.9;Late spermatids: 97.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026577 Enhanced NA NA "HPA026577: AB_1845810" "unprognostic (1.23e-1)" "unprognostic (5.32e-2)" "unprognostic (9.40e-2)" "unprognostic (3.59e-2)" "unprognostic (1.25e-1)" "unprognostic (9.81e-3)" "unprognostic (6.94e-2)" "unprognostic (2.44e-2)" "unprognostic (4.03e-1)" "unprognostic (2.67e-2)" "unprognostic (3.13e-3)" "unprognostic (4.22e-1)" "unprognostic (9.20e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-1)" "unprognostic (3.15e-2)" "unprognostic (1.25e-3)" 0.3 0.1 0.3 0.7 0.3 5.2 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 1.1 0.9 0.3 0.9 0.3 0.3 0.6 0.3 0.3 0.4 0.3 0.3 27.3 0.3 0.3 0.3 0.3 0.5 0.3 0.3 1.5 6.9 3.6 0.8 0.6 0.8 0.3 0.6 1.0 1.5 1.9 0.6 0.5 0.9 0.0 0.0 1.1 0.6 0.6 2.0 1.1 0.5 0.5 0.4 0.0 0.4 0.0 0.4 0.0 0.6 0.5 2.7 1.7 0.5 0.8 1.4 0.6 1.8 0.4 1.1 0.2 0.8 0.8 0.2 2.5 0.9 1.0 0.0 1.1 0.0 0.1 0.7 0.4 0.7 1.5 0.0 2.2 1.8 1.5 0.6 1.6 0.0 1.0 0.7 1.1 1.2 1.4 0.7 2.7 0.9 1.3 0.5 0.6 0.3 1.1 0.3 1.0 0.8 0.5 0.7 0.3 0.6 0.7 0.6 0.5 0.4 1.5 0.8 0.8 3.6 0.6 0.3 6.9 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 1.9 0.0 0.4 0.0 3.5 0.3 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 217.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 97.0 2.0 0.0 0.0 0.0 0.2 3.1 0.2 1.5 0.7 0.0 5.9 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.0 1.0 FAM222A "C12orf34, FLJ14721" ENSG00000139438 "Family with sequence similarity 222 member A" Q5U5X8 12 109714228-109770507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.9" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 31.4;Early spermatids: 23.4;Horizontal cells: 73.1;Rod photoreceptor cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040181, HPA058774" Uncertain Approved "Nucleoplasm,Plasma membrane,Focal adhesion sites,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" "Focal adhesion sites, Mitochondria" "HPA040181: AB_10796448, HPA058774: " "unprognostic (8.59e-3)" "prognostic favorable (1.82e-5)" "unprognostic (1.43e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-2)" "unprognostic (1.03e-1)" "unprognostic (6.66e-2)" "unprognostic (8.17e-2)" "prognostic favorable (4.81e-4)" "unprognostic (1.15e-1)" "unprognostic (4.16e-2)" "prognostic favorable (8.59e-4)" "unprognostic (3.93e-2)" "unprognostic (2.77e-1)" "unprognostic (1.24e-1)" 1.8 16.0 7.3 2.3 17.4 2.0 3.0 15.1 25.5 1.6 3.3 37.9 0.0 10.0 1.5 2.7 2.1 1.4 2.6 4.4 11.7 9.6 7.7 2.7 1.8 1.7 23.2 7.9 7.8 6.9 1.5 13.1 1.3 15.1 2.3 3.0 10.3 7.3 2.1 2.8 4.7 5.1 1.8 27.8 6.3 8.0 17.4 23.0 0.0 1.4 0.0 2.1 1.4 2.4 0.2 0.6 0.9 0.2 0.0 0.2 0.0 0.9 1.3 0.7 1.6 0.4 0.0 0.5 0.2 0.1 0.7 0.1 12.0 0.2 0.1 1.0 0.3 0.7 0.5 0.8 0.0 0.2 7.7 1.8 1.5 0.4 2.7 0.1 1.1 1.6 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.5 0.2 0.1 4.8 0.3 1.5 1.3 1.4 2.4 1.0 3.5 0.5 1.5 0.6 8.5 51.4 1.1 1.6 3.4 0.2 1.9 1.3 0.1 0.2 1.4 0.6 1.0 1.3 1.7 1.0 0.1 0.8 1.7 0.0 0.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 7.3 17.4 15.1 13.7 11.7 9.6 23.2 7.9 15.1 23.0 0.0 0.0 0.5 0.6 1.9 21.6 6.1 2.5 0.0 0.0 1.8 31.4 0.1 6.6 1.4 23.4 0.8 0.6 0.0 0.7 0.1 1.7 1.4 0.0 1.3 0.3 73.1 7.5 0.0 0.0 11.0 1.1 0.3 6.8 0.0 4.1 10.0 0.8 0.0 0.4 0.6 48.4 0.0 1.4 0.7 2.6 1.6 0.7 0.0 0.8 0.2 FAM227A ENSG00000184949 "Family with sequence similarity 227 member A" F5H4B4 22 38578120-38656629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.2;testis: 15.6" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 80.3;Cone photoreceptor cells: 37.3;Early spermatids: 62.3;Late spermatids: 43.0;Rod photoreceptor cells: 33.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HDLM-2: 11.4;Karpas-707: 21.5" HPA003077 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003077: AB_1079264" "unprognostic (7.52e-2)" "unprognostic (3.06e-2)" "unprognostic (1.63e-1)" "unprognostic (8.14e-2)" "unprognostic (5.85e-2)" "unprognostic (2.91e-3)" "unprognostic (4.79e-5)" "unprognostic (5.91e-2)" "unprognostic (3.04e-2)" "unprognostic (4.04e-2)" "unprognostic (1.85e-2)" "unprognostic (4.62e-2)" "unprognostic (6.46e-6)" "unprognostic (3.74e-1)" "unprognostic (3.47e-2)" "unprognostic (2.65e-3)" "unprognostic (1.35e-2)" 0.5 1.2 4.7 0.9 7.0 1.5 2.8 0.9 3.1 2.6 0.8 5.0 5.5 0.7 2.3 7.8 0.7 9.3 2.2 0.8 4.2 3.4 2.0 0.5 2.4 0.7 1.9 2.5 1.6 1.5 2.3 26.2 0.6 6.7 1.5 1.0 2.7 1.1 1.8 0.5 2.4 0.6 1.5 0.9 0.7 1.3 15.6 3.0 0.8 3.5 0.1 0.6 1.1 0.7 1.4 1.0 2.3 0.7 1.0 1.3 0.3 0.4 1.2 1.8 2.4 0.4 1.2 0.4 0.2 0.2 0.3 0.2 0.0 1.1 0.2 0.5 0.2 0.5 1.1 0.8 0.2 0.4 11.4 1.1 0.1 3.3 0.2 0.2 0.5 0.5 0.6 0.7 1.3 0.4 1.8 0.2 1.6 0.4 21.5 0.1 0.5 0.5 0.5 0.8 0.2 0.7 1.1 0.1 0.6 0.8 0.3 2.3 0.6 1.5 0.1 0.1 0.7 1.4 0.2 0.4 0.6 0.5 0.5 0.1 2.0 1.0 0.1 0.8 0.2 0.3 2.0 0.7 0.7 0.7 0.6 0.5 0.8 0.7 0.6 0.3 1.4 0.9 1.3 2.3 1.0 0.6 1.0 0.7 0.3 4.7 7.0 0.9 3.1 4.2 3.4 1.9 2.5 6.7 3.0 3.0 1.6 0.0 2.3 2.2 5.7 1.6 5.1 80.3 10.3 5.2 37.3 0.2 0.0 2.9 62.3 1.4 0.0 0.0 2.2 0.2 1.9 2.1 0.0 0.0 0.2 4.8 4.6 0.6 0.0 43.0 2.0 1.0 0.0 0.0 0.4 12.4 1.8 0.0 1.1 0.9 33.1 0.0 1.0 15.4 13.8 3.0 0.1 0.0 1.2 1.4 FAM228A "C2orf84, FLJ30851" ENSG00000186453 "Family with sequence similarity 228 member A" Q86W67 2 24175069-24200849 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "testis: 54.1" "Group enriched" "Detected in some" 10 "Early spermatids: 71.6;Spermatocytes: 138.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 5.5;hTERT-RPE1: 2.6;TIME: 8.5" NA NA "unprognostic (2.57e-1)" "unprognostic (7.14e-2)" "unprognostic (2.92e-2)" "unprognostic (1.98e-3)" "unprognostic (7.13e-4)" "unprognostic (2.19e-3)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (9.57e-2)" "unprognostic (2.14e-1)" "unprognostic (4.44e-5)" "unprognostic (1.73e-2)" "unprognostic (1.04e-4)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (2.30e-1)" "unprognostic (1.33e-2)" 1.4 0.9 1.1 0.6 0.9 0.0 1.0 0.6 1.4 0.7 1.4 0.5 3.0 0.2 0.7 0.9 0.9 0.3 1.1 1.2 0.8 0.9 0.3 0.3 1.5 0.7 0.8 0.2 0.6 0.2 0.0 0.2 1.1 0.6 1.0 0.3 0.8 0.6 3.2 0.3 0.3 0.4 3.6 0.7 0.3 0.4 54.1 0.2 0.6 0.7 0.2 0.5 1.1 0.2 0.0 3.1 0.7 1.1 0.0 1.6 0.5 0.2 0.0 0.8 0.0 0.4 0.2 0.0 0.6 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 5.5 0.1 0.2 0.4 0.0 0.0 0.0 2.6 0.9 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.5 1.1 0.0 0.0 0.4 0.7 0.0 0.2 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 1.2 0.0 0.0 0.6 0.0 0.6 1.1 1.6 0.0 0.3 0.6 0.0 0.0 0.6 0.8 0.7 0.0 0.3 3.1 0.0 0.5 1.1 0.9 0.6 1.1 0.8 0.9 0.8 0.2 0.6 0.2 3.0 0.3 0.0 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 71.6 0.1 0.0 0.0 0.4 0.2 1.4 0.1 0.0 0.0 0.4 1.6 0.0 0.6 0.0 10.5 2.6 0.2 0.0 0.0 0.0 0.5 0.9 0.0 4.2 0.0 0.0 6.5 1.6 138.4 6.8 0.1 0.1 0.0 0.0 0.1 FAM229A ENSG00000225828 "Family with sequence similarity 229 member A" H3BQW9 1 32361270-32364278 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 17 "testis: 71.8" "Group enriched" "Detected in many" 83 "Early spermatids: 2788.2;Late spermatids: 3116.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 12.8;U-2 OS: 4.0;U-266/70: 5.7" "Not detected" "Not detected" NA NA "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (5.73e-3)" "unprognostic (1.16e-1)" "unprognostic (4.82e-1)" "unprognostic (4.59e-3)" "unprognostic (1.99e-3)" "unprognostic (2.02e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (2.73e-3)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (2.46e-2)" "unprognostic (1.12e-1)" "unprognostic (8.03e-2)" "prognostic favorable (2.33e-4)" 1.7 1.0 1.3 0.6 1.3 4.1 0.5 1.4 2.1 1.0 1.4 1.0 0.5 1.1 1.0 1.6 0.5 1.2 0.7 0.5 0.9 0.8 1.5 1.8 0.9 0.5 0.8 1.5 2.3 0.5 0.2 0.6 0.6 1.0 1.3 0.3 1.0 0.5 0.6 2.2 3.5 1.5 0.5 1.1 3.2 0.9 71.8 1.1 0.6 1.3 0.8 0.6 0.6 0.6 0.6 0.0 0.9 0.1 0.0 1.8 0.4 0.6 0.3 0.2 0.5 0.0 0.0 3.4 0.5 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.0 0.1 0.6 0.0 0.0 0.0 0.8 12.8 0.7 0.7 0.2 0.0 0.4 1.1 0.3 0.0 0.0 0.2 0.4 0.0 1.0 0.8 0.9 0.0 1.2 0.4 3.4 1.5 0.1 0.1 3.2 0.4 1.9 0.1 0.0 0.8 3.1 0.0 0.3 1.4 0.0 0.4 0.7 1.0 0.6 4.0 0.7 1.5 5.7 1.7 0.0 0.9 0.5 0.0 0.0 0.1 0.8 0.4 0.0 1.5 0.0 0.0 0.1 0.0 0.6 1.8 0.6 0.9 0.0 0.0 0.0 0.0 0.4 1.3 1.3 1.4 2.1 0.9 0.8 0.8 1.5 1.0 1.1 3.0 1.9 0.0 1.9 2.1 4.3 3.1 5.1 0.0 0.0 8.7 0.0 0.7 18.3 2.5 2788.2 3.6 5.6 0.0 2.9 0.4 3.3 4.5 0.0 2.4 0.7 4.8 13.3 6.2 1.2 3116.7 35.6 0.7 0.0 1.0 6.6 7.5 4.2 6.0 30.8 2.4 6.2 19.4 1.3 33.5 14.3 1.3 0.2 2.5 4.3 2.5 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Group enriched" "Detected in many" 10 "Early spermatids: 2880.3;Late spermatids: 5153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favorable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.4 8.5 15.4 15.3 0.8 6.4 24.5 9.2 19.5 0.7 4.1 1.3 19.0 11.8 9.6 1.0 3.6 9.3 14.8 0.4 12.0 1.5 1.9 6.5 9.6 3.3 0.8 9.3 6.3 15.2 2.6 21.5 9.0 15.2 2.0 3.4 11.2 0.4 6.2 5.4 4.5 1.2 10.1 9.7 4.3 1.3 13.5 0.2 16.2 6.8 5.1 0.6 9.9 9.8 8.3 3.1 5.1 7.7 3.3 29.4 8.5 2.5 0.1 11.7 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 3.0 10.7 4.7 14.7 7.4 29.1 81.9 22.9 313.2 31.8 48.8 11.8 1.2 112.7 25.4 2880.3 27.2 0.0 0.0 9.2 4.2 30.9 16.9 1.1 39.9 2.7 15.9 2.9 34.4 1.9 5153.7 67.3 6.2 23.6 2.8 0.3 63.3 6.5 0.0 85.2 62.8 30.9 58.2 24.7 416.7 35.0 7.5 0.5 4.4 0.6 7.9 FAM230A DGCR15 ENSG00000277870 "Family with sequence similarity 230 member A" 22 18422244-18500594 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 16.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 29.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 1.1;myeloid DC: 1.3" "Group enriched" "Detected in many" 12 "dendritic cells: 1.3;monocytes: 1.1" "Cell line enhanced" "Detected in some" "A549: 16.4;HeLa: 6.3;Karpas-707: 7.7;RH-30: 6.9;U-266/84: 13.5" NA NA 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 16.4 0.2 0.0 0.2 0.1 1.3 0.0 1.1 0.0 0.0 0.1 1.9 16.4 1.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 5.8 6.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.5 7.7 0.0 4.1 0.3 0.6 3.2 0.0 1.2 1.1 6.9 4.6 0.0 0.8 5.7 0.0 0.3 4.5 0.9 0.1 0.0 2.1 0.0 1.4 0.3 0.0 0.2 0.6 13.5 0.0 0.0 3.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 FAM231C ENSG00000268674 "Family with sequence similarity 231 member C" "P0DMU3, P0DMU4, P0DMU5" Unmapped 35407-35916 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.1;U-698: 1.3" "HPA043267, HPA043292, HPA077864" Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA043267: , HPA043292: , HPA077864: AB_2686862" 0.0 0.3 0.1 0.0 0.1 0.1 0.0 5.6 0.3 0.1 0.3 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM234B KIAA1467 ENSG00000084444 "Family with sequence similarity 234 member B" A2RU67 12 13044284-13142521 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 17.4;Erythroid cells: 23.3" "Cancer enhanced" "Detected in all" "breast cancer: 16.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010803, HPA010850" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA010803: AB_1079200, HPA010850: AB_2732402" "unprognostic (1.85e-3)" "unprognostic (1.99e-1)" "unprognostic (1.93e-3)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (8.03e-3)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (9.55e-2)" "unprognostic (3.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "unprognostic (1.85e-3)" "unprognostic (5.22e-2)" "unprognostic (1.06e-1)" "unprognostic (4.06e-3)" "unprognostic (7.62e-2)" 4.4 3.6 9.6 2.3 17.5 3.5 21.2 21.3 28.5 3.4 1.6 4.4 4.2 2.6 3.6 4.4 2.8 4.0 2.4 1.9 10.8 12.4 7.3 3.0 3.6 2.1 9.1 16.7 3.5 3.4 4.8 5.2 7.1 13.6 8.1 1.9 3.4 3.4 5.0 2.8 15.5 2.5 3.2 5.1 2.9 1.7 6.8 5.0 0.5 10.9 0.1 2.2 3.6 2.8 6.8 4.3 1.9 6.9 2.7 4.5 1.4 2.9 3.0 9.2 6.5 7.3 7.1 7.2 2.0 2.3 4.5 8.9 3.1 4.4 12.0 2.5 2.4 7.9 4.5 11.5 2.2 9.5 1.4 6.4 7.1 3.3 2.5 3.9 6.2 4.1 5.4 4.7 6.5 5.0 6.8 5.9 8.4 1.8 4.4 4.9 9.8 5.2 4.0 12.1 2.3 1.7 6.8 12.0 1.3 2.8 7.2 12.9 4.2 4.4 2.9 3.5 16.5 3.7 3.5 3.0 3.0 5.1 5.5 2.1 2.4 3.1 7.8 9.6 2.8 3.7 0.3 2.7 1.9 2.6 4.5 3.4 4.6 2.9 2.5 2.3 6.8 4.3 4.5 0.7 2.7 6.9 4.3 2.3 1.4 9.6 17.5 21.3 28.5 10.8 12.4 9.1 16.7 13.6 5.0 3.0 3.5 0.9 1.7 0.0 11.3 0.0 2.5 0.0 0.0 17.4 2.0 5.6 1.7 1.9 7.0 0.0 0.0 23.3 1.2 2.7 1.0 3.8 0.0 2.0 3.1 3.2 11.7 4.9 1.3 2.7 5.2 0.5 0.0 2.8 0.1 3.8 1.2 0.0 4.9 1.0 2.9 0.0 0.0 8.8 10.9 0.0 3.0 0.0 0.0 1.1 FAM236A "DMRTC1-AS1, LINC00684" ENSG00000275520 "Family with sequence similarity 235 member A" A0A1B0GUQ0 X 72938163-72938958 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 29.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.5;AN3-CA: 1.5;CAPAN-2: 3.6;U-266/70: 2.6" NA NA 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 29.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM236B ENSG00000268994 "Family with sequence similarity 236 member B" A0A1B0GV22 X 72781865-72782660 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "testis: 36.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HDLM-2: 2.1;JURKAT: 5.4;MOLT-4: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM236C ENSG00000283594 "Family with sequence similarity 236 member C" P0DP71 X 72912615-72913401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 56 "blood: 2.3;testis: 8.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 23 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM236D ENSG00000225396 "Family with sequence similarity 236 member D" A0A1B0GTK5 X 72807425-72808210 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 15 "blood: 2.3;testis: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "eosinophil: 2.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HaCaT: 1.3;U-2197: 1.5" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM237A ENSG00000235118 "Family with sequence similarity 237 member A" A0A1B0GTK4 2 206642412-206649011 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "brain: 3.0;heart muscle: 1.1;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" NA NA "unprognostic (3.02e-1)" 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM237B ENSG00000283267 "Family with sequence similarity 237 member B" 7 90316503-90321308 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "prostate: 1.1;testis: 1.7" "Cell type enriched" "Detected in single" 20 "Ciliated cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.0;U-266/70: 1.0" "Group enriched" "Detected in some" 6 "hypothalamus: 1.9;thalamus: 5.4" "Low region specificity" "Detected in all" NA NA 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.7 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM240A ENSG00000283473 "Family with sequence similarity 240 member A" A0A1B0GVK7 3 46612435-46626543 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 4 "breast: 1.9;salivary gland: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.0" "Region enhanced" "Detected in single" "hippocampal formation: 0.7" "Low region specificity" "Detected in single" NA NA 0.6 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.0 0.5 0.4 0.8 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM240B ENSG00000283329 "Family with sequence similarity 240 member B" A0A1B0GVZ2 9 38694263-38720428 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 6.9;tongue: 6.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" "Low cell line specificity" "Detected in some" "Region enriched" "Detected in single" 9 "cerebellum: 0.8" NA NA 0.1 0.0 0.1 0.1 0.1 1.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 2.6 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.0 1.5 0.3 0.1 0.1 0.8 0.0 1.6 0.1 0.1 0.2 6.0 0.1 0.1 0.1 1.5 1.6 6.9 0.8 1.2 0.7 0.5 1.0 0.7 0.6 0.8 0.0 1.0 0.5 0.0 0.2 0.2 0.0 2.0 0.7 0.2 0.3 0.0 0.4 1.7 0.0 0.4 0.3 1.0 0.5 0.8 1.8 0.4 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.2 0.9 0.0 0.4 0.2 0.9 0.4 0.2 0.9 0.0 1.2 0.0 0.0 0.3 1.1 0.3 0.4 0.2 1.7 0.0 1.2 0.2 0.0 0.4 0.1 1.3 0.8 0.9 1.6 0.4 0.0 0.6 0.0 6.9 0.8 1.5 0.6 0.7 0.5 1.1 0.6 0.6 0.3 1.5 0.6 0.7 3.9 1.2 0.6 1.6 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM241A "C4orf32, FLJ39370" ENSG00000174749 "Family with sequence similarity 241 member A" Q8N8J7 4 112145397-112195256 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 49.5" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 52.1;Ciliated cells: 77.6;Club cells: 67.1;Collecting duct cells: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 26.5;HUVEC TERT2: 18.3" "Low region specificity" "Detected in all" "HPA062443, HPA069294" Approved Enhanced "Golgi apparatus" No No "Golgi apparatus" "HPA062443: AB_2684765, HPA069294: AB_2686111" "unprognostic (3.07e-1)" "unprognostic (1.11e-2)" "unprognostic (2.42e-2)" "unprognostic (5.58e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (1.61e-2)" "unprognostic (3.16e-1)" "unprognostic (1.21e-1)" "unprognostic (5.05e-2)" "unprognostic (4.81e-2)" "unprognostic (5.25e-2)" "unprognostic (9.20e-3)" "prognostic unfavorable (8.87e-4)" "unprognostic (4.08e-1)" "unprognostic (7.16e-2)" "unprognostic (1.39e-2)" 43.2 4.8 3.3 11.9 3.0 7.0 49.5 3.6 3.1 6.9 9.5 4.6 10.7 3.1 8.9 6.0 7.6 5.2 6.2 18.5 4.3 3.0 6.4 6.9 10.2 7.2 5.6 1.8 5.2 3.8 7.1 6.3 12.6 3.4 9.7 3.2 2.8 22.3 17.2 11.6 7.2 4.7 9.0 4.3 9.7 8.3 7.7 3.6 6.3 8.5 7.3 6.0 9.3 24.7 2.7 2.8 5.7 1.7 1.7 1.7 0.7 4.0 1.6 1.6 1.3 8.6 4.9 2.5 3.4 0.8 0.6 1.1 1.2 5.1 26.5 3.2 1.8 2.3 1.9 2.6 3.6 1.2 12.4 4.3 2.9 3.9 2.1 5.1 6.5 1.7 5.3 5.8 1.0 6.2 1.3 18.3 3.8 5.3 12.8 2.1 4.1 2.4 4.7 2.1 6.6 3.8 5.4 2.7 5.4 2.7 3.9 3.0 2.5 3.2 5.9 1.6 2.5 4.2 2.8 11.5 2.1 6.3 1.4 1.2 5.4 7.0 12.2 4.9 3.2 2.7 5.7 1.7 1.6 1.5 1.3 1.3 1.5 1.6 1.1 0.9 2.7 1.5 1.7 4.2 1.7 1.6 2.8 1.7 0.7 3.3 3.0 3.6 2.4 4.3 3.0 5.6 1.8 3.4 3.6 56.6 52.1 0.0 0.0 0.0 0.0 0.0 0.0 77.6 67.1 31.4 0.0 1.4 6.6 11.8 0.0 0.0 0.0 0.0 14.9 2.2 0.0 0.0 30.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 8.2 0.0 0.0 21.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 FAM241B C10orf35 ENSG00000171224 "Family with sequence similarity 241 member B" Q96D05 10 69630251-69633599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 15.7;Distal tubular cells: 10.0;Ductal cells: 23.4;Exocrine glandular cells: 15.9;Pancreatic endocrine cells: 15.7;Proximal tubular cells: 10.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.2" "Lineage enriched" "Detected in single" 25 "T-cells: 14.2" "Cell line enhanced" "Detected in many" "PC-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034591 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA034591: AB_10670572" "unprognostic (1.12e-1)" "unprognostic (6.37e-2)" "unprognostic (3.13e-2)" "unprognostic (1.17e-1)" "unprognostic (7.17e-3)" "prognostic unfavorable (8.64e-4)" "prognostic unfavorable (1.03e-4)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.63e-1)" "unprognostic (3.37e-2)" "unprognostic (3.12e-2)" "unprognostic (5.23e-2)" "unprognostic (2.52e-1)" "prognostic favorable (9.72e-4)" 1.4 3.3 13.1 2.0 13.5 1.1 5.3 34.5 23.9 1.3 3.0 3.2 0.6 3.0 2.7 13.0 4.0 4.8 2.1 6.9 15.0 17.8 4.7 2.3 4.1 2.7 10.8 14.4 2.0 7.9 5.6 5.3 1.3 8.3 7.8 2.6 5.1 5.6 5.6 1.6 2.4 2.2 4.5 4.6 0.8 4.2 11.4 2.4 0.7 6.0 0.1 2.4 2.6 1.6 0.3 0.0 0.5 0.0 0.2 14.2 2.8 13.3 14.5 1.8 14.9 0.0 0.0 6.5 1.3 0.3 2.4 2.6 10.5 11.0 0.0 20.4 0.3 8.6 5.5 7.8 4.5 3.4 13.2 10.7 0.0 3.2 4.0 3.9 0.0 4.8 0.0 4.4 0.1 2.3 1.8 0.0 20.1 4.9 0.0 0.2 17.9 0.1 0.0 9.0 5.4 26.9 0.0 0.0 0.1 5.1 7.6 7.6 10.4 5.5 14.0 8.5 3.9 9.6 2.3 0.6 0.3 9.3 0.0 3.9 2.4 6.6 0.0 0.2 0.0 0.3 0.0 0.0 0.0 3.4 0.0 8.9 0.1 8.5 5.6 0.0 0.3 14.2 4.9 0.5 0.2 0.0 0.0 5.3 2.8 13.1 13.5 34.5 23.9 15.0 17.8 10.8 14.4 8.3 2.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.1 5.7 15.7 0.0 5.6 10.0 23.4 0.0 0.0 0.0 0.0 15.9 4.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 15.7 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 FAM24A AC073585.4 ENSG00000203795 "Family with sequence similarity 24 member A" A6NFZ4 10 122910701-122913111 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 20.9" "Cell type enriched" "Detected in some" 17 "Early spermatids: 125.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;LHCN-M2: 1.2" HPA052490 Supported "Secreted in male reproductive system" NA NA "HPA052490: AB_2681851" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 1.2 0.0 0.0 0.5 0.6 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 FAM24B "AC073585.2, MGC45962" ENSG00000213185 "Family with sequence similarity 24 member B" Q8N5W8 10 122849078-122879641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 24.5" "Cell type enriched" "Detected in many" 4 "Distal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "hTERT-HME1: 43.9;LHCN-M2: 55.2;TIME: 17.8" HPA052490 Supported "Intracellular and membrane" NA NA "HPA052490: AB_2681851" "unprognostic (4.03e-2)" "unprognostic (4.27e-2)" "unprognostic (3.13e-3)" "unprognostic (8.40e-5)" "unprognostic (2.55e-2)" "unprognostic (3.31e-2)" "unprognostic (6.42e-7)" "unprognostic (2.99e-1)" "unprognostic (7.06e-3)" "unprognostic (3.00e-1)" "unprognostic (5.89e-2)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" "unprognostic (2.58e-1)" "unprognostic (9.23e-2)" "unprognostic (1.25e-1)" "unprognostic (8.81e-3)" 2.2 2.4 6.9 13.5 6.4 3.9 4.0 6.7 7.4 2.3 4.1 5.1 2.2 2.8 3.4 3.8 3.1 3.8 3.7 1.5 5.8 5.9 24.5 1.7 3.7 6.5 6.9 3.4 5.0 12.5 2.6 11.4 1.1 6.6 3.2 5.9 1.9 2.7 2.6 1.7 4.5 4.1 3.0 6.8 4.7 4.4 11.4 5.6 9.8 2.9 2.0 6.3 2.4 2.5 5.9 11.3 3.0 2.2 2.7 5.3 1.9 2.2 3.8 0.7 0.0 0.4 1.1 1.0 3.3 3.3 1.5 1.1 3.8 4.2 0.8 1.1 1.8 0.4 1.1 0.0 1.7 3.9 4.1 1.5 6.3 3.6 2.0 3.4 0.0 3.7 1.3 0.2 3.1 43.9 0.2 3.4 4.7 2.7 1.5 55.2 2.1 3.9 3.6 1.3 2.3 3.9 0.0 5.6 0.8 2.5 1.7 2.5 1.0 1.5 0.7 4.5 2.2 1.2 3.8 17.8 0.3 1.7 1.4 0.3 1.8 2.0 5.2 2.9 6.1 0.0 3.0 2.2 1.4 2.6 1.9 0.9 5.9 5.0 3.4 3.0 3.7 5.3 3.4 1.4 2.7 1.8 11.3 4.9 1.9 6.9 6.4 6.7 7.4 5.8 5.9 6.9 3.4 6.6 5.6 0.0 0.3 6.9 1.3 6.0 3.6 0.2 2.5 0.0 0.0 8.7 0.0 0.1 43.1 3.7 1.6 0.7 1.5 0.0 6.2 0.1 0.8 1.8 9.2 0.5 1.1 1.6 4.6 1.3 3.2 1.6 3.4 1.9 1.7 2.8 2.8 2.3 7.6 3.5 3.9 1.4 4.5 0.0 2.1 9.8 4.9 4.6 0.0 8.6 2.8 1.0 FAM25A bA96C23.5 ENSG00000188100 "Family with sequence similarity 25 member A" B3EWG3 10 87020306-87024730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 85.5;skin 1: 30.9;tongue: 61.1;vagina: 30.8" "Group enriched" "Detected in some" 6 "Suprabasal keratinocytes: 43.3;Syncytiotrophoblasts: 13.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 53.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A-431: 13.6;SK-BR-3: 40.1" HPA044808 Uncertain NA NA "HPA044808: AB_2679096" "unprognostic (9.94e-2)" "unprognostic (2.57e-1)" "unprognostic (7.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (1.05e-5)" "unprognostic (1.21e-1)" 0.2 0.1 0.2 0.2 0.2 0.0 1.9 0.2 0.2 21.6 0.2 0.2 0.2 0.0 1.1 0.2 85.5 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.0 0.2 0.2 0.0 0.2 19.9 0.2 0.3 30.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 61.1 16.9 0.2 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.6 0.0 0.0 0.0 40.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.7 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 13.5 0.0 0.0 0.7 FAM25C bA164N7.4 ENSG00000276430 "Family with sequence similarity 25 member C" B3EWG5 10 47995355-47999791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 7 "breast: 5.7;esophagus: 4.9;intestine: 5.0;lymphoid tissue: 2.8;skin 1: 10.3" "Group enriched" "Detected in some" 9 "Basal keratinocytes: 1.1;Suprabasal keratinocytes: 2.8" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 19.1" HPA044808 Uncertain NA NA "HPA044808: AB_2679096" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 10.3 5.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 FAM25G bA301J7.4 ENSG00000189090 "Family with sequence similarity 25 member G" B3EWG6 10 47487219-47491693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 42.4" "Cell type enriched" "Detected in some" 8 "Pancreatic endocrine cells: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 28 "SK-BR-3: 22.5" HPA044808 Uncertain NA NA "HPA044808: AB_2679096" "unprognostic (1.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 3.8 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 42.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.3 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 FAM3B "2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44" ENSG00000183844 "Family with sequence similarity 3 member B" P58499 21 41304212-41357431 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.8;pancreas: 120.3;salivary gland: 67.9" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 242.6;Exocrine glandular cells: 349.6;Pancreatic endocrine cells: 184.9;Syncytiotrophoblasts: 134.9" "Cancer enhanced" "Detected in many" "prostate cancer: 40.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 6.0;Hep G2: 15.3;OE19: 13.2;RPMI-8226: 42.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015885, HPA029777, CAB034131" Enhanced Approved Vesicles "Secreted to blood" NA NA 2080000 57000 Vesicles "CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194" "unprognostic (2.88e-1)" "unprognostic (3.31e-3)" "unprognostic (5.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (6.32e-3)" "unprognostic (1.41e-1)" "unprognostic (8.79e-3)" "unprognostic (9.38e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "unprognostic (3.78e-1)" "unprognostic (5.60e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "unprognostic (1.55e-3)" 0.6 0.2 0.2 4.5 0.4 0.0 4.3 0.2 0.3 1.8 38.5 0.4 29.9 38.2 0.2 8.8 17.4 4.5 6.9 0.4 0.2 0.2 5.2 0.6 2.0 0.7 0.3 0.2 0.7 120.3 0.0 1.9 7.9 0.4 10.0 0.0 0.2 67.9 36.0 0.2 0.9 83.8 2.0 0.3 0.5 30.8 2.0 0.2 2.3 3.9 7.4 17.6 17.5 4.7 0.2 1.3 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 13.2 0.0 0.0 0.0 42.4 0.0 2.8 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 6.9 0.0 0.6 1.3 0.0 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.2 20.8 18.8 0.0 11.2 1.1 0.0 0.1 81.5 22.7 50.0 62.8 0.0 242.6 21.6 113.7 19.2 1.0 0.0 0.0 349.6 6.2 5.7 99.4 1.1 0.0 23.0 0.0 0.0 0.0 2.5 7.0 0.6 8.1 5.0 3.6 0.9 0.0 184.9 0.0 0.4 0.4 0.0 0.0 0.9 26.7 7.2 1.1 134.9 0.0 0.0 104.8 FAM3D "EF7, OIT1" ENSG00000198643 "Family with sequence similarity 3 member D" Q96BQ1 3 58633946-58666848 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6" "Group enriched" "Detected in some" 6 "Enterocytes: 558.6;Mucus-secreting cells: 1112.4;Paneth cells: 854.0;Undifferentiated cells: 821.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 151.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 6.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.7" "Cell line enriched" "Detected in single" 72 "OE19: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA013844 Approved "Secreted to digestive system" NA NA 8200 "HPA013844: AB_2668897" "prognostic favorable (7.51e-4)" "unprognostic (1.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.67e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.89e-4)" "unprognostic (7.97e-2)" "unprognostic (6.54e-2)" "unprognostic (7.43e-2)" "unprognostic (5.48e-2)" "unprognostic (2.23e-2)" "unprognostic (1.42e-1)" "unprognostic (8.68e-2)" "unprognostic (1.64e-1)" "unprognostic (2.00e-1)" "unprognostic (6.97e-4)" "unprognostic (2.34e-2)" 0.3 0.2 0.3 8.5 0.3 0.0 2.2 0.2 0.2 4.4 48.2 0.3 26.1 11.2 0.5 0.3 61.2 0.3 20.0 0.2 0.2 0.2 0.5 0.2 1.5 0.2 0.3 0.2 0.2 0.8 0.0 0.3 0.5 0.3 3.3 69.2 0.3 146.0 88.6 0.4 0.8 26.1 0.8 0.2 0.3 9.5 0.3 0.2 0.3 0.6 15.2 47.1 2.2 13.1 0.0 0.7 6.7 1.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 38.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 6.7 0.0 0.5 0.0 0.0 0.9 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.0 0.6 0.0 7.9 0.0 0.0 0.2 56.0 28.1 9.1 14.0 0.0 0.0 0.0 0.6 0.4 0.6 558.6 0.0 0.0 0.0 0.0 70.7 9.2 0.0 0.3 0.0 146.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1112.4 0.0 1.9 854.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.0 821.7 144.0 FAM43B FLJ44952 ENSG00000183114 "Family with sequence similarity 43 member B" Q6ZT52 1 20552439-20555010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 21.9;brain: 14.9;epididymis: 8.7" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 1.2;Distal tubular cells: 3.3" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;BJ hTERT+: 3.3;fHDF/TERT166: 6.7;Hep G2: 4.9;SCLC-21H: 6.0;SiHa: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050813 Approved Approved Cytosol NA NA Cytosol "HPA050813: AB_2681244" "unprognostic (1.51e-1)" "unprognostic (5.85e-2)" "unprognostic (2.80e-3)" "unprognostic (1.48e-1)" "unprognostic (5.97e-3)" "unprognostic (1.74e-1)" "unprognostic (8.33e-2)" "unprognostic (5.87e-4)" "unprognostic (1.86e-2)" "unprognostic (7.46e-2)" "unprognostic (8.85e-3)" "unprognostic (2.73e-1)" "unprognostic (1.78e-4)" "unprognostic (1.06e-2)" "unprognostic (6.05e-3)" "unprognostic (6.48e-2)" "unprognostic (2.12e-2)" 3.2 21.9 5.6 1.5 14.9 0.9 1.5 8.8 14.4 1.6 1.3 2.4 0.0 1.1 1.4 8.7 1.3 1.6 1.5 3.3 5.3 12.1 2.6 1.4 1.2 1.0 10.1 6.0 1.0 1.2 0.9 0.7 2.5 11.2 1.4 1.1 0.5 1.2 1.3 2.8 1.0 1.2 2.9 4.0 1.4 0.9 1.3 2.8 0.0 1.3 1.7 0.9 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 4.6 0.2 0.1 0.0 0.5 3.3 0.6 0.0 0.1 0.0 0.0 0.2 6.7 1.2 0.0 0.7 0.0 0.1 0.0 1.0 0.2 0.3 4.9 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.0 0.7 11.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 14.9 8.8 14.4 5.3 12.1 10.1 6.0 11.2 2.8 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.3 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 FAM46A "C6orf37, FLJ20037" ENSG00000112773 "Family with sequence similarity 46 member A" Q96IP4 6 81491439-81752774 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 106.4" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 311.3;Horizontal cells: 276.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 22.1;fHDF/TERT166: 25.4;HeLa: 25.1;HL-60: 28.8;THP-1: 49.6;U-937: 22.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051067: , HPA067140: AB_2685788" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 10.0 7.1 1.4 4.9 1.4 64.7 5.6 2.8 0.9 14.4 17.7 1.3 24.2 5.1 12.8 20.0 4.2 8.8 17.1 19.4 1.2 4.4 3.2 11.8 5.8 2.3 1.4 0.9 20.1 3.5 6.5 20.4 106.4 3.5 16.2 5.6 4.9 49.8 45.6 4.5 7.0 32.6 15.3 2.5 5.8 13.2 6.8 1.4 1.2 7.7 6.7 3.7 13.4 31.1 12.0 12.4 22.4 22.2 8.3 6.2 6.1 1.0 1.5 1.0 0.0 22.1 9.8 1.9 8.4 6.0 5.0 7.6 15.7 0.8 0.1 0.3 25.4 3.2 0.9 0.7 1.3 3.7 0.0 1.9 0.0 25.1 2.4 6.9 28.8 2.2 4.3 0.7 3.9 0.7 16.4 0.6 0.2 0.4 0.0 3.3 4.4 0.0 20.4 0.2 8.9 1.2 0.0 9.1 0.0 0.6 1.9 1.0 1.4 3.7 1.6 2.5 3.3 0.3 49.6 1.4 5.7 1.2 2.4 2.3 0.1 0.1 0.1 8.1 22.3 2.4 16.1 14.9 22.4 6.2 15.1 3.7 8.0 2.4 3.0 12.4 12.0 4.7 4.4 7.3 8.3 22.2 4.3 2.7 6.1 1.4 1.4 2.8 0.9 1.2 4.4 1.4 0.9 3.5 1.4 59.6 92.4 0.9 134.5 49.9 25.9 0.0 45.9 21.4 102.4 0.0 70.7 30.7 0.0 0.0 0.4 20.4 311.3 23.3 0.0 89.3 98.1 34.0 210.9 34.5 26.7 276.5 183.7 6.7 35.9 0.5 95.3 46.7 62.4 0.0 64.6 75.7 0.0 105.2 37.1 0.0 45.1 25.8 43.8 0.9 5.4 31.7 135.5 20.3 33.3 105.6 FAM46B MGC16491 ENSG00000158246 "Family with sequence similarity 46 member B" Q96A09 1 27005020-27012836 "Predicted secreted proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 55.8;tongue: 42.0" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 59.6;Basal keratinocytes: 91.9;Suprabasal keratinocytes: 129.2" "Cancer enhanced" "Detected in many" "testis cancer: 87.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;intermediate monocyte: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 32.4;hTERT-HME1: 16.7;NTERA-2: 17.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted - unknown location" NA NA "unprognostic (1.67e-2)" "unprognostic (5.94e-3)" "unprognostic (1.61e-1)" "unprognostic (5.28e-3)" "unprognostic (3.20e-2)" "unprognostic (2.22e-2)" "unprognostic (2.44e-4)" "unprognostic (4.05e-2)" "unprognostic (1.39e-1)" "unprognostic (6.02e-3)" "unprognostic (1.34e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (5.82e-2)" "unprognostic (4.85e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" 3.3 0.6 0.6 3.9 0.3 0.1 10.4 0.3 0.4 20.6 13.4 0.4 3.6 0.8 8.0 2.8 55.8 5.5 4.0 9.1 0.2 0.0 3.8 0.5 11.6 0.7 0.4 0.9 3.8 1.2 1.0 0.7 7.4 0.9 6.8 1.2 1.5 23.5 11.1 0.9 36.3 3.5 21.5 0.3 0.4 6.8 4.6 0.1 0.6 3.1 42.0 18.7 23.0 13.6 0.0 0.4 1.3 2.5 0.0 0.0 0.0 1.9 0.3 4.0 1.2 0.5 0.6 1.0 2.8 0.9 11.3 4.5 7.7 2.6 0.0 4.8 1.5 2.5 6.3 0.7 10.3 3.0 0.0 0.6 0.1 1.5 1.3 5.7 0.0 0.2 2.6 32.4 3.4 16.7 0.0 0.1 0.0 0.2 0.0 1.4 1.5 0.0 0.6 17.0 1.4 0.8 0.2 0.0 0.1 11.0 0.0 0.4 0.3 5.4 12.2 7.1 8.7 9.6 0.1 0.2 2.7 9.4 0.3 0.6 0.1 0.4 0.0 0.5 0.0 1.7 0.0 0.0 1.3 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.4 0.2 0.0 0.4 0.9 0.9 0.1 59.6 1.9 0.0 24.5 91.9 0.1 0.0 0.0 2.7 0.0 0.0 0.0 1.7 0.0 0.0 1.4 0.5 1.1 0.0 0.0 2.6 2.4 12.8 0.0 0.0 0.5 0.0 7.0 1.8 0.0 1.4 4.6 0.8 6.8 0.0 1.2 5.0 0.0 0.0 1.8 0.0 0.6 0.0 17.8 5.8 3.9 129.2 4.5 0.0 0.9 10.6 FAM46C FLJ20202 ENSG00000183508 "Family with sequence similarity 46 member C" Q5VWP2 1 117605934-117628372 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction" "Nucleotidyltransferase, RNA-binding, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 114.0" "Group enriched" "Detected in many" 9 "Early spermatids: 418.3;Late spermatids: 1175.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 16.3" "Group enriched" "Detected in many" 17 "B-cells: 9.7;granulocytes: 16.3;T-cells: 9.2" "Cell line enhanced" "Detected in some" "Karpas-707: 74.8;RPMI-8226: 44.6;U-266/70: 20.8;U-266/84: 17.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA054049 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA054049: AB_2682356" "unprognostic (3.76e-2)" "unprognostic (3.85e-3)" "unprognostic (3.24e-3)" "prognostic favorable (3.75e-5)" "unprognostic (1.17e-1)" "unprognostic (1.55e-3)" "unprognostic (3.29e-1)" "unprognostic (2.88e-2)" "unprognostic (5.75e-2)" "unprognostic (1.36e-3)" "unprognostic (9.41e-3)" "unprognostic (3.91e-2)" "prognostic favorable (2.77e-5)" "unprognostic (6.26e-2)" "unprognostic (3.16e-2)" "unprognostic (3.08e-2)" "unprognostic (1.10e-2)" 3.2 1.8 1.2 24.5 1.1 28.9 4.4 1.1 1.1 8.1 16.1 1.8 8.4 5.6 4.8 16.6 6.9 3.3 9.7 6.4 1.2 1.1 5.0 5.5 11.2 16.3 1.2 0.1 8.3 114.0 7.2 5.3 10.6 3.9 6.4 9.5 4.4 37.8 11.9 10.0 1.8 10.6 4.7 1.4 19.1 12.2 34.0 0.2 1.5 10.3 10.9 37.0 9.5 8.6 9.7 0.2 16.3 0.0 0.6 9.2 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 6.7 0.1 0.0 0.4 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 4.2 0.4 9.2 0.0 0.0 0.0 5.4 11.9 0.0 0.0 0.1 0.0 0.0 0.0 2.5 1.2 74.8 0.0 0.9 0.0 5.5 0.9 1.1 0.6 0.0 0.0 44.6 0.0 0.9 0.5 0.0 0.4 0.6 0.4 0.1 0.4 0.0 0.1 0.0 0.5 0.0 0.1 20.8 17.2 0.4 0.4 1.9 0.6 16.3 0.0 10.5 2.5 0.0 2.2 9.7 2.5 3.1 0.0 8.0 0.3 1.4 1.1 0.6 0.0 0.2 9.2 2.1 1.2 1.1 1.1 1.1 1.2 1.1 1.2 0.1 3.9 0.2 6.0 42.9 52.6 7.5 7.6 0.0 0.0 5.1 21.4 36.4 0.0 0.0 1.9 0.0 0.0 418.3 2.8 12.0 93.5 0.0 2.0 7.3 6.6 7.0 4.3 1.1 0.0 19.0 0.0 1.5 1175.9 13.3 2.0 45.5 0.0 35.3 1.1 0.0 8.6 8.5 0.0 0.0 6.5 9.2 12.5 8.5 5.6 1.8 32.0 26.4 7.9 FAM46D "CT1.26, CT112, MGC26999" ENSG00000174016 "Family with sequence similarity 46 member D" Q8NEK8 X 80335504-80445311 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 53 "testis: 8.9" "Cell type enriched" "Detected in some" 6 "Early spermatids: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AN3-CA: 4.6;K-562: 2.5;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA059362 Uncertain NA NA "HPA059362: AB_2683991" "unprognostic (3.49e-1)" "unprognostic (1.14e-2)" "unprognostic (4.36e-1)" "unprognostic (1.59e-1)" "unprognostic (4.64e-1)" "unprognostic (4.28e-2)" "unprognostic (8.21e-3)" "unprognostic (2.95e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.9 0.0 0.0 0.0 0.0 0.0 FAM47A MGC27003 ENSG00000185448 "Family with sequence similarity 47 member A" Q5JRC9 X 34129756-34132314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 12.7" "Cell type enriched" "Detected in some" 5 "Early spermatids: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "REH: 1.5;U-266/84: 1.1" HPA000610 Uncertain NA NA "HPA000610: AB_1078805" "unprognostic (1.68e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 FAM47B FLJ35782 ENSG00000189132 "Family with sequence similarity 47 member B" Q8NA70 X 34942796-34944915 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 18.8" "Group enriched" "Detected in some" 52 "Early spermatids: 42.9;Late spermatids: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-138 MG: 1.6" "HPA046829, HPA050996" Uncertain NA NA "HPA046829: AB_2679828, HPA050996: AB_2681301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 FAM47C ENSG00000198173 "Family with sequence similarity 47 member C" Q5HY64 X 37008397-37011666 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 7.9" "Cell type enriched" "Detected in some" 4 "Early spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 FAM47E-STBD1 ENSG00000272414 "FAM47E-STBD1 readthrough" 4 76251721-76311129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 38.2;skeletal muscle: 41.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.7;Ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.1;Karpas-707: 23.8" HPA053331 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (3.52e-3)" "unprognostic (3.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (5.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-2)" "unprognostic (1.91e-1)" "unprognostic (6.92e-6)" "unprognostic (5.59e-2)" "unprognostic (1.52e-1)" "unprognostic (3.77e-1)" 17.4 2.3 7.8 1.6 8.0 4.0 7.6 1.9 13.9 2.5 8.2 8.6 4.1 2.1 3.0 7.3 3.5 5.0 4.2 16.5 9.4 3.9 4.2 38.2 7.5 0.6 5.4 14.6 2.6 4.6 2.8 9.2 9.4 11.4 6.3 9.0 2.5 5.0 5.0 41.3 1.6 10.7 6.5 9.6 1.6 3.7 6.1 5.8 0.0 8.1 1.3 0.9 4.9 2.5 0.2 1.0 2.2 1.5 3.4 1.6 0.4 2.0 2.4 1.0 2.1 17.1 5.8 2.2 3.4 7.1 2.9 3.0 4.0 2.2 0.0 2.1 8.1 7.9 1.1 3.5 1.4 2.7 2.6 0.5 0.8 4.8 5.7 1.8 1.7 2.4 2.5 9.0 2.8 3.6 11.1 0.3 0.0 0.2 23.8 7.0 3.7 0.0 1.8 1.0 13.2 1.6 0.0 0.5 1.5 3.3 6.0 1.0 4.2 1.5 4.7 0.1 2.2 0.9 1.0 0.9 1.5 0.7 3.8 2.9 5.7 2.6 0.0 4.2 1.8 1.3 0.0 0.5 2.2 1.1 1.5 0.6 0.2 1.1 1.2 0.9 0.1 0.9 1.3 1.3 3.4 0.1 1.0 1.6 0.4 7.8 8.0 1.9 13.9 9.4 3.9 5.4 14.6 11.4 5.8 6.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM49A "DKFZP566A1524, FLJ11080" ENSG00000197872 "Family with sequence similarity 49 member A" Q9H0Q0 2 16549459-16666331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.8;brain: 39.5" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 90.0;Kupffer cells: 96.6;monocytes: 191.2;Syncytiotrophoblasts: 125.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.3;HUVEC TERT2: 18.6;RH-30: 41.7;SK-BR-3: 12.2;TIME: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017847, HPA060398" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB017847: , HPA060398: AB_2684275" "unprognostic (3.45e-1)" "unprognostic (1.83e-2)" "unprognostic (6.50e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-1)" "unprognostic (7.78e-2)" "unprognostic (8.61e-2)" "unprognostic (3.83e-2)" "unprognostic (2.61e-1)" "unprognostic (2.00e-2)" "unprognostic (5.74e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.32e-2)" "unprognostic (3.43e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (4.46e-4)" 10.8 9.1 22.7 15.6 28.0 15.3 7.0 6.6 39.5 13.7 5.3 7.0 1.2 2.9 8.2 2.1 4.3 6.2 8.7 3.3 17.2 14.1 1.9 6.1 9.6 13.4 10.2 25.2 10.0 2.4 1.1 4.8 15.3 9.9 6.9 5.3 2.9 3.2 7.3 6.0 2.9 4.6 8.6 6.0 20.1 3.4 1.8 6.3 1.9 31.8 1.1 13.6 7.7 7.4 8.9 15.5 45.8 34.4 13.4 5.3 8.5 0.2 0.0 2.6 0.1 2.8 0.8 7.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 1.8 1.6 0.6 1.0 0.0 2.8 0.1 1.6 0.0 0.0 1.4 0.0 23.3 1.3 1.0 0.2 0.0 2.1 18.6 0.0 0.1 2.0 1.6 0.1 0.0 5.4 1.1 0.1 0.0 0.9 41.7 0.1 2.2 10.3 0.4 1.5 0.0 12.2 0.0 3.4 0.4 0.7 14.5 0.2 2.4 0.0 0.0 1.2 0.0 1.4 6.1 1.2 0.8 0.0 23.6 31.4 5.3 29.8 0.6 8.9 0.2 2.7 15.5 6.1 0.2 2.1 45.8 13.4 34.4 7.7 0.1 8.5 22.7 28.0 6.6 33.3 17.2 14.1 10.2 25.2 9.9 6.3 3.0 17.3 26.5 17.4 10.0 3.2 1.4 0.0 1.4 9.1 0.0 2.0 40.6 0.0 2.9 0.8 6.0 0.0 23.3 0.8 90.0 12.5 8.1 11.5 1.0 31.7 0.0 0.0 29.4 96.6 0.0 2.0 70.2 28.7 191.2 0.0 22.8 0.2 0.0 1.8 0.0 2.4 12.9 14.1 0.0 2.1 7.3 125.4 11.7 0.0 24.3 FAM49B BM-009 ENSG00000153310 "Family with sequence similarity 49 member B" Q9NUQ9 8 129839593-130017129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.5;bone marrow: 80.1" "Cell type enhanced" "Detected in many" 7 "monocytes: 468.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009076 Enhanced Approved Nucleoplasm,Cytosol NA NA 990000 Nucleoplasm Cytosol "HPA009076: AB_1848402" "unprognostic (4.35e-2)" "unprognostic (5.22e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.80e-2)" "unprognostic (9.61e-3)" "prognostic unfavorable (3.02e-6)" "unprognostic (4.75e-2)" "unprognostic (2.44e-1)" "unprognostic (6.53e-2)" "unprognostic (3.25e-2)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.09e-10)" "unprognostic (3.85e-3)" "unprognostic (1.95e-1)" "unprognostic (2.67e-1)" "unprognostic (2.46e-1)" 19.2 14.5 23.2 42.8 33.1 80.1 20.6 28.0 36.9 7.2 14.3 18.2 5.5 14.2 8.0 10.6 17.9 7.9 14.9 9.8 25.5 25.2 11.8 12.3 19.1 49.6 28.5 19.6 6.4 10.0 7.5 16.1 19.4 21.2 7.6 17.4 7.3 12.0 7.9 16.8 9.0 19.3 13.5 38.8 41.3 12.9 13.6 21.2 28.2 13.8 9.7 46.4 20.6 8.4 21.0 47.3 93.5 42.2 30.8 29.3 43.4 32.2 17.3 18.9 10.6 1.7 2.5 25.2 9.8 9.5 13.6 14.6 9.9 22.3 32.3 21.6 6.4 10.8 16.1 15.6 25.9 20.5 67.5 10.9 32.3 9.7 11.2 6.6 20.9 27.9 4.0 12.1 9.2 19.2 11.2 12.0 26.3 23.1 37.5 14.9 14.4 71.0 15.5 16.0 25.4 24.0 31.0 12.8 54.1 27.9 13.3 12.6 16.5 19.6 12.4 29.0 17.9 14.5 27.2 7.4 5.0 32.4 10.6 20.8 12.5 36.7 53.5 7.9 45.6 13.0 45.5 35.3 65.6 29.3 42.2 22.4 21.0 16.7 23.9 47.3 15.1 15.0 24.6 93.5 30.8 36.5 30.4 22.5 43.4 23.2 33.1 28.0 36.9 25.5 25.2 28.5 19.6 21.2 21.2 29.8 31.5 95.1 103.3 116.3 33.0 23.3 35.7 13.4 33.0 73.3 39.3 108.2 44.7 52.9 13.3 30.0 27.9 0.0 43.3 127.2 26.9 56.3 64.6 16.1 225.8 23.8 26.6 22.7 194.9 6.5 5.8 254.2 45.5 468.9 24.3 12.1 64.0 38.6 4.2 23.5 17.1 19.4 15.5 29.9 40.7 72.6 50.6 182.7 28.1 113.6 FAM53A DNTNP ENSG00000174137 "Family with sequence similarity 53 member A" Q6NSI3 4 1617915-1684302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.7" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 3.6;Early spermatids: 11.4;Spermatocytes: 14.4;Spermatogonia: 11.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 9.9" "Low region specificity" "Detected in all" "HPA036452, HPA058138" Enhanced Approved "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA036452: AB_10671841, HPA058138: AB_2683619" "unprognostic (8.78e-2)" "unprognostic (1.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.52e-1)" "unprognostic (7.59e-2)" "unprognostic (3.45e-2)" "unprognostic (5.27e-2)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (5.33e-3)" "unprognostic (7.80e-2)" "unprognostic (2.14e-3)" "unprognostic (3.73e-2)" "unprognostic (1.03e-1)" "unprognostic (5.26e-3)" "unprognostic (1.15e-3)" 1.3 0.8 0.8 0.6 0.7 0.9 1.2 1.6 1.1 0.9 1.0 0.0 1.6 6.0 0.8 2.1 1.5 0.5 1.1 0.7 0.7 1.2 0.7 0.9 1.5 1.5 4.0 1.3 6.8 0.1 1.1 0.2 1.7 0.8 1.5 3.3 0.4 1.0 2.7 0.8 0.9 12.7 5.7 0.2 0.9 0.6 2.4 4.9 0.6 3.8 0.9 4.4 1.0 1.2 0.8 2.0 4.0 1.4 3.5 0.8 6.6 3.6 6.4 4.3 1.6 2.9 3.2 3.3 1.8 2.5 0.2 0.0 1.3 1.7 0.8 0.9 0.8 0.3 0.7 5.6 0.0 1.2 2.7 3.8 3.2 6.4 1.3 1.0 6.8 2.4 0.9 2.8 0.8 1.9 2.0 2.5 0.6 9.1 0.9 0.5 0.1 1.7 1.9 9.9 4.2 2.5 0.5 4.7 1.5 3.1 2.1 1.6 0.3 0.4 1.2 0.8 0.4 1.6 0.8 0.1 1.2 7.8 0.0 1.1 0.6 0.5 3.8 1.2 2.4 0.7 0.8 2.5 1.6 4.4 0.2 0.0 0.9 1.5 4.9 1.0 1.0 0.0 0.0 0.0 0.4 1.1 0.8 3.6 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.3 11.4 0.5 0.0 0.0 0.8 0.0 0.4 0.4 0.0 0.8 0.2 0.0 0.0 1.3 0.0 1.3 0.6 0.3 0.0 1.0 0.0 0.3 0.4 0.0 0.4 0.3 0.4 0.0 0.9 14.4 11.8 0.4 0.0 0.0 0.4 0.1 FAM57A "CT120, FLJ22282" ENSG00000167695 "Family with sequence similarity 57 member A" Q8TBR7 17 732412-742972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 43.8" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 47.3;Suprabasal keratinocytes: 62.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.6;T-cells: 3.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.46e-1)" "unprognostic (6.16e-2)" "unprognostic (5.64e-2)" "prognostic favorable (3.53e-6)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "unprognostic (1.32e-3)" "unprognostic (2.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (4.88e-2)" "unprognostic (1.60e-1)" "unprognostic (8.05e-2)" "unprognostic (1.39e-2)" 5.5 2.2 3.8 3.6 3.3 1.4 8.7 4.7 5.1 8.0 9.1 2.7 23.7 7.0 4.7 5.8 15.3 4.6 15.3 3.6 3.1 3.6 3.8 3.5 4.3 3.7 2.9 1.7 7.0 14.3 3.3 5.8 4.7 6.2 6.9 6.0 4.9 7.8 17.8 3.0 43.8 13.6 5.1 3.0 2.1 10.7 7.2 1.8 2.5 6.3 16.6 11.8 8.4 9.5 1.6 0.4 0.0 0.0 0.0 3.4 0.4 22.1 14.7 11.1 14.5 14.7 18.7 10.3 17.5 16.1 18.1 20.5 7.1 4.0 5.6 10.4 19.7 6.8 22.5 21.9 15.5 19.6 13.8 16.0 5.2 9.7 17.2 11.6 4.8 7.9 15.3 15.6 10.4 24.7 10.7 13.7 8.0 4.5 0.7 10.9 8.8 2.0 1.2 5.0 16.9 4.6 9.0 4.3 0.6 15.9 19.3 5.4 9.3 10.7 1.0 6.6 8.2 4.2 5.8 9.6 18.4 9.0 23.3 21.3 1.4 4.5 5.9 18.0 8.4 10.9 0.0 0.0 0.0 3.2 0.0 3.0 0.3 0.6 1.3 0.4 1.6 0.2 0.8 0.0 0.0 0.0 0.4 3.4 0.4 3.8 3.3 4.7 5.1 3.1 3.6 2.9 1.7 6.2 1.8 0.0 9.8 0.5 34.2 47.3 1.8 0.8 10.2 5.3 4.5 8.7 3.9 0.9 0.0 17.3 27.2 5.2 2.9 0.0 15.5 16.1 9.4 20.2 8.1 0.0 8.0 0.0 6.4 6.7 1.5 14.5 3.4 1.8 10.1 6.4 10.1 0.9 16.6 3.5 2.8 0.7 1.1 0.0 4.1 0.9 0.7 62.0 2.1 0.7 6.8 30.4 FAM57B DKFZP434I2117 ENSG00000149926 "Family with sequence similarity 57 member B" Q71RH2 16 30024427-30052978 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;retina: 20.8;testis: 51.7" "Group enriched" "Detected in some" 6 "Bipolar cells: 45.7;Cone photoreceptor cells: 170.8;Early spermatids: 100.4;Late spermatids: 48.9;Rod photoreceptor cells: 171.7;Spermatocytes: 57.2" "Cancer enriched" "Detected in some" 5 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 8.2;SCLC-21H: 44.0;SH-SY5Y: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.31e-2)" "unprognostic (9.72e-4)" "unprognostic (7.78e-3)" "unprognostic (1.13e-1)" "unprognostic (8.06e-2)" "unprognostic (2.45e-1)" "unprognostic (1.54e-2)" "unprognostic (9.72e-2)" "unprognostic (2.60e-2)" "unprognostic (3.56e-2)" "unprognostic (1.12e-2)" "unprognostic (4.51e-2)" "unprognostic (2.40e-11)" "unprognostic (1.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.09e-3)" 1.2 3.8 12.0 1.4 14.2 2.6 1.5 36.4 35.7 1.1 1.3 1.7 0.0 1.5 1.2 1.1 1.5 1.3 1.2 1.2 11.8 7.9 1.2 1.2 1.2 1.6 7.6 9.5 1.2 1.3 1.2 10.4 1.2 29.4 1.3 1.3 20.8 1.4 1.2 13.9 1.5 1.3 1.2 3.9 1.2 1.4 51.7 2.8 0.0 1.2 1.8 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.3 1.6 0.7 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 1.1 0.5 0.0 0.0 0.2 0.3 0.1 0.0 0.4 1.3 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 4.7 0.0 4.7 0.1 0.3 1.3 0.3 8.2 0.1 0.4 3.4 0.6 0.5 0.0 0.0 44.0 16.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.2 0.2 0.2 4.3 0.1 0.1 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 12.0 14.2 36.4 35.7 11.8 7.9 7.6 9.5 29.4 2.8 0.0 0.0 0.0 0.2 0.1 45.7 0.6 0.0 0.0 0.0 0.0 170.8 0.0 0.0 0.0 100.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 15.9 0.0 0.0 0.3 48.9 2.6 0.0 0.0 0.0 0.0 15.2 0.2 0.0 1.1 0.0 171.7 0.0 0.3 57.2 1.7 0.0 0.0 0.0 0.0 0.1 FAM69C C18orf51 ENSG00000187773 "Family with sequence similarity 69 member C" Q0P6D2 18 74434099-74457944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;heart muscle: 10.8" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 197.8" "Group enriched" "Detected in some" 18 "glioma: 11.1;melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-MEL-30: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048928 Enhanced NA NA "HPA048928: AB_2680560" "unprognostic (6.35e-2)" "unprognostic (1.13e-2)" "unprognostic (8.09e-2)" "unprognostic (3.32e-2)" "unprognostic (4.08e-2)" "unprognostic (3.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (8.97e-2)" "unprognostic (2.43e-1)" "unprognostic (4.10e-2)" "unprognostic (1.91e-4)" "unprognostic (2.16e-1)" "unprognostic (6.73e-2)" "unprognostic (3.23e-2)" "unprognostic (4.40e-3)" 1.1 0.9 13.8 0.7 20.5 0.6 1.1 3.5 29.1 3.4 1.0 9.5 0.0 0.7 0.9 0.8 0.8 1.0 1.3 10.8 11.0 9.0 0.8 1.1 0.6 0.7 15.5 5.2 0.7 0.9 0.8 0.1 0.9 9.9 1.1 0.9 3.7 0.9 1.7 2.3 7.0 0.9 0.9 5.3 0.8 3.0 7.3 18.8 0.0 0.8 0.0 0.7 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 20.5 3.5 10.3 11.0 9.0 15.5 5.2 9.9 18.8 0.0 0.0 0.0 0.0 1.1 1.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.4 38.1 0.0 2.5 0.8 2.0 0.0 0.0 30.4 0.0 0.0 197.8 0.8 0.0 0.0 0.0 3.7 12.9 1.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 FAM71A FLJ32796 ENSG00000162771 "Family with sequence similarity 71 member A" Q8IYT1 1 212624474-212626778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 149 "testis: 57.1" "Group enriched" "Detected in many" 135 "Early spermatids: 1249.7;Late spermatids: 344.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;SK-BR-3: 1.6;U-266/70: 1.0" "Not detected" "Not detected" "HPA028462, HPA060344" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA028462: AB_10601904, HPA060344: " 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.8 0.5 0.0 0.0 2.5 0.0 3.4 0.0 0.0 2.0 0.0 0.4 1249.7 0.1 0.5 0.0 1.1 1.5 0.4 2.9 1.1 0.0 1.2 0.0 1.2 3.1 0.0 344.8 4.9 1.0 0.0 0.0 2.6 0.3 1.0 0.9 2.5 0.0 0.0 0.0 0.9 3.6 1.8 0.1 2.4 0.0 1.7 0.6 FAM71B MGC26988 ENSG00000170613 "Family with sequence similarity 71 member B" Q8TC56 5 157161846-157166264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "testis: 31.6" "Group enriched" "Detected in some" 149 "Early spermatids: 856.5;Late spermatids: 244.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039478, HPA040771" Enhanced NA NA "HPA039478: AB_10795106, HPA040771: AB_10805829" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 856.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 244.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.7 1.3 0.0 0.0 0.0 0.0 0.0 FAM71C MGC39520 ENSG00000180219 "Family with sequence similarity 71 member C" Q8NEG0 12 99647753-99650046 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "testis: 31.7" "Group enriched" "Detected in some" 33 "Early spermatids: 314.0;Late spermatids: 312.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.1" "Region enriched" "Detected in many" 4 "cerebellum: 18.6" NA NA "unprognostic (6.82e-2)" "unprognostic (3.58e-2)" "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 314.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 312.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.9 0.7 0.0 0.0 0.0 0.0 0.0 FAM71D C14orf54 ENSG00000172717 "Family with sequence similarity 71 member D" Q8N9W8 14 67189393-67228550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 42.6" "Group enriched" "Detected in many" 16 "Early spermatids: 196.4;Late spermatids: 192.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 2.5;U-2 OS: 4.1;U-937: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.58e-2)" "unprognostic (8.05e-4)" "unprognostic (2.34e-2)" "unprognostic (2.86e-1)" "unprognostic (5.80e-2)" "unprognostic (1.05e-1)" "unprognostic (2.44e-3)" "unprognostic (6.62e-2)" "unprognostic (5.01e-1)" "unprognostic (6.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.96e-5)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (8.85e-2)" "unprognostic (5.01e-5)" 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 1.8 2.0 0.7 0.9 0.9 0.1 0.9 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.2 0.6 0.0 0.0 0.6 0.4 2.5 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.8 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.6 0.7 0.0 0.7 0.0 0.0 1.6 1.0 0.0 0.7 0.3 0.0 0.8 0.0 0.4 0.5 0.0 0.0 1.0 4.1 0.3 0.5 0.9 1.1 0.2 0.6 3.1 0.0 0.1 0.7 0.0 0.9 0.3 0.0 0.4 0.2 0.2 0.2 0.4 0.7 0.6 2.0 0.9 0.3 1.8 0.5 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.2 2.9 0.0 1.8 0.0 12.0 5.7 0.0 0.0 3.7 0.0 7.6 196.4 0.8 5.4 0.0 6.5 2.8 1.7 0.1 10.4 0.9 2.6 0.0 9.9 1.3 1.2 192.4 3.4 2.5 0.0 8.2 9.0 0.4 7.7 7.0 0.7 0.2 0.7 0.0 1.4 2.3 1.5 1.9 3.7 1.7 8.5 0.1 FAM71E1 ENSG00000142530 "Family with sequence similarity 71 member E1" Q6IPT2 19 50466785-50476753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.0" "Group enriched" "Detected in many" 54 "Early spermatids: 1823.2;Late spermatids: 2935.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 17.3" "Low region specificity" "Detected in many" HPA048111 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA048111: " "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (8.19e-2)" "unprognostic (7.61e-2)" "unprognostic (1.99e-1)" "unprognostic (5.45e-3)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.35e-7)" "unprognostic (7.26e-2)" "unprognostic (1.45e-1)" "unprognostic (1.32e-1)" "unprognostic (2.37e-2)" 0.5 1.3 4.3 0.9 5.4 0.5 1.3 3.6 4.3 2.0 1.3 0.0 7.1 2.2 0.9 3.6 1.2 2.7 2.1 1.6 3.1 5.0 2.3 3.6 3.5 0.5 5.5 2.8 2.6 5.6 1.4 10.9 1.1 1.5 1.9 0.8 0.6 7.4 4.7 4.6 1.3 1.8 0.5 2.1 0.7 1.9 36.0 0.5 1.5 3.6 4.6 0.7 0.8 0.3 2.4 2.3 1.6 0.9 3.6 3.5 0.8 2.4 1.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.3 0.4 0.0 0.1 0.6 3.7 0.0 0.9 0.0 0.2 17.3 0.0 0.9 0.0 2.9 0.1 2.2 0.8 1.9 0.2 0.4 0.2 0.0 1.2 0.6 1.2 0.0 3.3 0.6 0.0 0.0 4.3 2.6 1.8 0.3 1.0 1.1 3.2 4.0 1.0 1.2 4.2 0.5 1.1 3.2 1.2 0.0 0.0 1.1 0.2 0.3 0.9 1.8 0.1 0.0 0.0 0.2 0.8 0.9 1.6 2.3 0.1 3.5 1.4 2.2 1.3 0.2 2.4 2.3 3.0 0.7 3.6 0.5 2.3 0.2 0.8 4.3 5.4 3.6 4.3 3.1 5.0 5.5 2.8 1.5 0.5 0.0 0.3 0.0 2.8 0.6 4.7 1.7 0.0 2.7 0.0 3.5 0.0 5.6 10.0 3.2 1823.2 0.6 1.3 0.0 4.8 3.2 0.9 3.6 0.0 1.5 1.6 4.8 2.9 1.8 0.0 2935.1 15.8 0.6 0.0 2.8 4.6 7.4 2.6 2.3 14.2 11.9 5.8 19.4 0.4 44.4 24.9 2.0 11.7 0.0 3.3 3.5 FAM71E2 "C19orf16, DKFZp434G1729" ENSG00000180043 "Family with sequence similarity 71 member E2" Q8N5Q1 19 55354908-55363260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 103 "testis: 41.0" "Group enriched" "Detected in some" 16 "Early spermatids: 3.6;Late spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "SCLC-21H: 4.4" NA NA "unprognostic (5.97e-2)" "unprognostic (2.27e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FAM71F1 "FAM137A, NYD-SP18" ENSG00000135248 "Family with sequence similarity 71 member F1" Q96KD3 7 128709061-128731743 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 146 "testis: 64.8" "Group enriched" "Detected in some" 103 "Early spermatids: 1001.4;Late spermatids: 1429.0" "Cancer enriched" "Detected in single" 23 "testis cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "NTERA-2: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020636 Uncertain Cytosol No NA Cytosol "HPA020636: AB_1854739" "unprognostic (3.09e-2)" "unprognostic (3.39e-3)" "unprognostic (6.03e-2)" "unprognostic (5.25e-1)" "unprognostic (2.97e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-5)" "unprognostic (1.48e-1)" "unprognostic (2.18e-6)" "unprognostic (6.97e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-3)" "unprognostic (1.99e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 1.5 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1001.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1429.0 11.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.3 0.0 1.8 0.0 0.0 11.7 5.5 0.1 1.0 0.0 0.0 0.0 FAM71F2 FAM137B ENSG00000205085 "Family with sequence similarity 71 member F2" Q6NXP2 7 128672288-128687872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 28.1" "Group enriched" "Detected in many" 7 "Early spermatids: 138.1;Late spermatids: 512.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA020513, HPA024248" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020513: AB_1853077, HPA024248: AB_2671497" "unprognostic (1.01e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (9.83e-2)" "unprognostic (8.29e-3)" "unprognostic (6.22e-2)" "unprognostic (2.67e-2)" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (3.65e-4)" "unprognostic (3.17e-2)" "unprognostic (3.85e-4)" "unprognostic (3.00e-2)" "unprognostic (2.79e-2)" "unprognostic (2.40e-4)" "unprognostic (2.47e-2)" 1.4 1.1 0.7 0.7 1.2 1.3 0.7 1.8 1.1 0.7 0.7 0.7 0.7 0.4 0.7 1.6 0.7 0.5 0.8 0.9 0.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.9 0.7 0.2 2.5 0.7 0.7 0.9 0.5 0.7 1.6 0.7 1.6 1.3 0.7 1.0 0.7 1.2 1.0 28.1 0.7 0.7 0.9 0.7 0.7 0.7 0.7 1.4 1.3 4.2 0.8 1.2 0.9 0.2 0.8 1.3 1.5 2.9 2.6 2.0 0.7 1.7 0.4 0.4 1.0 0.3 1.4 0.9 0.8 2.8 1.0 2.0 0.2 0.7 0.7 0.9 1.3 0.5 2.7 0.2 0.7 0.7 1.9 1.7 0.7 3.0 0.5 2.0 0.4 0.9 0.4 1.4 1.2 1.3 0.4 1.4 0.9 0.3 1.9 1.1 0.3 0.4 1.0 3.5 1.2 0.8 0.7 0.8 2.2 1.9 1.1 0.4 4.3 1.9 0.7 3.9 1.6 2.9 2.5 0.9 1.0 1.2 1.3 3.9 0.8 0.6 0.5 0.4 0.5 0.8 0.6 0.5 0.3 1.4 0.6 0.6 4.2 1.2 0.5 1.3 0.9 0.2 0.7 1.2 1.8 1.1 0.7 0.7 0.7 0.7 0.7 0.7 3.0 2.1 0.0 1.4 0.0 12.1 1.1 0.0 0.0 0.0 3.5 49.1 0.4 0.0 1.3 138.1 0.7 0.3 0.0 0.6 0.7 0.8 1.6 2.3 0.6 0.8 0.0 1.2 1.8 2.2 512.3 3.7 0.2 0.0 1.0 1.3 2.9 1.0 1.5 2.8 0.0 17.9 0.0 0.9 10.2 2.7 0.1 2.1 0.0 1.4 0.8 FAM72B RP11-439A17.6 ENSG00000188610 "Family with sequence similarity 72 member B" Q86X60 1 121167646-121185539 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 6.5;lymphoid tissue: 9.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 4.7;Spermatocytes: 14.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (8.53e-2)" "unprognostic (1.97e-2)" "unprognostic (1.63e-3)" "unprognostic (1.25e-3)" "unprognostic (4.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.26e-4)" "unprognostic (8.22e-5)" "unprognostic (1.30e-2)" "unprognostic (1.79e-2)" "unprognostic (1.36e-4)" "unprognostic (2.46e-2)" "unprognostic (0.00e+0)" "unprognostic (2.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-2)" "unprognostic (5.30e-2)" 1.0 0.8 1.3 4.1 1.0 6.5 0.6 5.1 1.0 0.5 1.0 1.3 0.4 0.2 3.0 0.5 1.0 0.2 1.6 0.9 0.3 0.4 0.8 9.3 1.4 0.4 0.1 1.5 0.1 1.4 0.2 1.3 0.5 0.0 0.0 2.1 1.3 0.7 1.4 3.2 0.9 3.6 0.2 7.9 0.9 0.9 0.8 3.3 0.1 2.4 0.8 1.4 1.1 12.0 4.4 7.4 3.6 0.7 1.1 5.8 6.4 2.7 7.5 6.3 0.1 6.3 26.6 8.9 1.2 7.4 7.5 10.1 3.6 11.6 17.6 7.5 11.5 4.9 5.3 0.4 20.0 10.3 0.6 0.4 5.9 12.0 1.9 4.5 22.2 15.0 16.4 5.4 5.0 10.0 16.5 13.9 6.5 9.1 15.0 15.9 12.2 2.9 1.4 8.0 4.6 4.8 3.8 3.7 7.9 5.0 15.6 1.5 6.2 10.5 12.0 11.3 14.6 18.2 26.3 5.5 21.7 14.3 0.0 2.4 0.0 0.0 0.9 0.0 0.8 0.4 0.5 3.3 0.3 0.0 0.1 0.1 0.8 1.1 0.4 1.4 1.1 0.0 0.0 3.7 0.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.7 1.0 1.7 0.0 0.2 1.9 0.5 0.0 0.0 0.0 0.9 0.0 0.0 3.1 0.6 1.2 0.6 0.7 0.0 3.6 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 14.9 3.4 0.9 0.1 1.0 0.4 0.0 FAM72C RP5-998N21.9 ENSG00000263513 "Family with sequence similarity 72 member C" H0Y354 1 143955364-143971965 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.6;lymphoid tissue: 6.4" "Cell type enhanced" "Detected in some" 16 "Extravillous trophoblasts: 3.6;Sertoli cells: 6.5;Spermatocytes: 10.0;Spermatogonia: 3.2" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 29.2" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA Yes Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (6.45e-3)" "unprognostic (2.69e-2)" "unprognostic (2.21e-1)" "unprognostic (3.98e-3)" "unprognostic (9.46e-5)" "unprognostic (1.23e-3)" "unprognostic (4.36e-1)" "unprognostic (7.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.95e-1)" "unprognostic (0.00e+0)" "unprognostic (2.95e-1)" "unprognostic (4.70e-2)" "unprognostic (5.82e-2)" "unprognostic (1.47e-2)" 0.1 0.0 1.6 3.6 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 1.5 0.0 0.1 0.5 0.1 1.9 0.0 6.4 0.4 1.1 0.4 0.0 1.0 1.7 2.2 0.6 8.6 5.0 6.1 2.7 0.3 0.8 5.9 4.3 1.4 5.8 4.5 0.8 10.4 20.6 5.7 0.5 5.5 8.3 8.1 2.6 6.3 7.1 4.8 8.9 4.4 1.5 0.3 18.1 8.1 0.2 0.0 4.5 11.9 1.3 2.5 16.6 15.5 9.7 0.3 0.6 10.7 14.0 4.9 9.7 3.3 13.6 4.4 14.6 1.0 1.1 3.1 5.6 4.2 2.4 2.3 6.6 6.0 15.6 1.7 4.6 7.6 6.0 9.4 20.3 29.2 12.2 2.5 11.3 2.9 0.0 1.0 0.0 0.1 0.3 0.0 1.1 0.4 0.5 0.4 0.0 0.1 0.0 0.0 1.7 0.6 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 1.0 0.0 0.0 0.2 3.6 0.3 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 10.0 3.2 0.3 0.2 0.0 0.0 0.0 FAM72D ENSG00000215784 "Family with sequence similarity 72 member D" Q6L9T8 1 145096000-145112696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Cell type enhanced" "Detected in some" 22 "Extravillous trophoblasts: 4.6;Spermatocytes: 17.9;Spermatogonia: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA043271, HPA067321" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA043271: AB_2678402, HPA067321: " "unprognostic (2.70e-2)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (4.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.10e-3)" "unprognostic (5.88e-5)" "unprognostic (7.65e-4)" "unprognostic (6.72e-2)" "unprognostic (2.36e-2)" "unprognostic (1.22e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (6.63e-2)" "unprognostic (1.72e-1)" "unprognostic (9.74e-2)" "unprognostic (6.50e-2)" 1.1 0.7 0.8 7.2 0.8 5.5 0.7 4.0 0.9 0.6 1.1 0.6 0.4 1.4 0.8 0.4 4.4 0.2 0.5 0.4 1.0 0.7 0.5 0.4 1.3 7.6 1.0 0.4 0.4 0.4 0.3 0.4 1.5 0.8 0.4 1.6 0.4 0.6 0.4 0.4 2.9 2.0 0.5 1.1 3.3 0.8 6.7 0.4 17.7 0.4 2.7 7.4 1.1 2.5 0.1 0.7 0.1 1.7 0.0 1.0 0.5 8.4 5.1 6.0 2.4 0.2 0.5 6.6 4.8 1.4 6.1 3.8 3.4 7.6 13.8 4.9 0.7 5.5 8.9 7.3 1.4 7.2 11.0 7.3 6.9 2.5 5.0 0.1 12.2 7.7 0.3 0.5 4.8 9.3 1.0 2.7 16.7 13.6 19.2 4.0 6.3 8.3 11.9 11.5 10.5 7.1 7.3 7.6 16.2 2.1 1.1 5.9 5.0 3.7 3.3 2.2 7.9 9.3 7.9 1.2 4.5 5.0 3.8 8.6 14.6 22.8 21.4 0.0 9.8 5.1 0.0 1.2 0.0 0.0 1.7 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.8 0.8 4.0 0.9 1.0 0.7 1.0 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.5 0.0 0.0 0.0 4.6 1.0 0.1 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.0 0.0 1.2 1.7 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 17.9 4.1 0.9 0.2 0.5 0.1 0.0 FAM78A "C9orf59, FLJ00024" ENSG00000126882 "Family with sequence similarity 78 member A" Q5JUQ0 9 131258076-131276547 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.7;skeletal muscle: 32.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 57.8;Early spermatids: 73.4;Late spermatids: 101.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 18.5;HEL: 17.4;HL-60: 17.2;NB-4: 27.2;THP-1: 24.3;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021472, HPA023914" Uncertain Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA021472: AB_1848411, HPA023914: AB_1848412" "unprognostic (5.16e-2)" "prognostic favorable (3.67e-4)" "unprognostic (3.65e-2)" "unprognostic (2.07e-2)" "unprognostic (2.71e-1)" "prognostic favorable (2.00e-4)" "unprognostic (3.24e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-2)" "unprognostic (5.83e-1)" "unprognostic (5.84e-2)" "unprognostic (6.79e-2)" "unprognostic (1.59e-3)" "unprognostic (2.61e-3)" "unprognostic (7.42e-2)" "unprognostic (2.61e-2)" "unprognostic (2.39e-1)" 4.9 1.5 2.9 9.3 4.6 12.4 2.5 1.1 4.3 1.0 1.6 3.4 0.8 1.8 1.2 1.1 1.1 1.1 2.0 19.2 3.8 2.0 2.1 2.5 8.0 18.4 4.3 1.0 1.8 0.8 0.8 1.0 5.8 3.2 1.3 1.1 5.4 2.7 0.7 32.3 0.8 6.1 1.2 3.6 15.9 2.3 20.1 2.4 23.7 1.5 1.8 15.0 3.1 0.8 14.4 5.2 14.5 10.9 2.5 10.5 6.9 0.3 0.1 1.1 2.6 0.8 0.2 18.5 0.2 0.1 0.2 0.1 0.1 0.1 7.7 0.1 0.1 0.3 0.0 7.4 0.1 0.0 1.9 0.6 17.4 0.2 0.1 0.3 17.2 0.8 0.2 0.4 0.0 0.0 0.2 10.3 5.0 6.1 2.2 0.2 2.6 0.7 27.2 1.2 0.1 0.3 1.8 1.1 10.7 0.1 0.0 0.7 0.9 1.0 0.3 1.0 0.4 0.6 24.3 0.3 1.1 1.2 0.6 0.0 1.6 0.8 4.4 0.1 16.3 0.2 0.4 8.6 14.5 8.6 10.9 6.8 12.5 8.3 9.3 5.2 14.4 10.5 8.7 8.8 2.5 8.1 2.4 8.2 6.9 2.9 4.6 1.1 4.3 3.8 2.0 4.3 1.0 3.2 2.4 0.0 1.0 24.3 0.0 0.8 57.8 12.8 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 73.4 3.1 0.0 0.0 0.0 28.2 1.3 0.0 1.1 0.0 22.1 0.0 0.0 3.7 14.3 101.2 4.6 10.1 1.7 5.4 0.0 0.8 0.2 0.0 3.2 0.0 1.7 0.0 0.5 1.2 0.4 0.6 1.1 14.4 0.0 0.1 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 29.6;Horizontal cells: 9.5;Melanocytes: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.5;plasmacytoid DC: 12.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.5" "Cell line enriched" "Detected in many" 4 "Daudi: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001847: AB_2666462, HPA065797: AB_2685560" "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 1.0 0.8 13.7 3.1 14.0 0.4 1.8 1.2 32.2 8.4 5.2 3.2 0.7 3.0 3.3 5.7 1.0 7.8 2.1 1.9 16.1 8.7 8.7 0.8 1.1 5.7 5.6 17.7 1.1 2.5 0.6 3.3 1.1 3.7 3.1 6.6 1.2 3.3 2.2 0.9 1.5 1.8 1.7 4.3 1.8 3.1 2.2 1.9 0.0 2.7 0.0 6.6 0.9 1.1 2.6 12.5 0.4 0.6 0.1 0.0 0.3 5.8 8.5 0.6 0.1 0.2 0.1 3.5 0.3 0.0 0.6 1.7 1.0 1.0 37.3 0.2 0.1 8.2 4.5 4.8 1.4 1.1 0.4 2.5 0.0 5.7 0.3 0.0 3.1 0.8 0.0 0.9 0.2 0.4 0.4 0.0 1.5 0.1 0.0 0.5 2.0 0.0 0.1 0.5 1.5 3.1 0.8 8.6 0.9 1.9 2.1 1.8 0.5 3.4 0.1 5.5 0.4 1.5 1.9 0.2 1.4 4.4 1.7 6.3 0.0 0.0 0.4 1.4 1.2 3.9 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 2.6 0.0 0.0 0.4 0.1 0.0 12.5 0.0 0.3 13.7 14.0 1.2 32.2 16.1 8.7 5.6 17.7 3.7 1.9 0.0 2.2 1.9 0.9 0.5 0.0 6.2 0.0 6.7 1.2 29.6 0.0 0.1 5.0 0.4 0.4 0.6 0.7 0.0 0.2 1.1 0.4 2.1 1.1 0.0 1.1 9.5 1.2 0.0 0.3 0.4 0.3 0.7 8.5 0.0 0.9 1.0 0.3 1.9 0.0 0.1 0.1 0.0 0.9 0.1 1.3 0.4 0.0 0.0 3.7 0.9 FAM81B FLJ25333 ENSG00000153347 "Family with sequence similarity 81 member B" Q96LP2 5 95391344-95450454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 27.3;testis: 33.8" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 285.0;Early spermatids: 696.2;Late spermatids: 1328.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 1.5;basal ganglia: 1.9;hippocampal formation: 2.2;hypothalamus: 2.6" "Cell type enriched" "Detected in single" 37 "basophil: 7.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 7.6" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 5.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA072554 Approved NA NA "HPA072554: AB_2686533" "unprognostic (2.22e-3)" "unprognostic (8.86e-3)" "unprognostic (2.61e-3)" "unprognostic (1.37e-2)" "unprognostic (2.62e-1)" "unprognostic (2.63e-1)" "unprognostic (4.19e-2)" "unprognostic (1.83e-2)" "unprognostic (2.89e-2)" "unprognostic (5.70e-2)" "unprognostic (5.86e-2)" "unprognostic (4.24e-2)" "unprognostic (1.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.28e-2)" 0.4 0.0 1.5 0.4 1.9 0.1 0.4 0.4 0.4 1.1 0.4 0.4 0.4 0.0 0.4 2.0 0.4 27.3 0.4 2.9 2.2 2.6 0.4 0.4 2.3 0.4 0.4 0.4 0.4 0.4 2.5 1.5 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.5 0.4 0.0 33.8 0.4 0.4 0.8 0.4 0.4 0.4 0.4 0.0 0.2 7.6 0.0 0.0 0.1 0.8 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.5 1.9 0.4 0.4 2.2 2.6 0.4 0.4 0.4 0.4 8.9 2.6 0.0 0.0 0.3 0.0 4.2 0.0 285.0 30.7 5.2 0.0 0.0 0.0 0.3 696.2 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.0 0.1 0.0 1.7 0.0 0.0 1328.6 7.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.2 0.0 6.5 0.0 8.2 6.8 0.0 0.0 0.0 0.0 0.1 FAM83A "BJ-TSA-9, MGC14128" ENSG00000147689 "Family with sequence similarity 83 member A" Q86UY5 8 123178960-123210079 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.8;lymphoid tissue: 28.6" "Cell type enhanced" "Detected in some" 14 "Pancreatic endocrine cells: 16.6;Suprabasal keratinocytes: 13.2;Urothelial cells: 19.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 52.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 24.3;HBEC3-KT: 37.9;hTCEpi: 20.3;K-562: 59.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052615 Approved Nucleoplasm NA NA Nucleoplasm "HPA052615: AB_2797244" "unprognostic (4.48e-2)" "unprognostic (2.03e-3)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.98e-9)" "unprognostic (2.62e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (2.04e-1)" "unprognostic (2.22e-16)" "unprognostic (2.76e-1)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "unprognostic (6.07e-2)" 0.1 0.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.6 0.4 0.0 8.3 0.6 0.8 2.0 44.8 2.8 1.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 2.7 0.0 1.3 0.0 0.0 3.1 13.6 0.1 4.4 2.5 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.3 13.4 28.6 3.1 18.4 0.4 0.3 0.7 0.2 0.3 0.4 0.0 24.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 7.8 0.0 37.9 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 20.3 0.0 5.2 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 2.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.4 0.1 0.3 0.1 0.2 0.1 0.0 0.4 0.1 0.2 0.7 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.4 0.0 0.6 0.0 4.0 4.5 1.8 0.0 0.0 0.0 0.3 0.6 0.0 0.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 1.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 13.2 0.0 0.0 0.4 19.7 FAM83B "C6orf143, FLJ30642" ENSG00000168143 "Family with sequence similarity 83 member B" Q5T0W9 6 54846771-54942022 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 32.7;intestine: 24.6;tongue: 30.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 29.9;Basal keratinocytes: 30.0;Suprabasal keratinocytes: 35.9;Urothelial cells: 28.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 12.6;HaCaT: 14.1;HBEC3-KT: 7.7;hTCEpi: 14.2;hTERT-HME1: 18.7;RT4: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA031464, HPA031465" Enhanced NA NA "HPA031464: AB_10599973, HPA031465: AB_10601566" "unprognostic (2.29e-1)" "unprognostic (3.93e-2)" "unprognostic (3.71e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (7.27e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (1.62e-1)" "unprognostic (3.19e-2)" "unprognostic (1.85e-1)" "unprognostic (4.35e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.86e-5)" 0.4 0.4 0.4 6.9 0.4 0.0 1.6 0.4 0.4 8.8 16.4 0.0 1.9 6.5 0.4 2.9 32.7 1.4 7.0 1.6 0.4 0.4 6.3 0.5 0.5 0.0 0.4 0.0 0.5 3.7 0.0 0.4 15.6 0.0 5.5 8.2 0.0 5.5 1.7 3.5 22.3 24.6 1.3 0.4 0.4 3.6 0.9 0.0 4.3 11.0 30.1 8.5 4.3 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 5.4 2.9 0.0 0.0 0.0 0.0 14.1 0.0 7.7 0.0 0.0 1.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 14.2 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.3 2.9 0.0 0.0 0.0 0.0 5.8 16.1 0.2 0.0 2.4 0.4 0.0 2.6 3.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 29.9 30.0 0.0 2.4 5.1 0.0 7.9 7.0 0.0 8.0 0.0 5.5 4.5 0.0 9.3 0.0 2.9 9.4 0.7 7.2 0.0 0.0 0.5 0.0 1.2 0.6 0.0 1.8 0.0 0.0 0.0 0.0 5.5 0.0 3.6 10.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 35.9 15.7 0.0 7.1 28.6 FAM83C "C20orf128, dJ614O4.7" ENSG00000125998 "Family with sequence similarity 83 member C" Q9BQN1 20 35285731-35292401 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 24.0;lymphoid tissue: 12.1;skin 1: 29.7;tongue: 22.3" "Cell type enhanced" "Detected in some" 28 "Basal keratinocytes: 24.7;Early spermatids: 10.8;Suprabasal keratinocytes: 56.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;Hep G2: 1.0;U-87 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034227, HPA049978" Uncertain NA NA "CAB034227: AB_1562876, HPA049978: AB_2680979" "unprognostic (3.76e-2)" "unprognostic (2.88e-1)" "unprognostic (1.02e-1)" "unprognostic (1.28e-3)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (3.61e-1)" "unprognostic (1.57e-1)" "unprognostic (4.38e-2)" "unprognostic (3.11e-1)" "unprognostic (9.17e-5)" "unprognostic (9.89e-3)" "unprognostic (1.71e-1)" "unprognostic (5.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.0 0.1 29.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 22.3 12.1 0.3 7.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.2 0.4 0.2 0.3 2.0 0.0 0.7 0.5 0.0 0.0 0.4 0.2 0.5 0.3 0.0 1.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.0 0.1 0.8 0.1 1.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 24.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 56.1 0.0 0.0 0.0 1.7 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;smooth muscle: 69.8" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: AB_2680717, HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.44e-6)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 0.5 0.5 0.5 4.9 0.8 7.9 0.7 0.4 1.2 1.7 29.6 0.4 0.7 3.4 0.8 1.5 39.0 0.2 5.6 1.5 0.5 0.1 2.2 1.4 2.6 1.5 0.3 0.5 0.7 0.2 0.0 0.3 2.2 0.7 7.6 3.6 1.2 3.1 1.0 0.4 4.1 16.2 69.8 0.4 1.0 22.8 3.8 0.2 9.2 0.5 8.6 17.9 24.5 6.4 1.6 0.1 0.0 0.4 2.4 4.6 1.2 31.5 19.5 15.4 12.9 1.7 2.0 27.7 14.2 8.9 28.2 17.3 29.8 14.5 8.0 14.1 9.3 21.9 27.2 21.1 24.4 26.5 2.6 8.3 9.3 15.0 21.4 1.4 4.1 4.9 1.0 1.2 16.2 9.4 3.4 15.4 3.6 8.2 11.6 16.0 17.0 6.3 6.0 12.8 18.4 24.9 6.1 28.5 4.4 8.1 8.1 7.1 11.9 41.5 34.7 6.1 15.0 21.7 4.2 7.3 18.7 23.0 21.2 31.3 3.5 5.4 8.3 8.4 6.1 13.7 0.0 0.0 0.0 0.7 0.4 2.3 1.6 2.4 2.7 0.1 1.6 2.7 3.4 0.0 2.4 0.1 0.0 4.6 1.2 0.5 0.8 0.4 1.2 0.5 0.1 0.3 0.5 0.7 0.2 0.0 2.2 0.0 5.2 2.1 0.0 0.8 0.0 1.4 1.2 0.0 0.0 2.6 0.0 0.0 0.4 0.5 2.6 23.3 0.0 36.2 0.9 0.7 0.0 5.4 4.0 0.0 1.7 1.8 2.1 0.6 0.3 0.4 0.0 0.0 2.2 0.0 0.1 3.7 0.0 4.3 0.0 19.4 2.1 11.1 14.5 1.6 127.6 2.2 2.5 4.3 FAM83E FLJ20200 ENSG00000105523 "Family with sequence similarity 83 member E" Q2M2I3 19 48600810-48614854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 29.5;intestine: 17.8;salivary gland: 15.6;stomach 1: 23.9" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 21.0;Enterocytes: 13.4;Mucus-secreting cells: 22.9;Paneth cells: 13.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.9;OE19: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA049305 Uncertain NA NA "HPA049305: AB_2680705" "unprognostic (1.36e-1)" "unprognostic (9.81e-3)" "unprognostic (3.83e-2)" "unprognostic (7.39e-2)" "unprognostic (4.77e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (2.26e-2)" "unprognostic (3.18e-1)" "unprognostic (2.71e-1)" "unprognostic (8.00e-2)" "unprognostic (9.31e-2)" "unprognostic (7.05e-8)" "unprognostic (5.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.70e-1)" "unprognostic (8.90e-3)" 0.4 0.0 0.4 8.2 0.4 0.0 0.7 0.4 0.5 5.0 15.3 0.5 1.2 17.0 1.9 0.4 4.3 2.7 29.5 0.4 0.4 0.0 0.5 0.4 5.3 0.4 0.4 0.4 0.7 2.1 0.0 0.4 0.8 0.6 1.8 5.6 0.5 15.6 1.2 0.4 0.9 17.8 0.4 0.4 0.4 23.9 1.0 0.4 0.4 0.4 2.6 2.9 1.2 1.9 2.2 0.1 2.1 0.7 0.1 1.3 0.1 0.6 0.5 0.2 1.2 0.1 0.2 1.0 0.2 0.0 0.1 0.1 0.5 5.9 1.2 0.4 0.5 0.0 0.5 0.3 0.1 0.0 0.9 0.4 0.2 0.4 0.1 0.1 0.2 0.7 0.3 0.3 0.0 0.1 0.0 0.1 0.4 0.2 0.5 0.0 1.1 0.1 1.5 2.2 11.5 1.4 0.5 0.2 0.6 0.0 0.4 0.9 0.5 0.0 0.4 0.3 0.3 0.3 0.1 0.1 0.0 1.0 0.3 0.0 0.5 0.8 0.0 0.3 0.3 0.1 0.3 0.2 0.0 0.3 0.4 0.6 2.2 0.3 0.8 0.1 0.4 0.3 1.3 2.1 0.1 0.7 0.1 0.4 0.1 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 8.9 11.2 0.0 0.8 0.0 0.0 2.0 5.1 6.7 10.3 1.8 0.0 0.0 0.0 0.1 21.0 0.0 13.4 0.0 1.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 5.2 0.0 0.0 6.8 0.3 0.0 0.0 0.0 22.9 0.0 0.9 13.6 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 9.1 7.1 FAM83F ENSG00000133477 "Family with sequence similarity 83 member F" Q8NEG4 22 39994949-40043529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 29.4;seminal vesicle: 33.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 31.6;Late spermatids: 52.5;Suprabasal keratinocytes: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 7.1;HaCaT: 7.6;HBEC3-KT: 9.2;hTCEpi: 23.0;hTERT-HME1: 7.2;OE19: 10.3;RT4: 11.0;SCLC-21H: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA051207, HPA064657" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA051207: AB_2681388, HPA064657: AB_2685313" "unprognostic (2.78e-2)" "unprognostic (3.91e-2)" "prognostic favorable (1.73e-4)" "unprognostic (5.36e-2)" "unprognostic (1.48e-5)" "unprognostic (1.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.75e-2)" "unprognostic (4.79e-1)" "unprognostic (2.48e-1)" "prognostic favorable (9.40e-4)" "unprognostic (3.25e-1)" "unprognostic (1.10e-7)" "unprognostic (2.93e-1)" "unprognostic (2.37e-1)" "unprognostic (2.98e-2)" "unprognostic (8.32e-2)" 1.1 0.2 0.1 2.8 0.2 0.8 4.7 0.2 0.3 2.6 6.9 0.1 29.4 3.0 0.2 7.5 15.4 1.1 4.0 1.5 0.2 0.1 4.8 2.1 1.0 0.1 0.2 0.1 0.5 14.4 2.6 2.6 0.5 0.1 6.3 3.1 0.4 7.8 33.3 0.1 13.8 12.5 0.8 0.2 0.1 5.9 24.9 0.1 1.3 12.6 12.8 8.1 3.0 4.1 0.7 0.5 2.7 0.4 0.6 0.3 0.1 4.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 7.1 1.4 0.0 0.0 0.0 0.0 7.6 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 23.0 0.0 7.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.3 0.0 0.0 0.0 0.0 0.1 11.0 24.3 0.0 0.2 2.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.3 2.2 0.6 0.3 0.5 0.1 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 11.8 25.4 0.5 5.1 2.5 2.7 1.2 22.7 0.0 0.1 3.3 8.6 20.7 0.8 31.6 0.0 13.2 0.1 1.6 13.1 1.1 1.0 0.2 0.0 12.6 0.0 0.8 52.5 1.7 0.9 1.7 0.0 18.3 1.0 11.4 20.1 2.1 5.0 0.7 0.0 0.8 7.2 2.2 30.2 1.1 0.0 12.7 15.2 FAM83G "FLJ41564, PAWS1" ENSG00000188522 "Family with sequence similarity 83 member G" A6ND36 17 18968789-19004804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.0;skin 1: 33.8;tongue: 28.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 69.0;Suprabasal keratinocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA023369, HPA023940" Enhanced Approved Cytosol NA NA Cytosol "HPA023369: AB_1848415, HPA023940: AB_1848416" "unprognostic (2.12e-2)" "unprognostic (5.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.48e-2)" "unprognostic (1.42e-3)" "unprognostic (2.04e-2)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.07e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-2)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.58e-6)" "unprognostic (9.68e-2)" "unprognostic (5.13e-2)" "unprognostic (3.74e-2)" 1.8 1.0 0.5 5.1 0.8 0.6 2.2 1.0 0.8 6.2 5.5 0.4 1.3 6.6 1.4 0.9 36.0 0.8 13.4 8.7 0.9 0.6 2.6 26.5 2.3 1.5 0.4 0.4 1.1 7.0 4.7 2.2 2.6 1.6 1.7 3.2 1.5 5.7 3.0 3.4 33.8 10.1 1.6 0.4 1.0 5.9 0.8 0.3 3.2 3.3 28.9 19.1 2.4 6.9 1.5 0.2 3.4 0.7 0.0 2.6 0.7 12.5 11.6 0.1 0.0 0.4 1.1 19.2 13.2 5.8 11.2 8.5 14.8 4.6 8.3 8.1 8.7 9.2 15.0 1.9 11.1 5.2 6.7 4.2 0.2 5.7 8.1 8.4 1.4 4.2 1.5 20.9 7.2 12.0 4.2 4.0 1.3 3.9 0.3 3.1 7.7 0.3 3.1 5.8 17.5 0.0 0.0 0.0 4.0 5.5 3.2 6.0 0.0 4.5 2.8 0.8 16.3 4.9 1.8 7.4 7.0 11.7 3.3 15.2 1.1 2.0 2.1 5.4 0.0 4.5 3.4 0.0 0.0 2.6 0.1 1.4 1.1 1.5 0.8 0.2 1.5 1.4 0.2 0.0 0.0 0.7 0.2 1.8 0.7 0.5 0.8 1.0 0.8 0.9 0.6 0.4 0.4 1.6 0.3 3.0 2.1 0.0 10.6 69.0 0.0 3.5 10.2 0.0 2.3 7.0 0.0 0.1 0.0 13.9 0.0 0.3 27.0 0.0 8.7 8.1 1.0 10.5 9.2 18.3 1.2 0.0 6.8 1.3 0.0 0.4 0.0 2.1 5.0 1.8 11.2 0.0 17.5 10.5 0.0 4.3 0.1 0.0 2.2 0.1 1.1 59.8 1.6 0.7 9.8 7.8 FAM83H FLJ46072 ENSG00000180921 "Family with sequence similarity 83 member H" Q6ZRV2 8 143723933-143733801 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.2;lymphoid tissue: 30.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 19.7;MCF7: 27.0;RT4: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024505, HPA024604" Enhanced Approved Cytosol NA NA Cytosol "HPA024505: AB_1848417, HPA024604: AB_1848418" "unprognostic (3.80e-2)" "unprognostic (3.75e-3)" "unprognostic (6.87e-2)" "unprognostic (1.63e-2)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.93e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (3.95e-2)" "unprognostic (9.69e-3)" "prognostic favorable (4.42e-4)" "unprognostic (5.54e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" 0.8 1.9 1.2 4.1 1.0 0.2 2.9 0.2 1.6 8.8 12.5 0.9 6.1 6.3 1.1 3.0 42.2 3.0 17.7 0.3 1.1 0.4 5.0 10.4 3.9 0.5 0.3 0.6 1.3 6.7 5.9 2.8 8.9 0.9 5.6 2.7 2.6 8.3 2.9 0.1 17.7 17.9 1.8 0.7 0.7 9.1 1.3 0.2 1.1 6.9 27.9 30.7 5.1 9.5 0.3 0.2 0.5 0.3 0.1 0.2 0.0 13.8 6.5 0.0 0.0 0.0 0.0 12.2 0.9 0.0 0.4 0.1 5.9 12.5 0.0 10.1 0.2 0.0 19.7 0.8 12.1 0.2 1.0 2.2 0.3 13.0 4.1 1.0 0.3 0.9 0.7 14.3 0.0 3.6 0.2 0.0 0.9 7.3 0.0 0.0 27.0 0.2 0.0 2.5 14.3 6.0 0.0 0.0 1.3 3.9 16.2 3.8 0.0 10.9 12.7 2.1 1.8 13.7 1.8 0.0 0.0 3.9 0.9 0.0 1.9 2.0 0.0 0.0 0.0 0.6 0.3 0.3 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 1.2 1.0 0.2 1.6 1.1 0.4 0.3 0.6 0.9 0.2 29.8 16.8 0.0 12.2 20.3 1.2 3.6 22.9 9.4 12.5 27.9 2.0 10.1 3.3 18.5 1.1 1.2 29.9 0.0 22.0 15.5 1.8 19.5 0.0 21.2 4.0 9.5 13.8 0.6 1.9 0.0 0.0 1.1 1.7 3.6 23.7 6.0 31.6 21.5 0.4 6.5 2.1 0.0 1.2 1.2 1.0 23.5 12.2 0.8 22.5 29.2 FAM84A "FLJ35392, NSE1" ENSG00000162981 "Family with sequence similarity 84 member A" Q96KN4 2 14632686-14650814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.0" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 143.9;Mucus-secreting cells: 133.7;Syncytiotrophoblasts: 173.8;Undifferentiated cells: 210.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.1;hTCEpi: 12.0;RT4: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047703 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047703: AB_2680123" "unprognostic (1.05e-2)" "unprognostic (9.22e-2)" "unprognostic (2.24e-3)" "unprognostic (1.13e-1)" "unprognostic (4.28e-2)" "unprognostic (7.38e-2)" "unprognostic (2.62e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-1)" "unprognostic (4.44e-2)" "unprognostic (1.20e-1)" "unprognostic (9.27e-2)" "unprognostic (3.52e-2)" "unprognostic (1.13e-1)" "unprognostic (1.58e-1)" "unprognostic (5.57e-3)" "unprognostic (1.36e-1)" 0.9 1.8 22.0 9.1 14.8 0.6 2.7 3.1 31.8 9.9 34.0 1.7 0.9 22.4 3.0 29.0 22.6 2.8 5.6 2.1 7.7 7.7 3.3 1.8 5.6 0.8 3.6 11.2 7.9 3.3 2.0 3.0 5.9 2.4 11.1 31.9 1.6 15.9 2.5 1.3 14.4 21.3 3.0 2.5 0.8 3.0 20.0 3.9 0.6 2.2 10.4 3.8 9.5 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 1.6 0.4 0.3 0.0 0.2 0.0 0.0 0.2 0.0 6.1 0.6 2.7 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 12.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.8 4.9 0.0 0.1 0.5 0.0 2.6 0.0 0.0 0.1 4.6 31.9 2.8 1.3 0.0 1.2 0.0 0.2 0.0 0.0 1.9 5.5 0.4 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 14.8 3.1 31.8 7.7 7.7 3.6 11.2 2.4 3.9 0.0 1.4 2.4 19.6 10.0 1.7 1.5 2.5 8.1 5.7 29.6 0.0 143.9 10.0 2.2 8.0 14.9 93.2 0.0 6.4 16.6 4.4 47.3 10.3 0.9 10.6 0.0 47.6 30.7 3.8 9.6 4.6 1.1 6.8 1.0 133.7 13.7 5.4 57.5 2.8 0.8 1.1 0.0 11.3 0.5 0.9 23.1 173.8 1.7 210.4 69.9 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 10.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 5.8" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.9 2.0 3.2 1.0 6.9 1.2 0.7 4.8 7.5 0.8 0.5 2.2 4.0 1.3 1.2 2.8 1.3 1.1 3.3 4.1 1.3 0.1 1.2 0.7 2.8 5.0 0.9 2.0 5.4 0.3 2.6 0.0 2.4 1.0 2.0 3.0 0.7 0.1 2.3 1.4 0.3 0.6 2.6 0.0 0.8 1.1 0.2 0.6 0.9 0.1 0.0 0.8 0.2 0.5 2.9 0.0 5.8 0.0 0.7 2.5 4.7 0.3 1.1 0.7 1.6 1.3 1.0 0.2 0.2 1.1 4.9 1.0 0.8 0.8 0.5 0.8 0.2 0.7 0.8 3.1 2.0 2.2 0.3 0.5 0.5 1.4 1.3 0.2 2.4 1.6 1.6 0.2 2.7 0.0 1.3 1.9 0.6 0.5 1.5 1.0 0.7 0.3 1.3 4.7 1.0 0.9 0.5 0.6 0.4 2.2 0.0 0.0 1.0 0.9 4.0 1.6 0.6 1.4 0.6 0.8 0.1 0.8 0.8 0.1 0.7 0.1 0.0 0.7 0.2 0.8 0.5 0.3 0.0 0.6 0.7 0.9 0.0 0.0 0.6 0.4 0.2 3.0 2.6 0.8 2.5 1.0 2.6 0.4 5.1 10.7 4.5 1.8 2.0 1.3 5.0 3.9 4.4 1.1 0.5 0.0 1.6 1.2 2.9 2.2 1.1 0.8 1.9 1.6 4.1 1.8 1.9 4.0 1.7 1.1 3.3 0.0 1.2 2.3 2.9 0.0 2.5 6.8 1.2 0.0 2.1 0.9 0.7 1.1 0.9 0.0 2.0 1.3 FAM86B2 ENSG00000145002 "Family with sequence similarity 86 member B2" P0C5J1 8 12425614-12436343 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 4.6" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Early spermatids: 1.2;Late spermatids: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hTERT-HME1: 6.3;RPMI-8226: 18.5" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (3.75e-2)" "unprognostic (1.87e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (3.26e-2)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.48e-1)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (6.04e-4)" "unprognostic (9.37e-2)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.13e-2)" 0.4 0.9 0.2 0.4 0.7 0.0 0.8 0.2 0.3 0.8 0.8 0.4 1.0 0.0 3.9 4.6 0.7 0.1 0.2 0.5 1.1 0.5 0.6 0.1 0.2 1.3 1.1 0.6 2.2 0.1 0.6 0.6 0.5 1.8 0.3 1.2 0.0 0.6 0.0 0.0 0.4 0.1 3.4 0.1 1.0 0.6 0.4 1.3 0.0 0.9 0.6 2.1 0.3 0.2 1.3 0.2 0.0 0.3 1.5 1.5 0.3 0.7 0.5 1.3 0.5 1.3 0.8 0.0 1.5 0.3 0.2 1.1 1.8 0.0 0.0 0.0 0.2 1.8 0.0 1.2 0.0 0.0 0.4 1.5 1.4 6.3 0.1 0.0 0.0 1.3 0.2 0.1 0.4 0.0 0.4 1.2 2.2 0.4 0.2 0.7 18.5 0.0 1.2 1.9 0.0 0.5 1.4 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.5 0.4 0.9 1.1 1.3 0.4 0.4 0.3 0.0 0.6 0.9 0.0 2.1 0.3 3.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 39.6;placenta: 48.3" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 143.5;Extravillous trophoblasts: 248.1;Rod photoreceptor cells: 96.4;Syncytiotrophoblasts: 232.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 52.2;SK-MEL-30: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: AB_2683890, HPA059578: AB_2684070" "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 39.6 12.9 8.0 3.7 8.5 3.9 32.8 3.9 5.4 5.1 3.6 4.9 2.0 1.6 5.7 2.1 3.4 2.7 4.6 4.7 7.9 11.2 8.7 5.7 10.5 6.7 14.0 2.3 4.7 15.0 4.0 4.2 48.3 13.1 4.7 2.4 12.0 3.5 3.9 4.2 14.1 1.8 3.5 10.9 9.6 3.1 2.8 8.3 0.8 3.9 5.0 3.6 4.3 9.7 1.2 0.0 4.3 0.7 0.3 3.0 0.8 0.3 4.8 2.2 4.7 5.5 1.1 52.2 2.7 2.0 1.0 1.8 7.3 4.3 0.0 0.6 1.7 6.0 2.9 4.2 0.6 0.8 14.5 10.2 2.3 0.1 0.3 21.2 1.7 12.6 18.4 9.5 0.0 4.8 0.0 2.6 5.3 18.0 3.0 0.9 1.7 1.1 3.0 3.3 4.3 1.5 5.7 7.3 5.5 3.6 5.1 2.0 5.8 0.9 0.4 27.3 5.2 0.2 10.1 0.4 8.2 0.0 0.1 5.0 6.6 7.9 4.0 2.4 3.4 16.1 4.3 0.7 0.0 0.6 0.1 1.1 1.2 0.8 1.5 0.0 0.6 1.3 3.0 0.0 0.3 0.2 0.0 0.0 0.8 8.0 8.5 3.9 5.4 7.9 11.2 14.0 2.3 13.1 8.3 0.0 1.6 2.7 15.8 26.8 32.0 3.0 2.5 0.0 1.2 0.0 72.6 143.5 3.3 2.1 1.1 20.1 0.0 0.0 2.9 248.1 6.4 12.7 4.6 10.6 41.7 7.9 0.0 5.5 13.1 1.8 2.6 3.0 20.3 0.0 0.4 22.8 4.3 0.0 1.4 4.4 96.4 0.0 2.1 3.8 8.9 28.7 232.7 2.2 0.9 13.3 FAM90A1 FLJ10408 ENSG00000171847 "Family with sequence similarity 90 member A1" Q86YD7 12 8221260-8227618 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.8" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 2.5;Early spermatids: 1.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 1.1;myeloid DC: 2.8;plasmacytoid DC: 2.0" "Group enriched" "Detected in many" 8 "dendritic cells: 2.8;monocytes: 1.1" "Cell line enhanced" "Detected in some" "BEWO: 5.3;HDLM-2: 7.9;NTERA-2: 19.1" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (2.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.21e-2)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.69e-3)" "unprognostic (1.94e-4)" "unprognostic (4.37e-3)" "unprognostic (4.43e-2)" "unprognostic (3.93e-2)" "unprognostic (3.97e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (5.30e-5)" "unprognostic (1.50e-1)" "unprognostic (5.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.06e-2)" 0.2 2.5 2.1 1.2 4.1 0.1 0.3 4.1 9.8 0.3 0.2 0.6 1.9 1.4 1.0 1.6 2.9 2.0 2.3 2.7 0.5 0.0 1.4 0.8 2.2 5.8 2.5 0.0 3.3 0.4 1.7 0.0 2.8 0.6 0.4 2.3 0.3 0.2 1.8 0.7 0.4 2.1 3.1 0.1 0.6 0.5 0.1 2.8 0.0 1.1 0.1 0.2 0.2 0.0 0.0 0.7 1.3 0.2 0.0 5.3 0.4 0.4 0.1 0.0 0.0 2.2 0.3 0.9 0.1 0.3 0.0 3.4 0.0 0.0 7.9 0.4 0.5 0.0 0.1 0.0 0.1 0.0 0.5 1.3 0.3 0.2 2.5 0.2 0.8 2.9 0.4 0.0 1.1 0.1 2.9 19.1 0.0 0.0 0.2 0.1 0.0 1.3 0.4 0.2 0.4 0.0 0.0 0.1 0.3 0.0 0.9 0.0 0.8 0.0 0.2 0.1 0.4 2.9 0.0 2.0 2.5 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.1 0.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.3 0.5 0.7 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.0 FAM90A26 FAM90A26P ENSG00000229924 "Family with sequence similarity 90 member A26" 4 9170409-9176730 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-RPE1: 1.1" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (1.80e-2)" "unprognostic (3.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (4.41e-1)" 0.0 0.6 0.1 0.0 0.3 0.1 0.1 0.2 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.4 0.3 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.3 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM92A "FAM92A1, FLJ38979" ENSG00000188343 "Family with sequence similarity 92 member A" A1XBS5 8 93698561-93731527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.0" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 46.8;Distal tubular cells: 34.9;Proximal tubular cells: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034760, HPA058942" Enhanced Approved Mitochondria NA NA Mitochondria "HPA034760: AB_10599947, HPA058942: AB_2732628" "unprognostic (2.65e-3)" "unprognostic (6.81e-2)" "unprognostic (2.48e-3)" "unprognostic (2.44e-1)" "unprognostic (1.62e-2)" "unprognostic (2.93e-1)" "unprognostic (3.56e-1)" "unprognostic (3.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (2.28e-3)" "unprognostic (1.97e-1)" "unprognostic (1.71e-1)" "unprognostic (6.85e-3)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (3.07e-2)" 11.2 13.3 15.9 4.2 14.7 2.8 8.4 13.6 19.1 9.4 7.0 2.9 5.5 2.8 12.0 19.9 5.5 10.1 10.5 16.3 12.9 11.2 15.3 11.4 7.1 4.2 8.4 15.9 13.8 15.1 15.2 21.6 7.5 9.7 9.8 4.8 5.2 3.3 9.2 6.9 5.1 4.1 11.1 6.2 3.7 5.4 71.0 6.4 1.8 9.4 3.1 2.7 11.6 10.6 0.9 6.2 0.3 3.8 2.8 1.6 1.0 13.6 7.3 19.7 20.3 21.3 30.6 5.3 12.5 18.3 17.0 16.4 1.3 3.1 1.1 16.3 18.4 19.5 9.8 19.9 11.9 15.4 0.4 11.0 8.0 7.3 6.7 24.5 0.3 2.0 19.3 5.3 16.6 13.6 24.5 18.1 6.7 4.7 0.6 13.3 5.1 8.4 1.4 8.3 0.3 0.4 0.8 14.8 0.2 13.3 3.1 5.7 7.3 9.0 0.1 15.1 9.3 3.0 4.2 10.0 16.7 6.7 17.3 10.1 0.9 0.9 0.4 14.6 1.1 5.8 0.3 3.8 0.0 0.4 2.2 0.5 0.9 1.1 0.4 6.2 0.2 0.2 0.7 0.1 2.8 0.3 0.8 1.6 1.0 15.9 14.7 13.6 19.1 12.9 11.2 8.4 15.9 9.7 6.4 8.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 46.8 15.9 7.0 0.0 10.8 34.9 16.9 0.0 0.0 0.0 0.0 14.8 11.6 0.0 0.0 3.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.8 0.0 0.0 14.6 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 FAM92B FLJ44299 ENSG00000153789 "Family with sequence similarity 92 member B" Q6ZTR7 16 85098358-85112508 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.2;fallopian tube: 50.7;lung: 13.8" "Cell type enriched" "Detected in some" 10 "Ciliated cells: 281.1" "Group enriched" "Detected in some" 5 "endometrial cancer: 5.4;lung cancer: 1.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 7.6;TIME: 2.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA041022 Enhanced NA NA "HPA041022: AB_10795500" "unprognostic (1.77e-4)" "unprognostic (7.44e-3)" "unprognostic (1.61e-1)" "unprognostic (2.11e-3)" "unprognostic (5.09e-3)" "unprognostic (1.14e-3)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (9.81e-2)" "unprognostic (3.70e-1)" "unprognostic (3.84e-2)" "unprognostic (2.05e-1)" "unprognostic (5.10e-13)" "unprognostic (2.76e-2)" "unprognostic (1.56e-1)" "unprognostic (2.47e-1)" "unprognostic (1.29e-1)" 0.1 0.9 2.0 0.7 8.3 0.3 0.3 0.7 0.6 2.0 0.5 6.3 0.0 0.9 0.9 10.8 0.1 50.7 0.2 0.1 2.7 5.0 0.1 0.1 13.8 0.3 0.0 0.0 8.8 0.1 0.1 13.5 0.1 14.2 0.2 0.4 0.0 0.3 0.2 0.1 0.3 0.5 0.1 0.4 0.6 0.3 0.7 1.8 0.0 0.1 0.0 1.2 1.3 0.0 1.2 0.2 0.9 0.3 2.5 0.4 0.2 0.4 0.0 0.5 0.3 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.4 0.3 0.6 0.3 0.1 0.6 0.0 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.2 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.3 0.0 0.6 0.0 0.1 0.5 0.1 0.2 0.2 0.5 0.2 0.3 0.4 7.6 0.9 0.0 0.1 0.2 0.3 0.8 0.7 2.2 0.6 0.5 0.1 0.2 0.2 0.2 0.4 0.4 0.2 1.6 0.1 0.2 0.1 0.4 0.3 0.2 1.2 0.2 0.1 0.2 0.3 0.2 0.2 0.9 2.5 0.1 0.2 0.0 0.2 2.0 8.3 0.7 0.6 2.7 5.0 0.0 0.0 14.2 1.8 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 281.1 27.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.0 3.4 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM96A "CIA2A, FLJ22875" ENSG00000166797 "Family with sequence similarity 96 member A" Q9H5X1 15 64072559-64094018 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040459, HPA063729" Approved Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" No No "Nucleoplasm, Cytosol" "HPA040459: AB_10796456, HPA063729: AB_2685105" "unprognostic (1.15e-1)" "unprognostic (8.49e-2)" "unprognostic (6.59e-2)" "unprognostic (3.58e-1)" "unprognostic (1.30e-1)" "unprognostic (8.07e-2)" "unprognostic (4.06e-3)" "unprognostic (5.02e-2)" "unprognostic (7.16e-2)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.48e-3)" "unprognostic (8.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-2)" "unprognostic (1.50e-2)" 13.6 32.3 11.2 19.1 12.8 17.0 13.9 9.0 10.3 8.5 24.3 13.6 17.7 31.3 8.1 14.9 13.6 8.3 14.0 20.6 11.2 10.8 39.4 89.7 18.1 22.7 15.2 8.0 7.8 27.0 10.6 15.4 25.2 11.2 17.2 20.2 10.7 16.5 15.7 28.2 7.6 45.5 6.4 14.9 25.2 17.9 8.9 13.8 20.5 30.1 18.3 19.3 14.6 9.0 51.8 63.7 23.7 48.6 11.8 21.3 38.2 19.9 29.3 17.9 11.2 15.2 18.7 11.8 15.7 17.5 21.0 22.3 28.9 32.3 33.2 27.7 9.9 27.9 22.1 35.0 15.4 17.9 27.1 18.9 27.0 26.5 27.1 12.0 43.7 23.4 14.7 15.5 13.6 12.2 14.3 21.2 18.7 36.9 25.7 14.8 33.8 16.6 37.9 26.0 24.9 15.6 26.8 23.7 73.5 27.1 23.5 19.2 14.5 12.5 28.6 30.4 20.8 21.0 45.8 12.7 16.7 23.7 19.0 33.8 24.9 58.7 29.8 20.2 79.2 15.8 16.2 48.6 16.9 10.1 44.1 12.4 51.8 15.3 13.5 42.6 48.8 12.3 11.6 23.7 11.8 36.7 63.7 21.3 38.2 11.2 12.8 9.0 10.3 11.2 10.8 15.2 8.0 11.2 13.8 35.7 30.8 96.4 18.3 15.9 7.2 70.8 79.0 45.5 40.9 33.2 3.9 101.5 140.9 70.9 2.4 23.8 94.1 0.0 74.8 83.9 35.7 38.2 19.7 217.6 196.6 14.3 55.4 41.1 140.8 3.6 15.3 99.6 40.5 211.0 97.7 14.5 84.6 87.7 7.8 151.8 6.7 12.9 23.7 21.4 49.8 19.2 74.3 58.6 129.3 21.4 FAM9A TEX39A ENSG00000183304 "Family with sequence similarity 9 member A" Q8IZU1 X 8790795-8801383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 9.2" "Group enriched" "Detected in some" 13 "Sertoli cells: 6.5;Spermatocytes: 20.0;Spermatogonia: 24.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.3" "Cell line enriched" "Detected in single" 17 "U-266/84: 14.0" HPA056076 Uncertain NA NA "HPA056076: AB_2683030" "unprognostic (3.43e-2)" 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.3 9.2 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 20.0 24.3 0.0 0.0 0.0 0.0 0.0 FAM9B TEX39B ENSG00000177138 "Family with sequence similarity 9 member B" Q8IZU0 X 9024232-9164639 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.4;liver: 3.7;testis: 11.4" "Group enriched" "Detected in some" 7 "Spermatocytes: 32.2;Spermatogonia: 62.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Group enriched" "Detected in some" 49 "U-266/70: 21.2;U-266/84: 22.8" HPA035135 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA035135: AB_10669999" "unprognostic (3.95e-1)" "unprognostic (4.49e-1)" "unprognostic (3.76e-2)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-10)" "unprognostic (4.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.54e-2)" 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.2 0.1 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.5 0.5 0.1 0.0 1.1 0.2 11.4 0.1 0.0 0.2 0.6 0.8 0.7 3.4 0.7 0.7 0.4 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 21.2 22.8 0.1 0.0 0.1 0.0 1.0 0.7 0.4 0.3 0.3 0.3 0.5 0.4 0.3 0.2 0.8 0.4 0.4 3.4 0.7 0.4 0.7 0.3 0.4 0.0 0.6 0.0 0.2 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.9 0.2 1.6 0.0 0.6 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 6.5 0.3 32.2 62.0 0.3 0.0 0.0 0.0 0.1 FAM9C TEX39C ENSG00000187268 "Family with sequence similarity 9 member C" Q8IZT9 X 13035618-13044682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 29.8;testis: 12.0" "Cell type enhanced" "Detected in some" 16 "Spermatocytes: 13.5;Spermatogonia: 8.1" "Cancer enriched" "Detected in single" 22 "testis cancer: 4.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 3.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 3.0" "Cell line enriched" "Detected in some" 55 "AN3-CA: 65.1" NA NA "unprognostic (2.28e-1)" "unprognostic (7.35e-2)" "unprognostic (1.90e-1)" "unprognostic (1.66e-1)" "unprognostic (3.35e-2)" "unprognostic (2.06e-4)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.3 0.0 2.0 0.0 0.1 0.0 0.1 29.8 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.0 0.1 0.0 0.3 0.0 0.1 0.1 0.3 65.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.4 0.0 0.1 0.5 0.0 0.6 0.1 0.0 0.2 0.5 0.0 0.0 0.3 0.3 0.1 0.5 0.0 0.2 0.4 0.4 0.2 0.3 0.2 0.2 1.1 0.2 0.1 0.3 0.4 0.2 0.2 0.3 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.5 1.4 0.3 2.5 1.4 1.2 0.0 2.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.4 0.2 1.1 0.0 0.4 0.0 0.0 0.0 0.3 3.1 0.9 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.6 0.0 0.0 13.5 8.1 0.5 0.1 0.0 0.0 0.0 FANCA "FA-H, FAA, FACA, FAH, FANCH" ENSG00000187741 "Fanconi anemia complementation group A" O15360 16 89737549-89816657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6;testis: 28.8" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3;Spermatocytes: 22.3;Spermatogonia: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063236 Supported Nucleoplasm NA Yes Nucleoplasm "HPA063236: AB_2684966" "unprognostic (5.99e-2)" "unprognostic (5.68e-2)" "unprognostic (2.36e-1)" "unprognostic (5.12e-2)" "unprognostic (1.87e-1)" "unprognostic (7.11e-2)" "unprognostic (1.45e-4)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (2.05e-1)" "unprognostic (4.82e-3)" "unprognostic (8.48e-4)" "unprognostic (7.82e-10)" "unprognostic (3.67e-2)" "unprognostic (2.05e-1)" "unprognostic (2.94e-1)" "unprognostic (1.62e-1)" 2.1 2.0 2.2 16.5 3.7 17.1 1.7 5.7 6.6 1.7 5.1 1.1 0.6 5.0 1.7 3.1 6.6 1.9 1.6 1.7 1.8 1.4 2.1 5.8 3.3 11.1 1.3 2.7 1.6 1.8 2.3 1.9 11.2 2.4 1.7 6.3 1.5 2.2 0.5 0.7 5.0 5.4 2.0 1.6 6.9 3.5 28.8 0.8 20.6 1.7 4.6 17.6 2.9 2.5 7.4 6.5 9.9 9.2 7.5 9.5 4.2 9.3 14.4 17.3 15.1 1.1 2.2 13.2 11.7 6.4 19.8 8.3 12.6 15.6 23.1 5.5 4.0 6.6 14.5 11.6 8.7 20.9 5.4 19.5 6.8 18.5 25.8 0.7 6.9 7.5 0.7 0.9 16.0 5.1 2.8 6.2 11.7 16.3 7.1 10.3 21.7 13.8 30.0 11.2 12.9 9.0 25.2 13.9 4.2 4.9 8.9 15.5 8.4 17.5 5.2 2.2 10.4 9.4 12.5 4.6 15.9 16.8 8.8 12.2 6.4 7.5 22.9 7.5 15.5 15.1 2.6 7.9 9.9 4.7 8.8 3.3 7.4 2.8 4.1 6.5 5.5 0.7 3.0 9.8 7.5 9.2 0.4 9.5 4.2 2.2 3.7 5.7 6.6 1.8 1.4 1.3 2.7 2.4 0.8 0.0 0.6 13.1 1.4 3.1 8.8 1.6 0.0 1.4 3.4 15.7 9.8 10.9 1.7 1.6 5.3 0.8 2.0 23.3 1.4 7.5 1.3 0.5 2.3 4.0 7.7 3.2 1.7 7.4 4.3 3.5 1.4 6.3 0.0 0.0 6.1 1.4 1.5 0.0 0.0 6.8 7.2 0.0 1.0 22.3 33.2 1.6 21.2 3.2 6.3 2.1 FANCB "FAAP95, FAB, FLJ34064" ENSG00000181544 "Fanconi anemia complementation group B" Q8NB91 X 14835961-14873069 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.9" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA003124 Uncertain NA NA "HPA003124: AB_1078813" "unprognostic (3.49e-2)" "unprognostic (1.92e-3)" "unprognostic (1.16e-2)" "unprognostic (8.42e-3)" "unprognostic (7.99e-2)" "unprognostic (2.42e-2)" "unprognostic (4.05e-5)" "unprognostic (6.93e-3)" "unprognostic (1.77e-3)" "unprognostic (7.70e-3)" "unprognostic (2.76e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-11)" "unprognostic (4.46e-2)" "unprognostic (1.92e-1)" "unprognostic (6.88e-2)" "unprognostic (5.96e-2)" 1.6 0.9 2.7 3.2 8.2 10.9 2.0 3.5 4.6 2.4 1.5 4.7 0.0 1.1 1.7 1.0 3.3 1.5 0.9 1.2 3.9 1.2 1.1 0.9 1.5 6.2 7.7 1.3 2.1 1.2 1.2 0.7 3.2 5.5 1.2 2.1 0.3 1.7 0.7 0.9 1.7 2.0 1.7 4.3 2.9 1.4 1.4 7.9 7.5 1.2 1.4 4.5 1.8 2.2 3.0 1.0 1.8 1.2 1.6 1.9 1.1 6.2 4.2 4.2 3.4 0.3 0.7 1.4 9.7 2.7 7.7 9.1 3.2 4.3 9.2 1.7 3.4 6.0 6.0 9.6 3.4 12.1 4.4 4.5 3.7 6.3 1.5 0.1 4.8 2.9 0.1 0.3 7.4 1.7 0.8 3.6 3.1 5.7 6.6 4.4 3.0 4.5 2.7 5.3 2.3 6.4 4.3 9.6 4.0 0.7 2.3 2.8 3.1 5.1 1.9 3.0 9.6 3.3 1.7 1.7 6.0 3.4 12.8 5.5 1.6 3.4 6.3 2.6 3.5 12.0 1.5 1.2 0.9 1.3 0.8 0.9 3.0 0.8 1.7 0.9 2.8 0.9 0.8 1.8 1.6 0.5 1.0 1.9 1.1 2.7 8.2 3.5 4.6 3.9 1.2 7.7 1.3 5.5 7.9 3.0 0.3 3.0 0.5 1.4 3.3 0.3 0.0 1.4 2.3 0.0 0.0 4.2 0.0 0.8 0.2 1.4 0.0 0.0 1.4 9.8 1.4 0.8 3.5 0.0 3.1 3.2 0.0 0.6 0.3 0.0 1.1 1.6 0.0 1.0 0.3 0.4 0.4 0.0 1.1 0.2 0.2 0.0 2.2 3.2 3.3 0.9 3.2 2.5 1.2 0.6 FANCC "FA3, FAC, FACC" ENSG00000158169 "Fanconi anemia complementation group C" Q00597 9 95099054-95426796 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 29.7" "Group enriched" "Detected in many" 5 "Early spermatids: 190.4;Late spermatids: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 10.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.4" "Cell line enhanced" "Detected in all" "RH-30: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017793, HPA030771" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB017793: , HPA030771: AB_2673604" "unprognostic (1.48e-2)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (2.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.32e-2)" "unprognostic (3.41e-3)" "unprognostic (1.26e-2)" "unprognostic (7.45e-3)" "unprognostic (1.37e-1)" "unprognostic (8.00e-3)" "unprognostic (3.19e-2)" "prognostic favorable (6.03e-6)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.71e-2)" 4.9 2.7 4.3 8.6 7.0 3.6 4.6 29.7 7.7 4.6 6.4 4.9 5.1 7.1 6.3 4.1 4.5 3.6 5.2 3.2 4.0 2.7 10.0 25.7 6.7 3.7 7.3 1.6 3.3 5.4 2.9 12.1 4.3 6.7 4.4 6.1 4.0 4.0 4.2 4.5 7.7 8.1 2.9 6.4 3.4 4.4 19.6 7.3 7.9 4.3 3.2 6.0 3.5 4.0 1.0 1.3 10.4 1.7 0.3 1.5 0.7 13.6 9.2 12.2 10.6 1.2 3.2 7.7 5.9 3.9 9.5 8.8 10.5 5.8 7.8 4.2 4.3 7.3 16.7 12.3 5.2 5.2 7.4 5.8 6.1 10.4 5.4 2.0 6.1 6.8 2.7 2.2 7.6 3.4 2.6 5.2 7.6 9.1 3.4 6.8 9.6 5.7 3.5 5.8 14.5 5.2 12.2 31.5 3.6 3.9 3.5 17.7 9.4 11.3 4.0 3.4 6.4 4.2 5.1 2.5 8.3 12.2 9.1 8.4 3.6 6.6 4.1 4.5 5.6 9.8 10.4 0.4 0.0 1.3 0.8 1.3 1.0 0.7 1.5 0.4 1.0 1.2 1.0 0.1 0.3 1.7 1.3 1.3 0.7 4.3 7.0 29.7 7.7 4.0 2.7 7.3 1.6 6.7 7.3 3.0 2.1 0.0 2.3 2.3 5.4 1.6 5.1 1.4 3.4 0.0 3.9 2.3 1.7 4.1 190.4 4.3 3.3 0.0 3.6 4.0 2.0 2.5 5.7 25.1 1.8 9.5 0.0 4.3 2.7 63.3 6.1 1.3 1.7 3.6 4.5 2.6 3.4 0.0 2.1 7.7 4.2 0.0 1.6 13.0 10.6 2.4 1.9 1.0 3.8 2.5 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "Fanconi anemia complementation group D2" Q9BXW9 3 10026414-10101930 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 24.4;testis: 23.3" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 46.7;Spermatocytes: 55.1;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 46.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 2.0 1.3 0.8 10.3 2.6 12.2 2.4 1.6 2.7 1.7 2.9 1.1 1.0 2.2 2.2 1.8 4.7 2.4 2.5 1.1 0.8 0.9 2.3 1.0 2.4 9.5 1.3 1.2 3.5 3.5 0.6 1.1 5.3 1.4 2.2 4.9 1.6 3.3 0.4 3.0 3.3 6.2 1.2 2.0 7.3 2.4 23.3 1.6 24.4 1.6 5.6 14.6 2.2 2.4 6.8 3.7 5.3 2.6 2.1 2.9 1.0 8.7 9.3 17.8 5.0 0.9 1.4 46.0 8.0 3.6 11.5 9.4 6.9 8.7 17.1 3.8 2.6 9.5 7.6 18.3 6.2 11.5 8.1 12.4 23.3 14.3 6.6 0.1 17.3 14.6 0.4 1.0 13.0 7.2 1.6 6.9 14.7 14.2 19.6 8.7 10.0 14.4 6.7 21.4 6.7 6.5 15.8 14.5 12.1 4.0 9.8 4.9 9.8 9.8 7.7 3.1 13.5 11.8 11.0 4.0 9.6 11.0 5.8 11.6 8.3 16.3 28.9 5.5 17.8 16.3 5.3 1.4 3.7 1.5 1.0 1.3 4.9 2.0 1.2 0.9 6.8 2.5 1.9 3.3 2.1 2.6 3.7 2.9 1.0 0.8 2.6 1.6 2.7 0.8 0.9 1.3 1.2 1.4 1.6 0.0 0.3 9.7 2.8 4.0 2.8 1.6 0.0 1.4 1.2 1.8 9.8 6.6 0.0 1.6 4.4 1.5 0.7 46.7 2.9 12.7 1.3 2.2 1.1 1.0 5.0 0.0 1.2 3.7 3.4 5.6 2.0 5.2 3.3 7.2 2.0 0.8 1.4 2.8 1.4 0.5 5.8 19.4 0.8 55.1 32.4 2.4 5.8 3.8 5.0 2.3 FANCD2OS "C3orf24, MGC40179" ENSG00000163705 "FANCD2 opposite strand" Q96PS1 3 10081317-10108231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 53.0" "Group enriched" "Detected in some" 88 "Early spermatids: 499.8;Late spermatids: 668.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Cell line enhanced" "Detected in some" "CACO-2: 4.8;Daudi: 1.5;HEL: 2.5;MCF7: 2.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA076166 Approved Vesicles NA NA Vesicles "HPA076166: " "unprognostic (5.99e-2)" "unprognostic (4.33e-3)" "unprognostic (8.04e-2)" "unprognostic (1.11e-3)" "unprognostic (3.51e-1)" "unprognostic (2.63e-2)" "unprognostic (4.78e-2)" "unprognostic (3.49e-1)" "unprognostic (2.53e-3)" "unprognostic (3.91e-2)" "unprognostic (9.45e-2)" "unprognostic (2.11e-7)" "unprognostic (2.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 8.4 1.6 0.4 0.4 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 0.6 1.5 0.7 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 2.3 1.3 0.0 0.1 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.8 0.2 0.1 0.0 1.2 0.6 0.3 0.9 0.6 0.4 0.5 0.3 0.3 0.4 0.2 0.4 0.2 0.1 0.8 0.3 0.3 8.4 0.4 1.6 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.8 0.0 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 668.2 6.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 5.1 2.4 0.0 0.0 0.0 0.0 0.0 FANCF FAF ENSG00000183161 "Fanconi anemia complementation group F" Q9NPI8 11 22622519-22626787 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 15.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 123.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008899 Supported Nucleoplasm NA NA Nucleoplasm "HPA008899: " "unprognostic (1.16e-2)" "unprognostic (4.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.37e-2)" "unprognostic (4.55e-2)" "unprognostic (8.84e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (4.29e-2)" "unprognostic (1.11e-1)" "unprognostic (2.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (3.73e-2)" "unprognostic (1.81e-1)" "unprognostic (9.14e-2)" "unprognostic (7.64e-3)" 1.2 4.1 2.9 3.1 2.8 1.1 3.2 1.0 2.7 3.1 3.4 5.3 3.0 6.0 3.0 6.1 1.7 1.9 2.9 3.9 3.2 4.2 1.8 4.9 3.3 4.2 9.0 3.4 4.5 1.5 2.9 3.7 3.8 3.1 0.4 3.1 4.9 1.1 3.5 5.4 4.6 4.3 3.6 4.8 2.6 2.0 15.2 9.7 11.5 5.7 10.0 15.1 7.3 1.4 4.3 5.6 6.1 2.9 3.5 2.3 2.8 3.3 3.2 3.5 2.8 2.2 7.1 0.7 2.8 5.8 6.1 4.5 4.6 1.6 11.6 2.1 2.7 1.7 4.9 3.4 4.9 2.9 3.3 8.9 1.1 4.9 5.5 5.0 10.3 6.8 9.3 2.0 4.5 12.5 4.6 6.4 12.0 5.4 10.8 2.6 8.0 6.0 5.6 20.9 9.8 1.5 4.9 4.8 6.2 9.9 4.5 3.6 3.3 3.5 5.9 3.9 5.4 6.9 2.1 5.4 2.0 7.6 5.7 5.4 11.5 11.5 5.5 13.5 11.8 10.8 10.8 6.4 15.2 15.1 12.4 0.8 10.0 5.7 9.7 7.3 7.3 3.0 2.1 10.5 5.3 3.0 15.7 4.4 10.2 22.7 2.3 3.5 9.8 9.4 38.1 15.4 123.7 4.7 9.6 0.0 16.2 7.1 3.8 3.9 2.3 8.1 6.0 15.9 3.4 1.8 5.9 13.7 8.9 5.3 5.0 9.0 16.2 11.8 10.5 10.5 9.2 15.4 17.2 6.5 3.1 21.0 15.8 1.9 1.9 11.4 15.5 2.3 FANCI "FLJ10719, KIAA1794" ENSG00000140525 "Fanconi anemia complementation group I" Q9NVI1 15 89243949-89317261 "Disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.4;testis: 28.3" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Spermatocytes: 45.0;Spermatogonia: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039972, HPA040379" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA039972: AB_10673265, HPA040379: AB_2676951" "unprognostic (6.88e-2)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.82e-3)" "unprognostic (1.15e-2)" "unprognostic (4.59e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.71e-13)" "unprognostic (2.40e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" 3.7 3.2 1.7 11.1 3.3 16.5 3.3 1.8 5.6 3.8 5.9 3.0 2.7 3.3 3.3 3.3 10.7 2.1 1.8 2.8 2.5 1.5 2.4 2.0 3.5 13.4 5.0 2.6 3.1 2.3 1.8 1.5 7.1 2.9 2.8 7.6 2.3 4.0 1.7 1.3 5.4 4.9 3.8 2.8 6.7 4.6 28.3 3.2 44.4 1.7 9.2 15.4 3.9 4.6 3.8 3.9 17.7 3.8 4.6 10.6 3.0 24.5 28.2 30.2 20.3 2.7 3.9 18.7 23.6 13.6 29.6 36.2 22.3 22.4 45.5 12.8 7.8 18.9 33.7 46.1 16.0 27.9 29.0 28.8 45.1 41.5 10.4 0.4 32.5 23.0 2.1 1.6 20.8 10.6 4.3 12.0 28.1 31.1 33.6 19.7 14.0 33.9 11.2 23.7 16.1 10.4 29.5 44.0 19.5 6.8 45.4 22.5 19.3 24.4 17.3 11.0 21.3 19.1 14.8 8.2 24.6 25.1 22.5 35.8 22.3 46.3 35.1 9.2 29.0 24.6 17.7 2.4 2.8 5.2 3.0 2.9 3.5 5.0 6.8 2.1 3.8 4.1 6.0 3.7 4.6 3.8 3.9 10.6 3.0 1.7 3.3 1.8 5.6 2.5 1.5 5.0 2.6 2.9 3.2 3.0 1.0 3.7 1.8 3.8 2.1 2.7 0.0 8.1 4.5 1.8 0.0 8.3 0.0 1.7 5.9 1.6 1.3 46.7 2.5 15.5 2.7 1.4 2.3 0.8 6.8 1.6 1.2 9.2 3.1 5.3 3.1 4.3 1.7 3.6 4.5 9.5 2.2 0.0 1.4 1.0 1.7 6.5 1.9 45.0 68.0 2.0 10.4 5.2 4.4 1.7 FANCL "FAAP43, FLJ10335, PHF9, Pog" ENSG00000115392 "Fanconi anemia complementation group L" Q9NW38 2 58159243-58241372 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 62.5" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033842, HPA036685, HPA036686" Supported Approved "Nuclear bodies,Vesicles" NA Yes "Nuclear bodies" Vesicles "CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844" "unprognostic (3.02e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-3)" "unprognostic (6.24e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (4.71e-2)" "unprognostic (2.63e-2)" "unprognostic (1.31e-2)" "unprognostic (3.50e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (9.08e-3)" "prognostic favorable (7.80e-5)" 6.3 29.2 16.0 11.2 22.9 10.6 16.2 7.1 18.1 11.6 9.6 30.7 7.9 9.2 16.6 15.7 8.6 11.7 9.8 10.2 17.0 23.5 7.1 16.7 7.7 10.9 25.0 15.2 21.3 10.8 16.8 62.5 10.0 33.5 11.6 12.4 13.7 14.8 9.1 6.5 14.4 10.1 11.3 23.4 12.0 10.5 14.7 28.2 8.6 14.2 6.9 12.0 10.1 12.7 10.8 7.1 5.6 6.9 8.8 5.5 2.7 18.5 13.5 27.6 13.5 4.9 6.5 14.7 13.6 8.5 13.5 17.6 11.9 23.3 12.8 17.7 4.4 18.6 10.8 15.3 10.3 22.6 30.1 24.2 21.0 19.0 16.1 5.3 20.2 11.6 4.8 4.9 9.9 3.9 12.0 10.6 9.2 19.5 11.7 9.2 9.4 7.1 25.1 29.8 29.7 2.8 13.5 21.0 10.0 11.8 18.3 31.3 15.7 19.4 8.0 12.7 15.5 7.4 13.6 6.2 12.1 18.2 8.8 15.0 12.1 7.6 7.5 25.7 13.7 18.3 2.7 3.7 5.6 4.9 6.9 3.8 10.8 4.1 5.4 7.1 10.0 1.4 3.1 1.1 8.8 4.9 6.5 5.5 2.7 16.0 22.9 7.1 18.1 17.0 23.5 25.0 15.2 33.5 28.2 17.9 18.3 5.8 13.7 9.2 12.4 13.2 5.1 20.1 10.3 8.7 3.9 25.0 10.0 6.9 1.7 10.5 7.3 0.0 3.6 12.2 8.9 6.8 10.4 10.4 9.4 7.9 8.6 10.4 8.5 1.7 10.0 6.9 25.3 9.0 16.3 20.3 4.6 13.1 13.4 4.1 18.8 12.9 8.1 47.7 30.4 5.9 6.2 5.0 13.6 5.9 FANK1 ENSG00000203780 "Fibronectin type III and ankyrin repeat domains 1" Q8TC84 10 125896539-126009592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.3;fallopian tube: 24.7;testis: 44.7" "Group enriched" "Detected in many" 5 "Ciliated cells: 171.3;Early spermatids: 463.3;Late spermatids: 423.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 14 "T-reg: 28.3" "Lineage enriched" "Detected in single" 284 "T-cells: 28.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.7;hTCEpi: 8.6;hTERT-RPE1: 11.4;RPTEC TERT1: 11.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038413 Supported Nucleoplasm NA NA Nucleoplasm "HPA038413: AB_10697249" "unprognostic (4.25e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.83e-4)" "unprognostic (1.17e-3)" "unprognostic (4.02e-2)" "unprognostic (6.29e-2)" "unprognostic (1.44e-1)" "unprognostic (3.12e-3)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (3.42e-2)" "unprognostic (9.53e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-2)" "unprognostic (1.10e-2)" "unprognostic (1.44e-1)" 0.5 2.4 4.1 1.3 8.3 0.7 3.4 0.8 1.8 2.5 2.2 4.0 3.8 1.6 2.3 18.5 2.2 24.7 4.9 0.5 4.9 6.4 4.5 0.1 4.0 0.8 2.7 1.3 5.6 3.1 2.3 7.8 2.0 14.1 1.5 3.3 2.0 1.5 2.9 0.2 3.9 1.9 1.3 2.1 0.3 3.5 44.7 2.4 0.4 5.8 1.1 1.7 1.7 1.4 0.0 0.0 0.0 0.0 0.0 28.3 0.1 6.0 2.1 0.5 3.5 2.7 2.7 3.9 2.4 1.7 0.6 0.5 0.1 16.7 0.0 0.4 1.7 0.9 8.1 0.0 2.9 0.5 0.2 0.1 0.0 0.7 0.0 1.0 0.3 0.6 0.8 8.6 2.3 0.8 11.4 0.9 0.0 0.3 0.0 1.0 5.1 0.0 1.2 0.4 5.5 0.2 0.0 0.2 0.5 11.9 1.7 0.4 1.8 1.8 3.9 0.4 6.7 0.6 0.3 0.8 1.2 2.0 1.6 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.1 4.1 8.3 0.8 1.8 4.9 6.4 2.7 1.3 14.1 2.4 11.9 4.6 0.0 3.4 4.5 1.5 0.4 2.5 171.3 28.4 12.2 31.4 1.9 11.6 9.8 463.3 2.1 2.0 0.0 7.7 4.4 1.3 3.6 3.5 0.0 0.8 3.2 0.0 1.8 0.3 423.7 3.4 2.2 1.7 0.0 13.0 5.8 9.3 6.8 4.2 6.7 9.5 0.0 1.0 66.4 16.4 3.0 4.2 1.3 4.1 3.3 FAP DPPIV ENSG00000078098 "Fibroblast activation protein alpha" Q12884 2 162170684-162245151 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 30.0" "Group enriched" "Detected in many" 6 "Fibroblasts: 25.9;Muller glia cells: 68.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 45.4;ASC TERT1: 48.2;BJ hTERT+: 38.0;hTERT-RPE1: 48.7;U-138 MG: 38.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA059739 Uncertain "Secreted to blood" NA NA 34000000 "HPA059739: AB_2684117" "unprognostic (7.48e-3)" "unprognostic (7.87e-3)" "unprognostic (4.10e-2)" "unprognostic (5.04e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.01e-2)" "unprognostic (1.05e-2)" "unprognostic (3.30e-2)" "unprognostic (4.89e-2)" "unprognostic (4.59e-2)" "unprognostic (3.52e-1)" "unprognostic (7.32e-11)" "unprognostic (1.72e-3)" "unprognostic (9.84e-3)" "unprognostic (7.97e-2)" "unprognostic (4.49e-3)" 19.8 0.7 2.6 3.2 1.2 0.0 7.5 0.6 3.7 17.6 4.5 0.4 4.0 0.1 30.0 13.7 4.1 5.1 14.9 5.2 3.1 0.9 2.0 0.9 4.7 0.8 2.6 1.2 4.1 2.3 0.5 1.0 17.0 1.9 4.1 1.5 2.4 5.3 3.9 8.1 2.9 1.4 17.9 2.2 0.9 1.7 9.8 3.4 0.0 3.5 9.0 0.8 12.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 48.2 0.0 18.5 38.0 3.9 5.9 0.0 0.0 0.0 0.1 7.0 0.0 0.0 0.0 1.2 1.9 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 15.5 0.2 6.4 1.2 48.7 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 1.9 0.0 0.0 0.0 19.0 38.7 0.7 9.4 0.0 0.0 0.0 0.0 8.7 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.2 0.6 3.7 3.1 0.9 2.6 1.2 1.9 3.4 0.0 0.0 0.0 0.1 3.9 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.9 2.9 0.0 0.0 0.2 1.6 25.9 0.1 0.0 0.0 0.8 1.6 4.7 2.5 0.0 2.3 7.8 0.3 3.3 0.0 0.0 68.0 1.6 0.0 0.0 0.6 1.5 0.0 1.4 0.2 0.0 3.8 1.5 0.0 0.0 0.0 FASLG "APT1LG1, CD178, FasL, TNFSF6" ENSG00000117560 "Fas ligand" P48023 1 172659018-172666874 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Apoptosis, Transcription, Transcription regulation" "Cytokine, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.6;lymphoid tissue: 13.4" "Cell type enriched" "Detected in some" 7 "T-cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "gdT-cell: 25.6" "Group enriched" "Detected in many" 12 "NK-cells: 16.0;T-cells: 25.6" "Cell line enhanced" "Detected in some" "ASC diff: 1.0;LHCN-M2: 2.5;NB-4: 1.2;RPTEC TERT1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054959 Approved "Secreted to blood" NA NA 73600 "HPA054959: AB_2682650" "unprognostic (1.09e-3)" "unprognostic (1.41e-2)" "unprognostic (8.69e-2)" "unprognostic (1.54e-7)" "unprognostic (3.29e-1)" "unprognostic (2.23e-3)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.67e-2)" "unprognostic (4.76e-2)" "unprognostic (8.88e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.59e-6)" "unprognostic (3.49e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.82e-3)" 0.9 1.1 0.5 1.9 0.7 3.6 1.8 0.5 0.8 0.7 2.6 0.6 0.0 3.0 3.9 1.2 1.0 0.8 1.6 1.2 0.5 0.5 1.2 2.2 6.8 7.7 1.4 0.0 1.5 0.6 0.0 0.7 2.4 0.6 4.7 1.2 2.8 1.9 0.3 0.4 0.5 3.8 1.9 1.7 13.4 2.1 0.4 0.0 1.2 1.1 0.0 10.1 1.4 0.9 0.0 0.0 1.6 0.0 16.0 25.6 5.5 0.0 0.0 0.3 0.1 1.0 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.5 0.5 0.1 0.0 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.7 0.1 0.0 0.1 0.3 0.6 2.5 0.0 0.0 1.2 0.4 0.2 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.8 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 25.6 0.0 15.8 0.0 5.4 13.7 0.0 0.0 1.1 11.7 0.8 16.0 0.0 0.0 0.1 5.5 0.5 0.7 0.5 0.8 0.5 0.5 1.4 0.0 0.6 0.0 0.0 4.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 30.5 0.0 0.0 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078333-82098332 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 147.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 103.0;Hepatocytes: 169.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 155.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" No No 1600000 "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 147.6 7.8 8.2 14.2 11.5 11.1 57.5 19.1 23.0 6.6 27.7 17.0 14.1 8.2 4.7 14.2 17.1 4.3 19.4 6.3 7.9 6.7 3.7 30.8 26.8 9.8 7.3 11.5 6.4 10.4 6.7 15.3 8.4 21.7 28.8 3.4 7.6 16.9 10.8 7.5 17.2 6.5 4.6 8.4 5.1 11.9 6.6 8.8 1.9 5.1 10.7 5.4 8.0 6.6 0.5 1.4 0.0 0.8 0.2 1.9 0.8 23.6 24.8 11.5 7.9 18.7 12.7 24.7 4.7 6.1 5.0 9.2 25.9 16.1 7.9 3.9 3.6 14.0 19.7 11.1 21.7 0.9 3.7 48.3 16.3 18.5 34.6 5.3 8.8 2.5 12.1 5.7 12.7 3.0 1.7 5.6 7.4 24.6 7.0 1.7 40.9 9.5 14.0 22.4 3.7 14.4 8.5 6.5 15.6 5.6 30.3 28.7 16.0 6.9 155.8 12.6 4.4 27.8 16.8 9.7 7.3 15.1 6.0 11.3 9.5 2.1 8.1 4.4 9.6 10.8 0.0 0.8 0.0 1.2 0.5 0.7 0.5 1.9 1.4 1.4 0.2 0.7 0.6 0.0 0.2 0.4 1.1 0.6 0.8 8.2 11.5 19.1 23.0 7.9 6.7 7.3 11.5 21.7 8.8 23.8 103.0 0.8 10.3 6.9 24.9 4.8 25.5 6.7 10.3 10.4 5.9 28.9 3.3 18.9 1.2 4.5 20.8 23.3 24.9 65.8 10.4 65.5 12.7 169.2 11.7 28.6 17.4 11.1 6.9 1.3 15.3 5.0 16.9 8.2 18.9 12.3 16.1 17.5 10.6 5.5 9.5 0.0 9.6 1.9 13.9 12.0 24.7 10.7 18.3 17.5 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favorable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 13.8 16.8 18.8 15.7 19.0 6.4 10.2 19.0 26.4 18.0 20.6 13.4 20.3 21.2 12.4 14.6 20.3 16.7 16.8 35.7 17.6 12.9 17.7 25.6 9.5 10.4 12.0 15.0 14.4 20.7 20.2 21.8 18.5 12.0 16.8 10.6 14.0 21.7 17.9 89.5 14.4 25.8 11.3 9.2 14.9 14.8 10.6 10.9 11.2 16.8 28.1 16.9 17.4 11.8 15.4 26.0 19.7 22.3 13.1 19.0 14.5 15.9 18.6 5.9 14.2 22.1 10.0 9.9 12.8 17.4 10.9 13.1 12.8 13.7 3.8 17.5 17.3 20.1 10.3 5.7 15.3 2.9 10.9 10.2 4.6 4.6 10.8 28.1 3.2 10.5 13.0 22.5 12.6 9.3 8.9 12.8 9.5 6.8 8.0 12.6 31.9 7.8 9.2 9.9 19.8 21.8 5.2 7.1 11.8 14.8 10.9 7.1 7.4 16.9 26.2 17.0 5.3 14.1 12.7 10.4 13.9 3.0 13.0 11.3 21.4 13.0 2.4 27.7 7.2 15.9 10.5 22.3 19.7 16.4 21.7 17.1 13.7 17.3 16.9 19.4 15.4 19.0 16.3 4.8 13.1 20.8 26.0 18.7 14.5 18.8 19.0 19.0 26.4 17.6 12.9 12.0 15.0 12.0 10.9 0.0 6.5 32.8 35.2 21.9 39.2 16.5 28.1 2.7 12.5 24.4 23.6 42.5 72.9 43.5 7.1 22.2 63.6 0.0 41.8 23.0 34.8 27.1 39.1 31.6 38.4 35.0 43.1 22.7 26.6 11.6 33.6 25.5 89.4 34.3 42.5 51.0 35.5 39.6 32.2 50.2 48.9 12.9 27.8 47.1 68.2 22.1 50.6 38.4 50.8 26.7 FAT1 "CDHF7, CDHR8, FAT" ENSG00000083857 "FAT atypical cadherin 1" Q14517 4 186587783-186726722 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.4" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 64.9;LHCN-M2: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001869, HPA023882" Enhanced "Intracellular and membrane" NA NA 120000 "HPA001869: AB_1078818, HPA023882: AB_1848429" "unprognostic (1.98e-1)" "unprognostic (4.91e-2)" "unprognostic (2.50e-2)" "unprognostic (1.86e-1)" "unprognostic (1.53e-2)" "unprognostic (5.82e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.15e-3)" "unprognostic (6.80e-2)" "unprognostic (3.57e-2)" "unprognostic (8.03e-3)" "unprognostic (9.41e-2)" "unprognostic (6.25e-3)" "unprognostic (4.27e-2)" 15.5 1.3 7.9 12.3 9.8 0.4 15.4 11.9 8.4 15.9 40.4 11.8 8.1 17.9 20.6 14.0 9.7 9.6 28.2 21.1 10.0 6.0 29.1 13.3 10.9 1.4 11.4 6.2 9.7 13.8 7.5 10.5 14.6 24.7 15.9 22.9 5.0 13.9 18.2 3.0 13.1 76.4 18.3 12.8 1.7 11.5 7.0 11.2 1.3 10.5 10.2 6.7 17.5 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 19.0 18.9 0.0 18.9 22.8 4.6 25.4 41.9 12.4 7.9 11.3 11.2 0.0 6.1 64.9 8.0 9.2 7.4 31.3 16.9 0.0 3.0 0.0 6.7 11.4 9.4 8.2 6.8 8.2 11.3 23.0 15.0 17.0 0.2 10.3 0.1 0.0 47.7 6.0 14.6 0.0 4.2 9.5 3.2 0.0 5.2 0.4 18.6 17.9 2.0 7.6 4.4 7.5 3.0 13.5 0.0 3.0 5.4 35.4 13.7 0.4 15.7 0.1 0.0 0.1 8.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 9.8 11.9 8.4 10.0 6.0 11.4 6.2 24.7 11.2 14.9 4.1 0.0 25.5 75.6 5.2 20.3 35.7 16.0 25.0 50.6 0.0 1.1 5.0 21.9 0.6 5.1 58.5 0.0 23.2 3.5 24.9 37.8 16.1 22.9 0.3 0.0 13.9 1.8 1.0 0.4 13.6 3.1 11.8 0.0 54.8 4.2 24.0 23.0 35.0 21.4 0.3 38.8 54.6 1.8 7.7 40.9 1.4 0.0 38.7 20.0 FAT2 "CDHF8, CDHR9, HFAT2, MEGF1" ENSG00000086570 "FAT atypical cadherin 2" Q9NYQ8 5 151504093-151568944 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 61.0;skin 1: 35.1" "Group enriched" "Detected in some" 7 "Basal glandular cells: 5.4;Basal keratinocytes: 16.0;Early spermatids: 12.8;Extravillous trophoblasts: 18.5;Late spermatids: 5.5;Melanocytes: 6.8;Suprabasal keratinocytes: 17.1;Urothelial cells: 13.7" "Group enriched" "Detected in many" 6 "cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6" "Region enriched" "Detected in some" 34 "cerebellum: 61.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "BEWO: 17.3;EFO-21: 10.4;HaCaT: 25.0;HBEC3-KT: 11.4;hTCEpi: 34.7" "Region enriched" "Detected in single" 18 "cerebellum: 35.9" "Region enriched" "Detected in some" 66 "cerebellum: 442.8" CAB033680 Enhanced NA NA "CAB033680: AB_2100956" "unprognostic (8.06e-3)" "unprognostic (6.01e-2)" "unprognostic (3.47e-1)" "unprognostic (4.80e-3)" "unprognostic (1.33e-1)" "unprognostic (4.43e-1)" "unprognostic (9.78e-3)" "unprognostic (2.28e-1)" "unprognostic (8.25e-2)" "unprognostic (2.65e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-7)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (6.77e-2)" "unprognostic (3.64e-3)" 0.4 0.0 0.4 0.4 1.7 0.0 2.2 61.0 0.4 2.4 0.4 0.4 0.4 0.0 0.4 1.0 11.8 0.5 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 1.3 0.4 0.0 0.4 0.4 0.9 0.9 0.0 0.4 3.8 3.2 0.4 35.1 0.4 0.4 0.4 0.4 0.0 2.7 0.4 0.4 0.4 0.4 1.9 1.0 4.9 0.2 0.6 0.1 0.4 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 17.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.1 25.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 1.7 61.0 0.4 0.4 0.0 0.4 0.4 0.9 0.4 0.0 0.0 0.0 5.4 16.0 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 12.8 0.0 0.0 0.0 0.0 18.5 0.4 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 17.1 0.8 0.0 0.0 13.7 FAT3 "CDHF15, CDHR10, KIAA1989" ENSG00000165323 "FAT atypical cadherin 3" Q8TDW7 11 92352096-92896470 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.5;seminal vesicle: 6.0" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.2;Collecting duct cells: 14.0;Peritubular cells: 7.1;Spermatogonia: 5.1" "Cancer enriched" "Detected in single" 6 "glioma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.1;fHDF/TERT166: 2.4;NTERA-2: 2.7;SuSa: 2.6;U-2 OS: 2.3;U-251 MG: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026878 Uncertain NA NA "HPA026878: AB_1848430" "unprognostic (5.00e-2)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.76e-6)" "unprognostic (1.27e-1)" "unprognostic (1.79e-1)" "unprognostic (1.56e-1)" "unprognostic (9.32e-2)" "unprognostic (1.08e-1)" "unprognostic (3.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (5.79e-2)" "unprognostic (3.66e-4)" "unprognostic (8.83e-2)" "unprognostic (7.72e-2)" "unprognostic (2.25e-1)" 0.5 0.1 2.6 0.1 10.5 0.1 0.3 1.4 7.3 0.4 0.2 0.1 0.4 1.0 0.1 0.4 0.2 0.2 1.8 2.2 0.4 0.1 1.4 0.0 2.2 0.8 0.0 0.0 1.8 0.2 3.2 0.2 0.1 6.0 0.2 0.1 0.1 0.2 0.2 0.2 1.2 0.8 0.0 0.4 1.3 0.3 0.2 0.2 0.7 0.0 0.2 0.3 0.0 0.0 0.3 8.1 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.0 0.0 0.0 1.6 2.4 0.0 1.3 0.0 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.6 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.1 11.2 1.2 0.0 0.0 0.0 14.0 0.0 0.1 0.0 0.5 3.6 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.1 0.0 0.0 0.0 0.0 0.7 0.3 0.0 7.1 0.0 0.9 0.0 3.3 0.4 5.1 0.0 0.0 0.0 0.0 0.0 FATE1 "CT43, FATE" ENSG00000147378 "Fetal and adult testis expressed 1" Q969F0 X 151716035-151723194 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 155 "testis: 100.9" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 16.5;Late spermatids: 42.8;Sertoli cells: 12.9;Spermatocytes: 7.9" "Group enriched" "Detected in some" 9 "renal cancer: 1.2;testis cancer: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;U-2197: 1.7;U-266/70: 1.5;U-87 MG: 1.3" "Not detected" "Not detected" HPA034604 Enhanced NA NA "HPA034604: AB_10602318" "unprognostic (1.82e-2)" "unprognostic (7.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.40e-5)" "unprognostic (2.10e-1)" "unprognostic (3.70e-3)" "unprognostic (2.58e-1)" "unprognostic (1.16e-1)" "unprognostic (5.07e-3)" "unprognostic (1.55e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (4.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.34e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 100.9 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 42.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 12.9 0.0 7.9 5.2 0.0 0.0 0.0 0.0 0.0 FAXDC2 "C5orf4, FLJ13758" ENSG00000170271 "Fatty acid hydroxylase domain containing 2" Q96IV6 5 154818491-154859252 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.9;parathyroid gland: 112.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 38.7;Leydig cells: 43.7;Muller glia cells: 45.6;Peritubular cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 21.4;ASC TERT1: 16.1;HSkMC: 14.3;hTERT-RPE1: 15.3;SK-MEL-30: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.38e-3)" "unprognostic (2.88e-2)" "unprognostic (6.26e-2)" "unprognostic (5.11e-2)" "unprognostic (3.12e-2)" "unprognostic (2.70e-2)" "prognostic favorable (3.87e-5)" "unprognostic (8.29e-2)" "unprognostic (2.52e-2)" "unprognostic (2.28e-1)" "unprognostic (1.76e-1)" "unprognostic (3.42e-2)" "prognostic favorable (9.71e-10)" "unprognostic (1.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.07e-3)" "unprognostic (3.94e-1)" 15.9 15.7 14.5 2.9 25.1 12.2 12.9 7.7 31.6 11.9 19.9 77.9 6.7 4.1 14.9 23.7 7.7 16.8 12.7 13.7 19.8 12.3 11.2 55.3 15.3 3.4 29.0 15.3 25.8 6.7 112.1 6.6 5.7 35.9 12.6 8.1 25.6 16.7 14.1 5.0 10.1 7.2 16.9 38.7 5.6 9.0 8.8 33.6 0.0 29.7 5.6 3.1 11.4 8.3 1.9 1.4 6.7 1.2 4.3 0.9 8.8 0.9 0.8 3.0 6.1 21.4 16.1 2.4 2.1 6.2 0.9 3.9 0.8 7.8 1.1 1.3 3.7 0.2 0.8 0.0 1.0 0.8 0.6 0.9 11.8 1.9 4.6 3.2 1.6 1.1 14.3 4.1 2.1 0.5 15.3 4.7 0.8 7.0 0.4 5.3 0.3 1.0 2.4 1.4 2.9 0.2 1.0 2.0 0.4 1.5 0.9 0.3 5.2 0.9 0.5 13.4 6.8 0.4 0.4 1.7 2.2 1.3 0.9 0.6 0.9 0.6 0.7 2.9 0.9 1.3 4.4 1.2 2.2 0.7 0.9 0.6 0.7 0.8 0.7 1.4 1.9 0.7 0.9 6.7 4.3 0.7 1.1 0.4 8.8 14.5 25.1 7.7 31.6 19.8 12.3 29.0 15.3 35.9 33.6 38.7 10.2 0.0 10.9 2.6 1.2 16.9 12.7 20.1 11.4 8.7 0.0 2.8 8.3 2.2 9.9 16.7 1.7 0.0 0.6 0.4 9.7 3.7 5.8 35.5 1.8 3.2 2.9 20.9 8.8 7.3 43.7 5.8 5.0 1.0 17.3 45.6 7.6 5.8 47.7 2.2 1.6 0.0 9.0 1.9 0.9 3.1 1.1 1.3 1.1 3.5 FBF1 "ALB, FBF-1, FLJ00103, KIAA1863" ENSG00000188878 "Fas binding factor 1" Q8TES7 17 75909574-75941140 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.4" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 33.1;Spermatocytes: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023677 Supported Centrosome NA NA Centrosome "HPA023677: AB_1848440" "unprognostic (7.40e-3)" "unprognostic (9.90e-3)" "unprognostic (6.62e-2)" "unprognostic (1.38e-3)" "unprognostic (3.14e-3)" "unprognostic (7.88e-4)" "unprognostic (5.76e-4)" "unprognostic (6.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.24e-3)" "unprognostic (6.31e-5)" "unprognostic (6.76e-2)" "unprognostic (1.08e-9)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "unprognostic (3.59e-1)" "unprognostic (1.77e-1)" 4.5 5.5 9.0 4.8 14.9 6.5 3.8 6.1 11.8 3.6 3.1 9.1 8.4 4.0 5.8 11.8 6.4 8.3 5.9 2.7 11.1 6.0 3.9 1.9 4.5 5.5 10.0 8.6 4.9 5.3 5.3 9.8 3.2 10.3 6.4 3.2 5.6 6.0 7.0 2.5 18.0 5.1 3.0 9.4 6.6 3.6 40.4 11.1 5.2 14.0 2.1 5.5 3.6 6.1 0.8 1.9 0.5 1.4 1.1 2.2 0.7 9.2 12.3 3.7 6.8 3.4 2.4 10.2 5.3 1.0 3.7 2.7 3.1 5.4 4.5 3.5 2.5 5.2 5.8 2.2 3.8 2.8 2.6 4.1 4.1 7.4 2.3 1.7 1.3 6.4 2.4 4.6 6.2 4.1 1.9 2.8 16.4 7.4 5.2 2.5 10.3 11.4 4.5 3.1 2.8 5.3 9.2 6.0 3.9 1.9 1.5 4.2 3.9 7.6 5.8 3.0 2.9 16.1 3.2 1.7 8.2 6.5 4.2 4.8 9.1 2.3 1.8 5.2 3.0 7.9 0.5 0.4 0.4 1.9 1.4 0.5 0.8 1.3 2.0 0.1 0.0 1.5 1.8 0.2 1.1 0.8 1.9 2.2 0.7 9.0 14.9 6.1 11.8 11.1 6.0 10.0 8.6 10.3 11.1 0.0 1.6 0.0 4.8 2.7 5.1 1.2 0.0 6.7 10.3 3.5 9.8 5.6 3.3 0.9 12.2 1.1 3.5 0.0 0.6 1.7 2.1 2.1 2.3 0.0 1.9 4.8 1.2 0.0 0.0 33.1 6.1 0.6 3.3 1.0 1.4 3.4 0.7 1.1 5.6 1.1 7.9 0.0 1.9 23.4 8.9 2.3 3.0 0.0 1.9 2.2 FBLL1 LOC345630 ENSG00000188573 "Fibrillarin like 1" A6NHQ2 5 168529116-168530634 "Predicted intracellular proteins" "rRNA processing" "Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 8.1;Cone photoreceptor cells: 5.9;Horizontal cells: 6.4;Intestinal endocrine cells: 6.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 19.4;SH-SY5Y: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049546, HPA077724" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA049546: AB_2680811, HPA077724: " "unprognostic (2.75e-3)" "unprognostic (2.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (1.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (4.41e-2)" "unprognostic (2.45e-1)" "unprognostic (3.80e-3)" "unprognostic (9.69e-2)" "unprognostic (6.55e-3)" "unprognostic (3.15e-1)" "unprognostic (6.18e-2)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.8 6.2 10.3 0.9 12.1 0.7 1.1 10.6 24.9 1.0 0.9 0.9 0.0 1.4 0.8 0.8 0.8 1.4 1.1 1.3 11.0 18.4 1.1 0.9 0.9 0.7 9.7 8.5 1.2 2.1 1.8 7.4 1.0 7.9 1.4 0.9 0.5 1.4 1.3 0.9 1.5 1.6 1.1 3.0 0.8 1.4 5.1 1.7 0.0 0.8 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.4 0.2 0.1 0.0 0.9 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.4 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 16.1 1.6 0.0 0.9 0.0 0.0 1.2 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 12.1 10.6 16.9 11.0 18.4 9.7 8.5 7.9 1.7 0.0 0.0 0.0 0.0 0.1 8.1 1.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.0 0.1 6.4 6.4 0.0 0.0 1.6 0.0 0.0 3.3 0.0 0.1 0.5 0.3 0.0 0.0 0.0 2.6 6.5 0.0 2.3 0.2 0.1 0.0 0.0 0.2 0.0 FBLN1 FBLN ENSG00000077942 "Fibulin 1" P23142 22 45502238-45601135 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 287.9;vagina: 228.2" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 571.3;Extravillous trophoblasts: 448.0;Fibroblasts: 795.3;Syncytiotrophoblasts: 1016.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 29.1" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.7" "Group enriched" "Detected in many" 4 "dendritic cells: 2.9;monocytes: 5.7" "Cell line enhanced" "Detected in many" "ASC diff: 157.8;ASC TERT1: 70.0;BJ: 84.6;BJ hTERT+: 134.5;HSkMC: 115.4;RT4: 121.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001612, HPA001613, CAB004393, CAB068187" Enhanced Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 34000000000 "Endoplasmic reticulum" "CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824" "unprognostic (6.62e-2)" "unprognostic (2.47e-2)" "unprognostic (1.64e-1)" "prognostic favorable (9.28e-4)" "unprognostic (1.26e-3)" "unprognostic (4.82e-2)" "unprognostic (9.79e-3)" "unprognostic (2.49e-1)" "unprognostic (6.30e-2)" "unprognostic (3.86e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.02e-10)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.29e-2)" "unprognostic (3.64e-2)" 42.3 14.9 2.6 16.9 3.7 0.0 101.2 2.9 6.0 141.6 20.5 11.6 30.3 8.6 62.4 69.7 48.3 47.1 123.7 86.4 6.6 1.3 8.1 2.9 42.5 9.2 3.8 4.2 46.6 12.3 30.0 10.0 287.9 29.1 99.0 10.0 35.3 12.8 21.8 11.5 33.1 16.9 136.1 6.1 2.7 30.3 20.7 2.8 1.1 21.6 18.9 5.3 67.1 228.2 0.4 2.9 0.9 5.7 0.1 0.3 0.2 1.4 3.4 10.2 21.4 157.8 70.0 46.9 84.6 134.5 7.5 2.8 14.5 0.4 0.0 3.6 3.1 0.2 7.4 6.4 0.2 0.9 0.0 1.7 0.0 18.4 9.7 20.9 0.0 0.0 115.4 1.3 7.5 2.7 0.1 0.0 0.1 0.0 0.1 5.2 0.2 0.0 0.2 14.4 0.3 1.2 0.1 0.0 0.1 3.4 121.1 0.7 13.6 10.4 49.3 0.0 30.3 0.3 0.4 0.6 1.4 9.4 38.9 0.0 0.1 0.0 0.1 0.1 0.0 3.6 0.9 0.1 0.0 0.2 0.7 0.2 0.1 0.2 0.1 1.2 0.4 0.3 0.2 0.6 0.1 5.7 2.9 0.2 0.2 2.6 3.7 2.9 6.0 6.6 1.3 3.8 4.2 29.1 2.8 6.0 2.2 0.0 92.6 151.8 0.0 8.6 12.7 1.4 13.6 1.8 0.0 571.3 0.0 0.5 8.4 22.5 0.0 0.0 0.2 448.0 795.3 17.7 1.1 0.4 73.2 0.0 0.0 36.2 0.0 18.3 85.4 3.3 161.9 0.0 0.0 0.0 0.7 0.0 28.7 0.3 0.5 116.4 93.7 18.7 76.7 113.9 1016.7 0.0 0.2 69.1 FBLN2 ENSG00000163520 "Fibulin 2" P98095 3 13549131-13638422 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 80.5" "Group enriched" "Detected in many" 6 "Fibroblasts: 266.2;Leydig cells: 158.2;Peritubular cells: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 9.2;naive CD8 T-cell: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 75.4;fHDF/TERT166: 49.5;HMC-1: 60.2;HSkMC: 43.7;U-2197: 26.7" "Region enriched" "Detected in some" 7 "olfactory region: 15.4" "Low region specificity" "Detected in all" "HPA001934, CAB018622" Enhanced Supported "Plasma membrane" "Secreted to extracellular matrix" NA NA 28000000 "Plasma membrane" "CAB018622: AB_2294196, HPA001934: AB_1078827" "unprognostic (1.19e-1)" "unprognostic (7.76e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (2.82e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.17e-4)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.89e-2)" "unprognostic (2.82e-2)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" 58.5 2.7 1.8 8.0 2.2 0.1 34.3 0.8 3.2 21.4 11.5 1.3 9.5 2.1 11.6 23.6 32.7 7.2 21.9 80.5 1.6 1.7 2.1 1.2 7.8 5.1 2.4 1.4 6.3 3.2 1.1 0.9 31.8 2.3 22.1 4.2 7.9 10.8 3.3 20.1 20.8 6.1 42.9 1.5 2.3 6.9 41.8 0.5 4.8 20.7 23.8 8.5 34.2 36.3 2.2 9.2 0.0 0.0 0.4 5.4 1.1 0.0 0.2 9.8 0.0 75.4 10.2 4.5 23.5 18.8 23.6 15.6 1.5 0.0 0.0 1.1 49.5 0.0 0.0 0.0 0.1 4.4 0.0 0.0 18.6 0.4 0.0 5.1 0.0 60.2 43.7 0.3 3.7 0.0 0.0 0.0 1.6 0.1 0.1 0.1 0.0 0.9 0.1 2.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.0 17.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.7 0.0 0.3 9.2 2.2 0.0 5.4 0.0 0.4 0.0 0.7 0.0 1.1 1.8 2.2 0.8 3.2 1.6 1.7 2.4 1.4 2.3 0.5 0.0 1.0 0.0 0.7 27.4 0.0 7.3 0.0 0.0 3.4 7.0 2.0 6.6 0.0 0.0 3.4 29.2 0.0 0.0 0.2 4.5 266.2 1.0 24.1 0.2 3.2 0.0 0.0 25.8 0.3 6.5 158.2 2.1 37.1 0.0 0.0 1.3 0.2 0.0 213.6 0.0 0.2 12.9 19.6 2.6 8.8 25.2 5.1 0.0 0.0 0.9 FBN1 "FBN, MASS, MFS1, OCTD, SGS, WMS" ENSG00000166147 "Fibrillin 1" P35555 15 48408306-48645849 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hormone" "Aortic aneurysm, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.8" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 91.8;Fibroblasts: 78.5;Leydig cells: 218.7;Peritubular cells: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 36.9;ASC TERT1: 79.9;fHDF/TERT166: 68.5;HSkMC: 43.2;hTERT-RPE1: 35.7;U-138 MG: 35.1;U-2197: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002670, HPA017759, HPA021057, CAB058696, CAB068188" Enhanced Approved Cytosol "Secreted to blood" NA NA 540000000 Cytosol "CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586" "unprognostic (3.97e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "unprognostic (9.50e-2)" "unprognostic (1.51e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-2)" "unprognostic (4.79e-2)" "unprognostic (7.82e-2)" "unprognostic (1.50e-2)" "unprognostic (2.78e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.44e-5)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.25e-2)" "unprognostic (8.69e-3)" "prognostic unfavorable (5.11e-4)" 34.2 5.4 2.1 7.8 2.7 1.8 10.9 1.0 2.8 24.6 11.1 3.5 10.7 2.2 18.4 25.6 22.1 12.1 15.5 24.3 2.5 2.3 2.9 1.9 10.7 5.8 2.8 2.6 20.4 2.5 2.6 3.3 69.8 3.1 11.8 6.9 13.4 5.7 7.8 15.4 6.6 6.9 21.5 3.8 11.3 7.2 13.6 1.6 1.9 17.9 16.3 4.9 22.8 11.2 0.8 0.8 1.8 0.6 1.1 0.6 0.2 0.0 0.8 3.3 3.7 36.9 79.9 0.0 28.8 10.4 8.6 5.5 0.0 0.0 0.0 1.3 68.5 0.0 0.1 0.6 0.1 7.8 3.3 0.2 0.3 14.7 0.0 20.8 0.1 0.0 43.2 0.0 22.7 2.6 35.7 9.2 0.2 0.0 0.0 9.2 0.0 0.2 0.0 0.6 0.0 1.1 0.0 2.8 0.0 1.0 0.0 0.0 2.1 0.0 0.3 0.0 2.7 0.0 0.2 17.4 35.1 1.0 51.0 6.0 0.2 0.1 0.0 23.5 0.0 2.3 1.1 0.5 0.7 0.5 0.3 0.4 0.5 0.4 0.4 0.2 0.8 0.5 0.6 1.8 1.1 0.6 0.8 0.3 0.2 2.1 2.7 1.0 2.8 2.5 2.3 2.8 2.6 3.1 1.6 0.0 2.2 0.0 1.1 22.8 4.5 9.3 0.0 5.3 10.3 12.2 0.0 91.8 0.0 0.2 6.3 21.7 0.0 0.0 0.5 16.3 78.5 0.5 1.1 0.6 13.5 0.0 0.0 38.1 1.0 15.7 218.7 4.4 40.5 3.6 0.0 0.5 2.0 0.0 213.6 0.6 0.1 25.8 44.7 3.0 2.1 18.1 55.0 0.0 0.0 0.1 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Cell line enhanced" "Detected in many" "HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.5 16.4 0.0 2.7 4.7 3.4 17.9 0.0 15.9 11.9 0.0 0.0 0.0 0.0 23.9 0.0 2.7 10.6 2.7 14.9 0.0 4.2 0.0 7.5 0.0 38.0 2.3 0.0 27.1 1.4 6.7 59.9 5.1 33.7 0.0 0.0 0.0 9.8 0.0 0.0 0.9 7.1 0.0 5.4 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 14.0 0.0 5.0 0.0 6.4 12.2 18.3 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 0.0 0.3 0.0 0.1 0.0 0.0 11.3 0.0 0.0 2.3 0.0 0.0 251.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 27.7 3.3 1.5 0.0 0.0 29.6 0.0 0.0 0.0 12.9 5.3 1.1 1.8 1.7 0.0 0.0 3.1 0.1 0.0 2.1 0.0 0.0 6.5 0.2 12.7 3.8 0.4 136.7 0.0 0.0 0.1 FBN3 ENSG00000142449 "Fibrillin 3" Q75N90 19 8065402-8149846 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 5.2;salivary gland: 7.5" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.4;Cardiomyocytes: 2.0" "Cancer enhanced" "Detected in many" "testis cancer: 8.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 3.7;NTERA-2: 12.6;REH: 18.2;SuSa: 4.9" "Low region specificity" "Detected in many" HPA049482 Uncertain "Secreted to extracellular matrix" NA NA "HPA049482: AB_2680786" "unprognostic (9.66e-3)" "unprognostic (5.15e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (4.14e-2)" "unprognostic (5.14e-3)" "unprognostic (6.26e-2)" "unprognostic (4.10e-3)" "unprognostic (3.17e-2)" "unprognostic (8.94e-2)" "unprognostic (4.61e-2)" "unprognostic (1.53e-1)" "unprognostic (2.76e-2)" "unprognostic (1.34e-2)" "unprognostic (2.57e-1)" "unprognostic (1.17e-2)" "unprognostic (3.17e-1)" 0.2 0.0 1.0 0.2 1.2 0.0 0.5 0.2 2.4 0.2 0.2 2.8 0.2 0.0 0.7 0.2 0.5 1.8 0.2 0.2 1.0 1.1 3.6 0.5 5.2 0.2 2.4 0.2 0.8 0.2 0.0 1.9 0.2 2.1 1.7 0.3 0.2 7.5 0.2 0.9 0.6 0.3 0.3 2.0 0.2 0.1 1.1 1.7 0.8 3.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 12.6 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.2 2.4 1.0 1.1 2.4 0.2 2.1 1.7 6.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 FBP1 FBP ENSG00000165140 "Fructose-bisphosphatase 1" P09467 9 94603133-94640249 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 248.1;lung: 87.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 322.6;Proximal tubular cells: 631.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "eosinophil: 73.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 20.5;MCF7: 64.2;RT4: 42.1;SK-BR-3: 12.3;U-698: 30.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005857, HPA012513, CAB033869" Enhanced Approved Mitochondria NA NA 23000000 Mitochondria "CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (1.40e-1)" "prognostic favorable (5.16e-4)" "unprognostic (1.13e-2)" "unprognostic (1.37e-1)" "prognostic favorable (1.79e-4)" "unprognostic (6.94e-3)" "unprognostic (4.52e-2)" "unprognostic (7.79e-2)" "unprognostic (7.59e-2)" "unprognostic (1.12e-1)" "prognostic favorable (6.86e-7)" "unprognostic (6.91e-2)" "unprognostic (3.22e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.64e-5)" 19.3 5.8 0.6 2.3 0.9 1.1 7.0 0.4 0.8 2.2 48.8 0.7 17.6 40.7 0.6 2.5 0.7 0.9 9.7 1.3 0.8 0.5 34.6 248.1 87.8 8.9 0.9 0.7 1.0 8.1 17.1 1.9 1.0 1.0 6.4 3.0 1.5 9.1 17.7 0.5 1.7 60.4 3.1 1.2 2.8 10.4 1.0 0.8 0.5 4.3 1.0 1.1 22.4 9.6 0.6 17.1 73.5 30.7 2.8 3.3 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.3 5.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 64.2 0.0 1.1 0.2 10.4 2.3 0.0 0.2 0.4 0.0 42.1 0.2 1.2 0.1 12.3 0.0 0.2 7.3 1.8 0.0 0.0 0.2 0.2 0.0 0.0 0.2 30.5 0.0 0.3 0.0 10.6 13.0 73.5 1.5 30.7 2.3 0.6 0.9 0.9 17.1 0.6 3.3 1.6 2.3 2.8 16.3 6.1 0.4 5.2 0.6 0.9 0.4 0.8 0.8 0.5 0.9 0.7 1.0 0.8 71.5 142.5 10.2 6.5 0.7 0.0 0.6 107.0 13.4 68.2 59.3 0.0 9.7 94.5 14.4 0.0 1.8 32.6 23.3 56.4 1.6 1.7 17.4 45.2 322.6 187.5 0.0 30.7 11.1 49.8 0.8 1.4 103.2 11.8 0.0 49.9 2.1 23.8 68.4 3.9 631.0 0.0 6.5 1.2 0.6 0.1 0.9 8.5 13.1 59.5 51.2 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 33.7;skeletal muscle: 134.7;tongue: 45.6" "Cell type enhanced" "Detected in some" 29 "Exocrine glandular cells: 1.2;Spermatogonia: 3.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 36 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA012513, HPA077371" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012513: AB_1848446, HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 2.0 0.4 0.1 0.0 0.1 0.0 0.2 0.1 0.9 0.1 0.1 3.8 4.4 1.0 0.1 1.0 1.6 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 1.2 4.1 0.1 0.0 33.7 0.2 0.0 5.0 1.4 1.8 134.7 0.1 0.1 0.1 0.2 0.1 9.0 0.4 0.0 0.0 0.2 45.6 2.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.0 2.5 0.0 0.0 7.1 0.0 0.0 0.1 0.0 3.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 2.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 5.0 3.7 0.0 0.0 0.1 0.0 2.4 0.6 0.1 4.9 1.1 0.0 0.2 0.4 0.1 0.0 0.0 2.3 2.2 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.7 0.1 0.1 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.1 0.0 0.0 0.0 FBXL12 "Fbl12, FLJ20188" ENSG00000127452 "F-box and leucine rich repeat protein 12" Q9NXK8 19 9810267-9827816 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002843 Approved Mitochondria NA NA Mitochondria "HPA002843: AB_2666679" "unprognostic (7.65e-2)" "unprognostic (5.88e-2)" "unprognostic (7.72e-2)" "unprognostic (3.82e-2)" "unprognostic (8.21e-2)" "prognostic favorable (3.21e-4)" "prognostic unfavorable (1.41e-4)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.38e-3)" "unprognostic (1.49e-2)" "unprognostic (4.07e-3)" "unprognostic (9.28e-3)" "unprognostic (1.41e-1)" "unprognostic (1.36e-1)" "unprognostic (2.61e-1)" "unprognostic (4.77e-3)" 14.3 10.4 6.6 12.4 9.8 25.1 16.3 12.2 12.6 14.7 16.8 10.5 8.6 16.2 18.6 18.7 13.2 17.0 15.6 12.1 6.9 7.1 12.0 15.3 14.8 14.1 8.8 8.7 19.3 12.4 8.2 13.4 16.3 10.5 16.5 11.7 10.0 9.9 17.8 17.3 11.3 18.6 14.5 6.7 13.9 12.9 11.8 7.6 87.9 13.5 9.2 12.7 17.8 13.4 19.0 17.1 27.3 14.7 22.5 18.4 11.6 9.5 4.8 11.3 10.7 12.8 11.4 12.7 10.3 10.7 11.3 13.5 14.7 6.4 9.0 16.7 10.4 8.8 9.1 8.4 9.1 9.0 8.9 16.2 17.2 9.6 14.6 16.6 12.4 10.7 16.3 6.2 10.9 9.7 8.3 8.1 23.4 13.0 18.7 5.9 7.6 18.4 38.6 12.8 5.8 9.1 10.8 8.3 16.2 8.0 13.0 6.9 9.5 7.6 5.7 11.8 10.8 7.8 14.8 9.2 15.6 7.5 20.8 10.1 25.3 9.8 13.9 6.6 11.3 7.3 20.8 14.7 27.3 15.9 12.1 18.2 13.6 15.6 18.3 16.6 19.0 18.4 14.5 10.9 22.5 11.3 17.1 16.5 11.6 6.6 9.8 12.2 12.6 6.9 7.1 8.8 8.7 10.5 7.6 6.0 8.6 10.9 13.9 6.5 7.3 20.7 7.6 6.7 7.9 12.2 3.9 36.4 5.0 9.9 1.1 18.8 27.5 0.0 8.5 25.3 20.3 11.5 3.5 6.6 14.9 7.9 12.1 14.7 8.9 2.1 24.5 10.8 10.1 22.6 15.0 8.6 8.0 18.1 20.5 7.9 10.5 12.9 20.4 20.4 18.1 9.7 53.0 17.5 16.9 18.7 FBXL13 "DRC6, Fbl13, MGC21636" ENSG00000161040 "F-box and leucine rich repeat protein 13" Q8NEE6 7 102813230-103074843 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 23.2;testis: 24.8" "Group enriched" "Detected in many" 6 "Early spermatids: 149.2;Late spermatids: 321.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 46 "eosinophil: 6.2;neutrophil: 23.2" "Lineage enriched" "Detected in single" 73 "granulocytes: 23.2" "Cell line enhanced" "Detected in some" "HEL: 6.7;HUVEC TERT2: 12.7;U-266/84: 15.5;U-87 MG: 8.9;U-937: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA057232 Uncertain NA NA "HPA057232: AB_2683375" "unprognostic (1.46e-2)" "unprognostic (1.91e-1)" "unprognostic (6.73e-4)" "unprognostic (1.97e-2)" "unprognostic (1.69e-3)" "unprognostic (4.41e-2)" "unprognostic (2.31e-2)" "unprognostic (6.64e-2)" "unprognostic (7.81e-2)" "unprognostic (1.49e-1)" "unprognostic (7.72e-2)" "unprognostic (2.62e-1)" "unprognostic (1.33e-3)" "unprognostic (4.54e-2)" "unprognostic (1.25e-1)" "unprognostic (1.93e-2)" "unprognostic (1.47e-1)" 0.7 1.7 1.9 0.6 2.6 0.6 0.6 0.5 2.1 1.0 0.5 3.4 2.8 0.4 2.2 5.2 0.5 6.7 0.6 0.6 1.6 1.1 1.3 0.4 1.3 0.5 1.5 0.8 4.6 0.9 0.5 6.0 0.4 7.3 0.8 0.6 4.0 0.5 0.7 0.4 0.7 0.5 0.7 1.8 0.7 6.2 24.8 1.5 0.0 1.5 0.0 0.3 0.6 0.6 0.3 0.0 23.2 0.0 0.0 0.1 0.0 0.5 0.1 0.2 1.1 0.0 0.2 0.1 0.4 0.4 0.2 0.2 0.5 0.4 0.9 0.4 0.3 0.8 0.3 0.0 0.0 0.4 0.5 0.2 6.7 1.1 0.2 2.3 6.1 0.3 0.0 0.1 3.6 0.1 1.1 12.7 0.7 2.0 0.3 0.9 0.4 0.5 5.6 0.9 0.1 0.4 0.2 0.0 0.5 1.6 0.3 0.5 0.5 0.2 0.0 0.1 0.3 0.0 0.2 0.3 1.9 3.6 1.5 0.1 0.8 15.5 1.6 8.9 11.0 5.4 0.0 0.0 6.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 23.2 0.0 0.0 0.0 0.0 0.0 1.9 2.6 0.5 2.1 1.6 1.1 1.5 0.8 7.3 1.5 0.0 0.6 0.0 0.8 1.5 0.8 0.6 0.0 38.8 2.3 0.0 11.8 0.1 3.3 1.1 149.2 1.0 0.0 0.0 1.0 0.1 0.7 0.6 0.0 0.0 0.1 0.0 1.7 0.6 0.0 321.2 0.6 0.8 0.0 0.0 0.0 1.8 1.1 0.0 3.2 1.1 8.5 12.9 21.7 12.2 6.3 0.6 0.1 0.0 0.0 0.7 FBXL16 "C16orf22, Fbl16, MGC33974" ENSG00000127585 "F-box and leucine rich repeat protein 16" Q8N461 16 692498-705829 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 102.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 36.2;Collecting duct cells: 10.4;Horizontal cells: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 9 "T-cells: 3.3" "Cell line enhanced" "Detected in many" "AN3-CA: 13.0;GAMG: 8.7;MCF7: 10.5;SCLC-21H: 21.7;SH-SY5Y: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039504, HPA056354" Enhanced NA NA "HPA039504: AB_10794197, HPA056354: AB_2683105" "unprognostic (5.51e-2)" "unprognostic (3.39e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.58e-2)" "unprognostic (4.79e-3)" "unprognostic (1.83e-1)" "unprognostic (1.19e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.34e-5)" "unprognostic (1.62e-3)" "prognostic favorable (1.87e-4)" "unprognostic (1.90e-2)" "unprognostic (4.71e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-2)" 1.7 5.7 53.5 2.0 75.8 1.6 1.8 17.7 102.2 1.6 1.8 2.5 0.1 2.2 1.6 1.6 1.7 1.8 1.6 1.6 44.9 10.2 2.1 1.6 1.7 1.8 10.2 25.8 1.6 3.6 2.6 3.8 1.6 5.1 1.9 1.6 0.0 5.5 2.4 1.6 2.2 1.9 1.5 2.5 2.0 2.8 5.0 11.9 0.0 2.0 0.0 1.7 1.6 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.3 0.4 0.6 0.2 13.0 0.1 0.1 0.4 0.4 0.1 2.4 0.1 1.2 0.1 0.2 3.5 0.0 8.7 2.4 1.0 1.4 0.1 6.4 0.3 0.0 3.0 0.5 0.0 1.3 0.3 0.0 2.0 0.0 1.2 1.1 0.0 0.5 0.7 3.2 0.0 10.5 0.3 0.0 0.6 0.1 4.1 0.0 0.0 7.3 0.1 0.0 21.7 16.2 2.2 0.4 0.2 0.0 1.1 0.0 0.0 0.1 4.5 0.0 1.7 0.6 3.7 1.6 1.8 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.5 0.2 0.0 0.0 3.3 0.7 0.0 0.0 0.0 0.0 1.2 0.3 53.5 75.8 17.7 56.5 44.9 10.2 10.2 25.8 5.1 11.9 0.0 3.0 0.0 0.8 0.9 36.2 1.1 0.0 0.0 6.8 10.4 2.0 0.4 1.7 0.2 0.9 0.0 0.4 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.1 30.2 9.2 0.6 0.0 0.4 0.6 0.0 0.0 0.0 0.8 2.6 0.4 0.0 0.0 0.2 4.2 0.0 0.0 5.5 4.3 1.4 2.1 0.9 0.4 0.2 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 65.9;smooth muscle: 68.0" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 10.5;Muller glia cells: 9.8;Peritubular cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 8.0;SCLC-21H: 9.1;U-937: 5.7" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 1.9 0.4 0.4 5.5 0.4 0.0 1.1 0.6 0.7 31.4 26.0 0.0 20.8 1.4 65.9 7.6 11.9 10.5 31.1 10.3 0.4 0.4 0.6 0.4 0.7 0.2 0.4 0.3 7.1 0.4 0.0 0.4 1.0 0.2 20.1 2.9 1.9 3.3 24.0 2.2 0.7 4.1 68.0 0.4 0.4 6.3 4.2 0.0 0.0 0.6 1.0 0.4 38.2 4.8 1.5 4.3 0.5 0.2 2.0 2.9 0.5 1.2 2.2 0.3 1.3 0.7 0.9 0.1 0.4 0.1 0.5 0.0 1.4 1.6 0.5 1.1 0.2 0.8 1.3 0.7 0.4 0.0 1.3 0.9 0.4 1.5 3.5 0.2 0.5 0.2 0.5 0.3 0.1 0.7 0.1 0.2 3.7 0.0 1.9 0.0 8.0 1.2 1.0 2.5 1.3 0.8 1.1 0.0 3.9 0.3 0.4 9.1 0.3 1.1 1.8 0.3 0.0 3.2 0.9 1.3 0.6 1.8 0.8 0.4 1.2 2.0 1.3 0.9 5.7 1.3 0.4 0.1 0.0 1.2 0.1 1.6 1.5 1.3 1.4 0.0 1.2 2.9 1.0 0.5 2.0 0.2 4.3 0.1 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.3 0.2 0.0 0.0 0.0 2.2 1.7 0.1 10.5 7.2 5.1 0.0 1.2 7.0 3.9 0.6 8.3 0.9 0.6 0.6 1.3 0.0 1.0 0.7 0.6 1.4 0.0 3.6 0.7 0.0 4.7 5.5 1.5 0.2 0.3 0.4 0.0 0.0 5.6 9.8 0.6 3.5 10.6 2.1 2.5 0.0 1.3 3.9 3.4 0.6 0.5 0.5 3.6 0.5 FBXO15 "FBX15, MGC39671" ENSG00000141665 "F-box protein 15" Q8NCQ5 18 74073353-74147865 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.2" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 56.2;Early spermatids: 27.6;Spermatocytes: 46.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 5 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "GAMG: 3.9;JURKAT: 5.5;SCLC-21H: 5.6" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "basal ganglia: 13.1" NA NA "unprognostic (1.69e-2)" "unprognostic (1.97e-1)" "unprognostic (6.34e-6)" "unprognostic (1.65e-2)" "unprognostic (4.20e-1)" "unprognostic (6.77e-2)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "unprognostic (1.27e-1)" "unprognostic (3.38e-2)" "unprognostic (1.00e-2)" "unprognostic (9.62e-2)" "unprognostic (4.46e-5)" "unprognostic (4.64e-2)" "unprognostic (3.35e-2)" "unprognostic (1.62e-4)" "unprognostic (2.87e-1)" 0.6 1.8 3.1 0.4 7.6 0.6 1.3 1.6 4.1 1.9 0.5 6.3 4.0 0.7 0.8 5.5 0.9 9.4 1.0 0.5 3.3 2.9 3.4 1.7 1.9 0.9 2.2 3.2 1.2 1.1 2.4 7.1 0.6 3.8 1.0 0.4 3.0 1.5 2.4 0.9 1.0 0.6 0.4 2.6 1.2 0.9 19.2 3.4 0.8 2.0 0.0 0.6 0.8 0.5 0.9 0.3 0.0 0.3 0.0 4.2 1.1 0.0 0.3 0.4 0.5 0.2 0.5 0.3 0.3 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.1 3.9 1.6 0.1 0.0 0.8 1.5 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 2.1 0.7 0.7 0.0 5.5 0.1 0.4 0.3 0.4 0.3 0.2 1.2 0.7 2.1 0.7 0.0 0.0 0.7 0.1 5.6 1.7 0.3 0.0 2.1 1.0 0.1 1.0 0.0 0.7 0.1 0.0 0.1 0.3 2.5 2.2 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 1.6 0.6 0.0 0.9 4.2 2.6 0.0 0.0 0.3 0.3 0.1 1.1 3.1 7.6 1.6 3.9 3.3 2.9 2.2 3.2 3.8 3.4 6.0 0.6 0.0 0.8 0.2 5.6 0.4 0.0 56.2 5.7 1.8 0.0 0.4 3.3 0.4 27.6 0.5 0.0 0.0 0.2 0.6 0.2 0.2 0.0 0.2 3.2 4.8 0.0 0.6 0.3 14.2 1.1 0.1 0.0 0.0 0.0 7.2 0.1 0.0 1.4 4.4 10.4 0.0 0.4 46.1 7.2 0.0 0.3 0.0 0.0 0.5 FBXO16 FBX16 ENSG00000214050 "F-box protein 16" Q8IX29 8 28348287-28490318 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 22.9;pituitary gland: 42.3" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 26.8;Cone photoreceptor cells: 33.4;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 8 "dendritic cells: 11.5" "Cell line enhanced" "Detected in many" "AF22: 15.7;Karpas-707: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058676, HPA076472" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Vesicles, Plasma membrane, Cytosol" "HPA058676: AB_2683795, HPA076472: " "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (3.37e-3)" "unprognostic (5.56e-3)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (2.55e-3)" "unprognostic (4.95e-3)" "unprognostic (6.49e-2)" "prognostic favorable (6.70e-5)" "unprognostic (3.41e-3)" "unprognostic (4.90e-2)" "unprognostic (7.15e-2)" "unprognostic (1.71e-2)" "unprognostic (4.85e-2)" "unprognostic (2.72e-2)" "unprognostic (2.07e-1)" 0.9 2.3 7.3 1.3 17.6 2.6 3.4 15.8 9.9 5.4 2.0 1.1 7.6 2.6 1.8 22.9 1.1 5.7 2.1 2.0 4.2 6.8 4.0 7.2 1.9 1.5 4.4 7.5 1.2 6.3 7.2 42.3 1.0 6.3 4.3 2.6 4.6 5.9 7.3 1.1 0.8 3.8 1.2 2.1 1.7 2.7 4.8 1.4 0.0 8.7 0.2 3.3 1.9 1.1 0.6 11.5 1.4 0.3 0.1 0.5 0.2 12.3 2.6 15.7 6.1 0.4 0.0 0.4 0.1 0.6 2.4 4.6 2.4 3.6 4.7 5.7 0.1 6.5 4.1 1.7 2.5 2.4 1.9 2.9 2.2 0.2 1.3 0.3 2.7 1.6 0.2 8.4 0.6 2.6 1.1 0.0 4.0 0.8 18.1 1.0 4.1 0.3 3.7 3.4 1.6 3.6 0.1 3.7 7.2 3.3 2.1 10.2 4.3 0.4 2.5 6.8 2.9 10.9 4.6 0.5 1.3 4.8 2.8 2.2 4.0 3.5 3.9 5.3 0.6 2.8 0.5 0.3 0.1 0.2 0.2 0.5 0.4 0.4 0.3 0.9 0.6 0.2 0.3 1.4 0.1 0.2 11.5 0.3 0.2 7.3 17.6 15.8 9.9 4.2 6.8 4.4 7.5 6.3 1.4 3.0 2.6 0.0 2.3 0.1 7.9 2.0 5.1 26.8 6.8 3.5 33.4 0.5 6.6 4.5 8.6 0.0 0.0 0.0 3.9 0.2 0.9 2.7 0.0 2.4 2.0 4.8 9.8 0.6 1.0 8.4 1.1 0.0 0.0 0.0 1.9 7.8 2.9 0.0 0.7 4.0 42.0 0.0 1.2 7.4 3.4 0.0 0.0 0.0 0.8 1.0 FBXO2 "Fbg1, Fbs1, FBX2, Nfb42, OCP1" ENSG00000116661 "F-box protein 2" Q9UK22 1 11637018-11655785 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.7;pancreas: 52.5" "Cell type enriched" "Detected in many" 5 "Exocrine glandular cells: 606.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 1.4;T-cells: 3.1" "Cell line enhanced" "Detected in some" "CACO-2: 21.1;HBEC3-KT: 18.5;Hep G2: 44.2;SiHa: 83.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005472 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005472: AB_2667332" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-1)" "unprognostic (8.13e-3)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (1.41e-1)" "unprognostic (5.44e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.45e-6)" "unprognostic (5.26e-2)" "unprognostic (5.21e-2)" "unprognostic (4.82e-2)" "unprognostic (1.64e-1)" 1.7 21.8 49.7 2.6 39.2 1.2 7.9 21.1 48.3 2.1 1.8 13.2 2.1 13.7 1.5 6.4 3.6 3.6 2.9 2.6 33.1 32.6 6.9 11.0 3.0 2.5 40.0 23.0 2.2 52.5 17.7 20.2 1.3 25.7 5.1 1.3 2.7 21.7 7.6 1.3 6.6 4.9 1.7 31.4 2.2 3.8 4.4 24.3 1.1 3.7 0.0 3.8 2.6 2.9 1.4 0.1 0.0 0.0 0.0 3.1 0.6 6.9 2.1 0.0 6.8 0.1 0.0 1.0 0.3 0.6 0.1 0.0 21.1 2.0 0.0 8.7 0.0 1.8 0.0 0.7 18.5 0.0 0.1 0.2 0.0 0.2 44.2 0.9 0.0 0.0 0.6 3.4 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.2 0.0 0.0 0.0 1.6 0.5 0.7 0.9 83.5 0.0 0.8 0.7 4.1 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 3.1 1.4 1.2 2.9 0.1 1.1 1.8 2.6 0.0 0.0 0.0 0.0 0.8 0.6 49.7 39.2 21.1 30.3 33.1 32.6 40.0 23.0 25.7 24.3 0.0 1.0 6.6 52.3 17.4 10.7 2.4 17.8 5.3 5.7 45.4 2.0 0.6 72.9 20.7 1.7 0.6 0.0 0.0 606.0 3.5 2.4 21.4 4.6 87.3 0.4 27.0 1.2 2.5 1.6 1.8 32.2 1.2 42.2 5.4 0.0 65.1 127.3 0.0 38.2 5.8 10.3 0.0 1.9 11.4 10.4 8.7 0.8 12.9 0.0 22.5 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141988-117190531 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 78.4" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 208.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria NA NA Mitochondria "HPA062411: AB_2684755, HPA071452: AB_2686398" "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favorable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 8.1 29.4 17.8 8.8 21.6 5.2 11.4 27.0 28.0 12.6 10.5 18.8 25.5 10.6 16.1 70.1 10.2 78.4 14.2 18.9 17.9 18.4 33.3 17.0 11.2 8.2 13.5 21.4 38.8 19.0 17.3 18.8 12.3 17.5 17.4 9.8 14.0 10.7 19.8 16.3 11.8 9.5 12.8 17.0 11.6 11.8 27.8 14.2 9.9 19.1 6.9 9.3 12.7 10.2 12.8 8.5 3.7 10.5 9.2 13.0 7.1 9.5 22.8 14.4 7.9 11.9 12.4 16.5 12.8 14.0 12.1 9.9 14.7 6.8 12.6 12.7 13.1 9.0 13.1 16.9 12.8 14.6 7.1 15.1 0.6 12.6 11.8 10.8 4.1 4.5 12.2 12.4 9.6 15.5 19.8 16.8 11.2 5.0 4.2 10.3 15.6 11.6 2.9 21.5 14.7 14.9 13.8 20.9 13.2 12.1 22.9 28.6 17.3 32.1 8.5 6.9 12.1 19.9 1.6 12.9 8.1 10.4 9.4 8.3 7.4 7.6 16.5 11.7 6.4 11.2 1.1 5.8 3.7 10.7 10.5 11.2 9.8 11.3 11.1 8.5 12.8 13.0 11.7 0.5 9.2 10.1 5.8 11.4 7.1 17.8 21.6 27.0 28.0 17.9 18.4 13.5 21.4 17.5 14.2 29.8 27.8 27.2 40.8 33.1 41.6 47.8 30.6 36.1 45.5 48.8 39.3 49.4 38.1 52.1 35.4 34.8 15.1 0.0 44.6 30.7 30.8 42.7 3.5 35.9 13.3 69.9 37.5 41.1 21.5 46.7 92.3 14.7 21.9 16.2 24.9 57.0 28.8 17.5 208.9 69.6 32.7 103.5 45.3 20.0 40.5 39.5 54.8 27.7 25.9 40.4 FBXO24 FBX24 ENSG00000106336 "F-box protein 24" O75426 7 100583982-100601117 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 43.3" "Group enriched" "Detected in some" 40 "Early spermatids: 485.7;Late spermatids: 455.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2 OS: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA050951 Enhanced NA NA "HPA050951: AB_2681286" "unprognostic (3.73e-1)" "unprognostic (2.83e-1)" "unprognostic (3.76e-4)" "unprognostic (3.52e-2)" "unprognostic (3.19e-2)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (3.86e-4)" "unprognostic (2.31e-2)" "unprognostic (1.15e-2)" "unprognostic (9.34e-3)" "unprognostic (1.44e-1)" "unprognostic (9.20e-2)" "unprognostic (7.71e-2)" "unprognostic (1.27e-1)" "unprognostic (1.05e-2)" "unprognostic (1.48e-2)" 0.2 0.2 0.2 0.3 0.6 0.2 0.2 0.2 0.5 0.4 0.2 0.3 0.2 0.0 0.6 0.4 0.3 0.4 0.5 0.3 0.2 0.1 0.3 0.2 0.6 0.6 0.5 0.2 1.0 0.2 0.0 0.7 0.3 0.3 0.4 0.0 0.3 1.6 0.2 0.2 0.8 0.3 0.2 1.1 0.4 0.2 43.3 0.3 0.3 0.2 0.2 0.2 0.2 0.4 1.7 2.1 1.7 0.7 0.1 1.8 1.2 1.1 1.0 1.4 1.9 3.9 0.2 0.9 0.9 0.6 0.5 0.4 1.9 3.3 1.7 0.6 0.1 0.5 0.9 0.2 0.4 0.0 0.7 2.3 0.2 0.6 0.1 0.8 0.0 2.9 1.9 1.9 0.0 0.0 0.1 0.6 2.3 0.5 2.5 0.0 2.9 0.5 3.7 2.1 2.6 0.9 0.1 0.1 0.5 0.1 1.2 0.2 2.3 1.7 2.3 1.2 3.2 1.9 0.8 0.0 1.5 5.9 4.6 0.3 1.3 0.6 0.6 0.6 2.0 2.4 0.0 0.5 0.0 0.2 0.7 0.6 1.7 0.5 0.3 1.1 0.6 0.7 1.0 1.7 0.1 0.0 2.1 1.8 1.2 0.2 0.6 0.2 0.5 0.2 0.1 0.5 0.2 0.3 0.3 0.0 0.0 0.0 0.6 0.2 0.4 1.4 0.0 0.0 0.0 0.0 7.9 0.2 0.0 0.4 485.7 0.1 0.0 0.0 0.5 0.4 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 455.7 3.4 0.0 0.0 1.0 0.0 0.8 0.3 0.0 3.5 0.0 1.2 0.0 0.0 11.8 4.2 0.3 0.1 0.0 0.3 0.3 FBXO25 FBX25 ENSG00000147364 "F-box protein 25" Q8TCJ0 8 406428-477967 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.1" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 455.6;Spermatocytes: 335.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 28.0;SK-MEL-30: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.63e-1)" "prognostic favorable (5.38e-5)" "unprognostic (2.74e-2)" "unprognostic (5.11e-3)" "unprognostic (2.48e-1)" "unprognostic (1.25e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-3)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (2.39e-3)" "unprognostic (3.30e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (2.11e-3)" "unprognostic (2.41e-1)" 10.2 15.1 7.1 6.7 9.6 5.4 11.9 9.3 13.3 8.3 12.1 10.8 11.1 9.4 7.4 12.7 8.6 7.5 12.0 13.3 7.1 7.1 12.0 36.9 9.9 7.8 8.6 11.7 7.5 22.2 9.7 12.4 7.3 8.4 19.3 15.1 10.7 12.5 13.2 14.2 9.8 9.0 12.8 9.8 7.5 11.6 57.1 7.9 15.3 15.3 8.1 8.7 10.3 7.1 14.5 8.9 6.0 9.5 8.2 11.4 6.5 6.4 5.2 2.5 4.1 3.7 2.8 9.2 4.8 9.7 5.9 8.7 3.2 5.1 0.2 1.7 8.8 7.9 3.8 5.2 10.9 8.6 4.1 7.8 3.7 3.5 11.6 11.8 4.6 5.6 7.7 19.0 1.9 9.2 8.2 2.2 28.0 4.0 0.0 6.8 5.7 22.3 6.8 1.2 13.0 2.3 1.1 1.6 8.9 8.1 9.8 6.7 7.9 5.3 2.1 26.6 6.5 3.7 4.6 3.6 2.3 1.8 0.4 4.6 4.9 7.6 6.1 6.7 2.6 6.9 1.1 8.6 6.0 8.9 9.5 10.7 14.5 10.6 8.5 8.5 10.6 9.6 9.2 0.8 8.2 8.4 8.9 11.4 6.5 7.1 9.6 9.3 13.3 7.1 7.1 8.6 11.7 8.4 7.9 17.9 22.0 23.1 15.7 30.9 32.2 34.6 35.7 14.7 19.4 33.2 9.8 17.5 61.3 43.2 455.6 32.1 28.9 23.3 88.9 15.9 17.0 38.2 19.7 60.1 22.5 50.9 41.6 23.4 23.2 187.1 35.9 21.6 37.1 42.3 54.2 19.9 62.7 31.7 27.6 38.3 36.5 25.8 15.6 335.6 119.4 35.4 13.5 26.2 33.6 18.9 FBXO32 "ATROGIN1, Fbx32, MAFbx" ENSG00000156804 "F-box protein 32" Q969P5 8 123497889-123541206 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 200.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5" "Group enriched" "Detected in many" 7 "granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6" "Cell line enhanced" "Detected in some" "GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058955, HPA065209" Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA058955: , HPA065209: AB_2685433" "unprognostic (2.55e-1)" "unprognostic (3.62e-1)" "unprognostic (1.80e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (1.23e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.93e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (8.58e-3)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (7.97e-3)" 3.5 1.5 2.4 4.9 5.1 0.8 13.2 1.0 3.8 5.6 31.1 8.9 14.4 2.6 25.3 5.8 8.1 15.8 16.6 26.1 2.9 2.1 1.5 1.0 1.7 4.1 10.2 2.5 9.5 2.0 0.9 5.6 4.9 7.3 19.7 8.0 4.2 8.0 23.1 200.5 3.7 6.5 36.9 8.8 1.7 10.8 3.5 7.6 0.2 9.0 15.1 3.1 24.8 16.1 0.6 0.2 2.9 0.3 4.4 7.6 1.4 1.7 0.3 0.0 0.0 3.8 0.9 0.6 0.3 3.9 0.2 0.4 0.0 1.0 0.0 1.1 2.9 17.4 0.1 0.0 0.3 0.3 59.1 1.3 0.0 2.0 0.0 5.2 0.0 0.2 7.6 2.6 0.9 1.1 20.6 0.2 0.8 0.1 0.5 0.2 0.4 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.5 0.1 0.3 0.4 6.7 6.8 0.4 6.6 0.1 0.2 1.1 0.3 0.3 17.7 6.1 0.8 0.1 4.5 0.0 0.8 2.9 0.3 0.0 3.7 0.2 3.6 0.6 5.1 5.4 0.2 0.6 6.0 7.6 0.2 4.4 0.2 0.1 4.5 1.4 2.4 5.1 1.0 3.8 2.9 2.1 10.2 2.5 7.3 7.6 0.0 3.0 0.9 172.4 10.2 7.9 242.3 2.5 2.7 20.5 7.0 33.4 13.8 8.3 11.6 2.6 7.7 43.7 23.3 26.4 10.2 11.3 165.2 0.0 1.5 4.9 20.6 98.1 0.6 3.2 2.7 36.8 2.9 42.2 1.0 40.8 51.7 39.4 23.2 57.7 3.3 92.8 19.4 73.6 5.4 1.3 5.5 91.3 21.0 19.3 65.2 FBXO33 Fbx33 ENSG00000165355 "F-box protein 33" Q7Z6M2 14 39397669-39432500 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 49.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046657 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA046657: AB_10960398" "unprognostic (8.84e-3)" "unprognostic (6.72e-2)" "unprognostic (3.65e-2)" "unprognostic (2.79e-1)" "unprognostic (1.08e-1)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.94e-4)" "unprognostic (1.24e-1)" "unprognostic (2.70e-2)" "unprognostic (1.17e-1)" "unprognostic (2.40e-1)" "prognostic favorable (4.58e-4)" "unprognostic (9.61e-2)" "unprognostic (4.54e-1)" "unprognostic (4.41e-2)" "unprognostic (8.58e-3)" 8.9 13.3 8.9 8.9 12.1 49.1 8.4 12.3 19.7 10.1 7.0 7.1 10.0 8.2 8.5 12.0 7.5 8.8 8.6 6.1 10.4 11.7 8.5 8.8 9.0 12.8 9.1 11.0 9.4 7.8 18.4 19.0 8.8 9.3 9.1 6.9 9.4 10.8 12.0 4.4 6.7 8.0 7.7 7.2 10.4 8.2 12.8 7.5 16.6 14.9 5.7 10.6 8.6 8.7 2.5 1.6 7.8 2.2 5.5 4.8 1.3 9.7 6.1 5.6 8.6 20.2 9.5 9.3 9.8 13.3 5.5 6.5 3.6 8.7 11.0 12.2 15.3 5.5 5.0 14.4 9.7 10.0 10.5 9.3 4.3 8.9 9.3 5.7 16.4 16.7 8.8 10.5 9.4 3.0 9.6 4.6 11.0 3.8 10.0 10.8 10.4 14.6 10.3 5.7 8.8 9.2 12.7 9.1 9.9 10.5 12.5 9.7 4.4 8.9 9.4 10.7 8.7 6.9 10.6 5.8 9.4 8.4 13.9 7.8 13.6 16.0 17.3 7.2 7.8 6.9 1.6 1.7 3.7 3.4 2.1 3.2 2.5 3.4 3.7 1.6 2.3 4.8 4.5 7.8 5.5 2.2 1.5 3.4 1.3 8.9 12.1 12.3 19.7 10.4 11.7 9.1 11.0 9.3 7.5 8.9 19.0 17.1 12.7 30.7 22.6 5.9 2.5 1.4 5.7 8.7 41.2 7.0 6.6 7.2 32.0 14.3 14.7 0.0 8.2 7.7 16.9 17.3 10.3 9.0 9.3 27.0 23.0 9.8 19.6 8.0 7.8 14.0 18.6 6.4 12.6 12.4 11.0 7.0 4.9 2.7 16.1 0.0 17.9 19.6 10.2 49.3 17.7 17.5 12.4 20.9 FBXO39 "CT144, Fbx39, MGC35179" ENSG00000177294 "F-box protein 39" Q8N4B4 17 6776223-6797101 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "testis: 39.2" "Group enriched" "Detected in some" 148 "Early spermatids: 350.7;Late spermatids: 407.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "gdT-cell: 1.6" "Lineage enriched" "Detected in single" 16 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.5;Karpas-707: 4.7;REH: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (6.73e-2)" "unprognostic (1.69e-2)" "unprognostic (1.78e-2)" "unprognostic (2.15e-2)" "unprognostic (7.19e-2)" "unprognostic (7.93e-2)" "unprognostic (2.89e-1)" "unprognostic (3.30e-2)" "unprognostic (1.18e-1)" "unprognostic (1.72e-3)" "unprognostic (2.36e-1)" "unprognostic (3.73e-9)" "unprognostic (5.11e-2)" "unprognostic (2.67e-1)" "unprognostic (5.93e-2)" "unprognostic (3.79e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.1 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 39.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.4 1.1 0.0 0.0 1.3 0.8 3.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.5 1.3 0.0 0.0 0.0 0.0 1.4 0.0 0.7 0.3 0.0 0.2 0.0 0.0 1.3 1.0 0.0 4.7 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 350.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 407.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 2.1 1.3 0.0 0.0 0.0 0.0 0.0 FBXO40 "Fbx40, KIAA1195" ENSG00000163833 "F-box protein 40" Q9UH90 3 121593119-121630295 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0" "Cell type enriched" "Detected in single" 2762 "Cardiomyocytes: 346.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.5;U-266/70: 3.0;U-266/84: 1.9" "Region enhanced" "Detected in some" "pons and medulla: 1.8" "Low region specificity" "Detected in single" NA NA "unprognostic (1.67e-2)" "unprognostic (1.23e-4)" "unprognostic (9.17e-2)" "unprognostic (6.65e-2)" "unprognostic (2.62e-1)" "unprognostic (1.43e-2)" "unprognostic (1.22e-1)" "unprognostic (7.01e-2)" "unprognostic (2.91e-1)" "unprognostic (2.50e-1)" "unprognostic (3.48e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-1)" "unprognostic (4.30e-2)" 1.0 0.1 0.2 0.0 0.1 0.3 0.1 0.1 1.0 0.1 0.1 0.0 0.0 0.1 0.1 0.6 1.1 0.1 0.1 48.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 1.3 2.3 0.0 58.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.9 38.0 3.9 0.1 0.1 0.5 0.6 2.8 0.8 0.2 0.9 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.6 0.1 0.3 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.3 0.5 0.4 0.0 0.0 0.0 3.0 1.9 0.8 0.2 0.1 0.0 0.2 0.8 0.8 0.9 0.6 0.3 0.2 0.8 0.2 0.2 0.5 0.4 0.6 2.8 0.2 0.4 0.6 0.9 0.1 0.2 0.1 0.1 1.0 0.1 0.1 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FBXO41 "Fbx41, KIAA1940" ENSG00000163013 "F-box protein 41" Q8TF61 2 73254682-73284431 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 10.8;Horizontal cells: 6.4;Intestinal endocrine cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055246, HPA058386" Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA055246: AB_2682758, HPA058386: AB_2683701" "unprognostic (1.15e-3)" "unprognostic (9.36e-2)" "unprognostic (2.17e-2)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.74e-2)" "unprognostic (5.85e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-1)" "unprognostic (7.97e-3)" "unprognostic (7.55e-2)" "unprognostic (9.13e-3)" "unprognostic (4.35e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (3.08e-2)" "unprognostic (1.24e-1)" "unprognostic (1.97e-1)" "unprognostic (1.11e-2)" 1.5 3.6 21.9 5.9 19.3 4.2 2.1 21.7 33.3 1.2 2.1 1.7 0.9 2.2 1.9 3.6 1.6 2.0 2.7 1.1 18.8 10.6 0.8 1.1 2.2 9.4 5.9 17.8 2.5 4.1 9.8 7.3 1.1 6.8 3.0 2.4 0.8 3.7 3.3 0.6 3.4 2.7 2.1 2.1 7.5 2.5 2.4 3.5 2.1 1.5 0.0 9.0 2.8 0.8 0.5 0.9 0.0 2.6 1.1 0.7 0.4 3.6 1.8 0.6 0.0 0.1 0.1 0.8 0.7 0.6 1.2 1.5 4.1 2.1 27.0 0.1 0.1 2.7 3.0 3.8 2.4 1.2 11.2 0.3 8.2 4.1 1.7 0.9 12.4 6.3 1.5 0.9 0.0 0.9 3.3 0.2 7.4 1.6 4.4 1.2 0.9 4.3 11.6 2.7 1.3 1.6 15.2 7.0 13.1 0.8 1.3 9.4 3.5 4.6 2.0 2.9 0.2 2.6 5.2 0.2 4.2 3.7 3.8 0.7 5.3 2.2 12.8 1.1 13.7 1.7 0.0 0.5 0.0 0.6 2.6 0.7 0.5 0.4 0.0 0.9 0.2 0.4 0.4 0.0 1.1 0.1 0.7 0.2 0.4 21.9 19.3 21.7 33.3 18.8 10.6 5.9 17.8 6.8 3.5 0.0 1.1 1.7 0.3 0.2 10.8 1.7 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.2 0.1 0.6 0.7 2.3 0.0 1.7 6.4 11.5 1.3 2.6 0.9 0.3 0.9 1.7 1.8 0.0 0.6 1.0 0.0 0.7 0.0 2.2 0.0 0.5 0.5 1.7 0.3 0.0 1.3 0.4 0.1 FBXO43 Fbx43 ENSG00000156509 "F-box protein 43" Q4G163 8 100133360-100145800 "Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "lymphoid tissue: 17.1;testis: 12.4" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 39.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 4.8;Karpas-707: 5.4;NB-4: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024292, HPA024295, HPA024824" Uncertain NA NA "HPA024292: AB_1848462, HPA024295: AB_1848463, HPA024824: AB_1848464" "unprognostic (4.94e-2)" "unprognostic (4.35e-2)" "unprognostic (2.09e-2)" "unprognostic (4.34e-2)" "unprognostic (5.06e-2)" "unprognostic (3.51e-2)" "unprognostic (1.07e-5)" "unprognostic (4.31e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.84e-2)" "unprognostic (1.46e-1)" "unprognostic (0.00e+0)" "unprognostic (7.97e-2)" "unprognostic (2.52e-2)" "unprognostic (5.91e-2)" "unprognostic (8.09e-2)" 0.1 0.1 0.3 4.9 0.2 0.4 1.3 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.6 0.3 0.2 0.0 0.7 0.3 0.2 0.1 0.2 0.4 0.7 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.7 0.2 0.0 0.3 0.2 0.3 0.8 0.5 0.2 12.4 0.1 17.1 0.1 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.7 1.2 3.9 0.0 0.4 0.0 0.0 1.9 3.4 4.3 0.0 0.3 1.8 0.1 0.5 0.6 0.0 0.0 0.0 4.8 3.9 0.0 1.1 0.5 0.4 0.0 0.5 0.7 0.0 0.2 1.7 1.5 0.0 0.9 1.5 0.0 5.4 1.7 0.0 0.6 4.5 0.3 0.5 0.7 3.7 0.0 0.7 1.7 0.0 0.5 0.0 0.0 0.0 1.7 0.2 0.1 0.9 0.0 0.0 0.0 0.7 0.0 0.8 1.0 1.4 1.4 3.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.6 0.1 3.0 2.6 0.0 0.5 0.8 1.3 0.3 0.0 1.4 5.7 0.0 0.0 0.3 0.0 0.0 8.8 0.1 0.0 0.0 0.3 0.2 0.9 0.2 1.1 0.0 0.4 0.0 1.2 0.0 0.8 5.6 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.7 0.0 0.3 39.9 4.4 0.4 0.2 1.0 0.1 0.1 FBXO44 "FBG3, FBX30, Fbx44, Fbxo6a, MGC14140" ENSG00000132879 "F-box protein 44" Q9H4M3 1 11654375-11663327 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 61.7" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003363 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003363: AB_1078831" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (9.59e-2)" "unprognostic (5.34e-2)" "unprognostic (2.82e-1)" "unprognostic (2.97e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-2)" "unprognostic (3.32e-1)" "unprognostic (1.93e-1)" "prognostic favorable (2.63e-4)" "unprognostic (2.57e-2)" "prognostic favorable (6.29e-5)" "unprognostic (1.34e-2)" "unprognostic (5.45e-1)" "unprognostic (1.77e-1)" "unprognostic (3.02e-3)" 6.6 21.1 26.6 8.3 39.0 5.3 7.0 61.7 45.0 6.5 5.0 12.3 8.9 14.2 8.5 10.3 7.7 12.1 10.5 13.7 28.7 26.4 12.2 7.7 8.1 16.3 20.7 27.4 11.3 17.8 21.7 19.5 2.4 23.1 13.7 3.4 9.9 25.5 15.4 6.4 22.1 7.8 6.2 14.2 13.4 8.1 8.5 15.3 3.2 13.0 3.3 9.9 7.4 7.5 10.9 5.1 1.5 2.5 1.5 11.7 6.1 7.5 12.2 4.5 17.2 6.7 7.0 6.1 6.1 7.4 6.7 5.8 8.9 14.3 0.2 13.6 6.7 11.2 1.9 9.0 20.3 2.8 8.6 11.0 0.2 6.6 14.8 9.3 0.2 1.1 9.0 13.5 6.3 4.8 13.9 5.2 14.1 4.6 1.9 1.7 4.7 12.6 1.4 4.7 6.8 8.7 5.1 0.2 2.5 10.8 2.7 13.7 11.3 16.0 6.2 27.0 5.8 11.1 6.9 6.4 4.9 11.9 6.5 4.8 12.7 7.1 4.6 11.3 3.2 11.6 1.1 2.1 0.6 11.7 2.4 9.0 10.0 8.0 8.9 3.3 10.9 10.9 7.5 1.5 1.5 2.5 5.1 7.1 6.1 26.6 39.0 61.7 45.0 28.7 26.4 20.7 27.4 23.1 15.3 0.0 9.0 9.1 10.8 16.4 20.1 3.6 5.1 2.7 5.7 15.7 13.7 1.3 26.6 8.0 3.6 3.8 0.8 0.0 5.7 2.4 10.1 9.3 3.5 3.9 5.1 38.1 4.1 5.5 6.2 9.9 21.3 5.0 10.1 5.4 2.0 14.8 6.5 1.1 27.3 9.1 6.8 0.0 6.6 11.1 7.2 14.9 0.7 20.0 2.1 4.7 FBXO47 ENSG00000204952 "F-box protein 47" Q5MNV8 17 38936432-38967402 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "testis: 12.2;vagina: 3.5" "Cell type enhanced" "Detected in some" 32 "Sertoli cells: 6.5;Spermatocytes: 26.2;Spermatogonia: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;Daudi: 1.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA057438 Uncertain NA NA "HPA057438: AB_2683441" "unprognostic (1.53e-1)" "unprognostic (2.98e-1)" "unprognostic (2.82e-1)" "unprognostic (3.92e-1)" "unprognostic (6.04e-2)" "unprognostic (2.59e-2)" "unprognostic (2.29e-2)" "unprognostic (6.85e-2)" "unprognostic (4.15e-1)" 0.1 0.1 0.1 0.0 0.5 0.0 1.9 0.7 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.3 0.1 0.1 0.0 0.4 0.1 1.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 1.2 0.1 0.1 12.2 0.7 0.0 0.1 0.0 0.0 0.1 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.4 0.0 0.1 0.1 0.0 1.2 1.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.7 0.4 0.1 0.1 1.0 0.3 1.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 26.2 6.8 0.0 0.0 0.0 0.0 0.1 FBXO5 "EMI1, FBX5, Fbxo31" ENSG00000112029 "F-box protein 5" Q9UKT4 6 152970519-152983579 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "bone marrow: 29.3;lymphoid tissue: 69.0" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 70.0;Spermatogonia: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008106, HPA029048" Approved Supported Nucleoplasm NA Yes Nucleoplasm "CAB008106: AB_828450, HPA029048: AB_10602132" "unprognostic (1.22e-2)" "unprognostic (7.21e-2)" "unprognostic (4.61e-3)" "unprognostic (1.24e-2)" "unprognostic (5.92e-2)" "unprognostic (2.94e-2)" "unprognostic (2.43e-8)" "unprognostic (2.46e-2)" "unprognostic (1.55e-2)" "unprognostic (7.32e-2)" "unprognostic (2.89e-1)" "unprognostic (5.86e-2)" "unprognostic (1.25e-9)" "prognostic favorable (8.65e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-1)" 4.2 2.9 2.7 13.7 3.1 29.3 3.5 6.6 3.3 5.3 6.1 1.8 1.8 3.5 5.8 3.7 6.1 4.4 3.0 2.4 2.8 2.3 3.0 4.1 3.8 10.8 4.4 1.6 5.1 3.1 2.0 3.4 8.2 3.5 3.9 4.1 1.6 6.9 2.4 1.6 3.3 5.0 3.9 2.4 10.6 3.5 4.2 3.9 69.0 5.6 4.8 11.2 3.5 4.5 6.8 5.3 0.0 3.5 8.8 7.9 3.2 11.1 5.8 24.6 16.5 1.9 3.9 7.8 27.2 12.2 20.5 23.1 11.9 6.7 27.4 8.4 7.2 13.8 10.7 19.4 9.1 24.7 14.6 17.3 27.4 8.6 12.9 3.6 24.5 17.0 2.7 1.7 13.8 10.9 5.0 9.3 14.4 28.9 25.8 18.6 8.5 27.9 15.8 14.3 8.6 8.6 23.6 19.7 17.7 7.2 6.1 16.1 16.7 19.3 10.4 5.1 9.0 7.5 23.0 7.0 15.4 20.1 17.7 31.7 8.6 9.5 40.5 11.2 18.2 18.6 0.0 2.4 0.0 3.8 3.0 5.4 6.8 6.3 6.9 4.6 6.0 6.2 6.4 0.0 8.8 3.5 5.3 7.9 3.2 2.7 3.1 6.6 3.3 2.8 2.3 4.4 1.6 3.5 3.9 0.0 0.6 13.7 3.5 8.9 2.8 1.4 2.5 2.7 5.7 1.8 5.9 6.7 3.3 2.7 0.5 4.5 1.0 70.0 1.4 24.6 7.2 2.7 2.3 1.7 6.5 1.6 4.6 6.2 1.0 0.0 4.0 4.8 1.7 2.8 2.7 4.0 1.3 0.0 5.6 2.9 3.0 12.9 6.6 8.8 32.4 4.5 4.9 7.0 4.3 1.7 FBXW10 "C17orf1, C17orf1A, Fbw10, HREP, SM2SH2" ENSG00000171931 "F-box and WD repeat domain containing 10" Q5XX13 17 18744024-18779349 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 15.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 8.1;Early spermatids: 30.2;Late spermatids: 8.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.8;ASC diff: 2.1;CAPAN-2: 3.1;HaCaT: 4.3;HeLa: 3.4" HPA047457 Approved Nucleoplasm NA NA Nucleoplasm "HPA047457: " "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "unprognostic (9.59e-2)" "unprognostic (7.47e-2)" "unprognostic (4.54e-1)" "unprognostic (5.08e-2)" "unprognostic (6.67e-2)" "unprognostic (3.89e-1)" "unprognostic (2.30e-1)" "unprognostic (6.30e-2)" "unprognostic (5.65e-2)" "unprognostic (3.49e-2)" "unprognostic (2.20e-7)" "unprognostic (3.16e-1)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (1.05e-1)" 0.1 0.7 0.1 0.1 0.7 0.0 0.1 1.9 0.6 0.6 0.1 0.1 0.1 0.4 0.1 2.1 0.2 0.8 0.4 0.1 0.6 0.3 0.2 1.1 0.3 0.1 0.1 0.8 0.1 0.1 0.1 0.4 0.1 1.6 0.1 0.0 0.4 0.3 0.2 0.8 0.1 0.4 0.1 0.1 0.1 0.3 15.9 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 5.8 0.0 0.1 2.1 1.3 0.1 0.0 0.2 0.0 0.3 0.1 3.1 0.1 0.1 0.4 0.2 4.3 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.9 0.6 0.6 0.3 0.1 0.8 1.6 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.4 0.1 0.0 0.0 0.0 0.1 FBXW12 "Fbw12, FBXO35" ENSG00000164049 "F-box and WD repeat domain containing 12" Q6X9E4 3 48372219-48401259 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "pancreas: 12.4" "Group enriched" "Detected in some" 10 "Early spermatids: 8.6;Late spermatids: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5" "HPA037491, HPA037492" Uncertain NA NA "HPA037491: AB_2675504, HPA037492: AB_2675505" "unprognostic (5.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-2)" "unprognostic (8.56e-2)" "unprognostic (2.17e-1)" "unprognostic (9.48e-2)" "unprognostic (2.95e-1)" "unprognostic (1.21e-3)" "unprognostic (6.96e-3)" "unprognostic (2.36e-1)" "unprognostic (6.29e-3)" "unprognostic (1.43e-1)" "unprognostic (1.29e-1)" "unprognostic (8.81e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 12.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 1.0 0.0 0.2 0.0 0.2 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 FBXW7 "AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10" ENSG00000109670 "F-box and WD repeat domain containing 7" Q969H0 4 152320544-152536063 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.1;skin 1: 45.0" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 179.3;Suprabasal keratinocytes: 152.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013793, CAB029987" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB013793: AB_2533451, CAB029987: AB_2246842" "unprognostic (3.32e-1)" "unprognostic (9.02e-2)" "unprognostic (1.84e-2)" "unprognostic (3.08e-2)" "unprognostic (3.87e-1)" "unprognostic (1.36e-3)" "unprognostic (4.37e-1)" "unprognostic (1.94e-1)" "unprognostic (8.28e-2)" "unprognostic (3.29e-1)" "unprognostic (5.32e-3)" "unprognostic (3.19e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (3.38e-2)" "unprognostic (1.41e-1)" "unprognostic (5.49e-3)" "unprognostic (2.17e-3)" 9.2 6.8 27.0 8.9 27.9 11.1 9.8 27.2 60.1 5.5 6.1 3.6 3.8 4.9 6.0 18.3 9.8 10.6 6.3 10.9 21.4 10.1 4.1 7.3 6.9 9.8 9.1 40.5 6.4 8.0 6.4 7.3 6.2 37.2 5.1 6.9 2.8 7.6 5.3 15.8 45.0 6.5 6.1 6.4 10.1 8.0 13.7 5.7 6.5 6.8 10.6 12.3 7.9 6.5 2.9 2.2 16.6 3.4 7.8 5.0 1.3 4.9 4.0 10.3 7.5 7.2 5.2 8.6 7.2 6.6 4.5 4.2 8.0 6.4 12.9 2.0 6.9 3.4 3.0 8.9 16.2 6.3 7.3 4.2 6.0 4.9 5.7 7.3 14.6 5.5 8.2 25.8 7.7 13.1 4.7 7.8 10.5 9.4 13.8 5.6 7.0 16.8 5.8 5.0 4.2 3.2 16.9 4.4 2.5 5.5 8.6 6.6 5.7 4.6 6.3 3.9 12.2 3.4 6.9 8.2 6.1 6.9 3.1 4.0 38.0 21.7 12.6 4.9 4.8 4.3 16.6 3.1 1.7 5.0 3.4 3.3 2.9 3.7 3.2 1.8 2.4 3.9 3.2 5.5 7.8 2.5 2.2 3.3 1.3 27.0 27.9 27.2 60.1 21.4 10.1 9.1 40.5 37.2 5.7 8.9 18.5 27.6 32.1 179.3 67.8 54.1 7.6 8.1 13.6 8.7 29.5 9.7 3.3 11.6 13.1 26.4 13.5 0.0 11.7 33.1 24.6 28.4 15.1 15.6 9.4 11.1 13.9 17.8 16.2 7.4 14.1 20.2 27.0 16.2 11.7 30.1 15.8 15.8 10.6 6.0 40.5 12.9 25.6 57.9 80.3 152.9 26.1 34.6 11.3 48.9 FCAMR "CD351, FCA/MR, FKSG87" ENSG00000162897 "Fc fragment of IgA and IgM receptor" Q8WWV6 1 206957965-206970625 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 26.5" "Cancer enhanced" "Detected in some" "renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;HMC-1: 1.0" HPA056505 Enhanced NA NA 3600000 "HPA056505: AB_2732604" "unprognostic (2.94e-1)" "unprognostic (1.06e-1)" "unprognostic (8.53e-2)" "unprognostic (2.92e-1)" "unprognostic (7.44e-2)" "unprognostic (4.55e-3)" "unprognostic (2.69e-3)" "unprognostic (1.08e-4)" "unprognostic (3.61e-2)" "unprognostic (1.25e-1)" "unprognostic (1.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.08e-1)" "unprognostic (1.26e-1)" 0.1 0.1 0.1 23.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 23.9 7.6 0.1 8.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.4 0.1 0.1 0.1 1.0 0.1 0.5 0.6 0.1 0.2 0.1 0.2 0.2 0.1 9.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.9 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.1 0.3 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 FCAR CD89 ENSG00000186431 "Fc fragment of IgA receptor" P24071 19 54874248-54890472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "IgA-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 3.7;Cardiomyocytes: 1.4;Ciliated cells: 1.4;Kupffer cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.6;neutrophil: 6.1" "Group enriched" "Detected in many" 44 "granulocytes: 6.1;monocytes: 2.6" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Low region specificity" "Detected in all" HPA014050 Approved Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA014050: AB_1846338" "unprognostic (1.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.30e-1)" "unprognostic (4.71e-3)" "unprognostic (3.46e-1)" "unprognostic (2.02e-1)" "unprognostic (7.99e-2)" "unprognostic (1.54e-2)" "unprognostic (1.59e-2)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.19e-6)" "unprognostic (9.23e-2)" "unprognostic (8.10e-3)" "unprognostic (8.04e-3)" "unprognostic (9.81e-2)" 4.0 0.6 0.4 1.5 4.4 28.1 0.8 0.1 1.0 0.6 0.6 0.7 0.0 0.6 0.6 0.6 0.6 3.8 0.6 8.2 2.0 0.4 0.6 1.8 19.5 15.9 1.2 0.0 2.2 0.6 0.6 0.3 1.5 4.3 0.6 0.6 0.9 0.6 0.6 0.6 0.6 0.6 0.7 2.7 14.9 0.9 2.1 0.0 1.0 0.6 0.3 0.6 4.4 4.8 0.0 0.0 6.1 2.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.7 0.4 4.4 0.1 1.0 2.0 0.4 1.2 0.0 4.3 0.0 0.0 3.7 0.0 0.2 0.1 0.1 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.0 1.0 0.0 0.0 0.0 5.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 FCER1A FCE1A ENSG00000179639 "Fc fragment of IgE receptor Ia" P12319 1 159289714-159308224 "FDA approved drug targets, Predicted membrane proteins" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "blood: 494.6" "Group enriched" "Detected in some" 4 "granulocytes: 258.2;Macrophages: 206.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 494.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 494.6" "Cell line enriched" "Detected in some" 94 "HEL: 100.1" "Low region specificity" "Detected in all" "CAB022102, HPA036051, CAB055526" Approved NA NA "CAB022102: , CAB055526: , HPA036051: AB_2674919" "unprognostic (1.78e-2)" "unprognostic (2.26e-2)" "unprognostic (7.32e-2)" "unprognostic (7.51e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-3)" "unprognostic (7.19e-2)" "unprognostic (1.97e-3)" "unprognostic (2.44e-1)" "unprognostic (7.20e-2)" "unprognostic (8.54e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.20e-4)" "unprognostic (1.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.70e-1)" "unprognostic (3.39e-2)" 5.8 1.4 1.6 3.6 0.8 6.0 9.2 0.9 1.3 8.0 3.4 1.1 3.4 3.2 10.6 5.6 12.1 2.0 25.4 4.1 4.3 1.3 3.6 2.4 27.8 0.6 1.0 5.3 1.5 2.6 0.5 1.9 0.5 2.7 9.4 5.4 6.5 5.9 4.7 1.2 17.9 4.1 6.0 2.8 3.5 2.3 1.5 6.8 2.4 2.5 19.7 16.2 3.8 4.9 0.0 75.4 494.6 0.3 0.4 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 494.6 0.3 0.9 0.0 0.1 0.1 0.0 0.1 0.0 75.4 0.0 0.0 0.1 0.4 0.4 0.2 10.4 0.0 3.0 1.6 0.8 0.9 1.3 4.3 1.3 1.0 5.3 2.7 6.8 6.0 53.5 20.1 0.0 33.5 0.0 0.2 0.0 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 7.2 0.0 258.2 0.0 6.6 0.0 0.0 0.0 2.5 0.6 0.0 206.7 43.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.6 0.0 0.2 29.7 0.0 0.0 0.0 0.0 FCER1G ENSG00000158869 "Fc fragment of IgE receptor Ig" P30273 1 161215234-161220699 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 262.7;lymphoid tissue: 176.3" "Group enriched" "Detected in many" 6 "granulocytes: 677.9;Hofbauer cells: 2071.1;Kupffer cells: 1979.2;Macrophages: 2000.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 262.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 17.5;HMC-1: 71.6;THP-1: 63.0;U-266/84: 19.4;U-937: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022108, HPA026872" Supported NA NA 9800000 "CAB022108: , HPA026872: AB_1848473" "unprognostic (3.71e-2)" "unprognostic (2.52e-2)" "unprognostic (2.40e-2)" "unprognostic (8.73e-3)" "unprognostic (1.46e-1)" "unprognostic (4.28e-2)" "unprognostic (3.10e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-1)" "unprognostic (9.63e-2)" "unprognostic (2.28e-2)" "unprognostic (5.67e-2)" "prognostic unfavorable (1.83e-6)" "unprognostic (1.99e-1)" "unprognostic (6.28e-2)" "unprognostic (2.04e-2)" "unprognostic (7.87e-2)" 62.6 20.5 12.1 49.5 22.4 71.5 17.6 2.4 10.8 10.6 14.6 14.1 1.3 8.0 7.2 15.9 6.9 20.5 18.8 21.2 15.3 11.2 18.9 35.9 71.2 124.8 23.4 4.5 11.4 7.4 2.9 7.9 38.1 17.0 9.7 21.3 9.7 12.8 7.4 11.9 5.7 13.6 28.5 33.3 176.3 10.9 11.6 16.0 6.5 11.5 6.7 14.7 22.4 10.5 0.9 135.4 73.5 262.7 66.6 2.0 132.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 17.5 0.1 3.3 0.0 3.6 71.6 1.4 0.7 0.5 0.0 0.1 0.1 0.4 0.0 1.7 0.5 0.1 0.3 8.5 0.3 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.6 0.3 0.0 63.0 0.1 0.4 0.1 0.2 0.2 0.7 19.4 0.2 0.4 19.7 0.1 64.3 129.8 12.1 0.5 210.3 0.6 0.9 0.4 0.4 97.1 0.3 0.7 2.0 73.5 66.6 262.7 135.4 0.8 132.1 12.1 22.4 2.4 10.8 15.3 11.2 23.4 4.5 17.0 16.0 80.4 219.7 81.8 1.4 35.1 0.0 4.0 20.4 28.1 50.0 17.4 0.0 11.9 0.0 0.5 1.4 15.7 0.6 46.7 0.8 13.5 26.5 1.8 677.9 7.6 2071.1 0.0 1.7 49.7 1979.2 4.7 4.9 2000.4 75.9 55.9 0.0 0.2 0.7 0.9 1.1 3.9 2.6 71.1 23.6 0.9 2.6 31.5 19.8 270.2 0.2 1.6 FCER2 "CD23, CD23A, CLEC4J, FCE2" ENSG00000104921 "Fc fragment of IgE receptor II" P06734 19 7688758-7702146 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgE-binding protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 87.2;lymphoid tissue: 38.4" "Cell type enriched" "Detected in some" 57 "B-cells: 110.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "memory B-cell: 28.2;naive B-cell: 87.2" "Lineage enriched" "Detected in many" 34 "B-cells: 87.2" "Cell line enriched" "Detected in some" 14 "HDLM-2: 99.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002624, HPA008928, HPA067430" Enhanced "Secreted to blood" NA NA 59000 "CAB002624: , HPA008928: AB_1846285, HPA067430: " "unprognostic (3.20e-4)" "unprognostic (1.87e-3)" "unprognostic (1.95e-2)" "unprognostic (2.44e-2)" "unprognostic (4.77e-2)" "unprognostic (1.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.89e-3)" "unprognostic (2.71e-1)" "unprognostic (1.88e-1)" "unprognostic (2.04e-2)" "unprognostic (8.55e-2)" "unprognostic (2.46e-4)" "unprognostic (2.99e-1)" "unprognostic (1.80e-1)" "unprognostic (4.89e-2)" "unprognostic (5.17e-2)" 2.4 0.3 0.5 17.1 0.5 2.3 1.2 0.3 1.1 0.3 1.0 0.1 0.4 1.3 0.3 2.3 1.0 0.4 0.5 0.8 0.3 0.3 0.6 0.6 0.8 21.1 0.3 0.0 0.4 0.3 0.0 0.3 0.3 0.1 0.3 0.8 0.0 7.5 0.7 0.4 0.6 7.7 0.4 0.3 38.4 0.8 0.5 0.0 6.3 0.7 0.0 33.8 2.0 0.5 87.2 0.7 0.2 2.5 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.5 0.0 0.0 2.5 0.0 28.2 0.0 0.0 0.7 87.2 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.0 0.5 0.5 0.3 0.3 0.3 0.3 0.3 0.0 0.1 0.0 0.0 1.1 110.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.3 0.6 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FCGBP FC(GAMMA)BP ENSG00000275395 "Fc fragment of IgG binding protein" 19 39863323-39934626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9" "Cell type enriched" "Detected in many" 10 "Mucus-secreting cells: 4433.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 9.8;JURKAT: 3.3;RH-30: 11.0;RPMI-8226: 3.8;U-266/70: 3.6" "Not detected" "Not detected" "HPA003517, HPA003564" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytokinetic bridge" NA NA "Plasma membrane" "Golgi apparatus, Cytokinetic bridge" "HPA003517: AB_1078838, HPA003564: AB_2231648" "unprognostic (1.65e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-3)" "unprognostic (1.77e-2)" "unprognostic (2.04e-2)" "prognostic favorable (1.28e-5)" "prognostic unfavorable (4.74e-5)" "unprognostic (1.36e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (9.70e-6)" "unprognostic (9.44e-2)" "unprognostic (3.03e-2)" "unprognostic (5.92e-3)" "unprognostic (8.60e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.08e-1)" 1.7 0.6 1.7 5.9 1.8 0.0 2.7 0.2 1.6 13.9 43.3 0.8 0.7 15.2 0.2 0.4 0.2 0.0 46.6 0.7 0.6 0.6 0.2 0.6 0.2 0.9 0.6 0.6 0.2 0.0 1.2 1.5 1.1 0.4 16.7 0.3 1.3 1.2 0.2 2.8 16.9 0.2 2.1 0.2 17.0 0.4 0.9 0.5 20.9 0.2 0.5 0.2 0.2 0.6 2.3 0.0 0.9 1.3 3.2 0.6 0.0 9.8 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.3 0.1 0.3 1.0 0.2 0.0 0.0 0.0 0.0 3.3 0.1 0.4 0.0 0.4 2.8 1.2 0.3 3.2 0.7 0.2 11.0 3.8 0.2 1.3 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.6 0.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.9 0.3 0.0 0.7 1.4 2.3 0.6 0.9 3.2 0.0 1.3 0.5 0.0 0.2 0.6 3.0 3.2 2.7 0.7 3.3 1.2 3.1 114.7 5.3 21.6 24.4 0.0 0.6 0.0 3.5 6.2 0.7 445.8 0.0 0.8 0.2 1.1 18.9 16.1 0.8 33.7 0.0 77.9 0.6 21.7 7.1 0.9 10.0 8.5 0.0 4433.7 0.0 2.4 241.9 0.0 1.3 1.0 58.2 0.4 0.7 2.4 5.9 0.3 2.9 169.3 4.7 FCGR1A "CD64, CD64A" ENSG00000150337 "Fc fragment of IgG receptor Ia" P12314 1 149782671-149792518 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Innate immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.6;epididymis: 33.2" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 235.7;Kupffer cells: 121.8;Late spermatids: 48.6;Macrophages: 101.0" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Group enriched" "Detected in some" 7 "classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5" "Group enriched" "Detected in many" 80 "dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6" "Cell line enriched" "Detected in some" 5 "THP-1: 61.0" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (5.27e-2)" "unprognostic (2.89e-2)" "unprognostic (2.34e-2)" "unprognostic (7.97e-2)" "unprognostic (8.44e-3)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.98e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (4.83e-8)" "unprognostic (1.28e-1)" "unprognostic (4.51e-2)" "unprognostic (9.99e-2)" "unprognostic (9.03e-2)" 3.9 2.4 6.7 14.1 4.4 5.0 0.7 0.3 3.5 1.1 0.3 0.0 0.1 33.2 0.3 0.7 2.4 0.7 5.3 4.9 1.0 1.1 8.9 3.4 10.1 0.3 1.0 0.5 1.2 10.8 0.4 0.3 0.7 0.2 0.0 0.0 0.1 5.5 14.3 7.0 0.3 0.9 0.3 0.0 3.3 0.0 0.2 9.5 25.5 35.6 0.0 0.2 11.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.5 35.6 0.4 0.0 14.0 0.2 0.2 0.0 0.1 9.5 0.0 0.0 0.0 25.5 0.0 2.8 0.2 0.1 11.2 0.0 1.9 3.5 0.0 0.1 1.5 1.2 2.5 1.4 2.3 0.0 2.0 2.1 0.0 0.0 28.2 0.1 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 235.7 0.0 0.0 1.3 121.8 48.6 0.3 101.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 6.5 0.0 0.7 0.4 0.0 3.4 0.0 0.0 0.0 FCGR1B CD64b ENSG00000198019 "Fc fragment of IgG receptor Ib" Q92637 1 121087345-121096310 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8;epididymis: 36.9" "Group enriched" "Detected in some" 5 "Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4" "Cancer enhanced" "Detected in single" "glioma: 1.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 19.2;neutrophil: 21.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "NB-4: 10.7;THP-1: 40.9" HPA026910 Uncertain "Golgi apparatus,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA026910: " "unprognostic (3.21e-2)" "unprognostic (4.35e-2)" "unprognostic (1.13e-2)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (9.60e-2)" "unprognostic (1.56e-2)" "unprognostic (6.42e-2)" "unprognostic (3.10e-2)" "unprognostic (8.17e-2)" "unprognostic (1.91e-1)" "unprognostic (3.65e-1)" "unprognostic (3.24e-10)" "unprognostic (8.99e-2)" "unprognostic (2.85e-2)" "unprognostic (7.86e-3)" "unprognostic (8.93e-2)" 4.2 2.3 6.6 13.2 6.2 3.9 1.3 0.8 3.2 0.8 0.5 3.0 0.2 0.5 0.9 36.9 0.5 0.8 1.5 7.4 5.0 4.2 1.0 1.1 4.8 7.9 8.9 0.2 1.1 1.9 0.4 1.5 8.1 6.4 0.6 0.6 0.4 1.3 0.5 0.2 0.0 0.4 4.2 11.3 6.8 0.5 0.5 6.2 0.4 1.8 0.2 0.4 1.5 0.2 0.0 5.2 21.8 19.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 19.2 0.2 0.0 11.3 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 21.8 0.0 6.2 0.1 0.0 5.3 6.6 6.2 0.8 3.0 5.0 4.2 8.9 0.2 6.4 6.2 0.0 1.3 0.8 0.0 0.0 0.8 2.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 68.7 3.2 0.0 0.0 38.3 8.2 1.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.4 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 FCGR2A "CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2" ENSG00000143226 "Fc fragment of IgG receptor IIa" P12318 1 161505430-161524013 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 182.8" "Cell type enhanced" "Detected in many" 17 "Hofbauer cells: 145.9;Kupffer cells: 155.0;Macrophages: 311.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 182.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 182.8" "Cell line enhanced" "Detected in some" "HEL: 14.3;HMC-1: 28.9;K-562: 8.4;NB-4: 8.1;THP-1: 30.7;U-937: 13.2" "HPA010718, HPA010776, HPA014730" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA 55000000 "Plasma membrane" "Golgi apparatus" "HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074" "unprognostic (2.57e-2)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (4.12e-2)" "unprognostic (5.89e-2)" "unprognostic (6.17e-2)" "unprognostic (1.24e-2)" "unprognostic (1.17e-1)" "unprognostic (7.63e-2)" "unprognostic (1.17e-3)" "unprognostic (2.43e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (6.49e-7)" "unprognostic (8.85e-3)" "unprognostic (6.47e-3)" "unprognostic (1.54e-1)" "unprognostic (3.42e-2)" 36.8 12.6 13.2 44.6 19.2 18.6 8.2 2.2 10.1 9.1 7.1 10.0 0.0 3.8 4.7 6.6 5.5 11.6 17.0 11.3 17.0 8.9 11.5 7.1 44.1 50.0 25.9 1.7 8.0 5.8 2.8 6.1 47.5 19.6 7.0 9.9 10.8 8.3 4.8 7.3 3.0 7.3 17.6 30.9 43.4 5.9 4.8 19.2 3.2 6.3 2.5 4.4 19.3 4.5 0.2 7.0 182.8 27.2 0.0 0.0 10.6 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.2 0.0 0.3 4.1 28.9 0.3 0.0 0.0 0.0 0.4 0.0 0.0 8.4 0.2 0.0 0.0 0.2 8.1 0.0 0.0 0.6 0.1 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 30.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 13.2 3.6 0.1 27.2 31.6 0.0 20.7 0.0 0.2 0.0 0.0 7.0 0.1 0.0 0.0 182.8 0.0 16.7 0.2 0.0 10.6 13.2 19.2 2.2 10.1 17.0 8.9 25.9 1.7 19.6 19.2 20.8 63.3 13.7 0.4 7.7 0.0 1.2 5.1 6.7 21.6 0.0 0.0 0.8 8.3 0.2 37.5 2.6 0.0 0.0 0.5 1.1 5.8 0.3 29.0 0.8 145.9 0.0 0.0 4.3 155.0 35.2 1.4 311.2 16.9 1.8 0.0 0.3 0.7 0.0 0.0 7.9 0.1 6.5 5.8 0.3 0.4 6.8 1.4 4.1 0.0 0.3 FCGR2B "CD32, CD32B, FCG2, FCGR2" ENSG00000072694 "Fc fragment of IgG receptor IIb" P31994 1 161663147-161678654 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Host-virus interaction" "IgG-binding protein, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 53.3;placenta: 83.2" "Group enriched" "Detected in many" 5 "Ito cells: 479.4;Macrophages: 138.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 53.3;memory B-cell: 42.2" "Group enriched" "Detected in many" 18 "B-cells: 42.2;dendritic cells: 14.5;granulocytes: 53.3" "Cell line enhanced" "Detected in some" "Daudi: 18.7;HMC-1: 23.5;NB-4: 5.2;RPMI-8226: 8.4" "CAB007796, HPA014730" Enhanced NA NA "CAB007796: AB_562288, HPA014730: AB_2669074" "unprognostic (1.58e-1)" "unprognostic (5.14e-2)" "unprognostic (3.32e-3)" "unprognostic (3.12e-2)" "unprognostic (6.79e-3)" "unprognostic (4.05e-3)" "unprognostic (1.27e-1)" "unprognostic (4.65e-3)" "unprognostic (1.91e-1)" "unprognostic (4.72e-2)" "unprognostic (2.89e-2)" "unprognostic (3.49e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (3.51e-2)" "unprognostic (6.36e-2)" "unprognostic (4.31e-1)" "unprognostic (3.37e-1)" 11.3 2.4 0.0 2.0 0.2 0.0 4.1 0.0 0.0 1.9 3.4 0.2 0.9 0.2 2.1 2.1 2.3 3.7 0.0 0.2 2.0 9.5 5.6 2.5 0.5 0.8 0.6 0.0 0.3 83.2 0.3 2.0 3.3 0.2 0.5 2.0 4.6 3.1 4.7 6.7 1.5 0.1 1.7 5.6 3.3 1.2 42.2 14.5 53.3 1.9 0.1 0.3 2.4 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.2 0.0 53.3 1.8 5.4 0.3 1.9 0.1 42.2 0.1 0.2 14.5 34.3 0.0 0.3 11.2 0.1 1.7 0.0 0.0 2.4 0.0 4.6 57.3 0.0 4.7 0.0 1.9 5.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 4.2 1.4 0.0 23.3 0.0 0.2 2.7 0.0 2.3 2.5 7.6 0.0 0.0 479.4 63.3 2.3 0.6 138.2 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.2 2.8 0.3 4.9 0.0 0.0 FCGR3A "CD16, CD16a, FCG3, FCGR3" ENSG00000203747 "Fc fragment of IgG receptor IIIa" P08637 1 161541759-161550737 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 223.6;lymphoid tissue: 60.8" "Cell type enhanced" "Detected in many" 22 "Hofbauer cells: 191.4;Kupffer cells: 556.1;Macrophages: 266.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 109.4;non-classical monocyte: 223.6" "Group enriched" "Detected in many" 4 "granulocytes: 73.0;monocytes: 223.6" "Cell line enhanced" "Detected in some" "BEWO: 1.0;HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.8" "CAB032435, HPA055431" Supported "Secreted to blood" NA NA 2500000000 "CAB032435: AB_626925, HPA055431: AB_2682815" "unprognostic (5.27e-2)" "unprognostic (9.95e-2)" "unprognostic (2.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.39e-1)" "unprognostic (1.82e-1)" "unprognostic (2.24e-2)" "unprognostic (6.06e-2)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (1.98e-2)" "unprognostic (7.52e-2)" "prognostic unfavorable (3.22e-6)" "unprognostic (1.14e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" "unprognostic (7.51e-2)" 11.9 9.7 7.5 20.5 12.4 4.4 4.1 1.6 7.0 1.9 2.1 5.5 0.8 0.8 1.1 2.4 1.0 2.4 5.1 6.4 6.3 7.3 2.6 22.5 43.2 8.0 12.7 1.9 1.4 2.9 1.8 3.9 14.6 6.8 2.6 2.3 2.2 2.7 1.3 1.3 0.3 1.2 14.3 25.7 60.8 1.3 1.2 8.0 1.4 1.8 1.3 1.3 6.3 2.3 0.1 11.7 73.0 223.6 7.9 33.9 35.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.5 1.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.5 0.5 0.0 0.0 0.8 0.5 0.4 0.0 0.0 0.5 1.3 0.4 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 1.1 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.3 1.6 0.5 33.9 109.4 0.3 0.1 0.3 13.2 11.7 0.0 0.2 12.2 73.0 7.9 223.6 0.2 0.1 35.8 7.5 12.4 1.6 7.0 6.3 7.3 12.7 1.9 6.8 8.0 20.8 30.6 13.0 0.0 0.5 0.1 0.4 7.6 10.7 19.4 3.5 2.0 1.1 0.0 0.0 0.9 0.8 0.0 0.0 0.0 1.1 0.3 0.0 17.4 3.4 191.4 0.0 0.0 9.2 556.1 1.5 0.3 266.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 19.4 0.0 0.0 0.5 0.0 1.7 99.7 0.0 0.1 FCGR3B "CD16, CD16b, FCG3, FCGR3" ENSG00000162747 "Fc fragment of IgG receptor IIIb" O75015 1 161623196-161631963 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "blood: 334.5" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 11.1;Ciliated cells: 4.0;Club cells: 5.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 95 "neutrophil: 334.5" "Lineage enriched" "Detected in many" 95 "granulocytes: 334.5" "Cell line enhanced" "Detected in single" "K-562: 1.5" "Secreted to blood" NA NA "unprognostic (1.60e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (4.16e-2)" "unprognostic (1.15e-1)" "unprognostic (6.52e-2)" "unprognostic (3.97e-2)" "unprognostic (6.96e-3)" "unprognostic (2.53e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (8.67e-2)" "unprognostic (5.16e-2)" "unprognostic (1.35e-1)" "unprognostic (8.37e-3)" "unprognostic (2.28e-1)" "unprognostic (9.24e-2)" 9.9 0.8 1.8 30.8 1.5 13.8 1.5 0.9 1.8 0.9 0.8 0.5 0.2 0.0 0.4 0.5 1.7 2.8 6.8 4.6 1.2 0.9 0.9 2.9 15.2 16.9 5.0 0.5 1.2 1.2 0.0 0.6 4.5 1.9 1.5 0.0 1.3 0.9 0.9 0.8 1.4 0.8 2.0 4.0 44.3 1.3 1.5 0.9 0.6 0.8 0.2 0.9 11.1 4.7 0.0 0.1 334.5 3.5 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.5 0.5 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 334.5 0.1 3.5 0.0 0.0 0.5 1.8 1.5 0.9 1.8 1.2 0.9 5.0 0.5 1.9 0.9 3.0 11.1 0.0 0.0 0.0 0.0 0.3 0.0 4.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 FCGRT "alpha-chain, FCRN" ENSG00000104870 "Fc fragment of IgG receptor and transporter" P55899 19 49506816-49526333 "Predicted intracellular proteins, Predicted membrane proteins" "IgG-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 164.3" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 863.1;Hofbauer cells: 1128.9;Paneth cells: 837.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 164.3" "Group enriched" "Detected in all" 16 "dendritic cells: 70.7;granulocytes: 164.3;monocytes: 100.2" "Cell line enhanced" "Detected in many" "ASC diff: 40.8;Hep G2: 34.8;OE19: 42.6;THP-1: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012122, HPA015130" Enhanced NA NA 17000000 "HPA012122: AB_1848474, HPA015130: AB_1848475" "unprognostic (2.19e-3)" "unprognostic (2.05e-2)" "unprognostic (1.89e-1)" "unprognostic (1.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.26e-1)" "unprognostic (8.58e-2)" "unprognostic (3.87e-3)" "unprognostic (2.81e-1)" "unprognostic (3.49e-2)" "unprognostic (2.00e-3)" "unprognostic (3.64e-1)" "unprognostic (3.67e-3)" "unprognostic (3.40e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (2.18e-3)" 55.6 25.4 10.9 30.0 10.7 20.9 68.7 5.3 9.6 41.7 104.2 14.3 15.3 54.7 30.8 41.7 19.8 28.7 49.3 42.9 12.0 5.8 32.4 87.4 41.7 51.6 15.8 8.7 41.0 32.2 16.1 17.3 32.0 13.2 28.0 30.3 27.5 20.9 19.4 19.9 22.1 125.2 23.8 14.2 66.3 24.1 24.6 10.2 14.1 28.5 15.3 13.1 20.1 27.9 4.4 70.7 164.3 100.2 2.0 7.0 72.1 0.0 8.5 1.5 30.5 40.8 20.7 1.3 6.5 18.1 5.2 5.7 12.0 5.4 0.0 13.5 10.6 2.9 2.1 0.3 0.2 3.3 0.0 11.5 16.9 0.1 34.8 24.3 0.2 3.0 24.6 0.4 4.1 0.0 20.7 20.3 12.1 2.8 2.8 13.7 0.2 0.1 3.3 0.4 42.6 5.5 0.6 7.8 0.8 23.5 2.3 0.5 5.8 1.4 0.0 0.9 5.3 6.5 45.8 6.5 13.2 2.4 0.2 0.2 0.6 3.2 2.3 2.0 15.3 1.8 29.3 100.2 63.3 1.9 65.6 2.3 4.1 3.1 3.0 70.7 4.4 7.0 3.9 164.3 2.0 42.3 40.1 1.9 72.1 10.9 10.7 5.3 9.6 12.0 5.8 15.8 8.7 13.2 10.2 62.5 86.1 44.6 103.6 112.0 0.4 24.1 104.4 41.5 50.0 69.8 3.9 11.0 51.4 65.2 5.3 238.2 863.1 46.7 54.3 21.5 241.8 68.4 70.3 290.5 1128.9 0.0 151.9 518.1 657.4 9.4 335.4 492.4 177.2 40.5 328.3 12.3 84.6 837.7 172.5 259.8 5.3 213.4 73.9 20.6 16.4 93.6 17.3 43.6 442.9 92.8 FCHO1 KIAA0290 ENSG00000130475 "FCH domain only 1" O14526 19 17747718-17788568 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4" "Cell type enhanced" "Detected in many" 6 "B-cells: 10.4;granulocytes: 9.2;Kupffer cells: 12.6;Macrophages: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 28.2;RPMI-8226: 19.4;U-937: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041653, HPA062981" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041653: AB_10795641, HPA062981: AB_2684915" "unprognostic (3.02e-1)" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (4.54e-3)" "unprognostic (3.62e-2)" "unprognostic (5.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (2.16e-1)" "unprognostic (6.93e-2)" "unprognostic (5.48e-3)" "unprognostic (1.72e-9)" "unprognostic (3.76e-3)" "unprognostic (1.18e-1)" "unprognostic (2.21e-1)" "unprognostic (9.77e-3)" 2.2 2.3 13.6 13.7 18.9 18.9 1.9 11.4 15.2 1.1 2.7 30.2 0.0 3.7 1.8 1.8 1.5 1.9 4.5 1.1 17.8 11.7 1.0 2.7 3.4 22.6 23.0 10.0 2.2 0.9 0.8 2.6 1.4 10.8 1.4 2.6 0.6 2.7 1.2 0.9 13.4 4.0 2.1 15.9 13.7 3.5 4.3 23.3 16.4 1.2 0.0 17.3 5.1 1.0 9.9 10.4 25.7 9.5 4.1 5.7 4.4 0.4 5.4 3.5 2.5 0.1 0.1 3.5 0.5 0.1 0.1 0.2 0.7 0.6 28.2 8.1 0.2 0.6 1.1 1.7 1.0 0.1 12.4 0.9 2.2 0.7 2.8 0.3 6.9 4.8 0.0 0.1 0.1 0.2 0.2 0.7 14.0 11.0 13.5 0.0 7.8 16.0 12.5 1.7 6.6 13.4 13.6 0.1 19.4 0.1 0.5 0.6 1.3 0.1 2.8 0.4 0.4 2.7 7.0 0.5 0.1 2.0 0.5 0.2 8.6 3.9 15.2 0.4 17.4 0.3 6.9 6.6 6.5 5.2 9.5 4.5 8.8 5.7 4.5 9.7 9.9 5.5 4.4 25.7 4.1 7.2 10.4 5.2 4.4 13.6 18.9 11.4 15.2 17.8 11.7 23.0 10.0 10.8 23.3 0.0 1.0 10.4 0.4 0.0 6.7 0.8 2.5 0.0 0.0 1.8 0.0 2.7 0.0 0.4 1.0 0.8 0.8 0.0 0.0 3.7 0.4 0.2 9.2 0.0 6.5 0.0 1.2 3.7 12.6 0.0 2.3 11.9 1.7 4.6 1.4 0.2 1.4 0.0 8.1 0.0 0.7 0.0 0.4 0.7 1.7 0.5 0.7 5.4 1.0 0.1 FCMR "FAIM3, TOSO" ENSG00000162894 "Fc fragment of IgM receptor" O60667 1 206904386-206923247 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9" "Group enriched" "Detected in many" 11 "B-cells: 125.3;T-cells: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 99.6;T-cells: 60.0" "Group enriched" "Detected in some" 5 "RPMI-8226: 53.0;U-266/70: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA003910 Approved Approved "Nucleoplasm,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 2400000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA003910: AB_1078798" "prognostic favorable (4.23e-4)" "unprognostic (1.16e-3)" "unprognostic (7.48e-2)" "unprognostic (3.06e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-3)" "unprognostic (1.15e-1)" "unprognostic (4.85e-3)" "unprognostic (1.03e-1)" "unprognostic (3.97e-1)" "unprognostic (3.23e-2)" "unprognostic (2.01e-1)" "unprognostic (8.15e-3)" "unprognostic (8.06e-2)" "unprognostic (2.12e-2)" "unprognostic (3.74e-2)" "unprognostic (5.05e-3)" 15.5 0.6 0.5 42.9 0.5 2.9 1.5 0.4 0.4 0.8 2.5 0.4 0.3 1.2 1.2 0.8 3.4 1.3 2.6 1.0 0.5 0.5 2.4 1.5 3.9 77.2 0.5 0.0 1.3 0.7 0.0 0.9 0.8 0.2 1.4 2.3 1.3 10.1 0.3 1.9 0.6 30.1 0.4 0.6 78.8 2.8 0.5 0.0 51.8 1.8 1.2 84.9 8.5 1.2 99.6 1.4 5.3 0.4 18.4 60.0 28.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 2.7 0.0 7.4 0.0 0.1 1.0 0.1 0.0 0.0 0.0 1.7 0.2 53.0 0.0 0.1 0.0 0.0 1.0 0.2 5.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 26.7 1.9 7.4 0.3 0.0 0.2 0.5 0.2 0.2 20.3 0.4 26.4 80.3 28.1 26.2 0.2 99.6 49.5 33.3 5.3 18.4 0.3 1.4 60.0 28.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.2 0.0 0.0 4.6 125.3 3.9 0.0 0.0 3.0 7.6 1.4 2.3 0.0 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 2.6 0.1 0.6 2.6 0.0 1.1 3.8 0.0 0.0 5.5 5.1 0.0 0.3 1.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.3 0.1 1.0 0.0 0.0 41.7 1.2 7.1 FCN1 FCNM ENSG00000085265 "Ficolin 1" O00602 9 134905890-134917963 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 318.5;bone marrow: 135.4" "Cell type enriched" "Detected in many" 9 "Kupffer cells: 627.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "classical monocyte: 318.5;intermediate monocyte: 218.1" "Lineage enhanced" "Detected in many" "monocytes: 318.5" "Group enriched" "Detected in some" 7 "NB-4: 15.7;U-937: 23.4" "HPA000685, HPA001295, CAB016760" Enhanced "Secreted to blood" NA NA 1060000000 63000000 "CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842" "unprognostic (1.57e-2)" "unprognostic (2.23e-1)" "unprognostic (1.14e-3)" "unprognostic (1.34e-1)" "unprognostic (9.91e-2)" "unprognostic (1.62e-3)" "unprognostic (3.66e-3)" "unprognostic (2.21e-1)" "unprognostic (1.14e-1)" "unprognostic (5.59e-2)" "unprognostic (2.49e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.73e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.28e-1)" 6.6 0.9 0.6 35.2 0.7 135.4 2.2 0.4 1.0 1.8 2.0 0.4 0.0 0.1 1.6 7.8 1.0 3.6 2.9 7.6 0.5 0.6 2.3 4.6 24.9 23.5 2.3 0.1 3.5 1.6 0.0 0.7 9.2 0.9 1.6 1.0 3.0 1.7 0.3 2.7 0.7 1.3 8.1 1.2 47.3 2.2 1.0 0.5 6.8 1.6 1.1 3.6 8.5 1.6 0.8 93.9 53.7 318.5 0.4 0.6 273.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.7 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.0 0.2 0.0 23.4 0.0 1.2 318.5 3.0 0.5 218.1 0.6 0.8 0.2 0.3 93.9 0.2 0.3 0.3 53.7 0.4 99.0 2.5 0.3 273.0 0.6 0.7 0.4 1.0 0.5 0.6 2.3 0.1 0.9 0.5 6.0 27.5 10.5 0.2 1.6 0.0 2.4 0.0 1.4 9.1 1.8 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.1 0.2 11.6 1.3 71.4 0.0 0.0 3.1 627.5 0.0 0.0 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.5 0.0 0.1 FCN2 "EBP-37, FCNL, ficolin-2, P35" ENSG00000160339 "Ficolin 2" Q15485 9 134880812-134887520 "Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 77.4" "Cell type enriched" "Detected in some" 16 "Ito cells: 1725.4" "Group enriched" "Detected in some" 8 "breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 6.0;intermediate monocyte: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2" "Secreted to blood" NA NA 8100000000 1800000000 "unprognostic (1.91e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-4)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.81e-1)" "unprognostic (2.82e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" "unprognostic (1.05e-1)" "unprognostic (3.07e-1)" 2.0 11.4 0.2 0.2 0.2 0.0 4.0 0.2 0.3 0.2 0.3 0.3 0.5 0.0 0.3 0.6 0.2 0.0 0.2 0.5 0.2 0.0 2.2 77.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.3 1.5 0.0 0.2 1.4 0.2 0.2 0.0 0.2 0.2 0.2 1.4 0.0 0.3 0.2 0.2 0.9 0.2 0.2 0.3 0.2 0.0 3.3 1.3 6.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.9 0.0 0.0 6.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.3 0.0 2.5 0.0 0.0 7.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 0.0 1725.4 106.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCN3 "FCNH, HAKA1" ENSG00000142748 "Ficolin 3" O75636 1 27369112-27374824 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 83.2;lung: 153.7" "Cell type enriched" "Detected in many" 14 "Ito cells: 3886.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.8;MCF7: 2.2;U-2197: 2.2" CAB025945 Approved "Secreted to blood" NA NA 22800000000 33000000000 "CAB025945: " "unprognostic (1.59e-1)" "unprognostic (5.25e-2)" "unprognostic (1.55e-2)" "unprognostic (8.27e-2)" "unprognostic (1.45e-3)" "unprognostic (1.27e-2)" "unprognostic (1.87e-3)" "unprognostic (1.21e-1)" "unprognostic (6.28e-4)" "unprognostic (7.07e-2)" "unprognostic (2.86e-2)" "unprognostic (3.23e-2)" "unprognostic (3.87e-3)" "unprognostic (4.14e-2)" "unprognostic (1.02e-1)" "unprognostic (6.97e-2)" "unprognostic (1.61e-2)" 7.2 5.0 0.1 1.7 0.2 0.0 21.2 0.1 0.3 0.3 0.6 0.4 0.1 0.2 0.3 0.1 1.0 0.5 0.5 25.0 0.4 0.0 13.0 83.2 153.7 1.0 0.1 0.1 0.3 2.3 0.7 2.1 6.7 1.1 0.5 0.2 0.8 0.4 0.2 1.0 0.3 0.7 0.6 0.2 2.7 0.8 0.5 0.2 0.1 9.1 0.3 0.3 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 1.2 0.8 0.0 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.8 0.4 0.6 0.0 1.0 1.1 0.0 0.4 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.3 0.2 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.6 0.0 0.0 0.4 0.3 2.2 0.2 0.3 0.1 0.5 0.4 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.4 0.0 0.1 0.1 1.1 0.2 0.0 15.2 66.2 0.3 0.7 0.0 2.0 81.5 4.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 99.1 0.0 93.5 0.0 0.0 0.2 0.4 3.5 6.8 0.3 0.0 0.0 3886.1 270.1 2.2 3.1 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.4 0.6 1.0 0.0 8.6 0.0 0.3 FCRL1 "CD307a, FCRH1, IFGP1, IRTA5" ENSG00000163534 "Fc receptor like 1" Q96LA6 1 157794403-157820105 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 31.6;lymphoid tissue: 55.1" "Cell type enriched" "Detected in some" 60 "B-cells: 69.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 51 "memory B-cell: 16.8;naive B-cell: 31.6" "Lineage enriched" "Detected in single" 66 "B-cells: 31.6" "Group enriched" "Detected in some" 33 "Daudi: 5.7;U-698: 19.4" "Low region specificity" "Detected in all" HPA013323 Enhanced NA NA 120000 "HPA013323: AB_1848480" "unprognostic (6.52e-4)" "unprognostic (3.49e-3)" "unprognostic (8.68e-3)" "unprognostic (8.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-5)" "unprognostic (1.47e-2)" "unprognostic (5.48e-3)" "unprognostic (1.40e-2)" "unprognostic (4.30e-2)" "unprognostic (1.81e-1)" "unprognostic (2.85e-2)" "unprognostic (1.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.65e-2)" "unprognostic (4.80e-2)" "unprognostic (6.74e-2)" 0.5 0.2 0.2 55.1 0.2 6.2 0.3 0.2 0.2 0.2 0.7 0.0 0.0 0.0 0.2 0.1 2.4 0.3 0.2 0.3 0.2 0.2 0.7 0.5 1.9 19.2 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.5 0.3 0.3 5.4 0.7 0.2 0.2 10.1 0.0 0.2 25.3 0.4 0.2 0.0 1.1 0.7 0.4 49.0 4.5 0.8 31.6 0.0 0.4 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.8 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 69.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCRL2 "CD307b, FCRH2, IRTA4, SPAP1" ENSG00000132704 "Fc receptor like 2" Q96LA5 1 157745733-157777132 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 20.2;intestine: 14.9;lymphoid tissue: 27.0" "Cell type enriched" "Detected in some" 17 "B-cells: 57.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 50 "memory B-cell: 20.2;naive B-cell: 10.8" "Lineage enriched" "Detected in single" 65 "B-cells: 20.2" "Group enriched" "Detected in some" 4 "Daudi: 15.0;U-698: 12.2" NA NA "unprognostic (3.94e-3)" "unprognostic (1.47e-3)" "unprognostic (3.49e-2)" "unprognostic (3.69e-3)" "unprognostic (5.11e-5)" "unprognostic (1.67e-2)" "unprognostic (4.77e-3)" "unprognostic (8.19e-2)" "unprognostic (8.66e-3)" "unprognostic (1.20e-2)" "unprognostic (4.19e-2)" "unprognostic (4.60e-7)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (7.92e-2)" "unprognostic (2.48e-1)" 0.4 0.2 0.2 22.6 0.2 1.5 0.2 0.1 0.2 0.2 1.3 0.1 0.1 1.2 0.3 0.1 1.4 0.2 0.4 0.2 0.2 0.2 0.5 0.9 0.7 15.6 0.3 0.1 0.5 0.2 0.0 0.2 0.1 0.2 0.4 1.7 0.6 2.8 0.7 0.1 0.2 14.9 0.1 0.2 27.0 0.8 0.2 0.1 0.3 0.5 0.1 23.3 1.4 0.2 20.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.2 0.0 12.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.0 1.4 57.3 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.1 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.3 FCRL3 "CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e" ENSG00000160856 "Fc receptor like 3" Q96P31 1 157674321-157700857 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;lymphoid tissue: 32.2" "Cell type enhanced" "Detected in some" 28 "B-cells: 38.7;Early spermatids: 7.0;Late spermatids: 7.6;T-cells: 14.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 20.3" "Group enriched" "Detected in many" 56 "B-cells: 20.3;NK-cells: 10.7;T-cells: 10.8" "Cell line enriched" "Detected in some" 7 "Daudi: 14.6" "Low region specificity" "Detected in single" HPA048022 Enhanced NA NA "HPA048022: AB_2732541" "unprognostic (6.73e-3)" "unprognostic (5.06e-4)" "unprognostic (1.13e-2)" "unprognostic (2.08e-4)" "unprognostic (3.86e-1)" "unprognostic (1.74e-5)" "unprognostic (1.09e-2)" "unprognostic (4.29e-3)" "unprognostic (3.69e-3)" "unprognostic (2.46e-4)" "unprognostic (1.13e-1)" "unprognostic (2.55e-2)" "unprognostic (2.01e-4)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (2.21e-1)" "unprognostic (6.69e-2)" 0.4 0.2 0.2 29.4 0.2 0.4 0.3 0.2 0.2 0.3 0.6 0.0 0.0 0.0 0.5 0.2 1.5 0.3 0.6 0.3 0.2 0.2 0.5 0.6 0.9 26.4 0.4 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.5 0.6 0.2 5.6 0.0 0.4 0.2 8.7 0.1 0.2 22.4 0.6 0.2 0.0 5.2 0.6 0.6 32.2 1.2 0.3 20.3 0.0 0.2 0.0 10.7 10.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 1.0 16.1 1.4 7.2 0.0 20.3 0.1 4.7 0.2 10.7 0.0 0.0 5.6 3.5 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.6 0.0 0.0 FCRL4 "CD307d, FCRH4, IGFP2, IRTA1" ENSG00000163518 "Fc receptor like 4" Q96PJ5 1 157573749-157598080 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 5.4;lymphoid tissue: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 12 "B-cells: 1.1" "Cell line enriched" "Detected in single" 104 "U-266/70: 10.4" "Not detected" "Not detected" HPA054030 Approved NA NA "HPA054030: " "unprognostic (6.06e-2)" "unprognostic (3.41e-3)" "unprognostic (2.57e-1)" "unprognostic (5.08e-2)" "unprognostic (4.69e-4)" "unprognostic (2.06e-2)" "unprognostic (6.38e-2)" "unprognostic (1.99e-1)" "unprognostic (2.14e-1)" "unprognostic (3.37e-1)" "unprognostic (6.77e-2)" 0.1 0.1 0.1 15.6 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 5.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 2.5 0.0 0.1 0.1 5.4 0.0 0.1 2.2 0.3 0.1 0.0 1.1 0.1 1.9 14.9 0.4 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FCRL5 "BXMAS1, CD307e, FCRH5, IRTA2" ENSG00000143297 "Fc receptor like 5" Q96RD9 1 157513377-157552520 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4" "Group enriched" "Detected in some" 7 "B-cells: 61.9;Early spermatids: 51.2;Melanocytes: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 11.4;naive B-cell: 13.3" "Lineage enriched" "Detected in single" 19 "B-cells: 13.3" "Group enriched" "Detected in some" 5 "U-266/70: 5.8;U-698: 12.3" "Secreted to blood" NA NA 169000000 36000000 "unprognostic (1.30e-3)" "unprognostic (3.51e-2)" "unprognostic (7.59e-3)" "unprognostic (1.57e-2)" "unprognostic (9.41e-3)" "unprognostic (4.32e-5)" "unprognostic (2.61e-2)" "unprognostic (6.93e-2)" "unprognostic (7.40e-2)" "unprognostic (7.66e-3)" "unprognostic (4.01e-1)" "unprognostic (1.39e-1)" "unprognostic (9.51e-10)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.99e-2)" "unprognostic (2.78e-1)" 0.7 0.4 0.3 33.9 0.3 1.1 1.3 0.3 0.3 1.6 7.4 0.1 0.0 3.6 0.5 0.1 4.6 0.8 0.8 0.4 0.3 0.3 1.6 0.8 1.6 17.4 0.3 0.0 0.6 0.4 0.0 0.3 0.0 0.0 0.5 2.7 1.0 12.4 0.8 0.3 0.3 6.4 0.1 0.3 29.5 2.5 0.9 0.0 3.1 1.1 0.7 39.1 5.3 0.6 13.3 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 4.5 61.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 51.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.6 0.3 4.4 0.3 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 1.1 0.0 0.0 0.6 0.5 0.0 0.0 FCRL6 "FcRH6, FLJ16056, IFGP6" ENSG00000181036 "Fc receptor like 6" Q6DN72 1 159800511-159816251 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.4;lymphoid tissue: 15.5" "Cell type enriched" "Detected in some" 37 "T-cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 39.4;memory CD8 T-cell: 36.0;naive CD8 T-cell: 29.2;NK-cell: 13.2" "Group enriched" "Detected in many" 27 "NK-cells: 13.2;T-cells: 39.4" "Cell line enhanced" "Detected in some" "HSkMC: 2.4;hTCEpi: 2.6;Karpas-707: 1.8;U-937: 1.7" "Low region specificity" "Detected in all" NA NA "unprognostic (2.64e-3)" "unprognostic (1.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.62e-3)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.79e-3)" "unprognostic (6.65e-3)" "unprognostic (2.76e-2)" "unprognostic (3.91e-1)" "unprognostic (1.98e-1)" "unprognostic (1.61e-1)" "unprognostic (1.52e-5)" "unprognostic (3.98e-1)" "unprognostic (1.13e-1)" "unprognostic (8.78e-2)" "unprognostic (9.18e-2)" 2.2 1.5 0.6 7.0 0.6 6.8 1.6 1.1 0.8 1.3 0.7 0.7 0.0 0.8 4.6 2.4 0.8 1.2 7.2 3.6 0.6 0.6 1.5 4.0 7.5 9.0 0.7 2.4 1.4 0.9 0.0 0.9 1.3 1.0 3.2 0.3 2.7 2.8 0.1 1.1 0.9 2.5 0.7 1.8 15.5 1.1 1.2 0.0 3.2 1.3 1.2 3.4 2.0 1.0 0.0 0.9 0.3 0.3 13.2 39.4 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 0.4 0.0 0.0 2.4 2.6 0.0 0.5 0.0 0.1 0.3 0.0 1.8 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.3 0.0 0.5 0.2 0.0 0.2 1.7 0.9 0.0 0.0 0.0 39.4 0.0 0.8 0.0 7.3 36.0 0.9 0.0 3.3 29.2 0.3 13.2 0.3 0.0 0.0 11.1 0.6 0.6 1.1 0.8 0.6 0.6 0.7 2.4 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 FCRLA "FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595" ENSG00000132185 "Fc receptor like A" Q7L513 1 161706972-161714352 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 66.3;lymphoid tissue: 51.8" "Group enriched" "Detected in some" 57 "B-cells: 105.0;Melanocytes: 64.1" "Cancer enriched" "Detected in many" 21 "melanoma: 38.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 66.3;naive B-cell: 61.9" "Lineage enriched" "Detected in many" 9 "B-cells: 66.3" "Group enriched" "Detected in some" 6 "Daudi: 94.0;SK-MEL-30: 38.7;U-698: 52.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB016545 Enhanced "Intracellular and membrane" NA NA "CAB016545: AB_2247037" "unprognostic (5.46e-4)" "unprognostic (7.19e-2)" "unprognostic (3.69e-3)" "unprognostic (4.75e-4)" "unprognostic (4.69e-2)" "unprognostic (1.48e-4)" "unprognostic (1.45e-2)" "unprognostic (4.15e-3)" "unprognostic (8.66e-2)" "unprognostic (3.58e-4)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (6.84e-5)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (2.08e-2)" 0.4 0.2 0.6 31.7 0.7 1.3 0.3 0.2 0.3 0.2 0.9 0.2 0.0 0.2 0.2 0.0 2.4 0.2 0.2 0.6 0.5 0.3 0.6 0.4 0.4 26.3 0.4 0.0 0.2 0.2 0.0 0.2 0.1 0.2 0.5 0.9 0.6 4.8 0.0 0.4 0.6 13.9 0.0 0.7 42.4 1.3 0.2 0.1 2.0 0.5 0.3 51.8 1.9 0.4 66.3 6.9 0.0 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.1 0.0 0.0 94.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 10.8 0.0 0.0 0.0 0.0 0.0 0.0 38.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 52.0 0.6 0.0 9.3 0.0 0.0 0.0 0.1 0.0 0.0 66.3 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 6.9 0.0 2.7 0.6 0.7 0.2 0.3 0.5 0.3 0.4 0.0 0.2 0.1 0.0 1.1 105.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 64.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 FCRLB "FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2" ENSG00000162746 "Fc receptor like B" Q6BAA4 1 161721563-161728143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.9;lymphoid tissue: 5.0" "Cell type enhanced" "Detected in many" 8 "Ito cells: 6.7;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 7.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "basophil: 8.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.1;Daudi: 7.4;fHDF/TERT166: 10.9;HMC-1: 9.4;PC-3: 5.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB026139 Uncertain Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB026139: " "unprognostic (1.87e-1)" "unprognostic (1.20e-4)" "unprognostic (5.77e-3)" "unprognostic (7.49e-3)" "unprognostic (1.73e-3)" "unprognostic (2.95e-1)" "unprognostic (2.98e-2)" "unprognostic (1.18e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.22e-2)" "unprognostic (2.25e-3)" "unprognostic (1.27e-1)" "unprognostic (9.92e-3)" "unprognostic (3.14e-2)" 0.5 0.2 0.2 3.4 0.3 0.0 0.3 1.0 0.8 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 1.4 0.6 0.3 2.4 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 1.2 0.0 0.2 0.7 2.7 0.2 0.3 0.8 0.2 0.4 1.5 0.2 0.2 0.2 0.2 0.3 0.2 5.0 0.8 0.2 4.9 0.6 8.9 0.2 5.3 2.7 0.6 0.7 0.1 0.0 0.3 0.5 0.8 0.0 4.6 6.1 1.5 1.5 0.1 0.2 7.4 0.2 10.9 0.3 0.1 0.2 0.4 4.0 0.1 0.3 0.2 0.1 0.2 0.2 0.0 9.4 1.4 0.0 2.7 0.2 0.5 1.3 0.0 0.4 0.3 0.2 0.4 0.0 2.6 0.2 0.0 5.5 0.0 0.5 0.3 0.2 0.2 0.0 0.0 0.0 0.2 2.3 0.3 0.0 0.0 0.8 1.6 0.7 1.7 0.8 0.0 0.0 2.9 3.3 0.4 0.8 8.9 0.1 2.4 2.7 0.1 1.0 4.6 1.6 1.5 0.6 4.9 0.8 1.2 1.5 5.3 0.2 0.0 0.0 0.6 0.2 0.3 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 2.2 1.0 1.0 0.0 1.6 0.0 0.0 0.0 3.5 0.0 1.8 5.0 1.1 0.1 1.1 0.0 0.0 1.0 4.6 0.7 0.4 0.0 0.8 1.3 0.0 1.2 6.7 2.4 0.0 0.0 2.3 1.7 0.0 0.0 3.1 0.9 0.0 0.4 10.5 0.4 0.0 1.4 2.7 1.2 0.4 0.7 2.2 0.0 0.7 FDCSP "C4orf7, FDC-SP" ENSG00000181617 "Follicular dendritic cell secreted protein" Q8NFU4 4 70226071-70235252 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 176.5;salivary gland: 452.5" "Cell type enriched" "Detected in single" 38 "Ductal cells: 37.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 336.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;GAMG: 10.9;HL-60: 2.0;RH-30: 3.0;U-87 MG: 8.0" "HPA014326, CAB014890" Enhanced "Secreted in other tissues" NA NA "CAB014890: , HPA014326: AB_1845719" "unprognostic (1.26e-3)" "unprognostic (2.32e-1)" "unprognostic (8.73e-3)" "unprognostic (9.62e-2)" "prognostic favorable (2.38e-4)" "unprognostic (5.99e-3)" "prognostic favorable (1.32e-4)" "unprognostic (2.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.79e-1)" "unprognostic (1.96e-1)" "unprognostic (3.68e-2)" "unprognostic (2.80e-1)" "unprognostic (7.83e-2)" 0.4 0.4 0.4 95.4 0.4 0.0 9.7 0.4 0.4 0.4 1.0 0.0 0.0 0.0 0.4 0.0 1.9 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.5 124.7 0.4 0.0 0.4 0.4 0.0 0.4 0.0 0.0 0.4 0.7 0.0 452.5 0.0 0.5 0.4 3.7 0.0 0.4 12.1 0.4 0.4 0.0 0.4 0.5 35.9 176.5 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.2 8.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FDX1 "ADX, FDX" ENSG00000137714 "Ferredoxin 1" P10109 11 110429883-110464881 "Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.9;seminal vesicle: 55.6" "Cell type enhanced" "Detected in all" 11 "Syncytiotrophoblasts: 953.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041630, HPA062087" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA041630: AB_10793970, HPA062087: AB_2630366" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.29e-3)" "unprognostic (4.67e-2)" "unprognostic (2.39e-1)" "unprognostic (4.32e-3)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (4.12e-1)" "unprognostic (3.10e-2)" "unprognostic (5.48e-2)" "prognostic favorable (3.58e-7)" "prognostic favorable (2.53e-4)" "unprognostic (1.10e-1)" "unprognostic (1.94e-1)" "unprognostic (2.80e-1)" 5.5 113.9 3.9 4.7 4.5 3.9 5.6 2.7 4.0 3.2 7.5 5.2 33.7 7.9 3.2 3.9 5.1 3.0 5.6 9.6 3.6 4.3 10.7 22.8 7.8 4.7 4.5 2.5 3.5 8.6 3.5 3.7 48.4 3.1 4.8 4.2 4.2 4.1 55.6 7.3 3.3 12.3 3.6 3.4 3.9 5.0 5.3 2.6 5.2 8.7 5.0 3.5 5.6 5.4 10.7 6.9 3.4 5.8 4.4 8.7 2.9 5.4 3.8 5.8 6.4 5.7 10.2 13.1 5.0 6.1 4.4 7.5 12.9 9.1 12.7 14.8 6.4 7.9 6.4 6.8 7.5 6.1 12.1 8.6 6.4 6.7 7.9 10.1 6.7 10.5 17.7 6.3 4.0 9.6 7.7 9.0 8.8 6.4 18.9 9.4 6.0 9.5 14.9 5.2 10.3 7.2 14.0 5.6 11.7 9.6 9.8 8.0 4.1 9.5 10.9 6.3 7.1 6.4 4.6 5.3 4.5 5.5 5.4 5.3 4.3 3.3 38.1 3.4 13.7 5.7 1.8 5.7 3.4 5.3 4.2 5.8 10.7 7.3 7.4 6.9 7.5 8.6 6.1 0.7 4.4 5.8 5.3 8.7 2.9 3.9 4.5 2.7 4.0 3.6 4.3 4.5 2.5 3.1 2.6 17.9 39.7 88.0 75.8 60.8 27.9 46.0 104.4 6.7 9.1 76.8 7.9 144.7 207.2 62.6 22.7 33.8 131.1 46.7 128.1 138.7 46.5 71.9 46.0 160.8 108.7 39.7 46.0 33.7 54.7 7.0 43.4 60.1 65.8 51.3 45.4 26.2 79.9 67.0 42.8 255.2 15.0 25.8 42.6 41.2 70.7 85.2 953.0 57.5 77.9 120.2 FDXR ADXR ENSG00000161513 "Ferredoxin reductase" P22570 17 74862497-74873031 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport" Oxidoreductase "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 93.9" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 47.2;Syncytiotrophoblasts: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 30.1;Hep G2: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008597, CAB009818, HPA044393, HPA053673" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225" "unprognostic (2.69e-2)" "unprognostic (1.17e-3)" "unprognostic (7.51e-2)" "prognostic favorable (2.38e-4)" "unprognostic (3.43e-2)" "unprognostic (1.20e-1)" "unprognostic (1.53e-1)" "unprognostic (1.68e-2)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (1.09e-1)" "unprognostic (6.30e-2)" "unprognostic (1.42e-2)" "unprognostic (1.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.03e-2)" "unprognostic (2.13e-1)" 1.7 93.9 2.6 2.1 3.1 1.3 1.8 8.4 2.7 2.1 4.6 3.2 6.4 2.6 2.6 23.8 8.7 6.6 6.1 1.9 3.4 1.7 2.7 4.1 4.4 1.7 2.9 3.5 7.1 3.9 2.3 1.5 2.6 3.6 3.3 2.1 0.9 5.3 4.2 7.9 5.6 2.5 2.0 4.4 9.7 2.2 32.1 3.0 3.9 2.0 7.7 3.7 3.0 3.0 5.4 7.4 4.8 6.4 10.0 15.2 5.6 4.0 21.6 3.2 3.6 2.3 3.1 30.1 4.8 5.3 2.9 5.8 6.0 3.5 9.6 0.8 2.0 1.6 8.3 2.3 6.0 0.8 9.1 5.0 7.3 3.5 55.1 6.5 1.6 25.5 10.1 6.8 3.0 1.0 2.3 14.7 3.6 11.5 1.6 4.4 17.1 6.2 3.3 1.8 3.8 4.7 3.4 5.4 5.1 2.4 6.8 1.7 4.0 3.3 7.2 3.5 3.8 15.7 1.5 6.8 2.0 17.9 3.1 2.4 4.4 0.7 2.1 5.4 2.5 6.7 1.8 6.4 4.8 6.2 4.3 5.3 5.4 5.6 7.3 7.4 2.8 4.9 6.1 2.1 10.0 3.2 1.4 15.2 5.6 2.6 3.1 8.4 2.7 3.4 1.7 2.9 3.5 3.6 3.0 3.0 4.6 3.7 12.8 8.7 4.9 3.4 5.1 21.4 5.7 8.7 3.9 47.2 5.0 9.7 5.2 2.8 14.8 0.0 6.8 14.1 6.1 4.3 5.7 12.5 18.6 3.2 6.8 12.3 4.6 12.2 5.5 3.6 5.0 3.6 10.8 10.9 8.3 21.0 4.2 16.3 4.9 0.0 6.4 7.1 7.6 15.8 38.6 8.5 17.6 13.1 FECH ENSG00000066926 Ferrochelatase P22830 18 57548283-57586772 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 87.9" "Group enriched" "Detected in many" 5 "Distal tubular cells: 132.6;Erythroid cells: 210.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044100, HPA048177" Approved NA NA "HPA044100: AB_2678809, HPA048177: AB_2680300" "unprognostic (2.30e-1)" "unprognostic (3.17e-2)" "unprognostic (4.59e-3)" "unprognostic (6.85e-2)" "unprognostic (7.60e-2)" "unprognostic (1.08e-1)" "unprognostic (3.86e-2)" "unprognostic (3.34e-2)" "unprognostic (2.85e-2)" "unprognostic (2.43e-1)" "unprognostic (1.92e-1)" "unprognostic (2.36e-1)" "prognostic favorable (2.38e-10)" "unprognostic (1.10e-1)" "unprognostic (8.30e-2)" "unprognostic (4.05e-3)" "unprognostic (3.58e-2)" 10.0 18.0 9.9 6.5 14.1 87.9 9.9 7.9 17.4 7.9 9.5 23.1 8.0 7.6 10.5 7.9 13.6 8.5 6.9 17.6 10.4 9.7 28.2 28.3 7.2 9.8 12.0 13.9 9.1 9.5 11.4 8.8 14.8 15.6 14.5 9.3 12.1 10.1 11.1 36.2 8.6 7.2 12.3 11.7 10.6 8.5 5.8 13.1 18.4 11.6 10.8 7.1 12.1 8.8 4.2 12.4 14.9 10.9 13.8 9.3 9.1 7.4 20.3 7.4 12.0 4.8 10.9 13.2 10.6 10.9 15.4 13.8 5.4 6.8 3.3 10.9 14.5 8.0 9.5 11.0 8.9 12.4 19.4 11.7 24.6 14.1 11.1 12.3 17.1 44.9 11.3 9.5 9.5 4.4 8.3 11.5 20.7 34.9 14.0 8.6 8.8 17.8 3.6 5.6 4.3 8.8 12.8 10.4 20.0 15.3 14.0 7.5 11.3 13.7 14.8 6.2 6.9 14.1 7.2 9.1 5.4 7.1 2.1 7.7 41.1 17.6 7.2 8.7 8.4 9.0 14.0 9.6 14.9 9.3 10.9 6.7 4.2 5.7 8.3 12.4 2.6 4.2 5.9 0.7 13.8 10.2 9.5 5.9 9.1 9.9 14.1 7.9 17.4 10.4 9.7 12.0 13.9 15.6 13.1 6.0 8.8 5.2 4.9 2.3 3.7 19.8 20.4 9.4 5.7 5.2 3.9 32.2 132.6 15.0 0.4 6.0 5.9 210.2 14.3 16.4 10.4 5.2 16.1 22.9 28.7 7.9 2.4 3.1 6.1 0.7 9.2 10.0 1.7 19.8 3.6 15.1 10.4 5.1 6.7 11.3 4.2 0.0 5.1 2.6 3.8 2.8 20.3 8.3 5.6 3.1 FEM1A ENSG00000141965 "Fem-1 homolog A" Q9BSK4 19 4791681-4801273 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 103.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016565, HPA063622" Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA016565: AB_1848489, HPA063622: AB_2685063" "unprognostic (4.62e-2)" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" "unprognostic (3.60e-1)" "unprognostic (2.42e-3)" "unprognostic (2.04e-1)" "unprognostic (6.74e-2)" "unprognostic (1.25e-2)" "unprognostic (9.21e-2)" "unprognostic (2.28e-3)" "unprognostic (6.25e-2)" "unprognostic (6.18e-5)" "unprognostic (3.72e-3)" "unprognostic (1.25e-1)" "unprognostic (1.91e-1)" "unprognostic (4.70e-2)" 3.0 2.4 3.3 2.2 4.4 3.3 4.0 4.1 5.0 2.0 2.7 3.0 0.9 2.2 2.7 4.0 4.2 2.1 1.9 8.6 3.3 2.6 2.2 4.4 2.3 3.8 3.2 2.5 2.1 4.2 4.4 2.3 4.5 3.1 2.8 2.0 2.7 3.1 2.1 103.9 6.9 2.3 2.3 2.2 2.7 2.2 2.2 3.2 4.2 2.1 18.6 3.0 2.5 2.3 7.2 6.8 9.1 8.2 6.8 6.9 4.2 7.2 5.0 4.7 10.1 5.2 3.1 6.8 4.3 3.6 7.0 4.9 7.8 3.3 8.2 4.4 5.3 3.8 7.5 8.2 7.2 4.6 9.7 9.4 8.0 4.0 5.8 7.9 13.2 10.3 4.5 11.1 5.4 7.8 3.3 5.0 11.3 11.7 15.8 4.8 7.3 11.0 4.8 14.4 4.5 12.1 10.3 6.1 8.6 6.3 9.3 15.2 10.8 5.7 10.8 8.1 3.8 8.3 11.5 7.0 6.4 4.6 10.0 11.4 18.4 15.2 7.1 6.6 9.5 9.0 9.1 7.3 7.1 6.9 8.2 6.0 5.3 5.5 6.3 6.8 7.2 5.0 5.7 6.6 6.8 7.3 6.6 3.9 4.2 3.3 4.4 4.1 5.0 3.3 2.6 3.2 2.5 3.1 3.2 23.8 42.3 20.9 12.5 17.9 16.3 5.6 7.6 16.0 21.6 1.8 15.7 18.1 11.6 9.6 4.0 8.8 10.0 23.3 10.1 12.1 7.1 11.5 22.0 13.9 11.0 11.1 12.6 14.1 17.0 2.7 8.3 8.1 3.3 15.4 14.8 11.4 9.9 7.0 7.8 7.9 17.0 6.5 10.3 12.1 5.7 25.7 22.7 12.1 11.9 15.0 FEM1C "EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785" ENSG00000145780 "Fem-1 homolog C" Q96JP0 5 115520908-115544894 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059919, HPA060977" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA059919: AB_2684161, HPA060977: AB_2684402" "unprognostic (1.14e-2)" "unprognostic (3.02e-1)" "prognostic favorable (1.83e-4)" "unprognostic (1.28e-1)" "unprognostic (3.31e-1)" "unprognostic (7.56e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (4.67e-2)" "unprognostic (5.52e-3)" "unprognostic (1.99e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" 18.2 6.8 15.9 8.6 19.4 58.5 14.6 21.1 19.6 15.1 14.2 12.2 10.7 12.1 11.3 7.5 16.4 8.7 13.8 28.6 13.9 8.6 8.7 16.8 15.3 7.3 12.9 17.1 10.7 12.1 6.9 8.2 7.2 14.9 11.5 13.7 6.4 8.5 9.9 24.3 13.1 17.4 12.2 15.3 9.0 14.2 14.1 14.5 4.1 9.5 15.4 7.4 16.5 10.2 3.3 6.1 6.4 10.9 3.0 5.5 3.6 8.3 5.0 7.3 11.3 13.1 18.5 5.9 13.3 10.6 10.0 11.7 5.5 7.5 8.6 9.1 9.7 11.6 6.6 5.8 11.1 14.8 13.2 5.5 4.5 7.2 4.2 8.7 3.0 6.1 12.1 9.4 12.5 11.4 9.4 9.8 7.2 2.8 11.3 15.1 3.6 7.7 5.0 5.1 5.3 6.4 6.6 13.3 9.3 11.2 15.9 6.0 4.8 8.6 6.0 14.3 6.1 7.8 6.0 17.2 17.3 9.0 15.8 11.8 9.0 6.5 6.9 10.1 8.4 6.9 2.5 6.1 6.4 3.8 9.4 5.5 3.3 4.0 2.8 6.1 1.9 4.6 3.7 6.4 3.0 10.9 1.6 4.4 3.6 15.9 19.4 21.1 19.6 13.9 8.6 12.9 17.1 14.9 14.5 20.8 9.9 10.7 13.5 23.6 14.9 28.2 20.4 13.4 11.4 10.4 19.6 3.5 5.0 10.4 38.8 19.0 31.9 46.7 7.2 6.7 26.4 18.1 12.7 36.5 6.8 4.8 16.0 17.2 16.7 59.6 8.1 16.4 28.7 5.4 24.9 18.7 16.0 17.6 6.3 9.1 26.4 0.0 24.7 6.9 6.1 21.7 4.2 6.9 17.8 26.6 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792637-61797244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.3" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.7;Spermatogonia: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 38000 Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 4.8 9.6 7.9 14.6 8.5 23.9 7.4 16.9 14.9 4.9 11.0 8.5 5.0 8.1 5.0 6.6 13.3 4.2 7.0 4.6 8.6 8.5 4.9 9.3 5.0 22.5 8.3 9.8 3.9 6.3 5.2 7.9 11.2 12.6 4.7 12.0 7.3 9.3 4.6 11.2 6.8 8.2 6.4 7.1 12.3 7.2 16.2 5.9 36.3 3.5 10.6 25.5 6.1 4.2 11.5 18.1 14.5 9.4 13.3 18.0 7.3 31.2 28.8 31.6 17.0 3.1 3.9 20.1 27.7 15.8 33.9 38.6 25.1 23.6 45.1 21.6 11.7 32.0 33.1 44.4 24.2 34.8 23.7 24.5 23.8 39.3 25.6 2.4 37.0 24.7 2.7 3.3 31.3 8.3 5.0 13.2 25.5 36.0 32.7 28.1 39.4 51.6 33.3 34.7 24.6 28.2 35.4 36.6 46.6 13.5 29.6 36.0 29.9 18.5 24.2 15.9 15.5 35.1 26.0 8.8 30.2 38.2 38.4 27.8 25.9 40.2 46.9 21.1 24.8 26.0 14.5 5.0 10.2 12.4 9.4 13.1 11.5 10.0 11.8 5.8 11.5 11.2 11.3 2.1 13.3 8.8 18.1 18.0 7.3 7.9 8.5 16.9 14.9 8.6 8.5 8.3 9.8 12.6 5.9 0.0 2.1 12.6 4.8 9.2 21.1 4.0 5.1 6.7 3.4 0.0 11.8 28.6 6.6 11.6 16.8 2.7 3.1 23.3 10.5 61.7 7.6 4.4 0.0 6.8 21.8 14.3 4.6 1.3 5.1 9.8 5.2 7.1 5.0 19.0 5.3 29.9 9.3 6.0 6.7 4.7 20.5 0.0 4.2 33.0 63.4 5.4 25.9 14.1 13.0 3.7 FER1L5 DKFZp434I0121 ENSG00000249715 "Fer-1 like family member 5" A0AVI2 2 96642737-96704887 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 17.9" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 15.5;Late spermatids: 4.2;Spermatocytes: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;AF22: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.4;HSkMC: 1.5;NTERA-2: 1.1;U-87 MG: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-3)" "unprognostic (5.81e-3)" "unprognostic (2.06e-1)" "unprognostic (1.12e-4)" "unprognostic (4.49e-4)" "unprognostic (1.39e-2)" "unprognostic (6.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.40e-1)" "unprognostic (2.95e-2)" "unprognostic (2.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.16e-3)" 0.2 0.2 2.8 0.2 3.7 0.2 1.2 2.0 3.2 0.4 0.2 1.5 1.9 0.2 0.4 1.5 0.3 0.8 0.5 0.3 1.6 0.6 0.2 0.5 0.2 0.0 3.8 0.7 1.3 0.3 3.2 0.5 0.4 1.0 0.2 2.0 0.4 3.0 0.2 0.2 0.2 0.3 0.2 0.3 0.3 17.9 0.6 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 1.4 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.0 1.1 0.0 0.0 1.1 0.0 2.7 1.2 0.0 0.0 0.0 1.7 0.4 15.5 0.0 0.0 0.0 0.6 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 3.3 1.0 0.0 0.2 0.0 0.0 0.3 FER1L6 C8ORFK23 ENSG00000214814 "Fer-1 like family member 6" Q2WGJ9 8 123851987-124120061 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "stomach 1: 29.3" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 12.4;Late spermatids: 25.1;Pancreatic endocrine cells: 6.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 4.2;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;ASC TERT1: 5.0;BJ hTERT+: 3.3;PC-3: 4.4;U-87 MG: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA054117 Enhanced NA NA "HPA054117: AB_2682387" "unprognostic (1.90e-1)" "unprognostic (3.08e-3)" "unprognostic (2.06e-3)" "unprognostic (3.91e-2)" "unprognostic (2.09e-1)" "unprognostic (9.49e-3)" "unprognostic (1.36e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (3.32e-2)" "unprognostic (3.23e-6)" "unprognostic (7.09e-2)" "unprognostic (8.43e-2)" "unprognostic (2.79e-3)" "unprognostic (6.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.1 1.7 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.4 0.0 3.8 0.0 0.0 0.0 29.3 3.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.2 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.3 1.3 4.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.9 0.0 0.0 0.0 3.9 0.0 6.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 FERD3L "bHLHa31, N-TWIST, NATO3" ENSG00000146618 "Fer3 like bHLH transcription factor" Q96RJ6 7 19144782-19145421 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.7;pituitary gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 160 "SCLC-21H: 15.9" "Region enhanced" "Detected in some" "thalamus: 1.0" "Region enriched" "Detected in many" 18 "midbrain: 34.7" HPA043494 Uncertain NA NA "HPA043494: AB_10964193" 0.3 0.4 1.4 0.0 0.1 0.0 0.5 0.0 2.7 0.2 0.0 2.2 0.0 0.0 0.5 0.0 0.4 0.2 0.0 0.9 1.1 1.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.4 1.3 1.4 0.1 0.2 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 1.8 1.1 1.5 1.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FERMT3 "KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2" ENSG00000149781 "Fermitin family member 3" Q86UX7 11 64206678-64223886 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7" "Cell type enhanced" "Detected in many" 10 "granulocytes: 94.6;Hofbauer cells: 174.8;Kupffer cells: 81.3;Macrophages: 95.8;monocytes: 155.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 62.7;HL-60: 27.4;HMC-1: 67.1;Karpas-707: 27.0;NB-4: 35.3;U-937: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065231 Approved Vesicles NA NA 450000000 Vesicles "HPA065231: AB_2685439" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.38e-3)" "prognostic favorable (9.89e-4)" "unprognostic (8.77e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.46e-1)" "unprognostic (4.20e-1)" "unprognostic (3.98e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.12e-5)" "unprognostic (3.08e-3)" "unprognostic (5.25e-2)" "unprognostic (4.97e-2)" "unprognostic (1.75e-1)" 20.0 5.6 3.1 29.4 5.5 57.6 5.6 0.9 3.2 3.4 8.8 3.4 0.7 8.1 3.4 6.0 3.6 5.8 6.5 7.2 2.2 2.4 5.3 5.5 17.8 39.1 6.3 0.8 4.9 2.8 0.2 2.6 7.5 3.7 4.2 3.0 5.6 8.9 2.9 3.2 2.8 12.4 3.3 4.8 52.7 10.6 2.5 4.3 51.2 4.0 2.4 29.6 6.2 2.9 13.7 47.3 54.7 49.5 22.6 30.6 59.4 0.2 0.3 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.5 0.4 6.6 0.6 1.3 0.1 0.5 0.2 0.1 0.1 17.0 0.1 62.7 0.2 0.0 2.3 27.4 67.1 0.2 0.2 1.1 0.0 0.1 17.0 16.0 1.4 27.0 1.8 0.7 24.4 35.3 0.2 0.2 0.4 14.7 1.8 0.1 0.0 0.1 0.4 0.1 0.1 0.9 0.3 0.1 0.4 19.1 1.6 0.2 0.5 0.4 0.1 0.3 0.6 12.0 4.1 28.4 18.1 40.6 49.5 54.7 30.6 46.3 29.4 13.7 24.4 28.4 39.0 13.4 16.1 21.1 45.0 22.6 33.5 47.3 28.3 59.4 3.1 5.5 0.9 3.2 2.2 2.4 6.3 0.8 3.7 4.3 8.9 17.1 42.2 0.6 4.1 0.6 2.0 5.1 1.4 6.8 0.0 0.0 0.9 0.0 0.6 0.1 3.6 5.9 23.3 2.2 1.1 5.3 0.9 94.6 1.7 174.8 0.0 0.0 17.2 81.3 0.8 0.9 95.8 16.9 155.9 22.4 0.1 2.8 10.5 2.5 0.2 0.2 6.5 6.1 1.1 0.7 4.0 2.2 69.2 13.9 0.7 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.8;lymphoid tissue: 49.7" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Group enriched" "Detected in many" 4 "dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5" "Cell line enhanced" "Detected in many" "HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 14.9 3.4 4.8 9.7 4.1 38.3 12.7 2.4 5.7 6.8 5.4 3.2 4.7 3.0 7.4 5.6 4.9 7.6 7.3 7.9 4.2 2.2 5.2 11.8 12.7 23.3 3.7 0.9 6.4 3.7 1.8 2.7 8.1 7.2 7.7 2.4 5.3 33.8 6.3 3.4 3.5 5.2 5.4 6.9 49.7 4.3 3.2 4.7 3.1 7.2 4.1 4.5 7.2 9.4 1.1 32.6 60.8 30.5 9.3 0.1 13.8 0.1 0.2 0.3 3.6 1.0 3.1 6.1 0.9 0.0 1.8 1.0 0.9 0.0 2.3 0.1 2.0 0.0 0.5 0.6 0.1 0.5 1.2 0.3 21.3 0.0 3.8 2.1 19.0 40.7 3.1 0.0 2.6 0.0 0.0 10.8 3.2 0.6 0.0 0.0 6.9 0.6 24.9 1.0 0.8 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.9 1.1 0.0 37.4 8.4 0.0 3.7 0.1 0.0 0.0 2.7 0.8 0.1 16.1 0.8 10.4 30.5 60.8 0.1 17.6 0.0 1.1 0.0 0.0 32.6 0.9 0.0 0.0 20.0 9.3 7.3 12.9 0.0 13.8 4.8 4.1 2.4 5.7 4.2 2.2 3.7 0.9 7.2 4.7 3.0 8.0 6.4 4.7 3.4 0.0 2.5 5.1 0.0 0.0 1.8 0.0 4.5 3.3 4.8 1.1 24.5 0.4 0.0 3.9 3.8 6.2 4.0 28.8 8.2 40.6 0.0 2.9 22.7 93.1 4.7 8.3 37.3 6.8 27.1 2.1 2.3 2.0 0.0 9.6 1.3 1.9 12.9 7.2 3.5 9.1 2.5 3.8 10.2 2.6 5.2 FETUB ENSG00000090512 "Fetuin B" Q9UGM5 3 186635969-186653141 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 76.1" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 37.1" "Cancer enriched" "Detected in some" 12 "liver cancer: 44.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;Hep G2: 4.5;HSkMC: 1.0;NTERA-2: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035132, HPA035133" Supported Approved Vesicles "Secreted to blood" NA NA 47500000000 4500000000 Vesicles "HPA035132: AB_10601650, HPA035133: " "unprognostic (9.01e-2)" "unprognostic (1.95e-1)" "unprognostic (4.62e-1)" "unprognostic (8.74e-2)" "unprognostic (6.28e-3)" "unprognostic (1.24e-2)" "unprognostic (7.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.73e-2)" "unprognostic (9.18e-2)" "unprognostic (1.79e-1)" "unprognostic (8.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 2.6 11.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.5 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.7 0.4 0.2 0.0 0.4 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 5.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 1.3 2.4 4.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 FEV Pet-1 ENSG00000163497 "FEV, ETS transcription factor" Q99581 2 218981087-218985657 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1" "Cell type enriched" "Detected in some" 123 "Intestinal endocrine cells: 716.0" "Group enriched" "Detected in some" 10 "pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4" "Region enhanced" "Detected in many" "pons and medulla: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HMC-1: 19.1;SH-SY5Y: 24.5" "Group enriched" "Detected in some" 13 "midbrain: 2.3;pons and medulla: 0.9" "Group enriched" "Detected in some" 35 "midbrain: 7.3;pons and medulla: 3.9" HPA067679 Supported Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA067679: AB_2685884" "unprognostic (4.58e-1)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "prognostic favorable (4.85e-4)" "unprognostic (2.87e-1)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (2.15e-1)" 0.1 4.1 0.0 1.2 3.5 0.0 0.0 0.0 2.6 0.0 2.0 0.7 0.0 7.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 5.4 0.0 6.9 4.0 3.2 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.1 0.0 6.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 2.6 1.1 0.2 0.2 0.0 6.9 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 716.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 5.8 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.1 FEZ1 UNC-76 ENSG00000149557 "Fasciculation and elongation protein zeta 1" Q99689 11 125445745-125496317 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 123.4" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 101.7;Horizontal cells: 157.3;Melanocytes: 74.2" "Cancer enriched" "Detected in all" 10 "glioma: 68.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7" "Lineage enriched" "Detected in many" 14 "T-cells: 30.8" "Cell line enhanced" "Detected in many" "AF22: 40.5;HBEC3-KT: 39.3;NTERA-2: 37.2;SCLC-21H: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038490, HPA076844" Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA038490: AB_10672647, HPA076844: " "unprognostic (5.68e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (7.40e-2)" "unprognostic (3.73e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-1)" "unprognostic (2.06e-1)" "unprognostic (8.30e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.14e-2)" "unprognostic (2.68e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" 6.6 5.6 48.3 4.4 50.1 1.3 4.3 28.2 121.4 6.4 5.1 58.8 0.2 2.9 6.9 4.0 5.9 4.1 9.4 12.4 54.2 38.2 2.7 7.4 10.0 3.5 68.2 29.8 6.0 1.4 5.0 2.3 6.0 43.4 6.6 5.3 1.4 2.4 12.9 1.7 3.5 3.5 13.0 123.4 3.9 2.5 7.2 51.4 0.0 2.2 0.0 2.9 16.8 2.1 0.0 0.4 2.1 0.5 1.0 30.8 5.0 0.0 0.0 40.5 0.0 26.7 24.4 0.0 6.3 8.2 1.6 0.3 0.0 0.0 0.0 7.4 11.9 3.9 0.1 18.4 39.3 0.9 3.2 0.3 18.6 0.0 0.0 22.6 0.0 0.1 19.9 9.1 7.3 19.4 0.1 17.9 0.0 2.5 0.2 1.9 1.0 0.1 0.0 37.2 0.2 0.4 0.0 0.0 0.0 0.0 14.2 39.7 4.1 0.1 0.0 0.6 15.2 3.0 18.2 16.0 0.1 1.0 0.0 5.3 0.4 0.1 0.0 4.4 0.0 17.1 2.1 0.5 0.0 30.8 0.1 18.0 0.0 1.1 8.9 0.4 0.0 0.4 7.7 0.6 1.0 0.0 0.0 0.0 5.0 48.3 50.1 28.2 97.4 54.2 38.2 68.2 29.8 43.4 51.4 0.0 6.9 1.7 4.4 7.1 15.1 101.7 0.0 1.4 3.4 0.0 2.0 5.7 23.2 2.7 52.4 14.0 0.0 0.0 0.3 1.2 36.9 3.0 0.0 0.6 68.8 157.3 5.2 53.4 15.9 52.7 23.6 1.6 74.2 1.0 0.0 65.9 0.5 0.0 33.2 1.1 13.4 19.4 30.1 11.8 7.0 4.8 3.5 9.6 0.0 1.6 FEZF1 ZNF312B ENSG00000128610 "FEZ family zinc finger 1" A0PJY2 7 122301394-122310691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 16.7;testis: 11.0" "Cell type enriched" "Detected in single" 5 "Spermatocytes: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 58.8;SCLC-21H: 25.7" "Region enriched" "Detected in single" 11 "hypothalamus: 13.7" "Region enriched" "Detected in some" 9 "hypothalamus: 6.9" "HPA064639, HPA073693" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA064639: AB_2685308, HPA073693: AB_2686626" "unprognostic (8.48e-2)" "unprognostic (3.41e-2)" "unprognostic (3.64e-1)" "unprognostic (3.43e-2)" "unprognostic (4.17e-1)" "unprognostic (4.10e-2)" "unprognostic (2.64e-3)" "unprognostic (2.54e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" 0.6 0.2 6.4 0.2 4.9 0.2 0.2 0.0 2.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 1.0 16.7 0.2 0.2 0.2 0.2 2.0 0.0 0.3 0.2 0.2 3.1 0.2 0.0 0.3 0.2 1.4 0.6 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 11.0 3.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 58.8 1.4 1.0 0.0 0.0 0.0 0.0 0.1 25.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 4.9 0.0 2.0 1.0 16.7 2.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 FEZF2 "FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312" ENSG00000153266 "FEZ family zinc finger 2" Q8TBJ5 3 62369681-62374324 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 22.0" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 1.7;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Rod photoreceptor cells: 2.7" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Group enriched" "Detected in many" 7 "amygdala: 12.2;basal ganglia: 6.4;cerebral cortex: 11.3;hippocampal formation: 22.0;olfactory region: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 5.2;NTERA-2: 3.5;U-266/84: 2.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 15.6;cerebral cortex: 15.0;hippocampal formation: 26.2" NA NA "unprognostic (2.37e-1)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" 0.7 0.5 12.2 0.4 6.4 0.4 0.5 0.0 18.0 0.4 1.4 1.8 0.0 0.4 0.5 0.4 0.4 0.5 0.5 0.5 22.0 1.8 0.7 0.5 0.5 0.4 1.1 10.0 0.5 0.4 0.4 0.7 0.5 0.0 0.6 0.4 1.1 0.5 0.5 0.8 0.6 0.5 0.4 0.0 0.8 0.9 0.5 0.3 3.3 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 6.4 0.0 11.3 22.0 1.8 1.1 10.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FFAR1 "FFA1R, GPR40" ENSG00000126266 "Free fatty acid receptor 1" O14842 19 35351552-35353862 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.7;brain: 4.1;ovary: 4.8;pancreas: 9.6" "Group enriched" "Detected in some" 4 "granulocytes: 1.1;Intestinal endocrine cells: 1.7" "Cancer enriched" "Detected in single" 13 "pancreatic cancer: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 2.9;HMC-1: 1.4;U-698: 5.5;WM-115: 2.1" "Not detected" "Not detected" NA NA "unprognostic (9.49e-2)" "unprognostic (2.08e-1)" "unprognostic (1.59e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (4.51e-2)" "unprognostic (1.03e-2)" "unprognostic (4.46e-2)" "unprognostic (6.19e-2)" "unprognostic (9.56e-3)" 0.0 0.0 1.2 0.2 1.6 5.7 0.0 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.8 0.0 0.0 1.9 0.9 0.0 0.0 0.1 0.7 1.7 4.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.0 4.1 0.3 1.6 0.1 0.0 0.2 0.0 0.0 1.2 0.5 1.9 0.3 0.7 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.4 0.1 0.2 0.4 0.0 0.0 0.1 0.3 0.3 0.9 0.2 0.0 0.1 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.7 0.1 0.1 0.0 1.1 0.2 0.0 0.0 0.3 0.1 0.4 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 5.5 0.1 0.2 2.1 1.6 0.3 0.7 0.4 0.2 0.4 0.3 0.3 0.2 0.0 1.2 0.3 0.4 1.9 0.7 0.2 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 FFAR2 "FFA2R, GPR43" ENSG00000126262 "Free fatty acid receptor 2" O15552 19 35443907-35451767 "G-protein coupled receptors, Predicted membrane proteins" "Immunity, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.2;lymphoid tissue: 22.9" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 5.6;Intestinal endocrine cells: 23.2;Kupffer cells: 6.2" "Cancer enhanced" "Detected in many" "prostate cancer: 6.0" "Region enhanced" "Detected in many" "midbrain: 7.0" "Group enriched" "Detected in some" 27 "eosinophil: 18.9;neutrophil: 60.2" "Lineage enriched" "Detected in many" 42 "granulocytes: 60.2" "Cell line enhanced" "Detected in some" "HMC-1: 8.7;OE19: 3.9;SK-BR-3: 2.5;THP-1: 2.7;U-937: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023985 Approved NA NA "HPA023985: AB_1849302" "unprognostic (7.75e-3)" "unprognostic (5.65e-2)" "unprognostic (4.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (6.16e-2)" "unprognostic (2.04e-1)" "unprognostic (1.92e-2)" "unprognostic (9.04e-2)" "unprognostic (2.30e-2)" "unprognostic (4.60e-2)" "unprognostic (5.17e-4)" "unprognostic (1.48e-1)" "unprognostic (4.76e-2)" "unprognostic (9.42e-2)" "unprognostic (1.03e-2)" 4.3 0.3 1.1 16.5 0.8 16.7 9.2 0.3 1.8 0.4 1.6 0.2 0.0 3.0 0.5 0.9 1.5 1.3 1.2 1.4 0.9 0.3 0.5 1.6 8.9 15.2 7.0 0.5 0.8 0.4 0.3 0.3 1.9 1.3 1.1 0.5 0.8 0.7 0.0 0.3 0.8 4.1 1.0 1.2 22.9 1.0 0.9 0.3 0.8 0.6 1.2 0.7 2.3 4.6 0.0 0.2 60.2 1.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.3 0.1 8.7 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.8 0.0 1.3 0.1 3.9 0.1 0.1 0.0 0.0 0.0 0.2 1.7 0.1 0.0 2.5 0.1 0.0 0.3 2.7 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 3.5 0.0 0.6 0.4 18.9 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 60.2 0.0 1.4 0.0 0.0 0.1 1.1 0.8 0.3 1.8 0.9 0.3 7.0 0.5 1.3 0.3 0.0 5.6 0.0 0.4 0.1 0.0 0.0 0.0 4.0 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 5.4 4.7 0.0 4.6 0.0 23.2 0.6 6.2 0.0 0.0 4.9 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.4 1.0 FFAR3 "FFA3R, GPR41" ENSG00000185897 "Free fatty acid receptor 3" O14843 19 35358460-35360485 "G-protein coupled receptors, Predicted membrane proteins" "Immunity, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.5;blood: 5.6;lymphoid tissue: 6.1" "Cell type enhanced" "Detected in single" 19 "Macrophages: 1.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 4.7;neutrophil: 5.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.6" "Group enriched" "Detected in some" 5 "ASC diff: 1.2;HHSteC: 3.9;HSkMC: 3.4;U-937: 1.5" HPA044681 Uncertain NA NA "HPA044681: AB_2679043" "unprognostic (1.15e-1)" "unprognostic (5.16e-3)" "unprognostic (1.45e-1)" "unprognostic (3.08e-2)" "unprognostic (1.03e-3)" "unprognostic (2.21e-2)" "unprognostic (4.46e-2)" "unprognostic (1.34e-1)" "unprognostic (1.92e-4)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (1.04e-3)" "unprognostic (2.18e-2)" "unprognostic (3.41e-1)" "unprognostic (3.22e-2)" 6.5 0.0 0.1 6.1 0.3 1.7 3.8 0.0 0.2 0.0 2.1 0.7 0.0 0.0 0.0 0.5 1.1 0.2 0.4 0.2 0.0 0.5 0.6 0.4 0.5 0.3 1.0 0.4 0.5 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.9 3.7 1.5 2.4 1.3 0.0 0.9 0.0 0.7 0.0 0.0 0.1 5.6 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.1 4.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "G-protein coupled receptors, Predicted membrane proteins" "Differentiation, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 15.8;lung: 11.7;pituitary gland: 39.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 18.7;Intestinal endocrine cells: 20.1;Mucus-secreting cells: 63.6" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "OE19: 16.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042563 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 5.2 0.6 1.8 2.8 1.7 0.2 1.9 0.1 2.6 0.2 11.3 1.1 0.0 0.7 0.1 0.1 0.4 1.4 2.6 1.2 0.9 1.6 0.3 0.6 11.7 1.3 0.6 1.0 0.3 1.1 0.1 39.2 0.4 0.8 0.2 15.8 0.3 0.9 0.1 0.5 1.3 1.0 0.3 2.6 0.2 0.7 2.0 0.9 0.7 0.2 0.0 0.6 0.3 0.2 0.5 3.4 1.3 3.0 0.7 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.4 0.4 0.1 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.2 0.3 0.6 0.2 0.4 0.2 0.2 3.4 0.5 0.2 0.3 1.3 0.7 0.4 0.4 0.1 0.8 1.8 1.7 0.1 2.6 0.9 1.6 0.6 1.0 0.8 0.9 0.0 0.3 0.0 0.4 0.0 0.0 0.3 12.7 0.0 1.2 0.0 0.0 0.1 0.0 0.6 18.7 0.1 6.5 0.0 0.0 0.5 0.2 0.3 0.0 0.0 7.8 0.0 20.1 0.0 3.2 12.2 0.6 3.8 1.7 0.0 63.6 0.0 1.4 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.2 FGA ENSG00000171560 "Fibrinogen alpha chain" P02671 4 154583126-154590766 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity" "Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 740 "liver: 2009.3" "Cell type enriched" "Detected in many" 40 "Hepatocytes: 16694.6" "Cancer enriched" "Detected in many" 43 "liver cancer: 2431.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 96.9" "Not detected" "Not detected" "CAB016776, HPA051370, HPA064755" Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 407000000 170000000000 "Endoplasmic reticulum" "CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345" "unprognostic (5.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "prognostic favorable (7.33e-4)" "unprognostic (1.29e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.23e-6)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.7 2009.3 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 96.9 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.4 83.9 0.0 0.0 0.0 0.4 420.4 17.4 5.7 0.0 0.0 0.0 1.7 5.5 23.9 0.0 0.0 256.9 1.5 0.0 0.0 0.0 0.0 16694.6 0.1 0.0 0.0 255.3 257.1 29.3 0.6 0.0 0.0 0.0 0.0 0.0 31.5 0.0 1.1 1.0 0.0 0.0 0.0 14.4 0.6 0.0 0.1 4.3 0.0 0.0 FGB ENSG00000171564 "Fibrinogen beta chain" P02675 4 154562956-154571086 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 189 "liver: 1908.6" "Cell type enriched" "Detected in some" 33 "Hepatocytes: 15347.2" "Cancer enriched" "Detected in many" 42 "liver cancer: 2262.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "Hep G2: 77.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001900, HPA001901, CAB008624" Enhanced Enhanced "Endoplasmic reticulum" "Secreted to blood" NA NA 120000000000 "Endoplasmic reticulum" "CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864" "unprognostic (1.16e-1)" "unprognostic (3.89e-2)" "unprognostic (4.65e-2)" "unprognostic (3.44e-1)" "unprognostic (2.20e-3)" "unprognostic (1.42e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.72e-5)" "unprognostic (2.48e-2)" "unprognostic (7.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.1 1908.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 77.7 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 153.8 0.0 0.0 0.0 0.4 257.4 0.0 0.0 3.5 0.0 0.0 1.7 3.0 0.4 0.0 0.0 467.2 3.2 0.1 0.0 0.0 0.0 15347.2 0.3 0.0 1.7 349.9 342.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 FGD2 ZFYVE4 ENSG00000146192 "FYVE, RhoGEF and PH domain containing 2" Q7Z6J4 6 37005646-37029070 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.5;lymphoid tissue: 43.1" "Cell type enhanced" "Detected in many" 15 "B-cells: 36.5;Kupffer cells: 86.8;Macrophages: 49.3;monocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 17 "classical monocyte: 8.8;intermediate monocyte: 25.4;memory B-cell: 9.3;myeloid DC: 13.7;naive B-cell: 7.8;non-classical monocyte: 25.5;plasmacytoid DC: 10.8" "Group enriched" "Detected in many" 19 "B-cells: 9.3;dendritic cells: 13.7;monocytes: 25.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.1;Daudi: 12.7;HDLM-2: 12.4;U-698: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA029145, HPA049692" Approved NA NA "HPA029145: AB_10601321, HPA049692: AB_2680852" "unprognostic (3.54e-2)" "unprognostic (1.40e-4)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (1.27e-1)" "unprognostic (1.67e-4)" "unprognostic (7.97e-2)" "unprognostic (1.58e-2)" "unprognostic (2.47e-2)" "unprognostic (2.78e-1)" "unprognostic (3.39e-2)" "unprognostic (2.82e-1)" "unprognostic (1.15e-2)" "unprognostic (3.91e-1)" "unprognostic (1.02e-2)" "unprognostic (3.88e-1)" "unprognostic (7.10e-2)" 11.3 4.3 6.7 21.8 10.3 5.4 3.3 1.0 4.6 2.4 3.4 5.9 1.3 3.8 2.2 7.6 3.0 4.1 4.3 2.6 7.2 2.4 3.0 3.3 8.7 21.7 10.3 1.4 1.8 2.3 0.3 2.1 2.8 7.4 2.4 2.9 2.5 4.2 2.2 1.5 3.0 11.2 4.6 8.3 43.1 3.8 1.2 9.2 3.0 3.5 1.8 18.9 5.1 2.5 9.3 13.7 0.8 25.5 0.1 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 12.7 0.0 0.0 0.0 0.4 0.0 0.0 0.3 12.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.6 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 8.8 0.8 0.0 25.4 0.0 9.3 0.0 0.0 13.7 7.8 0.0 0.0 0.1 0.1 25.5 10.8 0.0 2.1 6.7 10.3 1.0 4.6 7.2 2.4 10.3 1.4 7.4 9.2 6.0 11.9 36.5 2.9 1.8 0.4 2.5 0.0 4.0 0.0 0.0 0.0 0.2 0.0 1.7 10.9 0.7 0.0 0.0 0.8 0.2 1.0 1.2 7.0 0.2 15.5 0.0 0.0 3.1 86.8 1.9 1.4 49.3 1.7 32.5 0.0 0.3 0.8 0.3 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.9 0.3 2.2 0.2 4.6 FGD3 "FLJ00004, ZFYVE5" ENSG00000127084 "FYVE, RhoGEF and PH domain containing 3" Q5JSP0 9 92947451-93036236 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.2;lymphoid tissue: 48.1" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 52.4;Late spermatids: 74.6;T-cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 21.0;Karpas-707: 29.2;RT4: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA020963, HPA021018" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA020963: AB_2670542, HPA021018: AB_2670564" "unprognostic (5.66e-3)" "prognostic favorable (5.51e-4)" "unprognostic (5.05e-3)" "unprognostic (1.75e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.23e-7)" "unprognostic (2.26e-1)" "unprognostic (1.03e-2)" "unprognostic (2.61e-2)" "unprognostic (2.55e-1)" "unprognostic (2.68e-2)" "unprognostic (2.32e-1)" "unprognostic (8.56e-2)" "unprognostic (3.96e-1)" "unprognostic (1.60e-1)" "unprognostic (9.66e-2)" "unprognostic (1.22e-2)" 3.1 1.5 2.3 20.5 2.5 23.4 3.5 0.5 1.6 1.8 3.1 3.1 1.6 1.9 2.8 2.5 2.8 2.5 3.1 1.5 2.2 2.0 4.6 2.1 7.5 30.5 3.3 1.0 1.1 5.7 0.1 1.0 2.6 2.6 3.2 1.4 2.2 6.6 1.0 0.7 3.1 10.1 1.5 6.3 28.1 2.6 3.9 2.5 48.1 3.5 2.1 25.8 7.7 3.2 11.3 10.3 49.2 24.7 10.5 15.7 17.1 6.4 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 8.0 4.4 5.2 0.3 0.0 0.0 4.2 0.3 0.0 0.0 9.0 0.0 8.2 0.0 0.3 0.0 2.2 21.0 0.0 0.1 0.0 0.0 0.0 0.0 8.8 0.3 29.2 0.0 10.7 9.6 9.2 0.2 2.1 0.5 9.5 0.0 7.4 0.0 16.5 0.6 0.2 0.0 7.1 0.2 0.2 2.8 9.7 0.0 0.0 0.3 0.0 0.0 2.9 2.9 2.4 1.5 4.6 0.0 34.0 13.4 36.7 15.1 17.3 15.5 8.5 15.6 14.1 10.3 11.3 15.7 13.3 49.2 10.5 24.7 4.7 13.5 17.1 2.3 2.5 0.5 1.6 2.2 2.0 3.3 1.0 2.6 2.5 20.8 11.6 2.7 0.7 0.7 0.0 2.2 2.5 0.0 3.4 8.7 0.0 2.1 0.0 5.5 52.4 1.4 0.0 0.0 0.2 2.9 0.8 0.0 18.5 0.6 12.6 0.0 1.7 2.5 17.8 74.6 0.3 12.6 1.7 2.8 0.3 0.3 0.4 0.0 0.4 0.6 4.2 0.0 0.9 1.6 1.9 0.9 3.8 38.3 0.1 0.4 FGF1 "AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1" ENSG00000113578 "Fibroblast growth factor 1" P05230 5 142592178-142698070 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 65.0;heart muscle: 35.5;kidney: 41.5" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 49.6;Collecting duct cells: 19.2;Cone photoreceptor cells: 15.7;Muller glia cells: 68.6" "Cancer enriched" "Detected in many" 12 "glioma: 33.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 19.8;BJ hTERT+: 14.8;BJ hTERT+ SV40 Large T+: 16.3;BJ hTERT+ SV40 Large T+ RasG12V: 20.6;HBF TERT88: 29.5;hTEC/SVTERT24-B: 20.6;LHCN-M2: 13.7;U-2 OS: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003265, CAB017519" Enhanced Supported Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "CAB017519: AB_629473, HPA003265: AB_1848522" "unprognostic (1.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (2.55e-2)" "unprognostic (3.52e-1)" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.63e-1)" "unprognostic (1.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.54e-1)" "prognostic favorable (2.59e-5)" "unprognostic (3.72e-4)" "unprognostic (2.49e-1)" "prognostic favorable (3.45e-5)" "unprognostic (3.01e-4)" 7.3 3.5 44.2 2.0 43.1 1.5 9.7 10.5 59.9 1.8 1.7 65.0 0.0 1.6 3.1 8.7 2.3 2.1 2.7 35.5 47.4 33.0 41.5 2.0 2.9 1.4 62.6 13.8 1.5 1.4 3.4 1.6 2.3 36.3 2.2 1.8 0.8 5.8 2.6 2.3 2.0 1.7 2.6 57.7 5.5 1.1 2.2 48.6 0.0 4.9 0.8 2.2 1.7 0.4 1.2 1.0 1.8 0.6 0.1 2.3 0.2 2.4 0.1 0.1 0.7 0.5 1.5 0.8 19.8 14.8 16.3 20.6 0.1 0.1 0.5 1.4 6.8 0.9 0.3 0.0 1.5 29.5 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.2 0.7 0.5 20.6 1.2 4.4 0.0 0.1 0.0 0.7 13.7 0.3 0.0 0.4 0.6 0.0 0.6 0.1 0.7 0.2 0.6 0.1 0.5 1.0 0.0 0.4 0.2 3.9 0.0 0.1 0.4 2.6 14.7 0.3 9.3 0.3 0.1 0.1 3.7 0.1 0.7 0.3 0.3 1.8 2.3 0.1 1.8 0.4 0.8 0.9 0.2 1.2 0.9 1.9 1.7 0.1 0.6 1.0 0.5 0.2 44.2 43.1 10.5 22.6 47.4 33.0 62.6 13.8 36.3 48.6 0.0 0.0 0.0 3.4 0.3 1.6 49.6 0.0 0.0 3.4 19.2 15.7 0.5 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.4 1.8 1.4 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 0.0 0.0 3.3 0.0 0.0 68.6 0.7 0.0 0.4 0.0 9.6 6.5 4.7 0.0 0.1 0.0 0.7 0.0 0.0 0.3 FGF10 ENSG00000070193 "Fibroblast growth factor 10" O15520 5 44303544-44389706 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Disease mutation, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 26.4" "Group enriched" "Detected in some" 8 "Leydig cells: 7.8;Muller glia cells: 5.2;Peritubular cells: 9.9" "Cancer enriched" "Detected in some" 6 "breast cancer: 5.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "AF22: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB010315 Uncertain "Secreted in other tissues" NA NA "CAB010315: AB_2262731" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (8.54e-2)" "unprognostic (1.08e-1)" "unprognostic (3.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.54e-2)" "unprognostic (4.06e-3)" "unprognostic (2.72e-2)" "unprognostic (6.73e-2)" "unprognostic (5.59e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-2)" "unprognostic (1.11e-2)" "unprognostic (2.14e-2)" "unprognostic (5.23e-4)" 10.5 1.8 0.2 3.4 1.2 0.0 13.1 0.6 1.9 15.5 6.1 0.4 2.1 0.2 3.1 17.2 3.8 5.4 5.0 4.2 0.2 0.5 0.9 0.1 2.5 1.8 1.0 0.3 26.4 5.4 0.0 5.4 7.7 1.4 11.7 2.0 3.2 6.8 4.2 0.7 0.9 2.5 11.0 1.7 0.1 4.4 6.2 0.4 0.2 5.0 8.6 0.8 9.3 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.6 1.9 0.2 0.5 1.0 0.3 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 5.2 0.5 0.0 9.9 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FGF11 "FHF3, FLJ16061, MGC102953, MGC45269" ENSG00000161958 "Fibroblast growth factor 11" Q92914 17 7438273-7444937 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.5" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 17.5;Muller glia cells: 12.7;Suprabasal keratinocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 9.4;HaCaT: 17.3;LHCN-M2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066605, HPA075188" Enhanced Approved Centrosome NA NA Centrosome "HPA066605: AB_2685693, HPA075188: AB_2732283" "unprognostic (7.35e-2)" "unprognostic (1.14e-2)" "unprognostic (7.67e-3)" "unprognostic (2.79e-4)" "unprognostic (9.15e-2)" "unprognostic (3.28e-2)" "unprognostic (7.31e-2)" "unprognostic (3.11e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (4.69e-2)" "unprognostic (2.89e-3)" "unprognostic (2.00e-6)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.90e-3)" "unprognostic (4.97e-3)" 3.3 23.5 10.5 3.0 13.8 2.1 2.9 4.5 11.6 6.4 1.6 4.6 0.1 1.8 3.1 1.9 13.0 1.7 3.2 11.6 11.7 4.6 3.4 1.1 1.3 6.2 8.1 5.2 1.6 1.3 1.5 1.0 2.0 10.6 1.4 1.4 6.8 3.7 1.7 8.8 19.7 1.3 2.9 4.1 2.4 1.6 2.8 9.9 2.5 7.2 7.1 9.0 2.9 8.7 0.0 0.0 1.6 0.6 0.0 0.3 0.0 9.4 0.6 5.3 0.0 3.1 0.1 2.7 0.2 3.3 0.3 0.6 0.2 1.0 2.8 0.7 0.1 0.1 17.3 2.0 5.4 1.2 5.9 4.2 5.2 0.5 1.3 0.5 0.2 5.8 0.6 1.5 0.4 0.2 0.5 0.2 2.2 2.0 0.2 11.4 2.1 1.7 2.3 1.9 0.4 0.2 4.5 4.8 1.2 0.7 0.8 1.1 5.4 0.6 0.6 0.4 3.1 0.3 0.4 0.2 0.3 5.7 0.0 0.2 0.4 1.3 0.9 1.3 3.2 0.6 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.0 10.5 13.8 4.5 11.6 11.7 4.6 8.1 5.2 10.6 9.9 0.0 0.0 0.0 0.3 4.8 2.8 0.4 2.5 0.0 0.0 1.8 5.9 0.3 3.3 0.5 1.3 0.8 0.4 0.0 0.2 0.4 0.4 0.5 0.0 0.0 0.3 17.5 0.0 0.6 0.3 3.4 1.7 0.3 1.7 0.0 0.3 12.7 1.0 0.0 2.1 0.1 2.5 0.0 0.9 1.2 1.3 8.4 0.6 0.0 0.6 0.9 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139395-192767764 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 381.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA071557: AB_2686417" "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.2 21.5 8.8 0.7 15.8 0.6 1.0 17.7 31.9 0.9 0.9 1.9 0.0 1.0 1.2 0.7 1.5 1.5 0.9 75.7 6.8 4.1 2.0 0.9 1.2 0.7 5.1 15.8 1.1 4.9 0.7 2.9 0.8 22.3 1.3 0.8 1.1 3.6 4.2 1.1 0.7 0.7 1.0 2.7 6.8 0.9 1.7 2.8 0.0 1.4 0.0 0.7 0.8 0.8 1.1 0.3 1.2 0.4 0.5 0.4 0.1 0.0 0.8 11.8 0.0 0.0 0.0 0.1 0.0 0.1 1.1 1.4 0.0 0.1 0.6 5.7 0.2 0.2 0.1 0.0 0.0 1.3 0.1 0.1 2.4 5.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.0 3.3 0.0 0.0 8.1 5.4 0.2 0.0 0.1 0.0 3.7 1.4 18.9 0.0 0.0 0.4 0.0 1.4 0.9 0.2 0.3 4.9 2.5 0.0 11.3 0.1 1.8 0.0 1.0 0.0 13.7 1.2 0.2 0.5 0.2 0.3 0.4 1.1 0.2 0.2 0.1 0.5 0.4 0.3 0.6 0.5 0.4 0.3 0.3 0.1 8.8 15.8 17.7 31.9 6.8 4.1 5.1 15.8 22.3 2.8 0.0 0.0 0.0 4.3 0.6 77.1 381.1 0.0 1.4 3.4 5.2 3.9 0.1 6.6 0.7 15.9 4.9 0.0 0.0 11.4 0.2 0.8 1.0 0.0 0.0 0.1 31.8 0.0 8.6 0.3 21.4 6.4 0.0 1.7 0.0 0.0 2.9 4.0 0.2 1.1 0.2 13.0 0.0 0.5 2.1 6.1 0.1 0.0 0.0 0.0 1.4 FGF13 "FGF2, FHF2" ENSG00000129682 "Fibroblast growth factor 13" Q92913 X 138614731-139222777 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.7;parathyroid gland: 44.3;skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 22.0;Leydig cells: 24.2;Muller glia cells: 40.7;Peritubular cells: 23.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 7.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 7.4" "Cell line enhanced" "Detected in many" "AF22: 19.8;fHDF/TERT166: 17.1;HAP1: 18.1;RPMI-8226: 15.4;U-2197: 31.9;WM-115: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002809 Supported Cytosol NA NA Cytosol "HPA002809: AB_1078855" "unprognostic (3.23e-1)" "unprognostic (3.13e-2)" "unprognostic (5.42e-2)" "unprognostic (1.42e-2)" "unprognostic (1.87e-1)" "unprognostic (2.87e-3)" "unprognostic (9.92e-3)" "unprognostic (2.97e-3)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (5.22e-3)" "unprognostic (6.79e-2)" "unprognostic (4.96e-4)" "unprognostic (4.36e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (7.48e-2)" 11.1 1.9 30.0 1.9 29.5 2.7 4.2 0.9 22.9 7.9 3.1 1.5 2.4 2.7 7.0 2.8 4.4 2.6 4.1 1.3 36.7 22.3 4.9 1.4 1.7 3.1 19.7 12.9 6.0 0.9 44.3 2.4 8.4 7.8 11.6 3.3 4.8 6.5 3.5 37.0 1.1 3.1 4.5 3.3 3.8 2.9 2.7 4.1 0.0 3.6 7.9 1.6 3.5 5.7 0.5 0.9 7.4 0.5 0.2 0.3 0.1 0.0 0.2 19.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 17.1 0.1 1.2 18.1 0.0 0.0 0.2 5.0 0.1 0.1 0.7 0.7 0.1 0.2 0.3 0.4 0.0 0.0 0.1 0.0 1.1 0.7 5.7 2.0 0.1 0.0 0.1 2.0 0.0 6.5 2.9 1.3 15.4 2.9 0.1 0.1 0.0 0.0 0.1 12.1 10.2 0.0 0.1 0.4 0.6 0.9 31.9 8.4 7.5 4.2 0.0 7.1 5.7 17.1 2.7 0.5 1.6 0.2 0.3 0.1 0.5 0.2 0.1 0.1 0.4 0.3 0.2 7.4 0.2 0.5 0.9 0.2 0.1 30.0 29.5 0.9 22.9 36.7 22.3 19.7 12.9 7.8 4.1 0.0 0.0 0.0 3.1 0.3 3.1 1.6 12.7 2.7 4.5 7.0 0.0 0.2 14.9 3.2 0.0 1.9 0.0 0.0 4.8 0.2 2.7 15.0 0.0 0.0 22.0 0.0 2.4 1.3 2.5 0.2 24.2 0.7 1.7 1.0 0.5 40.7 5.7 5.8 23.0 2.5 4.5 32.3 11.8 0.0 1.3 0.6 0.1 0.0 0.1 0.6 FGF14 "FHF4, SCA27" ENSG00000102466 "Fibroblast growth factor 14" Q92915 13 101710804-102402457 "Disease related genes, Predicted intracellular proteins" "Growth factor" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 46.4;cervix, uterine: 23.2;fallopian tube: 15.7" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 37.1;Ciliated cells: 96.4;Horizontal cells: 30.2;Late spermatids: 22.8" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Region enhanced" "Detected in all" "cerebellum: 46.4" "Group enriched" "Detected in some" 11 "memory CD4 T-cell: 1.0;T-reg: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049828 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA049828: AB_2680901" "unprognostic (2.12e-1)" "unprognostic (1.57e-1)" "unprognostic (2.83e-2)" "unprognostic (2.27e-2)" "unprognostic (8.55e-2)" "unprognostic (1.28e-1)" "unprognostic (3.33e-1)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.22e-2)" "unprognostic (1.22e-1)" "unprognostic (2.45e-1)" "unprognostic (7.80e-3)" "unprognostic (2.20e-3)" "unprognostic (1.65e-1)" "unprognostic (3.86e-2)" "unprognostic (8.48e-2)" 1.6 4.4 6.0 0.8 12.1 0.4 0.8 46.4 13.6 23.2 0.9 1.0 0.1 1.2 0.8 1.5 2.4 15.7 1.1 3.5 4.5 10.4 1.3 2.1 3.0 0.6 2.3 4.5 0.5 1.5 0.5 4.6 0.6 6.5 0.7 1.1 0.0 1.2 1.4 0.7 1.2 0.8 0.8 1.8 0.6 3.2 3.5 3.6 0.0 0.7 0.0 0.5 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 4.9 20.9 0.0 0.0 0.1 0.2 0.0 0.0 0.5 0.2 0.3 0.3 0.0 0.3 0.0 0.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 6.0 12.1 46.4 11.4 4.5 10.4 2.3 4.5 6.5 3.6 3.0 1.0 0.0 0.5 0.5 37.1 5.6 5.1 96.4 14.8 0.0 0.0 0.0 0.0 0.1 15.2 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 2.4 0.1 30.2 18.4 0.0 0.0 22.8 2.3 0.0 1.7 0.0 0.1 5.7 0.2 0.0 0.0 0.3 2.9 0.0 0.5 3.0 7.0 0.5 0.0 0.0 0.0 0.0 FGF16 MF4 ENSG00000196468 "Fibroblast growth factor 16" O43320 X 77447405-77457278 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.2;seminal vesicle: 4.2" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebral cortex: 1.5;hypothalamus: 1.1;pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 22.7" "Group enriched" "Detected in some" 6 "basal ganglia: 3.7;hippocampal formation: 2.2;olfactory region: 8.3" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (4.01e-2)" "unprognostic (5.30e-2)" "unprognostic (1.12e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.31e-1)" "unprognostic (6.57e-2)" "unprognostic (1.49e-2)" 3.2 0.0 0.2 0.1 0.2 0.0 2.3 0.1 1.5 0.1 0.5 0.7 0.1 0.0 1.2 0.6 0.5 0.4 0.7 1.0 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 1.8 0.1 0.2 0.1 0.5 4.2 1.3 0.4 0.4 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 2.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 1.5 0.1 1.1 0.1 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 FGF17 FGF-13 ENSG00000158815 "Fibroblast growth factor 17" O60258 8 22042398-22048809 "Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 31.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 8.6;Cone photoreceptor cells: 13.7" "Cancer enhanced" "Detected in some" "testis cancer: 3.9" "Region enriched" "Detected in many" 4 "cerebellum: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.2;Hep G2: 2.4;MOLT-4: 2.3;RPMI-8226: 4.4" "Region enriched" "Detected in single" 4 "basal ganglia: 2.2" "Low region specificity" "Detected in some" HPA052600 Uncertain "Secreted in brain" NA NA "HPA052600: AB_2681881" "unprognostic (3.45e-2)" "unprognostic (1.64e-2)" "unprognostic (3.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.33e-2)" "unprognostic (3.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (7.92e-5)" "unprognostic (6.85e-2)" "unprognostic (2.58e-4)" "unprognostic (6.55e-3)" "unprognostic (7.18e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-3)" 0.4 4.9 2.5 0.4 3.2 0.2 0.4 31.3 7.7 0.5 0.4 0.4 0.4 0.2 2.2 0.6 0.4 0.7 0.6 0.4 2.2 4.7 0.4 0.4 0.5 0.4 1.3 2.9 0.5 2.6 3.6 2.1 0.4 3.3 1.2 0.2 0.4 2.4 0.5 0.4 0.9 0.4 1.0 0.9 3.0 0.8 0.6 0.4 1.6 2.3 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.6 0.6 1.0 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.9 0.7 0.0 2.4 0.1 0.0 1.5 0.0 0.3 0.0 0.1 1.4 0.0 1.2 0.1 0.1 0.0 0.7 2.3 0.8 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.0 1.6 0.0 0.0 0.2 0.3 0.0 1.2 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.2 31.3 7.7 2.2 4.7 1.3 2.9 3.3 0.4 0.0 0.0 0.0 0.2 0.0 8.6 0.8 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.1 0.1 0.0 1.1 0.0 1.1 0.0 0.3 0.2 0.2 0.0 0.2 0.0 0.0 0.1 FGF18 "FGF-18, ZFGF5" ENSG00000156427 "Fibroblast growth factor 18" O76093 5 171419656-171457623 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 23.0" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 6.0;Cardiomyocytes: 14.9;Smooth muscle cells: 6.2" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.0;ovarian cancer: 21.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 57 "EFO-21: 66.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA018795 Uncertain "Secreted in other tissues" NA NA "HPA018795: AB_1848523" "unprognostic (3.01e-1)" "unprognostic (2.38e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-3)" "unprognostic (6.62e-3)" "unprognostic (1.50e-1)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-3)" "unprognostic (3.65e-2)" "unprognostic (3.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.37e-8)" "unprognostic (7.33e-2)" "unprognostic (2.58e-1)" "unprognostic (3.19e-1)" "unprognostic (2.76e-2)" 4.4 0.6 0.6 2.8 0.6 0.1 2.0 0.4 1.2 1.3 0.8 0.5 0.0 1.1 1.6 1.5 0.9 2.0 1.4 23.0 0.5 0.4 1.3 0.4 2.9 0.5 0.4 0.0 1.6 0.9 0.1 1.8 0.9 1.6 2.2 0.3 0.3 1.0 0.7 5.4 1.8 2.2 1.2 0.9 1.1 0.7 1.0 0.3 0.2 2.2 2.5 0.8 2.2 0.5 0.9 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 66.7 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.6 0.4 1.2 0.5 0.4 0.4 0.0 1.6 0.3 6.0 0.0 0.0 0.7 2.2 0.0 14.9 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 4.1 3.5 0.4 0.0 0.0 0.2 2.7 3.0 0.0 0.0 0.1 0.0 1.7 4.9 0.0 0.4 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 6.2 0.5 1.0 2.8 0.0 0.0 1.2 0.9 FGF19 ENSG00000162344 "Fibroblast growth factor 19" O95750 11 69698232-69704642 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "gallbladder: 62.4" "Cell type enriched" "Detected in some" 5 "Cholangiocytes: 38.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CAPAN-2: 47.6" "Region enhanced" "Detected in single" "basal ganglia: 0.8" "Region enriched" "Detected in single" 19 "basal ganglia: 0.9" HPA036082 Approved "Secreted to blood" NA NA 133000 "HPA036082: AB_10669665" "unprognostic (7.46e-3)" "unprognostic (2.43e-3)" "unprognostic (5.52e-3)" "unprognostic (1.22e-1)" "unprognostic (4.68e-3)" "unprognostic (6.45e-2)" "unprognostic (5.72e-3)" "unprognostic (2.26e-1)" "unprognostic (6.39e-3)" "unprognostic (1.66e-2)" "unprognostic (8.82e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.4 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.4 38.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.1 0.0 0.0 0.1 1.6 FGF20 ENSG00000078579 "Fibroblast growth factor 20" Q9NP95 8 16992169-17002181 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 11 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;CAPAN-2: 10.5;OE19: 2.5" "Region enhanced" "Detected in some" "midbrain: 0.7" "Region enriched" "Detected in some" 5 "cerebellum: 3.4" "Secreted in other tissues" NA NA "unprognostic (1.93e-2)" "unprognostic (2.19e-1)" "unprognostic (5.57e-3)" "unprognostic (3.95e-2)" "unprognostic (1.59e-3)" "unprognostic (1.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.65e-2)" "unprognostic (9.32e-2)" "unprognostic (9.95e-2)" "unprognostic (3.92e-1)" "unprognostic (4.08e-2)" 0.2 2.0 1.9 0.2 1.6 0.0 1.1 9.0 3.7 3.9 0.1 4.0 0.1 0.4 0.1 2.5 0.1 0.8 1.2 0.3 2.3 2.1 0.1 0.1 0.1 0.5 2.9 2.4 2.5 0.2 0.0 0.9 0.5 2.7 0.6 0.2 0.8 3.8 0.6 0.1 0.0 0.2 0.1 4.2 3.6 2.2 0.8 1.1 0.1 0.5 0.1 1.6 0.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.4 0.0 1.2 3.3 0.5 1.6 0.0 10.5 0.0 0.0 0.0 0.4 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 9.0 3.7 2.3 2.1 2.9 2.4 2.7 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF21 ENSG00000105550 "Fibroblast growth factor 21" Q9NSA1 19 48755559-48758333 "Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 113 "liver: 37.8" "Cell type enriched" "Detected in some" 12 "Cardiomyocytes: 67.7" "Cancer enriched" "Detected in single" 315 "liver cancer: 33.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HHSteC: 3.1;U-2 OS: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061286 Supported "Secreted to blood" NA NA 254000 "HPA061286: AB_2684466" "unprognostic (1.64e-2)" "unprognostic (3.62e-1)" "unprognostic (3.21e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-1)" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 3.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF22 ENSG00000070388 "Fibroblast growth factor 22" Q9HCT0 19 639879-644371 "Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 14.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 7.5;Horizontal cells: 12.7;Rod photoreceptor cells: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (2.84e-3)" "unprognostic (1.04e-2)" "unprognostic (1.17e-1)" "unprognostic (5.25e-4)" "unprognostic (1.16e-1)" "unprognostic (3.66e-3)" "unprognostic (2.85e-1)" "unprognostic (1.27e-2)" "unprognostic (1.10e-4)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (3.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.31e-1)" "unprognostic (8.36e-2)" 0.5 0.7 2.2 0.0 2.6 0.1 0.4 0.9 3.5 0.1 0.1 0.4 0.4 0.0 0.1 0.2 0.0 0.1 1.8 2.3 0.2 0.1 0.2 0.1 2.0 2.7 0.0 0.0 0.0 0.2 0.6 0.1 1.2 0.4 1.3 14.1 0.2 0.1 0.8 0.2 0.1 0.6 0.1 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.7 1.0 0.3 5.9 0.4 0.0 1.4 0.4 0.0 0.2 0.0 1.4 0.2 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.0 0.9 2.5 0.3 1.7 0.7 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 1.7 0.3 0.0 2.1 0.0 0.0 1.1 0.4 0.6 1.2 2.2 1.5 0.0 0.3 0.2 1.0 0.5 0.7 0.5 0.0 0.6 0.0 0.4 0.1 1.7 0.3 0.5 0.6 0.4 0.2 0.4 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 1.7 0.7 7.5 1.4 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.5 0.4 0.0 0.0 0.3 1.0 2.2 0.0 0.2 0.2 12.7 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.3 3.2 0.2 0.0 0.0 0.1 5.6 0.0 2.1 0.7 1.4 0.9 2.9 0.7 0.3 0.5 FGF23 ENSG00000118972 "Fibroblast growth factor 23" Q9GZV9 12 4368227-4379728 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters" Differentiation "Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 9.8;Early spermatids: 3.8;Ito cells: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 5.5;HBEC3-KT: 4.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 56800 "unprognostic (1.31e-1)" "unprognostic (2.18e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" 0.3 0.4 0.2 0.2 0.2 0.8 0.2 0.2 0.8 0.2 0.2 0.2 0.2 0.4 0.5 3.5 1.2 0.5 0.2 9.1 0.2 0.2 0.3 10.1 0.3 2.6 0.2 0.2 0.3 0.2 0.1 0.4 0.3 0.2 0.2 1.4 0.2 1.0 0.2 2.5 0.4 0.3 0.7 0.2 1.1 0.2 0.9 0.2 0.6 0.3 0.2 1.3 6.7 0.2 3.1 2.9 11.1 3.6 3.4 3.1 1.7 0.2 0.0 5.5 1.8 2.9 0.6 0.8 0.1 0.1 0.0 0.2 1.0 2.0 0.3 0.2 0.9 0.3 1.2 0.8 4.0 0.2 0.2 0.6 0.2 0.7 0.6 1.6 1.2 0.5 1.6 0.2 2.5 3.3 0.3 0.4 0.2 0.5 2.3 0.1 0.0 0.7 1.4 1.4 0.3 0.2 0.9 0.1 0.9 0.7 1.1 1.2 1.1 0.0 1.8 0.2 1.0 1.3 0.8 0.0 2.0 0.5 1.4 0.3 0.1 0.2 0.3 1.2 0.4 1.3 11.1 2.3 2.9 2.6 2.4 3.1 2.9 2.5 2.0 1.8 3.1 2.8 2.9 7.2 3.4 3.6 2.9 2.3 1.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.8 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 1.6 0.0 14.1 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.1 FGF3 "HBGF-3, INT2" ENSG00000186895 "Fibroblast growth factor 3" P11487 11 69809969-69819024 "Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "brain: 16.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 38 "cerebellum: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 4.8" "Region enhanced" "Detected in some" "basal ganglia: 2.7" "Not detected" "Not detected" HPA012692 Enhanced "Secreted in brain" NA NA "HPA012692: AB_1848526" "unprognostic (6.42e-3)" "unprognostic (7.82e-2)" "unprognostic (1.89e-1)" "unprognostic (3.61e-1)" "unprognostic (7.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF4 "HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF" ENSG00000075388 "Fibroblast growth factor 4" P08620 11 69771016-69775403 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0" "Cell type enhanced" "Detected in single" 28 "Early spermatids: 2.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 13.9" "Group enriched" "Detected in some" 19 "midbrain: 2.6;pons and medulla: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 64 "NTERA-2: 18.6;SuSa: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA011209 Uncertain "Secreted in other tissues" NA NA 326000 "HPA011209: AB_1848527" "unprognostic (1.47e-2)" "unprognostic (6.22e-2)" "unprognostic (7.77e-2)" "unprognostic (8.56e-2)" 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 1.2 0.8 0.1 2.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 FGF5 ENSG00000138675 "Fibroblast growth factor 5" P12034 4 80266599-80336680 "Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 38.2" "Cell type enhanced" "Detected in some" 16 "Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "cerebellum: 38.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB010313, HPA042442" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Secreted in brain" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB010313: AB_2102677, HPA042442: AB_2678001" "unprognostic (6.44e-2)" "unprognostic (6.24e-3)" "unprognostic (8.49e-4)" "unprognostic (1.10e-1)" "unprognostic (2.91e-1)" "unprognostic (2.80e-3)" "unprognostic (6.87e-4)" "unprognostic (2.53e-1)" "unprognostic (1.69e-1)" "unprognostic (3.57e-3)" "unprognostic (1.17e-2)" "unprognostic (3.33e-16)" "unprognostic (3.02e-3)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" 0.1 0.1 0.1 1.7 0.1 0.5 0.1 38.2 1.3 0.1 3.1 0.0 0.0 0.4 0.4 0.1 1.3 0.1 9.2 0.3 1.6 0.2 2.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.0 1.3 0.1 4.1 0.2 0.1 0.0 0.1 0.0 0.5 0.4 2.8 2.4 0.3 0.1 0.8 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.7 1.7 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 7.2 0.0 20.2 38.1 5.3 3.9 0.0 0.0 0.0 0.0 27.5 0.4 0.0 0.0 7.0 28.7 0.0 0.3 0.0 0.0 0.0 0.5 0.2 0.0 2.0 0.0 15.6 7.5 9.0 1.8 0.0 0.0 0.1 25.7 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.5 35.6 1.4 1.7 17.0 0.0 0.0 0.0 2.0 0.0 0.7 1.7 0.3 0.3 0.4 0.2 0.5 0.2 0.3 0.4 0.2 0.7 0.5 0.5 0.9 0.2 0.2 0.7 0.2 0.0 0.1 0.1 38.2 1.3 1.6 0.2 0.2 0.2 4.1 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FGF6 ENSG00000111241 "Fibroblast growth factor 6" P10767 12 4428155-4445614 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "skeletal muscle: 24.6;tongue: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NB-4: 1.7;NTERA-2: 6.2;REH: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (4.29e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.9 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 6.2 0.0 0.0 6.6 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 FGF8 AIGF ENSG00000107831 "Fibroblast growth factor 8" P55075 10 101770130-101780369 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 30.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "endometrial cancer: 2.1;testis cancer: 3.3;urothelial cancer: 0.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 20 "RH-30: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (1.56e-1)" "unprognostic (3.90e-3)" "unprognostic (1.12e-2)" "unprognostic (4.88e-1)" "unprognostic (2.47e-2)" "unprognostic (9.09e-2)" "unprognostic (8.75e-3)" "unprognostic (8.12e-2)" "unprognostic (1.75e-1)" "unprognostic (2.95e-2)" "unprognostic (1.17e-2)" "unprognostic (2.35e-9)" "unprognostic (6.17e-3)" "unprognostic (9.01e-2)" "unprognostic (1.97e-1)" 0.3 0.0 0.6 0.1 0.6 0.0 0.2 0.1 2.2 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 1.9 1.9 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 30.5 0.0 0.1 0.1 0.2 0.3 0.0 3.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 2.1 1.6 4.8 3.0 2.6 2.5 1.3 0.4 0.1 0.2 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.5 0.0 0.0 0.4 0.2 0.0 0.0 0.8 0.7 0.2 0.1 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.2 0.6 0.0 0.3 0.4 1.6 0.1 0.0 0.0 0.4 31.3 0.6 0.0 0.2 0.6 0.7 0.0 0.4 0.3 0.0 0.5 0.0 0.4 0.5 0.9 0.6 0.1 0.1 0.5 0.9 0.6 0.5 0.6 4.8 1.5 1.8 1.2 1.9 2.5 1.6 1.9 1.5 1.4 2.1 2.4 2.3 4.2 2.6 3.0 1.6 1.7 1.3 0.6 0.6 0.1 2.2 1.9 1.9 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 FGF9 ENSG00000102678 "Fibroblast growth factor 9" P31371 13 21671383-21704498 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;kidney: 21.7" "Cell type enhanced" "Detected in many" 23 "Distal tubular cells: 33.2;Horizontal cells: 38.1;Muller glia cells: 152.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.0;T-cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.4;HEK 293: 2.4;JURKAT: 3.8;RPMI-8226: 3.6;RPTEC TERT1: 5.5;SCLC-21H: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067007 Enhanced Approved "Secreted in other tissues" NA NA "HPA067007: AB_2732755" "unprognostic (6.59e-3)" "unprognostic (9.09e-3)" "unprognostic (2.15e-2)" "unprognostic (9.24e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.42e-4)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (3.86e-1)" "unprognostic (2.38e-3)" "unprognostic (7.93e-2)" "prognostic favorable (1.70e-6)" "unprognostic (5.38e-2)" "unprognostic (1.27e-1)" "unprognostic (3.49e-1)" "unprognostic (6.92e-2)" 3.1 7.3 2.1 1.0 4.4 0.8 0.7 17.7 7.3 3.8 2.1 0.3 0.5 1.8 3.7 0.9 0.9 1.0 1.2 5.5 3.7 2.6 21.7 0.5 2.6 0.6 2.6 2.5 2.3 1.8 0.5 12.0 0.7 12.6 1.1 3.1 2.4 1.2 1.6 1.4 0.5 4.0 4.0 2.5 0.6 2.2 1.5 0.3 0.0 0.6 0.0 0.5 3.0 1.4 1.0 0.0 0.0 0.2 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 2.4 0.0 1.7 0.9 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 1.1 3.6 5.5 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.7 1.4 1.7 0.0 1.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 2.1 4.4 17.7 7.3 3.7 2.6 2.6 2.5 12.6 0.3 8.9 3.5 0.0 0.2 1.4 13.4 21.0 0.0 0.0 2.3 3.5 0.0 0.0 33.2 0.2 3.4 0.5 3.5 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 38.1 17.9 0.0 0.0 3.0 0.6 0.0 1.7 2.8 0.9 152.2 0.2 0.0 0.0 0.5 4.6 0.0 0.5 1.4 1.9 1.3 0.2 0.0 6.2 0.1 FGFBP1 "FGFBP, HBP17" ENSG00000137440 "Fibroblast growth factor binding protein 1" Q14512 4 15935569-15938740 "Cancer-related genes, Predicted secreted proteins" "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 927.5;Suprabasal keratinocytes: 687.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 246.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 79.0;HBEC3-KT: 136.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA004332 Enhanced "Secreted in other tissues" NA NA "HPA004332: AB_1078856" "unprognostic (2.87e-3)" "unprognostic (3.55e-1)" "unprognostic (5.03e-2)" "unprognostic (6.99e-2)" "unprognostic (1.86e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (5.03e-4)" "unprognostic (1.03e-1)" "unprognostic (1.34e-2)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (3.31e-3)" 0.2 0.0 0.2 0.6 0.2 0.0 4.1 0.2 0.2 27.1 5.1 0.2 0.2 0.4 1.1 0.2 106.6 0.1 0.3 0.2 0.2 0.0 0.3 0.2 1.9 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.7 0.2 0.3 4.6 0.4 14.1 0.2 0.2 14.6 1.3 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.3 133.1 56.8 1.8 31.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 20.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 1.5 0.0 0.0 79.0 0.0 136.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.7 0.0 0.0 0.0 13.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 5.9 0.0 92.0 927.5 0.0 0.0 0.0 37.5 51.2 0.0 0.0 0.1 0.0 10.2 0.0 0.0 32.6 0.0 6.6 0.0 6.1 13.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 70.9 1.0 12.3 0.0 81.1 20.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 687.3 1.9 0.0 8.4 179.5 FGFBP2 KSP37 ENSG00000137441 "Fibroblast growth factor binding protein 2" Q9BYJ0 4 15960243-15969309 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 79.8" "Group enriched" "Detected in many" 8 "Melanocytes: 43.9;T-cells: 86.3" "Group enriched" "Detected in many" 9 "glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9" "Region enriched" "Detected in many" 6 "midbrain: 16.0" "Cell type enhanced" "Detected in many" "gdT-cell: 79.8" "Lineage enriched" "Detected in many" 10 "T-cells: 79.8" "Cell line enhanced" "Detected in some" "SK-MEL-30: 11.2;T-47d: 5.5;WM-115: 2.2" "Secreted to blood" NA NA 346000000 6900000 "unprognostic (3.51e-3)" "unprognostic (8.81e-3)" "unprognostic (1.21e-1)" "unprognostic (2.54e-1)" "unprognostic (2.55e-2)" "unprognostic (1.54e-1)" "unprognostic (6.14e-2)" "unprognostic (1.35e-2)" "unprognostic (9.89e-2)" "unprognostic (1.76e-1)" "unprognostic (2.55e-2)" "unprognostic (3.33e-1)" "unprognostic (3.51e-2)" "unprognostic (1.87e-1)" "unprognostic (1.59e-2)" "unprognostic (9.61e-2)" "unprognostic (1.49e-2)" 21.0 1.4 0.3 0.4 1.0 33.4 19.4 0.0 0.9 1.1 7.1 0.2 0.9 0.2 0.6 6.0 3.4 0.7 0.8 16.1 0.4 0.2 0.5 0.8 6.7 1.9 16.0 1.0 0.9 0.2 0.1 0.2 0.8 2.8 3.1 0.8 30.7 5.7 0.9 6.7 14.4 1.8 5.3 5.0 10.4 1.2 11.3 0.0 5.8 0.7 3.8 1.9 1.5 3.7 0.1 0.2 1.2 0.2 8.3 79.8 39.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 11.2 0.3 5.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 2.2 0.4 0.1 0.3 79.8 0.1 0.7 0.1 19.7 47.0 0.1 0.0 7.6 47.5 1.2 8.3 0.2 0.2 0.1 39.3 0.3 1.0 0.0 0.9 0.4 0.2 16.0 1.0 2.8 0.0 0.0 7.7 0.9 0.0 8.5 0.0 1.4 0.0 0.0 2.3 5.2 7.9 0.2 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 5.2 0.0 3.5 0.2 0.0 0.0 0.0 4.9 0.3 1.7 0.0 2.2 43.9 0.0 0.0 1.0 0.2 0.0 0.4 0.8 0.3 0.0 0.8 0.3 0.1 6.8 0.8 86.3 0.0 0.0 FGFBP3 "C10orf13, MGC39320" ENSG00000174721 "Fibroblast growth factor binding protein 3" Q8TAT2 10 91906589-91909483 "Predicted secreted proteins" "Growth factor binding, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 20.6" "Cell type enhanced" "Detected in many" 10 "Intestinal endocrine cells: 44.4;Muller glia cells: 21.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "AF22: 85.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053943 Uncertain "Secreted in brain" NA NA "HPA053943: AB_2682318" "unprognostic (8.66e-2)" "unprognostic (6.00e-2)" "unprognostic (4.47e-2)" "unprognostic (2.88e-1)" "unprognostic (9.98e-3)" "unprognostic (7.76e-2)" "unprognostic (1.43e-1)" "unprognostic (1.96e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.39e-3)" "unprognostic (2.61e-1)" "unprognostic (3.90e-1)" "unprognostic (6.95e-2)" "unprognostic (2.85e-1)" "unprognostic (2.63e-1)" "unprognostic (6.76e-3)" 1.4 2.1 6.4 1.4 4.6 1.0 2.0 3.4 20.6 1.3 1.6 4.1 0.3 1.1 1.8 2.8 1.0 1.1 0.6 2.1 6.9 5.9 1.4 0.8 1.1 2.2 4.0 5.6 2.5 1.9 2.0 2.3 0.9 6.7 2.3 1.9 0.5 1.9 1.4 3.3 1.8 1.1 1.0 3.9 1.7 2.2 1.1 4.4 0.9 2.7 0.3 1.2 1.0 0.8 3.7 0.6 2.0 0.5 0.9 1.9 0.2 0.0 0.6 85.8 1.2 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.1 0.1 0.0 0.3 0.5 0.0 0.2 0.3 0.9 1.7 0.7 1.0 0.2 9.1 0.2 0.2 0.1 0.4 0.4 0.2 0.0 1.1 0.8 0.3 0.0 0.7 1.0 3.7 6.3 0.3 0.3 2.7 0.5 0.1 0.1 0.2 0.9 1.1 0.2 0.0 1.4 0.5 0.3 0.1 0.1 0.1 0.6 0.1 0.2 0.2 0.5 0.3 0.0 1.0 0.1 2.0 0.5 0.0 1.7 0.1 0.6 2.1 1.1 0.9 0.6 3.7 1.9 1.4 0.0 0.9 0.0 0.3 0.1 0.2 6.4 4.6 3.4 6.4 6.9 5.9 4.0 5.6 6.7 4.4 0.0 1.3 0.0 4.3 1.1 11.6 3.6 5.1 8.1 4.5 5.2 2.0 2.4 16.6 1.6 0.3 1.6 0.9 0.0 3.0 0.9 2.6 4.6 0.0 1.5 1.2 6.4 44.4 0.6 4.3 0.0 5.5 2.2 3.3 0.0 5.4 21.5 0.7 3.1 3.5 2.5 14.1 0.0 1.7 0.3 1.0 2.4 0.8 6.9 4.0 3.9 FGFR1OP FOP ENSG00000213066 "FGFR1 oncogene partner" O95684 6 166999182-167094789 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.3" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 225.5;Late spermatids: 194.1;Spermatocytes: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071876 Approved Supported Centrosome NA NA Centrosome "HPA071876: AB_2686467" "unprognostic (9.14e-2)" "unprognostic (2.24e-1)" "unprognostic (3.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (9.59e-2)" "unprognostic (1.00e-1)" "unprognostic (6.95e-2)" "unprognostic (8.83e-2)" "unprognostic (1.08e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (3.15e-1)" "unprognostic (2.09e-3)" 6.2 12.2 11.2 12.9 12.5 9.8 10.2 11.9 13.0 10.1 9.5 6.9 11.8 10.8 13.6 14.1 8.8 19.1 7.9 6.4 10.8 9.1 12.2 24.9 6.7 9.4 6.4 11.5 11.8 10.2 8.2 17.2 6.6 9.4 7.4 12.1 8.9 8.1 11.6 5.8 7.9 13.0 7.4 7.4 9.4 7.8 50.3 8.0 14.5 12.5 6.2 11.8 7.0 8.2 6.8 10.0 24.1 4.1 3.5 6.8 3.0 11.6 6.5 16.5 11.2 9.7 7.3 20.0 15.1 10.1 12.4 12.0 24.0 9.9 13.9 8.6 9.2 33.0 11.0 14.4 10.7 23.3 8.7 12.4 9.6 11.7 26.0 5.2 17.0 10.1 4.0 7.9 25.3 11.9 7.7 8.5 15.8 31.2 11.9 15.8 10.7 13.7 25.0 14.0 22.5 5.0 15.8 11.2 11.5 12.9 6.3 12.3 12.3 12.3 13.2 5.2 12.1 10.9 21.1 5.5 12.3 20.6 14.7 18.8 10.2 14.0 14.1 13.9 16.0 15.0 0.2 4.1 13.5 3.3 3.6 4.9 6.8 3.9 3.1 6.5 5.0 2.3 3.7 24.1 3.5 3.6 10.0 6.8 3.0 11.2 12.5 11.9 13.0 10.8 9.1 6.4 11.5 9.4 8.0 11.9 15.6 12.7 7.4 5.4 20.9 11.2 15.3 30.8 12.5 5.2 21.6 12.3 10.0 11.1 225.5 5.5 15.2 46.7 6.4 13.6 6.8 4.7 4.7 18.8 9.2 9.5 10.3 6.2 7.6 194.1 12.0 7.7 5.0 15.4 12.7 9.3 8.4 12.9 12.0 14.3 55.1 6.5 6.6 97.9 28.4 5.6 5.3 13.1 13.2 4.3 FGFR2 "BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25" ENSG00000066468 "Fibroblast growth factor receptor 2" P21802 10 121478334-121598458 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Apoptosis "Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.8" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 191.1;Club cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 10.8;eosinophil: 4.6" "Lineage enriched" "Detected in single" 35 "granulocytes: 10.8" "Cell line enhanced" "Detected in some" "AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010886, HPA035305" Uncertain Supported "Nucleoplasm,Vesicles,Cell Junctions" "Secreted - unknown location" NA NA 500000 "Cell Junctions" "Nucleoplasm, Vesicles" "CAB010886: AB_259379, HPA035305: AB_10672862" "unprognostic (5.53e-2)" "prognostic favorable (8.79e-4)" "unprognostic (1.08e-1)" "unprognostic (5.23e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.32e-4)" "unprognostic (1.53e-1)" "unprognostic (4.96e-3)" "unprognostic (1.74e-1)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (3.74e-2)" "unprognostic (1.01e-1)" "unprognostic (6.11e-2)" "unprognostic (2.54e-1)" "unprognostic (6.93e-2)" "unprognostic (2.25e-1)" 2.1 8.8 16.4 3.0 30.3 0.0 9.9 15.8 21.3 6.8 14.1 55.7 5.6 4.2 22.0 6.6 10.2 12.5 12.5 1.4 20.6 11.1 11.4 16.1 13.1 1.0 41.2 13.3 7.4 12.8 25.5 2.5 6.2 30.2 11.7 8.7 16.4 23.8 24.3 0.4 45.4 4.7 18.3 74.8 0.5 9.3 2.9 32.1 0.8 23.4 1.6 3.4 6.9 8.5 0.1 0.1 10.8 0.1 0.1 0.3 0.0 2.2 0.1 9.2 58.9 0.0 0.0 19.8 0.1 0.0 0.0 0.0 15.4 0.3 0.0 4.2 0.9 0.0 17.8 19.1 4.0 0.0 0.0 4.1 0.0 0.0 0.3 0.4 0.0 3.8 0.0 8.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 18.9 2.7 0.0 0.0 0.0 2.3 5.7 5.0 0.1 0.1 0.1 10.8 0.0 11.5 15.8 0.0 0.0 0.1 2.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 10.8 0.1 4.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 16.4 30.3 15.8 21.3 20.6 11.1 41.2 13.3 30.2 32.1 17.9 31.8 0.0 29.5 35.6 0.0 2.7 191.1 18.7 52.4 34.9 0.0 12.6 0.0 4.0 2.9 0.5 2.6 0.0 0.2 2.7 17.5 9.8 0.0 4.3 2.0 0.0 2.4 3.1 0.3 6.5 1.1 1.3 5.0 1.0 32.0 1.6 0.6 1.4 5.6 11.5 0.1 0.0 2.1 0.9 7.7 24.2 3.3 1.5 3.0 27.7 FGFR3 "ACH, CD333, CEK2, JTK4" ENSG00000068078 "Fibroblast growth factor receptor 3" P22607 4 1793293-1808872 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Apoptosis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Craniosynostosis, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skin 1: 131.7" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 92.2;Cholangiocytes: 94.3;Suprabasal keratinocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.3;HaCaT: 15.1;Hep G2: 32.5;NTERA-2: 15.8;RT4: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004231, HPA067204" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 670000 "Endoplasmic reticulum" "CAB004231: AB_627596, HPA067204: AB_2685804" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (5.90e-2)" "unprognostic (1.24e-3)" "unprognostic (7.22e-2)" "unprognostic (2.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (2.88e-2)" "unprognostic (1.30e-1)" "unprognostic (9.11e-3)" "unprognostic (1.98e-1)" "unprognostic (4.74e-2)" "unprognostic (1.97e-1)" 1.5 1.5 24.7 1.7 30.3 1.6 4.2 10.2 22.0 4.1 4.9 15.8 3.4 9.9 1.8 2.7 26.9 2.0 5.0 2.0 21.6 11.7 9.6 7.4 4.5 1.3 17.6 21.5 1.1 23.0 1.2 3.0 5.6 15.1 3.7 3.8 1.7 3.8 9.0 1.7 131.7 7.4 1.3 9.0 2.1 4.9 8.1 10.6 0.1 1.3 8.5 7.3 8.5 10.1 0.1 0.6 0.1 0.1 0.2 0.3 0.0 0.0 1.5 9.2 2.6 0.0 0.1 9.4 1.1 0.1 0.4 0.2 19.3 0.4 0.0 7.7 0.3 0.4 15.1 2.6 0.1 0.1 0.1 9.7 6.0 1.5 32.5 0.0 0.0 0.2 0.0 5.1 0.1 0.0 0.0 0.0 0.9 6.5 0.0 0.0 9.6 0.4 0.2 15.8 8.8 0.0 0.5 0.5 0.1 1.3 19.3 2.7 0.7 0.8 1.6 0.0 11.1 9.0 1.1 0.4 0.0 0.9 0.2 0.6 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.6 0.1 0.0 24.7 30.3 10.2 22.0 21.6 11.7 17.6 21.5 15.1 10.6 0.0 23.8 2.4 3.6 92.2 0.0 2.0 94.3 0.0 21.6 14.0 0.0 0.4 0.0 4.8 5.4 0.9 20.6 0.0 0.6 9.2 7.0 3.3 0.0 27.0 0.5 0.0 4.1 14.7 1.2 0.4 0.6 1.2 11.8 1.0 20.7 0.2 0.4 17.3 0.4 7.5 0.6 0.0 2.8 0.4 17.9 77.5 0.7 0.0 13.0 11.8 FGFR4 "CD334, JTK2" ENSG00000160867 "Fibroblast growth factor receptor 4" P22455 5 177086886-177098144 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.6;kidney: 37.7;liver: 45.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 50.9;Hepatocytes: 23.7;Proximal tubular cells: 19.5;Sertoli cells: 19.4;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CACO-2: 43.0;Hep G2: 43.0;RH-30: 69.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB005196, HPA027273, HPA027369, HPA028251" Approved "Intracellular and membrane" NA NA 4300000 "CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221" "unprognostic (1.96e-1)" "unprognostic (2.10e-2)" "unprognostic (1.12e-1)" "unprognostic (9.06e-3)" "unprognostic (2.87e-1)" "unprognostic (1.95e-2)" "unprognostic (7.85e-3)" "unprognostic (9.19e-2)" "unprognostic (4.25e-1)" "unprognostic (4.46e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (1.78e-1)" "unprognostic (1.71e-3)" "unprognostic (2.41e-1)" "unprognostic (5.75e-2)" "unprognostic (4.68e-2)" 0.5 5.7 0.7 14.3 0.6 0.1 1.6 2.6 0.5 2.8 10.4 0.9 0.7 13.5 0.9 4.8 1.6 1.7 33.6 0.7 0.8 0.3 37.7 45.3 25.3 2.5 0.7 1.0 13.6 26.0 0.0 0.7 1.3 0.8 4.0 3.7 2.0 1.6 0.3 4.3 0.5 17.3 1.6 0.8 11.2 5.4 2.9 0.4 0.3 0.8 2.3 0.7 1.9 3.6 1.1 0.9 3.0 1.1 0.4 0.4 0.0 0.7 12.1 0.2 2.9 0.0 0.0 5.9 0.0 0.0 0.0 0.0 43.0 1.6 1.3 5.6 0.0 0.6 0.6 2.4 0.4 0.0 0.7 2.8 0.1 0.6 43.0 1.3 0.1 1.0 0.2 0.0 2.1 0.0 0.0 0.0 0.8 4.0 0.1 0.9 9.8 0.0 0.8 7.3 7.6 1.0 1.9 69.1 7.2 5.8 0.1 0.4 0.7 0.4 3.1 1.4 1.6 2.9 0.6 0.2 0.0 5.8 0.0 0.1 0.4 0.4 0.7 0.0 0.2 0.5 1.5 1.1 0.4 0.4 0.3 0.3 1.1 0.4 0.0 0.1 0.6 0.4 0.4 3.0 0.4 0.3 0.9 0.2 0.0 0.7 0.6 2.6 0.5 0.8 0.3 0.7 1.0 0.8 0.4 0.0 0.0 0.8 0.6 0.6 0.4 0.8 50.9 0.0 0.0 3.5 0.0 1.1 3.3 8.4 0.1 0.1 10.6 0.0 4.4 3.2 1.7 0.3 0.0 23.7 0.3 0.0 4.1 2.5 0.8 0.0 0.6 0.0 0.0 1.0 5.2 0.9 3.6 2.9 1.4 19.5 0.1 19.4 0.5 1.6 12.8 0.4 7.3 0.0 33.6 0.6 FGFRL1 ENSG00000127418 "Fibroblast growth factor receptor like 1" Q8N441 4 1009936-1026897 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 51.1" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 29.6;Muller glia cells: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.5;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2" "Cell line enhanced" "Detected in many" "U-251 MG: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB026019, HPA068828" Approved Supported Vesicles No No Vesicles "CAB026019: , HPA068828: AB_2686043" "unprognostic (1.30e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "unprognostic (2.80e-2)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (2.62e-2)" "unprognostic (9.79e-2)" "unprognostic (4.87e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-3)" "unprognostic (1.49e-1)" "unprognostic (7.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.96e-2)" 21.8 22.9 16.0 6.1 20.5 5.8 21.5 13.8 20.6 8.1 6.6 9.1 5.3 6.6 6.6 5.0 4.7 19.7 9.8 12.2 16.6 3.6 11.5 25.1 6.4 4.0 8.8 8.4 14.0 51.1 12.6 9.0 3.1 17.0 7.6 4.8 12.7 29.3 3.1 9.6 3.7 6.0 4.1 14.0 5.3 15.0 3.2 11.1 1.0 33.8 3.9 3.6 6.2 11.5 0.4 0.3 1.2 3.6 0.1 1.2 0.4 8.5 11.6 4.2 12.8 4.5 4.7 1.1 15.2 2.3 4.9 3.2 8.4 17.7 0.9 19.8 23.2 22.0 2.2 8.1 5.1 4.5 3.2 7.9 0.1 15.2 22.1 9.2 4.9 2.1 9.9 4.4 8.4 3.6 18.3 4.6 3.4 9.3 3.3 2.9 11.1 5.7 13.5 5.3 14.4 31.6 9.4 6.2 6.0 8.5 1.3 0.4 0.8 14.1 0.3 5.6 5.3 8.4 4.3 9.9 26.2 10.7 13.2 36.8 3.6 4.8 1.3 6.9 5.7 8.4 1.2 0.1 0.0 0.7 3.5 0.1 0.4 1.2 0.2 0.3 0.1 0.2 0.5 0.0 0.1 3.6 0.3 0.1 0.4 16.0 20.5 13.8 20.6 16.6 3.6 8.8 8.4 17.0 11.1 3.0 5.5 0.5 2.9 5.8 4.7 7.5 7.6 9.4 4.5 7.0 0.0 1.2 0.0 8.0 0.2 2.2 3.2 0.0 8.9 16.2 4.6 8.6 1.1 29.6 2.6 0.0 1.7 4.9 2.1 1.0 4.0 2.9 6.8 1.0 8.1 87.5 15.6 3.5 3.2 6.2 5.1 0.0 4.2 0.2 2.2 4.1 1.3 2.5 3.2 5.1 FGG ENSG00000171557 "Fibrinogen gamma chain" P02679 4 154604134-154612967 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 495 "liver: 2225.7" "Cell type enriched" "Detected in many" 15 "Hepatocytes: 7797.1" "Cancer enriched" "Detected in many" 19 "liver cancer: 1503.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 55 "Hep G2: 128.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027529, CAB033120, HPA074638" Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 267000000000 68000000000 "Endoplasmic reticulum" "CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: " "unprognostic (1.26e-2)" "unprognostic (4.77e-3)" "unprognostic (6.33e-3)" "unprognostic (3.69e-3)" "unprognostic (2.18e-3)" "unprognostic (9.63e-2)" "unprognostic (7.57e-3)" "prognostic unfavorable (1.00e-6)" "unprognostic (1.75e-3)" "unprognostic (3.21e-1)" "unprognostic (1.14e-1)" 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 2.7 2225.7 4.4 0.0 0.0 0.0 0.2 0.7 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 128.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 17.9 218.6 146.9 0.0 0.0 0.0 0.2 507.0 2.7 4.5 0.0 0.0 0.0 0.0 3.8 2.8 0.0 0.0 327.1 40.0 0.1 0.0 0.0 10.5 7797.1 0.2 0.0 0.0 232.7 240.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 266.1 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.0 0.3 20.1 0.0 0.0 FGGY FLJ10986 ENSG00000172456 "FGGY carbohydrate kinase domain containing" Q96C11 1 59296638-59810647 "Disease related genes, Predicted intracellular proteins" "Kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.4" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 181.0;Cholangiocytes: 349.1;Hepatocytes: 122.9" "Cancer enhanced" "Detected in all" "liver cancer: 13.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 26.8;RH-30: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054971 Approved "Nucleoplasm,Nuclear bodies" NA NA 110000 "Nucleoplasm, Nuclear bodies" "HPA054971: " "unprognostic (4.15e-1)" "unprognostic (1.87e-1)" "unprognostic (2.31e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.47e-3)" "unprognostic (1.80e-2)" "unprognostic (4.09e-1)" "unprognostic (2.78e-1)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (4.36e-3)" "unprognostic (7.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.70e-1)" "unprognostic (1.78e-1)" 4.5 10.3 5.4 6.5 5.7 1.4 4.6 23.2 5.5 4.9 5.1 4.4 10.1 4.9 9.6 26.1 4.5 7.0 8.6 7.6 3.7 5.0 13.0 45.4 7.8 5.2 6.2 3.3 3.8 8.4 9.9 7.4 2.7 4.4 5.7 4.7 6.8 7.6 8.8 26.0 3.7 7.6 6.3 3.0 3.4 3.8 2.9 3.4 4.5 5.4 4.3 6.9 6.2 3.7 8.2 3.6 3.9 4.8 4.7 8.0 3.0 2.8 0.9 6.1 2.5 3.0 10.8 0.5 2.5 4.3 1.5 2.2 0.0 2.2 3.4 8.3 6.8 2.7 1.2 1.0 7.6 3.1 26.8 0.7 2.3 2.0 5.4 8.0 1.3 1.5 15.2 6.4 3.1 5.0 6.4 2.9 3.9 1.6 2.1 9.7 3.3 1.8 2.0 3.8 8.3 3.3 4.0 18.6 1.3 8.1 5.5 4.7 2.0 3.5 2.1 7.3 5.4 1.7 1.4 2.8 2.5 1.9 2.9 1.7 4.9 1.7 2.9 8.3 5.6 2.3 2.6 2.2 2.2 5.4 2.3 5.0 8.2 2.6 6.6 3.6 6.8 4.8 8.0 3.9 4.7 4.8 1.8 4.5 3.0 5.4 5.7 23.2 5.5 3.7 5.0 6.2 3.3 4.4 3.4 50.6 181.0 3.7 19.6 18.5 9.2 20.3 349.1 56.2 27.3 12.2 11.8 7.6 14.9 35.1 12.9 6.3 8.8 0.0 38.7 3.8 4.5 19.5 9.3 122.9 10.8 7.9 2.4 6.7 8.0 8.9 1.7 8.5 33.7 16.2 9.9 11.7 15.0 7.8 2.8 34.0 15.5 0.0 4.4 3.9 7.9 27.6 3.8 2.9 16.3 26.4 FGL1 HFREP-1 ENSG00000104760 "Fibrinogen like 1" Q08830 8 17864380-17910365 "Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 450.7" "Cell type enriched" "Detected in many" 23 "Hepatocytes: 6738.7" "Cancer enriched" "Detected in some" 40 "liver cancer: 399.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "A549: 22.2;Hep G2: 52.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 1800000 "unprognostic (3.62e-2)" "unprognostic (1.14e-2)" "unprognostic (1.75e-5)" "unprognostic (3.00e-1)" "unprognostic (3.54e-2)" "unprognostic (7.89e-2)" "unprognostic (2.15e-1)" "unprognostic (2.62e-1)" "unprognostic (2.71e-1)" "unprognostic (1.09e-2)" "unprognostic (2.86e-7)" "prognostic unfavorable (5.38e-4)" "unprognostic (3.62e-1)" "unprognostic (2.58e-2)" "unprognostic (1.35e-1)" 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 450.7 0.2 0.1 0.1 0.1 0.1 71.3 0.0 0.1 0.6 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 22.2 0.0 2.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.2 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 3.4 104.9 0.1 0.0 0.0 1.0 298.1 0.0 0.0 0.0 0.0 0.2 0.0 4.2 35.8 0.0 0.0 140.2 59.6 0.4 0.0 8.5 0.0 6738.7 15.3 0.0 0.0 190.3 185.3 19.0 0.6 0.0 0.0 2.8 0.0 0.0 121.6 0.0 0.4 0.0 0.0 0.0 0.3 0.7 0.5 0.0 0.8 0.0 0.0 0.1 FGL2 "pT49, T49" ENSG00000127951 "Fibrinogen like 2" Q14314 7 77193371-77199848 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.0" "Group enriched" "Detected in many" 5 "Kupffer cells: 431.4;Macrophages: 384.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 50 "classical monocyte: 59.3;eosinophil: 52.6;intermediate monocyte: 82.0;myeloid DC: 38.1;neutrophil: 68.4;non-classical monocyte: 73.5" "Group enriched" "Detected in many" 56 "dendritic cells: 38.1;granulocytes: 68.4;monocytes: 82.0" "Cell line enhanced" "Detected in some" "ASC diff: 4.1;Karpas-707: 3.8;LHCN-M2: 4.2;NB-4: 4.6;RPTEC TERT1: 8.0;U-937: 8.4;WM-115: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021011, HPA026682" Enhanced "Secreted to blood" NA NA 38800000 6400000 "HPA021011: AB_1848532, HPA026682: AB_1848533" "unprognostic (9.80e-3)" "unprognostic (4.70e-3)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (1.00e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-2)" "unprognostic (3.49e-1)" "unprognostic (2.70e-1)" "unprognostic (3.19e-1)" "unprognostic (1.27e-1)" "unprognostic (1.19e-1)" "unprognostic (5.00e-2)" "unprognostic (1.91e-2)" "unprognostic (2.33e-1)" "unprognostic (7.01e-2)" 30.0 8.7 6.0 28.7 10.7 1.5 18.0 5.7 4.7 8.0 29.5 5.0 7.7 14.2 7.6 18.4 41.4 13.8 16.2 17.8 5.1 5.5 23.3 14.3 17.0 28.1 10.3 4.1 6.4 3.0 1.8 8.0 7.0 11.4 17.9 20.3 6.8 11.7 4.4 6.2 8.6 40.9 73.7 18.4 63.4 16.9 3.4 8.6 12.0 19.2 18.3 9.1 55.8 7.7 1.0 38.1 68.4 82.0 0.7 1.1 34.6 0.0 0.0 0.0 0.0 4.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 3.8 4.2 0.1 0.0 4.6 0.3 0.0 0.2 0.2 0.5 0.4 8.0 1.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.3 8.4 9.0 0.6 59.3 52.6 1.1 82.0 0.5 1.0 0.7 1.0 38.1 0.5 0.4 0.8 68.4 0.7 73.5 1.2 1.1 34.6 6.0 10.7 5.7 4.7 5.1 5.5 10.3 4.1 11.4 8.6 6.0 18.4 34.2 1.0 33.9 1.1 3.2 0.0 4.0 9.1 83.7 9.8 1.1 5.0 0.2 7.0 45.8 11.9 0.0 0.0 1.0 69.5 0.8 9.3 4.2 36.4 1.6 0.0 56.4 431.4 7.1 25.6 384.4 47.2 1.0 0.3 11.3 0.1 2.8 18.4 5.4 7.7 0.0 9.5 0.5 0.3 27.4 3.1 19.2 0.3 1.4 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635277 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 30.1;U-266/70: 55.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 20.8 2.6 2.2 23.6 4.5 73.6 5.6 1.1 4.2 2.9 2.8 1.5 4.2 1.6 4.0 2.3 2.2 6.3 5.3 8.5 2.6 2.3 3.0 4.2 30.9 34.1 6.6 1.7 1.9 2.4 0.4 1.2 3.3 4.2 2.5 1.8 2.1 2.9 2.6 4.4 1.7 3.7 6.4 4.8 54.3 2.5 2.6 4.1 1.9 2.9 2.5 7.8 5.1 6.1 13.3 28.9 40.8 68.0 36.3 29.6 55.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 55.9 0.7 2.3 0.0 6.8 0.0 3.1 52.4 32.3 29.6 68.0 1.7 7.7 2.6 13.6 28.9 13.3 1.3 12.8 40.8 36.3 55.6 1.3 0.1 55.0 2.2 4.5 1.1 4.2 2.6 2.3 6.6 1.7 4.2 4.1 6.0 30.7 12.5 0.5 2.5 0.0 1.6 2.5 2.7 10.3 1.8 0.0 0.4 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.5 1.4 0.3 12.7 0.9 58.9 0.0 0.0 4.3 187.9 0.4 0.3 86.1 1.7 7.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.2 0.5 1.0 0.8 45.8 0.0 0.9 FH fumarase ENSG00000091483 "Fumarate hydratase" P07954 1 241497603-241519761 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Tricarboxylic acid cycle" Lyase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 161.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017785, HPA025770, HPA025948, HPA027341" Enhanced Supported Enhanced Mitochondria NA NA 2800000 Mitochondria "CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222" "unprognostic (1.03e-2)" "unprognostic (3.82e-2)" "unprognostic (9.46e-3)" "unprognostic (2.18e-1)" "unprognostic (2.10e-1)" "unprognostic (2.07e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-1)" "unprognostic (5.14e-2)" "unprognostic (1.85e-2)" "unprognostic (1.27e-2)" "unprognostic (1.09e-1)" "prognostic favorable (2.76e-7)" "unprognostic (1.05e-1)" "unprognostic (1.05e-1)" "unprognostic (4.41e-2)" "unprognostic (1.24e-2)" 14.3 28.1 15.7 10.4 20.2 9.3 13.3 15.7 24.4 10.5 22.7 9.9 16.7 23.2 13.7 10.7 17.7 10.3 9.5 59.0 22.9 13.9 35.0 93.4 9.9 13.3 15.2 19.4 9.4 13.9 25.2 11.4 14.3 18.4 12.3 24.4 10.2 18.4 20.6 65.1 13.4 21.4 14.7 14.4 11.1 17.5 14.0 11.7 13.8 12.3 45.2 13.4 13.4 11.2 16.0 26.4 4.5 18.8 10.4 13.9 8.9 29.3 24.6 23.3 21.0 22.9 27.1 37.0 36.4 28.5 41.1 25.8 35.1 18.3 18.6 24.1 27.8 18.0 41.8 35.6 27.0 35.8 21.3 11.5 17.5 26.0 30.0 20.6 40.8 15.9 19.6 16.9 23.0 26.0 14.4 25.2 41.2 53.1 24.1 29.9 14.6 35.1 27.3 24.8 42.8 52.8 29.1 25.5 83.6 39.6 24.9 30.0 26.0 30.6 36.3 23.2 16.8 27.7 27.7 24.8 18.5 23.8 32.6 60.5 21.6 23.1 22.6 20.6 46.9 26.5 4.5 12.8 2.7 9.7 18.8 12.6 16.0 11.4 9.0 26.4 14.1 13.9 12.7 0.7 10.4 15.7 13.2 13.2 8.9 15.7 20.2 15.7 24.4 22.9 13.9 15.2 19.4 18.4 11.7 35.7 27.5 27.0 18.6 17.7 23.0 151.3 33.1 30.8 22.7 22.7 13.7 91.1 66.3 49.6 161.2 17.9 46.4 23.3 39.2 43.6 21.6 16.1 18.5 73.1 45.3 33.4 17.2 11.6 12.6 20.1 22.2 26.8 23.6 29.7 35.6 28.0 29.4 35.1 25.1 58.8 32.6 38.8 21.7 82.8 44.5 16.3 138.9 12.9 60.7 16.3 FHAD1 KIAA1937 ENSG00000142621 "Forkhead associated phosphopeptide binding domain 1" B1AJZ9 1 15247272-15400283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5" "Group enriched" "Detected in many" 6 "Ciliated cells: 366.7;Early spermatids: 202.9;Late spermatids: 182.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "pons and medulla: 13.8" "Cell type enhanced" "Detected in many" "gdT-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HMC-1: 39.8;K-562: 8.5;U-87 MG: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054284 Enhanced NA NA "HPA054284: AB_2682436" "unprognostic (3.18e-2)" "unprognostic (1.12e-3)" "unprognostic (2.36e-3)" "unprognostic (2.15e-2)" "unprognostic (5.55e-2)" "unprognostic (8.32e-2)" "unprognostic (2.46e-1)" "unprognostic (2.06e-2)" "unprognostic (1.04e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-1)" "unprognostic (1.40e-1)" "unprognostic (1.17e-3)" "unprognostic (2.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.83e-1)" "unprognostic (1.04e-3)" 0.4 0.4 1.4 0.8 2.0 0.0 1.1 0.2 0.9 2.6 0.4 6.7 0.8 1.0 1.0 16.0 0.2 17.9 0.6 0.2 3.0 2.6 0.6 0.3 7.6 0.2 0.5 0.2 8.2 0.9 1.8 1.1 0.5 13.8 1.0 0.3 0.5 0.6 1.3 0.1 0.3 1.1 0.3 0.6 0.2 2.5 28.5 2.8 0.0 1.4 0.1 0.3 0.9 0.3 0.8 0.4 0.0 1.6 1.2 3.6 0.8 0.9 0.2 0.8 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.6 0.3 0.1 0.1 0.2 0.1 0.0 0.1 13.8 0.1 0.0 0.0 0.0 0.2 1.2 39.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 3.5 0.1 4.1 0.0 0.0 4.5 0.0 21.4 0.0 0.1 0.0 1.6 0.0 3.6 0.6 0.1 0.8 0.4 1.2 0.4 0.0 0.0 1.5 0.0 1.2 1.2 0.0 0.0 0.8 1.4 2.0 0.2 0.9 3.0 2.6 0.5 0.2 13.8 2.8 0.0 2.1 0.0 0.6 0.1 0.2 1.2 0.0 366.7 45.5 0.0 0.0 0.0 0.0 1.5 202.9 0.7 0.7 0.0 1.2 0.0 0.7 0.4 0.0 0.0 2.3 3.2 1.7 0.0 1.0 182.6 2.0 1.5 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.4 0.0 12.9 1.4 7.9 11.4 0.0 0.1 0.0 0.3 1.1 FHDC1 KIAA1727 ENSG00000137460 "FH2 domain containing 1" Q9C0D6 4 152936352-152979696 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 86.7" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 65.7;Erythroid cells: 70.0;Syncytiotrophoblasts: 66.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 24.5;RT4: 8.1;SK-BR-3: 11.4;WM-115: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008527 Uncertain NA NA "HPA008527: AB_2104099" "unprognostic (5.42e-2)" "unprognostic (8.12e-2)" "unprognostic (2.42e-2)" "unprognostic (1.99e-3)" "unprognostic (1.16e-1)" "unprognostic (2.25e-1)" "unprognostic (2.95e-4)" "unprognostic (1.37e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-2)" "unprognostic (2.40e-1)" "prognostic favorable (1.33e-5)" "unprognostic (4.04e-2)" "unprognostic (1.90e-1)" "unprognostic (9.36e-2)" "unprognostic (1.30e-1)" 0.7 0.2 0.5 2.0 4.3 11.3 1.9 2.8 4.4 2.4 4.0 0.5 1.4 3.0 1.8 1.6 8.0 1.1 4.9 0.6 0.9 0.8 1.5 0.4 7.7 0.8 0.9 0.8 1.0 1.8 7.4 3.4 86.7 1.5 6.8 4.3 6.9 4.4 1.4 0.4 11.0 6.7 1.0 0.9 4.4 4.2 1.5 0.7 0.8 15.0 4.6 8.7 1.3 3.8 0.5 0.4 2.8 0.3 1.0 0.3 0.0 4.3 0.4 0.8 0.6 0.4 0.2 24.5 0.3 0.9 1.0 0.1 0.3 2.7 0.2 0.1 0.4 0.8 0.9 0.2 1.8 0.3 0.5 0.3 0.5 2.5 0.3 0.1 0.1 0.7 0.1 2.2 0.0 0.5 1.0 0.0 0.4 1.1 0.5 0.3 2.7 0.1 0.1 5.0 0.4 0.3 0.0 0.2 0.1 4.5 8.1 4.4 0.2 1.5 11.4 1.6 5.8 1.7 0.3 0.1 0.3 0.8 2.0 1.0 0.6 0.4 0.1 0.2 0.1 8.4 0.6 0.3 0.5 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.5 0.2 0.3 2.8 1.0 0.2 0.4 0.1 0.0 0.5 4.3 2.8 1.6 0.9 0.8 0.9 0.8 1.5 0.7 14.9 65.7 0.0 2.3 5.3 0.0 0.6 5.1 5.3 21.6 3.5 2.0 10.4 0.0 0.8 1.7 0.9 7.4 70.0 2.7 11.1 1.4 6.4 3.5 0.0 1.8 0.0 13.3 0.0 0.0 0.0 0.9 0.4 0.0 0.0 7.8 0.0 5.2 7.8 0.7 0.0 0.0 0.0 0.0 0.4 0.2 6.1 66.9 0.0 6.4 2.5 FHL1 "bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA" ENSG00000022267 "Four and a half LIM domains 1" Q13642 X 136146702-136211359 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 557.6;tongue: 239.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 1067.5;Early spermatids: 313.2;Late spermatids: 886.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 20.6" "Group enriched" "Detected in many" 4 "dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 58.7;fHDF/TERT166: 53.1" "Low region specificity" "Detected in all" "HPA001040, HPA001391, CAB020817" Enhanced Supported "Plasma membrane,Cytosol" NA NA 18000000 Cytosol "Plasma membrane" "CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.61e-3)" "unprognostic (1.76e-2)" "unprognostic (2.51e-2)" "unprognostic (9.34e-2)" "unprognostic (7.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (1.72e-1)" "unprognostic (6.17e-3)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.05e-3)" "prognostic unfavorable (2.11e-4)" 61.9 4.1 7.6 11.0 9.5 0.7 30.6 6.3 7.2 31.5 30.6 3.9 10.0 5.0 25.5 27.7 43.2 14.2 11.7 79.0 6.1 8.1 3.3 2.5 13.7 2.5 5.5 8.1 6.7 2.4 13.4 5.0 13.5 4.4 23.4 10.0 13.5 16.5 30.1 557.6 4.9 11.4 77.7 4.3 2.5 22.1 5.7 3.0 0.6 18.2 239.4 22.1 47.0 14.3 3.4 12.5 0.7 0.4 20.6 11.4 6.2 0.0 9.6 13.3 12.5 29.0 11.7 0.2 37.3 58.7 7.5 18.1 0.0 2.7 0.1 13.0 53.1 21.0 0.1 25.8 31.8 6.3 0.1 29.7 0.1 7.9 0.0 27.2 0.0 6.2 21.7 5.2 9.0 28.6 3.1 7.8 7.3 0.0 5.6 17.5 0.4 5.2 0.3 4.1 0.0 11.3 14.6 0.5 7.9 0.2 0.0 9.4 14.1 1.4 0.0 2.7 5.6 0.0 0.5 22.0 34.7 16.1 1.3 9.3 1.5 3.2 0.2 2.6 0.3 3.8 0.0 0.4 0.0 3.2 0.0 8.6 3.4 11.4 4.5 1.8 2.3 7.6 2.3 0.7 20.6 0.0 12.5 1.2 6.2 7.6 9.5 6.3 7.2 6.1 8.1 5.5 8.1 4.4 3.0 44.7 16.0 6.4 17.4 50.3 30.5 1067.5 0.0 5.3 7.9 10.4 7.9 0.7 1.7 3.3 313.2 63.3 0.0 0.0 0.2 1.0 98.8 2.5 15.1 4.7 3.8 93.8 13.2 131.3 5.9 886.8 114.8 9.8 30.4 10.8 0.5 182.0 0.6 0.2 143.2 4.8 16.9 103.5 304.9 6.0 79.0 39.1 2.3 13.4 0.6 1.8 FHL2 "DRAL, SLIM3" ENSG00000115641 "Four and a half LIM domains 2" Q14192 2 105357712-105438513 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "heart muscle: 312.0;ovary: 80.7" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 732.1;Extravillous trophoblasts: 503.8;Leydig cells: 525.0;Peritubular cells: 986.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 7.8;T-cells: 4.6" "Cell line enhanced" "Detected in many" "LHCN-M2: 79.9;RPTEC TERT1: 73.7" "Group enriched" "Detected in many" 4 "amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3" "Low region specificity" "Detected in many" "HPA005922, HPA006028, CAB008368" Enhanced Enhanced "Actin filaments,Focal adhesion sites" NA Yes "Actin filaments, Focal adhesion sites" "CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858" "unprognostic (1.04e-1)" "unprognostic (1.63e-3)" "unprognostic (3.30e-1)" "unprognostic (3.42e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (2.80e-2)" "unprognostic (1.02e-3)" "unprognostic (1.81e-1)" "unprognostic (2.42e-2)" "unprognostic (3.34e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (6.42e-5)" "unprognostic (2.06e-1)" "unprognostic (3.49e-1)" "unprognostic (9.92e-3)" "unprognostic (4.73e-2)" 8.3 9.8 1.5 5.7 3.6 1.5 8.9 0.8 5.6 16.3 10.5 1.4 5.1 6.0 14.8 12.1 9.2 6.8 16.5 312.0 2.5 0.4 5.5 7.8 2.1 2.7 0.9 3.0 80.7 1.6 0.2 4.1 16.7 1.1 12.8 7.4 18.5 6.2 8.7 9.4 5.6 16.9 11.9 0.8 3.9 12.7 13.4 0.7 3.1 6.6 16.9 5.1 18.1 7.6 1.4 1.3 7.8 0.8 1.5 4.6 2.6 22.5 5.3 3.1 0.1 10.1 12.8 29.6 42.8 11.3 27.5 33.1 9.5 35.3 0.0 3.6 52.1 34.0 7.0 4.6 38.9 31.4 0.9 3.5 15.8 6.5 7.1 40.0 0.0 3.5 26.6 21.4 43.2 28.8 55.2 56.0 2.6 4.1 1.3 79.9 0.8 3.6 0.1 6.5 15.8 16.7 0.0 4.8 0.6 73.7 16.0 0.1 1.0 16.0 7.2 11.1 3.2 9.0 0.5 26.9 20.0 20.3 22.1 34.4 0.4 0.0 0.1 31.9 0.0 20.6 7.8 0.8 1.0 2.2 0.4 1.5 1.1 1.8 3.6 0.7 1.4 1.4 2.9 4.5 1.5 0.3 1.3 4.6 2.6 1.5 3.6 0.8 5.6 2.5 0.4 0.9 3.0 1.1 0.7 8.9 6.1 0.0 732.1 416.1 8.9 221.1 15.3 12.0 54.6 27.9 2.0 150.7 3.3 97.9 3.5 21.5 61.9 0.0 105.2 503.8 71.2 120.1 10.3 9.2 22.4 0.0 55.8 20.9 1.2 4.9 525.0 6.6 21.9 4.6 119.3 1.5 144.0 32.8 986.1 15.3 12.4 213.4 132.8 6.6 21.1 259.6 149.4 5.0 30.8 351.4 FHL3 SLIM2 ENSG00000183386 "Four and a half LIM domains 3" Q13643 1 37996770-38005606 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "blood: 67.9;skeletal muscle: 247.1;tongue: 100.1" "Cell type enhanced" "Detected in many" 7 "granulocytes: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 9 "eosinophil: 67.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 67.9" "Cell line enhanced" "Detected in many" "HEL: 29.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA045723 Approved Nucleoplasm NA NA Nucleoplasm "HPA045723: AB_10966278" "prognostic favorable (5.62e-4)" "unprognostic (1.12e-1)" "unprognostic (3.02e-3)" "unprognostic (6.97e-2)" "unprognostic (2.26e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (1.02e-3)" "unprognostic (1.80e-1)" "unprognostic (1.36e-1)" "unprognostic (9.05e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (4.20e-11)" "unprognostic (8.88e-3)" "unprognostic (2.38e-1)" "unprognostic (4.94e-2)" "unprognostic (2.77e-2)" 7.0 2.0 1.2 3.3 2.1 3.9 4.5 0.6 1.4 5.5 6.4 1.3 2.4 1.1 7.5 8.1 6.9 4.4 3.6 2.3 1.6 1.1 1.7 1.3 2.9 5.0 2.4 0.9 7.6 2.0 1.4 1.1 2.1 2.1 4.8 1.6 2.2 5.5 3.6 247.1 2.6 1.9 12.0 2.2 2.5 2.7 1.7 1.0 0.3 1.8 100.1 4.0 15.5 5.7 0.1 3.8 67.9 5.7 3.0 3.4 2.3 6.2 2.3 6.2 6.3 5.8 23.6 3.9 5.0 9.8 9.4 7.0 5.2 5.0 0.0 8.4 11.2 4.5 2.4 4.0 6.0 4.7 2.3 7.2 29.5 5.1 5.9 22.8 2.3 21.7 20.8 6.9 10.8 6.1 20.1 13.2 3.1 24.8 0.1 17.6 3.3 0.8 10.0 8.1 0.4 1.6 4.0 5.2 0.4 6.2 1.1 0.7 3.2 4.5 0.4 7.2 12.1 1.9 2.0 9.3 4.2 9.5 1.1 4.5 1.6 5.7 0.7 1.9 13.8 4.3 1.3 5.7 67.9 3.2 3.7 3.4 0.0 0.7 1.6 3.8 0.1 0.5 0.7 7.4 3.0 2.4 0.1 1.6 2.3 1.2 2.1 0.6 1.3 1.6 1.1 2.4 0.9 2.1 1.0 0.0 4.0 0.5 16.0 18.5 0.3 3.9 5.1 0.0 4.5 7.0 0.0 7.1 1.7 16.8 0.6 9.3 0.0 0.0 24.2 26.2 19.0 5.1 73.7 0.9 25.9 0.0 0.0 15.4 14.3 0.9 20.8 24.2 5.0 8.2 0.0 2.4 24.2 0.0 30.1 2.5 0.3 25.8 30.6 1.1 14.7 14.2 8.1 12.2 0.0 8.4 FHL5 "ACT, dJ393D12.2, FLJ33049" ENSG00000112214 "Four and a half LIM domains 5" Q5TD97 6 96562548-96616636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 95.7" "Group enriched" "Detected in some" 23 "Early spermatids: 1073.4;Late spermatids: 1344.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "ASC diff: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.56e-2)" "unprognostic (9.97e-2)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "prognostic favorable (4.81e-4)" "unprognostic (4.93e-2)" "unprognostic (1.91e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (6.56e-2)" "unprognostic (1.84e-1)" "unprognostic (9.30e-2)" "unprognostic (1.71e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.22e-1)" "unprognostic (3.48e-3)" 14.6 4.0 1.7 1.7 2.0 0.0 5.5 1.7 1.9 12.6 1.7 1.7 1.7 0.4 6.1 7.4 3.6 6.3 4.9 1.8 1.7 0.7 2.4 1.7 5.4 1.7 1.7 1.7 4.6 1.7 1.0 1.7 1.7 1.9 1.7 1.6 1.7 1.7 4.4 3.0 1.7 1.7 3.5 1.7 1.7 1.4 95.7 1.7 1.7 3.4 1.7 1.7 2.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.0 1.7 1.9 1.7 0.7 1.7 1.7 1.9 1.7 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1073.4 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1344.3 48.6 0.0 5.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 51.8 51.5 6.2 3.4 0.3 0.0 0.0 0.0 0.0 FHOD1 FHOS ENSG00000135723 "Formin homology 2 domain containing 1" Q9Y613 16 67229387-67247658 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.0;skeletal muscle: 61.1" "Cell type enhanced" "Detected in many" 5 "granulocytes: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HMC-1: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024468 Approved Supported Cytosol NA NA 2500000 Cytosol "HPA024468: AB_1848568" "unprognostic (6.53e-3)" "prognostic unfavorable (9.57e-4)" "unprognostic (5.42e-2)" "unprognostic (2.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.18e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-1)" "unprognostic (2.03e-1)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.27e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-3)" "unprognostic (4.70e-2)" 8.3 7.5 2.5 5.1 4.4 2.9 7.9 4.7 2.8 4.2 5.3 2.5 3.8 3.3 3.9 4.7 2.5 3.4 5.6 3.7 2.3 1.3 4.8 2.3 12.5 4.4 4.0 0.7 12.9 3.4 2.5 2.5 5.8 4.2 4.2 2.6 4.0 5.7 4.0 61.1 2.5 3.9 3.5 5.6 38.0 2.9 2.2 3.0 2.7 8.2 11.1 5.8 2.6 3.5 0.5 2.0 2.2 3.0 1.3 1.4 2.1 4.4 12.1 4.5 3.6 18.4 11.1 15.3 9.3 7.8 10.7 10.4 8.3 5.8 5.3 6.8 6.8 3.4 5.4 5.2 7.6 5.3 4.1 8.4 23.6 4.7 9.0 4.9 9.7 43.3 13.7 1.0 16.5 1.5 9.3 16.6 7.4 12.1 3.3 6.7 15.2 6.5 17.4 6.8 4.1 3.8 7.5 10.2 12.5 3.3 1.8 1.4 7.5 14.7 8.5 8.5 4.7 9.0 7.7 19.3 14.6 8.5 8.9 7.5 11.2 11.5 7.7 30.0 9.2 13.3 1.5 3.0 0.5 1.1 1.2 1.4 0.1 1.3 1.0 2.0 0.5 0.8 0.6 2.2 1.3 1.0 1.2 1.2 2.1 2.5 4.4 4.7 2.8 2.3 1.3 4.0 0.7 4.2 3.0 11.9 22.9 5.2 1.5 5.0 1.0 10.9 10.2 4.0 7.9 5.2 7.9 7.5 0.0 2.8 0.7 15.0 6.7 0.0 5.1 4.0 10.5 2.8 40.3 0.8 16.0 1.6 8.7 28.8 21.7 1.1 9.8 15.8 3.3 16.2 13.9 2.9 5.7 2.9 10.3 1.0 0.8 25.8 15.0 1.5 2.7 3.1 1.6 12.9 14.4 1.0 FHOD3 "FHOS2, FLJ22297, FLJ22717, KIAA1695" ENSG00000134775 "Formin homology 2 domain containing 3" Q2V2M9 18 36297714-36780055 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 70.0;seminal vesicle: 33.3" "Cell type enhanced" "Detected in many" 17 "Cardiomyocytes: 31.9;Ciliated cells: 26.8;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.9;HDLM-2: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021827, HPA024696" Uncertain "Intracellular and membrane" NA NA "HPA021827: AB_1848571, HPA024696: AB_1848573" "unprognostic (8.46e-2)" "unprognostic (8.76e-2)" "unprognostic (6.34e-2)" "unprognostic (3.44e-1)" "unprognostic (8.96e-2)" "unprognostic (8.30e-2)" "unprognostic (4.11e-4)" "unprognostic (2.73e-2)" "unprognostic (2.81e-1)" "unprognostic (2.44e-2)" "unprognostic (2.16e-3)" "unprognostic (4.55e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.64e-2)" "unprognostic (4.10e-2)" "unprognostic (3.00e-3)" "unprognostic (1.20e-1)" 2.0 13.2 11.4 1.5 6.3 0.4 6.2 2.1 10.9 2.8 5.6 3.2 5.6 1.2 1.9 22.0 5.1 6.0 3.9 70.0 9.5 6.7 10.7 0.8 1.1 0.9 6.0 8.5 4.6 1.4 0.5 4.4 1.0 20.1 14.1 2.1 6.6 6.1 33.3 23.3 3.1 2.4 5.1 4.8 1.0 1.6 2.8 1.8 0.0 2.2 1.7 2.2 6.3 3.3 0.0 0.6 0.0 0.1 0.0 0.6 0.0 6.1 2.2 14.3 3.4 0.1 0.0 1.0 14.0 29.9 2.8 2.7 0.0 10.1 1.1 3.7 6.6 8.1 8.0 4.7 6.1 1.7 32.0 1.6 0.0 0.4 0.0 0.2 0.0 0.5 1.9 3.0 1.5 0.6 15.4 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 3.1 0.0 2.0 0.0 0.0 7.5 13.5 6.9 8.0 18.7 3.0 0.0 1.9 1.3 0.0 0.0 16.2 9.0 0.7 0.4 11.8 13.3 0.0 0.0 10.1 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 11.4 6.3 2.1 10.9 9.5 6.7 6.0 8.5 20.1 1.8 0.0 0.0 0.0 0.8 2.9 2.5 31.9 0.0 26.8 3.4 12.2 82.5 0.0 3.3 1.2 1.4 0.0 0.0 0.0 0.8 9.4 2.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.1 0.0 0.0 7.0 2.8 0.0 0.4 6.8 30.7 0.0 4.4 1.1 1.5 0.5 0.3 0.0 0.1 0.3 FIBCD1 FLJ14810 ENSG00000130720 "Fibrinogen C domain containing 1" Q8N539 9 130902438-130939286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;parathyroid gland: 10.7;testis: 9.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 11 "hippocampal formation: 19.2" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 5.7" "Lineage enriched" "Detected in single" 11 "monocytes: 5.7" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2" "Group enriched" "Detected in many" 4 "basal ganglia: 18.2;hippocampal formation: 75.0" "Region enriched" "Detected in many" 4 "hippocampal formation: 81.5" HPA055353 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055353: AB_2682791" "unprognostic (1.18e-3)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (5.63e-2)" "unprognostic (9.11e-2)" "unprognostic (1.62e-1)" "unprognostic (4.16e-5)" "unprognostic (1.83e-3)" "unprognostic (3.14e-1)" "unprognostic (1.28e-1)" "unprognostic (2.05e-2)" "unprognostic (4.45e-2)" "unprognostic (1.42e-6)" "unprognostic (1.66e-1)" "unprognostic (5.53e-2)" "unprognostic (6.68e-3)" "unprognostic (2.77e-1)" 0.0 8.5 1.7 0.1 1.1 0.0 1.1 0.1 3.0 0.0 1.8 0.3 0.0 0.5 0.0 1.4 0.4 0.0 5.0 2.0 19.2 1.2 0.0 0.0 5.3 0.0 0.6 0.0 0.4 0.0 10.7 0.0 1.7 1.5 1.0 1.4 1.1 1.6 0.0 0.0 0.0 1.6 2.1 0.0 0.8 0.1 9.5 0.8 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.5 0.0 5.7 0.0 0.0 0.2 0.2 2.3 0.8 0.0 0.0 0.0 0.0 5.0 5.9 0.3 0.8 0.0 2.5 0.0 1.8 0.2 4.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 0.2 0.0 0.1 2.7 0.0 9.4 0.0 0.0 0.6 0.0 0.0 21.2 0.0 2.2 1.5 15.0 0.5 0.0 4.4 0.3 16.5 0.0 0.1 0.0 0.7 0.0 0.5 0.7 1.3 8.2 0.0 0.9 11.3 0.1 9.2 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.2 1.7 1.1 0.1 1.0 19.2 1.2 0.6 0.0 1.5 0.8 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 7.7 0.0 0.3 14.5 0.1 4.7 0.0 27.4 0.4 1.8 0.7 0.0 0.0 0.9 3.2 0.0 0.0 0.0 25.9 0.6 0.0 0.0 0.0 12.2 0.8 16.7 3.5 3.2 0.0 0.1 0.0 0.3 1.1 15.1 0.0 3.3 0.0 4.7 1.7 FIBIN MGC24932 ENSG00000176971 "Fin bud initiation factor homolog (zebrafish)" Q8TAL6 11 26994184-26996121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 58.9" "Cell type enhanced" "Detected in many" 15 "Fibroblasts: 70.5;Leydig cells: 35.1;Muller glia cells: 22.1;Peritubular cells: 32.9" "Cancer enhanced" "Detected in all" "glioma: 48.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 32.7;ASC TERT1: 20.8;fHDF/TERT166: 10.1;HHSteC: 42.4;HSkMC: 43.9;hTCEpi: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040120 Uncertain "Intracellular and membrane" NA NA "HPA040120: AB_10795243" "unprognostic (1.72e-1)" "unprognostic (2.61e-1)" "unprognostic (1.29e-1)" "unprognostic (9.04e-2)" "unprognostic (1.62e-2)" "unprognostic (5.42e-2)" "unprognostic (7.28e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (5.08e-3)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "prognostic favorable (1.93e-5)" "prognostic unfavorable (6.72e-4)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (1.02e-2)" 17.1 4.9 7.5 6.7 6.2 0.3 14.9 2.1 12.0 22.4 11.0 8.4 3.3 2.3 11.6 8.7 17.9 13.2 7.4 17.2 8.2 3.8 11.7 1.9 15.6 2.6 8.3 6.1 15.7 3.7 0.4 1.1 11.7 8.0 16.8 2.8 16.5 8.4 58.9 10.5 7.6 5.0 15.6 7.9 12.0 9.9 5.0 5.5 0.3 12.6 7.6 1.9 9.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 32.7 20.8 0.0 1.0 2.7 0.1 0.4 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.4 0.0 0.0 43.9 11.5 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 6.2 2.1 6.4 8.2 3.8 8.3 6.1 8.0 5.5 0.0 0.0 0.0 2.0 6.0 0.4 1.2 5.1 0.0 0.0 10.4 0.0 0.7 10.0 0.6 0.0 0.3 0.0 0.0 0.0 0.6 70.5 0.1 0.0 0.6 1.6 0.0 0.0 10.4 0.0 0.0 35.1 1.5 6.8 0.0 0.0 22.1 0.1 0.0 32.9 3.8 0.3 0.0 4.4 0.0 0.2 4.4 1.6 0.0 0.0 0.0 FIGLA bHLHc8 ENSG00000183733 "Folliculogenesis specific bHLH transcription factor" Q6QHK4 2 70777310-70790643 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.5;pancreas: 2.8;testis: 3.4" "Cell type enhanced" "Detected in single" 30 "Late spermatids: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "myeloid DC: 2.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.5" "Group enriched" "Detected in some" 7 "AN3-CA: 3.4;SH-SY5Y: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA071241 Supported NA NA "HPA071241: " "unprognostic (1.82e-1)" "unprognostic (4.04e-1)" "unprognostic (1.73e-2)" 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.3 0.0 2.1 2.8 0.0 0.0 0.0 0.5 0.1 0.8 0.1 0.3 0.2 0.4 0.3 0.0 0.6 0.2 3.4 0.0 0.0 0.2 0.3 0.0 2.5 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 FIGNL2 ENSG00000261308 "Fidgetin like 2" A6NMB9 12 51817840-51848766 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 16.7" "Cell type enriched" "Detected in single" 13 "Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.7;BEWO: 10.8;NTERA-2: 6.6;SuSa: 12.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.83e-1)" "unprognostic (3.77e-2)" "unprognostic (2.26e-2)" "unprognostic (7.36e-4)" "unprognostic (1.99e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.71e-2)" "unprognostic (4.75e-2)" "unprognostic (6.40e-2)" "unprognostic (9.78e-6)" "unprognostic (7.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.15e-2)" "unprognostic (1.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.48e-2)" 1.1 0.0 0.6 0.6 0.7 0.0 1.0 0.0 2.2 1.4 0.1 0.0 0.4 0.0 2.6 0.9 0.0 0.2 0.3 1.5 0.1 16.7 1.4 2.0 0.7 0.2 1.7 0.0 0.0 4.3 0.1 1.9 1.3 0.9 0.0 1.0 1.8 0.5 2.0 0.2 0.4 0.2 0.2 1.0 0.9 1.3 0.0 0.0 0.2 0.5 0.3 0.2 0.8 0.4 0.8 0.2 0.2 0.0 0.5 0.0 0.0 0.1 16.7 0.0 0.2 0.1 10.8 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.6 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.5 1.9 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.3 0.3 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FILIP1 "FILIP, KIAA1275" ENSG00000118407 "Filamin A interacting protein 1" Q7Z7B0 6 75291859-75493738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.6;smooth muscle: 44.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 542.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 10.7;HUVEC TERT2: 2.7;RPTEC TERT1: 3.0;U-266/70: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA053564 Enhanced Approved "Plasma membrane,Actin filaments" No NA "Plasma membrane, Actin filaments" "HPA053564: AB_2682192" "unprognostic (4.90e-2)" "unprognostic (3.77e-2)" "unprognostic (9.77e-3)" "unprognostic (3.83e-1)" "unprognostic (1.52e-1)" "unprognostic (4.98e-1)" "unprognostic (2.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.17e-3)" "unprognostic (3.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-3)" "unprognostic (3.97e-3)" "unprognostic (2.34e-1)" "unprognostic (4.65e-2)" "unprognostic (7.66e-3)" 11.0 1.3 2.0 6.3 3.0 0.2 2.5 0.6 2.5 8.2 10.9 0.0 4.1 1.3 8.8 4.1 10.5 4.5 5.9 37.6 3.7 1.2 2.7 2.4 7.5 1.2 1.1 0.7 4.4 1.4 5.4 5.1 3.7 0.8 14.9 2.6 4.3 1.5 2.8 29.4 0.9 4.1 44.7 1.4 0.6 3.9 2.8 0.0 0.0 2.3 10.8 0.7 30.7 6.0 1.4 0.9 1.8 0.8 0.6 0.9 0.0 0.1 1.9 0.3 0.1 0.1 0.3 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.2 10.7 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.2 0.1 0.0 0.3 0.2 1.4 0.1 0.2 0.1 0.1 2.7 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 3.0 0.6 0.2 0.2 0.0 0.1 0.1 2.5 0.1 0.4 0.0 0.1 0.0 0.1 0.1 10.7 1.0 0.1 0.1 0.5 0.1 1.2 0.6 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.2 1.4 0.9 0.6 1.8 0.6 0.8 0.9 0.3 0.0 2.0 3.0 0.6 1.9 3.7 1.2 1.1 0.7 0.8 0.0 119.1 78.3 0.0 0.6 0.6 3.3 542.5 0.0 83.0 14.8 0.0 0.0 0.7 1.7 0.0 36.1 36.8 0.0 0.0 0.3 0.3 26.7 0.6 1.1 0.6 1.2 0.0 0.0 58.3 1.9 16.2 2.3 2.0 1.7 0.0 0.0 4.5 0.0 0.0 4.2 0.0 3.8 90.5 88.2 4.5 6.4 0.6 0.7 0.0 0.0 0.4 FITM1 FIT1 ENSG00000139914 "Fat storage inducing transmembrane protein 1" A5D6W6 14 24131275-24132849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 228.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 17 "RH-30: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA019842 Uncertain NA NA "HPA019842: AB_1853025" "unprognostic (1.81e-2)" "unprognostic (4.29e-7)" "unprognostic (2.77e-1)" "unprognostic (2.02e-3)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "prognostic favorable (1.00e-3)" "unprognostic (1.20e-4)" "unprognostic (4.57e-1)" "unprognostic (2.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.68e-2)" "unprognostic (2.47e-1)" "unprognostic (2.86e-2)" "unprognostic (5.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.12e-3)" 0.8 1.7 0.0 0.2 0.0 0.6 0.3 0.4 0.2 0.2 0.3 0.0 0.0 0.5 0.2 2.2 1.2 0.2 0.2 56.1 0.0 0.0 0.2 13.1 0.2 0.3 0.0 0.0 0.2 11.9 0.2 0.2 0.2 0.0 0.7 0.2 0.1 2.9 0.3 94.7 0.5 0.4 0.2 0.0 2.5 0.3 0.3 0.0 0.0 0.5 79.9 3.6 0.3 0.0 0.8 0.3 0.0 1.1 0.4 1.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.6 0.1 0.0 0.7 0.7 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.2 27.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.5 1.1 0.3 0.2 1.1 1.5 0.3 0.8 0.6 0.6 0.0 0.4 0.4 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 228.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 1.9 0.3 2.0 0.0 2.6 0.1 0.5 0.4 0.0 26.1 0.2 0.0 1.2 0.6 1.5 2.7 0.0 0.1 0.0 1.0 1.0 0.8 1.1 0.0 0.7 0.1 0.3 0.0 0.4 1.2 0.2 0.5 0.6 0.8 0.8 0.1 FITM2 "C20orf142, dJ881L22.2, FIT2" ENSG00000197296 "Fat storage inducing transmembrane protein 2" Q8N6M3 20 44302838-44311169 "Predicted membrane proteins" "Deafness, Disease mutation, Dystonia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 56.7" "Cell type enriched" "Detected in many" 9 "Cardiomyocytes: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.92e-2)" "unprognostic (7.61e-2)" "unprognostic (2.27e-2)" "unprognostic (2.10e-3)" "unprognostic (1.02e-1)" "unprognostic (3.57e-3)" "unprognostic (1.63e-2)" "unprognostic (3.90e-2)" "unprognostic (8.43e-2)" "unprognostic (5.19e-2)" "unprognostic (6.56e-3)" "unprognostic (1.19e-1)" "prognostic favorable (8.98e-12)" "unprognostic (2.07e-1)" "unprognostic (2.54e-1)" "unprognostic (3.38e-3)" "unprognostic (2.49e-3)" 8.8 9.9 5.0 2.6 5.7 1.2 9.5 7.1 8.2 4.0 4.5 4.3 3.8 3.8 3.7 7.7 3.1 3.5 3.3 56.7 4.9 5.1 7.7 8.0 3.6 2.0 4.7 5.5 4.3 7.8 13.0 4.5 1.9 6.6 5.8 5.3 4.7 5.3 4.2 6.9 4.5 3.7 4.6 4.7 2.5 3.8 3.6 5.1 0.2 5.5 4.4 2.4 3.9 3.8 2.0 2.7 1.7 3.0 3.8 6.2 2.5 4.5 7.0 3.0 4.3 21.2 8.7 3.0 7.4 5.4 5.9 3.2 8.6 3.3 3.1 4.3 8.3 9.3 10.2 3.7 5.0 6.4 0.9 1.7 1.0 4.4 14.4 4.4 2.0 2.6 6.6 11.3 4.1 3.1 3.2 4.2 2.0 1.7 9.3 5.9 14.1 0.7 2.1 0.7 6.8 9.1 1.2 5.5 3.1 3.3 4.3 1.8 2.1 15.7 8.9 6.5 1.4 10.8 1.5 5.1 18.8 8.4 10.8 4.3 3.4 8.8 0.8 8.3 3.1 9.3 1.4 3.0 1.7 3.4 2.7 3.5 1.8 3.6 2.8 2.7 2.0 6.2 4.8 1.4 3.8 2.1 1.7 3.2 2.5 5.0 5.7 7.1 8.2 4.9 5.1 4.7 5.5 6.6 5.1 6.0 8.9 7.3 3.1 6.2 5.8 134.0 15.3 4.0 3.4 5.2 5.9 1.9 1.7 4.5 3.6 3.6 4.3 0.0 7.4 2.7 4.7 2.9 0.0 12.1 3.0 6.4 8.7 9.8 4.0 0.4 7.2 1.7 6.8 1.8 5.6 5.3 5.4 5.3 7.1 5.1 5.7 0.0 4.7 7.5 5.2 7.0 1.3 3.8 8.0 2.0 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four jointed box 1" Q86VR8 11 35618419-35620868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 15.5;Cytotrophoblasts: 18.7;Extravillous trophoblasts: 14.0;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059220: AB_2683950" "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavorable (6.56e-4)" 6.0 3.5 7.8 3.5 10.3 0.7 3.6 6.6 25.4 8.8 1.4 7.9 0.0 1.1 10.1 3.4 3.1 6.1 4.5 2.4 8.0 4.9 3.8 4.9 2.2 2.3 5.7 5.7 12.2 17.0 1.7 1.8 6.6 7.7 4.1 1.1 2.7 2.6 4.7 1.1 10.3 1.1 3.4 5.1 7.8 1.7 1.2 3.3 1.7 2.2 3.0 3.4 3.7 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 9.8 4.9 5.2 1.6 1.8 5.8 1.6 11.1 7.5 10.6 7.7 6.2 3.1 0.0 2.5 4.3 22.0 10.5 1.8 18.3 9.1 0.1 14.5 0.9 1.9 0.2 4.4 1.1 0.0 2.1 14.0 5.5 16.9 1.7 4.8 0.5 5.2 0.0 10.2 2.3 0.3 0.0 7.2 0.0 14.7 0.6 11.7 2.2 8.1 12.2 5.0 2.8 1.2 0.9 3.1 4.0 21.1 0.2 9.4 8.5 15.7 1.6 26.1 0.0 0.0 0.0 15.2 0.4 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 10.3 6.6 12.3 8.0 4.9 5.7 5.7 7.7 3.3 0.0 0.0 0.0 9.3 15.5 0.4 1.0 0.0 4.0 3.4 0.0 11.8 18.7 1.7 7.9 0.0 5.6 0.0 0.0 0.2 14.0 4.5 1.5 0.0 0.0 3.1 0.0 0.0 16.0 0.6 0.0 0.6 1.5 0.0 0.0 0.0 10.3 1.1 0.0 0.7 6.7 0.3 0.0 5.3 0.4 1.1 8.3 10.0 0.0 0.0 2.6 FKBP11 FKBP19 ENSG00000134285 "FK506 binding protein 11" Q9NYL4 12 48921518-48926474 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 175.6;salivary gland: 62.0" "Cell type enhanced" "Detected in all" 7 "Exocrine glandular cells: 145.3;Melanocytes: 258.1;T-cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 37.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 44.0;Karpas-707: 40.1;OE19: 56.1;RPMI-8226: 40.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041709 Enhanced Approved Centrosome NA NA Centrosome "HPA041709: AB_10794487" "unprognostic (7.45e-3)" "unprognostic (8.62e-2)" "unprognostic (2.40e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.70e-2)" "unprognostic (2.00e-1)" "unprognostic (3.46e-2)" "unprognostic (1.75e-1)" "unprognostic (7.64e-2)" "unprognostic (3.49e-3)" "unprognostic (1.24e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.15e-1)" "unprognostic (4.51e-1)" "unprognostic (2.79e-1)" "unprognostic (1.54e-1)" 5.6 4.6 1.1 8.2 1.4 3.7 3.7 0.9 2.2 7.5 6.9 0.9 21.6 9.2 4.4 12.9 4.4 4.8 8.1 3.4 1.3 2.4 4.8 38.4 5.8 16.6 1.0 1.3 3.7 175.6 0.2 12.3 3.3 1.6 4.8 6.3 1.9 62.0 20.9 1.4 1.7 7.6 2.9 1.0 18.7 10.0 1.9 0.9 2.2 4.7 4.9 14.5 8.2 4.3 11.1 8.3 1.1 0.3 5.1 37.6 7.3 2.0 2.7 0.5 0.7 12.0 18.2 1.0 15.9 22.8 17.6 20.8 10.2 11.4 30.9 0.5 25.9 0.2 8.5 5.5 7.0 9.1 6.5 1.1 1.1 2.9 0.1 44.0 0.6 0.8 20.3 13.5 13.5 25.1 7.5 9.9 10.5 0.4 40.1 6.4 5.8 4.6 1.1 1.4 56.1 5.1 12.7 0.7 40.1 2.2 0.4 6.5 1.9 5.3 7.9 3.5 0.6 0.4 0.9 7.9 3.4 0.6 0.3 0.3 23.5 19.4 15.7 2.1 0.7 5.6 0.9 0.2 0.6 22.5 0.3 37.6 11.1 15.6 17.7 0.3 4.8 9.4 14.4 1.1 5.1 0.1 8.3 6.4 7.3 1.1 1.4 0.9 2.2 1.3 2.4 1.0 1.3 1.6 0.9 14.9 18.4 30.6 44.0 25.1 4.9 1.7 35.7 28.1 19.4 8.7 37.3 19.0 6.6 17.0 15.1 19.7 11.7 46.7 145.3 59.9 74.1 89.1 12.7 90.3 9.7 1.6 24.1 49.1 14.2 13.2 25.6 9.7 258.1 5.4 84.9 1.5 80.1 7.0 13.1 12.2 15.0 6.5 22.1 8.0 6.8 18.6 35.4 152.0 40.1 37.6 FKBP1B "FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase" ENSG00000119782 "FK506 binding protein 1B" P68106 2 24049701-24063681 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1;intestine: 24.9" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 21.9;NTERA-2: 21.3;SH-SY5Y: 15.5;SuSa: 23.9;TIME: 18.6" "Low region specificity" "Detected in all" "HPA045572, HPA051798" Uncertain Approved Vesicles NA NA Vesicles "HPA045572: AB_2732521, HPA051798: AB_2681615" "unprognostic (3.01e-3)" "unprognostic (3.35e-1)" "unprognostic (7.05e-2)" "unprognostic (9.89e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-1)" "unprognostic (9.55e-2)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.43e-2)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" 2.9 5.9 25.0 2.8 30.7 1.9 5.9 15.7 23.1 5.1 7.2 1.6 7.4 24.9 3.6 4.2 4.5 4.5 7.1 3.4 31.1 14.0 4.4 4.6 9.0 2.2 13.0 19.7 4.6 4.9 6.4 2.8 5.6 7.9 5.1 4.6 2.4 3.3 9.2 1.1 3.6 6.7 4.0 5.2 1.8 13.3 1.6 4.4 0.6 5.0 1.1 3.2 7.1 3.5 1.5 2.2 4.4 0.8 0.3 5.4 1.1 0.1 0.9 8.5 0.0 5.4 2.1 3.0 2.8 2.9 1.2 1.8 0.5 1.0 0.0 2.1 5.0 7.7 3.3 12.5 9.8 0.8 1.4 8.0 2.9 0.1 21.9 2.0 0.0 7.0 2.0 2.3 2.9 0.6 7.3 7.9 3.3 0.7 0.0 2.8 0.0 0.9 0.0 21.3 0.7 1.5 1.5 0.7 0.0 0.9 0.5 2.1 15.5 0.1 0.0 2.7 23.9 0.5 1.0 18.6 0.0 2.6 0.1 0.6 0.5 0.2 0.0 3.1 0.0 0.6 1.3 0.8 4.4 0.3 0.7 0.0 0.3 0.6 0.5 2.2 1.5 0.0 0.2 0.1 0.3 0.0 0.4 5.4 1.1 25.0 30.7 15.7 23.1 31.1 14.0 13.0 19.7 7.9 4.4 0.0 5.0 0.0 11.5 8.1 1.2 0.4 28.1 1.4 0.0 7.0 0.0 4.5 11.6 24.5 0.4 9.3 9.3 0.0 33.8 22.1 7.8 15.8 1.1 9.8 6.2 1.6 9.1 11.1 3.4 1.8 2.6 9.4 27.0 19.8 7.9 12.1 37.4 28.1 3.9 4.1 2.5 25.8 11.2 1.4 3.0 6.5 4.3 0.0 3.4 14.5 FKBP3 "FKBP-25, PPIase" ENSG00000100442 "FK506 binding protein 3" Q00688 14 45115600-45135319 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000864, CAB012232, CAB012520" Supported Supported Cytosol NA NA 980000 Cytosol "CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873" "unprognostic (7.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (9.72e-2)" "unprognostic (1.25e-1)" "unprognostic (9.82e-3)" "unprognostic (3.58e-3)" "unprognostic (2.28e-1)" "unprognostic (5.04e-3)" "unprognostic (1.22e-3)" "unprognostic (7.47e-2)" "unprognostic (6.92e-3)" "unprognostic (1.00e-1)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" 11.7 13.2 28.1 10.2 40.7 9.8 15.5 25.1 32.1 12.0 14.6 11.4 8.3 13.2 9.9 20.4 14.6 8.8 9.1 31.3 26.0 24.4 16.5 20.5 8.0 14.6 23.2 23.8 9.9 10.9 15.0 17.1 14.0 22.9 17.9 15.2 6.6 10.7 12.2 113.3 11.3 13.9 12.8 19.6 9.9 10.6 13.5 22.4 12.7 12.4 24.2 16.5 12.7 9.3 19.5 27.5 13.5 17.4 15.4 19.4 13.0 37.3 41.6 60.6 31.9 27.0 29.4 23.9 23.0 26.4 36.3 40.1 36.3 32.1 19.9 24.3 25.9 20.6 31.1 45.0 29.6 51.9 28.7 26.8 16.4 32.3 46.9 26.6 28.2 17.7 27.7 30.9 21.1 19.7 33.6 47.3 31.7 23.6 15.1 43.1 45.6 45.3 37.9 30.7 41.9 39.5 43.6 44.7 24.2 58.1 43.2 37.0 14.5 36.8 22.9 35.2 47.7 53.6 21.2 30.4 27.8 48.1 14.5 17.6 25.4 45.1 31.0 16.8 19.5 25.9 11.6 14.6 13.5 13.0 17.2 15.7 19.5 17.5 17.6 21.8 13.6 16.8 18.8 2.3 15.4 17.4 27.5 19.4 13.0 28.1 40.7 25.1 32.1 26.0 24.4 23.2 23.8 22.9 22.4 38.7 36.9 49.1 82.5 42.5 68.8 177.9 45.9 77.6 69.4 89.0 9.8 264.9 213.9 116.4 165.9 49.2 61.3 0.0 64.1 95.4 67.9 74.9 51.0 84.7 113.7 38.1 53.9 39.3 36.8 297.6 74.8 68.0 65.8 155.9 63.2 57.4 80.6 52.6 91.9 168.1 44.8 103.5 53.3 145.7 112.4 41.9 138.0 47.9 83.1 70.8 FKBP4 "FKBP52, FKBP59" ENSG00000004478 "FK506 binding protein 4" Q02790 12 2794953-2805423 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "vagina: 209.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006148, CAB017441, HPA062857" Supported Enhanced Nucleoplasm,Cytosol NA NA 110000 Cytosol Nucleoplasm "CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883" "unprognostic (1.46e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.97e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.12e-5)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.43e-1)" "unprognostic (3.25e-2)" "unprognostic (1.72e-1)" "unprognostic (3.14e-1)" "unprognostic (3.89e-2)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (2.22e-1)" 16.2 21.6 26.0 13.7 30.7 13.3 40.7 50.4 31.9 19.9 22.6 22.8 36.2 13.1 20.1 30.7 34.2 25.7 16.4 20.4 25.0 32.5 31.6 31.3 15.8 11.7 44.7 23.4 23.9 30.3 30.1 19.5 32.0 39.4 30.2 25.3 11.5 30.1 31.6 33.5 25.3 16.1 26.4 25.2 11.5 25.3 36.0 42.1 15.6 47.1 16.5 18.5 17.4 209.6 13.8 6.0 10.9 13.7 8.4 14.0 9.9 15.3 34.2 9.9 16.6 12.3 7.3 47.5 15.1 5.4 25.0 16.9 34.0 18.8 20.5 4.3 9.7 17.4 21.1 61.5 20.5 30.1 37.5 39.4 22.6 25.1 12.0 9.5 17.6 6.2 6.6 18.8 29.5 29.6 14.9 14.5 20.8 20.7 29.3 10.0 44.1 30.9 16.0 84.3 45.3 24.7 18.6 17.4 12.3 21.0 19.6 14.3 20.5 17.5 47.8 7.6 64.7 64.4 12.0 7.7 12.3 38.7 13.8 38.0 7.3 11.2 30.3 10.9 26.4 12.5 10.9 10.8 5.9 12.5 9.8 14.0 13.3 11.1 11.8 6.0 13.8 11.8 13.7 1.5 8.4 13.7 5.3 10.1 9.9 26.0 30.7 50.4 31.9 25.0 32.5 44.7 23.4 39.4 42.1 6.0 8.6 47.9 182.5 127.9 60.2 11.7 40.8 16.0 12.5 50.6 70.7 148.6 131.0 77.3 90.2 33.8 86.8 0.0 22.4 85.7 62.6 189.3 39.1 41.9 54.7 92.2 101.7 12.3 15.0 26.1 32.2 42.7 87.7 52.3 61.6 41.8 62.2 84.2 36.4 112.7 51.3 84.1 88.6 179.1 92.0 116.1 186.7 20.2 77.5 121.3 FKBP5 "FKBP51, FKBP54, P54, PPIase, Ptg-10" ENSG00000096060 "FK506 binding protein 5" Q13451 6 35573585-35728583 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Chaperone, Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 277.2" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 325.8;Peritubular cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009315, HPA031092, HPA031093, HPA031095" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734" "unprognostic (2.09e-3)" "unprognostic (1.70e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.72e-1)" "unprognostic (6.30e-3)" "unprognostic (3.70e-3)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (7.48e-3)" "unprognostic (2.18e-3)" "unprognostic (8.31e-2)" "unprognostic (4.22e-2)" "unprognostic (6.90e-3)" 78.8 20.7 9.5 14.2 15.6 4.9 36.7 2.4 10.9 16.5 29.0 5.1 29.8 2.2 18.6 16.9 29.2 19.4 17.9 26.3 10.6 4.2 44.9 30.7 19.7 55.9 15.7 3.6 27.2 43.7 8.6 33.8 6.0 13.1 18.3 8.2 11.8 30.4 25.1 277.2 20.2 36.7 18.6 18.2 32.3 25.0 14.3 12.4 20.1 24.2 9.8 16.8 22.5 18.4 4.0 30.6 24.9 31.2 11.8 42.3 39.9 5.0 2.2 9.7 14.4 103.4 64.4 0.1 2.7 0.1 1.8 4.1 3.8 0.9 25.0 2.6 0.5 1.5 0.0 5.7 12.1 4.3 9.8 5.5 10.7 1.9 5.3 81.0 6.7 1.1 97.8 49.2 3.1 29.7 1.9 10.5 5.0 11.4 10.2 19.0 3.2 27.9 12.6 2.5 1.1 1.6 12.4 2.5 12.2 8.0 3.0 3.7 2.2 2.2 2.6 0.5 2.2 14.3 7.9 23.2 2.6 2.3 0.3 3.8 4.6 5.3 31.7 0.8 13.2 1.0 13.7 31.2 19.4 20.0 27.0 23.8 3.0 28.2 20.8 30.6 4.0 42.3 30.2 24.9 11.8 12.0 9.2 10.3 39.9 9.5 15.6 2.4 10.9 10.6 4.2 15.7 3.6 13.1 12.4 11.9 9.9 41.7 52.1 15.7 1.7 110.1 79.0 21.4 13.6 5.2 0.0 0.6 19.9 0.5 8.8 66.1 19.7 163.5 6.9 0.9 22.2 38.7 36.0 165.7 28.8 0.0 20.1 130.8 325.8 11.8 149.0 56.5 6.8 91.0 17.5 3.7 3.3 9.3 205.4 16.3 18.2 142.3 28.8 11.6 19.2 18.6 0.3 117.1 19.5 19.5 FKBP6 "FKBP36, PPIase" ENSG00000077800 "FK506 binding protein 6" O75344 7 73328164-73358637 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 33.0" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 62.1;Late spermatids: 61.4;Spermatocytes: 105.5;Spermatogonia: 35.0" "Cancer enriched" "Detected in single" 9 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.3;Karpas-707: 1.5;SiHa: 2.1;U-266/84: 1.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA061109 Enhanced NA NA "HPA061109: AB_2684430" "unprognostic (5.07e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-1)" "unprognostic (1.91e-1)" "unprognostic (1.05e-1)" "unprognostic (3.98e-2)" "unprognostic (8.72e-3)" "unprognostic (4.34e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-1)" "unprognostic (4.29e-2)" "unprognostic (1.48e-1)" "unprognostic (6.20e-2)" "unprognostic (9.15e-2)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.5 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.3 0.3 2.1 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.8 0.2 0.7 1.3 0.0 0.4 0.3 0.3 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.8 0.4 0.0 20.1 2.3 0.0 0.0 0.0 0.0 0.3 62.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 61.4 2.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 1.1 0.0 0.3 0.0 0.0 105.5 35.0 0.0 0.1 0.0 0.0 0.1 FLG ENSG00000143631 Filaggrin P20930 1 152302175-152325203 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 21.9;skin 1: 109.7;tongue: 38.6" "Cell type enriched" "Detected in some" 13 "Suprabasal keratinocytes: 38.5" "Cancer enriched" "Detected in some" 7 "melanoma: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 14.3;NTERA-2: 4.5;TIME: 3.0;U-2 OS: 3.5;U-2197: 3.7;WM-115: 2.8" "CAB002210, HPA027505, HPA030188, HPA030189" Enhanced Enhanced "Cytoplasmic bodies" NA NA 500000 "Cytoplasmic bodies" "CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999" "unprognostic (3.37e-2)" "unprognostic (3.76e-1)" "unprognostic (8.83e-2)" "unprognostic (2.96e-3)" "unprognostic (9.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.03e-2)" "unprognostic (1.12e-1)" "unprognostic (9.98e-2)" "unprognostic (1.73e-1)" "unprognostic (2.40e-1)" "unprognostic (2.35e-2)" "unprognostic (1.45e-1)" "unprognostic (4.28e-2)" "unprognostic (4.15e-2)" "unprognostic (7.41e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.8 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.4 109.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 38.6 7.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.7 0.0 14.3 0.0 0.0 0.0 1.5 0.1 1.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 3.0 1.2 3.5 3.7 2.6 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 FLG2 IFPS ENSG00000143520 "Filaggrin family member 2" Q5D862 1 152348735-152360006 "Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 107.4" "Cell type enriched" "Detected in some" 11 "Suprabasal keratinocytes: 21.1" "Cancer enriched" "Detected in some" 8 "melanoma: 7.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "HaCaT: 1.7" "Not detected" "Not detected" HPA028699 Approved NA NA 19000000 "HPA028699: AB_10601905" "unprognostic (2.58e-1)" "unprognostic (2.33e-1)" "unprognostic (3.08e-1)" "unprognostic (6.85e-2)" "unprognostic (6.59e-3)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (1.09e-1)" "unprognostic (2.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 7.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.3 107.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.9 0.1 19.6 0.4 0.1 0.2 0.3 0.3 1.2 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.7 0.2 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.2 0.3 0.9 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.8 0.4 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.2 21.1 0.0 0.0 0.0 0.3 FLI1 "EWSR2, SIC-1" ENSG00000151702 "Fli-1 proto-oncogene, ETS transcription factor" Q01543 11 128686535-128813267 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.2" "Group enriched" "Detected in many" 6 "B-cells: 32.3;Endothelial cells: 76.4;granulocytes: 22.0;Hofbauer cells: 36.1;Ito cells: 49.7;Kupffer cells: 85.1;Macrophages: 24.6;T-cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 41.0;HUVEC TERT2: 22.8;REH: 19.2;TIME: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065030, HPA073099" Approved Supported "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA065030: , HPA073099: AB_2686572" "unprognostic (1.38e-2)" "unprognostic (7.46e-2)" "unprognostic (6.16e-2)" "unprognostic (3.74e-2)" "unprognostic (6.22e-2)" "unprognostic (4.26e-3)" "unprognostic (1.33e-1)" "unprognostic (8.32e-3)" "unprognostic (2.97e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.79e-2)" "unprognostic (2.07e-2)" "unprognostic (2.62e-1)" "unprognostic (4.79e-2)" 14.7 2.5 3.5 15.8 4.4 10.6 9.9 1.4 3.2 6.7 5.1 3.8 2.1 3.3 7.8 6.5 4.8 5.3 6.0 7.5 3.8 3.1 4.2 3.6 17.4 24.4 6.2 1.6 4.0 3.2 2.5 2.0 11.4 3.8 4.3 3.1 4.8 4.2 3.3 5.2 3.2 6.9 5.7 6.6 40.2 4.1 2.7 4.6 26.8 5.7 2.8 17.9 6.2 6.7 4.5 13.1 20.1 12.0 7.8 8.8 11.6 0.0 0.0 2.1 0.0 0.2 0.4 0.0 1.2 3.4 1.4 1.2 0.0 0.0 7.0 12.5 4.1 0.4 0.0 0.3 5.1 1.6 3.2 0.1 41.0 0.2 0.0 2.4 4.9 5.8 0.3 0.4 3.0 6.9 4.3 22.8 9.8 0.0 9.0 0.3 0.0 4.9 2.8 0.6 0.0 1.2 19.2 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 7.9 23.6 0.2 0.0 0.1 1.3 2.9 6.0 6.0 0.0 11.9 1.9 20.1 9.5 16.1 7.2 10.3 8.8 4.5 6.2 5.8 13.1 3.6 2.6 5.6 7.8 7.8 12.0 2.2 7.4 11.6 3.5 4.4 1.4 3.2 3.8 3.1 6.2 1.6 3.8 4.6 6.0 7.7 32.3 0.2 4.5 0.0 5.0 5.1 1.4 0.0 1.8 0.0 0.3 0.0 0.0 0.5 76.4 0.0 0.0 0.0 0.2 5.6 0.3 22.0 1.0 36.1 0.0 0.0 49.7 85.1 0.0 1.7 24.6 6.8 6.4 0.0 0.1 0.0 0.0 0.7 0.3 0.0 6.5 2.8 0.3 0.1 3.6 0.2 47.8 0.0 0.4 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374638 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 396.7;urinary bladder: 276.1" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 470.6;Sertoli cells: 413.9;Smooth muscle cells: 354.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" NA NA 2900000000 "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavorable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.88e-4)" 42.8 8.8 2.9 46.4 3.9 22.9 30.7 2.0 5.2 106.5 204.2 6.3 86.0 13.1 158.9 54.4 140.2 79.9 121.0 18.8 3.2 2.2 17.2 5.5 29.1 21.1 3.4 5.9 77.4 7.3 1.6 4.8 20.0 9.4 129.3 13.4 19.0 12.6 98.8 13.7 15.0 50.2 396.7 3.6 25.5 82.7 29.9 2.9 12.1 11.7 16.3 15.1 276.1 64.5 6.3 13.1 7.1 19.7 5.9 22.6 24.1 87.1 67.8 23.9 30.8 20.9 27.7 39.3 58.4 65.1 53.6 47.7 43.9 16.2 7.5 151.5 90.7 94.6 50.1 21.5 51.2 15.1 30.8 7.5 24.2 88.6 15.2 38.5 28.6 31.7 26.4 12.4 79.8 31.9 52.5 39.8 9.2 6.8 52.3 38.3 20.0 13.6 9.9 25.2 9.1 45.1 13.7 21.7 6.7 20.8 18.1 5.3 12.1 48.8 7.9 39.3 19.2 7.6 9.0 95.2 61.2 59.0 61.9 107.5 32.8 19.2 15.2 56.8 19.2 61.2 4.1 11.5 7.1 22.6 15.2 14.3 6.3 10.5 18.7 13.1 3.0 4.0 9.1 2.6 5.9 19.7 1.7 12.8 24.1 2.9 3.9 2.0 5.2 3.2 2.2 3.4 5.9 9.4 2.9 53.6 43.8 55.7 72.4 110.4 2.7 24.1 43.3 4.0 20.5 33.2 0.0 18.9 1.7 255.8 1.7 80.7 1.4 0.0 117.7 74.6 126.9 16.4 25.4 2.1 124.7 11.1 1.7 85.3 148.7 6.8 113.4 134.1 84.4 135.3 1.3 35.9 247.2 0.8 470.6 0.9 2.8 413.9 354.2 2.3 8.3 64.4 16.7 76.7 3.1 31.4 FLNC "ABP-280, ABPL, FLN2" ENSG00000128591 "Filamin C" Q14315 7 128830377-128859274 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 546.8" "Cell type enriched" "Detected in many" 40 "Cardiomyocytes: 1815.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA006135, HPA071007" Enhanced Supported "Plasma membrane,Cytosol" NA NA 54000000 "Plasma membrane, Cytosol" "HPA006135: AB_1848602, HPA071007: " "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (4.47e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (1.64e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (2.17e-5)" "unprognostic (1.03e-3)" "unprognostic (2.35e-2)" "unprognostic (1.35e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (5.68e-3)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (3.73e-5)" 2.6 0.8 0.5 7.1 0.7 0.2 0.7 0.3 1.0 5.2 24.4 1.4 18.4 1.9 14.0 10.1 16.0 4.8 13.3 70.0 0.8 0.5 0.4 0.3 1.4 0.3 1.4 0.5 3.1 0.6 1.0 0.3 0.6 1.9 11.9 2.1 1.7 3.1 20.2 546.8 1.0 5.2 69.0 4.7 0.3 10.0 1.3 0.6 0.0 4.7 40.0 2.2 39.6 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 7.3 8.8 0.8 80.1 15.2 22.8 11.0 24.9 0.2 0.0 13.5 36.4 9.3 0.0 4.8 0.1 13.6 0.0 2.7 0.0 4.1 0.0 9.2 0.0 0.0 16.6 0.0 39.6 0.0 9.3 14.2 0.0 9.6 0.0 15.5 0.0 0.0 0.3 13.3 0.0 4.6 0.0 26.5 0.2 0.0 0.0 0.4 1.4 0.1 0.0 0.0 19.2 0.1 0.3 29.3 8.0 34.2 2.0 0.0 0.0 0.0 0.0 27.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.6 0.8 0.5 1.4 0.5 1.9 0.6 3.0 0.3 0.0 0.1 3.3 0.4 1815.4 0.0 0.0 3.4 1.8 0.0 0.3 0.0 0.6 0.2 6.2 0.0 0.0 0.2 0.7 11.9 1.4 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.0 4.9 0.8 5.0 0.0 0.0 0.1 1.8 0.0 9.9 1.0 0.1 0.0 45.3 0.2 0.4 4.0 1.6 0.0 0.0 0.4 FLRT1 "MGC21624, SPG68" ENSG00000126500 "Fibronectin leucine rich transmembrane protein 1" Q9NZU1 11 64103188-64119173 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.6;brain: 13.0" "Group enriched" "Detected in some" 7 "Bipolar cells: 7.3;Muller glia cells: 7.2;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.2;Karpas-707: 4.5;SCLC-21H: 6.1;SH-SY5Y: 15.2;THP-1: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054589 Uncertain "Intracellular and membrane" NA NA "HPA054589: AB_2682533" "unprognostic (5.13e-3)" "unprognostic (1.55e-1)" "unprognostic (1.63e-1)" "unprognostic (8.65e-2)" "unprognostic (2.89e-1)" "unprognostic (9.55e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (2.98e-1)" "unprognostic (4.64e-3)" "unprognostic (6.02e-2)" "unprognostic (1.79e-1)" "unprognostic (2.62e-2)" "unprognostic (5.62e-2)" "unprognostic (1.29e-3)" "unprognostic (4.37e-2)" 0.2 7.6 3.6 0.4 5.3 0.0 0.0 2.7 13.0 4.6 2.5 0.7 2.6 0.0 0.6 1.0 0.7 0.9 3.6 3.2 3.0 0.2 0.0 0.0 2.7 0.1 0.3 0.0 0.6 0.1 0.5 0.5 0.9 1.6 0.3 1.6 1.1 0.9 2.7 0.0 0.5 0.2 3.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 3.1 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.5 0.0 1.0 0.7 4.2 0.0 0.0 0.8 0.2 0.0 1.0 0.1 0.0 2.3 0.3 4.5 0.0 0.6 0.1 0.6 1.3 0.1 0.2 0.9 0.3 0.1 0.0 0.3 6.1 15.2 0.3 0.3 0.5 0.1 0.4 12.2 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.2 3.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLRT2 ENSG00000185070 "Fibronectin leucine rich transmembrane protein 2" O43155 14 85530144-85654426 "Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.8;retina: 50.6" "Cell type enhanced" "Detected in many" 17 "Leydig cells: 202.8;Peritubular cells: 117.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 27.1;HUVEC TERT2: 17.0;TIME: 24.1;U-138 MG: 26.5;U-2197: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 18000 "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "unprognostic (8.13e-3)" "unprognostic (4.59e-3)" "unprognostic (3.57e-2)" "unprognostic (1.46e-2)" "unprognostic (4.75e-2)" "unprognostic (9.46e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (5.34e-2)" "unprognostic (8.02e-6)" "unprognostic (1.98e-3)" "unprognostic (8.03e-2)" "unprognostic (1.50e-2)" "unprognostic (1.50e-5)" 10.5 5.1 6.5 4.6 13.2 0.4 3.9 0.8 16.1 12.2 3.8 1.6 2.3 1.2 6.7 4.3 3.9 7.4 9.5 6.6 4.7 3.6 2.1 1.5 2.6 6.5 3.7 5.8 31.7 34.8 1.4 2.6 1.5 1.4 5.8 3.5 50.6 2.2 3.9 6.7 6.4 2.3 7.3 4.2 5.9 2.6 9.2 0.8 0.0 6.5 2.2 2.9 6.9 12.3 0.6 0.3 2.3 0.2 0.4 0.3 0.0 0.0 0.1 3.9 0.0 3.6 6.7 0.0 4.2 2.8 4.0 3.8 0.0 0.0 0.0 0.0 12.3 0.4 0.9 5.9 8.1 9.8 0.0 3.4 0.0 2.2 0.0 11.5 0.9 0.0 3.6 4.7 3.3 27.1 1.2 17.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.8 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.9 0.0 1.0 0.0 1.4 5.5 0.0 0.0 24.1 26.5 4.5 19.1 7.5 0.0 0.0 0.0 8.3 0.0 2.5 2.3 0.2 2.0 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.6 0.3 0.3 1.0 0.4 0.2 0.3 0.1 0.0 6.5 13.2 0.8 16.1 4.7 3.6 3.7 5.8 1.4 0.8 0.0 2.2 0.0 1.2 19.1 0.4 3.5 2.5 2.7 0.0 1.8 0.0 0.3 0.0 43.3 2.3 12.8 0.0 0.0 37.5 0.2 24.6 0.4 0.0 0.0 2.4 9.5 0.0 31.3 0.6 4.5 202.8 1.2 1.7 1.0 0.0 14.3 31.9 0.0 117.4 0.0 1.4 12.9 3.8 1.2 0.2 21.0 0.7 0.0 0.0 0.1 FLRT3 ENSG00000125848 "Fibronectin leucine rich transmembrane protein 3" Q9NZU0 20 14322988-14337616 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 43.1" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056033 Enhanced Supported "Plasma membrane,Cell Junctions,Cytosol" "Intracellular and membrane" NA NA 240000 "Plasma membrane" "Cell Junctions, Cytosol" "HPA056033: AB_2683016" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.98e-1)" "unprognostic (1.14e-3)" "unprognostic (2.30e-1)" "unprognostic (6.00e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.85e-5)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.05e-1)" "prognostic favorable (1.49e-7)" "unprognostic (1.54e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-3)" "unprognostic (3.65e-1)" 7.3 4.3 3.4 2.2 7.4 0.1 2.7 27.5 18.9 3.8 5.0 0.7 3.2 12.4 2.6 5.5 2.5 2.7 5.6 1.6 9.3 4.1 43.1 28.9 26.2 0.2 2.3 5.3 11.9 2.3 4.6 2.1 2.0 2.9 12.7 1.0 1.9 1.5 16.4 2.1 6.9 6.0 3.9 2.3 0.8 9.7 1.7 0.7 4.8 8.5 1.8 0.4 12.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 15.6 0.0 0.0 0.0 0.0 1.5 0.4 0.1 0.0 8.5 3.1 0.0 0.5 0.3 0.0 4.4 0.0 4.6 0.1 0.0 1.0 0.0 0.2 0.1 1.3 0.0 0.0 2.7 29.4 0.0 5.5 0.0 0.0 0.1 0.0 0.1 3.0 0.2 1.9 0.0 5.1 3.4 0.0 0.0 0.1 0.0 9.9 1.9 0.3 3.2 0.0 0.0 4.9 9.2 0.2 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 7.4 27.5 18.9 9.3 4.1 2.3 5.3 2.9 0.7 202.5 116.8 0.0 129.3 7.7 13.3 0.9 17.8 22.7 126.3 21.0 5.9 0.3 11.6 18.8 0.0 1.6 2.0 0.0 13.0 0.0 5.4 11.3 4.7 7.8 0.2 6.4 10.9 1.8 0.0 0.2 3.4 0.9 5.0 2.8 1.0 0.5 9.4 2.9 0.4 41.7 2.9 0.0 0.1 0.0 0.0 14.4 0.0 0.5 1.5 9.0 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related tyrosine kinase 1" P17948 13 28300344-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 155.3" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1" "Group enriched" "Detected in many" 5 "B-cells: 3.7;granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" NA NA 876000 54000 "Plasma membrane" "Actin filaments" "CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 18.9 4.0 9.9 4.0 14.3 1.2 13.5 8.0 15.9 7.1 4.6 3.5 1.7 3.5 7.2 2.2 3.4 4.0 6.9 18.3 11.4 7.3 10.3 7.6 12.3 2.5 10.3 3.2 5.1 5.4 13.4 3.7 155.3 13.8 5.1 3.1 9.1 3.0 5.0 12.5 2.6 3.4 7.3 9.6 7.2 4.6 6.8 10.2 0.0 19.1 3.8 2.8 7.6 9.2 3.7 0.5 2.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 17.4 13.8 6.3 3.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 11.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 86.4 0.1 0.0 0.0 0.2 0.0 15.6 1.4 0.4 0.0 0.0 0.0 1.0 0.8 9.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 11.4 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.1 0.0 31.0 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.0 3.7 0.4 0.4 2.1 0.2 0.1 0.5 0.2 0.2 9.9 14.3 8.0 15.9 11.4 7.3 10.3 3.2 13.8 10.2 0.0 8.9 2.2 0.5 3.7 5.9 12.6 5.1 2.7 1.2 0.0 3.9 155.4 1.7 0.0 116.6 192.1 0.0 0.0 0.0 778.4 17.5 1.1 1.1 2.1 28.1 1.6 0.0 284.2 16.1 130.7 17.3 5.3 0.0 0.0 0.0 172.0 0.0 0.0 45.6 0.0 7.3 90.5 6.6 12.9 2.8 4.3 942.6 2.9 0.0 0.5 FLT3 "CD135, FLK2, STK1" ENSG00000122025 "Fms related tyrosine kinase 3" P36888 13 28003274-28100592 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.9;brain: 19.3;lymphoid tissue: 15.0" "Cell type enhanced" "Detected in some" 25 "Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9" "Cancer enhanced" "Detected in some" "breast cancer: 1.8" "Region enhanced" "Detected in many" "cerebellum: 19.3" "Group enriched" "Detected in some" 11 "myeloid DC: 29.9;plasmacytoid DC: 12.1" "Lineage enriched" "Detected in many" 16 "dendritic cells: 29.9" "Group enriched" "Detected in some" 11 "REH: 28.5;THP-1: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047539 Approved "Endoplasmic reticulum" NA NA 180000 "Endoplasmic reticulum" "HPA047539: AB_2680080" "unprognostic (2.19e-3)" "unprognostic (3.16e-3)" "unprognostic (6.54e-3)" "unprognostic (9.96e-2)" "unprognostic (3.88e-1)" "unprognostic (3.96e-7)" "unprognostic (7.99e-3)" "unprognostic (1.65e-2)" "unprognostic (5.37e-2)" "unprognostic (1.01e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (3.65e-1)" "unprognostic (3.91e-2)" "unprognostic (2.51e-1)" "unprognostic (2.22e-1)" 0.9 0.6 0.6 7.2 1.1 7.5 2.6 19.3 3.5 0.9 1.2 0.1 0.1 0.4 0.8 0.8 1.0 1.2 4.6 0.5 0.9 1.7 2.8 0.7 2.7 15.0 1.8 1.1 0.5 5.7 0.0 0.4 0.0 7.4 0.6 1.4 0.1 2.3 0.6 0.4 1.2 3.0 1.3 4.4 8.8 0.9 1.2 0.0 8.2 0.6 0.0 5.8 2.4 0.7 0.1 29.9 1.4 1.8 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.5 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 1.4 0.0 0.3 0.0 0.1 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.8 0.0 12.1 0.0 1.2 0.6 1.1 19.3 3.5 0.9 1.7 1.8 1.1 7.4 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.3 29.6 1.6 0.0 12.4 1.7 55.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.5 0.0 0.0 0.0 0.0 FLT3LG ENSG00000090554 "Fms related tyrosine kinase 3 ligand" P49771 19 49474207-49486231 "Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.8" "Cell type enhanced" "Detected in many" 9 "T-cells: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 18.2;MAIT T-cell: 33.7;memory CD4 T-cell: 37.3;memory CD8 T-cell: 23.7;naive CD4 T-cell: 41.1;naive CD8 T-cell: 32.0;T-reg: 35.9" "Lineage enriched" "Detected in all" 7 "T-cells: 41.1" "Cell line enhanced" "Detected in many" "HDLM-2: 17.9;U-266/70: 17.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.29e-3)" "prognostic favorable (2.17e-5)" "unprognostic (2.12e-3)" "unprognostic (9.16e-2)" "unprognostic (3.05e-1)" "unprognostic (3.81e-3)" "unprognostic (2.58e-1)" "unprognostic (1.55e-1)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (1.16e-2)" "unprognostic (2.88e-1)" "unprognostic (7.78e-6)" "unprognostic (2.17e-1)" "unprognostic (5.25e-2)" "unprognostic (8.22e-3)" "unprognostic (5.68e-2)" 12.8 5.9 4.5 21.0 6.7 14.0 11.1 1.9 4.0 14.1 12.4 5.1 6.6 9.4 12.1 8.0 11.3 9.2 14.8 6.8 3.4 2.7 8.6 4.8 10.5 32.7 4.3 2.6 16.3 4.5 2.2 5.7 3.5 4.7 12.9 3.4 6.6 9.6 7.7 7.1 8.8 11.0 10.8 4.9 17.0 8.1 5.5 6.3 49.8 8.5 9.0 32.7 11.6 16.0 3.1 1.2 4.9 6.0 6.0 41.1 10.4 4.2 0.4 0.6 1.5 7.2 11.9 0.4 3.3 6.8 7.0 11.7 0.3 4.7 4.2 1.7 4.6 2.1 4.7 1.1 3.8 1.7 17.9 1.7 3.0 1.8 1.6 12.6 2.7 10.6 8.1 0.6 4.8 1.0 4.2 2.4 5.7 1.3 14.1 2.1 2.7 2.8 4.5 0.2 0.7 0.8 2.2 2.2 4.7 1.0 2.6 0.3 1.0 1.0 1.2 1.9 0.2 1.7 2.1 2.0 8.9 1.9 5.2 4.7 17.9 5.5 1.7 4.3 5.8 2.5 1.1 1.6 4.9 18.2 4.5 33.7 3.1 37.3 23.7 1.2 2.6 41.1 32.0 1.7 6.0 6.0 0.5 35.9 10.4 4.5 6.7 1.9 4.0 3.4 2.7 4.3 2.6 4.7 6.3 0.0 3.0 1.4 6.3 4.5 1.5 0.3 2.5 0.0 9.1 3.5 5.9 0.6 0.0 1.5 0.1 3.5 0.3 0.0 1.6 0.7 9.8 2.6 5.7 1.5 1.9 7.9 1.7 5.5 1.9 0.0 15.3 4.8 8.5 3.6 1.3 3.5 1.3 0.9 7.4 2.2 2.4 6.5 5.2 0.3 1.8 4.1 0.2 36.3 0.8 3.8 FLT4 "PCL, VEGFR3" ENSG00000037280 "Fms related tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.3" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 31.7;Ito cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.7" "Lineage enriched" "Detected in single" 35 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906, HPA074389" Approved Supported "Nuclear speckles,Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 270000000 "Nuclear speckles, Plasma membrane" "Cell Junctions" "CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.8 7.1 1.6 4.9 6.0 0.7 28.5 1.3 2.7 6.3 7.3 1.9 2.1 3.1 7.3 6.2 5.7 9.2 5.3 6.4 1.7 0.9 11.7 10.2 14.1 23.6 2.0 0.8 5.8 2.3 2.3 6.2 56.3 2.1 4.9 1.4 6.7 3.3 4.4 4.8 2.8 4.7 4.7 1.5 14.5 2.4 3.5 2.0 0.3 19.4 4.4 2.3 6.1 14.7 0.0 0.1 0.2 0.0 0.0 7.7 0.2 0.1 2.0 2.7 8.3 0.0 0.0 10.1 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.8 0.1 0.5 0.3 2.8 0.1 0.2 0.1 12.5 1.0 0.4 0.4 0.1 7.4 0.2 0.2 0.0 0.1 0.3 0.3 8.1 10.0 0.3 0.3 1.7 4.5 0.1 0.4 5.8 0.2 0.5 6.5 0.0 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.0 2.7 11.9 0.2 12.6 0.1 5.9 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.9 0.0 7.7 0.0 0.4 1.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 1.6 6.0 1.3 2.7 1.7 0.9 2.0 0.8 2.1 2.0 0.0 1.7 0.9 0.2 0.8 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.2 9.2 0.0 0.0 0.0 31.7 0.6 0.2 2.3 0.4 1.1 0.0 0.0 65.1 5.7 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 4.3 1.0 0.8 0.7 0.0 0.1 FLVCR1 "AXPC1, FLVCR, MFSD7B, PCA" ENSG00000162769 "Feline leukemia virus subgroup C cellular receptor 1" Q9Y5Y0 1 212858255-212899363 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Erythrocyte maturation, Transport" Receptor "Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 40.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NTERA-2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046646 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA046646: AB_2679735" "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (1.01e-1)" "unprognostic (2.83e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.03e-1)" "unprognostic (1.21e-1)" "unprognostic (3.88e-2)" "prognostic favorable (3.50e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (7.15e-2)" "unprognostic (2.25e-1)" "unprognostic (3.91e-2)" "unprognostic (7.29e-3)" 3.2 3.8 4.6 4.5 7.2 7.8 4.8 11.3 5.9 4.4 12.9 4.7 3.3 13.5 4.0 7.5 3.2 3.6 3.6 2.5 5.0 7.5 3.5 3.1 3.7 4.1 5.3 5.9 4.0 5.1 7.0 16.8 3.5 7.2 5.3 4.4 4.0 2.9 4.3 1.6 4.3 40.6 3.8 4.8 4.2 7.1 4.0 5.5 5.4 3.6 2.1 3.3 4.0 5.0 1.2 1.6 4.7 0.8 0.7 1.4 0.2 4.8 6.4 10.0 3.0 1.7 2.1 18.9 1.4 1.1 2.9 1.8 9.4 9.0 5.3 2.7 1.0 6.2 7.4 10.8 3.2 2.9 3.1 4.7 3.1 6.3 8.5 2.0 8.3 5.1 1.6 2.1 3.1 4.0 1.5 2.2 3.7 8.3 4.4 1.9 1.8 2.3 4.1 33.1 6.4 4.6 5.2 9.2 6.1 3.6 4.7 10.9 7.7 6.6 6.6 6.0 8.7 10.8 3.9 1.3 1.4 3.4 4.6 6.5 2.7 5.5 6.3 2.1 4.8 1.7 1.6 0.8 4.7 0.8 0.6 0.9 0.9 1.2 1.0 0.5 1.2 1.2 1.1 2.6 0.7 0.8 1.6 1.4 0.2 4.6 7.2 11.3 5.9 5.0 7.5 5.3 5.9 7.2 5.5 11.9 13.6 12.6 8.8 12.7 22.7 3.3 7.6 9.4 15.9 19.2 33.4 3.0 1.7 3.8 3.2 7.7 17.9 0.0 11.7 5.3 7.8 10.1 6.9 4.9 5.5 15.9 31.2 10.4 10.3 5.3 5.8 9.0 5.0 8.2 8.6 6.3 7.3 10.5 2.5 4.1 31.2 6.5 7.2 10.1 5.9 8.2 2.1 8.9 6.5 3.7 FLVCR2 "C14orf58, FLJ20371, MFSD7C" ENSG00000119686 "Feline leukemia virus subgroup C cellular receptor family member 2" Q9UPI3 14 75578617-75663214 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 45.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 60.5;Late spermatids: 110.7;Syncytiotrophoblasts: 45.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 11.3;intermediate monocyte: 12.1;myeloid DC: 6.2;non-classical monocyte: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.2;monocytes: 12.1" "Cell line enhanced" "Detected in many" "ASC diff: 27.1;ASC TERT1: 11.8;BEWO: 36.2;MCF7: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA037984 Enhanced NA NA "HPA037984: AB_10672733" "unprognostic (2.42e-1)" "unprognostic (4.85e-2)" "unprognostic (4.19e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.44e-2)" "unprognostic (8.72e-2)" "unprognostic (2.78e-1)" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.22e-1)" "unprognostic (4.80e-2)" "prognostic favorable (2.53e-5)" "unprognostic (6.69e-2)" "unprognostic (9.94e-2)" "unprognostic (9.38e-2)" "unprognostic (1.16e-1)" 5.6 11.6 1.4 6.5 2.6 3.0 2.4 0.7 2.4 2.5 24.1 1.9 0.9 12.5 1.4 2.9 2.4 2.0 2.6 3.0 1.7 1.0 8.3 19.0 11.5 7.7 4.8 0.7 2.4 0.8 0.8 4.1 25.6 5.0 2.3 5.2 30.9 8.7 2.5 7.6 5.1 45.7 2.8 6.0 17.5 1.1 15.6 2.6 1.1 3.2 5.6 3.3 2.2 4.2 0.1 6.2 0.5 12.1 0.3 1.3 3.0 1.7 1.3 0.4 1.9 27.1 11.8 36.2 0.3 1.5 1.6 1.3 3.0 0.2 0.0 0.1 0.1 2.7 0.2 4.7 0.1 0.6 9.1 0.3 0.0 1.3 6.3 2.2 0.0 0.3 5.5 3.7 1.9 1.1 0.0 0.4 0.1 0.1 0.2 4.9 12.5 0.0 0.9 0.8 0.5 2.1 0.0 1.2 0.0 1.7 2.4 0.0 0.0 0.9 3.9 0.7 2.4 2.2 4.8 4.2 2.0 0.7 1.0 0.0 0.3 0.5 0.0 5.7 1.2 0.3 0.0 11.3 0.5 0.3 12.1 1.0 0.0 0.9 0.3 6.2 0.1 0.7 0.1 0.3 0.3 8.9 0.1 1.3 3.0 1.4 2.6 0.7 2.1 1.7 1.0 4.8 0.7 5.0 2.6 6.0 5.4 0.8 0.2 0.6 0.0 0.5 0.0 0.0 5.7 3.5 0.0 20.2 0.0 0.1 60.5 1.9 16.9 0.0 0.2 26.2 2.2 1.1 1.1 16.1 15.9 0.0 0.0 2.5 32.4 110.7 3.1 17.3 0.0 1.8 0.9 1.3 0.1 1.9 1.8 5.9 0.1 0.0 0.0 1.2 1.2 0.6 45.5 0.0 2.1 0.1 FMN1 "DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289" ENSG00000248905 "Formin 1" Q68DA7 15 32765545-33194733 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 21.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 121.0;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 98.9" "Cancer enriched" "Detected in many" 9 "melanoma: 14.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 9.5;RH-30: 12.8;SK-MEL-30: 13.3;T-47d: 11.6;U-138 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005465, HPA046786" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005465: AB_1859515, HPA046786: AB_10963545" "unprognostic (1.57e-1)" "unprognostic (5.92e-3)" "unprognostic (1.96e-1)" "unprognostic (2.10e-3)" "unprognostic (3.67e-2)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (2.84e-2)" "unprognostic (3.44e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "unprognostic (2.89e-2)" "unprognostic (3.73e-1)" "unprognostic (4.32e-1)" "unprognostic (7.61e-2)" 7.0 2.1 3.7 3.9 5.3 2.2 4.9 0.6 12.1 8.9 8.5 1.8 2.6 2.6 2.2 4.8 3.9 5.1 4.0 2.4 3.3 2.0 4.7 1.4 7.7 3.3 5.9 7.3 1.1 2.5 2.6 8.0 5.1 4.6 3.8 6.9 21.9 6.4 2.5 2.2 9.2 4.3 3.7 6.4 3.0 11.7 12.4 4.6 1.8 4.7 1.5 2.0 2.7 6.8 0.6 1.8 2.8 0.7 0.1 0.7 0.1 1.6 1.8 0.3 0.2 0.0 0.2 2.0 2.3 1.9 0.6 1.7 0.2 2.2 0.2 0.8 2.8 1.6 1.4 0.0 1.5 1.8 0.0 0.1 1.3 0.4 0.1 0.1 0.0 0.1 0.7 0.0 2.8 0.0 1.3 0.0 0.0 0.0 9.5 4.1 1.7 0.0 0.0 0.5 3.2 0.1 0.2 12.8 2.2 0.8 0.6 0.1 0.3 0.0 1.5 13.3 0.4 11.6 0.0 1.6 7.4 1.2 6.8 0.7 0.0 0.0 0.4 3.5 0.0 4.6 2.8 0.7 0.0 0.3 0.0 0.5 0.0 0.7 0.6 1.4 0.6 0.4 0.0 0.1 0.1 0.0 1.8 0.1 0.1 3.7 5.3 0.6 12.1 3.3 2.0 5.9 7.3 4.6 4.6 38.7 42.2 0.5 2.3 3.3 121.0 3.2 12.7 38.8 27.3 0.0 208.1 9.7 10.0 4.9 11.6 0.7 5.9 0.0 1.6 3.5 1.1 6.3 22.1 0.5 9.0 44.5 8.6 0.0 28.5 9.5 0.9 16.2 32.1 5.4 16.7 4.3 7.1 9.3 0.7 1.1 98.9 0.0 0.9 19.5 14.9 3.0 15.3 1.3 7.9 4.0 FMN2 ENSG00000155816 "Formin 2" Q9NZ56 1 240014348-240475189 "Disease related genes, Predicted intracellular proteins" "DNA damage, Protein transport, Stress response, Transport" "Actin-binding, Developmental protein" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 41.0;parathyroid gland: 26.6" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 28.2;Cone photoreceptor cells: 47.1;Horizontal cells: 117.6" "Group enriched" "Detected in some" 8 "glioma: 5.9;testis cancer: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 27.0;BJ hTERT+: 14.3;fHDF/TERT166: 26.6;LHCN-M2: 29.3;U-138 MG: 19.4;WM-115: 30.2" "Low region specificity" "Detected in all" HPA050649 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA050649: AB_2681202" "unprognostic (1.55e-2)" "unprognostic (8.21e-2)" "unprognostic (4.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.97e-3)" "unprognostic (2.11e-2)" "unprognostic (2.93e-1)" "unprognostic (3.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.08e-1)" "unprognostic (1.11e-2)" "unprognostic (8.03e-3)" "unprognostic (9.78e-2)" "unprognostic (3.10e-2)" "unprognostic (1.40e-3)" 1.2 7.3 17.1 1.3 14.5 0.9 1.3 17.2 41.0 1.1 3.2 9.4 0.0 1.4 2.5 2.1 2.1 3.7 2.0 0.9 16.2 11.8 2.9 0.9 1.4 0.9 9.9 15.5 3.9 2.1 26.6 5.6 1.2 12.2 2.9 3.0 1.4 1.3 3.6 0.9 1.0 1.3 2.7 12.3 1.2 1.2 3.4 12.3 0.0 1.3 0.0 1.0 1.2 0.4 0.5 0.4 0.6 0.3 0.4 2.3 0.0 0.0 0.8 2.9 0.0 7.4 5.6 0.0 27.0 14.3 10.7 5.8 0.0 0.0 0.0 0.0 26.6 0.5 0.0 0.4 0.0 10.5 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 3.5 0.7 6.8 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.1 0.0 0.0 0.0 4.5 4.0 0.0 0.1 0.1 0.1 1.1 0.0 0.1 19.4 0.1 7.3 7.0 0.0 0.0 0.0 3.8 0.0 30.2 0.6 0.3 0.1 0.3 0.2 0.2 0.1 0.9 0.1 0.1 0.5 2.3 1.4 0.5 0.4 0.1 0.4 0.3 0.0 17.1 14.5 17.2 19.3 16.2 11.8 9.9 15.5 12.2 12.3 0.0 0.0 0.0 0.0 0.1 28.2 1.2 0.0 0.0 0.0 1.8 47.1 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 117.6 11.6 0.6 1.2 2.4 0.3 0.2 1.7 0.0 0.2 1.8 0.0 0.0 0.0 0.0 2.4 0.0 0.3 1.6 4.4 0.0 0.5 0.0 0.0 0.0 FMNL1 "C17orf1, C17orf1B, FMNL" ENSG00000184922 "Formin like 1" O95466 17 45221444-45247320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.4;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 52.5;Kupffer cells: 54.4;Macrophages: 116.9;monocytes: 95.6;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 50.4;MOLT-4: 34.6;U-266/70: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008129, HPA028288" Enhanced Approved Cytosol NA NA Cytosol "HPA008129: AB_1848963, HPA028288: AB_10612110" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (8.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.24e-2)" "unprognostic (2.01e-1)" "unprognostic (1.58e-1)" "unprognostic (5.44e-2)" "unprognostic (6.06e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "prognostic unfavorable (4.23e-8)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (3.46e-2)" "unprognostic (2.16e-1)" 8.6 3.8 10.7 29.7 9.6 107.4 7.5 8.1 16.1 4.6 5.2 4.2 0.8 5.8 2.6 5.8 4.5 6.1 9.1 5.8 13.4 6.0 4.2 3.6 22.2 38.1 6.1 6.4 3.1 3.6 3.6 7.4 7.4 7.2 4.3 4.1 3.3 8.4 2.3 2.5 4.2 14.9 4.3 6.2 45.9 6.6 2.7 3.3 56.6 3.9 4.1 22.8 11.3 4.6 3.5 4.3 22.3 5.6 5.4 7.6 3.5 4.2 8.3 0.0 0.4 0.0 1.9 0.4 0.5 1.1 3.1 2.3 0.4 1.9 13.1 4.3 0.1 3.3 0.7 0.0 0.1 1.0 22.9 1.1 7.6 12.3 0.6 8.9 19.7 26.8 1.4 0.3 4.1 1.8 4.3 0.0 14.6 0.6 50.4 2.3 2.7 34.6 20.4 0.4 0.5 0.2 21.9 2.9 23.4 0.8 0.5 2.6 1.2 2.5 0.4 1.0 0.7 2.4 16.1 1.0 0.2 3.0 0.5 18.5 42.1 18.5 13.4 0.3 16.1 0.6 6.8 5.1 8.2 7.0 5.6 4.7 3.5 5.5 7.6 4.3 3.3 3.6 4.8 22.3 5.4 4.2 2.5 6.0 3.5 10.7 9.6 8.1 16.1 13.4 6.0 6.1 6.4 7.2 3.3 3.0 4.8 52.5 2.8 5.5 4.0 1.9 2.5 1.4 1.2 1.8 0.0 0.4 0.0 1.1 2.0 2.9 0.0 0.0 0.8 1.0 10.7 1.9 23.0 0.5 43.3 3.2 1.2 8.6 54.4 0.7 4.9 116.9 42.2 95.6 0.1 0.9 0.4 0.0 0.0 0.6 1.2 6.5 3.8 0.5 1.7 5.4 2.1 97.0 0.2 1.4 FMNL2 "FHOD2, KIAA1902" ENSG00000157827 "Formin like 2" Q96PY5 2 152335237-152649834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7;non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 5 "monocytes: 4.2" "Cell line enhanced" "Detected in many" "BEWO: 57.7;hTERT-HME1: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005464 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA005464: AB_1848965" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (8.75e-3)" "unprognostic (3.06e-2)" "unprognostic (7.40e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (9.04e-4)" "unprognostic (1.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (2.54e-1)" "unprognostic (4.66e-2)" "unprognostic (5.68e-2)" "unprognostic (1.05e-1)" "unprognostic (2.58e-1)" "unprognostic (3.73e-2)" "unprognostic (1.58e-1)" 15.1 13.6 26.2 7.0 44.6 0.8 9.4 18.3 55.0 8.5 6.6 55.0 1.4 5.8 13.6 10.2 4.6 6.7 11.1 4.8 32.0 20.6 9.7 5.3 17.9 8.2 63.4 27.9 35.9 7.4 17.8 10.2 35.9 39.2 8.9 8.4 5.4 20.1 8.2 31.0 4.0 5.5 10.7 74.1 12.0 8.2 5.8 56.7 1.3 14.5 3.2 5.4 9.1 11.6 0.0 0.9 0.0 4.2 0.0 0.1 0.0 4.1 4.4 13.8 7.6 16.7 18.1 57.7 4.2 8.7 7.5 10.6 4.7 0.2 0.0 9.0 3.6 16.2 4.7 6.6 13.5 12.0 0.0 7.0 0.0 2.8 20.2 4.8 1.1 0.2 11.8 8.4 14.5 37.5 14.6 13.2 1.9 0.1 0.1 4.1 1.1 0.2 1.3 8.8 3.6 8.9 7.4 2.9 6.0 21.9 2.9 14.1 11.5 3.6 1.3 14.6 12.2 0.3 0.4 14.7 11.4 0.3 3.8 7.2 0.4 0.1 0.0 10.5 0.9 23.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.9 0.1 0.0 26.2 44.6 18.3 36.7 32.0 20.6 63.4 27.9 39.2 56.7 23.8 23.4 0.8 14.1 23.5 20.5 2.8 2.5 10.7 23.9 10.4 0.0 30.2 11.6 15.8 18.3 19.7 1.4 0.0 5.9 11.6 29.6 14.2 1.1 1.3 36.8 0.0 7.9 16.0 47.8 6.5 32.5 31.0 6.8 4.6 3.0 3.6 8.9 0.0 38.9 6.3 1.3 6.5 9.0 6.2 6.9 14.8 22.5 1.9 6.6 10.1 FMO1 ENSG00000010932 "Flavin containing monooxygenase 1" Q01740 1 171248471-171285978 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 70.4" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 142.2" "Cancer enriched" "Detected in many" 8 "renal cancer: 18.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 36 "naive B-cell: 3.5" "Lineage enriched" "Detected in single" 36 "B-cells: 3.5" "Cell line enriched" "Detected in some" 7 "HSkMC: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA078132 Approved NA NA "HPA078132: " "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (5.87e-2)" "unprognostic (1.34e-1)" "unprognostic (5.32e-3)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-1)" "unprognostic (9.16e-2)" "unprognostic (9.03e-2)" "unprognostic (1.36e-2)" "unprognostic (2.23e-1)" "prognostic favorable (2.81e-4)" "unprognostic (6.49e-4)" "unprognostic (1.40e-1)" "unprognostic (3.58e-1)" "unprognostic (1.37e-1)" 3.4 3.6 0.1 0.1 0.3 0.0 5.6 0.1 0.4 5.6 0.8 0.3 0.8 0.0 2.5 3.0 5.0 3.3 1.8 0.9 0.1 0.0 70.4 1.0 0.8 0.1 0.1 0.1 5.9 2.4 0.1 1.1 0.8 0.2 1.1 0.0 4.0 4.2 1.5 0.1 4.0 14.4 1.5 0.1 0.1 0.5 1.6 0.1 1.8 1.7 5.3 10.3 1.4 1.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.4 2.9 0.0 8.7 5.1 0.0 0.0 3.5 0.0 0.2 11.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 8.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 10.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 2.5 142.2 0.0 6.5 1.4 0.0 0.0 1.9 0.7 0.0 0.0 0.0 FMO2 ENSG00000094963 "Flavin containing monooxygenase 2" Q99518 1 171185208-171211230 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;esophagus: 35.3;lung: 53.0" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 428.8;Club cells: 348.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 57 "ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028261 Approved NA NA "HPA028261: AB_10601012" "unprognostic (1.85e-2)" "unprognostic (3.14e-2)" "unprognostic (7.44e-2)" "unprognostic (3.75e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-3)" "unprognostic (3.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.58e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (3.83e-2)" 40.0 11.8 1.2 1.7 4.4 0.0 22.5 1.5 0.6 7.6 5.0 0.6 2.9 0.3 1.9 3.5 35.3 6.7 2.0 17.4 1.8 1.2 9.4 1.8 53.0 5.7 3.9 1.2 6.1 2.1 1.8 7.0 0.0 2.4 6.0 0.7 8.3 14.0 1.3 7.6 1.7 1.5 2.5 1.9 0.4 2.4 3.3 1.3 0.4 5.8 6.8 5.5 5.0 10.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 29.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 4.4 1.5 0.6 1.8 1.2 3.9 1.2 2.4 1.3 428.8 20.8 0.0 5.3 0.3 0.2 6.9 0.0 62.9 348.1 1.8 0.0 0.0 0.0 0.0 2.7 5.3 0.0 0.0 0.0 0.0 0.6 3.0 3.5 0.0 0.0 0.0 0.0 4.3 0.0 2.3 0.9 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.4 0.2 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 1.1 FMO3 ENSG00000007933 "Flavin containing monooxygenase 3" P31513 1 171090877-171117819 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 170.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 378.8" "Cancer enriched" "Detected in many" 13 "liver cancer: 94.9" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC diff: 25.4;ASC TERT1: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA013750 Enhanced NA NA "HPA013750: AB_1848968" "unprognostic (1.87e-2)" "unprognostic (6.30e-2)" "unprognostic (1.00e-1)" "unprognostic (6.81e-3)" "unprognostic (2.64e-1)" "unprognostic (1.31e-3)" "prognostic favorable (3.46e-4)" "prognostic favorable (5.60e-5)" "unprognostic (2.95e-1)" "unprognostic (9.34e-2)" "unprognostic (3.02e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (3.45e-1)" "unprognostic (7.27e-2)" 9.5 2.0 0.0 0.8 0.2 0.0 1.3 0.1 0.1 0.2 0.8 0.1 0.1 0.3 0.6 1.2 1.7 2.3 0.3 0.8 0.0 0.1 6.4 170.2 3.7 1.5 0.2 0.0 0.9 0.7 0.3 2.7 0.0 1.4 0.2 0.1 3.6 0.9 0.1 1.9 0.8 0.4 0.2 0.1 0.1 0.6 0.5 0.1 0.0 0.8 1.2 2.6 0.2 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 19.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 5.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.0 1.4 0.1 11.9 0.3 0.9 0.3 0.3 0.0 0.3 5.1 32.1 27.3 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 378.8 0.0 0.0 0.0 4.9 6.9 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 6.5 3.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 FMO4 FMO2 ENSG00000076258 "Flavin containing monooxygenase 4" P31512 1 171314208-171342084 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 33.8;liver: 42.2" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 24.9;Hepatocytes: 19.8;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.9;HSkMC: 9.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA049100, HPA072438" Approved Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA049100: AB_2680629, HPA072438: " "unprognostic (1.83e-2)" "unprognostic (1.17e-1)" "unprognostic (6.18e-2)" "unprognostic (3.01e-2)" "unprognostic (8.27e-2)" "unprognostic (4.13e-1)" "prognostic favorable (1.09e-4)" "prognostic favorable (7.45e-4)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (5.99e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.96e-4)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (7.45e-3)" "unprognostic (1.95e-1)" 5.3 3.6 1.4 5.1 4.8 0.9 4.5 0.6 2.7 4.5 6.0 4.8 3.1 4.2 3.0 10.0 4.6 3.8 4.6 6.3 2.3 1.5 33.8 42.2 3.4 2.8 7.5 2.8 4.1 3.2 5.5 5.0 2.3 3.7 3.9 3.7 6.7 2.7 2.0 1.6 2.9 16.1 2.0 7.0 3.8 3.9 2.0 6.2 2.7 4.5 3.3 3.4 2.9 3.7 5.3 2.9 0.9 4.0 3.9 4.9 2.0 0.1 0.0 0.4 0.6 5.5 5.0 0.2 1.1 5.0 1.6 1.7 0.8 7.2 4.4 7.9 0.0 2.6 0.3 0.8 1.3 2.2 2.1 1.1 0.0 0.0 0.1 0.8 0.9 1.0 9.3 3.2 0.6 1.3 0.6 0.3 2.2 0.2 3.3 0.7 1.0 2.1 1.9 0.5 1.3 1.6 0.4 0.5 2.5 3.5 0.0 0.2 0.0 1.5 1.5 3.0 5.7 3.1 1.3 0.1 1.3 0.4 1.4 1.0 4.0 1.3 2.7 2.4 1.5 1.1 0.6 2.6 0.9 2.5 4.0 1.8 3.1 2.4 3.3 2.2 5.3 3.3 2.5 0.5 3.9 2.7 2.9 4.9 2.0 1.4 4.8 0.6 2.7 2.3 1.5 7.5 2.8 3.7 6.2 0.0 1.6 0.5 3.8 2.5 0.0 3.5 2.5 6.7 0.0 8.7 0.0 2.1 24.9 1.6 4.0 0.9 8.6 0.0 1.2 1.2 3.1 1.1 1.1 19.8 3.2 0.0 1.2 1.8 5.7 0.4 1.4 2.3 5.0 1.8 1.9 1.5 0.9 0.0 0.4 33.2 0.0 0.0 1.2 0.2 0.2 1.4 1.6 0.5 1.4 1.7 FMO5 ENSG00000131781 "Flavin containing monooxygenase 5" P49326 1 147175351-147243050 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 61.1;liver: 119.4;stomach 1: 38.6" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 117.2;Hepatocytes: 260.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 43.0" "Group enriched" "Detected in many" 6 "basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012373 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA012373: AB_1848975" "unprognostic (2.70e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (3.96e-2)" "unprognostic (2.43e-2)" "unprognostic (2.94e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-2)" "unprognostic (2.93e-1)" "unprognostic (1.13e-1)" "prognostic favorable (1.34e-6)" "unprognostic (3.77e-1)" "unprognostic (1.38e-1)" "unprognostic (1.85e-1)" "unprognostic (4.11e-2)" 1.1 2.4 1.1 1.9 5.5 0.2 8.6 0.6 4.5 1.3 61.1 1.5 0.8 12.5 1.0 1.3 0.7 1.1 8.5 1.0 1.3 0.5 9.0 119.4 17.0 0.8 17.1 0.5 1.0 11.9 8.8 4.9 0.6 5.2 1.9 8.2 0.5 9.7 0.6 0.4 4.2 53.6 0.9 7.1 1.2 38.6 1.2 6.0 0.2 1.1 1.5 0.5 1.9 0.8 9.2 4.9 6.2 12.1 1.0 2.0 3.6 0.1 0.7 0.5 0.1 1.9 0.5 0.7 0.4 0.4 0.2 0.6 0.4 1.5 0.3 0.5 0.4 0.1 0.3 0.0 0.0 0.0 1.0 0.1 1.2 0.0 29.0 0.6 1.0 6.6 0.9 0.1 0.3 0.0 0.3 0.4 0.2 0.1 0.1 1.1 1.0 0.2 0.5 2.1 3.6 0.5 0.3 0.3 0.2 2.4 0.4 0.4 0.2 0.6 2.0 0.9 1.0 1.4 7.4 0.7 0.0 0.2 0.6 0.0 0.2 0.0 0.2 0.7 0.3 0.2 6.2 12.1 3.5 2.0 5.6 0.3 3.6 0.5 0.6 4.9 9.2 0.3 1.3 1.2 1.0 1.6 2.4 1.4 3.6 1.1 5.5 0.6 4.5 1.3 0.5 17.1 0.5 5.2 6.0 8.9 48.6 8.5 3.5 1.4 2.0 1.4 117.2 21.4 13.6 14.0 0.0 1.2 6.6 4.3 5.9 2.7 52.0 0.0 5.1 0.9 1.3 4.1 5.7 260.8 3.2 3.2 6.4 3.1 10.1 4.1 2.6 2.6 27.0 0.0 25.3 0.3 5.7 28.1 1.4 41.5 1.3 0.0 0.8 1.8 0.7 1.4 1.1 4.3 16.4 6.2 FMR1NB "CT37, FLJ25736, NY-SAR-35" ENSG00000176988 "FMR1 neighbor" Q8N0W7 X 147981329-148026667 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "testis: 38.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 302.9;Spermatogonia: 264.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-266/70: 35.2;U-266/84: 27.5" "HPA011284, CAB026403" Enhanced NA NA "CAB026403: , HPA011284: AB_1078898" "unprognostic (2.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.83e-1)" "unprognostic (4.38e-2)" "unprognostic (4.11e-3)" "unprognostic (2.85e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 38.8 0.0 302.9 264.0 0.0 0.2 0.0 0.0 0.0 FN1 "CIG, FINC, GFND2, LETS, MSF" ENSG00000115414 "Fibronectin 1" P02751 2 215360440-215436172 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Angiogenesis, Cell adhesion, Cell shape" Heparin-binding "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 235.4;placenta: 433.0" "Cell type enhanced" "Detected in many" 19 "Extravillous trophoblasts: 2156.8;Fibroblasts: 526.4;Hepatocytes: 963.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 833.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 845.3;HSkMC: 395.4;hTERT-HME1: 232.5;hTERT-RPE1: 257.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000126, HPA027066" Enhanced "Secreted to blood" NA NA 47000000000 "CAB000126: , HPA027066: AB_10602500" "unprognostic (8.08e-2)" "unprognostic (1.09e-3)" "unprognostic (2.20e-2)" "unprognostic (3.45e-3)" "unprognostic (1.82e-2)" "unprognostic (3.47e-3)" "unprognostic (3.36e-2)" "unprognostic (5.91e-3)" "unprognostic (2.96e-2)" "unprognostic (2.91e-3)" "unprognostic (1.41e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (3.44e-8)" "prognostic unfavorable (8.82e-5)" "unprognostic (7.88e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (3.33e-4)" 20.2 4.5 3.1 13.0 5.2 0.2 13.1 2.2 4.3 21.9 57.1 4.4 235.4 3.5 25.1 27.5 37.4 26.5 20.9 57.3 3.9 2.9 5.8 166.3 81.5 7.9 4.6 5.0 16.9 3.3 1.7 3.5 433.0 6.1 17.1 25.1 5.1 10.4 141.2 9.8 7.0 13.5 114.9 4.6 1.9 21.8 9.0 2.7 9.4 5.4 17.4 2.6 64.7 16.9 0.2 0.8 0.0 0.6 0.0 0.3 0.0 0.2 1.9 2.6 0.5 107.3 845.3 0.1 43.6 29.1 44.2 31.4 26.4 1.0 0.0 0.2 144.9 1.2 4.5 0.4 99.3 23.8 0.0 0.1 0.0 0.6 82.3 77.6 0.0 0.1 395.4 0.6 104.4 232.5 257.3 51.2 0.0 0.1 0.1 88.0 0.3 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.1 1.1 0.3 0.1 0.6 5.2 2.7 28.3 119.4 0.4 0.0 98.1 63.9 6.8 70.0 8.0 0.1 0.0 0.0 76.0 0.0 16.6 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.8 0.0 0.0 3.1 5.2 2.2 4.3 3.9 2.9 4.6 5.0 6.1 2.7 62.5 83.1 7.8 3.5 48.9 5.1 27.2 35.7 24.1 28.4 15.7 0.0 51.6 0.0 4.9 1.5 166.7 0.0 0.0 8.1 2156.8 526.4 18.4 17.4 963.3 368.5 1.6 20.2 165.1 27.1 2.6 172.6 39.4 104.6 1.8 4.3 1.4 19.0 0.0 83.1 0.6 9.7 71.1 163.2 1.1 4.5 32.6 172.1 0.9 3.7 1.6 FNDC1 "bA243O10.1, dJ322A24.1, FNDC2, KIAA1866" ENSG00000164694 "Fibronectin type III domain containing 1" Q4ZHG4 6 159169397-159272109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enriched" "Detected in some" 5 "Fibroblasts: 15.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Region enriched" "Detected in single" 6 "hippocampal formation: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA030962, HPA030963" Approved Approved "Nuclear speckles" "Secreted to extracellular matrix" NA NA "Nuclear speckles" "HPA030962: AB_10696212, HPA030963: AB_2673676" "unprognostic (4.59e-2)" "unprognostic (9.17e-3)" "unprognostic (7.62e-2)" "prognostic favorable (6.10e-5)" "unprognostic (4.57e-1)" "unprognostic (2.11e-1)" "unprognostic (5.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "unprognostic (4.18e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.93e-6)" "unprognostic (6.49e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.76e-3)" 5.2 0.6 0.5 7.6 0.7 0.0 2.5 0.3 0.7 9.7 12.9 3.2 0.0 2.1 4.8 2.2 2.2 0.9 13.1 3.5 4.8 0.5 1.0 1.5 1.2 2.1 0.7 0.0 4.8 1.2 0.0 0.4 0.7 0.5 0.7 1.6 1.0 2.5 0.6 6.2 1.2 7.0 10.2 1.5 0.7 0.7 2.1 0.1 1.0 36.6 11.8 3.6 1.5 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 2.4 6.6 0.3 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.0 0.0 0.9 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 7.4 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.7 4.8 0.5 0.7 0.0 0.5 0.1 0.0 1.1 0.0 0.0 2.9 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 15.5 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.4 0.3 1.3 0.1 0.0 0.0 0.0 FNDC10 C1orf233 ENSG00000228594 "Fibronectin type III domain containing 10" F2Z333 1 1598012-1600096 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.9;brain: 17.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 1.3;Distal tubular cells: 3.3;Hofbauer cells: 4.5;Pancreatic endocrine cells: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-2)" "unprognostic (8.35e-2)" "unprognostic (7.32e-3)" "unprognostic (4.33e-2)" "unprognostic (3.33e-1)" "unprognostic (3.12e-1)" "unprognostic (2.72e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.11e-4)" "unprognostic (2.09e-2)" "unprognostic (1.50e-1)" "unprognostic (6.00e-2)" "unprognostic (5.76e-2)" 1.6 16.9 10.2 2.6 7.6 4.0 2.7 6.3 17.2 2.2 2.0 2.1 0.0 3.9 1.0 1.3 8.5 1.6 3.9 1.6 10.1 16.3 2.1 0.7 3.8 3.3 9.4 8.6 2.2 1.7 0.4 6.2 2.0 17.1 0.9 1.1 4.5 2.7 1.0 0.6 10.4 2.8 1.2 5.6 3.7 3.1 6.3 1.5 0.1 6.3 2.0 2.0 3.3 1.6 0.1 2.1 4.5 2.4 0.1 1.0 0.6 0.0 2.8 2.7 8.4 5.6 1.3 3.8 6.6 1.3 10.6 0.6 2.5 11.8 0.0 7.9 3.2 0.0 1.7 0.6 1.4 0.9 0.0 2.4 0.1 2.9 6.1 1.3 2.0 19.6 1.8 6.7 0.5 0.0 1.3 0.6 7.6 5.3 0.0 1.2 12.6 1.5 6.1 11.6 3.9 4.1 0.0 0.0 6.4 3.7 0.6 12.6 10.4 7.0 10.5 6.9 1.8 0.0 6.3 1.1 0.0 2.1 4.5 0.0 2.0 0.2 0.1 0.0 4.2 3.0 0.0 2.4 4.5 0.4 1.7 0.5 0.1 0.9 1.0 2.1 0.1 1.0 0.6 0.2 0.1 2.0 0.0 0.7 0.6 10.2 7.6 6.3 17.2 10.1 16.3 9.4 8.6 17.1 1.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 1.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FNDC11 "C20orf195, MGC5356" ENSG00000125531 "Fibronectin type III domain containing 11" Q9BVV2 20 63547891-63556708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 52.5" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 12.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 3.2;naive B-cell: 6.6" "Lineage enriched" "Detected in many" 6 "B-cells: 6.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;EFO-21: 4.9;HaCaT: 2.7;OE19: 3.2;SH-SY5Y: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA041341 Approved Nucleoplasm,Vesicles,Aggresome NA NA "Nucleoplasm, Vesicles" Aggresome "HPA041341: AB_10794991" "unprognostic (2.01e-1)" "unprognostic (6.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.26e-1)" "unprognostic (1.51e-2)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (9.99e-3)" "unprognostic (7.94e-2)" "unprognostic (8.30e-4)" "unprognostic (3.68e-1)" "unprognostic (8.33e-2)" "unprognostic (3.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (3.75e-1)" "unprognostic (6.81e-2)" 0.1 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 2.2 0.2 1.1 0.2 0.1 0.1 0.3 0.2 0.1 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.3 52.5 0.2 0.1 0.1 0.1 0.3 0.2 0.2 6.6 0.0 1.0 0.0 0.0 0.8 0.2 0.3 0.0 1.8 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 0.1 9.5 0.6 4.9 0.1 0.2 2.7 0.2 0.3 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.0 1.2 0.0 0.2 0.7 0.0 0.0 0.9 0.0 0.7 0.0 0.0 1.0 0.0 0.1 0.2 3.2 0.8 0.0 0.0 0.1 1.7 0.0 0.4 6.0 0.0 0.0 0.3 0.4 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.6 0.3 0.0 0.0 1.0 0.1 0.0 0.0 3.2 0.2 0.6 0.0 6.6 0.4 0.2 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 2.3 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FNDC4 "FLJ22362, FRCP1" ENSG00000115226 "Fibronectin type III domain containing 4" Q9H6D8 2 27491883-27495245 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.9;liver: 57.6" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051804, HPA063581" Uncertain Approved Nucleoplasm,Aggresome,Cytosol "Intracellular and membrane" NA NA Nucleoplasm "Aggresome, Cytosol" "HPA051804: AB_2681617, HPA063581: AB_2685048" "unprognostic (2.57e-1)" "unprognostic (1.19e-3)" "unprognostic (3.87e-2)" "prognostic unfavorable (5.07e-4)" "unprognostic (1.46e-3)" "unprognostic (1.27e-1)" "unprognostic (4.77e-3)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (9.64e-2)" "unprognostic (8.28e-3)" "unprognostic (4.41e-2)" "unprognostic (1.28e-2)" "unprognostic (1.13e-2)" "unprognostic (5.74e-3)" "unprognostic (2.40e-3)" "prognostic unfavorable (6.11e-4)" 18.5 45.9 13.4 2.7 13.7 0.7 9.1 10.8 29.5 3.8 2.0 4.0 0.5 1.5 2.8 2.8 11.8 1.5 10.0 3.1 15.6 8.5 2.3 57.6 2.0 1.4 12.0 8.6 16.5 4.6 18.6 2.8 2.5 22.2 6.3 2.1 1.9 2.1 3.3 1.3 2.4 1.4 4.7 5.4 3.5 3.2 10.2 3.8 0.0 1.8 0.7 2.7 4.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 17.0 17.4 10.7 0.1 3.9 7.8 2.8 2.5 0.7 0.2 0.0 0.4 12.3 3.7 0.0 6.5 2.3 2.5 0.0 1.0 0.8 0.0 8.7 6.5 0.0 0.1 9.1 1.1 4.9 1.0 12.9 20.9 0.0 0.9 0.0 10.3 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.1 16.3 0.1 0.0 0.1 1.3 0.0 0.0 19.0 2.7 1.2 1.0 3.0 0.0 0.0 0.0 14.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.7 10.8 29.5 15.6 8.5 12.0 8.6 22.2 3.8 0.0 0.3 0.0 2.8 3.1 8.2 2.5 10.2 0.0 0.0 0.0 3.9 0.1 3.3 68.5 165.4 5.8 0.0 0.0 41.6 0.1 8.1 14.7 5.7 113.4 0.5 0.0 0.0 6.2 1.3 388.8 14.4 0.6 3.3 1.8 0.0 12.3 60.5 0.0 11.0 0.2 11.8 0.0 11.3 4.9 3.6 2.0 0.0 0.0 0.0 1.0 FNDC5 FRCP2 ENSG00000160097 "Fibronectin type III domain containing 5" Q8NAU1 1 32862268-32872482 "Predicted membrane proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 110.0;tongue: 33.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 68.2;Cardiomyocytes: 56.9;Early spermatids: 25.8;Muller glia cells: 40.4" "Group enriched" "Detected in many" 7 "glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RH-30: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051290 Enhanced "Intracellular and membrane" NA NA "HPA051290: AB_2681422" "unprognostic (4.36e-2)" "unprognostic (9.08e-3)" "unprognostic (7.62e-4)" "unprognostic (1.03e-2)" "unprognostic (3.77e-2)" "unprognostic (6.26e-2)" "unprognostic (5.68e-2)" "unprognostic (2.76e-2)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-3)" "unprognostic (1.63e-1)" "unprognostic (9.07e-2)" "unprognostic (7.07e-3)" "unprognostic (1.13e-1)" "unprognostic (3.37e-3)" "unprognostic (1.33e-2)" 1.2 6.3 3.4 0.6 5.1 0.6 0.9 26.7 13.6 1.0 0.8 1.7 0.0 0.9 2.1 1.5 4.9 2.6 1.4 15.9 3.6 4.1 0.9 8.6 1.0 0.6 5.0 3.7 3.0 0.8 2.5 2.3 0.8 9.5 2.0 0.7 8.2 12.3 1.0 110.0 0.6 1.0 1.5 2.8 0.6 2.3 1.3 1.7 0.0 1.0 33.3 1.3 0.9 0.4 0.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.9 0.2 0.0 1.3 0.1 0.4 0.1 0.5 0.1 0.9 0.2 0.1 0.6 0.3 0.2 0.0 3.9 0.0 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 2.4 0.0 0.3 0.0 0.5 0.0 0.2 0.7 0.1 0.9 0.1 0.1 0.1 1.4 0.0 0.1 0.4 32.7 0.2 0.0 0.0 5.6 0.9 0.3 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.6 1.5 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 5.1 26.7 13.6 3.6 4.1 5.0 3.7 9.5 1.7 0.0 0.0 0.0 0.1 0.1 68.2 56.9 0.0 0.0 0.0 1.8 3.9 0.0 1.7 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 2.6 4.9 0.0 0.0 0.0 0.0 40.4 0.2 0.0 5.3 0.1 7.3 0.0 1.0 0.5 0.9 0.0 0.2 0.0 0.3 0.1 FNDC7 FLJ35838 ENSG00000143107 "Fibronectin type III domain containing 7" Q5VTL7 1 108712657-108742740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.0;testis: 5.2" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 1.1;Early spermatids: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.1;Karpas-707: 1.2;U-87 MG: 1.8" "Not detected" "Not detected" "HPA028079, HPA054297" Enhanced Approved "Nucleoplasm,Actin filaments" "Secreted in male reproductive system" NA NA "Actin filaments" Nucleoplasm "HPA028079: AB_10602501, HPA054297: AB_2682441" "unprognostic (2.35e-2)" "unprognostic (2.65e-2)" "unprognostic (3.74e-1)" "unprognostic (8.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-4)" "unprognostic (1.90e-10)" "unprognostic (1.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 0.1 0.1 0.6 0.1 0.8 0.6 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.7 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.8 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 5.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.5 0.6 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.3 0.1 0.9 0.5 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.6 0.2 0.3 0.1 0.0 1.1 0.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.5 0.3 0.3 0.1 0.4 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.4 1.1 1.7 0.7 0.1 0.1 3.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 FNDC8 DKFZp434H2215 ENSG00000073598 "Fibronectin type III domain containing 8" Q8TC99 17 35121579-35130732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "testis: 85.2" "Group enriched" "Detected in some" 61 "Early spermatids: 549.6;Late spermatids: 1824.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 15 "B-cells: 1.3;T-cells: 2.0" "Cell line enhanced" "Detected in some" "HEK 293: 4.1;JURKAT: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA026521 Supported NA NA "HPA026521: AB_2106163" "unprognostic (1.45e-1)" "unprognostic (6.58e-2)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.25e-2)" "unprognostic (2.10e-1)" "unprognostic (5.88e-2)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-1)" "unprognostic (8.43e-2)" "unprognostic (3.48e-3)" "unprognostic (9.02e-2)" "unprognostic (6.41e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.2 0.7 2.1 0.7 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 2.4 0.4 0.0 0.2 0.2 0.2 0.0 0.0 0.6 4.1 0.1 0.7 0.2 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.7 1.2 0.1 0.4 1.7 1.1 0.5 0.3 0.4 2.5 1.2 2.4 0.0 0.6 0.5 0.6 0.9 0.6 0.4 0.1 0.4 0.7 0.0 0.0 0.2 0.7 0.9 1.6 2.1 2.3 0.2 0.7 0.5 0.0 0.1 0.0 0.2 0.1 1.3 0.6 0.6 0.0 0.0 1.3 2.0 0.7 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 549.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1824.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 19.4 0.0 6.8 4.1 0.0 0.0 0.0 0.0 0.0 FNDC9 "C5orf40, MGC27121" ENSG00000172568 "Fibronectin type III domain containing 9" Q8TBE3 5 157341600-157345721 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0" "Cell type enriched" "Detected in single" 5 "Bipolar cells: 3.4" "Cancer enriched" "Detected in single" 16 "glioma: 0.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6" "Group enriched" "Detected in many" 5 "basal ganglia: 21.9;hypothalamus: 28.4" "Low region specificity" "Detected in all" HPA011115 Uncertain NA NA "HPA011115: AB_1079374" "unprognostic (2.35e-3)" "unprognostic (3.80e-2)" "unprognostic (2.93e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-3)" "unprognostic (3.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.68e-1)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (6.35e-6)" "unprognostic (3.63e-2)" "unprognostic (6.39e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-3)" 0.6 9.4 3.9 1.5 21.1 2.0 0.6 9.1 24.0 0.5 1.1 0.0 0.0 0.6 0.6 0.9 0.5 0.6 0.6 0.7 1.9 22.0 0.7 0.6 0.5 0.9 1.3 3.8 0.5 0.5 0.5 10.0 0.6 5.8 0.6 1.2 0.0 0.5 0.6 0.6 0.6 0.8 0.8 1.3 0.6 0.6 0.5 0.4 0.0 0.6 0.0 0.5 0.6 0.0 0.5 0.3 0.8 0.8 0.0 1.9 0.1 0.0 0.2 0.4 0.4 0.0 0.0 0.4 1.0 0.0 0.2 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 3.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.4 0.1 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.6 1.0 0.3 0.3 1.6 0.0 1.0 0.4 0.0 0.1 0.0 0.0 0.8 1.9 0.2 0.1 0.0 0.6 1.3 0.0 0.5 0.8 1.5 0.2 0.0 0.8 0.3 0.0 0.1 3.9 21.1 9.1 13.3 1.9 22.0 1.3 3.8 5.8 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FNTB FPTB ENSG00000257365 "Farnesyltransferase, CAAX box, beta" P49356 14 64986720-65062652 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 75.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062743 Uncertain Approved Centrosome NA NA Centrosome "HPA062743: AB_2684861" "unprognostic (2.79e-1)" "unprognostic (1.50e-2)" "unprognostic (1.54e-1)" "unprognostic (8.57e-3)" "unprognostic (1.88e-1)" "unprognostic (6.88e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (6.21e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-2)" "unprognostic (1.70e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-3)" "unprognostic (2.36e-2)" "unprognostic (3.60e-1)" "unprognostic (5.56e-2)" "unprognostic (1.11e-3)" 7.4 9.0 6.3 4.9 21.9 2.3 7.8 11.4 13.7 8.0 6.3 24.3 6.2 5.6 6.4 6.6 13.5 9.0 5.1 12.0 8.1 7.9 8.0 5.6 7.0 5.1 34.0 7.2 7.4 5.9 13.6 7.9 8.2 25.4 8.9 7.9 4.4 8.0 9.6 14.3 10.3 5.1 11.6 75.0 4.6 5.7 9.0 22.2 4.7 5.6 5.8 7.3 7.4 7.8 2.4 6.4 12.3 10.3 2.8 8.8 5.3 18.7 13.6 10.6 6.0 6.8 6.0 7.8 10.8 8.0 12.3 12.7 7.2 7.7 3.2 6.2 11.4 6.8 12.5 25.5 8.4 10.1 4.5 7.2 12.7 3.7 10.5 4.4 4.3 17.6 5.1 7.3 5.3 2.9 11.5 10.2 5.9 6.8 4.6 7.1 12.4 6.5 7.2 4.6 11.6 13.9 6.4 9.9 4.0 8.4 6.9 6.8 6.7 6.7 13.3 14.7 8.8 12.2 7.5 8.0 8.9 18.4 4.0 6.9 2.4 2.7 3.2 10.3 5.6 20.5 12.3 10.3 9.2 3.6 8.6 8.8 2.4 5.5 4.3 6.4 1.9 4.5 3.3 2.7 2.8 4.3 4.9 5.1 5.3 6.3 21.9 11.4 13.7 8.1 7.9 34.0 7.2 25.4 22.2 11.9 2.1 0.0 2.9 2.2 4.4 6.1 2.5 1.4 6.8 3.5 2.0 13.7 0.0 5.9 5.2 2.9 3.3 0.0 4.2 12.8 5.8 5.0 0.0 7.3 7.0 4.8 7.5 5.5 9.5 4.5 5.2 3.4 5.0 7.2 5.5 7.0 4.0 0.0 8.1 4.6 4.0 19.4 2.7 2.1 3.2 3.1 6.9 2.5 5.0 2.6 FO681492.1 ENSG00000277758 10 47750864-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.2;brain: 6.7;lung: 10.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 37.0" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 0.5 0.0 0.1 0.0 0.0 6.7 0.3 0.0 0.0 0.1 0.0 2.4 1.1 0.4 0.4 0.0 0.0 10.6 2.3 0.3 1.4 0.0 1.1 0.0 0.0 1.4 0.4 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.9 0.7 2.5 0.4 5.2 0.9 1.1 0.4 0.5 4.2 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 0.0 2.7 3.0 0.0 0.2 1.2 0.8 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.2 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 3.3 37.0 0.1 0.2 3.2 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.3 2.3 0.3 0.7 2.8 1.1 0.7 1.1 0.8 2.5 0.3 0.5 0.7 0.4 0.9 5.2 1.0 0.7 0.4 3.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOCAD "FLJ20375, KIAA1797" ENSG00000188352 Focadhesin Q5VW36 9 20658309-20995955 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 62.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 62.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055015 Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA055015: AB_2682673" "unprognostic (3.05e-2)" "unprognostic (1.02e-1)" "prognostic favorable (3.25e-4)" "unprognostic (3.69e-3)" "unprognostic (4.14e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.64e-2)" "unprognostic (7.38e-2)" "unprognostic (1.23e-1)" "unprognostic (5.26e-2)" "unprognostic (9.15e-2)" "prognostic favorable (3.09e-8)" "unprognostic (1.90e-1)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (1.41e-2)" 3.6 9.0 4.5 3.6 7.2 1.9 3.9 8.7 9.0 4.9 4.8 15.0 3.6 1.8 3.9 6.3 3.6 7.4 3.6 5.3 7.1 7.3 3.8 3.6 3.7 3.6 4.4 3.6 3.6 5.5 10.4 11.8 4.1 62.1 5.6 5.6 6.8 5.8 3.7 5.1 4.2 3.6 4.7 3.6 3.6 4.2 3.6 3.6 3.6 11.8 3.6 3.6 3.6 3.6 3.4 6.9 8.9 5.7 4.5 7.1 3.1 16.3 11.3 12.3 9.2 11.6 13.3 6.5 9.7 15.5 6.9 8.0 7.5 5.6 6.7 5.2 13.9 5.8 5.7 10.7 19.3 12.1 29.8 7.9 5.2 13.9 9.2 6.0 8.7 6.8 12.2 13.3 6.9 11.4 9.7 26.4 5.7 0.1 9.9 11.5 6.3 6.5 16.4 9.7 8.7 11.4 0.0 5.6 4.5 10.8 7.0 8.2 4.1 6.4 11.0 2.6 17.3 6.9 5.1 16.1 0.0 4.5 7.6 8.8 2.4 13.7 7.6 0.0 12.3 4.1 8.9 2.8 8.0 5.3 5.7 7.1 2.7 4.7 5.1 6.9 3.4 4.2 5.0 2.2 4.5 3.1 2.8 4.3 3.1 4.5 7.2 8.7 9.0 7.1 7.3 4.4 3.6 62.1 3.6 8.9 14.3 3.9 2.7 2.6 5.7 10.0 7.6 13.4 7.9 15.7 3.9 4.1 1.7 7.4 11.0 4.4 4.1 0.0 7.4 5.7 6.2 6.5 4.7 3.4 4.6 11.1 16.8 12.3 5.4 3.7 4.6 4.3 8.5 1.0 10.9 7.3 8.1 0.0 3.5 2.8 3.8 6.5 5.7 14.9 7.8 3.1 2.7 3.5 8.9 2.6 FOLH1 "FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA" ENSG00000086205 "Folate hydrolase 1" Q04609 11 49146635-49208670 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.7;intestine: 111.2;prostate: 33.8" "Cell type enhanced" "Detected in some" 16 "Glandular cells: 41.1;Hepatocytes: 24.1;Muller glia cells: 17.3;Proximal tubular cells: 22.6" "Cancer enriched" "Detected in many" 27 "prostate cancer: 142.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 5.4;RPMI-8226: 3.8;SK-BR-3: 4.5;TIME: 2.9;U-2 OS: 2.7;WM-115: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001451, HPA010593" Enhanced NA NA "CAB001451: AB_563979, HPA010593: AB_1079685" "unprognostic (1.33e-1)" "unprognostic (1.19e-1)" "unprognostic (1.24e-1)" "prognostic favorable (5.24e-5)" "unprognostic (2.55e-1)" "unprognostic (8.31e-2)" "prognostic favorable (4.25e-4)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (2.67e-3)" "unprognostic (2.13e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.81e-2)" "unprognostic (7.27e-2)" "unprognostic (4.74e-3)" "unprognostic (4.04e-1)" 1.2 1.0 10.4 0.9 16.4 0.8 2.5 1.4 12.7 1.4 67.6 37.7 0.0 111.2 1.3 0.8 1.2 2.1 5.0 0.7 16.9 8.7 6.1 15.7 1.1 0.9 19.0 9.1 1.0 0.7 0.7 0.4 0.7 17.7 33.8 0.8 0.6 20.7 0.8 0.6 1.2 61.1 1.0 33.0 1.5 1.0 0.9 16.2 0.0 1.0 0.0 0.8 1.2 0.5 0.9 0.1 0.3 0.8 1.4 1.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.7 0.0 0.2 0.2 5.4 0.5 0.0 1.3 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.0 1.1 1.0 0.2 0.0 0.4 0.3 3.8 0.0 0.0 0.4 1.7 0.0 4.5 1.0 0.6 1.0 0.0 2.9 0.2 2.7 0.4 0.3 0.1 0.5 0.1 0.0 0.9 5.4 0.1 0.8 0.3 0.9 0.6 0.2 0.6 1.2 0.5 0.0 0.9 0.7 0.3 0.2 1.4 0.5 0.1 0.4 0.0 10.4 16.4 1.4 12.7 16.9 8.7 19.0 9.1 17.7 16.2 0.0 1.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 6.6 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.4 41.1 0.0 24.1 0.1 0.0 0.0 3.1 0.0 1.0 1.4 0.0 3.3 0.0 0.0 17.3 0.0 0.0 0.4 22.6 0.2 0.0 0.3 0.2 1.6 0.6 0.0 0.0 0.0 0.5 FOLR1 FOLR ENSG00000110195 "Folate receptor 1" P15328 11 72189558-72196323 "Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" Transport Receptor Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 157.6;salivary gland: 101.2" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 259.5" "Region enriched" "Detected in many" 20 "pons and medulla: 157.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HeLa: 83.6;RPTEC TERT1: 88.8" "Group enriched" "Detected in many" 5 "basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0" "Low region specificity" "Detected in all" HPA077030 Approved "Nuclear membrane" "Secreted to blood" NA NA 81000 "Nuclear membrane" "HPA077030: " "unprognostic (3.30e-1)" "unprognostic (2.19e-1)" "unprognostic (6.55e-2)" "unprognostic (3.49e-2)" "unprognostic (7.67e-3)" "unprognostic (1.98e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.18e-2)" "unprognostic (8.13e-2)" "unprognostic (2.47e-2)" "unprognostic (2.58e-2)" "unprognostic (2.87e-3)" "unprognostic (1.67e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (2.69e-1)" 0.0 0.7 1.3 0.2 1.7 0.0 6.6 0.6 3.5 31.4 0.1 21.4 2.8 0.0 1.0 3.5 1.6 46.7 1.0 0.2 7.9 1.8 38.8 0.2 47.0 0.0 0.8 0.4 8.9 1.8 0.4 3.5 24.5 157.6 1.5 0.0 17.0 101.2 4.0 0.1 0.9 0.1 0.0 0.7 0.0 7.4 0.4 0.2 0.0 12.7 2.6 3.5 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 7.8 7.9 0.0 8.1 0.1 0.0 0.1 0.4 0.3 0.0 0.0 0.2 0.1 83.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.0 88.8 0.0 0.0 0.5 0.2 1.2 0.0 7.3 11.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 1.7 0.6 3.5 7.9 1.8 0.8 0.4 157.6 0.2 461.6 156.4 0.0 7.8 0.8 0.0 0.3 35.7 178.0 316.2 301.8 0.0 307.8 112.7 15.6 0.0 0.0 0.0 0.0 1.2 101.0 3.8 4.7 4.7 0.0 26.1 0.0 1.7 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 1.4 4.1 0.0 0.0 286.0 0.0 0.0 0.1 0.0 0.1 0.1 216.6 0.0 0.0 8.6 FOLR3 FR-G ENSG00000110203 "Folate receptor 3" P41439 11 72114869-72139892 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 73.4;bone marrow: 43.4;lymphoid tissue: 22.6" "Cell type enriched" "Detected in some" 15 "Distal tubular cells: 344.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 5.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 12 "classical monocyte: 52.9;neutrophil: 73.4" "Group enriched" "Detected in many" 12 "granulocytes: 73.4;monocytes: 52.9" "Group enriched" "Detected in some" 5 "hTERT-HME1: 35.6;U-2197: 31.5" "Secreted to blood" NA NA 9600000 "unprognostic (1.47e-2)" "unprognostic (6.26e-3)" "unprognostic (1.94e-2)" "unprognostic (8.72e-3)" "unprognostic (6.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.58e-1)" "unprognostic (3.72e-1)" "unprognostic (1.72e-1)" "unprognostic (1.54e-1)" "unprognostic (7.35e-2)" "unprognostic (7.90e-2)" "unprognostic (8.39e-2)" "unprognostic (9.99e-4)" "unprognostic (1.96e-1)" "unprognostic (2.03e-6)" "unprognostic (4.17e-1)" 2.9 0.3 0.1 4.8 0.2 43.4 4.2 0.1 0.8 0.1 0.1 0.2 0.0 0.2 0.2 0.3 0.4 1.0 0.1 1.7 0.2 0.1 2.7 0.6 14.4 8.2 0.2 0.0 0.1 1.7 0.0 0.1 4.5 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.3 0.2 0.2 0.1 22.6 0.4 0.7 0.2 0.3 0.9 0.4 0.4 0.2 7.5 0.0 5.1 73.4 52.9 0.0 0.2 29.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.0 6.2 1.8 4.5 0.0 0.0 0.0 0.6 0.9 0.1 0.4 0.0 3.3 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 2.6 35.6 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.1 31.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.2 52.9 4.3 0.0 3.5 0.2 0.0 0.0 0.0 5.1 0.0 0.0 0.0 73.4 0.0 0.1 0.9 0.0 29.5 0.1 0.2 0.1 0.8 0.2 0.1 0.2 0.0 0.2 0.2 0.0 12.2 0.0 0.0 0.2 0.0 0.0 0.0 2.7 3.4 22.7 0.0 0.0 344.8 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 1.6 0.0 0.0 0.6 8.7 8.6 0.0 11.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 FOSL1 fra-1 ENSG00000175592 "FOS like 1, AP-1 transcription factor subunit" P15407 11 65892049-65900573 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.2;tongue: 46.8" "Group enriched" "Detected in many" 7 "Basal glandular cells: 279.5;Basal keratinocytes: 300.3;Glandular cells: 139.2;Suprabasal keratinocytes: 296.9;Urothelial cells: 386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "myeloid DC: 6.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.9" "Cell line enhanced" "Detected in many" "PC-3: 94.2;U-2197: 63.2;WM-115: 142.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004396, HPA030728" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB004396: AB_627632, HPA030728: " "unprognostic (2.88e-2)" "unprognostic (1.56e-1)" "unprognostic (9.46e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.80e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.26e-5)" "unprognostic (7.85e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (2.28e-1)" "unprognostic (2.82e-2)" 22.4 3.7 1.5 8.2 3.1 17.9 3.6 1.1 2.8 5.4 2.8 1.5 0.2 0.8 2.1 2.0 35.2 4.4 24.4 5.8 2.3 1.3 2.2 4.4 7.7 1.7 2.6 0.5 2.6 9.9 0.4 2.0 3.2 6.5 3.1 1.7 0.6 5.4 1.0 6.6 9.2 2.0 3.6 3.5 1.6 8.7 1.5 2.3 0.3 2.1 46.8 16.5 16.6 4.6 0.0 6.9 1.0 1.6 0.0 0.6 1.1 36.6 5.4 0.6 2.4 5.5 5.5 5.3 34.3 31.5 29.7 16.7 1.7 30.5 0.0 7.5 23.7 46.9 6.9 2.2 27.6 25.5 1.1 0.0 2.2 0.5 4.0 6.9 1.4 0.8 2.3 2.8 23.3 35.2 14.5 9.5 0.0 5.3 0.2 38.9 1.5 0.0 3.0 2.5 3.1 94.2 0.1 3.0 0.1 13.8 2.4 0.0 0.0 2.0 0.0 25.7 1.6 0.1 1.3 23.7 35.2 7.2 63.2 50.2 0.0 0.1 0.1 49.5 0.6 142.9 0.0 1.6 0.0 0.3 1.1 0.2 0.0 0.6 0.3 6.9 0.0 0.6 0.0 1.0 0.0 0.5 0.8 0.0 1.1 1.5 3.1 1.1 2.7 2.3 1.3 2.6 0.5 6.5 2.3 6.0 4.1 0.0 279.5 300.3 0.0 0.6 0.0 9.4 19.4 0.0 0.0 1.1 0.0 14.2 0.1 11.3 2.8 0.0 3.1 3.8 23.0 139.2 9.2 0.0 1.8 0.0 10.9 8.0 0.6 0.0 0.3 9.0 42.2 1.8 1.2 0.0 23.7 0.2 0.0 0.0 0.0 0.0 40.8 0.2 0.7 296.9 14.8 0.0 0.7 386.7 FOXA1 HNF3A ENSG00000129514 "Forkhead box A1" P55317 14 37589984-37596059 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 47.0;prostate: 44.4" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 103.5;Glandular cells: 100.2;Intestinal endocrine cells: 81.2;Urothelial cells: 133.4" "Cancer enhanced" "Detected in many" "prostate cancer: 127.0" "Region enriched" "Detected in single" 6 "midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.6;MCF7: 36.1;PC-3: 25.2;RT4: 33.8;SK-BR-3: 34.2;T-47d: 48.4" "Group enriched" "Detected in some" 15 "hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1" "Region enriched" "Detected in single" 6 "midbrain: 6.1" "CAB011595, HPA050505" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "CAB011595: AB_2104842, HPA050505: AB_2681148" "unprognostic (1.61e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.65e-1)" "unprognostic (2.58e-1)" "unprognostic (1.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.78e-1)" "unprognostic (1.71e-1)" "unprognostic (3.01e-1)" "unprognostic (1.54e-2)" "unprognostic (6.30e-2)" "unprognostic (0.00e+0)" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.69e-2)" "prognostic favorable (1.00e-4)" 0.1 0.0 0.1 6.1 0.1 0.0 23.5 0.1 0.3 1.5 9.4 0.1 0.1 4.6 0.1 0.5 7.2 1.3 6.5 0.1 0.1 0.3 0.4 47.0 13.2 0.1 2.0 0.1 0.6 0.2 0.0 1.1 0.1 0.2 44.4 6.0 0.2 9.4 0.7 0.1 0.7 5.1 2.4 0.1 0.1 13.0 0.6 0.1 0.2 0.1 4.4 9.9 12.5 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 7.4 0.9 0.0 0.5 0.0 0.0 8.4 4.7 1.1 0.0 0.0 8.3 0.0 1.4 16.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.0 36.1 0.0 0.1 0.0 11.0 25.2 0.0 0.4 0.1 3.5 33.8 4.3 0.0 1.6 34.2 0.0 0.0 48.4 0.1 0.0 0.3 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.3 2.0 0.1 0.2 0.1 26.8 38.7 0.0 103.5 0.9 0.0 1.1 25.5 52.2 37.5 3.5 0.0 0.0 0.0 1.8 0.3 0.3 14.7 0.0 2.1 0.0 0.0 100.2 2.3 27.6 0.0 0.0 81.2 1.3 1.2 0.5 0.0 0.1 3.3 1.8 34.4 0.0 3.1 21.0 0.0 0.0 0.0 0.0 0.1 0.5 1.3 0.1 0.0 0.0 25.3 133.4 FOXA2 HNF3B ENSG00000125798 "Forkhead box A2" Q9Y261 20 22581005-22585455 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.4;pancreas: 47.9;stomach 1: 20.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2" "Region enhanced" "Detected in single" "midbrain: 1.1" "Region enriched" "Detected in single" 7 "midbrain: 4.9" "CAB001388, HPA066846" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB001388: AB_2262810, HPA066846: AB_2685736" "unprognostic (1.19e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.57e-6)" "unprognostic (6.82e-2)" "unprognostic (1.50e-6)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "prognostic favorable (6.28e-4)" "prognostic favorable (2.34e-4)" "unprognostic (3.18e-1)" "unprognostic (2.55e-15)" "unprognostic (2.50e-2)" "unprognostic (1.68e-1)" "unprognostic (7.12e-2)" "unprognostic (3.93e-3)" 0.2 0.0 0.2 1.3 0.2 0.0 0.2 0.2 0.3 9.7 4.5 0.2 0.2 2.2 1.8 0.2 0.2 3.8 13.1 0.2 0.2 0.1 0.2 44.4 15.9 0.2 1.4 0.2 3.4 47.9 0.0 0.4 0.3 0.4 0.5 6.0 0.2 0.2 0.2 0.2 0.0 1.8 0.2 0.2 0.2 20.7 0.3 0.2 0.2 2.2 0.2 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.7 0.0 0.0 16.2 0.0 0.0 0.0 0.0 6.3 0.0 7.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.2 15.1 0.0 0.0 0.0 0.5 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 1.4 0.2 0.4 0.2 89.3 60.1 0.0 1.0 0.0 0.0 0.3 48.4 17.4 22.7 0.0 0.0 0.0 0.0 21.4 0.0 0.0 4.9 0.0 31.8 0.0 0.0 0.6 4.6 51.3 0.0 0.0 27.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 82.6 0.0 24.8 2.9 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 33.6 0.0 FOXA3 HNF3G ENSG00000170608 "Forkhead box A3" P55318 19 45863989-45873797 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 36.7;pancreas: 63.3" "Cell type enhanced" "Detected in many" 19 "Intestinal endocrine cells: 79.9;Mucus-secreting cells: 184.0;Paneth cells: 49.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 10 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.5;Hep G2: 12.9;K-562: 10.3;OE19: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB015154, HPA054034" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB015154: AB_647545, HPA054034: AB_2682349" "unprognostic (2.88e-1)" "unprognostic (6.95e-2)" "unprognostic (2.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "unprognostic (2.27e-1)" "unprognostic (2.39e-2)" "unprognostic (1.42e-1)" "unprognostic (6.87e-3)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-2)" "unprognostic (2.57e-2)" "unprognostic (1.91e-2)" "unprognostic (3.55e-1)" "unprognostic (3.75e-1)" "unprognostic (2.11e-1)" 0.3 0.0 0.2 5.9 0.2 0.0 0.1 0.1 0.3 0.5 9.7 0.3 0.7 4.7 0.2 0.1 0.2 0.1 13.7 0.5 0.1 0.0 0.9 36.7 0.6 0.1 0.1 0.1 0.1 63.3 0.7 0.1 0.1 0.2 0.3 8.0 0.1 1.0 0.8 0.1 0.1 9.0 0.1 0.1 0.1 17.1 0.7 0.3 0.2 0.1 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.7 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.5 0.5 0.1 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 10.3 0.0 0.0 0.1 0.0 0.0 5.2 45.3 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.0 0.0 0.7 3.2 0.0 0.3 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.2 0.3 0.0 4.5 1.4 0.5 0.2 0.0 0.4 10.2 0.0 0.0 1.8 0.0 0.0 0.0 9.7 0.1 0.6 22.2 0.0 21.3 0.0 0.1 6.3 4.6 31.7 0.0 0.0 79.9 0.6 2.1 0.0 0.0 0.0 1.7 0.0 184.0 0.0 26.3 49.1 0.0 0.2 0.0 0.0 0.5 2.3 6.4 0.3 0.0 0.0 36.6 0.9 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004222-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.7" "Cell type enriched" "Detected in some" 6 "Early spermatids: 18.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Region enhanced" "Detected in many" "pons and medulla: 16.7" "Cell type enriched" "Detected in single" 4 "T-reg: 3.8" "Lineage enriched" "Detected in single" 38 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1" "Region enhanced" "Detected in some" "hypothalamus: 7.7" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA073369: AB_2686597" "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 0.3 0.5 4.1 0.2 0.2 0.6 0.0 0.1 0.1 0.6 0.0 0.0 0.6 0.0 0.2 0.9 0.1 0.2 0.1 6.2 0.0 0.1 0.1 1.8 6.5 0.0 0.0 0.4 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 8.4 0.1 1.8 2.6 3.7 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 2.6 0.0 7.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.3 11.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.3 4.1 0.6 0.0 0.1 6.2 6.5 0.0 16.7 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 FOXB2 bA159H20.4 ENSG00000204612 "Forkhead box B2" Q5VYV0 9 77019655-77020953 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 2.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NTERA-2: 5.5" "Region enriched" "Detected in single" 16 "hypothalamus: 1.4" "Group enriched" "Detected in many" 4 "basal ganglia: 3.1;hypothalamus: 6.4;midbrain: 2.0;pons and medulla: 2.0" HPA067947 Uncertain NA NA "HPA067947: AB_2685930" "unprognostic (2.02e-1)" "unprognostic (8.58e-2)" "unprognostic (2.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXC1 "ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1" ENSG00000054598 "Forkhead box C1" Q12948 6 1609972-1613897 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Deafness, Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "retina: 32.7;salivary gland: 86.6" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 40.9;Ito cells: 36.2;Urothelial cells: 55.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "AN3-CA: 39.8;HEK 293: 38.8;RPTEC TERT1: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040670 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040670: AB_10673412" "unprognostic (2.65e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (3.53e-4)" "unprognostic (3.22e-2)" "unprognostic (3.22e-2)" "unprognostic (1.24e-1)" "unprognostic (3.30e-2)" "unprognostic (1.54e-2)" "unprognostic (4.04e-3)" "unprognostic (1.58e-1)" "unprognostic (2.33e-3)" "unprognostic (9.55e-2)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.04e-1)" "unprognostic (3.83e-3)" "unprognostic (3.74e-1)" 7.7 4.4 2.6 1.3 3.4 1.0 9.4 2.3 3.4 6.6 1.4 2.8 3.2 1.2 2.4 3.8 3.8 3.4 9.8 9.5 3.2 2.1 12.9 1.4 3.8 1.6 4.5 2.3 4.8 2.8 2.2 6.5 3.1 6.5 6.0 1.3 32.7 86.6 4.9 3.6 7.1 1.2 2.1 3.9 0.9 1.1 4.6 2.6 2.8 3.7 4.2 2.9 5.7 4.6 0.0 0.0 0.2 0.1 1.4 0.0 0.0 7.3 0.8 0.2 39.8 1.8 2.1 1.2 3.7 4.4 2.3 1.9 2.8 1.5 0.0 4.3 2.2 1.7 8.4 3.8 2.7 1.9 2.3 38.8 1.5 2.2 1.3 1.2 0.5 2.6 7.0 3.8 3.2 3.6 1.2 3.4 0.2 1.0 0.0 1.0 1.6 0.0 0.8 0.1 3.7 3.2 0.0 1.6 0.2 15.6 5.6 1.5 3.4 4.6 0.0 2.6 2.1 1.1 0.6 0.8 5.1 3.1 2.6 3.9 0.1 0.3 0.0 1.4 1.9 4.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.0 2.6 3.4 2.3 3.4 3.2 2.1 4.5 2.3 6.5 2.6 0.0 1.1 0.0 25.0 15.8 0.0 5.6 0.0 26.8 14.8 10.4 0.0 4.5 1.7 3.4 0.4 40.9 0.0 0.0 15.0 0.4 3.6 7.7 0.0 0.0 1.1 0.0 0.0 36.2 0.3 0.9 15.0 1.4 1.7 0.0 0.2 0.3 11.8 0.0 26.5 4.6 0.0 0.0 27.0 0.2 1.9 5.6 0.7 0.0 0.3 55.7 FOXC2 "FKHL14, MFH-1" ENSG00000176692 "Forkhead box C2" Q99958 16 86567251-86569728 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 17.6" "Group enriched" "Detected in some" 5 "Peritubular cells: 29.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 15.9;HUVEC TERT2: 12.2;LHCN-M2: 19.5;TIME: 21.7;U-138 MG: 11.6;U-2197: 19.5;U-87 MG: 15.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA056302 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA056302: AB_2683093" "unprognostic (3.17e-2)" "unprognostic (1.76e-3)" "unprognostic (4.87e-2)" "unprognostic (4.32e-1)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (4.49e-2)" "unprognostic (1.15e-2)" "unprognostic (4.71e-2)" "unprognostic (8.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (1.12e-2)" "unprognostic (3.47e-2)" "unprognostic (2.43e-1)" "unprognostic (1.84e-4)" 4.8 5.7 1.1 1.6 1.4 0.5 6.4 1.1 3.4 6.2 2.0 2.2 0.1 1.1 1.6 5.3 3.0 3.9 5.6 8.8 1.1 1.1 9.1 0.9 4.9 5.4 4.3 2.6 4.0 1.3 0.6 3.7 0.9 9.9 2.1 1.0 17.6 4.2 2.9 3.2 1.5 0.9 2.1 8.5 0.5 1.1 7.7 0.7 0.0 3.3 1.0 0.9 4.9 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.1 0.0 6.5 8.9 5.0 1.0 0.0 0.0 0.0 0.9 0.9 7.0 0.0 0.1 2.0 4.5 0.0 0.4 0.0 4.9 0.0 1.7 0.0 0.0 0.8 2.2 15.9 5.1 9.2 12.2 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.9 0.0 0.0 21.7 11.6 0.0 19.5 0.0 0.0 0.0 0.0 15.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 1.1 3.4 1.1 1.1 4.3 2.6 9.9 0.7 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 1.4 0.0 1.7 0.0 0.0 0.0 0.2 0.0 29.0 0.0 0.0 19.4 4.2 0.2 0.9 0.0 0.0 0.0 0.0 1.0 FOXD1 "FKHL8, FREAC4" ENSG00000251493 "Forkhead box D1" Q16676 5 73444827-73448527 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 13.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 8.0;Muller glia cells: 26.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 23.6;hTERT-RPE1: 27.7;U-138 MG: 31.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (7.06e-4)" "unprognostic (1.02e-3)" "unprognostic (3.00e-5)" "unprognostic (1.48e-4)" "unprognostic (1.09e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (1.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.26e-1)" "unprognostic (7.92e-2)" "unprognostic (2.06e-2)" "unprognostic (6.18e-2)" "unprognostic (2.61e-10)" "unprognostic (3.64e-2)" "unprognostic (2.75e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (9.65e-4)" 1.5 6.2 0.9 0.7 3.2 0.3 0.6 0.4 3.2 1.5 0.5 2.8 0.2 0.2 0.3 0.8 6.4 0.4 1.7 0.4 2.1 3.9 0.2 0.6 1.2 5.1 3.0 0.4 0.1 0.2 1.6 4.3 3.9 1.5 0.4 13.6 1.9 0.6 1.0 1.7 1.7 0.9 5.2 0.5 0.5 6.8 1.6 0.0 0.3 5.1 1.8 1.4 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.9 1.0 0.1 5.4 2.8 2.7 0.5 11.2 5.6 13.8 12.3 0.0 17.6 0.0 0.4 10.7 9.4 5.0 1.8 7.0 15.2 4.1 7.9 0.1 0.1 0.0 1.1 0.7 0.0 3.0 4.9 23.6 7.4 27.7 0.0 2.4 0.1 0.0 14.5 3.4 0.0 0.0 3.3 0.0 2.3 3.4 2.6 0.3 5.3 1.1 2.1 0.5 3.6 0.1 0.5 1.6 0.4 19.2 0.0 31.6 18.1 9.4 0.1 0.0 0.0 0.0 17.4 0.9 10.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 8.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 26.0 0.1 0.0 1.8 0.0 2.4 0.0 1.9 2.1 0.7 0.4 0.0 0.0 0.0 0.0 FOXD2 "FKHL17, FREAC9" ENSG00000186564 "Forkhead box D2" O60548 1 47436017-47440691 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 7.7" "Cell type enhanced" "Detected in some" 11 "Enterocytes: 14.4;Intestinal endocrine cells: 8.7;Mucus-secreting cells: 13.7;Paneth cells: 8.6;Sertoli cells: 6.5;Undifferentiated cells: 16.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 12.8;WM-115: 18.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.10e-2)" "unprognostic (4.55e-2)" "unprognostic (4.17e-2)" "unprognostic (1.49e-1)" "unprognostic (6.39e-2)" "unprognostic (9.85e-3)" "unprognostic (2.81e-3)" "unprognostic (1.92e-1)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (4.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.79e-12)" "unprognostic (1.00e-3)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (5.91e-2)" 0.5 1.2 0.0 0.9 0.0 0.0 0.3 0.0 0.1 2.1 7.7 0.8 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.1 3.2 0.9 0.4 0.3 0.0 0.0 0.2 0.0 2.0 0.1 2.4 5.7 0.3 0.2 0.1 0.2 0.6 0.0 0.1 1.1 1.1 0.5 0.2 0.0 0.2 0.8 0.8 0.2 1.5 0.6 0.3 2.1 0.2 0.9 0.4 0.0 12.8 0.0 0.1 1.1 0.5 0.1 0.0 0.1 1.2 0.2 1.1 0.7 0.0 1.5 0.6 0.3 0.0 0.0 2.0 2.0 0.7 0.8 0.3 0.0 0.7 1.5 0.0 0.4 0.0 0.0 0.3 0.0 1.5 0.9 1.0 0.0 0.6 0.7 0.7 0.0 0.3 0.6 2.6 1.9 0.6 0.0 0.9 2.2 0.0 0.8 0.6 1.3 0.6 2.6 0.8 0.5 0.7 3.3 0.3 1.0 1.3 0.9 1.2 0.5 1.7 18.4 0.6 0.5 1.4 2.1 0.6 1.5 0.8 0.8 1.6 0.2 0.6 0.6 1.3 1.5 0.3 0.5 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 14.4 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 8.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 13.7 3.7 0.2 8.6 0.7 0.0 0.1 6.5 0.9 0.5 0.7 0.1 0.0 0.0 16.6 0.0 FOXD4 "FKHL9, FOXD4a, FREAC5" ENSG00000170122 "Forkhead box D4" Q12950 9 116231-118204 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.7;testis: 3.1" "Cell type enriched" "Detected in single" 7 "monocytes: 4.6" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "THP-1: 8.9" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.27e-2)" "unprognostic (1.09e-2)" "unprognostic (2.38e-3)" "unprognostic (4.75e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-3)" "unprognostic (1.22e-1)" "unprognostic (4.20e-2)" "unprognostic (9.46e-2)" "unprognostic (2.52e-4)" "unprognostic (3.66e-4)" "unprognostic (7.06e-3)" "unprognostic (1.14e-2)" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "unprognostic (6.26e-2)" "unprognostic (1.02e-3)" 0.6 0.6 1.2 0.5 1.4 0.1 0.1 5.7 1.5 0.4 0.2 0.4 0.7 0.1 0.1 0.3 0.1 0.2 1.3 1.5 1.6 0.2 0.6 0.7 0.8 0.3 0.5 0.2 0.7 0.6 0.7 0.3 0.3 0.5 1.4 0.3 0.6 0.4 0.4 1.0 0.6 3.1 0.2 0.2 0.2 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.4 0.8 0.4 3.7 0.2 0.4 0.0 0.3 1.0 0.2 3.7 0.6 0.0 0.1 0.0 0.9 0.2 0.3 3.6 3.0 0.0 0.5 0.3 0.2 2.6 1.9 0.5 0.0 0.0 0.1 0.6 0.0 0.2 1.2 1.6 0.1 1.4 0.3 2.1 0.1 0.5 1.8 0.3 0.8 0.5 0.9 1.9 1.8 1.4 1.0 0.6 0.0 0.3 0.9 8.9 0.5 1.1 1.1 0.7 1.3 0.1 0.4 0.8 0.8 2.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 FOXD4L1 FOXD5 ENSG00000184492 "Forkhead box D4 like 1" Q9NU39 2 113498665-113501155 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1" "Cell type enriched" "Detected in single" 134 "monocytes: 54.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 22 "B-cells: 2.2" "Cell line enhanced" "Detected in some" "RH-30: 5.3;THP-1: 3.7" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (3.48e-1)" "unprognostic (3.66e-2)" "unprognostic (3.02e-2)" "unprognostic (6.61e-2)" "unprognostic (3.22e-1)" "unprognostic (6.41e-4)" "unprognostic (2.54e-1)" "unprognostic (5.77e-3)" "unprognostic (5.93e-2)" "unprognostic (4.21e-2)" "unprognostic (9.54e-4)" "unprognostic (3.98e-2)" "unprognostic (1.18e-8)" "unprognostic (1.57e-2)" "unprognostic (4.14e-2)" "unprognostic (9.57e-2)" "unprognostic (5.91e-4)" 0.2 0.5 0.4 1.2 1.2 3.0 0.1 3.3 0.8 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.6 0.6 0.4 0.1 0.4 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.2 3.1 0.2 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.6 0.7 1.1 0.0 1.5 0.0 0.6 0.0 0.1 0.3 0.0 2.0 0.9 0.1 0.2 0.1 0.6 0.0 0.1 1.9 1.4 0.8 1.0 1.0 0.0 2.1 1.6 0.0 0.7 0.2 0.0 0.8 0.0 0.9 1.2 1.7 0.3 0.1 0.3 0.9 0.0 0.2 0.7 0.6 5.3 0.7 0.1 0.6 0.7 0.4 0.5 0.1 0.3 0.0 0.4 3.7 0.4 1.7 1.5 0.6 1.3 1.4 1.4 0.7 0.3 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FOXD4L3 FOXD6 ENSG00000187559 "Forkhead box D4 like 3" Q6VB84 9 68302867-68304905 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.6;fallopian tube: 2.4;lymphoid tissue: 2.0" "Cell type enriched" "Detected in single" 12 "monocytes: 1.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 7 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;NB-4: 1.2;THP-1: 1.9" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (7.93e-4)" "unprognostic (8.71e-2)" "unprognostic (7.04e-2)" "unprognostic (4.75e-2)" 0.0 0.1 0.7 1.4 1.3 0.0 0.0 2.1 2.3 0.3 0.1 0.0 0.0 0.0 0.0 2.4 0.4 0.0 2.6 0.7 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.0 0.9 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.4 0.0 0.9 0.1 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.6 0.1 0.8 0.5 0.4 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L4 "bA460E7.2, FOXD4L2" ENSG00000184659 "Forkhead box D4 like 4" Q8WXT5 9 65736555-65738784 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (6.92e-2)" "unprognostic (5.48e-2)" "unprognostic (5.19e-2)" "unprognostic (7.78e-2)" "unprognostic (7.93e-3)" "unprognostic (7.14e-2)" 0.4 0.6 0.3 1.0 1.2 0.0 0.2 1.5 1.3 0.7 0.2 0.0 0.2 0.0 0.2 0.2 0.1 0.4 1.0 0.7 0.2 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.4 0.0 0.4 0.1 0.2 0.5 0.1 0.5 0.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.5 1.4 0.0 0.2 0.3 0.7 0.0 0.0 0.2 1.0 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.2 0.5 0.0 0.2 0.2 0.7 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.5 0.2 0.7 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.8 1.0 0.4 0.0 0.1 0.2 0.7 0.0 0.1 0.5 0.0 0.4 1.0 0.5 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L5 bA15J10.2 ENSG00000204779 "Forkhead box D4 like 5" Q5VV16 9 65282101-65285209 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (8.26e-2)" "unprognostic (6.95e-3)" "unprognostic (1.58e-1)" "unprognostic (5.76e-2)" "unprognostic (2.57e-1)" 0.7 1.1 0.3 0.1 0.5 0.0 0.7 0.6 2.2 0.3 0.1 0.1 0.1 1.1 0.4 0.7 0.1 0.2 1.0 0.5 0.5 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.2 0.5 0.3 0.0 1.2 0.1 0.5 2.0 0.3 0.0 0.2 0.2 0.4 1.0 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.2 1.1 0.7 2.8 0.5 0.3 3.5 0.6 0.2 0.0 0.0 0.7 0.3 2.0 0.4 0.2 0.3 0.0 1.5 0.2 0.2 2.8 1.7 1.8 0.8 0.9 0.0 1.5 2.7 0.2 0.8 0.2 0.6 1.0 0.0 0.2 2.7 1.1 0.3 0.6 0.3 1.0 0.8 0.3 0.9 0.6 2.2 0.7 0.7 1.4 1.4 2.6 0.6 0.3 0.2 1.8 0.9 3.5 0.4 0.4 2.1 1.2 1.1 0.8 1.7 0.5 0.3 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXD4L6 ENSG00000273514 "Forkhead box D4 like 6" Q3SYB3 9 41126430-41128463 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 1.8;lymphoid tissue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.8" HPA012836 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA012836: AB_2105429" "unprognostic (2.41e-1)" "unprognostic (3.41e-1)" "unprognostic (3.61e-1)" 0.0 0.0 1.5 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.7 0.2 0.0 0.5 1.0 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.1 0.2 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.1 0.6 0.4 0.6 0.2 0.6 0.5 0.3 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.7 0.3 0.0 0.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXE1 "FKHL15, FOXE2, HFKH4, TITF2, TTF-2" ENSG00000178919 "Forkhead box E1" O00358 9 97853254-97856715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "thyroid gland: 115.1" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 1.8;Spermatogonia: 3.7;Urothelial cells: 2.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 84.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.9;BJ hTERT+: 6.8;HaCaT: 6.3;HeLa: 16.2;RPTEC TERT1: 16.1;SiHa: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.78e-3)" "unprognostic (9.18e-3)" "unprognostic (3.79e-5)" "unprognostic (2.19e-4)" "unprognostic (8.29e-3)" "unprognostic (1.04e-1)" "unprognostic (7.65e-2)" "unprognostic (1.39e-1)" "unprognostic (3.11e-1)" "unprognostic (3.86e-1)" "unprognostic (6.05e-5)" "unprognostic (8.41e-2)" "unprognostic (1.86e-1)" "unprognostic (6.59e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 115.1 4.7 20.4 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.2 0.0 10.9 3.7 0.0 0.0 0.0 0.0 0.0 1.1 6.8 0.8 1.2 0.0 0.9 0.0 0.5 0.0 0.0 6.3 0.7 0.1 3.4 0.0 0.6 0.0 16.2 0.0 0.0 0.0 1.1 0.0 0.8 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 16.1 1.0 0.0 0.0 11.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.7 0.3 0.0 0.0 0.0 2.0 FOXE3 "FKHL12, FREAC8" ENSG00000186790 "Forkhead box E3" Q13461 1 47416072-47418052 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cataract, Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.9;lymphoid tissue: 4.6;testis: 2.9" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 4.2;Spermatogonia: 1.9" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Group enriched" "Detected in some" 5 "basal ganglia: 2.9;cerebellum: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "SuSa: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.11e-1)" "unprognostic (1.31e-2)" "unprognostic (1.23e-3)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (6.24e-2)" "unprognostic (1.24e-2)" "unprognostic (8.21e-2)" "unprognostic (1.49e-1)" "unprognostic (2.34e-1)" "unprognostic (5.15e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-7)" "unprognostic (2.41e-1)" "unprognostic (5.46e-2)" "unprognostic (3.60e-1)" 0.2 0.1 0.2 0.1 2.9 0.1 0.1 1.6 0.4 0.8 0.7 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 2.9 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 1.6 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 FOXF1 "FKHL5, FREAC1" ENSG00000103241 "Forkhead box F1" Q12946 16 86510527-86515418 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 54.7;urinary bladder: 48.5" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 4.7;Fibroblasts: 7.2;Ito cells: 4.9;Smooth muscle cells: 19.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ: 9.4;BJ hTERT+: 20.7;HHSteC: 20.3;U-2197: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA028886 Approved Nucleoplasm NA NA Nucleoplasm "HPA028886: AB_10601652" "unprognostic (7.91e-2)" "unprognostic (3.02e-3)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.08e-1)" "unprognostic (8.22e-2)" "unprognostic (6.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.91e-2)" "unprognostic (1.29e-2)" "unprognostic (4.89e-2)" "unprognostic (4.20e-2)" "unprognostic (7.11e-2)" "unprognostic (2.44e-1)" 2.2 0.3 2.5 15.4 2.9 0.0 0.8 2.3 4.2 7.9 34.6 1.3 1.6 7.2 2.1 0.9 17.9 1.2 39.7 0.6 3.4 1.9 1.2 2.4 33.1 2.4 3.5 1.0 0.6 0.9 1.1 0.4 18.5 3.5 35.7 9.2 0.5 0.9 4.8 0.3 0.4 18.4 54.7 3.0 0.5 18.4 0.6 3.7 0.0 3.6 2.6 3.3 48.5 25.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 20.7 2.9 1.0 0.0 0.1 0.0 0.0 0.8 2.0 0.0 1.6 0.0 2.5 0.0 1.1 0.0 1.5 0.0 20.3 0.0 1.7 2.1 0.0 3.3 0.4 0.3 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 8.9 0.0 0.0 0.0 0.0 1.9 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.5 2.9 2.3 4.2 3.4 1.9 3.5 1.0 3.5 3.7 0.0 1.1 0.0 0.2 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.3 7.2 0.7 0.0 0.0 0.3 0.0 0.0 4.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 19.6 0.0 0.4 0.3 1.0 0.0 0.0 0.2 FOXF2 "FKHL6, FREAC2" ENSG00000137273 "Forkhead box F2" Q12947 6 1389576-1395603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.5;intestine: 24.0;retina: 58.7" "Cell type enhanced" "Detected in some" 10 "Fibroblasts: 3.1;Leydig cells: 2.3;Melanocytes: 1.7;Peritubular cells: 2.5;Smooth muscle cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 40.0;HEK 293: 13.3;U-2197: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.39e-2)" "unprognostic (3.32e-2)" "unprognostic (8.12e-2)" "unprognostic (1.11e-1)" "unprognostic (9.89e-3)" "unprognostic (2.53e-1)" "unprognostic (4.50e-2)" "unprognostic (8.76e-2)" "unprognostic (8.75e-7)" "unprognostic (1.03e-1)" "unprognostic (4.74e-2)" "unprognostic (2.08e-2)" "unprognostic (8.29e-2)" 1.4 0.4 3.5 3.4 4.4 0.1 2.2 1.7 3.9 1.3 24.0 2.3 0.0 7.6 0.2 1.2 28.5 0.4 2.0 0.5 2.8 2.4 0.2 0.3 13.6 0.6 3.7 3.2 0.2 0.7 0.8 5.5 11.5 2.2 13.2 12.3 58.7 0.8 1.0 0.6 0.9 15.8 4.8 2.1 0.2 12.6 0.8 1.4 0.0 2.5 2.7 2.4 9.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.9 0.6 0.5 1.9 2.9 0.0 8.3 40.0 3.6 1.6 0.1 0.0 0.0 1.8 2.6 3.9 6.5 6.9 0.3 1.6 0.0 13.3 0.0 3.1 0.0 3.6 0.0 0.2 0.5 2.8 0.0 3.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 2.1 0.0 2.8 0.8 0.0 0.1 0.0 3.3 6.3 16.3 1.5 0.2 0.0 0.0 0.0 2.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.4 1.7 3.9 2.8 2.4 3.7 3.2 2.2 1.4 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.2 3.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.7 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.2 0.0 1.4 0.0 0.4 0.1 0.1 0.0 0.0 0.0 FOXG1 "BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN" ENSG00000176165 "Forkhead box G1" P55316 14 28760330-28770277 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 32.4" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 20.2" "Cancer enriched" "Detected in some" 10 "glioma: 15.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.5;SCLC-21H: 22.1;U-138 MG: 13.6;U-251 MG: 13.6" "Group enriched" "Detected in many" 7 "amygdala: 34.1;basal ganglia: 45.4;cerebral cortex: 40.1;hippocampal formation: 49.3;olfactory region: 31.7" "Group enriched" "Detected in many" 5 "amygdala: 84.2;basal ganglia: 118.5;cerebral cortex: 107.8;hippocampal formation: 165.6;olfactory region: 132.9" NA NA "unprognostic (2.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (3.49e-1)" "unprognostic (1.17e-3)" "unprognostic (2.14e-2)" "unprognostic (1.27e-11)" "unprognostic (4.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.60e-2)" 0.8 0.8 15.0 0.8 22.4 0.8 0.8 0.0 32.4 0.8 0.8 8.3 0.0 0.8 0.8 0.8 1.2 0.8 0.8 0.8 16.7 2.2 0.8 0.8 0.8 1.5 1.0 14.2 1.3 0.8 0.9 2.1 0.8 0.0 0.8 0.8 0.0 0.8 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 5.4 7.8 0.0 0.8 0.0 0.9 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 3.5 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 2.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 13.6 0.0 1.3 13.6 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 15.0 22.4 0.0 18.8 16.7 2.2 1.0 14.2 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.2 0.2 0.0 0.1 0.0 0.0 0.0 FOXH1 FAST1 ENSG00000160973 "Forkhead box H1" O75593 8 144473412-144476335 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.5" "Cell type enhanced" "Detected in single" 12 "Spermatogonia: 1.2" "Cancer enriched" "Detected in some" 26 "testis cancer: 23.2" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "NTERA-2: 21.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.62e-1)" "unprognostic (8.26e-2)" "unprognostic (4.70e-2)" "unprognostic (2.23e-2)" "unprognostic (2.10e-1)" "unprognostic (1.65e-1)" "unprognostic (1.09e-2)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (6.20e-2)" "unprognostic (3.99e-1)" "unprognostic (1.52e-1)" "unprognostic (2.65e-8)" "unprognostic (1.03e-1)" "unprognostic (3.39e-2)" "unprognostic (3.99e-1)" "unprognostic (9.35e-3)" 0.1 0.2 0.4 0.8 1.9 0.0 0.2 1.0 0.5 0.0 2.1 3.2 0.0 0.1 0.4 0.0 1.5 0.0 0.4 0.5 0.5 0.5 0.2 0.1 0.1 0.0 0.0 0.2 1.0 0.0 0.7 0.9 0.6 0.4 0.0 2.6 3.5 0.0 0.0 0.3 1.8 2.2 0.4 0.0 0.7 0.0 0.0 1.1 0.1 0.3 0.0 1.1 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.2 1.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.4 0.0 0.0 0.5 0.0 0.2 21.6 0.5 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 5.3 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 1.2 0.1 0.0 0.0 0.4 0.0 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109725 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 37.0;salivary gland: 12.4" "Cell type enriched" "Detected in some" 13 "Distal tubular cells: 23.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 48 "eosinophil: 4.7" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.7" "Group enriched" "Detected in some" 5 "MCF7: 4.0;SuSa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Uncertain Nucleoli,Vesicles NA NA "Nucleoli, Vesicles" "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 37.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 3.3 0.0 0.0 12.4 3.7 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.8 0.0 0.0 0.0 FOXI2 FLJ46831 ENSG00000186766 "Forkhead box I2" Q6ZQN5 10 127737235-127741186 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 6.5;pituitary gland: 10.3" "Group enriched" "Detected in some" 6 "Distal tubular cells: 3.3;Urothelial cells: 1.6" "Cancer enriched" "Detected in some" 6 "renal cancer: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "NTERA-2: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.28e-1)" "unprognostic (2.02e-1)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "unprognostic (5.12e-3)" "unprognostic (4.71e-4)" "unprognostic (6.78e-3)" "prognostic favorable (4.23e-7)" "unprognostic (6.31e-3)" "unprognostic (2.66e-1)" "unprognostic (7.18e-3)" "unprognostic (1.65e-2)" 0.7 0.0 0.1 3.0 0.1 0.0 0.7 0.1 0.3 5.4 0.4 0.1 3.1 0.1 1.8 2.7 4.7 0.7 0.2 0.5 0.1 0.1 6.5 0.1 0.4 0.9 0.1 0.1 1.2 0.2 0.1 10.3 0.1 0.4 1.2 0.0 0.1 2.3 1.7 0.3 1.4 0.4 0.5 0.1 2.3 0.5 0.3 0.1 0.4 0.1 0.9 0.8 1.6 2.5 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 FOXI3 ENSG00000214336 "Forkhead box I3" A8MTJ6 2 88446787-88452656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 11.6;retina: 15.7" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 3.2;Muller glia cells: 5.6;Syncytiotrophoblasts: 2.3" "Cancer enhanced" "Detected in some" "testis cancer: 10.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "BEWO: 24.7;SuSa: 33.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.72e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-1)" "unprognostic (6.72e-4)" "unprognostic (8.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (5.29e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 11.6 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.9 0.5 0.9 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 33.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.2 0.4 0.2 0.3 0.4 0.4 0.3 0.2 0.7 0.4 0.6 1.5 0.9 0.5 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 FOXJ1 "FKHL13, HFH-4, HFH4" ENSG00000129654 "Forkhead box J1" Q92949 17 76136333-76141299 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.9;epididymis: 20.4;fallopian tube: 45.9" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 93.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 9 "T-cells: 2.6" "Group enriched" "Detected in some" 9 "BEWO: 23.0;CAPAN-2: 19.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 55.6" HPA005714 Enhanced NA NA "HPA005714: AB_1078902" "prognostic favorable (9.39e-4)" "unprognostic (4.97e-3)" "unprognostic (1.22e-1)" "unprognostic (2.77e-3)" "unprognostic (1.19e-1)" "unprognostic (2.54e-3)" "unprognostic (1.71e-3)" "unprognostic (6.15e-2)" "unprognostic (1.00e-2)" "unprognostic (7.84e-3)" "unprognostic (1.43e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.49e-2)" "unprognostic (1.94e-1)" "unprognostic (2.27e-1)" "unprognostic (1.91e-1)" 0.4 0.4 4.1 0.5 8.9 0.6 0.4 0.1 2.2 5.1 0.9 19.9 0.4 0.6 2.4 20.4 0.4 45.9 0.4 0.4 6.5 6.6 1.5 0.4 17.0 0.4 2.0 1.2 14.7 1.2 0.4 1.2 0.4 19.6 0.6 0.6 0.1 0.4 2.8 0.4 0.8 0.6 0.5 1.8 0.4 0.9 15.2 3.4 0.0 2.9 0.0 0.4 1.1 0.2 0.0 0.0 0.0 0.0 0.2 2.6 0.1 0.0 0.4 1.3 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 2.3 19.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.6 2.6 0.0 0.2 0.0 0.0 0.0 0.1 4.1 8.9 0.1 2.2 6.5 6.6 2.0 1.2 19.6 3.4 8.9 1.9 0.9 1.0 0.7 0.4 0.8 2.5 93.7 13.6 8.7 3.9 0.1 0.0 0.5 19.5 0.1 0.0 0.0 0.0 0.5 0.3 0.3 1.1 0.0 0.1 0.0 1.7 0.6 0.0 11.7 0.3 0.0 0.0 0.0 1.1 2.5 0.2 0.0 0.4 0.7 6.7 0.0 0.0 8.8 1.7 0.6 0.2 1.3 1.8 0.0 FOXL1 "FKH6, FKHL11, FREAC7" ENSG00000176678 "Forkhead box L1" Q12952 16 86576368-86582160 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 15.8" "Group enriched" "Detected in some" 12 "Pancreatic endocrine cells: 6.1;Peritubular cells: 7.4;Sertoli cells: 6.5;Smooth muscle cells: 6.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 8.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.5;CAPAN-2: 16.0;hTEC/SVTERT24-B: 11.3;PC-3: 20.7;REH: 12.2;U-87 MG: 45.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.21e-1)" "unprognostic (3.31e-3)" "unprognostic (2.98e-1)" "unprognostic (1.12e-2)" "unprognostic (3.79e-1)" "unprognostic (4.62e-2)" "unprognostic (1.43e-3)" "unprognostic (1.79e-2)" "unprognostic (1.07e-3)" "unprognostic (1.19e-1)" "unprognostic (1.33e-3)" "unprognostic (1.35e-1)" "unprognostic (2.36e-8)" "unprognostic (1.50e-1)" "unprognostic (9.77e-2)" "unprognostic (3.16e-2)" "unprognostic (5.17e-3)" 2.8 1.0 1.4 3.4 1.4 0.1 1.6 0.4 2.0 2.8 7.2 0.6 0.0 6.4 1.5 1.9 1.1 1.9 15.8 4.5 0.6 0.4 2.8 0.5 2.7 3.5 0.9 0.7 3.8 0.2 0.1 1.3 0.3 1.6 3.5 5.1 6.7 1.2 1.0 4.9 0.9 5.9 1.1 2.1 0.2 5.8 5.8 0.6 0.1 1.2 1.5 0.3 6.2 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.7 5.7 0.0 3.8 12.5 3.4 1.2 0.0 16.0 0.0 0.8 1.1 1.7 0.4 0.0 1.2 3.8 0.0 0.0 0.0 3.3 0.0 1.7 0.0 0.0 1.4 0.4 11.3 2.6 1.3 1.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 20.7 12.2 0.7 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 2.6 5.8 0.0 8.7 2.2 0.0 0.0 1.1 45.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 1.4 0.4 2.0 0.6 0.4 0.9 0.7 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.1 0.0 7.4 0.0 0.0 6.5 6.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 FOXL2 "BPES, BPES1" ENSG00000183770 "Forkhead box L2" P58012 3 138944224-138947140 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.6;fHDF/TERT166: 6.5;HEL: 9.2;hTCEpi: 8.5;K-562: 9.4;SiHa: 6.5;THP-1: 6.7" "Not detected" "Not detected" HPA069613 Enhanced Supported "Nucleoplasm,Midbody ring" NA NA Nucleoplasm "Midbody ring" "HPA069613: AB_2686160" "unprognostic (1.46e-1)" "unprognostic (3.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.05e-1)" "unprognostic (5.16e-4)" "unprognostic (3.55e-2)" "unprognostic (2.35e-3)" "unprognostic (5.08e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-1)" "unprognostic (9.63e-8)" "unprognostic (2.16e-2)" "unprognostic (4.65e-1)" "unprognostic (2.90e-2)" "unprognostic (1.61e-2)" 0.0 1.5 0.3 0.0 1.2 0.0 0.0 0.3 1.0 13.9 0.0 0.6 0.0 0.0 10.0 0.4 0.1 6.4 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.4 55.5 0.6 15.3 13.1 1.4 0.8 0.2 0.0 1.7 0.0 0.4 0.0 0.2 0.0 0.9 0.3 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 2.2 0.3 4.0 0.1 0.0 1.7 0.2 0.0 0.4 0.1 0.0 0.4 0.0 2.7 6.5 0.2 1.3 0.0 0.0 0.1 0.0 0.0 9.2 1.1 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.4 0.0 0.0 9.4 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 6.5 0.0 0.0 0.3 0.0 6.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.3 1.0 0.4 0.2 0.3 0.4 0.8 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 FOXL2NB "C3orf72, FLJ43329" ENSG00000206262 "FOXL2 neighbor" Q6ZUU3 3 138947234-138953451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 51.6;parathyroid gland: 25.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;fHDF/TERT166: 10.7;HEL: 10.6;hTCEpi: 5.0;SiHa: 8.3" "HPA061017, HPA071790" Enhanced "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA061017: AB_2684415, HPA071790: AB_2686447" "unprognostic (3.32e-1)" "unprognostic (1.13e-1)" "unprognostic (3.86e-2)" "unprognostic (4.07e-2)" "unprognostic (4.40e-5)" "unprognostic (3.30e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.41e-10)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (2.77e-1)" "unprognostic (1.22e-2)" 0.1 1.0 0.6 0.1 1.4 0.2 0.1 0.2 0.9 15.3 0.1 0.5 0.1 0.0 12.6 0.9 0.2 7.3 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.5 0.4 51.6 0.4 25.0 9.4 3.2 1.0 0.1 0.0 1.3 0.1 0.5 0.1 0.3 0.1 2.5 0.3 0.1 0.0 0.4 0.3 0.1 0.4 0.3 0.1 0.4 2.3 0.6 0.5 2.8 0.4 0.7 0.4 0.0 2.1 1.4 0.7 5.5 0.3 0.1 2.3 0.1 0.0 0.2 0.0 0.3 0.4 0.2 1.1 10.7 0.1 0.5 0.2 0.1 0.2 0.1 0.3 10.6 3.3 0.1 0.0 0.1 0.4 0.2 5.0 0.2 0.1 0.6 0.0 0.3 4.0 0.3 2.6 0.3 0.1 0.3 0.3 0.2 0.2 0.1 0.0 0.0 0.5 1.5 0.2 0.2 8.3 0.2 0.0 1.0 0.2 3.1 0.2 0.4 0.3 0.3 0.1 0.4 0.2 0.1 0.3 0.3 0.1 1.3 0.4 0.3 0.4 0.3 0.2 0.4 0.3 0.3 0.2 0.6 0.4 0.3 2.8 0.7 0.2 0.5 0.4 0.0 0.6 1.4 0.2 0.9 0.3 0.2 0.5 0.4 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB017832 Uncertain Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.95e-6)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.5 29.0 22.5 20.7 3.4 4.5 28.7 18.7 18.4 37.9 34.4 36.6 25.6 18.5 4.0 26.7 43.1 22.2 33.7 17.1 37.2 34.5 18.0 20.8 27.8 15.6 0.5 16.7 17.1 2.3 1.9 35.2 24.8 9.0 26.7 21.2 11.6 41.5 29.8 26.8 22.7 7.9 49.7 29.7 21.7 16.5 34.2 9.6 8.9 18.3 12.7 20.1 23.9 20.1 10.9 44.4 19.6 18.7 10.7 30.8 46.8 35.9 64.8 5.5 9.1 26.8 14.3 16.1 32.6 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 0.0 2.2 0.8 0.7 2.6 1.6 0.5 2.5 0.0 1.2 1.8 3.9 1.4 1.7 0.2 16.5 0.3 1.7 23.3 0.0 15.0 1.3 0.8 0.0 0.9 7.3 4.8 0.0 3.1 1.9 20.0 0.9 1.7 0.0 1.8 3.7 0.6 0.2 0.0 0.7 0.0 4.4 0.0 0.0 7.6 5.9 1.3 1.6 2.5 3.7 1.3 FOXN1 "FKHL20, RONU, WHN" ENSG00000109101 "Forkhead box N1" O15353 17 28506243-28538896 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 15.1;lymphoid tissue: 37.0;skin 1: 27.9;tongue: 18.4" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 3.5;Glandular cells: 3.2;Suprabasal keratinocytes: 10.8;Urothelial cells: 13.3" "Cancer enhanced" "Detected in many" "cervical cancer: 7.0;head and neck cancer: 8.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enriched" "Detected in some" 6 "HaCaT: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.60e-1)" "prognostic favorable (6.43e-4)" "unprognostic (2.68e-3)" "unprognostic (5.98e-6)" "prognostic favorable (5.00e-4)" "unprognostic (2.85e-1)" "unprognostic (2.56e-1)" "unprognostic (3.89e-2)" "unprognostic (7.08e-3)" "unprognostic (1.26e-2)" "unprognostic (1.90e-3)" "unprognostic (4.68e-2)" "unprognostic (3.96e-1)" "unprognostic (1.34e-1)" "unprognostic (9.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.6 0.0 15.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 1.6 0.2 0.1 27.9 0.0 0.0 0.0 0.0 0.1 0.2 0.1 37.0 0.1 18.4 11.3 0.7 6.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 3.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.9 0.0 0.2 13.3 FOXN2 HTLF ENSG00000170802 "Forkhead box N2" P32314 2 48314637-48379294 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003485 Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA003485: AB_1078905" "unprognostic (5.38e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "unprognostic (2.65e-3)" "prognostic favorable (3.85e-4)" "unprognostic (4.00e-1)" "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (8.95e-2)" "unprognostic (2.59e-1)" "unprognostic (5.15e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.24e-2)" "unprognostic (1.55e-1)" "unprognostic (2.34e-2)" "unprognostic (1.12e-2)" 17.7 6.2 12.7 13.9 17.4 45.5 13.6 23.6 13.8 8.1 7.4 25.0 3.2 8.2 8.2 4.6 9.1 6.5 9.8 8.3 16.1 9.5 6.8 18.7 10.6 17.4 23.3 12.8 6.2 8.4 9.8 7.0 12.6 19.0 6.2 8.0 2.9 7.1 4.7 8.0 5.9 10.1 9.5 23.6 17.2 7.4 6.1 26.0 17.8 7.9 6.9 15.7 10.9 8.2 7.6 11.3 42.3 11.3 8.3 9.9 5.6 6.9 10.7 12.3 10.9 9.8 7.2 13.6 7.8 8.6 6.6 7.4 9.4 8.8 15.3 10.5 9.2 8.1 8.9 7.4 8.9 9.7 11.8 6.5 29.8 7.6 9.4 17.1 16.3 23.8 6.5 3.8 7.1 12.5 5.4 7.0 6.4 14.1 18.3 10.7 5.3 18.0 10.8 9.3 5.2 5.6 9.0 25.8 12.5 5.8 8.9 6.9 7.1 3.8 7.2 13.8 4.4 3.2 9.7 8.1 9.1 9.1 8.6 8.2 9.9 7.4 22.1 7.9 15.1 12.2 35.1 11.1 42.3 8.7 8.9 9.9 7.5 8.3 7.9 11.3 7.6 6.4 6.4 14.1 8.3 11.3 7.0 9.5 5.6 12.7 17.4 23.6 13.8 16.1 9.5 23.3 12.8 19.0 26.0 0.0 6.1 9.5 17.5 13.9 6.9 9.0 15.3 1.4 6.8 1.8 0.0 5.6 5.0 5.3 3.3 17.0 7.7 0.0 4.7 28.3 9.9 31.0 22.0 17.0 16.1 12.7 2.4 19.0 31.1 3.3 11.2 31.1 11.8 35.1 8.6 7.1 8.8 7.0 10.6 4.0 3.7 6.5 13.0 11.1 7.5 18.4 13.8 17.3 8.3 34.0 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell type enhanced" "Detected in some" 21 "Spermatocytes: 1.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 6.6 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 9.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.0 0.0 FOXO1 "FKH1, FKHR, FOXO1A" ENSG00000150907 "Forkhead box O1" Q12778 13 40469953-40666597 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Autophagy, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 85.9" "Cell type enhanced" "Detected in many" 6 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;Daudi: 20.4;HSkMC: 25.7;U-698: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001252, CAB022326" Approved Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022326: , HPA001252: AB_1078906" "unprognostic (4.72e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-2)" "unprognostic (4.35e-1)" "unprognostic (2.42e-1)" "unprognostic (2.52e-1)" "prognostic favorable (3.74e-4)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (8.65e-3)" "unprognostic (1.71e-1)" "unprognostic (1.31e-1)" "prognostic favorable (1.33e-5)" "unprognostic (1.93e-1)" "unprognostic (5.44e-1)" "unprognostic (9.09e-2)" "unprognostic (9.63e-2)" 41.6 6.9 7.0 18.4 11.2 8.0 35.5 2.3 5.0 21.4 13.4 8.4 7.7 3.5 27.4 9.8 9.5 17.2 13.3 9.9 7.8 3.9 8.3 25.6 15.3 22.4 8.3 3.9 46.0 12.2 3.8 6.2 9.5 6.5 7.9 6.8 5.7 7.5 9.3 85.9 12.3 7.6 18.6 9.7 10.8 7.4 12.3 9.0 9.4 13.1 9.0 15.6 14.4 16.2 6.1 0.5 2.8 1.6 1.1 7.1 1.0 0.3 0.6 5.7 0.1 19.3 3.8 5.5 0.8 1.1 0.2 0.1 1.5 1.3 20.4 3.8 0.5 0.9 4.9 4.5 2.4 0.3 9.2 4.6 0.0 0.6 4.5 9.2 0.1 0.5 25.7 16.7 0.1 3.2 1.1 14.5 1.5 0.3 6.5 1.4 0.7 0.0 0.2 8.3 2.8 1.4 14.5 6.7 1.6 10.7 2.6 1.2 0.3 0.7 3.9 0.8 6.9 0.6 0.5 8.5 0.1 1.1 0.0 0.5 3.7 1.4 26.4 0.5 0.9 2.6 0.9 0.8 0.5 1.5 1.0 2.3 3.2 3.9 2.2 0.5 6.1 7.1 5.3 2.8 1.1 1.6 0.0 5.5 1.0 7.0 11.2 2.3 5.0 7.8 3.9 8.3 3.9 6.5 9.0 0.0 4.1 9.5 18.7 26.1 3.0 9.8 7.6 9.4 9.1 8.7 11.8 0.2 0.0 9.5 5.5 37.9 19.3 0.0 15.3 1.7 28.8 9.2 1.1 39.4 5.7 4.8 50.2 72.4 15.5 2.0 17.3 11.0 11.8 18.0 18.4 5.0 15.9 13.6 12.4 6.3 8.3 6.5 9.3 4.8 14.9 23.3 0.7 12.9 9.8 9.1 FOXO4 "AFX1, MLLT7" ENSG00000184481 "Forkhead box O4" P98177 X 71096197-71103535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 98.6" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 207.8;Syncytiotrophoblasts: 257.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "BEWO: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039560, HPA040232" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039560: AB_2676572, HPA040232: AB_2676894" "unprognostic (4.64e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (4.79e-2)" "prognostic favorable (4.61e-4)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-2)" "unprognostic (2.13e-2)" "unprognostic (8.16e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (1.20e-1)" "unprognostic (1.75e-3)" 8.5 13.2 21.7 3.8 21.5 9.9 5.1 9.1 15.6 4.8 8.4 9.1 11.9 6.3 6.8 10.2 7.3 7.7 5.8 9.7 21.4 14.5 5.2 3.6 5.5 3.6 22.8 8.4 13.4 6.8 8.7 3.0 98.6 9.2 7.0 4.7 4.9 8.5 11.3 33.8 5.5 6.6 9.4 17.3 6.0 5.2 13.9 13.1 4.4 5.9 7.5 4.2 7.5 11.0 0.9 0.2 3.4 0.6 1.0 1.8 0.9 1.8 0.5 1.4 1.8 3.4 2.4 61.2 1.4 1.6 0.7 1.7 1.2 2.4 2.4 1.8 1.8 0.8 0.8 3.7 1.6 0.9 2.4 5.6 3.4 11.4 2.0 1.9 2.0 2.7 2.0 3.9 0.7 0.4 3.3 1.9 3.5 7.0 4.7 0.3 0.4 3.1 3.2 6.6 4.6 2.2 2.1 3.6 3.6 1.2 1.0 1.0 3.0 2.9 0.4 3.2 10.9 0.7 1.2 1.7 0.4 0.9 3.2 0.3 3.1 1.6 0.4 1.6 5.3 0.5 0.2 0.6 3.2 0.9 0.6 0.3 0.8 0.5 0.9 0.2 0.9 0.4 1.8 3.4 1.0 0.3 0.0 1.3 0.9 21.7 21.5 9.1 15.6 21.4 14.5 22.8 8.4 9.2 13.1 0.0 2.4 1.4 4.1 4.7 1.2 6.5 5.1 0.0 1.2 8.7 3.9 207.8 1.7 2.0 0.2 3.8 12.7 23.3 2.6 8.6 4.4 3.4 2.3 2.4 19.4 1.6 5.8 4.3 3.1 0.4 6.4 3.2 3.3 1.0 11.4 2.8 2.6 8.6 14.5 3.3 0.8 6.5 2.5 0.3 0.4 3.0 257.4 5.0 6.0 3.1 FOXO6 ENSG00000204060 "Forkhead box O6" A8MYZ6 1 41361922-41383590 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.2;placenta: 8.4" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 5.1;Muller glia cells: 7.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.70e-1)" "unprognostic (1.13e-1)" "unprognostic (7.35e-2)" "prognostic unfavorable (7.65e-6)" "unprognostic (5.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (2.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.71e-2)" "unprognostic (5.27e-2)" "unprognostic (6.55e-9)" "unprognostic (4.35e-2)" "unprognostic (4.28e-1)" "unprognostic (6.10e-2)" "unprognostic (8.10e-2)" 1.1 0.6 0.7 0.6 3.0 0.7 1.0 0.1 4.5 1.0 0.6 1.9 0.0 1.4 0.6 0.6 0.6 0.6 0.9 0.6 4.9 0.7 0.8 0.9 0.7 0.1 1.9 4.8 2.3 0.6 3.6 8.4 0.7 0.6 0.6 1.3 0.6 0.6 1.3 0.6 0.6 0.6 0.0 1.0 0.6 1.2 1.6 7.2 0.6 3.5 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 4.2 3.1 5.1 0.0 0.0 1.8 0.0 2.4 0.0 0.8 3.6 0.4 0.0 0.0 0.2 1.6 1.1 1.3 0.0 0.0 0.3 0.0 1.2 0.6 0.0 4.3 3.7 0.0 0.0 0.0 0.8 7.2 0.2 0.0 3.9 0.7 0.8 0.0 1.4 0.2 0.4 0.0 3.7 0.0 0.4 1.2 FOXP2 "CAGH44, SPCH1, TNRC10" ENSG00000128573 "Forkhead box P2" O15409 7 114086327-114693772 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 48.4;urinary bladder: 31.5" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 27.2;Muller glia cells: 42.1;Suprabasal keratinocytes: 22.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 15.0;RH-30: 27.6;THP-1: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000382, HPA000383, HPA001679" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415" "unprognostic (1.21e-1)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (8.83e-3)" "unprognostic (4.66e-1)" "unprognostic (3.69e-4)" "unprognostic (2.04e-2)" "unprognostic (6.22e-2)" "unprognostic (2.17e-1)" "unprognostic (6.70e-3)" "unprognostic (1.22e-1)" "unprognostic (1.77e-1)" "unprognostic (8.04e-2)" "unprognostic (4.16e-3)" "unprognostic (2.84e-1)" "unprognostic (9.81e-2)" "unprognostic (4.19e-2)" 1.7 1.5 0.9 9.4 2.9 0.0 2.0 0.6 2.8 9.4 20.4 0.7 3.6 2.7 18.1 2.1 12.4 3.5 7.7 1.2 0.7 2.9 1.5 2.9 1.4 0.6 2.0 1.0 11.1 4.5 0.0 0.9 0.7 1.8 13.3 5.7 1.4 2.8 1.5 4.6 3.3 4.2 48.4 0.9 0.6 4.6 0.9 0.9 0.6 5.3 3.2 1.2 31.5 5.4 9.4 16.5 11.1 7.2 6.3 10.3 16.3 0.2 2.2 15.0 0.0 3.5 4.7 0.9 2.4 2.6 0.5 0.3 1.0 0.2 0.2 0.6 0.8 0.1 0.3 0.6 0.0 0.1 0.1 5.1 5.6 3.4 4.6 0.0 0.3 0.3 1.2 0.6 0.0 0.0 0.9 0.6 0.0 1.2 2.1 0.5 1.1 1.2 0.8 0.8 0.2 0.7 0.4 27.6 5.3 0.3 6.0 3.9 1.6 0.0 0.9 0.7 1.0 0.7 8.2 1.1 1.0 0.4 1.4 0.4 5.4 0.4 0.6 1.1 0.5 0.4 7.5 5.2 11.1 6.2 7.2 6.3 9.4 7.0 6.8 6.8 7.3 7.2 8.1 5.6 6.3 5.9 16.5 10.3 16.3 0.9 2.9 0.6 2.7 0.7 2.9 2.0 1.0 1.8 0.9 0.0 5.1 0.0 1.7 27.2 0.0 1.4 7.6 12.0 7.9 3.5 2.0 0.1 0.0 0.0 8.1 2.2 4.3 0.0 4.8 0.0 7.2 3.1 0.0 10.6 0.2 12.7 4.1 9.8 1.9 4.5 4.9 0.7 3.3 0.0 11.9 42.1 2.0 16.1 0.7 2.2 1.0 0.0 1.0 0.1 0.2 22.3 0.2 0.0 12.1 2.4 FOXP3 "AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID" ENSG00000049768 "Forkhead box P3" Q9BZS1 X 49250436-49264826 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;lymphoid tissue: 23.3" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 1.1;granulocytes: 1.1;Horizontal cells: 3.2;Melanocytes: 1.7;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "T-reg: 25.9" "Lineage enriched" "Detected in single" 260 "T-cells: 25.9" "Cell line enhanced" "Detected in some" "MCF7: 8.3;SiHa: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026301, HPA045943" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026301: , HPA045943: AB_2679508" "unprognostic (2.46e-2)" "prognostic favorable (1.91e-4)" "unprognostic (4.95e-3)" "prognostic favorable (7.02e-4)" "unprognostic (2.55e-4)" "prognostic favorable (4.90e-4)" "unprognostic (2.42e-2)" "unprognostic (3.46e-1)" "unprognostic (1.04e-2)" "unprognostic (1.99e-3)" "unprognostic (8.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.73e-14)" "unprognostic (5.93e-2)" "unprognostic (4.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-1)" 0.4 0.4 1.4 20.2 1.3 1.4 0.6 2.2 1.2 0.7 0.8 0.5 1.0 0.6 1.1 7.2 2.6 0.3 3.3 0.4 1.3 1.0 1.1 4.7 1.9 23.3 0.9 0.4 0.6 0.4 0.1 1.2 0.4 0.4 0.9 0.6 0.6 4.0 0.6 0.4 2.5 4.0 0.4 0.7 4.7 1.8 2.7 0.4 23.3 0.8 1.8 20.6 4.9 0.6 0.0 0.0 0.0 0.0 0.0 25.9 0.4 0.3 0.5 0.5 1.2 0.3 0.0 1.5 0.4 0.0 0.4 0.1 0.4 0.3 0.9 0.4 0.4 0.6 0.4 1.0 0.0 0.3 3.1 0.5 0.4 0.6 0.1 0.7 0.7 0.9 0.3 0.5 0.7 0.8 0.0 0.0 1.6 1.5 0.9 0.1 8.3 0.3 0.6 1.3 0.3 0.8 0.6 0.3 0.6 0.4 0.5 0.7 0.4 4.9 0.5 3.0 0.7 1.8 0.7 0.1 0.1 1.6 0.8 0.2 0.9 1.6 1.0 0.5 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 25.9 0.4 1.4 1.3 2.2 1.2 1.3 1.0 0.9 0.4 0.4 0.4 0.0 1.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 0.0 2.5 0.0 0.0 FOXQ1 HFH1 ENSG00000164379 "Forkhead box Q1" Q9C009 6 1312440-1314748 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 65.5;vagina: 39.9" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 53.7;Collecting duct cells: 38.4;Suprabasal keratinocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;HaCaT: 16.4;Hep G2: 34.5;OE19: 46.8;RT4: 14.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA059700 Supported Nucleoplasm Yes NA Nucleoplasm "HPA059700: AB_2684107" "unprognostic (2.04e-3)" "unprognostic (3.44e-1)" "unprognostic (1.10e-1)" "unprognostic (7.18e-2)" "unprognostic (1.50e-3)" "unprognostic (2.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.68e-4)" "unprognostic (1.49e-2)" "unprognostic (3.16e-3)" "unprognostic (2.82e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 0.6 0.5 2.3 0.6 4.0 0.5 1.4 1.6 5.9 7.1 1.9 3.2 0.0 6.9 1.1 0.7 7.2 3.2 31.8 0.5 2.2 1.9 7.1 3.6 5.8 0.5 2.7 1.5 0.5 10.1 0.5 1.8 1.2 3.8 18.2 0.8 7.5 35.8 1.3 0.6 16.8 0.8 6.6 1.9 0.5 65.5 0.6 0.8 0.8 3.1 7.8 11.7 26.3 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 14.0 8.5 0.0 0.2 0.0 0.0 16.4 0.0 0.7 0.0 0.0 0.4 0.0 3.0 34.5 0.0 0.0 0.9 0.0 6.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.2 0.0 0.0 0.0 0.1 14.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.0 1.6 5.9 2.2 1.9 2.7 1.5 3.8 0.8 14.9 8.8 0.0 2.1 53.7 0.0 0.8 0.0 2.7 13.6 38.4 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 6.9 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 39.6 0.0 0.0 0.0 3.1 FOXR1 "DLNB13, FOXN5" ENSG00000176302 "Forkhead box R1" Q6PIV2 11 118971707-118981291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 8.9" "Group enriched" "Detected in some" 39 "Spermatocytes: 9.3;Spermatogonia: 33.3" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;HaCaT: 1.3;RT4: 1.1;U-937: 1.1" "Not detected" "Not detected" NA NA "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (1.47e-1)" 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 33.3 0.0 0.2 0.0 0.0 0.0 FOXR2 "FOXN6, MGC21658" ENSG00000189299 "Forkhead box R2" Q6PJQ5 X 55623400-55625325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 6.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 117 "NTERA-2: 11.7;SH-SY5Y: 10.3;U-266/70: 6.8;U-266/84: 17.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA034487, HPA057358" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA034487: AB_10795354, HPA057358: AB_2683418" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 FP565260.1 ENSG00000275464 21 5130871-5154734 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 17.2" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 10.8;Ductal cells: 8.0;Exocrine glandular cells: 6.9;Hofbauer cells: 5.1;monocytes: 5.4;Pancreatic endocrine cells: 7.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 38.1" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 3.0 3.0 1.1 3.0 2.2 3.3 1.4 1.1 6.8 1.7 1.9 7.2 1.1 2.8 1.6 2.6 1.9 2.4 4.8 2.9 3.2 1.8 1.1 1.8 4.2 2.4 1.1 1.9 2.0 2.5 1.1 2.3 2.9 1.8 2.7 1.1 1.7 1.1 6.8 1.8 2.2 3.4 1.1 2.8 1.4 1.4 1.1 1.1 1.7 1.1 2.3 2.4 1.1 8.9 6.6 5.0 12.9 7.4 17.2 7.5 11.8 8.9 6.0 9.3 2.6 2.0 3.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 5.5 4.0 8.0 7.9 16.7 7.3 0.0 2.5 5.4 38.1 4.6 4.5 4.2 17.4 11.3 7.2 8.9 10.2 8.0 1.9 7.8 5.9 21.2 4.2 2.5 10.4 12.8 12.0 23.7 13.7 11.1 20.1 5.6 10.5 5.3 9.5 5.7 10.4 9.8 14.8 5.6 1.6 12.3 9.4 3.8 4.5 11.6 0.1 12.3 4.9 5.3 23.9 8.1 23.1 6.3 2.6 5.5 5.0 15.0 9.7 17.2 8.7 9.1 11.0 6.6 8.9 9.2 12.6 3.3 7.4 12.9 4.4 6.0 7.5 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 2.3 0.0 8.0 0.0 0.0 0.0 0.0 6.9 1.6 0.0 0.0 4.7 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 7.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 FP565260.2 ENSG00000276612 21 5116343-5133805 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.7;blood: 3.1;intestine: 2.6" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 4.0;Club cells: 2.3;granulocytes: 11.5;Intestinal endocrine cells: 3.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 3.1;non-classical monocyte: 3.0" "Group enriched" "Detected in many" 6 "monocytes: 3.0;NK-cells: 3.1;T-cells: 2.2" "Cell line enhanced" "Detected in many" "RH-30: 6.4;SK-MEL-30: 5.0;U-937: 4.9" NA NA 1.2 2.7 0.0 0.0 0.0 1.1 0.0 0.0 2.6 0.4 0.0 0.1 0.7 0.0 0.4 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.1 0.0 1.0 1.1 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 3.0 3.1 2.2 0.2 0.0 1.5 0.5 2.0 4.7 1.0 0.5 0.6 0.0 0.8 0.4 2.1 0.0 0.0 0.1 0.0 1.9 0.0 3.0 2.6 0.6 1.8 0.3 4.6 1.1 1.0 2.7 0.0 0.5 1.0 0.0 3.0 3.1 2.3 1.2 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.5 6.4 2.1 0.0 0.0 3.8 0.3 0.9 0.0 5.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.6 0.1 1.3 0.5 4.9 1.4 0.0 0.3 0.0 1.1 0.0 0.0 0.1 2.2 0.4 0.0 0.2 0.6 1.0 0.0 3.1 3.0 0.5 0.2 0.2 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FP565260.3 ENSG00000277117 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enriched" "Detected in single" 22 "monocytes: 8.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.3;REH: 12.7;SiHa: 10.9" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane, Cytoplasmic bodies" "HPA029179: AB_2732445" "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 1.5 0.2 0.6 3.4 4.5 2.4 1.9 0.4 7.0 2.6 2.0 9.2 0.6 4.3 0.8 1.7 1.4 2.1 2.6 2.9 2.2 2.5 2.3 1.2 4.5 4.2 3.1 0.2 1.8 0.0 0.0 1.9 4.3 1.3 1.6 0.1 1.3 1.0 0.7 3.1 2.8 0.7 2.6 2.3 4.1 0.5 3.6 0.0 1.0 1.9 5.7 1.6 1.2 5.3 0.9 0.0 3.0 0.0 1.1 0.8 0.2 0.6 0.0 1.1 0.3 0.7 16.3 1.3 1.0 0.2 0.0 3.9 0.7 8.7 2.6 0.0 2.1 3.1 1.0 1.2 0.2 0.2 0.8 0.0 0.5 2.1 0.2 6.7 6.4 0.1 1.7 0.9 0.8 0.0 0.9 0.0 1.0 0.3 0.1 2.2 0.0 4.0 0.6 10.8 5.3 12.7 0.4 8.9 0.4 5.5 0.7 0.0 10.9 9.6 0.1 0.6 2.9 9.0 0.3 0.0 2.5 0.0 0.2 6.0 6.1 5.7 6.9 3.8 1.5 0.0 0.6 0.0 0.0 3.0 0.3 2.9 0.5 0.2 0.7 5.3 0.1 0.5 0.0 0.0 0.6 0.9 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FP565260.4 ENSG00000279493 21 5011799-5017145 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "kidney: 3.4;liver: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 6.0;HeLa: 2.6;Hep G2: 2.2;MCF7: 4.3;SiHa: 6.9" NA NA 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 10.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.0 0.0 0.0 6.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 6.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FP565260.6 ENSG00000280071 21 5079294-5128425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 3.4;Collecting duct cells: 3.5;Hofbauer cells: 7.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA018517 Uncertain Approved Centrosome,Mitochondria "Intracellular and membrane" NA NA Mitochondria Centrosome "HPA018517: AB_2669899" "unprognostic (4.87e-2)" "unprognostic (2.69e-3)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (2.96e-1)" "unprognostic (6.47e-2)" "unprognostic (1.43e-2)" "unprognostic (2.39e-2)" "unprognostic (7.65e-2)" "unprognostic (1.71e-2)" "unprognostic (1.15e-2)" "unprognostic (3.33e-2)" "unprognostic (6.67e-4)" "unprognostic (1.88e-2)" "unprognostic (6.80e-2)" "unprognostic (4.25e-1)" "unprognostic (2.84e-2)" 3.9 6.7 2.8 2.0 6.6 1.3 3.4 8.2 7.0 3.0 5.7 5.2 2.5 5.7 2.2 5.0 3.9 3.3 2.8 15.5 3.2 12.9 14.4 4.8 10.5 6.7 4.7 5.6 2.7 4.0 0.9 6.4 4.2 3.0 4.7 4.4 4.9 2.3 17.1 1.3 3.6 2.4 3.0 2.6 2.2 1.4 3.9 1.1 4.2 11.1 2.4 3.9 2.0 47.1 43.8 19.9 46.4 37.1 41.4 46.1 13.2 12.5 13.9 24.4 13.3 12.7 6.8 0.0 2.6 0.8 1.2 2.0 13.6 1.2 15.4 16.3 13.8 9.5 20.0 10.4 1.2 9.1 8.9 51.5 13.3 12.7 12.1 22.1 9.8 20.3 17.6 8.0 14.7 11.9 16.1 17.5 20.2 15.3 9.6 27.8 22.0 24.2 27.2 37.2 20.4 45.2 10.5 48.2 18.2 12.3 14.1 23.7 18.4 34.7 12.9 7.5 35.7 31.1 5.7 8.0 9.9 0.8 8.0 20.7 21.1 8.7 16.4 45.8 6.7 19.9 33.6 16.9 31.6 36.0 31.6 43.9 41.4 32.9 43.8 47.1 39.7 30.2 6.8 37.1 46.4 28.9 40.0 46.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 3.5 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 FP565260.7 ENSG00000280433 21 5155499-5165472 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 7.7" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 7.5;Ciliated cells: 6.7;Club cells: 2.3" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (1.36e-1)" "unprognostic (2.11e-3)" "unprognostic (1.01e-1)" "unprognostic (2.05e-1)" "unprognostic (5.60e-2)" "unprognostic (7.47e-2)" "unprognostic (9.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.46e-2)" "unprognostic (2.15e-2)" "unprognostic (1.17e-1)" "unprognostic (2.62e-2)" "unprognostic (7.41e-2)" "unprognostic (7.71e-6)" 1.4 1.7 1.3 0.9 1.3 2.4 0.9 3.0 2.3 0.3 2.7 0.0 0.4 1.1 0.0 3.0 1.4 1.1 4.4 0.2 0.2 2.3 0.5 0.3 2.8 0.9 0.4 0.0 2.1 2.8 0.4 3.5 1.1 0.5 1.5 1.5 0.6 2.9 0.8 2.1 1.5 3.7 7.7 1.3 6.4 1.9 5.5 3.8 6.5 3.9 3.3 2.2 2.3 0.9 2.0 1.1 3.1 3.0 2.2 5.4 7.2 4.1 5.4 3.6 2.0 2.1 2.8 11.1 3.4 4.8 6.3 8.4 8.3 6.1 8.4 4.5 4.7 4.1 5.5 4.6 5.3 3.6 4.5 5.7 4.3 15.4 7.1 7.7 3.1 4.4 2.7 3.4 10.0 5.7 4.1 7.3 3.9 7.4 7.3 2.6 5.0 15.4 3.4 4.3 2.9 0.9 6.4 3.2 3.4 5.7 4.2 11.6 3.0 0.4 0.2 2.1 3.9 0.8 7.7 2.9 2.0 3.6 0.4 2.4 1.9 2.4 1.1 3.7 1.5 0.8 0.7 1.3 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 2.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 FPGT-TNNI3K ENSG00000259030 "FPGT-TNNI3K readthrough" 1 74198235-74543982 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 28.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 7.9;Cone photoreceptor cells: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.0;CAPAN-2: 4.6;SiHa: 6.5" HPA072331 Approved Vesicles NA NA Vesicles "HPA072331: " "unprognostic (6.29e-2)" "unprognostic (4.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.24e-1)" "unprognostic (3.44e-3)" "unprognostic (8.37e-2)" "unprognostic (1.70e-2)" "unprognostic (6.63e-2)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (8.37e-2)" "unprognostic (6.76e-3)" "unprognostic (3.20e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (7.87e-3)" 8.5 5.5 5.4 3.1 6.3 2.7 6.1 16.1 8.2 6.4 6.3 6.6 3.4 2.5 9.3 4.2 6.0 5.7 4.2 28.0 5.4 4.9 6.3 3.7 6.1 3.5 8.0 5.2 5.6 3.1 4.7 15.0 3.8 7.4 5.5 3.7 5.2 5.4 6.0 11.2 8.0 5.1 6.3 8.5 5.9 4.9 4.1 7.1 2.9 5.1 3.0 3.5 5.5 4.9 2.4 2.4 4.9 4.7 0.8 4.9 3.5 0.0 1.1 0.7 1.5 0.8 5.0 0.1 2.1 1.0 0.2 0.4 1.1 4.6 0.1 3.3 0.2 0.0 0.0 0.3 3.1 0.4 0.1 0.2 1.7 0.1 0.1 0.8 0.4 0.3 2.1 2.1 0.2 0.2 0.6 0.2 0.2 0.0 1.7 1.0 0.0 0.1 0.2 0.1 1.7 0.9 2.3 3.9 0.0 0.4 0.0 1.1 3.4 6.5 0.3 0.3 0.0 0.0 2.3 0.1 0.7 0.2 0.2 0.8 0.2 0.1 1.7 1.0 1.0 1.1 3.6 4.1 3.5 1.1 4.7 3.5 2.1 3.9 2.2 2.4 2.4 4.9 2.5 4.9 0.8 1.2 2.1 3.8 3.5 5.4 6.3 16.1 8.2 5.4 4.9 8.0 5.2 7.4 7.1 3.0 0.6 0.0 0.4 0.1 4.9 7.9 2.5 1.4 1.2 0.0 9.8 0.1 0.0 0.1 0.9 0.5 0.0 0.0 0.9 0.1 0.5 0.3 2.3 0.4 0.2 4.8 2.9 2.5 1.9 0.2 2.6 0.1 1.7 0.0 0.0 1.2 0.9 1.4 0.7 0.5 2.7 0.0 0.5 1.8 1.4 0.1 0.0 0.0 0.2 0.2 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 21 "Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Cell line enriched" "Detected in some" 5 "U-87 MG: 35.0" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: AB_2679694, HPA061744: AB_2684600" "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 2.8 0.2 0.4 2.4 0.1 0.9 0.8 4.2 0.0 0.2 0.1 0.4 7.1 0.5 0.1 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.1 0.3 0.1 0.6 0.6 0.5 1.2 0.3 0.0 1.7 0.1 0.0 0.3 35.0 0.9 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 14.9 40.8 6.2 0.2 0.6 0.4 0.2 0.0 16.0 28.4 0.0 0.0 0.9 0.0 0.0 1.2 0.4 0.0 0.0 0.0 1.2 0.9 0.2 24.4 1.7 97.2 0.0 0.0 4.3 262.0 1.3 0.3 111.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.5 1.0 0.5 0.6 0.0 2.5 0.0 0.0 0.0 FPR2 "ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R" ENSG00000171049 "Formyl peptide receptor 2" P25090 19 51752026-51770526 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 128.2;lymphoid tissue: 32.2" "Cell type enhanced" "Detected in some" 13 "Hofbauer cells: 10.2;Kupffer cells: 24.7;Late spermatids: 14.9;Macrophages: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "neutrophil: 128.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 128.2" "Cell line enriched" "Detected in some" 18 "U-937: 26.0" HPA029154 Approved NA NA "HPA029154: AB_10602133" "unprognostic (3.11e-1)" "unprognostic (5.20e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (1.65e-1)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (3.90e-4)" "unprognostic (3.41e-5)" "unprognostic (1.08e-2)" "unprognostic (4.69e-2)" "unprognostic (5.10e-2)" "unprognostic (1.90e-1)" 7.9 1.1 0.6 30.7 2.1 8.7 0.8 0.4 1.9 0.6 0.8 0.8 0.0 0.4 0.6 0.2 1.0 2.6 3.3 5.0 1.9 0.6 1.3 2.4 17.3 32.2 2.8 0.0 1.6 1.1 0.0 1.1 4.4 2.3 0.6 0.1 1.1 1.0 0.0 1.1 0.4 1.1 3.3 3.0 29.1 1.2 2.5 1.6 0.8 1.0 0.9 0.3 4.4 2.2 0.0 1.7 128.2 12.7 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.7 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.8 26.0 0.0 0.4 12.7 0.6 0.0 11.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 128.2 0.0 7.5 0.3 0.0 3.9 0.6 2.1 0.4 1.9 1.9 0.6 2.8 0.0 2.3 1.6 0.0 5.3 0.8 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.4 10.2 0.0 0.0 0.6 24.7 14.9 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 FPR3 "FMLPY, FPRH1, FPRL2, RMLP-R-I" ENSG00000187474 "Formyl peptide receptor 3" P25089 19 51795163-51826189 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.9" "Group enriched" "Detected in some" 10 "Hofbauer cells: 59.4;Kupffer cells: 71.5;Macrophages: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "classical monocyte: 3.2;intermediate monocyte: 9.6;myeloid DC: 3.4" "Group enriched" "Detected in many" 43 "dendritic cells: 3.4;monocytes: 9.6" "Group enriched" "Detected in some" 4 "HEL: 14.7;hTERT-RPE1: 4.2" NA NA "unprognostic (3.77e-2)" "unprognostic (1.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.15e-1)" "unprognostic (1.84e-1)" "unprognostic (8.41e-2)" "unprognostic (1.39e-1)" "unprognostic (1.37e-2)" "unprognostic (7.14e-2)" "unprognostic (3.17e-1)" "unprognostic (9.37e-2)" "unprognostic (1.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (1.96e-1)" "unprognostic (4.28e-2)" 35.9 10.0 1.5 12.9 2.1 0.0 6.2 0.6 1.8 3.2 6.6 1.8 0.5 5.9 3.1 7.0 3.4 3.0 10.7 6.3 1.7 1.2 6.8 13.0 25.9 15.1 2.8 0.9 5.4 3.2 0.7 2.2 5.2 2.4 5.0 10.3 4.9 5.1 1.3 4.6 2.3 10.9 4.6 5.2 10.8 3.4 3.3 1.1 8.0 2.7 6.4 10.1 9.3 2.6 0.0 3.4 0.1 9.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 14.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 3.2 0.0 0.0 9.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.6 1.5 2.1 0.6 1.8 1.7 1.2 2.8 0.9 2.4 1.1 0.0 1.7 2.4 0.0 4.9 0.0 0.3 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.0 0.2 0.0 0.5 59.4 0.0 0.0 1.8 71.5 0.0 0.3 66.8 6.8 4.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 4.0 0.7 0.0 0.0 0.0 FRAS1 "FLJ14927, FLJ22031, KIAA1500" ENSG00000138759 "Fraser extracellular matrix complex subunit 1" Q86XX4 4 78057570-78544269 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 17.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 29.8;Cholangiocytes: 22.9;Collecting duct cells: 27.9;Cytotrophoblasts: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 23.4;Hep G2: 14.1;RH-30: 13.5;SiHa: 14.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051601 Approved "Intracellular and membrane" NA NA "HPA051601: AB_2681547" "unprognostic (1.33e-2)" "unprognostic (1.04e-2)" "unprognostic (9.37e-2)" "unprognostic (8.91e-2)" "unprognostic (2.97e-1)" "unprognostic (2.04e-1)" "unprognostic (1.45e-3)" "unprognostic (2.02e-2)" "unprognostic (1.07e-1)" "unprognostic (2.69e-2)" "unprognostic (2.09e-2)" "unprognostic (4.02e-2)" "prognostic favorable (4.69e-4)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.78e-3)" "unprognostic (6.09e-2)" 2.0 1.2 6.2 5.0 10.1 0.1 1.3 0.9 6.4 3.6 2.7 0.7 0.1 0.6 3.3 3.1 2.0 1.5 4.1 2.6 2.3 2.3 11.6 0.8 5.2 0.3 1.2 1.8 0.9 7.9 0.7 5.5 8.3 3.8 3.2 2.2 1.3 1.8 1.3 3.7 2.1 1.4 2.2 0.9 1.1 1.6 1.4 1.0 2.1 17.9 1.9 0.4 1.3 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.9 4.4 1.8 0.0 4.8 2.0 3.2 0.7 2.7 0.4 0.2 3.5 6.5 0.0 5.5 23.4 0.0 0.9 2.5 1.4 0.1 0.0 2.5 2.7 5.3 14.1 0.5 0.0 0.0 9.7 1.5 0.0 3.5 3.7 0.1 0.2 0.0 0.0 2.7 0.1 0.1 0.0 5.7 2.3 0.9 0.0 13.5 0.0 5.9 6.4 3.3 6.5 14.1 4.5 0.8 8.6 0.0 0.0 0.0 0.0 3.1 1.9 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 10.1 0.9 6.4 2.3 2.3 1.2 1.8 3.8 1.0 29.8 0.0 0.0 2.3 1.6 9.0 6.9 22.9 1.4 14.8 27.9 0.0 22.8 3.3 4.7 1.9 2.1 0.4 0.0 1.6 1.0 5.4 1.4 0.0 0.0 3.9 0.0 1.2 0.6 0.0 2.0 0.6 0.3 1.7 0.0 1.1 0.3 1.9 0.0 0.0 3.9 2.6 0.0 3.2 0.0 1.3 1.1 13.0 0.0 1.0 0.2 FREM1 "C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR" ENSG00000164946 "FRAS1 related extracellular matrix 1" Q5H8C1 9 14734666-14910995 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 33.3;epididymis: 30.8" "Group enriched" "Detected in some" 7 "Early spermatids: 69.1;Late spermatids: 99.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 22.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HEL: 63.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (1.13e-5)" "unprognostic (2.59e-3)" "unprognostic (2.89e-1)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (6.27e-3)" "unprognostic (2.50e-1)" "unprognostic (4.66e-3)" "unprognostic (4.43e-1)" "unprognostic (1.31e-1)" "unprognostic (3.62e-2)" "unprognostic (6.23e-2)" "unprognostic (8.95e-13)" "unprognostic (2.28e-3)" "unprognostic (8.53e-2)" "unprognostic (3.41e-2)" "unprognostic (2.86e-1)" 4.4 2.5 1.5 3.2 1.4 0.2 4.0 22.2 2.5 10.9 7.5 5.0 22.9 1.8 33.3 30.8 0.9 4.5 3.1 7.3 1.8 2.0 10.4 0.8 2.6 0.1 1.1 1.0 2.3 14.2 6.0 1.2 4.6 4.0 3.1 1.5 5.0 1.0 11.4 0.7 2.6 9.3 12.8 2.7 0.4 1.3 3.5 0.6 1.7 0.8 3.4 1.1 2.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 22.2 2.5 1.8 2.0 1.1 1.0 4.0 0.6 0.0 1.1 0.0 0.2 1.1 0.7 2.0 5.1 0.0 0.0 1.8 0.0 0.4 0.0 0.2 69.1 0.0 0.7 0.0 0.0 0.2 11.3 0.1 4.7 0.0 0.4 0.0 0.0 6.2 1.2 99.8 0.6 0.0 0.0 1.0 0.1 4.0 0.3 0.0 1.4 1.0 0.0 0.0 1.0 0.7 0.6 1.0 0.2 0.0 0.2 0.0 FREM2 DKFZp686J0811 ENSG00000150893 "FRAS1 related extracellular matrix protein 2" Q5SZK8 13 38687129-38887131 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 13.9;lung: 11.2;thyroid gland: 12.2" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 19.8;Cholangiocytes: 7.6;Proximal tubular cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.2;HAP1: 8.2;MCF7: 5.9;RT4: 5.5;SK-BR-3: 5.0;SuSa: 24.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA028831 Uncertain Approved Cytosol NA NA 170000 Cytosol "HPA028831: AB_10603668" "unprognostic (1.71e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (1.10e-1)" "unprognostic (4.69e-1)" "unprognostic (6.24e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.54e-2)" "unprognostic (1.64e-3)" "unprognostic (4.25e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.23e-7)" "unprognostic (7.21e-2)" "unprognostic (1.40e-1)" "unprognostic (9.92e-2)" "unprognostic (3.14e-1)" 0.6 0.4 1.3 0.1 1.7 0.1 0.5 1.5 6.4 0.7 1.3 1.2 1.1 0.4 1.1 0.5 0.2 0.9 1.5 0.2 2.8 0.4 13.9 3.4 11.2 0.1 0.4 0.8 1.8 5.2 0.1 1.1 2.6 0.8 3.5 0.4 2.9 0.4 1.5 6.3 0.6 0.7 0.7 0.4 0.3 2.2 1.8 1.5 0.1 12.2 4.1 0.1 1.5 0.3 0.3 0.3 0.9 0.2 0.2 0.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 8.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.8 0.0 0.1 0.0 1.1 0.1 1.8 5.5 0.1 0.1 0.0 5.0 0.2 24.6 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.6 0.9 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.2 0.7 0.2 0.2 0.3 0.1 0.0 1.3 1.7 1.5 6.4 2.8 0.4 0.4 0.8 0.8 1.5 0.0 19.8 0.0 0.1 0.6 0.1 2.0 7.6 5.3 2.3 1.8 0.0 5.1 5.0 1.7 0.6 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 1.3 0.0 0.0 22.4 0.2 0.0 0.0 0.1 0.4 0.1 1.6 0.0 0.0 0.0 FREM3 ENSG00000183090 "FRAS1 related extracellular matrix 3" P0C091 4 143577302-143700675 "Predicted secreted proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "brain: 5.0;lung: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "TIME: 3.2" "Group enriched" "Detected in some" 5 "basal ganglia: 3.3;hypothalamus: 3.2;thalamus: 4.8" "Low region specificity" "Detected in some" HPA041641 Uncertain "Secreted to extracellular matrix" NA NA "HPA041641: AB_2677592" "unprognostic (1.19e-2)" "unprognostic (4.09e-9)" "unprognostic (3.09e-3)" "unprognostic (2.74e-1)" "unprognostic (1.66e-1)" "unprognostic (4.74e-2)" "unprognostic (1.98e-1)" "unprognostic (1.91e-1)" "unprognostic (2.68e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (7.11e-3)" "unprognostic (3.24e-1)" 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 1.8 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRG2 FRG2A ENSG00000205097 "FSHD region gene 2" Q64ET8 4 190024351-190027257 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.0;brain: 2.8;skin 1: 3.8" "Cell type enriched" "Detected in single" 8 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 2.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "GAMG: 1.1;HMC-1: 2.1;Karpas-707: 1.1" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.2 0.1 2.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.6 0.0 0.2 0.0 1.1 0.3 0.1 0.0 0.0 1.1 0.4 0.8 0.4 0.3 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 0.3 0.3 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.7 0.2 0.3 0.2 0.2 0.0 0.2 0.3 0.2 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRG2B ENSG00000225899 "FSHD region gene 2 family member B" Q96QU4 10 133623895-133626795 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.0;kidney: 1.9;pancreas: 1.2" "Cell type enriched" "Detected in single" 33 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enriched" "Detected in single" 22 "HDLM-2: 13.4" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 13.4 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRG2C ENSG00000172969 "FSHD region gene 2 family member C" A6NGY1 3 75664330-75667220 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "kidney: 3.5;testis: 3.8" "Group enriched" "Detected in some" 150 "Distal tubular cells: 23.2;Early spermatids: 11.8;Late spermatids: 22.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "HDLM-2: 16.8" "HPA039264, HPA047769" Uncertain NA NA "HPA039264: AB_2676420, HPA047769: AB_2680149" "unprognostic (3.47e-2)" "unprognostic (8.28e-2)" "unprognostic (9.57e-2)" "unprognostic (2.59e-1)" "unprognostic (6.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "unprognostic (4.56e-2)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.4 1.4 0.0 0.1 0.1 0.1 0.0 3.5 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 3.8 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.2 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRK "GTK, PTK5, RAK" ENSG00000111816 "Fyn related Src family tyrosine kinase" P42685 6 115931149-116060758 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 73.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 19.0;RT4: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB025217, HPA030479, HPA072590" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB025217: , HPA030479: AB_2732457, HPA072590: " "unprognostic (7.70e-3)" "unprognostic (1.99e-2)" "unprognostic (1.11e-1)" "unprognostic (4.68e-3)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.58e-1)" "unprognostic (4.23e-2)" "unprognostic (5.82e-3)" "unprognostic (1.45e-1)" "unprognostic (7.54e-2)" "prognostic favorable (9.66e-7)" "unprognostic (1.52e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.10e-1)" 1.5 2.2 0.8 3.0 1.3 1.3 2.6 0.5 0.8 6.4 21.4 0.2 10.2 6.8 1.6 9.0 10.5 2.8 7.3 3.3 1.2 0.8 23.7 19.6 5.6 0.6 1.5 0.5 2.4 5.9 0.3 3.8 2.7 0.8 4.1 5.5 0.8 9.2 6.1 2.9 2.0 41.4 2.5 2.4 1.0 5.5 1.8 0.5 1.2 1.0 5.2 7.4 5.0 3.6 2.2 1.2 3.8 1.2 1.4 2.3 0.3 2.5 4.2 0.7 1.0 0.3 0.3 0.8 0.6 0.2 0.0 0.1 3.3 4.1 1.1 3.9 0.6 0.6 6.1 0.3 1.2 0.1 3.5 0.4 1.4 3.6 2.8 0.2 1.0 0.9 0.3 1.7 0.4 0.4 0.5 0.2 0.7 0.7 2.6 1.0 1.4 0.8 0.6 1.1 19.0 0.7 1.2 3.7 1.3 5.2 8.0 0.9 1.0 0.9 5.4 0.5 1.1 1.6 0.8 1.0 1.2 1.2 0.9 0.6 4.0 2.8 1.8 1.2 0.7 0.8 3.2 1.0 1.0 1.9 0.6 2.3 1.1 1.4 1.7 0.4 2.2 1.1 1.4 3.8 1.4 1.2 1.2 1.0 0.3 0.8 1.3 0.5 0.7 1.2 0.8 1.5 0.5 0.8 0.5 0.0 10.1 0.0 15.3 2.4 0.7 8.4 12.7 22.7 15.9 22.7 0.0 4.3 10.0 16.5 73.1 0.3 35.5 0.0 14.3 3.8 3.5 20.3 3.5 19.2 0.8 6.4 19.0 1.8 0.6 17.7 0.6 0.5 0.0 1.8 13.0 0.3 19.1 20.1 1.1 22.5 0.0 12.9 7.5 1.4 0.7 2.8 0.7 0.5 16.1 34.6 FRMD1 "bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260" ENSG00000153303 "FERM domain containing 1" Q8N878 6 168053166-168101511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 10.8;lymphoid tissue: 29.4" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 26.3;Paneth cells: 59.6;Proximal tubular cells: 14.4" "Cancer enriched" "Detected in single" 6 "colorectal cancer: 1.9" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 4.7;RPMI-8226: 7.5" "Low region specificity" "Detected in many" HPA030347 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA030347: AB_10600207" "unprognostic (2.43e-2)" "unprognostic (2.74e-1)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.25e-1)" "unprognostic (2.58e-4)" "unprognostic (8.63e-2)" "unprognostic (2.62e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (8.23e-2)" "unprognostic (1.71e-2)" "unprognostic (1.01e-1)" "unprognostic (9.11e-3)" 6.4 0.1 0.0 6.0 0.2 0.0 10.8 0.2 0.1 0.2 9.8 0.0 0.0 2.3 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 5.6 0.2 0.1 0.0 1.5 0.2 0.2 0.2 0.0 0.1 0.3 0.6 0.1 6.8 1.1 1.7 0.0 2.6 0.2 4.5 0.1 1.0 2.9 7.5 8.1 0.0 29.4 0.1 1.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 1.5 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.7 0.0 26.3 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.5 0.0 0.0 10.1 0.6 0.0 0.0 0.0 14.0 0.0 0.0 59.6 1.4 14.4 0.0 0.0 0.0 13.7 4.3 0.0 0.1 0.0 13.7 0.1 FRMD3 "EPB41L4O, MGC20553" ENSG00000172159 "FERM domain containing 3" A2A2Y4 9 83242990-83538546 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.5;skeletal muscle: 42.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 102.0;Cardiomyocytes: 66.5;Cone photoreceptor cells: 74.6;Early spermatids: 112.3;Horizontal cells: 95.3;Late spermatids: 100.0;Sertoli cells: 71.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 27.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.8;intermediate monocyte: 4.7;neutrophil: 3.8;non-classical monocyte: 2.1" "Group enriched" "Detected in many" 6 "granulocytes: 3.8;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HEL: 11.2;OE19: 23.5;RPMI-8226: 37.7;SCLC-21H: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017285 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA017285: AB_2669569" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.93e-1)" "unprognostic (6.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.93e-1)" "unprognostic (3.94e-2)" "unprognostic (1.06e-1)" "unprognostic (2.23e-1)" "unprognostic (5.87e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.12e-1)" "unprognostic (1.88e-1)" "prognostic favorable (1.79e-4)" "unprognostic (1.68e-3)" 12.7 4.6 3.5 2.8 2.3 3.0 16.8 2.0 3.0 4.6 7.1 1.7 14.3 1.9 5.5 9.8 4.1 1.9 2.9 48.5 3.2 4.5 11.7 0.7 2.9 0.9 3.6 1.7 1.4 1.4 8.9 6.1 8.7 2.9 5.1 4.1 5.3 2.1 35.3 42.1 1.6 10.9 3.5 2.8 4.3 2.2 6.1 0.8 0.0 8.8 11.1 0.7 3.8 5.0 0.6 0.6 3.8 4.7 0.4 0.6 9.2 0.0 2.1 1.8 0.1 0.3 0.1 0.1 2.0 0.1 0.0 0.0 0.2 2.5 0.4 2.3 0.9 0.4 0.1 0.1 0.0 0.0 0.1 0.1 11.2 2.4 1.3 0.1 0.0 0.1 0.5 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.2 23.5 3.5 0.0 1.5 37.7 3.1 4.9 13.9 6.7 0.7 0.1 0.4 0.3 0.8 0.4 2.1 0.1 0.3 0.0 1.4 0.2 0.1 0.0 0.5 3.6 1.4 0.0 2.8 0.0 0.4 4.7 0.6 0.5 0.2 0.1 0.4 0.6 0.1 0.0 3.8 0.4 2.1 0.6 0.0 9.2 3.5 2.3 2.0 3.0 3.2 4.5 3.6 1.7 2.9 0.8 20.8 0.6 0.0 1.0 0.9 102.0 66.5 10.2 0.0 2.3 1.8 74.6 0.3 14.9 2.5 112.3 13.1 26.2 0.0 1.7 0.9 2.1 1.0 0.0 0.2 0.8 95.3 1.2 3.1 4.6 100.0 2.0 1.5 0.0 0.0 19.4 2.0 2.0 7.0 4.6 8.7 4.7 71.1 28.9 1.6 1.4 1.1 0.1 0.0 1.6 1.3 FRMD5 MGC14161 ENSG00000171877 "FERM domain containing 5" Q7Z6J6 15 43870761-44195252 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.5;heart muscle: 48.9" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 12.9;Early spermatids: 10.3;Muller glia cells: 14.6;Pancreatic endocrine cells: 7.2" "Cancer enhanced" "Detected in many" "glioma: 6.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "B-cells: 1.6;T-cells: 1.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 11.9;HUVEC TERT2: 14.8;WM-115: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.54e-2)" "unprognostic (2.16e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (7.26e-7)" "unprognostic (3.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" "unprognostic (5.00e-3)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.01e-2)" "unprognostic (2.92e-4)" "unprognostic (1.21e-1)" "unprognostic (7.31e-2)" "unprognostic (1.18e-1)" "unprognostic (3.31e-1)" 1.0 7.2 8.9 1.4 12.3 1.6 1.3 8.2 15.1 1.0 1.7 24.5 0.0 1.0 0.9 1.3 1.2 2.0 1.3 48.9 10.9 6.9 1.2 0.8 1.0 1.1 14.7 4.8 1.0 1.1 1.1 1.6 0.9 10.7 1.2 1.8 2.9 2.0 1.2 0.8 1.2 1.3 1.1 13.4 1.2 2.2 4.3 11.5 0.0 1.2 0.0 0.8 1.1 0.2 1.6 0.3 0.0 0.0 0.0 1.6 0.0 3.3 1.9 1.2 0.7 1.5 0.1 0.2 0.7 1.1 2.1 4.2 5.6 3.7 0.2 0.7 0.5 5.6 4.0 1.8 3.9 1.9 0.2 2.0 0.5 1.7 2.4 0.1 0.0 0.2 0.0 0.4 5.9 11.9 4.3 14.8 3.0 0.1 0.4 2.3 0.3 0.5 0.0 1.0 11.4 1.9 0.0 2.7 0.0 2.0 1.2 7.8 2.7 0.4 0.0 8.0 1.0 0.1 0.1 0.5 4.1 7.1 1.0 10.5 0.2 1.0 0.4 5.9 0.2 33.8 0.0 0.0 0.0 0.8 0.0 1.6 1.6 1.2 0.4 0.0 0.5 0.6 0.9 0.0 0.0 0.0 0.3 1.6 0.0 8.9 12.3 8.2 12.4 10.9 6.9 14.7 4.8 10.7 11.5 0.0 0.0 0.0 0.0 0.3 6.2 12.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.2 10.3 0.0 0.0 0.0 5.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.2 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.3 14.6 7.2 0.0 0.0 0.6 4.1 0.0 0.0 5.8 2.5 0.0 0.0 0.0 0.6 0.0 FRMD7 "FLJ43346, NYS, NYS1" ENSG00000165694 "FERM domain containing 7" Q6ZUT3 X 132076993-132128020 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5" "Cell type enriched" "Detected in single" 30 "Distal tubular cells: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5" "Region enriched" "Detected in single" 29 "olfactory region: 80.8" "Region enriched" "Detected in single" 103 "olfactory region: 45.5" HPA000886 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA000886: AB_1079269" "unprognostic (3.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.07e-1)" "unprognostic (4.02e-2)" "unprognostic (1.64e-2)" "unprognostic (2.28e-1)" "unprognostic (2.18e-2)" "unprognostic (3.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.00e-1)" 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.4 1.1 0.0 1.1 0.0 0.1 0.0 0.1 6.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FRMPD1 "FRMD2, KIAA0967" ENSG00000070601 "FERM and PDZ domain containing 1" Q5SYB0 9 37651000-37746904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 28.1;testis: 15.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 52.3;Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 66.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042934 Uncertain NA NA "HPA042934: AB_10960422" "unprognostic (6.41e-2)" "unprognostic (6.74e-3)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (4.04e-1)" "unprognostic (7.26e-2)" "unprognostic (1.45e-1)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.53e-3)" "unprognostic (2.63e-3)" "unprognostic (3.94e-2)" "unprognostic (1.12e-3)" "unprognostic (7.80e-2)" "unprognostic (4.41e-2)" "unprognostic (2.13e-2)" "unprognostic (5.91e-2)" 1.0 0.7 3.0 2.9 4.7 4.1 1.4 2.0 5.6 0.5 0.9 2.8 0.2 1.0 1.5 1.0 2.6 1.4 2.5 1.0 3.1 2.7 1.1 1.2 1.1 2.0 4.2 3.8 0.6 1.7 1.3 2.0 0.6 7.2 0.8 0.7 28.1 5.8 0.8 5.7 10.0 1.6 0.5 5.3 0.5 0.8 15.3 4.2 0.0 1.7 0.0 1.5 1.2 0.6 1.8 1.3 5.6 1.3 3.7 1.0 0.4 0.6 0.8 3.1 0.4 0.0 0.0 3.9 1.4 0.1 0.3 0.4 1.5 1.5 0.9 0.5 0.8 1.2 2.2 2.4 1.2 0.9 1.0 0.9 0.4 1.8 0.7 0.0 0.0 0.8 1.6 0.0 1.3 0.6 1.5 0.0 2.3 1.3 0.8 0.6 0.7 0.3 0.5 2.0 0.2 1.6 1.6 2.5 0.4 0.1 2.4 6.4 4.4 0.0 4.0 1.9 1.1 2.1 0.8 0.0 1.4 1.3 1.4 1.0 1.1 1.7 1.3 1.4 0.8 1.0 5.6 1.3 0.8 0.9 1.1 0.7 0.8 0.7 0.7 0.3 1.8 1.0 0.9 3.4 3.7 1.0 1.3 0.7 0.4 3.0 4.7 2.0 5.6 3.1 2.7 4.2 3.8 7.2 4.2 3.0 14.6 0.5 0.3 0.1 52.3 0.8 5.1 2.7 3.4 0.0 143.3 0.2 0.0 0.1 2.7 0.1 0.0 0.0 0.2 0.4 0.3 0.2 4.7 0.5 0.1 1.6 0.0 1.3 0.6 0.8 0.9 0.0 0.0 0.0 0.0 7.0 0.1 0.0 0.4 0.0 66.0 0.0 0.0 0.2 1.3 0.4 0.6 0.0 0.0 0.3 FRMPD2 "MGC35285, PDZD5C, PDZK5C" ENSG00000170324 "FERM and PDZ domain containing 2" Q68DX3 10 48153088-48274870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.2;epididymis: 7.9;fallopian tube: 11.1;heart muscle: 6.3;retina: 11.4" "Cell type enhanced" "Detected in some" 21 "Ciliated cells: 53.5;Cone photoreceptor cells: 271.0;Early spermatids: 94.0;Late spermatids: 95.9;Rod photoreceptor cells: 95.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.8;HBEC3-KT: 2.8;Hep G2: 1.5;SCLC-21H: 2.9;SK-BR-3: 2.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 7.6" NA NA "unprognostic (1.53e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-4)" "unprognostic (7.59e-2)" "unprognostic (2.37e-1)" "unprognostic (2.06e-1)" "unprognostic (6.54e-3)" "unprognostic (1.85e-1)" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (3.25e-12)" "unprognostic (3.48e-2)" "unprognostic (5.43e-2)" "unprognostic (1.54e-1)" "unprognostic (7.43e-5)" 0.4 0.4 5.6 0.4 12.0 0.4 2.1 7.3 4.1 1.4 0.6 12.7 0.0 0.4 0.9 7.9 0.4 11.1 0.4 6.3 6.4 4.0 1.1 0.4 1.5 0.4 3.1 1.3 0.8 0.7 0.4 0.5 0.7 14.2 1.8 1.0 11.4 0.5 0.6 0.4 0.4 0.5 0.4 2.4 0.4 0.4 1.5 6.5 0.0 2.3 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 2.9 0.2 0.0 2.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 12.0 7.3 1.7 6.4 4.0 3.1 1.3 14.2 6.5 0.0 0.3 0.0 0.4 0.1 28.7 2.6 0.0 53.5 5.7 3.5 271.0 0.2 0.0 0.0 94.0 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.1 3.2 2.9 0.0 0.0 95.9 0.3 0.0 0.0 0.0 0.5 4.8 0.3 0.0 0.4 0.3 95.6 0.0 0.0 0.7 0.9 0.3 0.0 0.0 0.6 0.3 FRMPD3 "KIAA1817, RP5-1070B1.1" ENSG00000147234 "FERM and PDZ domain containing 3" Q5JV73 X 107522450-107605251 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.6;ovary: 10.3;thyroid gland: 6.0" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 1.1;Cone photoreceptor cells: 3.9;Melanocytes: 1.7" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive B-cell: 1.2" "Group enriched" "Detected in many" 15 "B-cells: 1.2;T-cells: 1.7" "Cell line enhanced" "Detected in some" "Daudi: 10.9;SCLC-21H: 3.3;U-698: 3.0;WM-115: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003164 Uncertain NA NA "HPA003164: AB_1078260" "unprognostic (1.27e-1)" "unprognostic (3.36e-1)" "unprognostic (5.44e-2)" "unprognostic (2.48e-4)" "unprognostic (1.69e-2)" "unprognostic (6.19e-2)" "unprognostic (2.43e-2)" "unprognostic (4.35e-2)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (7.29e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-9)" "unprognostic (4.59e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-3)" "unprognostic (1.26e-1)" 0.0 0.5 2.5 0.7 1.8 0.1 0.5 8.6 6.7 0.2 0.1 0.0 0.9 0.0 0.1 0.4 0.4 0.0 3.1 5.0 0.0 0.0 0.2 1.3 2.6 10.3 0.1 0.0 0.4 0.0 0.6 0.2 0.4 2.6 0.0 0.0 0.0 1.1 2.2 0.2 0.0 0.5 6.0 0.9 0.1 0.0 1.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 2.1 0.7 0.0 0.0 0.0 0.8 0.0 0.4 0.2 0.0 0.5 10.9 0.0 0.1 1.3 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.4 3.3 0.2 0.6 0.2 0.0 0.5 0.4 0.0 0.0 1.0 1.2 0.1 0.1 0.0 0.0 3.0 0.1 0.0 4.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.2 1.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 FRMPD4 "KIAA0316, PDZD10, PDZK10" ENSG00000169933 "FERM and PDZ domain containing 4" Q14CM0 X 12138466-12724523 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 16.4;parathyroid gland: 28.3" "Cell type enriched" "Detected in some" 54 "Horizontal cells: 158.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.3;LHCN-M2: 6.1;U-2197: 9.5;U-266/70: 8.7;U-266/84: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.05e-1)" "unprognostic (3.70e-2)" "unprognostic (3.50e-2)" "unprognostic (2.68e-3)" "unprognostic (8.84e-2)" "unprognostic (1.05e-2)" "unprognostic (3.56e-2)" "unprognostic (2.09e-2)" "unprognostic (1.62e-2)" "unprognostic (6.32e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.25e-1)" 0.6 0.6 5.5 0.6 10.9 0.5 0.6 3.8 16.4 0.7 1.1 1.0 0.0 0.6 0.7 1.0 0.7 0.6 0.6 2.1 8.1 3.5 0.6 0.6 0.6 0.5 2.7 6.9 0.6 0.5 28.3 0.6 0.5 2.9 1.1 0.8 1.9 0.5 0.6 1.1 0.6 0.6 0.6 0.8 0.5 0.6 1.0 1.5 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.8 0.0 1.1 2.1 3.4 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.4 2.2 3.5 0.0 0.2 0.0 0.1 0.0 0.0 1.5 0.0 1.3 2.4 0.3 0.0 0.0 0.0 0.7 6.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 1.1 9.5 1.0 8.7 3.9 0.0 2.4 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 10.9 3.8 14.6 8.1 3.5 2.7 6.9 2.9 1.5 0.0 0.0 0.0 0.0 0.1 2.9 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 FRRS1 "SDFR2, SDR2" ENSG00000156869 "Ferric chelate reductase 1" Q6ZNA5 1 99708632-99766631 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 27.1" "Cell type enhanced" "Detected in some" 5 "Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 5.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.5" "Cell line enhanced" "Detected in many" "HEL: 27.8;K-562: 18.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA017883 Approved NA NA "HPA017883: AB_2294223" "unprognostic (3.97e-2)" "unprognostic (8.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (8.54e-3)" "unprognostic (7.00e-2)" "unprognostic (2.64e-1)" "unprognostic (8.25e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (2.65e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (3.54e-2)" 10.3 6.2 0.6 2.7 1.2 1.5 5.1 0.5 1.2 6.4 6.1 1.2 14.5 2.6 10.7 6.5 11.2 2.0 3.4 2.9 0.6 0.6 1.9 27.1 3.8 1.7 2.1 0.0 5.3 2.0 1.5 2.3 9.8 0.9 4.4 4.0 1.6 8.4 13.4 2.0 7.2 8.0 3.3 3.1 1.5 4.2 2.9 1.3 1.4 5.6 5.4 6.0 5.1 7.0 0.3 0.5 5.5 0.8 0.0 0.1 0.1 5.5 1.0 2.4 2.1 7.7 4.1 12.3 1.4 2.7 1.7 6.5 6.7 7.3 3.2 5.8 1.6 2.3 12.8 3.8 5.9 2.2 6.5 2.5 27.8 2.7 7.3 1.1 3.1 7.5 6.1 7.6 3.4 1.3 0.4 0.3 2.1 18.6 0.2 1.4 1.7 1.0 1.2 1.7 12.5 5.1 0.0 9.1 1.3 1.1 13.9 0.5 0.1 2.3 10.5 5.4 1.9 3.8 4.0 0.6 3.0 4.1 2.6 1.5 2.3 0.0 5.5 6.7 1.3 1.4 0.5 0.4 5.5 0.0 0.8 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.6 1.2 0.5 1.2 0.6 0.6 2.1 0.0 0.9 1.3 0.0 0.0 0.0 1.7 1.6 0.0 0.7 0.0 2.7 0.0 1.8 0.0 2.1 0.0 0.2 0.1 0.1 1.3 0.0 0.0 1.6 1.3 1.0 0.0 2.5 1.0 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 1.0 0.0 0.8 0.3 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.3 2.4 3.1 0.0 0.2 2.2 FRRS1L "C9orf4, CG-6" ENSG00000260230 "Ferric chelate reductase 1 like" Q9P0K9 9 109130293-109167295 "Disease related genes, Predicted membrane proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.0;ovary: 15.2" "Group enriched" "Detected in many" 5 "Bipolar cells: 51.6;Horizontal cells: 92.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 3.8;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071086 Enhanced NA NA "HPA071086: AB_2686342" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (2.21e-1)" "unprognostic (9.01e-2)" "unprognostic (3.10e-1)" "unprognostic (8.12e-2)" "unprognostic (1.84e-1)" "unprognostic (9.94e-2)" "unprognostic (1.51e-1)" "unprognostic (9.21e-4)" "unprognostic (7.35e-3)" "unprognostic (7.02e-2)" "unprognostic (5.78e-3)" "unprognostic (5.89e-2)" "unprognostic (2.85e-1)" "unprognostic (5.38e-3)" 0.9 10.9 10.2 1.1 26.6 1.2 1.1 19.3 38.0 2.4 1.2 2.3 0.1 1.3 2.7 4.4 3.2 2.2 2.0 2.0 10.5 12.5 0.8 0.9 1.0 1.0 6.1 13.1 15.2 1.5 4.4 6.0 0.8 6.6 4.9 1.2 3.0 1.1 3.0 0.9 1.1 1.4 2.5 3.5 1.0 1.1 1.7 3.4 0.0 1.0 0.0 0.9 0.9 0.3 1.3 0.8 2.7 1.6 1.3 0.8 0.3 0.1 0.6 3.8 0.2 0.2 0.2 0.5 0.1 0.0 0.1 0.3 0.2 0.3 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.5 0.5 0.3 0.0 0.2 0.3 0.5 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.5 0.2 0.1 0.2 0.7 1.7 0.1 0.1 0.4 0.1 0.2 0.1 0.3 1.5 9.3 0.0 0.2 0.1 0.3 0.2 0.3 0.4 0.2 0.4 0.2 0.1 0.3 0.1 0.1 0.1 0.2 0.2 2.6 0.9 0.6 0.6 1.2 0.5 0.8 0.6 0.5 0.3 1.3 0.8 0.7 2.7 1.3 1.6 0.8 0.4 0.3 10.2 26.6 19.3 25.8 10.5 12.5 6.1 13.1 6.6 3.4 3.0 1.1 0.0 1.2 0.3 51.6 2.0 0.0 0.0 1.2 0.0 2.0 0.2 0.0 0.0 3.8 0.4 1.7 0.0 0.0 0.1 0.7 0.9 1.1 0.0 0.1 92.2 1.2 0.0 0.0 3.1 12.0 0.5 1.7 0.0 0.2 13.1 0.1 0.0 15.9 0.0 5.8 0.0 0.4 0.3 1.1 0.5 0.2 0.0 1.2 0.9 FRZB "FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3" ENSG00000162998 "Frizzled related protein" Q92765 2 182833275-182867162 "Disease related genes, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "retina: 265.8" "Cell type enriched" "Detected in many" 12 "Muller glia cells: 3160.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 21.7" "Group enriched" "Detected in some" 9 "memory B-cell: 3.0;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 12 "B-cells: 3.0" "Cell line enhanced" "Detected in some" "AF22: 17.7;ASC diff: 8.6;NTERA-2: 7.2;SH-SY5Y: 6.1" "Region enhanced" "Detected in many" "olfactory region: 69.9" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 27000 "unprognostic (5.39e-2)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" "unprognostic (1.79e-2)" "unprognostic (1.93e-1)" "unprognostic (2.09e-3)" "unprognostic (1.64e-2)" "unprognostic (2.38e-2)" "unprognostic (4.67e-2)" "unprognostic (8.58e-2)" "unprognostic (5.41e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (8.97e-6)" "unprognostic (3.53e-2)" "unprognostic (1.05e-2)" "unprognostic (6.04e-2)" "unprognostic (3.21e-1)" 4.4 1.4 2.8 4.8 5.4 0.0 5.1 2.9 3.5 7.1 5.1 3.3 2.6 4.5 5.5 3.5 3.6 2.8 12.9 8.4 2.8 2.8 5.5 2.2 3.7 4.8 3.6 3.4 4.4 2.4 0.6 11.3 44.3 21.7 4.0 6.6 265.8 5.1 5.4 8.4 4.3 4.7 10.5 2.9 28.2 12.0 4.2 2.3 3.1 5.0 3.1 3.4 3.5 6.2 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 17.7 0.2 8.6 0.2 0.1 0.0 0.8 3.1 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 7.2 0.0 0.0 0.6 0.7 0.0 0.0 0.0 1.1 6.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 5.4 2.9 3.5 2.8 2.8 3.6 3.4 21.7 2.3 0.0 0.3 0.0 0.4 7.2 34.0 2.2 0.0 0.0 2.3 0.0 31.4 4.3 0.0 0.1 0.3 2.1 1.0 0.0 7.5 3.0 28.8 1.7 0.0 0.9 6.8 25.4 1.2 4.3 1.5 1.9 3.4 0.8 232.8 0.0 99.8 3160.2 0.1 0.0 13.8 0.0 101.0 271.7 137.0 0.2 0.0 2.8 10.4 0.0 3.3 0.4 FSCB "C14orf155, DKFZP434F1017" ENSG00000189139 "Fibrous sheath CABYR binding protein" Q5H9T9 14 44504342-44507279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 27.0" "Group enriched" "Detected in some" 55 "Early spermatids: 273.7;Late spermatids: 442.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003546 Supported NA NA "HPA003546: AB_1845561" "unprognostic (8.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 273.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 442.7 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 6.5 0.0 4.4 1.9 0.0 0.0 0.0 0.0 0.0 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592823-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9" "Cell type enriched" "Detected in many" 9 "monocytes: 1791.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 82.1;K-562: 68.7;NB-4: 78.0;PC-3: 68.7;SH-SY5Y: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 4500000 Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203" "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 26.3 13.3 23.7 29.6 30.1 6.3 8.1 5.5 56.9 9.9 5.5 35.1 0.0 5.4 11.7 2.3 22.3 5.9 8.9 10.6 27.7 16.8 5.5 7.1 11.3 15.2 26.9 23.6 21.8 5.1 2.3 7.0 29.4 20.1 4.1 3.0 8.1 11.0 3.9 7.8 17.3 6.6 7.0 29.6 39.3 7.6 15.9 28.3 9.3 8.5 15.9 11.4 14.7 12.3 0.2 5.4 1.0 1.9 0.0 0.1 1.4 8.0 18.6 12.4 44.5 4.8 9.2 82.1 19.3 8.6 3.3 3.6 12.9 2.0 0.1 23.6 8.5 3.2 30.5 7.1 31.0 0.2 9.1 3.8 0.5 19.8 60.8 2.5 0.0 1.6 5.7 9.2 6.2 5.1 5.5 16.2 0.0 68.7 0.1 4.2 0.8 0.2 78.0 32.5 0.5 68.7 18.1 2.9 0.3 4.8 0.7 9.9 65.9 16.1 0.2 0.6 8.4 0.4 4.9 32.8 22.9 40.3 13.3 19.8 0.1 0.1 0.0 14.8 0.0 43.0 0.0 1.9 0.1 0.0 0.5 0.0 0.2 0.1 0.0 5.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 1.4 23.7 30.1 5.5 41.3 27.7 16.8 26.9 23.6 20.1 28.3 3.0 5.5 2.4 19.0 161.1 7.2 6.9 2.5 1.4 0.0 1.8 0.0 4.4 0.0 6.8 13.1 49.6 1.3 0.0 4.2 90.3 72.6 6.3 16.1 0.8 207.2 0.0 40.2 97.6 22.0 7.9 23.6 10.6 49.0 1791.8 0.7 69.1 10.4 0.0 8.5 0.2 2.3 0.0 16.5 4.7 9.0 128.6 12.2 4.3 0.9 28.3 FSCN2 "RFSN, RP30" ENSG00000186765 "Fascin actin-bundling protein 2, retinal" O14926 17 81528396-81537130 "Disease related genes, Predicted intracellular proteins" Actin-binding "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 21.9" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 23.6;Exocrine glandular cells: 10.3;Rod photoreceptor cells: 20.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 5.2;T-47d: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079270 Enhanced NA NA "HPA079270: " "unprognostic (3.50e-3)" "unprognostic (6.55e-2)" "unprognostic (2.73e-4)" "unprognostic (1.08e-3)" "unprognostic (1.11e-2)" "unprognostic (2.11e-2)" "unprognostic (6.49e-3)" "unprognostic (3.49e-1)" "unprognostic (1.64e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-1)" "unprognostic (1.91e-1)" "unprognostic (1.53e-1)" "unprognostic (1.74e-1)" "unprognostic (2.11e-1)" 0.6 0.0 0.6 0.6 0.6 0.1 0.7 1.0 0.8 1.7 0.6 0.6 0.6 0.5 1.7 1.2 0.6 1.1 0.6 0.6 0.6 0.6 0.8 0.6 1.1 0.6 0.6 0.6 1.2 6.8 7.0 1.3 0.9 0.6 0.9 0.2 21.9 4.2 1.1 0.6 1.2 0.6 0.6 0.6 0.6 2.0 0.6 0.6 0.6 6.2 0.6 0.6 0.6 0.6 0.9 0.7 0.0 0.1 0.0 0.6 0.0 1.9 1.2 0.8 1.4 0.4 0.0 1.4 0.8 1.4 0.0 0.2 1.0 1.4 1.4 5.2 1.3 0.9 1.5 0.0 0.0 0.0 2.0 1.2 0.0 1.0 0.5 0.7 0.3 0.0 0.4 0.0 0.0 0.2 1.7 0.2 0.0 0.3 1.3 0.0 2.5 0.0 0.5 0.3 1.1 0.4 1.0 0.6 0.5 0.5 0.6 1.6 0.1 0.1 0.1 1.8 1.0 5.6 0.0 1.6 1.8 0.4 0.2 0.5 0.1 0.3 0.1 2.2 0.0 0.9 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.0 0.8 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 3.7 1.0 0.0 0.0 0.0 0.0 23.6 0.1 1.7 0.4 0.4 0.0 0.0 0.0 10.3 0.2 0.0 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.3 0.3 0.0 0.0 1.8 0.0 1.8 4.1 0.0 0.0 0.0 20.5 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 FSCN3 ENSG00000106328 "Fascin actin-bundling protein 3" Q9NQT6 7 127591409-127602144 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 62.1" "Cell type enriched" "Detected in some" 6 "Late spermatids: 1905.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTCEpi: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA075174 Enhanced NA NA "HPA075174: " "unprognostic (7.77e-2)" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (9.59e-2)" "unprognostic (1.39e-1)" "unprognostic (3.87e-1)" "unprognostic (5.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.91e-3)" "unprognostic (2.00e-1)" "unprognostic (1.68e-4)" "unprognostic (1.34e-1)" "unprognostic (1.14e-5)" "unprognostic (1.27e-1)" "unprognostic (9.21e-3)" "unprognostic (2.01e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 62.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.3 0.0 0.0 0.3 0.0 0.0 1.1 0.3 0.8 0.0 0.0 1.4 0.1 0.4 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 2.5 0.6 0.0 0.0 0.0 0.5 0.3 0.6 0.0 0.7 0.7 0.7 1.4 0.0 0.0 0.5 0.7 0.2 0.0 0.5 0.2 0.3 0.0 1.5 0.0 0.3 0.0 0.6 0.0 0.1 0.1 0.5 0.0 0.8 0.3 0.7 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 317.1 0.3 0.0 0.0 0.2 0.2 0.2 0.3 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1905.7 8.6 0.9 1.7 0.0 0.1 0.2 0.2 0.6 7.8 0.0 0.4 0.0 0.3 9.8 5.8 1.1 0.2 0.0 0.1 0.1 FSD1 "MGC3213, MIR1" ENSG00000105255 "Fibronectin type III and SPRY domain containing 1" Q9BTV5 19 4304600-4323843 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 8.2;brain: 30.8;testis: 9.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.3;Distal tubular cells: 13.3;Horizontal cells: 15.9;Spermatogonia: 19.2" "Group enriched" "Detected in many" 6 "glioma: 9.2;testis cancer: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7;NK-cell: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.9;SH-SY5Y: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043141 Supported NA NA "HPA043141: AB_10797137" "unprognostic (8.31e-3)" "unprognostic (2.38e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.29e-2)" "unprognostic (9.72e-4)" "unprognostic (1.33e-1)" "unprognostic (9.87e-2)" "unprognostic (1.00e-1)" "unprognostic (3.15e-1)" "unprognostic (8.16e-3)" "unprognostic (1.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.82e-1)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-1)" 1.5 2.3 15.5 2.2 9.9 1.8 0.9 15.7 30.8 2.1 1.6 3.2 0.0 2.7 1.0 1.1 1.1 1.0 1.6 0.9 15.8 14.3 1.0 1.2 1.1 2.9 11.4 13.0 1.2 0.9 0.9 1.1 2.3 9.5 1.1 1.1 0.0 0.9 1.2 0.9 1.1 1.8 1.7 5.7 1.5 1.4 9.5 7.8 1.6 0.9 0.0 1.7 1.1 0.2 0.0 2.0 0.0 0.0 8.2 5.7 0.8 0.0 3.3 9.3 4.8 0.0 0.9 3.9 3.8 1.6 12.7 9.8 7.5 0.2 11.8 3.3 2.7 6.6 0.8 8.4 6.2 3.9 7.4 12.4 3.1 2.6 0.2 5.1 0.0 0.7 2.1 0.0 7.3 0.4 5.1 6.6 10.7 0.4 0.0 0.5 8.8 5.3 0.0 11.9 0.0 6.3 0.0 4.4 0.0 0.0 0.2 27.9 29.1 1.0 0.4 0.8 1.4 0.1 0.1 7.5 1.9 9.1 3.6 3.5 6.8 8.5 2.9 4.8 0.0 4.8 0.0 0.0 0.0 0.7 0.0 5.7 0.0 0.2 0.0 0.0 0.0 1.1 0.4 0.0 8.2 0.0 2.0 0.6 0.8 15.5 9.9 15.7 21.5 15.8 14.3 11.4 13.0 9.5 7.8 0.0 0.6 0.8 0.3 0.1 13.3 0.4 0.0 0.0 1.2 3.5 2.0 2.3 13.3 0.0 3.4 0.1 0.0 0.0 0.0 0.2 0.8 0.2 2.3 0.0 0.7 15.9 2.4 1.3 0.0 5.1 0.9 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.4 0.2 5.3 0.0 1.4 1.4 19.2 0.0 2.3 8.7 0.0 0.3 FSD2 "RP11-127F21, SPRYD1" ENSG00000186628 "Fibronectin type III and SPRY domain containing 2" A1L4K1 15 82755362-82806070 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 70.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 8.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA046263 Approved Cytosol NA NA Cytosol "HPA046263: AB_2679604" "unprognostic (2.80e-1)" "unprognostic (3.54e-1)" "unprognostic (6.63e-2)" "unprognostic (6.30e-2)" "unprognostic (7.71e-2)" "unprognostic (1.83e-1)" "unprognostic (5.97e-2)" "unprognostic (7.66e-2)" "unprognostic (1.07e-1)" "unprognostic (9.37e-2)" "unprognostic (3.05e-2)" "unprognostic (2.21e-1)" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-2)" "unprognostic (1.59e-2)" 1.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.6 0.7 0.1 0.0 20.8 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.4 1.0 0.0 54.0 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 18.1 1.4 0.0 0.1 1.4 0.8 2.3 0.9 0.8 2.2 0.5 1.3 1.3 2.0 2.4 0.0 0.0 1.2 1.3 0.0 0.0 0.0 1.1 2.1 4.1 0.9 0.0 1.1 5.0 0.0 0.0 0.4 0.7 5.4 2.3 5.7 1.8 0.0 1.4 0.9 0.1 0.2 0.0 0.6 1.4 0.0 1.7 2.0 3.7 0.0 1.2 0.7 2.4 1.9 0.8 1.1 1.3 1.5 1.0 0.2 2.3 1.9 1.7 1.0 1.0 1.5 1.0 1.7 1.8 0.8 3.0 1.6 1.1 1.8 8.5 3.6 1.4 1.8 4.9 0.7 2.3 0.8 0.8 1.0 0.7 0.8 1.4 1.1 0.9 0.8 1.1 2.2 1.1 1.1 0.8 0.9 0.8 1.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 1.0 0.3 2.6 70.6 2.5 0.0 1.2 0.0 5.9 0.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.1 0.2 0.3 1.1 0.0 0.2 11.1 1.2 0.0 0.8 1.8 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 3.6 0.0 0.3 0.7 0.2 0.5 0.2 0.0 0.0 0.3 FSHB ENSG00000131808 "Follicle stimulating hormone beta subunit" P01225 11 30231016-30235261 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "pituitary gland: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB023410, HPA069703" Enhanced "Secreted to blood" NA NA 47000 "CAB023410: AB_324983, HPA069703: AB_2686176" "unprognostic (1.04e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 70.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSHR "FSHRO, LGR1, ODG1" ENSG00000170820 "Follicle stimulating hormone receptor" P23945 2 48962157-49154537 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 5.3;ovary: 6.5;testis: 16.3" "Group enriched" "Detected in some" 24 "Early spermatids: 1.6;Late spermatids: 4.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basal ganglia: 1.5;cerebral cortex: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SuSa: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (5.94e-2)" "unprognostic (4.06e-3)" "unprognostic (5.78e-2)" 0.1 0.1 0.1 0.0 1.5 0.1 0.1 0.1 2.9 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.3 5.3 1.0 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 6.5 0.1 0.0 0.1 0.0 0.5 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.3 0.0 3.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.1 2.9 0.1 0.4 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.8;pituitary gland: 11.8;testis: 13.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Early spermatids: 47.1;Late spermatids: 39.8;Spermatocytes: 27.4" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 7.3" "Low region specificity" "Detected in many" HPA041002 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.8 0.7 2.9 0.7 9.3 1.1 1.9 1.0 5.7 0.8 11.7 1.5 0.8 0.5 1.4 2.5 0.6 2.3 0.7 0.8 3.1 3.0 1.6 0.7 0.9 0.5 1.2 4.1 0.7 0.6 1.7 11.8 0.8 4.5 0.8 17.8 0.6 0.5 0.7 0.9 1.7 0.6 0.9 1.1 0.6 1.1 13.9 1.4 0.5 1.0 0.0 0.5 1.0 0.9 1.0 1.0 1.8 1.3 1.5 3.4 1.4 0.6 2.3 6.2 0.9 1.1 2.1 0.1 7.3 1.5 1.2 2.2 1.7 0.6 0.5 0.6 2.1 3.1 1.5 1.0 1.2 1.9 2.5 0.6 4.5 1.7 0.1 0.6 0.9 5.0 1.4 5.2 2.8 1.2 1.6 1.3 2.5 0.2 0.6 1.9 0.3 0.6 0.4 0.7 0.3 1.2 0.6 1.2 0.1 2.4 2.7 1.6 4.7 1.5 0.2 0.3 0.5 2.1 0.5 1.0 3.0 1.7 1.6 0.8 1.3 2.7 0.3 6.2 1.7 1.4 1.8 1.3 1.5 3.4 0.8 2.7 0.8 1.8 2.1 1.0 1.0 1.1 0.9 1.1 1.5 1.0 0.0 0.4 1.4 2.9 9.3 1.0 5.7 3.1 3.0 1.2 4.1 4.5 1.4 0.0 0.3 0.5 0.3 0.6 1.0 0.6 2.5 17.4 3.4 1.8 11.8 0.7 1.7 0.6 47.1 0.1 4.9 0.0 0.4 0.1 0.9 0.7 15.1 0.0 0.1 0.0 0.0 0.6 0.0 39.8 1.1 0.1 0.0 0.0 2.2 1.5 0.1 0.0 0.7 2.4 4.9 0.0 0.2 27.4 7.8 0.0 4.7 1.0 1.5 0.3 FSIP2 FLJ34780 ENSG00000188738 "Fibrous sheath interacting protein 2" Q5CZC0 2 185738895-185833290 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 27.6" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 128.1;Alveolar cells type 2: 68.3;Ciliated cells: 83.0;Early spermatids: 179.5;Spermatocytes: 69.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HeLa: 2.2;Karpas-707: 2.8;OE19: 2.0;RT4: 4.7;SuSa: 2.1;U-266/70: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA036139 Approved Microtubules,Mitochondria NA NA Microtubules Mitochondria "HPA036139: AB_10602134" "unprognostic (5.28e-2)" "unprognostic (1.20e-2)" "unprognostic (4.17e-1)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (2.95e-1)" "unprognostic (6.31e-2)" "unprognostic (2.76e-3)" "unprognostic (1.55e-1)" "unprognostic (5.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.79e-3)" "unprognostic (4.89e-3)" "unprognostic (1.28e-1)" "unprognostic (7.52e-2)" "unprognostic (5.17e-2)" "unprognostic (4.64e-5)" 0.4 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.3 0.3 2.7 0.1 0.1 0.0 0.6 0.5 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.4 0.6 0.5 0.5 0.3 1.4 0.3 0.2 0.1 0.1 0.3 0.6 0.6 0.1 0.5 3.6 27.6 0.1 0.1 0.4 0.1 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.8 0.1 0.0 0.0 0.0 0.7 2.0 0.7 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 128.1 68.3 0.8 0.2 0.5 14.6 3.2 0.0 83.0 56.9 0.0 9.8 0.2 0.0 0.5 179.5 0.6 2.6 0.0 0.2 0.1 0.6 0.3 37.2 0.0 0.3 17.5 7.5 1.8 0.0 20.4 2.0 1.4 1.7 0.0 13.3 5.8 3.2 0.0 3.5 0.0 8.0 0.0 0.5 69.0 2.7 0.3 0.2 0.0 0.6 0.1 FST FS ENSG00000134363 Follistatin P19883 5 53480409-53487134 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 85.9;Hepatocytes: 22.9;Urothelial cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0" "Group enriched" "Detected in many" 5 "monocytes: 1.0;T-cells: 2.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.4;HaCaT: 50.3;HBEC3-KT: 32.1;HMC-1: 36.1;PC-3: 97.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA016612, CAB026025" Approved Approved Vesicles "Secreted to blood" NA NA 1800000 Vesicles "CAB026025: , HPA016612: " "unprognostic (1.43e-1)" "unprognostic (6.50e-2)" "unprognostic (1.44e-1)" "unprognostic (7.73e-3)" "unprognostic (2.30e-1)" "unprognostic (1.50e-3)" "unprognostic (8.02e-2)" "unprognostic (2.32e-2)" "unprognostic (3.06e-1)" "unprognostic (1.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.44e-5)" "unprognostic (1.21e-3)" "unprognostic (2.48e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-1)" 12.4 3.2 2.0 3.1 0.8 0.1 7.1 0.2 0.7 3.5 5.2 0.3 1.1 0.9 2.3 9.5 3.6 4.9 4.1 5.6 1.0 1.0 1.7 42.7 4.3 0.8 0.4 0.6 20.7 19.4 0.0 2.9 13.5 1.0 9.3 1.7 5.7 5.5 6.5 12.6 9.0 4.3 3.7 0.4 0.2 4.8 4.9 0.5 1.2 2.0 6.7 7.1 6.2 13.8 0.1 0.2 0.0 1.0 0.0 2.0 0.1 3.3 0.3 5.9 0.0 6.7 2.3 9.8 13.0 59.4 8.0 7.8 0.0 0.0 0.0 0.1 3.4 0.4 50.3 0.0 32.1 5.7 0.1 0.0 0.6 0.2 5.3 3.6 0.0 36.1 5.5 0.0 14.7 9.6 5.5 6.8 0.0 0.0 0.1 5.0 0.0 0.0 0.2 9.0 0.0 97.2 0.6 7.5 0.0 0.0 5.5 0.0 0.0 0.5 0.0 0.3 15.8 0.0 0.0 0.0 22.0 6.3 2.2 1.9 0.0 0.0 0.0 2.5 0.7 20.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.1 2.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.0 0.8 0.2 0.7 1.0 1.0 0.4 0.6 1.0 0.5 0.0 1.4 0.0 12.8 17.7 0.0 7.3 0.0 0.0 12.5 0.0 0.0 0.6 0.0 0.6 0.3 1.6 0.0 0.0 3.8 7.6 85.9 5.3 0.0 22.9 1.6 0.0 0.0 1.3 0.3 0.9 2.8 0.4 5.0 0.0 0.0 0.0 10.0 0.0 10.6 0.0 0.0 12.9 12.5 0.3 0.7 4.1 5.0 0.0 0.0 26.0 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676365-683399 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 201.0" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 2939.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Supported Nucleoplasm "Secreted in other tissues" NA Yes 6800000 Nucleoplasm "CAB024899: , HPA045378: AB_2679300" "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 19.9 29.1 4.0 10.7 6.2 5.6 24.7 1.3 4.2 13.1 14.9 3.8 8.1 3.8 12.8 15.6 12.7 14.1 13.1 27.0 5.0 2.0 13.7 5.1 26.9 8.7 7.3 4.5 16.8 11.7 1.4 5.3 201.0 6.0 14.3 3.1 12.0 4.5 11.0 4.1 6.2 6.5 20.6 10.4 3.9 9.1 34.5 4.9 0.7 7.2 5.5 1.4 16.7 18.3 0.9 2.2 0.1 4.4 0.6 2.6 2.0 1.9 15.9 1.1 0.8 5.0 12.8 36.2 27.0 4.0 6.8 2.5 5.8 3.1 0.8 10.9 18.2 3.9 13.9 0.9 23.0 2.2 1.6 1.9 0.7 22.2 4.7 21.6 1.4 2.6 16.0 40.0 7.5 31.3 17.6 1.2 0.8 1.7 1.1 10.2 7.0 0.5 0.8 1.3 13.1 5.5 1.5 0.7 1.8 9.4 0.3 0.7 1.2 73.8 1.5 0.8 1.4 1.3 0.7 16.2 6.8 23.5 38.1 9.9 1.8 0.8 0.4 1.0 4.2 3.1 0.0 4.4 0.0 1.0 4.4 0.2 0.3 1.4 1.1 2.2 0.9 2.6 1.6 0.1 0.6 3.2 0.9 0.2 2.0 4.0 6.2 1.3 4.2 5.0 2.0 7.3 4.5 6.0 4.9 17.9 3.4 2.2 19.6 12.9 1.6 12.8 30.6 2.7 1.2 8.7 0.0 22.7 6.6 69.7 5.6 4.5 0.9 0.0 56.0 2939.6 52.2 21.7 0.0 0.9 68.4 3.2 1.2 22.1 3.8 6.5 56.7 4.0 5.0 11.8 0.9 7.8 198.1 0.0 25.1 5.6 0.5 45.3 32.5 2.3 7.7 6.8 662.4 2.9 1.7 20.7 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612564 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045920 Uncertain Approved "Nuclear membrane,Mitochondria" "Secreted to blood" NA NA Mitochondria "Nuclear membrane" "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.7 2.2 8.4 1.0 14.6 3.0 1.1 18.5 18.0 1.0 1.6 1.7 0.0 1.1 0.5 2.8 3.1 1.6 0.7 0.6 1.5 3.2 4.8 0.5 2.0 0.4 1.9 10.1 0.8 2.9 7.1 4.0 6.4 2.6 2.9 1.9 1.4 1.4 0.1 1.5 5.3 1.2 0.3 1.0 0.5 2.3 2.8 4.7 0.0 1.3 0.0 1.7 10.2 1.6 2.8 1.2 3.4 1.1 0.8 2.3 1.2 4.4 7.6 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 6.8 0.9 0.3 6.2 0.0 0.8 0.1 0.9 0.2 0.0 0.4 0.3 0.3 7.4 0.6 0.0 0.0 0.4 0.1 1.1 0.0 0.0 0.2 0.0 0.3 3.4 4.0 0.0 7.2 0.8 0.3 8.2 7.8 0.8 0.3 0.7 7.7 0.0 8.4 33.1 0.7 1.7 1.4 0.1 7.8 2.8 0.3 0.2 0.3 1.4 0.4 0.2 11.9 11.8 0.3 0.1 0.0 0.2 3.4 1.1 0.6 1.2 0.4 2.3 2.8 1.7 1.2 0.6 2.6 2.1 1.3 2.4 0.8 0.7 1.2 1.6 1.2 8.4 14.6 18.5 18.0 1.5 3.2 1.9 10.1 2.6 4.7 0.0 1.9 0.0 1.7 1.4 10.3 7.3 0.0 6.7 7.9 0.0 13.7 0.3 0.0 0.2 31.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 8.6 0.0 0.0 13.9 0.3 0.0 10.1 0.0 0.0 3.3 0.8 0.0 0.7 2.3 2.4 6.5 0.0 0.4 0.6 1.4 0.0 0.0 0.0 2.6 FSTL5 "DKFZp566D234, KIAA1263" ENSG00000168843 "Follistatin like 5" Q8N475 4 161383897-162164035 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 106.9" "Group enriched" "Detected in some" 10 "Bipolar cells: 248.5;Cone photoreceptor cells: 435.9;Rod photoreceptor cells: 131.6" "Cancer enriched" "Detected in single" 6 "melanoma: 1.7" "Region enriched" "Detected in all" 6 "cerebellum: 106.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (4.90e-2)" "unprognostic (4.46e-1)" "unprognostic (1.52e-2)" "unprognostic (2.03e-1)" "unprognostic (3.66e-2)" "unprognostic (2.99e-2)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (3.39e-2)" "unprognostic (1.61e-1)" "unprognostic (1.08e-10)" "unprognostic (8.45e-4)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (6.60e-3)" 0.5 12.1 3.5 0.6 6.9 0.5 0.5 106.9 19.9 0.5 0.6 0.6 0.0 0.5 0.5 1.7 0.5 0.6 0.5 0.5 3.2 5.9 0.6 0.5 0.5 0.5 3.0 3.0 0.5 1.0 0.5 1.1 0.7 18.2 0.5 0.8 7.1 0.5 0.6 0.5 0.8 0.6 0.6 3.1 0.5 0.5 1.5 2.9 0.0 0.6 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 5.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 8.8 0.0 3.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.9 106.9 6.9 3.2 5.9 3.0 3.0 18.2 2.9 0.0 0.0 0.0 0.0 0.2 248.5 0.1 0.0 0.0 0.0 0.0 435.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 27.0 0.0 0.0 0.0 1.7 0.6 0.0 1.7 0.0 0.0 18.6 0.1 0.0 0.4 0.0 131.6 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 FTCD ENSG00000160282 "Formimidoyltransferase cyclodeaminase" O95954 21 46136262-46155567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" "Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 126.8" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0" "Cancer enriched" "Detected in some" 8 "liver cancer: 87.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enriched" "Detected in single" 25 "T-cells: 2.5" "Cell line enriched" "Detected in some" 29 "Hep G2: 45.4" "HPA020073, HPA030928, HPA030929, HPA036114" Enhanced Approved "Plasma membrane,Cytosol" No NA 580000 Cytosol "Plasma membrane" "HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-5)" "unprognostic (2.90e-2)" "unprognostic (1.13e-1)" "unprognostic (2.96e-1)" "prognostic favorable (1.70e-4)" "unprognostic (1.85e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-1)" "prognostic favorable (6.78e-5)" "unprognostic (1.80e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.80e-2)" "unprognostic (3.60e-1)" "unprognostic (9.37e-2)" "unprognostic (2.10e-1)" 0.2 0.0 0.6 0.2 1.6 0.0 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.3 0.2 2.0 0.2 0.0 0.2 0.2 0.5 0.4 25.9 126.8 0.2 0.2 0.4 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.1 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 45.4 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 2.5 0.1 0.6 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.2 0.2 0.0 0.0 24.9 0.0 0.1 1.0 1.0 68.8 0.0 0.0 8.7 0.0 0.0 39.7 0.0 75.4 0.6 0.0 0.0 0.0 0.0 0.8 0.5 0.0 338.0 0.1 3.2 0.0 22.7 22.3 92.6 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 322.0 0.4 0.0 0.1 10.7 12.2 0.4 0.0 6.9 0.0 0.0 FTH1 "FHC, FTH, FTHL6, PIG15, PLIF" ENSG00000167996 "Ferritin heavy chain 1" P02794 11 61959718-61967660 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Iron storage" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 756.2" "Cell type enhanced" "Detected in all" 9 "monocytes: 52379.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 756.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 555.5;HHSteC: 578.8" "Low region specificity" "Detected in all" CAB008623 Approved Approved Microtubules NA NA 9000000 Microtubules "CAB008623: " "unprognostic (7.15e-2)" "unprognostic (1.52e-2)" "unprognostic (2.27e-1)" "unprognostic (2.00e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (6.18e-4)" "unprognostic (3.08e-2)" "unprognostic (2.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.44e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.20e-5)" "unprognostic (2.99e-1)" "unprognostic (4.89e-2)" "unprognostic (3.44e-1)" "unprognostic (5.83e-2)" 155.1 118.0 177.6 138.9 92.6 162.0 302.9 38.5 163.7 104.2 142.4 97.8 72.0 72.2 81.6 102.4 88.8 70.6 83.5 236.1 124.7 91.2 113.5 128.2 297.3 394.0 118.5 110.6 81.7 150.8 49.7 46.7 70.1 77.5 60.9 138.5 79.5 180.5 65.1 124.1 42.5 110.0 140.0 182.1 84.4 81.0 67.8 88.2 58.5 100.3 64.1 48.9 106.7 94.0 69.5 163.3 756.2 424.5 30.7 69.2 284.2 65.4 183.8 28.0 74.1 555.5 269.1 154.7 60.1 258.0 61.3 61.9 22.2 90.9 7.6 381.6 172.8 234.7 112.1 25.0 49.7 39.8 31.2 12.3 38.1 254.7 145.1 578.8 17.8 59.9 364.4 244.0 122.3 230.1 194.4 76.7 44.1 56.7 87.4 214.0 88.5 20.0 29.2 47.9 229.9 310.8 19.9 34.6 54.5 313.4 178.2 23.8 30.2 206.4 22.7 97.7 96.5 40.4 24.1 85.4 191.7 45.9 84.8 37.7 15.1 52.0 23.4 261.3 8.0 45.6 401.9 297.7 247.4 40.8 367.6 40.2 68.6 58.3 40.4 163.3 69.5 49.3 38.2 756.2 30.7 424.5 121.2 69.2 284.2 177.6 92.6 38.5 163.7 124.7 91.2 118.5 110.6 77.5 88.2 1223.8 3688.2 1741.3 6882.7 4581.6 811.0 10.8 4076.4 2049.0 1899.5 1819.7 540.0 3704.8 9226.3 8116.7 214.1 3238.4 10084.1 4345.2 9486.9 4714.1 4023.6 8092.3 6278.5 3801.3 17699.0 697.6 2425.9 2794.1 10131.9 335.0 4320.5 19898.9 6750.0 52379.0 4287.5 3515.6 10476.1 8248.3 3589.2 14886.0 2120.1 2050.2 6618.7 591.9 960.7 3108.0 3865.9 1625.8 5251.4 8218.4 FTHL17 CT38 ENSG00000132446 "Ferritin heavy chain like 17" Q9BXU8 X 31071241-31072053 "Predicted intracellular proteins" "Iron storage" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.7" "Cell type enriched" "Detected in single" 23 "Spermatocytes: 14.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "hTERT-HME1: 1.4;T-47d: 1.2" NA NA "unprognostic (5.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.5 0.0 0.0 0.0 0.0 0.0 FTL "MGC71996, NBIA3" ENSG00000087086 "Ferritin light chain" P02792 19 48965301-48966878 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Iron storage" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 1149.4" "Cell type enhanced" "Detected in all" 10 "Hofbauer cells: 67925.7;Kupffer cells: 48067.7;Proximal tubular cells: 39652.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "granulocytes: 1149.4;monocytes: 890.5" "Cell line enhanced" "Detected in all" "HHSteC: 575.7;HSkMC: 481.6" "CAB020769, HPA041602" Enhanced Approved Cytosol NA NA 240000000 Cytosol "CAB020769: , HPA041602: AB_2677575" "unprognostic (2.95e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-1)" "unprognostic (1.56e-3)" "unprognostic (7.48e-2)" "unprognostic (5.28e-2)" "unprognostic (2.16e-3)" "unprognostic (6.17e-3)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" 326.0 111.3 147.1 113.6 130.9 179.8 321.8 25.8 101.3 105.7 107.5 134.7 58.2 120.5 54.9 85.4 85.0 71.3 214.6 140.8 111.7 88.2 295.2 526.9 391.6 444.6 139.4 49.6 126.8 108.0 27.0 63.6 166.3 89.0 108.0 92.3 114.4 59.4 75.4 75.6 48.3 159.4 149.2 194.5 317.9 105.2 53.9 74.5 45.1 130.0 57.5 67.5 159.8 172.1 147.8 231.2 1149.4 890.5 41.5 86.1 674.1 18.7 285.4 21.4 32.7 370.5 384.5 38.3 48.6 286.4 70.1 158.0 62.5 76.1 14.3 93.6 290.5 153.7 11.2 17.5 28.8 63.3 192.3 11.3 37.8 74.5 408.6 575.7 88.8 127.3 481.6 39.1 119.3 52.5 104.8 101.5 17.2 69.9 29.9 138.3 4.5 24.5 51.9 38.8 330.4 29.2 20.5 14.5 147.1 44.5 11.9 27.4 15.9 127.8 7.0 26.6 121.4 4.1 185.8 75.9 76.8 40.4 98.5 66.5 129.3 285.0 13.3 81.5 93.7 134.3 488.0 642.5 675.8 63.9 890.5 72.6 147.8 71.3 68.3 231.2 132.2 86.1 74.8 1149.4 41.5 768.3 97.2 83.8 674.1 147.1 130.9 25.8 101.3 111.7 88.2 139.4 49.6 89.0 74.5 1045.2 3325.0 4263.9 4805.4 2481.8 468.5 679.4 4145.2 769.6 1043.0 1917.5 166.9 816.1 9070.4 3524.4 247.8 2245.5 2735.4 2149.2 5208.6 1016.5 4146.4 6478.0 2236.8 16333.4 67925.7 503.7 1551.5 4087.4 48067.7 879.3 3866.6 17106.8 4823.4 23991.6 2116.7 1184.6 7872.5 3673.3 1890.2 39652.4 496.5 1319.4 4074.7 56.3 327.7 1946.3 1256.7 2296.9 2288.6 7488.3 FTMT MtF ENSG00000181867 "Ferritin mitochondrial" Q8N4E7 5 121851955-121852833 "Enzymes, Predicted intracellular proteins" "Iron storage" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "testis: 68.0" "Cell type enriched" "Detected in some" 9 "Early spermatids: 604.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 4 "HDLM-2: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 604.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.6 2.4 0.0 0.0 0.0 0.0 0.0 FUOM "C10orf125, FLJ26016, FucM, FucU" ENSG00000148803 "Fucose mutarotase" A2VDF0 10 133355154-133358035 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 183.8;Hepatocytes: 452.0;Hofbauer cells: 152.7;Proximal tubular cells: 264.0" "Cancer enhanced" "Detected in all" "liver cancer: 61.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039207 Uncertain NA NA 2500000 "HPA039207: AB_10795033" "unprognostic (1.15e-2)" "unprognostic (1.16e-1)" "unprognostic (4.48e-2)" "unprognostic (7.19e-2)" "unprognostic (4.82e-1)" "unprognostic (2.66e-2)" "unprognostic (1.66e-2)" "unprognostic (2.45e-1)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" "unprognostic (4.50e-2)" "unprognostic (8.67e-2)" "unprognostic (3.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.50e-1)" "unprognostic (4.88e-3)" "unprognostic (1.65e-1)" 4.9 3.3 1.9 7.1 2.1 2.2 4.5 1.1 2.4 2.2 15.2 2.6 4.9 20.5 2.1 6.3 3.6 2.8 5.8 6.8 1.6 1.3 14.2 68.3 7.5 6.7 2.1 0.9 3.7 6.9 0.8 2.3 2.0 3.0 2.4 2.2 6.7 18.8 3.0 1.9 2.6 28.3 2.4 1.7 9.7 3.0 2.4 1.2 2.8 2.4 3.3 6.1 2.9 2.6 13.0 28.7 2.1 25.6 5.7 6.0 10.1 11.1 3.5 6.9 14.1 2.0 4.9 12.5 8.9 10.4 3.3 4.1 22.4 6.2 0.0 10.4 6.8 0.0 0.6 2.5 3.1 0.3 4.0 2.4 10.9 5.4 24.1 10.3 11.9 7.4 5.0 0.1 1.3 0.7 1.5 4.6 11.3 10.4 14.8 6.9 11.0 1.8 16.0 4.8 6.6 1.6 10.4 0.2 6.4 3.7 0.0 0.7 5.5 3.3 10.2 12.2 3.7 0.1 18.4 9.1 0.0 9.4 0.0 0.0 7.8 1.2 7.7 2.8 4.9 3.4 0.0 25.6 2.1 6.0 25.6 5.6 12.6 5.4 5.0 20.7 13.0 5.8 5.0 1.2 5.7 5.4 28.7 3.5 10.1 1.9 2.1 1.1 2.4 1.6 1.3 2.1 0.9 3.0 1.2 6.0 10.6 30.7 8.0 10.8 0.0 11.4 25.5 2.7 6.8 8.7 0.0 8.9 26.6 11.7 2.9 12.8 183.8 0.0 10.8 7.3 21.6 10.1 26.5 452.0 152.7 0.0 2.9 25.8 94.2 7.2 9.5 67.5 25.3 76.7 19.9 2.3 15.4 112.3 3.5 264.0 1.0 12.9 9.0 10.9 12.1 8.7 5.5 20.8 22.4 7.6 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868592-90883458 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "liver: 118.4;placenta: 158.9;salivary gland: 337.9" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 102.2;Hepatocytes: 114.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 41000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 8.3 3.3 3.0 7.5 3.6 16.6 5.9 5.0 4.4 4.1 6.6 2.8 3.5 5.7 4.9 10.8 4.7 4.4 3.9 6.9 3.1 1.8 6.4 118.4 9.5 3.1 2.8 2.7 4.2 22.5 3.8 7.2 158.9 3.5 9.3 2.2 3.0 337.9 4.7 8.7 9.0 5.9 3.1 3.0 8.2 6.0 5.3 2.9 4.8 8.9 5.5 4.1 4.4 4.3 1.5 3.3 10.3 3.3 3.1 1.9 2.0 14.4 8.8 2.0 8.9 14.5 9.4 22.7 18.2 13.9 7.5 5.3 12.9 15.8 0.5 46.8 13.2 13.5 26.0 4.0 9.4 1.6 41.6 10.3 25.3 15.8 16.8 7.7 3.5 41.7 10.6 10.6 8.5 3.9 18.3 24.0 4.2 19.3 2.5 5.0 9.9 1.3 11.4 6.3 12.2 2.6 2.2 7.7 3.3 11.7 11.0 4.0 2.7 15.4 8.4 12.8 9.9 3.0 9.2 35.4 8.5 18.2 13.0 26.6 4.5 25.6 1.2 16.2 11.4 17.2 7.5 3.3 10.3 1.9 1.1 1.4 1.5 1.2 1.2 2.1 1.0 0.6 0.8 7.4 3.1 0.7 3.3 0.9 2.0 3.0 3.6 5.0 4.4 3.1 1.8 2.8 2.7 3.5 2.9 3.0 30.9 6.7 7.5 17.2 11.9 15.0 10.2 1.4 5.7 21.0 23.6 16.5 0.0 44.3 0.4 25.5 23.8 23.3 102.2 11.4 12.3 26.5 15.1 114.9 22.3 7.9 36.4 23.4 26.1 0.2 10.3 24.1 15.1 7.2 27.3 11.7 83.4 21.8 10.3 5.6 25.2 25.8 12.5 2.3 3.4 20.1 70.5 11.7 16.1 13.9 FUT1 "H, HSC" ENSG00000174951 "Fucosyltransferase 1 (H blood group)" P19526 19 48748011-48755390 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.5" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 5.1;Endothelial cells: 5.1;Ito cells: 8.6;Melanocytes: 5.0;Pancreatic endocrine cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 8.2;HEL: 10.2;hTCEpi: 8.1;RT4: 9.8" "Not detected" "Not detected" NA NA "unprognostic (2.90e-2)" "unprognostic (3.09e-2)" "unprognostic (8.05e-3)" "unprognostic (4.65e-3)" "unprognostic (2.92e-3)" "unprognostic (8.73e-2)" "unprognostic (2.58e-2)" "unprognostic (3.34e-2)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "prognostic favorable (3.99e-4)" "unprognostic (1.33e-1)" "unprognostic (3.22e-2)" "unprognostic (8.67e-3)" "unprognostic (3.98e-2)" 2.5 0.8 0.9 0.9 0.9 1.5 1.6 3.5 1.4 0.9 0.9 0.9 0.9 1.0 0.9 0.9 1.5 1.2 0.9 1.4 0.9 0.2 1.1 0.9 6.8 0.9 0.9 0.9 0.9 19.5 1.0 1.7 2.8 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.8 0.9 0.9 0.9 3.4 7.6 0.9 0.9 0.9 1.0 0.9 0.9 0.9 0.9 0.9 0.9 3.3 0.7 1.5 0.6 0.3 3.3 0.1 0.1 0.2 0.0 0.0 1.7 0.2 0.1 0.2 0.2 8.2 4.8 0.3 0.4 0.2 0.8 5.5 1.6 5.1 0.1 0.0 0.8 10.2 0.4 0.1 2.4 0.4 4.5 0.0 8.1 0.4 3.7 0.1 3.6 1.8 0.5 1.5 0.0 3.8 0.2 6.2 1.0 6.5 0.5 0.3 0.0 1.6 0.3 9.8 7.7 0.5 0.4 7.1 0.1 0.4 4.6 0.2 3.5 0.3 2.5 0.2 0.3 1.4 3.6 1.0 0.1 0.3 0.3 3.3 0.7 0.5 0.5 0.3 0.3 0.8 0.6 0.4 0.3 0.9 0.6 0.5 2.1 1.5 0.3 0.9 0.2 0.3 0.9 0.9 3.5 1.4 0.9 0.2 0.9 0.9 0.9 0.9 3.0 1.7 0.0 0.6 2.3 0.3 0.8 5.1 0.0 1.2 0.0 2.0 0.3 1.7 1.1 0.0 5.1 0.0 0.0 1.9 0.2 1.0 0.9 1.1 0.0 0.3 0.0 1.2 8.6 1.0 0.0 0.9 1.5 5.0 0.0 0.4 0.0 4.9 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 1.5 0.3 0.0 0.0 0.4 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "CAPAN-2: 34.7;OE19: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 0.9 0.9 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 34.7 0.3 0.2 0.0 0.2 6.1 0.0 0.0 0.0 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.4 0.0 0.4 0.4 0.8 0.2 38.7 0.3 0.3 0.1 1.5 0.0 0.3 1.8 0.2 0.1 0.3 0.0 0.2 5.2 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 0.0 1.1 0.0 2.5 0.8 2.7 0.4 43.3 12.0 10.3 19.2 2.0 0.0 1.7 5.5 0.5 0.3 109.6 0.0 41.1 0.0 0.2 2.5 0.0 0.0 0.1 0.0 10.9 0.0 0.3 0.0 0.0 0.0 1.7 0.0 39.5 0.8 25.6 73.7 0.0 0.0 3.8 0.0 0.2 0.2 0.2 1.3 0.1 2.2 44.3 14.7 FUT3 "CD174, LE" ENSG00000171124 "Fucosyltransferase 3 (Lewis blood group)" P21217 19 5842888-5851474 "Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 106.6;Mucus-secreting cells: 61.1;Paneth cells: 66.6;Undifferentiated cells: 39.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 29.9;hTCEpi: 4.7;OE19: 13.4;RH-30: 10.1;SK-BR-3: 4.8" HPA046966 Supported NA NA "HPA046966: AB_2679879" "prognostic unfavorable (6.86e-4)" "unprognostic (2.59e-1)" "unprognostic (1.06e-1)" "unprognostic (9.12e-2)" "unprognostic (8.58e-3)" "unprognostic (1.63e-3)" "unprognostic (3.88e-2)" "unprognostic (2.03e-2)" "unprognostic (4.02e-2)" "unprognostic (3.98e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "prognostic favorable (8.22e-7)" "unprognostic (5.66e-3)" "unprognostic (9.56e-2)" "unprognostic (4.30e-2)" "unprognostic (1.07e-1)" 0.2 0.1 0.2 14.5 0.2 0.0 0.4 0.2 0.2 10.9 40.4 0.2 32.5 18.8 0.4 0.5 53.6 0.7 21.5 0.1 0.2 0.2 3.8 0.9 5.1 0.1 0.2 0.1 0.5 4.7 0.0 0.3 0.6 0.1 1.0 18.1 0.2 27.5 31.6 0.1 1.0 49.3 1.0 0.2 0.1 8.1 1.3 0.1 0.3 0.1 14.9 38.4 2.9 16.1 0.2 1.6 0.8 0.6 0.0 0.5 0.0 29.9 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.4 0.0 0.0 1.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 13.4 0.0 0.0 10.1 1.0 0.0 0.5 0.0 0.1 0.0 4.8 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.8 0.0 0.0 1.6 0.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 4.5 0.0 1.8 0.0 1.4 0.3 12.7 2.7 2.3 0.0 0.0 0.0 0.0 33.7 4.3 0.0 106.6 0.0 12.8 0.1 0.0 0.5 9.2 0.2 0.0 0.0 13.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 61.1 1.4 29.6 66.6 0.0 12.0 32.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 39.4 16.0 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 20.4;Mucus-secreting cells: 20.8;Pancreatic endocrine cells: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 20.8;NB-4: 13.5;THP-1: 26.3;U-937: 18.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Approved Vesicles NA NA Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.2 2.9 5.3 1.5 0.7 1.3 1.5 7.1 2.3 0.0 3.6 2.5 0.7 0.8 1.7 0.1 1.3 10.7 1.7 5.3 1.2 0.1 1.6 20.8 4.7 2.5 0.0 1.7 0.0 0.3 2.1 4.8 5.3 0.0 1.6 0.8 4.3 13.5 2.0 6.5 2.0 3.9 0.0 0.0 1.4 1.1 1.4 0.5 0.9 2.1 0.8 3.1 1.2 26.3 1.9 1.1 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.7 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 0.0 0.0 0.0 2.3 1.4 0.6 0.8 20.4 2.7 2.3 1.8 3.9 12.9 0.0 12.8 0.2 1.3 12.1 0.0 15.5 2.0 4.6 1.6 0.0 0.8 7.7 0.0 9.8 2.5 10.6 0.2 4.0 3.3 3.3 10.0 20.8 0.5 18.4 3.5 1.1 1.9 8.8 0.0 1.4 0.9 3.2 0.5 1.8 2.5 14.4 1.2 FUT5 FUC-TV ENSG00000130383 "Fucosyltransferase 5" Q11128 19 5865826-5870540 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.8;SH-SY5Y: 3.0;U-266/70: 1.7" HPA046966 Uncertain NA NA "HPA046966: AB_2679879" "unprognostic (7.72e-2)" "unprognostic (3.59e-1)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" 0.2 0.1 1.0 0.1 0.5 3.6 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.3 1.1 0.4 0.3 0.2 1.1 0.1 0.2 0.9 0.2 0.5 0.1 0.3 0.1 0.1 0.1 0.4 0.1 1.2 0.5 0.1 0.1 0.8 0.2 0.1 1.6 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830610-5839731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0" "Cell type enhanced" "Detected in some" 13 "Enterocytes: 54.8;Mucus-secreting cells: 33.5;Proximal tubular cells: 29.8;Undifferentiated cells: 19.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1" "Group enriched" "Detected in many" 7 "granulocytes: 3.7;NK-cells: 2.1" "Group enriched" "Detected in some" 5 "Hep G2: 14.9;RPMI-8226: 5.6" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA043707: AB_2678628, HPA046966: AB_2679879" "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favorable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.2 0.2 0.2 7.2 0.2 0.1 0.8 0.2 0.2 9.2 26.4 0.0 9.5 15.6 0.7 7.6 40.8 0.6 25.4 0.2 0.2 0.2 27.2 6.5 1.3 0.2 0.2 0.0 0.2 2.2 0.0 0.8 0.0 0.0 0.3 6.9 0.0 37.0 19.1 0.2 0.2 44.4 0.2 0.2 0.2 2.8 0.3 0.0 0.0 0.2 16.4 33.9 0.2 12.4 0.4 0.3 3.7 0.3 2.1 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 14.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 1.2 5.6 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.3 0.1 3.7 0.3 0.4 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.4 0.3 0.2 1.2 2.1 0.1 0.3 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.3 15.3 1.4 0.0 1.8 0.0 0.1 3.3 4.7 0.2 0.0 54.8 0.0 0.3 0.1 0.3 0.2 0.0 4.9 0.1 0.0 4.7 0.6 0.0 0.0 0.3 0.0 0.0 0.0 33.5 0.5 1.6 15.6 0.0 29.8 12.1 0.0 0.1 0.6 0.5 0.1 0.0 0.0 19.9 1.4 FUT7 ENSG00000180549 "Fucosyltransferase 7" Q11130 9 137030174-137033010 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 40.4;lymphoid tissue: 10.5" "Cell type enhanced" "Detected in some" 24 "Kupffer cells: 7.0;monocytes: 19.8;T-cells: 5.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 40.4" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 10 "NB-4: 14.4;THP-1: 18.5;U-937: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA042780 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA042780: AB_2678162" "unprognostic (1.33e-2)" "unprognostic (4.20e-4)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (5.42e-2)" "unprognostic (5.01e-6)" "unprognostic (2.50e-1)" "unprognostic (2.35e-2)" "unprognostic (6.75e-4)" "unprognostic (4.68e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (6.69e-6)" "unprognostic (3.99e-2)" "unprognostic (4.14e-2)" "unprognostic (1.03e-1)" "unprognostic (8.75e-2)" 0.4 0.1 0.2 2.5 0.2 5.9 0.2 3.2 0.3 0.2 0.2 0.2 0.2 0.0 1.4 0.2 0.4 0.5 4.4 0.2 0.3 0.3 0.2 0.2 1.5 6.2 1.7 0.2 0.2 0.2 0.0 0.4 0.2 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.6 0.2 0.4 10.5 0.3 0.2 0.2 0.2 0.3 0.2 4.6 0.5 0.2 4.2 40.4 18.3 1.5 22.1 16.3 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.4 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.3 1.5 0.3 2.1 0.3 10.5 4.2 10.3 5.7 4.4 1.2 0.2 0.8 18.3 22.1 0.0 40.4 16.3 3.4 0.2 0.2 3.2 0.3 0.3 0.3 1.7 0.2 0.9 0.2 0.0 0.0 3.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 7.0 0.0 0.0 2.9 0.0 19.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.7 0.2 0.0 FUT9 Fuc-TIX ENSG00000172461 "Fucosyltransferase 9" Q9Y231 6 96015984-96215612 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 37.7;stomach 1: 35.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 2.9;Exocrine glandular cells: 1.6" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "MCF7: 4.2;OE19: 4.1;RT4: 9.5;SCLC-21H: 9.7;SK-BR-3: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070923 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Microtubules, Cytokinetic bridge, Cytosol" "HPA070923: AB_2686323" "unprognostic (1.60e-1)" "unprognostic (2.48e-1)" "unprognostic (5.99e-3)" "unprognostic (1.33e-1)" "unprognostic (2.40e-1)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (6.43e-3)" "unprognostic (5.60e-2)" "unprognostic (1.65e-2)" "unprognostic (3.03e-2)" 1.1 1.7 18.5 1.1 22.5 1.1 1.9 37.7 28.6 1.1 1.1 10.7 0.0 4.1 1.4 1.2 1.1 1.4 1.1 1.1 20.0 6.2 1.2 1.1 1.1 1.1 10.2 24.0 1.1 8.0 1.1 0.9 1.7 13.8 1.5 1.2 0.0 1.1 1.5 1.2 1.1 1.1 1.1 10.2 1.1 35.4 1.1 16.5 0.0 1.2 0.0 1.1 2.2 0.4 0.3 0.2 1.5 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 2.1 4.1 0.0 0.0 0.0 0.0 0.0 9.5 9.7 0.2 0.0 5.5 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.8 0.2 0.0 0.2 0.0 0.0 18.5 22.5 37.7 28.6 20.0 6.2 10.2 24.0 13.8 16.5 0.0 0.0 0.0 0.6 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 FUZ "FLJ22688, Fy" ENSG00000010361 "Fuzzy planar cell polarity protein" Q9BT04 19 49806869-49817376 "Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 116.2" "Group enriched" "Detected in many" 24 "Early spermatids: 1102.3;Late spermatids: 1611.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041779, HPA042196" Approved Approved Cytosol No NA Cytosol "HPA041779: AB_10793974, HPA042196: AB_10797383" "unprognostic (2.40e-3)" "unprognostic (1.31e-1)" "unprognostic (7.73e-2)" "unprognostic (2.13e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-2)" "unprognostic (4.36e-3)" "unprognostic (9.67e-2)" "unprognostic (1.47e-1)" "unprognostic (1.97e-2)" "unprognostic (1.06e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.50e-5)" "unprognostic (1.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.70e-1)" 5.6 7.8 7.4 2.1 8.4 4.7 4.1 5.4 9.0 6.5 3.8 11.3 3.5 3.7 6.1 6.6 3.4 17.8 4.7 4.5 7.7 5.8 9.0 3.0 4.4 4.1 7.8 5.6 9.8 7.0 5.6 5.2 3.6 6.8 4.5 1.7 4.8 6.2 7.1 15.1 2.0 3.2 3.8 7.9 3.6 4.6 116.2 8.1 5.4 6.8 3.4 3.2 3.5 3.0 5.7 12.3 14.9 4.0 3.0 4.6 2.4 0.0 6.6 6.1 8.0 5.4 6.3 1.7 3.0 3.4 5.3 7.1 0.5 10.8 1.9 6.4 2.9 1.5 2.8 1.5 5.8 2.3 6.2 12.6 7.5 4.4 0.0 6.6 4.5 4.3 6.6 3.9 10.2 2.4 4.0 4.4 11.7 1.8 5.4 2.5 0.4 8.9 9.6 10.3 4.7 3.5 15.4 4.5 4.3 5.9 1.4 17.4 20.1 0.6 6.6 10.7 2.5 3.8 2.9 2.3 4.4 3.9 1.1 1.1 15.5 15.4 4.9 4.9 0.1 5.4 5.4 4.0 14.9 4.6 1.9 3.6 4.6 2.8 3.7 3.2 5.7 3.5 4.0 8.9 3.0 1.3 12.3 3.2 2.4 7.4 8.4 5.4 9.0 7.7 5.8 7.8 5.6 6.8 8.1 0.0 3.2 10.4 15.2 3.4 7.2 3.4 10.2 10.7 2.3 7.0 3.9 13.8 56.3 10.8 1102.3 4.4 2.0 0.0 4.5 9.6 10.8 10.5 10.3 5.1 11.5 9.5 2.4 9.2 6.0 1611.7 25.6 6.7 0.0 11.8 3.2 23.6 4.8 3.1 16.6 53.1 10.1 0.0 7.1 46.0 10.9 3.6 10.1 7.2 3.9 13.1 FXR1 ENSG00000114416 "FMR1 autosomal homolog 1" P51114 3 180868141-180982753 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 215.4" "Group enriched" "Detected in all" 4 "Early spermatids: 827.9;Late spermatids: 1326.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018246, HPA055475" Approved Enhanced Cytosol NA NA Cytosol "HPA018246: AB_1849204, HPA055475: AB_2682828" "unprognostic (1.38e-1)" "unprognostic (1.59e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (1.04e-2)" "unprognostic (1.90e-3)" "prognostic unfavorable (2.70e-4)" "unprognostic (7.77e-3)" "unprognostic (9.20e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (7.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.02e-1)" "unprognostic (2.84e-2)" 12.4 13.8 13.0 7.6 16.1 13.7 11.7 14.8 15.0 11.5 14.3 10.5 11.4 7.5 14.7 10.1 13.4 11.7 8.9 36.1 13.7 14.3 10.1 11.3 8.5 9.4 19.4 9.6 16.9 11.4 11.4 17.3 12.7 18.1 13.1 7.4 6.5 10.2 11.8 215.4 7.7 7.9 12.3 23.4 9.1 10.5 39.1 19.4 17.2 16.2 22.7 10.0 15.6 28.8 13.8 14.9 11.4 14.0 11.0 21.8 9.4 36.1 16.8 36.4 28.2 28.0 32.0 16.5 28.8 29.5 32.4 32.1 24.7 18.3 18.5 47.6 19.8 51.2 17.5 29.3 17.6 45.4 24.4 19.7 18.8 22.2 28.2 29.9 11.6 15.5 33.7 20.2 16.3 39.1 48.6 32.6 18.2 15.0 22.5 40.7 13.0 22.1 19.6 41.0 22.4 18.5 15.4 46.5 19.7 24.9 11.3 15.4 19.7 24.9 29.0 37.2 53.4 40.3 22.4 25.9 24.4 27.3 15.2 56.5 21.0 26.3 22.0 25.5 16.8 31.1 8.9 12.9 10.0 12.9 14.0 13.6 13.8 13.8 11.7 14.9 9.5 17.6 14.4 11.4 11.0 10.2 10.5 21.8 9.4 13.0 16.1 14.8 15.0 13.7 14.3 19.4 9.6 18.1 19.4 59.6 64.8 54.7 82.6 69.6 69.6 196.5 38.2 131.2 89.9 33.2 53.0 80.5 49.7 73.6 827.9 71.9 29.3 93.5 65.6 84.4 66.3 54.2 121.5 58.7 58.6 82.6 51.6 52.2 63.0 1326.2 77.9 61.8 47.2 139.7 33.0 89.6 70.5 35.1 71.5 67.7 82.8 32.3 61.4 245.3 103.5 61.7 51.1 57.5 38.5 60.3 FXR2 FMR1L2 ENSG00000129245 "FMR1 autosomal homolog 2" P51116 17 7591230-7614871 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 55.0" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011205, HPA022997" Supported Supported Cytosol NA NA Cytosol "CAB011205: AB_476964, HPA022997: AB_1849208" "unprognostic (9.57e-2)" "unprognostic (1.23e-1)" "unprognostic (5.15e-3)" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (7.56e-3)" "unprognostic (1.96e-1)" "unprognostic (3.50e-3)" "unprognostic (2.15e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.49e-6)" "unprognostic (2.79e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "unprognostic (2.64e-1)" "unprognostic (7.79e-2)" "unprognostic (7.67e-2)" 10.4 13.6 15.9 7.4 22.5 5.8 7.5 21.2 25.2 9.6 9.5 14.5 11.2 9.2 9.7 8.3 11.1 9.0 7.4 31.9 16.1 18.1 11.1 9.6 10.5 8.5 18.8 18.5 10.2 11.2 19.2 13.9 10.6 22.4 11.8 8.0 13.5 10.9 13.2 55.0 9.1 8.5 11.7 15.1 8.4 7.8 13.5 18.2 8.3 9.4 9.5 9.8 8.9 8.3 2.4 3.1 6.0 2.2 2.1 4.6 1.9 15.6 20.7 19.2 20.0 16.5 11.3 14.8 23.5 19.6 34.0 23.7 11.5 5.1 14.6 15.7 15.9 15.0 17.2 25.2 10.6 22.9 16.4 27.1 8.2 18.1 6.6 16.1 0.1 17.7 10.5 15.7 25.8 25.1 19.2 11.7 11.6 14.6 5.0 16.8 7.8 11.2 8.0 11.5 8.0 11.2 16.4 11.6 8.9 12.5 5.5 11.5 21.3 15.9 10.7 15.9 19.0 11.0 6.1 10.9 15.9 10.1 10.4 27.7 8.4 7.5 6.5 18.3 6.7 20.9 6.0 2.0 5.8 2.4 2.2 3.2 1.1 3.8 4.6 3.1 2.4 3.1 3.3 5.1 2.1 1.4 2.1 3.8 1.9 15.9 22.5 21.2 25.2 16.1 18.1 18.8 18.5 22.4 18.2 29.8 14.1 7.3 9.7 10.2 43.8 35.9 5.1 6.7 10.3 15.7 29.5 13.4 1.7 9.2 1.4 9.7 12.2 0.0 8.0 9.8 8.1 11.6 2.3 9.7 7.8 60.4 9.2 14.1 7.8 2.0 8.9 6.9 0.0 7.2 10.3 21.1 13.8 11.0 14.5 6.6 51.7 6.5 9.2 14.4 22.4 12.5 14.3 6.1 8.0 8.3 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Group enriched" "Detected in many" 4 "Fibroblasts: 170.5;Hepatocytes: 393.6;Leydig cells: 398.4;Muller glia cells: 148.5;Peritubular cells: 120.6;Sertoli cells: 116.4;Smooth muscle cells: 231.4" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Cell line enhanced" "Detected in some" "ASC diff: 31.0;ASC TERT1: 9.0;HSkMC: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol No NA "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 31.0 9.0 0.8 3.7 0.1 0.0 0.0 0.0 0.2 2.4 1.0 0.0 0.1 0.6 0.7 0.4 0.0 2.2 0.9 0.4 0.0 1.2 3.5 0.2 0.2 12.8 0.0 0.1 0.3 0.3 0.1 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 1.8 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.2 0.1 4.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.6 0.4 5.1 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 0.0 0.0 3.7 5.1 26.2 1.4 0.3 2.5 5.3 0.0 24.4 3.9 1.3 0.0 0.1 1.2 6.0 1.3 0.0 4.2 1.5 170.5 2.1 0.0 393.6 4.2 0.0 0.0 49.1 11.0 5.1 398.4 4.1 50.6 0.0 0.4 148.5 1.6 2.5 120.6 0.0 7.0 116.4 231.4 3.8 11.7 23.8 2.4 4.9 0.6 2.3 FXYD2 "ATP1G1, HOMG2, MGC12372" ENSG00000137731 "FXYD domain containing ion transport regulator 2" P54710 11 117800844-117828698 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Disease mutation, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 258.1;pancreas: 68.9;salivary gland: 91.7" "Group enriched" "Detected in many" 5 "Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2" "Cancer enriched" "Detected in some" 8 "renal cancer: 49.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 14.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 25 "MOLT-4: 141.0;RPTEC TERT1: 323.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA064218, HPA068838" Supported Approved Mitochondria NA NA 26000 Mitochondria "HPA064218: AB_2685214, HPA068838: AB_2686047" "unprognostic (4.11e-4)" "unprognostic (1.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-3)" "unprognostic (1.09e-3)" "unprognostic (2.30e-2)" "unprognostic (3.65e-2)" "unprognostic (4.62e-1)" "unprognostic (4.01e-2)" "unprognostic (4.91e-2)" "unprognostic (1.24e-2)" "unprognostic (2.64e-1)" "prognostic favorable (3.23e-9)" "unprognostic (3.22e-3)" "unprognostic (4.38e-2)" "unprognostic (4.62e-1)" "unprognostic (3.00e-2)" 0.3 0.2 0.2 0.2 0.1 0.0 0.7 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.3 2.8 0.3 0.3 54.7 0.2 0.1 0.2 258.1 2.2 0.2 0.6 0.1 0.0 0.4 68.9 0.0 0.3 0.6 0.1 0.3 0.0 0.1 91.7 0.1 0.1 0.2 0.3 0.1 0.1 0.4 0.2 0.2 0.0 9.5 0.2 0.3 0.4 0.2 0.6 0.4 3.2 0.0 1.1 8.4 14.1 2.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.2 0.0 0.0 0.0 0.0 141.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 323.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 1.1 0.2 1.8 14.1 0.2 0.4 5.1 4.1 0.0 8.4 0.0 3.2 1.6 2.0 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.1 0.8 1434.4 0.0 0.0 413.5 0.0 0.1 2501.8 465.3 14.4 1.3 0.0 0.0 8.3 0.1 1.1 0.1 0.0 2.4 2.9 0.0 14.6 5.5 4.3 15.4 8.6 2.6 0.0 14.4 0.0 0.5 33.3 0.0 7.1 3101.2 3.5 6.5 3.9 0.4 0.2 0.6 0.2 0.0 0.0 0.0 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 12.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.4 18.5 0.0 0.0 0.0 0.1 70.3 0.0 26.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.0 239.6 0.1 0.0 0.0 0.0 0.0 66.8 15.7 0.1 0.0 65.8 4.8 0.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 708.7 211.8 0.0 720.0 512.4 2.3 1.3 239.5 860.6 417.5 127.4 0.0 696.6 1.7 18.8 0.1 3.8 1850.8 0.0 640.2 148.4 41.3 1079.2 23.0 0.6 70.8 1.6 937.0 0.0 0.0 0.0 0.0 12.2 391.4 2.8 1977.6 233.2 377.2 3546.9 0.0 0.6 8.5 0.0 25.8 0.2 0.2 756.6 1264.5 0.7 1253.7 1183.0 FXYD4 CHIF ENSG00000150201 "FXYD domain containing ion transport regulator 4" P59646 10 43371642-43376335 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 27 "kidney: 119.5" "Cell type enriched" "Detected in some" 120 "Collecting duct cells: 4780.5" "Group enriched" "Detected in many" 5 "renal cancer: 10.7;urothelial cancer: 20.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "SuSa: 15.9" "Not detected" "Not detected" HPA058421 Enhanced NA NA "HPA058421: AB_2683714" "unprognostic (2.92e-3)" "unprognostic (5.25e-1)" "unprognostic (9.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.19e-1)" "unprognostic (6.12e-2)" "unprognostic (7.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-1)" "unprognostic (2.09e-2)" 0.1 0.0 0.4 0.0 2.2 0.0 0.0 0.1 1.0 0.0 0.1 2.0 0.1 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.6 0.3 119.5 0.0 1.3 0.0 1.6 0.4 0.0 0.0 0.0 0.1 0.0 1.0 0.6 0.0 0.0 4.4 1.5 0.6 0.0 0.0 0.0 0.5 0.0 2.4 0.2 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.2 0.1 1.0 0.6 0.3 1.6 0.4 1.0 1.4 6.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4780.5 0.0 0.4 39.7 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.1 0.9 FXYD6 ENSG00000137726 "FXYD domain containing ion transport regulator 6" Q9H0Q3 11 117836976-117877486 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Group enriched" "Detected in many" 4 "Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3" "Cancer enriched" "Detected in all" 6 "glioma: 71.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "classical monocyte: 21.9" "Lineage enriched" "Detected in many" 6 "monocytes: 21.9" "Cell line enhanced" "Detected in some" "AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041334, HPA042284" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041334: AB_10970752, HPA042284: AB_2677931" "unprognostic (2.18e-3)" "unprognostic (2.70e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.31e-2)" "unprognostic (1.15e-1)" "prognostic favorable (5.87e-4)" "unprognostic (4.51e-2)" "unprognostic (3.78e-2)" "unprognostic (1.07e-2)" "prognostic favorable (5.97e-4)" "unprognostic (3.44e-2)" "prognostic favorable (4.38e-5)" "unprognostic (4.64e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.60e-4)" 12.9 38.7 41.2 9.5 46.2 3.1 8.1 49.1 142.8 24.3 52.0 30.2 9.2 7.6 54.8 19.0 9.8 26.7 29.0 25.6 35.4 51.6 12.3 10.4 21.5 8.5 18.4 59.5 82.8 9.5 3.5 28.5 5.6 20.2 35.6 11.7 11.9 9.8 22.9 11.0 3.9 16.3 58.5 12.8 42.8 17.6 23.2 18.5 2.9 15.9 6.4 5.9 38.1 13.9 0.0 3.6 0.5 21.9 0.0 0.3 5.1 0.0 0.2 37.9 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.4 0.1 25.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.4 1.6 0.1 7.6 0.0 0.0 0.0 15.7 0.2 0.9 0.0 57.4 32.7 0.0 0.1 1.3 10.9 0.6 0.6 0.0 0.0 9.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 21.9 0.0 0.0 5.3 0.3 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 5.1 41.2 46.2 49.1 78.8 35.4 51.6 18.4 59.5 20.2 18.5 6.0 2.1 0.0 2.7 6.0 2.1 4.8 2.5 2.7 1.2 0.0 2.0 0.8 1.7 5.2 2.2 57.8 0.0 0.0 0.3 1.1 30.7 2.3 0.0 0.4 57.8 1.6 12.0 132.6 22.4 8.6 220.4 9.7 15.1 3.6 0.0 51.6 0.6 0.0 341.9 0.0 3.0 349.3 63.8 1.4 3.2 3.3 1.1 0.0 0.0 1.4 FXYD7 ENSG00000221946 "FXYD domain containing ion transport regulator 7" P58549 19 35143250-35154301 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "blood: 24.4;brain: 76.1" "Cell type enhanced" "Detected in some" 8 "Melanocytes: 3.3;Sertoli cells: 6.5;Spermatogonia: 5.5;T-cells: 5.0" "Cancer enhanced" "Detected in some" "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 24.4" "Group enriched" "Detected in many" 22 "B-cells: 8.1;NK-cells: 24.4;T-cells: 12.9" "Cell line enhanced" "Detected in some" "HAP1: 3.2;HMC-1: 9.8;Karpas-707: 3.4;NTERA-2: 2.8;WM-115: 5.7" "Low region specificity" "Detected in all" HPA026916 Approved NA NA "HPA026916: AB_1849217" "unprognostic (1.25e-3)" "unprognostic (8.73e-3)" "unprognostic (4.64e-2)" "unprognostic (6.95e-4)" "unprognostic (8.47e-2)" "unprognostic (1.73e-2)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (1.90e-1)" "unprognostic (3.08e-2)" "unprognostic (5.70e-2)" "unprognostic (1.16e-1)" "unprognostic (6.90e-5)" "unprognostic (1.51e-2)" "unprognostic (3.32e-2)" "unprognostic (1.09e-1)" "unprognostic (1.37e-1)" 1.5 1.7 46.9 2.8 31.6 1.8 1.6 3.0 76.1 1.7 1.5 4.7 0.0 1.9 1.9 1.2 1.7 1.8 1.7 1.5 41.9 20.1 1.3 1.4 1.6 3.7 19.8 26.2 1.8 1.5 1.2 0.1 1.4 10.1 1.4 1.5 0.0 1.8 1.6 2.9 1.9 1.7 1.5 8.7 3.2 1.7 1.7 1.6 0.0 1.4 0.0 2.8 1.8 0.4 8.1 0.6 0.3 0.0 24.4 12.9 2.4 1.2 0.4 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.3 0.0 0.6 1.0 0.3 0.0 0.0 0.4 3.2 0.0 0.4 0.5 0.2 0.4 0.8 0.0 0.2 0.0 9.8 0.9 0.0 0.0 0.0 0.2 0.1 0.3 0.8 3.4 0.0 0.0 0.1 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.2 0.2 0.0 0.7 0.5 0.0 0.0 0.5 0.4 1.3 0.2 0.0 0.1 0.0 0.0 0.8 0.2 5.7 0.0 0.0 0.0 8.1 0.0 5.0 8.1 12.9 9.2 0.0 7.3 4.2 7.2 0.3 24.4 0.0 0.6 3.6 2.4 46.9 31.6 3.0 76.1 41.9 20.1 19.8 26.2 10.1 1.6 0.0 2.2 3.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 1.0 0.0 1.1 0.0 0.1 1.6 0.0 0.6 0.0 0.0 1.1 0.3 3.3 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 6.5 0.8 1.0 5.5 1.0 0.2 5.0 0.0 0.0 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105255-39274528 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 153.7;lymphoid tissue: 63.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 65.7;Hofbauer cells: 145.5;Macrophages: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 16.3;JURKAT: 58.0;MOLT-4: 55.5;REH: 16.2;U-937: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025336, HPA026796, HPA067427" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6600000 "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126, HPA067427: " "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 7.0 3.5 6.3 36.0 18.3 22.1 3.9 1.8 10.1 3.5 4.4 8.3 0.3 4.1 2.7 6.5 4.9 4.2 7.9 3.5 6.8 6.6 5.7 6.2 13.8 35.5 15.5 2.7 2.6 2.5 1.3 3.5 8.7 11.7 3.8 5.3 3.0 5.4 1.5 1.9 2.4 11.7 5.6 29.4 41.5 5.2 3.5 12.2 63.5 4.1 1.8 28.0 10.1 3.6 0.1 11.9 153.7 41.3 8.6 28.7 30.8 0.0 1.1 0.0 0.0 0.1 0.0 6.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.2 4.5 0.0 0.1 0.0 0.0 0.0 16.3 0.0 0.0 0.0 6.1 5.2 0.0 0.1 0.0 0.1 0.0 0.0 58.0 0.0 0.0 0.0 0.0 55.5 3.5 0.0 0.0 0.0 16.2 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.1 1.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 21.5 0.0 11.9 33.8 32.3 7.9 38.6 5.5 0.1 22.5 13.8 11.9 0.1 28.7 17.3 153.7 8.6 41.3 3.0 21.7 30.8 6.3 18.3 1.8 10.1 6.8 6.6 15.5 2.7 11.7 12.2 14.9 34.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 10.3 14.0 0.0 25.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 65.7 0.0 0.0 14.0 0.0 145.5 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 FYB2 "ARAP, C1orf168, FLJ43208, RP4-758N20.2" ENSG00000187889 "FYN binding protein 2" Q5VWT5 1 56718804-56819696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.5;liver: 22.6;retina: 16.7" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 1: 20.8;Ciliated cells: 89.7;Collecting duct cells: 29.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "hippocampal formation: 1.6;pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "T-47d: 10.9" "Region enhanced" "Detected in single" "hippocampal formation: 2.3" "Low region specificity" "Detected in some" NA NA "unprognostic (6.12e-5)" "unprognostic (1.78e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (9.19e-3)" "unprognostic (4.77e-3)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (3.71e-1)" "unprognostic (2.86e-4)" "unprognostic (3.84e-2)" "unprognostic (2.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-3)" 0.2 0.2 0.2 0.0 0.2 0.0 0.7 0.7 0.7 4.1 0.9 2.0 7.5 0.3 3.7 7.7 0.6 15.5 0.0 3.7 1.6 0.2 10.0 22.6 3.2 0.0 0.2 0.8 4.3 1.2 0.0 12.4 0.2 5.7 2.1 0.5 16.7 3.0 2.1 2.8 0.2 3.0 0.1 0.2 0.2 0.5 2.1 0.0 2.5 0.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.4 10.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.3 1.6 0.2 0.2 0.8 5.7 0.0 20.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 89.7 12.5 29.6 0.0 0.4 3.3 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FYCO1 "FLJ13335, ZFYVE7" ENSG00000163820 "FYVE and coiled-coil domain containing 1" Q9BQS8 3 45917899-45995824 "Disease related genes, Predicted intracellular proteins" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 105.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 78.1;Rod photoreceptor cells: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035526, HPA057966" Uncertain Enhanced Vesicles NA NA Vesicles "HPA035526: AB_10672867, HPA057966: AB_2683567" "unprognostic (2.45e-1)" "unprognostic (6.62e-2)" "unprognostic (6.97e-3)" "unprognostic (1.14e-3)" "unprognostic (7.65e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-2)" "unprognostic (4.53e-3)" "unprognostic (5.85e-2)" "unprognostic (8.85e-2)" "unprognostic (2.36e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.33e-11)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (2.89e-2)" "unprognostic (6.99e-2)" 11.6 7.8 4.1 11.4 4.7 3.1 11.6 1.4 3.5 13.5 20.2 7.3 11.4 4.2 19.8 11.1 12.6 7.9 22.0 29.1 4.2 2.7 5.7 6.2 7.9 5.0 4.7 3.5 14.8 15.9 11.4 4.9 4.3 6.1 14.5 5.6 16.2 9.5 11.6 105.8 9.9 7.7 39.9 6.4 6.4 11.6 5.0 5.3 8.5 10.4 25.5 9.5 23.3 27.0 0.6 2.8 1.1 1.1 3.0 6.0 1.3 6.4 6.3 1.8 8.1 17.9 14.1 3.1 6.2 14.7 8.4 9.3 3.4 5.7 4.8 3.6 8.8 8.0 4.9 5.3 10.5 9.9 2.0 5.6 6.8 5.2 3.8 12.2 5.2 5.0 15.6 10.5 13.2 13.1 12.8 16.5 8.3 4.4 7.0 5.9 4.0 5.3 3.2 2.8 5.3 6.0 1.8 5.2 2.6 10.0 22.8 1.4 2.1 3.9 12.4 10.9 2.9 6.0 3.5 12.7 3.1 3.7 10.7 3.4 4.0 2.5 1.6 10.9 6.7 5.9 1.1 1.0 0.6 4.4 1.1 6.0 0.6 2.6 4.6 0.4 0.6 1.1 1.8 0.9 3.0 0.7 2.8 2.6 1.3 4.1 4.7 1.4 3.5 4.2 2.7 4.7 3.5 6.1 5.3 26.8 10.7 3.0 4.1 3.7 10.8 78.1 7.6 14.7 11.4 15.7 33.4 3.6 3.3 6.9 0.0 7.5 6.3 0.0 7.1 2.0 6.1 11.8 2.3 9.5 3.6 0.0 9.2 12.3 5.9 0.4 11.8 3.2 10.1 0.0 7.9 16.2 9.8 0.0 16.6 4.4 38.5 6.5 9.8 2.6 0.7 3.6 2.4 6.9 5.7 5.2 FYTTD1 "DKFZp761B1514, UIF" ENSG00000122068 "Forty-two-three domain containing 1" Q96QD9 3 197737179-197787596 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054474, HPA074880" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA054474: , HPA074880: " "unprognostic (3.61e-2)" "unprognostic (6.01e-2)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.33e-2)" "unprognostic (3.80e-1)" "unprognostic (3.69e-2)" "unprognostic (9.57e-3)" "unprognostic (4.44e-2)" "unprognostic (1.66e-1)" "unprognostic (5.04e-3)" "unprognostic (8.74e-2)" "unprognostic (8.49e-3)" "unprognostic (3.40e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-1)" "unprognostic (3.15e-1)" 12.0 10.2 12.8 13.6 13.1 14.5 24.5 20.5 13.9 11.3 11.9 6.9 13.3 6.6 13.2 10.2 19.0 13.2 10.3 19.4 11.0 12.5 11.1 12.0 11.8 13.5 11.1 10.9 13.3 17.0 13.8 13.2 13.9 13.4 11.0 9.2 6.0 10.0 13.9 82.6 11.6 10.1 21.8 17.1 11.4 10.3 16.7 10.7 10.5 12.6 15.8 15.3 15.7 21.8 11.2 15.9 23.7 16.6 32.5 22.7 21.5 30.1 6.7 13.2 12.6 15.6 17.3 4.1 14.8 15.2 23.0 18.9 10.4 10.4 19.4 54.5 17.5 12.2 10.9 16.6 15.2 24.5 4.2 7.6 29.1 10.2 4.7 15.2 21.6 14.2 12.4 19.7 12.4 17.9 15.9 18.1 11.0 13.1 41.9 20.3 25.3 23.4 5.1 2.9 13.2 12.3 21.8 16.2 13.6 16.7 19.9 25.2 10.9 22.8 18.1 16.8 10.1 42.5 11.5 15.9 11.8 11.8 14.9 15.6 25.4 38.6 23.3 12.5 31.3 12.1 23.7 14.2 13.6 18.3 16.6 22.7 11.2 17.6 20.1 15.9 9.9 19.4 18.7 4.6 32.5 15.2 8.9 15.5 21.5 12.8 13.1 20.5 13.9 11.0 12.5 11.1 10.9 13.4 10.7 32.8 25.6 37.5 37.5 73.2 33.7 111.7 22.9 56.2 30.7 45.4 29.5 21.1 76.3 32.4 14.6 54.0 13.7 0.0 31.3 24.4 46.8 54.4 65.7 45.5 33.4 42.9 54.2 37.4 46.8 12.1 29.7 54.4 49.0 141.5 21.6 36.9 28.5 18.4 35.0 39.2 39.7 38.8 66.5 84.2 83.9 79.5 41.9 50.3 18.0 59.3 FZD1 DKFZp564G072 ENSG00000157240 "Frizzled class receptor 1" Q9UP38 7 91264364-91271326 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 61.1;Horizontal cells: 133.5;Peritubular cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 5.4" "Lineage enriched" "Detected in many" 4 "monocytes: 5.4" "Cell line enhanced" "Detected in many" "AF22: 16.6;HSkMC: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013008 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB013008: " "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (4.51e-3)" "unprognostic (2.09e-1)" "unprognostic (5.29e-3)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (5.48e-3)" "unprognostic (2.14e-1)" "unprognostic (7.39e-3)" "prognostic favorable (8.87e-7)" "unprognostic (1.05e-2)" "unprognostic (4.16e-2)" "unprognostic (5.53e-2)" "unprognostic (4.13e-2)" 5.8 4.6 2.6 4.9 3.5 0.9 10.7 8.2 2.8 17.6 8.5 4.1 9.3 4.9 10.1 9.9 7.8 6.1 11.0 12.3 6.1 1.8 15.3 3.9 10.5 1.4 2.0 3.2 15.0 7.9 2.5 4.6 10.0 5.7 12.3 3.7 11.1 9.2 17.5 3.1 10.7 8.3 7.2 4.6 3.4 4.5 4.4 3.5 1.4 61.2 6.5 2.9 10.4 13.9 0.1 1.3 0.2 5.4 0.0 0.0 0.4 0.5 1.6 16.6 1.7 13.5 11.7 3.0 6.0 3.8 2.2 1.6 0.7 2.8 0.0 1.5 3.8 2.8 3.0 2.5 1.3 1.5 0.0 3.2 0.1 3.2 0.8 1.0 2.7 0.7 22.1 2.4 5.1 1.6 8.5 0.5 1.8 0.9 2.4 6.4 3.9 0.5 0.7 4.2 0.8 2.8 3.3 10.2 0.3 3.5 7.7 2.3 4.3 4.5 3.7 0.9 4.0 1.9 2.4 2.5 9.4 7.1 10.0 2.4 2.2 1.5 0.2 10.1 2.3 10.9 0.0 1.4 0.0 0.0 4.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 5.4 0.1 0.0 0.4 2.6 3.5 8.2 2.8 6.1 1.8 2.0 3.2 5.7 3.5 3.0 1.0 1.3 30.9 3.8 0.8 12.1 61.1 0.0 4.5 12.2 2.0 3.0 0.0 4.5 0.2 3.6 4.6 0.0 1.8 1.6 12.0 11.7 12.7 0.5 3.6 133.5 3.4 10.4 14.3 0.4 30.8 11.2 16.9 0.0 3.2 3.7 2.1 3.4 42.5 10.8 3.1 0.0 9.4 0.4 2.0 4.4 1.7 0.5 3.5 5.9 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.9;lymphoid tissue: 18.6" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.9;Basal keratinocytes: 7.4;Smooth muscle cells: 14.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.6;BEWO: 9.9;hTCEpi: 5.7;RPTEC TERT1: 3.0;RT4: 4.8" "Region enhanced" "Detected in some" "thalamus: 7.6" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favorable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 1.1 0.4 1.0 0.5 1.9 0.2 1.5 5.4 2.1 11.6 0.6 2.1 1.6 0.4 5.1 3.4 26.9 2.2 7.1 0.5 1.0 1.0 0.4 0.2 2.0 0.9 1.6 1.2 3.4 1.1 0.2 1.4 9.2 1.9 3.7 0.6 3.0 5.4 3.1 1.2 10.2 0.7 0.9 1.2 0.3 1.0 0.7 2.0 0.6 1.7 9.0 18.6 5.1 7.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 3.0 4.8 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.9 5.4 2.1 1.0 1.0 1.6 1.2 1.9 2.0 0.0 0.3 0.0 3.9 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.3 2.5 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.4 0.0 0.4 7.4 0.7 0.0 0.0 1.1 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955391 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 75.7" "Cell type enhanced" "Detected in many" 18 "Collecting duct cells: 34.9;Endothelial cells: 26.3;Ito cells: 108.6;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;Hep G2: 32.6;HSkMC: 18.8;HUVEC TERT2: 36.8;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: AB_2686716" "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 75.7 5.3 3.4 6.0 4.8 0.5 57.8 1.5 4.3 11.5 9.0 1.4 32.6 2.0 13.1 13.5 6.3 9.6 8.7 12.5 3.1 2.2 17.0 8.9 19.0 4.7 2.9 3.2 12.8 6.0 4.4 10.1 7.3 5.5 9.3 4.3 20.0 7.1 56.0 17.9 3.7 5.4 8.6 2.8 8.6 8.2 5.5 1.6 0.5 11.4 11.1 3.0 8.3 20.7 0.4 0.2 0.8 0.4 1.4 0.3 0.0 0.5 0.4 1.1 2.0 25.9 6.8 1.5 3.2 2.9 1.2 1.3 2.7 0.3 0.0 0.7 1.0 1.7 1.1 1.2 0.5 1.0 0.1 0.8 1.0 0.8 32.6 7.7 0.0 0.0 18.8 0.2 1.1 0.2 3.0 36.8 0.0 1.4 0.1 0.8 0.8 0.0 0.0 1.5 2.8 7.4 0.0 1.9 0.0 3.6 5.3 0.2 0.3 1.3 0.4 0.5 2.3 4.7 0.0 18.0 3.1 2.1 3.6 0.6 0.1 0.5 0.0 0.4 0.0 0.8 0.7 0.3 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.8 1.4 0.4 0.2 0.0 0.0 3.4 4.8 1.5 4.3 3.1 2.2 2.9 3.2 5.5 1.6 0.0 2.2 1.9 0.4 1.3 0.7 7.8 7.6 1.4 1.2 34.9 9.8 0.1 3.3 0.6 0.4 26.3 0.8 0.0 1.4 0.1 4.3 0.8 0.0 10.4 0.2 0.0 0.0 108.6 11.2 1.7 8.6 0.9 0.0 0.0 1.1 0.3 1.0 0.0 6.3 6.9 0.1 32.3 5.1 0.2 3.0 0.5 0.2 0.0 0.6 0.1 FZD5 "C2orf31, DKFZP434E2135, HFZ5" ENSG00000163251 "Frizzled class receptor 5" Q13467 2 207762586-207769563 "G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.2;liver: 36.5" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 70.9;Hepatocytes: 53.8;Muller glia cells: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 48.3;CACO-2: 11.8;Hep G2: 16.2;NTERA-2: 14.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA052361 Approved NA NA "HPA052361: AB_2681799" "unprognostic (4.97e-2)" "unprognostic (6.94e-2)" "unprognostic (2.20e-1)" "unprognostic (2.56e-1)" "unprognostic (1.53e-1)" "unprognostic (2.82e-1)" "unprognostic (4.80e-3)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.48e-3)" "unprognostic (1.29e-1)" "unprognostic (8.00e-2)" "unprognostic (7.72e-2)" "unprognostic (2.51e-1)" "unprognostic (9.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.15e-3)" 5.3 5.9 1.7 5.8 3.9 3.3 6.5 0.6 2.0 4.3 25.4 7.2 8.5 17.5 2.8 1.0 3.9 1.6 5.3 1.9 1.7 2.2 12.1 36.5 12.4 0.9 3.9 1.4 4.5 20.8 1.2 6.1 6.5 2.6 6.4 14.4 6.6 3.7 3.9 2.5 1.4 35.2 2.5 1.9 2.8 10.8 0.8 4.2 1.3 18.5 1.8 2.9 2.6 3.4 0.3 1.4 0.5 1.1 0.2 0.4 0.4 1.4 2.6 0.1 1.4 1.2 0.0 48.3 0.2 0.3 0.4 0.3 11.8 2.7 0.2 3.2 0.1 0.9 2.2 4.1 1.7 0.3 0.1 3.1 3.3 1.2 16.2 0.9 0.6 0.9 0.1 1.7 0.5 1.4 0.9 0.4 0.5 6.7 0.5 0.3 1.0 0.3 0.8 14.1 6.3 0.9 0.8 1.5 0.6 3.4 5.1 2.3 0.3 0.6 0.2 0.6 6.9 0.7 0.6 0.1 0.7 1.4 1.4 1.1 0.8 1.7 0.6 1.0 0.7 0.2 0.3 1.1 0.2 0.1 0.8 0.4 0.1 0.0 0.0 1.4 0.3 0.1 0.2 0.5 0.2 0.4 0.1 0.1 0.4 1.7 3.9 0.6 2.0 1.7 2.2 3.9 1.4 2.6 4.2 29.8 24.6 0.9 5.2 4.5 1.9 5.7 25.5 4.0 4.5 1.8 31.4 13.9 0.0 13.5 0.4 3.4 70.9 0.0 21.0 5.2 3.1 10.1 0.0 53.8 8.8 6.4 12.1 2.5 6.5 0.0 1.7 2.2 1.7 1.0 47.7 56.2 16.8 34.5 0.4 13.4 6.9 0.0 3.6 1.4 0.9 3.6 3.3 0.0 45.3 5.0 FZD9 "CD349, FZD3" ENSG00000188763 "Frizzled class receptor 9" O00144 7 73433783-73436120 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.4" "Group enriched" "Detected in some" 5 "Early spermatids: 7.3;Late spermatids: 10.0;Muller glia cells: 4.8;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "melanoma: 6.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 8.4;MCF7: 3.6;NTERA-2: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (9.60e-2)" "unprognostic (4.03e-2)" "unprognostic (3.16e-2)" "unprognostic (9.15e-3)" "unprognostic (1.10e-1)" "unprognostic (6.91e-2)" "unprognostic (2.29e-2)" "unprognostic (2.26e-1)" "unprognostic (2.04e-1)" "unprognostic (7.17e-3)" "unprognostic (1.20e-1)" "unprognostic (7.24e-2)" "unprognostic (5.90e-5)" "unprognostic (8.99e-2)" "unprognostic (4.57e-2)" "unprognostic (1.22e-1)" "unprognostic (5.21e-2)" 4.4 1.2 6.8 0.7 4.7 2.4 1.1 3.3 7.0 1.1 1.3 4.5 0.0 1.9 0.9 0.9 1.3 0.9 0.7 0.8 7.1 6.3 0.9 0.8 0.9 0.9 7.0 4.5 0.9 3.8 1.6 4.3 1.9 5.0 3.0 0.8 1.4 4.4 1.4 14.4 1.7 2.9 0.9 3.6 1.0 1.0 5.4 6.7 0.3 0.9 1.7 0.8 0.7 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.6 2.7 2.8 3.1 0.0 0.1 0.0 1.9 0.0 0.4 0.1 0.7 0.0 0.0 0.9 0.1 1.2 0.2 1.4 0.0 0.0 0.0 8.4 0.0 0.6 0.9 1.2 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.0 2.8 0.0 0.2 3.6 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.7 2.4 1.7 1.8 0.4 1.7 0.9 0.1 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 6.8 4.7 3.3 7.0 7.1 6.3 7.0 4.5 5.0 6.7 0.0 0.0 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.3 0.6 0.0 0.0 0.3 0.2 0.3 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 1.0 0.0 4.8 0.2 0.0 0.4 0.0 0.7 6.5 0.5 0.4 0.3 1.0 0.0 0.0 0.0 0.3 G0S2 ENSG00000123689 "G0/G1 switch 2" P27469 1 209675420-209676388 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 203.9;liver: 154.7" "Cell type enhanced" "Detected in many" 6 "Pancreatic endocrine cells: 558.7;Urothelial cells: 443.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 62 "neutrophil: 89.5" "Lineage enriched" "Detected in single" 197 "granulocytes: 89.5" "Group enriched" "Detected in some" 6 "ASC diff: 77.1;HBEC3-KT: 116.4;PC-3: 29.2;RPMI-8226: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-3)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (3.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.04e-3)" "unprognostic (3.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.32e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (7.57e-3)" "unprognostic (1.53e-2)" "unprognostic (4.78e-2)" "unprognostic (2.64e-1)" 130.1 23.3 1.1 18.5 1.1 203.9 85.2 2.0 0.9 2.0 11.3 1.4 29.9 1.6 6.1 9.3 2.0 4.0 13.5 43.7 1.1 0.8 22.2 154.7 51.6 6.4 1.8 0.0 18.4 5.3 0.5 1.2 2.6 1.3 8.7 1.1 3.1 49.2 73.5 97.9 3.0 3.5 3.8 1.5 6.3 7.1 5.3 1.1 0.0 3.1 14.3 6.1 12.6 13.1 0.0 0.0 89.5 0.1 0.0 0.4 0.0 0.0 0.6 0.0 0.0 77.1 2.7 0.0 0.1 0.2 0.3 0.3 3.0 2.4 0.0 0.6 0.5 0.4 0.0 0.0 116.4 0.7 0.1 0.2 0.0 0.2 0.1 6.3 0.0 0.0 8.0 0.2 5.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 29.2 0.0 0.0 37.1 0.2 0.0 0.1 0.2 2.6 0.0 0.6 0.0 0.0 8.9 11.7 0.0 0.8 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 1.1 1.1 2.0 0.9 1.1 0.8 1.8 0.0 1.3 1.1 8.9 93.3 5.6 295.9 206.4 0.2 325.1 12.7 41.5 55.7 10.4 0.0 1.1 253.7 40.5 12.3 26.3 16.9 0.0 123.5 3.9 183.7 312.4 36.0 83.1 183.0 0.0 28.2 14.1 41.0 7.4 106.2 375.5 310.4 50.5 30.7 19.9 558.7 40.3 67.1 223.2 0.0 32.3 88.6 21.4 1.1 141.0 3.5 4.8 37.5 443.6 G2E3 "FLJ20333, KIAA1333, PHF7B" ENSG00000092140 "G2/M-phase specific E3 ubiquitin protein ligase" Q7L622 14 30559123-30620063 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.6" "Group enriched" "Detected in all" 7 "Early spermatids: 712.5;Late spermatids: 198.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001601 Uncertain Approved "Golgi apparatus,Vesicles,Cytosol" NA NA Cytosol "Golgi apparatus, Vesicles" "HPA001601: AB_1079198" "unprognostic (4.75e-2)" "unprognostic (6.31e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (9.10e-2)" "unprognostic (3.99e-2)" "unprognostic (5.44e-6)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (1.86e-1)" "unprognostic (3.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" 7.6 5.1 5.6 7.6 14.2 8.5 6.6 10.8 10.4 8.1 5.8 5.8 4.2 5.9 8.5 4.8 7.0 5.4 4.5 4.9 6.7 5.2 5.4 5.5 5.4 8.6 7.3 4.9 7.1 5.7 6.0 10.9 6.9 7.6 6.0 6.1 5.3 5.9 7.1 5.2 6.1 5.8 6.7 7.1 7.9 5.4 39.6 8.8 20.9 7.3 4.8 9.5 6.0 8.3 11.5 8.1 16.5 12.5 7.9 12.4 5.0 21.2 9.7 21.8 10.0 7.1 8.7 18.4 20.0 7.2 12.1 13.7 9.4 12.9 17.9 6.4 10.9 9.9 17.9 20.8 11.4 24.7 14.7 8.5 9.8 10.6 17.2 6.3 18.9 12.5 5.4 4.6 9.7 22.1 11.4 14.3 13.4 12.1 14.9 17.0 12.4 12.6 4.7 18.2 16.8 17.1 11.7 0.0 4.9 7.1 13.2 18.5 12.5 16.1 10.9 4.6 13.1 12.5 6.4 10.7 13.0 13.8 9.5 13.0 8.6 25.1 21.4 3.9 9.5 19.2 16.5 7.5 14.1 9.6 9.7 12.4 10.8 9.4 7.7 6.4 11.5 12.0 10.1 6.8 7.9 12.5 8.1 7.3 5.0 5.6 14.2 10.8 10.4 6.7 5.2 7.3 4.9 7.6 8.8 17.9 7.0 27.4 17.9 19.5 31.8 8.7 10.2 9.4 14.8 5.2 23.6 12.4 8.3 8.6 712.5 15.2 6.3 46.7 6.1 19.3 15.0 16.9 16.2 6.4 12.2 33.4 13.3 17.8 14.5 198.8 15.3 11.7 8.5 7.2 12.7 14.1 9.7 10.2 13.4 11.1 31.9 51.8 15.6 69.3 43.2 22.2 8.4 15.0 10.4 19.7 G6PC "G6PT, GSD1a" ENSG00000131482 "Glucose-6-phosphatase catalytic subunit" P35575 17 42900797-42913369 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 305.4" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 125.4" "Cancer enriched" "Detected in some" 72 "liver cancer: 151.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052324 Enhanced NA NA "HPA052324: AB_2681790" "unprognostic (4.23e-2)" "unprognostic (1.49e-2)" "prognostic favorable (5.42e-5)" "unprognostic (8.37e-2)" "prognostic favorable (3.79e-5)" "unprognostic (4.79e-2)" "unprognostic (6.46e-2)" "unprognostic (2.56e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.0 0.0 5.8 0.1 0.0 0.1 0.1 1.9 0.1 0.1 0.1 23.7 305.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 33.7 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.5 1.1 0.2 0.5 0.4 0.0 0.4 0.2 0.2 0.5 0.6 0.0 0.7 0.2 0.2 0.0 0.1 0.2 0.3 0.7 0.2 0.3 0.2 0.4 0.0 0.0 0.2 0.3 0.1 0.1 0.5 0.8 0.0 1.3 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.5 0.7 0.0 0.1 0.5 1.2 0.3 0.0 0.3 0.6 2.2 0.2 0.1 0.7 0.4 0.6 0.7 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.7 0.2 1.0 0.3 1.4 0.2 1.1 0.2 0.1 0.3 0.1 0.2 1.0 0.2 0.2 0.0 2.2 0.4 0.4 1.1 0.5 0.1 0.5 0.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 22.9 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 125.4 0.1 0.0 0.0 3.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 G6PC2 IGRP ENSG00000152254 "Glucose-6-phosphatase catalytic subunit 2" Q9NQR9 2 168901240-168910000 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Gluconeogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "pancreas: 28.8;retina: 12.1" "Cell type enriched" "Detected in some" 13 "Muller glia cells: 70.6" "Cancer enriched" "Detected in single" 92 "pancreatic cancer: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;SCLC-21H: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (6.42e-2)" "unprognostic (2.39e-2)" "unprognostic (6.04e-2)" "unprognostic (9.05e-2)" "unprognostic (2.97e-1)" "unprognostic (3.10e-2)" "unprognostic (1.54e-2)" "unprognostic (1.87e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 70.6 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 G6PD G6PD1 ENSG00000160211 "Glucose-6-phosphate dehydrogenase" P11413 X 154531391-154547572 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.1" "Cell type enhanced" "Detected in many" 6 "monocytes: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 77.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 77.3" "Cell line enhanced" "Detected in all" "A549: 229.1;MCF7: 86.9" "Low region specificity" "Detected in all" "HPA000247, HPA000834" Enhanced Enhanced "Centriolar satellite,Cytosol" No No 12000000 Cytosol "Centriolar satellite" "HPA000247: AB_1078978, HPA000834: AB_1078977" "unprognostic (1.73e-2)" "unprognostic (1.53e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (7.78e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (9.45e-13)" "unprognostic (2.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.66e-1)" "unprognostic (2.89e-3)" "unprognostic (2.83e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (7.25e-2)" 21.9 29.4 10.4 15.6 10.7 51.4 18.2 8.4 14.7 12.2 7.5 13.6 4.8 7.2 14.0 13.2 29.0 11.0 24.7 10.1 8.8 10.1 15.4 3.7 20.8 31.0 10.3 8.0 19.8 7.9 5.9 20.7 9.2 10.9 11.3 7.3 17.8 13.9 8.6 4.4 11.3 7.3 17.5 11.1 20.3 9.9 83.1 9.5 22.5 24.6 44.8 25.7 24.1 19.0 3.6 7.6 77.3 16.2 12.7 10.3 11.8 15.7 229.1 4.7 18.1 19.9 27.1 4.2 11.0 31.5 11.2 19.4 10.5 5.9 10.1 17.1 25.0 45.4 14.0 7.3 18.6 5.8 10.3 5.1 10.7 51.9 23.6 38.8 10.8 36.9 13.1 5.5 21.9 4.7 17.6 23.3 7.5 6.4 4.4 20.3 86.9 6.9 7.7 3.4 50.2 17.0 6.8 2.7 11.1 33.8 19.6 4.8 6.0 10.9 42.8 9.2 6.4 6.4 9.0 27.6 7.1 25.0 9.9 16.9 5.4 7.0 17.4 19.7 7.2 14.5 29.3 16.2 77.3 10.3 13.6 6.6 3.4 2.7 7.4 7.6 3.6 3.5 5.9 27.1 12.7 11.1 3.5 3.5 11.8 10.4 10.7 8.4 14.7 8.8 10.1 10.3 8.0 10.9 9.5 0.0 17.1 21.3 18.5 11.1 5.7 0.8 20.4 4.0 0.0 10.4 17.7 26.0 24.9 35.4 8.1 12.8 18.6 23.3 25.6 33.4 18.8 16.7 38.0 0.8 41.6 31.8 9.1 16.0 63.9 10.4 24.2 25.3 18.6 130.8 9.6 11.9 34.1 9.1 15.2 11.9 24.6 6.5 12.3 10.1 34.9 12.0 30.3 39.5 9.9 26.5 GAB1 ENSG00000109458 "GRB2 associated binding protein 1" Q13480 4 143336762-143474568 "Predicted intracellular proteins, RAS pathway related proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 64.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 38.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034333, HPA066404" Approved Approved "Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli fibrillar center" "CAB034333: AB_2107855, HPA066404: " "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "unprognostic (1.66e-1)" "unprognostic (4.71e-2)" "unprognostic (1.79e-2)" "unprognostic (4.17e-2)" "unprognostic (1.23e-1)" "unprognostic (1.35e-2)" "unprognostic (8.20e-2)" "unprognostic (2.10e-1)" "unprognostic (2.20e-1)" "prognostic favorable (3.91e-5)" "unprognostic (4.99e-2)" "unprognostic (2.70e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" 9.2 8.4 15.0 7.3 33.3 8.8 9.7 5.8 22.0 10.1 17.0 64.0 10.2 10.4 17.7 13.1 18.2 8.6 11.1 26.2 19.5 11.4 12.9 7.9 15.6 5.0 35.7 19.0 18.1 7.0 17.2 6.3 18.0 30.5 7.8 20.3 15.4 11.7 13.9 11.2 11.1 10.4 15.9 32.3 6.2 11.0 7.9 41.7 1.0 7.8 6.0 7.3 9.9 11.9 3.1 3.4 5.9 2.3 7.4 0.4 0.4 3.4 0.7 8.9 6.4 4.5 4.3 11.6 2.4 8.0 2.9 5.1 6.6 5.9 0.1 0.7 3.3 2.0 1.9 8.5 2.8 3.3 0.5 2.0 6.2 1.9 3.1 3.1 0.8 1.2 5.3 5.0 3.5 2.3 6.2 3.8 0.1 2.0 11.5 2.0 4.9 0.5 0.0 2.5 1.8 2.8 38.0 4.3 4.4 4.5 4.2 2.1 6.3 1.6 7.0 3.0 6.2 4.5 0.8 2.8 3.7 2.9 1.7 1.8 18.5 9.0 13.7 2.5 2.5 3.0 5.9 0.6 0.7 0.0 0.8 0.4 1.3 0.1 0.0 0.8 3.1 0.0 0.0 4.0 7.4 2.3 3.4 0.0 0.4 15.0 33.3 5.8 22.0 19.5 11.4 35.7 19.0 30.5 41.7 26.8 14.7 6.7 7.6 18.0 1.9 27.8 7.6 2.7 5.7 12.2 0.0 18.0 0.0 5.0 0.9 16.5 11.2 0.0 2.2 8.5 11.5 6.2 2.3 5.8 5.3 3.2 21.4 11.6 9.7 2.1 19.2 5.7 15.1 2.8 25.0 14.1 4.1 8.6 17.7 5.0 0.7 12.9 16.5 1.8 5.2 21.8 8.7 1.3 13.5 11.1 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215297-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.1" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.4;neutrophil: 16.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "BEWO: 19.8;SH-SY5Y: 31.7" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favorable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 15.5 8.4 31.1 12.0 26.9 32.9 11.6 5.7 21.5 10.2 8.9 49.1 1.6 13.7 16.8 4.6 8.2 13.5 9.1 13.6 30.4 21.3 5.2 4.5 16.1 6.8 31.5 14.8 20.0 5.9 10.4 7.0 14.6 24.7 6.5 10.9 6.6 5.4 7.3 5.2 8.8 10.1 17.1 35.4 11.8 7.4 5.5 26.0 9.4 6.5 3.0 5.6 9.3 12.3 0.5 1.7 16.3 3.4 0.0 0.1 0.7 1.8 1.5 4.5 0.5 6.6 2.8 19.8 2.8 3.4 2.0 1.7 11.7 0.9 0.5 12.6 3.9 0.5 2.9 10.5 0.2 2.6 17.5 1.1 7.0 2.7 2.0 3.3 2.6 1.4 3.1 1.0 7.9 1.2 6.0 11.7 2.1 18.5 0.6 3.4 0.7 1.3 6.6 1.4 4.1 2.1 13.3 4.3 0.2 3.7 6.6 3.8 31.7 0.7 1.4 7.2 6.8 6.6 7.6 9.6 0.9 2.3 7.7 0.6 4.9 0.7 0.3 0.8 4.2 8.4 9.4 2.4 0.7 0.0 1.4 0.0 0.5 0.0 0.0 0.8 0.3 0.0 0.0 16.3 0.0 3.4 1.7 0.1 0.7 31.1 26.9 5.7 19.3 30.4 21.3 31.5 14.8 24.7 26.0 3.0 23.1 4.7 0.6 1.8 4.2 9.3 2.5 2.7 1.2 0.0 0.0 4.4 0.0 2.1 5.6 7.7 8.4 0.0 5.4 12.2 6.3 2.7 5.7 0.8 10.3 15.9 10.3 4.9 18.9 2.6 7.5 10.1 6.8 11.8 3.8 0.5 6.5 0.0 10.3 0.5 2.2 12.9 3.8 2.4 1.8 2.5 18.5 2.5 9.2 1.3 GAB4 ENSG00000215568 "GRB2 associated binding protein family member 4" Q2WGN9 22 16961936-17008222 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 19.6" "Group enriched" "Detected in some" 4 "Early spermatids: 6.2;Late spermatids: 17.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.2" HPA044621 Uncertain NA NA "HPA044621: AB_10967265" 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.4 0.6 0.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.7 0.0 0.0 0.0 0.0 0.0 GABBR1 "GPRC3A, hGB1a" ENSG00000204681 "Gamma-aminobutyric acid type B receptor subunit 1" Q9UBS5 6 29555629-29633976 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.8" "Cell type enhanced" "Detected in many" 4 "Ito cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;HEL: 7.9;U-2 OS: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050483, HPA058459" Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA050483: AB_2681140, HPA058459: " "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (3.22e-3)" "unprognostic (2.93e-3)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (7.95e-4)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "prognostic favorable (2.54e-5)" "unprognostic (1.23e-3)" "prognostic unfavorable (3.77e-10)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.87e-2)" "unprognostic (2.55e-2)" 14.0 7.4 33.6 7.0 47.2 8.2 4.2 29.1 53.8 6.9 5.6 17.3 3.0 2.3 18.1 1.9 2.9 7.9 4.1 4.6 24.8 21.4 2.9 2.0 6.9 6.6 15.6 33.7 7.8 5.1 1.8 5.8 5.0 22.3 12.8 3.2 4.4 13.0 13.3 8.5 18.3 6.1 5.5 14.9 24.2 6.1 4.3 15.4 0.0 3.9 0.1 5.2 4.0 5.9 1.8 1.7 0.0 0.5 0.0 0.4 0.3 3.0 0.0 1.9 8.1 0.9 2.1 2.1 2.0 0.9 1.8 0.5 2.4 0.1 1.4 2.0 0.0 0.5 2.5 0.9 0.0 0.0 7.3 3.4 7.9 3.5 0.0 1.2 0.3 4.0 0.0 0.0 1.6 0.0 2.3 1.0 4.3 6.7 0.0 0.3 2.0 0.8 0.1 0.6 0.0 1.1 3.5 0.7 0.1 0.3 0.0 0.5 1.3 0.5 0.0 3.3 0.6 1.5 1.2 4.6 3.3 8.4 0.3 3.8 7.1 0.8 0.0 1.8 3.6 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 1.8 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 33.6 47.2 29.1 53.8 24.8 21.4 15.6 33.7 22.3 15.4 11.9 19.8 5.2 6.1 10.5 22.1 8.9 2.5 1.4 18.2 3.5 0.0 0.4 0.0 1.2 2.4 11.9 0.0 0.0 0.7 0.2 9.6 5.4 7.0 0.0 1.1 22.3 6.9 28.8 7.2 1.7 14.1 10.5 0.0 5.4 3.8 9.7 2.2 1.5 24.1 0.7 13.8 12.9 15.5 1.1 1.5 9.7 0.5 1.0 1.2 1.8 GABBR2 "GABABR2, GPR51, GPRC3B, HG20" ENSG00000136928 "Gamma-aminobutyric acid type B receptor subunit 2" O75899 9 98288082-98709197 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 52.7" "Group enriched" "Detected in some" 11 "Bipolar cells: 87.5;Early spermatids: 83.9;Late spermatids: 26.5" "Group enriched" "Detected in many" 10 "glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 11.1;fHDF/TERT166: 5.5;HUVEC TERT2: 23.0;U-138 MG: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013820, HPA031684, CAB079065" Enhanced Approved NA NA "CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993" "unprognostic (2.00e-1)" "unprognostic (7.56e-2)" "unprognostic (3.75e-1)" "unprognostic (3.09e-5)" "unprognostic (2.52e-1)" "unprognostic (1.16e-1)" "unprognostic (2.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.66e-1)" "unprognostic (4.43e-2)" "unprognostic (1.43e-2)" "unprognostic (2.06e-1)" "unprognostic (1.76e-2)" "unprognostic (3.52e-2)" "unprognostic (1.91e-1)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" 0.9 4.4 13.6 1.0 14.6 0.8 0.9 19.7 52.7 0.8 0.9 2.1 0.0 0.8 1.1 1.1 0.9 0.8 0.9 0.9 14.6 11.1 0.9 0.9 1.0 0.9 7.6 17.6 0.8 0.8 0.9 0.3 0.9 10.3 0.9 0.8 0.6 0.9 0.9 3.2 0.9 0.8 1.0 2.2 0.9 1.0 1.3 0.2 0.0 2.3 0.0 1.1 1.5 0.1 0.7 0.7 1.7 1.1 1.7 1.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 1.0 11.1 2.2 2.4 4.3 0.0 0.1 0.0 0.7 5.5 0.5 0.0 0.1 0.2 0.8 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.8 0.2 0.0 23.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.6 3.1 0.0 0.0 2.8 0.0 0.0 0.0 0.1 1.0 9.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 1.7 0.4 0.8 0.6 0.7 1.0 0.7 0.7 0.7 0.4 0.6 0.8 0.9 1.2 1.7 1.1 0.7 1.0 0.4 13.6 14.6 19.7 35.0 14.6 11.1 7.6 17.6 10.3 0.2 0.0 0.0 0.0 0.0 0.1 87.5 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 83.9 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 26.5 0.3 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 5.8 0.0 0.5 0.6 0.7 0.1 0.3 0.0 0.0 0.0 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell type enriched" "Detected in some" 24 "Bipolar cells: 209.5" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA029363, HPA055746" Enhanced Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022502: , HPA029363: , HPA055746: AB_2682904" "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 209.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Group enriched" "Detected in some" 4 "Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029363, CAB079061" Supported Uncertain "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079061: , HPA029363: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.1 0.8 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.2 0.0 0.4 0.0 0.3 0.9 1.8 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.6 0.4 0.4 0.1 0.5 9.6 0.5 0.1 0.8 1.2 0.2 4.5 0.4 5.1 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 38.4 3.9 0.0 3.3 0.0 6.4 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 6.9 0.6 0.0 1.7 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor alpha3 subunit" P34903 X 152166234-152451358 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 30.1" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 12.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000839, HPA029363" Approved Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA000839: AB_1078929, HPA029363: " "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.7 0.7 7.7 0.6 15.2 0.7 0.7 1.3 30.1 2.2 0.8 3.3 0.0 0.8 1.2 0.8 1.3 0.7 0.7 0.7 10.9 15.9 0.7 0.7 0.7 0.7 4.7 10.5 0.6 0.7 0.6 0.9 5.2 6.2 0.8 0.8 0.4 0.7 1.8 0.8 1.1 0.9 0.8 2.1 0.7 0.7 1.8 1.1 0.0 0.7 0.0 0.9 1.8 0.4 0.0 0.1 1.5 0.3 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 13.0 0.0 0.0 0.0 0.0 2.4 5.5 7.6 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.0 4.8 0.4 0.3 0.1 1.2 0.0 4.9 6.5 0.3 1.4 7.0 11.6 0.0 7.7 0.0 4.9 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.0 7.7 15.2 1.3 28.4 10.9 15.9 4.7 10.5 6.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 1.6 0.0 0.0 0.3 GABRA4 ENSG00000109158 "Gamma-aminobutyric acid type A receptor alpha4 subunit" P48169 4 46918900-46994407 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 16.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 11.0;Muller glia cells: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "REH: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.78e-2)" "unprognostic (6.57e-3)" "unprognostic (2.46e-1)" "unprognostic (2.23e-1)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "unprognostic (6.91e-2)" 0.0 0.1 2.7 0.1 8.9 0.0 0.0 0.3 16.1 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.1 4.0 1.9 1.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Cell type enhanced" "Detected in single" 18 "Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 26.4;HAP1: 9.1;NTERA-2: 10.9;U-2 OS: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029363, HPA077031, CAB079022" Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079022: , HPA029363: , HPA077031: AB_2686825" "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 9.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 GABRA6 ENSG00000145863 "Gamma-aminobutyric acid type A receptor alpha6 subunit" Q16445 5 161547063-161702593 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "brain: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 36 "cerebellum: 96.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 1.0;PC-3: 1.5;TIME: 1.1;U-266/70: 2.5" "Region enriched" "Detected in some" 40 "cerebellum: 1204.9" "Region enriched" "Detected in some" 44 "cerebellum: 189.6" CAB022462 Approved NA NA "CAB022462: " "unprognostic (3.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRB1 ENSG00000163288 "Gamma-aminobutyric acid type A receptor beta1 subunit" P18505 4 46993723-47426444 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.5;pituitary gland: 14.7" "Cell type enriched" "Detected in some" 25 "Muller glia cells: 39.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.4;REH: 4.2;SCLC-21H: 1.1;U-87 MG: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.11e-2)" "unprognostic (7.56e-3)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (4.98e-3)" "unprognostic (8.16e-3)" "unprognostic (6.22e-2)" "unprognostic (2.72e-2)" "unprognostic (2.34e-1)" 1.0 1.3 19.9 1.0 34.5 0.9 1.0 14.7 27.9 1.0 1.2 2.7 0.0 1.6 1.2 1.0 1.0 1.2 1.2 6.0 16.3 4.2 1.8 1.1 1.1 0.9 2.8 18.5 1.1 0.9 0.9 14.7 1.3 5.6 1.0 1.2 0.0 0.9 0.9 0.9 0.9 1.3 1.0 3.4 1.0 1.0 1.1 6.7 0.0 1.3 0.0 0.9 0.9 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 34.5 14.7 16.6 16.3 4.2 2.8 18.5 5.6 6.7 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 GABRB2 ENSG00000145864 "Gamma-aminobutyric acid type A receptor beta2 subunit" P47870 5 161288429-161549044 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 48.7" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 17.4;Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 9.0" "Cancer enriched" "Detected in some" 20 "thyroid cancer: 10.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001964, HPA067632" Enhanced NA NA "CAB001964: , HPA067632: AB_2685874" "unprognostic (5.46e-2)" "unprognostic (1.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.26e-6)" "unprognostic (2.33e-2)" "unprognostic (6.65e-2)" "unprognostic (3.58e-2)" "unprognostic (1.82e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (1.33e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.04e-2)" 1.2 3.6 7.7 0.8 19.2 0.7 0.9 48.7 45.4 1.3 1.5 0.9 0.0 2.0 0.9 5.8 0.8 1.2 0.8 0.9 8.1 4.6 2.8 0.7 1.8 0.8 3.7 16.3 0.9 0.9 0.8 0.5 1.0 4.3 0.9 2.2 0.1 1.3 1.5 0.8 0.8 1.4 0.9 1.1 3.4 1.2 1.5 1.8 0.0 1.3 0.0 0.8 0.8 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.7 19.2 48.7 34.1 8.1 4.6 3.7 16.3 4.3 1.8 0.0 0.0 0.0 0.0 0.2 17.4 1.6 0.0 0.0 0.0 0.0 25.5 0.0 5.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.4 2.6 9.0 0.0 0.4 2.7 1.5 0.4 0.0 0.0 3.0 0.0 GABRB3 ENSG00000166206 "Gamma-aminobutyric acid type A receptor beta3 subunit" P28472 15 26543546-26939539 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.6" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 136.2;Cone photoreceptor cells: 37.3;Horizontal cells: 71.5;Rod photoreceptor cells: 48.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 32.3;HAP1: 13.3;NTERA-2: 23.2;OE19: 10.0;SCLC-21H: 21.5;U-2 OS: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (3.20e-2)" "unprognostic (4.25e-2)" "unprognostic (1.66e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" "unprognostic (3.56e-3)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.33e-2)" "unprognostic (4.05e-1)" 1.2 6.2 16.8 1.1 22.6 0.7 1.5 12.7 48.6 3.0 1.8 1.6 0.1 1.4 2.4 1.6 1.9 3.0 13.9 7.4 14.3 11.7 7.8 1.5 1.5 0.7 4.6 13.7 2.5 5.2 1.2 12.2 0.7 3.7 5.7 1.6 3.2 1.2 1.9 0.7 1.3 1.2 2.0 2.5 1.2 6.0 4.4 3.4 0.0 9.1 0.0 0.9 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 32.3 5.1 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.6 1.6 0.0 0.0 0.0 0.0 0.0 7.0 0.9 0.0 0.0 0.0 2.2 0.0 23.2 10.0 1.6 0.0 0.0 0.0 2.3 0.0 21.5 8.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.8 22.6 12.7 25.7 14.3 11.7 4.6 13.7 3.7 3.4 11.9 2.2 0.0 1.0 0.0 136.2 8.9 17.8 18.7 2.3 5.2 37.3 0.4 0.0 3.3 9.0 1.3 0.5 0.0 0.4 0.0 0.2 3.6 0.0 0.5 0.0 71.5 9.9 1.3 0.0 4.9 1.7 0.0 0.0 0.0 1.8 6.7 1.4 0.0 3.2 6.3 48.7 0.0 0.9 5.1 15.1 0.1 0.2 0.0 0.4 0.3 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor delta subunit" O14764 1 2019298-2030758 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 87.0" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 9.3;Ciliated cells: 8.1;Club cells: 11.4;Horizontal cells: 12.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 87.0" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "EFO-21: 2.9;HMC-1: 2.5;MCF7: 8.3;NB-4: 5.3;NTERA-2: 2.1;SH-SY5Y: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA044371: AB_2678916" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 1.2 3.4 8.8 0.9 16.8 1.0 1.0 87.0 40.0 1.0 1.2 1.7 0.0 0.9 1.3 1.2 1.3 1.0 1.5 1.7 6.0 1.7 1.1 0.9 1.4 1.3 3.3 11.1 0.9 0.9 1.4 0.7 1.2 17.1 1.0 1.0 0.0 1.1 0.9 1.3 1.4 1.0 1.4 1.4 1.0 1.0 3.3 1.5 0.0 1.6 0.0 1.0 1.2 0.1 0.0 1.2 0.2 0.1 0.0 0.0 0.8 0.0 0.7 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 5.3 2.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.1 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.8 8.8 16.8 87.0 40.0 6.0 1.7 3.3 11.1 17.1 1.5 3.0 5.1 0.0 0.0 0.5 9.3 0.8 0.0 8.1 11.4 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.2 0.0 0.1 2.3 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 3.1 0.1 13.5 0.0 0.2 0.0 0.0 0.0 GABRE ENSG00000102287 "Gamma-aminobutyric acid type A receptor epsilon subunit" P78334 X 151953124-151974680 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 36.4;vagina: 27.7" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 51.4;Urothelial cells: 32.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "hypothalamus: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.4;EFO-21: 14.9;HeLa: 6.7;SiHa: 7.0" "Low region specificity" "Detected in many" HPA045918 Uncertain NA NA "HPA045918: AB_10961281" "unprognostic (1.33e-2)" "unprognostic (6.75e-2)" "unprognostic (3.50e-3)" "unprognostic (1.39e-3)" "unprognostic (2.43e-1)" "unprognostic (7.52e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (3.58e-2)" "unprognostic (1.55e-1)" "unprognostic (6.44e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (4.05e-11)" "unprognostic (1.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (5.28e-2)" 14.8 1.0 1.5 2.2 2.8 0.3 16.5 1.0 1.6 8.9 5.8 0.0 2.2 1.4 6.0 4.1 5.0 1.5 4.2 16.3 1.0 21.8 1.1 0.9 2.3 0.7 1.1 0.6 1.6 2.5 0.4 4.1 36.4 4.5 5.9 0.8 3.8 2.0 6.3 0.9 5.6 10.1 2.5 1.1 0.9 1.0 0.9 0.4 0.0 2.5 5.9 3.5 2.9 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.4 0.0 0.0 0.6 0.0 1.1 0.5 2.3 0.8 0.0 14.9 3.1 0.0 2.4 0.0 0.8 0.7 0.0 0.5 1.7 6.7 0.9 0.2 0.0 0.2 1.0 0.7 1.2 0.3 1.4 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.0 1.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 1.0 1.3 1.0 21.8 1.1 0.6 4.5 0.4 14.9 5.7 0.0 20.6 15.2 0.0 6.4 12.7 2.7 14.8 1.8 0.0 17.3 0.0 3.6 1.7 7.9 9.3 0.0 0.3 2.0 9.7 14.0 0.0 0.8 2.7 0.0 1.7 4.3 0.6 1.8 1.4 0.2 1.7 0.0 1.8 0.5 3.7 8.6 2.1 0.0 0.3 0.0 4.7 1.1 1.7 9.5 51.4 0.5 2.3 32.0 GABRG1 ENSG00000163285 "Gamma-aminobutyric acid type A receptor gamma1 subunit" Q8N1C3 4 46035769-46124081 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 35.7" "Group enriched" "Detected in some" 5 "Early spermatids: 5.9;Muller glia cells: 15.1;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 8 "glioma: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035622, HPA058102" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA035622: AB_10603669, HPA058102: " "unprognostic (2.50e-1)" "unprognostic (2.20e-1)" "unprognostic (6.06e-2)" "unprognostic (1.46e-2)" "unprognostic (7.39e-4)" "unprognostic (1.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.99e-1)" 1.5 1.5 20.3 1.2 25.9 1.2 1.3 26.4 35.7 1.3 1.3 12.2 0.0 1.4 1.4 1.3 1.3 1.7 1.3 1.2 26.0 14.6 1.4 1.4 1.2 1.3 10.2 14.0 3.9 1.2 1.3 1.6 1.2 17.9 1.2 1.3 0.0 1.2 1.3 1.2 1.2 1.4 1.4 17.8 1.4 1.3 1.8 17.8 0.0 1.5 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.3 1.8 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 25.9 26.4 18.5 26.0 14.6 10.2 14.0 17.9 17.8 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 1.8 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GABRG2 ENSG00000113327 "Gamma-aminobutyric acid type A receptor gamma2 subunit" P18507 5 162000057-162162977 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 47.1" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 81.7" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.3" "Group enriched" "Detected in many" 5 "B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2" "Cell line enhanced" "Detected in many" "CACO-2: 10.6;RPMI-8226: 10.2;SuSa: 11.4;U-266/70: 17.8;U-266/84: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB079060 Supported NA NA "CAB079060: " "unprognostic (2.88e-2)" "unprognostic (1.56e-2)" "unprognostic (6.31e-3)" "unprognostic (3.07e-3)" "unprognostic (1.52e-1)" 1.1 5.7 9.7 1.2 28.8 3.3 0.9 21.7 47.1 0.7 1.5 1.1 0.0 2.2 1.2 1.3 1.3 1.3 3.8 1.6 10.6 19.6 1.0 1.2 1.9 1.2 7.5 19.1 1.5 1.0 0.8 5.3 2.9 17.6 1.0 1.3 0.6 1.3 0.8 1.2 3.3 1.9 1.6 2.6 1.2 3.3 1.7 1.8 0.0 1.8 0.0 1.3 1.5 0.3 2.9 0.7 7.3 0.3 0.9 3.2 0.2 3.6 1.7 1.9 0.3 0.0 0.0 2.0 0.6 0.0 0.0 0.0 10.6 4.7 0.7 5.2 0.0 0.4 1.6 1.2 0.0 0.0 0.8 1.1 0.0 2.1 1.3 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.5 0.0 1.0 1.8 8.5 0.0 2.5 0.4 0.1 6.1 3.4 2.9 0.4 0.1 10.2 0.0 3.4 0.9 0.8 0.3 0.6 3.4 11.4 5.6 5.7 0.2 0.3 4.5 0.3 0.5 17.8 14.1 0.5 0.2 0.4 0.4 7.3 0.3 0.6 0.4 0.3 2.7 2.9 0.7 0.6 0.0 2.5 3.2 0.7 1.6 0.9 0.2 0.7 0.6 0.2 9.7 28.8 21.7 38.1 10.6 19.6 7.5 19.1 17.6 1.8 17.9 19.7 0.0 0.0 0.0 81.7 0.2 0.0 12.0 19.4 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.1 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 GABRG3 ENSG00000182256 "Gamma-aminobutyric acid type A receptor gamma3 subunit" Q99928 15 26971282-27541991 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.3;prostate: 13.5;testis: 16.6" "Group enriched" "Detected in some" 36 "Early spermatids: 81.6;Late spermatids: 207.6;Muller glia cells: 241.7" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 5.0;PC-3: 6.5;SK-MEL-30: 4.2;U-2 OS: 3.0;U-266/70: 3.8;U-87 MG: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054010 Approved NA NA "HPA054010: AB_2682342" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (3.50e-2)" "unprognostic (2.61e-1)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (4.41e-1)" "unprognostic (1.43e-5)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" 0.5 1.3 2.2 0.8 10.4 0.5 1.2 3.1 15.3 2.2 0.5 0.8 0.0 0.4 0.7 4.4 0.5 1.3 0.5 0.4 3.0 5.8 1.0 0.6 0.5 1.5 1.0 7.8 0.5 0.4 0.4 6.4 0.5 2.7 13.5 0.5 4.0 1.5 3.4 0.5 0.9 0.4 0.6 0.8 2.3 0.4 16.6 0.5 0.3 3.3 0.0 1.9 0.4 0.7 0.8 0.3 0.9 0.4 0.3 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 6.5 0.0 0.0 1.2 0.0 0.0 0.1 1.1 0.0 0.0 4.2 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.8 0.0 0.0 17.1 0.1 0.0 0.4 0.4 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.8 0.3 0.1 0.9 0.3 0.1 0.3 0.1 0.0 2.2 10.4 3.1 15.3 3.0 5.8 1.0 7.8 2.7 0.5 0.0 0.0 0.0 0.1 0.0 3.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 81.6 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 207.6 0.9 0.0 0.0 0.0 0.0 241.7 0.0 0.0 0.7 0.2 2.6 0.0 0.0 1.4 4.9 0.0 0.0 0.0 0.0 0.1 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor pi subunit" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;lymphoid tissue: 57.7" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 48.4;Pancreatic endocrine cells: 33.1;Urothelial cells: 141.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 10.1" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;monocytes: 6.1" "Cell line enhanced" "Detected in many" "A-431: 39.5;EFO-21: 46.1;HeLa: 27.7;PC-3: 63.2;SuSa: 85.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain NA NA "CAB014883: " "unprognostic (3.98e-3)" "prognostic favorable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 1.5 0.5 0.5 1.3 0.5 1.1 31.6 0.5 1.1 18.5 1.7 0.6 2.6 2.6 30.4 9.9 37.0 2.2 8.6 1.0 0.5 0.4 6.9 3.8 2.5 0.5 0.5 0.5 1.1 4.3 0.0 2.4 5.5 0.6 6.8 0.4 0.8 25.5 3.2 2.0 10.0 3.9 0.5 0.5 0.8 5.0 1.0 0.5 2.5 0.6 3.1 57.7 1.2 20.0 0.9 1.1 10.1 6.1 0.2 1.3 3.1 39.5 1.8 1.9 1.3 0.1 0.8 4.6 0.7 0.2 0.1 0.1 7.1 4.5 0.6 46.1 0.2 0.4 14.3 1.2 0.0 0.1 0.6 1.4 2.6 27.7 1.0 0.1 0.9 2.2 0.3 0.5 0.5 0.3 1.5 0.2 2.5 10.6 5.0 0.0 1.2 1.7 0.8 16.2 0.7 63.2 2.5 1.2 1.5 2.6 2.2 1.6 0.7 14.6 0.7 0.4 85.1 0.8 0.4 1.6 3.7 13.5 3.0 2.9 1.9 1.2 1.1 0.5 2.6 0.5 10.1 2.3 6.8 0.5 1.7 1.3 0.3 0.5 0.4 0.7 0.9 0.7 0.6 5.4 0.2 6.1 1.1 0.7 3.1 0.5 0.5 0.5 0.6 0.5 0.4 0.5 0.5 0.6 0.5 3.0 1.1 0.0 14.6 0.0 0.0 0.4 48.4 12.0 15.9 1.8 0.0 3.6 0.0 0.8 0.0 0.0 0.0 0.0 12.6 0.1 0.8 15.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.4 141.9 GABRQ THETA ENSG00000268089 "Gamma-aminobutyric acid type A receptor theta subunit" Q9UN88 X 152638183-152657534 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 28.9;cervix, uterine: 16.2" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.5;Spermatogonia: 1.1;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 9.0;SiHa: 8.7;SuSa: 4.1;U-87 MG: 28.8" "Region enriched" "Detected in many" 5 "hypothalamus: 61.6" "Region enhanced" "Detected in many" "midbrain: 24.9" NA NA "unprognostic (3.68e-3)" "unprognostic (7.78e-2)" "unprognostic (9.16e-2)" "unprognostic (1.17e-4)" "unprognostic (3.38e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-4)" "unprognostic (1.31e-1)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (3.73e-1)" "unprognostic (3.76e-2)" "unprognostic (3.10e-5)" "unprognostic (3.43e-3)" "unprognostic (1.84e-1)" "unprognostic (6.42e-2)" "unprognostic (7.70e-2)" 0.2 4.4 10.5 0.2 5.7 0.1 0.1 0.0 7.5 16.2 0.2 1.5 1.0 0.2 2.6 0.5 1.1 0.3 0.1 0.2 23.4 0.2 0.1 0.1 0.2 0.0 13.6 0.1 0.1 0.1 0.0 0.3 28.9 0.9 0.2 0.0 0.1 1.7 0.1 0.7 0.5 1.6 7.2 0.2 0.1 4.7 1.0 0.0 0.3 1.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 1.2 8.7 1.6 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 1.6 0.7 0.0 0.0 0.3 GABRR1 ENSG00000146276 "Gamma-aminobutyric acid type A receptor rho1 subunit" P24046 6 89177501-89231278 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "retina: 12.3;testis: 4.6" "Cell type enriched" "Detected in some" 11 "Bipolar cells: 53.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "amygdala: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6" "Not detected" "Not detected" NA NA "unprognostic (5.75e-2)" "unprognostic (3.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.90e-2)" "unprognostic (5.78e-2)" "unprognostic (4.90e-2)" "unprognostic (8.32e-3)" "unprognostic (2.52e-3)" "unprognostic (1.74e-1)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (1.62e-5)" "unprognostic (1.18e-1)" "unprognostic (9.90e-2)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" 0.4 0.0 2.2 0.1 0.1 0.0 0.2 0.3 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 1.0 0.3 0.2 0.1 12.3 0.2 0.1 0.7 0.6 0.7 0.1 0.1 0.1 0.0 4.6 0.1 0.1 0.1 0.1 0.2 0.6 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 6.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.6 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 53.4 0.3 0.0 0.0 0.0 0.0 3.9 0.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 3.8 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.1 GABRR2 ENSG00000111886 "Gamma-aminobutyric acid type A receptor rho2 subunit" P28476 6 89257208-89315299 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "retina: 18.8" "Cell type enriched" "Detected in some" 13 "Bipolar cells: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Lineage enhanced" "Detected in single" "dendritic cells: 1.0" "Cell line enhanced" "Detected in some" "U-266/70: 4.4;U-266/84: 1.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA "unprognostic (2.05e-2)" "unprognostic (1.47e-4)" "unprognostic (1.56e-1)" "unprognostic (1.88e-4)" "unprognostic (4.19e-1)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (9.13e-2)" "unprognostic (2.87e-1)" "unprognostic (1.10e-2)" "unprognostic (2.65e-1)" "unprognostic (1.41e-1)" "unprognostic (1.54e-6)" "unprognostic (3.69e-2)" "unprognostic (7.81e-2)" "unprognostic (5.79e-2)" "unprognostic (7.15e-3)" 0.2 0.6 0.2 0.5 0.4 0.3 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.0 0.7 0.5 0.2 0.1 0.4 0.2 0.3 0.2 0.3 0.4 0.1 0.9 0.3 0.1 0.1 0.8 0.0 0.2 0.1 0.1 0.3 0.0 18.8 0.6 0.2 1.5 0.5 0.1 0.1 0.2 0.4 0.1 0.6 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.3 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 0.0 0.0 0.0 4.4 1.6 0.0 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.4 0.3 0.3 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 19.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRR3 ENSG00000183185 "Gamma-aminobutyric acid type A receptor rho3 subunit (gene/pseudogene)" A8MPY1 3 97986673-98035304 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "retina: 18.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 10.5;Rod photoreceptor cells: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;U-266/70: 2.0;U-698: 4.7" "Not detected" "Not detected" NA NA "unprognostic (3.22e-2)" "unprognostic (2.06e-3)" "unprognostic (5.65e-2)" "unprognostic (2.82e-1)" "unprognostic (1.43e-4)" "unprognostic (2.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 18.2 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAD1 GAD ENSG00000128683 "Glutamate decarboxylase 1" Q99259 2 170813213-170861151 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 53.9" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 9.8;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 10.8;HEL: 34.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "olfactory region: 888.9" "CAB004415, HPA048871, HPA058412, CAB078176" Enhanced Supported Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane, Cytosol" "CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710" "unprognostic (1.28e-1)" "prognostic favorable (7.31e-4)" "unprognostic (1.87e-2)" "prognostic favorable (8.61e-4)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (4.97e-7)" "unprognostic (1.51e-1)" "unprognostic (7.72e-2)" "unprognostic (4.27e-4)" "unprognostic (6.75e-2)" "unprognostic (9.18e-3)" "unprognostic (6.90e-5)" "unprognostic (2.93e-2)" "unprognostic (6.57e-2)" "unprognostic (1.56e-2)" "unprognostic (3.08e-3)" 1.2 2.0 14.5 0.9 28.1 3.7 1.0 10.6 53.9 1.8 1.0 3.1 0.0 1.0 2.6 5.5 1.2 1.1 1.0 1.0 10.8 24.4 6.0 1.0 1.1 1.1 8.6 17.5 1.1 1.1 9.5 2.8 1.4 6.0 1.8 1.0 1.3 1.0 1.3 0.9 1.0 1.1 1.0 2.6 1.0 1.0 4.0 3.4 0.0 1.1 0.0 1.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.4 0.0 3.8 0.0 0.0 0.0 0.2 0.0 1.4 0.9 2.5 3.6 0.0 0.5 0.2 1.7 10.8 1.2 0.3 0.8 1.4 7.4 34.9 3.0 0.1 0.0 0.1 0.6 0.0 3.1 0.0 1.2 0.3 0.0 0.3 9.0 0.1 0.4 0.8 0.0 0.0 4.3 5.2 3.8 0.5 2.6 0.2 4.7 5.0 3.7 1.2 6.6 0.0 1.8 0.3 0.1 0.0 0.0 6.5 0.9 1.3 3.8 0.0 0.0 0.0 6.3 1.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 28.1 10.6 36.7 10.8 24.4 8.6 17.5 6.0 3.4 0.0 0.0 0.0 1.4 0.2 3.8 1.1 0.0 0.0 0.0 0.0 9.8 0.0 6.6 4.2 4.3 0.3 0.0 0.0 4.7 0.1 0.2 0.8 0.0 0.0 3.0 4.8 2.9 0.0 0.3 3.6 0.6 0.2 0.0 0.0 0.0 3.9 4.2 0.0 0.0 0.0 5.4 0.0 0.8 3.2 4.7 0.1 0.5 0.0 0.0 0.3 GAD2 GAD65 ENSG00000136750 "Glutamate decarboxylase 2" Q05329 10 26216307-26304558 "Enzymes, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 66.2" "Cell type enriched" "Detected in some" 11 "Pancreatic endocrine cells: 35.1" "Group enriched" "Detected in some" 21 "glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2" "Region enhanced" "Detected in all" "basal ganglia: 66.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "MOLT-4: 5.2;SCLC-21H: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044637, CAB078177" Enhanced NA NA "CAB078177: AB_2665779, HPA044637: AB_10794053" "unprognostic (8.67e-2)" "unprognostic (1.11e-1)" "unprognostic (4.93e-2)" "unprognostic (2.52e-5)" "unprognostic (5.44e-2)" "unprognostic (8.08e-2)" 1.0 0.9 6.3 0.9 66.2 1.0 0.9 5.6 28.7 0.9 0.9 1.4 0.0 1.2 0.9 1.1 0.9 0.9 0.9 0.9 5.2 13.2 1.0 0.9 0.9 0.9 5.4 10.0 0.9 12.9 0.9 0.4 0.9 6.8 1.2 1.0 0.0 0.9 0.9 0.9 1.3 1.1 0.9 1.3 0.9 1.2 1.7 8.1 0.0 0.9 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 66.2 5.6 18.2 5.2 13.2 5.4 10.0 6.8 8.1 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 35.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 GADD45A "DDIT1, GADD45" ENSG00000116717 "Growth arrest and DNA damage inducible alpha" P24522 1 67685061-67688338 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 86.7;skeletal muscle: 102.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2362.0;Urothelial cells: 1859.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in all" 5 "granulocytes: 24.9;T-cells: 9.3" "Cell line enhanced" "Detected in many" "HHSteC: 60.1;hTERT-HME1: 92.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053420 Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA053420: AB_2682144" "unprognostic (1.36e-2)" "unprognostic (3.29e-2)" "unprognostic (9.58e-2)" "unprognostic (3.76e-3)" "unprognostic (5.81e-2)" "unprognostic (1.36e-2)" "unprognostic (1.57e-3)" "unprognostic (2.80e-3)" "unprognostic (1.42e-1)" "unprognostic (6.26e-2)" "unprognostic (3.43e-2)" "unprognostic (5.21e-2)" "prognostic favorable (8.06e-6)" "unprognostic (6.11e-2)" "unprognostic (2.89e-1)" "unprognostic (3.43e-3)" "unprognostic (1.93e-1)" 29.6 6.8 10.7 8.2 20.9 46.2 20.9 1.7 15.8 11.7 10.8 5.8 18.8 10.1 23.3 13.8 12.2 8.8 16.7 12.9 18.1 9.8 86.7 66.9 17.1 4.9 11.4 4.1 13.8 8.3 4.1 5.1 10.8 21.2 16.5 9.0 9.4 9.5 15.6 102.1 14.8 20.4 16.1 15.5 7.4 14.1 9.2 7.5 9.2 26.2 10.1 10.9 23.9 11.1 1.1 2.2 24.9 3.2 3.1 9.3 4.8 22.2 1.4 3.8 1.1 6.8 7.1 35.9 39.6 18.5 13.2 14.4 7.8 3.8 9.6 12.1 6.4 33.1 13.4 0.4 33.9 24.9 7.0 3.8 12.0 3.5 7.8 60.1 3.5 1.1 12.0 17.2 16.7 92.9 6.6 9.4 2.3 25.6 17.1 15.5 0.7 1.0 4.2 4.8 2.9 15.7 2.6 29.5 9.8 6.8 16.8 16.4 2.9 8.3 2.3 23.7 13.5 0.4 3.7 9.7 13.8 18.6 14.5 27.7 43.8 8.5 17.5 6.1 1.7 13.4 7.2 3.2 24.9 3.7 1.5 3.0 1.1 2.5 3.0 1.4 0.7 0.7 1.2 4.1 3.1 1.0 2.2 9.3 4.8 10.7 20.9 1.7 15.8 18.1 9.8 11.4 4.1 21.2 7.5 59.6 21.3 30.0 2362.0 763.0 34.8 176.4 48.4 136.5 91.0 97.7 9.8 17.5 200.6 253.6 0.6 85.9 120.7 93.5 224.9 94.3 192.2 631.8 44.9 99.0 16.2 25.4 126.2 49.1 19.7 2.2 35.4 33.2 150.1 467.1 44.4 25.0 252.2 49.1 60.8 290.2 70.0 51.8 190.0 2.7 12.4 341.6 14.8 38.8 37.5 1859.7 GADD45G "CR6, DDIT2, GADD45gamma, GRP17" ENSG00000130222 "Growth arrest and DNA damage inducible gamma" O95257 9 89605013-89606555 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.6" "Cell type enriched" "Detected in many" 8 "Syncytiotrophoblasts: 1345.9" "Cancer enhanced" "Detected in all" "prostate cancer: 79.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 8.0" "Lineage enriched" "Detected in single" 22 "granulocytes: 8.0" "Group enriched" "Detected in some" 4 "HDLM-2: 47.8;SCLC-21H: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023606 Approved NA NA "HPA023606: AB_1849409" "unprognostic (5.84e-2)" "unprognostic (1.61e-2)" "unprognostic (1.08e-2)" "prognostic favorable (7.06e-4)" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.77e-3)" "unprognostic (3.75e-2)" "unprognostic (7.65e-3)" "unprognostic (4.16e-3)" "prognostic favorable (3.80e-5)" "unprognostic (1.11e-1)" "unprognostic (1.63e-2)" "unprognostic (4.95e-1)" "unprognostic (3.88e-2)" "unprognostic (3.41e-1)" "unprognostic (1.22e-1)" 7.0 23.6 4.6 4.4 7.7 8.4 6.7 4.8 5.4 23.3 7.4 2.8 12.0 4.2 21.3 6.5 6.1 6.4 5.9 53.4 4.1 3.8 6.7 48.4 4.6 1.5 5.3 3.7 14.1 28.7 4.9 25.4 65.6 7.4 12.7 1.6 3.0 14.7 10.2 58.0 5.5 6.0 5.5 6.7 1.3 6.5 13.0 3.0 0.8 8.4 26.8 2.6 5.1 6.2 0.0 0.2 8.0 0.3 0.0 0.1 0.1 1.2 0.0 6.8 0.0 0.0 0.0 9.0 0.4 0.0 0.0 0.0 1.0 0.1 0.0 1.1 0.0 0.3 1.0 2.2 0.0 0.0 47.8 0.4 0.1 0.1 0.0 0.3 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.9 0.1 0.4 6.3 1.1 0.1 0.5 2.0 0.4 0.0 0.3 25.2 5.7 0.4 2.6 0.0 1.3 1.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 0.1 4.6 7.7 4.8 5.4 4.1 3.8 5.3 3.7 7.4 3.0 6.0 50.9 0.5 17.9 25.3 38.5 139.3 68.8 34.8 33.0 10.4 5.9 64.8 77.9 10.9 1.3 20.7 22.6 0.0 37.3 9.4 67.6 115.9 18.5 161.3 53.6 3.2 52.5 8.6 11.6 7.4 78.2 47.7 33.7 19.0 25.9 28.3 24.6 5.7 42.8 35.3 19.1 129.4 86.5 1.1 1.6 17.1 1345.9 12.1 9.3 8.4 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 21.6" "Cell type enhanced" "Detected in some" 18 "Club cells: 2.3;Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.5 0.3 0.2 0.2 0.3 1.0 0.4 0.5 0.7 0.4 0.2 0.0 0.0 0.1 0.2 1.6 1.4 0.2 2.0 2.3 0.2 0.3 0.7 0.2 1.6 0.3 0.3 0.8 0.5 0.3 0.1 0.6 0.5 2.1 0.5 0.1 0.3 0.3 0.0 21.6 0.8 0.2 2.5 0.7 0.5 0.2 1.1 0.0 0.0 1.2 3.3 0.7 0.5 0.3 1.7 0.5 1.9 0.8 0.5 1.3 0.3 1.3 0.3 0.8 1.1 0.9 0.5 1.6 0.6 0.3 0.3 0.2 1.3 1.2 1.1 0.5 0.2 0.7 0.9 9.9 0.3 0.4 1.7 0.5 1.6 1.6 0.5 0.4 0.9 3.4 0.4 0.6 0.7 0.3 1.0 0.6 1.0 1.2 4.1 0.9 1.1 0.7 1.3 1.9 0.7 0.5 1.9 2.1 1.0 1.0 1.5 1.2 1.0 1.2 0.7 2.9 1.2 1.2 0.8 5.1 1.5 1.4 1.9 0.7 1.6 0.8 0.7 0.6 0.9 1.9 1.9 0.7 0.8 1.0 0.6 0.8 1.2 0.9 0.6 0.4 1.7 1.1 1.0 1.7 0.5 0.8 0.5 1.3 0.3 0.2 0.3 0.5 0.7 0.2 0.3 0.3 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GAGE1 CT4.1 ENSG00000205777 "G antigen 1" Q13068 X 49589496-49608536 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 36.8" "Cell type enriched" "Detected in some" 11 "Spermatogonia: 107.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "AN3-CA: 249.2" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.6 1.0 0.7 0.8 0.1 0.7 0.0 0.0 0.0 0.0 249.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.8 0.1 0.3 0.3 0.7 0.0 0.2 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.7 0.1 0.8 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 9.7 107.0 0.0 0.0 0.0 0.0 0.0 GAGE10 ENSG00000215274 "G antigen 10" A6NGK3 X 49303669-49319844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ovary: 3.9;pituitary gland: 3.1;testis: 2.9" "Cell type enhanced" "Detected in some" 28 "Leydig cells: 1.1;Peritubular cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.0;BJ hTERT+: 1.5;SuSa: 2.2;WM-115: 2.9" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (2.81e-2)" "unprognostic (2.26e-1)" "unprognostic (3.97e-1)" 0.0 0.0 0.6 0.0 1.8 0.1 0.8 0.5 0.3 0.0 0.2 0.0 0.5 2.0 0.0 1.7 0.1 0.5 0.5 0.5 0.0 0.0 0.0 0.6 0.4 3.9 0.0 0.0 3.1 0.0 0.4 0.3 0.2 1.1 0.2 0.0 0.0 1.4 0.2 0.3 0.0 2.9 0.8 0.2 0.0 0.1 0.0 0.7 0.0 0.5 0.1 0.5 0.3 0.0 0.0 0.6 7.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.2 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.0 0.1 0.5 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 4.9 0.1 0.0 0.0 0.0 0.1 GAGE12B ENSG00000236737 "G antigen 12B" X 49529869-49529985 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "intestine: 5.4;testis: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "JURKAT: 2.6;PC-3: 7.4;U-2197: 4.0" NA NA 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.8 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 21.5 0.0 0.0 0.0 0.1 0.0 0.3 2.0 0.5 0.0 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.8 0.7 0.0 0.0 0.1 0.8 2.0 0.0 0.5 0.3 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12C ENSG00000237671 "G antigen 12C" A1L429 X 49532211-49539538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "U-2 OS: 7.8;U-266/84: 27.7" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12D ENSG00000227488 "G antigen 12D" A1L429 X 49541767-49549094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 23.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "U-2 OS: 7.8;U-266/84: 27.7" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 GAGE12E ENSG00000216649 "G antigen 12E" A1L429 X 49551333-49558649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 9.6" "Cell type enriched" "Detected in some" 12 "Spermatogonia: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;HeLa: 4.1;Karpas-707: 2.0;T-47d: 1.7;U-266/84: 4.4;WM-115: 2.0" HPA043232 Supported Uncertain "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.6 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.5 0.3 0.0 0.0 0.7 4.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 11.5 0.0 0.0 0.0 0.0 0.0 GAGE12F ENSG00000236362 "G antigen 12F" "P0CL80, O76087, P0CL82" X 49551278-49568218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 16.2;testis: 58.6" "Cell type enriched" "Detected in single" 5 "Spermatogonia: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 136.7;K-562: 133.6" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 58.6 0.0 0.0 0.0 0.0 7.0 8.5 3.1 9.1 9.6 14.7 16.2 1.1 0.0 0.0 136.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.5 6.9 0.9 0.0 0.1 0.0 7.9 0.0 0.0 0.0 17.0 0.9 9.1 3.1 3.9 7.5 2.5 7.0 10.3 7.2 0.0 6.2 8.5 7.5 0.9 9.6 6.3 8.5 14.7 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 GAGE12G ENSG00000215269 "G antigen 12G" "P0CL81, O76087, P0CL82" X 49570434-49577754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 33 "blood: 7.4;stomach 1: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 7.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "AN3-CA: 149.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 1.3 2.5 0.4 7.4 6.2 0.0 0.0 0.0 149.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.4 2.5 1.3 0.8 2.2 1.3 1.5 3.6 0.5 0.0 2.6 0.6 3.2 0.0 0.4 1.8 1.4 7.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAGE12H ENSG00000224902 "G antigen 12H" A6NDE8 X 49579983-49587301 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 223 "testis: 22.3" "Cell type enriched" "Detected in single" 12 "Spermatogonia: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 52 "A-431: 19.6;U-266/84: 58.0" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 58.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.0 0.0 0.0 0.0 0.0 GAGE12J GAGE11 ENSG00000224659 "G antigen 12J" A6NER3 X 49322057-49329384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "AN3-CA: 48.3;K-562: 48.4" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 20.2 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.7 0.8 1.6 0.0 0.0 0.0 0.0 48.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 9.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.4 0.8 0.7 0.9 0.0 0.7 1.6 0.4 0.4 0.8 0.5 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 GAGE13 GAGE12A ENSG00000274274 "G antigen 13" X 49331616-49338952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 26.8" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AN3-CA: 129.9" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 129.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 13.9 0.0 0.0 0.0 0.0 0.0 GAGE2A "CT4.2, GAGE2" ENSG00000189064 "G antigen 2A" Q6NT46 X 49589529-49596827 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 46.7" "Cell type enriched" "Detected in some" 13 "Spermatogonia: 363.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Karpas-707: 19.6;T-47d: 67.6;WM-115: 74.4" HPA043232 Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 1.0 0.7 0.4 0.7 0.5 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 19.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 67.6 0.0 0.0 11.0 2.4 0.0 0.0 0.2 2.9 0.0 0.6 0.0 74.4 0.4 0.6 0.1 0.1 0.7 0.0 1.0 0.5 0.6 0.0 0.4 0.5 0.2 0.0 0.5 0.6 0.7 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 27.8 363.5 0.0 0.0 0.0 0.0 0.0 GAGE2E GAGE8 ENSG00000275113 "G antigen 2E" X 49341192-49345922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 52 "blood: 5.8;stomach 1: 18.4;testis: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 144.6;K-562: 69.2;T-47d: 35.0" HPA043232 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA043232: AB_2678376" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.4 4.9 0.0 0.0 0.0 2.5 2.6 0.7 1.2 0.7 5.8 0.2 0.0 0.0 0.0 144.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.2 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 35.0 0.0 0.4 8.9 0.3 0.0 0.0 0.1 2.6 0.0 0.1 0.0 15.2 0.7 1.2 0.3 1.0 0.0 0.0 1.5 0.4 2.2 0.0 2.5 4.9 0.0 0.7 0.7 0.0 2.6 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAL "GAL-GMAP, GALN, GLNN, GMAP" ENSG00000069482 "Galanin and GMAP prepropeptide" P22466 11 68683779-68691175 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Hormone, Neuropeptide" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 149.9" "Cell type enhanced" "Detected in many" 10 "Ductal cells: 39.1;Exocrine glandular cells: 43.2;Extravillous trophoblasts: 33.3;Glandular cells: 54.2;Pancreatic endocrine cells: 30.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "hypothalamus: 18.8" "Cell type enriched" "Detected in single" 15 "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 15 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 48.0;HEK 293: 22.4;K-562: 24.8;NB-4: 88.7;SH-SY5Y: 35.8" "Region enhanced" "Detected in many" "hypothalamus: 111.6" "Low region specificity" "Detected in many" "HPA049864, CAB079779" Enhanced Supported Supported "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 60000 "Golgi apparatus" Vesicles "CAB079779: , HPA049864: AB_2680922" "unprognostic (8.56e-2)" "unprognostic (1.45e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.70e-1)" "unprognostic (2.27e-2)" "unprognostic (8.07e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (5.98e-2)" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (7.42e-2)" "unprognostic (1.20e-1)" "unprognostic (8.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.38e-2)" "unprognostic (3.24e-2)" 2.8 0.2 0.1 14.8 0.5 0.4 4.5 0.6 2.0 0.2 6.0 0.1 0.4 1.7 0.2 0.7 0.7 0.2 0.3 0.6 1.3 18.8 0.3 0.2 0.2 0.1 0.2 0.6 0.2 2.9 0.0 149.9 0.9 2.2 0.7 4.1 0.6 0.5 1.8 0.3 4.5 2.2 9.7 0.3 0.2 1.5 0.5 0.4 0.7 0.2 0.4 0.3 1.5 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 4.5 6.8 0.0 0.1 0.0 48.0 1.8 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 22.4 1.1 14.4 0.0 0.2 0.6 0.0 0.3 0.7 0.0 0.0 0.0 1.1 0.0 24.8 0.0 0.0 13.6 0.0 88.7 11.4 0.5 4.3 0.0 0.0 9.1 0.1 0.0 9.4 35.8 4.7 0.2 0.0 5.3 0.2 10.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.7 1.3 18.8 0.2 0.6 2.2 0.4 0.0 0.0 0.0 15.3 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 39.1 0.0 0.2 0.0 0.0 43.2 33.3 2.4 54.2 4.6 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 13.7 0.4 11.4 3.0 1.6 0.0 0.6 11.9 GAL3ST1 CST ENSG00000128242 "Galactose-3-O-sulfotransferase 1" Q99999 22 30554635-30574587 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 38.2;Enterocytes: 17.4;Muller glia cells: 29.4;Proximal tubular cells: 18.9" "Cancer enriched" "Detected in many" 6 "renal cancer: 38.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 22.7;CACO-2: 6.3;EFO-21: 12.3;K-562: 5.3;OE19: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001220, HPA077138" Approved Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Vesicles Nucleoplasm "HPA001220: AB_1078933, HPA077138: " "unprognostic (2.69e-2)" "unprognostic (3.12e-4)" "unprognostic (5.93e-2)" "unprognostic (1.08e-2)" "unprognostic (2.32e-1)" "unprognostic (6.50e-3)" "unprognostic (1.53e-2)" "unprognostic (2.23e-1)" "unprognostic (2.89e-1)" "unprognostic (5.18e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (2.33e-1)" "unprognostic (4.23e-2)" "unprognostic (1.24e-1)" "unprognostic (3.56e-2)" 0.8 0.6 8.4 0.7 9.6 1.2 0.8 1.4 12.3 1.4 11.3 25.8 0.0 24.2 1.3 2.3 0.8 2.2 13.4 0.5 12.1 8.3 13.3 1.6 1.5 0.9 14.0 2.6 1.2 2.9 0.6 0.5 1.3 12.4 1.2 2.8 0.3 1.0 1.9 1.9 2.1 25.1 0.7 28.7 0.7 7.2 2.5 7.8 0.0 0.6 0.0 0.4 1.0 0.7 2.3 2.8 2.3 0.7 0.3 0.8 0.0 0.1 22.7 0.4 0.2 0.0 0.0 1.7 0.0 0.1 0.0 0.0 6.3 3.1 0.3 12.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.8 0.3 0.2 4.1 0.5 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.3 5.3 0.6 0.0 0.1 0.3 0.9 3.3 8.5 0.3 0.2 0.1 0.6 0.9 0.1 0.3 1.5 0.0 0.4 0.2 0.6 0.1 0.1 0.6 0.2 0.1 0.2 0.0 2.0 1.2 0.3 0.1 0.1 0.2 0.9 0.7 0.1 0.4 0.5 0.7 1.8 0.7 0.8 0.2 2.3 0.5 0.8 2.3 0.3 0.3 2.8 0.1 0.0 8.4 9.6 1.4 10.3 12.1 8.3 14.0 2.6 12.4 7.8 0.0 0.0 0.0 0.1 0.3 0.7 0.6 38.2 0.0 0.0 3.5 0.0 0.0 13.3 5.6 0.9 0.1 17.4 0.0 9.7 0.0 0.0 0.2 0.0 1.3 0.1 0.0 10.5 0.0 0.8 0.6 1.4 0.0 0.0 0.0 7.4 29.4 4.6 7.0 2.1 18.9 1.1 0.0 0.0 3.1 7.5 0.3 0.2 0.0 8.0 0.0 GAL3ST2 GP3ST ENSG00000154252 "Galactose-3-O-sulfotransferase 2" Q9H3Q3 2 241776825-241804208 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 8.6;intestine: 16.0;lymphoid tissue: 11.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 1.8;Hep G2: 6.5;HMC-1: 2.0" HPA071809 Enhanced "Intracellular and membrane" NA NA "HPA071809: AB_2686450" "unprognostic (5.22e-3)" "unprognostic (6.52e-2)" "unprognostic (1.85e-2)" "unprognostic (4.04e-3)" "unprognostic (3.04e-4)" "unprognostic (3.45e-2)" "unprognostic (2.48e-2)" "unprognostic (2.87e-1)" "unprognostic (4.13e-2)" "unprognostic (2.25e-3)" "unprognostic (2.58e-1)" "unprognostic (4.99e-2)" "unprognostic (2.87e-11)" "unprognostic (4.32e-2)" "unprognostic (1.55e-1)" "unprognostic (5.99e-3)" "unprognostic (3.49e-1)" 1.0 0.6 0.5 11.6 0.7 0.1 0.1 0.1 0.5 1.9 16.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 8.6 0.1 0.4 0.6 0.4 0.9 1.3 0.1 0.2 0.0 1.7 0.1 0.1 0.4 0.1 0.0 0.3 6.6 0.0 3.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.2 0.1 0.9 11.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GAL3ST3 GAL3ST2 ENSG00000175229 "Galactose-3-O-sulfotransferase 3" Q96A11 11 66041952-66049180 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.4;retina: 14.2;thyroid gland: 28.0" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 14.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Group enriched" "Detected in some" 5 "NTERA-2: 12.6;SH-SY5Y: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "prognostic unfavorable (6.53e-6)" "unprognostic (1.24e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "unprognostic (2.62e-1)" "unprognostic (6.08e-2)" "unprognostic (2.01e-3)" "unprognostic (7.26e-2)" "unprognostic (2.07e-2)" "unprognostic (1.40e-1)" "unprognostic (5.29e-1)" 0.8 0.7 6.3 0.7 15.4 0.7 0.7 7.5 14.5 5.4 0.8 2.4 0.3 0.8 8.0 1.0 0.8 2.5 0.8 5.9 6.1 4.3 4.0 0.7 0.7 0.9 2.9 5.0 0.9 1.5 1.9 3.5 0.7 3.7 2.2 0.7 14.2 0.8 5.9 1.3 1.0 0.8 9.7 1.2 0.7 0.7 2.6 2.0 0.0 28.0 0.0 0.8 0.7 0.2 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 12.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.3 15.4 7.5 14.5 6.1 4.3 2.9 5.0 3.7 2.0 0.0 0.0 0.0 0.0 0.0 2.9 2.4 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.1 0.0 14.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 GAL3ST4 FLJ12116 ENSG00000197093 "Galactose-3-O-sulfotransferase 4" Q96RP7 7 100159244-100168750 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.8" "Cell type enriched" "Detected in some" 6 "Hofbauer cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 26 "dendritic cells: 4.3;T-cells: 15.0" "Cell line enhanced" "Detected in many" "WM-115: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038137, HPA038138" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038137: AB_10697239, HPA038138: AB_2675854" "unprognostic (4.22e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (8.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (2.80e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (3.98e-2)" "unprognostic (9.67e-2)" "unprognostic (1.89e-2)" "unprognostic (5.36e-2)" 3.9 5.4 8.4 4.2 9.4 1.0 4.1 1.5 10.9 7.8 6.5 18.6 0.4 4.1 9.0 3.7 8.4 6.3 5.9 4.9 8.0 3.8 1.8 1.0 5.3 2.9 11.9 4.7 7.6 1.5 1.6 4.6 9.8 8.1 6.5 7.0 4.2 24.9 4.3 1.9 27.8 8.9 10.6 14.9 2.7 2.8 4.4 10.2 37.8 2.0 2.4 3.9 7.3 10.6 0.1 4.3 0.3 0.1 0.2 15.0 2.2 0.0 0.6 4.0 1.8 3.6 7.1 7.6 2.2 2.2 1.3 1.8 0.4 0.2 0.7 0.5 7.4 2.3 8.6 0.2 1.3 0.4 0.0 0.4 0.2 0.1 0.2 2.4 0.4 2.4 8.7 3.4 3.9 0.4 2.8 2.5 3.1 1.1 0.1 2.4 0.3 2.7 0.1 1.3 8.2 0.9 2.2 1.8 0.1 0.0 0.3 0.2 1.7 0.6 0.0 4.6 0.7 0.0 0.2 2.2 0.2 1.2 0.3 0.1 0.1 0.1 1.7 1.4 0.4 29.6 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.4 0.3 0.0 0.1 15.0 4.5 0.3 0.2 0.1 4.3 1.1 2.2 8.4 9.4 1.5 10.9 8.0 3.8 11.9 4.7 8.1 10.2 0.0 0.3 0.0 2.0 3.8 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.2 6.0 0.3 0.0 0.0 38.9 0.0 0.0 1.8 0.3 0.0 4.4 0.7 5.0 1.0 0.6 0.5 0.5 2.9 4.9 0.0 0.0 0.0 2.2 0.4 0.2 7.0 0.7 0.0 6.0 0.9 GALK1 GALK ENSG00000108479 "Galactokinase 1" P51570 17 75751594-75765711 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Kinase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 36.7" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007094, HPA016960" Approved Approved "Golgi apparatus,Cytosol" NA NA 8600 Cytosol "Golgi apparatus" "HPA007094: AB_1078939, HPA016960: AB_1849430" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (1.81e-2)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.04e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (3.04e-1)" "unprognostic (1.71e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.62e-5)" 6.4 3.3 3.8 6.2 4.4 3.6 14.2 4.6 5.1 4.7 9.3 3.7 3.5 15.9 4.7 5.0 9.0 4.8 3.8 7.2 3.6 3.6 12.3 31.6 4.7 11.7 4.3 3.8 5.2 16.0 1.9 2.6 4.6 3.2 4.7 1.3 3.6 14.9 4.7 5.4 6.2 17.3 3.7 4.0 7.2 5.3 5.7 3.3 7.6 3.3 5.1 4.8 3.6 5.0 10.6 36.7 20.7 30.2 5.7 9.4 14.6 8.1 30.7 1.9 8.6 2.7 6.8 7.2 6.6 5.5 6.8 6.4 17.0 1.6 12.7 8.3 3.5 5.0 4.8 2.0 1.9 0.7 5.5 19.2 7.9 11.6 28.5 9.3 5.3 17.6 6.1 2.7 3.4 1.5 3.4 15.8 7.2 6.2 7.8 4.1 34.9 14.6 19.9 2.1 3.8 15.9 17.5 21.4 21.1 3.8 3.3 4.2 11.6 5.6 14.5 14.4 1.5 11.8 8.7 13.9 10.1 9.7 9.6 5.8 19.7 4.8 3.2 11.3 12.4 7.8 2.6 30.2 8.3 9.4 25.5 8.5 10.6 7.8 8.6 27.2 6.8 4.2 6.2 20.7 5.7 20.2 36.7 8.7 14.6 3.8 4.4 4.6 5.1 3.6 3.6 4.3 3.8 3.2 3.3 14.9 11.7 15.8 8.2 7.7 6.8 17.6 20.4 0.0 3.4 12.2 0.0 41.6 58.0 23.3 0.6 17.9 12.3 0.0 47.9 88.4 28.2 7.0 27.6 107.1 49.1 3.2 8.1 30.7 45.2 3.6 28.7 28.4 37.1 27.9 13.6 15.8 25.0 25.1 22.6 75.3 6.2 6.5 12.3 1.2 22.0 10.9 35.4 15.0 24.0 7.6 GALM ENSG00000143891 "Galactose mutarotase" Q96C23 2 38665910-38741237 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 54.2" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 102.0;Proximal tubular cells: 198.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 29.7" "Group enriched" "Detected in all" 5 "granulocytes: 13.2;T-cells: 29.7" "Cell line enhanced" "Detected in many" "Karpas-707: 27.8;U-266/70: 31.3" "Low region specificity" "Detected in all" "HPA035472, HPA035473, HPA064835" Enhanced Approved Nucleoplasm NA NA 570000 Nucleoplasm "HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723" "unprognostic (5.02e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (9.20e-2)" "unprognostic (1.88e-2)" "unprognostic (9.99e-3)" "unprognostic (1.63e-2)" "unprognostic (2.80e-3)" "unprognostic (1.87e-1)" "unprognostic (7.17e-2)" "unprognostic (6.65e-2)" "unprognostic (6.45e-2)" "prognostic favorable (9.06e-5)" "unprognostic (1.70e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "prognostic favorable (1.32e-4)" 11.2 54.2 3.1 10.4 2.5 0.7 4.6 1.9 2.7 5.9 28.4 2.5 44.3 22.7 6.8 11.8 3.4 11.6 13.3 7.7 2.5 1.8 39.1 28.8 5.8 6.4 2.4 1.9 6.4 7.9 10.4 2.4 3.1 2.9 8.1 10.7 15.3 7.9 29.1 4.6 2.2 39.8 5.4 3.3 4.1 5.0 4.7 2.1 6.4 7.4 3.3 9.3 6.5 5.2 2.8 4.5 13.2 2.1 2.3 29.7 5.3 0.0 10.6 3.3 0.0 11.1 6.5 5.9 1.3 4.0 3.0 4.9 11.9 5.6 4.1 7.9 5.9 6.0 1.7 4.6 0.3 6.0 18.7 7.7 2.2 2.9 23.7 4.0 0.9 0.1 4.5 0.1 6.8 0.0 4.2 3.4 0.0 6.3 27.8 5.5 0.3 9.1 14.8 5.0 22.6 3.5 5.7 0.2 8.0 3.9 18.4 0.6 4.7 0.0 7.6 5.4 4.4 3.6 2.1 1.3 1.0 0.2 7.3 0.4 31.3 21.1 0.1 6.9 2.6 0.1 13.2 2.1 1.8 10.2 1.5 15.0 2.8 16.0 14.8 4.5 2.5 5.8 5.0 5.1 2.3 0.2 0.4 29.7 5.3 3.1 2.5 1.9 2.7 2.5 1.8 2.4 1.9 2.9 2.1 26.8 11.2 12.5 6.5 6.0 2.9 17.3 22.9 24.1 9.1 66.3 0.0 17.0 21.6 9.1 0.8 9.3 102.0 0.0 13.3 25.1 14.3 6.4 6.9 40.4 91.8 3.2 12.7 6.2 12.3 0.5 18.7 36.1 16.9 12.6 36.5 34.6 10.1 63.0 91.9 198.6 7.1 6.5 9.6 1.0 2.1 5.3 5.3 24.5 72.8 4.7 GALNT10 GalNAc-T10 ENSG00000164574 "Polypeptide N-acetylgalactosaminyltransferase 10" Q86SR1 5 154190730-154420984 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 43.7" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 74.0;TIME: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007525 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 830000 "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA007525: AB_1849443" "unprognostic (6.99e-2)" "unprognostic (4.33e-2)" "unprognostic (9.85e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.63e-1)" "unprognostic (6.98e-2)" "unprognostic (6.95e-3)" "unprognostic (2.38e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.69e-4)" "unprognostic (2.88e-3)" "unprognostic (2.63e-1)" "unprognostic (1.54e-1)" "unprognostic (7.76e-3)" "unprognostic (1.22e-1)" "unprognostic (1.61e-2)" "unprognostic (3.08e-1)" 9.5 13.5 8.4 15.4 9.1 10.1 8.7 3.2 6.2 15.9 10.6 14.4 1.0 8.8 4.9 11.5 5.9 9.2 17.8 7.7 6.9 7.5 6.8 3.4 10.1 11.5 7.2 5.2 43.7 9.2 14.1 9.7 5.2 10.1 8.3 9.4 31.6 11.6 2.4 5.6 4.0 12.4 14.1 7.7 16.7 13.8 4.3 9.2 5.6 10.6 4.2 9.3 7.5 10.0 4.7 3.1 5.7 3.8 3.9 7.5 2.1 6.2 21.4 5.2 4.5 11.1 9.9 4.0 18.1 10.1 7.2 6.9 3.0 14.4 4.1 12.8 30.4 12.9 1.1 2.4 14.1 6.6 10.6 1.7 11.2 4.1 4.0 8.5 2.4 10.9 12.3 3.3 5.8 8.6 74.0 13.8 3.1 2.5 13.0 12.3 6.5 0.2 1.6 2.0 17.6 4.4 1.2 2.7 4.1 10.0 4.3 0.7 1.7 8.0 30.0 2.3 8.0 11.6 1.8 40.5 17.6 4.2 4.3 19.2 3.7 3.6 2.2 11.5 4.8 5.3 3.4 2.7 5.3 7.5 3.6 6.6 4.5 4.3 4.8 3.1 4.7 1.9 5.3 5.7 3.9 3.8 2.7 3.5 2.1 8.4 9.1 3.2 6.2 6.9 7.5 7.2 5.2 10.1 9.2 8.9 36.1 12.3 3.5 4.2 3.5 4.1 5.1 0.0 12.5 14.0 3.9 0.6 8.3 9.3 10.6 13.4 15.5 23.3 26.2 1.2 9.1 9.9 10.3 4.7 7.2 0.0 2.9 19.0 15.4 16.0 35.4 9.7 0.0 6.4 16.1 20.8 26.5 11.5 47.0 2.9 11.4 6.5 7.3 1.7 3.1 3.1 0.7 13.8 9.3 2.8 GALNT11 GalNAc-T11 ENSG00000178234 "Polypeptide N-acetylgalactosaminyltransferase 11" Q8NCW6 7 152025674-152122347 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Notch signaling pathway" "Glycosyltransferase, Transferase" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 82.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 116.5;Proximal tubular cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039330 Uncertain NA NA "HPA039330: AB_10795249" "unprognostic (6.09e-2)" "unprognostic (1.22e-1)" "unprognostic (4.98e-2)" "unprognostic (3.48e-2)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.76e-1)" "unprognostic (9.10e-3)" "unprognostic (1.56e-3)" "unprognostic (1.38e-1)" "unprognostic (3.65e-1)" "unprognostic (3.82e-2)" "unprognostic (1.64e-1)" "prognostic favorable (2.24e-6)" "unprognostic (1.33e-1)" "unprognostic (1.17e-1)" "unprognostic (2.97e-1)" "unprognostic (9.51e-2)" 10.7 9.4 11.1 5.1 18.7 3.8 10.4 20.8 21.8 9.1 7.5 11.4 7.1 5.1 9.6 9.2 9.8 8.3 9.3 9.2 11.4 9.3 82.0 7.1 9.6 4.9 7.0 13.4 10.6 29.7 19.3 10.5 15.9 34.1 12.0 6.5 21.7 7.8 9.8 8.8 8.3 6.9 9.5 6.5 8.5 7.6 7.3 4.4 4.6 12.5 5.6 6.4 9.4 8.1 6.3 8.3 8.2 12.5 15.7 19.3 8.7 10.6 9.6 14.2 15.8 32.9 32.5 14.6 8.5 9.8 7.2 6.8 7.7 11.3 0.0 22.3 13.8 20.1 5.0 6.7 12.1 8.9 8.8 10.0 2.1 8.7 6.7 10.8 9.6 11.4 28.6 15.6 6.0 5.0 12.6 13.0 7.5 10.7 0.1 18.0 9.2 8.2 8.7 11.6 16.8 7.7 0.0 6.2 0.3 23.7 16.5 12.6 16.8 14.2 6.9 11.5 15.8 10.3 8.3 11.7 9.7 3.4 12.2 9.3 3.2 4.0 0.1 20.2 9.4 33.0 5.8 8.3 8.2 19.3 9.4 19.0 6.3 10.7 17.7 8.3 3.8 9.2 14.0 4.4 15.7 12.5 2.5 7.9 8.7 11.1 18.7 20.8 21.8 11.4 9.3 7.0 13.4 34.1 4.4 11.9 18.5 17.9 21.5 9.3 116.5 24.0 10.2 20.1 11.4 33.2 25.5 66.9 51.4 15.4 3.0 20.7 7.7 0.0 16.2 11.7 25.1 24.5 13.9 13.5 21.9 71.5 21.9 25.8 16.5 2.9 18.4 11.5 16.9 15.4 9.0 30.9 11.9 7.0 33.9 163.9 35.9 0.0 21.7 17.7 13.8 10.3 30.3 22.0 8.5 15.4 GALNT12 GalNAc-T12 ENSG00000119514 "Polypeptide N-acetylgalactosaminyltransferase 12" Q8IXK2 9 98807699-98850081 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 34.7" "Cell type enhanced" "Detected in many" 13 "Mucus-secreting cells: 122.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 17.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 41.8;U-2197: 54.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA048292 Enhanced "Intracellular and membrane" NA NA 15000 "HPA048292: AB_2680343" "unprognostic (7.85e-3)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (1.47e-2)" "unprognostic (2.97e-3)" "unprognostic (4.10e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (1.97e-1)" "unprognostic (2.61e-2)" "unprognostic (7.71e-2)" "prognostic favorable (3.24e-4)" "unprognostic (9.05e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-3)" "unprognostic (6.87e-2)" 7.5 1.7 1.0 9.5 2.3 0.6 3.7 17.7 1.6 4.0 29.6 1.7 7.4 14.6 1.8 34.7 15.2 3.2 20.5 1.1 1.4 1.6 2.9 0.4 13.8 1.1 3.3 1.0 1.0 9.2 4.0 3.1 1.0 2.7 4.2 24.8 4.0 15.2 6.6 1.1 2.6 22.4 15.4 1.3 1.5 23.5 3.4 1.1 2.8 9.3 8.1 23.9 9.0 3.4 0.8 0.4 1.6 0.0 2.2 2.5 0.4 1.7 1.3 1.1 4.5 3.4 2.7 0.0 0.4 0.7 0.7 1.5 0.2 7.2 0.0 1.7 0.3 4.1 12.6 1.0 0.4 0.5 8.4 0.6 0.8 0.0 0.0 0.1 0.5 0.1 1.3 0.3 2.1 0.0 0.9 0.8 6.4 9.6 0.0 0.2 4.5 0.8 1.5 5.6 41.8 1.8 2.1 0.1 0.0 0.8 2.5 4.2 0.4 0.1 10.3 1.0 2.7 1.5 1.4 1.4 0.0 0.1 54.3 0.0 0.7 1.5 0.7 12.7 0.0 0.3 0.0 0.0 1.6 1.4 0.0 2.5 0.1 1.9 0.8 0.2 0.8 2.3 1.5 0.1 2.2 0.0 0.4 0.1 0.4 1.0 2.3 17.7 1.6 1.4 1.6 3.3 1.0 2.7 1.1 3.0 22.6 0.9 1.3 2.2 0.9 0.5 25.5 13.4 14.8 10.4 15.7 0.9 0.0 6.4 1.4 0.7 29.9 0.0 21.7 1.5 5.6 10.5 2.3 0.0 2.1 0.0 19.1 0.0 0.3 1.1 2.0 1.7 0.0 0.0 122.4 0.3 23.8 31.7 7.1 3.0 0.1 0.0 1.2 4.7 12.1 1.1 0.9 3.8 33.7 8.2 GALNT13 "GalNAc-T13, KIAA1918" ENSG00000144278 "Polypeptide N-acetylgalactosaminyltransferase 13" Q8IUC8 2 153871913-154453849 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 23.8;Bipolar cells: 15.1;Cone photoreceptor cells: 49.1;Horizontal cells: 68.3" "Cancer enriched" "Detected in some" 5 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SH-SY5Y: 28.2;U-251 MG: 7.4;WM-115: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060775 Approved NA NA "HPA060775: AB_2684358" "unprognostic (1.97e-1)" "unprognostic (3.43e-3)" "unprognostic (2.47e-2)" "unprognostic (1.00e-3)" "unprognostic (4.21e-3)" "unprognostic (7.73e-3)" "unprognostic (6.50e-2)" "unprognostic (8.17e-2)" "unprognostic (3.57e-1)" "unprognostic (9.15e-2)" "unprognostic (3.83e-2)" "unprognostic (3.09e-2)" "unprognostic (5.17e-2)" "unprognostic (2.05e-5)" "unprognostic (8.61e-3)" "unprognostic (1.52e-1)" "unprognostic (2.05e-1)" 3.0 7.7 8.5 0.7 6.2 0.6 1.4 39.0 29.1 3.1 0.9 7.9 0.6 0.7 3.1 2.3 0.7 1.0 1.1 0.6 7.8 8.9 0.6 0.4 3.4 0.4 8.3 3.1 1.1 1.0 0.5 3.1 1.0 10.5 3.6 1.0 1.1 10.9 2.6 1.7 0.8 0.8 2.0 10.4 0.5 1.1 1.3 4.3 0.0 0.4 0.0 0.5 1.5 0.2 0.2 0.6 2.2 0.9 0.2 0.8 0.0 0.0 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.4 0.0 0.0 0.0 1.8 0.0 3.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.1 4.7 0.1 4.4 0.0 0.2 0.6 0.0 0.0 4.8 28.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.1 7.4 0.3 0.0 0.0 4.6 0.0 21.1 0.0 0.9 2.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.8 0.1 0.2 0.0 0.6 0.4 0.0 8.5 6.2 39.0 7.4 7.8 8.9 8.3 3.1 10.5 4.3 23.8 1.4 0.0 0.0 0.1 15.1 0.8 0.0 0.0 2.3 0.0 49.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 68.3 3.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.4 0.1 0.0 0.0 0.0 0.0 GALNT14 "FLJ12691, GalNac-T10, GalNac-T14" ENSG00000158089 "Polypeptide N-acetylgalactosaminyltransferase 14" Q96FL9 2 30910467-31155202 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 42.7" "Cell type enhanced" "Detected in some" 18 "Distal tubular cells: 11.6;Ito cells: 11.1;Proximal tubular cells: 39.7" "Cancer enriched" "Detected in many" 7 "renal cancer: 45.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 10.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 13.1;RPMI-8226: 15.2;RPTEC TERT1: 22.4;RT4: 16.6;SCLC-21H: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030138 Approved "Nucleoplasm,Golgi apparatus" NA NA 9400 "Golgi apparatus" Nucleoplasm "HPA030138: AB_2673332" "unprognostic (5.69e-2)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (2.82e-3)" "unprognostic (3.85e-2)" "unprognostic (2.10e-2)" "unprognostic (3.32e-1)" "unprognostic (7.58e-2)" "unprognostic (1.96e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (5.18e-3)" "unprognostic (2.67e-2)" "unprognostic (2.56e-1)" "unprognostic (9.51e-3)" 1.2 1.5 1.5 0.9 3.7 4.3 1.1 1.8 9.6 1.4 0.6 1.8 0.3 0.6 0.6 1.0 10.2 1.1 3.7 0.4 1.6 1.5 42.7 1.2 0.6 2.6 1.2 2.3 0.9 2.7 7.6 5.7 0.2 0.9 1.7 0.2 2.1 1.7 0.2 0.4 1.9 3.1 0.7 0.8 1.8 0.6 1.6 0.3 0.1 1.1 1.0 4.2 2.0 1.4 1.4 0.0 10.6 0.0 0.0 0.0 0.1 11.1 13.1 0.0 0.0 0.0 0.0 0.0 3.7 2.0 2.5 0.3 0.0 0.0 10.4 3.8 0.2 0.0 0.0 0.4 0.5 0.4 0.3 1.3 5.8 0.0 0.0 0.0 8.4 0.0 0.1 2.3 0.0 8.6 0.1 0.0 0.3 0.0 9.3 0.0 5.1 0.0 0.0 6.2 0.0 0.0 7.3 0.0 15.2 22.4 16.6 12.3 8.9 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.8 0.0 0.2 0.9 2.8 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 1.5 3.7 1.8 9.6 1.6 1.5 1.2 2.3 0.9 0.3 0.0 0.0 0.8 3.8 2.5 0.2 0.4 0.0 0.0 1.2 8.7 0.0 0.0 11.6 2.5 5.3 0.6 0.4 0.0 0.3 0.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 11.1 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 39.7 0.3 6.5 0.8 0.4 3.4 0.6 0.0 0.0 0.0 1.0 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174649-16231992 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 66.7;brain: 52.3" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 19.5;Endothelial cells: 15.2;Ito cells: 39.9;Muller glia cells: 48.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 44.9;ASC TERT1: 44.3;HSkMC: 33.7" "Group enriched" "Detected in many" 4 "cerebellum: 10.7;pons and medulla: 6.7" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 25000 "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 66.7 5.3 7.6 2.6 17.4 1.1 22.8 2.3 31.5 3.9 8.6 28.1 1.1 2.8 3.5 3.3 11.4 5.3 5.2 7.3 14.8 6.6 8.3 2.8 3.1 3.4 38.9 8.4 8.4 3.2 1.6 1.0 35.5 24.8 4.9 3.8 1.3 8.0 4.1 17.3 11.6 5.3 10.5 52.3 12.8 4.6 8.1 19.9 0.0 6.3 1.6 1.5 16.6 23.5 0.6 0.9 0.9 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 44.9 44.3 0.0 1.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 33.7 0.0 0.4 0.5 0.3 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 7.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.0 0.6 0.4 0.2 0.9 0.3 0.3 0.9 0.3 0.3 7.6 17.4 2.3 13.6 14.8 6.6 38.9 8.4 24.8 19.9 0.0 1.7 0.0 0.5 0.5 0.8 1.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.5 15.2 0.0 0.0 0.0 0.0 2.9 1.2 1.1 0.2 0.1 0.0 0.0 39.9 0.6 10.6 1.7 0.2 0.0 0.0 0.0 48.3 0.2 0.0 0.7 0.0 3.1 0.0 1.2 10.2 0.5 0.6 0.0 0.0 0.0 0.1 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132169-71713600 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Cell type enhanced" "Detected in single" 28 "Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 1.8 7.8 8.2 2.1 13.9 0.5 1.2 25.7 42.9 2.3 4.9 1.7 1.9 0.8 7.9 4.6 8.9 4.4 2.7 19.4 13.2 4.6 2.3 0.6 3.5 0.5 2.1 12.0 22.3 9.4 0.6 4.1 0.7 4.5 9.1 1.4 1.2 1.7 8.3 1.9 0.8 1.5 12.3 1.2 3.3 1.1 3.8 0.8 0.3 9.4 0.0 1.8 10.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.5 0.0 0.0 30.5 0.0 10.0 0.0 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 13.9 25.7 22.5 13.2 4.6 2.1 12.0 4.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT2 GalNAc-T2 ENSG00000143641 "Polypeptide N-acetylgalactosaminyltransferase 2" Q10471 1 230057990-230282124 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 140.3" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 114.0;Extravillous trophoblasts: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 90.9" "Low region specificity" "Detected in all" HPA011222 Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 11000000 "Golgi apparatus" "HPA011222: AB_1849446" "unprognostic (1.26e-1)" "prognostic unfavorable (1.22e-6)" "unprognostic (1.15e-2)" "unprognostic (1.35e-2)" "unprognostic (8.70e-3)" "unprognostic (7.77e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.48e-8)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (1.70e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.79e-13)" "unprognostic (3.79e-3)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" 19.5 25.6 11.1 19.6 10.1 6.9 20.4 7.7 12.5 11.7 12.7 9.1 10.5 11.3 13.7 11.5 11.5 13.2 17.0 13.9 12.5 8.5 17.5 140.3 13.2 20.4 8.4 9.0 24.8 35.9 4.3 7.3 16.6 12.6 10.8 7.5 10.5 11.1 9.6 42.2 8.4 11.3 14.6 13.6 9.5 18.0 12.7 8.2 28.4 10.7 10.7 7.0 14.9 13.1 6.7 13.5 3.5 10.1 2.7 5.3 6.3 16.2 21.7 12.8 15.1 24.6 21.0 26.4 30.7 19.1 12.5 12.0 9.3 30.9 4.1 22.9 16.2 29.2 31.7 8.4 25.8 10.5 41.0 11.0 12.5 48.5 10.4 13.4 4.7 24.6 30.0 12.8 16.7 6.7 27.5 14.6 23.2 15.5 6.3 13.8 4.4 24.6 4.8 17.5 10.9 20.7 27.5 18.3 12.6 12.3 19.3 4.0 15.1 31.1 1.6 18.7 7.1 9.9 9.0 34.6 12.3 23.7 27.7 24.3 21.0 12.0 9.2 31.6 9.6 90.9 1.1 10.1 3.5 4.7 9.6 3.6 3.8 2.9 4.7 7.9 6.7 2.8 5.3 3.2 2.7 9.6 13.5 3.4 6.3 11.1 10.1 7.7 11.8 12.5 8.5 8.4 9.0 12.6 8.2 14.9 14.7 24.2 16.5 13.6 27.5 13.9 22.9 9.4 15.9 22.7 31.4 5.3 5.0 41.3 43.0 13.8 16.1 0.0 114.0 106.1 24.4 21.9 12.7 80.2 23.0 27.0 16.1 15.4 38.3 19.2 33.1 18.8 23.6 47.7 17.9 11.2 87.4 17.6 27.6 18.9 69.7 12.9 11.3 3.6 10.6 6.9 13.8 15.2 15.3 14.0 GALNT5 GalNAc-T5 ENSG00000136542 "Polypeptide N-acetylgalactosaminyltransferase 5" Q7Z7M9 2 157257598-157314211 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008963, HPA009035" Approved Approved "Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA 630000 "Golgi apparatus, Cytosol" "Nucleoli, Vesicles" "HPA008963: AB_1078942, HPA009035: AB_1078943" "unprognostic (6.34e-3)" "unprognostic (9.31e-2)" "unprognostic (2.11e-2)" "unprognostic (9.89e-2)" "unprognostic (3.19e-2)" "unprognostic (2.46e-2)" "unprognostic (4.63e-3)" "unprognostic (1.88e-1)" "unprognostic (1.09e-1)" "unprognostic (6.93e-2)" "unprognostic (4.01e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-2)" "unprognostic (6.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (9.48e-3)" 0.4 0.2 0.2 1.5 0.2 0.5 1.1 28.2 0.2 7.5 12.0 0.7 0.0 2.3 0.5 0.5 9.0 0.2 17.1 0.9 0.4 0.2 0.3 0.2 15.5 0.0 0.2 0.0 0.3 1.5 0.0 6.8 0.1 4.4 1.6 16.1 0.3 18.9 0.2 0.2 0.5 8.4 0.8 0.3 0.3 15.2 0.5 0.0 0.1 0.3 12.2 11.7 2.3 6.6 0.2 0.1 0.2 0.1 0.1 0.5 0.0 23.6 2.6 0.0 0.0 1.0 8.3 0.0 15.5 27.8 0.2 0.6 1.1 13.6 0.0 0.0 32.4 0.0 27.7 0.5 5.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.5 0.0 0.0 0.0 16.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.2 0.2 28.2 0.2 0.4 0.2 0.2 0.0 4.4 0.0 145.9 29.7 0.0 10.3 0.7 0.0 0.4 2.5 5.3 36.4 0.0 0.0 0.0 0.0 0.8 5.1 0.0 18.6 23.3 2.9 0.0 2.1 7.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.6 3.3 2.8 66.8 0.0 31.4 31.7 0.0 0.0 0.0 0.0 0.1 2.6 0.2 0.1 0.0 0.0 20.7 121.3 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 35.4" "Cell type enriched" "Detected in many" 4 "granulocytes: 164.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 23.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 33.6;CACO-2: 33.2;OE19: 28.5;SK-BR-3: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 2900000 "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favorable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 3.1 1.8 4.0 4.1 9.5 4.4 10.6 1.0 5.1 19.5 13.4 15.4 0.5 11.8 0.9 14.4 2.8 3.7 6.8 0.8 7.1 3.6 2.5 0.8 4.1 4.0 14.4 3.6 1.4 6.3 0.4 1.6 9.9 5.8 1.3 3.9 0.9 23.8 6.3 0.6 5.5 16.9 0.8 8.3 5.5 35.4 0.8 9.7 6.6 1.8 2.3 6.6 2.2 2.2 2.9 3.7 23.8 6.5 10.8 3.4 2.8 11.5 1.2 0.2 0.0 0.0 0.1 18.5 19.3 33.6 8.3 5.6 33.2 6.1 0.1 1.8 10.9 0.0 11.1 0.6 8.4 5.2 2.6 1.2 7.3 0.2 0.2 0.3 3.9 26.1 0.7 7.8 7.4 7.1 0.0 20.3 4.2 1.6 0.3 0.0 22.6 12.4 2.9 1.6 28.5 20.9 0.0 0.0 3.3 6.5 0.8 0.1 7.4 0.1 33.8 0.0 3.9 18.8 1.7 23.9 0.0 4.2 0.0 0.0 0.6 0.1 1.0 2.3 8.7 0.1 4.5 4.4 23.8 3.4 3.7 1.4 0.8 1.7 2.6 3.7 2.9 2.7 2.3 0.8 10.8 6.5 3.1 1.1 2.8 4.0 9.5 1.0 5.1 7.1 3.6 14.4 3.6 5.8 9.7 3.0 3.7 15.2 2.7 2.6 0.4 0.8 2.5 10.7 14.8 1.8 0.0 11.3 3.3 2.7 1.6 1.4 20.4 0.0 9.8 40.7 1.7 5.0 164.7 0.0 13.2 0.0 0.0 2.5 12.0 1.0 0.0 11.8 1.7 1.0 14.2 0.0 15.6 26.2 0.4 1.8 0.0 0.0 0.9 0.2 1.2 8.2 4.0 8.7 9.2 5.4 GALNT7 GALNAC-T7 ENSG00000109586 "Polypeptide N-acetylgalactosaminyltransferase 7" Q86SF2 4 173168753-173323967 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 67.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064243, HPA065317" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 5000000 "Golgi apparatus" Nucleoplasm "HPA064243: AB_2685223, HPA065317: AB_2685465" "unprognostic (1.81e-1)" "unprognostic (2.11e-1)" "prognostic favorable (4.53e-4)" "unprognostic (1.37e-3)" "unprognostic (1.48e-1)" "unprognostic (6.86e-3)" "unprognostic (2.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (7.65e-4)" "unprognostic (1.33e-1)" "unprognostic (4.66e-3)" "unprognostic (3.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.34e-3)" "unprognostic (5.97e-2)" 3.7 4.4 8.4 7.4 8.4 5.0 12.0 27.6 8.0 13.4 23.3 9.4 2.8 14.1 9.3 5.5 12.0 4.9 9.5 3.5 6.5 5.2 4.9 1.2 4.5 5.2 10.8 7.0 7.2 14.9 5.3 5.6 6.3 11.2 20.3 26.7 6.2 20.1 4.2 1.4 3.1 16.2 8.4 16.3 5.7 32.8 6.4 8.8 67.4 6.6 4.4 9.6 9.4 4.8 5.0 9.8 16.8 11.4 5.5 6.8 4.7 20.4 10.7 10.6 3.3 5.7 8.4 15.2 5.4 6.1 5.1 7.0 3.3 32.5 11.4 4.0 4.8 13.7 17.5 4.4 9.5 6.9 44.2 8.7 13.9 22.3 0.1 3.8 20.4 9.9 5.4 8.6 11.3 5.7 19.3 33.5 8.3 9.2 17.8 25.7 6.7 15.0 11.3 10.4 20.4 7.1 15.0 9.8 2.9 37.2 9.6 8.5 6.5 2.5 15.0 7.4 14.4 6.0 6.1 40.0 3.6 16.2 0.1 11.6 5.2 0.0 6.1 14.8 12.3 13.0 9.6 11.4 14.6 4.3 6.0 6.2 5.0 4.9 4.6 9.8 3.1 3.9 3.0 16.8 5.5 6.1 4.1 6.8 4.7 8.4 8.4 27.6 8.0 6.5 5.2 10.8 7.0 11.2 8.8 6.0 29.4 4.7 7.8 1.5 36.4 5.9 12.7 14.7 30.7 19.2 2.0 0.9 0.0 12.2 1.8 6.9 70.2 0.0 43.4 2.9 6.6 85.7 23.1 0.0 9.6 9.5 21.9 8.0 21.3 3.1 8.6 8.8 8.5 8.2 125.7 7.5 33.8 50.7 4.9 8.6 23.6 12.9 6.8 2.3 4.4 1.0 0.7 4.4 37.4 15.7 GALNT8 GALNAC-T8 ENSG00000130035 "Polypeptide N-acetylgalactosaminyltransferase 8" "Q9NY28, P17658" 12 4720341-4851927 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Glycosyltransferase, Ion channel, Potassium channel, Transferase, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 12.7;intestine: 33.2;testis: 18.5" "Group enriched" "Detected in some" 6 "Early spermatids: 74.9;Late spermatids: 88.4;Mucus-secreting cells: 32.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 26.1;NTERA-2: 9.3;SuSa: 11.2;U-266/84: 7.5" "Not detected" "Not detected" "HPA012638, HPA073461" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" Yes No "Golgi apparatus, Vesicles" "HPA012638: AB_2294503, HPA073461: AB_2686604" "unprognostic (2.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.13e-2)" "unprognostic (1.75e-2)" "unprognostic (6.24e-2)" "unprognostic (2.87e-1)" "unprognostic (2.59e-2)" "unprognostic (3.79e-1)" "unprognostic (2.72e-1)" "unprognostic (5.76e-2)" "unprognostic (8.06e-5)" "unprognostic (1.16e-2)" "unprognostic (6.67e-5)" "unprognostic (5.18e-2)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-2)" 1.1 2.2 5.3 2.2 6.5 0.5 3.1 1.4 12.7 1.0 15.5 9.4 0.0 7.2 0.9 0.4 0.7 1.2 1.1 3.7 8.0 1.7 1.2 0.8 0.9 1.0 5.7 9.6 1.6 0.9 0.2 3.7 0.5 6.0 1.1 33.2 0.1 1.0 0.9 0.7 0.9 14.7 2.1 3.5 1.2 1.3 18.5 11.5 0.0 0.8 0.5 0.9 1.2 0.9 1.0 0.7 0.1 0.1 0.9 3.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 26.1 0.0 0.0 0.2 0.1 9.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 11.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.3 7.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.3 0.7 1.2 0.0 1.0 0.0 0.1 0.1 0.9 0.0 0.7 3.0 0.0 5.3 6.5 1.4 12.7 8.0 1.7 5.7 9.6 6.0 11.5 6.0 0.3 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.3 0.0 0.0 88.4 1.4 0.0 0.0 0.0 32.6 0.1 0.3 0.0 2.5 1.0 0.3 6.5 0.0 11.6 3.6 0.0 0.0 0.0 1.8 0.0 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329349 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 52.4" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 7.3;Collecting duct cells: 26.2;Proximal tubular cells: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.6" "Cell line enriched" "Detected in some" 4 "U-87 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles NA NA Vesicles "HPA075016: AB_2686729" "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 2.6 2.2 9.3 1.0 6.7 0.6 0.5 52.4 27.9 1.1 0.8 0.8 0.0 1.1 1.8 7.7 0.5 1.9 0.7 0.6 12.9 6.8 3.2 0.5 0.9 1.3 4.3 10.8 1.3 0.4 1.9 2.7 0.5 6.9 1.0 0.6 0.3 1.2 1.7 0.5 0.9 1.0 0.6 1.7 1.2 0.7 0.9 1.1 0.0 6.1 0.0 0.4 0.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.7 0.0 6.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 26.6 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 6.7 52.4 20.2 12.9 6.8 4.3 10.8 6.9 1.1 0.0 1.1 0.0 0.4 0.0 7.3 0.8 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.1 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.8 5.0 2.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.8 GALNTL5 "GalNAc-T5L, GALNT15" ENSG00000106648 "Polypeptide N-acetylgalactosaminyltransferase like 5" Q7Z4T8 7 151956379-152019934 "Disease related genes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 45.0" "Group enriched" "Detected in some" 89 "Early spermatids: 360.6;Late spermatids: 297.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011140 Enhanced NA NA "HPA011140: AB_1078944" "unprognostic (2.33e-2)" "unprognostic (2.09e-1)" "unprognostic (1.55e-1)" 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 1.9 1.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 360.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 297.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.7 1.5 0.0 0.0 0.0 0.0 0.0 GALNTL6 "GalNAc-T6L, GALNT17" ENSG00000174473 "Polypeptide N-acetylgalactosaminyltransferase like 6" Q49A17 4 171812254-173041559 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 7.3;testis: 6.4" "Group enriched" "Detected in some" 5 "Club cells: 3.4;Early spermatids: 11.9;Exocrine glandular cells: 3.7;Late spermatids: 13.6;Melanocytes: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.5;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 8 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.2;Karpas-707: 2.2;SCLC-21H: 2.3;SK-MEL-30: 1.8;U-266/70: 2.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031019 Uncertain "Intracellular and membrane" NA NA "HPA031019: AB_10601653" "unprognostic (6.84e-2)" "unprognostic (1.28e-1)" "unprognostic (2.01e-2)" "unprognostic (5.73e-2)" "unprognostic (7.50e-2)" "unprognostic (8.32e-2)" "unprognostic (3.25e-1)" "unprognostic (9.55e-2)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.06e-1)" "unprognostic (2.80e-1)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.11e-2)" "unprognostic (4.84e-3)" "unprognostic (1.73e-2)" 0.2 0.7 3.9 1.2 8.3 1.1 0.7 1.0 9.5 3.3 1.0 0.6 0.0 0.7 0.3 0.3 0.2 0.3 0.5 0.5 3.6 4.1 0.3 0.5 0.5 1.3 7.6 2.4 0.1 0.5 0.1 0.0 0.1 1.8 2.2 0.7 1.3 0.3 0.2 0.5 0.6 1.2 0.3 0.5 7.3 2.9 6.4 1.2 0.0 0.5 1.1 0.4 0.5 0.6 4.5 0.5 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.5 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.7 1.1 0.0 1.2 0.0 0.3 0.6 0.0 0.0 0.0 3.2 0.0 0.3 0.7 2.2 0.2 1.0 0.3 0.5 1.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.3 0.9 0.0 0.5 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 2.6 0.0 0.0 0.3 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 8.3 1.0 5.9 3.6 4.1 7.6 2.4 1.8 1.2 0.0 1.0 0.0 0.0 0.2 0.6 1.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.6 13.6 0.3 0.0 5.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.9 0.3 0.0 0.0 0.1 0.1 GALP ENSG00000197487 "Galanin like peptide" Q9UBC7 19 56176020-56185775 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Hormone, Neuropeptide" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 4.4;liver: 4.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Region enhanced" "Detected in many" "pons and medulla: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.1;EFO-21: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "hippocampal formation: 29.0" HPA053938 Uncertain "Secreted in brain" NA NA "HPA053938: AB_2682315" "unprognostic (8.51e-3)" "unprognostic (1.22e-2)" "unprognostic (2.65e-1)" "unprognostic (7.02e-2)" 0.0 0.2 1.2 0.0 1.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.1 1.1 0.7 0.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALR1 "GALNR, GALNR1" ENSG00000166573 "Galanin receptor 1" P47211 18 77250549-77277896 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 21.4;Early spermatids: 46.5;Intestinal endocrine cells: 16.9" "Cancer enriched" "Detected in single" 6 "glioma: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Region enhanced" "Detected in some" "hypothalamus: 6.1" "Low region specificity" "Detected in many" HPA074584 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074584: " "unprognostic (1.65e-1)" "unprognostic (1.56e-2)" "unprognostic (2.85e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-1)" "unprognostic (2.77e-3)" "unprognostic (1.31e-2)" "unprognostic (5.34e-3)" "unprognostic (7.33e-3)" "unprognostic (9.49e-2)" "unprognostic (2.18e-1)" 1.1 5.3 1.2 0.3 0.8 0.7 0.5 0.0 3.5 0.0 0.3 0.4 0.2 0.5 0.0 0.3 0.1 0.1 0.7 2.0 0.1 0.5 0.0 0.1 0.8 0.1 0.5 0.0 4.9 0.0 0.8 0.5 0.5 0.7 0.1 0.4 0.5 0.1 0.9 0.0 0.3 0.4 0.3 0.0 0.0 0.1 0.4 0.4 1.6 0.2 0.5 0.3 0.0 0.3 0.4 0.6 0.8 0.5 1.2 0.6 0.2 0.5 0.1 0.1 0.8 1.1 0.8 0.2 0.4 0.2 0.4 0.4 0.3 0.1 1.1 0.6 1.1 0.8 0.5 0.3 0.5 0.8 0.8 0.4 0.3 0.3 0.5 0.3 0.5 0.4 1.6 0.1 0.9 0.4 0.9 0.6 0.1 0.5 0.5 0.4 0.4 0.2 0.6 1.5 0.5 0.2 0.4 0.4 0.9 0.5 0.4 0.6 0.6 0.7 1.1 0.1 0.6 0.3 0.4 0.8 0.3 0.4 1.0 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.2 1.6 0.5 0.2 0.4 0.1 0.0 0.0 5.1 0.0 0.7 0.0 1.8 0.4 0.0 21.4 1.2 1.8 0.0 0.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.1 0.0 16.9 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 GALR2 GALNR2 ENSG00000182687 "Galanin receptor 2" O43603 17 76074794-76077541 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.5;intestine: 13.1;lymphoid tissue: 9.8;smooth muscle: 6.4" "Cell type enhanced" "Detected in single" 15 "B-cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 3.1;NTERA-2: 4.7;PC-3: 3.0;THP-1: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044513 Approved NA NA "HPA044513: AB_10962510" "unprognostic (1.26e-2)" "unprognostic (1.04e-2)" "unprognostic (1.16e-1)" "unprognostic (1.37e-2)" "unprognostic (2.62e-2)" "unprognostic (3.54e-1)" "unprognostic (3.49e-2)" "unprognostic (3.43e-1)" "unprognostic (7.62e-2)" "unprognostic (1.39e-1)" "unprognostic (9.32e-5)" "unprognostic (2.31e-1)" "unprognostic (2.11e-3)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (4.04e-2)" "unprognostic (8.14e-2)" 0.3 0.1 0.0 9.8 0.1 3.5 0.0 0.0 0.3 0.3 13.1 0.0 0.0 0.6 0.0 0.0 1.1 0.1 0.5 0.1 1.4 0.8 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.1 0.4 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.3 9.0 6.4 1.4 0.2 0.4 0.3 0.0 0.0 0.0 1.1 1.2 1.0 0.2 0.0 1.1 1.4 0.9 0.5 0.4 0.7 0.2 1.9 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.4 0.0 2.2 0.5 0.6 0.3 0.0 0.2 3.1 0.0 0.1 0.0 0.3 2.6 0.0 1.6 2.8 0.3 0.6 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.1 0.5 0.1 1.1 0.2 0.3 4.7 0.0 3.0 0.1 0.6 0.8 0.0 0.2 0.2 0.1 1.7 0.7 0.3 0.1 0.6 6.9 0.2 0.2 0.7 0.2 0.4 0.7 0.4 2.6 0.0 0.1 0.0 0.0 0.9 0.0 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.4 0.5 0.4 1.1 0.0 0.7 0.0 0.1 0.0 0.3 1.4 0.8 0.2 0.0 0.6 0.0 0.0 0.0 2.4 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.5 0.1 0.2 0.0 0.0 0.3 GALR3 ENSG00000128310 "Galanin receptor 3" O60755 22 37823382-37825495 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.0;skeletal muscle: 2.5" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.9;HEK 293: 2.3;Hep G2: 3.0;REH: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (4.45e-2)" "unprognostic (1.45e-2)" "unprognostic (4.60e-3)" "unprognostic (7.07e-2)" "unprognostic (7.63e-2)" "unprognostic (8.17e-2)" "unprognostic (4.18e-2)" "unprognostic (2.16e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (2.07e-1)" "unprognostic (1.66e-2)" "unprognostic (7.37e-2)" "unprognostic (8.35e-2)" "unprognostic (4.45e-2)" 0.0 0.0 0.6 0.0 1.3 0.7 0.0 2.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.9 0.0 0.0 0.2 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.9 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 1.2 0.0 1.0 0.4 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.4 0.3 1.2 0.0 0.1 0.0 0.9 1.3 0.0 0.1 0.4 0.3 0.0 0.3 0.4 0.3 0.1 0.7 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 GALT ENSG00000213930 "Galactose-1-phosphate uridylyltransferase" P07902 9 34638133-34651035 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Nucleotidyltransferase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004868, HPA005729" Enhanced Approved Cytosol NA NA 120000 Cytosol "HPA004868: AB_1079130, HPA005729: AB_1079131" "unprognostic (2.38e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-3)" "unprognostic (1.54e-1)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.13e-1)" "unprognostic (3.97e-2)" "unprognostic (1.13e-2)" "prognostic favorable (3.11e-5)" "unprognostic (9.68e-2)" "prognostic favorable (6.25e-6)" "unprognostic (7.90e-2)" "unprognostic (2.74e-1)" "unprognostic (3.56e-1)" "unprognostic (7.75e-2)" 6.3 16.1 8.0 13.8 12.5 7.4 6.6 9.3 7.3 8.5 19.4 5.8 12.4 18.1 7.2 8.4 7.7 6.5 10.5 10.9 6.7 8.6 11.8 47.0 6.8 10.8 9.0 6.0 8.7 7.6 12.1 10.3 21.7 7.5 7.2 6.8 11.0 12.5 13.4 9.5 14.4 26.1 5.9 5.0 9.4 8.1 2.6 7.1 11.3 8.5 7.2 10.6 7.0 6.5 16.3 15.9 10.9 17.5 20.5 21.1 13.1 5.0 6.7 6.1 2.5 8.4 8.5 7.1 3.7 10.7 3.9 4.5 8.3 4.7 5.6 3.9 4.5 1.5 2.7 1.1 10.4 0.7 8.4 4.5 2.3 13.4 8.4 8.2 1.3 3.0 12.3 6.6 2.5 3.1 8.3 9.5 7.4 1.9 6.2 6.3 4.4 4.8 9.5 2.1 5.8 1.2 7.4 5.6 3.0 10.8 7.0 1.4 5.4 4.7 9.4 5.1 4.6 8.4 7.3 1.4 1.8 3.3 3.3 0.0 3.5 2.0 1.2 4.1 4.0 9.9 10.9 17.5 8.3 12.1 15.0 16.7 16.3 19.8 16.3 15.9 9.3 12.2 12.0 3.3 20.5 14.1 13.3 21.1 13.1 8.0 12.5 9.3 7.3 6.7 8.6 9.0 6.0 7.5 7.1 6.0 23.4 12.3 13.7 19.3 40.6 20.7 15.3 6.7 10.3 15.7 45.2 59.8 24.9 16.7 6.9 12.0 18.0 0.0 6.5 29.6 13.1 4.5 19.7 52.9 21.0 44.5 15.6 20.3 11.9 31.3 17.0 13.3 20.3 14.4 15.1 18.9 8.5 21.8 13.1 29.4 37.0 6.5 10.1 4.2 4.7 17.7 49.4 23.3 19.8 7.8 GAMT "PIG2, TP53I2" ENSG00000130005 "Guanidinoacetate N-methyltransferase" Q14353 19 1397026-1401570 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 73.0;skeletal muscle: 222.2" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 641.0;Proximal tubular cells: 334.2" "Cancer enriched" "Detected in all" 5 "liver cancer: 173.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 52.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051806 Approved NA NA 38000 "HPA051806: AB_2681619" "unprognostic (3.25e-1)" "unprognostic (7.74e-3)" "unprognostic (3.22e-2)" "unprognostic (6.32e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (3.41e-2)" "unprognostic (7.10e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.54e-2)" 5.1 4.6 9.1 1.5 8.7 2.2 3.2 5.1 11.4 2.3 1.4 15.1 5.1 1.3 2.0 31.3 5.3 3.8 2.6 10.8 9.2 7.7 8.0 73.0 1.5 2.0 8.7 5.2 3.8 47.0 5.4 4.9 1.6 5.9 5.6 1.1 4.5 9.1 4.7 222.2 6.0 1.4 2.1 8.8 2.1 3.2 7.7 4.5 5.6 3.3 26.7 2.8 1.9 1.7 15.7 23.0 6.9 2.6 8.0 21.6 7.7 6.3 7.2 7.8 17.5 9.8 11.9 10.6 7.6 12.6 9.9 9.0 16.3 4.6 3.4 5.3 9.0 1.2 2.7 12.2 4.7 2.6 24.1 13.9 10.4 6.0 52.0 5.8 0.2 3.6 13.2 1.7 10.5 0.0 13.7 2.1 13.1 14.7 8.2 16.0 6.5 30.3 3.5 8.8 3.2 22.9 30.4 6.9 24.1 11.6 5.9 2.6 18.2 0.6 4.4 9.4 5.2 20.1 14.4 3.7 10.8 11.2 0.6 3.4 36.9 7.1 5.7 10.0 13.7 12.4 1.6 1.2 6.9 9.9 1.6 13.9 10.6 13.7 12.2 5.4 15.7 21.6 16.1 0.8 8.0 2.6 23.0 7.5 7.7 9.1 8.7 5.1 11.4 9.2 7.7 8.7 5.2 5.9 4.5 0.0 7.4 17.2 31.8 52.3 38.7 89.3 129.9 1.4 3.4 15.7 53.0 28.0 77.9 26.6 4.1 7.8 0.0 23.3 29.0 35.1 26.0 27.5 4.6 641.0 61.9 17.5 6.9 21.5 25.6 12.0 77.6 9.9 30.4 6.4 1.1 39.8 21.8 0.0 131.2 334.2 60.1 32.3 40.1 2.7 29.6 37.5 10.1 20.0 0.8 11.1 GAN "GAN1, KLHL16" ENSG00000261609 Gigaxonin Q9H2C0 16 81314952-81390884 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skin 1: 46.9" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 81.1;Cone photoreceptor cells: 84.4;Suprabasal keratinocytes: 114.0;Urothelial cells: 92.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011825, HPA049473" Approved Supported Microtubules NA NA Microtubules "CAB011825: AB_732515, HPA049473: AB_2680782" "unprognostic (1.78e-1)" "unprognostic (1.55e-1)" "unprognostic (8.23e-2)" "unprognostic (2.51e-2)" "unprognostic (8.37e-2)" "unprognostic (1.43e-1)" "unprognostic (2.42e-4)" "unprognostic (1.90e-1)" "unprognostic (3.86e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-3)" "unprognostic (5.91e-3)" "unprognostic (3.12e-3)" "unprognostic (5.93e-2)" "unprognostic (9.98e-2)" "unprognostic (1.46e-2)" "unprognostic (5.86e-2)" 3.1 2.8 7.5 2.9 7.6 2.8 6.2 8.0 7.8 3.9 4.0 10.9 3.2 3.0 3.3 3.7 8.4 2.6 2.8 2.9 10.8 5.0 2.5 2.5 3.0 2.8 5.5 7.5 3.0 3.5 4.1 2.9 3.1 7.5 3.9 3.9 2.7 4.1 3.0 4.0 46.9 3.0 4.3 8.1 3.0 4.2 3.2 7.7 2.0 3.1 6.2 4.0 3.3 6.6 2.2 3.3 2.4 1.6 3.2 3.7 0.6 2.1 3.1 2.1 2.6 2.6 1.3 13.4 1.9 1.3 1.4 0.7 6.4 2.4 3.3 2.2 2.1 1.0 4.0 4.2 1.7 3.1 1.0 1.9 2.9 2.5 4.9 2.6 2.7 3.3 1.5 4.9 1.9 4.6 1.6 2.4 2.6 3.8 1.6 1.5 11.3 2.5 3.5 5.2 2.8 1.1 4.6 2.0 1.3 2.1 7.0 2.3 1.3 6.4 5.4 1.7 5.1 3.9 2.4 3.3 3.1 3.9 1.2 2.4 2.8 3.7 8.3 1.7 2.9 2.4 2.4 1.6 0.8 3.1 1.4 2.8 1.7 3.1 2.5 0.9 2.2 2.9 3.7 1.3 3.2 1.3 3.3 2.2 0.6 7.5 7.6 8.0 7.8 10.8 5.0 5.5 7.5 7.5 7.7 11.9 8.0 14.4 51.6 81.1 25.3 11.0 7.6 9.4 5.7 5.2 84.4 15.9 0.0 9.5 1.9 12.8 15.0 0.0 5.8 12.9 14.3 54.5 1.1 6.8 5.1 22.3 5.2 16.5 4.5 3.2 8.9 10.5 35.4 5.4 12.3 11.6 12.9 14.2 12.0 3.1 42.1 6.5 25.8 10.1 5.8 114.0 17.8 13.8 13.3 92.7 GAP43 "B-50, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623324-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 132.7" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 2.4;Cone photoreceptor cells: 2.0;Fibroblasts: 1.7;Melanocytes: 1.7;Rod photoreceptor cells: 3.1;Smooth muscle cells: 1.9" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "naive CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "AF22: 16.7;NTERA-2: 35.6;SCLC-21H: 22.9;SH-SY5Y: 17.2;U-87 MG: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" NA NA "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 1.8 5.0 48.8 5.2 38.3 1.4 1.9 31.2 132.7 1.6 4.1 4.3 0.0 2.7 1.5 1.5 1.9 1.5 3.8 3.6 29.0 56.6 1.4 1.4 1.5 1.5 30.6 42.2 1.4 1.8 1.4 1.5 2.2 25.7 1.7 4.0 0.8 2.2 1.5 1.4 1.4 4.3 3.6 6.1 1.4 1.5 1.6 5.7 0.0 1.5 0.0 1.6 1.7 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 17.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 48.8 38.3 31.2 75.7 29.0 56.6 30.6 42.2 25.7 5.7 0.0 0.0 0.0 0.0 0.2 2.4 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.8 1.2 0.0 0.0 0.0 3.1 0.0 1.9 0.7 1.5 0.1 0.0 0.0 0.0 0.0 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6533927-6538374 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 1236.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005197, CAB016392, HPA040067, HPA061280" Supported Supported "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" No No 2200000000 "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavorable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 50.0 59.4 104.1 57.6 101.0 195.5 38.4 58.0 151.3 49.4 73.3 80.7 24.0 75.8 37.3 46.8 146.9 50.2 58.0 215.1 95.0 95.5 88.4 221.0 41.3 90.1 111.8 58.0 62.0 27.0 66.1 46.1 98.2 115.9 48.3 76.7 74.5 60.8 63.2 1236.8 54.4 74.4 68.0 95.6 50.7 41.1 36.4 35.9 101.9 38.3 238.7 105.3 89.5 50.5 57.9 171.0 110.0 201.6 60.5 108.8 271.9 188.4 332.6 95.9 149.5 93.6 154.4 209.1 143.2 204.0 209.6 218.8 234.7 129.4 220.4 28.3 168.8 159.1 107.3 89.1 332.2 145.5 193.2 96.8 121.9 208.7 199.3 126.2 197.0 98.1 129.1 108.5 206.0 232.8 501.3 230.7 161.2 65.4 46.4 238.1 376.0 224.4 103.7 354.5 226.1 110.8 182.6 170.9 104.9 238.5 230.6 68.0 109.1 126.4 329.8 190.3 285.1 51.5 139.2 143.9 163.6 197.8 84.4 247.4 105.5 76.7 284.0 346.8 124.9 256.0 110.0 201.6 37.0 74.1 103.2 65.3 57.9 77.9 74.4 171.0 32.2 44.1 51.2 106.5 60.5 92.3 25.2 108.8 271.9 104.1 101.0 58.0 151.3 95.0 95.5 111.8 58.0 115.9 35.9 220.3 245.0 821.1 1485.4 1615.7 992.1 33.2 1355.4 275.7 444.7 970.1 392.7 4082.4 2934.5 4447.1 583.7 1564.4 2836.9 443.9 3299.5 7140.5 1484.6 1124.2 551.6 1346.2 3470.6 2218.3 1273.2 1144.2 2599.6 1556.8 823.5 2367.4 4003.5 3613.2 2061.2 5234.8 4742.6 2687.7 965.3 5345.0 1026.0 1131.8 2133.1 429.6 390.5 1399.2 3925.6 1271.1 3009.6 2464.1 GAPDHS "GAPD2, GAPDH-2, GAPDS" ENSG00000105679 "Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic" O14556 19 35533412-35545316 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 154.6" "Cell type enriched" "Detected in some" 4 "Late spermatids: 6946.0" "Cancer enriched" "Detected in single" 97 "melanoma: 13.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042666 Enhanced Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA042666: AB_2678104" "unprognostic (3.74e-1)" "unprognostic (1.59e-1)" "unprognostic (7.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.06e-1)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.37e-1)" 0.3 0.5 0.3 0.8 0.3 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.6 0.5 1.6 0.6 0.2 0.8 0.8 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 0.7 1.3 0.0 0.3 0.3 0.3 0.3 0.0 4.2 1.3 0.3 0.3 4.4 0.6 0.3 0.3 1.2 0.4 154.6 0.3 0.3 3.6 0.3 0.3 0.6 0.3 2.1 1.0 1.2 0.8 1.4 2.0 0.8 4.5 16.5 4.6 6.9 0.0 0.0 3.9 1.3 0.0 0.0 0.0 10.0 7.6 7.5 2.2 0.0 1.9 5.5 0.0 0.0 0.0 7.3 8.0 5.0 10.5 5.1 0.1 4.5 6.0 0.0 0.0 0.0 0.0 2.9 0.0 7.3 12.0 4.4 0.0 14.1 1.7 2.1 6.2 2.9 2.2 5.3 3.2 5.8 0.0 4.5 8.3 3.7 1.7 4.2 4.9 3.3 3.4 1.9 1.5 5.3 6.0 1.3 1.9 12.3 3.3 4.4 2.9 8.1 1.9 0.0 0.8 1.2 1.1 0.6 2.0 1.1 0.4 1.9 1.0 2.1 1.1 1.2 0.0 1.4 0.3 0.8 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1712.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 6946.0 23.0 0.0 42.2 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 25.8 0.2 30.4 13.5 0.1 0.0 0.0 0.0 0.0 GAPT "C5orf29, FLJ33641" ENSG00000175857 "GRB2 binding adaptor protein, transmembrane" Q8N292 5 58491435-58497090 "Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 117.8" "Group enriched" "Detected in some" 9 "B-cells: 29.7;granulocytes: 52.1;Hofbauer cells: 15.1;Kupffer cells: 25.6;Macrophages: 34.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "eosinophil: 117.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 117.8" "Cell line enhanced" "Detected in some" "HEL: 27.4;HL-60: 15.8;NB-4: 16.5;THP-1: 13.0;U-937: 45.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011048, HPA011070" Uncertain Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA011048: , HPA011070: AB_1848887" "unprognostic (9.79e-2)" "unprognostic (5.67e-3)" "unprognostic (2.39e-2)" "unprognostic (3.26e-2)" "unprognostic (3.36e-2)" "unprognostic (8.09e-4)" "unprognostic (4.32e-1)" "unprognostic (1.23e-3)" "unprognostic (4.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.28e-2)" "unprognostic (2.93e-1)" "unprognostic (3.52e-3)" "unprognostic (3.74e-2)" "unprognostic (2.42e-2)" "unprognostic (2.33e-2)" "unprognostic (1.40e-2)" 1.4 0.8 1.4 15.5 2.7 8.5 1.0 0.6 1.2 1.8 1.4 1.6 0.4 1.8 1.3 2.2 3.3 1.2 3.1 1.1 1.5 1.7 1.6 1.0 7.2 19.4 4.5 0.9 0.7 1.2 0.0 1.5 0.8 4.4 2.6 2.0 1.4 2.3 0.4 0.5 0.9 8.2 2.4 5.9 25.8 1.7 0.8 3.2 5.2 1.1 0.5 23.5 5.1 1.2 12.0 25.4 117.8 8.2 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 15.8 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 16.5 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 12.3 8.2 117.8 0.0 5.7 0.0 12.0 0.0 0.0 9.4 11.9 0.0 0.0 10.1 0.1 6.6 25.4 0.0 3.4 1.4 2.7 0.6 1.2 1.5 1.7 4.5 0.9 4.4 3.2 3.0 3.4 29.7 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.1 0.0 15.1 0.0 0.0 0.6 25.6 0.0 0.0 34.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 GAREM1 "C18orf11, FAM59A, FLJ21610, GAREM" ENSG00000141441 "GRB2 associated regulator of MAPK1 subtype 1" Q9H706 18 32124877-32470484 "Predicted intracellular proteins" Mitogen "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.5" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 48.3;Urothelial cells: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 12.2;hTERT-HME1: 21.2;RT4: 18.0;SH-SY5Y: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040709, HPA042046" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040709: AB_2677090, HPA042046: AB_2677818" "unprognostic (9.52e-2)" "unprognostic (4.13e-3)" "unprognostic (2.67e-2)" "unprognostic (3.32e-3)" "unprognostic (3.62e-1)" "unprognostic (5.53e-3)" "unprognostic (1.87e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.73e-5)" "unprognostic (1.45e-1)" "prognostic favorable (5.49e-6)" "unprognostic (2.36e-1)" "unprognostic (2.56e-3)" "unprognostic (4.99e-2)" "unprognostic (4.65e-2)" 11.1 8.7 9.7 2.9 10.9 8.0 6.0 17.6 11.1 6.0 7.2 19.5 0.3 6.5 4.2 3.4 11.0 4.8 4.9 8.9 11.8 5.8 15.3 12.5 5.2 1.3 16.3 10.1 4.4 43.5 1.9 5.1 4.8 13.2 4.3 6.3 3.0 11.2 5.1 7.7 13.9 7.8 4.6 12.9 3.1 12.7 6.7 16.4 0.0 3.5 3.1 2.9 9.3 9.1 1.9 5.0 2.6 1.0 3.1 1.4 0.0 1.0 1.6 1.7 0.3 4.7 3.3 4.8 0.3 0.0 0.0 0.0 0.3 2.6 3.0 2.5 0.2 2.0 3.4 2.6 5.0 0.0 1.0 1.6 0.0 3.0 1.0 2.4 0.3 0.2 3.9 12.2 0.2 21.2 0.2 0.2 1.8 0.1 0.6 1.8 2.5 0.8 0.1 1.9 7.9 0.9 1.2 6.9 5.3 6.1 18.0 5.7 14.9 3.9 5.1 0.2 2.2 1.0 2.6 0.2 1.2 1.4 0.0 0.5 2.1 0.2 0.7 1.9 0.0 1.4 0.0 1.0 0.2 0.5 0.1 0.2 0.3 0.8 0.5 0.1 1.9 1.0 1.4 2.6 3.1 0.1 5.0 0.1 0.0 9.7 10.9 17.6 11.1 11.8 5.8 16.3 10.1 13.2 16.4 8.9 35.2 0.0 30.5 0.0 31.8 0.0 7.6 8.1 15.9 24.4 3.9 15.6 1.7 9.4 10.1 0.0 6.3 0.0 11.4 2.0 0.3 48.3 3.5 7.7 1.6 39.7 3.5 0.6 3.7 2.5 1.7 0.9 0.0 1.0 10.2 41.9 10.3 7.0 4.9 20.9 7.0 0.0 0.0 1.4 2.5 0.0 28.0 0.0 8.3 68.5 GAREM2 "FAM59B, FLJ00375, GAREML, KIAA2038" ENSG00000157833 "GRB2 associated regulator of MAPK1 subtype 2" Q75VX8 2 26173091-26189663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 21.2;parathyroid gland: 17.0" "Group enriched" "Detected in many" 5 "Distal tubular cells: 39.7;Muller glia cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 15.4;SH-SY5Y: 9.5;U-2 OS: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071575 Approved Cytosol NA NA Cytosol "HPA071575: AB_2686420" "unprognostic (1.70e-2)" "unprognostic (5.62e-2)" "unprognostic (7.61e-4)" "unprognostic (1.56e-2)" "unprognostic (8.27e-2)" "unprognostic (2.19e-1)" "unprognostic (2.90e-2)" "unprognostic (1.99e-1)" "unprognostic (2.12e-2)" "unprognostic (2.65e-1)" "unprognostic (1.33e-1)" "unprognostic (3.94e-2)" "unprognostic (1.15e-3)" "unprognostic (1.35e-1)" "unprognostic (3.22e-1)" "unprognostic (1.46e-2)" "unprognostic (1.04e-1)" 3.2 1.6 19.9 1.8 13.9 0.9 1.5 8.2 21.2 2.5 3.0 11.7 0.7 1.2 3.0 1.7 2.6 2.4 2.8 2.0 17.9 11.0 1.8 0.5 1.1 2.2 13.1 8.9 4.1 4.4 17.0 1.4 1.5 16.5 1.7 2.9 0.9 1.8 3.5 3.7 2.4 1.1 3.6 15.9 1.6 1.5 2.6 13.9 0.0 2.6 0.0 2.0 2.1 1.2 0.8 2.5 1.6 0.6 0.4 1.9 0.3 2.6 4.0 4.9 0.4 0.8 1.8 0.4 1.5 0.0 0.4 0.4 7.7 0.9 0.0 2.0 3.1 4.9 0.1 15.4 0.0 0.7 1.7 5.7 1.3 1.3 0.5 6.0 0.1 0.3 2.3 0.7 2.3 0.2 0.3 1.8 3.8 7.1 0.2 2.8 0.0 0.4 0.5 5.2 0.4 1.1 1.6 0.0 0.0 2.5 0.9 1.0 9.5 3.4 0.3 2.9 1.5 0.2 8.0 0.8 2.1 13.1 3.8 0.1 0.3 0.0 1.6 0.1 0.0 2.8 0.4 0.6 0.2 1.2 0.2 0.5 0.5 1.9 1.4 0.5 0.8 1.5 0.5 1.6 0.4 0.5 2.5 0.4 0.3 19.9 13.9 8.2 14.1 17.9 11.0 13.1 8.9 16.5 13.9 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 3.5 2.0 0.3 39.7 1.7 3.4 0.4 0.0 0.0 1.3 2.1 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.6 0.3 5.2 2.0 0.0 0.0 1.0 0.5 20.6 1.5 0.0 3.2 2.0 1.2 6.5 0.0 1.4 5.4 0.0 0.2 0.0 0.6 0.3 GARNL3 "bA356B19.1, DKFZp761J1523" ENSG00000136895 "GTPase activating Rap/RanGAP domain like 3" Q5VVW2 9 127224265-127393660 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 4 "dendritic cells: 3.8;T-cells: 1.3" "Cell line enhanced" "Detected in many" "OE19: 7.8;RPMI-8226: 5.6;SH-SY5Y: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028757, HPA074886" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA028757: AB_2294383, HPA074886: AB_2732270" "unprognostic (3.15e-2)" "unprognostic (7.19e-2)" "unprognostic (2.25e-2)" "unprognostic (3.40e-2)" "unprognostic (3.12e-2)" "unprognostic (1.19e-3)" "unprognostic (5.58e-3)" "unprognostic (3.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (6.88e-4)" "unprognostic (2.22e-1)" "unprognostic (3.23e-7)" "unprognostic (6.39e-2)" "unprognostic (6.60e-2)" "unprognostic (7.04e-3)" "unprognostic (1.78e-5)" 4.2 8.4 11.4 2.5 13.5 0.4 6.4 33.3 19.6 9.1 3.6 12.9 3.8 3.0 10.6 6.6 7.0 8.5 5.8 16.3 7.5 9.6 3.4 3.0 3.8 2.0 7.8 10.7 6.6 3.5 15.7 3.1 2.3 12.9 9.0 3.1 4.3 7.0 6.4 2.2 4.3 2.7 10.1 7.2 2.4 2.9 4.0 9.4 0.0 8.6 1.5 2.1 7.9 4.8 0.5 3.8 0.0 0.5 0.0 1.3 0.2 0.8 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.5 0.3 1.7 1.8 0.6 0.0 1.6 0.1 0.6 0.9 3.2 0.0 0.3 0.0 1.3 0.0 2.7 1.8 0.8 0.7 0.3 0.1 2.5 0.0 0.0 2.3 1.2 2.8 1.3 1.0 0.1 0.9 0.0 0.6 0.7 7.8 2.6 0.1 1.9 5.6 3.0 3.9 2.0 6.1 1.3 4.4 0.5 1.0 1.5 0.0 0.0 0.3 1.8 0.0 0.6 3.9 3.7 1.9 0.8 0.9 0.8 0.0 0.5 0.0 1.2 0.1 0.3 0.2 0.1 1.3 0.5 0.5 0.8 0.0 0.0 0.0 0.0 3.8 0.6 0.2 11.4 13.5 33.3 19.6 7.5 9.6 7.8 10.7 12.9 9.4 0.0 0.0 0.0 1.8 2.4 11.8 6.2 5.1 0.0 3.4 3.5 0.0 0.5 1.7 0.3 1.4 1.0 0.5 0.0 0.6 0.1 3.7 3.3 0.0 1.8 0.7 1.6 1.2 1.3 1.8 0.4 6.9 0.6 1.7 0.0 0.9 5.7 0.6 0.9 3.2 1.1 0.9 0.0 1.7 1.4 3.9 1.8 0.2 0.0 0.8 0.8 GAS1 ENSG00000180447 "Growth arrest specific 1" P54826 9 86944363-86947189 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Growth arrest" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 61.8" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 57.5;Muller glia cells: 106.0;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 19.7;ASC diff: 13.5;BJ hTERT+: 26.7;HSkMC: 19.1;RH-30: 40.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB024164, HPA036085, HPA066902" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "CAB024164: AB_2107950, HPA036085: AB_2674932, HPA066902: AB_2685746" "unprognostic (2.78e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.97e-2)" "unprognostic (6.15e-2)" "unprognostic (2.84e-2)" "unprognostic (6.46e-2)" "unprognostic (6.91e-2)" "unprognostic (3.32e-1)" "unprognostic (1.28e-3)" "unprognostic (2.25e-3)" "unprognostic (4.30e-2)" "prognostic unfavorable (1.96e-5)" "prognostic unfavorable (8.26e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.13e-5)" "unprognostic (3.59e-2)" 26.5 2.9 0.9 8.3 1.1 0.0 14.0 1.3 1.3 26.4 9.1 2.1 15.0 0.9 61.8 37.1 10.0 20.9 11.8 9.9 1.0 0.5 4.5 0.8 4.1 5.7 1.8 0.8 31.5 4.3 0.8 3.2 50.1 2.0 18.1 1.0 8.7 4.8 8.9 8.1 10.1 3.4 24.5 0.9 1.2 6.3 18.9 0.5 3.6 6.0 3.8 1.6 11.3 15.6 0.0 0.8 0.0 0.0 0.1 0.6 0.0 0.0 0.0 3.3 19.7 13.5 5.1 0.3 3.7 26.7 1.3 1.1 0.0 0.0 0.0 0.2 6.9 0.1 0.2 0.0 0.1 0.5 2.2 7.6 0.0 11.1 0.0 6.9 0.0 0.3 19.1 2.9 0.4 2.4 0.0 0.0 0.4 0.0 0.0 5.6 0.0 0.0 0.1 4.1 0.1 0.0 3.9 40.7 0.0 0.2 0.0 0.4 1.7 5.5 0.0 5.8 2.3 0.0 0.1 0.0 5.8 1.6 0.4 1.3 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.9 1.1 1.3 1.2 1.0 0.5 1.8 0.8 2.0 0.5 0.0 1.1 0.0 8.0 23.0 6.5 5.8 0.0 0.0 1.2 14.0 9.8 17.4 8.3 0.6 0.0 6.1 0.0 0.0 0.3 3.8 57.5 1.9 0.0 0.0 5.2 4.8 0.0 23.4 0.6 0.0 30.0 1.0 16.9 0.0 0.0 106.0 0.3 0.0 11.7 2.2 2.8 38.8 10.3 0.1 0.7 10.9 3.8 0.0 0.0 0.3 GAS2 ENSG00000148935 "Growth arrest specific 2" O43903 11 22625642-22813055 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell shape, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 10.9;Cholangiocytes: 10.2;Ciliated cells: 6.7;Hepatocytes: 20.2" "Cancer enhanced" "Detected in many" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Hep G2: 19.9;JURKAT: 11.3;Karpas-707: 40.7;SCLC-21H: 11.9;U-266/84: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058904 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" Yes NA "Plasma membrane, Cytosol" "Nucleoplasm, Nucleoli" "HPA058904: AB_2683850" "unprognostic (5.48e-3)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (1.16e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-2)" "unprognostic (1.08e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.30e-5)" "prognostic favorable (6.13e-4)" "unprognostic (5.85e-2)" "unprognostic (4.22e-2)" "unprognostic (7.94e-2)" "unprognostic (3.58e-2)" 0.7 1.1 2.1 1.1 3.6 0.4 0.9 0.9 2.2 1.2 0.7 1.4 1.2 2.0 1.1 1.3 1.0 1.5 2.7 3.6 2.1 2.5 5.3 37.2 1.3 1.1 4.3 1.2 2.3 22.7 0.5 4.8 0.7 4.5 1.3 0.7 0.5 2.2 0.9 4.8 1.0 1.8 0.6 8.6 1.5 2.6 1.1 3.2 19.6 1.1 3.0 1.0 1.8 0.7 1.0 0.6 0.3 0.0 0.1 1.7 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 0.1 0.0 19.9 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 11.3 0.7 40.7 0.0 0.1 0.1 0.0 0.1 1.1 0.0 0.4 0.2 2.0 0.0 0.5 11.9 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.2 0.5 0.0 0.5 13.5 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.0 1.7 1.0 0.4 0.0 0.0 0.9 1.6 0.4 0.0 0.1 0.0 0.6 0.3 0.1 2.1 3.6 0.9 2.2 2.1 2.5 4.3 1.2 4.5 3.2 0.0 0.0 0.0 0.2 0.1 2.7 10.9 10.2 6.7 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 20.2 0.0 0.0 0.0 0.6 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.3 2.6 0.3 0.0 2.1 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.3 GAS2L1 GAR22 ENSG00000185340 "Growth arrest specific 2 like 1" Q99501 22 29306582-29312785 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.5" "Cell type enhanced" "Detected in many" 6 "Ito cells: 77.3;Late spermatids: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.1" "Group enriched" "Detected in many" 10 "dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0" "Cell line enhanced" "Detected in many" "U-138 MG: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019858 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA019858: AB_1849486" "unprognostic (3.66e-1)" "unprognostic (5.22e-2)" "unprognostic (1.38e-1)" "unprognostic (4.95e-3)" "unprognostic (1.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-3)" "unprognostic (8.99e-2)" "unprognostic (1.28e-1)" "unprognostic (6.05e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "prognostic favorable (8.44e-4)" "unprognostic (4.23e-2)" "unprognostic (9.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-2)" 15.1 10.7 15.2 5.3 13.4 5.4 7.6 10.5 19.8 4.5 5.6 6.8 40.5 17.9 5.1 8.4 8.6 4.6 4.3 7.0 12.9 8.1 6.0 6.6 7.5 2.2 11.3 10.2 2.9 10.0 4.6 6.8 4.3 9.5 7.1 2.2 3.2 12.7 22.9 4.9 22.4 13.0 4.5 10.0 11.5 8.3 16.6 8.8 0.0 4.5 9.2 3.5 3.9 4.7 0.0 1.1 3.1 2.0 0.0 0.2 1.2 8.3 9.8 1.5 6.2 2.4 2.3 9.8 12.6 3.8 5.4 2.8 4.4 6.0 0.0 5.7 6.7 5.6 25.6 2.6 7.1 1.0 11.4 1.2 11.0 7.8 3.1 3.1 0.1 7.7 2.5 4.9 5.1 2.0 3.9 7.1 11.2 5.2 1.7 3.8 7.1 0.2 6.1 2.2 5.6 22.1 0.2 4.4 0.7 3.2 5.4 0.5 8.3 9.7 13.0 7.0 2.0 13.0 1.7 15.0 33.7 23.2 15.0 12.6 0.1 0.1 0.1 14.9 0.4 8.2 0.0 2.0 3.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.5 0.0 1.4 0.0 0.0 1.2 15.2 13.4 10.5 19.8 12.9 8.1 11.3 10.2 9.5 8.8 6.0 1.7 0.8 5.7 25.0 2.6 3.5 7.6 1.4 9.1 1.8 5.9 19.1 6.6 10.8 26.3 19.3 19.0 23.3 6.0 10.4 10.8 6.1 1.1 10.5 13.1 12.7 1.7 77.3 12.6 73.5 8.9 10.7 11.8 4.6 5.4 4.5 8.3 9.3 11.0 7.0 19.2 38.8 14.1 2.3 10.8 28.2 5.6 0.7 9.0 2.2 GAS2L2 GAR17 ENSG00000270765 "Growth arrest specific 2 like 2" Q8NHY3 17 35744511-35752878 "Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 8.4;fallopian tube: 20.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 16.0;Club cells: 5.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 6.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA044370 Enhanced NA NA "HPA044370: AB_2678915" "unprognostic (3.76e-2)" "unprognostic (1.43e-1)" "unprognostic (5.54e-3)" "prognostic favorable (7.00e-4)" "unprognostic (3.65e-2)" "unprognostic (1.07e-1)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (4.05e-2)" "unprognostic (4.09e-2)" "unprognostic (4.01e-4)" "unprognostic (3.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.16e-1)" "unprognostic (3.92e-2)" 0.6 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.2 0.1 0.1 4.0 3.4 0.0 1.2 8.4 0.1 20.1 0.0 0.0 0.5 0.0 0.0 6.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.1 0.7 0.0 0.0 0.0 1.5 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 6.1 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.2 0.0 0.4 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.4 0.0 16.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 GAS7 "KIAA0394, MGC1348" ENSG00000007237 "Growth arrest specific 7" O60861 17 9910609-10198551 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 49.9;Kupffer cells: 62.0;Late spermatids: 52.5" "Cancer enhanced" "Detected in all" "melanoma: 54.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 17.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "WM-115: 110.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004838, HPA064678" Enhanced Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane" "Actin filaments, Focal adhesion sites" "HPA004838: AB_2667263, HPA064678: AB_2685319" "unprognostic (1.68e-2)" "unprognostic (2.84e-3)" "unprognostic (1.80e-1)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-2)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (2.88e-1)" "unprognostic (1.50e-2)" "unprognostic (2.48e-1)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" "unprognostic (6.48e-2)" "unprognostic (8.78e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (6.89e-4)" 19.1 6.5 22.1 15.4 40.3 18.7 10.8 86.2 64.7 22.6 9.3 33.4 1.7 5.2 9.7 4.4 17.0 12.6 11.5 23.1 25.8 15.0 1.5 2.1 9.9 5.9 28.1 25.0 5.9 2.8 1.4 1.7 11.0 14.2 3.7 8.7 7.7 4.0 8.2 3.9 21.2 7.4 16.3 33.8 10.0 4.2 11.8 22.2 2.7 2.5 2.7 7.2 11.7 7.8 0.4 3.6 11.0 17.6 2.8 2.1 4.4 0.0 0.1 0.1 0.2 3.4 4.9 0.0 0.1 0.0 0.5 0.2 0.0 0.0 1.3 0.4 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.1 1.1 0.3 10.1 0.9 0.0 1.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 10.7 3.2 0.5 0.4 0.0 2.8 0.0 9.8 0.0 0.0 0.0 0.6 0.0 0.0 12.7 4.7 0.5 5.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 7.1 110.2 0.4 17.6 10.8 2.1 4.7 0.7 0.3 0.2 1.0 3.6 0.4 0.2 1.0 11.0 2.8 3.1 0.6 0.0 4.4 22.1 40.3 86.2 38.8 25.8 15.0 28.1 25.0 14.2 22.2 0.0 6.2 3.2 3.8 7.3 34.5 11.3 0.0 26.8 1.2 5.2 25.5 1.1 0.0 0.6 49.9 7.0 0.0 0.0 0.0 1.1 43.4 1.6 17.3 0.5 34.5 0.0 0.0 7.4 62.0 52.5 9.5 29.6 32.1 1.0 0.0 8.0 0.3 0.0 1.8 0.0 30.3 0.0 5.2 1.1 6.1 14.4 1.6 7.5 0.0 4.3 GAST GAS ENSG00000184502 Gastrin P01350 17 41712326-41715969 "Cancer-related genes, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 61 "stomach 1: 529.2" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 7.3" "Group enriched" "Detected in many" 6 "pancreatic cancer: 38.8;stomach cancer: 23.5" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 27.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" CAB000038 Enhanced "Secreted to digestive system" NA NA 43000 "CAB000038: " "unprognostic (1.27e-1)" "unprognostic (4.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.07e-2)" "unprognostic (2.75e-2)" "unprognostic (5.68e-2)" "unprognostic (2.11e-1)" "unprognostic (2.85e-1)" "unprognostic (3.17e-1)" "unprognostic (9.07e-2)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.2 0.1 1.7 6.9 0.0 2.4 7.3 0.0 0.0 0.0 2.6 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 529.2 0.1 0.0 8.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.0 0.0 0.1 GATA1 "ERYF1, GATA-1, GF1, NF-E1, NFE1" ENSG00000102145 "GATA binding protein 1" P15976 X 48786554-48794311 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "blood: 78.3;bone marrow: 37.0" "Group enriched" "Detected in some" 10 "Early spermatids: 11.8;Erythroid cells: 23.3;granulocytes: 35.9;Late spermatids: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "eosinophil: 78.3" "Lineage enriched" "Detected in single" 784 "granulocytes: 78.3" "Group enriched" "Detected in some" 9 "HEL: 50.8;HMC-1: 52.4;K-562: 54.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000232, HPA000233, CAB009195" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951" "unprognostic (1.93e-1)" "unprognostic (7.54e-2)" "unprognostic (8.95e-3)" "unprognostic (3.84e-3)" "unprognostic (2.25e-1)" "unprognostic (3.00e-4)" "unprognostic (4.87e-2)" "unprognostic (3.48e-2)" "unprognostic (4.44e-2)" "unprognostic (1.95e-2)" "unprognostic (6.04e-2)" "unprognostic (7.71e-3)" "unprognostic (4.13e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-1)" "unprognostic (9.10e-2)" "unprognostic (2.71e-2)" 0.7 0.2 0.1 2.4 0.7 37.0 0.3 0.0 0.3 0.7 0.3 0.0 0.0 0.6 4.9 2.4 0.4 0.3 0.6 2.3 0.1 0.3 0.4 0.8 5.6 0.2 0.6 0.0 0.1 0.1 0.1 0.5 2.8 0.3 1.4 0.4 1.6 0.3 0.2 0.1 0.6 0.8 2.4 0.3 4.9 0.5 3.1 0.0 1.5 0.6 1.1 0.6 0.9 0.6 0.0 0.0 78.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 78.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.1 0.7 0.0 0.3 0.1 0.3 0.6 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 23.3 0.0 0.7 0.0 0.0 35.9 0.0 0.5 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 GATA2 NFE1B ENSG00000179348 "GATA binding protein 2" P23769 3 128479427-128493185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Phagocytosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.2;ductus deferens: 85.8;seminal vesicle: 209.1" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 226.1;granulocytes: 616.3;Syncytiotrophoblasts: 268.8" "Cancer enhanced" "Detected in all" "prostate cancer: 36.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 339 "basophil: 81.2" "Lineage enriched" "Detected in single" 813 "granulocytes: 81.2" "Cell line enhanced" "Detected in many" "BEWO: 57.0;HEL: 70.3;HMC-1: 38.1;SH-SY5Y: 66.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005633, CAB024847" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB024847: , HPA005633: AB_1078954" "unprognostic (1.71e-1)" "unprognostic (8.90e-2)" "unprognostic (1.12e-1)" "unprognostic (8.61e-2)" "unprognostic (8.67e-2)" "unprognostic (4.17e-2)" "unprognostic (5.96e-3)" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.12e-2)" "unprognostic (3.58e-2)" "unprognostic (3.04e-1)" "prognostic favorable (2.04e-4)" "unprognostic (2.50e-1)" "unprognostic (8.07e-2)" "unprognostic (2.08e-1)" "prognostic favorable (5.22e-5)" 7.0 6.2 2.1 1.5 2.4 2.5 7.9 1.2 1.9 22.4 2.8 1.4 85.8 2.5 20.6 5.4 3.2 23.0 9.7 4.8 1.5 1.0 7.6 0.6 16.1 2.2 1.8 1.1 4.6 5.8 3.4 4.5 51.8 2.4 27.8 1.8 6.1 1.9 209.1 3.5 4.1 3.4 8.4 1.4 5.1 2.9 2.7 1.5 0.4 3.3 2.7 1.5 22.4 12.4 0.0 0.0 81.2 0.0 0.0 0.0 0.4 4.7 1.1 0.2 3.1 0.4 0.1 57.0 10.6 9.1 3.6 1.3 1.9 2.1 0.1 3.0 6.3 0.3 5.0 2.9 0.0 1.5 0.0 1.6 70.3 7.8 3.1 0.8 7.1 38.1 0.0 0.0 0.1 0.0 0.5 5.7 0.0 18.4 0.1 0.0 1.7 0.0 14.4 0.2 0.0 0.3 0.0 1.4 0.0 0.1 4.2 4.4 66.4 2.7 14.1 0.4 3.0 2.7 2.9 10.2 0.2 0.1 2.5 1.4 0.0 0.0 0.0 0.1 0.4 0.7 81.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 2.4 1.2 1.9 1.5 1.0 1.8 1.1 2.4 1.5 6.0 48.7 0.5 16.6 4.2 0.2 6.1 0.0 1.4 3.4 71.5 0.0 50.4 1.7 0.3 5.8 56.9 0.0 0.0 12.6 226.1 5.8 36.8 616.3 0.0 9.5 0.0 2.9 34.4 0.8 4.0 0.6 2.9 8.5 0.0 0.0 0.0 1.3 0.0 0.4 0.1 0.2 0.0 7.6 0.5 2.8 2.0 268.8 0.0 0.1 10.0 GATA3 HDR ENSG00000107485 "GATA binding protein 3" P23771 10 8045378-8075203 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 97.8;skin 1: 61.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 243.8;Extravillous trophoblasts: 651.3;Syncytiotrophoblasts: 949.1" "Group enriched" "Detected in many" 24 "breast cancer: 190.0;urothelial cancer: 87.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 42 "gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9" "Group enriched" "Detected in many" 54 "NK-cells: 16.6;T-cells: 18.9" "Cell line enhanced" "Detected in some" "BEWO: 33.3;MCF7: 79.6;RT4: 32.6;SH-SY5Y: 28.0;T-47d: 103.7" "Region enriched" "Detected in single" 6 "midbrain: 7.3" "Group enriched" "Detected in some" 38 "midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0" "CAB016217, HPA029730" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB016217: AB_2108591, HPA029730: AB_10601907" "unprognostic (1.70e-1)" "unprognostic (7.23e-2)" "unprognostic (3.58e-2)" "unprognostic (2.00e-1)" "unprognostic (7.03e-3)" "unprognostic (4.68e-3)" "unprognostic (4.23e-2)" "unprognostic (9.65e-2)" "unprognostic (2.06e-1)" "unprognostic (2.55e-1)" "unprognostic (3.83e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (6.31e-2)" "unprognostic (1.82e-3)" 2.0 2.0 0.3 3.4 0.3 0.9 17.8 0.3 0.3 1.8 0.5 0.1 44.4 0.1 0.4 13.5 0.8 0.4 0.4 0.9 0.3 0.4 12.9 0.7 1.6 2.7 0.8 0.0 0.3 0.4 55.0 3.8 53.4 1.4 8.1 0.0 1.8 8.9 97.8 0.8 61.7 1.2 3.4 0.4 2.7 0.5 0.8 0.1 42.4 3.3 0.6 3.4 26.9 16.4 0.2 0.0 0.3 0.0 16.6 18.9 3.0 5.5 1.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 0.0 2.0 5.0 0.0 0.0 0.0 0.0 4.9 0.5 0.1 0.0 16.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.3 0.1 2.6 7.8 0.0 0.0 0.0 79.6 8.7 0.0 0.6 1.0 0.7 0.4 0.4 0.1 0.0 32.6 1.6 28.0 0.0 4.5 0.0 6.1 103.7 0.0 0.0 0.4 1.0 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 9.7 0.0 13.3 0.2 18.2 14.1 0.0 0.0 10.0 9.0 0.3 16.6 0.0 0.0 18.9 3.0 0.3 0.3 0.3 0.3 0.3 0.4 0.8 0.0 1.4 0.1 0.0 8.9 0.5 60.9 84.1 0.0 1.2 0.0 0.0 1.2 169.3 0.0 243.8 0.0 0.2 0.0 4.9 0.0 0.0 0.3 651.3 6.9 27.0 2.3 0.5 27.7 0.0 0.0 9.8 4.0 0.0 0.0 2.2 8.5 1.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 173.9 949.1 56.1 0.0 68.0 GATA4 ENSG00000136574 "GATA binding protein 4" P43694 8 11676959-11760002 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 42.5;intestine: 29.9;ovary: 63.4;pancreas: 49.9" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 30.8;Exocrine glandular cells: 28.7;Ito cells: 61.4;Late spermatids: 28.1;Leydig cells: 38.3;Peritubular cells: 38.9" "Cancer enhanced" "Detected in many" "stomach cancer: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 15.1;HHSteC: 17.7;OE19: 5.3;SH-SY5Y: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013125, HPA073899" Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "CAB013125: AB_2533804, HPA073899: AB_2686641" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (8.68e-4)" "unprognostic (2.66e-3)" "unprognostic (1.71e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-2)" "unprognostic (5.47e-2)" "unprognostic (2.55e-1)" "unprognostic (2.78e-2)" "unprognostic (2.49e-1)" "unprognostic (1.67e-8)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.29e-2)" 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 16.8 0.1 0.0 13.4 0.5 0.4 0.1 1.0 15.4 42.5 0.0 0.0 0.0 26.5 0.1 0.8 0.0 0.0 63.4 49.9 0.0 0.1 4.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 13.8 18.3 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 15.1 17.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.2 1.0 0.0 0.0 1.3 17.1 0.0 0.0 0.1 3.4 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 30.8 2.5 0.0 0.0 0.0 0.0 0.2 0.0 1.1 16.2 0.0 0.0 0.0 28.7 0.2 3.1 0.0 0.0 10.5 0.5 0.0 0.0 61.4 3.8 28.1 38.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 38.9 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.7 0.0 0.0 0.0 GATA5 "bB379O24.1, GATAS" ENSG00000130700 "GATA binding protein 5" Q9BWX5 20 62463497-62475970 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 22.1;intestine: 23.6" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 4.1;Fibroblasts: 1.8;Ito cells: 4.3;Late spermatids: 1.5" "Cancer enhanced" "Detected in many" "stomach cancer: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.6;HEL: 5.0;K-562: 7.9;SiHa: 3.5;T-47d: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067583 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA067583: AB_2685867" "unprognostic (2.21e-1)" "unprognostic (2.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.62e-1)" "unprognostic (8.34e-2)" "unprognostic (1.69e-2)" "unprognostic (5.70e-2)" "unprognostic (1.27e-2)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" 1.9 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.4 15.9 0.0 5.2 14.8 3.8 1.7 0.3 9.1 22.1 6.8 0.0 0.0 3.3 0.7 1.6 0.0 0.0 0.0 3.1 0.0 0.3 0.6 0.6 0.0 11.3 0.0 1.0 0.4 0.8 0.1 0.3 23.6 18.3 0.2 0.1 10.3 16.8 0.0 0.0 1.2 0.0 0.0 14.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.6 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.3 5.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 3.5 0.0 0.0 1.6 8.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.3 0.0 0.0 4.3 0.0 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.0 0.0 GATA6 ENSG00000141448 "GATA binding protein 6" Q92908 18 22169443-22202528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 77.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 78.9;Mucus-secreting cells: 48.1;Undifferentiated cells: 48.1" "Cancer enhanced" "Detected in many" "stomach cancer: 26.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "basophil: 5.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "BEWO: 26.8;CACO-2: 32.6;hTERT-RPE1: 12.5;OE19: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011581, HPA066629" Approved Supported Nucleoplasm Yes No Nucleoplasm "CAB011581: AB_732529, HPA066629: AB_2685695" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.72e-2)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (4.36e-2)" "unprognostic (3.47e-1)" "unprognostic (2.61e-1)" "unprognostic (8.45e-3)" "prognostic unfavorable (1.92e-9)" "unprognostic (8.75e-3)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-2)" 9.7 26.6 0.2 8.4 0.2 0.0 9.4 0.2 0.2 9.8 24.7 0.9 1.5 12.5 19.5 10.3 3.3 15.3 51.3 40.4 0.2 0.2 3.9 15.5 14.9 11.1 0.2 0.1 77.2 52.2 0.1 0.5 5.2 0.7 24.3 6.0 0.4 1.5 1.1 1.5 0.9 43.5 32.2 0.4 18.9 26.9 9.7 0.0 0.1 6.3 0.7 0.6 30.3 16.5 0.0 0.0 5.7 0.0 0.0 0.4 0.0 4.7 0.7 0.0 0.0 1.0 0.5 26.8 0.1 0.1 0.4 0.4 32.6 1.8 0.0 1.6 0.5 1.7 5.2 0.2 2.1 0.7 0.0 6.5 0.0 2.0 2.8 7.1 0.2 0.3 0.2 4.2 5.9 4.4 12.5 4.5 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 17.4 4.6 0.0 0.5 0.1 0.2 1.3 0.4 0.0 5.0 2.9 1.3 1.4 0.8 0.0 0.3 0.7 0.8 5.5 0.8 0.0 0.0 0.0 3.0 0.1 4.7 5.7 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.7 0.0 41.7 27.5 0.0 3.5 0.8 0.0 78.9 25.5 2.7 7.9 0.0 0.0 0.5 0.0 22.6 47.7 6.2 29.3 0.0 16.9 9.5 20.0 2.8 4.7 8.3 1.4 0.0 25.0 17.8 0.3 5.9 3.1 0.8 0.0 0.0 48.1 0.0 30.5 17.5 9.6 0.0 0.0 32.3 5.5 0.9 1.0 0.6 1.6 0.0 48.1 2.1 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 186.3;liver: 252.2;pancreas: 286.1" "Group enriched" "Detected in many" 8 "Hepatocytes: 1105.8;Proximal tubular cells: 2889.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 6 "B-cells: 12.8;dendritic cells: 6.9" "Group enriched" "Detected in some" 4 "RH-30: 57.1;RT4: 15.0;U-266/70: 35.3;U-266/84: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria Yes NA 620000 Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 1.8 2.5 18.5 1.6 14.7 0.6 2.9 11.4 16.2 1.5 3.1 24.9 0.3 17.8 1.3 2.2 3.0 1.7 5.0 5.5 15.2 10.3 186.3 252.2 1.2 2.1 20.6 14.3 17.6 286.1 0.7 1.2 7.8 14.5 1.7 1.7 1.5 5.5 2.1 13.5 13.9 10.8 2.7 26.1 3.5 10.0 8.0 18.4 0.7 6.6 2.5 3.1 2.2 2.0 12.8 6.9 0.3 1.5 0.1 1.5 0.8 3.4 1.7 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 5.8 9.0 0.3 0.0 1.5 0.6 4.5 0.1 0.1 0.4 0.0 0.7 0.1 0.0 0.2 5.2 0.7 0.2 0.2 0.0 0.1 0.0 0.1 2.1 0.1 0.2 0.0 0.1 0.6 0.1 3.2 7.9 0.0 0.1 57.1 0.4 0.9 15.0 6.6 1.1 1.8 0.1 0.3 0.6 0.8 5.9 0.0 0.0 0.1 0.0 1.7 35.3 44.6 0.2 0.5 0.1 0.4 0.0 1.1 0.3 0.3 1.5 0.0 12.8 0.0 0.3 6.9 5.9 0.0 1.5 0.0 0.1 0.6 6.8 0.0 0.8 18.5 14.7 11.4 16.2 15.2 10.3 20.6 14.3 14.5 18.4 3.0 0.6 33.0 12.7 48.2 8.6 29.5 191.1 2.7 5.7 68.0 0.0 1.0 250.4 36.2 7.4 7.8 4.2 23.3 255.7 0.9 9.9 3.9 3.5 1105.8 69.7 7.9 0.0 20.9 55.8 11.0 4.0 39.6 21.9 5.4 0.2 18.7 151.7 0.3 3.2 2889.0 4.0 6.5 11.3 22.9 7.4 116.9 1.5 6.9 0.4 15.5 GBA "GBA1, GLUC" ENSG00000177628 "Glucosylceramidase beta" P04062 1 155234452-155244699 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism" "Glycosidase, Glycosyltransferase, Hydrolase, Transferase" "Disease mutation, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 101.2" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006667, CAB037171, CAB037289" Supported "Intracellular and membrane" NA NA 200000 "CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979" "unprognostic (6.03e-2)" "unprognostic (6.02e-2)" "unprognostic (3.41e-1)" "unprognostic (2.42e-1)" "unprognostic (6.00e-3)" "unprognostic (2.97e-1)" "unprognostic (1.04e-3)" "unprognostic (4.76e-2)" "unprognostic (1.22e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" "unprognostic (1.33e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-1)" "unprognostic (3.04e-2)" "unprognostic (3.15e-1)" "unprognostic (2.94e-2)" 19.2 29.7 14.8 13.9 24.5 21.9 15.3 8.7 33.4 16.5 20.1 25.2 18.1 13.8 16.9 30.4 18.9 12.7 16.5 13.6 15.8 18.9 31.8 24.6 17.9 15.4 18.5 16.5 13.1 19.2 101.2 32.1 46.2 28.1 14.4 23.5 25.3 22.3 24.3 6.0 21.6 16.6 17.7 19.3 24.5 14.6 9.7 13.1 13.7 22.2 8.7 17.5 16.3 15.2 7.3 13.9 17.9 22.3 6.6 14.0 12.4 8.5 16.6 5.9 8.0 62.2 13.7 6.8 15.2 54.1 22.7 28.7 9.7 31.5 5.9 16.9 35.6 36.4 17.5 8.3 10.8 12.1 12.5 5.8 4.9 11.0 5.2 17.8 5.8 20.8 17.9 9.1 47.7 7.2 24.0 20.1 5.2 5.2 10.1 26.6 18.6 7.2 2.7 3.8 14.1 11.8 6.1 9.7 24.4 15.2 6.6 5.7 7.8 13.3 31.9 33.7 11.4 23.9 14.2 15.3 17.1 7.6 21.4 12.1 20.2 17.0 4.6 29.9 5.3 13.1 12.2 21.6 9.1 13.4 22.3 8.7 7.3 10.3 9.0 13.9 5.5 7.4 7.8 17.9 6.6 21.2 7.8 14.0 12.4 14.8 24.5 8.7 33.4 15.8 18.9 18.5 16.5 28.1 13.1 3.0 3.2 4.5 5.7 5.4 3.4 7.9 17.8 6.7 2.3 12.2 2.0 27.5 3.3 26.2 1.1 11.3 17.3 0.0 28.1 23.9 12.9 8.2 6.9 20.7 57.7 4.8 14.0 20.9 39.9 2.2 9.2 13.9 25.3 28.9 13.1 13.2 25.6 19.8 8.5 17.0 5.4 0.0 6.7 4.8 5.7 3.9 49.7 9.6 11.6 4.3 GBE1 ENSG00000114480 "1,4-alpha-glucan branching enzyme 1" Q04446 3 81489699-81762161 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 61.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038073, HPA038074, HPA038075" Enhanced Approved Cytosol NA NA 5900000 Cytosol "HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545" "unprognostic (3.10e-1)" "unprognostic (1.02e-3)" "unprognostic (6.76e-2)" "unprognostic (1.05e-2)" "unprognostic (3.48e-2)" "unprognostic (1.89e-1)" "unprognostic (9.01e-3)" "unprognostic (1.17e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (2.19e-2)" "unprognostic (5.68e-2)" "unprognostic (1.46e-1)" "unprognostic (5.36e-2)" "unprognostic (4.42e-1)" "unprognostic (2.83e-3)" "unprognostic (3.78e-3)" 23.1 22.4 2.2 7.8 4.2 5.6 19.2 4.2 4.6 6.4 7.7 5.2 5.2 4.1 8.4 4.9 7.5 4.9 11.5 19.7 3.6 4.3 14.0 36.3 11.3 7.5 7.9 3.4 8.2 5.7 8.2 11.6 11.4 8.4 5.7 4.5 9.9 8.0 10.1 56.9 5.9 6.3 7.2 6.1 8.0 4.5 4.6 4.1 5.4 6.5 11.2 4.5 9.6 10.0 11.6 13.6 14.5 11.4 13.0 7.2 6.1 12.1 7.3 2.4 34.9 61.4 46.7 4.4 20.2 28.8 12.1 20.6 1.4 3.2 13.6 8.9 24.8 7.2 1.4 2.0 9.3 28.6 6.4 1.1 4.2 15.2 4.5 42.3 14.3 3.7 34.4 6.9 19.5 20.1 30.5 26.9 1.6 3.3 7.9 39.4 3.5 2.4 17.0 2.4 3.4 11.2 4.5 11.1 16.0 8.6 4.1 1.2 1.6 13.2 3.8 4.1 3.7 2.7 11.8 37.3 25.1 5.9 17.6 18.6 36.1 4.1 5.0 40.9 9.6 10.2 6.3 11.4 14.5 5.6 10.4 5.4 11.0 6.0 5.9 13.6 11.6 7.0 7.2 11.0 13.0 10.8 4.5 5.0 6.1 2.2 4.2 4.2 4.6 3.6 4.3 7.9 3.4 8.4 4.1 14.9 11.3 7.2 17.9 27.2 15.9 51.9 15.3 13.4 10.3 29.6 0.0 25.8 34.9 29.0 29.2 28.5 9.6 0.0 21.8 58.4 22.2 15.3 42.7 67.1 23.2 28.6 21.2 14.1 14.5 11.6 16.1 15.1 23.6 12.6 6.9 9.6 34.4 6.8 12.4 46.6 16.8 32.3 41.6 6.5 5.1 18.6 45.9 10.0 7.3 12.4 GBP3 FLJ10961 ENSG00000117226 "Guanylate binding protein 3" Q9H0R5 1 89006666-89022894 "Predicted intracellular proteins" "Antiviral defense, Immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 63.1" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 83.0;Enterocytes: 83.4;Paneth cells: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 30.9;BJ hTERT+ SV40 Large T+ RasG12V: 22.2;LHCN-M2: 27.4" HPA045657 Approved NA NA "HPA045657: AB_10961631" "unprognostic (1.14e-2)" "unprognostic (2.23e-1)" "unprognostic (6.30e-2)" "unprognostic (1.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.02e-1)" "unprognostic (2.18e-1)" "unprognostic (4.39e-2)" "unprognostic (3.47e-1)" "unprognostic (7.44e-2)" "unprognostic (4.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.86e-2)" "unprognostic (1.66e-2)" "unprognostic (9.70e-3)" "unprognostic (3.06e-2)" "unprognostic (5.06e-3)" 7.5 10.9 3.0 10.5 6.5 0.4 6.1 3.4 4.1 10.5 20.6 2.8 9.8 35.9 4.9 14.3 7.1 7.2 16.4 5.4 4.2 3.5 16.5 6.8 11.8 5.6 6.9 0.8 10.4 3.9 1.9 6.1 14.1 8.0 8.8 13.0 4.6 8.2 10.0 1.9 3.1 63.1 5.9 9.5 8.6 14.6 3.2 6.4 4.9 15.0 4.3 5.1 12.6 16.8 3.5 5.7 3.0 10.1 5.8 11.5 4.4 9.8 0.6 0.0 0.0 9.7 11.4 1.7 17.0 30.9 16.2 22.2 0.0 0.8 0.7 3.2 15.3 9.2 4.1 0.0 11.2 15.9 0.2 0.0 0.9 1.6 0.2 8.2 3.3 0.0 8.8 2.2 12.0 4.3 11.1 5.3 1.6 0.0 2.0 27.4 0.0 2.3 0.4 0.0 5.4 7.7 0.7 1.8 1.1 16.2 18.7 0.0 0.0 5.2 3.0 0.0 0.3 0.0 1.0 6.4 17.4 1.1 0.1 1.7 2.9 0.9 0.0 0.1 0.0 4.3 0.0 5.8 0.3 11.5 6.3 10.0 3.5 10.2 9.2 5.7 2.7 6.5 9.6 3.0 5.8 10.1 0.4 7.2 4.4 3.0 6.5 3.4 4.1 4.2 3.5 6.9 0.8 8.0 6.4 6.0 14.9 5.7 22.4 6.2 0.0 0.8 43.3 83.0 26.1 21.0 0.0 5.3 11.6 49.6 0.0 21.0 83.4 0.0 54.2 5.7 8.7 22.6 4.6 9.2 5.0 0.0 8.7 22.1 13.9 0.0 9.2 17.4 0.0 19.8 22.7 0.9 69.5 73.7 14.5 26.9 0.0 19.4 2.6 0.5 0.2 4.3 1.8 28.8 17.8 33.6 GBP5 ENSG00000154451 "Guanylate binding protein 5" Q96PP8 1 89258950-89272804 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Antimicrobial, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 13 "granulocytes: 10.4;Kupffer cells: 15.1;Macrophages: 11.7;T-cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 54.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 5.1;NB-4: 7.5;U-266/70: 16.3;U-937: 23.9" "Low region specificity" "Detected in all" HPA028656 Supported NA NA "HPA028656: AB_10601471" "unprognostic (2.72e-2)" "unprognostic (1.82e-2)" "prognostic favorable (9.54e-4)" "prognostic favorable (3.73e-6)" "unprognostic (8.33e-2)" "unprognostic (8.68e-3)" "unprognostic (3.71e-2)" "unprognostic (6.43e-3)" "unprognostic (2.37e-3)" "prognostic favorable (1.24e-4)" "unprognostic (3.47e-2)" "unprognostic (4.16e-1)" "prognostic unfavorable (5.53e-8)" "unprognostic (2.75e-2)" "unprognostic (3.68e-2)" "unprognostic (1.66e-1)" "unprognostic (4.11e-2)" 3.3 1.5 1.0 29.1 1.5 12.1 1.7 0.7 0.8 2.3 4.4 0.7 0.2 2.0 2.4 3.0 2.6 3.3 4.5 1.5 1.0 1.0 2.6 4.0 14.0 26.2 2.8 0.8 3.4 1.3 0.0 1.5 2.6 1.9 3.8 3.0 3.3 2.4 1.2 0.9 1.2 7.6 2.0 2.9 27.6 3.2 4.5 1.0 7.8 3.6 1.3 24.9 6.8 1.7 1.5 1.5 23.0 9.4 11.6 54.6 7.3 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.5 0.9 1.0 0.0 0.1 0.1 5.1 4.1 2.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.4 2.4 0.2 0.0 0.0 7.5 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.5 1.5 0.1 0.0 0.0 3.0 0.1 0.4 0.4 0.0 1.7 16.3 0.3 0.1 0.2 23.9 0.0 0.1 3.5 0.2 23.5 8.7 36.8 1.1 15.5 21.4 1.5 1.5 5.8 9.0 23.0 11.6 9.4 0.1 54.6 7.3 1.0 1.5 0.7 0.8 1.0 1.0 2.8 0.8 1.9 1.0 6.0 6.1 3.7 0.1 0.0 0.0 0.6 2.5 8.1 6.8 0.0 3.9 0.0 0.0 0.0 0.2 1.0 0.0 0.0 1.0 0.0 0.4 0.2 10.4 0.6 4.2 0.0 0.0 4.3 15.1 0.0 0.0 11.7 0.0 0.0 0.0 2.3 0.9 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.5 0.0 0.1 33.2 0.0 0.1 GBP6 DKFZp686G0786 ENSG00000183347 "Guanylate binding protein family member 6" Q6ZN66 1 89364058-89386461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 106.5;lymphoid tissue: 60.5;tongue: 61.3" "Group enriched" "Detected in some" 8 "Ciliated cells: 16.0;Club cells: 4.5" "Group enriched" "Detected in many" 7 "cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;T-cells: 2.7" "Group enriched" "Detected in some" 9 "A-431: 8.0;HaCaT: 17.7" HPA027744 Enhanced NA NA "HPA027744: AB_10602809" "unprognostic (7.60e-3)" "unprognostic (6.83e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (7.05e-3)" "unprognostic (5.85e-2)" "unprognostic (5.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.34e-1)" "unprognostic (7.99e-4)" "unprognostic (1.63e-1)" "unprognostic (2.04e-6)" "unprognostic (1.43e-1)" "unprognostic (1.03e-1)" "unprognostic (3.41e-1)" "unprognostic (3.91e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.1 0.0 106.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 15.6 0.1 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 61.3 60.5 0.1 6.8 0.6 0.6 3.4 0.6 0.3 2.7 0.4 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 17.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.4 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.9 0.6 0.4 0.7 0.2 1.2 0.6 0.9 1.2 0.4 0.4 0.7 0.7 3.4 0.3 0.4 0.6 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 16.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 GBP7 "FLJ38822, GBP4L" ENSG00000213512 "Guanylate binding protein 7" Q8N8V2 1 89131751-89176040 "Predicted intracellular proteins" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "liver: 48.1" "Cell type enhanced" "Detected in some" 20 "Endothelial cells: 6.0;Hepatocytes: 14.3;Ito cells: 3.7" "Cancer enriched" "Detected in single" 58 "liver cancer: 10.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA051245 Uncertain NA NA "HPA051245: AB_2681404" "unprognostic (4.22e-5)" "unprognostic (7.32e-2)" "unprognostic (6.30e-2)" "unprognostic (1.29e-1)" "unprognostic (1.63e-1)" "unprognostic (3.66e-3)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (2.80e-1)" "unprognostic (8.79e-2)" "unprognostic (1.57e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" "unprognostic (8.15e-2)" "unprognostic (1.57e-1)" "unprognostic (6.35e-2)" 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.3 1.3 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.5 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.5 0.0 0.2 0.0 0.2 0.9 0.2 0.1 0.3 0.2 0.1 0.1 0.3 0.2 0.2 1.3 1.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 14.3 1.0 0.0 0.0 3.7 0.6 0.0 0.6 0.8 0.0 0.0 0.0 2.8 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 1.0 0.0 0.4 GBX1 ENSG00000164900 "Gastrulation brain homeobox 1" Q14549 7 151148589-151174745 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 6.0;skeletal muscle: 16.6;testis: 9.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 1.0" "Region enhanced" "Detected in single" "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.9;HEK 293: 2.0;HMC-1: 5.7;PC-3: 1.1" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Low region specificity" "Detected in many" HPA055783 Uncertain NA NA "HPA055783: AB_2682919" "unprognostic (4.24e-2)" "unprognostic (3.87e-2)" "unprognostic (3.58e-2)" "unprognostic (2.40e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.91e-1)" "unprognostic (3.14e-1)" 1.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 6.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.5 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 GBX2 ENSG00000168505 "Gastrulation brain homeobox 2" P52951 2 236165236-236168369 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 11.9" "Cell type enhanced" "Detected in single" 26 "Early spermatids: 1.8" "Group enriched" "Detected in some" 6 "glioma: 1.7;testis cancer: 6.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 32.5;BEWO: 5.6;PC-3: 9.6;TIME: 5.1" "Group enriched" "Detected in some" 6 "basal ganglia: 0.7;thalamus: 1.4" "Region enhanced" "Detected in many" "thalamus: 6.3" HPA067809 Approved Nucleoplasm Yes NA Nucleoplasm "HPA067809: AB_2685900" "unprognostic (5.30e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (8.13e-2)" "unprognostic (6.99e-2)" "unprognostic (3.55e-4)" "unprognostic (8.69e-7)" "unprognostic (2.08e-1)" "unprognostic (1.01e-2)" "unprognostic (5.47e-2)" "unprognostic (9.39e-4)" 0.1 0.1 0.3 0.4 5.8 0.1 0.1 11.9 3.6 0.1 0.2 4.2 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.4 0.6 3.8 0.2 0.3 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.2 1.4 6.3 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.2 0.3 4.6 0.1 0.1 1.3 2.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 32.5 1.2 0.0 0.0 5.6 0.4 0.0 0.9 0.0 0.7 0.0 0.0 0.6 0.0 1.0 0.0 0.2 0.1 0.2 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.6 0.0 2.1 0.0 0.4 0.8 0.0 0.2 0.8 0.0 9.6 0.0 3.5 0.0 0.3 0.0 0.4 0.2 1.1 0.0 0.3 1.0 0.0 0.0 5.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.8 11.9 0.0 0.6 3.8 1.2 0.3 6.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 GC "DBP, hDBP, VDBP" ENSG00000145321 "GC, vitamin D binding protein" P02774 4 71741693-71804041 "Plasma proteins, Predicted secreted proteins" Transport Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 552.1" "Group enriched" "Detected in some" 30 "Cholangiocytes: 1228.0;Hepatocytes: 2290.1" "Cancer enriched" "Detected in many" 18 "liver cancer: 1016.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 4.2;K-562: 1.8;RH-30: 6.5;SiHa: 3.2;U-2 OS: 1.8;U-698: 2.3;U-937: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001526, CAB008596, HPA019855" Supported "Secreted to blood" NA NA 143000000000 69000000000 "CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545" "prognostic favorable (8.08e-4)" "unprognostic (1.06e-3)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.55e-1)" "unprognostic (2.15e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.9 0.0 0.0 2.6 0.1 0.2 0.1 0.1 43.7 0.1 0.1 0.1 2.0 552.1 0.1 0.0 0.1 0.0 0.1 6.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.1 0.4 2.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 1.0 0.0 0.0 0.0 0.3 3.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.8 0.0 2.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 1228.0 0.0 0.0 0.0 0.0 0.0 5.0 18.0 0.2 0.0 0.0 46.7 14.8 0.1 0.0 0.0 0.0 2290.1 0.1 0.0 0.0 57.1 59.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 19.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 41.1;neutrophil: 112.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 112.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" NA NA 890000 Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 13.1 6.8 13.4 24.8 21.3 116.0 7.8 6.9 15.8 6.0 7.7 15.3 3.2 8.2 4.6 11.0 5.0 7.2 9.7 11.2 15.9 13.0 8.5 7.6 15.6 51.8 26.0 9.7 4.4 11.5 4.8 8.1 10.6 24.6 5.7 8.6 3.7 6.9 4.9 2.2 3.7 7.8 7.7 30.2 50.0 10.3 10.7 20.8 5.8 7.4 2.5 10.3 10.0 6.3 3.1 8.9 112.7 18.2 0.3 1.3 8.4 1.4 2.1 5.9 0.0 1.4 1.3 0.2 2.1 6.2 3.4 6.2 4.8 16.4 1.9 15.2 0.1 7.8 0.8 2.2 6.9 4.2 9.2 9.3 17.3 1.5 9.2 1.7 21.5 5.0 1.5 2.4 3.1 0.7 9.0 0.4 14.1 0.3 6.7 0.3 16.9 0.5 12.5 3.7 12.0 8.4 7.5 1.4 9.7 18.1 9.6 3.8 6.5 2.8 12.7 10.7 7.2 8.6 9.7 0.4 0.8 6.3 9.8 3.2 6.3 11.8 0.3 5.4 8.4 4.0 4.4 18.2 41.1 0.4 10.7 0.5 3.0 0.6 0.6 8.9 3.1 1.1 0.7 112.7 0.3 8.0 2.2 1.3 8.4 13.4 21.3 6.9 15.8 15.9 13.0 26.0 9.7 24.6 20.8 14.9 44.6 45.9 25.1 13.7 9.0 2.8 50.9 26.8 12.5 31.4 2.0 46.0 64.6 39.8 106.9 25.9 14.7 0.0 53.4 16.4 13.6 27.8 42.8 11.6 91.1 11.1 37.8 39.3 188.7 17.6 10.0 119.8 15.1 66.7 26.1 17.3 34.6 28.1 6.0 52.8 4.6 6.5 18.9 62.9 11.5 15.8 39.2 10.7 26.4 20.4 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020460, HPA063924" Approved Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Yes No Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548, HPA063924: " "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.8 2.3 5.9 33.9 12.3 10.0 4.2 12.7 13.4 9.7 8.2 5.1 1.0 2.8 6.0 5.7 5.7 5.2 5.9 9.0 2.2 1.2 10.8 6.2 7.4 20.3 20.1 10.9 8.1 11.7 5.5 6.4 14.1 3.1 7.9 11.4 15.7 3.3 4.5 7.8 11.4 20.2 2.5 13.9 9.4 12.0 1.3 16.2 12.2 7.0 12.3 8.4 9.9 16.1 6.8 2.2 12.9 5.3 5.9 9.8 5.3 6.5 4.4 10.8 5.3 5.8 6.7 10.2 10.2 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 6.0 12.5 2.9 15.2 6.9 9.8 43.3 7.6 4.0 6.8 10.4 3.9 12.8 68.0 6.1 3.6 5.6 6.3 0.0 8.8 17.8 7.5 19.5 9.2 55.7 4.0 7.9 2.4 3.1 2.2 4.3 3.4 1.6 20.3 1.8 23.9 17.3 6.8 3.5 9.2 62.4 1.9 6.5 10.8 13.4 27.1 5.3 23.2 4.9 25.5 11.2 GCDH ACAD5 ENSG00000105607 "Glutaryl-CoA dehydrogenase" Q92947 19 12891026-12914207 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.6" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 102.5;Proximal tubular cells: 94.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043252, HPA048492" Enhanced Supported Mitochondria NA NA Mitochondria "HPA043252: AB_2678390, HPA048492: AB_2680418" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" "unprognostic (6.79e-3)" "unprognostic (8.07e-3)" "unprognostic (8.20e-3)" "unprognostic (3.14e-2)" "prognostic favorable (7.28e-5)" "prognostic favorable (3.35e-4)" "unprognostic (1.62e-1)" "unprognostic (3.03e-2)" "unprognostic (7.50e-3)" "unprognostic (7.46e-2)" "prognostic favorable (6.79e-8)" "unprognostic (7.09e-3)" "unprognostic (3.42e-1)" "unprognostic (5.32e-2)" "unprognostic (1.59e-1)" 12.5 12.1 11.4 8.6 13.3 8.2 9.5 11.5 14.0 9.5 10.5 15.5 8.6 9.1 11.7 7.3 9.1 10.5 7.5 19.8 9.3 8.0 20.2 62.6 6.3 12.1 15.5 14.1 13.7 12.3 7.9 8.7 4.9 9.7 10.4 6.9 9.6 14.7 9.7 17.5 6.6 8.1 8.2 8.7 8.6 11.3 4.9 11.8 13.0 10.9 13.7 9.0 12.0 6.6 10.9 14.5 7.2 8.1 21.7 20.6 12.3 11.2 6.3 6.8 12.5 9.9 5.0 6.3 8.4 5.0 9.8 7.5 11.5 4.8 16.3 15.9 4.6 4.9 7.1 9.3 7.2 4.9 14.0 9.9 10.5 10.9 14.1 11.4 19.7 8.4 6.3 9.0 6.9 7.5 4.0 8.4 19.3 25.4 5.1 4.9 12.3 23.1 17.3 7.7 9.8 16.2 22.1 6.9 31.7 5.7 5.2 15.0 9.0 11.8 10.4 7.2 4.5 8.0 13.1 6.0 8.0 6.0 14.9 8.1 27.5 13.9 17.2 5.6 22.6 6.9 7.2 8.1 4.6 11.7 7.1 11.6 10.7 15.0 13.7 14.5 10.9 20.6 15.5 2.0 21.7 5.3 8.6 12.5 12.3 11.4 13.3 11.5 14.0 9.3 8.0 15.5 14.1 9.7 11.8 3.0 4.0 29.5 12.5 7.0 13.8 9.2 20.4 6.7 1.2 10.4 23.6 13.5 44.7 12.0 2.2 4.9 11.4 23.3 9.8 18.6 8.7 10.2 6.9 102.5 18.9 7.9 15.0 13.5 13.0 1.2 12.0 6.9 16.9 27.1 10.8 16.7 9.8 8.6 12.0 94.5 12.2 0.0 7.8 7.2 6.4 4.5 13.6 15.0 19.3 11.8 GCG "GLP-1, GLP1, GLP2, GRPP" ENSG00000115263 Glucagon P01275 2 162142873-162152404 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "pancreas: 202.8" "Cell type enriched" "Detected in some" 14 "Intestinal endocrine cells: 5260.0" "Cancer enriched" "Detected in some" 209 "pancreatic cancer: 428.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 38.0;U-2 OS: 54.1" "Region enriched" "Detected in single" 10 "pons and medulla: 3.7" "Region enhanced" "Detected in single" "midbrain: 2.0" "CAB000040, HPA036760, HPA036761" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to blood" NA NA 127000 "Endoplasmic reticulum" Vesicles "CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297" "unprognostic (3.13e-3)" "unprognostic (9.99e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" 1.0 0.1 0.2 0.6 0.2 1.1 0.2 0.2 1.8 0.2 6.6 0.2 0.2 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 3.4 0.2 0.2 0.2 0.2 0.2 0.2 202.8 0.0 0.2 0.2 0.5 0.2 12.6 0.2 0.2 0.2 0.2 2.5 11.0 0.2 0.2 0.2 2.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.1 0.0 2.9 0.0 1.4 9.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5260.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 8.5 0.0 378.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814013 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 68.8" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 60.2" "Cancer enhanced" "Detected in many" "liver cancer: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 3.9;MCF7: 6.1;SK-BR-3: 5.3;U-87 MG: 6.1" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Not detected" "Not detected" HPA071228 Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA071228: AB_2686368" "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 3.9 0.1 0.6 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 11.4 68.8 0.1 0.1 0.1 0.1 0.1 0.5 3.9 0.1 0.1 0.5 0.2 0.0 1.4 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.6 0.0 5.3 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.0 0.0 0.0 3.5 2.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 0.1 0.0 0.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 GCH1 "DYT14, DYT5, DYT5a, GCH, GTPCH1" ENSG00000131979 "GTP cyclohydrolase 1" P30793 14 54842008-54902852 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" "Allosteric enzyme, Hydrolase" "Disease mutation, Dystonia, Parkinsonism, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.8;liver: 58.2" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 82.5;Intestinal endocrine cells: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.8;Daudi: 13.3;SH-SY5Y: 29.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 15.7" HPA028612 Approved Supported "Nucleoplasm,Nuclear membrane,Cytosol" No No Nucleoplasm "Nuclear membrane, Cytosol" "HPA028612: AB_10602135" "unprognostic (3.77e-2)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (2.39e-1)" "unprognostic (9.26e-2)" "unprognostic (1.27e-1)" "unprognostic (7.26e-2)" "unprognostic (1.75e-1)" "unprognostic (3.97e-1)" "prognostic favorable (8.69e-4)" "prognostic favorable (1.41e-4)" "unprognostic (1.23e-1)" "unprognostic (1.96e-2)" "unprognostic (7.22e-3)" "unprognostic (1.76e-2)" "unprognostic (2.23e-1)" "prognostic favorable (6.67e-4)" 4.8 5.2 1.3 5.7 4.5 26.8 2.1 0.6 1.1 2.2 5.5 1.2 1.5 7.5 1.8 1.9 3.8 1.3 1.6 1.5 1.6 4.3 7.9 58.2 11.6 6.7 2.9 0.7 1.4 3.2 0.3 2.5 2.5 2.8 2.9 4.0 5.2 2.5 4.7 1.4 2.5 9.1 2.0 1.7 10.0 4.2 3.6 1.1 13.0 2.3 2.0 8.5 2.9 2.5 1.6 3.0 0.4 11.5 2.3 3.2 1.3 1.9 0.6 0.7 3.5 0.0 0.0 11.8 0.0 1.2 0.8 2.2 0.9 0.6 13.3 3.3 0.1 1.8 2.0 5.7 0.9 0.0 5.2 5.0 0.3 0.2 1.9 5.7 0.0 1.2 1.4 1.6 1.9 0.0 0.0 0.4 9.1 0.8 0.0 0.0 6.8 7.2 0.2 1.1 2.9 4.5 5.9 1.4 0.0 1.7 2.8 5.9 29.7 2.5 1.5 0.7 0.3 5.7 1.6 0.2 0.1 2.0 3.7 2.3 5.7 4.3 3.2 2.5 4.6 0.0 0.0 3.0 0.2 3.0 6.3 2.5 0.8 1.6 2.1 3.0 1.6 3.2 1.8 0.4 2.3 11.5 0.1 2.3 1.3 1.3 4.5 0.6 1.1 1.6 4.3 2.9 0.7 2.8 1.1 3.0 4.5 8.1 28.1 66.2 0.0 3.3 5.1 2.7 7.9 5.2 2.0 1.8 6.6 8.3 0.4 11.7 16.0 23.3 8.1 40.5 8.2 17.3 0.0 82.5 5.6 0.0 203.8 6.2 24.0 0.6 0.3 13.3 10.1 6.4 15.2 0.3 9.8 14.0 4.6 38.4 0.2 0.0 15.5 1.1 4.7 66.6 3.5 22.3 8.9 32.9 GCHFR "GFRP, HsT16933" ENSG00000137880 "GTP cyclohydrolase I feedback regulator" P30047 15 40764020-40767710 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 655.3;Hofbauer cells: 541.0;Proximal tubular cells: 464.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 32.6;RPTEC TERT1: 41.8;SCLC-21H: 37.5;SK-BR-3: 26.8" "Group enriched" "Detected in many" 5 "cerebellum: 11.6;midbrain: 14.1;pons and medulla: 9.8" HPA046258 Enhanced Supported Nucleoplasm NA NA 59000 Nucleoplasm "HPA046258: AB_10967205" "unprognostic (2.50e-1)" "unprognostic (1.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.72e-2)" "unprognostic (9.89e-3)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "prognostic favorable (5.62e-4)" "unprognostic (4.63e-2)" "unprognostic (1.67e-1)" "unprognostic (3.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.03e-3)" "unprognostic (9.28e-3)" "unprognostic (2.91e-2)" "unprognostic (1.84e-1)" "unprognostic (2.55e-1)" 9.0 4.9 3.8 6.6 6.0 7.9 37.6 9.7 5.0 7.2 16.5 1.5 0.9 18.3 2.0 2.7 13.4 5.1 6.2 8.1 4.6 4.1 16.3 73.4 16.4 10.5 2.8 2.3 7.1 3.9 1.5 5.1 4.7 8.8 5.0 3.4 6.5 6.0 1.7 1.9 7.3 31.7 1.3 3.1 3.5 4.4 3.4 1.3 10.3 5.0 4.0 12.6 4.4 6.1 13.0 25.4 27.1 21.0 33.1 38.6 27.0 0.1 2.2 1.8 9.4 2.7 1.0 4.8 0.6 2.2 1.1 2.1 24.9 14.1 12.7 9.0 0.5 0.7 1.7 4.5 0.8 0.2 9.8 7.7 12.4 18.8 32.6 2.3 8.1 4.3 2.3 1.1 0.5 0.1 0.8 4.1 1.0 6.2 3.9 0.3 4.6 2.2 16.4 4.6 2.3 16.2 17.8 0.1 7.7 41.8 6.6 37.5 0.5 5.6 26.8 2.8 2.4 7.2 8.3 0.0 0.1 0.3 0.6 0.1 0.2 1.6 7.8 1.4 18.0 1.1 4.3 21.0 27.1 22.7 6.4 38.0 13.0 20.1 21.0 13.6 9.6 20.8 13.5 3.3 33.1 5.6 25.4 38.6 27.0 3.8 6.0 9.7 5.0 4.6 4.1 2.8 2.3 8.8 1.3 3.0 49.6 29.9 20.8 12.9 2.5 0.1 86.6 49.5 36.4 61.1 11.8 137.3 64.6 36.4 0.5 12.7 72.2 0.0 28.6 23.2 12.4 34.2 43.8 655.3 541.0 0.0 58.3 19.0 74.4 0.0 16.4 34.2 64.1 7.2 41.6 11.7 22.0 106.6 8.1 464.4 18.1 0.0 4.2 0.4 10.0 13.0 30.6 47.3 99.7 27.8 GCK "HK4, MODY2" ENSG00000106633 Glucokinase P35557 7 44144271-44198170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 46.8" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 5.5;Cardiomyocytes: 3.1;Fibroblasts: 3.9;Horizontal cells: 4.8;Muller glia cells: 3.0;Smooth muscle cells: 4.3" "Cancer enhanced" "Detected in some" "liver cancer: 4.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4;naive CD4 T-cell: 4.8" "Group enriched" "Detected in many" 17 "B-cells: 4.4;T-cells: 4.8" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 12.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA007034, HPA007093" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA007034: AB_1079050, HPA007093: AB_1079051" "unprognostic (3.09e-1)" "unprognostic (2.99e-2)" "unprognostic (3.32e-2)" "unprognostic (6.64e-7)" "unprognostic (8.00e-2)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (2.68e-1)" "unprognostic (1.24e-1)" "unprognostic (5.48e-2)" "unprognostic (8.11e-3)" "unprognostic (3.08e-1)" "unprognostic (3.79e-3)" "unprognostic (2.01e-2)" "unprognostic (3.24e-1)" "unprognostic (4.36e-2)" "unprognostic (1.53e-1)" 1.1 0.5 3.2 0.7 2.8 0.0 0.7 9.5 3.7 1.4 1.4 1.3 0.7 0.3 1.5 1.5 0.7 2.3 0.9 7.1 2.1 7.5 0.7 8.7 0.7 0.7 2.9 1.2 2.2 2.9 0.0 46.8 3.3 1.6 0.8 0.5 0.8 0.7 1.6 0.7 1.2 0.7 0.7 1.7 0.7 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.9 4.4 0.2 0.0 0.0 0.0 4.8 0.7 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.2 0.6 0.4 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.9 0.0 1.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.3 2.2 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.6 4.4 1.6 0.4 0.2 0.7 4.8 0.9 0.0 0.0 0.0 0.0 0.0 0.7 3.2 2.8 9.5 2.4 2.1 7.5 2.9 1.2 1.6 0.7 0.0 0.0 0.0 0.7 1.0 5.5 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 3.9 0.3 0.0 0.6 0.6 4.8 2.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.0 0.1 0.0 2.1 0.0 0.8 0.0 4.3 0.2 0.9 0.1 0.7 0.0 0.0 0.1 GCKR ENSG00000084734 "Glucokinase regulator" 2 27496842-27523684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 60.9" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 76.9" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 12.7;Hep G2: 19.4;HUVEC TERT2: 6.2;TIME: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB034098, HPA052227" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB034098: AB_2247323, HPA052227: " "unprognostic (3.31e-1)" "unprognostic (2.11e-3)" "unprognostic (2.27e-1)" "unprognostic (6.97e-2)" "unprognostic (1.68e-2)" "unprognostic (5.70e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (4.12e-1)" "unprognostic (2.25e-3)" "unprognostic (1.65e-1)" "unprognostic (1.02e-7)" "unprognostic (6.51e-2)" "unprognostic (1.18e-1)" "unprognostic (9.27e-3)" "unprognostic (1.50e-2)" 0.2 2.0 0.1 0.1 0.3 0.2 0.1 0.2 0.2 0.1 0.4 0.1 0.1 0.2 0.1 0.3 0.4 0.0 3.9 0.5 0.1 0.0 0.2 60.9 0.1 0.1 0.1 0.1 2.0 0.9 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.5 3.1 0.9 0.2 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.8 2.6 1.2 1.7 0.9 0.7 0.2 0.4 0.4 0.2 0.3 0.2 0.1 0.0 0.1 0.3 0.0 0.4 0.1 0.2 0.5 0.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 12.7 0.5 19.4 0.8 0.1 0.4 0.3 1.0 0.5 0.1 2.2 6.2 0.0 0.0 0.2 0.2 0.1 0.1 0.7 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.5 0.1 3.8 0.1 0.3 0.6 0.2 0.4 0.1 0.2 1.2 0.1 0.2 2.6 1.2 0.3 0.6 1.0 0.6 0.8 0.4 0.4 0.1 2.4 0.9 0.8 2.1 1.7 0.3 0.8 0.1 0.7 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.3 0.4 0.0 0.0 9.0 0.0 0.0 0.3 0.0 76.9 0.1 0.0 0.0 1.3 1.9 2.8 0.3 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 102.4;Intestinal endocrine cells: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 49.2;Hep G2: 42.0;OE19: 68.1;RT4: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favorable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 7.3 49.2 4.0 9.5 4.8 2.2 5.4 3.7 6.0 2.8 3.3 7.2 17.1 14.0 7.1 3.3 21.5 10.5 12.3 27.1 3.8 11.0 7.6 9.3 9.5 42.0 5.5 12.3 5.8 3.4 11.5 3.1 14.1 3.7 4.2 12.3 5.1 4.4 1.3 7.7 10.5 4.9 7.5 68.1 4.6 3.5 2.5 12.3 9.1 45.4 11.7 5.7 6.2 10.0 6.5 6.1 6.8 5.8 5.9 2.5 8.8 6.4 5.5 5.9 9.1 8.1 6.3 8.8 4.2 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 0.0 3.7 7.8 42.9 30.9 12.8 17.8 25.5 48.2 47.8 0.0 23.6 5.2 10.0 12.8 1.4 13.5 19.9 46.7 11.0 6.5 8.7 44.8 2.3 102.4 19.8 7.9 212.1 9.2 60.1 1.0 6.1 16.4 8.5 6.4 16.3 13.8 17.1 8.5 8.9 19.8 4.0 12.9 10.3 3.3 8.1 21.8 6.5 10.7 13.8 89.1 GCM1 "GCMA, hGCMa" ENSG00000137270 "Glial cells missing homolog 1" Q9NP62 6 53126964-53148829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "placenta: 102.4" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 166.4;Syncytiotrophoblasts: 222.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.5" "Group enriched" "Detected in many" 8 "B-cells: 1.8;granulocytes: 4.5" "Cell line enriched" "Detected in some" 5 "BEWO: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011343, HPA073469" Enhanced Approved Vesicles NA NA Vesicles "HPA011343: AB_2668489, HPA073469: " "unprognostic (2.81e-2)" "unprognostic (4.09e-2)" "unprognostic (1.89e-2)" "unprognostic (1.53e-1)" "unprognostic (3.17e-1)" "unprognostic (7.68e-2)" "unprognostic (8.47e-3)" "unprognostic (2.83e-2)" "unprognostic (2.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.42e-1)" "unprognostic (5.98e-2)" "unprognostic (1.29e-4)" "unprognostic (1.86e-1)" "unprognostic (7.42e-2)" "unprognostic (2.96e-2)" 0.3 0.3 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 1.5 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.2 102.4 0.1 0.2 0.0 0.1 0.1 0.1 3.1 0.0 0.4 0.1 0.1 2.2 0.0 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.8 0.2 4.5 0.3 0.4 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 30.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.0 6.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.6 0.3 2.2 0.2 0.1 0.2 0.7 0.1 0.1 0.2 1.8 0.2 0.2 4.5 0.4 0.3 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.3 1.9 0.0 0.0 0.0 0.2 166.4 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 222.5 0.0 0.0 0.0 GCM2 "GCMB, hGCMb" ENSG00000124827 "Glial cells missing homolog 2" O75603 6 10873223-10881941 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "parathyroid gland: 110.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.2;HMC-1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.55e-1)" "unprognostic (4.94e-1)" "unprognostic (2.18e-2)" "unprognostic (7.17e-2)" "unprognostic (2.63e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 GCNA "ACRC, NAAR1" ENSG00000147174 "Germ cell nuclear acidic peptidase" Q96QF7 X 71578411-71613583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 29.4" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 3.5;granulocytes: 2.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA023476, HPA030870" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA023476: AB_1844530, HPA030870: " "unprognostic (6.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.43e-2)" "unprognostic (4.37e-3)" "unprognostic (1.39e-1)" "unprognostic (2.35e-4)" "unprognostic (5.84e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-1)" "unprognostic (1.68e-1)" "unprognostic (1.03e-2)" "unprognostic (2.06e-1)" "unprognostic (5.07e-10)" "unprognostic (2.30e-1)" "unprognostic (5.06e-2)" "unprognostic (4.74e-1)" "unprognostic (1.15e-5)" 1.4 6.9 1.2 1.7 1.7 1.6 1.2 3.7 1.7 1.2 1.2 1.2 1.2 1.0 1.2 1.4 1.2 0.9 1.2 1.2 1.3 2.5 1.2 1.8 1.4 2.6 1.2 1.2 1.5 1.7 0.4 1.2 1.2 1.7 1.2 1.0 1.2 1.2 1.2 3.1 1.7 1.5 1.2 1.2 3.9 0.9 29.4 1.2 1.2 1.6 1.2 1.4 1.2 1.2 1.4 0.6 1.1 0.6 1.4 3.3 0.5 0.6 1.1 2.2 2.0 4.5 4.2 1.3 3.6 1.9 1.2 2.1 2.0 1.3 5.5 2.7 1.9 1.2 2.6 4.3 0.2 1.8 0.9 2.9 1.1 4.9 0.5 1.2 1.0 5.1 1.6 6.9 1.0 1.0 4.6 0.8 4.3 1.5 3.5 2.5 0.7 0.4 3.9 2.2 2.5 2.6 1.0 0.1 4.0 2.8 1.6 1.3 0.2 1.2 0.6 3.0 2.4 0.4 3.5 1.4 1.3 2.6 1.8 1.0 1.0 2.5 2.2 2.5 2.1 2.2 0.6 0.6 0.1 0.7 0.3 1.3 1.4 1.7 3.3 0.3 0.5 1.0 1.1 1.1 1.4 0.1 0.6 3.0 0.5 1.2 1.7 3.7 1.7 1.3 2.5 1.2 1.2 1.7 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GCNT1 "C2GNT, NACGT2, NAGCT2" ENSG00000187210 "Glucosaminyl (N-acetyl) transferase 1, core 2" Q02742 9 76419850-76507416 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.0;parathyroid gland: 57.8" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 26.5;Kupffer cells: 29.1;Undifferentiated cells: 26.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 16.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 26.3;HSkMC: 22.3;U-2197: 18.7" "Group enriched" "Detected in some" 6 "cerebellum: 8.2;olfactory region: 30.1" "Low region specificity" "Detected in all" "HPA003522, HPA003523, HPA031151" Uncertain Supported "Nuclear speckles" NA NA 72000 "Nuclear speckles" "HPA003522: , HPA003523: , HPA031151: AB_10602904" "unprognostic (3.14e-1)" "unprognostic (2.01e-1)" "unprognostic (2.19e-1)" "prognostic favorable (8.44e-4)" "unprognostic (5.53e-2)" "unprognostic (2.41e-1)" "unprognostic (1.65e-2)" "unprognostic (3.37e-2)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.90e-1)" "unprognostic (3.06e-1)" "unprognostic (3.02e-3)" "unprognostic (4.21e-1)" "unprognostic (2.00e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.96e-4)" 5.6 1.1 1.6 7.9 3.9 2.2 8.2 10.9 2.7 5.3 24.5 0.7 3.0 23.2 5.2 1.2 2.1 1.8 4.1 3.1 2.1 1.4 1.4 1.0 4.5 9.2 1.6 2.1 0.9 2.0 57.8 1.9 3.9 1.0 4.9 4.6 0.5 9.1 1.8 0.8 1.5 32.0 2.5 1.2 7.6 18.6 1.4 0.6 2.8 16.9 1.2 6.4 2.4 3.3 9.4 4.7 16.8 6.4 4.7 1.9 1.6 2.4 0.2 0.1 0.0 3.1 15.2 3.7 10.2 4.6 8.3 5.9 2.5 0.6 1.7 1.0 7.6 1.6 2.2 5.2 4.2 9.3 1.2 0.8 4.3 0.2 0.4 26.3 3.1 1.5 22.3 1.1 8.0 8.7 6.8 7.6 2.2 0.0 1.8 8.2 3.8 1.7 5.1 4.8 6.4 0.6 2.8 5.1 0.8 9.7 4.5 1.1 0.0 1.2 1.4 0.0 3.8 0.0 2.2 3.1 5.2 3.4 18.7 4.4 2.6 0.5 0.0 10.5 5.4 1.3 4.3 2.7 16.8 1.3 6.4 0.4 1.3 1.5 1.3 4.7 9.4 0.2 1.0 0.9 4.7 5.7 2.3 1.9 1.6 1.6 3.9 10.9 2.7 2.1 1.4 1.6 2.1 1.0 0.6 0.0 1.7 2.2 3.5 0.8 0.0 0.8 0.0 9.4 9.1 3.5 0.0 1.6 0.0 1.3 19.4 4.2 16.9 0.0 22.1 17.9 4.1 9.1 10.4 0.0 7.4 0.0 26.5 6.2 29.1 9.7 0.0 11.2 1.7 1.0 12.5 0.0 8.5 15.6 1.1 1.3 0.1 0.0 1.0 1.8 2.4 0.3 15.9 4.3 26.5 0.9 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 71.5;Melanocytes: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 26.4;Hep G2: 11.0;SuSa: 10.2" "Region enriched" "Detected in many" 4 "basal ganglia: 54.8" "Low region specificity" "Detected in all" HPA026776 Approved Approved "Golgi apparatus" No No 560000 "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 2.0 0.9 2.5 7.9 2.8 0.7 12.7 7.6 1.9 6.0 13.0 2.0 0.9 7.8 5.6 1.3 3.7 1.7 2.8 11.8 2.2 2.4 19.6 14.3 10.4 3.3 2.4 0.4 0.9 5.5 1.0 6.2 3.1 4.0 21.9 3.7 8.1 7.4 0.9 2.3 2.5 25.1 2.6 2.2 4.2 8.3 9.0 2.9 0.9 2.4 1.2 7.2 2.0 3.0 2.1 2.5 4.2 3.1 0.5 0.4 0.7 4.2 3.5 1.2 2.9 0.0 0.0 3.5 0.0 3.1 0.8 0.2 6.2 3.2 2.4 26.4 0.0 1.8 0.1 0.3 3.2 1.8 1.6 0.9 0.5 1.9 11.0 0.0 1.1 3.0 0.0 0.0 0.3 0.0 1.7 7.0 0.0 0.3 0.0 0.3 0.0 0.0 2.3 4.0 0.0 2.4 0.1 2.4 3.8 9.4 2.3 2.6 1.8 0.0 9.2 8.9 10.2 0.1 0.4 5.9 0.5 0.4 0.0 3.4 0.0 0.0 1.7 0.6 0.2 1.4 4.2 3.1 1.3 0.3 2.3 0.1 2.1 0.3 0.4 2.5 1.3 0.4 0.4 0.2 0.5 0.8 0.6 0.2 0.7 2.5 2.8 7.6 1.9 2.2 2.4 2.4 0.4 4.0 2.9 71.5 26.7 12.3 5.5 4.0 4.3 14.9 2.5 30.8 28.4 7.0 0.0 22.4 10.0 2.4 3.3 5.8 28.4 23.3 22.4 1.0 1.1 21.1 2.3 31.1 12.9 3.2 2.4 8.6 6.3 6.0 0.3 6.9 47.2 9.0 2.8 2.9 9.0 1.7 0.0 8.8 0.5 0.0 0.4 1.9 20.4 1.5 9.2 0.0 7.2 7.0 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 99.5;Ductal cells: 59.9;Enterocytes: 119.9;Pancreatic endocrine cells: 45.2;Paneth cells: 59.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 29.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 54.4;EFO-21: 9.4;Hep G2: 10.9;OE19: 27.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.3 0.5 0.3 8.8 0.4 0.0 0.3 0.3 0.3 5.3 37.6 0.3 0.3 25.4 1.3 0.4 8.7 0.7 29.6 0.3 0.3 0.2 9.9 0.4 0.7 0.3 0.3 0.3 1.1 1.7 0.0 0.4 1.0 0.5 1.0 33.4 0.3 27.4 0.3 0.3 0.2 103.3 0.9 0.3 0.3 6.5 1.7 0.3 0.5 0.7 5.2 15.5 0.7 14.0 1.2 1.4 3.4 0.8 1.1 0.7 0.1 0.0 54.4 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 2.3 2.2 0.2 9.4 0.0 3.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 10.9 0.0 0.1 0.1 0.1 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 27.6 0.1 0.1 0.0 0.2 3.8 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.1 0.1 0.2 3.4 0.1 0.0 2.6 0.8 0.6 0.7 0.4 0.4 0.6 0.5 0.3 0.2 1.2 0.4 0.6 3.4 1.1 0.4 1.4 0.5 0.1 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.5 0.3 0.0 2.1 0.0 6.7 0.0 0.0 0.5 12.7 0.0 0.0 99.5 0.0 0.0 0.0 59.9 7.6 0.0 119.9 0.0 13.4 0.0 0.0 4.7 0.0 0.0 0.1 0.0 7.5 0.0 0.3 13.3 0.0 0.0 0.0 1.8 18.6 0.0 45.2 59.6 0.0 3.3 0.0 6.5 0.0 0.9 0.1 0.0 0.0 0.0 30.8 43.7 GCNT4 C2GNT3 ENSG00000176928 "Glucosaminyl (N-acetyl) transferase 4, core 2" Q9P109 5 75025346-75030899 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.6;intestine: 13.1;stomach 1: 10.4" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 35.7;Cytotrophoblasts: 27.4;Syncytiotrophoblasts: 20.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Group enriched" "Detected in many" 54 "granulocytes: 13.6;T-cells: 11.6" "Cell line enriched" "Detected in some" 5 "RT4: 26.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037431 Approved Supported "Nucleoplasm,Golgi apparatus" No NA "Golgi apparatus" Nucleoplasm "HPA037431: AB_10670382" "unprognostic (1.88e-2)" "unprognostic (5.63e-2)" "unprognostic (6.05e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-1)" "unprognostic (4.98e-2)" "unprognostic (4.11e-3)" "unprognostic (1.63e-2)" "unprognostic (3.47e-1)" "unprognostic (2.20e-2)" "unprognostic (4.49e-3)" "unprognostic (6.04e-2)" "prognostic favorable (1.93e-7)" "unprognostic (8.39e-2)" "unprognostic (1.93e-1)" "unprognostic (6.06e-2)" "unprognostic (5.82e-2)" 0.6 0.6 0.3 1.0 0.7 0.0 0.9 0.0 2.3 1.1 1.1 13.1 1.4 0.6 1.3 1.1 2.5 0.3 0.3 0.1 1.8 0.4 1.0 1.7 0.1 0.9 3.0 8.4 0.1 3.0 1.0 0.2 0.5 2.4 1.0 1.5 10.8 0.7 0.0 0.6 10.4 1.0 0.5 1.1 6.4 2.0 0.0 0.0 13.6 0.1 0.2 11.6 1.6 0.2 0.1 1.0 1.6 1.8 0.6 0.1 2.0 5.2 1.0 0.9 2.5 0.1 0.0 0.2 1.5 0.6 0.7 1.0 1.8 0.2 0.0 0.0 0.8 0.2 0.2 0.8 0.0 0.0 0.3 2.9 0.1 0.4 0.0 0.0 1.5 0.0 0.3 0.1 0.0 1.4 0.0 0.4 5.7 0.0 0.0 0.0 2.6 0.2 26.6 0.0 0.0 0.2 0.0 0.0 5.4 0.0 0.0 0.0 0.5 0.1 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.1 13.6 0.0 0.0 0.9 0.0 3.5 0.0 8.1 2.6 0.0 0.0 8.1 5.9 0.1 0.2 0.1 0.0 11.6 1.6 3.0 5.3 0.0 5.5 0.6 0.0 0.4 35.7 0.0 4.5 12.2 0.0 27.4 8.3 6.1 0.1 1.0 6.7 0.0 3.7 0.7 1.1 1.5 7.0 0.8 2.1 0.0 0.0 4.9 0.8 0.0 3.7 0.0 0.0 1.0 0.5 0.0 4.9 1.7 2.5 0.6 0.0 6.5 0.9 0.0 0.2 0.1 20.4 0.0 0.6 4.1 GCNT7 "C20orf105, dJ1153D9.2" ENSG00000124091 "Glucosaminyl (N-acetyl) transferase family member 7" Q6ZNI0 20 56491492-56525925 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 3.9;bone marrow: 9.6" "Cell type enhanced" "Detected in single" 33 "Early spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA052617, HPA059403" Uncertain Approved "Nuclear bodies,Vesicles,Cytosol" NA NA "Nuclear bodies, Vesicles" Cytosol "HPA052617: AB_2681886, HPA059403: " "unprognostic (3.57e-2)" "unprognostic (1.39e-1)" "unprognostic (7.74e-2)" "unprognostic (1.89e-1)" "unprognostic (3.96e-2)" "unprognostic (9.08e-2)" "unprognostic (3.10e-1)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (2.38e-1)" "unprognostic (9.69e-2)" "unprognostic (2.84e-2)" "unprognostic (2.16e-3)" "unprognostic (1.84e-1)" "unprognostic (1.74e-1)" "unprognostic (1.96e-1)" "unprognostic (8.69e-2)" 0.2 0.2 0.0 0.7 0.0 9.6 0.3 0.6 0.3 0.0 0.2 0.3 0.2 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.3 0.4 0.4 0.0 0.5 0.5 0.0 0.6 0.1 0.3 0.0 0.4 0.0 0.3 1.0 0.4 0.0 0.1 0.5 0.3 1.6 0.3 0.0 0.6 0.3 1.0 0.9 3.9 0.7 0.3 1.1 0.1 0.6 1.0 0.8 0.5 0.0 0.0 1.1 1.0 0.0 0.0 0.0 2.1 0.5 0.1 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.1 1.2 1.7 0.5 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.0 1.5 0.0 1.3 0.7 1.4 0.5 0.1 0.7 0.1 0.4 0.5 0.0 1.9 1.0 0.5 1.2 1.0 0.2 0.5 0.8 0.2 0.0 2.2 0.4 0.5 0.6 1.6 0.1 0.5 0.3 0.6 0.5 1.1 0.7 0.9 0.8 0.5 0.8 0.7 0.7 0.5 0.4 1.0 1.1 0.4 3.9 0.3 0.7 0.9 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GCOM1 "FLJ30973, GRINL1A, MYZAP-POLR2M" ENSG00000137878 "GRINL1A complex locus 1" 15 57591908-57714745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 107.1;smooth muscle: 42.3" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Cardiomyocytes: 2.8;Paneth cells: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebellum: 10.4;pons and medulla: 3.9" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6;naive CD4 T-cell: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 3.6;monocytes: 1.5;T-cells: 4.0" "Cell line enhanced" "Detected in some" "HEL: 25.3;RH-30: 7.1;RT4: 8.0;TIME: 10.9" "HPA039827, HPA068141" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039827: AB_10673364, HPA068141: AB_2685962" "unprognostic (1.10e-1)" "unprognostic (3.62e-4)" "unprognostic (1.10e-1)" "unprognostic (5.43e-3)" "unprognostic (1.31e-3)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (7.69e-4)" "unprognostic (1.22e-1)" "unprognostic (3.22e-3)" "unprognostic (3.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (7.44e-2)" "unprognostic (1.67e-1)" "unprognostic (5.78e-2)" 6.7 4.6 1.2 1.9 1.4 2.9 10.3 10.4 1.3 4.1 3.6 0.1 2.3 3.6 5.2 1.2 9.9 1.3 2.3 107.1 1.2 1.6 1.2 0.9 7.6 1.7 1.2 0.0 2.3 5.6 0.4 1.0 9.1 3.9 10.2 1.3 0.0 4.6 2.7 7.3 2.6 5.8 42.3 1.0 2.6 3.3 2.5 0.0 0.0 1.1 5.0 4.8 25.3 9.5 3.6 0.5 0.4 1.5 0.0 4.0 4.5 3.3 0.6 0.0 3.3 0.0 0.0 0.8 0.6 2.3 1.1 1.0 2.4 3.3 0.0 0.5 0.0 2.9 2.1 0.0 2.0 0.9 0.0 0.1 25.3 0.7 0.1 0.0 0.1 0.1 0.1 0.1 0.3 5.0 0.1 1.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.1 4.6 0.1 0.0 7.1 0.0 0.0 8.0 0.0 0.8 0.7 0.7 0.0 0.5 3.2 0.0 10.9 0.3 2.1 0.3 0.2 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 1.2 0.7 0.0 0.5 3.6 4.0 0.0 0.4 0.0 1.5 0.0 0.3 4.5 1.2 1.4 10.4 1.3 1.2 1.6 1.2 0.0 3.9 0.0 3.0 0.3 0.0 0.2 0.0 0.0 2.8 0.0 1.4 1.2 0.0 0.0 0.1 0.0 1.4 0.0 0.3 1.3 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 1.3 3.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.3 GCSAM "GCET2, HGAL, MGC40441" ENSG00000174500 "Germinal center associated signaling and motility" Q8N6F7 3 112120841-112133305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 59.7;skin 1: 15.4" "Cell type enhanced" "Detected in some" 31 "B-cells: 9.3;monocytes: 39.7;T-cells: 10.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Daudi: 50.7;U-698: 29.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002473 Approved NA NA "HPA002473: AB_1078960" "unprognostic (8.23e-4)" "unprognostic (1.64e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (2.33e-1)" "unprognostic (4.17e-3)" "unprognostic (9.20e-2)" "unprognostic (8.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.69e-3)" "unprognostic (1.97e-1)" "unprognostic (5.78e-2)" "unprognostic (3.32e-2)" "unprognostic (3.77e-1)" "unprognostic (3.43e-2)" "unprognostic (2.35e-2)" "unprognostic (2.38e-2)" 0.8 0.2 0.1 29.0 0.3 1.2 0.6 0.1 0.3 0.6 1.6 0.3 0.7 1.3 0.3 0.5 3.2 0.5 1.0 0.8 0.1 0.0 1.0 1.1 2.4 16.4 0.3 0.1 0.5 4.4 0.0 0.8 0.1 0.3 1.0 0.6 0.4 3.0 0.4 0.6 15.4 4.0 0.5 0.2 11.1 2.7 0.4 0.2 59.7 3.4 1.3 24.6 1.8 1.0 10.8 5.7 5.9 0.1 0.5 10.1 3.1 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.4 0.0 50.7 0.0 0.0 0.3 1.1 0.0 0.9 0.0 1.0 0.3 0.3 0.1 0.1 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.4 0.0 2.9 0.0 0.0 4.7 0.0 0.4 0.2 0.2 5.5 0.4 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.1 0.3 0.5 0.0 0.3 0.4 0.2 0.0 0.0 0.2 0.0 29.0 0.0 0.0 0.1 5.9 0.0 0.0 2.0 0.1 0.4 9.0 10.1 5.2 5.7 10.8 9.5 5.1 0.3 0.5 0.0 3.1 1.5 3.1 0.1 0.3 0.1 0.3 0.1 0.0 0.3 0.1 0.3 0.2 0.0 0.3 9.3 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 1.0 0.0 0.0 0.5 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 10.9 0.0 0.6 GCSAML "C1orf150, FLJ44728" ENSG00000169224 "Germinal center associated signaling and motility like" Q5JQS6 1 247507058-247577690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 48.3;brain: 17.6" "Cell type enriched" "Detected in some" 27 "granulocytes: 214.1" "Cancer enriched" "Detected in single" 13 "prostate cancer: 1.9" "Region enriched" "Detected in some" 10 "cerebellum: 17.6" "Cell type enriched" "Detected in single" 439 "basophil: 48.3" "Lineage enriched" "Detected in single" 439 "granulocytes: 48.3" "Group enriched" "Detected in some" 73 "HEL: 28.5;HMC-1: 113.3" "Low region specificity" "Detected in single" "HPA027507, HPA027510" Uncertain Approved Cytosol NA NA Cytosol "HPA027507: AB_10600756, HPA027510: AB_2672309" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (4.07e-3)" "unprognostic (3.48e-2)" "unprognostic (1.72e-1)" "unprognostic (2.76e-4)" "unprognostic (3.21e-1)" "unprognostic (6.14e-2)" "unprognostic (5.42e-2)" "unprognostic (2.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.81e-1)" "unprognostic (9.51e-3)" "unprognostic (3.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.40e-2)" 3.7 0.3 0.4 1.1 0.4 2.4 1.6 17.6 0.4 3.8 2.1 0.2 0.0 2.2 2.4 2.2 1.9 0.6 2.7 1.3 0.4 0.5 0.5 0.4 5.6 1.1 0.5 0.0 0.3 0.5 0.1 0.4 0.3 1.7 9.5 2.4 0.4 1.0 0.9 0.5 1.2 2.5 6.6 0.9 0.5 1.4 5.3 0.0 1.4 0.4 2.4 1.5 3.4 9.4 0.1 0.0 48.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 113.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 48.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 17.6 0.4 0.4 0.5 0.5 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.6 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 6.7 0.1 0.0 0.0 0.0 0.0 0.3 1.3 214.1 0.0 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 6.9 1.6 0.5 0.0 0.0 0.0 0.0 GCSAML-AS1 ENSG00000284824 "GCSAML antisense RNA 1" Q8N628 1 247524679-247532613 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.1;hTERT-HME1: 1.0;SK-MEL-30: 1.2" HPA058578 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 GCSH ENSG00000140905 "Glycine cleavage system protein H" P23434 16 81081938-81096425 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 501.6;Extravillous trophoblasts: 1237.6;Proximal tubular cells: 489.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041368, HPA057079" Supported Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA041368: AB_10804001, HPA057079: " "unprognostic (4.09e-2)" "unprognostic (2.98e-2)" "unprognostic (2.29e-1)" "unprognostic (2.47e-3)" "unprognostic (2.55e-3)" "unprognostic (4.87e-2)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.96e-2)" "unprognostic (6.92e-2)" "unprognostic (2.80e-2)" "prognostic favorable (6.26e-6)" "unprognostic (1.12e-2)" "unprognostic (2.59e-1)" "unprognostic (6.31e-2)" "unprognostic (6.47e-2)" 10.9 10.0 28.9 3.7 26.8 3.0 11.4 8.1 21.8 9.9 6.4 15.0 14.2 3.8 9.4 35.9 6.0 10.4 6.3 11.7 23.5 20.6 37.3 55.9 4.0 5.8 30.8 15.8 8.9 10.2 19.4 7.2 12.9 18.7 9.9 7.0 10.4 9.4 9.3 18.1 4.3 3.1 6.9 27.6 2.6 5.2 3.5 17.9 6.7 48.7 5.9 4.8 6.6 4.9 4.4 12.2 2.8 2.6 7.9 7.3 2.9 18.1 8.0 25.3 11.0 12.4 9.6 51.7 10.6 7.9 12.9 6.3 10.7 17.0 4.8 9.6 4.6 9.8 9.3 19.3 10.7 21.6 1.3 25.2 6.2 10.7 33.0 14.1 20.0 7.2 9.8 14.4 8.0 16.5 4.0 6.5 13.5 24.0 1.0 12.8 19.2 13.0 40.6 33.4 14.6 16.8 20.4 13.3 7.2 29.2 16.7 13.1 13.6 15.2 9.9 20.0 20.4 14.5 9.6 5.7 8.4 14.7 13.3 10.9 4.1 8.7 29.0 5.6 12.0 6.7 2.8 1.7 1.7 3.4 2.6 5.7 4.4 3.3 4.9 4.5 3.3 5.8 7.3 2.2 7.9 2.0 12.2 2.6 2.9 28.9 26.8 8.1 21.8 23.5 20.6 30.8 15.8 18.7 17.9 3.0 5.1 31.8 74.7 25.8 44.4 11.8 33.1 20.1 13.6 76.8 35.3 501.6 250.4 57.2 25.7 29.8 9.8 0.0 37.0 1237.6 66.3 92.3 36.8 317.5 102.2 36.5 25.3 31.3 17.6 15.2 130.3 25.7 81.0 24.4 29.9 130.3 38.6 14.0 132.6 489.6 42.3 32.3 58.7 20.0 68.6 23.7 191.3 21.0 48.6 56.2 GDA ENSG00000119125 "Guanine deaminase" Q9Y2T3 9 72114595-72257193 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;intestine: 54.5;liver: 27.6" "Group enriched" "Detected in many" 7 "Enterocytes: 113.2;Hepatocytes: 49.7;Paneth cells: 91.2;Proximal tubular cells: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 11.1;EFO-21: 44.1;HeLa: 15.4;hTCEpi: 20.6;OE19: 50.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4" "HPA019352, HPA024099, HPA030387" Enhanced Approved Nucleoplasm No NA 1300000 Nucleoplasm "HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351" "unprognostic (2.64e-2)" "unprognostic (7.10e-2)" "unprognostic (2.83e-2)" "unprognostic (2.92e-1)" "unprognostic (4.35e-2)" "unprognostic (8.45e-2)" "unprognostic (2.00e-1)" "unprognostic (5.60e-2)" "unprognostic (3.26e-1)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "prognostic favorable (2.66e-5)" "unprognostic (2.23e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (8.30e-4)" 0.5 1.7 26.7 1.8 27.7 0.5 0.5 0.4 33.8 1.0 20.6 0.9 7.7 47.4 2.4 0.6 0.5 4.7 13.1 0.5 25.7 15.0 21.4 27.6 0.5 0.5 2.9 27.4 0.4 1.7 10.8 1.7 10.3 0.8 0.4 5.5 0.0 0.4 4.1 1.1 1.6 54.5 0.5 0.6 0.5 2.0 1.0 0.2 0.0 0.4 1.0 2.6 3.4 0.5 1.4 0.5 3.0 0.7 1.0 1.0 0.1 11.1 1.4 0.0 0.0 0.0 0.0 0.2 0.0 8.1 0.0 0.0 1.0 6.3 0.0 44.1 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 50.0 0.0 0.0 0.0 0.3 0.3 2.5 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.3 1.0 0.6 0.3 0.6 0.5 0.4 0.3 1.4 0.7 0.7 1.9 1.0 0.4 0.5 0.5 0.1 26.7 27.7 0.4 33.8 25.7 15.0 2.9 27.4 0.8 0.2 0.0 0.3 1.7 0.5 0.0 0.0 0.6 12.7 0.0 0.0 0.0 0.0 0.1 3.3 9.2 1.0 0.0 113.2 0.0 9.7 1.0 0.4 0.6 0.0 49.7 0.2 0.0 4.6 1.3 1.0 0.0 0.3 0.0 0.0 1.0 11.2 0.0 4.4 91.2 0.0 84.2 0.0 0.0 0.3 0.4 4.2 0.1 1.6 0.0 7.8 0.8 GDAP1 "CMT2K, CMT4, CMT4A" ENSG00000104381 "Ganglioside induced differentiation associated protein 1" Q8TB36 8 74321130-74488872 "Disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.3" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 42.1;Cone photoreceptor cells: 45.2;Horizontal cells: 44.5;Rod photoreceptor cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014266, HPA024334" Enhanced Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA014266: AB_1849581, HPA024334: AB_1849583" "unprognostic (3.19e-2)" "unprognostic (1.52e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (3.31e-1)" "unprognostic (4.36e-2)" "unprognostic (1.72e-2)" "prognostic favorable (2.68e-4)" "unprognostic (3.88e-1)" "unprognostic (4.17e-1)" "unprognostic (9.44e-3)" "unprognostic (2.44e-1)" "unprognostic (5.40e-2)" "unprognostic (3.29e-1)" "unprognostic (6.99e-2)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.73e-1)" 2.8 11.2 19.2 3.8 25.9 2.1 5.6 24.9 48.3 3.2 2.9 7.6 1.1 3.2 5.4 5.7 5.3 3.7 3.4 2.8 17.6 21.4 5.3 2.0 3.2 3.7 16.5 19.2 8.2 10.8 12.3 16.4 2.3 23.3 5.6 3.6 3.7 2.9 5.4 2.6 2.1 3.0 3.9 14.6 2.9 3.2 5.4 9.6 0.7 7.5 0.5 3.4 3.8 1.8 2.7 1.7 2.8 7.2 1.9 4.6 1.4 2.3 7.7 12.0 2.7 1.0 0.9 1.2 1.0 5.7 6.1 7.0 4.1 2.7 9.2 1.4 1.3 6.4 4.0 6.4 3.9 11.9 7.9 2.0 4.8 4.3 7.9 1.3 3.9 9.9 2.9 1.3 2.9 6.2 0.7 0.7 3.9 2.3 0.1 3.6 2.9 8.0 0.6 13.9 12.5 10.6 4.1 5.7 1.7 2.0 7.2 11.8 28.9 7.1 2.7 6.0 3.6 11.9 1.3 0.1 8.9 4.1 2.0 2.8 6.1 5.7 4.5 4.0 0.2 9.3 0.0 1.7 2.8 1.5 4.3 1.8 2.7 1.6 1.9 1.7 1.9 1.3 1.6 0.0 1.9 7.2 0.0 4.6 1.4 19.2 25.9 24.9 25.8 17.6 21.4 16.5 19.2 23.3 9.6 6.0 3.2 3.5 6.4 1.5 42.1 4.8 5.1 4.0 3.4 3.5 45.2 0.4 8.3 4.1 4.4 6.4 2.4 0.0 5.2 0.3 2.9 3.7 17.3 1.6 4.1 44.5 19.5 5.5 4.0 0.5 3.7 4.9 1.7 1.0 2.0 18.0 3.6 0.3 5.3 5.0 45.4 0.0 6.6 14.2 11.7 1.1 0.0 1.5 1.4 3.3 GDAP1L1 ENSG00000124194 "Ganglioside induced differentiation associated protein 1 like 1" Q96MZ0 20 44247099-44280917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 8.8;Early spermatids: 7.1;Horizontal cells: 14.3;Late spermatids: 21.0" "Cancer enriched" "Detected in single" 14 "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 9.8;SCLC-21H: 24.2;SH-SY5Y: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054182, HPA063265" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA054182: , HPA063265: AB_2684972" "unprognostic (6.58e-3)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (2.23e-4)" "unprognostic (3.69e-1)" "unprognostic (5.15e-1)" "unprognostic (6.45e-2)" "unprognostic (7.69e-2)" "unprognostic (1.53e-1)" "unprognostic (5.07e-1)" "unprognostic (4.74e-3)" "unprognostic (2.41e-1)" "unprognostic (3.81e-5)" "unprognostic (8.57e-2)" "unprognostic (1.87e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-1)" 1.1 3.9 18.9 1.3 14.9 1.2 1.1 17.8 47.4 1.2 1.2 1.4 0.0 1.0 1.5 1.1 1.1 1.2 1.1 1.3 13.1 14.3 1.1 1.0 1.0 1.0 9.1 12.2 3.0 1.8 2.4 7.1 1.0 10.6 1.1 1.1 0.9 1.0 1.1 1.1 1.5 1.3 1.2 2.6 1.0 1.9 2.8 1.6 0.0 1.1 0.0 1.0 1.1 0.0 0.1 0.0 0.7 0.1 0.5 0.8 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 11.8 0.0 0.1 1.0 0.2 0.0 3.1 0.1 0.9 0.5 0.2 0.0 0.0 0.1 0.6 0.8 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.7 0.5 0.1 0.0 0.0 0.0 18.9 14.9 17.8 25.7 13.1 14.3 9.1 12.2 10.6 1.6 0.0 0.0 0.0 0.0 0.0 8.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.3 0.0 0.0 0.0 21.0 0.6 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.4 0.0 4.1 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 GDF1 ENSG00000130283 "Growth differentiation factor 1" P27539 19 18868545-18896096 "Disease related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 36.4;skeletal muscle: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.4;EFO-21: 5.3;HEK 293: 6.4;NB-4: 8.3;NTERA-2: 4.3;SCLC-21H: 3.6" "Secreted to blood" NA NA 2.2 2.1 25.6 2.2 28.6 1.9 1.9 11.7 32.1 2.0 2.0 36.4 0.0 1.9 2.0 1.9 2.0 2.0 2.0 2.1 24.6 18.0 2.0 1.9 1.9 1.9 26.2 18.3 2.4 2.0 2.0 1.1 1.9 30.4 2.2 1.9 1.4 2.1 2.0 15.5 1.9 2.0 2.0 33.7 1.9 2.0 4.9 19.8 0.0 2.0 0.0 1.9 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 3.4 0.0 0.0 0.3 0.2 0.0 0.3 0.3 0.8 0.0 0.0 5.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.7 0.0 8.3 4.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.6 2.3 0.0 0.0 1.5 0.1 0.6 2.6 0.0 0.0 1.0 0.8 0.5 0.3 0.0 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 28.6 11.7 32.1 24.6 18.0 26.2 18.3 30.4 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GDF10 BMP-3b ENSG00000266524 "Growth differentiation factor 10" P55107 10 47300386-47313547 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.8;tongue: 14.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 17.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 34.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "AF22: 17.7;MOLT-4: 3.8;SH-SY5Y: 7.2" "Region enriched" "Detected in many" 8 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA015498 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA015498: AB_1849584" "unprognostic (4.34e-2)" "unprognostic (3.10e-1)" "unprognostic (1.41e-1)" "unprognostic (5.09e-1)" "unprognostic (3.17e-1)" "unprognostic (9.84e-3)" "unprognostic (1.37e-2)" "unprognostic (2.26e-2)" "unprognostic (1.55e-1)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-7)" "unprognostic (3.49e-2)" "unprognostic (1.48e-1)" "unprognostic (2.59e-3)" "unprognostic (2.63e-1)" 6.8 4.4 1.4 0.3 2.8 0.0 10.8 7.6 5.2 1.9 0.4 1.7 0.0 0.0 2.3 2.4 5.4 0.5 2.9 2.1 3.0 0.0 0.0 15.8 0.9 0.0 5.0 0.1 11.6 0.2 0.0 0.0 0.9 2.8 0.3 6.8 3.0 0.3 2.5 0.3 0.1 0.6 0.8 0.1 0.1 10.5 0.8 0.0 3.7 14.8 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.3 17.8 0.6 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 4.7 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.2 0.9 0.0 1.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 34.3 0.0 0.1 0.2 0.5 0.6 0.0 0.0 0.0 0.0 GDF11 BMP-11 ENSG00000135414 "Growth differentiation factor 11" O95390 12 55743280-55757278 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 35.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 71.9;Cone photoreceptor cells: 72.6;Horizontal cells: 54.0;Rod photoreceptor cells: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060985, HPA069609" Approved Approved Vesicles "Secreted to blood" No No 46400 270000 Vesicles "HPA060985: AB_2684403, HPA069609: AB_2686159" "unprognostic (5.21e-2)" "unprognostic (1.62e-1)" "unprognostic (3.20e-2)" "unprognostic (2.41e-2)" "unprognostic (2.78e-2)" "unprognostic (3.39e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (8.96e-3)" "unprognostic (1.23e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.69e-1)" "unprognostic (1.62e-2)" "unprognostic (1.27e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" "unprognostic (9.48e-2)" 4.6 4.9 15.9 5.6 13.9 2.6 1.9 10.7 13.3 10.3 4.5 9.2 6.6 2.7 10.0 3.5 4.0 6.9 7.4 11.4 13.3 12.9 3.2 1.6 3.1 4.1 13.9 7.3 7.5 4.7 4.6 4.6 3.3 9.3 7.7 2.8 35.4 7.0 16.0 1.9 2.1 3.6 7.3 13.1 5.7 3.5 1.7 9.5 5.7 4.6 1.6 2.9 7.5 2.9 2.4 2.3 1.4 1.2 0.8 3.9 0.5 1.9 3.1 13.8 7.7 10.5 7.7 3.5 4.1 3.9 5.3 4.5 10.6 0.9 3.8 5.5 4.3 2.5 1.9 10.4 7.4 1.8 7.3 9.4 4.7 5.2 1.6 2.1 3.9 54.1 7.4 0.4 7.7 2.2 5.9 6.8 5.2 5.2 12.6 6.7 3.7 6.3 3.4 11.1 0.1 7.8 10.1 3.8 2.4 3.2 2.7 9.4 5.7 2.5 1.2 1.1 5.9 4.4 4.3 4.1 6.4 9.9 5.0 3.0 3.4 1.0 1.9 3.4 3.9 4.4 0.7 0.7 1.4 3.9 0.5 3.6 2.3 2.4 2.5 0.6 2.4 2.2 3.0 1.2 0.8 1.2 2.3 1.7 0.5 15.9 13.9 10.7 10.0 13.3 12.9 13.9 7.3 9.3 9.5 0.0 0.6 5.4 8.5 0.5 71.9 23.4 0.0 0.0 1.2 0.0 72.6 2.9 0.0 4.3 0.4 4.5 1.3 0.0 1.2 3.9 5.8 4.5 5.7 0.0 1.4 54.0 10.3 3.7 0.6 0.4 8.3 0.3 3.3 2.8 1.3 28.4 3.1 2.9 5.3 0.4 49.9 12.9 5.7 1.2 3.5 0.6 3.9 17.3 2.0 5.3 GDF15 "MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB" ENSG00000130513 "Growth differentiation factor 15" Q99988 19 18374731-18389176 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 463.0" "Cell type enhanced" "Detected in many" 18 "Glandular cells: 1046.1;Syncytiotrophoblasts: 3600.0;Urothelial cells: 2603.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 10 "pons and medulla: 6.5" "Cell type enhanced" "Detected in some" "neutrophil: 6.3" "Group enriched" "Detected in many" 5 "granulocytes: 6.3;monocytes: 2.3" "Cell line enhanced" "Detected in many" "BEWO: 72.3;Hep G2: 37.2;HHSteC: 100.5;TIME: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011191, CAB062554, HPA070957" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1260000 890000 "Golgi apparatus" "CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168" "unprognostic (1.04e-1)" "unprognostic (1.89e-2)" "unprognostic (3.45e-2)" "unprognostic (3.36e-2)" "unprognostic (2.04e-2)" "unprognostic (2.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.30e-2)" "unprognostic (2.80e-1)" "unprognostic (2.89e-1)" "unprognostic (5.09e-2)" "unprognostic (1.46e-1)" "unprognostic (6.55e-3)" "unprognostic (3.81e-2)" "unprognostic (8.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.04e-3)" 13.4 2.2 0.4 1.0 0.6 0.0 13.1 0.4 0.5 3.9 13.0 1.0 1.9 1.8 5.9 1.9 2.4 1.1 13.1 1.2 0.5 0.0 64.7 24.1 12.6 0.8 0.4 0.5 2.9 21.9 0.3 2.4 463.0 6.5 25.5 11.0 1.6 2.4 5.1 13.6 1.1 1.8 4.8 1.2 1.4 12.0 2.5 0.4 0.4 5.2 0.5 0.8 47.0 2.7 0.2 0.8 6.3 2.3 0.0 0.0 0.3 0.3 16.2 1.6 0.6 3.9 3.3 72.3 5.6 3.0 0.2 3.3 0.7 5.0 0.0 10.2 0.5 16.9 0.1 0.0 2.0 0.8 0.0 0.3 0.2 1.5 37.2 100.5 0.0 6.2 8.6 24.3 15.7 10.2 0.1 17.1 0.0 24.8 0.1 3.9 3.9 0.0 0.1 0.9 5.7 9.0 0.0 0.6 0.0 11.9 15.9 0.1 0.1 0.0 0.9 20.2 6.4 0.4 0.0 36.0 0.0 1.3 0.3 0.2 0.2 0.6 0.0 9.0 0.0 4.7 0.0 1.8 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 6.3 0.0 2.3 0.0 0.0 0.3 0.4 0.6 0.4 0.5 0.5 0.0 0.4 0.5 6.5 0.4 32.8 67.9 2.2 222.2 1.1 0.0 0.4 45.9 80.3 68.2 246.0 0.0 48.7 28.2 235.7 0.0 5.8 50.0 0.0 324.0 161.2 17.1 1046.1 28.8 5.0 31.5 0.0 81.4 3.7 1.8 0.0 0.9 5.9 3.3 17.2 220.9 0.2 679.3 95.1 1.4 74.0 0.5 0.0 14.6 0.0 0.6 1.5 3600.0 0.5 186.1 2603.9 GDF2 "BMP-9, BMP9" ENSG00000263761 "Growth differentiation factor 2" Q9UK05 10 47322490-47326270 "Disease related genes, Plasma proteins, Predicted secreted proteins" Angiogenesis "Cytokine, Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 273 "liver: 27.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB023357 Uncertain "Secreted to blood" NA NA 2210000 300000 "CAB023357: AB_2111086" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GDF3 ENSG00000184344 "Growth differentiation factor 3" Q9NR23 12 7689782-7695776 "Disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 6.4;lymphoid tissue: 6.6" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 422 "testis cancer: 383.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "NTERA-2: 101.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA018468 Uncertain "Secreted to blood" NA NA "HPA018468: AB_1849586" "unprognostic (9.48e-2)" "unprognostic (3.90e-2)" "unprognostic (3.30e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-1)" "unprognostic (5.40e-2)" "unprognostic (3.09e-1)" "unprognostic (2.08e-1)" "unprognostic (2.89e-1)" "unprognostic (1.07e-1)" "unprognostic (9.20e-2)" "unprognostic (1.25e-3)" "unprognostic (8.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.45e-1)" "unprognostic (2.03e-1)" 1.3 1.1 0.0 1.1 0.7 0.0 6.4 0.0 0.0 0.5 0.2 0.0 0.0 0.4 0.5 1.5 0.4 1.4 0.9 2.2 0.0 0.0 4.7 0.5 0.5 0.9 0.0 0.0 1.7 0.0 0.1 2.0 0.0 0.0 0.7 0.1 0.6 0.2 1.9 0.2 0.3 1.4 0.7 0.0 6.6 0.2 1.8 0.0 0.0 1.2 1.0 0.3 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 101.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 GDF5 "BMP14, CDMP1" ENSG00000125965 "Growth differentiation factor 5" P43026 20 35433347-35454746 "Disease related genes, Plasma proteins, Predicted secreted proteins" Chondrogenesis "Cytokine, Growth factor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 16.4" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 2.1;granulocytes: 1.1;Spermatocytes: 1.0" "Cancer enriched" "Detected in single" 7 "endometrial cancer: 3.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 16.9;BJ hTERT+: 5.0;GAMG: 8.7;HHSteC: 5.5;HSkMC: 13.7;U-87 MG: 6.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA015648 Uncertain "Secreted to blood" NA NA "HPA015648: AB_1849589" "unprognostic (4.59e-3)" "unprognostic (3.48e-2)" "unprognostic (5.53e-3)" "unprognostic (2.47e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (4.64e-1)" "unprognostic (2.17e-3)" "unprognostic (4.38e-2)" "unprognostic (1.40e-1)" "unprognostic (8.02e-2)" "unprognostic (2.77e-1)" "unprognostic (5.57e-3)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (1.38e-1)" "unprognostic (8.96e-3)" 1.3 0.2 0.6 0.2 1.9 0.2 0.9 0.2 1.3 0.7 2.3 0.1 1.0 0.1 0.9 0.2 0.2 0.2 0.5 0.9 0.3 0.1 0.8 0.1 3.3 0.1 0.7 0.0 0.4 0.1 0.1 4.1 0.2 0.6 1.6 0.2 0.5 16.4 2.4 0.2 0.2 0.1 1.1 1.0 0.1 0.3 0.7 0.0 1.0 0.5 1.1 0.1 0.5 0.2 0.0 0.2 0.8 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.3 16.9 0.1 2.6 5.0 0.4 0.9 0.0 0.0 0.0 0.0 4.0 8.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 13.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.2 0.0 0.1 0.6 1.9 0.2 1.3 0.3 0.1 0.7 0.0 0.6 0.0 0.0 2.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.1 GDF5OS ENSG00000204183 "Growth differentiation factor 5 opposite strand" Q5U4N7 20 35433029-35435450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2197: 2.8;U-87 MG: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA062720 Uncertain NA NA "HPA062720: AB_2684848" "unprognostic (2.87e-2)" "unprognostic (9.00e-3)" "unprognostic (7.43e-2)" "unprognostic (1.46e-1)" "unprognostic (4.13e-4)" "unprognostic (1.13e-1)" 1.4 0.2 0.0 0.0 0.1 1.6 0.3 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.4 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.7 0.6 0.1 0.1 0.0 0.0 0.4 0.1 0.2 0.0 1.8 0.0 0.1 0.9 0.1 0.0 0.0 0.4 0.0 1.6 0.1 0.0 0.4 0.0 1.0 0.6 2.3 0.5 0.5 1.3 0.0 0.2 0.7 0.1 0.6 0.0 1.0 0.8 1.0 0.3 0.1 0.0 0.3 0.8 0.1 0.3 0.0 1.0 0.7 0.0 0.0 0.0 0.4 0.3 0.2 1.0 0.2 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.1 1.4 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.3 0.0 0.9 0.4 0.0 0.2 0.5 0.0 0.5 0.6 0.0 0.0 1.1 0.4 2.8 0.3 0.4 0.0 0.5 1.8 0.4 0.1 1.0 0.5 0.9 0.2 0.2 0.3 0.3 0.5 0.2 0.1 1.0 0.2 0.3 2.3 0.5 0.3 0.6 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" NA NA Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.4 2.9 1.9 0.0 1.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 15.4 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 GDF7 BMP12 ENSG00000143869 "Growth differentiation factor 7" Q7Z4P5 2 20666664-20679245 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 13.3;seminal vesicle: 22.0" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 1: 6.0;Cardiomyocytes: 6.2;Club cells: 5.7;Collecting duct cells: 5.2;Hepatocytes: 6.2;Horizontal cells: 4.8;Proximal tubular cells: 4.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 8 "B-cells: 2.6" "Cell line enhanced" "Detected in some" "HAP1: 2.6;Hep G2: 6.3;RT4: 12.2;SH-SY5Y: 5.0" "Region enhanced" "Detected in single" "amygdala: 0.3" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.35e-1)" "unprognostic (9.93e-3)" "unprognostic (5.10e-1)" "unprognostic (2.44e-3)" "unprognostic (1.35e-1)" "unprognostic (2.06e-3)" "unprognostic (8.63e-3)" "unprognostic (6.31e-3)" "unprognostic (8.00e-3)" "unprognostic (3.85e-1)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.28e-3)" "unprognostic (8.02e-3)" "unprognostic (2.05e-1)" "unprognostic (3.44e-2)" "unprognostic (1.89e-3)" 0.3 0.3 0.4 1.5 0.5 0.0 0.2 0.5 1.3 13.3 0.4 0.2 4.7 0.0 6.8 3.1 0.9 0.6 1.8 2.4 0.2 0.2 3.3 7.2 0.5 3.1 2.9 0.9 0.4 0.8 0.0 0.6 2.3 0.4 3.6 0.0 2.4 1.1 22.0 0.6 1.5 1.5 1.0 0.2 3.2 0.7 0.7 1.2 0.2 0.2 0.0 1.5 1.6 6.0 2.6 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.0 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.2 1.9 12.2 0.0 5.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.5 0.5 1.3 0.2 0.2 2.9 0.9 0.4 1.2 6.0 0.0 0.5 0.5 0.0 0.2 6.2 0.0 1.4 5.7 5.2 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 6.2 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.2 GDF9 ENSG00000164404 "Growth differentiation factor 9" O60383 5 132861181-132866884 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 6.6;testis: 11.1" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 3.9;Early spermatids: 10.3;Late spermatids: 4.0;Spermatocytes: 13.6" "Cancer enriched" "Detected in some" 5 "breast cancer: 2.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069146 Supported "Secreted in female reproductive system" NA NA "HPA069146: AB_2686094" "unprognostic (4.64e-1)" "unprognostic (1.22e-1)" "unprognostic (1.25e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-2)" "unprognostic (2.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.61e-2)" "unprognostic (4.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.70e-3)" "unprognostic (1.04e-1)" "unprognostic (1.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (4.75e-3)" "unprognostic (3.10e-2)" 0.1 0.7 1.3 0.1 1.9 0.1 1.1 0.4 1.1 0.4 0.2 0.4 0.3 6.6 0.1 1.1 0.1 0.1 1.0 1.4 1.5 0.7 0.1 0.5 1.1 0.6 1.0 1.4 2.0 0.1 0.7 0.3 1.0 0.6 0.6 1.4 0.3 0.1 0.8 0.4 0.8 11.1 1.4 0.4 0.7 0.1 0.1 0.8 1.2 0.6 0.0 1.1 0.3 0.4 0.4 1.1 2.3 1.7 0.7 0.4 0.0 0.2 0.4 0.3 0.8 1.8 0.6 1.5 0.2 2.1 0.5 0.9 1.0 0.4 0.8 1.7 1.1 0.9 0.3 0.4 0.2 0.1 0.8 1.3 0.1 0.8 0.2 0.0 8.8 0.2 2.8 0.6 0.6 1.5 1.7 0.4 0.2 0.2 1.4 0.1 0.4 0.7 0.5 2.1 2.0 0.4 0.3 1.1 1.7 1.1 0.3 0.2 2.1 0.9 0.4 0.3 3.0 3.6 0.2 0.5 0.4 0.2 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.8 0.1 0.8 0.1 1.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.4 3.3 0.0 10.3 0.0 0.4 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.6 0.3 4.0 0.6 0.0 0.0 0.0 0.5 1.2 0.1 0.0 0.4 0.2 0.9 0.0 0.0 13.6 1.1 0.1 0.6 0.0 0.5 0.1 GDI1 "FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4" ENSG00000203879 "GDP dissociation inhibitor 1" P31150 X 154436913-154443467 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 122.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012979, HPA049290, HPA057668" Enhanced Approved Vesicles NA NA 70000000 Vesicles "CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498" "prognostic unfavorable (6.84e-4)" "unprognostic (1.13e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.53e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" "unprognostic (1.31e-3)" "unprognostic (1.36e-1)" "unprognostic (1.46e-2)" "unprognostic (1.30e-1)" "unprognostic (2.98e-3)" "unprognostic (3.86e-2)" "unprognostic (3.88e-3)" "unprognostic (1.70e-1)" "unprognostic (8.12e-2)" "unprognostic (1.92e-2)" "unprognostic (1.72e-1)" 19.8 27.1 51.7 16.2 65.3 10.5 12.0 61.3 122.3 16.7 13.6 46.2 6.5 11.5 20.1 15.7 14.4 23.0 15.2 25.7 53.7 54.3 13.7 10.3 16.9 15.1 45.1 49.6 27.7 16.2 18.8 26.9 19.0 65.3 19.6 13.9 13.8 13.6 24.0 14.3 17.2 13.1 25.6 46.4 17.1 13.5 12.9 31.3 6.8 12.7 6.2 15.7 13.9 11.8 7.6 8.3 20.6 13.4 5.6 13.0 4.9 20.3 18.9 42.6 35.2 17.5 20.7 13.4 29.5 19.8 31.1 32.5 10.9 10.8 16.3 30.9 29.9 47.4 16.1 37.4 18.0 21.6 29.4 18.4 5.1 27.7 7.3 25.7 4.9 18.6 21.2 22.3 36.0 22.1 34.0 20.0 20.6 6.2 25.9 36.9 20.6 15.6 12.3 11.3 22.7 34.4 15.6 11.1 9.3 21.7 9.5 59.0 45.7 14.2 18.5 22.3 34.6 11.0 8.9 22.5 28.7 24.9 29.6 43.1 36.7 38.8 25.9 31.1 11.1 35.2 14.9 5.7 17.2 8.9 8.6 13.0 7.3 9.6 8.6 4.7 7.6 7.6 7.5 20.6 5.6 13.4 8.3 10.8 4.9 51.7 65.3 61.3 96.6 53.7 54.3 45.1 49.6 65.3 31.3 14.9 33.8 24.4 21.0 24.2 64.9 56.8 22.9 44.2 18.2 26.2 23.6 18.6 26.6 37.0 2.2 31.8 21.6 0.0 27.5 30.2 32.7 23.2 33.4 12.1 31.9 57.2 87.1 27.6 30.7 4.0 34.8 27.8 16.9 88.4 21.4 35.7 37.8 21.0 37.4 22.4 28.6 51.8 45.7 19.7 64.1 26.5 41.4 39.9 13.3 20.3 GDNF "ATF1, ATF2, HFB1-GDNF" ENSG00000168621 "Glial cell derived neurotrophic factor" P39905 5 37812677-37839686 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes, Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;skeletal muscle: 12.4" "Cell type enhanced" "Detected in single" 9 "Fibroblasts: 1.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 14.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Low region specificity" "Detected in many" "CAB005210, HPA070283" Supported Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA Vesicles Nucleoplasm "CAB005210: AB_2247684, HPA070283: AB_2686246" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (3.54e-2)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.08e-1)" "unprognostic (5.33e-2)" "unprognostic (1.92e-1)" "unprognostic (3.71e-2)" "unprognostic (2.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.10e-1)" "unprognostic (1.16e-4)" "unprognostic (2.04e-1)" "unprognostic (8.86e-2)" "unprognostic (1.05e-1)" "unprognostic (4.42e-2)" 1.9 0.3 0.6 1.9 2.3 0.0 0.4 14.1 1.3 0.8 9.4 0.4 0.4 1.6 1.7 3.4 1.0 0.9 0.9 0.9 0.6 0.4 1.0 0.7 0.4 0.4 0.6 1.2 4.5 0.4 0.0 0.4 6.3 1.4 1.6 3.1 1.1 0.4 6.3 12.4 1.4 2.5 2.5 0.5 0.4 1.9 3.9 2.4 0.4 0.4 1.5 0.4 0.6 1.1 0.8 0.4 1.2 0.3 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 3.4 2.1 0.6 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.2 0.3 0.1 0.1 0.0 1.0 0.1 25.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 1.7 7.8 0.0 0.0 0.0 3.4 0.0 0.8 3.9 2.3 0.0 0.0 7.6 0.0 27.5 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.8 0.2 0.4 1.2 0.9 0.2 0.4 0.1 0.0 0.6 2.3 14.1 1.3 0.6 0.4 0.6 1.2 1.4 2.4 0.0 0.0 0.0 0.0 0.8 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 0.6 0.0 0.8 0.3 0.1 0.0 0.0 0.5 GDPD1 "FLJ37451, GDE4" ENSG00000153982 "Glycerophosphodiester phosphodiesterase domain containing 1" Q8N9F7 17 59220467-59275967 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 28.4;Spermatocytes: 31.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 22.6;K-562: 12.8;SCLC-21H: 14.3" "Low region specificity" "Detected in all" NA NA "unprognostic (8.33e-2)" "unprognostic (6.63e-3)" "unprognostic (2.68e-2)" "unprognostic (5.98e-3)" "unprognostic (7.12e-2)" "unprognostic (5.35e-2)" "unprognostic (4.85e-6)" "prognostic favorable (2.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.36e-2)" "unprognostic (1.24e-3)" "unprognostic (2.73e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-3)" "unprognostic (4.72e-2)" "unprognostic (1.32e-2)" "unprognostic (6.28e-3)" 1.5 3.6 9.4 1.8 13.1 2.3 3.5 16.6 22.3 2.5 3.9 9.2 0.9 10.7 2.8 1.9 1.7 3.2 3.8 2.2 10.6 13.2 4.2 2.0 4.3 1.7 9.3 10.3 2.2 2.3 14.8 3.1 9.2 15.1 4.4 3.1 2.0 4.1 3.0 2.6 2.8 7.8 2.9 7.1 2.8 10.4 13.0 8.9 3.2 5.5 0.3 2.0 3.6 1.7 1.5 2.9 4.5 3.0 3.0 3.5 1.0 0.8 1.4 4.8 3.5 0.6 0.5 3.6 0.5 1.9 0.7 3.6 0.0 1.7 2.2 5.2 0.1 2.9 0.7 8.1 1.0 2.1 4.0 8.4 22.6 0.5 3.2 1.8 1.3 4.4 0.8 4.9 2.0 0.5 2.3 2.6 5.2 12.8 1.3 0.8 0.8 3.9 0.3 1.0 7.0 1.2 2.7 0.4 2.1 2.5 1.4 14.3 4.2 1.4 0.4 5.4 1.7 4.0 1.4 3.0 0.2 1.6 0.1 0.5 4.3 3.1 0.8 1.2 1.5 2.1 4.5 1.9 0.8 2.2 3.0 1.7 0.7 2.2 3.2 0.9 1.5 3.0 3.5 2.0 3.0 2.3 2.9 1.2 1.0 9.4 13.1 16.6 17.7 10.6 13.2 9.3 10.3 15.1 8.9 3.0 5.1 0.0 1.1 0.5 5.8 2.4 0.0 6.7 12.5 5.2 9.8 0.2 0.0 1.6 28.4 1.1 1.3 0.0 1.6 4.9 0.4 1.2 0.0 0.4 1.6 6.4 1.2 0.6 1.0 5.1 0.6 1.8 1.7 2.8 1.2 1.7 1.5 2.0 1.4 0.3 3.8 0.0 1.2 31.7 4.3 0.4 1.9 1.5 0.9 1.4 GDPD2 "FLJ20207, GDE3, OBDPF" ENSG00000130055 "Glycerophosphodiester phosphodiesterase domain containing 2" Q9HCC8 X 70423031-70433390 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 50.5;Enterocytes: 47.9;Muller glia cells: 24.7" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "AF22: 9.4;NTERA-2: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.53e-3)" "unprognostic (5.79e-2)" "unprognostic (5.37e-2)" "unprognostic (5.00e-7)" "unprognostic (3.15e-3)" "unprognostic (3.65e-2)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (1.19e-1)" "unprognostic (8.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.41e-2)" "unprognostic (5.52e-2)" "unprognostic (2.22e-1)" "unprognostic (8.91e-2)" 0.4 0.4 6.8 0.6 5.7 0.4 1.0 1.1 4.0 0.3 13.0 8.2 8.3 8.0 0.4 22.5 0.4 0.5 0.5 0.8 7.6 4.0 0.6 0.3 0.4 0.4 4.3 5.6 0.4 0.4 0.3 2.6 0.4 8.4 0.3 3.0 0.2 1.1 0.6 0.6 33.2 19.5 0.4 1.5 37.5 1.6 0.3 4.9 0.0 0.4 0.6 0.3 1.0 0.3 0.4 0.1 1.4 0.2 0.1 0.2 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 20.2 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.4 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.0 6.8 5.7 1.1 4.0 7.6 4.0 4.3 5.6 8.4 4.9 0.0 0.0 0.0 0.0 50.5 0.1 1.4 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.7 0.1 2.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 2.7 0.0 1.5 0.1 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Group enriched" "Detected in many" 5 "MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Low region specificity" "Detected in many" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.9 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.1 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 1.5 2.1 2.0 0.4 0.9 0.7 13.7 0.4 0.9 1.1 16.9 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.5 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 6.0 0.6 0.0 0.6 1.1 1.1 0.9 0.0 1.4 1.2 5.2 0.0 20.4 5.0 1.0 50.9 4.0 43.6 0.0 1.2 52.5 2.1 1.4 0.0 0.0 2.8 1.6 3.4 3.7 3.0 201.8 3.1 0.7 1.7 1.0 28.5 0.2 11.2 12.9 2.8 62.4 1.7 6.5 1.4 1.2 1.2 1.8 7.8 1.5 4.7 3.9 GDPD4 GDE6 ENSG00000178795 "Glycerophosphodiester phosphodiesterase domain containing 4" Q6W3E5 11 77216558-77301687 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.6" "Group enriched" "Detected in some" 14 "Early spermatids: 8.8;Late spermatids: 13.7;Spermatocytes: 12.7;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 10 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.6;HEL: 3.5;U-937: 1.1" "Region enriched" "Detected in single" 24 "olfactory region: 2.8" NA NA "unprognostic (6.73e-6)" "unprognostic (3.30e-1)" "unprognostic (2.01e-2)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (3.55e-4)" "unprognostic (4.13e-2)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "unprognostic (2.63e-2)" "unprognostic (3.10e-2)" "unprognostic (4.75e-2)" "unprognostic (1.05e-4)" "unprognostic (1.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.29e-2)" "unprognostic (1.64e-2)" 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.7 4.5 0.0 0.2 0.0 0.0 0.0 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525903 "Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.2;placenta: 41.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 64.5;Cone photoreceptor cells: 139.4;Late spermatids: 125.5;Rod photoreceptor cells: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Group enriched" "Detected in many" 5 "granulocytes: 9.3;T-cells: 3.1" "Cell line enhanced" "Detected in many" "EFO-21: 17.4;fHDF/TERT166: 16.6;HDLM-2: 34.0;U-2 OS: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 16.5 6.0 3.3 3.3 4.6 7.8 8.0 23.2 7.9 3.3 3.0 3.3 1.6 2.0 6.4 3.1 1.6 3.2 3.6 2.8 3.0 1.8 2.3 2.7 5.4 4.3 3.0 2.6 2.9 13.4 0.4 7.0 41.7 4.2 3.1 1.3 18.8 15.5 4.1 5.9 2.3 3.2 4.9 3.4 37.2 1.4 11.9 5.5 2.0 2.6 1.4 3.4 3.5 11.5 1.1 1.1 9.3 1.2 0.0 3.1 0.7 1.0 3.8 1.7 1.9 1.1 0.6 5.8 1.2 1.6 0.6 0.4 5.1 2.3 7.3 17.4 16.6 4.3 2.4 2.1 1.9 0.3 34.0 1.6 1.3 5.9 10.6 1.7 0.8 5.7 1.3 1.0 0.4 0.8 1.7 13.9 6.6 2.3 3.3 0.7 2.2 1.9 3.6 3.0 1.8 5.5 2.2 0.5 1.9 0.4 1.8 0.9 0.6 2.5 9.6 4.6 2.3 1.4 3.2 4.1 3.9 16.2 3.1 1.3 0.8 0.1 1.3 0.9 4.3 0.4 9.3 1.2 0.7 2.0 0.6 2.9 1.1 2.3 1.6 0.3 0.4 1.2 1.5 0.1 0.0 0.0 1.1 3.1 0.7 3.3 4.6 23.2 7.9 3.0 1.8 3.0 2.6 4.2 5.5 6.0 0.0 0.0 0.2 0.9 64.5 2.8 0.0 1.4 1.2 0.0 139.4 2.3 0.0 3.7 37.5 1.8 0.3 0.0 8.0 0.9 3.3 0.9 4.6 1.9 1.8 4.8 0.0 21.5 4.1 125.5 5.5 3.4 5.0 1.8 0.5 5.6 5.4 0.0 2.5 0.0 81.6 0.0 1.3 4.7 7.7 1.0 38.4 2.2 0.2 0.4 GEM KIR ENSG00000164949 "GTP binding protein overexpressed in skeletal muscle" P55040 8 94249253-94262350 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 78.5" "Cell type enriched" "Detected in many" 10 "Smooth muscle cells: 879.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "myeloid DC: 4.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 4.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 27.9;U-266/70: 48.0;U-87 MG: 36.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024798 Approved NA NA "HPA024798: AB_10602137" "unprognostic (1.24e-1)" "unprognostic (2.12e-1)" "unprognostic (4.82e-3)" "unprognostic (1.22e-1)" "unprognostic (4.76e-1)" "unprognostic (3.94e-1)" "unprognostic (2.17e-1)" "unprognostic (4.00e-1)" "unprognostic (1.45e-1)" "unprognostic (9.04e-2)" "unprognostic (7.92e-2)" "unprognostic (9.15e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (1.65e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.93e-3)" 24.5 20.3 5.0 15.7 8.9 0.8 19.6 1.1 4.8 20.1 39.0 7.8 9.5 5.6 32.6 15.8 20.2 13.2 78.5 24.3 7.1 3.9 9.5 8.2 11.1 7.4 10.0 2.9 13.3 5.2 1.5 10.5 2.4 10.7 31.1 12.8 32.1 4.7 6.5 5.2 4.1 15.3 53.7 9.5 6.9 21.1 10.8 7.7 1.2 9.3 5.7 8.9 44.0 30.7 0.0 4.4 0.0 0.1 0.2 0.9 0.3 0.5 2.0 0.9 0.2 8.0 10.7 0.1 5.3 27.9 7.3 10.3 0.7 1.4 0.0 0.3 2.0 13.8 0.1 0.9 0.4 9.7 3.9 0.5 0.0 0.2 0.0 1.0 0.0 9.0 4.6 0.0 11.7 6.5 8.4 0.3 0.4 0.2 0.9 4.3 0.2 0.3 0.0 1.3 1.1 6.1 0.0 1.6 0.0 2.6 0.0 7.0 4.1 0.0 0.0 0.9 1.2 0.6 0.0 0.4 10.1 2.8 6.5 10.9 48.0 0.2 0.0 36.1 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.9 0.3 5.0 8.9 1.1 4.8 7.1 3.9 10.0 2.9 10.7 7.7 6.0 23.1 0.5 88.6 60.6 20.9 84.4 2.5 1.4 4.5 1.8 17.7 0.3 0.0 6.2 0.5 4.0 4.7 0.0 0.3 1.1 53.6 17.7 13.8 0.0 2.8 28.6 24.0 11.1 0.6 0.0 3.1 4.0 87.7 1.0 1.1 40.0 1.6 3.5 5.3 2.1 20.0 32.3 879.6 0.4 1.1 43.5 2.9 0.7 2.4 7.6 GEN1 "FLJ40869, Gen" ENSG00000178295 "GEN1, Holliday junction 5' flap endonuclease" Q17RS7 2 17753858-17788941 "Predicted intracellular proteins" "DNA damage, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.5" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA020078, HPA021141" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA020078: AB_2670352, HPA021141: AB_2670599" "unprognostic (2.25e-1)" "unprognostic (2.33e-1)" "unprognostic (1.52e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (8.64e-2)" "unprognostic (1.67e-3)" "unprognostic (7.90e-4)" "unprognostic (4.53e-2)" "unprognostic (1.70e-3)" "unprognostic (8.60e-3)" "unprognostic (8.04e-2)" "unprognostic (6.99e-2)" "unprognostic (1.89e-12)" "unprognostic (3.97e-3)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" "unprognostic (1.49e-3)" 3.0 3.0 2.8 15.6 4.0 14.9 3.9 2.3 5.1 3.2 5.9 3.7 4.3 3.3 2.1 11.1 9.0 2.4 4.7 2.8 2.9 2.5 3.4 11.2 3.3 11.9 2.3 3.2 1.8 3.8 2.6 8.6 4.4 4.8 4.6 7.6 7.3 8.8 3.7 2.7 8.8 6.9 1.6 2.8 8.5 3.4 27.5 2.2 24.3 3.4 11.3 13.7 2.6 5.2 5.1 2.2 1.1 1.4 1.2 2.1 1.0 16.3 8.6 9.6 7.4 2.3 3.3 14.0 11.8 4.4 7.4 8.0 10.4 8.6 19.7 4.6 4.8 6.4 11.5 9.5 8.6 10.8 11.6 6.1 10.6 9.6 5.9 1.6 12.1 10.9 2.2 3.3 9.5 5.8 2.3 4.8 9.1 11.7 13.0 12.1 9.7 9.4 11.3 6.7 6.8 4.3 10.8 22.0 7.2 4.3 10.8 10.4 13.8 5.9 10.3 4.7 7.1 6.7 5.4 5.6 15.5 7.1 8.5 12.5 8.0 14.1 30.0 6.9 12.7 10.0 0.3 1.4 1.1 1.1 1.1 0.9 5.1 1.2 2.1 2.0 2.9 1.3 1.4 0.7 1.2 1.3 2.2 1.7 1.0 2.8 4.0 2.3 5.1 2.9 2.5 2.3 3.2 4.8 2.2 6.0 2.2 6.5 2.3 2.5 5.5 3.9 2.5 6.7 11.4 3.5 11.8 3.1 0.0 1.9 3.9 1.4 6.4 23.3 2.0 3.6 3.9 2.5 1.1 4.2 3.3 3.2 1.7 1.3 3.5 2.7 1.7 2.6 1.7 2.8 4.8 3.8 2.0 3.5 0.7 2.1 3.2 6.5 3.8 12.3 9.0 1.6 2.7 1.0 4.3 2.6 GFAP FLJ45472 ENSG00000131095 "Glial fibrillary acidic protein" P14136 17 44903161-44916937 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 61 "brain: 595.5" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 48.9" "Cancer enriched" "Detected in some" 368 "glioma: 2468.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.8" "Group enriched" "Detected in many" 5 "granulocytes: 9.8;NK-cells: 2.9" "Cell line enhanced" "Detected in many" "U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000039, HPA056030, HPA063513" Enhanced Supported Supported "Intermediate filaments" No No 220000000 "Intermediate filaments" "CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027" "unprognostic (1.79e-2)" "unprognostic (2.74e-1)" "unprognostic (9.83e-2)" "unprognostic (2.12e-5)" "unprognostic (4.08e-1)" "unprognostic (5.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (6.57e-3)" "unprognostic (7.35e-2)" "unprognostic (5.86e-2)" "unprognostic (1.24e-1)" "unprognostic (7.63e-2)" "unprognostic (2.75e-5)" "unprognostic (1.49e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-1)" 3.0 2.9 122.2 3.2 105.4 5.8 3.0 33.9 595.5 2.7 3.0 171.0 0.0 2.8 2.9 3.0 3.6 3.2 3.1 4.0 143.0 175.1 3.0 2.8 3.0 3.1 227.0 67.3 3.0 3.0 3.4 1.3 2.8 212.7 3.0 2.9 0.0 3.1 2.9 3.2 3.3 2.8 2.9 482.0 3.0 3.0 2.9 119.0 0.0 3.0 0.0 2.9 3.4 0.0 1.1 0.8 9.8 1.2 2.9 0.8 0.3 1.7 1.1 2.0 3.8 0.0 0.8 0.5 1.7 2.1 2.5 2.1 2.2 2.5 3.5 3.2 0.9 1.4 4.3 2.2 0.7 3.0 4.3 1.9 2.9 2.9 1.5 0.1 0.8 4.3 0.2 1.3 1.7 0.0 2.6 0.0 3.7 1.3 8.5 0.6 2.2 3.0 4.2 2.8 0.2 5.3 1.2 1.3 2.8 1.1 1.5 2.7 3.0 0.5 3.5 0.3 1.7 2.3 2.2 1.2 2.1 1.6 1.9 2.6 1.2 2.3 2.8 9.6 3.5 3.4 1.9 1.2 0.5 0.5 1.1 0.4 0.4 0.5 0.7 0.3 1.1 0.6 0.8 9.8 2.9 0.7 0.8 0.4 0.3 122.2 105.4 33.9 69.4 143.0 175.1 227.0 67.3 212.7 119.0 0.0 0.0 0.0 0.0 0.0 0.7 4.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 GFI1 "GFI-1, GFI1A, ZNF163" ENSG00000162676 "Growth factor independent 1 transcriptional repressor" Q99684 1 92474762-92486876 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.9;lymphoid tissue: 56.1" "Group enriched" "Detected in some" 6 "Mucus-secreting cells: 10.4;T-cells: 13.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "gdT-cell: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 16.7;HMC-1: 13.4;NB-4: 17.3;THP-1: 34.8;U-937: 71.9" "Not detected" "Not detected" "Not detected" "Not detected" CAB011197 Uncertain NA NA "CAB011197: AB_532302" "unprognostic (5.67e-4)" "unprognostic (8.67e-3)" "prognostic favorable (5.68e-5)" "unprognostic (4.88e-3)" "unprognostic (3.57e-2)" "unprognostic (5.86e-3)" "unprognostic (2.06e-1)" "unprognostic (3.87e-3)" "unprognostic (1.26e-3)" "unprognostic (4.47e-3)" "unprognostic (5.20e-2)" "unprognostic (1.72e-1)" "unprognostic (6.80e-6)" "unprognostic (2.63e-1)" "unprognostic (8.27e-2)" "unprognostic (3.97e-1)" "unprognostic (4.37e-2)" 1.2 0.4 0.1 3.6 0.3 31.9 0.7 0.2 0.3 1.1 3.9 0.1 0.1 3.0 0.7 0.7 1.2 1.0 2.6 0.6 0.2 0.1 1.0 0.9 3.4 5.4 0.5 0.3 0.5 12.4 0.0 0.7 0.7 0.5 1.1 3.1 0.9 1.2 1.3 0.7 0.4 6.8 0.6 0.8 8.9 1.8 1.1 0.2 56.1 1.2 0.5 5.0 1.9 0.8 0.0 1.6 0.8 0.0 0.3 4.9 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 1.4 0.0 16.7 13.4 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 4.3 0.0 0.5 10.5 17.3 0.0 0.0 0.0 2.1 0.7 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.4 0.0 0.0 6.2 0.4 1.1 0.0 71.9 0.0 0.0 0.0 0.8 4.9 0.0 2.2 0.0 2.1 3.0 0.0 0.0 0.8 4.5 0.1 0.3 0.0 1.6 0.7 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.5 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 13.1 0.2 0.0 GFI1B ZNF163B ENSG00000165702 "Growth factor independent 1B transcriptional repressor" Q5VTD9 9 132944000-132991687 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 71.0;bone marrow: 29.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 70.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "basophil: 31.2;eosinophil: 71.0" "Lineage enriched" "Detected in many" 26 "granulocytes: 71.0" "Group enriched" "Detected in some" 5 "HEL: 55.6;HMC-1: 36.0;K-562: 17.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004420, HPA006291" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB004420: AB_2110132, HPA006291: " "unprognostic (1.79e-2)" "unprognostic (2.90e-4)" "unprognostic (6.54e-2)" "unprognostic (1.76e-1)" "unprognostic (2.33e-1)" "unprognostic (1.54e-2)" "unprognostic (2.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.54e-1)" "unprognostic (4.61e-2)" "unprognostic (3.71e-2)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (1.53e-2)" "unprognostic (1.41e-1)" 0.2 0.0 0.2 2.2 0.2 29.2 0.1 0.1 0.2 0.9 4.2 0.2 0.0 0.8 0.4 0.7 0.8 0.2 3.5 0.8 0.2 0.1 0.3 0.4 2.5 0.0 0.1 0.0 0.1 0.2 0.0 0.1 1.2 0.0 4.2 0.3 0.2 0.1 0.1 0.3 0.8 6.3 1.0 0.2 3.3 0.3 4.0 0.0 1.0 0.2 0.0 0.5 0.4 0.2 0.0 0.3 71.0 2.7 0.1 0.1 2.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.1 7.8 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 55.6 0.1 0.0 0.0 0.0 36.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 31.2 0.0 71.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.1 2.7 0.1 0.0 2.4 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 70.0 0.0 0.1 0.0 0.5 13.9 0.0 0.1 0.0 1.2 0.0 0.8 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.3 0.1 GFPT2 GFAT2 ENSG00000131459 "Glutamine-fructose-6-phosphate transaminase 2" O94808 5 180300690-180353387 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 65.6" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 28.9;Peritubular cells: 17.7;Smooth muscle cells: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 7.1" "Lineage enriched" "Detected in single" 49 "T-cells: 7.1" "Cell line enhanced" "Detected in many" "ASC diff: 24.3;ASC TERT1: 41.6;GAMG: 30.6;HSkMC: 26.7;hTEC/SVTERT24-B: 49.5;U-87 MG: 86.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056892, HPA059910" Uncertain Approved Vesicles NA NA Vesicles "HPA056892: AB_2683266, HPA059910: AB_2684157" "unprognostic (3.48e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.91e-2)" "unprognostic (1.08e-2)" "unprognostic (6.28e-2)" "unprognostic (3.39e-3)" "unprognostic (3.05e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (7.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.50e-2)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.58e-14)" "unprognostic (3.67e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.52e-3)" 65.6 3.9 4.5 15.8 5.6 0.9 11.0 17.0 9.2 10.0 9.2 9.3 5.4 2.1 9.0 16.7 5.9 15.9 14.6 16.4 7.1 3.8 2.8 2.6 11.0 3.1 6.2 6.8 17.5 11.1 3.5 2.5 6.0 8.4 7.7 3.6 2.9 4.0 8.0 6.0 4.0 5.0 10.0 17.2 1.7 6.6 6.3 7.7 0.0 5.6 5.4 3.5 14.3 14.6 0.0 0.1 0.0 0.0 0.1 7.1 0.2 0.0 5.4 4.2 5.5 24.3 41.6 0.4 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.3 4.5 30.6 0.0 2.3 0.0 0.2 0.5 0.8 0.0 2.6 0.0 10.1 0.0 0.0 26.7 0.2 49.5 0.1 8.4 8.0 0.2 0.0 0.0 21.2 0.7 0.0 0.0 9.1 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.3 8.3 0.1 0.3 5.2 0.3 0.0 3.8 13.7 2.1 8.8 10.0 0.0 0.0 0.0 86.1 0.0 0.3 0.0 0.0 0.0 1.4 0.0 7.1 0.0 0.8 2.4 0.1 0.0 0.8 1.1 0.0 0.1 0.0 0.1 0.0 0.2 4.5 5.6 17.0 9.2 7.1 3.8 6.2 6.8 8.4 7.7 3.0 4.5 0.0 0.3 6.5 0.0 2.2 0.0 2.7 5.7 1.8 0.0 0.9 1.7 0.8 4.5 0.6 0.0 0.0 0.7 0.4 28.9 0.9 1.1 0.0 0.4 0.0 0.0 1.8 0.8 2.0 9.5 1.8 8.5 0.0 0.0 5.2 0.5 0.0 17.7 0.3 0.0 0.0 16.5 9.1 5.3 3.8 2.3 3.8 0.0 0.4 GFRA2 "GDNFRB, NTNRA, RETL2, TRNR2" ENSG00000168546 "GDNF family receptor alpha 2" O00451 8 21690403-21812357 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;thyroid gland: 17.4" "Group enriched" "Detected in many" 5 "Horizontal cells: 208.2;Late spermatids: 217.5" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 6.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.1;monocytes: 10.9" "Cell line enhanced" "Detected in some" "HEL: 9.0;HMC-1: 20.6;WM-115: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024704, CAB032791" Uncertain Uncertain Vesicles "Intracellular and membrane" NA NA 3300000 Vesicles "CAB032791: AB_2110428, HPA024704: AB_1849629" "unprognostic (4.24e-2)" "unprognostic (1.11e-2)" "unprognostic (4.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.93e-2)" "unprognostic (1.08e-2)" "unprognostic (7.48e-4)" "unprognostic (2.87e-1)" "unprognostic (6.11e-2)" "unprognostic (4.40e-3)" "unprognostic (2.11e-3)" "unprognostic (7.82e-2)" "unprognostic (1.50e-4)" "unprognostic (8.45e-4)" "unprognostic (1.74e-1)" "unprognostic (4.68e-2)" "unprognostic (9.63e-3)" 4.2 3.4 2.6 3.4 6.7 1.2 1.4 2.1 19.2 4.9 3.6 0.7 2.6 3.4 1.3 4.0 3.0 4.3 1.2 3.2 6.8 8.9 1.1 1.9 2.2 4.3 4.3 7.1 1.0 0.9 0.2 2.0 11.5 3.2 1.3 2.0 3.7 2.0 4.9 0.4 1.2 3.2 3.5 1.9 12.2 2.2 6.7 0.2 1.0 17.4 0.0 1.5 2.4 2.6 0.1 3.1 0.9 10.9 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.4 0.9 0.0 10.9 0.0 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.5 0.0 1.4 0.0 0.0 0.9 2.6 6.7 2.1 19.2 6.8 8.9 4.3 7.1 3.2 0.2 0.0 2.6 0.0 0.1 1.5 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.8 0.0 0.0 0.0 0.0 0.1 1.0 0.1 1.1 0.0 0.5 208.2 0.0 1.3 25.5 217.5 0.6 6.0 0.0 0.0 0.0 1.5 0.0 0.0 1.8 0.0 1.7 6.5 2.1 1.2 1.9 0.6 0.2 0.0 0.0 0.1 GFRA4 ENSG00000125861 "GDNF family receptor alpha 4" Q9GZZ7 20 3659292-3663399 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;thyroid gland: 4.9" "Group enriched" "Detected in some" 7 "Early spermatids: 1.2;Late spermatids: 2.5" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (3.50e-2)" "unprognostic (2.36e-1)" 0.0 0.0 1.7 0.0 0.6 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 GFRAL "bA360D14.1, C6orf144, GRAL, UNQ9356" ENSG00000187871 "GDNF family receptor alpha like" Q6UXV0 6 55327469-55402493 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.9;blood: 2.2;liver: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.6;Karpas-707: 1.5" "Region enriched" "Detected in single" 10 "pons and medulla: 0.3" "Low region specificity" "Detected in many" HPA047372 Uncertain NA NA "HPA047372: AB_2680017" "unprognostic (2.31e-1)" 1.9 0.0 0.1 0.3 0.1 0.4 0.6 0.2 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.9 0.0 0.1 0.0 0.0 1.2 0.7 2.2 0.6 0.6 0.3 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.5 0.3 0.1 0.8 0.6 0.2 0.2 0.1 0.1 0.8 0.2 0.1 0.0 1.2 0.3 0.3 2.2 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GFY Goofy ENSG00000261949 "Golgi associated olfactory signaling regulator" I3L273 19 49423749-49428818 "Predicted membrane proteins" "Olfaction, Sensory transduction" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "brain: 2.1;testis: 4.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 3.9;SCLC-21H: 9.2;T-47d: 2.5;U-266/84: 5.6" "Region enriched" "Detected in single" 14 "olfactory region: 1.8" "Region enriched" "Detected in many" 7 "cerebellum: 14.5" NA NA "unprognostic (8.04e-2)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (8.99e-2)" "unprognostic (8.85e-2)" "unprognostic (1.42e-1)" "unprognostic (1.82e-1)" "unprognostic (9.62e-3)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.0 0.0 3.9 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.9 0.0 0.1 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 GGA1 ENSG00000100083 "Golgi associated, gamma adaptin ear containing, ARF binding protein 1" Q9UJY5 22 37608475-37633564 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.8" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 173.5;Spermatocytes: 198.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048280, HPA051016" Supported Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA048280: AB_2680338, HPA051016: AB_2681312" "unprognostic (1.64e-1)" "unprognostic (1.42e-2)" "unprognostic (4.08e-1)" "unprognostic (9.23e-3)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.42e-2)" "unprognostic (1.53e-2)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.16e-3)" 10.7 15.8 13.5 12.2 14.0 17.3 10.8 21.8 18.4 11.6 10.6 19.3 14.5 13.1 12.9 14.1 13.3 13.8 11.8 10.2 12.5 10.6 12.0 14.1 10.9 14.0 17.7 13.2 18.1 13.9 20.6 19.4 12.5 13.5 12.0 9.6 17.7 16.7 16.7 17.1 17.1 12.0 9.3 14.2 15.8 12.8 83.8 16.6 12.1 15.4 9.9 14.2 10.6 11.0 6.4 5.0 4.9 7.7 7.6 18.0 7.6 18.4 12.9 16.2 15.7 14.2 11.7 17.8 15.2 12.3 13.5 15.0 11.5 10.5 28.3 10.4 10.9 8.3 17.2 14.3 17.0 12.4 24.2 23.8 11.2 23.2 12.3 13.9 27.5 21.9 14.2 15.2 19.1 12.1 22.1 12.6 14.4 22.6 18.4 13.8 17.6 12.2 29.5 12.7 18.6 13.3 13.6 13.0 12.1 13.9 15.0 14.9 26.5 9.7 20.4 23.6 16.1 21.3 20.0 15.1 18.4 18.0 16.5 12.1 39.7 15.9 29.3 20.6 16.7 16.1 4.9 7.7 4.3 14.0 7.6 17.3 6.4 5.6 18.0 5.0 4.1 4.2 13.0 3.3 7.6 5.5 4.3 5.8 7.6 13.5 14.0 21.8 18.4 12.5 10.6 17.7 13.2 13.5 16.6 23.8 36.3 43.5 27.8 21.5 53.9 15.9 15.3 34.8 22.7 41.8 78.5 30.7 5.0 30.2 118.6 26.2 53.9 0.0 17.7 31.6 17.1 20.5 48.5 18.1 69.1 23.8 31.2 32.5 44.8 173.5 24.5 44.5 15.1 46.9 35.7 41.0 27.7 42.1 21.2 10.3 73.2 25.8 21.2 198.9 40.2 25.0 47.5 91.4 34.6 30.1 GGACT A2LD1 ENSG00000134864 "Gamma-glutamylamine cyclotransferase" Q9BVM4 13 100530164-100589528 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.0" "Cell type enhanced" "Detected in many" 10 "Proximal tubular cells: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "SCLC-21H: 55.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065320 Enhanced NA NA 75000 "HPA065320: AB_2685466" "unprognostic (1.93e-1)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (1.30e-3)" "unprognostic (9.12e-3)" "unprognostic (1.64e-2)" "unprognostic (1.58e-2)" "unprognostic (2.07e-2)" "unprognostic (7.41e-2)" "unprognostic (2.81e-1)" "unprognostic (3.03e-2)" "unprognostic (2.45e-1)" "unprognostic (1.95e-2)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" 3.6 6.6 3.2 3.4 3.4 0.9 3.4 2.6 4.5 2.0 4.9 3.6 1.7 5.7 4.0 3.4 2.8 2.5 5.5 1.7 2.6 2.2 47.0 10.9 2.4 4.6 3.5 2.1 2.5 9.8 1.8 1.9 2.1 4.4 2.4 3.4 4.1 12.0 14.2 2.7 3.1 6.7 3.4 4.3 6.1 4.4 11.0 3.3 3.7 2.5 5.0 6.4 2.5 2.5 5.2 4.2 1.0 7.5 8.0 8.3 4.2 5.6 0.7 4.6 5.0 3.9 6.1 2.0 3.5 0.9 0.6 1.6 0.0 5.1 0.5 2.0 2.5 0.1 0.3 0.7 1.0 0.2 7.9 3.1 2.3 0.5 0.3 5.6 3.3 7.8 7.2 4.0 0.1 0.3 0.0 2.3 2.6 1.2 0.1 0.9 0.3 0.5 0.4 0.2 10.8 1.5 0.3 1.1 0.6 5.7 0.9 55.0 2.1 1.1 2.5 2.5 4.5 2.4 11.2 2.2 0.0 0.0 1.2 0.9 3.0 1.6 0.2 0.3 2.5 2.5 0.0 5.1 1.0 7.9 7.2 7.3 5.2 6.4 8.3 4.2 5.0 4.0 5.9 0.0 8.0 7.5 3.0 6.5 4.2 3.2 3.4 2.6 4.5 2.6 2.2 3.5 2.1 4.4 3.3 0.0 1.0 10.4 3.4 2.4 1.1 0.8 0.0 0.0 2.3 7.0 13.7 9.8 6.6 8.4 4.1 3.1 5.3 0.0 9.0 10.2 2.8 2.2 5.7 13.2 10.5 1.6 7.5 4.3 7.8 6.7 2.6 3.6 0.0 8.2 4.5 4.8 8.0 2.9 3.5 65.3 2.1 6.5 0.9 18.2 10.5 1.8 3.7 5.0 7.1 1.6 GGCX VKCFD1 ENSG00000115486 "Gamma-glutamyl carboxylase" P38435 2 85544723-85561547 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 74.8" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018284 Enhanced NA NA "HPA018284: AB_1849641" "unprognostic (4.88e-3)" "unprognostic (1.13e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.82e-6)" "unprognostic (5.67e-2)" "unprognostic (1.85e-3)" "unprognostic (2.96e-2)" "unprognostic (3.77e-2)" "unprognostic (5.64e-2)" "unprognostic (2.18e-2)" "unprognostic (6.45e-3)" "unprognostic (5.23e-2)" "unprognostic (8.17e-3)" "unprognostic (7.85e-2)" "unprognostic (2.59e-1)" "unprognostic (7.63e-3)" "unprognostic (9.38e-2)" 7.1 7.8 4.8 4.2 6.3 1.6 10.8 6.3 6.6 6.4 4.9 5.4 8.3 4.0 6.3 8.1 6.5 5.9 7.0 6.8 5.4 3.6 9.0 74.8 8.1 5.4 5.4 5.0 7.0 11.4 15.1 5.6 13.8 5.9 6.3 5.5 5.8 7.4 7.9 6.8 4.9 5.5 7.2 5.1 4.5 6.0 3.6 5.7 3.4 8.5 5.3 5.4 7.3 6.0 0.9 4.9 6.0 7.2 2.2 3.2 3.2 6.8 11.2 8.0 8.9 40.4 11.5 17.8 12.3 14.6 9.1 13.0 19.3 8.5 2.5 12.6 20.2 11.4 11.3 5.7 15.5 10.1 4.4 7.8 4.5 7.5 18.2 15.0 2.8 4.2 14.3 9.2 18.5 12.6 15.1 12.9 4.4 5.3 3.6 26.4 9.0 1.4 2.1 3.7 19.4 9.7 2.6 18.8 6.2 12.7 13.3 3.0 5.1 11.0 21.9 11.4 14.2 10.7 2.7 11.8 11.7 10.3 11.4 8.4 2.9 7.9 2.1 11.3 2.9 16.4 6.0 7.2 3.6 3.2 7.2 3.0 0.7 1.3 1.2 4.9 0.9 3.2 3.0 3.2 2.2 4.4 4.0 1.9 3.2 4.8 6.3 6.3 6.6 5.4 3.6 5.4 5.0 5.9 5.7 26.8 38.9 20.9 16.3 16.7 19.1 20.2 35.7 14.7 17.0 27.9 15.7 51.8 6.6 24.1 3.2 18.0 14.4 23.3 34.3 40.8 26.7 15.3 15.1 132.3 27.6 7.9 13.8 24.5 21.6 1.3 18.7 22.6 20.3 28.9 15.2 19.0 23.2 12.4 19.1 21.4 28.4 6.5 16.5 16.9 8.1 13.2 45.0 14.9 15.8 18.8 GGH ENSG00000137563 "Gamma-glutamyl hydrolase" Q92820 8 63015079-63039171 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 42.5;liver: 59.5" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 501.9;Early spermatids: 395.4;Syncytiotrophoblasts: 631.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 18.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019296, HPA025226" Approved "Intracellular and membrane" NA NA 1400000000 "CAB019296: , HPA025226: AB_1849645" "unprognostic (9.29e-2)" "unprognostic (1.22e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (3.99e-7)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (1.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.11e-2)" "unprognostic (1.32e-1)" "unprognostic (1.69e-2)" "unprognostic (9.62e-3)" "unprognostic (1.50e-1)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" 3.5 3.6 7.4 4.7 8.6 12.3 11.8 15.5 9.9 3.5 17.6 1.5 1.0 3.7 2.6 3.7 11.0 1.6 2.8 5.9 7.9 7.6 42.5 59.5 3.5 5.0 4.7 7.0 1.9 4.2 1.0 1.6 17.7 14.8 1.9 26.4 2.2 6.5 1.8 1.7 11.1 3.6 4.2 7.6 3.7 3.2 14.0 3.8 5.2 1.4 14.5 7.6 3.9 6.6 4.1 18.2 2.1 1.9 2.9 1.4 1.4 20.0 19.3 19.8 3.0 19.5 8.2 14.6 12.4 21.2 19.7 28.5 27.0 35.6 13.7 3.5 15.3 33.2 16.8 19.6 20.7 29.2 27.8 14.8 22.5 10.4 18.2 3.7 10.5 13.5 6.0 5.9 19.8 9.5 12.5 23.7 14.0 12.0 50.3 36.8 11.3 5.1 10.5 9.3 44.9 18.3 15.3 19.3 18.4 15.2 7.0 7.9 13.6 18.0 19.7 18.8 19.1 21.7 11.7 12.5 21.2 23.8 20.3 22.2 23.6 24.0 16.1 32.7 0.0 37.3 0.0 1.9 2.1 1.1 1.1 0.5 4.1 1.3 1.3 0.6 1.9 1.0 1.3 1.8 2.9 1.2 18.2 1.4 1.4 7.4 8.6 15.5 9.9 7.9 7.6 4.7 7.0 14.8 3.8 14.9 8.2 22.6 16.2 26.9 1.7 1.6 17.8 14.7 14.8 21.0 0.0 501.9 31.5 20.1 395.4 8.3 17.2 46.7 6.4 234.3 29.8 8.2 10.4 171.3 65.1 0.0 12.7 15.4 18.7 97.7 5.5 15.0 23.6 54.1 74.6 20.3 6.2 8.6 7.8 214.6 1.1 25.8 10.8 73.7 141.6 37.6 631.0 10.1 104.6 12.5 GGN "FLJ35713, MGC33369" ENSG00000179168 Gametogenetin Q86UU5 19 38384265-38388082 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 84.1" "Group enriched" "Detected in some" 66 "Early spermatids: 431.4;Late spermatids: 617.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "BEWO: 6.4;HEK 293: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (8.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-2)" "unprognostic (6.22e-3)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.88e-2)" "unprognostic (1.64e-1)" "unprognostic (8.10e-2)" "unprognostic (1.06e-2)" "unprognostic (5.89e-4)" "unprognostic (4.86e-4)" "unprognostic (1.30e-2)" "unprognostic (1.97e-1)" "unprognostic (2.00e-1)" "unprognostic (2.40e-1)" 0.3 0.0 0.6 0.2 0.5 0.3 0.1 0.3 0.9 0.2 2.2 0.1 0.1 3.2 0.3 1.0 0.3 0.1 0.5 0.1 0.7 0.4 0.2 0.1 0.1 0.1 0.3 0.1 0.2 0.4 0.2 0.6 0.3 0.3 0.3 0.0 0.6 0.6 0.3 0.2 0.5 4.6 0.1 0.1 0.1 0.1 84.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.4 3.2 0.6 0.0 0.2 0.1 0.4 1.0 0.3 0.6 0.0 0.6 6.4 3.5 0.8 0.4 0.8 1.6 0.7 0.7 2.5 1.1 0.2 0.9 0.0 0.1 0.0 2.2 4.4 0.6 1.1 0.6 0.7 1.7 0.2 0.3 0.0 1.1 0.0 1.8 1.7 0.3 1.9 1.1 0.1 0.5 0.2 0.1 0.5 0.2 1.5 0.4 0.6 0.0 1.6 0.9 0.5 3.8 0.5 0.4 0.1 0.4 0.8 0.0 2.1 0.5 3.4 2.3 1.6 0.6 1.3 0.0 2.2 0.7 1.8 0.0 0.2 3.2 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.6 0.5 0.3 0.8 0.7 0.4 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.6 0.5 0.5 0.5 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.4 431.4 0.2 0.9 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 617.4 6.1 0.2 0.0 0.0 0.0 0.7 0.4 0.0 3.5 0.0 0.0 0.0 0.4 8.0 3.1 0.3 0.3 0.0 0.0 0.1 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24583750-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.1;seminal vesicle: 41.7" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles "Intracellular and membrane" NA NA 4600000 Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favorable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 1.6 0.5 1.7 1.7 2.2 2.7 8.2 2.3 2.6 7.3 7.9 1.6 23.7 22.3 1.4 19.9 1.2 0.8 12.2 2.0 1.8 1.2 54.1 29.2 14.3 3.2 1.7 1.6 1.3 17.3 0.0 1.6 1.4 2.2 14.7 2.4 1.4 8.7 41.7 0.9 1.1 20.9 1.7 1.9 4.7 6.6 5.0 2.1 2.4 4.8 1.6 5.5 2.1 1.1 3.3 7.5 15.9 14.6 6.6 8.6 6.6 0.2 19.3 0.2 0.0 0.0 0.1 0.5 0.1 0.6 0.2 0.2 2.6 4.2 0.2 4.3 0.0 3.8 2.8 1.4 0.2 0.1 35.6 2.9 0.1 8.6 14.0 1.5 0.3 11.9 0.4 0.2 0.6 0.4 0.3 0.1 5.3 2.0 52.5 0.2 0.4 0.3 14.6 1.4 37.9 0.2 0.2 2.2 51.6 48.0 0.6 0.2 0.3 0.1 9.3 0.2 5.5 9.3 11.1 2.2 3.5 2.3 10.8 0.3 15.8 5.9 0.2 7.4 15.0 0.1 5.2 14.6 0.4 1.4 6.8 5.2 3.3 7.7 3.4 7.5 0.3 1.0 1.9 15.9 6.6 5.5 0.1 8.6 6.6 1.7 2.2 2.3 2.6 1.8 1.2 1.7 1.6 2.2 2.1 74.5 21.4 3.4 0.1 0.7 0.4 0.4 40.8 2.7 7.9 1.8 0.0 0.9 1.7 54.8 1.1 0.1 80.7 0.0 7.2 0.3 1.3 3.0 5.7 34.1 4.7 0.0 1.2 2.5 3.0 4.1 0.0 2.9 1.7 5.4 2.5 2.0 33.5 23.0 0.4 32.7 0.0 0.0 0.2 0.6 0.7 0.4 0.7 3.2 4.2 0.0 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles NA NA Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.2 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 1.0 8.4 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.4 0.5 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.1 0.5 0.6 13.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.5 0.3 3.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 GGT6 FLJ90165 ENSG00000167741 "Gamma-glutamyltransferase 6" Q6P531 17 4556927-4560818 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.4;salivary gland: 52.7" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 136.8;Mucus-secreting cells: 63.3;Paneth cells: 98.2;Undifferentiated cells: 77.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Group enriched" "Detected in some" 8 "RT4: 30.5;SK-BR-3: 10.4;T-47d: 32.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023362, HPA027213" Approved NA NA 33000 "HPA023362: AB_1848955, HPA027213: AB_10601326" "unprognostic (2.23e-2)" "unprognostic (1.20e-2)" "unprognostic (2.14e-3)" "unprognostic (4.51e-2)" "unprognostic (9.71e-2)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "prognostic favorable (4.35e-4)" "unprognostic (2.10e-1)" "unprognostic (2.33e-1)" "unprognostic (3.07e-2)" "unprognostic (5.06e-2)" "prognostic favorable (9.42e-7)" "unprognostic (1.56e-1)" "unprognostic (5.71e-2)" "unprognostic (9.17e-2)" "unprognostic (8.07e-3)" 0.3 0.4 0.3 12.7 0.3 0.0 3.2 0.3 0.4 4.1 24.9 0.4 1.0 17.0 0.9 15.9 25.2 3.0 7.7 0.3 0.3 0.1 18.8 0.6 4.2 0.3 0.3 0.3 1.5 28.6 0.0 1.0 0.4 0.4 5.7 12.7 0.4 52.7 3.7 0.3 25.2 40.4 2.8 0.3 0.3 8.7 0.8 0.3 1.0 0.7 19.6 18.8 16.5 8.2 0.6 0.7 3.5 0.5 0.6 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 30.5 0.1 0.1 0.0 10.4 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.5 0.2 0.4 0.3 0.2 0.3 0.5 0.3 0.1 0.6 0.5 0.4 1.9 0.6 0.5 0.7 0.4 0.0 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.4 0.3 32.8 5.8 2.2 16.1 3.7 0.0 0.2 17.8 33.5 29.6 22.7 2.0 0.0 18.3 16.4 0.0 0.0 136.8 0.0 33.4 0.0 0.3 3.4 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 0.6 1.3 0.0 3.6 63.3 0.2 14.4 98.2 0.0 32.1 0.2 0.0 1.0 0.0 0.1 18.2 0.0 0.5 77.9 19.7 GGTLC1 "dJ831C21.1, dJ831C21.2, GGTLA3, GGTLA4" ENSG00000149435 "Gamma-glutamyltransferase light chain 1" Q9BX51 20 23985050-23988779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "lung: 24.2;testis: 11.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 128.1;Early spermatids: 37.6;Late spermatids: 92.1" "Cancer enriched" "Detected in some" 8 "lung cancer: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.3;SK-BR-3: 1.7;T-47d: 1.2;U-2197: 4.5" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (1.94e-2)" "unprognostic (5.32e-1)" "unprognostic (4.19e-1)" "unprognostic (1.00e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.1 0.0 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.1 4.5 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 128.1 14.9 0.0 0.0 0.0 0.0 0.0 5.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 37.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 GGTLC2 GGTL4 ENSG00000100121 "Gamma-glutamyltransferase light chain 2" Q14390 22 22644475-22647903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.1" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 20.8;Early spermatids: 22.5;Late spermatids: 5.2;Spermatocytes: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.6;RPMI-8226: 4.6;THP-1: 2.8;U-2 OS: 2.4" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (2.58e-2)" "unprognostic (2.35e-2)" "unprognostic (7.17e-2)" "unprognostic (2.96e-1)" "unprognostic (4.31e-1)" "unprognostic (1.57e-2)" "unprognostic (1.06e-3)" "unprognostic (1.48e-2)" "unprognostic (1.55e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.3 0.9 1.4 1.3 0.8 0.7 0.6 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 4.6 1.0 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.3 2.8 0.0 0.0 2.4 0.0 0.0 0.7 0.5 0.1 0.0 0.2 0.0 0.5 1.3 0.0 0.0 0.5 0.2 0.3 0.7 0.4 0.9 0.0 0.0 0.3 1.4 0.8 0.7 0.0 0.7 0.6 20.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 10.9 0.1 0.0 0.0 0.0 0.0 0.0 GGTLC3 ENSG00000274252 "Gamma-glutamyltransferase light chain family member 3" B5MD39 22 18516344-18518161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 4.2;salivary gland: 3.0" "Group enriched" "Detected in some" 21 "Alveolar cells type 1: 3.0;Early spermatids: 4.1;Late spermatids: 10.4;Spermatocytes: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.9;SuSa: 5.3;U-2197: 3.6" "HPA045635, HPA047534" Uncertain NA NA "HPA045635: AB_2679400, HPA047534: AB_2680079" "unprognostic (1.37e-1)" "unprognostic (2.06e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 4.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.5 1.2 0.0 0.0 1.2 0.3 0.0 0.7 0.6 1.1 0.3 0.0 0.0 5.3 0.0 0.0 0.0 0.3 1.4 3.6 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 GH1 "GH, GH-N, GHN, hGH-N" ENSG00000259384 "Growth hormone 1" P01241 17 63917200-63918838 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pituitary gland: 994.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.1;T-reg: 2.2" "Group enriched" "Detected in many" 4 "B-cells: 2.1;T-cells: 2.2" "Cell line enriched" "Detected in some" 5 "U-698: 7.6" HPA043715 Supported "Secreted to blood" NA NA 2690000 180000 "HPA043715: AB_2678632" "unprognostic (1.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-1)" "unprognostic (9.45e-4)" "unprognostic (2.48e-1)" "unprognostic (2.09e-4)" "unprognostic (2.03e-2)" "unprognostic (6.57e-2)" "unprognostic (2.33e-1)" 0.3 0.0 0.0 0.5 0.0 1.1 0.2 0.1 0.1 0.4 0.4 0.0 0.0 3.3 1.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.3 994.5 217.7 0.1 0.2 0.5 0.0 0.1 0.2 0.8 0.9 0.4 0.1 0.0 1.6 0.3 0.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 2.1 0.0 0.0 0.5 0.0 2.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 1.6 7.6 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.5 0.0 2.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 GH2 "GH-V, GHL, GHV, hGH-V" ENSG00000136487 "Growth hormone 2" P01242 17 63880215-63881935 "Cancer-related genes, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 309 "pituitary gland: 47.3;placenta: 138.4" "Group enriched" "Detected in some" 22 "Extravillous trophoblasts: 7.9;Syncytiotrophoblasts: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BEWO: 13.7" HPA043715 Supported "Secreted to blood" NA NA "HPA043715: AB_2678632" "unprognostic (1.02e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 138.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 19.8 0.0 0.0 0.0 GHR GHBP ENSG00000112964 "Growth hormone receptor" P10912 5 42423777-42721878 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4" "Cell type enhanced" "Detected in many" 19 "Hepatocytes: 103.6;Syncytiotrophoblasts: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HSkMC: 13.6;T-47d: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045339, HPA057705" Enhanced Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" "Secreted to blood" NA NA 2200000 21000000 "Plasma membrane, Cytosol, Cytoplasmic bodies" "HPA045339: AB_2679294, HPA057705: AB_2683507" "unprognostic (2.18e-2)" "unprognostic (5.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.96e-2)" "unprognostic (3.12e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.73e-6)" "unprognostic (1.06e-1)" "unprognostic (3.92e-2)" "unprognostic (3.73e-2)" "unprognostic (6.15e-3)" "unprognostic (2.67e-2)" "unprognostic (1.67e-3)" "unprognostic (4.29e-4)" "unprognostic (7.82e-2)" "unprognostic (7.33e-4)" "unprognostic (8.35e-6)" 44.4 2.8 0.7 5.4 1.3 0.3 31.5 0.4 1.4 4.0 6.9 0.5 1.7 0.6 5.7 3.9 2.4 2.5 3.9 6.0 1.3 1.6 5.3 82.4 2.3 2.2 1.2 1.4 5.0 1.3 3.6 2.0 4.0 2.0 8.7 2.5 2.4 2.3 7.4 23.4 3.0 2.4 5.2 1.0 2.6 3.5 1.6 0.2 0.1 2.9 4.3 0.5 3.8 8.4 0.6 0.3 1.8 0.5 0.4 0.3 0.1 0.0 0.0 0.3 3.1 2.1 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.6 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 13.6 4.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.1 0.4 34.7 0.0 1.8 3.0 1.3 1.6 0.3 0.3 0.0 0.0 0.3 0.0 1.6 1.8 0.3 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.3 1.7 0.4 0.5 0.3 0.2 0.1 0.7 1.3 0.4 1.4 1.3 1.6 1.2 1.4 2.0 0.2 0.0 0.3 0.0 2.8 4.1 0.6 13.6 2.5 0.0 0.0 1.8 0.0 8.6 1.7 0.0 3.3 2.9 0.0 0.0 0.2 0.9 9.3 3.5 0.0 103.6 1.6 0.0 2.9 4.9 1.9 1.8 17.3 0.3 1.7 0.0 2.0 0.8 0.2 0.0 11.3 8.8 0.2 12.9 4.4 0.0 0.3 3.1 33.6 0.0 1.5 0.9 GHRH GHRF ENSG00000118702 "Growth hormone releasing hormone" P01286 20 37251082-37261835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.3" "Cell type enriched" "Detected in single" 4 "Cardiomyocytes: 1.1" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 8.5" "Region enriched" "Detected in some" 15 "hypothalamus: 37.3" "Cell type enhanced" "Detected in single" "eosinophil: 2.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "NTERA-2: 3.6;U-266/84: 12.7" "Region enriched" "Detected in some" 9 "hypothalamus: 38.7" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (4.78e-2)" "unprognostic (2.57e-2)" "unprognostic (1.58e-1)" "unprognostic (3.10e-1)" 0.1 2.7 0.3 0.1 2.4 0.0 0.6 0.1 1.0 0.1 4.0 0.1 0.1 8.1 0.1 0.1 0.7 0.0 0.1 6.5 0.1 37.3 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 7.7 0.1 0.1 0.1 1.9 0.1 0.1 7.5 0.4 0.1 0.1 0.1 0.1 0.0 0.7 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.1 1.0 0.1 37.3 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GHRHR ENSG00000106128 "Growth hormone releasing hormone receptor" Q02643 7 30938669-30993254 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "pituitary gland: 108.9" "Cell type enhanced" "Detected in single" 31 "Spermatogonia: 2.4" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (8.32e-2)" "unprognostic (1.45e-1)" "unprognostic (9.30e-2)" "unprognostic (1.39e-1)" "unprognostic (7.23e-2)" "unprognostic (4.15e-1)" "unprognostic (2.28e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (1.43e-2)" "unprognostic (1.47e-1)" "unprognostic (5.87e-3)" 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 108.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 GHRL "ghrelin, MTLRP, obestatin" ENSG00000157017 "Ghrelin and obestatin prepropeptide" Q9UBU3 3 10285675-10292947 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8;stomach 1: 64.9" "Cell type enhanced" "Detected in many" 5 "B-cells: 8.2;Bipolar cells: 7.7;Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 6.2;classical monocyte: 6.0;eosinophil: 6.0;myeloid DC: 21.8;neutrophil: 13.5;plasmacytoid DC: 15.0" "Group enriched" "Detected in many" 7 "dendritic cells: 21.8;granulocytes: 13.5;monocytes: 6.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA014246, CAB022731" Enhanced "Secreted to blood" NA NA 2580000 69000 "CAB022731: , HPA014246: AB_1849659" "unprognostic (1.74e-2)" "unprognostic (3.01e-4)" "unprognostic (3.75e-1)" "unprognostic (1.05e-2)" "unprognostic (2.94e-2)" "unprognostic (1.60e-3)" "unprognostic (2.12e-1)" "unprognostic (1.06e-3)" "unprognostic (3.85e-1)" "unprognostic (5.45e-3)" "unprognostic (1.54e-3)" "unprognostic (2.71e-2)" "unprognostic (1.64e-3)" "unprognostic (4.52e-2)" "unprognostic (8.56e-2)" "unprognostic (2.14e-1)" "unprognostic (1.79e-4)" 1.2 0.6 1.8 4.2 1.7 1.5 0.6 0.7 1.5 0.6 1.2 1.8 2.2 7.4 0.9 2.3 1.1 1.0 1.7 1.3 1.6 0.7 0.8 0.8 1.8 14.5 0.9 0.4 1.0 1.7 0.2 0.8 0.2 1.1 1.2 0.2 0.7 3.2 0.1 0.7 0.8 1.4 0.3 0.9 4.9 64.9 0.7 1.3 1.7 1.2 0.0 4.3 0.7 0.5 0.8 21.8 13.5 6.0 2.1 0.1 2.0 0.7 0.3 3.0 2.3 2.2 0.0 5.5 2.8 0.0 0.8 0.2 3.2 0.6 1.6 1.0 0.1 2.4 0.4 0.0 0.7 0.0 0.5 3.3 3.4 1.8 6.8 0.0 3.5 6.1 0.4 0.0 0.1 0.1 0.2 0.6 2.1 1.4 16.6 0.0 0.7 1.3 4.8 1.5 0.5 6.0 0.9 0.3 0.9 0.0 3.6 2.1 0.3 1.8 1.2 0.1 2.1 1.7 4.2 2.9 1.4 0.9 1.3 1.8 2.0 2.8 3.5 0.5 3.9 0.6 6.2 6.0 6.0 0.1 2.8 0.0 0.8 0.1 0.0 21.8 0.5 0.1 0.0 13.5 2.1 0.2 15.0 0.1 2.0 1.8 1.7 0.7 1.5 1.6 0.7 0.9 0.4 1.1 1.3 0.0 1.4 8.2 3.3 1.1 7.7 0.0 0.0 0.0 0.0 1.8 9.8 1.3 0.0 1.0 0.2 1.1 0.0 0.0 1.2 1.0 1.0 2.1 0.0 0.0 1.5 3.2 0.0 0.6 2.8 0.4 0.3 7.1 1.7 4.6 0.0 2.9 0.6 0.0 0.4 0.0 5.4 6.5 1.2 1.2 0.8 0.5 0.2 5.2 0.6 1.7 GHSR ENSG00000121853 "Growth hormone secretagogue receptor" Q92847 3 172445133-172448456 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.4;blood: 2.4;pituitary gland: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "NK-cell: 2.4" "Lineage enriched" "Detected in single" 25 "NK-cells: 2.4" "Cell line enriched" "Detected in single" 4 "HMC-1: 1.8" "Region enhanced" "Detected in some" "hypothalamus: 3.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.27e-1)" "unprognostic (3.31e-2)" 0.0 2.4 0.0 0.8 0.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GID4 "C17orf39, VID24" ENSG00000141034 "GID complex subunit 4 homolog" Q8IVV7 17 18039292-18068404 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.2" "Group enriched" "Detected in many" 17 "Early spermatids: 643.1;Late spermatids: 883.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044348 Uncertain Approved Cytosol NA NA Cytosol "HPA044348: AB_10959602" "unprognostic (1.52e-1)" "unprognostic (4.19e-2)" "unprognostic (4.65e-1)" "unprognostic (4.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.38e-1)" "unprognostic (3.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.04e-1)" "unprognostic (8.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-1)" "unprognostic (3.64e-3)" "unprognostic (2.11e-1)" "unprognostic (8.68e-2)" "unprognostic (3.58e-2)" "unprognostic (4.76e-3)" 10.9 5.7 9.6 4.7 9.4 5.6 7.5 13.4 9.3 9.0 9.4 6.9 7.3 4.5 7.9 7.2 13.0 6.7 5.5 10.1 8.8 5.3 6.2 6.2 5.6 5.3 9.5 5.8 8.6 7.8 10.8 3.9 6.7 7.0 9.5 5.1 4.6 7.7 9.3 24.7 11.6 5.1 9.5 7.0 6.3 6.4 55.2 10.2 8.0 7.1 5.8 6.2 13.3 10.8 4.4 3.2 6.8 2.4 3.8 3.6 1.0 6.4 6.7 3.8 6.2 10.0 9.8 6.6 5.4 8.7 6.0 6.8 5.8 2.6 8.2 4.6 6.3 5.6 7.3 5.5 6.0 7.8 4.4 11.0 3.6 5.7 4.2 8.7 2.2 6.4 7.3 10.5 6.0 9.4 8.1 6.7 11.9 3.2 2.4 4.8 1.7 6.9 4.6 3.3 8.1 5.0 5.9 13.5 8.0 4.0 2.6 2.9 4.3 3.6 3.2 3.8 39.5 2.1 2.7 5.5 3.9 2.2 8.9 2.7 4.1 3.6 1.8 5.5 3.7 4.9 6.8 2.4 6.6 2.6 1.3 2.9 4.4 2.4 2.5 1.9 4.4 2.9 2.9 6.3 3.8 1.5 3.2 3.6 1.0 9.6 9.4 13.4 9.3 8.8 5.3 9.5 5.8 7.0 10.2 0.0 0.6 3.4 6.6 9.8 5.2 10.6 2.5 2.7 1.2 1.8 3.9 6.6 8.3 5.0 643.1 7.1 2.6 0.0 4.9 10.6 5.3 7.6 5.7 6.4 6.4 15.9 1.2 7.4 6.3 883.9 11.8 5.3 6.8 5.4 7.2 4.2 8.2 0.0 14.9 9.6 3.7 12.9 5.1 45.4 22.8 15.8 12.9 5.2 5.0 6.5 GIF "IF, IFMH, INF, TCN3" ENSG00000134812 "Gastric intrinsic factor" P27352 11 59829268-59845501 "Disease related genes, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "stomach 1: 185.6" "Cell type enriched" "Detected in single" 108 "Exocrine glandular cells: 10.8" "Cancer enriched" "Detected in some" 11 "stomach cancer: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "THP-1: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039908, HPA040774" Enhanced "Secreted to digestive system" NA NA "HPA039908: AB_10796335, HPA040774: AB_10795626" "unprognostic (2.78e-4)" "unprognostic (1.04e-1)" "unprognostic (2.45e-1)" "unprognostic (3.59e-1)" "unprognostic (1.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 7.1 0.0 0.0 0.0 0.0 3.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 185.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIMAP1-GIMAP5 ENSG00000281887 "GIMAP1-GIMAP5 readthrough" 7 150716668-150743646 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "monocytes: 15.5;NK-cells: 21.5;T-cells: 37.5" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 8.4;JURKAT: 5.0;MOLT-4: 13.1;THP-1: 3.2;TIME: 6.2" HPA053441 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA053441: AB_2682152" 12.2 2.1 1.8 12.9 2.7 1.0 6.4 0.0 2.2 5.2 2.2 1.3 1.8 7.0 7.8 3.1 3.6 2.1 3.3 3.8 1.9 3.0 2.5 6.2 15.5 2.0 0.8 1.6 1.9 0.7 0.0 4.6 2.3 3.6 0.5 2.9 2.2 0.9 4.4 0.2 3.1 2.7 2.5 16.4 3.0 1.3 2.0 3.9 4.7 3.0 7.6 2.5 7.2 0.2 4.8 1.5 15.5 21.5 37.5 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 5.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 15.5 0.0 23.3 13.5 27.9 0.2 26.4 34.0 4.8 0.2 37.5 30.2 1.5 21.5 9.8 0.3 16.4 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GIMAP2 "DKFZp586D0824, HIMAP2, IAN12, IMAP2" ENSG00000106560 "GTPase, IMAP family member 2" Q9UG22 7 150685697-150693641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.8;lymphoid tissue: 38.1" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 34.8;Ito cells: 35.6;Kupffer cells: 100.1;T-cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 28.0;JURKAT: 15.5;MOLT-4: 33.8;REH: 14.7;U-937: 14.1" "Low region specificity" "Detected in many" HPA013589 Approved NA NA "HPA013589: AB_1849666" "prognostic favorable (3.50e-4)" "unprognostic (4.73e-2)" "unprognostic (2.53e-1)" "unprognostic (3.56e-3)" "unprognostic (6.60e-2)" "unprognostic (6.64e-3)" "unprognostic (4.60e-2)" "unprognostic (5.97e-2)" "unprognostic (3.39e-2)" "unprognostic (3.91e-1)" "unprognostic (5.52e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.56e-2)" "unprognostic (3.08e-2)" 13.0 7.3 4.8 21.3 7.1 4.6 8.3 2.6 4.2 7.6 7.8 3.3 4.0 5.7 7.8 7.1 5.5 4.5 8.1 7.8 6.7 4.2 6.6 7.7 14.9 35.4 7.3 3.3 8.7 2.7 0.9 3.3 9.2 6.2 6.5 7.6 4.6 7.7 3.0 3.9 2.9 12.7 5.4 12.3 38.1 5.3 2.5 6.5 26.7 6.3 4.4 26.7 9.4 9.6 3.9 11.6 10.0 28.3 31.4 44.8 28.0 0.7 0.0 0.0 0.0 0.3 0.3 0.3 0.0 8.0 1.0 2.3 0.0 10.5 1.8 0.1 0.6 4.4 0.4 0.0 0.4 0.1 8.5 0.0 5.6 0.0 0.2 1.3 4.2 5.7 3.1 0.8 0.7 0.0 2.4 28.0 15.5 0.1 2.2 0.4 0.0 33.8 10.7 0.0 0.0 0.0 14.7 0.3 4.2 0.0 2.6 0.0 0.0 0.0 0.0 2.6 0.0 0.4 11.0 6.2 0.4 0.1 0.1 0.0 2.5 2.3 0.0 1.0 14.1 1.5 2.7 20.7 1.7 24.6 28.3 31.0 3.8 32.2 29.7 11.6 3.9 44.8 32.6 10.0 31.4 27.6 1.4 25.6 28.0 4.8 7.1 2.6 4.2 6.7 4.2 7.3 3.3 6.2 6.5 11.9 2.1 8.7 1.7 3.0 0.0 1.2 2.5 4.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 17.5 2.0 0.0 0.6 0.3 2.1 1.9 19.6 3.8 34.8 0.0 0.0 35.6 100.1 0.0 3.7 21.0 1.7 12.6 3.9 0.3 0.7 3.5 0.7 0.8 0.0 6.5 0.8 0.0 0.2 2.8 0.3 62.3 3.3 2.0 GIMAP4 "FLJ11110, HIMAP4, IAN1, IMAP4" ENSG00000133574 "GTPase, IMAP family member 4" Q9NUV9 7 150567277-150573955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 78.6" "Group enriched" "Detected in many" 6 "Endothelial cells: 177.9;Hofbauer cells: 83.4;Ito cells: 198.2;Kupffer cells: 164.1;Macrophages: 61.9;T-cells: 207.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 26 "HUVEC TERT2: 83.7" "Not detected" "Not detected" "HPA019135, HPA019137, HPA027198" Enhanced NA NA "HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599" "unprognostic (5.03e-2)" "unprognostic (3.30e-3)" "unprognostic (4.08e-2)" "prognostic favorable (7.63e-4)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" "unprognostic (7.00e-2)" "unprognostic (2.40e-2)" "unprognostic (1.87e-2)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.65e-1)" "unprognostic (3.32e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-1)" 26.7 7.7 9.2 27.2 12.2 1.5 19.5 2.6 8.8 11.5 10.2 6.8 4.0 6.2 12.5 9.1 8.7 10.0 9.7 14.0 9.7 6.6 11.0 11.5 30.5 47.3 11.3 4.1 5.8 4.8 3.1 4.8 19.2 10.8 11.2 9.1 6.8 6.4 5.6 13.6 5.2 15.0 15.2 13.7 43.4 7.6 5.9 11.6 10.4 14.5 8.2 32.5 14.1 9.2 0.3 15.4 43.1 48.7 31.3 58.3 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 45.0 0.6 44.1 48.7 54.4 0.3 55.2 53.8 15.4 0.1 58.3 48.7 43.1 31.3 37.2 0.6 37.8 78.6 9.2 12.2 2.6 8.8 9.7 6.6 11.3 4.1 10.8 11.6 3.0 18.0 4.1 0.1 6.1 0.0 4.1 0.0 1.4 3.4 10.4 0.0 0.5 0.0 0.1 0.4 177.9 0.0 0.0 0.2 0.5 3.9 0.3 5.8 2.5 83.4 0.0 0.0 198.2 164.1 0.5 4.6 61.9 10.1 24.4 0.0 0.2 0.1 0.0 0.0 1.4 0.0 12.9 2.2 0.0 0.5 5.4 0.7 207.5 0.0 0.3 GIMAP5 "HIMAP3, IAN4L1, IAN5" ENSG00000196329 "GTPase, IMAP family member 5" Q96F15 7 150722253-150750033 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 61.0;lymphoid tissue: 58.3" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 9.8;Endothelial cells: 18.8;Ito cells: 11.6;Suprabasal keratinocytes: 9.4;T-cells: 17.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "NK-cells: 17.3;T-cells: 61.0" "Cell line enriched" "Detected in some" 4 "MOLT-4: 24.9" NA NA "unprognostic (6.77e-2)" "unprognostic (8.83e-3)" "unprognostic (1.61e-1)" "unprognostic (4.68e-2)" "unprognostic (2.49e-1)" "unprognostic (2.34e-3)" "unprognostic (2.21e-3)" "unprognostic (6.42e-2)" "unprognostic (2.12e-1)" "unprognostic (1.61e-2)" "unprognostic (2.96e-2)" "unprognostic (9.87e-2)" "unprognostic (2.77e-3)" "unprognostic (4.13e-1)" "unprognostic (7.15e-3)" "unprognostic (1.86e-1)" "unprognostic (1.47e-2)" 26.8 6.6 4.7 23.3 5.8 1.7 26.6 1.9 4.3 9.3 9.2 3.4 4.5 2.4 15.2 12.0 7.1 8.7 7.9 12.4 5.5 3.7 8.2 9.2 25.8 58.3 5.2 2.1 4.1 5.2 2.0 3.8 10.3 6.1 7.0 7.9 8.4 9.1 4.2 8.7 5.6 11.7 14.2 5.7 28.7 6.6 3.3 5.6 5.5 12.8 9.2 30.7 10.4 10.2 0.1 0.4 0.7 9.5 17.3 61.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 1.1 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.4 4.7 0.1 30.2 9.5 37.9 0.1 52.1 35.0 0.4 0.0 61.0 30.8 0.7 17.3 3.0 0.1 17.1 51.1 4.7 5.8 1.9 4.3 5.5 3.7 5.2 2.1 6.1 5.6 0.0 1.7 0.5 0.2 9.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.3 0.2 0.2 2.3 0.8 2.4 0.0 0.0 11.6 3.5 0.0 0.0 3.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.1 9.4 0.2 17.3 0.0 0.1 GIMAP7 "IAN7, MGC27027" ENSG00000179144 "GTPase, IMAP family member 7" Q8NHV1 7 150514830-150521073 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 155.1" "Group enriched" "Detected in many" 7 "Endothelial cells: 154.6;Ito cells: 251.0;Kupffer cells: 150.3;T-cells: 350.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "monocytes: 41.1;NK-cells: 65.0;T-cells: 155.1" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 39.9;MOLT-4: 32.4" "Low region specificity" "Detected in some" "HPA020266, HPA020268" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA020266: AB_1849680, HPA020268: AB_1849682" "unprognostic (4.85e-3)" "unprognostic (1.65e-3)" "unprognostic (6.11e-2)" "unprognostic (1.32e-2)" "unprognostic (3.71e-1)" "prognostic favorable (7.43e-4)" "prognostic favorable (8.98e-5)" "unprognostic (6.49e-3)" "unprognostic (5.24e-2)" "unprognostic (6.12e-3)" "unprognostic (2.36e-2)" "unprognostic (2.81e-1)" "unprognostic (2.07e-3)" "unprognostic (2.07e-1)" "unprognostic (3.14e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" 32.2 7.3 6.2 30.1 9.8 1.9 19.7 4.3 8.0 19.9 9.5 2.1 5.3 7.6 13.4 11.9 12.2 10.2 9.4 14.6 9.3 6.4 20.1 10.5 22.8 54.7 10.0 3.3 7.0 4.7 3.3 4.9 12.5 7.2 13.5 8.8 6.2 10.7 4.6 17.0 4.6 20.5 12.4 8.1 51.5 7.7 6.7 8.2 18.7 16.7 11.3 34.9 13.4 11.0 0.4 18.0 3.4 41.1 65.0 155.1 131.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.9 4.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 41.1 0.5 79.6 36.9 77.6 0.4 118.6 95.4 18.0 0.3 155.1 108.0 3.4 65.0 38.6 1.0 64.7 131.0 6.2 9.8 4.3 8.0 9.3 6.4 10.0 3.3 7.2 8.2 0.0 19.9 6.5 0.2 2.2 0.0 8.9 7.6 1.4 1.2 1.8 0.0 0.1 0.0 0.0 1.3 154.6 0.0 0.0 0.6 0.0 2.3 0.2 12.8 2.6 14.9 0.0 0.0 251.0 150.3 0.7 2.3 34.3 1.7 12.6 0.0 0.3 0.7 0.2 0.4 1.6 0.2 0.0 1.4 0.0 0.5 2.9 0.3 350.3 0.0 0.0 GIMD1 ENSG00000250298 "GIMAP family P-loop NTPase domain containing 1" P0DJR0 4 106357485-106368825 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "intestine: 24.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;HBF TERT88: 1.0;HEL: 1.0;NB-4: 1.2;U-138 MG: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 23.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 1.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GINS1 "KIAA0186, PSF1" ENSG00000101003 "GINS complex subunit 1" Q14691 20 25407727-25452628 "Predicted intracellular proteins" "DNA replication" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.1;testis: 21.4" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 43.6;Extravillous trophoblasts: 14.7;Late spermatids: 17.2;Spermatogonia: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051185 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA051185: AB_2681378" "unprognostic (6.10e-3)" "unprognostic (2.58e-1)" "unprognostic (5.37e-3)" "unprognostic (1.74e-3)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (5.86e-3)" "unprognostic (1.42e-2)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.42e-11)" "unprognostic (5.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (2.55e-1)" 1.5 1.9 4.1 11.7 4.2 4.5 2.2 7.4 4.3 2.2 4.5 1.3 0.0 4.3 2.2 1.0 8.5 1.4 2.3 1.0 2.2 2.2 2.2 2.0 1.4 7.2 1.9 2.1 1.7 1.8 1.1 0.8 5.5 2.2 1.4 5.9 1.3 2.1 0.7 0.7 5.3 4.1 2.8 1.8 3.4 2.9 21.4 0.9 20.1 1.0 6.4 10.5 2.6 3.2 2.6 2.3 1.3 1.0 1.9 3.5 0.9 18.0 16.4 20.2 13.1 1.1 1.6 20.4 8.0 3.9 15.5 16.5 14.2 18.1 22.3 9.2 3.3 11.5 21.0 17.6 14.8 18.0 5.9 6.1 15.3 6.0 17.2 0.4 20.0 7.0 0.7 0.8 14.7 3.0 2.1 8.2 12.8 14.7 14.7 9.2 19.5 30.7 15.0 13.7 12.6 8.6 22.0 23.3 15.1 5.9 12.2 8.5 8.9 8.2 19.6 6.9 11.9 18.6 10.1 3.7 12.2 13.2 7.9 14.6 5.9 16.7 17.6 3.2 19.6 13.7 0.8 0.8 0.5 1.5 1.0 0.9 2.6 1.1 0.5 2.1 1.7 0.8 1.4 1.3 1.9 1.0 2.3 3.5 0.9 4.1 4.2 7.4 4.3 2.2 2.2 1.9 2.1 2.2 0.9 0.0 1.1 0.8 0.4 2.9 1.3 0.3 0.0 2.7 2.3 1.8 0.0 5.0 0.0 1.3 43.6 0.1 0.5 0.0 0.6 14.7 1.4 0.4 1.1 0.0 4.8 0.0 1.2 1.3 1.3 17.2 0.6 1.5 0.0 0.0 1.2 1.3 0.4 0.0 1.1 1.8 0.1 0.0 0.9 8.9 20.9 1.3 2.1 0.0 2.8 0.4 GINS2 "Pfs2, PSF2" ENSG00000131153 "GINS complex subunit 2" Q9Y248 16 85676198-85690073 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.2;testis: 21.3" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 65.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 11.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 72.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA057285 Uncertain Approved Nucleoplasm No Yes Nucleoplasm "HPA057285: AB_2683398" "unprognostic (3.22e-2)" "unprognostic (1.13e-3)" "unprognostic (2.04e-3)" "unprognostic (2.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.30e-1)" "unprognostic (2.45e-3)" "unprognostic (2.58e-2)" "unprognostic (1.67e-2)" "unprognostic (2.52e-3)" "unprognostic (2.19e-2)" "unprognostic (5.82e-3)" "unprognostic (5.70e-3)" "unprognostic (4.54e-2)" "unprognostic (6.30e-2)" "unprognostic (5.44e-3)" "unprognostic (1.60e-1)" 0.9 1.5 3.5 15.9 3.7 13.2 3.6 3.8 2.1 1.9 6.5 1.9 1.5 4.7 1.8 2.6 7.1 0.9 2.2 1.6 4.8 1.5 1.3 3.3 1.4 8.7 2.2 1.5 1.9 4.4 2.6 1.4 4.6 1.6 2.6 7.4 1.9 2.0 0.7 3.2 3.1 5.9 1.5 2.3 7.6 2.1 21.3 1.8 25.2 1.8 8.0 13.3 1.9 3.0 1.4 1.7 1.5 3.3 4.3 11.1 2.4 13.4 9.7 19.0 7.9 0.5 1.9 5.0 9.3 3.7 13.7 8.5 12.8 9.0 15.9 5.1 3.2 7.2 10.3 20.0 7.6 13.3 5.5 17.3 7.8 7.4 14.4 0.1 5.4 4.3 0.5 0.9 8.2 3.2 1.7 5.8 12.9 21.4 3.8 7.9 28.2 19.1 20.5 10.6 11.9 7.4 26.8 11.5 8.8 4.4 5.6 26.2 8.3 13.4 2.7 2.7 7.9 27.6 7.4 3.5 9.0 12.1 8.4 10.6 7.1 12.5 72.1 5.2 11.5 10.2 0.7 0.3 1.5 1.4 1.3 0.2 1.4 4.7 3.1 1.7 1.0 2.2 1.6 1.2 4.3 3.3 1.0 11.1 2.4 3.5 3.7 3.8 2.1 4.8 1.5 2.2 1.5 1.6 1.8 3.0 0.0 6.7 6.6 8.1 7.1 1.1 0.0 2.7 4.5 3.5 2.0 17.0 3.3 6.0 8.2 0.6 1.6 23.3 1.3 22.7 3.1 2.7 1.1 1.7 19.7 7.9 2.9 0.0 0.6 22.2 1.1 2.8 0.0 1.0 8.2 3.4 1.5 5.8 1.8 0.3 8.0 19.4 3.1 65.9 96.9 3.3 10.6 5.1 29.9 1.6 GIP ENSG00000159224 "Gastric inhibitory polypeptide" P09681 17 48958554-48968596 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 64 "intestine: 87.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 63 "testis cancer: 74.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 8.8;BEWO: 8.0;Hep G2: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021612, HPA064596" Enhanced "Secreted to blood" NA NA 33900 "HPA021612: AB_1849506, HPA064596: " "unprognostic (2.95e-1)" "unprognostic (2.70e-3)" "unprognostic (4.42e-2)" "unprognostic (1.82e-1)" 0.2 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 87.5 0.0 0.0 75.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 61.7 0.0 0.1 0.1 0.2 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.1 0.0 0.4 0.7 8.0 0.4 0.0 0.1 0.0 2.2 0.9 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.0 0.0 1.3 0.0 1.5 12.6 0.1 0.0 0.1 0.2 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GIPC2 "FLJ20075, SEMCAP-2" ENSG00000137960 "GIPC PDZ domain containing family member 2" Q8TF65 1 77979542-78138449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 48.7;Proximal tubular cells: 149.4;Undifferentiated cells: 50.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.9;naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 17 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.2;HaCaT: 4.9;Hep G2: 18.3;HUVEC TERT2: 19.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051212, HPA062684" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051212: , HPA062684: AB_2684833" "unprognostic (1.72e-2)" "unprognostic (9.37e-2)" "prognostic favorable (5.49e-4)" "unprognostic (1.09e-2)" "unprognostic (1.43e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.35e-1)" "unprognostic (7.63e-2)" "unprognostic (2.22e-1)" "unprognostic (5.91e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.11e-6)" "unprognostic (6.55e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-2)" "unprognostic (1.29e-1)" 6.4 17.0 0.8 3.2 0.9 0.0 4.0 0.4 1.0 2.6 27.0 0.3 0.2 19.6 5.4 4.5 5.7 1.4 8.1 3.1 0.5 0.5 21.3 10.4 3.2 2.2 0.5 0.3 3.7 24.7 3.3 2.5 1.6 1.3 2.1 7.8 1.5 6.9 1.0 1.8 2.7 64.0 1.4 0.6 22.7 3.0 2.2 0.4 0.1 1.5 4.9 1.4 2.5 5.1 0.1 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 5.2 0.0 0.8 0.0 0.4 0.9 4.1 2.7 1.2 0.0 0.4 0.0 4.9 0.0 0.0 2.7 0.1 0.0 0.6 0.0 18.3 1.0 0.0 0.0 0.8 0.0 2.9 0.1 0.0 19.3 0.0 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 1.0 0.6 0.0 0.1 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.4 1.0 0.5 0.5 0.5 0.3 1.3 0.4 0.0 2.2 1.3 2.0 11.4 0.4 2.6 25.5 12.0 3.4 8.7 2.0 5.2 28.2 9.6 1.7 13.7 48.7 0.0 29.0 1.9 1.6 0.5 0.0 39.9 10.0 0.0 2.9 11.1 0.6 0.5 1.1 0.2 0.0 1.8 34.6 0.0 18.0 31.7 0.0 149.4 0.5 0.0 1.3 0.5 0.2 19.1 1.4 0.5 50.7 5.6 GIPR ENSG00000010310 "Gastric inhibitory polypeptide receptor" P48546 19 45668244-45683724 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;stomach 1: 26.1" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 33.5;Club cells: 13.6;Intestinal endocrine cells: 28.7;Rod photoreceptor cells: 18.6" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 4.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.1;HMC-1: 18.4;SCLC-21H: 12.2;U-266/70: 15.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" CAB022710 Uncertain NA NA "CAB022710: " "unprognostic (2.40e-2)" "unprognostic (9.03e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-2)" "unprognostic (2.65e-1)" "unprognostic (3.70e-4)" "unprognostic (1.82e-2)" "unprognostic (2.94e-2)" "unprognostic (1.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.85e-3)" "unprognostic (2.78e-1)" "unprognostic (1.72e-2)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" "unprognostic (3.37e-2)" "unprognostic (2.59e-2)" 8.0 0.4 2.3 4.5 8.4 2.4 6.6 1.8 10.5 2.9 4.5 9.4 0.1 4.3 0.7 1.5 1.8 10.0 1.8 12.3 3.7 2.6 1.7 0.5 4.8 3.6 21.3 1.4 1.0 8.5 9.0 2.0 0.4 6.3 5.3 5.8 2.6 5.8 0.6 0.4 3.3 3.6 0.5 4.6 4.1 26.1 0.4 16.2 0.2 1.8 0.8 4.4 3.0 3.3 2.3 1.2 2.5 0.8 4.1 2.3 0.7 0.7 0.4 1.2 0.7 0.5 0.0 0.2 0.9 0.7 0.1 0.7 0.4 3.4 1.6 0.5 0.6 0.6 1.8 0.3 0.1 0.1 8.1 0.3 1.4 0.8 0.3 0.1 0.5 18.4 0.0 0.3 0.2 0.2 1.6 0.1 1.8 3.7 1.9 0.0 0.2 0.2 1.2 0.1 2.4 0.9 0.5 0.3 3.6 0.4 0.9 12.2 1.2 0.1 0.8 0.1 0.5 1.7 2.6 0.3 0.0 0.6 0.3 0.3 15.0 0.2 0.3 0.5 1.4 0.3 2.5 0.7 2.0 2.3 0.8 0.8 0.9 0.9 1.6 0.9 2.3 1.1 1.8 2.2 4.1 0.5 1.2 1.8 0.7 2.3 8.4 1.8 10.5 3.7 2.6 21.3 1.4 6.3 16.2 3.0 4.6 0.5 3.1 0.8 0.4 3.6 5.1 33.5 13.6 5.2 0.0 0.0 0.0 1.6 0.3 0.3 2.6 0.0 3.1 0.1 0.2 1.1 1.1 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 4.4 0.5 3.6 7.0 0.0 0.0 18.6 12.9 0.5 0.0 0.2 0.4 0.1 0.7 1.2 2.0 GJA10 CX62 ENSG00000135355 "Gap junction protein alpha 10" Q969M2 6 89894469-89921760 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 2.3" "Cell type enriched" "Detected in single" 148 "Horizontal cells: 17.5" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 2.8;NTERA-2: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA021145 Uncertain NA NA "HPA021145: AB_2670600" "unprognostic (1.09e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA3 "CX46, CZP3" ENSG00000121743 "Gap junction protein alpha 3" Q9Y6H8 13 20138255-20161049 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.1;parathyroid gland: 6.2" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 12.5" "Cancer enhanced" "Detected in some" "melanoma: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 5.6;CAPAN-2: 10.2;HL-60: 8.4;U-266/84: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA014821 Supported NA NA "HPA014821: AB_2669097" "unprognostic (2.32e-1)" "unprognostic (1.01e-1)" "unprognostic (4.37e-2)" "unprognostic (2.58e-3)" "unprognostic (2.98e-2)" "unprognostic (1.04e-2)" "unprognostic (6.87e-3)" "unprognostic (1.84e-1)" "unprognostic (1.73e-1)" "unprognostic (7.52e-2)" "unprognostic (7.70e-2)" "unprognostic (4.02e-2)" "unprognostic (9.65e-8)" "unprognostic (2.87e-1)" "unprognostic (1.91e-1)" "unprognostic (2.55e-2)" "unprognostic (8.04e-3)" 0.2 0.0 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.8 0.1 0.5 23.1 0.1 0.0 1.2 0.1 0.2 0.1 0.1 0.1 0.1 0.3 6.2 0.1 3.9 0.2 0.4 0.0 0.2 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.2 0.0 4.2 0.1 0.2 0.1 1.0 1.6 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 5.6 0.3 0.0 5.0 0.2 1.5 0.0 0.7 4.7 0.8 1.0 0.5 10.2 0.0 0.2 1.7 1.7 0.1 3.3 2.8 0.7 0.2 2.6 2.4 0.0 0.0 0.1 8.4 0.0 0.3 1.6 0.2 0.5 0.0 0.0 3.8 0.6 0.0 0.2 0.0 0.0 0.0 0.7 0.1 2.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 5.0 0.2 1.1 1.9 0.0 0.0 0.0 2.0 0.3 2.3 5.9 0.0 0.0 0.1 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 GJA5 CX40 ENSG00000265107 "Gap junction protein alpha 5" P36382 1 147756199-147773362 "Disease related genes, Predicted membrane proteins" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 60.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 113.4;Extravillous trophoblasts: 273.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 55.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013080, HPA071370" Enhanced NA NA "CAB013080: AB_2533263, HPA071370: " "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-2)" "unprognostic (2.94e-2)" "unprognostic (3.88e-2)" "unprognostic (8.95e-2)" "unprognostic (1.23e-3)" "unprognostic (5.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (7.57e-2)" "unprognostic (1.97e-2)" "unprognostic (2.44e-1)" "unprognostic (4.41e-2)" "unprognostic (3.43e-2)" "unprognostic (8.93e-2)" 8.8 0.2 0.6 1.5 1.1 0.0 2.1 0.7 0.7 2.1 2.2 0.8 2.8 0.6 1.2 1.6 1.2 2.6 1.7 15.1 0.9 7.0 0.2 9.3 0.3 0.9 0.0 2.2 0.7 0.8 0.0 60.6 1.2 1.6 0.9 2.0 0.2 3.1 1.7 0.0 1.4 2.5 0.9 1.9 0.0 1.3 0.3 0.0 2.1 0.4 0.5 2.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 0.0 0.0 0.0 2.3 1.8 0.9 0.9 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.1 0.0 3.8 1.5 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 55.6 0.0 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.0 6.2 0.5 0.0 0.0 0.0 9.4 0.0 1.4 0.0 3.5 0.0 113.4 0.0 0.0 6.1 2.1 0.0 0.0 0.0 273.7 2.1 0.0 0.0 0.0 13.6 0.0 0.0 30.1 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 4.7 1.4 0.4 0.3 26.0 0.0 0.0 0.0 GJA8 "CAE, CAE1, CX50, CZP1" ENSG00000121634 "Gap junction protein alpha 8" P48165 1 147907956-147909257 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 76 "testis: 18.0" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Early spermatids: 6.8;Late spermatids: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "RPTEC TERT1: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014715, HPA062940" Enhanced NA NA "HPA014715: AB_2732411, HPA062940: AB_2732693" "unprognostic (3.73e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 GJA9 "CX58, CX59, GJA10" ENSG00000131233 "Gap junction protein alpha 9" P57773 1 38874451-38881587 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.3" "Low region specificity" "Detected in all" HPA067850 Uncertain NA NA "HPA067850: AB_2685910" "unprognostic (2.00e-1)" "unprognostic (8.78e-2)" "unprognostic (4.55e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-2)" "unprognostic (1.20e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-1)" "unprognostic (2.75e-2)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (4.11e-3)" "unprognostic (2.32e-2)" 1.1 0.1 0.7 0.4 0.9 0.2 0.4 0.9 1.0 0.4 0.7 0.7 0.4 0.9 0.4 0.4 1.4 0.6 0.8 2.3 1.2 0.6 0.4 0.4 0.4 0.4 1.2 0.4 0.4 0.4 0.0 0.9 0.4 0.7 0.5 1.3 1.8 0.8 0.4 0.6 1.9 0.5 0.4 1.8 0.4 1.2 15.8 0.4 0.4 1.1 0.4 0.4 1.2 0.7 1.5 1.0 1.8 1.2 0.4 1.5 0.4 0.5 0.8 0.7 0.5 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.2 1.7 0.4 0.1 0.0 4.3 0.2 0.0 0.3 0.2 0.7 0.7 0.3 0.6 1.1 0.0 0.8 0.6 0.0 0.4 0.3 0.0 0.2 0.0 0.9 0.3 1.2 0.1 0.2 0.4 0.1 0.3 0.3 0.4 0.6 0.2 0.1 0.0 1.3 0.7 0.7 0.0 0.5 1.4 1.1 0.3 0.4 1.8 1.6 0.4 0.4 0.1 0.3 0.6 0.4 1.6 0.5 0.7 0.0 1.1 0.0 0.6 1.2 0.4 0.9 0.5 0.3 1.0 1.5 1.1 0.6 1.8 0.4 0.3 0.3 1.5 0.4 0.7 0.9 0.9 1.0 1.2 0.6 1.2 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJB1 "CMTX, CMTX1, CX32" ENSG00000169562 "Gap junction protein beta 1" P08034 X 71215194-71225516 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.4;liver: 114.4;pancreas: 37.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 112.1;Enterocytes: 72.8;Hepatocytes: 237.9" "Cancer enhanced" "Detected in many" "liver cancer: 163.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 46.8;SK-MEL-30: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012994 Uncertain NA NA "CAB012994: AB_2533228" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (8.78e-2)" "unprognostic (2.71e-3)" "unprognostic (2.70e-1)" "unprognostic (4.11e-1)" "unprognostic (2.92e-1)" "unprognostic (3.68e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (7.36e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.85e-6)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (4.97e-2)" 0.4 0.4 7.2 2.5 9.3 0.3 2.6 1.9 14.4 3.3 12.0 46.3 2.5 14.6 0.9 8.1 0.5 9.5 19.8 0.4 13.4 8.0 14.8 114.4 1.2 0.4 22.4 5.6 0.4 37.1 0.3 0.4 0.4 23.0 4.3 8.3 0.5 19.6 8.7 0.4 0.6 11.7 1.0 52.4 0.4 5.7 3.1 12.1 0.0 0.4 0.0 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 9.3 1.9 14.4 13.4 8.0 22.4 5.6 23.0 12.1 0.0 3.7 3.4 0.5 0.6 0.0 0.0 112.1 0.0 2.3 8.7 0.0 0.0 8.3 19.1 0.1 0.0 72.8 0.0 50.9 0.0 0.0 3.9 4.6 237.9 0.0 0.0 9.2 3.1 3.7 0.0 0.3 0.0 21.9 1.0 23.0 0.0 47.9 51.0 0.4 59.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 56.4 2.4 GJB2 "CX26, DFNA3, DFNB1, NSRD1" ENSG00000165474 "Gap junction protein beta 2" P29033 13 20187463-20193010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1" "Cancer enhanced" "Detected in all" "head and neck cancer: 447.5" "Region enhanced" "Detected in some" "pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013093, HPA014362" Uncertain Approved Mitochondria NA NA Mitochondria "CAB013093: AB_2533903, HPA014362: " "unprognostic (2.21e-1)" "unprognostic (1.25e-3)" "unprognostic (2.43e-2)" "unprognostic (6.14e-2)" "prognostic unfavorable (4.45e-4)" "unprognostic (9.77e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (6.25e-4)" "unprognostic (1.33e-1)" "unprognostic (3.69e-3)" "prognostic unfavorable (2.90e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (2.53e-6)" "unprognostic (5.78e-3)" "unprognostic (2.40e-1)" "unprognostic (1.17e-2)" "unprognostic (8.93e-3)" 0.2 0.0 0.2 1.5 0.3 0.5 0.7 1.0 0.5 52.8 3.9 0.4 0.4 2.4 4.2 0.6 128.1 0.1 2.7 0.1 0.5 0.1 3.5 9.1 0.1 0.0 1.3 0.7 0.1 0.1 0.0 0.5 0.2 4.5 0.3 3.4 0.3 19.7 0.2 0.2 10.3 1.9 0.4 3.7 0.0 1.5 0.2 0.2 3.2 0.2 129.0 71.1 2.3 64.9 0.0 0.0 0.4 0.6 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.4 43.7 0.0 0.2 0.0 0.3 8.7 1.6 4.3 0.0 3.6 0.5 0.0 0.0 0.1 0.0 0.0 1.5 0.7 32.6 0.5 6.0 0.0 0.0 0.6 0.0 3.2 0.0 0.4 0.3 0.0 0.1 22.7 4.3 0.0 0.0 2.4 0.0 50.8 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.1 0.0 0.0 0.0 0.7 6.5 2.6 2.7 0.0 5.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.5 0.5 0.1 1.3 0.7 4.5 0.2 3.0 0.0 0.8 8.0 62.0 0.0 0.4 5.1 0.0 3.4 1.8 0.0 0.0 0.0 3.5 0.7 0.2 19.0 0.0 8.8 0.2 1.6 7.8 0.0 24.2 0.7 0.0 4.1 0.0 0.8 0.9 0.0 1.2 1.7 8.2 3.9 0.0 8.1 15.0 0.0 14.7 0.0 0.0 2.0 0.2 0.4 25.1 0.1 0.0 19.7 15.6 GJB3 "CX31, DFNA2, EKV" ENSG00000188910 "Gap junction protein beta 3" O75712 1 34781189-34786369 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1" "Group enriched" "Detected in many" 7 "Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA074472 Supported "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA074472: AB_2686694" "unprognostic (1.34e-3)" "unprognostic (2.30e-1)" "unprognostic (2.84e-2)" "unprognostic (5.22e-3)" "unprognostic (3.82e-2)" "unprognostic (2.00e-2)" "unprognostic (1.21e-4)" "prognostic unfavorable (4.56e-4)" "unprognostic (2.30e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.50e-2)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-2)" "unprognostic (2.46e-2)" 0.1 0.1 1.0 2.4 0.4 0.0 3.4 1.4 1.2 6.3 2.2 0.0 0.6 0.0 0.7 3.0 40.1 0.5 4.1 0.1 0.2 0.1 0.5 0.8 0.6 0.4 0.1 0.1 0.2 0.2 0.0 0.1 11.3 0.0 3.7 2.8 0.0 3.7 0.9 0.2 49.3 0.6 0.2 0.1 0.1 3.2 0.5 0.0 0.7 0.2 32.1 25.0 4.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 3.6 0.0 0.0 30.4 0.0 26.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 42.7 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 16.3 6.8 0.0 0.0 0.0 12.7 10.0 0.0 0.0 4.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.4 1.2 0.2 0.1 0.1 0.1 0.0 0.0 3.0 0.0 0.0 49.4 123.0 0.0 0.3 2.5 1.4 2.3 5.2 0.0 0.0 0.0 15.7 0.0 0.1 3.1 0.0 6.3 0.1 3.1 16.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.9 0.0 70.6 7.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 149.2 0.1 0.0 16.1 169.4 GJB4 CX30.3 ENSG00000189433 "Gap junction protein beta 4" Q9NTQ9 1 34759741-34763724 "Disease related genes, Predicted membrane proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 11.1;skin 1: 26.2" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 91.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.7;HaCaT: 9.9;HBEC3-KT: 6.4;hTCEpi: 4.2;OE19: 3.7;RPTEC TERT1: 3.9;RT4: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055112, HPA073904" Enhanced Supported "Cell Junctions" NA NA "Cell Junctions" "HPA055112: AB_2682699, HPA073904: " "unprognostic (3.30e-2)" "prognostic favorable (5.48e-4)" "unprognostic (1.57e-1)" "unprognostic (2.70e-2)" "unprognostic (4.21e-2)" "unprognostic (2.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.18e-2)" "unprognostic (5.40e-2)" "unprognostic (3.65e-1)" "prognostic unfavorable (3.24e-5)" "unprognostic (3.73e-2)" "unprognostic (5.81e-3)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.52e-4)" "unprognostic (5.42e-2)" 0.1 0.1 0.1 1.2 0.1 0.0 1.5 0.1 0.1 1.7 0.3 0.0 2.9 0.0 0.1 11.1 2.9 0.1 8.3 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 3.4 0.0 2.0 0.2 0.0 0.8 2.0 0.1 26.2 0.3 1.2 0.1 0.1 0.2 0.7 0.0 0.1 0.1 1.6 2.4 3.2 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 6.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.0 0.0 0.1 9.9 0.0 6.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 3.9 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.7 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 91.2 GJB5 CX31.1 ENSG00000189280 "Gap junction protein beta 5" O95377 1 34755047-34758512 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0" "Group enriched" "Detected in some" 16 "Basal glandular cells: 21.6;Basal keratinocytes: 43.0;Suprabasal keratinocytes: 73.0;Urothelial cells: 70.5" "Group enriched" "Detected in many" 5 "cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.9;HaCaT: 31.8;HBEC3-KT: 14.2;hTCEpi: 52.7;hTERT-HME1: 8.4;RT4: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038146 Uncertain NA NA "HPA038146: AB_10697242" "unprognostic (2.62e-1)" "unprognostic (1.63e-1)" "unprognostic (3.48e-1)" "unprognostic (5.71e-2)" "unprognostic (8.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.89e-2)" "unprognostic (2.76e-2)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.30e-2)" "unprognostic (1.09e-3)" "unprognostic (2.36e-1)" "unprognostic (2.41e-3)" "unprognostic (5.59e-2)" "unprognostic (5.67e-3)" 0.0 0.1 0.7 0.0 0.5 0.1 2.6 0.6 2.3 7.5 0.1 0.0 0.5 0.0 0.1 2.1 39.0 0.4 3.3 0.1 0.8 0.1 0.1 0.1 0.3 0.0 0.2 0.5 0.1 0.6 0.0 0.4 7.0 0.2 3.0 0.1 0.0 5.6 2.1 0.2 37.7 0.1 0.3 0.1 0.0 0.1 0.8 0.0 0.6 0.6 28.0 26.1 3.4 11.7 0.0 0.0 0.0 0.8 0.0 0.1 0.8 9.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 31.8 0.0 14.2 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 52.7 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 17.7 0.0 0.0 1.2 0.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.8 0.7 0.5 0.6 2.3 0.8 0.1 0.2 0.5 0.2 0.0 0.0 0.6 0.0 21.6 43.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 73.0 0.3 0.0 0.0 70.5 GJB6 "CX30, DFNA3, ED2, EDH, HED" ENSG00000121742 "Gap junction protein beta 6" O95452 13 20221962-20232395 "Disease related genes, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 50.5;esophagus: 97.1;tongue: 43.6" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 10.9;Early spermatids: 3.4;Late spermatids: 4.4;Suprabasal keratinocytes: 3.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 145.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Lineage enhanced" "Detected in many" "T-cells: 5.7" "Cell line enriched" "Detected in some" 9 "RT4: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014846 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA014846: AB_1847135" "unprognostic (5.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "unprognostic (7.90e-2)" "unprognostic (2.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.83e-1)" "unprognostic (8.96e-2)" "unprognostic (9.64e-2)" "unprognostic (2.82e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-2)" "unprognostic (1.14e-11)" "unprognostic (8.99e-2)" "unprognostic (1.16e-1)" "unprognostic (6.35e-3)" "unprognostic (5.04e-2)" 1.2 1.0 15.3 1.1 17.0 50.5 3.3 9.0 15.9 16.9 1.0 1.9 0.0 1.0 1.6 1.1 97.1 1.2 1.8 1.0 16.3 7.9 1.0 1.0 1.1 1.4 11.1 11.3 1.0 1.0 1.0 0.7 1.0 9.2 1.1 1.1 0.0 8.7 1.0 1.0 18.7 1.0 1.0 3.7 1.1 1.2 1.7 6.0 7.9 4.1 43.6 15.7 6.3 30.9 1.4 0.0 1.2 0.0 0.0 5.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 1.4 2.7 1.5 1.2 0.0 0.0 0.0 5.7 0.6 15.3 17.0 9.0 15.9 16.3 7.9 11.1 11.3 9.2 6.0 0.0 0.0 0.0 1.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.3 0.0 0.0 0.0 2.0 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282978-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6" "Low region specificity" "Detected in many" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.0 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.0 0.7 0.1 1.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 5.8 0.0 0.1 1.8 6.7 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 1.2 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.6 1.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 29.4 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.0 0.2 4.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 6.1 0.0 0.2 0.1 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149852-228159826 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 34.3" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 11.8;Peritubular cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "EFO-21: 9.9;SCLC-21H: 5.2;TIME: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.4 1.9 4.6 1.2 10.0 0.5 2.0 2.2 14.8 2.8 2.6 34.3 0.0 0.6 4.5 2.0 1.7 4.8 1.4 1.6 9.3 5.3 0.6 0.5 3.1 1.2 27.2 5.6 3.4 0.9 2.9 0.6 1.2 18.3 2.1 0.8 0.0 1.5 4.0 1.5 2.4 1.2 3.8 32.6 1.9 1.2 1.0 15.7 0.0 0.9 0.0 0.7 1.3 1.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.5 1.4 0.7 1.9 1.4 0.4 0.6 0.8 0.9 1.2 0.2 9.9 2.6 0.8 1.0 0.3 0.3 0.3 0.4 1.6 0.3 2.5 2.2 2.5 0.0 0.0 0.4 0.2 0.8 0.5 1.2 0.2 1.7 1.1 0.3 0.4 0.6 1.9 0.6 0.6 0.0 2.0 0.4 0.3 0.1 0.8 0.0 5.2 3.0 0.4 0.1 0.3 0.1 0.1 0.3 4.6 1.4 3.8 4.5 1.6 0.3 0.6 0.2 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.6 10.0 2.2 10.4 9.3 5.3 27.2 5.6 18.3 15.7 0.0 1.1 0.0 1.2 3.1 1.5 1.4 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.4 0.0 1.2 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.6 0.0 2.3 0.0 1.7 0.0 0.0 0.3 0.7 0.0 3.9 0.0 0.6 0.0 1.7 0.0 0.0 1.5 0.0 0.0 0.1 0.9 GJC3 "CX30.2, GJE1" ENSG00000176402 "Gap junction protein gamma 3" Q8NFK1 7 99923269-99929620 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 9.1;pancreas: 12.1;salivary gland: 9.0" "Cell type enhanced" "Detected in many" 11 "Exocrine glandular cells: 20.9;Glandular cells: 18.1;Pancreatic endocrine cells: 8.3;Proximal tubular cells: 8.2;Urothelial cells: 9.7" "Group enriched" "Detected in many" 5 "breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.5;T-reg: 2.1" "Lineage enriched" "Detected in single" 22 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "OE19: 3.3;SK-MEL-30: 5.7;U-2197: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015024 Uncertain NA NA "HPA015024: AB_1847132" "unprognostic (9.31e-2)" "unprognostic (6.43e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-2)" "unprognostic (2.54e-1)" "unprognostic (2.88e-2)" "unprognostic (7.68e-2)" "unprognostic (9.14e-2)" "unprognostic (6.71e-2)" "unprognostic (4.78e-2)" "unprognostic (1.20e-1)" "unprognostic (3.88e-3)" "unprognostic (1.14e-1)" "unprognostic (4.17e-1)" "unprognostic (3.49e-1)" "unprognostic (5.81e-3)" 1.0 0.5 0.1 0.0 0.3 0.0 9.1 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 1.1 2.8 0.1 0.1 0.6 0.3 12.1 0.0 0.1 1.2 4.3 0.0 9.0 0.0 0.0 2.0 0.0 0.1 0.7 0.0 0.8 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.6 0.8 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.4 1.2 2.6 0.0 0.0 1.0 0.5 0.5 0.0 0.0 0.2 0.3 0.9 0.2 2.3 0.0 0.4 0.3 0.4 0.0 0.1 0.6 0.2 1.1 1.8 1.4 1.7 0.3 1.3 0.5 1.2 3.0 3.3 0.2 0.0 1.2 0.8 0.0 1.1 0.5 0.6 0.3 1.0 5.7 1.5 1.8 0.2 0.8 0.2 1.0 4.8 0.3 0.4 1.4 0.1 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 2.1 0.4 3.0 3.0 0.0 4.8 0.2 0.0 0.0 2.5 0.0 1.2 1.8 0.0 0.0 1.7 0.3 0.2 0.6 0.0 0.0 20.9 0.0 0.0 18.1 4.6 3.9 0.1 0.0 1.2 0.0 0.0 0.5 0.3 0.0 0.0 1.0 0.0 3.7 8.3 0.0 0.0 8.2 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 9.7 GJD2 "CX36, GJA9" ENSG00000159248 "Gap junction protein delta 2" Q9UKL4 15 34751032-34754965 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 13.8;pancreas: 8.7;pituitary gland: 23.9;retina: 9.1" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 11.5;Cone photoreceptor cells: 37.3;Horizontal cells: 6.4;Rod photoreceptor cells: 12.7" "Cancer enriched" "Detected in single" 32 "pancreatic cancer: 4.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SuSa: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.30e-2)" "unprognostic (2.87e-2)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" 0.3 13.8 1.3 0.3 2.1 0.3 0.2 1.4 4.5 0.4 0.3 0.1 0.0 0.2 0.4 0.2 0.2 0.2 0.3 7.0 1.1 1.6 0.9 0.2 0.3 0.2 0.8 2.8 0.2 8.7 0.2 23.9 0.3 3.4 0.2 0.3 9.1 0.2 0.2 0.3 0.3 0.3 0.3 0.2 0.3 0.4 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.5 0.6 2.1 1.1 1.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 7.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.4 0.8 0.5 0.6 0.7 0.5 0.5 0.3 0.5 0.5 0.6 0.6 2.1 1.0 1.1 0.6 0.5 0.4 1.3 2.1 1.4 4.5 1.1 1.6 0.8 2.8 3.4 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.7 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJD3 "Cx30.2, CX31.9, GJA11, GJC1" ENSG00000183153 "Gap junction protein delta 3" Q8N144 17 40362931-40363815 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Cell type enriched" "Detected in single" 8 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 13.3;HaCaT: 11.8;HEK 293: 9.8;MCF7: 10.0;T-47d: 9.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.54e-4)" "unprognostic (4.53e-2)" "unprognostic (1.69e-2)" "unprognostic (6.07e-3)" "unprognostic (5.84e-2)" "unprognostic (8.01e-3)" "unprognostic (3.75e-3)" "unprognostic (7.89e-2)" "unprognostic (5.35e-2)" "unprognostic (2.23e-1)" "unprognostic (8.43e-3)" "unprognostic (9.91e-3)" "unprognostic (1.01e-3)" "unprognostic (1.90e-1)" "unprognostic (1.73e-4)" 1.9 0.6 0.1 1.2 0.2 0.0 0.8 0.1 0.2 1.1 3.4 1.8 1.3 0.0 2.1 0.5 0.0 0.7 0.1 0.3 1.6 1.0 1.8 0.3 0.1 0.2 0.8 0.0 0.4 0.3 1.7 0.0 1.3 1.1 2.0 2.7 2.2 0.0 0.0 7.2 4.0 0.4 1.7 0.0 2.2 1.1 0.0 0.0 0.0 0.1 1.4 0.1 0.0 3.6 7.7 0.1 1.5 0.0 0.0 13.3 4.0 0.0 0.1 0.1 0.3 1.0 0.0 3.8 0.0 0.0 11.8 0.0 0.0 0.0 4.3 9.8 0.7 0.8 6.2 3.3 1.7 5.5 0.2 0.0 0.0 0.0 0.3 0.0 1.1 7.5 0.0 0.0 10.0 0.8 3.3 0.9 0.2 2.7 5.0 0.0 0.3 0.0 7.5 0.5 3.4 5.1 0.0 1.6 0.0 9.9 2.6 3.9 0.0 0.1 2.9 0.0 1.5 0.0 1.5 0.7 0.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJD4 "CX40.1, FLJ90023" ENSG00000177291 "Gap junction protein delta 4" Q96KN9 10 35605410-35608935 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.4;brain: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 5.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "RH-30: 5.9" "Not detected" "Not detected" HPA038266 Uncertain NA NA "HPA038266: AB_10672741" "unprognostic (2.05e-1)" "unprognostic (2.58e-1)" "unprognostic (5.74e-6)" "unprognostic (2.00e-1)" "unprognostic (8.96e-2)" "unprognostic (3.92e-2)" "unprognostic (8.49e-2)" "unprognostic (7.70e-2)" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (1.19e-10)" "unprognostic (3.06e-1)" "unprognostic (1.43e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-1)" 0.2 0.2 0.7 0.2 1.0 2.5 0.2 0.2 3.5 0.5 0.2 0.2 0.2 1.0 0.7 0.2 0.3 0.2 1.3 0.3 0.6 1.3 0.2 0.3 0.2 0.4 0.8 0.2 0.2 0.4 0.3 0.5 0.4 0.2 0.3 0.3 0.2 0.8 0.2 1.5 2.6 0.8 0.2 0.3 0.4 0.8 0.9 0.2 0.2 0.9 0.2 0.2 0.4 0.2 0.7 0.9 5.4 0.6 0.6 0.8 0.2 0.9 0.9 0.5 1.5 0.2 0.0 1.4 0.2 0.0 0.0 0.3 0.7 1.4 1.0 0.6 0.1 0.6 1.5 0.1 0.3 0.3 1.1 0.8 0.9 0.4 0.6 0.0 0.2 0.9 0.3 0.3 0.4 0.1 1.2 0.2 0.9 1.8 2.0 0.2 1.3 1.4 1.0 0.9 0.6 2.4 0.8 5.9 0.4 0.1 1.6 1.2 0.8 0.8 0.6 1.3 0.7 1.0 1.4 1.4 1.1 2.0 0.8 0.6 1.0 0.6 0.3 0.9 0.8 1.0 1.8 0.6 0.7 0.5 0.2 0.4 0.6 0.5 0.4 0.4 0.7 0.8 0.7 5.4 0.6 0.2 0.9 0.2 0.2 0.7 1.0 0.2 3.3 0.6 1.3 0.8 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 GK "GK1, GKD" ENSG00000198814 "Glycerol kinase" P32189 X 30653359-30731456 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 80.4;Macrophages: 98.4;Proximal tubular cells: 143.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 51.4" "Lineage enriched" "Detected in all" 8 "granulocytes: 51.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.5;Hep G2: 27.3" HPA060687 Supported NA NA "HPA060687: AB_2684343" "unprognostic (8.78e-3)" "unprognostic (8.41e-3)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (5.52e-2)" "unprognostic (1.42e-2)" "unprognostic (3.85e-1)" "unprognostic (8.56e-3)" "unprognostic (1.30e-2)" "unprognostic (1.58e-2)" "prognostic favorable (3.24e-9)" "unprognostic (1.59e-1)" "unprognostic (9.35e-2)" "unprognostic (4.57e-3)" "unprognostic (4.11e-3)" 2.8 4.9 2.4 17.0 7.6 1.6 1.8 2.5 4.7 3.0 7.5 2.7 1.5 28.4 2.5 4.0 4.9 2.7 7.9 4.9 4.6 2.6 35.4 40.7 11.7 8.1 3.8 2.5 2.0 1.9 3.2 5.3 2.3 4.1 1.9 3.4 2.9 6.6 0.6 1.4 3.1 37.9 1.9 6.0 6.4 2.0 2.0 2.2 5.4 2.2 3.8 4.5 4.3 1.7 1.7 4.0 51.4 6.6 1.2 3.2 1.6 2.6 2.1 2.7 4.8 1.7 6.6 1.1 6.4 22.5 4.7 5.3 3.4 2.4 7.5 1.0 2.4 4.2 0.1 5.1 2.1 6.2 4.8 5.7 4.4 4.2 27.3 10.8 8.2 9.6 4.0 3.2 14.8 14.0 1.2 3.6 5.9 2.3 10.7 1.2 3.8 6.3 8.8 4.6 2.9 2.4 8.8 4.3 7.7 3.5 8.8 2.9 3.7 5.6 5.7 12.5 2.9 6.5 5.9 1.4 3.4 1.4 0.1 2.9 5.6 6.0 7.3 5.9 5.4 3.4 1.3 6.6 2.2 0.5 2.0 0.4 0.8 0.9 0.6 4.0 1.7 0.5 0.6 51.4 1.2 2.4 1.2 3.2 1.6 2.4 7.6 2.5 4.7 4.6 2.6 3.8 2.5 4.1 2.2 14.9 24.3 9.1 8.9 6.2 4.1 3.9 10.2 56.2 20.5 7.0 15.7 1.0 29.9 19.8 39.8 3.6 80.4 0.0 9.5 1.0 3.8 12.9 13.9 33.1 30.8 4.8 11.6 4.3 33.0 23.1 1.1 98.4 13.5 44.1 11.5 36.9 13.5 17.5 2.1 143.3 17.9 0.0 4.7 9.9 1.5 14.8 0.7 17.3 7.8 22.6 GK2 "GKP2, GKTA" ENSG00000196475 "Glycerol kinase 2" Q14410 4 79406352-79408293 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 61.0" "Group enriched" "Detected in some" 6 "Early spermatids: 439.5;Late spermatids: 112.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "SCLC-21H: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060687 Uncertain NA NA "HPA060687: AB_2684343" "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 439.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 44.6 2.7 0.0 0.0 0.0 0.0 0.0 GK3P "GKP3, GKTB" ENSG00000229894 "Glycerol kinase 3 pseudogene" Q14409 4 165277812-165279679 "Enzymes, Predicted membrane proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.0" "Cell type enriched" "Detected in single" 17 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 2.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.9" "Cell line enhanced" "Detected in single" "TIME: 1.1" HPA060687 Uncertain NA NA "HPA060687: AB_2684343" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (3.01e-2)" "unprognostic (1.17e-2)" "unprognostic (2.11e-2)" "unprognostic (3.94e-1)" "unprognostic (1.61e-1)" "unprognostic (2.04e-1)" "unprognostic (6.19e-2)" "unprognostic (6.99e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (4.56e-1)" "unprognostic (3.34e-4)" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 2.9 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GKAP1 "FKSG21, GKAP42" ENSG00000165113 "G kinase anchoring protein 1" Q5VSY0 9 83739421-83829516 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 98.8" "Group enriched" "Detected in many" 5 "Early spermatids: 991.0;Late spermatids: 314.1;Spermatocytes: 374.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035117, HPA035118, HPA066173" Enhanced Supported Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA035117: AB_2674473, HPA035118: AB_10671100, HPA066173: AB_2732740" "unprognostic (1.91e-1)" "unprognostic (2.94e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (9.62e-2)" "unprognostic (2.50e-1)" "unprognostic (2.52e-3)" "unprognostic (7.66e-3)" "unprognostic (3.04e-1)" "unprognostic (1.86e-2)" "prognostic favorable (6.96e-5)" "unprognostic (4.18e-1)" "prognostic favorable (1.05e-6)" "unprognostic (9.73e-2)" "unprognostic (1.38e-2)" "unprognostic (2.06e-1)" "unprognostic (6.24e-3)" 4.4 4.2 6.0 2.8 6.1 2.5 9.2 15.6 6.1 4.7 5.0 4.1 6.6 3.0 5.5 4.5 3.2 3.9 3.4 9.0 6.1 6.8 4.2 5.1 2.9 2.6 6.5 3.1 7.0 5.2 6.2 7.9 2.0 6.1 6.6 2.7 3.2 4.2 5.9 25.0 1.7 3.0 8.1 8.0 2.4 3.5 98.8 7.2 8.4 8.1 5.2 2.7 6.0 14.7 1.9 0.6 3.0 0.8 5.3 1.9 0.1 4.8 6.0 4.4 5.8 0.6 0.0 6.3 1.9 1.5 3.0 3.1 0.8 2.7 7.5 1.9 0.8 10.1 1.0 4.4 0.5 5.2 9.0 3.9 4.3 3.0 4.3 6.5 2.0 0.4 0.2 3.5 1.5 1.6 8.8 2.7 7.3 3.5 6.3 0.9 4.6 10.5 6.9 3.6 2.3 3.1 7.5 9.9 2.6 3.1 0.8 14.8 8.8 4.3 2.0 3.4 7.1 0.8 4.1 0.9 1.0 7.1 0.7 3.3 10.4 22.7 3.0 2.2 1.4 1.2 3.0 0.8 0.6 1.4 0.0 1.3 1.7 1.3 1.5 0.6 1.9 1.0 1.9 2.5 5.3 0.3 0.3 1.5 0.1 6.0 6.1 15.6 6.1 6.1 6.8 6.5 3.1 6.1 7.2 6.0 9.1 10.2 16.1 6.3 45.6 47.4 12.7 6.7 2.3 14.0 43.2 7.1 11.6 8.8 991.0 11.7 6.2 23.3 5.8 2.3 4.7 20.1 2.3 18.8 3.5 114.4 12.6 10.4 3.2 314.1 24.5 5.2 10.1 1.0 12.0 43.9 6.4 6.8 20.1 11.6 73.0 25.8 8.4 374.4 52.7 4.0 2.4 12.1 10.8 8.1 GKN1 "AMP18, BRICD1, CA11" ENSG00000169605 "Gastrokine 1" Q9NS71 2 68974573-68980974 "Plasma proteins, Predicted secreted proteins" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "stomach 1: 918.9" "Cell type enriched" "Detected in some" 61 "Pancreatic endocrine cells: 201.5" "Cancer enriched" "Detected in some" 116 "stomach cancer: 255.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.2;HMC-1: 14.2;MOLT-4: 9.9;NTERA-2: 13.5;REH: 5.8;U-2 OS: 8.8;U-266/70: 8.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA047684 Enhanced "Secreted to digestive system" NA NA 26000000 "HPA047684: AB_2680120" "unprognostic (5.40e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.54e-1)" "prognostic favorable (4.53e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.4 0.0 2.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 918.9 0.0 0.0 1.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 0.0 13.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 8.8 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 201.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GKN2 "blottin, BRICD1B, GDDR, PRO813, TFIZ1, VLTI465" ENSG00000183607 "Gastrokine 2" Q86XP6 2 68945232-68952970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "stomach 1: 311.1" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 107.2;Alveolar cells type 2: 78.7;Club cells: 30.7;Pancreatic endocrine cells: 70.5" "Cancer enriched" "Detected in some" 8 "stomach cancer: 43.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "A549: 3.7;HaCaT: 2.0;HMC-1: 3.7;MOLT-4: 2.8;NTERA-2: 4.2;PC-3: 7.9;U-2 OS: 3.1;U-266/70: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA057765 Enhanced "Secreted to digestive system" NA NA "HPA057765: AB_2683520" "unprognostic (1.81e-1)" "unprognostic (1.44e-4)" "unprognostic (2.22e-1)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 2.1 0.1 0.0 0.1 0.1 0.2 0.0 1.4 0.1 0.1 0.0 0.1 0.1 38.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 311.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 4.2 0.0 7.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.1 0.3 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 107.2 78.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.2 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 70.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GLB1L MGC10771 ENSG00000163521 "Galactosidase beta 1 like" Q6UWU2 2 219236606-219245478 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.0" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043058 Enhanced "Secreted - unknown location" NA NA "HPA043058: AB_10806375" "unprognostic (4.30e-2)" "unprognostic (6.93e-2)" "unprognostic (2.68e-2)" "unprognostic (2.08e-3)" "unprognostic (4.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.67e-3)" "unprognostic (3.32e-2)" "unprognostic (4.77e-1)" "unprognostic (2.39e-1)" "unprognostic (8.48e-3)" "unprognostic (3.27e-1)" "unprognostic (3.62e-1)" "unprognostic (1.28e-1)" "unprognostic (9.23e-3)" "unprognostic (1.33e-1)" "unprognostic (8.50e-2)" 6.9 5.4 2.7 2.0 3.7 2.3 5.6 1.6 3.3 4.0 5.8 4.6 4.5 1.6 5.3 7.9 2.5 14.3 8.6 3.4 3.1 3.5 18.5 3.5 4.1 2.5 2.1 2.1 6.1 3.1 11.7 6.7 7.4 5.6 4.5 2.0 13.2 5.8 3.0 1.4 2.5 4.4 3.4 2.3 3.9 2.1 57.0 1.4 3.1 5.0 1.4 2.4 4.0 2.0 1.7 2.8 3.2 8.9 1.4 1.8 2.2 2.4 4.3 6.7 5.4 7.4 9.1 3.4 4.1 8.7 5.2 4.9 1.6 6.9 0.8 3.7 3.6 3.9 1.3 1.9 4.0 4.1 2.2 3.3 2.5 6.2 3.9 18.3 0.9 4.0 10.8 2.5 4.9 3.0 12.3 4.6 3.8 1.5 4.8 4.8 3.5 2.1 2.5 1.1 0.9 1.2 2.2 3.7 3.4 10.5 1.4 4.3 3.9 3.4 4.8 4.0 4.7 7.5 2.2 3.6 4.4 5.3 2.5 2.2 4.6 1.3 1.3 8.1 1.1 11.0 2.0 7.0 0.5 1.1 8.9 0.6 0.6 0.9 1.1 2.8 1.7 1.8 1.3 3.2 1.4 6.7 1.2 0.3 2.2 2.7 3.7 1.6 3.3 3.1 3.5 2.1 2.1 5.6 1.4 3.0 3.2 0.8 2.5 1.5 4.8 1.7 2.5 24.1 7.9 3.5 11.8 2.9 3.3 3.1 21.1 2.5 2.1 0.0 1.6 1.5 4.4 2.7 0.0 1.0 11.7 3.2 4.7 9.8 6.1 17.2 10.0 4.5 8.5 1.0 2.8 3.5 1.7 2.3 6.0 15.3 9.5 6.5 1.2 80.3 5.4 1.5 1.1 2.1 1.7 1.6 GLB1L2 ENSG00000149328 "Galactosidase beta 1 like 2" Q8IW92 11 134331874-134378341 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 36.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 158.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 11.2" "Cell type enhanced" "Detected in many" "gdT-cell: 5.8;NK-cell: 5.8" "Group enriched" "Detected in many" 23 "NK-cells: 5.8;T-cells: 5.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA054808, HPA059955" Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA Nucleoplasm Vesicles "HPA054808: AB_2682608, HPA059955: AB_2684178" "unprognostic (2.63e-2)" "unprognostic (9.77e-3)" "unprognostic (2.32e-2)" "unprognostic (2.20e-2)" "unprognostic (8.07e-2)" "unprognostic (1.54e-1)" "unprognostic (5.98e-2)" "unprognostic (2.08e-2)" "unprognostic (1.51e-1)" "unprognostic (8.31e-2)" "unprognostic (1.67e-1)" "unprognostic (1.48e-1)" "unprognostic (4.73e-2)" "unprognostic (1.22e-2)" "unprognostic (2.64e-1)" "unprognostic (3.88e-3)" "unprognostic (1.01e-1)" 0.8 1.2 1.6 4.4 4.2 0.1 4.5 0.3 2.5 6.0 13.5 4.5 8.7 3.6 20.5 6.6 3.0 17.1 15.7 0.8 2.2 2.7 13.8 0.3 4.1 1.3 0.9 1.4 9.5 6.5 22.7 8.6 5.4 11.2 23.5 7.8 36.2 5.2 17.4 0.8 5.9 2.7 5.6 0.7 0.2 5.7 7.0 0.3 1.4 15.0 5.2 2.6 5.1 2.9 0.2 0.0 0.0 0.0 5.8 5.8 0.8 6.0 0.6 3.3 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 5.1 19.6 0.0 6.5 0.0 2.7 20.7 9.9 0.1 0.0 0.0 9.4 0.0 2.6 0.2 0.9 0.0 11.4 0.1 0.3 0.0 0.0 0.0 0.0 3.0 9.9 0.0 0.0 5.8 1.6 1.1 1.8 47.6 7.2 0.0 0.0 0.5 5.6 4.3 14.0 5.2 4.4 5.6 0.0 0.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 5.8 0.0 2.3 0.0 1.3 2.3 0.0 0.2 1.6 2.6 0.0 5.8 0.0 0.0 0.0 0.8 1.6 4.2 0.3 2.5 2.2 2.7 0.9 1.4 11.2 0.3 0.0 2.6 0.0 4.2 1.9 6.1 1.0 2.5 8.1 3.4 0.0 39.3 0.2 0.0 2.0 1.7 0.6 9.7 0.0 2.1 0.9 1.5 7.6 0.0 0.0 0.2 4.8 8.6 0.0 0.0 4.9 1.1 0.0 5.0 0.0 5.8 8.1 1.7 8.2 0.7 8.1 158.9 0.0 1.9 2.3 4.2 0.6 0.1 1.3 10.7 2.6 GLB1L3 FLJ90231 ENSG00000166105 "Galactosidase beta 1 like 3" Q8NCI6 11 134274245-134319564 "Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 18.5;seminal vesicle: 10.8" "Group enriched" "Detected in some" 4 "Early spermatids: 2.2;Extravillous trophoblasts: 3.0;Spermatocytes: 3.9;Spermatogonia: 7.5" "Cancer enhanced" "Detected in some" "prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "gdT-cell: 2.3;memory CD4 T-cell: 5.7;memory CD8 T-cell: 3.5;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6;T-reg: 2.4" "Lineage enriched" "Detected in single" 57 "T-cells: 5.7" "Cell line enhanced" "Detected in some" "HEK 293: 6.8;JURKAT: 14.3;NTERA-2: 4.2;PC-3: 5.6;SCLC-21H: 8.9" "Not detected" "Not detected" HPA039916 Uncertain NA NA "HPA039916: AB_2676746" "unprognostic (1.64e-3)" "unprognostic (7.80e-3)" "unprognostic (5.12e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.55e-2)" "unprognostic (8.69e-3)" "prognostic favorable (1.97e-4)" "unprognostic (6.58e-3)" "unprognostic (3.81e-1)" "unprognostic (6.95e-3)" "unprognostic (9.73e-2)" "unprognostic (1.52e-5)" "unprognostic (1.39e-1)" "unprognostic (6.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.07e-1)" 0.5 2.7 4.0 1.2 19.1 0.6 1.2 10.3 14.4 0.8 1.2 0.0 0.0 0.5 3.8 0.4 0.5 0.4 0.5 0.4 2.7 2.6 1.3 0.4 0.5 2.1 1.4 6.1 0.4 0.6 0.4 1.1 0.5 5.8 18.5 0.5 1.0 3.4 10.8 0.5 5.4 0.5 0.5 0.6 0.6 0.6 2.4 1.4 0.0 3.4 0.0 0.8 0.9 1.2 0.0 0.0 0.0 0.0 0.0 5.7 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.1 0.3 0.0 2.4 6.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 2.5 0.0 4.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 8.9 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 5.7 3.5 0.0 0.0 4.8 3.6 0.0 0.0 0.0 0.0 2.4 1.0 4.0 19.1 10.3 14.4 2.7 2.6 1.4 6.1 5.8 1.4 0.0 0.0 0.0 0.0 0.5 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 3.0 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.6 0.0 0.0 3.9 7.5 0.1 1.0 0.0 0.0 0.0 GLCCI1 "FAM117C, GIG18, TSSN1" ENSG00000106415 "Glucocorticoid induced 1" Q86VQ1 7 7968794-8094272 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.7" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 77.4;Bipolar cells: 61.8;Early spermatids: 62.5;Spermatocytes: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7;U-266/70: 41.2;U-698: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001674, HPA005987" Approved Approved Nucleoli NA NA Nucleoli "HPA001674: AB_1078971, HPA005987: AB_1078970" "unprognostic (6.12e-2)" "unprognostic (7.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.45e-1)" "unprognostic (6.17e-3)" "unprognostic (1.02e-2)" "unprognostic (4.40e-1)" "unprognostic (1.68e-3)" "unprognostic (3.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.17e-3)" "unprognostic (3.35e-1)" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.56e-1)" "unprognostic (3.09e-1)" "unprognostic (9.20e-3)" 4.6 4.3 5.6 19.1 12.5 7.6 4.1 26.6 8.0 5.4 4.9 3.4 0.9 5.7 3.4 1.8 3.0 2.8 3.9 2.2 3.7 4.1 3.9 3.8 18.4 13.8 3.1 5.6 5.1 2.3 8.0 6.5 9.3 4.4 3.2 4.7 3.1 6.3 2.0 3.0 7.5 5.6 2.5 3.2 9.2 6.4 14.2 3.7 55.7 20.7 1.9 15.9 7.7 3.3 3.1 2.4 3.7 0.4 4.7 4.5 0.7 2.3 0.3 3.9 0.9 1.2 1.7 0.8 2.0 2.8 1.2 1.1 1.2 0.8 6.5 0.5 1.6 2.0 0.4 3.6 1.1 1.6 3.2 2.8 1.9 5.0 0.8 2.0 3.0 2.8 0.8 1.3 0.8 2.7 2.0 1.0 2.4 7.0 17.7 2.1 1.3 1.4 3.0 9.8 1.0 2.4 6.9 3.0 3.4 1.1 2.7 6.5 12.8 3.1 3.9 0.2 11.1 4.6 7.9 0.9 2.2 1.0 1.9 1.0 41.2 13.1 18.6 2.3 3.2 1.6 3.7 0.1 1.5 2.7 0.4 2.5 1.8 2.8 2.0 0.1 3.1 1.6 1.8 1.2 4.7 0.1 2.4 4.5 0.7 5.6 12.5 26.6 8.0 3.7 4.1 3.1 5.6 4.4 3.7 77.4 34.3 13.7 7.2 9.2 61.8 5.7 0.0 5.3 31.8 7.0 41.2 10.4 1.7 0.7 62.5 3.8 2.4 0.0 1.4 7.5 6.9 15.8 5.7 5.9 10.7 7.9 18.6 6.7 3.5 12.3 7.5 5.2 8.5 0.0 6.2 14.3 2.4 3.5 10.6 1.5 20.5 6.5 6.4 66.0 37.4 11.4 24.0 18.7 3.9 8.0 GLCE "HSEPI, KIAA0836" ENSG00000138604 "Glucuronic acid epimerase" O94923 15 69160584-69272217 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 58.4" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040481, HPA048216" Uncertain Approved Mitochondria "Intracellular and membrane" NA NA 78000 Mitochondria "HPA040481: AB_2677004, HPA048216: AB_2680317" "unprognostic (1.30e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" "unprognostic (7.77e-2)" "unprognostic (1.58e-1)" "unprognostic (5.55e-3)" "unprognostic (1.00e-1)" "unprognostic (2.84e-1)" "unprognostic (1.48e-1)" "unprognostic (2.56e-1)" "unprognostic (7.47e-2)" "unprognostic (1.41e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (6.00e-2)" "unprognostic (5.23e-1)" "unprognostic (4.07e-2)" 8.3 12.2 6.5 4.9 14.2 0.6 8.8 58.4 12.1 8.4 12.1 12.4 7.8 13.5 6.3 6.9 10.2 5.9 7.2 5.5 5.8 8.5 13.3 16.0 8.4 5.3 9.4 8.1 12.9 5.9 9.0 12.0 12.6 14.4 5.7 14.0 10.8 11.7 8.9 4.1 9.8 11.2 6.8 10.2 4.0 8.8 6.1 7.6 5.4 4.1 8.4 5.8 6.3 5.6 0.6 4.0 0.1 4.4 0.5 4.0 1.9 3.9 3.5 2.4 4.2 8.2 7.8 0.8 7.4 9.9 5.8 11.0 2.9 10.0 2.4 3.7 6.0 7.3 6.0 5.2 4.8 11.8 0.9 5.7 4.0 6.7 3.0 7.9 1.7 8.2 5.3 3.3 7.1 8.1 4.2 50.9 1.8 1.6 2.6 10.8 2.4 1.0 3.0 1.2 4.0 2.5 2.4 9.8 3.0 5.3 4.2 7.7 1.6 7.6 4.7 15.7 1.7 3.4 2.4 17.7 5.6 6.9 6.1 6.5 1.1 1.5 0.5 5.6 2.9 8.0 0.0 4.4 0.1 0.7 3.4 1.2 0.6 1.8 0.8 3.6 0.5 1.2 1.5 0.1 0.5 4.4 4.0 4.0 1.9 6.5 14.2 58.4 12.1 5.8 8.5 9.4 8.1 14.4 7.6 0.0 12.5 5.7 9.1 4.2 10.3 6.2 7.6 25.4 5.7 10.4 9.8 20.3 5.0 10.4 3.2 13.9 15.7 0.0 12.1 9.9 5.9 4.9 2.3 24.6 13.5 7.9 19.5 16.5 14.6 3.3 5.8 7.7 8.5 11.8 26.4 12.9 12.9 23.4 16.6 14.0 15.4 12.9 3.9 13.0 13.4 5.6 27.6 4.4 26.5 12.1 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.6 7.2 0.0 0.1 66.8 0.0 0.0 0.0 0.0 15.9 0.1 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.3 3.8 0.0 0.0 10.6 0.0 0.0 14.5 0.0 0.0 0.5 0.0 0.2 2.7 1.2 0.0 0.1 0.3 0.3 0.2 0.0 7.8 1.2 1.2 0.3 0.0 0.1 27.7 0.3 6.4 3.3 0.0 6.2 0.0 4.1 1.4 0.0 0.9 0.1 0.2 0.8 0.3 0.3 9.2 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 0.0 0.0 4.3 0.0 0.0 0.3 0.6 7.6 0.0 0.0 29.6 0.0 59.4 5.0 0.0 8.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.0 126.2 6.1 0.0 0.0 3.1 2.1 9.0 0.3 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 29.3 0.2 0.0 0.3 4.4 5.0 0.0 38.4 0.5 0.0 0.0 GLDN "CLOM, COLM, colmedin, CRG-L2, UNC-112" ENSG00000186417 Gliomedin Q6ZMI3 15 51341629-51408013 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.3" "Group enriched" "Detected in many" 4 "Paneth cells: 30.0;Syncytiotrophoblasts: 84.0" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 5.7;SuSa: 3.9;U-266/70: 6.8;U-266/84: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059441 Uncertain "Secreted to extracellular matrix" NA NA 190000 "HPA059441: AB_2684018" "unprognostic (5.04e-2)" "unprognostic (2.57e-2)" "unprognostic (5.15e-5)" "unprognostic (3.21e-3)" "unprognostic (2.82e-2)" "unprognostic (2.33e-1)" "unprognostic (2.07e-4)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (3.30e-2)" "unprognostic (3.15e-1)" "unprognostic (2.14e-2)" "unprognostic (9.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (3.80e-3)" "unprognostic (1.37e-1)" 16.6 3.3 8.1 2.9 22.8 1.5 5.2 1.8 22.7 2.3 5.7 42.8 0.0 0.9 0.9 1.4 1.2 1.5 5.5 7.7 14.2 8.3 0.9 0.7 10.4 0.7 43.3 10.1 0.7 1.1 1.1 0.6 16.0 20.1 1.6 10.3 1.3 1.1 1.6 1.0 4.5 1.0 1.4 26.8 2.6 3.8 0.7 25.4 0.0 0.8 0.8 0.8 2.4 1.0 0.1 1.9 1.0 0.8 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.3 0.1 1.4 0.0 0.0 0.1 0.6 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 5.7 0.0 0.1 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.6 0.3 0.0 0.2 1.0 1.7 0.1 0.0 0.0 0.0 2.2 0.4 0.1 0.0 2.1 0.0 3.9 0.0 1.1 0.0 0.0 0.0 0.3 0.0 6.8 5.5 0.0 0.8 0.0 0.0 1.0 0.2 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.4 0.1 0.8 1.9 0.1 0.0 8.1 22.8 1.8 12.4 14.2 8.3 43.3 10.1 20.1 25.4 0.0 1.6 0.0 0.0 5.6 1.2 3.0 0.0 1.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.5 2.3 0.1 0.0 0.0 5.1 0.0 1.2 0.0 13.7 0.0 0.3 8.1 3.3 0.0 1.6 0.3 0.1 30.0 0.0 0.0 0.8 0.0 4.4 0.0 0.0 3.4 84.0 0.0 3.1 0.5 GLI2 "HPE9, THP1, THP2" ENSG00000074047 "GLI family zinc finger 2" P10070 2 120735623-120992653 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 23.3" "Group enriched" "Detected in some" 4 "Leydig cells: 23.3;Peritubular cells: 29.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 19.6;NTERA-2: 11.9;U-2 OS: 20.3;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB008558, HPA074275" Approved Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "CAB008558: AB_2111910, HPA074275: AB_2686677" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (9.83e-3)" "unprognostic (4.63e-2)" "unprognostic (2.04e-1)" "unprognostic (9.43e-2)" "unprognostic (1.65e-2)" "unprognostic (2.19e-3)" "unprognostic (2.58e-1)" "unprognostic (9.23e-3)" "unprognostic (1.81e-2)" "unprognostic (4.49e-10)" "unprognostic (1.13e-1)" "unprognostic (8.88e-2)" "unprognostic (2.32e-2)" "unprognostic (1.42e-3)" 2.1 1.6 3.6 2.9 5.3 0.2 2.3 3.1 3.4 8.0 4.4 1.9 1.5 0.9 8.6 2.6 3.9 5.8 8.8 3.3 3.7 1.0 1.7 0.8 2.9 0.7 1.3 1.5 23.3 0.8 0.7 2.6 1.7 3.6 6.2 1.4 5.9 1.8 2.4 1.6 3.7 3.2 4.5 1.6 2.0 3.9 5.4 2.1 1.7 1.6 4.7 2.6 4.3 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 19.6 3.9 2.1 4.2 0.0 7.5 1.7 3.3 2.1 0.0 0.6 0.0 0.8 3.7 0.5 0.3 5.5 0.0 1.6 0.0 3.5 0.5 4.8 0.0 4.7 0.0 1.5 2.1 0.0 10.6 0.0 2.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 11.9 1.2 6.0 0.0 2.2 1.2 0.0 0.0 0.8 3.4 3.4 0.0 0.5 4.1 0.0 0.2 5.9 0.0 20.3 2.1 0.0 0.0 0.0 0.0 7.4 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 5.3 3.1 3.4 3.7 1.0 1.3 1.5 3.6 2.1 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 6.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 23.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 29.0 0.0 0.0 0.0 2.3 0.0 3.8 1.5 0.0 0.0 0.0 0.0 GLI3 "ACLS, GCPS, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV" ENSG00000106571 "GLI family zinc finger 3" P10071 7 41960950-42237870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.8;Syncytiotrophoblasts: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.6;WM-115: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005534 Approved Supported Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA005534: AB_1078973" "unprognostic (2.53e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.35e-3)" "unprognostic (2.24e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-1)" "unprognostic (3.54e-2)" "unprognostic (1.48e-5)" "unprognostic (9.13e-3)" "unprognostic (5.41e-2)" "unprognostic (3.21e-3)" "unprognostic (7.00e-2)" 7.3 2.6 4.6 6.8 5.4 0.3 9.4 0.8 6.4 21.1 13.1 2.9 10.9 1.4 31.6 10.0 7.3 10.8 7.0 2.0 4.2 1.7 2.3 0.7 5.8 2.4 1.8 2.1 17.6 1.5 0.8 1.9 13.4 1.8 10.6 3.8 5.1 3.7 14.3 2.2 9.7 4.2 13.8 0.9 1.8 3.8 2.3 3.0 1.7 6.1 8.7 4.0 6.4 9.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 26.6 0.2 6.9 12.6 1.7 1.6 5.6 4.8 5.6 0.1 0.0 0.0 1.0 11.1 6.2 5.5 3.6 4.3 4.1 0.0 3.3 0.0 3.3 0.0 4.4 0.0 0.1 10.4 6.3 5.0 4.0 2.8 4.4 2.9 0.0 0.1 2.2 2.4 0.3 0.0 12.0 0.0 10.1 6.3 0.1 0.7 0.0 4.4 0.7 0.0 2.6 3.3 2.0 11.4 4.4 0.0 4.6 5.9 8.5 8.2 2.8 0.0 0.0 0.0 4.4 0.1 19.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.4 0.8 6.4 4.2 1.7 1.8 2.1 1.8 3.0 0.0 4.8 0.0 6.8 20.8 1.8 1.4 0.0 1.4 1.2 1.8 0.0 17.7 0.0 0.0 11.6 2.8 0.0 0.0 0.0 12.0 18.1 3.2 1.1 0.0 2.8 0.0 0.0 2.5 0.3 4.3 17.8 0.0 8.5 0.0 0.0 11.8 0.1 0.0 3.2 3.4 0.8 12.9 14.6 0.4 0.9 13.6 28.6 0.0 0.0 3.7 GLIPR1 "GliPR, RTVP1" ENSG00000139278 "GLI pathogenesis related 1" P48060 12 75480680-75503853 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.8" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 303.3;Hofbauer cells: 220.1;Kupffer cells: 261.5;Macrophages: 237.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 40.8;U-138 MG: 79.5;U-87 MG: 31.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011014 Approved "Intracellular and membrane" NA NA "HPA011014: AB_1849714" "unprognostic (2.32e-3)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-2)" "unprognostic (2.19e-1)" "unprognostic (3.31e-1)" "unprognostic (2.32e-3)" "unprognostic (4.09e-1)" "unprognostic (7.58e-2)" "unprognostic (3.10e-1)" "unprognostic (7.23e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.69e-9)" "unprognostic (9.06e-3)" "unprognostic (5.08e-2)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" 32.0 12.5 6.7 30.4 7.5 10.9 11.8 2.5 10.2 14.7 13.1 5.2 6.0 4.5 28.8 19.2 8.0 20.2 23.1 12.7 6.3 5.4 10.3 8.2 18.6 45.4 9.3 6.6 18.3 4.5 1.4 5.6 24.2 11.1 12.3 9.0 7.2 13.7 12.5 3.3 3.7 16.2 27.0 19.6 32.0 15.4 7.2 8.1 8.9 7.3 4.3 20.9 20.6 8.9 15.2 39.7 76.8 55.1 3.0 20.0 34.7 1.4 1.5 1.2 0.1 4.8 10.3 0.2 19.7 20.8 16.6 12.1 0.8 0.6 4.9 4.1 21.3 14.7 0.2 0.0 8.1 27.2 7.9 0.3 0.2 1.8 1.2 5.5 1.7 0.2 9.5 3.0 40.8 9.0 26.8 13.4 0.3 0.3 6.2 31.0 0.0 0.8 4.1 0.1 0.0 0.6 0.2 0.9 0.1 1.7 0.3 0.0 0.0 8.1 0.0 0.0 2.8 0.2 1.4 21.6 79.5 7.5 8.4 30.0 1.1 0.1 0.4 31.5 2.0 1.1 2.8 55.1 6.3 20.0 38.0 13.5 12.0 14.3 15.7 39.7 15.2 4.3 9.1 76.8 3.0 40.6 33.4 14.6 34.7 6.7 7.5 2.5 10.2 6.3 5.4 9.3 6.6 11.1 8.1 11.9 16.5 78.6 66.6 12.0 2.5 0.7 7.6 12.0 4.5 3.5 3.9 3.6 0.0 94.4 10.2 6.3 0.0 0.0 71.1 303.3 25.7 70.6 9.3 3.4 220.1 6.4 3.4 13.5 261.5 4.5 13.3 237.2 15.1 13.6 0.3 2.0 65.0 2.9 50.5 1.4 2.8 12.9 27.4 1.9 1.1 8.5 14.1 117.9 0.1 23.7 GLIPR1L1 MGC26856 ENSG00000173401 "GLIPR1 like 1" Q6UWM5 12 75334639-75370560 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 45.6" "Cell type enriched" "Detected in some" 11 "Early spermatids: 154.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "NTERA-2: 50.2" "Low region specificity" "Detected in all" HPA042095 Enhanced "Secreted in male reproductive system" NA NA "HPA042095: AB_10796898" "unprognostic (2.45e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.72e-1)" "unprognostic (7.47e-2)" "unprognostic (3.04e-1)" "unprognostic (2.70e-1)" "unprognostic (4.79e-2)" "unprognostic (3.01e-1)" "unprognostic (2.89e-1)" "unprognostic (7.90e-3)" "unprognostic (1.08e-1)" "unprognostic (9.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-1)" "unprognostic (2.11e-2)" 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.4 0.8 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.5 0.1 0.5 0.9 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.5 0.1 0.0 0.3 0.1 0.3 0.1 0.0 0.1 0.4 0.1 0.2 0.8 0.1 0.1 0.1 0.2 0.2 45.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 2.4 1.5 0.4 1.7 0.5 1.5 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 50.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 7.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.4 1.5 0.4 0.8 1.3 1.1 0.3 0.2 2.4 0.5 0.9 0.0 0.5 1.7 1.5 0.6 0.4 0.1 0.1 0.4 0.8 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.3 4.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.1 0.3 6.5 0.0 12.1 1.8 0.0 0.0 0.0 0.0 0.0 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391070-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 44.0" "Group enriched" "Detected in many" 13 "Early spermatids: 154.8;Spermatocytes: 290.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 5.8;SK-BR-3: 8.5;U-2 OS: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.3 3.1 5.5 1.2 10.4 0.8 3.0 2.9 5.8 2.2 1.2 4.2 2.9 1.0 2.7 4.2 1.4 3.5 1.5 2.5 5.5 4.6 2.5 1.9 2.7 1.1 6.6 3.9 7.7 3.0 7.3 5.2 1.3 6.2 2.3 0.8 2.0 1.4 3.6 2.4 2.2 1.2 1.5 8.1 1.9 1.0 44.0 5.0 1.4 2.8 0.5 0.8 1.7 1.4 1.4 2.6 2.0 0.7 1.0 3.4 0.6 0.3 0.6 0.3 0.6 4.4 2.6 0.7 0.6 0.5 0.2 0.3 0.1 0.4 0.3 1.5 0.4 1.1 0.2 0.1 0.1 0.4 0.8 0.3 0.1 0.6 5.8 3.3 0.6 0.1 0.9 1.4 0.6 2.3 3.8 0.2 0.2 0.3 0.7 1.1 0.1 0.6 0.4 0.3 1.2 0.2 0.1 0.1 0.3 0.1 0.4 1.1 0.6 0.7 8.5 2.5 0.4 2.5 0.2 1.2 1.0 11.3 1.2 0.4 1.0 1.0 0.3 0.4 0.3 0.8 1.8 0.3 0.5 1.1 0.2 0.7 1.1 1.2 2.0 0.4 1.4 2.2 3.3 2.0 1.0 0.7 2.6 3.4 0.6 5.5 10.4 2.9 5.8 5.5 4.6 6.6 3.9 6.2 5.0 0.0 1.9 0.0 3.9 0.8 4.6 3.6 0.0 14.7 1.2 0.0 0.0 1.3 8.3 0.4 154.8 1.0 0.0 0.0 0.0 0.2 1.1 0.8 1.1 0.0 0.5 1.6 0.0 0.0 0.0 14.7 6.9 0.1 0.0 0.0 0.0 5.6 0.2 0.0 5.3 1.0 2.0 6.5 1.0 290.6 16.8 0.4 0.3 0.0 0.0 2.3 GLIPR2 "C9orf19, GAPR-1" ENSG00000122694 "GLI pathogenesis related 2" Q9H4G4 9 36136536-36163913 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.9" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 191.0;Macrophages: 162.9;monocytes: 200.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 26.8;HDLM-2: 25.6;TIME: 45.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029478 Approved Uncertain Vesicles,Microtubules NA NA 18000000 Vesicles Microtubules "HPA029478: AB_10670038" "unprognostic (1.57e-2)" "unprognostic (5.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.28e-1)" "unprognostic (1.46e-2)" "unprognostic (1.33e-2)" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (1.84e-2)" "unprognostic (4.26e-2)" "unprognostic (3.21e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (6.54e-7)" "unprognostic (6.57e-3)" "unprognostic (4.94e-1)" "unprognostic (1.02e-1)" "unprognostic (2.43e-2)" 28.5 10.8 8.1 25.5 12.1 32.5 15.6 5.7 11.2 19.9 32.4 23.3 9.1 7.5 40.3 16.8 16.3 18.7 13.0 11.7 9.4 7.1 4.9 3.5 31.2 26.5 14.7 6.5 13.4 2.8 0.4 2.9 4.7 12.3 20.1 17.1 11.6 7.9 21.3 4.8 6.1 14.9 35.5 21.8 21.1 13.8 5.0 13.2 10.1 10.6 7.4 9.4 19.2 14.2 3.3 28.8 92.9 48.6 15.8 24.8 45.5 1.2 1.0 7.6 8.0 26.8 12.8 0.8 12.2 7.4 2.8 5.2 0.4 0.1 0.0 3.8 10.9 7.2 0.0 2.8 0.4 1.7 25.6 2.4 3.0 2.4 0.1 10.6 1.9 10.5 8.6 0.3 16.4 2.8 5.2 22.5 8.2 0.1 1.8 6.5 2.9 9.6 5.2 7.3 0.1 3.9 6.6 16.1 0.3 0.6 0.6 2.0 4.1 1.6 0.8 1.2 16.2 0.8 8.5 45.4 3.9 9.3 3.5 9.8 2.9 0.7 4.4 4.1 12.4 0.9 30.1 48.6 71.9 24.8 22.3 13.1 3.2 17.2 15.8 28.8 3.3 7.3 11.5 92.9 15.8 16.2 2.5 17.6 45.5 8.1 12.1 5.7 9.8 9.4 7.1 14.7 6.5 12.3 13.2 3.0 29.7 14.3 2.0 11.8 0.2 1.6 5.1 40.2 23.9 5.2 0.0 2.7 0.0 16.4 0.6 7.1 4.5 23.3 1.1 2.9 35.5 17.3 51.9 0.4 191.0 0.0 8.1 17.8 102.3 0.9 16.7 162.9 59.1 200.2 27.5 14.0 6.0 10.5 24.4 0.3 0.5 45.3 35.8 1.1 3.2 8.9 2.9 62.3 48.7 2.0 GLIS1 FLJ36155 ENSG00000174332 "GLIS family zinc finger 1" Q8NBF1 1 53506237-53738106 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 8.9;seminal vesicle: 14.7" "Cell type enhanced" "Detected in some" 10 "Basal keratinocytes: 6.0;Early spermatids: 2.7;Late spermatids: 2.5;Melanocytes: 3.3;Proximal tubular cells: 5.0;Spermatogonia: 2.8" "Cancer enhanced" "Detected in some" "renal cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;BJ hTERT+: 5.9;GAMG: 7.8;hTERT-RPE1: 6.3;PC-3: 9.5;U-138 MG: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001409 Uncertain NA NA "HPA001409: AB_1078974" "unprognostic (1.30e-1)" "unprognostic (1.46e-1)" "unprognostic (2.07e-1)" "unprognostic (5.31e-2)" "unprognostic (3.67e-2)" "unprognostic (1.54e-2)" "unprognostic (8.91e-3)" "unprognostic (1.92e-1)" "unprognostic (2.27e-3)" "unprognostic (2.30e-1)" "unprognostic (3.03e-2)" "unprognostic (1.15e-2)" "unprognostic (1.93e-1)" "unprognostic (4.06e-2)" "unprognostic (1.55e-1)" "unprognostic (6.37e-4)" "unprognostic (1.98e-4)" 1.1 0.1 0.5 0.6 1.2 0.0 0.9 3.9 1.6 4.2 0.5 0.5 0.5 0.6 1.4 1.0 0.6 0.8 1.0 1.0 2.3 0.7 3.3 0.5 0.5 0.5 0.5 0.5 1.0 0.5 0.0 0.5 1.2 0.8 8.9 0.1 5.5 0.5 14.7 0.5 1.7 0.6 0.5 0.5 0.5 0.9 4.1 0.5 0.5 0.5 0.5 1.0 2.7 4.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 3.8 5.0 0.0 2.6 5.9 2.3 1.7 0.0 0.0 0.0 0.1 2.7 7.8 0.0 0.0 0.0 0.7 0.0 1.7 0.0 1.7 0.1 1.3 0.0 0.0 3.5 0.2 2.8 2.6 6.3 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 9.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 1.2 0.1 1.7 0.0 0.0 4.2 0.5 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 3.9 1.6 2.3 0.7 0.5 0.5 0.8 0.5 0.0 0.0 0.0 0.0 6.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 1.1 5.0 0.0 0.0 1.4 1.9 2.8 1.5 0.1 0.0 0.0 0.0 GLIS3 "MGC33662, ZNF515" ENSG00000107249 "GLIS family zinc finger 3" Q8NEA6 9 3824127-4348392 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Congenital hypothyroidism, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 57.8" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 45.9;Collecting duct cells: 66.3;Ductal cells: 42.5;Intestinal endocrine cells: 42.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.4;HSkMC: 23.4;RPTEC TERT1: 14.5;U-251 MG: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056426 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056426: AB_2683128" "unprognostic (6.24e-2)" "unprognostic (2.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.63e-3)" "unprognostic (4.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.81e-2)" "unprognostic (7.14e-2)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.63e-1)" "unprognostic (1.91e-3)" "unprognostic (6.88e-3)" "unprognostic (8.54e-2)" "unprognostic (1.04e-1)" "unprognostic (6.35e-2)" 5.6 2.8 5.6 4.4 7.4 1.0 2.9 3.5 9.5 13.4 2.9 10.7 33.5 1.6 6.1 6.5 1.5 15.0 14.7 4.7 8.9 4.5 11.4 5.1 5.7 2.6 7.7 3.8 10.4 17.3 6.4 8.8 2.8 16.3 5.3 4.0 4.6 5.2 57.8 2.1 1.4 2.2 5.1 26.7 3.8 3.2 4.6 10.2 0.0 29.3 1.4 1.7 5.6 8.8 0.0 0.0 1.8 0.9 0.3 0.7 0.0 0.6 6.7 2.0 0.0 2.7 7.4 0.2 5.1 15.4 2.3 3.4 1.1 2.4 0.0 4.0 3.7 7.7 0.0 1.3 0.0 4.8 1.5 1.0 0.0 0.3 0.0 8.1 0.7 0.0 23.4 0.0 7.1 0.7 4.2 0.4 0.0 0.0 0.1 1.9 0.2 0.0 0.9 0.1 0.0 0.9 0.0 4.6 0.0 14.5 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 5.1 2.6 0.6 2.7 12.1 0.0 0.0 0.0 7.1 0.0 3.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.7 1.1 0.3 0.9 0.0 0.1 0.0 5.6 7.4 3.5 9.5 8.9 4.5 7.7 3.8 16.3 10.2 8.9 20.0 0.9 6.4 1.6 0.2 1.1 45.9 29.4 30.7 66.3 0.0 2.0 0.0 42.5 3.6 5.8 2.0 0.0 20.0 2.7 6.6 10.3 1.1 6.6 2.1 0.0 42.0 6.2 1.0 1.8 12.7 2.7 3.3 3.6 1.1 22.1 34.5 2.9 10.6 17.0 0.2 0.0 10.3 0.7 4.3 1.1 3.5 1.0 3.5 3.9 GLOD5 ENSG00000171433 "Glyoxalase domain containing 5" A6NK44 X 48761750-48773648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.2;kidney: 10.2;liver: 7.8" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 11.6;Enterocytes: 17.1;Paneth cells: 10.5;Proximal tubular cells: 31.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;Hep G2: 2.2;K-562: 1.9;MCF7: 6.5;SCLC-21H: 1.3;T-47d: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010667 Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA010667: AB_1078975" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (7.78e-2)" "unprognostic (7.04e-2)" "unprognostic (3.14e-1)" "unprognostic (6.11e-2)" "unprognostic (1.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.05e-8)" "unprognostic (2.08e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (6.79e-4)" 0.2 0.0 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.4 14.7 0.2 0.2 10.3 0.4 5.6 0.3 1.6 3.5 0.2 0.2 0.0 10.2 7.8 1.5 0.2 0.2 0.2 0.4 1.1 0.0 0.6 0.2 0.2 0.4 5.7 1.5 0.6 0.2 0.2 0.1 25.2 0.2 0.2 0.2 1.3 0.7 0.2 0.4 1.9 0.2 0.5 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.3 0.4 0.3 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 1.6 0.0 0.4 0.0 0.2 0.0 2.5 4.0 0.0 7.0 0.0 0.0 11.6 0.4 0.1 0.0 17.1 0.0 0.8 0.1 0.0 0.5 0.0 6.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.3 1.2 10.5 0.0 31.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.5 GLP1R GLP-1R ENSG00000112164 "Glucagon like peptide 1 receptor" P43220 6 39048798-39087743 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 19.0" "Cell type enhanced" "Detected in single" 37 "Cardiomyocytes: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;HAP1: 1.3;HMC-1: 1.5;NTERA-2: 3.3;SCLC-21H: 8.1;SH-SY5Y: 1.8" "Group enriched" "Detected in some" 5 "basal ganglia: 16.1;hypothalamus: 4.8" "Low region specificity" "Detected in some" NA NA "unprognostic (4.06e-3)" "unprognostic (5.38e-6)" "unprognostic (1.80e-2)" "unprognostic (4.16e-2)" "unprognostic (4.98e-2)" "unprognostic (3.55e-1)" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (9.76e-2)" "unprognostic (3.29e-1)" "unprognostic (1.73e-1)" "unprognostic (8.60e-3)" "unprognostic (2.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.42e-2)" 0.2 0.1 0.1 0.0 1.8 0.0 0.9 0.1 2.2 0.1 0.1 0.8 0.0 2.4 0.1 0.6 0.1 0.0 3.5 4.8 1.4 1.4 0.1 0.0 0.5 1.0 0.1 2.3 0.0 19.0 0.0 0.1 0.0 2.0 0.1 0.0 0.0 4.1 0.0 0.4 0.3 0.1 0.0 1.4 0.1 1.8 0.4 0.0 0.4 0.8 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.1 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.7 1.4 1.4 0.1 2.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLP2R ENSG00000065325 "Glucagon like peptide 2 receptor" O95838 17 9822206-9892102 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "gallbladder: 32.7" "Cell type enriched" "Detected in some" 6 "Rod photoreceptor cells: 24.5" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.1" "Group enriched" "Detected in some" 4 "basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HeLa: 42.8" "Group enriched" "Detected in some" 6 "cerebral cortex: 2.1;hippocampal formation: 2.6" "Low region specificity" "Detected in some" "CAB022690, HPA049244" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022690: , HPA049244: AB_2680690" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (2.66e-3)" "unprognostic (2.21e-2)" "unprognostic (3.81e-3)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (5.15e-2)" "unprognostic (7.63e-2)" "unprognostic (7.14e-2)" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (3.40e-8)" "unprognostic (9.53e-5)" "unprognostic (5.51e-2)" "unprognostic (3.92e-1)" "unprognostic (6.48e-3)" 7.9 0.7 0.6 2.0 2.9 0.0 2.6 0.3 4.3 6.6 14.5 0.0 1.7 12.4 1.9 0.4 5.3 1.4 32.7 0.9 0.6 0.5 0.4 3.2 1.4 0.7 0.6 1.6 0.8 2.1 0.0 0.3 1.5 0.5 8.4 7.5 0.8 0.4 0.2 0.3 0.3 15.4 15.6 0.6 0.3 4.9 1.1 0.2 0.0 0.5 0.1 0.4 13.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.3 4.1 0.6 0.5 0.6 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLRA1 STHE ENSG00000145888 "Glycine receptor alpha 1" P23415 5 151822513-151924842 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 31.7" "Cell type enhanced" "Detected in some" 26 "Basal glandular cells: 1.1;Bipolar cells: 4.9;Horizontal cells: 1.6" "Not detected" "Not detected" "Region enriched" "Detected in many" 10 "pons and medulla: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.4" "Group enriched" "Detected in many" 4 "hypothalamus: 11.0;midbrain: 18.1;pons and medulla: 27.6" "Region enhanced" "Detected in all" "pons and medulla: 54.9" CAB079042 Supported NA NA "CAB079042: " "unprognostic (3.17e-1)" "unprognostic (2.47e-1)" "unprognostic (3.85e-7)" "unprognostic (8.24e-2)" "unprognostic (9.45e-3)" 0.3 3.2 1.2 0.1 0.7 0.2 0.1 3.2 0.9 0.1 0.2 0.0 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.2 0.1 0.1 0.1 2.7 0.0 0.1 2.2 0.1 0.1 0.2 31.7 0.1 0.1 1.6 0.1 0.1 0.6 0.1 0.1 0.1 12.6 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 3.2 0.9 0.1 2.7 2.7 0.0 31.7 0.0 0.0 0.0 0.0 1.1 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 GLRA2 GLR ENSG00000101958 "Glycine receptor alpha 2" P23416 X 14529298-14731812 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 21.0;intestine: 11.1" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.2;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "AN3-CA: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070422 Approved NA NA "CAB070422: AB_11153055" "unprognostic (2.52e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.90e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (3.39e-1)" "unprognostic (5.82e-2)" "unprognostic (7.95e-3)" "unprognostic (1.13e-1)" "unprognostic (2.76e-1)" "unprognostic (6.69e-2)" 0.4 0.5 14.5 0.7 13.2 0.7 0.5 21.0 10.8 0.4 4.1 0.1 0.0 0.7 0.5 0.5 0.4 0.8 0.7 0.4 3.6 13.9 0.5 0.5 0.4 0.5 1.6 8.4 0.9 0.5 0.4 0.5 0.8 10.1 0.4 11.1 1.1 0.8 0.5 0.5 0.8 0.9 0.7 6.5 0.5 0.5 0.9 0.8 0.0 0.5 0.0 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 20.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 13.2 21.0 10.4 3.6 13.9 1.6 8.4 10.1 0.8 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 GLRA3 ENSG00000145451 "Glycine receptor alpha 3" O75311 4 174636914-174829314 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.2;breast: 6.1;pituitary gland: 12.5" "Group enriched" "Detected in some" 9 "Early spermatids: 18.4;Late spermatids: 13.2" "Cancer enhanced" "Detected in single" "breast cancer: 1.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 2.7;Karpas-707: 6.3;U-698: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.75e-3)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (1.36e-1)" "unprognostic (9.02e-2)" "unprognostic (3.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.12e-2)" "unprognostic (4.26e-2)" "unprognostic (1.64e-5)" "unprognostic (4.61e-4)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" 0.5 2.6 13.3 0.6 7.3 0.6 6.1 0.7 15.2 0.5 0.5 0.3 0.0 0.5 0.7 0.5 0.5 0.4 0.6 0.4 2.7 7.4 0.5 0.4 0.5 0.9 4.6 8.7 0.4 1.4 0.5 12.5 0.5 4.4 0.5 0.5 0.0 0.5 0.5 0.4 0.7 0.5 0.8 2.1 0.6 0.5 1.7 0.0 0.0 0.5 0.0 0.9 0.4 0.2 2.7 0.1 1.1 0.0 0.3 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.6 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.6 0.0 0.7 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 2.3 0.1 0.1 0.1 0.6 0.0 0.4 0.1 0.0 0.5 2.7 0.2 0.1 0.0 0.5 0.2 0.2 1.1 0.3 0.0 0.1 0.1 0.0 13.3 7.3 0.7 14.5 2.7 7.4 4.6 8.7 4.4 0.0 0.0 1.1 0.0 1.0 0.0 0.7 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.6 0.0 0.4 0.2 1.5 0.1 0.0 0.0 0.0 0.3 GLRA4 ENSG00000188828 "Glycine receptor alpha 4" Q5JXX5 X 103707224-103728655 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7" "Cell type enriched" "Detected in single" 21 "Enterocytes: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SCLC-21H: 7.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044759 Uncertain NA NA "HPA044759: AB_10795885" "unprognostic (4.96e-2)" "unprognostic (2.09e-2)" "unprognostic (3.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (4.94e-7)" "unprognostic (4.49e-1)" "unprognostic (1.94e-1)" "unprognostic (1.87e-1)" 0.0 0.0 0.9 0.1 1.5 0.0 0.3 2.8 3.5 1.9 1.4 0.9 0.0 2.2 5.1 0.1 0.2 0.6 0.1 0.1 1.5 1.8 0.0 0.0 0.0 0.0 0.5 1.0 1.2 0.0 2.4 0.2 0.0 1.2 0.5 1.8 0.0 0.0 0.4 0.1 0.3 2.3 6.7 1.5 0.0 0.1 1.4 0.0 2.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.5 7.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 1.5 2.8 3.5 1.5 1.8 0.5 1.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLRB ENSG00000109738 "Glycine receptor beta" P48167 4 157076057-157172090 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.1;parathyroid gland: 37.0" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 12.6;Cholangiocytes: 7.6;Ciliated cells: 8.1;Muller glia cells: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 18 "dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "AN3-CA: 17.5;hTERT-RPE1: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052363 Approved NA NA "HPA052363: AB_2681800" "unprognostic (7.36e-2)" "unprognostic (6.53e-2)" "unprognostic (1.44e-1)" "unprognostic (2.59e-3)" "unprognostic (5.65e-2)" "unprognostic (1.18e-1)" "unprognostic (9.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.19e-2)" "unprognostic (2.99e-2)" "unprognostic (6.81e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.89e-4)" "unprognostic (4.32e-3)" "unprognostic (1.85e-1)" "unprognostic (5.61e-2)" "unprognostic (1.66e-2)" 4.5 7.2 12.6 1.5 20.9 0.7 10.3 15.9 43.1 9.4 2.3 2.8 0.1 1.1 3.3 5.4 1.5 7.4 3.5 9.9 18.3 17.3 4.1 1.6 3.4 0.8 11.1 21.3 1.8 14.2 37.0 6.7 2.9 16.5 6.5 1.4 0.7 16.7 5.2 3.3 1.5 1.2 4.0 6.1 0.6 2.2 1.9 4.5 0.0 1.5 0.5 0.7 1.9 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 4.8 2.0 5.8 17.5 11.3 4.6 0.0 9.6 6.2 4.7 8.9 0.0 14.8 0.0 2.3 9.7 5.8 0.0 4.4 1.5 8.9 0.0 5.8 2.9 2.2 0.2 5.2 3.7 0.0 4.1 1.3 8.2 1.2 23.3 4.2 3.1 0.0 0.0 8.5 0.0 0.4 0.0 0.3 0.0 1.3 0.0 7.9 0.0 12.7 0.8 6.3 3.8 0.0 4.5 0.7 0.9 4.1 0.9 6.2 2.8 8.3 4.7 9.3 0.0 0.0 0.0 6.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 20.9 15.9 43.1 18.3 17.3 11.1 21.3 16.5 4.5 0.0 0.6 0.0 0.7 1.0 6.9 12.6 7.6 8.1 3.4 0.0 2.0 0.3 0.0 6.9 0.2 1.0 0.0 0.0 1.5 0.0 2.6 0.6 1.1 0.0 0.1 1.6 0.0 1.8 0.0 0.0 0.3 0.0 3.3 1.0 0.0 11.6 1.9 0.0 3.2 0.4 1.6 0.0 1.1 1.1 3.0 0.3 0.1 0.0 0.0 0.1 GLRX "GRX, GRX1" ENSG00000173221 Glutaredoxin P35754 5 95751319-95823005 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 94.4;skeletal muscle: 141.6" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 613.5;Extravillous trophoblasts: 605.3;Proximal tubular cells: 870.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 85.0;RPTEC TERT1: 65.0;U-87 MG: 69.9" "Low region specificity" "Detected in all" "CAB008634, HPA046431, CAB069419" Approved Supported "Plasma membrane,Cytosol" NA NA 13000000 "Plasma membrane, Cytosol" "CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (1.94e-2)" "unprognostic (4.81e-2)" "unprognostic (2.01e-2)" "unprognostic (2.22e-2)" "unprognostic (8.62e-3)" "unprognostic (9.31e-3)" "unprognostic (1.99e-2)" "unprognostic (1.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (2.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.61e-1)" 17.7 20.7 6.2 15.0 6.6 30.6 10.5 15.5 15.5 5.4 22.6 3.1 4.0 40.2 2.9 4.6 3.1 3.7 9.5 25.2 12.1 7.8 45.9 46.9 23.1 21.5 7.8 5.9 3.5 2.6 9.5 6.4 63.9 7.6 5.7 8.8 2.4 17.9 5.5 141.6 7.3 42.5 4.5 7.3 15.2 8.2 2.2 4.0 14.4 6.3 6.4 14.3 11.6 5.8 16.0 52.2 94.4 81.6 11.2 48.9 71.1 3.3 15.0 1.1 2.4 32.4 46.6 0.2 50.1 85.0 5.4 9.1 3.7 1.5 13.0 7.1 15.0 12.2 1.3 1.9 23.8 15.1 11.3 3.7 9.4 9.9 34.4 61.7 10.0 27.9 29.1 2.9 34.3 3.3 12.0 10.3 26.7 1.2 7.8 34.0 1.1 17.2 17.7 3.3 0.4 17.1 27.9 10.2 16.1 65.0 2.4 3.4 1.8 13.1 6.5 5.7 3.1 1.8 9.9 11.9 14.2 16.0 11.3 2.1 5.6 28.7 10.4 69.9 25.1 3.0 3.8 81.6 94.4 26.2 51.0 35.7 16.0 24.1 19.5 52.2 10.7 24.1 22.1 85.7 11.2 40.5 18.0 48.9 71.1 6.2 6.6 15.5 15.5 12.1 7.8 7.8 5.9 7.6 4.0 20.8 27.9 60.2 35.5 15.2 1.5 153.4 79.0 53.5 27.3 89.0 0.0 19.8 613.5 47.8 0.2 38.0 373.9 23.3 81.2 605.3 54.7 75.6 30.1 177.3 241.8 0.0 30.4 44.2 275.4 0.9 17.5 243.9 65.8 117.2 64.0 5.5 118.2 157.8 13.1 870.9 3.3 19.4 70.2 0.5 1.1 18.1 238.6 103.6 64.3 137.4 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880827-190965552 "Enzymes, Predicted intracellular proteins" Hydrolase "Cataract, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 127.9" "Cell type enhanced" "Detected in all" 6 "Collecting duct cells: 371.6;Proximal tubular cells: 372.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 141.8;RPTEC TERT1: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" No No 25000 Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 16.5 37.3 37.8 20.4 24.7 10.7 34.3 43.8 47.3 11.9 13.1 5.8 8.9 36.9 14.6 11.9 7.6 11.0 17.7 15.7 23.3 22.8 127.9 5.3 22.6 25.4 20.6 36.8 14.1 17.0 26.4 10.1 14.8 35.1 9.4 13.1 10.8 9.0 13.9 7.4 13.0 40.9 15.5 11.7 19.3 8.7 6.9 12.1 15.0 17.7 8.0 22.9 14.1 16.1 5.2 5.0 6.0 2.1 3.9 9.4 1.5 6.4 7.1 5.0 6.6 15.7 11.0 13.0 19.2 14.6 14.0 16.1 8.7 6.4 13.2 141.8 40.5 7.1 8.4 8.8 7.5 20.6 32.5 5.7 21.9 10.5 10.7 14.4 12.7 10.3 9.9 7.9 11.0 7.5 14.0 18.1 5.5 10.1 26.9 31.1 3.4 8.6 12.3 13.4 3.8 11.7 11.0 12.9 11.4 65.2 11.8 6.9 7.2 26.2 5.8 24.4 18.7 2.3 7.9 12.9 20.3 14.9 10.1 23.2 8.7 19.8 18.1 7.3 10.5 16.1 6.0 1.5 2.5 5.5 2.1 9.4 4.8 6.5 7.0 2.2 5.2 6.8 8.1 3.0 3.9 1.4 5.0 5.6 1.5 37.8 24.7 43.8 47.3 23.3 22.8 20.6 36.8 35.1 12.1 175.7 95.7 52.1 47.3 155.0 91.0 32.2 30.6 16.0 40.9 371.6 198.3 3.3 43.1 22.6 4.4 51.8 120.5 23.3 20.9 10.2 63.7 42.0 35.8 4.9 25.8 25.4 56.7 57.7 27.2 3.6 26.4 55.5 84.4 88.4 25.7 10.0 29.5 31.6 40.7 372.1 117.6 19.4 70.9 10.7 11.0 142.3 3.3 62.3 28.1 52.1 GLS2 "GA, GLS, hLGA, LGA" ENSG00000135423 "Glutaminase 2" Q9UI32 12 56470944-56488414 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 92.2" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 52.1" "Cancer enhanced" "Detected in single" "liver cancer: 1.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 29 "B-cells: 1.8;T-cells: 3.8" "Cell line enhanced" "Detected in some" "Daudi: 25.6;RPMI-8226: 4.6;SCLC-21H: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038608 Uncertain NA NA "HPA038608: AB_10673176" "unprognostic (5.59e-2)" "unprognostic (1.51e-2)" "unprognostic (8.73e-2)" "unprognostic (7.15e-2)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "unprognostic (3.27e-3)" "unprognostic (1.98e-6)" "unprognostic (1.55e-1)" "unprognostic (5.33e-2)" "unprognostic (1.29e-2)" "unprognostic (1.52e-1)" "unprognostic (5.65e-5)" "unprognostic (1.42e-2)" "unprognostic (2.59e-1)" "unprognostic (9.02e-2)" "unprognostic (4.44e-2)" 0.9 1.7 5.7 1.0 8.6 0.9 1.4 12.8 15.0 1.0 1.2 0.2 0.0 1.0 1.2 2.0 1.4 2.8 0.9 1.0 4.2 4.1 1.6 92.2 1.4 1.2 1.9 9.7 1.2 15.8 3.0 6.2 0.8 8.6 1.4 1.7 2.5 1.4 2.0 0.9 2.0 1.0 1.1 3.2 1.1 1.4 1.1 1.4 0.0 1.4 0.0 1.4 1.1 0.8 1.8 0.0 0.0 0.0 0.0 3.8 1.4 4.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.5 0.9 25.6 0.5 0.0 0.0 0.6 0.0 3.8 0.0 0.0 3.8 0.0 0.3 4.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.8 0.8 0.4 0.0 0.1 4.6 2.7 1.8 7.3 0.4 0.8 0.3 0.0 0.7 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 1.8 3.3 1.0 0.0 0.6 3.8 3.5 0.0 0.0 0.0 0.0 0.6 1.4 5.7 8.6 12.8 15.0 4.2 4.1 1.9 9.7 8.6 1.4 0.0 2.4 1.9 4.2 1.4 9.5 0.0 0.0 2.7 6.8 0.0 5.9 0.1 6.6 0.4 0.0 0.3 0.0 0.0 1.6 0.0 0.1 1.5 1.1 52.1 0.1 3.2 1.2 1.3 1.5 0.0 0.9 0.0 1.7 0.0 0.0 2.3 0.8 0.0 0.0 0.5 10.2 0.0 0.0 0.0 1.0 1.0 0.2 0.0 0.2 0.3 GLT1D1 FLJ31978 ENSG00000151948 "Glycosyltransferase 1 domain containing 1" Q96MS3 12 128853427-128984968 "Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.1;bone marrow: 25.4;liver: 24.7" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 11.5;Hepatocytes: 7.9;Kupffer cells: 11.4;Late spermatids: 34.0;Muller glia cells: 9.8" "Group enriched" "Detected in some" 6 "liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 23.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 23.1" "Group enriched" "Detected in some" 6 "MOLT-4: 12.4;NTERA-2: 18.0;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039051, HPA039052" Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA039051: AB_10673299, HPA039052: AB_10672839" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (3.60e-2)" "unprognostic (3.47e-3)" "unprognostic (2.88e-1)" "unprognostic (2.53e-1)" "unprognostic (4.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (3.93e-5)" "unprognostic (2.39e-2)" "unprognostic (2.20e-1)" "unprognostic (1.55e-3)" "unprognostic (2.41e-1)" 3.0 0.6 7.0 7.0 12.4 25.4 0.6 7.1 15.5 1.8 0.6 1.2 0.2 0.5 4.1 1.4 0.9 2.1 2.1 1.2 6.3 10.5 1.2 24.7 2.2 4.5 5.8 6.4 0.6 1.2 0.4 1.0 1.0 7.6 1.3 0.7 2.6 0.4 1.9 8.2 1.3 0.6 3.6 1.6 9.2 0.6 14.7 1.3 0.1 2.0 0.0 0.8 1.7 0.6 0.0 1.4 23.1 3.8 0.0 0.3 0.8 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.3 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.1 0.0 1.1 1.4 0.0 0.8 7.0 12.4 7.1 15.5 6.3 10.5 5.8 6.4 7.6 1.3 0.0 0.0 0.5 0.0 0.8 0.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.5 0.0 0.0 1.8 11.4 34.0 0.3 1.7 1.7 0.0 0.0 9.8 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.6 0.2 0.3 0.1 0.0 0.0 0.0 GLT6D1 GLTDC1 ENSG00000204007 "Glycosyltransferase 6 domain containing 1" Q7Z4J2 9 135623656-135639540 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 28 "testis: 10.3" "Group enriched" "Detected in some" 22 "Early spermatids: 13.2;Late spermatids: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023424 Uncertain "Intracellular and membrane" NA NA "HPA023424: AB_1849729" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 GLTP ENSG00000139433 "Glycolipid transfer protein" Q9NZD2 12 109850943-109880488 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3" "Cell type enhanced" "Detected in many" 8 "Suprabasal keratinocytes: 418.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056461, HPA065503" Approved Supported Cytosol NA NA 280000 Cytosol "HPA056461: AB_2683138, HPA065503: " "unprognostic (1.18e-1)" "prognostic favorable (2.01e-5)" "unprognostic (7.46e-2)" "unprognostic (6.22e-3)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (7.68e-4)" "unprognostic (6.63e-2)" "unprognostic (1.56e-1)" "unprognostic (1.62e-1)" "unprognostic (2.47e-1)" "unprognostic (3.03e-1)" "unprognostic (4.83e-2)" "unprognostic (4.46e-2)" "unprognostic (2.20e-1)" "prognostic favorable (4.17e-6)" "unprognostic (3.28e-2)" 7.0 5.8 11.4 6.1 16.4 6.6 10.5 4.7 19.3 21.8 13.2 31.3 6.6 5.4 5.4 13.4 82.0 4.9 5.4 6.4 15.9 9.7 13.7 4.5 9.2 7.0 22.4 8.9 5.9 7.7 5.7 3.4 7.9 14.8 8.0 11.8 4.0 21.2 8.0 6.1 84.3 8.2 7.1 48.7 7.4 7.6 4.0 24.7 6.2 8.9 60.6 78.0 10.8 38.5 11.8 23.2 16.7 32.3 21.2 26.7 17.2 14.2 10.2 5.9 6.3 14.1 16.3 4.3 17.7 22.0 13.7 11.6 4.0 5.5 12.6 9.5 21.7 6.7 17.6 9.1 20.8 19.6 12.8 8.1 8.2 6.2 6.1 12.4 8.8 9.7 12.0 26.2 24.5 17.4 20.8 23.0 13.1 3.7 8.7 20.1 19.7 11.9 7.2 10.6 11.8 13.8 10.7 14.0 13.2 7.7 42.9 7.5 7.5 11.1 29.0 9.4 5.7 13.5 3.1 31.4 15.7 8.5 23.1 13.3 11.5 9.6 8.6 31.7 9.2 9.7 16.7 32.3 16.5 26.7 30.8 16.2 11.8 16.1 23.3 23.2 11.4 10.5 18.8 15.8 21.2 24.8 3.7 17.6 17.2 11.4 16.4 4.7 19.3 15.9 9.7 22.4 8.9 14.8 24.7 23.8 58.2 25.4 91.0 129.1 11.8 13.3 20.4 29.4 52.4 41.8 13.7 64.4 169.1 34.4 12.2 35.0 79.9 0.0 49.6 16.3 33.4 71.1 19.7 11.9 31.9 12.7 31.2 28.3 40.0 9.7 21.3 47.5 57.3 45.9 41.0 15.1 42.3 35.1 17.0 25.6 11.6 38.8 41.8 17.0 22.0 418.8 176.1 43.3 42.2 95.9 GLTPD2 ENSG00000182327 "Glycolipid transfer protein domain containing 2" A6NH11 17 4788959-4790390 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;kidney: 9.8;liver: 44.4" "Group enriched" "Detected in some" 6 "Hepatocytes: 65.2;Proximal tubular cells: 128.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 25.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 3.2" "Lineage enriched" "Detected in single" 6 "monocytes: 3.2" "Cell line enhanced" "Detected in some" "BEWO: 4.7;CACO-2: 11.8;Hep G2: 15.5;MCF7: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058295, HPA065267" Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA058295: AB_2683671, HPA065267: AB_2685451" "unprognostic (4.00e-1)" "unprognostic (1.93e-1)" "unprognostic (1.95e-3)" "unprognostic (1.70e-1)" "unprognostic (3.03e-2)" "unprognostic (1.79e-4)" "unprognostic (1.40e-1)" "unprognostic (1.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.33e-2)" "unprognostic (5.62e-4)" "unprognostic (7.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.25e-1)" "unprognostic (4.79e-1)" "unprognostic (1.71e-4)" "unprognostic (7.59e-3)" 0.2 0.3 0.5 0.2 0.7 0.8 0.2 0.8 1.8 0.2 8.0 0.3 0.2 8.6 0.3 0.2 0.4 0.3 0.2 0.2 0.5 0.7 9.8 44.4 0.6 0.2 0.5 0.4 0.2 0.5 0.2 0.5 0.2 0.4 0.2 0.0 0.5 0.8 0.2 0.8 1.4 13.0 0.2 0.4 0.8 0.9 0.2 0.2 0.4 0.2 1.6 0.3 0.4 0.3 0.0 0.5 0.0 3.2 0.0 0.2 0.2 0.6 2.5 0.2 2.1 0.0 0.0 4.7 0.4 0.0 0.0 0.0 11.8 0.9 1.2 1.3 0.0 0.4 2.3 0.0 0.1 0.0 2.2 1.8 0.1 1.0 15.5 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.7 0.6 0.0 5.4 0.2 0.2 0.3 0.6 1.0 0.9 0.6 0.3 0.0 0.9 1.6 1.0 2.2 0.4 0.6 0.1 1.4 0.1 2.5 0.8 1.0 0.5 0.4 0.2 0.6 0.1 0.3 0.7 0.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.2 0.5 0.7 0.8 0.7 0.5 0.7 0.5 0.4 0.4 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.3 0.0 65.2 0.1 0.0 0.0 1.8 1.3 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 128.9 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.5 GLUD1 "GDH, GLUD" ENSG00000148672 "Glutamate dehydrogenase 1" P00367 10 87050486-87094866 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 182.4" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 357.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 108.1" "HPA042492, HPA044839, HPA061369" Approved Supported Mitochondria "Intracellular and membrane" NA NA 26000000 Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.48e-1)" "unprognostic (1.26e-2)" "unprognostic (3.55e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.81e-4)" "unprognostic (1.31e-1)" "unprognostic (1.91e-2)" "unprognostic (5.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.57e-3)" "prognostic unfavorable (1.76e-5)" "unprognostic (1.13e-1)" "prognostic favorable (1.44e-6)" "unprognostic (2.29e-1)" "unprognostic (4.23e-2)" "unprognostic (7.19e-2)" "unprognostic (4.27e-2)" 15.5 21.5 57.8 9.9 54.5 5.9 23.2 13.4 37.9 12.1 14.5 19.9 5.5 18.4 10.9 7.5 17.0 11.5 12.6 16.7 44.1 35.3 56.2 182.4 13.1 11.5 40.6 30.8 17.5 15.2 8.7 6.6 13.5 31.1 26.5 14.6 8.1 10.0 13.3 9.2 15.3 19.8 14.0 22.7 10.2 12.2 6.4 33.2 12.6 16.1 8.7 13.1 14.0 9.5 9.2 15.8 9.2 14.6 13.7 11.9 5.9 24.5 19.8 15.6 26.4 29.7 36.6 17.1 19.4 33.6 18.8 20.7 45.8 24.1 27.6 15.9 28.3 10.8 38.7 20.3 19.5 20.2 19.9 16.0 13.4 11.9 108.1 66.3 31.3 19.4 25.2 36.9 20.9 62.6 28.7 22.4 21.8 13.5 25.0 20.3 17.8 28.2 28.1 17.8 26.7 16.0 21.4 19.9 18.0 54.1 20.1 8.0 15.0 17.4 13.8 24.7 15.7 19.0 22.1 22.2 9.8 8.7 19.8 19.7 15.0 15.4 33.0 23.6 35.9 5.8 5.5 13.8 9.2 8.7 11.1 10.9 9.2 11.8 10.6 15.8 8.8 10.6 8.5 1.3 13.7 14.6 5.9 11.9 5.9 57.8 54.5 13.4 37.9 44.1 35.3 40.6 30.8 31.1 33.2 20.8 19.2 40.4 53.0 94.2 20.7 49.8 53.5 17.4 45.5 57.6 35.3 77.3 132.6 27.7 11.2 45.6 54.7 46.7 29.4 52.4 55.2 96.0 43.7 357.2 63.1 14.3 37.8 50.3 67.1 18.7 81.4 68.2 99.5 30.7 44.6 133.3 37.2 42.1 85.2 119.8 60.1 64.7 76.2 9.6 6.4 107.0 39.8 55.4 40.7 75.9 GLUD2 GLUDP1 ENSG00000182890 "Glutamate dehydrogenase 2" P49448 X 121047588-121050080 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.3;testis: 31.9" "Cell type enhanced" "Detected in some" 6 "Cytotrophoblasts: 2.7;Hepatocytes: 3.2;Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 8.0;K-562: 8.8;SK-MEL-30: 11.3;THP-1: 5.6;WM-115: 12.7" "HPA042492, HPA044839, HPA061369" Uncertain Approved Mitochondria NA NA Mitochondria "HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494" "unprognostic (1.44e-1)" "unprognostic (5.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.27e-3)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (2.42e-1)" "unprognostic (2.61e-1)" "unprognostic (2.35e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (4.77e-3)" "unprognostic (5.96e-2)" 3.1 2.5 4.8 0.8 7.3 0.5 1.6 2.2 3.5 1.1 0.7 2.0 0.6 0.6 1.0 5.2 0.7 1.0 1.6 1.5 5.7 1.8 4.7 11.3 0.9 0.9 2.7 6.2 0.7 1.5 0.7 0.7 2.7 4.3 0.8 0.6 0.2 0.9 3.1 0.7 0.8 1.0 1.0 1.5 0.5 0.9 31.9 4.1 0.0 1.4 0.0 0.8 0.8 0.6 0.8 1.2 0.7 1.1 1.2 0.7 0.4 0.0 2.1 0.5 0.0 0.0 0.0 0.1 0.6 0.6 0.1 0.3 0.0 1.1 0.0 0.8 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 1.7 0.0 0.0 1.6 4.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 11.3 0.3 2.7 5.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.6 0.8 0.7 0.4 1.1 0.7 0.8 0.7 0.7 1.2 0.4 0.7 0.5 0.0 1.2 1.1 0.2 0.7 0.4 4.8 7.3 2.2 3.5 5.7 1.8 2.7 6.2 4.3 4.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.0 2.7 1.7 0.1 1.8 0.0 0.0 0.0 0.3 0.3 0.6 0.3 0.0 3.2 0.5 0.0 0.0 0.0 1.9 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.9 1.1 0.1 2.1 0.0 0.0 0.1 GLYAT "ACGNAT, GAT" ENSG00000149124 Glycine-N-acyltransferase Q6IB77 11 58640426-58731974 "Enzymes, Predicted intracellular proteins" Detoxification "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "kidney: 91.2;liver: 115.1" "Group enriched" "Detected in some" 7 "Hepatocytes: 306.5;Proximal tubular cells: 1137.1" "Group enriched" "Detected in some" 158 "liver cancer: 21.7;renal cancer: 25.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 0.7" "HPA040251, HPA044094" Enhanced NA NA "HPA040251: AB_2676902, HPA044094: AB_2678807" "unprognostic (2.15e-2)" "unprognostic (9.38e-4)" "unprognostic (4.60e-2)" "unprognostic (1.65e-3)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "prognostic favorable (1.31e-6)" "unprognostic (2.69e-1)" 11.1 0.0 0.1 0.1 0.1 0.0 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 4.5 0.1 0.0 0.1 0.2 0.1 0.0 91.2 115.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.3 1.1 0.7 2.9 0.7 0.2 0.8 0.0 1.5 0.6 1.0 3.3 3.3 2.1 2.1 0.9 0.9 1.5 0.9 0.4 2.0 2.4 1.4 1.4 0.5 1.5 2.3 2.4 2.0 0.1 0.7 3.2 0.6 3.4 2.4 1.8 1.8 2.4 7.6 2.6 2.7 1.3 2.9 1.8 0.9 1.3 3.7 1.2 2.1 3.5 3.0 2.4 1.0 1.4 2.2 0.5 6.8 1.6 0.8 2.5 1.7 1.4 1.4 3.1 2.4 1.5 1.7 1.9 2.0 2.1 1.2 1.5 2.2 1.1 0.6 4.6 2.0 1.0 0.7 0.3 0.4 0.3 0.4 0.1 0.4 0.8 0.2 1.1 0.5 0.5 2.9 0.2 0.3 0.7 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.2 10.2 0.0 0.0 29.6 0.0 0.0 104.5 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 306.5 0.0 0.0 0.0 9.2 8.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1137.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GLYATL1 "FLJ34646, MGC15397" ENSG00000166840 "Glycine-N-acyltransferase like 1" Q969I3 11 58905398-59043527 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 113.8" "Cell type enhanced" "Detected in some" 31 "Distal tubular cells: 91.2;Hepatocytes: 198.3;Proximal tubular cells: 523.1" "Group enriched" "Detected in some" 8 "liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "CACO-2: 3.9;Daudi: 9.7;RPTEC TERT1: 3.3;U-2197: 2.5" HPA039501 Supported Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (9.46e-3)" "unprognostic (5.33e-2)" "unprognostic (3.90e-5)" "unprognostic (3.93e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-1)" "prognostic favorable (3.69e-4)" "unprognostic (3.62e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (2.92e-1)" "prognostic favorable (3.03e-5)" "unprognostic (1.50e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 27.7 113.8 0.1 0.0 0.2 0.0 0.2 0.2 0.9 0.1 0.0 0.5 2.1 0.0 0.5 1.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.1 1.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 1.3 0.0 0.5 0.2 1.1 0.9 3.9 0.0 9.7 0.0 0.7 0.8 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.6 2.2 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 3.3 0.0 0.2 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.2 0.1 2.5 1.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.3 17.8 0.0 0.0 14.0 0.0 0.0 91.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 198.3 0.0 0.0 0.0 1.8 6.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 523.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 GLYATL1B GLYATL1P3 ENSG00000255151 "Glycine-N-acyltransferase like 1B" 11 59086307-59094786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 4.9;breast: 12.5;lymphoid tissue: 4.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Group enriched" "Detected in some" 17 "memory B-cell: 1.9;naive B-cell: 4.9" "Lineage enriched" "Detected in single" 24 "B-cells: 4.9" "Cell line enhanced" "Detected in some" "Daudi: 4.9;JURKAT: 2.0;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 5.0" HPA039501 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA039501: AB_2676545" "unprognostic (1.39e-1)" "unprognostic (3.46e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (5.20e-2)" "unprognostic (2.62e-1)" "unprognostic (2.11e-1)" "unprognostic (3.21e-4)" "unprognostic (3.45e-1)" 0.0 0.0 1.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.1 2.2 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.5 2.5 0.2 5.0 1.6 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYATL2 "BXMAS2-10, MGC24009" ENSG00000156689 "Glycine-N-acyltransferase like 2" Q8WU03 11 58834065-58904215 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 11.2;cervix, uterine: 18.8;lymphoid tissue: 9.9;salivary gland: 25.8" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 2.2;Glandular cells: 1.9;Melanocytes: 1.7;Sertoli cells: 6.5;Suprabasal keratinocytes: 1.8;Urothelial cells: 1.8" "Cancer enhanced" "Detected in many" "breast cancer: 16.7;endometrial cancer: 15.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.2;HAP1: 6.6;SK-BR-3: 15.8;U-2197: 7.6" "Not detected" "Not detected" "HPA060292, HPA065454" Uncertain Approved Mitochondria NA NA Mitochondria "HPA060292: AB_2684245, HPA065454: " "unprognostic (1.02e-2)" "unprognostic (3.79e-3)" "unprognostic (8.11e-4)" "prognostic favorable (9.05e-7)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "unprognostic (2.66e-2)" "unprognostic (9.98e-3)" "unprognostic (1.27e-1)" "unprognostic (9.18e-3)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (7.42e-5)" "unprognostic (7.79e-3)" "unprognostic (8.28e-2)" "unprognostic (9.11e-3)" "unprognostic (2.31e-2)" 0.4 0.0 0.4 0.1 0.2 0.0 11.2 0.1 0.3 18.8 0.1 0.1 0.1 0.1 1.2 0.1 0.8 0.1 6.6 0.2 0.3 0.4 0.1 0.1 0.6 0.2 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.0 0.1 25.8 0.1 0.1 1.2 0.1 0.1 1.5 1.1 0.1 0.1 0.1 0.1 0.1 4.4 9.9 0.1 0.3 0.4 0.1 2.1 0.4 0.2 0.2 0.9 0.0 0.0 0.5 0.0 0.9 3.1 0.0 1.9 5.9 2.6 4.2 0.0 0.0 0.2 0.0 1.6 1.2 0.5 6.6 0.0 2.2 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.0 0.6 0.2 2.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 15.8 0.0 0.0 0.0 0.0 0.0 2.2 0.1 7.6 2.3 0.0 0.0 0.1 0.0 0.0 0.8 0.8 0.2 0.2 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.1 2.1 0.2 0.0 0.1 0.0 0.9 0.4 0.2 0.1 0.3 0.3 0.4 0.6 0.1 0.1 0.1 0.0 0.0 0.0 2.2 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 6.5 1.0 0.0 0.0 1.8 0.0 0.0 0.0 1.8 GLYATL3 "bA28H17.2, C6orf140" ENSG00000203972 "Glycine-N-acyltransferase like 3" Q5SZD4 6 49499958-49527047 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "intestine: 2.0;liver: 5.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 73 "T-47d: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044044 Uncertain NA NA "HPA044044: AB_10960855" "unprognostic (3.57e-1)" "unprognostic (6.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GLYCTK "HBEBP2, HBEBP4" ENSG00000168237 "Glycerate kinase" Q8IVS8 3 52287089-52293476 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 108.4" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 46.7;Hepatocytes: 151.6;Proximal tubular cells: 59.6" "Cancer enriched" "Detected in all" 6 "liver cancer: 52.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.0;Hep G2: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006913 Approved Approved "Golgi apparatus,Cytosol,Rods & Rings" NA NA Cytosol "Golgi apparatus, Rods & Rings" "HPA006913: AB_1078993" "unprognostic (1.51e-2)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.64e-4)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (7.73e-3)" "unprognostic (1.82e-1)" "unprognostic (3.36e-3)" "unprognostic (2.15e-1)" "unprognostic (3.30e-2)" "unprognostic (3.42e-1)" "unprognostic (3.77e-1)" "unprognostic (3.82e-2)" "unprognostic (9.00e-3)" 6.4 4.9 1.9 8.4 5.0 5.2 4.8 2.7 6.2 2.3 7.9 7.1 4.2 23.8 4.3 4.8 2.8 2.5 7.2 2.7 1.9 2.2 10.7 108.4 3.1 6.5 2.5 4.9 2.3 3.6 1.9 2.5 3.1 3.9 2.8 3.5 4.7 3.2 3.0 7.0 1.9 17.8 1.9 1.8 5.5 6.0 2.7 1.8 3.3 3.1 2.4 5.9 2.7 2.2 8.3 9.1 10.9 9.5 5.7 11.8 6.3 2.3 5.6 3.0 1.1 16.1 2.2 1.8 2.5 2.6 4.8 3.5 19.0 1.9 5.9 1.6 2.2 3.6 1.5 1.7 6.2 0.9 1.6 2.0 8.3 6.7 25.2 1.6 2.7 5.0 2.2 3.1 7.0 2.7 1.6 9.0 4.8 2.3 4.3 3.6 1.7 4.6 2.2 1.6 12.2 4.6 1.6 2.7 8.9 4.8 3.2 2.2 2.2 2.4 1.3 2.5 0.9 3.2 1.3 3.9 3.7 4.4 2.4 4.8 4.6 3.1 3.9 2.6 4.5 2.8 3.0 9.5 10.9 11.8 5.1 6.1 8.3 9.0 10.3 9.1 5.7 6.8 10.1 7.8 5.7 6.1 5.6 11.7 6.3 1.9 5.0 2.7 6.2 1.9 2.2 2.5 4.9 3.9 1.8 6.0 2.7 9.3 2.6 0.3 1.4 1.2 15.3 1.4 2.3 8.7 0.0 6.7 16.6 4.3 0.1 4.4 29.7 46.7 5.4 4.3 2.1 2.5 1.1 151.6 11.4 0.0 22.4 12.9 16.5 0.0 1.1 7.2 3.3 6.4 9.1 1.0 3.5 34.5 0.0 59.6 1.5 0.0 0.2 0.2 7.7 1.1 9.3 10.2 11.5 3.1 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 108.7" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 163.9;Hofbauer cells: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4" "Cell line enhanced" "Detected in many" "BEWO: 44.5;HBEC3-KT: 61.5;hTCEpi: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 23000000 "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 55.8 16.1 17.8 15.5 18.8 9.6 15.2 8.1 15.2 20.5 10.3 31.7 6.4 8.4 9.5 17.3 39.5 8.8 12.6 13.8 18.0 12.6 7.5 13.2 24.8 30.2 22.4 13.0 12.2 9.3 11.7 5.6 108.7 18.9 11.9 14.5 14.1 13.3 10.4 3.9 42.8 11.2 10.9 35.9 28.5 8.2 8.9 15.3 21.9 7.1 25.9 39.7 21.0 32.0 15.9 19.0 4.2 19.4 1.9 3.3 8.0 4.6 3.0 3.2 15.3 21.3 10.6 44.5 7.3 15.8 4.0 5.5 6.3 5.4 15.0 7.7 5.6 11.0 12.7 3.5 61.5 5.8 8.4 2.2 2.4 3.8 7.7 5.2 3.9 25.2 14.2 61.3 5.2 3.5 5.6 5.8 19.1 2.3 6.5 6.3 1.9 8.2 3.7 2.2 2.3 6.9 3.7 1.5 9.4 3.9 9.1 0.8 2.9 6.0 28.4 12.0 11.7 6.5 4.6 5.1 10.0 3.9 8.2 2.2 16.2 19.3 41.1 11.4 6.2 4.1 3.5 19.4 1.1 1.9 6.5 1.4 14.9 2.3 2.0 19.0 15.9 3.3 2.5 4.2 1.9 1.4 13.7 2.4 8.0 17.8 18.8 8.1 13.9 18.0 12.6 22.4 13.0 18.9 15.3 14.9 23.1 14.7 13.3 13.3 4.5 26.2 0.0 13.4 12.5 17.4 2.0 45.1 1.7 5.8 0.4 6.3 4.6 0.0 6.9 163.9 8.0 7.4 66.0 16.3 98.1 6.4 3.5 7.4 38.4 1.1 7.5 34.4 8.5 55.1 5.0 8.0 5.4 3.5 13.1 4.5 3.1 0.0 5.7 1.4 4.9 20.8 43.8 3.8 5.6 32.5 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489196 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1000000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favorable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 14.2 13.2 37.9 12.9 26.7 14.2 15.3 25.1 41.6 11.8 19.8 23.9 6.1 19.1 11.6 8.5 9.3 8.4 9.7 9.6 36.7 30.1 19.9 14.7 13.8 13.3 36.9 28.3 9.8 7.3 10.1 13.6 17.9 25.6 9.0 20.7 6.6 7.0 8.0 4.1 7.8 17.5 10.5 54.4 10.1 10.7 6.2 21.7 6.4 12.8 6.1 13.5 10.0 7.4 9.1 12.8 16.4 14.5 9.0 8.8 6.8 30.9 12.6 25.1 18.4 27.2 34.0 18.8 31.8 23.4 23.1 28.9 14.4 27.5 28.5 15.0 31.2 13.9 11.5 25.3 22.0 36.6 10.3 8.7 14.3 14.1 13.3 23.2 19.9 12.5 25.7 20.6 20.0 19.8 24.1 20.8 13.2 10.4 10.1 36.5 15.4 12.1 7.7 16.2 17.6 13.4 12.3 29.5 8.2 29.5 29.5 14.9 23.2 22.1 18.9 24.1 21.7 20.8 15.8 16.4 33.6 25.5 17.0 19.7 3.6 6.3 17.8 28.3 12.3 21.2 8.7 11.0 9.2 6.1 13.5 8.5 7.6 7.2 6.0 12.8 9.1 7.8 8.2 16.4 9.0 14.5 5.2 8.8 6.8 37.9 26.7 25.1 33.5 36.7 30.1 36.9 28.3 25.6 21.7 23.8 14.4 20.4 43.8 53.1 17.7 15.0 22.9 8.1 19.4 24.4 3.9 33.3 18.3 34.4 20.5 17.5 29.2 0.0 20.1 73.0 27.8 40.5 21.8 23.6 41.6 20.6 28.7 16.0 30.4 3.9 18.7 44.4 43.9 37.9 30.3 17.7 30.2 31.6 14.9 40.9 14.6 12.9 26.8 12.6 9.8 38.1 48.7 22.4 32.6 39.2 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5" "Cell type enhanced" "Detected in many" 8 "B-cells: 303.1;Hofbauer cells: 397.1;Ito cells: 301.4;Kupffer cells: 575.9;Macrophages: 461.8;T-cells: 456.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 77.0;JURKAT: 55.8;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1500000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favorable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 22.6 6.1 7.3 29.6 7.4 80.9 16.8 2.2 4.8 6.0 8.8 4.0 1.7 5.3 4.4 9.4 6.4 7.3 8.7 7.5 6.0 4.9 9.4 9.7 28.5 42.2 8.6 2.3 4.7 3.6 1.1 3.1 18.0 5.8 6.1 7.9 4.9 8.1 2.3 5.4 4.2 17.8 6.8 8.2 86.0 5.9 2.9 5.6 109.5 9.8 7.0 37.1 11.1 7.5 39.1 57.2 276.5 79.4 41.6 88.0 106.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.8 33.5 0.3 0.0 0.0 0.2 0.0 0.1 0.1 11.3 0.0 36.4 0.0 0.5 0.6 39.0 77.0 0.1 0.0 0.0 0.1 0.1 2.0 55.8 1.3 59.8 0.3 0.0 35.5 43.6 0.0 0.0 0.0 49.0 0.4 21.9 0.0 5.2 0.1 0.0 0.1 0.2 0.2 0.0 0.1 76.8 20.0 0.0 0.4 0.1 0.1 3.4 11.6 38.3 0.2 52.7 0.3 185.2 79.4 178.1 37.7 72.3 40.0 39.1 56.7 46.6 57.2 35.0 55.9 46.4 276.5 41.6 78.9 22.2 88.0 106.7 7.3 7.4 2.2 4.8 6.0 4.9 8.6 2.3 5.8 5.6 26.8 152.0 303.1 2.8 16.6 0.0 3.1 10.2 16.0 31.8 0.0 0.0 3.0 0.0 0.8 9.5 165.1 0.3 23.3 0.6 3.4 16.0 1.1 229.0 5.5 397.1 0.0 0.0 301.4 575.9 18.8 1.7 461.8 70.9 127.2 0.3 0.3 0.3 0.0 0.4 3.9 0.0 45.3 14.6 8.1 3.0 12.9 4.6 456.6 0.3 1.4 GMIP ARHGAP46 ENSG00000089639 "GEM interacting protein" Q9P107 19 19629476-19643667 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 20.7;Kupffer cells: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042484, HPA045481" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042484: AB_2678018, HPA045481: AB_2679343" "unprognostic (7.54e-2)" "unprognostic (5.35e-3)" "unprognostic (3.10e-3)" "unprognostic (4.54e-3)" "unprognostic (1.44e-1)" "unprognostic (1.24e-3)" "unprognostic (1.23e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.30e-1)" "unprognostic (6.85e-2)" "unprognostic (6.75e-3)" "prognostic unfavorable (3.97e-5)" "prognostic favorable (3.03e-4)" "unprognostic (4.92e-2)" "unprognostic (2.54e-1)" "prognostic favorable (5.15e-4)" 6.1 2.8 3.5 20.3 4.9 31.0 4.0 0.9 4.1 2.9 6.9 4.3 2.7 7.0 2.7 3.2 6.2 4.4 7.9 3.3 4.3 3.4 4.2 3.9 11.7 28.0 4.2 2.5 2.4 4.6 10.6 3.0 3.9 3.4 4.1 4.6 2.7 6.0 4.5 1.5 4.9 15.3 2.9 4.9 40.0 11.1 2.2 3.1 26.8 6.2 2.7 23.2 6.1 4.5 6.6 6.7 32.7 13.9 4.2 6.4 4.6 4.4 2.1 2.8 3.0 3.1 1.6 11.2 2.8 2.5 1.7 1.6 1.7 6.1 11.0 5.8 2.0 2.2 5.4 1.8 3.1 1.1 3.8 2.8 3.5 3.3 1.8 0.9 9.8 43.8 2.0 2.1 1.8 1.0 2.0 3.8 9.9 2.3 4.0 1.8 6.6 6.1 16.2 1.6 5.8 3.8 10.6 1.2 6.3 3.2 10.7 2.4 7.2 3.9 4.1 1.6 2.2 3.8 14.1 7.0 3.2 1.8 3.6 2.1 2.0 0.8 9.1 2.0 12.9 2.1 2.9 8.3 21.5 6.4 10.6 5.9 5.9 4.0 5.7 6.7 6.6 4.5 4.6 32.7 4.2 13.9 6.1 4.5 4.6 3.5 4.9 0.9 4.1 4.3 3.4 4.2 2.5 3.4 3.1 0.0 15.1 15.6 1.1 1.0 0.0 0.6 2.5 1.4 2.3 0.0 0.0 0.5 0.0 3.8 0.1 1.4 13.3 0.0 4.2 4.6 0.9 1.6 6.9 0.9 20.7 0.0 0.0 2.5 34.3 0.0 0.6 16.5 1.7 17.2 6.3 0.2 9.4 12.2 0.7 0.6 0.0 0.0 0.9 0.1 1.5 1.0 0.7 15.9 5.8 2.6 GML LY6DL ENSG00000104499 "Glycosylphosphatidylinositol anchored molecule like" Q99445 8 142834247-142916506 "Predicted intracellular proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "adrenal gland: 68.3" "Cell type enhanced" "Detected in some" 28 "granulocytes: 4.6;Sertoli cells: 6.5;Spermatocytes: 24.7;Spermatogonia: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Lineage enhanced" "Detected in single" "T-cells: 2.2" "Group enriched" "Detected in some" 19 "HMC-1: 1.2;JURKAT: 2.1;SK-MEL-30: 1.6;U-937: 2.5" "Intracellular and membrane" NA NA 0.0 68.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 0.0 2.2 0.0 0.8 1.4 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 24.7 7.2 0.0 0.0 0.0 0.0 0.0 GMNC GEMC1 ENSG00000205835 "Geminin coiled-coil domain containing" A6NCL1 3 190852877-190892429 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 12.7;kidney: 26.9;liver: 8.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 8.1;Early spermatids: 8.8;Hepatocytes: 5.7;Proximal tubular cells: 6.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 4.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043663 Uncertain NA NA "HPA043663: AB_10959313" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (5.45e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.22e-3)" "unprognostic (2.73e-2)" "unprognostic (2.55e-3)" 0.1 0.1 3.5 0.1 2.9 0.1 0.1 0.2 0.7 0.8 0.1 5.0 0.0 0.1 2.0 4.4 0.1 12.7 0.1 0.9 4.6 1.4 26.9 8.5 0.1 0.1 0.6 0.9 0.5 1.1 0.1 0.2 0.3 4.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 2.0 0.1 0.1 2.3 3.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.9 0.2 0.7 4.6 1.4 0.6 0.9 4.2 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.1 0.0 0.0 2.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 GMNN Gem ENSG00000112312 "Geminin, DNA replication inhibitor" O75496 6 24774931-24786099 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "DNA replication inhibitor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 95.0" "Cell type enhanced" "Detected in many" 8 "Paneth cells: 272.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011458, CAB047327, CAB047328, HPA049977, HPA054597" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538" "unprognostic (1.37e-1)" "unprognostic (3.43e-3)" "unprognostic (3.91e-3)" "unprognostic (1.52e-2)" "unprognostic (1.28e-1)" "unprognostic (4.37e-2)" "unprognostic (2.90e-3)" "unprognostic (8.29e-2)" "unprognostic (1.23e-3)" "prognostic favorable (4.13e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (1.33e-2)" "prognostic unfavorable (7.82e-5)" "unprognostic (2.25e-1)" "unprognostic (7.92e-2)" "unprognostic (3.63e-2)" "unprognostic (5.90e-3)" 4.5 3.9 10.7 11.2 19.0 24.1 10.7 15.6 9.4 4.9 17.1 3.2 9.7 7.6 5.3 6.3 8.0 7.3 4.7 3.7 11.0 10.2 10.8 8.4 4.4 12.0 13.6 9.8 7.2 95.0 2.6 7.5 7.9 10.7 18.4 18.9 3.4 4.2 11.6 3.7 17.3 7.4 5.7 7.9 12.6 9.7 19.6 11.9 26.1 13.2 11.0 9.7 15.2 7.4 8.5 9.2 15.8 6.7 5.3 15.2 5.6 24.9 14.8 37.6 15.5 5.3 5.7 25.1 24.5 13.0 29.5 32.4 28.7 9.0 25.1 31.3 7.9 21.7 14.7 32.5 18.1 31.8 9.3 34.0 34.4 26.4 47.0 5.0 26.7 12.6 4.6 5.9 17.9 7.0 6.1 14.5 19.6 43.2 13.4 20.8 19.5 50.1 28.9 20.5 20.4 11.7 29.2 29.4 32.2 12.4 21.8 30.2 18.6 11.0 18.2 21.6 22.1 19.1 16.4 7.1 18.1 18.3 20.8 41.5 14.9 45.7 47.1 5.5 50.4 25.9 5.3 5.3 15.8 4.6 6.7 5.8 8.5 8.9 7.1 7.4 4.5 6.6 7.3 3.0 5.3 4.7 9.2 15.2 5.6 10.7 19.0 15.6 9.4 11.0 10.2 13.6 9.8 10.7 11.9 6.0 14.1 15.7 25.3 29.3 8.9 9.4 15.3 33.5 52.4 41.8 2.0 52.0 8.3 78.3 58.9 14.3 21.2 0.0 100.1 110.5 15.8 27.7 12.7 15.3 45.0 11.1 24.9 9.8 9.2 17.5 8.9 12.4 21.9 19.8 24.9 29.4 43.9 272.7 10.3 14.6 12.1 19.4 12.3 132.2 59.4 55.6 40.7 17.5 87.0 19.7 GMPR ENSG00000137198 "Guanosine monophosphate reductase" P36959 6 16238580-16295549 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 103.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 72.9;Erythroid cells: 186.9;Glandular cells: 74.5;Melanocytes: 87.7;Peritubular cells: 76.0" "Cancer enhanced" "Detected in all" "melanoma: 95.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.8;NK-cell: 8.3" "Group enriched" "Detected in many" 5 "granulocytes: 7.8;monocytes: 4.2;NK-cells: 8.3" "Cell line enhanced" "Detected in many" "HEL: 46.2;HMC-1: 78.9;SK-MEL-30: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA021476" Uncertain NA NA 3800000 "HPA000904: AB_1078998, HPA021476: AB_1849858" "unprognostic (2.74e-1)" "unprognostic (1.05e-1)" "unprognostic (2.14e-1)" "unprognostic (4.97e-3)" "unprognostic (3.52e-2)" "unprognostic (1.05e-1)" "unprognostic (3.06e-1)" "prognostic favorable (8.07e-4)" "unprognostic (4.12e-1)" "prognostic favorable (2.06e-4)" "unprognostic (3.15e-1)" "unprognostic (2.86e-1)" "prognostic favorable (2.94e-5)" "unprognostic (3.01e-1)" "unprognostic (1.81e-1)" "unprognostic (7.31e-2)" "unprognostic (2.17e-1)" 2.8 7.3 14.6 1.4 11.0 9.6 6.5 3.8 6.9 2.7 3.7 9.1 2.0 1.5 4.2 7.9 2.5 22.4 1.9 31.5 13.3 11.5 10.3 2.7 3.7 2.5 14.0 5.7 15.7 7.4 4.4 6.8 3.4 21.3 25.5 1.8 22.0 5.2 4.2 103.3 4.3 1.5 4.3 11.8 3.3 8.3 25.1 10.9 1.4 2.7 16.2 1.5 2.0 1.2 0.7 1.3 7.8 4.2 8.3 1.0 14.1 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.9 3.8 6.8 13.9 0.3 0.1 0.0 2.2 1.4 4.8 0.0 1.6 0.2 1.1 0.0 1.2 46.2 0.0 0.0 3.0 0.2 78.9 0.9 0.7 2.1 0.0 5.6 12.2 0.1 10.3 0.0 1.2 0.9 0.0 0.9 0.4 0.0 1.8 0.0 10.4 0.0 9.0 1.3 2.3 0.3 0.4 0.8 17.6 3.1 0.7 0.3 3.0 0.1 0.0 0.3 1.8 0.5 0.0 0.0 0.2 4.9 5.3 7.8 2.9 0.4 0.6 4.2 1.0 0.2 0.1 0.4 1.3 0.7 0.0 0.2 3.0 8.3 1.3 1.2 0.0 14.1 14.6 11.0 3.8 6.9 13.3 11.5 14.0 5.7 21.3 10.9 0.0 0.0 0.5 29.7 4.5 0.9 50.8 22.9 8.1 2.3 19.2 0.0 23.1 72.9 10.6 10.2 5.8 0.8 186.9 4.4 2.8 6.1 74.5 56.3 2.9 8.0 0.0 7.5 11.1 2.2 8.5 31.9 4.3 87.7 10.8 2.3 7.3 3.2 0.3 76.0 10.4 0.4 0.0 8.5 4.7 17.0 1.6 5.7 1.3 2.5 5.8 GNA11 "FBH, FBH2, FHH2, HHC2" ENSG00000088256 "G protein subunit alpha 11" P29992 19 3094410-3124004 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 103.3" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048886 Approved NA NA "HPA048886: AB_2680544" "unprognostic (4.64e-3)" "unprognostic (2.21e-1)" "unprognostic (3.12e-1)" "unprognostic (2.23e-2)" "unprognostic (1.30e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (4.86e-4)" "unprognostic (2.56e-2)" "unprognostic (1.40e-1)" "unprognostic (6.26e-2)" "unprognostic (7.85e-3)" "unprognostic (2.43e-1)" "prognostic favorable (1.48e-11)" "unprognostic (1.05e-2)" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (3.02e-1)" 19.3 14.2 17.3 13.7 17.1 5.9 14.2 38.5 28.0 16.1 40.8 18.6 18.3 65.9 19.8 14.5 17.2 19.8 19.5 21.9 16.0 12.8 17.8 16.6 15.1 5.0 11.7 12.6 19.4 19.6 14.2 13.8 20.0 14.1 18.2 23.0 27.1 17.5 30.5 27.3 20.0 103.3 17.6 12.2 10.5 17.2 20.1 12.5 3.9 18.0 13.5 7.6 19.2 22.1 2.4 3.9 9.1 2.4 0.7 2.2 0.4 20.5 12.6 11.4 19.8 16.9 11.2 12.6 20.5 20.4 27.7 22.7 15.7 10.6 5.1 11.3 28.5 17.1 15.0 14.4 16.3 17.7 11.1 8.5 1.4 13.6 9.0 16.7 1.3 4.6 15.4 14.2 18.7 11.3 14.3 22.0 1.7 10.3 1.0 18.5 9.6 1.4 6.1 7.9 14.3 11.3 9.0 10.1 4.7 13.4 16.1 25.8 16.3 14.7 17.6 10.2 7.8 12.7 2.9 18.9 18.3 13.0 33.0 27.3 0.5 1.5 3.3 13.1 1.1 19.8 2.8 2.4 0.5 1.1 1.3 1.4 1.3 0.9 1.1 0.4 2.4 2.2 1.6 9.1 0.7 2.4 3.9 0.3 0.4 17.3 17.1 38.5 28.0 16.0 12.8 11.7 12.6 14.1 12.5 29.8 23.7 9.0 7.9 29.0 17.2 15.5 38.2 22.7 6.8 26.2 35.3 11.2 6.6 18.6 27.8 23.8 264.0 0.0 21.8 10.5 18.3 14.0 4.6 26.3 7.4 42.9 52.5 62.6 6.2 13.4 46.3 3.2 21.9 0.0 73.7 28.4 28.3 80.7 75.7 16.1 14.9 19.4 17.3 17.6 9.1 36.0 17.0 2.2 62.2 12.7 GNA13 "G13, MGC46138" ENSG00000120063 "G protein subunit alpha 13" Q14344 17 65010715-65056839 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010087 Approved Supported Cytosol NA NA 4000000 Cytosol "HPA010087: AB_10601478" "unprognostic (2.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.33e-3)" "unprognostic (1.23e-3)" "unprognostic (8.21e-2)" "unprognostic (7.05e-2)" "unprognostic (4.22e-3)" "unprognostic (1.09e-1)" "unprognostic (7.77e-2)" "unprognostic (4.66e-1)" "unprognostic (1.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" 28.2 17.4 16.4 25.3 17.5 75.6 15.1 15.1 15.0 14.2 19.1 23.0 13.0 14.0 12.9 12.1 13.2 12.1 17.7 15.4 16.8 13.3 12.4 17.4 27.6 27.5 18.5 9.4 16.3 10.0 12.1 10.0 25.0 14.8 16.8 17.3 10.7 10.5 13.9 35.0 11.4 17.5 15.9 32.1 22.5 13.6 11.3 20.4 34.9 11.9 9.0 27.5 28.3 26.0 5.7 5.5 15.8 13.4 7.8 11.2 4.4 11.8 13.4 12.4 8.3 12.8 11.6 12.8 9.2 10.8 12.7 14.5 7.5 8.0 48.4 6.1 9.9 15.6 8.2 13.1 11.3 19.6 12.5 7.6 25.2 8.2 14.7 18.6 18.8 16.8 9.8 17.3 12.3 16.9 11.5 19.1 13.1 10.2 30.2 14.7 11.2 28.9 6.8 7.6 11.5 10.0 16.7 24.7 17.6 12.8 19.5 9.1 19.1 6.7 14.1 15.8 25.0 14.5 18.4 13.7 21.2 18.6 9.1 12.1 22.4 26.6 55.0 7.7 12.3 11.2 7.1 6.4 8.5 7.2 13.4 7.3 5.7 8.9 8.5 5.5 4.8 5.2 5.7 15.8 7.8 8.3 2.5 11.2 4.4 16.4 17.5 15.1 15.0 16.8 13.3 18.5 9.4 14.8 20.4 11.9 15.4 28.6 22.0 60.2 5.4 10.3 15.3 9.4 5.7 8.7 3.9 13.6 6.6 10.8 3.2 27.0 28.1 23.3 9.9 12.6 19.5 23.8 29.0 13.7 52.3 6.4 16.1 31.9 52.2 6.3 10.6 56.9 65.8 36.9 12.7 31.7 11.8 16.1 22.6 12.2 5.9 32.3 25.0 5.4 15.6 57.6 11.7 39.9 12.9 27.4 GNA15 GNA16 ENSG00000060558 "G protein subunit alpha 15" P30679 19 3136193-3163769 "Plasma proteins, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.4;esophagus: 46.0;lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 95.5;Suprabasal keratinocytes: 83.7;Urothelial cells: 166.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 31.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 19.9;HMC-1: 46.9;MOLT-4: 46.9;NB-4: 17.6;REH: 35.1;THP-1: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043113 Approved NA NA "HPA043113: AB_10967343" "prognostic favorable (7.57e-5)" "unprognostic (6.06e-2)" "unprognostic (3.43e-1)" "prognostic favorable (2.01e-4)" "unprognostic (4.34e-2)" "unprognostic (2.09e-1)" "unprognostic (1.14e-2)" "unprognostic (5.38e-3)" "unprognostic (1.82e-1)" "unprognostic (3.22e-2)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (4.26e-6)" "unprognostic (1.04e-1)" "unprognostic (2.16e-3)" "unprognostic (2.36e-1)" "unprognostic (2.07e-1)" 4.9 1.7 1.6 7.2 2.3 37.4 3.9 1.1 2.0 7.9 1.3 1.6 1.0 1.0 0.8 1.8 46.0 1.3 2.8 2.6 1.6 1.1 1.3 1.2 7.6 3.7 3.1 1.3 1.0 0.7 0.2 0.8 4.5 2.7 5.9 1.1 1.3 9.2 1.7 0.8 20.0 1.1 1.8 2.8 5.6 2.5 1.1 2.2 42.2 0.7 29.0 25.3 10.4 16.2 0.0 31.0 6.2 12.6 2.1 3.9 5.1 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 10.9 0.0 19.9 0.0 0.0 0.0 5.6 0.0 0.0 0.0 8.0 46.9 0.0 12.4 0.0 8.2 0.0 0.0 5.0 0.0 0.1 0.0 0.0 46.9 17.6 0.0 0.8 0.0 35.1 0.0 0.0 0.0 7.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 5.8 12.6 6.2 0.0 9.7 0.5 0.0 1.0 0.1 13.0 0.0 0.0 0.0 3.1 2.1 6.5 31.0 3.9 5.1 1.6 2.3 1.1 2.0 1.6 1.1 3.1 1.3 2.7 2.2 8.9 9.1 0.0 95.5 59.6 0.1 0.6 0.0 1.4 12.5 3.5 0.0 0.4 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.5 5.6 57.4 34.5 0.0 58.7 0.0 6.3 0.6 33.9 0.4 0.0 47.4 20.3 30.7 1.8 0.0 7.7 0.0 0.0 0.0 0.0 19.4 4.1 3.2 2.2 83.7 0.3 1.3 1.4 166.1 GNAL ENSG00000141404 "G protein subunit alpha L" P38405 18 11688956-11885685 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.7" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 15.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 82.7" "Group enriched" "Detected in some" 4 "basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7" "Group enriched" "Detected in many" 5 "granulocytes: 1.7;T-cells: 4.2" "Cell line enhanced" "Detected in many" "Daudi: 18.4;HeLa: 18.8;U-2 OS: 9.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 13 "basal ganglia: 183.9" "CAB015464, HPA051160" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015464: AB_831819, HPA051160: AB_2732564" "unprognostic (2.29e-3)" "unprognostic (7.43e-2)" "unprognostic (8.14e-3)" "unprognostic (3.41e-5)" "unprognostic (4.71e-2)" "unprognostic (9.58e-3)" "unprognostic (9.93e-3)" "unprognostic (1.87e-1)" "unprognostic (2.36e-1)" "unprognostic (7.17e-2)" "unprognostic (1.82e-3)" "unprognostic (6.05e-2)" "unprognostic (1.23e-3)" "unprognostic (1.09e-1)" "unprognostic (3.85e-2)" "unprognostic (4.26e-2)" "unprognostic (7.03e-2)" 7.2 1.5 17.8 3.0 82.7 0.7 4.2 2.7 18.1 8.0 3.7 3.2 3.3 1.6 6.7 2.4 8.2 4.1 4.6 2.2 7.1 7.6 4.2 1.3 2.5 5.1 6.6 5.3 3.2 1.3 1.0 20.7 2.9 8.8 9.9 3.7 2.1 4.6 18.1 18.3 7.0 2.0 9.9 3.3 1.8 2.1 6.2 11.3 0.9 8.0 1.4 5.7 9.5 7.7 0.4 0.2 1.7 0.2 0.5 4.2 1.4 0.5 6.1 7.4 0.5 0.6 0.1 0.8 0.1 0.2 0.5 0.0 6.5 1.1 18.4 1.2 0.1 4.2 0.3 6.9 5.9 0.0 3.8 6.3 0.1 18.8 3.7 0.0 0.2 0.4 0.9 8.8 0.0 0.1 0.3 0.0 0.2 1.6 0.2 0.2 0.2 0.2 0.5 6.1 5.0 0.1 0.1 1.0 0.2 0.4 0.2 6.9 0.1 8.6 0.4 2.1 1.8 0.2 0.2 1.0 0.7 9.7 0.3 1.8 0.3 0.1 0.1 0.3 0.2 0.2 1.1 0.2 0.4 4.2 0.1 0.1 0.4 0.5 2.9 0.0 0.3 0.2 2.2 1.7 0.5 0.1 0.2 0.1 1.4 17.8 82.7 2.7 12.7 7.1 7.6 6.6 5.3 8.8 11.3 3.0 5.1 0.0 10.1 9.4 6.7 3.4 0.0 13.4 7.9 3.5 15.7 0.4 1.7 0.4 3.6 4.4 1.4 0.0 2.7 2.8 5.6 4.9 5.7 1.3 0.9 3.2 0.0 0.6 0.3 2.2 0.9 1.3 13.5 0.0 0.2 0.9 1.2 2.0 2.8 3.8 3.1 6.5 13.9 1.9 5.3 6.6 0.5 1.3 1.2 12.9 GNAO1 G-ALPHA-o ENSG00000087258 "G protein subunit alpha o1" P09471 16 56191347-56357457 "Disease related genes, Predicted intracellular proteins" Transducer "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 102.5" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 161.5;Horizontal cells: 74.7;Peritubular cells: 41.8" "Cancer enriched" "Detected in many" 5 "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 17.0;BJ hTERT+ SV40 Large T+: 11.3;SCLC-21H: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008387, HPA040878" Enhanced NA NA "CAB008387: AB_591430, HPA040878: AB_2677184" "unprognostic (1.50e-1)" "unprognostic (1.36e-3)" "unprognostic (8.12e-2)" "unprognostic (1.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (6.87e-2)" "unprognostic (1.68e-4)" "unprognostic (3.08e-1)" "unprognostic (1.74e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.71e-1)" "unprognostic (6.86e-3)" "unprognostic (6.28e-2)" "unprognostic (1.21e-1)" "unprognostic (6.00e-1)" "unprognostic (9.70e-5)" 4.6 9.4 42.6 4.7 50.8 1.8 2.3 40.6 102.5 3.4 9.9 24.4 9.1 4.7 5.2 4.6 4.5 4.3 4.2 12.8 37.9 34.8 2.3 7.7 2.6 2.7 28.1 38.5 2.6 5.4 1.9 10.2 2.2 25.2 6.9 6.7 3.1 2.7 18.2 3.5 2.7 5.3 11.2 20.5 2.9 6.2 10.2 32.5 0.0 2.5 0.0 2.7 5.9 0.9 0.0 0.1 0.0 0.0 0.0 1.7 1.0 4.0 0.0 0.3 0.0 0.0 0.0 0.5 4.2 17.0 11.3 5.4 0.2 0.0 0.0 0.1 0.0 4.2 0.3 2.7 0.0 7.6 0.1 0.5 0.0 1.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.4 0.0 0.0 6.3 0.1 0.0 0.0 4.0 0.1 0.0 0.0 34.6 6.9 7.0 0.1 0.4 1.8 0.1 0.0 0.0 0.1 4.0 0.0 1.9 0.5 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.7 0.5 0.1 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 42.6 50.8 40.6 45.7 37.9 34.8 28.1 38.5 25.2 32.5 0.0 0.3 0.0 0.2 0.7 161.5 33.6 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 21.4 1.4 0.0 0.0 0.0 0.2 2.1 0.3 0.0 9.4 0.1 74.7 22.3 1.3 0.6 38.1 32.2 0.0 3.3 0.0 0.0 19.9 0.5 0.0 41.8 0.1 12.5 0.0 3.6 16.6 9.2 0.4 0.1 2.9 0.0 0.1 GNAS "GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI" ENSG00000087460 "GNAS complex locus" "O95467, P63092, P84996, Q5JWF2" 20 58839718-58911192 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transducer "Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 303.3;thyroid gland: 304.5" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 1781.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010337, HPA018122, HPA027478, HPA028386" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane, Cytosol" "CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983" "unprognostic (7.48e-2)" "unprognostic (1.41e-1)" "unprognostic (3.90e-2)" "unprognostic (4.77e-2)" "unprognostic (8.37e-3)" "unprognostic (2.82e-2)" "unprognostic (4.53e-3)" "unprognostic (8.01e-2)" "unprognostic (4.29e-2)" "prognostic favorable (8.76e-4)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (5.24e-3)" "unprognostic (1.61e-1)" "unprognostic (8.25e-2)" "unprognostic (1.36e-1)" 56.2 79.0 84.2 34.4 44.5 42.1 87.4 86.0 107.4 43.2 42.3 25.4 27.0 33.2 37.2 44.7 41.0 43.6 34.4 106.0 71.0 144.0 39.6 35.3 46.6 44.6 75.8 64.7 43.6 118.1 120.9 303.3 49.8 85.6 36.3 31.5 42.7 171.6 31.1 172.9 26.3 34.9 40.5 61.4 36.9 42.4 18.2 27.4 56.0 304.5 80.6 41.0 37.3 44.6 27.3 41.5 29.9 36.2 25.3 24.2 24.6 9.7 32.8 55.4 25.8 94.2 43.0 49.8 56.4 51.6 64.5 46.3 95.8 50.6 32.0 87.9 73.2 46.2 42.3 50.8 75.1 43.7 21.1 30.6 35.6 49.9 62.7 43.5 20.7 22.4 51.3 38.2 31.3 42.2 51.2 48.9 39.5 31.2 43.7 42.5 133.6 105.4 50.6 17.6 6.4 34.7 64.9 48.5 56.5 51.7 38.7 68.7 157.4 78.4 77.9 62.9 50.7 59.5 56.7 53.7 85.7 77.0 30.8 53.1 76.8 49.5 67.6 37.6 10.1 43.7 29.9 24.8 29.5 20.7 35.7 22.1 26.7 22.0 22.2 37.8 27.3 21.3 24.2 29.1 25.3 36.2 41.5 23.3 24.6 84.2 44.5 86.0 107.4 71.0 144.0 75.8 64.7 85.6 27.4 205.4 224.1 189.5 151.9 115.9 363.0 884.0 242.0 250.3 255.9 247.7 53.0 672.6 376.4 220.5 577.5 343.9 323.7 303.7 196.1 292.5 221.9 260.9 133.0 165.2 333.8 1781.3 444.7 335.7 327.9 1338.6 245.7 276.8 210.9 147.9 250.3 861.2 313.5 239.3 185.3 130.9 175.1 207.0 226.4 48.2 25.4 103.0 1013.3 142.4 268.2 212.5 GNAT1 CSNBAD3 ENSG00000114349 "G protein subunit alpha transducin 1" P11488 3 50191612-50196516 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "retina: 171.9" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 1622.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.4;MCF7: 2.4;RT4: 2.6;SCLC-21H: 1.1" "Not detected" "Not detected" HPA045393 Enhanced NA NA "HPA045393: AB_2679310" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (8.56e-3)" "unprognostic (3.32e-2)" "unprognostic (2.13e-1)" "unprognostic (7.72e-2)" "unprognostic (2.82e-3)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.87e-1)" "unprognostic (3.02e-1)" "unprognostic (9.48e-3)" 0.3 0.5 0.3 0.0 0.3 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.2 0.0 0.3 0.3 0.1 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 171.9 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 177.2 0.3 0.0 0.0 0.0 0.0 227.8 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 26.2 0.6 0.0 0.0 0.0 0.0 228.8 0.1 0.0 0.0 0.0 1622.9 0.0 0.0 1.7 0.4 0.0 0.1 0.0 0.0 0.1 GNAT2 ACHM4 ENSG00000134183 "G protein subunit alpha transducin 2" P19087 1 109603267-109619929 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 27.6" "Cell type enriched" "Detected in some" 14 "Cone photoreceptor cells: 56.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "HAP1: 5.5;U-698: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 0.1 0.4 0.1 0.1 0.3 0.0 0.4 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.6 0.2 0.2 0.2 0.1 2.5 0.5 0.3 0.1 0.1 0.1 0.4 0.4 0.8 1.2 0.3 0.2 0.5 27.6 0.4 0.3 0.1 0.1 0.6 0.2 0.1 0.4 0.1 6.4 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 0.3 3.0 0.4 0.0 0.3 0.0 0.9 0.2 0.3 0.9 0.4 0.3 0.1 0.5 0.3 0.6 0.1 2.2 0.8 2.4 2.1 0.1 0.8 0.2 5.5 0.1 0.9 0.0 0.1 0.1 0.5 0.9 0.0 2.2 0.3 1.1 0.8 1.3 1.0 0.0 1.4 0.5 1.4 1.5 0.8 1.8 0.7 0.2 1.0 1.1 0.5 0.7 0.0 1.1 0.7 0.6 1.8 0.0 1.9 0.5 2.9 0.0 0.4 0.0 0.0 0.4 0.6 1.0 0.5 2.7 1.6 3.9 0.7 0.4 0.5 0.0 0.0 3.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.1 0.3 0.2 0.3 0.2 0.2 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 56.9 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.1 0.0 0.0 0.0 GNAT3 "GDCA, gustducin" ENSG00000214415 "G protein subunit alpha transducin 3" A8MTJ3 7 80458671-80512020 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 14.5" "Cell type enriched" "Detected in single" 22 "Early spermatids: 2.2" "Group enriched" "Detected in some" 6 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 8.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "olfactory region: 1.8" NA NA "unprognostic (2.01e-1)" 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 6.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNAZ ENSG00000128266 "G protein subunit alpha z" P19086 22 23070361-23125037 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Group enriched" "Detected in many" 6 "Horizontal cells: 117.6;Rod photoreceptor cells: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 25.1;SH-SY5Y: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003011 Enhanced Approved Vesicles NA NA 6900000 Vesicles "HPA003011: AB_1078918" "unprognostic (7.61e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (3.45e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-3)" "unprognostic (1.68e-2)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (6.63e-2)" "unprognostic (2.82e-1)" "unprognostic (1.30e-1)" 8.8 6.9 15.4 3.2 13.4 1.8 3.2 17.8 34.4 2.2 6.0 11.1 6.9 2.3 6.2 3.7 5.9 6.9 12.1 2.0 17.7 14.7 2.2 0.6 1.7 2.2 16.4 13.0 9.9 2.2 4.7 11.1 0.9 13.5 7.8 2.3 6.8 2.4 19.5 1.9 1.2 2.4 12.9 19.0 5.1 5.3 4.3 7.7 0.0 1.9 0.0 1.7 3.6 1.5 1.3 0.1 1.7 1.4 0.2 0.6 5.3 0.0 1.2 4.2 9.0 0.0 0.0 0.2 5.7 11.4 5.6 3.8 0.0 0.0 10.9 0.4 0.5 7.7 0.2 5.3 0.2 4.1 1.4 4.4 0.7 6.4 7.9 0.4 0.0 0.9 0.0 0.2 0.1 0.3 1.4 0.1 0.6 0.1 3.4 0.1 3.9 0.0 0.0 2.6 0.3 3.5 0.0 4.3 1.7 0.1 0.1 25.1 15.5 1.3 2.8 1.1 0.5 1.2 0.1 0.0 4.7 5.4 1.2 0.1 4.3 7.3 5.7 2.3 0.4 1.7 1.7 0.3 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.3 0.0 0.6 0.9 0.2 1.4 0.0 0.0 5.3 15.4 13.4 17.8 19.4 17.7 14.7 16.4 13.0 13.5 7.7 3.0 0.0 0.0 0.3 0.2 11.7 1.0 7.6 1.4 1.2 3.5 7.9 0.0 0.0 1.7 1.2 2.1 0.0 0.0 1.5 0.0 0.9 0.3 0.0 0.0 0.1 117.6 4.6 3.7 0.0 2.1 3.7 0.4 1.7 0.0 0.2 12.8 0.7 0.0 3.9 0.5 32.2 0.0 4.2 1.6 3.2 0.4 0.0 0.0 0.0 0.1 GNB3 ENSG00000111664 "G protein subunit beta 3" P16520 12 6839954-6847393 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "pituitary gland: 27.0;retina: 79.9" "Group enriched" "Detected in some" 9 "Bipolar cells: 509.6;Cone photoreceptor cells: 877.7;Rod photoreceptor cells: 442.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 1.5" "Cell line enhanced" "Detected in many" "Daudi: 8.5;NTERA-2: 10.3;U-698: 25.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 10.4" HPA040736 Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (3.86e-2)" "unprognostic (1.58e-1)" "unprognostic (4.96e-2)" "unprognostic (8.75e-2)" "unprognostic (2.53e-2)" "unprognostic (5.74e-3)" "unprognostic (5.98e-2)" "unprognostic (4.43e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.25e-5)" "unprognostic (3.21e-2)" "unprognostic (4.77e-11)" "unprognostic (2.43e-1)" "unprognostic (6.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.07e-2)" 0.8 1.6 0.9 1.4 2.0 0.5 0.8 6.9 1.6 1.1 1.0 0.8 0.8 2.3 2.7 0.8 0.8 1.0 1.1 5.4 1.0 1.3 0.8 0.8 0.8 1.4 1.1 0.8 3.5 0.8 3.2 27.0 0.8 1.6 1.6 0.4 79.9 2.6 1.8 1.5 0.6 1.6 4.1 0.9 0.9 0.9 0.8 0.8 0.8 1.2 1.0 1.8 2.1 0.8 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 5.0 0.8 0.6 0.9 0.5 2.9 0.6 1.6 1.1 1.1 0.3 8.5 0.0 3.1 0.1 0.3 4.9 0.2 1.5 0.7 1.1 2.2 2.7 0.7 0.5 0.6 1.4 1.2 0.2 1.5 2.1 5.3 1.4 1.1 0.8 0.7 0.4 0.4 0.4 0.5 10.3 0.0 0.3 0.4 1.7 0.5 0.3 0.2 0.8 1.2 0.2 0.0 0.6 1.7 0.0 0.5 2.6 1.3 2.1 2.5 3.8 0.7 0.5 25.9 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 6.9 1.5 1.0 1.3 1.1 0.8 1.6 0.8 0.0 0.0 0.0 0.4 0.3 509.6 4.6 0.0 0.0 0.0 0.0 877.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.0 0.0 0.1 69.9 0.0 0.0 0.0 0.0 3.4 0.0 1.7 0.0 0.0 58.9 0.2 0.0 3.2 0.0 442.8 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 GNE "IBM2, Uae1" ENSG00000159921 "Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase" Q9Y223 9 36214441-36277056 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.0;salivary gland: 45.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 95.4;Mucus-secreting cells: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007045, HPA027258" Approved Supported Cytosol NA NA Cytosol "HPA007045: AB_1079003, HPA027258: AB_1849873" "unprognostic (7.54e-2)" "unprognostic (1.61e-2)" "unprognostic (1.07e-3)" "unprognostic (7.28e-2)" "unprognostic (7.00e-2)" "unprognostic (1.85e-2)" "unprognostic (2.78e-3)" "unprognostic (5.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.88e-3)" "unprognostic (4.20e-2)" "prognostic favorable (9.28e-11)" "unprognostic (2.90e-1)" "unprognostic (8.28e-2)" "unprognostic (2.95e-1)" "unprognostic (1.72e-2)" 7.7 6.7 6.0 6.5 8.3 8.3 16.6 11.1 12.1 7.9 20.7 7.0 4.6 2.9 8.0 3.9 7.6 6.7 5.2 7.6 7.8 6.8 6.8 55.0 5.5 6.0 6.0 7.8 9.8 8.4 4.1 7.0 20.2 10.2 10.1 30.1 4.8 45.3 5.0 10.5 3.7 7.2 11.7 10.9 4.5 4.9 3.4 5.3 3.2 4.6 4.2 7.9 8.6 7.9 3.9 2.2 1.2 2.7 2.4 4.2 1.8 4.4 19.9 8.9 7.6 10.1 10.1 12.9 6.2 7.9 8.6 11.1 4.8 14.2 5.8 6.6 10.3 22.4 1.7 6.7 2.0 9.6 10.9 0.6 5.0 11.7 6.6 6.9 0.1 14.3 6.6 2.0 14.3 13.5 6.3 3.6 9.0 6.3 12.1 8.3 0.7 8.1 2.6 5.1 2.8 11.2 6.7 7.5 1.6 47.6 8.2 7.6 6.9 6.6 2.3 5.7 3.3 2.1 5.1 5.2 5.7 5.9 6.8 5.4 5.3 11.3 3.2 7.8 4.3 8.1 0.7 1.7 0.9 2.7 2.2 1.8 2.4 3.4 2.9 1.4 3.9 4.0 4.2 1.2 2.4 2.7 2.2 1.5 1.8 6.0 8.3 11.1 12.1 7.8 6.8 6.0 7.8 10.2 5.3 8.9 10.6 4.5 2.8 1.6 7.9 5.9 10.2 18.7 14.8 8.7 5.9 7.5 1.7 9.3 2.8 4.5 18.3 0.0 5.2 7.3 5.1 7.6 9.3 95.4 2.7 11.1 11.1 8.0 5.0 2.3 10.0 4.3 1.7 6.4 67.2 2.0 4.2 23.0 6.0 1.7 6.2 12.9 4.1 1.1 2.7 1.4 16.6 5.0 21.2 5.6 GNG13 "G(gamma)13, h2-35" ENSG00000127588 "G protein subunit gamma 13" Q9P2W3 16 798041-800733 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 78.6;retina: 22.9" "Cell type enriched" "Detected in some" 20 "Bipolar cells: 323.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "cerebellum: 78.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 11.2;HEK 293: 9.9;HeLa: 5.9;MCF7: 13.9" "Region enhanced" "Detected in all" "cerebellum: 1054.1" "Group enriched" "Detected in many" 6 "cerebellum: 43.5;olfactory region: 18.2" HPA046272 Enhanced NA NA "HPA046272: AB_10960062" "unprognostic (1.84e-1)" "unprognostic (2.75e-1)" "unprognostic (3.78e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-2)" "unprognostic (5.41e-2)" "unprognostic (8.47e-2)" "unprognostic (9.16e-3)" "unprognostic (4.04e-2)" "unprognostic (1.78e-1)" "unprognostic (6.77e-2)" "unprognostic (7.12e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" 0.2 0.2 1.8 0.7 3.3 0.9 0.3 78.6 11.3 0.2 2.9 3.4 0.0 5.4 0.2 0.7 0.2 0.2 0.3 0.2 1.1 1.6 0.2 0.2 0.3 0.6 1.3 2.7 0.3 0.2 0.2 0.3 0.4 2.7 0.4 0.6 22.9 0.2 0.2 0.2 0.5 5.1 0.4 1.9 0.4 0.8 1.5 0.2 0.2 0.3 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.5 1.2 0.0 0.0 0.9 1.0 0.0 0.0 0.0 11.2 0.3 1.2 0.3 0.0 0.1 1.7 0.0 0.0 0.0 1.3 9.9 1.4 5.9 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.9 0.9 0.0 13.9 1.3 0.8 1.3 0.1 1.2 3.0 3.2 0.7 0.0 1.7 1.0 0.9 1.0 0.4 0.2 0.4 0.8 0.1 0.0 1.5 1.4 1.9 0.3 0.5 2.5 4.5 0.1 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.3 78.6 11.3 1.1 1.6 1.3 2.7 2.7 0.2 0.0 0.0 0.0 0.1 0.0 323.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNG14 ENSG00000283980 "G protein subunit gamma 14" A0A1W2PPG7 19 12687998-12688422 "Predicted intracellular proteins" Transducer "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 3.1;skin 1: 3.2;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;HEK 293: 5.4;MCF7: 5.1" "Region enriched" "Detected in single" 44 "thalamus: 132.6" "Low region specificity" "Detected in all" NA NA 0.1 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.7 3.1 0.0 0.0 0.2 0.0 0.9 0.0 0.0 3.2 0.3 0.0 0.0 0.0 2.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 2.4 0.0 0.0 1.8 0.9 0.0 0.0 0.0 2.0 0.3 0.0 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 5.4 0.0 2.1 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.8 0.0 5.1 0.6 1.3 0.4 0.0 1.4 0.2 0.0 0.7 0.0 2.0 0.7 1.4 0.6 0.0 0.0 0.0 2.0 0.4 0.0 0.7 0.7 2.1 0.1 0.2 2.7 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.4;brain: 50.5;testis: 55.7" "Group enriched" "Detected in many" 4 "Early spermatids: 648.7;Late spermatids: 811.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.9;fHDF/TERT166: 36.9;MOLT-4: 28.7;SH-SY5Y: 24.3;WM-115: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favorable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 22.0 10.4 50.5 17.4 18.5 25.0 11.7 4.9 46.1 5.9 13.0 5.2 1.6 6.8 5.7 4.7 6.5 3.5 7.9 6.6 30.9 50.3 4.0 5.6 8.5 19.4 10.7 20.7 7.1 3.3 1.6 12.2 8.6 8.9 6.6 9.1 8.3 4.5 4.4 2.3 3.5 9.9 8.8 8.5 41.2 7.3 55.7 2.5 39.6 3.9 4.3 19.5 8.5 4.0 8.0 13.9 68.4 34.9 5.0 36.5 27.6 0.0 0.8 20.9 13.0 3.2 4.2 0.3 3.4 4.2 1.6 1.3 1.7 0.0 0.0 0.5 36.9 2.4 0.0 2.7 0.0 1.1 9.4 0.3 0.0 0.2 0.0 1.6 1.9 0.1 6.9 0.0 1.6 0.1 8.8 0.0 18.1 0.0 1.7 10.6 0.0 28.7 3.1 11.0 0.0 2.5 10.2 1.6 0.5 1.7 0.0 3.1 24.3 0.0 0.0 9.0 0.7 0.0 0.0 0.0 5.1 0.8 0.1 2.6 0.0 0.0 1.4 4.2 10.2 66.5 68.4 13.5 36.0 36.5 23.3 24.6 8.0 20.3 29.7 13.9 7.3 12.9 22.8 39.9 5.0 34.9 6.0 28.8 27.6 50.5 18.5 4.9 44.2 30.9 50.3 10.7 20.7 8.9 2.5 6.0 11.1 29.6 0.2 10.2 12.4 0.6 0.0 0.0 0.0 3.5 2.0 0.4 1.7 0.1 648.7 6.3 0.1 0.0 0.0 0.6 18.4 0.2 31.2 0.9 39.5 0.0 168.9 12.3 83.7 811.3 9.2 65.9 52.3 14.4 1.0 0.5 0.8 0.0 5.6 0.8 1.8 38.8 8.0 11.9 3.8 5.8 0.6 100.2 0.4 0.1 GNG3 ENSG00000162188 "G protein subunit gamma 3" P63215 11 62707658-62709201 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 136.6" "Cell type enhanced" "Detected in some" 26 "Bipolar cells: 34.7;Early spermatids: 16.6;Late spermatids: 82.8" "Cancer enriched" "Detected in some" 14 "glioma: 12.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 30 "memory B-cell: 13.4;naive B-cell: 11.8" "Lineage enriched" "Detected in single" 32 "B-cells: 13.4" "Group enriched" "Detected in some" 7 "Karpas-707: 39.1;SCLC-21H: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.43e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-1)" "unprognostic (4.68e-4)" "unprognostic (2.73e-2)" "unprognostic (7.60e-2)" "unprognostic (1.77e-2)" "unprognostic (1.69e-1)" "unprognostic (6.03e-3)" "unprognostic (3.04e-1)" "unprognostic (2.33e-3)" "unprognostic (1.50e-1)" "unprognostic (5.37e-5)" "unprognostic (3.16e-1)" "unprognostic (1.63e-1)" "unprognostic (1.00e-1)" "unprognostic (1.00e-1)" 1.7 11.8 51.6 2.9 47.6 2.3 1.7 41.0 136.6 1.7 3.5 6.0 0.0 2.5 1.8 2.3 1.8 1.8 1.9 1.8 45.3 39.6 1.9 1.9 1.7 1.9 39.8 36.0 1.9 2.0 2.2 6.7 1.8 43.7 1.8 3.5 1.5 2.0 2.2 2.0 1.9 3.2 2.5 7.4 1.8 2.0 5.7 4.8 0.0 2.0 0.0 1.8 1.6 0.0 13.4 0.0 0.4 0.2 0.2 0.1 0.3 0.1 0.2 1.9 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.6 0.3 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 39.1 0.0 0.3 0.0 1.0 8.6 0.1 0.0 0.5 0.3 0.2 0.1 0.6 77.4 0.7 0.2 0.2 0.0 0.4 0.4 0.1 0.1 0.4 0.8 0.2 0.1 0.2 0.5 0.2 0.4 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 13.4 0.1 0.1 0.0 11.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 51.6 47.6 41.0 83.2 45.3 39.6 39.8 36.0 43.7 4.8 0.0 0.0 0.8 0.4 0.0 34.7 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 16.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.3 4.8 0.0 0.0 0.0 82.8 0.9 0.0 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.2 9.1 0.0 0.0 3.1 1.9 0.3 0.0 0.0 0.0 0.1 GNG4 ENSG00000168243 "G protein subunit gamma 4" P50150 1 235547687-235650754 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1;ovary: 25.1;pituitary gland: 18.8" "Cell type enhanced" "Detected in many" 15 "Glandular cells: 31.6;Intestinal endocrine cells: 41.2;Mucus-secreting cells: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 29.0;SCLC-21H: 30.7;SH-SY5Y: 43.2;U-2197: 12.9" "Region enriched" "Detected in many" 6 "olfactory region: 574.6" "Region enhanced" "Detected in all" "olfactory region: 427.7" NA NA "unprognostic (1.50e-3)" "unprognostic (8.33e-3)" "unprognostic (7.14e-2)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (4.94e-2)" "unprognostic (2.22e-2)" "unprognostic (3.10e-2)" "unprognostic (3.47e-2)" "unprognostic (3.49e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (2.56e-9)" "unprognostic (1.22e-1)" "unprognostic (1.62e-1)" "unprognostic (1.68e-3)" "unprognostic (5.01e-3)" 1.9 9.4 16.8 2.0 21.5 0.9 1.1 8.6 24.1 1.8 3.4 6.5 0.5 2.5 8.3 1.1 8.4 1.6 1.2 0.9 10.2 20.8 1.3 0.8 0.9 4.7 6.3 7.7 25.1 4.5 0.8 18.8 4.2 11.2 17.1 3.0 1.7 1.4 1.4 0.8 1.1 4.8 5.8 7.1 0.9 3.6 2.1 2.8 3.1 0.9 0.0 3.9 1.2 1.1 1.3 0.8 3.8 0.6 1.0 0.8 0.3 6.8 0.4 5.1 0.0 0.0 0.2 0.4 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.0 2.1 1.7 0.8 5.4 0.2 1.3 3.5 2.0 0.0 0.1 2.6 0.1 0.0 2.3 0.4 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.3 0.2 29.0 0.0 0.0 0.0 2.7 0.1 0.0 0.2 30.7 43.2 0.2 0.1 0.6 0.3 0.0 1.0 0.0 0.3 0.9 12.9 0.9 1.0 0.0 0.0 0.9 0.0 8.5 3.8 0.6 0.6 0.5 0.5 0.4 1.0 0.8 0.5 0.2 1.3 0.6 0.6 2.3 1.0 0.5 0.8 0.6 0.3 16.8 21.5 8.6 21.7 10.2 20.8 6.3 7.7 11.2 2.8 0.0 0.0 0.0 1.6 0.5 2.3 0.4 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 1.0 0.4 3.1 0.0 7.4 5.8 0.5 31.6 0.0 0.0 0.8 1.6 41.2 0.0 0.0 0.6 0.3 0.6 0.0 1.8 11.8 0.5 2.6 0.6 0.4 2.6 1.0 0.0 0.5 1.2 2.1 0.0 5.3 0.0 1.5 0.9 GNG7 FLJ00058 ENSG00000176533 "G protein subunit gamma 7" O60262 19 2511219-2702709 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 115.9" "Group enriched" "Detected in many" 5 "B-cells: 132.4;Cardiomyocytes: 52.7;Distal tubular cells: 104.5;Hofbauer cells: 49.0;Horizontal cells: 160.5;Melanocytes: 49.0;Muller glia cells: 53.2" "Cancer enhanced" "Detected in all" "glioma: 21.9" "Region enriched" "Detected in all" 5 "basal ganglia: 115.9" "Group enriched" "Detected in many" 4 "memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 4 "B-cells: 23.9;dendritic cells: 19.9" "Cell line enhanced" "Detected in many" "Daudi: 10.5;REH: 31.0;SK-MEL-30: 14.3;U-266/70: 29.8;U-266/84: 13.7" "Region enriched" "Detected in many" 6 "basal ganglia: 1142.7" "Region enriched" "Detected in all" 6 "basal ganglia: 484.6" HPA057790 Supported Supported NA NA "HPA057790: AB_2683527" "unprognostic (3.97e-3)" "unprognostic (1.16e-4)" "unprognostic (4.92e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-1)" "unprognostic (8.42e-4)" "prognostic favorable (3.05e-4)" "prognostic favorable (1.35e-5)" "unprognostic (1.27e-2)" "unprognostic (4.95e-2)" "prognostic favorable (3.71e-4)" "unprognostic (1.27e-1)" "prognostic favorable (0.00e+0)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" "unprognostic (6.36e-2)" "unprognostic (4.96e-2)" 3.1 4.8 19.8 4.5 115.9 5.4 4.1 9.7 28.2 2.6 3.8 23.4 0.8 4.7 4.8 4.9 11.1 6.5 3.3 22.5 20.3 11.4 6.0 2.2 3.0 8.0 20.0 10.0 10.0 7.2 5.4 4.6 1.4 20.9 7.1 3.0 12.2 22.8 5.7 2.9 1.7 4.9 3.4 28.5 11.0 5.8 5.5 22.0 0.1 3.7 0.4 8.2 3.4 1.4 23.9 19.9 5.0 0.6 0.0 0.5 1.3 0.1 0.0 1.5 3.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 10.5 0.5 0.1 0.1 0.1 1.7 0.0 0.0 0.0 1.4 0.2 0.0 1.2 0.8 0.0 6.3 0.2 0.2 0.0 0.1 0.1 0.0 1.2 0.1 6.8 0.0 1.0 0.2 0.6 1.2 0.2 0.6 31.0 0.0 2.8 0.1 0.0 0.0 4.5 0.0 0.0 14.3 1.1 0.2 2.6 0.0 0.0 1.5 0.1 0.1 29.8 13.7 2.2 0.1 3.3 7.9 1.1 0.6 3.2 0.1 0.2 0.4 23.9 0.2 0.1 2.5 20.5 0.5 0.3 5.0 0.0 0.0 19.9 0.0 1.3 19.8 115.9 9.7 20.0 20.3 11.4 20.0 10.0 20.9 22.0 6.0 3.4 132.4 10.1 2.3 5.4 52.7 10.2 5.3 5.7 8.7 7.9 0.5 104.5 10.7 4.3 12.1 0.5 0.0 4.2 0.9 1.7 8.1 12.7 11.6 49.0 160.5 5.8 14.7 7.2 7.4 2.3 6.6 49.0 12.6 2.6 53.2 3.9 1.5 2.5 15.8 10.2 6.5 8.0 1.7 2.9 1.8 2.9 2.2 1.7 6.7 GNG8 ENSG00000167414 "G protein subunit gamma 8" Q9UK08 19 46634076-46634685 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 21.5;blood: 12.7;brain: 13.0" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 10.6;Melanocytes: 30.4;monocytes: 16.2" "Cancer enhanced" "Detected in many" "urothelial cancer: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 12.7" "Group enriched" "Detected in many" 4 "B-cells: 12.7;T-cells: 5.2" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 162.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.23e-4)" "unprognostic (4.96e-6)" "unprognostic (9.00e-2)" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.14e-5)" "unprognostic (1.94e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.80e-1)" "unprognostic (9.60e-2)" "unprognostic (9.83e-2)" "unprognostic (5.90e-8)" "unprognostic (2.67e-2)" "unprognostic (1.70e-1)" "unprognostic (4.22e-2)" "unprognostic (4.41e-1)" 0.6 21.5 4.5 4.7 4.9 0.5 0.6 4.1 5.9 2.5 3.2 1.1 0.6 1.5 2.2 0.6 0.6 1.0 0.6 8.4 9.2 13.0 1.2 0.6 1.0 3.4 5.3 2.8 1.2 0.6 0.0 5.8 0.6 3.1 0.7 1.8 1.1 0.6 1.5 0.6 0.0 2.3 2.7 4.4 2.3 0.7 0.8 3.3 1.2 0.6 0.6 5.4 0.9 0.9 12.7 0.0 2.0 0.1 0.0 5.2 4.6 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 37.1 162.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 12.7 2.4 1.2 2.0 0.0 0.0 0.0 5.2 4.6 4.5 4.9 4.1 4.3 9.2 13.0 5.3 2.8 3.1 3.3 0.0 0.0 0.0 0.1 0.1 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 30.4 16.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.1 GNGT1 GNG1 ENSG00000127928 "G protein subunit gamma transducin 1" P63211 7 93591573-93911265 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 107.2" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 1939.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.5;HeLa: 4.2;SK-BR-3: 4.0;SuSa: 6.1;T-47d: 6.8;U-266/70: 3.9;U-266/84: 5.2" "Not detected" "Not detected" HPA042721 Enhanced NA NA "HPA042721: AB_10806370" "unprognostic (1.30e-1)" "unprognostic (2.55e-4)" "unprognostic (3.32e-4)" "unprognostic (5.01e-2)" "unprognostic (2.54e-2)" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (4.55e-1)" "unprognostic (2.23e-4)" "unprognostic (1.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.5 0.3 0.1 1.9 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.1 0.1 7.9 0.3 0.0 0.0 107.2 1.0 0.0 0.0 0.4 0.0 0.1 0.3 0.1 0.4 0.7 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.5 0.5 1.6 0.2 0.1 1.2 0.6 1.4 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.1 12.5 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.4 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.6 0.1 1.9 0.1 0.0 2.0 0.2 0.1 0.0 0.0 0.6 0.3 1.5 3.6 1.3 0.2 4.0 0.1 6.1 6.8 0.2 0.2 0.0 3.7 0.2 0.0 3.9 5.2 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.7 0.1 0.9 0.5 1.0 0.9 0.3 0.4 0.8 0.8 1.3 0.1 0.2 0.5 1.2 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 300.7 0.0 0.0 1.4 1.2 0.0 363.2 0.4 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 187.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 352.7 0.0 0.0 0.0 3.7 1939.7 0.0 0.0 0.0 0.2 0.0 5.9 0.0 0.0 0.0 GNGT2 GNG9 ENSG00000167083 "G protein subunit gamma transducin 2" O14610 17 49202791-49210574 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "blood: 29.1;lymphoid tissue: 21.1;retina: 46.7" "Cell type enhanced" "Detected in many" 18 "Cone photoreceptor cells: 68.7;Kupffer cells: 22.4;Macrophages: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 29.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 36.4;HDLM-2: 31.2;HUVEC TERT2: 9.4;RH-30: 11.6;TIME: 9.1;U-698: 11.2" "Low region specificity" "Detected in some" HPA043381 Enhanced NA NA "HPA043381: AB_2678455" "unprognostic (9.11e-2)" "unprognostic (4.09e-3)" "unprognostic (1.99e-2)" "unprognostic (4.62e-5)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (1.75e-1)" "unprognostic (7.37e-2)" "unprognostic (1.30e-2)" "unprognostic (2.11e-2)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (1.23e-1)" 2.7 2.1 2.7 9.4 3.7 1.3 1.8 0.7 2.2 2.1 2.3 2.0 0.4 2.6 1.6 1.2 1.8 1.7 3.3 2.4 2.5 1.9 3.0 2.6 6.2 12.2 3.2 0.4 1.7 1.2 0.1 1.4 1.9 2.2 2.2 3.3 46.7 1.6 1.1 0.6 0.6 4.9 2.9 4.5 21.1 1.7 0.8 2.5 6.0 2.5 1.4 16.6 3.6 5.1 2.0 9.7 0.9 29.1 10.6 14.4 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.7 0.5 0.0 0.0 36.4 0.3 0.1 0.0 0.0 0.0 0.0 2.1 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 9.4 4.5 0.0 0.2 0.8 0.0 2.7 2.2 0.3 0.0 0.0 7.0 11.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 9.1 0.0 5.8 0.0 0.0 0.1 1.6 11.2 0.1 0.1 0.0 0.0 4.3 0.4 14.4 21.5 12.6 1.9 2.4 10.2 9.7 2.0 1.5 5.9 0.9 10.6 29.1 0.8 1.8 5.4 2.7 3.7 0.7 2.2 2.5 1.9 3.2 0.4 2.2 2.5 0.0 1.4 5.6 0.0 0.3 2.3 0.6 0.0 0.0 1.2 0.0 68.7 0.0 3.3 0.0 0.6 4.7 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 11.1 0.0 0.0 2.5 22.4 6.5 0.6 17.7 0.0 7.2 0.0 3.3 0.0 0.0 0.0 0.0 12.3 6.5 0.0 0.0 0.0 0.1 0.2 14.0 0.0 0.0 GNLY "D2S69E, LAG-2, LAG2, NKG5, TLA519" ENSG00000115523 Granulysin P22749 2 85685175-85698854 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 444.6" "Cell type enhanced" "Detected in many" 26 "Alveolar cells type 2: 120.7;Melanocytes: 75.9;T-cells: 467.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 226.1;NK-cell: 444.6" "Group enriched" "Detected in many" 55 "NK-cells: 444.6;T-cells: 226.1" "Cell line enhanced" "Detected in some" "BEWO: 1.4;JURKAT: 1.5;NB-4: 3.4;SuSa: 1.4;U-2197: 2.0;U-87 MG: 2.5" "CAB025186, HPA058021" Enhanced "Secreted to blood" NA NA 2920000 "CAB025186: , HPA058021: AB_2683581" "unprognostic (5.80e-2)" "unprognostic (5.64e-3)" "unprognostic (6.68e-2)" "prognostic favorable (3.48e-5)" "unprognostic (4.34e-2)" "unprognostic (9.22e-2)" "unprognostic (2.60e-1)" "unprognostic (2.79e-2)" "prognostic favorable (6.60e-5)" "unprognostic (2.61e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (8.46e-2)" "unprognostic (3.37e-1)" "unprognostic (1.86e-1)" "prognostic favorable (8.07e-4)" 7.1 1.0 2.1 3.5 2.3 72.0 3.3 1.2 2.0 1.7 2.4 5.8 0.0 1.2 31.5 2.2 4.4 2.0 2.1 4.0 2.3 3.2 1.8 5.7 20.8 10.7 3.8 0.8 1.0 0.6 0.1 1.4 45.2 3.6 3.2 2.1 4.9 2.6 1.9 5.7 0.8 12.4 1.4 4.2 34.3 1.5 0.7 1.8 2.0 2.4 3.9 5.9 2.3 1.6 0.8 1.5 6.1 0.8 444.6 226.1 175.3 0.0 0.0 0.0 0.0 0.7 0.0 1.4 0.0 0.6 0.3 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.5 0.7 0.0 1.5 0.3 0.8 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.2 0.0 0.0 0.0 2.0 0.0 0.3 0.1 0.0 2.5 0.6 0.0 4.0 0.7 0.4 226.1 0.6 61.2 0.8 26.0 96.4 0.6 0.5 7.4 89.8 6.1 444.6 0.8 1.5 1.0 175.3 2.1 2.3 1.2 2.0 2.3 3.2 3.8 0.8 3.6 1.8 11.9 120.7 9.9 0.3 6.3 0.0 1.6 0.0 6.7 11.4 0.0 2.0 1.0 1.7 0.0 0.0 9.8 1.3 70.0 0.0 1.3 3.2 0.1 48.8 1.5 5.5 0.0 1.7 14.7 5.7 0.0 0.3 5.7 75.9 0.0 0.3 0.0 0.0 0.0 0.0 7.2 0.1 0.0 3.1 0.2 0.2 6.8 0.9 467.7 0.2 0.5 GNMT ENSG00000124713 "Glycine N-methyltransferase" Q14749 6 42960758-42963880 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 83.9;pancreas: 100.1" "Cell type enriched" "Detected in many" 34 "Hepatocytes: 729.0" "Group enriched" "Detected in many" 20 "liver cancer: 69.6;prostate cancer: 49.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9" "Region enriched" "Detected in some" 4 "cerebellum: 17.7" "Not detected" "Not detected" HPA027501 Enhanced Approved Cytosol NA NA 150000 Cytosol "HPA027501: AB_1849879" "unprognostic (1.53e-2)" "unprognostic (8.02e-4)" "unprognostic (3.11e-2)" "unprognostic (4.24e-3)" "unprognostic (3.91e-2)" "unprognostic (6.40e-4)" "prognostic favorable (1.86e-4)" "unprognostic (4.08e-6)" "unprognostic (1.01e-1)" "unprognostic (2.67e-2)" "unprognostic (1.63e-3)" "unprognostic (2.52e-1)" "unprognostic (3.50e-3)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" "unprognostic (2.49e-2)" "unprognostic (4.92e-2)" 0.3 0.1 0.2 0.2 0.2 0.7 1.8 0.5 0.5 0.3 0.5 0.2 1.3 0.0 0.2 0.9 0.3 0.1 0.2 1.3 0.2 0.2 0.3 83.9 1.3 0.1 0.1 0.2 0.4 100.1 0.0 2.5 0.1 0.4 5.2 0.0 0.9 8.2 0.9 0.6 0.1 0.2 0.4 0.1 0.3 6.5 0.6 0.1 0.2 0.9 0.3 0.4 0.2 0.1 0.7 3.2 2.0 0.9 0.0 1.2 0.3 0.5 0.4 1.8 5.1 0.6 0.2 0.3 0.4 2.0 0.8 1.2 0.1 0.1 1.7 0.2 0.4 0.9 0.6 0.3 0.3 0.2 2.0 1.6 1.3 1.0 10.5 0.0 1.1 2.4 0.4 0.0 0.4 0.2 1.2 0.0 3.8 1.5 1.9 0.3 2.3 2.0 3.7 0.2 0.5 0.5 1.7 1.6 1.0 0.9 0.2 12.4 1.7 0.1 1.7 0.6 0.5 7.9 3.6 0.4 0.9 0.9 0.5 1.0 1.3 1.2 1.5 0.2 2.1 1.0 0.0 0.8 0.1 0.2 0.9 0.1 0.7 0.3 0.3 0.9 0.1 0.6 1.2 2.0 0.0 0.1 3.2 0.3 0.3 0.2 0.2 0.5 0.5 0.2 0.2 0.1 0.2 0.4 0.1 0.0 2.1 3.4 4.2 0.2 1.2 4.5 15.3 5.3 0.0 1.8 0.0 0.1 3.3 0.4 0.2 0.1 0.0 0.0 0.7 0.1 0.2 16.1 0.0 729.0 0.5 1.6 0.0 16.5 21.5 0.0 0.9 0.3 0.0 0.0 0.0 0.3 0.9 0.0 2.5 2.2 0.3 0.0 0.7 0.5 0.6 0.1 0.1 0.0 0.0 1.6 GNPNAT1 "FLJ10607, Gpnat1" ENSG00000100522 "Glucosamine-phosphate N-acetyltransferase 1" Q96EK6 14 52775194-52791668 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.3" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044647 Approved NA NA 17000 "HPA044647: AB_10795986" "unprognostic (4.55e-3)" "unprognostic (1.19e-2)" "unprognostic (4.47e-3)" "unprognostic (5.18e-3)" "unprognostic (4.23e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (3.19e-3)" "unprognostic (1.03e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (8.52e-5)" "unprognostic (5.82e-2)" "unprognostic (3.22e-3)" "unprognostic (2.16e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "unprognostic (4.05e-2)" 13.4 6.9 6.4 6.7 6.6 2.1 10.6 9.2 9.2 10.0 11.2 4.6 6.8 9.3 8.1 6.4 8.4 6.3 9.3 6.3 5.8 6.3 11.5 47.3 6.4 8.6 5.4 5.2 9.3 28.4 6.9 12.4 6.5 7.1 10.1 14.0 4.1 22.2 4.7 9.4 4.8 8.5 8.2 6.3 7.3 12.0 12.5 4.2 3.6 5.4 6.0 7.1 7.3 7.2 6.1 5.1 6.6 5.7 7.7 8.4 4.2 33.0 13.2 10.5 11.9 11.4 25.8 17.3 21.6 13.9 18.9 19.5 15.0 19.6 18.8 12.1 21.3 9.0 13.4 20.1 21.7 32.7 10.7 10.8 12.6 12.7 18.6 16.5 14.0 6.8 10.8 18.6 31.9 34.2 9.7 21.0 12.0 12.1 4.6 24.1 28.7 16.7 7.3 11.0 43.3 23.3 11.6 4.9 11.3 17.8 17.7 10.8 14.8 17.8 24.2 15.4 7.5 27.6 4.8 23.4 19.2 20.1 33.8 16.6 4.8 9.3 8.3 9.0 9.2 11.1 6.6 2.2 0.1 7.1 2.7 8.4 6.1 7.3 6.2 5.1 5.4 8.4 6.8 0.7 7.7 5.7 3.2 8.4 4.2 6.4 6.6 9.2 9.2 5.8 6.3 5.4 5.2 7.1 4.2 14.9 8.9 6.0 18.9 17.1 10.1 3.4 25.5 16.0 13.6 12.2 3.9 21.4 28.2 29.2 16.2 12.4 8.5 0.0 32.6 61.8 19.0 28.0 6.9 81.6 14.0 3.2 5.2 9.2 7.1 5.4 18.1 8.3 6.8 4.6 38.1 5.0 34.9 14.0 17.0 12.2 6.5 19.4 14.6 24.2 4.1 18.6 10.2 7.7 25.6 33.5 GNRH1 "GNRH, GRH, LHRH" ENSG00000147437 "Gonadotropin releasing hormone 1" P01148 8 25419260-25424654 "Disease related genes, Predicted secreted proteins" Hormone "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 9.2;Peritubular cells: 9.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "basal ganglia: 23.5;cerebellum: 6.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.5" "Group enriched" "Detected in many" 4 "basal ganglia: 20.8;hypothalamus: 14.2;olfactory region: 8.3" "Group enriched" "Detected in some" 30 "basal ganglia: 21.7;hypothalamus: 66.0" HPA027532 Supported "Secreted to blood" NA NA "HPA027532: AB_10612111" "unprognostic (6.49e-3)" "unprognostic (7.62e-2)" "unprognostic (2.90e-1)" "unprognostic (5.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.53e-4)" "unprognostic (7.80e-3)" "unprognostic (2.97e-2)" "unprognostic (1.39e-1)" "unprognostic (7.99e-2)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.08e-9)" "unprognostic (7.98e-3)" "unprognostic (5.11e-2)" "unprognostic (3.49e-1)" "unprognostic (3.68e-2)" 2.0 1.3 1.7 1.7 23.5 3.6 5.0 6.9 2.3 2.4 2.6 2.1 1.7 2.6 2.5 6.7 2.3 1.9 2.8 2.3 1.7 3.7 2.3 1.7 2.7 2.8 1.7 1.7 4.3 2.8 0.8 2.0 1.9 1.7 3.6 2.5 1.7 3.3 2.4 4.0 12.6 2.9 1.7 1.7 3.1 1.5 1.7 3.2 1.7 1.8 1.7 2.3 1.7 3.9 0.9 1.1 1.7 0.3 0.2 1.9 0.1 1.0 1.7 4.6 2.5 1.6 5.4 2.0 4.0 1.6 1.3 1.9 1.7 1.2 1.3 0.9 2.4 2.9 4.1 1.4 0.3 3.0 1.8 2.4 1.5 6.1 1.8 1.3 0.3 1.5 3.1 2.4 0.9 0.8 4.1 1.0 1.4 1.7 1.3 2.1 0.7 1.5 3.1 1.6 1.4 0.5 1.0 0.6 0.6 1.2 0.7 21.5 0.8 1.1 0.8 1.4 1.8 0.9 1.9 3.8 3.6 1.7 4.1 1.5 0.2 0.3 2.0 1.7 1.1 1.6 0.0 0.0 0.0 1.9 0.1 0.8 0.3 0.2 0.6 0.1 0.9 0.4 0.3 1.7 0.2 0.3 1.1 1.6 0.1 1.7 23.5 6.9 2.3 1.7 3.7 1.7 1.7 1.7 3.2 0.0 0.3 0.0 1.7 4.4 2.8 1.8 0.0 0.0 1.2 3.5 3.9 0.1 0.0 0.2 0.3 1.1 1.6 0.0 0.6 0.2 3.1 3.3 0.0 0.2 0.4 0.0 1.7 1.8 0.3 0.0 9.2 0.2 3.3 0.0 0.6 0.5 0.5 0.0 9.2 0.0 4.5 0.0 1.0 1.9 1.1 2.0 0.1 1.0 1.4 1.3 GNRH2 ENSG00000125787 "Gonadotropin releasing hormone 2" O43555 20 3043622-3045747 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 10.2" "Cell type enriched" "Detected in single" 7 "Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 7.5" HPA004338 Uncertain "Secreted to blood" NA NA "HPA004338: AB_1079012" "unprognostic (1.29e-1)" "unprognostic (1.88e-1)" "unprognostic (1.20e-2)" "unprognostic (2.51e-1)" "unprognostic (2.26e-2)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (7.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.47e-4)" "unprognostic (2.69e-1)" "unprognostic (2.98e-2)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" 0.8 0.9 0.6 1.2 0.9 0.4 0.5 5.1 1.7 1.6 0.5 0.5 0.5 0.3 1.3 10.2 0.5 2.4 2.0 1.1 0.7 1.2 1.7 3.3 0.5 0.6 1.5 0.5 5.6 0.5 0.5 1.8 0.5 1.2 4.2 0.1 1.0 1.6 2.0 0.5 0.1 0.5 0.5 0.5 0.5 2.2 3.9 0.5 0.5 2.8 0.5 0.5 0.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.2 3.2 4.0 2.0 0.5 0.6 0.8 0.0 0.5 0.8 1.9 0.8 1.5 0.1 0.2 1.2 3.3 1.3 1.1 0.9 1.2 3.6 1.3 1.1 2.5 0.0 0.2 2.2 2.5 2.6 2.5 0.0 0.4 0.8 2.6 1.5 0.5 1.3 1.1 0.8 2.5 1.4 0.0 0.0 0.9 0.4 0.8 0.5 2.8 4.5 2.1 0.2 2.7 1.5 1.5 2.9 1.4 0.0 1.9 0.9 1.6 1.8 1.1 7.5 1.0 1.7 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 5.1 1.7 0.7 1.2 1.5 0.5 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNRHR "GRHR, LHRHR" ENSG00000109163 "Gonadotropin releasing hormone receptor" P30968 4 67739328-67754360 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "pituitary gland: 56.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 3.0" "Not detected" "Not detected" HPA013424 Enhanced NA NA "HPA013424: AB_2668840" "unprognostic (2.77e-1)" "unprognostic (1.58e-1)" "unprognostic (4.05e-1)" "unprognostic (1.78e-1)" "unprognostic (4.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.90e-1)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.63e-1)" "unprognostic (9.03e-2)" "unprognostic (3.23e-2)" "unprognostic (9.67e-2)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" 0.1 3.9 0.1 0.4 0.2 0.2 0.1 0.3 1.7 0.3 0.1 0.1 0.1 0.7 0.1 0.1 1.6 0.0 0.2 0.2 0.2 0.2 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.3 0.0 56.6 0.1 0.5 0.2 0.0 0.1 0.3 0.1 0.2 0.9 0.1 0.1 0.1 0.2 0.3 0.3 0.1 0.2 1.0 0.1 0.4 0.1 0.5 1.3 0.2 0.0 0.0 0.4 0.3 0.0 0.2 1.5 1.5 1.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.5 1.7 1.3 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.3 0.5 0.3 0.3 0.7 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.7 0.0 1.2 3.0 0.0 0.0 0.8 0.6 0.4 1.0 0.5 0.0 0.6 1.3 0.6 0.0 0.0 0.9 2.1 0.0 0.3 0.0 0.3 0.3 0.2 1.0 0.1 0.2 0.6 0.2 1.2 0.3 0.6 1.4 0.8 0.9 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.1 0.0 0.0 1.3 0.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.2 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6A "GLP, GOLGA6" ENSG00000159289 "Golgin A6 family member A" Q9NYA3 15 74069857-74082550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 29 "liver: 6.2;testis: 15.7" "Cell type enriched" "Detected in some" 16 "Early spermatids: 37.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SuSa: 2.3;U-266/70: 5.2" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.3 0.1 0.1 0.0 0.0 0.2 0.3 0.0 5.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA6B ENSG00000215186 "Golgin A6 family member B" A6NDN3 15 72654738-72666394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 34 "liver: 8.4;testis: 10.5" "Cell type enriched" "Detected in single" 60 "Early spermatids: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SuSa: 1.3;U-266/70: 2.5;U-266/84: 1.1" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (5.47e-3)" "unprognostic (1.88e-2)" "unprognostic (2.07e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.6 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6C ENSG00000167195 "Golgin A6 family member C" A6NDK9 15 75258599-75270199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 12.5" "Cell type enriched" "Detected in single" 72 "Early spermatids: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.3;SuSa: 1.6" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (6.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 1.3 0.0 0.1 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.6 0.3 0.0 0.7 0.0 0.1 0.1 0.0 0.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6D ENSG00000140478 "Golgin A6 family member D" P0CG33 15 75282835-75295807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 14.2" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.6;Karpas-707: 1.1;NTERA-2: 1.5;SuSa: 3.2;U-266/70: 2.9;U-266/84: 1.3" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (7.95e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 2.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L1 ENSG00000273976 "Golgin A6 family-like 1" 15 23128268-23136822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 7.4" "Cell type enriched" "Detected in some" 6 "Early spermatids: 44.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain NA NA "HPA047733: " 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 0.1 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA6L10 GOLGA6L18 ENSG00000278662 "Golgin A6 family-like 10" A6NI86 15 82339998-82349475 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.4;testis: 8.2" "Cell type enriched" "Detected in many" 7 "Early spermatids: 126.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 3.4" "Lineage enhanced" "Detected in single" "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "HaCaT: 2.9;HEK 293: 7.7;SK-MEL-30: 3.9;SuSa: 3.6" NA NA "unprognostic (8.06e-2)" "unprognostic (2.56e-1)" "unprognostic (2.51e-1)" "unprognostic (8.31e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (7.37e-2)" "unprognostic (6.12e-2)" "unprognostic (7.01e-2)" "unprognostic (4.10e-1)" "unprognostic (2.36e-4)" "unprognostic (8.30e-2)" "unprognostic (6.06e-6)" "unprognostic (4.13e-2)" "unprognostic (3.08e-1)" "unprognostic (2.16e-1)" "unprognostic (5.34e-2)" 0.0 0.3 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.9 1.6 0.0 0.0 0.1 0.2 8.2 0.2 0.0 0.0 0.1 0.0 0.9 0.0 3.4 0.2 0.0 0.1 0.1 0.4 0.3 0.1 0.4 0.0 0.5 0.3 1.2 0.1 0.0 0.0 0.8 0.4 0.4 1.3 2.9 0.2 0.1 0.0 0.1 7.7 0.0 1.9 0.9 0.4 0.0 0.1 0.0 0.3 0.1 0.3 0.8 0.1 1.2 2.7 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 1.0 0.1 0.0 0.2 0.8 1.7 0.3 0.6 0.0 3.9 3.6 0.5 0.2 0.0 0.9 0.3 0.7 0.0 2.3 0.4 0.2 0.6 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 3.4 0.0 0.0 0.0 0.0 6.0 5.6 0.0 3.7 0.0 4.5 2.0 2.5 4.0 5.7 5.2 3.9 2.2 0.0 1.9 126.0 0.6 1.0 0.0 2.5 0.4 0.7 4.2 1.1 1.8 0.7 3.2 4.7 2.5 0.8 19.1 3.4 0.6 0.0 0.0 2.2 5.1 3.5 2.3 1.4 0.0 5.9 0.0 0.5 17.2 11.0 0.0 0.2 0.0 4.1 2.4 GOLGA6L2 "CT105, FLJ36144" ENSG00000174450 "Golgin A6 family-like 2" Q8N9W4 15 23439498-23447234 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 125 "testis: 29.9" "Cell type enriched" "Detected in some" 13 "Early spermatids: 300.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-266/70: 18.6" NA NA "unprognostic (1.45e-1)" "unprognostic (4.86e-2)" "unprognostic (4.12e-1)" "unprognostic (1.92e-2)" "unprognostic (1.24e-1)" "unprognostic (5.52e-2)" "unprognostic (8.71e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 300.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 2.2 0.0 0.1 0.0 0.0 0.0 GOLGA6L22 ENSG00000277865 "Golgin A6 family-like 22" 15 22458903-22469230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 7.7" "Cell type enriched" "Detected in some" 9 "Early spermatids: 49.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HeLa: 1.0;Karpas-707: 1.1;U-266/70: 1.7" HPA047733 Uncertain NA NA "HPA047733: " "unprognostic (2.71e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 7.7 0.0 0.0 0.0 0.2 0.3 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.6 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA6L6 FLJ36131 ENSG00000277322 "Golgin A6 family-like 6" A8MZA4 15 20531856-20541800 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 21 "testis: 7.2" "Cell type enriched" "Detected in some" 7 "Early spermatids: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SCLC-21H: 1.3" HPA047733 Uncertain NA NA "HPA047733: " "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA6L7 GOLGA6L7P ENSG00000261649 "Golgin A6 family like 7" 15 28841833-28848675 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 17 "testis: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;HMC-1: 3.1;THP-1: 2.6;U-266/70: 4.1;U-266/84: 4.2" NA NA "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (3.65e-5)" "unprognostic (3.84e-1)" "unprognostic (6.81e-2)" "unprognostic (1.66e-2)" "unprognostic (5.10e-2)" "unprognostic (5.62e-11)" "unprognostic (2.53e-1)" "unprognostic (3.14e-1)" "unprognostic (2.59e-1)" 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.4 0.0 1.0 0.2 0.2 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.6 0.8 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.1 0.0 4.1 4.2 0.0 0.0 0.1 0.0 0.6 0.2 0.1 0.3 0.2 0.1 0.3 0.6 0.0 0.0 0.4 0.1 0.1 1.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L9 GOLGA6L20 ENSG00000197978 "Golgin A6 family-like 9" A6NEM1 15 82430018-82439153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "stomach 1: 3.4" "Cell type enhanced" "Detected in many" 10 "Club cells: 36.4;Early spermatids: 53.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 6.8;HDLM-2: 5.9;U-266/84: 5.2" NA NA "unprognostic (2.13e-1)" "unprognostic (1.51e-2)" "unprognostic (3.80e-1)" "unprognostic (7.40e-2)" "unprognostic (1.53e-1)" "unprognostic (9.09e-3)" "unprognostic (5.73e-2)" "unprognostic (2.48e-3)" "unprognostic (2.92e-2)" "unprognostic (4.76e-3)" "unprognostic (1.22e-2)" "unprognostic (6.63e-3)" "unprognostic (5.09e-5)" "unprognostic (4.78e-2)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.29e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 1.4 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.2 0.0 1.2 0.3 0.0 0.0 0.2 0.4 0.0 3.4 1.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.6 0.1 0.0 2.5 1.5 6.8 0.0 0.0 3.7 1.1 0.1 0.3 0.1 0.0 2.3 2.7 0.0 0.3 0.0 1.1 1.0 0.5 0.2 5.9 0.0 0.0 2.2 1.5 0.8 0.2 2.3 0.1 2.6 0.0 0.9 1.2 0.9 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.2 2.5 0.0 0.0 4.2 0.0 4.3 0.0 1.7 3.5 1.3 1.1 0.0 0.0 0.0 3.6 2.7 2.8 3.4 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.3 0.0 1.6 0.4 0.6 0.0 0.4 0.0 0.0 0.0 0.1 8.9 19.3 3.0 1.7 0.1 5.0 4.3 5.1 13.4 36.4 3.5 7.9 1.1 0.0 3.3 53.2 1.5 3.5 0.0 3.3 0.7 0.6 1.7 1.1 1.7 0.6 6.4 15.5 4.9 0.0 6.6 1.1 0.8 0.0 1.8 6.9 4.8 5.3 2.9 1.1 0.0 8.9 0.0 2.1 9.9 5.6 0.0 0.7 0.0 7.2 2.0 GOLGA7B "bA451M19.3, bA459F3.4, C10orf132, C10orf133" ENSG00000155265 "Golgin A7 family member B" Q2TAP0 10 97850239-97871580 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 39.6;epididymis: 35.9;skin 1: 21.4" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 11.1;Cholangiocytes: 15.3;Intestinal endocrine cells: 11.5;Rod photoreceptor cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 24 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "A-431: 4.7;GAMG: 13.6;HDLM-2: 5.1;SK-MEL-30: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046878 Uncertain NA NA "HPA046878: AB_2679854" "unprognostic (7.90e-2)" "unprognostic (1.70e-3)" "unprognostic (7.10e-3)" "unprognostic (1.06e-2)" "unprognostic (8.97e-2)" "unprognostic (1.54e-1)" "unprognostic (6.20e-4)" "unprognostic (1.95e-1)" "unprognostic (4.45e-1)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (4.13e-2)" "unprognostic (1.15e-7)" "unprognostic (2.12e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-3)" "unprognostic (5.90e-3)" 2.5 4.5 16.4 2.1 12.0 1.3 2.5 39.6 24.1 1.3 1.5 4.4 1.3 3.2 1.3 35.9 2.3 1.1 1.5 3.4 19.8 12.8 1.0 1.1 1.7 2.8 11.1 20.4 1.0 6.6 1.0 6.7 1.3 10.7 1.3 1.8 0.6 1.4 1.7 4.9 21.4 3.8 1.2 5.4 1.5 2.3 1.7 6.2 0.0 1.4 0.5 2.5 1.2 1.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 4.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.1 0.0 13.6 1.8 0.0 0.3 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.9 0.3 0.0 1.7 0.1 0.1 0.3 0.7 1.4 0.0 0.9 20.3 0.0 2.0 0.1 0.1 0.1 0.0 0.0 0.2 1.6 0.7 0.0 3.7 2.1 2.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 2.3 1.9 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 1.2 0.3 16.4 12.0 39.6 24.1 19.8 12.8 11.1 20.4 10.7 6.2 0.0 0.3 0.0 0.1 11.1 2.7 2.2 15.3 0.0 0.0 1.8 2.0 0.0 0.0 6.4 4.5 0.6 0.4 0.0 3.7 0.0 0.2 0.2 0.0 0.0 5.4 3.2 11.5 0.6 0.0 8.8 0.3 0.0 6.8 1.0 1.1 2.8 7.5 0.0 0.4 0.0 17.0 0.0 0.2 1.9 1.6 4.4 0.0 0.0 0.2 0.2 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 25.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 178.6;Club cells: 128.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "basophil: 2.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "HeLa: 14.6;Hep G2: 13.0;NB-4: 20.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 2.6 3.4 0.0 2.8 0.6 6.8 4.3 2.5 2.7 2.5 2.0 0.0 4.1 6.1 0.8 3.8 2.8 1.6 0.0 0.7 3.0 2.3 4.5 8.0 0.0 9.0 25.2 0.1 4.9 0.9 5.4 0.1 4.6 5.2 1.8 3.3 5.4 0.5 0.0 5.2 4.0 5.3 16.4 3.1 3.0 1.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 2.0 2.3 0.2 4.3 2.4 4.7 6.1 1.9 0.6 2.1 3.5 2.2 2.9 0.0 4.1 2.0 0.2 1.7 0.8 1.9 1.8 3.0 7.1 0.3 14.6 13.0 3.5 1.8 2.3 6.7 2.7 1.3 3.9 2.4 2.1 3.3 0.7 0.2 1.9 1.0 0.9 20.1 2.7 4.1 3.9 0.1 0.0 0.3 1.8 4.1 3.2 4.9 1.0 0.3 2.2 3.4 1.9 3.9 0.0 3.1 7.4 0.9 3.3 1.4 1.3 3.0 1.0 0.9 0.8 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 178.6 44.8 21.6 8.2 19.5 41.4 30.9 17.8 53.5 128.5 29.6 68.7 5.9 1.7 7.8 32.7 8.9 3.2 0.0 11.0 3.6 7.6 6.5 9.2 25.1 1.4 42.9 6.9 12.9 8.1 3.9 36.5 6.7 20.3 9.0 8.5 9.4 15.0 3.5 35.3 2.2 68.6 12.9 8.1 34.9 26.8 12.9 2.4 37.1 6.9 6.0 GOLGA8F DKFZp434P162 ENSG00000153684 "Golgin A8 family member F" Q08AF8 15 28378621-28392018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 136 "testis: 13.6" "Cell type enhanced" "Detected in single" 33 "Spermatocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 35 "NB-4: 7.0" NA NA "unprognostic (4.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8G DKFZp434K052 ENSG00000183629 "Golgin A8 family member G" 15 28519611-28533014 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 126 "testis: 12.6" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 18.1 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA8H GOLGA6L11 ENSG00000261794 "Golgin A8 family member H" P0CJ92 15 30604126-30614561 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "testis: 9.2" "Cell type enhanced" "Detected in some" 23 "Club cells: 2.3;Early spermatids: 12.7;granulocytes: 2.3;monocytes: 2.8;Spermatocytes: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 5.5;RH-30: 7.8;SH-SY5Y: 4.3;TIME: 4.1" NA NA "unprognostic (4.32e-3)" "unprognostic (7.13e-2)" "unprognostic (4.86e-2)" "unprognostic (2.92e-1)" "unprognostic (2.71e-1)" "unprognostic (7.33e-2)" "unprognostic (6.91e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (6.44e-3)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-2)" "unprognostic (1.10e-1)" "unprognostic (6.08e-2)" "unprognostic (1.14e-1)" 1.5 0.3 0.3 0.2 0.5 4.0 0.7 0.0 0.6 1.2 0.5 0.0 1.1 0.6 0.3 1.9 0.6 1.9 0.1 0.2 0.3 0.0 1.1 0.4 0.3 0.8 2.4 1.5 0.6 0.1 0.4 0.3 0.4 0.3 0.3 0.2 0.4 0.9 0.4 0.5 0.4 9.2 3.0 0.0 1.4 0.5 1.6 1.2 2.0 0.6 1.0 0.8 0.4 0.0 2.7 0.9 0.0 0.0 0.1 0.0 0.1 0.1 0.2 1.1 0.5 0.6 0.2 1.2 0.0 2.8 0.0 2.3 0.0 0.0 0.2 1.9 3.5 0.2 0.1 0.0 1.1 5.5 0.2 0.2 0.2 0.2 3.3 1.0 2.6 0.6 0.2 0.5 0.5 0.2 0.2 0.4 0.1 0.7 0.1 7.8 0.0 0.6 0.4 0.5 4.3 0.2 0.0 0.0 0.4 0.4 2.6 4.1 0.0 1.6 0.0 0.5 0.6 0.1 1.8 0.0 3.2 0.4 0.0 0.5 2.0 0.6 0.2 0.2 1.6 0.5 0.0 0.6 1.6 0.6 0.8 0.0 1.0 0.6 1.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA8J ENSG00000179938 "Golgin A8 family member J" A6NMD2 15 30083053-30093499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 19 "testis: 3.4" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 3.9;Early spermatids: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 GOLGA8K ENSG00000249931 "Golgin A8 family member K" D6RF30 15 32392782-32403292 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "testis: 9.2" "Cell type enriched" "Detected in single" 14 "Early spermatids: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;HEL: 2.0;HMC-1: 2.3;JURKAT: 3.0;THP-1: 4.2;U-937: 4.1" NA NA "unprognostic (2.47e-1)" "unprognostic (3.27e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-2)" "unprognostic (6.62e-2)" "unprognostic (7.35e-2)" "unprognostic (2.86e-1)" "unprognostic (5.75e-2)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (4.81e-2)" "unprognostic (1.18e-2)" "unprognostic (9.81e-2)" 0.7 0.2 0.0 0.2 0.1 1.3 0.3 0.0 0.2 0.6 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 1.7 0.5 0.5 0.0 0.2 0.1 0.2 0.2 0.1 0.2 0.4 0.3 0.2 0.3 0.2 9.2 1.8 0.4 0.9 0.3 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 1.5 2.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.5 0.0 0.8 0.4 3.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.6 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8M ENSG00000188626 "Golgin A8 family member M" H3BSY2 15 28701954-28738384 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "thyroid gland: 12.6" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Early spermatids: 9.1;Horizontal cells: 3.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 2.8;U-937: 9.9" NA NA "unprognostic (1.40e-1)" "unprognostic (3.90e-2)" "unprognostic (2.04e-1)" "unprognostic (2.00e-2)" "unprognostic (5.25e-3)" "unprognostic (1.28e-1)" "unprognostic (2.05e-1)" "unprognostic (6.16e-3)" "unprognostic (8.16e-4)" "unprognostic (4.32e-2)" "unprognostic (2.66e-4)" "unprognostic (8.24e-3)" "unprognostic (4.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.60e-1)" 2.4 0.5 0.0 0.0 0.1 0.7 1.5 0.0 0.0 0.7 0.0 0.0 0.2 0.9 0.0 0.4 0.5 0.3 0.0 0.0 0.6 2.4 0.2 0.1 0.0 3.3 0.2 0.0 1.1 3.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 4.3 12.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.1 0.1 0.4 2.5 1.4 0.0 0.0 0.0 0.0 1.7 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 3.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.2 0.9 0.0 0.1 0.0 0.0 0.1 GOLGA8N ENSG00000232653 "Golgin A8 family member N" F8WBI6 15 32593456-32607310 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 15.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 15.2;Early spermatids: 51.2" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 6 "gdT-cell: 2.7;NK-cell: 5.9" "Group enriched" "Detected in many" 6 "NK-cells: 5.9;T-cells: 2.7" "Group enriched" "Detected in some" 5 "HEL: 35.3;THP-1: 23.0;U-937: 30.1" NA NA "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.55e-3)" "unprognostic (5.11e-3)" "unprognostic (1.78e-2)" "unprognostic (5.67e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (2.59e-3)" "unprognostic (1.93e-1)" "unprognostic (8.26e-2)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 2.4 1.3 0.6 1.4 0.8 7.7 2.0 0.6 0.6 3.3 1.8 0.9 2.9 9.2 1.1 3.3 0.6 2.8 0.6 0.7 1.4 1.9 1.7 1.4 1.1 5.5 15.2 5.6 5.1 0.2 2.4 0.4 1.8 1.9 2.2 2.2 1.8 1.0 1.7 2.5 1.7 6.2 11.7 0.7 3.2 2.2 0.2 0.6 0.1 0.1 5.9 2.7 0.2 0.1 0.0 0.1 0.2 1.3 1.8 0.1 0.6 0.3 0.1 0.1 0.0 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.0 0.2 0.0 0.3 35.3 0.0 0.0 0.5 0.6 0.3 0.5 0.6 0.0 0.4 1.9 0.0 0.0 0.1 0.0 0.3 0.5 0.0 6.2 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.0 23.0 1.4 0.7 0.1 0.0 0.0 1.4 1.4 0.4 0.2 30.1 0.3 0.1 0.1 0.0 2.7 0.0 0.4 0.2 0.4 0.4 0.4 0.1 0.5 0.5 0.0 5.9 0.0 0.6 0.0 0.2 17.9 15.2 0.0 0.4 0.0 1.0 11.8 2.5 12.0 11.4 1.8 0.0 0.2 0.0 0.2 51.2 1.5 1.0 0.0 1.7 0.0 0.4 0.2 5.8 2.9 0.5 12.7 3.4 2.5 1.8 3.4 5.2 0.9 0.0 1.8 1.1 2.2 1.0 0.0 2.1 0.4 1.9 0.0 0.5 5.7 0.7 0.0 0.1 2.2 1.0 0.1 GOLGA8O ENSG00000206127 "Golgin A8 family member O" A6NCC3 15 32445106-32455634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.1" "Cell type enhanced" "Detected in some" 22 "Club cells: 1.2;Early spermatids: 3.4;granulocytes: 1.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "gdT-cell: 2.8;NK-cell: 5.5" "Group enriched" "Detected in many" 9 "NK-cells: 5.5;T-cells: 2.8" "Group enriched" "Detected in some" 14 "HEL: 16.4;U-937: 23.6" NA NA "unprognostic (2.68e-2)" "unprognostic (4.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (3.71e-1)" "unprognostic (3.13e-3)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (8.25e-2)" "unprognostic (6.04e-2)" "unprognostic (3.06e-2)" 1.2 0.6 0.0 1.1 0.4 6.8 1.7 0.4 0.7 1.2 1.1 0.3 1.7 4.5 0.8 1.0 1.1 2.5 0.2 0.1 0.7 0.9 0.9 0.4 0.5 3.7 2.9 0.3 3.5 0.6 0.9 1.0 1.2 0.4 1.3 0.7 1.0 0.8 1.1 1.3 0.9 11.1 6.7 0.4 2.1 1.4 0.2 0.4 0.0 0.0 5.5 2.8 0.2 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.7 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 16.4 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.1 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 23.6 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.2 0.3 0.4 0.3 0.1 0.5 0.4 0.0 5.5 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8Q ENSG00000178115 "Golgin A8 family member Q" 15 30552078-30562501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "thyroid gland: 18.7" "Cell type enriched" "Detected in some" 5 "Early spermatids: 30.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 8 "NK-cells: 2.0" "Group enriched" "Detected in some" 7 "THP-1: 9.4;U-937: 12.8" NA NA "unprognostic (2.65e-2)" "unprognostic (6.48e-2)" "unprognostic (2.24e-1)" "unprognostic (5.52e-4)" "unprognostic (9.86e-3)" "unprognostic (1.26e-1)" "unprognostic (7.17e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" 1.3 0.4 0.0 0.2 0.1 2.9 0.9 0.0 0.1 1.4 0.7 0.1 1.7 3.0 0.3 1.3 0.2 1.1 0.1 0.0 0.5 0.5 1.1 0.1 0.2 2.7 2.1 2.7 2.3 0.1 0.8 0.5 0.8 0.4 0.4 0.6 0.6 1.0 0.5 0.3 0.7 4.1 18.7 0.2 1.2 0.9 0.0 0.0 0.0 0.0 2.0 0.2 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.6 0.0 1.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 9.4 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 12.8 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.6 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.8 0.4 4.8 1.2 0.6 1.3 0.7 2.0 0.8 1.7 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.6 6.5 0.9 3.3 1.7 0.1 0.0 1.0 0.0 0.1 GOLGA8R ENSG00000186399 "Golgin A8 family member R" I6L899 15 30403740-30414162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 10.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 43.1;Horizontal cells: 7.9;Sertoli cells: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 22.1;THP-1: 7.5;U-937: 8.8" NA NA "unprognostic (1.13e-1)" "unprognostic (8.96e-3)" "unprognostic (1.27e-2)" "unprognostic (9.06e-2)" "unprognostic (1.87e-2)" "unprognostic (4.70e-2)" "unprognostic (2.12e-2)" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (9.09e-2)" "unprognostic (9.79e-4)" "unprognostic (2.29e-1)" "unprognostic (2.12e-1)" "unprognostic (4.41e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (9.68e-2)" 2.3 1.2 0.3 1.7 0.7 5.9 1.9 0.3 0.7 2.2 1.5 1.0 2.3 2.9 1.1 2.1 1.6 2.5 0.4 0.4 1.1 1.5 1.3 0.9 0.7 5.0 3.5 2.8 4.3 0.4 1.2 0.5 1.7 0.9 1.4 2.7 1.5 1.4 1.4 1.6 1.6 4.2 10.3 0.6 2.8 2.1 0.0 0.9 0.3 0.3 0.4 0.9 0.0 0.1 0.0 0.2 0.0 0.0 1.6 0.0 0.6 0.3 0.0 0.2 0.0 0.1 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 22.1 0.0 0.0 0.3 0.0 0.0 0.4 0.4 0.1 0.0 1.5 0.1 0.2 0.1 0.1 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.1 0.1 7.5 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 8.8 0.2 0.0 0.3 0.3 0.9 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.9 0.0 0.0 0.0 1.0 0.0 0.2 0.0 2.3 0.6 2.5 1.4 2.3 0.0 0.0 0.1 0.0 0.2 43.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.5 0.3 7.9 0.0 0.0 0.3 1.6 1.1 0.2 0.0 1.0 0.0 1.1 0.1 0.0 0.4 0.0 3.3 12.9 0.1 2.8 1.9 0.0 0.0 0.0 0.2 0.2 GOLGA8S ENSG00000261739 "Golgin A8 family member S" 15 23354748-23367231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "testis: 3.8" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Ciliated cells: 4.0;Early spermatids: 5.5;Horizontal cells: 6.4;Spermatocytes: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.64e-2)" "unprognostic (7.02e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" "unprognostic (1.00e-1)" "unprognostic (3.68e-1)" "unprognostic (2.80e-2)" "unprognostic (1.75e-2)" "unprognostic (9.39e-3)" "unprognostic (8.10e-2)" "unprognostic (3.01e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.2 0.0 0.0 0.0 0.0 0.0 GOLGA8T ENSG00000261247 "Golgin A8 family member T" 15 30135149-30145567 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 8.4" "Cell type enriched" "Detected in single" 6 "Early spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (5.20e-2)" "unprognostic (5.37e-2)" "unprognostic (2.10e-2)" 0.2 0.2 0.0 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.7 0.8 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 8.4 1.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLM1 "bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73" ENSG00000135052 "Golgi membrane protein 1" Q8NBJ4 9 86026146-86100173 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 83.7;stomach 1: 114.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 319.9;Paneth cells: 285.1" "Cancer enhanced" "Detected in all" "prostate cancer: 343.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 79.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010638, HPA011929, CAB015341" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 70000000 "Golgi apparatus" "CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" "unprognostic (1.10e-1)" "prognostic favorable (8.14e-5)" "unprognostic (1.97e-1)" "unprognostic (4.40e-3)" "prognostic unfavorable (1.30e-4)" "unprognostic (4.89e-3)" "unprognostic (2.81e-1)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "unprognostic (1.34e-2)" "unprognostic (5.59e-3)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (2.87e-3)" "unprognostic (1.23e-1)" 6.1 53.6 23.3 15.6 18.2 1.9 11.6 23.1 27.7 21.0 53.1 16.5 6.0 62.8 11.9 9.3 4.2 11.1 83.7 4.0 24.7 26.3 22.0 6.6 4.4 2.8 17.4 20.4 11.1 19.5 7.8 15.1 5.3 22.3 39.9 45.5 10.9 43.0 3.5 2.6 4.6 16.5 8.4 25.5 11.3 114.2 5.0 16.4 5.0 19.5 7.9 36.6 11.6 11.0 1.2 2.2 7.2 5.9 1.2 5.7 2.5 29.5 29.0 21.8 24.6 28.1 16.3 23.0 13.5 9.8 21.3 17.3 14.2 59.3 0.6 13.4 26.1 20.6 22.9 13.3 13.3 15.5 1.0 21.2 9.2 19.3 0.7 16.7 13.6 7.4 24.7 7.2 20.0 7.3 26.8 36.3 4.4 5.7 0.9 12.0 13.9 1.6 10.2 34.3 38.7 21.0 8.7 24.9 4.5 35.5 12.7 24.6 15.4 18.4 40.0 15.1 14.7 22.5 14.0 23.1 5.6 15.7 16.8 16.0 79.6 7.5 0.2 24.1 6.1 12.1 2.1 5.5 0.8 5.7 3.9 0.7 1.1 0.5 0.8 0.7 1.2 0.7 1.3 7.2 1.2 5.9 2.2 0.3 2.5 23.3 18.2 23.1 20.8 24.7 26.3 17.4 20.4 22.3 16.4 8.9 11.7 0.0 9.8 2.1 16.9 4.3 71.4 69.6 61.4 33.2 7.9 5.4 21.6 148.1 319.9 21.5 193.3 0.0 197.4 30.2 20.6 130.5 1.1 12.5 9.8 63.5 70.2 9.8 7.5 196.5 17.0 3.3 21.9 1.0 76.8 15.7 203.7 285.1 12.4 11.5 6.1 0.0 10.3 8.9 34.3 0.9 5.4 4.3 129.2 17.6 GOLT1A "CGI-141, FLJ42654, GOT1, MGC62027, YMR292W" ENSG00000174567 "Golgi transport 1A" Q6ZVE7 1 204198160-204214092 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 35.9;liver: 74.9" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 38.2;Hepatocytes: 109.9" "Cancer enriched" "Detected in many" 6 "liver cancer: 80.7" "Group enriched" "Detected in many" 5 "basal ganglia: 8.8;cerebellum: 3.8;hypothalamus: 3.8" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.5" "Lineage enriched" "Detected in single" 12 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 10.8;Hep G2: 13.3;MCF7: 22.5;OE19: 8.5;RT4: 14.7;SK-BR-3: 14.8" "Not detected" "Not detected" NA NA "unprognostic (3.43e-1)" "unprognostic (1.13e-1)" "unprognostic (2.22e-3)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (6.20e-3)" "unprognostic (2.14e-1)" "unprognostic (8.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.26e-2)" "unprognostic (7.33e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.35e-5)" "unprognostic (1.37e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-3)" "prognostic favorable (1.51e-4)" 0.3 0.0 1.2 0.8 8.8 0.0 1.7 3.8 0.8 3.5 13.7 0.4 1.7 15.5 0.3 3.6 0.3 1.0 3.4 0.3 1.0 3.8 5.9 74.9 3.1 0.3 0.8 0.4 0.4 12.5 7.1 8.7 1.0 0.9 2.9 1.6 0.5 1.0 3.7 0.6 0.0 35.9 1.6 0.6 0.3 1.9 0.5 0.3 0.4 0.6 0.3 0.4 10.9 2.5 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.2 4.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 9.3 10.8 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.1 8.5 0.1 0.0 0.0 0.2 4.6 14.7 0.7 1.0 0.4 14.8 0.0 0.4 4.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 1.4 1.4 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.6 1.2 8.8 3.8 0.8 1.0 3.8 0.8 0.4 0.9 0.3 0.0 17.9 0.0 11.9 0.0 2.5 0.3 38.2 0.0 5.7 15.7 0.0 11.4 11.6 24.4 0.6 0.0 13.1 0.0 16.1 0.2 0.4 10.6 1.1 109.9 1.1 1.6 9.9 3.1 2.8 0.0 0.0 0.0 1.7 0.0 3.2 0.0 18.5 1.7 0.0 10.4 0.1 0.0 0.1 2.3 0.9 0.1 22.1 0.0 7.4 12.9 GORASP2 "GOLPH6, GRASP55, GRS2" ENSG00000115806 "Golgi reassembly stacking protein 2" Q9H8Y8 2 170928464-170967129 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 120.2" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 275.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035274, HPA035275, CAB075758" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600" "unprognostic (2.04e-2)" "unprognostic (4.37e-3)" "unprognostic (4.61e-1)" "unprognostic (1.64e-1)" "unprognostic (9.94e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (3.13e-2)" "unprognostic (3.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.58e-1)" "unprognostic (4.56e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.38e-8)" "unprognostic (1.26e-1)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (3.13e-1)" 6.6 9.4 6.6 6.6 6.9 4.0 7.3 6.6 6.6 12.1 6.9 6.6 9.6 7.2 9.1 15.5 9.0 6.5 6.6 10.1 6.6 7.1 6.6 10.3 6.6 6.6 6.6 6.6 6.7 13.6 6.6 13.1 10.4 6.6 7.4 7.1 6.6 12.8 9.8 7.1 7.5 6.6 7.2 7.0 6.6 7.5 120.2 6.6 6.6 8.7 6.6 6.6 7.5 6.9 12.3 16.9 11.7 10.7 16.0 23.7 14.2 11.8 9.8 14.0 11.4 27.4 20.7 17.1 19.8 21.9 17.5 22.2 25.8 16.2 17.8 11.2 27.4 11.9 15.0 15.8 18.3 20.8 10.4 21.6 20.2 9.1 40.4 27.8 16.8 13.1 15.7 20.6 17.5 29.4 19.0 19.1 12.4 17.5 13.6 15.9 19.7 15.5 27.0 14.8 21.5 12.2 13.1 12.8 22.1 25.5 17.1 12.7 11.5 11.1 19.7 19.7 12.6 12.5 16.0 17.3 16.9 11.2 16.1 10.8 14.9 9.5 21.4 17.4 12.0 19.0 11.7 10.0 6.4 15.2 10.6 23.7 12.3 17.2 18.1 12.6 10.2 17.4 14.5 2.4 16.0 10.7 16.9 14.5 14.2 6.6 6.9 6.6 6.6 6.6 7.1 6.6 6.6 6.6 6.6 38.7 30.1 27.4 29.3 33.1 32.2 35.0 22.9 14.7 40.9 19.2 29.5 97.0 48.0 54.4 187.2 27.0 30.6 0.0 68.7 90.0 49.3 42.4 19.7 42.9 42.1 39.7 30.1 46.6 19.8 275.6 54.4 28.0 45.5 58.7 49.9 31.0 60.3 38.6 46.7 34.9 30.2 58.2 34.0 31.9 40.3 31.6 192.1 36.3 42.5 66.5 GOT1 AST1 ENSG00000120053 "Glutamic-oxaloacetic transaminase 1" P17174 10 99396870-99430624 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Amino-acid biosynthesis" "Aminotransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 398.1;Distal tubular cells: 203.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064532, HPA072629" Enhanced Supported Nucleoplasm,Cytosol NA Yes 130000000 Nucleoplasm Cytosol "HPA064532: AB_2685279, HPA072629: AB_2686540" "unprognostic (6.40e-2)" "prognostic favorable (6.23e-4)" "unprognostic (5.99e-2)" "unprognostic (2.84e-2)" "unprognostic (2.82e-1)" "unprognostic (2.96e-2)" "unprognostic (5.25e-2)" "unprognostic (1.08e-3)" "unprognostic (6.67e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (1.79e-1)" "prognostic favorable (3.72e-13)" "unprognostic (1.93e-2)" "unprognostic (4.23e-1)" "unprognostic (6.85e-2)" "unprognostic (1.00e-1)" 3.3 14.0 15.7 3.6 32.1 2.0 5.9 22.9 56.4 13.5 12.0 9.7 5.9 14.7 3.4 7.0 10.3 4.6 12.2 116.9 19.4 19.0 34.6 82.9 3.5 3.4 17.8 16.4 3.8 8.2 15.9 4.9 3.7 49.9 5.9 14.7 9.0 12.4 7.2 102.1 4.5 12.7 5.4 7.7 3.6 10.1 9.3 4.7 3.3 11.7 31.3 7.1 4.9 4.0 10.6 21.4 3.9 16.8 11.4 15.6 8.8 17.2 9.6 11.3 28.6 8.7 7.5 32.0 14.2 26.1 24.7 27.1 21.7 14.1 16.9 4.9 11.9 21.0 21.7 25.8 18.7 27.4 5.8 11.0 6.4 12.3 28.2 46.5 18.3 11.0 11.9 20.2 21.0 57.1 16.8 12.0 11.2 16.5 26.5 15.8 15.6 9.8 13.8 7.2 27.0 13.4 10.7 10.8 17.6 43.2 9.5 4.9 7.2 10.7 15.2 52.9 17.4 29.0 6.3 5.5 6.3 14.1 6.8 16.2 18.9 22.3 17.3 16.6 9.6 8.4 2.4 5.3 3.9 12.4 14.7 11.4 10.6 13.5 12.9 12.9 10.2 10.2 14.5 0.5 11.4 16.8 21.4 15.6 8.8 15.7 32.1 22.9 56.4 19.4 19.0 17.8 16.4 49.9 4.7 14.9 14.4 29.9 39.5 10.5 86.5 398.1 96.8 26.8 14.8 69.8 58.9 29.8 203.9 43.4 86.1 13.5 75.3 46.7 27.1 14.9 9.9 11.6 32.2 145.9 26.2 71.5 18.9 17.2 11.6 9.5 10.3 9.5 47.2 14.4 30.8 29.4 25.5 30.3 13.4 123.7 55.6 12.9 14.1 28.9 11.5 9.2 46.1 12.1 50.2 36.7 GOT1L1 MGC33309 ENSG00000169154 "Glutamic-oxaloacetic transaminase 1 like 1" Q8NHS2 8 37934281-37940129 "Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 16.4" "Cell type enriched" "Detected in some" 7 "Early spermatids: 100.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA028778 Uncertain NA NA "HPA028778: AB_10602138" "unprognostic (6.93e-3)" "unprognostic (5.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 GOT2 "KAT4, KATIV, KYAT4, mitAAT" ENSG00000125166 "Glutamic-oxaloacetic transaminase 2" P00505 16 58707131-58734357 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Lipid transport, Transport" "Aminotransferase, Transferase" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 167.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 269.3;Hepatocytes: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018139 Enhanced "Intracellular and membrane" NA NA 7000000 "HPA018139: AB_1849903" "unprognostic (1.50e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-3)" "unprognostic (2.63e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (1.61e-4)" "prognostic favorable (5.75e-5)" "unprognostic (1.12e-2)" "unprognostic (3.19e-1)" "unprognostic (3.72e-2)" "unprognostic (2.27e-1)" "unprognostic (3.00e-1)" "prognostic favorable (2.90e-9)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (2.22e-1)" 6.1 21.0 12.7 8.0 19.1 5.5 10.7 19.4 35.7 10.6 15.9 16.0 33.3 10.6 10.4 19.5 17.7 13.5 8.9 78.1 15.8 16.7 24.6 85.5 7.1 11.1 16.2 17.8 8.7 8.8 27.0 13.0 7.3 27.7 17.2 18.8 23.4 13.0 20.5 167.8 10.4 9.4 13.5 12.3 8.0 13.6 10.8 9.9 10.7 12.3 53.9 15.0 15.5 11.2 14.3 17.6 3.5 9.9 14.5 24.5 14.3 27.6 37.6 19.8 24.1 14.4 13.0 26.0 21.3 22.7 42.0 23.1 32.5 25.0 61.9 25.3 23.5 18.4 40.9 42.4 41.3 53.6 17.0 38.9 16.6 20.5 36.3 18.3 26.7 15.4 12.6 23.5 26.4 23.1 24.0 42.1 30.0 33.4 6.4 21.3 24.7 33.2 25.8 26.9 18.5 73.0 36.5 30.2 59.4 39.6 40.7 31.7 23.0 40.7 43.9 15.3 18.7 22.1 8.7 16.9 15.3 28.0 11.9 27.0 14.9 13.8 50.7 16.3 26.8 15.4 2.3 9.9 3.5 15.2 8.6 23.5 14.3 18.0 18.4 17.6 10.6 16.7 15.3 0.9 14.5 8.5 15.5 24.5 14.3 12.7 19.1 19.4 35.7 15.8 16.7 16.2 17.8 27.7 9.9 8.9 12.0 18.2 27.1 28.4 31.7 269.3 33.1 13.4 14.8 34.9 72.6 40.0 48.0 48.1 3.5 16.6 29.5 23.3 36.8 30.5 15.1 29.5 13.9 145.0 34.4 19.1 19.8 25.8 17.4 5.6 16.7 14.4 23.6 9.0 29.0 15.2 34.5 5.8 21.2 51.6 42.1 0.0 14.7 11.2 14.7 26.2 19.8 14.4 49.8 58.8 GP1BA "CD42b, GP1B, GPIbalpha" ENSG00000185245 "Glycoprotein Ib platelet alpha subunit" P07359 17 4932297-4935030 "CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation, von Willebrand disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 37.8" "Cell type enhanced" "Detected in some" 6 "Distal tubular cells: 3.3;Ito cells: 3.7;Rod photoreceptor cells: 3.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 7 "basophil: 7.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 7.5" "Cell line enriched" "Detected in some" 24 "HEL: 40.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002496, HPA013316" Supported NA NA 2000000000 "CAB002496: AB_563748, HPA013316: AB_1855459" "unprognostic (4.87e-4)" "unprognostic (8.21e-2)" "unprognostic (2.81e-2)" "unprognostic (6.11e-3)" "unprognostic (1.50e-2)" "unprognostic (1.59e-3)" "unprognostic (7.30e-3)" "unprognostic (5.58e-2)" "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "unprognostic (6.54e-4)" "unprognostic (1.27e-1)" "unprognostic (4.85e-3)" "unprognostic (4.58e-3)" "unprognostic (2.56e-1)" "unprognostic (3.53e-4)" "unprognostic (8.35e-2)" 0.7 0.1 0.4 15.8 1.2 5.3 0.7 1.9 0.7 0.7 1.0 0.2 0.2 1.5 0.6 0.7 5.7 0.8 0.3 4.2 0.5 0.4 1.0 1.6 3.5 37.8 0.4 0.2 0.7 0.4 0.0 0.4 1.1 0.4 0.7 0.6 0.3 7.7 0.2 3.0 4.6 3.7 0.2 0.4 13.0 0.9 0.6 0.2 2.0 0.8 0.8 17.6 0.9 1.1 0.0 0.3 7.5 0.2 0.0 0.2 3.6 0.0 1.3 0.3 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.2 0.1 1.2 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.4 1.0 40.2 0.5 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.4 0.4 0.0 0.4 0.3 0.2 0.1 0.1 0.2 0.7 0.3 0.2 0.0 0.7 0.0 0.2 0.5 0.0 0.2 0.4 1.7 0.7 0.2 0.2 0.2 0.9 0.1 0.7 0.2 1.0 0.6 0.6 0.4 7.5 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 1.0 0.0 0.1 0.3 0.0 3.6 0.4 1.2 1.9 0.4 0.5 0.4 0.4 0.2 0.4 0.2 0.0 0.0 0.0 0.4 1.3 1.9 0.8 0.0 0.0 0.0 0.0 2.0 0.3 3.3 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.8 0.1 0.0 0.0 3.7 1.9 0.2 0.3 1.1 0.0 1.0 0.0 0.4 0.0 0.0 1.8 0.6 3.1 0.0 0.3 0.9 0.6 1.6 0.2 0.5 0.0 0.3 GP1BB "CD42c, GPIbbeta" ENSG00000203618 "Glycoprotein Ib platelet beta subunit" P13224 22 19722945-19724771 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.7;brain: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 6.3;neutrophil: 11.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.0" "Cell line enhanced" "Detected in some" "HEK 293: 5.8;K-562: 10.3;NB-4: 8.6;REH: 10.5;SH-SY5Y: 5.0;U-2 OS: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA 110000000 0.9 0.5 16.7 1.2 19.6 0.5 0.5 7.3 9.0 0.5 1.7 1.2 0.7 0.5 1.8 0.5 0.7 2.9 15.0 4.1 0.5 0.9 0.6 0.6 2.7 0.5 0.5 0.5 2.5 0.6 1.3 0.7 1.9 0.5 1.2 10.4 0.5 1.0 0.2 1.8 1.9 0.5 0.7 0.7 0.5 0.2 0.1 1.7 11.0 1.2 0.1 0.3 61.7 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 1.7 5.8 2.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.3 0.1 0.1 0.4 0.4 8.6 0.4 0.0 3.2 10.5 0.0 0.1 0.0 0.0 3.8 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 6.3 1.2 1.1 0.2 0.3 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.1 11.0 0.1 0.0 1.7 0.3 61.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GP2 ZAP75 ENSG00000169347 "Glycoprotein 2" P55259 16 20309572-20327808 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 354 "pancreas: 1812.8" "Cell type enhanced" "Detected in some" 30 "Cholangiocytes: 117.2;Exocrine glandular cells: 424.3;Glandular cells: 76.3" "Cancer enriched" "Detected in many" 14 "pancreatic cancer: 320.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015739, HPA016668" Enhanced "Intracellular and membrane" NA NA 27000 "HPA015739: AB_1849905, HPA016668: AB_1849907" "unprognostic (2.14e-2)" "unprognostic (1.97e-2)" "unprognostic (5.68e-2)" "unprognostic (4.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.84e-1)" "unprognostic (6.35e-2)" "unprognostic (8.17e-3)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 5.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.4 1812.8 0.0 0.1 0.1 0.1 0.8 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.4 1.4 2.3 0.9 0.6 0.8 0.3 0.5 0.3 0.6 1.0 0.0 0.2 1.3 0.3 0.0 0.5 0.2 1.3 0.7 1.3 1.4 0.4 0.6 0.7 0.1 0.4 0.7 0.3 0.2 0.4 1.3 0.2 0.0 0.4 0.9 0.0 0.3 0.2 0.0 0.5 0.0 0.5 0.8 0.8 0.5 0.0 0.5 0.6 0.1 0.1 1.2 0.8 0.8 1.8 0.1 0.2 0.7 0.5 0.6 1.4 0.2 0.7 0.5 0.5 0.0 1.1 2.2 0.8 1.0 0.7 0.8 0.3 0.3 0.6 0.3 2.0 0.9 0.7 0.8 0.3 0.5 0.6 0.7 0.7 0.1 1.4 0.7 0.7 2.3 0.6 0.2 1.4 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.1 117.2 0.0 0.0 0.0 0.0 0.0 8.3 0.8 6.1 0.0 0.6 0.0 424.3 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 7.2 2.0 0.2 32.3 13.9 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.0 1.4 GP5 CD42d ENSG00000178732 "Glycoprotein V platelet" P40197 3 194394821-194398354 "CD markers, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;T-cells: 2.2" "Cell line enriched" "Detected in some" 9 "HEL: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA072646 Approved Cytosol NA NA 400000000 Cytosol "HPA072646: " "unprognostic (3.74e-2)" "unprognostic (3.40e-1)" "unprognostic (5.22e-2)" "unprognostic (2.96e-2)" "unprognostic (1.74e-2)" "unprognostic (1.35e-3)" "unprognostic (1.69e-3)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" "unprognostic (2.80e-2)" "unprognostic (1.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (4.18e-2)" "unprognostic (3.14e-1)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" 0.3 0.0 0.4 2.1 0.5 1.6 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.5 0.3 0.3 0.4 0.6 0.3 0.6 0.9 3.7 0.3 0.3 0.8 0.3 0.0 0.4 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.9 0.3 0.3 1.7 0.2 0.3 0.3 0.3 1.0 0.3 1.9 0.3 0.5 0.1 1.1 0.2 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.4 0.1 0.1 2.0 2.2 0.1 0.0 0.0 1.1 0.0 0.4 0.4 0.5 0.3 0.3 0.4 0.6 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GP6 GPVI ENSG00000088053 "Glycoprotein VI platelet" Q9HCN6 19 55013705-55038264 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.9" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 5.9;Early spermatids: 10.5;Late spermatids: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "HEL: 13.9;K-562: 5.9;U-2 OS: 4.0" HPA066482 Approved Approved Nucleoplasm "Intracellular and membrane" NA NA 28000000 Nucleoplasm "HPA066482: AB_2685674" "unprognostic (3.06e-3)" "unprognostic (4.58e-2)" "unprognostic (1.74e-5)" "unprognostic (1.94e-1)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (7.50e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (4.18e-2)" "unprognostic (3.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.53e-1)" "unprognostic (2.62e-1)" "unprognostic (3.32e-2)" "unprognostic (5.44e-3)" "unprognostic (2.70e-2)" 0.3 0.3 0.8 0.4 1.4 4.4 0.9 4.6 1.6 1.3 0.4 0.3 0.3 0.1 1.1 0.3 2.1 0.5 0.5 5.4 0.7 0.9 0.4 1.5 1.4 0.3 0.3 0.3 0.6 0.3 0.6 0.3 2.8 0.3 0.6 0.4 2.0 0.7 3.0 0.3 3.2 0.3 0.3 0.3 8.9 0.1 4.2 1.0 0.3 0.6 0.3 0.3 0.7 1.8 0.0 0.3 1.3 0.2 0.0 0.1 4.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.6 0.2 0.0 0.2 0.2 0.5 13.9 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.3 5.9 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.2 0.1 4.0 0.1 0.0 0.3 0.0 0.4 0.1 0.4 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 4.0 0.8 1.4 4.6 1.6 0.7 0.9 0.3 0.3 0.3 1.0 0.0 0.0 0.0 0.1 0.0 1.5 0.4 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 10.5 0.3 0.3 0.0 0.3 0.2 0.2 0.3 1.1 0.0 0.1 3.2 0.0 2.5 1.2 6.4 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.9 0.1 0.5 0.0 0.0 0.7 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060767-129062406 "CD markers, Disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5" "Group enriched" "Detected in some" 11 "Early spermatids: 14.0;Late spermatids: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 8.8;neutrophil: 7.5" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.8" "Cell line enriched" "Detected in some" 14 "HEL: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 68000000 "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.2 0.1 0.1 0.1 0.1 10.0 0.1 0.0 0.6 0.4 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 5.0 0.8 0.1 0.1 0.4 4.8 0.0 0.8 0.2 0.5 0.1 0.0 0.3 1.5 0.4 0.1 0.4 0.2 0.0 0.6 0.2 0.0 0.1 0.0 0.1 24.5 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.6 3.0 0.1 1.5 8.8 0.6 0.0 0.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.6 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.0 7.5 0.0 0.0 1.5 0.0 27.1 0.1 0.1 0.0 0.6 0.8 0.1 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPA33 A33 ENSG00000143167 "Glycoprotein A33" Q99795 1 167052836-167166479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 101.1" "Group enriched" "Detected in some" 10 "Enterocytes: 384.9;Mucus-secreting cells: 185.3;Paneth cells: 288.3;Undifferentiated cells: 97.5" "Cancer enriched" "Detected in many" 6 "colorectal cancer: 84.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 17.8;T-reg: 13.0" "Lineage enriched" "Detected in many" 7 "T-cells: 17.8" "Cell line enriched" "Detected in some" 12 "OE19: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018858, CAB025943" Enhanced NA NA "CAB025943: , HPA018858: AB_1849909" "unprognostic (2.41e-2)" "unprognostic (1.71e-3)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (8.39e-4)" "unprognostic (1.55e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-2)" "unprognostic (9.63e-2)" "unprognostic (2.10e-2)" "unprognostic (9.44e-2)" "unprognostic (6.75e-2)" "unprognostic (5.22e-3)" "unprognostic (3.13e-1)" "unprognostic (9.68e-3)" "unprognostic (2.96e-3)" 0.2 0.2 0.2 12.1 0.2 0.0 0.2 0.2 0.2 0.2 46.9 0.2 0.1 31.6 0.2 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 1.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.3 0.2 0.2 43.5 0.2 0.3 0.1 0.2 0.2 101.1 1.4 0.2 0.6 0.2 0.2 0.1 0.6 0.2 0.1 0.6 0.2 0.2 1.7 1.7 0.1 2.5 0.1 17.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.4 1.4 17.2 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 2.5 1.1 0.1 7.6 3.9 1.7 1.7 17.8 2.4 0.1 0.1 1.6 0.0 13.0 4.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 384.9 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.5 0.0 25.1 0.0 2.6 1.3 0.3 0.9 0.0 0.0 185.3 0.7 0.1 288.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 97.5 0.1 GPAM "GPAT1, KIAA1560, MGC26846" ENSG00000119927 "Glycerol-3-phosphate acyltransferase, mitochondrial" Q9HCL2 10 112149864-112215377 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 107.3;liver: 56.6" "Group enriched" "Detected in many" 5 "Hepatocytes: 165.5;Horizontal cells: 42.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 20.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 76.6;Hep G2: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046339, HPA060090" Approved Approved Mitochondria NA NA Mitochondria "HPA046339: AB_2679627, HPA060090: AB_2684202" "unprognostic (1.82e-1)" "unprognostic (6.28e-2)" "unprognostic (1.13e-1)" "unprognostic (1.30e-1)" "unprognostic (6.80e-2)" "unprognostic (8.75e-2)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" "unprognostic (4.59e-1)" "unprognostic (4.80e-1)" "unprognostic (2.37e-2)" "unprognostic (5.44e-2)" "prognostic favorable (4.54e-6)" "unprognostic (2.84e-1)" "unprognostic (4.41e-2)" "unprognostic (2.52e-2)" "unprognostic (1.37e-1)" 107.3 17.2 11.4 2.6 12.1 1.8 30.8 6.6 11.0 2.0 3.2 6.5 5.1 2.2 4.1 32.1 2.4 1.9 3.0 5.8 12.2 2.9 2.4 56.6 2.2 2.3 7.2 7.3 3.5 2.8 3.2 2.3 1.8 5.6 2.3 2.6 12.0 6.8 2.9 3.6 1.8 3.3 3.4 3.8 1.7 2.4 2.8 7.2 2.8 6.1 2.4 2.3 3.2 1.6 3.2 2.0 0.5 1.2 1.1 3.4 1.0 2.8 2.1 2.9 3.8 76.6 2.8 3.8 2.7 3.1 1.9 1.5 5.0 1.7 2.0 1.5 1.9 1.8 3.6 4.6 2.3 3.7 1.4 2.4 1.8 2.3 20.6 2.3 3.2 1.0 13.4 3.9 3.5 7.1 15.0 1.7 2.8 2.3 1.8 2.2 1.6 2.7 2.5 2.4 1.6 3.0 2.7 7.6 1.4 1.3 1.9 1.2 3.6 3.7 1.8 4.2 2.8 1.8 1.1 1.3 2.3 1.4 2.8 4.2 1.8 2.0 4.2 2.6 2.8 1.7 0.0 1.0 0.5 2.5 1.2 3.2 1.9 1.9 1.9 1.2 3.2 2.0 3.4 0.0 1.1 1.0 2.0 1.9 1.0 11.4 12.1 6.6 11.0 12.2 2.9 7.2 7.3 5.6 7.2 8.9 19.0 7.8 0.6 0.3 5.8 15.7 17.8 5.3 5.7 5.2 9.8 4.6 1.7 2.5 0.4 4.5 1.7 0.0 2.8 2.1 2.5 1.2 2.3 165.5 2.5 42.9 1.2 5.5 8.9 0.4 4.9 2.1 1.7 0.0 3.8 6.0 2.6 2.9 11.3 2.7 8.9 6.5 1.9 2.9 3.2 0.1 1.6 3.2 4.5 0.5 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.2;kidney: 43.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 42.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029414, CAB033749" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB033749: AB_2224941, HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (8.21e-4)" 7.9 0.7 0.7 5.2 1.4 5.2 17.5 4.2 2.9 3.7 18.0 1.2 1.3 20.2 3.0 2.1 5.1 2.1 6.0 24.8 1.2 2.2 43.7 9.0 3.2 4.5 1.9 0.8 12.9 1.7 11.8 5.8 1.2 9.5 2.6 5.7 1.3 3.6 1.9 35.9 1.9 47.2 3.7 3.0 4.3 7.4 4.6 1.4 0.9 26.6 14.6 3.4 4.5 7.2 0.0 23.2 42.0 9.7 0.5 1.8 2.9 9.8 9.7 0.0 0.1 0.5 1.2 0.2 0.7 1.4 0.2 0.2 0.7 51.6 0.0 1.1 1.8 39.2 2.2 4.6 0.9 0.1 0.6 2.2 0.0 3.1 9.5 1.4 2.8 19.0 0.6 0.0 0.3 1.1 3.8 4.8 2.7 7.9 7.8 0.2 1.0 0.7 0.7 0.2 14.5 4.2 0.1 2.2 3.7 9.8 0.6 0.2 0.0 1.9 2.0 5.4 0.5 0.4 0.5 0.2 2.3 4.2 2.3 9.3 0.4 0.6 0.0 22.6 5.6 17.2 42.0 9.7 1.0 0.2 7.7 1.8 0.0 1.0 0.6 23.2 0.0 0.7 0.3 26.4 0.5 6.1 0.1 0.6 2.9 0.7 1.4 4.2 2.9 1.2 2.2 1.9 0.8 9.5 1.4 6.0 5.0 0.0 41.3 0.0 0.0 0.0 7.6 2.7 9.1 10.4 0.0 0.2 13.3 1.6 68.5 0.6 21.6 0.0 5.9 1.0 0.1 25.8 7.0 11.9 15.3 4.8 1.2 5.5 16.7 17.2 1.1 28.3 0.0 5.4 4.8 0.0 6.6 8.0 0.7 50.3 0.2 6.5 0.0 8.8 1.7 0.0 0.8 0.0 2.1 25.4 GPBAR1 "BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5" ENSG00000179921 "G protein-coupled bile acid receptor 1" Q8TDU6 2 218259496-218263859 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 85.6;gallbladder: 73.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 14.0;Intestinal endocrine cells: 44.2;Kupffer cells: 42.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 3.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 85.6;non-classical monocyte: 78.5" "Lineage enriched" "Detected in many" 5 "monocytes: 85.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HHSteC: 5.1;SCLC-21H: 2.6;U-937: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA062890 Enhanced NA NA "HPA062890: AB_2684896" "unprognostic (8.47e-2)" "unprognostic (3.72e-3)" "unprognostic (1.88e-2)" "unprognostic (9.49e-2)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (2.54e-1)" "unprognostic (2.63e-1)" "unprognostic (8.76e-3)" "unprognostic (4.32e-2)" "unprognostic (4.64e-2)" "unprognostic (1.55e-1)" "unprognostic (7.40e-7)" "unprognostic (4.18e-2)" "unprognostic (4.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.29e-1)" 19.9 1.1 0.3 2.6 0.4 1.8 11.4 0.2 0.4 0.7 2.7 0.5 0.8 1.0 1.1 1.4 1.3 0.9 73.8 3.8 0.2 0.0 3.2 1.7 2.2 3.8 0.4 0.2 1.4 1.5 0.0 0.7 8.9 0.4 2.0 0.5 0.9 0.5 0.9 0.8 0.8 3.2 10.3 0.2 6.5 5.5 1.5 0.2 1.0 1.5 1.8 0.6 3.2 0.7 0.0 17.4 0.8 85.6 0.0 0.1 15.8 0.2 0.1 0.4 0.0 3.1 0.1 0.9 0.0 0.4 0.0 0.1 0.8 0.4 0.2 0.3 0.3 0.2 0.1 0.1 0.3 0.0 0.0 0.8 0.3 0.5 0.4 5.1 0.4 1.4 0.0 2.5 0.0 0.0 0.2 0.2 0.4 0.3 0.5 0.6 0.3 0.2 0.7 0.2 0.0 0.0 0.2 0.0 0.2 1.6 1.1 2.6 2.3 0.3 0.7 0.4 0.2 0.0 0.8 0.0 0.1 0.3 0.3 0.2 0.3 0.7 0.1 0.3 5.1 0.3 0.0 36.4 0.0 0.1 85.6 0.1 0.0 0.0 0.1 17.4 0.0 0.0 0.0 0.8 0.0 78.5 0.7 0.1 15.8 0.3 0.4 0.2 0.4 0.2 0.0 0.4 0.2 0.4 0.2 0.0 4.3 0.9 0.1 0.2 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.4 10.0 0.0 2.6 0.5 0.0 0.0 0.4 2.8 1.9 0.1 1.1 0.0 14.0 0.0 44.2 3.1 42.9 1.6 3.1 6.8 0.0 1.0 0.3 0.0 0.4 0.8 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.4 1.4 0.0 0.1 0.2 GPC1 glypican ENSG00000063660 "Glypican 1" P35052 2 240435671-240468078 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 142.6" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 181.5;Syncytiotrophoblasts: 85.9;Urothelial cells: 90.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030571, HPA070449" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 6500000 "Plasma membrane, Cytosol" "HPA030571: AB_10602322, HPA070449: " "unprognostic (1.22e-2)" "unprognostic (2.53e-2)" "prognostic unfavorable (5.78e-5)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.95e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (1.00e-2)" "unprognostic (2.15e-1)" "unprognostic (5.08e-3)" "unprognostic (2.28e-1)" "unprognostic (4.38e-1)" "unprognostic (1.91e-1)" "unprognostic (4.40e-2)" "unprognostic (2.92e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-2)" 13.6 22.8 32.4 7.2 21.0 1.9 8.1 42.7 33.6 11.5 8.1 10.1 9.5 5.4 9.6 9.8 26.3 7.8 7.1 40.7 26.5 11.9 8.5 11.0 7.4 4.0 8.8 22.5 14.1 18.1 5.8 14.4 20.2 13.6 29.5 4.0 6.3 16.3 17.6 62.9 142.6 4.9 12.0 8.3 5.2 6.5 20.0 10.5 1.7 4.5 24.3 10.7 10.5 15.2 0.9 0.1 0.0 0.0 0.1 0.8 0.3 16.2 22.4 5.3 13.9 16.2 15.6 21.6 39.0 19.4 4.5 5.3 7.9 18.2 0.4 5.4 41.3 24.7 44.9 2.8 27.7 0.9 7.8 2.4 0.0 20.6 9.8 23.3 0.3 1.5 13.7 18.1 10.1 5.3 9.5 2.3 0.8 0.1 0.8 11.5 8.5 0.3 0.1 8.3 1.8 5.0 2.9 24.2 3.7 3.6 26.3 5.3 3.5 25.5 22.5 2.3 5.0 7.1 1.6 10.9 24.3 41.2 11.5 16.1 0.1 0.1 0.1 17.3 0.4 27.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.1 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.3 32.4 21.0 42.7 33.6 26.5 11.9 8.8 22.5 13.6 10.5 14.9 6.7 0.0 52.5 40.8 12.0 50.2 22.9 8.1 23.9 24.4 2.0 58.0 6.6 25.6 0.6 3.7 0.9 0.0 9.3 181.5 28.8 15.7 4.6 19.2 8.0 23.8 0.0 15.4 0.0 2.1 17.5 2.7 33.7 2.8 4.3 27.8 13.4 0.0 7.1 2.2 4.9 25.8 16.5 0.5 4.9 40.4 85.9 0.7 2.7 90.8 GPC2 "cerebroglycan, DKFZp547M109, FLJ38962" ENSG00000213420 "Glypican 2" Q8N158 7 100169606-100177372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 34.3;skin 1: 9.4;testis: 16.7" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 30.9;Intestinal endocrine cells: 10.3;Spermatocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 24.2;AN3-CA: 9.7;BEWO: 8.6;SH-SY5Y: 26.7" "Low region specificity" "Detected in all" CAB025423 Uncertain "Intracellular and membrane" NA NA "CAB025423: " "unprognostic (4.33e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-4)" "unprognostic (3.42e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-3)" "unprognostic (6.67e-2)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-4)" "unprognostic (7.25e-4)" "unprognostic (1.67e-4)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.94e-4)" 0.5 0.5 3.2 3.5 1.9 1.9 0.6 2.2 4.3 0.8 0.9 2.1 0.0 0.5 2.6 0.3 0.2 0.4 0.4 0.3 2.9 1.6 0.2 0.1 0.5 2.2 2.0 0.9 0.8 0.3 0.5 0.7 0.3 1.5 0.5 0.8 0.5 1.7 0.4 0.8 9.4 0.7 0.8 3.3 1.4 0.3 16.7 2.0 34.3 0.3 0.7 2.0 0.6 1.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.1 24.2 9.7 0.0 0.0 8.6 0.8 0.0 0.1 0.2 0.0 0.3 2.0 0.5 0.2 1.4 0.8 0.8 0.3 0.0 0.0 0.7 0.2 0.3 0.0 0.4 0.5 3.7 0.8 0.4 0.5 0.0 0.4 1.1 5.4 0.9 0.0 0.6 0.3 5.5 0.7 4.2 0.4 1.4 6.3 1.7 0.0 0.1 0.4 6.4 26.7 0.5 0.6 0.8 3.5 0.4 0.4 0.9 0.2 3.9 0.5 0.1 0.8 0.3 2.8 0.2 1.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.3 3.2 1.9 2.2 1.7 2.9 1.6 2.0 0.9 1.5 2.0 0.0 0.0 0.0 0.9 1.5 0.1 1.4 0.0 0.0 0.0 1.8 3.9 0.3 0.0 1.1 30.9 0.6 0.0 0.0 0.8 0.6 0.6 0.7 0.0 0.0 0.3 0.0 10.3 0.0 0.3 4.1 0.9 0.6 0.0 0.0 0.8 1.7 1.2 0.0 1.1 0.0 1.8 0.0 0.9 12.5 5.5 3.3 0.3 0.0 1.2 0.6 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985895 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 262.7" "Cell type enhanced" "Detected in many" 10 "Fibroblasts: 127.3;Muller glia cells: 96.7;Syncytiotrophoblasts: 124.3" "Cancer enhanced" "Detected in all" "liver cancer: 269.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7" "Group enriched" "Detected in many" 12 "NK-cells: 1.7;T-cells: 5.0" "Group enriched" "Detected in some" 5 "HAP1: 54.2;Hep G2: 214.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006316 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 30.1 5.9 0.4 3.6 0.7 0.0 50.2 0.6 0.4 3.3 4.5 0.5 2.2 0.5 2.5 11.7 2.0 3.4 9.2 8.0 0.4 1.1 21.2 1.1 37.0 1.9 1.6 0.4 6.0 4.6 0.3 16.9 262.7 1.6 3.6 1.0 6.3 3.8 2.3 4.1 5.5 1.8 3.3 2.1 0.9 4.0 2.1 0.3 2.3 7.2 11.2 3.0 7.6 8.0 0.0 0.2 0.0 0.0 1.7 5.0 0.6 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 54.2 0.0 0.0 0.0 2.5 0.0 0.1 214.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 14.8 0.7 1.8 4.4 0.0 0.0 0.0 26.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.2 0.0 5.0 3.5 0.0 1.7 0.0 0.0 0.0 0.6 0.4 0.7 0.6 0.4 0.4 1.1 1.6 0.4 1.6 0.3 0.0 1.7 0.0 5.4 9.3 0.2 0.3 0.0 44.2 35.2 5.2 0.0 43.0 16.6 0.3 0.9 0.5 0.3 0.0 1.3 32.7 127.3 0.9 0.0 0.0 24.0 0.0 1.7 2.5 0.0 1.3 9.8 1.4 3.3 0.0 1.5 96.7 2.2 0.2 2.8 26.9 1.9 0.0 5.0 1.6 6.1 3.4 124.3 0.0 2.1 0.5 GPC5 ENSG00000179399 "Glypican 5" P78333 13 91398607-92873682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;kidney: 14.8;testis: 11.3" "Cell type enriched" "Detected in some" 23 "Distal tubular cells: 54.7" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 11 "CACO-2: 31.4;HeLa: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040152, HPA044081" Enhanced Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA040152: AB_2676863, HPA044081: AB_2678801" "unprognostic (4.99e-3)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (9.93e-5)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.46e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (9.49e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-5)" "unprognostic (2.19e-2)" "unprognostic (1.82e-6)" "unprognostic (3.03e-2)" "unprognostic (2.43e-1)" "unprognostic (1.11e-1)" "unprognostic (6.69e-3)" 0.8 3.8 11.8 1.1 18.3 0.8 0.7 3.1 18.9 0.6 1.5 2.9 0.1 0.7 0.6 0.9 0.6 0.8 1.6 2.3 11.8 6.0 14.8 2.9 6.5 1.0 7.3 5.6 1.5 0.8 0.6 7.7 1.4 19.4 0.9 1.5 0.0 0.8 1.5 0.6 0.7 0.8 0.8 4.4 0.7 0.9 11.3 6.6 0.0 2.7 0.0 0.7 0.6 0.3 0.5 0.4 0.3 1.8 2.0 1.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.1 1.2 0.4 0.2 0.0 0.5 0.3 2.0 1.8 0.0 0.0 0.2 11.8 18.3 3.1 8.6 11.8 6.0 7.3 5.6 19.4 6.6 0.0 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.1 54.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 GPD1 ENSG00000167588 "Glycerol-3-phosphate dehydrogenase 1" P21695 12 50103819-50111319 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 116.3;skeletal muscle: 106.9" "Group enriched" "Detected in many" 5 "Hepatocytes: 94.2;Proximal tubular cells: 265.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC diff: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044620 Enhanced NA NA 3800000 "HPA044620: AB_10796803" "unprognostic (2.65e-2)" "unprognostic (5.60e-2)" "unprognostic (3.28e-2)" "unprognostic (3.37e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (1.45e-3)" "unprognostic (7.19e-2)" "unprognostic (9.42e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.37e-1)" "unprognostic (9.58e-2)" "unprognostic (3.37e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-2)" 116.3 1.2 2.4 3.6 3.0 0.3 44.9 1.6 3.9 0.3 13.4 12.2 0.4 16.2 0.3 3.0 1.2 0.3 8.1 3.9 4.3 2.7 30.6 31.4 4.0 1.6 6.8 1.2 0.2 1.8 2.3 0.3 0.2 13.5 0.5 0.9 0.1 17.7 0.5 106.9 2.0 23.5 0.5 24.7 0.2 0.8 0.3 2.0 0.0 0.7 14.1 0.3 1.1 0.3 0.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.1 0.0 0.0 0.0 0.0 10.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 11.9 0.1 0.0 0.2 0.0 0.0 0.6 0.4 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 3.0 1.6 3.9 4.3 2.7 6.8 1.2 13.5 2.0 3.0 2.7 7.4 0.2 0.0 2.9 4.8 12.7 0.0 2.3 5.2 7.9 0.0 36.5 0.3 0.0 0.0 7.8 0.0 0.6 0.0 0.0 0.1 0.0 94.2 2.4 3.2 1.2 1.8 0.3 0.0 0.0 0.2 1.7 1.8 4.2 2.7 0.6 5.8 0.0 265.1 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.1 GPD1L KIAA0089 ENSG00000152642 "Glycerol-3-phosphate dehydrogenase 1 like" Q8N335 3 32105689-32168713 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Brugada syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 142.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 51.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.23e-1)" "unprognostic (3.12e-2)" "prognostic favorable (7.05e-4)" "unprognostic (2.63e-1)" "unprognostic (9.67e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (5.71e-5)" "unprognostic (2.49e-2)" "unprognostic (1.74e-1)" "unprognostic (2.00e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.33e-15)" "unprognostic (1.50e-1)" "unprognostic (1.99e-1)" "unprognostic (2.31e-3)" "unprognostic (5.51e-3)" 14.6 18.8 7.4 4.5 12.2 2.9 13.3 8.3 15.7 10.0 16.1 7.2 5.3 10.6 7.1 6.7 17.0 11.0 6.7 49.5 8.3 8.4 14.2 1.4 12.7 6.1 8.2 11.7 7.5 9.0 7.9 5.7 8.3 10.8 25.1 15.2 8.5 15.2 18.0 65.5 5.4 15.5 14.5 11.6 4.9 11.9 3.2 6.3 0.8 16.9 22.5 9.6 22.4 9.0 1.9 6.6 6.5 4.1 8.3 10.1 3.2 4.0 3.6 1.3 5.8 18.8 4.5 51.2 3.2 1.1 3.7 2.6 3.9 2.0 7.1 5.0 2.2 4.5 4.7 8.6 3.3 4.4 3.0 7.9 4.0 5.7 6.0 4.7 10.4 14.8 13.6 4.5 3.5 4.6 3.6 6.0 5.9 2.8 2.3 2.7 5.3 4.5 3.4 0.8 9.9 16.8 8.4 5.9 14.4 5.6 24.4 5.7 5.7 2.6 22.6 9.0 1.9 14.7 5.1 3.1 4.0 2.0 6.3 8.7 1.8 0.7 7.0 9.2 8.1 2.2 0.4 3.2 6.5 4.3 4.1 10.1 1.9 5.5 5.1 6.6 1.7 3.2 4.7 1.9 8.3 2.5 5.3 10.0 3.2 7.4 12.2 8.3 15.7 8.3 8.4 8.2 11.7 10.8 6.3 26.8 33.2 2.2 3.8 4.0 3.6 142.4 5.1 10.7 14.8 8.7 2.0 30.5 33.2 1.8 7.4 8.7 36.9 0.0 3.2 5.6 6.4 16.3 39.2 0.4 8.3 1.6 7.5 7.4 5.9 13.3 5.5 4.7 8.5 0.0 21.4 29.9 3.8 14.0 12.0 15.3 3.6 0.0 7.3 0.5 1.9 6.0 22.7 10.2 20.6 5.2 GPHA2 "A2, GPA2, MGC126572, ZSIG51" ENSG00000149735 "Glycoprotein hormone alpha 2" Q96T91 11 64934471-64935888 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 98.0" "Cell type enhanced" "Detected in some" 28 "Exocrine glandular cells: 15.7;Pancreatic endocrine cells: 3.7;Spermatocytes: 4.7;Spermatogonia: 2.5" "Cancer enriched" "Detected in some" 7 "testis cancer: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "Hep G2: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA067068 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA067068: " "unprognostic (1.13e-1)" "unprognostic (8.31e-3)" "unprognostic (1.51e-2)" "unprognostic (9.22e-4)" "unprognostic (7.88e-3)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (3.20e-2)" "unprognostic (1.82e-1)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (9.86e-3)" "unprognostic (1.70e-1)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.7 98.0 0.0 15.1 0.1 0.2 0.7 0.0 0.7 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 4.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 21.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.4 0.0 0.0 0.0 4.7 2.5 0.0 0.0 0.0 0.0 0.1 GPHB5 "GPB5, ZLUT1" ENSG00000179600 "Glycoprotein hormone beta 5" Q86YW7 14 63312835-63318879 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPIHBP1 "GPI-HBP1, LOC338328" ENSG00000277494 "Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1" Q8IV16 8 143213193-143217170 "Disease related genes, Predicted intracellular proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.6;brain: 18.5" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 5.6;Endothelial cells: 23.6;Ito cells: 15.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.6" HPA066302 Enhanced "Intracellular and membrane" NA NA "HPA066302: AB_2685654" "unprognostic (2.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.71e-3)" "unprognostic (2.43e-3)" "unprognostic (1.58e-1)" "unprognostic (9.50e-2)" "unprognostic (1.75e-3)" "unprognostic (8.01e-2)" "unprognostic (2.04e-1)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (8.69e-2)" "unprognostic (5.06e-3)" "unprognostic (9.65e-3)" "unprognostic (1.41e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-3)" 47.6 2.2 0.0 0.3 11.5 0.1 9.0 0.6 7.5 1.6 1.7 17.9 0.0 0.4 1.6 0.2 2.0 2.2 3.7 8.3 2.1 2.6 0.7 13.0 1.3 18.5 2.9 1.9 0.6 0.3 0.0 4.0 9.7 0.7 0.4 1.1 0.5 1.1 16.0 1.6 0.3 1.5 12.8 4.2 0.4 1.4 10.2 0.0 0.6 0.4 0.7 1.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.1 1.3 0.0 2.8 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.1 23.6 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 15.4 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.9 0.0 0.2 1.0 0.0 0.0 0.0 0.0 GPLD1 ENSG00000112293 "Glycosylphosphatidylinositol specific phospholipase D1" P80108 6 24424565-24495205 "Enzymes, Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 61.6" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 17.5;Cone photoreceptor cells: 64.8;Hepatocytes: 55.7" "Cancer enriched" "Detected in some" 11 "liver cancer: 6.8" "Region enriched" "Detected in many" 4 "cerebellum: 8.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 10.5;U-698: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008625, HPA012500" Uncertain "Secreted to blood" NA NA 103000000000 3700000000 "CAB008625: AB_1621070, HPA012500: AB_1849931" "unprognostic (6.80e-3)" "unprognostic (2.27e-1)" "unprognostic (1.59e-1)" "unprognostic (4.81e-5)" "unprognostic (3.65e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.12e-4)" "unprognostic (6.37e-4)" "unprognostic (7.93e-2)" "unprognostic (2.86e-2)" "unprognostic (6.07e-4)" "unprognostic (2.68e-1)" "unprognostic (5.28e-4)" "unprognostic (2.20e-1)" "unprognostic (9.98e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" 2.2 0.4 0.8 0.6 1.2 0.3 0.6 8.5 1.8 0.6 0.6 0.6 0.6 0.1 0.8 0.6 0.6 0.4 0.6 0.6 0.6 1.9 0.6 61.6 0.6 0.6 0.7 0.6 0.7 0.6 1.5 1.3 0.6 0.6 1.0 0.1 0.6 0.6 3.3 0.7 4.8 0.6 0.8 0.6 0.6 0.3 0.8 0.6 6.6 1.6 0.6 0.7 1.0 1.0 1.1 1.6 0.4 0.2 0.1 1.8 0.0 0.7 1.3 1.2 1.9 0.0 0.1 3.0 0.1 0.3 0.4 0.3 5.4 0.1 10.5 1.2 0.2 0.3 0.0 1.7 0.3 0.2 1.3 3.5 1.5 1.4 4.4 0.0 1.8 0.2 0.1 0.2 0.1 0.0 1.2 0.0 2.6 0.7 0.5 0.3 0.7 1.0 0.6 4.0 0.7 0.5 2.0 0.3 0.1 0.4 5.2 3.3 3.5 1.1 0.1 0.5 0.9 0.5 0.5 0.1 1.3 1.3 0.1 1.4 3.1 4.8 10.7 0.2 0.5 0.5 0.4 0.2 0.1 0.4 0.1 1.4 0.6 0.3 0.2 0.0 1.1 0.3 1.8 0.4 0.1 0.1 1.6 0.2 0.0 0.8 1.2 8.5 1.8 0.6 1.9 0.7 0.6 0.6 0.6 0.0 3.0 0.0 0.4 0.0 17.5 10.1 0.0 1.4 2.3 1.8 64.8 0.2 0.0 0.3 3.0 1.0 0.0 0.0 0.3 0.3 0.3 0.3 0.0 55.7 0.1 14.3 1.7 0.6 1.3 2.3 2.8 0.0 0.0 0.0 0.3 4.3 0.1 0.0 3.2 0.3 10.5 0.0 0.5 0.5 5.3 0.5 0.0 0.0 0.4 2.2 GPM6A GPM6 ENSG00000150625 "Glycoprotein M6A" P51674 4 175632934-176002664 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 249.7" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 1: 89.3;Bipolar cells: 197.8;Horizontal cells: 117.6;Muller glia cells: 415.5" "Cancer enriched" "Detected in many" 107 "glioma: 110.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 22.2;naive B-cell: 9.1" "Lineage enriched" "Detected in many" 12 "B-cells: 22.2" "Group enriched" "Detected in some" 10 "AF22: 26.8;Daudi: 22.3;HAP1: 9.2;U-251 MG: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017338 Supported NA NA "HPA017338: AB_1849933" "unprognostic (1.36e-4)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.34e-2)" "unprognostic (9.45e-2)" "unprognostic (1.34e-1)" "unprognostic (3.82e-5)" "unprognostic (2.24e-1)" "unprognostic (9.13e-3)" "unprognostic (1.06e-1)" "unprognostic (3.69e-2)" "unprognostic (7.73e-2)" "unprognostic (2.24e-2)" "unprognostic (3.53e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-3)" "unprognostic (2.60e-3)" 2.4 3.1 81.8 2.0 51.1 1.8 2.5 83.3 249.7 4.1 4.1 15.9 0.0 2.2 4.3 2.7 2.3 4.4 3.1 2.3 54.4 31.2 4.3 6.2 8.8 2.4 23.5 39.4 6.5 2.2 2.0 1.0 1.7 13.1 3.7 3.8 6.3 1.9 4.2 1.8 1.9 2.3 5.5 9.6 6.9 2.0 2.1 17.0 0.0 5.9 0.0 2.0 2.4 0.5 22.2 1.7 0.3 0.1 0.0 0.0 0.4 0.1 0.4 26.8 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.5 0.4 22.3 0.1 0.1 0.9 0.4 9.2 0.7 0.0 0.1 2.1 0.2 1.8 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.9 0.0 0.6 0.8 0.3 0.6 0.0 0.3 0.1 0.1 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.1 0.2 0.3 0.0 0.1 0.5 0.3 0.3 26.5 0.8 0.0 1.3 0.9 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.1 9.1 0.0 0.0 0.1 0.0 0.1 1.7 0.0 0.4 81.8 51.1 83.3 79.7 54.4 31.2 23.5 39.4 13.1 17.0 89.3 8.3 7.5 4.6 1.5 197.8 0.6 0.0 0.0 1.2 0.0 13.7 0.0 1.7 0.0 6.9 10.3 0.0 0.0 0.2 0.1 0.2 6.5 0.0 0.8 0.3 117.6 0.0 71.2 4.1 2.5 3.1 0.6 0.0 0.0 0.0 415.5 0.0 0.0 1.4 0.9 24.7 0.0 0.7 0.2 0.0 0.6 0.1 0.0 0.0 4.2 GPM6B "M6B, MGC17150, MGC54284" ENSG00000046653 "Glycoprotein M6B" Q13491 X 13771031-13938638 "Predicted membrane proteins" "Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 219.5" "Cell type enriched" "Detected in many" 6 "Muller glia cells: 1904.1" "Group enriched" "Detected in many" 14 "glioma: 192.5;melanoma: 41.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 222 "plasmacytoid DC: 33.4" "Lineage enriched" "Detected in single" 240 "dendritic cells: 33.4" "Cell line enhanced" "Detected in some" "AF22: 42.8;AN3-CA: 42.4;ASC TERT1: 21.8;HSkMC: 32.1;SK-MEL-30: 42.1" "Low region specificity" "Detected in all" HPA002913 Approved NA NA "HPA002913: AB_2263553" "unprognostic (1.56e-2)" "unprognostic (3.42e-1)" "unprognostic (1.83e-1)" "unprognostic (3.70e-2)" "unprognostic (8.55e-2)" "unprognostic (2.75e-3)" "unprognostic (2.12e-2)" "unprognostic (1.92e-2)" "unprognostic (4.27e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.79e-2)" "unprognostic (4.78e-2)" "unprognostic (2.38e-3)" "unprognostic (8.34e-2)" "unprognostic (2.12e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" 4.6 5.5 68.4 3.9 55.1 2.0 12.4 24.1 219.5 10.2 5.7 68.7 1.1 3.6 4.3 6.7 6.4 4.2 3.9 5.9 62.6 33.1 4.5 2.0 6.7 2.6 68.9 47.3 3.1 2.9 1.9 2.6 2.1 44.1 9.9 4.9 3.2 7.4 16.9 2.1 7.1 4.3 3.8 109.4 7.2 3.3 3.0 64.8 0.0 3.5 0.0 2.3 3.3 2.7 0.1 33.4 0.1 0.0 0.1 0.1 0.2 0.1 0.1 42.8 42.4 12.1 21.8 0.1 0.2 1.9 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.3 2.1 0.2 0.0 0.1 7.0 0.1 2.8 0.1 0.4 0.1 0.2 32.1 0.2 0.0 0.5 0.1 0.0 0.8 0.1 1.9 0.4 0.1 0.9 0.1 13.4 0.0 0.7 0.5 3.8 6.5 0.0 0.1 2.1 1.2 0.2 1.2 42.1 12.3 0.2 0.9 0.0 0.2 0.3 0.1 0.5 0.1 0.0 0.1 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 33.4 0.0 0.2 68.4 55.1 24.1 43.1 62.6 33.1 68.9 47.3 44.1 64.8 0.0 3.2 20.4 22.0 29.3 74.8 1.1 0.0 13.4 5.7 21.0 82.5 3.8 0.0 3.2 0.4 6.3 3.8 0.0 3.3 2.8 24.2 20.1 4.6 0.4 1.0 25.4 1.2 16.5 1.0 1.5 22.5 1.8 339.1 2.8 2.6 1904.1 1.9 3.2 30.1 0.6 143.8 45.3 22.6 4.3 9.4 14.9 11.4 15.2 2.9 12.6 GPNMB "HGFIN, NMB" ENSG00000136235 "Glycoprotein nmb" Q14956 7 23235967-23275108 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 137.7" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 290.6;Hofbauer cells: 788.7;Melanocytes: 566.8;Suprabasal keratinocytes: 314.4" "Cancer enhanced" "Detected in all" "melanoma: 354.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.8;intermediate monocyte: 7.1" "Lineage enriched" "Detected in many" 6 "monocytes: 7.1" "Cell line enriched" "Detected in many" 5 "ASC diff: 329.4" "Region enhanced" "Detected in some" "olfactory region: 12.1" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA 41000000 "unprognostic (3.37e-2)" "unprognostic (1.18e-1)" "unprognostic (6.65e-2)" "unprognostic (1.82e-1)" "unprognostic (5.14e-2)" "unprognostic (4.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.89e-2)" "unprognostic (7.13e-2)" "unprognostic (2.79e-1)" "unprognostic (2.83e-1)" "unprognostic (6.40e-2)" "unprognostic (2.08e-3)" "unprognostic (1.24e-2)" "unprognostic (3.46e-2)" "unprognostic (4.82e-1)" "unprognostic (6.95e-2)" 137.7 4.3 7.7 9.5 5.9 0.7 33.8 1.0 5.5 56.0 20.7 7.9 9.2 3.5 56.5 34.6 32.6 17.3 45.8 50.0 5.5 2.8 10.8 8.9 58.7 24.1 4.4 5.0 39.7 4.0 0.3 3.7 52.7 18.2 24.8 15.7 115.7 18.1 9.8 11.3 97.2 12.1 26.2 15.7 8.4 11.2 19.8 1.5 20.6 14.0 31.7 26.7 33.4 41.9 0.4 0.8 1.2 7.1 0.3 0.2 0.8 1.1 0.0 0.0 0.0 329.4 60.0 0.0 2.1 35.7 1.7 7.6 0.0 0.0 0.0 0.0 6.8 3.2 7.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 41.3 8.6 2.9 0.3 47.8 0.0 0.0 0.0 0.0 9.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.5 27.8 0.1 0.0 0.0 11.1 51.4 0.0 0.1 0.1 0.0 10.5 1.2 19.1 0.3 0.3 0.5 0.0 3.6 0.1 10.5 0.9 3.8 0.1 0.2 7.1 0.1 0.2 0.0 0.0 0.8 0.4 0.2 0.1 1.2 0.3 0.3 0.8 0.1 0.8 7.7 5.9 1.0 5.5 5.5 2.8 4.4 5.0 18.2 1.5 17.9 28.2 2.7 6.4 290.6 0.4 176.6 2.5 2.7 14.8 71.5 0.0 5.9 3.3 0.4 2.4 9.6 0.0 0.0 0.7 2.7 76.6 1.8 20.9 3.8 788.7 1.6 0.0 6.2 136.5 2.1 120.3 119.7 566.8 4.6 0.0 0.2 0.7 0.0 101.5 0.7 0.5 0.0 64.0 3.8 1.2 314.4 24.1 0.0 0.0 10.9 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 10.0;Muller glia cells: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 53.7;hTCEpi: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 3.0 0.2 5.5 9.5 3.4 2.9 0.0 0.0 0.0 0.3 2.7 0.2 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 53.7 0.0 0.0 2.2 24.2 4.9 7.9 4.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 2.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.0 0.6 0.0 0.0 0.1 4.1 1.9 4.8 0.4 0.0 0.0 0.0 1.5 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.6 0.0 0.0 0.3 GPR101 ENSG00000165370 "G protein-coupled receptor 101" Q96P66 X 137030148-137031674 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "brain: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 1.6;JURKAT: 2.3" "Region enhanced" "Detected in many" "hypothalamus: 44.7" "Low region specificity" "Detected in many" HPA001084 Uncertain NA NA "HPA001084: AB_1078920" 0.0 0.0 0.0 0.0 11.1 0.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR119 "GPCR2, hGPCR2" ENSG00000147262 "G protein-coupled receptor 119" Q8TDV5 X 130384440-130385447 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.5;pancreas: 8.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 11 "pancreatic cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "CACO-2: 2.7;Hep G2: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "prognostic favorable (6.93e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR12 "GPCR21, PPP1R84" ENSG00000132975 "G protein-coupled receptor 12" P47775 13 26755200-26760785 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 29.4;salivary gland: 7.7" "Group enriched" "Detected in some" 5 "Hofbauer cells: 13.2;Horizontal cells: 31.8;Intestinal endocrine cells: 9.4" "Group enriched" "Detected in some" 7 "breast cancer: 0.5;glioma: 0.8;ovarian cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "basophil: 2.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050972 Uncertain NA NA "HPA050972: AB_2681295" "unprognostic (2.37e-2)" "unprognostic (9.64e-3)" "unprognostic (3.75e-1)" "unprognostic (3.30e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-2)" "unprognostic (1.42e-1)" "unprognostic (7.35e-2)" "unprognostic (5.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.40e-1)" 1.1 0.7 4.9 0.5 29.4 0.9 4.6 17.7 14.6 1.4 0.7 1.6 0.0 0.7 0.6 0.5 0.8 2.5 0.7 0.7 5.6 2.6 0.6 0.5 0.7 0.6 2.2 4.8 0.6 0.5 0.5 0.7 1.6 1.1 0.6 0.7 1.9 7.7 0.6 0.9 4.4 0.9 0.9 0.7 0.8 0.7 0.8 6.6 0.0 0.6 0.0 0.6 0.6 0.0 0.3 0.2 2.4 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.5 0.1 0.1 0.2 0.0 0.1 4.9 29.4 17.7 8.4 5.6 2.6 2.2 4.8 1.1 6.6 0.0 0.0 0.0 0.2 0.1 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 13.2 31.8 9.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.2 GPR132 G2A ENSG00000183484 "G protein-coupled receptor 132" Q9UNW8 14 105049389-105065445 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Stress response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.0;lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 11 "B-cells: 8.9;granulocytes: 12.7;Macrophages: 18.8;monocytes: 22.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "HDLM-2: 20.3;Karpas-707: 21.0;THP-1: 6.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029694, HPA029695" Supported NA NA "HPA029694: AB_10600213, HPA029695: AB_10601984" "unprognostic (2.71e-3)" "prognostic favorable (3.21e-4)" "unprognostic (1.68e-2)" "unprognostic (1.07e-3)" "unprognostic (1.16e-1)" "prognostic favorable (6.44e-4)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (3.35e-2)" "unprognostic (8.54e-2)" "unprognostic (1.10e-1)" "unprognostic (4.18e-1)" "prognostic unfavorable (1.71e-5)" "unprognostic (6.71e-2)" "unprognostic (4.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.72e-1)" 2.9 1.2 1.8 11.5 2.7 9.3 1.5 0.7 1.8 1.5 2.4 3.3 0.0 1.3 1.0 1.6 1.4 3.0 2.9 1.4 1.6 1.2 4.5 0.8 5.9 20.2 3.3 1.0 1.1 0.8 0.4 0.9 2.0 2.2 1.4 1.2 1.5 3.0 0.7 0.8 3.5 6.6 1.0 3.7 15.4 2.1 0.6 2.5 4.3 6.5 0.7 17.4 3.1 1.9 8.6 9.1 9.8 14.0 9.3 10.6 6.6 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 2.7 0.5 0.0 0.0 0.6 0.0 0.0 0.0 20.3 0.3 0.5 0.1 0.0 0.0 1.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.5 0.0 2.0 0.1 0.0 0.0 1.6 0.1 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.3 6.3 0.3 0.0 0.1 0.0 0.2 0.5 1.9 0.2 0.0 1.8 0.0 9.8 9.0 8.6 10.6 12.5 9.9 7.2 8.2 9.2 9.1 8.6 8.6 8.9 7.9 9.3 14.0 5.2 5.8 6.6 1.8 2.7 0.7 1.8 1.6 1.2 3.3 1.0 2.2 2.5 0.0 3.4 8.9 0.1 1.4 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.4 0.1 12.7 0.0 3.8 0.0 0.0 0.0 7.9 0.0 0.0 18.8 5.0 22.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 7.5 0.0 1.0 GPR135 "HUMNPIIY20, PAFR" ENSG00000181619 "G protein-coupled receptor 135" Q8IZ08 14 59429022-59465342 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.1" "Group enriched" "Detected in many" 15 "Early spermatids: 121.5;Late spermatids: 153.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045337 Uncertain NA NA "HPA045337: AB_10960528" "unprognostic (1.55e-1)" "unprognostic (3.00e-1)" "unprognostic (6.09e-3)" "unprognostic (1.14e-1)" "unprognostic (4.20e-2)" "unprognostic (8.47e-2)" "unprognostic (3.22e-1)" "unprognostic (3.91e-2)" "unprognostic (4.64e-2)" "unprognostic (1.09e-1)" "unprognostic (2.47e-2)" "unprognostic (1.55e-1)" "unprognostic (2.75e-5)" "unprognostic (1.33e-2)" "unprognostic (1.90e-1)" "unprognostic (2.71e-2)" "unprognostic (2.68e-3)" 2.1 3.7 2.0 1.2 3.4 0.4 1.2 3.2 2.7 2.9 1.8 2.1 2.3 0.5 3.8 3.4 1.6 6.7 2.7 3.0 2.0 3.3 1.5 0.9 1.3 1.1 1.2 3.7 4.4 4.7 6.8 12.3 1.3 4.7 4.3 1.2 1.7 0.7 6.2 1.0 0.7 1.1 2.7 0.9 1.0 1.4 34.1 1.8 0.4 3.6 0.2 0.7 2.7 2.4 0.1 0.4 0.0 0.4 0.3 1.6 0.1 1.1 1.2 2.1 2.5 1.8 2.6 1.7 2.2 1.3 1.5 1.6 0.5 2.3 1.0 1.7 2.7 0.7 1.3 1.0 0.9 2.1 2.1 0.8 0.7 5.7 0.8 1.5 1.3 1.0 1.5 1.6 2.2 1.0 3.3 1.0 1.1 1.3 1.7 2.2 0.7 0.4 3.1 1.5 0.2 4.6 1.5 1.6 1.1 1.5 1.0 2.7 3.3 5.2 0.9 0.2 1.1 1.1 0.5 3.7 3.8 3.1 1.1 2.5 0.4 0.0 0.9 1.3 1.5 1.7 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.7 0.0 0.4 0.1 0.2 0.4 0.0 0.3 0.4 0.0 1.6 0.1 2.0 3.4 3.2 2.6 2.0 3.3 1.2 3.7 4.7 1.8 0.0 0.3 0.0 0.8 0.2 3.5 2.0 0.0 9.4 4.5 3.5 2.0 0.3 0.0 0.6 121.5 0.4 0.0 0.0 0.6 0.2 1.5 0.5 0.0 0.0 0.1 1.6 2.9 1.3 0.0 153.7 2.8 0.1 0.0 0.0 0.0 3.0 0.5 0.0 3.5 0.6 2.5 0.0 1.0 6.7 1.1 0.1 0.1 0.0 0.4 0.2 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 157.3;Late spermatids: 445.6;Spermatocytes: 157.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" NA NA "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: AB_2684889" "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favorable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 9.0 20.3 7.0 20.2 13.7 7.3 29.7 10.8 9.1 10.8 7.0 14.9 12.8 9.3 18.8 6.8 19.4 18.2 9.8 6.0 3.1 29.5 12.3 8.9 20.8 9.5 7.8 5.8 17.3 9.1 9.5 9.4 7.2 7.4 5.8 11.2 7.9 22.8 6.4 23.0 6.5 15.8 9.5 7.4 20.2 13.2 7.5 15.1 7.5 12.4 11.2 13.6 13.1 18.0 11.7 7.4 19.7 2.5 9.3 30.0 20.8 22.6 7.8 18.3 33.5 7.8 21.4 5.0 18.2 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 3.0 9.1 11.8 16.0 12.8 13.4 4.4 10.2 9.4 4.5 12.2 11.8 40.6 13.3 33.8 157.3 14.0 21.2 0.0 23.3 58.9 21.7 17.8 2.3 8.9 21.4 19.1 15.5 9.8 9.1 445.6 17.8 11.8 13.5 20.8 13.8 33.6 24.9 14.0 15.2 15.2 6.0 25.8 12.5 157.6 37.2 13.2 100.0 12.8 13.4 18.0 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52553148-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.1;epididymis: 16.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.6;Rod photoreceptor cells: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles NA NA Vesicles "HPA003640: AB_2667025, HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 1.4 2.2 7.1 1.0 11.0 3.3 1.9 31.1 20.2 1.4 1.2 7.5 0.2 2.0 2.5 16.6 1.7 1.2 2.8 2.4 5.9 10.6 1.2 1.3 1.7 2.1 6.3 7.5 1.6 0.7 2.3 1.8 1.8 13.3 1.6 1.5 3.2 1.7 1.5 1.3 1.8 1.2 1.5 7.0 2.5 1.4 6.5 8.3 0.0 2.1 0.0 1.2 2.1 0.7 0.7 0.5 2.4 0.5 3.9 4.1 0.8 0.8 0.3 8.2 7.5 2.4 0.7 3.3 3.4 2.3 3.6 8.6 1.5 1.6 0.8 2.5 2.8 7.6 1.9 2.7 0.5 5.3 1.2 1.9 0.9 2.3 0.9 0.3 0.5 1.9 0.4 0.0 3.3 0.2 0.8 1.8 1.8 1.2 3.6 5.1 4.0 0.3 1.1 2.0 1.5 4.8 1.8 5.1 0.3 1.1 5.7 8.3 10.5 1.7 0.5 0.2 3.6 5.1 0.0 0.3 8.2 8.7 5.9 2.8 0.8 2.0 1.8 2.0 0.4 2.4 1.2 0.5 0.5 3.1 0.1 4.1 0.3 2.0 3.9 0.2 0.7 1.5 1.8 2.4 3.9 0.4 0.5 1.4 0.8 7.1 11.0 31.1 14.1 5.9 10.6 6.3 7.5 13.3 8.3 0.0 2.2 0.0 0.7 0.6 19.6 2.2 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 1.3 3.0 0.0 0.0 0.2 0.2 1.5 2.4 0.0 0.4 0.4 6.4 1.2 3.7 1.0 1.5 0.6 0.6 1.7 0.0 0.5 5.1 0.0 0.0 0.7 0.1 19.2 0.0 2.1 4.1 2.8 0.6 0.1 0.0 0.0 0.3 GPR139 PGR3 ENSG00000180269 "G protein-coupled receptor 139" Q6DWJ6 16 20031485-20073917 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.8;endometrium 1: 2.1;smooth muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA046596 Uncertain NA NA "HPA046596: AB_2679713" "unprognostic (2.94e-1)" 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR141 PGR13 ENSG00000187037 "G protein-coupled receptor 141" Q7Z602 7 37683796-37833788 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;brain: 18.1" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 4.8;granulocytes: 22.0;Kupffer cells: 8.5;Macrophages: 4.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 11.4;eosinophil: 8.1;gdT-cell: 4.8;memory CD8 T-cell: 4.5;myeloid DC: 5.8;naive CD8 T-cell: 3.3;neutrophil: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.8;HMC-1: 30.8;NTERA-2: 16.6;THP-1: 4.9;U-937: 13.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.91e-2)" "unprognostic (3.44e-1)" "unprognostic (3.26e-4)" "unprognostic (4.70e-3)" "unprognostic (8.67e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.51e-2)" "unprognostic (7.93e-3)" "unprognostic (1.44e-1)" "unprognostic (1.51e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-3)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (1.60e-1)" 1.7 0.9 2.5 4.4 3.3 27.6 0.9 1.0 3.2 1.9 1.4 0.6 0.0 1.0 1.9 2.0 1.8 1.5 3.7 1.7 3.2 1.4 1.2 1.3 4.3 10.0 5.3 0.7 0.6 1.5 0.3 1.0 2.8 5.8 2.0 2.0 2.7 1.7 0.5 0.6 1.2 1.8 1.8 18.1 10.0 1.2 1.5 5.1 2.9 1.1 1.0 2.1 4.8 2.3 0.0 5.8 10.7 11.4 0.6 4.8 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 7.8 0.6 0.0 0.0 0.1 30.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 4.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 13.0 0.0 0.0 11.4 8.1 4.8 0.9 0.0 0.0 1.2 4.5 5.8 0.0 0.5 3.3 10.7 0.6 0.1 0.2 0.0 3.4 2.5 3.3 1.0 3.2 3.2 1.4 5.3 0.7 5.8 5.1 3.0 4.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.8 0.0 0.0 0.0 8.5 0.6 0.0 4.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.5 0.0 0.0 GPR142 PGR2 ENSG00000257008 "G protein-coupled receptor 142" Q7Z601 17 74367407-74372622 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.3;lymphoid tissue: 1.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-937: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA031392 Uncertain Uncertain "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA031392: AB_10601935" "unprognostic (6.81e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (1.36e-1)" "unprognostic (6.54e-5)" "unprognostic (4.16e-2)" "unprognostic (4.85e-7)" "unprognostic (3.95e-2)" "unprognostic (7.72e-4)" "unprognostic (1.93e-1)" "unprognostic (1.68e-3)" 0.2 0.0 0.0 1.3 0.1 0.0 0.1 1.3 0.2 0.3 0.1 0.8 0.6 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.8 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR143 OA1 ENSG00000101850 "G protein-coupled receptor 143" P51810 X 9725346-9786297 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "retina: 51.5" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 34.8;Melanocytes: 119.8" "Cancer enriched" "Detected in all" 9 "melanoma: 84.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.0" "Cell line enriched" "Detected in some" 6 "SK-MEL-30: 58.4" "Not detected" "Not detected" HPA003648 Enhanced NA NA "HPA003648: AB_2667028" "unprognostic (4.60e-2)" "prognostic favorable (8.73e-4)" "unprognostic (7.43e-3)" "unprognostic (5.41e-2)" "unprognostic (4.62e-3)" "unprognostic (2.00e-2)" "unprognostic (3.05e-1)" "unprognostic (2.64e-3)" "unprognostic (3.78e-1)" "unprognostic (5.89e-2)" "unprognostic (8.18e-2)" "unprognostic (8.40e-2)" "prognostic favorable (2.45e-5)" "unprognostic (2.75e-1)" "unprognostic (2.07e-1)" "unprognostic (8.76e-2)" "unprognostic (1.59e-2)" 0.8 1.3 4.2 0.0 7.6 0.0 2.1 1.5 4.5 2.0 1.6 3.0 3.6 0.6 3.9 7.0 2.8 3.7 1.1 0.4 3.4 3.7 6.6 2.0 1.2 0.4 5.7 3.1 4.5 2.1 3.0 2.0 7.9 6.3 3.4 1.8 51.5 4.1 6.3 0.2 11.5 0.5 1.2 4.3 0.2 0.9 1.0 2.2 1.0 4.2 1.0 1.8 1.8 1.1 0.5 0.1 5.0 0.3 0.1 0.3 0.0 0.7 0.1 1.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.9 0.0 1.3 0.0 0.6 0.0 0.0 9.5 2.5 0.0 0.0 0.0 0.0 4.4 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 8.4 1.2 0.3 0.0 0.1 0.0 58.4 4.3 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.3 0.2 0.3 0.1 0.1 0.4 0.1 0.1 0.1 0.5 0.1 0.2 0.8 0.1 0.1 0.0 0.0 0.0 4.2 7.6 1.5 4.5 3.4 3.7 5.7 3.1 6.3 2.2 0.0 0.0 0.0 1.0 4.8 0.4 0.6 0.0 4.0 5.7 7.0 0.0 34.8 1.7 4.6 0.2 0.7 0.2 0.0 0.6 1.3 1.0 1.5 0.0 0.0 4.0 0.0 0.0 3.7 0.0 1.3 1.7 0.0 119.8 0.0 0.4 1.4 1.3 0.0 6.0 3.9 0.0 0.0 0.3 0.2 1.2 0.5 8.5 0.0 1.9 1.4 GPR148 PGR6 ENSG00000173302 "G protein-coupled receptor 148" Q8TDV2 2 130729070-130730336 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.6;pancreas: 1.1;pituitary gland: 2.2;stomach 1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 2.5;SCLC-21H: 2.5" "Low region specificity" "Detected in all" HPA060527 Uncertain NA NA "HPA060527: AB_2684307" "unprognostic (7.16e-4)" "unprognostic (3.38e-1)" 0.0 0.2 0.1 0.0 0.4 0.0 0.0 2.6 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR149 "IEDA, PGR10, R35" ENSG00000174948 "G protein-coupled receptor 149" Q86SP6 3 154337672-154429715 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7" "Cell type enhanced" "Detected in single" 37 "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 23.5;pons and medulla: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Region enhanced" "Detected in many" "basal ganglia: 15.0" "Low region specificity" "Detected in all" HPA018020 Uncertain NA NA "HPA018020: AB_1849334" 0.2 0.3 0.2 0.2 23.5 0.2 0.2 0.0 0.8 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.8 0.0 0.2 0.2 0.2 6.5 0.2 6.5 0.3 0.3 0.4 0.2 8.7 0.2 0.3 0.3 0.2 0.6 0.2 0.5 1.1 2.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.5 0.0 0.8 0.2 1.9 0.8 0.0 6.5 2.1 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPR15 ENSG00000154165 "G protein-coupled receptor 15" P49685 3 98531899-98533150 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9" "Group enriched" "Detected in many" 30 "B-cells: 4.4;T-cells: 12.9" "Cell line enhanced" "Detected in some" "GAMG: 2.1;HDLM-2: 11.1;U-266/70: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA013775 Approved NA NA "HPA013775: AB_1849264" "unprognostic (8.03e-2)" "unprognostic (1.04e-2)" "unprognostic (3.72e-3)" "unprognostic (5.66e-2)" "unprognostic (9.48e-3)" "unprognostic (5.60e-5)" "unprognostic (5.17e-1)" "unprognostic (6.77e-3)" "unprognostic (3.96e-1)" "unprognostic (3.03e-2)" "unprognostic (2.82e-1)" "unprognostic (2.83e-1)" "unprognostic (4.04e-3)" "unprognostic (4.23e-3)" "unprognostic (1.89e-1)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" 0.9 0.1 0.1 13.4 0.1 0.0 2.5 0.1 0.2 1.1 15.3 0.1 0.1 1.8 0.1 0.1 2.6 0.2 2.1 0.2 0.1 0.1 0.3 0.4 1.9 24.9 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.3 1.4 27.1 0.3 4.6 0.7 0.1 0.4 11.8 1.5 0.2 4.3 1.1 0.2 0.1 3.6 0.7 2.0 26.3 9.4 2.4 4.4 0.2 0.2 0.0 0.0 12.9 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.9 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.4 4.4 12.9 6.1 0.0 0.7 0.6 1.0 0.2 0.0 0.0 0.2 12.9 2.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR150 PGR11 ENSG00000178015 "G protein-coupled receptor 150" Q8NGU9 5 95620078-95622142 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.5;pancreas: 13.4" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 3.0;Extravillous trophoblasts: 2.8;granulocytes: 5.7;Hofbauer cells: 2.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.3;memory CD4 T-cell: 2.5;NK-cell: 2.1" "Group enriched" "Detected in many" 12 "NK-cells: 2.1;T-cells: 2.5" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;SiHa: 3.1;TIME: 6.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA026635 Uncertain NA NA "HPA026635: AB_1849266" "unprognostic (3.03e-2)" "unprognostic (6.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.01e-2)" "unprognostic (5.95e-2)" "unprognostic (5.34e-4)" "unprognostic (1.98e-2)" "unprognostic (6.36e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (1.94e-3)" "unprognostic (1.88e-2)" "unprognostic (1.76e-1)" "unprognostic (3.23e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" 1.5 0.7 4.3 0.4 2.6 0.4 1.2 0.4 11.5 0.6 0.9 0.3 0.4 0.5 0.4 0.6 0.3 0.5 0.5 0.5 2.3 1.3 0.3 0.4 1.2 1.0 0.6 8.0 0.3 13.4 3.8 1.0 0.6 0.2 0.7 0.7 1.4 0.3 1.1 0.4 1.0 0.6 0.4 0.2 0.8 2.1 0.6 0.0 0.0 0.3 0.0 0.7 0.6 0.3 0.2 0.0 0.0 0.0 2.1 2.5 0.2 0.0 0.0 0.1 0.0 3.8 1.7 0.1 1.2 0.3 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 1.4 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.6 0.0 0.0 2.0 1.5 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.1 1.3 3.1 0.0 0.6 0.1 0.0 1.0 6.9 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.5 0.0 2.3 0.2 2.5 0.0 0.0 0.0 1.0 0.2 0.0 2.1 0.0 0.0 0.0 0.2 4.3 2.6 0.4 11.5 2.3 1.3 0.6 8.0 0.2 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.2 2.8 0.0 0.3 5.7 0.5 2.8 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 GPR151 "GALR4, PGR7" ENSG00000173250 "G protein-coupled receptor 151" Q8TDV0 5 146513103-146516190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 1.5;brain: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "thalamus: 36.8" "Region enriched" "Detected in many" 7 "thalamus: 4.6" HPA065728 Supported NA NA "HPA065728: " "unprognostic (2.09e-1)" "unprognostic (2.30e-1)" "unprognostic (1.14e-1)" "unprognostic (1.32e-2)" 0.0 0.1 0.4 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.1 0.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR152 PGR5 ENSG00000175514 "G protein-coupled receptor 152" Q8TDT2 11 67451301-67452729 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.7;lymphoid tissue: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RPMI-8226: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA035078 Uncertain NA NA "HPA035078: AB_10670286" "unprognostic (3.81e-2)" "unprognostic (1.69e-1)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (3.76e-3)" 0.1 0.0 0.0 0.6 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.1 1.7 0.0 0.1 1.6 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.1 1.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.5 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;stomach 1: 43.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 117.8;Melanocytes: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 16.3;WM-115: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.5 10.1 9.3 6.6 34.5 2.6 3.0 15.1 17.3 3.2 11.4 6.1 2.2 4.0 2.6 13.1 6.7 2.5 5.9 6.8 15.5 9.4 19.8 7.3 3.3 5.9 7.7 11.5 3.0 16.9 8.0 3.2 4.7 27.4 8.0 4.2 4.9 3.7 8.8 5.1 13.4 5.1 7.8 6.9 5.3 43.2 2.6 9.9 1.6 8.3 0.8 3.8 6.6 3.6 1.5 0.8 9.6 6.8 4.7 7.0 1.9 0.7 0.4 1.0 2.5 5.7 3.2 0.6 4.3 1.5 0.7 2.4 0.3 0.4 2.4 1.4 3.0 1.5 0.4 1.4 1.3 2.4 0.9 1.7 2.6 1.4 0.2 1.1 0.9 1.4 4.6 3.6 2.1 0.7 4.6 1.1 3.4 0.4 6.2 4.8 0.7 1.7 1.2 0.6 2.6 1.7 2.1 6.2 1.2 2.4 1.6 6.7 5.7 1.3 1.0 2.2 3.1 0.4 0.4 3.1 3.1 1.2 4.5 0.6 16.3 2.3 0.4 3.6 0.8 10.8 1.5 2.9 0.1 2.4 5.4 2.2 1.3 4.4 4.0 0.8 1.5 3.5 5.4 9.6 4.7 6.8 0.5 7.0 1.9 9.3 34.5 15.1 16.2 15.5 9.4 7.7 11.5 27.4 9.9 11.9 2.2 11.7 2.9 37.9 30.8 21.8 2.5 0.0 10.3 10.4 117.8 1.2 1.7 2.0 0.3 9.0 0.3 0.0 5.0 1.0 7.7 3.4 1.1 16.1 5.9 47.7 12.2 20.9 36.6 0.9 13.8 21.7 145.1 1.8 0.2 15.6 5.6 0.0 30.1 34.6 22.9 0.0 10.8 3.3 2.6 25.0 0.7 17.9 1.1 1.5 GPR156 "GABABL, PGR28" ENSG00000175697 "G protein-coupled receptor 156" Q8NFN8 3 120164645-120285094 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Group enriched" "Detected in some" 8 "Early spermatids: 6.5;Late spermatids: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.1;PC-3: 3.0;SiHa: 8.1;U-2 OS: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028642, HPA028644" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028642: AB_10599711, HPA028644: AB_10600441" "unprognostic (2.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.53e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.62e-4)" "unprognostic (2.03e-1)" "unprognostic (4.54e-4)" "unprognostic (5.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (4.03e-5)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (4.91e-3)" "unprognostic (6.71e-2)" 0.9 0.5 0.8 1.6 2.2 0.0 1.0 0.1 1.0 1.4 0.7 0.0 0.0 0.0 1.2 0.0 1.9 3.4 1.3 0.2 0.4 0.3 0.3 0.0 0.2 0.0 0.3 0.0 1.4 0.0 0.0 1.4 1.2 0.7 1.9 0.2 0.4 2.4 1.5 0.1 0.3 0.2 1.6 1.5 0.1 0.3 7.7 1.2 0.0 0.1 0.0 0.4 2.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.8 0.1 0.9 1.3 0.1 0.6 0.0 0.9 3.1 0.7 0.1 0.1 0.1 0.5 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 2.0 0.2 0.5 0.0 0.2 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 1.0 1.6 8.1 0.0 1.0 0.4 1.1 0.1 0.2 0.2 4.5 0.0 0.3 1.0 0.4 0.1 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.1 1.0 0.4 0.3 0.3 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell type enriched" "Detected in many" 5 "monocytes: 184.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.7 2.7 0.8 2.2 0.7 0.7 4.4 1.5 1.0 1.2 1.7 2.1 1.8 0.6 1.9 1.5 1.6 10.1 2.4 1.0 1.8 13.1 4.0 0.0 7.8 3.2 2.7 0.0 1.1 0.7 2.1 2.1 1.3 1.2 1.0 2.0 0.7 17.3 0.5 3.4 1.9 1.0 0.9 2.3 3.4 0.3 0.7 2.3 0.8 3.2 1.2 3.3 5.8 34.0 2.8 1.7 4.8 0.6 7.1 4.3 1.1 11.1 0.7 16.7 2.7 0.0 3.2 6.7 1.8 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 6.0 9.9 0.5 6.4 12.0 0.2 12.1 5.1 2.7 6.8 5.2 2.0 25.6 0.0 3.0 0.0 2.9 5.6 0.0 3.3 9.1 3.8 4.4 0.0 12.9 3.8 1.6 0.0 0.0 1.2 0.0 1.7 4.5 6.8 184.0 4.3 1.4 9.2 4.8 4.9 1.4 1.5 0.0 3.9 0.5 2.5 21.2 40.3 2.1 4.3 13.7 GPR158 KIAA1136 ENSG00000151025 "G protein-coupled receptor 158" Q5T848 10 25175062-25602226 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;seminal vesicle: 11.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 136.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 21.2;T-47d: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013185 Uncertain NA NA "HPA013185: AB_2113957" "unprognostic (4.43e-2)" "unprognostic (3.14e-2)" "unprognostic (7.42e-2)" "unprognostic (2.66e-5)" "unprognostic (5.67e-2)" "unprognostic (9.37e-2)" "unprognostic (4.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-2)" "unprognostic (8.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.60e-6)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (3.90e-1)" 0.9 2.4 3.6 1.0 16.2 0.8 0.8 28.4 25.2 0.8 1.1 1.6 6.1 0.9 0.8 1.0 0.8 0.8 0.8 0.8 1.9 2.8 0.8 0.9 0.9 0.8 2.4 4.8 0.8 0.9 1.5 8.9 1.5 14.9 1.2 1.1 1.4 0.8 11.2 0.8 0.8 1.2 0.8 4.0 0.9 1.1 1.9 2.9 0.0 1.0 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 21.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.2 0.0 0.0 1.2 0.0 0.5 1.1 1.9 0.0 5.8 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 16.2 28.4 11.6 1.9 2.8 2.4 4.8 14.9 2.9 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 136.7 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.8 0.7 0.0 0.2 0.0 0.0 0.0 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037929-170085403 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.0" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 186.9;Rod photoreceptor cells: 156.5;Undifferentiated cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 31.0;SK-BR-3: 24.8;THP-1: 48.9;U-266/70: 54.0;U-266/84: 31.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA006970 Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favorable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favorable (3.61e-4)" 7.0 1.4 3.1 21.7 2.5 23.6 8.2 0.9 1.8 2.6 31.2 1.5 7.9 18.0 1.9 21.5 2.6 1.8 16.2 3.0 1.9 1.7 27.4 2.1 23.2 25.6 2.7 0.4 1.6 14.7 71.0 3.5 2.9 1.8 10.7 18.1 11.8 14.2 4.7 2.0 1.8 43.2 0.9 4.7 17.9 18.0 2.9 2.4 6.6 3.8 1.0 10.7 9.1 6.9 11.2 2.9 10.1 1.1 0.3 3.0 1.2 15.9 0.3 0.0 0.1 0.1 0.1 4.0 0.1 0.1 0.1 0.5 2.9 2.0 7.4 3.4 0.1 1.0 0.1 2.2 0.1 0.2 11.3 4.4 4.8 0.2 6.0 0.0 9.4 6.5 0.0 0.2 0.5 0.6 0.7 0.3 3.5 1.5 19.2 0.1 10.2 0.7 2.0 2.6 9.8 0.6 1.3 0.3 31.0 8.4 22.1 1.6 0.4 0.2 24.8 1.1 2.2 14.5 48.9 0.5 0.0 0.1 1.8 1.2 54.0 31.0 12.9 0.2 10.2 0.7 1.5 1.1 8.1 0.5 0.4 0.9 6.8 0.9 0.4 2.2 11.2 3.0 1.1 10.1 0.3 0.1 2.9 0.3 1.2 3.1 2.5 0.9 1.8 1.9 1.7 2.7 0.4 1.8 2.4 8.9 39.0 27.8 3.1 0.3 7.9 1.0 25.5 18.7 18.2 59.3 37.3 2.6 46.4 10.6 24.4 4.5 103.3 0.0 63.8 15.0 0.4 47.4 1.1 0.5 7.0 14.3 186.9 16.0 9.2 32.2 0.6 10.0 27.0 97.4 129.6 7.7 48.2 137.8 0.4 121.7 156.5 0.0 0.3 6.4 11.9 0.6 22.8 2.5 149.6 25.7 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.1;smooth muscle: 21.0" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 149.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 2.4 0.9 2.1 3.6 1.7 0.0 1.9 1.2 4.0 7.3 4.9 3.1 8.5 0.8 27.1 8.2 7.4 7.7 5.6 2.4 2.8 1.5 1.1 0.4 2.8 0.4 3.0 1.2 7.6 11.0 4.9 1.3 1.3 3.0 8.2 2.3 3.4 2.3 9.4 0.8 1.5 2.1 21.0 3.0 1.2 2.2 3.0 0.8 1.4 1.2 1.7 0.7 2.8 6.8 0.3 1.2 1.5 0.5 0.2 0.3 0.2 6.1 3.8 15.5 9.9 3.7 6.6 0.0 5.9 6.5 5.1 5.4 24.0 1.0 0.0 3.3 8.9 9.6 18.4 3.7 5.8 3.0 2.3 4.8 2.2 3.0 0.1 1.6 0.6 1.5 2.3 3.8 4.4 7.1 11.9 10.2 1.9 2.0 0.1 7.7 0.5 0.7 0.1 6.3 10.3 6.0 1.8 6.7 0.0 2.7 1.7 3.1 13.7 6.5 0.2 17.8 6.1 3.4 0.7 13.7 10.5 5.5 14.1 6.7 0.0 0.0 0.0 2.8 0.0 2.7 1.5 0.3 0.2 0.1 0.3 0.1 0.1 0.1 0.0 1.2 0.3 0.1 0.3 1.3 0.2 0.5 0.3 0.0 0.2 2.1 1.7 1.2 4.0 2.8 1.5 3.0 1.2 3.0 0.8 3.0 0.6 0.0 5.0 1.9 1.7 2.0 0.0 1.4 1.2 0.0 0.0 0.4 0.0 3.6 0.4 6.3 0.0 0.0 7.2 0.2 6.3 4.6 0.0 0.0 0.7 149.4 0.0 4.3 1.8 0.6 6.9 1.3 1.7 1.8 1.7 2.7 2.9 0.0 15.9 0.0 1.5 19.4 12.2 0.0 0.7 1.3 0.3 0.0 2.3 2.3 GPR162 "A-2, GRCA" ENSG00000250510 "G protein-coupled receptor 162" Q16538 12 6821545-6829972 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.6" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 75.9;Ciliated cells: 49.5;Horizontal cells: 38.1;Muller glia cells: 46.3" "Cancer enriched" "Detected in many" 6 "glioma: 16.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7" "Group enriched" "Detected in many" 6 "granulocytes: 14.7;monocytes: 6.3" "Cell line enhanced" "Detected in many" "AF22: 13.0;AN3-CA: 15.4;hTERT-RPE1: 13.4;NTERA-2: 14.5;SH-SY5Y: 9.9;U-2 OS: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055135 Enhanced Approved "Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" "HPA055135: AB_2682710" "unprognostic (4.76e-2)" "unprognostic (8.00e-2)" "unprognostic (8.24e-3)" "unprognostic (1.31e-2)" "unprognostic (1.31e-1)" "unprognostic (2.38e-1)" "unprognostic (4.78e-2)" "unprognostic (2.25e-2)" "unprognostic (5.83e-3)" "unprognostic (1.18e-1)" "prognostic favorable (4.29e-5)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.37e-6)" "unprognostic (3.10e-3)" "unprognostic (1.77e-1)" "unprognostic (3.22e-1)" "unprognostic (3.64e-2)" 2.7 6.7 19.6 4.2 13.2 1.5 2.4 41.3 47.6 2.1 3.4 4.7 0.8 3.1 3.8 2.8 1.9 16.9 5.7 4.2 25.9 18.4 1.4 3.7 6.0 1.7 9.9 17.7 2.0 1.7 5.3 8.4 4.3 10.2 2.1 3.0 3.6 1.3 2.1 1.6 1.7 4.2 5.7 5.3 2.8 2.0 1.2 3.6 0.1 1.1 0.0 1.1 2.4 0.5 0.0 1.8 14.7 6.3 0.0 0.0 1.7 0.0 2.9 13.0 15.4 1.4 1.0 0.0 1.0 3.4 2.9 1.7 0.2 0.0 0.0 0.1 1.8 0.1 0.0 2.0 0.0 1.4 0.0 0.9 1.5 0.1 0.0 2.2 0.3 0.0 2.4 0.0 4.4 0.2 13.4 7.9 1.1 0.7 0.1 1.0 0.0 0.4 1.1 14.5 0.0 0.1 0.0 1.6 2.6 1.0 0.0 1.1 9.9 0.0 0.0 0.4 9.3 0.1 3.8 5.2 2.0 12.3 1.0 1.7 0.0 0.9 0.0 2.2 2.7 0.2 0.0 6.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 14.7 0.0 1.3 1.6 0.0 1.7 19.6 13.2 41.3 32.4 25.9 18.4 9.9 17.7 10.2 3.6 0.0 0.0 0.0 0.1 0.7 75.9 1.1 0.0 49.5 1.2 1.8 3.9 0.1 1.7 0.0 0.0 2.4 0.0 0.0 0.0 0.1 2.1 0.5 0.0 0.4 2.2 38.1 0.0 5.5 3.4 0.4 6.9 3.2 0.0 0.0 0.0 46.3 0.1 0.0 13.8 0.3 7.8 0.0 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GPR17 ENSG00000144230 "G protein-coupled receptor 17" Q13304 2 127645864-127652639 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 43.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 32 "glioma: 16.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 4.0" "Lineage enriched" "Detected in single" 11 "B-cells: 4.0" "Cell line enhanced" "Detected in some" "HeLa: 4.6;REH: 7.7;TIME: 7.6;U-2 OS: 3.2;U-2197: 3.6;U-251 MG: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029766 Enhanced Supported Approved Vesicles NA NA Vesicles "HPA029766: AB_10612114" "unprognostic (8.10e-2)" "unprognostic (1.73e-1)" "unprognostic (2.61e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (5.19e-2)" "unprognostic (2.77e-5)" "unprognostic (8.40e-3)" "unprognostic (2.92e-1)" "unprognostic (3.25e-2)" "unprognostic (1.61e-3)" "unprognostic (6.60e-2)" "unprognostic (2.11e-3)" "unprognostic (3.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" 7.0 2.2 23.7 6.8 21.3 0.8 5.4 4.1 25.6 2.4 16.4 43.8 0.0 3.3 11.2 3.3 5.0 4.0 4.3 12.5 20.6 1.2 2.3 1.6 9.3 2.4 9.1 9.9 1.4 4.6 0.5 0.4 2.7 18.8 3.9 0.8 0.1 1.7 0.5 13.1 6.7 3.8 0.5 6.3 12.6 5.0 1.8 22.6 0.0 2.8 0.0 0.5 6.1 3.9 4.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.6 0.9 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.6 0.3 0.1 0.0 0.2 7.7 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 2.3 0.3 0.0 7.6 0.0 3.2 3.6 4.5 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.7 21.3 4.1 25.6 20.6 1.2 9.1 9.9 18.8 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR171 H963 ENSG00000174946 "G protein-coupled receptor 171" O14626 3 151197832-151203201 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0" "Cell type enhanced" "Detected in many" 26 "Horizontal cells: 20.6;monocytes: 22.6;T-cells: 87.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 45.2" "Lineage enriched" "Detected in many" 18 "T-cells: 45.2" "Cell line enriched" "Detected in single" 26 "U-266/70: 25.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067323 Supported NA NA "HPA067323: " "unprognostic (6.82e-6)" "unprognostic (4.90e-3)" "unprognostic (7.10e-2)" "unprognostic (6.85e-4)" "unprognostic (2.80e-3)" "unprognostic (1.04e-3)" "unprognostic (4.19e-4)" "unprognostic (6.09e-2)" "unprognostic (4.93e-3)" "unprognostic (1.01e-3)" "unprognostic (8.84e-2)" "unprognostic (1.08e-1)" "unprognostic (4.72e-6)" "unprognostic (1.31e-1)" "unprognostic (4.17e-2)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" 4.1 0.9 0.4 15.1 0.4 0.4 1.6 0.3 0.3 4.0 6.8 0.3 0.6 3.5 1.4 1.6 2.7 3.9 4.6 1.3 0.4 0.4 4.3 2.7 10.7 33.0 0.7 0.5 1.9 1.0 0.0 0.7 0.8 1.5 2.2 3.8 1.7 2.4 1.2 1.0 1.1 19.5 1.1 2.7 20.7 4.0 1.0 0.5 19.9 2.2 1.8 8.5 7.0 2.4 0.1 0.8 1.0 0.1 2.5 45.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 11.6 0.0 45.2 0.0 16.2 21.5 0.8 0.1 9.9 8.4 0.3 2.5 0.1 0.7 8.0 3.4 0.4 0.4 0.3 0.3 0.4 0.4 0.7 0.5 1.5 0.5 0.0 2.1 2.4 0.3 1.0 3.6 0.3 0.0 0.0 2.3 0.0 2.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 2.3 1.1 0.1 20.6 0.0 3.1 3.1 0.0 0.0 6.9 0.0 22.6 0.0 5.6 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.9 0.1 0.5 0.6 87.7 0.0 0.3 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavorable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favorable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.1 0.5 4.6 2.7 0.0 1.3 2.9 2.1 2.5 0.8 0.1 0.2 2.0 2.8 6.4 0.6 10.2 0.0 1.9 0.6 1.0 0.5 8.3 0.3 6.7 0.5 0.1 6.6 0.0 3.3 4.6 7.5 3.5 0.0 0.0 5.7 3.2 4.2 0.0 0.0 6.3 0.4 3.6 0.1 2.4 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 5.5 1.1 0.1 6.4 3.5 5.1 2.3 1.1 0.2 0.3 0.7 2.5 0.0 1.9 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 0.0 0.0 0.0 0.4 0.2 6.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.2 6.4 3.4 1.8 0.3 0.0 2.8 0.0 1.7 0.0 0.1 2.7 0.1 0.0 4.2 0.0 2.8 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144663-79175315 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 73.8" "Group enriched" "Detected in some" 20 "Alveolar cells type 2: 3.7;Club cells: 1.2;Collecting duct cells: 1.8;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "JURKAT: 24.1;MOLT-4: 39.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA041025 Enhanced Uncertain Vesicles NA NA Vesicles "HPA041025: AB_10794260" "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 2.2 0.5 0.4 20.3 0.4 2.6 1.3 0.3 0.4 2.4 5.1 0.0 0.5 2.1 1.6 0.9 2.6 0.9 1.9 1.0 0.4 0.4 1.9 1.7 8.2 16.6 0.5 0.0 1.0 0.7 0.0 1.1 0.3 0.2 1.7 2.0 1.6 3.8 0.1 0.5 0.7 9.1 0.2 1.0 21.0 2.2 0.5 0.0 73.8 2.5 1.6 28.1 5.1 1.8 4.0 1.8 6.0 9.1 6.5 8.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.7 0.0 0.0 39.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 4.7 5.7 3.4 1.7 4.0 7.5 8.6 0.1 3.9 6.1 6.8 0.4 6.5 9.1 1.8 7.6 2.7 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 GPR176 Gm1012 ENSG00000166073 "G protein-coupled receptor 176" Q14439 15 39799032-39920892 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 9.4;Early spermatids: 17.9;Late spermatids: 11.5;Muller glia cells: 13.2;Pancreatic endocrine cells: 8.3;Sertoli cells: 12.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 69.8;fHDF/TERT166: 47.0;U-138 MG: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039943, HPA039979" Approved NA NA "HPA039943: AB_10697711, HPA039979: AB_2676782" "unprognostic (4.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (1.04e-2)" "unprognostic (2.75e-2)" "unprognostic (1.38e-3)" "unprognostic (9.32e-2)" "unprognostic (3.23e-2)" "unprognostic (2.74e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (9.38e-7)" "prognostic unfavorable (6.84e-5)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (3.26e-2)" 9.8 9.6 9.7 5.9 18.4 0.5 8.9 22.6 16.0 8.0 2.9 2.5 1.3 2.8 5.6 3.1 2.9 3.8 10.5 5.4 8.4 12.7 4.7 2.8 5.4 8.0 7.2 7.4 2.5 2.3 3.3 4.1 3.6 11.3 10.9 3.5 3.2 2.5 5.7 3.1 3.0 2.5 6.9 3.0 5.6 2.5 9.9 2.0 1.2 5.1 3.1 8.0 9.5 4.5 0.0 0.5 2.8 0.0 0.0 0.0 0.0 12.6 0.6 0.8 0.1 9.2 16.7 0.0 27.0 69.8 16.6 25.7 1.0 2.1 0.1 2.4 47.0 9.6 0.4 2.0 2.1 24.9 0.4 3.1 2.0 2.1 0.0 10.3 0.0 0.1 12.6 0.2 14.9 12.4 16.6 6.2 0.7 0.3 0.2 22.8 0.6 0.0 0.0 0.8 0.1 2.6 0.8 8.4 0.1 0.4 0.1 3.4 13.2 7.0 0.0 1.1 0.2 2.5 0.1 7.8 30.6 8.9 1.8 9.9 0.3 1.0 0.0 6.3 0.0 11.9 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.7 18.4 22.6 14.3 8.4 12.7 7.2 7.4 11.3 2.0 0.0 0.0 0.0 0.2 1.5 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.9 1.1 0.0 0.0 3.2 0.0 2.5 2.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 11.5 1.1 0.8 1.7 0.0 0.0 13.2 8.3 0.0 1.1 1.2 1.1 12.9 4.7 2.1 3.1 0.9 0.0 0.0 0.0 0.0 GPR179 "CSNB1E, GPR158L1" ENSG00000277399 "G protein-coupled receptor 179" 17 38325530-38343847 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0;retina: 7.5" "Cell type enriched" "Detected in some" 13 "Bipolar cells: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA017885 Uncertain NA NA "HPA017885: AB_2279357" "unprognostic (1.65e-1)" "unprognostic (2.27e-1)" "unprognostic (1.24e-4)" "unprognostic (8.89e-3)" "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (3.04e-2)" "unprognostic (4.76e-2)" "unprognostic (2.34e-2)" "unprognostic (6.57e-3)" "unprognostic (5.31e-2)" "unprognostic (5.09e-10)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.41e-4)" 0.2 0.6 1.6 0.0 3.0 0.0 0.2 0.8 1.9 0.1 0.1 0.2 0.0 0.3 0.2 1.0 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 7.5 0.6 0.3 1.5 0.0 0.3 0.1 0.6 0.0 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR18 ENSG00000125245 "G protein-coupled receptor 18" Q14330 13 99254714-99261744 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 25.4;lymphoid tissue: 25.1;testis: 15.0" "Group enriched" "Detected in some" 6 "Early spermatids: 170.3;Late spermatids: 143.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 25.4;NK-cells: 19.6;T-cells: 17.6" "Group enriched" "Detected in some" 4 "Daudi: 8.6;THP-1: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013873 Enhanced NA NA "HPA013873: AB_1849285" "unprognostic (3.87e-6)" "unprognostic (1.31e-3)" "unprognostic (3.22e-2)" "unprognostic (1.31e-6)" "unprognostic (2.89e-1)" "unprognostic (7.55e-4)" "unprognostic (4.27e-5)" "unprognostic (3.45e-3)" "unprognostic (2.31e-3)" "unprognostic (5.43e-2)" "unprognostic (9.70e-2)" "unprognostic (4.03e-1)" "unprognostic (3.20e-6)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (6.92e-3)" 0.7 0.3 0.3 13.2 0.3 6.0 0.4 0.3 0.2 0.5 1.2 0.0 0.0 0.4 0.4 0.4 0.8 0.3 0.7 0.6 0.3 0.3 0.6 0.9 1.9 25.1 0.3 0.0 0.4 0.4 0.0 0.5 0.5 0.4 1.0 0.5 0.2 2.8 0.0 0.3 0.5 5.3 0.0 0.5 24.0 0.8 15.0 0.0 14.4 0.7 0.3 20.6 4.0 0.7 25.4 4.8 0.9 2.0 19.6 17.6 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.4 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 20.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 3.3 0.0 0.1 0.7 0.2 10.0 2.0 16.9 25.4 9.0 13.8 4.7 21.4 17.6 15.6 0.9 19.6 1.9 4.8 2.3 5.0 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.0 0.4 0.0 0.0 2.2 25.1 0.0 0.2 0.8 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 170.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 143.8 0.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 1.2 0.4 0.3 0.0 21.0 0.0 0.0 GPR182 "ADMR, AM-R, G10D, hrhAMR" ENSG00000166856 "G protein-coupled receptor 182" O15218 12 56994446-56998441 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "liver: 9.5;lymphoid tissue: 29.1;testis: 12.9" "Group enriched" "Detected in some" 32 "Early spermatids: 67.2;Ito cells: 90.2;Late spermatids: 117.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.2;RH-30: 6.2;SuSa: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027037 Enhanced NA NA "HPA027037: AB_1844622" "unprognostic (6.13e-2)" "unprognostic (6.23e-2)" "unprognostic (3.56e-2)" "unprognostic (5.88e-2)" "unprognostic (2.60e-2)" "unprognostic (3.30e-1)" "unprognostic (2.10e-4)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (4.94e-1)" "unprognostic (1.67e-2)" "unprognostic (8.13e-2)" "unprognostic (5.62e-3)" "unprognostic (9.31e-2)" "unprognostic (2.88e-2)" "unprognostic (1.42e-1)" "unprognostic (4.34e-3)" 0.4 3.2 0.0 0.8 0.0 0.0 0.6 0.1 0.3 0.7 0.4 0.0 0.6 0.0 1.2 0.7 1.3 0.7 0.1 0.3 0.0 0.0 1.3 9.5 1.9 7.5 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.1 0.3 0.3 0.7 0.0 29.1 0.2 12.9 0.0 0.2 1.4 0.3 0.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.5 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.8 0.8 0.0 1.4 1.1 0.7 0.0 0.1 0.0 0.3 6.2 0.0 0.0 0.6 0.1 0.5 0.0 0.2 0.0 1.8 0.4 0.0 0.0 0.1 0.5 0.3 0.0 0.5 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 90.2 2.8 117.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 GPR183 EBI2 ENSG00000169508 "G protein-coupled receptor 183" P32249 13 99294530-99307405 "G-protein coupled receptors, Predicted membrane proteins" "Adaptive immunity, Immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.7" "Cell type enhanced" "Detected in many" 15 "B-cells: 189.0;Macrophages: 550.4;monocytes: 424.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 22 "HDLM-2: 53.8;HL-60: 36.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028847, CAB033690, HPA075590" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "CAB033690: AB_2114269, HPA028847: AB_10603672, HPA075590: " "unprognostic (3.28e-3)" "prognostic favorable (9.77e-4)" "unprognostic (6.03e-2)" "unprognostic (4.61e-3)" "unprognostic (3.45e-1)" "unprognostic (7.11e-2)" "unprognostic (1.71e-1)" "unprognostic (6.29e-2)" "unprognostic (2.12e-1)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (2.33e-1)" "unprognostic (4.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.97e-3)" "unprognostic (9.31e-3)" "unprognostic (9.86e-3)" 27.0 5.5 3.1 33.8 5.0 40.8 7.6 1.1 2.9 5.9 11.2 7.5 4.5 3.2 3.8 9.2 9.3 6.4 17.3 11.7 4.8 6.1 5.4 7.2 26.5 53.7 7.5 2.6 4.4 2.1 2.1 4.8 11.1 9.3 7.4 9.2 4.8 6.6 2.0 4.1 5.3 19.2 9.0 31.3 46.5 6.0 3.7 7.4 13.2 6.5 8.3 38.9 34.9 5.2 46.8 30.6 101.7 1.2 55.0 60.2 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 53.8 0.0 0.4 0.1 0.0 0.0 36.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.2 0.0 101.7 1.2 46.1 5.7 0.4 34.0 46.8 60.2 30.9 9.3 19.1 38.1 5.2 1.2 55.0 0.4 30.6 47.3 27.8 3.1 5.0 1.1 2.9 4.8 6.1 7.5 2.6 9.3 7.4 14.9 41.9 189.0 0.4 54.7 0.2 1.8 0.0 6.7 10.3 0.0 5.9 0.9 1.7 0.1 0.6 2.3 0.0 0.0 2.5 1.3 21.6 0.4 60.0 0.5 114.3 0.0 0.0 0.6 92.9 1.3 0.3 550.4 138.3 424.8 0.0 0.1 0.7 0.0 0.0 0.3 0.8 6.5 3.6 0.5 0.2 46.7 1.5 126.8 0.0 0.3 GPR19 ENSG00000183150 "G protein-coupled receptor 19" Q15760 12 12660891-12696207 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.2;brain: 13.3;pituitary gland: 9.8;testis: 9.8" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 1.5;Early spermatids: 3.2;Muller glia cells: 1.5;Spermatocytes: 4.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 9.2" "Group enriched" "Detected in many" 16 "granulocytes: 4.2;T-cells: 9.2" "Cell line enhanced" "Detected in many" "HDLM-2: 22.7;NTERA-2: 23.6;SuSa: 17.8;WM-115: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013955 Uncertain NA NA "HPA013955: AB_1849287" "unprognostic (1.92e-1)" "unprognostic (3.38e-2)" "unprognostic (1.72e-1)" "unprognostic (8.62e-5)" "unprognostic (1.60e-1)" "unprognostic (3.21e-1)" "unprognostic (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" "unprognostic (6.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.70e-2)" "unprognostic (2.67e-12)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-1)" 1.0 2.4 7.5 4.8 13.3 2.3 1.2 11.5 13.0 0.8 1.5 2.8 0.0 1.1 0.7 0.7 1.5 1.0 1.1 0.7 8.5 8.4 0.7 0.8 0.8 4.3 5.6 6.3 0.5 1.1 1.0 9.8 1.1 3.7 0.5 1.9 0.4 0.6 0.6 0.4 2.2 1.1 1.1 6.7 1.7 1.3 9.8 3.6 0.3 0.7 0.0 5.8 1.3 0.2 0.3 0.0 4.2 0.0 0.4 9.2 0.5 0.9 0.3 9.8 0.2 0.0 0.0 4.2 0.9 1.0 1.7 1.5 3.8 5.9 3.9 1.5 0.7 1.3 0.7 1.6 0.2 2.9 22.7 0.2 0.9 0.4 0.6 0.0 1.0 0.4 0.0 0.0 1.9 1.1 0.7 0.3 0.4 0.1 8.2 0.3 1.4 0.3 0.5 23.6 1.0 1.8 2.5 1.5 0.1 0.1 0.8 3.2 3.0 0.4 0.8 7.5 17.8 0.5 0.9 0.0 0.5 4.4 0.8 2.2 4.5 3.9 7.6 1.8 2.7 12.0 0.0 0.0 0.0 1.8 0.0 1.4 0.3 3.8 2.1 0.0 0.1 0.7 1.4 4.2 0.4 0.0 0.0 9.2 0.5 7.5 13.3 11.5 10.6 8.5 8.4 5.6 6.3 3.7 3.6 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.2 0.0 0.1 0.8 0.0 0.0 GPR21 ENSG00000188394 "G protein-coupled receptor 21" Q99679 9 123034527-123035696 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HBEC3-KT: 8.4" "Low region specificity" "Detected in many" HPA041651 Uncertain NA NA "HPA041651: AB_10794673" "unprognostic (9.22e-3)" "unprognostic (1.46e-1)" 3.6 0.0 1.1 1.7 2.2 0.2 1.1 0.1 4.6 2.1 0.4 0.0 2.7 1.0 1.9 0.9 0.8 0.5 0.7 0.4 0.3 0.0 0.5 1.9 0.3 1.4 0.0 0.2 0.0 1.5 0.1 0.6 0.1 0.7 0.4 0.6 0.3 1.7 0.4 0.9 0.5 0.0 1.0 0.9 1.3 2.0 0.9 0.0 0.1 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR22 ENSG00000172209 "G protein-coupled receptor 22" Q99680 7 107470018-107475659 "G-protein coupled receptors, Predicted membrane proteins" "Cilium biogenesis/degradation" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 31.5;heart muscle: 18.7" "Group enriched" "Detected in some" 8 "Bipolar cells: 15.6;Cardiomyocytes: 57.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 33 "SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (5.52e-2)" "unprognostic (7.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.27e-3)" "unprognostic (1.62e-1)" "unprognostic (8.76e-3)" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (5.85e-4)" "unprognostic (1.55e-1)" "unprognostic (7.53e-3)" "unprognostic (2.27e-3)" "unprognostic (2.04e-1)" 0.6 2.7 10.9 0.6 4.4 0.7 0.6 15.5 31.5 6.3 0.6 0.0 0.0 0.6 4.1 0.6 0.6 0.6 0.6 18.7 19.4 2.0 1.0 0.6 0.6 0.6 1.8 13.0 0.6 0.6 0.6 0.3 0.6 6.0 0.6 0.6 0.0 0.6 0.8 0.6 0.6 0.6 1.0 0.7 0.6 0.6 0.6 1.1 0.0 0.6 0.0 0.6 0.6 1.7 1.0 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.3 0.9 0.4 0.5 0.0 1.0 0.4 1.0 0.3 0.2 0.2 0.2 0.4 0.0 10.9 4.4 15.5 31.5 19.4 2.0 1.8 13.0 6.0 1.1 0.0 0.0 0.0 0.0 0.2 15.6 57.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GPR25 ENSG00000170128 "G protein-coupled receptor 25" O00155 1 200872955-200874178 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 22.9;lymphoid tissue: 11.6;stomach 1: 7.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 15.1;T-reg: 22.9" "Group enriched" "Detected in many" 63 "B-cells: 8.1;T-cells: 22.9" "Cell line enriched" "Detected in single" 6 "U-266/70: 5.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (2.80e-3)" "unprognostic (1.73e-2)" "unprognostic (1.06e-1)" "unprognostic (1.25e-4)" "unprognostic (2.21e-3)" "unprognostic (4.49e-5)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.61e-1)" "unprognostic (1.23e-2)" "unprognostic (1.04e-1)" "unprognostic (9.03e-2)" "unprognostic (1.29e-6)" "unprognostic (1.48e-2)" "unprognostic (3.71e-2)" "unprognostic (2.42e-2)" "unprognostic (3.22e-6)" 0.2 0.2 0.1 3.4 0.9 0.2 0.1 0.1 0.7 0.2 0.6 0.4 0.0 0.5 0.7 0.1 2.6 0.8 0.2 1.6 0.1 0.4 0.2 0.1 1.7 1.7 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 5.2 0.1 0.3 0.1 1.9 0.1 0.1 2.9 7.3 1.5 0.0 1.0 0.3 1.5 11.6 0.9 0.5 8.1 0.0 0.1 0.0 0.2 22.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 6.1 8.1 15.1 4.8 0.0 0.7 0.4 1.3 0.1 0.2 0.0 0.0 22.9 3.1 0.1 0.9 0.1 0.7 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR26 ENSG00000154478 "G protein-coupled receptor 26" Q8NDV2 10 123666355-123694607 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 8.6" "Cell type enhanced" "Detected in single" 28 "Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 13 "breast cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "SCLC-21H: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062736 Enhanced NA NA "HPA062736: AB_2684855" "unprognostic (4.15e-2)" "unprognostic (5.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.12e-1)" "unprognostic (9.09e-2)" "unprognostic (9.98e-2)" "unprognostic (2.12e-2)" "unprognostic (1.16e-2)" "unprognostic (1.12e-1)" 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.6 2.4 0.0 0.3 0.0 0.1 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71754050-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2;parathyroid gland: 29.6" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 11.0;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "eosinophil: 3.7;neutrophil: 10.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.5" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HL-60: 12.5;MCF7: 10.8;NTERA-2: 21.5;RPTEC TERT1: 10.4;SH-SY5Y: 8.2;T-47d: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.7 4.5 14.9 1.7 23.2 14.5 4.3 4.4 15.4 3.4 1.0 5.8 1.7 0.6 5.5 3.3 2.7 7.7 1.2 3.5 12.8 12.4 3.2 0.9 2.4 5.5 10.6 8.8 5.0 2.6 29.6 5.1 2.0 5.9 5.7 0.7 3.3 1.7 5.1 1.8 1.9 0.7 3.3 16.8 3.7 2.4 4.2 3.6 0.0 6.8 1.2 0.5 2.1 2.8 0.0 0.2 10.5 0.8 0.0 0.4 0.1 0.0 0.8 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 13.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 12.5 0.7 0.0 2.2 0.0 0.9 0.0 0.0 2.7 0.0 0.0 0.0 10.8 0.9 0.2 21.5 0.0 0.0 0.0 0.0 0.0 10.4 5.8 2.3 8.2 2.8 0.0 0.0 2.9 7.5 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.8 3.7 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 10.5 0.0 0.1 0.0 0.0 0.1 14.9 23.2 4.4 9.9 12.8 12.4 10.6 8.8 5.9 3.6 0.0 1.4 0.0 4.0 1.6 11.0 2.8 5.1 2.7 2.3 12.2 3.9 1.1 1.7 0.4 0.1 0.0 0.0 0.0 0.0 1.1 0.9 4.5 0.0 0.0 1.0 0.0 1.2 0.0 5.1 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.4 0.0 1.1 0.0 0.3 0.0 0.4 0.2 0.9 1.5 0.2 0.0 0.0 1.8 GPR3 ACCA ENSG00000181773 "G protein-coupled receptor 3" P46089 1 27392644-27395814 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 1.8;Cardiomyocytes: 3.2;Horizontal cells: 4.8;Intestinal endocrine cells: 4.6;Smooth muscle cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB006254 Uncertain NA NA "CAB006254: AB_425462" "unprognostic (4.42e-2)" "unprognostic (2.22e-1)" "unprognostic (4.05e-2)" "unprognostic (1.55e-2)" "unprognostic (1.38e-2)" "unprognostic (1.27e-1)" "unprognostic (7.30e-3)" "unprognostic (6.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-1)" "unprognostic (5.94e-2)" "unprognostic (1.97e-1)" "unprognostic (1.46e-1)" "unprognostic (8.17e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (1.03e-2)" 3.5 1.5 4.0 2.8 7.5 3.2 1.5 5.5 12.3 1.2 1.1 2.1 0.2 1.0 2.3 0.5 2.0 1.1 2.9 7.1 5.0 6.3 1.9 2.0 2.7 1.0 4.4 1.7 1.2 2.6 2.8 6.1 1.8 13.9 1.8 1.1 1.1 0.7 1.0 0.6 0.6 0.9 2.5 6.5 0.7 1.3 0.8 0.5 0.0 3.0 0.8 0.7 1.6 0.5 0.7 0.4 0.0 0.1 0.0 0.1 0.0 1.6 0.9 4.8 5.4 0.2 0.6 0.6 3.1 3.6 4.8 3.5 1.4 1.0 0.3 0.7 1.4 4.9 1.2 1.3 3.8 3.7 0.1 0.2 1.3 0.3 3.0 0.6 3.0 4.1 0.7 0.0 6.7 1.5 0.5 1.5 2.1 3.7 5.3 5.8 2.4 0.6 4.2 7.1 2.4 7.6 8.1 3.8 2.2 2.0 0.4 0.9 2.3 1.5 0.6 5.7 2.2 0.1 0.6 0.9 3.6 6.5 21.0 3.7 0.7 3.6 0.4 5.4 1.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.0 7.5 5.5 12.3 5.0 6.3 4.4 1.7 13.9 0.5 0.0 0.0 0.0 1.8 0.1 1.4 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.0 0.2 4.8 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.3 0.1 GPR31 "12-HETER, HETER1" ENSG00000120436 "G protein-coupled receptor 31" O00270 6 167156271-167158329 "G-protein coupled receptors, Predicted membrane proteins" "Lipid metabolism" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "myeloid DC: 2.7" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014014, HPA027108" Uncertain NA NA "HPA014014: AB_1849292, HPA027108: AB_10601474" "unprognostic (9.92e-2)" "unprognostic (1.52e-1)" "unprognostic (1.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.42e-3)" "unprognostic (2.20e-3)" "unprognostic (5.95e-3)" "unprognostic (4.03e-2)" "unprognostic (3.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (8.10e-4)" "unprognostic (2.45e-1)" "unprognostic (6.01e-2)" 0.0 0.0 0.1 0.9 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.5 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 4.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.2 2.1 0.3 1.1 0.1 1.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR32 RVDR1 ENSG00000142511 "G protein-coupled receptor 32" O75388 19 50770464-50771732 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 52 "parathyroid gland: 63.4" "Group enriched" "Detected in some" 10 "Extravillous trophoblasts: 4.2;Syncytiotrophoblasts: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "BEWO: 29.5" "Low region specificity" "Detected in some" NA NA "unprognostic (4.77e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 63.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 GPR33 ENSG00000214943 "G protein-coupled receptor 33 (gene/pseudogene)" Q49SQ1 14 31482875-31488142 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 5.7" "Lineage enhanced" "Detected in many" "dendritic cells: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.20e-1)" "unprognostic (8.10e-3)" "unprognostic (6.53e-4)" "unprognostic (9.13e-2)" "unprognostic (2.55e-1)" "unprognostic (2.10e-1)" 0.1 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 2.0 0.0 1.1 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 1.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 1.9 0.1 0.5 0.0 1.5 0.1 0.0 0.6 1.3 0.0 0.0 5.7 1.8 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR34 ENSG00000171659 "G protein-coupled receptor 34" Q9UPC5 X 41688973-41697277 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.8" "Cell type enhanced" "Detected in some" 23 "granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2" "Cancer enhanced" "Detected in all" "glioma: 26.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 60.8;eosinophil: 25.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 60.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010668, CAB025490" Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB025490: , HPA010668: AB_1849294" "unprognostic (1.26e-2)" "unprognostic (1.08e-1)" "unprognostic (1.43e-2)" "unprognostic (1.44e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.59e-2)" "unprognostic (9.81e-3)" "unprognostic (7.19e-2)" "unprognostic (1.74e-1)" "unprognostic (3.96e-1)" "unprognostic (2.72e-3)" "unprognostic (1.14e-1)" "unprognostic (1.88e-3)" "unprognostic (3.18e-2)" 25.1 12.4 15.1 9.7 16.6 0.4 15.0 2.1 11.7 10.5 9.1 13.5 1.0 4.4 4.9 6.6 5.8 5.5 12.2 5.9 16.0 9.5 11.7 5.3 11.4 26.8 22.4 7.5 5.4 4.4 2.8 3.3 29.3 15.4 5.7 9.3 4.9 7.1 6.4 2.1 2.4 11.4 11.5 34.0 22.3 5.1 5.0 21.4 1.9 3.4 1.5 11.1 12.5 3.7 0.3 0.4 60.8 2.8 3.0 0.1 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.4 0.0 0.2 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.2 0.7 0.3 0.0 0.4 0.1 1.1 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 0.8 0.1 0.0 0.0 0.1 0.6 1.3 0.0 60.8 2.2 25.3 0.0 2.8 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.2 3.0 1.5 0.0 0.1 0.5 15.1 16.6 2.1 11.7 16.0 9.5 22.4 7.5 15.4 21.4 0.0 3.2 2.7 0.2 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.3 1.7 0.1 35.9 0.0 198.9 0.0 1.2 3.1 113.1 0.6 0.9 46.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 19.4 0.0 0.0 0.1 0.9 2.1 1.7 0.0 0.0 GPR35 ENSG00000178623 "G protein-coupled receptor 35" Q9HC97 2 240605431-240631259 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 109.6" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 80.6;granulocytes: 38.0;Mucus-secreting cells: 25.1;Paneth cells: 24.6;Undifferentiated cells: 21.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 20.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "classical monocyte: 16.4;eosinophil: 16.8;intermediate monocyte: 22.7;myeloid DC: 14.5;non-classical monocyte: 6.1" "Group enriched" "Detected in many" 14 "dendritic cells: 14.5;granulocytes: 16.8;monocytes: 22.7" "Cell line enhanced" "Detected in some" "CACO-2: 10.8;CAPAN-2: 27.2;HDLM-2: 9.0;Hep G2: 17.3;HMC-1: 17.1;OE19: 20.1;U-937: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.53e-1)" "unprognostic (5.99e-2)" "unprognostic (3.94e-3)" "unprognostic (2.71e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.98e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.59e-5)" "unprognostic (7.03e-3)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-3)" 0.8 0.2 1.5 7.0 1.8 2.4 1.4 2.4 2.2 1.6 50.4 1.0 0.5 27.2 1.7 1.8 1.1 3.4 24.1 0.8 1.5 1.5 2.2 0.7 3.1 6.6 1.6 0.8 2.5 0.5 0.3 3.2 0.7 1.8 1.8 11.2 0.6 0.8 0.7 3.9 1.2 109.6 1.3 1.4 8.9 10.8 2.0 1.6 1.9 1.2 0.9 2.4 1.0 1.0 0.0 14.5 16.8 22.7 0.3 1.3 5.5 0.0 0.2 0.1 0.5 0.5 0.0 0.2 0.0 0.1 0.0 0.1 10.8 27.2 0.1 0.1 0.1 0.4 0.2 0.0 0.0 0.0 9.0 0.3 4.5 0.2 17.3 0.2 0.2 17.1 0.1 0.0 0.3 0.1 0.2 0.0 0.7 0.2 1.5 0.0 0.3 0.2 8.4 0.4 20.1 0.1 1.0 0.0 0.2 0.1 0.1 1.0 0.4 0.0 0.1 0.2 0.3 0.1 3.0 0.4 0.1 0.1 0.7 0.0 1.9 0.8 0.1 0.0 9.5 0.2 0.0 16.4 16.8 0.7 22.7 1.3 0.0 0.4 0.4 14.5 0.0 0.2 0.5 0.2 0.3 6.1 0.3 0.1 5.5 1.5 1.8 2.4 2.2 1.5 1.5 1.6 0.8 1.8 1.6 0.0 7.9 0.0 0.0 1.8 1.3 0.8 2.5 0.0 0.0 1.8 0.0 0.1 0.0 1.2 0.0 0.2 80.6 0.0 2.9 0.0 0.4 0.1 38.0 0.0 11.0 1.6 6.4 0.0 5.1 0.0 0.3 8.8 0.0 2.8 25.1 0.2 8.3 24.6 1.1 2.1 2.4 0.0 0.5 1.1 0.7 1.0 0.2 2.5 21.8 0.1 GPR37 "EDNRBL, hET(B)R-LP, PAELR" ENSG00000170775 "G protein-coupled receptor 37" O15354 7 124745997-124765627 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 62.4" "Cell type enriched" "Detected in many" 36 "Muller glia cells: 779.4" "Cancer enhanced" "Detected in many" "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042903, HPA068009" Approved Approved "Nuclear membrane,Cytosol" No No 48000 "Nuclear membrane, Cytosol" "HPA042903: AB_2678219, HPA068009: AB_2685940" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-2)" "unprognostic (7.29e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (6.19e-2)" "prognostic favorable (7.26e-4)" "unprognostic (6.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.16e-2)" "unprognostic (6.12e-3)" "unprognostic (2.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.71e-4)" 1.6 1.0 14.5 1.1 19.6 0.9 1.7 2.3 52.6 1.5 1.4 62.4 0.0 1.0 2.1 1.4 7.8 2.1 1.4 0.9 23.9 11.3 1.2 8.8 1.3 1.1 33.5 12.3 1.0 3.0 0.8 0.3 10.0 23.3 1.8 1.5 3.5 1.6 1.8 1.1 4.1 1.3 3.0 49.4 4.3 1.2 15.5 26.5 0.0 0.9 0.0 0.9 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 9.4 0.0 0.0 0.0 2.7 0.5 2.5 2.4 0.6 0.4 0.8 0.0 0.0 22.0 0.3 0.2 2.8 0.0 0.5 0.4 1.2 0.1 5.9 0.0 2.8 0.0 0.4 0.0 9.8 0.0 0.1 0.0 4.5 0.0 0.0 4.3 0.0 0.5 0.0 0.0 1.4 0.0 4.5 0.0 0.0 0.0 0.0 0.1 2.2 3.3 0.0 8.5 3.2 10.6 2.2 0.0 15.3 2.0 0.7 0.0 0.0 1.3 0.0 0.0 1.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 19.6 2.3 19.6 23.9 11.3 33.5 12.3 23.3 26.5 0.0 0.0 0.0 0.3 4.0 21.7 0.4 2.5 0.0 0.0 1.8 5.9 7.1 0.0 4.3 0.2 0.5 0.0 0.0 0.5 15.1 2.7 2.1 0.0 21.5 1.0 17.5 0.0 0.0 0.3 0.9 2.6 0.0 3.3 1.0 0.4 779.4 0.4 0.0 0.7 0.0 12.5 0.0 0.9 0.6 0.7 8.9 2.5 0.0 0.0 0.1 GPR37L1 ETBR-LP-2 ENSG00000170075 "G protein-coupled receptor 37 like 1" O60883 1 202122858-202133592 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 44.0" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 51.7" "Cancer enriched" "Detected in some" 57 "glioma: 36.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HaCaT: 2.9;MCF7: 3.3;T-47d: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064454 Enhanced NA NA "HPA064454: AB_2685268" "unprognostic (2.12e-2)" "unprognostic (1.83e-1)" "unprognostic (2.96e-1)" "unprognostic (1.61e-3)" "unprognostic (4.52e-1)" "unprognostic (8.20e-2)" "unprognostic (2.26e-4)" "unprognostic (5.83e-2)" "unprognostic (3.46e-3)" "unprognostic (2.07e-1)" "unprognostic (1.83e-1)" "unprognostic (3.28e-2)" "unprognostic (4.86e-3)" "unprognostic (1.14e-1)" "unprognostic (4.58e-2)" "unprognostic (1.18e-3)" "unprognostic (3.49e-1)" 1.6 2.0 20.5 1.6 25.2 1.9 1.6 13.2 44.0 2.0 2.4 33.4 0.0 1.9 1.8 1.8 1.7 1.8 1.7 1.6 22.3 12.6 1.5 1.6 1.6 1.5 17.7 22.1 1.7 1.5 1.5 0.4 1.6 23.8 1.7 1.9 0.9 1.9 2.3 1.7 1.8 2.1 1.7 11.1 1.6 1.6 1.9 15.7 0.0 1.8 0.0 1.5 1.6 0.2 0.9 0.9 1.8 0.9 0.6 1.4 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.2 0.0 0.1 2.9 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.1 1.2 0.0 0.1 9.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.0 0.8 0.7 0.5 0.9 0.7 0.6 0.3 0.2 0.6 0.9 0.7 0.5 1.8 0.6 0.4 0.9 1.4 0.2 20.5 25.2 13.2 39.3 22.3 12.6 17.7 22.1 23.8 15.7 0.0 0.0 0.0 0.5 0.3 1.1 0.8 0.0 0.0 2.3 0.0 3.9 0.0 0.0 2.5 3.5 0.0 1.0 0.0 1.1 0.8 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.5 51.7 1.5 2.9 1.8 0.0 4.7 0.0 0.2 0.0 0.1 0.1 0.6 0.0 0.4 0.8 GPR39 ENSG00000183840 "G protein-coupled receptor 39" O43194 2 132416574-132646559 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 22.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 14.9;Club cells: 10.3;Early spermatids: 16.6;Late spermatids: 12.5;Spermatocytes: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 44 "dendritic cells: 4.3" "Cell line enhanced" "Detected in many" "A-431: 17.5;CAPAN-2: 15.0;hTEC/SVTERT24-B: 18.0;RT4: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA022111 Approved NA NA "HPA022111: AB_1849298" "unprognostic (4.06e-2)" "unprognostic (2.49e-1)" "unprognostic (2.23e-1)" "unprognostic (1.50e-2)" "unprognostic (5.19e-2)" "unprognostic (1.85e-1)" "unprognostic (8.54e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.28e-1)" "unprognostic (1.64e-1)" "unprognostic (3.72e-1)" "unprognostic (4.69e-2)" "unprognostic (1.25e-1)" "unprognostic (6.58e-3)" 0.5 0.1 0.6 4.9 1.1 0.0 2.2 0.4 0.3 4.8 14.4 0.1 3.5 4.7 3.2 1.8 1.5 3.4 10.0 0.7 0.5 0.5 8.7 8.6 9.3 0.0 0.6 0.0 1.4 22.0 14.1 0.4 1.3 0.6 3.0 6.0 1.6 1.3 8.7 0.1 1.0 14.4 0.8 0.3 0.1 6.5 0.8 0.0 0.6 4.1 0.0 1.0 6.5 1.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 17.5 8.4 0.1 0.0 0.3 2.3 0.0 1.2 6.3 3.4 1.9 9.6 15.0 0.0 3.3 1.0 6.8 8.3 0.0 7.3 3.3 0.0 0.0 0.0 0.9 0.3 0.4 0.0 0.0 0.6 5.6 18.0 1.8 3.6 0.0 0.0 0.0 0.0 2.3 1.4 0.0 0.0 0.1 4.0 5.4 0.0 0.2 0.0 11.5 15.8 0.0 0.1 1.0 5.9 0.0 0.3 3.4 0.0 3.0 7.2 5.4 1.5 5.3 0.0 0.0 0.0 8.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.6 1.1 0.4 0.3 0.5 0.5 0.6 0.0 0.6 0.0 14.9 5.4 0.0 0.7 0.1 0.0 0.2 2.5 8.1 10.3 0.0 0.0 0.0 0.0 4.5 16.6 0.0 4.9 0.0 2.7 0.0 0.2 0.2 0.0 2.6 0.0 0.0 2.4 0.0 0.6 12.5 0.3 0.0 0.0 1.0 1.2 1.5 3.8 2.9 0.4 0.6 0.0 0.0 0.0 11.2 0.6 0.0 0.0 0.0 3.8 0.5 GPR4 ENSG00000177464 "G protein-coupled receptor 4" P46093 19 45589764-45602208 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "vagina: 32.0" "Group enriched" "Detected in some" 7 "Endothelial cells: 19.4;Ito cells: 25.2;Sertoli cells: 6.5;Smooth muscle cells: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HUVEC TERT2: 15.0;TIME: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014278 Uncertain NA NA "HPA014278: AB_1849300" "unprognostic (2.49e-2)" "unprognostic (6.62e-3)" "unprognostic (1.33e-2)" "unprognostic (2.93e-2)" "unprognostic (2.70e-1)" "unprognostic (1.31e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (1.29e-1)" "unprognostic (6.23e-2)" "unprognostic (1.70e-1)" "unprognostic (4.66e-2)" "prognostic unfavorable (2.07e-5)" "unprognostic (6.46e-3)" "unprognostic (1.93e-1)" "unprognostic (9.18e-2)" "unprognostic (2.49e-3)" 22.6 5.4 6.7 8.4 14.8 1.9 19.7 6.1 12.0 3.3 3.3 3.0 0.3 3.0 5.4 2.7 2.9 4.0 8.6 23.1 8.1 4.5 7.5 4.9 18.6 4.1 8.4 1.3 3.8 6.6 4.5 4.4 10.3 18.6 4.1 2.5 4.5 2.1 3.2 7.7 2.2 3.1 6.8 13.0 4.5 4.4 1.8 8.9 0.0 12.7 2.4 2.2 5.4 32.0 1.1 0.7 1.4 0.3 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.2 0.0 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 24.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.5 0.3 0.4 0.5 0.4 0.4 0.1 1.1 0.4 0.8 1.4 0.7 0.2 0.7 0.3 0.0 6.7 14.8 6.1 12.0 8.1 4.5 8.4 1.3 18.6 8.9 0.0 0.3 0.0 0.2 2.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 19.4 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 25.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.5 10.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 GPR42 "FFAR3L, GPR41L, GPR42P" ENSG00000126251 "G protein-coupled receptor 42 (gene/pseudogene)" O15529 19 35370929-35372962 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.3;blood: 2.1;intestine: 2.1" "Cell type enriched" "Detected in single" 4 "Alveolar cells type 2: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 1.9;neutrophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "HHSteC: 1.0;RPMI-8226: 1.1" HPA044681 Uncertain NA NA "HPA044681: AB_2679043" "unprognostic (1.73e-3)" "unprognostic (1.31e-4)" 2.3 0.0 0.0 1.5 0.1 0.1 1.2 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.1 1.3 0.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 2.1 0.2 0.4 0.8 1.3 0.0 0.5 0.0 0.3 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GPR45 "PSP24, PSP24A" ENSG00000135973 "G protein-coupled receptor 45" Q9Y5Y3 2 105241743-105243049 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 5.7" "Group enriched" "Detected in some" 42 "Early spermatids: 3.5;Late spermatids: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 3.1;U-2 OS: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055940 Uncertain NA NA "HPA055940: AB_2682977" "unprognostic (3.80e-3)" "unprognostic (5.92e-2)" "unprognostic (2.19e-3)" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.87e-2)" "unprognostic (2.21e-1)" "unprognostic (1.13e-1)" "unprognostic (3.96e-1)" "unprognostic (1.61e-3)" "unprognostic (1.11e-2)" "unprognostic (3.13e-4)" "unprognostic (2.25e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" 0.1 0.1 1.4 0.1 2.3 0.0 0.1 0.0 5.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 1.4 3.1 0.1 0.0 0.0 0.3 1.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.2 0.4 0.4 0.0 0.4 0.2 0.2 1.2 0.3 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.1 9.9 0.0 0.1 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 9.6;SuSa: 8.1" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in some" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA049862: AB_2680920, HPA054678: AB_2682570" "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR52 ENSG00000203737 "G protein-coupled receptor 52" Q9Y2T5 1 174448111-174449198 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "basal ganglia: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.0;Daudi: 1.5;Karpas-707: 2.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (1.15e-1)" "unprognostic (8.60e-2)" "unprognostic (2.61e-2)" "unprognostic (3.65e-1)" "unprognostic (2.27e-1)" "unprognostic (4.49e-1)" 0.3 0.3 0.8 0.2 28.0 2.2 0.1 0.2 7.4 0.1 0.2 0.1 0.0 0.1 0.4 0.4 0.2 0.2 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.1 0.9 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.6 0.2 0.6 0.0 0.2 0.3 0.4 5.0 0.0 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 28.0 0.2 3.2 0.2 0.7 0.2 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR55 ENSG00000135898 "G protein-coupled receptor 55" Q9Y2T6 2 230907318-230961066 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;intestine: 8.2;lymphoid tissue: 13.2;testis: 7.7" "Cell type enhanced" "Detected in some" 17 "granulocytes: 1.1;Intestinal endocrine cells: 1.7;T-cells: 4.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 27.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.88e-4)" "unprognostic (2.60e-2)" "unprognostic (2.27e-1)" "unprognostic (4.24e-3)" "unprognostic (5.93e-2)" "unprognostic (1.12e-4)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "unprognostic (4.37e-2)" "unprognostic (3.18e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-2)" "unprognostic (4.26e-1)" 0.4 0.1 0.4 6.9 7.8 0.2 0.7 0.1 1.2 0.6 4.8 0.7 0.1 2.1 0.9 0.5 0.8 0.2 1.6 0.1 0.5 0.7 0.9 0.1 0.8 8.8 0.2 0.1 0.1 0.1 0.1 0.5 0.1 0.3 1.2 1.5 0.1 1.9 2.1 0.1 0.6 8.2 0.1 0.3 6.6 0.9 7.7 0.1 7.0 0.4 1.2 13.2 2.2 0.4 3.0 1.9 0.5 0.2 2.2 3.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.5 0.0 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 27.0 0.0 0.0 0.2 0.7 0.5 0.0 0.8 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 4.9 0.0 0.0 1.9 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.3 1.2 1.2 0.9 0.4 3.0 0.5 2.3 0.5 2.2 0.2 1.9 3.1 4.6 0.4 7.8 0.1 1.2 0.5 0.7 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.7 0.6 0.8 0.4 0.0 0.5 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.4 0.0 0.0 GPR6 ENSG00000146360 "G protein-coupled receptor 6" P46095 6 109978256-109980718 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 9 "basal ganglia: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 22 "SCLC-21H: 4.6" "Region enriched" "Detected in some" 11 "basal ganglia: 81.5" NA NA "unprognostic (1.14e-2)" "unprognostic (1.59e-2)" "unprognostic (7.10e-3)" 0.4 0.5 3.5 0.4 42.5 0.5 0.4 0.0 6.5 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.8 0.4 0.4 0.4 0.4 0.1 0.8 0.4 0.4 0.4 2.2 0.4 0.0 0.4 0.4 0.0 0.5 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.8 0.5 4.6 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 42.5 0.0 4.0 1.3 1.8 0.1 0.8 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR61 BALGR ENSG00000156097 "G protein-coupled receptor 61" Q9BZJ8 1 109539872-109548406 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;pituitary gland: 6.3;retina: 6.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 13.7;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.1;naive CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;T-cells: 1.0" "Cell line enhanced" "Detected in some" "JURKAT: 1.6;Karpas-707: 1.0;U-266/70: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007326, HPA026088" Supported NA NA "HPA007326: AB_1849308, HPA026088: AB_10602323" "unprognostic (1.70e-1)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (2.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.70e-2)" "unprognostic (7.51e-2)" "unprognostic (3.63e-3)" "unprognostic (2.94e-2)" "unprognostic (4.50e-2)" "unprognostic (1.46e-4)" "unprognostic (3.27e-1)" "unprognostic (4.08e-4)" "unprognostic (1.33e-1)" "unprognostic (1.07e-1)" "unprognostic (6.72e-2)" "unprognostic (3.85e-2)" 0.5 4.0 4.9 0.7 8.2 0.7 0.5 6.4 10.6 0.5 0.6 0.2 0.0 0.8 0.8 0.6 0.7 0.5 0.7 0.9 5.4 3.9 0.6 0.6 0.5 0.8 1.7 8.3 0.6 0.5 0.5 6.3 0.6 4.9 0.6 0.5 6.3 0.7 0.5 2.3 0.8 1.0 0.5 1.2 0.6 0.6 1.7 1.2 0.0 3.6 0.0 0.5 0.7 0.3 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 1.0 0.0 0.4 0.1 0.2 0.2 0.0 0.2 0.3 0.3 0.0 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.3 0.5 0.0 2.3 0.4 0.2 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.1 0.0 4.9 8.2 6.4 10.6 5.4 3.9 1.7 8.3 4.9 1.2 0.0 0.0 0.0 0.0 0.0 13.7 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GPR62 ENSG00000180929 "G protein-coupled receptor 62" Q9BZJ7 3 51955314-51957504 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 24.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 1.7;Cone photoreceptor cells: 3.9;Distal tubular cells: 1.7;Horizontal cells: 4.8;Rod photoreceptor cells: 1.4" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.5" "Low region specificity" "Detected in all" NA NA "unprognostic (9.56e-3)" "unprognostic (3.32e-3)" "unprognostic (2.21e-1)" "unprognostic (6.38e-2)" "unprognostic (7.98e-2)" "unprognostic (1.66e-2)" "unprognostic (9.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.03e-2)" "unprognostic (6.17e-2)" "unprognostic (3.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.82e-5)" "unprognostic (3.64e-2)" "unprognostic (2.45e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-2)" 1.0 1.3 5.6 0.6 12.5 0.6 0.8 1.4 16.2 0.8 0.7 24.2 0.0 0.7 1.1 1.4 0.8 1.1 1.0 1.3 9.7 5.3 1.2 1.0 0.7 0.7 17.8 5.4 2.1 0.8 1.3 0.4 0.7 10.6 0.9 0.7 0.0 1.1 1.0 1.3 0.8 0.7 0.8 18.6 0.8 1.0 0.8 14.5 0.0 0.9 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.2 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.2 0.2 0.2 0.0 0.0 0.1 6.5 1.3 1.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.1 0.6 0.2 0.0 0.4 0.9 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 12.5 1.4 8.5 9.7 5.3 17.8 5.4 10.6 14.5 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 19 "granulocytes: 306.4;Kupffer cells: 79.3;monocytes: 79.4;T-cells: 135.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 6.3;HEL: 6.8;HL-60: 8.1;HMC-1: 10.4;RH-30: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.8 0.0 0.0 0.3 8.1 10.4 0.4 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 3.0 35.3 38.9 0.4 3.8 0.0 0.3 5.1 1.4 2.3 0.0 0.0 0.2 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.1 1.5 0.2 306.4 1.0 60.2 0.0 0.0 4.3 79.3 1.0 0.6 64.5 3.3 79.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.1 4.5 0.3 135.4 0.0 0.1 GPR68 OGR1 ENSG00000119714 "G protein-coupled receptor 68" Q15743 14 91232532-91253925 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Amelogenesis imperfecta, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.0" "Cell type enhanced" "Detected in some" 12 "Hofbauer cells: 12.9;T-cells: 15.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 16.4" "Group enriched" "Detected in many" 10 "NK-cells: 12.8;T-cells: 16.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.2;U-87 MG: 26.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.44e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.10e-2)" "unprognostic (1.58e-1)" "unprognostic (6.84e-2)" "unprognostic (9.63e-2)" "unprognostic (9.42e-2)" "unprognostic (3.73e-1)" "unprognostic (8.31e-9)" "unprognostic (1.70e-2)" "unprognostic (3.19e-2)" "unprognostic (9.44e-2)" "unprognostic (2.78e-3)" 5.1 1.6 2.1 7.9 2.0 1.6 4.4 6.1 6.1 3.9 2.6 0.4 0.0 2.6 1.0 0.7 8.6 0.9 6.3 3.0 1.1 5.2 1.1 0.8 5.4 7.8 0.9 3.9 0.8 1.8 1.5 17.0 4.8 2.3 3.1 2.2 0.9 4.0 0.8 0.5 9.2 3.2 5.3 1.4 4.3 6.5 1.5 0.0 0.8 2.2 3.7 9.6 7.3 3.2 0.4 0.1 1.5 0.1 12.8 16.4 2.5 0.1 0.1 0.4 0.0 0.1 1.0 0.4 0.8 0.5 0.0 0.0 0.2 0.8 0.7 0.4 7.2 0.0 0.8 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.4 3.4 0.3 0.1 4.4 0.0 3.6 0.3 2.4 4.4 0.7 3.2 1.0 0.6 5.0 0.1 0.0 0.1 0.3 0.2 0.2 0.1 0.3 2.6 3.7 0.1 0.1 0.0 0.2 1.2 0.3 2.2 5.4 0.1 0.9 0.3 0.8 1.0 0.1 26.5 0.9 0.1 0.0 0.1 0.0 16.4 0.0 10.1 0.4 3.6 9.4 0.1 0.2 0.5 3.4 1.5 12.8 0.0 0.0 5.8 2.5 2.1 2.0 6.1 6.1 1.1 5.2 0.9 3.9 2.3 0.0 0.0 4.5 0.0 0.2 3.2 0.5 1.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 4.0 0.5 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 12.9 0.0 0.0 0.6 0.0 1.0 0.3 1.7 3.3 1.0 0.0 0.0 1.7 0.0 4.2 0.1 0.1 0.0 0.9 0.2 0.4 2.6 0.6 15.2 0.0 0.2 GPR75 WI-31133 ENSG00000119737 "G protein-coupled receptor 75" O95800 2 53852913-53859989 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0" "Cell type enhanced" "Detected in single" 19 "Cone photoreceptor cells: 2.0" "Cancer enhanced" "Detected in many" "glioma: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (2.77e-1)" "unprognostic (4.44e-2)" "unprognostic (5.96e-2)" "unprognostic (5.27e-3)" "unprognostic (8.31e-3)" "unprognostic (2.59e-3)" "unprognostic (4.71e-2)" "unprognostic (2.20e-1)" "unprognostic (3.07e-4)" "unprognostic (1.10e-1)" "unprognostic (3.97e-3)" "unprognostic (8.23e-2)" "unprognostic (1.94e-1)" "unprognostic (3.38e-1)" "unprognostic (5.75e-2)" 2.9 3.6 19.6 2.6 20.7 2.9 4.8 16.6 23.0 2.7 1.6 18.9 0.1 1.3 3.5 2.2 2.3 3.3 3.2 1.5 20.1 5.7 1.4 6.0 2.1 2.5 9.0 15.2 4.7 2.7 9.0 7.3 1.5 17.3 3.8 1.9 5.3 3.4 3.4 2.1 2.2 1.8 3.8 10.7 3.3 2.5 2.0 15.6 0.0 4.6 0.0 2.0 2.1 1.5 1.4 1.0 1.4 0.2 0.1 0.8 0.0 2.6 2.9 4.2 3.8 1.5 0.9 5.5 2.2 1.4 2.6 2.5 7.4 1.1 5.6 1.9 3.0 2.2 4.1 4.9 4.0 4.1 4.8 3.2 6.5 4.0 4.0 1.0 3.7 4.6 1.9 1.3 6.5 1.2 1.4 2.1 2.0 3.8 1.6 2.2 2.0 1.7 2.8 5.5 0.8 3.3 2.8 3.8 1.1 1.4 4.1 2.4 3.6 1.9 1.5 1.0 4.6 1.4 1.2 5.4 4.5 4.4 3.6 6.1 1.3 0.8 1.8 4.2 3.8 3.1 0.0 0.2 0.0 0.5 0.0 0.4 0.7 0.0 0.8 0.2 1.4 0.6 0.1 1.4 0.1 0.0 1.0 0.0 0.0 19.6 20.7 16.6 19.3 20.1 5.7 9.0 15.2 17.3 15.6 0.0 0.0 0.0 0.2 0.6 0.1 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.1 GPR75-ASB3 ENSG00000270898 "GPR75-ASB3 readthrough" 2 53670293-53860160 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.4" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 6.4;Cardiomyocytes: 4.4;granulocytes: 4.6;Melanocytes: 3.3;Smooth muscle cells: 6.2;Suprabasal keratinocytes: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.8;K-562: 4.0;REH: 2.8;RH-30: 3.4" HPA003940 Uncertain NA NA "HPA003940: AB_1845067" "unprognostic (4.77e-4)" "unprognostic (1.49e-1)" "unprognostic (1.89e-2)" "unprognostic (1.10e-1)" "unprognostic (2.25e-1)" "unprognostic (3.68e-2)" "unprognostic (9.02e-3)" "unprognostic (1.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.34e-1)" "unprognostic (1.37e-2)" "unprognostic (1.53e-3)" "unprognostic (1.07e-2)" "unprognostic (9.17e-2)" "unprognostic (4.42e-2)" "unprognostic (3.47e-1)" "unprognostic (1.91e-1)" 1.3 1.1 12.7 1.1 13.4 1.1 1.3 10.7 12.5 1.7 1.4 12.2 0.0 1.1 1.5 1.1 1.1 1.7 1.1 1.8 13.0 2.2 1.1 1.4 1.2 1.5 5.5 9.7 3.0 1.1 1.1 4.3 1.4 11.1 1.1 1.1 3.0 1.3 1.5 1.1 1.1 1.1 1.1 6.6 3.0 1.4 1.3 10.0 0.0 1.3 0.0 1.1 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.3 0.0 0.0 2.5 0.9 0.0 0.0 0.0 1.8 0.0 0.3 0.6 0.0 0.5 1.8 0.0 0.0 0.6 0.7 2.8 2.7 0.0 1.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.3 0.0 1.4 0.0 0.2 0.8 0.0 2.7 2.8 3.4 1.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 1.9 1.0 0.1 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 13.4 10.7 12.5 13.0 2.2 5.5 9.7 11.1 10.0 0.0 1.0 0.0 0.0 6.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 7.3 0.0 0.0 0.0 0.0 GPR78 ENSG00000155269 "G protein-coupled receptor 78" Q96P69 4 8558725-8619761 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 53.3" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 4.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 202 "BEWO: 21.7" HPA013209 Uncertain NA NA "HPA013209: AB_10601657" "unprognostic (6.41e-2)" "unprognostic (1.77e-2)" "unprognostic (1.17e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-2)" "unprognostic (3.70e-2)" "unprognostic (3.82e-4)" "unprognostic (6.46e-3)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.29e-1)" "unprognostic (4.88e-15)" "unprognostic (5.55e-3)" "unprognostic (3.93e-2)" "unprognostic (9.90e-3)" "unprognostic (8.15e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 GPR82 ENSG00000171657 "G protein-coupled receptor 82" Q96P67 X 41724155-41730135 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 23.2;lymphoid tissue: 12.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 19.6;Kupffer cells: 18.0;Macrophages: 18.7;T-cells: 20.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "eosinophil: 23.2;NK-cell: 6.6" "Group enriched" "Detected in many" 9 "granulocytes: 23.2;NK-cells: 6.6" "Cell line enriched" "Detected in single" 16 "HMC-1: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035914 Approved NA NA "HPA035914: AB_10670671" "unprognostic (5.62e-3)" "unprognostic (1.81e-2)" "unprognostic (4.65e-2)" "unprognostic (3.88e-3)" "unprognostic (1.15e-2)" "unprognostic (3.28e-2)" "unprognostic (4.62e-4)" "unprognostic (1.41e-3)" "unprognostic (2.12e-2)" "unprognostic (5.00e-2)" "unprognostic (1.39e-1)" "unprognostic (3.01e-1)" "unprognostic (7.45e-2)" "unprognostic (2.37e-2)" "unprognostic (2.26e-1)" "unprognostic (8.00e-3)" "unprognostic (1.18e-1)" 1.2 2.2 1.6 3.9 5.9 0.2 1.1 0.6 1.5 0.9 2.7 0.3 0.0 3.0 0.8 1.1 1.1 1.1 1.1 0.7 2.5 1.1 4.7 5.0 10.0 9.0 2.5 0.1 0.7 1.5 0.1 1.1 0.3 3.2 1.1 2.1 0.8 0.8 0.7 0.4 0.7 5.2 0.6 7.3 3.6 1.6 0.4 2.3 1.6 0.8 0.6 12.0 2.4 0.9 0.1 0.2 23.2 1.6 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.3 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.2 23.2 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 6.6 1.4 0.0 0.0 0.1 1.6 5.9 0.6 1.5 2.5 1.1 2.5 0.1 3.2 2.3 0.0 11.1 5.2 4.1 4.1 14.7 0.3 0.0 1.4 9.1 1.8 19.6 0.7 0.0 1.8 0.2 2.2 3.9 0.0 1.0 0.2 5.1 2.7 0.0 0.8 1.3 12.7 1.2 4.3 18.0 0.0 3.7 18.7 3.3 1.8 1.3 0.9 1.7 4.2 2.8 0.0 16.7 0.0 3.8 1.0 1.1 2.4 0.6 20.2 3.2 3.1 GPR83 GPR72 ENSG00000123901 "G protein-coupled receptor 83" Q9NYM4 11 94377311-94401419 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 20.0;thyroid gland: 9.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.7" "Region enhanced" "Detected in many" "basal ganglia: 61.1" "Low region specificity" "Detected in all" NA NA "unprognostic (6.74e-2)" "unprognostic (7.78e-3)" "unprognostic (8.58e-2)" "unprognostic (2.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.88e-1)" "unprognostic (6.36e-3)" "unprognostic (6.89e-2)" "unprognostic (6.03e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (6.17e-2)" "unprognostic (1.47e-12)" "unprognostic (3.16e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-2)" "unprognostic (8.28e-3)" 0.6 2.6 3.3 0.8 6.1 2.0 0.6 20.0 11.7 0.8 0.7 0.9 0.0 0.7 0.8 1.2 0.5 0.8 0.8 1.2 19.8 6.7 1.2 1.2 0.7 1.1 1.0 3.7 0.7 0.7 0.5 0.6 0.5 1.7 0.5 0.6 0.3 0.6 0.6 1.3 1.4 0.8 0.6 1.8 1.1 0.8 1.1 1.0 0.0 9.3 0.0 0.7 0.5 0.3 0.7 0.5 2.6 0.6 1.6 0.6 0.2 0.3 0.5 0.9 1.2 0.0 0.2 0.9 0.7 0.1 0.1 0.2 5.7 1.1 1.1 0.5 0.1 0.4 1.3 0.4 0.2 0.1 0.8 0.5 1.2 1.2 0.7 0.0 1.6 3.0 0.2 0.5 0.4 0.2 0.6 0.0 1.0 1.2 1.3 0.1 0.8 0.4 2.5 1.1 0.6 0.7 1.1 0.2 0.8 0.1 0.9 0.7 0.7 0.5 0.8 0.2 1.3 0.9 0.1 0.4 0.8 1.3 0.8 0.9 1.2 1.5 0.5 0.5 1.0 1.2 2.6 0.6 0.5 0.5 0.3 0.4 0.4 0.5 0.6 0.2 0.7 0.4 0.4 1.4 1.6 0.6 0.5 0.3 0.2 3.3 6.1 20.0 11.7 19.8 6.7 1.0 3.7 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 GPR84 EX33 ENSG00000139572 "G protein-coupled receptor 84" Q9NQS5 12 54362445-54364487 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 20.5;Macrophages: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "basophil: 6.0;classical monocyte: 8.7;myeloid DC: 12.9;neutrophil: 5.3" "Group enriched" "Detected in many" 53 "dendritic cells: 12.9;granulocytes: 6.0;monocytes: 8.7" "Group enriched" "Detected in some" 5 "HL-60: 9.4;NB-4: 29.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027603 Enhanced NA NA "HPA027603: AB_10612115" "unprognostic (5.40e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (3.92e-2)" "unprognostic (2.36e-2)" "unprognostic (4.54e-2)" "unprognostic (6.16e-3)" "unprognostic (7.43e-2)" "unprognostic (9.29e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (2.92e-1)" "unprognostic (1.36e-9)" "unprognostic (1.27e-1)" "unprognostic (4.42e-2)" "unprognostic (1.40e-1)" "unprognostic (9.44e-2)" 7.2 2.3 2.7 11.2 6.8 27.2 0.7 0.4 3.3 1.0 0.9 5.0 0.0 0.8 0.6 0.9 1.1 1.7 1.8 3.2 1.6 2.1 2.4 0.8 5.3 2.7 4.4 0.0 2.7 1.0 0.7 2.3 6.7 5.0 1.2 1.3 0.7 1.2 0.7 1.1 1.4 0.8 2.8 6.7 8.0 1.2 2.1 7.5 0.9 2.1 0.0 2.8 3.0 2.1 0.0 12.9 6.0 8.7 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.4 1.6 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 3.7 0.0 6.0 8.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 12.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.8 2.7 6.8 0.4 3.3 1.6 2.1 4.4 0.0 5.0 7.5 0.0 0.3 0.0 0.1 0.8 2.9 0.1 0.0 0.0 1.2 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 20.5 0.0 0.0 0.0 2.7 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.4 0.7 0.0 0.0 0.0 GPR85 SREB2 ENSG00000164604 "G protein-coupled receptor 85" P60893 7 113078331-113087778 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 15.0;skeletal muscle: 30.4" "Group enriched" "Detected in many" 5 "Bipolar cells: 34.4;Early spermatids: 106.1;Horizontal cells: 79.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "HEL: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.80e-2)" "unprognostic (1.93e-2)" "unprognostic (6.98e-3)" "unprognostic (3.92e-2)" "unprognostic (2.68e-2)" "unprognostic (2.41e-2)" "unprognostic (9.90e-2)" "unprognostic (1.94e-1)" "unprognostic (6.09e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (1.68e-1)" "unprognostic (1.34e-5)" "unprognostic (5.89e-3)" "unprognostic (9.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-2)" 2.1 1.1 8.9 1.2 15.0 1.9 0.9 12.2 11.2 0.7 0.9 2.4 0.0 0.9 1.2 1.1 1.1 1.9 4.4 2.4 11.8 9.2 0.7 4.5 2.5 1.6 10.8 7.7 0.5 1.6 2.0 4.0 5.3 6.2 1.2 0.8 0.9 2.8 0.8 30.4 0.9 1.0 1.2 8.1 3.1 1.0 3.4 4.3 0.0 0.9 0.0 1.0 1.4 0.3 1.3 1.0 3.0 2.1 1.5 1.1 0.5 0.1 0.1 0.3 0.3 1.0 1.5 0.3 1.3 2.0 2.8 3.8 0.1 0.5 0.1 0.3 1.1 0.9 0.2 0.2 1.2 5.9 0.2 0.1 49.4 0.5 0.1 0.5 9.2 0.5 2.0 0.2 4.7 0.1 0.1 0.1 0.4 0.2 0.5 3.1 0.2 1.0 5.9 0.6 0.0 0.3 0.2 0.7 0.2 0.0 0.8 1.4 1.1 0.1 0.6 0.4 0.3 0.3 2.1 0.3 3.4 0.5 0.9 1.2 1.1 0.1 0.6 4.0 3.6 1.3 3.0 1.2 1.0 1.0 1.4 1.0 0.9 0.8 0.6 0.6 1.3 1.1 1.0 2.1 1.5 2.1 1.0 0.9 0.5 8.9 15.0 12.2 10.8 11.8 9.2 10.8 7.7 6.2 4.3 0.0 1.0 0.0 11.9 7.8 34.4 2.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 106.1 2.9 0.0 0.0 0.2 0.7 1.9 13.8 1.1 0.0 10.0 79.4 0.0 0.6 5.1 8.6 1.1 3.2 10.1 0.0 0.0 1.7 0.1 0.0 0.4 0.4 4.5 0.0 4.2 0.7 0.4 9.3 0.3 0.0 0.0 9.0 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.1 25.2 0.0 33.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 44.8 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.1 13.2 0.0 0.0 5.6 0.1 0.0 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 127.1 52.7 0.0 0.0 0.0 4.0 20.5 3.5 0.0 46.3 0.0 1.3 0.1 0.2 0.0 0.0 0.6 10.3 2.1 36.4 1.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 59.6 171.4 0.0 0.0 178.7 GPR88 ENSG00000181656 "G protein-coupled receptor 88" Q9GZN0 1 100538137-100542018 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 62.7" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 9 "liver cancer: 12.0" "Group enriched" "Detected in many" 7 "basal ganglia: 62.7;thalamus: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HSkMC: 4.9;SCLC-21H: 6.1" "Region enriched" "Detected in many" 11 "basal ganglia: 643.5" "Region enriched" "Detected in some" 34 "basal ganglia: 223.4" HPA007488 Approved NA NA "HPA007488: AB_2667844" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (8.30e-2)" "unprognostic (8.37e-3)" "unprognostic (5.41e-1)" "unprognostic (5.63e-2)" "unprognostic (1.82e-1)" "unprognostic (1.28e-1)" "unprognostic (1.03e-2)" "unprognostic (7.76e-2)" "unprognostic (8.23e-3)" "unprognostic (2.45e-1)" "unprognostic (3.93e-4)" "unprognostic (1.85e-2)" "unprognostic (5.56e-2)" "unprognostic (4.41e-1)" "unprognostic (1.35e-2)" 0.7 0.6 1.2 0.5 62.7 0.2 10.9 0.0 6.8 0.1 0.3 0.8 0.0 0.6 0.2 0.2 0.2 0.1 0.2 0.4 0.9 0.8 0.3 13.1 0.2 0.3 0.7 1.1 3.8 0.1 4.6 0.5 0.2 7.0 0.6 0.5 0.3 0.7 0.1 0.3 0.1 0.5 0.3 0.5 13.7 0.4 0.2 32.8 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 62.7 0.0 6.8 0.9 0.8 0.7 1.1 7.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRASP1 "GASP, GASP1" ENSG00000198932 "G protein-coupled receptor associated sorting protein 1" Q5JY77 X 102651366-102659083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.0" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 41.0;Cardiomyocytes: 21.2;Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.2" "Group enriched" "Detected in many" 5 "B-cells: 1.4;T-cells: 5.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 6.8;REH: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000161, HPA031061" Approved Supported Cytosol NA NA Cytosol "HPA000161: AB_2247872, HPA031061: AB_2673718" "unprognostic (3.92e-3)" "unprognostic (1.10e-1)" "unprognostic (2.07e-4)" "unprognostic (1.42e-1)" "unprognostic (3.32e-2)" "unprognostic (1.71e-3)" "unprognostic (3.57e-1)" "unprognostic (2.33e-2)" "unprognostic (1.58e-1)" "unprognostic (2.82e-1)" "prognostic favorable (1.77e-5)" "unprognostic (3.34e-1)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.23e-2)" 3.5 16.6 19.0 3.7 34.3 2.5 4.0 28.2 37.0 8.9 7.2 4.3 1.6 1.9 18.2 8.1 3.3 8.7 5.5 10.6 19.9 18.3 5.2 1.4 3.8 6.2 7.9 30.3 29.9 3.0 22.4 16.1 2.2 20.6 12.0 3.5 4.0 5.1 13.4 4.0 2.2 4.1 11.7 6.6 6.8 3.5 2.9 5.6 0.9 11.9 0.8 5.4 6.3 6.3 1.4 0.6 0.0 0.0 0.3 5.2 1.0 0.4 0.8 2.6 1.6 2.6 2.7 1.5 2.7 0.2 4.1 6.8 0.3 0.5 0.0 0.6 5.6 0.4 0.7 0.8 0.1 5.9 0.0 0.3 0.2 0.7 0.7 2.1 0.3 0.4 3.5 1.1 5.0 0.4 0.7 0.4 2.6 0.5 0.2 6.4 0.6 5.3 0.2 1.8 0.4 0.9 8.1 2.6 0.0 0.4 0.6 2.6 4.1 0.9 0.4 0.7 2.2 0.4 1.3 0.8 1.3 1.6 0.8 0.4 0.4 0.7 0.0 0.6 0.4 1.7 0.0 0.0 0.0 1.3 0.0 2.9 0.6 2.4 1.0 0.0 1.4 5.2 4.8 0.0 0.3 0.0 0.6 1.8 1.0 19.0 34.3 28.2 37.0 19.9 18.3 7.9 30.3 20.6 5.6 0.0 2.2 0.8 4.4 3.2 41.0 21.2 0.0 0.0 5.7 5.2 35.3 0.3 0.0 0.2 0.3 4.5 0.1 0.0 0.2 0.1 3.8 5.1 2.3 0.6 0.3 6.4 5.8 7.4 0.0 0.5 14.1 1.2 1.7 0.0 0.0 14.1 0.4 0.0 14.5 1.1 18.4 6.5 8.1 1.2 0.8 0.6 0.1 4.1 0.6 1.4 GPRASP2 "FLJ37327, GASP2" ENSG00000158301 "G protein-coupled receptor associated sorting protein 2" Q96D09 X 102712176-102717733 "Predicted intracellular proteins" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;NK-cells: 2.1;T-cells: 4.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017438 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA017438: AB_1849504" "unprognostic (8.74e-3)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (5.14e-3)" "unprognostic (4.60e-2)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (1.89e-2)" "unprognostic (2.99e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.71e-4)" "unprognostic (1.42e-1)" "prognostic favorable (4.60e-6)" "unprognostic (1.19e-2)" "unprognostic (9.03e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (6.63e-5)" 3.7 12.2 13.8 1.5 22.6 0.2 6.1 16.9 30.0 7.7 3.7 3.4 1.7 1.3 13.8 7.4 3.3 8.8 4.0 10.9 15.8 22.3 8.1 5.2 3.9 1.2 8.7 22.5 24.8 7.1 13.3 11.5 2.8 18.7 10.2 2.5 3.6 6.6 9.8 5.2 4.4 1.8 8.3 7.2 3.0 2.2 3.6 4.1 0.8 12.0 1.3 1.3 3.6 3.8 0.4 1.6 0.0 0.6 2.1 4.7 1.2 0.5 5.1 13.7 10.5 4.3 5.2 1.0 7.8 7.0 6.7 13.1 1.7 2.4 0.0 2.7 8.0 3.4 1.8 16.3 4.2 8.5 0.0 6.3 0.7 1.5 0.4 3.1 1.2 1.0 5.4 4.5 7.5 0.3 7.9 4.7 1.3 1.9 0.5 8.1 2.4 3.6 0.5 6.8 1.6 7.1 4.7 2.2 0.0 4.2 1.9 3.0 9.4 7.8 1.6 1.0 4.4 4.4 2.7 4.2 4.8 10.0 9.6 7.4 0.2 0.3 0.0 6.4 0.8 2.6 0.0 0.4 0.0 0.9 0.6 0.8 0.4 1.1 1.3 0.8 0.4 4.7 1.9 0.0 2.1 0.2 1.6 1.6 1.2 13.8 22.6 16.9 30.0 15.8 22.3 8.7 22.5 18.7 4.1 0.0 1.0 0.0 5.3 2.1 16.1 14.9 10.2 0.0 4.5 5.2 2.0 5.0 8.3 1.3 0.4 4.3 0.2 0.0 0.8 0.6 4.9 3.2 0.0 7.3 0.8 15.9 2.9 8.0 1.6 0.8 11.2 0.3 0.0 0.0 1.3 10.0 1.5 1.9 11.7 7.7 6.4 6.5 4.1 4.4 4.3 2.6 1.8 0.0 1.1 0.5 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" NA Yes "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: AB_2679685" "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavorable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 42.7 34.2 0.0 0.1 0.4 0.2 2.2 12.9 4.9 8.4 6.4 6.0 164.8 0.0 1.1 10.3 8.9 43.2 0.1 6.2 12.9 0.0 0.5 0.0 14.1 0.2 3.1 0.0 0.0 0.2 8.4 3.5 0.8 10.4 5.1 0.0 0.0 0.0 0.3 30.0 0.0 0.0 0.1 15.6 5.4 0.0 0.9 0.0 16.6 8.5 0.0 0.0 60.6 4.6 1.9 6.9 1.3 0.1 0.5 0.3 10.9 19.6 0.5 0.0 0.0 0.0 4.4 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 872.5 165.8 0.0 282.3 11.1 0.0 1.0 5.1 69.6 257.0 43.6 0.0 0.7 0.0 49.3 0.0 7.5 159.2 0.0 63.3 8.9 57.8 325.5 9.3 0.0 1.5 0.0 7.9 4.9 0.0 0.0 12.4 10.7 49.0 1.0 28.8 1.3 368.5 52.7 9.6 0.0 0.2 0.0 24.7 0.0 0.2 8.0 0.9 1.3 79.7 1048.5 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 172.9;Late spermatids: 145.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Cell line enhanced" "Detected in many" "EFO-21: 39.2;HHSteC: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.6 12.5 2.2 12.9 0.9 2.3 0.1 3.1 1.2 0.8 11.5 0.4 0.0 39.2 0.4 8.2 0.6 9.2 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.8 0.0 0.0 1.1 0.0 2.1 0.0 3.3 6.1 0.3 2.6 0.2 2.8 0.6 0.0 0.0 13.7 0.0 6.0 3.6 0.0 0.0 0.4 5.8 9.7 0.8 1.4 0.8 11.3 4.1 0.0 0.2 1.2 0.0 1.5 6.1 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 0.0 4.0 0.9 4.6 1.1 30.1 13.4 35.7 5.3 7.9 29.6 0.0 3.9 1.7 47.7 172.9 30.1 0.0 0.0 56.2 1.2 9.7 4.3 0.0 0.0 3.3 0.0 0.0 6.2 1.0 145.0 22.2 1.1 15.1 1.8 0.0 20.5 53.7 0.0 25.1 0.1 5.7 12.9 9.2 2.8 1.5 1.5 2.1 0.0 0.0 1.7 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 76.2" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 31.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 9 "dendritic cells: 10.2;monocytes: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0" "Region enriched" "Detected in many" 9 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 4.3 4.1 5.2 2.2 5.3 0.0 7.7 31.1 5.7 19.7 15.4 4.4 17.0 10.0 5.8 9.9 5.3 12.5 17.6 7.7 5.3 2.6 43.8 46.1 11.5 2.8 4.8 4.9 12.3 76.2 12.0 3.4 4.5 6.1 15.1 6.2 18.0 16.8 11.7 25.4 9.2 15.2 3.9 4.6 5.1 44.7 4.4 4.1 1.9 42.2 10.2 3.5 12.6 8.0 0.7 10.2 0.1 4.7 0.0 0.1 0.3 4.6 16.7 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 21.4 0.0 13.3 0.1 5.4 14.7 2.2 0.3 0.0 0.0 2.7 0.0 1.2 24.0 4.9 0.0 42.2 0.4 7.6 0.0 0.0 22.7 0.0 0.0 1.2 0.3 0.0 5.2 0.1 4.5 2.7 23.1 19.4 0.0 0.0 1.1 56.9 26.3 8.1 0.7 0.8 1.8 0.0 10.9 32.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 2.1 0.6 0.1 0.0 1.7 0.1 0.0 3.4 0.0 0.7 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 4.7 10.2 0.0 0.3 5.2 5.3 31.1 5.7 5.3 2.6 4.8 4.9 6.1 4.1 3.0 48.9 1.5 39.6 12.0 0.8 193.6 68.8 22.7 18.2 129.1 0.0 0.7 24.9 53.1 0.1 8.7 61.7 0.0 58.9 7.1 19.9 46.9 10.3 148.3 9.6 4.8 43.7 25.8 8.5 0.5 16.7 4.2 3.3 5.4 47.3 18.8 37.9 149.7 20.8 51.6 0.8 142.3 56.7 0.4 3.0 9.8 21.2 1.5 44.1 40.9 GPRC5D ENSG00000111291 "G protein-coupled receptor class C group 5 member D" Q9NZD1 12 12940775-12952147 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.4;skin 1: 33.9" "Group enriched" "Detected in some" 12 "B-cells: 3.9;Early spermatids: 5.3;Late spermatids: 4.5;Melanocytes: 5.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.1" "Cell type enriched" "Detected in some" 4 "memory B-cell: 18.4" "Lineage enriched" "Detected in many" 17 "B-cells: 18.4" "Group enriched" "Detected in some" 10 "Karpas-707: 37.5;RPMI-8226: 36.3;U-266/84: 10.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071909 Approved NA NA "HPA071909: AB_2686470" "unprognostic (4.27e-2)" "unprognostic (8.58e-2)" "unprognostic (4.68e-2)" "unprognostic (2.02e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.09e-4)" "unprognostic (3.00e-5)" "unprognostic (4.06e-2)" "unprognostic (3.06e-2)" "unprognostic (5.53e-2)" "unprognostic (7.01e-2)" "unprognostic (2.27e-2)" "unprognostic (8.33e-3)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-2)" "unprognostic (6.63e-2)" 1.0 0.5 0.4 3.1 0.4 0.3 4.2 0.4 0.4 0.8 3.8 0.4 0.4 2.4 1.0 0.4 3.7 0.3 1.5 0.7 0.4 0.2 0.8 0.7 4.4 5.9 0.4 0.4 0.4 2.9 0.0 1.0 0.9 2.1 0.9 3.4 0.7 8.6 0.4 0.4 33.9 3.8 0.4 0.4 5.1 3.3 3.7 0.4 0.4 1.3 5.2 4.1 1.3 0.7 18.4 0.1 1.0 0.0 0.0 0.2 1.9 0.5 0.6 0.0 0.6 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.5 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 37.5 0.1 1.3 0.0 0.0 0.3 1.6 0.0 0.0 0.0 36.3 0.0 1.5 1.2 0.2 0.8 0.6 0.0 1.6 0.0 0.0 1.0 0.0 1.7 0.0 0.0 1.9 10.3 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 18.4 0.1 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 2.1 0.4 0.0 0.0 3.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRC6A bA86F4.3 ENSG00000173612 "G protein-coupled receptor class C group 6 member A" Q5T6X5 6 116792085-116829037 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6" "Cell type enhanced" "Detected in single" 35 "Intestinal endocrine cells: 1.7" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "U-266/70: 6.0;U-266/84: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.16e-2)" "unprognostic (2.48e-1)" "unprognostic (4.38e-3)" 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.2;Horizontal cells: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 27.7;SCLC-21H: 30.7" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA036478: AB_2675145, HPA070892: AB_2686321" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavorable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 1.3 3.2 16.9 1.8 6.4 0.9 0.9 16.9 28.2 1.1 1.6 0.2 0.0 6.4 1.3 0.6 1.1 0.7 1.1 0.7 11.1 11.1 0.7 0.7 1.1 1.7 3.6 11.4 0.5 1.5 0.7 5.8 1.0 4.4 0.7 1.3 0.7 0.7 0.6 0.7 1.5 4.0 1.7 1.9 0.9 1.9 2.2 0.7 0.0 0.8 0.0 2.3 0.9 0.1 0.9 0.0 0.0 0.0 0.5 0.3 0.0 3.6 3.9 5.0 7.2 1.1 2.4 4.2 4.9 2.5 3.8 5.0 4.7 2.4 8.4 10.1 2.6 11.3 3.2 3.2 3.4 3.4 27.7 2.1 0.1 2.1 1.6 0.4 0.2 2.1 1.2 2.6 4.1 0.6 0.8 2.8 1.9 4.4 12.2 3.2 9.6 0.8 0.0 5.0 2.5 7.8 15.6 5.6 4.9 4.3 3.8 30.7 17.6 5.7 1.6 8.7 0.6 3.8 3.2 3.4 7.2 8.3 2.7 7.2 0.2 1.1 2.4 6.2 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.9 6.4 16.9 14.3 11.1 11.1 3.6 11.4 4.4 0.7 0.0 0.0 0.0 0.0 2.2 13.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.7 0.0 0.0 1.5 0.7 0.4 0.2 0.0 0.0 0.7 20.6 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 3.1 0.0 0.0 0.5 2.3 1.3 0.1 0.0 0.2 0.0 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 8.9;lung: 10.5;skin 1: 13.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 17.9;Exocrine glandular cells: 18.0;Mucus-secreting cells: 22.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.8;A549: 28.4;SiHa: 5.3;SK-BR-3: 15.7" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.0 0.0 0.0 0.6 0.2 0.0 1.1 6.5 0.0 0.2 5.7 6.6 0.0 0.0 2.8 0.1 0.0 0.0 0.0 5.2 1.7 0.0 10.5 0.0 1.2 0.0 4.1 0.0 3.0 0.0 1.6 4.0 4.2 1.5 0.0 13.8 8.9 0.0 0.2 0.0 5.1 1.3 2.3 0.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.3 0.0 1.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.2 0.0 0.0 0.0 0.0 1.5 0.4 0.7 0.1 5.3 15.7 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 3.0 0.0 2.4 1.4 0.4 0.1 5.1 2.7 1.2 3.5 0.0 0.0 0.0 11.6 7.9 0.0 12.8 0.0 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.3 0.0 0.0 12.9 0.3 0.0 0.0 0.0 22.0 0.0 9.1 10.5 0.4 2.4 0.0 0.0 0.0 0.5 0.4 5.4 0.0 0.0 6.3 1.1 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236386-89308010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.0" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 75.7;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 41.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 53.1" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 7.0 1.8 4.0 11.5 9.1 8.9 3.2 41.0 5.0 3.5 7.2 2.8 0.0 8.4 2.3 1.7 1.8 2.1 5.6 5.4 3.6 4.1 5.5 2.8 11.2 12.7 4.1 3.1 4.8 7.0 1.1 12.4 1.4 6.5 2.1 9.8 6.4 2.9 1.0 2.1 1.6 7.0 2.0 6.0 12.9 4.7 1.1 6.2 5.3 2.9 1.4 10.5 4.5 2.4 0.3 1.5 0.1 2.2 2.9 6.6 1.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 12.1 0.1 0.0 12.6 0.2 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.3 5.7 0.0 0.2 0.0 0.0 0.1 0.5 0.0 4.8 1.7 6.6 0.3 4.7 3.7 1.5 0.1 1.9 1.9 0.1 2.9 2.2 0.0 5.3 1.4 4.0 9.1 41.0 5.0 3.6 4.1 4.1 3.1 6.5 6.2 0.0 19.9 3.7 0.7 1.0 9.4 14.6 5.1 1.4 9.1 3.5 0.0 0.1 1.7 1.1 0.1 3.6 9.6 0.0 8.2 0.0 2.3 0.2 7.0 0.0 18.9 25.4 75.7 2.5 26.9 0.0 0.3 31.5 1.7 5.4 25.1 0.8 1.7 5.8 1.1 1.8 10.3 77.6 8.2 0.1 0.1 0.9 0.2 34.6 21.8 0.3 GPSM2 "DFNB82, LGN, Pins" ENSG00000121957 "G protein signaling modulator 2" P81274 1 108875350-108934545 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Transport" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 35.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 125.7;Syncytiotrophoblasts: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007327, HPA008408, CAB018962" Uncertain Supported Cytosol NA Yes Cytosol "CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939" "unprognostic (1.97e-1)" "unprognostic (6.80e-2)" "prognostic favorable (7.86e-5)" "unprognostic (1.37e-3)" "unprognostic (3.18e-2)" "unprognostic (1.97e-2)" "unprognostic (8.57e-6)" "unprognostic (7.12e-2)" "unprognostic (2.76e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.55e-3)" "prognostic unfavorable (3.02e-4)" "unprognostic (6.27e-3)" "unprognostic (1.00e-1)" "unprognostic (5.14e-3)" "unprognostic (6.00e-2)" 3.8 4.0 16.6 4.4 17.9 13.9 8.5 10.1 20.6 7.5 13.6 17.9 2.5 8.0 6.9 4.3 30.4 2.9 3.1 3.0 15.2 14.1 2.6 1.9 6.6 5.8 19.7 9.0 2.4 2.4 4.0 2.1 7.6 19.6 6.3 15.4 1.3 7.0 5.7 8.0 35.6 10.1 10.6 25.1 2.0 5.3 11.4 18.8 14.1 2.3 23.5 12.1 6.5 10.6 1.8 1.6 8.6 1.2 0.7 4.4 0.4 41.3 5.9 13.6 10.7 13.7 8.2 10.2 8.3 21.1 10.3 15.9 6.4 10.6 9.5 2.3 11.6 7.9 9.1 8.8 21.8 13.3 9.8 5.9 7.0 11.6 7.0 1.8 9.3 6.4 1.5 44.6 11.2 44.5 3.8 11.0 7.4 5.3 14.3 22.1 12.8 7.5 4.7 3.5 18.0 10.1 6.6 22.0 2.5 8.9 6.5 10.4 9.0 11.4 23.2 8.8 3.7 9.1 9.0 6.8 7.9 12.4 21.1 15.7 6.4 5.9 9.4 12.7 15.5 36.7 0.1 1.2 8.6 0.8 0.9 0.5 0.7 0.6 1.1 1.6 1.8 1.1 0.8 1.6 0.7 0.4 0.7 4.4 0.4 16.6 17.9 10.1 13.6 15.2 14.1 19.7 9.0 19.6 18.8 14.9 3.5 5.2 16.6 55.6 46.3 2.1 0.0 6.7 14.8 7.0 125.7 42.8 10.0 2.2 39.6 3.8 8.0 0.0 1.6 37.2 12.8 3.8 2.3 0.5 7.7 41.3 8.7 1.8 5.2 16.4 17.3 4.6 25.3 6.4 12.1 7.1 3.2 7.0 4.9 0.3 43.8 0.0 5.3 15.2 25.1 35.5 74.6 7.7 11.8 13.3 GPSM3 "AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1" ENSG00000213654 "G protein signaling modulator 3" Q9Y4H4 6 32190766-32195523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.9;lymphoid tissue: 66.2" "Group enriched" "Detected in many" 5 "B-cells: 274.2;Hofbauer cells: 247.8;Kupffer cells: 319.4;Macrophages: 253.8;monocytes: 287.7;T-cells: 292.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "granulocytes: 29.9" "Cell line enhanced" "Detected in many" "HMC-1: 26.4;NB-4: 14.6;THP-1: 15.3;U-937: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA 160000 "unprognostic (2.93e-2)" "unprognostic (2.51e-2)" "unprognostic (2.02e-2)" "prognostic favorable (5.98e-4)" "unprognostic (3.55e-1)" "unprognostic (3.07e-2)" "unprognostic (3.66e-1)" "unprognostic (6.61e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (6.92e-9)" "unprognostic (2.01e-2)" "unprognostic (1.69e-2)" "unprognostic (5.47e-2)" "unprognostic (5.87e-2)" 7.1 3.3 3.4 28.8 5.3 20.6 4.4 1.3 3.6 2.3 3.9 5.2 0.4 3.4 2.2 4.2 4.1 4.2 5.5 4.7 3.6 3.0 5.2 5.1 17.3 32.2 5.3 1.0 2.1 1.9 0.8 2.5 6.1 4.7 4.0 4.0 4.7 7.2 1.8 1.2 2.5 18.4 2.2 9.1 66.2 4.8 2.0 4.6 53.0 3.4 1.5 33.3 8.1 3.4 5.7 6.3 29.9 6.6 3.4 7.4 4.6 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.4 1.6 0.7 0.9 0.1 0.6 4.4 2.1 0.7 0.0 0.1 0.0 1.1 0.7 5.5 0.1 6.2 0.0 0.2 1.8 0.0 26.4 0.5 0.0 0.2 0.9 0.3 3.0 4.8 2.9 7.4 0.1 0.0 3.1 14.6 0.0 0.0 0.0 2.5 0.3 6.7 0.3 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.2 15.3 2.9 0.4 1.2 0.0 0.3 0.3 0.3 4.8 0.1 9.0 1.6 4.6 6.5 19.2 5.2 6.6 4.8 5.7 6.9 6.0 6.3 5.3 7.4 5.6 29.9 3.4 6.4 4.4 4.7 4.6 3.4 5.3 1.3 3.6 3.6 3.0 5.3 1.0 4.7 4.6 0.0 2.1 274.2 11.5 10.0 0.0 0.3 2.5 0.0 2.3 3.5 0.0 2.9 0.0 8.2 3.9 21.7 0.5 0.0 4.6 4.3 7.7 4.9 58.6 2.8 247.8 0.0 1.2 23.4 319.4 9.5 1.1 253.8 42.2 287.7 5.7 0.4 12.5 14.4 0.0 2.0 0.3 6.5 8.5 0.6 2.5 7.4 5.3 292.4 4.0 20.7 GPT "ALT1, GPT1" ENSG00000167701 "Glutamic--pyruvic transaminase" P24298 8 144502973-144507174 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 56.8;skeletal muscle: 27.0" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 117.6;Erythroid cells: 70.0;Hepatocytes: 219.3;Proximal tubular cells: 85.9" "Cancer enriched" "Detected in many" 7 "liver cancer: 38.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.3;non-classical monocyte: 2.9" "Lineage enriched" "Detected in single" 6 "monocytes: 2.9" "Cell line enhanced" "Detected in many" "HaCaT: 4.4;Hep G2: 4.8;Karpas-707: 5.8;U-266/70: 6.1" "Low region specificity" "Detected in all" "HPA031059, HPA031060, CAB032997, CAB032999" Enhanced NA NA 15000000 "CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178" "unprognostic (8.22e-3)" "unprognostic (2.52e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (3.38e-1)" "unprognostic (1.37e-2)" "prognostic favorable (1.47e-5)" "unprognostic (9.42e-2)" "unprognostic (2.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.41e-1)" "unprognostic (9.22e-2)" "prognostic favorable (2.19e-4)" "unprognostic (2.83e-2)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (1.98e-2)" 9.0 0.8 1.7 8.7 2.2 1.1 3.9 1.5 2.3 0.2 17.4 2.0 4.6 10.9 0.2 1.7 0.9 0.5 19.8 16.9 1.7 0.9 8.7 56.8 0.2 0.2 1.3 2.2 0.4 3.6 0.5 1.1 0.1 2.0 0.7 3.5 1.6 17.0 2.7 27.0 6.1 19.2 0.2 0.7 0.4 8.6 0.8 1.6 0.0 0.6 13.9 3.3 0.3 0.5 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.5 1.5 0.4 1.2 0.9 0.0 1.3 0.8 0.0 0.0 0.0 0.5 1.9 0.8 0.7 0.0 0.1 4.4 0.0 0.0 0.0 1.5 2.8 0.7 2.6 4.8 0.0 0.1 0.8 0.0 0.4 0.0 0.0 0.7 0.0 1.0 0.5 5.8 0.0 2.6 0.9 0.9 0.7 1.1 1.0 0.9 0.3 3.1 0.0 1.9 1.2 1.8 0.5 1.5 0.2 0.3 3.9 0.3 0.4 0.4 1.3 1.3 0.2 6.1 0.4 0.4 0.8 1.9 0.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.7 2.2 1.5 2.3 1.7 0.9 1.3 2.2 2.0 1.6 0.0 0.0 14.9 1.1 1.4 1.0 6.5 20.4 0.0 0.0 7.0 0.0 0.0 18.3 1.0 17.0 0.0 117.6 70.0 2.1 2.2 0.2 1.1 9.2 219.3 0.1 3.2 2.4 11.6 8.2 39.1 0.6 0.0 1.7 0.0 32.3 13.8 1.4 42.1 0.4 85.9 2.0 0.0 0.1 0.7 0.4 4.0 0.0 3.8 23.4 1.1 GPT2 ALT2 ENSG00000166123 "Glutamic--pyruvic transaminase 2" Q8TD30 16 46884378-46931297 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 103.0;skeletal muscle: 60.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 105.1;Muller glia cells: 57.6;Syncytiotrophoblasts: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051514 Approved Approved Mitochondria No No Mitochondria "HPA051514: AB_2681516" "unprognostic (1.65e-2)" "unprognostic (3.32e-2)" "unprognostic (2.87e-1)" "unprognostic (3.87e-2)" "unprognostic (3.41e-1)" "unprognostic (1.27e-1)" "unprognostic (1.95e-3)" "unprognostic (3.44e-2)" "unprognostic (6.12e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.90e-1)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.44e-2)" "unprognostic (4.86e-1)" "unprognostic (3.54e-3)" "unprognostic (3.18e-1)" 19.9 4.1 20.2 2.1 17.8 1.9 6.4 3.9 15.1 2.5 3.4 11.8 10.0 1.3 2.1 13.4 30.8 3.7 4.4 3.0 13.4 8.0 9.8 40.4 1.4 2.1 12.9 7.8 1.5 103.0 4.3 4.3 1.8 11.3 10.2 2.6 1.5 27.6 8.5 60.9 14.9 1.7 1.9 11.3 1.4 15.4 6.0 12.3 0.7 3.6 19.0 14.6 1.9 2.1 4.2 1.4 1.3 0.7 0.0 0.4 0.4 13.0 6.0 7.6 29.0 10.8 2.3 13.9 9.1 3.4 9.9 6.2 20.4 5.5 9.2 8.0 6.5 5.0 10.5 13.7 13.5 6.6 4.3 6.7 3.2 3.4 49.2 7.4 23.1 3.0 5.0 11.9 9.6 15.0 6.6 4.8 17.7 2.6 7.4 3.2 23.4 4.5 19.3 8.1 16.2 17.2 0.1 8.4 21.4 4.0 6.5 23.8 12.2 4.7 24.4 12.4 3.2 6.2 21.1 3.5 6.9 13.5 4.5 7.3 35.6 10.8 26.1 10.6 15.0 3.7 1.3 0.7 0.0 0.3 0.0 0.0 4.2 0.0 0.3 1.4 2.5 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.4 20.2 17.8 3.9 15.1 13.4 8.0 12.9 7.8 11.3 12.3 6.0 4.3 3.0 4.2 14.2 13.4 14.7 12.7 0.0 6.8 17.4 21.6 7.1 10.0 7.8 9.4 1.6 5.5 0.0 26.2 22.2 7.7 12.4 3.5 105.1 3.3 6.4 12.6 4.3 3.5 17.1 4.4 2.4 8.5 1.0 7.4 57.6 23.6 4.9 14.5 29.4 5.9 0.0 1.4 2.2 19.2 14.3 69.7 1.5 3.2 3.8 GPX2 GSHPX-GI ENSG00000176153 "Glutathione peroxidase 2" P18283 14 64939152-64942905 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 126.9;liver: 195.2" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 484.1;Hepatocytes: 821.3;Mucus-secreting cells: 410.2;Undifferentiated cells: 621.9;Urothelial cells: 833.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "OE19: 309.4" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Not detected" "Not detected" HPA003545 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003545: AB_10962695" "unprognostic (3.54e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.90e-3)" "unprognostic (4.75e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.96e-2)" "unprognostic (2.93e-2)" "unprognostic (7.87e-2)" "unprognostic (1.54e-2)" "unprognostic (8.45e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (4.39e-2)" "unprognostic (3.39e-2)" "unprognostic (6.66e-4)" "unprognostic (1.73e-2)" 0.1 0.0 0.1 23.8 0.2 0.0 0.8 0.2 0.1 5.5 50.4 0.5 2.0 14.4 0.3 1.0 53.0 0.6 126.9 0.2 0.1 0.2 29.4 195.2 2.0 0.1 0.1 0.1 0.9 7.0 0.0 0.2 0.1 0.2 16.8 71.6 0.1 59.7 4.1 0.3 3.9 35.4 5.6 0.2 0.1 57.8 0.4 0.1 0.5 0.2 44.0 7.4 56.3 15.0 0.2 0.0 0.5 0.8 2.4 0.1 0.0 0.0 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.4 0.0 0.1 19.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 66.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 309.4 0.0 0.0 0.0 0.0 0.0 47.5 21.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 11.8 173.3 8.9 0.1 0.4 484.1 2.7 2.3 22.7 0.0 0.1 10.0 152.1 13.5 0.5 203.5 0.0 233.6 0.1 0.4 34.2 13.8 821.3 0.0 0.0 110.6 14.1 19.9 38.7 0.9 0.3 0.0 5.4 410.2 0.0 220.5 261.9 0.0 18.9 0.6 0.0 1.0 0.5 0.0 8.4 0.0 6.9 621.9 833.9 GPX3 ENSG00000211445 "Glutathione peroxidase 3" P22352 5 151020438-151028993 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 844.2;thyroid gland: 424.1" "Group enriched" "Detected in many" 4 "Muller glia cells: 3198.5;Proximal tubular cells: 9534.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 856.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 16.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.7" "Cell line enriched" "Detected in some" 12 "ASC diff: 427.5" "Region enhanced" "Detected in many" "hypothalamus: 279.6" "Group enriched" "Detected in many" 4 "basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3" CAB069456 Approved "Secreted to blood" NA NA 5090000000 10000000000 "CAB069456: AB_1616682" "unprognostic (4.03e-1)" "unprognostic (7.35e-2)" "unprognostic (5.05e-3)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "unprognostic (8.13e-2)" "unprognostic (1.39e-2)" "unprognostic (1.62e-1)" "unprognostic (5.75e-3)" "unprognostic (2.70e-3)" "unprognostic (8.17e-3)" "unprognostic (1.14e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (2.14e-1)" "unprognostic (5.11e-2)" "unprognostic (1.26e-1)" 177.5 21.9 1.2 6.6 5.5 1.6 310.9 3.1 6.3 26.2 33.9 5.1 6.5 7.5 11.8 16.8 44.4 27.0 17.3 108.1 2.7 5.0 844.2 64.1 88.2 43.8 3.9 1.8 28.8 13.0 5.5 32.3 44.8 17.6 41.3 8.3 160.8 14.8 12.4 56.7 18.7 18.5 48.5 3.5 29.6 19.5 23.6 1.2 0.5 424.1 19.0 9.8 58.8 164.2 0.0 3.5 16.7 3.6 0.0 0.2 1.2 0.1 0.5 0.4 0.1 427.5 0.3 0.4 0.1 0.0 0.4 0.1 9.1 0.2 0.0 11.7 0.2 0.1 0.1 2.1 23.0 0.3 0.3 0.1 0.0 0.2 9.9 16.4 0.0 0.2 36.1 2.2 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 4.0 0.2 0.6 0.6 0.0 1.7 0.1 1.9 2.3 0.1 0.1 0.1 1.0 0.2 0.0 0.1 0.7 0.1 0.3 0.1 0.0 0.0 3.6 0.1 0.0 1.4 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 16.7 0.0 0.1 0.0 0.0 1.2 1.2 5.5 3.1 3.6 2.7 5.0 3.9 1.8 17.6 1.2 8.9 50.9 26.2 69.3 16.5 21.7 621.6 15.3 28.1 26.1 615.9 41.2 663.5 1502.1 3.9 2.4 100.8 0.7 0.0 42.8 818.8 102.8 81.4 10.5 137.7 137.1 15.9 43.8 697.9 65.5 7.5 413.6 35.5 21.9 1.0 5.6 3198.5 11.1 7.0 38.5 9534.8 68.9 672.6 191.9 3.8 10.7 18.9 1478.3 13.8 0.6 29.7 GPX5 ENSG00000224586 "Glutathione peroxidase 5" O75715 6 28525925-28534952 "Enzymes, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 27.7" "Group enriched" "Detected in some" 32 "Early spermatids: 10.4;Late spermatids: 26.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 1.0;NB-4: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "unprognostic (3.34e-2)" "unprognostic (3.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 GPX6 GPXP3 ENSG00000198704 "Glutathione peroxidase 6" P59796 6 28503296-28528215 "Enzymes, Predicted secreted proteins" "Oxidoreductase, Peroxidase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 9.3" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 2.5;Late spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;HEL: 1.6" "Region enriched" "Detected in single" 16 "basal ganglia: 21.3" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (2.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 41.9;Cone photoreceptor cells: 108.0;Horizontal cells: 42.9;Rod photoreceptor cells: 85.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Group enriched" "Detected in many" 4 "A549: 22.2;HDLM-2: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008557, HPA075204" Approved Supported "Endoplasmic reticulum,Vesicles,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" Vesicles "HPA008557: AB_1079197, HPA075204: " "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavorable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 22.2 1.2 0.0 0.1 0.2 3.6 7.4 5.3 1.6 0.6 0.9 0.1 1.3 3.9 3.7 2.5 0.0 2.3 0.0 1.7 58.9 2.0 0.0 10.0 0.2 0.0 7.6 0.0 0.4 0.0 2.8 0.0 1.9 0.7 0.6 0.0 0.0 1.4 0.1 1.3 2.6 2.8 9.9 8.4 4.0 3.6 2.4 0.1 0.0 7.4 6.0 1.7 0.1 0.0 3.4 0.2 4.3 4.4 8.9 1.4 1.5 0.3 0.0 0.0 0.0 1.8 8.0 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 0.0 0.3 0.0 0.0 0.0 41.9 5.5 25.5 0.0 0.0 5.2 108.0 4.5 3.3 0.5 5.2 0.7 0.3 0.0 0.4 3.0 1.1 0.1 0.0 0.0 2.3 42.9 0.0 0.6 3.5 2.3 0.6 2.8 0.0 1.0 0.8 21.5 2.3 0.2 0.7 5.5 85.7 0.0 0.8 1.0 1.5 0.4 2.1 1.0 0.4 0.0 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 65.5;Cytotrophoblasts: 93.9;Syncytiotrophoblasts: 123.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Group enriched" "Detected in some" 12 "BEWO: 59.5;SK-BR-3: 27.1" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 27.1 0.0 2.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 65.5 13.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 3.5 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 0.0 GRAMD4 "DIP, KIAA0767" ENSG00000075240 "GRAM domain containing 4" Q6IC98 22 46576012-46679790 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.67e-3)" "unprognostic (1.78e-3)" "unprognostic (2.19e-2)" "unprognostic (8.11e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.04e-4)" "unprognostic (1.08e-1)" "unprognostic (7.07e-2)" "unprognostic (5.72e-2)" "unprognostic (1.44e-3)" "unprognostic (1.54e-2)" "unprognostic (4.11e-1)" "unprognostic (1.61e-2)" "unprognostic (2.73e-2)" "unprognostic (2.08e-1)" "unprognostic (5.38e-2)" "unprognostic (8.69e-2)" 9.2 20.5 12.2 10.5 13.6 12.6 7.9 7.6 19.6 6.9 24.7 9.2 5.6 21.3 8.2 7.9 14.2 10.4 22.9 18.9 13.0 7.7 9.1 83.9 12.0 9.9 8.0 15.3 6.9 14.8 8.1 14.4 6.5 9.3 9.0 16.9 14.8 10.2 4.7 15.7 27.8 28.7 7.2 9.4 10.2 17.7 6.3 7.3 12.2 12.3 6.0 16.1 7.3 10.8 2.0 4.7 2.5 2.9 6.9 3.7 1.4 5.1 5.8 6.9 8.8 9.3 5.5 7.1 3.9 2.5 1.6 2.0 2.1 8.1 18.6 6.8 4.4 4.7 10.9 4.1 2.1 2.5 4.9 4.7 6.3 4.3 5.0 7.6 38.8 25.6 3.6 5.2 1.2 2.8 5.7 2.3 14.5 11.7 12.8 2.2 8.9 22.6 20.8 3.8 11.5 2.7 10.3 1.0 12.2 3.1 6.0 4.9 13.7 4.2 8.6 15.0 8.3 8.4 13.9 3.3 2.1 4.2 2.8 2.5 2.6 8.2 10.0 4.7 15.3 18.0 2.5 2.9 1.9 1.4 1.9 0.6 2.0 1.1 1.0 3.9 0.7 1.0 0.6 1.1 6.9 0.8 4.7 3.7 1.4 12.2 13.6 7.6 19.6 13.0 7.7 8.0 15.3 9.3 7.3 14.9 13.6 4.5 3.1 7.2 3.8 15.7 5.1 5.3 2.3 3.5 0.0 3.0 0.0 3.8 0.1 4.5 38.0 0.0 6.0 2.2 4.1 2.6 6.9 17.9 11.9 3.2 20.0 2.5 10.8 1.1 4.4 8.8 6.8 1.0 22.8 10.0 7.0 14.4 5.3 3.1 1.5 0.0 2.8 0.9 2.5 9.2 2.9 5.7 18.1 2.7 GRAP ENSG00000154016 "GRB2-related adaptor protein" Q13588 17 19020673-19047637 "Plasma proteins, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.3;lymphoid tissue: 20.9" "Cell type enhanced" "Detected in some" 20 "B-cells: 11.5;Endothelial cells: 11.3;Ito cells: 41.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 28.2;T-cells: 37.3" "Cell line enhanced" "Detected in some" "Daudi: 32.2;HUVEC TERT2: 13.3;JURKAT: 10.2;REH: 16.9;TIME: 26.1;U-698: 22.6" "HPA046595, HPA066654" Uncertain Approved Centrosome NA NA Centrosome "HPA046595: AB_10966385, HPA066654: AB_2685699" "unprognostic (3.02e-1)" "unprognostic (6.85e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (3.43e-2)" "unprognostic (3.86e-6)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (4.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (5.11e-2)" "unprognostic (2.67e-5)" "unprognostic (2.25e-1)" "unprognostic (1.57e-2)" "unprognostic (2.16e-1)" "unprognostic (5.77e-3)" 2.8 1.4 0.7 5.7 0.9 2.4 2.8 0.1 0.4 1.4 0.6 0.3 1.4 0.0 0.5 1.9 2.1 0.6 0.8 0.6 2.2 2.7 3.5 15.8 1.0 0.6 0.1 0.0 0.7 2.5 1.0 0.4 0.4 1.6 0.3 0.8 7.7 1.1 1.0 20.9 0.5 2.5 2.7 14.2 1.7 0.8 28.2 2.7 5.6 2.5 4.9 37.3 13.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.2 0.1 0.0 0.0 0.0 6.6 0.5 0.3 0.0 0.0 16.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.2 26.1 0.0 0.0 3.2 0.0 0.0 0.0 22.6 0.0 0.0 0.1 5.6 2.5 0.3 5.9 1.3 5.9 28.2 18.5 7.7 2.7 22.8 37.3 17.9 0.7 4.9 0.1 2.0 15.4 13.0 6.0 2.6 11.5 0.0 0.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 1.9 11.3 0.0 0.0 0.0 0.6 0.1 0.0 2.3 0.8 6.4 0.0 0.0 41.7 6.5 0.0 0.0 0.8 0.0 2.8 0.1 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.1 0.4 0.9 0.2 6.9 0.0 0.0 GRAP2 "GADS, GRBLG, GrbX, Grf40, Mona" ENSG00000100351 "GRB2-related adaptor protein 2" O75791 22 39901082-39973721 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 138.0" "Group enriched" "Detected in many" 4 "granulocytes: 142.1;T-cells: 44.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 22.5" "Cell line enhanced" "Detected in some" "HEL: 14.4;JURKAT: 57.1;K-562: 13.9;MOLT-4: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA005788, CAB022073" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 260000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB022073: , HPA005788: AB_1079021" "unprognostic (1.96e-4)" "unprognostic (1.82e-4)" "unprognostic (4.19e-2)" "unprognostic (8.91e-4)" "unprognostic (2.92e-2)" "unprognostic (5.56e-5)" "unprognostic (1.27e-2)" "unprognostic (8.41e-3)" "unprognostic (4.69e-2)" "unprognostic (9.29e-2)" "unprognostic (5.17e-3)" "unprognostic (2.83e-2)" "unprognostic (1.75e-3)" "unprognostic (2.10e-1)" "unprognostic (2.20e-2)" "unprognostic (1.34e-1)" "unprognostic (8.06e-2)" 1.6 0.4 0.3 7.7 0.7 7.6 1.5 0.3 0.4 1.1 2.3 0.6 0.4 2.9 2.3 1.6 1.6 1.2 3.5 2.8 0.6 0.4 1.2 1.8 6.4 12.6 0.9 0.4 1.0 0.8 0.0 0.6 1.1 0.6 2.4 1.9 1.2 2.4 1.2 0.5 1.4 6.2 2.0 2.2 13.2 2.9 2.4 0.3 138.0 1.3 1.5 11.3 3.0 1.9 2.1 0.4 2.5 0.2 1.7 22.5 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 14.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 57.1 13.9 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.8 0.2 0.0 19.5 0.1 14.4 1.0 14.4 21.1 0.4 2.1 12.2 22.5 2.5 1.7 0.1 0.3 12.0 25.9 0.3 0.7 0.3 0.4 0.6 0.4 0.9 0.4 0.6 0.3 0.0 10.7 1.3 0.0 1.4 0.7 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.1 0.0 23.3 0.2 0.0 1.1 0.6 142.1 1.7 0.2 0.0 1.2 1.8 1.8 2.1 0.3 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 4.4 1.5 1.0 0.1 44.5 0.0 0.3 GRAPL ENSG00000189152 "GRB2 related adaptor protein like" Q8TC17 17 19127469-19159176 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Ito cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 10.8" "Lineage enriched" "Detected in many" 5 "B-cells: 10.8" "Group enriched" "Detected in some" 6 "Daudi: 22.2;HUVEC TERT2: 9.2;TIME: 24.6;U-698: 20.6" "HPA051796, HPA066654" Uncertain Approved Centrosome NA NA Centrosome "HPA051796: AB_2681613, HPA066654: AB_2685699" "unprognostic (2.85e-1)" "unprognostic (3.37e-1)" "unprognostic (5.09e-4)" "unprognostic (4.49e-2)" "unprognostic (6.45e-2)" "unprognostic (1.61e-3)" "unprognostic (1.97e-1)" "unprognostic (1.76e-1)" "unprognostic (5.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.28e-2)" "unprognostic (8.29e-2)" "unprognostic (2.14e-1)" "unprognostic (1.28e-1)" "unprognostic (1.76e-1)" 4.6 1.6 0.7 9.5 1.7 1.0 1.7 0.4 2.0 1.5 1.3 0.1 2.9 0.7 3.6 1.9 2.5 1.6 2.2 3.4 1.7 0.8 2.8 1.8 4.6 15.6 1.1 1.2 1.1 0.4 0.0 1.0 1.7 1.0 1.4 1.3 1.0 1.4 1.3 2.3 0.7 9.7 1.9 0.9 20.6 0.8 1.1 0.5 7.7 2.7 1.7 17.0 1.7 2.3 10.8 0.1 0.0 0.0 0.0 2.2 0.7 0.0 1.2 1.5 0.0 0.2 0.0 0.4 0.2 0.0 0.0 0.0 0.6 0.3 22.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 3.1 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.7 0.0 2.7 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.1 24.6 0.0 0.2 1.1 0.0 0.0 0.0 20.6 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 10.8 1.4 0.3 0.1 4.1 2.2 0.7 0.0 0.0 0.0 0.0 0.9 0.7 0.7 1.7 0.4 2.0 1.7 0.8 1.1 1.2 1.0 0.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GRB10 ENSG00000106070 "Growth factor receptor bound protein 10" Q13322 7 50590063-50793462 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 65.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 82.5;Early spermatids: 134.4;Late spermatids: 152.5;Rod photoreceptor cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "basophil: 11.4;eosinophil: 3.5" "Lineage enriched" "Detected in single" 26 "granulocytes: 11.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019423, HPA027502, HPA031818" Enhanced Supported Vesicles NA NA Vesicles "CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057" "unprognostic (2.82e-2)" "unprognostic (1.69e-3)" "unprognostic (1.25e-2)" "unprognostic (1.45e-2)" "unprognostic (3.68e-2)" "unprognostic (1.60e-1)" "unprognostic (6.83e-2)" "unprognostic (5.91e-3)" "unprognostic (1.67e-2)" "unprognostic (2.31e-3)" "unprognostic (4.44e-1)" "unprognostic (2.07e-1)" "unprognostic (1.23e-3)" "unprognostic (1.73e-3)" "unprognostic (8.16e-3)" "unprognostic (2.63e-2)" "unprognostic (8.50e-2)" 14.3 14.6 14.7 4.9 26.7 6.5 18.8 22.0 20.9 9.7 10.5 14.6 2.0 12.3 8.9 8.0 7.3 9.0 15.6 19.1 13.8 14.8 19.8 15.6 8.3 4.3 19.8 10.7 6.5 65.8 6.0 21.5 10.6 20.9 10.6 5.1 16.5 7.0 11.7 35.7 3.7 8.4 13.0 9.9 15.9 7.2 11.4 16.9 0.4 18.3 4.2 3.2 12.7 17.3 0.0 0.1 11.4 0.2 0.0 0.4 0.1 0.1 10.6 17.6 7.1 8.2 6.3 9.3 4.3 3.7 8.4 10.1 6.4 0.1 0.2 7.7 5.4 24.3 1.0 18.1 4.6 4.1 0.1 7.3 18.4 10.9 4.6 17.5 11.5 28.6 16.5 7.2 12.9 12.8 8.3 21.4 1.3 34.8 0.2 6.3 1.2 2.0 15.5 19.1 8.9 18.6 5.4 0.0 0.1 5.6 4.2 7.7 0.0 0.5 2.7 22.9 11.9 9.3 23.4 26.1 7.4 10.2 15.2 16.4 0.7 0.2 0.1 23.6 10.5 25.1 11.4 0.1 3.5 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.1 14.7 26.7 22.0 20.9 13.8 14.8 19.8 10.7 20.9 16.9 6.0 8.8 0.9 5.6 6.6 11.0 12.2 58.6 1.4 3.4 5.2 82.5 3.7 1.7 16.5 134.4 28.6 8.6 23.3 21.0 11.9 11.5 17.1 0.0 22.5 1.4 4.8 0.0 52.2 11.4 152.5 1.7 2.3 6.8 1.0 2.2 18.0 30.3 2.9 0.4 14.7 83.0 0.0 12.7 1.4 19.2 3.8 2.2 0.9 3.3 5.6 GRB14 ENSG00000115290 "Growth factor receptor bound protein 14" Q14449 2 164492812-164621848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 17.7" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 77.9;Hepatocytes: 35.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.7;HUVEC TERT2: 10.8;RPTEC TERT1: 8.9;TIME: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022294, HPA035052, HPA035053" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB022294: , HPA035052: , HPA035053: AB_2674432" "unprognostic (2.60e-1)" "unprognostic (6.34e-2)" "unprognostic (1.74e-2)" "unprognostic (6.75e-2)" "unprognostic (7.47e-2)" "unprognostic (8.33e-5)" "unprognostic (5.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (8.33e-3)" "unprognostic (2.71e-1)" "unprognostic (1.89e-3)" "unprognostic (7.10e-2)" "unprognostic (5.19e-2)" "unprognostic (9.27e-2)" 1.6 2.9 1.0 1.2 1.5 0.0 6.0 0.7 3.6 0.8 1.2 0.0 1.1 1.2 0.6 7.5 1.7 0.5 0.3 10.8 5.7 1.1 8.3 17.7 0.7 0.1 0.9 2.0 2.4 6.0 0.0 1.8 2.2 1.4 0.8 0.4 1.2 1.0 0.5 3.2 0.5 0.8 0.6 0.6 0.6 1.1 3.1 0.4 0.0 5.5 3.0 0.1 0.6 1.1 0.0 0.0 0.4 0.1 0.0 0.0 3.0 0.9 5.7 0.4 0.0 0.7 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.6 0.0 3.5 0.0 1.0 0.4 0.9 1.6 0.4 0.0 4.9 0.0 0.3 1.4 0.1 0.0 0.0 0.4 1.0 2.1 0.0 1.9 10.8 0.0 0.0 0.1 1.7 2.3 0.0 0.0 2.1 0.2 1.4 0.0 0.0 0.1 8.9 0.4 3.4 0.4 0.0 0.3 0.0 1.1 0.6 0.0 13.5 0.2 1.5 0.0 0.1 0.5 0.1 0.0 3.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.0 1.0 1.5 0.7 3.6 5.7 1.1 0.9 2.0 1.4 0.4 0.0 4.8 0.0 0.3 0.1 0.1 16.1 15.3 0.0 0.0 15.7 0.0 0.1 77.9 7.2 1.3 0.8 0.0 0.0 2.9 0.1 0.2 0.5 0.0 35.1 0.0 0.0 0.0 1.8 0.6 2.1 8.6 0.1 18.6 1.0 2.7 0.1 6.3 0.0 16.3 12.2 0.8 12.9 0.0 0.7 2.1 0.0 0.1 0.0 0.2 0.1 GRB7 ENSG00000141738 "Growth factor receptor bound protein 7" Q14451 17 39737927-39747291 "Cancer-related genes, Predicted intracellular proteins" "Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebellum: 7.4" "Cell type enriched" "Detected in single" 20 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enriched" "Detected in some" 5 "OE19: 193.7" "Region enhanced" "Detected in some" "cerebellum: 9.3" "Low region specificity" "Detected in all" "CAB005226, HPA057084, CAB073538" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330" "unprognostic (8.46e-2)" "unprognostic (2.06e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.60e-7)" "unprognostic (7.06e-3)" "unprognostic (2.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.10e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (2.59e-2)" "prognostic favorable (8.23e-5)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (5.49e-3)" "unprognostic (4.01e-2)" 2.9 0.1 0.1 2.8 0.6 0.0 16.1 7.4 1.2 6.7 12.7 0.3 25.0 6.7 2.6 8.1 53.9 14.5 16.3 0.8 0.2 0.1 23.4 5.2 12.3 0.1 0.1 0.4 3.1 20.5 5.8 3.7 42.6 1.6 10.2 6.4 0.7 14.0 25.5 0.5 19.1 12.4 2.0 0.1 0.3 7.2 2.3 0.3 0.5 8.5 6.5 17.2 7.2 11.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 4.9 2.8 0.0 0.4 0.0 0.1 2.6 0.0 1.8 0.0 0.0 0.2 0.0 0.6 4.3 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 193.7 0.4 0.0 0.0 1.9 2.2 1.6 1.1 0.0 2.1 42.8 0.0 2.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 7.4 1.2 0.2 0.1 0.1 0.4 1.6 0.3 20.8 10.0 0.0 79.7 34.0 0.0 2.0 15.3 17.4 7.9 21.0 0.0 27.0 8.3 29.6 0.0 0.5 18.0 0.0 16.9 18.8 1.9 69.7 1.1 4.0 2.5 0.0 13.8 0.0 0.0 0.0 2.6 0.9 5.0 2.8 16.8 0.3 20.5 24.6 1.1 8.6 0.0 0.0 1.0 0.4 0.2 36.6 82.5 0.9 22.1 65.1 GREB1 KIAA0575 ENSG00000196208 "Growth regulation by estrogen in breast cancer 1" Q4ZG55 2 11482341-11642788 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 74.9" "Cell type enhanced" "Detected in many" 18 "Leydig cells: 18.7;Peritubular cells: 51.9" "Cancer enhanced" "Detected in many" "prostate cancer: 17.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.1;Hep G2: 14.3;MCF7: 22.4;SH-SY5Y: 15.3;T-47d: 51.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024616, HPA027843, HPA028416" Uncertain Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344" "unprognostic (1.52e-2)" "unprognostic (4.63e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.23e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.68e-1)" "unprognostic (3.63e-2)" "unprognostic (7.51e-4)" "unprognostic (2.42e-2)" "unprognostic (3.34e-1)" "unprognostic (2.46e-3)" "unprognostic (4.80e-2)" 1.2 2.0 3.0 0.6 5.0 0.5 11.1 1.3 5.4 13.7 0.5 2.8 3.0 0.7 21.3 15.6 0.6 11.2 1.8 2.3 3.9 3.0 1.3 1.5 0.6 0.6 3.9 3.5 74.9 2.9 0.6 5.0 9.4 3.8 19.2 0.5 2.8 0.7 2.4 2.1 1.2 0.6 7.3 3.2 0.4 0.8 10.9 3.2 0.0 0.5 0.5 0.5 0.8 5.7 0.8 1.0 2.8 0.6 1.0 1.3 0.4 0.0 0.4 15.1 0.1 0.1 0.1 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.1 0.0 2.6 0.1 1.1 0.0 0.0 1.8 1.3 0.0 0.1 14.3 0.1 0.1 0.8 0.2 0.8 0.2 0.1 0.1 0.0 1.4 0.1 0.3 0.1 22.4 0.4 0.7 4.9 0.0 0.0 10.4 0.0 0.6 0.0 0.0 4.4 15.3 0.3 0.4 11.1 2.1 51.8 0.2 0.0 1.5 0.7 0.1 0.0 2.2 1.5 8.8 2.6 4.3 0.4 2.6 0.6 0.8 0.7 0.3 0.3 0.5 0.5 0.4 0.4 0.8 0.5 1.3 2.8 1.0 0.5 1.0 0.5 0.4 3.0 5.0 1.3 5.4 3.9 3.0 3.9 3.5 3.8 3.2 0.0 0.3 0.0 1.7 0.7 3.1 7.3 7.6 5.3 1.2 0.0 2.0 0.1 0.0 0.4 0.5 1.4 0.0 0.0 0.2 2.1 5.1 9.8 3.5 6.0 2.5 3.2 0.0 0.6 0.0 1.3 18.7 0.3 5.0 0.0 0.0 0.2 0.5 0.0 51.9 1.9 0.3 0.0 0.8 0.9 1.5 0.3 0.2 0.0 0.0 2.6 GREB1L "C18orf6, FLJ13687, KIAA1772" ENSG00000141449 "Growth regulation by estrogen in breast cancer 1 like" Q9C091 18 21242242-21525417 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 25.0" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 49.1;Leydig cells: 42.6;Peritubular cells: 33.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "AF22: 22.1;BEWO: 44.8;CACO-2: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041647, HPA044218" Uncertain Approved Mitochondria NA NA Mitochondria "HPA041647: AB_2677597, HPA044218: AB_2678859" "unprognostic (1.88e-3)" "unprognostic (9.01e-4)" "unprognostic (2.92e-1)" "unprognostic (2.45e-1)" "unprognostic (5.03e-2)" "unprognostic (3.67e-3)" "unprognostic (3.65e-1)" "unprognostic (1.11e-2)" "unprognostic (1.07e-1)" "unprognostic (1.97e-1)" "unprognostic (4.32e-3)" "unprognostic (2.87e-2)" "unprognostic (3.30e-8)" "unprognostic (4.72e-3)" "unprognostic (1.89e-1)" "unprognostic (8.80e-2)" "unprognostic (1.35e-1)" 5.0 3.2 12.5 0.8 5.9 0.8 5.5 2.3 4.5 2.5 1.1 4.0 25.0 0.8 4.9 12.4 0.9 6.7 0.8 9.2 5.5 3.9 1.3 3.9 0.7 0.7 5.6 2.6 7.2 0.5 0.9 3.1 5.4 5.8 3.8 0.7 1.0 1.3 14.2 15.9 2.5 1.5 2.1 2.8 0.6 1.7 12.0 3.0 0.0 7.4 0.0 0.5 0.5 1.7 0.2 0.2 2.8 0.1 0.0 0.6 0.0 0.0 0.3 22.1 0.0 5.1 0.0 44.8 1.1 1.0 1.8 1.7 20.1 1.6 0.0 2.3 3.3 0.0 4.2 8.5 1.0 3.2 0.3 4.2 0.0 5.4 0.1 0.1 0.0 0.0 0.0 0.3 0.0 4.1 0.2 0.0 0.6 0.0 0.1 4.4 1.4 0.1 0.1 2.1 0.2 2.7 0.0 0.0 0.8 2.1 3.7 1.4 0.0 0.0 0.7 0.1 6.0 1.1 0.0 9.2 0.2 1.3 2.1 0.0 0.0 0.2 0.0 0.9 0.0 0.1 2.8 0.1 0.1 0.6 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.6 0.0 0.0 0.2 0.2 0.0 12.5 5.9 2.3 4.5 5.5 3.9 5.6 2.6 5.8 3.0 0.0 0.3 0.0 0.1 0.1 49.1 10.6 0.0 4.0 1.2 3.5 2.0 1.3 0.0 0.1 6.6 0.1 0.0 0.0 0.4 11.2 1.8 0.4 0.0 3.0 0.5 0.0 0.0 0.0 0.0 11.7 42.6 0.0 1.7 0.0 0.0 0.7 1.7 0.0 33.6 0.0 1.5 6.5 0.2 0.7 4.7 0.6 1.3 0.0 0.0 0.1 GREM1 "CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS" ENSG00000166923 "Gremlin 1, DAN family BMP antagonist" O60565 15 32717974-32745107 "Disease related genes, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 66.8;smooth muscle: 42.5" "Cell type enriched" "Detected in many" 7 "Collecting duct cells: 62.8" "Cancer enhanced" "Detected in many" "stomach cancer: 24.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 32.8;BJ hTERT+: 50.3;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 100.9;hTEC/SVTERT24-B: 31.6" "Group enriched" "Detected in some" 5 "hippocampal formation: 3.6;olfactory region: 13.4" "Low region specificity" "Detected in single" HPA007526 Uncertain "Secreted to blood" NA NA 242000000 "HPA007526: AB_1849971" "unprognostic (4.74e-2)" "unprognostic (2.78e-1)" "unprognostic (4.63e-2)" "unprognostic (6.80e-2)" "unprognostic (3.58e-1)" "unprognostic (1.72e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (7.20e-3)" "unprognostic (2.79e-1)" "unprognostic (2.13e-11)" "unprognostic (1.77e-2)" "unprognostic (6.60e-2)" "unprognostic (3.29e-2)" "unprognostic (1.16e-3)" 14.9 1.2 3.1 23.1 10.2 1.1 11.7 0.8 5.6 31.3 15.2 6.6 1.1 2.6 5.1 1.0 15.4 1.0 66.8 1.1 4.4 2.0 1.2 1.5 1.2 8.0 6.6 6.4 1.0 1.5 1.0 0.2 1.1 5.5 6.4 15.2 0.0 1.0 5.1 2.4 4.1 24.4 42.5 4.8 1.3 23.7 1.1 9.3 0.0 1.4 2.2 2.3 27.3 32.2 0.4 0.5 1.4 0.4 0.7 0.3 0.0 0.0 0.5 0.0 0.0 1.3 1.7 0.0 32.8 50.3 12.4 31.6 0.0 0.0 0.0 0.0 100.9 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 31.6 0.0 7.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.4 0.5 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.3 0.3 1.4 0.7 0.4 0.5 0.2 0.0 3.1 10.2 0.8 5.6 4.4 2.0 6.6 6.4 5.5 9.3 0.0 0.0 0.0 6.2 6.0 1.9 2.6 0.0 0.0 0.0 62.8 2.0 0.1 0.0 0.4 0.1 0.7 0.0 0.0 0.0 0.1 2.8 8.5 0.0 1.0 1.0 1.6 0.0 0.6 0.3 0.0 0.0 0.0 3.3 4.6 0.1 0.2 0.2 0.0 0.4 0.3 0.5 0.0 4.7 0.0 0.2 4.0 0.2 1.0 0.0 6.3 GREM2 "CKTSF1B2, DAND3, FLJ21195, Prdc" ENSG00000180875 "Gremlin 2, DAN family BMP antagonist" Q9H772 1 240489573-240612149 "Disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Heparin-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 90.3;parathyroid gland: 31.4" "Cell type enriched" "Detected in many" 14 "Syncytiotrophoblasts: 249.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2;memory CD4 T-cell: 2.5" "Lineage enriched" "Detected in single" 5 "T-cells: 2.5" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 26.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB009920 Approved "Secreted to blood" NA NA "CAB009920: AB_2279266" "unprognostic (2.01e-1)" "unprognostic (2.49e-1)" "unprognostic (7.41e-2)" "unprognostic (7.58e-3)" "unprognostic (2.82e-3)" "unprognostic (1.34e-1)" "unprognostic (8.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.31e-2)" "unprognostic (6.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.97e-2)" "unprognostic (3.07e-8)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (5.13e-2)" "unprognostic (1.38e-2)" 0.6 0.9 3.0 9.5 4.5 0.0 2.2 0.7 5.1 0.8 14.2 0.5 0.9 6.5 8.2 1.9 10.7 1.3 90.3 0.2 2.1 3.6 1.1 21.9 1.3 0.6 1.4 4.8 4.2 0.3 31.4 5.2 5.2 3.0 2.8 12.8 1.7 7.5 1.1 6.5 2.3 11.7 3.8 1.8 1.7 6.4 0.5 0.9 0.0 0.7 3.0 4.1 2.2 0.7 0.0 0.0 0.5 0.0 0.1 2.5 0.2 0.0 0.0 0.1 0.0 1.6 2.1 0.0 5.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.9 0.0 2.5 1.1 0.0 0.0 3.3 0.4 0.7 0.3 0.9 0.0 0.0 2.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 2.5 1.3 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.2 3.0 4.5 0.7 5.1 2.1 3.6 1.4 4.8 3.0 0.9 0.0 0.0 0.0 0.0 4.1 17.3 0.3 0.0 1.4 0.0 0.0 11.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.3 0.0 10.5 1.5 0.0 1.2 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.1 0.0 4.2 0.0 6.1 0.0 2.2 0.4 0.4 3.1 249.2 0.0 0.0 0.1 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.3;skin 1: 34.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 69.0;Suprabasal keratinocytes: 115.9;Syncytiotrophoblasts: 154.4;Urothelial cells: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 4.8;neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.8" "Group enriched" "Detected in some" 4 "BEWO: 66.4;SK-BR-3: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 1.7 0.6 1.5 0.2 2.4 2.8 15.9 2.0 1.6 10.2 0.9 0.2 10.8 0.3 0.9 3.8 40.3 0.7 1.0 1.6 1.9 1.2 2.5 4.9 2.3 0.2 0.7 1.4 0.5 1.5 12.9 2.6 31.0 0.8 6.1 0.2 1.8 17.5 9.7 0.9 34.4 0.7 5.1 0.6 0.6 1.3 1.6 0.4 0.4 2.8 22.3 25.3 6.7 16.9 0.1 0.2 4.8 0.2 0.5 0.6 4.5 3.2 0.0 0.4 0.9 0.1 0.1 66.4 0.3 0.4 0.2 0.3 0.2 2.3 0.4 0.1 0.0 0.4 2.0 4.0 0.4 0.9 0.9 1.8 0.1 0.6 1.2 0.0 0.2 0.3 0.1 1.7 1.9 0.0 0.0 0.3 0.7 0.6 1.2 0.0 4.2 0.6 0.5 0.2 1.0 0.7 0.2 0.3 0.5 0.4 12.6 0.7 0.5 0.6 34.9 0.8 5.7 4.2 0.1 0.3 0.2 0.8 1.0 0.4 0.8 0.5 0.4 0.2 0.5 0.5 0.0 0.2 4.8 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.6 4.5 1.5 2.4 2.0 1.6 1.9 1.2 0.7 1.4 0.8 0.4 3.0 7.2 0.0 18.6 35.5 20.9 1.2 0.0 6.7 29.6 19.2 58.9 48.9 0.0 2.8 6.0 3.1 0.5 0.0 8.0 69.0 6.1 30.1 10.3 5.7 6.7 11.1 3.4 3.1 1.3 2.1 0.0 2.7 20.3 1.0 0.6 1.7 4.8 0.0 0.4 1.7 11.8 0.0 6.1 5.1 5.3 115.9 154.4 1.3 0.4 97.4 GRHL2 "BOM, DFNA28, FLJ13782, TFCP2L3" ENSG00000083307 "Grainyhead like transcription factor 2" Q6ISB3 8 101492432-101669726 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 47.9;seminal vesicle: 42.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 29.8;Ciliated cells: 40.2;Club cells: 27.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 15.6;CACO-2: 11.4;HaCaT: 19.1;hTCEpi: 14.9;MCF7: 13.1;OE19: 15.3;RT4: 28.1;T-47d: 33.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004820, HPA062839" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004820: AB_1857928, HPA062839: AB_2684878" "prognostic unfavorable (6.43e-4)" "unprognostic (2.54e-2)" "unprognostic (4.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.68e-1)" "unprognostic (4.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (2.61e-2)" "unprognostic (8.29e-4)" "unprognostic (4.54e-3)" "unprognostic (2.64e-1)" "unprognostic (1.08e-1)" "unprognostic (1.03e-2)" 0.4 0.3 0.4 3.3 0.4 0.0 11.3 0.3 0.4 6.0 9.9 0.0 34.7 2.1 1.6 16.4 18.7 5.2 10.3 0.4 0.4 0.4 6.4 0.7 11.3 0.0 0.4 0.0 1.5 22.1 7.1 1.5 47.9 0.1 15.2 5.6 0.1 15.0 42.4 0.4 18.0 8.6 1.6 0.4 0.4 5.9 0.6 0.0 1.7 12.7 14.3 12.2 7.4 8.4 0.0 0.0 0.0 0.0 1.2 0.2 0.0 15.6 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 11.4 7.8 0.0 0.0 0.0 0.0 19.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 28.1 0.5 0.0 0.0 6.2 0.0 1.9 33.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.0 0.1 0.0 29.8 8.8 0.0 9.3 21.6 0.0 0.4 10.2 40.2 27.3 10.4 0.0 12.4 5.0 6.5 2.2 0.4 5.9 0.0 4.8 5.9 0.8 10.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 4.1 0.0 0.0 1.7 1.0 10.0 0.0 7.4 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 22.7 16.6 0.0 7.6 5.1 GRHL3 "SOM, TFCP2L4" ENSG00000158055 "Grainyhead like transcription factor 3" Q8TE85 1 24319322-24364482 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 86.8;Urothelial cells: 72.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 28.9" "Region enhanced" "Detected in some" "pons and medulla: 3.6" "Group enriched" "Detected in some" 12 "eosinophil: 1.0;neutrophil: 1.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 21.4;HaCaT: 16.8;MCF7: 25.9;OE19: 9.4;RT4: 29.6;SuSa: 16.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059960 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA059960: AB_2684180" "unprognostic (8.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.95e-2)" "unprognostic (7.83e-3)" "unprognostic (7.58e-3)" "unprognostic (6.28e-3)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (9.01e-3)" "unprognostic (4.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.36e-2)" "unprognostic (8.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (6.97e-3)" "unprognostic (7.42e-2)" 0.1 0.1 0.1 0.1 0.9 0.0 1.0 0.2 0.9 9.0 0.1 0.2 0.0 0.2 0.6 0.8 59.0 0.2 0.6 0.1 1.1 0.3 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.9 0.1 1.1 3.6 3.6 0.1 0.0 5.9 0.9 0.2 21.7 0.1 0.5 3.0 0.0 0.2 1.1 0.1 0.5 0.1 51.5 60.1 12.3 11.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.5 1.2 0.4 0.0 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 16.8 0.0 1.5 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 25.9 0.0 0.1 1.1 9.4 0.0 0.0 0.0 0.1 2.1 29.6 0.1 0.0 0.0 2.9 0.0 16.3 1.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.2 0.1 1.1 0.3 0.1 0.0 3.6 0.1 0.0 1.1 0.0 8.8 12.8 0.0 0.4 0.0 2.7 2.3 1.8 0.0 3.5 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.3 9.1 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 86.8 15.4 0.0 0.0 72.5 GRHPR "GLXR, PH2" ENSG00000137106 "Glyoxylate and hydroxypyruvate reductase" Q9UBQ7 9 37422666-37436990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 172.0" "Cell type enhanced" "Detected in all" 9 "Hepatocytes: 748.4;Proximal tubular cells: 664.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022971, HPA078575" Enhanced Approved Nucleoplasm,Cytosol NA NA 1400000 Cytosol Nucleoplasm "HPA022971: AB_1849975, HPA078575: " "prognostic favorable (7.00e-5)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.64e-3)" "unprognostic (5.78e-3)" "unprognostic (3.04e-1)" "unprognostic (1.02e-3)" "unprognostic (1.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.49e-2)" "unprognostic (5.88e-2)" "unprognostic (2.36e-1)" "prognostic favorable (5.39e-9)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" 12.8 33.7 16.3 13.8 17.4 9.9 12.3 9.5 22.3 12.1 17.6 27.5 11.6 17.2 14.3 18.1 17.6 12.9 18.1 29.2 15.8 14.7 41.9 172.0 9.7 13.8 20.0 16.5 17.0 15.5 9.5 8.8 13.2 15.5 14.2 10.2 13.5 21.6 14.0 40.0 14.8 14.6 14.2 19.4 10.0 13.3 13.0 18.7 9.5 15.1 25.2 13.6 13.4 11.7 30.6 33.2 17.8 30.3 28.9 25.9 22.4 31.9 46.2 26.2 23.9 24.1 26.8 26.5 25.6 34.0 35.0 38.1 17.4 13.9 30.7 15.1 30.0 26.2 14.5 15.0 33.4 20.9 41.0 18.8 18.0 43.0 30.9 38.1 17.1 18.7 31.9 29.4 20.2 26.1 29.6 30.3 21.0 32.9 12.7 30.7 24.5 16.6 17.6 15.9 29.2 20.1 16.4 19.2 17.0 46.6 18.2 10.9 19.6 22.0 42.1 23.9 24.7 23.7 22.1 32.9 19.2 30.9 13.3 22.1 10.1 7.7 20.5 27.3 9.9 28.1 17.8 30.2 15.0 19.4 30.3 16.2 28.6 20.7 22.0 33.2 30.6 20.4 17.3 7.0 28.9 24.7 29.8 25.9 22.4 16.3 17.4 9.5 22.3 15.8 14.7 20.0 16.5 15.5 18.7 53.6 20.9 43.5 39.7 38.5 33.3 86.0 219.1 29.4 26.1 48.8 19.6 128.8 210.5 67.4 10.2 41.4 82.6 46.7 77.8 76.0 63.3 42.0 49.6 748.4 97.6 22.3 59.7 76.1 83.4 10.4 69.0 49.3 75.9 86.6 59.5 85.7 64.8 60.5 92.6 664.7 23.4 77.6 62.6 17.5 16.2 49.2 74.4 37.9 71.9 35.2 GRIA1 "GluA1, GLUR1, GLURA" ENSG00000155511 "Glutamate ionotropic receptor AMPA type subunit 1" P42261 5 153489615-153813869 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 52.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 34.6;Muller glia cells: 48.7" "Cancer enriched" "Detected in some" 15 "glioma: 9.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.7;ASC diff: 4.2;BJ: 6.5;BJ hTERT+: 3.4;LHCN-M2: 9.7;U-266/70: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035202 Enhanced NA NA "HPA035202: AB_2674516" "unprognostic (2.51e-1)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (4.20e-2)" "unprognostic (6.95e-2)" "unprognostic (2.43e-1)" "unprognostic (2.61e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (2.35e-2)" "unprognostic (5.14e-4)" "unprognostic (7.97e-2)" "unprognostic (2.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.70e-1)" "unprognostic (2.80e-1)" "unprognostic (7.61e-2)" 1.8 1.6 44.9 1.2 23.1 1.0 1.5 23.6 52.6 1.4 1.2 3.7 0.0 1.3 1.2 2.0 1.2 1.2 1.1 2.0 50.4 13.4 1.1 1.1 9.5 1.0 4.8 20.0 1.3 1.4 1.2 0.5 1.1 4.6 1.1 1.2 0.7 1.1 1.7 1.1 1.1 1.3 2.3 2.3 1.1 1.2 2.1 5.2 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 4.2 2.9 0.0 6.5 3.4 0.4 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 23.1 23.6 24.3 50.4 13.4 4.8 20.0 4.6 5.2 0.0 0.0 0.0 0.0 0.0 34.6 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIA2 "GluA2, GLUR2, GLURB" ENSG00000120251 "Glutamate ionotropic receptor AMPA type subunit 2" P42262 4 157204182-157366075 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 242.0;Horizontal cells: 130.3" "Group enriched" "Detected in some" 10 "breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008441 Enhanced NA NA "HPA008441: AB_1078983" "unprognostic (1.36e-1)" "unprognostic (9.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (3.87e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-3)" "unprognostic (7.40e-2)" "unprognostic (2.91e-5)" "unprognostic (2.42e-1)" "unprognostic (1.31e-1)" "unprognostic (1.82e-1)" "unprognostic (6.55e-2)" 1.2 6.5 36.9 1.3 39.1 1.1 2.0 22.1 95.9 8.2 1.3 5.6 0.0 1.2 13.5 9.8 1.2 9.6 1.2 1.2 30.1 15.7 1.5 1.1 1.4 1.2 10.0 30.6 1.7 2.2 1.2 10.5 1.2 7.1 1.8 1.2 0.1 2.1 3.0 1.2 1.1 1.2 6.1 6.9 1.3 1.5 2.1 8.8 0.0 1.2 0.0 1.2 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.9 2.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.2 0.0 0.0 0.6 0.0 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 39.1 22.1 41.2 30.1 15.7 10.0 30.6 7.1 8.8 0.0 0.0 0.0 0.0 0.0 242.0 2.2 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 130.3 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 3.1 0.0 0.0 0.4 0.0 14.0 0.0 0.7 3.9 1.5 0.0 0.0 0.0 0.0 0.0 GRIA3 "GluA3, GLUR3, GLURC, MRX94" ENSG00000125675 "Glutamate ionotropic receptor AMPA type subunit 3" P42263 X 123184153-123490915 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Cell type enriched" "Detected in some" 22 "Horizontal cells: 187.5" "Cancer enriched" "Detected in some" 11 "glioma: 10.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "BJ: 14.4;BJ hTERT+: 20.9;fHDF/TERT166: 27.5;U-2197: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058659, HPA073344" Enhanced "Intracellular and membrane" NA NA "HPA058659: AB_2683791, HPA073344: " "unprognostic (2.14e-2)" "unprognostic (6.00e-2)" "unprognostic (2.02e-2)" "unprognostic (2.94e-3)" "unprognostic (5.09e-2)" "unprognostic (4.29e-4)" "unprognostic (2.42e-1)" "unprognostic (6.74e-2)" "unprognostic (1.44e-1)" "unprognostic (2.36e-1)" "unprognostic (1.65e-3)" "unprognostic (1.31e-1)" "unprognostic (3.78e-3)" "unprognostic (8.05e-3)" "unprognostic (6.40e-2)" "unprognostic (1.57e-1)" "unprognostic (2.03e-1)" 1.5 10.7 31.4 1.0 27.4 0.7 2.3 3.5 40.8 9.1 1.3 3.7 0.1 0.9 3.0 4.9 1.1 2.0 1.9 2.7 26.1 8.1 3.4 9.3 1.0 1.1 10.2 21.2 5.6 2.6 0.6 0.6 1.1 4.9 2.1 1.5 0.7 0.9 3.0 0.9 1.2 1.0 2.9 8.4 0.7 3.0 1.4 7.8 0.0 0.8 0.0 1.5 1.3 1.8 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 14.4 20.9 0.2 0.5 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.1 0.0 9.2 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 27.4 3.5 27.5 26.1 8.1 10.2 21.2 4.9 7.8 0.0 0.0 0.0 0.0 0.2 4.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 3.1 0.5 0.0 4.7 0.1 187.5 0.0 0.6 0.0 0.0 8.6 0.0 1.7 0.0 0.0 1.5 0.5 0.0 3.9 6.0 3.1 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 GRIA4 "GluA4, GLUR4, GLURD" ENSG00000152578 "Glutamate ionotropic receptor AMPA type subunit 4" P48058 11 105609994-105982092 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 55.4" "Cell type enriched" "Detected in some" 22 "Horizontal cells: 444.9" "Group enriched" "Detected in some" 18 "glioma: 5.9;renal cancer: 1.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 15.8;NTERA-2: 5.2;RPMI-8226: 3.0;SCLC-21H: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "unprognostic (4.09e-4)" "unprognostic (4.45e-3)" "unprognostic (1.92e-3)" "unprognostic (4.14e-4)" "unprognostic (1.40e-2)" "unprognostic (3.73e-4)" "unprognostic (1.62e-1)" "unprognostic (3.89e-1)" "unprognostic (2.04e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (2.48e-1)" "unprognostic (1.38e-1)" "unprognostic (3.35e-2)" "unprognostic (1.28e-1)" 1.1 7.4 11.4 1.5 13.1 0.9 4.5 55.4 52.9 2.6 1.8 8.1 0.0 0.9 1.5 2.9 1.0 2.2 1.2 0.9 9.3 16.0 1.4 0.9 1.0 1.6 12.1 17.4 1.3 1.6 0.9 2.2 1.3 24.8 1.2 2.0 2.8 4.1 1.5 1.0 1.5 4.5 1.0 11.5 0.9 6.6 1.1 6.9 0.0 1.0 0.0 1.3 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 3.0 0.0 0.0 5.8 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.1 55.4 23.3 9.3 16.0 12.1 17.4 24.8 6.9 0.0 0.0 0.0 0.0 0.1 18.9 1.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 444.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.5 7.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 GRID1 "GluD1, KIAA1220" ENSG00000182771 "Glutamate ionotropic receptor delta type subunit 1" Q9ULK0 10 85599555-86366493 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 9.5;Melanocytes: 5.0;Peritubular cells: 4.2;Sertoli cells: 12.9" "Group enriched" "Detected in many" 5 "glioma: 3.6;thyroid cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "Daudi: 6.4;HEL: 6.2;SH-SY5Y: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.60e-2)" "unprognostic (2.75e-2)" "unprognostic (5.92e-2)" "unprognostic (4.31e-2)" "unprognostic (4.24e-1)" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (4.21e-2)" "unprognostic (5.09e-2)" "unprognostic (1.49e-3)" "unprognostic (8.30e-2)" "unprognostic (8.26e-2)" "unprognostic (4.58e-9)" "unprognostic (3.15e-3)" "unprognostic (5.91e-2)" "unprognostic (2.21e-1)" "unprognostic (8.65e-3)" 2.5 4.2 8.8 1.0 13.0 0.8 1.6 3.1 15.7 4.5 1.4 20.9 0.0 1.7 2.6 3.4 1.3 4.8 1.6 1.3 8.8 6.9 1.0 1.3 2.1 1.7 19.6 8.7 1.4 1.2 1.1 0.9 3.1 9.9 2.1 1.3 1.0 1.1 4.4 1.4 2.1 1.7 2.4 6.4 0.9 1.2 2.8 14.2 0.0 7.0 0.0 1.5 1.2 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.8 6.4 0.2 0.0 0.1 0.0 0.9 0.0 0.0 0.3 1.4 6.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.8 13.0 3.1 14.3 8.8 6.9 19.6 8.7 9.9 14.2 3.0 0.3 0.0 0.1 0.5 9.5 1.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 2.0 0.0 5.0 0.0 0.0 0.7 0.0 0.0 4.2 0.0 0.5 12.9 1.9 0.1 0.9 0.0 0.1 0.0 0.0 0.0 GRID2 "GluD2, GluR-delta-2" ENSG00000152208 "Glutamate ionotropic receptor delta type subunit 2" O43424 4 92303622-93810157 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 45.1;testis: 38.2" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 94.0;Early spermatids: 359.2;Late spermatids: 508.8;Muller glia cells: 141.0" "Cancer enriched" "Detected in single" 7 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "U-2 OS: 12.9;U-266/70: 5.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 130.6" "HPA056253, HPA058538" Enhanced NA NA "HPA056253: AB_2683079, HPA058538: AB_2683747" "unprognostic (2.78e-1)" "unprognostic (1.29e-4)" "unprognostic (7.23e-3)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (3.50e-2)" "unprognostic (3.34e-1)" "unprognostic (6.92e-2)" "unprognostic (7.96e-3)" "unprognostic (4.36e-2)" "unprognostic (9.31e-2)" "unprognostic (7.38e-3)" 0.6 3.5 8.0 0.6 13.6 0.6 0.6 45.1 7.0 1.1 0.7 2.8 0.0 0.8 0.7 0.9 0.6 0.9 0.6 0.7 6.2 3.4 0.8 0.6 0.7 0.6 7.6 6.4 3.7 0.6 0.6 0.3 0.6 7.2 0.6 0.7 0.6 0.6 0.9 0.6 0.6 0.8 0.6 9.0 0.7 0.6 38.2 7.9 0.0 0.7 0.0 0.6 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 12.9 0.0 0.0 5.8 0.0 0.6 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 13.6 45.1 7.0 6.2 3.4 7.6 6.4 7.2 7.9 0.0 0.0 0.0 0.0 0.0 94.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 359.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 27.0 0.0 0.0 0.0 508.8 4.6 0.0 0.0 0.0 0.0 141.0 0.0 0.0 1.1 0.0 3.9 6.5 0.7 3.4 2.0 0.0 0.0 0.0 0.0 0.0 GRID2IP ENSG00000215045 "Grid2 interacting protein" A4D2P6 7 6497462-6551436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 23.6" "Cell type enhanced" "Detected in single" 12 "Rod photoreceptor cells: 1.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 23.6" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "REH: 8.9" "Group enriched" "Detected in some" 5 "cerebellum: 25.2;thalamus: 7.9" "Group enriched" "Detected in all" 5 "cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7" HPA045381 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA045381: AB_10962495" "unprognostic (1.77e-1)" "unprognostic (2.64e-1)" "unprognostic (3.39e-4)" "unprognostic (1.19e-3)" "unprognostic (5.52e-2)" "unprognostic (2.50e-2)" "unprognostic (2.82e-1)" "unprognostic (2.37e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.54e-2)" "unprognostic (8.08e-2)" "unprognostic (1.87e-1)" "unprognostic (3.17e-1)" 0.2 1.7 0.8 0.6 3.6 1.1 1.1 23.6 6.6 0.6 1.4 6.5 0.0 1.8 0.4 0.1 1.2 1.1 0.6 0.3 1.6 1.6 0.7 0.3 1.2 0.5 0.7 1.2 0.9 1.8 3.9 3.0 0.2 5.5 2.3 0.7 0.3 2.1 1.6 0.2 3.4 1.6 0.0 1.5 1.4 2.2 1.2 6.8 2.5 1.6 0.0 0.6 0.9 0.8 0.7 0.2 0.0 0.2 1.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.5 0.0 0.7 0.7 0.0 0.2 0.8 0.0 8.9 0.3 0.2 0.2 0.3 0.1 1.1 0.0 0.8 0.0 0.3 2.0 0.2 0.1 0.0 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.4 0.0 0.0 1.1 0.2 0.2 0.0 0.1 0.8 3.6 23.6 6.6 1.6 1.6 0.7 1.2 5.5 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 GRIFIN ENSG00000275572 "Galectin-related inter-fiber protein" A4D1Z8 7 2474844-2476894 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.6;skin 1: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.18e-2)" "unprognostic (2.98e-2)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.68e-2)" "unprognostic (4.31e-1)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" 1.6 0.7 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIK1 "GluK1, GLUR5" ENSG00000171189 "Glutamate ionotropic receptor kainate type subunit 1" P39086 21 29536933-29940033 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 23.7;brain: 44.2;retina: 12.0" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 6.8;Early spermatids: 4.6;Late spermatids: 7.9;Melanocytes: 3.3;Rod photoreceptor cells: 4.8" "Group enriched" "Detected in some" 7 "glioma: 4.5;prostate cancer: 0.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014623 Uncertain NA NA "HPA014623: AB_1850305" "unprognostic (1.39e-1)" "unprognostic (6.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.04e-2)" "unprognostic (1.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.07e-1)" "unprognostic (2.12e-3)" "unprognostic (1.25e-1)" "unprognostic (8.77e-2)" "unprognostic (4.89e-3)" "unprognostic (1.20e-3)" "unprognostic (1.47e-8)" "unprognostic (2.09e-1)" "unprognostic (2.68e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-3)" 0.8 23.7 9.8 0.9 10.2 0.7 4.1 6.6 18.3 1.2 1.2 2.9 0.0 0.7 0.7 4.3 1.2 0.7 0.8 0.6 10.0 13.4 0.6 0.8 0.8 0.9 7.1 7.6 1.1 0.6 0.6 0.3 1.3 44.2 5.3 1.5 12.0 0.7 0.8 0.8 2.1 1.3 0.8 2.6 0.8 0.7 1.4 2.7 0.0 0.7 0.0 0.6 1.0 0.6 0.4 0.3 1.6 1.1 0.2 0.4 0.0 0.2 0.5 0.8 0.3 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.7 4.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 1.3 1.0 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 1.8 0.0 0.0 0.4 1.0 1.1 0.1 0.3 0.2 1.2 0.3 0.0 0.4 0.1 0.3 0.1 1.0 0.1 0.6 0.5 1.0 0.4 0.6 1.0 0.2 0.2 0.5 0.9 0.2 0.8 0.8 1.8 0.0 1.1 0.6 0.1 0.8 0.0 0.2 0.1 0.0 0.3 0.4 0.3 0.1 1.6 0.2 0.5 0.1 0.4 0.0 9.8 10.2 6.6 18.3 10.0 13.4 7.1 7.6 44.2 2.7 0.0 0.0 0.0 0.0 0.2 6.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 7.9 0.3 0.0 3.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GRIK2 "GluK2, GLUR6, MRT6" ENSG00000164418 "Glutamate ionotropic receptor kainate type subunit 2" Q13002 6 101398788-102070083 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 4.6;Cardiomyocytes: 2.8;Ciliated cells: 2.7;Early spermatids: 3.3;Late spermatids: 5.6" "Cancer enhanced" "Detected in some" "glioma: 3.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 11.7;BJ hTERT+: 19.4;fHDF/TERT166: 14.5;HAP1: 7.5;SiHa: 7.8;WM-115: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014395, HPA014623, CAB022463" Approved "Intracellular and membrane" NA NA "CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305" "unprognostic (1.43e-3)" "unprognostic (1.26e-2)" "unprognostic (3.99e-2)" "unprognostic (3.20e-1)" "unprognostic (1.92e-1)" "unprognostic (3.48e-2)" "unprognostic (2.57e-1)" "unprognostic (4.32e-2)" "unprognostic (8.46e-2)" "unprognostic (9.19e-2)" "unprognostic (4.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.34e-5)" "unprognostic (1.94e-3)" "unprognostic (7.78e-2)" "unprognostic (1.09e-2)" "unprognostic (8.68e-4)" 0.8 3.9 16.1 1.1 22.5 1.0 0.8 40.6 22.8 3.1 1.2 1.6 0.0 1.4 1.2 2.5 1.2 0.9 1.5 7.6 9.1 11.4 1.9 0.6 0.7 0.6 4.1 17.0 1.1 5.2 0.5 13.0 4.3 8.5 2.1 1.2 0.4 2.0 2.6 1.8 3.8 1.5 0.9 2.7 1.1 0.8 1.8 5.3 0.0 6.3 0.0 0.4 1.1 0.9 1.4 1.2 2.7 0.7 1.2 0.9 0.4 0.0 0.1 2.5 0.2 2.6 0.1 0.0 11.7 19.4 0.7 0.4 0.0 0.2 0.1 0.0 14.5 0.0 3.9 7.5 0.0 0.2 0.0 0.0 1.3 6.7 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.7 1.8 0.0 0.0 0.0 0.3 4.3 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 2.6 5.1 7.8 0.0 0.4 0.4 0.0 0.7 0.0 1.6 0.3 0.1 0.9 0.0 0.0 0.0 1.1 0.0 17.7 2.5 0.7 0.7 0.6 0.7 0.4 0.7 0.6 0.4 0.2 1.4 0.8 0.9 2.7 1.2 0.7 1.2 0.3 0.4 16.1 22.5 40.6 21.9 9.1 11.4 4.1 17.0 8.5 5.3 0.0 0.3 0.0 0.9 0.6 4.6 2.8 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.5 0.0 0.6 0.7 0.0 0.0 0.1 0.0 1.7 0.0 0.0 5.6 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.9 0.0 0.5 0.0 0.3 0.5 0.0 0.0 0.0 0.9 GRIK3 "GluK3, GLUR7" ENSG00000163873 "Glutamate ionotropic receptor kainate type subunit 3" Q13003 1 36795527-37034129 "Plasma proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;pituitary gland: 13.1" "Group enriched" "Detected in some" 5 "Late spermatids: 5.1;Muller glia cells: 14.3" "Cancer enhanced" "Detected in some" "glioma: 13.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.20e-2)" "unprognostic (1.90e-1)" "unprognostic (7.66e-2)" "unprognostic (9.26e-3)" "unprognostic (2.87e-1)" "unprognostic (1.60e-1)" "unprognostic (1.45e-1)" "unprognostic (2.60e-3)" "unprognostic (9.06e-2)" "unprognostic (1.04e-1)" "unprognostic (3.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.28e-2)" "unprognostic (3.53e-3)" "unprognostic (2.06e-1)" "unprognostic (9.37e-2)" "unprognostic (2.08e-2)" 1.7 4.6 5.4 1.8 9.4 0.6 5.4 5.7 24.7 2.1 8.4 3.3 1.5 2.1 0.8 4.5 3.1 1.2 2.2 1.9 3.8 9.6 0.8 0.7 0.9 0.9 9.1 10.4 1.3 1.6 1.5 13.1 0.6 13.1 1.9 3.3 9.0 2.2 5.8 0.7 1.1 2.9 1.8 3.6 1.0 2.1 2.0 2.7 0.0 1.0 0.2 1.4 1.1 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.3 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 9.4 5.7 14.2 3.8 9.6 9.1 10.4 13.1 2.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.3 0.0 1.7 0.0 0.0 14.3 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRIK4 "GluK4, GRIK, KA1" ENSG00000149403 "Glutamate ionotropic receptor kainate type subunit 4" Q16099 11 120511700-120988904 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.3;ovary: 8.5" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 33.4" "Cancer enriched" "Detected in some" 5 "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 6.4;HEL: 19.7;T-47d: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074453 Enhanced NA NA "HPA074453: AB_2732255" "unprognostic (9.63e-2)" "unprognostic (4.96e-2)" "unprognostic (1.58e-1)" "unprognostic (2.49e-1)" "unprognostic (2.37e-1)" "unprognostic (6.64e-4)" "unprognostic (1.48e-2)" "unprognostic (7.26e-2)" "unprognostic (3.16e-1)" "unprognostic (2.38e-1)" "unprognostic (4.53e-2)" "unprognostic (2.50e-1)" "unprognostic (4.84e-11)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (4.47e-3)" "unprognostic (2.58e-2)" 1.0 5.4 11.3 1.0 9.0 0.8 1.3 3.9 19.3 1.2 1.1 9.4 0.0 1.2 1.1 0.9 1.2 1.7 1.1 1.6 13.9 7.2 1.0 0.8 3.1 1.0 8.7 11.0 8.5 0.8 0.8 2.6 1.5 12.3 1.5 1.1 0.0 1.1 1.0 1.0 1.3 1.2 1.0 6.3 1.4 0.9 2.0 8.2 0.0 6.3 0.0 1.0 1.2 0.4 0.0 0.0 0.0 0.0 0.7 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 6.4 0.6 19.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.6 5.1 0.0 0.2 0.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 11.3 9.0 3.9 14.0 13.9 7.2 8.7 11.0 12.3 8.2 0.0 1.1 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.3 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.1 0.0 0.0 0.4 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074001: AB_2732248" "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 14.5 0.0 0.4 0.0 0.4 0.0 0.1 0.1 0.0 8.9 0.1 0.0 24.4 0.0 0.1 4.0 0.0 7.0 15.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 0.0 0.0 0.0 0.1 0.3 21.4 2.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 4.6 0.0 0.0 17.5 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.4 0.0 20.6 0.0 0.9 3.8 1.5 0.4 0.0 0.0 0.0 0.0 GRIN1 "GluN1, NMDAR1" ENSG00000176884 "Glutamate ionotropic receptor NMDA type subunit 1" Q05586 9 137138390-137168762 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "brain: 97.5" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 5.6;Cardiomyocytes: 2.4;monocytes: 3.6;Rod photoreceptor cells: 5.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.6;REH: 3.1;RPMI-8226: 4.3;SCLC-21H: 10.0;SH-SY5Y: 6.9;T-47d: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067773 Enhanced NA NA "HPA067773: " "unprognostic (3.58e-2)" "unprognostic (4.51e-1)" "unprognostic (2.68e-2)" "unprognostic (5.48e-4)" "unprognostic (5.20e-2)" "unprognostic (1.25e-1)" "unprognostic (2.34e-2)" "unprognostic (2.81e-2)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.21e-3)" "unprognostic (4.47e-2)" "unprognostic (1.44e-1)" "unprognostic (3.56e-3)" "unprognostic (4.72e-2)" 1.7 2.0 23.6 2.0 47.5 1.7 1.8 28.1 97.5 1.8 2.0 3.2 0.0 2.2 1.7 1.8 1.7 1.7 1.7 1.7 29.1 26.4 1.8 1.7 1.8 1.8 15.4 37.9 1.7 1.8 1.8 0.0 1.7 22.0 2.2 1.8 0.7 2.5 1.8 1.7 1.8 2.2 1.8 4.7 1.8 1.8 1.9 6.3 0.0 1.7 0.0 1.8 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.5 0.1 0.0 0.2 0.2 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.1 2.6 0.0 3.1 0.0 4.3 0.0 0.0 10.0 6.9 0.1 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 23.6 47.5 28.1 87.9 29.1 26.4 15.4 37.9 22.0 6.3 0.0 0.0 0.0 0.4 0.0 5.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 1.6 1.7 0.0 0.0 0.4 0.0 0.0 0.0 3.6 1.7 1.6 0.3 0.0 0.0 0.0 5.7 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.3 GRIN2A "GluN2A, NMDAR2A" ENSG00000183454 "Glutamate ionotropic receptor NMDA type subunit 2A" Q12879 16 9753404-10182754 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 25.2" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 14.9;Early spermatids: 13.4;Late spermatids: 13.0;Muller glia cells: 17.7;Rod photoreceptor cells: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.8;hTERT-RPE1: 3.4;RPMI-8226: 2.9;U-138 MG: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB022725 Enhanced NA NA "CAB022725: " "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (5.97e-2)" "unprognostic (3.21e-2)" "unprognostic (3.13e-2)" "unprognostic (1.59e-2)" "unprognostic (1.62e-1)" "unprognostic (2.10e-1)" "unprognostic (2.08e-1)" "unprognostic (5.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "unprognostic (3.75e-3)" "unprognostic (4.79e-3)" "unprognostic (2.05e-1)" "unprognostic (3.92e-3)" "unprognostic (3.33e-2)" 0.9 1.0 5.4 0.5 5.9 0.4 0.6 8.5 25.2 0.6 0.7 1.5 0.0 0.9 0.8 4.5 2.1 4.1 0.5 4.0 8.0 1.9 0.9 0.4 1.0 0.5 1.7 10.3 0.5 0.6 0.4 0.3 0.4 1.4 0.5 0.7 1.4 0.7 1.0 0.5 1.2 0.7 0.9 1.2 0.4 1.1 5.2 0.8 0.0 0.8 0.0 0.7 0.6 0.5 0.6 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 1.9 0.6 1.4 0.0 0.1 0.0 0.0 7.8 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 8.5 0.8 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 5.4 5.9 8.5 17.9 8.0 1.9 1.7 10.3 1.4 0.8 0.0 0.0 0.0 1.9 1.6 3.6 14.9 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.6 13.4 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.1 1.6 0.0 0.0 0.0 13.0 0.9 0.0 0.0 0.0 0.0 17.7 1.2 0.0 0.0 0.0 12.1 0.0 4.2 3.2 3.8 0.4 0.0 0.0 0.0 0.3 GRIN2B "GluN2B, NMDAR2B" ENSG00000273079 "Glutamate ionotropic receptor NMDA type subunit 2B" Q13224 12 13437942-13981957 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 36.5" "Group enriched" "Detected in some" 10 "Early spermatids: 36.4;Late spermatids: 25.3" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 19.5;basal ganglia: 26.0;cerebral cortex: 36.5;hippocampal formation: 19.6;olfactory region: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.4;AF22: 3.4;CACO-2: 3.9;Daudi: 1.6;NTERA-2: 4.9;RPTEC TERT1: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069762 Approved NA NA "HPA069762: AB_2686192" "unprognostic (2.01e-2)" "unprognostic (4.07e-2)" "unprognostic (7.89e-2)" "unprognostic (3.77e-3)" "unprognostic (3.39e-3)" "unprognostic (9.36e-2)" "unprognostic (5.92e-2)" "unprognostic (1.77e-2)" "unprognostic (6.85e-2)" "unprognostic (2.24e-1)" "unprognostic (4.68e-2)" "unprognostic (4.12e-2)" "unprognostic (4.48e-5)" "unprognostic (2.43e-1)" "unprognostic (8.76e-2)" "unprognostic (1.63e-1)" "unprognostic (2.37e-1)" 1.9 0.9 19.5 0.8 26.0 0.8 0.9 0.9 36.5 0.8 1.9 1.9 0.0 0.8 0.8 0.8 0.9 0.8 0.8 0.8 19.6 3.5 1.0 1.6 0.8 1.4 1.8 15.0 0.9 0.8 0.8 0.4 0.9 2.6 0.8 1.2 0.0 0.8 0.8 0.8 0.8 1.8 0.8 0.8 0.9 1.0 1.5 3.6 0.0 0.8 0.0 1.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 26.0 0.9 36.5 19.6 3.5 1.8 15.0 2.6 3.6 0.0 0.0 0.0 0.0 0.0 0.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 36.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.0 GRIN2C "GluN2C, NMDAR2C" ENSG00000161509 "Glutamate ionotropic receptor NMDA type subunit 2C" Q14957 17 74842023-74861504 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 15.9;Hofbauer cells: 9.4;Muller glia cells: 18.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.3" "Region enriched" "Detected in many" 5 "cerebellum: 43.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 11.3;RPMI-8226: 4.0;SCLC-21H: 5.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 13 "cerebellum: 65.6" NA NA "unprognostic (7.21e-3)" "unprognostic (4.68e-2)" "unprognostic (9.38e-3)" "unprognostic (2.24e-5)" "unprognostic (3.42e-1)" "unprognostic (1.53e-2)" "unprognostic (1.84e-1)" "unprognostic (1.82e-2)" "unprognostic (1.78e-1)" "unprognostic (2.95e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-3)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (1.51e-2)" "unprognostic (1.14e-1)" 1.0 1.4 7.8 0.5 9.1 1.0 0.5 43.6 8.9 0.5 0.5 2.4 0.0 0.5 0.5 0.5 0.4 0.6 0.6 13.2 4.5 1.4 0.3 0.2 0.3 0.3 3.2 4.5 0.4 0.2 0.5 0.0 2.7 4.2 0.3 0.4 0.3 14.2 0.5 0.6 0.4 0.6 0.5 1.0 0.4 0.3 2.7 0.9 0.0 12.4 0.0 0.3 0.4 0.0 0.2 1.3 0.3 0.1 0.2 0.7 0.0 0.0 0.4 0.4 0.1 0.1 0.0 11.3 0.0 0.0 0.0 0.0 1.4 0.2 0.5 0.1 0.0 0.1 0.4 0.1 0.0 0.0 1.0 0.3 0.2 0.3 0.3 0.0 0.8 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 0.3 0.0 1.7 0.1 0.1 0.1 0.1 0.1 0.3 0.9 4.0 0.0 0.3 5.2 0.4 2.2 0.2 0.8 0.8 0.7 0.1 0.2 0.4 2.0 0.5 0.2 1.1 0.1 0.2 0.5 0.7 0.2 0.1 0.1 0.3 0.7 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.3 0.2 0.3 0.2 0.0 1.3 0.2 0.0 7.8 9.1 43.6 6.3 4.5 1.4 3.2 4.5 4.2 0.9 0.0 0.0 0.0 0.0 0.1 2.5 15.9 2.5 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 9.4 1.6 0.0 1.3 0.3 4.3 0.0 0.0 1.7 0.0 0.0 18.3 0.0 0.0 0.4 0.0 2.4 0.0 1.0 3.0 2.5 0.0 0.6 0.0 0.0 0.0 GRIN2D "EB11, GluN2D, NMDAR2D, NR2D" ENSG00000105464 "Glutamate ionotropic receptor NMDA type subunit 2D" O15399 19 48394875-48444931 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.9" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 2.8;Extravillous trophoblasts: 3.1;Ito cells: 3.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 12.9;EFO-21: 8.9;HMC-1: 22.0;NB-4: 12.9;SK-BR-3: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009006 Approved NA NA "CAB009006: AB_2279191" "unprognostic (9.96e-2)" "unprognostic (6.98e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-3)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (1.43e-4)" "unprognostic (7.84e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (6.66e-13)" "unprognostic (2.15e-2)" "unprognostic (1.92e-2)" "unprognostic (1.26e-3)" "unprognostic (1.14e-1)" 0.5 0.1 4.1 1.1 1.7 0.1 0.1 2.0 5.0 0.1 0.6 1.8 0.0 0.1 0.0 0.2 1.1 0.3 2.4 6.9 0.0 0.0 0.4 0.3 3.1 0.0 0.0 1.4 0.0 3.2 0.8 0.0 0.5 0.1 0.1 1.0 2.8 0.4 1.1 0.4 0.7 1.6 1.0 0.1 0.5 0.1 0.0 0.8 0.0 1.2 0.0 0.0 0.0 1.0 12.9 0.3 0.0 1.0 2.8 7.6 1.6 0.0 0.4 0.1 0.9 7.6 0.3 8.9 0.8 0.0 0.1 0.1 0.1 0.2 1.3 0.3 3.9 0.2 1.6 1.5 0.3 22.0 1.0 0.0 0.8 0.0 0.1 0.3 0.1 7.2 0.4 0.1 2.3 0.0 12.9 0.4 6.4 0.2 0.0 0.0 0.1 0.2 0.0 1.3 1.2 0.5 11.5 0.1 0.2 0.0 4.9 4.3 0.0 0.1 0.0 0.0 2.0 2.4 0.0 0.0 1.5 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.1 0.0 0.0 0.2 3.1 1.3 0.2 0.0 0.0 1.2 0.0 0.0 3.1 0.3 1.3 0.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.1 0.0 0.0 0.3 0.2 0.0 1.5 0.0 0.0 0.0 GRIN3A GluN3A ENSG00000198785 "Glutamate ionotropic receptor NMDA type subunit 3A" Q8TCU5 9 101569353-101738580 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 17.3" "Cell type enhanced" "Detected in some" 21 "Cone photoreceptor cells: 3.9;Early spermatids: 1.4;Sertoli cells: 6.5" "Cancer enriched" "Detected in single" 7 "prostate cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "intermediate monocyte: 3.3;non-classical monocyte: 2.5" "Lineage enriched" "Detected in single" 7 "monocytes: 3.3" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.29e-1)" "unprognostic (7.10e-3)" "unprognostic (3.01e-5)" "unprognostic (3.39e-2)" "unprognostic (6.32e-2)" "unprognostic (7.06e-4)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (7.56e-2)" "unprognostic (7.34e-3)" "unprognostic (1.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.87e-1)" "unprognostic (9.41e-2)" 0.6 0.6 7.4 0.8 4.2 0.5 0.7 0.4 17.3 4.1 1.0 2.6 0.0 0.6 1.0 1.0 0.5 0.6 0.5 1.2 6.8 6.4 0.6 0.6 0.7 1.1 3.8 12.4 2.4 0.5 0.4 0.4 0.4 4.6 1.8 0.8 2.7 0.6 2.6 0.7 1.0 0.7 0.7 3.0 1.8 0.6 1.0 2.3 0.0 0.5 0.0 0.8 0.5 0.6 0.0 0.4 0.1 3.3 0.0 0.4 0.2 0.0 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.2 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.3 0.7 0.1 0.5 0.3 0.4 0.1 0.0 0.3 6.4 0.7 0.2 0.2 0.2 0.6 0.2 0.3 0.3 0.4 0.1 0.7 0.3 0.6 1.0 0.3 0.7 0.3 1.2 0.0 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 2.5 0.0 0.4 0.2 7.4 4.2 0.4 13.4 6.8 6.4 3.8 12.4 4.6 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 GRIN3B GluN3B ENSG00000116032 "Glutamate ionotropic receptor NMDA type subunit 3B" O60391 19 1000419-1009732 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.7" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 2.7;Early spermatids: 2.6;Spermatogonia: 9.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 8.4" "Region enhanced" "Detected in single" "pons and medulla: 1.6" "Low region specificity" "Detected in some" NA NA "unprognostic (7.86e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-2)" "unprognostic (3.43e-3)" "unprognostic (1.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.36e-1)" "unprognostic (9.20e-2)" "unprognostic (1.49e-1)" "unprognostic (3.78e-3)" "unprognostic (9.35e-3)" "unprognostic (3.62e-2)" "unprognostic (3.34e-5)" "unprognostic (1.94e-1)" "unprognostic (1.63e-1)" "unprognostic (1.72e-1)" "unprognostic (1.33e-1)" 0.3 0.5 0.1 0.4 0.4 0.2 0.1 0.6 0.1 2.0 0.0 0.7 0.3 0.0 0.1 8.7 0.0 0.0 0.3 0.4 1.0 0.0 2.2 1.1 0.0 0.2 0.6 0.0 0.7 0.2 0.2 0.0 0.5 0.0 0.4 1.6 0.4 0.0 0.2 3.0 0.4 0.7 0.6 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 1.0 0.7 0.3 0.3 1.5 2.6 1.3 0.2 0.0 0.0 0.1 0.2 1.2 1.7 0.0 0.7 0.8 0.0 0.2 0.0 0.5 2.6 0.5 0.6 0.3 0.1 0.2 1.9 0.1 0.1 0.0 0.0 0.1 0.1 0.5 0.5 1.2 0.0 0.8 0.4 0.3 0.4 0.1 0.1 2.7 0.3 1.0 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.2 0.4 1.0 1.1 0.3 0.7 0.8 0.1 8.4 2.0 0.2 0.1 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 1.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 9.0 0.0 0.0 0.0 0.0 0.0 GRIP2 KIAA1719 ENSG00000144596 "Glutamate receptor interacting protein 2" 3 14489111-14556075 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 10.3;skeletal muscle: 25.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 9.4;Cardiomyocytes: 7.3;Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 21.1;Sertoli cells: 19.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.3;NTERA-2: 3.6;PC-3: 10.2;SCLC-21H: 5.7;U-2 OS: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035673 Approved Cytosol NA NA Cytosol "HPA035673: AB_10669776" "unprognostic (1.48e-1)" "unprognostic (6.26e-3)" "unprognostic (2.43e-2)" "unprognostic (3.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.14e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-2)" "unprognostic (9.14e-2)" "unprognostic (2.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (5.82e-1)" "unprognostic (4.01e-1)" 0.5 0.8 3.2 0.4 2.6 0.0 0.5 0.7 6.0 0.4 0.4 1.2 1.9 0.1 1.3 0.5 1.7 0.3 1.0 10.3 3.2 1.5 0.1 0.2 0.1 0.0 3.3 2.0 0.2 0.1 0.1 3.0 1.1 0.4 0.7 0.6 0.4 0.2 25.7 1.4 0.4 0.6 0.0 1.0 2.7 0.4 1.0 0.0 0.0 4.6 0.4 0.5 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.5 0.3 0.0 0.5 5.2 0.6 3.3 2.0 0.0 0.0 1.3 0.3 0.9 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 2.4 10.2 0.0 0.1 0.0 0.0 0.0 5.7 1.1 0.5 0.0 1.8 1.9 0.0 0.0 0.0 0.3 3.9 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 9.4 7.3 0.0 0.0 1.2 0.0 13.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.0 0.1 0.0 4.1 0.6 0.0 3.4 3.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.1 21.1 19.4 0.5 0.0 0.8 0.0 0.1 0.0 0.0 0.0 GRK1 "GPRK1, RHOK, RK" ENSG00000185974 "G protein-coupled receptor kinase 1" Q15835 13 113667155-113737735 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "retina: 51.5" "Group enriched" "Detected in some" 26 "Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 86.9" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035200, HPA059376" Enhanced NA NA "HPA035200: AB_2674515, HPA059376: AB_2683996" "unprognostic (7.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.24e-5)" "unprognostic (1.76e-3)" "unprognostic (1.53e-1)" "unprognostic (3.59e-2)" "unprognostic (2.21e-2)" "unprognostic (1.84e-3)" "unprognostic (2.00e-2)" "unprognostic (4.02e-2)" "unprognostic (6.91e-2)" "unprognostic (6.18e-2)" "unprognostic (6.11e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 86.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRK2 "ADRBK1, BARK1" ENSG00000173020 "G protein-coupled receptor kinase 2" P25098 11 67266410-67286556 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 78.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 26.5;granulocytes: 19.8;Hofbauer cells: 31.0;monocytes: 15.4;Pancreatic endocrine cells: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 56.3;REH: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005021, CAB037248, HPA048330" Enhanced Approved Vesicles NA NA Vesicles "CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: AB_2680361" "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (2.01e-2)" "unprognostic (5.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.29e-3)" "unprognostic (3.31e-2)" "unprognostic (6.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-2)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (3.66e-1)" "unprognostic (2.40e-1)" "unprognostic (4.04e-2)" "unprognostic (5.19e-3)" 13.1 10.7 24.5 35.8 17.0 78.2 17.0 32.9 35.3 12.8 17.2 12.2 12.6 17.5 11.4 9.9 20.2 12.6 17.6 13.6 21.9 17.4 13.0 14.1 19.1 42.8 13.4 19.0 9.8 10.4 9.7 12.2 12.7 15.7 17.8 16.2 9.3 17.4 20.8 20.8 23.5 26.3 12.2 12.5 59.6 17.4 6.8 11.1 35.9 10.1 13.6 37.5 17.1 15.5 4.1 6.0 21.0 18.3 3.8 5.3 7.4 7.6 5.4 5.3 8.9 4.3 3.9 5.3 4.6 4.4 6.3 5.2 12.0 12.8 39.5 7.4 4.2 8.4 10.4 7.7 6.2 3.3 48.1 4.8 22.4 6.2 5.4 5.3 47.0 45.0 3.5 7.3 5.0 6.7 4.7 8.0 16.2 8.1 20.3 5.4 14.3 26.1 56.3 6.6 23.1 8.2 74.7 10.5 11.7 6.4 10.1 10.7 5.8 6.8 10.0 16.3 3.4 9.2 51.1 4.4 5.0 6.6 6.3 5.1 12.9 11.9 35.4 6.5 27.9 4.5 6.9 10.3 10.5 5.3 15.9 4.0 3.8 4.0 4.3 6.0 4.1 3.2 3.1 21.0 3.8 18.3 5.3 2.6 7.4 24.5 17.0 32.9 35.3 21.9 17.4 13.4 19.0 15.7 11.1 3.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.9 5.2 0.0 7.8 1.7 9.4 0.0 0.0 0.0 0.0 10.9 5.1 0.0 0.0 19.8 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 15.4 0.0 0.0 22.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 GRK3 "ADRBK2, BARK2" ENSG00000100077 "G protein-coupled receptor kinase 3" P35626 22 25564849-25729294 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.0" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000804 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA000804: AB_1078281" "unprognostic (1.02e-1)" "unprognostic (4.38e-2)" "unprognostic (5.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.09e-1)" "unprognostic (3.67e-2)" "unprognostic (3.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (3.54e-1)" "unprognostic (1.95e-3)" "unprognostic (5.79e-2)" "unprognostic (1.01e-3)" "unprognostic (1.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.89e-2)" "prognostic favorable (1.29e-4)" 28.0 6.0 11.9 12.4 10.8 7.0 11.3 7.9 18.9 4.7 4.0 3.1 0.7 3.0 5.7 3.1 2.7 9.1 5.0 4.6 15.7 8.3 3.0 3.4 9.4 14.1 9.7 9.8 4.1 8.4 4.4 8.2 4.5 9.6 8.2 4.3 4.8 3.7 1.9 1.4 4.1 6.1 6.2 4.9 23.2 4.0 14.8 2.7 11.6 4.5 1.3 15.2 6.7 2.5 6.2 3.7 5.6 8.0 0.0 0.4 1.6 0.0 1.9 5.8 1.9 4.1 0.5 8.5 0.6 1.8 1.8 3.2 3.0 3.3 10.6 0.1 0.1 5.2 0.1 5.8 4.3 5.5 20.4 3.8 4.9 0.6 6.7 0.1 15.8 8.3 1.0 3.0 1.3 2.3 0.3 0.3 33.6 0.5 0.0 2.1 2.6 11.3 1.1 4.1 5.7 0.0 5.1 9.3 1.8 0.0 3.1 13.7 18.5 1.0 0.0 4.4 5.6 1.6 6.3 0.1 0.0 12.0 0.1 2.3 1.2 4.2 8.3 7.8 5.6 1.8 0.6 4.8 5.6 0.0 8.0 0.3 4.9 0.0 0.3 3.7 6.2 0.1 0.2 0.3 0.0 7.4 3.2 0.4 1.6 11.9 10.8 7.9 18.9 15.7 8.3 9.7 9.8 9.6 2.7 14.9 44.1 0.0 0.0 0.0 0.0 0.0 0.0 12.0 30.7 0.0 0.0 1.5 1.7 7.0 0.0 0.0 0.0 0.0 1.6 22.7 0.0 0.0 17.4 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 47.7 0.0 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 GRK4 "GPRK2L, GPRK4" ENSG00000125388 "G protein-coupled receptor kinase 4" P32298 4 2963608-3040747 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.2" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 115.8;Early spermatids: 282.7;Late spermatids: 377.5;Spermatocytes: 110.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028737, HPA057023" Approved Approved Lysosomes NA NA Lysosomes "HPA028737: AB_2672757, HPA057023: AB_2683313" "unprognostic (1.86e-2)" "unprognostic (2.88e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (3.65e-1)" "unprognostic (1.84e-1)" "unprognostic (1.21e-1)" "unprognostic (2.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.87e-1)" "unprognostic (3.90e-4)" "unprognostic (3.20e-1)" "unprognostic (1.01e-2)" "unprognostic (4.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.89e-1)" 3.4 3.6 5.4 1.6 5.1 1.7 4.8 12.5 5.9 3.0 2.1 4.2 1.0 1.5 2.7 3.1 2.4 2.0 3.0 5.6 5.2 4.8 2.8 2.3 2.4 1.6 5.3 5.3 3.4 7.9 3.9 6.2 2.2 5.9 2.4 2.0 3.1 4.0 2.9 5.0 2.9 1.7 2.8 5.4 1.9 2.5 41.2 3.7 1.6 4.1 1.6 1.7 2.5 3.3 1.2 2.5 4.5 2.0 1.6 1.7 1.0 2.5 0.9 3.0 8.7 7.4 7.1 1.9 4.9 2.1 2.8 2.4 2.4 0.8 5.6 2.1 7.7 5.4 0.8 4.0 4.0 2.5 3.8 4.0 6.1 3.5 2.8 4.4 2.4 2.2 4.8 6.3 4.9 2.3 3.1 5.2 6.0 5.7 7.4 6.5 2.8 5.2 5.2 2.4 3.5 6.9 6.6 3.9 2.2 2.6 3.1 17.6 5.4 2.9 1.3 4.4 2.2 6.7 3.8 6.0 7.6 2.0 5.1 4.3 7.6 4.3 4.3 3.7 5.4 2.5 4.5 1.1 2.1 1.1 2.0 1.4 1.1 0.7 0.7 0.3 1.2 1.7 1.6 4.0 1.6 0.7 2.5 0.4 1.0 5.4 5.1 12.5 5.9 5.2 4.8 5.3 5.3 5.9 3.7 3.0 9.0 0.0 2.5 10.0 48.5 9.0 7.6 1.4 7.9 3.5 115.8 1.8 11.6 2.4 282.7 3.8 1.0 0.0 3.3 3.5 9.9 1.5 5.7 2.5 3.0 17.5 9.9 3.1 2.2 377.5 12.0 3.2 6.8 2.8 1.7 10.3 1.8 0.0 7.8 3.6 48.9 6.5 4.4 110.9 13.6 9.9 2.5 4.4 1.2 2.3 GRK6 GPRK6 ENSG00000198055 "G protein-coupled receptor kinase 6" P43250 5 177403204-177442901 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.1" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 57.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015327, HPA018903" Approved Approved Mitochondria NA NA 7500 Mitochondria "HPA015327: AB_1850334, HPA018903: AB_1850335" "unprognostic (1.06e-1)" "unprognostic (3.39e-2)" "unprognostic (4.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.66e-6)" "unprognostic (2.63e-1)" "unprognostic (6.45e-2)" "unprognostic (8.96e-2)" "prognostic favorable (1.22e-4)" "unprognostic (1.74e-2)" "unprognostic (1.99e-2)" "unprognostic (1.83e-3)" "unprognostic (1.15e-1)" "unprognostic (4.00e-2)" "unprognostic (3.47e-1)" 6.8 5.5 7.8 26.8 7.3 68.1 10.2 7.7 10.9 5.9 9.2 6.6 5.0 10.9 8.0 6.0 11.0 6.6 9.3 6.2 8.0 7.3 5.7 6.6 11.1 37.6 7.1 10.7 6.1 12.1 3.5 5.6 4.9 6.7 8.1 5.5 5.0 10.8 5.2 7.4 7.7 14.5 7.8 5.4 34.3 9.1 10.5 5.1 32.3 5.3 6.4 26.5 11.4 6.5 9.2 5.7 32.1 22.6 17.4 11.7 9.1 12.1 13.3 4.8 21.1 1.4 2.4 20.7 8.9 4.7 11.3 11.2 30.8 10.4 14.5 13.7 4.7 16.7 8.9 7.5 20.5 4.4 39.6 23.4 12.8 10.8 10.4 7.9 17.2 16.3 3.8 5.1 11.2 6.6 2.8 6.3 26.7 13.3 52.3 3.4 34.8 17.7 18.1 8.3 6.1 14.7 17.0 7.8 20.9 3.3 9.9 11.2 15.2 7.4 13.1 17.3 2.3 10.4 19.0 8.0 9.2 13.8 9.8 22.4 15.1 18.3 11.8 6.2 28.2 8.9 4.5 9.5 32.1 11.7 16.5 8.4 9.2 9.8 10.7 5.5 9.2 10.4 9.0 23.2 17.4 22.6 5.7 11.7 9.1 7.8 7.3 7.7 10.9 8.0 7.3 7.1 10.7 6.7 5.1 0.0 2.1 37.2 46.6 21.1 9.5 2.0 7.6 0.0 3.4 3.5 5.9 10.9 13.3 3.9 31.4 4.5 11.3 23.3 7.1 10.5 8.0 37.0 14.9 5.3 18.5 15.9 10.9 8.6 27.3 57.4 5.8 20.0 13.5 1.8 13.4 6.1 8.1 13.3 4.9 6.9 7.3 12.9 10.3 2.2 3.6 17.8 10.6 41.1 16.3 52.8 GRK7 GPRK7 ENSG00000114124 "G protein-coupled receptor kinase 7" Q8WTQ7 3 141778148-141818490 "Enzymes, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.4" "Cell type enriched" "Detected in some" 168 "Cone photoreceptor cells: 310.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HeLa: 1.5;U-937: 1.8" "Not detected" "Not detected" "HPA075093, HPA078232" Enhanced Approved Mitochondria NA NA Mitochondria "HPA075093: , HPA078232: " "unprognostic (1.11e-1)" "unprognostic (1.70e-2)" "unprognostic (3.35e-3)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-2)" "unprognostic (5.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.53e-8)" "unprognostic (3.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.91e-1)" 0.2 0.5 0.3 0.5 0.4 1.5 0.2 0.9 0.3 0.2 0.1 0.4 0.3 0.0 0.3 0.3 0.0 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.6 0.3 0.7 0.2 0.2 0.3 0.0 0.4 0.2 1.6 1.5 0.4 0.0 0.2 0.4 0.1 1.0 0.1 0.3 0.1 0.3 0.7 0.2 2.4 0.4 0.5 0.6 0.1 0.0 0.1 0.1 0.6 0.4 0.0 4.1 0.1 0.0 0.0 0.1 0.2 0.6 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.5 0.5 0.2 1.5 0.2 0.0 0.4 0.3 0.1 1.1 0.0 0.1 0.0 0.0 0.3 0.2 0.2 0.0 0.2 0.2 0.7 0.4 0.2 0.2 0.2 0.1 0.2 0.0 0.5 0.3 0.4 0.2 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 1.8 0.2 0.2 0.4 0.3 0.4 0.2 0.6 0.6 0.5 0.3 0.1 0.7 0.5 0.5 2.4 0.5 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.3 1.0 0.2 0.0 0.0 0.0 0.0 310.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 GRM1 "GPRC1A, mGlu1, MGLUR1, PPP1R85" ENSG00000152822 "Glutamate metabotropic receptor 1" Q13255 6 146027646-146437598 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 113.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 39.9" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015701 Approved Supported Approved Vesicles NA NA Vesicles "HPA015701: AB_1853917" "unprognostic (1.04e-2)" "unprognostic (7.33e-2)" "unprognostic (3.73e-3)" "unprognostic (9.77e-3)" "unprognostic (6.75e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-2)" "unprognostic (4.31e-2)" "unprognostic (2.93e-2)" "unprognostic (9.48e-3)" "unprognostic (7.92e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (8.33e-3)" "unprognostic (9.76e-2)" 0.5 0.5 6.6 0.4 6.0 0.4 0.5 39.9 13.0 0.5 0.5 0.9 0.0 0.4 0.5 0.7 0.5 0.7 0.5 7.7 6.0 2.7 2.7 0.5 0.6 0.5 2.6 4.1 0.5 0.5 0.4 0.2 0.5 3.6 0.5 0.4 2.6 0.5 0.8 0.4 0.5 0.5 0.5 1.0 0.6 0.5 1.3 0.9 0.0 0.8 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.3 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.6 0.0 0.0 1.2 0.1 0.0 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.9 0.5 0.1 0.1 0.4 0.1 0.0 0.4 0.1 0.0 0.1 0.6 0.2 0.2 0.0 0.1 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 6.6 6.0 39.9 10.5 6.0 2.7 2.6 4.1 3.6 0.9 0.0 0.0 0.0 0.0 0.0 13.4 3.9 0.0 0.0 0.0 1.8 15.7 0.0 1.7 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 113.7 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 GRM2 "GPRC1B, mGlu2, MGLUR2" ENSG00000164082 "Glutamate metabotropic receptor 2" Q14416 3 51707070-51718613 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 13.2" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 1.6;Spermatocytes: 3.7" "Cancer enhanced" "Detected in single" "testis cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027868, HPA065166" Approved Supported NA NA "HPA027868: , HPA065166: AB_2685425" "unprognostic (1.01e-1)" "unprognostic (8.61e-4)" "unprognostic (7.66e-2)" "unprognostic (7.29e-3)" "unprognostic (1.98e-1)" "unprognostic (3.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.45e-1)" "unprognostic (1.74e-1)" "unprognostic (1.37e-2)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (2.93e-2)" "unprognostic (1.19e-2)" 0.8 0.6 4.6 0.8 6.3 1.6 0.7 3.8 13.2 0.6 0.6 0.4 0.0 0.6 0.8 0.4 0.5 0.5 0.4 0.9 3.0 3.1 0.5 0.5 0.6 0.7 1.2 7.0 0.5 0.4 0.4 0.4 0.6 8.3 0.7 0.5 0.6 0.8 0.6 1.8 1.3 0.5 0.6 0.5 1.1 0.5 1.3 0.2 0.0 0.5 0.0 0.5 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 6.3 3.8 13.2 3.0 3.1 1.2 7.0 8.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 1.6 0.0 0.0 3.7 0.9 0.3 0.0 0.0 0.0 0.0 GRM3 "GPRC1C, mGlu3, MGLUR3" ENSG00000198822 "Glutamate metabotropic receptor 3" Q14832 7 86643914-86864884 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "brain: 53.3" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 5.4;Cone photoreceptor cells: 3.9;Early spermatids: 16.8;Horizontal cells: 12.7" "Cancer enriched" "Detected in single" 7 "glioma: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (2.05e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-1)" "unprognostic (2.70e-3)" "unprognostic (3.16e-1)" "unprognostic (1.07e-3)" "unprognostic (6.99e-3)" "unprognostic (2.98e-1)" "unprognostic (2.71e-1)" "unprognostic (9.13e-3)" "unprognostic (1.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.91e-3)" "unprognostic (4.00e-2)" "unprognostic (9.34e-2)" "unprognostic (1.72e-3)" "unprognostic (1.12e-2)" 1.2 2.2 10.6 1.2 22.5 1.2 1.2 4.6 53.3 1.3 1.3 23.9 0.0 1.3 1.3 1.2 1.2 1.2 1.3 1.3 12.6 5.6 1.4 1.2 1.3 1.2 18.9 13.0 1.2 1.2 1.2 0.2 1.2 11.5 1.7 1.2 0.0 1.3 1.3 2.1 1.2 1.2 1.2 12.0 1.8 1.3 2.2 22.1 0.0 1.2 0.0 1.2 1.4 0.1 0.5 0.1 0.5 0.0 0.1 0.3 0.1 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 10.6 22.5 4.6 20.2 12.6 5.6 18.9 13.0 11.5 22.1 0.0 0.0 0.0 0.7 0.1 5.4 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 16.8 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.5 0.3 0.0 1.7 0.0 0.0 0.3 0.1 0.0 0.4 0.0 1.8 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 GRM4 "GPRC1D, mGlu4, MGLUR4" ENSG00000124493 "Glutamate metabotropic receptor 4" Q14833 6 34018645-34155622 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "brain: 101.6" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 1.8;Early spermatids: 3.4;Intestinal endocrine cells: 2.9;Late spermatids: 1.5;Spermatogonia: 4.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Region enriched" "Detected in many" 21 "cerebellum: 101.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 6.5;SCLC-21H: 26.0" "Region enhanced" "Detected in all" "cerebellum: 83.5" "Region enriched" "Detected in all" 4 "cerebellum: 252.6" CAB022096 Enhanced NA NA "CAB022096: " "unprognostic (1.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (7.00e-2)" "unprognostic (4.03e-2)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (3.56e-1)" "unprognostic (9.45e-2)" "unprognostic (2.08e-2)" "unprognostic (6.21e-3)" "unprognostic (2.44e-1)" "unprognostic (2.15e-11)" "unprognostic (5.32e-2)" "unprognostic (9.16e-2)" "unprognostic (6.57e-2)" "unprognostic (3.07e-1)" 0.2 0.1 0.4 0.3 4.9 0.2 0.2 101.6 7.2 0.6 0.1 0.3 0.1 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.5 0.9 0.2 0.3 0.3 0.2 0.3 0.4 0.2 3.5 0.1 0.0 0.3 4.3 0.3 0.2 0.1 0.1 0.2 0.3 0.6 0.8 0.7 1.1 0.1 0.2 1.6 0.5 0.0 0.3 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.9 101.6 1.0 0.5 0.9 0.3 0.4 4.3 0.5 0.0 0.0 0.0 0.3 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 4.0 0.0 0.1 0.0 0.0 0.1 GRM5 "GPRC1E, mGlu5, MGLUR5, PPP1R86" ENSG00000168959 "Glutamate metabotropic receptor 5" P41594 11 88504576-89065945 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 27.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 27.0;Early spermatids: 14.2;Late spermatids: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "Hep G2: 2.2;U-266/70: 1.5;U-937: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.94e-1)" "unprognostic (9.62e-2)" "unprognostic (9.57e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (2.62e-1)" "unprognostic (1.26e-1)" "unprognostic (7.16e-2)" "unprognostic (8.15e-4)" "unprognostic (3.43e-2)" 0.5 0.5 11.4 0.5 11.0 0.6 0.5 2.6 27.7 0.6 0.5 1.0 0.0 0.5 0.5 0.5 0.5 0.7 0.7 0.5 6.0 3.2 0.7 0.5 0.7 0.5 2.1 10.0 0.5 0.5 0.5 0.8 0.6 1.5 0.5 0.5 0.0 0.5 0.5 0.6 1.1 0.5 0.5 1.2 0.6 0.5 3.1 1.5 0.0 0.5 0.0 0.5 0.5 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.7 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.6 0.2 0.0 0.0 1.5 0.0 0.2 0.1 1.1 0.8 1.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.4 11.0 2.6 13.2 6.0 3.2 2.1 10.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 27.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 15.3 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 GRM6 "CSNB1B, GPRC1F, mGlu6, MGLUR6" ENSG00000113262 "Glutamate metabotropic receptor 6" O15303 5 178978327-178996206 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Receptor, Transducer" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 22.0" "Cell type enriched" "Detected in some" 31 "Bipolar cells: 422.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA014511 Enhanced NA NA "HPA014511: AB_2669025" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (8.41e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-1)" "unprognostic (2.25e-3)" "unprognostic (7.72e-2)" "unprognostic (2.32e-2)" "unprognostic (2.12e-3)" "unprognostic (6.27e-2)" "unprognostic (3.34e-4)" "unprognostic (2.58e-1)" "unprognostic (3.36e-4)" "unprognostic (1.23e-1)" "unprognostic (6.45e-2)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" 0.3 0.5 0.6 0.4 0.6 1.6 0.3 1.9 1.6 0.4 0.4 0.3 0.3 0.3 0.6 0.5 0.3 0.5 0.7 0.4 0.5 1.2 0.4 0.4 0.4 0.5 0.8 0.3 0.7 0.9 0.1 2.9 0.3 1.2 1.1 0.1 22.0 0.6 0.3 1.3 1.8 0.3 0.3 0.3 0.5 0.3 2.2 0.3 0.3 0.9 0.3 0.3 0.3 0.3 0.9 1.1 2.4 0.4 0.6 0.6 0.1 0.5 0.3 0.7 1.3 0.3 0.1 0.7 0.2 0.0 0.1 0.0 0.5 0.9 0.9 0.6 0.0 0.6 0.7 0.0 0.1 0.0 0.2 0.7 0.5 0.7 1.0 0.2 0.8 1.0 0.1 0.3 0.1 0.5 0.3 0.0 0.9 0.9 1.7 0.0 1.0 0.2 0.8 0.6 0.5 0.6 0.6 0.3 0.8 0.1 0.6 0.9 1.2 0.5 0.7 0.5 1.1 0.9 1.1 0.9 0.5 0.5 0.4 0.5 0.7 0.6 0.4 0.4 0.7 0.3 1.9 0.4 0.5 0.6 0.3 0.4 0.4 0.4 0.3 0.2 0.9 0.4 0.4 2.4 0.6 0.2 1.1 0.2 0.1 0.6 0.6 1.9 0.5 0.5 1.2 0.8 0.3 1.2 0.3 0.0 0.3 0.0 0.1 0.3 422.6 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.0 0.0 3.7 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.8;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 22.5;Early spermatids: 24.2;Late spermatids: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.9 5.3 8.1 0.6 10.5 0.6 0.9 1.6 15.8 2.9 0.8 2.1 0.0 0.9 3.1 0.5 0.6 1.0 0.7 0.6 11.1 9.3 0.5 0.7 0.8 0.5 2.3 10.1 0.8 0.7 11.3 0.6 0.9 4.3 1.2 0.8 0.8 2.1 1.4 0.5 0.6 0.6 5.9 2.8 0.8 0.6 2.8 4.1 0.0 0.7 0.0 0.7 1.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.5 1.6 15.8 11.1 9.3 2.3 10.1 4.3 4.1 0.0 0.0 0.0 0.9 0.1 22.5 1.1 7.6 6.7 1.2 0.0 7.9 0.0 1.7 0.0 24.2 0.1 0.0 0.0 0.0 0.1 0.7 1.1 1.1 0.0 0.1 1.6 0.0 0.0 0.0 29.9 0.3 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.2 6.5 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.6 GRM8 "GLUR8, GPRC1H, mGlu8, MGLUR8" ENSG00000179603 "Glutamate metabotropic receptor 8" O00222 7 126438598-127253294 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.5;liver: 8.0" "Group enriched" "Detected in some" 22 "Early spermatids: 53.0;Late spermatids: 55.2" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.6;HEK 293: 2.9;NTERA-2: 7.2;RH-30: 4.3;SCLC-21H: 6.5;SH-SY5Y: 3.5;U-2 OS: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051481 Uncertain NA NA "HPA051481: AB_2681499" "unprognostic (4.57e-3)" "unprognostic (5.10e-4)" "unprognostic (1.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.83e-1)" "unprognostic (5.54e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-1)" "unprognostic (8.90e-2)" "unprognostic (1.31e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-1)" "unprognostic (3.12e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (1.32e-2)" "unprognostic (1.12e-2)" 0.2 1.5 2.0 2.0 4.6 0.1 0.2 1.1 6.4 0.3 4.5 4.0 0.0 0.3 0.3 0.3 0.2 0.5 3.5 5.5 2.6 4.0 1.9 8.0 0.7 0.2 2.9 2.6 2.3 1.4 0.2 0.7 0.2 14.5 0.4 5.0 3.5 0.2 0.2 0.1 0.3 0.2 0.5 1.2 0.2 0.8 3.8 1.5 0.0 2.4 0.0 0.3 1.4 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 7.2 0.0 0.1 0.0 4.3 0.1 0.2 0.0 6.5 3.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 2.3 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.6 1.1 5.4 2.6 4.0 2.9 2.6 14.5 1.5 0.0 0.0 0.0 0.0 0.0 0.2 1.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.2 0.6 0.0 55.2 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.6 0.0 GRP ENSG00000134443 "Gastrin releasing peptide" P07492 18 59220168-59230774 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.6;pituitary gland: 13.2;retina: 22.5" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 8.5;Glandular cells: 6.6;Late spermatids: 9.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BJ hTERT+: 8.6;fHDF/TERT166: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 12.7;hippocampal formation: 34.7;midbrain: 24.8" "Secreted to blood" NA NA 340000 "unprognostic (3.91e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-3)" "unprognostic (3.21e-2)" "unprognostic (7.86e-3)" "unprognostic (3.01e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (1.79e-1)" "unprognostic (5.86e-4)" "unprognostic (2.65e-4)" "unprognostic (9.94e-2)" "unprognostic (6.99e-2)" "unprognostic (5.16e-2)" 0.7 0.7 3.6 0.5 0.7 0.2 5.2 0.5 3.7 0.5 2.3 1.3 0.0 0.4 0.9 0.9 0.6 0.3 1.3 0.2 11.7 5.6 0.3 0.2 15.6 0.2 4.9 0.7 0.2 4.7 4.7 13.2 0.2 10.5 1.9 0.4 22.5 0.2 0.5 0.2 0.4 0.7 2.3 1.6 0.3 12.7 3.0 0.1 0.1 11.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.7 0.0 10.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 0.5 3.7 11.7 5.6 4.9 0.7 10.5 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 GRPEL2 "DKFZp451C205, FLJ23713, Mt-GrpE#2" ENSG00000164284 "GrpE like 2, mitochondrial" Q8TAA5 5 149345430-149354583 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 43.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018173, HPA023211" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA018173: AB_1850358, HPA023211: AB_1850360" "unprognostic (3.13e-2)" "unprognostic (1.69e-1)" "prognostic favorable (3.87e-5)" "prognostic unfavorable (2.21e-4)" "unprognostic (3.22e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (6.16e-8)" "unprognostic (1.34e-1)" "unprognostic (8.16e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.20e-4)" "unprognostic (3.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.20e-1)" "unprognostic (2.26e-1)" 7.4 5.1 5.4 6.5 6.4 5.3 9.8 10.9 8.9 13.3 4.8 3.7 3.9 6.0 5.4 5.8 43.1 5.1 4.3 6.3 5.5 5.6 7.5 5.7 10.2 8.1 5.1 5.2 7.5 6.8 7.2 6.5 8.5 8.4 5.1 4.8 3.7 7.2 6.7 7.8 5.4 5.8 4.3 4.4 5.9 6.1 4.9 5.1 7.4 7.9 14.4 12.8 6.1 11.5 3.5 3.8 8.2 2.5 3.7 13.5 4.6 9.1 4.9 7.2 25.6 4.6 4.7 14.3 8.1 6.9 7.9 11.1 12.0 6.1 9.4 8.6 4.2 10.7 7.0 11.4 11.7 10.1 5.0 9.5 11.9 9.4 6.8 13.7 11.1 6.1 6.9 14.4 9.7 15.3 3.3 4.7 12.4 10.3 23.4 5.8 6.4 7.3 9.6 9.4 5.6 18.0 9.1 9.9 12.5 5.1 8.5 14.8 12.2 8.1 15.1 24.1 4.9 13.2 13.4 5.3 8.6 9.5 6.1 11.9 8.6 11.5 9.2 8.6 16.3 7.7 8.2 2.5 3.3 5.1 2.4 6.2 3.5 7.7 5.7 3.8 1.9 10.3 7.7 1.9 3.7 2.5 1.0 13.5 4.6 5.4 6.4 10.9 8.9 5.5 5.6 5.1 5.2 8.4 5.1 8.9 5.4 1.4 4.4 15.9 6.6 7.7 2.5 1.4 4.5 8.7 7.9 7.8 1.7 5.1 5.7 14.0 4.5 0.0 5.1 14.0 6.0 4.4 2.3 7.5 5.1 3.2 5.8 18.4 10.1 4.0 3.7 3.6 6.8 3.6 4.4 4.3 6.3 3.5 4.9 4.8 6.6 0.0 5.1 10.3 10.8 17.1 4.7 6.9 7.0 6.7 GRPR "BB2, BB2R" ENSG00000126010 "Gastrin releasing peptide receptor" P30550 X 16123556-16153021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 24.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 6.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "PC-3: 18.0;T-47d: 22.5;U-138 MG: 30.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069604 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA069604: AB_2686158" "unprognostic (3.32e-2)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (2.87e-1)" "unprognostic (9.17e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (1.01e-1)" "unprognostic (3.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (5.59e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-1)" "unprognostic (2.86e-2)" 0.5 0.4 3.4 4.7 2.3 0.2 3.5 0.3 3.5 3.7 1.4 0.0 2.5 0.2 1.0 2.8 7.5 0.3 0.2 0.5 3.5 0.4 0.3 0.3 0.4 0.2 0.3 1.9 0.3 24.5 0.4 0.3 0.2 1.1 0.7 0.6 2.0 0.4 0.4 0.4 0.3 0.5 1.2 0.4 0.3 2.1 0.4 0.0 0.0 0.4 0.0 0.2 0.4 0.4 0.6 0.2 0.4 1.9 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.5 0.0 2.3 1.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 22.5 0.0 0.1 30.8 0.3 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.4 0.0 1.6 0.1 0.0 0.4 3.4 2.3 0.3 3.5 3.5 0.4 0.3 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRSF1 ENSG00000132463 "G-rich RNA sequence binding factor 1" Q12849 4 70815782-70839945 "Predicted intracellular proteins" "mRNA processing, tRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.8" "Cell type enhanced" "Detected in many" 9 "monocytes: 449.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036984, HPA036985" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA036984: AB_2675415, HPA036985: AB_10672785" "unprognostic (1.45e-3)" "unprognostic (1.82e-2)" "prognostic favorable (1.47e-5)" "unprognostic (8.63e-2)" "unprognostic (6.73e-2)" "unprognostic (4.15e-3)" "prognostic unfavorable (8.29e-5)" "unprognostic (1.94e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (7.68e-2)" "unprognostic (8.05e-2)" "prognostic favorable (2.72e-9)" "unprognostic (6.12e-2)" "unprognostic (1.23e-1)" "unprognostic (1.78e-1)" "unprognostic (9.65e-3)" 17.9 33.4 21.3 22.3 19.9 8.8 29.0 19.1 42.5 16.8 22.7 19.7 15.0 18.1 17.2 18.2 21.7 18.9 22.9 33.3 22.9 22.6 23.9 23.6 23.7 24.6 24.8 20.2 17.3 26.9 19.6 13.7 18.3 23.6 17.7 27.1 12.0 32.1 20.9 101.8 18.7 17.2 18.1 24.1 17.3 22.5 13.6 19.1 37.0 19.7 31.1 21.7 21.1 15.4 5.7 20.0 7.6 11.6 14.3 11.7 5.6 32.3 22.1 26.0 27.0 27.6 32.3 37.4 39.3 24.9 29.7 24.4 22.5 33.3 46.8 30.1 40.4 15.4 12.4 46.0 30.7 39.8 25.4 15.1 24.6 22.7 31.1 34.1 35.9 14.2 27.1 29.6 29.9 20.9 35.9 30.5 26.1 28.1 27.2 41.2 34.6 59.1 25.3 27.7 35.4 23.4 24.4 40.5 19.9 36.6 40.5 27.2 24.5 18.5 52.8 64.8 31.8 22.9 17.7 27.8 27.8 29.3 22.9 24.7 22.7 18.0 30.1 23.0 23.4 27.0 7.6 11.6 5.2 7.6 8.8 9.5 5.7 11.2 11.7 20.0 4.9 11.2 9.5 1.6 14.3 10.5 19.3 9.3 5.6 21.3 19.9 19.1 42.5 22.9 22.6 24.8 20.2 23.6 19.1 29.8 29.3 32.1 42.4 44.4 17.5 125.4 40.8 21.4 26.1 26.2 23.6 87.9 63.0 61.2 5.7 32.2 41.3 0.0 53.0 115.0 34.8 51.4 17.3 45.7 56.0 27.0 66.2 28.8 58.2 5.3 32.2 42.5 59.1 449.1 69.7 23.1 55.3 42.1 36.7 56.1 17.4 19.4 40.1 21.9 55.1 44.2 64.5 37.9 79.0 54.6 GRTP1 "FLJ22474, TBC1D6" ENSG00000139835 "Growth hormone regulated TBC protein 1" Q5TC63 13 113324164-113364148 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 39.2;liver: 37.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 30.2;T-47d: 27.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA046201 Enhanced NA NA "HPA046201: AB_2679584" "unprognostic (5.31e-2)" "unprognostic (2.27e-3)" "unprognostic (1.94e-1)" "unprognostic (1.89e-1)" "unprognostic (4.42e-2)" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (6.05e-2)" "unprognostic (1.30e-2)" "unprognostic (3.07e-3)" "prognostic favorable (1.50e-5)" "unprognostic (4.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.56e-2)" "unprognostic (4.50e-3)" 2.1 7.2 1.9 7.0 2.2 1.5 8.6 1.1 1.9 7.6 25.9 1.3 14.6 28.2 6.4 7.4 10.5 4.8 16.7 1.2 3.3 1.0 10.8 37.4 2.9 2.4 1.8 2.4 6.6 11.5 2.8 1.4 8.7 4.1 8.7 8.2 9.0 12.1 8.3 5.5 14.4 39.2 4.5 3.2 3.7 7.5 9.4 3.1 1.8 1.9 5.0 6.2 6.5 8.0 3.3 2.8 6.7 2.5 1.6 2.4 1.9 5.3 1.9 4.0 6.8 0.7 1.0 12.3 0.9 0.0 0.3 0.1 11.1 12.1 0.3 0.9 0.3 2.8 7.9 3.3 0.9 0.0 0.2 4.6 6.8 5.6 10.9 1.1 0.7 2.7 0.3 1.5 0.8 0.2 0.6 0.0 0.7 4.1 0.5 0.0 10.0 0.1 1.2 10.8 30.2 1.6 0.8 0.2 0.3 0.9 6.3 0.5 3.5 0.3 5.8 1.3 4.9 27.9 0.7 0.5 0.3 1.5 1.0 0.4 2.1 2.3 0.9 4.4 1.6 2.3 4.0 2.5 2.2 1.3 1.4 1.0 2.8 1.6 1.0 0.9 3.3 2.4 1.6 6.7 1.6 2.2 2.8 0.5 1.9 1.9 2.2 1.1 1.9 3.3 1.0 1.8 2.4 4.1 3.1 0.0 5.9 2.7 20.8 19.3 5.1 1.2 28.1 9.4 10.3 3.5 76.6 24.4 19.9 9.0 0.4 2.4 45.1 0.0 8.3 8.3 2.8 12.9 0.0 27.9 1.5 3.2 3.5 7.4 0.6 0.4 7.5 1.2 1.7 4.6 27.1 11.6 8.7 40.7 8.1 29.1 67.2 0.0 6.2 0.2 10.3 20.7 21.2 0.9 35.3 23.4 GRXCR1 "DFNB25, PPP1R88" ENSG00000215203 "Glutaredoxin and cysteine rich domain containing 1" A8MXD5 4 42893267-43030658 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "seminal vesicle: 11.0" "Cell type enriched" "Detected in single" 9 "Early spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040824 Uncertain NA NA "HPA040824: AB_10794863" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 GRXCR2 DFNB101 ENSG00000204928 "Glutaredoxin and cysteine rich domain containing 2" A6NFK2 5 145858521-145937126 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "heart muscle: 2.9;skin 1: 2.0;testis: 3.5" "Group enriched" "Detected in some" 15 "Early spermatids: 14.9;Late spermatids: 8.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "CACO-2: 1.5;GAMG: 1.1;RPMI-8226: 1.5;T-47d: 1.1;U-87 MG: 1.0" "Region enriched" "Detected in single" 4 "amygdala: 1.3" "Low region specificity" "Detected in all" HPA059421 Uncertain NA NA "HPA059421: AB_2684010" "unprognostic (4.71e-2)" "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 3.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 1.5 0.4 0.1 0.2 0.0 1.1 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.5 0.1 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSAP "LOC54103, PION" ENSG00000186088 "Gamma-secretase activating protein" A4D1B5 7 77310751-77416400 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 33.1" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 11.2;U-937: 14.7" "Low region specificity" "Detected in many" HPA023994 Approved Vesicles NA NA Vesicles "HPA023994: AB_1855386" "prognostic favorable (3.36e-4)" "unprognostic (3.70e-1)" "unprognostic (8.55e-3)" "unprognostic (4.53e-3)" "unprognostic (6.80e-3)" "unprognostic (3.52e-3)" "unprognostic (4.36e-2)" "unprognostic (7.18e-3)" "unprognostic (1.09e-1)" "unprognostic (9.98e-3)" "unprognostic (2.07e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (3.61e-1)" "unprognostic (1.82e-2)" "unprognostic (9.49e-2)" "prognostic favorable (4.15e-5)" 5.7 6.3 3.8 19.9 3.9 7.0 5.7 1.7 6.6 3.5 6.4 4.4 2.8 2.0 3.9 6.7 5.0 5.7 8.0 7.3 4.2 5.4 6.2 13.9 33.1 24.0 4.5 2.2 4.0 5.4 9.4 14.0 3.6 4.2 5.8 4.1 5.6 5.6 5.3 2.5 3.7 10.1 8.0 5.5 21.5 6.9 1.9 3.3 3.8 9.4 3.4 14.8 5.5 3.4 13.7 11.7 1.3 9.7 11.2 6.6 5.7 3.2 1.7 0.0 0.0 0.5 2.2 0.3 2.0 6.8 1.1 2.9 0.5 4.7 0.7 0.2 0.0 3.9 1.6 0.1 1.6 3.0 2.1 1.4 3.5 0.2 9.0 3.0 0.3 0.0 0.8 6.2 5.5 11.2 8.2 0.5 0.0 0.0 0.3 9.2 1.8 0.0 7.0 0.5 5.1 2.4 0.0 0.1 0.1 6.2 2.7 0.2 5.2 2.2 1.1 5.3 0.4 2.0 2.9 0.0 1.7 1.2 0.2 6.1 1.3 0.0 1.2 7.9 14.7 1.4 0.0 9.7 0.9 6.6 8.9 3.9 13.7 2.2 4.5 11.7 12.3 2.9 4.8 1.3 11.2 6.4 0.3 0.1 5.7 3.8 3.9 1.7 6.6 4.2 5.4 4.5 2.2 4.2 3.3 71.5 50.8 31.3 9.0 4.6 16.8 7.3 5.1 12.0 29.6 3.5 15.7 2.4 21.6 6.2 0.0 9.9 0.9 0.0 5.3 0.7 2.6 10.5 12.7 13.2 9.6 19.1 5.2 3.7 33.4 0.0 4.9 31.0 8.5 13.6 5.3 37.9 6.0 5.7 3.5 6.8 21.3 6.5 3.1 1.1 0.4 4.0 1.4 15.9 4.3 15.9 GSC ENSG00000133937 "Goosecoid homeobox" P56915 14 94768216-94770230 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 11.6" "Cell type enhanced" "Detected in some" 10 "Ductal cells: 2.6;Exocrine glandular cells: 2.2;Smooth muscle cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "gdT-cell: 7.1" "Lineage enriched" "Detected in single" 17 "T-cells: 7.1" "Cell line enhanced" "Detected in some" "AN3-CA: 2.3;HEK 293: 3.6;MCF7: 5.3;REH: 5.5;SH-SY5Y: 6.2;T-47d: 4.3;U-251 MG: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (3.15e-2)" "unprognostic (5.11e-2)" "unprognostic (2.49e-1)" "unprognostic (3.70e-3)" "unprognostic (1.82e-3)" "unprognostic (3.87e-2)" "unprognostic (3.41e-1)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.28e-1)" "unprognostic (5.18e-10)" "unprognostic (4.96e-2)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (1.16e-1)" 8.5 0.2 0.1 0.3 0.1 0.1 11.6 0.1 1.5 1.7 0.9 0.0 1.5 0.5 0.5 2.3 0.9 1.0 1.1 1.9 0.1 0.3 0.4 0.1 0.2 1.1 0.2 0.0 1.5 2.1 0.3 0.7 0.1 0.6 2.4 0.2 2.8 4.8 1.8 6.2 1.5 0.2 0.1 0.1 0.1 0.8 1.7 0.2 0.1 5.1 1.7 0.9 2.0 7.9 0.0 0.1 0.4 0.1 0.2 7.1 0.4 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.5 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 1.2 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.3 0.0 0.5 0.7 0.1 0.0 0.1 0.9 0.4 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.2 0.0 0.6 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.7 0.6 0.0 0.5 0.0 0.0 GSC2 GSCL ENSG00000063515 "Goosecoid homeobox 2" O15499 22 19148576-19150283 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 12 "testis: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "THP-1: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043011 Uncertain NA NA "HPA043011: AB_10959883" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSDMA "FLJ39120, GSDM, GSDM1" ENSG00000167914 "Gasdermin A" Q96QA5 17 39953263-39977766 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 35.7;tongue: 19.4" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 3.5;Hofbauer cells: 4.9;Kupffer cells: 6.0;Suprabasal keratinocytes: 2.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 1.9;T-cells: 5.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 7.3;hTCEpi: 5.0;hTERT-HME1: 9.8" "Not detected" "Not detected" "HPA023313, HPA064826" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 7100 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA023313: AB_1850378, HPA064826: AB_2685361" "unprognostic (1.32e-2)" "unprognostic (2.01e-1)" "unprognostic (2.95e-2)" "unprognostic (1.06e-1)" "unprognostic (3.62e-1)" "unprognostic (1.97e-1)" "unprognostic (7.77e-2)" "unprognostic (1.39e-1)" "unprognostic (3.24e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" "unprognostic (2.90e-2)" "unprognostic (1.06e-2)" "unprognostic (9.86e-2)" "unprognostic (7.45e-2)" "unprognostic (3.63e-2)" "unprognostic (3.79e-2)" 2.1 0.4 0.2 0.4 0.1 0.0 2.2 0.1 0.1 1.1 0.6 0.0 0.0 0.1 0.4 8.6 1.9 0.3 0.3 2.0 0.2 0.2 0.4 0.2 0.7 8.5 0.2 0.7 0.2 0.2 1.0 0.9 0.9 0.1 0.2 0.6 0.0 0.6 0.0 0.9 35.7 0.3 0.5 0.2 0.3 0.2 0.9 0.0 0.8 0.2 19.4 7.8 0.8 1.1 0.6 0.5 1.9 0.4 0.6 5.6 1.0 0.4 0.1 0.0 0.3 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 7.3 0.0 0.2 0.5 0.9 0.6 0.5 0.0 0.3 1.6 0.0 5.0 0.9 9.8 0.1 0.0 0.1 0.2 2.4 0.0 1.0 0.0 0.2 0.1 0.5 0.1 0.6 0.0 0.9 0.2 0.7 0.0 0.2 0.2 0.3 0.0 0.1 0.6 0.1 0.1 0.3 0.7 0.1 0.1 0.3 0.1 0.6 0.4 0.1 0.0 1.7 0.4 0.4 4.8 0.2 5.6 0.3 3.1 1.8 0.2 0.6 1.6 2.5 1.9 0.6 0.3 0.5 1.1 1.0 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 1.3 6.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 GSDMB "GSDML, PRO2521" ENSG00000073605 "Gasdermin B" Q8TAX9 17 39904595-39919854 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 71.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 65.9;Mucus-secreting cells: 26.1;Paneth cells: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "SK-BR-3: 103.0" "CAB013681, HPA023925, HPA052407" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819" "unprognostic (5.78e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "unprognostic (6.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.10e-1)" "unprognostic (6.44e-2)" "unprognostic (3.81e-1)" "unprognostic (8.72e-2)" "unprognostic (2.34e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (5.13e-11)" "unprognostic (1.88e-1)" "unprognostic (1.99e-1)" "unprognostic (8.91e-2)" "prognostic favorable (5.91e-9)" 4.0 0.0 1.3 13.3 2.0 1.3 2.8 4.8 1.7 2.1 33.1 1.4 2.0 25.2 1.3 1.7 1.3 1.3 14.4 1.3 1.3 0.6 2.2 17.1 2.4 3.5 1.3 1.3 2.0 2.8 0.0 1.3 1.8 1.3 3.5 22.4 1.3 1.3 2.7 1.3 2.8 71.3 3.9 1.3 4.7 18.1 1.4 1.5 1.6 2.9 1.3 2.8 4.1 4.5 0.8 0.0 1.8 0.0 0.1 2.8 0.4 0.4 0.3 0.6 0.1 1.5 1.0 0.6 0.4 0.2 0.1 0.4 0.3 12.2 0.6 0.5 0.3 0.2 1.6 0.3 0.3 0.9 2.5 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.6 2.0 0.5 0.7 1.0 0.2 2.0 0.2 0.7 0.1 0.1 0.6 1.3 0.1 3.9 0.4 0.6 0.2 0.9 0.0 0.4 0.2 0.3 0.1 103.0 0.3 3.1 0.5 0.4 0.3 0.4 0.7 1.1 0.2 2.2 1.9 0.6 0.1 0.4 0.0 0.0 0.0 1.8 1.1 0.0 0.0 0.8 2.8 1.4 0.0 0.0 2.6 0.6 0.7 0.1 0.0 0.0 0.4 0.4 1.3 2.0 4.8 1.7 1.3 0.6 1.3 1.3 1.3 1.5 3.0 11.8 4.2 1.2 1.6 2.1 2.4 12.7 2.7 4.5 5.2 3.9 1.2 0.0 1.6 4.4 1.4 65.9 0.0 7.0 0.6 1.4 1.5 1.1 8.1 0.3 1.6 5.8 0.0 1.9 3.3 1.1 1.1 3.3 1.8 26.1 2.0 7.3 57.5 1.8 0.0 2.3 0.0 2.1 0.5 1.1 3.0 0.2 2.5 15.0 5.0 GSDMC MLZE ENSG00000147697 "Gasdermin C" Q9BYG8 8 129748196-129786888 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 41.3;Suprabasal keratinocytes: 46.4" "Group enriched" "Detected in many" 6 "cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 8.3;HaCaT: 5.9;hTCEpi: 3.1;HUVEC TERT2: 3.3;TIME: 8.7" "HPA023670, HPA024767, HPA026317" Supported Approved Mitochondria NA NA Mitochondria "HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008" "unprognostic (6.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.61e-3)" "unprognostic (4.23e-2)" "unprognostic (2.11e-2)" "unprognostic (4.22e-3)" "unprognostic (1.43e-2)" "unprognostic (1.15e-1)" "unprognostic (8.28e-2)" "unprognostic (7.51e-2)" "unprognostic (4.92e-3)" "unprognostic (5.71e-2)" "unprognostic (2.93e-3)" "unprognostic (1.87e-2)" "unprognostic (1.88e-1)" "unprognostic (8.66e-2)" "unprognostic (1.90e-1)" 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 0.2 25.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.0 3.4 0.0 0.0 14.1 0.0 0.0 0.2 25.0 0.0 0.0 0.0 0.1 0.1 19.2 17.5 1.4 5.9 0.3 0.3 1.2 0.1 0.4 0.3 0.0 8.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 5.9 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.2 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.9 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.7 41.3 0.0 2.4 0.0 0.0 3.4 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 46.4 0.0 0.0 0.0 2.3 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.9" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.6;K-562: 48.4;T-47d: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036365, HPA042090" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036365: AB_10601762, HPA042090: " "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favorable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 15.8 11.1 4.9 18.2 6.6 17.3 21.4 18.0 9.5 13.5 14.9 2.9 14.6 9.7 11.0 11.7 11.6 10.9 16.1 18.7 3.8 5.8 11.1 10.1 23.5 6.5 3.8 5.7 17.8 28.0 34.4 26.9 81.9 3.7 8.7 7.2 18.2 17.7 25.2 22.5 13.3 14.8 8.8 4.2 12.1 13.2 10.4 2.1 59.0 14.9 12.0 17.4 10.2 16.9 3.5 2.5 4.5 6.0 1.9 3.2 1.1 4.5 8.2 5.5 13.8 3.5 3.2 43.6 6.2 4.3 3.5 1.3 7.0 6.3 2.7 7.5 7.0 3.1 4.3 8.7 2.3 1.8 5.0 7.3 19.8 7.7 8.6 4.6 9.1 11.3 6.1 5.7 3.7 1.8 3.6 0.9 16.1 48.4 0.5 1.1 30.7 32.6 8.0 9.6 5.0 2.4 21.5 1.8 6.9 3.2 1.7 35.9 24.9 12.2 22.9 1.1 5.2 49.9 22.8 1.5 7.2 9.0 1.9 1.6 7.5 4.5 15.9 4.1 5.8 6.3 4.0 1.6 4.5 3.2 2.9 3.1 3.5 1.2 2.0 2.5 3.4 0.6 2.4 1.3 1.9 6.0 0.0 0.0 1.1 4.9 6.6 18.0 9.5 3.8 5.8 3.8 5.7 3.7 2.1 62.5 65.7 11.5 7.5 12.5 61.9 31.4 33.1 24.1 29.6 36.6 137.4 45.4 1.7 14.3 3.8 19.0 19.6 46.7 10.5 65.7 18.6 12.3 41.7 26.7 11.0 33.4 57.4 15.4 8.9 4.7 43.7 13.5 10.1 3.6 60.0 5.2 16.5 17.3 57.7 4.4 61.6 6.5 7.1 1.8 17.8 26.2 152.4 17.0 22.4 10.5 GSG1 MGC3146 ENSG00000111305 "Germ cell associated 1" Q2KHT4 12 13083560-13103683 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 60 "testis: 156.4" "Cell type enriched" "Detected in many" 5 "Late spermatids: 9027.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 9.6;LHCN-M2: 11.0;RPTEC TERT1: 13.7;U-2 OS: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.50e-1)" "unprognostic (2.21e-2)" "unprognostic (6.33e-2)" "unprognostic (2.36e-2)" "unprognostic (1.34e-1)" "unprognostic (8.01e-2)" "unprognostic (1.04e-1)" "unprognostic (4.52e-1)" "unprognostic (6.85e-2)" "unprognostic (8.23e-2)" "unprognostic (5.91e-2)" "unprognostic (3.20e-3)" "unprognostic (1.48e-1)" "unprognostic (3.65e-2)" "unprognostic (1.79e-1)" "unprognostic (6.32e-3)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 156.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.7 2.6 0.7 0.5 1.2 0.1 0.1 0.5 0.3 0.1 2.3 1.4 0.5 0.2 0.4 0.4 0.5 0.2 0.1 0.2 0.2 9.6 0.8 0.1 0.2 0.0 0.9 0.2 0.0 0.2 0.6 0.3 0.0 0.2 0.1 0.9 0.0 1.8 0.1 0.1 0.0 0.1 0.1 1.8 11.0 0.3 0.1 1.1 2.3 0.1 0.2 0.1 4.0 0.2 13.7 0.2 0.6 0.3 0.2 0.0 0.1 0.3 0.1 1.6 0.1 0.6 6.9 0.3 0.3 0.6 0.4 0.1 3.0 0.3 0.2 1.3 0.5 0.9 1.2 0.4 0.6 0.8 0.6 1.0 0.4 1.3 0.8 0.9 2.6 0.5 0.7 0.7 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.0 3.0 1.4 0.0 0.1 0.1 9.4 0.4 0.0 0.0 0.0 0.0 5.9 0.1 1.7 0.4 1969.0 0.0 0.0 23.3 0.0 0.1 0.0 0.1 0.0 0.0 0.7 1.6 26.4 2.5 0.0 9027.4 49.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 37.4 0.0 14.7 6.5 0.0 51.2 19.7 0.0 0.0 0.0 0.0 0.0 GSG1L "KTSR5831, MGC18079, PRO19651" ENSG00000169181 "GSG1 like" Q6UXU4 16 27787535-28063509 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.6;heart muscle: 19.3" "Group enriched" "Detected in some" 8 "Bipolar cells: 1.4;Cardiomyocytes: 4.1;Club cells: 1.2;Early spermatids: 2.5;Horizontal cells: 1.6;Late spermatids: 1.8;Rod photoreceptor cells: 1.4;Spermatogonia: 1.2" "Cancer enriched" "Detected in some" 7 "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Group enriched" "Detected in some" 7 "HMC-1: 13.6;THP-1: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014479 Enhanced NA NA "HPA014479: AB_2247974" "unprognostic (1.85e-1)" "unprognostic (2.41e-1)" "unprognostic (2.38e-1)" "unprognostic (7.06e-4)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (2.05e-2)" "unprognostic (6.68e-2)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" "unprognostic (6.66e-2)" "unprognostic (1.55e-1)" "unprognostic (3.13e-1)" "unprognostic (6.35e-2)" "unprognostic (9.77e-2)" 0.7 0.8 8.7 0.6 14.6 0.7 0.6 1.8 13.3 0.8 1.1 2.7 0.0 1.1 1.1 1.0 0.6 3.4 0.5 19.3 6.0 6.8 1.1 1.1 0.9 0.6 10.0 3.3 0.4 0.7 0.4 0.2 2.0 6.5 0.8 0.7 1.2 0.8 0.6 1.0 1.8 1.2 0.5 3.5 0.9 2.5 2.2 3.3 0.0 1.0 0.0 0.5 0.5 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.3 0.0 0.3 0.2 0.2 0.2 0.3 0.3 0.1 0.0 0.0 13.6 0.0 0.0 0.0 0.2 0.4 0.4 0.1 0.2 0.2 0.5 0.9 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.7 0.4 0.1 5.0 1.3 0.0 0.9 0.0 0.2 1.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 8.7 14.6 1.8 10.7 6.0 6.8 10.0 3.3 6.5 3.3 0.0 0.0 0.0 0.0 0.1 1.4 4.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 GSG1L2 ENSG00000214978 "GSG1 like 2" A8MUP6 17 9802386-9822071 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 36 "brain: 4.8;retina: 3.3;testis: 2.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 95 "renal cancer: 4.7" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.7;olfactory region: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 2.8" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 1.7 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 337.2;Late spermatids: 220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" No No "Golgi apparatus, Vesicles" Nucleoli "HPA043054: AB_2678293, HPA046782: AB_2679803" "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 6.6 7.1 11.2 8.0 21.9 7.1 6.7 5.1 14.6 6.6 29.5 5.4 6.7 23.5 5.5 6.4 20.8 5.5 7.0 5.2 12.0 9.6 12.8 36.4 5.3 8.7 9.2 9.7 3.6 6.1 4.0 10.8 11.1 10.7 7.1 28.3 8.7 7.8 5.2 5.5 8.5 63.0 8.0 10.4 6.6 11.3 26.4 7.2 9.0 5.8 10.7 10.7 8.2 9.0 20.1 11.2 27.5 16.6 17.8 34.1 14.8 9.6 13.8 15.5 10.5 11.7 13.6 26.3 18.0 13.8 11.9 13.2 10.2 16.4 9.3 11.0 13.6 7.4 10.7 10.1 10.7 17.4 21.9 9.6 3.8 7.9 7.8 10.9 9.9 6.7 11.0 17.2 15.2 15.3 9.4 15.5 10.6 8.4 8.4 15.1 23.9 7.2 8.0 17.2 15.1 17.5 7.3 14.4 8.4 28.0 36.1 5.5 17.7 20.3 19.2 15.6 16.3 14.4 6.4 17.0 5.5 7.1 11.7 5.6 10.0 28.4 7.8 14.1 7.2 8.8 27.5 10.8 24.3 15.5 12.6 24.0 20.1 21.7 18.3 11.2 16.6 21.4 19.8 21.7 17.8 16.6 9.6 34.1 14.8 11.2 21.9 5.1 14.6 12.0 9.6 9.2 9.7 10.7 7.2 11.9 9.0 19.3 19.8 40.2 24.1 14.2 20.4 14.7 5.7 19.2 39.3 37.6 61.3 30.4 337.2 14.6 80.6 0.0 34.7 35.8 17.9 30.7 19.6 15.5 20.9 22.3 26.9 17.8 22.8 220.8 7.5 17.5 18.6 32.5 63.8 16.2 32.2 98.2 7.4 38.6 79.0 19.4 18.4 37.4 36.7 57.6 100.0 26.1 53.7 34.5 GSTA1 ENSG00000243955 "Glutathione S-transferase alpha 1" P08263 6 52791664-52803910 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Oxidoreductase, Peroxidase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4" "Group enriched" "Detected in many" 6 "liver cancer: 555.4;renal cancer: 135.0" "Region enriched" "Detected in single" 6 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "Hep G2: 89.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA 27800000 Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (4.84e-3)" "unprognostic (2.40e-2)" "unprognostic (3.40e-1)" "unprognostic (4.78e-2)" "unprognostic (1.72e-1)" "unprognostic (1.26e-1)" "unprognostic (1.00e-2)" "prognostic favorable (8.66e-4)" "unprognostic (5.75e-2)" "unprognostic (6.90e-3)" "unprognostic (3.00e-1)" "unprognostic (8.27e-2)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.21e-1)" "unprognostic (4.26e-3)" "unprognostic (1.02e-1)" "unprognostic (2.16e-2)" 0.6 119.4 0.6 0.7 4.2 0.0 0.6 0.6 0.7 0.8 64.3 4.3 0.6 59.9 0.6 1.2 0.7 6.9 16.4 0.6 0.6 0.0 79.7 214.4 7.1 0.6 0.6 0.6 8.5 16.9 0.0 0.7 0.9 0.7 1.8 0.2 1.0 2.6 0.8 0.6 0.1 202.4 0.6 0.6 0.6 10.7 78.2 0.6 0.7 0.6 2.1 4.4 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 89.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.7 0.0 0.0 0.7 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 4.2 0.6 0.7 0.6 0.0 0.6 0.6 0.7 0.6 6.0 7.7 0.0 2.8 0.0 0.0 0.0 614.0 837.9 106.9 69.8 0.0 0.1 454.3 72.7 8.0 0.0 11.8 46.7 1419.6 0.0 0.0 51.4 2.3 628.5 0.1 0.0 2.9 23.4 22.6 21.8 60.7 4.4 0.0 22.6 33.3 0.0 1010.1 6.0 4.2 2005.4 0.0 0.0 0.0 5.6 3.4 0.0 0.5 4.3 29.3 42.0 GSTA2 GST2 ENSG00000244067 "Glutathione S-transferase alpha 2" P09210 6 52750089-52763569 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 63.4;liver: 192.2;pancreas: 54.1" "Cell type enhanced" "Detected in many" 15 "Cholangiocytes: 338.8;Ciliated cells: 780.3;Pancreatic endocrine cells: 549.6;Proximal tubular cells: 368.8" "Group enriched" "Detected in many" 16 "liver cancer: 124.6;renal cancer: 48.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "CACO-2: 20.7;Hep G2: 15.9" "HPA004342, HPA048934, HPA053817" Supported Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (6.43e-3)" "unprognostic (2.41e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.34e-2)" "unprognostic (1.91e-1)" "unprognostic (6.54e-2)" 0.2 1.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 6.4 0.2 0.2 13.4 0.2 0.3 0.2 0.0 9.9 0.2 0.2 0.0 63.4 192.2 5.3 0.2 0.2 0.2 0.3 54.1 0.0 0.2 0.3 0.2 0.7 0.0 0.2 0.3 0.2 0.2 0.0 27.6 0.2 0.2 0.2 1.5 14.1 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 20.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.3 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 5.9 0.5 0.1 0.0 0.0 0.0 338.8 780.3 46.6 15.7 0.0 0.0 180.8 6.3 4.5 0.0 0.0 0.0 201.6 0.1 0.0 5.3 0.0 50.4 0.1 0.0 0.0 1.3 1.6 6.5 1.1 1.3 0.0 9.0 0.4 0.0 549.6 0.0 0.4 368.8 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.1 1.0 GSTA3 ENSG00000174156 "Glutathione S-transferase alpha 3" Q16772 6 52896639-52909685 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "pons and medulla: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2" "HPA004342, HPA048934, HPA053817" Approved Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (7.51e-2)" "unprognostic (7.06e-3)" "unprognostic (3.10e-1)" "unprognostic (5.53e-2)" "unprognostic (4.38e-3)" "unprognostic (2.86e-3)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (9.35e-2)" 0.2 36.5 0.2 0.2 0.6 0.0 0.7 0.3 0.2 0.9 0.2 1.0 0.2 0.0 0.3 6.6 0.2 32.4 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 0.2 0.2 3.8 0.2 1.1 0.2 51.9 2.1 0.2 0.0 0.5 0.6 0.2 0.2 12.5 0.2 0.2 0.2 0.2 1.0 6.4 0.3 0.2 0.2 0.9 0.2 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.2 0.2 0.2 0.2 0.2 2.1 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 33.5 10.3 0.0 0.0 121.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.4 0.2 0.0 1.1 0.2 13.5 0.0 0.0 0.0 0.0 1.3 1.4 0.0 23.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 8.5 430.9 0.0 0.0 0.0 GSTA4 ENSG00000170899 "Glutathione S-transferase alpha 4" O15217 6 52977948-52995378 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 105.4" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 233.2;Syncytiotrophoblasts: 376.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "non-classical monocyte: 17.4" "Lineage enriched" "Detected in many" 6 "monocytes: 17.4" "Cell line enhanced" "Detected in many" "AF22: 32.5;ASC TERT1: 32.2" "Low region specificity" "Detected in all" HPA048934 Approved NA NA "HPA048934: AB_2680563" "unprognostic (5.13e-3)" "unprognostic (2.75e-1)" "unprognostic (5.04e-2)" "unprognostic (1.38e-1)" "unprognostic (5.24e-2)" "unprognostic (3.63e-3)" "unprognostic (1.81e-1)" "unprognostic (1.63e-2)" "unprognostic (5.05e-3)" "unprognostic (9.26e-2)" "unprognostic (3.31e-3)" "unprognostic (2.29e-2)" "unprognostic (1.34e-2)" "unprognostic (2.21e-1)" "unprognostic (4.07e-3)" "unprognostic (1.53e-1)" "unprognostic (1.13e-1)" 6.3 105.4 15.0 3.4 27.0 0.8 12.2 23.8 29.6 11.2 6.7 13.2 4.3 7.2 12.2 21.0 18.6 8.8 7.8 6.7 16.7 17.8 10.7 11.3 15.1 2.8 11.7 19.2 18.4 10.2 29.1 27.3 16.2 21.6 14.0 8.5 15.5 13.9 10.1 10.6 45.2 6.6 8.9 11.3 5.1 12.1 12.7 6.8 0.9 8.5 18.4 9.4 5.9 13.6 2.8 1.9 0.0 17.4 3.1 3.1 0.9 0.4 3.4 32.5 26.5 18.7 32.2 2.9 4.8 11.2 3.1 5.2 4.9 0.1 0.3 3.2 8.7 3.5 1.4 22.9 4.4 4.0 0.8 10.4 1.1 2.8 17.3 13.8 0.0 0.7 27.4 6.7 4.1 3.3 10.0 19.0 5.7 4.1 5.1 10.4 0.0 0.4 0.1 12.2 19.4 5.9 0.9 13.7 5.8 11.1 0.5 14.5 21.0 0.1 3.4 8.3 17.0 0.8 1.0 10.0 3.4 8.0 3.3 3.6 7.1 0.8 0.1 5.2 0.6 3.6 0.0 0.0 0.0 3.1 1.0 2.0 0.9 0.8 1.5 0.8 2.8 0.6 0.9 0.0 3.1 17.4 1.9 0.9 0.9 15.0 27.0 23.8 29.6 16.7 17.8 11.7 19.2 21.6 6.8 47.6 58.1 0.0 20.6 40.0 37.9 8.4 12.7 20.1 23.9 26.2 0.0 233.2 46.4 9.4 1.1 16.8 6.3 23.3 7.7 97.4 41.6 38.0 5.7 19.0 55.1 35.0 23.0 25.8 2.7 6.5 38.6 3.5 91.1 3.6 29.1 70.2 16.8 7.0 36.7 36.1 10.2 19.4 25.4 5.4 9.1 118.4 376.6 5.0 17.0 11.1 GSTA5 ENSG00000182793 "Glutathione S-transferase alpha 5" Q7RTV2 6 52831655-52846095 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Cell type enriched" "Detected in single" 5 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004342, HPA048934, HPA053817" Uncertain Approved Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (1.97e-2)" "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 GSTM1 "GST1, H-B, MU" ENSG00000134184 "Glutathione S-transferase mu 1" P09488 1 109687814-109709039 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 163.2;seminal vesicle: 101.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 8.9;Ciliated cells: 9.4;Club cells: 11.4;Ito cells: 8.0;Kupffer cells: 10.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 63.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 26.9;HeLa: 32.1;HHSteC: 25.7;hTEC/SVTERT24-B: 23.2;HUVEC TERT2: 19.7;MOLT-4: 34.6" "CAB022669, CAB047357, HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (2.22e-2)" "unprognostic (5.35e-2)" "unprognostic (3.87e-3)" "unprognostic (3.20e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (3.56e-2)" "unprognostic (1.81e-1)" "unprognostic (2.41e-1)" "unprognostic (6.55e-2)" "unprognostic (2.34e-1)" "unprognostic (3.45e-1)" "unprognostic (3.17e-2)" "unprognostic (2.12e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (4.72e-3)" 14.5 25.4 15.2 6.9 15.6 2.9 8.2 5.6 19.2 22.0 7.8 16.9 0.0 7.7 9.8 20.2 22.5 13.8 8.2 6.4 14.4 6.8 14.1 163.2 7.7 1.0 7.8 32.1 29.0 18.2 41.4 5.3 2.9 8.2 38.1 6.6 25.7 11.8 101.4 25.1 18.8 17.7 18.2 6.8 21.7 7.5 15.1 11.2 10.9 7.6 1.6 14.5 30.8 19.5 14.6 34.9 14.1 18.9 13.3 17.3 10.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 2.2 8.2 0.0 12.9 0.0 0.4 0.0 0.1 0.2 0.0 0.1 26.9 32.1 0.5 25.7 0.0 0.2 0.0 0.0 23.2 0.1 15.4 19.7 15.8 0.0 18.0 0.8 0.0 34.6 0.2 17.3 0.0 0.0 0.1 0.1 3.4 2.8 0.0 1.7 0.2 0.0 0.1 0.1 0.8 0.3 14.2 0.0 11.5 0.6 0.2 0.0 14.4 19.0 1.1 9.9 0.3 0.6 0.7 12.2 14.1 14.8 18.9 15.7 14.6 15.8 13.7 34.9 14.6 16.5 15.6 1.0 13.3 7.4 19.2 17.3 10.0 15.2 15.6 5.6 19.2 14.4 6.8 7.8 32.1 8.2 11.2 8.9 5.0 0.0 1.0 1.5 0.0 5.6 5.1 9.4 11.4 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 2.3 0.6 0.1 0.0 0.0 8.0 10.1 0.0 3.4 0.8 0.0 1.0 0.0 2.3 0.8 0.0 2.1 0.0 0.0 0.0 0.6 0.2 0.2 1.4 0.0 5.3 0.0 0.1 GSTM3 GST5 ENSG00000134202 "Glutathione S-transferase mu 3" P21266 1 109733932-109741038 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 115.3;testis: 96.0" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 1724.2;Late spermatids: 2908.0;Spermatocytes: 818.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.1" "Group enriched" "Detected in many" 7 "granulocytes: 4.1;T-cells: 11.1" "Cell line enhanced" "Detected in many" "SK-BR-3: 45.7;T-47d: 96.9;WM-115: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017130, HPA035190, CAB040583, HPA055972" Enhanced Approved Cytosol NA NA 560000 Cytosol "CAB017130: , CAB040583: , HPA035190: AB_10795023, HPA055972: AB_2682992" "unprognostic (2.13e-2)" "unprognostic (2.76e-2)" "unprognostic (1.95e-1)" "unprognostic (5.87e-2)" "unprognostic (1.25e-1)" "unprognostic (7.28e-2)" "unprognostic (3.28e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.89e-4)" "unprognostic (3.45e-1)" "unprognostic (1.51e-1)" "unprognostic (2.30e-1)" "unprognostic (6.16e-3)" "unprognostic (1.38e-2)" "unprognostic (1.21e-2)" "unprognostic (1.90e-2)" "unprognostic (3.48e-2)" 7.5 11.3 21.4 2.9 27.8 0.9 23.1 8.5 18.4 15.4 11.7 9.9 51.0 12.6 9.0 67.2 11.1 8.8 12.3 27.6 14.0 14.4 54.0 5.3 5.2 2.4 9.6 22.0 32.3 26.5 7.3 9.4 5.8 30.7 13.6 5.6 13.4 4.5 115.3 15.5 15.0 7.5 15.9 13.3 3.3 14.2 96.0 6.4 0.1 15.8 15.6 3.3 17.4 12.0 0.6 0.8 4.1 0.3 1.0 11.1 1.4 0.0 1.3 9.9 0.0 13.5 8.3 1.7 10.7 1.8 11.8 11.5 4.3 0.3 0.0 6.2 5.4 8.2 0.5 2.0 4.4 16.4 0.0 2.9 10.0 32.5 6.4 14.4 0.0 23.3 8.3 5.4 17.7 0.0 13.1 14.5 12.4 0.9 0.1 5.3 5.8 2.7 0.2 1.1 0.0 18.6 0.0 6.4 0.4 3.3 23.0 17.5 9.4 22.4 45.7 2.1 3.0 96.9 14.6 11.4 0.1 4.3 12.0 7.0 1.5 2.4 0.0 0.1 0.0 37.6 0.8 0.3 4.1 4.2 0.1 1.2 0.6 5.3 3.1 0.1 0.6 11.1 5.5 2.0 1.0 0.2 0.8 2.3 1.4 21.4 27.8 8.5 18.4 14.0 14.4 9.6 22.0 30.7 6.4 6.0 11.5 8.1 96.3 127.5 19.3 82.7 40.8 1.4 17.0 211.1 5.9 13.4 679.8 74.2 1724.2 31.5 27.6 0.0 131.2 7.7 152.1 47.5 9.2 2.5 8.6 14.3 48.5 54.0 6.6 2908.0 356.9 16.6 57.3 5.4 23.4 255.3 110.8 25.9 259.6 35.7 14.3 187.5 89.7 818.6 48.1 93.8 8.6 7.9 40.9 29.8 GSTM4 ENSG00000168765 "Glutathione S-transferase mu 4" Q03013 1 109656081-109674836 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 85.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "eosinophil: 69.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 69.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048652, HPA055972, HPA055973" Approved Approved "Cytokinetic bridge,Cytosol" NA NA 660000 Cytosol "Cytokinetic bridge" "HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "prognostic favorable (9.96e-5)" "unprognostic (1.96e-3)" "unprognostic (7.49e-2)" "unprognostic (9.92e-3)" "unprognostic (1.48e-1)" "unprognostic (1.08e-2)" "unprognostic (8.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.20e-1)" "unprognostic (4.76e-2)" "unprognostic (3.73e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-1)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" 12.5 17.6 14.0 12.3 20.2 3.6 10.9 12.9 24.7 12.6 33.2 18.0 9.4 85.3 12.1 15.3 15.9 11.0 14.5 14.7 13.7 12.3 27.2 22.0 7.4 10.1 14.8 16.9 31.4 12.2 23.1 9.9 5.1 15.8 14.7 23.2 20.5 15.4 26.3 47.4 10.6 77.2 19.0 16.1 16.2 14.7 11.8 14.0 4.0 14.9 14.5 12.8 22.2 14.2 3.6 7.8 69.8 3.0 2.5 3.1 2.3 5.3 2.4 4.3 32.5 9.7 15.0 5.5 1.7 14.0 4.1 5.4 17.1 0.6 5.0 6.7 7.7 8.0 5.5 11.1 5.8 2.6 7.4 0.0 10.9 10.1 15.3 15.8 3.7 13.2 9.5 5.8 5.2 0.0 11.5 3.3 12.9 5.0 7.5 2.8 5.0 3.1 16.4 3.3 22.5 13.0 6.7 2.4 7.3 16.0 3.8 3.1 7.2 0.0 28.2 21.8 3.4 7.6 8.0 1.4 4.7 18.7 5.2 2.5 11.2 19.6 0.4 15.6 5.5 13.3 2.0 2.9 69.8 2.7 3.0 1.6 3.6 2.0 3.1 7.8 2.8 2.0 2.3 0.4 2.5 0.7 2.7 2.8 2.3 14.0 20.2 12.9 24.7 13.7 12.3 14.8 16.9 15.8 14.0 8.9 2.4 13.5 21.7 16.1 5.5 25.8 25.5 10.7 7.9 29.6 0.0 18.5 86.2 40.9 2.6 9.0 85.7 0.0 50.8 15.9 20.4 8.2 20.7 21.9 30.0 4.8 6.9 16.0 14.6 4.7 27.9 17.0 38.8 15.4 33.9 22.1 36.3 28.8 23.3 64.5 4.7 32.3 32.0 5.7 6.9 13.4 7.3 17.8 57.6 10.4 GSTM5 ENSG00000134201 "Glutathione S-transferase mu 5" P46439 1 109712255-109775428 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "breast: 237.6;ovary: 66.1" "Group enriched" "Detected in many" 6 "Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 5 "dendritic cells: 5.7;T-cells: 1.9" "Group enriched" "Detected in some" 7 "fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3" "HPA048652, HPA055972, HPA055973" Approved Uncertain "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993" "unprognostic (1.46e-2)" "unprognostic (8.64e-3)" "unprognostic (5.58e-2)" "unprognostic (1.42e-1)" "unprognostic (5.34e-3)" "unprognostic (8.09e-2)" "unprognostic (9.64e-4)" "unprognostic (1.31e-2)" "unprognostic (1.44e-1)" "unprognostic (9.16e-2)" "unprognostic (3.31e-1)" "unprognostic (1.92e-2)" "unprognostic (1.42e-2)" "unprognostic (3.74e-2)" "unprognostic (4.39e-2)" "unprognostic (3.03e-3)" "unprognostic (1.40e-1)" 5.8 3.5 25.7 2.6 23.4 1.6 237.6 15.8 24.6 27.2 4.2 14.0 4.7 2.1 14.0 12.0 4.8 19.8 9.0 4.8 24.9 6.2 2.9 2.1 5.7 2.6 4.9 17.9 66.1 2.7 1.6 2.7 1.6 8.9 12.8 4.0 23.0 3.9 11.9 2.4 3.7 3.5 9.8 11.0 3.5 3.9 5.1 11.9 0.0 2.6 2.1 3.2 10.5 16.1 0.0 5.7 0.6 0.2 0.7 1.9 0.9 0.0 0.0 0.0 0.0 1.6 1.6 0.3 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.2 0.0 0.7 0.0 5.7 1.9 0.9 25.7 23.4 15.8 24.6 24.9 6.2 4.9 17.9 8.9 11.9 0.0 0.3 0.0 0.5 6.0 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.2 0.8 0.0 0.0 0.0 0.1 12.3 0.1 0.0 0.0 0.2 0.0 0.0 7.4 1.2 9.9 132.9 0.6 10.1 0.0 0.0 217.3 0.0 0.0 119.5 0.0 5.8 25.8 7.6 1.9 1.1 5.6 0.0 0.0 0.0 0.1 GSTO1 "GSTTLp28, P28" ENSG00000148834 "Glutathione S-transferase omega 1" P78417 10 104235356-104267459 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 137.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 123.8" "Low region specificity" "Detected in all" "HPA037603, HPA037604" Enhanced Approved Nucleoplasm,Cytosol NA NA 200000000 Cytosol Nucleoplasm "HPA037603: AB_2675574, HPA037604: AB_10672283" "prognostic favorable (6.95e-4)" "unprognostic (9.23e-2)" "unprognostic (1.43e-2)" "unprognostic (6.83e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.23e-3)" "unprognostic (4.57e-2)" "unprognostic (7.65e-2)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.86e-2)" "unprognostic (1.29e-1)" "unprognostic (5.51e-3)" "unprognostic (5.82e-2)" 29.6 31.9 19.9 21.8 24.4 35.8 20.0 15.0 24.3 17.8 29.7 16.8 17.8 36.3 16.5 21.4 22.6 15.2 24.7 67.9 19.7 21.5 32.7 137.3 32.0 35.7 23.2 23.1 19.7 21.2 18.6 23.2 26.3 17.0 18.2 20.8 18.0 25.3 21.2 42.7 13.3 41.0 21.4 18.9 26.8 19.8 7.0 14.2 30.8 32.9 24.0 16.8 28.0 18.8 18.7 55.4 85.5 68.3 21.8 25.5 68.0 31.7 21.8 16.9 28.8 23.7 45.3 7.3 41.5 73.7 27.6 30.0 27.3 34.0 28.3 18.0 27.5 35.2 18.3 11.0 36.8 29.1 14.1 26.4 20.9 15.5 59.6 42.5 26.7 35.1 34.3 15.7 40.0 48.3 39.3 52.7 26.5 42.9 17.7 57.7 17.3 20.7 37.6 15.6 34.4 15.2 15.3 11.1 11.9 40.9 20.4 8.4 10.5 13.4 9.6 123.8 29.8 10.5 21.5 48.6 32.7 17.1 50.8 36.9 0.3 0.4 0.2 61.3 46.5 12.9 85.5 68.3 19.2 18.3 57.2 22.0 18.7 22.6 23.4 55.4 15.0 19.7 19.8 19.5 21.8 43.9 25.7 25.5 68.0 19.9 24.4 15.0 24.3 19.7 21.5 23.2 23.1 17.0 14.2 71.5 58.2 98.7 286.1 83.2 26.3 290.4 244.5 58.9 78.5 96.0 19.6 399.2 281.8 289.2 13.5 118.6 130.2 70.0 215.9 135.5 154.5 94.2 142.1 611.8 643.1 22.3 99.4 338.8 323.0 12.0 106.2 397.5 119.8 265.1 129.8 50.2 258.3 117.9 106.1 410.6 24.7 148.8 123.7 5.4 2.6 68.8 92.8 101.2 167.3 176.7 GSTT2B GSTT2P ENSG00000133433 "Glutathione S-transferase theta 2B (gene/pseudogene)" P0CG30 22 23957414-23961186 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "breast: 83.4" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 24.9;Erythroid cells: 23.3;Hepatocytes: 27.7;Muller glia cells: 19.5;Peritubular cells: 26.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 22.6;HHSteC: 33.3;SK-MEL-30: 23.0;T-47d: 25.5" HPA000750 Uncertain Supported Nucleoplasm,Cytosol No No Cytosol Nucleoplasm "HPA000750: AB_1849804" "prognostic favorable (5.06e-4)" "unprognostic (5.14e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (7.13e-2)" "unprognostic (8.41e-3)" "unprognostic (2.58e-1)" "unprognostic (7.99e-2)" "unprognostic (1.15e-1)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (4.11e-1)" "unprognostic (1.18e-2)" "unprognostic (2.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.48e-2)" "unprognostic (2.19e-3)" 1.6 11.7 2.7 0.7 1.9 0.0 83.4 0.0 4.2 2.6 1.5 0.1 1.7 2.9 2.6 1.4 1.1 2.4 1.7 2.9 1.3 6.1 2.0 0.1 2.5 3.1 3.2 0.9 3.6 0.8 6.1 0.2 1.2 2.5 1.3 11.4 0.7 2.7 1.4 0.9 2.6 0.5 2.5 0.1 0.7 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 6.5 0.3 0.0 22.6 0.5 0.6 0.9 3.2 1.8 4.6 4.8 9.7 0.0 0.0 5.1 7.9 12.0 9.5 0.0 10.0 2.1 0.0 0.8 0.3 12.7 1.5 33.3 0.0 3.6 13.7 1.6 13.2 2.7 13.3 3.7 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.1 0.3 4.8 0.0 16.8 0.0 10.2 0.0 0.4 9.5 3.1 0.0 23.0 0.0 25.5 0.3 12.3 3.8 2.6 0.5 2.4 0.0 0.0 0.0 2.4 0.0 9.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 2.2 0.0 8.7 0.0 3.5 0.1 2.5 0.0 2.3 0.0 0.0 1.2 24.9 7.2 0.4 1.6 0.0 23.3 7.9 3.6 0.1 7.9 1.1 27.7 8.3 0.0 1.2 15.4 4.0 1.3 9.2 0.2 0.0 5.4 0.4 19.5 4.7 0.0 26.9 3.8 2.6 6.5 0.3 0.5 0.4 0.0 1.5 0.0 0.0 2.3 GSTT4 "GSTTP1, HS322B1A" ENSG00000276950 "Glutathione S-transferase theta 4" 22 23998401-24005453 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 63 "testis: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "Karpas-707: 1.6;PC-3: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.66e-2)" "unprognostic (1.77e-2)" "unprognostic (6.83e-4)" "unprognostic (4.36e-1)" "unprognostic (5.47e-1)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320884-77331597 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 90.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 348.1;Late spermatids: 326.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol NA NA 62000 Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favorable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 4.6 12.9 5.6 5.9 6.8 2.8 8.5 2.1 9.0 5.0 8.1 10.8 7.5 8.1 4.1 9.5 9.0 5.5 8.0 5.5 5.4 5.0 8.9 90.4 4.4 10.7 6.9 6.9 2.8 7.1 9.3 5.1 11.0 5.8 8.0 8.0 9.5 22.5 4.7 14.8 7.4 7.2 3.8 7.9 5.0 5.9 18.2 5.2 8.6 8.3 14.3 8.9 4.9 4.5 8.2 15.3 7.2 16.0 3.4 5.6 5.0 6.5 12.5 9.9 7.0 6.3 8.7 16.8 4.1 4.2 7.7 10.9 4.2 16.5 14.6 5.9 4.8 4.8 8.4 6.7 7.9 7.4 7.7 6.7 7.1 4.8 8.9 9.9 2.6 5.9 8.1 8.6 4.4 7.5 4.3 6.6 8.7 5.9 13.5 5.1 60.8 4.0 5.5 2.9 22.6 10.0 7.0 10.4 11.3 11.7 8.0 10.9 9.9 9.1 18.2 12.9 5.8 29.7 3.9 4.5 6.0 20.4 6.8 3.0 10.1 10.8 12.8 15.6 4.0 7.5 6.6 11.1 7.2 1.9 16.0 1.9 6.4 3.4 2.8 15.3 8.2 2.9 2.4 1.1 3.4 13.5 10.4 5.6 5.0 5.6 6.8 2.1 9.0 5.4 5.0 6.9 6.9 5.8 5.2 6.0 8.1 12.7 18.0 11.8 6.8 12.0 50.9 10.7 5.7 8.7 3.9 76.5 39.7 34.9 105.1 8.7 47.2 23.3 59.7 57.9 10.6 19.8 3.5 348.1 39.6 15.9 27.6 9.8 28.3 326.5 10.9 14.4 16.9 35.1 36.9 20.9 39.0 38.6 5.6 58.4 11.2 0.0 10.3 33.5 24.7 12.3 63.7 7.7 45.9 17.7 GSX1 "Gsh-1, GSH1" ENSG00000169840 "GS homeobox 1" Q9H4S2 13 27792643-27794768 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "brain: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "glioma: 3.9" "Region enhanced" "Detected in many" "hypothalamus: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 3.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA047096 Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA047096: AB_2679929" "unprognostic (1.62e-1)" 0.1 0.1 1.6 0.1 3.2 0.1 0.1 0.9 4.0 0.1 0.1 2.5 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.7 7.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.9 1.5 0.7 7.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GSX2 Gsh2 ENSG00000180613 "GS homeobox 2" Q9BZM3 4 54099523-54102505 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Dystonia, Mental retardation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.8;retina: 16.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 2.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.9;hTERT-RPE1: 1.6;RPTEC TERT1: 1.8" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Low region specificity" "Detected in single" NA NA "unprognostic (4.48e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (1.89e-1)" 0.0 0.0 3.3 0.4 4.8 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.7 0.1 0.0 0.0 0.4 1.0 0.8 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 16.7 0.0 0.0 0.0 1.7 0.3 0.0 0.7 0.2 0.1 2.2 0.5 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 4.8 0.0 0.9 0.7 0.7 1.0 0.8 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GTF2A1L ALF ENSG00000242441 "General transcription factor IIA subunit 1 like" Q9UNN4 2 48617798-48733148 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 47.7" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 6.8;Late spermatids: 1.7;Spermatocytes: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.1;HHSteC: 2.8;hTERT-RPE1: 3.4;SuSa: 2.5" NA NA "unprognostic (3.59e-1)" "unprognostic (7.00e-2)" "unprognostic (2.63e-1)" "unprognostic (4.77e-1)" "unprognostic (5.02e-2)" 0.7 0.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.9 4.3 0.3 0.3 0.4 2.3 0.9 0.6 0.8 0.7 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.9 0.3 0.1 0.3 0.3 0.3 0.9 0.1 0.3 0.3 0.3 0.4 0.1 0.6 0.5 0.3 0.4 1.4 47.7 0.3 0.3 0.3 0.3 0.3 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 5.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.8 0.0 0.0 0.9 0.3 0.0 0.0 3.4 0.9 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.7 0.0 2.5 0.3 0.0 0.0 0.4 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.1 GTF2A2 "HsT18745, TFIIA" ENSG00000140307 "General transcription factor IIA subunit 2" P52657 15 59638062-59657541 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 117.1" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 673.0;Late spermatids: 563.9;Spermatocytes: 832.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056239 Supported Nucleoplasm NA NA Nucleoplasm "HPA056239: AB_2683074" "unprognostic (2.18e-2)" "unprognostic (3.21e-1)" "unprognostic (9.37e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (3.06e-2)" "unprognostic (1.31e-2)" "unprognostic (7.35e-2)" "unprognostic (6.29e-2)" "unprognostic (3.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.58e-1)" "unprognostic (2.79e-1)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" 20.7 25.7 19.3 22.6 27.5 26.3 35.2 19.1 21.8 17.4 26.6 14.3 18.3 17.5 20.6 24.3 27.0 18.3 18.6 38.6 21.0 20.3 22.3 24.2 24.1 28.3 22.5 18.3 21.4 23.8 13.0 26.1 18.6 24.9 18.2 22.6 16.1 26.3 25.3 26.7 14.6 18.2 20.0 28.8 19.4 18.2 117.1 15.9 20.8 21.8 26.3 21.2 18.2 24.7 41.1 65.0 53.2 44.1 36.2 41.8 39.2 31.2 44.5 29.8 28.6 18.2 15.2 34.4 35.3 16.3 28.9 29.2 48.0 12.7 29.0 33.0 22.6 43.5 26.9 30.0 21.2 21.3 50.4 24.6 33.0 34.6 30.2 24.2 35.9 29.7 14.5 20.5 24.4 20.8 21.0 18.9 22.4 47.1 29.7 23.7 21.9 23.3 27.6 40.0 10.5 26.1 22.0 31.5 35.5 28.2 37.0 32.3 34.7 32.8 37.7 32.9 41.8 26.2 38.0 26.0 28.1 49.9 31.3 63.2 29.6 85.8 63.1 32.0 60.5 34.0 45.3 44.0 53.2 31.0 44.1 32.2 41.1 36.3 34.3 56.6 33.0 31.3 34.1 22.9 36.2 40.8 65.0 41.8 39.2 19.3 27.5 19.1 21.8 21.0 20.3 22.5 18.3 24.9 15.9 38.7 50.9 81.9 137.1 87.6 47.3 113.7 63.7 109.7 76.2 61.1 45.2 183.6 179.1 136.5 673.0 78.8 67.4 93.5 130.5 166.8 100.9 133.1 78.7 71.5 131.0 47.7 78.8 68.2 95.2 563.9 116.5 102.0 75.9 159.7 82.6 100.0 143.4 101.9 129.0 103.7 52.7 64.7 97.3 832.7 160.9 93.3 127.0 86.6 107.2 228.6 GTF2IRD1 "BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12" ENSG00000006704 "GTF2I repeat domain containing 1" Q9UHL9 7 74453790-74602604 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 62.8" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 29.7;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044254 Approved Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA044254: AB_10964747" "unprognostic (8.92e-2)" "unprognostic (6.94e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.71e-5)" "unprognostic (2.24e-1)" "unprognostic (3.35e-2)" "unprognostic (2.71e-3)" "unprognostic (3.77e-2)" "unprognostic (1.84e-2)" "unprognostic (6.26e-2)" "unprognostic (4.89e-3)" "unprognostic (3.31e-1)" "unprognostic (2.53e-1)" "unprognostic (8.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-3)" 4.6 7.6 4.3 5.1 6.8 0.6 6.3 4.4 7.8 9.4 8.2 8.2 9.2 7.0 7.4 8.7 16.4 7.0 8.6 7.7 3.9 5.5 9.3 3.6 7.2 2.6 8.5 5.3 8.6 10.0 21.1 25.3 5.3 6.6 8.2 5.5 21.6 11.3 8.3 62.8 15.6 5.2 12.1 5.6 1.6 8.8 4.5 5.7 1.3 16.4 12.9 7.3 10.5 13.2 0.6 1.8 2.7 0.5 0.6 0.7 0.1 9.3 5.9 12.9 14.1 10.4 5.1 0.1 4.0 10.6 7.8 8.2 10.2 13.4 2.4 3.0 8.0 19.2 5.4 10.2 4.7 5.8 0.1 6.1 0.4 19.9 11.4 33.4 0.1 0.3 7.1 19.2 5.4 22.6 18.3 4.0 4.7 6.8 0.0 8.7 11.8 1.2 8.2 10.3 11.3 6.1 12.6 7.5 8.7 14.8 6.5 10.6 14.5 9.8 17.8 8.7 6.8 10.6 9.3 2.2 8.1 8.3 5.2 9.0 0.5 1.4 3.9 3.3 0.1 6.5 1.2 0.5 0.5 0.3 0.2 0.3 0.4 0.7 0.2 1.8 0.6 0.3 0.4 2.7 0.6 0.1 0.6 0.2 0.1 4.3 6.8 4.4 7.8 3.9 5.5 8.5 5.3 6.6 5.7 8.9 8.0 0.0 9.4 7.0 29.7 7.2 7.6 10.7 4.5 8.7 31.4 0.9 10.0 6.4 0.5 2.7 3.3 0.0 8.1 1.4 4.6 16.3 2.3 2.6 2.2 20.6 4.1 1.8 2.4 0.0 3.7 4.0 6.8 1.0 4.0 5.6 8.5 2.9 5.3 12.4 38.9 0.0 4.6 0.0 5.1 5.8 2.4 0.0 6.8 14.2 GTF3C6 "bA397G5.3, C6orf51, TFIIIC35" ENSG00000155115 "General transcription factor IIIC subunit 6" Q969F1 6 110958560-110967890 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056179, HPA061345" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA056179: AB_2683058, HPA061345: AB_2684485" "unprognostic (6.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (3.04e-1)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (2.08e-2)" "unprognostic (9.79e-3)" "unprognostic (2.89e-1)" "unprognostic (5.42e-2)" "unprognostic (7.75e-2)" "unprognostic (1.42e-3)" "unprognostic (9.31e-2)" "unprognostic (1.69e-1)" "unprognostic (2.39e-2)" "unprognostic (1.14e-2)" 17.0 21.6 26.4 14.3 25.3 12.8 14.6 10.9 17.4 15.8 22.1 14.2 12.7 17.4 12.3 12.9 17.3 16.4 23.0 32.1 21.2 20.1 31.1 23.5 10.9 15.6 24.8 17.8 15.6 14.7 21.6 15.5 11.0 18.1 32.7 18.4 12.1 14.7 16.1 95.8 10.4 17.5 15.7 21.4 19.7 18.1 20.3 20.3 17.9 13.2 30.7 18.7 17.2 13.1 36.2 38.8 19.0 37.6 23.4 63.5 33.3 14.8 27.8 19.6 20.6 9.7 19.2 26.8 25.1 18.3 24.1 19.6 40.2 11.1 21.0 24.0 22.3 4.6 6.3 21.9 21.4 18.1 31.6 36.9 39.5 25.8 51.8 19.6 56.0 32.2 19.3 17.3 18.4 17.6 13.1 26.6 26.6 47.4 11.4 34.9 28.7 27.6 58.1 27.1 14.8 22.4 27.6 15.0 17.6 31.3 32.6 17.4 24.7 18.1 2.4 18.6 13.8 9.1 30.1 28.3 6.0 18.2 44.1 37.9 10.0 20.4 35.9 6.3 33.7 30.0 19.0 26.9 14.9 25.1 37.6 27.9 36.2 31.6 30.9 35.6 26.3 24.8 29.2 4.3 23.4 29.9 38.8 63.5 33.3 26.4 25.3 10.9 17.4 21.2 20.1 24.8 17.8 18.1 20.3 65.5 40.1 59.5 60.5 27.0 36.8 263.0 203.8 61.6 42.1 99.5 15.7 80.1 258.6 151.4 140.9 51.7 98.6 23.3 256.8 207.8 47.9 134.2 52.1 79.5 242.8 25.4 105.5 52.8 67.6 203.2 60.1 78.3 52.3 200.2 92.0 74.5 175.0 112.2 64.3 317.0 26.5 64.7 52.8 104.2 113.1 26.0 75.6 66.1 106.5 98.7 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296741-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0;testis: 22.3" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 1.1 1.3 0.3 10.4 0.8 10.2 1.3 1.0 1.1 1.2 2.5 0.7 0.1 4.1 1.1 1.3 6.6 0.4 0.4 0.8 1.0 0.3 0.9 0.9 1.3 9.0 0.6 0.4 0.9 0.5 0.0 0.9 2.8 1.8 0.6 2.6 0.7 1.5 0.1 0.3 2.4 3.3 1.0 0.6 4.6 2.4 22.3 0.3 20.0 0.5 5.8 8.8 1.1 2.1 1.4 1.9 3.0 0.2 1.8 1.6 0.9 21.8 10.4 20.5 16.2 0.4 1.2 9.8 19.0 9.0 27.7 22.9 10.8 8.3 20.7 5.0 7.3 12.7 11.5 18.3 4.8 17.8 12.4 19.7 13.8 14.6 8.4 0.0 24.7 16.9 0.2 0.3 11.9 6.1 2.9 11.9 15.0 10.5 26.0 16.5 12.2 22.1 12.1 14.3 9.0 11.7 22.0 23.0 13.5 4.5 4.0 10.6 14.5 18.1 11.8 8.4 9.6 10.0 9.6 9.4 15.8 30.0 12.9 19.9 14.9 7.1 21.0 10.0 11.9 23.0 0.1 0.2 1.5 1.3 0.1 0.4 1.4 0.6 0.6 0.3 0.6 0.4 0.3 3.0 1.8 0.1 1.9 1.6 0.9 0.3 0.8 1.0 1.1 1.0 0.3 0.6 0.4 1.8 0.3 0.0 0.0 0.8 0.6 2.5 0.6 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 3.9 0.4 0.5 93.5 0.2 27.0 1.1 0.6 0.0 0.5 16.0 0.0 1.2 5.5 6.2 3.8 0.3 3.5 0.0 0.0 2.0 0.2 0.4 0.0 0.7 0.4 0.1 6.5 0.9 47.7 20.4 2.3 1.3 2.9 3.7 1.4 GTSF1 "FAM112B, FLJ32942" ENSG00000170627 "Gametocyte specific factor 1" Q8WW33 12 54455950-54473602 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 20.3;testis: 62.3" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 927.5;Late spermatids: 1408.5;Spermatocytes: 345.5" "Cancer enriched" "Detected in many" 5 "testis cancer: 23.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 47.4;HMC-1: 35.4;K-562: 46.4;NB-4: 71.8;THP-1: 66.2;U-266/84: 53.1;U-937: 35.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038876, HPA038877" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA038876: AB_10670911, HPA038877: AB_2676251" "unprognostic (1.17e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (1.59e-1)" "unprognostic (1.11e-2)" "unprognostic (6.74e-3)" "unprognostic (2.56e-2)" "unprognostic (3.94e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.45e-1)" "unprognostic (7.59e-2)" "unprognostic (3.97e-5)" "unprognostic (4.16e-3)" "unprognostic (1.92e-1)" "unprognostic (2.77e-1)" "unprognostic (9.18e-2)" 0.3 0.2 0.3 1.5 0.4 1.8 0.5 0.1 0.2 0.1 0.2 0.2 0.0 0.3 0.1 0.5 0.3 0.2 0.3 0.3 0.4 0.2 0.3 0.4 0.7 1.7 0.3 0.0 0.2 0.2 0.0 0.2 9.9 0.2 0.2 0.6 0.1 0.2 0.0 0.4 0.2 0.6 0.0 0.3 3.3 0.2 62.3 0.0 3.0 0.2 0.0 3.5 0.5 0.2 19.7 19.7 13.5 6.1 17.6 20.3 9.7 0.1 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 8.9 0.0 0.0 0.0 25.3 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 47.4 35.4 0.0 0.0 0.0 0.0 0.0 0.0 14.2 46.4 19.2 0.0 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 66.2 0.2 0.0 1.7 0.0 0.1 19.3 53.1 0.1 0.0 35.4 0.0 13.5 5.9 10.5 14.4 5.6 17.9 19.7 17.0 20.3 9.7 16.5 15.8 16.6 2.7 17.6 6.1 19.7 17.6 9.7 0.3 0.4 0.1 0.2 0.4 0.2 0.3 0.0 0.2 0.0 0.0 1.1 3.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 927.5 0.0 0.0 0.0 0.0 96.3 0.2 0.0 1.1 0.0 10.8 0.0 0.0 0.0 2.4 1408.5 14.7 3.3 3.3 15.4 0.0 0.0 0.0 0.0 9.6 0.0 0.0 12.9 0.3 345.5 99.5 0.3 22.5 7.5 0.0 0.0 GTSF1L "C20orf65, dJ1028D15.4, FAM112A" ENSG00000124196 "Gametocyte specific factor 1 like" Q9H1H1 20 43726164-43726998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 104.1" "Group enriched" "Detected in some" 119 "Early spermatids: 2558.4;Late spermatids: 2369.0" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 7.5" "Lineage enriched" "Detected in many" 5 "T-cells: 7.5" "Cell line enhanced" "Detected in some" "Daudi: 1.3;EFO-21: 1.3;REH: 4.0;U-698: 4.4" "Low region specificity" "Detected in some" HPA054694 Enhanced Uncertain Nucleoli NA NA Nucleoli "HPA054694: AB_2682576" "unprognostic (2.61e-2)" "unprognostic (4.24e-6)" "unprognostic (9.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.50e-2)" "unprognostic (6.70e-2)" "unprognostic (2.15e-2)" "unprognostic (3.06e-2)" "unprognostic (2.45e-7)" "unprognostic (1.19e-1)" "unprognostic (9.54e-2)" "unprognostic (6.07e-3)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 104.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.9 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 0.0 1.4 0.6 0.8 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2558.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2369.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 6.5 0.0 20.6 8.0 0.0 0.0 0.0 0.0 0.0 GUCA1A "C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1" ENSG00000048545 "Guanylate cyclase activator 1A" P43080 6 42155406-42180056 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 91.2;testis: 62.2" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 628.3;Late spermatids: 331.5;Rod photoreceptor cells: 949.8" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.5" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Cell type enriched" "Detected in single" 84 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in single" 84 "dendritic cells: 8.4" "Group enriched" "Detected in some" 8 "NTERA-2: 7.2;SH-SY5Y: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005561, HPA075056" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA005561: AB_2667361, HPA075056: " "unprognostic (1.91e-2)" "unprognostic (3.92e-3)" "unprognostic (2.49e-2)" "unprognostic (9.16e-2)" "unprognostic (1.04e-4)" "unprognostic (9.70e-2)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (3.08e-3)" "unprognostic (2.79e-1)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" 0.2 0.2 2.7 0.3 10.0 0.2 0.2 0.1 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.2 0.1 1.5 5.4 0.1 0.1 0.2 0.3 1.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 91.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.1 62.2 0.1 0.1 0.1 0.1 0.5 0.3 0.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 2.7 10.0 0.1 0.8 1.5 5.4 1.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 118.0 0.3 0.0 0.0 0.0 0.0 628.3 0.4 0.0 0.0 108.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 62.0 0.0 0.0 0.0 331.5 1.7 0.0 0.0 9.0 0.0 125.6 0.0 0.0 1.8 0.0 949.8 0.0 0.0 2.8 1.9 0.0 0.2 0.0 0.0 0.0 GUCA1B "GCAP2, RP48" ENSG00000112599 "Guanylate cyclase activator 1B" Q9UMX6 6 42184401-42194916 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "retina: 88.4" "Group enriched" "Detected in some" 10 "Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 52.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 8.6;U-698: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA055479 Enhanced NA NA "HPA055479: AB_2732598" "unprognostic (1.61e-1)" "unprognostic (3.28e-1)" "unprognostic (1.14e-6)" "unprognostic (5.39e-2)" "unprognostic (1.73e-2)" "unprognostic (2.87e-3)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (5.57e-1)" "unprognostic (1.66e-1)" "unprognostic (1.72e-2)" "unprognostic (3.28e-7)" "unprognostic (4.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-2)" "unprognostic (2.59e-3)" 1.8 0.9 1.9 1.4 2.5 2.7 2.9 6.6 2.5 1.8 1.4 1.4 1.4 0.7 2.8 2.8 1.4 2.6 1.4 1.4 1.8 1.6 1.4 1.9 1.4 1.4 2.0 1.4 3.5 1.4 0.7 1.4 1.4 1.4 1.4 1.1 88.4 1.4 1.7 6.0 7.0 1.4 2.8 1.9 2.3 0.6 2.7 1.4 1.4 1.4 1.4 2.2 1.4 1.4 0.7 0.7 0.5 0.1 0.0 1.2 0.0 0.2 1.6 3.5 1.0 2.4 2.4 0.8 1.4 1.9 2.3 1.7 3.6 1.0 3.7 1.8 0.3 0.2 1.1 3.6 0.8 2.2 3.0 1.2 0.8 0.0 0.5 0.7 2.8 1.1 0.9 8.6 1.7 2.9 0.9 0.2 2.8 2.2 2.7 0.3 2.1 1.4 2.0 0.1 0.5 0.7 0.3 1.5 0.0 1.0 1.2 1.3 2.4 0.0 0.4 0.2 0.6 0.3 2.4 0.0 0.5 3.5 0.8 1.2 5.4 2.3 8.4 0.6 1.1 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.7 0.1 0.0 1.9 2.5 6.6 1.7 1.8 1.6 2.0 1.4 1.4 1.4 0.0 0.0 0.0 0.1 0.2 3.8 0.2 0.0 0.0 0.0 0.0 78.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 4.5 0.1 0.0 0.0 0.0 52.8 0.0 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.1 GUCA1C GCAP3 ENSG00000138472 "Guanylate cyclase activator 1C" O95843 3 108907792-108953895 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "heart muscle: 10.2;pancreas: 31.0;retina: 15.7" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 117.8" "Cancer enriched" "Detected in single" 7 "pancreatic cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 84 "RPTEC TERT1: 18.0" HPA041597 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA041597: AB_10795501" "unprognostic (7.56e-2)" "unprognostic (6.56e-2)" 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.7 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.7 31.0 0.0 0.2 0.0 0.5 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.7 0.0 0.0 0.0 0.0 0.0 2.8 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.7 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 7.4 5.5 0.0 0.0 0.0 0.0 117.8 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 8.2 0.5 0.0 0.0 0.0 19.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 GUCA2A "GUCA2, STARA" ENSG00000197273 "Guanylate cyclase activator 2A" Q02747 1 42162691-42164718 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 265.7" "Group enriched" "Detected in some" 16 "Enterocytes: 4125.7;Paneth cells: 4082.4" "Group enriched" "Detected in many" 7 "colorectal cancer: 31.6;urothelial cancer: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 34.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA018215 Enhanced "Secreted to blood" NA NA 26000000 "HPA018215: AB_1850443" "unprognostic (7.98e-3)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (9.07e-2)" "unprognostic (1.14e-1)" "unprognostic (8.06e-2)" "unprognostic (2.89e-1)" "unprognostic (3.10e-1)" "unprognostic (9.15e-2)" 0.2 0.1 0.2 8.0 0.2 0.0 0.2 0.2 0.2 0.2 87.3 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.7 0.0 0.2 3.5 0.2 0.2 91.9 0.2 0.2 0.2 0.2 0.1 265.7 2.1 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 4125.7 0.0 1.0 2.7 0.0 0.0 23.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 263.8 0.0 0.1 4082.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 76.4 0.1 GUCA2B ENSG00000044012 "Guanylate cyclase activator 2B" Q16661 1 42153421-42155824 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "intestine: 92.4" "Group enriched" "Detected in some" 27 "Enterocytes: 716.3;Paneth cells: 2864.6" "Cancer enhanced" "Detected in many" "liver cancer: 5.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 19 "monocytes: 1.9" "Group enriched" "Detected in some" 6 "A549: 3.3;CACO-2: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 740000 "unprognostic (2.59e-2)" "unprognostic (1.44e-2)" "unprognostic (1.34e-1)" "unprognostic (6.22e-2)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.1 55.2 0.1 0.1 13.5 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.0 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 8.7 0.1 0.1 0.1 0.1 0.0 92.4 0.1 0.1 0.2 5.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 9.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 716.3 0.0 43.1 0.1 0.0 0.0 23.0 2.6 0.1 0.0 21.9 0.6 0.0 1.1 0.0 0.0 0.0 0.0 67.1 0.0 3.8 2864.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 33.2 0.0 GUCD1 "C22orf13, LLN4, MGC1842" ENSG00000138867 "Guanylyl cyclase domain containing 1" Q96NT3 22 24540423-24555935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 73.3" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022786 Approved Nucleoplasm NA NA Nucleoplasm "HPA022786: AB_1845711" "unprognostic (1.58e-1)" "prognostic favorable (6.84e-4)" "unprognostic (2.83e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-2)" "unprognostic (1.89e-1)" "prognostic favorable (7.26e-4)" "unprognostic (1.28e-1)" "unprognostic (3.55e-2)" "unprognostic (1.76e-2)" "unprognostic (4.36e-2)" "unprognostic (8.63e-2)" "unprognostic (1.59e-1)" "unprognostic (3.01e-2)" 16.7 12.8 7.6 13.6 7.2 25.8 19.0 5.1 7.5 9.0 37.4 8.7 9.7 23.3 7.8 9.8 14.3 7.4 19.7 35.7 7.0 5.6 29.3 73.3 12.2 11.9 8.0 5.3 10.2 30.0 7.0 6.7 11.3 6.8 11.7 12.8 9.0 8.7 8.7 28.9 8.8 59.9 13.5 8.0 14.9 15.8 9.1 5.7 13.4 10.6 14.5 13.8 14.3 8.0 23.3 6.5 23.7 7.0 3.3 4.4 5.5 13.9 13.1 11.7 14.3 24.6 23.1 9.3 13.9 22.4 24.4 23.9 19.9 10.9 26.5 9.1 18.9 15.1 18.6 13.4 16.2 13.1 25.4 16.2 11.3 13.0 18.1 19.9 29.3 22.4 23.3 13.0 24.3 11.2 15.0 25.7 13.3 11.3 26.6 18.3 16.5 16.9 12.6 11.0 35.2 11.3 19.5 19.0 26.0 19.1 15.5 12.2 12.0 16.7 22.8 11.9 9.5 18.0 20.9 17.1 52.6 21.7 16.3 11.7 25.9 17.7 18.6 21.6 16.5 17.7 7.8 7.0 23.7 3.8 7.0 4.4 18.6 3.6 3.9 6.5 23.3 3.5 3.9 7.4 3.3 6.6 4.7 3.4 5.5 7.6 7.2 5.1 7.5 7.0 5.6 8.0 5.3 6.8 5.7 14.9 23.9 38.4 10.3 11.0 4.9 45.6 94.3 2.7 10.3 5.2 5.9 15.8 44.7 22.0 10.3 15.4 117.4 46.7 56.9 16.4 16.6 31.1 15.0 103.6 23.7 3.2 19.0 20.9 20.4 5.8 17.5 13.3 16.9 33.3 46.5 13.7 39.7 66.2 15.2 65.8 12.4 25.8 17.9 20.5 32.8 9.7 13.6 9.5 37.7 15.7 GUCY1A1 "GC-SA3, GUC1A3, GUCY1A3" ENSG00000164116 "Guanylate cyclase 1 soluble subunit alpha 1" Q02108 4 155666711-155732349 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 55.2" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 41.4;Club cells: 12.5;Collecting duct cells: 10.4;Distal tubular cells: 16.6;Ductal cells: 15.1;Proximal tubular cells: 10.2" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6" "Group enriched" "Detected in many" 27 "dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6" "Cell line enhanced" "Detected in some" "HAP1: 6.1;HEK 293: 5.0;Karpas-707: 8.7;MOLT-4: 15.9;RPTEC TERT1: 10.9;RT4: 12.7;SH-SY5Y: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010887, HPA056004, HPA058617" Uncertain Supported Nucleoplasm NA NA 6100 Nucleoplasm "CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624" "unprognostic (4.81e-3)" "unprognostic (2.60e-1)" "unprognostic (3.03e-1)" "unprognostic (2.15e-1)" "unprognostic (1.99e-2)" "unprognostic (7.77e-3)" "unprognostic (1.07e-1)" "prognostic favorable (2.38e-4)" "unprognostic (1.85e-3)" "unprognostic (6.46e-2)" "unprognostic (3.42e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.59e-4)" "unprognostic (1.60e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (2.27e-1)" "unprognostic (6.55e-3)" 10.9 5.3 12.4 10.2 19.9 0.9 11.1 3.4 11.6 13.7 31.2 7.3 2.8 5.6 14.7 6.0 7.0 6.8 8.3 21.0 9.0 7.2 11.6 5.1 13.2 7.3 4.7 12.5 5.4 8.5 55.2 5.8 16.3 6.3 17.2 6.9 39.7 7.0 9.8 4.5 3.6 10.1 18.8 6.6 8.5 12.9 2.1 8.5 4.5 8.1 7.3 5.9 6.4 10.6 0.1 11.6 0.3 9.2 7.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.1 0.0 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 3.3 0.0 8.7 0.0 0.0 15.9 0.0 0.0 0.0 0.2 3.5 0.0 2.6 10.9 12.7 2.2 8.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.3 0.0 2.3 0.1 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 7.6 9.2 11.6 0.0 1.0 12.4 19.9 3.4 11.6 9.0 7.2 4.7 12.5 6.3 8.5 8.9 41.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 12.5 10.4 0.0 0.4 16.6 15.1 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 3.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GUCY1A2 "GC-SA2, GUC1A2" ENSG00000152402 "Guanylate cyclase 1 soluble subunit alpha 2" P33402 11 106674012-107018524 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 23.0;placenta: 23.6" "Cell type enhanced" "Detected in many" 16 "Muller glia cells: 27.1;Sertoli cells: 103.5;Smooth muscle cells: 57.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 12.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009534 Uncertain NA NA "CAB009534: AB_2279509" "unprognostic (7.53e-2)" "unprognostic (6.67e-2)" "unprognostic (7.99e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-2)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (6.53e-3)" "unprognostic (9.70e-3)" "unprognostic (8.00e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.48e-4)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" 5.5 3.3 4.6 1.3 10.9 0.6 3.9 4.3 10.7 19.2 1.5 1.2 1.1 0.9 23.0 5.0 1.3 8.4 2.6 3.8 4.6 4.0 3.2 2.8 11.8 1.6 3.7 5.3 3.9 6.2 1.8 1.5 23.6 5.5 3.2 1.3 1.4 1.4 10.1 4.1 1.4 1.2 18.0 2.4 7.9 1.0 2.8 5.4 0.0 2.4 3.0 1.0 2.2 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 4.3 0.0 0.2 2.6 2.4 0.3 12.5 1.6 14.6 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 7.8 0.0 1.2 0.0 0.1 0.0 0.2 0.0 1.7 0.7 0.0 1.9 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 3.8 0.0 0.8 0.5 0.9 0.2 4.8 4.0 3.3 0.9 1.3 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 10.9 4.3 9.9 4.6 4.0 3.7 5.3 5.5 5.4 0.0 0.3 0.0 1.4 1.4 23.1 5.9 0.0 0.0 0.0 3.5 11.8 0.1 0.0 3.2 2.2 3.9 0.0 0.0 0.2 0.0 6.1 1.1 0.0 0.0 0.3 17.5 0.0 2.5 0.6 4.9 22.7 0.0 3.3 0.0 0.0 27.1 0.5 0.0 23.7 0.0 4.0 103.5 57.5 0.9 1.5 1.0 0.2 0.0 0.0 1.2 GUCY1B1 "GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3" ENSG00000061918 "Guanylate cyclase 1 soluble subunit beta 1" Q02153 4 155758992-155807591 "Enzymes, Plasma proteins, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.6" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 6.0;Collecting duct cells: 8.7;Ductal cells: 14.1;Proximal tubular cells: 19.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "intermediate monocyte: 5.6;non-classical monocyte: 17.8" "Lineage enriched" "Detected in many" 12 "monocytes: 17.8" "Cell line enhanced" "Detected in many" "HEL: 25.3;Karpas-707: 13.4;MOLT-4: 16.0;RPTEC TERT1: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010890, HPA020870" Approved Approved Cytosol NA NA 5200 Cytosol "CAB010890: AB_259911, HPA020870: AB_1850444" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (3.55e-2)" "unprognostic (9.10e-3)" "unprognostic (4.69e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (6.69e-3)" "unprognostic (3.03e-3)" "unprognostic (1.47e-1)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (7.35e-3)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.14e-1)" "unprognostic (6.36e-3)" 8.8 5.4 18.7 9.8 42.0 1.8 5.5 12.2 36.8 8.1 14.9 5.7 0.4 4.2 11.3 4.7 5.9 9.5 9.2 12.2 16.1 25.0 9.2 5.4 9.4 6.6 14.5 23.2 3.7 7.4 71.6 3.8 28.0 20.6 9.8 6.2 5.8 3.2 8.7 3.8 2.2 5.9 16.3 6.7 7.2 8.9 2.1 5.5 2.6 4.6 2.4 5.1 8.0 6.8 0.2 1.4 1.1 17.8 0.9 0.0 4.8 0.0 0.2 3.6 0.0 1.2 6.8 0.0 1.1 2.0 0.1 0.0 0.0 0.0 0.0 1.7 0.6 2.9 0.0 7.4 0.1 0.4 0.0 2.7 25.3 0.0 0.0 0.7 0.0 0.0 3.0 0.2 0.0 0.1 2.5 0.0 5.7 0.0 13.4 1.8 1.1 16.0 0.0 0.2 0.0 1.9 1.8 0.5 0.4 25.7 2.4 0.4 4.5 0.0 0.1 0.0 3.7 0.0 0.0 0.0 4.2 0.9 7.2 5.3 0.1 0.0 0.0 9.2 0.0 0.0 1.1 0.4 0.3 0.0 5.6 0.0 0.1 0.0 0.0 1.4 0.2 0.0 0.0 0.4 0.9 17.8 1.2 0.0 4.8 18.7 42.0 12.2 36.8 16.1 25.0 14.5 23.2 20.6 5.5 6.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.5 5.0 14.1 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696585 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 85.1" "Cell type enhanced" "Detected in some" 21 "Enterocytes: 37.2;Intestinal endocrine cells: 169.6;Mucus-secreting cells: 61.9;Paneth cells: 99.3;Undifferentiated cells: 41.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.2;CAPAN-2: 4.6;SiHa: 4.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles NA NA Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.2 0.1 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 38.8 0.2 0.2 28.0 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 17.5 0.2 0.5 0.2 0.2 1.0 85.1 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 4.3 0.7 2.7 1.7 0.0 0.0 0.6 1.1 0.1 0.0 3.7 0.0 0.0 2.2 0.2 0.0 0.0 0.0 3.2 4.6 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.6 4.2 0.3 0.0 1.1 0.4 0.1 0.0 0.0 0.0 0.9 0.1 1.3 0.8 1.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.7 2.3 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.3 99.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 41.2 0.0 GUCY2D "CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1" ENSG00000132518 "Guanylate cyclase 2D, retinal" Q02846 17 8002594-8020339 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 10.6;retina: 33.3" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 55.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 31 "plasmacytoid DC: 10.6" "Lineage enriched" "Detected in single" 53 "dendritic cells: 10.6" "Cell line enriched" "Detected in some" 4 "JURKAT: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.57e-4)" "unprognostic (5.05e-1)" "unprognostic (1.49e-1)" "unprognostic (9.75e-5)" "unprognostic (5.94e-2)" "unprognostic (1.86e-1)" "unprognostic (4.44e-2)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" "unprognostic (4.44e-1)" "unprognostic (7.59e-5)" "unprognostic (1.05e-1)" "unprognostic (3.46e-1)" "unprognostic (3.08e-1)" "unprognostic (1.07e-1)" 0.1 0.0 0.1 0.3 0.1 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 1.3 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 33.3 0.4 0.1 0.1 0.4 0.1 0.1 0.1 0.6 0.1 5.0 0.1 0.2 0.1 0.1 0.9 0.1 0.2 0.0 10.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.1 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 1.2 0.3 2.4 1.6 0.0 0.0 0.0 0.0 58.9 1.2 1.7 0.1 6.8 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.8 1.1 0.0 0.0 0.0 0.3 11.0 0.0 0.0 0.0 1.0 0.0 2.5 0.2 0.0 0.4 0.5 55.6 0.0 0.0 0.2 0.0 0.3 1.8 0.0 0.0 0.4 GUCY2F "CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2" ENSG00000101890 "Guanylate cyclase 2F, retinal" P51841 X 109372906-109482072 "Enzymes, Plasma proteins, Predicted membrane proteins" "cGMP biosynthesis, Sensory transduction, Vision" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 23.1" "Cell type enriched" "Detected in some" 33 "Rod photoreceptor cells: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "THP-1: 4.5;U-266/70: 1.6;U-937: 1.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 0.4" NA NA "unprognostic (1.91e-1)" "unprognostic (4.45e-2)" "unprognostic (2.96e-1)" "unprognostic (2.23e-1)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP, engulfment adaptor PTB domain containing 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 86.0" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 131.2;Muller glia cells: 100.6;Syncytiotrophoblasts: 170.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 32.7;WM-115: 71.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020587 Enhanced Approved Vesicles NA NA Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favorable (4.25e-6)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 8.0 15.0 3.1 7.6 9.8 0.0 9.7 0.7 8.0 22.6 11.8 2.2 14.4 6.5 23.3 40.6 11.5 10.4 8.9 5.1 2.5 4.8 11.4 1.0 9.0 1.2 2.4 4.5 17.9 32.3 23.9 3.7 86.0 14.3 14.3 3.8 19.4 10.7 16.1 5.9 5.0 10.5 15.1 2.8 3.2 11.9 17.0 2.2 0.3 8.0 6.1 3.1 11.3 20.2 0.6 0.4 1.5 1.9 0.6 0.2 0.3 3.8 9.4 32.7 7.3 5.1 5.0 6.1 5.3 9.0 8.7 7.0 5.9 18.9 0.0 4.0 4.2 8.4 2.5 6.5 0.4 6.3 0.0 4.3 8.0 7.1 0.0 4.7 0.0 0.0 3.0 1.2 4.1 4.4 13.3 4.0 0.0 6.7 0.1 5.9 0.5 0.0 0.1 8.3 5.5 14.6 0.0 7.7 3.8 17.3 1.6 0.1 24.6 0.0 4.4 11.3 14.7 1.5 0.0 1.9 2.6 1.2 8.8 2.9 0.0 0.0 0.0 1.4 0.0 71.2 1.3 1.9 0.4 0.2 1.1 0.1 0.3 0.1 0.1 0.4 0.6 0.2 0.2 1.5 0.6 0.7 0.2 0.1 0.3 3.1 9.8 0.7 8.0 2.5 4.8 2.4 4.5 14.3 2.2 14.9 12.0 0.8 22.6 14.0 1.2 1.2 50.9 49.5 37.5 22.7 0.0 32.9 38.1 25.9 3.4 21.5 13.4 0.0 33.1 5.1 35.1 61.3 0.0 0.2 2.8 1.6 131.2 5.5 0.6 4.7 19.0 3.6 33.7 1.8 2.0 100.6 43.4 5.8 57.7 30.0 1.5 6.5 40.6 35.4 22.8 24.1 170.9 0.0 0.8 15.0 GVQW2 ENSG00000279968 "GVQW motif containing 2" A0A096LPI5 6 138725211-138773652 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 5.4;bone marrow: 3.7;gallbladder: 2.2" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 23.4;Late spermatids: 5.8;Spermatocytes: 8.1" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 5.4;eosinophil: 1.7;memory B-cell: 1.6;naive B-cell: 2.2;neutrophil: 2.3" "Group enriched" "Detected in many" 6 "B-cells: 2.2;granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HSkMC: 6.4;MCF7: 2.2;U-266/70: 1.8" NA NA "unprognostic (2.47e-1)" "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (6.78e-2)" "unprognostic (1.90e-1)" "unprognostic (5.87e-2)" "unprognostic (7.99e-3)" "unprognostic (1.06e-2)" "unprognostic (1.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.48e-2)" "unprognostic (1.67e-2)" "unprognostic (3.65e-5)" "unprognostic (5.71e-2)" "unprognostic (2.91e-2)" "unprognostic (5.11e-1)" "unprognostic (5.42e-4)" 0.5 0.9 0.7 3.7 0.0 0.0 0.5 0.4 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.2 0.4 5.4 0.4 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 1.2 0.0 0.3 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 5.4 0.4 1.7 0.0 0.3 0.2 1.6 0.6 0.1 0.2 2.2 0.3 0.3 2.3 0.3 0.4 0.4 0.1 0.5 0.0 0.0 0.0 0.8 0.0 0.1 0.0 2.5 2.7 0.0 1.8 0.0 1.8 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.5 0.0 0.0 1.8 0.0 5.8 0.0 0.3 0.0 1.0 0.1 0.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 8.1 2.5 0.0 0.7 0.0 0.4 0.8 GYG1 GYG ENSG00000163754 "Glycogenin 1" P46976 3 148991341-149027668 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.0" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 202.8;Early spermatids: 172.2;Late spermatids: 292.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030497, HPA073229" Supported Approved Vesicles NA NA Vesicles "HPA030497: AB_10602326, HPA073229: " "unprognostic (2.68e-2)" "unprognostic (6.31e-3)" "unprognostic (3.21e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (7.75e-3)" "unprognostic (1.29e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" 10.8 7.9 7.0 8.5 8.5 55.7 10.0 9.2 7.5 10.6 31.0 6.0 11.9 4.8 15.6 15.4 18.1 11.1 12.0 32.0 8.0 9.0 8.5 6.3 9.1 14.7 11.6 7.1 13.3 14.3 6.5 7.8 6.5 10.0 16.3 7.6 7.7 11.3 19.4 113.0 4.7 8.4 32.5 8.1 13.6 12.8 47.3 7.4 4.2 9.4 39.6 8.5 28.7 14.6 7.0 26.7 16.8 26.7 17.7 32.5 17.5 18.8 12.2 9.1 10.2 25.3 26.5 12.4 27.8 23.2 40.6 38.1 15.9 19.3 0.0 13.8 32.2 21.7 5.8 23.9 12.3 41.1 6.3 10.3 14.4 5.8 18.0 22.9 14.6 21.8 14.5 20.1 13.4 17.0 21.2 23.3 9.5 8.8 34.3 23.3 33.2 2.8 11.7 10.9 14.6 10.0 8.0 13.8 27.0 11.2 17.7 7.5 3.5 14.7 20.3 15.8 9.0 20.1 15.6 19.3 20.8 6.2 14.9 20.3 31.2 17.3 13.4 17.6 22.6 6.7 7.2 23.4 16.8 17.4 24.5 32.5 7.0 11.6 18.1 26.7 5.1 6.3 10.7 11.6 17.7 26.7 10.7 15.9 17.5 7.0 8.5 9.2 7.5 8.0 9.0 11.6 7.1 10.0 7.4 11.9 12.0 15.2 20.5 10.8 7.4 202.8 10.2 16.0 11.4 31.4 17.7 31.4 23.2 37.5 172.2 32.3 12.4 0.0 67.2 38.6 32.6 36.2 17.4 13.9 84.7 6.4 13.8 43.0 102.9 292.0 49.2 51.1 38.8 27.9 13.4 81.1 32.6 13.3 72.2 12.2 4.9 64.7 60.5 46.6 19.8 13.0 24.5 62.3 12.1 16.9 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 15.8;Intestinal endocrine cells: 19.5" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.1;Hep G2: 13.7;NTERA-2: 16.9;SK-MEL-30: 36.5;SuSa: 27.1" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol No No "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: AB_2685323" "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favorable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.2 17.1 0.0 10.2 0.0 12.4 0.5 3.0 3.0 3.8 12.7 0.3 0.0 1.4 2.1 3.1 0.0 9.6 0.2 2.9 0.1 2.7 0.0 0.2 13.7 3.0 0.0 4.2 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.8 0.0 0.4 16.9 0.1 0.0 2.8 5.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 36.5 27.1 1.6 10.4 0.0 0.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 0.0 0.0 0.0 0.9 0.3 0.9 0.6 2.5 0.0 0.0 0.0 3.9 5.3 5.0 0.8 0.3 0.0 0.2 0.0 3.4 7.0 1.9 1.7 0.0 15.8 0.9 0.0 19.5 0.0 1.3 0.0 0.6 0.0 3.3 0.0 1.3 1.8 2.8 0.0 2.8 2.1 0.0 0.0 0.9 0.3 0.4 0.3 1.9 0.0 2.0 0.5 GYPA "CD235a, GPA, MN, MNS" ENSG00000170180 "Glycophorin A (MNS blood group)" P02724 4 144109303-144140786 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Host-virus interaction" "Blood group antigen, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "bone marrow: 56.9" "Cell type enriched" "Detected in some" 311 "Erythroid cells: 1331.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "HEL: 57.0" "CAB002658, HPA014811" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "CAB002658: , HPA014811: AB_1849827" "unprognostic (1.60e-1)" "unprognostic (2.47e-2)" 0.1 0.0 0.2 0.1 0.4 56.9 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.3 1.7 1.3 3.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 4.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.3 0.4 0.2 0.2 0.6 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.2 0.9 0.1 0.2 0.2 1.5 0.2 0.6 0.2 0.2 0.2 0.3 0.0 0.8 0.2 0.4 0.1 0.5 0.2 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.3 0.0 0.0 1331.6 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GYPB "CD235b, GPB, MNS, SS" ENSG00000250361 "Glycophorin B (MNS blood group)" P06028 4 143996104-144019345 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 37.1" "Cell type enriched" "Detected in some" 591 "Erythroid cells: 981.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 61.4" "Intracellular and membrane" NA NA 0.2 0.0 0.2 0.1 0.1 37.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.2 3.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 981.2 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GYPE "GPE, MNS" ENSG00000197465 "Glycophorin E (MNS blood group)" P15421 4 143870867-143905563 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 14.5;lymphoid tissue: 6.9" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 70.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Group enriched" "Detected in many" 12 "B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3" "Group enriched" "Detected in some" 11 "HEL: 50.9;K-562: 16.4" NA NA "unprognostic (2.17e-1)" "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.00e-2)" "unprognostic (4.71e-2)" "unprognostic (1.09e-4)" "unprognostic (2.05e-2)" "unprognostic (1.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.10e-1)" "unprognostic (1.53e-2)" "unprognostic (2.81e-3)" "unprognostic (1.10e-4)" "unprognostic (7.81e-3)" "unprognostic (1.76e-1)" "unprognostic (2.97e-1)" "unprognostic (3.49e-2)" 2.7 0.2 1.2 1.5 0.5 14.5 1.2 0.5 1.2 0.9 0.5 0.5 0.5 0.0 0.5 0.8 0.5 0.1 0.7 2.6 1.1 0.3 0.7 0.5 3.7 1.0 0.5 0.5 1.5 0.5 0.0 0.5 5.7 1.1 0.5 0.4 0.5 0.5 0.6 0.5 0.5 1.7 0.5 0.7 6.9 0.4 0.8 0.5 1.5 1.4 0.5 3.1 0.9 0.5 3.5 0.1 0.0 0.0 2.1 1.3 0.0 0.0 0.0 0.0 0.0 3.0 3.0 0.0 1.2 2.7 0.6 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 50.9 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.5 0.0 0.0 0.0 1.1 0.8 0.6 0.0 2.1 0.0 0.1 0.0 0.0 1.2 0.5 0.5 1.2 1.1 0.3 0.5 0.5 1.1 0.5 14.9 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 70.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.0 GYS1 "GSY, GYS" ENSG00000104812 "Glycogen synthase 1" P13807 19 48968125-48993310 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007793, HPA041598" Enhanced Approved Microtubules,Cytosol NA NA 10000 "Microtubules, Cytosol" "CAB007793: AB_562291, HPA041598: AB_2677571" "unprognostic (3.37e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (6.83e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (3.30e-2)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.46e-4)" "unprognostic (4.04e-2)" "unprognostic (6.76e-2)" "unprognostic (5.87e-3)" "unprognostic (3.81e-2)" 9.7 7.3 5.1 6.1 6.5 16.0 10.6 11.3 6.2 5.3 7.3 6.2 5.8 6.1 6.2 6.9 11.5 5.9 6.1 37.3 6.8 4.0 7.2 4.3 5.0 6.3 5.3 5.5 6.8 4.4 6.4 5.1 5.0 5.9 8.7 6.1 12.4 7.2 7.6 106.1 8.1 6.1 6.8 6.0 5.8 7.3 2.2 5.5 6.4 5.2 42.6 9.0 7.9 6.9 6.7 15.9 8.2 10.5 12.8 10.9 7.3 28.7 11.5 8.5 11.7 19.9 7.8 16.9 20.0 14.1 21.1 24.7 11.2 9.4 12.0 12.2 19.5 5.6 20.6 14.2 25.4 18.5 7.4 20.6 9.9 14.7 9.9 11.2 10.8 7.4 19.2 12.2 13.5 11.5 18.3 17.6 12.7 6.9 16.1 26.4 10.9 13.4 9.4 4.5 12.5 13.2 11.4 14.9 11.8 20.9 30.9 5.3 7.4 17.8 23.3 4.7 11.9 12.3 11.3 13.6 25.9 10.0 11.6 21.6 13.3 13.8 5.9 26.4 9.5 5.8 8.2 10.5 7.5 8.8 6.3 10.9 6.7 7.6 8.2 15.9 5.5 6.3 5.6 4.4 12.8 8.5 8.6 10.1 7.3 5.1 6.5 11.3 6.2 6.8 4.0 5.3 5.5 5.9 5.5 0.0 13.9 2.2 3.1 4.5 2.2 62.1 5.1 6.7 3.4 0.0 15.7 7.4 0.0 6.9 0.2 5.4 9.5 0.0 5.9 22.2 4.6 4.3 4.6 4.4 7.1 0.0 6.9 9.8 6.5 0.7 4.9 3.8 6.8 8.2 11.8 2.7 8.9 10.4 5.3 4.8 11.1 0.0 7.6 1.7 3.1 3.6 3.3 4.4 9.8 3.1 GYS2 ENSG00000111713 "Glycogen synthase 2" P54840 12 21536189-21604847 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 75.1" "Cell type enriched" "Detected in some" 46 "Hepatocytes: 57.8" "Cancer enriched" "Detected in single" 29 "liver cancer: 12.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 8 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;HEL: 1.9;SuSa: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039482 Approved NA NA "HPA039482: AB_10795107" "unprognostic (7.22e-3)" "unprognostic (2.85e-2)" "unprognostic (8.88e-2)" "unprognostic (1.78e-2)" "unprognostic (5.68e-2)" "unprognostic (3.16e-1)" "prognostic favorable (7.62e-5)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (1.68e-1)" "unprognostic (4.68e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.85e-1)" "unprognostic (2.66e-4)" 8.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.1 75.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 2.4 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.2 0.6 1.9 0.2 0.0 0.3 0.5 0.4 0.5 0.2 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.6 0.0 0.3 0.3 0.2 0.0 0.0 0.5 0.2 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.1 0.2 0.1 0.4 0.0 0.1 0.2 0.1 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 57.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GZMA "CTLA3, HFSP" ENSG00000145649 "Granzyme A" P12544 5 55102648-55110252 "Enzymes, Predicted secreted proteins" "Apoptosis, Cytolysis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 92.3;intestine: 31.0;lymphoid tissue: 40.9" "Cell type enriched" "Detected in many" 28 "T-cells: 796.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "gdT-cell: 92.3;MAIT T-cell: 90.8;memory CD4 T-cell: 25.4;memory CD8 T-cell: 89.3;naive CD8 T-cell: 50.5;NK-cell: 61.9" "Group enriched" "Detected in many" 38 "NK-cells: 61.9;T-cells: 92.3" "Cell line enhanced" "Detected in some" "HL-60: 8.4;JURKAT: 6.3;REH: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA054134, HPA076751" Enhanced "Secreted to blood" NA NA "HPA054134: AB_2682395, HPA076751: " "prognostic favorable (7.27e-4)" "unprognostic (7.29e-3)" "unprognostic (1.50e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.96e-3)" "unprognostic (1.85e-3)" "unprognostic (8.30e-3)" "unprognostic (1.15e-2)" "unprognostic (5.15e-3)" "unprognostic (3.03e-2)" "unprognostic (1.77e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (1.26e-6)" "unprognostic (5.91e-2)" "unprognostic (5.57e-1)" "unprognostic (5.73e-3)" "unprognostic (3.33e-3)" 4.3 1.8 1.1 16.3 1.2 10.0 2.5 0.7 0.8 3.9 12.5 0.9 1.3 10.3 5.2 2.9 2.9 2.9 9.6 4.5 1.1 1.1 4.6 5.2 11.8 20.3 1.7 0.9 3.0 5.8 0.0 1.9 5.8 1.5 3.4 6.3 4.5 5.1 1.3 2.6 1.2 31.0 2.5 2.6 40.9 3.9 1.1 0.6 1.9 3.1 4.2 11.1 6.6 2.9 0.2 0.2 2.0 0.3 61.9 92.3 52.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 92.3 0.2 90.8 0.2 25.4 89.3 0.2 0.1 5.2 50.5 2.0 61.9 0.3 0.2 2.9 52.0 1.1 1.2 0.7 0.8 1.1 1.1 1.7 0.9 1.5 0.6 3.0 28.1 9.2 0.0 0.3 0.0 0.7 2.5 5.3 5.7 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.1 0.8 0.1 7.0 2.4 0.2 0.0 0.0 12.3 16.8 0.0 0.0 1.3 3.3 0.0 0.6 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.4 0.0 0.0 1.3 0.6 796.9 0.5 0.0 GZMB "CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT" ENSG00000100453 "Granzyme B" P10144 14 24630954-24634267 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "blood: 298.5" "Cell type enriched" "Detected in many" 4 "T-cells: 243.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 298.5" "Lineage enriched" "Detected in many" 5 "dendritic cells: 298.5" "Cell line enriched" "Detected in some" 5 "HMC-1: 21.2" "CAB000376, HPA003418" Enhanced "Secreted to blood" NA NA "CAB000376: AB_323716, HPA003418: AB_1079020" "prognostic favorable (7.27e-4)" "unprognostic (2.82e-3)" "unprognostic (8.54e-2)" "prognostic favorable (1.58e-5)" "unprognostic (2.07e-3)" "unprognostic (1.48e-3)" "unprognostic (4.43e-2)" "unprognostic (8.25e-2)" "unprognostic (3.70e-2)" "unprognostic (3.05e-3)" "unprognostic (4.26e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.10e-7)" "unprognostic (1.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-3)" 6.4 0.7 0.8 8.0 1.1 26.4 3.2 0.7 0.7 1.6 3.0 0.5 1.3 0.8 3.9 1.5 4.0 1.0 3.1 4.8 0.7 2.4 2.1 5.7 21.7 16.7 1.1 0.0 1.4 0.7 0.0 1.0 7.5 0.8 2.6 0.9 4.0 2.7 2.3 3.5 0.6 2.9 1.8 1.5 33.0 3.5 0.9 0.4 6.1 4.4 5.3 16.8 6.0 1.5 0.2 298.5 2.0 0.2 19.9 60.5 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.7 2.9 0.3 0.1 0.2 60.5 0.1 0.7 0.2 4.6 28.4 0.2 0.1 1.4 28.7 2.0 19.9 0.2 298.5 0.1 53.6 0.8 1.1 0.7 0.7 0.7 2.4 1.1 0.0 0.8 0.4 6.0 57.5 21.4 0.2 2.5 0.0 0.4 0.0 8.1 13.6 0.0 0.0 0.1 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 1.6 0.2 16.3 1.1 0.2 0.0 0.0 3.1 2.1 0.0 0.0 5.5 40.5 0.0 0.0 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.5 0.0 0.0 3.6 0.2 243.7 0.2 0.1 GZMH "CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2" ENSG00000100450 "Granzyme H" P20718 14 24606480-24609699 "Enzymes, Predicted secreted proteins" Cytolysis "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 134.9" "Cell type enriched" "Detected in some" 9 "T-cells: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 134.9;memory CD4 T-cell: 41.8;memory CD8 T-cell: 109.7;naive CD8 T-cell: 102.7" "Lineage enriched" "Detected in many" 8 "T-cells: 134.9" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;JURKAT: 1.8;RPMI-8226: 2.0;THP-1: 1.4;U-266/70: 4.5" "Low region specificity" "Detected in many" HPA029200 Enhanced "Secreted to blood" NA NA "HPA029200: AB_10602908" "unprognostic (3.72e-3)" "unprognostic (1.47e-3)" "unprognostic (5.35e-2)" "prognostic favorable (2.00e-6)" "unprognostic (8.80e-2)" "unprognostic (1.65e-3)" "unprognostic (2.08e-3)" "unprognostic (1.13e-1)" "unprognostic (1.62e-2)" "unprognostic (4.41e-2)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "prognostic unfavorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.80e-1)" "unprognostic (3.35e-2)" "unprognostic (2.77e-3)" 3.6 3.1 1.1 5.0 1.2 16.5 3.6 0.5 1.0 1.9 3.1 0.4 0.2 0.9 1.0 2.7 2.6 1.8 8.1 4.8 1.0 1.1 1.7 3.6 16.4 11.5 2.6 1.3 3.0 1.1 0.0 3.7 1.6 1.2 4.5 1.1 5.1 5.4 4.2 4.5 0.8 2.2 2.0 3.1 22.6 2.5 2.5 0.7 0.2 2.5 3.4 6.4 5.1 1.9 0.4 3.2 1.8 0.3 17.6 134.9 82.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.4 0.9 1.8 0.2 0.1 134.9 0.2 2.4 0.4 41.8 109.7 0.2 0.2 13.9 102.7 1.5 17.6 0.3 3.2 0.3 82.9 1.1 1.2 0.5 1.0 1.0 1.1 2.6 1.3 1.2 0.7 0.0 5.8 3.0 0.0 1.0 0.0 0.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.1 0.8 0.1 0.0 0.0 9.2 2.7 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.0 1.6 0.0 79.8 0.0 0.0 GZMK "PRSS, TRYP2" ENSG00000113088 "Granzyme K" P49863 5 55024253-55034570 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.8;lymphoid tissue: 37.3" "Cell type enriched" "Detected in some" 11 "T-cells: 137.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 95.8;memory CD8 T-cell: 59.0" "Group enriched" "Detected in many" 191 "NK-cells: 56.9;T-cells: 95.8" "Cell line enriched" "Detected in single" 10 "JURKAT: 5.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA063181, HPA065895" Enhanced "Secreted to blood" NA NA "HPA063181: AB_2684955, HPA065895: " "prognostic favorable (8.68e-4)" "unprognostic (3.26e-3)" "unprognostic (2.23e-2)" "unprognostic (1.83e-3)" "unprognostic (2.61e-2)" "unprognostic (1.12e-3)" "unprognostic (1.03e-3)" "unprognostic (8.13e-3)" "unprognostic (3.50e-2)" "unprognostic (4.53e-2)" "unprognostic (9.74e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.06e-4)" "unprognostic (2.04e-1)" "unprognostic (2.42e-1)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" 3.5 1.6 0.6 10.5 0.6 3.6 3.1 0.5 0.5 4.1 3.7 0.2 1.7 0.4 3.2 2.6 2.8 1.8 7.4 1.6 0.6 0.7 4.3 4.1 10.2 37.3 0.7 0.2 2.1 1.5 0.0 1.0 0.9 0.5 6.6 1.9 2.9 5.7 2.1 0.8 0.8 7.4 0.8 1.6 36.4 2.4 2.1 0.3 3.3 3.1 2.7 28.2 4.9 2.6 0.0 0.1 0.4 0.1 56.9 95.8 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 21.1 0.1 95.8 0.0 13.2 59.0 0.0 0.0 0.6 10.5 0.4 56.9 0.1 0.1 0.8 9.9 0.6 0.6 0.5 0.5 0.6 0.7 0.7 0.2 0.5 0.3 3.0 12.4 0.0 0.0 1.3 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.3 1.0 0.2 0.0 0.0 8.0 8.7 0.2 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.2 137.0 0.0 0.0 GZMM "LMET1, MET1" ENSG00000197540 "Granzyme M" P51124 19 544034-549924 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Cytolysis, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 79.2;lymphoid tissue: 28.6" "Cell type enriched" "Detected in some" 8 "T-cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "gdT-cell: 79.2" "Group enriched" "Detected in many" 31 "NK-cells: 22.7;T-cells: 79.2" "Cell line enhanced" "Detected in some" "EFO-21: 4.6;HDLM-2: 3.7;HMC-1: 4.6;JURKAT: 7.5;MOLT-4: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015624 Enhanced "Secreted to blood" NA NA "HPA015624: AB_2669245" "unprognostic (2.97e-3)" "unprognostic (2.29e-3)" "unprognostic (7.53e-2)" "prognostic favorable (1.89e-4)" "unprognostic (1.07e-1)" "prognostic favorable (1.87e-7)" "unprognostic (2.35e-1)" "unprognostic (7.46e-2)" "unprognostic (1.67e-1)" "unprognostic (4.98e-2)" "unprognostic (4.53e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.32e-1)" "unprognostic (9.51e-2)" "unprognostic (2.69e-3)" "unprognostic (9.94e-2)" 1.8 1.0 0.7 13.6 0.9 15.6 1.0 4.3 1.4 1.0 3.5 0.2 0.1 1.8 1.0 2.9 2.0 1.1 4.7 1.6 0.7 0.6 1.1 2.6 4.8 15.1 0.7 0.4 0.8 0.4 0.0 0.9 1.6 0.5 1.7 0.1 1.5 12.0 0.3 0.8 0.7 5.1 0.5 1.1 21.1 3.0 1.5 0.4 28.6 1.4 1.1 10.9 1.1 1.2 0.4 0.4 1.6 0.2 22.7 79.2 27.0 0.1 0.6 0.1 0.3 0.2 0.0 0.6 0.0 0.1 0.1 0.0 0.5 0.2 0.1 4.6 0.0 0.1 0.1 0.0 0.0 0.0 3.7 0.4 0.0 0.6 0.2 0.5 0.4 4.6 0.2 0.0 0.1 0.0 0.0 0.1 7.5 1.4 0.3 0.0 1.0 3.0 1.3 0.8 0.2 0.7 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.9 0.3 1.0 0.3 0.7 0.3 0.8 0.1 0.1 79.2 0.2 49.8 0.1 26.4 63.6 0.1 0.4 25.8 53.1 1.6 22.7 0.2 0.4 12.2 27.0 0.7 0.9 4.3 1.4 0.7 0.6 0.7 0.4 0.5 0.4 0.0 0.0 0.8 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.4 0.0 23.3 0.3 0.3 1.9 0.0 0.0 0.8 0.2 0.0 0.0 2.5 2.8 0.8 0.0 1.6 1.7 0.0 0.1 1.5 0.2 0.0 0.0 0.7 1.4 0.0 0.2 0.1 0.7 1.3 0.5 184.9 0.0 0.1 H1F0 "H10, H1FV" ENSG00000189060 "H1 histone family member 0" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 158.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 85.2;U-2 OS: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" Yes No "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favorable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 21.7 13.6 27.5 14.7 24.9 158.1 32.3 35.7 41.7 48.2 37.9 20.4 11.3 35.8 42.7 18.5 66.0 31.7 38.5 30.3 23.5 17.6 33.2 90.6 22.8 15.0 16.0 23.8 48.5 43.5 20.2 25.6 33.6 23.5 43.7 34.0 28.3 43.2 12.4 53.5 53.2 59.2 28.0 18.6 16.3 34.6 15.2 18.8 56.3 36.1 33.4 32.0 24.9 45.2 0.1 6.3 12.5 9.0 0.1 2.4 4.7 20.2 8.8 27.4 12.1 7.2 6.6 38.9 16.5 34.6 48.5 69.2 35.9 32.5 0.0 4.1 13.7 11.3 39.8 0.0 11.4 34.6 0.1 2.0 34.3 3.2 23.8 25.4 0.0 0.1 6.2 20.3 24.3 27.4 0.5 12.8 7.9 0.0 0.0 3.7 33.6 5.7 3.3 10.6 85.2 43.5 9.5 16.3 7.0 7.6 5.5 6.3 35.4 45.7 31.2 60.2 12.8 24.3 21.5 8.5 3.7 110.7 16.3 3.3 0.0 2.3 0.1 4.5 12.4 10.5 12.5 7.6 11.3 0.1 9.0 0.1 0.0 0.8 0.2 6.3 0.1 2.4 0.3 4.2 0.1 7.7 5.7 0.2 4.7 27.5 24.9 35.7 41.7 23.5 17.6 16.0 23.8 23.5 18.8 26.8 114.5 10.0 163.5 62.0 29.8 40.3 107.0 97.7 135.4 97.7 3.9 33.1 106.1 132.1 1.8 71.9 117.5 280.4 159.3 112.5 82.5 175.2 22.0 68.2 59.5 42.9 119.1 63.3 67.8 3.7 85.4 44.3 81.0 92.8 180.5 46.0 119.5 160.1 57.0 42.8 5.6 109.9 96.7 55.8 24.9 78.3 183.8 7.0 103.1 138.2 H1FNT "H1T2, HANP1" ENSG00000187166 "H1 histone family member N, testis specific" Q75WM6 12 48328980-48330279 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 57 "testis: 71.7" "Group enriched" "Detected in some" 102 "Early spermatids: 1547.2;Late spermatids: 3533.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Group enriched" "Detected in some" 7 "U-266/70: 5.0;U-266/84: 1.2" "Not detected" "Not detected" HPA046204 Approved NA NA "HPA046204: AB_2679586" "unprognostic (2.94e-1)" "unprognostic (2.50e-1)" "unprognostic (1.95e-1)" "unprognostic (1.50e-3)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-5)" "unprognostic (1.91e-1)" "unprognostic (7.68e-4)" "unprognostic (3.41e-1)" "unprognostic (2.87e-2)" "unprognostic (5.79e-3)" "unprognostic (9.84e-2)" 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1547.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3533.3 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 12.9 0.0 25.0 12.1 0.0 0.0 0.0 0.0 0.0 H1FOO ENSG00000178804 "H1 histone family member O oocyte specific" Q8IZA3 3 129543214-129551467 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 80 "testis: 10.8" "Cell type enriched" "Detected in some" 11 "Early spermatids: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.1;SCLC-21H: 1.5" "Low region specificity" "Detected in many" HPA037992 Enhanced NA NA "HPA037992: AB_10671517" "unprognostic (5.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 H1FX "H1X, MGC15959, MGC8350" ENSG00000184897 "H1 histone family member X" Q92522 3 129314771-129316277 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "bone marrow: 381.6;lymphoid tissue: 238.6" "Cell type enhanced" "Detected in all" 6 "Basal glandular cells: 485.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 139.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 23.1 13.1 11.9 19.0 14.5 381.6 33.7 29.0 22.9 30.9 21.0 9.6 13.4 21.1 26.0 19.6 34.5 25.1 24.0 27.5 11.3 11.2 12.9 24.9 30.9 44.2 6.7 16.3 39.0 22.4 18.4 20.5 15.0 6.9 26.2 7.8 18.4 32.3 16.3 30.8 40.5 26.0 19.1 9.6 29.9 29.0 14.2 6.3 238.6 21.9 18.1 20.5 35.6 25.0 5.7 10.8 15.9 5.3 4.8 8.3 2.2 19.9 10.6 20.1 8.7 2.0 2.4 19.1 8.8 6.4 10.5 11.1 6.3 11.0 2.5 9.7 3.1 7.0 20.1 8.4 5.6 1.6 18.3 16.3 7.6 8.2 8.6 8.7 8.8 2.0 4.9 7.7 4.2 9.7 4.7 6.0 35.4 11.7 45.5 1.4 20.9 40.7 17.5 18.8 3.6 12.0 29.4 8.6 23.7 3.2 4.2 32.1 37.2 9.3 4.6 26.6 4.0 18.2 17.8 5.9 8.1 42.6 7.9 7.3 139.5 53.3 21.5 6.6 8.4 8.9 0.4 5.3 15.9 4.3 3.7 4.0 4.4 6.7 5.1 7.4 5.7 8.3 4.3 1.2 4.8 3.3 10.8 5.1 2.2 11.9 14.5 29.0 22.9 11.3 11.2 6.7 16.3 6.9 6.3 14.9 12.8 95.3 485.3 89.5 119.1 25.5 63.7 2.7 3.4 89.0 29.5 60.0 94.5 42.6 7.4 89.9 34.4 70.0 71.0 93.0 97.3 173.5 5.7 38.5 77.7 138.2 153.1 85.3 93.5 8.0 92.0 75.7 118.1 25.2 86.3 209.9 59.2 48.9 48.8 25.1 84.3 122.9 82.1 13.2 36.5 96.0 57.2 72.6 52.5 312.3 H2AFB1 ENSG00000274183 "H2A histone family member B1" P0C5Y9 X 154884972-154885558 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 6.4" "Group enriched" "Detected in some" 9 "Early spermatids: 16.0;Late spermatids: 25.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 19 "HDLM-2: 17.2" NA NA 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.6 0.1 0.3 0.0 6.4 0.0 0.0 0.0 0.9 0.0 1.5 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 17.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.4 0.0 0.1 0.9 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.7 0.7 0.0 0.0 0.0 0.9 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 H2AFB2 ENSG00000277858 "H2A histone family member B2" P0C5Z0 X 155380787-155381134 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.3;pancreas: 2.4;salivary gland: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 3.3;HeLa: 4.3;NB-4: 2.7;U-937: 2.0" NA NA 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.0 0.0 0.5 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.2 2.4 0.0 0.1 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.4 1.2 2.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.2 0.0 0.3 0.7 1.1 0.0 0.0 0.2 1.6 0.0 4.3 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.7 1.1 2.7 0.0 0.1 0.0 0.7 0.0 0.0 1.4 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.2 0.5 0.9 0.0 2.0 1.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H2AFB3 H2AFB ENSG00000277745 "H2A histone family member B3" P0C5Z0 X 155459415-155460005 "Predicted intracellular proteins" "mRNA processing" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 14.6" "Group enriched" "Detected in some" 12 "Early spermatids: 2.8;Late spermatids: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.9" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 14.6 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.7 0.0 0.5 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.3 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.8 1.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 H2AFJ "FLJ10903, MGC921" ENSG00000246705 "H2A histone family member J" Q9BTM1 12 14774383-14778002 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 148.5" "Group enriched" "Detected in all" 5 "Early spermatids: 2365.3;Late spermatids: 2711.3" "Cancer enhanced" "Detected in all" "prostate cancer: 151.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 52.0;MCF7: 67.2;RT4: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.38e-2)" "unprognostic (8.49e-2)" "unprognostic (9.15e-2)" "unprognostic (7.06e-2)" "unprognostic (2.43e-3)" "unprognostic (4.70e-2)" "unprognostic (3.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (3.32e-3)" "unprognostic (3.43e-2)" "unprognostic (8.66e-3)" "unprognostic (5.22e-3)" "unprognostic (3.87e-3)" 37.8 27.6 3.6 15.0 11.6 14.6 36.7 2.2 5.2 19.1 27.3 9.9 21.7 16.0 15.4 26.7 29.9 13.9 34.0 24.8 4.3 3.8 22.2 16.7 22.7 16.9 9.0 5.1 12.7 47.7 4.8 5.0 25.5 6.8 49.2 8.6 18.2 67.6 25.7 20.4 26.8 18.7 18.6 11.8 15.7 17.8 148.5 5.8 14.4 19.3 25.3 17.4 26.5 29.3 7.2 39.1 23.8 44.5 19.8 25.1 24.2 21.2 52.0 2.0 0.0 23.7 15.8 33.9 16.0 8.9 6.5 6.3 10.2 35.1 0.0 10.1 7.7 0.0 20.4 1.2 12.1 1.7 1.1 0.9 0.8 18.4 8.6 34.1 0.0 8.1 20.5 13.3 8.9 8.3 2.6 12.9 0.0 0.0 0.0 3.2 67.2 0.1 5.6 3.3 15.5 11.9 8.4 0.0 4.1 10.3 48.2 0.6 0.2 20.3 25.2 0.0 7.5 38.4 6.5 12.7 0.0 6.2 9.5 3.1 5.2 7.5 0.0 1.8 0.0 5.1 23.8 44.5 9.3 18.0 24.5 16.3 5.8 17.8 13.4 39.1 7.2 12.7 13.7 15.4 19.8 21.4 19.4 25.1 24.2 3.6 11.6 2.2 5.2 4.3 3.8 9.0 5.1 6.8 5.8 41.7 33.7 49.1 304.8 105.8 15.7 27.9 175.8 202.1 68.2 136.1 21.6 108.3 127.6 141.6 2365.3 89.2 383.6 303.7 335.4 99.7 141.6 500.9 63.4 107.1 207.7 11.1 230.0 119.7 205.3 2711.3 162.8 122.0 217.6 210.2 226.5 28.4 179.6 287.5 91.9 223.3 35.9 265.1 186.8 506.4 29.2 123.0 134.1 87.3 219.6 347.8 H2AFX H2AX ENSG00000188486 "H2A histone family member X" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 135.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes No Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 5.9 10.1 10.7 17.9 9.4 24.0 4.2 9.4 13.9 5.0 12.0 15.2 2.5 15.4 5.7 2.8 9.8 5.5 4.0 4.7 10.6 10.1 6.4 5.0 7.1 17.0 13.3 5.3 8.0 9.2 3.8 8.1 12.8 9.3 6.4 5.4 6.3 5.8 6.3 7.2 10.8 13.7 4.2 13.6 11.1 12.6 28.3 9.5 135.1 5.9 11.3 23.2 4.8 6.6 2.0 3.4 7.4 2.4 3.8 3.4 1.8 26.4 16.0 25.3 15.1 2.3 1.7 26.7 30.1 9.2 17.0 15.0 25.3 11.4 18.2 18.2 6.9 12.8 27.5 11.9 8.6 4.6 26.8 33.5 36.9 4.4 26.0 2.4 18.1 23.0 1.4 1.9 7.2 4.4 2.7 8.5 24.0 29.8 30.0 8.1 67.5 41.4 54.2 18.4 12.1 33.9 40.5 29.8 8.5 7.7 11.5 27.0 32.1 23.9 13.9 4.2 4.5 20.8 13.8 10.4 16.5 43.6 13.4 22.3 8.2 8.0 18.4 3.8 29.5 32.1 7.0 2.4 7.4 3.4 1.1 1.8 2.0 3.4 3.4 3.4 1.8 2.3 2.0 1.2 3.8 1.5 1.5 2.8 1.8 10.7 9.4 9.4 13.9 10.6 10.1 13.3 5.3 9.3 9.5 6.0 12.6 41.6 30.9 27.4 17.4 16.3 15.3 2.7 9.1 7.0 19.6 39.1 10.0 14.6 7.0 21.1 36.5 46.7 9.9 93.2 26.6 29.8 32.3 3.6 37.9 9.5 33.3 25.8 20.0 2.5 13.3 24.5 18.6 37.9 33.9 37.9 14.1 24.5 10.3 7.5 43.2 12.9 36.5 72.1 17.9 24.7 53.7 30.5 50.3 20.8 H2BFM ENSG00000101812 "H2B histone family member M" P0C1H6 X 104039949-104042454 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 19.0" "Group enriched" "Detected in some" 13 "Early spermatids: 4.4;Late spermatids: 7.4;Spermatocytes: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 5.3;hTERT-RPE1: 6.3;Karpas-707: 6.9" NA NA "unprognostic (1.87e-1)" "unprognostic (1.87e-1)" "unprognostic (1.54e-1)" 0.4 0.3 0.6 0.4 0.7 0.7 0.9 0.5 0.5 0.4 0.4 0.4 0.4 0.0 2.4 1.5 0.4 1.4 0.9 0.4 0.6 0.5 0.4 0.4 0.4 1.2 0.4 0.4 4.0 0.4 0.4 0.4 0.4 0.4 0.8 0.2 0.4 0.4 1.0 0.4 1.0 0.4 2.0 0.4 0.6 0.3 19.0 0.4 0.4 0.4 0.4 1.1 0.5 0.4 0.3 1.1 2.6 0.0 0.4 0.4 0.1 0.0 0.6 5.3 3.7 1.0 1.9 0.4 0.6 0.5 1.2 1.5 1.1 0.2 1.2 0.4 0.4 0.9 0.0 0.5 0.0 2.3 1.3 2.6 0.7 0.0 0.0 1.2 0.4 0.7 0.3 0.5 1.6 0.4 6.3 1.1 2.6 0.0 6.9 2.3 0.9 3.3 0.0 2.5 0.0 0.5 1.7 2.2 0.7 1.7 1.3 1.1 4.5 0.0 0.0 0.0 1.9 0.0 0.8 1.6 4.0 0.7 0.8 1.3 0.4 0.0 2.3 0.6 0.3 0.8 2.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.3 0.4 0.2 0.0 0.4 0.0 1.1 0.0 0.1 0.6 0.7 0.5 0.5 0.6 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.7 0.0 0.0 0.0 0.0 0.0 H2BFS ENSG00000234289 "H2B histone family member S" P57053 21 43565189-43565648 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 65.0" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (2.06e-2)" 1.1 0.9 0.2 7.4 0.3 1.8 2.6 0.3 0.8 1.8 1.7 0.4 1.1 2.3 2.4 4.3 4.9 4.2 4.2 4.9 0.5 0.5 4.0 3.3 12.2 0.1 0.5 2.2 4.2 0.0 0.0 4.5 0.4 5.3 1.8 0.8 3.0 2.1 1.0 0.4 3.0 1.8 0.7 5.7 2.0 7.9 0.0 65.0 2.6 7.1 6.1 2.1 1.3 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.1 3.3 0.6 0.9 2.2 0.9 2.4 2.6 1.3 3.2 2.0 4.6 1.1 0.6 8.8 0.8 2.5 2.5 0.2 0.7 0.9 2.2 3.6 0.6 5.0 0.2 0.3 0.9 4.5 2.5 0.4 0.6 0.0 1.2 0.3 0.4 23.7 2.8 0.9 6.1 1.0 2.2 0.3 4.1 2.6 0.8 0.5 8.7 0.7 0.7 3.5 2.5 10.5 3.2 2.1 0.5 11.1 1.4 0.9 1.7 23.4 1.1 0.6 7.6 23.8 5.0 1.1 11.8 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 H2BFS ENSG00000274559 "H2B histone family member S" 21 5972924-5973383 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 16.0" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 2.9;Ciliated cells: 4.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.37e-2)" "unprognostic (2.63e-1)" 0.4 0.3 0.5 1.0 0.0 0.0 1.0 0.9 1.4 1.3 2.9 3.3 2.8 2.8 0.0 0.0 2.2 0.3 2.3 0.2 1.2 0.0 0.8 3.7 0.9 1.9 0.0 0.0 0.0 1.8 0.7 0.6 1.1 0.9 1.6 1.0 1.2 7.7 6.2 16.0 4.9 1.6 3.6 3.2 2.1 3.3 0.6 0.9 2.2 0.9 2.4 2.6 1.3 3.2 2.0 4.6 1.1 0.6 8.8 0.8 2.5 2.5 0.2 0.7 0.9 2.2 3.6 0.6 5.0 0.2 0.3 0.9 4.5 2.5 0.4 0.6 0.0 1.2 0.3 0.4 23.7 2.8 0.9 6.1 1.0 2.2 0.3 4.1 2.6 0.8 0.5 8.7 0.7 0.7 3.5 2.5 10.5 3.2 2.1 0.5 11.1 1.4 0.9 1.7 23.4 1.1 0.6 7.6 23.8 5.0 1.1 11.8 1.0 10.0 2.1 15.0 1.2 2.2 1.0 5.7 1.2 1.3 2.8 7.7 1.6 1.1 16.0 1.6 4.9 6.2 3.6 3.2 11.9 2.9 0.9 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 1.0 0.0 0.0 0.0 1.8 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.6 H2BFWT ENSG00000123569 "H2B histone family member W, testis specific" Q7Z2G1 X 104011147-104013687 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Group enriched" "Detected in some" 6 "Spermatocytes: 2.3;Spermatogonia: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.9;OE19: 1.7;SiHa: 1.0;U-266/84: 3.3" HPA056289 Uncertain NA NA "HPA056289: AB_2683087" "unprognostic (5.07e-2)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (1.85e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 2.1 0.0 0.0 0.0 0.0 0.0 H3.Y ENSG00000269466 "Histone cluster 2, H3c pseudogene" 5 17654870-17655847 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 1.4;epididymis: 1.3;testis: 1.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-2 OS: 6.3" HPA042570 Uncertain NA NA "HPA042570: AB_2678056" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 H3F3A "H3.3A, H3F3" ENSG00000163041 "H3 histone family member 3A" P84243 1 226061851-226072001 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 258.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 258.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 258.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011481, CAB037178, HPA042570" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011481: AB_880446, CAB037178: AB_532248, HPA042570: AB_2678056" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.19e-3)" "unprognostic (2.83e-2)" "unprognostic (3.74e-1)" "unprognostic (9.83e-3)" "unprognostic (4.71e-2)" "unprognostic (1.77e-3)" "unprognostic (3.69e-2)" "unprognostic (1.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (3.66e-2)" "unprognostic (8.03e-3)" "unprognostic (2.21e-3)" "unprognostic (6.03e-2)" 39.0 43.4 37.2 83.4 33.4 126.8 67.9 45.0 42.8 44.6 54.0 31.6 62.9 47.9 43.4 60.6 66.3 42.4 49.6 59.4 36.1 31.2 45.9 59.2 73.2 217.9 37.8 23.2 44.4 79.7 30.8 34.8 59.1 29.2 38.4 59.4 42.7 49.0 49.7 37.0 47.1 50.0 42.0 48.6 71.9 41.4 87.6 31.7 148.9 38.5 71.0 84.1 43.5 47.6 39.2 44.6 258.7 56.9 23.6 34.9 60.5 53.9 30.8 120.2 67.8 33.4 38.9 90.3 25.6 31.1 41.6 32.9 32.1 90.0 51.9 56.9 31.4 20.7 51.8 59.4 46.6 40.9 32.1 102.6 64.2 45.6 42.9 33.1 65.9 78.0 35.6 54.0 29.1 38.3 56.4 61.5 67.9 90.4 88.9 47.3 31.2 136.8 122.6 163.0 137.1 61.1 92.6 87.8 133.8 86.0 57.7 117.4 174.5 73.0 92.4 63.2 71.8 104.7 154.7 34.6 30.3 42.3 40.9 74.1 39.6 50.7 90.7 28.9 63.0 64.7 40.0 56.9 80.8 23.1 44.9 23.6 39.2 25.0 24.9 44.6 36.0 23.7 25.7 258.7 23.6 50.8 36.6 34.9 60.5 37.2 33.4 45.0 42.8 36.1 31.2 37.8 23.2 29.2 31.7 485.3 628.9 1112.7 1421.3 1190.0 539.7 34.4 1036.9 1187.2 831.4 919.5 155.1 1193.7 1374.4 1195.9 1414.0 1038.4 1355.7 2359.5 1184.4 1689.1 947.0 1270.6 649.3 699.9 1338.0 554.6 1437.2 842.8 2198.6 1327.8 1016.5 1622.8 1010.6 1191.2 1707.9 908.2 1197.9 2104.2 985.0 1310.8 429.3 976.6 889.6 588.0 858.5 1210.5 1352.2 961.6 1983.9 1893.1 H3F3B H3.3B ENSG00000132475 "H3 histone family member 3B" P84243 17 75776434-75785893 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 570.8;bone marrow: 441.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 570.8" "Lineage enriched" "Detected in all" 6 "granulocytes: 570.8" "Low cell line specificity" "Detected in all" "CAB037166, CAB037187, CAB037221, HPA042570" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056" "unprognostic (1.66e-1)" "unprognostic (8.42e-3)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.64e-1)" "unprognostic (5.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-3)" "unprognostic (9.20e-2)" "unprognostic (4.81e-2)" "unprognostic (2.33e-1)" "unprognostic (1.99e-1)" 57.2 41.2 38.1 58.9 48.6 441.9 71.4 60.2 47.0 86.6 44.6 65.9 42.7 37.9 60.5 77.7 93.2 70.2 75.8 35.1 38.5 33.9 42.8 48.1 64.2 62.3 50.4 41.2 141.0 90.9 33.0 41.5 58.5 42.7 60.5 26.6 65.8 58.4 55.4 71.1 114.0 58.0 63.7 51.8 65.9 45.1 66.9 46.2 78.6 58.9 69.1 55.7 78.5 71.9 78.9 88.1 570.8 98.4 80.0 77.2 203.5 117.9 104.8 43.8 43.2 25.0 39.2 60.6 55.9 49.5 68.7 55.2 112.2 84.0 59.1 53.4 32.5 48.6 46.5 34.6 77.3 39.1 32.2 78.0 52.7 55.9 94.9 56.5 87.5 67.9 42.8 47.9 70.4 90.8 30.6 51.6 38.6 74.6 106.3 35.3 173.6 125.6 73.5 35.1 38.2 117.1 93.6 80.2 64.4 54.2 70.1 88.9 98.7 56.7 83.2 120.0 24.4 65.2 94.6 48.1 123.3 109.1 53.2 148.0 128.6 76.0 71.0 65.2 83.5 67.2 182.8 98.4 259.3 74.4 86.9 70.2 78.9 71.8 70.5 86.7 65.3 77.2 64.5 570.8 80.0 78.9 88.1 76.0 203.5 38.1 48.6 60.2 47.0 38.5 33.9 50.4 41.2 42.7 46.2 851.6 868.5 887.7 3350.2 2457.1 1722.8 361.5 690.4 1184.5 958.9 922.9 382.9 1428.6 1080.9 1926.0 2467.5 1156.8 1059.1 327.1 1563.3 1285.8 1898.2 1719.4 1592.3 352.8 1655.2 575.2 1610.5 672.8 901.1 452.7 934.0 1810.8 1808.5 1233.6 1221.5 2460.8 1745.6 1627.3 545.9 699.9 1161.2 983.1 2751.1 2035.3 943.0 3026.0 2929.8 1269.9 852.2 2611.9 H3F3C H3.5 ENSG00000188375 "H3 histone family member 3C" Q6NXT2 12 31791185-31792241 "Cancer-related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 34.7;testis: 23.5" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 79.9;Early spermatids: 92.9;Spermatocytes: 44.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in all" "neutrophil: 34.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 34.7" "Cell line enhanced" "Detected in many" "SH-SY5Y: 5.6" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (2.82e-1)" "unprognostic (2.80e-4)" "unprognostic (2.60e-2)" "unprognostic (9.21e-2)" "unprognostic (3.77e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "unprognostic (1.45e-1)" "unprognostic (7.56e-2)" "unprognostic (2.39e-1)" "unprognostic (4.06e-2)" "unprognostic (3.53e-2)" "unprognostic (2.73e-3)" "unprognostic (4.02e-2)" "unprognostic (2.99e-2)" "unprognostic (2.80e-2)" "unprognostic (3.86e-2)" 1.8 0.5 0.5 2.1 0.9 4.2 1.6 0.6 0.6 2.0 0.8 0.6 1.3 0.9 1.8 1.7 1.9 0.8 0.8 0.5 1.1 0.5 0.5 1.1 1.0 0.7 0.6 0.9 3.1 1.0 0.5 0.6 0.7 0.6 1.5 0.3 1.5 1.7 1.4 0.6 1.3 1.2 1.7 0.6 1.9 1.0 23.5 0.9 0.9 1.0 3.3 1.1 1.7 0.8 6.7 6.1 34.7 7.0 6.7 6.1 14.9 3.6 0.7 1.6 0.7 0.4 0.0 1.4 0.5 0.2 1.0 0.4 1.1 1.5 0.5 1.4 0.0 0.7 1.2 0.1 0.1 0.2 1.1 0.0 0.1 1.0 0.5 0.0 1.1 1.4 0.2 0.1 0.0 1.3 0.4 0.1 0.1 0.4 1.6 0.0 0.1 2.8 3.6 0.7 0.3 0.2 1.7 0.8 2.4 0.2 0.6 2.9 5.6 0.1 2.2 4.0 0.5 1.2 3.5 0.3 2.1 3.6 1.4 4.6 2.7 1.0 1.4 1.7 1.7 1.7 13.8 6.7 18.9 5.1 7.0 4.5 6.7 5.3 5.0 6.1 5.2 5.6 5.3 34.7 6.7 6.1 5.9 6.1 14.9 0.5 0.9 0.6 0.5 1.1 0.5 0.6 0.9 0.6 0.9 0.0 0.0 1.9 14.2 10.1 0.7 79.9 2.5 1.4 2.3 0.0 2.0 2.3 0.0 0.2 92.9 4.5 3.8 0.0 0.2 2.2 9.5 9.1 6.9 0.9 2.7 0.0 15.5 3.1 3.7 14.1 3.7 4.5 10.1 0.0 3.6 0.8 0.1 5.3 1.8 0.2 0.7 0.0 9.5 44.0 3.2 14.2 6.9 9.6 3.2 5.4 H6PD GDH ENSG00000049239 "Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase" O95479 1 9234775-9271337 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Hydrolase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 116.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 29.2;ASC TERT1: 33.5;HSkMC: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004824, HPA005440" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 91000000 Cytosol "HPA004824: AB_1079037, HPA005440: AB_1079036" "unprognostic (4.83e-3)" "unprognostic (3.91e-2)" "unprognostic (1.18e-1)" "unprognostic (3.49e-1)" "unprognostic (5.53e-3)" "unprognostic (2.86e-2)" "unprognostic (8.35e-2)" "unprognostic (5.18e-2)" "unprognostic (9.73e-2)" "unprognostic (1.26e-3)" "unprognostic (2.16e-2)" "unprognostic (7.35e-3)" "unprognostic (8.20e-2)" "unprognostic (3.61e-1)" "unprognostic (1.30e-1)" "unprognostic (8.65e-2)" "unprognostic (1.95e-1)" 18.3 16.1 4.1 10.7 5.5 4.8 12.2 4.1 6.3 16.6 11.9 10.5 8.2 6.3 22.0 18.0 11.1 15.6 11.9 11.9 3.7 3.0 7.0 116.9 12.2 11.1 6.8 2.6 38.3 10.6 8.0 8.7 14.9 6.0 11.6 5.3 11.8 29.8 8.1 24.7 20.7 10.4 10.2 6.6 10.7 9.9 12.4 5.5 16.2 12.6 12.9 14.1 12.2 10.1 4.5 3.7 4.1 6.3 3.1 4.7 3.0 3.9 3.2 2.8 10.5 29.2 33.5 2.7 3.9 9.8 2.9 4.6 0.6 8.1 4.3 4.6 6.1 3.7 4.1 0.7 1.9 4.3 12.9 0.9 0.0 1.0 2.6 16.3 1.4 1.7 32.9 3.8 7.0 4.6 6.5 13.4 2.4 1.1 7.5 5.7 2.3 1.5 3.2 1.5 2.9 1.9 0.5 0.3 3.6 3.8 1.6 0.9 5.0 5.2 4.1 4.9 2.0 3.1 7.0 13.3 10.1 1.7 2.5 1.1 10.0 2.9 1.0 16.9 6.3 6.4 3.5 6.2 0.9 4.7 6.3 3.7 3.5 3.5 4.1 2.8 4.5 3.4 3.2 4.1 3.1 5.8 3.7 2.8 3.0 4.1 5.5 4.1 6.3 3.7 3.0 6.8 2.6 6.0 5.5 23.8 29.3 11.2 11.1 12.7 18.1 13.0 58.6 10.7 12.5 19.2 25.5 9.0 0.0 15.8 0.8 14.7 15.1 0.0 18.5 6.5 24.0 16.2 3.5 132.8 11.5 15.9 7.5 17.8 18.0 1.5 44.5 10.3 11.8 64.9 15.2 11.2 20.1 17.5 34.6 8.2 11.5 0.0 9.2 4.7 4.6 11.2 4.9 13.8 24.1 11.4 HAAO ENSG00000162882 "3-hydroxyanthranilate 3,4-dioxygenase" P46952 2 42767089-42792593 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 78.7" "Group enriched" "Detected in many" 6 "Hepatocytes: 199.6;Proximal tubular cells: 138.8" "Group enriched" "Detected in all" 5 "liver cancer: 46.5;renal cancer: 13.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 15.7" "Group enriched" "Detected in many" 5 "dendritic cells: 15.7;granulocytes: 12.6;monocytes: 11.8" "Cell line enhanced" "Detected in some" "CACO-2: 9.0;Hep G2: 31.8;REH: 6.6;THP-1: 6.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA036394, HPA042024" Enhanced NA NA 150000 "HPA036394: AB_10673131, HPA042024: AB_2677803" "unprognostic (6.97e-3)" "unprognostic (1.86e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-2)" "unprognostic (1.78e-1)" "unprognostic (7.23e-3)" "prognostic favorable (5.77e-4)" "unprognostic (6.20e-2)" "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-2)" "unprognostic (1.05e-1)" "unprognostic (8.67e-2)" "unprognostic (1.37e-1)" "unprognostic (2.56e-1)" "unprognostic (2.03e-1)" 2.9 1.8 1.6 6.8 1.2 0.7 3.5 0.4 1.1 5.8 11.9 1.9 3.5 5.8 3.6 6.2 2.7 3.2 2.7 2.2 0.9 0.8 10.9 78.7 1.8 2.1 1.4 1.6 5.0 8.6 1.7 1.6 3.8 1.4 6.5 2.9 12.1 1.4 3.1 0.9 1.6 24.5 6.5 1.5 1.8 2.4 1.7 0.9 1.6 2.0 1.3 1.9 4.3 3.2 2.8 15.7 12.6 11.8 0.5 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 3.1 9.0 0.1 0.0 0.1 0.4 0.0 0.0 3.2 0.0 0.5 0.0 1.1 3.6 0.0 31.8 0.3 1.2 0.1 1.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.8 0.1 0.0 6.6 0.7 0.1 0.0 0.0 0.1 0.0 0.4 0.7 0.0 0.9 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.7 11.8 12.6 0.0 7.0 0.0 2.2 0.0 0.0 15.7 2.8 0.0 0.0 3.7 0.5 1.8 5.1 0.0 3.5 1.6 1.2 0.4 1.1 0.9 0.8 1.4 1.6 1.4 0.9 0.0 1.4 0.9 5.2 3.5 0.0 0.4 12.7 0.0 0.0 1.8 0.0 1.0 14.9 5.1 0.0 0.5 20.2 0.0 11.5 0.6 8.4 2.0 30.0 199.6 18.5 0.0 6.4 4.9 12.9 0.0 11.5 4.9 5.0 7.2 8.7 2.1 7.7 18.1 9.9 138.8 0.2 12.9 12.3 0.1 0.5 4.3 1.0 1.7 11.3 1.6 HABP2 "FSAP, HABP, HGFAL, PHBP" ENSG00000148702 "Hyaluronan binding protein 2" Q14520 10 113550837-113589602 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 135.4" "Group enriched" "Detected in some" 13 "Cholangiocytes: 122.3;Hepatocytes: 184.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 92.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "OE19: 33.5;RPTEC TERT1: 27.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA019518 Uncertain "Secreted to blood" NA NA 20200000000 3200000000 "HPA019518: AB_1850467" "unprognostic (3.89e-2)" "unprognostic (6.15e-2)" "unprognostic (1.33e-1)" "unprognostic (1.24e-1)" "unprognostic (1.45e-1)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (5.86e-3)" "unprognostic (1.67e-1)" "unprognostic (9.78e-2)" "unprognostic (5.10e-2)" "unprognostic (4.77e-2)" "unprognostic (9.18e-3)" "unprognostic (2.62e-3)" "unprognostic (2.11e-1)" "unprognostic (3.22e-1)" "unprognostic (9.05e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.6 0.6 0.3 0.0 0.4 26.4 0.4 0.0 0.0 20.9 135.4 0.2 0.0 0.0 0.0 0.8 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 11.5 0.0 0.0 0.0 0.2 122.3 0.0 0.0 1.8 0.0 0.0 3.3 10.0 0.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 184.9 0.7 0.0 0.0 6.7 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HABP4 "IHABP4, SERBP1L" ENSG00000130956 "Hyaluronan binding protein 4" Q5JVS0 9 96450201-96491336 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.8" "Group enriched" "Detected in many" 11 "Early spermatids: 193.7;Late spermatids: 710.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.1;T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055969, HPA062366" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA055969: AB_2682991, HPA062366: " "unprognostic (1.67e-1)" "unprognostic (7.99e-2)" "unprognostic (2.12e-3)" "unprognostic (2.40e-1)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.36e-2)" "unprognostic (3.63e-2)" "unprognostic (3.49e-1)" "unprognostic (2.42e-2)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.25e-1)" "unprognostic (1.40e-1)" "unprognostic (4.93e-2)" "unprognostic (3.62e-2)" 13.2 11.9 31.2 6.1 44.8 1.7 6.5 14.1 40.6 7.9 5.5 12.4 1.5 3.0 8.2 6.8 7.2 5.3 8.1 19.1 26.1 24.9 23.5 5.7 6.1 6.8 27.1 20.5 11.7 4.8 13.8 7.4 3.4 31.6 8.3 4.2 8.4 4.1 10.6 9.4 6.1 3.3 10.6 19.4 5.0 5.0 21.8 13.0 0.4 11.2 2.2 4.9 7.6 6.5 4.1 0.1 0.3 0.8 1.0 4.0 0.7 7.3 8.4 10.7 11.4 23.7 20.3 7.6 10.0 11.2 7.5 8.2 12.5 12.3 3.7 5.0 14.8 24.0 5.4 8.9 1.9 6.1 4.5 5.3 1.4 4.0 20.8 12.1 0.3 1.5 8.2 3.4 8.6 6.8 11.5 5.3 4.3 1.7 11.1 13.5 7.5 0.1 2.3 5.0 10.3 8.2 3.8 9.3 0.1 12.8 3.2 6.8 4.6 5.3 3.2 15.9 8.3 2.3 1.6 9.1 10.4 2.4 19.0 8.4 7.0 6.9 1.6 8.3 2.9 15.3 0.0 0.1 0.0 1.4 0.3 1.4 4.1 4.0 3.2 0.0 1.7 2.8 2.8 0.3 1.0 0.8 0.1 3.0 0.7 31.2 44.8 14.1 33.8 26.1 24.9 27.1 20.5 31.6 13.0 0.0 6.1 3.4 7.8 10.2 22.0 10.6 15.3 1.4 9.1 17.4 0.0 2.2 14.9 3.7 193.7 17.8 0.8 0.0 5.0 6.7 7.8 8.5 1.1 5.0 5.5 22.3 12.6 13.5 1.5 710.5 12.7 4.0 16.9 3.6 0.9 17.1 4.8 0.0 22.3 39.6 11.3 6.5 17.6 18.6 5.9 6.9 1.1 7.5 1.1 5.1 HACD1 "CAP, PTPLA" ENSG00000165996 "3-hydroxyacyl-CoA dehydratase 1" B0YJ81 10 17589032-17617377 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Developmental protein, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 80.1" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 116.4;Collecting duct cells: 29.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "T-reg: 27.6" "Lineage enriched" "Detected in many" 16 "T-cells: 27.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (3.54e-1)" "unprognostic (2.62e-2)" "unprognostic (4.10e-1)" "unprognostic (5.67e-3)" "unprognostic (4.21e-2)" "unprognostic (3.04e-2)" "unprognostic (2.38e-1)" "unprognostic (1.70e-2)" "unprognostic (2.61e-2)" "unprognostic (3.43e-1)" "unprognostic (2.46e-2)" "unprognostic (2.93e-2)" "unprognostic (3.40e-2)" "unprognostic (1.10e-1)" "unprognostic (6.49e-2)" 6.6 4.7 2.1 3.8 3.9 5.4 12.6 3.4 3.1 5.1 17.6 3.9 7.4 2.3 13.1 6.0 12.6 6.5 4.8 80.1 2.4 3.7 3.6 1.1 7.9 1.1 5.1 1.8 3.9 2.5 0.6 2.4 1.5 3.8 8.8 3.3 9.4 2.1 13.2 22.8 2.5 4.2 21.5 4.8 1.5 9.4 3.0 3.4 2.6 5.9 6.2 1.2 12.6 9.8 0.6 1.6 1.7 0.5 1.6 27.6 0.7 10.8 9.3 2.6 12.8 11.9 2.3 0.2 15.4 9.3 20.2 19.1 6.2 13.2 0.1 2.3 25.0 29.1 2.7 6.6 4.7 11.2 7.1 3.9 25.0 6.7 16.9 15.5 0.1 1.9 5.5 6.6 11.6 4.5 15.6 3.9 13.4 0.2 0.5 26.5 7.8 18.4 2.5 5.6 0.8 2.5 16.6 2.7 0.3 7.9 2.1 2.9 7.5 13.1 0.2 21.6 8.6 9.3 6.2 3.7 11.9 6.9 7.2 7.0 0.4 0.3 0.1 8.7 2.8 1.6 1.7 0.5 0.4 0.6 0.1 0.1 0.2 2.8 0.5 1.6 0.6 0.5 0.4 1.6 1.6 0.1 0.8 27.6 0.7 2.1 3.9 3.4 2.8 2.4 3.7 5.1 1.8 3.8 3.4 26.8 12.9 0.0 16.5 0.0 0.6 116.4 2.5 1.4 4.5 29.6 0.0 0.5 3.3 13.0 8.3 4.8 0.0 0.0 6.9 1.6 2.3 12.0 5.8 0.8 5.0 0.0 3.5 11.6 3.5 1.6 1.7 2.4 0.0 1.0 2.3 0.2 18.1 0.0 0.7 2.0 0.5 0.0 25.7 5.5 5.1 0.0 2.5 0.0 3.8 5.5 HACE1 KIAA1320 ENSG00000085382 "HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1" Q8IYU2 6 104728093-104859919 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 41.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046071 Supported "Nuclear bodies,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear bodies" "HPA046071: AB_2679524" "unprognostic (6.32e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (1.12e-2)" "unprognostic (3.75e-2)" "unprognostic (3.75e-3)" "unprognostic (1.22e-3)" "unprognostic (4.63e-2)" "unprognostic (7.41e-2)" "unprognostic (1.24e-1)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.12e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (1.75e-1)" 6.4 5.4 12.7 3.7 16.1 4.3 6.1 15.5 13.1 6.6 4.8 6.8 2.5 3.6 8.5 2.9 8.1 5.4 5.0 5.2 7.5 8.6 9.4 2.9 5.7 3.5 8.8 9.6 6.4 3.8 12.0 7.4 41.9 10.2 6.1 3.3 7.7 6.2 6.9 4.4 4.8 3.6 6.5 9.5 4.1 3.9 14.1 8.9 5.4 7.1 2.7 3.9 6.4 5.8 2.9 2.4 2.2 2.9 2.2 3.9 1.6 3.6 2.5 10.9 13.6 6.5 8.7 12.9 7.3 11.3 4.6 7.0 2.3 2.1 2.1 3.3 5.5 7.9 2.5 2.7 5.0 9.8 8.4 6.9 7.2 2.3 3.1 6.5 6.2 2.4 5.8 4.6 6.0 5.1 6.1 7.6 8.7 6.9 2.3 9.1 2.6 4.6 3.7 4.7 2.7 2.5 7.3 12.4 0.8 3.7 6.2 5.8 8.8 3.9 4.1 2.1 7.3 2.6 8.5 8.0 3.7 3.1 10.0 6.9 3.3 3.7 7.0 3.9 5.9 6.8 0.0 1.9 2.2 3.7 2.9 3.9 2.9 3.7 3.6 1.9 2.7 3.9 3.0 0.4 2.2 1.5 2.4 1.2 1.6 12.7 16.1 15.5 13.1 7.5 8.6 8.8 9.6 10.2 8.9 3.0 0.6 0.0 1.6 4.1 11.4 6.3 2.5 0.0 4.5 5.2 43.2 7.5 1.7 1.7 3.1 6.7 1.3 0.0 1.3 4.6 4.8 2.2 1.1 2.5 4.6 15.9 1.7 4.3 2.2 3.3 5.8 2.4 1.7 4.6 1.4 5.8 1.1 2.9 3.5 4.1 30.6 6.5 6.6 12.5 2.7 4.1 5.3 2.2 2.1 1.8 HADH "HADH1, HADHSC, SCHAD" ENSG00000138796 "Hydroxyacyl-CoA dehydrogenase" Q16836 4 107989714-108035175 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.3" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039588, HPA043888" Supported Supported Mitochondria No No 8700000 Mitochondria "HPA039588: AB_10673425, HPA043888: AB_2678716" "unprognostic (1.73e-1)" "unprognostic (3.32e-3)" "unprognostic (3.05e-3)" "unprognostic (8.86e-3)" "unprognostic (1.83e-1)" "unprognostic (6.83e-2)" "unprognostic (9.26e-3)" "unprognostic (1.55e-2)" "unprognostic (9.22e-2)" "unprognostic (3.24e-2)" "unprognostic (2.96e-1)" "unprognostic (1.18e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.67e-1)" "unprognostic (4.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.88e-2)" 36.6 19.5 8.5 15.6 9.2 6.1 41.7 5.4 9.7 15.2 29.7 10.6 9.4 23.3 18.3 13.3 20.5 15.7 12.4 98.3 7.8 8.1 37.2 60.3 10.6 8.8 10.0 7.0 17.1 17.8 9.8 6.8 5.1 9.2 15.6 25.0 11.6 20.4 12.5 64.6 9.0 37.1 19.6 10.2 8.0 19.1 12.6 7.2 40.9 16.1 38.0 13.1 14.2 10.6 18.6 22.6 5.6 10.7 20.2 13.0 8.9 8.7 8.2 17.7 12.9 42.7 13.8 8.6 12.9 19.2 14.0 13.8 5.9 16.5 49.8 6.9 10.5 9.1 11.8 23.6 17.8 15.5 15.2 12.3 11.6 15.6 13.0 6.8 24.4 5.4 14.3 9.5 9.9 9.1 11.5 9.4 35.0 14.3 26.5 15.8 15.9 41.4 9.7 8.4 38.7 10.9 31.6 24.9 24.9 15.1 35.6 21.5 12.3 12.4 44.5 12.7 10.8 21.2 19.3 5.2 9.9 5.6 13.9 7.0 15.0 17.3 21.6 13.5 16.6 7.6 0.0 6.1 5.6 10.1 7.8 12.5 18.6 11.4 12.1 19.7 15.5 13.0 13.0 0.7 20.2 10.7 22.6 10.0 8.9 8.5 9.2 5.4 9.7 7.8 8.1 10.0 7.0 9.2 7.2 26.8 26.0 29.0 45.8 13.9 7.3 194.2 61.1 81.7 36.4 33.2 3.9 27.5 135.9 37.9 159.1 14.3 244.0 46.7 28.1 33.2 15.5 29.6 10.4 229.1 96.2 6.4 31.2 19.0 32.4 78.4 42.8 17.2 20.3 6.4 71.1 24.6 30.7 84.2 33.2 241.4 5.7 38.8 30.8 25.1 20.1 15.8 14.2 16.2 172.2 38.7 HADHB MTPB ENSG00000138029 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta" P55084 2 26243170-26290468 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.0;skeletal muscle: 155.6" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 922.0;Distal tubular cells: 441.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037539, HPA037540, HPA066099" Enhanced Supported Mitochondria No No 1100000 Mitochondria "HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618" "unprognostic (5.15e-2)" "unprognostic (8.72e-2)" "unprognostic (8.21e-2)" "unprognostic (8.67e-2)" "unprognostic (7.70e-2)" "unprognostic (2.59e-2)" "unprognostic (7.29e-2)" "unprognostic (9.70e-2)" "unprognostic (2.01e-1)" "unprognostic (2.09e-1)" "unprognostic (2.03e-1)" "unprognostic (8.94e-2)" "prognostic favorable (1.37e-9)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (2.88e-1)" "unprognostic (9.68e-2)" 23.3 45.5 24.8 11.0 24.7 9.9 16.6 16.6 17.4 13.8 21.4 31.1 19.3 43.6 17.1 16.2 20.6 13.9 12.6 126.0 18.0 20.0 45.8 62.4 12.8 16.1 34.8 18.3 16.2 23.7 19.9 13.1 12.6 27.8 15.8 22.8 19.9 27.2 15.9 155.6 13.2 35.0 20.3 29.5 15.3 19.5 15.8 23.8 10.6 22.4 44.9 14.5 18.5 12.8 20.2 45.2 21.5 49.1 23.8 26.8 33.9 23.1 18.3 12.8 22.9 79.0 43.7 13.0 19.5 29.9 20.1 19.7 21.8 22.6 11.6 13.7 31.9 22.6 18.3 21.2 27.6 24.7 26.1 18.5 26.6 10.9 42.7 33.9 21.5 20.4 42.3 45.5 20.9 34.0 34.3 37.2 18.0 22.3 18.8 41.9 17.0 12.0 41.5 8.9 34.8 19.9 13.3 42.2 22.0 41.3 32.9 6.1 21.1 33.4 38.1 51.2 16.0 23.6 38.4 25.7 19.0 19.9 17.8 14.0 14.1 21.2 20.4 21.8 34.3 18.8 21.0 49.1 18.9 14.2 43.4 18.1 20.2 19.3 17.6 45.2 14.8 18.0 16.3 21.5 23.8 33.2 15.3 26.8 33.9 24.8 24.7 16.6 17.4 18.0 20.0 34.8 18.3 27.8 23.8 44.7 32.2 48.9 103.6 55.2 29.0 922.0 127.4 46.8 42.1 92.5 53.0 177.3 441.0 96.4 60.4 68.1 196.9 116.8 50.2 61.8 59.6 61.5 62.2 218.5 127.1 12.7 71.9 67.5 100.7 74.5 52.3 80.0 84.4 77.5 85.7 52.4 56.5 91.7 59.1 244.7 72.5 71.1 92.4 75.6 46.1 47.8 156.1 48.0 100.9 85.2 HAGH "GLO2, GLXII, HAGH1" ENSG00000063854 "Hydroxyacylglutathione hydrolase" Q16775 16 1795620-1827194 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 91.4" "Cell type enhanced" "Detected in all" 7 "Proximal tubular cells: 487.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043041, HPA061143" Approved NA NA 3000000 "HPA043041: AB_2678284, HPA061143: AB_2684439" "unprognostic (3.11e-1)" "prognostic favorable (5.82e-5)" "unprognostic (2.54e-1)" "unprognostic (1.93e-2)" "unprognostic (5.84e-2)" "unprognostic (1.54e-1)" "prognostic favorable (5.33e-6)" "unprognostic (5.78e-3)" "unprognostic (3.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.34e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.81e-6)" "unprognostic (1.20e-1)" "unprognostic (6.24e-2)" "unprognostic (7.18e-3)" "prognostic favorable (5.19e-4)" 14.8 36.9 24.9 7.8 26.7 26.2 16.4 26.8 35.3 9.7 12.9 13.6 19.6 17.6 6.8 13.0 11.7 11.8 9.9 50.9 28.0 24.5 38.8 91.4 14.5 8.5 23.2 24.5 6.3 24.6 17.1 19.7 9.2 18.5 12.4 9.5 11.9 12.5 16.2 67.1 11.0 17.1 11.7 20.7 10.1 13.1 33.8 13.7 7.4 14.1 18.3 7.2 9.7 18.2 13.7 28.9 27.7 36.5 10.9 18.3 12.5 11.5 17.5 15.8 17.9 13.9 5.5 14.3 14.5 13.5 22.4 18.1 9.0 10.1 2.4 29.8 12.4 15.4 12.6 15.0 14.5 6.7 23.9 24.1 4.4 17.9 25.6 20.0 5.8 24.3 6.7 31.2 11.2 7.7 19.8 19.2 30.4 5.8 21.7 7.0 19.0 15.0 12.6 6.0 11.9 16.2 12.7 10.0 27.2 28.7 5.2 21.3 18.4 15.9 20.4 31.1 12.5 15.0 19.5 14.6 6.8 8.5 14.2 16.6 24.6 23.2 7.1 11.6 5.4 10.9 14.4 15.3 27.7 12.6 25.8 9.2 13.7 16.2 12.9 13.7 12.4 15.8 13.2 13.5 10.9 36.5 28.9 18.3 12.5 24.9 26.7 26.8 35.3 28.0 24.5 23.2 24.5 18.5 13.7 8.9 32.9 46.9 39.2 21.2 110.6 73.4 58.6 26.8 11.4 43.6 60.9 45.4 134.3 38.1 141.4 30.0 81.5 280.4 33.8 33.2 26.9 51.0 30.0 169.8 67.1 130.3 38.1 41.7 39.3 41.7 43.4 47.0 52.3 57.7 36.1 79.2 45.7 70.2 51.6 487.6 102.8 71.1 36.8 224.6 49.5 39.9 57.4 54.2 35.0 42.0 HAGHL MGC2605 ENSG00000103253 "Hydroxyacylglutathione hydrolase like" Q6PII5 16 726936-735525 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 50.9;Ciliated cells: 34.8;Distal tubular cells: 29.9;Hofbauer cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 30.0;U-266/70: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074402 Approved NA NA "HPA074402: AB_2732254" "unprognostic (6.74e-2)" "unprognostic (1.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.49e-1)" "unprognostic (4.56e-2)" "unprognostic (5.62e-3)" "unprognostic (9.52e-2)" "unprognostic (2.16e-1)" "unprognostic (1.83e-2)" "unprognostic (6.37e-2)" "unprognostic (1.77e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.92e-2)" "unprognostic (5.36e-1)" "unprognostic (3.41e-2)" "unprognostic (2.41e-1)" 2.7 8.7 10.0 6.2 19.7 4.5 1.2 13.0 15.5 1.7 2.1 9.4 2.5 2.9 3.7 2.7 1.1 7.9 2.6 5.3 10.6 10.9 4.9 1.4 4.0 8.3 15.9 6.7 1.4 2.4 5.8 8.1 2.3 10.7 2.6 0.9 4.5 9.6 4.0 1.3 2.7 4.5 1.1 13.9 8.4 5.8 3.5 9.1 2.9 0.9 1.6 3.8 1.8 1.0 13.1 3.7 1.3 1.5 8.5 7.2 3.1 2.1 2.3 0.6 3.1 0.5 1.1 2.4 2.0 1.3 0.4 0.5 1.0 3.0 4.9 3.0 0.1 0.8 2.9 0.5 0.8 0.0 14.3 2.0 1.6 5.4 1.8 3.7 6.1 4.6 2.1 0.8 0.0 1.0 1.3 0.3 4.9 2.8 4.4 0.6 14.6 0.1 8.6 3.3 3.6 5.1 3.2 1.4 30.0 1.2 0.7 11.3 6.7 1.0 8.8 9.3 0.1 5.5 10.7 1.9 2.4 3.6 0.8 1.2 32.2 4.1 6.8 3.8 6.2 4.3 0.0 1.5 1.3 6.2 0.5 7.2 13.1 4.1 6.8 1.9 3.5 1.2 4.6 0.0 8.5 0.2 3.7 4.7 3.1 10.0 19.7 13.0 14.1 10.6 10.9 15.9 6.7 10.7 9.1 3.0 1.1 11.5 1.9 1.0 50.9 10.1 0.0 34.8 3.4 3.5 0.0 0.4 29.9 2.8 4.3 0.6 0.0 0.0 0.0 1.0 2.4 4.9 8.1 0.6 34.5 11.1 3.5 0.6 5.4 9.1 6.4 7.2 18.6 6.4 1.1 10.3 2.2 0.3 5.6 6.9 7.8 0.0 2.0 7.5 6.5 0.3 0.3 10.2 1.4 0.6 HAL HIS ENSG00000084110 "Histidine ammonia-lyase" P42357 12 95972662-95996365 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 29.5;liver: 96.8;skin 1: 26.9" "Group enriched" "Detected in some" 13 "Erythroid cells: 46.7;Hepatocytes: 134.4" "Cancer enriched" "Detected in some" 11 "liver cancer: 23.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 20.1;neutrophil: 29.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.5" "Cell line enhanced" "Detected in some" "BEWO: 3.2;NB-4: 4.0;THP-1: 15.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038547, HPA038548" Enhanced Approved Cytosol NA NA 67000 Cytosol "HPA038547: AB_10669541, HPA038548: AB_10673175" "unprognostic (3.39e-1)" "unprognostic (4.46e-2)" "unprognostic (1.53e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (5.05e-2)" "unprognostic (2.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-3)" "unprognostic (1.89e-2)" "unprognostic (3.74e-1)" "unprognostic (4.03e-2)" "unprognostic (2.87e-2)" 0.5 0.0 0.1 1.1 0.3 4.4 0.9 0.1 0.3 0.3 0.2 0.1 0.1 0.1 1.1 0.3 0.5 0.2 0.3 0.2 0.1 0.0 0.2 96.8 1.7 2.3 0.5 0.1 0.3 0.5 0.0 7.4 0.4 0.2 0.2 0.0 0.1 0.2 0.1 0.2 26.9 0.2 0.2 0.3 2.7 0.1 0.2 0.2 0.1 0.2 0.9 1.3 0.2 0.5 0.0 1.4 29.5 6.3 0.3 0.1 1.6 0.6 0.0 0.2 0.1 0.0 0.0 3.2 0.0 0.2 0.1 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.2 0.5 0.4 0.2 0.0 0.0 0.6 0.7 0.0 0.9 0.4 0.4 0.1 0.3 0.4 0.0 0.2 0.1 0.0 0.2 4.0 1.3 0.1 0.7 0.3 0.1 0.1 0.1 0.8 0.2 0.4 0.5 0.1 0.0 0.1 0.0 15.5 0.2 0.1 0.2 0.2 0.2 0.7 0.7 0.2 0.0 2.4 0.0 20.1 6.3 0.9 0.0 2.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 29.5 0.3 5.1 0.1 0.1 1.6 0.1 0.3 0.1 0.3 0.1 0.0 0.5 0.1 0.2 0.2 0.0 1.4 0.0 0.1 0.1 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 46.7 0.2 0.2 0.0 0.1 0.0 134.4 0.3 0.0 0.0 1.8 6.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.2 0.1 HAMP "HEPC, HFE2B, LEAP-1, LEAP1" ENSG00000105697 "Hepcidin antimicrobial peptide" P81172 19 35280716-35285143 "Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Fungicide, Hormone" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 716.5" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 1549.8" "Group enriched" "Detected in many" 12 "glioma: 6.5;liver cancer: 16.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "myeloid DC: 2.5;plasmacytoid DC: 7.6" "Lineage enriched" "Detected in single" 13 "dendritic cells: 7.6" "Cell line enriched" "Detected in single" 229 "Hep G2: 69.9" "Not detected" "Not detected" "Secreted to blood" NA NA 1900000 3900000 "unprognostic (5.53e-2)" "unprognostic (5.02e-4)" "unprognostic (2.10e-3)" "unprognostic (4.69e-3)" "unprognostic (5.35e-2)" "unprognostic (2.24e-1)" "unprognostic (3.92e-2)" "unprognostic (9.36e-2)" "unprognostic (2.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.61e-1)" "unprognostic (1.86e-1)" "unprognostic (3.68e-7)" "unprognostic (4.11e-2)" "unprognostic (3.93e-2)" "unprognostic (4.08e-2)" "unprognostic (7.77e-2)" 0.4 0.5 1.8 0.6 10.8 1.2 0.7 0.2 4.4 0.6 0.3 0.2 0.0 0.5 0.4 0.4 0.4 0.9 0.4 45.1 10.0 1.8 0.3 716.5 0.4 1.0 4.2 0.0 1.1 8.7 0.4 0.5 0.7 6.7 0.6 0.3 0.0 0.4 0.6 0.5 0.4 0.3 0.4 13.9 0.3 0.4 0.5 4.0 0.0 0.3 0.0 1.0 0.4 0.0 0.5 7.6 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 69.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.5 0.0 7.6 0.0 0.0 1.8 10.8 0.2 4.4 10.0 1.8 4.2 0.0 6.7 4.0 0.0 0.0 9.3 0.9 0.5 0.0 1.1 30.6 0.0 1.2 0.0 0.0 0.6 0.0 0.4 0.0 0.6 0.0 23.3 82.0 0.9 0.5 5.2 69.8 1549.8 198.8 0.0 0.0 28.3 41.3 0.0 0.0 3.4 0.0 0.0 1.0 0.5 36.6 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 16.3 0.6 1.5 0.2 1.7 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478264 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 13.6" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.6;testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 36.0;SuSa: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040925 Uncertain Uncertain "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA040925: AB_10796563" "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 6.0 0.1 9.7 0.1 0.0 0.1 0.1 0.1 0.1 35.1 0.0 0.0 4.4 0.1 0.0 0.1 0.1 5.3 25.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 3.6 0.0 5.4 2.6 0.1 0.1 0.0 0.1 0.1 20.8 14.2 0.1 0.1 0.1 0.2 0.0 0.7 0.1 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 36.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.4;placenta: 62.9" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 81.1;Leydig cells: 36.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 120.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019591, CAB025576" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB025576: , HPA019591: AB_2670199" "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 4.2 24.2 0.2 10.9 0.2 0.0 4.7 0.4 0.2 34.3 42.7 0.2 7.5 1.9 42.7 7.9 16.6 9.7 61.4 54.1 0.2 0.2 0.2 8.2 0.2 0.1 0.2 0.0 13.4 3.8 0.0 0.3 62.9 0.0 13.1 3.6 5.2 1.1 4.2 0.6 1.7 13.5 37.5 0.2 1.8 19.9 5.4 0.0 0.0 1.5 2.7 2.2 25.7 12.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.9 3.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.5 0.0 0.0 0.7 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 81.1 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.0 0.4 1.1 13.7 0.0 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.8 36.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 2.2 0.1 0.1 0.3 1.9 0.0 0.0 0.0 HAO1 "GOX, GOX1" ENSG00000101323 "Hydroxyacid oxidase 1" Q9UJM8 20 7882981-7940474 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 594 "liver: 121.8" "Cell type enriched" "Detected in some" 44 "Hepatocytes: 293.3" "Cancer enriched" "Detected in some" 184 "liver cancer: 93.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.7;RH-30: 2.3;U-251 MG: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049552, HPA072442" Enhanced NA NA 200000 "HPA049552: AB_2680814, HPA072442: " "unprognostic (4.88e-2)" "unprognostic (2.87e-3)" "unprognostic (1.08e-2)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 121.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.8 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 293.3 0.0 0.0 0.0 6.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAO2 "GIG16, HAOX2" ENSG00000116882 "Hydroxyacid oxidase 2" Q9NYQ3 1 119368779-119394130 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 60 "kidney: 65.1;liver: 90.2" "Group enriched" "Detected in some" 6 "Hepatocytes: 210.7;Proximal tubular cells: 261.6" "Group enriched" "Detected in some" 26 "liver cancer: 25.6;renal cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;BJ hTERT+: 1.2;HL-60: 2.0;SiHa: 1.5;U-698: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050355 Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA050355: " "unprognostic (1.13e-1)" "unprognostic (1.68e-2)" "unprognostic (2.07e-1)" "unprognostic (1.00e-1)" "unprognostic (6.22e-2)" "unprognostic (5.33e-3)" "unprognostic (2.80e-2)" "unprognostic (3.27e-1)" "unprognostic (3.15e-1)" "unprognostic (3.17e-1)" "unprognostic (1.41e-1)" "unprognostic (1.73e-1)" "prognostic favorable (4.92e-4)" "unprognostic (9.66e-2)" "unprognostic (1.79e-1)" "unprognostic (2.89e-2)" "unprognostic (5.14e-4)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 65.1 90.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.3 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.7 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.3 0.5 0.0 0.6 0.8 2.0 0.4 0.0 0.2 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.8 0.2 1.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.2 2.5 0.0 0.0 10.4 0.0 0.0 41.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 210.7 0.1 0.0 0.0 3.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;stomach 1: 23.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 5.8;Syncytiotrophoblasts: 13.2" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "REH: 45.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023394, HPA076992" Enhanced Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA023394: AB_1850492, HPA076992: AB_2686822" "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.7 3.2 11.7 1.1 16.2 0.8 2.0 5.6 13.1 4.8 1.3 3.8 2.2 5.2 4.6 3.5 0.9 2.8 3.1 0.6 10.1 30.5 1.1 1.2 1.4 0.9 6.6 6.6 1.0 2.2 0.5 6.8 3.1 15.5 1.6 1.4 0.4 3.4 3.0 1.0 1.6 2.5 1.7 8.3 3.3 23.3 3.4 2.2 0.0 7.2 0.0 1.0 0.9 1.2 1.2 0.8 2.6 0.6 1.5 1.0 0.1 0.1 1.5 0.7 1.5 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.9 0.1 0.1 0.5 0.1 0.2 6.3 3.3 0.2 0.0 0.0 1.6 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.8 9.0 0.4 45.8 0.0 1.7 0.3 0.5 0.2 0.0 0.3 0.2 0.0 0.8 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.6 0.6 0.5 0.6 0.3 0.4 0.5 0.5 0.6 0.2 1.2 0.8 1.0 2.6 1.5 0.6 0.8 0.8 0.1 11.7 16.2 5.6 9.3 10.1 30.5 6.6 6.6 15.5 2.2 0.0 1.7 0.0 5.8 2.7 1.4 2.0 0.0 2.7 2.3 0.0 2.0 1.2 0.0 0.3 0.2 2.5 0.2 0.0 0.8 0.6 2.3 3.9 0.0 0.8 0.4 0.0 0.0 0.6 0.8 0.0 0.3 1.9 0.0 0.0 0.2 0.8 0.8 0.0 0.7 0.0 1.2 0.0 1.0 0.0 4.5 2.8 13.2 0.7 1.0 3.1 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83721613 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 41.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavorable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 5.4 1.5 3.9 0.0 0.1 0.6 4.7 0.1 4.7 0.1 0.1 3.8 0.5 0.1 1.2 0.0 0.5 1.8 3.4 1.3 0.4 0.1 0.9 0.1 1.7 0.7 0.2 0.2 0.0 0.1 41.8 1.5 4.9 5.8 1.5 0.9 0.1 0.1 0.5 9.3 0.3 0.6 0.1 2.4 0.1 0.1 0.1 0.3 0.5 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.1 0.0 0.0 28.3 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.6 4.4 3.4 1.3 1.7 0.7 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.4 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 HAPLN2 BRAL1 ENSG00000132702 "Hyaluronan and proteoglycan link protein 2" Q9GZV7 1 156619294-156625725 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 39 "brain: 108.1" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 32.3" "Cancer enriched" "Detected in some" 10 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 1.1;U-266/70: 4.6;U-87 MG: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045765 Enhanced "Secreted in brain" NA NA "HPA045765: AB_10964781" "unprognostic (3.19e-3)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (3.41e-1)" "unprognostic (1.88e-1)" "unprognostic (2.44e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-3)" "unprognostic (1.31e-1)" "unprognostic (8.25e-2)" "unprognostic (5.54e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-2)" "unprognostic (1.08e-1)" "unprognostic (2.25e-1)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 1.5 1.5 11.0 1.3 21.1 1.3 1.3 4.4 45.3 1.3 1.3 43.6 0.0 2.7 1.6 1.3 1.3 1.4 1.3 1.3 21.2 13.9 1.4 1.3 1.4 1.3 49.3 9.3 1.3 1.3 1.6 0.0 1.3 43.1 1.9 1.3 0.0 1.4 1.5 1.9 1.6 1.7 1.3 108.1 1.3 1.3 1.7 31.5 0.0 1.3 0.0 1.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 4.6 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 21.1 4.4 15.1 21.2 13.9 49.3 9.3 43.1 31.5 0.0 0.0 0.0 0.0 0.1 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 32.3 7.6 0.7 1.9 0.0 0.0 0.0 0.0 0.1 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 899.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;U-2 OS: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.4 0.9 9.8 2.8 3.0 3.1 2.7 0.6 1.0 1.3 2.8 4.1 0.0 7.8 3.4 1.6 1.0 9.3 1.2 0.0 21.0 8.2 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 2.0 0.1 0.1 4.6 0.4 0.0 6.0 0.4 0.1 0.0 0.0 7.3 0.0 0.1 0.0 0.4 7.3 1.8 0.1 0.1 2.7 0.5 0.5 3.7 1.2 0.0 0.4 0.8 7.1 21.0 5.3 0.4 0.9 0.0 0.0 2.5 0.0 6.1 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 0.0 4.3 0.9 6.0 28.4 2.6 7.7 0.0 1.4 5.7 1.8 9.8 5.6 0.0 5.7 0.0 18.6 0.0 0.0 1.8 899.6 9.3 3.9 1.1 0.0 17.6 0.0 0.0 3.1 0.0 0.0 0.9 2.9 16.9 16.2 0.2 2.4 8.7 0.0 0.7 0.1 108.4 12.9 38.9 0.5 1.7 21.1 17.0 3.2 0.2 6.8 HAPLN4 "BRAL2, KIAA1926" ENSG00000187664 "Hyaluronan and proteoglycan link protein 4" Q86UW8 19 19255641-19262796 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 38.5;intestine: 24.3" "Cell type enriched" "Detected in single" 6 "Hepatocytes: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 5.7;NTERA-2: 14.9;SCLC-21H: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055856 Enhanced "Secreted in brain" NA NA "HPA055856: AB_2682946" "unprognostic (3.36e-4)" 0.5 1.9 3.0 0.4 7.5 0.4 0.7 8.9 38.5 2.4 0.6 1.6 0.0 19.6 1.6 0.5 0.4 0.7 0.6 0.5 8.9 9.4 0.5 7.5 0.6 0.4 7.8 2.7 1.4 1.3 0.4 0.2 0.7 26.4 1.1 0.6 0.4 0.5 0.8 0.4 0.4 24.3 0.6 3.8 0.4 0.8 0.5 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 5.7 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.5 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 7.5 8.9 38.5 8.9 9.4 7.8 2.7 26.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "eosinophil: 5.9;neutrophil: 1.6" "Lineage enriched" "Detected in single" 15 "granulocytes: 5.9" "Cell line enriched" "Detected in some" 4 "U-87 MG: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067602: AB_2685871" "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.7 0.5 0.6 13.7 1.3 2.8 1.0 1.5 1.9 0.6 1.2 0.4 1.1 0.1 0.8 2.5 1.3 5.8 5.5 5.9 1.4 2.0 0.3 0.6 4.5 0.3 0.6 0.3 23.6 2.2 0.0 0.3 0.3 0.6 0.4 0.5 1.0 0.3 1.2 2.1 2.7 4.0 3.6 0.9 0.7 0.7 0.9 0.3 0.3 0.3 0.8 0.3 1.8 0.3 0.1 0.1 5.9 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 1.3 1.5 1.7 1.4 2.0 0.6 0.3 0.6 0.3 0.0 2.6 0.0 0.1 23.7 4.2 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.1 2.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.3 8.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.6 0.0 24.7 0.0 0.1 15.6 0.1 0.0 0.0 0.1 HAS2 ENSG00000170961 "Hyaluronan synthase 2" Q92819 8 121612116-121641390 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 22.8" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 44.7;Fibroblasts: 34.9;Melanocytes: 28.7;Urothelial cells: 95.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HBF TERT88: 34.7;hTEC/SVTERT24-B: 33.4;LHCN-M2: 44.3;U-138 MG: 87.1;U-251 MG: 25.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052060 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA052060: AB_2681712" "unprognostic (7.01e-2)" "unprognostic (1.34e-2)" "unprognostic (4.07e-2)" "unprognostic (4.65e-2)" "unprognostic (1.17e-1)" "unprognostic (2.91e-2)" "unprognostic (5.33e-2)" "unprognostic (2.57e-3)" "unprognostic (3.44e-2)" "unprognostic (1.34e-1)" "unprognostic (8.19e-3)" "unprognostic (1.24e-1)" "unprognostic (1.66e-7)" "unprognostic (1.47e-3)" "unprognostic (3.67e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-3)" 22.8 0.9 1.6 9.1 2.4 0.0 5.5 0.8 1.7 4.0 8.5 2.0 0.0 2.6 1.5 2.5 4.8 3.9 7.7 8.3 1.7 1.7 1.2 2.7 6.5 4.5 1.8 0.6 1.2 1.8 0.3 0.7 2.1 5.7 4.3 5.6 2.7 1.9 0.1 2.7 3.8 9.5 3.7 4.2 0.3 2.3 3.2 2.6 0.4 1.7 5.5 2.1 5.7 1.4 0.0 0.2 0.7 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 1.0 2.6 0.0 4.9 3.7 6.5 11.2 0.0 0.0 0.0 0.0 4.4 0.0 0.8 0.0 0.0 34.7 0.0 0.1 0.0 0.1 0.0 4.4 0.0 0.0 6.8 0.0 33.4 3.0 0.1 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.7 0.0 0.0 0.4 0.0 0.1 2.1 0.0 1.1 2.0 0.0 0.0 0.0 87.1 0.3 8.1 25.8 0.0 0.0 0.0 1.8 0.0 1.7 0.5 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.3 0.2 0.2 0.1 0.0 1.6 2.4 0.8 1.7 1.7 1.7 1.8 0.6 5.7 2.6 0.0 0.0 0.0 44.7 14.4 0.0 1.2 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.7 12.7 2.2 0.0 0.0 0.0 0.0 34.9 5.5 13.8 0.0 0.2 0.0 1.2 0.0 0.0 1.6 1.7 1.6 28.7 0.0 1.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.8 0.2 0.0 10.5 0.1 0.0 3.3 95.7 HAS3 ENSG00000103044 "Hyaluronan synthase 3" O00219 16 69105564-69118719 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;urinary bladder: 22.9" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2" "Group enriched" "Detected in many" 8 "cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 14.4;PC-3: 76.9;RT4: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031554, CAB033850" Supported Approved Microtubules NA NA Microtubules "CAB033850: AB_2116418, HPA031554: AB_10670703" "unprognostic (3.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (7.59e-3)" "unprognostic (2.86e-3)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (2.46e-1)" "unprognostic (3.27e-3)" "unprognostic (3.25e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-2)" "unprognostic (3.40e-3)" 0.4 0.2 0.4 0.4 1.0 0.3 5.5 1.1 1.3 3.3 3.7 0.4 0.4 1.9 0.8 1.1 22.6 0.7 3.5 2.4 0.6 0.6 1.2 0.7 18.0 0.4 0.4 0.4 0.9 2.2 0.1 1.0 3.3 1.1 3.5 2.3 0.6 7.6 2.1 0.6 5.7 2.1 1.4 0.4 0.4 9.0 2.0 0.4 0.5 4.0 11.7 11.1 22.9 13.6 1.5 1.2 2.2 1.4 0.4 2.0 1.1 0.9 4.8 0.3 0.2 0.1 0.1 1.8 0.3 0.1 0.2 0.1 1.0 2.5 0.2 0.6 0.1 1.1 14.4 0.8 8.6 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 2.4 0.3 0.8 1.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.1 4.3 5.0 76.9 0.5 0.0 0.0 7.9 30.4 5.4 0.2 0.5 0.0 0.1 0.9 0.2 0.2 0.1 0.2 0.2 8.4 0.5 0.3 0.2 0.0 0.3 0.0 0.1 0.8 1.4 2.2 1.4 0.7 1.3 0.7 1.1 0.5 1.2 1.5 2.0 0.7 0.5 0.4 1.1 1.0 1.5 1.1 0.4 1.0 1.1 1.3 0.6 0.6 0.4 0.4 1.1 0.4 0.0 25.0 0.0 35.3 144.1 1.4 1.4 0.0 0.0 4.5 0.0 2.0 0.9 0.0 3.2 10.2 2.0 2.0 0.0 3.1 0.7 0.8 9.4 0.0 0.0 0.3 0.0 0.0 1.3 0.0 17.0 1.1 0.6 3.3 0.0 0.3 0.1 2.3 0.0 0.4 0.6 0.9 0.0 2.5 0.6 0.4 138.5 0.2 0.5 1.5 89.2 HASPIN GSG2 ENSG00000177602 "Histone H3 associated protein kinase" Q8TF76 17 3723903-3726699 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7" "Cell type enriched" "Detected in single" 5 "Extravillous trophoblasts: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027422, HPA030698" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA027422: AB_10601812, HPA030698: AB_2673575" "unprognostic (1.15e-2)" "unprognostic (2.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.14e-2)" "unprognostic (8.05e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (6.60e-2)" "unprognostic (1.77e-1)" "unprognostic (2.75e-3)" "unprognostic (3.82e-3)" "unprognostic (0.00e+0)" "unprognostic (5.65e-3)" "unprognostic (3.09e-2)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" 1.2 0.3 0.3 11.8 0.6 7.5 1.8 0.5 0.3 0.5 1.5 0.2 0.0 2.2 0.3 0.4 2.8 0.6 1.3 0.6 0.2 0.2 0.8 0.4 2.6 5.8 0.4 0.0 0.4 0.5 0.0 0.3 1.3 0.2 0.7 1.5 0.2 1.0 0.0 1.2 0.9 3.6 0.4 1.2 4.9 1.7 26.7 0.3 26.7 0.7 1.7 7.3 0.8 1.0 2.8 1.5 2.1 0.6 0.0 1.2 0.4 7.5 8.3 7.7 8.6 0.5 1.0 6.4 7.0 5.3 13.8 13.6 6.5 3.1 18.6 4.0 3.8 5.5 12.3 13.8 6.7 13.2 0.1 11.5 9.2 6.7 3.8 0.3 5.3 9.5 0.6 0.5 10.3 6.4 1.6 6.3 14.8 8.1 16.4 6.9 3.9 10.7 3.1 6.7 5.8 5.7 11.2 9.7 5.0 2.0 5.3 3.1 4.5 6.1 4.2 2.4 7.0 4.2 5.0 3.2 6.1 7.0 6.8 12.1 3.1 3.5 9.0 3.6 7.7 7.3 0.4 0.6 2.1 0.2 0.5 0.2 0.7 0.8 0.0 1.1 2.8 1.2 0.2 0.2 0.0 0.0 1.5 0.1 0.4 0.3 0.6 0.5 0.3 0.2 0.2 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 37.6" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "A549: 36.6;CACO-2: 44.0;RPTEC TERT1: 17.5" "HPA007173, CAB075697" Uncertain Approved Vesicles NA NA 155000 Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavorable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favorable (1.32e-4)" 0.4 0.1 0.2 1.0 0.2 0.9 0.2 0.2 0.2 0.2 6.7 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 0.2 0.3 0.2 37.6 0.5 0.6 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 5.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.5 0.5 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 1.3 1.2 2.0 1.8 2.1 3.4 2.3 0.0 36.6 0.1 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 44.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 1.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 1.8 0.5 0.7 1.1 1.0 0.8 1.8 0.9 1.2 1.3 3.4 2.5 1.3 2.1 0.8 0.8 2.8 2.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 HAVCR2 "CD366, FLJ14428, Tim-3, TIM3, TIMD3" ENSG00000135077 "Hepatitis A virus cellular receptor 2" Q8TDQ0 5 157085832-157142869 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 34.6" "Cell type enhanced" "Detected in many" 12 "granulocytes: 80.6;Hofbauer cells: 135.6;Kupffer cells: 75.1;Macrophages: 74.2;monocytes: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.2;intermediate monocyte: 14.5;myeloid DC: 34.6;NK-cell: 24.1;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 6 "dendritic cells: 34.6;monocytes: 14.5;NK-cells: 24.1" "Cell line enhanced" "Detected in some" "ASC diff: 5.9;Daudi: 3.9;HDLM-2: 17.4;HMC-1: 4.3;RPMI-8226: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB026003 Enhanced NA NA 2900000 "CAB026003: " "unprognostic (2.50e-2)" "unprognostic (1.11e-2)" "unprognostic (5.18e-2)" "unprognostic (2.04e-3)" "unprognostic (3.79e-2)" "unprognostic (1.14e-1)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (8.48e-2)" "unprognostic (5.13e-2)" "unprognostic (7.83e-2)" "unprognostic (1.89e-1)" "unprognostic (1.83e-2)" "unprognostic (2.13e-1)" "unprognostic (1.34e-1)" 16.8 8.6 9.3 16.0 12.3 10.3 6.5 8.4 10.7 5.1 5.3 15.5 1.8 4.1 3.9 5.9 4.2 5.3 11.4 4.8 9.8 9.3 23.3 8.9 19.8 21.7 15.5 7.5 4.4 3.8 2.4 5.5 14.3 11.3 4.2 6.5 4.1 6.2 3.1 3.3 3.1 6.0 7.2 24.8 23.1 4.2 5.8 12.1 4.7 3.8 2.9 11.1 10.3 2.9 0.3 34.6 3.1 14.5 24.1 3.8 9.7 0.0 0.1 0.1 0.1 5.9 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 3.9 0.3 0.0 0.1 0.1 0.0 0.0 0.0 17.4 0.0 0.8 0.0 0.0 0.0 0.0 4.3 0.2 0.3 0.0 0.1 0.0 0.0 0.4 0.1 2.1 0.0 0.0 0.1 2.8 0.2 0.0 0.0 0.1 2.2 14.2 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.1 0.2 0.0 0.7 0.3 0.2 0.0 0.3 1.2 0.2 0.1 0.4 0.1 3.1 13.2 0.0 3.8 14.5 0.8 0.3 1.6 2.0 34.6 0.1 2.0 2.9 0.7 24.1 8.6 4.1 3.1 9.7 9.3 12.3 8.4 10.7 9.8 9.3 15.5 7.5 11.3 12.1 6.0 9.2 10.3 0.1 0.9 1.0 0.8 0.0 0.0 3.4 0.0 0.0 0.6 6.6 0.0 10.7 0.9 0.0 0.0 0.0 0.7 1.3 0.5 80.6 0.0 135.6 0.0 0.0 1.3 75.1 6.0 0.3 74.2 3.3 60.5 0.0 0.1 0.1 0.0 0.0 38.9 0.0 6.5 0.7 0.2 0.5 1.1 0.9 28.7 0.1 0.4 HBA1 HBA-T3 ENSG00000206172 "Hemoglobin subunit alpha 1" P69905 16 176680-177522 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 1020.7" "Cell type enriched" "Detected in many" 24 "Erythroid cells: 99681.0" "Cancer enhanced" "Detected in many" "glioma: 6.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 11.7;plasmacytoid DC: 7.4" "Group enriched" "Detected in many" 4 "dendritic cells: 7.4;granulocytes: 11.7" "Group enriched" "Detected in some" 37 "HEL: 248.9;K-562: 175.4" "CAB032534, HPA043780" Enhanced NA NA 17000000000 "CAB032534: AB_2294993, HPA043780: AB_2678667" "unprognostic (1.16e-1)" "unprognostic (1.45e-2)" "unprognostic (8.87e-2)" "unprognostic (9.78e-3)" "unprognostic (3.02e-1)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-1)" "unprognostic (6.21e-3)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.02e-2)" "unprognostic (3.59e-2)" "unprognostic (3.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.67e-2)" "unprognostic (9.56e-2)" 12.6 8.8 7.1 5.0 6.6 1020.7 5.0 7.9 10.0 2.2 3.2 3.0 2.2 1.3 2.2 4.1 2.8 4.8 4.0 16.9 5.2 5.1 20.6 15.7 30.3 8.1 10.1 5.8 4.9 2.2 0.9 7.5 104.1 3.3 4.8 1.4 4.5 6.7 3.3 9.4 1.9 2.2 5.1 7.9 101.4 1.6 6.7 2.2 2.2 9.3 2.2 2.2 3.4 9.4 0.6 7.4 11.7 0.5 0.9 2.1 186.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 248.9 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 175.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 3.3 1.9 0.0 0.0 0.6 0.2 0.7 0.7 0.4 0.7 2.1 11.7 0.9 0.0 7.4 0.0 186.1 7.1 6.6 7.9 10.0 5.2 5.1 10.1 5.8 3.3 2.2 0.0 0.0 18.2 0.0 9.4 0.2 0.8 2.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 4.6 0.5 0.7 99681.0 0.0 0.0 0.0 0.1 0.0 30.9 0.0 0.0 1.2 17.2 53.0 11.2 0.0 0.0 4114.8 0.0 0.9 0.3 0.1 1.7 0.4 3.7 14.8 0.0 179.2 0.1 5.1 11.5 0.0 21.3 1.4 0.0 HBA2 HBA-T2 ENSG00000188536 "Hemoglobin subunit alpha 2" P69905 16 172876-173710 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 427.1;bone marrow: 1094.2" "Cell type enriched" "Detected in many" 20 "Erythroid cells: 168432.0" "Cancer enhanced" "Detected in all" "glioma: 59.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 9.8;neutrophil: 33.6;plasmacytoid DC: 15.7" "Group enriched" "Detected in many" 8 "dendritic cells: 15.7;granulocytes: 33.6" "Group enriched" "Detected in some" 18 "HEL: 161.2;K-562: 43.2" "CAB038417, HPA043780" Enhanced NA NA 17000000000 "CAB038417: , HPA043780: AB_2678667" "unprognostic (1.57e-1)" "unprognostic (7.02e-2)" "unprognostic (2.59e-2)" "unprognostic (2.13e-1)" "unprognostic (3.59e-1)" "unprognostic (3.18e-1)" "unprognostic (3.39e-2)" "unprognostic (2.12e-1)" "unprognostic (4.99e-2)" "unprognostic (4.43e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.72e-3)" "unprognostic (1.36e-1)" "unprognostic (2.11e-1)" "unprognostic (4.73e-2)" "unprognostic (8.92e-2)" 15.4 11.8 7.2 6.9 7.3 1094.2 7.6 4.1 4.1 4.1 4.1 4.1 4.1 1.1 4.1 4.1 4.1 7.7 5.8 19.5 5.8 6.2 24.3 17.7 38.4 4.1 11.2 4.1 4.1 4.1 0.5 8.9 128.7 4.1 4.1 1.3 4.1 9.2 5.6 17.7 0.9 4.1 4.1 9.3 98.3 1.9 4.1 4.1 4.1 12.5 4.1 4.1 4.1 20.1 1.4 15.7 33.6 0.9 1.5 3.0 427.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.1 1.6 1.3 0.1 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 9.8 3.0 0.0 0.1 1.4 0.3 0.2 1.4 0.8 0.8 2.6 33.6 1.5 0.0 15.7 0.0 427.1 7.2 7.3 4.1 4.1 5.8 6.2 11.2 4.1 4.1 4.1 3.0 1.0 72.9 0.1 39.4 1.2 4.0 12.7 4.0 1.2 0.0 0.0 0.0 46.4 0.0 2.6 9.0 1.0 168432.0 0.0 0.0 2.1 0.2 1.1 54.4 0.0 0.0 2.9 39.9 114.1 9.4 0.0 1.1 8337.5 0.0 1.3 1.3 0.0 3.7 0.0 12.3 41.0 0.0 364.9 0.2 6.6 39.0 0.0 20.8 0.7 0.0 HBB "beta-globin, CD113t-C" ENSG00000244734 "Hemoglobin subunit beta" P68871 11 5225464-5229395 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Hypotensive agent, Vasoactive" "Congenital dyserythropoietic anemia, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "bone marrow: 3646.7" "Cell type enriched" "Detected in many" 16 "Erythroid cells: 407904.6" "Cancer enhanced" "Detected in all" "glioma: 244.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "neutrophil: 19.3;plasmacytoid DC: 9.9" "Group enriched" "Detected in many" 12 "dendritic cells: 9.9;granulocytes: 19.3" "Cell line enhanced" "Detected in some" "HEL: 5.5;SCLC-21H: 4.8;SH-SY5Y: 6.1;U-266/70: 22.3;U-266/84: 3.7" "CAB009526, HPA043234" Enhanced NA NA 15000000000 "CAB009526: AB_2143058, HPA043234: AB_2678378" "unprognostic (2.41e-1)" "unprognostic (8.55e-2)" "unprognostic (2.40e-1)" "unprognostic (4.40e-2)" "unprognostic (1.14e-1)" "unprognostic (3.22e-1)" "unprognostic (4.88e-2)" "unprognostic (7.46e-2)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (8.11e-3)" "unprognostic (2.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.42e-1)" "unprognostic (8.87e-3)" "unprognostic (6.41e-2)" 32.7 20.0 20.9 10.1 21.0 3646.7 43.4 6.5 10.7 9.2 11.3 7.2 3.4 3.2 7.3 11.1 36.6 28.4 30.4 38.9 17.9 17.4 45.0 37.6 305.8 7.0 31.6 10.8 82.6 28.4 2.9 18.6 236.8 23.7 23.1 7.5 32.0 17.4 12.8 29.5 3.8 3.9 12.0 26.5 216.8 4.0 9.3 3.8 5.6 46.4 20.2 7.6 124.5 256.7 0.6 9.9 19.3 0.6 1.2 1.1 523.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.1 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.4 0.3 0.0 0.0 4.8 6.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 22.3 3.7 0.0 0.0 0.0 0.0 2.2 0.6 1.9 0.9 0.0 0.1 0.6 0.2 0.0 0.9 0.4 0.4 1.1 19.3 1.2 0.1 9.9 0.0 523.2 20.9 21.0 6.5 10.7 17.9 17.4 31.6 10.8 23.7 3.8 3.0 5.9 120.0 0.0 139.4 3.4 2.0 28.1 49.5 2.3 7.0 3.9 1.1 43.1 0.0 0.0 20.2 1.0 407904.6 0.0 2.3 16.4 0.0 0.0 226.1 6.6 3.2 3.5 92.1 289.2 0.0 0.0 2.3 25972.5 0.0 3.8 6.2 0.1 2.9 0.0 79.6 86.7 0.0 737.5 0.0 0.0 220.7 1.8 46.8 0.6 0.0 HBD ENSG00000223609 "Hemoglobin subunit delta" P02042 11 5232678-5243657 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "bone marrow: 233.7" "Cell type enriched" "Detected in some" 231 "Erythroid cells: 15231.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 31.3;U-266/70: 42.6" "CAB037087, HPA043234" Supported NA NA 11000000000 "CAB037087: AB_260051, HPA043234: AB_2678378" "unprognostic (1.32e-2)" "unprognostic (4.87e-2)" "unprognostic (4.14e-2)" "unprognostic (2.26e-3)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "unprognostic (1.04e-1)" "unprognostic (8.67e-2)" "unprognostic (2.83e-2)" "unprognostic (3.17e-1)" "unprognostic (6.24e-2)" "unprognostic (3.17e-1)" 1.6 0.2 0.4 0.3 0.6 233.7 0.8 0.1 0.5 0.2 0.2 1.5 0.0 0.2 0.4 0.2 0.9 0.5 0.2 4.3 1.3 0.4 1.4 3.9 22.5 0.2 1.0 0.0 1.1 0.2 0.2 1.3 12.0 0.8 0.5 0.2 1.0 0.9 0.2 1.0 0.2 0.2 0.2 0.4 29.6 0.2 0.2 0.0 1.2 4.4 0.0 0.4 1.7 11.9 0.0 0.5 0.8 0.0 0.0 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 31.3 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 31.6 0.4 0.6 0.1 0.5 1.3 0.4 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15231.4 0.0 0.0 0.5 0.0 0.0 1.6 0.1 0.0 0.0 0.6 9.3 0.0 0.0 0.0 65.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 HBE1 HBE ENSG00000213931 "Hemoglobin subunit epsilon 1" P02100 11 5268345-5505652 "Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.7;liver: 6.7" "Cell type enriched" "Detected in some" 6 "Hofbauer cells: 131.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.1" "Cell line enriched" "Detected in some" 15 "K-562: 472.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043234 Approved NA NA "HPA043234: AB_2678378" "unprognostic (7.59e-2)" "unprognostic (6.70e-2)" "unprognostic (3.76e-2)" "unprognostic (4.25e-1)" "unprognostic (1.64e-1)" "unprognostic (9.03e-2)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (7.32e-2)" "unprognostic (1.02e-3)" "unprognostic (2.14e-1)" "unprognostic (5.80e-2)" "unprognostic (7.34e-2)" 1.8 1.1 1.1 0.4 1.0 1.3 0.9 1.0 1.9 0.7 0.4 0.4 0.4 0.1 0.6 2.0 0.4 1.0 0.6 0.4 1.4 0.8 0.9 6.7 0.6 0.4 7.7 5.1 1.9 0.5 0.1 0.6 3.6 3.2 1.1 0.3 0.4 0.7 0.6 1.5 0.6 0.4 1.2 0.5 1.0 0.4 2.2 0.4 1.6 0.6 0.4 0.4 0.4 0.7 0.0 0.0 2.1 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 472.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.7 1.1 1.0 1.0 1.9 1.4 0.8 7.7 5.1 3.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.5 0.0 0.0 23.3 0.0 16.6 0.2 0.0 0.0 0.0 131.4 0.0 0.0 0.0 0.0 1.4 0.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 12.4 0.0 0.0 0.0 HBG1 HBG-T2 ENSG00000213934 "Hemoglobin subunit gamma 1" P69891 11 5248079-5249859 "Predicted intracellular proteins" "Oxygen transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "placenta: 74.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 27 "K-562: 195.5" HPA043234 Approved NA NA "HPA043234: AB_2678378" "unprognostic (3.17e-2)" 1.5 0.1 0.5 0.1 0.6 0.4 0.1 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.5 0.4 1.2 0.9 2.6 0.1 0.7 0.2 0.1 0.1 0.4 74.0 0.1 0.1 0.2 0.2 0.9 0.1 0.1 0.1 1.1 7.0 0.5 0.2 0.8 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 195.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HBG2 HBG-T1 ENSG00000196565 "Hemoglobin subunit gamma 2" P69892 11 5253190-5505605 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 41 "placenta: 553.0" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 1.3;Late spermatids: 1.3;Spermatocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 175 "HEL: 321.3;K-562: 334.0" "CAB016143, HPA043234" Approved NA NA "CAB016143: AB_2295004, HPA043234: AB_2678378" "unprognostic (4.48e-3)" "unprognostic (2.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.41e-1)" "unprognostic (8.94e-2)" "unprognostic (4.22e-1)" "unprognostic (5.29e-1)" "unprognostic (3.95e-2)" "unprognostic (2.99e-1)" "unprognostic (3.52e-2)" "unprognostic (4.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-5)" "unprognostic (1.64e-1)" "unprognostic (2.65e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" 2.6 0.3 1.4 0.7 1.2 3.7 0.7 0.9 0.8 0.7 0.7 0.7 0.7 0.4 0.7 0.7 0.7 0.3 0.7 2.3 1.0 1.0 2.3 2.2 5.5 0.7 1.7 0.7 0.7 0.8 0.3 1.0 553.0 0.7 0.7 0.3 0.8 0.7 0.7 1.3 0.3 0.7 0.7 2.3 13.3 0.5 1.1 0.7 0.7 1.7 0.7 0.7 0.7 0.8 0.0 0.1 0.4 0.7 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 334.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 9.5 1.4 1.2 0.9 0.8 1.0 1.0 1.7 0.7 0.7 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.1 HBM "HBAP2, HBK" ENSG00000206177 "Hemoglobin subunit mu" Q6B0K9 16 153892-166768 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 109.8;placenta: 50.2" "Cell type enriched" "Detected in some" 740 "Erythroid cells: 12474.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.3" "Low region specificity" "Detected in some" NA NA 400000 "unprognostic (1.30e-1)" "unprognostic (7.59e-2)" 0.9 0.2 0.4 0.2 0.5 109.8 0.3 0.1 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.6 0.2 0.2 4.4 0.3 0.4 1.7 2.6 16.5 0.2 0.7 0.0 1.6 0.2 0.2 1.1 50.2 1.2 0.5 0.2 1.2 0.2 0.2 0.4 0.2 0.2 0.2 0.4 17.5 0.2 0.2 0.0 1.0 2.0 0.1 0.3 2.1 4.9 0.1 0.5 0.5 0.0 0.9 0.4 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.0 10.5 0.4 0.5 0.1 0.2 0.3 0.4 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12474.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.3 0.1 0.0 0.0 0.0 0.0 HBQ1 HBQ ENSG00000086506 "Hemoglobin subunit theta 1" P09105 16 180453-181181 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7" "Cell type enriched" "Detected in some" 8 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "granulocytes: 2.5;T-cells: 2.3" "Group enriched" "Detected in some" 7 "HEL: 13.4;Hep G2: 9.4;K-562: 33.1" "Low region specificity" "Detected in all" HPA062473 Enhanced Approved "Lipid droplets" NA NA 47000 "Lipid droplets" "HPA062473: AB_2684774" "unprognostic (4.24e-1)" "unprognostic (3.38e-1)" "unprognostic (2.11e-2)" "unprognostic (2.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.75e-2)" "unprognostic (2.33e-1)" "unprognostic (8.92e-2)" "unprognostic (2.02e-3)" "unprognostic (8.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.02e-1)" "unprognostic (5.55e-1)" 0.5 0.6 12.2 0.5 10.0 29.4 0.5 0.6 6.3 0.5 0.5 0.2 0.0 0.6 0.5 0.5 0.5 0.5 0.5 0.9 5.6 4.0 0.5 0.5 2.1 0.5 2.2 3.7 0.6 0.5 0.5 0.5 2.6 2.4 0.6 0.5 0.0 0.8 0.5 0.9 0.5 0.5 0.5 0.7 2.8 0.5 1.3 0.3 0.0 0.5 0.0 0.5 0.6 10.7 0.4 0.2 2.5 0.0 0.0 2.3 8.0 0.0 0.8 0.2 2.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 2.3 0.0 0.0 0.3 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 13.4 0.5 9.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 33.1 0.0 0.0 0.1 1.4 0.0 1.8 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.3 1.8 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 2.3 0.4 0.7 1.6 0.1 0.0 0.5 1.2 2.5 0.0 0.0 0.2 0.0 8.0 12.2 10.0 0.6 6.3 5.6 4.0 2.2 3.7 2.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 303.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 2.5 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.8 40.3 0.1 0.2 0.0 0.0 0.0 HBZ "HBZ-T1, HBZ1" ENSG00000130656 "Hemoglobin subunit zeta" P02008 16 152687-154503 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.9;placenta: 5.0;testis: 9.9" "Group enriched" "Detected in some" 4 "Hofbauer cells: 144.1;Late spermatids: 212.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 79 "K-562: 227.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA063268, HPA064073, HPA071726" Approved Approved Nucleoplasm,Cytosol NA NA 160000000 Cytosol Nucleoplasm "HPA063268: , HPA064073: , HPA071726: AB_2732184" "unprognostic (3.56e-1)" "unprognostic (1.32e-1)" 0.8 0.0 0.8 0.1 0.5 8.9 0.6 0.6 0.6 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.6 3.3 0.7 0.3 0.1 1.1 0.6 0.1 1.1 0.1 0.7 0.1 0.0 0.1 5.0 0.1 1.2 0.0 0.1 0.1 0.1 0.9 0.5 0.1 0.1 0.1 0.8 0.1 9.9 0.1 0.1 0.1 0.1 0.1 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 227.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.5 0.6 0.6 0.7 0.3 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 41.3 0.7 0.0 23.3 0.0 16.4 1.4 0.0 0.0 0.0 144.1 0.0 0.0 0.0 0.0 212.4 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.7 6.5 2.0 1.1 0.9 0.1 8.7 0.0 0.0 0.0 HCAR1 "FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR" ENSG00000196917 "Hydroxycarboxylic acid receptor 1" Q9BXC0 12 122726076-122730843 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 13.9;parathyroid gland: 41.4" "Group enriched" "Detected in some" 4 "Club cells: 5.7;Early spermatids: 8.6;Extravillous trophoblasts: 2.5;Late spermatids: 4.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.6;MCF7: 6.2;RT4: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "prognostic unfavorable (3.61e-5)" "unprognostic (8.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-2)" "unprognostic (3.80e-4)" "unprognostic (5.43e-4)" "unprognostic (1.41e-1)" "unprognostic (7.74e-2)" "unprognostic (2.22e-1)" "unprognostic (6.85e-3)" "unprognostic (1.26e-1)" "unprognostic (2.66e-3)" "unprognostic (2.14e-2)" "unprognostic (2.51e-1)" "unprognostic (2.38e-1)" "unprognostic (1.87e-2)" 7.1 0.4 0.4 0.0 0.4 0.4 13.9 0.4 0.4 0.5 0.5 0.2 12.2 0.1 0.4 2.8 0.9 0.9 0.7 2.1 0.4 0.4 1.2 0.4 0.6 0.6 0.4 0.2 0.5 0.4 41.4 0.5 1.0 0.5 1.8 0.0 2.4 8.0 3.2 0.4 0.9 0.5 0.6 2.2 5.2 0.7 1.4 0.0 0.0 2.0 0.0 0.5 1.0 1.8 1.5 1.2 4.4 0.9 1.4 0.9 0.3 0.1 0.2 0.2 0.3 0.0 0.1 1.6 0.1 0.0 0.0 0.1 1.9 9.6 0.2 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.5 1.4 0.2 0.2 0.2 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.2 0.5 0.1 6.2 0.2 0.3 0.3 2.3 0.6 0.2 0.2 0.2 0.1 27.4 2.1 0.2 0.1 3.3 0.0 0.3 2.8 0.1 0.3 0.3 0.2 0.2 0.1 0.4 0.1 0.3 0.2 0.2 0.3 4.4 0.9 0.8 0.9 0.5 0.7 0.8 0.8 0.6 0.3 1.5 0.8 0.8 4.0 1.4 0.5 1.2 0.5 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 0.5 0.0 0.0 0.3 0.0 1.2 0.1 0.4 0.3 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 8.6 0.0 0.0 0.0 0.0 2.5 0.2 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.7 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 HCAR2 "GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG" ENSG00000182782 "Hydroxycarboxylic acid receptor 2" Q8TDS4 12 122701293-122703343 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 69.6;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 92.8" "Group enriched" "Detected in many" 8 "cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "neutrophil: 50.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 50.9" "Cell line enriched" "Detected in some" 6 "HaCaT: 52.0" HPA028660 Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA028660: AB_10602139" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (1.77e-1)" "unprognostic (2.05e-1)" "unprognostic (6.65e-2)" "unprognostic (1.33e-1)" "unprognostic (3.33e-3)" "unprognostic (7.26e-2)" "unprognostic (2.17e-1)" "unprognostic (1.77e-2)" "unprognostic (7.10e-2)" "unprognostic (7.33e-2)" "unprognostic (4.83e-4)" "unprognostic (5.76e-2)" "unprognostic (5.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.63e-2)" 16.1 0.2 0.4 6.4 0.5 13.2 8.3 0.2 0.7 5.8 3.6 0.3 6.2 0.4 0.8 1.6 26.0 0.4 1.1 1.2 0.8 0.2 1.9 1.8 11.3 0.7 3.3 0.2 1.2 0.2 4.4 0.9 8.2 1.0 8.6 0.0 0.3 9.7 10.7 0.7 17.8 0.7 0.4 0.9 16.5 0.8 2.8 1.1 1.1 0.4 13.5 21.5 3.5 8.3 0.0 0.5 50.9 6.6 0.0 0.0 0.3 1.9 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 52.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 9.0 0.6 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 50.9 0.0 6.6 0.0 0.0 0.3 0.4 0.5 0.2 0.7 0.8 0.2 3.3 0.2 1.0 1.1 0.0 7.0 0.0 69.6 83.9 0.4 0.0 0.0 6.7 33.0 0.0 0.0 0.4 0.0 0.0 21.5 0.4 0.0 0.0 0.0 22.6 2.3 8.9 2.3 0.0 3.8 0.0 0.0 0.0 4.1 2.3 0.0 30.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.8 2.2 0.0 0.0 18.6 HCAR3 "GPR109B, HCA3, HM74" ENSG00000255398 "Hydroxycarboxylic acid receptor 3" P49019 12 122714756-122716892 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.7" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 75.5;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 93.0;Urothelial cells: 41.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 3.5" "Group enriched" "Detected in some" 6 "basophil: 12.1;neutrophil: 47.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 49 "granulocytes: 47.7;monocytes: 21.3" "Group enriched" "Detected in some" 5 "HaCaT: 7.2;RT4: 27.9" HPA028660 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA028660: AB_10602139" "unprognostic (2.32e-1)" "unprognostic (5.82e-2)" "unprognostic (8.23e-2)" "unprognostic (2.27e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" "unprognostic (1.64e-3)" "unprognostic (1.60e-1)" "unprognostic (6.29e-2)" "unprognostic (9.87e-2)" "unprognostic (1.50e-2)" "unprognostic (2.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.16e-1)" "unprognostic (9.28e-2)" 4.8 0.2 0.6 7.9 0.3 20.8 4.0 0.4 0.5 2.3 0.9 0.2 2.2 0.1 0.4 0.4 18.2 0.5 0.5 1.0 0.3 0.3 0.9 2.5 10.2 3.5 3.5 0.0 1.6 0.2 6.6 1.1 3.0 0.7 4.2 0.0 0.3 2.9 4.3 0.6 13.9 0.3 0.4 1.2 21.6 0.5 1.6 0.4 0.3 0.5 12.0 14.9 5.7 7.2 0.0 0.7 47.7 21.3 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 7.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 12.1 0.5 0.2 0.0 4.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 47.7 0.0 21.3 0.0 0.0 0.6 0.6 0.3 0.4 0.5 0.3 0.3 3.5 0.0 0.7 0.4 3.0 10.7 0.0 75.5 83.9 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 19.1 2.0 5.3 3.5 0.0 6.1 0.0 0.0 0.0 7.3 0.0 0.0 22.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 93.0 11.6 0.0 0.0 41.6 HCFC1R1 "FLJ20568, HPIP" ENSG00000103145 "Host cell factor C1 regulator 1" Q9NWW0 16 3022620-3024286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 204.8" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 247.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059647 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA059647: AB_2684094" "unprognostic (2.24e-2)" "unprognostic (8.13e-2)" "unprognostic (9.85e-3)" "unprognostic (6.03e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (1.61e-2)" "unprognostic (2.12e-1)" "unprognostic (3.43e-3)" "unprognostic (2.23e-1)" "unprognostic (2.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.23e-1)" 19.7 28.9 49.3 10.2 61.0 7.8 23.9 25.4 37.5 30.4 17.5 13.5 17.7 14.3 20.5 18.4 20.7 19.4 28.0 27.8 37.2 38.6 24.9 11.1 19.1 10.6 40.9 23.9 24.3 10.4 19.9 19.5 16.5 23.0 22.8 10.0 11.5 15.1 42.4 204.8 25.0 13.9 28.7 23.2 9.1 11.2 11.4 14.7 7.5 13.5 37.0 9.1 24.7 17.2 14.1 26.2 8.4 21.6 13.7 20.2 9.6 12.4 32.9 6.6 8.0 27.1 35.7 6.3 3.9 24.9 12.3 33.8 6.9 15.0 8.7 13.5 23.3 10.7 16.4 6.6 24.2 5.7 11.9 15.6 3.8 26.2 11.5 22.2 6.3 7.5 44.1 15.7 12.8 14.0 84.8 17.1 6.6 5.2 17.4 13.7 11.2 3.8 9.9 14.4 7.2 6.9 13.7 5.9 24.3 43.8 2.5 11.4 9.6 9.6 15.4 15.5 16.8 10.2 5.8 4.9 20.3 56.9 17.2 10.6 10.6 10.3 7.6 8.6 3.9 4.6 2.7 21.6 8.4 12.3 15.5 11.6 14.1 15.9 13.3 26.2 13.5 11.8 14.2 4.5 13.7 13.5 13.0 20.2 9.6 49.3 61.0 25.4 37.5 37.2 38.6 40.9 23.9 23.0 14.7 53.6 12.9 28.9 60.6 75.9 26.6 39.3 50.9 16.0 18.2 188.5 5.9 91.7 203.9 41.6 3.8 35.9 68.0 0.0 23.5 101.8 139.4 33.1 39.3 41.9 104.8 19.1 42.0 61.4 66.0 10.1 89.2 41.2 60.8 50.5 33.1 31.3 26.9 48.9 167.6 247.7 19.7 122.9 137.0 14.0 37.3 57.5 45.1 20.8 42.9 31.5 HCK JTK9 ENSG00000101336 "HCK proto-oncogene, Src family tyrosine kinase" P08631 20 32052188-32101856 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 107.1;lymphoid tissue: 72.6" "Group enriched" "Detected in many" 8 "Hofbauer cells: 131.2;Kupffer cells: 133.2;Macrophages: 170.5;monocytes: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1" "Group enriched" "Detected in many" 15 "dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1" "Group enriched" "Detected in some" 8 "THP-1: 23.1;U-937: 66.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005195, HPA063768" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "CAB005195: AB_631619, HPA063768: AB_2685118" "unprognostic (6.22e-2)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "unprognostic (7.98e-2)" "unprognostic (8.83e-2)" "unprognostic (5.50e-2)" "unprognostic (4.09e-2)" "unprognostic (1.72e-2)" "unprognostic (4.34e-2)" "unprognostic (1.59e-1)" "unprognostic (4.08e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (4.92e-2)" "unprognostic (4.42e-2)" "unprognostic (6.95e-2)" "unprognostic (1.12e-1)" 12.3 5.8 5.9 40.8 13.1 20.8 4.0 1.8 5.3 3.0 5.8 6.1 0.9 5.9 2.5 5.7 3.1 5.9 6.5 8.8 6.0 3.7 4.0 7.9 20.9 50.3 11.2 1.2 3.4 2.8 0.7 2.9 8.8 8.0 3.8 5.9 3.1 4.1 1.9 3.1 2.8 7.8 10.2 9.1 72.6 3.7 2.6 8.2 5.8 3.3 1.2 16.4 9.4 3.5 4.7 31.6 73.0 107.1 1.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 23.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 3.4 0.0 66.3 0.0 0.5 50.8 62.5 0.1 96.5 0.1 4.7 0.1 0.1 31.6 3.7 0.1 0.0 73.0 1.1 107.1 2.8 0.1 40.2 5.9 13.1 1.8 5.3 6.0 3.7 11.2 1.2 8.0 8.2 6.0 21.8 10.3 3.5 2.7 0.0 1.7 2.5 2.7 6.8 7.0 0.0 0.8 1.7 0.0 0.2 1.4 0.0 0.0 0.5 0.7 1.3 0.0 5.8 0.8 131.2 0.0 1.7 1.8 133.2 0.0 0.0 170.5 1.7 221.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 1.0 1.4 0.5 0.0 4.6 HCLS1 "CTTNL, HS1" ENSG00000180353 "Hematopoietic cell-specific Lyn substrate 1" P14317 3 121631399-121660927 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 149.7;lymphoid tissue: 110.1" "Cell type enhanced" "Detected in many" 15 "Kupffer cells: 535.9;Macrophages: 194.3;monocytes: 183.1;T-cells: 152.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 43.1;HMC-1: 61.2;Karpas-707: 39.8;RPMI-8226: 40.9;THP-1: 42.7;U-266/70: 60.6;U-698: 60.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA019143 Enhanced Supported "Plasma membrane,Cytosol" NA NA 200000 "Plasma membrane, Cytosol" "HPA019143: AB_1850532" "unprognostic (2.27e-2)" "unprognostic (1.79e-3)" "unprognostic (5.38e-3)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" "unprognostic (4.02e-3)" "unprognostic (2.35e-1)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "unprognostic (6.76e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-3)" "unprognostic (2.93e-1)" "unprognostic (3.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" 24.7 10.7 7.8 44.9 14.7 35.5 9.1 1.3 7.4 6.3 10.4 8.5 2.2 5.5 5.6 8.2 4.8 9.1 10.1 7.5 6.7 5.0 10.5 10.1 18.7 59.4 12.9 3.2 4.6 5.1 1.4 6.1 15.4 10.9 6.1 8.6 4.9 7.4 3.1 7.0 4.6 23.0 8.9 15.1 110.1 7.1 3.6 11.6 41.0 6.1 4.4 61.5 12.5 5.6 33.4 59.6 149.7 84.9 24.3 44.1 103.5 0.1 0.0 0.0 0.0 3.6 2.0 0.9 0.6 0.6 0.1 0.2 0.0 0.0 43.1 21.0 0.0 0.0 0.0 1.1 1.6 0.1 19.2 0.0 27.9 0.0 0.0 2.0 30.6 61.2 0.3 0.0 0.0 0.3 0.0 25.4 17.6 5.5 39.8 0.0 0.0 21.7 25.9 0.0 0.0 0.7 22.0 0.0 40.9 0.0 11.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 42.7 33.1 0.0 0.3 0.0 0.1 60.6 18.4 60.6 0.3 29.5 0.0 26.6 64.1 104.2 40.2 80.6 32.9 33.4 33.3 36.8 59.6 29.4 28.5 33.0 149.7 24.3 84.9 18.5 44.1 103.5 7.8 14.7 1.3 7.4 6.7 5.0 12.9 3.2 10.9 11.6 8.9 51.2 119.0 0.8 2.9 0.4 1.7 7.6 18.7 12.5 0.0 0.0 96.0 0.0 0.3 0.8 14.6 0.1 23.3 0.2 50.7 6.0 0.3 70.6 2.1 117.6 0.0 0.0 33.2 535.9 0.9 3.1 194.3 18.6 183.1 0.3 0.6 0.3 0.0 1.1 0.6 0.7 12.9 6.6 0.3 0.6 3.9 121.6 152.2 0.2 1.8 HCN1 "BCNG-1, BCNG1, HAC-2" ENSG00000164588 "Hyperpolarization activated cyclic nucleotide gated potassium channel 1" O60741 5 45254950-45696498 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 16.1" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 184.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;WM-115: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019195 Enhanced NA NA "HPA019195: AB_2670094" "unprognostic (1.30e-1)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (6.82e-2)" "unprognostic (1.10e-1)" "unprognostic (9.63e-3)" "unprognostic (4.11e-3)" "unprognostic (6.78e-2)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (3.68e-3)" 1.0 2.8 6.0 1.0 13.0 1.3 1.2 9.8 26.4 0.9 1.0 0.5 0.0 0.9 1.1 0.9 1.1 1.0 1.0 4.6 8.1 4.5 0.9 1.0 1.0 1.0 2.6 11.1 1.1 1.7 0.9 4.0 0.9 9.2 1.0 1.0 16.1 1.0 0.9 3.6 1.6 1.1 0.9 1.2 1.1 1.1 1.2 0.0 0.0 1.1 0.0 0.9 0.9 0.3 0.6 0.2 0.6 0.2 0.3 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.3 0.1 0.4 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.3 4.7 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.2 0.3 0.6 0.3 0.1 0.2 0.0 0.0 6.0 13.0 9.8 26.4 8.1 4.5 2.6 11.1 9.2 0.0 0.0 0.0 0.0 0.0 0.1 25.3 3.6 0.0 0.0 0.0 0.0 125.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.0 0.0 0.0 184.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 HCN2 "BCNG-2, BCNG2, HAC-1" ENSG00000099822 "Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2" Q9UL51 19 589893-617159 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.1;heart muscle: 16.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 58.4;Horizontal cells: 38.1;Rod photoreceptor cells: 14.2" "Group enriched" "Detected in many" 6 "glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 18.0;HeLa: 9.6;MCF7: 16.7;U-138 MG: 12.6;U-87 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.69e-2)" "unprognostic (3.97e-3)" "unprognostic (3.31e-4)" "unprognostic (1.44e-1)" "unprognostic (2.44e-1)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" "unprognostic (5.32e-2)" "unprognostic (1.19e-3)" "unprognostic (8.00e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.07e-1)" "unprognostic (1.41e-1)" "unprognostic (5.53e-4)" "unprognostic (9.72e-3)" 1.1 4.8 12.0 1.4 29.1 1.5 1.0 8.5 38.1 1.1 1.2 8.2 0.0 1.2 1.0 1.3 2.2 1.0 1.1 16.8 18.3 11.7 1.5 1.1 1.1 1.5 22.0 6.6 1.0 1.5 1.2 3.0 1.1 11.4 1.2 1.1 0.6 1.4 1.2 1.1 1.7 1.2 1.2 24.5 1.3 1.3 3.7 7.3 0.0 1.1 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 18.0 0.2 0.6 1.9 1.3 0.6 1.2 1.5 0.5 0.1 2.5 0.1 0.0 4.0 1.7 1.3 0.1 0.4 0.1 0.0 3.0 7.6 0.0 9.6 0.2 1.4 0.2 3.4 3.5 0.3 0.1 0.0 0.5 0.1 0.4 1.0 0.1 1.3 16.7 0.0 0.0 0.9 0.4 0.5 0.1 0.1 0.4 0.3 0.5 7.0 3.6 4.4 0.0 1.3 0.3 3.6 0.6 1.7 12.6 1.9 0.2 4.9 0.3 0.2 0.1 25.9 0.8 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 12.0 29.1 8.5 19.6 18.3 11.7 22.0 6.6 11.4 7.3 0.0 0.0 0.0 0.0 0.6 58.4 3.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 38.1 1.2 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 14.2 0.0 0.8 0.1 0.9 0.5 0.2 0.0 0.0 0.0 HCN3 KIAA1535 ENSG00000143630 "Hyperpolarization activated cyclic nucleotide gated potassium channel 3" Q9P1Z3 1 155277583-155289848 "Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026584 Approved NA NA "HPA026584: AB_1850534" "unprognostic (1.04e-1)" "unprognostic (6.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.34e-1)" "unprognostic (3.17e-1)" "unprognostic (1.48e-3)" "unprognostic (1.63e-1)" "unprognostic (5.97e-2)" "unprognostic (4.44e-2)" "unprognostic (1.84e-2)" "unprognostic (4.36e-3)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.55e-2)" "unprognostic (1.85e-1)" "unprognostic (5.90e-2)" "prognostic favorable (6.93e-4)" 1.6 3.5 4.5 2.0 7.5 1.5 2.1 20.3 9.5 3.6 4.4 3.3 3.6 7.7 4.5 2.1 3.9 2.2 3.0 1.6 4.0 8.2 4.4 10.2 1.9 2.3 4.1 8.5 4.7 4.7 6.4 12.6 2.4 9.5 2.7 5.0 4.0 4.4 3.6 1.1 9.2 6.6 2.8 3.0 1.9 3.2 1.7 2.1 1.6 2.6 1.3 3.0 2.3 3.6 0.3 0.0 0.0 0.1 0.0 0.6 0.0 1.6 1.8 7.9 3.2 1.3 1.5 1.9 1.3 1.2 1.6 1.9 2.8 5.5 1.5 1.1 1.0 3.4 6.9 2.2 1.0 0.9 2.1 2.8 0.6 5.1 1.8 0.5 0.6 1.6 0.9 1.0 1.1 0.2 1.8 0.3 2.5 3.7 4.4 1.9 2.2 1.1 0.6 2.7 4.2 2.1 3.9 1.9 2.9 2.2 1.7 6.5 4.6 1.2 1.6 0.5 1.5 2.8 1.3 0.1 1.9 1.7 4.0 1.2 1.4 0.6 1.3 1.5 1.1 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 7.5 20.3 9.5 4.0 8.2 4.1 8.5 9.5 2.1 0.0 1.1 0.0 0.6 1.1 2.4 0.8 2.5 0.0 1.2 1.8 3.9 0.3 0.0 0.9 0.1 0.0 4.6 0.0 0.3 0.3 1.3 0.8 1.1 1.5 0.7 0.0 4.1 3.1 0.0 0.4 0.9 1.3 0.0 1.0 2.3 1.4 0.9 2.9 1.1 0.8 1.8 0.0 0.3 1.5 2.1 2.4 0.0 0.5 3.8 0.9 HCN4 ENSG00000138622 "Hyperpolarization activated cyclic nucleotide gated potassium channel 4" Q9Y3Q4 15 73319859-73369264 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 4.3;heart muscle: 12.5;testis: 9.6" "Group enriched" "Detected in some" 7 "Early spermatids: 28.7;Late spermatids: 33.9" "Group enriched" "Detected in some" 8 "testis cancer: 3.1;thyroid cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.6;CACO-2: 3.2;HDLM-2: 2.1;NTERA-2: 9.5;SuSa: 2.5;U-2 OS: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073174 Approved NA NA "HPA073174: " "unprognostic (2.21e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-2)" "unprognostic (3.14e-2)" "unprognostic (5.30e-3)" "unprognostic (1.92e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-2)" "unprognostic (2.37e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (6.05e-5)" "unprognostic (5.56e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-2)" "unprognostic (7.95e-2)" 0.2 1.3 4.3 0.2 1.1 0.1 0.1 0.9 3.4 0.2 0.4 2.1 0.0 1.2 0.1 0.2 0.1 0.3 0.2 12.5 0.6 2.0 0.4 0.1 0.3 0.1 1.8 0.9 0.1 0.2 0.1 2.1 0.1 3.9 0.6 0.3 0.2 0.1 1.0 0.1 0.2 0.4 0.2 0.7 0.1 0.6 9.6 1.9 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 1.5 0.0 0.6 0.2 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.1 0.9 3.4 0.6 2.0 1.8 0.9 3.9 1.9 0.0 0.0 0.0 0.0 0.0 0.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 28.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 1.2 0.0 0.1 0.6 1.3 0.0 0.0 0.0 0.0 0.0 HCRT "OX, PPOX" ENSG00000161610 "Hypocretin neuropeptide precursor" O43612 17 42184060-42185452 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 84.3" "Cell type enhanced" "Detected in some" 12 "Collecting duct cells: 1.8;Intestinal endocrine cells: 2.9;Kupffer cells: 1.8" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;Karpas-707: 1.0;RPMI-8226: 3.7" "Region enriched" "Detected in some" 5 "hypothalamus: 110.5" "Region enriched" "Detected in some" 57 "hypothalamus: 152.0" "HPA064801, CAB079778" Enhanced Supported "Secreted to blood" NA NA "CAB079778: , HPA064801: " "unprognostic (3.34e-2)" "unprognostic (7.76e-5)" "unprognostic (3.21e-2)" "unprognostic (3.01e-2)" "unprognostic (2.20e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 0.9 0.0 0.0 1.1 0.2 0.9 0.0 0.0 0.7 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.3 0.4 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 2.7 0.4 2.3 0.5 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 1.0 0.0 0.0 0.8 0.8 0.4 0.9 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.7 0.8 0.2 0.0 0.1 0.0 2.3 0.5 0.0 1.2 0.4 2.2 1.5 0.9 1.6 0.4 2.7 1.4 1.3 0.1 0.4 0.2 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.9 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.7 0.1 HCRTR1 OX1R ENSG00000121764 "Hypocretin receptor 1" O43613 1 31617686-31632518 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.0" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 1.1;Late spermatids: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.7;HUVEC TERT2: 3.0;TIME: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014018 Approved NA NA "HPA014018: AB_1854810" "unprognostic (2.96e-2)" "unprognostic (2.34e-2)" "unprognostic (7.86e-3)" "unprognostic (3.72e-3)" "unprognostic (2.42e-1)" "unprognostic (3.45e-3)" "unprognostic (2.54e-5)" "unprognostic (3.58e-2)" "unprognostic (4.17e-2)" "unprognostic (1.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.93e-1)" "unprognostic (3.77e-3)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" 3.3 4.3 0.9 0.3 1.4 1.6 2.7 0.7 4.5 0.1 0.3 0.0 0.0 0.2 0.6 0.3 0.7 0.5 0.8 1.8 0.8 4.6 0.5 0.1 0.2 0.6 1.1 0.0 0.5 0.3 0.0 1.7 2.3 8.0 0.5 0.2 0.7 0.5 0.0 2.4 1.1 0.5 0.0 0.5 0.6 0.4 0.4 0.0 0.0 2.9 0.8 0.2 0.6 0.1 1.1 0.2 0.0 0.2 0.2 0.5 0.1 0.4 0.0 0.4 0.1 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.6 0.6 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.7 0.0 0.0 1.0 0.4 0.0 0.0 0.5 0.0 0.5 3.0 0.5 0.4 0.2 0.0 0.5 0.1 0.1 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.7 0.1 0.4 0.3 0.2 0.0 0.8 0.2 0.0 1.7 0.1 0.2 0.3 0.4 0.5 0.1 0.2 0.0 0.6 1.0 0.0 0.2 0.0 0.5 0.2 0.0 0.1 0.2 0.0 0.1 1.1 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.9 1.4 0.7 4.5 0.8 4.6 1.1 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 HCRTR2 OX2R ENSG00000137252 "Hypocretin receptor 2" O43614 6 55106460-55282620 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.4" "Cell type enhanced" "Detected in some" 24 "Distal tubular cells: 1.7;Peritubular cells: 3.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "pons and medulla: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "AF22: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054516 Enhanced NA NA "HPA054516: AB_2682513" "unprognostic (4.86e-1)" "unprognostic (2.69e-2)" "unprognostic (1.86e-2)" "unprognostic (2.32e-1)" "unprognostic (7.45e-2)" "unprognostic (7.39e-2)" 0.1 0.2 1.7 0.0 1.3 0.0 0.1 0.6 2.2 0.1 0.1 0.3 0.0 0.0 0.1 0.5 0.0 0.1 0.1 1.1 0.9 4.2 3.7 0.1 0.4 0.1 2.6 1.7 1.7 0.0 0.0 0.3 2.2 17.4 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.1 0.5 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 1.3 0.6 2.2 0.9 4.2 2.6 1.7 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 HCST "DAP10, DKFZP586C1522, KAP10, PIK3AP" ENSG00000126264 "Hematopoietic cell signal transducer" Q9UBK5 19 35902480-35904377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1" "Group enriched" "Detected in many" 5 "granulocytes: 237.5;Hofbauer cells: 491.9;Kupffer cells: 329.9;Macrophages: 424.4;T-cells: 835.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 52.9;HL-60: 30.5;HMC-1: 35.3;THP-1: 40.0;U-937: 60.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB034435, HPA063026" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Vesicles "CAB034435: AB_2117803, HPA063026: " "unprognostic (1.40e-3)" "unprognostic (3.07e-2)" "unprognostic (3.04e-2)" "unprognostic (7.27e-3)" "unprognostic (1.23e-1)" "unprognostic (8.23e-3)" "unprognostic (1.85e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.97e-2)" "unprognostic (1.94e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.59e-10)" "unprognostic (3.78e-1)" "unprognostic (3.25e-2)" "unprognostic (1.65e-1)" "unprognostic (1.56e-1)" 29.4 4.0 6.5 19.9 5.2 84.0 5.9 1.4 3.1 3.9 4.9 4.8 0.5 4.5 5.4 6.0 3.0 4.5 6.3 7.3 5.7 5.9 5.6 6.9 38.4 79.1 7.7 2.2 3.4 2.9 0.7 4.3 10.6 4.9 5.5 3.6 7.1 6.2 3.7 2.4 2.8 10.9 4.5 12.7 49.5 5.6 1.7 4.4 56.8 3.4 3.3 26.7 5.2 3.6 6.1 66.6 15.9 57.0 96.4 134.0 89.5 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.2 0.2 5.7 0.3 0.4 0.1 0.2 0.0 0.0 0.0 0.1 0.0 52.9 0.1 0.1 0.1 30.5 35.3 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.4 7.6 0.1 0.0 3.5 11.9 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 40.0 0.1 0.3 0.4 0.0 0.0 0.3 0.2 8.7 0.3 60.0 0.0 7.3 57.0 7.9 134.0 42.0 99.3 6.1 57.4 108.5 32.6 3.7 48.3 96.4 15.9 96.4 23.0 66.6 48.5 89.5 6.5 5.2 1.4 3.1 5.7 5.9 7.7 2.2 4.9 4.4 6.0 65.6 87.2 1.1 25.3 0.2 0.8 5.1 8.1 11.4 8.7 0.0 3.2 0.0 2.1 0.3 9.0 1.4 0.0 1.0 3.2 13.1 0.6 237.5 11.3 491.9 1.6 0.0 19.6 329.9 1.8 2.0 424.4 42.2 31.5 0.7 0.2 1.1 0.9 0.0 4.4 1.9 19.4 1.9 1.7 2.8 18.3 5.0 835.8 1.7 0.8 HDAC4 "BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288" ENSG00000068024 "Histone deacetylase 4" P56524 2 239048168-239401654 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Autism spectrum disorder, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 73.9;Late spermatids: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 10.5;classical monocyte: 7.4;neutrophil: 28.3" "Group enriched" "Detected in many" 8 "granulocytes: 28.3;monocytes: 7.4" "Cell line enhanced" "Detected in many" "JURKAT: 30.4;MOLT-4: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048723, HPA071448" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Nuclear speckles" "Nucleoplasm, Cytosol" "HPA048723: AB_2680501, HPA071448: " "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.33e-1)" "unprognostic (1.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.39e-3)" "unprognostic (3.06e-4)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.33e-4)" "prognostic favorable (1.13e-4)" "unprognostic (1.40e-1)" "unprognostic (4.82e-3)" "unprognostic (2.40e-1)" "unprognostic (3.26e-2)" "unprognostic (1.32e-2)" "unprognostic (6.04e-2)" 7.9 6.8 6.1 6.8 5.2 17.1 4.6 6.4 12.3 11.3 21.4 4.6 4.3 2.5 10.2 6.4 8.8 9.0 24.6 5.2 5.0 6.0 3.2 3.1 4.2 4.3 6.1 5.4 8.5 5.8 4.9 8.3 2.5 5.2 7.5 4.8 8.3 3.7 7.3 54.6 6.9 6.5 15.8 4.2 5.4 7.0 8.1 4.3 6.5 4.8 13.2 5.6 10.2 4.6 0.5 1.7 28.3 7.4 2.1 1.2 0.4 3.8 3.8 4.9 5.9 2.8 4.7 5.8 4.0 2.7 3.2 3.1 1.7 7.0 1.8 1.6 3.4 4.6 3.8 3.4 1.6 1.6 10.6 1.8 2.8 4.7 5.6 3.7 4.3 2.6 3.2 4.1 5.9 4.7 1.6 3.4 30.4 4.0 4.1 1.5 4.7 28.1 5.9 3.8 4.8 2.0 7.3 9.2 2.8 3.7 4.9 3.9 6.9 5.6 2.5 9.8 2.9 1.3 11.9 5.4 3.7 0.3 6.4 5.4 2.9 2.7 3.5 5.4 6.0 7.4 10.5 7.4 1.1 0.9 2.4 1.1 0.5 0.9 0.8 0.8 0.5 0.5 1.0 28.3 2.1 1.0 1.7 1.2 0.4 6.1 5.2 6.4 7.5 5.0 6.0 6.1 5.4 5.2 4.3 3.0 9.0 3.7 2.2 7.0 11.5 10.1 7.6 0.0 3.4 10.4 2.0 1.2 0.0 2.4 73.9 5.8 4.5 0.0 1.8 1.5 8.0 5.0 2.3 5.8 2.9 15.9 5.8 13.5 22.7 47.3 10.9 5.5 5.0 0.0 5.5 10.1 1.7 0.0 11.7 1.2 7.1 0.0 5.6 2.2 2.1 8.4 1.1 8.7 5.7 2.2 HDAC7 "DKFZP586J0917, HDAC7A" ENSG00000061273 "Histone deacetylase 7" Q8WUI4 12 47782722-47833132 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 85.8" "Cell type enhanced" "Detected in many" 4 "Ito cells: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 10.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004775 Supported Cytosol NA NA Cytosol "HPA004775: AB_1850548" "unprognostic (3.83e-1)" "unprognostic (9.49e-3)" "unprognostic (1.37e-2)" "unprognostic (4.46e-2)" "unprognostic (6.56e-3)" "unprognostic (2.22e-2)" "unprognostic (2.50e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.28e-1)" "unprognostic (2.07e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (6.24e-2)" "unprognostic (4.38e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.65e-4)" 26.0 21.6 8.2 22.7 10.8 17.3 24.4 8.4 10.7 28.2 20.7 8.7 15.4 8.0 27.9 21.5 19.2 25.2 22.1 16.5 10.3 4.3 17.7 5.1 27.6 21.1 8.2 8.0 25.4 8.9 23.7 11.5 17.5 10.0 20.1 4.1 17.6 16.3 18.9 12.5 19.7 13.9 24.9 10.3 23.1 14.9 9.5 11.5 85.8 20.9 12.9 21.0 24.8 25.0 1.4 0.6 10.5 1.9 1.7 1.5 1.8 14.2 9.7 10.1 16.5 7.9 22.1 9.1 14.0 10.9 10.2 6.7 12.9 13.5 28.6 46.8 12.7 5.0 13.2 2.3 10.9 3.7 13.4 4.8 9.8 9.5 3.0 8.6 3.0 0.4 14.4 3.8 10.1 5.5 18.4 21.0 16.4 10.3 11.7 6.4 6.2 28.1 7.5 14.1 3.1 10.8 21.7 5.4 10.3 4.3 9.3 2.9 6.9 10.7 5.0 5.1 6.8 4.7 4.1 23.8 20.9 22.7 17.0 9.9 26.5 19.2 22.7 8.6 14.5 6.8 0.0 1.9 0.0 1.5 0.8 1.5 1.4 1.3 1.1 0.6 1.1 1.5 1.0 10.5 1.7 0.7 0.5 0.6 1.8 8.2 10.8 8.4 10.7 10.3 4.3 8.2 8.0 10.0 11.5 38.7 36.7 31.8 21.0 12.2 18.0 11.5 30.6 5.3 22.7 34.9 0.0 3.9 1.7 29.4 13.4 71.6 1.1 0.0 19.7 2.5 28.8 40.0 8.1 0.4 13.7 27.0 7.0 87.8 29.5 4.9 50.9 11.5 13.5 12.6 9.7 13.6 47.3 9.7 31.1 2.9 3.2 25.8 20.6 0.9 3.1 18.9 2.4 26.6 7.6 38.2 HDC ENSG00000140287 "Histidine decarboxylase" P19113 15 50241947-50266026 "Enzymes, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 83.5;brain: 36.0;epididymis: 36.9" "Cell type enriched" "Detected in some" 7 "granulocytes: 556.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 52 "hypothalamus: 36.0" "Cell type enriched" "Detected in single" 835 "basophil: 83.5" "Lineage enriched" "Detected in single" 835 "granulocytes: 83.5" "Group enriched" "Detected in some" 4 "HEL: 61.2;HMC-1: 147.3" "Region enriched" "Detected in many" 5 "hypothalamus: 51.5" "Low region specificity" "Detected in all" HPA038891 Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA038891: AB_10673231" "unprognostic (4.97e-2)" "unprognostic (7.42e-2)" "unprognostic (1.43e-4)" "unprognostic (1.08e-1)" "unprognostic (6.16e-2)" "unprognostic (3.93e-7)" "unprognostic (4.18e-5)" "unprognostic (8.79e-3)" "unprognostic (1.48e-1)" "unprognostic (8.46e-2)" "unprognostic (4.60e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-1)" "unprognostic (7.20e-2)" "unprognostic (9.78e-2)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" 1.7 0.2 0.2 5.1 0.4 2.4 1.1 0.2 0.3 2.7 1.9 0.2 1.2 2.1 3.1 36.9 2.7 0.6 6.6 2.1 0.2 36.0 0.6 0.8 4.9 2.3 0.6 0.1 0.4 0.5 0.3 0.7 0.2 0.3 2.2 1.9 3.0 0.9 1.3 1.8 1.8 2.4 5.4 0.2 0.4 6.9 2.4 0.2 0.4 0.3 0.4 1.7 1.8 2.7 0.0 0.0 83.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 61.2 0.0 0.0 0.0 0.1 147.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.3 0.2 36.0 0.6 0.1 0.3 0.2 11.9 81.4 0.0 0.0 0.7 0.5 0.3 0.0 8.1 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 556.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 HDGFL1 "dJ309H15.1, Hdgfrp1, HRP-1, PWWP1" ENSG00000112273 "HDGF like 1" Q5TGJ6 6 22569493-22571666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 296 "testis: 97.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 75.8;Late spermatids: 90.5;Spermatocytes: 112.6" "Cancer enriched" "Detected in some" 41 "testis cancer: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 5.0" "HPA045679, HPA063707" Enhanced NA NA "HPA045679: AB_2679415, HPA063707: AB_2685099" "unprognostic (1.55e-1)" "unprognostic (6.18e-2)" "unprognostic (4.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 112.6 23.3 0.0 0.0 0.0 0.0 0.0 HDGFL2 "Hdgfrp2, HRP2" ENSG00000167674 "HDGF like 2" Q7Z4V5 19 4472287-4502211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042559, HPA044208" Enhanced Supported Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "HPA042559: AB_2678049, HPA044208: AB_2678858" "unprognostic (1.33e-1)" "unprognostic (2.38e-2)" "unprognostic (5.47e-3)" "unprognostic (6.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.96e-2)" "unprognostic (1.52e-2)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (1.97e-1)" "prognostic favorable (6.57e-4)" "unprognostic (2.12e-2)" "unprognostic (1.36e-1)" "unprognostic (9.73e-3)" "unprognostic (4.75e-1)" "unprognostic (1.58e-1)" "unprognostic (2.05e-1)" 10.3 9.6 15.4 10.0 13.6 8.1 10.3 15.3 21.0 9.7 8.8 9.0 8.0 10.1 12.3 10.4 6.6 10.2 9.9 8.5 16.6 13.5 9.8 9.9 7.3 10.2 11.9 13.2 15.9 10.6 8.3 10.2 9.6 10.5 10.1 5.0 7.8 11.3 16.8 39.4 10.9 9.2 12.0 8.8 10.3 9.2 49.1 9.5 13.6 7.3 6.2 7.4 7.7 9.0 7.0 2.2 3.6 1.8 2.3 2.4 0.8 27.7 16.4 28.5 26.4 12.4 12.7 19.9 22.4 12.1 24.7 22.0 18.7 12.1 24.5 13.1 16.4 13.0 15.9 18.9 20.4 14.5 27.3 30.0 15.0 12.3 24.6 16.1 14.8 21.5 18.1 11.1 16.9 8.3 17.6 22.5 23.2 17.2 30.9 11.9 19.7 33.4 29.7 32.6 11.2 29.5 33.3 23.5 15.7 15.3 14.2 31.5 31.1 21.8 12.5 18.1 16.3 12.3 23.6 29.7 15.6 21.4 29.3 21.1 38.4 20.0 17.2 21.9 23.9 16.4 0.0 1.8 3.6 1.4 1.1 0.4 1.1 1.5 1.1 1.6 7.0 2.4 0.9 0.5 2.3 0.6 2.2 1.8 0.8 15.4 13.6 15.3 21.0 16.6 13.5 11.9 13.2 10.5 9.5 6.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 17.4 9.1 12.2 0.0 31.1 16.6 22.5 0.0 0.0 0.0 0.0 17.5 24.9 0.0 0.0 1.1 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 26.2 0.0 0.0 19.1 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 HDHD3 "C9orf158, MGC12904" ENSG00000119431 "Haloacid dehalogenase like hydrolase domain containing 3" Q9BSH5 9 113373419-113376999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 54.7" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 204.4;Paneth cells: 171.9;Proximal tubular cells: 218.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020427, HPA024158, HPA024585" Enhanced Enhanced Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565" "unprognostic (1.30e-1)" "prognostic favorable (2.72e-4)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (8.24e-3)" "unprognostic (1.57e-2)" "unprognostic (6.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (5.87e-2)" "prognostic favorable (3.54e-7)" "unprognostic (2.16e-2)" "unprognostic (1.84e-1)" "unprognostic (4.68e-1)" "unprognostic (1.19e-3)" 4.9 54.7 5.1 10.1 8.4 3.3 12.7 6.2 8.5 6.0 29.8 5.6 10.6 38.2 6.4 15.5 13.8 5.8 18.1 9.1 4.6 5.3 17.7 36.6 4.4 6.3 4.5 9.4 7.2 23.7 20.5 9.1 6.5 7.3 10.6 16.8 8.3 24.4 12.5 2.8 11.4 47.1 8.0 4.8 6.0 17.7 4.5 4.0 8.0 18.2 6.1 6.8 7.0 6.9 12.1 10.6 5.9 2.9 5.6 12.3 5.8 3.4 9.7 2.1 5.8 5.2 2.3 17.7 2.5 4.8 4.1 4.5 17.8 17.0 7.5 3.2 1.4 8.2 13.3 3.3 3.9 1.4 10.4 7.6 10.3 5.3 11.0 6.1 0.6 8.0 3.6 8.3 3.3 9.5 4.8 2.1 7.0 8.1 1.9 1.9 22.1 4.7 3.0 4.7 34.0 7.6 3.9 0.0 6.0 5.2 7.1 5.3 3.4 4.3 18.8 6.3 4.8 11.8 2.1 2.1 0.8 0.0 0.7 0.8 4.6 9.0 3.1 1.0 0.0 0.6 0.1 2.9 5.9 9.9 1.6 11.2 11.3 11.5 9.0 4.5 12.1 12.0 8.9 1.9 5.6 0.2 10.6 12.3 5.8 5.1 8.4 6.2 8.5 4.6 5.3 4.5 9.4 7.3 4.0 8.9 8.5 18.1 18.5 8.9 9.4 12.0 73.9 22.7 11.4 22.7 9.8 23.7 72.9 66.3 0.1 8.9 204.4 23.3 138.2 16.2 7.5 24.3 7.0 74.9 17.6 1.6 38.8 8.6 5.1 0.9 13.3 6.7 10.1 19.8 61.9 10.8 96.2 171.9 8.5 218.3 12.1 6.5 7.5 0.2 6.1 12.8 26.4 17.3 72.5 40.4 HDLBP "HBP, VGL" ENSG00000115677 "High density lipoprotein binding protein" Q00341 2 241227264-241317061 "Plasma proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 210.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004189, CAB026457" Enhanced Supported Cytosol NA NA Cytosol "CAB026457: , HPA004189: AB_1079044" "unprognostic (2.57e-2)" "unprognostic (1.13e-2)" "unprognostic (2.13e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (1.70e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-2)" "unprognostic (4.39e-3)" "unprognostic (3.92e-2)" "unprognostic (9.48e-3)" "unprognostic (2.47e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.39e-5)" "prognostic unfavorable (4.12e-4)" 38.2 38.7 18.1 18.1 27.7 15.9 37.4 18.1 27.0 39.6 30.4 24.7 38.2 22.5 34.8 43.2 35.3 38.7 30.9 37.5 17.9 15.9 33.9 92.0 29.9 20.9 19.8 16.6 40.1 210.4 40.5 40.0 44.4 22.5 35.9 29.4 26.1 105.2 34.3 80.2 27.6 36.1 29.9 18.5 23.0 39.2 39.6 19.3 20.8 39.0 45.7 34.7 31.9 31.0 10.9 22.4 11.6 28.8 10.1 12.3 12.4 34.4 27.7 29.0 46.2 74.2 91.1 41.3 86.0 88.3 39.1 56.0 24.8 35.3 10.5 10.4 124.4 39.5 27.6 43.2 56.3 64.2 16.7 26.7 33.5 35.0 60.5 72.7 23.9 29.2 67.3 45.8 56.8 64.0 61.5 53.3 16.9 31.8 14.1 61.0 35.9 13.7 12.5 28.1 33.9 18.4 12.8 56.4 20.9 31.9 41.1 24.2 27.7 37.5 39.5 33.5 37.7 31.2 23.4 66.9 47.9 30.5 66.1 36.0 16.7 13.7 18.6 60.7 17.8 43.8 11.6 20.0 9.1 9.3 21.9 12.3 10.9 10.6 11.1 22.4 7.4 9.6 8.9 11.5 10.1 28.8 14.7 9.8 12.4 18.1 27.7 18.1 27.0 17.9 15.9 19.8 16.6 22.5 19.3 71.5 78.3 34.3 93.1 62.4 40.0 194.7 68.8 192.7 135.4 71.5 41.2 101.3 114.4 97.3 89.3 67.6 127.8 23.3 105.3 136.3 141.1 173.9 65.9 177.0 82.5 65.2 92.7 87.8 59.9 303.9 137.8 58.4 54.0 82.0 181.5 47.2 115.6 122.0 164.4 96.7 35.3 64.7 111.0 124.2 118.4 67.9 180.2 35.2 119.7 133.4 HDX "CXorf43, FLJ30678" ENSG00000165259 "Highly divergent homeobox" Q7Z353 X 84317874-84502479 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 19.1;Urothelial cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047189 Uncertain Approved Cytosol NA NA Cytosol "HPA047189: AB_10965463" "unprognostic (7.26e-2)" "unprognostic (3.53e-2)" "unprognostic (1.64e-2)" "unprognostic (1.51e-5)" "unprognostic (3.23e-4)" "unprognostic (5.52e-2)" "unprognostic (1.44e-1)" "unprognostic (6.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (6.40e-6)" "unprognostic (1.14e-1)" "unprognostic (7.20e-2)" "unprognostic (3.86e-3)" "unprognostic (2.34e-1)" "unprognostic (1.30e-2)" "unprognostic (3.66e-2)" 5.1 7.4 8.3 3.3 7.9 0.6 6.4 23.1 10.2 8.2 4.6 2.6 3.5 1.8 7.4 5.3 4.2 6.3 5.5 4.8 5.5 4.6 4.3 4.5 4.4 2.3 6.5 7.0 8.0 2.2 5.5 16.4 1.4 6.6 6.0 4.5 2.0 4.5 6.2 1.7 1.9 2.9 6.6 5.7 4.2 3.2 4.0 7.1 0.4 5.7 2.7 2.7 5.2 8.3 2.7 6.1 0.0 6.9 1.4 1.4 1.1 0.0 2.2 9.0 0.0 5.4 4.7 0.0 2.9 3.9 6.9 7.8 0.4 1.2 0.0 0.6 3.0 8.8 0.5 0.1 1.1 5.4 0.0 0.6 0.0 1.7 0.0 5.0 0.0 0.0 3.2 0.1 4.4 2.9 3.9 6.9 0.0 0.0 0.0 6.8 0.1 0.0 0.0 6.6 0.0 3.0 0.0 7.6 0.1 3.2 1.5 0.3 5.1 0.0 0.2 0.0 3.8 0.4 0.0 7.3 3.8 2.6 1.2 2.7 0.2 0.0 0.0 1.8 0.0 1.6 0.0 4.3 0.0 1.4 6.9 0.2 2.7 0.4 0.3 6.1 1.0 1.2 0.7 0.0 1.4 5.9 0.6 0.2 1.1 8.3 7.9 23.1 10.2 5.5 4.6 6.5 7.0 6.6 7.1 0.0 2.4 1.3 19.1 2.3 8.5 1.6 2.5 1.4 4.5 5.2 11.8 0.0 0.0 5.2 3.8 7.1 0.7 0.0 1.6 0.0 5.1 11.0 1.1 0.2 0.9 6.4 6.8 1.8 1.6 1.0 3.7 2.6 0.0 3.6 1.3 3.3 2.8 2.0 3.2 1.7 5.0 0.0 3.3 0.5 0.0 1.5 0.1 1.3 0.9 18.0 HEATR4 MGC48595 ENSG00000187105 "HEAT repeat containing 4" Q86WZ0 14 73478484-73558947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 14.0" "Cell type enriched" "Detected in some" 6 "Early spermatids: 54.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 5.8;SCLC-21H: 5.8" "Not detected" "Not detected" "HPA003642, HPA079348" Enhanced NA NA "HPA003642: AB_1079376, HPA079348: " "unprognostic (5.25e-2)" "unprognostic (2.45e-3)" "unprognostic (2.85e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-2)" "unprognostic (2.60e-2)" "unprognostic (3.50e-1)" "unprognostic (8.09e-2)" "unprognostic (3.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (5.50e-2)" "unprognostic (1.96e-1)" "unprognostic (4.82e-3)" 0.3 0.3 0.7 0.7 1.1 0.8 0.4 3.4 1.1 0.7 0.3 2.0 1.0 0.1 0.5 0.7 0.7 0.7 0.9 0.8 0.3 0.9 0.4 1.6 0.5 1.0 0.8 0.5 0.5 0.1 0.5 0.0 0.8 0.0 2.0 4.4 0.7 0.0 0.8 0.9 0.7 14.0 1.0 0.0 0.2 0.7 3.0 1.0 1.7 0.7 1.4 2.3 0.4 1.6 1.8 0.9 1.3 0.1 0.0 0.7 0.8 0.0 0.1 0.3 0.5 0.4 1.8 0.1 0.0 0.3 3.6 0.0 0.0 0.2 0.5 0.4 1.3 0.3 0.1 0.3 1.2 2.4 0.0 0.0 0.2 0.0 1.3 0.0 1.9 0.6 0.7 0.0 5.8 0.5 2.1 0.8 0.4 1.8 1.0 0.9 0.8 0.0 2.5 5.8 0.7 2.0 2.6 2.9 1.3 3.0 0.2 1.1 0.2 2.2 1.8 0.2 1.5 0.5 0.4 1.2 0.5 0.2 1.0 0.7 0.3 1.8 0.5 1.0 2.1 2.2 1.2 0.3 3.0 2.3 2.3 1.7 1.4 0.1 1.0 1.1 0.4 0.0 1.0 0.0 0.3 0.2 0.8 0.8 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 54.9 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 8.7 0.6 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 1.5 0.6 0.1 0.0 0.0 0.1 HEATR9 "C17orf66, FLJ32830" ENSG00000270379 "HEAT repeat containing 9" A2RTY3 17 35854946-35868891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 30.7" "Group enriched" "Detected in some" 73 "Early spermatids: 68.2;Late spermatids: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;U-937: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023129 Uncertain NA NA "HPA023129: AB_1845599" "unprognostic (1.02e-1)" "unprognostic (2.63e-3)" "unprognostic (5.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.05e-2)" "unprognostic (7.44e-4)" "unprognostic (1.30e-3)" "unprognostic (2.43e-2)" "unprognostic (2.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.61e-10)" "unprognostic (6.78e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (5.61e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 30.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.9 0.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.4 0.9 0.1 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.7 0.0 0.0 HECTD4 "C12orf51, FLJ34154, KIAA0614" ENSG00000173064 "HECT domain E3 ubiquitin protein ligase 4" 12 112160188-112382439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 133.5;Horizontal cells: 76.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041062, HPA045473" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA041062: AB_2677281, HPA045473: AB_2679338" "unprognostic (9.27e-2)" "unprognostic (2.35e-1)" "unprognostic (6.50e-2)" "unprognostic (1.33e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (3.52e-2)" "unprognostic (2.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.95e-2)" "unprognostic (1.06e-1)" "unprognostic (2.89e-2)" "unprognostic (2.81e-2)" "unprognostic (1.89e-1)" "unprognostic (1.58e-2)" "unprognostic (4.51e-3)" 6.8 7.1 11.3 6.3 16.3 26.6 7.7 43.3 22.7 8.9 9.0 14.0 10.8 5.4 11.1 10.0 10.0 9.0 6.5 6.6 10.1 10.3 7.4 6.3 7.3 8.1 11.4 13.7 10.9 10.1 13.8 14.0 8.0 17.2 12.3 7.4 9.4 8.7 9.6 12.9 16.6 7.0 8.8 13.0 7.4 8.8 14.6 12.7 8.3 12.8 5.0 7.7 8.3 9.0 2.9 2.4 2.8 1.2 1.0 1.8 0.7 5.6 10.7 8.6 7.6 11.7 7.9 4.9 4.2 4.0 5.4 4.6 10.4 1.9 6.0 3.8 6.8 5.7 5.8 11.2 5.5 4.1 7.7 10.1 8.4 11.3 5.8 4.2 6.0 8.3 6.6 6.7 8.3 5.5 10.1 8.2 11.2 10.5 4.7 5.1 6.3 7.1 12.7 4.1 7.8 8.0 9.6 4.4 3.9 4.3 9.0 14.0 9.6 9.7 9.5 3.7 8.4 7.1 8.5 11.9 6.3 4.6 6.6 5.6 15.9 6.0 6.7 5.1 3.9 4.0 2.8 1.2 0.6 1.8 0.5 1.2 1.1 0.6 0.9 0.8 2.9 1.0 0.9 1.4 1.0 1.1 2.4 0.1 0.7 11.3 16.3 43.3 22.7 10.1 10.3 11.4 13.7 17.2 12.7 17.9 17.3 9.3 7.3 10.2 47.4 18.5 12.7 10.7 5.7 12.2 133.5 8.5 0.0 7.5 5.6 10.9 9.7 0.0 7.5 3.9 9.1 13.7 8.1 13.9 5.7 76.3 26.5 16.0 7.6 4.5 10.6 7.0 6.8 7.2 12.4 17.8 8.4 8.6 14.9 4.4 55.4 0.0 8.3 19.1 8.0 13.0 7.4 7.9 11.9 6.5 HECW1 "KIAA0322, NEDL1" ENSG00000002746 "HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1" Q76N89 7 43112599-43566001 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;kidney: 15.4" "Group enriched" "Detected in some" 4 "Early spermatids: 118.3;Horizontal cells: 42.9;Late spermatids: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.5;GAMG: 4.9;U-266/70: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007203, HPA007593, HPA007609" Approved Supported Cytosol NA NA Cytosol "HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518" "unprognostic (1.40e-1)" "unprognostic (2.85e-3)" "unprognostic (2.57e-1)" "unprognostic (4.39e-1)" "unprognostic (2.43e-2)" "unprognostic (2.80e-2)" "unprognostic (8.65e-4)" "unprognostic (6.93e-2)" "unprognostic (7.30e-2)" "unprognostic (7.31e-2)" "unprognostic (3.43e-2)" "unprognostic (2.67e-2)" "unprognostic (1.43e-3)" "unprognostic (1.64e-2)" "unprognostic (5.23e-3)" "unprognostic (1.89e-2)" "unprognostic (2.42e-2)" 0.7 0.5 10.3 0.8 12.1 1.4 0.8 13.6 24.0 0.6 0.8 1.1 0.0 0.4 0.8 1.7 2.6 0.5 4.0 0.4 3.9 4.1 15.4 0.6 0.6 1.3 3.8 15.5 1.0 0.4 1.7 0.4 0.6 10.2 3.2 0.5 0.6 1.0 0.8 1.8 2.1 0.6 0.7 1.4 0.6 1.0 3.7 1.6 0.0 1.5 0.0 0.8 1.2 0.6 2.4 1.6 7.0 1.7 1.6 0.7 0.1 0.1 5.5 0.6 0.8 0.0 0.0 0.0 1.6 2.8 0.1 0.7 0.0 0.0 0.2 3.1 2.7 4.9 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.4 0.2 0.2 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.0 0.0 0.0 0.0 0.0 2.4 0.1 0.9 0.5 0.0 0.0 0.0 0.1 0.2 0.7 0.5 0.1 0.0 0.3 0.4 0.0 0.0 0.8 1.1 1.3 0.4 15.7 0.5 0.0 3.5 0.4 0.0 6.4 1.7 1.1 0.7 1.0 0.5 1.0 0.7 0.3 0.2 2.4 0.6 0.7 7.0 1.6 0.9 1.6 0.2 0.1 10.3 12.1 13.6 24.0 3.9 4.1 3.8 15.5 10.2 1.6 0.0 0.0 0.0 0.3 0.3 13.6 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 118.3 0.3 2.0 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 42.9 0.0 0.6 0.0 44.2 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.6 0.4 15.9 1.8 0.0 0.8 2.1 2.5 0.3 0.0 0.5 0.4 0.3 HELLS "LSH, Nbla10143, PASG, SMARCA6" ENSG00000119969 "Helicase, lymphoid specific" Q9NRZ9 10 94501434-94613905 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Developmental protein, Helicase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.4" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 69.2;Spermatogonia: 174.0" "Cancer enhanced" "Detected in all" "testis cancer: 16.1" "Region enhanced" "Detected in many" "cerebellum: 11.9" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004491, HPA063242" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" No Yes Nucleoplasm "Golgi apparatus, Vesicles" "CAB004491: AB_627895, HPA063242: AB_2684968" "unprognostic (1.94e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.85e-2)" "unprognostic (3.38e-2)" "unprognostic (8.65e-2)" "unprognostic (4.85e-3)" "unprognostic (1.76e-5)" "unprognostic (7.59e-3)" "unprognostic (7.03e-3)" "unprognostic (6.49e-2)" "unprognostic (2.05e-2)" "unprognostic (9.45e-5)" "unprognostic (9.93e-13)" "unprognostic (2.25e-2)" "unprognostic (1.72e-1)" "unprognostic (6.24e-2)" "unprognostic (3.03e-2)" 1.4 2.0 1.2 28.8 1.5 14.8 3.0 11.9 3.2 4.2 5.0 0.7 3.3 3.5 5.8 6.0 8.6 2.5 3.6 2.1 1.3 2.0 3.9 2.0 2.5 11.9 1.4 1.7 4.3 1.9 2.7 4.7 9.0 1.3 3.4 5.5 3.3 2.8 2.0 0.6 5.2 5.3 2.1 1.7 8.3 3.6 18.7 0.7 46.4 1.7 8.1 15.1 3.6 4.4 13.6 22.0 0.7 0.8 5.6 10.9 1.5 19.9 19.7 25.5 32.3 1.0 2.4 13.8 15.3 9.9 12.8 20.2 26.0 16.2 24.7 6.1 5.1 10.8 20.2 14.6 12.2 18.3 23.9 16.8 13.1 20.0 20.8 0.6 24.7 11.9 1.3 0.7 15.3 7.3 3.5 8.8 16.7 7.1 15.8 15.1 20.1 26.0 12.3 26.4 14.6 8.8 24.3 22.7 5.7 8.7 25.8 10.2 8.3 18.1 5.2 2.7 22.2 22.1 8.0 6.2 14.0 7.1 12.8 18.3 8.2 15.6 26.4 7.0 15.3 6.4 0.1 0.5 0.0 4.4 0.8 1.5 10.9 7.2 6.2 1.3 13.6 3.5 5.0 0.7 5.6 0.6 22.0 10.9 1.5 1.2 1.5 11.9 3.2 1.3 2.0 1.4 1.7 1.3 0.7 8.9 3.8 23.8 8.2 19.2 13.6 0.8 7.6 8.1 17.0 21.0 0.0 25.8 3.3 5.8 0.8 4.9 2.1 23.3 5.5 31.3 11.0 3.1 5.7 2.6 12.8 6.4 10.4 8.0 1.3 3.6 8.3 6.2 1.7 9.0 6.5 5.0 3.9 0.0 5.3 1.4 9.4 19.4 6.2 69.2 174.0 8.7 9.3 12.5 23.7 4.4 HELT "bHLHb44, HCM1228, HESL, MEGANE, Mgn" ENSG00000187821 "Helt bHLH transcription factor" A6NFD8 4 185018841-185020804 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 2.9;lung: 2.2;skin 1: 2.0" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 5.2;HEK 293: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036188, HPA036189" Uncertain NA NA "HPA036188: AB_10672237, HPA036189: AB_2674997" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 71.1;placenta: 20.2;testis: 32.5" "Group enriched" "Detected in some" 149 "Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.2" "Group enriched" "Detected in many" 27 "granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2" "Cell line enriched" "Detected in some" 4 "K-562: 77.0" "Region enriched" "Detected in all" 5 "cerebellum: 55.9" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.3 0.2 0.2 0.4 0.2 71.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.3 1.0 0.2 0.2 0.3 0.9 5.4 0.5 0.2 0.0 0.6 0.2 0.0 0.3 20.2 1.1 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.3 2.8 0.2 32.5 0.0 17.1 0.3 0.2 0.5 1.4 4.8 0.0 0.1 2.1 0.1 2.9 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 77.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.1 0.8 0.0 2.3 1.1 0.1 0.0 8.2 3.3 1.0 2.9 0.0 0.0 1.2 4.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1388.7 0.0 0.0 724.2 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.3 1114.5 5.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 7.2 3.3 0.0 0.5 0.0 0.0 0.0 HENMT1 "C1orf59, FLJ30525, HEN1" ENSG00000162639 "HEN methyltransferase 1" Q5T8I9 1 108648290-108661526 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;testis: 45.2" "Group enriched" "Detected in many" 4 "Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 15 "cerebellum: 18.1" "HPA028464, HPA028497" Uncertain Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA028464: AB_10600103, HPA028497: AB_10601552" "unprognostic (1.82e-1)" "prognostic favorable (2.56e-4)" "prognostic favorable (9.95e-4)" "unprognostic (2.92e-3)" "unprognostic (1.91e-1)" "unprognostic (3.88e-3)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.95e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.53e-1)" "unprognostic (2.43e-1)" "unprognostic (2.18e-1)" "unprognostic (1.65e-1)" 3.5 2.2 6.7 5.1 10.2 7.7 5.5 3.6 11.6 6.1 4.4 4.2 1.4 3.4 2.8 3.4 1.9 1.8 4.5 3.1 9.5 10.1 1.8 1.4 4.9 9.8 8.2 5.6 3.8 1.5 0.6 3.9 3.8 10.7 2.7 6.6 1.3 2.4 2.6 2.0 2.6 5.2 2.5 6.9 8.0 3.2 45.2 2.5 10.3 1.7 1.2 7.3 5.5 1.6 5.4 10.6 18.2 12.0 22.9 28.8 15.9 5.8 3.0 0.2 0.0 0.2 0.2 0.0 1.4 0.5 3.5 0.5 8.8 9.3 0.0 3.2 2.6 0.0 0.0 0.0 0.0 2.2 1.9 0.0 15.0 11.3 0.0 3.0 8.8 13.4 2.9 0.1 0.7 0.0 0.0 0.7 25.7 0.0 6.7 0.1 14.9 23.6 26.4 8.7 4.7 1.3 10.3 0.0 0.5 0.0 6.4 14.7 0.0 12.6 3.5 0.0 0.9 0.0 19.8 0.1 0.0 11.7 6.4 0.0 4.1 5.1 0.0 0.0 34.8 0.1 16.0 8.8 18.2 28.8 10.1 26.0 5.4 14.2 26.0 10.6 2.9 11.8 21.7 8.6 22.9 12.0 8.5 13.1 15.9 6.7 10.2 3.6 11.6 9.5 10.1 8.2 5.6 10.7 2.5 0.0 0.6 0.0 1.4 1.4 3.8 1.5 17.8 1.4 1.2 5.2 0.0 10.4 3.3 2.8 8.7 2.6 3.9 0.0 1.2 16.4 3.1 0.6 6.9 0.4 14.0 0.0 4.7 6.7 11.7 17.0 4.6 8.5 1.7 7.2 2.5 2.0 1.9 6.8 2.8 0.7 2.6 6.5 2.8 118.4 74.4 1.4 4.3 38.3 5.6 2.5 HEPACAM "FLJ25530, GLIALCAM, hepaCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919193-124936412 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 17.3;brain: 64.7;liver: 19.6" "Group enriched" "Detected in some" 7 "Hepatocytes: 9.3;Muller glia cells: 13.0" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 31 "Hep G2: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles NA NA Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 17.3 1.8 25.6 1.7 25.7 1.5 2.6 8.5 64.7 1.6 1.8 55.4 0.0 1.6 1.6 1.7 1.6 1.6 1.6 1.7 31.0 10.8 1.6 19.6 1.6 1.7 30.3 22.4 1.5 1.6 1.5 0.6 1.5 27.9 1.6 1.8 0.0 1.7 2.1 1.6 1.6 1.6 1.6 21.5 1.5 1.6 1.7 35.5 0.0 1.6 0.0 2.3 1.5 0.3 1.5 1.2 3.0 1.4 2.0 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 1.1 1.2 1.1 1.2 1.5 1.5 1.4 1.0 1.2 1.3 1.7 1.5 1.3 2.0 1.4 1.0 1.1 1.5 25.6 25.7 8.5 29.7 31.0 10.8 30.3 22.4 27.9 35.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 HEPACAM2 FLJ38683 ENSG00000188175 "HEPACAM family member 2" A8MVW5 7 93188586-93226524 "Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 43.4;kidney: 24.5;pituitary gland: 16.1" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 209.3;Mucus-secreting cells: 364.1;Paneth cells: 298.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 37 "SCLC-21H: 63.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012381 Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes NA 89000 "Vesicles, Mitotic spindle" Nucleoplasm "HPA012381: AB_1853037" "unprognostic (2.01e-3)" "unprognostic (6.05e-2)" "prognostic favorable (9.73e-5)" "unprognostic (1.33e-2)" "unprognostic (7.27e-2)" "unprognostic (2.24e-2)" "unprognostic (4.48e-2)" "unprognostic (8.40e-3)" "unprognostic (7.61e-2)" "unprognostic (8.68e-2)" "unprognostic (5.37e-3)" "unprognostic (4.93e-2)" "unprognostic (3.64e-3)" "unprognostic (2.06e-1)" "unprognostic (4.73e-2)" "unprognostic (3.82e-1)" "unprognostic (6.34e-2)" 0.1 0.2 0.2 8.5 0.2 0.6 3.4 0.1 0.1 0.1 29.4 0.1 5.3 11.8 0.1 0.4 0.2 0.1 0.8 0.3 0.2 0.2 24.5 0.2 0.4 0.1 0.2 0.1 0.1 5.5 0.0 16.1 0.4 0.2 0.7 38.9 0.1 4.1 1.2 0.1 0.1 43.4 0.4 0.2 0.2 4.0 1.4 0.1 0.3 0.1 0.1 2.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 8.3 0.0 2.1 0.0 6.7 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 209.3 0.0 0.0 1.9 0.0 0.0 6.8 0.0 364.1 0.0 0.0 298.7 0.0 0.0 0.0 0.0 0.0 4.5 0.7 0.1 0.1 0.0 12.4 0.0 HEPH "CPL, KIAA0698" ENSG00000089472 Hephaestin Q9BQS7 X 66162549-66268867 "Predicted intracellular proteins, Predicted membrane proteins" "Copper transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 68.7" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 139.7;Mucus-secreting cells: 80.7;Paneth cells: 106.6;Undifferentiated cells: 56.0" "Cancer enhanced" "Detected in all" "colorectal cancer: 37.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;HEL: 11.0;HSkMC: 16.6;K-562: 30.8;LHCN-M2: 12.7;SuSa: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA005824 Approved NA NA 1200000 "HPA005824: AB_1850603" "unprognostic (3.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.25e-2)" "unprognostic (4.25e-2)" "unprognostic (1.29e-3)" "unprognostic (2.25e-1)" "unprognostic (4.94e-2)" "unprognostic (6.17e-2)" "unprognostic (1.40e-2)" "unprognostic (3.35e-1)" "unprognostic (2.40e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (3.08e-2)" "unprognostic (4.46e-2)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" 4.0 12.2 8.3 10.9 9.3 0.0 3.9 3.7 10.1 11.6 38.4 9.7 8.9 32.9 18.3 9.0 7.5 8.7 21.4 14.8 8.1 5.0 3.7 1.4 7.1 1.3 9.2 10.2 10.2 1.0 0.9 2.5 0.9 8.5 11.0 33.5 11.4 3.0 14.5 0.5 2.8 68.7 34.8 6.7 4.4 8.6 3.2 8.8 0.0 3.2 2.7 1.1 11.2 6.4 0.0 0.2 0.0 0.0 0.0 0.6 0.5 0.0 0.0 12.9 1.0 0.0 0.0 0.3 3.2 0.1 0.0 0.0 7.6 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 11.0 0.0 0.0 0.1 0.0 0.0 16.6 0.0 0.0 0.0 4.5 0.0 0.0 30.8 0.3 12.7 0.0 0.0 0.2 6.3 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 32.6 0.0 0.0 0.3 7.4 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 8.3 9.3 3.7 10.1 8.1 5.0 9.2 10.2 8.5 8.8 0.0 0.0 0.5 0.0 0.8 0.7 23.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.5 2.3 139.7 0.0 1.0 0.0 6.2 0.3 0.0 0.0 0.2 0.0 39.2 6.2 0.0 1.1 10.6 0.0 0.0 0.0 80.7 24.9 3.0 106.6 28.0 0.0 0.8 6.5 12.5 0.0 0.2 0.5 0.0 0.0 56.0 0.1 HEPHL1 DKFZp686F22190 ENSG00000181333 "Hephaestin like 1" Q6MZM0 11 94021361-94113751 "Predicted membrane proteins" "Copper transport, Ion transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 68.0" "Cell type enriched" "Detected in some" 5 "Basal keratinocytes: 9.3" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 20.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.4;HaCaT: 4.2;HBEC3-KT: 7.5" "Region enriched" "Detected in single" 21 "olfactory region: 1.4" "Not detected" "Not detected" HPA031517 Uncertain NA NA 51000000 "HPA031517: AB_10603769" "unprognostic (9.16e-2)" "prognostic unfavorable (4.94e-4)" "unprognostic (2.40e-1)" "unprognostic (3.26e-6)" "unprognostic (3.17e-1)" "unprognostic (3.45e-1)" "unprognostic (1.72e-2)" "unprognostic (6.71e-2)" "unprognostic (5.34e-1)" "unprognostic (1.09e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (1.25e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 68.0 16.2 0.0 4.8 1.1 0.3 0.1 0.0 0.9 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.1 4.2 0.0 7.5 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.3 1.1 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 HEPN1 ENSG00000221932 "Hepatocellular carcinoma, down-regulated 1" Q6WQI6 11 124919244-124920677 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 43.3" "Cell type enriched" "Detected in some" 10 "Muller glia cells: 23.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 240 "Hep G2: 34.3" "HPA043768, HPA063054" Uncertain Approved "Golgi apparatus" Yes NA "Golgi apparatus" "HPA043768: AB_2678662, HPA063054: AB_2684932" 8.4 0.5 22.0 0.4 20.4 0.3 0.3 4.2 43.3 0.3 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.5 17.9 11.0 0.4 4.5 0.3 0.5 19.3 0.4 0.3 0.3 0.0 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.5 0.3 19.4 0.3 0.4 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.6 0.0 0.4 0.6 0.0 0.0 0.0 0.0 23.5 0.0 0.0 1.1 0.0 1.4 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 HERC5 CEB1 ENSG00000138646 "HECT and RLD domain containing E3 ubiquitin protein ligase 5" Q9UII4 4 88457117-88506163 "Predicted membrane proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.9" "Cell type enriched" "Detected in many" 9 "Spermatogonia: 510.0" "Cancer enhanced" "Detected in all" "testis cancer: 31.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 32.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.1;SK-MEL-30: 19.3" "Low region specificity" "Detected in all" HPA043929 Supported NA NA "HPA043929: AB_10962492" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (4.46e-5)" "unprognostic (3.00e-1)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (2.58e-1)" "unprognostic (9.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.35e-1)" "unprognostic (2.54e-2)" "unprognostic (2.56e-1)" "unprognostic (2.23e-2)" "unprognostic (3.18e-2)" "unprognostic (7.54e-2)" "unprognostic (1.61e-1)" 12.3 4.8 4.1 6.8 6.1 11.6 6.6 1.2 4.0 9.8 5.2 4.0 2.6 2.8 19.1 5.9 3.1 6.0 4.2 3.5 4.2 3.4 5.1 6.8 6.0 11.3 3.9 3.7 13.3 8.7 8.9 7.4 7.6 5.3 7.8 1.9 4.5 7.7 4.4 2.9 2.5 4.7 9.9 5.3 8.0 4.4 48.9 4.1 13.2 5.9 1.5 5.2 7.3 8.7 5.2 5.8 18.1 6.0 5.6 19.5 3.7 2.5 1.2 0.7 0.1 0.1 0.3 10.0 0.2 3.8 32.6 45.1 0.3 7.0 0.1 1.7 0.0 14.8 0.5 4.8 0.7 2.8 15.9 3.0 4.2 4.7 0.1 0.3 5.0 2.0 0.3 0.2 8.1 0.0 1.7 0.2 8.6 0.1 10.1 0.6 0.3 15.5 6.2 2.7 0.1 0.8 15.6 12.9 0.6 0.5 0.6 0.2 4.2 5.3 0.1 19.3 8.8 0.4 2.8 0.1 0.4 0.1 0.1 2.0 14.0 12.2 0.1 3.1 3.7 0.3 7.7 5.2 8.0 6.0 6.0 6.6 5.2 6.8 4.9 1.9 3.7 4.3 3.7 18.1 5.6 5.2 5.8 19.5 3.7 4.1 6.1 1.2 4.0 4.2 3.4 3.9 3.7 5.3 4.1 0.0 0.3 2.7 4.4 3.5 2.3 1.7 5.1 1.4 1.2 1.8 17.7 19.2 19.9 2.4 56.1 18.6 0.3 0.0 4.3 9.4 4.0 6.3 2.3 5.5 13.0 0.0 0.0 8.6 7.0 12.8 9.2 9.9 6.8 2.8 0.4 9.2 4.2 2.9 8.5 6.9 2.5 19.4 8.0 51.1 510.0 1.6 10.0 8.6 0.1 1.6 HES2 bHLHb40 ENSG00000069812 "Hes family bHLH transcription factor 2" Q9Y543 1 6412418-6424670 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;placenta: 60.9" "Cell type enhanced" "Detected in many" 11 "Mucus-secreting cells: 46.1;Paneth cells: 29.4;Syncytiotrophoblasts: 83.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 4.9;neutrophil: 3.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "BEWO: 10.9;HaCaT: 20.3;HBEC3-KT: 17.5;hTCEpi: 10.1;PC-3: 7.3;TIME: 29.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039462 Uncertain NA NA "HPA039462: AB_10673533" "unprognostic (1.96e-1)" "unprognostic (7.00e-2)" "unprognostic (1.66e-1)" "unprognostic (6.82e-3)" "unprognostic (1.13e-2)" "unprognostic (1.89e-1)" "unprognostic (2.56e-4)" "unprognostic (4.74e-2)" "unprognostic (7.41e-2)" "unprognostic (3.20e-2)" "unprognostic (5.63e-3)" "unprognostic (1.38e-1)" "unprognostic (7.67e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-2)" 0.8 0.0 0.2 0.7 0.2 0.2 0.7 0.2 0.3 6.7 6.0 0.2 0.2 0.1 0.4 0.4 22.6 2.5 0.2 0.2 0.2 0.0 1.0 0.4 3.8 0.2 0.2 0.2 0.5 0.2 0.2 0.4 60.9 0.3 1.2 4.6 0.5 2.9 0.6 0.2 14.5 0.9 0.2 0.2 0.2 0.0 1.8 0.2 0.7 0.2 8.6 6.0 0.3 11.9 0.6 0.6 4.9 0.4 0.5 0.6 0.2 0.9 0.3 0.0 0.1 0.2 0.0 10.9 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.9 0.1 0.1 20.3 0.5 17.5 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 10.1 0.0 0.4 0.0 5.3 0.0 0.1 0.2 0.0 1.5 0.0 0.8 0.0 1.1 7.3 0.0 0.0 0.1 0.1 0.3 0.1 0.0 1.0 5.7 0.2 1.1 0.8 0.3 29.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.4 0.6 0.5 0.3 0.3 0.4 0.5 0.4 0.1 0.6 0.4 0.6 3.9 0.5 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.2 8.9 4.6 0.8 5.2 5.8 1.5 8.1 0.0 16.0 7.9 1.8 3.9 1.5 0.0 0.3 11.3 1.8 8.9 0.0 0.0 3.6 1.9 8.3 1.1 0.0 0.9 0.0 2.9 1.8 0.3 25.8 0.3 1.3 1.7 0.0 46.1 1.2 0.3 29.4 0.7 3.3 5.4 0.0 1.0 5.6 5.7 17.1 83.1 0.0 11.0 21.1 HES3 bHLHb43 ENSG00000173673 "Hes family bHLH transcription factor 3" Q5TGS1 1 6244192-6245578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 6.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 28 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "NTERA-2: 16.1" "Region enriched" "Detected in single" 30 "cerebellum: 39.0" "Low region specificity" "Detected in many" "HPA047927, HPA072697" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047927: AB_2680213, HPA072697: " "unprognostic (7.42e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HES5 bHLHb38 ENSG00000197921 "Hes family bHLH transcription factor 5" Q5TA89 1 2528745-2530245 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 105.2" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065458, HPA076164" Enhanced Approved "Nucleoplasm,Nuclear speckles,Cytosol" No NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA065458: AB_2685492, HPA076164: AB_2732303" "unprognostic (2.04e-3)" "unprognostic (2.83e-2)" "unprognostic (4.26e-2)" "unprognostic (2.75e-3)" "unprognostic (5.26e-3)" "unprognostic (1.60e-4)" "unprognostic (1.76e-4)" "unprognostic (1.60e-1)" "unprognostic (5.30e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-1)" "unprognostic (4.67e-1)" "unprognostic (9.95e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (3.89e-2)" "unprognostic (1.72e-1)" 1.1 0.9 11.1 1.1 12.7 1.4 2.8 3.5 16.7 1.0 1.9 1.2 0.4 1.2 1.9 2.7 1.6 1.1 1.2 2.3 9.7 11.2 1.0 1.0 1.4 1.1 4.1 15.8 1.0 0.9 1.0 2.4 2.2 1.6 1.3 1.4 6.3 1.2 1.1 1.6 6.2 1.2 0.9 0.9 1.0 1.2 2.0 1.9 0.0 1.1 1.9 1.4 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 12.7 3.5 16.7 9.7 11.2 4.1 15.8 1.6 1.9 0.0 0.0 0.0 0.2 0.1 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 105.2 0.0 3.5 0.0 0.0 4.8 0.0 0.7 0.0 0.0 1.3 0.0 0.0 1.1 0.1 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 105.3;Mucus-secreting cells: 104.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 8.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "NB-4: 51.5;SCLC-21H: 34.1;SK-MEL-30: 49.2;THP-1: 22.8;U-937: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073997 Approved "Nuclear bodies,Cytosol" NA No "Nuclear bodies" Cytosol "HPA073997: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.79e-4)" "prognostic favorable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 2.1 5.2 15.4 3.4 10.6 10.5 3.0 7.3 47.4 3.7 12.2 17.1 0.8 18.1 6.3 1.5 1.6 14.3 5.7 1.7 17.5 9.1 1.9 2.5 2.2 3.3 11.4 12.3 1.3 13.9 5.3 23.6 1.7 14.3 2.0 9.6 1.5 3.8 1.7 8.2 1.7 12.9 3.3 18.8 4.6 5.2 9.4 11.7 0.4 5.5 1.7 2.8 1.3 1.0 0.3 1.4 8.0 0.3 0.1 1.0 0.2 1.2 1.5 6.5 7.4 0.4 0.2 4.2 0.4 0.5 0.6 1.0 1.2 0.8 0.0 1.0 0.1 2.7 0.8 6.6 0.5 0.2 2.8 7.9 1.5 1.0 13.4 1.1 10.7 9.0 0.6 4.0 0.9 1.3 0.3 0.4 6.9 13.5 0.1 0.4 3.2 1.6 51.5 10.4 1.2 1.1 7.3 16.5 3.1 0.8 0.6 34.1 14.9 2.0 2.9 49.2 0.8 2.6 22.8 0.6 0.6 1.3 3.6 3.8 3.0 0.5 2.2 2.3 26.2 1.1 0.1 0.3 8.0 1.0 0.2 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.3 1.4 0.7 0.2 15.4 10.6 7.3 39.3 17.5 9.1 11.4 12.3 14.3 11.7 0.0 1.4 8.0 4.1 3.0 8.1 2.8 0.0 9.4 3.4 3.5 21.6 1.0 6.6 9.9 10.9 3.7 18.1 46.7 27.8 3.1 3.8 5.1 0.0 3.8 4.8 3.2 105.3 3.7 1.6 5.6 1.4 5.5 33.7 11.8 104.6 6.1 11.9 16.9 1.4 3.7 4.7 0.0 14.6 24.6 32.4 1.8 0.2 6.2 33.2 1.8 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120590-8124092 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.3;salivary gland: 10.5" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 2.4;Melanocytes: 3.3;Smooth muscle cells: 4.2" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.7;Daudi: 7.2;HAP1: 9.2;HDLM-2: 7.3;HeLa: 13.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 0.8" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA072105: AB_2686488" "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.4 0.4 1.0 0.3 1.0 0.2 0.5 9.3 2.4 1.4 0.3 0.6 0.2 0.0 2.0 0.2 0.7 0.6 0.6 1.3 1.5 0.5 1.1 0.2 0.9 0.6 1.0 0.2 1.5 0.5 0.0 0.4 3.6 2.1 0.6 0.2 0.9 10.5 2.5 1.1 0.6 0.3 0.4 1.5 0.3 0.2 2.3 0.2 0.2 0.8 0.2 0.5 1.3 0.9 0.2 0.1 0.0 0.1 0.3 0.2 0.1 6.7 0.5 0.5 2.3 0.2 0.3 0.3 0.4 0.6 0.8 2.4 0.1 0.4 7.2 0.1 0.0 1.1 0.7 9.2 0.6 0.0 7.3 4.4 0.3 13.7 0.1 0.8 0.8 0.9 0.2 1.2 2.0 5.2 1.3 0.1 1.2 0.2 3.2 0.1 0.1 0.1 0.4 0.2 0.5 1.7 0.7 0.4 1.2 0.2 0.0 0.3 3.3 0.4 0.0 0.4 0.1 0.1 0.0 0.7 0.0 1.5 1.6 2.3 4.5 0.9 0.4 0.7 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.1 1.0 1.0 9.3 2.4 1.5 0.5 1.0 0.2 2.1 0.2 0.0 0.0 0.0 0.9 1.9 2.4 0.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1.2 1.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.3 1.0 0.0 0.5 0.0 0.0 0.4 0.0 0.8 0.0 4.2 0.0 0.6 1.4 0.2 0.0 0.0 0.1 HESX1 "ANF, RPX" ENSG00000163666 "HESX homeobox 1" Q9UBX0 3 57197843-57226521 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 14.7;lymphoid tissue: 15.2" "Cell type enhanced" "Detected in some" 11 "Spermatocytes: 10.7;Spermatogonia: 5.8" "Cancer enhanced" "Detected in many" "testis cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.0;plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 40.4;U-266/84: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024187 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA024187: AB_1850620" "unprognostic (6.47e-2)" "unprognostic (1.66e-3)" "unprognostic (5.50e-2)" "unprognostic (1.19e-3)" "unprognostic (5.04e-2)" "unprognostic (2.83e-2)" "unprognostic (3.96e-1)" "unprognostic (3.21e-2)" "unprognostic (1.93e-1)" "unprognostic (3.46e-3)" "unprognostic (9.48e-2)" "unprognostic (2.79e-3)" "unprognostic (1.39e-3)" "unprognostic (4.17e-2)" "unprognostic (3.15e-2)" "unprognostic (4.50e-3)" "unprognostic (1.14e-1)" 1.5 2.6 2.1 1.4 2.0 4.2 3.5 1.4 2.3 1.4 1.4 1.4 14.7 1.0 1.4 5.7 1.4 1.2 2.1 1.4 2.2 2.3 2.7 4.8 1.5 15.2 3.3 2.4 2.1 2.5 3.4 2.6 3.4 1.4 1.9 0.8 2.3 1.5 7.0 1.4 5.7 1.4 1.4 5.1 4.6 2.1 8.7 2.0 3.0 3.3 1.4 1.8 1.4 1.4 1.5 4.6 0.3 4.0 1.1 0.3 0.5 0.7 0.6 1.4 2.7 0.2 1.0 0.4 0.0 0.2 0.4 0.8 0.2 2.4 1.9 0.4 0.0 0.6 0.1 0.7 0.7 0.5 1.1 1.5 2.7 0.7 0.1 1.8 1.0 0.2 2.5 0.7 0.2 1.5 1.3 0.4 4.3 0.4 2.5 0.1 0.1 1.2 5.1 40.4 0.5 0.5 0.4 0.9 1.0 1.9 0.2 0.6 2.0 0.6 0.8 1.5 0.8 0.6 4.1 0.3 1.8 0.7 0.6 0.8 7.4 12.5 6.0 0.7 1.7 1.0 0.0 2.1 0.3 0.3 4.0 0.0 1.5 0.1 0.0 1.1 1.1 0.2 0.0 0.3 1.1 0.3 4.6 0.0 0.5 2.1 2.0 1.4 2.3 2.2 2.3 3.3 2.4 1.4 2.0 0.0 0.3 0.0 0.8 0.3 0.2 0.5 2.5 0.0 0.0 1.8 0.0 1.4 0.0 0.2 0.3 1.6 0.8 0.0 0.2 1.0 0.6 0.7 0.0 0.9 1.7 1.6 0.0 0.6 1.8 0.0 0.9 1.3 0.0 1.0 0.0 2.0 0.6 0.0 0.4 1.0 2.4 0.0 0.3 10.7 5.8 1.0 0.5 0.5 0.4 0.0 HEXB ENSG00000049860 "Hexosaminidase subunit beta" P07686 5 74640023-74722647 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 174.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 108.4;GAMG: 90.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055409, HPA056010" Enhanced "Intracellular and membrane" NA NA 43000000 "HPA055409: AB_2682808, HPA056010: AB_2683008" "unprognostic (3.45e-1)" "unprognostic (5.84e-2)" "unprognostic (1.85e-2)" "unprognostic (8.72e-2)" "unprognostic (1.12e-2)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (2.21e-1)" "unprognostic (5.01e-2)" "unprognostic (1.58e-3)" "unprognostic (6.45e-2)" "unprognostic (2.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (1.31e-2)" "unprognostic (9.67e-2)" "unprognostic (1.64e-2)" 48.0 21.9 7.7 13.6 11.6 11.1 26.1 7.4 11.2 25.8 34.2 9.5 18.0 21.6 22.1 77.3 20.6 17.3 28.1 46.3 7.1 9.1 30.4 44.5 40.9 19.3 8.5 6.7 22.7 30.4 21.8 14.3 174.3 9.3 22.6 26.3 21.0 34.6 13.3 21.0 15.3 33.6 21.0 8.7 20.5 20.7 16.2 6.1 10.8 33.7 15.2 15.4 24.0 19.7 8.9 59.8 23.8 65.9 7.6 16.4 42.9 20.3 16.0 5.6 18.5 108.4 33.5 18.2 25.0 81.1 24.4 53.0 18.8 26.6 0.0 19.8 20.5 90.2 16.4 6.0 25.4 32.3 11.4 10.8 2.6 15.5 14.1 31.8 2.2 22.0 29.5 15.0 25.6 17.2 38.5 27.9 6.4 7.5 33.3 26.7 20.6 2.6 5.1 5.2 19.3 7.2 6.2 8.1 26.5 16.8 18.6 3.6 4.5 19.4 13.2 24.1 10.1 13.9 15.1 16.6 16.1 4.0 29.6 23.0 15.4 26.5 0.1 36.7 20.0 29.2 14.5 65.9 18.6 14.2 24.5 16.4 8.9 11.7 13.1 59.8 5.5 11.2 10.9 23.8 7.6 14.6 18.0 13.7 42.9 7.7 11.6 7.4 11.2 7.1 9.1 8.5 6.7 9.3 6.1 38.7 35.5 39.5 70.4 39.0 9.5 18.9 63.7 20.1 18.2 27.9 7.9 395.6 16.6 123.0 1.1 60.6 71.9 0.0 111.0 143.1 100.1 65.8 69.2 62.8 319.1 9.5 21.9 83.4 134.6 1.7 78.9 151.2 69.2 83.8 50.0 34.8 68.2 51.8 67.8 65.5 10.6 45.3 54.5 0.2 1.1 28.4 412.8 37.3 76.2 54.8 HEXDC FLJ23825 ENSG00000169660 "Hexosaminidase D" Q8WVB3 17 82418318-82442645 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 30.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022834, HPA023379, HPA027844" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center, Mitochondria" "HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711" "unprognostic (8.69e-3)" "prognostic favorable (7.70e-4)" "unprognostic (7.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.51e-2)" "prognostic favorable (2.71e-4)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (2.71e-1)" "unprognostic (1.14e-2)" "prognostic favorable (5.57e-4)" "unprognostic (9.04e-3)" "unprognostic (1.83e-1)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.52e-5)" 12.7 8.5 7.1 16.6 9.3 14.3 8.7 13.2 7.3 10.1 7.6 8.8 12.8 8.0 10.0 11.1 7.9 10.3 9.4 5.7 7.2 4.6 9.9 11.6 12.4 11.6 12.8 5.5 13.6 72.9 10.2 14.6 5.7 7.4 14.1 4.2 7.0 13.3 9.2 20.4 11.3 12.3 6.0 6.1 15.6 8.8 4.7 11.4 8.6 11.7 8.6 10.7 8.3 8.8 5.9 30.3 3.3 11.5 11.9 9.8 4.4 3.0 7.7 3.4 5.3 10.4 9.0 10.5 3.9 4.8 4.1 4.7 2.7 10.4 8.1 4.3 1.6 2.8 4.3 2.0 2.3 1.9 5.6 13.1 3.6 6.8 4.5 9.3 2.4 9.3 6.4 2.3 1.1 4.2 5.6 5.3 6.2 4.6 2.8 1.1 7.0 8.4 9.0 3.1 5.6 4.7 10.0 2.9 15.8 3.1 4.6 4.8 10.2 8.1 5.3 7.3 1.6 8.5 9.2 5.3 2.7 5.1 2.0 2.7 12.7 2.4 6.0 2.1 6.9 2.7 3.3 1.7 2.7 9.8 11.5 6.5 4.6 2.2 3.4 2.0 5.9 3.5 5.1 3.0 11.9 4.9 30.3 1.4 4.4 7.1 9.3 13.2 7.3 7.2 4.6 12.8 5.5 7.4 11.4 3.0 8.5 8.3 9.5 4.1 19.2 4.4 12.7 9.4 12.5 17.4 17.7 4.7 8.3 5.4 1.2 8.0 16.8 0.0 8.2 5.3 6.2 10.5 10.3 12.9 13.7 39.7 13.3 16.0 9.5 2.1 33.1 11.5 5.0 16.2 14.4 18.7 5.8 10.1 23.3 6.1 29.0 19.4 6.2 6.0 10.2 2.0 3.3 12.9 12.0 7.5 HEXIM2 FLJ32384 ENSG00000168517 "Hexamethylene bisacetamide inducible 2" Q96MH2 17 45160700-45170040 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Group enriched" "Detected in many" 6 "Early spermatids: 121.3;Late spermatids: 208.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023323, HPA028455" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA023323: AB_1850651, HPA028455: AB_10602603" "unprognostic (9.03e-3)" "unprognostic (2.18e-2)" "unprognostic (4.01e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.36e-1)" "unprognostic (6.35e-3)" "unprognostic (9.70e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "prognostic favorable (9.85e-4)" "unprognostic (2.34e-3)" "unprognostic (1.93e-1)" "unprognostic (1.29e-2)" "unprognostic (2.32e-3)" "unprognostic (6.98e-2)" "unprognostic (2.04e-1)" "unprognostic (1.90e-2)" 4.0 7.7 8.3 4.2 8.0 3.6 3.4 9.0 11.8 4.3 4.8 5.0 6.5 8.8 4.3 5.6 4.2 5.1 7.9 6.3 6.7 6.2 9.3 9.6 4.1 5.6 7.8 6.7 5.7 9.3 7.5 6.1 3.0 6.6 5.1 2.5 6.9 9.9 5.5 36.4 5.6 6.4 4.3 5.4 5.2 6.9 27.7 6.4 6.4 9.1 6.6 3.0 4.7 4.7 9.7 13.2 10.0 12.2 7.3 8.6 13.3 5.0 18.2 4.0 8.9 4.5 7.4 7.7 2.8 3.4 4.6 5.1 6.9 13.5 3.1 14.8 2.0 2.3 8.4 3.9 3.4 1.4 7.2 6.3 2.3 17.0 30.9 3.2 2.0 5.2 6.4 3.3 4.0 1.4 8.9 2.2 6.5 2.5 7.8 2.1 8.7 3.2 4.3 4.4 7.1 8.0 4.3 6.1 9.5 5.8 5.0 4.8 4.2 2.5 5.1 11.7 3.0 13.6 3.4 2.2 8.3 4.4 5.5 6.6 12.2 12.9 2.9 6.5 3.7 6.2 8.4 12.2 10.0 5.4 9.7 8.6 9.7 3.8 6.1 10.3 6.5 3.0 5.3 8.3 7.3 3.0 13.2 4.6 13.3 8.3 8.0 9.0 11.8 6.7 6.2 7.8 6.7 6.6 6.4 0.0 1.0 4.7 3.5 1.8 12.7 0.2 5.1 0.0 1.2 1.8 3.9 10.7 16.6 3.9 121.3 4.0 4.0 0.0 1.4 4.5 3.4 1.8 6.9 6.2 6.3 3.2 4.6 2.5 7.0 208.9 5.5 2.8 3.3 4.6 4.3 8.0 2.1 3.5 6.7 26.1 10.6 0.0 3.4 18.2 12.0 2.6 5.1 1.3 4.1 1.6 HEY1 "bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1" ENSG00000164683 "Hes related family bHLH transcription factor with YRPW motif 1" Q9Y5J3 8 79764010-79767863 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.6" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 39.4;Extravillous trophoblasts: 39.7;Intestinal endocrine cells: 35.4;Melanocytes: 32.1" "Cancer enhanced" "Detected in all" "glioma: 43.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.9" "Cell line enhanced" "Detected in many" "HEK 293: 49.4;PC-3: 11.2;SK-MEL-30: 33.8;WM-115: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055599, HPA063472" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Nucleoplasm, Nuclear membrane, Cytosol" "HPA055599: AB_2682858, HPA063472: AB_2685018" "unprognostic (1.15e-1)" "unprognostic (5.06e-2)" "unprognostic (5.13e-3)" "unprognostic (2.12e-1)" "unprognostic (1.86e-3)" "unprognostic (8.47e-2)" "unprognostic (4.21e-3)" "unprognostic (9.56e-2)" "unprognostic (1.72e-1)" "unprognostic (7.22e-2)" "unprognostic (1.25e-2)" "unprognostic (6.71e-3)" "unprognostic (5.92e-3)" "unprognostic (5.77e-2)" "unprognostic (8.53e-2)" "unprognostic (1.74e-2)" "unprognostic (1.00e-1)" 13.3 3.8 13.7 3.6 22.9 1.8 8.8 11.2 60.6 8.9 4.4 10.7 0.0 3.3 3.8 2.4 4.6 3.9 5.7 13.4 11.3 11.6 3.8 2.9 16.4 3.3 11.9 9.3 2.6 4.3 3.0 9.9 20.3 12.5 4.5 3.9 10.3 4.5 3.0 10.3 3.5 3.2 4.4 9.1 2.8 3.6 3.9 10.5 1.3 5.0 3.7 3.7 5.2 2.5 0.0 0.0 9.9 1.7 0.0 0.3 0.1 0.6 0.0 0.4 3.5 0.3 0.3 9.0 0.8 0.8 0.1 0.1 0.1 0.0 1.6 0.9 0.3 0.4 2.2 1.8 0.1 0.2 0.1 49.4 0.0 1.6 0.9 0.5 0.0 0.4 0.5 1.4 0.0 6.2 0.3 1.6 0.0 3.2 1.4 0.5 0.1 0.0 0.2 0.2 0.1 11.2 0.0 1.9 1.4 0.1 1.5 2.0 5.7 0.0 1.0 33.8 8.4 0.0 0.0 1.1 0.2 0.9 0.0 0.6 1.2 0.2 0.0 1.2 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.9 0.0 1.7 0.0 0.0 0.1 13.7 22.9 11.2 12.3 11.3 11.6 11.9 9.3 12.5 10.5 0.0 2.6 0.0 2.2 2.9 5.3 3.2 0.0 8.1 3.4 0.0 0.0 5.4 13.3 2.1 3.3 39.4 0.9 0.0 1.0 39.7 2.7 1.6 10.4 0.5 1.6 20.6 35.4 13.5 0.6 1.6 0.0 2.1 32.1 0.0 1.9 6.0 0.5 5.8 0.4 0.3 11.5 0.0 6.1 0.7 4.1 2.6 19.6 0.0 2.3 1.8 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.5" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.9;Late spermatids: 59.0;Muller glia cells: 32.0;Sertoli cells: 51.8;Smooth muscle cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6;naive CD8 T-cell: 1.4" "Lineage enriched" "Detected in single" 20 "T-cells: 2.6" "Cell line enhanced" "Detected in some" "AN3-CA: 5.2;HEK 293: 6.7;SK-MEL-30: 6.1;TIME: 13.9;U-266/70: 16.9" "Region enriched" "Detected in all" 4 "olfactory region: 34.5" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" NA NA "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: AB_2686718" "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 6.0 1.8 7.4 1.8 9.2 0.7 5.5 5.7 11.8 10.4 2.9 13.1 0.7 2.2 11.3 24.0 2.8 19.3 7.6 28.5 8.2 6.2 3.6 7.8 3.7 1.2 8.2 11.4 10.7 4.1 7.1 5.4 5.4 12.8 2.3 2.4 10.4 3.0 4.5 19.1 2.1 2.2 2.9 11.3 2.9 2.0 6.5 7.2 0.0 3.6 4.9 1.4 3.5 4.9 0.0 0.0 0.0 0.1 0.0 2.6 0.4 0.0 0.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.4 6.7 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.5 0.0 0.4 0.0 0.0 3.0 0.0 0.3 0.5 0.6 0.8 0.0 0.1 2.2 0.0 0.0 0.0 6.1 3.2 1.8 0.0 13.9 0.3 0.0 0.1 0.7 16.9 0.3 0.1 0.6 0.0 1.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 1.4 0.0 0.0 0.1 0.0 0.0 0.4 7.4 9.2 5.7 5.9 8.2 6.2 8.2 11.4 12.8 7.2 3.0 0.6 0.5 0.3 3.4 0.4 17.9 0.0 6.7 1.2 0.0 7.9 0.0 8.3 0.0 37.9 3.7 0.0 23.3 1.6 0.1 3.0 0.3 0.0 7.3 0.1 1.6 0.0 1.3 0.3 59.0 6.1 0.6 3.3 0.0 0.0 32.0 1.8 0.0 21.9 4.2 5.0 51.8 35.0 10.8 7.0 1.8 0.0 0.5 0.0 0.4 HEYL "bHLHb33, HESR3, HEY3" ENSG00000163909 "Hes related family bHLH transcription factor with YRPW motif-like" Q9NQ87 1 39624153-39639945 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 66.3" "Cell type enhanced" "Detected in many" 13 "Leydig cells: 24.2;Peritubular cells: 53.4;Sertoli cells: 51.8;Smooth muscle cells: 35.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 6.5;LHCN-M2: 17.6;RH-30: 21.7;THP-1: 5.0;U-266/84: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001438, HPA076960" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA001438: AB_1079052, HPA076960: AB_2732326" "unprognostic (1.98e-2)" "unprognostic (7.92e-2)" "unprognostic (4.19e-3)" "unprognostic (3.49e-1)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (7.20e-2)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (2.35e-1)" "unprognostic (8.50e-2)" "prognostic unfavorable (2.26e-6)" "prognostic unfavorable (3.57e-4)" "unprognostic (2.67e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.63e-5)" 10.0 8.3 2.9 4.7 6.2 0.5 6.5 1.8 4.0 14.7 4.4 2.9 5.1 1.9 21.7 13.2 4.0 11.2 13.9 28.2 3.2 4.8 12.3 3.3 12.5 2.0 6.8 2.9 14.4 66.3 1.7 8.2 22.1 7.1 8.1 2.9 10.9 2.3 11.4 8.9 1.9 2.7 18.9 2.4 4.5 3.4 25.4 4.4 0.0 11.0 6.8 1.9 6.0 8.8 1.1 0.5 0.0 0.3 0.0 0.1 0.0 0.0 2.4 4.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 1.6 0.2 0.0 1.4 0.4 0.0 0.0 2.2 0.0 0.2 0.0 2.6 4.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.5 0.4 0.5 17.6 1.4 0.0 0.0 0.0 0.2 0.1 1.1 21.7 0.1 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.9 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.2 1.8 4.0 3.2 4.8 6.8 2.9 7.1 4.4 0.0 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 0.7 0.0 0.0 3.1 0.2 3.8 0.2 0.0 0.0 0.3 1.6 0.0 1.3 0.0 11.8 24.2 1.1 5.0 0.0 0.0 0.2 4.5 0.0 53.4 0.0 3.7 51.8 35.4 0.1 1.7 0.1 0.2 0.0 0.4 0.1 HFE2 "haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC" ENSG00000168509 "Hemochromatosis type 2 (juvenile)" Q6ZVN8 1 146017468-146036746 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 49.4;skeletal muscle: 128.9;tongue: 28.2" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 163.4" "Cancer enriched" "Detected in some" 96 "liver cancer: 87.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HSkMC: 5.0;K-562: 4.8;RH-30: 1.7" "Low region specificity" "Detected in many" NA NA 42000 "unprognostic (2.30e-1)" "unprognostic (6.98e-4)" "unprognostic (7.06e-2)" "unprognostic (1.11e-2)" "unprognostic (2.77e-3)" "unprognostic (2.55e-1)" "unprognostic (8.50e-2)" "unprognostic (2.36e-1)" "unprognostic (7.14e-2)" "unprognostic (1.18e-1)" "unprognostic (8.96e-8)" "unprognostic (6.61e-2)" "unprognostic (2.72e-1)" "unprognostic (1.76e-2)" 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.5 0.0 0.0 14.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 128.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 28.2 2.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 163.4 0.0 0.0 0.0 2.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HFM1 "FLJ36760, FLJ39011, MER3, SEC63D1" ENSG00000162669 "HFM1, ATP dependent DNA helicase homolog" A2PYH4 1 91260766-91404869 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Meiosis "Helicase, Hydrolase" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3;testis: 19.9" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 10.1;Spermatocytes: 40.0;Spermatogonia: 7.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.3;AN3-CA: 4.9;K-562: 5.0;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035036, HPA035557" Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA035036: AB_2797224, HPA035557: AB_10696507" "unprognostic (1.35e-2)" "unprognostic (9.39e-2)" "unprognostic (1.17e-1)" "unprognostic (2.83e-4)" "unprognostic (2.05e-2)" "unprognostic (1.52e-1)" "unprognostic (7.43e-3)" "unprognostic (1.79e-1)" "unprognostic (7.75e-2)" "unprognostic (7.97e-2)" "unprognostic (1.76e-4)" "unprognostic (2.81e-2)" "unprognostic (1.06e-2)" "unprognostic (2.89e-3)" "unprognostic (2.78e-2)" "unprognostic (1.77e-4)" "unprognostic (9.59e-2)" 0.8 0.7 2.6 0.3 4.1 0.4 0.8 11.3 4.4 1.7 0.9 1.5 2.7 0.6 3.7 2.5 0.4 1.2 0.6 1.0 2.3 0.9 1.3 0.4 0.5 1.6 0.7 1.4 6.4 1.2 0.1 7.8 0.9 3.9 1.1 0.7 2.7 1.0 2.0 2.3 0.4 0.5 1.7 4.7 0.7 0.6 19.9 1.5 0.0 2.7 0.5 0.4 0.7 2.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.3 4.9 0.0 0.2 0.1 0.5 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 1.9 1.0 0.0 0.1 0.2 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.6 0.2 2.4 0.0 0.0 0.3 1.4 0.1 0.0 0.0 3.1 3.8 0.0 0.0 1.3 2.6 0.0 0.8 0.1 0.0 1.0 0.9 0.1 4.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 4.1 11.3 4.4 2.3 0.9 0.7 1.4 3.9 1.5 0.0 0.6 0.0 0.0 0.0 3.7 2.6 0.0 0.0 0.0 0.0 5.9 0.4 0.0 0.2 10.1 0.3 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 3.7 0.0 0.0 0.0 0.0 3.1 0.1 0.0 2.1 0.0 6.4 0.0 0.3 40.0 7.8 0.0 0.0 0.0 0.0 0.0 HGD "AKU, HGO" ENSG00000113924 "Homogentisate 1,2-dioxygenase" Q93099 3 120628173-120682571 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 176.7" "Group enriched" "Detected in many" 4 "Hepatocytes: 460.4;Proximal tubular cells: 326.4" "Cancer enhanced" "Detected in many" "liver cancer: 119.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "EFO-21: 20.1;Hep G2: 38.7;OE19: 68.2;RPTEC TERT1: 50.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA047374, HPA052359" Enhanced Approved "Golgi apparatus" NA NA 210000 "Golgi apparatus" "HPA047374: AB_2680019, HPA052359: AB_2681798" "unprognostic (1.36e-1)" "unprognostic (9.89e-2)" "unprognostic (3.93e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.56e-1)" "unprognostic (2.05e-1)" "unprognostic (5.65e-3)" "unprognostic (7.20e-2)" "unprognostic (6.05e-2)" "unprognostic (2.41e-3)" "unprognostic (2.68e-2)" "unprognostic (1.16e-1)" "unprognostic (4.29e-3)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.43e-1)" 0.2 0.2 0.2 0.6 0.6 0.0 1.8 0.2 0.5 3.7 7.2 0.3 1.4 4.7 0.6 4.0 0.2 0.4 11.5 0.3 0.2 0.1 33.3 176.7 0.7 0.3 0.2 0.2 0.3 6.9 0.0 0.4 0.3 0.3 6.7 2.7 5.9 3.3 1.0 0.4 0.3 15.0 0.3 0.4 0.3 3.9 0.3 0.2 0.2 8.1 0.3 0.3 0.2 0.2 0.0 0.3 2.8 0.4 0.0 0.0 5.1 0.0 2.5 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.3 2.6 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 38.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 68.2 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 5.1 0.2 0.6 0.2 0.5 0.2 0.1 0.2 0.2 0.3 0.2 0.0 1.3 26.4 0.5 0.0 0.2 0.3 73.9 0.0 0.0 26.2 2.0 0.0 87.9 3.5 0.0 0.0 22.2 23.3 15.6 0.0 0.0 6.7 1.1 460.4 0.2 0.0 42.1 18.4 11.1 0.0 0.0 0.0 0.0 1.8 14.1 2.7 17.1 25.9 0.0 326.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 7.0 0.2 HGF "DFNB39, F-TCF, HGFB, HPTA, SF" ENSG00000019991 "Hepatocyte growth factor" P14210 7 81699008-81770438 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Serine protease homolog" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 116.9" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 19.8;Ito cells: 40.5;Muller glia cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "basophil: 33.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 33.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.8;HHSteC: 35.8;HL-60: 20.1;hTEC/SVTERT24-B: 22.5;Karpas-707: 62.0;U-87 MG: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010333, HPA040360, HPA044088" Approved "Secreted to blood" NA NA 4110000 "CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804" "unprognostic (5.24e-2)" "unprognostic (6.77e-2)" "unprognostic (1.72e-2)" "unprognostic (5.12e-2)" "unprognostic (1.85e-2)" "unprognostic (7.45e-5)" "unprognostic (1.66e-1)" "unprognostic (9.28e-3)" "unprognostic (3.28e-2)" "unprognostic (2.97e-2)" "unprognostic (2.74e-1)" "unprognostic (5.29e-2)" "prognostic unfavorable (5.59e-4)" "unprognostic (7.90e-3)" "unprognostic (2.92e-2)" "unprognostic (1.14e-2)" "unprognostic (2.06e-2)" 6.2 10.6 1.4 2.9 1.2 4.6 4.8 0.5 4.5 5.1 4.0 0.4 2.9 1.5 5.2 3.1 2.9 4.0 7.1 9.3 3.6 1.3 7.3 27.5 15.8 2.0 1.3 1.4 3.2 1.4 1.6 4.3 116.9 1.9 10.8 1.9 2.0 2.2 3.2 1.4 0.9 1.8 15.1 6.0 6.6 2.3 2.0 0.9 0.5 5.3 1.4 1.4 10.5 21.5 0.0 2.0 33.5 7.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.7 45.8 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 35.8 20.1 0.1 10.8 0.0 22.5 0.0 0.0 0.5 0.0 0.0 62.0 0.1 0.0 0.0 13.9 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 16.4 4.2 0.0 33.5 6.6 1.6 0.0 7.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 6.7 0.4 0.0 1.5 1.4 1.2 0.5 4.5 3.6 1.3 1.3 1.4 1.9 0.9 0.0 5.5 0.0 0.3 0.9 0.1 0.8 2.5 0.0 1.2 0.0 0.0 4.6 0.0 0.0 11.8 6.3 0.0 0.0 0.0 3.2 19.8 0.2 1.1 0.5 17.6 0.0 0.0 40.5 14.3 1.7 17.0 5.5 1.7 3.6 0.0 30.6 0.0 0.0 10.3 0.0 0.3 12.9 13.8 0.0 0.1 0.1 10.1 0.0 0.0 0.1 HGFAC "HGFA, HGFAP" ENSG00000109758 "HGF activator" Q04756 4 3441887-3449495 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 141 "liver: 128.0" "Group enriched" "Detected in some" 14 "Early spermatids: 70.8;Hepatocytes: 52.3;Late spermatids: 115.2" "Cancer enriched" "Detected in some" 22 "liver cancer: 26.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 10.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058279, HPA059076" Enhanced "Secreted to blood" NA NA 7590000 11000000000 "HPA058279: AB_2683665, HPA059076: AB_2683898" "unprognostic (2.70e-2)" "unprognostic (8.20e-2)" "unprognostic (1.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.39e-2)" "unprognostic (2.85e-3)" "unprognostic (5.37e-3)" "unprognostic (5.90e-2)" "unprognostic (1.81e-1)" "unprognostic (8.54e-3)" "unprognostic (5.52e-2)" "prognostic unfavorable (9.31e-4)" "unprognostic (2.87e-1)" "unprognostic (2.24e-1)" "unprognostic (9.49e-2)" "unprognostic (3.74e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.2 0.0 1.3 0.7 0.4 0.1 0.0 0.0 0.6 1.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.5 0.8 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.3 0.0 3.2 0.0 2.5 3.5 115.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 0.3 0.0 0.0 0.0 5.7 1.3 0.0 0.0 0.0 0.0 0.0 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702827 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 57.1;heart muscle: 184.7;skeletal muscle: 93.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 96.4;Cardiomyocytes: 54.3;Muller glia cells: 48.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.2;HSkMC: 1.3;Karpas-707: 1.2;NTERA-2: 1.4;RPMI-8226: 4.2;THP-1: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018174 Enhanced NA NA "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 1.5 1.6 12.9 1.3 29.0 1.3 1.9 2.3 15.2 1.5 1.4 36.5 0.0 1.3 1.7 1.5 2.7 2.0 1.5 184.7 14.5 8.9 1.4 1.3 1.5 1.4 51.6 10.5 1.4 1.8 1.4 0.9 1.4 25.9 1.9 1.4 5.4 4.7 1.4 93.6 1.6 1.4 1.4 57.1 1.4 1.3 1.7 39.9 0.0 9.3 7.2 1.4 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.5 0.0 4.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.3 0.5 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 29.0 2.3 15.2 14.5 8.9 51.6 10.5 25.9 39.9 0.0 0.0 0.0 0.0 0.3 96.4 54.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 48.8 0.3 0.0 0.0 0.0 9.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689951-92695646 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 71.4" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 94.3;Ductal cells: 86.4;Endothelial cells: 66.2;Hepatocytes: 48.7;Hofbauer cells: 58.0;Ito cells: 65.1;Kupffer cells: 61.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 56.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 46 "basophil: 7.9;classical monocyte: 14.7;eosinophil: 21.4;intermediate monocyte: 16.4;memory B-cell: 21.4;myeloid DC: 11.3;naive B-cell: 25.0;neutrophil: 11.8;non-classical monocyte: 17.8;plasmacytoid DC: 13.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 26.0;HEL: 28.2;HMC-1: 31.3;HUVEC TERT2: 30.9;K-562: 42.9;NB-4: 28.6;U-937: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051894, HPA055460" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051894: AB_2681653, HPA055460: AB_2682820" "prognostic favorable (8.83e-4)" "prognostic favorable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 6.3 8.2 2.8 12.0 3.6 28.1 13.7 0.9 2.2 4.5 3.2 3.0 1.1 2.3 3.6 3.8 2.9 2.7 18.0 7.3 2.8 2.1 2.8 33.1 15.3 29.7 3.6 0.9 1.9 15.6 0.7 1.5 6.4 2.8 4.3 2.4 2.3 1.9 1.6 2.8 2.2 8.4 9.3 2.9 18.3 2.7 1.9 2.8 1.8 71.4 2.0 11.3 6.5 7.1 25.0 13.5 21.4 17.8 0.3 0.3 4.9 3.1 5.9 3.1 0.0 0.2 0.2 0.0 1.6 13.5 2.2 1.9 1.1 0.7 3.0 26.0 0.2 0.0 0.6 2.7 0.0 2.7 0.0 3.2 28.2 2.4 19.0 6.3 16.4 31.3 0.0 0.0 1.9 0.0 1.1 30.9 0.0 42.9 0.0 0.1 0.9 0.1 28.6 0.0 8.6 3.4 9.6 0.9 0.0 0.2 1.2 1.4 0.3 1.8 0.0 0.0 0.1 0.9 8.7 10.7 0.0 0.1 0.0 0.0 0.7 0.5 6.0 0.0 22.7 14.9 7.9 14.7 21.4 0.3 16.4 0.1 21.4 0.0 0.0 11.3 25.0 0.0 0.0 11.8 0.3 17.8 13.5 0.1 4.9 2.8 3.6 0.9 2.2 2.8 2.1 3.6 0.9 2.8 2.8 0.0 4.8 30.4 1.6 5.7 0.0 2.0 94.3 1.4 2.3 0.0 0.0 0.5 0.0 86.4 0.2 66.2 0.0 0.0 10.0 0.8 2.1 2.9 6.9 48.7 58.0 0.0 5.1 65.1 61.3 0.4 0.3 22.7 6.8 1.8 0.3 0.0 14.5 0.0 1.1 0.0 0.0 0.0 1.9 0.2 1.4 3.1 0.9 5.2 0.2 0.6 HHIP "FLJ20992, HIP" ENSG00000164161 "Hedgehog interacting protein" Q96QV1 4 144646021-144745271 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.5;lung: 29.7" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 177.0;Leydig cells: 126.0;Peritubular cells: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.6" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 69.8;TIME: 80.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012616 Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA012616: AB_1850687" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (7.12e-3)" "unprognostic (8.18e-2)" "unprognostic (2.43e-2)" "unprognostic (1.02e-1)" "unprognostic (3.60e-1)" "unprognostic (1.95e-2)" "unprognostic (4.20e-1)" "unprognostic (1.90e-2)" "unprognostic (1.89e-1)" "unprognostic (9.66e-3)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" "unprognostic (5.18e-2)" "unprognostic (2.38e-1)" 4.0 5.2 9.9 1.7 22.2 2.3 1.1 2.3 16.0 3.4 6.5 31.5 0.0 5.5 4.1 8.1 1.0 1.2 3.0 1.1 16.0 6.3 2.4 12.7 29.7 1.0 21.6 9.9 2.2 4.8 1.0 1.1 1.0 17.5 9.8 6.8 4.4 1.3 6.2 1.3 1.1 8.2 1.3 12.3 1.0 11.2 3.7 26.5 2.3 1.6 0.0 1.0 7.1 1.0 0.1 2.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.7 3.8 69.8 6.2 0.0 0.0 1.0 0.0 9.8 0.0 0.9 0.0 0.6 0.1 14.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.5 0.0 0.8 0.0 0.5 0.4 0.0 2.1 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.0 9.9 22.2 2.3 16.0 16.0 6.3 21.6 9.9 17.5 26.5 11.9 177.0 0.0 0.0 0.0 1.4 1.1 0.0 8.1 6.8 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.4 0.0 16.1 0.0 0.1 0.0 0.0 16.0 0.0 1.8 126.0 1.0 1.7 0.0 0.0 0.2 0.1 0.0 41.4 0.0 3.5 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.0 HHIPL1 KIAA1822 ENSG00000182218 "HHIP like 1" Q96JK4 14 99645110-99680569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 14.1" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 11.2;Melanocytes: 3.3;Muller glia cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "EFO-21: 5.3;fHDF/TERT166: 9.1;SiHa: 6.1;THP-1: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA 59000 "unprognostic (6.16e-2)" "unprognostic (3.44e-2)" "unprognostic (3.43e-2)" "unprognostic (1.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (2.75e-2)" "unprognostic (4.70e-3)" "unprognostic (6.68e-2)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "unprognostic (1.35e-3)" "unprognostic (8.49e-6)" "unprognostic (2.52e-2)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (7.12e-6)" 3.8 1.6 9.8 4.0 12.7 1.1 2.1 5.1 14.1 3.2 2.7 2.5 2.9 2.2 4.8 2.6 3.3 2.7 6.2 3.6 7.3 4.9 1.3 1.6 2.0 4.5 4.8 6.8 2.4 1.2 1.1 1.6 2.5 5.4 4.4 1.7 4.4 2.4 3.8 2.5 1.9 2.2 6.3 3.2 3.3 2.1 1.7 2.7 0.0 1.1 1.6 2.4 2.5 1.8 0.1 0.0 1.2 0.1 0.0 0.1 0.0 0.1 0.4 0.7 0.2 0.2 0.0 2.9 2.6 0.7 0.6 0.2 0.2 0.8 0.3 5.3 9.1 0.1 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.3 0.0 2.9 0.0 0.1 1.6 0.3 2.1 0.3 0.3 2.5 0.1 0.1 0.2 1.6 0.4 0.1 0.4 2.1 0.0 0.1 0.8 0.0 0.3 0.1 0.2 0.3 1.1 6.1 0.1 0.0 1.1 0.1 6.4 1.6 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 9.8 12.7 5.1 10.8 7.3 4.9 4.8 6.8 5.4 2.7 0.0 0.0 0.0 0.0 0.0 11.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.0 1.5 0.0 0.0 1.3 1.6 0.0 0.3 0.0 3.3 0.0 0.0 12.4 0.0 0.6 1.8 0.0 1.4 0.0 0.8 0.3 0.2 0.0 0.1 0.0 0.0 0.1 HHIPL2 "FLJ13840, KIAA1822L" ENSG00000143512 "HHIP like 2" Q6UWX4 1 222522258-222548103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 9.4;testis: 10.4;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 14.1;Late spermatids: 21.2;Spermatocytes: 8.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 16.2;Hep G2: 4.9;RH-30: 18.4;SuSa: 7.1;U-87 MG: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA059673 Enhanced Uncertain Mitochondria,Cytosol "Secreted in other tissues" No NA Mitochondria Cytosol "HPA059673: AB_2684100" "unprognostic (1.35e-2)" "unprognostic (4.62e-3)" "unprognostic (2.91e-1)" "unprognostic (9.21e-2)" "unprognostic (3.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.74e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.07e-2)" "unprognostic (3.64e-1)" "unprognostic (2.29e-2)" "unprognostic (2.14e-2)" "unprognostic (0.00e+0)" "unprognostic (6.52e-2)" "unprognostic (4.21e-4)" "unprognostic (2.30e-3)" "unprognostic (8.38e-2)" 0.3 0.7 0.0 0.1 0.6 0.1 0.2 0.1 1.4 0.7 0.0 0.6 0.0 0.0 0.1 0.5 0.5 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.9 9.4 0.2 0.3 1.9 3.9 0.0 0.1 0.1 0.0 0.0 0.1 0.1 10.4 0.0 0.0 4.6 0.0 0.3 0.2 0.7 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 16.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.3 0.0 18.4 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.8 0.2 0.0 0.2 0.0 0.1 0.0 9.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.1 1.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.0 0.0 0.0 0.0 0.0 HHLA1 PLA2L ENSG00000132297 "HERV-H LTR-associating 1" C9JL84 8 132061486-132111159 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "placenta: 1.3" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 13.7;Ciliated cells: 2.7;Club cells: 4.5;granulocytes: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "NTERA-2: 4.8;SuSa: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.6 0.0 2.7 4.5 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HHLA2 "B7-H5, B7H7, B7y" ENSG00000114455 "HERV-H LTR-associating 2" Q9UM44 3 108296490-108378285 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 125.2" "Cell type enriched" "Detected in many" 5 "Enterocytes: 168.4" "Group enriched" "Detected in many" 12 "colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.1;Karpas-707: 5.9" "Low region specificity" "Detected in all" HPA055478 Enhanced NA NA "HPA055478: AB_2682830" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.11e-1)" "unprognostic (2.30e-1)" "unprognostic (1.59e-2)" "unprognostic (8.14e-5)" "unprognostic (1.76e-1)" "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-3)" "unprognostic (1.24e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-1)" "unprognostic (2.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.66e-2)" 0.2 0.2 0.3 4.3 0.3 0.0 0.2 0.2 0.3 0.3 39.6 0.2 0.2 25.5 0.2 0.5 0.2 0.9 8.5 0.2 0.3 0.3 7.8 0.4 2.2 0.2 0.3 0.2 0.6 1.2 0.0 0.3 0.2 0.2 0.2 25.2 0.2 0.2 0.2 0.2 0.1 125.2 0.3 0.5 0.3 2.5 1.9 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.3 5.1 1.2 1.5 0.3 0.5 0.7 0.4 0.6 0.4 0.5 0.0 0.0 1.6 0.1 0.0 0.0 0.5 3.5 0.5 0.3 0.4 0.1 0.2 0.4 1.2 0.0 0.0 8.1 0.3 0.2 2.7 0.5 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.7 5.9 0.0 0.5 0.8 3.0 1.2 0.4 0.6 0.7 0.3 1.7 0.1 0.4 1.5 1.4 1.4 0.1 0.4 1.1 0.3 0.4 0.3 0.3 1.5 0.5 0.4 3.1 1.4 0.8 0.1 1.0 0.2 1.2 0.3 1.1 0.1 0.4 0.1 0.3 0.2 0.5 5.1 0.3 0.2 0.1 0.5 0.3 1.5 0.1 0.0 0.7 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.1 20.4 24.1 2.3 0.0 0.0 0.0 0.0 5.2 2.6 0.0 168.4 0.0 32.0 0.1 0.0 0.1 2.3 0.0 0.1 0.0 1.7 0.0 0.0 3.1 0.3 0.2 0.0 1.8 9.4 0.0 36.5 9.5 0.0 19.5 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 13.6 0.0 HID1 "C17orf28, DMC1, HID-1" ENSG00000167861 "HID1 domain containing" Q8IV36 17 74950743-74973166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.3" "Cell type enhanced" "Detected in many" 8 "Mucus-secreting cells: 67.2;Paneth cells: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.8" "Group enriched" "Detected in many" 34 "B-cells: 1.5;dendritic cells: 5.8;T-cells: 2.8" "Cell line enhanced" "Detected in many" "MCF7: 34.4;OE19: 29.5;SH-SY5Y: 17.8;SK-BR-3: 52.7;T-47d: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031406 Approved Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA031406: AB_2673866" "unprognostic (7.41e-2)" "unprognostic (1.96e-1)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (4.47e-3)" "unprognostic (6.79e-3)" "unprognostic (4.00e-2)" "unprognostic (1.11e-1)" "unprognostic (2.78e-1)" "unprognostic (3.90e-1)" "unprognostic (1.54e-3)" "unprognostic (1.37e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.17e-1)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.34e-4)" 5.4 3.8 10.1 3.9 21.2 1.3 8.9 62.3 22.2 12.2 9.2 19.9 21.3 21.9 7.1 17.3 2.4 11.3 16.7 5.4 12.8 13.3 4.7 2.0 7.5 3.0 21.3 12.2 1.3 49.4 9.0 16.9 11.4 15.8 19.7 10.4 4.1 46.7 20.0 2.6 2.9 15.3 4.0 10.5 6.4 31.2 2.6 17.1 0.7 8.5 1.4 3.7 7.4 3.8 1.5 5.8 0.0 0.0 0.0 2.8 1.3 1.5 3.4 0.4 4.8 0.0 0.0 0.8 0.0 0.2 0.3 0.3 3.1 1.7 0.0 0.3 0.0 0.4 1.5 4.4 0.3 0.2 0.0 3.5 0.0 0.1 2.9 0.8 0.0 0.3 0.0 1.8 0.0 0.7 0.1 7.9 1.1 0.2 1.2 0.0 34.4 0.2 0.0 0.1 29.5 2.1 0.0 0.0 6.5 4.5 13.4 6.5 17.8 0.0 52.7 0.0 1.1 31.1 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 1.5 2.3 1.8 0.0 0.4 2.5 2.8 0.0 0.0 0.0 5.8 0.0 1.3 10.1 21.2 62.3 22.2 12.8 13.3 21.3 12.2 15.8 17.1 0.0 5.6 0.0 2.4 1.3 14.1 3.5 5.1 5.3 3.4 0.0 0.0 21.0 3.3 16.2 0.3 14.0 16.0 0.0 23.6 1.0 1.1 25.9 0.0 0.2 2.1 19.1 33.9 18.4 1.0 0.5 0.9 0.5 6.8 1.0 67.2 2.8 20.7 42.1 0.0 0.6 4.6 0.0 1.4 0.0 1.9 0.4 29.3 1.3 7.6 7.9 HIGD1B "CLST11240, CLST11240-15" ENSG00000131097 "HIG1 hypoxia inducible domain family member 1B" Q9P298 17 44846353-44850480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.8" "Group enriched" "Detected in some" 32 "Sertoli cells: 750.3;Smooth muscle cells: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079501 Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA079501: " "unprognostic (6.85e-2)" "unprognostic (9.41e-2)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (8.46e-2)" "unprognostic (2.37e-2)" "unprognostic (4.98e-3)" "unprognostic (3.61e-1)" "unprognostic (1.18e-2)" "unprognostic (3.98e-1)" "unprognostic (6.19e-2)" "unprognostic (3.56e-1)" "unprognostic (1.61e-3)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.52e-2)" 6.4 0.7 12.4 0.7 18.2 0.6 3.2 4.5 9.7 5.7 1.9 3.6 0.4 1.5 6.4 7.6 2.5 3.1 7.1 11.0 12.4 10.1 2.6 0.6 21.6 1.7 15.8 6.8 2.0 2.0 2.5 0.3 61.8 8.7 3.6 1.0 0.7 1.3 4.4 7.9 1.3 1.3 7.3 6.2 0.4 1.5 1.2 8.9 0.1 3.4 1.8 1.1 3.0 1.6 1.1 3.3 4.6 2.9 1.9 3.5 1.1 0.5 1.8 0.0 2.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 1.0 0.6 1.7 0.5 0.0 0.1 0.7 0.0 0.0 0.0 1.4 2.0 0.4 2.1 1.3 0.0 2.6 3.7 0.0 0.0 0.0 0.0 0.6 0.0 2.6 2.1 1.5 0.0 0.7 1.9 2.0 1.3 0.7 1.0 2.2 1.2 2.5 0.0 1.3 2.2 1.0 0.6 0.0 0.3 0.1 0.9 1.1 0.0 1.8 0.6 1.2 1.4 1.3 3.9 2.0 1.6 3.1 2.2 4.6 1.9 0.7 3.5 2.9 1.3 0.7 2.3 2.6 3.3 1.1 2.5 2.3 0.0 1.9 0.3 0.9 2.0 1.1 12.4 18.2 4.5 9.7 12.4 10.1 15.8 6.8 8.7 8.9 0.0 0.3 0.0 0.5 3.1 0.4 3.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.1 14.7 0.0 0.0 0.0 0.2 2.0 0.3 0.0 0.0 0.6 1.6 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.5 750.3 198.1 0.0 0.2 2.0 0.2 0.0 0.0 0.7 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675783-72686149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 11.6" "Group enriched" "Detected in some" 13 "Early spermatids: 11.0;Late spermatids: 7.1;Spermatocytes: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;ASC TERT1: 1.1;Karpas-707: 1.0" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: AB_2678127" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.6 0.2 0.0 0.7 0.0 1.3 0.7 1.1 0.0 0.0 0.4 0.0 0.6 0.6 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.2 0.0 0.6 0.0 1.0 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.9 0.9 0.7 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 15.1 0.9 0.1 0.1 0.0 0.0 0.1 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4;esophagus: 71.4" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 142.7;Syncytiotrophoblasts: 201.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 31.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" NA NA "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavorable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 24.5 5.2 25.3 5.5 34.2 14.1 16.2 8.6 53.9 15.7 14.4 6.4 2.8 4.7 9.1 6.3 71.4 7.9 7.2 16.7 25.1 8.5 10.4 10.3 13.2 4.9 22.4 3.1 22.9 5.0 3.0 4.2 25.7 46.5 7.0 6.2 2.8 7.7 6.1 5.2 14.4 4.4 6.9 66.4 3.0 6.4 10.1 21.1 1.7 5.6 6.9 6.0 60.5 18.6 9.2 5.9 31.7 3.6 6.9 3.3 2.0 11.2 23.8 13.0 14.2 17.8 6.6 24.4 4.1 5.2 8.7 9.7 5.9 10.3 7.7 3.3 6.2 8.9 7.2 7.3 8.8 11.1 4.2 6.7 4.7 5.0 5.3 4.0 7.4 6.5 10.9 7.6 6.8 4.6 8.9 7.1 12.2 6.8 3.2 8.6 13.9 22.2 13.5 16.1 8.3 10.5 16.8 6.1 11.9 4.8 16.8 12.5 11.5 6.4 45.2 8.0 12.2 36.8 7.2 5.2 11.2 5.5 8.4 5.1 3.1 2.3 9.8 21.1 11.5 9.6 9.2 3.5 31.7 2.3 3.6 3.3 7.8 2.9 2.8 3.4 9.2 3.0 2.9 1.4 6.9 2.7 5.9 1.9 2.0 25.3 34.2 8.6 53.9 25.1 8.5 22.4 3.1 46.5 21.1 8.9 5.6 5.8 11.4 57.1 6.2 3.1 5.1 33.5 47.8 1.8 17.7 95.4 0.0 16.4 0.3 26.9 2.9 0.0 7.6 142.7 49.5 20.7 17.4 3.2 23.2 25.4 12.6 7.4 4.3 1.7 28.1 20.8 35.4 20.8 7.7 14.1 55.4 5.5 23.0 8.4 22.5 6.5 49.5 5.9 16.3 45.5 201.6 5.1 15.3 8.0 HINT3 FLJ33126 ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956781-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 260.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavorable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favorable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 11.4 16.3 27.4 8.0 23.3 7.2 15.6 19.4 24.3 13.1 13.1 24.8 10.6 10.4 11.5 12.6 15.2 11.4 10.9 19.0 28.1 23.0 15.1 18.5 13.9 7.0 28.7 17.0 10.4 12.8 16.3 13.4 12.1 20.7 20.5 12.1 10.3 16.0 16.2 65.8 11.6 10.5 15.2 40.8 6.8 16.0 21.9 17.0 7.7 15.9 16.8 7.4 16.1 8.8 11.0 11.1 15.0 13.2 7.9 9.9 7.0 7.0 5.6 7.8 16.1 3.1 8.4 9.7 7.6 11.0 5.9 6.1 13.6 3.9 15.3 14.2 5.1 13.1 10.6 9.9 6.4 6.9 14.4 12.8 6.4 8.4 11.4 14.4 10.1 10.9 6.6 14.3 5.9 15.0 15.2 8.8 11.4 19.9 10.3 5.8 10.6 8.0 7.3 2.6 14.4 5.4 6.7 5.3 5.1 12.1 12.9 15.7 9.7 6.9 9.9 35.6 5.9 10.0 15.5 6.2 4.0 5.6 19.2 10.8 15.0 17.2 9.7 11.4 9.6 5.1 14.4 13.2 11.4 7.2 8.4 7.8 11.0 9.2 7.5 11.1 10.4 9.9 8.7 15.0 7.9 10.8 6.9 9.1 7.0 27.4 23.3 19.4 24.3 28.1 23.0 28.7 17.0 20.7 17.0 74.5 57.0 16.0 9.5 16.1 22.3 37.6 10.2 24.1 31.8 15.7 7.9 16.0 28.2 27.0 260.9 11.3 12.3 0.0 17.5 5.7 10.8 19.4 9.2 16.3 23.3 6.4 15.6 6.2 14.5 54.5 9.2 17.0 20.3 9.0 22.7 30.7 20.3 28.1 16.3 21.4 23.9 6.5 13.7 89.1 27.7 15.2 22.1 7.0 19.9 17.1 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929192-113977869 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 90.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 62.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 15.1 16.8 21.2 14.7 23.0 90.1 13.6 38.1 20.4 20.4 14.4 20.7 14.5 10.2 15.5 14.2 18.7 27.3 17.5 27.9 22.9 17.2 14.8 13.8 19.3 14.7 15.0 16.4 18.7 16.8 20.7 23.8 13.8 21.3 14.4 15.2 20.7 13.0 14.9 19.7 18.5 13.4 15.1 18.3 15.9 14.8 33.5 21.3 47.2 23.3 13.1 15.5 17.3 26.7 2.3 6.2 9.8 4.2 4.3 6.0 2.3 8.2 6.7 9.3 7.1 10.9 5.7 6.3 5.7 6.9 8.1 7.8 7.7 3.2 11.1 7.8 9.0 3.0 5.6 12.0 6.6 11.8 8.0 6.0 16.1 8.4 8.1 9.1 12.8 20.0 6.2 9.7 10.4 10.6 7.7 12.0 19.7 11.0 12.0 11.6 62.4 16.8 7.3 9.5 6.2 6.0 10.2 27.3 3.9 7.3 7.1 4.1 5.5 10.4 11.2 7.3 10.8 6.5 18.5 11.6 8.0 10.8 13.0 8.6 7.5 5.8 9.6 9.0 10.4 18.2 3.4 4.2 8.2 5.5 3.7 5.2 1.7 4.9 4.9 3.1 2.3 5.0 6.0 9.8 4.3 2.6 6.2 3.6 2.3 21.2 23.0 38.1 20.4 22.9 17.2 15.0 16.4 21.3 21.3 50.6 37.0 12.9 14.8 54.6 47.6 27.1 22.9 64.3 20.5 26.2 66.8 9.7 5.0 12.5 82.7 29.3 18.8 70.0 18.3 7.9 25.0 26.7 45.1 33.6 19.9 69.9 35.7 23.9 54.6 73.8 20.4 35.5 20.3 15.4 24.2 28.9 17.0 17.3 35.0 13.4 60.3 25.8 37.0 35.4 26.0 70.4 11.9 47.3 22.4 23.0 HIPK2 ENSG00000064393 "Homeodomain interacting protein kinase 2" Q9H2X6 7 139561570-139777778 "Enzymes, Plasma proteins, Predicted membrane proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 209.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 17.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 17.8" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007611 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007611: AB_1850730" "unprognostic (1.35e-3)" "unprognostic (1.49e-2)" "unprognostic (1.65e-1)" "unprognostic (7.65e-2)" "unprognostic (5.50e-2)" "unprognostic (9.44e-2)" "unprognostic (2.76e-1)" "unprognostic (4.66e-2)" "unprognostic (1.44e-1)" "unprognostic (2.76e-2)" "unprognostic (3.42e-3)" "unprognostic (4.58e-2)" "prognostic favorable (9.99e-4)" "unprognostic (1.38e-1)" "unprognostic (7.82e-2)" "unprognostic (3.93e-3)" "unprognostic (1.03e-2)" 19.6 9.8 58.8 7.4 53.6 14.4 12.6 8.5 39.8 5.5 7.4 54.5 5.2 8.2 4.7 5.2 10.2 9.9 5.5 30.5 60.0 39.9 28.2 17.5 8.6 5.3 66.1 16.4 6.6 12.3 17.2 7.6 10.8 26.4 10.7 5.8 9.4 11.5 7.1 21.6 3.2 6.2 4.8 56.2 7.3 15.4 2.6 38.6 1.7 10.4 2.8 4.9 6.8 7.4 0.6 0.5 17.8 2.9 0.2 1.4 0.5 4.1 18.5 8.6 5.2 21.0 15.1 1.0 2.3 2.3 2.6 2.7 1.3 2.3 0.0 5.3 4.3 16.0 0.2 3.9 6.0 6.5 42.6 1.6 19.0 3.0 6.5 11.8 5.2 5.2 22.9 3.9 11.8 17.8 6.1 6.4 3.6 11.0 5.2 19.8 3.1 6.5 3.7 2.2 2.3 12.7 7.8 4.7 0.5 11.7 0.7 5.2 4.8 5.2 0.1 2.6 1.6 2.9 2.1 21.5 9.1 4.3 10.5 11.3 25.8 15.3 3.7 18.6 2.8 4.9 17.8 1.1 2.7 0.2 0.9 0.3 0.6 0.5 0.1 0.5 0.3 1.4 0.4 1.5 0.2 2.9 0.2 0.0 0.5 58.8 53.6 8.5 25.2 60.0 39.9 66.1 16.4 26.4 38.6 14.9 31.1 34.2 22.5 8.2 100.5 179.2 58.6 29.4 29.6 61.1 143.3 6.0 29.9 26.8 2.4 43.9 23.1 0.0 58.5 1.5 18.6 91.5 42.8 127.8 14.7 209.7 64.5 159.0 115.1 3.1 12.0 28.9 42.2 32.5 35.2 61.0 53.9 17.5 17.7 62.8 59.6 45.3 63.6 0.9 1.7 8.3 8.0 30.2 23.3 40.0 HIPK4 FLJ32818 ENSG00000160396 "Homeodomain interacting protein kinase 4" Q8NE63 19 40379271-40390187 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 34.7" "Group enriched" "Detected in some" 31 "Early spermatids: 64.9;Late spermatids: 23.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 3.1;AN3-CA: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.07e-2)" "unprognostic (6.25e-2)" "unprognostic (2.58e-2)" "unprognostic (5.53e-3)" "unprognostic (4.00e-2)" "unprognostic (1.36e-1)" "unprognostic (3.69e-2)" "unprognostic (2.52e-3)" "unprognostic (1.08e-1)" "unprognostic (7.48e-3)" "unprognostic (8.85e-2)" "unprognostic (9.09e-2)" "unprognostic (3.06e-2)" "unprognostic (8.71e-3)" "unprognostic (3.64e-2)" "unprognostic (2.03e-2)" "unprognostic (4.63e-2)" 0.3 0.1 2.3 0.3 7.4 0.2 0.3 1.2 5.7 0.3 0.3 0.3 0.3 0.2 0.4 0.3 0.5 0.2 0.3 0.8 2.9 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.3 0.4 0.3 1.4 0.2 0.3 0.3 0.3 0.3 0.1 34.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.7 0.0 0.4 1.1 0.3 0.1 0.1 3.1 0.2 2.4 0.2 0.3 0.0 0.7 1.1 0.8 0.4 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.5 1.2 0.3 0.3 0.2 0.1 0.4 0.3 0.0 0.2 0.7 0.1 0.1 0.1 0.1 0.4 0.1 0.3 0.3 0.0 0.4 0.0 0.3 0.4 0.1 0.0 0.0 0.4 0.1 0.6 1.3 1.3 1.1 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.3 7.4 1.2 3.5 2.9 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.5 0.6 0.3 0.0 0.0 0.0 0.1 HIRA "DGCR1, TUP1, TUPLE1" ENSG00000100084 "Histone cell cycle regulator" P54198 22 19330698-19447450 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 50.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB039243, CAB039244, HPA050714, HPA052902" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984" "unprognostic (1.32e-1)" "unprognostic (1.74e-3)" "unprognostic (2.45e-3)" "unprognostic (1.11e-1)" "unprognostic (4.59e-2)" "unprognostic (2.46e-1)" "unprognostic (2.42e-2)" "unprognostic (2.17e-2)" "unprognostic (2.50e-1)" "prognostic favorable (8.11e-4)" "prognostic favorable (3.97e-4)" "unprognostic (9.05e-2)" "prognostic favorable (5.18e-6)" "unprognostic (4.84e-2)" "unprognostic (8.57e-2)" "unprognostic (6.36e-2)" "unprognostic (1.32e-3)" 9.9 9.8 14.8 10.0 13.6 19.9 7.4 16.7 16.3 8.0 11.7 10.9 9.4 12.4 11.9 8.4 9.7 11.5 10.0 9.2 13.4 11.6 12.8 15.0 9.1 11.4 11.3 10.0 10.8 11.3 25.6 11.4 7.6 9.8 7.6 9.4 8.9 8.6 8.7 15.3 10.8 12.1 10.3 8.3 10.2 10.1 10.5 10.6 20.3 50.0 4.6 10.0 8.9 18.2 8.2 2.9 6.1 1.2 3.6 2.4 1.2 8.1 7.1 10.1 10.4 9.9 6.5 7.1 6.8 7.9 11.3 11.2 16.2 4.7 15.7 3.4 8.8 6.8 9.6 14.3 8.6 7.3 9.8 16.6 14.6 7.7 14.8 10.8 33.7 10.8 7.9 8.4 8.8 8.7 6.1 8.1 15.9 74.9 8.4 6.4 10.0 16.5 12.0 9.2 19.2 7.2 13.2 14.4 4.6 6.5 9.0 14.8 9.9 7.8 7.9 9.4 5.3 5.0 11.8 9.4 7.8 11.6 7.9 8.0 9.0 8.9 16.5 9.0 10.9 6.4 6.1 1.2 5.0 2.3 1.2 2.4 3.7 1.3 2.3 1.5 8.2 0.6 1.7 2.2 3.6 0.6 2.9 0.6 1.2 14.8 13.6 16.7 16.3 13.4 11.6 11.3 10.0 9.8 10.6 6.0 0.3 6.9 1.9 8.1 8.5 2.0 5.1 0.0 0.0 5.2 2.0 3.2 5.0 5.3 5.7 3.6 7.0 0.0 7.7 3.0 4.1 3.8 0.0 18.1 5.6 15.9 2.4 7.4 10.8 1.6 4.6 2.5 10.1 3.6 8.5 4.5 6.6 10.8 6.3 9.3 4.0 6.5 4.2 7.1 7.5 9.3 2.5 3.3 13.3 1.8 HIST1H1A "H1.1, H1a, H1F1" ENSG00000124610 "Histone cluster 1 H1 family member a" Q02539 6 26017085-26017732 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 57.2" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 131.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "T-reg: 4.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.1;REH: 4.4;RPTEC TERT1: 1.5;U-2 OS: 3.9" "Not detected" "Not detected" "HPA043753, HPA056830" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA043753: AB_2678654, HPA056830: " "unprognostic (3.80e-1)" "unprognostic (1.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (3.05e-1)" 0.8 1.4 1.0 3.9 0.9 1.1 0.8 0.9 3.3 3.5 0.8 0.0 0.4 0.7 3.6 3.9 6.2 1.1 3.4 2.8 1.0 0.8 3.7 5.3 0.7 1.3 0.8 0.6 7.9 0.8 0.7 1.0 0.7 0.6 0.9 0.9 0.9 0.7 1.5 0.7 2.0 0.8 0.7 0.7 0.9 0.8 57.2 0.0 15.1 2.7 10.6 12.4 1.2 0.8 1.4 1.2 0.0 0.1 0.0 4.9 0.4 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.6 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.4 0.0 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 3.9 0.5 0.0 0.2 0.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 1.5 0.1 0.0 1.4 2.8 0.3 0.6 0.0 1.7 0.1 0.0 0.0 0.0 1.2 4.9 0.4 1.0 0.9 0.9 3.3 1.0 0.8 0.8 0.6 0.6 0.0 0.0 0.3 0.0 1.0 0.1 0.0 3.4 0.0 1.4 1.2 0.0 0.0 0.1 14.9 0.0 0.3 0.0 0.0 0.0 0.2 3.6 0.6 0.2 1.1 2.1 1.6 0.0 0.0 4.3 0.3 0.9 0.9 0.2 1.7 0.0 0.0 0.5 0.2 0.0 1.8 0.3 1.0 0.0 0.4 4.9 131.8 0.4 0.3 0.0 0.0 0.3 HIST1H1B "H1.5, H1b, H1F5, H1s-3" ENSG00000184357 "Histone cluster 1 H1 family member b" P16401 6 27866849-27867529 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 342.6" "Cell type enhanced" "Detected in some" 10 "Extravillous trophoblasts: 3.8;Hofbauer cells: 2.6;Kupffer cells: 2.2;Macrophages: 1.8;T-cells: 1.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4" "Cell line enhanced" "Detected in many" "MOLT-4: 14.0;NB-4: 7.7;U-698: 6.0" "CAB012241, HPA055907, HPA060331" Supported Supported Nucleoplasm NA NA 510000 Nucleoplasm "CAB012241: , HPA055907: AB_2682966, HPA060331: " "unprognostic (2.34e-1)" "unprognostic (3.75e-4)" "unprognostic (2.12e-2)" "unprognostic (3.63e-2)" "unprognostic (1.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.20e-1)" "unprognostic (8.47e-2)" "unprognostic (6.23e-3)" "unprognostic (5.85e-2)" "unprognostic (5.68e-4)" "unprognostic (2.10e-1)" "unprognostic (9.79e-2)" "unprognostic (1.35e-1)" 1.1 0.4 0.4 22.9 0.5 18.2 2.1 0.5 0.4 1.7 7.3 0.0 0.0 0.3 0.5 1.0 10.2 0.3 1.9 0.6 0.5 0.5 0.4 0.6 3.9 10.7 0.5 0.0 0.4 0.4 0.3 0.4 6.4 0.0 0.4 0.5 0.0 0.8 0.3 0.4 1.4 7.0 0.3 1.7 14.4 1.3 1.7 0.0 342.6 0.6 10.5 26.0 2.0 0.7 13.0 12.7 0.7 1.1 1.8 3.4 2.1 2.2 0.0 0.8 0.0 0.0 0.0 1.7 0.7 0.6 1.0 0.6 0.7 1.5 2.7 0.4 0.8 0.7 0.8 0.0 0.0 0.1 0.8 1.0 3.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.9 1.9 2.7 1.9 0.1 0.4 14.0 7.7 2.1 2.1 0.0 4.2 0.0 0.0 0.4 0.0 1.9 1.1 2.4 0.3 0.0 0.8 1.0 2.5 0.8 1.4 0.1 1.4 1.1 2.9 0.0 6.0 2.0 0.9 1.3 0.0 0.9 0.0 3.3 0.9 1.7 4.8 3.1 3.4 5.1 13.0 1.7 1.8 0.7 1.8 1.1 12.7 3.4 2.1 0.4 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.1 0.0 0.0 2.6 0.0 0.0 0.6 2.2 0.0 0.3 1.8 0.0 0.0 0.3 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.6 1.8 0.9 0.1 HIST1H1C "H1.2, H1c, H1F2, H1s-1" ENSG00000187837 "Histone cluster 1 H1 family member c" P16403 6 26055787-26056428 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 353.5" "Cell type enhanced" "Detected in all" 6 "Glandular cells: 442.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 79.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 79.7" "Cell line enhanced" "Detected in many" "K-562: 50.0;SiHa: 47.6;U-2 OS: 93.7;U-266/70: 103.9;U-266/84: 98.7" "Low region specificity" "Detected in all" "CAB011507, HPA055907" Supported Supported "Nucleoplasm,Nucleoli rim" NA NA 1800000 "Nucleoplasm, Nucleoli rim" "CAB011507: AB_2117984, HPA055907: AB_2682966" "unprognostic (4.43e-2)" "unprognostic (1.57e-3)" "unprognostic (1.31e-2)" "unprognostic (2.96e-2)" "unprognostic (5.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.96e-1)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.85e-1)" "unprognostic (8.93e-2)" "unprognostic (3.08e-1)" "prognostic favorable (8.06e-5)" 25.1 17.4 10.1 32.1 10.2 94.7 36.0 23.8 12.8 29.8 23.3 8.1 14.3 15.0 24.7 21.0 48.6 16.6 27.4 37.6 9.3 7.3 23.8 43.1 31.4 37.2 8.2 8.7 34.4 46.6 2.3 5.8 29.1 6.9 44.3 21.2 26.5 22.0 9.5 69.1 21.0 21.1 22.9 12.5 28.4 25.6 33.7 5.4 353.5 21.7 28.5 39.7 38.8 28.0 14.9 5.9 79.7 3.2 3.3 8.6 4.2 5.9 4.2 3.1 3.4 8.1 1.6 0.1 2.9 4.9 14.1 15.0 2.3 4.3 0.4 17.2 3.9 5.1 2.6 1.0 2.3 3.9 5.7 3.7 2.4 4.7 2.6 2.4 1.1 5.9 11.5 3.1 1.8 3.1 4.3 2.2 2.7 50.0 37.6 7.0 2.6 3.0 2.6 1.7 14.5 6.5 1.6 1.4 19.1 8.3 4.3 8.2 2.8 47.6 8.2 3.3 3.1 10.1 1.7 1.0 6.4 93.7 1.9 1.3 103.9 98.7 4.5 4.7 38.9 2.2 35.8 2.6 79.7 3.8 2.6 4.8 9.8 6.3 4.1 5.6 14.9 5.8 4.4 43.0 3.3 3.2 5.9 8.6 4.2 10.1 10.2 23.8 12.8 9.3 7.3 8.2 8.7 6.9 5.4 65.5 28.8 111.5 307.6 7.2 72.6 41.5 30.6 100.4 35.2 66.3 47.1 37.6 44.7 79.4 2.2 29.5 161.7 256.9 100.4 59.2 37.4 442.5 18.6 102.4 61.4 49.3 37.3 33.7 27.5 4.2 24.2 37.4 3.3 16.2 65.1 147.0 86.1 92.5 10.3 161.0 135.9 25.8 23.3 14.2 90.3 6.9 249.6 48.4 36.8 295.6 HIST1H1D "H1.3, H1d, H1F3, H1s-2" ENSG00000124575 "Histone cluster 1 H1 family member d" P16402 6 26234268-26234933 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 182.1" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 15.9;Spermatogonia: 13.2;T-cells: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 8.5;MOLT-4: 13.6;NB-4: 6.2;REH: 5.6;SiHa: 5.6;U-266/70: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA055907 Supported NA NA "HPA055907: AB_2682966" "unprognostic (8.78e-2)" "unprognostic (1.01e-4)" "unprognostic (8.69e-2)" "unprognostic (5.67e-2)" "unprognostic (2.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.11e-2)" "unprognostic (2.13e-1)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (1.14e-2)" "unprognostic (8.96e-2)" "unprognostic (3.61e-8)" "unprognostic (8.78e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-3)" "unprognostic (1.33e-2)" 3.2 1.1 0.4 14.7 0.9 37.5 5.0 2.8 0.9 4.1 5.2 0.1 2.0 1.0 3.9 4.8 10.7 1.3 3.7 2.5 0.8 0.8 1.5 1.1 9.9 21.2 0.6 0.0 3.4 0.9 0.9 0.6 2.3 0.1 3.7 2.4 1.4 1.8 1.0 0.9 6.1 4.9 1.2 4.4 14.2 1.6 4.6 0.0 182.1 1.7 4.5 17.6 8.3 9.2 26.3 17.9 8.6 3.8 12.5 21.2 8.0 1.0 0.8 0.2 0.0 0.4 0.0 8.5 0.4 0.3 1.1 0.8 0.2 1.0 0.0 0.2 0.1 0.5 1.0 0.3 0.0 0.5 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.2 0.3 0.0 0.4 1.2 2.3 2.3 0.1 0.0 13.6 6.2 0.7 0.0 2.5 5.6 0.1 3.2 0.0 0.0 2.8 0.4 5.6 2.4 0.0 0.9 1.1 1.3 0.0 0.4 0.0 0.2 0.9 7.0 3.5 0.4 1.0 1.8 0.7 8.6 3.8 3.2 17.7 2.4 12.6 16.5 16.3 12.0 9.5 26.3 21.2 16.4 1.4 12.5 3.4 17.9 12.1 8.0 0.4 0.9 2.8 0.8 0.8 0.8 0.6 0.0 0.1 0.0 0.0 3.0 9.7 7.4 0.5 0.7 0.7 0.0 9.4 6.8 0.0 0.0 1.0 0.0 0.0 0.0 1.6 2.3 0.0 0.0 15.9 0.4 2.0 7.0 0.0 6.0 0.0 1.2 4.3 4.0 0.0 1.1 7.9 0.0 1.8 2.3 7.0 0.0 0.3 0.0 0.5 0.3 0.0 0.4 0.2 13.2 0.3 3.0 30.2 1.3 2.4 HIST1H1E "H1.4, H1e, H1F4, H1s-4" ENSG00000168298 "Histone cluster 1 H1 family member e" P10412 6 26156354-26157107 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Muller glia cells: 63.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 9.8;U-266/70: 12.1;U-266/84: 13.5;U-87 MG: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB011506, HPA055907" Supported Supported "Nuclear speckles" NA Yes "Nuclear speckles" "CAB011506: AB_470256, HPA055907: AB_2682966" "unprognostic (6.96e-2)" "unprognostic (1.25e-1)" "unprognostic (3.06e-2)" "unprognostic (1.86e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-2)" "unprognostic (5.78e-3)" "unprognostic (2.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-1)" "unprognostic (7.72e-13)" "unprognostic (4.54e-3)" "unprognostic (3.46e-2)" "unprognostic (1.30e-3)" "unprognostic (2.18e-2)" 6.7 3.6 3.1 14.3 3.5 102.3 10.3 8.1 9.0 10.7 7.7 4.7 4.2 4.1 6.8 7.5 13.7 4.0 11.3 7.4 4.0 3.5 6.6 6.7 13.1 18.4 3.4 2.4 19.3 17.1 3.7 9.0 7.3 3.5 10.2 4.4 9.8 10.0 4.0 4.1 14.4 9.0 7.4 6.8 14.6 5.3 5.9 0.7 123.9 4.6 10.0 18.4 14.3 10.7 39.6 14.6 56.4 12.9 19.2 24.4 9.4 2.4 0.3 0.5 5.3 0.1 0.0 6.4 0.0 0.4 1.2 0.8 0.1 1.5 1.2 0.7 0.1 0.5 1.2 0.3 0.7 0.5 1.7 1.5 0.8 0.5 0.4 0.1 0.7 1.1 0.1 0.3 0.3 0.5 0.1 0.5 1.4 3.9 6.8 0.1 0.5 7.9 7.2 1.9 0.7 0.8 3.6 1.2 9.8 0.3 0.0 3.9 0.9 3.1 0.8 1.1 0.6 1.0 2.6 0.4 2.4 3.7 1.5 2.4 12.1 13.5 5.4 12.3 2.1 1.1 56.4 12.7 30.0 21.1 12.9 24.4 21.4 16.7 19.2 14.3 39.6 12.7 11.6 18.6 19.2 10.9 14.6 16.4 9.4 3.1 3.5 8.1 9.0 4.0 3.5 3.4 2.4 3.5 0.7 32.8 16.3 10.4 23.8 0.6 26.5 9.8 5.1 34.8 45.5 1.8 7.9 5.2 3.3 11.4 0.5 6.7 5.1 46.7 7.4 9.1 1.9 6.7 4.7 8.7 6.9 15.9 0.0 10.4 10.0 1.1 4.4 14.0 1.7 8.2 2.5 63.4 7.0 3.5 1.8 4.1 26.6 6.5 6.4 2.8 6.3 0.0 6.1 26.1 2.5 10.2 HIST1H1T "H1FT, H1t" ENSG00000187475 "Histone cluster 1 H1 family member t" P22492 6 26107419-26108136 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "testis: 257.2" "Group enriched" "Detected in some" 22 "Spermatocytes: 1.9;Spermatogonia: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 44 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SiHa: 4.0;U-2 OS: 1.0;U-266/84: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065718, HPA068266" Enhanced NA NA "HPA065718: AB_2685543, HPA068266: AB_2685967" "unprognostic (1.06e-2)" "unprognostic (1.80e-2)" "unprognostic (9.52e-2)" "unprognostic (9.94e-2)" "unprognostic (5.12e-1)" "unprognostic (1.57e-1)" "unprognostic (7.48e-3)" "unprognostic (6.51e-2)" "unprognostic (6.86e-3)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (6.28e-3)" 0.0 0.0 0.2 0.8 0.3 0.4 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.0 0.0 0.3 0.1 0.1 0.6 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.2 0.2 0.0 257.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.0 1.8 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 4.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.7 0.2 0.3 0.0 0.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 4.7 0.0 0.1 0.0 0.0 0.0 HIST1H2AA "bA317E16.2, H2AFR" ENSG00000164508 "Histone cluster 1 H2A family member a" Q96QV6 6 25726132-25726527 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 518 "testis: 453.1" "Group enriched" "Detected in some" 15 "Spermatocytes: 219.3;Spermatogonia: 217.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "HEK 293: 3.0" "Not detected" "Not detected" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 453.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 219.3 217.6 0.0 0.0 0.0 0.0 0.0 HIST1H2AB "H2A/m, H2AFM" ENSG00000278463 "Histone cluster 1 H2A family member b" P04908 6 26033176-26033568 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "lymphoid tissue: 133.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 2.2;Early spermatids: 2.6;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 9.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.53e-3)" "unprognostic (3.93e-2)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (7.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.49e-1)" "unprognostic (1.04e-3)" "unprognostic (3.28e-1)" "unprognostic (7.78e-2)" "unprognostic (1.47e-1)" "unprognostic (1.47e-3)" 0.7 0.3 0.2 7.6 0.0 9.6 2.6 0.2 0.6 0.5 1.7 0.0 0.0 0.3 0.5 0.3 5.0 0.3 0.7 2.6 0.0 0.6 0.3 1.7 5.9 0.0 0.0 0.3 0.3 0.3 0.0 2.6 0.0 0.5 0.3 0.2 0.3 0.3 0.3 0.3 2.2 0.3 0.1 8.2 0.7 8.3 0.0 133.2 0.3 1.5 12.2 0.3 0.0 4.2 1.8 3.4 1.5 1.4 2.4 0.3 0.2 1.0 0.5 3.6 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 0.3 1.8 0.9 0.0 0.1 0.6 0.5 0.0 0.6 0.9 2.2 1.1 0.5 9.2 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.4 1.0 0.0 1.4 2.0 2.0 3.6 0.0 3.5 1.2 0.7 1.5 0.0 3.0 0.4 0.1 2.1 0.0 0.1 0.1 0.6 1.0 0.0 0.3 4.0 0.3 0.2 1.5 2.5 0.1 0.6 3.7 0.3 0.0 0.1 3.4 0.8 1.5 0.0 4.2 1.5 2.4 1.8 3.1 0.6 0.8 0.7 1.4 0.1 0.2 0.6 0.3 0.0 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.6 0.3 1.0 0.0 0.0 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 1.1 0.0 0.5 0.0 0.4 0.5 HIST1H2AC H2AFL ENSG00000180573 "Histone cluster 1 H2A family member c" Q93077 6 26124145-26139116 "Cancer-related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 116.1;lymphoid tissue: 202.5" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 177.7;Urothelial cells: 208.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 116.1" "Lineage enriched" "Detected in all" 17 "granulocytes: 116.1" "Cell line enhanced" "Detected in many" "HSkMC: 31.4;OE19: 26.8;SiHa: 26.9;U-2 OS: 27.1;U-266/84: 27.0" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.89e-2)" "unprognostic (1.97e-1)" "unprognostic (7.15e-3)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (1.37e-1)" "unprognostic (8.16e-2)" "unprognostic (2.57e-1)" "unprognostic (1.61e-3)" "unprognostic (1.75e-1)" "unprognostic (1.19e-2)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (5.89e-3)" 13.6 14.5 13.6 22.5 16.4 19.0 29.9 7.3 9.8 35.6 21.0 12.2 17.9 18.1 13.2 32.8 27.5 23.6 13.9 12.6 18.5 12.4 21.4 34.1 29.2 28.5 18.6 8.5 23.8 15.7 3.7 13.4 26.2 8.5 37.2 15.0 21.1 10.4 17.0 17.5 15.4 21.6 14.4 27.0 26.4 26.9 16.3 10.4 202.5 24.5 9.2 34.9 29.6 25.8 6.6 4.5 116.1 3.6 1.9 2.1 48.3 5.5 1.6 1.9 0.6 16.1 8.8 0.8 2.8 1.7 8.5 7.3 2.1 1.4 0.2 13.8 5.6 5.7 6.7 1.5 2.9 6.1 5.3 0.9 0.9 0.7 0.3 12.6 0.9 6.4 31.4 5.0 1.8 5.5 10.8 0.5 0.7 13.9 10.2 3.7 4.6 0.9 1.0 2.3 26.8 0.5 0.6 1.0 16.3 8.1 0.6 2.9 1.2 26.9 5.7 8.8 8.2 13.1 1.4 1.8 5.2 27.1 2.3 1.2 13.3 27.0 1.5 1.9 14.0 2.2 36.0 2.0 24.4 1.4 1.5 1.2 3.3 1.5 1.0 1.4 6.6 2.1 1.1 116.1 1.9 3.6 4.5 2.0 48.3 13.6 16.4 7.3 9.8 18.5 12.4 18.6 8.5 8.5 10.4 32.8 12.8 27.7 117.6 2.6 22.0 22.6 15.3 24.1 12.5 68.0 7.9 13.9 23.2 18.9 3.5 18.0 86.9 0.0 11.7 21.5 13.7 177.7 10.4 51.3 13.8 17.5 93.4 16.0 10.5 0.5 13.0 8.0 5.0 12.6 30.9 10.9 33.5 129.8 7.1 77.4 22.6 19.4 16.5 2.4 2.2 7.3 63.5 18.7 26.1 208.4 HIST1H2AD "H2A.3, H2A/g, H2AFG" ENSG00000196866 "Histone cluster 1 H2A family member d" P20671 6 26198851-26199243 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "lymphoid tissue: 225.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 16.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "U-266/70: 21.2;U-266/84: 6.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.03e-2)" "unprognostic (1.11e-2)" "unprognostic (7.27e-2)" "unprognostic (3.56e-1)" "unprognostic (9.17e-2)" "unprognostic (1.45e-1)" "unprognostic (9.09e-3)" "unprognostic (6.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.34e-1)" "unprognostic (1.81e-1)" "unprognostic (2.88e-2)" "unprognostic (1.10e-9)" "unprognostic (2.00e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" 2.6 1.8 0.9 13.8 1.1 14.7 6.3 0.8 1.3 8.0 4.6 0.0 3.2 1.5 2.0 3.1 9.2 1.3 2.8 5.5 1.2 1.3 2.3 3.6 4.8 15.9 1.1 0.5 3.4 1.9 1.1 1.5 4.6 1.0 6.8 2.2 1.5 2.5 4.3 1.2 3.2 4.3 2.3 3.6 10.8 1.8 5.7 0.6 225.6 1.4 5.1 14.3 5.3 8.6 7.0 5.7 16.0 1.8 1.1 3.8 0.8 0.8 0.0 0.3 0.3 0.0 0.0 0.0 0.6 0.3 1.9 0.0 2.4 0.3 0.0 1.7 0.3 0.2 0.4 0.0 0.3 0.2 0.1 1.3 0.2 1.6 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 3.5 1.7 0.0 0.1 2.9 1.3 1.7 0.0 0.3 1.5 0.5 1.5 0.4 0.1 1.5 0.3 0.7 1.4 0.1 0.0 0.5 0.5 0.0 1.5 4.1 0.0 1.1 21.2 6.9 2.5 0.8 1.8 0.7 2.2 0.2 3.2 1.1 1.8 1.1 2.0 1.5 3.8 1.0 7.0 1.4 1.1 16.0 1.1 1.3 5.7 2.0 0.8 0.9 1.1 0.8 1.3 1.2 1.3 1.1 0.5 1.0 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 HIST1H2AE "H2A.1, H2A/a, H2AFA" ENSG00000277075 "Histone cluster 1 H2A family member e" P04908 6 26216975-26217483 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 139.6" "Group enriched" "Detected in many" 7 "Basal glandular cells: 99.4;Glandular cells: 104.2;Urothelial cells: 88.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 26.7" "CAB012242, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB012242: AB_470265, HPA041189: AB_2677357" "unprognostic (4.26e-2)" "unprognostic (1.55e-2)" "unprognostic (4.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (1.50e-1)" "unprognostic (2.48e-2)" "unprognostic (7.22e-2)" "unprognostic (1.24e-2)" "unprognostic (6.99e-2)" "unprognostic (1.21e-3)" "unprognostic (1.30e-2)" "unprognostic (7.64e-2)" "unprognostic (1.15e-1)" "unprognostic (2.41e-1)" "unprognostic (2.20e-1)" "unprognostic (9.36e-2)" 0.3 1.8 0.9 19.1 0.9 13.5 33.8 4.9 6.2 3.7 3.8 0.2 3.2 2.8 2.2 13.6 7.2 3.0 2.4 2.2 0.5 0.8 1.5 1.9 11.4 0.0 3.0 2.0 1.1 0.4 0.0 2.9 0.5 10.6 1.6 1.4 2.7 2.5 0.1 2.4 3.4 2.0 3.5 5.9 2.0 5.1 0.0 139.6 2.0 7.4 11.4 2.3 0.0 6.1 15.4 11.4 2.1 4.0 4.2 10.1 2.8 0.0 2.1 0.0 3.5 0.7 0.5 0.9 1.4 3.1 2.1 1.4 2.3 0.1 7.8 0.3 2.8 2.4 1.0 1.4 1.2 3.1 2.6 1.9 4.2 1.8 0.6 0.2 2.9 6.2 0.7 1.3 0.1 0.9 1.5 0.5 7.7 2.1 0.2 5.2 6.3 5.4 2.5 9.8 2.6 5.0 1.7 9.9 1.3 1.6 8.6 3.6 7.7 2.6 1.7 1.5 10.6 2.8 0.0 0.1 0.6 1.3 1.2 26.7 0.0 0.0 1.1 3.8 1.9 11.4 2.0 6.3 2.7 2.1 3.8 4.3 3.0 4.2 5.0 6.1 1.6 2.1 9.4 4.0 1.2 15.4 3.6 10.1 3.0 13.0 11.1 99.4 1.3 3.3 0.4 0.0 0.0 2.3 1.8 0.0 6.5 1.7 2.8 2.5 0.5 13.7 0.0 0.0 4.1 2.1 104.2 2.3 2.1 14.1 3.2 10.4 1.8 1.5 1.8 0.9 5.7 0.0 2.8 12.1 1.7 0.3 10.8 0.4 4.0 0.1 0.0 0.2 0.7 9.1 1.3 11.6 10.0 8.1 88.8 HIST1H2AG "H2A.1b, H2A/p, H2AFP, pH2A/f" ENSG00000196787 "Histone cluster 1 H2A family member g" P0C0S8 6 27133042-27135291 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 305.4" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 16.3;Enterocytes: 7.3;Late spermatids: 10.6;Paneth cells: 10.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 9.7" "Group enriched" "Detected in many" 4 "B-cells: 4.4;granulocytes: 9.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "K-562: 9.9;SiHa: 11.5;U-266/84: 31.2" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (4.86e-2)" "unprognostic (6.89e-2)" "unprognostic (1.66e-1)" "unprognostic (3.94e-1)" "unprognostic (8.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.95e-1)" "unprognostic (5.78e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (7.36e-2)" "unprognostic (5.98e-2)" "unprognostic (6.48e-2)" "unprognostic (8.22e-3)" "unprognostic (9.54e-2)" 2.4 1.6 1.1 25.1 1.2 6.3 8.7 0.7 1.0 3.3 9.7 0.0 1.0 3.8 2.0 3.7 15.7 1.0 3.2 2.7 1.3 1.6 1.1 2.6 6.0 13.5 2.3 0.0 1.4 0.9 0.3 1.0 8.7 0.3 2.5 2.3 0.3 2.1 1.5 1.1 1.4 7.1 0.9 2.3 20.2 1.8 16.1 0.0 305.4 1.5 12.3 28.9 2.4 2.0 4.4 1.3 9.7 0.8 1.1 3.8 7.7 1.3 1.8 1.6 1.4 4.9 1.0 1.0 0.5 0.7 1.6 0.2 0.8 1.4 0.4 2.0 0.5 1.5 2.8 1.9 0.8 1.1 2.4 1.1 0.7 3.6 0.0 1.0 0.7 1.5 1.8 0.4 0.5 0.5 0.8 0.5 1.3 9.9 4.7 0.1 1.7 1.8 1.1 0.9 2.0 1.2 1.2 1.5 5.1 0.3 0.3 6.1 1.5 11.5 1.8 0.6 0.7 0.0 0.4 0.6 1.8 4.0 1.4 0.7 8.4 31.2 3.2 0.3 1.1 1.1 9.7 0.4 0.7 0.6 0.3 1.3 3.0 2.3 1.6 0.6 4.4 2.2 1.8 3.5 1.1 0.8 1.3 3.8 7.7 1.1 1.2 0.7 0.9 1.3 1.6 2.3 0.0 0.3 0.0 0.0 1.4 2.2 1.4 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 16.3 0.3 7.3 0.0 0.0 2.9 0.3 1.4 0.0 0.4 2.1 4.8 1.2 0.0 0.6 10.6 0.0 1.0 0.0 1.0 3.1 1.2 0.1 10.5 0.0 0.0 0.0 0.0 0.3 2.2 3.0 0.4 2.5 2.5 2.9 1.0 HIST1H2AH "dJ86C11.1, H2A/S, H2AFALii" ENSG00000274997 "Histone cluster 1 H2A family member h" Q96KK5 6 27147129-27147515 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 301.1" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive B-cell: 16.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2" "CAB004030, HPA041189" Supported Approved Nucleoplasm NA Yes Nucleoplasm "CAB004030: AB_2118804, HPA041189: AB_2677357" "unprognostic (4.07e-1)" "unprognostic (2.73e-3)" "unprognostic (4.04e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" "unprognostic (5.35e-3)" "unprognostic (3.90e-2)" "unprognostic (3.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.38e-3)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (9.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.26e-4)" 0.8 0.7 0.0 26.0 0.0 20.2 1.5 0.0 0.4 3.1 6.6 0.0 0.6 1.0 1.8 2.6 6.4 1.0 2.7 1.3 0.0 0.5 0.4 4.1 5.4 0.0 0.0 2.4 0.5 0.4 0.0 9.0 0.0 0.6 0.9 0.1 1.7 0.6 0.4 0.6 6.5 0.9 0.0 13.9 0.7 23.5 0.0 301.1 0.6 9.0 27.3 1.9 0.0 16.2 2.2 0.0 2.4 5.1 4.7 2.3 2.6 3.5 1.1 4.9 0.0 0.0 0.7 0.3 0.6 0.6 0.0 2.6 1.0 3.8 0.9 0.0 0.6 0.3 1.0 0.0 0.0 2.1 9.0 4.7 3.0 0.0 0.0 3.2 1.8 0.0 0.0 1.2 0.0 0.0 0.9 1.8 4.8 2.4 0.9 0.4 9.3 10.2 3.2 0.9 1.2 3.4 3.1 5.0 0.0 0.3 2.5 0.6 1.4 0.5 0.2 0.1 1.0 1.5 0.0 0.8 2.8 0.2 2.7 2.9 2.9 6.1 1.3 4.6 0.8 0.0 0.9 0.0 2.6 2.4 1.2 3.8 4.7 4.2 2.2 16.2 2.4 1.6 0.0 5.1 1.5 1.5 0.8 2.3 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.7 0.0 0.3 1.7 0.1 1.6 23.3 0.3 1.9 0.3 0.8 1.1 0.0 0.7 0.0 1.7 1.8 1.2 4.3 0.6 0.6 0.0 0.0 0.3 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.5 0.2 2.5 1.0 0.6 HIST1H2AI "H2A/c, H2AFC" ENSG00000196747 "Histone cluster 1 H2A family member i" P0C0S8 6 27808199-27808701 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 349.3" "Cell type enhanced" "Detected in single" 10 "T-cells: 1.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 17.7;U-266/84: 48.6" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (6.82e-2)" "unprognostic (5.57e-3)" "unprognostic (1.38e-1)" "unprognostic (4.48e-2)" "unprognostic (9.11e-3)" "unprognostic (1.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (9.54e-5)" "unprognostic (5.50e-2)" "unprognostic (1.50e-5)" "unprognostic (1.43e-1)" "unprognostic (1.85e-1)" "unprognostic (1.89e-1)" "unprognostic (6.24e-2)" 1.7 1.2 0.7 36.2 0.9 10.7 2.8 0.6 0.7 1.5 6.3 0.0 0.5 2.3 1.1 1.4 14.2 1.4 2.8 4.8 1.1 1.1 1.0 1.3 3.5 25.8 0.6 0.0 1.2 0.4 1.4 0.6 5.4 0.0 1.3 5.8 0.0 1.3 0.3 0.5 1.1 7.1 0.5 4.3 21.9 2.2 4.3 0.0 349.3 1.0 15.2 26.8 2.3 2.0 3.0 2.6 4.8 0.8 2.5 4.0 2.0 0.9 3.7 0.9 0.6 0.4 0.2 0.3 0.7 0.1 1.2 0.9 1.1 0.6 1.0 2.2 0.3 0.6 0.7 0.0 0.6 0.5 3.6 4.8 1.5 5.9 3.1 0.4 0.4 0.8 1.7 0.2 0.4 0.1 1.0 0.2 1.2 17.7 4.2 0.0 4.6 2.6 2.8 0.9 3.1 1.3 1.3 0.0 6.9 1.4 0.7 5.2 1.0 10.3 1.5 0.3 0.3 6.3 0.4 0.2 0.5 2.0 0.4 0.4 3.9 48.6 2.0 0.4 4.1 0.3 0.0 0.5 3.6 0.9 0.8 0.7 2.1 3.2 0.9 2.3 3.0 0.7 0.4 4.8 2.5 0.8 2.6 4.0 2.0 0.7 0.9 0.6 0.7 1.1 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.2 0.4 HIST1H2AJ "H2A/E, H2AFE" ENSG00000276368 "Histone cluster 1 H2A family member j" Q99878 6 27814354-27814740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "lymphoid tissue: 357.7" "Cell type enriched" "Detected in some" 29 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8" "Low region specificity" "Detected in some" HPA041189 Supported Approved Nucleoplasm NA Yes Nucleoplasm "HPA041189: AB_2677357" "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.6 0.1 0.0 7.2 0.0 16.5 0.2 0.0 0.2 1.0 5.2 0.0 0.0 0.3 0.3 0.6 6.6 0.3 0.8 0.2 0.0 0.3 0.4 2.2 3.1 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.4 3.9 0.1 0.0 10.5 0.8 5.2 0.0 357.7 0.1 7.9 23.1 1.5 0.0 4.2 2.7 2.5 0.5 0.4 5.9 5.0 4.0 0.0 1.2 0.0 0.0 0.0 1.0 1.2 1.2 1.1 2.6 2.1 0.2 3.9 0.4 0.7 0.1 1.1 0.0 1.1 0.6 1.9 0.6 5.6 0.5 10.0 0.3 0.0 2.1 0.0 0.3 0.5 0.3 0.0 1.5 2.1 0.0 12.1 0.3 16.8 6.7 6.1 2.0 1.7 3.5 6.0 0.0 2.3 0.2 2.4 0.5 0.8 1.1 1.2 0.5 0.3 0.4 4.1 0.0 0.0 2.4 0.4 0.2 6.2 3.9 3.8 1.3 4.5 2.8 0.0 0.1 0.0 0.7 0.5 0.9 0.7 3.4 3.1 2.7 4.2 1.1 0.4 2.5 0.4 0.2 0.3 5.9 5.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.7 0.0 1.6 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.4 0.3 HIST1H2AK "H2A/d, H2AFD" ENSG00000275221 "Histone cluster 1 H2A family member k" P0C0S8 6 27837947-27838339 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 115.7" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 1.4;granulocytes: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.3;AN3-CA: 4.9;HeLa: 5.1;SCLC-21H: 4.8;U-266/84: 7.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" 1.5 4.1 0.0 11.1 0.5 3.2 3.5 0.9 1.3 2.8 2.3 0.2 0.5 1.0 1.7 1.6 4.4 2.7 4.1 2.5 0.0 0.2 0.4 4.4 8.4 0.8 0.0 3.3 0.0 0.0 0.1 1.7 0.3 2.3 0.4 0.9 1.7 1.1 0.7 0.0 1.5 0.3 1.6 7.0 1.3 3.9 0.5 115.7 1.6 2.8 12.3 2.1 0.0 6.0 1.2 0.0 0.6 1.1 3.8 5.1 0.0 4.3 0.0 4.9 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.4 0.0 0.2 0.2 0.8 0.5 2.2 1.0 0.0 0.6 1.4 1.2 1.7 5.1 0.6 0.7 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.6 1.9 0.0 0.0 0.7 1.6 0.0 0.0 0.2 0.0 0.6 0.4 0.0 1.0 0.3 4.8 0.8 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.5 0.5 0.0 0.3 1.9 7.2 1.0 0.0 0.3 0.5 0.0 0.1 0.0 2.3 0.0 1.8 5.8 2.6 2.4 0.0 6.0 3.8 2.8 0.0 1.1 0.6 1.2 2.7 5.1 0.0 0.3 0.5 0.3 0.1 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 HIST1H2AL "dJ193B12.9, H2A/i, H2AFI" ENSG00000276903 "Histone cluster 1 H2A family member l" P0C0S8 6 27865355-27865747 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 288.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.2;MOLT-4: 8.9" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.45e-2)" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.46e-3)" "unprognostic (3.17e-1)" "unprognostic (1.82e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-2)" "unprognostic (4.18e-1)" "unprognostic (2.38e-1)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (2.41e-2)" "unprognostic (2.12e-1)" "unprognostic (6.21e-2)" 1.1 0.5 0.0 24.8 0.0 16.4 1.3 0.0 0.5 1.1 4.5 0.0 0.0 1.1 0.8 1.7 7.6 0.3 1.8 1.5 0.0 0.4 0.4 3.4 10.2 0.0 0.0 0.3 0.3 1.5 0.0 5.2 0.0 0.3 0.3 0.0 0.7 0.3 0.3 0.5 4.4 0.3 0.0 12.9 0.7 13.1 0.0 288.3 0.3 9.6 26.4 0.5 0.0 9.6 4.7 8.8 3.6 0.1 2.0 1.1 4.2 1.7 0.9 0.0 0.0 0.0 1.1 1.7 0.7 1.4 1.7 0.0 1.4 3.2 1.2 0.0 1.0 1.2 0.0 0.0 0.4 3.1 7.2 1.2 0.0 1.2 0.0 0.8 1.5 0.0 0.0 0.4 0.0 0.0 0.0 1.7 5.5 3.3 0.5 3.8 8.9 6.4 2.9 1.7 1.3 4.6 0.0 0.5 0.7 2.6 2.1 2.0 1.2 0.0 0.8 0.0 0.4 1.2 0.0 0.2 0.0 1.4 3.0 5.6 0.0 6.5 1.4 4.1 1.3 2.4 2.0 1.3 0.1 1.7 0.0 3.3 1.7 2.0 4.7 9.6 0.7 1.0 8.8 0.1 3.6 3.4 1.7 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.1 0.0 0.4 0.5 HIST1H2AM "H2A.1, H2A/n, H2AFN" ENSG00000278677 "Histone cluster 1 H2A family member m" P0C0S8 6 27892757-27893149 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "lymphoid tissue: 315.3" "Cell type enhanced" "Detected in some" 11 "B-cells: 2.2;Ciliated cells: 4.0;granulocytes: 2.3;T-cells: 3.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 25.2" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (6.05e-2)" "unprognostic (4.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.79e-1)" "unprognostic (1.26e-1)" "unprognostic (1.11e-2)" "unprognostic (6.48e-2)" "unprognostic (2.70e-1)" "unprognostic (6.36e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-3)" "unprognostic (4.24e-1)" "unprognostic (8.85e-6)" "unprognostic (2.44e-1)" "unprognostic (3.18e-1)" "unprognostic (8.80e-2)" "unprognostic (1.30e-1)" 1.2 1.5 0.0 30.7 0.0 9.3 2.3 0.2 0.2 2.1 6.1 0.1 2.3 1.4 1.3 2.6 10.7 0.3 3.9 2.2 0.0 0.6 1.7 4.7 12.7 0.0 0.0 0.4 1.2 0.0 0.0 10.4 0.3 0.9 1.8 0.0 1.3 2.2 0.7 1.0 6.5 0.0 1.1 15.3 1.7 4.8 0.0 315.3 1.3 11.4 28.9 2.5 0.0 10.3 14.7 28.7 6.2 4.8 8.5 7.0 3.2 2.7 2.1 5.1 0.3 0.3 4.5 0.9 0.7 2.6 3.5 1.0 1.3 5.4 3.7 0.8 2.5 2.2 1.6 1.7 1.7 3.5 1.3 2.7 3.4 3.6 0.0 1.6 2.2 1.3 0.0 1.8 0.0 0.2 2.6 3.9 11.6 7.5 0.4 5.3 11.0 7.8 3.8 2.0 1.3 6.7 3.5 9.6 1.3 0.7 8.1 1.5 5.6 0.6 0.7 1.1 4.9 1.6 0.0 1.1 0.1 1.2 1.7 8.1 25.2 12.6 1.5 9.5 1.0 28.7 3.4 12.5 6.8 3.8 4.1 8.9 5.9 5.7 11.4 10.3 2.5 2.8 11.5 4.8 6.2 14.7 8.5 7.0 0.0 0.0 2.2 0.1 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.1 2.3 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.2 0.4 0.0 HIST1H2BA "bA317E16.3, H2BFU, STBP, TSH2B" ENSG00000146047 "Histone cluster 1 H2B family member a" Q96A08 6 25726777-25727292 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 695 "testis: 617.2" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 7.3;Late spermatids: 2.5;Spermatocytes: 13.4;Spermatogonia: 5.3" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB011603, HPA042205, HPA043013" Enhanced NA NA "CAB011603: AB_2118143, HPA042205: AB_2677900, HPA043013: AB_2678269" "unprognostic (3.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 617.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 13.4 5.3 0.0 0.0 0.0 0.0 0.0 HIST1H2BB "H2B/f, H2BFF" ENSG00000276410 "Histone cluster 1 H2B family member b" P33778 6 26043277-26043657 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 104.9" "Cell type enhanced" "Detected in some" 10 "Enterocytes: 1.6;Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 3.7;Karpas-707: 3.6;MOLT-4: 4.5;NB-4: 4.9;THP-1: 5.5;U-266/84: 6.1" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.92e-2)" "unprognostic (9.15e-2)" "unprognostic (3.29e-1)" "unprognostic (2.18e-1)" "unprognostic (2.36e-1)" "unprognostic (1.26e-1)" "unprognostic (6.10e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (2.58e-1)" 0.4 0.3 1.0 6.4 0.3 6.6 0.6 0.5 1.0 0.5 1.0 0.0 0.0 1.1 0.4 0.5 4.1 0.6 0.3 1.0 0.2 0.8 0.3 1.7 3.0 0.1 0.4 0.3 0.5 0.3 0.0 0.9 1.0 0.3 0.3 0.2 0.3 0.3 1.3 1.0 0.8 0.3 0.8 5.8 0.5 15.8 0.1 104.9 0.3 4.8 7.4 0.3 0.0 2.1 10.5 4.2 1.1 0.2 3.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.4 1.1 1.6 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.6 0.0 0.3 1.4 0.6 3.7 3.6 0.0 0.0 4.5 4.9 2.2 0.7 2.1 2.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.3 5.5 0.0 0.3 0.3 0.3 0.9 0.8 6.1 0.0 0.7 1.8 1.3 4.2 1.1 0.8 1.5 0.1 3.9 2.1 3.9 1.6 3.3 1.6 2.0 0.8 3.6 0.2 0.4 10.5 2.9 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.6 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 1.5 0.3 0.1 0.0 0.3 0.0 HIST1H2BC "H2B.1, H2B/l, H2BFL" ENSG00000180596 "Histone cluster 1 H2B family member c" P62807 6 26114873-26123926 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 115.7;lymphoid tissue: 143.2" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 42.1;Glandular cells: 78.6;Urothelial cells: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 20 "neutrophil: 115.7" "Lineage enriched" "Detected in all" 26 "granulocytes: 115.7" "Cell line enhanced" "Detected in many" "K-562: 17.0;SiHa: 33.6;U-2 OS: 23.5;U-266/70: 19.4;U-266/84: 23.8" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (8.30e-3)" "unprognostic (2.60e-2)" "unprognostic (2.37e-2)" "unprognostic (9.26e-2)" "unprognostic (3.20e-2)" "unprognostic (5.08e-2)" "unprognostic (4.72e-1)" "unprognostic (6.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (9.01e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (5.41e-2)" "unprognostic (7.38e-2)" "unprognostic (2.49e-1)" "unprognostic (6.60e-3)" 7.8 5.8 5.5 21.3 7.1 31.3 10.7 2.1 5.9 12.9 11.5 5.9 12.8 5.2 4.1 13.1 20.9 10.8 8.1 5.8 6.5 4.6 8.4 20.2 15.3 11.4 5.4 4.1 5.6 9.6 1.7 9.9 17.5 3.8 31.7 4.1 5.9 12.4 18.6 20.0 10.0 6.0 4.3 10.4 11.7 10.6 9.4 4.5 143.2 6.4 8.7 23.4 12.9 14.3 4.3 2.8 115.7 1.3 1.2 1.8 2.7 3.0 1.8 0.9 0.9 0.9 0.5 1.1 3.0 1.1 2.0 1.7 2.4 1.8 1.1 5.7 1.0 1.5 2.3 1.2 1.2 1.0 2.7 1.0 0.9 2.7 4.1 1.2 1.4 3.8 12.6 0.7 0.8 0.5 1.0 0.8 0.9 17.0 9.5 3.8 3.4 3.2 3.1 1.0 3.2 5.5 1.4 1.3 7.0 3.5 0.7 4.3 1.4 33.6 2.6 1.2 2.6 14.3 1.3 2.4 2.5 23.5 1.5 1.2 19.4 23.8 5.7 1.1 3.7 1.7 4.5 1.1 5.8 1.2 1.3 1.6 2.3 1.8 1.7 0.8 4.3 1.4 1.0 115.7 1.2 1.2 2.8 1.1 2.7 5.5 7.1 2.1 5.9 6.5 4.6 5.4 4.1 3.8 4.5 6.0 2.7 3.0 40.5 0.8 3.0 1.8 5.1 21.4 7.9 3.5 0.0 3.9 1.7 6.8 42.1 2.9 9.5 0.0 8.0 5.4 4.1 78.6 4.6 13.0 5.8 0.0 1.7 1.8 3.7 4.5 1.4 4.6 0.0 1.8 7.4 2.9 25.5 9.9 1.1 3.5 3.9 0.0 1.8 1.8 3.2 1.0 35.8 10.1 4.9 103.5 HIST1H2BD "H2B/b, H2BFB" ENSG00000158373 "Histone cluster 1 H2B family member d" P58876 6 26158146-26171349 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 174.9" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 105.0;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 37.2;U-266/84: 39.2" "Low region specificity" "Detected in some" "HPA042205, HPA043013, HPA048671, CAB062336" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.39e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.32e-1)" "unprognostic (1.98e-1)" "unprognostic (2.83e-2)" "unprognostic (1.54e-1)" "unprognostic (8.10e-2)" "unprognostic (2.28e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-3)" "unprognostic (2.17e-1)" "unprognostic (4.74e-3)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (3.91e-2)" "unprognostic (1.34e-2)" 7.9 6.6 6.0 33.2 9.0 36.4 17.3 14.0 8.9 33.6 17.0 2.9 13.2 8.2 9.5 21.4 18.2 17.4 11.1 17.4 7.5 4.2 19.9 25.3 13.8 32.3 7.7 7.1 33.1 21.7 2.2 11.5 10.1 7.4 43.4 12.9 8.3 13.0 14.7 12.0 14.7 9.5 13.0 18.7 11.0 18.8 7.1 5.6 174.9 9.5 23.9 18.9 13.2 32.7 15.6 12.9 19.3 4.5 6.8 9.6 2.0 5.3 12.2 3.7 2.1 29.3 2.7 1.1 4.7 2.7 6.2 3.9 4.1 4.4 2.4 30.1 5.6 6.9 8.5 2.1 2.0 2.9 11.0 5.2 1.6 9.8 4.3 3.1 2.1 4.6 19.2 3.2 1.7 2.4 2.4 1.5 2.3 16.9 13.5 1.1 19.3 4.8 5.4 3.9 23.1 5.7 1.9 2.4 16.0 5.8 3.9 12.0 5.1 29.9 7.8 4.6 7.6 19.8 0.8 0.9 7.7 20.1 3.1 1.0 37.2 39.2 6.1 1.0 10.0 1.5 19.3 1.5 10.5 5.8 3.4 7.4 8.4 8.9 9.6 3.7 15.6 8.4 5.7 16.6 6.8 4.5 12.9 5.8 2.0 6.0 9.0 14.0 8.9 7.5 4.2 7.7 7.1 7.4 5.6 3.0 5.6 15.9 54.2 1.5 13.9 21.3 12.7 53.5 10.3 21.0 0.0 6.4 19.9 4.3 27.1 2.8 22.0 0.0 3.8 6.2 3.0 105.0 2.3 20.7 3.9 41.3 44.7 1.3 4.0 5.4 6.6 6.9 3.3 3.6 20.2 4.0 12.0 33.1 1.4 75.4 10.4 0.0 1.4 0.9 0.7 2.4 33.0 6.9 14.3 63.6 HIST1H2BE "H2B.h, H2B/h, H2BFH" ENSG00000274290 "Histone cluster 1 H2B family member e" P62807 6 26172059-26184655 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "lymphoid tissue: 165.1" "Cell type enhanced" "Detected in many" 7 "B-cells: 5.6;Glandular cells: 5.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 8.2;REH: 8.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-1)" "unprognostic (7.06e-3)" "unprognostic (8.28e-2)" "unprognostic (1.31e-1)" "unprognostic (7.98e-2)" "unprognostic (3.16e-1)" "unprognostic (1.58e-1)" "unprognostic (1.69e-2)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.55e-6)" "unprognostic (3.03e-2)" "unprognostic (4.86e-2)" "unprognostic (2.30e-1)" "unprognostic (3.11e-2)" 0.7 1.1 0.4 12.2 0.8 5.9 1.8 0.6 1.7 2.5 2.9 0.1 1.8 1.1 1.5 2.9 5.5 1.6 1.6 1.9 0.5 1.7 0.3 1.5 6.7 0.0 1.2 2.1 1.2 0.7 0.0 2.4 0.2 5.2 1.5 0.7 4.0 2.2 2.1 1.9 2.0 1.8 1.6 4.5 2.5 5.4 0.0 165.1 1.2 6.4 7.1 1.8 0.0 3.6 3.1 5.5 1.7 1.6 2.9 0.8 0.5 3.7 3.0 0.9 3.0 0.4 0.4 3.1 1.0 0.5 0.3 0.8 2.1 0.7 1.4 0.5 1.7 4.3 0.5 1.1 0.6 1.6 1.0 0.5 1.5 0.2 0.2 0.3 2.5 0.6 0.2 0.6 0.3 1.1 0.3 0.9 2.4 1.8 0.1 1.6 4.6 8.2 2.4 1.6 1.0 8.0 0.2 2.6 1.4 1.8 2.7 3.7 4.0 1.5 0.9 1.6 2.8 1.6 0.8 1.5 2.7 1.1 1.9 2.4 4.5 0.6 0.6 1.4 0.5 5.2 1.7 2.4 2.0 1.3 1.6 2.1 2.0 2.5 0.7 3.6 1.8 1.7 5.5 1.6 1.5 3.1 2.9 0.8 0.0 0.0 5.6 4.5 0.0 4.3 0.3 2.5 2.7 0.0 1.8 3.9 0.7 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.9 0.3 5.8 1.1 1.0 0.8 9.5 1.2 0.6 4.1 0.0 1.4 0.7 0.0 1.0 0.4 1.2 0.2 0.0 0.7 0.4 2.4 0.0 0.0 1.6 0.9 0.0 0.7 0.0 1.6 4.0 HIST1H2BF "H2B/g, H2BFG" ENSG00000277224 "Histone cluster 1 H2B family member f" P62807 6 26199520-26200715 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "lymphoid tissue: 252.2" "Cell type enhanced" "Detected in some" 8 "B-cells: 6.7;Basal glandular cells: 3.6;Bipolar cells: 5.4;Glandular cells: 5.5;Urothelial cells: 5.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "U-266/70: 21.8;U-266/84: 15.3" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (1.12e-1)" "unprognostic (1.38e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-1)" "unprognostic (1.47e-1)" "unprognostic (6.80e-3)" "unprognostic (3.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.95e-1)" "unprognostic (7.27e-3)" "unprognostic (4.29e-11)" "unprognostic (4.88e-3)" "unprognostic (4.45e-1)" "unprognostic (1.15e-2)" "unprognostic (1.30e-1)" 0.4 1.2 0.0 17.3 0.1 3.8 5.7 0.3 0.7 2.7 3.3 0.4 1.0 0.5 1.6 1.3 9.9 1.3 1.2 0.6 0.0 0.5 0.4 2.5 7.0 0.0 0.2 0.8 0.6 0.4 0.0 3.2 0.2 5.4 1.1 0.5 1.4 1.3 0.2 0.4 3.0 0.3 0.9 8.3 1.3 2.2 0.1 252.2 0.4 3.3 14.6 2.4 0.0 3.0 0.7 6.2 0.7 0.4 1.5 1.2 0.4 0.2 0.2 0.4 0.3 0.0 0.2 0.1 0.1 0.6 0.1 0.5 0.0 0.5 0.9 0.0 0.3 0.9 0.4 0.1 0.3 0.7 0.2 0.3 1.4 0.1 0.1 0.1 0.7 0.2 0.0 0.1 0.1 0.0 0.1 0.4 1.7 3.9 0.0 0.1 3.3 1.4 0.5 0.7 0.5 1.2 0.6 2.4 0.1 0.1 2.1 0.3 4.2 0.8 0.0 0.3 3.8 0.2 0.1 0.3 1.9 0.0 0.5 21.8 15.3 1.2 0.1 1.0 0.4 0.0 0.2 1.4 0.7 0.3 1.5 0.7 0.7 0.8 0.4 3.0 0.6 1.2 6.2 0.4 0.7 0.7 0.6 1.2 0.0 0.3 6.7 3.6 0.0 5.4 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.4 0.0 5.5 0.0 0.4 1.0 0.0 0.0 1.3 0.8 0.0 0.0 0.8 0.0 0.0 0.4 1.2 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.5 2.5 1.0 5.1 HIST1H2BG "H2B.1A, H2B/a, H2BFA" ENSG00000273802 "Histone cluster 1 H2B family member g" P62807 6 26215159-26216692 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 75.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 58.7;Glandular cells: 91.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 8.9;T-47d: 18.1;U-266/70: 16.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.40e-2)" "unprognostic (1.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.13e-1)" "unprognostic (1.05e-1)" "unprognostic (4.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.54e-2)" "unprognostic (6.69e-2)" "unprognostic (1.55e-1)" "unprognostic (2.36e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (1.70e-8)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.97e-2)" 0.4 1.5 0.7 16.5 1.2 8.9 20.2 5.1 3.4 4.3 2.9 0.5 5.1 1.8 2.8 4.0 6.6 2.1 1.8 1.7 0.2 1.2 0.6 2.0 7.2 0.1 2.0 1.3 1.9 0.4 0.5 1.6 0.7 10.3 3.0 1.2 5.0 5.8 0.3 1.6 2.2 2.8 4.7 3.1 2.9 6.7 0.3 75.2 1.0 6.9 8.3 4.3 0.0 5.8 14.6 12.0 1.6 1.3 6.2 2.0 2.5 0.1 1.2 0.0 3.9 0.2 0.3 3.1 0.2 2.0 0.8 0.3 2.2 0.0 3.2 0.3 0.8 2.7 1.1 1.0 1.1 2.2 1.3 0.7 1.2 1.1 0.6 0.3 2.1 1.5 0.5 0.6 0.0 0.1 0.4 0.1 7.8 0.1 0.0 1.8 2.2 1.7 1.2 5.9 1.6 1.5 0.7 4.4 1.2 0.6 7.3 1.1 8.9 3.3 1.0 3.4 18.1 0.8 0.2 0.0 1.0 0.3 0.4 16.9 0.1 0.0 0.3 1.1 0.5 12.0 1.2 2.5 2.0 0.9 6.2 3.7 3.1 3.8 4.4 5.8 1.5 1.3 5.6 1.3 1.6 14.6 2.7 2.0 0.0 12.7 29.3 58.7 0.8 40.1 0.7 5.1 4.0 4.5 5.2 5.9 6.3 0.0 4.8 0.6 0.5 27.1 0.0 0.0 6.6 3.2 91.9 9.3 2.5 17.2 23.8 29.8 2.5 3.5 0.0 2.0 8.0 0.0 1.8 17.9 9.5 1.1 16.4 0.0 1.3 3.0 6.5 0.4 1.4 16.2 0.0 20.1 10.7 14.2 42.2 HIST1H2BH "H2B/j, H2BFJ" ENSG00000275713 "Histone cluster 1 H2B family member h" Q93079 6 26251651-26253710 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "lymphoid tissue: 220.5" "Cell type enhanced" "Detected in some" 13 "B-cells: 6.7;Enterocytes: 8.5;Extravillous trophoblasts: 21.0;Paneth cells: 8.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "AF22: 7.5;U-266/70: 18.1" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.83e-2)" "unprognostic (6.27e-3)" "unprognostic (4.50e-2)" "unprognostic (9.18e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.06e-3)" "unprognostic (3.08e-3)" "unprognostic (1.58e-2)" "unprognostic (2.75e-2)" "unprognostic (1.86e-1)" "unprognostic (3.22e-1)" "unprognostic (2.96e-8)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (2.40e-2)" "unprognostic (1.95e-3)" 0.9 0.6 0.0 25.6 0.0 3.1 2.1 0.0 0.0 0.9 5.5 0.0 0.9 7.8 1.0 2.4 8.4 1.5 4.0 1.8 0.0 0.7 0.0 2.2 11.3 0.0 0.0 0.4 0.1 0.0 0.0 4.9 0.0 1.2 2.2 0.0 1.8 0.1 0.0 0.6 8.1 0.1 0.0 9.6 1.6 3.3 0.0 220.5 0.4 9.5 23.3 1.4 0.0 1.0 0.9 4.7 0.4 1.0 0.7 9.3 1.8 0.1 7.5 0.0 0.0 0.1 1.2 0.9 0.4 1.3 0.6 2.5 1.1 0.0 1.8 0.1 1.9 3.6 0.0 0.6 1.9 0.9 0.1 1.4 5.6 0.4 0.0 0.0 4.3 0.3 0.3 0.5 0.5 0.0 0.3 1.0 2.7 6.6 0.1 2.0 3.8 2.7 1.7 0.0 1.9 4.1 0.0 1.0 0.0 2.8 3.4 3.1 4.4 1.5 0.6 0.3 2.2 3.4 0.0 0.6 0.0 0.8 3.2 18.1 4.5 0.0 0.5 1.5 4.0 3.5 0.4 0.7 0.5 0.0 0.2 1.0 0.3 0.7 0.9 0.6 0.1 0.2 4.7 1.0 0.2 0.4 0.7 9.3 0.0 0.0 6.7 2.8 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 8.5 0.0 0.2 21.0 0.5 1.0 0.0 0.0 6.1 0.0 0.0 0.6 2.2 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 8.6 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.3 3.8 4.9 3.7 3.6 HIST1H2BI "H2B/k, H2BFK" ENSG00000278588 "Histone cluster 1 H2B family member i" P62807 6 26272976-26273356 "Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 150.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 5.4;MOLT-4: 15.1;THP-1: 6.3" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.59e-1)" "unprognostic (7.10e-2)" "unprognostic (8.53e-2)" "unprognostic (1.52e-1)" "unprognostic (2.80e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (7.22e-3)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" 0.5 0.1 0.0 19.0 0.0 8.9 1.2 0.4 0.1 1.3 3.1 0.0 0.5 0.1 0.7 2.1 6.6 0.4 2.0 1.3 0.0 0.3 0.1 2.0 6.3 0.0 0.0 0.7 0.1 0.1 0.0 2.8 0.0 0.1 0.3 0.0 1.3 0.3 0.1 1.2 1.9 0.1 0.1 11.1 0.4 1.9 0.0 150.8 0.4 8.2 14.5 2.2 0.0 4.7 0.7 0.9 1.3 0.4 4.6 0.2 1.9 0.8 1.2 0.0 0.0 0.0 0.2 0.7 0.7 2.0 5.4 0.8 0.0 0.9 0.5 0.5 0.7 0.9 1.8 0.5 0.8 2.7 0.0 0.4 0.8 0.6 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 1.8 2.2 0.0 3.9 0.0 0.8 15.1 2.5 2.9 0.6 0.0 4.1 0.0 5.0 0.0 0.4 0.3 0.9 1.1 1.0 0.0 0.1 0.0 6.3 0.9 0.9 0.0 0.6 3.1 3.2 0.4 0.0 1.1 0.5 2.2 0.2 0.5 0.0 3.4 1.3 2.2 2.2 3.2 4.6 0.7 4.7 1.4 0.8 0.9 0.4 0.1 0.3 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 HIST1H2BJ "H2B/r, H2BFR" ENSG00000124635 "Histone cluster 1 H2B family member j" P06899 6 27125897-27132750 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 124.3" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 63.4;Erythroid cells: 23.3;Glandular cells: 25.8;Spermatocytes: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 13.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 13.6" "Cell line enhanced" "Detected in many" "K-562: 42.1;Karpas-707: 24.8;SiHa: 37.9;U-2 OS: 42.0;U-266/70: 35.8;U-266/84: 44.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (4.02e-2)" "prognostic favorable (1.51e-4)" "unprognostic (8.58e-2)" "unprognostic (2.34e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (3.03e-1)" "unprognostic (2.98e-1)" "unprognostic (1.88e-1)" "unprognostic (1.49e-2)" "unprognostic (1.90e-3)" "unprognostic (2.23e-1)" "unprognostic (3.57e-4)" "unprognostic (8.67e-2)" "unprognostic (5.80e-2)" "unprognostic (1.57e-2)" "unprognostic (6.16e-2)" 4.1 2.2 1.5 30.0 2.4 10.7 11.3 0.9 1.9 12.8 6.2 1.6 3.9 2.1 3.1 5.9 12.8 5.1 2.8 6.0 2.5 1.7 1.9 3.9 7.3 12.0 3.2 0.9 1.3 5.1 0.6 1.2 5.1 2.9 8.0 3.0 0.5 4.0 4.8 5.9 2.9 2.8 2.8 5.9 12.0 5.1 30.5 2.2 124.3 2.7 10.1 22.3 5.2 9.4 2.2 1.0 13.6 0.6 0.7 2.4 14.7 3.8 4.8 1.4 1.3 7.2 0.5 1.9 2.1 1.3 8.5 3.6 4.1 2.2 0.6 6.9 2.3 3.9 2.8 2.1 1.9 4.7 4.5 3.6 1.1 5.5 0.2 0.6 0.5 3.0 3.4 0.2 1.8 0.8 1.2 0.5 1.7 42.1 24.8 2.2 2.0 1.7 2.5 1.7 3.9 4.5 0.9 1.2 3.8 1.0 1.4 9.4 1.1 37.9 2.5 1.1 2.1 0.1 1.5 1.1 2.1 42.0 1.6 0.9 35.8 44.0 10.1 0.5 11.8 1.0 1.8 0.6 0.7 0.5 0.5 0.8 1.6 0.7 0.3 0.4 2.2 0.4 0.5 13.6 0.7 0.2 1.0 2.4 14.7 1.5 2.4 0.9 1.9 2.5 1.7 3.2 0.9 2.9 2.2 0.0 0.0 0.0 10.4 5.5 0.0 2.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.4 63.4 0.6 4.0 23.3 0.3 3.2 2.4 25.8 0.0 1.5 3.3 0.0 12.6 4.9 2.6 19.3 1.1 2.4 6.8 4.6 2.6 0.0 2.4 7.0 1.4 0.0 0.0 0.0 3.1 30.9 9.1 4.6 5.1 4.5 2.3 9.5 HIST1H2BK "H2BFAiii, H2BFT" ENSG00000197903 "Histone cluster 1 H2B family member k" O60814 6 27146418-27146798 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 243.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 23.8;Basal keratinocytes: 28.0;Melanocytes: 38.8;Suprabasal keratinocytes: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 117.4;U-2 OS: 107.1;U-266/84: 140.9" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.78e-2)" "unprognostic (4.70e-3)" "unprognostic (9.00e-3)" "unprognostic (1.30e-1)" "unprognostic (3.81e-1)" "unprognostic (4.50e-2)" "unprognostic (6.50e-2)" "unprognostic (4.27e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-3)" "unprognostic (3.46e-3)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (3.93e-2)" "unprognostic (1.49e-1)" "unprognostic (7.59e-2)" "unprognostic (2.37e-2)" 9.4 6.0 3.0 39.8 4.1 7.8 8.6 2.4 3.6 14.9 11.0 2.5 10.5 8.4 8.0 14.6 19.1 13.5 10.5 9.8 4.3 3.7 4.0 19.3 12.7 25.9 3.6 2.3 8.5 17.4 0.6 5.9 18.7 2.0 16.0 5.3 3.5 11.3 10.7 3.7 6.3 10.3 6.9 7.6 28.0 13.7 30.6 1.9 243.8 8.9 32.3 26.4 11.5 16.7 26.5 22.1 60.7 16.2 5.0 11.5 12.5 6.2 16.3 2.6 4.5 11.7 4.4 9.0 10.4 7.5 15.0 9.7 14.7 8.3 2.0 35.1 5.9 10.5 8.2 3.1 3.2 2.2 9.3 15.7 3.5 10.2 0.5 5.1 2.7 21.3 21.0 2.8 2.5 2.8 4.2 3.0 1.3 117.4 23.8 6.7 17.1 5.0 5.0 2.3 22.7 7.0 3.2 1.7 26.5 5.6 2.8 13.2 7.6 61.8 21.2 5.6 2.4 54.8 3.2 3.4 6.7 107.1 6.2 1.8 32.7 140.9 18.6 3.9 28.0 3.8 33.8 9.4 60.7 4.1 8.3 3.9 20.3 4.2 4.1 9.6 26.5 5.0 3.9 60.1 5.0 16.2 22.1 11.5 12.5 3.0 4.1 2.4 3.6 4.3 3.7 3.6 2.3 2.0 1.9 23.8 9.4 4.3 0.6 28.0 0.0 0.4 0.0 13.4 6.8 0.0 0.0 1.2 0.0 1.3 0.1 2.1 2.6 0.0 1.0 2.6 1.9 0.5 4.7 1.7 0.9 0.0 0.0 2.5 2.2 0.0 0.0 4.9 38.8 4.6 1.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 1.5 0.4 3.0 29.2 3.2 9.6 1.2 0.5 HIST1H2BL "dJ97D16.4, H2B/c, H2BFC" ENSG00000185130 "Histone cluster 1 H2B family member l" Q99880 6 27807444-27807931 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "lymphoid tissue: 217.6" "Cell type enhanced" "Detected in single" 13 "Club cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 13.2;U-266/84: 13.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.32e-3)" "unprognostic (2.46e-2)" "unprognostic (2.22e-1)" "unprognostic (1.02e-3)" "unprognostic (2.32e-3)" "unprognostic (2.66e-1)" "unprognostic (9.22e-2)" "unprognostic (1.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (8.02e-3)" "unprognostic (3.25e-2)" "unprognostic (1.81e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" 1.2 1.0 0.2 13.9 1.0 13.7 1.6 1.4 0.6 1.8 5.1 0.0 0.3 0.6 0.8 0.6 7.4 0.9 0.9 1.3 0.9 0.7 0.3 0.6 1.5 3.5 0.5 0.0 1.3 1.2 1.2 0.2 1.9 0.0 1.2 1.1 0.0 0.7 0.2 0.2 0.9 3.9 0.7 2.8 4.8 0.8 1.5 0.0 217.6 1.2 5.9 15.6 1.1 1.2 1.9 1.2 7.7 0.6 0.4 2.0 0.9 2.4 2.2 0.7 2.3 0.0 0.0 0.1 1.4 0.4 1.3 3.3 1.0 1.7 0.9 0.5 0.3 0.7 1.6 0.0 0.2 0.4 1.1 3.2 1.7 3.1 3.8 0.0 2.8 2.4 1.0 0.0 0.0 0.0 0.2 0.7 2.1 2.2 5.8 0.0 6.1 13.2 4.9 2.2 1.6 3.4 3.1 0.0 1.4 0.0 2.2 3.1 1.1 4.0 1.6 0.2 0.2 1.4 1.0 0.5 0.1 1.7 1.3 1.0 3.3 13.0 4.3 0.4 5.1 0.5 0.6 0.5 4.0 1.1 0.2 1.3 1.9 0.6 1.1 1.2 1.3 0.4 0.6 7.7 0.4 0.6 0.7 2.0 0.9 0.2 1.0 1.4 0.5 0.9 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.2 HIST1H2BM "dJ160A22.3, H2B/e, H2BFE" ENSG00000273703 "Histone cluster 1 H2B family member m" Q99879 6 27815044-27815424 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "lymphoid tissue: 232.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.6;NK-cells: 1.5;T-cells: 1.7" "Cell line enhanced" "Detected in many" "Karpas-707: 17.7;NB-4: 11.4;REH: 7.3;U-266/70: 13.7;U-698: 7.0" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (3.83e-1)" "unprognostic (8.85e-4)" "unprognostic (3.74e-1)" "unprognostic (2.00e-1)" "unprognostic (3.00e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.37e-1)" "unprognostic (9.46e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-1)" "unprognostic (2.65e-1)" 0.1 0.1 0.0 19.9 0.0 11.6 0.1 0.0 0.2 1.6 3.4 0.0 0.0 0.1 0.7 0.9 8.4 0.1 1.4 0.3 0.0 0.1 0.3 1.8 7.3 0.0 0.0 0.3 0.1 0.1 0.0 1.5 0.0 0.5 1.1 0.0 0.3 0.1 0.1 0.8 3.8 0.1 0.5 13.9 0.5 3.5 0.0 232.2 0.1 9.4 27.6 0.1 0.0 2.6 0.4 0.3 0.3 1.5 1.7 0.0 1.5 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.5 2.1 0.4 0.3 2.3 0.0 0.0 0.5 1.1 0.0 0.0 0.0 1.2 0.0 0.8 0.2 0.8 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.2 17.7 0.0 0.5 4.6 11.4 3.4 1.1 0.8 7.3 0.0 0.4 0.0 0.0 0.2 2.0 0.8 1.1 0.0 0.1 1.0 3.4 0.0 0.0 2.0 1.2 0.1 13.7 0.5 7.0 1.1 1.3 0.9 0.0 0.1 0.1 1.5 0.3 1.7 1.9 1.7 1.5 0.4 2.6 0.1 1.2 0.3 1.5 0.0 0.2 0.6 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 HIST1H2BN "H2B/d, H2BFD" ENSG00000233822 "Histone cluster 1 H2B family member n" Q99877 6 27837760-27865798 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "lymphoid tissue: 193.3" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 27.8;Rod photoreceptor cells: 26.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 14.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 8.9;SCLC-21H: 9.8;U-266/84: 9.2" "Low region specificity" "Detected in all" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.33e-1)" "unprognostic (3.25e-2)" "unprognostic (3.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-1)" "unprognostic (4.41e-2)" "unprognostic (2.95e-3)" "unprognostic (2.05e-3)" "unprognostic (1.14e-4)" "unprognostic (9.62e-2)" "unprognostic (3.91e-1)" "unprognostic (9.62e-2)" "unprognostic (2.22e-2)" 2.4 7.2 2.3 14.0 3.3 9.3 3.1 4.9 6.2 3.4 4.5 1.0 4.4 1.8 3.4 3.7 7.6 3.2 3.7 6.4 3.7 2.4 2.3 5.3 5.4 8.0 4.1 4.2 5.0 8.3 4.2 3.8 4.5 1.4 4.0 2.5 1.7 3.3 4.7 4.6 2.3 4.3 2.5 9.4 7.0 2.4 6.8 0.5 193.3 6.1 6.2 10.9 3.6 2.2 6.0 6.2 14.6 2.6 1.0 2.8 1.4 1.4 0.2 1.5 1.5 1.2 2.0 0.9 0.7 1.1 0.7 0.8 0.5 0.9 0.8 3.0 0.7 0.9 2.1 1.3 0.5 0.3 1.5 4.5 0.7 3.7 1.4 1.4 1.0 3.7 1.3 0.4 0.1 1.3 1.1 0.2 1.4 8.9 7.0 0.8 1.8 2.9 4.5 1.4 1.2 1.0 2.1 1.0 5.3 0.4 0.9 9.8 2.0 3.5 1.3 3.0 1.0 2.5 0.8 1.5 2.2 2.1 1.2 0.7 6.1 9.2 3.6 0.7 1.7 0.7 2.3 2.6 1.7 2.6 2.4 1.8 5.8 2.0 1.9 5.0 6.0 1.3 1.2 14.6 1.0 1.8 6.2 2.8 1.4 2.3 3.3 4.9 6.2 3.7 2.4 4.1 4.2 1.4 0.5 0.0 3.2 20.4 5.8 0.9 7.5 2.3 0.0 5.3 2.3 0.0 2.0 9.8 1.7 0.1 3.8 2.7 27.8 0.0 0.7 3.9 3.3 5.0 3.5 1.7 9.0 6.4 4.1 1.8 4.3 0.9 2.8 4.9 6.8 1.0 10.0 15.8 0.8 7.0 1.8 2.0 26.9 0.0 8.3 0.9 2.1 2.0 4.2 20.0 5.2 1.7 HIST1H2BO "H2B.2, H2B/n, H2BFN" ENSG00000274641 "Histone cluster 1 H2B family member o" P23527 6 27893463-27893843 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 164.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 29.4" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (7.22e-2)" "unprognostic (1.77e-3)" "unprognostic (9.47e-2)" "unprognostic (4.43e-2)" "unprognostic (6.67e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.48e-2)" "unprognostic (1.55e-2)" "unprognostic (7.91e-2)" "unprognostic (7.81e-3)" "unprognostic (2.88e-3)" "unprognostic (4.04e-7)" "unprognostic (4.39e-2)" "unprognostic (3.41e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.89e-4)" 1.9 0.4 0.0 14.9 0.0 8.1 1.5 0.0 0.0 0.9 3.9 0.0 0.0 0.9 0.6 1.6 9.9 0.0 0.7 1.5 0.0 0.3 0.5 2.6 7.4 0.0 0.0 0.0 0.0 0.7 0.0 4.4 0.1 0.3 1.5 0.0 1.2 0.0 0.3 1.5 2.1 0.1 0.5 8.1 0.7 1.4 0.0 164.5 0.0 7.1 15.4 1.1 0.0 2.6 2.2 6.5 0.8 1.3 1.7 5.5 2.2 2.9 1.5 4.4 0.7 0.0 2.7 0.8 0.1 5.5 5.4 1.1 1.3 2.6 1.9 0.2 1.2 2.3 2.5 0.5 0.7 1.8 1.9 1.7 4.5 1.7 0.0 0.2 1.1 0.3 0.0 0.4 0.5 0.1 1.4 2.1 6.5 7.3 0.2 0.5 11.2 9.4 1.7 1.7 2.2 6.5 1.5 4.9 0.9 0.3 6.3 1.3 4.7 1.2 0.7 0.5 2.0 0.2 0.0 1.5 0.3 1.7 2.0 8.1 29.4 7.5 0.9 9.5 0.7 1.3 0.3 3.8 0.8 0.6 1.1 1.4 0.8 1.7 2.2 2.6 0.5 0.5 6.5 1.3 0.8 1.7 1.4 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 HIST1H3A "H3/A, H3FA" ENSG00000275714 "Histone cluster 1 H3 family member a" P68431 6 26020490-26020900 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.1;testis: 78.7" "Cell type enhanced" "Detected in some" 5 "Club cells: 2.3;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 5.6;U-2 OS: 9.0" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (3.07e-1)" "unprognostic (3.47e-2)" "unprognostic (4.60e-2)" "unprognostic (2.36e-5)" "unprognostic (2.85e-2)" "unprognostic (3.48e-1)" "unprognostic (3.48e-1)" "unprognostic (4.02e-2)" "unprognostic (5.03e-3)" "unprognostic (4.39e-2)" "unprognostic (6.34e-3)" "unprognostic (2.00e-2)" "unprognostic (8.85e-3)" "unprognostic (1.58e-2)" "unprognostic (1.39e-1)" "unprognostic (8.15e-2)" "unprognostic (3.21e-2)" 1.6 2.1 0.8 6.3 0.5 23.5 1.2 8.0 7.2 2.1 1.2 0.0 1.2 0.9 1.9 4.8 3.0 1.5 2.1 2.5 0.9 1.8 1.1 2.1 2.6 0.0 2.5 1.6 2.9 0.9 1.1 1.2 2.4 1.4 1.8 1.6 1.2 1.0 0.9 1.3 1.5 2.3 0.8 2.6 1.3 78.7 0.0 40.1 1.6 4.1 8.4 0.9 0.0 3.9 5.2 14.6 1.6 8.8 3.9 1.5 1.5 0.0 1.7 0.0 1.5 0.7 0.0 2.4 0.0 2.0 4.3 0.0 0.8 1.5 0.9 0.0 0.6 0.0 2.6 0.6 4.0 0.8 3.1 2.5 0.8 0.0 0.0 0.3 2.2 0.0 0.0 0.4 0.0 0.0 2.0 1.9 0.2 0.2 0.0 5.6 4.0 1.8 2.2 1.1 2.5 2.7 1.2 0.0 0.5 1.3 1.2 2.5 1.9 3.2 0.5 0.0 0.2 2.0 0.0 0.0 9.0 0.8 1.0 0.5 0.4 0.0 1.1 3.1 2.9 11.1 1.5 4.3 3.9 1.6 3.3 2.1 2.8 2.3 3.0 3.9 2.2 1.7 14.6 8.8 0.9 5.2 3.8 1.5 0.0 1.4 0.8 0.4 0.3 0.6 0.3 0.0 1.4 2.3 0.0 0.0 0.2 0.0 0.0 0.6 0.4 1.8 0.0 0.0 0.2 0.6 0.2 1.1 0.5 0.6 0.0 0.0 0.6 1.5 0.0 0.0 0.6 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 1.0 0.0 0.3 1.4 1.9 0.1 0.0 1.9 0.2 0.1 HIST1H3B "H3/l, H3FL" ENSG00000274267 "Histone cluster 1 H3 family member b" P68431 6 26031650-26032060 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "lymphoid tissue: 343.5" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 5.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 12.0" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (2.82e-1)" "unprognostic (2.64e-2)" "unprognostic (1.09e-1)" "unprognostic (5.59e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-2)" "unprognostic (2.31e-2)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (2.03e-2)" "unprognostic (1.08e-2)" "unprognostic (5.34e-2)" "unprognostic (2.31e-7)" "unprognostic (8.52e-2)" "unprognostic (2.78e-1)" "unprognostic (1.90e-3)" 1.7 0.7 0.0 36.1 0.0 18.1 3.6 0.0 0.3 0.8 6.9 0.0 0.0 0.3 0.8 2.5 11.8 0.5 1.9 2.4 0.0 0.6 0.3 3.4 10.4 0.0 0.0 0.3 0.3 0.3 0.0 7.8 0.0 0.3 0.8 0.0 1.0 0.3 0.3 0.3 6.3 0.8 0.0 14.7 0.5 26.9 0.0 343.5 0.8 18.2 27.7 0.3 0.0 0.8 0.1 1.2 0.0 0.0 1.4 3.1 1.8 4.6 1.3 4.0 0.0 0.4 0.0 0.2 0.8 0.8 0.7 1.1 1.0 3.0 2.0 0.3 1.2 0.7 1.6 1.2 1.7 2.0 4.4 3.2 6.0 1.3 0.0 2.4 2.1 2.9 0.0 0.6 0.0 0.1 1.0 0.9 6.5 5.9 1.1 1.0 7.4 7.4 3.1 0.7 3.2 4.3 2.9 8.5 0.5 0.0 2.1 1.7 5.1 1.6 0.5 0.1 2.8 1.5 1.4 1.4 4.1 0.7 1.7 9.6 12.0 3.9 3.4 4.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 0.1 0.5 0.0 0.2 1.2 0.0 0.0 0.0 1.4 3.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.1 0.2 0.0 0.6 0.1 HIST1H3C "H3.1, H3/c, H3FC" ENSG00000278272 "Histone cluster 1 H3 family member c" P68431 6 26045411-26045821 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 306.0" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 1.7;Enterocytes: 2.1;Extravillous trophoblasts: 1.6;Spermatogonia: 3.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-937: 11.1" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.29e-1)" "unprognostic (1.91e-1)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.79e-1)" "unprognostic (2.21e-1)" "unprognostic (5.78e-3)" "unprognostic (7.63e-2)" "unprognostic (1.42e-1)" "unprognostic (4.39e-3)" "unprognostic (3.08e-3)" "unprognostic (1.65e-1)" "unprognostic (1.13e-2)" "unprognostic (2.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (5.27e-2)" 1.7 0.2 0.0 23.3 0.0 12.8 1.8 0.0 0.7 1.0 5.1 0.0 0.0 1.2 0.5 1.5 10.1 0.4 1.6 1.8 0.0 2.8 0.6 3.0 10.9 0.0 0.0 0.2 0.4 0.2 0.0 6.6 0.0 0.6 1.1 0.0 1.0 0.2 0.2 0.7 5.4 0.2 0.0 18.8 1.0 29.9 0.0 306.0 0.2 9.9 25.2 2.3 0.0 2.2 1.0 0.3 0.2 3.3 3.7 1.9 2.6 0.6 1.3 0.0 0.6 0.0 0.0 2.1 0.9 5.1 5.2 0.0 0.4 0.0 0.1 0.5 2.4 1.3 0.0 0.5 3.6 3.7 0.4 4.2 0.5 3.7 0.4 2.7 1.7 0.0 0.4 1.4 0.0 0.7 1.6 0.4 0.0 0.0 0.0 0.0 4.0 5.2 2.3 2.6 5.1 4.7 0.0 0.0 0.6 5.6 0.1 1.7 5.1 3.2 0.5 0.2 1.4 1.6 0.0 0.0 0.0 2.1 3.5 2.4 0.1 0.0 1.5 11.1 3.5 0.0 0.2 0.0 1.5 0.1 0.0 1.5 0.6 1.1 1.0 2.2 0.6 2.2 0.3 3.3 0.0 0.9 3.7 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.1 0.2 0.0 2.1 0.0 0.0 1.6 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.8 0.0 0.5 0.0 1.0 0.1 HIST1H3D "H3/b, H3FB" ENSG00000197409 "Histone cluster 1 H3 family member d" P68431 6 26196840-26197250 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 185.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 8.1;U-266/70: 11.4;U-266/84: 6.2" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (8.64e-2)" "unprognostic (1.27e-2)" "unprognostic (9.06e-3)" "unprognostic (2.00e-1)" "unprognostic (6.59e-2)" "unprognostic (1.43e-2)" "unprognostic (8.62e-2)" "unprognostic (1.56e-1)" "unprognostic (2.95e-1)" "unprognostic (2.69e-2)" "unprognostic (2.80e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (1.78e-6)" "unprognostic (2.44e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (4.94e-2)" 1.2 2.7 0.6 18.3 0.6 24.3 1.5 2.0 1.3 4.4 4.1 0.0 3.0 2.9 1.0 3.0 8.0 1.2 2.3 1.3 1.2 0.9 2.3 3.1 2.5 8.0 0.8 0.7 4.3 1.0 1.0 1.6 2.6 0.3 6.4 1.2 0.7 3.3 4.3 1.0 1.6 3.8 1.4 2.4 9.2 2.2 12.4 0.0 185.6 1.4 5.9 19.9 3.2 6.8 8.9 3.4 15.3 1.8 1.6 6.6 0.5 0.9 0.2 0.0 2.1 0.0 0.5 0.9 0.0 0.5 0.3 2.6 3.5 0.2 2.2 2.1 0.3 0.0 0.6 0.2 0.5 0.0 3.0 0.8 0.0 1.7 0.0 0.1 0.7 1.1 0.4 0.4 0.0 0.0 0.0 0.3 0.4 0.3 8.1 0.0 1.7 2.2 4.1 0.4 0.0 1.1 2.6 0.0 1.2 0.0 0.3 0.1 0.0 0.0 2.1 1.0 0.2 0.4 2.9 0.0 0.0 4.0 0.0 1.6 11.4 6.2 0.7 2.0 1.7 0.9 8.9 1.4 3.3 2.5 0.8 6.6 5.5 1.6 2.0 3.0 8.9 1.5 2.6 15.3 1.6 1.8 3.4 1.9 0.5 0.6 0.6 2.0 0.6 1.2 0.9 0.8 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 HIST1H3E "H3.1, H3/d, H3FD" ENSG00000274750 "Histone cluster 1 H3 family member e" P68431 6 26224199-26227473 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 22.4;testis: 19.9;tongue: 25.6" "Cell type enhanced" "Detected in some" 6 "Hepatocytes: 3.4;Mucus-secreting cells: 2.9;Paneth cells: 3.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 11.9;hTERT-RPE1: 8.5;SCLC-21H: 13.4;T-47d: 8.2" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (2.42e-2)" "unprognostic (1.78e-1)" "unprognostic (1.78e-3)" "unprognostic (9.07e-2)" "unprognostic (1.34e-1)" "unprognostic (3.65e-1)" "unprognostic (1.23e-1)" "unprognostic (3.90e-1)" "unprognostic (1.83e-1)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (2.39e-2)" "unprognostic (1.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (7.66e-2)" 0.6 4.8 0.0 2.8 1.2 0.2 2.6 2.4 1.2 2.6 3.6 1.9 5.2 6.1 2.5 6.9 14.5 1.6 3.0 7.4 0.0 0.7 0.9 2.1 4.1 4.1 0.0 2.5 0.6 2.5 0.5 2.9 1.8 4.6 2.4 0.5 4.4 1.8 6.1 1.3 6.1 2.5 1.8 2.3 3.5 19.9 3.2 22.4 3.6 25.6 8.8 2.7 0.3 2.6 3.9 6.5 1.8 0.5 3.1 1.4 2.0 2.2 3.2 1.4 3.8 1.8 0.2 1.5 1.6 0.8 0.6 0.7 1.2 0.0 11.9 0.6 1.1 2.5 0.0 0.4 0.7 3.1 2.8 0.4 1.0 0.7 1.2 0.2 1.9 2.6 2.7 0.3 0.8 8.5 1.2 0.2 0.3 2.4 2.2 1.9 0.4 0.1 0.2 1.5 2.1 1.5 0.6 0.3 6.4 1.2 13.4 1.5 2.1 3.3 3.6 0.5 8.2 1.3 0.6 1.5 0.5 0.4 0.3 0.9 0.3 0.2 0.7 0.1 0.8 0.4 1.8 0.0 1.3 1.5 1.7 1.4 1.8 1.7 1.2 2.6 1.7 1.8 6.5 0.5 1.3 3.9 3.1 1.4 0.0 2.2 0.0 0.5 0.0 0.4 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 2.0 0.0 0.2 0.2 0.0 0.6 0.0 3.4 0.8 1.6 0.0 1.3 1.2 0.7 0.6 0.0 0.0 1.0 2.9 0.3 0.1 3.5 0.0 1.0 0.0 0.0 0.1 0.1 0.5 0.0 1.1 0.0 0.6 0.1 HIST1H3F "H3/i, H3FI" ENSG00000277775 "Histone cluster 1 H3 family member f" P68431 6 26250195-26250605 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "lymphoid tissue: 198.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 8.5;U-266/84: 9.5" "HPA042570, CAB070190" Approved NA NA "CAB070190: AB_10001790, HPA042570: AB_2678056" "unprognostic (1.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (6.10e-3)" "unprognostic (1.91e-6)" "unprognostic (9.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (2.14e-1)" "unprognostic (1.00e-1)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.60e-4)" 1.1 0.9 0.0 26.8 0.0 8.0 3.9 0.0 0.2 0.5 4.5 0.0 0.2 1.5 0.7 2.4 8.6 0.4 2.2 4.2 0.0 0.3 0.2 2.5 17.0 0.0 0.0 0.2 0.2 0.2 0.0 3.8 0.0 0.4 0.4 0.0 0.8 0.2 0.7 0.7 4.6 0.5 0.0 10.8 1.1 2.8 0.0 198.6 0.4 11.5 25.3 0.9 0.0 4.5 1.3 0.0 0.6 0.0 0.9 0.4 1.4 0.0 2.2 0.0 0.0 0.0 1.6 1.3 0.0 2.5 0.7 0.0 0.0 0.2 1.1 0.0 0.6 0.9 0.0 1.1 0.0 1.5 0.5 1.7 4.6 0.0 0.0 0.0 2.7 0.0 0.0 0.8 0.0 0.0 1.3 1.8 2.5 1.9 0.0 1.9 3.5 8.5 0.0 0.0 2.5 3.8 0.0 1.3 0.0 0.3 4.4 1.0 1.6 0.8 0.0 0.3 3.2 2.8 0.0 0.4 0.0 0.2 2.0 2.2 9.5 0.0 2.5 3.1 1.1 0.0 0.5 0.0 0.5 0.0 0.1 4.5 0.1 0.0 1.3 1.3 0.3 0.0 0.0 0.0 0.6 0.0 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 HIST1H3G "H3/h, H3FH" ENSG00000273983 "Histone cluster 1 H3 family member g" P68431 6 26269405-26271815 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "lymphoid tissue: 247.1" "Cell type enhanced" "Detected in some" 23 "Spermatogonia: 11.1;Undifferentiated cells: 2.8" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SiHa: 10.3;U-266/70: 9.7" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.88e-1)" "prognostic favorable (8.75e-4)" "unprognostic (3.14e-1)" "unprognostic (2.58e-1)" "unprognostic (6.94e-2)" "unprognostic (8.74e-2)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-1)" "unprognostic (2.02e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (1.21e-3)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (3.90e-2)" "unprognostic (7.23e-2)" 0.7 0.4 0.0 14.6 0.0 1.9 1.7 0.0 0.0 0.5 5.2 0.0 0.0 2.1 0.1 2.2 9.1 1.5 0.8 1.1 0.0 0.2 0.0 1.0 7.3 0.0 0.0 0.1 0.0 0.3 0.0 4.8 0.0 0.1 1.6 0.0 0.4 0.4 0.0 0.3 4.7 0.4 0.0 13.6 1.0 5.0 0.0 247.1 1.0 8.0 15.9 0.7 0.0 1.6 0.4 0.6 0.4 0.2 1.5 0.7 1.1 0.2 1.1 0.0 0.1 0.2 0.5 0.5 0.2 1.2 0.5 4.0 0.0 0.0 0.6 0.1 1.2 3.3 1.3 0.6 0.8 1.0 0.0 0.1 2.6 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.3 0.0 0.3 0.8 0.0 2.3 0.0 2.4 1.1 0.4 2.0 3.6 0.0 0.8 0.0 1.4 0.7 0.8 0.3 0.6 10.3 3.2 0.0 0.0 0.1 0.6 0.3 0.5 0.0 0.0 0.2 9.7 0.3 0.0 0.5 0.0 1.2 0.0 0.0 0.3 0.3 0.1 0.4 1.1 1.5 1.0 0.4 1.6 0.0 0.5 0.6 0.2 0.4 0.0 1.5 0.7 0.0 0.0 0.8 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 1.6 0.0 0.0 1.6 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.6 0.6 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.7 0.0 2.8 0.1 HIST1H3H "H3/k, H3F1K, H3FK" ENSG00000278828 "Histone cluster 1 H3 family member h" P68431 6 27810064-27811300 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "blood: 55.3;lymphoid tissue: 204.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 9.9;Intestinal endocrine cells: 5.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 15.9;neutrophil: 10.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 15.9" "Cell line enhanced" "Detected in many" "K-562: 17.8;SiHa: 15.5;U-266/70: 13.2;U-266/84: 32.1" HPA042570 Approved NA Yes "HPA042570: AB_2678056" "unprognostic (1.61e-1)" "prognostic favorable (4.35e-4)" "unprognostic (1.79e-1)" "unprognostic (1.63e-2)" "unprognostic (3.68e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (3.01e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (9.25e-6)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.73e-5)" "unprognostic (4.09e-1)" "unprognostic (4.94e-1)" "unprognostic (3.70e-1)" "unprognostic (2.82e-2)" 1.2 2.6 0.0 25.2 0.0 7.5 1.7 0.2 0.3 1.7 4.7 0.0 2.5 2.3 1.6 2.5 9.0 0.6 3.0 1.3 0.0 0.4 3.1 4.4 8.1 0.0 0.0 2.2 1.5 1.4 0.0 3.4 0.1 2.7 5.3 0.5 0.9 2.8 0.8 0.3 3.9 1.0 0.2 11.0 3.1 3.4 0.0 204.8 1.3 10.6 22.6 1.7 0.9 1.1 1.8 15.9 1.1 0.3 2.0 55.3 1.0 3.9 1.7 1.4 2.4 0.3 0.2 0.6 0.4 1.9 0.7 1.2 1.1 0.7 3.7 0.4 1.1 2.1 0.6 0.9 1.2 4.9 2.4 0.9 3.5 5.0 0.6 0.8 1.5 3.2 0.3 0.4 0.4 0.8 0.8 0.9 17.8 8.6 0.3 7.8 1.6 1.9 0.8 7.2 1.5 0.8 0.0 8.9 2.0 0.4 5.2 1.0 15.5 3.2 0.6 0.9 7.5 0.2 0.8 0.8 2.5 0.5 0.2 13.2 32.1 2.7 0.0 4.2 0.2 15.9 1.1 2.1 0.3 0.3 0.4 0.3 0.6 0.5 0.8 1.1 0.4 0.3 10.3 0.3 0.3 1.8 2.0 55.3 0.0 1.0 2.7 3.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 9.9 0.0 0.2 2.9 0.8 4.6 0.0 1.5 1.8 0.0 5.8 0.0 1.8 0.0 0.6 0.0 1.7 1.0 2.9 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.3 0.0 1.0 0.1 4.3 4.3 1.7 1.4 HIST1H3I "H3.f, H3/f, H3FF" ENSG00000275379 "Histone cluster 1 H3 family member i" P68431 6 27871905-27872315 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "lymphoid tissue: 236.8" "Cell type enhanced" "Detected in single" 15 "Alveolar cells type 2: 1.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.0" "Cell type enhanced" "Detected in many" "NK-cell: 12.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 4.6;MOLT-4: 8.4;NB-4: 5.6;REH: 8.8" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.60e-1)" "unprognostic (5.58e-2)" "unprognostic (8.16e-2)" "unprognostic (1.06e-1)" "unprognostic (6.48e-2)" "unprognostic (2.39e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-2)" 1.0 0.8 0.0 16.7 0.0 7.9 2.4 0.0 0.4 0.9 2.9 0.0 1.6 0.4 0.4 1.4 7.1 0.5 2.9 1.8 0.0 0.4 0.4 1.9 9.2 0.0 0.0 0.4 5.0 0.4 0.0 2.4 0.0 0.5 0.4 0.0 1.0 0.7 0.4 0.4 3.6 0.4 0.0 10.2 0.8 1.8 0.0 236.8 0.6 11.6 14.5 0.4 0.0 4.1 4.7 1.0 1.2 12.4 2.4 2.2 1.3 1.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.2 2.9 0.4 0.0 0.5 0.9 0.0 0.0 0.5 1.3 1.7 4.6 0.0 0.0 1.0 2.8 0.7 0.7 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.4 5.6 1.3 0.2 0.0 8.8 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.6 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.2 0.5 2.4 0.6 2.0 0.8 2.0 1.5 3.3 4.1 1.7 2.2 1.0 12.4 0.5 4.7 1.9 2.2 0.0 1.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 HIST1H3J "H3/j, H3FJ" ENSG00000197153 "Histone cluster 1 H3 family member j" P68431 6 27890382-27893106 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 31 "lymphoid tissue: 290.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 4.8;U-266/84: 15.5" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.15e-1)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (3.18e-1)" "unprognostic (1.71e-4)" "unprognostic (2.91e-2)" "unprognostic (4.09e-3)" "unprognostic (6.37e-3)" "unprognostic (6.67e-2)" "unprognostic (4.68e-3)" "unprognostic (1.34e-1)" "unprognostic (2.63e-8)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.82e-3)" "unprognostic (8.04e-2)" 0.9 0.4 0.2 25.1 0.3 5.7 1.1 0.5 0.4 1.2 5.5 0.0 0.0 0.3 0.4 0.5 9.4 0.4 1.2 0.9 0.4 0.4 0.3 1.2 1.5 8.8 0.4 0.0 0.3 0.4 0.3 0.3 4.7 0.0 0.6 0.3 0.0 0.4 0.6 0.3 1.6 3.7 0.3 1.1 15.1 0.6 2.4 0.0 290.9 0.9 7.8 14.6 1.1 1.1 2.1 2.5 0.0 0.7 0.6 2.5 0.7 1.1 0.7 1.6 0.3 0.6 0.5 0.9 0.0 0.0 1.6 0.2 0.0 0.4 4.8 0.9 0.4 0.8 0.2 1.3 0.4 0.0 0.2 0.9 1.1 1.9 0.0 0.4 0.2 0.3 0.0 0.0 0.7 0.0 0.0 0.8 0.6 2.6 1.2 0.0 1.2 3.7 4.4 2.6 1.3 0.4 1.7 0.5 0.5 0.0 0.0 2.8 1.7 1.8 1.3 0.0 0.5 0.5 0.9 0.0 0.4 0.0 0.2 0.5 3.6 15.5 1.2 0.8 0.6 2.5 0.0 0.0 0.0 1.4 0.3 0.0 0.0 2.3 2.5 2.5 2.1 0.5 1.0 0.0 0.6 0.7 0.0 2.2 0.7 0.2 0.3 0.5 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 HIST1H4A H4FA ENSG00000278637 "Histone cluster 1 H4 family member a" P62805 6 26021679-26021990 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 87.7" "Cell type enhanced" "Detected in some" 9 "Cone photoreceptor cells: 2.0;Enterocytes: 1.1;granulocytes: 1.1;Rod photoreceptor cells: 1.3" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in many" 4 "neutrophil: 14.0" "Lineage enriched" "Detected in many" 10 "granulocytes: 14.0" "Cell line enhanced" "Detected in many" "MOLT-4: 13.8;NB-4: 10.1;REH: 12.6" "CAB021887, HPA042201" Supported NA NA 30000000 "CAB021887: AB_2279758, HPA042201: AB_2677898" "unprognostic (5.71e-2)" "unprognostic (3.41e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.75e-1)" "unprognostic (1.75e-2)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (9.76e-2)" "unprognostic (5.99e-2)" "unprognostic (6.42e-2)" 0.5 0.5 0.0 5.2 0.0 7.1 2.1 16.7 3.2 0.6 1.5 0.0 0.0 5.2 1.5 1.8 3.7 0.3 1.2 3.2 0.0 0.5 0.1 2.0 3.5 0.0 1.8 1.4 0.8 0.1 0.0 0.8 0.2 0.4 1.0 1.6 0.8 1.0 0.8 0.9 1.1 3.6 0.1 2.5 0.7 2.6 0.0 87.7 2.5 3.6 9.6 2.0 0.0 0.8 0.9 14.0 1.0 1.2 1.4 0.2 3.8 1.8 3.5 0.0 0.8 0.0 0.0 0.3 1.3 1.6 2.3 0.0 5.7 2.6 0.9 0.0 0.1 5.0 2.6 0.0 0.5 0.4 1.8 2.6 1.5 0.0 0.0 0.6 6.1 0.0 0.0 0.5 0.0 0.0 1.6 3.6 1.3 4.1 0.0 1.5 13.8 10.1 2.3 1.0 0.0 12.6 2.2 2.2 0.0 0.4 4.3 1.9 1.6 6.2 0.1 0.0 3.3 2.8 0.0 3.1 7.9 3.0 3.0 1.5 2.4 0.0 1.4 4.2 5.9 0.0 1.0 3.4 1.3 0.8 0.2 0.4 1.1 0.3 0.9 0.8 0.4 0.3 14.0 1.2 0.2 0.4 1.4 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.3 0.2 0.3 1.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.0 0.1 0.2 0.1 0.2 0.5 0.2 0.0 HIST1H4B "H4/I, H4FI" ENSG00000278705 "Histone cluster 1 H4 family member b" P62805 6 26026815-26027252 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 102.5" "Cell type enhanced" "Detected in some" 9 "B-cells: 2.2;Collecting duct cells: 1.8;Enterocytes: 3.2" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in many" 6 "neutrophil: 25.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 25.8" "Low cell line specificity" "Detected in many" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (1.16e-1)" "unprognostic (2.18e-2)" "unprognostic (2.12e-1)" "unprognostic (6.31e-3)" "unprognostic (2.32e-1)" "unprognostic (1.52e-1)" "unprognostic (6.07e-2)" "unprognostic (2.57e-1)" "unprognostic (1.52e-1)" "unprognostic (7.87e-2)" "unprognostic (2.56e-1)" "unprognostic (6.30e-2)" "unprognostic (1.69e-3)" "unprognostic (4.39e-2)" "unprognostic (3.17e-1)" "unprognostic (4.50e-2)" "unprognostic (1.58e-2)" 2.6 1.0 0.3 6.2 0.4 11.3 2.3 6.2 1.0 4.0 3.2 0.0 4.2 1.8 5.7 1.8 5.7 3.3 2.0 1.6 0.2 5.0 1.7 3.0 4.7 0.2 0.0 8.6 19.9 1.0 0.5 2.4 0.4 3.6 1.4 6.0 4.0 3.5 2.3 1.6 2.7 2.0 0.0 6.3 2.2 10.5 0.2 102.5 8.0 3.0 8.9 3.5 4.3 4.3 1.3 25.8 1.2 0.2 1.0 0.3 1.8 0.0 0.2 3.8 0.0 0.0 0.0 2.8 0.3 1.7 1.2 0.7 0.5 1.4 0.6 0.6 1.1 0.5 0.8 0.0 1.0 0.6 3.9 4.8 1.8 2.1 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 5.4 0.5 2.8 4.7 3.7 0.9 0.8 0.6 3.4 1.7 3.0 0.0 1.3 1.0 0.7 0.4 2.1 0.0 0.0 0.5 2.5 0.0 1.1 2.5 2.0 3.7 3.0 2.8 2.3 1.4 1.5 1.9 0.0 0.5 0.7 0.9 0.6 0.9 1.7 1.0 0.8 0.4 4.3 0.8 0.4 25.8 0.2 1.2 1.3 0.7 0.3 0.0 0.0 2.2 0.4 0.3 0.3 0.2 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.1 0.4 0.0 0.8 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.3 0.1 0.2 0.0 0.2 1.1 0.0 0.3 0.7 0.9 0.0 0.2 0.0 0.6 0.1 HIST1H4C "dJ221C16.1, H4/g, H4FG" ENSG00000197061 "Histone cluster 1 H4 family member c" P62805 6 26103876-26104310 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 172.4;lymphoid tissue: 88.7" "Group enriched" "Detected in all" 5 "Erythroid cells: 5349.6;Spermatocytes: 1544.2;Spermatogonia: 2680.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 12.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 26.7;PC-3: 14.4" HPA042201 Supported NA Yes 30000000 "HPA042201: AB_2677898" "unprognostic (1.28e-1)" "unprognostic (5.91e-4)" "unprognostic (6.95e-2)" "unprognostic (8.93e-3)" "unprognostic (5.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (4.31e-3)" "unprognostic (3.79e-1)" "unprognostic (1.01e-2)" "unprognostic (2.30e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (5.74e-6)" "unprognostic (2.42e-2)" "unprognostic (3.02e-1)" "unprognostic (2.82e-1)" "unprognostic (2.79e-3)" 4.8 4.3 6.9 13.2 6.2 23.5 4.6 12.5 8.8 4.6 6.9 0.9 6.4 3.9 4.8 4.2 6.5 4.8 5.0 3.4 6.2 5.6 6.6 6.4 4.2 12.0 5.5 7.9 4.5 19.4 2.3 5.2 5.9 4.3 3.8 7.5 5.2 11.1 5.0 3.6 4.5 5.4 3.5 6.4 7.0 4.8 25.5 4.4 88.7 8.0 12.4 9.9 8.0 5.2 54.3 26.9 45.5 25.4 25.4 46.6 172.4 1.5 1.4 0.5 2.3 0.0 0.2 0.0 0.7 0.6 0.4 0.8 2.1 0.3 0.5 0.7 0.2 0.6 0.8 1.7 0.5 0.4 1.3 26.7 1.0 2.8 3.2 0.7 1.2 0.9 1.2 0.0 0.3 0.0 0.0 0.6 0.4 1.4 1.1 0.4 0.2 5.8 2.9 1.5 0.9 14.4 1.7 0.8 2.5 0.9 0.1 1.5 1.0 0.7 1.0 0.6 0.7 0.7 3.8 0.4 1.6 1.6 0.8 1.3 2.2 2.0 2.5 1.0 2.1 0.8 39.9 25.4 17.8 31.4 10.2 30.0 54.3 40.5 25.6 18.5 48.6 46.6 35.1 45.5 25.4 10.2 26.9 26.7 172.4 6.9 6.2 12.5 8.8 6.2 5.6 5.5 7.9 4.3 4.4 113.2 96.8 203.6 96.4 200.8 385.3 149.9 540.1 141.8 212.7 291.4 178.7 298.1 261.9 329.5 3.7 206.3 206.8 5349.6 321.8 569.2 94.6 66.7 135.8 494.9 220.3 125.5 94.0 248.6 132.2 25.7 128.3 121.7 37.1 83.0 263.6 673.8 310.1 136.8 154.5 261.4 631.5 226.4 105.6 1544.2 2680.9 182.2 184.2 191.9 173.9 53.7 HIST1H4D "H4/b, H4FB" ENSG00000277157 "Histone cluster 1 H4 family member d" P62805 6 26188765-26189076 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 71.3" "Cell type enhanced" "Detected in some" 6 "Early spermatids: 1.1;Enterocytes: 1.2;Intestinal endocrine cells: 1.2;Muller glia cells: 1.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 9.9;RT4: 16.0" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.09e-2)" "unprognostic (1.98e-2)" "unprognostic (2.06e-2)" "unprognostic (7.63e-2)" "unprognostic (3.80e-2)" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" "unprognostic (5.37e-2)" "unprognostic (3.53e-2)" "unprognostic (1.30e-1)" "unprognostic (7.77e-4)" "unprognostic (1.56e-1)" "unprognostic (5.44e-2)" "unprognostic (1.17e-1)" "unprognostic (6.11e-3)" 1.4 4.7 1.9 10.1 5.2 6.5 5.6 1.2 4.5 3.9 3.1 0.0 4.5 0.9 3.3 3.5 8.3 6.5 2.0 4.6 1.4 1.6 1.8 1.6 3.5 0.0 4.4 6.5 5.8 0.9 1.3 4.2 1.6 6.0 2.1 1.4 1.4 2.7 0.9 0.9 2.3 2.2 1.6 4.1 2.2 9.8 0.8 71.3 5.3 4.8 9.5 5.5 0.0 6.8 0.6 1.3 0.9 0.2 2.3 0.7 1.3 2.2 1.5 0.0 2.7 0.0 0.8 1.3 0.4 3.6 1.8 3.4 0.8 6.9 0.4 0.0 2.6 0.9 4.5 0.7 1.2 0.5 9.9 1.0 6.8 2.5 0.0 0.7 0.2 0.0 0.0 0.5 1.5 0.0 3.1 0.8 1.7 1.2 0.0 3.5 2.4 4.0 2.3 1.6 0.7 0.7 0.0 0.9 0.9 16.0 0.7 0.4 1.4 0.6 0.9 0.7 1.2 0.5 0.0 0.5 4.4 0.5 1.7 1.6 1.8 0.0 1.1 1.7 1.0 0.1 0.9 0.0 0.9 0.1 0.6 1.4 2.3 0.5 0.6 6.8 0.3 0.6 1.3 0.2 0.5 0.1 0.1 0.7 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.1 0.6 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.3 0.4 HIST1H4E "H4/j, H4FJ" ENSG00000276966 "Histone cluster 1 H4 family member e" P62805 6 26204552-26206038 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 71.9" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 9.4;Mucus-secreting cells: 9.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 7.6;U-266/70: 14.9" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (8.62e-2)" "unprognostic (4.86e-2)" "unprognostic (5.71e-3)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" "unprognostic (5.08e-3)" "unprognostic (7.99e-2)" "unprognostic (1.21e-1)" "unprognostic (6.57e-2)" "unprognostic (2.34e-3)" "unprognostic (4.34e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (1.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" 2.2 4.8 2.4 5.4 6.8 13.0 4.6 15.1 17.3 7.3 4.7 5.2 5.1 7.4 4.9 6.6 5.2 6.5 5.0 5.1 2.0 3.0 1.9 2.6 5.1 1.3 5.7 11.2 1.6 2.5 2.6 4.7 2.4 10.5 5.0 6.7 7.5 4.6 1.8 2.2 4.6 6.5 2.0 4.9 4.8 7.7 1.8 71.9 6.5 2.7 7.7 7.8 0.0 10.4 5.1 4.8 8.0 3.7 5.9 2.1 1.3 1.0 1.7 4.0 0.7 0.0 0.9 1.5 0.4 0.7 0.5 0.6 1.5 0.5 2.1 0.4 1.0 2.5 0.9 0.1 1.0 1.1 1.0 0.4 1.6 0.8 0.0 0.6 1.6 0.4 0.1 0.6 0.5 0.4 0.5 1.4 2.9 3.4 0.2 0.5 7.6 3.6 1.7 0.7 1.4 3.4 1.9 3.4 0.7 0.5 4.9 1.2 1.1 1.7 0.5 0.6 1.6 0.7 0.7 2.0 2.8 0.6 1.2 14.9 5.8 2.1 0.4 1.4 1.4 3.2 3.7 2.9 3.8 3.1 5.3 3.9 5.5 3.6 5.1 10.4 5.9 4.5 4.8 3.7 8.0 4.7 3.3 2.1 0.0 1.1 6.0 2.2 0.3 9.4 1.0 2.5 0.0 0.0 0.0 0.0 2.3 0.0 1.7 0.0 1.3 7.9 0.0 0.0 1.2 0.5 7.7 4.7 0.8 3.7 1.6 3.5 2.5 1.9 0.0 0.9 2.0 0.0 1.0 9.5 7.0 0.2 2.9 0.4 1.0 1.5 0.0 0.0 1.7 2.7 0.5 2.9 6.4 5.3 1.3 HIST1H4F "H4, H4/c, H4FC" ENSG00000274618 "Histone cluster 1 H4 family member f" P62805 6 26240426-26240737 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 118.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "MCF7: 2.8;MOLT-4: 11.3;REH: 5.1" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (1.47e-1)" "unprognostic (1.17e-2)" "unprognostic (2.05e-1)" 1.2 0.5 0.0 8.8 0.0 7.1 0.5 0.0 1.7 0.9 1.3 0.0 1.8 0.5 1.2 2.2 5.9 0.5 1.4 1.8 0.0 1.2 0.5 2.1 4.5 0.0 0.0 0.6 0.5 0.5 0.0 4.1 0.0 0.6 1.0 0.1 0.5 0.5 0.5 0.5 1.3 0.5 0.0 9.3 0.8 18.9 0.0 118.4 3.1 3.7 19.1 2.4 0.0 7.9 7.9 14.8 3.6 2.2 5.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.8 11.3 1.4 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 4.3 3.9 2.8 3.2 6.2 4.9 5.1 4.6 7.9 4.3 2.7 14.8 2.2 2.4 7.9 1.3 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.1 0.2 0.0 0.0 0.0 HIST1H4G "H4/l, H4FL" ENSG00000275663 "Histone cluster 1 H4 family member g" Q99525 6 26246681-26246977 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "intestine: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "AF22: 1.1;CAPAN-2: 1.2;PC-3: 3.4;SCLC-21H: 1.8;THP-1: 2.4" HPA042201 Supported NA NA "HPA042201: AB_2677898" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST1H4H "H4/h, H4FH" ENSG00000158406 "Histone cluster 1 H4 family member h" P62805 6 26277609-26285638 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 119.1" "Cell type enhanced" "Detected in many" 5 "B-cells: 15.9;Glandular cells: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "eosinophil: 6.0;neutrophil: 17.5" "Lineage enriched" "Detected in many" 11 "granulocytes: 17.5" "Cell line enhanced" "Detected in many" "U-266/84: 37.3" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (4.39e-1)" "unprognostic (1.62e-1)" "unprognostic (3.08e-3)" "unprognostic (5.00e-2)" "unprognostic (3.01e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (6.84e-4)" "unprognostic (5.40e-2)" "unprognostic (1.36e-1)" "unprognostic (4.71e-2)" "unprognostic (1.71e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (7.44e-2)" "unprognostic (8.16e-2)" "unprognostic (6.55e-2)" "unprognostic (6.36e-2)" 6.2 3.6 4.4 10.6 4.4 5.2 23.0 6.4 4.6 7.0 6.6 1.2 5.6 6.5 4.5 6.8 13.9 4.0 5.5 8.3 5.2 5.2 5.2 3.3 5.5 4.1 7.1 2.8 9.4 2.8 1.2 4.0 9.0 2.5 16.7 4.0 3.8 3.9 4.5 30.9 3.7 9.9 7.6 10.9 10.9 3.8 11.0 1.9 119.1 9.5 10.3 23.1 7.3 7.3 1.6 1.1 17.5 1.0 0.2 0.8 4.4 2.4 2.5 0.6 0.3 6.0 0.3 1.5 3.9 0.4 1.1 0.3 2.4 0.7 1.1 6.5 1.0 0.7 1.8 0.3 0.5 0.3 3.6 1.1 2.3 4.6 2.4 2.6 0.9 2.1 6.0 0.4 1.2 0.9 0.5 2.0 0.7 7.3 7.3 2.1 3.1 9.5 6.1 1.2 2.7 3.4 6.5 1.4 4.2 0.8 2.5 4.3 0.8 7.9 4.4 2.9 0.6 6.4 3.2 0.6 1.4 12.3 1.2 4.3 9.2 37.3 2.2 0.7 8.6 2.0 1.9 0.6 6.0 0.5 1.0 0.3 0.7 0.4 0.6 0.5 1.6 0.4 0.6 17.5 0.2 0.3 1.1 0.8 4.4 4.4 4.4 6.4 4.6 5.2 5.2 7.1 2.8 2.5 1.9 3.0 9.6 15.9 3.8 1.6 0.2 0.0 0.0 4.0 1.2 3.5 0.0 1.8 3.3 1.4 0.4 0.4 8.9 0.0 0.6 1.3 2.6 15.4 3.5 0.4 1.5 0.0 3.5 1.3 8.2 0.4 1.1 3.1 1.7 2.8 8.7 1.0 1.6 2.9 1.1 5.1 0.2 0.0 2.1 1.8 2.5 1.3 8.7 7.5 5.0 2.4 HIST1H4I "H4/m, H4FM" ENSG00000276180 "Histone cluster 1 H4 family member i" P62805 6 27138588-27139881 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 14.5" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.1;Cardiomyocytes: 1.8;Early spermatids: 2.7;Enterocytes: 1.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 29.8;SiHa: 17.9;U-2 OS: 30.7;U-266/84: 31.0" HPA042201 Approved NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (2.49e-2)" "prognostic favorable (9.70e-4)" "unprognostic (1.97e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.25e-1)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (2.85e-1)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (6.28e-2)" "unprognostic (1.49e-1)" "unprognostic (1.80e-1)" "unprognostic (2.02e-2)" 0.1 2.5 2.4 1.7 0.0 0.1 0.0 0.8 2.7 1.1 0.0 1.7 0.0 1.3 0.5 0.0 1.9 0.8 2.6 0.8 2.7 0.0 1.5 2.0 0.0 1.6 0.0 0.0 0.2 2.9 0.0 2.3 3.2 1.8 2.6 0.0 1.9 6.0 5.5 14.5 4.6 2.4 3.4 3.1 1.7 3.5 1.9 1.2 1.3 0.1 2.1 3.3 0.1 0.1 0.1 3.3 2.5 0.5 9.6 0.0 5.3 2.6 0.3 0.1 0.0 2.3 5.1 1.2 5.6 0.1 0.2 1.0 6.2 0.4 0.1 0.0 0.1 3.3 0.1 1.2 29.8 9.2 0.0 5.1 1.5 2.2 0.7 12.3 2.2 1.3 1.1 8.4 0.1 0.9 6.5 2.3 17.9 8.3 1.9 2.3 15.8 0.7 1.1 2.4 30.7 2.8 0.3 9.3 31.0 5.8 1.4 6.7 2.4 9.2 2.6 14.1 1.5 2.0 1.3 4.6 1.3 1.4 2.5 6.0 1.6 1.7 14.5 2.4 4.6 5.5 3.4 3.1 0.0 1.1 0.8 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 0.0 1.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.1 0.3 0.0 0.6 0.0 HIST1H4J "H4/e, H4F2iv, H4FE" ENSG00000197238 "Histone cluster 1 H4 family member j" P62805 6 27824108-27824480 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.9;lymphoid tissue: 68.3" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 16.4;monocytes: 16.2;Mucus-secreting cells: 13.9;Paneth cells: 14.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 58.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 58.9" "Cell line enhanced" "Detected in many" "Hep G2: 31.9;MCF7: 32.0" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (3.79e-2)" "unprognostic (2.05e-2)" "unprognostic (7.65e-2)" "unprognostic (8.35e-2)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" "unprognostic (2.99e-1)" "unprognostic (7.30e-2)" "unprognostic (3.77e-1)" "unprognostic (2.17e-1)" "unprognostic (1.53e-1)" "unprognostic (4.18e-2)" "unprognostic (1.79e-3)" "unprognostic (3.50e-1)" "unprognostic (2.77e-1)" "unprognostic (2.08e-1)" "unprognostic (4.24e-3)" 5.9 9.4 2.9 15.6 4.1 25.9 4.0 3.7 15.5 5.3 9.9 0.2 6.8 7.9 4.4 4.7 7.6 5.6 6.2 7.5 5.9 1.9 4.0 18.1 8.3 26.7 2.2 7.1 5.2 4.1 0.6 4.5 3.2 2.3 8.0 4.6 0.7 2.0 3.7 0.7 2.7 7.6 3.8 6.0 13.9 7.5 19.3 0.8 68.3 8.6 8.0 10.8 5.4 4.9 12.0 7.7 58.9 10.8 10.6 13.2 10.8 3.9 4.7 10.8 18.2 6.5 2.7 6.3 4.5 2.3 4.4 2.8 8.8 1.3 6.3 8.0 1.9 1.1 9.3 0.2 6.7 1.4 8.9 1.7 4.1 9.5 31.9 3.8 6.1 5.4 8.6 1.9 2.8 1.5 0.6 4.1 3.5 8.0 13.3 0.0 32.0 10.9 6.2 6.8 6.5 10.5 4.5 0.7 4.4 0.6 1.7 5.9 8.1 7.6 4.5 7.1 1.5 5.8 3.0 4.0 2.2 10.8 1.1 0.0 8.6 8.1 10.9 2.8 7.7 4.3 58.9 3.4 14.8 11.7 8.5 8.9 11.0 11.5 12.7 5.2 12.0 6.6 8.3 6.9 10.6 10.8 7.7 13.2 10.8 2.9 4.1 3.7 15.5 5.9 1.9 2.2 7.1 2.3 0.8 0.0 3.0 3.0 0.5 0.2 0.0 0.3 0.0 2.7 2.3 0.0 0.0 0.7 0.0 2.5 0.8 0.7 8.6 0.0 7.3 6.2 0.5 0.7 5.8 3.9 4.0 0.0 16.4 4.3 4.8 0.2 0.0 1.8 0.0 16.2 13.9 0.0 2.0 14.0 0.0 0.3 0.0 0.0 0.3 0.5 2.5 0.0 1.4 1.9 10.5 0.7 HIST1H4K "dJ160A22.1, H4/d, H4F2iii, H4FD" ENSG00000273542 "Histone cluster 1 H4 family member k" P62805 6 27831216-27831527 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.4;lung: 2.9;lymphoid tissue: 3.1" "Group enriched" "Detected in some" 11 "Alveolar cells type 2: 1.1;Cardiomyocytes: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HHSteC: 2.9;LHCN-M2: 2.9;RT4: 1.6;U-87 MG: 1.7" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (3.19e-1)" "unprognostic (9.09e-3)" "unprognostic (1.16e-1)" "unprognostic (4.84e-3)" "unprognostic (9.63e-2)" "unprognostic (9.13e-2)" "unprognostic (1.48e-1)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.79e-2)" "unprognostic (3.13e-2)" "unprognostic (2.79e-1)" "unprognostic (3.45e-1)" "unprognostic (4.16e-2)" "unprognostic (1.02e-1)" 0.7 0.0 1.0 3.1 3.4 0.0 0.0 0.7 2.0 0.4 0.6 0.3 0.0 0.0 0.0 0.5 2.1 0.0 1.3 0.0 0.3 0.1 0.0 2.9 2.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.7 1.1 0.0 0.9 0.0 2.1 0.5 2.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST1H4L "H4.k, H4/k, H4FK" ENSG00000275126 "Histone cluster 1 H4 family member l" P62805 6 27873199-27873510 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 133.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.2" "Cell type enhanced" "Detected in many" "naive B-cell: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MOLT-4: 10.3;NB-4: 5.5;REH: 2.6" HPA042201 Approved NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (1.15e-1)" "unprognostic (6.05e-4)" 0.4 0.3 0.0 23.6 0.0 4.6 2.8 0.0 0.3 0.4 3.0 0.0 0.5 0.3 0.3 0.3 3.4 0.3 1.2 0.5 0.0 0.3 0.3 1.2 4.2 0.0 0.0 0.3 8.4 0.3 0.0 2.5 0.0 0.3 1.0 0.0 0.5 0.3 0.3 0.3 2.2 0.3 0.0 11.5 0.8 4.0 0.0 133.0 0.3 7.6 16.4 0.3 0.0 7.7 3.8 0.0 1.8 1.7 1.9 0.6 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.5 0.5 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 10.3 5.5 0.0 1.2 0.0 2.6 0.7 0.0 0.0 0.0 0.0 1.3 1.6 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 1.0 0.0 1.3 0.8 0.3 1.8 1.1 1.9 2.6 7.7 0.5 1.4 0.0 1.7 1.8 3.8 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST2H2AA3 "H2A.2, H2A/q, H2AFO, HIST2H2AA" ENSG00000203812 "Histone cluster 2 H2A family member a3" Q6FI13 1 149842188-149842736 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 67.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 76.9;Ciliated cells: 64.3;granulocytes: 22.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 19.8;U-266/70: 96.9;U-266/84: 53.8" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (2.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.53e-1)" "unprognostic (2.89e-1)" "unprognostic (2.20e-1)" 6.1 2.7 3.7 6.8 3.7 67.4 7.8 3.7 5.4 10.1 4.0 3.7 3.7 4.2 3.7 3.7 6.5 5.4 5.0 4.5 3.7 1.6 5.6 9.9 14.6 4.4 3.7 3.7 5.1 3.7 0.4 3.7 8.9 3.7 35.8 1.7 3.7 22.4 3.7 4.5 11.7 3.7 3.7 8.0 12.8 9.6 11.2 3.7 18.9 3.7 3.7 5.4 3.7 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.3 0.6 0.0 5.3 2.5 3.6 3.0 0.0 1.0 1.5 3.8 2.3 0.0 0.9 0.3 1.1 0.4 2.5 0.0 0.7 7.0 0.9 2.4 0.0 0.7 11.8 2.0 0.9 1.0 0.0 0.9 0.0 7.8 19.8 1.2 0.0 0.0 5.9 0.0 2.9 4.2 0.8 0.0 7.4 1.4 1.8 0.0 0.0 6.7 0.0 0.2 0.0 5.2 2.0 2.0 0.7 8.9 0.0 0.5 96.9 53.8 2.1 5.6 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.7 3.7 5.4 3.7 1.6 3.7 3.7 3.7 3.7 17.9 76.9 0.0 7.4 10.5 0.0 2.8 0.0 64.3 13.6 1.8 0.0 0.2 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.1 2.8 4.2 22.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 9.3 10.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 13.7 1.8 1.9 0.0 4.1 HIST2H2AA4 H2A/r ENSG00000272196 "Histone cluster 2 H2A family member a4" Q6FI13 1 149851061-149851624 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 164.8;lymphoid tissue: 101.1" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 89.0;Ciliated cells: 155.2;Club cells: 42.1;granulocytes: 40.7" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Cell type enriched" "Detected in all" 5 "neutrophil: 164.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 164.8" "Cell line enhanced" "Detected in many" "SiHa: 27.3;U-266/70: 68.1;U-266/84: 60.4" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (1.63e-1)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (8.47e-2)" 4.5 6.5 0.0 9.8 1.2 9.0 2.5 0.3 2.6 5.2 5.7 1.5 2.5 5.7 5.5 3.4 9.1 2.4 4.2 4.0 0.7 3.0 2.5 8.8 7.1 0.1 0.0 4.3 5.0 0.0 0.5 6.5 1.6 9.5 0.0 2.1 4.2 2.6 3.5 5.8 5.4 0.9 0.8 8.4 4.2 21.6 0.1 101.1 1.9 4.8 11.5 5.8 2.3 9.3 17.2 164.8 17.9 3.5 4.2 18.8 3.8 9.7 1.3 2.2 0.0 1.2 3.1 8.2 0.0 0.0 0.0 6.6 3.9 0.0 9.3 0.0 2.6 5.3 0.0 0.0 0.0 5.3 12.8 1.2 8.0 4.3 0.0 1.2 7.5 0.0 0.0 0.0 0.0 2.3 0.0 4.4 8.3 19.7 0.0 24.7 4.2 1.2 3.7 21.0 10.2 3.7 1.5 6.7 0.0 2.0 9.8 4.1 27.3 7.5 2.1 1.3 13.0 2.7 0.0 2.7 20.9 3.8 1.0 68.1 60.4 4.6 0.0 6.2 3.1 24.2 17.9 32.8 3.2 10.5 3.3 5.9 2.8 3.0 12.0 9.3 2.2 2.0 164.8 3.5 12.4 17.2 4.2 18.8 23.8 89.0 0.0 6.7 0.0 0.0 22.0 0.0 155.2 42.1 3.5 0.0 0.3 0.0 0.6 1.5 0.0 0.0 0.0 0.3 0.2 0.3 5.6 40.7 1.6 0.9 0.0 0.0 0.0 0.6 1.0 0.3 0.7 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 2.2 0.9 0.1 4.8 HIST2H2AB ENSG00000184270 "Histone cluster 2 H2A family member b" Q8IUE6 1 149887524-149887916 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 126.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 2.4;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Muller glia cells: 4.3;Rod photoreceptor cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 8.0;U-266/70: 4.9;U-266/84: 5.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011483, HPA041189" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB011483: AB_732909, HPA041189: AB_2677357" "unprognostic (6.31e-2)" "unprognostic (6.63e-2)" "unprognostic (2.22e-2)" "unprognostic (2.31e-1)" "unprognostic (3.09e-1)" "unprognostic (3.34e-1)" "unprognostic (2.42e-3)" "unprognostic (1.99e-1)" "unprognostic (1.53e-1)" "unprognostic (2.03e-1)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (9.97e-3)" "unprognostic (5.33e-2)" "unprognostic (2.00e-2)" "unprognostic (4.36e-2)" 2.4 1.6 1.2 6.4 1.6 21.1 2.9 2.6 2.4 6.8 2.6 0.6 0.6 1.2 1.9 1.6 5.1 1.5 2.2 1.5 1.4 1.3 1.6 1.8 4.2 3.0 1.2 1.9 7.4 3.0 2.2 1.4 2.3 0.0 4.2 2.0 3.9 1.9 1.9 2.5 4.7 2.9 4.0 2.7 4.8 1.9 2.1 0.1 126.3 1.7 2.1 9.0 7.1 2.4 10.2 4.3 11.6 2.0 4.3 4.5 0.8 1.3 0.0 0.7 0.7 0.0 0.0 1.1 0.9 0.0 0.0 1.4 0.0 1.0 0.8 0.6 0.0 0.0 1.0 1.0 0.0 0.0 0.3 1.5 0.0 0.8 0.7 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.2 0.0 1.1 1.1 1.1 0.7 0.0 8.0 3.4 0.9 0.8 1.7 1.7 0.5 1.3 0.0 0.5 2.3 1.0 2.3 0.0 0.2 0.2 0.3 3.5 0.0 1.0 3.4 0.0 0.7 4.9 5.3 1.4 2.1 0.3 0.6 1.3 1.6 0.8 2.7 2.0 2.7 3.8 4.5 4.0 2.3 10.2 2.7 2.7 11.6 4.3 1.9 4.3 2.6 0.8 1.2 1.6 2.6 2.4 1.4 1.3 1.2 1.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 2.4 0.4 0.0 0.0 0.0 1.8 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 HIST2H2AC "H2A, H2A/q, H2AFQ" ENSG00000184260 "Histone cluster 2 H2A family member c" Q16777 1 149886975-149887364 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 47.7;bone marrow: 86.5;lymphoid tissue: 80.6" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "MCF7: 45.3" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.50e-3)" "unprognostic (4.97e-2)" "unprognostic (9.34e-2)" "unprognostic (6.95e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-3)" "unprognostic (1.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (3.24e-2)" "unprognostic (4.25e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (1.20e-10)" "unprognostic (1.42e-1)" "unprognostic (1.73e-1)" "unprognostic (4.89e-2)" "prognostic favorable (7.86e-5)" 10.5 8.5 4.2 6.5 4.2 86.5 8.6 3.1 4.1 13.8 7.5 2.8 5.4 4.6 8.1 6.0 10.9 6.4 8.1 13.2 3.9 3.1 8.2 6.1 10.5 12.5 2.9 3.7 15.3 15.8 3.6 7.6 8.4 2.3 10.6 4.3 13.8 6.0 10.1 7.2 10.1 6.4 9.7 7.6 10.7 5.8 4.9 2.4 80.6 6.0 8.1 10.5 16.2 8.9 15.8 11.6 47.7 15.9 7.9 11.0 10.8 2.6 3.2 3.7 11.2 0.0 0.6 5.5 0.7 0.9 1.8 2.7 1.9 0.7 5.5 0.1 0.2 0.3 1.2 0.2 1.2 0.0 0.3 4.4 1.3 0.4 9.4 0.0 3.2 2.9 0.7 0.2 0.1 0.4 0.1 1.3 1.4 1.1 6.7 0.4 45.3 3.8 3.2 4.8 3.1 7.8 1.2 1.5 1.0 0.7 1.9 1.1 5.2 1.5 0.8 2.5 0.3 0.4 3.2 1.1 0.8 7.4 1.4 1.9 3.1 1.9 2.8 2.0 4.4 1.6 17.0 15.9 8.1 11.0 10.6 10.0 6.2 9.7 8.7 8.1 15.8 6.8 6.7 47.7 7.9 10.6 11.6 7.3 10.8 4.2 4.2 3.1 4.1 3.9 3.1 2.9 3.7 2.3 2.4 6.0 6.4 11.2 15.2 3.3 9.8 1.6 7.6 2.7 5.7 1.8 9.8 4.0 8.3 12.0 3.7 6.8 8.0 46.7 11.6 15.4 4.3 7.6 8.1 6.4 8.1 7.9 9.1 6.2 7.6 2.1 7.5 12.4 3.3 19.0 6.1 13.7 11.0 4.3 6.0 3.9 14.1 0.0 6.2 0.4 1.6 5.5 7.3 11.7 6.3 11.2 HIST2H2BE "H2B, H2B.1, H2B/q, H2BFQ" ENSG00000184678 "Histone cluster 2 H2B family member e" Q16778 1 149884459-149886652 "Predicted intracellular proteins" "Antibiotic, Antimicrobial, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.1" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 128.7;Syncytiotrophoblasts: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 29.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 29.9" "Cell line enhanced" "Detected in many" "Karpas-707: 24.3;U-266/70: 40.5;U-266/84: 21.7" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.63e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (1.37e-1)" "unprognostic (8.28e-2)" "unprognostic (4.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (4.74e-2)" "unprognostic (4.41e-2)" "unprognostic (7.82e-2)" "unprognostic (2.20e-1)" "unprognostic (2.86e-3)" 14.3 16.2 9.8 22.2 10.0 19.4 16.9 17.2 14.0 31.3 9.0 11.2 10.5 6.4 18.5 24.9 25.5 13.3 9.6 51.1 13.1 10.1 12.5 10.2 27.5 24.5 12.4 8.7 28.0 13.4 5.8 15.4 17.2 8.5 72.8 7.6 19.4 24.1 15.3 43.1 33.5 8.6 18.8 18.2 22.0 17.5 9.3 11.6 198.1 12.1 12.4 25.3 27.2 33.8 2.3 4.5 29.9 5.5 0.7 1.2 5.1 1.1 1.1 1.9 0.4 10.3 2.8 0.9 4.1 2.7 1.7 0.5 0.4 1.8 0.2 1.1 3.6 2.4 4.5 1.5 0.7 0.9 1.4 1.2 0.3 4.6 0.8 3.2 0.3 5.4 9.4 3.4 0.7 2.8 2.1 0.5 1.7 4.9 24.3 2.1 6.9 1.2 2.1 1.2 9.4 2.5 1.5 0.7 5.5 1.6 0.9 13.1 2.1 14.1 1.9 1.0 4.8 10.0 0.9 0.7 1.3 14.7 0.9 0.3 40.5 21.7 1.1 1.7 1.5 0.8 8.4 2.1 3.8 0.7 3.2 1.2 0.8 0.9 1.1 1.6 2.3 1.2 1.1 29.9 0.7 5.5 4.5 1.0 5.1 9.8 10.0 17.2 8.5 13.1 10.1 12.4 8.7 8.5 11.6 8.9 11.7 10.4 57.7 5.4 47.2 56.8 2.5 12.0 5.7 34.9 21.6 22.3 23.2 13.5 1.1 4.5 15.3 23.3 5.9 10.4 14.1 128.7 10.5 5.9 22.3 20.6 53.7 8.6 11.0 0.0 4.6 16.7 18.6 4.6 18.8 12.9 8.3 21.0 0.4 8.8 32.5 0.0 9.8 0.5 6.1 11.8 134.0 22.4 9.0 59.1 HIST2H2BF ENSG00000203814 "Histone cluster 2 H2B family member f" Q5QNW6 1 149782689-149812373 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 117.6" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 21.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 21.7" "Cell line enhanced" "Detected in many" "U-266/70: 32.1" "Not detected" "Not detected" "CAB007814, HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB007814: AB_598159, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (9.02e-3)" "unprognostic (7.78e-2)" "unprognostic (5.30e-4)" "unprognostic (3.00e-1)" "unprognostic (1.21e-1)" "unprognostic (2.17e-1)" "unprognostic (2.08e-2)" "unprognostic (8.33e-2)" "unprognostic (3.46e-2)" "unprognostic (5.36e-2)" "unprognostic (3.87e-5)" "unprognostic (3.72e-2)" "unprognostic (3.54e-7)" "unprognostic (1.84e-1)" "unprognostic (2.59e-2)" "unprognostic (9.42e-3)" "unprognostic (7.62e-2)" 5.6 17.7 3.9 14.9 3.5 3.7 7.1 8.5 5.6 17.4 3.8 3.7 3.2 1.5 5.6 6.2 7.1 7.9 3.6 12.1 3.4 2.4 5.0 4.2 14.6 27.5 3.2 3.8 24.2 6.2 2.6 4.4 5.1 3.2 16.7 2.5 3.5 3.7 5.5 1.2 10.9 3.4 6.0 7.7 12.7 7.9 5.9 3.1 117.6 4.4 6.3 16.7 6.1 21.5 2.0 0.8 21.7 1.1 0.6 0.8 0.2 0.4 0.6 0.6 0.6 4.6 3.1 0.3 7.9 4.1 6.0 5.3 0.3 2.2 0.4 0.6 4.5 5.2 1.3 0.1 0.5 4.7 1.2 0.9 0.4 1.5 0.0 6.7 0.2 1.8 5.5 0.0 7.8 1.9 1.7 3.4 0.3 1.2 2.4 0.8 0.9 3.1 3.8 0.4 4.1 1.0 0.3 1.1 0.7 2.9 0.4 2.7 7.3 4.2 3.5 0.3 0.7 1.3 9.8 1.4 1.5 0.0 11.5 2.0 32.1 1.0 1.3 5.3 0.3 3.4 0.0 1.0 0.2 0.6 0.8 0.7 0.6 0.8 0.3 0.8 2.0 0.4 0.3 21.7 0.6 1.1 0.8 0.2 0.2 3.9 3.5 8.5 5.6 3.4 2.4 3.2 3.8 3.2 3.1 0.0 0.3 2.2 6.9 0.3 6.0 1.7 0.0 4.0 1.2 1.8 2.0 1.5 3.3 1.0 0.9 0.4 5.1 0.0 0.3 1.2 0.9 16.2 0.0 0.6 6.7 4.8 3.4 2.5 4.9 1.4 2.6 2.9 0.0 1.8 2.7 6.6 0.7 2.9 0.0 0.5 0.9 6.5 1.5 0.2 0.4 0.5 4.3 4.9 1.8 5.7 HIST2H3A "H3/n, H3/o" ENSG00000203852 "Histone cluster 2 H3 family member a" Q71DI3 1 149852619-149854274 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "lymphoid tissue: 126.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.0" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 5.6;SiHa: 8.4;U-266/70: 7.4;U-266/84: 7.3" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "unprognostic (3.99e-2)" 1.3 0.9 1.3 22.4 2.0 4.6 2.1 5.0 3.6 0.5 4.4 0.0 0.0 1.2 0.5 1.5 6.6 0.9 1.3 1.9 1.3 0.6 0.4 1.0 1.6 5.9 0.7 0.0 0.3 2.4 0.2 0.7 4.5 0.0 2.4 0.3 0.0 1.3 0.3 0.6 0.9 2.9 0.2 1.1 6.1 1.5 2.1 0.0 126.9 0.4 8.5 12.6 0.7 0.7 0.4 0.6 1.6 0.2 0.2 0.1 0.2 0.5 3.3 0.6 0.4 0.1 0.0 1.1 0.5 0.1 0.7 0.1 0.5 0.6 0.3 0.5 0.0 0.4 2.6 0.0 0.1 0.2 0.8 5.6 0.5 2.5 0.1 0.0 0.4 1.5 0.0 0.0 0.1 0.2 0.3 0.1 0.6 2.5 3.1 0.1 2.3 1.5 2.1 1.8 4.0 1.3 1.3 0.3 1.5 0.0 0.3 4.9 1.1 8.4 2.3 0.4 1.0 1.5 1.8 0.0 0.6 4.8 0.3 0.4 7.4 7.3 1.7 0.5 0.6 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.1 1.6 0.2 0.2 0.6 0.0 0.2 1.3 2.0 5.0 1.1 1.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST2H3C "H3, H3.2, H3/m, H3F2, H3FM, MGC9629" ENSG00000203811 "Histone cluster 2 H3 family member c" Q71DI3 1 149839538-149841193 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.8;brain: 5.1;prostate: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 5.6;SiHa: 8.4;U-266/70: 7.4;U-266/84: 7.3" "HPA042570, CAB069990" Approved NA NA "CAB069990: AB_10804539, HPA042570: AB_2678056" "unprognostic (1.78e-1)" "unprognostic (2.25e-1)" "unprognostic (2.42e-1)" "unprognostic (1.36e-2)" 0.4 0.5 0.7 0.4 1.4 3.8 0.0 5.1 2.9 0.1 0.3 0.8 0.2 0.0 0.4 1.0 0.0 1.4 0.7 0.2 0.1 0.6 0.3 0.5 0.3 0.0 1.9 0.0 0.1 0.3 3.6 0.0 0.9 0.0 0.2 0.5 0.6 0.0 0.4 0.4 1.1 1.4 0.1 0.0 0.4 0.6 0.4 0.6 1.6 0.2 0.2 0.1 0.2 0.5 3.3 0.6 0.4 0.1 0.0 1.1 0.5 0.1 0.7 0.1 0.5 0.6 0.3 0.5 0.0 0.4 2.6 0.0 0.1 0.2 0.8 5.6 0.5 2.5 0.1 0.0 0.4 1.5 0.0 0.0 0.1 0.2 0.3 0.1 0.6 2.5 3.1 0.1 2.3 1.5 2.1 1.8 4.0 1.3 1.3 0.3 1.5 0.0 0.3 4.9 1.1 8.4 2.3 0.4 1.0 1.5 1.8 0.0 0.6 4.8 0.3 0.4 7.4 7.3 1.7 0.5 0.6 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.1 1.6 0.2 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST2H3D ENSG00000183598 "Histone cluster 2 H3 family member d" Q71DI3 1 149813271-149813681 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.6;bone marrow: 9.3;lymphoid tissue: 10.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 12.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-266/70: 22.2" HPA042570 Approved NA NA "HPA042570: AB_2678056" "unprognostic (3.35e-2)" "unprognostic (1.84e-1)" "unprognostic (4.73e-2)" "unprognostic (2.88e-2)" "unprognostic (9.27e-3)" "unprognostic (3.39e-1)" "unprognostic (1.83e-2)" "unprognostic (9.61e-2)" "unprognostic (1.48e-2)" "unprognostic (7.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.59e-1)" "unprognostic (8.93e-4)" "unprognostic (6.95e-2)" "unprognostic (1.57e-1)" "unprognostic (2.04e-2)" "unprognostic (2.48e-3)" 1.1 1.2 1.5 1.7 1.4 9.3 5.7 2.6 2.0 1.1 0.9 0.6 0.6 0.5 0.6 0.6 3.8 1.2 3.1 1.9 0.6 0.5 0.6 1.4 1.9 2.9 0.6 0.6 2.4 1.1 0.0 0.6 0.6 1.2 1.9 0.1 0.6 0.6 0.6 0.6 1.1 1.6 0.6 2.3 2.2 2.6 2.3 1.3 10.2 0.7 2.2 1.1 2.7 1.3 6.9 2.7 12.6 1.8 0.4 2.4 0.5 0.8 0.0 0.2 2.4 0.4 0.0 0.5 1.4 0.0 0.0 0.1 0.4 0.2 0.6 0.2 0.0 0.2 1.1 0.0 0.0 0.0 1.4 0.7 0.2 3.5 0.1 0.4 0.0 1.9 0.8 0.0 0.5 0.3 0.4 0.0 0.7 1.8 2.0 0.0 1.6 2.2 5.5 2.1 0.4 4.0 1.2 0.4 1.6 0.0 1.1 0.5 0.3 1.4 0.0 0.1 0.2 0.4 0.6 0.5 1.2 0.0 1.0 0.0 22.2 2.3 1.4 0.2 0.4 0.8 0.0 1.3 0.5 1.2 1.8 2.4 1.3 1.6 1.8 1.2 6.9 0.6 0.4 12.6 0.4 0.6 2.7 0.2 0.5 1.5 1.4 2.6 1.1 0.6 0.5 0.6 0.6 1.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 HIST2H3PS2 p06 ENSG00000203818 "Histone cluster 2 H3 pseudogene 2" 1 143905556-143905966 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 9.1;lymphoid tissue: 7.0;ovary: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 8.6;NB-4: 9.8;SH-SY5Y: 10.4;THP-1: 10.0;U-2197: 7.4;U-87 MG: 5.5" HPA042570 Approved NA NA "HPA042570: AB_2678056" 0.6 9.1 0.5 0.6 0.5 0.0 0.2 1.4 0.3 0.2 0.1 0.1 0.7 0.0 1.4 1.1 1.1 0.3 0.5 0.7 0.0 0.0 0.5 1.3 0.7 8.9 0.7 0.3 0.3 0.0 2.3 0.0 0.5 0.4 0.0 0.3 0.2 1.4 1.5 7.0 4.7 0.9 1.0 0.4 2.4 0.2 1.5 1.0 0.1 3.5 2.4 0.3 0.8 0.0 0.0 0.0 0.0 3.5 0.9 0.0 8.6 1.9 1.7 1.6 0.0 1.2 0.0 1.0 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 2.1 0.0 3.4 0.0 0.2 2.0 0.0 0.3 0.0 0.0 0.0 0.0 9.8 0.0 1.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.4 0.0 3.1 0.0 0.0 0.0 10.0 0.0 1.0 0.0 7.4 0.4 0.2 0.0 0.0 5.5 0.0 0.2 0.0 1.2 0.0 0.0 1.7 0.0 0.7 0.1 0.3 1.0 1.5 0.0 0.1 0.1 2.4 3.5 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIST2H4A "H4/n, H4F2, H4FN, HIST2H4" ENSG00000270882 "Histone cluster 2 H4 family member a" P62805 1 149832659-149839767 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 56.4" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 14.3;Ciliated cells: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SiHa: 27.4;U-2 OS: 24.5;U-266/70: 22.9" HPA042201 Approved NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (1.90e-1)" "unprognostic (6.29e-2)" "unprognostic (1.50e-2)" "unprognostic (6.68e-2)" "unprognostic (3.65e-2)" "unprognostic (1.99e-2)" "unprognostic (6.99e-2)" "unprognostic (8.36e-2)" "unprognostic (4.66e-2)" "unprognostic (3.44e-1)" "unprognostic (4.91e-2)" "unprognostic (8.70e-2)" "unprognostic (6.78e-4)" "unprognostic (6.15e-2)" "unprognostic (3.63e-3)" "unprognostic (1.62e-2)" "unprognostic (5.99e-2)" 1.5 2.3 0.8 10.5 1.9 4.6 1.7 3.8 2.0 3.7 2.9 0.8 0.6 1.9 2.0 1.5 4.1 5.9 4.3 3.5 1.0 1.9 0.2 1.8 4.7 0.8 1.2 3.0 5.5 0.0 1.4 2.5 1.9 6.4 0.0 0.9 2.9 3.4 0.4 0.0 3.2 1.8 0.7 4.9 1.7 3.5 0.5 56.4 4.8 5.1 7.0 5.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 18.5 1.0 3.3 3.8 1.2 1.4 1.5 1.3 5.0 2.3 3.7 4.9 1.1 5.4 0.5 1.6 8.7 0.0 3.2 0.1 6.9 10.4 1.3 13.9 1.3 3.5 1.2 1.1 5.7 4.2 1.6 2.6 0.1 0.8 1.4 5.6 12.5 0.2 16.7 4.4 2.9 4.4 5.5 7.0 3.8 2.5 10.3 0.5 1.2 17.9 5.2 27.4 2.6 4.2 0.6 11.5 2.4 0.0 2.3 24.5 3.1 2.5 22.9 19.3 6.6 2.3 3.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 14.3 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 HIST2H4B H4/o ENSG00000270276 "Histone cluster 2 H4 family member b" P62805 1 149854045-149861210 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.4" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.1;SiHa: 9.2;U-266/70: 10.9;U-266/84: 9.1" HPA042201 Supported NA NA 30000000 "HPA042201: AB_2677898" "unprognostic (8.20e-2)" "unprognostic (2.69e-1)" "unprognostic (1.77e-1)" 1.5 3.2 0.0 1.2 0.5 2.3 0.0 0.1 1.3 1.9 2.4 0.0 2.8 0.0 1.9 0.8 0.7 0.2 0.4 1.4 1.1 0.0 0.2 1.4 0.4 0.5 0.5 1.8 0.0 0.3 2.0 1.2 0.8 0.0 0.0 0.0 0.0 8.3 4.1 9.4 3.4 2.1 4.4 4.4 0.0 0.0 1.0 0.2 1.0 1.1 0.2 1.7 3.3 0.2 0.0 0.0 0.7 1.0 1.7 0.9 0.2 0.0 0.6 0.0 0.2 1.8 0.6 0.0 3.8 0.0 0.0 0.1 0.0 2.7 0.0 0.3 0.0 1.4 1.3 2.4 0.0 5.6 0.1 3.6 0.3 0.5 0.1 1.0 0.0 1.3 0.4 0.1 0.4 0.7 6.1 3.7 9.2 1.0 0.3 0.0 2.0 0.2 2.2 0.4 2.2 0.6 0.2 10.9 9.1 1.5 0.9 0.3 1.4 2.6 2.1 2.4 2.5 3.4 4.4 3.2 2.9 2.1 3.1 8.3 2.3 3.7 9.4 2.1 1.7 4.1 4.2 4.4 3.0 0.6 0.9 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 HIST3H2A MGC3165 ENSG00000181218 "Histone cluster 3 H2A" Q7L7L0 1 228456979-228457873 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.8;lymphoid tissue: 62.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 35.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 18.7;SCLC-21H: 15.8;U-266/70: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA041189: AB_2677357" "unprognostic (3.65e-3)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.73e-4)" "unprognostic (1.84e-3)" "unprognostic (2.49e-2)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-2)" "unprognostic (3.20e-2)" "unprognostic (1.96e-1)" "unprognostic (6.67e-3)" "unprognostic (1.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" 2.5 20.5 4.3 7.0 8.3 11.1 5.8 35.8 8.1 9.9 3.8 2.4 2.0 7.7 5.0 4.4 7.0 4.2 3.8 4.9 5.4 4.6 1.6 1.0 2.5 5.1 5.6 5.3 8.3 4.5 3.5 5.0 3.4 6.5 7.0 2.8 13.9 6.6 3.9 1.0 6.4 4.2 1.5 5.2 6.6 4.7 3.5 4.8 62.3 1.9 5.6 9.3 2.9 9.3 3.4 3.4 5.1 7.1 6.8 11.7 4.3 3.6 1.9 2.6 3.5 2.1 2.2 3.1 1.8 1.7 5.2 3.6 1.9 3.0 1.6 2.2 0.4 0.0 8.9 1.8 0.8 1.2 2.6 18.7 2.6 2.5 0.0 5.0 1.8 5.2 4.8 5.3 1.0 2.2 2.1 2.2 3.4 9.0 0.0 0.0 5.1 2.3 0.0 3.9 2.1 4.8 0.0 0.0 13.6 0.8 2.2 15.8 11.1 6.3 5.6 12.1 0.4 9.9 1.3 0.8 0.0 0.0 7.0 1.6 18.8 13.4 0.0 1.8 1.8 1.3 5.1 1.7 0.0 7.1 3.1 5.1 3.4 6.8 5.3 3.4 2.0 5.3 5.2 0.7 6.8 7.1 0.6 11.7 4.3 4.3 8.3 35.8 5.9 5.4 4.6 5.6 5.3 6.5 4.8 0.0 0.3 7.5 21.8 1.1 18.2 5.5 5.1 18.7 13.6 3.5 45.2 11.8 6.6 3.3 0.6 1.0 6.0 23.3 2.7 9.5 3.1 30.8 13.9 0.0 23.0 39.7 35.1 1.3 8.0 1.1 19.2 14.3 3.3 25.2 26.6 24.1 9.7 17.3 8.1 1.1 6.4 0.0 4.6 0.5 2.7 5.1 45.0 41.5 17.4 32.1 HIST3H2BB ENSG00000196890 "Histone cluster 3 H2B family member b" Q8N257 1 228458107-228460470 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 56.0" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 6.0;Cone photoreceptor cells: 5.9;Erythroid cells: 23.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 12.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-266/70: 18.5" "HPA042205, HPA043013, HPA048671" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488" "unprognostic (5.53e-3)" "unprognostic (2.41e-1)" "unprognostic (3.39e-3)" "unprognostic (5.25e-2)" "unprognostic (8.20e-3)" "unprognostic (8.78e-3)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (2.96e-2)" "unprognostic (1.05e-1)" "unprognostic (2.34e-2)" "unprognostic (9.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (2.59e-1)" 2.0 4.7 1.2 12.1 3.1 2.8 1.3 12.8 3.2 8.9 1.3 1.1 0.6 2.1 1.4 2.0 4.1 6.2 1.7 2.2 1.5 2.2 1.3 0.9 2.1 5.4 1.2 1.5 1.6 1.7 1.7 2.0 1.5 4.1 2.2 1.5 3.4 2.0 2.0 1.8 4.8 1.7 1.2 6.2 4.5 2.4 2.1 0.7 56.0 1.7 5.9 11.8 2.0 7.9 1.5 1.1 3.4 1.5 1.1 0.9 0.5 0.2 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.5 1.0 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.1 0.6 0.6 0.0 0.8 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.2 0.1 0.0 0.3 0.4 0.1 0.4 0.3 0.2 0.0 0.0 0.8 0.0 0.2 1.5 0.5 1.0 0.4 0.3 0.1 3.7 0.1 0.1 0.0 0.0 0.5 0.1 18.5 4.4 0.0 0.2 0.1 0.1 1.7 1.0 0.5 0.5 0.5 0.7 1.3 0.8 0.9 0.2 1.5 0.9 0.7 3.4 1.1 1.5 1.1 0.7 0.5 1.2 3.1 12.8 3.1 1.5 2.2 1.2 1.5 4.1 0.7 6.0 0.0 0.0 1.2 0.1 3.8 0.8 0.0 4.0 0.0 0.0 5.9 0.2 1.7 0.0 0.0 0.0 0.2 23.3 0.0 0.1 0.0 0.5 0.0 0.0 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.7 2.9 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.3 0.8 2.5 0.4 0.5 HIST3H3 "H3.4, H3/g, H3FT, H3t" ENSG00000168148 "Histone cluster 3 H3" Q16695 1 228424845-228425325 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 194 "testis: 107.8" "Cell type enhanced" "Detected in some" 29 "Early spermatids: 2.8;Late spermatids: 13.2;Spermatocytes: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;MCF7: 1.3;THP-1: 1.8" "CAB001386, CAB003812, HPA042570" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB001386: , CAB003812: AB_365490, HPA042570: AB_2678056" "unprognostic (4.45e-1)" "unprognostic (4.66e-2)" "unprognostic (1.36e-1)" "unprognostic (3.78e-3)" "unprognostic (1.75e-2)" "unprognostic (4.04e-2)" "unprognostic (1.39e-2)" "unprognostic (2.26e-2)" 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 107.8 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.2 0.0 0.8 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 HIST4H4 MGC24116 ENSG00000197837 "Histone cluster 4 H4" P62805 12 14767999-14771131 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 9.8;Enterocytes: 9.5;Rod photoreceptor cells: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.1" "CAB011503, CAB037279, HPA042201" Supported Supported Nucleoplasm NA NA 30000000 Nucleoplasm "CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.16e-2)" "unprognostic (4.86e-2)" "unprognostic (3.67e-2)" "unprognostic (9.69e-3)" "unprognostic (4.54e-2)" "unprognostic (3.25e-2)" "unprognostic (5.35e-2)" "unprognostic (6.62e-3)" "unprognostic (4.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.33e-3)" "unprognostic (2.01e-1)" "unprognostic (1.28e-3)" 7.1 4.6 2.3 7.4 7.6 2.5 4.7 6.7 4.9 6.9 6.2 1.1 3.3 5.0 5.4 7.1 8.9 6.0 5.4 5.9 2.8 2.5 11.0 3.3 6.3 7.2 2.5 2.1 8.3 36.7 2.1 5.1 7.1 2.1 16.0 4.8 6.1 12.7 5.5 2.8 6.4 8.9 3.3 3.1 21.8 10.1 6.6 1.7 16.9 9.9 6.8 18.6 6.6 6.8 5.5 3.6 19.7 2.1 2.1 3.4 1.1 2.1 0.8 0.1 2.6 2.9 0.0 1.5 1.3 0.1 1.1 0.9 1.4 8.1 2.0 0.5 0.7 0.0 1.4 0.0 1.0 0.6 2.5 1.1 0.0 5.2 2.1 0.8 0.5 2.0 2.0 0.6 0.2 1.2 0.0 0.0 0.6 0.0 2.6 0.1 1.1 0.5 0.7 2.8 0.7 0.3 2.2 0.0 3.9 0.0 5.8 1.0 1.4 5.3 1.4 0.3 0.6 1.0 1.0 1.8 0.5 4.2 1.1 1.6 2.8 1.7 5.8 1.9 0.0 1.3 0.0 1.9 0.2 2.0 2.1 3.4 4.1 2.3 2.2 2.1 5.5 2.0 2.2 19.7 2.1 0.7 3.6 3.2 1.1 2.3 7.6 6.7 4.9 2.8 2.5 2.5 2.1 2.1 1.7 0.0 0.0 2.2 1.3 0.5 6.2 2.0 0.0 1.4 1.2 1.8 9.8 0.8 0.0 0.7 0.0 0.6 9.5 0.0 1.0 0.3 0.9 0.6 0.0 0.9 1.4 0.0 1.7 0.6 2.1 0.0 1.1 0.6 0.0 1.8 1.4 2.3 0.8 2.0 0.7 0.8 18.8 0.0 1.3 0.2 0.5 1.0 1.4 4.5 1.4 0.5 HIVEP3 "FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C" ENSG00000127124 "Human immunodeficiency virus type I enhancer binding protein 3" Q5T1R4 1 41506365-42035925 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3;lymphoid tissue: 16.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 17.9;hTEC/SVTERT24-B: 9.3;Karpas-707: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005728 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA005728: AB_10612117" "unprognostic (2.87e-3)" "unprognostic (2.38e-2)" "unprognostic (4.65e-2)" "unprognostic (2.56e-1)" "unprognostic (1.55e-2)" "unprognostic (6.50e-2)" "unprognostic (2.70e-3)" "unprognostic (3.73e-1)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (2.07e-8)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" 4.2 1.5 7.5 5.4 5.7 3.8 3.6 20.3 11.7 1.2 1.4 5.1 0.0 1.2 1.1 1.1 3.2 1.3 2.0 2.1 6.1 3.0 1.4 1.2 4.6 4.1 4.8 4.7 1.6 2.4 2.3 8.3 1.8 6.5 2.2 1.5 0.5 3.7 1.1 1.6 11.7 1.3 2.2 5.0 2.9 1.9 1.4 5.1 16.6 2.9 1.8 5.4 1.9 1.6 1.0 1.5 0.1 3.7 0.2 2.1 1.1 1.8 0.6 0.2 1.7 2.3 1.0 0.0 0.9 0.2 2.3 4.0 0.1 0.3 3.8 0.6 0.9 1.4 2.6 0.4 0.4 3.1 17.9 0.5 0.2 0.8 0.0 0.4 0.3 0.3 5.6 0.4 9.3 1.1 0.6 0.5 1.3 0.0 10.8 1.7 1.1 2.8 0.8 0.6 0.6 2.2 1.9 2.8 2.0 1.5 0.3 2.0 0.6 2.5 0.7 0.5 1.1 0.8 3.2 3.3 2.0 2.2 0.6 4.4 3.2 1.3 2.6 8.1 0.2 7.3 0.1 1.7 0.0 2.1 3.7 0.5 0.6 0.9 1.0 1.5 1.0 0.2 0.8 0.1 0.2 3.1 0.3 0.3 1.1 7.5 5.7 20.3 11.7 6.1 3.0 4.8 4.7 6.5 5.1 6.0 8.0 2.2 24.6 21.1 15.2 5.1 0.0 1.4 12.5 1.8 2.0 0.3 1.7 3.1 7.6 4.3 2.1 23.3 2.4 2.8 11.6 16.0 1.1 2.8 6.1 23.8 3.5 13.5 5.1 18.7 8.1 10.5 5.0 0.0 1.1 15.6 2.3 0.0 3.9 2.2 3.5 6.5 9.0 8.6 8.3 7.5 0.7 17.0 0.8 7.3 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria" Yes Yes "Nucleoplasm, Nucleoli, Nucleoli rim" Mitochondria "HPA008436: AB_1850757, HPA027261: AB_2672184" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.37e-5)" "prognostic unfavorable (2.46e-4)" "prognostic unfavorable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavorable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.1 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.7 5.3 2.9 10.1 32.6 20.0 18.0 13.3 24.4 12.5 6.8 20.6 18.6 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 5.2 11.4 16.5 17.4 13.3 33.6 17.2 23.7 18.7 19.3 13.4 16.0 18.4 33.9 9.5 9.4 10.3 13.0 8.1 14.8 11.2 10.5 10.8 8.4 13.1 8.3 19.8 21.6 14.5 27.7 12.7 10.0 21.4 11.9 12.5 49.3 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.8 0.4 1.1 0.0 0.8 0.0 0.0 3.4 0.0 0.0 1.1 0.0 0.0 12.4 0.1 0.9 46.7 0.0 13.7 0.3 0.4 0.0 0.0 5.7 0.0 0.0 2.5 2.4 7.4 0.6 2.1 0.0 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.3 18.4 12.9 0.6 1.3 1.3 1.2 0.6 HK3 ENSG00000160883 "Hexokinase 3" P52790 5 176880869-176899332 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6" "Group enriched" "Detected in some" 13 "Hofbauer cells: 32.3;Kupffer cells: 47.9;Macrophages: 21.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 76.2" "Group enriched" "Detected in many" 11 "granulocytes: 76.2;monocytes: 31.4" "Cell line enriched" "Detected in some" 4 "U-937: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056743 Enhanced NA NA 1700000 "HPA056743: AB_2683222" "unprognostic (4.22e-2)" "unprognostic (4.07e-2)" "unprognostic (1.23e-1)" "unprognostic (8.63e-2)" "unprognostic (2.02e-2)" "unprognostic (1.39e-1)" "unprognostic (8.69e-2)" "unprognostic (2.11e-1)" "unprognostic (5.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (3.82e-1)" "prognostic unfavorable (3.84e-8)" "unprognostic (7.02e-2)" "unprognostic (6.01e-3)" "unprognostic (1.46e-1)" "unprognostic (5.42e-2)" 9.2 2.6 0.6 8.5 1.0 55.0 1.3 0.3 1.2 0.4 1.7 0.3 0.0 0.9 0.8 2.6 1.9 3.0 0.9 5.4 0.6 0.3 1.6 4.1 16.3 24.1 1.2 0.5 1.2 1.0 0.0 0.4 2.9 0.5 0.9 0.6 0.9 0.9 0.1 0.8 0.3 1.6 3.4 0.6 40.6 1.2 0.6 0.2 1.3 1.5 0.2 1.2 1.8 5.3 0.0 5.1 76.2 31.4 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.8 0.1 0.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 21.3 0.0 76.2 15.4 32.9 0.0 29.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.4 0.0 31.4 0.2 0.0 6.0 0.6 1.0 0.3 1.2 0.6 0.3 1.2 0.5 0.5 0.2 0.0 1.4 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.2 32.3 0.0 0.0 0.6 47.9 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 HKDC1 "FLJ22761, FLJ37767" ENSG00000156510 "Hexokinase domain containing 1" Q2TB90 10 69220303-69267559 "Enzymes, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 77.4" "Cell type enhanced" "Detected in many" 25 "Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 8.3;T-reg: 6.6" "Lineage enriched" "Detected in single" 29 "T-cells: 8.3" "Cell line enhanced" "Detected in some" "A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2" "Region enhanced" "Detected in some" "cerebral cortex: 12.2" "Low region specificity" "Detected in all" "HPA064198, HPA064230" Enhanced Enhanced Mitochondria No No Mitochondria "HPA064198: AB_2685210, HPA064230: AB_2685219" "unprognostic (1.29e-2)" "unprognostic (2.26e-2)" "unprognostic (1.86e-1)" "unprognostic (8.47e-2)" "unprognostic (1.55e-1)" "unprognostic (3.05e-1)" "unprognostic (6.31e-3)" "unprognostic (5.03e-2)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (3.11e-1)" "unprognostic (1.04e-3)" "unprognostic (1.35e-1)" "unprognostic (2.24e-1)" "unprognostic (2.10e-3)" "unprognostic (2.19e-1)" 0.2 0.0 0.9 1.2 1.6 0.0 0.2 0.8 1.4 0.5 29.8 0.5 0.2 29.9 0.5 1.0 0.3 2.5 11.2 0.2 0.5 0.6 15.6 4.6 1.3 0.3 0.3 0.2 1.0 4.7 0.0 0.5 0.2 0.4 0.2 2.3 12.0 0.2 0.2 0.2 0.0 77.4 0.2 0.2 0.2 0.4 0.6 0.2 0.2 5.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 8.3 1.6 0.4 14.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.1 41.7 0.0 12.9 0.1 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.2 1.0 0.0 0.0 0.0 0.1 0.1 1.2 0.2 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.5 0.0 0.4 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.7 0.0 4.4 1.4 0.0 0.0 8.3 3.2 0.0 0.2 0.0 0.0 6.6 1.6 0.9 1.6 0.8 0.4 0.5 0.6 0.3 0.2 0.4 0.2 3.0 3.7 0.8 0.0 0.0 1.0 0.8 30.6 0.0 0.0 15.7 0.0 0.0 1.7 30.8 0.4 0.0 44.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 172.8 19.9 7.0 0.0 9.5 4.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.2 0.1 HLA-DOA "HLA-D0-alpha, HLA-DNA, HLA-DZA" ENSG00000204252 "Major histocompatibility complex, class II, DO alpha" P06340 6 33004178-33009612 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 30.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 31.2;B-cells: 33.8;Macrophages: 41.0;monocytes: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.1;naive B-cell: 11.2" "Group enriched" "Detected in many" 9 "B-cells: 11.2;dendritic cells: 9.1;monocytes: 4.4" "Cell line enhanced" "Detected in some" "Daudi: 6.5;HDLM-2: 4.6;REH: 20.7;U-698: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045038 Enhanced NA NA "HPA045038: AB_10959457" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" "unprognostic (1.19e-1)" "unprognostic (3.01e-1)" "unprognostic (3.83e-2)" "unprognostic (2.60e-1)" "unprognostic (9.86e-3)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (3.68e-1)" "unprognostic (4.39e-2)" "unprognostic (1.91e-1)" "unprognostic (9.95e-2)" "unprognostic (3.65e-2)" "unprognostic (8.70e-2)" "unprognostic (5.94e-2)" 5.7 5.7 2.2 18.4 3.9 2.0 5.1 1.5 2.1 4.5 4.0 8.3 2.2 5.1 4.6 6.0 2.7 4.6 4.8 9.3 2.8 3.1 10.0 3.4 18.1 24.7 5.5 2.0 5.7 2.9 3.3 3.3 1.0 5.4 5.4 4.7 4.0 4.5 3.2 1.2 2.5 12.3 2.4 9.6 25.5 4.5 1.2 3.9 14.7 3.8 3.2 30.6 3.4 3.1 11.2 9.1 0.3 4.4 0.1 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 0.0 7.4 0.0 0.3 9.1 11.2 0.1 0.9 0.3 0.1 2.0 2.8 0.7 1.4 2.2 3.9 1.5 2.1 2.8 3.1 5.5 2.0 5.4 3.9 3.0 31.2 33.8 0.5 1.6 0.0 1.1 0.0 0.0 3.4 3.5 0.0 0.1 0.0 1.6 0.0 4.6 0.0 0.0 0.2 0.0 0.9 0.5 4.7 0.0 14.2 0.0 0.0 0.6 16.4 0.0 0.3 41.0 0.0 64.1 0.0 0.9 0.5 0.0 0.0 2.6 0.2 0.0 0.2 0.0 0.2 1.0 0.1 1.3 0.0 0.1 HLA-DOB ENSG00000241106 "Major histocompatibility complex, class II, DO beta" P13765 6 32812763-32817048 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.1;lymphoid tissue: 33.0" "Group enriched" "Detected in some" 6 "B-cells: 90.0;monocytes: 75.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "memory B-cell: 42.0;naive B-cell: 51.1" "Lineage enriched" "Detected in many" 19 "B-cells: 51.1" "Group enriched" "Detected in some" 5 "Daudi: 33.5;U-698: 11.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA013846 Enhanced NA NA "HPA013846: AB_1853928" "prognostic favorable (4.29e-4)" "unprognostic (3.84e-2)" "unprognostic (7.12e-3)" "unprognostic (6.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "unprognostic (4.48e-2)" "unprognostic (4.26e-3)" "unprognostic (6.95e-2)" "prognostic favorable (4.17e-5)" "unprognostic (2.37e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.15e-5)" "unprognostic (1.37e-1)" "unprognostic (1.64e-1)" "unprognostic (7.18e-2)" "unprognostic (2.46e-1)" 0.7 0.4 0.3 28.8 0.3 2.7 1.4 0.7 0.3 1.2 2.7 0.4 0.0 1.7 0.7 0.5 1.3 0.5 1.4 2.2 0.2 0.4 1.8 0.7 3.3 33.0 0.4 0.2 0.5 0.2 0.0 1.8 0.5 0.8 0.7 2.4 0.7 3.8 0.9 0.4 1.0 12.2 0.2 0.7 28.5 1.4 1.7 0.1 5.8 1.1 0.9 29.8 5.5 0.8 51.1 2.6 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 1.7 33.5 0.1 0.1 0.0 0.2 1.0 1.8 0.0 1.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.6 0.3 11.8 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 2.6 51.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.5 0.3 0.3 0.7 0.3 0.2 0.4 0.4 0.2 0.8 0.1 0.0 4.5 90.0 0.1 0.9 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 1.0 0.5 0.0 0.0 0.2 0.3 0.4 0.1 1.1 0.0 0.7 0.0 0.0 0.0 0.3 0.2 0.0 3.9 13.5 75.7 0.0 0.6 0.2 0.0 0.0 0.0 0.7 6.5 0.3 0.0 0.2 1.4 0.0 1.0 0.0 0.3 HLA-DPA1 HLA-DP1A ENSG00000231389 "Major histocompatibility complex, class II, DP alpha 1" P20036 6 33064569-33080775 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.5" "Cell type enhanced" "Detected in many" 18 "B-cells: 1100.8;Hofbauer cells: 1218.6;Kupffer cells: 965.1;Macrophages: 2476.0;monocytes: 4193.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1" "Group enriched" "Detected in all" 8 "B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8" "Cell line enhanced" "Detected in some" "Daudi: 15.8;HDLM-2: 48.6;REH: 12.4;U-698: 11.4" HPA017967 Enhanced Supported Vesicles NA NA 92000 Vesicles "HPA017967: AB_1853929" "unprognostic (8.93e-3)" "unprognostic (3.15e-2)" "unprognostic (3.64e-2)" "unprognostic (9.40e-3)" "unprognostic (9.07e-2)" "unprognostic (2.80e-2)" "unprognostic (5.69e-2)" "unprognostic (1.82e-2)" "unprognostic (7.28e-2)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.17e-1)" "unprognostic (4.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.06e-1)" 25.2 12.8 3.3 13.3 3.6 4.7 16.3 3.5 3.3 11.8 6.8 3.1 4.3 8.6 8.5 15.9 8.5 5.7 14.7 11.1 4.2 6.2 12.4 9.7 35.9 20.2 6.2 3.8 3.8 5.4 3.8 5.2 6.5 4.8 7.4 7.3 7.5 7.4 15.7 4.1 5.8 14.7 6.4 20.4 37.6 5.6 8.6 4.1 10.9 14.2 9.5 21.5 8.5 17.8 30.0 59.5 1.3 37.8 4.0 5.6 20.3 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.2 0.1 0.2 0.0 0.0 2.1 15.8 2.2 0.3 3.1 0.0 0.0 0.0 0.0 48.6 1.0 2.6 0.0 0.0 0.0 0.0 5.1 0.7 0.0 1.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 12.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 1.1 3.5 0.0 0.0 0.0 2.4 0.3 11.4 5.5 0.1 1.9 0.3 16.3 1.3 4.6 37.8 1.2 30.0 2.1 5.0 59.5 26.7 0.7 3.4 0.6 4.0 23.2 17.1 5.6 20.3 3.3 3.6 3.5 3.3 4.2 6.2 6.2 3.8 4.8 4.1 77.4 317.2 1100.8 5.1 183.6 2.5 10.5 76.5 80.3 113.7 22.7 0.0 4.2 8.3 15.4 2.1 188.1 6.1 0.0 15.8 5.3 55.4 10.4 62.4 4.5 1218.6 4.8 9.8 60.2 965.1 4.3 16.7 2476.0 286.8 4193.1 9.2 4.8 4.8 4.5 25.8 32.7 3.1 51.8 21.8 0.9 2.9 153.2 5.7 100.5 4.1 8.9 HLA-DPB1 HLA-DP1B ENSG00000223865 "Major histocompatibility complex, class II, DP beta 1" P04440 6 33075926-33087201 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 99.4" "Cell type enhanced" "Detected in many" 19 "B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 90.1" "Group enriched" "Detected in all" 8 "B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6" "Group enriched" "Detected in some" 6 "HDLM-2: 47.2;REH: 22.5" "HPA011078, HPA058509" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA 730000 "Cell Junctions" Nucleoplasm "HPA011078: AB_1079378, HPA058509: AB_2683737" "unprognostic (5.44e-3)" "unprognostic (7.03e-3)" "unprognostic (9.84e-2)" "prognostic favorable (3.38e-4)" "unprognostic (9.43e-2)" "unprognostic (1.80e-2)" "unprognostic (1.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.77e-2)" "unprognostic (5.64e-2)" "unprognostic (1.57e-1)" "unprognostic (4.34e-1)" "unprognostic (4.35e-2)" "unprognostic (1.80e-1)" "unprognostic (4.17e-2)" "unprognostic (3.58e-2)" "unprognostic (1.85e-1)" 29.6 31.9 9.8 52.8 15.1 6.9 22.0 6.1 7.7 15.5 11.8 14.9 6.9 14.4 15.3 23.4 9.8 11.0 26.6 29.6 9.7 10.4 25.5 12.4 79.9 99.4 23.5 6.0 10.8 10.5 4.3 11.5 6.2 19.6 19.4 6.6 22.2 25.0 15.4 6.1 14.8 33.7 8.9 35.3 88.8 15.8 4.3 16.2 51.9 14.2 20.7 69.3 35.5 11.9 57.8 90.1 1.1 40.6 2.8 7.6 23.5 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.2 0.1 0.0 0.0 0.0 0.0 47.2 2.2 1.3 0.0 0.0 0.0 0.0 0.1 1.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 22.5 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.0 0.2 0.0 0.0 6.0 0.1 3.9 0.0 0.0 0.0 0.2 18.7 1.1 5.3 40.6 0.7 57.8 1.9 7.6 90.1 56.9 0.7 4.2 0.4 2.8 17.0 25.7 7.2 23.5 9.8 15.1 6.1 7.7 9.7 10.4 23.5 6.0 19.6 16.2 62.5 286.9 1312.2 21.4 267.0 12.2 9.3 73.9 46.8 77.3 27.9 15.7 5.1 3.3 33.6 3.2 238.9 10.6 0.0 13.0 4.7 50.0 41.9 61.1 5.5 1159.7 7.9 9.2 88.4 1265.6 4.0 25.3 2334.4 307.1 5192.2 12.2 24.1 8.0 4.0 19.8 36.3 19.2 45.3 33.2 1.2 5.9 203.9 7.6 173.0 6.5 13.9 HLA-DQA1 "CELIAC1, HLA-DQA" ENSG00000196735 "Major histocompatibility complex, class II, DQ alpha 1" P01909 6 32628179-32647062 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 91.5;lymphoid tissue: 113.3" "Cell type enhanced" "Detected in many" 18 "B-cells: 621.2;Hofbauer cells: 402.6;Macrophages: 675.1;monocytes: 1355.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 91.5" "Group enriched" "Detected in many" 19 "B-cells: 43.3;dendritic cells: 91.5;monocytes: 32.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 176.7" HPA012315 Enhanced NA NA "HPA012315: AB_1853930" "unprognostic (4.24e-3)" "unprognostic (1.47e-2)" "unprognostic (1.43e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (3.26e-1)" "unprognostic (5.81e-3)" "unprognostic (2.84e-2)" "unprognostic (1.17e-1)" "unprognostic (4.65e-2)" "unprognostic (1.15e-1)" "unprognostic (5.36e-2)" "unprognostic (6.74e-2)" "unprognostic (2.27e-1)" "unprognostic (7.43e-2)" "unprognostic (1.57e-1)" 44.6 8.9 3.9 63.5 6.9 0.7 14.8 1.2 3.1 11.4 13.6 7.4 6.1 0.0 10.6 45.5 8.1 6.1 23.7 4.4 3.8 4.9 23.8 17.2 69.0 48.2 8.7 2.6 16.4 5.1 0.0 6.5 3.7 8.9 5.8 22.1 14.8 11.4 1.2 7.6 11.3 26.1 4.2 19.5 97.0 17.3 2.1 6.7 113.3 8.5 0.5 63.6 42.3 6.6 43.3 91.5 0.4 32.1 1.0 2.9 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 176.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.2 0.1 19.5 3.2 0.0 0.0 0.1 14.8 0.0 0.3 32.1 0.1 42.8 0.4 2.3 91.5 43.3 0.0 0.6 0.4 1.0 8.1 22.7 2.9 15.8 3.9 6.9 1.2 3.1 3.8 4.9 8.7 2.6 8.9 6.7 11.9 132.6 621.2 0.4 44.6 0.0 2.0 12.7 10.7 21.6 0.0 2.0 0.7 1.7 1.4 0.4 35.0 0.3 0.0 3.8 1.1 13.6 1.2 46.5 0.4 402.6 0.0 0.0 9.8 236.5 0.2 2.8 675.1 67.4 1355.3 0.3 0.5 2.1 0.0 0.0 5.1 1.8 6.5 2.0 0.0 0.8 36.4 1.7 27.7 0.4 0.4 HLA-DQA2 HLA-DXA ENSG00000237541 "Major histocompatibility complex, class II, DQ alpha 2" P01906 6 32741342-32747215 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.7;lymphoid tissue: 51.1" "Cell type enhanced" "Detected in many" 22 "B-cells: 96.0;Hofbauer cells: 116.5;Kupffer cells: 86.7;Macrophages: 348.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.06e-3)" "unprognostic (2.46e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "unprognostic (2.69e-1)" "unprognostic (5.44e-2)" "unprognostic (2.64e-1)" "unprognostic (2.57e-2)" "unprognostic (8.85e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.67e-2)" "unprognostic (1.18e-1)" "unprognostic (2.19e-2)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.48e-2)" 6.1 2.7 0.5 1.5 0.5 1.5 3.6 0.0 1.5 6.3 1.8 2.1 0.0 1.5 3.8 1.5 2.5 1.9 27.2 16.5 1.0 0.9 12.5 3.5 37.7 43.6 1.3 0.6 1.5 1.5 1.5 1.5 1.9 3.0 7.9 1.5 6.5 19.9 2.5 1.5 4.7 11.7 1.5 5.9 35.5 2.3 1.5 0.0 40.5 3.5 6.7 51.1 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.2 1.0 0.9 1.3 0.6 3.0 0.0 3.0 2.2 96.0 0.2 20.8 0.0 0.4 0.0 5.3 5.7 3.5 0.0 0.2 0.0 0.0 0.5 8.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 116.5 0.0 2.4 3.1 86.7 0.5 1.1 348.8 23.6 35.1 0.0 0.0 0.3 0.0 0.0 1.5 0.0 6.5 0.2 0.0 0.0 20.5 0.3 21.5 0.0 0.7 HLA-DQB1 "CELIAC1, HLA-DQB, IDDM1" ENSG00000179344 "Major histocompatibility complex, class II, DQ beta 1" 6 32659467-32668383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 74.6" "Group enriched" "Detected in many" 4 "B-cells: 690.1;Hofbauer cells: 446.2;Macrophages: 1016.1;monocytes: 1484.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4" "Group enriched" "Detected in all" 6 "B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8" "Cell line enriched" "Detected in some" 6 "HDLM-2: 114.5" HPA013667 Enhanced Supported "Golgi apparatus,Rods & Rings" NA NA "Rods & Rings" "Golgi apparatus" "HPA013667: AB_1853932" "unprognostic (8.60e-3)" "unprognostic (1.91e-2)" "unprognostic (5.91e-2)" "unprognostic (9.85e-3)" "unprognostic (4.48e-1)" "unprognostic (5.30e-2)" "unprognostic (4.75e-2)" "unprognostic (1.06e-2)" "unprognostic (2.51e-2)" "unprognostic (1.48e-1)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.34e-2)" "unprognostic (3.13e-1)" "unprognostic (4.16e-1)" "unprognostic (2.43e-1)" "unprognostic (1.40e-1)" 23.9 10.0 3.5 40.4 3.0 9.0 17.0 1.0 4.9 11.0 18.8 8.8 4.5 0.0 9.9 42.6 9.6 8.0 21.7 12.7 4.1 5.3 35.4 9.9 61.2 61.1 6.1 4.2 6.3 4.0 0.0 9.2 4.0 7.9 11.3 10.7 13.5 11.8 5.6 7.8 12.4 27.6 4.6 15.5 74.5 32.7 4.6 2.9 63.5 13.3 7.9 74.6 37.9 7.4 35.6 68.2 4.6 27.8 1.5 7.1 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.4 0.0 0.0 3.7 0.0 3.7 0.0 114.5 2.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.6 2.1 0.0 0.0 0.1 0.1 0.0 13.7 0.3 12.6 9.5 0.0 0.0 0.0 27.8 4.6 2.4 24.1 1.1 30.9 1.2 3.7 68.2 35.6 0.0 1.1 1.9 1.5 6.6 21.4 7.1 31.9 3.5 3.0 1.0 4.9 4.1 5.3 6.1 4.2 7.9 2.9 38.7 182.5 690.1 8.0 79.8 4.8 2.5 22.9 21.4 40.9 17.4 9.8 1.7 6.6 16.1 13.8 55.5 8.1 0.0 17.6 1.9 15.3 7.5 36.0 0.9 446.2 0.0 21.9 12.3 206.1 4.7 6.1 1016.1 92.8 1484.2 9.0 1.0 19.0 5.8 9.2 15.4 1.7 6.5 4.2 2.1 2.1 58.1 2.5 41.5 4.1 32.4 HLA-DQB2 HLA-DXB ENSG00000232629 "Major histocompatibility complex, class II, DQ beta 2" P05538 6 32756098-32763534 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6;skin 1: 25.8" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 25.2;Macrophages: 78.8;Melanocytes: 25.3;Suprabasal keratinocytes: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1" "Group enriched" "Detected in many" 7 "B-cells: 3.0;dendritic cells: 3.1;monocytes: 1.2" "Group enriched" "Detected in some" 4 "Daudi: 1.0;HDLM-2: 3.6;U-266/70: 1.0" HPA073187 Enhanced NA NA "HPA073187: " "prognostic favorable (5.55e-4)" "unprognostic (3.75e-3)" "unprognostic (2.16e-1)" "unprognostic (2.50e-2)" "unprognostic (2.10e-1)" "unprognostic (6.60e-2)" "unprognostic (8.15e-2)" "unprognostic (3.73e-3)" "unprognostic (6.48e-2)" "unprognostic (1.25e-1)" "unprognostic (3.74e-1)" "unprognostic (1.94e-1)" "unprognostic (6.66e-2)" "unprognostic (1.23e-1)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.92e-2)" 2.1 0.9 0.4 3.5 0.4 0.3 2.0 0.4 0.3 2.1 0.5 0.6 0.2 0.4 0.3 1.8 5.5 0.6 0.8 0.3 0.3 0.2 1.2 0.4 9.7 3.0 1.3 0.2 0.9 0.2 0.0 0.8 0.2 0.8 0.6 1.1 0.8 2.7 0.8 0.5 25.8 3.1 0.2 1.4 7.2 2.2 0.5 0.3 25.6 1.0 11.3 17.8 1.1 2.3 3.0 3.1 0.3 1.2 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.4 0.2 0.1 0.2 0.8 0.1 0.1 1.2 0.0 2.8 0.0 0.1 3.1 3.0 0.1 0.1 0.3 0.3 0.4 0.5 0.2 1.2 0.4 0.4 0.4 0.3 0.3 0.2 1.3 0.2 0.8 0.3 3.0 8.8 6.7 0.0 25.2 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 2.5 0.0 0.0 0.0 8.2 0.0 0.9 78.8 25.3 8.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.1 0.1 0.0 0.0 0.1 HLA-DRA HLA-DRA1 ENSG00000204287 "Major histocompatibility complex, class II, DR alpha" P01903 6 32439842-32445046 "Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 211.6" "Group enriched" "Detected in many" 5 "B-cells: 2551.2;Hofbauer cells: 2965.8;Kupffer cells: 2919.1;Macrophages: 6482.8;monocytes: 9158.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.8;intermediate monocyte: 46.8;memory B-cell: 59.4;naive B-cell: 61.7;non-classical monocyte: 28.0;plasmacytoid DC: 29.6" "Group enriched" "Detected in all" 5 "B-cells: 61.7;dendritic cells: 29.6;monocytes: 46.8" "Cell line enhanced" "Detected in some" "Daudi: 56.6;HDLM-2: 101.0;REH: 41.1;U-266/70: 24.9;U-698: 58.2;U-87 MG: 40.5" "Low region specificity" "Detected in all" "CAB002798, CAB015402, HPA050162, HPA053176" Enhanced NA NA 1600000 "CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070" "unprognostic (1.20e-3)" "unprognostic (4.70e-3)" "prognostic favorable (5.30e-4)" "unprognostic (3.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (2.77e-2)" "unprognostic (3.05e-2)" "unprognostic (3.92e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (1.98e-1)" "unprognostic (4.42e-2)" "unprognostic (5.67e-2)" "unprognostic (2.52e-2)" 51.8 33.5 14.1 79.1 20.2 1.8 37.3 2.3 10.1 21.1 38.9 21.5 10.9 30.8 16.5 76.8 15.9 33.9 21.8 34.7 13.1 16.2 60.9 17.8 147.2 211.6 27.3 7.4 14.7 10.0 1.7 14.7 9.7 23.5 21.9 33.8 23.5 21.6 12.6 12.9 27.6 86.2 9.0 52.8 127.3 68.7 7.2 21.6 53.7 18.6 25.9 151.6 53.5 15.1 61.7 29.6 9.3 46.8 1.8 2.7 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 56.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 101.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 24.9 0.0 58.2 40.5 0.0 0.0 0.6 29.8 9.3 0.3 46.8 0.1 59.4 0.3 1.7 0.5 61.7 0.2 0.3 2.2 1.8 28.0 29.6 2.7 29.9 14.1 20.2 2.3 10.1 13.1 16.2 27.3 7.4 23.5 21.6 271.0 1055.7 2551.2 15.4 664.8 2.8 17.1 140.1 283.7 312.8 143.1 0.0 12.6 24.9 102.1 5.1 500.2 61.2 70.0 51.5 11.7 106.8 41.9 162.6 8.5 2965.8 1.6 62.4 159.6 2919.1 12.4 27.9 6482.8 733.9 9158.9 74.1 8.3 54.7 48.9 4.2 202.9 18.7 71.1 73.3 3.5 5.0 503.6 21.6 91.4 51.9 59.2 HLA-DRB1 HLA-DR1B ENSG00000196126 "Major histocompatibility complex, class II, DR beta 1" "P01911, P04229, Q29974, Q9GIY3" 6 32578769-32589848 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 95.6;lung: 95.9" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 1496.4;Macrophages: 3257.5;monocytes: 4435.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 95.6" "Group enriched" "Detected in all" 10 "B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5" "Cell line enhanced" "Detected in some" "HDLM-2: 157.6;HMC-1: 22.4;THP-1: 18.9;U-266/70: 21.0;U-698: 27.1;U-87 MG: 43.5" "CAB015400, CAB034021, HPA043151" Enhanced NA NA "CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342" "unprognostic (3.69e-3)" "unprognostic (3.66e-3)" "unprognostic (1.80e-2)" "unprognostic (2.40e-3)" "unprognostic (2.21e-1)" "unprognostic (5.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.22e-3)" "unprognostic (8.56e-2)" "unprognostic (3.00e-2)" "unprognostic (1.23e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-3)" "unprognostic (6.16e-2)" "unprognostic (1.19e-1)" "unprognostic (5.10e-2)" "unprognostic (1.53e-1)" 36.8 18.7 9.7 32.2 15.9 8.7 24.9 3.6 10.0 14.2 18.2 11.5 11.2 0.2 10.5 27.2 12.1 13.3 12.0 11.9 8.5 6.9 50.0 15.6 95.9 80.8 18.9 5.4 6.9 8.0 0.0 9.4 5.7 14.8 9.5 23.7 16.1 11.3 2.4 8.2 13.3 42.1 3.8 19.7 62.1 38.1 5.6 13.2 33.6 14.1 3.8 44.7 29.7 17.0 41.3 95.6 6.3 52.5 2.7 4.7 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.2 0.0 0.6 0.0 157.6 1.7 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 3.5 0.2 0.6 18.9 0.0 0.0 0.1 0.3 0.0 21.0 0.5 27.1 43.5 0.7 0.0 0.2 34.6 6.3 1.8 52.5 0.3 32.7 1.2 3.7 95.6 41.3 0.1 1.6 1.2 2.7 26.9 20.4 4.7 37.7 9.7 15.9 3.6 10.0 8.5 6.9 18.9 5.4 14.8 13.2 137.0 520.2 984.8 8.4 154.2 1.7 28.0 109.5 140.5 174.0 134.3 0.0 2.5 21.6 104.5 3.5 441.7 148.8 0.0 65.2 4.6 54.7 18.7 119.2 3.4 1496.4 0.0 34.5 186.6 1186.4 7.6 13.8 3257.5 205.8 4435.6 52.0 8.3 76.3 364.7 25.1 169.2 9.4 25.8 72.3 1.8 3.4 129.4 5.7 137.1 73.6 61.3 HLA-DRB5 ENSG00000198502 "Major histocompatibility complex, class II, DR beta 5" Q30154 6 32517343-32530287 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 71.8;lymphoid tissue: 64.8" "Cell type enhanced" "Detected in many" 11 "B-cells: 354.6;Hofbauer cells: 502.6;Kupffer cells: 564.1;Macrophages: 808.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 26.4" "Group enriched" "Detected in many" 10 "B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0" "Group enriched" "Detected in some" 5 "HDLM-2: 112.0;HMC-1: 28.3;U-698: 33.5;U-87 MG: 44.2" HPA043151 Supported NA NA "HPA043151: AB_2678342" "unprognostic (1.97e-3)" "unprognostic (4.74e-2)" "unprognostic (3.30e-2)" "prognostic favorable (7.89e-4)" "unprognostic (2.28e-2)" "unprognostic (4.68e-3)" "unprognostic (9.09e-3)" "unprognostic (2.08e-3)" "unprognostic (1.06e-2)" "unprognostic (5.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.87e-1)" "unprognostic (2.89e-2)" "unprognostic (1.45e-1)" "unprognostic (7.60e-3)" "unprognostic (9.72e-2)" "unprognostic (5.48e-2)" 21.8 14.2 2.9 22.1 3.9 3.7 16.2 2.0 3.2 16.7 21.7 7.0 6.4 2.3 8.7 22.1 9.5 12.6 6.6 9.1 4.3 4.0 32.2 9.3 71.8 60.4 7.3 0.8 4.9 4.9 0.0 6.0 4.9 5.4 9.5 10.2 11.2 9.0 2.7 7.4 8.8 34.7 4.7 12.2 64.8 40.3 4.6 4.5 15.3 9.5 11.2 27.6 21.8 6.5 13.3 26.4 1.5 16.0 0.9 1.8 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 112.0 1.1 0.0 0.0 0.0 0.0 0.1 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 9.9 0.0 0.6 0.1 0.3 0.0 7.6 0.1 33.5 44.2 0.3 0.0 0.0 10.1 1.5 0.4 16.0 0.0 10.5 0.4 1.1 26.4 13.3 0.0 0.5 0.3 0.9 8.1 5.9 1.8 15.4 2.9 3.9 2.0 3.2 4.3 4.0 7.3 0.8 5.4 4.5 14.9 139.1 354.6 2.3 92.6 0.6 6.9 137.6 5.3 7.9 14.0 3.9 1.1 1.7 1.1 2.3 236.0 13.4 0.0 6.9 2.7 11.4 6.5 57.8 3.4 502.6 0.0 1.7 114.2 564.1 3.7 14.7 808.2 114.7 129.0 14.9 0.0 18.4 51.8 32.2 19.6 1.4 19.4 37.4 0.7 0.2 79.3 2.6 71.0 3.5 18.2 HLA-G ENSG00000204632 "Major histocompatibility complex, class I, G" P17693 6 29826967-29831125 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 66.0" "Cell type enriched" "Detected in many" 15 "Extravillous trophoblasts: 586.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 1.2;SuSa: 3.9" CAB016158 Enhanced "Secreted to blood" NA NA 32800000 "CAB016158: AB_627938" "unprognostic (1.13e-2)" "unprognostic (9.95e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-3)" "unprognostic (2.51e-1)" "prognostic favorable (3.91e-5)" "unprognostic (6.34e-2)" "unprognostic (8.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (1.52e-2)" "unprognostic (3.19e-3)" 0.2 0.1 0.0 0.5 0.1 0.2 0.3 0.1 0.1 0.2 0.5 0.1 0.0 1.2 0.2 0.6 0.1 0.1 0.2 0.3 0.2 0.0 0.5 0.2 2.8 0.7 0.1 0.1 0.3 1.9 0.1 15.2 66.0 0.1 0.2 0.2 0.3 0.4 0.6 0.2 0.2 0.8 0.1 0.2 1.2 0.9 2.2 0.2 1.3 0.4 0.2 0.2 0.2 0.3 0.3 0.3 2.2 0.9 0.2 1.2 5.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.9 1.2 0.7 0.5 1.2 0.3 0.1 0.5 0.3 0.3 0.6 1.2 2.2 0.2 0.6 0.1 0.5 5.7 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 1.1 1.4 6.4 20.3 0.0 0.8 5.1 0.0 0.0 0.0 0.0 7.8 0.0 2.8 16.1 5.2 2.6 0.0 4.7 586.1 11.7 5.5 0.0 1.1 21.9 0.0 16.8 8.0 11.0 5.3 2.3 3.3 11.8 0.0 39.2 0.0 15.5 20.1 2.5 0.2 0.0 0.0 3.3 4.7 3.0 30.7 33.9 6.9 9.7 6.7 HLF MGC33822 ENSG00000108924 "HLF, PAR bZIP transcription factor" Q16534 17 55265012-55325065 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 78.8" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 122.6;Hepatocytes: 152.5;Horizontal cells: 87.4" "Cancer enhanced" "Detected in many" "liver cancer: 13.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 2.4;T-reg: 2.1" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enriched" "Detected in some" 6 "Hep G2: 60.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068156, HPA071210" Enhanced Nucleoplasm Yes NA Nucleoplasm "HPA068156: AB_2685963, HPA071210: AB_2686361" "unprognostic (1.24e-1)" "unprognostic (1.19e-3)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "prognostic favorable (1.88e-4)" "unprognostic (5.30e-3)" "prognostic favorable (2.71e-7)" "unprognostic (1.42e-1)" "unprognostic (3.44e-2)" "unprognostic (1.24e-3)" "unprognostic (2.19e-1)" "prognostic favorable (3.55e-6)" "unprognostic (8.47e-2)" "unprognostic (1.64e-1)" "unprognostic (6.85e-2)" "unprognostic (1.60e-2)" 9.5 15.2 13.3 2.0 26.2 1.0 10.8 15.2 38.0 10.5 10.6 6.4 2.4 1.7 10.3 8.5 18.1 9.3 6.1 15.9 12.6 6.9 9.2 78.8 9.5 2.1 6.6 24.5 34.6 2.7 2.8 8.0 1.5 12.3 9.9 3.1 23.7 15.9 9.5 5.3 11.6 3.0 14.3 5.5 5.7 4.7 3.4 6.3 0.0 23.4 7.1 5.6 9.2 5.2 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 10.0 0.2 0.0 0.0 60.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.1 0.1 5.0 0.0 4.2 0.2 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 1.9 1.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 13.3 26.2 15.2 38.0 12.6 6.9 6.6 24.5 12.3 6.3 3.0 36.8 0.0 4.7 19.8 122.6 31.9 15.3 1.4 11.4 7.0 9.8 0.1 10.0 1.5 0.9 8.6 0.0 0.0 0.8 0.0 6.0 1.2 0.0 152.5 0.1 87.4 2.9 4.9 4.1 2.7 26.2 1.0 10.1 0.0 0.1 54.5 0.3 0.0 36.7 18.9 13.0 12.9 6.2 0.3 2.7 24.1 1.0 2.2 0.0 0.5 HLX "HB24, HLX1" ENSG00000136630 "H2.0 like homeobox" Q14774 1 220879400-220885059 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 54.0" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Hofbauer cells: 27.0;Ito cells: 38.6;monocytes: 67.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 25.8;neutrophil: 28.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 28.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 13.5;THP-1: 47.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA005968 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA005968: AB_1079066" "unprognostic (6.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.57e-2)" "unprognostic (9.19e-3)" "unprognostic (1.76e-1)" "unprognostic (1.40e-1)" "unprognostic (5.14e-3)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" "unprognostic (3.19e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.28e-6)" "unprognostic (8.44e-3)" "unprognostic (3.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" 27.7 3.0 2.7 8.8 3.0 54.0 18.4 0.9 2.3 5.7 24.3 2.0 3.8 4.5 7.4 3.6 8.7 5.0 7.5 15.2 3.3 0.9 4.0 11.5 14.3 10.5 6.2 0.3 4.9 4.9 1.8 2.0 14.0 2.5 6.9 2.4 4.2 2.3 3.8 10.4 5.7 11.1 4.2 6.4 10.9 3.1 3.9 3.1 1.4 6.3 3.0 3.2 10.4 12.9 2.2 5.5 28.5 6.3 0.2 0.1 1.8 0.0 1.9 0.0 1.4 4.3 6.9 3.6 5.2 8.6 6.0 5.0 0.4 0.1 0.0 0.1 3.2 1.1 0.0 1.1 0.0 2.5 1.3 3.8 0.0 2.2 0.2 7.6 1.7 0.4 8.0 0.2 6.7 0.4 0.5 2.6 0.0 2.2 0.0 0.8 0.0 0.0 6.2 0.2 0.0 3.6 0.1 4.1 0.0 0.6 0.0 0.0 2.0 0.7 0.1 13.5 0.3 0.0 47.4 0.8 4.0 0.0 0.6 4.1 0.0 0.0 0.0 6.5 5.4 1.6 25.8 6.3 10.7 0.0 1.8 0.0 2.2 0.0 0.0 5.5 1.1 0.0 0.0 28.5 0.2 0.3 3.5 0.1 1.8 2.7 3.0 0.9 2.3 3.3 0.9 6.2 0.3 2.5 3.1 8.9 7.7 1.5 0.1 2.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.3 11.7 0.0 23.3 0.3 0.6 4.6 0.1 3.5 6.7 27.0 0.0 0.0 38.6 17.7 0.0 2.3 17.3 0.0 67.7 0.0 0.0 0.2 0.0 1.4 0.0 0.0 6.5 9.5 0.1 1.0 2.8 0.3 0.0 0.0 0.1 HMBS "PBGD, PORC, UPS" ENSG00000256269 "Hydroxymethylbilane synthase" P08397 11 119084866-119093549 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 75.2" "Cell type enriched" "Detected in many" 16 "Erythroid cells: 794.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006114, HPA050659" Supported Approved "Lipid droplets" NA NA 28000000 "Lipid droplets" "HPA006114: AB_1079067, HPA050659: AB_2681206" "unprognostic (6.24e-2)" "unprognostic (9.10e-3)" "unprognostic (1.42e-2)" "unprognostic (4.98e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (2.29e-3)" "unprognostic (2.81e-1)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (6.83e-2)" "unprognostic (5.06e-2)" "unprognostic (2.90e-3)" "unprognostic (3.91e-3)" "unprognostic (9.53e-2)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" 5.5 11.0 5.3 6.2 9.3 75.2 8.6 5.2 8.0 5.5 8.3 6.0 6.0 7.9 6.9 7.9 9.4 5.5 6.4 11.5 5.9 5.5 9.9 22.2 5.8 14.5 8.8 4.5 3.7 21.2 7.9 5.9 9.7 8.4 5.5 9.2 4.1 10.1 7.2 17.4 6.0 7.9 6.8 9.7 10.4 7.1 7.4 7.5 6.0 8.4 13.0 9.3 5.7 4.8 7.7 19.1 12.0 14.0 3.8 7.4 9.4 9.2 14.1 6.8 12.0 5.4 6.8 10.2 7.4 8.3 10.9 9.4 17.5 14.7 14.3 16.6 9.4 10.3 13.2 10.1 14.4 7.0 9.8 10.4 23.6 5.7 12.8 10.1 8.8 7.7 7.4 9.2 17.2 13.2 4.8 5.0 13.5 34.9 6.4 8.6 37.2 8.5 17.0 7.6 17.1 9.0 9.9 6.7 14.0 11.0 8.5 7.5 10.2 5.9 9.3 6.5 5.1 15.9 12.2 4.7 8.3 6.3 8.1 8.6 3.5 4.1 8.5 5.5 11.6 9.8 12.0 14.0 1.4 5.1 12.2 6.7 7.7 4.8 5.7 19.1 7.2 7.4 5.6 0.4 3.8 7.3 12.3 4.9 9.4 5.3 9.3 5.2 8.0 5.9 5.5 8.8 4.5 8.4 7.5 8.9 7.0 9.3 7.6 7.0 4.7 12.6 7.6 10.7 4.5 10.4 25.5 50.1 16.6 18.3 1.2 4.9 8.5 794.3 27.0 50.5 8.4 10.8 2.3 20.2 25.6 9.5 12.7 6.7 10.8 1.8 5.5 10.1 13.5 15.4 15.5 5.7 19.8 8.6 8.1 18.1 24.3 0.0 8.2 1.1 24.4 7.0 19.5 4.1 27.6 5.9 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB032200, HPA065612, HPA068442" Enhanced Approved Nucleoplasm,Nucleoli NA NA 18000 Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 15.8 3.5 14.8 35.7 13.5 55.4 13.0 13.8 19.0 26.1 22.0 5.9 7.7 42.3 8.6 7.2 79.4 15.1 17.8 13.0 11.7 12.6 14.6 6.9 16.0 46.1 10.7 8.7 3.9 13.0 4.1 5.1 31.8 12.5 8.7 21.2 9.9 22.0 6.9 33.7 38.3 36.0 3.8 8.4 31.6 24.2 32.6 7.2 107.3 12.5 39.6 72.7 13.0 29.6 26.6 33.4 12.8 10.1 7.3 22.4 11.0 121.6 48.2 24.7 17.2 11.5 85.4 108.0 49.2 56.3 38.2 21.3 31.5 85.4 57.4 24.8 20.1 24.0 26.1 29.1 87.7 30.4 12.5 19.5 17.6 16.2 42.1 24.4 62.8 20.3 36.6 9.8 69.1 36.1 98.7 115.2 32.8 70.8 2.9 53.1 12.3 54.4 77.4 120.4 60.7 81.6 80.9 0.5 63.3 25.8 11.2 43.2 18.3 5.2 25.0 45.4 40.8 10.0 67.4 99.8 19.9 62.8 28.9 46.0 23.6 36.5 74.1 42.1 26.2 99.3 6.2 10.1 12.8 10.2 10.1 13.3 26.6 18.7 16.0 30.7 16.4 22.4 17.7 2.6 7.3 9.4 33.4 21.0 11.0 14.8 13.5 13.8 19.0 11.7 12.6 10.7 8.7 12.5 7.2 26.8 23.7 124.5 686.8 384.1 27.4 24.5 38.2 10.7 36.4 38.4 3.9 784.6 39.7 243.5 6.1 27.0 148.7 46.7 242.2 663.0 71.9 750.7 66.8 10.6 337.7 11.1 112.2 16.0 59.4 17.5 5.2 107.5 86.0 66.7 165.5 27.9 1097.2 162.4 2.5 9.0 27.8 0.0 34.9 38.5 398.0 315.9 688.1 51.7 282.8 1250.0 HMGA2 "BABL, HMGIC, LIPO" ENSG00000149948 "High mobility group AT-hook 2" P52926 12 65824131-65966295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.3" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 15.7;Hofbauer cells: 6.8;Late spermatids: 6.8;Pancreatic endocrine cells: 11.8;Undifferentiated cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 63.0;hTERT-RPE1: 46.0;SuSa: 44.3" "Not detected" "Not detected" "CAB017809, HPA039076" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB017809: , HPA039076: AB_2676335" "unprognostic (2.39e-1)" "unprognostic (6.00e-2)" "unprognostic (2.08e-1)" "unprognostic (3.68e-3)" "unprognostic (5.21e-3)" "prognostic unfavorable (4.79e-4)" "unprognostic (4.05e-3)" "unprognostic (6.17e-3)" "unprognostic (6.71e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-6)" "unprognostic (3.33e-2)" "unprognostic (4.55e-5)" "unprognostic (4.22e-2)" "unprognostic (2.53e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (2.86e-4)" 6.5 0.3 0.5 3.8 0.8 8.1 2.1 0.2 0.6 2.5 7.6 0.4 0.0 2.4 2.7 0.1 1.1 2.4 3.3 0.5 0.3 0.4 1.0 0.4 0.5 0.1 0.3 1.3 2.1 1.7 0.0 1.7 0.3 0.6 0.5 4.6 0.4 0.5 1.8 2.0 0.7 5.1 0.7 1.7 0.8 2.1 25.3 0.0 0.8 1.1 3.0 0.1 0.8 2.8 0.7 0.3 3.8 2.1 1.3 0.7 0.1 9.1 4.0 63.0 9.0 3.0 16.5 0.0 29.1 13.3 5.1 5.1 5.2 3.9 0.0 18.9 1.3 24.0 4.0 10.4 25.1 24.5 0.0 10.9 0.0 0.1 31.5 1.7 0.8 0.1 12.5 1.5 11.0 19.8 46.0 20.1 0.0 0.0 0.1 29.1 0.0 0.0 5.1 36.9 0.8 18.1 2.4 3.1 0.0 13.6 0.0 0.0 0.0 0.0 0.0 16.0 44.3 0.1 0.1 23.5 18.5 5.5 14.1 8.7 0.0 0.0 0.0 22.4 0.0 4.2 3.8 1.0 0.7 0.5 0.6 0.3 0.3 0.4 0.5 0.2 0.7 0.4 0.7 2.5 1.3 2.1 0.3 0.3 0.1 0.5 0.8 0.2 0.6 0.3 0.4 0.3 1.3 0.6 0.0 0.0 1.4 0.0 2.2 0.0 0.0 1.2 0.0 4.0 0.0 0.0 0.0 0.8 0.0 3.0 15.7 0.1 3.3 0.0 0.7 0.3 0.9 0.4 0.0 0.0 6.8 0.0 0.0 0.6 0.0 6.8 0.3 0.0 0.0 0.0 4.7 0.0 11.8 3.5 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.1 0.7 0.0 8.5 0.9 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331695-173335125 "Plasma proteins, Predicted intracellular proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1" "Cell type enhanced" "Detected in all" 15 "Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 166.6;MOLT-4: 171.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" NA Yes 380000 Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109" "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 18.8 5.9 10.3 48.9 13.2 325.8 19.9 6.6 9.5 17.1 24.0 8.6 7.9 15.7 18.6 16.2 28.6 15.4 13.8 23.4 9.5 10.2 13.2 6.9 25.4 59.8 12.5 8.2 29.0 5.8 2.9 8.0 18.5 9.3 19.0 21.2 12.2 13.8 8.6 46.2 15.5 21.5 25.3 13.3 36.7 13.0 26.7 10.6 187.1 18.7 23.0 61.6 27.1 18.5 11.6 16.8 95.9 20.5 11.9 39.9 14.3 34.9 8.4 72.2 32.2 9.0 9.0 27.7 26.1 19.9 28.8 25.8 23.7 48.8 118.3 5.9 14.5 15.4 13.7 47.3 14.2 45.0 72.4 22.1 130.0 21.2 34.7 8.8 115.0 50.2 8.7 4.3 14.4 32.8 15.7 29.5 62.9 49.0 166.6 26.3 29.2 171.4 106.6 26.3 20.9 14.6 86.7 37.1 43.9 16.5 15.0 62.5 56.4 26.3 15.3 11.7 26.4 21.2 83.9 16.9 12.9 38.3 15.9 39.1 53.9 30.1 135.4 11.0 84.1 33.6 95.9 20.5 57.6 15.6 8.5 14.1 11.6 22.7 21.2 16.8 8.8 15.0 14.3 47.8 11.9 6.8 6.8 39.9 14.3 10.3 13.2 6.6 9.5 9.5 10.2 12.5 8.2 9.3 10.6 26.8 58.1 117.6 176.4 141.0 43.0 211.0 35.7 147.2 66.0 52.4 33.4 154.7 121.0 20.6 24.5 124.1 53.3 2616.4 14.4 751.8 109.8 81.7 104.4 22.2 176.6 42.9 71.7 149.1 275.5 29.5 97.5 149.6 64.1 109.2 104.0 79.8 10.0 83.9 54.1 36.3 129.5 77.6 96.6 461.9 435.2 117.1 107.7 264.5 185.0 64.8 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990775 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 54.3" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 108.8;U-698: 98.0" HPA062583 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA062583: AB_2684800" "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 4.4 5.4 7.9 4.8 7.1 20.3 4.1 2.8 10.3 10.8 12.0 4.7 3.9 7.3 6.3 13.4 10.2 4.4 3.2 4.5 9.8 7.6 9.0 41.6 5.9 6.3 6.1 7.3 3.1 7.1 18.7 1.6 54.3 9.7 3.7 9.2 5.3 9.7 4.3 20.5 6.8 7.6 3.6 5.0 8.4 4.0 26.0 3.2 18.2 6.2 5.1 9.5 4.9 3.7 3.1 6.5 11.8 5.3 0.9 6.2 2.3 37.7 16.7 52.8 27.5 2.2 6.6 65.8 16.6 10.9 19.3 10.0 13.2 15.7 26.5 53.5 12.7 10.9 18.2 48.1 108.8 21.8 18.0 14.0 23.0 16.2 20.8 3.3 34.6 11.7 5.2 25.8 7.9 20.0 4.9 24.9 16.3 11.9 15.7 22.9 29.0 38.1 26.6 31.3 24.8 20.5 46.8 43.0 15.0 14.2 18.1 38.1 24.9 24.7 26.6 8.2 31.5 23.5 22.9 18.7 8.0 19.0 25.5 36.5 14.3 17.8 98.0 9.6 17.7 16.3 0.0 4.8 11.8 0.5 3.2 0.1 3.1 2.4 3.3 6.5 0.6 0.0 0.2 0.6 0.9 5.3 3.3 6.2 2.3 7.9 7.1 2.8 10.3 9.8 7.6 6.1 7.3 9.7 3.2 35.7 27.4 16.2 16.0 21.1 0.5 13.2 10.2 145.9 134.2 29.6 2.0 337.0 31.5 72.8 184.3 11.3 24.9 186.9 75.5 539.5 20.8 18.7 8.1 72.9 88.3 0.0 63.0 10.4 18.3 46.6 3.4 26.0 20.3 35.1 29.3 3.1 76.6 25.9 3.2 39.4 1.4 0.0 8.3 19.9 49.6 17.8 1171.0 14.0 52.8 17.0 HMGB4 FLJ40388 ENSG00000176256 "High mobility group box 4" Q8WW32 1 33860475-33864791 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 346 "testis: 34.6" "Group enriched" "Detected in some" 143 "Early spermatids: 10561.9;Late spermatids: 15960.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035699 Enhanced NA NA "HPA035699: AB_10960531" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10561.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15960.0 92.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.5 0.0 0.0 45.3 0.0 90.7 44.3 0.0 0.0 0.0 0.0 0.0 HMGCL HL ENSG00000117305 "3-hydroxymethyl-3-methylglutaryl-CoA lyase" P35914 1 23801885-23838620 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 81.4" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 147.7;Proximal tubular cells: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004727 Enhanced "Intracellular and membrane" NA NA 120000 "HPA004727: AB_1079074" "unprognostic (8.24e-2)" "unprognostic (3.21e-2)" "prognostic favorable (7.67e-4)" "unprognostic (1.23e-3)" "unprognostic (5.47e-3)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (3.05e-1)" "unprognostic (8.24e-2)" "prognostic favorable (5.07e-8)" "unprognostic (1.72e-1)" "unprognostic (2.46e-2)" "unprognostic (8.60e-2)" "unprognostic (3.39e-3)" 7.4 18.5 6.4 8.2 6.6 1.6 14.3 4.3 7.7 7.6 13.9 9.0 12.0 12.0 6.2 13.2 9.1 9.7 12.8 11.2 5.9 6.0 30.3 81.4 8.8 11.1 7.5 7.1 6.1 15.2 13.1 7.8 8.5 7.9 8.7 14.2 10.0 8.9 11.5 15.2 7.0 15.4 11.7 9.3 8.6 10.8 7.2 6.1 8.3 14.5 8.1 8.3 8.8 6.7 24.1 27.7 40.8 33.8 24.5 21.2 26.8 10.5 6.1 6.9 5.1 28.0 21.4 2.6 8.4 14.7 9.1 11.1 3.8 20.5 5.5 17.3 13.0 7.4 8.5 8.2 13.6 9.9 11.2 6.2 7.4 5.4 8.7 36.2 2.8 4.9 24.8 20.2 11.9 23.0 24.5 12.3 10.5 7.5 7.8 16.6 10.8 4.5 5.7 1.7 28.9 8.5 6.4 5.6 10.2 21.4 5.5 5.8 5.1 10.9 4.1 18.5 9.5 13.0 7.2 9.2 7.5 4.6 13.7 3.6 11.2 5.5 4.9 18.7 10.7 8.8 40.8 32.4 30.1 18.4 30.4 20.1 21.9 20.0 21.2 27.7 24.1 20.3 19.4 12.2 24.5 33.8 20.6 20.8 26.8 6.4 6.6 4.3 7.7 5.9 6.0 7.5 7.1 7.9 6.1 11.9 21.7 21.7 27.4 5.3 24.1 30.3 43.3 28.1 12.5 47.1 17.7 37.1 101.2 42.9 1.5 21.1 59.4 0.0 21.2 21.2 16.6 28.0 17.3 147.7 52.8 33.4 8.6 31.3 25.4 3.2 20.1 21.3 20.3 60.5 44.3 33.5 28.9 49.2 23.0 159.0 20.1 6.5 18.9 4.1 3.3 5.6 34.6 15.2 47.0 22.5 HMGCLL1 "bA418P12.1, DKFZP434G1411" ENSG00000146151 "3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1" Q8TB92 6 55434369-55579214 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4;pituitary gland: 14.8" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 14.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.74e-3)" "unprognostic (1.54e-2)" "unprognostic (4.08e-3)" "unprognostic (6.11e-2)" "unprognostic (1.41e-1)" "unprognostic (9.54e-3)" "unprognostic (8.97e-3)" "unprognostic (2.12e-2)" "unprognostic (9.27e-3)" "unprognostic (4.11e-2)" "unprognostic (1.18e-4)" "unprognostic (3.13e-3)" "unprognostic (7.57e-2)" "unprognostic (2.55e-1)" "unprognostic (1.52e-1)" 2.2 7.7 7.7 0.9 14.5 0.5 3.4 10.1 18.4 2.2 1.7 3.1 0.3 0.8 0.8 0.6 2.5 1.5 1.8 4.1 8.7 12.6 2.2 1.8 5.7 1.1 9.1 10.0 1.3 3.6 0.8 14.8 12.5 14.6 7.0 2.2 4.8 2.1 2.9 2.4 0.6 2.4 1.6 10.1 0.6 2.9 5.5 3.3 0.0 0.9 0.0 1.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.3 0.0 0.0 0.0 2.3 0.9 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 14.5 10.1 12.6 8.7 12.6 9.1 10.0 14.6 3.3 0.0 2.2 0.0 0.0 0.0 14.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 1.4 0.0 3.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 HMGCS1 HMGCS ENSG00000112972 "3-hydroxy-3-methylglutaryl-CoA synthase 1" Q01581 5 43289395-43313512 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 117.0" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 206.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032907, HPA036913, HPA036914" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No 310000 "Nucleoplasm, Cytosol" "Plasma membrane" "CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751" "unprognostic (1.31e-1)" "unprognostic (5.12e-3)" "unprognostic (6.82e-3)" "unprognostic (4.59e-2)" "unprognostic (8.39e-2)" "unprognostic (2.49e-2)" "unprognostic (1.03e-1)" "unprognostic (3.14e-2)" "unprognostic (1.27e-2)" "unprognostic (3.13e-1)" "unprognostic (6.40e-3)" "unprognostic (9.15e-2)" "prognostic favorable (3.87e-6)" "unprognostic (1.09e-1)" "unprognostic (9.22e-2)" "unprognostic (3.03e-2)" "unprognostic (2.37e-2)" 6.0 16.5 13.3 8.1 24.4 4.3 12.8 8.4 38.2 16.9 15.5 16.9 9.5 27.8 6.8 11.5 53.0 4.1 7.5 5.1 19.4 18.8 10.5 117.0 26.9 6.2 10.4 20.7 15.4 8.4 10.8 5.0 6.9 59.3 12.9 14.2 13.0 18.5 7.7 5.0 25.2 17.1 6.3 25.8 4.4 13.4 9.8 8.1 3.3 7.5 58.1 23.3 6.1 21.4 9.3 7.8 6.9 7.7 6.7 7.9 3.3 14.9 7.2 120.5 13.8 7.0 27.9 8.1 2.4 9.5 3.4 6.9 12.5 21.6 15.9 5.4 3.4 80.3 11.8 30.0 69.5 3.6 3.4 36.0 5.9 6.6 16.9 11.1 12.8 4.2 15.3 8.4 18.1 7.2 2.1 3.5 14.8 10.5 43.5 2.8 6.9 11.5 15.6 21.6 6.0 3.8 8.3 16.9 17.6 53.4 23.2 10.3 5.0 12.3 6.2 3.6 18.2 9.6 17.0 4.2 2.6 13.0 2.7 2.2 5.9 8.9 21.7 2.3 15.4 2.3 5.5 4.0 3.7 5.6 7.4 5.6 9.3 6.2 7.9 7.8 7.5 5.3 7.3 6.9 6.7 7.7 6.5 5.7 3.3 13.3 24.4 8.4 32.1 19.4 18.8 10.4 20.7 59.3 8.1 62.5 124.5 45.6 35.9 96.3 27.9 7.4 56.0 48.2 36.4 45.4 49.1 20.4 11.6 30.6 5.0 19.7 86.8 0.0 52.0 35.5 35.0 65.2 59.8 78.4 20.7 46.1 88.4 23.4 20.8 1.8 11.8 17.2 25.3 78.5 44.0 19.7 36.3 30.9 13.4 17.7 43.3 0.0 24.9 14.1 7.8 206.6 37.2 20.1 31.2 65.0 HMGCS2 ENSG00000134240 "3-hydroxy-3-methylglutaryl-CoA synthase 2" P54868 1 119747996-119768905 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 257.0" "Cell type enhanced" "Detected in many" 24 "Hepatocytes: 901.4;Mucus-secreting cells: 249.3;Undifferentiated cells: 248.3" "Cancer enhanced" "Detected in many" "liver cancer: 441.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "OE19: 35.4;RT4: 63.6" "Low region specificity" "Detected in all" "HPA027423, HPA027442, CAB032906" Enhanced Supported Mitochondria NA NA 820000 Mitochondria "CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277" "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "unprognostic (7.62e-2)" "unprognostic (1.49e-2)" "prognostic favorable (2.43e-7)" "unprognostic (9.68e-2)" "unprognostic (3.21e-2)" "prognostic favorable (2.17e-4)" "unprognostic (1.20e-1)" "unprognostic (6.42e-2)" "prognostic favorable (3.43e-5)" "unprognostic (9.57e-2)" "unprognostic (2.31e-1)" "unprognostic (5.00e-2)" "unprognostic (1.54e-3)" 0.3 0.1 0.3 8.7 0.3 0.0 20.6 0.3 0.3 0.3 30.8 0.4 0.3 13.8 0.3 0.3 0.7 0.1 4.4 42.0 0.4 0.0 7.4 257.0 0.8 0.3 0.3 0.3 0.3 1.4 0.0 0.3 0.8 0.7 3.8 19.8 18.9 5.1 0.3 1.4 1.8 12.2 1.9 0.3 0.3 8.1 6.1 0.3 0.4 0.3 0.6 2.1 7.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.4 0.0 0.0 0.2 0.2 0.0 63.6 0.0 0.2 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.3 0.7 0.3 3.0 6.7 7.5 3.6 0.1 0.0 4.5 68.8 0.0 0.0 29.6 0.0 0.2 0.0 0.0 1.5 0.0 76.1 0.0 0.0 0.1 0.0 10.3 4.6 901.4 0.2 0.0 70.2 16.0 17.8 2.7 1.4 0.0 5.0 0.0 249.3 0.0 0.1 126.7 0.0 0.3 0.0 6.5 0.0 0.5 0.4 0.3 7.9 0.0 248.3 15.4 HMGN5 NSBP1 ENSG00000198157 "High mobility group nucleosome binding domain 5" P82970 X 81113701-81201942 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.0;Karpas-707: 66.4" "Low region specificity" "Detected in all" "HPA000511, HPA076238" Approved Supported Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA000511: AB_1079505, HPA076238: " "unprognostic (1.49e-2)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (3.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (9.63e-3)" "prognostic favorable (6.60e-4)" "unprognostic (2.78e-3)" "unprognostic (1.16e-1)" "unprognostic (2.32e-3)" "unprognostic (3.06e-2)" "unprognostic (1.07e-1)" "unprognostic (6.53e-2)" "unprognostic (1.08e-1)" 5.2 11.4 14.7 3.1 15.6 12.5 6.5 6.0 12.0 8.6 10.6 5.1 12.3 10.2 7.7 30.9 9.8 7.5 4.8 5.4 16.1 14.3 16.2 9.9 3.9 2.0 13.2 10.1 9.5 5.6 11.9 39.8 2.0 10.4 7.0 7.9 3.5 5.6 9.3 3.6 5.2 10.8 7.3 22.1 8.2 5.9 48.6 19.6 10.9 8.1 8.6 2.7 7.8 6.0 6.5 11.0 2.8 3.1 3.4 10.2 3.4 0.2 2.2 5.9 28.8 5.0 1.6 1.2 1.6 2.5 0.4 0.7 0.7 10.9 45.0 5.1 0.7 0.4 1.9 34.8 4.1 1.1 26.3 13.9 18.8 21.2 0.3 0.5 31.2 18.6 1.3 1.1 1.8 1.7 1.6 2.3 29.0 24.8 66.4 2.9 1.0 28.4 11.1 26.2 6.3 7.6 1.1 24.6 21.2 7.1 0.8 0.2 0.7 0.2 0.6 1.9 5.3 3.6 7.4 2.6 0.9 7.7 4.5 6.1 4.6 1.9 7.2 2.8 12.3 1.6 2.0 3.1 1.4 8.5 1.6 7.7 3.6 5.2 4.6 5.3 6.5 10.2 8.7 2.8 3.4 2.5 11.0 1.7 3.4 14.7 15.6 6.0 12.0 16.1 14.3 13.2 10.1 10.4 19.6 8.9 13.1 10.4 21.3 14.2 2.8 11.3 17.8 72.3 14.8 43.6 0.0 0.5 58.0 9.9 14.1 16.1 17.1 70.0 16.2 0.4 10.2 18.1 12.7 74.1 13.2 1.6 16.7 19.0 13.3 43.8 27.3 13.9 8.5 1.0 22.4 20.4 6.7 17.5 38.5 60.3 1.5 45.3 19.4 7.2 8.4 13.0 0.3 7.5 39.1 17.4 HMGXB3 "HMGX3, KIAA0194, SMF" ENSG00000113716 "HMG-box containing 3" Q12766 5 150000046-150053142 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "parathyroid gland: 151.8" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005967 Approved Nucleoli NA NA Nucleoli "HPA005967: AB_1080044" "unprognostic (3.66e-2)" "unprognostic (3.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (3.37e-5)" "unprognostic (9.72e-2)" "unprognostic (3.36e-1)" "unprognostic (3.89e-3)" "unprognostic (3.74e-2)" "unprognostic (2.11e-1)" "unprognostic (3.24e-3)" "unprognostic (1.30e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-2)" 12.0 14.2 8.2 14.5 14.4 15.3 16.1 14.5 17.4 11.3 10.3 15.0 15.4 8.3 13.9 20.0 9.3 13.5 12.1 9.4 8.6 8.3 11.6 11.7 14.7 10.3 10.1 11.0 15.0 13.8 151.8 15.3 11.8 12.9 17.6 10.8 16.8 12.4 18.4 12.5 13.1 9.9 12.8 8.9 14.4 12.0 17.7 7.3 15.3 14.7 10.1 12.0 11.2 10.1 5.8 6.2 5.1 5.9 2.2 8.1 3.7 11.5 13.5 9.6 15.0 13.8 11.7 16.7 11.1 20.6 16.8 21.2 18.9 14.1 11.0 13.1 15.2 35.9 8.5 18.1 19.1 14.6 10.2 13.0 9.6 14.2 9.2 19.2 18.4 21.9 15.2 14.4 24.5 19.4 21.4 11.9 8.9 12.6 11.6 17.6 9.1 11.4 9.6 7.2 7.7 20.3 10.0 13.3 10.6 10.0 14.4 12.4 12.4 9.7 23.9 24.7 8.7 11.1 12.0 10.2 25.1 10.7 12.1 20.5 13.6 12.9 15.7 29.3 14.1 12.9 5.1 4.7 4.0 7.0 5.9 5.5 5.8 5.7 4.9 6.2 5.0 4.4 4.6 0.5 2.2 3.9 4.6 8.1 3.7 8.2 14.4 14.5 17.4 8.6 8.3 10.1 11.0 12.9 7.3 8.9 13.8 19.3 22.2 10.1 30.5 6.7 17.8 30.8 21.6 8.7 33.4 13.0 18.3 19.2 5.0 17.9 6.9 0.0 19.0 10.2 11.0 28.3 17.4 11.3 23.8 68.3 14.9 16.0 9.4 1.6 12.4 12.5 3.3 27.1 10.4 22.7 26.2 8.6 11.7 8.5 42.8 12.9 8.5 22.9 20.4 10.7 12.9 12.5 14.0 24.4 HMHB1 "HB-1, HB-1Y" ENSG00000158497 "Histocompatibility minor HB-1" O97980 5 143812161-143820719 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 16.7;testis: 4.4" "Group enriched" "Detected in some" 12 "Early spermatids: 4.0;Late spermatids: 2.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 16.7" "Lineage enriched" "Detected in single" 24 "dendritic cells: 16.7" "Group enriched" "Detected in some" 7 "Karpas-707: 6.5;REH: 9.0;RPMI-8226: 2.4" NA NA "unprognostic (1.99e-1)" "unprognostic (6.19e-2)" "unprognostic (2.67e-2)" "unprognostic (6.33e-5)" "unprognostic (7.45e-2)" "unprognostic (1.44e-1)" "unprognostic (4.86e-3)" 1.1 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.2 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.4 0.4 2.0 0.1 0.1 0.0 16.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 HMMR "CD168, RHAMM" ENSG00000072571 "Hyaluronan mediated motility receptor" O75330 5 163460203-163491945 "CD markers, FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.5;testis: 16.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002433, HPA040025, HPA043926, HPA061524" Enhanced Enhanced Microtubules,Centrosome,Cytosol Yes Yes Microtubules "Centrosome, Cytosol" "CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551" "unprognostic (3.53e-3)" "unprognostic (1.01e-1)" "unprognostic (3.38e-3)" "unprognostic (8.88e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (5.52e-4)" "prognostic unfavorable (1.93e-7)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.68e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.02e-1)" "unprognostic (0.00e+0)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.77e-2)" 1.6 1.4 0.6 13.4 0.6 11.4 2.4 0.4 0.9 1.7 5.0 0.6 0.6 4.5 0.6 2.3 6.4 0.5 0.9 1.6 0.8 0.7 1.4 1.8 2.5 10.9 1.0 0.4 0.6 1.1 0.6 0.5 6.9 1.1 0.7 5.6 0.4 1.6 0.2 1.4 2.3 4.8 1.4 1.9 8.6 2.6 16.7 0.3 54.5 0.7 5.6 10.8 1.8 2.1 1.2 1.8 0.6 0.7 1.5 4.8 0.8 21.1 13.3 27.2 14.5 1.4 2.7 20.3 20.1 9.8 25.2 22.9 27.0 40.9 35.2 19.2 6.2 34.4 24.5 31.4 19.1 43.1 31.9 9.7 21.0 9.5 13.2 0.4 18.6 19.4 0.7 1.1 23.7 18.6 4.2 14.3 24.2 19.9 28.8 26.2 7.7 19.6 10.6 23.4 14.2 14.6 21.4 36.4 17.6 9.8 5.7 22.7 12.6 29.9 9.4 11.4 13.5 27.7 15.0 9.3 18.1 15.4 14.5 26.9 15.5 25.9 28.4 12.0 28.9 17.4 0.5 0.7 0.0 0.5 0.3 0.9 1.2 1.0 0.6 0.9 0.9 0.4 0.7 0.6 1.5 0.0 1.8 4.8 0.8 0.6 0.6 0.4 0.9 0.8 0.7 1.0 0.4 1.1 0.3 0.0 0.6 15.5 0.8 2.3 0.6 1.7 7.6 4.0 4.5 0.0 0.0 5.1 0.0 0.6 60.3 0.1 1.3 256.9 0.2 50.4 2.4 0.8 0.0 1.7 17.7 0.0 1.2 3.1 3.5 44.1 2.0 4.3 0.0 3.6 1.6 0.0 0.1 0.0 0.7 2.4 0.7 6.5 0.0 80.6 18.5 1.3 3.8 1.0 4.2 0.9 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 209.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 439.8;Kupffer cells: 915.4;monocytes: 247.9;Syncytiotrophoblasts: 419.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4" "Lineage enriched" "Detected in many" 6 "monocytes: 53.4" "Cell line enhanced" "Detected in many" "BEWO: 108.8;GAMG: 71.3;U-138 MG: 63.5;U-87 MG: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" NA NA 17000 "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 28.4 10.3 4.1 12.5 8.7 16.3 13.8 0.8 20.6 5.7 12.0 6.1 0.6 22.0 2.5 8.5 8.8 9.8 9.8 10.2 4.1 3.1 23.0 63.7 54.0 76.3 12.5 1.3 28.6 8.8 0.5 2.7 21.1 7.5 3.6 4.9 3.3 3.5 0.8 21.9 13.8 22.8 6.9 11.2 209.8 4.6 5.9 7.6 3.6 4.2 7.3 8.3 6.7 10.2 4.8 7.9 8.4 53.4 1.1 0.3 10.1 1.4 22.1 0.2 4.5 18.1 5.3 108.8 10.2 6.0 4.8 5.2 9.8 1.3 0.0 2.3 8.3 71.3 1.2 1.3 0.2 1.5 36.6 1.1 0.5 6.7 20.0 25.2 1.3 6.9 16.6 0.4 31.7 2.1 7.7 14.4 0.0 0.0 10.6 15.3 1.1 0.0 0.5 2.2 13.6 2.5 0.1 1.9 3.4 3.4 11.9 0.3 0.3 26.4 2.3 1.7 9.6 1.0 0.3 5.4 63.5 2.8 10.3 9.9 6.6 8.5 1.0 61.6 0.6 1.0 2.0 17.7 1.2 0.2 40.5 0.0 4.8 0.1 0.3 7.9 0.5 0.0 0.0 8.4 1.1 53.4 0.2 0.2 10.1 4.1 8.7 0.8 4.8 4.1 3.1 12.5 1.3 7.5 7.6 3.0 21.3 13.8 5.9 14.5 0.0 3.1 10.2 1.4 0.0 5.2 0.0 39.4 18.3 10.3 1.6 20.2 43.4 0.0 1.3 204.4 21.6 85.9 11.5 19.5 439.8 0.0 15.3 30.7 915.4 1.3 28.7 175.5 33.7 247.9 5.3 0.2 8.7 10.5 4.9 128.1 0.4 0.0 16.5 0.9 2.7 13.7 419.8 10.0 4.1 91.1 HMSD "ACC-6, ACC6, C18orf53" ENSG00000221887 "Histocompatibility minor serpin domain containing" "A8MTL9, P0C7T4" 18 63949301-63981774 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 26.1" "Cell type enriched" "Detected in some" 5 "monocytes: 49.5" "Cancer enhanced" "Detected in single" "cervical cancer: 1.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 5.0" "Lineage enriched" "Detected in single" 18 "dendritic cells: 5.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 7.7;GAMG: 8.7;HDLM-2: 18.0;Karpas-707: 7.1" "Secreted to blood" NA NA "unprognostic (5.83e-3)" "unprognostic (1.40e-1)" "unprognostic (1.40e-2)" "unprognostic (5.42e-3)" "unprognostic (6.20e-2)" "unprognostic (1.16e-2)" "unprognostic (4.91e-2)" "unprognostic (3.80e-1)" "unprognostic (1.41e-2)" "unprognostic (5.19e-3)" "unprognostic (8.67e-2)" "unprognostic (1.44e-1)" "unprognostic (7.14e-6)" "unprognostic (1.22e-1)" "unprognostic (2.85e-1)" "unprognostic (1.45e-3)" "unprognostic (3.55e-1)" 1.7 1.9 3.9 3.4 8.4 0.5 1.5 0.6 4.8 0.4 0.8 11.3 0.0 0.7 0.3 0.2 1.3 0.8 0.4 1.0 5.8 4.2 0.3 1.9 3.0 5.9 15.1 1.0 1.2 0.9 0.2 0.3 0.3 12.1 0.3 2.1 0.0 0.6 0.5 0.5 2.9 1.0 0.4 26.1 2.1 1.5 2.1 11.2 1.4 0.8 0.2 4.9 0.5 1.3 0.2 5.0 0.0 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 3.3 7.7 0.0 0.6 2.1 0.3 4.0 0.0 0.8 0.0 0.0 0.9 8.7 3.3 1.3 0.2 2.6 18.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.2 0.0 2.8 0.1 1.0 0.0 0.0 0.0 7.1 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.0 3.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.2 3.9 8.4 0.6 3.7 5.8 4.2 15.1 1.0 12.1 11.2 3.0 0.0 0.0 0.1 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 49.5 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 9.4 0.1 0.1 0.0 0.5 0.0 HMX1 "H6, NKX5-3" ENSG00000215612 "H6 family homeobox 1" Q9NP08 4 8846076-8871817 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cataract, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;retina: 17.4" "Group enriched" "Detected in some" 16 "Horizontal cells: 252.6;Muller glia cells: 197.6" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 12.1;EFO-21: 7.1;HEK 293: 13.1;SH-SY5Y: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.11e-2)" "unprognostic (1.63e-2)" "unprognostic (2.97e-1)" "unprognostic (6.35e-2)" "unprognostic (7.94e-2)" "unprognostic (9.36e-2)" "unprognostic (1.97e-1)" 0.5 1.0 3.9 0.4 3.6 0.3 0.3 0.8 5.0 0.3 0.3 1.1 0.0 0.8 0.3 0.3 0.3 0.3 0.3 0.3 3.1 3.5 0.3 0.3 0.3 0.3 3.6 0.1 0.3 0.3 0.3 0.4 0.3 2.7 0.3 0.4 17.4 0.5 0.3 0.5 0.6 0.3 0.3 1.8 0.3 0.4 3.5 1.6 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 1.7 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.6 0.8 2.8 3.1 3.5 3.6 0.1 2.7 1.6 0.0 0.0 0.0 0.0 0.0 14.5 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 252.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.6 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 HMX2 NKX5-2 ENSG00000188816 "H6 family homeobox 2" A2RU54 10 123148122-123150672 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.0;brain: 5.1;kidney: 5.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 0.9" "Group enriched" "Detected in some" 41 "hypothalamus: 5.1;pons and medulla: 3.0" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in some" 13 "REH: 29.0" "Region enhanced" "Detected in single" "hypothalamus: 0.6" "Group enriched" "Detected in some" 4 "basal ganglia: 1.1;hypothalamus: 4.0" "CAB013268, CAB022752" Approved NA NA "CAB013268: , CAB022752: " "unprognostic (3.98e-2)" "unprognostic (1.00e-3)" "unprognostic (1.44e-1)" "unprognostic (7.18e-2)" "unprognostic (2.73e-2)" "unprognostic (7.64e-2)" "unprognostic (3.29e-1)" "unprognostic (2.10e-3)" "unprognostic (5.29e-1)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 HMX3 NKX5-1 ENSG00000188620 "H6 family homeobox 3" A6NHT5 10 123135962-123137741 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;intestine: 5.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 11 "hypothalamus: 6.8;pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HEL: 5.6;HeLa: 5.1;K-562: 18.3;NB-4: 6.3;SiHa: 5.1" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Group enriched" "Detected in many" 5 "basal ganglia: 2.3;hypothalamus: 8.0" HPA069659 Approved "Nucleoplasm,Centriolar satellite" Yes No Nucleoplasm "Centriolar satellite" "HPA069659: AB_2686165" "unprognostic (1.79e-1)" "unprognostic (9.65e-2)" "unprognostic (6.07e-2)" 1.9 0.1 0.0 1.5 0.1 0.0 0.0 0.0 0.4 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.9 0.0 0.4 0.2 0.0 0.0 0.9 0.7 0.0 1.3 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.0 0.0 0.0 0.8 0.7 5.6 5.1 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 18.3 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 6.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HNF1A "HNF1, LFB1, MODY3, TCF1" ENSG00000135100 "HNF1 homeobox A" 12 120978543-121002512 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 24.2;kidney: 17.2;liver: 15.6" "Cell type enhanced" "Detected in some" 8 "Enterocytes: 16.0;Hepatocytes: 13.9;Paneth cells: 14.4;Proximal tubular cells: 13.2;Undifferentiated cells: 8.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 6.2;CACO-2: 20.5;Hep G2: 22.4;OE19: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010430, HPA035231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB010430: AB_2116746, HPA035231: AB_2674528" "unprognostic (5.92e-3)" "unprognostic (8.47e-2)" "unprognostic (4.12e-3)" "unprognostic (6.18e-3)" "unprognostic (3.72e-1)" "unprognostic (1.27e-2)" "unprognostic (9.18e-2)" "unprognostic (9.18e-2)" "unprognostic (2.99e-1)" "unprognostic (2.01e-1)" "unprognostic (9.77e-3)" "unprognostic (5.21e-2)" "unprognostic (6.25e-3)" "unprognostic (5.55e-2)" "unprognostic (2.48e-1)" "unprognostic (6.93e-3)" 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.1 17.3 0.1 0.1 13.7 0.1 1.5 0.1 0.8 5.1 0.1 0.1 0.0 17.2 15.6 0.1 0.1 0.1 0.1 0.2 6.3 0.0 0.1 0.1 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.0 24.2 0.5 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.5 1.8 0.3 0.3 0.4 0.2 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.2 0.2 0.3 0.2 0.3 0.4 0.4 0.1 0.5 0.4 0.4 1.6 0.3 0.3 0.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.8 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.3 0.0 0.0 16.0 0.0 4.6 0.1 0.0 0.4 0.0 13.9 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.5 3.2 14.4 0.0 13.2 0.2 0.0 0.1 0.1 0.0 0.3 0.0 0.0 8.9 0.2 HNF1B "HNF1beta, LFB3, MODY5, TCF2, VHNF1" ENSG00000275410 "HNF1 homeobox B" P35680 17 37686432-37745247 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 34.7;kidney: 66.2;pancreas: 18.6" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 73.9;Collecting duct cells: 54.1;Distal tubular cells: 38.1;Ductal cells: 37.2" "Cancer enhanced" "Detected in many" "renal cancer: 32.5" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 5 "B-cells: 1.0" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 53.3" "Group enriched" "Detected in some" 5 "basal ganglia: 0.7;hypothalamus: 2.3" "Not detected" "Not detected" "HPA002083, CAB068192" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB068192: AB_2665649, HPA002083: AB_1080232" "unprognostic (2.52e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (5.29e-3)" "unprognostic (5.29e-2)" "unprognostic (3.00e-2)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.51e-1)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "prognostic favorable (6.00e-4)" "unprognostic (7.06e-2)" "unprognostic (2.26e-1)" "unprognostic (7.49e-2)" "prognostic favorable (2.51e-6)" 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.1 4.5 0.0 4.8 3.8 0.9 7.8 0.0 2.8 34.7 0.0 0.0 66.2 7.7 3.7 0.0 0.0 0.0 0.8 18.6 1.6 0.0 0.6 0.0 1.6 3.4 0.0 0.0 3.8 0.0 0.0 5.5 0.3 0.0 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.8 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 53.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.9 10.2 0.0 2.2 0.0 0.0 0.6 73.9 5.3 3.4 54.1 0.0 0.0 38.1 37.2 26.8 0.0 10.9 0.0 22.1 0.0 0.0 1.8 5.7 4.0 0.1 0.0 13.8 0.0 0.3 7.4 0.6 0.0 0.0 1.8 11.4 0.0 25.3 7.0 0.0 31.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 19.4 2.7 HNF4A "HNF4, MODY, MODY1, NR2A1, TCF14" ENSG00000101076 "Hepatocyte nuclear factor 4 alpha" P41235 20 44355700-44434596 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 65.5;kidney: 30.5;liver: 57.3" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 146.5;Hepatocytes: 160.5;Paneth cells: 94.8;Proximal tubular cells: 115.9;Undifferentiated cells: 91.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 48.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CACO-2: 52.3;Hep G2: 38.5;OE19: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004712, CAB019417" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB019417: AB_2295208, HPA004712: AB_1079075" "unprognostic (2.47e-1)" "unprognostic (3.08e-1)" "unprognostic (2.34e-1)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-2)" "unprognostic (4.79e-3)" "unprognostic (2.59e-2)" "unprognostic (3.77e-2)" "unprognostic (2.45e-2)" "unprognostic (1.05e-1)" "unprognostic (2.75e-2)" "unprognostic (8.40e-3)" "unprognostic (2.12e-1)" "unprognostic (2.70e-2)" 0.2 0.2 0.2 13.4 0.2 0.0 0.2 0.2 0.3 0.2 54.0 0.2 0.1 33.0 0.2 6.2 0.2 0.4 15.7 0.2 0.2 0.2 30.5 57.3 0.3 0.1 0.2 0.1 0.3 22.7 0.0 0.2 0.1 0.2 0.2 14.4 0.2 0.2 0.1 0.2 0.2 65.5 0.3 0.2 0.2 7.1 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.4 0.4 0.6 1.2 0.8 0.8 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.3 2.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 0.4 0.4 0.7 0.8 0.8 0.6 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.3 0.0 0.0 1.1 43.3 0.0 0.0 12.2 0.0 0.0 13.3 6.8 3.1 0.0 146.5 0.0 19.4 0.0 0.0 0.3 4.6 160.5 0.0 0.0 34.4 3.7 5.1 16.4 0.3 0.0 0.0 1.8 62.7 0.0 17.5 94.8 0.4 115.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 91.6 0.1 HNF4G NR2A2 ENSG00000164749 "Hepatocyte nuclear factor 4 gamma" Q14541 8 75407914-75566843 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 139.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 53.6;Mucus-secreting cells: 31.7;Paneth cells: 41.9;Undifferentiated cells: 25.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 4.5;CAPAN-2: 16.8;Karpas-707: 4.7;OE19: 10.3;PC-3: 5.1;THP-1: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005438, HPA010610" Enhanced Enhanced "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA005438: AB_1850822, HPA010610: AB_2668318" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.77e-2)" "unprognostic (9.44e-2)" "unprognostic (5.60e-2)" "unprognostic (4.65e-2)" "unprognostic (5.26e-2)" "unprognostic (1.27e-2)" "unprognostic (3.92e-1)" "unprognostic (8.09e-2)" "unprognostic (3.68e-2)" "unprognostic (1.83e-2)" "unprognostic (6.93e-3)" "unprognostic (1.67e-2)" "unprognostic (2.11e-1)" "unprognostic (4.22e-2)" "unprognostic (2.47e-2)" 0.2 0.2 0.5 5.0 0.5 0.0 0.3 0.3 0.3 0.6 56.2 0.1 0.3 35.9 0.4 1.1 0.4 0.3 12.6 0.2 0.3 0.3 6.1 12.1 0.4 0.0 0.4 0.2 0.2 10.9 0.0 0.2 0.0 0.3 0.6 6.9 0.2 0.4 0.6 0.2 0.2 139.6 0.2 0.3 0.2 2.6 0.9 0.1 0.1 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 4.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 16.8 0.0 2.4 0.0 2.0 0.0 2.1 0.0 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.3 10.3 5.1 0.0 0.0 0.3 2.9 0.1 0.3 1.7 0.3 0.1 0.0 0.2 0.3 5.6 0.0 0.3 0.1 0.1 0.0 1.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.3 0.3 0.3 0.4 0.2 0.3 0.1 0.0 0.6 0.5 0.6 0.0 0.0 0.2 17.8 9.4 1.2 3.5 0.0 0.0 5.0 2.2 1.7 0.0 53.6 0.0 3.7 0.0 0.0 1.1 0.0 9.0 0.0 0.0 15.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 31.7 0.0 5.6 41.9 0.0 13.6 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 25.9 2.8 HNRNPCL1 HNRPCL1 ENSG00000179172 "Heterogeneous nuclear ribonucleoprotein C-like 1" O60812 1 12847408-12848725 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.8" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "WM-115: 1.0" NA NA "unprognostic (2.13e-1)" "unprognostic (3.57e-1)" "unprognostic (2.57e-1)" "unprognostic (4.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (3.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.11e-1)" "unprognostic (1.05e-1)" "unprognostic (6.03e-1)" "unprognostic (1.71e-1)" "unprognostic (8.28e-2)" "unprognostic (8.64e-3)" "unprognostic (8.88e-2)" "unprognostic (3.43e-3)" 0.1 0.3 0.3 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.1 0.9 0.4 0.0 0.2 0.1 0.0 0.2 0.2 0.2 0.2 0.5 0.1 0.2 0.3 0.5 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.0 0.1 0.3 0.3 1.2 0.1 0.0 0.0 0.2 1.0 1.4 1.2 0.9 0.8 0.9 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.7 0.5 0.8 0.1 0.0 0.9 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.8 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.5 0.5 0.3 0.1 0.5 0.3 1.0 0.5 0.8 0.5 0.5 0.9 0.8 0.8 0.9 0.9 1.4 1.0 0.9 0.9 1.2 0.8 0.6 0.5 0.7 1.8 0.0 0.0 0.0 0.8 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 1.5 0.2 0.0 0.0 0.3 HOGA1 "C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2" ENSG00000241935 "4-hydroxy-2-oxoglutarate aldolase 1" Q86XE5 10 97584323-97612802 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 39.8;liver: 31.0" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 35.7;Distal tubular cells: 24.9;Hepatocytes: 41.0;Proximal tubular cells: 71.6" "Group enriched" "Detected in many" 5 "liver cancer: 4.5;renal cancer: 9.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "AN3-CA: 6.1;EFO-21: 7.3;Hep G2: 19.0;RPTEC TERT1: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA039466 Approved NA NA 15000 "HPA039466: AB_2676522" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (7.50e-2)" "unprognostic (2.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.29e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-3)" "unprognostic (4.72e-1)" "unprognostic (2.37e-1)" "unprognostic (1.28e-1)" "unprognostic (6.80e-2)" "prognostic favorable (9.08e-4)" "unprognostic (2.20e-1)" "unprognostic (1.80e-1)" "unprognostic (2.94e-3)" "unprognostic (7.20e-4)" 3.3 5.4 3.3 0.6 3.8 0.8 2.1 7.0 4.3 0.8 0.6 8.2 1.5 0.7 0.9 4.0 1.3 2.0 3.8 10.1 4.2 2.8 39.8 31.0 0.9 0.7 9.3 5.2 0.6 12.0 2.0 2.4 0.6 7.2 1.3 0.6 3.6 1.8 2.2 2.0 1.2 0.6 0.8 8.2 0.7 0.6 0.7 6.9 0.0 1.8 4.1 0.6 0.8 0.6 2.1 1.7 4.4 1.2 1.2 1.3 0.5 0.3 2.8 0.1 6.1 1.2 0.3 0.1 0.1 0.2 0.1 0.0 2.3 0.3 0.2 7.3 0.1 0.3 2.0 0.1 0.2 0.1 0.2 3.2 0.1 1.1 19.0 0.8 0.2 0.2 0.3 0.6 0.2 0.1 1.5 0.3 0.1 0.1 0.4 0.5 1.2 0.1 0.2 0.2 0.2 0.0 0.2 0.5 0.4 23.3 0.4 0.5 0.9 0.1 1.1 0.7 0.2 2.1 0.1 0.3 0.7 0.2 0.4 0.2 0.4 0.7 0.1 1.5 0.3 0.1 2.4 1.1 1.2 1.2 0.9 1.0 1.1 1.3 0.9 0.5 2.1 1.1 1.2 4.4 1.2 1.2 1.7 0.9 0.5 3.3 3.8 7.0 3.9 4.2 2.8 9.3 5.2 7.2 6.9 0.0 0.0 0.0 0.6 0.1 0.1 5.3 35.7 5.3 0.0 8.7 0.0 0.0 24.9 4.4 2.9 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 41.0 0.1 1.6 0.0 0.0 1.8 12.3 0.0 0.0 1.7 0.0 0.0 2.0 0.5 0.0 0.0 71.6 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HOMER1 "HOMER-1B, SYN47, Ves-1" ENSG00000152413 "Homer scaffolding protein 1" Q86YM7 5 79372636-79514217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9;skeletal muscle: 28.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 87.3;Syncytiotrophoblasts: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004437, HPA036521, HPA036522" Enhanced Supported Approved Cytosol No No Cytosol "CAB004437: AB_627742, HPA036521: AB_2675170, HPA036522: AB_2675171" "unprognostic (2.80e-1)" "unprognostic (5.30e-2)" "unprognostic (4.00e-2)" "unprognostic (5.79e-2)" "unprognostic (8.83e-2)" "unprognostic (6.40e-2)" "unprognostic (2.00e-3)" "unprognostic (2.41e-3)" "unprognostic (2.22e-1)" "unprognostic (3.79e-1)" "unprognostic (3.07e-3)" "unprognostic (3.98e-1)" "unprognostic (7.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (2.83e-2)" "unprognostic (2.86e-3)" 3.0 1.6 11.3 2.4 19.7 0.6 2.7 8.4 28.9 4.4 1.6 1.2 0.0 1.0 6.8 4.5 4.7 2.5 6.9 19.1 8.5 4.2 5.9 2.0 5.1 1.3 2.9 13.3 4.7 2.4 4.5 3.6 5.3 5.3 2.0 1.3 2.1 1.9 2.1 28.0 2.6 1.2 4.7 2.2 1.1 2.1 5.1 3.5 1.7 14.4 4.8 1.7 5.0 2.2 2.0 0.6 0.2 0.0 0.4 2.3 0.5 8.4 5.9 8.9 14.0 3.4 2.2 20.5 5.4 4.3 5.5 5.9 9.2 6.0 0.1 16.5 4.6 10.0 4.6 10.9 14.6 9.5 1.2 8.6 10.2 2.5 9.1 5.5 4.8 3.3 3.6 9.5 4.9 13.8 2.2 2.5 15.9 12.4 5.6 7.1 11.9 20.0 3.3 14.9 3.0 5.0 13.1 14.5 12.9 5.8 13.2 9.0 5.4 10.2 7.3 5.4 10.3 10.0 4.2 0.4 4.1 10.3 4.9 9.5 2.7 6.1 5.0 11.6 1.9 7.8 0.0 0.0 0.1 2.3 0.0 1.3 2.0 0.9 0.7 0.0 1.6 0.5 1.7 0.2 0.4 0.0 0.6 0.0 0.5 11.3 19.7 8.4 18.8 8.5 4.2 2.9 13.3 5.3 3.5 47.6 11.1 9.8 25.1 57.1 25.5 87.3 10.2 13.4 13.6 15.7 25.5 45.8 10.0 3.7 3.6 4.7 2.6 0.0 3.7 37.8 15.1 20.5 5.7 7.3 10.1 49.3 10.9 3.7 9.0 3.9 5.2 10.5 20.3 1.8 5.0 3.3 4.6 2.9 8.1 5.3 9.1 12.9 15.1 3.3 8.3 47.9 70.6 4.9 2.5 18.0 HOMER2 "CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2" ENSG00000103942 "Homer scaffolding protein 2" Q9NSB8 15 82836946-82986153 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 80.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 186.0;Exocrine glandular cells: 66.4;Glandular cells: 96.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 21.5;Karpas-707: 38.1;SCLC-21H: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040134, CAB079014" Uncertain Supported Supported Cytosol NA NA Cytosol "CAB079014: , HPA040134: AB_10795272" "unprognostic (7.34e-2)" "unprognostic (3.58e-2)" "unprognostic (5.75e-4)" "unprognostic (3.31e-3)" "unprognostic (4.85e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-2)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (2.75e-1)" "unprognostic (8.16e-4)" "unprognostic (2.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.26e-1)" "unprognostic (4.45e-3)" 0.7 2.9 3.9 0.5 3.8 1.6 9.9 5.1 6.5 8.9 1.4 4.6 2.7 3.2 3.4 13.0 8.0 9.6 12.9 12.5 5.0 3.1 2.8 19.4 2.5 1.0 2.5 4.2 1.7 80.9 2.7 4.5 0.4 13.2 21.8 0.6 12.7 34.5 2.0 36.0 15.9 0.6 0.7 5.4 2.3 17.8 2.3 2.0 0.2 13.4 14.2 5.0 0.8 4.3 1.4 4.1 1.6 0.6 0.4 1.1 1.0 6.5 2.8 3.0 7.7 0.0 0.0 0.5 0.4 0.0 0.7 0.2 0.5 4.7 0.0 3.6 3.4 3.4 3.7 21.5 10.1 0.5 17.8 13.7 4.2 0.1 3.3 0.3 0.1 13.6 0.7 15.5 0.2 0.9 0.8 0.0 8.4 0.1 38.1 2.8 19.2 1.2 0.4 4.7 0.6 2.1 0.8 4.7 2.2 10.4 8.1 21.1 5.4 7.5 5.8 7.0 2.2 7.0 1.4 0.1 7.2 13.3 0.5 6.0 4.9 2.3 0.7 12.1 0.1 2.6 0.3 0.6 1.5 0.4 0.5 0.3 0.7 0.8 0.2 4.1 1.4 0.6 0.4 1.6 0.4 0.3 1.8 1.1 1.0 3.9 3.8 5.1 6.5 5.0 3.1 2.5 4.2 13.2 2.0 14.9 8.5 2.4 45.7 4.0 9.9 19.3 186.0 1.4 19.4 10.4 17.7 0.8 6.6 25.6 1.4 2.8 0.3 0.0 66.4 0.4 2.5 96.8 0.0 53.3 14.1 19.1 2.9 0.6 2.5 1.8 1.7 5.0 35.4 10.0 0.2 15.8 25.6 0.0 0.7 5.9 4.8 0.0 4.6 4.3 11.4 5.3 0.6 0.9 0.4 25.6 HOMER3 HOMER-3 ENSG00000051128 "Homer scaffolding protein 3" Q9NSC5 19 18929201-18941261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.8" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 64.5;Muller glia cells: 59.6;Proximal tubular cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 14.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.1;monocytes: 14.7" "Cell line enhanced" "Detected in many" "NB-4: 62.2;THP-1: 74.8;U-266/84: 64.3" "Region enriched" "Detected in many" 6 "cerebellum: 212.2" "Low region specificity" "Detected in all" "CAB032656, HPA040999, CAB079015" Enhanced Supported Supported "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242" "unprognostic (3.41e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.24e-5)" "unprognostic (1.19e-1)" "unprognostic (2.06e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.07e-1)" "unprognostic (8.88e-2)" "unprognostic (5.78e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-2)" "unprognostic (5.99e-2)" "unprognostic (3.76e-2)" "unprognostic (2.33e-1)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" 11.4 8.3 11.1 6.5 16.0 12.4 31.0 42.3 12.2 8.7 6.7 17.6 2.1 4.9 8.2 5.2 7.6 4.8 10.9 11.9 15.8 9.0 21.2 4.1 7.0 5.5 19.4 7.2 8.2 5.3 13.6 2.4 9.7 15.5 8.1 4.5 15.4 8.4 7.0 49.2 10.9 5.5 7.6 24.2 64.8 6.5 3.4 14.6 2.2 19.6 7.8 3.3 12.3 16.8 2.4 1.2 5.1 14.7 0.0 0.7 3.6 19.6 5.1 9.7 8.1 9.1 9.2 4.8 19.5 17.3 19.6 9.9 2.6 7.6 0.1 9.2 21.9 14.1 12.3 3.3 25.3 11.0 0.7 2.0 0.0 1.6 4.8 8.5 3.7 0.3 7.4 16.4 10.9 14.7 21.0 23.8 1.4 0.5 5.2 14.2 5.3 0.3 62.2 5.0 1.0 21.1 9.7 2.9 9.2 7.1 5.0 0.0 8.3 4.8 5.7 13.8 1.9 2.5 74.8 18.9 17.5 7.8 21.0 23.4 50.7 64.3 16.3 27.6 48.1 12.7 0.1 14.7 2.6 0.1 5.1 0.0 2.4 0.7 0.3 1.2 1.7 0.1 0.0 5.1 0.0 1.4 0.2 0.7 3.6 11.1 16.0 42.3 12.2 15.8 9.0 19.4 7.2 15.5 14.6 3.0 0.0 2.4 17.6 10.5 1.9 3.4 2.5 0.0 2.3 12.2 0.0 0.6 10.0 17.4 1.3 13.1 0.0 0.0 11.6 1.4 13.0 10.5 10.3 0.8 64.5 1.6 1.7 20.9 18.2 1.7 12.7 16.1 11.8 1.0 0.9 59.6 32.9 0.0 10.3 70.5 4.1 0.0 6.1 1.0 5.1 12.7 0.9 0.5 0.1 19.7 HOOK1 HK1 ENSG00000134709 "Hook microtubule tethering protein 1" Q9UJC3 1 59814786-59876378 "Predicted intracellular proteins" "Differentiation, Protein transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 35.9" "Group enriched" "Detected in many" 6 "Early spermatids: 575.1;Late spermatids: 758.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 19.6;RPTEC TERT1: 18.1;SK-BR-3: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018537, HPA018820" Enhanced NA NA "HPA018537: AB_1850907, HPA018820: AB_1850910" "unprognostic (9.82e-3)" "unprognostic (4.29e-1)" "prognostic favorable (4.53e-6)" "unprognostic (4.26e-2)" "unprognostic (3.42e-1)" "prognostic favorable (4.42e-4)" "unprognostic (1.79e-1)" "unprognostic (5.55e-2)" "unprognostic (3.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-1)" "unprognostic (3.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.23e-1)" 1.0 4.5 3.6 3.6 8.3 1.9 7.6 11.6 8.0 3.3 9.9 0.6 7.5 7.7 2.0 6.0 12.8 4.5 2.4 2.4 6.8 2.9 20.9 35.9 3.8 3.2 1.3 5.5 1.4 16.7 24.6 18.4 2.3 3.6 4.1 9.0 8.4 18.1 7.6 0.4 9.3 13.0 0.2 0.7 1.9 6.6 10.4 1.4 2.7 9.2 4.0 3.2 1.9 4.9 3.5 0.0 1.5 0.0 2.1 9.9 1.1 8.7 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 7.7 0.0 19.6 0.0 0.0 5.1 1.9 3.9 0.0 0.3 8.6 0.1 2.5 9.3 0.0 0.0 2.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.7 0.0 0.0 7.4 12.9 3.6 0.0 0.0 9.7 18.1 9.1 7.4 3.0 0.1 17.5 0.2 7.9 10.3 0.1 0.0 0.0 0.0 0.0 0.0 11.9 8.8 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.4 0.0 2.5 1.7 2.7 0.6 0.0 3.5 9.9 2.9 0.1 2.1 0.0 0.0 0.4 1.1 3.6 8.3 11.6 8.0 6.8 2.9 1.3 5.5 3.6 1.4 14.9 25.1 9.0 13.8 35.1 119.7 15.6 38.2 62.9 75.1 19.2 74.6 18.4 26.6 23.9 575.1 1.5 39.3 0.0 29.8 1.6 1.3 21.3 0.0 45.7 1.4 74.7 35.1 1.8 0.8 758.0 4.6 1.9 15.1 1.0 32.4 94.4 19.8 35.1 3.2 51.9 91.1 0.0 1.0 27.7 7.8 43.4 30.0 2.5 39.5 17.1 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.8;skin 1: 154.6" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 696.8;Alveolar cells type 2: 414.3;Basal keratinocytes: 368.4;Suprabasal keratinocytes: 329.7;Syncytiotrophoblasts: 269.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 68.6;NK-cell: 90.9" "Group enriched" "Detected in many" 14 "NK-cells: 90.9;T-cells: 68.6" "Cell line enhanced" "Detected in some" "HDLM-2: 13.4;HUVEC TERT2: 29.7;RT4: 22.1;TIME: 33.6;U-266/70: 11.7" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 1.7 5.0 24.1 5.2 13.0 2.0 23.1 4.0 28.2 26.4 3.1 3.6 3.0 3.4 2.5 106.2 90.3 2.3 6.7 5.7 20.0 8.2 2.3 0.7 112.4 3.4 12.1 12.9 1.4 1.1 2.3 1.2 128.8 15.0 4.5 1.6 1.0 19.0 12.9 3.4 154.6 3.4 20.9 11.2 2.3 3.2 9.6 1.9 1.8 65.9 93.2 66.3 6.8 37.8 5.6 0.4 1.5 0.5 90.9 68.6 38.2 0.0 0.0 0.0 0.0 2.3 7.3 2.6 0.0 0.0 0.6 0.4 0.0 0.0 5.4 0.3 0.1 1.0 1.0 0.6 0.0 0.8 13.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 5.4 1.6 0.0 1.5 29.7 0.0 0.0 0.2 1.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.1 0.0 22.1 0.4 0.2 0.0 0.0 0.0 2.1 0.0 0.0 33.6 0.0 0.1 0.2 0.0 11.7 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.2 68.6 0.4 37.4 5.6 17.1 30.1 0.3 4.3 3.1 21.0 1.5 90.9 0.5 0.4 1.0 38.2 24.1 13.0 4.0 28.2 20.0 8.2 12.1 12.9 15.0 1.9 696.8 414.3 13.2 36.1 368.4 1.6 11.3 0.0 20.1 221.8 1.8 0.0 1.7 1.7 0.0 27.8 9.0 0.5 0.0 0.2 4.7 21.3 17.3 9.3 0.8 3.5 0.0 8.1 5.5 16.3 34.5 2.8 8.0 33.7 62.3 1.9 104.0 2.3 0.0 2.8 0.2 4.3 32.3 77.3 2.6 10.4 329.7 269.1 177.7 0.3 25.7 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720888 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 78.1" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 709.1" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 1.2;neutrophil: 4.4" "Group enriched" "Detected in many" 4 "granulocytes: 4.4;monocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 3.2 0.1 0.1 0.1 0.4 0.0 78.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.6 4.4 1.2 0.0 0.2 0.1 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.1 6.8 0.0 11.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.2 0.3 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.1 0.0 0.0 4.4 0.0 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 54.2 0.1 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.6 22.1 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 32.3 0.1 709.1 118.4 8.2 1.8 0.0 0.0 0.0 HORMAD2 "CT46.2, MGC26710" ENSG00000176635 "HORMA domain containing 2" Q8N7B1 22 30080174-30177075 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 115.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "THP-1: 1.2;U-2197: 3.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA003074, HPA043880" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA003074: AB_1850916, HPA043880: " "unprognostic (1.43e-1)" "unprognostic (6.77e-3)" "unprognostic (2.33e-1)" "unprognostic (1.36e-2)" "unprognostic (8.19e-3)" "unprognostic (1.96e-1)" "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 115.1 2.7 0.0 0.0 0.0 0.0 0.0 HOXA1 "HOX1, HOX1F" ENSG00000105991 "Homeobox A1" P49639 7 27092993-27095996 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 12.9" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 2.1;granulocytes: 2.3;Intestinal endocrine cells: 2.9;Ito cells: 3.1;Kupffer cells: 1.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 10 "pons and medulla: 5.0" "Group enriched" "Detected in many" 5 "intermediate monocyte: 6.0;NK-cell: 6.8;non-classical monocyte: 8.7" "Group enriched" "Detected in many" 6 "monocytes: 8.7;NK-cells: 6.8" "Cell line enhanced" "Detected in many" "HMC-1: 12.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" "Group enriched" "Detected in some" 5 "midbrain: 1.3;pons and medulla: 1.9" NA NA "unprognostic (7.39e-2)" "unprognostic (1.26e-3)" "unprognostic (1.05e-1)" "unprognostic (2.17e-4)" "unprognostic (2.79e-2)" "prognostic unfavorable (6.73e-5)" "unprognostic (4.70e-2)" "unprognostic (2.72e-2)" "unprognostic (6.65e-2)" "unprognostic (2.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-4)" "unprognostic (2.03e-1)" "unprognostic (2.82e-1)" "unprognostic (5.77e-3)" "unprognostic (1.17e-1)" 1.5 1.2 0.2 3.7 0.4 0.4 2.9 0.2 0.3 1.1 1.9 0.4 0.0 0.4 1.2 3.6 8.2 2.2 2.9 0.9 0.2 0.2 2.9 0.5 0.8 2.1 0.4 0.0 3.8 0.4 3.2 0.3 0.9 5.0 3.7 1.9 0.3 0.3 5.3 0.7 4.1 3.0 2.6 4.9 8.0 1.2 0.8 0.0 3.1 0.4 1.3 5.2 12.9 10.6 0.4 1.2 1.0 8.7 6.8 1.3 0.6 5.4 2.4 0.2 3.1 0.0 0.0 5.0 0.7 3.2 2.1 2.5 12.2 3.5 3.8 7.3 1.9 7.8 11.9 4.3 3.5 1.5 0.3 12.6 4.9 0.2 0.1 0.6 4.1 12.8 2.3 3.5 2.5 5.1 0.0 3.1 3.9 5.3 0.0 4.2 0.1 0.0 6.7 0.0 2.2 0.5 4.7 1.4 0.0 7.0 5.3 0.4 0.0 2.7 0.0 3.3 4.3 0.0 1.9 2.3 0.5 5.0 3.7 0.9 0.0 0.0 1.7 1.9 7.3 5.2 1.0 0.3 0.6 1.2 6.0 1.2 0.4 1.3 1.2 1.2 0.0 0.6 1.2 0.3 6.8 8.7 0.0 1.2 0.6 0.2 0.4 0.2 0.3 0.2 0.2 0.4 0.0 5.0 0.0 0.0 0.0 0.0 1.2 2.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.2 0.2 2.3 0.0 0.1 0.0 2.9 3.1 1.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.1 1.0 0.0 1.0 0.9 1.1 HOXA10 "HOX1, HOX1H" ENSG00000253293 "Homeobox A10" P31260 7 27170591-27180261 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 48.2;endometrium 1: 45.6" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 28.2;Intestinal endocrine cells: 65.4;Mucus-secreting cells: 25.9;Paneth cells: 38.6;Undifferentiated cells: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 7.8;NK-cell: 12.7" "Group enriched" "Detected in many" 4 "granulocytes: 7.8;NK-cells: 12.7" "Cell line enhanced" "Detected in many" "HEK 293: 56.0;THP-1: 29.4;U-937: 30.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB019384, HPA071918" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB019384: , HPA071918: " "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.73e-3)" "unprognostic (2.61e-2)" "unprognostic (1.41e-2)" "unprognostic (8.05e-2)" "unprognostic (2.71e-2)" "unprognostic (3.83e-3)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (8.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-2)" 5.9 2.7 0.3 4.6 0.4 1.2 2.5 0.3 0.3 48.2 15.9 0.3 4.0 0.0 45.6 5.4 0.3 3.4 0.5 0.3 0.3 0.0 7.9 0.3 0.3 0.5 0.3 0.3 1.3 0.3 0.0 0.3 7.7 0.3 22.2 5.3 0.3 0.6 6.6 28.0 2.4 3.1 19.2 0.4 0.3 0.0 3.4 0.3 2.2 0.3 0.3 0.3 19.0 7.6 0.2 1.2 7.8 0.1 12.7 2.3 0.3 6.2 1.3 0.0 18.7 9.4 9.1 0.0 12.4 8.5 5.7 5.3 1.8 5.5 0.0 3.5 9.7 0.0 7.0 4.8 0.0 4.2 2.8 56.0 6.5 4.8 0.1 0.2 2.8 9.9 5.7 0.3 0.4 0.0 0.0 8.6 1.9 0.2 0.0 4.1 0.0 0.0 19.0 0.0 5.0 5.9 0.6 1.2 0.0 10.9 2.9 14.8 0.0 4.3 0.0 0.0 2.1 0.0 29.4 0.0 0.0 5.2 6.6 0.0 0.1 0.0 0.0 0.0 30.5 0.1 7.8 0.1 0.3 2.3 0.0 0.0 0.1 0.0 0.2 1.2 0.2 0.0 0.0 0.0 12.7 0.0 0.4 0.0 0.3 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 5.8 3.3 0.0 1.0 0.0 0.0 0.0 7.0 0.0 0.4 16.6 0.0 0.0 0.2 18.7 0.0 0.0 0.4 28.2 11.3 0.0 0.0 0.7 0.0 65.4 0.0 4.6 0.0 0.0 2.3 5.0 0.0 25.9 0.0 0.0 38.6 0.4 20.7 0.0 0.0 12.7 1.4 2.3 3.6 0.5 4.4 27.1 7.4 HOXA11 "HOX1, HOX1I" ENSG00000005073 "Homeobox A11" P31270 7 27181510-27185223 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3" "Cell type enhanced" "Detected in some" 10 "Distal tubular cells: 5.0;Fibroblasts: 4.3;Intestinal endocrine cells: 5.1;Smooth muscle cells: 2.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 14.7;BJ hTERT+: 17.8;HEK 293: 25.0;THP-1: 17.9;U-937: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006770, HPA035623" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA006770: AB_2667672, HPA035623: AB_10601576" "unprognostic (5.95e-2)" "unprognostic (9.23e-2)" "unprognostic (3.07e-2)" "unprognostic (2.70e-2)" "unprognostic (6.29e-2)" "unprognostic (9.78e-2)" "unprognostic (2.82e-3)" "unprognostic (4.36e-2)" "unprognostic (1.61e-2)" "unprognostic (3.05e-2)" "unprognostic (2.08e-3)" "unprognostic (1.73e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (2.17e-2)" "unprognostic (6.90e-2)" "unprognostic (2.03e-2)" "unprognostic (2.56e-1)" 1.5 0.4 0.0 1.7 0.0 0.0 2.0 0.0 0.0 35.7 9.3 0.0 5.7 0.0 60.9 8.8 0.0 0.7 0.0 0.2 0.0 0.0 3.6 0.1 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 9.0 0.0 16.5 2.4 0.0 0.1 6.3 4.9 0.7 0.2 27.3 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 20.1 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.1 0.0 6.8 8.4 5.9 0.0 14.7 17.8 10.5 7.5 0.1 0.8 0.0 3.4 12.5 0.0 1.6 8.7 0.0 7.7 0.8 25.0 3.1 6.1 0.3 0.5 6.2 0.9 3.7 0.3 0.0 0.0 0.0 7.6 0.6 0.2 0.0 1.1 0.1 0.0 4.8 0.0 2.1 7.4 0.4 0.0 0.1 5.0 4.3 3.2 0.0 3.6 0.0 1.0 2.1 0.6 17.9 0.0 0.1 7.2 1.6 0.7 0.0 0.0 0.0 0.1 23.4 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.3 2.0 0.0 0.0 0.3 0.0 5.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 0.7 HOXA13 "HOX1, HOX1J" ENSG00000106031 "Homeobox A13" P31271 7 27193503-27200106 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 48.5;prostate: 25.1" "Group enriched" "Detected in some" 15 "Basal glandular cells: 2.9;Enterocytes: 7.7;Fibroblasts: 3.5;Glandular cells: 4.8;Intestinal endocrine cells: 8.1;Mucus-secreting cells: 9.8;Paneth cells: 5.8;Undifferentiated cells: 9.7;Urothelial cells: 2.8" "Cancer enhanced" "Detected in many" "prostate cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.5;HEK 293: 21.6;PC-3: 10.7;RT4: 23.9;THP-1: 10.2;U-937: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046098, HPA069061" Supported "Nucleoplasm,Mitotic chromosome,Intermediate filaments" NA NA Nucleoplasm "Mitotic chromosome, Intermediate filaments" "HPA046098: AB_2679536, HPA069061: " "unprognostic (7.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (8.04e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-2)" "unprognostic (9.22e-3)" "unprognostic (7.30e-3)" "unprognostic (8.39e-3)" "unprognostic (1.54e-1)" "unprognostic (1.42e-11)" "unprognostic (2.58e-3)" "unprognostic (1.38e-1)" "unprognostic (1.72e-1)" "unprognostic (1.36e-2)" 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 48.5 6.9 0.0 7.1 0.0 5.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 16.5 0.0 25.1 8.6 0.0 0.1 17.9 1.2 0.4 0.1 15.7 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 12.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 1.4 0.1 0.0 0.0 7.6 8.3 3.0 1.9 1.5 0.1 0.0 0.9 3.5 0.4 0.0 15.5 0.0 2.5 0.0 21.6 1.0 4.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 4.9 0.0 6.6 10.7 1.5 0.4 0.0 0.0 23.9 0.4 0.0 1.9 0.0 0.1 1.2 0.0 10.2 0.0 0.3 2.7 0.1 0.1 0.0 0.0 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.7 0.0 0.0 0.1 3.5 4.8 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 9.7 2.8 HOXA2 HOX1K ENSG00000105996 "Homeobox A2" O43364 7 27100354-27102811 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1" "Cell type enhanced" "Detected in some" 17 "Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 44 "pons and medulla: 15.7" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5" "Region enriched" "Detected in single" 35 "pons and medulla: 6.1" "Region enriched" "Detected in single" 27 "pons and medulla: 7.7" HPA078220 Approved Nucleoplasm,Vesicles Yes NA "Nucleoplasm, Vesicles" "HPA078220: AB_2686880" "unprognostic (7.30e-2)" "unprognostic (4.90e-4)" "unprognostic (2.81e-1)" "unprognostic (7.43e-4)" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (1.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.85e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (1.58e-2)" "unprognostic (4.98e-9)" "unprognostic (1.34e-1)" "unprognostic (1.33e-1)" "unprognostic (9.36e-2)" "unprognostic (1.28e-2)" 2.7 1.6 0.3 1.9 0.1 0.0 2.6 0.1 0.2 1.4 4.5 0.2 8.7 1.5 3.4 9.7 8.3 6.3 4.9 1.8 0.1 0.0 4.2 0.7 4.7 1.9 0.3 0.1 3.8 0.4 9.6 0.1 0.1 15.7 2.8 3.5 0.1 0.1 4.1 1.2 2.7 4.3 2.4 18.1 2.9 3.7 0.8 0.1 3.8 2.2 2.9 3.3 3.2 3.5 0.0 0.0 1.8 0.3 0.0 0.1 0.0 1.2 0.8 4.2 16.8 0.0 0.0 0.0 0.2 0.1 0.0 0.1 2.2 4.1 0.2 1.9 0.2 2.3 6.9 0.2 0.0 0.0 0.0 2.4 0.0 0.1 0.4 1.9 0.1 0.3 1.0 0.0 3.6 3.4 0.0 2.8 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 1.1 1.0 0.7 0.0 5.5 0.7 1.2 0.0 0.2 0.0 1.1 0.3 0.0 0.0 2.8 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.1 0.7 3.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.1 15.7 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 4.6 6.2 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.4 0.3 HOXA5 "HOX1, HOX1C" ENSG00000106004 "Homeobox A5" P20719 7 27141052-27143668 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 42.0" "Cell type enhanced" "Detected in many" 7 "Ito cells: 16.0;Paneth cells: 15.9;Proximal tubular cells: 21.3;Undifferentiated cells: 18.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 46 "pons and medulla: 16.3" "Group enriched" "Detected in some" 4 "basophil: 3.0;neutrophil: 1.6;NK-cell: 2.5" "Group enriched" "Detected in many" 5 "granulocytes: 3.0;NK-cells: 2.5" "Cell line enhanced" "Detected in many" "AN3-CA: 33.1;HEK 293: 56.5;RPTEC TERT1: 12.8" "Region enriched" "Detected in single" 88 "pons and medulla: 23.0" "Region enriched" "Detected in single" 22 "pons and medulla: 5.5" NA NA "unprognostic (2.43e-1)" "unprognostic (3.98e-3)" "unprognostic (2.99e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.87e-1)" "unprognostic (7.80e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.02e-2)" "unprognostic (5.54e-2)" "unprognostic (2.31e-1)" "unprognostic (5.47e-2)" "unprognostic (3.00e-2)" "unprognostic (4.37e-2)" "unprognostic (3.26e-2)" "unprognostic (3.47e-3)" "unprognostic (2.00e-1)" 6.8 42.0 0.2 2.1 0.2 1.2 10.9 0.2 0.3 1.9 6.6 1.0 16.0 1.1 6.0 25.0 12.3 22.1 2.5 1.4 0.2 0.0 16.8 1.8 23.9 1.5 0.2 0.2 9.3 1.3 2.0 0.5 0.3 16.3 3.9 3.3 0.2 0.2 7.1 5.6 3.4 6.8 3.0 19.4 4.4 5.6 2.6 0.2 0.2 1.3 0.2 0.2 6.6 3.3 0.2 0.4 3.0 0.5 2.5 0.2 0.1 1.9 1.0 0.0 33.1 0.0 0.0 0.1 0.5 0.4 0.6 0.5 0.6 3.4 1.0 4.9 1.0 0.7 2.6 1.8 0.1 0.6 0.4 56.5 0.7 0.4 1.9 0.3 1.2 0.8 3.7 0.2 1.1 1.9 0.0 7.3 1.9 0.1 0.0 1.1 0.6 0.0 0.3 0.0 0.7 1.0 4.5 0.1 0.0 12.8 2.6 3.9 0.0 2.5 0.0 1.1 0.1 0.4 0.4 2.9 0.1 0.4 2.0 1.3 0.0 0.0 1.1 0.2 3.6 3.6 3.0 0.4 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.4 0.2 0.2 0.1 1.6 2.5 0.5 0.4 0.1 0.1 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 16.3 0.2 0.0 0.6 0.0 3.8 3.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 5.1 9.3 0.0 0.0 0.0 1.3 2.2 0.0 0.0 0.6 0.0 8.6 16.0 4.1 0.0 0.3 0.9 1.7 1.0 8.4 0.0 0.0 15.9 0.0 21.3 0.0 0.0 3.3 0.2 0.7 2.5 0.1 0.0 18.1 5.0 HOXA6 "HOX1, HOX1B" ENSG00000106006 "Homeobox A6" P31267 7 27145396-27150603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 10.4" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 5.0;Enterocytes: 3.5;Intestinal endocrine cells: 8.6;Paneth cells: 4.8;Undifferentiated cells: 4.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 5.9;NK-cell: 2.0" "Group enriched" "Detected in many" 8 "granulocytes: 5.9;NK-cells: 2.0" "Group enriched" "Detected in some" 9 "AN3-CA: 29.3;HEK 293: 39.9" "Region enriched" "Detected in single" 34 "pons and medulla: 3.5" "HPA004203, HPA077900" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA004203: AB_1079079, HPA077900: " "unprognostic (1.70e-1)" "unprognostic (6.76e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.06e-1)" "unprognostic (6.06e-2)" "unprognostic (9.73e-2)" "unprognostic (6.32e-2)" "unprognostic (2.94e-2)" "unprognostic (7.82e-2)" "unprognostic (2.17e-1)" "prognostic favorable (2.03e-4)" "unprognostic (1.45e-1)" "unprognostic (2.81e-2)" "unprognostic (3.93e-1)" 3.2 2.9 0.0 1.2 0.0 0.0 2.3 0.0 0.0 1.6 5.4 0.0 6.7 4.6 0.1 10.4 0.0 0.0 0.0 0.0 5.9 0.0 2.3 0.8 0.0 0.0 0.0 0.5 0.0 0.0 2.5 1.5 0.0 2.2 1.0 3.2 4.2 1.4 1.0 0.0 1.2 0.0 0.0 0.0 4.3 1.3 0.1 0.5 5.9 0.1 2.0 0.2 0.0 0.5 0.9 0.0 29.3 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.7 3.4 0.7 1.1 0.2 0.1 1.3 0.7 0.0 0.0 0.8 39.9 0.4 0.5 0.4 0.0 0.6 1.0 2.4 0.0 0.0 0.3 0.0 1.3 0.9 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.1 1.0 3.8 0.0 0.0 2.8 1.8 3.1 0.0 1.3 0.1 0.6 0.0 0.3 0.3 0.0 0.0 0.4 1.6 1.0 0.0 0.0 0.6 0.0 2.8 2.9 5.9 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 4.8 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 4.4 1.0 HOXA7 "HOX1, HOX1A" ENSG00000122592 "Homeobox A7" P31268 7 27153716-27157936 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.8" "Group enriched" "Detected in many" 5 "Distal tubular cells: 111.0;Proximal tubular cells: 39.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 14 "pons and medulla: 9.2" "Cell type enriched" "Detected in some" 5 "NK-cell: 7.7" "Lineage enriched" "Detected in many" 5 "NK-cells: 7.7" "Cell line enhanced" "Detected in many" "HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7" "Region enriched" "Detected in single" 12 "pons and medulla: 1.4" "Region enriched" "Detected in single" 10 "pons and medulla: 2.9" HPA074048 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA074048: AB_2686655" "unprognostic (5.40e-2)" "unprognostic (2.34e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (7.87e-5)" "unprognostic (3.30e-1)" "unprognostic (2.53e-1)" "unprognostic (3.02e-1)" "unprognostic (3.24e-2)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.04e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.15e-5)" "unprognostic (9.08e-2)" "unprognostic (8.90e-2)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" 6.5 14.5 0.2 4.8 0.2 0.0 11.2 0.3 0.6 7.3 10.0 0.2 7.9 0.0 5.0 15.4 3.0 12.2 0.5 0.2 0.2 0.0 25.4 0.4 2.6 3.5 0.2 0.2 6.2 0.2 0.3 0.2 1.3 9.2 8.2 7.2 0.2 0.2 8.9 27.8 8.2 6.1 8.1 14.3 3.7 3.2 2.7 0.2 1.6 0.9 0.2 1.1 11.4 6.7 0.2 0.9 0.0 0.0 7.7 1.6 0.2 6.9 2.4 0.0 7.5 0.0 0.0 0.4 2.5 4.3 5.2 6.0 3.6 2.7 4.8 7.0 1.9 0.2 4.8 19.7 0.0 3.1 0.0 12.4 0.3 2.8 0.1 0.5 0.4 0.2 4.1 0.2 0.6 7.0 0.0 9.8 8.4 0.0 0.0 1.9 1.2 0.0 1.1 0.3 5.0 0.7 2.5 4.6 0.0 24.4 4.8 19.7 0.0 13.6 0.0 0.0 1.4 0.2 1.9 0.8 0.0 4.7 14.0 2.4 0.0 0.1 0.1 0.0 9.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.9 0.0 0.0 0.1 0.0 7.7 0.0 0.6 0.4 0.2 0.2 0.2 0.3 0.6 0.2 0.0 0.2 0.2 9.2 0.2 0.0 0.0 0.0 7.5 8.0 0.0 0.3 0.0 0.0 0.0 12.2 0.0 0.4 111.0 0.0 15.9 2.2 3.0 0.0 0.0 4.6 2.7 4.0 0.0 0.0 0.2 0.0 15.5 0.0 0.0 2.1 0.6 0.5 3.3 0.0 11.2 0.0 0.1 10.4 0.0 39.0 0.0 0.0 7.3 0.4 0.2 10.8 0.2 0.9 15.7 2.6 HOXA9 "HOX1, HOX1G" ENSG00000078399 "Homeobox A9" P31269 7 27162435-27175180 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7" "Cell line enhanced" "Detected in some" "HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5" "HPA061982, HPA076200" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA061982: AB_2684651, HPA076200: " "unprognostic (4.72e-1)" "unprognostic (1.23e-2)" "unprognostic (2.86e-1)" "unprognostic (5.24e-3)" "unprognostic (2.36e-1)" "unprognostic (2.02e-1)" "unprognostic (8.35e-2)" "unprognostic (8.44e-3)" "unprognostic (5.50e-2)" "unprognostic (5.71e-2)" "unprognostic (9.87e-3)" "unprognostic (4.42e-2)" "unprognostic (2.80e-3)" "unprognostic (6.45e-2)" "unprognostic (7.58e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" 3.2 3.4 0.2 8.8 0.1 2.4 8.7 0.1 0.2 15.5 12.8 0.2 4.1 0.0 10.4 16.8 1.4 12.2 0.3 0.1 0.1 0.0 35.1 0.1 0.8 0.7 0.1 0.1 2.0 0.1 0.0 0.1 1.4 0.4 16.6 4.5 0.2 0.5 5.6 21.0 13.3 8.2 13.1 0.7 1.0 0.0 2.4 0.1 2.6 0.3 0.3 0.3 16.2 11.4 0.5 6.0 5.4 1.0 11.7 1.5 0.5 12.7 0.0 0.0 6.4 2.1 1.6 0.0 5.1 4.1 0.4 0.4 0.8 0.5 0.1 0.5 2.7 0.0 11.9 8.2 0.0 0.4 0.0 43.6 0.1 0.3 0.0 0.2 0.0 0.1 2.2 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 15.2 2.7 0.0 0.0 15.0 0.2 40.5 0.0 5.4 0.0 0.1 0.2 0.0 10.7 0.4 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.0 14.5 0.0 5.4 1.0 0.0 1.5 0.2 0.2 0.2 0.0 0.1 6.0 0.5 0.3 0.1 0.9 11.7 0.4 1.9 0.2 0.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.8 10.6 22.2 0.0 0.6 0.0 0.0 0.0 17.4 0.0 0.3 46.4 0.0 0.0 0.2 7.9 0.0 0.0 0.3 10.8 14.2 0.0 0.0 0.3 0.0 37.7 0.0 4.8 0.0 0.0 1.6 5.0 0.0 19.1 0.0 0.0 18.4 0.0 60.8 0.0 0.0 3.6 0.0 0.6 24.1 0.2 4.4 19.4 11.5 HOXB1 "HOX2, HOX2I" ENSG00000120094 "Homeobox B1" P14653 17 48528526-48531001 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 2.2;testis: 1.9;urinary bladder: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SuSa: 3.3;T-47d: 1.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA044576 Uncertain NA NA "HPA044576: AB_10794501" "unprognostic (1.80e-2)" "unprognostic (9.50e-3)" "unprognostic (8.22e-2)" "unprognostic (1.22e-1)" "unprognostic (6.26e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (6.74e-2)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.1 0.1 2.2 0.8 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.0 1.9 0.1 0.1 0.1 0.1 0.1 1.5 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 HOXB13 ENSG00000159184 "Homeobox B13" Q92826 17 48724763-48729178 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 18.6;prostate: 38.3" "Cell type enhanced" "Detected in some" 17 "Glandular cells: 62.7;Intestinal endocrine cells: 187.8;Mucus-secreting cells: 92.1;Paneth cells: 66.2;Undifferentiated cells: 64.4" "Cancer enriched" "Detected in many" 17 "prostate cancer: 187.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.3" "Cell line enriched" "Detected in some" 13 "PC-3: 59.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004438, HPA062852, HPA065019" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406" "unprognostic (4.81e-2)" "unprognostic (2.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.33e-2)" "unprognostic (5.85e-3)" "unprognostic (1.88e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (1.17e-2)" "unprognostic (6.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.27e-2)" "unprognostic (4.73e-11)" "unprognostic (1.39e-2)" "unprognostic (4.50e-2)" "unprognostic (1.12e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 2.4 10.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.4 0.1 38.3 18.6 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 3.6 2.4 0.1 0.2 1.3 0.1 0.1 0.1 0.0 0.6 2.0 0.0 4.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.9 1.0 0.0 1.0 0.0 0.5 0.0 3.0 0.0 0.0 0.3 1.4 0.9 0.6 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.1 0.0 0.1 0.0 0.7 59.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.4 0.2 0.0 0.2 0.0 0.2 1.7 1.7 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 37.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.4 0.0 0.0 0.2 0.3 62.7 0.0 0.0 0.1 0.0 187.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 92.1 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 64.4 6.4 HOXB2 "HOX2, HOX2H" ENSG00000173917 "Homeobox B2" P14652 17 48540894-48544989 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 53.1" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 50.6;Distal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 6 "pons and medulla: 12.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 21.0;EFO-21: 20.3;HEK 293: 23.0;HMC-1: 45.9;WM-115: 20.1" "Region enriched" "Detected in single" 34 "pons and medulla: 4.7" "Region enriched" "Detected in single" 29 "pons and medulla: 5.4" HPA047857 Supported Nucleoplasm NA NA Nucleoplasm "HPA047857: AB_2680184" "unprognostic (8.58e-3)" "unprognostic (4.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.12e-2)" "unprognostic (7.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.75e-2)" "unprognostic (2.60e-1)" "unprognostic (3.24e-1)" "unprognostic (3.04e-3)" "unprognostic (4.12e-1)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (2.89e-1)" 9.2 11.0 0.2 6.3 0.3 1.9 24.2 0.3 0.2 14.5 15.4 0.4 53.1 2.4 6.9 32.5 19.3 12.2 12.8 4.5 0.5 0.1 25.6 2.8 6.4 4.4 2.0 0.3 6.4 1.6 8.9 0.9 1.7 12.9 8.2 1.7 0.8 0.6 33.2 6.1 3.7 6.4 7.5 19.4 6.8 6.7 2.7 0.2 2.4 3.0 3.9 2.6 7.9 16.3 0.8 6.0 5.0 0.4 2.2 9.5 1.3 0.0 0.7 21.0 0.0 4.8 5.6 0.0 1.9 0.0 0.0 0.0 0.3 0.1 0.0 20.3 5.8 0.0 0.0 3.1 0.0 0.0 0.1 23.0 7.9 0.8 0.0 8.5 0.0 45.9 3.5 0.0 9.1 3.6 0.2 3.3 0.0 15.5 0.0 12.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.4 0.0 15.0 1.8 0.0 0.0 1.5 0.0 12.0 1.5 11.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 0.0 0.0 8.2 0.0 20.1 5.0 0.4 0.0 4.2 0.4 1.3 0.2 6.2 4.7 1.9 0.8 9.5 3.9 0.0 2.2 0.3 6.0 7.3 1.3 0.2 0.3 0.3 0.2 0.5 0.1 2.0 0.3 12.9 0.2 3.0 1.4 5.2 6.2 6.3 0.0 0.8 0.0 1.4 2.3 50.6 0.0 14.4 132.6 0.8 0.6 5.6 0.0 0.0 0.2 23.9 18.1 7.9 20.7 0.0 6.8 0.0 2.4 21.5 12.6 0.9 0.0 11.9 11.8 6.4 1.3 0.0 0.1 1.1 0.0 17.2 0.0 0.0 30.9 1.7 6.8 5.0 20.8 27.4 0.7 21.3 HOXB3 "HOX2, HOX2G" ENSG00000120093 "Homeobox B3" P14651 17 48548870-48604912 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4" "Group enriched" "Detected in many" 5 "Collecting duct cells: 94.2;Early spermatids: 27.9;Ito cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 20.7;EFO-21: 18.1;HEK 293: 21.9;RPTEC TERT1: 17.0;U-251 MG: 19.5" "Region enriched" "Detected in single" 40 "pons and medulla: 9.3" "Region enriched" "Detected in single" 29 "pons and medulla: 12.9" "CAB009860, HPA064990" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB009860: AB_2119262, HPA064990: AB_2685398" "unprognostic (5.88e-2)" "unprognostic (1.01e-1)" "unprognostic (5.61e-2)" "unprognostic (7.04e-2)" "unprognostic (8.39e-3)" "unprognostic (1.72e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (3.09e-2)" "unprognostic (4.32e-3)" "unprognostic (8.14e-2)" "unprognostic (8.27e-2)" "unprognostic (3.17e-1)" "unprognostic (7.60e-2)" "unprognostic (7.85e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.45e-6)" 8.3 4.5 1.0 7.3 1.1 0.2 8.0 1.0 1.0 11.3 16.4 1.0 56.7 2.3 10.1 44.9 5.5 17.7 3.6 1.7 1.0 0.0 16.3 1.6 4.8 1.6 1.0 1.0 2.8 1.7 6.7 1.0 3.8 2.6 4.1 4.9 1.0 1.0 68.4 4.0 2.9 11.3 3.5 4.8 6.5 7.8 3.7 1.0 1.0 1.8 1.0 1.1 6.4 5.2 0.1 2.8 1.7 0.9 1.4 1.1 0.4 3.3 7.0 4.7 2.2 3.9 5.5 1.2 0.1 0.0 0.1 0.1 3.2 20.7 1.7 18.1 14.8 2.3 0.1 1.0 0.3 0.0 5.3 21.9 5.1 3.1 0.0 6.4 0.0 13.6 6.4 0.0 6.1 0.4 2.8 6.4 6.7 6.9 0.1 3.8 0.1 0.3 0.1 0.1 6.7 0.7 0.0 3.4 0.7 17.0 3.1 0.0 0.0 0.7 0.0 3.3 3.8 6.6 1.4 7.2 2.2 7.1 1.2 19.5 1.8 2.1 0.1 4.6 0.0 3.8 1.7 0.1 0.0 0.9 0.1 0.4 0.0 0.5 1.1 0.3 0.1 0.8 1.0 0.0 1.4 0.9 2.8 1.1 0.4 1.0 1.1 1.0 1.0 1.0 0.0 1.0 1.0 2.6 1.0 0.0 3.4 0.0 2.3 2.3 0.0 0.8 0.0 0.0 1.2 94.2 0.0 2.5 6.6 0.2 27.9 7.7 7.4 0.0 0.0 0.7 5.1 3.6 8.1 0.2 0.6 0.0 2.4 27.6 2.1 7.9 0.3 1.0 5.0 0.0 6.3 0.0 0.4 3.5 0.4 0.6 0.0 0.0 3.3 4.5 9.2 1.3 0.3 1.3 9.7 4.7 HOXB4 "HOX2, HOX2F" ENSG00000182742 "Homeobox B4" P17483 17 48575513-48580111 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 13.3" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 61.1;Cytotrophoblasts: 18.4;Spermatogonia: 21.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 23.4;HEK 293: 11.3;HMC-1: 14.4;K-562: 11.4" "Region enriched" "Detected in single" 36 "pons and medulla: 3.7" "Region enriched" "Detected in single" 23 "pons and medulla: 7.5" HPA057432 Uncertain Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA057432: AB_2683437" "unprognostic (2.71e-2)" "unprognostic (3.87e-2)" "unprognostic (8.97e-3)" "unprognostic (5.39e-3)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (2.65e-2)" "unprognostic (1.59e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (3.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.41e-1)" "unprognostic (2.10e-1)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "unprognostic (3.41e-3)" 4.4 2.4 0.0 1.5 0.0 0.0 2.9 0.0 0.0 4.2 8.1 1.2 2.3 13.3 2.7 8.5 1.5 0.4 0.0 0.0 5.7 0.7 3.6 0.6 0.0 0.0 0.7 1.8 0.0 1.0 0.6 1.1 0.0 4.8 0.8 0.9 4.3 2.0 2.4 3.0 3.9 0.5 0.6 0.2 1.3 1.7 0.3 2.4 0.0 0.1 0.6 0.7 0.1 0.1 0.3 0.0 0.1 4.9 3.9 1.9 0.0 0.0 0.2 0.1 2.2 2.0 3.1 23.4 1.5 0.4 0.1 4.1 0.0 0.0 8.0 11.3 7.6 0.7 0.0 5.0 0.0 14.4 3.8 0.0 5.7 0.0 0.8 6.6 5.2 11.4 0.2 5.6 0.0 1.8 0.0 0.0 2.1 0.0 0.0 4.4 1.6 4.6 1.9 0.0 0.0 0.6 0.0 2.9 1.6 0.4 1.5 2.5 0.3 0.2 0.8 0.2 1.9 4.0 0.7 1.6 0.0 2.2 0.0 0.1 0.0 0.7 0.0 0.1 0.3 0.2 0.5 0.0 0.1 0.2 0.1 0.0 0.6 0.0 2.4 0.0 0.1 0.0 0.0 1.7 0.9 3.4 0.0 0.8 0.0 1.4 0.0 61.1 0.0 18.4 10.0 0.1 0.0 7.1 0.8 0.0 0.0 11.0 9.7 0.4 3.5 0.0 3.2 0.0 0.0 15.4 1.8 0.0 0.3 1.9 5.0 0.0 2.0 0.0 0.0 1.9 0.0 1.4 0.0 0.0 5.2 0.2 21.8 1.6 5.0 10.5 1.5 2.6 HOXB5 "HOX2, HOX2A" ENSG00000120075 "Homeobox B5" P09067 17 48591257-48593961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 28.1" "Region enriched" "Detected in single" 33 "pons and medulla: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 21.5;RPTEC TERT1: 16.1" "Region enriched" "Detected in single" 90 "pons and medulla: 24.0" "Region enriched" "Detected in single" 128 "pons and medulla: 14.7" "HPA043851, HPA074454" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA043851: AB_2732509, HPA074454: AB_2686690" "unprognostic (6.50e-2)" "unprognostic (1.63e-1)" "unprognostic (4.22e-2)" "prognostic favorable (6.28e-4)" "unprognostic (6.48e-3)" "unprognostic (7.12e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (2.47e-1)" "unprognostic (1.47e-3)" "unprognostic (5.10e-2)" "unprognostic (9.64e-2)" "unprognostic (7.61e-3)" "unprognostic (8.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.86e-2)" "prognostic favorable (8.59e-5)" 3.4 3.1 0.2 2.1 0.2 0.0 5.0 0.2 0.7 5.4 10.5 0.2 25.9 1.5 2.2 18.5 0.6 7.2 0.2 0.7 0.2 0.0 16.0 0.4 5.2 0.8 0.2 0.2 1.9 0.5 0.9 0.2 1.2 25.4 1.3 4.7 0.2 0.6 27.6 0.2 0.5 9.5 1.6 22.5 2.0 4.3 0.7 0.2 0.2 0.7 0.2 0.2 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.8 0.0 2.5 2.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.2 2.7 0.6 0.0 0.2 0.0 0.0 0.0 21.5 0.9 5.6 0.0 4.2 0.0 1.2 1.4 0.0 2.9 0.0 0.8 1.4 0.1 1.6 0.0 3.3 0.0 0.0 0.0 0.0 2.7 1.7 0.0 1.0 0.0 16.1 1.6 0.0 0.0 0.1 0.0 2.3 0.1 0.4 0.0 5.3 0.7 2.1 0.5 0.3 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 25.4 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 50.6 0.0 0.0 21.6 0.0 0.6 2.4 8.9 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.5 0.0 4.1 9.2 5.0 0.0 0.0 0.0 1.7 0.0 13.9 0.0 0.0 3.5 0.4 0.4 0.0 0.0 1.0 7.2 10.8 0.3 0.0 0.0 11.5 0.0 HOXB6 "HOX2, HOX2B" ENSG00000108511 "Homeobox B6" P17509 17 48595751-48604992 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 73.7;seminal vesicle: 56.7" "Group enriched" "Detected in many" 8 "Collecting duct cells: 129.1;Distal tubular cells: 96.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 32.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.5" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.0" "Cell line enhanced" "Detected in many" "EFO-21: 13.4;HEK 293: 36.8;RPTEC TERT1: 25.0;TIME: 13.9" "Region enriched" "Detected in single" 60 "pons and medulla: 10.6" "Region enriched" "Detected in single" 25 "pons and medulla: 14.6" HPA042063 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA042063: AB_10796470" "unprognostic (5.01e-2)" "unprognostic (4.48e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.46e-4)" "unprognostic (1.30e-1)" "unprognostic (8.80e-3)" "unprognostic (5.64e-2)" "unprognostic (2.06e-3)" "unprognostic (3.97e-2)" "unprognostic (1.84e-2)" "unprognostic (6.97e-2)" "unprognostic (6.64e-2)" "unprognostic (2.50e-3)" "unprognostic (2.53e-3)" "unprognostic (5.76e-2)" "unprognostic (7.11e-2)" "unprognostic (4.19e-3)" 5.2 4.3 0.3 18.1 0.3 0.0 3.8 0.3 0.3 12.0 8.5 0.3 73.7 0.5 7.2 30.5 0.4 8.7 0.3 0.3 0.3 0.0 26.6 0.4 3.4 0.3 0.3 0.3 0.6 0.6 1.9 0.3 1.5 0.9 4.3 3.8 0.3 0.3 56.7 1.0 0.6 8.2 1.8 10.0 1.7 5.9 1.8 0.3 0.3 0.3 0.3 0.3 4.2 10.0 1.5 0.2 0.0 0.0 0.0 1.0 0.3 2.3 5.5 0.0 2.9 2.5 2.7 0.0 0.0 0.0 0.0 0.0 2.9 3.6 0.0 13.4 6.5 0.9 0.0 0.6 0.2 0.0 0.1 36.8 3.2 9.1 0.0 3.8 0.2 8.6 3.3 0.1 5.3 0.1 2.0 2.5 0.2 2.1 0.0 7.3 0.1 0.0 0.1 0.0 9.1 2.2 0.0 6.2 0.3 25.0 1.2 0.0 0.0 2.0 0.0 3.6 0.0 0.9 1.2 13.9 0.5 2.9 2.3 10.1 0.0 0.0 0.0 0.4 0.0 4.5 0.0 0.0 0.0 0.7 0.0 0.2 1.4 0.4 1.0 0.2 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.9 0.3 0.0 0.0 0.0 0.4 0.7 0.0 0.2 0.0 0.0 0.0 129.1 0.0 0.2 96.2 0.1 0.6 2.2 14.0 0.0 1.6 1.6 2.6 0.3 0.0 0.0 1.4 0.0 7.5 4.9 14.7 0.0 0.9 1.7 0.0 0.0 7.5 0.0 0.9 14.1 0.0 2.1 0.0 0.0 2.1 4.2 6.8 1.0 0.2 1.0 10.3 0.6 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607227-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 62.3" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8" "Region enriched" "Detected in single" 45 "pons and medulla: 6.0" "Region enriched" "Detected in single" 14 "pons and medulla: 1.5" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 8.3 8.3 0.0 7.3 0.3 0.1 17.2 0.1 0.6 10.0 8.1 0.1 24.1 0.5 4.1 62.3 0.8 4.2 0.3 1.1 0.0 0.0 23.7 0.8 1.7 2.4 0.1 0.3 2.3 0.6 0.4 0.5 4.1 4.1 5.2 7.0 0.1 0.1 22.1 2.4 2.2 12.4 3.5 20.1 2.2 4.6 3.0 0.2 0.1 0.5 0.1 0.6 5.8 15.1 2.2 1.8 0.0 0.0 2.0 4.7 0.5 16.9 7.4 0.0 0.1 5.3 8.0 0.0 0.0 0.0 0.1 0.3 11.3 0.3 0.3 30.4 7.1 8.8 2.5 0.0 0.0 0.0 7.8 5.5 2.6 5.8 0.0 4.4 0.0 5.5 5.2 2.3 5.2 0.0 1.3 16.0 5.3 2.8 0.1 16.8 4.4 0.3 0.1 0.0 26.5 0.0 0.0 14.4 1.9 24.2 5.7 0.0 0.0 5.7 0.0 28.8 0.4 1.4 1.6 13.7 0.0 9.3 7.5 13.1 0.9 2.2 0.0 0.1 0.0 21.3 0.0 0.0 0.0 3.8 0.0 1.9 1.9 0.7 2.1 0.0 2.2 0.0 1.4 0.0 2.0 0.0 1.8 4.7 0.5 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.3 4.1 0.2 0.0 0.0 3.7 0.8 4.8 0.0 0.3 0.0 0.0 0.0 82.0 0.0 6.2 126.0 0.0 0.1 2.2 102.1 0.0 1.1 14.9 8.2 0.7 4.7 0.0 8.8 0.0 35.1 1.3 7.8 0.0 0.6 2.8 23.6 2.8 73.3 0.0 0.5 56.1 0.0 27.8 0.0 0.0 8.0 1.4 23.4 1.8 1.5 1.0 65.0 3.1 HOXB8 "HOX2, HOX2D" ENSG00000120068 "Homeobox B8" P17481 17 48611377-48614939 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6" "Group enriched" "Detected in some" 7 "Collecting duct cells: 83.7;Distal tubular cells: 61.3;Intestinal endocrine cells: 42.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 33.3" "Region enriched" "Detected in single" 82 "pons and medulla: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 20.9;HDLM-2: 9.4;HEK 293: 21.6;LHCN-M2: 11.0;RPTEC TERT1: 23.0" "Region enriched" "Detected in single" 48 "pons and medulla: 6.8" "Low region specificity" "Detected in many" HPA075905 Supported Nucleoplasm NA NA Nucleoplasm "HPA075905: AB_2686767" "unprognostic (4.44e-1)" "unprognostic (2.60e-1)" "unprognostic (1.01e-1)" "unprognostic (2.13e-1)" "unprognostic (1.94e-2)" "unprognostic (9.07e-5)" "unprognostic (6.63e-3)" "unprognostic (1.40e-3)" "unprognostic (6.00e-2)" "unprognostic (5.66e-3)" "unprognostic (2.93e-2)" "unprognostic (1.14e-2)" "prognostic favorable (1.30e-7)" "unprognostic (1.77e-2)" "unprognostic (6.64e-2)" "unprognostic (4.57e-2)" "unprognostic (2.88e-3)" 3.5 4.3 0.0 1.6 0.0 0.0 2.5 0.0 0.0 7.7 2.1 0.0 45.4 0.0 2.1 39.2 0.0 0.9 0.0 0.0 0.0 0.0 16.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.2 0.2 8.2 1.9 0.8 0.0 0.1 34.6 0.2 0.4 4.0 1.1 49.3 0.0 4.3 2.8 0.0 0.1 0.1 0.0 0.0 5.0 6.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 3.3 0.0 0.4 0.4 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 20.9 3.3 0.4 0.0 0.0 0.0 0.0 9.4 21.6 0.5 0.0 0.0 0.2 0.0 3.1 0.6 0.0 0.0 0.0 0.4 1.4 0.1 6.2 0.0 11.0 0.0 0.0 0.2 0.0 7.0 0.0 0.0 2.1 0.0 23.0 0.6 0.0 0.0 0.3 0.0 3.1 0.0 0.2 0.0 5.2 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 83.7 0.0 0.0 61.3 0.0 0.1 0.5 1.3 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.2 0.0 42.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.3 0.5 9.6 0.0 0.0 0.0 4.1 0.0 HOXB9 "HOX2, HOX2E" ENSG00000170689 "Homeobox B9" P17482 17 48621159-48626356 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 55.8;Distal tubular cells: 33.2;Intestinal endocrine cells: 169.5;Mucus-secreting cells: 37.2;Undifferentiated cells: 43.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 79.2;HEK 293: 30.5;HMC-1: 31.3;K-562: 33.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA004928 Supported Nucleoplasm NA No Nucleoplasm "HPA004928: " "unprognostic (2.16e-2)" "unprognostic (1.46e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.47e-4)" "unprognostic (1.38e-4)" "prognostic unfavorable (6.64e-5)" "unprognostic (3.15e-2)" "unprognostic (1.60e-3)" "unprognostic (6.30e-3)" "unprognostic (3.41e-2)" "unprognostic (5.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.28e-3)" "unprognostic (1.43e-1)" "unprognostic (5.34e-2)" "unprognostic (1.85e-1)" "unprognostic (6.00e-2)" 0.5 0.8 0.1 1.9 0.2 0.0 0.4 0.1 0.3 5.3 16.6 0.1 27.3 0.0 1.4 42.8 0.1 0.4 0.1 0.1 0.1 0.1 15.3 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.3 0.5 0.2 1.1 10.4 0.1 0.1 23.5 0.2 0.2 11.3 1.0 3.5 0.2 0.2 2.0 0.1 0.1 0.1 0.1 0.1 2.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.1 1.4 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 1.7 0.0 8.5 0.2 0.9 0.0 1.3 0.0 0.0 79.2 30.5 13.8 0.5 0.0 0.5 0.2 31.3 0.0 0.0 0.0 0.8 2.4 0.0 0.6 33.6 0.0 1.3 0.0 0.0 0.1 0.0 1.8 1.3 0.0 5.3 0.4 13.8 0.0 0.0 0.0 1.0 0.0 8.7 0.1 0.1 0.0 0.1 0.0 7.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 55.8 0.0 0.0 33.2 0.0 0.1 0.2 12.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 169.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 37.2 0.0 0.1 11.5 0.0 0.7 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 43.2 0.1 HOXC10 HOX3I ENSG00000180818 "Homeobox C10" Q9NYD6 12 53985065-53990279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 16.2;skeletal muscle: 53.2" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 18.8;Distal tubular cells: 53.0;Proximal tubular cells: 81.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 78.1;ASC diff: 23.1;ASC TERT1: 21.3;fHDF/TERT166: 17.9;T-47d: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053919 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA053919: AB_2682308" "unprognostic (1.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.56e-4)" "unprognostic (1.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (1.23e-1)" "unprognostic (9.60e-3)" "unprognostic (3.96e-2)" "unprognostic (7.37e-3)" "unprognostic (2.25e-2)" "unprognostic (3.56e-2)" "unprognostic (5.07e-2)" "unprognostic (5.24e-3)" "unprognostic (1.91e-1)" 8.0 0.7 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.5 0.3 0.0 0.4 0.0 1.6 6.8 0.1 2.5 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 1.3 53.2 6.8 0.8 0.5 0.9 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.8 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.8 0.0 78.1 23.1 21.3 0.1 2.7 6.5 3.7 3.5 0.1 0.2 0.1 0.7 17.9 0.5 8.4 1.1 0.0 1.8 3.9 1.5 0.7 9.7 0.0 0.1 0.0 1.0 10.0 0.1 0.2 0.0 0.0 0.0 2.2 0.6 0.0 2.5 0.4 0.0 1.9 0.0 9.5 0.3 0.0 0.1 0.0 8.2 0.0 0.0 1.0 1.8 2.7 4.0 0.1 26.6 0.5 0.0 2.2 2.8 0.0 3.4 0.3 0.0 0.0 0.0 0.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.3 0.0 0.0 0.0 15.7 0.0 0.0 53.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.7 81.2 0.0 0.0 0.1 3.0 4.5 16.8 0.1 0.0 0.0 0.0 HOXC11 HOX3H ENSG00000123388 "Homeobox C11" O43248 12 53973126-53977643 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 7.0;skin 1: 9.2" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 6.6;Distal tubular cells: 1.7;Fibroblasts: 2.3;Melanocytes: 3.3;Spermatocytes: 3.8;Suprabasal keratinocytes: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 23.3;BJ hTERT+: 11.7;HaCaT: 10.3;T-47d: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA038291 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA038291: AB_10674552" "unprognostic (1.50e-3)" "unprognostic (1.93e-2)" "unprognostic (1.14e-2)" "unprognostic (1.51e-1)" "unprognostic (1.93e-3)" "unprognostic (1.17e-2)" "unprognostic (6.90e-3)" "unprognostic (1.32e-2)" "unprognostic (7.41e-3)" "unprognostic (4.46e-3)" "unprognostic (2.25e-1)" "unprognostic (3.26e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-1)" "unprognostic (1.82e-1)" 4.8 0.0 0.1 0.1 0.1 0.0 1.2 0.1 0.1 2.5 0.1 0.1 0.1 0.8 2.0 1.0 0.1 0.7 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.7 0.1 0.1 0.5 0.1 0.0 0.1 0.6 0.3 0.5 0.0 0.1 0.1 2.0 7.0 9.2 2.7 0.4 0.1 0.1 0.0 1.6 0.1 0.5 0.1 0.1 0.1 1.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.7 0.0 23.3 2.2 3.4 0.0 3.4 11.7 5.0 3.7 0.2 0.9 0.0 0.2 3.2 0.0 10.3 4.4 0.0 2.3 0.6 0.1 0.1 7.6 0.0 0.0 0.1 0.1 0.6 0.9 0.0 0.3 0.0 0.0 0.2 1.0 0.0 3.2 1.4 0.0 0.0 0.0 6.6 0.0 0.0 0.4 0.0 0.4 0.8 0.0 0.1 2.1 5.3 2.0 0.2 18.4 0.0 0.0 0.0 4.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 3.8 0.2 3.3 0.0 0.0 0.0 0.0 HOXC12 "HOC3F, HOX3, HOX3F" ENSG00000123407 "Homeobox C12" P31275 12 53954834-53958956 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.0;lymphoid tissue: 8.1;skin 1: 6.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 17.0;OE19: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA055632 Uncertain NA NA "HPA055632: AB_2682867" "unprognostic (6.95e-2)" "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.37e-2)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.17e-3)" "unprognostic (3.84e-2)" "unprognostic (2.55e-1)" 3.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.5 6.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.8 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOXC13 "HOX3, HOX3G" ENSG00000123364 "Homeobox C13" P31276 12 53938765-53946544 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 4.4;skin 1: 13.5;tongue: 4.1" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 1.4;Spermatogonia: 1.5;Suprabasal keratinocytes: 2.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;HaCaT: 33.1;SK-BR-3: 18.3;T-47d: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA051634 Enhanced NA NA "HPA051634: AB_2616459" "unprognostic (5.16e-3)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (2.27e-3)" "unprognostic (2.78e-2)" "unprognostic (1.20e-1)" "unprognostic (2.20e-1)" "unprognostic (4.04e-2)" "unprognostic (1.53e-1)" "unprognostic (9.77e-2)" "unprognostic (9.74e-9)" "unprognostic (2.41e-1)" "unprognostic (1.41e-1)" "unprognostic (1.68e-1)" 2.6 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.3 0.4 0.5 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 2.5 0.0 0.6 13.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 5.2 0.0 15.7 0.2 0.0 9.4 1.0 2.2 1.4 0.8 1.3 0.2 0.0 0.2 0.0 1.0 33.1 4.0 1.0 0.8 0.0 3.2 0.0 4.3 0.0 0.0 0.0 3.3 0.0 7.8 0.0 3.1 0.0 0.0 0.0 5.6 0.0 5.8 9.7 0.0 0.0 0.1 3.2 1.3 0.0 0.2 0.0 0.0 2.9 0.0 0.0 5.2 18.3 2.4 3.9 14.1 0.0 0.0 0.0 6.8 0.1 2.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.0 0.1 0.0 0.0 0.0 HOXC4 "HOX3, HOX3E" ENSG00000198353 "Homeobox C4" P09017 12 54016931-54056030 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;ovary: 31.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 3.5;Leydig cells: 2.8;Proximal tubular cells: 2.4;Sertoli cells: 6.5;Spermatocytes: 2.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 27 "pons and medulla: 29.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 14.1;HDLM-2: 18.1;HEK 293: 19.9;SH-SY5Y: 16.9" "Region enriched" "Detected in single" 24 "pons and medulla: 9.9" "Region enriched" "Detected in single" 13 "pons and medulla: 3.7" HPA053910 Supported Nucleoplasm NA NA Nucleoplasm "HPA053910: AB_2682305" "unprognostic (2.78e-2)" "unprognostic (8.51e-2)" "unprognostic (2.96e-6)" "unprognostic (3.30e-2)" "unprognostic (6.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-3)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (8.83e-3)" "unprognostic (4.37e-2)" "unprognostic (7.81e-2)" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-4)" "unprognostic (9.82e-2)" 16.2 4.4 0.7 3.2 0.7 0.0 17.9 0.7 0.7 1.3 2.3 0.6 1.4 0.9 11.5 17.8 6.0 20.9 1.0 1.0 0.7 0.7 15.4 0.8 0.9 3.2 1.1 0.0 31.6 0.7 0.0 0.7 5.8 29.7 2.4 0.0 0.3 0.7 1.3 8.1 4.2 9.2 4.4 10.5 1.2 2.6 8.3 0.9 0.0 1.0 0.0 1.8 2.1 3.4 1.1 0.5 0.0 0.0 0.0 1.1 0.0 3.0 3.1 0.0 14.1 5.9 3.0 0.0 1.4 1.5 1.4 1.0 0.1 2.6 12.2 0.1 10.7 0.0 2.7 0.2 0.3 0.9 18.1 19.9 0.1 1.4 0.0 0.7 1.4 0.4 7.8 1.4 8.5 1.4 0.0 0.2 4.0 0.6 0.0 5.4 0.1 1.7 0.3 0.1 0.5 0.0 3.9 4.5 0.0 6.1 0.0 0.0 16.9 2.2 0.7 7.9 0.7 10.6 0.7 0.0 7.4 4.2 0.6 7.5 3.2 3.5 6.3 0.4 1.3 7.7 0.0 0.0 0.0 0.8 0.0 0.8 1.1 0.0 0.8 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.5 0.6 0.0 0.7 0.7 0.7 0.7 0.7 0.7 1.1 0.0 29.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 1.8 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.4 0.0 6.5 0.0 2.8 0.4 0.0 0.2 0.7 0.0 0.0 HOXC5 "HOX3, HOX3D" ENSG00000172789 "Homeobox C5" Q00444 12 54032853-54035358 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.8;ovary: 13.4" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Region enriched" "Detected in single" 14 "pons and medulla: 8.8" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 59 "T-cells: 5.9" "Cell line enhanced" "Detected in many" "AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3" "Region enriched" "Detected in single" 40 "pons and medulla: 4.8" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" HPA026794 Uncertain Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA026794: AB_10612118" "unprognostic (1.57e-1)" "unprognostic (7.73e-3)" "unprognostic (1.70e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-3)" "unprognostic (2.87e-3)" "unprognostic (6.89e-2)" "unprognostic (9.53e-3)" "unprognostic (1.86e-2)" "unprognostic (2.69e-2)" "unprognostic (2.01e-3)" "unprognostic (1.17e-2)" "unprognostic (7.53e-3)" "unprognostic (2.19e-3)" "unprognostic (1.08e-2)" 1.8 1.6 0.2 1.0 0.2 0.0 1.8 0.2 0.6 0.2 1.6 0.2 0.2 0.3 0.5 5.3 1.7 8.0 1.5 0.2 0.2 0.0 1.5 0.2 0.2 0.3 0.4 0.2 13.4 0.2 0.0 0.2 1.4 8.8 0.2 0.0 0.8 0.2 0.2 4.2 2.1 4.6 2.5 2.6 0.2 3.9 2.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.3 0.9 2.2 0.0 8.5 5.1 6.2 0.0 0.5 0.4 1.0 0.7 3.6 0.5 0.0 0.6 2.5 0.0 1.4 0.2 0.0 0.3 2.7 3.0 0.0 1.0 0.1 0.2 0.0 0.1 5.8 0.6 4.1 0.4 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.0 0.1 0.0 1.5 0.3 0.0 0.0 0.0 1.2 0.0 0.0 9.3 0.6 0.2 4.4 1.2 1.7 0.1 0.0 1.5 0.9 3.2 0.3 0.0 0.0 0.0 0.2 0.2 3.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.0 0.4 0.2 8.8 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 2.1 3.2 0.6 0.6 0.2 0.0 0.0 0.0 HOXC6 "HOX3, HOX3C" ENSG00000197757 "Homeobox C6" P09630 12 53990624-54030823 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 31.2" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 17 "pons and medulla: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8" "Region enriched" "Detected in single" 23 "pons and medulla: 1.5" "Not detected" "Not detected" HPA054981 Supported Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA054981: AB_2682662" "unprognostic (3.54e-2)" "unprognostic (9.20e-2)" "unprognostic (1.68e-6)" "unprognostic (3.92e-2)" "unprognostic (1.10e-3)" "unprognostic (5.01e-4)" "unprognostic (5.52e-3)" "unprognostic (3.32e-3)" "unprognostic (2.81e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (3.70e-3)" "prognostic unfavorable (3.55e-6)" "unprognostic (8.63e-2)" "unprognostic (5.76e-2)" "unprognostic (1.40e-2)" "unprognostic (4.71e-2)" 10.9 11.2 0.4 1.2 0.4 0.0 16.3 0.4 0.4 0.7 1.9 0.6 0.4 0.0 3.9 14.8 3.1 13.5 0.4 2.0 0.4 0.0 11.3 0.4 0.9 3.0 0.4 0.4 31.2 0.4 0.0 0.4 4.0 7.0 0.8 0.0 0.4 0.4 0.4 11.0 7.6 8.8 6.1 8.1 1.0 0.3 3.3 0.4 0.4 0.6 0.8 0.4 0.7 2.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 2.5 1.8 0.0 38.1 13.9 13.3 0.4 1.9 1.9 3.1 2.9 1.6 2.9 1.1 2.5 19.0 0.9 4.3 1.5 0.2 2.8 31.8 11.0 2.0 4.9 0.0 1.5 0.2 4.8 12.6 2.0 6.2 2.2 0.0 0.1 0.1 1.3 0.0 11.0 0.6 0.0 1.2 0.0 0.3 1.6 0.0 1.4 0.0 9.6 0.1 0.0 4.7 2.9 2.8 7.8 3.4 6.7 0.5 0.0 4.0 8.6 4.3 2.7 0.3 0.3 0.0 1.4 0.3 8.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 7.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.3 14.9 0.0 1.1 0.2 0.0 0.0 0.0 2.5 27.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 20.8 0.4 11.8 0.0 0.0 0.2 0.0 0.0 14.2 7.8 1.9 6.5 5.0 39.3 1.1 3.4 0.2 0.0 0.0 0.0 HOXC8 "HOX3, HOX3A" ENSG00000037965 "Homeobox C8" P31273 12 54009106-54012362 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 17.3;Melanocytes: 10.1;Peritubular cells: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;ASC TERT1: 15.8;fHDF/TERT166: 28.1;HSkMC: 19.3;LHCN-M2: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028911, CAB037020" Uncertain Supported Nucleoplasm,Microtubules NA NA Nucleoplasm Microtubules "CAB037020: AB_1840935, HPA028911: AB_10602236" "unprognostic (1.03e-1)" "unprognostic (5.90e-2)" "unprognostic (6.26e-6)" "unprognostic (4.89e-2)" "unprognostic (5.20e-4)" "unprognostic (5.34e-3)" "unprognostic (2.43e-3)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (1.45e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (2.47e-1)" "unprognostic (1.84e-2)" "unprognostic (4.68e-2)" "unprognostic (1.14e-2)" 5.2 5.4 0.4 0.7 0.2 0.0 7.1 0.2 0.3 0.5 0.5 0.2 0.2 0.0 0.3 16.7 0.4 6.3 0.6 0.6 0.2 0.0 7.0 0.2 0.2 2.2 0.2 0.5 25.2 0.2 0.0 0.2 1.9 0.4 0.3 0.0 0.2 0.2 0.2 12.8 2.6 4.8 7.9 2.5 0.2 0.0 2.6 0.2 0.3 0.7 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 8.5 24.2 15.8 0.1 1.6 0.0 2.8 1.8 2.5 1.3 0.0 0.2 28.1 0.4 1.0 2.2 0.7 3.2 2.9 3.0 0.4 1.1 0.0 3.0 0.0 3.3 19.3 2.2 9.0 5.3 0.3 0.2 0.5 0.3 0.0 21.1 0.7 0.0 0.2 0.0 0.1 0.4 0.0 0.0 0.0 3.2 0.0 0.0 1.1 2.9 0.5 7.4 2.1 0.8 0.0 0.0 0.5 4.5 3.9 0.9 0.0 0.0 0.0 0.5 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.0 0.2 0.5 0.4 0.2 0.0 0.0 0.0 0.1 4.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 17.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 10.1 0.0 0.0 0.0 0.0 0.0 7.4 4.4 0.8 6.5 1.7 5.4 2.7 3.8 0.2 0.0 0.0 0.0 HOXC9 "HOX3, HOX3B" ENSG00000180806 "Homeobox C9" P31274 12 53994895-54003337 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.9;skeletal muscle: 28.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 34.9;Fibroblasts: 20.8;Melanocytes: 37.1;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 14.7;HDLM-2: 18.7;HEK 293: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063965, HPA072160" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063965: AB_2685162, HPA072160: AB_2686491" "unprognostic (2.38e-1)" "unprognostic (1.03e-1)" "unprognostic (3.19e-5)" "unprognostic (1.23e-1)" "unprognostic (4.09e-3)" "unprognostic (7.12e-2)" "unprognostic (6.92e-3)" "unprognostic (1.06e-3)" "unprognostic (4.32e-1)" "unprognostic (1.58e-2)" "unprognostic (7.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.85e-2)" "unprognostic (8.33e-2)" "unprognostic (2.01e-1)" "unprognostic (2.74e-2)" "unprognostic (1.53e-1)" 18.9 2.5 0.0 1.2 0.0 0.1 12.8 0.0 0.1 0.5 0.2 0.0 0.4 0.1 1.7 7.8 0.3 6.3 0.1 0.1 0.0 0.0 12.2 0.1 0.1 4.3 0.0 0.0 5.6 1.0 0.1 0.0 2.0 0.0 0.9 0.1 0.0 0.5 0.2 28.3 5.7 4.4 1.2 0.5 0.1 0.1 4.3 0.0 0.1 0.2 0.2 0.3 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 2.2 0.0 14.7 5.9 4.9 1.0 1.5 1.4 1.9 1.3 0.6 2.2 0.0 1.1 5.8 0.3 2.6 0.3 1.5 1.7 18.7 22.8 0.4 3.3 0.5 0.6 0.0 3.4 5.5 2.5 2.8 1.3 0.0 1.8 0.1 4.6 0.0 3.9 1.6 0.0 1.3 0.0 1.1 0.2 0.2 2.8 0.0 4.4 1.4 0.0 4.3 5.3 2.8 5.8 0.4 4.4 0.2 0.0 3.5 6.3 1.0 1.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.3 34.9 0.0 3.4 0.1 0.0 0.0 0.3 10.4 20.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.6 4.4 0.3 37.1 0.0 0.0 0.0 0.3 0.0 7.4 16.7 0.0 6.5 2.5 7.6 8.9 8.3 0.3 0.0 0.0 0.0 HOXD1 "HOX4, HOX4G" ENSG00000128645 "Homeobox D1" Q9GZZ0 2 176188579-176190907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 21.0;Distal tubular cells: 21.6;Enterocytes: 18.8;Mucus-secreting cells: 16.6;Undifferentiated cells: 20.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 6.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.9;Hep G2: 6.0;RPTEC TERT1: 18.8;RT4: 14.4;SCLC-21H: 5.0" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "HPA040062, HPA056900" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040062: AB_2676826, HPA056900: AB_2683270" "unprognostic (8.78e-2)" "unprognostic (9.97e-2)" "unprognostic (7.11e-3)" "unprognostic (1.06e-3)" "unprognostic (2.70e-1)" "unprognostic (3.19e-2)" "unprognostic (7.33e-2)" "unprognostic (4.10e-2)" "unprognostic (2.85e-1)" "unprognostic (2.44e-1)" "unprognostic (9.64e-2)" "unprognostic (4.02e-1)" "unprognostic (1.54e-5)" "unprognostic (4.33e-3)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" 2.4 0.6 1.5 1.1 3.5 0.3 2.0 0.6 3.9 0.5 5.2 18.8 11.8 0.7 0.8 14.1 0.9 8.8 1.4 0.3 4.1 2.2 6.8 0.2 5.7 0.9 9.8 1.3 1.2 0.5 0.2 0.2 0.3 15.5 1.7 3.7 0.3 1.0 20.4 0.3 1.2 4.4 0.9 18.9 1.5 0.7 2.2 6.3 0.0 0.4 0.0 0.5 4.6 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 5.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 18.8 14.4 5.0 0.9 0.0 0.0 0.9 0.8 0.0 0.0 3.3 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.5 0.6 3.2 4.1 2.2 9.8 1.3 15.5 6.3 3.0 21.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 4.5 7.0 0.0 0.0 21.6 0.0 0.0 2.9 18.8 0.0 0.0 0.0 0.1 0.5 2.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 3.3 0.0 16.6 0.0 0.1 11.5 0.4 2.9 0.0 0.0 0.1 2.6 6.4 2.3 0.0 0.0 20.6 1.8 HOXD10 "HOX4, HOX4D" ENSG00000128710 "Homeobox D10" P28358 2 176108790-176119942 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.7;endometrium 1: 38.2" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 14.0;Distal tubular cells: 13.3;Intestinal endocrine cells: 23.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 7.3;HEK 293: 26.0;RPTEC TERT1: 18.7;SCLC-21H: 7.3;SiHa: 10.9;U-251 MG: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA065871 Approved "Nucleoplasm,Cytosol,Cytoplasmic bodies" No NA Nucleoplasm "Cytosol, Cytoplasmic bodies" "HPA065871: AB_2685573" "unprognostic (4.29e-3)" "unprognostic (2.51e-1)" "unprognostic (2.98e-3)" "unprognostic (1.69e-1)" "unprognostic (1.80e-3)" "unprognostic (6.82e-2)" "unprognostic (1.04e-5)" "unprognostic (1.19e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-1)" "unprognostic (5.24e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (2.15e-3)" "unprognostic (4.57e-2)" "unprognostic (4.86e-1)" "unprognostic (1.27e-1)" 0.9 0.0 0.1 1.2 0.1 0.0 21.7 0.1 0.1 10.3 9.5 0.1 1.4 0.0 38.2 2.8 1.2 1.6 0.6 0.6 0.1 0.0 16.3 0.1 0.8 0.2 0.1 0.1 2.7 0.1 0.0 0.1 3.0 0.1 9.5 4.3 0.1 0.5 5.1 0.2 1.0 0.1 14.2 0.1 0.1 0.0 3.9 0.1 0.2 0.3 0.4 1.4 2.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 7.3 0.0 0.0 0.3 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 18.7 0.0 7.3 1.9 10.9 0.0 0.0 1.4 0.0 0.0 1.6 0.0 1.4 0.6 8.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.6 0.8 0.0 0.3 0.0 0.0 0.0 14.0 0.0 0.0 13.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.1 0.0 23.2 0.0 0.0 0.0 1.7 0.0 1.7 0.0 3.9 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 5.2 2.0 HOXD11 "HOX4, HOX4F" ENSG00000128713 "Homeobox D11" P31277 2 176104216-176109754 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 15.8" "Group enriched" "Detected in some" 4 "Basal glandular cells: 21.0;Collecting duct cells: 21.0;Distal tubular cells: 8.3;Glandular cells: 6.3;Intestinal endocrine cells: 19.9;Mucus-secreting cells: 8.7;Undifferentiated cells: 6.0;Urothelial cells: 11.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 20.8;RPTEC TERT1: 2.6;SCLC-21H: 6.3;SiHa: 2.5;U-251 MG: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA055155 Supported Nucleoplasm NA NA Nucleoplasm "HPA055155: AB_2682719" "unprognostic (1.99e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.05e-2)" "unprognostic (1.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.93e-2)" "unprognostic (2.13e-2)" "unprognostic (6.73e-2)" "unprognostic (5.00e-2)" "unprognostic (2.11e-8)" "unprognostic (2.09e-3)" "unprognostic (2.49e-2)" "unprognostic (2.27e-3)" 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 5.4 4.2 0.0 0.0 0.0 15.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.3 5.7 0.9 0.0 0.0 2.9 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 1.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.3 0.0 0.0 0.1 0.0 20.8 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 6.3 0.3 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 21.0 0.3 0.0 0.2 0.0 0.0 0.0 21.0 0.0 0.0 8.3 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.9 6.3 0.0 0.0 0.3 0.0 19.9 0.0 0.0 0.0 0.9 0.0 1.7 0.0 8.7 0.0 0.1 2.9 1.1 0.2 0.0 0.0 0.1 0.0 0.3 0.6 0.0 0.0 6.0 11.2 HOXD12 HOX4H ENSG00000170178 "Homeobox D12" P35452 2 176099730-176101193 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7" "Cell type enriched" "Detected in single" 17 "Cardiomyocytes: 1.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 41 "basal ganglia: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 4.0;REH: 6.9;SCLC-21H: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA059444 Uncertain NA NA "HPA059444: AB_2684020" "unprognostic (1.00e-1)" "unprognostic (2.40e-3)" "unprognostic (1.32e-2)" "unprognostic (3.53e-2)" "unprognostic (1.71e-2)" "unprognostic (1.36e-2)" "unprognostic (7.11e-2)" "unprognostic (4.54e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" 0.1 0.0 0.1 0.1 4.3 0.0 0.1 0.1 0.1 1.4 3.5 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.8 3.4 0.1 0.1 4.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.1 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.1 0.1 0.9 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.9 0.1 1.0 0.5 0.0 0.1 6.9 0.0 0.0 0.0 0.1 1.9 0.1 0.6 0.0 0.9 0.0 0.9 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HOXD13 "HOX4I, SPD" ENSG00000128714 "Homeobox D13" P35453 2 176092891-176095938 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0" "Cell type enhanced" "Detected in some" 20 "Basal glandular cells: 10.8;Intestinal endocrine cells: 28.0;Mucus-secreting cells: 11.6;Undifferentiated cells: 8.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 9.8;HEK 293: 28.1;HL-60: 31.2;JURKAT: 8.8;NB-4: 18.6;SCLC-21H: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA064064 Approved Nucleoplasm NA NA Nucleoplasm "HPA064064: AB_2685186" "unprognostic (2.04e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.95e-5)" "unprognostic (2.52e-3)" "unprognostic (7.25e-2)" "unprognostic (2.08e-2)" "unprognostic (4.62e-2)" "unprognostic (1.77e-1)" "unprognostic (4.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.82e-4)" "unprognostic (4.95e-2)" "unprognostic (3.70e-2)" "unprognostic (9.98e-3)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 14.0 13.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 13.8 8.8 0.1 0.1 19.0 0.6 0.0 0.1 3.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 3.8 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 9.8 0.0 1.5 0.0 28.1 4.2 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 2.0 0.0 0.0 0.0 0.0 18.6 1.0 0.0 1.5 0.0 0.1 0.0 0.0 0.2 8.2 2.0 1.9 0.0 4.5 0.1 0.0 0.0 0.0 1.0 0.0 0.4 2.6 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 10.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 8.3 5.5 HOXD3 "HOX1D, HOX4, HOX4A" ENSG00000128652 "Homeobox D3" P31249 2 176136612-176173102 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6" "Group enriched" "Detected in some" 5 "Collecting duct cells: 8.7;Distal tubular cells: 13.3;Early spermatids: 12.5;Leydig cells: 3.7;Peritubular cells: 4.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;HSkMC: 9.5;RPTEC TERT1: 9.9;SCLC-21H: 14.2;SH-SY5Y: 9.5;SK-MEL-30: 3.9" "Region enriched" "Detected in single" 36 "pons and medulla: 3.8" "Region enriched" "Detected in single" 32 "pons and medulla: 6.7" "HPA051831, HPA063671" Supported "Nucleoplasm,Nuclear bodies" No NA Nucleoplasm "Nuclear bodies" "HPA051831: , HPA063671: AB_2685083" "unprognostic (1.13e-1)" "unprognostic (3.28e-1)" "unprognostic (1.52e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (1.54e-2)" "unprognostic (9.56e-2)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (2.57e-4)" "unprognostic (1.47e-3)" "unprognostic (1.55e-1)" "unprognostic (3.44e-1)" "unprognostic (7.44e-2)" 6.2 1.1 0.4 3.2 0.4 0.2 19.6 0.2 0.2 8.7 3.6 0.0 22.5 0.3 25.9 36.4 1.1 4.8 2.0 0.4 0.8 0.5 8.5 0.2 0.3 0.8 1.5 0.0 7.0 0.3 0.2 0.2 0.2 0.5 2.1 0.4 0.0 0.6 22.6 0.7 0.7 0.4 4.0 7.2 1.9 0.3 3.6 0.0 0.0 0.4 0.2 0.3 1.7 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 9.9 0.5 14.2 9.5 0.1 0.1 3.9 0.2 0.0 0.0 0.6 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.2 0.8 0.5 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 13.3 0.0 12.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 1.6 0.0 0.0 0.3 0.7 0.5 1.1 0.0 0.0 0.5 0.0 HOXD4 "HOX4, HOX4B" ENSG00000170166 "Homeobox D4" P09016 2 176151222-176153226 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.0;seminal vesicle: 26.2" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.3" "Region enriched" "Detected in some" 7 "pons and medulla: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1" "Region enriched" "Detected in single" 28 "pons and medulla: 8.2" "HPA054383, HPA070349" Approved Supported "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA054383: AB_2682470, HPA070349: AB_2686258" "unprognostic (9.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (1.10e-3)" "unprognostic (9.21e-2)" "unprognostic (5.17e-3)" "unprognostic (5.19e-2)" "unprognostic (6.69e-3)" "unprognostic (1.66e-1)" "unprognostic (3.47e-1)" "unprognostic (1.49e-1)" "unprognostic (2.50e-1)" "unprognostic (7.78e-2)" "unprognostic (1.12e-2)" "unprognostic (9.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.61e-1)" 3.4 4.9 0.5 0.5 0.5 0.0 4.0 0.5 0.7 2.8 3.4 0.5 13.8 0.2 15.6 21.0 0.5 7.9 0.5 0.5 0.5 0.0 10.2 0.5 0.5 0.6 1.1 0.5 9.7 0.5 0.0 0.5 0.5 7.6 1.5 0.8 0.5 0.5 26.2 1.3 1.0 3.5 5.3 3.7 4.4 0.4 1.5 0.5 0.5 0.8 0.5 0.5 2.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.1 1.8 0.0 0.1 0.4 0.0 0.6 0.5 0.0 0.0 9.3 1.6 0.4 0.1 1.5 0.0 0.2 0.0 22.1 0.2 0.0 0.0 0.3 0.0 0.0 5.0 1.5 0.0 0.2 0.1 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 16.4 2.6 1.3 2.2 0.3 0.0 6.1 0.4 0.0 0.0 2.8 0.2 0.1 1.4 1.2 0.0 0.0 0.0 1.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.7 0.5 0.0 1.1 0.5 7.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 3.7 2.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 4.4 0.0 1.7 0.0 0.6 0.0 0.1 0.0 2.8 5.3 0.0 6.5 0.5 0.2 0.2 0.5 0.0 0.0 1.2 0.0 HOXD8 "HOX4, HOX4E" ENSG00000175879 "Homeobox D8" P13378 2 176129694-176132695 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 37.6;epididymis: 42.6" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 57.6;Distal tubular cells: 180.8;Early spermatids: 75.5;Peritubular cells: 50.5;Spermatocytes: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 21.6;RPTEC TERT1: 35.3;TIME: 15.4" "Region enriched" "Detected in single" 15 "pons and medulla: 0.6" "Not detected" "Not detected" NA NA "unprognostic (1.22e-1)" "unprognostic (6.31e-2)" "unprognostic (2.19e-3)" "unprognostic (2.68e-2)" "unprognostic (3.35e-1)" "unprognostic (3.49e-1)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.78e-4)" "unprognostic (2.79e-1)" "unprognostic (1.40e-2)" "unprognostic (3.93e-1)" "unprognostic (3.05e-1)" "unprognostic (3.63e-2)" "unprognostic (4.80e-2)" "unprognostic (5.21e-2)" "unprognostic (8.31e-2)" "unprognostic (2.80e-2)" 11.1 9.1 0.3 2.4 0.3 0.0 9.8 0.2 0.4 10.3 5.9 0.4 37.6 0.3 12.6 42.6 2.0 7.7 2.5 2.6 0.3 0.0 32.8 0.2 0.7 1.9 0.2 0.2 16.9 1.7 0.2 0.2 1.4 1.2 5.6 1.8 0.3 0.8 27.5 6.9 2.4 4.2 5.3 11.5 9.1 0.8 21.0 0.2 0.3 2.9 2.3 0.9 5.3 10.8 0.2 0.0 0.0 0.0 0.0 0.2 0.0 6.4 1.0 0.0 0.0 4.3 6.8 0.1 0.8 3.4 1.0 0.1 0.0 0.0 0.0 8.3 4.9 0.8 0.0 2.2 0.2 2.6 0.0 3.2 1.0 0.3 0.0 1.4 0.6 0.4 11.9 21.6 0.1 3.3 0.0 10.7 2.0 0.1 0.0 1.7 0.0 0.0 0.1 0.1 0.0 1.2 0.0 2.3 0.0 35.3 4.4 6.9 13.0 2.0 0.0 12.8 0.6 0.0 0.0 15.4 0.6 4.4 7.3 4.3 0.0 0.0 0.0 10.3 0.0 12.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.4 0.3 0.0 0.2 0.2 1.2 0.2 0.0 0.6 0.0 2.2 2.4 0.0 2.0 0.0 1.4 0.0 57.6 0.0 0.0 180.8 0.0 75.5 29.8 0.9 0.0 0.0 0.0 9.7 1.5 0.0 0.0 0.1 0.0 4.6 0.6 0.0 19.6 47.5 0.0 10.1 0.0 1.3 0.0 0.0 0.0 50.5 16.1 0.0 32.3 3.3 62.8 9.6 2.5 0.1 0.0 4.1 0.5 HOXD9 "HOX4, HOX4C" ENSG00000128709 "Homeobox D9" P28356 2 176122720-176124937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 26.2" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 22.7;Distal tubular cells: 31.5;Leydig cells: 31.7;Peritubular cells: 25.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.7;HEK 293: 12.2;RPTEC TERT1: 14.4;SH-SY5Y: 16.8;SK-MEL-30: 9.2;TIME: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA068683 Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA068683: AB_2686018" "unprognostic (1.89e-1)" "unprognostic (9.41e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.03e-2)" "prognostic favorable (9.58e-4)" "prognostic unfavorable (1.08e-5)" "unprognostic (6.62e-2)" "unprognostic (4.58e-2)" "unprognostic (1.54e-2)" "unprognostic (2.56e-3)" "unprognostic (6.71e-2)" "unprognostic (4.77e-3)" "unprognostic (8.38e-2)" "unprognostic (5.94e-2)" "unprognostic (1.89e-1)" "unprognostic (9.44e-2)" 4.1 2.7 0.2 1.7 0.4 0.0 11.4 0.2 0.2 13.1 10.8 0.2 10.4 0.0 26.2 12.0 1.6 5.1 2.6 0.5 0.2 0.0 19.7 0.2 0.7 2.4 0.2 0.2 8.9 0.2 0.0 0.2 1.6 0.4 13.0 2.2 0.2 0.4 16.0 3.8 3.9 1.1 12.6 0.6 3.7 0.1 9.8 0.2 0.3 2.2 2.2 1.3 2.4 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 1.2 0.8 1.0 0.8 0.0 0.0 0.0 8.7 1.1 0.6 5.7 0.0 0.0 0.7 0.0 12.2 0.0 0.7 0.0 0.1 0.0 0.0 2.8 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 14.4 5.3 3.3 16.8 4.1 0.0 9.2 0.8 0.0 0.0 12.7 0.0 2.8 4.1 4.4 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 1.5 2.2 0.0 0.6 0.0 0.0 0.0 22.7 0.0 0.0 31.5 0.0 0.2 11.7 0.0 0.0 0.0 0.2 1.0 0.9 0.0 0.0 0.2 0.0 7.5 0.0 0.0 0.5 31.7 0.0 1.7 0.0 2.1 0.0 0.0 0.0 25.1 2.2 0.0 38.8 0.8 0.7 1.2 1.6 0.0 0.0 4.1 0.5 HP ENSG00000257017 Haptoglobin P00738 16 72054592-72061055 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Immunity" "Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "liver: 1156.9" "Cell type enriched" "Detected in many" 51 "Hepatocytes: 52541.7" "Cancer enriched" "Detected in many" 81 "liver cancer: 1297.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 20.0;eosinophil: 30.9" "Group enriched" "Detected in many" 7 "granulocytes: 30.9;monocytes: 20.0" "Group enriched" "Detected in some" 5 "Hep G2: 66.2;HSkMC: 37.9" "CAB003787, HPA047750" Enhanced Approved Vesicles "Secreted to blood" NA NA 998000000000 140000000000 Vesicles "CAB003787: , HPA047750: AB_2680146" "unprognostic (6.38e-3)" "unprognostic (7.73e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (2.34e-3)" "unprognostic (2.07e-1)" "unprognostic (7.79e-3)" "unprognostic (1.37e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "prognostic unfavorable (6.94e-13)" "unprognostic (4.34e-4)" "unprognostic (1.80e-1)" "unprognostic (6.61e-2)" "unprognostic (2.49e-2)" 9.8 0.0 0.3 0.4 0.3 4.4 0.3 0.3 0.3 1.5 0.4 0.3 0.3 0.0 0.3 0.5 0.3 1.1 0.3 3.0 0.3 0.0 0.4 1156.9 1.4 0.4 0.3 0.3 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 1.4 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.0 3.5 30.9 20.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.4 0.0 66.2 0.1 9.5 1.8 37.9 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.6 0.1 0.8 0.0 0.0 0.3 7.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 2.1 1.4 0.0 0.2 0.0 0.0 1.2 0.0 4.5 0.0 3.7 0.0 2.6 20.0 30.9 0.0 0.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 5.8 0.0 0.9 0.0 0.0 5.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 17.9 220.1 295.8 0.8 0.1 0.2 72.5 853.5 10.7 10.3 0.0 0.0 0.0 0.0 0.0 0.1 6.8 0.0 864.3 9.6 0.0 0.2 0.2 3.5 52541.7 2.4 0.0 0.0 971.0 1021.7 0.0 9.5 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.1 0.0 0.9 0.0 0.0 0.3 0.1 23.0 0.0 0.0 HPCA ENSG00000121905 Hippocalcin P84074 1 32885994-32898441 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 46 "brain: 118.9" "Group enriched" "Detected in many" 7 "Bipolar cells: 146.4;Early spermatids: 133.0;Late spermatids: 89.6" "Cancer enriched" "Detected in many" 9 "glioma: 8.0" "Group enriched" "Detected in many" 5 "basal ganglia: 118.9;cerebral cortex: 40.4;hippocampal formation: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 10.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 1321.6;hippocampal formation: 1344.5" "CAB012340, HPA043245" Enhanced NA NA "CAB012340: AB_2120209, HPA043245: AB_2678385" "unprognostic (4.60e-2)" "unprognostic (5.96e-3)" "unprognostic (2.16e-3)" "unprognostic (1.19e-3)" "unprognostic (6.72e-3)" "unprognostic (5.18e-2)" "unprognostic (9.08e-3)" "unprognostic (6.71e-3)" "unprognostic (1.18e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-3)" "unprognostic (1.98e-2)" "unprognostic (2.36e-2)" "unprognostic (1.12e-2)" "unprognostic (6.42e-2)" "unprognostic (3.09e-2)" "unprognostic (2.85e-3)" 1.2 1.5 13.5 1.2 118.9 1.1 1.2 4.8 82.2 1.4 1.5 2.2 0.0 1.2 1.4 1.2 1.1 1.4 1.3 1.2 42.5 2.8 1.3 1.1 1.1 1.2 3.7 14.5 1.5 1.2 1.1 0.0 1.2 0.0 1.3 1.5 0.6 1.3 1.3 1.1 1.2 1.4 1.3 0.8 1.2 1.2 2.5 12.2 0.0 1.3 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.4 0.3 0.4 0.0 0.1 0.1 0.2 0.3 0.9 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.6 0.1 0.0 0.1 0.7 0.0 0.0 10.2 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.3 0.2 0.0 1.0 0.8 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 13.5 118.9 4.8 40.4 42.5 2.8 3.7 14.5 0.0 12.2 0.0 0.0 0.0 1.0 0.0 146.4 0.4 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.3 133.0 0.1 1.0 0.0 0.4 0.3 0.2 1.3 0.0 0.0 0.1 12.7 17.2 0.0 0.0 89.6 1.1 0.0 0.0 0.0 2.5 5.0 0.5 2.9 0.4 0.6 18.2 0.0 0.1 3.1 7.8 0.3 0.1 0.0 2.1 0.9 HPCAL1 "BDR1, HLP2, VILIP-3" ENSG00000115756 "Hippocalcin like 1" P37235 2 10302889-10427617 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 103.3" "Cell type enhanced" "Detected in all" 5 "Horizontal cells: 216.1;Mucus-secreting cells: 210.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 60.0;HDLM-2: 60.0;PC-3: 66.1;U-87 MG: 65.1" "Low region specificity" "Detected in all" HPA043245 Supported NA NA 35000 "HPA043245: AB_2678385" "unprognostic (3.22e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (4.11e-5)" "unprognostic (2.73e-1)" "unprognostic (6.76e-3)" "unprognostic (5.26e-2)" "unprognostic (7.36e-3)" "unprognostic (4.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (4.06e-1)" "unprognostic (3.64e-2)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" 11.8 20.7 30.5 13.8 17.7 7.5 19.7 103.3 42.2 9.8 16.8 8.6 5.4 20.5 22.6 10.3 4.8 12.1 9.7 10.9 18.0 41.0 16.3 13.4 31.9 14.4 17.9 31.1 6.1 26.5 2.9 15.3 14.8 17.6 5.7 12.8 14.0 10.6 5.9 6.2 6.1 35.3 17.1 14.5 14.6 28.1 13.2 6.0 10.0 10.2 3.8 10.0 6.7 8.3 13.6 21.0 33.8 23.9 11.0 24.3 12.4 9.5 16.6 1.2 4.8 2.7 7.0 11.6 7.7 21.1 11.2 12.4 5.8 24.3 3.7 9.2 5.7 60.0 3.5 3.1 10.7 5.1 60.0 5.3 8.2 18.6 12.6 12.1 5.0 16.7 3.8 4.9 26.7 8.4 40.2 14.8 5.7 7.6 24.7 20.0 12.9 4.2 30.9 6.3 8.0 66.1 5.5 4.7 16.1 16.1 2.7 4.4 29.5 8.1 9.8 18.8 4.3 3.1 13.4 17.6 14.1 4.3 14.9 13.0 7.5 8.0 1.9 65.1 12.5 33.0 10.8 23.9 28.5 11.1 19.0 12.5 13.6 19.9 14.3 21.0 11.3 24.3 15.5 33.8 11.0 16.6 7.6 15.9 12.4 30.5 17.7 103.3 42.2 18.0 41.0 17.9 31.1 17.6 6.0 77.4 104.4 47.7 10.9 30.0 75.1 12.3 25.5 10.7 27.3 17.4 15.7 2.8 79.6 45.4 20.6 55.4 40.0 23.3 32.6 117.6 17.4 13.4 54.3 30.1 62.6 216.1 60.2 81.0 69.9 14.1 15.8 61.3 54.0 31.5 210.7 33.8 39.1 66.6 10.3 75.3 30.4 6.5 15.3 12.0 16.8 26.3 34.6 49.8 36.8 12.8 HPCAL4 "DKFZp761G122, HLP4" ENSG00000116983 "Hippocalcin like 4" Q9UM19 1 39678648-39691689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 80.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 36.4;Distal tubular cells: 10.0" "Group enriched" "Detected in some" 11 "glioma: 5.4;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0" "Lineage enriched" "Detected in single" 33 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "Karpas-707: 4.0;SH-SY5Y: 13.4;SK-MEL-30: 4.2;U-2 OS: 2.8;U-266/70: 3.5;U-266/84: 4.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (2.62e-1)" "unprognostic (2.37e-1)" "unprognostic (2.13e-2)" "unprognostic (8.56e-4)" "unprognostic (4.73e-3)" "unprognostic (1.99e-1)" "unprognostic (7.57e-2)" "unprognostic (4.89e-3)" "unprognostic (1.27e-1)" "unprognostic (3.18e-2)" "unprognostic (4.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.62e-3)" "unprognostic (3.78e-3)" "unprognostic (2.77e-2)" "unprognostic (3.97e-2)" "unprognostic (2.63e-1)" 1.2 10.2 35.8 1.8 46.0 1.5 1.2 31.1 80.4 1.2 1.2 3.7 0.0 1.3 1.2 1.5 5.5 1.2 1.3 1.4 28.3 17.0 3.5 1.2 1.7 1.9 7.5 32.7 3.7 4.7 1.2 0.4 1.2 6.8 1.4 1.3 0.0 1.2 1.3 2.1 1.2 1.3 1.2 4.4 1.4 1.3 4.1 3.0 0.0 1.2 0.0 1.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 5.6 1.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 2.1 0.3 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 0.0 1.2 13.4 0.4 0.0 4.2 0.3 0.0 0.1 0.0 0.0 2.8 0.0 0.0 3.5 4.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 5.6 1.0 0.1 0.0 5.0 1.8 0.0 0.0 0.0 0.0 3.8 1.8 35.8 46.0 31.1 40.4 28.3 17.0 7.5 32.7 6.8 3.0 0.0 0.0 0.0 0.1 0.0 36.4 0.8 0.0 0.0 1.2 1.8 0.0 0.0 10.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 5.0 0.1 0.0 1.4 0.0 1.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 HPD "4-HPPD, 4HPPD, GLOD3, PPD" ENSG00000158104 "4-hydroxyphenylpyruvate dioxygenase" P32754 12 121839527-121863596 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 267.5" "Group enriched" "Detected in some" 9 "Hepatocytes: 1077.2;Proximal tubular cells: 1892.6" "Cancer enriched" "Detected in many" 100 "liver cancer: 540.9" "Region enriched" "Detected in single" 29 "pons and medulla: 13.7" "Group enriched" "Detected in many" 4 "eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;granulocytes: 9.8" "Cell line enriched" "Detected in some" 30 "Hep G2: 107.2" "Region enriched" "Detected in single" 8 "amygdala: 0.4" "Not detected" "Not detected" "HPA038321, HPA038322" Enhanced Uncertain "Nuclear speckles" NA NA 23000000 "Nuclear speckles" "HPA038321: AB_2675957, HPA038322: AB_10670778" "unprognostic (3.01e-2)" "unprognostic (2.30e-1)" "unprognostic (4.81e-3)" "unprognostic (1.42e-3)" "unprognostic (1.10e-2)" "unprognostic (9.08e-2)" "unprognostic (1.13e-2)" "unprognostic (8.84e-2)" "unprognostic (5.58e-2)" "unprognostic (6.14e-3)" "unprognostic (9.72e-3)" "unprognostic (8.61e-3)" "unprognostic (7.16e-2)" "unprognostic (1.97e-1)" "unprognostic (4.12e-1)" "unprognostic (3.06e-2)" "unprognostic (2.34e-1)" 0.1 0.5 0.0 0.1 0.1 0.0 0.4 0.1 0.3 0.2 0.1 2.1 0.3 0.0 0.3 0.4 0.1 0.7 0.2 0.3 0.4 0.0 51.3 267.5 0.2 0.4 0.1 0.0 0.7 0.7 0.0 0.1 0.0 13.7 0.5 0.0 3.8 0.0 0.8 0.2 0.0 0.1 0.4 0.2 0.2 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.6 0.2 0.1 5.0 9.8 1.4 0.0 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 107.2 2.5 0.3 3.5 0.8 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.8 9.8 0.0 1.0 0.1 0.1 0.1 0.1 1.3 0.1 0.3 0.2 4.8 0.0 1.4 5.0 0.0 0.3 0.0 0.1 0.1 0.3 0.4 0.0 0.1 0.0 13.7 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.3 48.4 0.0 0.0 87.2 0.0 0.6 164.2 0.3 33.1 0.0 0.0 0.0 14.8 0.2 0.0 0.0 0.0 1077.2 0.3 0.0 0.0 33.2 23.4 97.3 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.9 1892.6 0.0 0.0 0.0 1.7 1.1 0.0 0.9 0.0 0.0 0.0 HPDL "4-HPPD-L, GLOXD1, MGC15668" ENSG00000186603 "4-hydroxyphenylpyruvate dioxygenase like" Q96IR7 1 45326905-45328533 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 38.4" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 24.6;Undifferentiated cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 47.2;HL-60: 13.3;NB-4: 16.6;SK-BR-3: 29.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 35 "hippocampal formation: 0.7;hypothalamus: 0.9;midbrain: 2.0;pons and medulla: 0.9;thalamus: 0.8" "HPA031997, HPA057346" Supported Nucleoplasm,Mitochondria No NA Mitochondria Nucleoplasm "HPA031997: AB_10602909, HPA057346: AB_2683415" "prognostic favorable (1.81e-4)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (1.02e-2)" "unprognostic (6.71e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.03e-4)" "unprognostic (1.08e-3)" "unprognostic (2.52e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" "unprognostic (1.00e-1)" "unprognostic (3.03e-2)" "unprognostic (1.43e-1)" 0.9 0.7 2.7 3.1 4.2 3.6 1.0 7.6 3.4 2.0 8.4 2.4 0.0 5.4 1.0 1.3 3.6 1.0 1.8 3.0 2.7 2.4 0.7 0.2 0.8 2.6 2.5 1.8 1.0 0.3 0.2 0.4 5.1 3.1 1.7 7.1 38.4 1.3 0.6 3.3 1.1 4.7 0.9 2.2 2.8 7.8 1.4 0.6 6.4 1.0 4.2 2.3 0.8 1.6 3.1 0.7 0.0 0.3 2.1 1.5 0.8 0.0 0.4 0.1 0.0 0.0 0.1 47.2 0.6 0.0 0.8 0.2 11.7 3.1 2.4 0.1 0.6 0.0 2.8 0.0 0.1 0.2 0.0 0.1 0.2 5.1 0.0 0.3 13.3 0.3 0.5 0.1 0.5 0.0 0.0 0.9 0.0 0.0 2.2 0.1 5.8 8.6 16.6 0.2 9.1 0.0 2.6 0.0 7.7 0.1 0.1 9.3 0.6 6.0 29.8 4.6 0.6 0.0 2.5 0.4 0.0 0.1 0.4 0.0 0.3 0.1 8.3 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.1 1.5 3.1 0.7 1.2 0.7 0.3 0.9 0.8 0.0 2.1 0.0 0.0 0.4 0.8 2.7 4.2 7.6 3.4 2.7 2.4 2.5 1.8 3.1 0.6 0.0 0.0 1.9 1.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 24.6 3.3 0.5 0.1 0.3 0.7 0.0 0.0 1.7 0.4 0.9 0.0 0.0 2.1 0.0 1.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 3.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 0.4 0.0 2.1 1.0 4.2 0.0 6.6 1.0 HPGD SDR36C1 ENSG00000164120 "15-hydroxyprostaglandin dehydrogenase" P15428 4 174490177-174523154 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 193.3" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 52.4" "Region enriched" "Detected in single" 4 "pons and medulla: 3.8" "Group enriched" "Detected in many" 5 "basophil: 37.7;T-reg: 15.1" "Group enriched" "Detected in many" 71 "granulocytes: 37.7;T-cells: 15.1" "Cell line enhanced" "Detected in some" "A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004919, HPA005679" Enhanced Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA004919: AB_1079081, HPA005679: AB_1079080" "unprognostic (1.23e-3)" "unprognostic (1.61e-1)" "unprognostic (5.96e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (2.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.28e-2)" "unprognostic (3.54e-3)" "unprognostic (2.34e-2)" "prognostic favorable (3.20e-4)" "unprognostic (2.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.37e-4)" "unprognostic (2.33e-2)" 5.1 2.6 0.5 7.9 0.6 0.0 24.6 0.4 0.6 23.0 73.3 0.5 2.5 22.9 13.4 7.5 32.0 4.5 10.7 1.2 0.6 0.7 8.5 63.7 22.9 7.9 0.8 0.5 2.3 0.4 0.0 0.9 193.3 3.8 20.1 8.4 4.6 3.0 1.1 1.6 15.3 64.5 9.3 0.5 2.9 36.3 1.9 0.5 5.5 0.4 5.0 7.9 61.2 31.8 0.1 0.2 37.7 0.1 0.3 15.1 1.0 0.0 27.7 0.0 0.0 17.2 1.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.0 0.5 60.6 2.1 0.0 0.0 0.3 0.1 0.9 0.4 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 15.8 1.4 2.8 0.0 0.2 5.7 94.3 0.1 0.1 0.0 0.2 0.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 37.7 0.1 5.4 3.7 0.0 5.7 0.1 1.9 1.6 0.2 0.0 0.6 1.5 0.4 0.3 0.0 0.0 15.1 1.0 0.5 0.6 0.4 0.6 0.6 0.7 0.8 0.5 3.8 0.5 14.9 46.1 5.2 57.7 15.3 3.1 0.4 43.3 5.3 20.5 21.0 0.0 25.6 18.3 2.4 1.1 0.5 273.6 0.0 86.5 488.8 12.1 51.1 816.1 165.7 20.7 0.0 8.1 18.4 16.1 0.2 18.4 10.6 72.6 1.0 48.2 0.0 26.0 217.5 0.0 68.8 0.6 0.0 6.6 0.4 0.4 19.6 47.4 50.3 31.0 266.0 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in many" 10 "granulocytes: 1000.1;Hofbauer cells: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Group enriched" "Detected in some" 8 "HEL: 32.4;HMC-1: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 2.5 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 11.9 75.3 0.0 0.8 3.7 0.0 0.0 0.0 2.7 6.8 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 4.0 1000.1 0.0 476.4 0.0 6.8 0.0 3.9 0.0 0.3 14.5 3.3 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 4.6 4.6 0.0 0.0 0.1 HPN TMPRSS1 ENSG00000105707 Hepsin P05981 19 35040506-35066571 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "kidney: 55.4;liver: 146.5;pancreas: 80.1" "Group enriched" "Detected in many" 7 "Hepatocytes: 406.8;Proximal tubular cells: 178.8" "Cancer enhanced" "Detected in many" "liver cancer: 127.5" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Group enriched" "Detected in some" 9 "EFO-21: 19.8;Hep G2: 28.1;T-47d: 13.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA006804 Approved NA NA 1000000 "HPA006804: AB_1079046" "unprognostic (6.74e-3)" "unprognostic (6.00e-2)" "unprognostic (4.10e-2)" "unprognostic (1.16e-1)" "unprognostic (2.72e-1)" "unprognostic (9.96e-2)" "unprognostic (4.22e-3)" "unprognostic (1.27e-1)" "unprognostic (4.13e-3)" "unprognostic (9.54e-2)" "unprognostic (3.54e-1)" "unprognostic (1.16e-1)" "prognostic favorable (5.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (7.96e-2)" 0.2 0.0 0.3 0.1 0.5 0.0 3.2 0.4 1.1 0.3 0.3 0.2 8.4 0.2 1.1 10.7 0.1 1.9 3.2 0.7 0.6 0.3 55.4 146.5 4.9 0.1 0.9 0.2 0.4 80.1 2.6 3.2 0.2 0.4 5.3 0.0 0.4 4.1 8.5 8.5 0.0 0.2 0.1 0.9 0.3 6.9 0.8 0.3 0.1 4.3 0.4 0.2 0.3 0.1 0.2 0.2 0.0 0.1 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.1 0.0 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.0 0.1 0.1 0.0 0.1 0.3 13.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.0 0.6 0.2 0.5 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.5 0.4 1.1 0.6 0.3 0.9 0.2 0.4 0.3 8.9 26.7 17.7 4.9 0.1 4.5 2.4 35.7 0.0 2.3 31.4 0.0 0.0 44.7 3.3 7.0 0.3 0.0 0.0 23.6 0.3 0.2 7.9 2.3 406.8 0.8 0.0 2.4 8.0 10.0 20.0 0.0 0.5 0.0 1.0 1.7 1.3 23.4 0.0 0.4 178.8 0.5 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.5 HPR ENSG00000261701 "Haptoglobin-related protein" P00739 16 72063224-72077246 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 151.4" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 430.8" "Cancer enriched" "Detected in some" 53 "liver cancer: 185.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "Hep G2: 33.6" HPA047750 Supported Approved Vesicles "Secreted to blood" NA NA 49000000000 77000000000 Vesicles "HPA047750: AB_2680146" "unprognostic (2.43e-1)" "unprognostic (4.69e-2)" "unprognostic (5.97e-3)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.66e-1)" "unprognostic (8.21e-2)" "unprognostic (2.30e-1)" "unprognostic (3.44e-6)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" 0.2 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 15.2 0.7 0.8 0.1 151.4 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 2.9 1.1 1.0 0.4 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.6 1.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 1.3 1.0 0.1 0.5 0.4 0.4 0.3 1.1 2.0 1.1 0.3 0.4 0.3 2.9 2.3 0.3 0.0 9.8 0.0 0.0 0.1 0.0 14.9 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 23.3 0.2 0.0 0.2 0.0 0.0 430.8 0.0 0.0 0.0 9.8 7.3 2.1 9.2 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.9 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HPSE2 "HPA2, HPR2, UFS" ENSG00000172987 "Heparanase 2 (inactive)" Q8WWQ2 10 98457077-99235862 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 31.0;smooth muscle: 22.2" "Group enriched" "Detected in some" 6 "Early spermatids: 23.2;Late spermatids: 41.7" "Cancer enhanced" "Detected in some" "prostate cancer: 4.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.3;T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Group enriched" "Detected in some" 19 "BJ hTERT+: 12.3;HEL: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA044603 Uncertain "Secreted to extracellular matrix" NA NA "HPA044603: AB_10794051" "unprognostic (2.44e-1)" "unprognostic (4.28e-3)" "unprognostic (4.83e-3)" "unprognostic (6.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.59e-1)" "unprognostic (3.05e-2)" "unprognostic (1.82e-2)" "unprognostic (4.03e-2)" "unprognostic (7.94e-2)" "unprognostic (1.38e-1)" "unprognostic (2.02e-1)" "unprognostic (1.86e-4)" "unprognostic (5.79e-2)" "unprognostic (2.51e-1)" "unprognostic (9.39e-3)" "unprognostic (6.13e-3)" 1.6 0.1 2.0 4.1 9.7 0.1 5.5 2.7 4.2 31.0 3.1 5.4 0.9 3.4 8.0 0.2 17.2 2.3 2.1 0.1 1.7 8.3 1.4 0.1 2.4 0.1 12.2 1.4 0.2 0.1 0.1 0.2 1.7 12.4 12.1 3.2 0.4 1.0 4.9 0.2 1.4 5.1 22.2 11.9 0.1 2.5 2.2 7.6 0.0 0.2 0.2 0.4 12.4 12.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 12.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 23.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.6 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 2.0 9.7 2.7 3.1 1.7 8.3 12.2 1.4 12.4 7.6 0.0 0.0 0.0 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 5.1 1.8 0.1 0.0 0.0 0.0 0.7 HPX ENSG00000110169 Hemopexin P02790 11 6431049-6442617 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 949 "liver: 528.6" "Cell type enriched" "Detected in some" 46 "Hepatocytes: 5619.6" "Cancer enriched" "Detected in many" 79 "liver cancer: 571.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "Hep G2: 21.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB016725, HPA065318, HPA068847" Approved "Secreted to blood" NA NA 425000000000 230000000000 "CAB016725: , HPA065318: , HPA068847: " "unprognostic (3.39e-2)" "unprognostic (9.26e-2)" "unprognostic (3.88e-1)" "unprognostic (6.19e-4)" "unprognostic (2.05e-2)" "unprognostic (2.41e-1)" "prognostic favorable (2.26e-4)" "unprognostic (6.33e-2)" "unprognostic (5.67e-3)" "unprognostic (3.88e-1)" "unprognostic (5.08e-3)" "unprognostic (2.78e-2)" "unprognostic (5.82e-12)" "unprognostic (2.01e-1)" "unprognostic (4.48e-1)" "unprognostic (1.84e-2)" "unprognostic (2.14e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 528.6 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.3 1.4 0.0 0.8 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.2 0.7 0.1 21.3 0.0 2.9 0.0 0.8 0.6 0.1 0.0 0.5 0.1 0.2 0.4 0.1 0.1 0.4 0.0 0.0 0.3 0.9 0.0 0.1 1.4 0.2 0.0 0.1 0.2 0.0 1.0 3.1 0.2 0.3 1.1 0.0 0.4 0.3 0.2 1.1 0.1 0.3 0.2 0.9 0.2 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.3 49.0 0.1 0.6 0.9 0.4 73.9 0.0 0.0 0.0 2.0 0.0 0.0 0.1 2.5 0.3 0.3 116.8 0.5 0.1 0.2 1.8 0.0 5619.6 0.2 0.0 0.0 121.5 102.4 2.8 0.3 0.3 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.2 0.3 HR "ALUNC, AU" ENSG00000168453 "HR, lysine demethylase and nuclear receptor corepressor" O43593 8 22114415-22133384 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Oxidoreductase" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 50.5;tongue: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 93.6;Cone photoreceptor cells: 31.4;Paneth cells: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.9;HaCaT: 38.1;OE19: 18.4;SiHa: 13.2;T-47d: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054888 Supported Nucleoplasm NA NA Nucleoplasm "HPA054888: AB_2682630" "unprognostic (9.11e-2)" "unprognostic (2.12e-2)" "unprognostic (7.32e-2)" "unprognostic (4.68e-3)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" "unprognostic (1.75e-1)" "unprognostic (2.27e-2)" "unprognostic (8.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" 2.6 1.8 3.8 3.2 6.1 0.8 4.7 19.8 17.0 2.1 7.5 9.6 0.1 5.5 1.5 0.9 12.1 1.9 6.7 1.9 5.3 4.0 0.9 0.8 1.2 1.0 6.1 6.8 0.8 1.3 0.7 1.7 0.9 4.9 2.3 4.0 6.7 3.4 5.4 1.1 50.5 5.3 2.3 3.8 1.1 8.4 5.2 6.6 0.0 2.6 23.8 4.4 3.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 9.8 0.7 0.5 38.1 0.0 0.9 0.0 0.0 0.0 0.0 8.0 0.0 2.2 0.0 0.0 1.9 6.2 0.0 0.6 0.6 0.0 1.0 0.0 0.1 0.0 5.7 0.6 0.1 0.0 18.4 7.6 0.8 0.0 0.2 0.1 2.6 0.4 2.2 13.2 3.0 3.0 0.1 14.1 0.0 0.0 0.2 8.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.1 19.8 17.0 5.3 4.0 6.1 6.8 4.9 6.6 0.0 0.0 0.0 4.2 10.6 93.6 2.4 0.0 0.0 0.0 1.8 31.4 0.0 0.0 0.1 0.1 0.4 16.7 0.0 0.6 0.1 1.3 2.3 0.0 0.0 0.0 9.5 7.5 0.6 0.0 1.1 3.1 0.0 20.3 0.0 10.4 3.9 0.2 28.1 6.7 0.0 6.6 0.0 5.1 0.0 0.3 15.6 0.7 0.0 12.0 3.9 HRASLS "H-REV107, HRASLS1" ENSG00000127252 "HRAS like suppressor" 3 193241125-193277738 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "skeletal muscle: 40.9;testis: 42.1" "Cell type enriched" "Detected in many" 4 "Early spermatids: 449.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "HAP1: 8.7;NTERA-2: 7.6;PC-3: 16.8;RH-30: 7.4;SCLC-21H: 15.3;U-2 OS: 9.3;U-251 MG: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051179 Uncertain Approved "Focal adhesion sites,Cytosol" No No "Focal adhesion sites" Cytosol "HPA051179: AB_2681375" "unprognostic (3.01e-2)" "unprognostic (4.21e-2)" "unprognostic (7.93e-3)" "unprognostic (4.82e-3)" "unprognostic (2.79e-1)" "unprognostic (1.87e-1)" "unprognostic (9.97e-3)" "unprognostic (9.68e-3)" "unprognostic (1.84e-1)" "unprognostic (3.55e-1)" "unprognostic (1.77e-4)" "unprognostic (5.09e-2)" "unprognostic (1.38e-5)" "unprognostic (1.61e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.98e-3)" "unprognostic (1.13e-2)" 0.6 1.1 1.8 0.2 3.1 0.1 1.0 0.6 3.3 0.5 0.6 1.7 0.0 0.1 0.6 3.1 2.4 0.5 0.2 4.3 2.0 1.1 0.6 0.6 0.5 0.1 1.5 2.1 0.6 0.8 0.5 0.7 0.1 2.4 0.5 0.1 3.1 6.1 0.5 40.9 1.7 0.6 0.7 0.6 0.6 0.6 42.1 1.7 0.2 3.7 6.2 0.2 0.5 0.6 0.0 0.2 1.7 0.1 0.0 0.0 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.3 0.0 0.1 0.0 0.1 0.0 3.7 0.0 8.7 0.2 0.4 0.0 3.9 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.6 0.2 16.8 0.0 7.4 0.0 2.5 0.0 15.3 2.9 1.0 2.2 0.0 1.4 4.4 0.0 0.1 0.0 9.3 0.0 11.7 0.0 0.0 0.0 4.8 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.2 1.8 3.1 0.6 3.3 2.0 1.1 1.5 2.1 2.4 1.7 0.0 0.0 0.0 0.1 0.9 10.8 10.6 2.5 0.0 1.2 0.0 31.4 0.7 0.0 0.7 449.3 0.6 0.0 0.0 0.2 0.8 0.4 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.3 85.3 6.9 0.8 1.7 0.0 0.0 1.6 0.5 0.0 4.6 0.1 5.6 0.0 0.4 112.1 25.2 5.4 0.3 0.0 0.0 0.0 HRASLS2 FLJ20556 ENSG00000133328 "HRAS like suppressor 2" Q9NWW9 11 63552770-63563383 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 16.1;intestine: 42.5" "Group enriched" "Detected in many" 6 "Basal glandular cells: 19.5;Ciliated cells: 45.5;Enterocytes: 59.0;Proximal tubular cells: 75.2;Urothelial cells: 43.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 16.1;naive B-cell: 5.3" "Lineage enriched" "Detected in many" 12 "B-cells: 16.1" "Cell line enriched" "Detected in some" 8 "U-266/70: 54.4" HPA058997 Approved Approved Mitochondria NA NA Mitochondria "HPA058997: AB_2683874" "unprognostic (4.76e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.20e-1)" "unprognostic (3.07e-2)" "unprognostic (1.43e-1)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (9.69e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (1.38e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (1.57e-2)" 0.4 0.0 0.4 1.5 0.4 0.0 4.7 0.4 0.4 0.6 20.6 0.5 0.4 33.4 0.6 1.1 0.5 2.1 0.4 1.0 0.4 0.2 5.5 1.9 3.3 1.1 0.4 0.4 0.4 0.4 0.0 0.4 1.4 0.4 0.4 6.5 0.4 0.7 0.4 0.4 0.2 42.5 0.4 0.4 0.7 8.8 0.4 0.4 0.4 0.4 0.4 0.5 0.4 0.4 16.1 0.8 0.1 0.1 1.2 0.9 3.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.4 0.0 0.4 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.1 0.0 3.5 0.8 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 54.4 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.9 16.1 0.2 0.9 0.0 5.3 0.2 0.6 0.1 1.2 0.0 0.8 0.0 3.6 0.4 0.4 0.4 0.4 0.4 0.2 0.4 0.4 0.4 0.4 3.0 0.6 3.0 19.5 0.1 0.0 0.3 5.1 45.5 5.7 0.0 0.0 0.1 8.3 0.4 0.3 0.0 59.0 0.0 0.4 0.3 0.0 6.2 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.7 7.0 0.0 75.2 0.0 0.0 0.0 0.7 0.1 0.0 0.7 1.0 0.9 43.6 HRASLS5 HRLP5 ENSG00000168004 "HRAS like suppressor family member 5" Q96KN8 11 63461404-63491194 "Predicted intracellular proteins" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.5;testis: 49.4" "Group enriched" "Detected in some" 43 "Early spermatids: 348.1;Late spermatids: 719.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 65 "basophil: 5.1;eosinophil: 14.5" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.5" "Group enriched" "Detected in some" 4 "HAP1: 15.8;NB-4: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042493 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA042493: AB_10797499" "unprognostic (3.16e-1)" "unprognostic (3.45e-2)" "unprognostic (2.83e-3)" "unprognostic (4.24e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (7.11e-3)" "unprognostic (2.14e-1)" "unprognostic (6.66e-2)" "unprognostic (9.46e-2)" "unprognostic (8.89e-3)" "unprognostic (3.15e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-5)" "unprognostic (1.52e-1)" "unprognostic (1.21e-2)" "unprognostic (2.57e-3)" "unprognostic (4.50e-4)" 12.4 0.5 2.2 0.4 2.2 0.3 7.6 0.3 2.3 0.4 0.8 2.5 1.7 0.4 0.7 1.0 1.0 1.1 0.9 1.3 1.3 0.9 0.4 0.3 0.8 0.3 1.2 2.1 1.0 11.0 0.2 0.4 0.2 1.7 0.9 0.4 0.6 0.7 2.5 0.3 0.4 0.5 1.3 3.3 0.3 0.6 49.4 0.9 0.0 0.4 0.3 0.3 0.8 0.4 0.0 0.0 14.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.1 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 2.2 0.3 2.3 1.3 0.9 1.2 2.1 1.7 0.9 3.0 0.6 0.0 1.8 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 348.1 0.1 0.0 0.0 0.3 0.1 2.0 0.5 1.1 0.0 0.1 0.0 0.0 0.0 0.0 719.6 3.1 0.7 0.0 0.0 0.0 2.4 0.1 0.0 4.2 1.1 0.0 6.5 0.3 12.4 4.7 0.0 0.8 0.0 0.0 1.0 HRC MGC133236 ENSG00000130528 "Histidine rich calcium binding protein" P23327 19 49151198-49155424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 155.8;skeletal muscle: 82.1" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 1159.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 6.4;HSkMC: 6.6;K-562: 8.7;THP-1: 15.6;U-266/84: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA004833 Enhanced "Intracellular and membrane" NA NA 23000 "HPA004833: AB_1079083" "unprognostic (1.06e-1)" "unprognostic (1.04e-3)" "unprognostic (1.46e-2)" "unprognostic (4.94e-2)" "unprognostic (5.66e-2)" "unprognostic (9.75e-3)" "unprognostic (3.44e-1)" "unprognostic (1.74e-1)" "unprognostic (4.09e-1)" "unprognostic (1.62e-1)" "unprognostic (7.41e-3)" "unprognostic (5.85e-3)" "unprognostic (4.04e-2)" "unprognostic (6.68e-2)" "unprognostic (1.07e-1)" "unprognostic (1.86e-1)" "unprognostic (1.46e-1)" 2.4 0.8 0.2 0.1 0.5 0.0 0.8 0.0 0.6 1.6 0.3 0.3 0.3 0.2 1.8 4.3 1.3 1.0 0.5 155.8 0.2 0.2 0.7 0.4 0.3 0.4 0.4 0.3 0.7 0.3 0.4 0.2 0.4 0.3 1.4 0.2 1.3 1.4 0.6 82.1 0.3 0.3 0.5 0.2 0.1 0.2 0.7 0.1 0.0 1.7 25.9 2.0 0.4 0.6 0.5 0.1 0.9 0.5 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.5 6.4 0.0 0.0 1.3 6.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.1 0.0 0.0 0.3 0.7 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 15.6 0.2 0.0 0.0 0.3 0.0 0.1 4.7 0.0 0.0 0.0 0.3 0.9 0.0 0.3 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.2 0.4 0.1 0.2 0.0 0.2 0.5 0.0 0.6 0.2 0.2 0.4 0.3 0.3 0.1 0.0 0.0 0.0 0.2 0.2 0.0 1159.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.3 0.0 0.2 0.0 0.7 0.1 0.0 0.4 0.1 3.2 1.2 0.6 0.0 0.0 7.8 0.0 3.3 0.0 2.8 1.0 0.1 0.0 7.8 0.0 0.1 64.7 36.8 0.0 0.1 0.1 0.1 0.0 1.2 0.1 HRCT1 "LGLL338, PRO537, UNQ338" ENSG00000196196 "Histidine rich carboxyl terminus 1" Q6UXD1 9 35906192-35907141 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.3" "Cell type enhanced" "Detected in many" 22 "Enterocytes: 63.2;Mucus-secreting cells: 49.5;Paneth cells: 238.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.8;HBEC3-KT: 7.6;HeLa: 11.3;Hep G2: 8.5;U-2197: 20.4;U-251 MG: 9.5" "Low region specificity" "Detected in all" HPA067038 Approved Nucleoplasm NA NA Nucleoplasm "HPA067038: AB_2685767" "unprognostic (2.48e-2)" "unprognostic (4.88e-2)" "unprognostic (2.43e-2)" "unprognostic (2.49e-1)" "unprognostic (5.69e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (6.63e-2)" "unprognostic (2.53e-2)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-1)" "unprognostic (2.00e-1)" "unprognostic (9.41e-2)" "unprognostic (2.80e-1)" "unprognostic (9.43e-2)" 25.3 1.9 1.9 3.6 2.8 0.4 21.4 0.9 3.4 5.3 16.8 1.8 1.4 11.2 4.2 3.9 6.6 3.5 2.1 7.6 2.6 1.6 17.6 1.8 5.2 5.0 2.4 2.3 2.2 1.6 0.3 0.7 4.7 3.6 3.6 14.8 5.8 4.6 4.0 6.1 4.2 14.3 6.5 1.5 0.8 2.5 5.3 1.4 0.0 3.5 1.2 1.5 4.6 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.6 4.6 0.0 0.2 0.4 0.1 0.0 0.1 1.2 0.0 13.8 0.3 2.6 0.0 0.0 7.6 0.0 0.0 0.0 0.0 11.3 8.5 1.8 0.0 0.0 4.5 3.9 1.5 0.9 0.6 4.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 3.5 1.8 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 3.9 0.2 4.1 20.4 9.5 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.8 0.9 3.4 2.6 1.6 2.4 2.3 3.6 1.4 6.0 1.0 0.0 0.4 1.9 1.5 0.6 2.5 1.4 3.4 0.0 0.0 20.6 1.7 0.8 0.0 21.2 63.2 0.0 0.2 6.6 4.2 0.6 0.0 0.4 1.6 0.0 1.2 35.0 0.8 0.0 10.0 0.9 1.7 0.0 49.5 7.5 2.7 238.4 8.9 9.3 2.6 12.9 4.6 0.0 0.2 1.6 2.2 0.0 18.6 0.1 HRG "HPRG, HRGP" ENSG00000113905 "Histidine rich glycoprotein" P04196 3 186660216-186678240 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis" Heparin-binding "Disease mutation, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 205 "liver: 425.4" "Cell type enriched" "Detected in some" 17 "Hepatocytes: 394.5" "Cancer enriched" "Detected in some" 262 "liver cancer: 406.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.8;HL-60: 5.9;RH-30: 6.9;RPTEC TERT1: 1.7;SiHa: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050269, HPA054598" Supported "Secreted to blood" NA NA 120000000000 30000000000 "HPA050269: AB_2681068, HPA054598: AB_2682539" "unprognostic (2.67e-1)" "unprognostic (1.74e-2)" "unprognostic (7.58e-5)" "prognostic favorable (9.64e-5)" "unprognostic (1.44e-1)" "unprognostic (2.98e-3)" "unprognostic (2.22e-1)" "unprognostic (1.55e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 425.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.2 0.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 5.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 6.9 0.0 1.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.8 0.0 1.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 394.5 0.0 0.0 0.0 13.5 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 HRH2 ENSG00000113749 "Histamine receptor H2" P25021 5 175658030-175710756 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 45.7;bone marrow: 30.1" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 21.0;Kupffer cells: 24.0;Macrophages: 14.4;Smooth muscle cells: 45.1" "Cancer enhanced" "Detected in many" "renal cancer: 4.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 45.7" "Group enriched" "Detected in many" 5 "granulocytes: 45.7;monocytes: 13.1" "Group enriched" "Detected in some" 4 "RPMI-8226: 36.2;SK-MEL-30: 10.8;THP-1: 10.0;U-937: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013770 Approved NA NA "HPA013770: AB_1851086" "unprognostic (8.56e-3)" "unprognostic (1.62e-1)" "unprognostic (6.66e-2)" "unprognostic (5.96e-2)" "unprognostic (3.49e-2)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (4.77e-2)" "unprognostic (9.93e-2)" "unprognostic (5.76e-2)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (3.71e-3)" "unprognostic (2.01e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-3)" "unprognostic (1.77e-2)" 7.9 1.5 5.9 11.1 11.6 30.1 2.8 1.0 12.1 3.9 2.8 0.9 0.5 5.9 2.3 1.3 1.6 2.7 2.6 18.6 3.4 1.7 2.4 1.2 5.4 12.3 2.3 4.9 1.6 1.6 0.3 1.3 9.5 2.4 3.0 1.3 0.6 1.7 4.8 1.2 2.1 7.2 3.5 4.4 9.9 10.3 1.2 5.6 9.9 1.8 0.2 3.0 2.8 2.0 0.0 6.4 45.7 13.1 0.6 2.3 3.7 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.8 1.7 0.0 0.0 3.9 0.0 36.2 0.0 0.2 0.2 0.0 0.0 0.0 10.8 1.0 0.0 10.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 2.4 28.9 12.9 13.6 0.0 12.0 0.1 0.0 1.1 0.2 6.4 0.0 2.3 1.4 45.7 0.6 13.1 5.0 0.8 3.7 5.9 11.6 1.0 12.1 3.4 1.7 2.3 4.9 2.4 5.6 0.0 4.5 0.5 0.1 0.7 4.5 21.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 2.2 0.1 5.2 0.1 2.3 0.0 10.1 1.6 0.0 0.0 24.0 0.7 0.0 14.4 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 45.1 0.2 1.1 0.3 0.0 2.5 0.0 0.0 HRH3 GPCR97 ENSG00000101180 "Histamine receptor H3" Q9Y5N1 20 62214970-62220267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "brain: 50.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 4.2;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.56e-1)" "unprognostic (3.22e-1)" "unprognostic (4.15e-2)" "unprognostic (1.79e-1)" "unprognostic (2.77e-2)" "unprognostic (1.62e-2)" "unprognostic (7.30e-2)" "unprognostic (3.17e-4)" "unprognostic (2.40e-1)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "unprognostic (3.59e-2)" 1.0 2.3 5.7 0.8 50.1 0.9 0.9 16.7 20.6 0.8 0.9 2.8 0.0 1.0 0.8 0.8 0.9 0.8 0.8 0.8 5.1 16.5 0.9 0.9 0.9 0.9 2.7 8.7 0.8 0.8 0.8 0.7 0.8 2.6 1.4 0.9 0.0 1.1 0.8 0.8 1.6 0.9 0.9 1.0 0.8 0.9 1.6 10.5 0.0 0.8 0.0 0.9 2.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 19.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 50.1 16.7 15.1 5.1 16.5 2.7 8.7 2.6 10.5 0.0 0.0 0.0 0.0 0.0 4.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 HRH4 "AXOR35, GPCR105, GPRv53, H4R, HH4R" ENSG00000134489 "Histamine receptor H4" Q9H3N8 18 24460629-24479957 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 48.5" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 1.1;Club cells: 2.3;granulocytes: 1.1;Late spermatids: 1.1;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 96 "basophil: 48.5;eosinophil: 16.7" "Lineage enriched" "Detected in single" 142 "granulocytes: 48.5" "Cell line enhanced" "Detected in some" "HEL: 2.9;HL-60: 5.0;HMC-1: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA035009 Uncertain NA NA "HPA035009: AB_10671507" "unprognostic (1.88e-1)" "unprognostic (2.62e-1)" "unprognostic (4.68e-2)" "unprognostic (9.83e-6)" "unprognostic (1.31e-2)" "unprognostic (3.61e-2)" "unprognostic (1.22e-1)" "unprognostic (8.96e-2)" "unprognostic (2.20e-1)" "unprognostic (3.30e-1)" "unprognostic (7.25e-2)" "unprognostic (2.91e-1)" "unprognostic (6.65e-7)" "unprognostic (1.89e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-4)" "unprognostic (7.70e-2)" 1.7 0.6 0.4 1.5 0.4 2.8 0.6 0.3 0.3 0.4 0.6 0.3 0.3 2.1 1.4 1.9 1.3 0.3 0.8 0.5 0.4 0.4 0.4 1.7 1.9 0.7 0.4 0.3 0.8 0.4 0.0 2.5 0.3 0.8 1.0 0.4 1.0 1.1 0.3 0.8 2.3 1.9 2.8 2.6 1.4 0.9 1.4 0.3 0.3 0.5 0.3 5.1 1.9 0.6 0.0 0.0 48.5 0.0 0.0 0.3 0.1 0.4 0.3 0.2 0.9 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.8 0.7 0.1 0.5 0.2 0.3 0.8 0.2 0.3 0.2 0.2 0.2 2.9 0.9 0.7 0.2 5.0 3.0 0.2 1.0 0.1 0.0 0.5 0.3 0.4 0.2 0.5 0.1 0.4 0.4 0.8 0.3 0.2 0.3 0.3 0.3 0.3 0.5 0.6 0.5 0.2 0.2 0.1 0.2 0.1 0.3 1.1 0.3 1.2 0.2 0.8 0.1 0.5 0.2 0.2 0.9 0.8 0.5 48.5 0.0 16.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.4 0.3 0.3 0.4 0.4 0.4 0.3 0.8 0.3 0.0 1.1 0.0 0.5 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.2 0.5 0.0 0.0 0.0 0.3 HRK DP5 ENSG00000135116 "Harakiri, BCL2 interacting protein" O00198 12 116856144-116881441 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.3;lymphoid tissue: 12.9;thyroid gland: 8.1" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 6.7;Cone photoreceptor cells: 13.7;Early spermatids: 9.4;Intestinal endocrine cells: 10.9;Paneth cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "eosinophil: 2.2;memory B-cell: 6.7;naive B-cell: 5.5" "Group enriched" "Detected in many" 45 "B-cells: 6.7;granulocytes: 2.2" "Cell line enhanced" "Detected in some" "Daudi: 7.8;SCLC-21H: 6.7;SH-SY5Y: 5.7;SK-MEL-30: 15.2;U-698: 26.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB025973 Uncertain NA NA "CAB025973: " "unprognostic (9.38e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-3)" "unprognostic (2.54e-1)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.67e-2)" "unprognostic (1.10e-1)" "unprognostic (8.44e-3)" "unprognostic (1.28e-1)" "unprognostic (1.46e-1)" "unprognostic (7.24e-3)" "unprognostic (5.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.66e-1)" "unprognostic (9.42e-2)" 0.5 1.9 10.1 1.2 3.2 1.7 2.9 0.5 17.3 0.4 0.6 1.3 0.0 0.4 0.5 0.4 0.5 1.4 0.4 0.6 12.1 3.6 0.4 0.3 0.6 1.9 1.8 4.1 0.4 0.6 0.3 5.0 0.4 2.6 0.4 0.7 0.0 1.0 0.3 1.3 0.6 0.5 0.4 1.1 0.8 0.4 1.4 0.6 12.9 8.1 0.0 1.8 0.4 0.2 6.7 0.0 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.3 0.0 0.1 3.2 1.7 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.0 1.5 0.0 0.0 0.0 0.1 0.3 0.0 0.7 0.0 0.1 0.7 0.0 1.0 0.1 0.0 6.7 5.7 0.4 0.0 15.2 0.3 0.4 0.1 0.0 0.0 1.3 0.2 0.0 0.7 0.3 26.4 0.0 0.3 0.0 0.1 0.0 2.2 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 10.1 3.2 0.5 8.5 12.1 3.6 1.8 4.1 2.6 0.6 0.0 0.0 0.9 0.1 0.1 4.1 1.7 0.0 6.7 1.2 0.0 13.7 0.0 0.0 0.0 9.4 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 10.9 0.0 0.0 2.3 0.0 0.0 3.3 1.0 0.0 0.1 0.0 11.5 0.0 0.0 0.5 0.0 0.0 0.5 2.6 0.0 0.1 0.0 0.6 0.1 HRNR "FLG3, S100A16, S100a18" ENSG00000197915 Hornerin Q86YZ3 1 152212082-152224193 "Plasma proteins, Predicted intracellular proteins" Keratinization "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 4.0" "Cell type enhanced" "Detected in some" 24 "Horizontal cells: 1.6;Rod photoreceptor cells: 3.3" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "A549: 1.6;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.2;TIME: 1.2;U-2 OS: 1.6;U-2197: 1.5" HPA031469 Uncertain Approved Mitochondria No No 210000000 Mitochondria "HPA031469: AB_10603771" "unprognostic (1.34e-1)" "unprognostic (4.51e-2)" "unprognostic (3.01e-2)" "unprognostic (8.72e-4)" "unprognostic (1.61e-2)" "unprognostic (1.45e-1)" "unprognostic (2.11e-1)" "unprognostic (1.79e-1)" "unprognostic (6.09e-2)" "unprognostic (3.38e-2)" "unprognostic (1.87e-2)" "unprognostic (1.59e-2)" "unprognostic (1.65e-2)" "unprognostic (2.49e-2)" "unprognostic (1.71e-1)" "unprognostic (2.07e-1)" "unprognostic (3.64e-2)" 0.3 0.4 0.0 0.1 0.2 0.1 0.3 0.0 1.3 0.7 0.1 0.1 0.5 0.0 1.8 0.8 0.6 0.5 0.1 0.1 1.0 0.0 0.1 0.4 0.0 1.6 1.5 0.0 0.4 0.1 0.6 0.0 0.2 0.0 0.1 4.0 0.2 0.0 0.1 0.1 0.1 1.3 1.6 0.0 0.4 0.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.6 1.2 0.1 1.6 1.5 0.3 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 HS3ST1 3OST1 ENSG00000002587 "Heparan sulfate-glucosamine 3-sulfotransferase 1" O14792 4 11393150-11429765 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;gallbladder: 31.9;ovary: 30.3" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 64.3;Club cells: 83.0;granulocytes: 93.6;Peritubular cells: 84.8;Urothelial cells: 90.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "cerebellum: 27.4;cerebral cortex: 9.0" "Group enriched" "Detected in some" 39 "memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3" "Group enriched" "Detected in many" 99 "B-cells: 15.8;dendritic cells: 22.3" "Cell line enhanced" "Detected in some" "A-431: 4.5;CAPAN-2: 14.4;HaCaT: 4.3;RPTEC TERT1: 12.6;RT4: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002237 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA002237: AB_1079085" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (4.01e-2)" "prognostic favorable (7.73e-4)" "unprognostic (3.32e-2)" "unprognostic (8.90e-3)" "unprognostic (4.21e-1)" "unprognostic (2.08e-1)" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.99e-8)" "unprognostic (9.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.57e-1)" "prognostic favorable (8.67e-4)" 2.3 2.9 1.6 2.8 2.2 2.8 2.0 27.4 9.0 3.3 2.7 1.1 3.6 3.5 4.3 5.0 10.2 4.3 31.9 2.2 1.7 1.8 10.4 0.9 3.4 2.1 1.9 1.5 30.3 1.1 0.7 8.9 1.0 2.4 3.2 1.7 1.7 3.7 2.4 0.7 0.8 2.9 1.7 2.2 3.0 7.0 3.0 0.3 3.8 1.8 7.0 7.4 7.3 2.4 15.8 22.3 0.1 0.1 0.0 0.1 0.6 4.5 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.4 0.0 0.4 0.0 0.0 4.3 0.0 2.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.9 1.2 1.0 0.0 0.0 12.6 10.3 3.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 2.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 7.3 0.0 0.0 0.3 15.8 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.6 1.6 2.2 27.4 9.0 1.7 1.8 1.9 1.5 2.4 0.3 3.0 8.0 2.2 9.8 8.0 1.5 2.4 15.3 64.3 83.0 19.2 3.9 0.5 0.0 17.1 0.8 23.4 3.0 0.0 1.8 31.9 5.0 4.1 93.6 0.0 37.3 1.6 2.4 9.2 2.7 0.8 8.1 9.0 1.7 7.2 5.6 39.8 32.0 2.6 84.8 3.7 2.2 0.0 6.4 6.0 5.5 7.0 1.1 0.9 3.7 90.2 HS3ST2 3OST2 ENSG00000122254 "Heparan sulfate-glucosamine 3-sulfotransferase 2" Q9Y278 16 22814177-22916338 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 12.7;brain: 38.2;lung: 13.4" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 3.2;Bipolar cells: 3.5;Hofbauer cells: 13.5;Peritubular cells: 5.3;Smooth muscle cells: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 10.5;SH-SY5Y: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017736 Approved NA NA "HPA017736: AB_1851095" "unprognostic (4.09e-2)" "unprognostic (2.90e-3)" "unprognostic (5.97e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (2.17e-3)" "unprognostic (1.83e-1)" "unprognostic (2.75e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "prognostic favorable (1.35e-4)" "unprognostic (4.89e-2)" "unprognostic (1.16e-1)" "unprognostic (1.35e-1)" "unprognostic (3.00e-2)" 12.7 1.7 3.8 1.1 6.5 1.1 2.4 0.5 38.2 2.0 1.4 0.3 0.3 1.0 1.0 1.0 1.2 1.0 1.1 3.8 7.8 4.3 1.0 2.2 13.4 2.1 2.2 8.4 4.5 1.0 1.0 0.4 1.2 1.5 2.0 1.4 5.0 2.9 1.1 1.0 2.0 1.0 1.2 1.0 1.1 1.1 1.1 0.0 0.0 1.8 0.4 1.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.5 0.5 19.1 7.8 4.3 2.2 8.4 1.5 0.0 0.0 0.0 0.0 0.1 3.2 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 13.5 0.0 0.0 0.6 0.6 0.7 1.1 0.4 0.0 0.0 0.0 0.0 0.6 0.0 5.3 0.0 0.6 0.0 4.1 0.0 0.0 1.8 0.2 0.0 0.0 0.7 HS3ST3B1 "30ST3B1, 3OST3B1" ENSG00000125430 "Heparan sulfate-glucosamine 3-sulfotransferase 3B1" Q9Y662 17 14301083-14349404 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.7;pons and medulla: 6.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.6" "Group enriched" "Detected in many" 5 "dendritic cells: 20.6;T-cells: 14.7" "Cell line enhanced" "Detected in many" "AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2" HPA064126 Approved Vesicles NA NA Vesicles "HPA064126: AB_2685194" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (2.85e-3)" "unprognostic (5.22e-2)" "unprognostic (5.03e-3)" "unprognostic (1.79e-1)" "unprognostic (2.93e-1)" "unprognostic (8.13e-3)" "unprognostic (8.80e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-3)" "unprognostic (7.77e-3)" "unprognostic (9.46e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-3)" 1.4 1.4 0.6 8.7 0.8 1.3 3.0 0.9 2.7 3.8 1.8 0.0 0.8 1.4 1.0 0.3 2.8 1.7 2.6 2.0 0.6 0.7 3.6 29.1 3.7 26.6 0.6 0.0 4.7 1.3 0.4 1.4 33.5 6.0 2.4 1.9 5.3 12.6 2.5 1.8 2.2 2.5 0.6 2.9 4.9 1.4 0.7 0.0 13.2 1.5 2.5 5.9 1.5 5.3 0.4 20.6 0.5 0.4 3.8 14.7 2.7 0.0 0.3 15.5 0.0 4.7 5.3 11.1 4.4 6.4 4.0 4.2 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.4 2.4 2.0 1.3 3.2 0.3 2.0 13.5 6.2 0.5 2.3 15.4 0.8 1.4 3.7 0.9 0.0 0.8 4.6 0.0 3.2 0.8 0.7 0.6 0.5 0.1 0.4 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.3 0.4 0.0 3.9 0.0 0.0 14.2 0.0 0.0 0.0 3.0 0.0 0.9 0.1 0.2 0.0 6.3 0.4 5.0 0.4 7.6 4.9 0.4 0.4 7.7 7.5 0.5 3.8 0.4 20.6 14.7 2.7 0.6 0.8 0.9 2.7 0.6 0.7 0.6 0.0 6.0 0.0 0.0 0.6 1.4 0.2 10.2 2.0 2.2 2.5 4.0 1.2 7.0 37.3 5.1 0.0 0.6 11.1 2.5 0.0 0.0 0.2 10.4 9.0 0.7 0.0 32.1 1.4 7.9 0.0 34.4 3.7 1.4 2.6 4.3 1.7 1.8 0.0 6.0 0.1 0.0 1.1 0.0 15.2 12.9 2.7 0.6 0.4 12.9 30.3 11.7 0.0 0.1 HS3ST4 3OST4 ENSG00000182601 "Heparan sulfate-glucosamine 3-sulfotransferase 4" Q9Y661 16 25692026-26137688 "Enzymes, Predicted membrane proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 23.9" "Cell type enriched" "Detected in single" 8 "Bipolar cells: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 5.5;SCLC-21H: 2.3;SuSa: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.09e-2)" "unprognostic (1.87e-1)" "unprognostic (2.95e-1)" "unprognostic (2.24e-1)" "unprognostic (1.43e-3)" "unprognostic (1.27e-1)" "unprognostic (3.84e-1)" "unprognostic (8.81e-3)" "unprognostic (6.71e-2)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (3.67e-2)" 0.7 0.8 6.9 0.6 9.3 0.6 5.1 6.8 23.9 1.1 0.6 2.6 0.0 0.6 0.7 1.3 0.9 0.7 0.6 0.6 11.5 10.0 0.7 0.6 0.6 0.6 5.9 10.8 0.7 0.6 0.6 0.1 0.6 14.3 2.0 0.6 0.3 0.8 0.6 0.6 0.7 0.6 0.6 2.2 3.7 1.1 1.3 1.5 0.0 0.6 0.0 0.8 1.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 9.3 6.8 13.4 11.5 10.0 5.9 10.8 14.3 1.5 0.0 0.0 0.0 0.4 0.0 5.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HS3ST5 3-OST-5 ENSG00000249853 "Heparan sulfate-glucosamine 3-sulfotransferase 5" Q8IZT8 6 114055586-114343045 "Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 5.0;Collecting duct cells: 10.4;Cone photoreceptor cells: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 5.0;RT4: 9.2;SCLC-21H: 17.8;U-266/70: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021823, HPA064677" Approved NA NA "HPA021823: AB_1851100, HPA064677: AB_2685318" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-2)" "unprognostic (1.04e-2)" "unprognostic (1.72e-2)" "unprognostic (3.00e-2)" "unprognostic (7.98e-4)" "unprognostic (5.39e-2)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (5.72e-2)" "unprognostic (3.28e-2)" "unprognostic (3.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.53e-2)" 0.5 1.9 3.3 0.9 13.1 1.3 0.5 0.6 11.9 0.8 1.0 9.1 3.5 0.7 0.8 0.5 0.6 0.6 0.7 0.5 4.2 3.5 0.9 0.5 1.1 0.5 6.1 2.7 0.6 1.3 0.5 0.3 0.6 7.8 0.7 0.9 0.6 0.7 9.4 10.1 1.3 1.2 0.9 7.5 0.5 1.2 0.9 8.0 0.0 0.6 0.0 0.5 2.5 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 2.5 5.0 0.0 1.0 0.0 0.0 9.2 17.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.1 4.5 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.3 13.1 0.6 5.7 4.2 3.5 6.1 2.7 7.8 8.0 0.0 0.0 0.0 0.0 1.1 5.0 0.7 0.0 0.0 0.0 10.4 17.7 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.2 HS3ST6 HS3ST5 ENSG00000162040 "Heparan sulfate-glucosamine 3-sulfotransferase 6" Q96QI5 16 1911463-1918440 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 18.8;skin 1: 15.0" "Cell type enhanced" "Detected in some" 15 "Horizontal cells: 20.6;Suprabasal keratinocytes: 8.0;Urothelial cells: 17.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 2.8;HaCaT: 2.8;U-2 OS: 1.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (5.72e-2)" "prognostic favorable (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-1)" "unprognostic (4.99e-3)" "unprognostic (2.10e-2)" "unprognostic (6.55e-3)" "unprognostic (2.42e-1)" "unprognostic (3.61e-1)" "unprognostic (2.26e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.1 0.1 6.6 0.4 0.0 0.4 0.0 0.3 0.9 18.8 1.2 0.0 0.1 0.1 0.1 0.2 0.1 1.9 0.1 0.1 0.0 0.5 0.1 0.0 0.2 1.9 0.0 3.6 0.0 0.6 0.4 0.1 0.3 15.0 0.1 1.0 0.1 0.1 0.1 0.1 0.0 2.1 0.1 2.7 3.2 6.7 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.3 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.5 0.0 0.4 0.0 0.0 0.2 4.1 1.4 0.0 0.0 0.2 20.6 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.3 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.0 0.1 0.0 0.8 17.7 HS6ST2 ENSG00000171004 "Heparan sulfate 6-O-sulfotransferase 2" Q96MM7 X 132626016-132961395 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;kidney: 17.3;ovary: 18.2" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 29.5" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Lineage enhanced" "Detected in single" "NK-cells: 1.8" "Cell line enhanced" "Detected in some" "HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5" "Low region specificity" "Detected in all" "HPA034625, HPA034626" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA034625: AB_10612119, HPA034626: AB_2674252" "unprognostic (7.62e-3)" "unprognostic (4.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.41e-1)" "unprognostic (3.24e-1)" "unprognostic (5.54e-2)" "unprognostic (1.44e-1)" "unprognostic (1.71e-2)" "unprognostic (1.14e-2)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (3.57e-1)" "unprognostic (8.39e-5)" "unprognostic (1.36e-3)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "prognostic favorable (6.03e-4)" 0.4 3.2 6.5 0.9 29.5 0.1 2.6 3.0 6.7 1.0 0.8 0.8 0.6 0.3 4.5 3.2 5.0 2.5 0.5 0.4 4.1 9.1 17.3 0.2 1.0 0.3 3.5 0.9 18.2 6.5 0.1 1.3 9.9 3.3 5.4 1.2 0.0 1.1 1.6 6.7 0.3 0.2 2.0 3.3 0.2 1.1 7.9 0.7 0.7 0.6 1.7 2.7 2.3 0.6 0.0 0.0 0.0 0.0 1.8 0.6 0.0 4.3 0.0 6.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.1 0.0 0.0 6.5 0.0 0.0 0.2 9.2 0.0 0.0 0.0 19.6 0.0 13.3 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 5.0 3.0 0.2 0.0 28.4 0.0 5.7 14.1 0.7 35.5 6.2 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 4.1 9.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.5 29.5 3.0 5.8 4.1 9.1 3.5 0.9 3.3 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 13.4 7.9 3.5 0.0 31.0 5.0 0.0 0.4 0.4 0.0 0.0 1.6 1.3 2.2 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.4 58.1 0.0 0.0 0.0 0.0 5.3 1.2 0.0 33.2 0.0 0.0 0.0 0.3 0.2 1.2 0.3 14.5 0.0 0.0 0.2 HS6ST3 ENSG00000185352 "Heparan sulfate 6-O-sulfotransferase 3" Q8IZP7 13 96090839-96839562 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Horizontal cells: 3.2;Pancreatic endocrine cells: 1.0;Rod photoreceptor cells: 1.8;Spermatogonia: 1.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RT4: 19.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078257 Approved "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA 9800 "Nucleoplasm, Nuclear membrane" "Plasma membrane, Actin filaments" "HPA078257: AB_2732374" "unprognostic (2.34e-2)" "unprognostic (1.90e-2)" "unprognostic (2.82e-2)" "unprognostic (1.72e-2)" "unprognostic (4.88e-2)" "unprognostic (2.78e-2)" "unprognostic (1.55e-1)" "unprognostic (3.67e-3)" "unprognostic (8.11e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.12e-5)" "unprognostic (1.54e-4)" "unprognostic (2.24e-1)" "unprognostic (1.57e-3)" "unprognostic (9.89e-2)" 0.9 4.5 1.5 0.0 1.9 0.0 0.0 0.4 18.7 1.9 0.0 0.2 2.1 2.2 0.2 0.1 0.0 0.2 3.2 2.7 0.7 0.0 0.0 0.0 0.9 0.0 2.1 0.0 0.7 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.0 1.6 0.4 0.0 0.7 0.1 2.4 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 19.6 1.0 0.8 0.1 0.1 0.0 0.3 0.6 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 HSD11B1 "HSD11, HSD11B, SDR26C1" ENSG00000117594 "Hydroxysteroid 11-beta dehydrogenase 1" P28845 1 209686178-209734950 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 183.4" "Cell type enriched" "Detected in many" 13 "Hepatocytes: 560.1" "Cancer enriched" "Detected in all" 28 "liver cancer: 197.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 9.2" "Lineage enriched" "Detected in single" 20 "T-cells: 9.2" "Cell line enriched" "Detected in some" 5 "ASC diff: 151.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047729 Enhanced NA NA 77000 "HPA047729: AB_2680135" "unprognostic (1.08e-3)" "unprognostic (2.13e-1)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (3.63e-2)" "unprognostic (8.35e-3)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.97e-10)" "unprognostic (3.41e-2)" "unprognostic (3.91e-2)" "unprognostic (6.45e-2)" "unprognostic (1.59e-2)" 4.6 1.6 1.1 3.0 3.1 0.3 2.4 9.9 3.9 0.6 1.0 1.6 2.7 0.5 0.8 8.7 1.5 0.9 1.9 3.0 1.8 0.9 2.6 183.4 7.2 1.3 8.2 2.0 12.6 0.9 0.3 1.5 26.5 3.3 7.1 0.9 1.5 0.6 3.0 1.5 6.3 0.9 2.7 1.3 3.5 1.4 2.3 2.5 0.0 1.0 0.6 0.6 3.9 1.4 0.2 0.0 0.2 0.1 0.4 9.2 0.8 0.0 0.0 0.0 0.0 151.9 15.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.2 9.2 2.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 2.4 0.8 1.1 3.1 9.9 3.9 1.8 0.9 8.2 2.0 3.3 2.5 3.0 0.0 2.4 0.5 0.1 0.0 0.8 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 10.8 0.5 0.0 560.1 8.7 0.0 0.0 8.6 8.9 2.2 27.0 2.2 0.0 1.0 0.0 15.4 0.2 0.0 7.4 0.0 0.3 0.0 2.1 0.0 0.2 0.1 0.2 0.5 0.0 1.6 HSD11B1L "SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 34.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 17.2" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" NA NA Vesicles "HPA049078: AB_2680622" "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.9 8.8 34.4 2.1 19.2 4.7 5.0 10.3 29.7 3.9 2.9 5.4 3.7 2.6 3.6 8.5 2.2 7.6 4.8 3.8 25.4 16.1 6.7 3.5 4.4 2.3 11.7 20.4 6.1 6.2 5.8 8.5 2.5 10.7 4.0 1.9 3.2 9.1 6.9 15.0 6.9 2.9 2.7 6.0 2.6 3.3 4.3 7.5 0.0 6.6 1.3 1.8 2.5 2.2 2.5 4.8 2.5 5.8 1.4 4.5 1.7 2.9 2.8 10.4 1.9 4.9 5.3 2.1 2.2 4.5 1.0 4.5 1.3 2.9 0.7 4.9 1.9 0.8 1.5 1.2 1.6 1.0 2.4 3.1 1.9 2.5 1.8 3.4 0.7 7.1 5.2 3.5 1.6 1.5 9.6 1.6 4.4 1.9 2.8 4.2 0.4 1.8 2.0 2.8 12.5 3.3 3.3 0.4 2.5 8.7 0.7 2.8 17.2 0.5 1.5 11.0 3.8 2.4 0.6 2.8 2.6 4.6 4.4 1.8 6.9 2.3 0.8 7.2 1.1 2.0 1.7 2.5 0.2 1.2 5.8 1.6 1.2 3.2 3.6 2.3 2.5 4.5 3.9 2.5 1.4 2.9 4.8 0.9 1.7 34.4 19.2 10.3 29.7 25.4 16.1 11.7 20.4 10.7 7.5 0.0 1.6 0.8 7.6 7.2 11.2 2.0 5.1 13.4 4.5 22.7 13.7 4.0 13.3 8.9 6.8 3.8 3.8 0.0 4.1 3.9 8.9 8.0 10.3 3.2 4.2 7.9 24.6 8.0 2.8 9.6 6.6 3.6 5.0 2.8 4.3 17.0 4.8 2.8 12.0 23.7 11.7 0.0 9.9 10.3 10.6 8.9 2.4 3.3 3.5 7.5 HSD11B2 SDR9C3 ENSG00000176387 "Hydroxysteroid 11-beta dehydrogenase 2" P80365 16 67430652-67437553 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.8;kidney: 119.9;salivary gland: 66.0" "Group enriched" "Detected in many" 5 "Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032443, HPA042186, HPA056385" Enhanced Approved "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110" "unprognostic (2.87e-3)" "unprognostic (5.24e-2)" "unprognostic (7.10e-2)" "unprognostic (6.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.14e-1)" "unprognostic (2.68e-2)" "unprognostic (2.07e-1)" "unprognostic (2.21e-3)" "unprognostic (2.25e-3)" "unprognostic (3.27e-2)" "unprognostic (2.34e-1)" "prognostic favorable (9.51e-5)" "unprognostic (7.20e-2)" "unprognostic (3.19e-1)" "unprognostic (1.55e-2)" "unprognostic (1.84e-1)" 0.4 1.0 0.6 22.2 2.3 0.0 3.2 2.0 1.7 4.8 42.8 0.3 1.3 9.4 3.8 3.6 2.5 2.4 8.3 0.5 0.5 0.1 119.9 1.2 2.3 0.7 0.3 0.8 4.8 2.1 0.0 0.4 42.3 1.1 3.7 24.5 0.4 66.0 1.4 0.4 13.8 62.8 4.3 0.3 1.5 2.1 1.4 1.3 0.5 3.8 3.3 1.6 1.5 4.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.8 0.3 1.1 0.1 1.3 2.8 0.0 0.0 0.1 0.1 4.5 1.0 0.0 2.1 0.0 0.1 5.8 3.9 0.4 0.0 0.0 1.3 0.0 0.5 4.8 0.4 0.5 0.0 1.3 2.3 0.2 0.0 0.0 0.0 3.5 0.3 0.0 0.0 2.8 0.1 0.1 8.7 21.3 0.7 0.0 0.1 10.2 0.4 10.3 11.4 0.7 0.6 10.2 0.4 1.0 4.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 2.3 2.0 1.7 0.5 0.1 0.3 0.8 1.1 1.3 0.0 0.3 0.0 8.0 1.3 0.0 0.5 33.1 0.0 1.2 181.5 0.0 0.8 38.1 1.7 0.1 0.0 273.5 0.0 2.7 0.7 3.1 15.6 9.2 1.3 1.3 0.0 25.8 1.3 0.0 0.0 23.6 0.0 1.7 0.0 229.5 0.0 0.8 137.2 6.3 14.6 0.0 12.9 0.4 0.2 1.0 3.0 95.8 0.0 114.3 5.7 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42549214-42555213 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 217.6" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 1251.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "BEWO: 89.7" "Low region specificity" "Detected in single" "HPA021032, HPA065296" Enhanced Supported Cytosol NA NA Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 2.8 1.5 2.0 1.7 2.1 1.1 1.8 2.7 3.1 1.3 1.3 1.3 1.3 1.9 1.5 1.3 4.3 1.4 1.3 1.4 2.4 1.4 1.4 1.3 1.3 1.6 2.4 1.3 5.8 2.6 0.2 1.4 217.6 1.3 1.5 0.2 1.3 2.9 1.3 3.5 4.1 1.9 1.3 1.9 2.1 2.0 2.3 1.3 1.3 1.8 1.3 1.3 1.3 1.8 6.0 5.5 7.5 8.6 6.1 5.4 5.5 1.6 1.8 0.9 4.6 0.6 0.1 89.7 1.2 0.0 0.0 0.0 1.0 0.9 0.0 1.2 0.0 1.0 2.6 0.1 0.7 0.0 2.4 2.8 1.2 1.1 1.5 0.2 1.0 1.4 0.2 2.6 0.1 0.5 1.5 0.0 1.3 1.7 0.4 0.0 1.6 1.3 1.1 0.4 0.6 0.8 1.3 1.1 0.8 0.1 1.4 1.3 1.8 0.7 9.1 1.4 1.0 11.0 0.8 1.4 1.4 1.8 1.0 0.8 2.6 1.5 0.6 0.6 0.9 1.1 3.6 7.6 7.5 4.9 8.6 5.3 5.6 5.4 5.1 5.5 6.0 5.1 4.4 7.2 6.1 5.3 4.3 3.7 5.5 2.0 2.1 2.7 1.5 2.4 1.4 2.4 1.3 1.3 1.3 0.0 2.1 0.5 6.3 2.7 8.7 2.4 2.5 4.0 2.3 5.2 11.8 250.4 19.9 1.5 1.0 4.1 3.2 0.0 4.9 23.6 3.4 13.0 2.3 5.6 26.4 9.5 4.1 4.9 0.8 1.7 1.7 0.5 1.7 1.0 2.4 9.0 2.0 2.5 3.2 10.5 8.2 0.0 2.8 0.7 2.6 6.5 1251.0 1.3 1.9 8.4 HSD17B11 "17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2" ENSG00000198189 "Hydroxysteroid 17-beta dehydrogenase 11" Q8NBQ5 4 87336610-87391386 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1;intestine: 81.3" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 489.8;Paneth cells: 501.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 100.1" "Group enriched" "Detected in all" 4 "granulocytes: 100.1;monocytes: 25.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 68.5" "Low region specificity" "Detected in all" HPA021608 Enhanced Supported "Lipid droplets" "Intracellular and membrane" NA NA 14000 "Lipid droplets" "HPA021608: AB_1847660" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (4.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.92e-1)" "unprognostic (3.35e-1)" "unprognostic (3.70e-2)" "unprognostic (1.78e-1)" "unprognostic (8.53e-2)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (2.65e-3)" "unprognostic (5.53e-2)" "unprognostic (2.13e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-2)" 22.0 23.8 11.1 15.5 8.4 23.6 18.9 23.8 12.8 19.6 58.3 7.2 9.5 53.0 19.1 15.7 6.5 14.6 26.3 9.0 10.1 6.4 18.1 57.4 25.3 14.7 14.2 7.9 18.0 24.5 3.0 12.6 11.4 9.7 15.5 36.2 5.7 6.7 9.0 6.4 6.2 81.3 15.2 14.2 12.2 11.6 11.6 10.6 15.8 8.1 8.4 8.2 21.0 15.9 7.7 14.2 100.1 25.8 10.4 10.3 18.7 0.2 10.7 5.2 13.1 16.1 22.2 7.4 5.8 9.1 3.8 7.0 8.9 68.5 0.0 11.2 5.9 3.6 0.2 15.2 1.2 4.2 16.9 3.2 14.7 5.9 30.0 9.1 26.2 27.5 15.7 0.4 5.2 1.8 12.1 7.3 6.4 15.3 7.6 7.0 0.4 5.3 32.1 8.9 33.3 1.8 14.7 4.8 17.3 10.5 16.4 1.7 16.7 11.4 0.3 19.5 7.0 0.0 25.6 6.1 2.6 11.8 10.5 3.0 3.7 1.5 1.6 4.9 18.6 17.8 61.0 25.8 55.9 8.7 18.4 10.3 7.7 8.8 9.0 14.2 6.6 8.1 9.0 100.1 10.4 15.2 4.8 9.9 18.7 11.1 8.4 23.8 12.8 10.1 6.4 14.2 7.9 9.7 10.6 291.8 133.2 72.8 64.6 24.8 1.2 4.4 310.8 75.0 111.5 41.8 2.0 27.4 21.6 38.6 0.9 71.4 489.8 0.0 51.8 45.8 75.4 36.7 98.1 303.2 118.3 17.5 90.0 101.9 213.8 0.9 96.4 169.0 64.1 36.1 155.1 34.2 52.9 501.0 55.9 148.1 3.9 71.1 54.2 2.6 13.1 18.7 12.5 110.7 226.2 80.0 HSD17B13 "SCDR9, SDR16C3" ENSG00000170509 "Hydroxysteroid 17-beta dehydrogenase 13" Q7Z5P4 4 87303789-87322906 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 158.8" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 61.6;Club cells: 78.5;Hepatocytes: 112.8;Urothelial cells: 30.7" "Cancer enriched" "Detected in some" 26 "liver cancer: 52.9" "Region enriched" "Detected in single" 6 "cerebellum: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 4.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA029125 Uncertain Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA Vesicles "Golgi apparatus" "HPA029125: AB_10601580" "unprognostic (2.49e-1)" "unprognostic (7.46e-2)" "unprognostic (7.02e-2)" "unprognostic (1.86e-4)" "unprognostic (4.74e-2)" "unprognostic (8.44e-2)" "prognostic favorable (2.94e-4)" "prognostic favorable (7.80e-4)" "unprognostic (4.97e-1)" "unprognostic (2.22e-2)" "unprognostic (1.00e-1)" "unprognostic (2.46e-1)" "unprognostic (7.18e-4)" "unprognostic (3.62e-1)" "unprognostic (1.01e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-3)" 8.0 0.1 0.1 0.2 0.1 0.3 1.8 1.0 0.1 1.3 0.3 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.1 0.9 0.1 0.0 0.1 158.8 0.8 0.1 0.1 0.1 0.1 2.4 0.0 0.1 0.3 0.1 2.4 0.1 0.1 0.2 0.1 0.1 1.4 0.1 1.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.1 0.3 2.7 1.8 0.6 3.7 0.7 0.8 0.8 0.1 0.2 0.3 0.8 0.9 1.1 0.8 0.6 0.1 0.3 0.0 0.1 0.0 1.8 0.6 0.6 0.3 0.1 0.4 0.2 0.2 0.2 0.6 0.3 1.0 1.1 1.8 0.8 2.6 1.1 0.4 0.0 0.0 0.1 0.9 0.3 0.9 0.8 0.9 0.3 0.3 0.4 4.9 0.4 1.4 0.5 0.8 1.0 0.3 0.3 0.5 0.5 2.1 0.6 0.4 0.2 0.5 0.2 1.6 1.0 0.5 2.7 0.7 0.4 0.5 0.3 0.5 0.3 2.0 1.0 3.7 0.7 1.5 0.4 0.2 0.4 1.8 0.4 0.4 0.1 1.1 0.8 0.7 2.8 0.8 0.3 0.6 0.4 0.1 0.1 0.1 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 5.4 0.0 19.6 2.3 0.0 0.3 2.5 61.6 78.5 1.8 0.0 0.1 0.0 0.0 2.1 0.4 0.0 0.0 0.4 0.2 1.0 1.1 0.0 112.8 0.2 0.0 1.7 1.3 1.6 1.8 0.0 0.5 0.0 0.0 0.7 0.3 0.2 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.6 30.7 HSD17B14 "DHRS10, retSDR3, SDR47C1" ENSG00000087076 "Hydroxysteroid 17-beta dehydrogenase 14" Q9BPX1 19 48813017-48836678 "Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 44.3" "Cell type enhanced" "Detected in many" 19 "Distal tubular cells: 66.3;Hofbauer cells: 120.5;Proximal tubular cells: 271.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8" "Cell line enhanced" "Detected in many" "GAMG: 23.0;HHSteC: 21.7;hTERT-RPE1: 16.3;Karpas-707: 24.6;RT4: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA021467 Approved NA NA "HPA021467: AB_1847652" "unprognostic (2.03e-1)" "unprognostic (7.94e-3)" "prognostic unfavorable (4.39e-5)" "unprognostic (4.32e-2)" "unprognostic (8.03e-2)" "unprognostic (1.47e-1)" "unprognostic (7.54e-2)" "unprognostic (7.76e-3)" "unprognostic (2.71e-1)" "unprognostic (4.04e-1)" "prognostic favorable (2.87e-5)" "unprognostic (4.56e-1)" "unprognostic (5.50e-3)" "unprognostic (9.05e-3)" "unprognostic (1.01e-1)" "unprognostic (5.51e-2)" "unprognostic (1.81e-2)" 5.9 25.7 15.5 2.9 16.2 1.4 4.2 20.2 14.1 11.5 4.1 9.7 3.7 3.3 13.2 8.1 3.3 8.3 9.2 4.8 10.5 13.5 44.3 24.0 11.6 5.7 11.9 15.8 32.2 6.0 15.3 9.2 6.5 9.8 8.0 2.1 34.4 2.6 8.1 1.3 3.4 3.7 7.3 9.0 6.7 3.2 4.5 7.1 5.0 16.6 3.2 3.5 7.8 8.0 5.9 0.7 0.0 0.0 7.5 4.8 1.3 0.0 6.0 6.0 1.0 7.1 1.1 0.1 1.1 8.3 0.5 0.5 5.5 0.1 3.7 6.2 0.2 23.0 0.0 0.6 0.0 0.6 0.2 0.4 1.6 0.1 0.8 21.7 0.0 9.7 8.4 0.2 0.6 0.2 16.3 7.8 2.1 0.0 24.6 0.0 0.2 0.5 0.2 0.5 3.5 4.1 3.3 0.0 0.7 0.0 17.6 1.6 4.1 0.0 0.8 4.6 2.6 0.2 0.2 0.0 0.1 2.3 0.2 0.0 4.2 7.8 0.2 5.3 0.6 0.0 0.0 0.0 0.0 1.4 0.0 2.1 5.9 2.6 1.1 0.0 4.5 4.8 3.6 0.0 7.5 0.0 0.7 0.7 1.3 15.5 16.2 20.2 12.8 10.5 13.5 11.9 15.8 9.8 7.1 3.0 8.6 1.5 3.1 2.3 5.0 1.4 0.0 0.0 3.4 7.0 0.0 1.0 66.3 1.4 0.3 3.6 0.0 0.0 1.0 2.1 11.5 3.7 6.9 26.6 120.5 11.1 12.7 21.5 7.6 0.9 3.7 13.5 20.3 13.6 0.0 38.4 4.0 0.0 6.7 271.8 1.4 0.0 4.1 0.9 7.0 1.6 1.8 2.2 0.0 2.3 HSD17B2 "HSD17, SDR9C2" ENSG00000086696 "Hydroxysteroid 17-beta dehydrogenase 2" P37059 16 82035004-82098534 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.1;liver: 52.9;placenta: 110.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9" "Cancer enhanced" "Detected in many" "liver cancer: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6" "Group enriched" "Detected in some" 5 "midbrain: 2.6;pons and medulla: 3.5" "Not detected" "Not detected" "HPA021826, HPA050235" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA021826: AB_10961148, HPA050235: AB_2681059" "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.48e-2)" "unprognostic (2.58e-1)" "unprognostic (1.77e-1)" "unprognostic (4.29e-2)" "unprognostic (2.60e-1)" "unprognostic (7.35e-2)" "unprognostic (6.05e-3)" "unprognostic (4.98e-2)" "unprognostic (7.35e-2)" "unprognostic (6.31e-4)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.83e-4)" 0.7 0.1 0.2 4.1 0.2 0.0 3.9 0.2 0.3 0.7 41.3 0.3 0.2 71.3 0.6 0.2 1.7 0.2 13.3 0.2 0.2 0.2 2.8 52.9 1.0 0.2 0.2 0.2 0.2 16.0 0.0 0.6 110.8 0.4 3.1 9.4 21.3 9.4 0.2 0.3 1.8 83.1 1.5 0.2 0.2 3.2 0.2 0.2 0.2 0.2 1.1 1.3 21.4 6.6 1.3 1.4 3.6 1.1 1.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 22.4 0.0 0.0 4.1 0.6 0.0 4.5 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 17.8 0.1 0.1 0.1 0.0 1.2 0.0 10.7 0.2 0.3 0.0 0.0 0.1 3.3 0.0 0.0 0.3 0.1 32.8 8.1 0.0 0.0 0.4 0.4 36.8 0.2 0.6 0.0 1.0 0.1 0.0 0.0 0.0 20.6 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.6 1.1 0.6 0.7 0.5 0.4 0.6 0.4 0.4 0.3 1.3 0.4 0.6 3.6 1.0 0.6 1.4 0.3 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 3.0 3.8 0.0 2.7 0.3 0.1 0.4 137.6 6.7 2.3 0.0 0.0 2.1 0.0 47.5 0.1 0.2 250.1 0.0 5.5 1.5 3.1 1.8 0.0 98.5 3.0 0.0 2.9 3.1 2.4 0.8 0.0 0.0 1.7 0.0 19.3 42.0 13.6 199.9 0.0 1.0 0.6 0.0 0.3 0.0 0.0 1.0 5.4 0.0 33.8 10.0 HSD17B3 SDR12C2 ENSG00000130948 "Hydroxysteroid 17-beta dehydrogenase 3" P37058 9 96235306-96302152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 41.9" "Cell type enriched" "Detected in some" 8 "Leydig cells: 100.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA056833 Enhanced Approved Vesicles NA NA Vesicles "HPA056833: AB_2683252" "unprognostic (2.78e-1)" "unprognostic (6.61e-3)" "unprognostic (1.03e-1)" "unprognostic (5.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (3.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.74e-1)" "unprognostic (5.13e-2)" "unprognostic (3.26e-4)" "unprognostic (3.45e-1)" "unprognostic (5.48e-8)" "unprognostic (8.47e-3)" "unprognostic (1.15e-1)" "unprognostic (7.24e-2)" "unprognostic (3.11e-2)" 0.5 0.4 1.0 0.5 1.0 0.4 0.5 0.5 0.9 0.8 0.5 0.5 0.5 0.4 0.5 0.5 0.5 1.3 0.5 0.5 1.7 0.5 1.0 6.3 0.5 0.5 1.6 0.5 0.5 1.3 0.4 0.5 0.5 0.5 0.8 0.4 0.5 0.5 0.5 0.5 0.5 1.1 0.5 1.9 0.5 0.4 41.9 0.5 0.5 4.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 1.0 0.5 0.9 1.7 0.5 1.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.4 0.3 0.0 0.4 0.0 0.2 0.1 0.0 1.6 0.0 0.0 1.7 0.0 0.0 7.8 100.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 12.0 0.0 0.2 0.0 0.5 0.3 1.9 0.3 0.1 0.0 0.2 0.0 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 241.2" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 1569.2" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 11.8;U-266/84: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059141: AB_2683922" "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favorable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 1.1 0.5 3.6 1.4 5.2 0.2 0.3 1.2 2.4 9.4 3.3 0.5 2.6 0.6 4.1 0.7 1.6 0.9 2.6 0.4 1.6 1.4 0.5 241.2 8.7 0.3 2.0 2.6 1.1 0.3 0.2 0.0 0.9 0.6 7.9 1.3 1.4 0.2 10.2 0.2 0.2 0.7 11.3 1.0 6.2 0.8 3.2 0.8 0.0 13.3 0.0 0.3 9.9 2.3 2.0 2.0 0.1 1.3 0.1 3.4 0.8 0.3 0.7 1.7 0.3 1.7 1.2 2.0 3.6 3.1 1.7 1.7 0.4 0.4 10.2 1.5 0.4 0.5 0.3 5.3 0.9 1.0 6.5 2.0 3.2 1.0 0.5 1.1 1.6 5.3 0.9 0.3 1.0 0.5 0.5 0.0 9.0 0.9 11.8 0.8 2.1 4.6 1.0 6.6 0.6 0.6 6.3 0.7 2.5 0.2 1.2 9.7 2.0 1.7 3.1 0.8 0.6 0.5 1.3 0.3 0.8 0.8 3.6 0.9 10.3 14.6 6.7 1.2 5.9 0.6 0.0 0.2 0.1 3.0 0.6 3.4 2.0 2.5 2.4 0.6 1.1 3.3 2.2 0.0 0.1 1.3 2.0 2.8 0.8 3.6 5.2 1.2 2.4 1.6 1.4 2.0 2.6 0.6 0.8 160.8 89.7 28.7 2.3 1.1 0.2 0.2 35.7 2.7 17.0 0.0 0.0 1.3 0.0 0.0 2.5 0.4 0.0 23.3 0.0 2.4 4.8 9.9 0.0 1569.2 0.3 0.0 0.0 31.3 41.1 1.5 11.5 0.1 0.0 1.8 0.3 1.0 0.1 0.0 1.4 0.0 0.6 12.9 3.7 13.6 10.6 1.4 0.3 4.4 0.3 0.9 HSD17B7 "PRAP, SDR37C1" ENSG00000132196 "Hydroxysteroid 17-beta dehydrogenase 7" P56937 1 162790702-162812817 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.3;liver: 16.8" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047496 Approved NA NA "HPA047496: AB_2680068" "unprognostic (2.93e-1)" "unprognostic (1.36e-2)" "unprognostic (6.03e-2)" "unprognostic (1.12e-1)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (2.57e-1)" "unprognostic (2.51e-2)" "unprognostic (1.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.47e-5)" "unprognostic (6.25e-2)" "unprognostic (1.90e-1)" "unprognostic (6.35e-2)" "unprognostic (3.17e-2)" 1.9 9.2 1.4 2.0 1.0 0.7 4.3 1.4 1.9 2.8 2.9 3.1 2.1 4.4 4.7 2.2 1.6 1.6 1.9 2.6 2.2 16.8 4.3 3.7 1.5 3.6 2.6 2.5 4.1 1.8 2.8 4.0 3.1 1.3 2.0 3.6 3.1 1.8 3.2 2.9 2.9 0.6 2.8 3.9 2.2 2.8 12.5 9.6 15.8 7.4 7.0 16.3 10.5 6.3 6.5 17.3 7.7 10.0 10.8 11.3 2.6 8.3 5.1 10.2 9.0 20.6 15.3 5.9 2.2 31.0 10.3 15.7 22.2 5.3 6.7 8.4 3.9 4.9 14.1 8.3 6.9 6.9 6.5 12.4 19.6 6.4 4.0 8.4 10.7 7.3 10.6 4.3 4.5 8.9 7.4 11.0 12.3 8.1 5.0 10.4 9.8 18.0 10.2 14.8 7.7 4.1 4.0 3.9 15.6 6.5 8.8 4.9 2.3 5.6 3.5 5.0 6.5 6.4 15.2 3.7 0.6 5.7 15.8 6.0 11.2 13.9 6.1 14.6 12.5 10.5 13.4 6.5 10.9 13.0 13.1 5.0 7.0 7.4 9.6 16.3 10.5 0.0 23.8 19.9 22.2 9.7 23.0 2.0 15.3 18.7 15.9 10.4 58.9 14.2 3.3 11.4 1.7 11.7 10.9 0.0 23.7 12.6 13.1 20.2 4.7 22.5 11.6 11.1 5.8 7.4 2.8 1.0 6.4 13.0 16.9 10.0 7.9 14.1 12.6 14.0 6.7 9.3 42.9 0.0 11.3 2.1 5.4 11.0 16.0 20.2 8.5 11.5 HSD17B8 "D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1" ENSG00000204228 "Hydroxysteroid 17-beta dehydrogenase 8" Q92506 6 33204642-33206831 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 47.8" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 106.1;Proximal tubular cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042132 Enhanced NA NA 52000 "HPA042132: AB_10793978" "prognostic favorable (9.99e-4)" "unprognostic (4.24e-1)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (2.10e-1)" "unprognostic (8.11e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.50e-3)" "unprognostic (3.12e-1)" "unprognostic (1.34e-2)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "prognostic favorable (2.18e-12)" "unprognostic (2.82e-2)" "unprognostic (5.57e-1)" "unprognostic (3.09e-1)" "unprognostic (3.23e-2)" 3.5 11.5 4.1 5.4 4.1 3.0 6.1 3.4 5.9 5.3 12.4 5.3 17.7 6.6 3.2 14.7 11.3 8.1 8.6 11.0 4.1 3.7 13.9 24.0 8.1 7.7 5.3 4.6 3.3 47.8 12.8 6.6 3.5 4.7 4.5 5.6 9.3 16.7 30.1 14.6 10.6 11.2 4.1 5.3 5.4 5.8 5.1 2.4 10.3 11.2 15.5 10.7 5.3 5.2 4.8 4.8 0.4 3.1 4.1 7.8 6.0 1.1 2.1 1.0 1.3 0.3 0.6 0.4 0.1 0.7 0.0 0.0 1.5 2.5 7.0 2.0 0.1 0.3 4.2 1.0 3.2 0.1 1.2 1.2 0.3 2.0 3.8 3.0 0.0 0.5 0.7 4.3 0.0 7.4 0.0 0.3 2.5 0.1 6.8 0.6 2.3 5.2 0.1 0.3 3.3 0.9 3.0 0.1 14.8 4.1 0.1 2.0 1.1 0.4 5.6 1.3 0.7 9.6 0.2 0.1 0.2 1.2 0.0 0.0 14.6 7.0 2.6 0.4 0.1 0.2 0.0 1.4 0.4 4.8 3.1 7.8 4.8 7.2 7.3 2.8 3.1 7.6 7.8 0.1 4.1 3.1 4.8 5.2 6.0 4.1 4.1 3.4 5.9 4.1 3.7 5.3 4.6 4.7 2.4 17.9 16.3 6.7 21.5 26.4 10.3 24.3 38.2 26.8 14.8 21.0 5.9 25.7 106.1 24.6 5.1 8.5 30.9 23.3 28.3 10.1 10.0 13.7 6.9 60.4 14.9 1.6 17.2 6.7 8.9 11.1 6.9 10.0 47.2 10.0 23.7 28.7 19.1 21.0 5.6 106.8 11.8 0.0 5.9 7.5 5.5 32.5 14.5 14.0 43.6 21.3 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 36.4;SuSa: 16.3" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.0 0.4 0.5 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 115.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.8 0.0 0.0 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 1.9 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 HSD3B7 "C(27)-3BETA-HSD, SDR11E3" ENSG00000099377 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7" Q9H2F3 16 30985207-30989152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis Oxidoreductase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.1" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 52.9;Hofbauer cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 22 "basophil: 24.5;eosinophil: 13.5" "Lineage enriched" "Detected in single" 29 "granulocytes: 24.5" "Cell line enhanced" "Detected in many" "HDLM-2: 31.6;Hep G2: 23.1;HMC-1: 35.9;U-2197: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015965, HPA050521, HPA060847" Uncertain Enhanced "Lipid droplets" NA NA "Lipid droplets" "HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379" "unprognostic (5.41e-3)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.62e-2)" "unprognostic (5.06e-3)" "unprognostic (1.47e-2)" "unprognostic (3.52e-2)" "unprognostic (1.85e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (3.20e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (1.60e-6)" "unprognostic (2.45e-1)" "unprognostic (1.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.79e-1)" 21.6 11.2 2.5 7.5 4.7 1.8 7.3 2.7 4.0 4.9 8.3 4.6 2.8 11.2 5.3 6.4 9.4 4.4 7.4 5.2 3.1 1.6 25.6 74.1 6.4 5.6 3.5 1.4 9.3 17.7 5.6 2.6 6.1 3.7 5.9 3.2 2.9 4.5 2.6 5.1 7.8 13.3 6.7 4.8 8.3 4.8 3.6 3.7 1.0 2.9 4.5 4.6 8.0 3.9 0.1 0.8 24.5 0.8 0.2 0.0 0.3 7.0 8.1 0.8 4.1 2.9 10.7 0.5 8.8 14.0 1.7 3.6 0.6 12.3 0.4 2.9 10.8 0.3 2.1 0.8 1.3 0.9 31.6 1.9 0.5 6.4 23.1 2.7 0.1 35.9 5.1 2.2 8.4 1.7 4.1 0.8 0.4 1.6 0.3 6.6 15.1 0.2 5.0 0.6 3.0 1.1 0.8 2.8 7.8 5.4 0.4 3.0 1.5 1.1 5.8 0.8 0.4 11.2 0.5 4.1 3.7 1.0 34.9 0.9 0.6 5.1 0.4 14.3 0.9 0.3 24.5 0.8 13.5 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.3 2.5 4.7 2.7 4.0 3.1 1.6 3.5 1.4 3.7 3.7 3.0 6.2 2.7 2.2 7.0 0.7 1.6 25.5 1.4 0.0 14.0 0.0 1.7 13.3 34.6 37.8 6.5 20.6 0.0 26.8 2.6 9.0 2.5 9.2 52.9 55.1 1.6 7.5 6.7 7.9 1.1 6.1 14.8 13.5 21.6 7.2 1.9 19.4 11.2 4.9 33.2 0.4 12.9 9.0 0.6 1.1 11.0 1.1 1.0 15.7 2.4 HSDL2 "C9orf99, SDR13C1" ENSG00000119471 "Hydroxysteroid dehydrogenase like 2" Q6YN16 9 112379937-112472410 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 160.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 5 "granulocytes: 23.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042890, HPA050453" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA042890: AB_2678216, HPA050453: AB_2681131" "unprognostic (3.17e-3)" "unprognostic (1.62e-2)" "unprognostic (1.90e-3)" "prognostic favorable (9.23e-6)" "unprognostic (3.94e-2)" "unprognostic (1.43e-2)" "unprognostic (1.17e-1)" "unprognostic (5.15e-2)" "unprognostic (7.58e-2)" "unprognostic (6.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.82e-1)" "prognostic favorable (9.29e-7)" "unprognostic (1.44e-1)" "unprognostic (2.33e-1)" "unprognostic (1.35e-2)" "unprognostic (7.35e-2)" 31.0 26.3 18.3 5.8 17.7 4.1 13.8 5.7 12.1 10.1 14.1 11.9 6.2 15.2 11.0 5.0 14.4 8.8 7.6 52.1 16.1 13.7 29.3 70.5 11.4 7.8 17.9 10.8 21.3 11.4 7.9 7.7 9.9 12.4 12.2 11.0 10.2 7.3 6.9 54.1 12.5 18.3 13.3 12.9 10.1 9.9 5.9 14.5 5.7 13.2 27.7 6.9 14.2 10.7 3.6 4.6 23.3 5.0 2.6 4.1 2.4 15.0 13.5 10.2 5.1 17.7 17.5 11.7 10.3 6.4 7.4 6.2 25.9 17.0 9.7 5.7 15.1 9.5 17.3 10.9 14.5 9.1 40.5 7.2 10.0 21.8 25.3 11.0 5.6 6.5 18.6 10.5 11.0 8.0 10.8 8.5 11.9 13.9 6.5 20.1 9.9 13.9 5.3 6.0 36.1 17.5 9.1 30.7 14.2 15.6 13.7 7.3 5.2 25.9 17.2 8.7 8.7 24.3 6.9 9.7 10.7 10.0 29.7 10.0 7.7 18.9 4.6 13.2 8.4 6.2 21.9 4.0 15.2 2.3 3.9 3.5 3.3 2.5 2.6 4.5 3.6 3.0 3.1 23.3 2.6 5.0 4.6 4.1 2.4 18.3 17.7 5.7 12.1 16.1 13.7 17.9 10.8 12.4 14.5 92.3 61.8 13.9 14.4 11.7 9.4 160.9 12.7 48.2 43.3 14.0 5.9 21.7 54.7 13.9 135.8 13.9 29.7 0.0 16.4 25.3 13.4 15.9 30.0 98.6 31.2 6.4 14.3 19.6 18.9 127.6 25.3 23.6 8.5 56.9 28.3 22.3 14.4 24.6 44.2 86.7 14.6 45.3 30.3 11.8 16.2 14.2 26.5 7.5 34.3 26.2 HSF2BP ENSG00000160207 "Heat shock transcription factor 2 binding protein" O75031 21 43529192-43659493 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 28.5" "Group enriched" "Detected in many" 6 "Early spermatids: 98.0;Late spermatids: 32.5;Spermatocytes: 127.5;Spermatogonia: 47.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.5;NK-cells: 1.5;T-cells: 2.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 14.6" "Low region specificity" "Detected in some" "HPA031724, HPA075775" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA031724: AB_10601022, HPA075775: " "unprognostic (1.91e-2)" "unprognostic (1.19e-1)" "unprognostic (7.27e-3)" "unprognostic (1.54e-4)" "unprognostic (2.62e-1)" "unprognostic (1.78e-2)" "unprognostic (9.36e-4)" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (1.79e-1)" "unprognostic (3.11e-1)" "unprognostic (1.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.77e-4)" "unprognostic (6.00e-2)" 0.7 0.8 1.3 0.6 3.1 0.5 1.1 1.4 4.1 0.9 0.6 3.5 1.8 0.6 1.1 1.1 0.8 1.2 0.7 0.7 1.3 1.5 0.8 0.6 0.6 0.7 2.3 3.0 1.4 0.6 1.2 2.3 1.6 2.7 0.8 0.6 2.6 1.2 1.4 0.5 0.8 0.7 0.7 2.0 0.5 0.7 28.5 1.6 1.0 1.0 0.0 0.6 0.8 0.8 1.5 0.2 0.0 0.1 1.5 2.8 0.8 5.1 1.1 1.4 0.6 0.2 1.4 1.3 1.8 1.1 1.9 1.6 6.9 5.1 3.9 2.9 1.0 6.6 2.0 0.7 14.6 0.6 1.0 1.3 0.6 2.2 0.4 1.7 1.6 0.4 0.9 9.6 0.8 4.5 8.8 0.5 2.3 1.5 1.2 4.5 0.9 2.2 1.6 4.5 1.2 2.2 3.3 1.4 0.5 2.3 1.0 1.5 1.1 3.8 1.9 2.0 0.6 2.0 1.9 2.9 1.0 3.5 0.2 2.7 1.4 0.9 3.1 1.0 3.4 2.6 0.0 0.1 0.0 0.2 0.0 1.6 1.2 0.5 1.4 0.2 1.5 2.7 2.8 0.0 1.5 0.1 0.2 0.0 0.8 1.3 3.1 1.4 3.6 1.3 1.5 2.3 3.0 2.7 1.6 0.0 0.0 0.0 1.2 0.8 1.0 0.4 0.0 4.0 1.2 0.0 0.0 1.5 0.0 1.0 98.0 0.1 0.0 0.0 0.2 2.3 1.0 0.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 32.5 1.7 0.3 0.0 0.0 0.0 2.3 1.6 0.0 1.4 0.5 2.5 12.9 1.0 127.5 47.1 0.4 0.7 0.0 0.0 1.0 HSF5 FLJ40311 ENSG00000176160 "Heat shock transcription factor 5" Q4G112 17 58420167-58488384 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 65.6" "Group enriched" "Detected in some" 5 "Early spermatids: 28.4;Spermatocytes: 63.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "B-cells: 3.7;T-cells: 3.2" "Cell line enhanced" "Detected in single" "CACO-2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA063613 Enhanced NA NA "HPA063613: AB_2685060" "unprognostic (2.13e-1)" "unprognostic (1.21e-4)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (7.48e-3)" "unprognostic (7.40e-2)" "unprognostic (8.85e-3)" "unprognostic (2.13e-3)" "unprognostic (2.58e-2)" "unprognostic (6.65e-4)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (8.75e-2)" "unprognostic (3.64e-2)" 0.1 0.0 0.0 2.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 65.6 0.0 3.3 0.0 0.1 2.4 0.0 0.0 3.7 0.1 0.0 0.0 0.5 3.2 0.8 0.0 0.0 0.1 0.4 0.0 0.6 0.2 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 3.1 1.7 1.5 0.1 3.7 3.2 2.2 0.0 0.5 0.0 0.1 2.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.4 0.0 0.0 63.6 3.1 0.0 0.0 0.0 0.0 0.0 HSFX2 ENSG00000268738 "Heat shock transcription factor family, X-linked 2" Q9UBD0 X 149592515-149594716 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 9.3" "Cell type enriched" "Detected in single" 11 "Cardiomyocytes: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.7;naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 2.7;hTCEpi: 3.4" HPA063040 Supported NA NA "HPA063040: AB_2732695" "unprognostic (7.64e-2)" "unprognostic (6.92e-3)" "unprognostic (2.00e-1)" 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.5 0.1 0.1 0.3 0.6 1.3 0.1 0.5 0.0 0.1 0.0 0.0 9.3 0.0 0.0 0.1 0.2 0.5 1.7 0.2 0.2 1.8 0.3 0.6 0.0 1.9 0.3 0.0 1.1 0.2 1.0 0.9 1.2 0.1 1.6 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.9 0.8 0.0 0.9 0.8 0.0 0.2 0.2 0.2 0.8 1.6 3.4 1.2 0.0 0.4 0.0 1.0 0.0 0.0 0.0 1.0 0.2 2.5 0.9 0.5 1.3 0.1 0.0 0.4 1.4 0.8 0.0 0.4 0.0 0.5 1.1 0.9 0.3 0.9 1.4 2.4 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.5 0.5 1.7 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.2 1.8 0.1 1.1 0.2 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSFX3 ENSG00000283697 "Heat shock transcription factor family, X-linked member 3" A0A1B0GWH4 X 149548210-149549932 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.5;HEK 293: 1.3;HeLa: 1.6;NB-4: 2.4;PC-3: 1.5;SK-BR-3: 1.0;U-87 MG: 1.0" NA NA 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.4 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.7 0.0 2.4 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.4 0.1 0.3 0.0 0.4 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSFX4 ENSG00000283463 "Heat shock transcription factor family, X-linked member 4" A0A1B0GTS1 X 149929645-149931287 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "adrenal gland: 5.5;testis: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HeLa: 1.6;RT4: 2.0;U-266/70: 2.5" NA NA 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.6 0.1 0.1 0.2 0.6 0.9 0.8 0.0 0.0 0.4 0.6 0.0 0.0 0.0 1.7 0.0 0.5 0.4 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.4 0.3 1.6 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.2 0.0 2.0 1.3 0.2 0.0 0.0 0.2 0.5 0.4 0.2 0.9 0.5 0.9 1.4 0.9 2.5 0.0 0.2 0.2 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSFY1 "HSF2L, HSFY" ENSG00000172468 "Heat shock transcription factor, Y-linked 1" Q96LI6 Y 18546671-18588963 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.4;THP-1: 1.6" NA NA 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.8 0.2 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.7 0.6 1.8 0.5 0.5 0.5 0.2 0.2 0.0 0.1 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.5 0.4 0.4 0.1 0.7 0.0 0.7 0.0 0.0 0.0 0.5 0.9 0.0 0.3 0.9 0.8 0.3 0.4 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.0 1.4 0.0 0.0 0.4 0.1 0.7 0.3 0.0 0.2 0.0 0.6 0.3 0.2 0.8 0.6 0.0 0.2 0.5 0.2 0.6 1.6 0.6 0.4 0.0 0.0 0.9 0.4 0.4 0.2 0.2 0.1 0.5 1.8 0.5 0.3 0.3 0.2 0.2 0.3 0.3 0.4 0.2 0.7 0.2 0.4 1.0 0.5 0.1 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSFY2 FLJ25453 ENSG00000169953 "Heat shock transcription factor, Y-linked 2" Q96LI6 Y 18731440-18828662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 25 "testis: 18.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "TIME: 1.3" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSH2D "ALX, FLJ14886, HSH2" ENSG00000196684 "Hematopoietic SH2 domain containing" Q96JZ2 19 16134028-16158575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.4;lymphoid tissue: 33.8" "Cell type enhanced" "Detected in many" 14 "B-cells: 71.7;T-cells: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 47.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 13.2;HL-60: 13.7;HMC-1: 18.9;NB-4: 44.6;RPMI-8226: 20.0;U-266/84: 12.9;U-937: 43.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036616 Approved "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA036616: AB_10671962" "unprognostic (1.69e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (9.46e-6)" "unprognostic (1.06e-1)" "unprognostic (5.50e-3)" "unprognostic (5.21e-3)" "unprognostic (9.35e-2)" "unprognostic (4.78e-2)" "unprognostic (4.21e-3)" "unprognostic (9.96e-2)" "unprognostic (1.57e-2)" "unprognostic (2.22e-2)" "prognostic unfavorable (6.49e-6)" "unprognostic (9.17e-3)" "unprognostic (6.18e-2)" "unprognostic (3.21e-2)" "prognostic favorable (3.47e-5)" 1.2 1.1 1.2 31.5 1.1 19.2 1.2 1.1 1.1 1.4 8.9 0.0 5.2 5.5 1.1 6.2 2.0 1.5 10.3 1.2 1.1 1.1 1.3 1.5 6.0 16.7 1.0 0.0 1.1 4.8 0.9 3.7 2.3 0.3 2.2 4.0 1.0 8.8 5.2 1.1 1.1 12.1 0.7 1.1 21.8 5.4 1.1 0.0 8.5 1.7 2.4 33.8 4.7 1.1 14.5 6.0 47.4 8.4 19.0 4.3 3.6 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 7.0 13.2 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.7 0.0 0.2 0.1 0.8 0.0 13.7 18.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 12.4 0.0 2.8 0.0 44.6 0.0 1.7 0.0 0.9 0.0 20.0 0.1 1.8 0.0 0.0 0.0 0.4 0.1 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 1.9 12.9 7.3 0.0 43.8 0.0 47.4 3.7 23.0 4.3 5.0 3.9 14.5 1.9 2.8 6.0 8.6 1.8 2.3 43.7 19.0 8.4 1.8 2.9 3.6 1.2 1.1 1.1 1.1 1.1 1.1 1.0 0.0 0.3 0.0 3.0 9.9 71.7 0.7 0.2 0.0 0.6 2.5 4.0 4.5 5.2 0.0 2.1 0.0 5.3 0.0 0.0 13.5 0.0 4.4 3.1 0.4 4.3 5.8 0.0 1.1 0.0 8.1 1.8 1.5 0.0 0.0 2.5 10.1 2.8 14.1 0.0 6.8 10.5 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.1 2.9 40.6 7.7 3.2 HSP90AA1 "FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA" ENSG00000080824 "Heat shock protein 90 alpha family class A member 1" P07900 14 102080738-102139699 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 519.3" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 6915.7;Urothelial cells: 5558.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002058 Approved Supported Cytosol NA NA 94000000 Cytosol "CAB002058: " "prognostic unfavorable (5.59e-4)" "unprognostic (3.77e-2)" "unprognostic (1.78e-2)" "unprognostic (9.25e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (7.79e-3)" "unprognostic (5.71e-2)" "unprognostic (7.81e-3)" "unprognostic (3.68e-2)" "unprognostic (1.65e-2)" "prognostic favorable (1.18e-5)" "unprognostic (1.04e-1)" "unprognostic (2.54e-1)" "unprognostic (1.43e-1)" "unprognostic (1.12e-1)" 50.8 75.3 96.1 46.7 106.8 64.1 118.6 81.3 113.4 51.0 47.3 50.7 43.0 31.0 40.7 55.5 40.9 94.7 61.0 70.9 99.6 113.3 75.6 62.5 51.7 48.1 134.4 58.6 53.4 40.1 94.9 121.6 67.2 143.6 63.2 53.3 23.4 57.0 57.0 65.2 35.6 38.9 51.0 139.7 35.7 41.3 84.6 132.7 53.5 91.5 34.3 59.5 54.2 519.3 30.7 46.9 31.8 29.9 57.7 63.1 21.9 86.8 118.8 75.9 52.3 46.1 39.0 100.8 96.7 46.5 118.6 66.9 72.1 81.6 106.8 91.1 62.1 77.8 96.5 217.7 94.5 216.3 80.8 71.7 82.4 67.9 92.0 22.8 122.7 63.6 36.6 40.2 75.8 27.9 74.2 65.4 115.4 113.8 54.9 107.3 117.4 131.1 56.4 78.8 160.2 112.4 126.5 103.1 46.1 68.8 112.3 100.0 72.2 122.2 92.0 53.9 132.9 118.3 49.0 46.2 83.0 53.7 123.3 183.5 52.0 162.1 158.0 78.5 75.9 99.9 31.8 19.9 24.0 47.8 29.9 63.1 29.6 40.5 49.0 23.9 30.7 30.1 43.5 13.5 57.7 27.5 46.9 39.2 21.9 96.1 106.8 81.3 102.7 99.6 113.3 134.4 58.6 143.6 132.7 1057.1 642.7 718.4 6915.7 1191.0 1040.4 2043.0 677.7 2973.9 1019.1 486.8 1981.1 1152.8 290.1 998.3 319.6 818.5 645.6 934.5 749.7 1610.0 1217.1 2796.5 903.1 527.2 1188.6 683.3 908.6 338.8 568.8 289.5 677.7 1578.9 1233.2 998.3 507.2 1211.6 739.1 659.3 679.6 610.3 3287.9 608.0 1393.6 3574.3 1881.8 973.5 1714.6 761.4 693.9 5558.4 HSP90B1 "GP96, GRP94, TRA1" ENSG00000166598 "Heat shock protein 90 beta family member 1" P14625 12 103930107-103953645 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 325.1;thyroid gland: 338.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003901, CAB005224, HPA008424, CAB078151" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 410000000 "Endoplasmic reticulum" "CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184" "unprognostic (1.03e-1)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (5.70e-2)" "unprognostic (1.17e-2)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (7.22e-2)" "unprognostic (8.77e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.03e-10)" "unprognostic (2.95e-1)" "unprognostic (2.39e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-2)" 49.0 57.1 26.9 50.0 32.0 45.9 60.3 16.5 25.5 45.7 43.4 17.5 108.5 32.1 42.2 127.2 34.3 42.0 32.4 67.0 27.1 32.0 74.0 325.1 46.6 49.2 31.5 26.0 53.9 95.5 47.1 50.0 123.6 29.4 46.9 46.9 15.8 43.8 136.8 25.4 19.2 54.4 45.0 37.8 89.3 37.0 25.7 27.9 44.5 338.5 24.0 36.9 66.1 106.1 25.6 81.0 22.2 23.8 40.2 53.3 33.9 72.0 39.1 78.9 81.0 80.8 76.3 107.1 121.5 91.9 64.7 86.4 69.7 67.6 21.1 96.6 127.5 83.5 50.4 77.7 130.5 87.4 49.8 29.6 56.7 44.1 71.9 124.7 57.1 44.4 44.7 58.2 79.7 114.4 219.3 124.5 25.7 45.3 80.2 85.5 25.9 34.3 63.9 64.9 73.3 47.1 31.3 50.9 88.1 86.6 45.5 23.4 56.2 75.8 78.5 76.6 126.8 63.8 84.9 71.6 49.0 42.0 39.8 50.6 82.1 76.8 39.0 97.7 42.3 75.8 22.2 21.2 6.9 45.6 23.8 53.3 25.6 26.7 39.3 28.0 15.9 18.0 31.3 4.9 40.2 19.3 81.0 16.4 33.9 26.9 32.0 16.5 25.5 27.1 32.0 31.5 26.0 29.4 27.9 220.3 319.5 129.9 714.2 274.9 44.0 581.2 221.7 394.9 445.9 244.3 147.3 520.4 48.0 366.6 40.3 299.0 344.0 186.9 218.9 824.3 597.0 564.5 392.9 721.4 494.0 73.1 389.8 556.8 268.7 19.1 521.5 350.1 399.9 234.4 276.1 146.4 329.7 262.6 317.5 229.3 75.2 213.4 401.9 313.5 187.6 227.8 770.3 202.8 314.4 519.2 HSPA12A "FLJ13874, KIAA0417" ENSG00000165868 "Heat shock protein family A (Hsp70) member 12A" O43301 10 116671192-116850236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.7" "Cell type enhanced" "Detected in many" 7 "Leydig cells: 58.7;Muller glia cells: 46.8;Peritubular cells: 64.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "basophil: 3.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011273, HPA073244" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA011273: AB_1851190, HPA073244: AB_2686586" "unprognostic (7.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-2)" "unprognostic (1.44e-1)" "unprognostic (7.31e-3)" "unprognostic (5.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.32e-1)" "unprognostic (3.62e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (3.75e-1)" "unprognostic (5.55e-4)" 21.2 24.9 15.4 4.0 21.8 1.1 7.5 10.2 47.7 7.6 6.3 6.8 3.3 2.1 9.4 8.0 5.3 9.1 5.9 6.4 17.1 15.5 23.5 1.9 2.8 2.0 17.1 17.8 23.5 3.0 4.0 17.2 4.2 23.3 4.1 4.9 7.4 3.6 9.1 4.9 9.5 2.9 8.6 8.2 3.6 2.8 8.2 8.6 0.0 6.8 1.2 1.6 4.1 6.6 0.0 0.0 3.1 0.0 0.0 0.4 0.0 2.3 9.0 0.9 7.9 9.1 6.6 0.4 4.6 9.1 2.3 1.2 8.3 0.1 0.0 2.4 5.6 3.2 5.9 5.8 0.7 7.5 0.0 3.1 0.0 3.2 8.8 1.2 0.0 0.7 2.7 3.6 6.7 0.6 11.7 0.0 0.1 0.0 0.0 1.2 1.5 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.1 34.2 0.1 2.0 11.8 2.6 2.2 3.1 2.0 1.7 0.0 0.0 2.1 3.6 12.0 4.4 0.1 0.0 0.0 3.7 0.0 1.5 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 21.8 10.2 32.4 17.1 15.5 17.1 17.8 23.3 8.6 6.0 2.2 0.0 1.3 9.8 28.7 7.4 0.0 18.7 3.4 12.2 21.6 0.0 13.3 3.5 4.2 2.9 0.0 0.0 2.9 0.1 10.4 1.1 0.0 0.2 0.1 28.6 0.0 4.3 0.0 6.5 58.7 1.1 25.3 0.0 0.0 46.8 2.5 0.0 64.3 21.4 8.6 12.9 15.6 0.6 5.9 4.4 0.2 0.0 0.0 0.7 HSPA1A "HSP70-1, HSPA1" ENSG00000204389 "Heat shock protein family A (Hsp70) member 1A" P0DMV8 6 31815464-31817946 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "breast: 216.1;vagina: 741.6" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 6419.7;Glandular cells: 2245.3;Urothelial cells: 2114.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5" "Cell line enriched" "Detected in some" 10 "HEK 293: 310.1" "CAB017451, CAB032815, HPA052504" Supported Approved Nucleoplasm,Vesicles,Cytosol NA Yes 77000000 "Nucleoplasm, Vesicles" Cytosol "CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (6.17e-3)" "unprognostic (2.47e-2)" "unprognostic (1.74e-2)" "unprognostic (8.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" "unprognostic (6.48e-2)" "unprognostic (4.12e-2)" "unprognostic (1.51e-1)" 29.1 74.5 35.3 18.4 48.0 3.5 216.1 40.4 36.0 8.8 22.6 27.4 41.1 3.6 33.1 32.3 36.7 14.5 14.6 40.3 37.5 28.8 35.3 49.5 54.7 14.1 89.2 10.8 15.1 31.2 3.5 23.8 22.1 67.4 47.8 11.4 6.1 28.3 52.7 66.7 57.9 17.3 36.4 47.0 35.6 19.3 10.9 85.9 1.3 26.8 16.3 11.8 41.3 741.6 1.0 0.5 8.8 4.7 1.2 4.5 0.5 0.0 31.3 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.7 0.0 0.0 0.0 2.3 0.0 0.2 310.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.4 4.5 1.8 4.7 1.0 1.0 2.5 2.3 0.5 0.4 1.2 1.1 8.8 1.2 2.5 0.5 4.5 0.5 35.3 48.0 40.4 36.0 37.5 28.8 89.2 10.8 67.4 85.9 137.0 84.3 135.2 6419.7 321.9 290.0 857.6 71.4 100.4 76.2 120.4 357.4 38.6 34.9 77.7 73.7 681.4 145.3 0.0 18.8 85.4 940.7 2245.3 456.0 74.4 220.0 193.9 449.0 109.9 284.5 25.8 558.4 1365.8 796.3 117.2 187.3 954.1 43.5 340.1 151.0 60.4 639.2 148.8 1629.0 48.6 175.8 294.0 87.2 208.8 111.9 2114.2 HSPA1B HSP70-2 ENSG00000204388 "Heat shock protein family A (Hsp70) member 1B" P0DMV9 6 31827735-31830255 "Predicted intracellular proteins" "Host-virus interaction, Stress response" "Chaperone, Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 508.1" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 2896.7;Glandular cells: 1002.7;Smooth muscle cells: 978.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A549: 24.5;Karpas-707: 72.8" "CAB008640, HPA052504" Approved Approved Nucleoplasm,Vesicles,Cytosol NA Yes "Vesicles, Cytosol" Nucleoplasm "CAB008640: AB_1617331, HPA052504: AB_2681854" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (4.23e-3)" "unprognostic (3.23e-2)" "unprognostic (3.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.76e-3)" "unprognostic (9.50e-2)" "unprognostic (3.45e-1)" "unprognostic (4.42e-2)" "unprognostic (6.92e-2)" "unprognostic (4.88e-2)" "unprognostic (5.74e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-3)" "unprognostic (4.69e-2)" "unprognostic (5.99e-2)" 21.9 89.9 25.0 20.3 31.1 5.7 129.4 30.8 23.6 8.4 14.6 17.0 36.6 6.2 19.9 40.5 24.4 13.2 12.6 29.2 25.5 22.5 18.6 28.7 30.8 6.3 61.9 8.5 29.3 36.7 35.1 21.6 6.4 53.8 31.1 8.4 5.6 39.7 48.5 102.8 11.3 11.0 27.9 33.4 10.0 20.5 11.8 55.1 0.9 32.1 14.3 9.7 43.4 508.1 1.1 0.6 1.4 1.3 0.4 0.4 0.3 0.2 24.5 0.1 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 7.6 1.3 0.0 1.0 0.0 0.0 0.0 0.5 7.6 0.0 0.2 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 72.8 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.0 0.1 5.1 0.0 0.1 11.9 0.1 0.1 0.0 0.0 0.0 0.5 1.3 1.4 0.1 0.2 0.1 0.2 0.4 0.0 0.6 1.1 0.0 0.0 0.8 0.4 0.7 0.5 0.3 0.3 25.0 31.1 30.8 23.6 25.5 22.5 61.9 8.5 53.8 55.1 104.2 64.8 61.6 2896.7 212.6 40.4 440.6 20.4 54.9 58.0 66.3 123.7 73.9 16.6 33.6 1.7 185.0 221.9 0.0 13.7 87.7 515.0 1002.7 354.9 16.3 116.6 44.5 304.9 19.6 74.0 3.1 204.3 481.3 609.0 26.2 172.9 237.3 22.8 291.0 51.6 32.9 140.4 103.5 978.7 12.8 50.3 194.0 217.2 75.6 121.8 675.8 HSPA1L "HSP70-HOM, hum70t" ENSG00000204390 "Heat shock protein family A (Hsp70) member 1 like" P34931 6 31809619-31815065 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "testis: 29.1;vagina: 17.0" "Group enriched" "Detected in many" 19 "Early spermatids: 201.6;Late spermatids: 418.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.8;U-266/70: 2.8;U-266/84: 2.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA043285, HPA052504" Enhanced Approved Nucleoplasm,Vesicles NA NA 49000000 Vesicles Nucleoplasm "HPA043285: AB_10962482, HPA052504: AB_2681854" "unprognostic (1.80e-1)" "unprognostic (8.70e-2)" "unprognostic (2.52e-3)" "unprognostic (6.97e-4)" "unprognostic (2.69e-2)" "unprognostic (1.17e-2)" "unprognostic (4.24e-2)" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "prognostic favorable (1.02e-4)" "unprognostic (5.26e-3)" "unprognostic (9.96e-2)" "prognostic favorable (4.63e-4)" "unprognostic (4.48e-2)" "unprognostic (4.30e-1)" "unprognostic (1.02e-1)" "unprognostic (1.53e-3)" 0.4 0.5 1.8 0.5 2.2 0.5 1.2 1.4 3.1 0.5 0.7 1.5 0.0 0.3 0.8 3.0 0.8 1.5 0.3 0.5 2.0 1.1 0.9 0.7 1.7 0.7 4.5 0.8 1.1 1.5 0.3 0.7 1.0 2.6 1.2 0.6 0.2 0.4 1.5 3.9 0.6 0.8 0.5 4.6 1.1 0.8 29.1 3.2 0.0 2.0 0.0 0.7 0.5 17.0 0.3 0.0 0.4 0.1 0.0 1.7 1.1 0.0 1.7 0.0 0.0 1.9 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 1.0 0.0 0.0 6.8 0.0 0.0 0.2 0.2 1.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.2 0.0 0.0 0.2 0.3 0.0 2.8 2.4 0.0 1.7 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.0 1.3 0.0 0.3 1.5 1.6 0.3 0.0 0.0 0.0 1.7 1.1 1.8 2.2 1.4 3.1 2.0 1.1 4.5 0.8 2.6 3.2 0.0 0.6 0.0 0.6 0.8 2.1 3.6 0.0 1.4 1.2 0.0 7.9 0.4 0.0 0.7 201.6 1.0 0.5 0.0 0.2 0.4 0.5 1.1 0.0 0.9 1.1 3.2 1.7 3.1 2.4 418.3 4.6 1.5 5.0 1.8 0.6 3.3 0.3 0.8 2.1 0.3 2.8 0.0 1.4 16.4 7.7 0.1 0.3 2.5 1.0 0.3 HSPA2 ENSG00000126803 "Heat shock protein family A (Hsp70) member 2" P54652 14 64535905-64546173 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0;skeletal muscle: 90.5" "Group enriched" "Detected in many" 5 "Collecting duct cells: 125.6;Distal tubular cells: 202.2;Extravillous trophoblasts: 456.2;Spermatocytes: 391.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 25.1;BEWO: 39.2;BJ hTERT+: 33.5;CAPAN-2: 17.8;SCLC-21H: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000798, HPA052504" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA 77000000 Vesicles Nucleoplasm "HPA000798: AB_1079090, HPA052504: AB_2681854" "prognostic favorable (1.78e-4)" "unprognostic (1.72e-1)" "unprognostic (2.73e-1)" "unprognostic (1.08e-2)" "unprognostic (3.78e-2)" "unprognostic (2.90e-2)" "unprognostic (7.11e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.31e-1)" "unprognostic (3.14e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" 5.2 3.3 21.1 5.2 45.3 1.5 5.2 3.7 37.6 3.3 23.3 87.0 0.1 4.4 13.8 12.8 25.2 7.2 4.2 22.8 33.2 18.7 26.6 2.6 4.5 3.2 71.0 20.6 2.4 3.8 7.5 4.3 37.6 37.7 3.8 6.9 3.5 10.2 4.0 90.5 14.8 7.8 17.9 83.8 8.5 5.7 58.8 65.2 0.0 2.3 8.2 3.9 12.4 4.0 0.7 0.3 2.4 0.6 0.9 3.7 0.5 9.9 25.1 3.9 0.0 2.8 0.2 39.2 14.2 33.5 5.7 9.4 0.9 17.8 2.4 5.7 15.4 1.2 11.2 0.0 0.7 3.5 1.4 1.9 0.0 1.4 0.0 2.8 0.0 3.4 1.3 0.5 0.8 0.0 1.4 0.4 0.1 0.0 2.0 2.8 4.4 0.1 0.1 2.8 3.8 3.0 1.9 0.0 0.0 8.8 1.5 34.8 2.0 0.6 1.2 0.0 1.4 0.9 1.0 0.5 0.1 0.0 1.2 0.0 2.6 0.0 0.0 3.1 0.0 3.8 0.9 0.2 0.1 1.8 0.4 0.1 0.7 1.7 0.8 0.0 0.5 0.6 0.6 2.4 0.9 0.6 0.3 3.7 0.5 21.1 45.3 3.7 28.3 33.2 18.7 71.0 20.6 37.7 65.2 0.0 6.9 3.7 22.1 48.0 0.8 28.8 5.1 0.0 1.2 125.6 0.0 29.0 202.2 6.3 19.7 28.0 12.9 0.0 4.7 456.2 53.6 6.7 12.7 0.8 13.8 0.0 27.0 29.4 4.3 20.1 8.1 5.5 28.7 0.0 33.0 13.8 5.0 6.6 7.1 1.2 2.3 25.8 25.0 391.8 54.3 36.9 63.5 5.3 9.3 12.3 HSPA4L "APG-1, HSPH3, Osp94" ENSG00000164070 "Heat shock protein family A (Hsp70) member 4 like" O95757 4 127781821-127840733 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.0;vagina: 32.0" "Group enriched" "Detected in many" 4 "Early spermatids: 393.1;Late spermatids: 711.4;Spermatocytes: 194.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "HAP1: 38.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034450, HPA039149, HPA061446" Enhanced Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520" "unprognostic (6.66e-2)" "unprognostic (2.39e-1)" "unprognostic (5.33e-2)" "unprognostic (9.40e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (1.23e-3)" "unprognostic (2.41e-1)" "unprognostic (3.90e-1)" "unprognostic (2.38e-4)" "unprognostic (1.40e-2)" "unprognostic (3.28e-1)" "prognostic favorable (3.80e-9)" "unprognostic (8.53e-2)" "unprognostic (1.56e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (6.78e-4)" 1.6 9.3 7.4 1.4 9.0 2.8 5.5 16.6 11.4 2.9 2.5 1.7 1.6 2.5 1.5 1.7 10.9 5.9 3.5 5.3 6.1 10.1 10.6 5.9 1.9 1.0 6.6 6.6 3.5 3.6 12.2 23.2 2.8 20.1 3.9 3.5 3.5 4.6 4.7 1.5 6.5 1.6 3.8 5.0 1.4 2.1 73.0 5.2 1.0 3.7 4.1 4.0 2.8 32.0 0.7 0.5 3.9 0.4 0.5 0.4 0.1 9.1 12.0 6.5 10.3 4.5 4.6 7.6 4.2 1.7 4.0 4.5 8.8 4.2 0.0 7.7 1.2 3.3 2.1 38.0 15.0 5.6 17.0 11.3 4.9 16.5 10.7 1.7 18.8 8.4 4.2 14.0 2.6 9.6 4.2 5.2 4.3 8.7 5.6 5.0 6.6 6.0 1.6 1.5 9.7 10.0 0.0 0.7 0.9 13.8 4.2 12.0 4.4 7.5 13.1 0.7 4.1 10.0 3.2 1.4 1.4 0.0 1.7 10.0 11.0 12.6 2.9 5.5 12.9 4.3 1.6 0.4 3.9 0.4 0.2 0.2 0.4 0.3 0.3 0.5 0.7 0.4 0.4 1.3 0.5 0.3 0.4 0.3 0.1 7.4 9.0 16.6 11.4 6.1 10.1 6.6 6.6 20.1 5.2 3.0 9.4 0.8 68.9 25.2 54.9 12.6 12.7 56.2 31.8 8.7 98.2 9.5 16.6 6.7 393.1 5.4 0.4 0.0 2.5 1.7 7.0 17.8 15.1 8.3 1.0 38.1 17.6 2.5 1.6 711.4 9.5 7.3 8.5 4.6 2.0 15.2 3.2 0.0 9.2 19.6 62.8 0.0 15.5 194.6 9.3 37.1 14.0 2.9 2.9 72.9 HSPA6 HSP70B' ENSG00000173110 "Heat shock protein family A (Hsp70) member 6" P17066 1 161524540-161526910 "Plasma proteins, Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;vagina: 99.8" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 208.5;Cone photoreceptor cells: 119.8;Glandular cells: 327.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 67.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 67.6" "Cell line enriched" "Detected in some" 7 "Karpas-707: 34.0" "CAB017452, HPA028549, HPA052504" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854" "unprognostic (3.90e-2)" "unprognostic (2.05e-1)" "unprognostic (5.87e-2)" "unprognostic (2.59e-1)" "unprognostic (2.40e-1)" "unprognostic (6.36e-3)" "prognostic unfavorable (7.26e-4)" "unprognostic (4.61e-2)" "unprognostic (1.29e-1)" "unprognostic (1.93e-1)" "unprognostic (1.68e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" 6.8 11.9 9.4 10.3 12.4 3.5 43.0 3.5 6.0 1.4 1.9 2.2 1.7 1.9 2.2 1.3 3.2 1.1 9.6 4.5 4.5 9.3 3.1 14.6 13.5 2.1 13.7 1.3 9.3 5.4 0.9 5.4 20.8 5.7 3.3 1.9 1.7 2.9 5.8 1.4 4.4 1.7 4.2 13.2 11.2 3.6 1.4 5.0 1.3 5.8 1.8 2.8 3.1 99.8 0.0 2.5 67.6 9.0 1.6 1.4 2.1 0.5 1.0 0.0 0.2 0.0 0.8 0.7 0.4 0.3 0.1 0.3 0.3 0.5 0.1 1.5 0.1 0.5 0.2 0.3 0.2 0.2 0.3 0.0 0.2 0.9 0.0 0.0 0.1 2.2 0.1 0.7 0.3 0.0 0.0 0.0 0.1 0.4 34.0 0.0 0.0 0.1 0.8 0.0 0.2 3.6 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.1 0.6 1.9 0.1 0.3 0.4 0.1 0.1 0.3 0.3 2.3 4.7 0.2 0.0 0.9 0.8 1.5 0.8 7.5 2.7 1.4 9.0 0.2 0.0 0.1 0.7 2.5 0.0 0.0 0.3 67.6 1.6 7.3 0.0 0.0 2.1 9.4 12.4 3.5 6.0 4.5 9.3 13.7 1.3 5.7 5.0 8.9 12.4 14.4 208.5 26.1 28.3 9.9 0.0 2.7 2.3 5.2 119.8 0.9 0.0 0.1 1.3 20.4 0.0 0.0 0.0 6.9 58.3 327.0 2.3 0.0 62.4 9.5 68.0 1.3 51.5 0.4 5.2 96.6 97.8 0.0 0.0 27.5 0.4 0.0 0.0 1.0 32.8 0.0 68.0 1.9 0.2 19.1 15.3 34.5 0.0 46.1 HSPB1 "CMT2F, Hs.76067, Hsp25, HSP27, HSP28" ENSG00000106211 "Heat shock protein family B (small) member 1" P04792 7 76302544-76304295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 565.5" "Group enriched" "Detected in many" 4 "Basal glandular cells: 13325.7;Exocrine glandular cells: 5786.9;Urothelial cells: 14386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 165.4;MCF7: 232.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000497, CAB004439, CAB047330, CAB047331, CAB047332" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 57000000 "Plasma membrane, Cytosol" "CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172" "unprognostic (2.55e-1)" "unprognostic (7.25e-3)" "prognostic unfavorable (9.94e-5)" "unprognostic (7.07e-3)" "unprognostic (3.47e-3)" "unprognostic (6.61e-3)" "unprognostic (4.08e-3)" "unprognostic (4.50e-2)" "unprognostic (1.27e-1)" "unprognostic (9.78e-2)" "unprognostic (8.70e-2)" "unprognostic (2.21e-1)" "unprognostic (5.72e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.56e-1)" "unprognostic (3.63e-1)" 67.6 41.7 23.0 42.9 22.8 7.3 186.2 10.1 21.3 127.6 84.9 10.8 89.2 27.1 126.5 65.9 410.5 57.7 52.2 164.8 21.4 22.5 85.4 26.3 43.3 25.1 25.7 14.3 63.4 34.7 16.6 15.5 106.9 32.8 99.6 12.0 31.1 50.5 101.3 439.2 164.4 24.6 139.7 27.3 17.8 37.6 22.0 23.4 31.9 72.9 207.3 126.8 146.2 565.5 27.8 17.8 4.1 27.9 23.2 36.8 14.4 74.1 55.2 6.0 44.0 35.9 31.7 0.3 31.5 16.7 17.1 21.5 4.9 43.5 0.6 24.4 40.9 35.3 68.1 25.8 18.4 5.6 41.4 8.7 3.4 42.6 23.3 19.2 5.0 31.1 39.4 165.4 25.8 3.8 32.5 56.6 12.7 27.0 75.8 19.6 232.3 8.4 34.3 30.2 15.0 48.3 26.2 12.1 60.3 25.5 28.3 0.4 33.8 22.2 90.4 28.2 17.6 106.6 35.5 30.5 51.5 76.9 16.0 79.5 5.3 8.7 0.7 37.7 15.5 37.5 4.1 4.5 2.8 18.6 21.1 9.6 27.5 30.6 20.2 11.1 27.8 36.8 31.5 1.7 23.2 27.9 17.8 19.7 14.4 23.0 22.8 10.1 21.3 21.4 22.5 25.7 14.3 32.8 23.4 253.1 212.2 115.1 13325.7 1643.2 181.1 724.5 257.4 163.3 246.9 1085.2 304.3 116.8 1271.6 1614.7 8.7 728.0 540.2 0.0 5786.9 328.3 1183.3 2785.1 218.6 220.1 1062.0 66.7 404.2 589.9 103.8 18.4 277.3 433.3 1950.2 307.4 101.7 223.5 2381.8 1422.3 502.4 1699.1 24.3 601.5 2360.7 6.2 90.5 1959.6 2034.5 83.1 148.1 14386.7 HSPB2 "Hs.78846, MKBP" ENSG00000170276 "Heat shock protein family B (small) member 2" Q16082 11 111912242-111914093 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 40.5;heart muscle: 51.6;skeletal muscle: 52.6" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 95.6;Fibroblasts: 55.7;Leydig cells: 40.3;Melanocytes: 35.4;Smooth muscle cells: 44.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 15.7;ASC TERT1: 6.2;fHDF/TERT166: 20.8;HSkMC: 7.4;LHCN-M2: 12.0;U-138 MG: 9.2" HPA079414 Approved NA NA "HPA079414: " "unprognostic (5.46e-2)" "unprognostic (1.46e-1)" "unprognostic (2.30e-1)" "unprognostic (7.69e-3)" "unprognostic (6.82e-2)" "unprognostic (1.51e-2)" "unprognostic (4.37e-2)" "unprognostic (3.25e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-2)" "unprognostic (3.55e-2)" "unprognostic (2.19e-1)" "unprognostic (1.36e-1)" "unprognostic (1.69e-3)" "unprognostic (2.63e-1)" "unprognostic (1.99e-1)" "unprognostic (1.46e-2)" 11.5 2.5 3.1 2.8 3.6 0.8 40.5 7.8 3.7 8.4 5.8 1.4 3.9 1.7 8.2 10.6 5.4 5.3 6.3 51.6 2.8 2.5 5.0 1.2 4.7 7.5 3.8 2.5 6.0 1.3 0.8 0.8 4.2 4.0 4.8 2.5 5.1 2.5 5.3 52.6 4.4 2.4 8.5 3.0 2.2 2.9 3.6 2.0 0.0 2.7 22.0 1.5 6.7 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 15.7 6.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 7.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 9.2 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.6 7.8 3.7 2.8 2.5 3.8 2.5 4.0 2.0 0.0 0.0 0.0 0.2 6.3 0.2 95.6 0.0 0.0 1.2 1.8 0.0 0.8 1.7 0.4 0.0 1.6 0.0 0.0 0.0 0.8 55.7 0.3 0.0 0.0 1.2 0.0 0.0 6.7 0.0 0.0 40.3 0.8 35.4 0.0 0.0 5.6 0.1 0.0 20.5 14.6 0.5 12.9 44.2 0.3 0.4 5.1 1.3 0.0 0.0 0.0 HSPB3 HSPL27 ENSG00000169271 "Heat shock protein family B (small) member 3" Q12988 5 54455601-54456384 "Disease related genes, Predicted intracellular proteins" "Stress response" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3" "Cell type enriched" "Detected in some" 55 "Cardiomyocytes: 353.4" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 7.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 37.9;fHDF/TERT166: 17.0;HSkMC: 7.4;LHCN-M2: 5.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA062124 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA062124: AB_2684690" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.78e-3)" "unprognostic (3.06e-1)" "unprognostic (2.25e-3)" "unprognostic (1.13e-1)" "unprognostic (4.41e-3)" "unprognostic (6.42e-2)" "unprognostic (1.85e-1)" "unprognostic (2.70e-2)" "unprognostic (2.73e-1)" "unprognostic (2.82e-2)" "unprognostic (7.15e-2)" 0.7 0.1 1.1 0.1 1.0 0.0 0.5 0.0 2.7 0.2 1.0 0.0 0.1 0.1 1.8 4.3 3.7 0.7 0.1 106.0 0.5 0.4 0.0 0.0 0.5 0.0 0.1 1.1 0.3 0.0 0.0 0.9 0.0 0.2 2.0 0.5 0.1 2.1 0.2 46.1 0.5 0.2 2.4 0.0 0.2 0.2 0.3 0.0 0.0 0.1 22.3 0.9 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 37.9 0.0 0.0 0.1 0.0 0.0 0.1 17.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 7.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 1.0 0.0 2.7 0.5 0.4 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.2 5.7 0.0 353.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.5 5.7 0.5 0.0 4.5 0.1 0.0 0.0 0.3 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754569-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 356.8" "Group enriched" "Detected in many" 5 "Leydig cells: 251.7;Peritubular cells: 207.2;Smooth muscle cells: 65.1" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 189.0;ASC TERT1: 79.8;HHSteC: 64.1;HSkMC: 74.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 86000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610" "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.43e-6)" 95.3 39.5 3.9 18.3 8.1 1.1 40.5 1.1 6.1 49.7 48.4 3.8 18.6 5.7 42.6 57.4 24.6 33.3 80.6 132.0 4.4 2.4 6.2 3.5 8.7 7.2 5.4 2.8 53.4 5.8 1.7 1.2 12.7 8.1 42.1 8.7 18.2 8.6 35.8 356.8 2.5 14.3 128.2 10.2 1.9 32.4 22.6 4.9 0.0 11.0 153.5 16.4 121.6 23.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 189.0 79.8 0.1 8.4 0.1 0.5 0.9 0.1 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 64.1 0.0 0.1 74.6 0.0 1.9 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 1.8 0.0 0.1 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 8.1 1.1 6.1 4.4 2.4 5.4 2.8 8.1 4.9 3.0 1.1 0.0 0.2 1.5 7.4 26.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 19.2 2.2 0.0 0.0 0.0 2.8 35.4 0.4 0.0 0.0 4.5 0.0 0.0 28.3 0.3 14.1 251.7 2.0 1.7 1.0 0.0 30.6 0.2 0.0 207.2 0.0 2.1 25.8 65.1 2.2 1.2 1.8 4.0 0.0 0.0 0.5 HSPB7 cvHSP ENSG00000173641 "Heat shock protein family B (small) member 7" Q9UBY9 1 16014028-16019594 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "heart muscle: 524.6;skeletal muscle: 551.1" "Cell type enriched" "Detected in many" 48 "Cardiomyocytes: 2261.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "fHDF/TERT166: 83.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA027639 Approved Approved Nucleoplasm NA NA 43000 Nucleoplasm "HPA027639: AB_10601756" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (1.28e-3)" "unprognostic (7.44e-3)" "unprognostic (8.35e-2)" "prognostic unfavorable (5.29e-4)" "unprognostic (1.02e-1)" "unprognostic (5.32e-2)" "unprognostic (2.47e-3)" "unprognostic (3.19e-3)" "unprognostic (6.94e-2)" "unprognostic (1.55e-1)" "unprognostic (1.20e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (1.26e-4)" 32.3 9.6 0.1 3.3 0.1 0.1 9.0 0.9 0.2 7.0 8.4 0.3 1.3 0.7 12.6 8.0 15.7 4.5 8.2 524.6 0.1 0.0 4.1 0.2 1.2 2.7 0.2 0.3 4.8 1.0 1.1 0.2 0.7 0.9 4.7 0.9 1.7 4.4 2.7 551.1 1.0 2.1 20.1 0.4 0.3 6.1 1.3 0.0 0.0 9.6 70.1 7.2 12.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 19.6 0.8 0.4 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.3 0.0 0.3 0.0 3.9 0.1 0.4 0.0 2.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.1 2.9 0.2 2261.8 0.0 0.0 0.0 3.5 0.0 2.4 11.6 1.1 29.5 0.7 0.0 0.0 0.2 1.4 11.2 0.3 0.0 0.0 1.4 1.6 0.0 0.0 0.0 47.4 13.3 0.3 0.0 0.0 0.0 3.0 0.0 0.0 6.3 0.0 0.4 0.0 43.4 1.7 1.0 2.3 2.7 0.0 0.0 0.1 HSPB8 "CMT2L, E2IG1, H11, HSP22, HspB8" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119178642-119221131 "Disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 152.6" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 553.3;Syncytiotrophoblasts: 1120.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 28.7;HeLa: 21.4;MCF7: 37.7;SuSa: 24.7;U-87 MG: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 12.2 4.4 19.3 8.2 22.7 0.7 6.8 2.0 18.1 15.3 52.7 34.1 13.1 2.8 18.6 7.2 42.9 9.6 12.0 107.9 17.4 17.6 16.3 1.7 13.4 3.3 27.4 14.7 5.7 7.7 73.3 3.0 64.3 24.5 40.1 11.9 21.7 11.4 79.4 152.6 10.0 7.9 65.5 35.0 13.6 20.6 3.6 19.3 5.4 8.0 42.1 26.7 55.6 18.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.3 4.9 0.2 0.0 5.7 4.5 18.8 10.6 9.4 2.1 0.1 11.8 0.2 0.0 28.7 14.6 16.9 0.7 0.1 0.0 0.3 0.0 0.4 0.0 21.4 1.0 3.9 0.0 0.0 4.9 1.7 7.1 0.6 7.8 4.3 0.0 0.0 0.0 5.2 37.7 0.0 0.1 2.2 0.0 7.0 0.0 7.8 1.0 15.5 2.0 0.1 0.3 4.0 0.5 2.2 24.7 9.7 0.0 6.0 5.2 13.2 6.8 0.5 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 22.7 2.0 16.0 17.4 17.6 27.4 14.7 24.5 19.3 41.7 54.8 0.5 84.4 90.9 0.6 553.3 10.2 4.0 6.8 5.2 7.9 125.9 0.0 51.2 12.3 27.0 0.0 0.0 9.8 10.9 43.0 15.6 1.1 0.0 16.9 1.6 0.0 27.0 1.8 8.5 1.4 3.2 11.8 1.8 0.0 46.4 18.4 0.0 0.4 38.9 2.2 6.5 115.6 0.2 0.0 25.1 1120.5 3.2 0.0 73.8 HSPB9 CT51 ENSG00000260325 "Heat shock protein family B (small) member 9" Q9BQS6 17 42121431-42123352 "Predicted intracellular proteins" "Stress response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.3;pancreas: 2.8;testis: 7.2" "Group enriched" "Detected in some" 29 "Early spermatids: 308.5;Late spermatids: 637.9" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 3.9" "Not detected" "Not detected" NA NA "unprognostic (2.36e-1)" "unprognostic (2.63e-1)" "unprognostic (8.35e-2)" "unprognostic (1.99e-2)" "unprognostic (5.67e-2)" "unprognostic (8.37e-2)" "unprognostic (2.30e-2)" "unprognostic (3.42e-6)" "unprognostic (2.31e-1)" "unprognostic (5.13e-2)" "unprognostic (3.82e-1)" "unprognostic (8.62e-2)" "unprognostic (3.36e-3)" "unprognostic (3.68e-4)" "unprognostic (4.78e-2)" "unprognostic (4.01e-1)" "unprognostic (1.24e-1)" 0.0 0.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.3 0.1 0.0 0.1 0.1 7.2 0.0 0.0 0.0 1.2 2.3 1.9 1.2 0.3 1.2 0.2 0.6 0.9 0.9 2.1 0.0 0.0 3.5 0.8 0.0 0.3 0.5 2.6 0.7 0.8 0.3 0.0 0.4 0.8 0.5 0.2 0.0 0.4 3.1 0.8 1.3 0.6 0.0 0.7 1.7 0.1 0.1 0.1 0.0 0.9 0.0 1.2 1.4 0.8 0.0 0.5 1.1 2.7 1.0 0.7 0.0 0.8 0.9 1.2 0.0 1.3 1.7 0.6 0.1 3.9 1.0 0.7 1.1 0.4 1.1 1.0 1.1 1.4 0.8 2.3 0.7 1.0 0.5 1.0 0.5 0.6 0.5 0.4 0.4 0.1 0.9 0.4 0.8 0.2 0.7 1.2 1.2 0.5 1.9 0.3 1.2 2.3 0.3 0.2 0.0 0.0 0.0 0.4 0.3 0.6 0.4 2.5 0.0 0.0 0.0 2.0 2.6 16.6 0.0 308.5 0.0 0.3 0.0 1.0 0.5 0.3 0.3 0.0 13.2 0.2 3.2 0.0 2.5 0.6 637.9 6.6 0.0 0.0 0.0 0.6 0.1 0.5 0.0 6.3 0.7 0.4 0.0 0.3 6.6 3.6 0.3 0.2 0.0 0.2 0.1 HSPD1 "GroEL, HSP60, SPG13" ENSG00000144381 "Heat shock protein family D (Hsp60) member 1" P10809 2 197486581-197516737 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Chaperone, Isomerase" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 162.6" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001523, CAB002775, HPA050025, CAB072816" Supported Enhanced Mitochondria NA NA 53000000 Mitochondria "CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995" "unprognostic (2.79e-2)" "unprognostic (1.72e-2)" "unprognostic (5.21e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.59e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (2.25e-4)" "unprognostic (3.51e-2)" "unprognostic (9.91e-2)" "unprognostic (8.63e-3)" "unprognostic (3.47e-2)" "unprognostic (7.83e-3)" "unprognostic (5.64e-3)" "unprognostic (1.73e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (4.10e-2)" 28.5 125.2 28.7 23.4 31.8 21.0 55.9 18.2 24.3 17.4 30.3 17.8 23.3 28.9 17.5 18.5 27.2 25.3 16.3 24.0 24.2 27.8 67.1 147.5 22.4 25.3 35.5 16.1 30.2 50.6 32.5 25.9 27.1 33.6 25.9 37.2 11.9 17.6 21.0 36.4 13.7 32.0 23.6 32.4 22.7 25.2 10.9 35.8 22.7 38.7 29.4 30.3 33.3 162.6 25.6 30.3 6.2 29.3 23.1 33.5 22.2 41.2 50.8 42.6 38.2 29.2 30.6 62.0 43.0 22.7 51.8 38.0 170.3 24.9 125.5 56.1 22.4 64.2 42.2 166.7 47.4 73.5 30.8 66.9 89.1 82.2 197.1 27.5 98.7 28.0 34.5 55.0 45.9 80.9 36.5 40.6 69.3 109.7 49.2 38.0 52.8 61.2 99.9 84.2 54.3 106.3 73.7 52.6 90.6 54.4 43.2 55.8 31.7 43.1 46.7 55.2 91.1 32.3 58.6 18.1 32.2 44.7 41.4 67.9 27.6 60.7 104.2 37.8 59.7 34.5 4.5 19.7 5.3 15.5 29.3 28.8 25.6 25.0 21.8 30.3 21.0 33.5 29.0 6.2 23.1 25.8 20.2 19.7 22.2 28.7 31.8 18.2 24.3 24.2 27.8 35.5 16.1 33.6 35.8 154.9 133.3 218.4 1171.9 219.0 70.0 213.1 150.3 448.3 361.7 75.0 241.5 780.7 318.3 195.2 4.9 145.2 151.1 70.0 125.9 299.2 219.4 456.8 297.3 264.5 289.1 90.6 262.9 61.4 70.1 9.9 120.8 249.2 155.3 160.5 166.4 117.0 164.4 153.9 106.8 589.7 103.4 84.1 310.2 68.2 82.2 181.0 837.2 136.4 347.8 853.1 HSPG2 "perlecan, PRCAN, SJS1" ENSG00000142798 "Heparan sulfate proteoglycan 2" P98160 1 21822245-21937297 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 104.4" "Cell type enriched" "Detected in many" 7 "Ito cells: 621.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 3.0" "Lineage enriched" "Detected in single" 12 "dendritic cells: 3.0" "Cell line enhanced" "Detected in many" "EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009820, HPA018892, CAB020718, HPA072690" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 1700000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: " "unprognostic (1.61e-1)" "unprognostic (1.57e-2)" "unprognostic (4.93e-2)" "unprognostic (9.60e-2)" "unprognostic (2.38e-2)" "unprognostic (8.56e-2)" "unprognostic (4.55e-1)" "unprognostic (1.90e-2)" "unprognostic (9.35e-2)" "unprognostic (2.19e-3)" "unprognostic (5.82e-2)" "unprognostic (2.83e-1)" "unprognostic (1.21e-3)" "unprognostic (1.17e-2)" "unprognostic (4.86e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (2.82e-4)" 54.8 12.8 1.1 22.9 1.5 0.2 19.8 0.8 1.5 37.3 32.3 2.4 37.2 6.2 62.8 37.6 32.7 20.6 60.0 30.2 1.2 1.2 15.7 8.9 12.5 7.8 2.5 1.2 19.8 9.4 4.6 3.4 24.6 3.8 32.0 2.5 24.6 15.5 22.3 20.8 12.2 13.7 104.4 1.8 16.4 18.9 11.4 0.7 3.4 16.9 20.1 8.5 66.2 28.2 0.2 3.0 0.0 0.0 0.0 0.2 0.0 7.0 6.5 2.2 7.7 22.6 17.2 8.6 10.7 2.7 3.1 2.8 7.9 14.5 0.5 46.8 16.5 0.1 4.4 0.5 5.2 0.7 0.1 0.7 2.4 7.0 5.7 4.7 0.0 0.6 10.4 1.6 3.2 0.9 4.7 103.4 0.0 3.1 0.9 4.2 1.9 0.0 3.2 1.9 3.2 2.9 1.0 9.2 0.9 6.0 0.9 0.2 0.6 8.1 3.4 4.7 2.0 1.3 1.2 82.5 6.1 8.0 4.7 0.3 0.0 1.0 0.4 1.6 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 3.0 0.0 0.0 1.1 1.5 0.8 1.5 1.2 1.2 2.5 1.2 3.8 0.7 65.5 28.7 5.2 10.9 23.5 0.7 4.5 40.8 1.4 12.5 87.2 0.0 9.4 0.0 63.1 1.0 75.0 34.2 0.0 21.9 85.1 58.4 6.6 22.0 2.8 6.1 3.2 2.4 621.2 31.6 2.2 69.6 3.5 57.3 2.8 12.8 1.4 55.1 20.7 65.0 0.5 0.5 32.3 38.8 0.4 4.1 15.6 7.8 6.4 13.9 8.3 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134974-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "vagina: 286.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 738.6;Urothelial cells: 485.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol No Yes 820000 Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 13.7 19.8 36.6 12.2 57.1 9.8 33.7 11.7 44.0 14.7 10.6 9.8 13.0 6.1 13.3 21.7 13.9 31.0 18.1 14.2 34.8 40.3 16.6 14.8 15.9 17.4 36.5 16.3 13.4 10.1 15.1 24.1 19.8 32.7 14.5 14.5 3.6 7.0 17.3 10.5 11.0 6.4 15.7 34.8 9.0 12.2 35.0 34.6 12.1 22.5 7.8 23.8 17.0 286.1 9.0 6.8 2.1 14.6 13.7 12.8 5.5 13.7 26.5 21.8 2.1 21.0 11.9 14.5 23.9 21.3 37.2 17.3 31.1 21.5 35.8 15.0 16.6 52.9 26.8 84.1 21.2 48.1 28.0 10.6 31.0 14.6 27.4 6.9 21.5 24.8 7.5 49.2 24.8 14.3 19.5 21.5 12.6 25.9 5.7 26.1 18.8 30.8 24.6 31.0 67.6 19.8 24.3 17.9 11.8 28.1 16.8 22.6 18.8 21.8 21.4 11.0 34.9 7.2 21.0 13.1 12.8 16.3 18.4 26.4 4.5 14.7 30.7 10.7 26.1 21.4 1.0 3.9 2.1 6.6 9.6 8.1 9.0 8.4 10.0 6.8 7.8 12.8 11.9 0.4 13.7 14.6 5.3 5.3 5.5 36.6 57.1 11.7 44.0 34.8 40.3 36.5 16.3 32.7 34.6 122.1 81.5 33.2 738.6 190.6 38.7 130.6 17.8 302.5 185.4 43.6 392.7 17.7 24.9 44.8 71.1 92.6 26.2 0.0 31.1 55.8 207.2 407.7 251.8 21.5 79.0 28.6 217.9 24.5 27.7 22.4 31.4 113.0 155.3 47.7 22.5 16.6 37.1 45.6 36.7 22.8 57.7 38.8 156.8 128.9 138.0 125.3 35.6 28.0 26.7 485.8 HTN1 HIS1 ENSG00000126550 "Histatin 1" P15515 4 70050402-70058845 "Predicted secreted proteins" Biomineralization "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1306 "salivary gland: 1826.6" "Cell type enhanced" "Detected in single" 33 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;hTCEpi: 1.0;SK-MEL-30: 3.6" HPA077315 Approved "Secreted to digestive system" NA NA "HPA077315: " "unprognostic (2.22e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1826.6 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 1.3 1.1 0.1 0.1 0.2 0.4 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 HTN3 HIS2 ENSG00000205649 "Histatin 3" P15516 4 70028413-70036538 "Predicted secreted proteins, Transporters" Biomineralization "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 535 "salivary gland: 3346.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 4.5;HL-60: 4.9" CAB073541 Enhanced "Secreted to digestive system" NA NA "CAB073541: " 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.2 1.4 0.0 6.2 0.0 0.0 0.2 0.0 0.0 3346.6 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 3.3 0.3 0.1 0.1 1.2 0.6 2.2 1.2 0.5 1.0 0.4 1.1 1.4 0.5 0.5 0.0 0.3 0.4 0.2 0.0 0.6 0.6 0.2 1.6 1.7 0.8 0.2 2.0 0.9 0.0 0.3 0.1 4.5 0.7 0.3 0.9 0.6 0.0 4.9 3.5 0.4 0.8 0.1 0.0 0.5 0.7 0.8 0.6 3.0 0.5 0.6 1.3 2.4 1.2 0.6 1.4 3.0 0.8 0.6 0.3 0.6 2.0 1.2 1.1 0.8 0.9 1.0 2.2 1.3 0.0 1.2 1.8 1.2 0.9 2.0 2.3 0.7 1.1 1.5 2.5 2.2 0.7 0.5 0.5 1.1 0.3 1.0 0.8 0.4 0.4 1.2 1.0 0.6 2.0 0.5 1.2 0.6 0.5 0.4 0.1 0.2 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR1A "5-HT1A, ADRB2RL1, ADRBRL1" ENSG00000178394 "5-hydroxytryptamine receptor 1A" P08908 5 63960356-63962507 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 21.5;ovary: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 14.7;cerebral cortex: 10.7;hippocampal formation: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "NTERA-2: 5.4;SCLC-21H: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018073 Uncertain NA NA "HPA018073: AB_1856704" "unprognostic (1.81e-1)" 0.2 0.4 14.7 0.2 1.0 0.2 0.2 0.1 10.7 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.5 21.5 2.4 0.2 0.2 0.3 0.2 0.7 2.7 10.4 0.2 0.2 0.1 0.2 0.9 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.6 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 1.0 0.1 10.7 21.5 2.4 0.7 2.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR1B "5-HT1B, 5-HT1DB, HTR1D2, S12" ENSG00000135312 "5-hydroxytryptamine receptor 1B" P28222 6 77461753-77463773 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;placenta: 14.2;stomach 1: 10.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 11.8" "Cell type enriched" "Detected in single" 17 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Group enriched" "Detected in some" 15 "HUVEC TERT2: 41.8;TIME: 18.4" "Region enriched" "Detected in many" 4 "basal ganglia: 34.5" HPA028808 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028808: AB_2672782" "unprognostic (3.86e-2)" "unprognostic (3.56e-1)" "unprognostic (7.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-1)" "unprognostic (8.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-3)" "unprognostic (3.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 2.2 1.5 1.3 1.1 11.8 0.3 2.4 0.4 3.7 2.9 0.6 0.1 0.0 0.6 1.1 1.0 1.4 0.8 2.8 0.4 1.0 2.1 0.9 0.3 1.1 0.3 1.2 0.9 1.1 0.5 0.3 0.5 14.2 3.0 1.6 0.4 0.3 1.3 1.2 0.9 0.5 0.4 4.1 0.6 0.4 10.2 1.5 0.6 0.0 0.5 0.0 0.3 2.6 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.4 1.1 0.8 41.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 11.8 0.4 3.7 1.0 2.1 1.2 0.9 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR1D "5-HT1D, HT1DA, HTRL, RDC4" ENSG00000179546 "5-hydroxytryptamine receptor 1D" P28221 1 23191895-23194729 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;intestine: 12.2" "Cell type enriched" "Detected in single" 12 "Cholangiocytes: 7.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 8.5;hTERT-RPE1: 8.2;OE19: 11.4;TIME: 21.3;U-2 OS: 7.2" "Region enhanced" "Detected in some" "basal ganglia: 7.6" "Low region specificity" "Detected in many" NA NA "unprognostic (1.73e-2)" "unprognostic (8.69e-3)" "unprognostic (8.86e-3)" "unprognostic (2.03e-1)" "unprognostic (2.65e-2)" "unprognostic (5.97e-4)" "prognostic unfavorable (1.86e-4)" "unprognostic (3.87e-3)" "unprognostic (8.88e-2)" "unprognostic (4.00e-2)" "prognostic unfavorable (5.30e-4)" "unprognostic (3.17e-2)" "unprognostic (3.28e-6)" "unprognostic (9.14e-2)" "unprognostic (2.27e-1)" "unprognostic (2.45e-1)" "unprognostic (8.02e-3)" 0.0 0.0 0.3 0.0 3.9 0.1 0.0 0.0 0.2 0.0 0.1 12.2 0.0 0.0 0.0 0.5 1.9 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 10.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 1.0 0.7 2.2 1.2 1.2 0.9 0.2 2.5 8.5 0.0 0.0 0.0 0.2 0.7 0.0 0.6 0.3 0.3 0.5 6.1 0.0 2.5 0.3 4.3 1.8 1.7 0.0 0.4 0.0 0.7 0.0 5.0 0.1 0.3 0.0 0.0 0.1 0.1 1.0 0.3 8.2 5.0 0.1 0.0 0.0 0.2 1.0 0.0 0.0 2.0 11.4 0.1 0.0 0.0 0.0 0.2 0.0 2.1 0.0 5.7 0.3 0.1 0.7 0.1 0.0 21.3 0.0 7.2 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 1.2 0.5 0.6 0.8 0.4 1.0 0.9 0.6 0.4 1.0 0.6 0.6 2.2 1.2 1.0 0.7 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.3 7.6 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 HTR1E 5-HT1E ENSG00000168830 "5-hydroxytryptamine receptor 1E" P28566 6 86937306-87016683 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.4;ovary: 13.3" "Cell type enriched" "Detected in some" 4 "Early spermatids: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "PC-3: 2.9;SH-SY5Y: 11.6" "Low region specificity" "Detected in many" HPA004931 Approved NA NA "HPA004931: AB_1856706" "unprognostic (2.25e-2)" "unprognostic (1.32e-1)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (1.25e-1)" 0.5 0.6 8.9 0.6 13.3 0.5 0.5 5.4 16.4 1.6 0.5 0.0 0.0 0.5 5.1 1.1 0.6 0.5 0.8 0.5 4.1 2.8 0.5 0.5 0.5 0.5 1.8 11.4 13.3 0.8 0.5 0.3 0.5 2.2 1.1 0.5 0.0 0.5 1.2 0.5 0.5 0.5 2.9 0.6 0.5 3.6 1.4 1.5 0.0 2.7 0.0 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.3 11.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 13.3 5.4 16.4 4.1 2.8 1.8 11.4 2.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 HTR1F "5-HT1F, HTR1EL" ENSG00000179097 "5-hydroxytryptamine receptor 1F" P30939 3 87990696-87993835 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 5.7" "Group enriched" "Detected in some" 10 "Muller glia cells: 19.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Group enriched" "Detected in some" 6 "A549: 1.2;K-562: 4.5;LHCN-M2: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005555 Uncertain NA NA "HPA005555: AB_1856708" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.03e-2)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (4.78e-1)" "unprognostic (1.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (2.67e-6)" "unprognostic (1.25e-4)" "unprognostic (1.55e-2)" "unprognostic (3.33e-2)" "unprognostic (3.31e-2)" 2.8 0.5 0.7 0.0 0.6 1.5 1.6 0.0 1.8 1.4 0.0 0.0 1.2 0.3 0.1 0.4 0.1 0.3 0.6 0.4 0.6 0.0 0.9 0.1 0.8 0.4 0.7 0.3 1.4 5.7 0.4 0.0 0.1 1.0 0.6 0.4 0.0 1.3 0.3 1.7 0.0 0.3 1.5 0.5 0.6 0.7 0.1 0.2 3.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 19.5 0.1 0.0 0.0 0.0 1.0 19.4 11.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 HTR2A "5-HT2A, HTR2" ENSG00000102468 "5-hydroxytryptamine receptor 2A" P28223 13 46831550-46897076 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Behavior, Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 30.4" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 1.3;Late spermatids: 1.4;Muller glia cells: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "neutrophil: 1.2;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;granulocytes: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;ASC TERT1: 9.3;BEWO: 2.9;HEL: 2.8;U-138 MG: 4.7;U-2 OS: 3.0;U-87 MG: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014011 Enhanced NA NA "HPA014011: AB_1856709" "unprognostic (8.01e-2)" "unprognostic (2.71e-2)" "unprognostic (9.49e-2)" "unprognostic (7.40e-2)" "unprognostic (2.78e-1)" "unprognostic (1.99e-1)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (5.27e-2)" "unprognostic (3.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.90e-1)" "unprognostic (9.94e-5)" "unprognostic (4.78e-3)" "unprognostic (2.54e-1)" "unprognostic (2.91e-2)" "unprognostic (8.28e-2)" 1.9 1.0 9.5 1.7 13.5 0.6 1.3 0.6 30.4 1.6 1.2 1.2 0.0 1.1 1.6 0.6 1.4 1.1 2.9 1.5 3.8 5.1 0.7 0.6 1.0 0.6 3.3 13.3 1.0 0.6 0.6 0.5 0.6 1.8 0.9 1.6 2.0 0.6 1.5 0.9 0.7 1.1 4.4 1.2 0.6 1.0 1.5 0.7 0.0 0.7 0.0 0.8 1.9 1.5 0.1 1.2 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 3.8 9.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.1 4.7 3.0 0.0 0.2 0.1 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 1.2 0.0 1.5 9.5 13.5 0.6 26.4 3.8 5.1 3.3 13.3 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.4 0.9 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.0 0.2 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 HTR2B "5-HT(2B), 5-HT2B" ENSG00000135914 "5-hydroxytryptamine receptor 2B" P41595 2 231108230-231125118 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 26.0" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 3.9;Ito cells: 5.5;monocytes: 10.8;Peritubular cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 3.8;T-reg: 2.9" "Group enriched" "Detected in many" 29 "granulocytes: 3.8;T-cells: 2.9" "Group enriched" "Detected in some" 4 "HHSteC: 7.0;HSkMC: 13.3;SK-MEL-30: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012867, HPA063658" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012867: AB_1856710, HPA063658: AB_2685079" "unprognostic (1.86e-1)" "unprognostic (3.55e-2)" "unprognostic (1.20e-3)" "unprognostic (1.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.15e-4)" "unprognostic (3.59e-1)" "unprognostic (2.17e-2)" "unprognostic (1.42e-3)" "unprognostic (7.44e-4)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" 2.3 17.9 0.2 5.8 0.3 0.7 4.1 0.3 0.6 17.8 7.3 0.2 1.7 1.0 14.9 9.5 5.7 1.9 0.8 4.6 0.3 0.3 5.6 2.5 1.8 0.5 0.3 0.4 4.3 0.3 0.3 0.4 26.0 0.9 2.6 1.5 1.8 0.5 1.0 0.2 0.2 6.3 12.8 0.3 0.4 5.2 3.3 0.3 2.4 6.8 1.0 0.4 4.9 0.8 0.0 0.1 3.8 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.1 0.4 3.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.3 13.3 0.0 0.0 0.0 0.0 2.5 1.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 24.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 2.9 0.0 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.9 2.6 1.6 0.0 5.5 1.2 0.0 0.6 0.0 0.0 10.8 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 HTR2C "5-HT2C, 5HTR2C, HTR1C" ENSG00000147246 "5-hydroxytryptamine receptor 2C" P28335 X 114584078-114910061 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "brain: 45.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Region enhanced" "Detected in many" "basal ganglia: 45.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 5.0;RPMI-8226: 2.4;U-266/70: 8.9;U-266/84: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-1)" "unprognostic (6.09e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (2.89e-2)" "unprognostic (3.42e-2)" "unprognostic (9.22e-4)" "unprognostic (1.37e-1)" "unprognostic (6.84e-2)" 0.5 0.5 2.4 0.4 45.3 0.5 0.5 0.0 9.4 2.3 0.4 8.5 0.0 0.4 0.5 0.6 0.4 0.4 0.5 0.4 2.4 9.8 0.5 0.5 0.5 0.4 2.0 1.2 0.4 0.4 0.4 0.3 1.0 29.7 0.9 0.4 0.8 0.4 1.1 0.4 0.4 0.4 0.4 1.7 0.4 0.4 0.6 2.4 0.0 0.4 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.3 1.2 0.0 0.0 0.0 2.4 0.0 1.4 0.0 0.0 0.1 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.9 0.0 0.0 8.9 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.4 45.3 0.0 4.6 2.4 9.8 2.0 1.2 29.7 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3A "5-HT3A, 5-HT3R, HTR3" ENSG00000166736 "5-hydroxytryptamine receptor 3A" P46098 11 113974881-113990313 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.1;lymphoid tissue: 12.0;salivary gland: 8.6" "Group enriched" "Detected in some" 11 "Ductal cells: 14.6;Exocrine glandular cells: 44.3;Pancreatic endocrine cells: 54.7" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 15.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "memory B-cell: 4.1;naive B-cell: 9.7;plasmacytoid DC: 11.1" "Group enriched" "Detected in many" 104 "B-cells: 9.7;dendritic cells: 11.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;Daudi: 6.0;NTERA-2: 3.8;SCLC-21H: 20.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 15 "amygdala: 3.3;cerebral cortex: 4.0;hippocampal formation: 4.2" HPA069442 Supported NA NA "HPA069442: AB_2732132" "unprognostic (6.46e-3)" "prognostic favorable (6.26e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (3.36e-3)" "unprognostic (8.36e-3)" "unprognostic (1.65e-5)" "unprognostic (1.46e-2)" "unprognostic (8.87e-2)" "unprognostic (6.21e-2)" "unprognostic (6.80e-3)" "unprognostic (3.00e-2)" "unprognostic (1.65e-2)" "unprognostic (8.72e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.40e-2)" 0.3 0.5 2.2 4.4 3.9 0.0 0.3 0.3 0.9 0.3 2.5 0.3 0.3 1.0 0.3 0.3 0.8 0.0 0.3 0.3 2.1 0.0 0.3 0.3 0.3 9.7 0.3 0.3 0.3 3.7 0.0 0.3 0.3 0.3 0.3 0.6 0.3 8.6 0.3 0.3 0.6 2.0 1.0 0.3 3.0 0.9 0.3 0.3 0.7 0.3 0.3 12.0 0.3 0.3 9.7 11.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 6.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.6 9.7 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.2 2.2 3.9 0.3 0.9 2.1 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 44.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 54.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3B 5-HT3B ENSG00000149305 "5-hydroxytryptamine receptor 3B" O95264 11 113904677-113946565 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebral cortex: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "hypothalamus: 0.4" "Not detected" "Not detected" HPA039559 Approved NA NA "HPA039559: AB_10672779" "unprognostic (1.60e-2)" "unprognostic (8.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.28e-1)" "unprognostic (1.71e-1)" "unprognostic (2.46e-1)" 0.2 0.2 1.0 0.8 2.1 2.4 0.2 0.4 8.7 0.3 0.4 0.2 0.0 0.3 0.5 1.6 2.6 0.2 0.2 0.2 1.2 0.7 1.0 0.2 0.2 0.5 0.8 1.4 0.3 0.3 0.1 0.2 0.2 0.0 0.2 0.5 0.0 0.5 0.1 0.5 1.2 0.5 0.1 0.7 0.5 0.3 1.5 0.0 0.0 0.5 0.0 0.5 0.3 0.6 1.6 1.3 2.9 0.9 1.9 0.9 0.1 0.5 1.4 0.8 0.8 1.6 0.9 1.2 0.1 0.2 0.2 0.2 1.0 0.9 1.9 0.5 0.5 0.7 0.5 0.6 0.6 0.8 0.5 0.8 0.6 1.9 1.8 0.3 1.6 1.4 1.1 0.5 0.2 0.0 0.6 0.2 1.0 0.8 1.5 0.3 0.2 0.9 1.6 0.4 0.7 0.2 0.8 1.4 0.9 0.9 0.7 0.7 2.8 0.5 1.6 1.1 1.3 0.6 0.4 1.8 1.5 1.1 1.5 1.1 1.1 0.7 1.4 0.9 0.6 0.8 1.6 0.9 0.3 0.9 0.5 0.7 1.3 0.8 0.6 0.5 1.6 0.9 0.9 2.9 1.9 0.3 1.3 0.7 0.1 1.0 2.1 0.4 8.7 1.2 0.7 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3C ENSG00000178084 "5-hydroxytryptamine receptor 3C" Q8WXA8 3 184053047-184060671 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 6.8" "Cell type enriched" "Detected in single" 7 "Intestinal endocrine cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "GAMG: 3.8" "Not detected" "Not detected" NA NA "unprognostic (4.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (1.61e-1)" "unprognostic (2.88e-2)" "unprognostic (1.68e-2)" "unprognostic (8.72e-2)" "unprognostic (1.75e-1)" "unprognostic (3.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.0 0.1 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 HTR3E ENSG00000186038 "5-hydroxytryptamine receptor 3E" A5X5Y0 3 184097064-184106995 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 7.0" "Cell type enriched" "Detected in single" 24 "Intestinal endocrine cells: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "RH-30: 5.5" HPA049764 Enhanced NA NA "HPA049764: AB_2680869" "unprognostic (4.12e-2)" "unprognostic (5.86e-2)" "unprognostic (2.15e-1)" "unprognostic (4.57e-4)" "unprognostic (3.61e-3)" "unprognostic (1.15e-1)" "unprognostic (3.16e-1)" "unprognostic (4.47e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-1)" "unprognostic (4.16e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 HTR4 5-HT4 ENSG00000164270 "5-hydroxytryptamine receptor 4" Q13639 5 148451032-148677235 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 18.1;heart muscle: 7.2;intestine: 14.6;pituitary gland: 5.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 4.3;Enterocytes: 2.8;Undifferentiated cells: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 18.1" "Cell type enriched" "Detected in single" 8 "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enriched" "Detected in single" 5 "Karpas-707: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040591 Enhanced NA NA "HPA040591: AB_2677028" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" "unprognostic (7.74e-2)" "unprognostic (2.37e-1)" "unprognostic (5.02e-2)" "unprognostic (3.77e-2)" "unprognostic (4.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (2.25e-1)" "unprognostic (4.49e-2)" "unprognostic (8.83e-5)" 0.4 1.4 1.9 1.1 18.1 0.1 0.2 0.1 3.2 0.6 4.3 0.0 0.0 8.0 0.3 0.1 0.3 0.4 1.5 7.2 5.2 0.6 0.1 0.2 0.3 0.2 0.5 1.3 0.2 0.1 0.1 5.9 0.1 0.1 0.1 4.9 0.0 0.2 0.2 0.2 0.2 14.6 1.1 0.3 0.2 0.2 0.2 2.4 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 1.9 18.1 0.1 3.2 5.2 0.6 0.5 1.3 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 HTR5A 5-HT5A ENSG00000157219 "5-hydroxytryptamine receptor 5A" P47898 7 155070324-155085749 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 15.4" "Group enriched" "Detected in some" 14 "Early spermatids: 6.5;Late spermatids: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB017467 Approved NA NA "CAB017467: AB_2122566" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.4 0.4 2.6 0.4 3.9 0.4 0.4 15.4 15.0 0.4 0.4 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 2.6 5.9 0.4 0.4 0.4 0.4 2.3 2.5 0.4 0.4 0.4 0.1 0.4 2.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.8 0.4 0.4 1.4 0.3 3.3 0.4 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 3.9 15.4 9.8 2.6 5.9 2.3 2.5 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 HTR6 "5-HT6, 5-HT6R" ENSG00000158748 "5-hydroxytryptamine receptor 6" P50406 1 19665287-19679562 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Group enriched" "Detected in many" 5 "basal ganglia: 24.6;cerebral cortex: 6.6" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "MCF7: 1.2;NTERA-2: 2.4;SH-SY5Y: 6.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 9.5" HPA068165 Uncertain NA NA "HPA068165: " "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (7.19e-3)" "unprognostic (3.84e-5)" "unprognostic (1.38e-4)" "unprognostic (2.69e-2)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (5.33e-3)" "unprognostic (8.63e-2)" "unprognostic (5.47e-4)" "unprognostic (1.28e-1)" "unprognostic (2.49e-1)" "unprognostic (6.13e-3)" "unprognostic (2.02e-1)" 0.4 0.5 1.2 1.4 24.6 0.4 0.4 0.2 6.6 0.6 0.4 0.0 0.0 0.6 0.6 0.5 0.5 0.6 0.5 0.4 1.4 1.0 0.3 0.3 0.3 1.4 0.5 2.2 0.3 0.3 0.3 0.4 0.3 0.4 0.4 0.3 0.0 0.5 0.3 0.3 0.8 0.5 0.5 0.2 0.4 0.5 0.8 3.2 0.0 0.3 0.0 2.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 2.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.2 24.6 0.2 6.6 1.4 1.0 0.5 2.2 0.4 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR7 5-HT7 ENSG00000148680 "5-hydroxytryptamine receptor 7" P34969 10 90740823-90857698 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 30.8;testis: 14.3" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 4.8;Hofbauer cells: 1.3;Kupffer cells: 1.5;Late spermatids: 2.0;Spermatocytes: 1.4" "Group enriched" "Detected in some" 5 "cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "myeloid DC: 4.6" "Lineage enriched" "Detected in single" 12 "dendritic cells: 4.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.2;hTCEpi: 7.5;hTERT-HME1: 25.0;LHCN-M2: 10.0;U-87 MG: 7.7;WM-115: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022708, HPA073617" Approved Supported Supported "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "CAB022708: , HPA073617: AB_2732228" "unprognostic (1.17e-1)" "unprognostic (1.24e-2)" "unprognostic (4.72e-2)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (1.71e-2)" "unprognostic (1.89e-1)" "unprognostic (1.44e-1)" "unprognostic (1.15e-1)" "unprognostic (4.58e-3)" "unprognostic (3.32e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-1)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" 1.0 0.5 2.4 1.1 2.5 0.5 0.7 0.3 4.3 0.6 0.8 1.7 1.2 0.8 0.4 0.3 1.0 0.4 1.3 0.6 9.9 5.1 0.3 0.6 0.5 0.7 1.7 1.8 0.4 1.4 30.8 0.2 0.5 3.1 1.0 1.2 0.4 0.6 0.3 1.7 0.9 2.2 3.6 1.5 1.3 1.5 14.3 1.0 0.0 0.3 0.1 0.6 3.5 2.1 0.0 4.6 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.2 0.5 0.8 0.0 0.9 0.0 0.0 0.1 1.5 3.4 0.9 8.2 2.1 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.4 5.9 7.5 2.5 25.0 4.7 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.1 0.9 0.0 1.2 0.7 0.1 0.0 0.0 0.9 0.3 0.0 0.3 0.0 3.9 0.4 0.0 0.2 0.2 4.6 0.0 0.0 6.9 0.0 0.0 0.0 7.7 0.0 9.5 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 4.6 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.1 0.1 2.4 2.5 0.3 4.3 9.9 5.1 1.7 1.8 3.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.6 1.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 0.1 0.1 0.0 0.0 0.2 HTRA3 "Prsp, Tasp" ENSG00000170801 "HtrA serine peptidase 3" P83110 4 8269765-8307111 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 57.9" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 14.0;Fibroblasts: 45.9;Leydig cells: 40.3;Peritubular cells: 40.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 9 "basal ganglia: 8.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-2197: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021187, HPA063810" Approved Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA021187: AB_1851311, HPA063810: AB_2685129" "unprognostic (5.87e-2)" "unprognostic (1.40e-2)" "unprognostic (2.89e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-1)" "unprognostic (3.09e-2)" "unprognostic (1.12e-3)" "unprognostic (5.29e-2)" "unprognostic (3.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.95e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.61e-9)" "unprognostic (1.65e-3)" "unprognostic (2.56e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.34e-2)" 23.7 1.8 0.6 7.3 8.2 5.3 35.6 0.7 0.9 12.3 9.4 0.8 5.4 3.7 19.6 26.6 14.4 7.9 19.8 57.9 0.7 0.3 1.7 1.6 15.4 4.3 0.8 0.9 30.7 2.8 0.0 5.1 9.6 0.9 15.4 2.0 8.6 6.6 3.0 12.9 9.0 6.7 50.1 0.8 1.8 6.8 7.2 0.6 1.3 9.3 11.6 3.0 28.7 12.7 0.0 0.4 1.3 0.3 0.0 0.0 0.1 0.0 0.3 0.4 0.0 2.1 3.9 0.1 0.8 0.0 1.0 0.2 0.0 0.0 0.0 4.8 2.1 0.5 0.0 0.4 0.0 0.3 0.0 0.8 0.4 5.0 0.0 2.2 0.0 0.2 0.4 0.0 1.4 0.0 0.6 3.4 0.0 0.1 0.0 3.5 0.0 0.0 12.2 2.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 5.6 0.1 9.1 0.1 0.0 10.6 0.0 0.4 2.7 0.5 1.7 64.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.6 8.2 0.7 0.9 0.7 0.3 0.8 0.9 0.9 0.6 0.0 0.0 0.0 0.3 4.6 0.0 14.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.6 3.1 0.0 0.0 0.0 3.7 45.9 0.1 0.0 0.0 1.1 0.0 0.0 4.3 0.0 0.5 40.3 0.9 0.0 0.0 0.0 0.0 0.2 0.0 40.3 0.0 0.0 0.0 5.1 0.2 0.9 4.5 1.1 0.0 0.0 0.1 HTRA4 FLJ90724 ENSG00000169495 "HtrA serine peptidase 4" P83105 8 38974164-38988662 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 55.2" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 319.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 23 "BEWO: 72.8" "Region enhanced" "Detected in some" "hippocampal formation: 2.3" "Low region specificity" "Detected in some" HPA045402 Enhanced "Secreted in female reproductive system" NA NA "HPA045402: AB_2679316" "unprognostic (1.20e-1)" "unprognostic (5.83e-4)" "unprognostic (8.02e-2)" "unprognostic (2.13e-2)" "unprognostic (8.20e-2)" "unprognostic (2.42e-2)" "unprognostic (1.80e-1)" "unprognostic (7.40e-3)" "unprognostic (1.40e-1)" "unprognostic (5.14e-4)" "unprognostic (1.01e-1)" "unprognostic (8.68e-2)" "unprognostic (1.42e-1)" "unprognostic (4.58e-1)" "unprognostic (5.19e-3)" "unprognostic (2.39e-3)" "unprognostic (1.19e-3)" 2.6 1.1 0.2 0.3 0.2 3.4 0.9 0.2 0.4 1.2 0.5 0.2 1.9 0.0 2.3 0.5 0.5 0.1 0.2 0.2 0.2 0.0 0.2 0.2 4.3 1.0 0.2 0.2 0.4 0.3 0.4 0.5 55.2 0.4 0.5 0.3 1.8 0.8 0.5 0.6 0.4 0.6 0.3 1.8 2.5 0.1 0.4 0.2 0.2 0.6 0.2 0.8 0.5 0.9 3.1 2.2 2.5 1.0 1.0 1.7 0.0 0.1 0.1 0.1 0.2 0.3 0.2 72.8 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 3.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 1.5 0.8 2.3 1.4 0.7 1.7 1.5 1.3 1.2 0.6 3.1 1.3 1.4 2.5 1.0 1.0 2.2 1.4 0.0 0.2 0.2 0.2 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 1.1 0.1 0.5 0.4 0.0 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 319.8 0.2 1.2 0.0 0.0 10.7 1.6 0.0 2.5 0.3 0.0 0.0 1.5 1.7 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 33.8 0.0 0.2 0.7 HUS1B ENSG00000188996 "HUS1 checkpoint clamp component B" Q8NHY5 6 655939-656963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3" "Cell type enhanced" "Detected in some" 9 "monocytes: 3.6;Sertoli cells: 6.5;Spermatocytes: 7.6;Spermatogonia: 4.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 4.4;U-266/84: 5.1;WM-115: 5.5" "Not detected" "Not detected" "HPA034511, HPA063449" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034511: AB_2674203, HPA063449: AB_2685014" "unprognostic (3.56e-4)" "unprognostic (3.68e-2)" "unprognostic (4.81e-2)" "unprognostic (1.95e-1)" "unprognostic (3.45e-2)" "unprognostic (1.36e-1)" "unprognostic (4.95e-2)" "unprognostic (6.53e-2)" "unprognostic (9.44e-2)" "unprognostic (8.46e-2)" "unprognostic (8.76e-3)" "unprognostic (1.43e-1)" "unprognostic (4.13e-10)" "unprognostic (7.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" 0.5 0.1 0.1 0.5 0.1 3.3 0.6 0.0 0.0 1.4 0.4 1.3 0.9 0.7 0.9 0.2 0.6 0.5 0.2 0.1 0.6 0.8 1.0 0.2 0.3 0.8 0.0 0.0 0.8 1.1 1.4 0.2 0.5 0.1 0.0 0.9 0.3 1.0 0.6 1.0 0.1 4.3 0.7 0.2 0.3 1.2 1.6 1.6 0.0 0.7 0.0 1.9 0.6 0.7 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.1 0.0 0.1 0.8 0.1 0.3 0.5 0.1 0.4 0.0 0.5 0.0 0.4 1.3 4.4 0.9 0.0 0.0 0.4 0.0 1.5 0.0 0.3 0.4 0.4 0.0 0.1 1.1 1.7 1.0 0.5 0.0 0.5 2.4 2.8 0.0 1.4 0.9 0.8 2.5 0.2 0.6 1.0 0.2 0.3 0.0 0.7 0.5 0.1 0.1 0.4 0.7 0.8 1.5 0.4 2.3 5.1 1.0 0.1 0.6 5.5 0.0 0.7 0.0 0.7 0.3 0.5 1.6 1.1 0.9 0.0 0.8 1.0 1.9 0.0 0.0 0.0 1.6 0.7 0.6 0.0 0.0 0.5 0.6 0.6 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 0.7 0.7 0.0 0.0 0.5 1.0 0.4 0.5 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.9 0.0 0.0 3.6 0.0 0.5 0.9 0.0 1.1 0.0 1.7 6.5 0.5 7.6 4.7 1.5 1.3 1.5 0.2 0.3 HVCN1 "Hv1, MGC15619, VSOP" ENSG00000122986 "Hydrogen voltage gated channel 1" Q96D96 12 110627841-110704950 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 99.8;lymphoid tissue: 40.6" "Cell type enhanced" "Detected in many" 7 "B-cells: 65.1;Early spermatids: 69.1;Hofbauer cells: 51.3;Late spermatids: 55.1;Macrophages: 42.5;Spermatocytes: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 99.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "NB-4: 78.2;U-698: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039329 Enhanced NA NA "HPA039329: AB_10674284" "unprognostic (3.43e-2)" "unprognostic (6.32e-3)" "unprognostic (7.05e-2)" "unprognostic (1.54e-2)" "unprognostic (4.62e-3)" "unprognostic (3.89e-2)" "unprognostic (1.96e-1)" "unprognostic (5.85e-3)" "unprognostic (2.40e-1)" "unprognostic (3.09e-2)" "unprognostic (1.54e-2)" "unprognostic (5.67e-2)" "unprognostic (3.35e-3)" "unprognostic (4.82e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-1)" 4.8 3.3 7.6 17.6 12.2 3.8 3.3 4.7 7.4 5.6 3.9 20.4 3.2 3.0 6.4 7.0 2.9 5.8 5.0 13.8 9.7 11.3 2.6 2.6 8.0 34.6 26.9 5.0 8.6 1.5 1.5 2.0 4.8 36.7 5.9 4.1 14.2 2.6 5.5 4.6 1.9 10.8 6.1 9.4 25.6 4.3 24.5 8.2 5.0 2.5 2.8 40.6 7.5 5.3 99.8 15.4 75.6 24.2 19.8 3.3 18.8 0.0 0.2 0.8 0.0 1.3 1.3 0.4 0.2 0.3 0.7 0.4 0.1 0.0 0.7 0.7 1.4 0.0 0.1 0.9 0.0 1.0 0.0 0.2 0.0 0.0 0.2 1.1 11.9 0.8 1.8 0.1 0.6 0.0 0.1 1.8 3.8 0.5 0.7 1.3 0.0 1.7 78.2 0.9 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 11.9 0.5 0.0 0.0 0.1 0.0 7.7 0.9 24.4 0.0 0.6 0.0 39.8 24.2 75.6 1.7 23.0 0.9 63.0 1.6 2.8 10.4 99.8 3.2 2.1 38.4 19.8 19.9 15.4 3.3 18.8 7.6 12.2 4.7 7.4 9.7 11.3 26.9 5.0 36.7 8.2 3.0 7.7 65.1 2.0 0.7 0.4 6.3 0.0 2.7 3.4 1.8 0.0 0.3 0.0 0.4 69.1 10.6 0.0 0.0 0.2 1.2 3.5 0.5 8.1 0.2 51.3 0.0 0.0 9.8 31.3 55.1 12.4 42.5 11.8 1.8 0.1 16.0 0.2 0.0 13.1 0.4 1.5 12.9 9.8 72.9 2.5 0.4 1.0 4.9 0.0 1.0 HYAL1 "FUS2, HYAL-1, LUCA1, NAT6" ENSG00000114378 "Hyaluronoglucosaminidase 1" Q12794 3 50299889-50312381 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 105.8" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 116.0;Proximal tubular cells: 50.7" "Cancer enhanced" "Detected in all" "liver cancer: 37.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Group enriched" "Detected in some" 4 "Hep G2: 45.8;SK-BR-3: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002112 Uncertain "Secreted to blood" NA NA 15000 "HPA002112: AB_1857412" "unprognostic (1.39e-1)" "unprognostic (8.68e-2)" "prognostic favorable (2.07e-4)" "unprognostic (5.23e-2)" "unprognostic (3.18e-1)" "unprognostic (8.71e-2)" "unprognostic (9.35e-2)" "unprognostic (3.59e-2)" "unprognostic (6.56e-2)" "unprognostic (1.31e-1)" "unprognostic (6.65e-3)" "unprognostic (1.16e-1)" "prognostic favorable (1.56e-11)" "unprognostic (4.51e-2)" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.90e-2)" 4.9 6.3 1.0 0.9 1.3 0.0 8.4 0.9 1.4 2.9 1.8 1.7 1.3 1.2 3.5 3.5 5.8 1.9 19.3 18.2 1.1 0.5 25.0 105.8 11.3 2.5 1.2 0.9 1.9 3.1 8.0 0.8 1.3 2.9 1.4 1.0 3.1 3.6 1.2 5.2 5.8 1.4 2.7 1.2 28.0 7.2 1.7 0.8 0.2 3.1 4.2 1.0 1.3 4.3 1.2 1.1 7.3 0.9 0.7 1.5 0.2 1.3 0.8 0.1 0.4 0.2 0.3 0.2 0.0 0.1 0.0 0.2 5.2 1.4 0.0 0.4 0.2 0.3 3.1 0.1 0.2 0.0 0.0 0.0 0.1 3.9 45.8 2.1 0.3 0.3 1.9 6.6 0.0 0.2 0.4 1.3 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.3 3.3 0.2 0.0 0.1 0.1 2.7 0.1 0.1 1.0 0.0 13.3 0.1 1.2 1.0 0.1 0.9 0.3 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.3 0.1 2.2 0.9 2.9 0.7 0.3 1.5 0.9 0.7 1.0 0.4 1.2 1.5 0.8 7.3 0.7 0.7 1.1 0.9 0.2 1.0 1.3 0.9 1.4 1.1 0.5 1.2 0.9 2.9 0.8 17.9 14.4 0.0 0.2 2.6 1.1 19.5 17.8 1.4 0.0 10.4 3.9 0.0 19.9 13.8 7.3 16.5 0.7 0.0 13.2 0.0 1.0 0.2 0.0 116.0 0.1 0.0 1.7 30.1 4.0 6.7 2.0 0.9 0.0 0.0 0.8 0.2 7.9 0.0 1.1 50.7 0.5 6.5 2.3 0.0 1.0 2.8 0.6 0.0 0.2 1.6 HYAL2 "LuCa-2, LUCA2" ENSG00000068001 "Hyaluronoglucosaminidase 2" Q12891 3 50317790-50322906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 107.0" "Group enriched" "Detected in many" 4 "Endothelial cells: 160.0;Ito cells: 253.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in all" 4 "HUVEC TERT2: 68.6;TIME: 93.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036436 Uncertain NA NA "HPA036436: AB_10670104" "unprognostic (9.97e-3)" "unprognostic (2.60e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-3)" "unprognostic (3.44e-1)" "unprognostic (7.41e-2)" "unprognostic (7.93e-2)" "unprognostic (4.70e-1)" "unprognostic (1.44e-1)" "unprognostic (6.76e-2)" "unprognostic (2.36e-1)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (7.36e-2)" "unprognostic (2.72e-1)" "unprognostic (7.02e-3)" "unprognostic (5.62e-2)" 46.5 16.4 5.4 11.0 13.9 1.2 52.1 3.5 7.6 16.0 9.5 6.6 9.0 7.3 18.8 11.3 16.0 16.5 19.9 33.6 11.1 6.0 35.7 20.2 61.1 25.6 7.5 4.0 13.6 11.2 7.9 11.9 34.4 16.3 10.3 4.8 20.4 10.9 9.7 11.6 9.7 9.9 15.1 8.0 107.0 10.2 8.6 5.5 1.1 23.2 16.0 8.3 14.8 20.2 0.9 4.4 8.6 11.3 2.0 3.4 2.6 4.9 7.3 12.0 12.2 7.4 6.5 7.8 5.9 7.7 8.0 6.3 8.3 14.6 1.3 20.2 8.0 15.9 5.2 4.5 10.9 2.1 2.7 3.9 1.7 6.8 12.6 6.4 1.4 4.8 10.1 9.2 8.1 2.6 7.3 68.6 3.4 3.2 1.5 6.6 6.7 3.2 3.0 14.0 4.3 11.3 2.9 2.4 4.8 9.9 4.4 3.2 10.5 5.8 6.0 5.9 4.2 6.6 3.7 93.9 9.7 9.9 6.5 8.8 2.8 4.4 4.0 5.7 4.7 14.0 0.0 8.0 8.6 1.3 11.3 2.8 0.9 1.1 3.4 4.4 0.9 0.4 0.6 7.6 2.0 10.4 3.3 1.4 2.6 5.4 13.9 3.5 7.6 11.1 6.0 7.5 4.0 16.3 5.5 17.9 6.9 3.0 22.2 11.6 6.2 6.5 17.8 4.0 2.3 31.4 5.9 25.4 10.0 47.4 4.0 160.0 12.7 0.0 34.5 32.3 14.1 25.0 0.0 9.7 38.3 7.9 7.0 253.5 15.5 4.2 22.7 8.6 16.9 8.2 10.7 19.8 35.0 14.0 20.8 10.5 5.5 38.8 13.3 5.9 45.9 11.0 27.3 5.7 15.0 28.5 HYAL3 "LUCA-3, LUCA14, Minna14" ENSG00000186792 "Hyaluronoglucosaminidase 3" O43820 3 50292831-50299468 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.9;bone marrow: 48.8;brain: 12.5;testis: 31.1" "Group enriched" "Detected in many" 16 "Early spermatids: 73.0;Late spermatids: 206.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 12.1;eosinophil: 26.9" "Lineage enriched" "Detected in all" 6 "granulocytes: 26.9" "Cell line enhanced" "Detected in many" "HEL: 22.4;HMC-1: 40.2;THP-1: 41.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049402 Uncertain "Secreted to blood" NA NA "HPA049402: AB_2680746" "unprognostic (1.21e-3)" "unprognostic (2.55e-2)" "unprognostic (5.45e-2)" "unprognostic (8.19e-2)" "unprognostic (3.07e-1)" "unprognostic (1.65e-2)" "unprognostic (7.98e-3)" "unprognostic (7.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" "unprognostic (5.40e-2)" "unprognostic (5.71e-2)" "unprognostic (2.61e-1)" "unprognostic (8.09e-2)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.12e-5)" 3.5 4.2 6.3 3.1 8.8 48.8 3.3 11.4 12.5 4.2 3.6 3.8 6.1 3.8 2.7 5.1 5.6 3.7 5.4 3.4 6.4 5.6 2.9 7.0 3.2 4.2 5.3 5.6 4.3 3.7 2.6 3.1 3.6 11.1 4.9 2.9 3.7 6.7 5.6 3.9 3.0 4.1 4.6 3.4 2.8 6.6 31.1 2.7 3.0 3.3 5.1 3.7 4.8 3.8 1.1 4.2 26.9 2.1 1.0 2.2 1.2 2.2 2.6 1.5 1.7 3.1 1.6 0.9 2.5 2.2 3.2 2.4 3.5 2.4 2.0 1.2 2.9 4.9 2.5 2.7 5.9 1.2 4.6 1.4 22.4 6.8 2.8 2.2 2.4 40.2 3.3 4.5 3.2 2.1 2.3 3.2 2.2 1.7 2.5 1.5 1.3 0.9 14.2 1.1 2.6 6.6 1.0 2.0 3.6 3.8 1.0 1.8 2.1 3.6 2.9 2.0 1.8 1.9 41.3 4.3 2.7 1.9 8.6 1.4 1.2 2.5 1.5 2.4 8.6 2.2 12.1 2.1 26.9 0.7 1.1 1.2 0.9 2.2 1.0 4.2 1.1 0.6 0.8 0.7 1.0 0.7 1.1 1.3 1.2 6.3 8.8 11.4 12.5 6.4 5.6 5.3 5.6 11.1 2.7 3.0 1.4 0.0 2.2 2.7 1.5 0.3 0.0 1.4 4.5 3.5 3.9 2.5 8.3 4.5 73.0 3.4 0.3 0.0 0.6 4.1 1.8 2.3 6.9 1.0 2.0 4.8 4.1 7.4 1.8 206.1 1.7 2.8 3.3 9.0 1.2 1.5 3.1 0.0 2.5 1.9 0.4 6.5 3.1 4.3 3.8 3.1 2.5 1.3 1.6 3.0 HYAL4 ENSG00000106302 "Hyaluronoglucosaminidase 4" Q2M3T9 7 123828983-123877478 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 7.1;skeletal muscle: 8.3" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 4.0;Extravillous trophoblasts: 5.9;Spermatogonia: 2.8;Syncytiotrophoblasts: 1.8" "Cancer enriched" "Detected in single" 48 "testis cancer: 8.4" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.5;CAPAN-2: 7.2;RT4: 17.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA029453 Uncertain NA NA "HPA029453: AB_10601432" "unprognostic (5.19e-5)" "unprognostic (4.18e-2)" "unprognostic (4.82e-2)" "unprognostic (2.20e-1)" "unprognostic (4.14e-2)" "unprognostic (2.60e-1)" "unprognostic (8.24e-2)" "unprognostic (5.26e-2)" "unprognostic (8.15e-3)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (5.55e-3)" 0.1 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.4 0.4 0.2 0.0 0.4 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.1 0.6 0.0 0.1 7.1 0.2 0.0 1.2 0.0 8.3 1.4 0.2 0.0 0.1 1.0 0.2 3.4 0.4 1.5 1.0 0.1 1.3 0.6 3.3 0.6 1.0 0.9 0.1 0.3 0.6 0.1 0.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 7.2 0.3 0.4 0.0 0.7 1.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.0 17.0 0.2 0.1 0.0 1.0 0.0 1.4 0.4 0.2 2.4 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.5 0.4 0.6 0.5 0.5 0.4 0.5 0.5 0.2 1.3 0.7 0.9 3.3 1.0 0.6 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 1.8 0.0 0.0 0.1 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN, axonemal central pair apparatus protein" Q4G0P3 16 70807378-71230722 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 23.6;testis: 19.1" "Cell type enhanced" "Detected in many" 22 "Ciliated cells: 180.7;Cone photoreceptor cells: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 3.5;RPTEC TERT1: 5.3;SiHa: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA067155: AB_2685792, HPA074129: AB_2686665" "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.8 0.9 6.3 1.2 13.9 1.7 1.5 2.9 4.2 2.1 1.2 13.3 4.4 1.0 2.4 18.4 0.9 14.5 1.9 1.0 6.9 4.3 3.5 1.8 7.1 1.1 2.3 4.1 7.2 1.6 9.0 23.6 0.7 21.5 1.4 0.8 3.9 0.9 1.5 0.8 1.7 1.1 1.0 3.1 1.5 1.1 19.1 3.8 0.0 3.2 0.0 0.6 1.2 0.8 0.9 1.1 3.7 1.3 0.7 1.2 0.2 0.1 0.1 2.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.3 0.2 0.4 0.3 3.5 0.7 0.3 0.2 1.6 0.4 0.5 0.1 0.1 0.2 0.4 0.5 0.2 0.4 0.5 0.0 0.0 0.8 0.0 2.2 0.4 0.1 0.1 0.0 0.7 0.8 1.3 0.1 0.7 0.3 0.2 0.8 5.3 0.7 2.5 0.5 11.0 0.3 0.4 0.4 0.7 0.0 0.3 0.3 0.8 0.1 0.3 1.8 0.1 1.0 0.9 0.2 0.6 1.5 1.0 0.8 1.2 0.9 1.2 0.6 1.0 1.1 0.3 0.9 0.9 0.8 3.7 0.7 1.3 1.1 0.6 0.2 6.3 13.9 2.9 4.2 6.9 4.3 2.3 4.1 21.5 3.8 3.0 1.6 0.0 0.2 0.0 13.2 2.0 0.0 180.7 29.6 8.7 49.1 0.0 1.7 1.7 26.1 0.1 0.0 0.0 0.5 0.0 0.9 0.8 0.0 0.0 0.1 0.0 3.4 0.0 0.0 21.2 2.3 0.0 3.3 0.0 0.0 12.9 0.5 0.0 4.2 1.4 26.6 0.0 0.7 17.1 6.1 0.0 0.0 0.0 0.0 0.1 HYI HT036 ENSG00000178922 "Hydroxypyruvate isomerase (putative)" Q5T013 1 43451003-43453989 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 130.4;seminal vesicle: 80.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 39.2;WM-115: 33.2" "Low region specificity" "Detected in all" HPA040092 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Golgi apparatus" "HPA040092: AB_10795374" "prognostic favorable (9.18e-4)" "unprognostic (1.67e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.68e-2)" "unprognostic (3.86e-1)" "unprognostic (4.40e-2)" "prognostic unfavorable (5.55e-4)" "unprognostic (2.75e-2)" "unprognostic (1.42e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (4.43e-2)" "prognostic unfavorable (2.75e-5)" "unprognostic (5.10e-2)" "unprognostic (7.93e-2)" "unprognostic (3.58e-2)" "prognostic favorable (2.72e-5)" 16.5 12.5 11.6 12.1 10.1 5.3 12.8 11.3 9.7 14.6 16.5 13.0 130.4 23.4 15.8 14.8 8.4 15.3 16.7 10.9 9.2 10.0 15.9 25.8 17.8 6.7 10.9 9.3 25.1 34.0 13.8 11.2 10.8 9.0 15.6 7.5 15.0 20.8 80.0 8.8 8.4 22.1 13.4 14.3 7.6 14.1 4.5 11.1 4.9 12.8 9.6 6.4 10.7 11.3 3.2 21.6 6.2 1.2 4.8 5.4 3.0 17.4 2.2 0.7 1.2 3.4 6.4 0.0 15.2 13.7 19.2 12.9 8.9 30.5 0.0 1.1 9.8 7.7 3.2 0.0 16.1 7.9 4.3 6.3 2.8 8.0 0.0 22.7 0.0 0.0 3.8 4.6 21.8 0.0 19.4 39.2 0.1 0.2 0.0 12.9 0.3 2.6 2.9 3.2 1.6 4.5 13.5 0.0 0.1 13.3 0.6 8.3 6.1 17.1 9.6 3.8 2.8 2.5 21.9 18.1 1.2 0.0 3.4 29.7 0.0 0.0 0.0 1.0 4.0 33.2 6.2 1.1 2.4 3.3 0.9 4.1 3.2 5.4 2.6 4.1 2.7 5.1 1.5 0.1 4.8 1.2 21.6 0.5 3.0 11.6 10.1 11.3 9.7 9.2 10.0 10.9 9.3 9.0 11.1 17.9 66.3 11.9 39.0 24.8 15.2 0.3 68.8 10.7 20.5 54.1 9.8 14.0 38.1 94.3 0.9 20.2 81.2 23.3 74.3 97.6 32.9 36.0 43.7 49.7 24.9 7.9 66.7 21.5 7.0 3.1 29.4 17.5 38.8 23.4 57.1 28.8 107.8 112.2 28.7 115.0 14.1 25.8 53.4 0.9 2.1 19.3 10.1 10.0 43.0 29.2 HYLS1 FLJ32915 ENSG00000198331 "HYLS1, centriolar and ciliogenesis associated" Q96M11 11 125883614-125900648 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 72.7;Late spermatids: 40.2;Spermatocytes: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 4.3 4.3 6.5 3.6 8.8 2.8 5.2 12.3 11.6 5.9 5.5 2.7 6.0 7.0 5.3 8.3 5.7 5.0 3.2 5.7 6.7 7.2 8.7 7.2 3.1 6.7 5.0 8.6 5.0 3.4 3.4 5.5 5.1 7.6 6.2 6.0 2.2 3.9 7.6 3.7 5.7 6.7 7.1 3.5 5.6 6.2 28.6 4.3 7.6 5.1 4.6 9.6 5.0 3.8 11.8 14.3 3.2 6.0 4.6 10.3 4.7 4.6 10.2 3.7 2.7 7.4 5.0 6.5 11.8 4.7 11.1 7.5 0.1 7.7 2.0 5.0 10.3 3.7 7.0 5.3 4.1 12.9 11.4 3.7 1.5 1.1 2.1 5.5 5.2 7.9 3.2 4.8 11.0 12.5 2.4 8.0 4.6 2.6 12.7 14.5 7.9 3.8 15.7 8.3 19.6 17.3 8.0 0.0 6.8 11.9 7.8 5.3 3.3 12.5 9.7 4.7 5.0 23.9 11.6 7.2 0.8 9.7 8.8 2.0 4.7 4.6 4.9 2.3 11.5 9.7 3.2 5.5 1.1 8.1 6.0 7.6 11.5 10.2 9.4 6.7 11.8 10.3 7.4 0.9 4.6 4.2 14.3 10.3 4.7 6.5 8.8 12.3 11.6 6.7 7.2 5.0 8.6 7.6 4.3 0.0 0.3 8.0 2.4 3.8 7.9 4.0 2.5 4.0 0.0 1.8 3.9 12.5 10.0 3.9 72.7 3.5 3.3 23.3 3.6 10.5 5.1 2.6 0.0 5.5 6.3 0.0 4.7 4.3 1.9 40.2 7.8 2.2 6.8 14.4 2.1 4.4 3.9 6.0 5.6 10.2 5.6 6.5 5.0 98.2 33.7 3.8 3.7 6.4 5.0 1.4 HYOU1 "Grp170, HSP12A, ORP150" ENSG00000149428 "Hypoxia up-regulated 1" Q9Y4L1 11 119044189-119057202 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 97.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 24.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 95.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049296 Approved "Intracellular and membrane" NA NA 140000000 "HPA049296: AB_2680702" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "unprognostic (8.46e-2)" "prognostic favorable (2.58e-4)" "unprognostic (2.19e-1)" "unprognostic (1.35e-2)" "unprognostic (1.61e-3)" "unprognostic (1.81e-1)" "unprognostic (8.98e-2)" "unprognostic (7.93e-2)" "unprognostic (2.01e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (5.10e-5)" "unprognostic (3.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.38e-2)" 10.8 13.1 10.7 18.1 18.1 11.0 13.4 11.9 20.2 16.7 15.0 10.5 22.9 12.3 14.1 36.7 12.6 13.2 11.2 16.4 11.2 18.1 21.6 97.5 14.4 10.9 12.0 14.3 11.2 75.1 15.3 22.8 17.4 16.6 15.0 15.5 8.8 43.5 16.1 5.8 6.5 13.5 13.5 9.7 13.5 15.2 24.3 11.3 14.7 49.9 5.1 14.1 12.2 15.7 4.0 24.1 2.8 4.3 4.9 9.4 2.7 8.6 7.6 17.0 49.8 9.6 4.5 23.9 13.0 8.3 14.3 10.7 22.8 22.6 18.4 95.1 8.9 28.2 13.1 15.9 15.6 12.1 19.8 6.0 33.2 7.7 16.3 43.5 19.2 16.8 5.6 20.3 12.5 42.3 13.0 22.2 12.8 11.5 30.3 7.5 20.9 12.4 10.2 12.3 18.3 7.7 13.6 12.8 30.5 10.7 15.3 10.3 15.5 17.9 23.3 11.5 15.4 17.4 17.8 17.0 13.6 10.8 6.1 17.0 19.5 13.9 13.4 12.1 16.6 29.9 2.8 3.1 1.4 8.5 4.3 9.4 4.0 4.7 6.1 3.6 2.7 3.0 4.4 0.9 4.9 2.9 24.1 3.5 2.7 10.7 18.1 11.9 20.2 11.2 18.1 12.0 14.3 16.6 11.3 8.9 16.0 6.0 15.2 15.9 11.3 12.7 15.3 10.7 14.8 24.4 41.2 10.0 8.3 17.9 71.6 15.8 23.0 23.3 16.3 18.7 14.7 39.6 15.1 38.9 20.2 23.8 34.3 16.0 6.7 29.8 12.0 14.5 21.9 14.4 21.4 8.2 31.0 21.0 12.7 14.8 12.3 12.9 15.5 21.4 33.7 17.3 16.1 13.1 16.6 14.9 HYPM "CXorf27, HIP17" ENSG00000187516 "Huntingtin interacting protein M" O75409 X 37990817-37991317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 110 "testis: 28.3" "Group enriched" "Detected in some" 61 "Early spermatids: 264.2;Late spermatids: 732.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 5.4" HPA003356 Enhanced NA NA "HPA003356: AB_1078593" "unprognostic (2.99e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 264.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 732.2 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 4.8 1.7 0.0 0.9 0.0 0.0 0.0 IAPP "AMYLIN, DAP, IAP" ENSG00000121351 "Islet amyloid polypeptide" P10997 12 21354959-21379978 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "pancreas: 63.1" "Group enriched" "Detected in some" 5 "Early spermatids: 21.2;Pancreatic endocrine cells: 24.8" "Cancer enriched" "Detected in single" 76 "pancreatic cancer: 21.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 3.2;NTERA-2: 1.6;U-2 OS: 4.9;U-698: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000352, HPA053194" Enhanced "Secreted to blood" NA NA 11900 "CAB000352: AB_2121635, HPA053194: AB_2682076" "unprognostic (5.52e-3)" "unprognostic (1.00e-1)" "unprognostic (4.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.91e-1)" 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.1 63.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 1.3 1.8 0.6 0.7 0.7 0.1 0.1 0.0 0.9 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 0.2 0.3 0.0 0.2 0.1 0.5 0.4 0.2 1.1 0.0 0.1 0.7 0.0 0.0 0.2 0.3 0.1 0.1 0.1 0.2 0.5 0.9 0.1 0.3 0.0 0.3 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.9 0.4 0.0 0.3 0.3 4.9 0.1 0.8 0.5 1.2 1.7 0.2 0.2 0.1 1.8 0.6 0.1 0.4 0.2 0.1 0.4 0.5 0.2 0.3 0.7 0.4 0.7 1.5 0.7 0.2 1.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 21.2 0.0 0.0 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 1.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.0 0.9 IBSP "BSP, BSP-II, SP-II" ENSG00000029559 "Integrin binding sialoprotein" P21815 4 87799581-87812435 "Cancer-related genes, Predicted secreted proteins" "Biomineralization, Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2" "Cell type enriched" "Detected in single" 46 "Hofbauer cells: 6.1" "Cancer enhanced" "Detected in many" "glioma: 12.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-138 MG: 13.0" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.53e-2)" "unprognostic (3.55e-2)" "unprognostic (1.49e-2)" "unprognostic (3.93e-1)" "unprognostic (3.75e-2)" "unprognostic (9.48e-3)" "unprognostic (1.03e-3)" "unprognostic (4.07e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (2.02e-3)" "unprognostic (5.81e-11)" "unprognostic (6.20e-2)" "unprognostic (1.96e-1)" "unprognostic (1.30e-3)" "unprognostic (2.11e-1)" 0.2 0.0 1.9 0.6 0.4 1.0 0.1 2.0 4.5 4.0 0.1 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.8 1.3 1.0 0.1 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.8 6.2 1.1 2.6 0.4 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 13.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 2.0 1.5 1.0 0.1 0.9 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ICA1 "ICA69, ICAp69" ENSG00000003147 "Islet cell autoantigen 1" Q05084 7 8113184-8262687 "Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 58.6" "Group enriched" "Detected in many" 8 "Early spermatids: 546.5;Late spermatids: 690.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "T-reg: 20.8" "Lineage enriched" "Detected in many" 8 "T-cells: 20.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.3;MCF7: 15.3;OE19: 17.5;RT4: 17.9;SCLC-21H: 25.1;SH-SY5Y: 41.4;SK-BR-3: 19.6;T-47d: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017646, HPA061452" Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA017646: AB_1851382, HPA061452: AB_2684525" "unprognostic (1.39e-1)" "unprognostic (1.37e-1)" "unprognostic (3.74e-1)" "unprognostic (6.83e-3)" "unprognostic (9.49e-2)" "unprognostic (8.57e-3)" "unprognostic (1.37e-2)" "unprognostic (3.54e-1)" "unprognostic (7.61e-2)" "unprognostic (3.42e-1)" "unprognostic (5.84e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.23e-8)" "unprognostic (1.30e-1)" "unprognostic (1.29e-1)" "unprognostic (2.77e-2)" "unprognostic (4.08e-2)" 8.9 6.1 12.6 4.2 15.3 11.7 13.0 19.4 24.2 10.7 13.2 2.5 8.7 7.7 5.5 8.5 5.8 8.1 10.4 25.7 7.7 7.8 9.1 5.3 9.2 6.9 4.8 12.4 1.6 58.6 13.2 13.5 4.6 10.5 13.7 14.3 2.5 21.2 8.3 2.8 7.0 10.4 3.7 2.8 7.6 17.9 16.0 3.2 0.8 8.1 4.1 5.5 9.6 4.1 0.3 1.7 2.4 1.6 0.7 20.8 1.1 0.0 0.3 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.3 16.3 0.1 1.6 0.0 0.3 0.0 0.3 0.7 0.0 0.0 2.5 3.4 0.3 0.0 0.1 2.8 0.5 0.0 1.1 0.0 0.0 0.1 11.9 3.2 9.6 0.0 0.0 15.3 0.1 0.0 3.7 17.5 0.1 0.0 0.0 7.1 7.0 17.9 25.1 41.4 0.0 19.6 0.2 4.4 15.9 5.2 7.0 0.0 0.3 0.0 0.3 5.2 2.4 0.0 0.0 2.2 3.4 0.5 1.6 0.1 0.2 0.5 0.4 0.2 3.9 0.3 1.7 0.3 0.2 0.1 2.4 0.7 0.2 0.4 20.8 1.1 12.6 15.3 19.4 24.2 7.7 7.8 4.8 12.4 10.5 3.2 26.8 16.6 0.8 11.9 18.2 10.0 32.3 20.4 14.7 17.0 21.0 5.9 2.2 36.5 31.7 546.5 36.1 22.9 0.0 65.8 0.7 3.3 58.9 8.1 0.8 19.0 0.0 74.0 36.2 8.3 690.2 6.9 5.8 13.5 9.0 64.9 0.8 53.9 47.2 2.8 7.3 1.6 6.5 4.7 7.5 6.4 7.9 1.8 8.9 33.8 34.2 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 568.7;Alveolar cells type 2: 522.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 31.6;Karpas-707: 90.1;RPMI-8226: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Approved "Plasma membrane,Cytosol" NA NA 87900000 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favorable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.4 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.8 4.2 12.7 2.8 9.5 7.7 26.2 0.7 19.3 1.7 0.3 0.0 8.9 23.1 0.0 0.7 0.2 11.5 31.6 0.2 4.5 11.1 0.7 2.6 4.1 0.4 2.1 0.9 2.9 90.1 0.3 0.6 0.1 6.5 0.5 0.1 4.8 0.2 0.0 28.6 7.2 0.0 0.0 0.2 11.6 0.6 18.4 0.7 1.4 0.5 6.5 4.3 0.4 2.4 0.1 27.5 28.3 4.8 7.0 4.9 6.3 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 568.7 522.3 12.0 22.9 75.8 0.0 0.8 20.4 80.3 159.3 3.5 0.0 1.0 0.0 152.6 1.9 139.3 0.5 0.0 84.4 2.5 171.6 19.1 133.1 12.9 75.0 0.0 2.4 56.4 41.3 1.1 4.4 160.6 72.6 168.7 0.3 2.3 107.4 0.0 1.4 9.4 0.3 6.5 95.4 0.5 1.7 60.6 1.0 12.7 0.5 10.0 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 167.1;TIME: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.4 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.9 11.7 2.1 0.0 0.0 0.0 0.1 0.0 0.2 2.6 0.0 10.5 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.0 167.1 9.9 8.6 6.9 0.0 0.0 13.1 1.5 0.0 0.0 0.0 7.9 0.0 16.3 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 42.2 0.0 0.1 0.8 0.0 6.6 2.2 10.5 0.0 2.2 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 0.0 12.5 46.1 3.4 6.5 0.0 0.3 0.0 6.7 6.8 7.0 0.0 0.4 0.0 0.8 0.5 80.1 0.3 0.0 1.2 0.3 6.9 1.6 11.5 1.0 18.7 0.0 1.2 147.3 54.5 0.0 0.3 23.4 27.0 6.4 1.4 0.4 5.1 5.8 1.8 0.5 0.3 6.5 4.4 0.2 0.2 4.6 0.8 52.4 1.7 2.6 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "Cell line enhanced" "Detected in many" "Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: AB_2680897" "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.7 1.3 1.0 3.0 1.6 1.3 1.7 1.7 1.1 1.4 1.2 1.1 1.8 0.0 5.8 1.5 0.0 1.1 0.0 1.2 0.4 20.3 0.8 5.2 1.2 5.1 0.8 18.7 21.1 1.1 1.0 1.6 0.6 1.5 0.6 10.9 2.8 65.6 1.6 5.5 2.4 42.3 0.7 6.9 9.2 1.5 0.6 49.2 1.4 2.4 0.3 1.3 1.4 4.6 3.7 0.5 4.0 5.3 1.1 6.5 0.5 7.1 1.6 3.2 34.9 7.8 4.6 34.5 5.0 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 3.0 43.3 138.5 7.1 7.2 0.1 0.0 25.5 9.4 4.5 5.2 0.0 10.4 53.0 13.7 4.2 18.0 53.5 0.0 30.7 20.6 13.1 14.3 30.0 150.6 21.1 1.6 5.2 26.4 110.3 7.2 5.8 19.9 52.3 12.6 29.1 1.5 17.7 45.3 3.9 54.2 1.2 0.0 13.3 0.5 0.9 7.3 3.9 189.2 31.2 8.4 ICAM4 "CD242, LW" ENSG00000105371 "Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)" Q14773 19 10286967-10288522 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 53.1;bone marrow: 13.7;lung: 13.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 75.3;Club cells: 34.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.0;pons and medulla: 2.4" "Cell type enriched" "Detected in many" 5 "non-classical monocyte: 53.1" "Lineage enriched" "Detected in many" 6 "monocytes: 53.1" "Cell line enhanced" "Detected in some" "HEL: 36.1;HMC-1: 9.1;K-562: 18.6;NB-4: 15.5;U-937: 8.7" "Intracellular and membrane" NA NA 1.9 0.4 0.4 1.6 0.4 13.7 0.6 0.2 2.0 1.0 2.9 0.2 0.0 1.1 1.1 2.9 2.3 1.1 1.1 1.1 0.5 0.3 1.6 1.7 13.5 3.3 0.4 0.0 1.2 0.4 0.1 0.4 1.9 2.4 2.4 0.5 0.9 2.5 2.7 1.7 0.8 1.4 0.2 0.9 2.8 1.6 0.6 0.3 1.5 0.9 0.0 4.5 3.3 0.7 0.5 8.4 4.5 53.1 0.1 0.6 2.4 0.1 0.1 0.1 0.2 0.0 0.0 3.1 0.3 0.1 0.0 0.0 4.0 0.2 0.4 0.4 0.0 0.2 0.3 0.1 0.0 0.0 0.3 0.2 36.1 0.2 5.4 1.0 0.6 9.1 0.2 0.0 0.1 0.1 0.0 0.0 5.8 18.6 1.6 0.0 0.1 1.0 15.5 0.1 0.0 0.1 2.6 1.5 6.8 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.4 0.1 1.0 0.3 0.1 0.0 0.3 0.0 0.5 1.0 0.1 0.3 8.7 0.2 4.5 2.6 2.6 0.2 9.7 0.5 0.5 0.3 0.2 8.4 0.4 0.3 0.1 0.7 0.1 53.1 2.7 0.6 2.4 0.4 0.4 0.2 2.0 0.5 0.3 0.4 0.0 2.4 0.3 62.5 75.3 0.8 0.9 0.9 0.0 0.0 0.0 4.0 34.2 0.0 0.0 0.3 0.0 0.5 0.0 6.7 0.0 0.0 1.8 0.7 11.2 1.4 20.9 0.0 5.2 0.0 0.0 1.8 3.5 0.0 0.0 8.1 5.0 19.8 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.1 1.1 0.7 0.0 0.0 1.6 ICAM5 "TLCN, TLN" ENSG00000105376 "Intercellular adhesion molecule 5" Q9UMF0 19 10289981-10296778 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 32.6" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 33.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 4.8" "Group enriched" "Detected in many" 15 "amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.5;K-562: 10.8;RPMI-8226: 12.3;U-266/70: 14.8;U-87 MG: 8.8" "Group enriched" "Detected in many" 9 "amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4" "Group enriched" "Detected in many" 13 "amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5" "HPA008943, HPA009083, CAB025178" Enhanced NA NA 2400000 "CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094" "unprognostic (7.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.66e-2)" "unprognostic (4.24e-2)" "unprognostic (8.23e-3)" "unprognostic (2.58e-1)" "unprognostic (8.12e-2)" "unprognostic (9.99e-3)" "unprognostic (2.58e-1)" "unprognostic (2.44e-2)" "unprognostic (3.90e-3)" "unprognostic (9.89e-3)" "unprognostic (5.29e-5)" "unprognostic (6.47e-2)" "unprognostic (4.86e-2)" "unprognostic (5.44e-3)" "unprognostic (6.28e-3)" 0.8 0.9 22.5 0.8 24.3 2.0 0.9 0.0 32.6 0.8 0.8 1.0 0.0 0.8 0.8 0.8 0.8 0.9 0.8 1.0 23.0 1.4 1.1 0.8 3.6 1.2 0.9 15.9 1.4 0.8 0.8 0.1 1.1 0.0 0.9 0.8 0.0 0.8 0.9 0.8 0.8 1.0 0.8 0.1 1.0 1.0 1.9 1.6 0.0 0.8 0.0 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 2.9 0.0 0.0 6.2 0.0 0.0 0.1 4.4 0.7 0.1 0.4 0.0 0.1 4.7 2.0 0.0 0.0 5.4 0.2 0.0 0.0 0.1 0.9 13.5 4.3 0.4 0.1 0.0 2.7 0.0 0.5 0.1 0.0 0.0 0.0 1.7 10.8 0.1 0.0 0.6 0.0 1.9 0.0 0.2 4.4 0.1 0.0 12.3 0.2 0.0 0.8 0.1 2.0 0.1 0.3 0.0 2.2 0.0 0.0 1.3 0.0 0.6 0.0 14.8 2.4 2.7 8.8 0.0 1.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 24.3 0.0 32.6 23.0 1.4 0.9 15.9 0.0 1.6 6.0 3.2 0.0 0.2 0.2 0.0 33.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.4 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 1.6 0.1 0.1 0.0 0.0 0.1 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936748-203961577 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8" "Cell type enriched" "Detected in some" 4 "T-cells: 23.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 18.4" "Lineage enriched" "Detected in single" 58 "T-cells: 18.4" "Group enriched" "Detected in some" 7 "HEL: 6.0;MOLT-4: 15.7" "Low region specificity" "Detected in single" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favorable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 1.5 0.3 0.2 15.6 0.2 13.8 0.7 0.2 0.2 0.8 1.2 0.0 0.2 0.5 1.2 0.5 1.1 1.2 1.6 0.5 0.2 0.2 1.0 0.8 4.0 19.4 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.7 1.1 0.7 2.9 0.0 0.2 0.6 6.2 0.3 0.4 6.1 1.0 0.6 0.0 51.8 1.4 2.4 28.9 3.0 0.9 0.0 0.0 0.0 0.0 0.3 18.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.9 0.0 10.5 4.6 0.0 0.0 11.0 5.0 0.0 0.3 0.0 0.0 18.4 3.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 5.8 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.6 0.1 23.5 0.0 0.0 ICOSLG "B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653" ENSG00000160223 "Inducible T cell costimulator ligand" O75144 21 44217014-44240966 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, B-cell activation, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;monocytes: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 14.1" "CAB026037, HPA029179" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA 150000000 "Plasma membrane, Cytoplasmic bodies" "CAB026037: , HPA029179: AB_2732445" "unprognostic (3.03e-2)" "unprognostic (1.40e-4)" "unprognostic (3.52e-2)" "unprognostic (1.94e-2)" "unprognostic (6.74e-2)" "unprognostic (9.40e-2)" "unprognostic (6.94e-2)" "unprognostic (3.71e-1)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (2.42e-1)" "unprognostic (3.00e-2)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.84e-1)" 2.3 3.0 5.3 3.9 7.1 14.1 2.3 2.3 5.9 2.9 2.3 2.3 2.3 1.8 2.3 2.3 4.0 2.7 3.5 3.7 8.8 3.7 5.3 2.7 2.3 6.5 6.5 2.3 2.3 2.3 0.0 2.3 2.3 2.3 2.3 1.2 2.3 2.3 2.3 2.3 5.5 2.9 2.3 8.4 3.2 4.2 2.3 2.3 2.3 2.3 2.3 4.5 2.4 2.6 6.5 1.6 1.0 0.8 0.5 1.1 0.4 0.3 3.3 0.1 2.8 0.8 1.1 7.7 0.7 0.7 0.4 0.2 5.6 0.4 14.1 2.1 0.3 1.3 4.3 2.0 1.3 0.2 1.4 1.4 0.4 2.7 1.6 0.7 6.1 10.4 1.1 1.9 0.9 0.9 0.2 0.8 0.5 2.3 1.3 0.2 3.7 0.3 8.0 2.0 9.5 3.5 12.0 0.9 8.2 0.6 7.5 1.4 0.0 9.4 13.3 0.3 1.1 3.9 8.7 0.8 0.4 3.3 0.3 0.2 12.1 8.3 11.8 4.4 5.7 1.9 0.6 0.8 0.4 0.3 0.8 0.3 3.7 0.8 0.5 0.5 6.5 0.8 1.1 1.0 0.5 0.5 1.6 0.4 0.4 5.3 7.1 2.3 2.3 8.8 3.7 6.5 2.3 2.3 2.3 0.0 1.0 17.5 5.3 6.6 0.4 0.3 0.0 0.0 1.2 8.7 0.0 0.3 0.0 1.3 0.7 3.1 4.2 0.0 0.6 0.9 4.8 11.7 0.0 1.9 3.4 0.0 5.1 1.3 6.7 2.7 2.8 10.5 8.5 34.3 4.4 1.3 0.7 1.4 10.3 3.6 0.8 0.0 8.1 0.0 0.2 5.6 0.5 0.0 3.9 5.9 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 163.1" "Cell type enhanced" "Detected in many" 8 "Ito cells: 1636.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.9" "Cell line enhanced" "Detected in many" "EFO-21: 75.9;HaCaT: 72.3;PC-3: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 28.6 12.3 8.2 15.2 9.1 4.4 33.2 5.6 13.8 36.3 33.3 15.4 38.5 36.4 25.9 11.6 78.0 25.1 19.0 33.5 8.7 8.4 22.3 23.4 57.4 17.9 10.0 7.9 12.3 5.8 4.0 25.7 22.1 14.3 56.4 13.1 34.9 10.5 163.1 23.0 16.5 40.6 16.9 8.1 15.3 48.6 7.8 4.0 2.4 78.8 36.2 21.0 80.0 26.4 0.4 0.7 3.9 0.7 0.3 0.5 0.5 10.7 35.5 0.4 7.2 4.7 2.1 27.7 45.5 1.8 8.4 0.9 18.7 16.2 0.0 75.9 12.1 9.9 72.3 5.9 2.5 1.3 0.8 3.7 5.9 30.8 60.2 6.4 0.1 0.3 8.7 10.4 0.0 0.6 14.0 5.1 4.0 13.0 0.3 16.1 14.0 1.6 0.2 25.5 48.0 75.7 0.1 29.7 0.5 1.6 29.7 13.8 12.9 37.8 13.6 0.3 20.1 8.3 1.0 27.1 22.6 44.0 7.2 30.5 0.8 0.8 0.6 26.3 5.6 3.0 0.0 0.6 0.9 0.1 0.2 0.0 0.1 0.1 0.0 0.7 0.4 0.0 0.5 3.9 0.3 0.7 0.0 0.0 0.5 8.2 9.1 5.6 13.8 8.7 8.4 10.0 7.9 14.3 4.0 220.3 143.7 26.8 631.9 90.9 1.0 20.7 76.5 89.7 271.8 216.3 3.9 104.2 31.5 429.0 5.6 483.5 528.2 0.0 472.2 442.0 137.2 501.4 21.9 90.9 22.4 0.0 550.7 1636.4 76.9 5.9 26.4 25.7 86.0 13.6 450.7 80.6 190.0 770.0 0.4 2.7 4.0 12.9 193.3 1.9 2.2 76.9 74.5 24.9 241.9 477.9 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684453 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 274.1" "Cell type enhanced" "Detected in all" 12 "monocytes: 3286.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 110.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 108.1;HEK 293: 69.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" NA NA "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 34.2 37.4 24.9 19.1 20.6 69.8 31.5 11.3 57.3 21.9 34.0 22.9 13.2 20.7 18.6 11.6 12.1 28.1 33.5 46.1 20.0 14.6 31.2 117.5 25.4 22.4 19.0 35.3 59.7 15.0 274.1 17.2 14.8 20.0 27.2 26.4 13.3 24.5 72.7 8.8 16.6 20.4 19.2 15.8 21.3 16.2 7.1 14.2 19.0 46.8 15.1 10.2 31.8 38.0 0.3 25.0 110.4 26.0 90.9 42.4 18.0 0.2 20.0 8.2 10.1 13.3 2.1 31.5 22.8 2.7 10.2 4.3 40.0 1.0 0.5 27.1 39.0 2.6 17.2 5.3 0.1 3.0 108.1 69.9 14.4 12.3 48.9 3.9 10.7 40.5 3.6 0.4 4.7 0.2 2.8 0.2 1.0 0.8 17.1 15.8 6.7 1.1 1.2 15.0 47.9 15.7 1.4 5.7 10.7 10.2 9.0 15.6 22.1 1.2 17.3 1.7 21.7 2.9 6.4 4.1 12.6 2.2 18.7 1.3 1.3 1.0 12.4 16.0 33.0 6.8 9.0 8.2 110.4 42.4 24.2 25.3 0.3 13.1 29.5 25.0 0.2 16.4 31.4 11.2 90.9 26.0 1.1 1.0 18.0 24.9 20.6 11.3 57.3 20.0 14.6 19.0 35.3 20.0 14.2 131.0 257.3 44.9 93.2 116.7 9.4 147.7 272.6 71.0 147.9 96.0 15.7 219.0 470.9 258.1 11.1 189.7 226.3 46.7 138.3 130.1 269.8 153.6 916.1 393.6 669.0 6.4 409.1 414.4 336.8 15.3 115.1 499.1 268.2 3286.8 521.6 478.8 95.2 300.6 30.8 190.8 24.4 19.4 173.1 1.6 4.7 91.5 557.0 879.8 224.4 39.6 ID3 "bHLHb25, HEIR-1" ENSG00000117318 "Inhibitor of DNA binding 3, HLH protein" Q02535 1 23557918-23559794 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Myogenesis, Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 117.9" "Cell type enhanced" "Detected in many" 6 "Ito cells: 1041.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 47.4;naive B-cell: 42.9" "Group enriched" "Detected in many" 37 "B-cells: 47.4;T-cells: 24.9" "Cell line enhanced" "Detected in many" "U-698: 84.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021353, HPA024677" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB021353: , HPA024677: AB_2671647" "unprognostic (6.73e-2)" "unprognostic (2.48e-1)" "unprognostic (5.19e-2)" "prognostic favorable (1.27e-5)" "unprognostic (5.58e-3)" "unprognostic (1.46e-1)" "unprognostic (8.98e-2)" "unprognostic (7.76e-2)" "unprognostic (3.89e-2)" "unprognostic (6.47e-3)" "unprognostic (2.42e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.01e-1)" "unprognostic (4.37e-3)" "unprognostic (8.36e-2)" 33.5 12.2 13.3 18.9 15.5 6.0 41.6 2.4 14.4 22.0 25.9 16.6 31.4 18.9 21.7 17.8 20.6 33.8 22.9 42.2 21.1 12.4 21.3 11.1 25.8 15.3 16.6 9.1 27.2 10.2 4.2 31.1 31.3 17.7 38.9 13.0 42.6 9.1 117.9 17.0 14.2 17.0 13.3 16.9 12.4 21.6 6.9 20.7 20.5 82.8 19.3 10.7 35.0 72.1 47.4 0.9 0.5 0.2 0.0 24.9 6.1 3.3 20.4 7.0 24.5 3.2 0.4 8.2 24.6 2.1 13.8 1.7 1.2 0.1 21.8 25.4 9.2 2.9 28.2 8.6 3.2 1.4 0.1 9.0 0.3 26.6 11.0 9.9 0.0 0.0 10.3 17.3 0.3 0.2 12.1 12.2 8.7 0.1 0.2 12.5 8.0 2.9 0.0 6.1 16.3 5.1 27.2 13.0 0.7 0.1 7.7 10.3 8.1 23.5 17.4 1.7 5.5 4.5 0.6 25.3 19.6 10.5 9.7 12.8 6.8 6.2 84.2 4.3 0.2 11.4 0.0 0.2 0.0 0.6 0.2 0.2 47.4 10.9 2.1 0.7 42.9 18.2 7.2 0.5 0.0 0.2 0.9 24.9 6.1 13.3 15.5 2.4 14.4 21.1 12.4 16.6 9.1 17.7 20.7 107.2 66.6 152.0 308.3 182.4 2.9 23.8 20.4 28.1 46.6 198.9 9.8 146.2 19.9 195.6 1.1 558.2 223.7 0.0 376.5 627.5 200.0 250.3 15.0 3.4 67.3 4.8 415.6 1041.7 65.7 1.8 38.0 95.2 236.2 34.3 461.1 365.1 130.9 345.5 0.7 5.7 12.4 511.0 604.0 0.5 0.6 165.7 233.5 45.9 226.0 105.9 ID4 bHLHb27 ENSG00000172201 "Inhibitor of DNA binding 4, HLH protein" P47928 6 19837386-19840684 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "thyroid gland: 154.6" "Group enriched" "Detected in many" 4 "Basal glandular cells: 188.3;Muller glia cells: 371.8;Smooth muscle cells: 607.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 17.2;AN3-CA: 22.6;EFO-21: 51.6;HEK 293: 28.9;SCLC-21H: 46.6;SuSa: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075639 Supported Nucleoplasm NA NA Nucleoplasm "HPA075639: " "unprognostic (3.25e-3)" "unprognostic (7.37e-3)" "unprognostic (1.80e-1)" "unprognostic (6.34e-3)" "unprognostic (4.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" "prognostic favorable (2.49e-4)" "unprognostic (7.26e-2)" "unprognostic (1.66e-3)" "unprognostic (2.41e-2)" "unprognostic (3.13e-2)" "unprognostic (1.03e-3)" "unprognostic (2.57e-3)" 33.1 2.1 29.3 5.3 29.6 1.1 16.9 13.2 31.1 21.1 5.1 29.0 7.2 4.9 22.9 7.0 12.1 34.1 6.8 25.2 32.3 20.6 11.7 2.4 14.6 3.5 14.5 19.0 22.9 11.8 2.0 13.1 13.2 24.9 18.7 4.6 5.7 16.0 26.6 1.8 31.3 4.0 14.2 12.5 11.4 11.9 10.8 20.0 0.0 154.6 4.4 3.5 10.5 11.5 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 17.2 22.6 0.5 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 51.6 5.8 0.1 8.8 0.0 0.0 0.2 0.0 28.9 0.0 0.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.4 2.4 0.0 0.0 0.0 0.0 3.0 6.1 46.6 0.6 0.0 0.8 3.0 15.0 1.4 0.0 0.0 0.1 2.7 0.0 0.7 0.0 0.0 0.5 0.7 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 29.3 29.6 13.2 19.2 32.3 20.6 14.5 19.0 24.9 20.0 89.3 35.7 0.0 188.3 73.7 10.2 30.8 0.0 10.7 26.1 64.6 2.0 7.6 43.1 14.4 1.3 5.8 7.9 0.0 2.9 6.2 57.9 86.7 0.0 0.0 2.5 3.2 87.7 17.2 0.3 4.4 7.5 4.1 84.4 0.0 4.8 371.8 2.1 31.7 0.0 61.2 12.2 0.0 607.2 0.9 0.6 68.6 4.9 0.0 2.8 35.0 IDH2 ENSG00000182054 "Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial" P48735 15 90083045-90102504 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 126.2;skeletal muscle: 190.7" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 682.3;Distal tubular cells: 989.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007831 Enhanced Supported Mitochondria NA NA 53000000 Mitochondria "HPA007831: AB_1851397" "unprognostic (2.45e-2)" "prognostic favorable (5.15e-5)" "unprognostic (2.92e-1)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (8.46e-2)" "unprognostic (3.83e-2)" "unprognostic (2.55e-3)" "unprognostic (1.86e-2)" "unprognostic (1.89e-2)" "unprognostic (2.76e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-3)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" 5.4 2.0 14.9 10.1 16.6 22.6 8.8 4.9 19.1 6.4 16.2 13.8 12.4 16.1 5.9 15.3 23.7 6.0 9.4 126.2 10.2 9.3 25.0 93.2 6.9 15.8 14.4 12.0 3.0 25.1 8.4 3.3 15.1 11.9 13.3 14.5 6.0 28.0 21.9 190.7 11.0 13.9 15.8 11.0 7.5 27.9 1.2 7.6 28.2 3.4 69.0 13.6 11.0 8.6 16.8 32.8 17.2 56.3 22.2 29.5 31.2 10.3 5.9 30.6 30.3 4.3 5.2 26.0 13.0 19.8 12.3 13.2 2.8 9.0 12.3 3.7 10.7 11.7 3.6 4.4 3.9 5.8 24.2 2.9 21.0 2.2 20.6 5.2 14.4 21.3 11.0 2.2 2.9 2.3 14.9 25.1 43.6 3.1 10.6 9.4 30.2 69.1 22.4 9.1 14.2 2.4 58.6 21.9 36.7 18.9 12.5 44.1 22.4 16.1 64.4 5.2 17.8 51.9 44.5 6.0 21.9 3.2 2.8 6.0 17.5 3.2 1.4 7.0 30.3 12.6 9.0 26.4 17.2 26.1 48.0 12.4 16.8 18.7 29.5 32.8 9.8 10.2 18.2 5.1 22.2 56.3 17.8 15.9 31.2 14.9 16.6 4.9 19.1 10.2 9.3 14.4 12.0 11.9 7.6 6.0 21.8 67.0 66.5 35.4 5.3 402.1 104.4 56.2 21.6 71.5 9.8 682.3 989.8 188.2 4.7 25.3 53.5 23.3 255.6 386.0 36.6 189.5 30.1 240.4 229.9 9.5 59.3 41.1 60.4 2.5 13.0 70.5 55.6 96.4 122.1 17.5 127.7 132.1 33.2 128.5 5.1 12.9 38.3 0.5 4.5 58.6 479.2 123.2 268.2 90.1 IDI2 IPPI2 ENSG00000148377 "Isopentenyl-diphosphate delta isomerase 2" Q9BXS1 10 1018907-1025859 "Enzymes, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "skeletal muscle: 141.6" "Cell type enhanced" "Detected in some" 13 "Club cells: 1.2;Horizontal cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 1.4;NB-4: 2.7;NTERA-2: 1.5;SK-MEL-30: 3.4" HPA041254 Uncertain Vesicles NA NA Vesicles "HPA041254: AB_10794270" "unprognostic (6.69e-3)" "unprognostic (4.05e-2)" "unprognostic (1.64e-1)" 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 141.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.5 0.1 0.0 0.7 0.0 0.8 0.1 0.0 1.0 0.0 0.0 0.4 0.4 0.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.5 0.0 0.3 0.9 1.4 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.3 2.7 1.5 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 3.4 0.2 1.0 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 IDNK "bA522I20.2, C9orf103, hGntK" ENSG00000148057 "IDNK, gluconokinase" Q5T6J7 9 83623049-83644130 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.9;liver: 39.1" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 68.0;Proximal tubular cells: 149.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020378, HPA058429" Approved Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA020378: AB_1845794, HPA058429: AB_2683716" "unprognostic (1.49e-3)" "unprognostic (7.94e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (5.41e-3)" "unprognostic (1.81e-2)" "unprognostic (6.08e-2)" "unprognostic (1.57e-1)" "unprognostic (2.61e-2)" "unprognostic (3.00e-1)" "unprognostic (5.86e-3)" "unprognostic (7.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.55e-1)" "unprognostic (3.11e-2)" 4.3 6.1 9.4 2.9 20.3 2.2 4.5 12.3 8.3 2.3 11.3 7.0 3.1 14.2 2.5 7.4 4.1 6.8 4.5 2.8 7.6 8.6 27.2 39.1 3.7 4.7 7.3 6.3 3.2 6.6 3.6 5.2 1.8 6.2 4.2 4.7 5.2 4.6 5.0 1.2 3.3 20.2 3.5 7.0 4.2 4.3 2.0 6.8 14.5 7.0 1.2 4.3 2.8 2.1 17.5 9.6 35.9 20.5 15.0 23.0 11.4 3.4 8.2 1.1 1.3 3.7 5.4 6.0 2.3 6.9 2.6 2.1 2.1 3.0 4.3 4.0 3.7 2.5 5.7 0.9 1.6 2.8 9.5 1.0 1.6 3.2 9.4 16.4 1.0 2.0 3.7 2.2 5.7 5.4 3.9 5.9 10.3 1.3 4.6 3.8 19.0 2.6 1.0 0.9 13.8 3.7 3.2 3.1 2.5 6.9 4.0 5.3 6.8 5.5 4.3 5.8 1.6 4.3 5.8 6.0 1.1 0.8 10.7 4.4 6.6 7.6 0.6 5.9 1.8 2.1 35.9 6.1 8.6 14.7 10.6 12.3 17.5 12.7 12.1 8.5 11.4 10.2 13.8 1.1 15.0 20.5 9.6 23.0 11.4 9.4 20.3 12.3 8.3 7.6 8.6 7.3 6.3 6.2 6.8 11.9 5.4 5.9 2.6 6.1 7.5 8.7 15.3 22.7 9.1 5.2 0.0 6.3 68.0 10.1 0.3 6.0 10.8 0.0 14.3 3.8 8.4 5.2 19.7 37.2 10.0 9.5 7.0 3.1 9.5 1.1 4.0 7.7 11.8 27.9 10.6 17.7 5.2 11.5 3.9 149.6 3.1 0.0 9.5 1.1 1.5 5.1 2.5 17.5 7.8 2.7 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell type enriched" "Detected in some" 552 "monocytes: 4555.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Cell line enriched" "Detected in some" 7 "EFO-21: 36.6" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favorable (5.27e-4)" "prognostic favorable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 2.6 0.1 0.3 0.0 36.6 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.5 2.6 0.9 0.0 0.0 6.7 0.0 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 8.2 1.3 0.0 6.0 0.0 4555.6 0.0 3.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.4 IDO2 INDOL1 ENSG00000188676 "Indoleamine 2,3-dioxygenase 2" Q6ZQW0 8 39934614-40016391 "Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "liver: 9.7;placenta: 21.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 16.8;Late spermatids: 5.3;monocytes: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;U-266/70: 1.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA054911 Approved Cytosol NA NA Cytosol "HPA054911: " "unprognostic (2.00e-3)" "unprognostic (2.34e-5)" "unprognostic (2.22e-3)" "unprognostic (4.41e-3)" "unprognostic (5.37e-2)" "unprognostic (3.69e-5)" "unprognostic (1.19e-1)" "unprognostic (4.73e-3)" "unprognostic (1.20e-2)" "unprognostic (2.78e-1)" "unprognostic (4.11e-3)" "unprognostic (2.25e-1)" "unprognostic (6.47e-7)" "unprognostic (3.25e-2)" "unprognostic (1.96e-3)" "unprognostic (3.35e-2)" "unprognostic (3.08e-3)" 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 9.7 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 IDS SIDS ENSG00000010404 "Iduronate 2-sulfatase" P22304 X 149476990-149521096 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA078003 Approved "Intracellular and membrane" NA NA 8900000 "HPA078003: " "unprognostic (9.88e-2)" "unprognostic (1.10e-2)" "unprognostic (6.59e-2)" "unprognostic (1.45e-3)" "unprognostic (2.83e-2)" "unprognostic (4.52e-3)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (1.20e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-1)" "unprognostic (9.76e-3)" "unprognostic (3.61e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (1.87e-1)" 11.6 20.4 92.9 12.1 81.5 16.0 12.0 30.4 107.9 13.1 9.3 15.0 8.1 9.1 17.8 29.5 11.3 14.8 12.3 16.2 83.6 42.7 10.5 7.0 17.9 12.5 36.7 51.8 22.6 10.6 19.5 17.8 7.4 33.0 14.0 10.7 7.7 9.1 19.5 8.9 12.9 11.6 14.1 21.0 14.1 10.6 3.8 14.7 1.9 13.2 4.9 14.7 11.4 8.6 8.7 11.7 63.4 16.6 8.5 18.2 13.3 14.3 16.3 7.2 4.2 7.9 14.1 3.0 8.3 21.8 7.7 14.8 3.3 10.8 34.4 22.2 12.3 16.2 8.3 6.9 13.0 10.0 12.3 5.9 3.7 5.3 1.9 6.1 5.9 33.2 7.7 7.0 16.7 11.0 32.6 12.2 6.5 1.7 25.2 11.3 18.3 5.9 3.1 5.6 9.2 11.1 3.9 6.5 6.6 9.9 3.6 9.6 22.1 3.2 7.3 10.2 11.7 2.3 2.6 14.3 10.2 10.3 16.5 22.3 17.6 13.9 25.1 45.9 14.2 7.2 23.9 13.8 39.6 18.2 14.9 13.5 8.7 11.2 13.6 11.7 6.6 7.5 11.3 63.4 8.5 16.6 8.8 16.9 13.3 92.9 81.5 30.4 90.7 83.6 42.7 36.7 51.8 33.0 14.7 92.3 66.3 80.1 47.2 29.5 173.4 41.9 7.6 78.9 62.6 78.5 43.2 23.8 18.3 43.2 1.1 38.4 37.1 0.0 64.9 19.5 73.6 58.5 220.6 30.0 43.2 209.7 161.6 51.0 68.1 1.7 67.3 78.5 49.0 118.2 26.2 42.9 66.6 45.6 84.1 19.0 58.2 58.2 64.9 2.9 5.1 38.1 119.6 113.6 17.9 87.2 IER2 ETR101 ENSG00000160888 "Immediate early response 2" Q9BTL4 19 13150415-13154908 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 57.5;U-266/84: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055387, HPA060574" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055387: AB_2682802, HPA060574: AB_2684324" "unprognostic (3.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.99e-1)" "unprognostic (4.86e-2)" "unprognostic (3.86e-2)" "unprognostic (2.47e-2)" "unprognostic (2.10e-1)" "unprognostic (3.31e-1)" "unprognostic (2.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" "unprognostic (2.86e-1)" "unprognostic (1.01e-1)" 34.1 24.4 11.5 13.4 16.1 68.2 19.1 13.3 16.8 16.4 20.3 10.1 28.7 12.6 20.3 13.0 22.3 66.8 16.4 16.2 14.1 5.9 16.8 19.9 25.4 14.0 19.2 13.7 33.9 21.6 15.1 17.0 19.9 14.9 26.4 10.0 11.6 34.4 27.1 4.2 45.6 13.7 24.1 15.3 17.1 25.3 7.0 14.2 6.7 29.0 6.7 11.9 18.3 26.4 23.8 14.3 120.1 27.5 28.4 38.4 30.3 14.0 8.4 6.6 10.0 4.4 5.9 14.6 10.9 5.9 7.5 4.4 7.1 8.5 8.3 11.1 7.9 12.7 9.5 3.0 6.3 3.8 4.9 5.7 10.9 14.3 5.9 5.4 13.7 12.2 3.0 15.7 8.1 5.1 9.2 8.8 8.7 27.5 11.2 2.9 23.0 8.2 57.5 12.6 15.2 36.4 16.0 6.7 9.9 6.8 8.3 8.2 11.8 12.2 37.7 24.7 5.4 4.4 8.3 15.8 16.0 10.9 13.2 31.4 33.1 73.6 8.6 8.6 27.4 12.3 40.5 23.4 37.6 38.4 27.5 33.1 21.3 27.0 30.7 14.3 23.8 18.1 22.7 120.1 28.4 24.7 6.5 25.3 30.3 11.5 16.1 13.3 16.8 14.1 5.9 19.2 13.7 14.9 14.2 163.8 583.5 268.0 446.3 283.3 80.9 53.2 336.3 91.0 145.6 90.7 33.4 412.8 44.7 562.1 8.3 433.3 636.2 23.3 334.1 457.3 546.3 696.8 470.7 72.3 507.9 14.3 939.8 260.9 263.5 8.1 127.8 482.9 224.4 162.3 744.6 230.0 421.9 589.0 36.4 32.7 128.3 633.8 468.1 4.5 8.9 386.1 765.7 449.7 550.7 402.2 IER3 "DIF-2, IEX-1, IEX-1L, PRG1" ENSG00000137331 "Immediate early response 3" P46695 6 30743199-30744554 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 142.2" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 1054.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "A-431: 40.4;EFO-21: 15.2;HBEC3-KT: 50.4;RPTEC TERT1: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA043847 Approved NA NA "HPA043847: AB_2678699" "unprognostic (2.83e-3)" "unprognostic (9.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.78e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (5.57e-4)" "prognostic unfavorable (6.36e-5)" "unprognostic (1.38e-3)" "unprognostic (1.69e-1)" "unprognostic (9.28e-2)" "unprognostic (1.53e-3)" "unprognostic (1.19e-2)" "prognostic unfavorable (3.10e-7)" "unprognostic (1.76e-1)" "unprognostic (1.70e-1)" "unprognostic (2.71e-2)" "unprognostic (8.77e-2)" 30.1 24.1 1.9 43.2 1.5 3.0 6.1 0.8 2.7 21.5 9.0 4.7 77.8 2.7 7.3 12.5 47.2 10.0 16.7 22.8 2.1 1.3 17.9 15.9 20.1 6.0 3.1 0.5 11.2 17.7 2.7 3.8 10.3 5.1 9.9 2.7 6.4 10.8 142.2 5.8 14.2 4.2 7.2 5.4 12.1 18.6 5.5 1.7 3.9 4.5 37.1 27.8 33.9 22.5 0.4 0.0 1.6 0.4 0.0 0.4 0.0 40.4 0.0 0.0 4.8 1.2 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.2 2.6 4.3 0.0 0.0 50.4 0.0 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 6.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 1.5 0.8 1.8 2.1 1.3 3.1 0.5 5.1 1.7 193.5 141.7 10.9 611.5 406.6 1.2 8.3 135.0 77.6 313.9 96.0 0.0 32.4 69.6 1054.7 1.1 105.7 199.7 0.0 630.2 37.5 548.2 532.9 122.3 15.3 304.1 3.2 141.8 63.8 77.5 1.3 9.2 412.4 224.4 450.0 306.7 13.5 576.2 307.8 6.3 10.9 2.9 25.8 695.2 0.0 1.9 287.7 69.5 14.1 220.4 511.6 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904281-18956686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 76.8" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "basophil: 10.6" "Lineage enriched" "Detected in many" 11 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: AB_2685296" "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 3.5 5.1 3.8 5.0 7.8 5.7 8.9 22.3 6.4 6.7 4.6 6.2 4.9 1.4 4.7 2.2 28.7 3.6 4.8 2.7 4.4 4.0 4.9 8.9 5.0 5.3 6.8 3.6 2.4 14.5 13.0 4.0 4.7 9.3 6.6 2.0 3.4 7.9 6.5 4.3 76.8 2.5 13.5 8.9 3.9 2.9 1.4 4.6 3.2 4.3 33.2 11.3 6.3 8.8 0.8 0.6 10.6 0.3 0.3 1.0 0.1 8.4 13.8 3.7 10.3 2.4 1.9 6.0 6.4 4.2 3.5 2.4 18.9 9.9 0.1 8.2 4.8 4.0 21.2 2.8 13.5 2.8 50.5 2.5 0.1 2.6 7.4 1.7 1.4 16.2 1.2 13.8 4.7 6.0 5.8 7.4 0.4 0.6 1.7 2.3 1.7 1.4 1.3 1.6 8.7 3.3 4.7 2.3 3.6 2.0 5.4 11.9 0.6 4.8 6.8 4.7 4.0 1.8 0.7 20.2 4.7 6.6 2.7 18.3 3.6 3.9 0.2 3.2 2.1 5.5 10.6 0.3 0.0 0.6 0.3 0.8 0.8 0.5 0.7 0.1 0.3 0.5 1.0 0.1 0.3 0.0 0.6 0.5 0.1 3.8 7.8 22.3 6.4 4.4 4.0 6.8 3.6 9.3 4.6 3.0 4.8 0.9 68.5 107.4 5.7 5.5 15.3 12.0 4.5 1.8 0.0 4.1 1.7 12.7 1.2 7.1 1.0 0.0 15.2 5.8 3.6 12.6 3.5 3.9 2.0 23.8 2.4 6.2 0.8 2.2 1.1 4.0 13.5 2.8 0.6 5.1 13.4 2.9 2.8 8.1 1.6 0.0 8.5 0.7 0.5 87.7 3.3 2.9 1.0 39.7 IFI27L1 FAM14B ENSG00000165948 "Interferon alpha inducible protein 27 like 1" Q96BM0 14 94081282-94103846 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 249.4;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 52.2" NA NA "unprognostic (7.89e-3)" "unprognostic (1.47e-1)" "unprognostic (6.31e-2)" "unprognostic (8.54e-3)" "unprognostic (2.53e-1)" "unprognostic (4.81e-2)" "unprognostic (1.84e-2)" "unprognostic (2.63e-1)" "unprognostic (3.68e-1)" "unprognostic (7.63e-3)" "unprognostic (2.50e-1)" "unprognostic (2.00e-1)" "unprognostic (3.90e-2)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" "unprognostic (5.93e-3)" "unprognostic (2.92e-1)" 7.9 22.3 12.5 7.7 11.3 9.4 5.7 10.9 11.5 5.3 8.1 6.0 8.8 6.7 5.9 12.6 5.2 8.7 6.2 7.8 12.6 11.1 7.4 4.9 6.5 4.3 14.3 10.5 20.8 6.2 4.1 6.7 3.4 12.0 3.9 9.9 7.4 6.3 7.4 9.3 9.3 7.1 6.8 9.9 5.1 9.6 39.1 11.9 5.9 3.7 7.3 6.5 3.0 4.4 6.7 10.9 7.0 2.5 5.6 7.0 3.6 4.5 5.2 8.7 7.3 7.7 10.1 3.5 6.8 5.3 6.1 13.8 1.9 10.5 4.7 8.5 5.2 6.8 5.1 2.1 2.9 4.6 10.9 7.5 3.6 10.4 3.0 3.9 4.5 4.0 7.7 3.9 8.1 4.5 8.8 5.2 20.2 7.4 52.2 9.3 4.1 4.8 5.1 2.5 8.6 4.5 9.4 5.5 6.9 6.0 1.3 7.0 4.3 8.4 4.6 8.9 6.6 6.7 6.2 4.6 2.9 3.0 7.1 3.8 12.4 11.4 6.7 9.3 5.9 3.2 7.0 2.0 4.8 4.9 2.5 3.3 6.7 6.1 7.0 4.0 5.6 5.1 4.1 1.2 5.6 2.4 10.9 6.1 3.6 12.5 11.3 10.9 11.5 12.6 11.1 14.3 10.5 12.0 11.9 26.8 10.7 11.5 17.0 15.1 16.7 15.1 15.3 12.0 9.1 19.2 9.8 16.1 23.2 21.5 249.4 20.2 64.6 23.3 23.3 11.7 19.9 15.5 5.7 13.2 29.7 12.7 14.9 24.5 7.3 110.8 39.4 12.5 25.3 5.4 44.1 28.4 21.0 31.6 53.7 27.4 22.9 12.9 12.3 18.1 35.3 12.4 5.9 20.1 24.9 14.8 IFI30 "GILT, IFI-30, IP-30, IP30, MGC32056" ENSG00000216490 "IFI30, lysosomal thiol reductase" P13284 19 18173162-18178117 "Predicted intracellular proteins, Predicted membrane proteins" Immunity Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 348.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 159.4;Kupffer cells: 201.6;Macrophages: 219.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 348.5" "Group enriched" "Detected in all" 8 "dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5" "Cell line enhanced" "Detected in many" "Daudi: 76.0;RPMI-8226: 82.4;SK-BR-3: 55.7;U-266/84: 91.1" "Low region specificity" "Detected in many" HPA026650 Enhanced Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 89000 "Vesicles, Cytosol" "HPA026650: AB_10602237" "unprognostic (4.66e-2)" "unprognostic (1.25e-4)" "unprognostic (2.35e-3)" "unprognostic (7.40e-2)" "unprognostic (1.76e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-3)" "unprognostic (2.40e-1)" "unprognostic (4.01e-2)" "unprognostic (9.19e-3)" "unprognostic (3.04e-1)" "unprognostic (1.19e-1)" "unprognostic (7.29e-11)" "unprognostic (3.50e-1)" "unprognostic (1.62e-2)" "unprognostic (3.39e-2)" "unprognostic (9.59e-3)" 104.2 31.0 5.8 85.5 10.8 28.3 13.9 1.2 5.2 5.3 17.4 6.5 3.2 23.3 5.0 13.7 9.3 15.9 13.1 16.2 5.0 4.0 37.5 60.4 109.7 139.5 12.0 0.8 15.0 14.6 2.0 7.6 123.2 11.0 8.6 18.2 9.2 18.7 4.3 7.2 10.1 28.5 18.9 13.3 140.6 19.4 5.7 7.9 20.6 15.6 9.6 41.2 24.5 8.2 24.3 145.5 95.4 348.5 1.7 1.0 213.4 12.8 6.8 0.0 4.5 1.3 1.8 12.2 1.4 1.9 3.9 10.2 15.3 23.0 76.0 11.7 4.4 20.2 10.1 8.1 3.0 0.4 20.2 5.8 0.9 12.6 21.7 13.0 2.2 5.9 7.9 6.9 6.4 2.3 0.5 0.2 2.3 10.7 47.8 1.9 25.2 1.0 0.2 2.5 44.2 6.8 7.4 0.5 82.4 11.7 0.4 0.6 0.8 23.6 55.7 1.3 0.9 3.8 0.9 0.3 6.8 4.1 13.9 1.4 1.6 91.1 43.3 18.8 15.0 1.0 2.0 228.9 95.4 1.0 348.5 1.0 24.3 0.7 0.8 145.5 16.8 0.5 0.6 52.5 1.7 230.0 4.3 1.0 213.4 5.8 10.8 1.2 5.2 5.0 4.0 12.0 0.8 11.0 7.9 8.9 51.2 68.0 1.9 3.2 0.1 0.6 7.6 13.4 31.8 12.2 0.0 4.4 1.7 1.2 0.2 2.2 3.8 0.0 1.0 12.3 1.9 3.5 12.8 1.5 159.4 0.0 0.0 4.9 201.6 0.0 0.3 219.1 5.0 58.7 4.6 0.6 1.7 2.5 0.0 4.8 0.4 0.0 0.9 0.0 0.7 2.9 10.1 3.8 5.1 1.3 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666061-27672218 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 225.6" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria NA NA Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 32.3 27.5 24.9 13.5 28.2 37.3 10.9 14.2 36.1 11.4 13.8 22.9 6.5 16.5 26.8 68.0 8.6 11.9 113.9 19.3 23.0 42.3 44.8 23.5 31.6 5.8 20.0 17.0 14.1 21.3 5.9 60.1 225.6 34.3 13.9 10.1 31.6 111.4 10.1 7.4 5.4 12.5 17.0 26.0 27.3 35.4 15.4 6.8 24.8 35.2 7.9 9.7 7.8 7.6 9.7 19.4 84.9 58.6 15.8 27.5 16.8 1.4 0.4 2.2 1.4 7.3 4.0 9.0 4.7 21.7 134.5 157.3 0.7 5.7 0.5 54.1 2.1 35.6 0.5 0.5 1.0 4.4 11.1 1.8 3.4 1.1 0.4 1.9 1.1 4.5 4.3 0.1 8.1 0.1 2.1 1.2 3.1 0.2 9.5 1.5 0.4 4.1 14.5 0.4 2.7 4.5 2.8 1.2 1.3 1.1 0.0 3.2 2.9 5.8 1.3 95.5 0.7 0.6 4.4 2.1 1.2 1.9 0.9 0.8 11.3 6.4 0.3 2.4 10.1 3.5 29.3 44.4 39.4 22.7 58.6 22.4 9.7 23.0 20.7 19.4 8.0 24.3 23.6 84.9 15.8 38.8 2.0 27.5 16.8 24.9 28.2 14.2 36.1 23.0 42.3 20.0 17.0 34.3 6.8 131.0 105.4 20.9 17.6 20.8 10.1 13.4 73.9 88.3 37.5 61.1 9.8 3308.6 16.6 186.8 2.9 139.0 7.0 0.0 304.1 1015.8 142.9 71.5 60.2 43.3 628.8 3.2 56.0 68.2 47.6 8.5 102.4 129.6 67.4 56.9 22.2 79.9 144.2 8.7 192.3 28.3 5.5 109.9 38.2 1.7 0.9 19.6 3573.6 51.2 8.0 13.6 IFIT1B "bA149I23.6, IFIT1L" ENSG00000204010 "Interferon induced protein with tetratricopeptide repeats 1B" Q5T764 10 89378056-89385205 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 23.2;placenta: 14.6" "Cell type enriched" "Detected in single" 1635 "Erythroid cells: 163.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.7" HPA062924 Approved NA NA "HPA062924: AB_2684906" "unprognostic (2.59e-1)" "unprognostic (3.13e-1)" "unprognostic (6.62e-3)" "unprognostic (4.55e-2)" "unprognostic (4.11e-2)" "unprognostic (9.34e-2)" "unprognostic (1.76e-1)" "unprognostic (6.86e-2)" 0.4 0.0 0.2 0.0 0.2 23.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.3 0.1 0.2 0.5 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 14.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.6 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.9 0.2 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.1 1.7 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 0.0 2.4 0.2 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFIT2 "cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K" ENSG00000119922 "Interferon induced protein with tetratricopeptide repeats 2" P09913 10 89283694-89309276 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 93.4" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 93.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 93.4" "Group enriched" "Detected in many" 4 "BJ hTERT+ SV40 Large T+: 50.6;BJ hTERT+ SV40 Large T+ RasG12V: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003408 Approved Approved Vesicles NA NA Vesicles "HPA003408: AB_1079100" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (1.75e-2)" "unprognostic (9.28e-2)" "unprognostic (6.71e-3)" "unprognostic (2.22e-1)" "unprognostic (5.40e-1)" "unprognostic (1.36e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.92e-2)" "unprognostic (1.03e-2)" "unprognostic (5.33e-3)" "unprognostic (6.46e-2)" 15.5 7.7 10.2 8.9 11.9 31.9 5.5 8.1 10.5 4.5 3.7 15.6 2.1 4.7 3.5 7.4 2.3 6.7 9.7 4.8 10.4 9.2 10.5 14.9 14.4 6.5 23.7 6.7 6.9 2.4 4.5 3.3 11.3 20.4 3.9 3.1 5.2 5.8 4.7 1.8 2.5 4.1 4.6 29.4 18.0 2.6 1.3 17.9 3.9 4.2 0.4 3.7 7.3 3.5 4.0 2.9 93.4 17.0 1.7 2.2 3.4 10.0 0.4 0.1 4.7 4.8 5.3 1.4 3.8 10.6 50.6 40.3 0.0 7.4 1.1 2.2 2.6 7.6 10.6 0.2 0.5 5.4 4.2 0.0 1.8 5.4 0.0 8.3 0.2 0.8 3.0 0.2 3.8 0.5 3.1 0.2 1.0 0.0 0.2 0.7 0.0 1.2 2.3 0.1 0.0 2.0 0.7 1.3 0.2 1.7 2.0 0.0 0.0 1.1 0.3 9.1 0.3 0.2 0.5 0.3 0.5 0.1 1.4 0.3 0.4 1.7 0.1 0.8 0.9 1.0 17.9 7.0 21.8 2.2 15.1 1.2 4.0 1.7 1.5 2.3 3.5 1.8 1.6 93.4 1.7 17.0 2.9 0.9 3.4 10.2 11.9 8.1 10.5 10.4 9.2 23.7 6.7 20.4 17.9 38.7 4.1 7.5 5.0 1.3 1.0 5.7 5.1 5.3 12.5 12.2 0.0 1.8 8.3 25.1 0.1 18.3 9.6 0.0 3.7 1.0 5.0 15.4 4.7 5.5 25.2 23.8 3.4 14.1 17.2 0.0 7.5 16.8 6.8 8.2 5.2 12.8 7.5 5.8 11.0 8.4 0.6 0.0 3.1 0.0 0.0 0.5 1.1 11.7 1.5 3.9 IFIT3 "CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G" ENSG00000119917 "Interferon induced protein with tetratricopeptide repeats 3" O14879 10 89327894-89340971 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 80.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 80.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 80.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 35.1;BJ hTERT+ SV40 Large T+: 82.1;BJ hTERT+ SV40 Large T+ RasG12V: 95.4" "Low region specificity" "Detected in all" HPA059914 Approved Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA059914: AB_2684159" "unprognostic (2.81e-1)" "unprognostic (5.62e-2)" "unprognostic (4.94e-2)" "unprognostic (5.25e-3)" "unprognostic (3.33e-3)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (5.18e-3)" "unprognostic (2.99e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (9.80e-3)" "unprognostic (5.09e-2)" 50.5 15.7 14.9 11.3 17.3 22.1 10.6 6.9 17.0 6.8 9.7 7.6 4.1 14.5 8.8 16.8 6.2 10.9 15.1 8.9 14.2 12.9 19.3 17.0 25.9 10.0 13.5 12.4 11.3 4.3 3.8 5.5 22.9 23.0 9.7 5.4 9.2 19.6 8.1 8.1 5.0 11.3 11.1 18.4 26.0 7.2 5.1 12.1 14.3 14.9 5.5 2.9 11.0 5.9 1.6 2.5 80.0 18.4 0.3 2.6 3.2 6.4 0.4 0.1 1.7 7.5 8.1 0.0 4.1 35.1 82.1 95.4 0.3 9.2 0.5 1.8 6.6 19.1 5.8 0.1 0.8 6.1 0.9 0.0 2.4 1.8 0.2 4.3 0.7 2.1 5.0 0.1 7.1 0.6 3.1 0.5 0.2 0.1 1.4 2.1 0.0 1.5 1.9 0.1 0.0 2.0 1.5 0.5 0.4 2.3 3.0 0.0 0.0 0.7 0.1 16.1 0.2 0.2 0.8 0.6 1.3 0.2 2.2 1.0 2.3 1.8 0.1 1.9 3.0 1.3 15.2 7.5 26.6 0.7 16.0 0.1 1.6 1.1 0.5 2.5 1.4 0.7 0.8 80.0 0.3 18.4 0.5 2.6 3.2 14.9 17.3 6.9 17.0 14.2 12.9 13.5 12.4 23.0 12.1 47.6 8.5 5.9 8.9 2.9 7.9 30.7 12.7 16.0 15.9 8.7 3.9 3.4 18.3 47.8 0.3 46.8 13.4 0.0 31.7 6.8 10.8 7.2 12.8 11.0 32.4 57.2 0.0 15.4 21.3 0.0 28.1 21.7 3.3 10.0 2.5 23.1 19.3 5.1 26.5 8.8 1.8 45.3 10.2 0.9 1.0 1.6 1.6 4.9 2.5 5.5 IFITM10 ENSG00000244242 "Interferon induced transmembrane protein 10" A6NMD0 11 1732410-1750591 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 31.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 17.2;granulocytes: 27.7;Hofbauer cells: 21.3;Ito cells: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.9;hTERT-RPE1: 6.6;MCF7: 5.5;SH-SY5Y: 13.1;U-87 MG: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.22e-6)" "unprognostic (6.49e-3)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" "unprognostic (3.66e-1)" "unprognostic (4.09e-1)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.68e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-1)" "unprognostic (2.44e-2)" "unprognostic (3.76e-2)" 1.9 13.3 0.7 1.0 2.2 4.3 0.9 1.4 2.0 0.7 0.8 4.3 2.2 1.2 0.7 1.0 0.8 0.7 3.0 0.6 1.0 0.7 1.8 6.6 2.1 0.7 7.4 0.2 0.8 0.6 0.5 0.4 1.0 4.1 2.7 0.6 31.4 6.7 4.8 1.2 2.0 1.0 1.0 8.2 2.2 0.6 1.6 2.7 0.0 0.5 10.8 1.6 2.6 3.4 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.1 6.6 0.1 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.1 0.0 0.0 2.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.2 0.3 0.8 0.0 7.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 1.4 2.0 1.0 0.7 7.4 0.2 4.1 2.7 3.0 1.1 2.2 10.8 1.9 17.2 1.7 2.5 4.0 5.7 0.0 0.0 1.2 1.7 2.1 0.1 0.5 3.3 0.0 2.1 0.5 2.1 0.8 27.7 0.6 21.3 1.6 0.0 54.6 6.5 0.0 0.9 3.0 0.0 3.6 0.7 2.0 2.1 3.5 1.4 0.0 1.3 0.0 1.7 0.5 1.1 0.6 2.2 2.5 1.5 10.5 IFITM2 1-8D ENSG00000185201 "Interferon induced transmembrane protein 2" Q01629 11 307631-315272 "Predicted membrane proteins, Transporters" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 875.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 875.3" "Lineage enriched" "Detected in all" 12 "granulocytes: 875.3" "Cell line enhanced" "Detected in many" "HHSteC: 99.8;HMC-1: 113.9;HSkMC: 123.4;U-937: 88.6" HPA004337 Uncertain NA NA "HPA004337: AB_1851427" "unprognostic (2.39e-2)" "unprognostic (2.69e-2)" "unprognostic (4.54e-1)" "unprognostic (1.65e-2)" "unprognostic (3.41e-2)" "unprognostic (1.86e-1)" "unprognostic (3.56e-2)" "unprognostic (3.87e-2)" "unprognostic (3.87e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-3)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.37e-9)" "unprognostic (2.79e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" 101.0 25.2 14.3 95.5 20.9 56.3 143.6 8.2 16.6 70.8 40.2 10.9 14.3 9.5 63.6 46.1 56.0 70.8 28.5 91.1 13.3 10.8 83.0 326.2 141.9 255.5 29.3 3.3 106.5 31.1 68.6 18.9 48.0 21.1 54.3 17.7 39.1 20.1 37.7 72.7 20.1 24.0 63.2 21.7 233.4 28.4 38.5 15.6 12.5 83.4 26.2 35.4 98.0 119.7 27.5 21.6 875.3 74.9 52.8 33.3 47.1 4.2 13.0 36.0 0.2 23.4 68.0 0.1 13.2 25.6 7.6 17.5 0.4 38.8 0.0 32.2 67.4 0.0 8.7 0.1 2.3 3.2 0.0 5.4 13.0 14.8 14.4 99.8 20.8 113.9 123.4 0.4 2.1 1.1 16.9 24.7 4.1 0.5 42.8 5.4 29.0 0.1 76.2 4.4 0.7 30.4 14.3 3.7 0.2 69.8 0.0 0.1 0.8 9.8 11.3 3.9 1.1 16.4 7.4 64.8 1.2 4.1 5.9 0.2 0.1 0.6 0.6 2.1 88.6 4.0 77.9 19.8 138.8 33.3 53.2 24.6 27.5 30.0 29.4 21.6 24.5 26.0 28.1 875.3 52.8 74.9 9.1 15.8 47.1 14.3 20.9 8.2 16.6 13.3 10.8 29.3 3.3 21.1 15.6 285.9 694.3 247.8 177.4 92.7 0.2 31.1 163.1 124.5 320.8 235.5 0.0 7.0 412.8 337.7 5.7 710.3 6.8 46.7 224.8 10.2 373.5 99.0 503.9 361.8 178.2 0.0 9.2 617.5 355.0 16.0 470.0 230.3 199.1 21.6 27.9 38.6 121.6 101.8 210.4 27.2 0.9 310.4 755.0 7.7 7.8 72.5 19.6 655.6 24.8 92.5 IFITM5 "BRIL, fragilis4, Hrmp1" ENSG00000206013 "Interferon induced transmembrane protein 5" A6NNB3 11 298200-299526 "Disease related genes, Predicted membrane proteins" "Mineral balance" "Developmental protein" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 11.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;HMC-1: 1.3;JURKAT: 1.5;Karpas-707: 5.0;NB-4: 1.0;PC-3: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (9.84e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (5.80e-2)" "unprognostic (7.46e-2)" "unprognostic (4.20e-2)" "unprognostic (4.42e-2)" "unprognostic (8.31e-2)" "unprognostic (7.99e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (4.90e-2)" 0.1 0.0 0.1 0.3 0.1 2.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.3 2.2 0.3 0.1 0.1 0.1 11.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.4 0.1 0.1 0.5 0.0 0.2 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 0.0 0.0 0.2 1.0 0.0 0.0 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA1 "IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13" ENSG00000197919 "Interferon alpha 1" P01562 9 21440454-21441316 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.3;urinary bladder: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "cerebellum: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;HeLa: 5.7;hTERT-RPE1: 5.9;NB-4: 1.3" HPA047557 Uncertain "Secreted to blood" NA NA 10000 "HPA047557: AB_2680087" "unprognostic (3.14e-1)" "unprognostic (1.55e-1)" "unprognostic (9.75e-2)" "unprognostic (5.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA13 ENSG00000233816 "Interferon alpha 13" P01562 9 21367424-21368962 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.1;epididymis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.7;HeLa: 1.6;hTERT-RPE1: 1.2;NB-4: 3.5;TIME: 1.5" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 1.1 0.0 2.1 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.0 0.0 1.5 0.6 0.4 0.0 0.2 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA14 "IFN-alphaH, LEIF2H" ENSG00000228083 "Interferon alpha 14" P01570 9 21239002-21239991 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.1;kidney: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "HMC-1: 1.0" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA2 "IFN-alphaA, IFNA" ENSG00000188379 "Interferon alpha 2" P01563 9 21384254-21385388 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.6;brain: 1.3;lymphoid tissue: 1.1" "Cell type enriched" "Detected in single" 20 "Cardiomyocytes: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Cell line enhanced" "Detected in single" "SuSa: 1.3" HPA047557 Uncertain "Secreted to blood" NA NA 253000 "HPA047557: AB_2680087" 0.1 0.0 0.8 0.1 1.3 0.8 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.4 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 1.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.3 0.4 1.0 0.4 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA21 IFN-alphaI ENSG00000137080 "Interferon alpha 21" P01568 9 21165637-21166660 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.2;brain: 2.1;lymphoid tissue: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in single" "NB-4: 1.0" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.4 0.3 0.3 0.9 0.0 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.3 1.3 0.0 0.0 0.1 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA4 "IFN-alpha4a, MGC142200" ENSG00000236637 "Interferon alpha 4" P05014 9 21186694-21187671 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA5 IFN-alphaG ENSG00000147873 "Interferon alpha 5" P01569 9 21304326-21305312 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ: 1.5" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.3 0.3 0.0 0.0 0.2 0.2 0.2 1.0 0.2 0.2 0.5 0.6 0.4 2.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA6 IFN-alphaK ENSG00000120235 "Interferon alpha 6" P05013 9 21349835-21351378 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 1.2 0.0 2.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNA8 IFN-alphaB ENSG00000120242 "Interferon alpha 8" P32881 9 21409147-21410185 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "HeLa: 3.2" HPA047557 Uncertain "Secreted to blood" NA NA "HPA047557: AB_2680087" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNB1 "IFB, IFF, IFNB" ENSG00000171855 "Interferon beta 1" P01574 9 21077105-21077963 "Cancer-related genes, Predicted secreted proteins" "Antiviral defense" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.8;bone marrow: 3.7;breast: 5.9" "Cell type enriched" "Detected in single" 21 "Hofbauer cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 8 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;GAMG: 1.2;NB-4: 1.2" "Low region specificity" "Detected in many" HPA073843 Supported "Secreted to blood" NA NA 3750 "HPA073843: " "unprognostic (2.38e-1)" "unprognostic (2.60e-4)" 0.1 0.3 0.0 0.0 0.0 3.7 5.9 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 4.8 0.0 0.0 0.1 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IFNE IFNE1 ENSG00000184995 "Interferon epsilon" Q86WN2 9 21480839-21482313 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 3.9;urinary bladder: 4.1" "Cell type enhanced" "Detected in some" 21 "Basal glandular cells: 3.6;Glandular cells: 1.1;Urothelial cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "intermediate monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "BJ: 4.1;HeLa: 10.6;hTERT-RPE1: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (1.52e-3)" "unprognostic (8.36e-2)" "unprognostic (5.44e-2)" "unprognostic (1.56e-5)" "unprognostic (2.70e-1)" "unprognostic (2.25e-1)" "unprognostic (5.14e-3)" "unprognostic (6.32e-1)" "unprognostic (2.68e-2)" "unprognostic (1.14e-2)" "unprognostic (1.43e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" "unprognostic (6.58e-3)" "unprognostic (3.34e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.6 2.6 0.2 1.3 0.0 1.4 0.3 3.9 3.3 1.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.1 0.8 0.0 0.0 2.4 0.0 0.0 0.1 1.5 0.0 0.6 0.7 4.1 1.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 2.5 0.0 0.0 1.2 1.2 0.2 4.1 0.2 0.2 0.3 0.1 2.7 0.0 0.8 0.8 0.4 1.4 0.0 2.6 0.4 0.0 0.0 0.0 10.6 0.0 0.7 0.0 0.0 1.1 0.5 1.6 2.3 13.1 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 IFNG ENSG00000111537 "Interferon gamma" P01579 12 68154768-68159747 "Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Antiviral defense, Growth regulation" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.4;lung: 14.5" "Cell type enriched" "Detected in some" 14 "T-cells: 93.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "gdT-cell: 7.3;memory CD4 T-cell: 3.3;memory CD8 T-cell: 8.6;naive CD8 T-cell: 5.2" "Lineage enriched" "Detected in many" 7 "T-cells: 8.6" "Cell line enhanced" "Detected in some" "Karpas-707: 2.3;U-266/70: 2.3;U-698: 1.2" "Low region specificity" "Detected in some" CAB010344 Approved "Secreted to blood" NA NA 1470 "CAB010344: AB_2123447" "unprognostic (2.16e-4)" "unprognostic (1.93e-3)" "unprognostic (9.21e-2)" "unprognostic (1.04e-4)" "unprognostic (5.14e-1)" "unprognostic (3.96e-3)" "unprognostic (1.33e-1)" "unprognostic (3.17e-4)" "unprognostic (7.79e-2)" "unprognostic (7.97e-3)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (7.62e-9)" "unprognostic (3.54e-2)" "unprognostic (5.36e-1)" "unprognostic (6.32e-2)" "unprognostic (7.38e-3)" 2.4 0.9 0.3 4.5 0.3 14.4 0.5 0.1 1.0 1.4 0.9 0.5 0.0 0.2 0.6 1.4 1.3 0.2 0.6 1.0 0.3 0.3 0.7 4.1 14.5 8.5 1.5 0.4 0.4 0.2 0.0 0.5 0.8 0.6 1.2 0.4 1.1 1.4 0.2 1.7 0.3 0.7 0.7 1.3 4.1 0.8 0.2 0.0 0.8 1.3 3.1 4.7 2.2 0.6 0.5 0.0 0.2 0.0 1.2 8.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 3.3 8.6 0.0 0.5 0.8 5.2 0.2 1.2 0.0 0.0 0.2 1.1 0.3 0.3 0.1 1.0 0.3 0.3 1.5 0.4 0.6 0.0 0.0 0.0 0.5 0.4 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.8 0.1 0.0 0.0 1.3 3.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 93.0 0.1 0.1 IFNK ENSG00000147896 "Interferon kappa" Q9P0W0 9 27524314-27526498 "Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;skin 1: 1.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5" "Region enhanced" "Detected in single" "pons and medulla: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.8" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (5.58e-3)" "unprognostic (4.64e-3)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.1 0.5 0.7 0.1 0.5 0.1 1.0 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.8 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.1 0.3 0.1 0.1 1.7 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.5 0.1 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNL1 "IL-29, IL29" ENSG00000182393 "Interferon lambda 1" Q8IU54 19 39296325-39298673 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.1" "Cell type enriched" "Detected in single" 24 "T-cells: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "gdT-cell: 4.4;MAIT T-cell: 4.4;memory CD4 T-cell: 2.1;memory CD8 T-cell: 4.1;myeloid DC: 3.3;naive CD8 T-cell: 2.3;NK-cell: 6.1" "Group enriched" "Detected in many" 46 "dendritic cells: 3.3;NK-cells: 6.1;T-cells: 4.4" "Cell line enhanced" "Detected in some" "AN3-CA: 1.1;GAMG: 2.5;SK-MEL-30: 1.0;U-266/84: 1.9" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 97000 "unprognostic (3.08e-2)" "unprognostic (8.74e-2)" "unprognostic (2.46e-4)" "unprognostic (5.76e-2)" "unprognostic (6.91e-3)" "unprognostic (5.73e-3)" "unprognostic (3.94e-2)" "unprognostic (4.80e-2)" "unprognostic (2.96e-5)" "unprognostic (7.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" 0.1 0.0 0.1 0.9 0.1 0.6 0.1 0.1 0.1 0.3 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.0 0.2 0.3 0.9 0.4 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.5 0.3 0.1 0.1 1.6 0.1 0.6 0.1 1.8 1.6 0.1 0.1 0.1 0.1 0.0 3.3 0.0 0.0 6.1 4.4 0.9 0.0 0.9 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.9 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.8 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 4.4 0.0 2.1 4.1 3.3 0.0 0.2 2.3 0.0 6.1 0.0 0.0 0.3 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.0 IFNL2 "IL-28A, IL28A" ENSG00000183709 "Interferon lambda 2" Q8IZJ0 19 39268514-39270092 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 4.1;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "HDLM-2: 16.7" CAB025489 Uncertain "Secreted to blood" NA NA "CAB025489: " "unprognostic (1.37e-1)" "unprognostic (2.84e-1)" "unprognostic (1.05e-1)" "unprognostic (2.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFNL3 "IL-28B, IL28B, IL28C" ENSG00000197110 "Interferon lambda 3" Q8IZI9 19 39243553-39245129 "Predicted secreted proteins" "Antiviral defense" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.1;salivary gland: 1.0;skin 1: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 1.1;CACO-2: 3.3;GAMG: 2.2;HDLM-2: 1.8" "Secreted to blood" NA NA 1700 "unprognostic (2.67e-1)" "unprognostic (9.19e-2)" "unprognostic (4.17e-1)" "unprognostic (6.86e-2)" "unprognostic (1.89e-2)" "unprognostic (1.66e-1)" 0.1 0.0 0.5 0.0 0.3 0.2 0.0 1.1 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422968-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 93.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 25.6;neutrophil: 44.2" "Lineage enriched" "Detected in all" 12 "granulocytes: 44.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024122, HPA072413" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA024122: AB_1851452, HPA072413: " "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favorable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 19.5 18.0 16.7 12.9 19.6 83.1 24.0 14.3 15.7 10.7 18.3 15.6 11.7 18.7 15.7 12.5 12.7 11.4 12.7 16.0 15.2 13.3 11.9 14.1 19.2 7.9 30.9 13.2 16.9 93.0 12.5 23.1 18.7 16.9 14.7 11.7 11.2 14.3 11.0 37.6 12.3 19.0 23.9 28.2 11.7 17.7 17.9 22.0 7.5 16.5 13.5 7.4 14.7 37.5 3.8 2.9 44.2 3.2 3.4 3.7 2.6 15.0 10.1 15.7 14.8 26.9 17.5 14.6 14.9 14.3 19.3 17.4 16.7 12.7 7.3 28.5 7.7 38.4 9.0 10.9 12.6 26.4 12.4 15.5 8.2 18.8 16.0 30.8 11.1 6.5 13.3 27.0 20.4 23.4 15.5 8.0 12.6 25.0 16.5 7.8 13.6 14.1 18.7 35.8 14.0 17.8 12.3 6.3 13.6 5.8 4.2 25.3 13.1 17.0 14.5 48.1 29.7 5.6 12.0 6.9 32.9 7.0 25.6 44.9 14.8 17.5 20.0 8.9 30.9 37.6 5.7 3.2 25.6 3.6 2.8 2.8 3.8 3.5 3.4 2.9 3.0 3.4 3.3 44.2 3.4 2.8 2.1 3.7 2.6 16.7 19.6 14.3 15.7 15.2 13.3 30.9 13.2 16.9 22.0 29.8 31.8 25.5 140.2 175.3 48.0 49.5 22.9 13.4 33.0 17.4 84.4 63.5 14.9 41.7 32.2 54.5 231.2 23.3 49.6 52.8 71.4 123.0 75.8 18.7 104.1 20.6 132.5 47.9 76.5 7.5 33.9 78.9 97.8 73.1 82.8 22.6 50.8 210.5 38.5 11.0 72.9 38.8 197.8 13.7 11.5 110.2 126.9 55.4 87.9 126.0 IFT122 "SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 84.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 61.8;Late spermatids: 52.6;Spermatocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 7.4 5.7 11.1 4.9 14.0 6.4 9.1 13.3 13.1 10.2 5.6 7.6 6.4 3.5 10.2 9.6 5.4 18.5 5.0 10.0 7.8 6.4 8.8 6.7 6.7 4.5 4.4 9.2 19.0 9.6 13.1 18.9 7.7 7.2 5.7 5.2 10.5 6.3 6.7 3.7 9.9 4.1 7.6 4.2 3.7 6.7 84.7 5.7 7.6 9.6 2.0 4.2 5.3 6.9 4.7 6.0 8.3 5.7 2.8 5.5 3.8 11.0 16.7 14.5 9.5 21.1 15.0 7.7 5.9 8.9 10.3 10.0 8.0 7.3 7.1 7.0 7.6 10.2 7.1 5.6 5.2 9.4 3.8 6.0 5.4 13.6 6.8 5.8 14.9 5.0 17.5 3.9 7.9 6.2 9.0 13.9 15.2 5.5 15.3 8.3 12.2 12.2 7.7 9.7 8.3 4.8 10.9 5.5 5.1 11.1 2.0 18.4 7.5 16.9 5.7 5.1 5.7 15.5 12.0 6.1 7.3 6.2 9.4 7.0 10.5 7.3 6.2 6.6 7.6 5.5 8.3 5.7 6.6 1.9 3.9 3.3 3.8 3.3 4.5 6.0 4.7 3.7 4.5 2.7 2.8 1.7 1.4 5.5 3.8 11.1 14.0 13.3 13.1 7.8 6.4 4.4 9.2 7.2 5.7 8.9 8.0 2.4 4.9 2.4 9.5 5.6 7.6 13.4 4.5 24.4 35.3 5.6 6.6 4.5 61.8 6.0 5.8 0.0 7.8 5.0 8.8 2.8 4.7 3.9 8.4 4.8 2.9 17.8 6.5 52.6 17.3 2.5 3.3 1.8 9.2 10.8 3.4 3.5 13.1 6.0 19.6 0.0 7.1 117.0 35.3 2.5 2.2 3.2 7.0 2.2 IFT140 "gs114, KIAA0590, WDTC2" ENSG00000187535 "Intraflagellar transport 140" Q96RY7 16 1510427-1612110 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 42.3" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 22.7;Cone photoreceptor cells: 23.6;Late spermatids: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 6.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042197 Approved NA NA "HPA042197: AB_2677895" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "unprognostic (1.30e-1)" "unprognostic (5.21e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-2)" "unprognostic (5.27e-3)" "unprognostic (3.28e-2)" "unprognostic (2.63e-1)" "unprognostic (4.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.52e-1)" "unprognostic (2.77e-2)" "unprognostic (7.55e-2)" "unprognostic (8.95e-2)" "unprognostic (2.91e-3)" "unprognostic (6.22e-3)" 4.9 10.3 8.1 3.5 11.4 2.7 7.6 14.7 11.7 9.5 5.7 7.0 8.2 5.4 14.8 8.3 5.9 23.3 8.3 5.0 9.4 9.3 8.8 2.9 12.2 3.7 6.7 9.6 12.4 10.4 16.3 14.8 5.0 8.5 7.7 2.4 9.2 7.9 9.1 2.6 5.9 3.7 8.3 4.4 3.4 8.4 42.3 8.3 7.8 19.6 2.7 3.5 12.8 6.0 1.1 1.1 0.3 0.8 1.8 6.9 1.4 1.7 10.7 8.3 8.3 6.7 5.3 4.8 2.2 8.4 2.4 3.0 2.9 8.5 3.3 6.5 3.4 3.2 6.5 1.5 1.2 1.6 2.8 6.6 1.9 7.5 7.1 6.1 1.1 4.1 7.6 5.3 2.8 3.7 9.3 1.7 6.6 2.2 1.9 1.8 10.2 5.7 3.3 9.0 2.1 2.5 5.3 3.0 4.8 7.1 5.3 15.7 8.8 2.5 4.4 3.1 4.7 15.1 4.2 3.4 2.0 6.3 3.5 0.9 6.0 2.1 2.0 3.3 0.6 2.5 0.0 0.8 0.3 0.9 0.5 6.9 1.1 1.2 2.6 1.1 0.4 3.5 5.5 0.0 1.8 0.5 0.9 0.2 1.4 8.1 11.4 14.7 11.7 9.4 9.3 6.7 9.6 8.5 8.3 11.9 7.8 0.0 2.8 1.4 3.4 2.9 7.6 22.7 7.9 10.4 23.6 4.7 1.7 2.2 18.6 1.3 1.5 0.0 0.9 1.1 2.8 1.6 1.1 0.8 1.9 7.9 5.2 2.5 0.8 20.6 4.4 0.3 0.0 0.0 4.9 6.7 2.2 0.0 3.9 3.0 17.5 0.0 2.1 19.8 7.0 1.0 1.8 0.0 2.9 1.3 IFT20 ENSG00000109083 "Intraflagellar transport 20" Q8IY31 17 28328325-28335489 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021376 Approved Approved Microtubules NA NA Microtubules "HPA021376: AB_1851460" "unprognostic (1.29e-1)" "unprognostic (2.35e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (8.65e-4)" "unprognostic (1.13e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (8.02e-2)" "unprognostic (4.86e-3)" "unprognostic (2.42e-1)" "unprognostic (2.48e-2)" "unprognostic (6.19e-3)" "prognostic unfavorable (5.09e-7)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (2.59e-2)" "unprognostic (4.71e-3)" 11.4 17.1 15.3 10.8 15.4 37.6 15.9 20.0 15.9 12.4 16.3 8.8 20.7 16.6 11.9 23.7 10.8 13.5 18.8 9.8 13.8 14.6 15.1 23.3 11.8 12.9 18.7 13.1 11.4 77.1 9.7 26.1 16.9 14.4 14.7 12.0 11.2 26.7 19.2 4.5 8.1 18.3 16.6 13.4 12.7 19.0 28.6 15.9 9.6 20.6 7.7 11.0 15.7 13.9 24.2 41.0 38.1 36.9 17.2 25.2 26.8 10.8 15.2 10.3 8.3 30.7 31.4 9.8 18.9 22.9 11.6 18.2 23.1 5.1 5.3 10.2 23.1 7.0 11.5 6.6 13.8 17.0 21.7 28.8 3.2 16.2 10.6 29.9 13.3 6.7 23.8 18.6 9.9 16.1 20.0 18.4 10.2 9.4 13.6 9.1 14.6 11.7 10.8 6.8 32.5 8.6 5.5 13.6 13.5 18.2 10.5 12.9 18.8 12.6 26.4 28.6 19.0 16.6 14.7 20.5 7.1 10.5 10.2 10.1 19.8 17.1 6.7 25.5 9.7 10.1 20.8 36.9 26.5 21.3 25.7 25.2 22.8 22.3 21.5 41.0 24.2 22.9 20.0 38.1 17.2 23.4 29.6 23.0 26.8 15.3 15.4 20.0 15.9 13.8 14.6 18.7 13.1 14.4 15.9 35.7 48.5 39.6 33.1 32.7 69.0 4.7 43.3 111.1 37.5 48.8 56.9 63.1 119.3 52.5 191.7 45.8 29.3 23.3 98.0 72.8 51.4 47.5 23.1 46.5 47.8 54.0 60.2 31.3 43.7 32.2 55.8 49.4 30.4 57.7 52.5 33.9 70.1 31.6 54.1 73.3 72.1 77.6 35.0 141.9 41.9 37.4 68.1 43.1 43.2 38.2 IFT22 "DKFZp761N0823, FLJ13225, FLJ14117, RABL5" ENSG00000128581 "Intraflagellar transport 22" Q9H7X7 7 101313367-101321823 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.5" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 478.2;Late spermatids: 1059.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042930 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA042930: AB_10794537" "unprognostic (1.55e-2)" "unprognostic (7.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (6.70e-3)" "unprognostic (1.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (9.99e-2)" "unprognostic (1.73e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-2)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" 6.6 12.3 18.1 4.4 19.9 2.9 9.3 4.8 17.1 11.2 9.9 10.1 9.5 3.1 13.0 28.8 7.6 39.9 12.0 15.9 14.6 15.8 25.5 6.1 7.9 5.7 12.9 13.9 15.3 13.2 15.6 16.2 3.9 13.5 11.2 4.6 15.5 10.6 12.7 14.7 6.5 3.5 13.8 8.6 2.9 7.7 59.5 6.4 9.2 26.2 6.7 4.6 9.3 5.8 9.9 6.7 1.5 5.1 8.3 7.9 3.0 15.1 19.0 15.4 29.6 9.8 12.5 3.9 8.0 7.1 10.7 8.3 7.3 13.7 2.2 14.8 12.5 24.8 8.1 7.8 9.3 7.5 3.5 7.6 0.7 9.7 6.3 9.2 5.4 3.1 10.0 8.3 16.2 4.4 19.9 8.6 10.8 6.3 1.4 8.9 47.3 11.5 6.2 11.4 9.3 10.0 9.5 9.0 2.4 17.8 8.2 12.9 22.8 18.2 11.4 7.5 16.6 12.1 2.9 7.6 18.5 15.9 42.3 11.1 1.3 7.1 4.7 14.7 1.2 10.7 1.0 1.2 1.5 6.5 2.0 6.7 9.9 7.9 5.9 2.3 9.3 7.0 6.8 1.1 8.3 5.1 6.7 3.1 3.0 18.1 19.9 4.8 17.1 14.6 15.8 12.9 13.9 13.5 6.4 23.8 11.0 19.2 21.0 0.0 26.4 37.5 48.4 188.7 35.2 47.1 51.1 16.8 117.7 62.7 478.2 9.5 2.0 0.0 32.2 14.6 27.1 19.5 9.2 8.9 15.3 30.2 17.7 14.1 2.6 1059.8 35.1 9.9 0.0 4.6 11.8 43.3 28.1 9.3 38.9 121.8 87.3 12.9 21.1 208.9 81.0 0.0 5.5 5.7 8.5 12.1 IFT80 "KIAA1374, WDR56" ENSG00000068885 "Intraflagellar transport 80" Q9P2H3 3 160256986-160399880 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 52.0" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035868 Uncertain NA NA "HPA035868: AB_10959463" "unprognostic (2.71e-2)" "unprognostic (4.47e-3)" "unprognostic (2.13e-1)" "unprognostic (5.29e-2)" "unprognostic (3.03e-1)" "unprognostic (7.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.29e-2)" "unprognostic (5.95e-2)" "unprognostic (6.70e-2)" "unprognostic (8.31e-2)" "unprognostic (4.24e-3)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (5.60e-3)" 6.2 8.9 14.9 7.1 15.9 4.6 10.1 16.2 22.2 12.4 6.4 9.0 11.1 5.6 13.4 15.3 7.4 15.8 10.2 8.3 19.3 13.4 14.0 5.8 12.7 9.6 17.1 17.1 15.2 8.3 26.2 52.0 6.3 14.2 9.5 9.0 10.4 6.1 9.8 3.5 10.6 6.5 9.9 16.5 7.8 9.3 20.2 9.3 21.0 15.9 4.9 9.9 8.7 7.3 3.4 5.0 3.1 2.0 3.5 4.2 2.2 11.6 7.9 18.7 8.5 17.5 31.0 4.6 9.9 14.7 8.1 9.9 6.5 16.9 7.6 13.3 9.6 11.9 10.2 6.5 9.4 17.5 11.6 7.5 10.2 10.7 4.8 17.5 4.7 8.8 17.1 6.6 8.9 9.4 34.3 8.5 9.9 4.3 14.8 12.1 5.6 9.0 5.6 6.3 7.5 4.9 8.0 9.9 12.6 16.1 3.4 11.4 12.5 10.8 10.4 12.4 12.7 18.1 4.6 7.8 8.0 5.5 11.0 9.7 21.4 13.8 13.9 13.4 8.6 7.8 3.1 2.0 1.7 2.7 0.9 2.4 3.4 3.2 2.9 2.7 3.2 4.2 2.9 2.3 3.5 1.7 5.0 3.9 2.2 14.9 15.9 16.2 22.2 19.3 13.4 17.1 17.1 14.2 9.3 38.7 27.0 4.7 4.8 3.0 16.4 7.3 17.8 80.3 18.2 22.7 15.7 2.6 6.6 4.2 17.6 4.5 2.1 0.0 1.6 2.3 6.6 2.9 2.3 2.9 2.5 1.6 10.9 6.7 4.6 5.6 15.3 2.7 1.7 1.0 5.3 7.1 2.6 2.9 20.5 5.9 16.8 6.5 5.6 36.1 8.7 3.3 0.6 6.5 4.7 3.3 IFT88 "D13S1056E, hTg737, MGC26259, Tg737, TTC10" ENSG00000032742 "Intraflagellar transport 88" Q13099 13 20567069-20691437 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.1" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 141.8;Cone photoreceptor cells: 111.9;Rod photoreceptor cells: 130.4;Spermatocytes: 215.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.96e-2)" "unprognostic (6.57e-2)" "unprognostic (3.22e-2)" "unprognostic (7.71e-3)" "unprognostic (2.94e-1)" "unprognostic (3.21e-1)" "unprognostic (2.60e-1)" "unprognostic (7.80e-2)" "unprognostic (1.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (5.17e-4)" "unprognostic (4.11e-1)" "prognostic favorable (1.33e-4)" "unprognostic (5.25e-2)" "unprognostic (3.18e-2)" "unprognostic (2.57e-1)" "unprognostic (4.53e-2)" 4.9 8.1 7.7 4.9 10.2 5.0 6.7 6.6 9.9 10.5 6.3 12.3 7.6 7.2 11.4 12.7 4.0 15.8 7.3 5.4 8.2 9.0 19.0 12.9 7.2 4.3 9.8 7.1 11.9 6.9 9.7 36.5 4.5 12.5 7.3 7.1 11.5 4.7 9.1 5.7 4.4 7.0 8.9 10.1 5.5 5.4 53.1 13.7 10.3 15.8 3.6 5.0 6.2 7.2 10.1 4.4 11.0 6.2 9.0 8.9 3.3 6.3 8.7 12.5 15.1 6.8 13.7 8.7 5.1 7.7 7.6 5.5 5.1 11.4 5.5 5.3 7.9 8.7 12.0 8.8 7.3 11.5 5.5 3.8 7.1 4.4 9.5 10.3 7.3 5.5 7.4 7.7 17.5 9.5 15.3 11.1 10.9 9.2 2.3 13.4 5.9 8.8 6.3 4.4 14.8 3.0 10.4 9.0 1.1 15.0 3.5 5.7 12.2 10.0 4.6 10.6 9.6 13.0 9.3 6.8 5.4 5.3 8.8 6.3 3.0 6.3 4.5 6.8 3.4 8.5 1.8 5.2 4.1 5.7 5.9 5.1 8.3 5.8 5.7 4.4 10.1 6.2 8.9 11.0 9.0 6.2 3.6 5.1 3.3 7.7 10.2 6.6 9.9 8.2 9.0 9.8 7.1 12.5 13.7 29.8 9.6 3.7 9.6 3.0 24.2 15.4 15.3 141.8 30.7 33.2 111.9 10.4 23.2 12.2 71.8 10.8 14.0 0.0 5.2 5.8 9.4 6.0 11.5 19.1 6.4 20.6 9.2 10.4 6.0 70.7 24.7 8.8 3.3 4.6 13.0 30.3 6.7 14.2 19.1 41.1 130.4 25.8 7.3 215.8 55.3 2.9 4.9 7.0 12.3 4.3 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 0.0 0.0 0.0 0.2 0.0 4.0 0.5 0.0 0.0 0.0 1.8 31.4 90.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 38.7 0.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 12.6 0.0 34.6 0.0 0.0 0.0 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381464-65423072 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 14.1" "Cell type enhanced" "Detected in some" 13 "Cone photoreceptor cells: 29.5;Fibroblasts: 17.9;Leydig cells: 32.2;Rod photoreceptor cells: 12.0" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.1;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.7;SuSa: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol NA NA 34000000 "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 1.7 6.2 8.3 3.7 5.0 0.2 1.3 2.0 4.9 6.1 1.4 8.0 0.0 1.0 2.3 7.2 2.6 2.9 6.7 2.2 6.2 4.1 0.6 0.3 0.7 1.1 5.6 3.1 13.3 0.7 0.2 2.4 8.2 6.1 0.9 1.2 1.6 1.5 1.3 14.1 1.5 1.7 3.1 5.0 0.5 1.9 2.5 6.5 0.0 4.6 4.0 1.5 4.7 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 10.2 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.4 0.6 8.9 0.0 5.1 0.4 0.0 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.4 0.0 0.0 5.7 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.8 7.7 0.0 0.0 0.0 2.5 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.5 6.1 0.0 0.0 0.0 4.1 2.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.0 2.0 3.9 6.2 4.1 5.6 3.1 6.1 6.5 0.0 0.0 0.0 0.0 2.1 5.8 2.0 0.0 0.0 0.0 3.5 29.5 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 17.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 32.2 0.4 5.0 0.0 0.0 0.5 0.3 0.0 3.9 0.7 12.0 6.5 0.5 0.4 0.9 1.0 0.7 0.0 0.0 0.0 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: AB_2667860, HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favorable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 15.2 0.1 0.4 0.0 115.4 0.0 0.0 1.1 0.0 0.3 0.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 79.2 20.3 0.0 0.0 24.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 45.5 0.3 0.0 0.1 0.1 0.0 0.2 0.0 56.5 0.1 0.0 0.1 4.5 68.8 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 871.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2792.3 0.0 0.0 0.0 0.0 192.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1348.9 0.0 0.0 0.0 IGF2 ENSG00000284779 "Insulin like growth factor 2" 11 2129112-2158658 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "liver: 24.1" "Cell type enriched" "Detected in many" 5 "Leydig cells: 2784.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;RH-30: 3.3" "Intracellular and membrane" NA NA 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.9 0.0 0.6 4.7 0.0 0.0 2.5 1.4 1.2 3.5 0.0 0.0 0.0 0.0 9.1 11.3 0.0 0.0 0.0 0.0 3.9 0.3 0.0 350.3 0.0 0.0 0.0 38.1 8.5 19.9 2784.7 1.7 3.3 0.0 0.0 0.1 0.0 0.0 605.3 0.0 0.3 64.7 7.3 3.2 4.3 3.6 0.0 0.0 0.0 0.1 IGF2BP1 IMP-1 ENSG00000159217 "Insulin like growth factor 2 mRNA binding protein 1" Q9NZI8 17 48997412-49055650 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 17.6;testis: 17.8" "Cell type enhanced" "Detected in some" 15 "Extravillous trophoblasts: 31.6;Spermatocytes: 17.9;Spermatogonia: 21.1" "Cancer enriched" "Detected in many" 16 "testis cancer: 28.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 36.1;CACO-2: 56.9;Hep G2: 26.7;K-562: 28.8;NTERA-2: 28.9;REH: 33.0;SuSa: 28.8" "Not detected" "Not detected" "HPA021367, HPA062273" Enhanced Supported Cytosol NA NA Cytosol "HPA021367: AB_1851480, HPA062273: AB_2684733" "unprognostic (6.79e-4)" "unprognostic (2.76e-1)" "unprognostic (4.86e-3)" "unprognostic (2.30e-6)" "unprognostic (1.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.80e-2)" "unprognostic (1.01e-2)" "unprognostic (9.55e-3)" "unprognostic (2.58e-1)" "unprognostic (2.86e-2)" "unprognostic (5.91e-2)" "unprognostic (2.80e-6)" "unprognostic (2.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.32e-3)" "unprognostic (1.47e-1)" 0.1 0.1 0.0 0.9 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.1 0.3 0.5 0.1 0.3 0.1 0.1 0.0 0.1 17.6 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 17.8 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 36.1 0.0 1.3 1.9 25.9 2.0 0.0 2.9 5.0 56.9 0.9 2.9 0.2 0.2 0.8 0.0 22.2 0.0 5.2 0.0 13.1 21.6 7.7 26.7 1.7 11.3 5.8 2.6 0.0 0.7 0.0 1.0 6.0 4.0 28.8 0.0 4.0 0.2 0.0 9.5 28.9 0.0 0.0 33.0 11.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 28.8 0.0 3.2 0.1 0.0 0.3 3.0 0.0 0.0 0.0 19.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 6.0 0.6 0.0 0.3 0.1 0.0 3.6 0.0 1.4 1.2 0.0 0.0 2.1 0.0 0.0 3.5 0.3 0.0 0.0 0.0 31.6 1.2 0.2 1.1 0.0 5.4 0.0 0.0 0.0 0.0 3.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 17.9 21.1 0.1 2.4 0.0 0.0 0.3 IGF2BP2 IMP-2 ENSG00000073792 "Insulin like growth factor 2 mRNA binding protein 2" Q9Y6M1 3 185643739-185825056 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 43.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 118.2;Rod photoreceptor cells: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 60.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017126, HPA035145" Enhanced Enhanced Cytosol NA NA Cytosol "CAB017126: , HPA035145: AB_2674491" "unprognostic (7.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.12e-5)" "unprognostic (2.46e-3)" "unprognostic (8.25e-3)" "unprognostic (4.17e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (9.45e-2)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.94e-3)" 7.9 8.9 1.0 6.4 1.9 7.6 4.9 8.6 1.6 6.5 16.4 1.6 1.5 11.3 7.6 4.8 3.7 8.3 8.1 9.9 1.7 1.4 8.0 2.6 14.0 4.0 2.8 0.7 6.7 11.3 7.6 2.9 43.0 4.5 4.9 11.6 16.9 9.0 1.6 3.2 4.3 21.4 3.3 3.7 5.8 9.9 5.1 1.5 2.4 8.6 3.2 3.3 6.2 12.5 0.0 5.5 0.9 3.3 1.3 0.0 1.2 28.3 2.4 27.8 5.2 15.2 24.0 17.0 15.0 21.2 23.3 28.0 20.4 8.0 0.0 22.3 12.6 29.9 12.9 13.0 21.8 37.9 0.0 13.4 8.1 0.1 14.1 32.5 0.2 0.0 17.5 11.6 15.5 60.3 12.2 21.4 2.1 7.9 0.0 17.0 0.2 0.0 6.8 20.3 4.8 10.3 2.9 11.0 8.5 15.1 0.1 1.7 0.2 1.1 0.0 26.7 28.8 2.2 18.9 32.4 8.1 17.7 10.1 17.2 0.1 0.0 0.0 8.0 0.0 11.3 0.9 3.0 0.5 0.0 2.8 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.2 1.3 3.3 1.0 0.0 1.2 1.0 1.9 8.6 1.6 1.7 1.4 2.8 0.7 4.5 1.5 11.9 12.3 0.0 21.8 17.5 3.2 13.6 28.1 48.2 35.2 24.4 15.7 1.7 3.3 33.9 118.2 12.2 59.3 23.3 22.6 14.2 28.3 47.6 2.3 0.0 13.3 1.6 34.2 44.2 10.5 64.7 4.9 7.4 13.5 4.6 42.1 30.6 38.8 84.6 0.4 7.6 160.2 0.0 8.6 2.8 7.0 12.8 5.3 0.0 34.5 53.7 IGF2BP3 "CT98, IMP-3, IMP3" ENSG00000136231 "Insulin like growth factor 2 mRNA binding protein 3" O00425 7 23310209-23470467 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "placenta: 74.0" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 68.4;Extravillous trophoblasts: 72.8;Hofbauer cells: 30.1;Syncytiotrophoblasts: 65.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 49.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002037, HPA076951" Enhanced Supported Cytosol NA NA Cytosol "HPA002037: AB_1851483, HPA076951: " "unprognostic (5.72e-2)" "unprognostic (3.12e-1)" "unprognostic (7.25e-2)" "unprognostic (3.56e-3)" "unprognostic (1.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.64e-3)" "unprognostic (3.18e-2)" "unprognostic (2.60e-3)" "unprognostic (3.67e-1)" "unprognostic (1.02e-5)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (1.43e-1)" "unprognostic (7.95e-2)" "unprognostic (2.87e-4)" "unprognostic (7.51e-3)" 0.4 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.3 0.4 0.3 0.4 0.1 0.0 0.2 1.3 4.8 0.7 0.1 0.5 0.3 0.2 0.2 0.3 1.2 3.4 0.2 0.0 0.2 1.5 0.0 0.2 74.0 0.7 0.2 0.0 0.3 0.7 0.1 0.2 0.2 0.3 0.0 1.2 1.0 0.2 6.5 0.0 11.4 0.6 0.2 6.0 0.2 0.6 1.2 0.4 1.5 1.5 0.0 0.2 3.0 13.8 4.1 31.1 9.2 4.9 13.2 19.0 2.3 10.5 5.8 7.3 13.1 11.0 10.4 12.6 6.1 26.0 9.1 13.4 10.2 10.3 1.6 5.3 5.5 11.1 10.9 15.3 10.0 3.9 13.4 7.2 4.4 1.9 34.8 49.8 5.9 25.2 0.0 14.1 0.0 6.1 6.7 24.8 10.6 12.8 9.5 10.4 13.4 11.5 1.2 8.2 17.9 1.4 0.0 11.6 37.1 0.0 1.9 20.0 5.6 0.3 12.1 6.0 0.0 4.4 16.5 22.4 11.2 21.5 0.0 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.0 0.4 0.9 0.2 0.0 1.5 0.0 0.0 0.0 0.0 3.0 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.0 0.7 0.0 0.0 0.0 1.7 0.6 0.2 0.5 0.3 0.0 4.0 0.0 0.0 0.0 68.4 0.0 1.1 21.3 0.1 0.0 0.0 0.2 72.8 0.5 0.2 3.5 0.0 30.1 1.6 0.0 1.3 0.0 16.9 2.0 1.3 3.3 0.0 0.0 0.3 0.8 0.0 0.0 0.0 1.7 0.0 0.4 1.9 1.5 0.4 65.7 0.0 0.0 0.5 IGFALS ALS ENSG00000099769 "Insulin like growth factor binding protein acid labile subunit" P35858 16 1790413-1794971 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 107.6" "Group enriched" "Detected in some" 4 "Cholangiocytes: 12.7;Hepatocytes: 39.9" "Cancer enhanced" "Detected in many" "liver cancer: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 5.3;T-47d: 2.1;U-266/70: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040692, HPA040948" Supported "Secreted to blood" NA NA 14700000000 44000000000 "HPA040692: AB_10794067, HPA040948: AB_10794999" "unprognostic (2.74e-3)" "unprognostic (1.95e-1)" "unprognostic (9.13e-2)" "prognostic unfavorable (6.06e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-2)" "prognostic favorable (5.97e-4)" "unprognostic (5.54e-4)" "unprognostic (3.00e-1)" "unprognostic (1.17e-1)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.49e-1)" "unprognostic (1.23e-1)" "unprognostic (4.39e-1)" "unprognostic (5.51e-2)" 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.8 0.2 0.1 0.4 0.1 0.1 0.2 0.2 0.1 0.1 0.2 7.4 0.1 0.1 0.2 0.2 107.6 0.4 0.1 0.1 0.1 0.1 0.8 0.0 0.2 0.1 0.4 0.1 0.0 1.4 0.6 0.1 0.2 0.2 0.1 0.1 0.3 0.1 5.0 0.5 0.1 1.7 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.9 5.3 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.0 0.0 1.3 0.2 0.5 0.2 0.1 0.0 1.3 0.5 1.6 0.0 0.0 0.4 0.3 0.3 0.0 0.7 0.1 2.1 0.2 0.2 0.4 1.5 0.2 0.2 5.2 1.8 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.2 1.6 12.7 0.0 0.0 0.0 5.9 0.0 0.0 1.4 0.9 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 0.6 0.3 0.5 0.0 0.0 1.7 0.0 5.0 0.2 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.0 IGFBP1 "AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12" ENSG00000146678 "Insulin like growth factor binding protein 1" P08833 7 45888357-45893668 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "liver: 157.6;placenta: 292.3" "Cell type enriched" "Detected in some" 23 "Hepatocytes: 863.0" "Cancer enriched" "Detected in many" 29 "liver cancer: 385.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Hep G2: 18.0;U-2197: 29.5;U-87 MG: 51.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004445, HPA046972, HPA050640" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 28100000 22000000 "Golgi apparatus" "CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197" "unprognostic (8.66e-3)" "unprognostic (1.45e-1)" "unprognostic (9.41e-2)" "unprognostic (7.80e-2)" "unprognostic (7.04e-2)" "unprognostic (2.93e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.89e-2)" "unprognostic (2.09e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.90e-11)" "prognostic unfavorable (6.64e-4)" "unprognostic (7.20e-2)" "unprognostic (7.98e-2)" "unprognostic (3.43e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 10.7 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.2 157.6 0.1 0.0 0.1 0.0 9.3 0.0 0.0 0.2 292.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.5 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 18.0 0.1 0.3 0.0 0.0 0.2 3.9 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.5 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 38.2 0.0 1.2 0.0 0.0 0.7 0.0 6.7 0.1 0.0 0.0 23.3 0.0 2.0 1.0 0.0 0.0 863.0 1.6 0.0 3.4 9.2 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.0 IGFBP2 IBP2 ENSG00000115457 "Insulin like growth factor binding protein 2" P18065 2 216632828-216664436 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth regulation" "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 165.3;pancreas: 228.7" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 536.0;Collecting duct cells: 251.2;Hepatocytes: 556.2;Intestinal endocrine cells: 307.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 141.7;HMC-1: 330.5;NB-4: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077723 Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 303000000 1000000000 "Endoplasmic reticulum" "HPA077723: AB_2686853" "unprognostic (2.58e-1)" "unprognostic (5.95e-2)" "unprognostic (1.94e-1)" "unprognostic (3.32e-3)" "unprognostic (9.50e-3)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (9.11e-3)" "prognostic unfavorable (2.43e-4)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.22e-5)" "unprognostic (5.04e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (1.22e-1)" 21.7 6.4 0.9 13.7 2.8 2.6 17.5 1.0 10.4 11.9 12.6 4.5 20.6 11.4 28.7 37.7 26.4 19.4 11.8 29.6 1.5 0.9 21.3 165.3 8.7 3.8 1.4 3.4 35.7 228.7 0.8 8.2 32.0 7.6 25.7 5.2 8.0 9.1 32.6 5.3 3.1 7.8 7.5 1.8 46.7 50.2 13.7 1.0 12.1 8.4 29.3 12.9 23.4 11.4 0.0 0.3 0.0 0.4 2.0 0.8 1.3 0.0 3.2 25.9 25.2 141.7 43.3 0.5 7.8 3.9 0.3 0.0 0.0 0.0 0.0 11.1 0.0 0.9 0.7 9.3 9.9 0.0 0.0 5.3 5.6 0.0 1.6 3.5 2.3 330.5 14.4 1.0 0.1 0.4 0.8 0.0 11.7 0.2 0.7 0.1 6.3 9.8 68.2 27.9 6.1 0.3 8.5 0.5 0.1 0.1 7.3 5.4 28.6 0.0 0.2 0.1 24.6 21.2 4.1 0.0 0.1 0.1 0.1 0.3 0.4 0.0 0.5 0.3 10.8 30.2 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 1.3 0.9 2.8 1.0 10.4 1.5 0.9 1.4 3.4 7.6 1.0 3.0 1.1 8.3 536.0 12.2 0.0 11.2 10.2 13.4 3.4 251.2 2.0 1.6 24.9 2.4 0.6 38.2 7.3 0.0 111.9 2.0 21.3 92.5 4.6 556.2 4.8 0.0 307.8 26.4 24.0 2.6 5.2 2.5 3.3 1.8 53.3 3.8 95.4 31.9 74.6 1.0 1.6 103.5 14.6 2.8 44.3 4.8 1.8 13.8 47.1 201.7 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell type enhanced" "Detected in many" 19 "Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3250000000 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.6 2.9 5.7 0.0 4.3 1.8 0.0 42.1 7.6 3.6 1.9 0.0 7.8 0.0 13.4 422.0 1.8 23.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.8 0.6 0.7 2.7 5.7 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 3.9 2.6 20.8 0.6 1.6 14.6 0.5 0.7 13.3 0.0 0.0 0.0 41.7 0.0 175.0 2.3 0.6 0.0 0.0 90.6 0.0 14.0 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 3.0 4.6 0.0 95.2 406.6 0.6 9.7 7.6 33.5 117.2 216.3 0.0 45.9 10.0 71.8 0.8 62.6 0.4 0.0 1.7 1874.7 137.7 80.4 1.1 1.7 72.5 0.0 263.4 181.7 8.2 1.9 266.9 3.0 15.1 12.6 1.6 0.4 19.7 2.9 6.3 0.7 0.6 0.0 28.8 0.4 0.4 213.8 129.0 8.2 0.6 581.2 IGFBP4 "BP-4, HT29-IGFBP, IBP4, IGFBP-4" ENSG00000141753 "Insulin like growth factor binding protein 4" P22692 17 40443461-40457731 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 370.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 472.5;Ito cells: 497.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.6;NK-cell: 20.5" "Group enriched" "Detected in many" 5 "NK-cells: 20.5;T-cells: 12.6" "Cell line enhanced" "Detected in many" "A549: 111.6;ASC diff: 84.3;ASC TERT1: 82.6;BJ: 89.6;BJ hTERT+: 92.2;HSkMC: 175.6;U-2197: 75.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066240 Supported "Secreted to blood" NA NA 227000000 500000000 "HPA066240: AB_2685643" "unprognostic (1.03e-3)" "unprognostic (1.61e-1)" "unprognostic (1.85e-1)" "prognostic favorable (3.54e-4)" "unprognostic (7.44e-3)" "unprognostic (1.00e-1)" "prognostic favorable (5.49e-4)" "unprognostic (4.55e-2)" "unprognostic (1.19e-2)" "unprognostic (2.28e-2)" "unprognostic (2.52e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (6.23e-2)" "unprognostic (1.73e-1)" "unprognostic (2.36e-1)" "unprognostic (3.81e-2)" 79.7 23.3 2.5 36.8 5.2 0.0 198.7 1.8 3.1 115.0 57.1 3.2 41.1 9.9 88.8 126.5 67.7 67.4 117.5 119.1 2.2 1.8 72.3 255.6 88.2 101.4 3.7 2.3 370.8 21.5 6.5 19.4 99.8 5.1 66.7 17.0 46.2 24.4 38.6 36.3 22.3 36.8 80.4 6.4 68.1 38.7 53.2 2.3 4.2 81.0 50.4 22.5 89.9 123.9 3.6 0.1 0.0 0.0 20.5 12.6 0.9 0.0 111.6 5.7 0.0 84.3 82.6 0.1 89.6 92.2 17.1 13.4 4.9 1.4 0.0 48.6 42.6 2.3 0.9 1.9 0.5 7.8 0.3 0.1 0.3 8.1 7.3 52.9 0.2 0.0 175.6 0.4 22.9 3.2 2.0 29.7 0.0 1.7 0.0 24.6 3.3 0.0 20.6 3.1 4.8 15.1 5.5 0.1 0.1 0.7 3.5 1.5 4.5 40.4 0.1 1.3 5.7 41.3 2.0 44.7 23.9 1.2 75.4 0.0 0.0 0.0 0.1 14.2 0.8 6.1 0.0 0.0 0.0 1.8 0.0 12.6 0.4 3.3 4.4 0.0 3.6 0.2 0.4 0.0 20.5 0.0 0.1 0.0 0.9 2.5 5.2 1.8 3.1 2.2 1.8 3.7 2.3 5.1 2.3 8.9 44.4 38.9 76.3 50.0 1.2 15.1 99.3 8.1 12.5 7.0 0.0 4.9 14.9 3.0 5.5 236.2 69.3 0.0 2.2 4.7 103.0 15.8 2.3 472.5 206.0 1.6 8.1 497.8 43.5 7.0 228.1 14.8 69.2 5.4 77.9 3.8 23.2 69.1 111.4 154.4 1.0 187.5 232.9 2.3 6.4 41.8 6.3 14.4 110.8 67.4 IGFBP5 ENSG00000115461 "Insulin like growth factor binding protein 5" P24593 2 216672105-216695525 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 245.3" "Cell type enhanced" "Detected in many" 13 "Leydig cells: 1692.8;Muller glia cells: 665.4;Peritubular cells: 922.8;Sertoli cells: 1254.7;Smooth muscle cells: 840.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 79.7;BJ hTERT+: 211.9;T-47d: 51.5;U-138 MG: 70.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059827, HPA070407" Supported Approved "Nuclear bodies,Golgi apparatus,Vesicles" "Secreted to blood" NA NA 110000000 330000000 "Golgi apparatus, Vesicles" "Nuclear bodies" "HPA059827: AB_2732640, HPA070407: " "unprognostic (7.69e-2)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.58e-2)" "unprognostic (3.47e-1)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (1.32e-1)" "unprognostic (9.58e-2)" "unprognostic (1.12e-1)" "unprognostic (2.41e-2)" "unprognostic (4.04e-2)" "unprognostic (9.62e-3)" "unprognostic (1.55e-1)" "unprognostic (3.28e-2)" "unprognostic (1.91e-3)" 47.3 23.4 6.2 19.2 6.3 0.1 41.3 3.6 6.5 191.7 23.1 19.7 15.8 3.9 94.6 91.0 30.0 96.9 21.4 16.9 8.2 2.4 34.8 7.8 9.3 14.5 12.1 7.4 245.3 3.5 6.5 37.7 32.7 7.0 31.4 7.9 188.5 12.0 15.1 47.0 13.5 14.2 71.8 7.4 7.6 36.9 51.7 12.0 1.5 130.1 34.5 17.6 28.8 45.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 20.5 0.0 23.7 0.7 0.0 79.7 211.9 10.6 1.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 2.5 0.0 0.5 0.0 0.7 20.5 0.4 0.0 10.3 0.0 0.1 3.3 0.0 1.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 6.9 23.7 1.4 0.8 1.4 9.8 0.0 1.3 51.5 0.0 7.6 70.3 4.3 10.6 3.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.2 6.3 3.6 6.5 8.2 2.4 12.1 7.4 7.0 12.0 3.0 4.1 2.4 13.8 91.0 5.3 81.7 0.0 100.4 23.9 106.4 5.9 4.0 5.0 13.3 6.4 89.9 0.0 0.0 0.0 5.9 302.8 15.2 2.3 0.9 7.6 3.2 0.0 62.6 0.8 10.9 1692.8 25.6 96.2 1.0 0.0 665.4 3.2 0.0 922.8 1.1 10.8 1254.7 840.1 1.9 2.1 59.5 4.7 1.0 0.0 13.1 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 67.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 18.6 0.0 0.1 0.0 19.5 0.1 0.0 0.0 69.8 67.7 1.1 0.0 0.0 43.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 IGFL1 UNQ644 ENSG00000188293 "IGF like family member 1" Q6UW32 19 46229752-46231243 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 51.5;tongue: 29.7" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 1.4;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in many" 7 "cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 6.3;RT4: 23.4;SK-BR-3: 8.0" HPA014001 Uncertain "Secreted in other tissues" NA NA "HPA014001: AB_2668919" "unprognostic (1.35e-1)" "unprognostic (9.70e-2)" "unprognostic (2.89e-1)" "unprognostic (1.01e-1)" "unprognostic (1.64e-2)" "unprognostic (2.67e-2)" "unprognostic (3.06e-1)" "unprognostic (4.50e-3)" "unprognostic (6.70e-3)" "unprognostic (1.67e-1)" "unprognostic (1.80e-1)" "unprognostic (1.64e-1)" "unprognostic (3.23e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.1 14.7 0.1 0.0 0.0 0.1 0.3 0.1 51.5 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.0 11.0 0.1 0.1 1.8 0.1 0.1 0.0 0.2 0.1 0.3 0.0 1.9 0.1 29.7 14.4 0.4 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 6.3 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.2 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.0 0.0 0.0 0.0 0.0 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Group enriched" "Detected in some" 64 "CACO-2: 28.9;OE19: 58.1" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" NA NA Nucleoplasm "Plasma membrane" "HPA059137: AB_2683920" "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.9 1.9 0.4 0.0 0.0 1.2 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.4 8.0 7.0 4.1 2.2 0.0 1.3 0.0 IGFL3 UNQ483 ENSG00000188624 "IGF like family member 3" Q6UXB1 19 46120071-46124674 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 22.4" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 2.7;Exocrine glandular cells: 5.9;Melanocytes: 1.7;Suprabasal keratinocytes: 6.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.3;CACO-2: 2.2;hTEC/SVTERT24-B: 2.8;U-2 OS: 3.0;U-87 MG: 5.6" HPA062776 Uncertain "Secreted in other tissues" NA NA "HPA062776: AB_2684866" "unprognostic (8.61e-2)" "unprognostic (6.26e-2)" "unprognostic (2.69e-1)" "unprognostic (4.78e-2)" "unprognostic (7.45e-3)" "unprognostic (2.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.90e-1)" "unprognostic (1.86e-4)" "unprognostic (2.86e-2)" "unprognostic (1.90e-1)" "unprognostic (3.69e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 22.4 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.9 0.1 2.7 0.1 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.3 0.6 0.5 2.2 0.3 0.0 0.4 0.0 0.3 0.1 0.0 0.0 1.5 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.1 1.2 0.5 2.8 0.3 1.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.0 0.0 0.1 0.7 0.0 0.2 5.6 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.6 0.6 0.1 0.2 0.2 1.5 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 IGFL4 ENSG00000204869 "IGF like family member 4" Q6B9Z1 19 46039748-46077118 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.5;skin 1: 13.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 13.7;Rod photoreceptor cells: 40.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 6.6;HaCaT: 5.9;OE19: 10.3" HPA047655 Approved Approved Cytosol "Secreted - unknown location" NA NA Cytosol "HPA047655: AB_2680113" "unprognostic (1.22e-2)" "unprognostic (3.37e-2)" "unprognostic (2.57e-1)" "unprognostic (7.96e-2)" "unprognostic (5.48e-2)" "unprognostic (1.03e-1)" "unprognostic (2.39e-1)" "unprognostic (8.25e-2)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (1.09e-2)" "unprognostic (3.59e-4)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" 0.1 0.8 4.4 0.3 4.4 0.2 0.3 3.9 8.5 0.2 0.3 0.0 0.0 0.9 1.0 2.9 1.9 0.4 1.1 1.9 2.8 2.8 0.3 0.4 0.7 0.9 1.2 6.0 2.0 0.2 3.3 4.5 0.2 2.1 0.9 0.5 4.6 1.1 0.0 0.5 13.9 0.7 0.1 1.6 0.5 0.7 0.8 0.5 0.0 1.5 0.6 0.2 1.2 0.2 0.3 1.6 1.3 0.7 0.2 0.5 0.1 0.1 6.6 0.2 0.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 1.4 0.3 0.9 0.1 0.1 0.9 5.9 0.0 0.0 0.0 0.7 1.1 0.0 0.8 1.6 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.7 0.0 0.7 0.1 0.5 0.3 10.3 0.3 0.1 2.9 1.4 0.0 0.3 0.4 0.4 0.0 0.1 1.7 0.8 0.4 1.2 0.6 0.8 1.4 0.4 0.4 0.8 0.4 0.2 0.1 0.9 1.8 1.3 0.7 0.7 0.5 0.3 0.3 0.3 0.2 0.1 0.1 0.3 0.1 0.4 0.9 0.2 0.1 1.6 0.4 0.1 4.4 4.4 3.9 8.5 2.8 2.8 1.2 6.0 2.1 0.5 0.0 0.0 0.0 0.0 0.9 5.1 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.4 1.3 1.0 0.0 0.0 0.0 0.0 IGFLR1 "FLJ22573, TMEM149, U2AF1L4" ENSG00000126246 "IGF like family receptor 1" Q9H665 19 35738801-35742453 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 121.2;liver: 46.2;lymphoid tissue: 40.7" "Cell type enriched" "Detected in many" 5 "monocytes: 187.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 121.2" "Lineage enriched" "Detected in all" 4 "dendritic cells: 121.2" "Cell line enhanced" "Detected in many" "HMC-1: 22.3;Karpas-707: 17.1;U-266/70: 22.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA012369 Uncertain Approved "Focal adhesion sites" "Intracellular and membrane" NA NA "Focal adhesion sites" "HPA012369: AB_1858095" "unprognostic (5.97e-3)" "prognostic favorable (6.55e-4)" "unprognostic (1.94e-1)" "unprognostic (5.42e-2)" "unprognostic (8.31e-3)" "unprognostic (2.34e-4)" "unprognostic (6.71e-2)" "unprognostic (1.74e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.59e-5)" "unprognostic (1.44e-3)" "unprognostic (3.52e-1)" "unprognostic (8.72e-12)" "unprognostic (2.74e-1)" "unprognostic (1.22e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-3)" 5.3 7.3 4.5 17.8 7.6 10.1 4.1 2.0 5.3 3.1 5.0 3.8 0.0 5.6 2.6 4.7 3.4 4.5 5.9 5.8 4.5 3.1 17.0 46.2 8.5 40.7 7.7 1.6 4.5 6.9 1.1 3.4 3.8 5.6 4.0 5.4 2.2 7.4 1.8 3.9 4.6 8.4 3.5 5.4 20.2 6.3 3.5 4.5 14.6 10.0 3.2 19.3 8.0 4.9 22.3 121.2 28.6 26.5 18.1 17.4 16.3 1.3 6.5 2.3 5.4 0.8 1.2 1.3 1.5 0.7 1.2 3.1 1.9 1.6 2.8 2.1 0.4 0.4 1.0 1.3 1.3 0.6 2.1 3.3 10.0 2.7 6.8 1.9 1.3 22.3 1.8 0.8 2.3 0.5 0.9 1.2 5.0 3.0 17.1 0.3 5.5 3.1 10.5 1.6 5.9 1.7 3.8 2.2 5.2 1.1 2.4 1.6 3.1 2.1 1.5 1.1 1.1 2.4 5.4 0.3 2.8 1.3 1.7 2.5 22.5 4.7 1.7 3.3 3.8 2.1 16.2 26.5 23.6 13.3 22.2 15.2 22.3 15.4 12.6 33.9 21.8 13.9 11.1 28.6 18.1 15.5 121.2 17.4 16.3 4.5 7.6 2.0 5.3 4.5 3.1 7.7 1.6 5.6 4.5 0.0 15.7 9.9 0.3 0.6 0.2 0.6 2.5 6.7 9.1 0.0 0.0 0.4 1.7 1.6 0.0 0.5 0.8 0.0 3.6 1.5 0.7 0.3 38.1 16.4 13.3 0.0 2.9 2.5 14.3 0.2 0.0 28.0 5.0 187.6 1.7 1.2 1.5 0.0 0.0 4.4 0.1 0.0 0.9 0.5 0.5 0.6 0.2 8.5 1.2 0.0 IGFN1 "DKFZp434B1231, EEF1A2BP1" ENSG00000163395 "Immunoglobulin-like and fibronectin type III domain containing 1" Q86VF2 1 201190825-201228952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skeletal muscle: 118.8" "Group enriched" "Detected in some" 8 "Leydig cells: 20.4;Peritubular cells: 8.5" "Group enriched" "Detected in some" 11 "renal cancer: 1.8;thyroid cancer: 8.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HeLa: 37.7" HPA050415 Enhanced Approved "Midbody ring" Yes NA "Midbody ring" "HPA050415: AB_2681120" "unprognostic (2.09e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-2)" "unprognostic (3.25e-1)" "unprognostic (1.02e-2)" "unprognostic (2.00e-2)" "unprognostic (9.80e-3)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (3.80e-2)" "prognostic unfavorable (1.27e-8)" "unprognostic (3.55e-4)" "unprognostic (6.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" 0.5 0.0 0.6 0.1 0.4 0.0 0.1 0.4 1.4 0.3 0.2 0.3 0.1 0.0 4.3 6.4 0.1 0.3 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.3 0.2 0.3 4.6 0.0 0.7 0.1 1.7 0.2 0.0 1.6 0.1 0.1 118.8 0.0 0.1 0.3 0.1 0.1 0.0 1.1 0.2 0.1 11.3 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.4 0.3 0.3 0.2 0.3 0.2 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 20.4 0.0 1.7 0.0 0.0 0.0 0.4 0.0 8.5 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 IGLL1 "14.1, CD179B, IGL5, IGLL, IGVPB" ENSG00000128322 "Immunoglobulin lambda like polypeptide 1" P15814 22 23573125-23580308 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8" "Group enriched" "Detected in some" 10 "Early spermatids: 60.5;Late spermatids: 104.2;Melanocytes: 113.1" "Cancer enhanced" "Detected in some" "stomach cancer: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 11.6;naive B-cell: 9.8" "Lineage enriched" "Detected in many" 8 "B-cells: 11.6" "Cell line enriched" "Detected in some" 34 "REH: 129.9" "HPA051134, HPA071406" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 100000000000 "Endoplasmic reticulum" "HPA051134: AB_2681356, HPA071406: AB_2686393" "unprognostic (6.21e-2)" "unprognostic (5.12e-2)" "unprognostic (7.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.56e-1)" "unprognostic (5.91e-6)" "unprognostic (1.08e-1)" "unprognostic (5.27e-2)" "unprognostic (6.17e-3)" "unprognostic (5.89e-2)" "unprognostic (9.07e-2)" "unprognostic (1.99e-4)" "unprognostic (2.35e-2)" "unprognostic (5.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.1 0.1 0.2 37.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 20.8 0.0 29.4 0.0 0.0 1.1 0.0 0.0 11.6 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 129.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 60.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 104.2 1.1 0.0 113.1 0.0 0.0 0.0 0.0 0.0 0.4 4.4 0.0 0.0 0.0 9.7 0.5 0.3 0.0 0.0 0.0 0.1 IGLL5 ENSG00000254709 "Immunoglobulin lambda like polypeptide 5" B9A064 22 22887780-22896107 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 87.9;lymphoid tissue: 102.9" "Cell type enriched" "Detected in some" 923 "Melanocytes: 89092.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 230 "memory B-cell: 87.9;naive B-cell: 72.8" "Lineage enriched" "Detected in single" 252 "B-cells: 87.9" "Group enriched" "Detected in some" 7 "Daudi: 103.5;U-266/70: 74.1;U-698: 70.4" "Secreted to blood" NA NA 120000000000 "prognostic favorable (6.10e-4)" "unprognostic (7.64e-3)" "unprognostic (4.33e-2)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.76e-2)" "unprognostic (2.18e-1)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-1)" "prognostic unfavorable (5.94e-8)" "unprognostic (1.85e-1)" "unprognostic (4.63e-1)" "unprognostic (8.52e-2)" "unprognostic (6.50e-2)" 3.5 1.8 1.3 82.6 1.5 6.5 12.3 1.3 1.5 3.3 37.7 1.4 1.3 39.0 1.5 1.7 7.5 4.3 5.8 1.3 1.3 0.3 4.6 3.6 10.8 22.8 1.5 1.3 2.1 1.3 0.0 1.3 1.5 1.7 2.1 23.3 3.3 42.9 2.8 1.5 0.6 25.2 1.3 1.3 102.9 27.7 3.1 1.3 5.8 5.8 2.9 69.8 38.2 2.6 87.9 0.3 0.1 0.0 0.0 0.0 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 103.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 74.1 12.0 70.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.9 0.0 0.0 0.1 72.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 10.7 1.3 1.5 1.3 1.5 1.3 0.3 1.5 1.3 1.7 1.3 3.0 54.3 41.7 0.0 96.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 23.3 0.0 0.0 1.0 0.0 10.5 0.0 0.0 0.0 1.2 1.3 0.3 2.7 0.0 1.6 89092.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.8 0.0 0.9 0.0 0.0 IGLON5 LOC402665 ENSG00000142549 "IgLON family member 5" A6NGN9 19 51311848-51330354 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 33.6;testis: 11.5" "Group enriched" "Detected in some" 15 "Bipolar cells: 30.6;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "testis cancer: 12.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 25.2;NTERA-2: 11.4;SH-SY5Y: 16.4;SuSa: 7.4;U-2 OS: 4.8" "Low region specificity" "Detected in all" HPA041994 Approved "Secreted in brain" NA NA "HPA041994: AB_10794641" "unprognostic (2.09e-1)" "unprognostic (5.76e-2)" "unprognostic (1.80e-2)" "unprognostic (8.87e-3)" "unprognostic (2.33e-1)" "unprognostic (2.66e-1)" "unprognostic (3.47e-4)" "unprognostic (6.38e-5)" "unprognostic (4.54e-2)" "unprognostic (7.89e-3)" "unprognostic (1.59e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.62e-7)" "unprognostic (1.77e-2)" "unprognostic (9.28e-2)" "unprognostic (1.36e-2)" "unprognostic (1.86e-3)" 2.0 4.6 9.6 1.1 6.0 1.9 0.7 33.6 16.5 0.6 0.8 0.8 0.0 0.9 0.8 2.2 2.8 0.7 1.0 1.2 9.5 13.7 0.6 2.3 0.6 0.6 11.1 8.4 1.5 1.1 0.5 0.5 1.3 29.3 1.1 0.7 3.0 1.1 2.4 0.6 1.5 1.1 0.8 10.9 0.7 0.7 11.5 2.6 0.0 0.6 0.0 0.6 1.1 0.4 0.0 0.9 1.4 0.3 0.2 0.3 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 2.4 0.0 0.1 0.1 16.4 0.0 0.0 0.0 7.4 0.1 1.5 0.0 0.0 4.8 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.9 0.0 0.0 9.6 6.0 33.6 10.7 9.5 13.7 11.1 8.4 29.3 2.6 0.0 0.0 0.0 0.0 0.0 30.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 74.7 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 0.0 IGSF1 "IGCD1, IGDC1, INHBP, KIAA0364, MGC75490, PGSF2" ENSG00000147255 "Immunoglobulin superfamily member 1" Q8N6C5 X 131273506-131578899 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 138.7" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Bipolar cells: 11.5;Horizontal cells: 3.2;Melanocytes: 3.3" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 65.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 23.5;SH-SY5Y: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012732, HPA035582" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 430000 Cytosol "HPA012732: AB_2732404, HPA035582: AB_2674687" "unprognostic (1.40e-3)" "unprognostic (1.79e-1)" "unprognostic (4.11e-1)" "prognostic unfavorable (4.25e-8)" "unprognostic (1.01e-1)" "unprognostic (2.40e-2)" "unprognostic (1.90e-3)" "unprognostic (2.52e-3)" "unprognostic (8.03e-3)" "unprognostic (9.36e-2)" "unprognostic (5.65e-2)" "unprognostic (1.13e-1)" "unprognostic (1.38e-1)" "unprognostic (5.96e-2)" "unprognostic (1.66e-1)" "unprognostic (2.35e-1)" "unprognostic (5.13e-2)" 0.8 11.9 1.4 0.4 5.3 0.0 2.7 0.6 6.2 2.7 0.5 3.3 1.2 0.2 1.1 1.5 1.3 1.6 0.8 5.6 3.3 15.4 0.5 1.5 0.2 0.0 3.8 1.9 1.0 1.7 0.0 138.7 0.6 4.7 3.9 0.2 2.2 2.0 6.4 0.3 0.6 0.4 3.2 2.7 0.2 0.5 11.8 1.9 0.2 5.3 0.8 0.5 0.6 0.5 0.6 0.4 1.5 0.3 0.3 0.3 0.2 0.3 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.2 0.0 0.0 0.0 1.3 0.0 0.0 4.1 0.3 0.0 1.7 23.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 2.7 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 21.2 0.0 0.2 0.0 3.2 0.4 0.0 0.0 0.3 0.6 0.0 2.4 0.7 0.3 0.0 0.0 0.0 0.0 1.5 0.3 0.2 0.2 0.1 0.2 0.3 0.3 0.3 0.1 0.6 0.3 0.2 1.2 0.3 0.1 0.4 0.3 0.2 1.4 5.3 0.6 2.3 3.3 15.4 3.8 1.9 4.7 1.9 3.0 1.1 0.0 0.2 0.0 11.5 2.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.8 0.2 0.0 0.4 0.0 3.2 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.5 0.0 0.4 0.6 0.5 0.0 0.3 0.0 0.4 0.4 0.2 0.0 0.0 0.1 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.8" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 118.2;Horizontal cells: 57.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Group enriched" "Detected in some" 5 "HeLa: 25.6;HL-60: 12.4;REH: 9.2;RPMI-8226: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012655, HPA012921" Uncertain Approved Vesicles "Secreted - unknown location" NA NA 280000 Vesicles "HPA012655: , HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 2.5 2.9 0.6 0.1 0.4 0.0 4.5 0.0 0.2 0.3 0.5 0.0 0.7 0.8 2.0 3.4 7.3 4.1 0.7 0.8 0.0 0.0 6.7 0.5 0.3 17.8 0.1 0.7 1.5 0.0 0.0 0.6 3.7 0.0 0.0 1.2 0.7 0.7 0.3 0.2 0.4 0.3 1.3 1.6 1.5 0.1 0.2 1.5 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.2 4.0 25.6 0.0 0.9 12.4 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 29.6 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.1 3.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.5 1.2 2.2 14.0 1.1 2.5 13.4 10.3 1.8 3.9 18.9 0.0 0.2 118.2 0.7 0.0 0.0 1.2 2.6 5.4 0.9 0.0 0.0 1.2 57.2 5.8 0.0 0.3 22.0 6.4 1.6 3.3 1.0 0.4 23.5 0.3 0.0 1.1 0.3 2.2 0.0 0.9 6.7 2.4 2.0 25.9 0.0 0.0 0.0 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;ovary: 21.1;testis: 39.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 1.1 10.5 12.5 1.4 14.6 0.9 1.2 3.4 23.9 1.3 2.6 27.8 0.0 1.1 1.6 2.3 2.0 1.6 1.9 2.2 12.3 6.0 10.6 0.9 1.0 1.0 25.2 8.9 21.1 5.1 3.8 1.4 1.1 15.3 1.3 1.8 7.0 1.4 2.0 2.9 2.6 1.6 1.5 20.5 1.0 1.4 39.9 20.7 0.0 5.0 0.0 1.1 1.1 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.2 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 2.0 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 26.2 1.7 0.5 0.1 0.0 0.0 1.0 0.0 0.0 9.1 10.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.5 14.6 3.4 13.6 12.3 6.0 25.2 8.9 15.3 20.7 0.0 0.0 0.0 0.1 0.3 5.1 1.1 0.0 0.0 0.0 0.0 70.7 0.1 0.0 0.3 226.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 237.3 3.4 0.2 3.3 0.0 0.0 24.3 0.2 0.0 1.8 5.1 24.8 0.0 0.0 11.7 5.9 0.0 0.1 0.0 0.0 0.2 IGSF21 "MGC15730, RP11-121A23.1" ENSG00000117154 "Immunoglobin superfamily member 21" Q96ID5 1 18107746-18378483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.5;lymphoid tissue: 16.5" "Cell type enriched" "Detected in some" 17 "Bipolar cells: 179.6" "Group enriched" "Detected in many" 5 "breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 7900 "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.50e-3)" "unprognostic (7.06e-2)" "unprognostic (3.29e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (1.66e-2)" "unprognostic (7.87e-2)" "unprognostic (2.77e-3)" "unprognostic (4.34e-2)" "unprognostic (2.33e-1)" "unprognostic (7.85e-4)" "unprognostic (3.76e-5)" "unprognostic (2.10e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-2)" 3.1 9.0 14.1 1.7 12.3 1.6 6.0 48.5 32.7 3.0 1.8 7.2 0.0 0.9 1.9 1.8 2.6 1.8 2.4 1.8 21.1 10.4 1.7 1.7 2.5 1.3 10.9 13.9 2.0 4.1 1.8 1.1 3.3 10.1 4.5 1.5 5.5 1.9 3.0 1.4 1.5 1.2 2.7 6.5 16.5 1.6 1.8 4.5 0.0 1.4 0.0 2.1 4.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 12.3 48.5 27.4 21.1 10.4 10.9 13.9 10.1 4.5 0.0 0.0 0.9 0.0 0.2 179.6 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 1.6 2.9 0.0 10.5 8.3 0.6 1.6 0.0 0.0 0.0 3.7 0.2 0.6 0.0 0.0 10.8 6.5 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.1 IGSF22 "FLJ37794, IGFN2" ENSG00000179057 "Immunoglobulin superfamily member 22" Q8N9C0 11 18704305-18726230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "salivary gland: 22.7" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 22.7;Distal tubular cells: 18.3" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 3.9" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "RH-30: 2.9" "CAB026459, HPA037851" Uncertain Approved Mitochondria NA NA Mitochondria "CAB026459: , HPA037851: " "unprognostic (4.05e-2)" "unprognostic (3.65e-2)" "unprognostic (2.34e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (8.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.24e-2)" "unprognostic (1.99e-4)" "unprognostic (9.35e-2)" "unprognostic (3.72e-4)" "unprognostic (2.87e-1)" "unprognostic (2.18e-1)" "unprognostic (3.43e-1)" "unprognostic (7.94e-3)" 0.3 0.1 0.7 0.2 3.9 0.0 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.6 0.3 0.2 0.2 0.1 0.7 0.3 0.4 1.5 0.2 0.2 0.2 0.3 0.3 0.2 1.2 0.5 0.0 0.5 0.2 0.2 0.2 0.0 0.2 22.7 0.2 0.5 4.6 0.4 0.2 0.2 0.2 0.0 2.2 0.2 0.2 0.2 1.3 0.3 0.5 0.2 0.2 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.2 0.7 3.9 0.2 1.1 0.4 1.5 0.3 0.2 0.2 0.2 0.0 0.3 1.5 3.6 2.2 1.3 1.5 0.0 2.7 1.2 22.7 0.0 0.0 18.3 2.6 1.0 0.0 0.7 0.0 3.8 0.0 0.6 3.7 2.3 0.0 1.3 1.6 3.5 0.6 0.3 3.2 1.4 0.8 0.0 1.0 4.9 0.5 7.4 3.5 0.7 1.4 0.9 0.0 0.5 0.0 0.4 1.5 0.0 1.7 2.9 7.5 IGSF23 ENSG00000216588 "Immunoglobulin superfamily member 23" A1L1A6 19 44613630-44636781 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 6.0;intestine: 19.9;liver: 20.6" "Group enriched" "Detected in some" 8 "Cholangiocytes: 7.6;Early spermatids: 7.7;Hepatocytes: 9.2;Late spermatids: 8.1" "Cancer enriched" "Detected in some" 10 "liver cancer: 12.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "CACO-2: 14.0;Hep G2: 8.3;SiHa: 6.4" "HPA051811, HPA054591" Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA051811: AB_2681621, HPA054591: AB_2682535" "unprognostic (1.54e-1)" "unprognostic (1.84e-3)" "unprognostic (5.74e-2)" "unprognostic (1.53e-3)" "unprognostic (4.58e-2)" "unprognostic (1.11e-1)" "prognostic favorable (7.20e-6)" "unprognostic (7.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.27e-2)" "unprognostic (2.93e-3)" "unprognostic (1.52e-1)" "unprognostic (1.19e-8)" "unprognostic (1.26e-1)" "unprognostic (6.38e-2)" "unprognostic (9.17e-2)" "unprognostic (2.85e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.8 0.1 0.1 12.2 0.1 0.5 0.1 0.1 0.1 0.6 0.1 0.1 0.4 20.6 0.1 0.1 0.1 0.1 0.1 3.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.9 0.1 0.1 0.0 19.9 0.1 0.6 0.1 0.0 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 6.0 1.2 0.0 0.0 0.2 0.4 0.8 0.0 0.5 0.0 0.0 0.7 0.5 0.7 0.0 0.6 14.0 0.5 0.0 1.0 0.4 0.3 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3 8.3 0.0 0.0 0.1 0.4 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 6.4 2.3 0.0 0.0 0.3 0.0 2.6 0.5 0.5 0.6 0.0 1.2 0.0 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 7.7 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 62.5;WM-115: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036305: AB_2675050, HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.4 9.3 7.2 1.8 1.6 3.5 19.3 0.0 0.2 0.7 0.2 5.3 3.1 0.0 2.9 0.0 4.0 15.2 3.2 7.5 0.3 62.5 2.3 2.9 3.6 0.1 0.0 0.2 5.7 0.4 5.9 0.0 1.3 1.3 0.0 1.0 0.9 0.0 0.1 19.1 0.2 0.1 4.5 3.3 0.2 2.2 8.8 0.0 5.5 6.8 4.2 12.8 2.2 21.5 13.7 14.4 7.2 0.3 0.0 1.2 4.3 0.0 5.6 0.0 0.3 0.0 0.5 0.1 60.3 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 14.9 25.2 0.0 7.0 17.4 1.9 14.4 12.7 8.1 5.7 14.0 0.0 10.1 3.3 13.2 1.8 2.1 14.7 0.0 1.7 24.6 6.6 7.2 1.1 0.0 1.9 6.4 2.9 1.8 1.6 2.1 1.1 0.9 8.5 5.4 5.5 12.8 11.2 8.6 0.0 11.3 0.5 0.0 2.1 0.5 4.3 24.2 11.1 0.0 7.1 9.6 IGSF5 JAM4 ENSG00000183067 "Immunoglobulin superfamily member 5" Q9NSI5 21 39745407-39802096 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 5.8" "Cell type enriched" "Detected in some" 9 "Syncytiotrophoblasts: 95.4" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Cell type enriched" "Detected in single" 5 "neutrophil: 2.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "T-47d: 10.8" "Low region specificity" "Detected in all" HPA057282 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA057282: AB_2683395" "unprognostic (1.06e-1)" "unprognostic (2.53e-1)" "unprognostic (7.06e-2)" "unprognostic (9.73e-5)" "unprognostic (1.56e-2)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (2.09e-1)" "unprognostic (8.35e-2)" "unprognostic (9.61e-2)" "unprognostic (4.01e-1)" "unprognostic (4.18e-1)" "unprognostic (3.75e-2)" "unprognostic (6.89e-2)" "unprognostic (1.07e-2)" 0.0 2.0 0.9 0.0 3.4 0.1 1.3 0.1 0.7 1.1 0.3 0.2 0.9 3.4 0.0 0.9 0.3 5.8 1.2 2.3 0.3 0.3 0.1 0.2 1.3 1.5 2.5 0.3 1.5 4.3 2.4 0.9 0.9 0.4 0.0 0.6 0.1 0.4 0.7 0.3 0.6 1.5 0.8 0.2 0.5 0.2 0.4 0.3 2.2 0.4 0.0 0.4 0.0 1.3 0.7 4.5 1.1 4.4 3.6 1.2 0.8 1.2 1.3 2.0 0.7 1.3 1.4 1.2 1.7 1.7 1.2 1.5 3.0 2.5 2.3 2.1 1.4 3.3 0.5 2.8 1.9 0.6 3.2 5.5 2.9 3.2 2.2 0.6 0.7 2.6 0.9 1.7 1.6 0.3 0.6 2.5 1.1 0.8 0.7 2.0 0.8 1.9 1.9 2.0 0.5 1.2 3.0 1.8 2.1 10.8 1.1 0.4 2.0 2.3 1.0 1.8 1.0 0.8 0.9 1.1 1.4 2.0 0.1 0.4 0.4 0.4 0.0 0.2 0.1 0.3 0.1 0.1 0.4 0.1 0.2 2.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 8.7 0.0 0.0 0.0 1.8 0.0 0.9 5.0 0.3 11.1 0.0 0.0 0.0 0.2 0.9 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.4 2.7 0.1 0.0 0.2 0.5 0.1 0.0 95.4 0.0 0.0 0.9 IGSF6 DORA ENSG00000140749 "Immunoglobulin superfamily member 6" O95976 16 21639537-21652660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 96.8;lymphoid tissue: 49.7" "Group enriched" "Detected in many" 7 "Hofbauer cells: 183.3;Kupffer cells: 173.4;Macrophages: 302.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 96.8" "Lineage enhanced" "Detected in many" "granulocytes: 96.8" "Cell line enhanced" "Detected in some" "THP-1: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041023, HPA041072" Uncertain NA NA "HPA041023: AB_10794434, HPA041072: AB_10794262" "unprognostic (7.94e-2)" "prognostic favorable (4.92e-4)" "unprognostic (1.18e-2)" "prognostic favorable (1.54e-5)" "unprognostic (3.27e-1)" "unprognostic (4.03e-2)" "unprognostic (2.31e-1)" "unprognostic (1.74e-2)" "unprognostic (1.35e-2)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (8.12e-2)" "unprognostic (1.81e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-1)" "unprognostic (2.02e-1)" 17.8 3.9 5.0 16.7 7.7 2.0 2.0 0.9 5.1 2.3 5.8 3.8 0.0 4.1 1.1 2.7 1.2 2.1 1.3 3.6 4.7 2.7 1.7 8.5 16.2 30.2 6.5 0.2 3.5 1.4 0.8 1.1 6.5 5.9 2.1 1.6 0.8 3.6 2.1 0.7 0.9 3.5 1.3 10.6 49.7 2.4 0.6 6.2 3.4 1.2 0.9 2.1 1.5 1.0 0.2 18.7 96.8 28.5 0.2 0.1 12.7 0.1 0.3 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.6 1.7 0.1 0.1 1.0 0.4 0.1 0.1 0.1 1.0 0.0 0.4 0.0 0.7 0.0 1.6 1.2 0.1 0.0 0.1 0.0 0.2 0.2 0.3 0.5 0.4 0.1 0.5 0.7 0.9 0.6 0.0 0.0 1.7 0.0 0.6 0.3 0.8 0.5 0.3 0.3 0.1 0.2 0.2 0.3 2.0 0.4 1.7 0.1 0.1 0.9 0.8 0.4 1.3 0.6 0.8 0.3 0.0 23.7 3.4 0.0 28.5 0.0 0.2 0.0 0.0 18.7 0.0 0.0 0.1 96.8 0.2 18.6 4.0 0.0 12.7 5.0 7.7 0.9 5.1 4.7 2.7 6.5 0.2 5.9 6.2 3.0 13.5 13.7 0.7 2.9 1.2 1.1 5.1 8.1 9.1 1.8 9.8 0.5 0.0 0.0 0.3 1.5 0.0 0.0 0.0 1.0 2.6 0.4 9.3 0.9 183.3 0.0 0.0 2.5 173.4 0.0 0.9 302.4 8.5 29.7 0.0 0.9 0.0 0.0 0.0 0.3 1.8 0.0 1.2 0.1 0.0 1.8 1.1 2.5 0.0 0.3 IGSF8 "CD316, CD81P3, EWI2, PGRL" ENSG00000162729 "Immunoglobulin superfamily member 8" Q969P0 1 160091340-160098943 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.2" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 187.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011917, HPA075970" Approved Supported Vesicles NA NA 190000 Vesicles "HPA011917: AB_1851536, HPA075970: " "unprognostic (4.08e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.20e-1)" "unprognostic (1.71e-1)" "unprognostic (1.01e-3)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.31e-1)" "unprognostic (2.60e-2)" "unprognostic (2.35e-1)" "unprognostic (3.74e-3)" "unprognostic (1.75e-3)" 9.9 10.4 25.2 9.0 30.3 2.4 11.1 40.9 54.2 9.6 11.8 53.5 6.4 18.2 8.6 16.6 7.0 13.9 8.5 11.6 32.4 24.1 10.4 19.3 10.1 10.3 32.2 29.9 15.1 19.1 9.0 8.7 7.8 25.9 13.8 7.4 11.2 21.0 14.0 6.0 34.0 14.4 5.1 42.6 10.6 9.8 11.5 25.3 6.2 10.0 5.9 6.2 6.0 6.9 14.3 5.6 1.2 4.0 4.7 15.6 6.4 8.9 5.4 7.0 17.9 4.1 2.6 14.8 4.4 5.8 9.5 8.9 6.1 6.2 13.2 16.6 6.4 8.2 17.3 2.8 6.5 1.3 15.7 5.1 1.7 6.0 10.4 6.9 4.5 14.7 3.2 13.2 6.1 2.0 6.7 1.9 14.6 2.3 7.6 2.2 8.5 11.2 10.5 14.8 18.8 8.6 6.4 3.6 9.5 8.6 9.3 2.9 12.8 5.0 16.5 58.9 6.4 11.7 5.8 1.9 4.2 9.1 7.5 3.5 21.0 23.2 5.9 14.8 1.8 10.9 0.0 2.9 1.2 13.3 4.0 11.7 12.2 11.0 15.4 3.3 14.3 14.8 15.6 0.8 4.7 2.4 5.6 14.9 6.4 25.2 30.3 40.9 54.2 32.4 24.1 32.2 29.9 25.9 25.3 8.9 3.5 22.5 26.4 38.8 54.6 3.2 12.7 0.0 1.2 36.6 9.8 28.1 5.0 30.1 3.1 7.9 34.9 0.0 10.8 187.6 24.7 18.9 10.3 26.8 13.7 62.0 19.1 9.8 3.2 0.5 15.5 8.0 40.5 85.6 23.2 90.2 17.8 37.4 14.9 13.3 11.7 6.5 16.3 1.7 5.8 54.5 58.0 14.4 27.4 24.0 IGSF9 "IGSF9A, KIAA1355, Nrt1" ENSG00000085552 "Immunoglobulin superfamily member 9" Q9P2J2 1 159927039-159945604 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 65.3" "Cell type enhanced" "Detected in many" 17 "Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 150.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 15.2;HaCaT: 22.2;hTCEpi: 9.8;NTERA-2: 11.3;SCLC-21H: 19.9;SH-SY5Y: 10.2;T-47d: 11.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA037753 Uncertain "Intracellular and membrane" NA NA "HPA037753: AB_10672915" "unprognostic (5.73e-2)" "unprognostic (2.86e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (3.30e-2)" "unprognostic (6.06e-3)" "unprognostic (8.93e-3)" "unprognostic (1.37e-1)" "unprognostic (5.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.04e-2)" "unprognostic (2.15e-2)" "unprognostic (6.03e-3)" "unprognostic (2.87e-1)" "unprognostic (8.60e-2)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" 2.7 0.0 0.3 4.5 0.5 0.0 2.2 0.4 0.3 2.3 6.7 0.4 3.4 6.6 1.3 5.9 6.8 4.2 1.4 0.7 0.4 0.1 0.4 65.3 0.7 0.3 0.3 0.3 2.4 1.0 0.9 0.3 1.5 0.6 4.0 3.8 21.2 4.0 6.2 0.3 20.2 13.7 0.9 0.5 0.3 11.8 3.0 0.4 1.1 1.1 7.0 2.7 2.1 3.9 0.9 1.4 1.6 0.1 0.0 0.2 0.0 5.0 0.0 2.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 7.1 2.6 0.0 0.2 0.0 0.0 22.2 1.1 3.1 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.3 0.0 0.0 0.8 0.2 0.0 0.0 9.4 0.2 0.0 11.3 8.5 2.3 0.0 0.0 0.9 0.0 6.8 19.9 10.2 0.6 8.7 0.0 2.0 11.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.2 1.4 0.9 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.3 0.5 0.4 0.3 0.4 0.1 0.3 0.3 0.6 0.4 0.0 0.0 0.0 3.4 11.8 11.2 1.2 15.3 2.7 2.3 0.0 88.4 1.0 0.0 3.9 16.7 0.3 29.4 0.0 30.5 2.6 1.5 1.7 0.0 11.4 0.2 1.6 7.9 0.6 0.3 2.4 0.3 0.0 0.0 0.0 7.6 3.7 19.4 12.2 0.0 0.0 150.3 0.0 0.4 0.5 1.0 10.9 0.6 0.0 3.2 1.3 IGSF9B KIAA1030 ENSG00000080854 "Immunoglobulin superfamily member 9B" Q9UPX0 11 133908564-133956985 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 3.1;Bipolar cells: 2.2;Cardiomyocytes: 2.6;Distal tubular cells: 1.7;Muller glia cells: 2.0;Suprabasal keratinocytes: 4.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 39.7" "Cell type enriched" "Detected in single" 9 "T-reg: 1.8" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "OE19: 8.2;SCLC-21H: 17.7;SH-SY5Y: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010744, HPA010802" Uncertain Approved Cytosol NA NA Cytosol "HPA010744: AB_2668357, HPA010802: AB_1079194" "unprognostic (9.04e-4)" "unprognostic (1.74e-2)" "unprognostic (7.52e-3)" "unprognostic (4.38e-4)" "unprognostic (8.35e-2)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" "unprognostic (1.38e-1)" "unprognostic (8.10e-2)" "unprognostic (2.81e-1)" "unprognostic (2.99e-4)" "unprognostic (3.17e-1)" "unprognostic (2.19e-1)" "unprognostic (1.41e-1)" "unprognostic (9.14e-4)" "unprognostic (3.12e-3)" 2.2 2.1 4.9 3.7 6.8 0.7 1.2 39.7 12.4 7.4 6.8 2.4 4.6 1.1 7.7 4.3 5.9 7.6 4.9 13.4 2.9 3.1 1.1 0.5 1.8 1.6 2.1 4.0 2.4 2.1 1.5 6.2 1.3 3.8 4.2 2.4 6.1 2.1 6.4 5.0 2.4 2.4 12.8 1.6 1.8 3.7 5.0 2.3 0.0 4.9 2.6 1.2 5.2 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.3 1.2 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.0 2.6 1.6 0.8 0.5 0.4 3.1 2.6 0.0 0.1 2.8 2.4 0.0 0.0 0.0 0.2 0.7 3.8 0.0 0.0 0.0 0.5 0.2 0.0 3.3 0.0 0.0 0.0 1.8 0.3 0.3 1.9 8.2 0.1 0.0 0.0 0.0 0.3 0.0 17.7 9.0 0.1 0.2 0.0 2.9 1.8 0.0 0.0 1.3 1.4 1.1 0.8 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 4.9 6.8 39.7 9.7 2.9 3.1 2.1 4.0 3.8 2.3 0.0 0.0 0.0 0.1 3.1 2.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.4 0.0 0.7 0.0 1.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 IHH "BDA1, HHG2" ENSG00000163501 "Indian hedgehog" Q14623 2 219054420-219060467 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.1;intestine: 42.8;lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 16 "Enterocytes: 15.4;Intestinal endocrine cells: 47.3;Mucus-secreting cells: 35.7;Undifferentiated cells: 20.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 20.4;OE19: 9.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 13000000 "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.63e-2)" "prognostic favorable (3.67e-6)" "unprognostic (4.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.28e-1)" "unprognostic (1.06e-1)" "unprognostic (5.86e-2)" "unprognostic (2.74e-1)" "unprognostic (6.31e-2)" "unprognostic (3.33e-3)" "unprognostic (1.81e-3)" "unprognostic (2.05e-1)" "unprognostic (5.31e-1)" "unprognostic (1.51e-2)" "unprognostic (2.91e-2)" 0.1 0.1 0.1 20.2 0.1 0.0 0.1 0.3 0.2 4.5 33.1 0.1 0.7 10.7 14.3 10.3 0.7 0.7 19.1 0.1 0.1 0.2 3.7 3.4 3.3 0.1 0.1 0.1 0.7 0.1 0.0 0.6 0.2 0.1 2.3 11.4 8.2 0.1 1.1 0.1 0.1 42.8 0.5 0.1 0.1 11.6 0.3 0.1 0.1 1.1 0.1 0.1 0.9 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 2.5 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 3.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.4 11.5 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.3 0.3 IKBKE "IKK-i, IKKE, KIAA0151" ENSG00000263528 "Inhibitor of nuclear factor kappa B kinase subunit epsilon" Q14164 1 206470476-206496889 "Enzymes, Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.8;lymphoid tissue: 19.5" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 20.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 25.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015788, CAB025983" Approved Supported Cytosol NA NA Cytosol "CAB025983: , HPA015788: AB_1851566" "unprognostic (6.43e-2)" "unprognostic (3.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.76e-2)" "unprognostic (7.78e-3)" "unprognostic (7.37e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (5.09e-3)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.34e-7)" "unprognostic (1.48e-2)" "unprognostic (5.77e-2)" "unprognostic (2.84e-3)" "unprognostic (2.84e-2)" 2.1 0.9 1.0 17.3 3.4 4.3 1.4 1.1 1.7 2.2 4.8 1.5 1.7 3.9 2.0 3.9 6.1 1.2 3.6 1.1 2.9 1.5 0.6 3.7 13.6 2.1 0.7 1.0 1.5 0.0 0.8 2.5 1.9 1.8 4.3 1.5 8.3 2.9 0.1 8.9 4.2 1.0 2.9 12.8 4.0 0.0 2.4 18.8 2.6 4.4 19.5 4.4 0.4 12.9 4.6 4.2 15.9 10.8 24.8 12.3 9.0 7.1 2.0 0.2 3.6 5.2 2.1 3.6 11.5 5.0 5.6 5.6 14.7 17.9 9.9 7.3 6.0 12.2 0.0 9.3 1.0 2.9 1.7 2.5 4.2 3.9 4.7 15.2 8.1 6.6 1.6 4.1 0.8 5.8 7.2 4.9 1.2 5.5 5.2 1.8 9.7 25.6 2.9 2.1 5.5 5.2 2.1 14.2 5.9 15.4 0.0 0.0 1.6 12.3 2.2 2.6 7.3 10.8 14.0 5.0 3.1 3.6 4.1 1.9 0.9 11.6 9.4 12.8 2.0 4.2 15.9 0.3 10.5 11.2 7.5 12.9 16.7 15.2 4.6 7.4 13.3 13.6 1.1 10.8 6.4 1.5 24.8 12.3 0.0 5.0 8.9 3.6 1.6 0.0 0.8 0.0 2.7 0.0 0.0 0.0 3.5 0.0 10.6 2.7 0.6 10.5 0.0 10.9 3.6 2.4 2.6 4.7 0.8 12.5 0.0 3.5 1.3 11.9 5.2 0.9 5.3 6.8 1.8 6.8 0.0 12.0 20.1 0.7 2.0 0.0 0.0 0.5 0.2 0.5 4.3 1.3 14.4 8.0 9.6 IKBKG "FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9" ENSG00000269335 "Inhibitor of nuclear factor kappa B kinase subunit gamma" Q9Y6K9 X 154541199-154565046 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Disease mutation, Ectodermal dysplasia, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.8" "Cell type enhanced" "Detected in many" 5 "monocytes: 63.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000426, CAB010373" Uncertain Enhanced Cytosol NA NA Cytosol "CAB010373: AB_2124846, HPA000426: AB_1851572" "unprognostic (7.53e-2)" "unprognostic (2.76e-3)" "unprognostic (1.09e-1)" "unprognostic (3.37e-3)" "unprognostic (9.77e-2)" "unprognostic (3.68e-1)" "unprognostic (9.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (9.87e-2)" "unprognostic (3.57e-2)" "unprognostic (4.41e-2)" "unprognostic (2.78e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-2)" 6.5 5.8 5.2 10.2 6.1 15.1 5.0 5.4 9.2 5.2 4.5 9.1 5.9 7.5 5.2 6.2 6.3 4.5 7.7 5.1 4.9 3.9 16.3 6.5 10.4 6.9 5.1 5.1 6.1 3.5 2.0 6.8 6.7 5.0 3.9 5.6 5.7 3.9 4.6 11.4 6.6 8.1 3.7 10.8 7.4 4.2 6.2 6.9 5.0 6.9 9.9 4.9 6.2 11.3 13.7 28.8 21.8 13.8 17.9 13.5 15.6 16.1 3.9 12.8 8.9 7.5 10.8 10.5 13.7 11.2 16.2 11.4 9.4 12.6 26.6 11.8 32.1 14.7 5.7 9.6 4.8 15.0 8.0 10.3 23.3 21.3 13.8 10.1 36.1 8.9 8.1 15.7 6.3 7.5 13.3 12.6 5.7 12.6 9.0 15.2 10.4 16.9 3.6 12.2 26.8 11.5 6.2 13.4 11.1 10.0 7.0 7.0 13.0 12.2 7.5 3.5 7.1 11.3 13.6 10.4 12.1 27.8 25.1 24.7 17.5 23.6 15.5 18.3 15.2 10.5 15.4 28.8 17.9 20.5 12.3 11.3 11.4 13.0 13.7 10.1 9.5 11.3 25.4 13.8 21.8 12.2 13.0 13.5 3.0 11.0 14.9 10.9 11.0 5.1 6.1 15.3 5.3 7.9 12.2 9.8 20.4 1.7 16.8 0.7 11.9 11.2 23.3 14.9 14.8 12.4 9.6 28.8 28.0 25.4 23.8 4.7 9.2 21.2 1.6 13.3 18.6 11.8 63.1 6.7 11.4 17.2 11.5 13.1 6.5 9.8 6.5 12.5 3.4 13.6 9.3 31.8 22.4 7.6 12.2 IKZF1 "hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1" ENSG00000185811 "IKAROS family zinc finger 1" Q13422 7 50304068-50405101 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 46.7;Kupffer cells: 47.2;Macrophages: 43.8;monocytes: 70.3;T-cells: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 26.9;HDLM-2: 45.8;HMC-1: 42.9;JURKAT: 26.3;MOLT-4: 33.5;REH: 36.3;U-698: 68.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009247, HPA035221, HPA035222" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525" "prognostic favorable (4.28e-4)" "prognostic favorable (2.02e-4)" "unprognostic (2.49e-3)" "unprognostic (2.41e-3)" "unprognostic (5.59e-1)" "prognostic favorable (8.63e-4)" "unprognostic (1.45e-2)" "unprognostic (1.37e-2)" "unprognostic (1.15e-2)" "unprognostic (2.43e-1)" "unprognostic (6.63e-2)" "unprognostic (2.95e-1)" "unprognostic (1.69e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-2)" "unprognostic (6.77e-2)" "unprognostic (4.67e-2)" 3.5 1.5 2.9 25.5 3.8 55.2 2.3 0.7 1.8 1.6 3.6 2.8 0.8 2.4 1.6 2.1 2.2 2.4 2.9 1.6 3.4 1.8 2.5 2.3 8.3 44.4 5.9 1.1 1.1 1.3 0.2 1.2 1.2 3.4 2.2 2.5 1.5 5.2 0.7 0.9 1.9 14.5 1.4 5.1 31.0 3.7 1.1 4.1 86.7 2.4 1.2 26.3 4.5 2.9 24.0 12.6 12.8 23.6 12.8 28.7 12.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 9.2 0.0 0.0 0.0 16.3 42.9 0.0 0.0 0.0 0.0 0.0 0.0 26.3 11.9 3.2 0.0 0.0 33.5 16.2 0.4 0.0 0.0 36.3 0.0 7.6 0.0 0.0 0.3 0.3 0.1 0.2 0.1 0.0 0.0 22.5 0.0 0.0 0.3 0.0 0.0 14.6 7.5 68.8 0.1 17.7 0.1 10.2 7.7 12.8 20.4 23.6 17.0 24.0 21.2 19.9 8.2 21.3 28.7 20.7 11.2 12.8 22.3 12.6 17.1 12.7 2.9 3.8 0.7 1.8 3.4 1.8 5.9 1.1 3.4 4.1 3.0 16.4 46.7 0.1 2.5 0.0 1.1 5.1 2.7 3.4 1.8 0.0 0.3 0.0 0.1 3.0 2.9 0.0 23.3 0.0 0.2 3.4 0.1 22.0 1.0 27.1 0.0 0.0 4.3 47.2 4.5 0.0 43.8 18.6 70.3 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 2.1 0.0 0.7 2.4 0.6 103.3 0.0 0.1 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 21.4;T-cells: 23.3;Urothelial cells: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 7.2;T-cells: 7.1" "Cell line enhanced" "Detected in many" "JURKAT: 36.7;MOLT-4: 15.5;RT4: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 3.4 2.4 6.1 4.1 12.4 5.9 4.0 8.0 8.6 4.9 2.6 5.3 7.6 1.0 2.3 3.9 24.8 3.4 3.6 2.8 6.3 2.6 2.1 2.1 3.7 7.4 11.8 3.4 2.5 3.0 9.7 6.9 3.2 8.6 5.4 2.0 2.3 13.5 9.2 4.3 10.4 2.5 1.2 9.1 5.9 5.2 2.8 13.4 55.8 9.2 5.5 7.5 11.9 11.6 1.5 0.7 5.7 0.0 7.2 7.1 0.3 1.4 0.5 2.8 0.1 9.2 9.4 1.7 1.7 2.0 0.4 0.9 0.7 2.4 1.9 2.3 1.0 0.2 3.4 0.0 0.9 1.4 0.0 0.4 1.0 1.8 0.2 0.1 4.5 0.3 9.1 0.8 0.0 0.2 2.3 0.0 36.7 0.5 1.6 0.8 2.6 15.5 4.5 0.5 1.1 0.4 9.2 1.8 0.0 0.8 14.7 0.8 0.5 0.0 1.9 0.0 2.4 2.5 0.4 4.7 2.6 2.0 1.2 0.3 3.1 0.9 10.6 1.3 0.0 0.5 4.1 0.0 5.7 2.5 0.0 6.5 0.2 0.8 1.9 0.0 1.5 0.4 1.9 0.0 7.2 0.0 0.7 7.1 0.3 6.1 12.4 8.0 8.6 6.3 2.6 11.8 3.4 8.6 13.4 8.9 9.3 3.9 11.1 5.3 4.0 6.2 0.0 21.4 15.9 7.0 3.9 3.0 0.0 1.6 1.0 2.2 1.1 0.0 2.6 1.1 1.5 14.9 3.5 1.7 1.6 0.0 2.9 1.3 1.3 0.0 1.7 1.8 1.7 1.0 2.3 2.4 3.4 0.0 2.1 0.9 7.0 0.0 2.7 0.7 0.4 7.5 3.3 23.3 1.0 48.0 IKZF3 "Aiolos, ZNFN1A3" ENSG00000161405 "IKAROS family zinc finger 3" Q9UKT9 17 39757715-39864188 "Predicted intracellular proteins, Transcription factors" "B-cell activation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7;lymphoid tissue: 55.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 27.4;B-cells: 90.1;granulocytes: 44.2;T-cells: 76.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 8.3;T-cells: 17.7" "Group enriched" "Detected in some" 4 "Daudi: 27.2;Karpas-707: 14.3;U-266/70: 17.3;U-266/84: 19.2;U-698: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA024377, HPA073266" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024377: AB_1859477, HPA073266: " "unprognostic (5.43e-3)" "prognostic favorable (6.85e-6)" "unprognostic (6.10e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "prognostic favorable (4.16e-4)" "unprognostic (1.36e-2)" "unprognostic (3.14e-3)" "prognostic favorable (5.42e-4)" "unprognostic (8.03e-3)" "unprognostic (1.65e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (7.38e-4)" "unprognostic (9.13e-2)" "unprognostic (2.20e-1)" "unprognostic (5.51e-2)" "unprognostic (1.05e-3)" 1.7 0.7 0.5 41.7 0.5 3.1 1.0 0.5 0.5 1.1 4.5 0.0 0.6 1.8 1.2 0.6 3.6 1.2 2.4 0.9 0.6 0.6 1.5 1.4 5.3 30.5 0.6 0.0 0.9 0.9 0.0 0.7 0.4 0.1 1.5 1.7 1.2 5.5 1.3 0.6 0.8 11.3 1.2 0.9 41.0 3.3 2.6 0.1 55.1 1.6 1.8 54.1 4.0 1.3 8.3 0.3 0.7 0.1 2.6 17.7 4.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 27.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.1 1.6 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 14.3 0.0 0.1 2.4 0.9 0.1 1.5 0.0 0.1 0.1 4.9 0.0 1.6 0.1 0.1 0.5 0.2 0.0 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.0 17.3 19.2 44.1 0.0 0.1 0.0 0.5 0.1 0.4 16.3 0.1 17.7 8.3 6.7 12.1 0.0 7.7 2.8 7.5 0.7 2.6 0.1 0.3 10.6 4.1 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.0 0.1 0.1 8.9 27.4 90.1 2.1 0.1 1.4 4.0 0.0 1.4 10.3 1.8 0.0 0.1 0.0 0.1 11.6 1.2 0.0 0.0 0.0 0.3 0.2 1.4 44.2 0.6 0.1 0.0 0.0 5.5 6.5 7.4 0.0 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 1.4 0.0 0.1 4.9 2.0 0.1 0.2 76.1 0.0 1.4 IL10 "CSIF, IL-10, IL10A, TGIF" ENSG00000136634 "Interleukin 10" P22301 1 206767602-206772494 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.3" "Group enriched" "Detected in some" 5 "Hofbauer cells: 25.9;Kupffer cells: 36.4;Macrophages: 43.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 5.4;intermediate monocyte: 4.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.4" "Group enriched" "Detected in some" 8 "HMC-1: 18.6;U-266/70: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB013120, HPA071391" Approved "Secreted to blood" NA NA 5670 "CAB013120: , HPA071391: " "unprognostic (3.65e-2)" "unprognostic (1.14e-1)" "unprognostic (1.03e-2)" "unprognostic (8.71e-2)" "unprognostic (2.20e-1)" "unprognostic (2.63e-3)" "unprognostic (2.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (4.26e-1)" "unprognostic (8.01e-2)" "unprognostic (4.00e-1)" "unprognostic (4.66e-4)" "unprognostic (7.11e-2)" "unprognostic (1.93e-2)" "unprognostic (2.73e-1)" "unprognostic (1.96e-2)" 10.9 3.1 1.1 10.7 1.2 4.1 2.1 0.3 1.3 1.6 1.8 2.1 0.5 0.8 1.0 1.9 1.7 4.0 5.2 3.9 0.8 0.9 1.3 3.1 4.3 9.2 1.8 0.9 1.5 1.2 0.4 2.3 3.6 2.3 1.7 1.8 2.1 1.6 0.8 0.9 0.7 2.1 4.6 2.2 28.3 2.0 1.6 1.4 2.2 2.4 0.9 3.5 4.1 1.0 0.2 0.5 0.5 5.4 0.1 1.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 9.6 0.3 0.3 0.0 0.1 0.0 0.5 5.4 0.1 0.2 4.0 0.0 0.1 0.2 1.0 0.5 0.2 0.1 0.1 0.3 0.1 1.4 0.1 0.9 1.0 1.1 1.2 0.3 1.3 0.8 0.9 1.8 0.9 2.3 1.4 0.0 3.4 1.4 0.3 0.9 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 6.9 0.3 0.0 0.0 0.0 0.1 0.6 0.3 1.1 0.0 25.9 0.0 0.0 0.6 36.4 2.2 0.0 43.8 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.1 1.0 0.1 1.3 0.0 0.4 IL10RA "CD210, CD210a, CDW210A, HIL-10R, IL10R" ENSG00000110324 "Interleukin 10 receptor subunit alpha" Q13651 11 117986348-118003037 "CD markers, Disease related genes, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.2" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 88.9;Kupffer cells: 162.4;Macrophages: 88.5;monocytes: 146.1;T-cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.9;HDLM-2: 37.1;Karpas-707: 13.9;RPMI-8226: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065647, HPA069086" Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA065647: , HPA069086: " "unprognostic (1.01e-2)" "unprognostic (2.07e-3)" "unprognostic (1.58e-2)" "unprognostic (7.08e-2)" "unprognostic (8.27e-2)" "prognostic favorable (4.47e-4)" "unprognostic (5.27e-2)" "unprognostic (4.84e-2)" "unprognostic (7.70e-3)" "unprognostic (5.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.82e-1)" "unprognostic (8.43e-3)" "unprognostic (2.19e-1)" "unprognostic (1.27e-1)" 11.3 6.5 2.9 29.6 3.5 27.2 7.2 1.1 3.0 3.4 7.9 4.7 0.5 3.8 5.5 11.0 4.3 4.9 9.7 7.6 3.0 3.6 5.0 6.4 13.6 49.8 4.7 1.4 3.4 3.6 1.3 3.4 6.9 4.5 5.8 7.5 6.4 7.9 1.9 2.6 3.0 17.6 5.0 8.0 56.2 4.9 3.1 3.5 9.6 3.6 3.9 32.2 9.5 3.4 4.6 15.4 1.2 23.9 23.7 30.7 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.3 0.0 0.2 0.0 0.0 37.1 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 13.9 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 3.9 0.0 5.6 0.0 1.1 15.8 0.8 19.7 23.9 14.2 4.6 19.0 22.7 15.4 2.3 6.9 12.3 1.2 23.7 18.8 6.0 30.7 22.8 2.9 3.5 1.1 3.0 3.0 3.6 4.7 1.4 4.5 3.5 6.0 26.0 27.4 0.5 5.0 0.0 2.0 0.0 2.7 2.3 0.0 0.0 1.2 0.0 0.1 0.0 1.2 0.0 0.0 0.7 88.9 2.8 0.0 11.6 0.5 54.1 0.0 0.0 4.3 162.4 0.0 0.3 88.5 16.9 146.1 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 1.0 0.1 0.2 3.6 2.7 102.0 0.0 0.4 IL11 "AGIF, IL-11" ENSG00000095752 "Interleukin 11" P20809 19 55364389-55370463 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Group enriched" "Detected in some" 8 "Ductal cells: 10.9;Pancreatic endocrine cells: 37.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebellum: 9.2;hypothalamus: 3.7;pons and medulla: 2.7" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 18.3;BJ hTERT+: 20.8;hTEC/SVTERT24-B: 17.0;U-251 MG: 65.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 34800 "unprognostic (6.60e-3)" "unprognostic (7.23e-3)" "unprognostic (1.12e-1)" "unprognostic (3.18e-3)" "unprognostic (3.32e-3)" "unprognostic (6.33e-2)" "unprognostic (1.04e-2)" "unprognostic (7.84e-5)" "unprognostic (2.47e-1)" "unprognostic (2.52e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (4.83e-2)" "unprognostic (4.07e-8)" "unprognostic (1.23e-1)" "unprognostic (1.41e-1)" "unprognostic (3.82e-3)" "unprognostic (3.08e-2)" 1.1 0.1 0.6 7.7 0.9 1.5 0.6 9.2 1.0 0.6 0.6 1.8 0.6 0.3 6.1 0.6 2.3 0.0 5.9 0.6 0.6 3.7 3.4 0.6 0.9 0.6 1.2 0.6 0.6 0.6 0.0 5.3 2.3 2.7 3.7 0.2 0.6 0.6 1.1 0.6 2.5 0.6 0.6 0.6 0.6 2.8 1.4 0.6 0.6 0.6 0.6 0.6 2.3 0.6 0.7 0.3 2.8 0.3 0.8 0.4 0.0 0.7 0.4 0.1 0.3 0.0 0.0 0.1 18.3 20.8 9.7 12.8 0.3 0.4 0.2 0.8 1.6 5.0 0.9 0.1 0.4 13.0 0.7 0.5 0.0 1.1 1.2 1.0 0.0 0.1 0.1 0.4 17.0 0.1 4.1 0.0 0.0 0.1 0.5 1.1 0.5 0.0 0.1 0.3 0.6 1.5 0.0 6.1 0.0 0.1 0.1 0.9 0.6 2.3 0.3 0.4 2.3 0.2 0.1 0.2 5.8 7.0 0.0 65.9 0.3 0.7 0.1 12.5 0.1 2.9 1.4 0.3 0.5 0.3 0.2 0.2 0.7 0.3 0.1 0.1 0.7 0.3 0.4 2.8 0.8 0.1 0.3 0.2 0.0 0.6 0.9 9.2 0.8 0.6 3.7 1.2 0.6 2.7 0.6 0.0 0.3 0.0 0.3 2.9 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.8 0.2 0.0 0.0 2.3 0.8 1.9 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 0.0 0.2 37.7 0.2 1.4 0.0 0.2 0.0 0.4 0.3 0.9 0.5 0.2 0.0 0.2 0.3 IL12A "CLMF, IL-12A, NFSK, NKSF1, p35" ENSG00000168811 "Interleukin 12A" P29459 3 159988750-159996019 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.1" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 8.1;Sertoli cells: 6.5;Spermatogonia: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 5.1" "Group enriched" "Detected in many" 7 "B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 7.5;HDLM-2: 11.4;SK-BR-3: 17.1" "Region enhanced" "Detected in single" "cerebral cortex: 2.7" "Low region specificity" "Detected in some" HPA001886 Uncertain "Secreted to blood" NA NA "HPA001886: AB_1079132" "unprognostic (6.23e-2)" "unprognostic (7.82e-5)" "unprognostic (1.25e-1)" "unprognostic (3.10e-2)" "unprognostic (4.22e-1)" "unprognostic (7.18e-2)" "unprognostic (4.18e-5)" "unprognostic (2.22e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (9.57e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (9.61e-2)" 0.7 1.4 3.4 1.6 6.2 3.3 2.0 2.6 5.6 0.5 1.6 1.0 0.0 1.5 1.2 0.8 10.1 5.7 0.6 1.4 3.1 2.2 1.2 0.6 5.2 2.9 3.2 1.7 1.6 1.1 0.1 1.0 0.4 5.4 0.9 1.3 0.2 2.1 1.1 0.4 0.2 1.5 0.8 2.7 2.8 1.2 0.9 4.1 0.0 0.5 0.5 2.1 0.9 1.1 5.1 0.1 1.3 0.3 0.0 1.6 0.3 2.8 0.3 0.4 2.4 0.0 0.1 0.2 3.1 1.9 3.6 7.5 1.2 0.1 0.0 0.2 0.5 4.2 0.3 0.8 0.5 3.4 11.4 3.9 0.1 0.1 0.8 2.6 0.6 5.3 0.6 0.9 6.4 2.5 2.5 1.2 0.3 0.0 2.0 2.2 0.0 0.1 0.0 0.4 0.1 1.7 2.2 0.0 0.4 0.4 0.2 0.1 1.2 0.0 17.1 0.4 0.6 0.8 1.2 0.8 0.9 0.8 2.1 5.8 1.2 0.0 0.0 1.4 5.2 0.7 0.0 0.1 1.3 0.9 0.3 1.4 1.3 0.4 1.6 0.1 5.1 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.3 3.4 6.2 2.6 5.6 3.1 2.2 3.2 1.7 5.4 4.1 0.0 1.1 1.9 1.1 0.1 0.0 0.2 0.0 8.1 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.5 0.1 0.0 0.0 0.5 1.6 IL12B "CLMF, CLMF2, IL-12B, NKSF, NKSF2" ENSG00000113302 "Interleukin 12B" P29460 5 159314783-159330887 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 10.8" "Cell type enriched" "Detected in single" 60 "monocytes: 11.8" "Cancer enriched" "Detected in single" 20 "testis cancer: 3.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 3.0;NB-4: 2.7;SCLC-21H: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA040970 Supported "Secreted to blood" NA NA 140000 "HPA040970: AB_10796234" "unprognostic (5.96e-5)" "unprognostic (4.59e-5)" "unprognostic (1.05e-1)" "unprognostic (3.40e-1)" "unprognostic (9.13e-4)" "unprognostic (6.89e-2)" "unprognostic (2.58e-4)" "unprognostic (6.69e-3)" "unprognostic (3.83e-2)" "unprognostic (4.50e-2)" "unprognostic (2.53e-1)" "unprognostic (7.15e-3)" "unprognostic (9.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.07e-1)" "unprognostic (1.02e-2)" 0.2 0.2 0.2 0.7 0.2 1.4 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 1.2 0.4 0.2 0.7 0.2 0.2 0.2 0.6 0.3 0.9 1.8 0.2 0.2 0.2 0.2 0.0 2.4 0.2 0.2 0.2 0.6 0.2 0.7 0.2 0.2 1.3 0.5 0.2 0.2 1.8 0.9 0.5 0.2 10.8 0.4 0.2 0.9 0.3 0.2 1.1 0.3 2.9 0.5 1.0 0.2 0.0 0.3 0.4 0.6 0.7 0.1 0.0 0.2 0.5 0.0 0.0 0.5 0.6 0.9 0.5 0.1 0.1 0.2 0.4 0.1 0.1 0.0 0.5 0.9 0.1 1.5 0.2 0.1 0.4 1.1 0.3 0.3 0.1 0.0 0.7 0.1 0.4 0.2 3.0 0.0 0.2 0.5 2.7 0.6 0.1 0.4 0.6 0.8 1.8 0.0 0.2 3.7 0.2 0.3 0.3 0.0 0.8 0.4 0.4 0.4 0.5 0.2 0.2 0.2 0.2 0.1 0.3 0.7 0.5 0.2 1.7 0.5 0.2 0.2 0.1 0.1 1.1 0.2 0.1 0.1 0.3 0.2 0.2 2.9 1.0 0.1 0.3 0.1 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 20 "B-cells: 9.0;Kupffer cells: 10.0;T-cells: 35.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 10.7;HDLM-2: 18.0;Karpas-707: 30.8;U-698: 9.0" "Low region specificity" "Detected in all" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA074414: AB_2686687" "unprognostic (7.70e-3)" "prognostic favorable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 1.9 1.5 1.3 17.5 2.1 5.6 1.2 0.5 1.0 0.9 3.4 2.4 1.1 2.9 1.0 2.4 1.3 1.5 2.5 1.4 1.3 1.2 1.8 1.8 5.0 16.0 2.0 0.2 1.1 1.3 1.2 1.1 2.4 1.4 1.7 2.0 1.1 6.6 0.2 0.9 1.0 8.0 1.0 2.4 21.4 2.3 0.7 2.2 10.1 1.3 0.7 16.9 3.8 1.0 4.9 5.9 6.2 14.0 16.2 28.6 9.0 0.2 0.1 0.1 0.2 0.0 0.1 0.5 0.1 0.1 0.2 0.6 0.2 1.0 10.7 0.1 0.1 0.3 0.2 0.1 0.0 0.0 18.0 0.2 1.2 0.3 0.2 0.4 0.7 1.7 0.0 0.0 0.3 0.1 0.1 0.0 2.4 0.2 30.8 0.0 0.1 5.1 0.2 0.1 0.0 0.1 3.6 0.1 0.5 0.0 0.0 0.3 0.1 0.2 0.2 0.2 0.1 0.2 5.8 0.2 0.3 0.3 0.1 0.1 3.7 5.5 9.0 0.4 6.2 0.7 3.3 5.1 3.6 22.8 14.0 28.6 4.9 15.5 18.3 5.9 3.7 8.7 15.2 6.2 16.2 13.2 3.5 20.5 9.0 1.3 2.1 0.5 1.0 1.3 1.2 2.0 0.2 1.4 2.2 0.0 4.8 9.0 0.6 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.4 0.4 4.6 0.0 5.9 0.0 0.0 0.6 10.0 0.0 0.0 5.8 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.6 0.1 35.2 0.0 1.0 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67396900 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;pancreas: 15.0" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 2.9;Hofbauer cells: 2.9;Melanocytes: 1.7;T-cells: 6.4" "Cancer enhanced" "Detected in many" "melanoma: 5.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 18.2" "Group enriched" "Detected in many" 42 "NK-cells: 18.2;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HMC-1: 4.5;SCLC-21H: 8.9;SK-MEL-30: 22.4;THP-1: 13.0" "Region enhanced" "Detected in single" "olfactory region: 1.8" "Low region specificity" "Detected in all" HPA024168 Uncertain Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 3.8 1.0 1.8 3.1 3.6 1.5 3.7 0.6 7.7 2.4 1.0 0.0 0.0 0.7 0.8 1.1 3.2 0.9 1.1 5.2 9.6 1.1 1.5 1.4 1.8 4.3 1.0 6.0 0.8 15.0 0.9 0.8 14.1 1.6 1.2 0.9 1.3 7.2 1.7 11.4 2.1 1.4 1.0 1.0 2.5 1.0 2.3 0.0 1.1 1.1 3.2 1.6 1.4 1.2 0.0 0.0 0.2 0.0 18.2 6.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 2.1 1.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.4 0.0 0.0 22.4 0.0 0.0 13.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 2.7 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 3.9 1.0 1.8 3.6 0.6 7.7 9.6 1.1 1.0 6.0 1.6 0.0 0.0 2.9 0.0 0.2 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.4 0.0 0.1 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.7" "Group enriched" "Detected in some" 7 "Early spermatids: 74.4;Late spermatids: 141.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "HDLM-2: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 40000 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 3.0 0.0 0.0 0.1 0.0 0.0 1.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 20.7 0.0 2.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 141.6 2.6 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.2 1.2 0.5 0.0 0.0 0.0 0.0 IL13RA2 "CD213a2, CT19, IL-13R, IL13BP" ENSG00000123496 "Interleukin 13 receptor subunit alpha 2" Q14627 X 115003975-115019977 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 16.1;testis: 31.5" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6" "Cancer enhanced" "Detected in many" "glioma: 17.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6" "Region enhanced" "Detected in some" "olfactory region: 8.7" "Low region specificity" "Detected in many" "HPA045831, HPA067363" Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Vesicles" "HPA045831: , HPA067363: " "unprognostic (1.97e-1)" "unprognostic (2.83e-1)" "unprognostic (6.62e-4)" "unprognostic (7.39e-2)" "unprognostic (8.45e-2)" "unprognostic (1.80e-1)" "prognostic favorable (3.55e-4)" "unprognostic (3.54e-1)" "unprognostic (2.85e-1)" "unprognostic (1.92e-2)" "unprognostic (2.20e-3)" "unprognostic (2.19e-2)" "unprognostic (1.53e-5)" "unprognostic (1.58e-1)" "unprognostic (1.63e-1)" "unprognostic (9.70e-3)" "unprognostic (1.20e-1)" 0.5 4.8 3.7 3.9 11.3 0.0 0.8 0.3 3.1 1.2 0.4 2.1 5.7 0.3 0.9 4.4 0.5 0.1 0.8 0.6 5.1 11.2 3.5 9.6 1.0 0.1 1.2 2.6 0.1 0.1 0.5 16.1 2.1 3.9 4.3 0.7 1.6 0.8 3.7 0.0 0.1 0.3 0.4 0.6 0.2 0.1 31.5 1.4 0.0 1.3 0.2 0.2 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.7 0.0 5.9 5.7 0.0 0.0 0.0 0.0 0.0 0.1 2.9 9.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 86.8 58.3 0.0 0.0 0.0 34.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 11.3 0.3 3.1 5.1 11.2 1.2 2.6 3.9 1.4 0.0 0.0 0.0 2.6 0.1 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 253.7 1.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.4 0.0 0.0 4.1 63.3 4.8 36.6 2.6 0.0 0.0 1.0 0.0 0.0 5.5 0.0 4.6 0.0 0.0 0.0 0.2 64.6 2.1 0.0 0.0 0.0 0.0 2.5 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.7;lymphoid tissue: 97.9" "Cell type enhanced" "Detected in many" 14 "B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 40.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8" "Group enriched" "Detected in some" 13 "cerebellum: 61.1;hippocampal formation: 29.7" "Region enriched" "Detected in single" 37 "cerebellum: 96.7" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to blood" Yes NA 208000 14000 "Nuclear speckles" "Plasma membrane, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 8.8 2.4 4.1 48.0 5.8 19.5 7.8 40.1 4.3 4.7 4.8 4.6 0.9 3.8 5.4 2.9 3.4 9.7 5.6 5.1 4.9 2.1 2.5 3.9 14.7 58.0 5.8 2.3 3.7 1.7 0.7 1.4 3.0 6.7 3.5 5.9 3.4 13.5 1.5 1.8 6.1 19.2 3.3 7.8 38.2 5.0 2.2 5.5 97.9 3.7 2.4 54.8 8.7 5.4 43.3 37.1 75.7 35.0 49.3 60.5 66.5 0.0 0.0 0.0 0.0 8.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 13.2 0.0 0.0 0.4 9.3 23.8 0.4 0.0 0.0 0.2 0.0 0.2 1.6 1.4 5.0 0.0 0.0 0.7 9.9 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.1 0.1 0.1 0.1 0.4 0.0 28.3 2.4 11.7 0.8 15.8 0.7 52.7 27.4 75.7 43.1 35.0 48.6 43.3 45.1 47.1 37.1 39.9 60.5 48.6 69.1 49.3 33.7 28.0 47.0 66.5 4.1 5.8 40.1 4.3 4.9 2.1 5.8 2.3 6.7 5.5 3.0 10.0 169.7 0.1 7.2 0.0 1.2 10.2 8.1 3.4 1.8 0.0 0.2 0.0 0.1 1.3 4.9 0.0 70.0 0.2 0.2 6.6 0.1 25.5 2.4 16.6 0.0 0.0 36.2 59.0 0.7 10.0 30.8 27.0 0.0 0.3 0.4 0.0 0.3 17.0 0.3 0.6 6.5 3.7 2.1 4.7 3.1 0.3 92.0 0.0 0.0 IL17A "CTLA8, IL-17, IL-17A, IL17" ENSG00000112115 "Interleukin 17A" Q16552 6 52186387-52190638 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 37 "Karpas-707: 7.3;U-266/84: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052258 Uncertain "Secreted to blood" NA NA 9920 "HPA052258: " "unprognostic (5.55e-1)" "unprognostic (2.18e-4)" "unprognostic (3.05e-4)" "unprognostic (1.41e-2)" "unprognostic (2.22e-2)" 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.0 1.3 0.5 0.6 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 12.2 7.6 4.4 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL17C "CX2, IL-17C, IL-21, MGC126884, MGC138401" ENSG00000124391 "Interleukin 17C" Q9P0M4 16 88638591-88640473 "Predicted secreted proteins" "Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 7.6" "Cell type enriched" "Detected in single" 6 "Exocrine glandular cells: 3.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebellum: 1.2" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Lineage enhanced" "Detected in single" "B-cells: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 3.6;RPMI-8226: 1.6;SCLC-21H: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA065051 Supported "Secreted to blood" NA NA 30500 "HPA065051: AB_2685413" "unprognostic (1.60e-1)" "unprognostic (1.69e-1)" "unprognostic (7.31e-2)" "unprognostic (4.45e-1)" "unprognostic (5.58e-2)" "unprognostic (2.93e-2)" "unprognostic (3.50e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-2)" "unprognostic (3.46e-1)" "unprognostic (1.89e-2)" "unprognostic (3.04e-3)" "unprognostic (2.73e-2)" "unprognostic (7.91e-2)" "unprognostic (3.56e-3)" "unprognostic (8.37e-3)" 0.1 0.0 0.1 0.1 0.6 0.8 0.1 1.2 0.1 1.0 0.1 0.1 0.1 0.0 7.6 0.1 0.8 0.2 1.4 2.3 0.1 0.0 0.1 0.1 3.6 0.2 0.1 0.1 0.1 0.1 0.2 0.3 1.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.9 0.5 0.1 0.1 1.3 0.9 2.0 0.1 0.1 0.1 2.5 0.1 1.2 0.1 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.6 0.0 0.2 0.0 0.1 0.0 0.2 0.0 1.6 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 IL17D "FLJ30846, IL-17D, IL-22, IL-27, IL27" ENSG00000172458 "Interleukin 17D" Q8TAD2 13 20702127-20723098 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 36.1;skeletal muscle: 65.7" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 15.7;Late spermatids: 24.2;Leydig cells: 10.6;Melanocytes: 8.5;Muller glia cells: 18.6" "Group enriched" "Detected in many" 9 "glioma: 10.8;melanoma: 3.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD8 T-cell: 1.0;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 1.0" "Cell line enhanced" "Detected in many" "TIME: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 25000 "unprognostic (1.76e-2)" "unprognostic (2.05e-1)" "unprognostic (1.38e-2)" "unprognostic (2.23e-1)" "unprognostic (4.26e-2)" "unprognostic (3.86e-2)" "unprognostic (5.96e-2)" "unprognostic (1.37e-2)" "unprognostic (4.00e-2)" "unprognostic (3.28e-2)" "unprognostic (1.35e-3)" "unprognostic (1.43e-1)" "unprognostic (1.33e-3)" "unprognostic (1.68e-1)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (5.97e-2)" 2.5 3.2 22.4 1.3 24.6 0.6 2.1 9.5 36.1 3.6 1.9 16.1 0.2 5.6 2.9 1.1 5.5 1.4 3.2 3.9 16.5 13.9 0.8 0.5 3.5 1.0 16.7 9.4 5.3 3.7 0.7 0.6 1.4 11.0 3.1 0.7 2.2 1.8 1.4 65.7 2.0 3.5 1.2 14.6 0.7 1.4 1.9 10.9 0.0 2.5 1.1 0.6 2.6 1.6 0.3 0.0 0.1 0.1 1.9 1.0 0.1 10.7 1.5 2.4 5.2 5.7 3.2 12.5 3.0 0.8 0.3 0.6 5.0 5.9 7.3 0.6 0.3 3.7 5.7 1.0 0.1 0.1 2.6 8.3 0.5 0.5 6.0 0.7 7.9 1.6 4.4 0.1 0.4 0.0 4.7 3.4 10.3 2.9 0.0 2.0 10.4 8.7 6.5 7.3 12.7 1.8 11.6 5.9 0.8 0.1 9.4 14.2 4.6 1.7 2.6 11.8 4.4 6.5 6.8 18.2 1.2 2.1 0.9 3.7 1.3 1.1 1.9 2.8 3.8 5.3 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.2 1.0 0.0 0.2 0.1 0.0 0.1 1.9 0.0 0.0 0.0 0.1 22.4 24.6 9.5 15.2 16.5 13.9 16.7 9.4 11.0 10.9 0.0 0.0 0.0 0.2 2.2 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 15.7 0.4 0.2 0.0 0.2 6.2 2.0 0.1 0.0 0.0 0.3 0.0 0.0 1.8 0.0 24.2 10.6 0.0 8.5 0.0 0.0 18.6 0.3 0.0 1.1 0.0 4.3 0.0 1.4 0.5 0.7 1.8 0.9 0.0 0.2 0.1 IL17F "IL-17F, ML-1, ML1" ENSG00000112116 "Interleukin 17F" Q96PD4 6 52236681-52244537 "Disease related genes, Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 2.2;lymphoid tissue: 6.4;urinary bladder: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 30000 "unprognostic (1.40e-1)" "unprognostic (1.20e-1)" "unprognostic (3.02e-1)" "unprognostic (2.52e-1)" 0.0 0.0 0.1 1.7 0.3 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 6.4 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL17RA "CD217, CDw217, hIL-17R, IL-17RA, IL17R" ENSG00000177663 "Interleukin 17 receptor A" Q96F46 22 17084954-17115694 "CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.0" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 84.8;Macrophages: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 27.6;NB-4: 24.3;THP-1: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB024996 Enhanced Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 20000 "Nucleoplasm, Cytosol" "CAB024996: " "unprognostic (1.92e-1)" "unprognostic (3.15e-1)" "unprognostic (1.65e-2)" "unprognostic (9.83e-2)" "unprognostic (7.66e-2)" "unprognostic (5.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-2)" "unprognostic (1.41e-2)" "unprognostic (8.52e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (1.96e-2)" "prognostic favorable (8.35e-4)" "unprognostic (2.16e-2)" "unprognostic (1.27e-1)" "unprognostic (6.51e-3)" 17.7 7.6 6.5 13.6 13.8 40.5 24.7 4.0 6.7 8.6 8.1 7.7 4.6 6.2 7.4 9.4 6.8 7.8 7.4 8.8 6.1 4.9 8.3 11.6 16.8 39.2 10.3 2.0 7.7 7.7 6.9 5.4 6.2 8.3 6.9 5.7 5.3 7.0 5.3 5.3 8.6 9.1 8.3 11.2 23.4 7.3 5.3 9.7 50.0 7.9 3.2 11.0 6.3 12.8 0.5 3.6 15.6 6.9 1.4 2.4 2.0 3.6 2.1 1.9 2.5 3.9 2.3 2.5 5.5 3.6 2.6 3.3 2.0 2.4 3.3 2.3 5.5 3.4 6.0 2.7 2.6 1.8 5.4 3.2 0.0 1.2 1.3 4.5 27.6 8.6 3.4 3.8 2.3 1.8 2.5 2.7 2.7 1.4 3.5 2.6 3.1 3.3 24.3 1.1 4.7 2.1 0.7 0.4 0.6 2.4 2.7 1.3 0.0 3.8 3.3 2.7 2.3 2.5 35.0 7.5 2.0 2.9 3.0 2.0 2.8 1.5 1.6 2.9 13.4 2.1 6.7 6.9 6.1 1.1 3.2 0.9 0.4 1.5 1.1 3.6 0.5 2.4 1.8 15.6 1.4 2.9 1.7 0.9 2.0 6.5 13.8 4.0 6.7 6.1 4.9 10.3 2.0 8.3 9.7 11.9 13.1 6.7 5.5 7.8 2.0 4.5 15.3 5.3 3.4 5.2 7.9 5.4 0.0 8.0 2.5 9.3 15.1 0.0 10.8 10.6 8.2 8.5 7.0 9.6 29.2 3.2 12.7 20.9 84.8 1.4 8.3 43.1 8.5 3.6 13.1 3.8 10.5 11.8 4.2 3.1 3.2 12.9 9.0 1.4 14.7 5.9 5.4 20.0 10.6 9.3 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846580-53865800 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.0;liver: 26.6" "Group enriched" "Detected in many" 4 "Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002837, HPA005482" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "Mitotic spindle, Centriolar satellite" "HPA002837: , HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 1.1 2.1 13.4 2.2 12.2 0.9 9.2 15.1 14.7 17.1 5.8 6.8 0.0 5.1 5.0 1.3 1.9 3.2 2.4 2.5 17.1 7.4 63.0 26.6 3.5 2.3 11.9 6.4 1.8 5.3 1.4 3.9 1.2 11.2 2.5 6.1 1.9 4.1 1.0 1.4 2.3 5.1 1.2 11.3 1.4 3.4 2.5 15.2 0.0 2.9 0.0 1.0 1.7 1.0 0.9 1.1 4.1 0.6 0.5 3.1 0.5 0.8 1.7 2.5 1.9 0.0 0.0 4.0 1.7 0.0 0.0 0.0 11.1 0.8 2.5 0.6 0.5 0.9 0.4 6.8 0.0 0.0 0.9 1.9 3.3 3.4 32.2 0.0 3.0 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.9 2.6 1.2 0.0 2.2 0.5 1.2 6.8 25.2 1.4 0.9 1.0 2.9 0.7 2.9 3.6 2.1 5.6 1.3 1.0 1.9 5.2 1.1 1.3 1.7 1.9 1.5 2.1 2.6 2.9 1.6 1.5 1.8 0.9 4.1 0.6 0.2 1.0 0.6 0.6 0.5 2.1 0.6 0.2 0.9 0.8 0.9 0.3 0.5 0.2 1.1 3.1 0.5 13.4 12.2 15.1 14.7 17.1 7.4 11.9 6.4 11.2 15.2 0.0 2.6 0.0 2.0 0.2 0.0 3.4 10.2 0.0 2.3 0.0 0.0 0.3 8.3 3.7 0.8 0.0 1.3 0.0 1.3 0.9 0.2 6.7 2.3 8.9 0.1 0.0 28.0 0.6 0.0 0.0 1.1 0.8 0.0 0.0 4.3 4.5 2.7 2.0 0.4 57.9 0.0 0.0 0.6 0.4 1.3 0.1 0.3 0.0 6.6 0.5 IL17RE FLJ23658 ENSG00000163701 "Interleukin 17 receptor E" Q8NFR9 3 9902612-9916402 "Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 71.8;Mucus-secreting cells: 43.2;Paneth cells: 38.6;Undifferentiated cells: 36.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 4 "cerebellum: 19.0" "Group enriched" "Detected in some" 8 "basophil: 3.1;MAIT T-cell: 1.9;memory CD8 T-cell: 2.0" "Group enriched" "Detected in many" 19 "granulocytes: 3.1;T-cells: 2.0" "Cell line enhanced" "Detected in many" "ASC diff: 11.0;ASC TERT1: 27.1;BEWO: 10.1;hTCEpi: 11.1;T-47d: 12.9" "Region enhanced" "Detected in single" "cerebellum: 1.7" HPA019011 Uncertain "Intracellular and membrane" NA NA "HPA019011: AB_1851667" "unprognostic (1.08e-2)" "unprognostic (7.58e-2)" "unprognostic (2.06e-1)" "unprognostic (1.43e-3)" "unprognostic (1.09e-1)" "unprognostic (9.81e-2)" "unprognostic (1.50e-1)" "unprognostic (8.43e-2)" "unprognostic (6.69e-2)" "unprognostic (6.31e-2)" "unprognostic (3.55e-3)" "unprognostic (4.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-2)" 7.6 0.9 0.6 6.9 4.3 0.0 7.8 19.0 0.7 4.5 39.3 0.0 1.9 15.5 2.4 4.0 10.4 1.9 18.3 1.4 0.7 0.8 3.4 1.0 13.5 0.5 0.7 0.1 0.9 12.7 3.6 1.7 4.6 2.5 4.7 10.5 2.6 17.7 3.9 1.0 16.8 55.7 1.2 0.7 1.3 12.4 0.6 0.4 5.1 4.8 6.8 5.3 2.1 4.4 0.0 0.0 3.1 0.0 0.1 2.0 0.0 1.9 0.2 0.0 0.0 11.0 27.1 10.1 1.5 0.9 0.2 0.6 2.0 1.5 0.0 0.5 1.9 0.0 4.5 0.0 4.1 0.0 0.0 0.1 0.5 0.3 4.6 0.3 0.0 2.0 1.9 11.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.5 2.2 0.3 8.1 0.4 5.3 0.4 0.0 0.0 0.0 2.0 2.3 0.5 0.1 0.0 4.3 0.0 0.2 12.9 0.5 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.3 4.9 0.1 3.1 0.0 0.0 0.0 0.0 1.9 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 4.3 19.0 0.7 0.7 0.8 0.7 0.1 2.5 0.4 6.0 0.6 3.0 10.3 12.9 3.0 0.8 15.3 0.0 1.2 15.7 0.0 3.9 6.6 2.7 0.1 1.0 71.8 0.0 4.1 1.1 3.8 9.2 0.0 13.6 2.2 1.6 32.2 1.8 0.0 0.0 2.0 1.4 5.0 0.0 43.2 2.7 2.3 38.6 3.2 5.6 1.0 19.4 6.4 1.0 1.9 12.9 0.7 1.3 36.3 2.7 IL17REL FLJ41993 ENSG00000188263 "Interleukin 17 receptor E like" Q6ZVW7 22 49994513-50012659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.7;stomach 1: 4.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.9;hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.2;SK-BR-3: 3.9" HPA045546 Supported NA NA "HPA045546: AB_10963836" "unprognostic (3.33e-1)" "unprognostic (1.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-1)" "unprognostic (6.33e-2)" "unprognostic (4.65e-4)" "unprognostic (2.72e-2)" "unprognostic (1.01e-3)" "unprognostic (4.45e-2)" "unprognostic (1.52e-1)" "unprognostic (3.94e-1)" "unprognostic (3.02e-2)" "unprognostic (4.60e-4)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (6.31e-3)" "unprognostic (8.31e-2)" 0.1 0.1 0.3 11.7 0.3 0.0 0.1 0.2 1.9 0.3 0.4 0.0 0.0 1.7 0.2 0.9 0.2 0.3 0.0 0.1 0.2 1.4 0.1 0.1 0.8 3.9 0.4 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.5 0.0 2.0 0.0 0.1 0.3 3.3 0.0 0.1 1.9 4.6 0.6 0.0 8.1 0.2 0.6 8.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 3.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.9 0.2 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 160.8;Kupffer cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.5 9.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.1 42.1 0.0 6.1 0.0 0.7 38.5 0.0 29.0 0.0 0.0 0.2 4.0 9.5 2.1 0.9 2.1 7.7 0.0 44.4 0.0 10.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 7.3 25.8 0.0 0.0 0.0 19.0 5.7 0.0 0.0 18.3 12.2 0.1 0.2 7.3 5.8 0.0 0.1 50.0 0.3 8.2 0.1 0.0 0.1 0.0 15.4 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 160.8 35.5 7.5 33.3 109.2 1.7 0.7 22.9 73.6 43.3 8.7 0.0 2.1 68.0 27.4 1.8 2.4 69.7 0.0 126.1 2.6 5.4 10.6 97.2 2.0 69.6 0.0 13.9 6.2 163.5 0.9 0.0 66.1 3.3 30.7 23.3 1.7 111.9 97.0 4.2 13.2 37.2 6.5 2.2 0.6 0.5 97.2 1.5 27.7 45.4 67.4 IL18BP IL18BPa ENSG00000137496 "Interleukin 18 binding protein" O95998 11 71998541-72005715 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 54.3;lymphoid tissue: 71.5" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB025980, HPA041061" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 3070000 14000000 "Endoplasmic reticulum" "CAB025980: , HPA041061: AB_2677280" "unprognostic (2.66e-3)" "unprognostic (2.04e-3)" "unprognostic (9.14e-3)" "unprognostic (1.70e-2)" "unprognostic (5.58e-3)" "unprognostic (7.75e-2)" "unprognostic (1.41e-1)" "unprognostic (6.20e-2)" "unprognostic (1.19e-2)" "unprognostic (1.75e-3)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.93e-6)" "unprognostic (1.19e-1)" "unprognostic (4.14e-2)" "unprognostic (6.76e-2)" "unprognostic (1.93e-2)" 23.7 10.6 6.5 19.7 7.7 6.0 7.2 6.2 5.7 6.3 6.7 6.7 1.0 7.1 6.1 4.1 4.1 5.8 7.2 4.7 3.8 4.1 37.0 54.3 20.8 20.2 7.0 1.9 10.1 4.9 2.8 6.4 28.4 9.0 8.9 9.8 5.3 6.4 4.0 6.2 5.1 9.2 11.4 6.1 71.5 6.1 3.0 6.3 6.1 17.3 3.6 15.6 8.6 6.2 13.6 22.3 22.2 30.5 1.9 23.4 13.9 2.0 2.7 6.2 3.6 1.3 1.9 7.0 3.4 2.0 3.3 4.5 13.2 2.6 1.2 2.7 1.7 3.8 5.1 3.7 2.8 2.6 3.0 4.4 5.2 7.0 3.7 1.4 3.0 12.6 2.9 3.2 3.0 1.6 4.5 6.4 8.1 8.9 2.3 1.8 3.4 3.8 6.5 4.5 2.4 2.5 5.8 6.4 2.1 2.2 5.5 3.3 6.4 3.8 4.3 5.0 6.6 4.3 2.8 13.8 5.4 4.2 6.2 2.1 3.7 2.2 2.5 2.3 11.0 2.6 2.3 8.5 22.2 23.4 30.5 10.5 13.6 12.4 13.8 15.5 7.0 10.4 15.0 3.6 1.9 23.7 22.3 6.1 13.9 6.5 7.7 6.2 5.7 3.8 4.1 7.0 1.9 9.0 6.3 6.0 3.5 5.7 0.4 1.8 3.1 0.8 0.0 2.7 1.2 0.0 9.8 0.7 0.0 1.9 0.0 7.9 0.7 0.0 11.8 0.9 2.3 0.9 7.0 0.5 10.7 3.2 0.0 8.0 7.2 0.0 0.9 11.1 0.0 0.0 0.7 1.6 7.3 0.0 0.7 0.7 3.0 0.0 1.2 0.5 0.4 1.8 0.7 3.2 0.6 0.1 IL18R1 "CD218a, IL-1Rrp, IL1RRP" ENSG00000115604 "Interleukin 18 receptor 1" Q13478 2 102311529-102398775 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.3" "Cell type enriched" "Detected in many" 5 "granulocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 26.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 13.8;HHSteC: 29.8;HMC-1: 20.0;U-937: 32.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA007615 Approved Approved Mitochondria "Intracellular and membrane" Yes No Mitochondria "HPA007615: AB_1851675" "unprognostic (3.60e-3)" "unprognostic (9.75e-3)" "unprognostic (1.12e-3)" "unprognostic (3.01e-2)" "unprognostic (2.34e-3)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.74e-2)" "unprognostic (3.59e-1)" "unprognostic (7.86e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (4.52e-4)" "unprognostic (2.62e-1)" "unprognostic (1.62e-2)" "unprognostic (5.71e-2)" "unprognostic (2.48e-2)" 17.8 2.6 1.4 8.3 1.7 12.5 11.2 0.8 1.3 8.2 8.1 0.7 6.6 5.1 4.2 5.7 4.5 4.5 14.1 10.5 1.7 1.9 7.4 8.8 39.3 29.6 2.0 0.1 3.3 2.6 0.8 4.6 10.7 1.6 6.3 3.4 5.0 3.0 28.4 2.8 3.2 10.7 7.9 1.9 19.5 4.6 2.4 0.4 2.5 3.2 3.2 6.6 8.2 12.9 0.1 6.8 5.5 0.1 26.8 10.6 1.1 0.9 0.3 0.0 0.0 0.7 0.7 1.6 0.0 0.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.5 0.0 1.9 0.0 13.8 0.8 2.5 0.6 0.1 29.8 5.2 20.0 6.8 1.1 2.2 3.6 0.0 5.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.7 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.4 2.4 0.4 0.0 0.0 0.0 0.1 32.0 2.3 5.5 0.0 2.4 4.2 0.1 10.6 0.1 2.4 3.0 2.0 0.1 0.4 0.8 4.1 26.8 0.0 6.8 2.4 1.1 1.4 1.7 0.8 1.3 1.7 1.9 2.0 0.1 1.6 0.4 0.0 13.3 0.0 1.0 0.7 0.0 1.5 0.0 5.3 3.4 1.8 0.0 0.0 1.7 0.8 0.0 7.1 0.0 0.0 0.5 0.7 2.2 0.8 104.4 6.2 0.1 0.0 0.0 13.5 3.1 0.0 0.3 19.4 3.3 0.0 0.0 0.3 0.7 0.0 0.0 0.8 0.0 6.5 0.9 0.2 0.4 0.9 0.0 22.4 0.0 0.7 IL18RAP "AcPL, CD218b" ENSG00000115607 "Interleukin 18 receptor accessory protein" O95256 2 102418689-102452565 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.6;bone marrow: 50.2;lymphoid tissue: 29.8" "Cell type enriched" "Detected in some" 8 "T-cells: 24.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 34.6" "Group enriched" "Detected in many" 108 "granulocytes: 22.5;NK-cells: 34.6;T-cells: 22.1" "Cell line enriched" "Detected in some" 10 "U-937: 34.8" "Not detected" "Not detected" "Not detected" "Not detected" CAB025270 Enhanced NA NA "CAB025270: " "unprognostic (1.73e-3)" "unprognostic (6.27e-3)" "unprognostic (5.07e-3)" "unprognostic (4.64e-6)" "unprognostic (2.90e-1)" "unprognostic (1.18e-2)" "unprognostic (5.86e-5)" "unprognostic (5.09e-3)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (4.78e-2)" "unprognostic (5.31e-2)" "unprognostic (1.51e-2)" "unprognostic (2.71e-1)" "unprognostic (6.35e-2)" "unprognostic (8.56e-2)" "unprognostic (2.73e-2)" 3.6 0.3 0.2 6.1 0.5 50.2 0.9 0.3 0.4 1.2 4.8 0.5 0.0 1.2 1.2 2.1 0.8 3.8 3.0 2.1 0.2 0.2 0.9 2.6 9.6 16.4 0.9 0.0 1.1 0.4 0.0 0.9 0.8 0.2 0.6 0.9 1.5 0.8 0.3 0.6 0.2 8.1 1.0 1.0 29.8 1.5 1.3 0.0 1.3 0.8 0.9 3.5 2.5 1.3 0.0 0.2 22.5 0.0 34.6 22.1 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 1.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.8 0.2 0.0 0.0 6.1 15.7 0.0 22.1 0.0 2.0 4.2 0.1 0.0 0.0 0.5 22.5 34.6 0.0 0.2 0.1 2.0 0.2 0.5 0.3 0.4 0.2 0.2 0.9 0.0 0.2 0.0 3.0 0.6 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 IL19 "IL-10C, IL-19, MDA1, NG.1, ZMDA1" ENSG00000142224 "Interleukin 19" Q9UHD0 1 206798870-206842981 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7" "Cell type enriched" "Detected in single" 4 "Exocrine glandular cells: 1.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 172000 "unprognostic (6.21e-2)" "unprognostic (3.84e-2)" "unprognostic (3.55e-1)" "unprognostic (2.17e-2)" "unprognostic (2.48e-5)" "unprognostic (1.07e-1)" "unprognostic (8.72e-3)" "unprognostic (8.42e-2)" "unprognostic (2.04e-3)" "unprognostic (9.17e-2)" "unprognostic (7.20e-2)" "unprognostic (4.91e-2)" "unprognostic (2.78e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.1 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.3 0.3 0.9 0.8 0.7 0.6 1.4 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 11.8 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.1 0.2 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.4 0.2 0.1 0.2 0.1 0.2 0.7 0.1 0.6 0.1 0.3 0.4 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 IL1A "IL-1A, IL1, IL1-ALPHA, IL1F1" ENSG00000115008 "Interleukin 1 alpha" P01583 2 112773915-112784590 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Cytokine, Mitogen, Pyrogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Early spermatids: 6.2;Late spermatids: 3.2;Macrophages: 4.8;Pancreatic endocrine cells: 2.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 22.3;urothelial cancer: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HBEC3-KT: 86.6;hTCEpi: 42.9;hTERT-HME1: 56.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 10800 "unprognostic (3.41e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.99e-2)" "unprognostic (4.28e-2)" "unprognostic (2.08e-1)" "unprognostic (8.03e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.62e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-3)" "unprognostic (1.22e-1)" "unprognostic (4.30e-3)" "prognostic unfavorable (4.03e-4)" "unprognostic (1.66e-1)" "unprognostic (2.44e-1)" "unprognostic (8.62e-2)" 0.7 0.3 0.7 1.2 1.4 0.8 0.3 0.2 1.2 5.8 0.3 2.3 0.5 0.0 2.6 0.7 17.6 0.3 2.4 0.3 3.1 0.8 0.2 0.2 3.7 0.2 1.2 0.1 0.3 0.2 0.3 0.4 3.1 2.1 0.3 0.1 0.0 1.9 1.2 0.2 1.2 0.3 0.0 1.8 0.5 0.2 10.9 1.2 0.0 0.2 17.9 22.2 5.4 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.1 0.0 10.4 0.0 13.1 0.7 0.0 86.6 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 42.9 0.7 56.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.2 0.9 3.1 0.8 1.2 0.1 2.1 1.2 6.0 1.4 0.0 0.7 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 6.2 0.0 0.0 0.0 0.7 0.1 0.0 0.2 1.1 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 4.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.3 IL1B "IL-1B, IL1-BETA, IL1F2" ENSG00000125538 "Interleukin 1 beta" P01584 2 112829751-112836903 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Cytokine, Mitogen, Pyrogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 62.3;lymphoid tissue: 35.4" "Cell type enriched" "Detected in many" 7 "Macrophages: 764.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "neutrophil: 34.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 34.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 93.2;HBEC3-KT: 42.4;HMC-1: 34.6;hTEC/SVTERT24-B: 46.6;hTERT-RPE1: 40.3;U-87 MG: 85.2" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 2330 "unprognostic (1.55e-3)" "prognostic unfavorable (1.31e-4)" "unprognostic (2.75e-2)" "unprognostic (5.71e-2)" "unprognostic (1.34e-1)" "unprognostic (7.12e-2)" "unprognostic (2.63e-2)" "unprognostic (1.61e-2)" "unprognostic (1.07e-1)" "unprognostic (3.63e-3)" "unprognostic (3.72e-2)" "unprognostic (5.57e-2)" "prognostic unfavorable (7.49e-5)" "unprognostic (1.29e-2)" "unprognostic (4.42e-2)" "unprognostic (5.09e-2)" "unprognostic (4.01e-2)" 19.6 3.3 4.2 20.4 15.3 62.3 0.8 1.1 10.8 1.6 3.2 12.7 0.2 1.2 3.0 1.5 3.5 3.4 7.5 3.7 19.0 3.6 1.7 4.0 17.3 5.0 5.9 0.3 3.4 2.4 2.4 3.0 10.3 24.9 2.6 2.6 1.0 2.2 0.8 0.4 0.9 3.7 3.5 29.7 35.4 20.9 1.6 5.8 0.8 1.1 13.5 14.0 10.4 1.2 0.0 6.9 34.4 7.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 93.2 0.4 1.0 0.0 0.0 0.0 2.6 0.0 1.6 2.1 0.0 42.4 5.8 0.0 0.0 4.1 0.0 0.0 0.3 0.0 34.6 0.1 1.3 46.6 15.7 40.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 3.5 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 85.2 1.9 3.2 0.5 4.2 1.5 0.0 7.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 34.4 0.0 2.7 0.0 0.0 1.0 4.2 15.3 1.1 10.8 19.0 3.6 5.9 0.3 24.9 5.8 8.9 45.3 1.4 4.6 27.4 0.0 4.3 0.0 13.4 7.9 1.8 0.0 1.2 0.0 12.2 0.1 2.2 0.3 0.0 0.5 2.1 9.9 2.3 39.4 0.0 109.6 0.0 0.0 1.3 54.0 0.0 0.0 764.6 21.9 0.0 2.2 0.0 3.6 6.2 0.0 0.5 0.2 0.0 4.3 0.0 0.2 17.8 3.7 2.2 0.0 4.6 IL1F10 "FKSG75, IL-1F10, IL-1HY2, IL1-theta, MGC11983, MGC119832, MGC119833" ENSG00000136697 "Interleukin 1 family member 10" Q8WWZ1 2 113067970-113075850 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 5.9;skin 1: 14.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;GAMG: 2.0" "Not detected" "Not detected" "Secreted to blood" NA NA 222000 "unprognostic (3.89e-1)" "unprognostic (6.25e-2)" "unprognostic (1.48e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL1R2 "CD121b, IL1RB" ENSG00000115590 "Interleukin 1 receptor type 2" P27930 2 101991844-102028544 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.2;lymphoid tissue: 74.1" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 131.3;Kupffer cells: 197.6;Macrophages: 236.7;Mucus-secreting cells: 105.1;Pancreatic endocrine cells: 123.7;Suprabasal keratinocytes: 73.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "midbrain: 9.2" "Cell type enriched" "Detected in some" 25 "neutrophil: 73.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 73.2" "Cell line enriched" "Detected in some" 8 "HDLM-2: 102.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA027597, HPA027598" Uncertain "Secreted to blood" NA NA 7130000 21000000 "HPA027597: AB_10600768, HPA027598: AB_10601229" "unprognostic (3.54e-2)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (3.83e-2)" "unprognostic (6.59e-2)" "unprognostic (1.42e-1)" "unprognostic (6.36e-2)" "unprognostic (4.82e-3)" "unprognostic (1.62e-2)" "unprognostic (7.15e-2)" "unprognostic (8.20e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.58e-12)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "unprognostic (1.77e-1)" "unprognostic (6.62e-2)" 9.1 3.2 1.2 16.4 1.9 22.3 1.6 1.2 1.9 6.4 13.4 0.4 0.1 0.1 1.3 1.3 20.4 9.7 3.4 15.1 1.2 0.5 5.8 8.2 25.5 74.1 9.2 0.2 2.5 1.4 0.0 2.4 24.9 2.2 1.1 20.0 1.8 4.3 0.8 2.8 14.1 2.2 1.3 4.4 47.5 14.6 1.6 1.1 1.6 1.8 8.5 25.1 3.2 9.1 0.0 2.8 73.2 0.8 0.0 1.1 0.2 1.5 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.3 0.0 0.0 0.6 0.0 0.1 0.0 102.2 0.1 0.0 0.0 0.8 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 73.2 0.0 0.0 0.0 1.1 0.2 1.2 1.9 1.2 1.9 1.2 0.5 9.2 0.2 2.2 1.1 6.0 0.6 5.4 8.6 131.3 0.0 0.4 17.8 4.0 0.0 1.8 0.0 0.4 5.0 8.0 2.6 1.9 8.6 0.0 7.3 28.9 9.3 2.5 2.3 14.4 5.9 0.0 6.4 4.3 197.6 1.5 0.3 236.7 30.4 1.0 105.1 0.0 123.7 31.7 0.0 0.4 0.0 6.5 8.9 0.0 1.4 73.4 23.2 1.0 20.4 7.1 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.5;liver: 91.8;placenta: 35.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 100.2;Hepatocytes: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "neutrophil: 36.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 36.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 260000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 3.4 1.7 3.7 5.2 4.5 7.8 2.8 0.8 6.0 2.9 1.8 3.4 0.7 1.1 2.6 1.7 9.1 3.2 5.7 3.3 7.4 2.9 1.9 91.8 6.3 12.6 3.5 2.5 2.2 2.0 1.0 1.4 35.9 5.5 2.1 1.4 1.6 4.7 2.0 1.2 5.8 1.5 3.1 6.3 7.1 2.3 1.0 2.9 2.3 2.2 3.8 3.4 3.3 4.4 0.9 1.4 36.5 2.2 0.1 1.3 0.5 3.9 1.0 1.6 0.2 2.9 2.4 3.1 1.7 3.5 4.1 4.0 1.7 8.8 0.7 18.3 4.8 9.5 10.2 0.9 17.1 5.7 0.7 1.0 0.8 1.7 4.2 6.1 5.8 2.8 3.2 7.0 5.9 18.9 8.6 1.8 1.8 0.1 0.0 1.9 1.8 0.5 2.6 2.6 1.7 1.8 2.8 2.5 1.4 1.5 4.2 0.3 0.0 8.0 4.4 72.7 1.6 2.9 4.2 2.4 3.2 3.2 9.7 7.9 1.5 0.0 0.1 5.4 5.3 18.6 3.5 1.5 8.5 0.7 1.7 1.3 0.9 0.8 0.9 1.4 0.9 0.8 0.5 36.5 0.1 2.2 0.2 0.8 0.5 3.7 4.5 0.8 6.0 7.4 2.9 3.5 2.5 5.5 2.9 0.0 14.3 1.4 14.3 39.8 5.4 4.0 43.3 2.7 20.5 3.5 7.9 3.1 0.0 6.5 2.3 7.1 1.3 0.0 6.4 100.2 7.0 5.6 7.0 172.7 6.9 0.0 5.2 8.0 33.0 0.0 4.0 18.3 8.5 1.0 1.3 0.9 14.8 0.0 2.5 0.8 0.6 0.0 3.1 0.0 0.6 32.5 20.3 2.5 1.2 12.8 IL1RAPL1 "IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2" ENSG00000169306 "Interleukin 1 receptor accessory protein like 1" Q9NZN1 X 28587399-29956723 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Receptor" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 26.7" "Cell type enriched" "Detected in some" 15 "granulocytes: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "GAMG: 14.0;WM-115: 4.1" "Low region specificity" "Detected in all" NA NA "unprognostic (2.51e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (3.75e-3)" "unprognostic (1.17e-1)" "unprognostic (3.98e-1)" "unprognostic (2.25e-2)" "unprognostic (4.45e-2)" "unprognostic (1.29e-1)" "unprognostic (5.85e-2)" "unprognostic (3.95e-2)" "unprognostic (8.02e-2)" "unprognostic (1.08e-2)" "unprognostic (5.74e-4)" "unprognostic (2.29e-1)" "unprognostic (5.22e-2)" "unprognostic (3.58e-3)" 1.5 1.0 12.9 1.0 21.8 0.9 1.5 6.9 17.2 1.2 1.5 15.0 0.0 1.1 1.2 1.5 1.7 1.0 1.5 2.7 10.9 3.3 1.1 1.8 1.1 1.1 21.7 10.1 2.3 1.2 1.0 1.5 1.6 12.3 2.1 1.5 0.0 1.2 2.1 2.2 0.9 1.7 1.2 9.9 0.9 1.4 1.6 26.7 0.0 1.7 0.0 1.0 2.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 14.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 2.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 21.8 6.9 17.2 10.9 3.3 21.7 10.1 12.3 26.7 0.0 0.3 0.0 0.1 0.1 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 26.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.1 0.1 0.0 0.0 0.0 IL1RAPL2 "IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1" ENSG00000189108 "Interleukin 1 receptor accessory protein like 2" Q9NP60 X 104566315-105767829 "Predicted membrane proteins" "Hydrolase, Receptor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.0;parathyroid gland: 8.9" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 1.2;Early spermatids: 1.5;Leydig cells: 5.5;Syncytiotrophoblasts: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.8;hTERT-HME1: 11.0;NTERA-2: 2.0;RT4: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.62e-1)" "unprognostic (1.50e-1)" "unprognostic (1.66e-2)" "unprognostic (3.09e-1)" "unprognostic (1.48e-4)" "unprognostic (9.32e-3)" "unprognostic (1.67e-1)" "unprognostic (6.80e-5)" "unprognostic (1.78e-2)" "unprognostic (2.79e-3)" "unprognostic (5.91e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.84e-2)" 0.2 4.2 1.5 0.0 5.0 0.0 1.2 1.1 8.0 0.4 0.6 0.0 0.8 0.4 0.1 0.2 0.2 0.4 1.9 0.5 0.4 0.8 0.4 2.8 0.1 0.0 1.1 2.2 0.9 0.2 8.9 0.1 1.1 2.2 0.4 0.1 0.0 0.8 1.1 0.1 0.3 0.2 0.4 0.3 0.1 0.4 1.9 0.5 0.0 0.2 0.0 0.1 2.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.7 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.0 1.1 8.0 0.4 0.8 1.1 2.2 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.4 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Cell type enriched" "Detected in many" 11 "granulocytes: 477.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Group enriched" "Detected in some" 6 "HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 19100000 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 3.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.7 0.1 0.1 55.4 0.4 82.4 1.1 0.3 1.3 8.9 0.1 40.2 0.0 0.2 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 8.9 22.8 0.0 15.1 7.6 0.0 1.8 0.0 12.0 13.6 1.8 0.0 0.0 0.0 0.0 0.2 29.2 0.0 0.0 0.4 0.1 4.2 8.9 477.2 0.0 0.0 0.0 0.0 44.2 0.3 0.9 0.9 11.2 3.3 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.2 38.8 5.2 0.0 0.0 4.4 0.0 4.3 0.0 11.1 IL1RL2 "IL1R-rp2, IL1RRP2" ENSG00000115598 "Interleukin 1 receptor like 2" Q9HB29 2 102186973-102240002 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 4.9;Distal tubular cells: 3.3;Suprabasal keratinocytes: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 11.3;ASC TERT1: 7.6;HaCaT: 5.4;HSkMC: 6.3;hTCEpi: 3.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (6.70e-2)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" "unprognostic (2.76e-4)" "unprognostic (3.42e-3)" "unprognostic (2.60e-1)" "unprognostic (3.13e-3)" "unprognostic (6.79e-2)" "unprognostic (9.10e-3)" "unprognostic (9.17e-2)" "unprognostic (4.61e-2)" "unprognostic (2.38e-1)" "unprognostic (1.05e-2)" "unprognostic (8.33e-3)" "unprognostic (3.80e-1)" "unprognostic (1.47e-1)" "unprognostic (7.65e-2)" 1.0 1.8 1.1 0.5 1.1 0.0 2.8 0.5 1.4 1.8 0.7 0.5 6.0 0.0 1.0 2.0 7.4 2.4 2.4 0.7 0.6 0.7 2.3 3.3 0.8 0.5 0.5 0.5 0.5 0.5 6.0 0.5 0.5 1.1 1.3 1.0 0.5 2.9 10.3 0.9 14.4 0.5 0.5 0.5 0.5 1.6 0.5 0.5 0.5 3.7 8.8 4.0 0.9 3.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 2.3 7.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 5.4 0.0 1.2 0.6 0.6 0.0 0.0 1.5 0.0 2.2 0.0 0.0 6.3 3.5 1.7 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.5 1.4 0.6 0.7 0.5 0.5 1.1 0.5 0.0 1.4 0.0 2.4 4.9 0.0 0.3 2.5 0.0 0.0 1.8 0.0 0.1 3.3 0.2 0.1 0.1 0.0 0.0 0.2 0.1 1.2 1.4 0.0 1.5 0.7 0.0 1.2 0.0 1.0 0.0 1.4 2.1 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 4.8 0.1 0.0 0.4 1.6 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Cell line enhanced" "Detected in some" "A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 41.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.1 7.9 0.0 5.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.1 4.0 4.7 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 6.0 10.6 0.5 50.9 163.8 0.0 0.3 12.7 18.7 17.0 3.5 0.0 1.3 0.0 17.2 35.3 2.2 6.5 0.0 25.2 2.5 6.6 30.8 9.3 38.4 319.3 0.0 0.0 3.1 35.8 72.7 0.6 100.5 23.6 1.0 0.6 0.0 89.0 0.0 0.4 0.0 0.0 0.0 6.6 0.7 0.1 294.2 3.8 0.9 2.2 333.6 IL2 "IL-2, TCGF" ENSG00000109471 "Interleukin 2" P60568 4 122451470-122456725 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Cytokine, Growth factor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.9;intestine: 2.4;lymphoid tissue: 1.9" "Group enriched" "Detected in some" 6 "Melanocytes: 3.3;T-cells: 3.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Group enriched" "Detected in some" 19 "JURKAT: 1.7;MOLT-4: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB010310 Uncertain "Secreted to blood" NA NA 20300 "CAB010310: AB_649346" "unprognostic (8.87e-5)" "unprognostic (6.13e-3)" "unprognostic (1.38e-3)" "unprognostic (9.79e-3)" "unprognostic (2.56e-2)" "unprognostic (7.32e-2)" "unprognostic (2.06e-5)" "unprognostic (5.21e-3)" "unprognostic (8.01e-2)" 0.6 0.0 0.0 0.6 0.0 0.4 0.5 0.0 0.0 0.9 0.3 0.5 0.1 0.0 0.8 0.6 0.5 0.0 0.0 0.0 0.2 0.3 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.9 0.1 0.0 0.0 0.4 2.4 0.0 0.2 0.8 0.3 0.0 0.4 1.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.8 0.0 0.0 IL20 "IL-20, IL10D, ZCYTO10" ENSG00000162891 "Interleukin 20" Q9NYY1 1 206865354-206869223 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "seminal vesicle: 19.5" "Cell type enriched" "Detected in some" 7 "Basal keratinocytes: 61.8" "Cancer enhanced" "Detected in some" "breast cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.9;GAMG: 1.6;hTCEpi: 1.0;SiHa: 5.9;SK-MEL-30: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" CAB025802 Uncertain "Secreted to blood" NA NA 109000 "CAB025802: " "unprognostic (3.08e-2)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-2)" "unprognostic (6.45e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.46e-1)" "unprognostic (1.60e-1)" "unprognostic (3.38e-2)" "unprognostic (1.67e-1)" "unprognostic (1.71e-1)" 4.6 2.2 0.2 0.2 0.2 0.0 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.8 0.2 0.4 0.7 1.3 0.2 0.2 0.0 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.3 0.0 0.2 0.6 19.5 0.2 3.8 0.2 3.2 0.2 0.2 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.9 0.0 2.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 5.3 61.8 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.2 8.7 0.0 0.0 0.0 5.8 IL20RA "IL-20R1, ZCYTOR7" ENSG00000016402 "Interleukin 20 receptor subunit alpha" Q9UHF4 6 136999971-137045180 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 28.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 33.5;Muller glia cells: 36.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.4;HaCaT: 6.8;OE19: 9.7;RT4: 11.3;SH-SY5Y: 10.9;T-47d: 10.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB024990, HPA042281" Approved Approved Cytosol NA NA Cytosol "CAB024990: , HPA042281: AB_10806235" "unprognostic (3.75e-2)" "unprognostic (8.23e-2)" "unprognostic (1.96e-2)" "prognostic favorable (1.43e-6)" "unprognostic (1.57e-2)" "prognostic favorable (2.29e-5)" "unprognostic (9.87e-3)" "unprognostic (1.64e-1)" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (8.03e-3)" "unprognostic (2.18e-1)" "unprognostic (1.85e-6)" "unprognostic (9.38e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-3)" "unprognostic (1.64e-3)" 0.6 7.0 2.0 1.6 5.9 0.1 21.2 4.4 2.8 13.9 3.5 4.3 0.6 2.4 5.5 3.7 6.4 13.6 7.9 5.9 3.6 3.0 0.4 0.8 4.7 0.1 3.7 2.3 5.4 16.3 0.2 1.8 0.4 4.6 7.3 3.7 3.5 11.8 7.8 0.5 28.9 1.3 2.9 5.5 0.0 4.9 2.9 3.3 1.0 2.2 3.7 5.6 5.6 9.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 9.4 0.0 0.1 1.4 0.1 6.8 1.2 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 9.7 1.4 0.0 0.4 0.0 0.0 11.3 0.7 10.9 0.5 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.9 4.4 2.8 3.6 3.0 3.7 2.3 4.6 3.3 3.0 18.4 0.0 11.2 19.5 1.7 3.9 25.5 33.5 14.8 3.5 0.0 2.4 0.0 11.1 0.2 0.6 5.2 0.0 0.6 6.6 2.4 18.3 2.3 0.0 0.4 0.0 7.0 0.6 0.0 0.5 8.1 1.7 13.5 0.0 18.4 36.8 8.0 2.9 14.2 0.6 0.7 0.0 1.2 0.2 3.4 15.7 6.9 0.0 13.3 17.1 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 64.5;skin 1: 61.2" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 106.6" "Region enriched" "Detected in single" 9 "cerebellum: 0.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA063914: AB_2732709" "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.6 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 13.2 0.2 0.0 0.0 0.0 1.3 0.3 64.5 0.1 0.1 0.3 0.0 0.0 0.1 2.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.2 2.8 0.0 1.6 0.3 0.4 4.1 0.2 0.4 61.2 0.1 0.1 0.3 0.0 0.1 0.9 0.0 0.5 0.2 22.6 17.1 0.9 19.2 0.1 0.4 0.0 0.3 0.0 0.6 0.0 4.9 0.0 0.0 0.0 3.0 12.9 0.5 0.1 0.3 0.0 0.2 0.4 0.6 0.0 2.8 1.8 0.1 16.0 0.0 26.4 0.1 0.0 0.0 0.0 3.3 0.0 17.8 0.0 0.0 2.2 106.6 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.5 0.8 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 38.8 1.0 0.6 0.0 0.2 1.1 0.8 1.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 24.0 0.3 0.8 3.3 2.8 0.7 0.0 0.8 0.0 0.7 0.1 0.0 0.0 2.3 0.6 1.5 33.2 1.4 0.0 0.5 4.8 IL21 "IL-21, Za11" ENSG00000138684 "Interleukin 21" Q9HBE4 4 122612628-122621069 "Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 16.1" "Cell type enriched" "Detected in some" 7 "Early spermatids: 11.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "memory CD4 T-cell: 2.2;T-reg: 1.0" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Group enriched" "Detected in some" 4 "HeLa: 4.3;Karpas-707: 1.1;SiHa: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 55700 "unprognostic (2.42e-1)" "unprognostic (2.12e-1)" "unprognostic (6.80e-2)" 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 3.5 0.1 7.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402162-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 17.9;lymphoid tissue: 47.8" "Cell type enhanced" "Detected in some" 10 "B-cells: 11.8;Early spermatids: 5.2;Hofbauer cells: 7.0;T-cells: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 10.3;HDLM-2: 43.9;Karpas-707: 20.4;RH-30: 15.4;RPMI-8226: 24.5;U-266/70: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.8 0.6 0.6 33.6 3.7 5.7 0.6 0.5 1.6 0.5 0.9 0.3 0.0 0.5 0.5 1.3 1.0 0.8 1.1 1.8 0.6 2.3 1.6 1.3 5.6 20.9 1.3 0.0 0.5 0.5 0.0 0.9 0.9 1.9 0.9 0.9 1.8 3.7 0.3 0.7 0.7 4.0 0.6 1.7 11.2 1.3 1.0 1.4 47.8 1.3 0.8 31.7 2.7 0.8 11.5 1.6 0.7 17.9 6.3 10.3 4.2 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.0 0.0 0.9 0.0 0.0 10.3 0.1 0.8 0.5 0.0 0.0 0.0 0.0 43.9 0.0 2.1 0.0 0.3 1.4 0.0 0.6 1.6 0.0 2.8 0.0 0.3 0.0 0.2 0.1 20.4 1.5 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.4 24.5 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.5 1.1 0.8 0.3 0.2 0.0 10.3 3.6 2.3 2.1 0.5 0.0 0.2 0.3 0.0 9.8 5.8 3.6 1.0 6.3 10.3 1.6 11.5 6.9 6.7 0.7 6.3 17.9 0.7 7.6 4.2 0.6 3.7 0.5 1.6 0.6 2.3 1.3 0.0 1.9 1.4 0.0 2.2 11.8 0.1 0.3 1.5 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 7.0 0.0 0.0 1.3 4.5 4.0 0.0 2.2 1.7 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.6 0.1 8.2 0.0 0.0 IL22 "IL-21, IL-22, IL-D110, IL-TIF, ILTIF, MGC79382, MGC79384, TIFa, TIFIL-23, zcyto18" ENSG00000127318 "Interleukin 22" Q9GZX6 12 68248242-68253607 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.8;urinary bladder: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTERT-HME1: 1.6" "Not detected" "Not detected" "Secreted to blood" NA NA 86900 "unprognostic (2.57e-1)" "unprognostic (4.24e-2)" 0.2 0.0 0.0 2.8 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.5 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.5 0.8 0.0 0.1 0.0 0.7 0.0 0.6 3.6 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 IL22RA1 "CRF2-9, IL22R" ENSG00000142677 "Interleukin 22 receptor subunit alpha 1" Q8N6P7 1 24119771-24143121 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "pancreas: 123.4" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 31.9;Exocrine glandular cells: 10.6;Mucus-secreting cells: 7.9;Pancreatic endocrine cells: 7.7;Paneth cells: 7.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.9;Hep G2: 7.8;OE19: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.68e-3)" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-3)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (7.63e-2)" "unprognostic (1.72e-3)" "unprognostic (2.28e-1)" "unprognostic (4.78e-3)" "unprognostic (1.05e-2)" "unprognostic (2.57e-1)" "unprognostic (2.63e-1)" "unprognostic (1.64e-2)" 0.2 0.1 0.2 1.1 0.3 0.0 0.8 0.6 0.3 1.2 10.9 0.2 0.5 7.8 0.4 0.6 5.2 0.4 3.2 0.2 0.2 0.0 2.8 2.0 0.4 0.1 0.2 0.1 0.4 123.4 0.0 1.0 0.4 0.4 0.4 3.9 0.2 0.9 0.3 0.2 12.9 22.3 0.1 0.2 0.2 1.2 0.3 0.3 0.1 0.7 4.6 3.6 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.1 2.8 2.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 1.3 1.5 10.9 4.7 0.0 0.9 0.3 4.8 5.0 0.6 2.9 0.5 3.6 0.0 0.0 1.4 7.8 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.1 0.1 18.1 1.0 0.0 0.0 0.1 0.0 0.6 0.1 0.1 1.4 0.0 1.5 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 4.2 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.6 0.3 0.2 0.0 0.2 0.1 0.4 0.3 0.0 0.0 0.0 0.6 0.8 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 31.9 0.0 10.6 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.0 7.7 7.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.7 0.1 IL22RA2 "CRF2-S1, IL-22BP" ENSG00000164485 "Interleukin 22 receptor subunit alpha 2" Q969J5 6 137143820-137173648 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5" "Cell type enriched" "Detected in single" 6 "Syncytiotrophoblasts: 1.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "HL-60: 2.8;U-937: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030582, CAB034906" Uncertain "Secreted to blood" NA NA 40500000 "CAB034906: AB_2124501, HPA030582: AB_10600716" "unprognostic (1.09e-1)" "unprognostic (7.97e-4)" "unprognostic (1.32e-3)" "unprognostic (1.24e-2)" "unprognostic (4.03e-3)" "unprognostic (1.11e-1)" "unprognostic (4.51e-1)" "unprognostic (1.92e-1)" "unprognostic (1.07e-1)" "unprognostic (1.10e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" "unprognostic (1.62e-1)" "unprognostic (6.61e-2)" 0.1 0.0 0.1 2.5 0.1 0.0 6.9 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.2 0.3 0.1 0.0 0.1 0.1 0.1 2.0 0.1 0.1 0.1 0.1 0.0 0.1 11.5 0.1 0.2 0.5 0.1 0.1 0.1 0.1 1.4 1.5 0.1 0.1 1.9 0.3 0.1 0.1 0.1 0.1 0.1 6.2 0.8 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 IL23A "IL-23, IL-23A, IL23P19, P19, SGRF" ENSG00000110944 "Interleukin 23 subunit alpha" Q9NPF7 12 56334174-56340410 "FDA approved drug targets, Predicted secreted proteins" "Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling" Cytokine "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.0;lymphoid tissue: 15.2;testis: 12.1" "Cell type enhanced" "Detected in many" 10 "Ductal cells: 26.3;monocytes: 58.7;Pancreatic endocrine cells: 46.8;Spermatocytes: 41.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "MAIT T-cell: 8.4;memory B-cell: 10.6;memory CD4 T-cell: 15.5;memory CD8 T-cell: 7.4;naive B-cell: 10.6;naive CD4 T-cell: 17.0;naive CD8 T-cell: 10.6;T-reg: 8.4" "Group enriched" "Detected in many" 14 "B-cells: 10.6;T-cells: 17.0" "Cell line enhanced" "Detected in some" "A-431: 9.4;CAPAN-2: 16.5;U-266/70: 27.6;U-266/84: 12.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA001554 Approved Approved Cytosol "Secreted to blood" NA NA 11000 Cytosol "HPA001554: AB_1079135" "unprognostic (2.34e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.06e-1)" "unprognostic (5.24e-2)" "unprognostic (4.01e-3)" "unprognostic (4.40e-1)" "unprognostic (1.43e-3)" "unprognostic (1.30e-1)" "unprognostic (6.79e-2)" "unprognostic (3.38e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-10)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.83e-1)" "unprognostic (4.50e-3)" 0.7 0.5 0.4 3.9 0.5 3.6 0.4 0.3 0.3 0.5 0.6 0.3 0.3 0.0 1.3 0.8 6.0 0.5 2.0 0.3 0.4 0.5 1.3 1.4 1.2 7.5 0.4 0.3 0.3 1.1 0.0 1.1 0.6 0.3 1.0 0.2 0.3 1.8 0.3 0.3 0.8 2.5 1.0 0.4 2.8 0.7 12.1 0.3 12.9 0.6 10.4 15.2 7.4 0.6 10.6 0.5 0.1 0.2 1.0 17.0 5.9 9.4 0.2 0.3 0.3 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.4 16.5 0.5 4.9 0.0 0.5 0.9 0.0 1.6 0.0 0.6 0.3 0.3 0.1 0.7 0.0 0.2 0.6 0.1 0.0 0.0 0.4 2.1 0.0 2.2 0.4 4.1 0.0 0.4 0.3 0.5 1.4 0.2 0.3 0.2 0.1 0.4 5.7 4.7 0.3 0.4 0.2 0.2 0.8 1.4 0.1 4.4 0.3 0.3 0.3 0.3 1.1 27.6 12.4 1.2 0.3 2.4 0.2 0.0 0.2 0.0 1.7 0.0 8.4 10.6 15.5 7.4 0.5 10.6 17.0 10.6 0.1 1.0 0.0 0.0 8.4 5.9 0.4 0.5 0.3 0.3 0.4 0.5 0.4 0.3 0.3 0.3 3.0 2.1 14.5 10.2 3.2 0.0 0.3 0.0 2.7 5.7 1.8 0.0 0.3 1.7 26.3 4.7 0.6 0.3 0.0 6.4 0.3 1.4 5.0 0.0 0.6 2.4 0.0 0.0 0.0 0.0 3.2 0.3 8.1 8.5 58.7 0.0 0.1 46.8 0.0 0.7 0.5 0.1 0.0 1.9 41.1 5.3 3.4 0.0 10.2 0.0 13.9 IL23R IL-23R ENSG00000162594 "Interleukin 23 receptor" Q5VWK5 1 67138907-67259979 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 18.1;lymphoid tissue: 11.0" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 8.3;Intestinal endocrine cells: 2.9;Late spermatids: 5.1;monocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 18.1" "Lineage enriched" "Detected in single" 35 "T-cells: 18.1" "Cell line enhanced" "Detected in some" "HL-60: 2.7;HMC-1: 10.7;K-562: 4.0;U-2197: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056427 Uncertain NA NA "HPA056427: AB_2683129" "unprognostic (4.01e-3)" "unprognostic (8.04e-2)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.16e-3)" "unprognostic (1.57e-1)" "unprognostic (2.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (8.64e-5)" "unprognostic (1.43e-1)" "unprognostic (3.02e-1)" "unprognostic (2.73e-2)" "unprognostic (6.41e-3)" 0.2 4.8 0.2 11.0 0.3 0.0 0.2 0.2 0.2 0.2 2.4 0.2 0.0 0.9 0.3 1.0 0.3 0.2 0.6 0.2 0.2 0.2 0.3 0.5 0.5 4.8 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.2 2.6 0.6 2.3 0.0 0.2 0.2 2.7 0.0 0.2 3.3 1.3 4.1 0.0 1.2 0.2 1.4 7.6 0.9 0.3 0.0 0.0 0.0 0.0 0.5 18.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 2.7 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 16.2 0.0 0.3 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 18.1 0.0 0.5 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 5.1 0.0 0.0 0.0 2.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.2 0.1 IL24 "C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16" ENSG00000162892 "Interleukin 24" Q13007 1 206897443-206904139 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.7;lymphoid tissue: 22.5" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 2.2;Basal keratinocytes: 6.1;Smooth muscle cells: 1.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 18.7;T-cells: 12.0" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 63.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 0.9" CAB025972 Uncertain "Secreted to blood" NA NA 140000 "CAB025972: " "prognostic favorable (5.09e-4)" "unprognostic (3.79e-1)" "unprognostic (2.89e-2)" "unprognostic (4.09e-3)" "unprognostic (3.98e-1)" "unprognostic (2.68e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-2)" "unprognostic (3.98e-1)" "unprognostic (3.35e-2)" "unprognostic (8.04e-2)" "unprognostic (7.63e-2)" "unprognostic (3.43e-4)" "unprognostic (5.41e-2)" "unprognostic (1.29e-1)" "unprognostic (7.91e-2)" "unprognostic (3.33e-2)" 5.3 0.0 0.2 9.2 0.2 1.6 0.2 0.2 0.4 0.2 1.3 0.2 0.2 0.3 0.9 0.7 0.9 1.4 1.7 0.8 0.2 0.0 0.6 2.4 2.5 22.5 0.2 0.2 0.9 0.2 0.0 0.2 1.1 1.3 1.3 0.0 0.2 0.2 0.2 3.9 0.2 1.3 0.2 0.2 19.6 0.9 0.5 0.2 0.4 0.2 0.9 2.7 3.3 0.3 18.7 0.4 0.7 0.0 3.4 12.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.8 0.0 0.1 0.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.9 7.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.6 0.1 5.1 0.2 0.0 0.0 0.0 0.9 0.4 2.8 0.1 3.3 0.2 0.5 0.5 0.0 0.1 0.4 0.0 0.0 4.3 0.0 6.2 18.7 6.8 6.4 0.0 18.6 11.8 6.5 0.7 3.4 0.0 0.4 12.0 3.6 0.2 0.2 0.2 0.4 0.2 0.0 0.2 0.2 1.3 0.2 0.0 2.2 0.8 1.3 6.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.1 0.0 0.0 0.0 0.5 IL25 "IL-17E, IL-25, IL17E" ENSG00000166090 "Interleukin 25" Q9H293 14 23372809-23376403 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2.2;testis: 2.3" "Cell type enriched" "Detected in single" 40 "Cardiomyocytes: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB024864 Uncertain "Secreted to blood" NA NA 4230000 "CAB024864: " "unprognostic (1.49e-1)" "unprognostic (6.82e-2)" 0.5 0.2 0.4 0.3 0.6 0.0 0.6 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.5 0.3 0.0 0.0 0.0 1.4 0.3 0.1 0.0 0.5 0.0 0.0 0.8 0.0 0.3 0.5 0.8 1.0 0.2 0.7 0.5 0.5 0.0 2.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 IL26 "AK155, IL-26" ENSG00000111536 "Interleukin 26" Q9NPH9 12 68201351-68225821 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1" "Lineage enriched" "Detected in single" 10 "T-cells: 2.2" "Cell line enriched" "Detected in some" 5 "HDLM-2: 17.1" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 35700 "unprognostic (2.71e-1)" "unprognostic (8.87e-2)" "unprognostic (3.26e-5)" "unprognostic (7.10e-2)" "unprognostic (5.90e-2)" "unprognostic (2.96e-1)" "unprognostic (3.69e-5)" "unprognostic (3.80e-1)" "unprognostic (5.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.79e-2)" 0.1 0.0 0.5 6.0 0.2 0.0 0.0 0.7 0.1 0.1 1.0 0.0 0.0 0.2 0.0 0.0 1.4 0.1 0.5 0.3 1.0 0.2 0.1 0.1 0.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 2.3 0.0 0.0 0.5 1.4 0.0 0.1 1.1 0.3 0.3 0.0 0.5 0.1 5.4 3.5 4.4 0.3 0.2 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.2 1.5 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 0.5 0.2 0.7 0.1 1.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 IL27 "IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28" ENSG00000197272 "Interleukin 27" Q8NEV9 16 28499362-28512051 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antiviral protein, Cytokine" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.3;brain: 6.5;liver: 21.2" "Group enriched" "Detected in some" 5 "Hepatocytes: 17.1;Syncytiotrophoblasts: 19.3" "Cancer enriched" "Detected in some" 8 "liver cancer: 4.3" "Region enhanced" "Detected in many" "hippocampal formation: 6.5" "Cell type enhanced" "Detected in many" "classical monocyte: 6.2;intermediate monocyte: 6.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "BEWO: 20.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB024722 Approved "Secreted to blood" NA NA 521000 "CAB024722: " "unprognostic (4.79e-3)" "unprognostic (2.66e-3)" "unprognostic (4.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.09e-1)" "unprognostic (6.55e-3)" "prognostic favorable (1.30e-4)" "unprognostic (3.76e-2)" "unprognostic (8.23e-3)" "unprognostic (1.29e-2)" "unprognostic (6.07e-3)" "unprognostic (4.57e-2)" "unprognostic (2.41e-7)" "unprognostic (6.44e-2)" "unprognostic (1.04e-3)" "unprognostic (2.13e-1)" "unprognostic (2.83e-2)" 0.8 0.2 0.1 1.4 0.9 0.9 0.1 0.1 1.0 0.2 0.2 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.1 6.5 0.1 0.1 21.2 0.6 0.4 0.2 0.0 0.0 0.1 0.0 0.1 0.8 2.2 0.2 0.0 0.4 0.1 0.0 0.6 0.1 0.1 0.2 1.4 2.9 0.1 0.5 1.2 1.9 0.4 0.0 0.0 0.2 0.0 0.3 1.1 3.5 6.3 2.7 0.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 6.2 1.3 0.1 6.3 0.2 0.3 0.0 0.1 1.1 0.0 0.0 0.0 3.5 2.7 0.2 0.0 0.4 1.5 0.1 0.9 0.1 1.0 6.5 0.1 0.2 0.0 2.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 17.1 0.8 0.0 0.0 0.0 3.7 0.0 0.0 1.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031748-14053216 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 25.2;lymphoid tissue: 32.3" "Cell type enhanced" "Detected in many" 9 "B-cells: 31.8;Kupffer cells: 33.3;T-cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles NA NA 4100000 Vesicles "HPA073441: " "prognostic favorable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 8.4 2.1 2.8 26.0 2.7 3.5 20.6 3.0 3.5 3.5 3.9 1.1 2.7 3.6 3.6 2.0 3.4 4.2 4.1 5.8 3.8 3.6 4.8 2.1 11.8 25.3 2.6 2.3 2.3 3.5 8.1 1.1 2.0 2.5 5.0 3.4 1.2 7.4 2.1 2.8 2.6 9.0 3.0 2.5 18.0 4.1 2.4 1.6 32.3 4.9 2.2 28.3 6.0 6.8 14.6 18.2 5.3 19.7 19.1 25.2 16.9 8.3 3.6 3.7 4.9 0.3 1.9 1.5 3.9 8.2 7.2 10.4 1.7 6.8 0.1 4.2 3.5 3.3 1.6 5.7 2.3 5.6 16.0 3.9 20.3 0.8 3.0 0.6 9.7 0.3 1.9 0.9 3.4 0.7 5.8 2.8 5.1 14.0 15.2 0.3 11.7 7.2 21.1 4.8 5.0 2.5 6.4 2.1 7.7 4.4 2.0 3.2 1.7 5.0 0.3 5.7 2.0 6.4 6.0 4.5 0.7 9.0 7.3 4.2 15.8 7.6 7.4 0.7 19.8 4.7 5.3 19.7 0.5 22.9 16.3 20.2 14.6 22.7 18.9 18.2 12.8 25.2 19.4 1.5 19.1 7.5 6.8 19.9 16.9 2.8 2.7 3.0 3.5 3.8 3.6 2.6 2.3 2.5 1.6 0.0 10.6 31.8 10.6 1.6 0.0 1.2 5.1 0.0 7.9 3.5 0.0 0.5 0.0 9.0 0.3 16.3 0.0 0.0 2.3 1.6 3.0 6.3 17.3 0.8 20.7 1.6 2.4 20.9 33.3 0.0 3.1 26.0 5.0 4.6 0.9 0.2 4.1 0.0 3.2 0.7 0.0 0.0 1.7 0.1 13.4 1.1 0.1 61.2 1.1 3.1 IL2RA "CD25, IDDM10, IL2R" ENSG00000134460 "Interleukin 2 receptor subunit alpha" P01589 10 6010689-6062370 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 16.5;blood: 55.4;lymphoid tissue: 56.7" "Cell type enriched" "Detected in some" 4 "monocytes: 309.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 2.4" "Group enriched" "Detected in many" 6 "basophil: 30.3;T-reg: 55.4" "Group enriched" "Detected in many" 12 "granulocytes: 30.3;T-cells: 55.4" "Cell line enriched" "Detected in some" 59 "HDLM-2: 157.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002419, HPA054622" Enhanced NA NA 110000 "CAB002419: AB_563538, HPA054622: AB_2682546" "unprognostic (2.82e-1)" "unprognostic (8.10e-3)" "unprognostic (1.75e-2)" "unprognostic (5.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-3)" "unprognostic (2.78e-2)" "unprognostic (2.73e-1)" "unprognostic (5.03e-2)" "unprognostic (6.32e-2)" "unprognostic (7.21e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.08e-9)" "unprognostic (2.10e-2)" "unprognostic (4.66e-2)" "unprognostic (2.22e-1)" "unprognostic (5.10e-2)" 16.5 2.5 0.3 10.9 0.6 0.1 1.4 0.3 0.3 0.6 3.1 0.1 0.0 1.3 0.8 4.9 1.9 0.8 2.2 1.9 0.4 0.5 2.6 1.3 4.0 50.4 0.5 0.0 0.6 1.0 0.0 1.8 1.8 2.4 1.1 1.6 3.4 2.2 0.5 0.8 0.6 10.3 3.5 2.2 56.7 1.4 0.4 0.0 4.5 4.2 2.0 16.8 5.0 0.6 3.6 0.0 30.3 0.0 2.9 55.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 30.3 0.0 4.5 0.1 0.0 0.5 3.6 6.8 0.7 0.0 1.5 0.5 0.0 0.2 2.9 0.0 0.0 55.4 0.7 0.3 0.6 0.3 0.3 0.4 0.5 0.5 0.0 2.4 0.0 0.0 2.6 7.5 0.1 0.8 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 74.4 0.0 0.3 0.0 0.0 0.6 5.6 0.0 0.0 3.7 3.3 309.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.0 7.7 0.0 0.1 IL2RB "CD122, IL15RB" ENSG00000100385 "Interleukin 2 receptor subunit beta" P14784 22 37125838-37175054 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5" "Group enriched" "Detected in many" 8 "Extravillous trophoblasts: 80.1;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 14.7;NK-cell: 51.6" "Group enriched" "Detected in many" 32 "NK-cells: 51.6;T-cells: 14.7" "Cell line enriched" "Detected in some" 8 "HDLM-2: 106.6" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Low region specificity" "Detected in single" HPA062657 Enhanced NA NA "HPA062657: AB_2684822" "unprognostic (3.38e-3)" "unprognostic (1.21e-2)" "prognostic favorable (6.76e-4)" "prognostic favorable (3.18e-5)" "unprognostic (2.44e-2)" "unprognostic (9.69e-3)" "unprognostic (2.60e-1)" "unprognostic (5.22e-2)" "unprognostic (1.03e-3)" "unprognostic (5.37e-2)" "unprognostic (1.09e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (4.63e-2)" "unprognostic (7.96e-2)" "unprognostic (3.94e-3)" "unprognostic (2.46e-2)" 2.2 1.0 0.8 20.5 0.8 12.3 1.6 0.6 0.7 1.3 5.5 0.6 1.4 1.8 4.3 2.8 2.6 1.8 5.8 3.7 0.7 0.8 1.9 6.0 7.4 20.8 0.8 0.2 1.5 1.0 0.0 1.1 58.5 0.7 3.5 1.8 2.9 3.7 2.1 0.9 4.0 7.3 0.6 1.1 35.0 2.3 1.1 0.2 21.0 2.1 1.8 28.7 4.0 1.5 0.3 0.0 1.0 0.1 51.6 14.7 7.9 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.1 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 2.8 0.0 0.1 7.7 13.2 0.0 0.1 0.0 0.1 1.0 0.0 0.1 14.7 0.1 8.1 0.1 3.3 8.2 0.0 0.3 1.1 4.3 0.3 51.6 0.1 0.0 6.8 7.9 0.8 0.8 0.6 0.7 0.7 0.8 0.8 0.2 0.7 0.2 3.0 11.6 1.5 0.8 2.9 0.0 1.1 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.2 80.1 1.1 0.1 9.3 1.0 2.1 0.0 0.0 8.6 1.6 0.9 0.3 0.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.0 97.0 0.0 0.0 IL2RG "CD132, CIDX, IMD4, SCIDX1" ENSG00000147168 "Interleukin 2 receptor subunit gamma" P31785 X 71107404-71112108 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 115.3;lymphoid tissue: 169.3" "Cell type enhanced" "Detected in many" 12 "B-cells: 121.6;Enterocytes: 82.5;monocytes: 130.8;T-cells: 235.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "Karpas-707: 225.6" "HPA046641, HPA049691" Enhanced Approved Vesicles NA NA Vesicles "HPA046641: AB_2679733, HPA049691: AB_2680851" "unprognostic (2.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.73e-4)" "unprognostic (8.25e-2)" "unprognostic (1.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.91e-3)" "unprognostic (1.23e-2)" "unprognostic (4.36e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.28e-7)" "unprognostic (1.73e-1)" "unprognostic (4.69e-2)" "unprognostic (4.89e-2)" "unprognostic (9.54e-2)" 5.8 1.3 1.4 39.5 1.4 12.8 3.6 0.8 0.9 2.9 16.6 0.9 0.9 8.2 3.0 2.1 5.3 3.1 5.3 2.6 1.4 1.5 3.7 4.7 13.6 70.4 1.8 0.6 2.9 1.5 0.0 1.2 5.3 1.5 3.2 20.8 2.9 10.4 1.8 1.6 2.7 28.6 1.5 2.9 58.7 6.0 2.0 0.9 169.3 3.3 4.2 61.4 7.6 3.1 51.9 30.6 65.6 19.7 94.6 115.3 99.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 17.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 14.8 0.0 2.3 0.0 0.0 0.0 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 21.0 3.9 225.6 0.0 0.0 32.6 17.8 0.0 0.0 0.0 7.5 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 12.9 22.7 11.3 0.2 37.8 0.0 35.2 8.5 13.4 107.2 19.7 105.6 51.9 97.7 110.4 20.3 51.6 68.0 84.9 65.6 94.6 13.5 30.6 115.3 99.0 1.4 1.4 0.8 0.9 1.4 1.5 1.8 0.6 1.5 0.9 3.0 15.7 121.6 6.6 7.2 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 1.0 0.0 4.5 82.5 0.0 2.0 0.2 3.3 3.6 38.1 1.5 32.3 0.0 74.7 6.7 21.7 0.0 0.0 41.4 40.5 130.8 19.5 0.0 16.5 58.8 0.4 1.1 0.2 0.0 4.1 0.0 0.0 5.9 0.2 235.1 18.0 6.8 IL3 "IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF" ENSG00000164399 "Interleukin 3" P08700 5 132060529-132063204 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8;lymphoid tissue: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "HMC-1: 7.6" "Secreted to blood" NA NA 17800 "unprognostic (9.74e-2)" 0.1 0.1 0.0 0.3 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.9 0.0 2.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL31 IL-31 ENSG00000204671 "Interleukin 31" Q6EBC2 12 122172030-122174199 "Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "HDLM-2: 1.3;Karpas-707: 2.5" CAB025657 Uncertain "Secreted to blood" NA NA 37800 "CAB025657: " "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 IL31RA "CRL, CRL3, GLM-R, Glmr, IL-31RA" ENSG00000164509 "Interleukin 31 receptor A" Q8NI17 5 55851379-55922853 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Immunity Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;tongue: 6.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 1.8;Spermatocytes: 2.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 6 "amygdala: 10.3" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;myeloid DC: 1.2" "Group enriched" "Detected in many" 8 "dendritic cells: 1.2;monocytes: 2.2" "Cell line enhanced" "Detected in some" "GAMG: 25.6;HBEC3-KT: 7.8;hTERT-HME1: 9.4;U-2 OS: 13.9;U-87 MG: 16.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.5;hippocampal formation: 1.1" "HPA051532, HPA068114" Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA051532: , HPA068114: AB_2732779" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.13e-2)" "unprognostic (2.70e-2)" "unprognostic (2.95e-3)" "unprognostic (7.34e-2)" "unprognostic (3.54e-1)" "unprognostic (5.38e-2)" "unprognostic (2.95e-3)" "unprognostic (7.75e-5)" "unprognostic (5.55e-2)" "unprognostic (2.65e-6)" "unprognostic (7.73e-2)" "unprognostic (7.68e-2)" "unprognostic (4.02e-1)" "unprognostic (1.76e-2)" 0.3 0.1 10.3 1.0 0.1 5.3 0.2 0.1 0.4 0.2 1.5 0.0 0.0 0.4 1.2 1.8 1.7 0.1 0.2 0.4 1.6 0.2 0.3 0.3 0.5 0.1 0.1 0.0 0.5 0.7 0.0 0.7 0.7 0.0 1.0 0.4 0.4 1.3 0.2 2.6 2.5 0.8 1.8 0.1 0.3 0.5 5.9 0.0 1.4 0.5 6.4 0.5 0.5 2.2 0.0 1.2 0.2 2.2 0.0 0.1 0.4 0.0 1.0 0.0 0.0 0.0 0.4 0.4 0.1 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.2 25.6 0.0 0.0 7.8 1.6 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 5.2 2.6 3.7 9.4 0.4 2.9 0.0 0.0 0.3 1.2 0.0 0.0 1.2 0.0 0.0 5.2 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 1.3 0.4 13.9 0.0 0.8 0.0 0.0 0.0 16.1 0.0 2.2 0.1 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 10.3 0.1 0.1 0.4 1.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.9 0.0 0.0 0.0 IL32 "NK4, TAIF, TAIFb, TAIFd" ENSG00000008517 "Interleukin 32" P24001 16 3065297-3082192 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 216.2;liver: 316.2;pancreas: 196.4" "Cell type enhanced" "Detected in many" 12 "Ductal cells: 1462.7;Enterocytes: 1496.0;Exocrine glandular cells: 1263.1;Pancreatic endocrine cells: 3369.3;Proximal tubular cells: 2476.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 216.2" "Lineage enriched" "Detected in many" 9 "T-cells: 216.2" "Cell line enhanced" "Detected in many" "CACO-2: 67.9;CAPAN-2: 46.0;HDLM-2: 96.7;Hep G2: 65.8;Karpas-707: 57.9;MOLT-4: 43.0;RH-30: 49.4;U-937: 42.8" "HPA029397, CAB030029" Uncertain "Secreted to blood" NA NA 46100 "CAB030029: AB_1089175, HPA029397: AB_10612120" "unprognostic (2.00e-2)" "unprognostic (2.89e-2)" "unprognostic (2.86e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.95e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (2.58e-2)" "unprognostic (1.73e-3)" "unprognostic (2.19e-2)" "unprognostic (3.32e-3)" "unprognostic (3.51e-1)" "unprognostic (3.30e-2)" "unprognostic (8.08e-2)" "unprognostic (3.86e-2)" "unprognostic (3.16e-2)" "unprognostic (4.29e-3)" 18.8 6.1 2.7 45.3 3.3 3.9 16.7 1.4 1.9 4.5 46.5 2.2 4.7 36.3 6.3 10.9 7.7 3.1 18.3 21.5 2.4 2.5 78.1 316.2 42.8 43.3 3.5 1.9 6.7 196.4 0.0 3.3 8.3 3.1 9.5 15.6 4.0 23.5 4.1 51.4 3.5 149.0 8.7 3.9 73.8 8.1 4.6 1.5 48.8 21.3 113.6 40.3 10.5 11.2 0.4 0.6 2.3 0.5 24.7 216.2 88.7 34.5 1.5 0.1 0.0 0.0 4.0 2.8 1.6 4.3 2.1 3.5 67.9 46.0 0.0 8.5 1.0 13.1 1.5 0.1 4.1 2.6 96.7 0.3 0.1 6.9 65.8 7.9 0.1 2.9 4.8 0.5 1.8 7.7 1.7 8.2 1.1 0.0 57.9 2.7 0.2 43.0 1.0 1.0 0.4 1.0 0.1 49.4 4.5 32.8 2.2 0.1 0.5 15.3 1.0 0.2 7.5 0.9 0.5 22.3 8.1 9.5 0.4 4.9 0.6 1.4 0.2 0.1 42.8 4.2 1.1 0.5 0.5 134.0 0.4 132.1 0.4 122.1 126.9 0.4 0.4 47.6 89.8 2.3 24.7 0.4 0.6 216.2 88.7 2.7 3.3 1.4 1.9 2.4 2.5 3.5 1.9 3.1 1.5 184.6 95.2 38.9 79.1 52.9 0.0 2.4 257.4 12.0 22.7 113.4 0.0 1.4 213.9 1462.7 0.2 120.5 1496.0 23.3 1263.1 8.0 41.1 84.6 51.9 80.5 3.7 0.0 129.8 68.2 41.3 1.1 32.5 49.5 62.4 345.4 194.0 0.0 3369.3 645.3 43.2 2476.2 0.5 19.4 101.0 0.7 0.8 45.0 5.5 783.6 79.7 80.6 IL34 "C16orf77, IL-34, MGC34647" ENSG00000157368 "Interleukin 34" Q6ZMJ4 16 70579895-70660682 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 65.1;skin 1: 31.9" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 17.0;Muller glia cells: 14.3;Peritubular cells: 38.2;Sertoli cells: 19.4;Suprabasal keratinocytes: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 12 "eosinophil: 15.9" "Lineage enriched" "Detected in single" 160 "granulocytes: 15.9" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.8;BJ hTERT+: 3.3;Hep G2: 4.5;HSkMC: 4.3;NTERA-2: 9.5;U-138 MG: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 57100 "unprognostic (3.76e-3)" "prognostic favorable (7.41e-4)" "unprognostic (5.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.27e-2)" "prognostic favorable (9.69e-4)" "unprognostic (8.19e-2)" "unprognostic (1.59e-3)" "unprognostic (3.83e-2)" "unprognostic (6.11e-3)" "unprognostic (3.18e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.52e-8)" "unprognostic (6.47e-3)" "unprognostic (4.58e-2)" "unprognostic (5.83e-2)" "unprognostic (4.37e-2)" 3.3 10.8 13.4 3.3 13.1 0.6 5.3 5.4 17.7 3.8 2.7 2.7 2.7 4.6 2.2 1.8 10.1 2.8 4.9 3.4 8.6 6.6 2.6 1.6 7.6 5.6 3.9 9.5 1.6 1.5 1.5 5.5 0.9 4.8 2.6 2.2 9.8 6.7 3.4 3.4 31.9 5.1 2.3 1.7 65.1 1.9 2.7 3.0 0.3 2.3 5.0 4.3 3.7 6.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.4 3.8 0.4 0.3 3.3 0.4 0.3 0.7 0.1 0.0 0.5 0.5 0.2 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.0 4.5 1.6 0.0 2.8 4.3 0.2 0.4 0.0 0.4 0.9 0.1 0.0 0.0 1.1 0.0 0.1 0.1 9.5 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.3 0.8 0.2 0.3 0.1 0.5 0.0 0.0 0.0 6.3 0.3 0.3 0.4 0.4 0.0 0.0 0.8 1.9 0.1 1.3 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 13.1 5.4 17.7 8.6 6.6 3.9 9.5 4.8 3.0 0.0 2.6 0.0 1.7 7.3 0.8 0.4 2.5 0.0 0.0 0.0 3.9 0.1 0.0 5.9 0.1 1.2 0.0 0.0 1.9 0.7 5.7 1.7 0.0 0.0 2.9 4.8 0.0 4.9 0.0 0.0 17.0 0.3 11.8 0.0 0.0 14.3 0.6 0.0 38.2 0.3 0.5 19.4 2.3 0.0 0.4 17.9 0.7 0.0 0.2 1.8 IL36A "FIL1, FIL1E, IL-1F6, IL1(EPSILON), IL1F6, MGC129552, MGC129553" ENSG00000136694 "Interleukin 36 alpha" Q9UHA7 2 113005461-113008044 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "esophagus: 106.0;lymphoid tissue: 87.9;tongue: 90.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 8.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.7" "Lineage enriched" "Detected in single" 15 "T-cells: 2.7" "Group enriched" "Detected in some" 5 "JURKAT: 4.0;MOLT-4: 3.9;REH: 1.5;U-266/70: 4.2" "Not detected" "Not detected" "Secreted to blood" NA NA 327000 "unprognostic (1.37e-1)" "unprognostic (9.66e-3)" "unprognostic (5.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 106.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.7 87.9 0.0 4.8 0.0 0.0 0.0 0.0 0.1 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.2 0.3 0.6 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 1.1 0.0 0.1 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL36B "FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882" ENSG00000136696 "Interleukin 36 beta" Q9NZH7 2 113022091-113052867 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 3.6;lymphoid tissue: 6.3;skin 1: 11.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "GAMG: 34.4;U-87 MG: 35.3" HPA035664 Uncertain "Secreted to blood" NA NA 15300 "HPA035664: AB_10669672" "unprognostic (8.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.56e-2)" "unprognostic (1.06e-1)" "unprognostic (3.77e-2)" "unprognostic (2.40e-3)" "unprognostic (2.05e-1)" "unprognostic (7.10e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL36G "IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1" ENSG00000136688 "Interleukin 36 gamma" Q9NZH8 2 112973203-112985665 "Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 31.5;skin 1: 22.1;tongue: 94.1" "Group enriched" "Detected in some" 6 "Suprabasal keratinocytes: 11.5;Urothelial cells: 6.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 36.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;GAMG: 3.7;HaCaT: 3.1;HMC-1: 3.2;hTERT-RPE1: 2.9" "Secreted to blood" NA NA "unprognostic (1.56e-2)" "unprognostic (2.88e-1)" "unprognostic (7.27e-2)" "unprognostic (3.15e-2)" "unprognostic (4.91e-2)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (3.68e-1)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (5.79e-2)" "unprognostic (5.58e-2)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 10.9 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 2.8 0.1 0.1 22.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 94.1 31.5 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 2.3 0.0 0.0 0.0 0.7 0.0 1.7 0.1 1.2 0.0 0.0 0.0 0.7 0.0 3.7 3.1 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.3 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.5 0.4 0.0 1.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.5 0.0 0.0 0.0 6.7 IL36RN "FIL1, FIL1(DELTA), FIL1D, IL-1F5, IL1F5, IL1HY1, IL1L1, IL1RP3, IL36RA, MGC29840" ENSG00000136695 "Interleukin 36 receptor antagonist" Q9UBH0 2 113058638-113065382 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" Cytokine "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 26.7;skin 1: 31.9;tongue: 68.9" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 7.8;Syncytiotrophoblasts: 3.2" "Cancer enriched" "Detected in some" 7 "head and neck cancer: 25.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "BEWO: 21.5;GAMG: 9.1;U-87 MG: 16.6" "Not detected" "Not detected" "Secreted to blood" NA NA 107000 "unprognostic (3.88e-3)" "unprognostic (3.16e-1)" "unprognostic (2.88e-1)" "unprognostic (4.29e-1)" "unprognostic (8.68e-3)" "unprognostic (9.80e-2)" "unprognostic (2.48e-1)" "unprognostic (5.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.39e-1)" "unprognostic (3.99e-2)" "unprognostic (5.37e-2)" "unprognostic (3.85e-3)" "unprognostic (4.23e-3)" 0.1 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.4 0.1 0.0 0.0 0.0 2.3 0.0 0.0 31.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 68.9 26.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 9.1 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 3.2 0.0 0.0 0.1 IL37 "FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7" ENSG00000125571 "Interleukin 37" Q9NZH6 2 112912971-112918882 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 55.0" "Cell type enhanced" "Detected in single" 22 "Suprabasal keratinocytes: 2.5" "Cancer enriched" "Detected in some" 6 "lung cancer: 6.5" "Cell type enriched" "Detected in single" 28 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 28 "NK-cells: 2.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.9;PC-3: 10.6;RT4: 5.7" "HPA054371, HPA057950" Uncertain Supported Nucleoplasm,Vesicles "Secreted to blood" NA NA 76700 "Nucleoplasm, Vesicles" "HPA054371: AB_2682465, HPA057950: AB_2683561" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" "unprognostic (3.71e-5)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.09e-2)" "unprognostic (1.28e-2)" "unprognostic (9.54e-2)" "unprognostic (8.26e-3)" "unprognostic (3.95e-2)" "unprognostic (1.66e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.9 0.0 0.8 0.1 0.0 0.0 0.2 0.4 4.9 0.3 0.5 0.5 0.6 0.0 0.5 0.3 0.5 0.1 0.2 0.8 1.5 0.3 0.0 1.8 0.2 0.8 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.4 0.0 0.1 0.0 0.1 1.1 0.0 0.0 1.4 0.5 0.4 10.6 0.1 0.0 0.0 0.0 5.7 0.4 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 2.5 0.0 0.0 0.0 0.0 IL3RA CD123 ENSG00000185291 "Interleukin 3 receptor subunit alpha" P26951 X 1336616-1382689 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 163.1;breast: 50.7;vagina: 65.4" "Group enriched" "Detected in many" 5 "Endothelial cells: 40.7;Macrophages: 35.6;monocytes: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "basophil: 163.1;plasmacytoid DC: 49.1" "Group enriched" "Detected in many" 33 "dendritic cells: 49.1;granulocytes: 163.1" "Cell line enhanced" "Detected in some" "HDLM-2: 49.0;NB-4: 9.4;RPMI-8226: 20.0" "HPA003539, CAB018374" Uncertain NA NA "CAB018374: AB_2233620, HPA003539: AB_1078438" "prognostic favorable (9.78e-4)" "prognostic favorable (4.27e-4)" "unprognostic (8.13e-2)" "unprognostic (9.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.29e-3)" "unprognostic (1.32e-1)" "unprognostic (1.67e-1)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" "unprognostic (5.77e-3)" "unprognostic (1.43e-1)" "unprognostic (1.50e-3)" "unprognostic (9.41e-2)" "unprognostic (2.85e-3)" "unprognostic (2.49e-1)" "unprognostic (1.46e-1)" 14.9 1.2 7.8 7.7 7.8 12.1 50.7 5.0 10.1 9.7 4.6 1.5 1.5 2.4 13.8 1.5 2.8 4.2 5.6 9.2 11.1 2.4 5.4 1.5 15.9 12.3 8.5 3.9 7.6 2.6 0.6 3.7 9.3 10.9 4.4 3.1 1.5 5.6 1.5 5.7 6.8 5.4 6.1 7.6 5.3 4.2 1.5 7.9 1.5 7.0 1.5 6.4 6.8 65.4 0.7 49.1 163.1 3.2 1.1 0.0 0.7 0.1 4.0 1.5 0.5 0.0 0.0 0.5 0.5 0.1 0.0 0.0 0.4 0.6 0.5 2.8 0.0 0.2 3.9 0.0 0.0 0.0 49.0 1.6 0.2 0.7 0.1 0.0 0.3 6.7 0.0 0.0 0.0 0.0 1.7 3.2 0.4 0.1 2.5 0.0 0.6 0.2 9.4 1.2 0.3 0.2 0.6 1.8 20.0 0.0 0.5 0.2 0.2 0.2 0.1 1.1 0.7 0.5 7.5 0.1 0.2 0.6 0.2 0.1 5.3 1.5 0.4 4.4 1.1 0.0 163.1 0.4 6.7 0.0 2.4 0.0 0.2 0.0 0.0 1.1 0.7 0.0 0.0 0.3 1.1 3.2 49.1 0.0 0.7 7.8 7.8 5.0 10.1 11.1 2.4 8.5 3.9 10.9 7.9 3.0 2.6 7.7 0.5 5.3 2.7 2.4 2.5 0.0 1.2 0.0 9.8 0.0 0.0 0.3 0.0 40.7 0.4 0.0 0.2 0.1 2.8 0.4 11.5 0.0 4.4 0.0 0.0 14.1 3.5 0.0 0.3 35.6 8.5 120.0 1.3 0.8 0.1 3.4 0.7 0.0 2.2 0.0 4.1 0.0 0.2 4.8 0.2 0.0 0.2 1.8 IL4 "BCGF-1, BCGF1, BSF1, IL-4, MGC79402" ENSG00000113520 "Interleukin 4" P05112 5 132673986-132682676 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "B-cell activation" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "blood: 73.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 679 "basophil: 73.8" "Lineage enriched" "Detected in single" 679 "granulocytes: 73.8" "Cell line enriched" "Detected in some" 5 "MOLT-4: 21.4" "Low region specificity" "Detected in many" "HPA072995, CAB078477" Approved "Secreted to blood" NA NA 13600 "CAB078477: AB_417057, HPA072995: AB_2732215" "unprognostic (3.40e-2)" "unprognostic (9.19e-2)" "unprognostic (1.41e-1)" "unprognostic (2.49e-1)" "unprognostic (2.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.69e-1)" "unprognostic (7.33e-2)" "unprognostic (2.26e-2)" "unprognostic (1.96e-1)" "unprognostic (1.47e-10)" "unprognostic (9.21e-3)" "unprognostic (2.88e-1)" "unprognostic (4.93e-2)" "unprognostic (1.24e-2)" 0.4 1.2 0.3 1.1 0.3 0.9 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 1.1 0.3 0.7 0.8 0.8 0.3 0.3 0.1 0.5 0.3 4.6 1.1 0.3 0.3 0.3 0.3 3.7 1.4 0.3 0.3 0.4 0.0 0.3 0.4 0.3 0.3 1.6 1.0 0.3 0.3 0.7 0.2 1.0 0.3 1.3 0.8 0.3 0.3 0.3 0.3 0.0 0.0 73.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 73.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 IL4I1 FIG1 ENSG00000104951 "Interleukin 4 induced 1" Q96RQ9 19 49889654-49929539 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.6;testis: 48.8" "Cell type enriched" "Detected in many" 12 "monocytes: 1188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 38.6" "Group enriched" "Detected in many" 6 "monocytes: 13.0;T-cells: 38.6" "Cell line enhanced" "Detected in some" "EFO-21: 18.0;HDLM-2: 31.2;Karpas-707: 25.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA045598 Enhanced Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA "Nucleoplasm, Cytosol" "HPA045598: AB_10969138" "unprognostic (6.23e-2)" "unprognostic (1.32e-2)" "unprognostic (8.39e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.61e-2)" "unprognostic (3.74e-3)" "unprognostic (7.03e-2)" "unprognostic (2.52e-2)" "unprognostic (3.84e-3)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.23e-10)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-3)" 5.4 3.3 4.0 30.9 4.6 7.1 4.1 5.8 5.6 4.6 4.1 5.5 2.9 8.2 5.9 3.4 4.5 8.2 5.4 4.2 3.9 3.5 11.0 3.5 6.7 15.5 4.0 3.2 6.2 3.7 1.5 5.1 6.8 4.3 5.3 3.8 3.9 4.1 5.0 6.2 3.4 7.4 3.8 7.2 7.6 6.2 48.8 4.4 14.6 4.1 4.4 12.3 6.5 4.9 0.2 4.1 0.1 13.0 0.4 38.6 3.0 0.5 0.6 0.4 0.4 0.0 0.4 0.1 0.3 1.0 0.8 1.1 0.3 1.0 1.8 18.0 0.2 1.5 0.3 0.2 0.0 0.1 31.2 0.1 0.8 0.0 0.2 0.1 0.6 6.4 0.5 0.2 0.3 0.0 0.2 1.4 0.2 0.1 25.3 0.0 0.2 0.4 1.0 0.2 0.4 0.1 0.5 0.5 1.7 1.2 1.6 0.4 0.4 0.2 0.5 0.3 0.1 0.2 1.4 1.5 3.8 0.5 0.0 0.5 2.2 4.7 1.0 0.5 0.2 0.4 0.1 8.0 0.1 2.3 13.0 38.6 0.2 5.0 4.3 4.1 0.1 0.1 0.0 0.1 0.4 1.6 0.4 0.2 3.0 4.0 4.6 5.8 5.6 3.9 3.5 4.0 3.2 4.3 4.4 0.0 0.0 0.0 0.5 8.7 0.0 0.6 0.0 0.0 1.2 3.5 0.0 0.3 0.0 1.9 52.0 3.1 0.0 0.0 3.4 0.6 1.4 1.0 1.1 0.0 102.3 0.0 0.0 1.8 1.8 11.1 0.3 40.3 3.3 1188.5 0.0 0.1 0.5 0.0 0.4 1.6 0.2 0.0 2.1 11.9 2.5 7.2 0.7 5.0 0.1 1.4 IL5 "EDF, IL-5, TRF" ENSG00000113525 "Interleukin 5" P05113 5 132541444-132556838 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.8;testis: 10.6" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 24.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 6 "memory B-cell: 3.8" "Lineage enriched" "Detected in single" 6 "B-cells: 3.8" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;HEK 293: 2.2;Hep G2: 7.2;TIME: 3.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB010304 Approved "Secreted to blood" NA NA 4130 "CAB010304: AB_2296159" "unprognostic (1.66e-1)" "unprognostic (4.76e-2)" "unprognostic (5.30e-3)" "unprognostic (2.35e-1)" "unprognostic (9.07e-2)" "unprognostic (7.98e-2)" "unprognostic (2.03e-2)" "unprognostic (3.51e-2)" "unprognostic (1.97e-1)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (2.09e-1)" "unprognostic (5.27e-2)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" 0.1 0.1 0.3 0.3 1.0 0.0 0.1 0.3 1.3 0.2 0.1 0.0 0.0 1.0 0.5 0.0 0.1 0.7 1.1 0.4 1.0 0.3 0.1 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 2.0 0.0 0.9 0.1 0.3 0.0 0.1 0.0 0.1 0.1 1.8 0.1 0.3 0.1 0.3 10.6 0.0 0.4 0.7 0.0 0.2 0.2 0.2 3.8 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.8 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.6 0.8 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.4 0.9 0.4 0.8 0.0 0.2 0.8 0.0 0.0 0.0 0.5 0.0 0.0 3.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.0 0.3 1.3 1.0 0.3 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.7 0.1 0.0 0.0 0.0 0.0 IL5RA "CD125, CDw125, IL5R" ENSG00000091181 "Interleukin 5 receptor subunit alpha" Q01344 3 3066326-3126613 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 70.1;fallopian tube: 18.6" "Cell type enhanced" "Detected in some" 18 "Ciliated cells: 21.4;granulocytes: 18.5;Melanocytes: 5.0" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 196 "basophil: 31.4;eosinophil: 70.1" "Lineage enriched" "Detected in single" 308 "granulocytes: 70.1" "Cell line enriched" "Detected in some" 30 "HMC-1: 42.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 92000 "unprognostic (1.38e-3)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (6.13e-3)" "unprognostic (2.66e-1)" "unprognostic (1.54e-3)" "unprognostic (7.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.83e-1)" "unprognostic (1.67e-1)" "unprognostic (9.84e-4)" "unprognostic (4.32e-3)" "unprognostic (3.08e-2)" "unprognostic (6.95e-2)" "unprognostic (2.20e-1)" "unprognostic (7.49e-2)" "unprognostic (4.93e-2)" 0.5 0.2 6.7 0.6 6.2 0.7 1.3 0.2 0.3 1.8 0.9 1.8 0.0 2.2 0.6 8.2 0.6 18.6 2.0 2.4 2.3 2.1 0.6 1.3 7.9 1.2 0.1 0.0 3.8 0.5 0.1 7.5 0.1 11.8 2.6 1.4 0.5 2.2 0.1 0.3 0.4 2.1 0.6 0.6 4.6 1.3 1.6 0.7 1.1 0.4 1.1 1.9 4.2 0.4 0.1 0.0 70.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 31.4 0.0 70.1 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 6.7 6.2 0.2 0.3 2.3 2.1 0.1 0.0 11.8 0.7 0.0 4.5 0.0 0.0 0.1 0.0 2.4 0.0 21.4 2.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 18.5 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.0 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 IL6 "BSF2, HGF, HSF, IFNB2, IL-6" ENSG00000136244 "Interleukin 6" P05231 7 22725884-22732002 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cytokine, Growth factor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.1;lymphoid tissue: 48.0" "Cell type enriched" "Detected in many" 9 "Smooth muscle cells: 589.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8" "Group enriched" "Detected in some" 70 "memory B-cell: 6.1;naive B-cell: 7.7" "Lineage enriched" "Detected in single" 77 "B-cells: 7.7" "Group enriched" "Detected in some" 4 "BJ hTERT+: 208.4;GAMG: 141.1" "Low region specificity" "Detected in single" "CAB023406, CAB072821" Supported Approved Vesicles "Secreted to blood" NA NA 5700 Vesicles "CAB023406: AB_617317, CAB072821: " "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (3.59e-2)" "unprognostic (9.88e-3)" "unprognostic (1.35e-1)" "unprognostic (3.07e-3)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (1.10e-11)" "unprognostic (2.45e-3)" "unprognostic (2.10e-1)" "unprognostic (4.31e-2)" "unprognostic (7.80e-2)" 60.1 5.6 1.4 48.0 10.0 15.3 11.5 0.7 4.4 2.9 8.1 1.2 0.4 0.7 2.1 4.6 14.3 7.8 16.1 21.6 3.9 1.5 1.3 5.2 34.9 3.0 1.8 0.2 5.3 8.3 5.7 14.2 4.5 12.8 6.5 7.5 3.3 3.1 0.8 6.9 2.8 4.5 8.2 7.0 3.5 6.5 3.2 1.2 0.1 4.5 12.7 3.5 34.9 8.4 7.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.8 208.4 3.9 13.4 0.0 0.0 0.0 6.8 1.3 141.1 0.1 0.0 0.0 5.3 8.2 0.0 0.0 0.3 0.0 4.4 0.0 0.0 0.5 0.0 39.8 5.7 3.8 1.4 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 13.5 0.0 0.0 0.7 0.0 0.0 1.2 1.3 0.1 2.4 0.4 0.0 2.3 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 10.0 0.7 4.4 3.9 1.5 1.8 0.2 12.8 1.2 6.0 27.2 7.2 1.9 39.6 0.0 0.9 0.0 13.4 20.5 3.5 0.0 0.5 0.0 5.8 0.3 40.7 0.0 0.0 2.4 3.1 63.9 7.3 5.8 0.0 4.2 0.0 0.0 3.1 6.1 0.0 0.0 46.2 38.8 7.2 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 589.1 0.0 0.0 29.2 1.1 0.0 0.0 9.0 IL6R CD126 ENSG00000160712 "Interleukin 6 receptor" P08887 1 154405193-154469450 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 107.2;Hepatocytes: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 35.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "THP-1: 55.9;U-266/84: 65.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 24800000 22000000 "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (1.19e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-2)" "unprognostic (3.27e-1)" "unprognostic (6.42e-2)" "prognostic favorable (1.65e-4)" "unprognostic (7.94e-2)" "unprognostic (1.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" 8.4 4.0 4.7 14.8 5.1 9.0 6.5 1.4 6.3 6.1 16.9 4.8 1.2 9.6 6.3 4.7 5.2 7.9 6.9 5.0 5.2 2.9 8.9 38.1 20.8 15.4 7.2 2.2 5.7 5.3 0.0 7.7 3.7 7.8 4.5 6.0 3.6 5.4 1.7 59.6 4.7 12.6 5.3 5.0 11.3 6.6 3.7 5.0 4.2 2.5 6.1 13.3 6.3 4.8 0.6 14.3 35.0 11.7 0.5 8.0 5.5 0.8 1.5 0.1 0.1 0.9 1.3 0.1 0.8 0.6 0.5 0.2 0.1 1.0 0.0 1.9 1.0 3.1 0.4 0.3 4.5 0.4 15.1 0.5 0.2 0.6 3.4 0.1 2.4 1.3 0.8 2.7 0.4 6.8 0.1 0.6 0.0 0.1 6.2 0.1 0.3 0.0 3.9 0.4 0.2 3.4 0.0 0.0 13.0 2.8 1.1 0.1 0.0 0.2 9.2 15.1 1.2 0.8 55.9 0.6 0.9 0.9 0.8 0.5 10.7 65.8 0.1 1.1 15.2 1.4 2.8 11.7 10.4 0.2 7.1 0.6 0.6 6.4 0.7 14.3 0.2 6.4 2.2 35.0 0.5 3.0 5.1 8.0 5.5 4.7 5.1 1.4 6.3 5.2 2.9 7.2 2.2 7.8 5.0 107.2 76.2 9.0 41.2 33.7 0.0 8.5 25.5 37.5 59.1 1.8 0.0 0.4 0.0 3.5 35.4 7.1 43.2 0.0 1.0 0.9 20.1 71.1 57.9 81.0 36.1 0.0 7.5 3.1 36.2 9.6 0.3 29.9 23.6 39.7 5.7 5.6 4.9 5.3 0.4 12.6 0.2 0.0 27.0 0.2 0.9 26.0 0.8 4.4 11.5 12.5 IL7 IL-7 ENSG00000104432 "Interleukin 7" P13232 8 78675743-78805523 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.5;lymphoid tissue: 26.3" "Group enriched" "Detected in many" 6 "Ciliated cells: 40.2;Early spermatids: 81.1;Late spermatids: 98.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 10.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HDLM-2: 13.2;HEL: 14.0;HMC-1: 20.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA019590 Approved "Secreted to blood" NA NA 60700 "HPA019590: AB_10794621" "unprognostic (3.19e-3)" "unprognostic (1.44e-1)" "unprognostic (9.57e-3)" "unprognostic (5.45e-2)" "unprognostic (9.37e-3)" "unprognostic (3.36e-1)" "unprognostic (1.71e-1)" "unprognostic (1.65e-2)" "unprognostic (2.28e-1)" "unprognostic (2.47e-1)" "unprognostic (3.02e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.69e-4)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (6.55e-2)" "unprognostic (2.11e-4)" 6.8 1.9 1.3 13.4 1.8 1.8 2.2 1.7 1.7 2.6 9.5 0.4 1.3 7.0 1.9 5.0 5.0 5.2 8.2 1.5 1.0 0.9 5.6 8.9 6.5 26.3 0.8 0.1 2.4 2.6 0.0 1.3 1.0 1.0 5.0 4.8 1.1 7.9 2.0 0.9 9.6 20.5 2.4 1.2 8.6 4.4 3.0 0.9 2.0 4.1 4.4 10.4 3.9 3.3 10.9 2.4 5.4 0.8 0.5 7.5 0.6 0.2 0.0 0.1 0.0 0.4 0.3 0.0 1.2 1.1 1.0 1.5 0.0 6.0 0.1 0.0 3.4 3.6 3.4 0.1 0.0 0.0 13.2 0.0 14.0 0.3 1.7 0.0 0.1 20.7 1.0 0.0 0.1 0.5 3.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 4.3 2.4 0.0 2.0 2.0 0.2 0.2 0.0 0.1 0.0 0.2 0.7 0.8 0.0 1.6 0.2 0.0 0.0 2.7 0.0 1.5 5.4 0.3 0.0 0.4 0.2 0.0 10.9 1.1 1.1 2.4 8.2 0.3 0.3 0.0 0.5 0.8 0.3 7.5 0.6 1.3 1.8 1.7 1.7 1.0 0.9 0.8 0.1 1.0 0.9 0.0 2.2 9.0 3.2 5.4 0.0 0.4 5.1 40.2 3.4 1.8 0.0 0.0 8.3 1.2 81.1 1.9 7.0 0.0 4.6 0.0 1.1 1.1 0.0 2.4 1.0 0.0 2.9 1.3 1.0 98.2 0.6 2.6 0.0 5.4 5.5 1.8 2.1 11.5 1.1 6.8 0.3 0.0 0.6 1.0 0.7 5.6 0.0 1.5 3.4 0.7 IL7R CD127 ENSG00000168685 "Interleukin 7 receptor" P16871 5 35852695-35879603 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1" "Group enriched" "Detected in many" 5 "monocytes: 441.0;T-cells: 326.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1" "Group enriched" "Detected in many" 33 "NK-cells: 19.1;T-cells: 70.3" "Cell line enhanced" "Detected in many" "BJ: 22.2;BJ hTERT+ SV40 Large T+: 20.1;fHDF/TERT166: 41.6;HBF TERT88: 38.3;REH: 86.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB010215, HPA067550" Supported "Plasma membrane" "Intracellular and membrane" NA NA 180000 "Plasma membrane" "CAB010215: AB_673727, HPA067550: " "unprognostic (2.93e-3)" "unprognostic (3.38e-2)" "unprognostic (3.82e-3)" "unprognostic (5.58e-3)" "unprognostic (3.06e-2)" "unprognostic (1.74e-1)" "unprognostic (2.51e-3)" "unprognostic (5.53e-2)" "unprognostic (1.12e-1)" "unprognostic (9.29e-3)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (1.76e-2)" "unprognostic (5.64e-2)" "unprognostic (3.27e-3)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" 6.7 3.6 0.7 34.0 0.7 3.1 4.8 0.5 0.6 4.8 20.6 0.3 0.9 3.5 1.8 2.9 6.6 3.7 8.5 1.9 0.7 0.7 7.0 2.7 52.6 133.1 0.8 0.1 2.5 1.7 0.0 1.5 1.2 0.8 3.3 5.4 1.7 13.2 1.8 0.9 1.8 34.0 1.2 1.5 32.3 7.8 3.0 0.4 130.9 5.1 5.3 42.9 12.6 4.6 0.4 0.3 1.3 0.2 19.1 70.3 12.7 0.1 0.0 0.1 0.1 0.1 0.1 0.2 22.2 11.2 20.1 11.9 0.1 0.1 2.1 0.0 41.6 3.7 3.5 0.0 1.3 38.3 1.8 0.2 0.6 2.4 0.0 0.3 0.2 1.6 0.3 0.0 4.3 0.9 0.5 0.5 0.1 0.1 0.3 15.7 0.0 0.5 0.2 0.1 0.0 1.0 86.5 1.2 0.1 0.0 1.2 0.0 0.0 3.7 0.3 0.0 0.1 0.1 0.0 1.5 7.9 13.4 3.4 2.9 0.2 0.0 2.5 4.0 2.1 6.1 0.5 0.2 0.1 19.2 0.2 70.3 0.2 39.9 28.0 0.1 0.4 34.5 22.5 1.3 19.1 0.2 0.3 6.7 12.7 0.7 0.7 0.5 0.6 0.7 0.7 0.8 0.1 0.8 0.4 14.9 19.4 10.9 1.9 10.3 0.0 3.2 0.0 10.7 4.5 0.0 0.0 0.1 0.0 0.9 0.1 3.6 0.0 23.3 1.6 0.1 7.1 1.1 18.5 4.5 10.4 0.0 0.0 17.8 12.7 0.0 0.0 79.7 20.3 441.0 0.0 0.0 0.2 0.9 0.0 0.6 0.0 0.0 9.0 0.0 0.0 9.2 0.2 326.6 0.0 3.8 IL9 "HP40, IL-9, P40" ENSG00000145839 "Interleukin 9" P15248 5 135892246-135895827 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.0;skin 1: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 267 "HDLM-2: 31.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 11000 0.1 0.2 0.3 0.0 2.2 0.0 0.0 0.3 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 2.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 2.2 0.3 1.1 0.7 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL9R CD129 ENSG00000124334 "Interleukin 9 receptor" Q01113 X 155997581-156010817 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.3;urinary bladder: 10.9" "Cell type enriched" "Detected in some" 4 "granulocytes: 4.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.4" "Group enriched" "Detected in some" 6 "basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5" "Cell type enhanced" "Detected in many" "eosinophil: 6.3" "Group enriched" "Detected in many" 25 "B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4" "Cell line enriched" "Detected in some" 11 "HMC-1: 76.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA063240, HPA064557" Approved "Intracellular and membrane" NA NA "HPA063240: AB_2732700, HPA064557: AB_2732716" "unprognostic (1.07e-2)" "unprognostic (3.27e-3)" "unprognostic (9.52e-3)" "unprognostic (4.13e-2)" "unprognostic (7.35e-2)" "unprognostic (3.26e-4)" "unprognostic (8.94e-2)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.82e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (3.98e-8)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (4.07e-1)" "prognostic favorable (1.90e-7)" 0.3 0.1 0.3 1.1 1.7 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.7 3.0 0.3 0.5 0.4 0.9 0.3 0.3 0.2 0.3 0.5 1.3 3.2 0.3 0.3 0.3 0.3 0.0 0.3 0.3 4.7 0.4 1.2 0.3 0.4 0.3 0.3 0.4 2.4 0.3 0.3 3.5 0.8 0.3 1.5 0.3 0.4 0.3 2.9 10.9 0.3 4.1 0.0 6.3 0.0 0.1 2.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 7.0 0.0 0.0 0.0 0.1 76.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.2 0.0 0.3 2.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 1.8 0.8 1.3 0.0 4.1 0.0 0.0 1.8 0.1 0.0 0.0 2.4 0.3 0.3 1.7 0.4 0.3 0.3 0.2 0.3 0.3 4.7 1.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 ILDR1 "DFNB42, MGC50831" ENSG00000145103 "Immunoglobulin like domain containing receptor 1" Q86SU0 3 121987323-122022258 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 28.9;seminal vesicle: 27.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Ciliated cells: 13.4;Club cells: 11.4;Collecting duct cells: 19.2;Cytotrophoblasts: 12.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.7;HDLM-2: 9.8;MCF7: 6.1;RT4: 9.1;T-47d: 6.5;U-266/70: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA018207 Approved "Intracellular and membrane" NA NA "HPA018207: AB_1851742" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (9.24e-2)" "unprognostic (4.46e-3)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-2)" "unprognostic (2.80e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (7.78e-2)" "unprognostic (2.37e-1)" "prognostic favorable (5.79e-9)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (3.25e-3)" "unprognostic (2.21e-2)" 0.3 1.5 0.3 0.7 0.4 0.0 1.8 0.3 0.3 8.6 5.6 0.3 28.9 2.0 1.6 17.2 5.9 3.4 4.7 0.3 0.3 0.2 8.0 0.4 2.9 0.3 0.3 0.3 0.9 16.5 14.8 4.1 2.6 0.4 4.9 5.0 1.3 10.6 27.8 0.3 1.7 2.4 0.3 0.3 1.1 0.3 1.5 0.3 0.9 5.1 1.9 3.7 5.6 1.6 5.1 0.5 1.5 0.7 0.1 1.0 0.4 3.4 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 7.7 1.4 0.1 0.0 0.1 1.2 0.0 0.0 0.0 9.8 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 6.1 0.0 0.1 0.1 1.4 0.0 0.0 0.1 2.8 3.5 9.1 0.4 0.1 0.0 0.9 0.1 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.1 7.5 1.6 1.4 0.0 0.2 0.1 0.6 0.7 0.1 0.2 0.4 0.2 5.1 0.2 0.3 0.5 3.4 0.4 0.3 1.5 0.1 0.2 0.4 1.0 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.4 0.3 11.9 6.1 0.0 0.5 0.0 0.0 0.4 2.5 13.4 11.4 19.2 0.0 12.1 1.7 6.0 0.2 0.0 3.9 0.0 3.3 0.4 0.0 3.0 0.0 0.0 1.1 0.0 3.4 0.0 0.6 0.0 0.0 0.0 1.7 0.0 7.6 0.0 3.1 7.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 4.2 0.0 6.9 2.8 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 116.0" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.4 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.2 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.1 0.2 0.0 5.1 0.0 3.3 0.1 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 1.0 0.0 0.9 0.0 0.0 12.5 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.1 1.6 1.2 0.0 0.0 13.8 0.6 0.0 0.0 1.0 0.0 116.0 0.1 0.0 0.0 4.6 6.5 0.0 0.1 3.3 1.3 0.0 0.2 0.0 0.2 0.0 IMPA2 ENSG00000141401 "Inositol monophosphatase 2" O14732 18 11981025-12030883 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 90.1" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 373.0;Extravillous trophoblasts: 196.1;Proximal tubular cells: 383.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 14.4;neutrophil: 18.7" "Group enriched" "Detected in many" 14 "dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8" "Cell line enhanced" "Detected in many" "BEWO: 60.5;OE19: 67.8;RPTEC TERT1: 29.2;SiHa: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029561 Approved Approved Nucleoplasm,Mitochondria Yes No Nucleoplasm Mitochondria "HPA029561: AB_10601932" "unprognostic (1.16e-1)" "unprognostic (1.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.50e-2)" "unprognostic (4.25e-2)" "unprognostic (3.25e-3)" "unprognostic (4.26e-3)" "unprognostic (4.08e-2)" "unprognostic (1.87e-1)" "unprognostic (1.96e-2)" "unprognostic (4.56e-2)" "unprognostic (4.24e-3)" "prognostic favorable (0.00e+0)" "unprognostic (1.95e-1)" "unprognostic (1.19e-1)" "unprognostic (2.08e-2)" "unprognostic (3.35e-2)" 6.2 2.8 1.5 5.2 1.9 6.9 10.7 0.3 1.5 6.8 12.2 0.7 1.6 5.6 7.3 3.0 40.3 4.1 17.5 20.1 1.4 0.5 41.3 21.0 6.5 4.6 2.2 0.3 3.1 90.1 1.0 5.7 35.6 1.3 17.5 7.8 3.4 9.8 2.5 55.0 30.4 9.2 40.0 1.4 4.8 13.5 1.5 2.0 3.1 8.0 31.4 10.3 22.6 14.7 0.7 5.3 18.7 6.8 0.1 0.6 1.8 6.2 9.7 2.6 4.6 3.4 2.5 60.5 1.6 4.3 0.7 1.0 7.8 5.0 1.3 3.8 2.3 5.7 4.3 3.1 1.6 0.2 7.4 3.8 0.0 12.7 6.7 2.0 10.7 0.5 5.8 8.7 2.3 1.2 2.0 0.9 7.0 1.5 0.0 2.5 6.2 4.3 5.6 9.1 67.8 7.3 7.3 7.3 6.4 29.2 3.5 3.5 0.0 36.5 8.3 3.5 3.4 7.8 13.4 0.0 1.3 2.5 17.9 1.6 5.0 13.3 3.7 5.8 7.2 2.2 3.3 6.8 14.4 0.4 4.9 0.2 0.7 0.4 0.1 5.3 0.2 0.2 0.3 18.7 0.1 3.0 3.7 0.6 1.8 1.5 1.9 0.3 1.5 1.4 0.5 2.2 0.3 1.3 2.0 17.9 25.4 6.9 15.2 93.8 0.2 10.6 45.9 9.4 9.1 21.0 0.0 35.5 373.0 57.8 2.3 5.8 44.1 0.0 96.5 196.1 13.1 33.2 2.3 62.3 36.5 0.0 16.8 8.6 39.4 4.7 4.4 16.7 13.5 4.6 70.8 21.8 73.4 51.8 3.5 383.7 0.9 103.5 9.5 0.4 11.7 123.6 88.9 4.4 78.2 45.7 IMPG1 "GP147, IPM150, SPACR" ENSG00000112706 "Interphotoreceptor matrix proteoglycan 1" Q17R60 6 75921115-76072678 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Heparin-binding, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 110.5" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 634.2;Rod photoreceptor cells: 409.1" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;AF22: 3.0;HaCaT: 4.1;TIME: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027142, HPA030332, HPA030333" Enhanced "Secreted in other tissues" NA NA "HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433" "unprognostic (6.65e-2)" "unprognostic (4.13e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.49e-3)" "unprognostic (5.97e-2)" "unprognostic (3.56e-3)" "unprognostic (1.89e-2)" "unprognostic (2.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-3)" "unprognostic (2.84e-1)" "unprognostic (1.73e-2)" "unprognostic (2.09e-1)" "unprognostic (6.01e-2)" "unprognostic (1.96e-2)" 0.6 0.0 0.4 0.4 10.3 0.0 0.4 1.0 2.8 0.4 0.4 0.4 0.4 2.8 0.4 0.4 0.4 0.1 1.1 0.5 0.5 0.4 0.8 0.4 0.5 0.4 0.5 0.4 0.4 5.4 0.0 0.4 0.6 0.4 0.7 0.0 110.5 0.6 0.4 0.6 4.0 2.3 0.4 0.4 0.5 0.7 0.9 0.4 0.4 0.8 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.1 3.0 0.0 0.0 0.6 1.6 0.8 0.0 0.0 0.0 1.8 0.6 0.0 0.3 0.0 0.1 4.1 0.0 0.0 0.0 0.1 1.5 0.7 0.1 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.2 0.6 0.1 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.7 0.7 1.2 0.0 1.8 0.4 0.6 0.0 0.3 2.4 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.3 1.0 1.9 0.5 0.4 0.5 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 44.9 0.2 0.0 0.0 0.0 0.0 634.2 0.1 3.3 0.0 1.5 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.2 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.3 0.0 0.0 0.0 0.0 409.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IMPG2 "IPM200, RP56" ENSG00000081148 "Interphotoreceptor matrix proteoglycan 2" Q9BZV3 3 101222546-101320560 "Disease related genes, Predicted membrane proteins" "Heparin-binding, Receptor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 72.1" "Group enriched" "Detected in some" 29 "Cone photoreceptor cells: 486.9;Rod photoreceptor cells: 298.9" "Cancer enriched" "Detected in single" 12 "ovarian cancer: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008779, HPA015907" Enhanced NA NA "HPA008779: AB_2668138, HPA015907: AB_2669323" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (1.28e-1)" "unprognostic (4.80e-5)" "unprognostic (6.66e-4)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (6.59e-2)" "unprognostic (7.51e-3)" "unprognostic (1.28e-1)" "unprognostic (4.50e-9)" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (6.08e-2)" 0.2 0.3 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.1 0.3 0.3 0.1 16.5 0.2 0.3 0.3 0.6 0.3 0.1 0.1 0.4 0.5 0.1 0.4 0.2 0.1 0.4 0.1 0.4 0.2 0.2 72.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.6 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.1 1.0 0.1 1.1 0.3 0.0 0.1 0.0 1.1 1.3 0.4 1.0 0.1 0.1 0.2 0.3 0.5 0.0 0.1 0.1 1.0 0.1 0.4 0.0 0.3 0.1 1.1 0.4 0.3 0.6 0.4 0.1 0.1 0.3 2.0 1.3 0.7 0.2 0.0 0.6 1.8 0.2 0.0 1.2 0.9 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.7 0.3 1.6 0.2 0.0 0.0 0.1 0.8 0.2 0.4 1.4 1.2 0.6 0.4 0.7 0.6 1.1 0.2 0.0 0.0 1.2 0.6 0.1 0.3 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.3 1.0 1.1 0.1 0.1 0.1 0.0 0.2 0.4 0.2 0.2 0.3 0.6 0.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 13.2 0.6 0.0 0.0 0.0 0.0 486.9 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.8 0.0 13.7 0.1 0.0 0.7 0.0 298.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 INA "NEF5, NF-66" ENSG00000148798 "Internexin neuronal intermediate filament protein alpha" Q16352 10 103277163-103290351 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 65.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 51.8;Cone photoreceptor cells: 21.6;Early spermatids: 34.2;Horizontal cells: 42.9;Late spermatids: 14.9;Rod photoreceptor cells: 32.4" "Cancer enhanced" "Detected in many" "testis cancer: 18.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 21.1;SCLC-21H: 41.4;SH-SY5Y: 23.6;SiHa: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002059, HPA007572, HPA008057" Enhanced Supported Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833" "unprognostic (1.77e-1)" "unprognostic (2.50e-2)" "unprognostic (9.54e-2)" "unprognostic (5.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.45e-3)" "unprognostic (1.31e-1)" "unprognostic (2.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "unprognostic (8.09e-3)" "unprognostic (3.07e-2)" "unprognostic (1.78e-3)" "unprognostic (1.66e-1)" "unprognostic (1.90e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" 1.5 15.7 16.6 2.6 21.3 1.3 1.3 26.9 65.2 1.3 2.7 2.3 0.0 2.0 1.3 1.4 1.9 1.3 1.5 1.3 13.2 34.0 1.3 1.4 1.5 1.4 27.2 17.7 1.3 3.6 1.3 12.8 1.5 65.4 1.5 2.8 5.5 1.3 1.4 1.3 2.2 2.5 2.2 7.9 1.3 2.6 4.1 3.3 0.0 1.5 0.0 1.5 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 4.7 0.0 0.0 0.0 7.7 5.2 1.3 1.2 0.1 0.0 0.0 0.0 2.2 0.3 0.6 0.7 4.3 0.0 0.3 9.4 1.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 5.1 0.0 21.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 41.4 23.6 28.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 21.3 26.9 42.0 13.2 34.0 27.2 17.7 65.4 3.3 0.0 0.0 0.0 0.1 0.2 51.8 0.4 0.0 0.0 0.0 0.0 21.6 0.2 0.0 0.1 34.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 42.9 7.5 0.0 0.0 14.9 0.3 0.0 0.0 0.0 0.0 7.6 0.7 0.0 0.4 0.0 32.4 0.0 0.0 4.3 3.8 0.4 0.1 0.0 0.0 0.6 INAFM2 "LINC00984, OGU1" ENSG00000259330 "InaF motif containing 2" P0DMQ5 15 40323664-40326715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 24.1" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 16.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 5.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.5;granulocytes: 5.8;monocytes: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.59e-2)" "unprognostic (9.05e-2)" "unprognostic (8.01e-3)" "unprognostic (2.43e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (1.88e-7)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" 4.6 3.2 3.7 3.6 3.1 4.0 2.2 2.3 6.4 2.7 12.1 3.5 10.4 2.2 3.8 2.7 4.6 6.0 24.1 12.2 4.6 2.1 2.2 4.5 1.5 2.5 3.5 5.5 4.5 5.6 2.4 7.4 4.2 5.6 5.7 3.8 4.7 10.7 3.8 0.5 6.3 7.4 3.8 4.7 2.9 3.8 2.6 0.6 15.7 0.8 1.9 6.1 5.5 0.6 2.5 5.8 2.4 0.2 0.5 1.5 8.8 0.8 8.3 5.2 7.2 3.5 19.2 11.2 5.6 8.9 7.4 3.3 1.8 0.7 9.9 6.1 5.3 20.3 12.9 13.2 12.6 2.6 4.3 24.0 3.3 1.8 9.3 12.7 17.1 9.2 4.9 3.3 9.4 13.2 9.2 6.3 12.9 19.5 12.5 1.2 3.7 10.2 6.1 6.9 6.9 1.9 10.0 21.3 6.5 10.3 17.9 7.1 4.0 4.8 3.8 14.9 4.6 15.9 11.9 12.4 9.2 6.2 8.0 5.1 1.2 2.3 9.2 20.9 11.8 1.4 2.4 5.8 0.3 2.3 0.2 0.6 0.3 0.1 1.3 0.1 0.0 0.3 1.8 0.2 2.3 2.5 0.5 1.5 0.0 3.0 0.9 0.9 0.0 5.9 12.3 7.6 2.7 1.2 3.5 3.9 2.5 0.0 1.8 11.0 3.5 0.5 0.0 2.1 0.4 1.3 2.4 1.1 2.4 16.3 7.9 2.4 13.5 12.0 2.1 1.1 7.6 0.0 1.0 1.9 5.8 2.1 0.0 4.6 0.7 4.5 0.0 1.6 9.2 3.6 0.0 1.1 0.0 1.3 2.6 INAVA "C1orf106, FLJ10901" ENSG00000163362 "Innate immunity activator" Q3KP66 1 200891048-200915735 "Disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.3" "Cell type enhanced" "Detected in some" 16 "Ductal cells: 31.1;Exocrine glandular cells: 40.0;Pancreatic endocrine cells: 75.5;Proximal tubular cells: 23.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 24.0;CAPAN-2: 20.7;HaCaT: 28.4;OE19: 21.7;RPMI-8226: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027499, HPA027511" Uncertain NA NA "HPA027499: AB_10599708, HPA027511: AB_10600334" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.78e-5)" "unprognostic (4.56e-2)" "unprognostic (2.18e-1)" "unprognostic (2.74e-2)" "unprognostic (6.62e-3)" "unprognostic (2.84e-2)" "unprognostic (9.38e-2)" "unprognostic (2.52e-2)" "unprognostic (2.81e-1)" "unprognostic (3.23e-3)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.73e-2)" 0.2 0.0 1.2 7.2 1.3 1.5 0.6 0.5 1.3 5.7 41.6 1.2 0.4 24.3 0.6 2.8 26.0 1.9 29.5 0.2 1.0 0.8 12.0 0.6 3.0 0.2 0.7 0.6 1.0 11.2 0.0 0.6 3.1 0.8 6.6 14.1 0.7 6.9 2.4 0.2 23.4 62.3 1.3 0.3 0.2 14.2 0.7 1.0 0.9 0.2 12.3 21.8 11.0 9.3 0.8 0.3 1.2 0.2 0.4 1.2 0.1 11.5 16.4 8.7 0.0 0.0 0.0 24.0 0.0 0.0 0.2 0.2 19.3 20.7 0.0 5.8 0.0 0.4 28.4 0.0 7.3 0.2 0.0 1.9 1.4 0.7 6.5 0.0 2.9 0.3 0.0 10.6 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 17.1 21.7 3.5 0.0 3.7 19.5 9.3 14.6 0.0 1.1 0.9 16.7 0.0 10.6 6.8 2.8 0.0 0.0 4.1 0.0 1.0 18.0 7.4 0.0 0.0 3.1 0.7 0.5 0.2 1.2 0.4 0.1 0.3 0.6 0.4 0.2 0.1 0.8 0.3 0.4 1.0 0.4 0.2 0.3 1.2 0.1 1.2 1.3 0.5 1.3 1.0 0.8 0.7 0.6 0.8 1.0 11.9 6.5 0.0 0.0 0.0 0.0 0.0 0.0 8.1 9.1 14.0 0.0 5.8 5.0 31.1 0.0 0.0 0.0 0.0 40.0 11.7 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 75.5 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 41.6" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 105.7;Late spermatids: 240.7;Spermatocytes: 81.7;Spermatogonia: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: AB_2681816" "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favorable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 1.7 2.2 5.5 3.5 6.3 0.5 2.5 10.1 7.2 2.3 2.2 3.1 1.0 7.0 3.3 1.6 3.1 2.0 4.5 3.9 4.9 2.1 2.3 2.6 2.7 5.0 5.1 3.0 5.5 2.2 0.9 4.4 1.6 5.9 2.7 0.3 1.7 3.6 1.5 6.1 5.0 4.9 1.2 4.1 4.3 3.1 41.6 3.6 0.5 5.2 1.3 0.4 2.8 9.4 1.5 1.3 0.7 4.4 0.3 2.4 0.6 4.0 4.6 3.3 3.0 2.2 0.9 3.9 4.4 0.4 1.2 1.2 3.2 4.8 19.1 2.9 1.2 3.8 11.4 0.5 0.2 0.7 8.0 4.8 4.1 5.5 2.1 1.5 0.6 10.2 1.2 0.0 0.7 0.4 7.1 0.4 6.8 5.1 9.0 0.8 2.1 5.8 1.3 1.4 1.8 1.2 7.1 1.7 1.7 0.8 1.3 9.7 2.9 2.1 2.8 2.6 3.6 5.7 0.9 8.8 4.1 1.6 3.9 3.3 1.5 0.8 0.9 4.0 10.2 2.1 0.5 2.4 0.0 0.8 4.4 2.0 1.5 1.2 1.7 0.9 1.0 2.4 1.9 0.7 0.3 3.4 1.3 0.7 0.6 5.5 6.3 10.1 7.2 4.9 2.1 5.1 3.0 5.9 3.6 0.0 0.6 0.5 1.2 1.0 0.4 0.5 2.5 1.4 1.2 3.5 2.0 0.5 0.0 0.6 105.7 0.6 6.8 0.0 1.4 0.6 1.4 0.5 4.6 1.3 1.2 0.0 0.0 0.6 0.0 240.7 6.6 1.2 1.7 1.0 1.6 4.6 1.1 7.0 1.1 1.7 0.8 6.5 1.2 81.7 50.4 0.6 0.7 0.0 1.8 0.9 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123973-62153163 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.1" "Cell type enhanced" "Detected in many" 4 "monocytes: 8.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.9;NK-cell: 4.0" "Group enriched" "Detected in many" 6 "granulocytes: 2.9;NK-cells: 4.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 5.1 5.0 6.9 9.2 8.2 23.8 7.7 19.3 13.6 6.9 6.5 5.7 2.8 9.5 5.7 11.7 22.2 5.3 4.7 4.1 5.9 5.0 3.9 3.8 5.0 14.1 6.9 7.9 5.3 5.4 6.0 3.1 5.7 6.9 4.2 5.3 4.9 10.6 4.6 6.7 9.8 7.5 4.9 5.1 7.5 6.4 12.3 6.4 36.1 8.5 8.5 13.2 5.9 8.6 0.2 0.0 2.9 0.3 4.0 0.5 0.0 27.0 25.9 19.7 16.8 2.6 3.2 10.5 17.0 7.4 15.9 10.2 13.6 18.4 25.1 14.1 5.8 17.6 26.6 19.5 10.3 12.5 22.3 13.5 16.4 25.5 11.1 1.0 18.8 23.4 1.6 2.3 15.3 8.9 2.6 9.5 18.3 17.3 21.0 8.7 22.0 30.3 15.4 21.2 10.5 12.7 28.4 24.8 18.9 4.5 13.6 15.0 16.3 17.1 11.1 10.5 8.2 17.4 6.8 10.6 15.7 20.1 22.4 18.1 11.2 17.2 28.2 8.7 12.4 18.8 2.9 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.2 4.0 0.1 0.0 0.0 0.0 6.9 8.2 19.3 13.6 5.9 5.0 6.9 7.9 6.9 6.4 3.0 2.9 2.2 0.8 4.9 1.9 0.9 0.0 4.0 5.7 0.0 0.0 1.6 0.0 1.7 0.8 0.8 1.3 0.0 2.1 6.0 0.8 1.0 3.5 0.9 3.5 0.0 0.0 0.0 0.8 0.2 2.6 2.5 3.3 8.2 2.0 2.3 1.7 1.5 1.4 0.3 2.2 0.0 0.4 6.9 5.8 2.9 1.8 2.5 1.7 1.0 ING3 "Eaf4, FLJ20089, MEAF4, p47ING3" ENSG00000071243 "Inhibitor of growth family member 3" Q9NXR8 7 120950749-120977216 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004762, HPA067388, HPA067575" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863" "unprognostic (1.35e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.78e-1)" "unprognostic (3.03e-1)" "unprognostic (1.39e-2)" "unprognostic (4.26e-2)" "unprognostic (7.09e-3)" "unprognostic (4.07e-2)" "unprognostic (5.18e-2)" "unprognostic (8.04e-3)" "unprognostic (2.86e-1)" "unprognostic (6.90e-2)" "unprognostic (3.96e-2)" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (5.64e-2)" 9.6 9.1 7.4 8.8 9.9 57.7 9.6 21.5 13.8 9.0 9.6 5.5 11.1 7.3 11.1 9.7 8.0 9.7 7.7 7.6 7.3 7.3 8.8 8.4 12.3 11.9 7.6 12.2 11.9 12.1 7.9 17.7 13.0 11.1 9.5 10.6 6.7 10.0 11.5 7.7 6.1 12.9 11.4 8.8 16.4 10.4 8.6 9.6 19.0 12.6 10.4 11.2 8.3 8.4 15.8 15.0 32.7 19.5 18.5 16.9 9.8 9.3 2.8 12.7 7.1 4.8 3.8 4.3 6.4 5.1 9.3 10.9 3.6 10.9 15.2 2.9 5.6 9.8 4.6 12.2 5.0 10.7 10.6 21.4 11.0 10.6 2.1 6.6 21.2 13.1 2.8 2.6 8.2 5.8 4.5 14.5 9.6 24.6 24.7 8.9 3.2 17.4 12.7 15.3 5.3 5.2 8.6 9.1 12.6 9.4 9.7 11.5 12.5 6.6 13.7 6.9 8.2 3.1 8.3 5.1 9.5 3.5 20.4 11.6 11.3 7.2 22.9 4.8 14.3 7.9 22.3 19.1 16.5 13.9 19.5 13.4 14.4 14.1 12.6 15.0 15.8 14.4 13.1 32.7 18.5 19.1 11.2 16.9 9.8 7.4 9.9 21.5 13.8 7.3 7.3 7.6 12.2 11.1 9.6 17.9 13.6 22.2 20.2 6.8 20.4 12.6 7.6 13.4 7.9 7.0 3.9 33.3 18.3 10.3 4.0 18.5 17.3 23.3 15.7 21.2 19.3 14.2 33.4 11.1 15.3 25.4 11.5 19.6 26.6 3.9 12.7 19.0 15.1 15.4 14.0 17.3 12.9 14.8 9.2 9.7 17.2 19.4 22.6 15.0 13.9 9.8 38.2 21.8 12.4 13.9 INHA ENSG00000123999 "Inhibin alpha subunit" P05111 2 219569162-219575713 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 276.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "basal ganglia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.5;HEL: 5.6;SK-BR-3: 12.8;SuSa: 6.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB000047, HPA019141, HPA048834" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA Vesicles "Golgi apparatus" "CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: " "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 0.5 24.2 0.8 0.5 8.4 0.0 0.5 1.7 0.9 0.5 0.5 1.4 0.5 0.0 0.5 1.2 0.5 0.6 0.6 4.8 0.8 0.9 0.5 0.5 0.5 0.5 0.5 0.6 31.5 6.5 0.2 1.5 39.3 0.6 0.5 0.0 0.5 0.9 0.7 0.5 1.1 0.5 0.5 0.5 0.5 0.1 77.6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 2.5 0.8 0.2 4.5 0.5 0.4 0.7 0.2 0.3 4.3 0.0 0.3 1.0 0.7 2.6 0.3 0.7 0.0 0.0 0.8 5.6 2.0 3.0 0.4 0.0 0.0 0.9 1.3 0.0 0.7 2.5 0.0 0.0 3.3 0.0 0.1 3.0 0.0 0.2 1.7 0.2 1.1 0.1 0.2 0.0 0.7 0.3 0.4 1.0 1.6 12.8 0.4 6.6 0.8 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 8.4 1.7 0.9 0.8 0.9 0.5 0.6 0.6 0.5 0.0 0.0 0.0 0.1 0.0 3.4 1.4 0.0 0.0 0.0 7.0 2.0 6.0 0.0 1.5 0.7 0.0 0.0 0.0 7.9 29.6 0.2 0.0 0.0 0.0 2.3 6.4 0.0 1.3 0.3 4.1 3.7 0.0 0.0 0.0 0.0 3.3 3.3 0.0 1.4 0.0 0.0 0.0 0.0 1.1 0.4 0.0 276.8 0.0 0.0 0.0 INHBA ENSG00000122641 "Inhibin beta A subunit" P08476 7 41667168-41705834 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 148.2" "Cell type enhanced" "Detected in many" 17 "Leydig cells: 127.4;Smooth muscle cells: 270.9;Syncytiotrophoblasts: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.2;hTEC/SVTERT24-B: 58.9;hTERT-HME1: 24.3;hTERT-RPE1: 36.3;TIME: 30.4;U-138 MG: 45.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 290000 "unprognostic (4.11e-3)" "prognostic unfavorable (1.46e-5)" "unprognostic (4.22e-2)" "unprognostic (1.08e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.44e-1)" "unprognostic (1.31e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (7.91e-8)" "unprognostic (6.22e-3)" "unprognostic (1.11e-2)" "unprognostic (3.25e-2)" "unprognostic (3.18e-3)" 1.7 1.0 1.2 3.6 3.7 6.6 1.3 0.7 3.5 1.7 1.5 0.8 1.3 0.3 13.6 4.2 3.8 1.6 17.3 9.3 1.9 1.6 2.0 7.9 26.4 0.6 1.2 0.7 5.2 1.2 0.0 0.8 148.2 4.8 2.4 0.2 1.4 4.3 3.8 1.2 2.9 0.8 3.8 8.7 0.4 1.5 3.9 1.3 0.4 1.5 2.6 0.7 4.8 1.8 0.2 0.7 1.8 1.3 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.8 1.9 0.0 4.6 0.5 2.5 0.8 0.0 0.1 0.0 0.3 1.7 3.0 3.8 0.0 19.2 2.5 1.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.8 1.1 58.9 24.3 36.3 2.0 0.0 0.1 0.0 5.9 0.0 0.0 0.1 0.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 0.1 0.0 1.7 0.0 0.0 30.4 45.9 13.3 4.9 4.8 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 1.8 0.0 1.3 0.0 0.0 0.3 1.2 3.7 0.7 1.3 1.9 1.6 1.2 0.7 4.8 1.3 3.0 17.8 0.5 7.8 15.3 0.0 4.8 0.0 4.0 5.7 0.0 0.0 0.4 0.0 4.5 0.5 3.1 0.0 0.0 1.6 2.6 14.6 5.6 7.0 11.4 1.4 0.0 0.0 1.3 2.7 1.9 127.4 45.7 13.5 46.9 0.0 12.6 10.6 0.0 21.9 0.0 0.9 0.0 270.9 0.5 0.1 7.9 149.2 0.0 0.0 2.3 INHBB ENSG00000163083 "Inhibin beta B subunit" P09529 2 120346143-120351808 "Cancer-related genes, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 15.3;Ciliated cells: 41.5;Cone photoreceptor cells: 23.6;Ito cells: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "A549: 15.5;ASC diff: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 13.0;MCF7: 18.6;PC-3: 30.2;SK-BR-3: 54.1;T-47d: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (7.80e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.26e-2)" "unprognostic (4.26e-2)" "unprognostic (3.61e-3)" "unprognostic (2.13e-2)" "unprognostic (5.52e-2)" "unprognostic (6.99e-2)" "unprognostic (3.59e-1)" "unprognostic (1.59e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.57e-3)" "unprognostic (4.14e-1)" "prognostic favorable (1.02e-4)" "unprognostic (1.76e-2)" 23.3 3.6 6.0 1.2 3.5 0.2 19.2 0.9 3.8 7.0 0.8 3.1 2.6 1.3 3.9 2.6 1.5 3.3 2.4 3.5 4.7 1.4 1.2 19.2 2.7 1.0 2.2 3.1 1.6 3.5 4.5 3.8 1.2 4.7 7.7 0.3 0.5 7.8 0.9 4.9 7.6 0.9 2.1 1.9 0.4 1.8 14.4 2.2 0.4 19.1 1.6 1.3 4.4 7.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 7.8 15.5 0.0 0.0 21.5 1.7 0.0 1.0 1.2 6.9 13.0 0.3 0.0 0.0 2.8 0.4 0.0 0.0 1.2 0.0 9.7 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.8 1.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 1.5 30.2 0.0 0.0 0.3 1.8 0.0 1.8 0.0 0.0 54.1 0.0 0.0 12.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.0 3.5 0.9 3.7 4.7 1.4 2.2 3.1 4.7 2.2 3.0 2.1 0.0 2.0 3.5 0.0 0.6 15.3 41.5 7.9 1.8 23.6 0.0 0.0 0.3 0.6 8.4 0.0 0.0 0.0 0.2 2.1 9.5 0.0 9.6 0.1 0.0 0.0 15.4 1.6 1.9 10.9 0.2 1.7 0.0 0.0 0.3 0.1 0.0 6.3 0.0 0.3 0.0 2.5 0.0 7.1 2.6 0.1 0.0 0.0 1.8 INHBC ENSG00000175189 "Inhibin beta C subunit" P55103 12 57434760-57450828 "Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 256 "liver: 121.3" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 5.0" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 9.7;Karpas-707: 10.0;RH-30: 5.0;U-266/70: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 11000000 "unprognostic (5.26e-2)" "unprognostic (4.58e-1)" "unprognostic (3.43e-3)" "unprognostic (4.08e-3)" "unprognostic (3.76e-1)" "unprognostic (1.98e-2)" "unprognostic (1.03e-2)" "unprognostic (1.10e-1)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.68e-4)" "unprognostic (2.90e-2)" "unprognostic (1.52e-1)" "unprognostic (3.55e-3)" "unprognostic (5.05e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 2.3 0.1 0.0 0.0 0.2 0.2 0.1 0.1 1.5 0.1 0.5 0.0 9.7 0.0 0.4 0.1 0.4 0.0 0.0 0.7 0.0 0.0 2.7 0.1 10.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 5.0 0.7 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.1 0.5 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 INHBE "activin, MGC4638" ENSG00000139269 "Inhibin beta E subunit" P58166 12 57452323-57459280 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 40 "liver: 127.6" "Cell type enriched" "Detected in single" 51 "Hepatocytes: 32.6" "Cancer enriched" "Detected in some" 27 "liver cancer: 34.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 15.2;Karpas-707: 22.8;RH-30: 10.7;U-266/70: 76.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016843, CAB034017" Enhanced Supported Vesicles "Secreted to blood" NA NA 1400000 Vesicles "CAB034017: AB_2233745, HPA016843: AB_1851796" "unprognostic (7.34e-2)" "unprognostic (6.73e-2)" "unprognostic (3.45e-1)" "unprognostic (4.69e-5)" "unprognostic (2.61e-1)" "unprognostic (2.50e-1)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.79e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.66e-8)" "unprognostic (4.09e-3)" "unprognostic (1.56e-1)" "unprognostic (3.57e-2)" "unprognostic (7.52e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 127.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 1.0 0.9 3.1 0.6 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.8 2.2 0.0 2.7 0.1 0.0 1.1 0.5 0.2 0.0 0.1 0.5 0.0 0.3 5.1 0.0 0.0 0.0 3.3 15.2 0.6 0.7 1.4 1.5 0.3 3.3 0.1 0.0 0.5 1.3 22.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 2.3 0.0 0.0 5.7 0.2 0.0 0.0 2.1 0.1 0.1 2.4 0.0 0.0 1.2 0.0 0.1 76.9 2.4 1.0 0.4 0.1 0.1 1.9 0.5 0.5 0.3 0.4 0.4 0.9 0.1 0.2 0.1 1.0 0.2 0.5 3.1 0.6 0.6 0.9 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 INMT ENSG00000241644 "Indolethylamine N-methyltransferase" O95050 7 30697985-30757602 "Enzymes, Predicted intracellular proteins" Detoxification "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 73.5" "Group enriched" "Detected in many" 10 "Ito cells: 257.8;Leydig cells: 264.1;Peritubular cells: 428.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 22.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "CACO-2: 18.7;HHSteC: 8.0" HPA061343 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA061343: AB_2684483" "unprognostic (1.70e-1)" "unprognostic (4.36e-2)" "unprognostic (5.26e-2)" "unprognostic (6.78e-3)" "unprognostic (1.59e-1)" "unprognostic (3.39e-4)" "prognostic favorable (5.72e-4)" "unprognostic (3.08e-2)" "unprognostic (3.94e-2)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (9.07e-2)" "unprognostic (4.97e-2)" "unprognostic (1.62e-2)" "unprognostic (1.43e-2)" "unprognostic (9.71e-2)" "unprognostic (1.58e-2)" 19.7 18.0 0.3 3.0 0.7 0.0 5.9 0.3 0.6 4.9 3.7 1.3 14.0 0.8 9.8 18.9 12.4 16.3 14.7 24.6 0.6 0.4 11.8 24.3 73.5 12.1 1.1 0.8 20.2 4.0 0.7 3.2 12.9 2.5 10.1 1.6 13.0 6.1 19.9 4.7 1.5 3.9 11.3 1.3 6.5 5.0 28.2 0.2 0.5 9.4 3.8 2.8 9.6 6.4 1.7 1.1 4.2 1.0 2.2 1.0 0.6 0.0 0.1 0.1 0.1 1.8 2.6 0.4 0.2 2.4 0.0 0.0 18.7 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 8.0 0.1 0.3 0.9 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.3 0.3 0.1 0.0 0.4 0.9 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.6 0.1 0.8 0.0 0.8 0.2 0.1 1.1 0.1 0.8 0.3 0.1 0.8 0.3 0.1 0.2 0.1 0.3 4.2 1.0 0.8 0.7 0.4 0.7 1.2 0.7 0.6 0.4 1.7 1.0 0.8 3.0 2.2 0.4 1.1 0.6 0.6 0.3 0.7 0.3 0.6 0.6 0.4 1.1 0.8 2.5 0.2 0.0 5.1 0.0 0.2 1.9 0.0 7.8 2.5 1.4 4.5 0.0 0.0 0.5 0.0 0.0 1.3 9.7 0.0 0.0 0.0 0.2 21.8 0.2 0.0 3.0 0.7 0.0 1.2 257.8 19.4 8.5 264.1 0.5 3.3 0.0 0.0 0.0 0.0 0.0 428.2 0.0 0.0 32.3 16.0 1.4 1.4 1.9 1.5 0.0 0.0 0.3 INO80C "C18orf37, FLJ38183, hIes6, IES6" ENSG00000153391 "INO80 complex subunit C" Q6PI98 18 35452230-35497991 "Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 65.5" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 123.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA049060 Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA049060: AB_2680617" "unprognostic (3.40e-1)" "prognostic favorable (3.58e-4)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.62e-5)" "unprognostic (5.56e-2)" "unprognostic (9.68e-2)" "unprognostic (1.72e-3)" "unprognostic (2.03e-1)" "unprognostic (3.32e-3)" "unprognostic (2.08e-3)" "unprognostic (2.61e-1)" "unprognostic (6.94e-3)" "unprognostic (1.18e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-2)" "unprognostic (5.14e-3)" "unprognostic (5.38e-2)" 6.7 7.7 12.4 13.0 16.7 19.4 7.8 10.9 11.0 7.1 10.6 7.3 4.5 8.7 6.4 7.1 20.1 6.8 10.4 11.8 10.8 12.9 9.5 9.9 8.4 11.3 7.9 9.2 4.6 5.7 2.7 17.8 26.3 8.0 6.0 10.8 11.5 13.2 5.2 18.2 19.8 11.7 5.3 6.7 14.2 15.0 65.5 8.1 11.1 9.1 19.2 13.5 8.2 10.5 17.5 23.9 24.5 14.3 8.1 14.9 8.2 15.9 10.4 9.5 5.1 3.4 8.7 10.5 6.2 4.6 9.7 13.1 12.8 13.6 26.2 13.3 4.0 14.9 11.1 18.2 39.4 8.8 7.6 9.9 33.4 12.6 13.8 7.6 19.2 21.4 3.8 11.4 25.2 13.7 12.1 28.0 11.3 10.0 9.8 15.6 16.5 12.3 16.4 12.3 11.0 6.3 9.6 6.7 8.8 20.3 20.5 13.3 9.1 10.3 11.2 7.7 15.6 11.0 15.5 18.6 11.1 4.9 8.6 11.1 8.7 9.1 46.6 9.0 17.8 6.6 13.9 11.1 24.5 9.4 14.3 9.2 17.5 13.1 12.2 15.8 13.0 13.3 11.0 17.0 8.1 12.4 23.9 14.9 8.2 12.4 16.7 10.9 11.0 10.8 12.9 7.9 9.2 8.0 8.1 6.0 8.5 29.2 18.4 21.3 4.3 13.2 12.7 24.1 10.3 12.2 3.9 51.3 26.6 30.2 123.3 22.4 45.2 0.0 34.8 86.5 15.8 17.9 19.7 16.8 44.0 4.8 14.5 16.5 18.1 32.1 5.8 12.8 21.9 10.8 19.5 16.3 101.7 31.6 6.7 65.2 13.1 0.0 14.5 85.2 40.5 34.9 61.2 11.7 32.2 29.2 INPP5D "hp51CN, SHIP, SHIP1" ENSG00000168918 "Inositol polyphosphate-5-phosphatase D" Q92835 2 233059967-233207903 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 9 "B-cells: 58.1;Kupffer cells: 48.3;T-cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.4;HEL: 31.9;HMC-1: 33.5;hTCEpi: 30.7;NB-4: 29.9;THP-1: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016300, HPA070455" Enhanced Approved Cytosol No No Cytosol "CAB016300: AB_628250, HPA070455: AB_2686267" "unprognostic (5.29e-2)" "unprognostic (2.05e-3)" "unprognostic (1.99e-2)" "unprognostic (6.71e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "unprognostic (2.29e-2)" "unprognostic (3.74e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.14e-2)" "unprognostic (1.66e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (6.54e-2)" 7.1 3.1 7.2 33.0 10.7 24.6 4.7 1.7 6.9 3.6 3.7 12.5 0.7 3.5 4.1 2.9 3.3 3.3 6.7 3.2 6.6 9.1 5.1 3.3 8.0 26.1 8.8 2.6 1.9 2.1 1.6 3.4 7.4 7.6 4.5 4.5 3.3 18.8 3.0 1.9 3.4 15.8 3.4 17.6 40.9 4.1 2.4 9.5 16.7 3.1 3.4 32.3 6.2 3.5 14.5 12.0 10.5 18.2 11.9 16.7 14.0 0.0 0.0 0.2 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.4 6.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 5.1 0.0 31.9 0.0 3.0 0.2 9.6 33.5 0.6 30.7 0.1 3.4 0.1 4.4 0.9 0.1 2.8 0.1 0.0 4.4 29.9 1.0 0.0 0.0 9.3 0.0 2.2 0.0 1.8 0.0 0.0 0.0 0.6 0.0 4.1 0.0 21.4 3.6 0.0 0.5 0.0 0.0 0.0 1.7 9.2 0.0 12.4 0.0 9.8 9.8 10.5 16.7 15.8 11.4 14.5 7.5 12.3 12.0 13.9 6.3 8.8 9.9 11.9 18.2 6.0 10.2 14.0 7.2 10.7 1.7 6.9 6.6 9.1 8.8 2.6 7.6 9.5 3.0 25.7 58.1 1.2 1.4 0.1 3.2 2.5 4.0 4.5 3.5 0.0 0.4 0.0 0.3 12.8 17.5 0.0 0.0 0.4 0.6 1.0 0.4 14.0 1.3 24.6 0.0 0.0 13.5 48.3 10.6 0.0 20.7 0.0 13.6 0.2 0.0 0.2 0.9 1.1 0.3 0.0 0.0 1.2 0.4 0.7 1.0 0.9 51.0 0.4 1.0 INPP5F "hSac2, KIAA0966, SAC2" ENSG00000198825 "Inositol polyphosphate-5-phosphatase F" Q9Y2H2 10 119726097-119829278 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 30.5;SH-SY5Y: 24.2;SK-MEL-30: 46.0;SuSa: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042605 Supported Vesicles NA NA Vesicles "HPA042605: AB_10793886" "unprognostic (2.65e-2)" "unprognostic (3.23e-1)" "unprognostic (3.42e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-2)" "unprognostic (1.57e-3)" "unprognostic (2.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (6.46e-2)" "unprognostic (7.78e-2)" "unprognostic (1.02e-1)" "unprognostic (9.91e-2)" "unprognostic (2.96e-2)" "unprognostic (6.21e-2)" 4.6 12.3 17.5 5.9 50.4 3.2 5.7 37.0 52.9 10.9 5.0 5.5 2.2 3.1 11.8 18.0 4.5 4.2 5.5 4.1 24.6 53.1 7.3 2.0 4.2 7.6 23.7 29.1 9.8 4.6 8.9 34.0 8.2 69.7 8.3 6.1 3.4 7.1 8.4 7.5 10.4 3.8 10.8 19.2 4.1 3.8 10.1 7.3 1.4 8.4 1.4 9.3 5.3 4.5 12.2 7.4 1.5 4.5 3.8 6.7 2.2 3.9 2.7 30.5 4.4 3.3 3.4 2.7 5.5 3.0 2.6 2.6 4.0 5.0 2.5 2.1 6.9 3.6 4.4 3.3 3.2 4.0 1.6 3.0 1.7 1.4 4.1 4.6 1.1 5.6 4.1 3.0 5.2 5.2 5.4 8.8 2.0 1.5 4.1 6.2 2.2 1.5 4.6 2.9 3.6 3.5 2.1 5.4 0.6 4.4 2.0 2.2 24.2 6.1 1.9 46.0 63.8 1.3 1.2 5.8 2.6 3.4 3.4 5.3 4.6 2.0 1.1 3.3 3.9 10.7 1.1 4.0 1.5 1.3 3.5 1.6 8.1 2.8 1.9 7.4 12.2 3.2 1.4 1.0 3.8 4.5 1.8 6.7 2.2 17.5 50.4 37.0 50.5 24.6 53.1 23.7 29.1 69.7 7.3 6.0 4.5 10.0 9.8 8.0 24.8 5.3 0.0 2.7 5.7 12.2 15.7 7.7 10.0 3.1 28.7 7.4 6.4 0.0 3.9 7.2 6.7 8.4 2.3 2.8 8.6 39.7 1.2 4.9 5.7 18.7 4.9 11.5 18.6 21.6 5.8 18.8 5.5 5.5 3.5 16.7 21.0 6.5 7.5 10.3 40.3 9.2 11.1 4.3 6.0 10.2 INPP5J "INPP5, PIB5PA, PIPP" ENSG00000185133 "Inositol polyphosphate-5-phosphatase J" Q15735 22 31122731-31134696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.2;thyroid gland: 71.2" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 33.2;Enterocytes: 31.9;Muller glia cells: 20.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 63.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.4" "Cell line enhanced" "Detected in many" "HL-60: 12.3;SK-BR-3: 26.8;T-47d: 16.9;U-698: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034539 Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA034539: AB_10670974" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-2)" "unprognostic (2.21e-3)" "prognostic favorable (1.47e-5)" "unprognostic (6.81e-2)" "unprognostic (1.86e-2)" "unprognostic (4.29e-4)" "unprognostic (1.47e-1)" "prognostic favorable (1.12e-7)" "unprognostic (2.79e-3)" "unprognostic (3.65e-2)" "unprognostic (2.14e-1)" "unprognostic (1.39e-2)" 0.8 0.9 4.6 0.8 6.3 0.5 3.7 27.4 13.4 1.5 6.4 0.8 16.7 7.9 1.3 0.8 1.0 1.0 1.0 9.5 7.4 2.0 9.5 0.5 1.5 0.7 2.3 4.6 0.8 5.3 65.2 3.7 0.5 5.5 3.5 2.2 5.6 15.5 19.2 1.6 1.7 21.7 1.2 0.9 0.6 3.8 1.6 1.1 0.0 71.2 0.0 0.7 1.1 0.9 0.3 2.4 0.0 0.4 0.0 0.0 0.2 1.3 1.3 0.8 1.5 0.2 0.2 0.7 0.5 0.5 2.7 2.6 0.8 0.8 0.0 0.6 0.2 0.3 1.6 1.6 0.7 1.1 0.0 4.3 0.0 5.6 0.2 0.5 12.3 0.1 0.1 0.8 2.2 0.2 1.8 0.1 0.0 1.1 1.9 0.0 4.1 0.1 0.0 1.5 1.7 0.2 0.0 0.3 2.9 1.1 1.6 6.5 4.9 1.0 26.8 0.3 0.7 16.9 1.0 0.0 0.1 4.9 0.5 0.3 0.0 2.1 11.6 0.4 0.0 2.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.2 4.6 6.3 27.4 13.4 7.4 2.0 2.3 4.6 5.5 1.1 0.0 2.6 0.0 2.3 0.8 7.9 4.8 0.0 0.0 1.2 33.2 0.0 0.0 10.0 1.2 0.3 0.0 31.9 0.0 1.9 0.1 0.2 3.7 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 5.0 20.3 1.0 10.5 0.0 0.6 2.3 0.0 0.3 1.7 0.9 1.1 0.1 0.0 6.8 0.9 INPP5K SKIP ENSG00000132376 "Inositol polyphosphate-5-phosphatase K" Q9BT40 17 1494571-1516888 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cataract, Congenital muscular dystrophy, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 114.9" "Cell type enhanced" "Detected in many" 11 "Late spermatids: 261.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.47e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.91e-2)" "prognostic favorable (2.33e-5)" "unprognostic (3.25e-1)" "unprognostic (9.22e-2)" "unprognostic (1.50e-1)" "unprognostic (7.50e-2)" "unprognostic (2.00e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.47e-6)" "unprognostic (4.71e-2)" "unprognostic (9.35e-3)" "unprognostic (3.01e-2)" "unprognostic (7.20e-2)" "unprognostic (4.28e-3)" "unprognostic (1.04e-1)" 27.9 10.5 12.7 13.8 13.5 25.9 37.0 14.9 17.7 13.4 13.4 14.9 9.8 9.1 12.8 12.2 12.0 10.4 12.9 17.5 12.8 12.6 11.6 10.5 20.8 14.3 12.8 12.0 14.3 18.9 12.0 10.8 15.9 21.2 13.5 11.4 114.9 12.9 12.2 26.4 22.3 13.9 10.9 10.7 16.2 12.8 20.8 11.3 22.1 27.3 13.8 16.4 12.5 14.1 12.1 16.5 36.4 27.0 17.0 30.8 24.6 9.5 13.2 5.4 10.4 14.1 7.9 8.1 8.0 13.5 9.1 11.6 8.2 5.7 8.5 15.4 12.2 7.5 12.5 13.0 5.2 9.3 22.0 21.8 5.3 10.1 3.2 17.9 5.0 10.3 9.3 13.8 9.1 9.0 5.8 14.4 14.5 5.7 15.3 6.0 6.8 15.1 4.1 2.3 14.3 9.0 11.6 4.3 8.0 7.3 5.9 4.3 10.9 6.3 12.3 14.3 8.4 10.4 4.1 10.2 8.0 8.2 11.5 10.3 8.1 13.5 4.5 9.0 5.2 10.0 36.4 19.9 31.9 22.2 18.7 18.2 12.1 20.7 22.4 16.5 11.3 17.7 18.9 33.3 17.0 27.0 11.9 30.8 24.6 12.7 13.5 14.9 17.7 12.8 12.6 12.8 12.0 21.2 11.3 29.8 13.1 9.5 13.9 26.7 7.5 31.5 5.1 5.3 7.9 22.7 2.0 11.5 11.6 15.2 90.2 27.4 20.9 0.0 21.2 13.3 15.4 14.1 19.6 8.9 10.7 19.1 16.7 21.5 19.1 261.4 10.6 16.0 30.4 48.7 17.0 20.3 21.3 21.0 7.1 9.0 7.6 19.4 16.4 31.6 16.7 26.5 26.0 36.3 11.0 14.4 INS "IDDM1, IDDM2" ENSG00000254647 Insulin P01308 11 2159779-2161341 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism" Hormone "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 193 "pancreas: 514.0" "Cell type enriched" "Detected in some" 21 "Pancreatic endocrine cells: 2404.6" "Cancer enriched" "Detected in single" 7166 "pancreatic cancer: 1751.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "EFO-21: 53.7;U-2 OS: 70.4;U-698: 22.2" "Region enriched" "Detected in single" 13 "midbrain: 1.7" "CAB000048, HPA004932, CAB012098, CAB053843" Enhanced "Secreted to blood" NA NA 437000 "CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816" "unprognostic (7.61e-2)" 0.4 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 514.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 2.6 0.1 0.1 0.1 0.1 1.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.4 0.0 5.4 0.0 2.4 22.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.2 0.0 0.0 2404.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INS-IGF2 ENSG00000129965 "INS-IGF2 readthrough" F8WCM5 11 2132538-2161209 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 148 "pancreas: 467.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.2;SH-SY5Y: 5.8" CAB019430 Enhanced "Secreted to digestive system" NA NA "CAB019430: AB_10691857" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.3 0.1 0.0 0.3 0.0 0.4 467.6 0.0 0.1 3.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.4;liver: 143.2" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 494.0" "Cancer enhanced" "Detected in all" "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 45.7;non-classical monocyte: 81.4" "Lineage enriched" "Detected in all" 6 "monocytes: 81.4" "Cell line enhanced" "Detected in many" "Karpas-707: 155.1;RPMI-8226: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Uncertain Vesicles NA NA Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.62e-4)" "unprognostic (4.97e-2)" 18.4 9.2 8.5 8.3 8.8 9.7 14.1 10.1 14.3 6.0 7.4 21.8 7.5 12.5 5.2 8.3 15.6 4.6 8.0 5.6 10.8 11.6 6.4 143.2 18.5 6.9 8.6 8.3 16.4 27.2 4.6 5.2 17.5 23.9 15.9 6.7 11.9 31.4 3.1 2.4 10.5 14.2 5.1 19.2 4.5 13.4 8.2 8.3 10.7 3.3 6.1 6.9 11.2 5.6 10.0 13.6 10.7 81.4 4.0 12.7 12.5 19.2 3.6 9.6 6.0 25.4 34.0 5.2 1.5 22.0 4.6 30.7 2.2 28.0 12.6 4.5 11.9 35.9 10.4 6.5 11.4 5.5 3.8 19.2 3.4 6.6 0.0 12.5 5.8 57.0 21.1 6.3 35.5 3.3 3.4 6.1 25.1 6.3 155.1 5.9 10.0 28.5 15.4 10.0 3.6 2.2 5.3 0.0 72.7 36.3 9.6 7.2 5.6 5.1 3.7 8.1 3.7 3.6 19.6 6.9 5.1 1.5 9.6 4.0 37.8 6.6 11.2 22.6 22.8 4.7 3.1 4.9 2.1 8.7 45.7 4.4 7.7 6.0 7.4 13.6 10.0 5.9 6.7 10.7 4.0 81.4 7.7 12.7 12.5 8.5 8.8 10.1 14.3 10.8 11.6 8.6 8.3 23.9 8.3 38.7 98.0 59.2 52.4 124.6 12.6 22.7 28.1 48.2 35.2 38.4 9.8 43.4 14.9 38.4 16.5 50.6 41.6 0.0 120.7 153.6 37.0 96.2 61.0 494.0 42.6 36.5 121.5 36.2 57.7 5.6 14.7 90.2 234.5 28.9 44.4 73.4 47.8 10.5 17.3 8.4 17.2 19.4 86.4 38.0 53.2 135.8 109.0 47.3 19.0 105.7 INSL3 "MGC119818, MGC119819, RLF, RLNL" ENSG00000248099 "Insulin like 3" P51460 19 17816512-17821574 "Disease related genes, Predicted secreted proteins" Hormone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 234.1" "Group enriched" "Detected in some" 68 "Leydig cells: 1148.3;Peritubular cells: 938.7" "Cancer enriched" "Detected in many" 21 "testis cancer: 39.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 8.9;PC-3: 4.1;SCLC-21H: 8.2;SH-SY5Y: 7.4" HPA028615 Enhanced "Secreted to blood" NA NA 566000 "HPA028615: AB_10600717" "unprognostic (3.25e-1)" "unprognostic (2.25e-4)" "unprognostic (3.50e-5)" "unprognostic (7.04e-2)" "unprognostic (1.74e-4)" "unprognostic (4.60e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.44e-1)" "unprognostic (1.73e-1)" "unprognostic (4.46e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-10)" "unprognostic (6.80e-3)" "unprognostic (1.41e-1)" "unprognostic (8.85e-2)" "unprognostic (1.09e-5)" 0.1 0.4 0.1 1.1 0.2 0.3 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 9.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 1.1 0.1 234.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 2.4 0.3 5.7 1.2 1.3 2.9 1.1 0.4 1.0 0.2 0.8 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 1.7 0.2 2.3 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.1 0.7 0.0 0.3 0.0 0.1 2.0 1.3 0.9 0.0 0.0 0.0 0.0 0.2 0.1 8.9 0.0 1.6 0.3 1.6 0.0 1.7 4.1 1.3 0.0 0.2 0.2 0.5 8.2 7.4 0.1 2.5 0.0 0.1 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.7 3.1 0.2 0.1 2.0 0.0 0.8 0.5 0.0 1.8 1.2 1.8 0.3 2.4 2.3 0.3 2.4 2.1 2.9 5.7 1.3 0.3 0.3 2.0 1.1 0.1 0.2 0.2 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 15.4 1148.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 938.7 0.0 0.0 0.0 0.0 2.6 4.7 0.0 0.5 0.0 0.0 0.0 INSL4 EPIL ENSG00000120211 "Insulin like 4" Q14641 9 5231419-5235304 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "placenta: 88.0" "Cell type enriched" "Detected in some" 11 "Syncytiotrophoblasts: 2990.3" "Cancer enhanced" "Detected in some" "lung cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "A549: 23.6" HPA065145 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA065145: " "unprognostic (9.77e-2)" "unprognostic (2.02e-1)" "unprognostic (4.66e-1)" "unprognostic (7.74e-2)" 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.8 0.1 0.0 0.0 0.2 0.0 0.1 0.8 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 88.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 23.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 269.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2990.3 0.0 0.0 0.0 INSL5 ENSG00000172410 "Insulin like 5" Q9Y5Q6 1 66797741-66801256 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "intestine: 52.9" "Cell type enriched" "Detected in some" 577 "Intestinal endocrine cells: 8520.8" "Group enriched" "Detected in some" 5 "colorectal cancer: 1.2;prostate cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;hTCEpi: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030100, CAB033849" Enhanced "Secreted to blood" NA NA 38500000 "CAB033849: AB_2264904, HPA030100: AB_10601915" "unprognostic (2.48e-1)" "unprognostic (4.41e-2)" "unprognostic (2.91e-1)" "unprognostic (1.18e-1)" "unprognostic (2.76e-2)" "unprognostic (1.30e-1)" "unprognostic (2.62e-2)" "unprognostic (7.53e-2)" 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.1 1.0 0.0 30.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 1.8 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.2 52.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8520.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 INSL6 RIF1 ENSG00000120210 "Insulin like 6" Q9Y581 9 5131979-5185668 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 22.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 106.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;HL-60: 1.6" "Low region specificity" "Detected in single" HPA021364 Enhanced "Secreted to blood" NA NA "HPA021364: AB_1851807" "unprognostic (3.85e-4)" "unprognostic (7.41e-4)" "unprognostic (1.28e-1)" "unprognostic (1.94e-1)" "unprognostic (2.22e-1)" "unprognostic (6.92e-2)" "unprognostic (2.31e-2)" "unprognostic (3.82e-2)" "unprognostic (2.30e-1)" "unprognostic (2.52e-3)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 22.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 106.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 20.6 9.0 0.0 0.2 0.0 0.0 0.0 INSM1 "IA-1, IA1" ENSG00000173404 "INSM transcriptional repressor 1" Q01101 20 20368121-20370949 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 13.2;brain: 15.5;pituitary gland: 29.2" "Cell type enriched" "Detected in some" 23 "Intestinal endocrine cells: 486.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.3" "Cell line enriched" "Detected in some" 20 "SCLC-21H: 93.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.86e-2)" "unprognostic (5.25e-4)" "unprognostic (7.59e-2)" "unprognostic (3.49e-2)" "unprognostic (1.07e-1)" "unprognostic (1.07e-3)" "unprognostic (4.34e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.38e-3)" "unprognostic (1.33e-1)" "unprognostic (1.52e-1)" "unprognostic (2.77e-1)" "unprognostic (1.33e-1)" "unprognostic (5.23e-1)" "unprognostic (1.22e-1)" 0.4 13.2 2.4 1.2 4.6 0.2 0.5 15.5 3.8 0.1 6.2 2.8 0.2 5.5 0.1 0.1 0.1 0.1 0.2 0.1 3.4 4.4 0.2 0.1 0.3 1.1 1.8 1.4 0.1 5.5 0.1 29.2 0.1 1.0 0.6 3.6 0.0 0.1 0.6 0.1 0.3 3.7 0.2 0.4 0.5 10.4 0.7 1.4 8.3 0.2 0.0 0.7 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 4.6 0.0 0.0 93.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.4 4.6 15.5 3.8 3.4 4.4 1.8 1.4 1.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 486.9 0.0 0.0 0.0 0.0 0.0 3.3 20.8 2.3 0.0 2.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 2.1 0.0 INSM2 "IA-6, Mlt1" ENSG00000168348 "INSM transcriptional repressor 2" Q96T92 14 35534042-35537054 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.3;brain: 5.2;salivary gland: 1.6;testis: 2.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 2.0;Rod photoreceptor cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 134 "SH-SY5Y: 50.5" "Region enhanced" "Detected in single" "hypothalamus: 1.3" "Low region specificity" "Detected in some" "HPA044885, HPA051925" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA044885: AB_10794779, HPA051925: AB_2681664" "unprognostic (9.88e-2)" "unprognostic (8.74e-2)" "unprognostic (2.35e-1)" "unprognostic (1.08e-3)" "unprognostic (3.29e-3)" "unprognostic (1.72e-1)" "unprognostic (2.51e-1)" "unprognostic (2.26e-3)" "unprognostic (2.60e-3)" "unprognostic (7.51e-2)" "unprognostic (1.75e-2)" "unprognostic (2.36e-3)" "unprognostic (5.00e-1)" 0.3 2.3 1.0 0.5 2.8 0.2 0.3 0.5 5.2 0.2 0.2 1.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.8 5.0 0.2 0.2 0.3 0.2 1.9 1.2 0.2 0.2 0.2 0.1 0.2 2.7 0.2 0.2 0.7 1.6 0.2 0.2 0.4 0.2 0.2 0.4 0.2 0.2 2.9 0.2 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 50.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.5 4.6 0.8 5.0 1.9 1.2 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294034 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 64.5" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 230.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5" "Cell line enhanced" "Detected in many" "Karpas-707: 31.3;U-266/70: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" NA NA 72000 Vesicles "Plasma membrane" "HPA036302: AB_2675048, HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.9 14.7 7.1 3.5 8.2 4.5 12.0 12.0 8.2 10.3 15.2 11.7 10.6 8.4 15.5 6.1 4.7 13.1 7.7 17.7 6.4 5.8 18.7 32.5 5.3 2.2 10.1 4.9 28.3 64.5 11.6 11.6 26.2 8.0 10.5 8.9 11.0 12.0 10.6 15.1 7.3 16.0 10.6 6.8 47.3 8.7 6.9 9.7 2.2 17.1 5.0 3.2 11.3 16.0 1.1 8.8 5.1 10.5 0.8 0.7 1.3 3.8 2.1 2.0 3.0 10.9 3.8 6.5 2.2 2.0 1.2 1.2 5.4 4.4 4.8 5.4 3.9 2.6 1.0 4.7 1.0 0.7 0.0 3.8 0.0 1.5 11.8 4.7 2.2 3.9 5.9 2.4 0.1 2.8 2.4 2.2 2.7 5.9 31.3 0.9 1.7 1.7 3.9 1.8 2.0 3.4 16.7 1.1 4.2 0.1 15.8 3.7 2.9 3.9 2.1 2.1 3.7 1.0 11.0 2.0 2.3 1.4 4.9 2.8 23.1 12.6 11.2 2.6 3.9 0.0 2.0 8.2 5.1 0.2 7.8 0.3 0.8 0.3 0.1 8.8 1.1 0.7 0.1 1.7 0.8 10.5 7.4 0.0 1.3 7.1 8.2 12.0 8.2 6.4 5.8 10.1 4.9 8.0 9.7 44.7 26.7 8.2 54.6 57.7 38.7 85.3 107.0 41.5 50.0 59.3 74.6 15.8 13.3 41.1 2.9 52.3 87.1 0.0 68.2 39.2 29.8 84.0 3.5 214.7 8.6 36.5 157.1 201.3 47.7 3.6 89.2 26.7 49.0 8.2 103.9 26.9 67.8 56.1 230.5 116.2 22.2 58.2 42.3 6.2 1.2 60.1 32.0 6.4 56.3 113.2 INSRR IRR ENSG00000027644 "Insulin receptor related receptor" P14616 1 156840063-156859018 "Enzymes, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.5;brain: 5.9;kidney: 8.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 1.3;Cardiomyocytes: 1.7;Early spermatids: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 5.5;SH-SY5Y: 19.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA025285 Uncertain NA NA "HPA025285: AB_1851814" "unprognostic (1.19e-1)" "unprognostic (7.69e-2)" "unprognostic (2.42e-2)" "unprognostic (6.76e-4)" "unprognostic (1.51e-1)" "unprognostic (9.07e-3)" "unprognostic (5.57e-2)" "unprognostic (1.75e-1)" "unprognostic (6.17e-2)" "unprognostic (5.57e-2)" "unprognostic (2.20e-2)" "unprognostic (7.00e-2)" "unprognostic (4.22e-5)" "unprognostic (2.82e-1)" "unprognostic (9.55e-2)" "unprognostic (2.75e-3)" "unprognostic (3.66e-2)" 0.9 5.5 0.0 0.3 5.9 0.1 0.8 1.9 1.4 1.9 0.1 0.0 0.0 0.1 2.7 0.1 0.1 0.6 0.3 1.9 0.5 1.3 8.3 0.1 0.1 0.4 0.8 0.6 0.3 0.9 0.1 1.7 0.4 5.6 2.7 0.1 2.1 0.6 0.5 0.4 0.1 0.2 0.3 0.0 0.2 3.0 4.2 0.4 0.3 0.3 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 19.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.9 1.4 0.5 1.3 0.8 0.6 5.6 0.4 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 IP6K3 "IHPK3, INSP6K3" ENSG00000161896 "Inositol hexakisphosphate kinase 3" Q96PC2 6 33721670-33746905 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 22.5;skeletal muscle: 87.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA053644, HPA062531" Approved Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA053644: AB_2682214, HPA062531: " "unprognostic (3.23e-2)" "unprognostic (2.87e-1)" "unprognostic (2.07e-5)" "unprognostic (1.07e-3)" "unprognostic (2.20e-1)" "unprognostic (5.10e-3)" "unprognostic (1.38e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "unprognostic (2.47e-2)" "unprognostic (1.24e-2)" "unprognostic (2.94e-3)" "prognostic unfavorable (6.09e-4)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (2.66e-3)" "unprognostic (1.33e-1)" 2.2 1.0 2.1 0.8 13.0 0.5 0.9 0.6 6.2 1.2 2.2 11.8 1.4 0.8 1.6 1.4 5.2 1.3 0.6 10.0 3.2 1.3 4.7 7.7 2.0 0.6 22.5 1.1 0.6 0.7 0.5 0.5 3.8 7.7 2.8 1.0 1.2 1.4 1.8 87.9 0.5 1.1 1.8 9.2 1.4 0.9 0.6 15.2 0.0 9.9 8.1 0.5 1.5 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.1 0.2 0.2 1.9 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 16.2 0.0 0.0 5.8 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.4 4.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 13.0 0.6 6.2 3.2 1.3 22.5 1.1 7.7 15.2 0.0 0.0 0.0 0.0 0.0 2.2 10.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 5.8 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.1 6.5 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.1 IPCEF1 "KIAA0403, PIP3-E" ENSG00000074706 "Interaction protein for cytohesin exchange factors 1" Q8WWN9 6 154154496-154356792 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9" "Cell type enhanced" "Detected in many" 17 "Kupffer cells: 14.6;Macrophages: 9.5;T-cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HMC-1: 19.7;THP-1: 10.0;U-937: 10.5" "HPA028708, HPA028710" Enhanced Approved "Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies" NA NA "Nuclear speckles, Plasma membrane" "Nucleoli, Cytoplasmic bodies" "HPA028708: AB_10601916, HPA028710: AB_2732442" "unprognostic (1.23e-2)" "unprognostic (8.93e-3)" "unprognostic (4.18e-2)" "unprognostic (5.63e-3)" "unprognostic (2.05e-1)" "unprognostic (6.55e-3)" "unprognostic (1.30e-3)" "unprognostic (2.57e-2)" "unprognostic (3.87e-1)" "unprognostic (5.84e-2)" "unprognostic (3.27e-2)" "unprognostic (4.87e-2)" "unprognostic (5.01e-2)" "unprognostic (8.64e-2)" "unprognostic (5.45e-2)" "unprognostic (1.42e-2)" "unprognostic (1.51e-4)" 1.3 0.7 5.3 6.9 12.9 15.2 1.9 20.0 26.4 3.4 1.6 5.5 0.0 1.1 1.7 1.8 1.9 2.5 3.2 1.0 3.8 4.6 3.4 2.4 2.0 12.4 3.9 14.1 1.3 1.4 0.4 1.3 2.0 5.5 1.3 1.6 0.0 1.4 0.8 0.7 1.2 2.9 1.3 4.2 6.4 2.6 1.5 4.9 10.0 36.9 0.0 11.7 2.4 1.1 0.0 7.1 30.1 6.3 6.0 13.5 5.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 19.7 0.1 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 1.1 1.0 0.0 0.5 0.2 0.2 0.5 1.0 2.1 0.3 0.4 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.5 0.0 1.4 6.3 30.1 6.1 2.8 13.1 0.0 7.7 5.8 7.1 0.0 13.5 7.9 19.3 6.0 3.4 0.2 9.9 5.3 5.3 12.9 20.0 26.4 3.8 4.6 3.9 14.1 5.5 4.9 0.0 1.7 0.5 0.4 0.6 0.0 0.9 0.0 1.4 2.3 1.8 0.0 1.4 6.6 0.9 0.7 1.4 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.8 2.2 3.2 0.0 2.5 14.6 0.0 0.3 9.5 0.0 0.0 0.3 0.3 0.0 0.0 0.4 1.2 0.1 0.0 0.4 0.2 0.1 0.5 2.3 30.5 0.2 1.2 IPO13 "IMP13, KIAA0724, RANBP13" ENSG00000117408 "Importin 13" O94829 1 43946939-43968022 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 80.5" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 39.4;Late spermatids: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070425 Uncertain NA NA "CAB070425: AB_11157631" "unprognostic (7.15e-3)" "unprognostic (1.85e-1)" "unprognostic (1.56e-1)" "unprognostic (2.04e-1)" "unprognostic (4.15e-2)" "unprognostic (7.11e-2)" "prognostic unfavorable (8.26e-7)" "unprognostic (1.21e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-1)" "prognostic favorable (2.21e-4)" "unprognostic (1.18e-1)" "unprognostic (1.93e-3)" "unprognostic (6.42e-2)" "unprognostic (4.22e-2)" "unprognostic (8.13e-2)" "unprognostic (5.93e-3)" 8.1 10.7 21.8 7.3 28.5 6.7 6.8 17.6 27.6 8.4 7.4 42.1 4.5 7.2 8.5 11.1 12.2 10.7 7.4 17.4 27.6 16.6 16.0 9.2 7.2 7.0 27.8 18.4 7.6 8.0 21.6 10.8 8.0 18.4 10.4 8.2 7.4 10.5 13.1 80.5 11.1 6.1 12.1 35.8 7.7 7.3 25.1 27.6 6.3 13.8 13.0 7.9 8.1 5.8 2.8 5.5 2.6 3.7 4.5 4.9 2.2 13.6 11.1 11.2 17.7 30.6 15.9 9.4 13.1 12.2 19.7 15.1 8.5 6.9 14.3 13.6 17.1 12.5 15.3 20.1 23.1 13.1 14.5 17.2 14.9 20.1 11.6 21.6 9.9 13.9 16.2 23.6 25.5 16.0 14.8 13.0 11.2 14.9 13.2 15.6 9.5 10.0 13.1 10.3 11.7 18.7 13.9 14.1 15.0 14.5 13.2 18.0 8.3 12.3 20.8 17.0 15.4 13.0 13.8 10.6 19.7 11.9 17.1 14.7 14.8 18.1 6.9 12.6 21.5 17.1 0.0 3.3 2.6 4.9 3.7 4.4 2.8 3.2 4.9 5.5 2.2 2.9 3.6 1.1 4.5 3.7 5.3 3.8 2.2 21.8 28.5 17.6 27.6 27.6 16.6 27.8 18.4 18.4 27.6 0.0 1.3 6.5 2.5 3.0 14.7 21.7 10.2 5.3 3.4 10.4 7.9 5.2 1.7 5.8 39.4 5.2 7.5 0.0 3.7 3.3 4.2 3.3 0.0 10.2 14.0 27.0 2.9 4.9 9.1 63.2 7.8 2.8 8.5 8.2 4.6 11.2 5.2 0.0 14.9 14.7 7.3 0.0 4.7 19.1 11.9 3.8 3.4 5.0 4.7 3.4 IPO4 "FLJ23338, Imp4" ENSG00000196497 "Importin 4" Q8TEX9 14 24180219-24188964 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.5" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 59.5;Late spermatids: 85.2;Spermatocytes: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039043, HPA064572" Uncertain Approved Cytosol NA NA Cytosol "HPA039043: AB_10673233, HPA064572: AB_2685291" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (9.45e-2)" "unprognostic (2.60e-1)" "unprognostic (5.13e-2)" "unprognostic (6.75e-2)" "unprognostic (9.28e-2)" "prognostic unfavorable (3.20e-4)" "unprognostic (8.59e-4)" "unprognostic (5.45e-2)" "unprognostic (2.18e-1)" "unprognostic (2.15e-2)" 5.3 8.1 1.2 5.2 2.2 6.9 6.1 1.7 3.3 6.5 5.8 2.8 5.5 7.5 5.4 6.5 8.8 6.3 4.4 3.6 2.2 1.6 18.0 29.0 4.4 10.8 1.8 1.2 9.8 27.0 2.2 6.4 4.4 4.1 5.0 2.3 3.0 8.7 7.9 17.2 8.5 4.7 5.3 2.4 8.8 6.9 49.5 1.4 8.8 6.5 11.0 7.4 5.7 4.0 3.5 5.3 0.3 3.0 3.6 5.4 2.2 7.8 10.4 0.9 6.2 0.8 1.2 10.7 4.8 0.2 2.3 0.7 8.9 3.9 11.3 7.8 1.7 2.7 8.8 3.7 6.9 0.3 5.4 15.6 7.0 3.3 20.1 0.8 8.5 5.1 1.6 2.2 2.1 0.7 0.5 2.3 6.2 13.1 0.9 2.4 17.4 5.5 7.6 9.5 5.4 22.9 7.5 4.4 6.1 2.2 5.5 8.1 8.7 8.0 3.8 4.1 0.6 6.9 2.0 4.0 4.8 11.6 5.2 7.0 8.0 12.0 10.0 3.2 4.6 7.9 0.0 1.9 0.3 4.8 2.6 5.4 2.8 4.6 4.4 3.1 3.5 3.6 5.0 0.0 3.6 3.0 5.3 2.2 2.2 1.2 2.2 1.7 2.8 2.2 1.6 1.8 1.2 4.1 1.4 0.0 6.4 4.7 3.4 5.3 0.6 1.8 10.2 9.4 11.4 5.2 3.9 10.1 0.0 11.4 59.5 3.5 0.7 0.0 9.4 8.5 4.2 2.5 0.0 5.1 7.2 1.6 4.1 1.3 1.9 85.2 4.6 1.4 0.0 1.0 5.6 1.3 7.2 0.0 5.3 9.8 2.7 6.5 4.4 44.5 17.3 5.5 4.9 1.3 8.3 2.6 IQANK1 ENSG00000203499 "IQ motif and ankyrin repeat containing 1" 8 143734140-143790644 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 12.2;skin 1: 15.5;testis: 31.2" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 22.7;Club cells: 6.8;Collecting duct cells: 7.0;Cytotrophoblasts: 6.5;Syncytiotrophoblasts: 8.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.1;HaCaT: 12.4;hTCEpi: 15.2;MCF7: 29.6;OE19: 28.3;RT4: 12.7;SK-BR-3: 12.8;T-47d: 27.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.45e-3)" "unprognostic (3.38e-1)" "unprognostic (7.46e-2)" "unprognostic (4.94e-3)" "unprognostic (4.31e-3)" "unprognostic (1.98e-1)" "unprognostic (5.88e-2)" "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (2.22e-3)" "unprognostic (3.29e-2)" "unprognostic (4.49e-3)" "unprognostic (1.42e-2)" "unprognostic (1.47e-1)" "unprognostic (1.79e-1)" "unprognostic (9.40e-2)" 0.2 0.0 0.2 0.2 0.9 0.0 2.9 0.2 0.7 1.0 0.3 0.9 1.6 0.1 0.4 12.2 6.1 3.7 0.2 0.2 0.8 0.6 0.5 1.5 0.2 0.2 0.4 0.7 1.0 1.7 1.0 1.3 0.8 1.8 0.8 2.4 1.5 3.2 0.2 15.5 0.7 0.6 0.7 0.2 1.7 31.2 0.3 0.2 2.0 0.2 1.4 2.1 0.2 1.6 0.9 5.1 1.0 0.9 0.7 0.2 7.2 0.4 0.1 0.3 0.0 0.1 8.4 0.1 0.0 0.0 0.1 3.8 11.1 0.0 0.8 0.0 0.0 12.4 0.3 1.4 0.1 0.1 0.3 0.0 1.1 0.9 0.2 0.1 0.1 0.1 15.2 0.1 0.3 0.2 0.0 0.2 0.5 0.1 0.0 29.6 0.0 0.1 0.6 28.3 0.5 0.1 0.0 0.2 0.8 12.7 4.2 0.1 1.1 12.8 0.4 1.0 27.4 0.1 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.2 2.1 1.0 0.7 0.7 0.9 0.4 1.0 0.6 0.5 0.2 1.6 0.5 0.6 5.1 0.9 0.9 0.9 0.3 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 22.7 6.8 7.0 0.0 6.5 0.0 1.6 0.0 0.0 0.0 0.0 1.4 5.2 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 IQCA1 "DRC11, FLJ22527, IQCA" ENSG00000132321 "IQ motif containing with AAA domain 1" Q86XH1 2 236324147-236507542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 27.8;thyroid gland: 30.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 163.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 4.4" "Group enriched" "Detected in many" 4 "NK-cells: 1.2;T-cells: 4.4" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA057320 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA057320: " "unprognostic (1.73e-2)" "unprognostic (6.38e-2)" "unprognostic (3.75e-3)" "unprognostic (1.62e-2)" "unprognostic (6.27e-3)" "unprognostic (1.73e-2)" "unprognostic (3.23e-5)" "unprognostic (1.55e-1)" "unprognostic (7.23e-3)" "unprognostic (1.39e-1)" "unprognostic (3.03e-2)" "unprognostic (1.62e-1)" "prognostic favorable (2.54e-4)" "unprognostic (1.19e-3)" "unprognostic (1.67e-3)" "unprognostic (1.91e-3)" "unprognostic (5.30e-2)" 1.8 2.7 13.4 1.4 19.2 0.8 3.5 3.8 11.6 2.2 1.0 6.7 0.4 0.9 3.4 9.1 1.6 17.8 3.5 1.1 12.9 10.0 6.6 0.8 5.1 1.3 8.8 9.3 4.7 2.4 0.9 27.8 1.1 13.0 3.1 1.0 2.7 2.6 2.8 0.8 0.9 1.2 1.5 3.2 5.5 1.1 7.4 8.0 1.4 30.0 0.0 1.6 3.0 1.0 0.7 0.0 0.0 0.0 1.2 4.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.1 0.0 0.0 4.0 0.0 1.1 0.0 0.0 3.7 0.0 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 8.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.1 0.0 15.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.8 0.0 0.7 1.1 4.4 0.0 1.2 0.0 0.0 0.3 0.1 13.4 19.2 3.8 10.0 12.9 10.0 8.8 9.3 13.0 8.0 14.9 15.9 0.0 6.7 0.5 20.3 0.8 12.7 163.3 30.7 3.5 15.7 0.4 0.0 10.2 19.7 3.8 0.0 0.0 1.4 3.6 0.9 1.1 1.1 0.0 0.3 0.0 0.0 1.3 0.0 11.0 2.0 0.5 0.0 0.0 0.0 0.2 1.7 0.0 5.6 7.9 1.8 0.0 0.3 23.3 27.1 0.3 0.2 0.0 0.0 2.6 IQCA1L "IQCA1P1, TCAG_9762" ENSG00000278685 "IQ motif containing with AAA domain 1 like" 7 151190873-151205496 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 7.0" "Group enriched" "Detected in some" 58 "Early spermatids: 22.5;Late spermatids: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-266/70: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.13e-1)" "unprognostic (2.26e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 IQCC FLJ10547 ENSG00000160051 "IQ motif containing C" Q4KMZ1 1 32205661-32208687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.6" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 23.3;Spermatocytes: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028602, HPA028686" Approved Approved Vesicles NA NA Vesicles "HPA028602: AB_10600298, HPA028686: AB_10601985" "unprognostic (1.45e-3)" "unprognostic (4.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (2.56e-1)" "unprognostic (4.00e-3)" "unprognostic (7.81e-6)" "prognostic favorable (5.65e-4)" "unprognostic (4.97e-2)" "unprognostic (2.97e-2)" "prognostic favorable (8.23e-5)" "unprognostic (2.00e-1)" "unprognostic (3.28e-1)" "unprognostic (3.12e-3)" "prognostic favorable (3.79e-4)" "unprognostic (4.22e-2)" "unprognostic (1.66e-1)" 2.2 4.2 5.0 3.3 8.2 4.4 5.0 9.7 11.7 3.8 3.5 5.1 4.4 2.5 5.5 10.2 3.1 8.3 3.4 2.8 4.0 4.3 4.3 1.9 2.9 3.5 3.1 5.9 5.4 8.1 5.6 9.5 2.7 3.4 4.3 3.5 4.7 4.8 5.7 4.1 4.9 3.1 3.0 3.1 3.2 4.4 26.6 4.6 4.4 8.3 1.0 3.7 2.8 2.9 5.1 2.8 3.4 1.1 3.9 3.8 1.2 7.5 2.5 6.2 5.8 1.1 2.3 3.9 4.3 5.0 9.1 8.5 6.1 6.8 2.7 4.8 1.3 1.6 6.4 6.2 3.8 7.7 4.1 7.0 4.8 5.8 2.6 1.5 5.1 3.3 1.6 4.0 8.1 3.6 3.7 1.9 10.5 8.4 0.7 4.1 5.2 8.4 5.3 3.9 4.1 5.7 11.9 3.7 6.2 3.4 2.9 8.7 3.4 8.6 5.0 4.6 5.9 6.0 5.4 2.6 3.4 6.3 4.9 7.3 3.4 2.4 2.4 4.8 4.9 6.9 1.6 1.0 0.4 3.3 1.0 3.1 5.1 3.4 2.5 1.8 2.5 3.8 2.2 3.4 3.9 1.1 2.8 3.7 1.2 5.0 8.2 9.7 11.7 4.0 4.3 3.1 5.9 3.4 4.6 0.0 2.9 0.0 0.8 0.2 4.8 1.6 2.5 4.0 0.0 3.5 5.9 1.4 3.3 1.2 0.6 1.1 0.9 23.3 1.2 1.6 1.6 0.5 1.1 0.5 0.8 6.4 2.9 0.0 0.0 1.1 1.1 0.2 0.0 1.8 2.7 2.3 1.0 1.5 2.5 0.4 8.4 0.0 0.5 18.9 9.8 0.6 0.8 1.9 1.7 0.2 IQCD "CFAP84, DRC10" ENSG00000166578 "IQ motif containing D" Q96DY2 12 113195441-113221094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.4;testis: 33.8" "Group enriched" "Detected in many" 7 "Ciliated cells: 124.5;Early spermatids: 118.9;Late spermatids: 69.7;Spermatocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.6;classical monocyte: 2.8;myeloid DC: 2.1;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 3.6;monocytes: 2.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.4;GAMG: 8.9;RPTEC TERT1: 11.1;U-698: 12.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046810, HPA048782" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA046810: AB_2679818, HPA048782: AB_2680519" "unprognostic (3.90e-2)" "unprognostic (4.61e-2)" "unprognostic (4.97e-2)" "unprognostic (4.28e-3)" "unprognostic (1.81e-1)" "unprognostic (7.11e-2)" "unprognostic (2.26e-5)" "unprognostic (2.23e-1)" "unprognostic (3.38e-2)" "unprognostic (3.04e-1)" "prognostic favorable (3.90e-4)" "unprognostic (1.54e-1)" "unprognostic (3.48e-3)" "unprognostic (4.09e-2)" "unprognostic (3.22e-2)" "unprognostic (1.79e-1)" "unprognostic (5.20e-2)" 1.2 1.2 2.8 1.3 6.4 0.6 1.8 2.0 3.8 2.6 1.1 6.8 1.7 0.6 2.3 6.3 1.8 22.4 1.4 1.6 3.8 3.2 3.4 0.6 3.0 1.3 4.8 1.5 2.5 1.4 5.4 8.7 1.2 11.4 1.1 1.2 1.6 1.2 1.7 0.7 0.9 0.7 1.4 2.5 0.6 1.0 33.8 6.4 0.0 4.0 1.1 3.3 1.6 1.0 0.6 3.7 3.6 2.8 0.0 0.1 0.5 2.7 3.2 1.1 0.8 1.2 1.3 0.7 0.4 22.4 1.1 1.5 0.5 8.7 3.0 2.4 0.6 8.9 0.5 0.5 0.9 1.8 0.2 0.9 1.0 1.1 0.5 0.7 0.3 0.7 0.5 0.7 3.5 1.1 6.1 0.7 1.2 0.2 0.2 0.2 3.2 0.2 5.8 0.2 1.4 0.8 0.2 0.5 0.8 11.1 3.4 2.5 1.0 0.7 1.1 3.5 0.9 4.0 1.7 0.3 0.5 1.7 1.1 0.6 0.9 0.7 12.0 1.6 0.1 1.9 3.6 2.8 0.0 0.1 0.2 0.0 0.6 0.0 0.0 2.1 0.2 0.0 0.1 0.1 0.0 0.0 3.7 0.0 0.5 2.8 6.4 2.0 3.8 3.8 3.2 4.8 1.5 11.4 6.4 3.0 1.7 0.0 2.7 2.2 0.4 3.4 5.1 124.5 11.4 5.2 13.7 1.2 11.6 2.3 118.9 0.1 1.3 0.0 0.7 0.2 2.4 1.7 0.0 0.4 1.9 0.0 6.3 1.8 0.0 69.7 2.0 1.3 3.3 2.8 0.6 6.5 0.7 0.3 4.9 11.8 4.8 0.0 1.4 74.6 4.7 1.5 1.6 0.8 0.0 3.5 IQCF1 MGC39725 ENSG00000173389 "IQ motif containing F1" Q8N6M8 3 51894876-51903335 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 228 "testis: 47.4" "Group enriched" "Detected in some" 151 "Early spermatids: 1159.2;Late spermatids: 2587.3" "Cancer enriched" "Detected in single" 30 "testis cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 1.4;PC-3: 3.1;U-2 OS: 1.0" "Low region specificity" "Detected in many" NA NA "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1159.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2587.3 9.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 11.2 5.1 0.0 0.0 0.0 0.0 0.0 IQCF2 ENSG00000184345 "IQ motif containing F2" Q8IXL9 3 51861629-51863424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "testis: 22.3" "Group enriched" "Detected in some" 168 "Early spermatids: 1079.4;Late spermatids: 1957.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.5;U-2197: 1.1" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1079.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1957.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 9.0 4.3 0.0 0.0 0.0 0.0 0.0 IQCF3 ENSG00000229972 "IQ motif containing F3" P0C7M6 3 51817604-51830856 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 48 "testis: 71.2" "Group enriched" "Detected in some" 141 "Early spermatids: 1497.4;Late spermatids: 4174.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "HMC-1: 1.1;U-2 OS: 2.2;U-698: 1.0;U-937: 4.6" NA NA "unprognostic (2.83e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.2 0.1 0.2 0.7 0.0 1.0 0.0 4.6 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1497.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4174.7 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 12.9 0.0 18.9 8.5 0.0 0.0 0.0 0.0 0.0 IQCF5 ENSG00000214681 "IQ motif containing F5" A8MTL0 3 51873721-51875584 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 92 "testis: 41.2" "Group enriched" "Detected in some" 68 "Early spermatids: 751.7;Late spermatids: 1880.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.1;U-2 OS: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 751.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1880.8 11.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 19.4 0.0 11.9 5.3 0.0 0.0 0.0 0.0 0.0 IQCF6 ENSG00000214686 "IQ motif containing F6" A8MYZ5 3 51778561-51779241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 19.2" "Group enriched" "Detected in some" 202 "Early spermatids: 334.6;Late spermatids: 125.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 2.7;U-937: 6.0" "Not detected" "Not detected" NA NA "unprognostic (4.98e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 334.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 IQCG "CFAP122, DKFZp434B227, DRC9" ENSG00000114473 "IQ motif containing G" Q9H095 3 197889075-197960142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 44.9;testis: 34.2" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 433.6;Early spermatids: 224.8;Late spermatids: 337.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042787, HPA051981" Enhanced Approved "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA042787: AB_10797021, HPA051981: AB_2732572" "unprognostic (1.50e-2)" "unprognostic (6.20e-3)" "unprognostic (6.20e-2)" "unprognostic (1.10e-2)" "unprognostic (2.51e-2)" "unprognostic (9.20e-2)" "unprognostic (1.05e-1)" "unprognostic (4.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (7.54e-2)" "unprognostic (1.79e-1)" "unprognostic (2.94e-2)" "unprognostic (9.15e-2)" "unprognostic (1.73e-1)" "unprognostic (2.72e-3)" "unprognostic (7.75e-2)" 6.2 5.0 10.9 3.0 14.6 3.0 5.4 3.6 7.6 5.7 3.0 12.3 4.1 2.5 4.5 11.6 3.9 44.9 4.4 4.2 12.6 12.9 5.9 3.6 8.0 3.9 9.0 5.7 5.0 2.1 4.5 12.0 3.4 20.8 3.9 3.7 5.3 2.5 4.6 2.0 2.8 2.6 4.1 9.2 3.1 3.4 34.2 11.2 1.4 7.4 1.0 3.9 4.5 2.2 8.9 7.3 8.9 8.4 6.6 9.1 5.0 3.9 4.3 5.6 5.4 12.1 12.4 2.2 4.8 5.3 5.7 5.9 0.8 3.8 1.3 5.4 3.9 7.4 3.7 4.0 3.7 9.3 3.0 2.8 2.4 2.3 2.0 2.8 3.1 3.8 6.4 4.7 6.2 2.0 4.7 2.7 6.6 2.5 5.4 4.3 9.0 1.7 1.5 3.4 5.7 5.8 5.0 3.7 1.9 5.5 1.6 4.9 5.9 8.0 3.2 3.3 5.2 24.4 2.1 2.7 3.7 2.5 11.0 4.4 4.7 13.2 2.3 13.6 4.5 5.9 4.6 8.4 8.9 8.2 6.4 5.3 8.9 6.9 5.4 7.3 4.2 6.2 9.1 5.8 6.6 5.7 6.5 6.8 5.0 10.9 14.6 3.6 7.6 12.6 12.9 9.0 5.7 20.8 11.2 6.0 7.7 5.1 2.8 8.2 12.5 9.7 0.0 433.6 42.1 5.2 70.7 5.1 13.3 5.5 224.8 6.9 1.7 0.0 3.7 4.6 6.8 2.4 8.1 3.9 5.8 9.5 4.1 6.7 5.7 337.4 21.0 10.2 13.5 1.0 2.6 13.5 8.6 1.9 22.3 7.8 44.0 6.5 4.6 84.6 32.3 7.9 4.3 11.3 2.3 2.0 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254800-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.5;testis: 20.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 30.8;Early spermatids: 45.3;Late spermatids: 30.4;Spermatocytes: 43.6;Spermatogonia: 18.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040845 Uncertain Approved Cytosol NA NA Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.9 1.8 1.3 0.4 2.9 0.2 2.5 0.9 2.8 1.4 0.8 2.9 4.1 0.3 1.3 6.4 0.9 10.0 2.1 1.3 1.6 2.1 3.3 1.5 2.4 0.5 1.2 1.8 2.7 1.4 6.5 14.5 0.5 2.6 1.2 1.1 3.5 1.0 1.4 0.9 1.0 0.8 0.6 1.4 0.8 1.6 20.9 1.4 0.6 6.1 0.7 0.4 1.3 1.0 1.0 1.2 0.1 0.3 0.2 2.1 0.3 2.8 3.0 1.3 2.2 2.0 4.6 1.0 1.5 1.2 2.4 1.6 0.3 3.1 1.8 1.4 2.5 2.6 4.8 4.4 1.8 4.0 0.3 2.1 0.6 3.0 0.4 3.5 0.9 0.6 3.1 1.8 5.0 4.8 2.1 0.9 5.2 4.2 2.0 1.7 3.0 0.7 0.8 1.6 1.8 1.9 0.6 2.1 2.1 2.7 1.2 4.6 1.2 2.0 2.8 7.9 2.9 7.2 0.5 2.0 2.6 1.3 4.1 1.8 4.1 5.4 0.5 5.3 2.2 2.7 0.0 0.3 0.1 1.2 0.0 2.1 0.4 1.0 1.1 1.1 1.0 0.9 0.8 0.0 0.2 0.1 1.2 0.8 0.3 1.3 2.9 0.9 2.8 1.6 2.1 1.2 1.8 2.6 1.4 3.0 0.6 0.0 0.9 1.1 1.4 0.8 0.0 30.8 3.4 1.8 7.9 0.2 0.0 0.8 45.3 0.7 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 30.4 0.9 0.0 0.0 1.8 0.5 1.4 0.7 0.0 0.7 1.7 6.0 0.0 0.5 43.6 18.5 0.4 0.2 0.0 0.0 0.9 IQCJ ENSG00000214216 "IQ motif containing J" Q1A5X6 3 158962928-159266307 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 19.5" "Group enriched" "Detected in some" 105 "Early spermatids: 26.3;Late spermatids: 33.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "Daudi: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052835 Uncertain NA NA "HPA052835: AB_2681970" "unprognostic (1.99e-2)" 0.5 0.5 19.5 0.5 10.0 0.5 1.6 0.4 14.5 0.5 0.5 0.1 0.0 0.5 0.5 0.5 0.8 0.5 0.7 1.0 9.4 0.6 0.6 0.5 0.5 0.9 0.9 7.4 0.6 0.5 0.5 3.6 0.5 6.8 0.5 0.5 0.0 0.5 0.9 0.5 0.5 0.5 0.5 0.5 0.5 0.5 4.8 1.5 0.0 0.5 0.0 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 10.0 0.4 14.5 9.4 0.6 0.9 7.4 6.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 IQCJ-SCHIP1 ENSG00000283154 "IQCJ-SCHIP1 readthrough" B3KU38 3 158962235-159897366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Basal glandular cells: 6.9;Bipolar cells: 12.0;Cone photoreceptor cells: 5.9" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA003243, HPA003445" Approved Approved Cytosol NA NA Cytosol "HPA003243: AB_1079877, HPA003445: AB_1079875" 5.3 2.1 11.1 4.1 12.4 0.5 2.4 1.5 30.0 1.9 3.8 17.8 0.3 1.7 5.6 2.8 7.3 1.4 5.8 16.4 7.7 7.6 6.3 6.8 0.6 18.8 10.6 0.8 0.9 0.2 1.3 10.9 13.1 6.3 3.0 0.4 0.6 10.0 1.8 0.8 1.7 11.8 7.3 1.2 1.0 1.7 15.1 0.0 0.6 0.1 0.4 5.9 0.9 0.0 1.0 0.1 0.0 0.9 0.2 0.2 28.8 5.0 9.9 11.8 2.3 2.2 8.7 24.9 5.9 20.6 14.1 18.6 7.1 1.4 16.1 8.2 7.8 11.7 3.8 8.4 17.0 24.0 9.4 0.0 11.0 0.9 2.7 1.3 0.1 2.3 7.2 9.1 10.9 17.1 15.2 1.6 0.0 0.1 9.4 1.2 0.1 0.0 8.3 2.3 10.9 3.4 20.1 0.0 19.8 1.6 2.0 9.4 13.4 5.7 7.1 11.9 3.3 0.2 12.6 11.9 16.5 7.9 33.7 0.1 0.1 0.1 6.6 4.1 31.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.9 0.0 1.0 0.0 0.2 6.0 0.0 0.0 6.9 1.3 12.0 0.4 0.0 4.0 2.3 1.8 5.9 0.0 0.0 0.6 1.2 0.2 0.0 0.0 0.5 0.0 0.5 0.4 2.3 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.3 0.8 0.0 1.0 0.1 0.4 0.8 0.0 1.1 2.7 0.5 0.0 3.4 0.0 0.4 0.6 0.0 0.0 0.2 1.4 IQCM ENSG00000234828 "IQ motif containing M" A0A1B0GVH7 4 149351903-149896233 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 20 "testis: 16.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "fHDF/TERT166: 2.3" NA NA "unprognostic (3.22e-1)" "unprognostic (1.17e-3)" "unprognostic (2.18e-1)" "unprognostic (2.85e-2)" "unprognostic (1.91e-1)" "unprognostic (8.47e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCN KIAA1683 ENSG00000130518 "IQ motif containing N" Q9H0B3 19 18257097-18274509 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "testis: 59.9" "Cell type enriched" "Detected in some" 13 "Alveolar cells type 2: 58.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 5.9" HPA042409 Enhanced NA NA "HPA042409: AB_10794421" "unprognostic (1.36e-3)" "unprognostic (5.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-1)" "unprognostic (2.15e-4)" "unprognostic (9.79e-2)" "unprognostic (9.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (1.64e-4)" "unprognostic (4.17e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (7.68e-2)" "unprognostic (1.30e-1)" "unprognostic (4.92e-3)" 0.8 0.2 0.7 0.7 0.7 2.3 1.2 1.5 0.7 1.7 0.7 0.7 0.7 0.0 2.7 1.6 0.7 2.4 0.7 0.7 0.7 0.6 1.0 2.7 1.5 0.7 0.7 0.7 2.7 0.8 0.4 1.6 0.7 0.7 0.8 0.4 0.7 0.7 0.7 1.3 2.2 1.0 1.0 0.7 1.4 0.8 59.9 0.7 0.7 2.0 0.7 0.7 0.7 0.9 2.4 2.0 5.3 1.0 1.3 1.2 0.4 0.0 5.9 0.9 3.6 1.6 2.8 1.0 0.8 0.7 0.0 0.4 1.9 2.0 1.5 0.6 1.8 1.0 0.1 0.0 0.6 0.0 1.6 0.4 2.2 2.2 1.2 0.2 0.4 0.7 1.5 0.5 0.5 1.1 3.3 0.7 0.3 0.3 1.7 0.0 2.3 0.7 1.0 0.7 1.5 0.0 0.5 0.0 0.6 0.9 1.4 2.7 0.6 0.5 0.9 1.3 2.0 2.0 0.7 0.0 0.2 0.7 2.1 0.0 0.8 0.5 0.5 1.2 0.1 0.0 1.4 1.0 0.8 1.1 0.4 0.5 1.0 1.0 0.4 0.3 2.4 1.2 0.9 5.3 1.3 0.4 2.0 0.7 0.4 0.7 0.7 1.5 0.7 0.7 0.6 0.7 0.7 0.7 0.7 3.0 58.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.3 1.8 0.0 1.2 0.0 1.6 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 4.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 IQGAP2 ENSG00000145703 "IQ motif containing GTPase activating protein 2" Q13576 5 76403249-76708132 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.1" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 913.2;Late spermatids: 268.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 22.0;Hep G2: 18.2;HMC-1: 65.2;RPMI-8226: 23.8;U-937: 17.0" "Region enhanced" "Detected in many" "hippocampal formation: 34.4" "Low region specificity" "Detected in all" "CAB004241, HPA037403, HPA037404" Uncertain Approved "Vesicles,Plasma membrane" NA NA 8400000 "Vesicles, Plasma membrane" "CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460" "unprognostic (9.46e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (9.03e-3)" "unprognostic (8.85e-2)" "prognostic favorable (5.65e-4)" "unprognostic (5.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "prognostic favorable (9.44e-12)" "unprognostic (3.29e-2)" "unprognostic (9.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.27e-2)" 11.1 11.3 1.4 14.7 1.7 6.3 8.0 1.1 1.2 6.1 21.6 0.6 36.2 16.8 2.6 14.7 3.3 2.7 21.7 4.2 1.6 1.6 13.2 66.1 7.8 13.0 1.3 0.7 4.2 14.8 25.5 2.3 42.5 2.1 9.1 6.8 15.2 18.9 34.3 1.4 3.7 35.7 3.4 2.0 16.5 12.4 30.7 0.4 7.7 12.8 2.8 7.7 4.3 4.2 0.6 7.8 14.9 3.2 4.1 5.9 1.3 0.0 2.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.2 0.8 0.0 0.8 0.0 3.6 0.0 0.0 2.5 3.6 8.1 2.1 18.2 0.0 4.5 65.2 0.0 0.0 0.0 0.0 0.0 0.3 4.5 7.1 6.5 0.0 0.0 3.9 12.3 4.5 7.5 0.1 1.4 0.0 23.8 0.0 0.0 0.1 1.0 5.1 0.3 0.0 10.1 0.0 2.7 0.1 0.0 0.1 0.0 0.0 6.1 0.0 5.6 0.0 17.0 0.9 14.9 3.2 1.8 4.8 2.4 4.0 0.6 5.0 4.1 2.9 0.2 2.0 3.6 6.3 4.1 3.1 7.8 5.9 1.3 1.4 1.7 1.1 1.2 1.6 1.6 1.3 0.7 2.1 0.4 11.9 16.4 11.2 18.7 4.1 5.9 2.4 101.9 20.1 13.6 33.2 102.1 11.9 6.6 28.5 913.2 3.6 83.5 23.3 58.0 0.6 7.5 28.7 91.4 219.4 58.8 1.6 8.7 20.3 125.0 268.6 6.9 72.8 15.1 19.0 45.0 11.3 23.8 38.6 4.9 53.7 118.4 0.0 2.3 14.9 4.4 3.3 6.1 66.1 31.5 5.5 IQGAP3 ENSG00000183856 "IQ motif containing GTPase activating protein 3" Q86VI3 1 156525405-156572604 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.8;intestine: 13.0" "Cell type enhanced" "Detected in some" 14 "Cholangiocytes: 5.1;Late spermatids: 16.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA030142, HPA030143" Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes Yes "Nucleoli rim" Nucleoplasm "HPA030142: AB_10600108, HPA030143: AB_10601104" "unprognostic (9.99e-3)" "unprognostic (5.24e-2)" "unprognostic (3.26e-1)" "unprognostic (1.55e-3)" "unprognostic (1.52e-1)" "unprognostic (4.69e-3)" "prognostic unfavorable (8.94e-6)" "unprognostic (1.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.98e-1)" "unprognostic (6.35e-3)" "unprognostic (1.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.46e-2)" "unprognostic (1.53e-1)" "unprognostic (6.30e-2)" "unprognostic (6.81e-2)" 3.2 1.2 0.3 5.4 0.3 14.8 0.6 0.3 0.8 1.4 10.1 0.4 1.3 7.0 1.1 3.7 9.8 0.3 1.8 1.8 0.4 0.2 1.5 1.1 2.6 1.4 0.3 0.3 0.5 0.4 0.0 0.3 6.5 0.8 0.8 5.5 0.4 1.8 0.3 0.5 3.8 13.0 2.9 1.5 1.5 5.1 6.8 0.3 12.2 0.4 3.1 7.3 0.9 3.1 0.2 0.9 0.5 0.3 0.6 2.6 0.0 23.5 11.4 10.7 7.5 0.6 1.7 5.2 17.5 11.7 17.2 15.5 13.0 21.8 2.1 6.5 10.3 9.1 22.5 7.3 9.0 15.5 0.0 6.5 3.1 22.4 6.4 0.1 3.8 0.0 0.5 1.0 14.4 21.3 4.2 10.0 5.1 6.3 3.4 12.6 12.4 2.2 5.5 7.8 23.3 11.5 7.6 12.0 2.4 4.4 8.1 6.8 10.5 15.9 18.7 6.4 13.1 14.9 10.3 6.5 15.6 18.7 12.7 20.6 1.6 0.8 1.0 5.2 6.1 17.6 0.5 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.6 0.1 0.1 0.1 0.2 0.6 0.3 0.9 2.6 0.0 0.3 0.3 0.3 0.8 0.4 0.2 0.3 0.3 0.8 0.3 0.0 0.0 0.5 0.0 1.1 0.0 0.8 5.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.7 0.0 1.1 0.0 0.0 3.1 0.5 0.2 0.0 0.0 3.4 0.0 1.2 4.3 0.3 16.8 0.3 2.2 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 3.8 2.4 0.9 0.7 0.0 2.9 0.4 IQSEC2 "KIAA0522, MRX1, MRX18, MRX78" ENSG00000124313 "IQ motif and Sec7 domain 2" Q5JU85 X 53225828-53321350 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.2" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 29.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 10.0;plasmacytoid DC: 10.2" "Group enriched" "Detected in many" 15 "dendritic cells: 10.2;monocytes: 10.0" "Cell line enhanced" "Detected in many" "A549: 24.8;GAMG: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003973, HPA076533" Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA003973: AB_2280343, HPA076533: " "unprognostic (1.85e-1)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (1.32e-1)" "unprognostic (4.66e-3)" "unprognostic (6.02e-2)" "unprognostic (2.80e-1)" "unprognostic (3.78e-2)" "unprognostic (2.82e-1)" "unprognostic (9.05e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.56e-2)" "unprognostic (1.75e-1)" "unprognostic (4.30e-2)" "prognostic favorable (2.38e-4)" 8.1 10.0 16.6 4.3 22.0 1.5 4.7 32.1 34.2 7.0 6.9 3.7 4.9 9.9 4.7 3.5 4.9 8.5 4.9 6.0 19.4 9.0 10.8 1.3 6.5 2.0 6.7 12.7 4.7 5.4 8.1 6.1 2.9 13.4 6.4 5.6 2.8 5.1 7.8 25.6 5.7 10.7 5.9 4.4 3.5 5.5 4.2 5.2 0.2 5.3 4.3 2.6 4.7 4.1 0.2 10.2 0.6 10.0 0.0 0.1 2.2 2.3 24.8 0.9 2.3 3.5 7.6 2.7 4.0 7.0 3.0 5.7 0.6 9.2 0.1 6.6 9.4 30.4 3.3 0.8 4.0 2.3 2.5 4.3 2.7 10.8 0.6 7.6 0.1 1.5 5.4 6.1 8.6 4.8 7.8 4.2 0.0 8.6 2.8 6.5 5.8 0.0 0.5 7.8 7.4 10.9 1.8 1.9 2.9 4.6 5.2 1.0 0.9 9.3 5.8 3.7 4.6 8.2 1.2 4.8 3.0 5.7 1.6 1.8 0.8 0.1 0.1 18.5 1.8 1.6 0.1 10.0 0.5 0.0 3.6 0.1 0.2 0.0 0.1 5.2 0.1 0.1 0.1 0.6 0.0 1.8 10.2 0.0 2.2 16.6 22.0 32.1 34.2 19.4 9.0 6.7 12.7 13.4 5.2 6.0 5.1 0.5 5.8 3.5 0.4 3.6 12.7 5.3 4.5 14.0 0.0 6.8 18.3 4.8 16.6 4.9 19.6 0.0 6.1 5.4 5.6 11.3 3.5 0.8 12.6 0.0 3.5 6.2 14.6 26.5 1.4 9.1 10.1 10.0 10.3 2.4 5.3 11.8 2.1 29.4 0.0 0.0 5.2 0.7 1.1 3.3 3.8 0.5 11.4 12.9 IQSEC3 "KIAA1110, MGC30156" ENSG00000120645 "IQ motif and Sec7 domain 3" Q9UPP2 12 66765-178460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8" "Group enriched" "Detected in some" 4 "Bipolar cells: 32.6;Horizontal cells: 108.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.7;U-266/70: 13.0;U-266/84: 3.1;U-937: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039025 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039025: AB_10672768" "unprognostic (2.73e-2)" "unprognostic (1.56e-2)" "unprognostic (1.26e-2)" "unprognostic (4.24e-3)" "unprognostic (4.32e-2)" "unprognostic (1.28e-1)" "unprognostic (4.44e-2)" "unprognostic (5.14e-2)" "unprognostic (3.91e-1)" "unprognostic (8.82e-3)" "unprognostic (2.83e-3)" "unprognostic (7.16e-2)" "unprognostic (2.28e-2)" "unprognostic (1.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-2)" "unprognostic (1.36e-2)" 5.6 1.3 5.6 0.7 4.2 0.8 0.4 19.8 15.5 1.6 0.4 0.5 0.0 0.5 2.0 0.5 0.4 5.2 2.2 1.9 6.5 5.1 2.4 0.2 2.9 0.5 3.7 4.7 2.1 1.2 0.0 2.2 1.3 5.0 1.5 0.2 0.4 0.2 4.5 1.3 0.2 0.7 1.9 1.4 0.3 0.6 1.2 0.8 0.0 0.3 0.0 0.2 1.3 0.6 0.0 2.1 0.0 0.0 0.5 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 13.0 3.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 1.2 0.0 0.5 0.0 2.1 0.0 0.4 5.6 4.2 19.8 12.4 6.5 5.1 3.7 4.7 5.0 0.8 3.0 0.0 0.0 0.0 0.2 32.6 1.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 1.1 0.1 2.3 0.0 1.2 108.1 0.0 1.8 1.0 3.3 0.6 0.0 0.0 0.0 0.0 6.1 0.2 0.0 0.0 4.5 15.7 0.0 0.0 2.2 8.8 0.1 0.0 0.5 0.0 0.0 IQUB FLJ35834 ENSG00000164675 "IQ motif and ubiquitin domain containing" Q8NA54 7 123452400-123535077 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 20.8;testis: 35.5" "Group enriched" "Detected in many" 7 "Ciliated cells: 91.0;Early spermatids: 206.9;Late spermatids: 121.6;Spermatocytes: 83.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.9;RPTEC TERT1: 7.2;T-47d: 2.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049626 Approved "Nuclear speckles,Intermediate filaments,Cytosol" NA NA "Nuclear speckles, Intermediate filaments" Cytosol "HPA049626: AB_2732554" "unprognostic (8.71e-2)" "unprognostic (1.25e-2)" "unprognostic (1.98e-1)" "unprognostic (6.42e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (6.23e-2)" "unprognostic (7.97e-2)" "unprognostic (1.46e-1)" "unprognostic (1.73e-1)" "unprognostic (2.40e-2)" "unprognostic (3.76e-1)" "unprognostic (5.44e-6)" "unprognostic (2.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.14e-1)" "unprognostic (7.30e-2)" 0.6 1.0 1.3 0.3 2.9 0.3 0.9 3.0 3.5 1.2 0.5 1.8 3.2 0.4 1.4 6.9 1.8 5.7 1.6 0.6 2.6 1.2 8.5 0.4 3.2 0.3 0.7 1.2 2.7 0.7 2.7 20.8 0.5 6.4 0.9 0.4 0.3 0.7 4.3 0.6 0.5 0.5 0.6 1.0 0.4 0.6 35.5 2.8 0.0 5.6 0.0 0.3 0.7 0.6 0.8 0.0 0.0 0.3 0.5 0.7 0.0 0.3 0.0 1.3 0.6 0.6 0.6 0.1 0.0 0.1 0.0 0.3 0.0 0.8 0.8 0.0 0.4 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.7 0.3 0.2 0.3 0.7 0.0 0.2 1.9 0.2 0.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 7.2 1.6 1.1 0.4 0.0 0.0 0.1 1.1 2.5 0.0 0.0 0.5 0.3 0.5 0.2 0.5 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.7 0.3 0.4 0.2 0.2 0.2 0.0 0.8 0.7 0.2 0.0 0.5 0.1 0.0 0.3 0.0 1.3 2.9 3.0 3.5 2.6 1.2 0.7 1.2 6.4 2.8 6.0 0.3 0.0 0.5 0.5 2.7 1.0 0.0 91.0 15.9 17.4 3.9 0.3 1.7 0.9 206.9 0.4 0.0 0.0 0.4 0.2 0.5 0.6 1.1 0.0 0.1 3.2 1.7 0.6 0.0 121.6 2.3 0.1 0.0 0.0 0.0 2.5 0.1 0.0 2.8 4.3 8.8 6.5 0.9 83.1 7.1 0.1 0.6 0.0 0.0 0.3 IRAK1BP1 "AIP70, SIMPL" ENSG00000146243 "Interleukin 1 receptor associated kinase 1 binding protein 1" Q5VVH5 6 78867472-78946440 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 79.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 31.4;Early spermatids: 52.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035742, HPA035743" Uncertain Approved Vesicles NA NA Vesicles "HPA035742: AB_10670119, HPA035743: AB_2674764" "unprognostic (2.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (5.82e-2)" "unprognostic (2.12e-1)" "unprognostic (2.38e-3)" "unprognostic (3.93e-2)" "unprognostic (6.55e-2)" "unprognostic (2.34e-2)" "unprognostic (1.32e-2)" "unprognostic (9.88e-2)" "unprognostic (2.81e-2)" "unprognostic (4.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.39e-2)" "unprognostic (2.58e-1)" 2.8 4.0 6.9 3.4 12.4 79.6 3.9 8.8 8.1 6.4 4.1 3.4 6.2 3.5 7.2 7.7 3.2 7.3 5.3 3.6 5.6 4.1 7.0 2.6 4.4 6.0 3.0 6.5 7.0 8.1 4.2 17.9 2.8 4.3 5.2 2.7 5.1 4.2 6.5 2.3 5.7 4.7 4.1 3.6 4.7 5.5 15.4 5.7 8.8 7.6 1.9 2.3 4.5 4.0 1.4 1.6 3.9 1.4 1.3 2.0 0.4 1.6 3.2 5.2 4.7 2.2 4.8 4.5 1.1 2.7 1.1 1.9 3.8 3.0 3.2 1.4 2.5 2.7 3.0 9.4 4.4 1.9 4.8 3.8 4.0 4.7 2.0 2.8 9.7 3.7 4.2 4.5 2.0 2.5 3.6 3.5 6.6 5.1 7.8 1.7 0.8 2.9 6.5 2.4 0.7 2.7 1.1 3.0 2.3 4.8 6.5 6.9 8.3 1.5 1.7 1.2 3.4 3.8 6.5 3.2 2.8 2.6 1.5 4.0 7.8 4.6 4.8 0.8 0.7 3.1 3.9 0.3 0.4 1.5 0.2 1.1 1.4 1.4 0.8 0.6 0.9 1.9 2.0 2.5 1.3 1.4 1.6 1.6 0.4 6.9 12.4 8.8 8.1 5.6 4.1 3.0 6.5 4.3 5.7 17.9 5.6 0.5 4.8 2.3 7.8 13.2 7.6 28.1 14.8 3.5 31.4 3.0 8.3 4.4 52.1 5.8 0.4 0.0 5.2 0.6 2.4 1.2 0.0 2.1 1.4 4.8 6.3 2.5 1.8 27.4 9.8 1.2 0.0 1.0 2.6 12.8 3.7 0.0 7.8 10.2 17.4 12.9 2.1 25.8 14.7 2.3 0.7 1.0 3.5 1.7 IRAK2 ENSG00000134070 "Interleukin 1 receptor associated kinase 2" O43187 3 10164865-10243743 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.7" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 18.1;Glandular cells: 20.2;Urothelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.2;BJ hTERT+: 16.9;CAPAN-2: 17.1;GAMG: 30.8;RT4: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013483, HPA050520" Uncertain Approved Vesicles NA NA Vesicles "CAB013483: , HPA050520: AB_2681154" "unprognostic (1.31e-1)" "unprognostic (2.04e-2)" "unprognostic (1.46e-2)" "unprognostic (4.61e-3)" "unprognostic (8.71e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.89e-2)" "unprognostic (8.01e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.24e-1)" "unprognostic (3.10e-2)" "unprognostic (7.22e-2)" "unprognostic (4.38e-2)" "unprognostic (3.91e-2)" "prognostic favorable (6.60e-5)" 12.1 5.8 3.6 8.6 5.9 28.7 5.4 4.5 7.0 3.3 4.0 12.2 2.3 3.3 3.5 2.6 8.4 2.4 6.8 2.7 3.6 5.2 4.3 15.4 12.7 5.3 10.4 3.7 1.9 3.2 2.4 1.8 3.5 7.8 6.4 3.1 2.1 4.8 3.4 19.6 6.2 6.7 3.4 6.1 5.9 5.2 1.7 8.6 3.9 4.1 2.7 16.7 14.3 7.2 5.0 1.3 2.5 1.2 8.4 7.9 2.5 1.2 3.7 0.1 0.5 4.0 3.4 16.2 1.3 16.9 2.3 2.2 1.7 17.1 0.0 0.4 2.0 30.8 0.4 0.4 4.3 3.1 1.0 1.2 0.3 0.8 4.7 2.0 0.0 0.5 2.1 0.7 8.5 11.0 6.1 4.7 0.1 0.8 5.2 2.7 0.0 0.0 0.8 0.1 2.0 3.6 0.8 0.0 0.2 5.1 23.4 0.2 0.1 1.6 0.0 0.1 0.4 0.4 0.8 4.8 5.3 0.4 3.2 3.3 1.7 5.1 1.0 11.3 2.2 0.9 0.2 1.2 0.1 7.5 0.7 7.9 5.0 2.2 4.1 1.3 4.5 1.6 3.9 2.5 8.4 0.2 0.1 0.9 2.5 3.6 5.9 4.5 7.0 3.6 5.2 10.4 3.7 7.8 8.6 0.0 5.5 0.9 18.1 7.1 0.6 1.6 0.0 0.0 2.3 0.0 0.0 0.1 0.0 8.5 3.3 2.1 1.1 0.0 3.5 0.4 1.0 20.2 0.0 4.7 2.9 0.0 0.0 1.3 2.5 1.1 0.9 4.3 5.0 2.8 0.1 1.7 10.4 0.0 0.0 1.0 0.0 0.0 3.1 0.4 0.4 6.5 0.8 1.5 0.4 22.1 IRAK3 IRAK-M ENSG00000090376 "Interleukin 1 receptor associated kinase 3" Q9Y616 12 66188879-66254622 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.0" "Cell type enhanced" "Detected in many" 14 "Ito cells: 36.2;Kupffer cells: 118.3;Macrophages: 66.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6" "Group enriched" "Detected in many" 12 "dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;ASC TERT1: 12.4;HEL: 12.8;HL-60: 17.0;NB-4: 13.6;THP-1: 20.6;U-937: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043097 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA043097: AB_10795612" "unprognostic (7.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-1)" "unprognostic (7.56e-3)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (8.52e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (5.58e-2)" "unprognostic (4.64e-2)" "unprognostic (3.41e-2)" "unprognostic (3.23e-2)" 21.8 3.7 2.1 10.6 3.6 58.0 13.4 1.0 2.4 8.7 6.5 2.3 5.5 1.7 6.2 8.6 4.9 7.0 7.6 16.0 2.9 2.1 3.6 2.9 22.1 25.6 4.6 0.3 5.9 2.7 1.3 17.9 6.1 3.7 7.0 3.0 5.5 6.0 5.5 5.5 3.3 4.9 6.4 5.9 25.3 6.2 5.1 2.8 1.0 4.9 4.5 5.4 9.5 11.4 0.4 6.2 7.2 20.6 0.9 0.3 3.6 0.0 0.0 0.2 0.0 15.0 12.4 0.0 1.6 0.0 0.9 1.3 0.0 1.2 0.0 0.8 3.0 0.0 0.0 1.8 0.0 0.7 0.0 0.0 12.8 0.7 0.0 7.8 17.0 2.4 7.8 0.0 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.5 0.0 0.0 13.6 0.7 0.0 0.0 0.0 3.7 0.0 0.1 1.9 0.1 0.0 6.7 0.0 0.7 0.0 0.0 20.6 4.7 0.0 0.0 0.0 0.0 0.5 0.1 1.2 0.0 14.9 0.0 5.6 13.1 2.2 0.0 13.2 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 7.2 0.9 20.6 0.0 0.3 3.6 2.1 3.6 1.0 2.4 2.9 2.1 4.6 0.3 3.7 2.8 8.9 20.8 0.8 4.1 1.3 0.3 2.2 0.0 6.7 20.5 3.5 0.0 0.2 0.0 0.6 3.6 29.3 0.0 0.0 1.0 0.1 17.3 1.4 26.5 0.0 8.9 0.0 0.0 36.2 118.3 3.0 6.6 66.9 5.0 2.8 1.0 0.2 2.8 0.0 10.6 0.2 0.0 0.0 7.2 0.7 0.9 1.1 0.2 2.5 0.2 2.2 IRF1 MAR ENSG00000125347 "Interferon regulatory factor 1" P10914 5 132481609-132490798 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 103.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011662, HPA063131" Supported Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB011662: AB_775784, HPA063131: AB_2684945" "unprognostic (1.30e-3)" "unprognostic (2.00e-2)" "unprognostic (2.47e-3)" "unprognostic (1.21e-1)" "unprognostic (2.27e-1)" "unprognostic (4.48e-2)" "unprognostic (3.67e-1)" "unprognostic (1.64e-1)" "unprognostic (1.52e-2)" "unprognostic (2.24e-2)" "unprognostic (6.93e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.09e-7)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (9.53e-3)" 19.7 8.5 4.1 64.2 9.9 43.8 21.0 3.9 4.6 10.6 27.3 4.0 4.4 31.1 11.4 9.9 12.4 11.8 18.1 11.8 4.2 3.5 14.2 20.9 49.3 41.0 6.8 1.4 11.5 14.5 2.8 8.8 24.7 10.3 18.9 13.6 10.3 13.2 10.3 14.0 8.4 52.1 11.3 8.0 51.7 17.5 5.7 4.9 36.6 26.5 14.7 33.0 14.7 26.7 12.1 16.2 103.0 42.1 21.3 28.5 21.3 9.0 7.4 0.6 2.5 7.2 6.2 14.9 4.3 18.5 13.9 17.4 3.8 27.1 9.0 5.9 6.5 20.8 12.7 2.3 10.5 4.7 19.1 2.5 12.1 3.5 2.7 47.5 5.9 10.4 11.8 2.6 10.3 9.8 8.7 6.5 6.0 2.1 34.8 3.8 5.0 32.0 9.9 0.8 2.8 5.2 37.2 7.8 11.0 7.1 10.2 1.4 1.1 4.6 10.4 4.4 3.4 1.7 8.1 4.1 8.0 2.8 4.6 6.4 27.6 6.9 6.4 9.1 9.4 5.7 23.1 26.2 40.2 28.5 40.0 19.4 12.1 18.7 22.9 16.2 11.5 11.5 16.0 103.0 21.3 42.1 8.2 20.2 21.3 4.1 9.9 3.9 4.6 4.2 3.5 6.8 1.4 10.3 4.9 95.3 109.6 113.9 70.4 78.3 13.4 11.8 35.7 113.8 61.4 21.0 31.4 19.3 16.6 94.9 95.1 107.4 136.0 23.3 99.6 32.8 121.3 247.1 102.7 13.6 47.7 1.6 83.5 49.7 57.7 7.8 25.3 107.0 69.2 266.1 57.5 16.3 73.7 119.3 7.4 13.9 36.6 12.9 178.3 1.1 3.6 72.3 9.4 207.0 53.2 80.6 IRF4 "LSIRF, MUM1" ENSG00000137265 "Interferon regulatory factor 4" Q15306 6 391739-411447 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.7" "Group enriched" "Detected in some" 6 "Melanocytes: 42.2;monocytes: 92.8" "Cancer enriched" "Detected in many" 9 "melanoma: 27.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 9.5;myeloid DC: 9.0;naive B-cell: 9.7;plasmacytoid DC: 10.4;T-reg: 4.8" "Group enriched" "Detected in many" 5 "B-cells: 9.7;dendritic cells: 10.4;T-cells: 4.8" "Cell line enhanced" "Detected in some" "HDLM-2: 50.2;Karpas-707: 46.7;RPMI-8226: 45.1;U-266/70: 42.2;U-266/84: 31.4;WM-115: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002038, HPA002698, CAB013508" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893" "prognostic favorable (6.44e-4)" "unprognostic (1.88e-3)" "unprognostic (1.00e-3)" "unprognostic (1.72e-4)" "unprognostic (2.74e-1)" "prognostic favorable (1.64e-6)" "unprognostic (4.72e-2)" "unprognostic (1.05e-1)" "unprognostic (1.89e-2)" "unprognostic (5.74e-4)" "unprognostic (8.51e-2)" "unprognostic (1.12e-1)" "unprognostic (9.18e-7)" "unprognostic (2.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.90e-1)" "unprognostic (3.65e-2)" 7.1 0.5 0.4 36.6 0.4 18.4 4.0 0.4 0.4 17.4 13.9 0.1 0.4 5.0 2.2 0.7 6.4 1.2 4.1 1.6 0.4 0.5 1.4 5.6 4.2 31.5 0.5 0.0 1.9 0.7 0.0 0.7 0.5 0.1 1.5 4.8 15.8 21.3 1.9 0.7 4.5 11.1 0.3 0.6 33.8 4.6 1.7 0.1 15.2 1.3 2.4 48.7 8.4 4.2 9.7 10.4 0.0 1.6 0.2 4.8 1.3 0.1 0.0 0.0 0.0 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.9 0.0 45.1 0.0 0.0 0.1 0.0 0.0 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 31.4 13.7 0.0 0.0 25.6 0.0 1.6 0.0 0.6 1.2 0.0 9.5 0.9 0.9 9.0 9.7 1.6 0.7 0.0 0.2 1.2 10.4 4.8 1.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.0 0.1 0.1 0.0 4.0 12.0 0.1 7.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.6 0.2 0.0 0.2 0.2 0.0 0.0 1.8 0.0 0.0 3.1 6.9 42.2 92.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 3.8 0.1 6.2 0.0 0.0 IRF5 ENSG00000128604 "Interferon regulatory factor 5" Q13568 7 128937612-128950035 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.1" "Cell type enhanced" "Detected in many" 17 "Hofbauer cells: 34.3;Kupffer cells: 30.3;Macrophages: 27.6;monocytes: 91.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 7 "B-cells: 8.9;dendritic cells: 20.6;monocytes: 24.2" "Cell line enhanced" "Detected in many" "HDLM-2: 46.0;RPMI-8226: 33.4;THP-1: 18.6;U-937: 22.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA046700, HPA076024" Enhanced NA NA "HPA046700: AB_2679761, HPA076024: " "unprognostic (4.01e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-2)" "unprognostic (3.45e-1)" "unprognostic (1.57e-2)" "unprognostic (5.69e-3)" "unprognostic (1.49e-1)" "unprognostic (2.74e-1)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" "unprognostic (6.85e-2)" "unprognostic (1.53e-3)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (6.58e-2)" "unprognostic (3.20e-3)" 5.4 3.6 6.2 10.1 8.4 16.8 8.8 2.0 5.0 2.7 3.5 5.6 40.1 8.0 1.6 2.5 12.0 4.1 5.3 12.3 7.3 5.2 12.6 5.1 15.8 18.9 12.3 2.2 1.4 7.0 10.2 5.7 3.4 7.5 3.3 2.9 2.0 6.3 24.0 1.1 7.1 10.0 2.5 7.0 25.5 3.6 1.6 8.4 3.9 2.2 1.6 9.9 6.8 5.1 8.9 20.6 1.8 24.2 2.0 2.7 8.5 5.8 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.1 2.3 4.1 2.1 0.0 5.5 5.1 1.3 0.9 0.1 46.0 1.2 6.4 0.0 0.7 0.0 0.9 9.3 0.0 6.0 0.2 0.6 0.4 0.0 0.0 0.0 12.5 0.0 1.8 0.0 1.9 0.1 0.6 1.1 0.3 0.0 33.4 1.7 2.9 0.1 0.7 1.0 1.0 0.5 0.0 1.8 18.6 0.0 0.0 0.1 0.1 0.4 7.3 4.8 1.6 0.2 22.9 0.1 0.8 19.0 1.8 0.5 24.2 1.9 8.9 1.1 0.4 20.6 6.8 0.0 0.0 1.3 2.0 17.1 4.9 2.7 8.5 6.2 8.4 2.0 5.0 7.3 5.2 12.3 2.2 7.5 8.4 0.0 5.1 9.5 0.9 0.7 0.1 0.6 5.1 2.7 0.0 19.2 0.0 0.3 3.3 2.9 0.1 0.7 1.3 0.0 2.1 0.2 0.6 0.4 8.1 0.5 34.3 0.0 0.0 0.0 30.3 0.0 0.0 27.6 0.0 91.0 1.2 0.0 2.0 1.7 0.0 3.7 0.2 0.0 0.4 0.0 0.2 1.8 1.3 4.9 1.5 1.4 IRF7 ENSG00000185507 "Interferon regulatory factor 7" Q92985 11 612553-615999 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 12 "plasmacytoid DC: 81.1" "Lineage enriched" "Detected in all" 12 "dendritic cells: 81.1" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;JURKAT: 2.9;Karpas-707: 10.7;SCLC-21H: 5.3;SK-BR-3: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017694, HPA052757" Approved Supported Nucleoplasm,Cytosol No NA Nucleoplasm Cytosol "CAB017694: AB_2280489, HPA052757: AB_2681937" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.08e-3)" "unprognostic (2.45e-1)" "unprognostic (4.52e-2)" "unprognostic (2.73e-1)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-1)" "unprognostic (1.16e-1)" "unprognostic (7.08e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (1.71e-10)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (2.58e-1)" "unprognostic (4.71e-2)" 9.6 4.7 4.5 9.9 6.1 17.2 12.1 2.9 4.9 4.8 4.6 2.5 2.2 2.2 4.2 5.1 6.9 4.9 9.0 5.2 3.7 2.0 8.2 23.3 11.6 12.8 4.6 1.4 4.8 3.6 2.2 3.8 4.8 5.5 5.3 2.9 5.2 5.4 7.4 6.1 4.1 8.4 5.7 4.5 19.0 4.5 4.0 5.2 8.5 9.0 2.4 12.8 7.5 3.9 2.5 81.1 3.7 6.6 2.1 1.5 1.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.3 0.0 0.0 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.1 2.9 0.0 10.7 0.9 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 5.3 0.0 0.0 3.2 0.0 0.9 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.7 3.7 1.1 6.6 1.1 2.5 1.0 1.2 3.3 2.4 1.1 1.2 1.7 2.1 6.1 81.1 1.5 1.8 4.5 6.1 2.9 4.9 3.7 2.0 4.6 1.4 5.5 5.2 14.9 24.2 54.6 23.1 30.6 0.2 4.4 12.7 16.0 9.1 19.2 0.0 5.2 8.3 25.9 3.8 20.4 38.6 23.3 15.1 33.9 18.3 29.0 31.1 24.9 34.1 0.0 25.2 10.4 19.3 16.9 11.2 41.8 35.4 75.7 24.1 2.9 23.7 31.6 4.6 5.9 4.3 12.9 17.5 0.4 6.1 24.8 20.1 31.9 10.1 30.8 IRF8 "ICSBP, ICSBP1, IRF-8" ENSG00000140968 "Interferon regulatory factor 8" Q02556 16 85898803-85922609 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Autophagy, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 197.4;lymphoid tissue: 64.4" "Cell type enhanced" "Detected in many" 13 "B-cells: 159.1;Hofbauer cells: 61.3;Kupffer cells: 76.1;Macrophages: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "plasmacytoid DC: 197.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 197.4" "Cell line enhanced" "Detected in some" "Daudi: 35.6;THP-1: 60.1;U-698: 140.9;U-937: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002267, HPA002531, CAB013480" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904" "unprognostic (2.09e-3)" "unprognostic (7.51e-2)" "unprognostic (5.16e-2)" "unprognostic (1.19e-1)" "unprognostic (7.54e-2)" "unprognostic (3.46e-3)" "unprognostic (3.19e-2)" "unprognostic (5.31e-3)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.66e-1)" "unprognostic (5.31e-2)" "unprognostic (3.14e-3)" "unprognostic (3.97e-2)" "unprognostic (9.66e-3)" "unprognostic (4.04e-1)" "unprognostic (1.10e-2)" 12.4 4.0 6.8 36.1 8.8 19.2 6.7 2.6 5.3 2.3 7.8 8.3 6.8 12.3 2.3 3.0 3.7 2.9 5.6 2.9 5.8 3.3 5.6 9.9 11.7 60.4 9.3 3.1 2.1 3.1 0.2 2.2 2.7 6.7 3.3 10.0 2.2 6.1 8.9 1.5 2.6 36.4 3.6 10.9 64.4 6.5 2.2 8.8 18.4 3.6 2.3 63.3 8.3 2.1 31.8 197.4 0.7 10.8 8.9 0.3 9.8 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.8 0.0 35.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 1.1 0.1 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 60.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 140.9 0.0 19.9 0.0 0.5 10.7 0.2 0.2 10.8 0.3 29.3 0.1 0.1 23.7 31.8 0.3 0.2 0.7 8.9 7.2 197.4 0.0 9.8 6.8 8.8 2.6 5.3 5.8 3.3 9.3 3.1 6.7 8.8 0.0 6.2 159.1 1.1 9.3 0.0 1.2 2.5 0.0 2.3 0.0 0.0 0.5 1.7 0.4 1.4 3.9 16.1 0.0 1.2 4.7 6.4 0.9 2.3 5.6 61.3 0.0 27.5 3.1 76.1 3.7 0.3 82.3 42.2 7.2 5.8 0.4 0.2 11.9 0.0 2.2 0.0 6.5 4.4 0.5 5.5 8.2 0.9 13.8 19.3 2.5 IRGC "CINEMA, Iigp5, IRGC1" ENSG00000124449 "Immunity related GTPase cinema" Q6NXR0 19 43716010-43720021 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 41 "testis: 49.4" "Group enriched" "Detected in some" 133 "Early spermatids: 1421.4;Late spermatids: 1839.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in single" "Karpas-707: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046769, HPA060064" Enhanced NA NA "HPA046769: AB_2679797, HPA060064: AB_2684195" "unprognostic (3.38e-2)" "unprognostic (3.83e-2)" "unprognostic (8.52e-2)" "unprognostic (1.26e-1)" "unprognostic (2.55e-1)" "unprognostic (2.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1421.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1839.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 6.5 0.0 12.2 5.3 0.0 0.0 0.0 0.0 0.0 IRGM "IFI1, IRGM1, LRG-47, LRG47" ENSG00000237693 "Immunity related GTPase M" A1A4Y4 5 150846523-150900736 "Disease related genes, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.5" "Cell type enriched" "Detected in single" 10 "granulocytes: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "basophil: 5.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "HL-60: 3.0;JURKAT: 4.2;NB-4: 5.4;THP-1: 2.9;U-937: 7.0" NA NA "unprognostic (8.73e-2)" "unprognostic (2.28e-2)" "unprognostic (2.96e-2)" "unprognostic (2.29e-1)" "unprognostic (4.71e-2)" "unprognostic (9.62e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-3)" "unprognostic (1.43e-1)" "unprognostic (9.36e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-3)" "unprognostic (1.12e-10)" "unprognostic (5.93e-2)" "unprognostic (8.28e-2)" "unprognostic (2.53e-1)" "unprognostic (1.11e-1)" 0.6 0.1 0.4 1.1 0.4 1.6 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.8 0.4 0.4 0.1 2.7 0.4 0.8 0.9 0.4 0.4 0.5 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.3 1.8 0.4 0.4 1.3 0.8 3.3 0.4 0.4 0.6 0.4 0.4 0.7 0.4 0.8 0.4 5.5 0.3 0.7 1.3 0.5 0.2 0.1 0.2 0.2 0.2 0.0 0.7 0.0 0.0 0.4 0.1 0.7 0.1 0.1 0.3 0.0 0.4 0.3 0.2 0.2 0.1 1.2 0.4 0.3 0.8 0.2 0.0 3.0 0.9 0.2 0.2 0.0 0.2 0.1 0.0 4.2 0.3 1.7 0.0 0.6 1.0 5.4 2.5 0.0 0.4 1.1 0.1 0.1 0.1 0.0 0.3 0.4 0.3 0.7 0.6 0.3 0.4 2.9 0.0 0.4 0.9 0.6 0.3 0.6 0.5 0.6 0.5 7.0 0.1 5.5 0.3 0.2 0.6 0.2 1.3 0.3 0.6 0.7 0.1 0.8 0.6 0.7 1.3 0.7 0.2 0.4 0.2 0.5 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.5 0.0 0.1 IRS2 ENSG00000185950 "Insulin receptor substrate 2" Q9Y4H2 13 109752698-109786568 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 70.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "hTERT-HME1: 18.2;LHCN-M2: 17.3;SH-SY5Y: 19.1;THP-1: 28.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016944, HPA054664" Approved Supported Aggresome,Cytosol NA NA Cytosol Aggresome "CAB016944: , HPA054664: AB_2682563" "unprognostic (2.87e-3)" "unprognostic (5.73e-3)" "unprognostic (4.39e-2)" "unprognostic (1.09e-3)" "unprognostic (1.08e-1)" "unprognostic (5.49e-3)" "unprognostic (2.10e-1)" "unprognostic (9.28e-2)" "unprognostic (9.70e-2)" "unprognostic (2.34e-3)" "unprognostic (1.17e-1)" "unprognostic (2.09e-2)" "unprognostic (6.21e-3)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (3.17e-2)" "unprognostic (1.24e-1)" 38.9 24.3 27.6 10.9 25.2 70.1 33.5 19.6 30.6 13.5 10.9 13.0 6.7 8.7 14.4 12.2 7.1 7.7 8.4 13.5 23.6 14.6 7.7 24.6 11.6 5.3 24.2 22.1 27.1 7.9 6.1 23.0 13.6 19.5 20.0 7.5 9.3 11.5 12.2 20.9 15.3 9.7 9.7 25.1 9.0 8.3 6.3 21.3 2.0 10.7 4.7 5.3 8.4 17.8 0.5 0.1 6.9 1.4 0.2 0.5 0.2 2.6 3.0 2.0 0.0 16.7 3.3 1.1 2.9 3.5 1.8 1.5 0.3 3.3 0.0 1.8 2.0 2.6 1.2 1.0 2.6 2.2 1.0 13.8 1.3 4.3 0.0 17.0 4.8 1.6 7.0 14.1 0.5 18.2 11.7 0.6 0.2 0.8 0.0 17.3 1.3 0.0 14.1 2.1 1.5 0.6 5.9 1.8 1.2 5.0 0.7 2.9 19.1 1.5 0.0 11.8 1.7 0.4 28.8 0.0 3.7 0.0 0.2 3.9 0.0 1.4 0.9 2.8 4.7 6.4 2.7 1.4 1.9 0.2 0.3 0.3 0.1 0.4 0.1 0.1 0.5 0.5 0.4 6.9 0.2 0.4 0.1 0.5 0.2 27.6 25.2 19.6 30.6 23.6 14.6 24.2 22.1 19.5 21.3 29.8 35.6 13.7 47.7 101.2 24.8 56.1 71.4 20.1 43.3 29.6 108.0 17.8 5.0 31.2 32.2 11.3 53.1 23.3 2.7 8.4 42.1 75.9 24.3 103.6 21.1 23.8 117.6 11.6 115.0 5.0 34.5 51.6 123.2 5.4 28.3 37.5 20.9 45.6 19.1 3.3 28.3 25.8 34.0 18.6 8.8 110.3 25.6 24.9 31.0 20.7 IRS4 "IRS-4, PY160" ENSG00000133124 "Insulin receptor substrate 4" O14654 X 108732482-108736409 "Cancer-related genes, Predicted intracellular proteins" Transducer "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 56.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 7 "hypothalamus: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 14.0;NTERA-2: 1.7;RT4: 4.1;WM-115: 3.1" "Group enriched" "Detected in some" 5 "basal ganglia: 12.8;hypothalamus: 52.4" "Group enriched" "Detected in many" 6 "basal ganglia: 21.5;hypothalamus: 55.3" HPA017372 Uncertain NA NA "HPA017372: AB_2669600" "unprognostic (3.74e-3)" "unprognostic (3.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.89e-1)" "unprognostic (2.12e-1)" "unprognostic (1.65e-1)" "unprognostic (1.05e-2)" "unprognostic (1.77e-1)" "unprognostic (9.28e-4)" "unprognostic (8.71e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 1.9 0.0 0.1 0.3 0.1 2.6 0.3 0.3 0.5 0.0 0.0 0.3 4.6 0.0 0.0 0.1 0.0 0.5 0.1 9.5 0.0 0.0 56.0 0.1 0.6 0.2 0.0 2.7 0.0 0.5 0.0 0.6 0.0 1.0 0.2 0.1 0.5 0.1 0.5 5.1 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.3 4.6 0.5 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IRX1 IRX-5 ENSG00000170549 "Iroquois homeobox 1" P78414 5 3596054-3601403 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.1;breast: 36.0;salivary gland: 20.9" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 6.0;Collecting duct cells: 5.2;Distal tubular cells: 13.3;Smooth muscle cells: 4.5" "Group enriched" "Detected in many" 6 "breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 7.2;REH: 29.0;U-251 MG: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043160 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA043160: AB_10794771" "unprognostic (1.52e-2)" "unprognostic (1.26e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-2)" "unprognostic (4.30e-3)" "unprognostic (2.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.03e-2)" "unprognostic (9.78e-4)" "unprognostic (5.11e-2)" "unprognostic (2.78e-2)" "unprognostic (3.58e-2)" 5.3 0.4 2.6 0.4 2.1 1.4 36.0 6.6 1.5 0.4 0.4 2.0 6.0 0.4 0.4 1.7 0.8 0.4 0.4 1.0 3.1 3.2 13.9 0.4 8.0 0.6 4.2 1.0 0.4 0.7 0.4 0.7 0.4 16.1 0.5 0.4 2.8 20.9 1.5 0.4 6.8 0.4 0.4 5.1 0.4 0.4 0.5 1.6 3.0 0.5 0.5 0.9 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.4 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 29.0 0.0 0.0 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.1 6.6 0.2 3.1 3.2 4.2 1.0 16.1 1.6 6.0 3.0 0.0 0.0 3.2 0.5 2.0 0.0 2.7 1.2 5.2 0.0 0.2 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.5 0.0 0.2 2.6 0.2 0.0 0.0 0.0 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751662 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3" "Group enriched" "Detected in many" 5 "midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3" "Low region specificity" "Detected in all" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: AB_2682566" "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favorable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 2.4 0.1 0.8 0.1 2.8 0.1 27.9 8.4 1.7 0.4 0.7 0.7 4.4 0.1 0.1 2.5 3.1 0.2 0.1 2.1 1.9 1.7 14.3 0.1 32.8 0.3 3.9 0.2 0.1 1.9 2.7 1.4 9.0 36.9 3.9 0.3 1.8 26.6 1.4 0.3 17.7 0.1 0.1 4.8 0.1 8.7 3.1 2.2 0.0 1.4 3.1 3.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 40.5 0.0 2.2 1.6 24.3 2.4 1.3 2.0 1.6 4.8 0.0 0.0 0.0 4.5 0.0 13.8 0.0 9.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 26.6 0.9 8.2 0.0 0.0 0.0 0.0 0.0 1.4 7.8 0.0 0.0 4.5 10.5 0.0 0.0 2.5 0.0 9.0 0.0 1.5 0.0 7.9 16.3 0.0 6.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.8 8.4 0.5 1.9 1.7 3.9 0.2 36.9 2.2 101.3 59.1 0.0 14.0 179.6 0.5 2.4 0.0 10.7 30.7 7.0 0.0 23.0 23.2 0.1 3.9 0.5 0.5 0.0 0.0 17.1 12.8 15.9 1.1 0.0 2.8 0.0 0.0 0.0 0.0 8.9 0.0 1.3 18.6 0.0 1.5 0.2 0.5 1.9 0.0 0.5 2.4 0.0 16.9 0.7 3.8 114.7 12.7 0.0 1.9 9.2 IRX3 IRX-1 ENSG00000177508 "Iroquois homeobox 3" P78415 16 54283304-54286763 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 87.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 59.7;Basal glandular cells: 41.5;Ciliated cells: 72.3;Club cells: 48.9;Suprabasal keratinocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 29.1;NB-4: 48.3;RPTEC TERT1: 58.2;T-47d: 30.1;THP-1: 48.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA062522 Approved Vesicles NA NA Vesicles "HPA062522: AB_2797268" "unprognostic (4.21e-3)" "unprognostic (4.50e-2)" "unprognostic (2.34e-2)" "unprognostic (1.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.35e-2)" "unprognostic (1.52e-1)" "unprognostic (9.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (3.15e-2)" "unprognostic (5.40e-2)" "unprognostic (2.39e-1)" "unprognostic (8.20e-2)" "unprognostic (1.25e-1)" 4.4 2.5 1.8 0.1 2.1 0.0 38.3 3.8 0.7 15.3 0.5 1.5 46.8 0.1 4.0 18.1 14.1 5.3 0.2 46.9 3.2 3.6 9.8 1.0 46.8 1.9 4.6 0.3 1.6 2.1 15.4 3.4 1.0 7.8 10.0 0.0 5.9 20.5 87.8 9.1 33.8 0.2 0.6 8.2 0.2 7.7 1.4 3.2 0.4 8.9 9.1 6.5 2.6 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.2 0.2 3.8 3.7 2.1 0.8 0.4 1.6 3.5 3.4 0.8 1.0 1.6 0.0 0.5 2.4 1.3 7.1 3.0 0.8 4.6 3.4 2.4 0.0 5.1 3.5 0.1 3.9 1.0 0.6 14.8 6.5 3.0 2.4 0.0 4.6 0.0 0.0 29.1 1.8 7.2 48.3 0.2 0.0 0.0 5.5 4.7 0.0 58.2 1.5 2.6 0.4 4.9 12.6 0.5 0.4 30.1 48.1 0.8 14.4 1.6 2.6 1.2 0.0 0.0 0.0 9.4 12.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.8 2.1 3.8 0.3 3.2 3.6 4.6 0.3 7.8 3.2 17.9 59.7 0.0 41.5 22.1 0.3 10.6 0.0 72.3 48.9 5.2 0.0 0.0 1.7 4.6 0.0 5.1 0.0 0.0 0.2 0.1 14.7 23.1 0.0 2.9 0.3 0.0 0.0 6.2 1.2 0.0 0.0 2.3 10.1 0.0 0.0 10.6 0.2 0.0 0.0 2.2 0.9 0.0 4.2 0.5 0.4 36.1 0.0 0.0 0.0 31.4 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 43.0;Glandular cells: 12.7;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 19 "pons and medulla: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.0;HaCaT: 11.5;HBEC3-KT: 6.4;MCF7: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "pons and medulla: 1.9" HPA064094 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.1 0.1 0.1 0.3 5.1 0.1 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.1 11.2 0.1 0.1 11.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 2.7 7.8 0.1 0.1 6.7 0.1 1.2 14.2 0.1 1.0 0.1 0.1 0.1 1.7 0.1 0.1 0.1 2.5 2.1 0.1 7.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.5 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.7 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.7 0.1 0.0 0.0 0.0 4.2 43.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.6 12.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 17.7 3.1 0.0 0.0 1.3 IRX5 IRX-2a ENSG00000176842 "Iroquois homeobox 5" P78411 16 54930862-54934485 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Vision" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 19.0;heart muscle: 26.5" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 18.7;Ciliated cells: 18.7;Club cells: 21.6;Muller glia cells: 47.9" "Cancer enhanced" "Detected in many" "breast cancer: 20.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 18.1;T-47d: 24.7;THP-1: 13.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "cerebellum: 4.1;hypothalamus: 3.2;midbrain: 7.6;pons and medulla: 5.7;thalamus: 4.7" HPA047130 Approved "Nuclear speckles,Microtubules,Cytosol" No NA "Nuclear speckles" "Microtubules, Cytosol" "HPA047130: AB_10962983" "unprognostic (2.63e-1)" "unprognostic (4.49e-2)" "unprognostic (8.03e-2)" "unprognostic (8.56e-2)" "unprognostic (1.42e-2)" "unprognostic (3.89e-2)" "unprognostic (5.38e-3)" "prognostic favorable (4.59e-4)" "unprognostic (8.52e-2)" "unprognostic (1.02e-1)" "unprognostic (1.56e-2)" "unprognostic (3.43e-2)" "unprognostic (1.17e-3)" "unprognostic (3.34e-2)" "unprognostic (8.90e-2)" "unprognostic (1.77e-3)" "unprognostic (4.28e-2)" 3.3 0.7 0.2 0.2 1.4 0.2 19.0 5.8 0.3 3.6 0.5 1.7 0.2 0.2 0.4 1.9 7.6 0.3 0.4 26.5 0.9 1.3 4.7 0.2 10.3 0.3 2.6 0.0 0.5 0.3 0.5 0.3 0.2 5.3 4.2 0.2 6.5 13.6 0.5 6.7 13.9 0.2 0.3 4.5 0.2 3.3 0.9 2.2 0.4 0.2 1.0 2.4 0.8 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 5.8 2.2 2.1 0.4 0.2 2.2 5.5 0.7 0.5 1.3 0.5 0.0 0.5 2.9 0.2 5.6 2.0 2.4 0.4 3.9 2.7 0.6 2.4 0.0 0.0 1.3 2.2 0.6 10.3 3.6 1.6 1.0 0.0 3.2 0.3 0.0 4.2 2.1 6.1 8.0 0.1 0.8 1.6 3.2 3.0 0.3 18.1 0.1 2.0 2.0 0.9 5.0 2.4 0.0 24.7 13.2 0.3 4.1 0.1 2.8 0.8 2.5 1.4 1.9 6.6 2.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 5.8 0.2 0.9 1.3 2.6 0.0 5.3 2.2 8.9 18.7 0.0 8.4 7.3 1.1 9.4 0.0 18.7 21.6 0.0 0.0 0.2 0.0 0.2 0.9 0.7 0.0 0.0 0.5 0.0 2.1 4.4 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.7 0.0 0.0 5.0 0.0 0.5 47.9 1.8 0.0 0.0 0.7 1.9 0.0 1.2 0.2 3.0 6.9 0.0 0.0 0.3 6.1 IRX6 "IRX-3, IRX7" ENSG00000159387 "Iroquois homeobox 6" P78412 16 55323760-55330760 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 11.1;breast: 18.9;heart muscle: 11.1;skin 1: 9.3" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 5.2;Hofbauer cells: 3.5;Late spermatids: 3.8;Melanocytes: 3.3" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 11 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEK 293: 2.9;RPTEC TERT1: 10.6;SK-MEL-30: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA018332 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA018332: AB_1851920" "unprognostic (1.22e-1)" "unprognostic (1.02e-1)" "unprognostic (4.93e-4)" "unprognostic (2.48e-2)" "unprognostic (6.50e-2)" "unprognostic (3.46e-1)" "prognostic favorable (3.34e-4)" "unprognostic (3.63e-2)" "unprognostic (4.36e-2)" "unprognostic (2.93e-2)" "unprognostic (1.50e-2)" "unprognostic (2.83e-2)" "unprognostic (9.63e-3)" "unprognostic (7.12e-3)" "unprognostic (5.48e-2)" "unprognostic (5.23e-3)" 11.1 0.0 0.2 0.2 1.4 0.0 18.9 0.2 0.5 3.3 0.2 0.2 0.2 0.0 0.6 0.2 0.5 0.0 0.2 11.1 0.2 0.4 1.5 0.2 2.3 0.2 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.2 0.0 2.0 2.5 0.2 2.7 9.3 0.2 0.2 0.2 1.6 0.0 0.6 0.2 3.5 0.7 0.2 2.3 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 10.6 0.0 0.2 0.1 0.1 1.8 6.8 0.1 0.6 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.6 1.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.8 0.0 0.0 3.3 1.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 ISG15 "G1P2, IFI15, UCRP" ENSG00000187608 "ISG15 ubiquitin-like modifier" P05161 1 1001138-1014541 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 103.3;salivary gland: 116.2" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 427.6;Smooth muscle cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 140.4;BJ hTERT+ SV40 Large T+ RasG12V: 141.7;HeLa: 45.8;SK-MEL-30: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004627 Approved "Secreted to blood" NA NA 5000000 "HPA004627: AB_1079152" "unprognostic (3.65e-1)" "unprognostic (1.06e-1)" "unprognostic (1.12e-2)" "unprognostic (4.62e-2)" "unprognostic (3.96e-3)" "unprognostic (1.38e-1)" "unprognostic (4.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.48e-2)" "unprognostic (3.78e-3)" "unprognostic (2.07e-3)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.11e-10)" "unprognostic (4.55e-2)" "unprognostic (4.13e-2)" "unprognostic (1.12e-2)" "unprognostic (7.46e-2)" 25.0 5.5 22.6 14.5 14.8 48.5 8.5 2.3 22.7 15.2 11.3 6.2 5.5 17.4 12.8 20.4 7.9 4.3 12.7 12.0 13.2 16.4 29.8 28.9 18.3 13.0 12.0 8.6 6.5 8.2 2.6 10.7 50.1 13.4 9.9 3.5 7.6 116.2 9.0 7.1 3.4 16.8 7.8 17.8 26.9 11.2 4.9 6.4 28.7 16.7 6.2 9.4 9.3 9.1 30.4 22.0 103.3 50.6 31.4 61.3 27.7 5.4 0.8 0.4 3.7 0.5 1.1 3.3 3.8 9.1 140.4 141.7 8.8 8.8 4.8 27.7 3.1 24.5 3.4 0.4 1.6 2.1 5.4 2.4 2.2 45.8 5.9 5.3 1.4 9.3 2.4 0.5 8.9 0.1 0.4 4.3 6.5 1.3 2.6 1.1 25.9 4.6 23.5 0.4 3.4 29.9 8.0 1.1 2.4 1.8 1.6 0.1 0.1 7.4 1.2 44.5 0.2 0.2 2.8 2.4 2.8 2.7 1.2 0.8 3.5 1.8 3.5 2.7 5.5 0.2 55.8 35.9 103.3 30.3 50.6 39.3 30.4 35.1 33.5 22.0 23.5 22.7 26.2 83.7 31.4 42.9 7.3 61.3 27.7 22.6 14.8 2.3 22.7 13.2 16.4 12.0 8.6 13.4 6.4 35.7 20.3 41.2 41.4 39.6 1.5 18.2 35.7 24.1 26.1 43.6 0.0 12.7 5.0 129.5 3.0 180.0 253.7 0.0 242.3 427.6 85.6 41.8 60.0 52.1 238.9 0.0 33.7 74.9 63.0 9.3 30.5 163.4 84.4 57.7 87.1 19.4 135.8 228.0 38.9 17.0 1.4 97.0 303.7 1.7 1.1 32.2 27.0 93.5 15.6 46.9 ISG20 "CD25, HEM45" ENSG00000172183 "Interferon stimulated exonuclease gene 20" Q96AZ6 15 88636153-88656483 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 116.8;lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 5 "B-cells: 305.7;monocytes: 313.8;Urothelial cells: 376.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.6;Karpas-707: 21.7;SK-MEL-30: 121.9;U-698: 21.8" "Not detected" "Not detected" NA NA "unprognostic (2.55e-3)" "unprognostic (1.19e-3)" "unprognostic (2.00e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (4.54e-2)" "unprognostic (1.35e-3)" "prognostic favorable (1.85e-5)" "unprognostic (5.60e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.86e-8)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "unprognostic (3.39e-1)" "unprognostic (1.58e-2)" 8.4 2.4 2.2 39.6 3.6 12.1 7.3 0.8 3.1 4.1 18.3 1.9 8.3 25.9 2.7 8.2 9.9 3.9 36.6 4.9 2.4 2.6 6.1 9.9 26.0 56.6 3.2 1.8 6.8 6.4 0.2 10.1 4.6 3.2 6.0 3.0 2.2 13.2 8.1 4.1 3.4 39.4 1.2 3.6 53.8 21.9 2.5 1.8 29.1 14.5 6.1 41.4 10.7 4.2 99.2 12.3 116.8 5.1 31.0 104.4 29.7 1.6 2.5 0.0 0.0 0.0 0.0 0.4 0.0 1.1 7.5 10.4 0.8 3.6 36.6 1.9 0.1 3.5 0.5 0.1 0.8 0.2 11.5 0.1 0.1 1.2 1.5 5.0 0.0 0.0 0.7 1.4 2.6 1.7 0.1 1.2 2.6 0.1 21.7 0.0 2.6 0.1 0.2 0.3 5.8 5.5 1.4 0.1 6.8 0.6 0.3 0.1 0.1 0.3 14.5 121.9 0.0 0.4 0.8 1.5 0.2 0.8 0.0 0.5 15.4 4.1 21.8 0.3 0.5 1.5 8.4 3.0 6.2 27.7 5.1 36.6 94.6 47.9 39.7 2.6 99.2 35.5 37.2 116.8 31.0 3.8 12.3 104.4 29.7 2.2 3.6 0.8 3.1 2.4 2.6 3.2 1.8 3.2 1.8 44.7 47.2 305.7 100.8 158.8 0.0 1.2 50.9 65.6 50.0 3.5 0.0 1.5 1.7 54.2 12.1 28.6 92.1 116.8 133.1 66.9 47.5 249.9 7.0 10.4 8.0 0.0 36.0 14.1 25.6 3.3 2.0 43.4 214.2 313.8 83.6 0.0 202.6 80.7 1.8 5.5 0.1 25.8 27.8 0.9 2.1 250.9 43.5 278.6 6.2 376.0 ISG20L2 FLJ12671 ENSG00000143319 "Interferon stimulated exonuclease gene 20 like 2" Q9H9L3 1 156721891-156728799 "Predicted intracellular proteins" "Ribosome biogenesis" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 98.1" "Group enriched" "Detected in many" 29 "Early spermatids: 725.4;Late spermatids: 2397.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028005, HPA054285" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA028005: AB_2126319, HPA054285: " "unprognostic (1.67e-2)" "unprognostic (7.87e-2)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (3.52e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (1.02e-1)" "unprognostic (9.55e-2)" "unprognostic (6.05e-2)" "unprognostic (2.40e-1)" "unprognostic (8.17e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (5.11e-2)" "unprognostic (2.68e-1)" "unprognostic (3.82e-3)" "unprognostic (2.32e-1)" 8.0 7.9 8.5 9.5 10.5 12.1 9.7 15.4 11.2 8.6 8.9 10.2 8.9 7.7 10.6 8.5 13.8 9.3 7.9 8.2 7.9 6.1 8.6 10.1 7.9 11.1 8.5 7.6 11.1 9.3 8.4 10.6 10.5 8.3 8.8 11.3 7.5 8.8 9.0 7.2 10.6 10.5 11.6 7.9 10.6 9.2 98.1 9.4 14.1 8.4 7.6 14.3 9.8 9.2 9.5 8.0 20.4 10.6 11.9 9.9 5.5 13.5 10.2 9.5 10.1 9.9 7.7 14.6 9.7 9.2 13.4 9.3 14.0 10.8 25.6 12.3 7.9 6.0 18.8 22.0 16.3 10.3 13.3 13.8 13.8 7.9 7.9 9.8 33.1 15.1 7.7 16.1 12.4 13.6 8.2 12.1 11.8 22.1 12.0 8.6 18.5 15.0 8.6 30.1 29.2 17.6 18.5 10.8 16.9 9.2 10.6 18.6 23.5 11.7 32.0 9.3 14.7 20.6 21.3 7.2 7.6 11.0 8.7 18.8 15.9 24.6 33.3 6.8 16.8 9.8 20.4 8.3 15.5 8.5 10.1 9.9 7.7 7.0 8.7 8.0 9.5 6.8 8.3 16.0 11.9 10.6 5.1 6.2 5.5 8.5 10.5 15.4 11.2 7.9 6.1 8.5 7.6 8.3 9.4 26.8 40.8 21.7 36.3 47.1 22.4 9.3 25.5 21.4 35.2 7.0 23.6 30.5 14.9 20.2 725.4 23.9 29.3 0.0 15.0 33.1 22.9 32.1 26.6 16.8 18.7 22.3 30.6 18.4 19.8 2397.2 27.0 25.7 21.9 10.8 28.3 18.4 18.3 21.0 24.4 10.9 18.9 25.8 24.7 35.8 26.8 53.1 31.4 27.7 23.0 34.6 ISL1 "Isl-1, ISLET1" ENSG00000016082 "ISL LIM homeobox 1" P61371 5 51383391-51394738 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 30.3" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 118.7;Horizontal cells: 41.3;Intestinal endocrine cells: 87.9;Syncytiotrophoblasts: 28.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Group enriched" "Detected in some" 5 "basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 82.3" "Group enriched" "Detected in some" 8 "basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5" "Group enriched" "Detected in some" 11 "basal ganglia: 8.5;hypothalamus: 8.6" "HPA048613, HPA057416" Approved Approved "Nucleoplasm,Nuclear speckles,Mitochondria" NA NA Nucleoplasm "Nuclear speckles, Mitochondria" "HPA048613: , HPA057416: AB_2683431" "unprognostic (4.97e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-1)" "unprognostic (2.41e-3)" "unprognostic (5.52e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-2)" "unprognostic (9.42e-2)" "unprognostic (5.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.48e-1)" "unprognostic (9.11e-3)" "unprognostic (4.39e-3)" 2.2 1.5 0.0 0.0 4.0 0.0 0.1 0.0 0.2 14.4 1.6 0.0 4.2 2.3 1.3 0.5 0.2 0.0 0.2 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.8 10.0 2.0 13.2 2.5 6.4 1.0 30.3 0.1 1.1 0.7 0.6 0.1 0.0 10.7 1.6 0.7 3.1 0.3 0.2 0.4 2.4 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.6 1.2 0.9 0.0 0.0 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.8 0.0 0.0 0.0 5.3 82.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.0 0.0 0.2 0.0 5.5 0.0 0.0 2.0 0.7 0.0 0.0 0.0 3.5 1.3 118.7 0.3 0.0 0.0 0.0 0.0 3.9 20.5 0.0 0.0 13.2 0.1 0.0 0.0 0.0 8.9 0.4 1.2 0.0 0.0 2.3 41.3 87.9 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.6 3.4 6.8 0.0 0.0 0.0 11.3 0.0 0.1 0.7 0.7 0.9 28.6 0.0 0.0 3.7 ISL2 FLJ10160 ENSG00000159556 "ISL LIM homeobox 2" Q96A47 15 76336724-76342476 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.3;pituitary gland: 12.6;salivary gland: 11.8" "Cell type enriched" "Detected in some" 8 "Cone photoreceptor cells: 25.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "neutrophil: 11.3;non-classical monocyte: 3.9" "Group enriched" "Detected in many" 6 "granulocytes: 11.3;monocytes: 3.9" "Cell line enhanced" "Detected in many" "HEK 293: 15.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA075192 Approved "Rods & Rings" NA NA "Rods & Rings" "HPA075192: AB_2686738" "unprognostic (7.30e-2)" "unprognostic (7.96e-2)" "unprognostic (9.01e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-1)" "unprognostic (7.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.45e-1)" "unprognostic (1.67e-1)" "unprognostic (2.84e-1)" "unprognostic (9.03e-2)" "unprognostic (3.93e-2)" "unprognostic (3.55e-15)" "unprognostic (1.78e-1)" "unprognostic (4.19e-1)" "unprognostic (4.07e-1)" "unprognostic (2.26e-1)" 0.9 0.2 0.0 0.8 1.1 0.3 0.3 0.0 0.9 2.8 3.8 2.0 0.0 2.9 0.2 0.2 1.2 0.2 1.9 0.7 0.3 0.0 0.2 0.2 0.4 0.9 0.7 0.0 0.2 0.2 0.2 12.6 0.3 1.0 4.1 0.5 1.9 11.8 0.3 0.2 1.1 2.0 0.4 1.8 1.0 3.2 2.7 1.9 0.0 0.2 4.0 1.2 0.2 6.4 1.2 0.2 11.3 3.9 0.0 0.6 0.5 1.4 1.7 0.0 1.6 0.1 0.1 1.5 4.4 2.0 1.1 1.5 3.4 0.7 3.3 2.1 0.0 1.1 1.8 6.3 0.1 0.2 3.1 15.7 1.5 3.6 4.0 1.4 3.3 4.2 0.0 0.9 0.0 0.0 0.0 0.0 4.9 4.8 2.5 0.4 0.1 4.1 8.1 0.0 0.6 3.0 2.7 2.0 4.0 0.0 0.6 4.8 5.3 2.8 0.0 0.0 0.9 0.3 7.6 0.0 1.4 3.2 0.6 4.2 3.7 3.9 1.9 1.0 2.4 0.0 0.0 1.0 0.0 0.2 1.0 0.0 1.0 0.0 0.6 0.2 1.2 0.2 0.1 11.3 0.0 3.9 0.0 0.0 0.5 0.0 1.1 0.0 0.9 0.3 0.0 0.7 0.0 1.0 1.9 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 25.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 1.7 0.0 0.0 0.2 0.0 0.0 3.0 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;testis: 11.6" "Group enriched" "Detected in some" 7 "Early spermatids: 48.2;Late spermatids: 45.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "SCLC-21H: 27.5;SH-SY5Y: 41.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012930, HPA067333" Uncertain NA NA 66000 "HPA012930: AB_2668772, HPA067333: AB_2685824" "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.6 2.1 7.5 1.0 16.8 0.4 1.5 2.0 25.9 2.4 1.2 0.1 0.0 1.1 3.9 0.6 1.2 2.0 1.6 6.3 3.5 4.8 0.5 0.5 1.2 2.6 0.7 7.2 0.6 1.3 1.3 0.6 0.6 1.7 0.7 0.9 3.0 0.9 1.1 3.0 1.0 2.0 1.8 0.3 1.5 1.0 11.6 3.4 0.0 0.7 2.1 0.6 0.9 0.4 1.1 0.9 2.5 0.7 0.5 0.4 0.2 0.0 0.1 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 41.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 1.5 0.7 0.2 0.4 0.3 0.2 0.5 0.3 0.2 0.2 1.1 0.4 0.4 2.5 0.5 0.4 0.9 0.2 0.2 7.5 16.8 2.0 20.3 3.5 4.8 0.7 7.2 1.7 3.4 0.0 1.1 0.0 0.0 0.1 0.3 6.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 48.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.9 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.0 ISM1 "bA149I18.1, C20orf82" ENSG00000101230 "Isthmin 1" B1AKI9 20 13221771-13300651 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 33.8" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 4.0;Fibroblasts: 8.1;Proximal tubular cells: 3.1;Suprabasal keratinocytes: 2.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "memory CD4 T-cell: 4.0;naive CD4 T-cell: 3.3" "Lineage enriched" "Detected in single" 40 "T-cells: 4.0" "Group enriched" "Detected in some" 5 "ASC diff: 36.3;Hep G2: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.13e-2)" "unprognostic (3.55e-1)" "unprognostic (4.43e-3)" "unprognostic (5.27e-3)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.06e-1)" "unprognostic (4.48e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.32e-6)" "unprognostic (2.58e-2)" "unprognostic (2.10e-1)" "unprognostic (6.83e-2)" "unprognostic (1.81e-2)" 7.8 2.4 0.8 0.5 1.1 0.0 17.0 0.7 1.5 2.4 2.1 0.8 2.0 0.3 1.8 2.3 4.5 2.3 4.4 2.2 1.0 1.7 2.4 4.5 3.2 1.0 0.7 0.9 1.1 5.7 0.1 1.0 12.7 1.3 1.9 0.2 0.8 8.9 0.7 2.3 9.2 1.1 1.7 0.6 4.8 1.9 1.2 0.8 1.4 33.8 5.5 1.1 3.8 6.1 0.0 0.0 0.0 0.0 0.0 4.0 1.5 0.0 0.3 0.2 0.5 36.3 5.1 0.2 0.3 3.0 0.0 0.0 2.0 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 13.9 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.2 0.0 0.3 0.3 0.0 0.2 1.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 1.0 0.1 0.7 0.0 0.0 0.0 2.1 0.3 0.1 0.2 0.0 3.4 0.6 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 1.5 0.8 1.1 0.7 1.5 1.0 1.7 0.7 0.9 1.3 0.8 0.0 0.3 0.0 0.5 4.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 2.3 0.0 0.0 0.0 0.2 8.1 0.1 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.8 0.0 0.2 2.5 0.6 0.5 0.0 0.1 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498850 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "placenta: 193.8" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 91.4" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.7 0.0 0.2 0.2 4.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.3 0.1 2.7 0.9 0.2 0.5 0.1 0.1 0.1 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.5 193.8 0.2 3.2 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.2 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.1 0.3 0.1 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 240.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 440.1 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 148.4 0.0 0.0 0.0 ISOC2 FLJ23469 ENSG00000063241 "Isochorismatase domain containing 2" Q96AB3 19 55452985-55462343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.9" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 256.8;Proximal tubular cells: 330.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 68.8" "Low region specificity" "Detected in all" HPA043142 Enhanced Approved Mitochondria,Cytosol NA NA 230000 Mitochondria Cytosol "HPA043142: AB_10794653" "unprognostic (2.74e-1)" "unprognostic (8.38e-3)" "unprognostic (7.34e-2)" "unprognostic (3.09e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-1)" "unprognostic (3.09e-1)" "unprognostic (5.82e-2)" "unprognostic (8.59e-2)" "unprognostic (9.90e-3)" "unprognostic (2.24e-1)" "unprognostic (2.42e-1)" "unprognostic (9.20e-2)" "unprognostic (2.09e-2)" 12.7 16.4 13.4 12.8 15.0 10.5 28.1 9.0 15.6 10.9 15.9 9.9 17.1 20.6 8.9 13.5 14.7 10.7 19.2 20.9 13.4 12.9 33.2 93.9 11.2 10.2 15.4 11.2 9.1 23.8 12.8 14.2 5.5 14.6 12.0 10.0 7.2 23.3 21.2 47.2 10.0 20.5 12.0 13.9 15.8 12.9 23.3 13.4 5.9 14.9 22.9 11.8 12.8 8.8 11.5 18.1 0.5 20.0 14.1 10.4 9.1 12.7 19.4 5.4 14.4 3.7 7.8 17.2 9.1 9.6 12.1 12.4 9.6 22.8 24.4 17.0 11.1 11.7 12.9 10.4 12.0 4.0 9.3 68.8 13.8 4.7 31.5 14.9 15.4 42.4 11.5 11.6 7.7 5.9 5.5 10.9 10.0 22.5 16.3 7.7 25.3 0.0 18.1 8.3 29.0 55.4 17.5 11.1 31.9 20.0 12.1 6.4 18.1 8.8 20.0 10.3 3.3 16.7 27.6 7.8 8.8 12.6 9.9 10.9 19.8 17.1 19.0 13.9 19.7 15.2 0.4 9.9 0.5 8.3 20.0 8.2 11.5 7.7 10.4 18.1 8.8 7.8 7.8 0.4 14.1 16.1 14.8 9.1 9.1 13.4 15.0 9.0 15.6 13.4 12.9 15.4 11.2 14.6 13.4 6.0 4.6 47.7 58.7 52.9 10.1 19.8 40.8 6.7 4.5 59.3 2.0 32.1 137.6 59.7 16.0 29.2 194.8 0.0 59.2 95.0 50.3 45.4 46.0 256.8 86.3 12.7 68.5 30.1 38.8 34.9 35.9 49.5 59.1 27.9 102.3 53.5 50.1 94.8 29.0 330.6 8.4 25.8 37.6 55.3 11.7 60.0 18.1 24.9 124.1 54.8 ISX RAXLX ENSG00000175329 "Intestine specific homeobox" Q2M1V0 22 35066136-35087387 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 22.2" "Group enriched" "Detected in some" 49 "Enterocytes: 22.5;Intestinal endocrine cells: 18.7;Mucus-secreting cells: 15.4;Paneth cells: 21.0;Undifferentiated cells: 19.5" "Cancer enhanced" "Detected in some" "colorectal cancer: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "CACO-2: 3.5;Hep G2: 9.8" "Not detected" "Not detected" HPA060328 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA060328: AB_2684254" "unprognostic (5.02e-2)" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "unprognostic (3.33e-1)" "unprognostic (3.86e-1)" "unprognostic (2.55e-1)" 0.1 0.0 0.1 2.0 0.1 0.0 0.1 0.1 0.1 0.1 16.3 0.1 0.1 22.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 15.8 0.1 0.1 0.1 0.1 0.0 19.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 ISYNA1 "Ino1, INOS, IPS" ENSG00000105655 "Inositol-3-phosphate synthase 1" Q9NPH2 19 18434388-18438301 "Enzymes, Predicted intracellular proteins" "Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 83.6" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 829.0;Sertoli cells: 310.4;Syncytiotrophoblasts: 865.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.0;NK-cells: 11.9;T-cells: 8.5" "Cell line enriched" "Detected in many" 4 "BEWO: 103.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007931, HPA008232, CAB020720" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018" "unprognostic (1.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.98e-2)" "unprognostic (3.16e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-2)" "unprognostic (2.49e-1)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.28e-2)" "unprognostic (2.73e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (2.23e-2)" "unprognostic (9.26e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" 7.9 8.4 7.1 3.0 5.7 4.5 7.1 2.7 6.7 9.9 3.5 10.0 44.2 3.4 13.9 12.3 4.5 20.0 6.5 8.0 5.7 7.4 12.7 4.1 4.7 3.8 4.1 4.1 31.6 25.5 7.7 12.6 44.2 16.2 9.5 1.3 19.3 8.8 34.4 8.2 3.4 3.9 3.0 2.3 10.5 3.7 83.6 3.5 3.0 5.6 3.8 3.3 5.9 7.8 4.0 1.9 0.9 0.2 11.9 8.5 4.9 2.8 8.6 20.5 6.1 0.1 0.0 103.8 1.3 0.2 0.1 0.0 4.9 5.2 0.0 7.0 0.6 0.0 7.4 0.6 0.0 0.0 7.7 23.6 10.3 0.5 15.9 2.2 0.1 0.2 1.6 0.1 0.6 0.1 0.0 1.3 0.2 21.1 0.4 0.0 16.6 0.7 0.7 10.7 2.6 6.9 14.2 0.0 4.8 1.7 0.0 6.3 15.8 0.3 1.9 10.5 4.4 14.0 1.1 3.9 0.1 0.2 0.1 0.3 3.3 1.4 0.6 0.6 0.4 3.6 0.9 0.1 0.0 7.6 0.2 5.9 4.0 7.4 6.7 0.7 2.3 6.1 8.5 0.8 11.9 0.1 1.9 5.2 4.9 7.1 5.7 2.7 6.7 5.7 7.4 4.1 4.1 16.2 3.5 3.0 0.6 2.2 67.1 10.6 0.0 4.2 7.6 4.0 4.5 45.4 2.0 829.0 44.7 34.8 81.2 19.7 1.3 0.0 7.5 57.3 25.4 8.5 13.9 0.9 73.6 0.0 62.2 19.0 5.3 178.1 34.5 3.7 21.9 7.2 2.6 7.2 4.6 0.0 47.4 4.7 0.5 310.4 167.1 59.2 21.8 5.0 865.2 9.6 4.6 31.8 ITGA11 HsT18964 ENSG00000137809 "Integrin subunit alpha 11" Q9UKX5 15 68296533-68432162 "Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.3;Fibroblasts: 8.2;Leydig cells: 6.4;Peritubular cells: 12.7;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 55.3;hTERT-RPE1: 83.9;U-138 MG: 38.5;WM-115: 21.3" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 4 "basal ganglia: 6.1" HPA051813 Uncertain NA NA 42000 "HPA051813: AB_2681622" "unprognostic (4.85e-2)" "unprognostic (3.51e-1)" "unprognostic (6.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (9.29e-3)" "unprognostic (6.63e-2)" "unprognostic (5.68e-3)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (8.38e-3)" "unprognostic (2.28e-4)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" 4.5 2.9 0.4 3.5 0.9 0.0 2.9 0.5 3.6 41.9 1.5 0.9 3.5 0.6 59.6 11.4 2.6 8.0 3.4 9.0 0.5 0.5 4.9 0.7 1.3 0.5 0.8 0.5 15.7 0.8 0.2 1.5 2.2 1.3 4.5 1.4 1.5 0.9 8.9 1.9 2.1 1.6 30.2 0.9 4.0 1.3 3.4 0.7 0.2 1.8 5.8 0.7 5.6 7.4 1.7 1.3 1.8 1.0 0.8 1.5 0.1 0.0 0.0 0.1 0.2 1.8 0.0 0.0 3.7 7.1 0.8 0.2 0.0 0.0 0.0 0.2 55.3 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.0 0.0 4.8 0.0 3.1 0.6 0.0 1.5 0.1 83.9 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 8.7 0.0 0.1 2.3 38.5 0.2 0.8 0.0 0.0 0.0 0.0 5.7 0.0 21.3 1.6 1.0 0.9 1.2 0.9 1.5 0.8 1.1 1.0 0.7 1.7 1.3 1.2 1.8 0.8 0.8 1.3 1.0 0.1 0.4 0.9 0.5 3.6 0.5 0.5 0.8 0.5 1.3 0.7 0.0 0.0 0.0 0.6 0.7 1.3 10.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.3 0.3 1.0 0.0 0.0 0.0 0.1 8.2 0.4 0.0 0.8 0.3 0.0 0.0 2.5 0.6 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 12.7 0.0 1.9 19.4 2.1 0.0 0.0 0.4 0.1 0.0 0.0 0.4 ITGA2B "CD41, CD41B, GP2B, PPP1R93" ENSG00000005961 "Integrin subunit alpha 2b" P08514 17 44372180-44389505 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 7.9;Early spermatids: 14.4;granulocytes: 18.4;Late spermatids: 20.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "basophil: 28.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 28.5" "Group enriched" "Detected in some" 13 "HEL: 71.0;HMC-1: 121.4" "Low region specificity" "Detected in single" "CAB018611, HPA031168, HPA031169, HPA031170, HPA031171" Enhanced Approved "Plasma membrane" NA NA 1100000000 "Plasma membrane" "CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773" "unprognostic (6.11e-2)" "unprognostic (3.23e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "unprognostic (3.98e-3)" "unprognostic (4.23e-5)" "unprognostic (1.25e-1)" "unprognostic (1.33e-2)" "unprognostic (7.22e-2)" "unprognostic (2.97e-3)" "unprognostic (1.30e-1)" "unprognostic (8.83e-9)" "unprognostic (7.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.25e-1)" 0.7 0.2 1.4 0.4 1.0 15.2 0.6 3.8 2.4 1.2 0.9 0.4 0.4 0.1 1.1 25.2 0.7 1.9 1.4 10.6 0.9 1.6 1.0 0.4 6.5 0.5 0.7 0.8 2.1 2.5 0.1 2.5 1.9 1.1 0.6 0.3 0.6 0.4 1.6 0.8 0.1 0.6 0.4 0.8 22.8 0.2 3.0 0.4 0.4 5.2 1.0 0.6 0.7 1.9 0.0 0.5 28.5 0.2 0.0 0.2 11.1 0.0 0.1 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 71.0 0.1 0.7 0.0 0.0 121.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 7.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 28.5 0.2 2.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 11.1 1.4 1.0 3.8 2.4 0.9 1.6 0.7 0.8 1.1 0.4 0.0 1.0 0.0 0.5 0.2 4.5 1.2 0.0 0.0 2.3 5.2 7.9 0.5 0.0 0.0 14.4 0.6 0.0 0.0 0.0 1.1 0.8 0.3 18.4 0.0 0.2 3.2 0.0 0.6 0.3 20.0 1.7 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.8 0.0 3.1 0.0 0.0 0.7 3.4 0.0 0.6 0.0 0.0 0.1 ITGA4 CD49d ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181536187 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.4;lymphoid tissue: 101.6" "Cell type enhanced" "Detected in many" 11 "B-cells: 42.0;Erythroid cells: 70.0;monocytes: 36.1;T-cells: 59.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 39.1;HEL: 62.0;JURKAT: 32.6;MOLT-4: 72.3" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 26.0" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" NA NA 100000 "Plasma membrane" "HPA074961: AB_2732273" "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favorable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.8 1.7 1.3 39.7 1.1 19.2 3.2 2.4 1.9 6.7 4.8 0.5 1.1 3.8 3.0 3.1 2.9 2.1 6.9 1.7 2.9 1.3 3.0 2.5 13.6 33.7 1.2 0.5 1.8 1.6 0.0 1.3 7.1 0.9 3.8 4.9 2.9 7.5 2.0 1.0 1.5 11.6 2.4 1.6 36.0 4.4 1.2 0.2 101.6 2.6 1.5 14.3 6.0 4.1 11.0 19.1 38.4 38.3 8.8 15.9 16.2 0.0 0.2 1.0 0.0 9.2 13.9 0.0 9.0 11.3 4.8 10.2 0.0 0.0 7.2 0.0 39.1 4.2 5.3 3.2 0.1 5.8 0.0 0.7 62.0 0.2 0.0 0.9 27.4 1.5 9.9 0.0 0.3 0.0 4.7 0.5 32.6 0.0 10.5 3.0 0.0 72.3 19.2 0.8 0.0 0.0 15.9 4.5 1.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.4 0.0 18.1 4.9 1.5 0.9 0.1 1.8 20.5 15.2 4.1 0.8 13.6 20.8 6.7 16.2 38.4 12.9 38.3 9.7 11.0 14.6 15.9 19.1 10.0 8.5 10.4 2.1 8.8 37.5 5.0 3.7 16.2 1.3 1.1 2.4 1.9 2.9 1.3 1.2 0.5 0.9 0.2 0.0 7.9 42.0 0.2 0.2 2.4 0.8 5.1 1.4 3.4 0.0 5.9 0.1 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.2 2.9 0.3 17.4 0.0 5.8 0.0 0.0 1.8 21.0 0.0 0.6 22.7 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 1.6 0.4 0.9 0.5 0.3 59.7 0.0 0.2 ITGA5 "CD49e, FNRA" ENSG00000161638 "Integrin subunit alpha 5" P08648 12 54395261-54419460 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 137.7" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 377.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 31.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 67.2;HUVEC TERT2: 141.7;TIME: 134.9;U-87 MG: 67.3" "Region enriched" "Detected in single" 7 "basal ganglia: 9.3" "Not detected" "Not detected" "HPA002642, CAB009008" Enhanced NA NA 23000000 "CAB009008: AB_647474, HPA002642: AB_1078469" "unprognostic (7.51e-3)" "prognostic unfavorable (4.07e-6)" "prognostic unfavorable (8.43e-4)" "unprognostic (1.58e-1)" "unprognostic (8.51e-3)" "prognostic unfavorable (2.91e-4)" "prognostic unfavorable (2.23e-5)" "prognostic unfavorable (2.44e-4)" "unprognostic (2.76e-2)" "unprognostic (6.19e-2)" "unprognostic (8.99e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.11e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (8.89e-4)" "unprognostic (2.18e-3)" 23.3 7.9 2.1 32.2 2.8 9.2 30.5 1.2 2.2 16.0 66.9 2.2 19.0 3.4 19.3 13.8 18.2 12.0 12.4 20.3 2.9 0.8 4.6 15.2 20.4 9.2 3.2 1.2 13.6 5.3 3.7 1.8 57.7 3.3 26.6 10.2 4.9 4.4 28.9 10.0 8.8 14.9 137.7 3.5 3.1 19.7 6.6 2.5 3.0 7.3 5.8 4.5 82.1 20.6 0.1 22.2 31.5 22.9 9.1 5.6 12.4 6.6 2.4 4.6 0.0 14.4 30.6 12.1 30.2 31.4 31.1 23.0 1.7 1.5 0.0 22.0 31.5 15.7 1.0 1.2 8.4 21.6 0.0 1.2 2.9 3.4 0.1 19.9 9.0 4.6 22.1 4.2 36.5 28.0 67.2 141.7 1.5 2.4 0.0 17.6 0.6 1.4 10.1 1.9 0.4 2.0 1.4 3.1 0.6 4.9 0.1 0.0 0.0 6.0 0.4 0.2 10.6 0.7 8.2 134.9 37.9 6.7 9.2 12.5 0.0 0.3 0.0 67.3 8.6 12.3 5.6 22.9 0.1 5.6 10.0 4.4 0.0 4.2 4.2 22.2 0.1 3.1 2.6 31.5 9.1 7.6 1.2 1.7 12.4 2.1 2.8 1.2 2.2 2.9 0.8 3.2 1.2 3.3 2.5 3.0 4.1 1.4 2.7 12.7 0.8 13.2 5.1 1.4 4.5 0.0 0.0 2.7 0.0 32.2 0.1 93.4 0.0 0.0 3.0 377.0 54.1 3.6 19.6 20.7 27.5 0.0 0.0 77.3 18.7 0.4 6.1 35.5 10.1 9.0 0.0 0.0 7.2 0.0 4.2 0.0 1.3 12.9 33.1 0.0 0.7 9.4 28.9 8.2 0.0 1.7 ITGA7 ENSG00000135424 "Integrin subunit alpha 7" Q13683 12 55684568-55716043 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Cell shape" "Integrin, Receptor" "Congenital muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 66.4;skeletal muscle: 81.3" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 123.1;Sertoli cells: 161.7;Smooth muscle cells: 105.1" "Cancer enhanced" "Detected in all" "glioma: 35.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008427 Uncertain Approved "Nuclear speckles,Vesicles,Plasma membrane" NA NA 770000 "Plasma membrane" "Nuclear speckles, Vesicles" "HPA008427: AB_1851823" "unprognostic (4.71e-2)" "unprognostic (1.55e-1)" "unprognostic (2.00e-3)" "unprognostic (3.02e-3)" "unprognostic (2.50e-1)" "unprognostic (2.36e-1)" "unprognostic (1.66e-2)" "unprognostic (2.20e-1)" "unprognostic (2.20e-2)" "unprognostic (3.57e-1)" "prognostic favorable (1.75e-4)" "unprognostic (2.85e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-1)" "unprognostic (5.10e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (9.59e-5)" 46.2 3.4 6.1 7.2 6.8 0.9 20.6 3.6 7.6 6.3 22.4 5.7 5.9 6.6 15.1 13.5 11.6 12.9 14.8 66.4 7.8 2.6 3.1 4.1 3.4 2.9 3.9 7.6 5.1 1.9 3.4 3.1 1.0 5.7 8.9 3.7 5.6 3.3 14.6 81.3 3.6 7.2 33.3 4.5 2.4 10.3 2.9 5.3 0.2 6.5 10.6 2.2 13.6 14.1 0.5 1.7 0.0 1.0 0.0 0.8 0.3 0.0 1.0 1.9 3.2 18.2 3.6 0.2 1.3 2.3 3.1 3.2 2.1 1.7 0.6 1.9 0.8 0.2 0.2 1.3 0.0 2.7 0.0 1.0 0.2 0.6 0.8 0.1 0.0 0.7 5.1 0.0 17.2 0.1 85.4 0.0 0.5 0.2 0.4 10.4 1.3 0.0 0.7 5.6 0.4 0.1 0.0 7.5 0.1 0.0 0.0 0.2 0.7 0.1 0.0 12.6 1.1 0.2 3.5 0.0 0.3 3.4 0.2 2.1 0.8 0.5 0.2 15.6 2.1 0.1 0.0 0.7 0.0 0.4 1.0 0.0 0.1 0.0 0.8 1.7 0.5 0.3 0.4 0.0 0.0 1.0 0.6 0.0 0.3 6.1 6.8 3.6 7.6 7.8 2.6 3.9 7.6 5.7 5.3 0.0 0.0 0.0 0.5 1.6 1.0 123.1 5.1 0.0 0.0 1.8 3.9 0.0 0.0 0.2 0.1 5.1 1.1 0.0 0.0 0.1 1.1 0.6 0.0 0.9 0.5 0.0 7.5 1.3 1.8 0.0 6.1 1.2 3.3 0.0 1.1 4.4 0.4 0.0 6.0 0.6 0.2 161.7 105.1 3.7 2.2 1.9 0.1 0.0 0.8 0.3 ITGAD "ADB2, CD11d" ENSG00000156886 "Integrin subunit alpha D" Q13349 16 31393312-31426505 "CD markers, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 25.4" "Cell type enhanced" "Detected in single" 21 "Kupffer cells: 2.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;NK-cell: 2.6" "Group enriched" "Detected in many" 19 "NK-cells: 2.6;T-cells: 1.1" "Cell line enhanced" "Detected in single" "NB-4: 1.7" "Low region specificity" "Detected in many" HPA026786 Uncertain NA NA "HPA026786: AB_10603773" "unprognostic (2.79e-2)" "unprognostic (2.39e-4)" "unprognostic (2.88e-2)" "unprognostic (3.24e-2)" "unprognostic (6.17e-2)" "unprognostic (1.79e-2)" "unprognostic (7.44e-4)" "unprognostic (6.99e-3)" "unprognostic (6.89e-3)" "unprognostic (5.02e-4)" "unprognostic (5.50e-2)" "unprognostic (1.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (3.17e-1)" "unprognostic (8.10e-2)" "unprognostic (5.51e-2)" 0.3 0.1 0.1 1.0 0.1 2.5 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.2 0.2 0.2 0.1 0.1 0.1 1.2 0.7 4.0 0.1 0.0 1.6 0.1 0.0 0.1 1.2 0.0 0.1 0.0 0.2 1.5 0.0 1.3 0.1 0.3 0.0 0.2 25.4 0.1 0.2 0.0 0.4 0.1 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 2.6 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 ITGAE "CD103, HUMINAE" ENSG00000083457 "Integrin subunit alpha E" P38570 17 3714628-3801243 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9" "Lineage enriched" "Detected in many" 7 "T-cells: 7.4" "Cell line enriched" "Detected in single" 21 "MOLT-4: 16.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036313, HPA052147" Enhanced NA NA 13000 "HPA036313: AB_10795355, HPA052147: " "unprognostic (9.81e-2)" "unprognostic (1.78e-3)" "unprognostic (7.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (2.17e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-1)" "unprognostic (8.02e-2)" "unprognostic (2.92e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.34e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (8.40e-3)" "unprognostic (1.15e-1)" "unprognostic (1.82e-2)" "prognostic favorable (3.56e-4)" 3.6 0.2 0.3 13.0 0.6 8.0 0.9 0.2 0.2 0.6 9.6 0.2 0.0 4.9 0.4 0.4 2.0 1.5 2.7 0.2 0.5 0.4 0.3 0.3 25.9 8.1 0.3 0.0 0.9 1.2 0.5 0.4 0.1 0.2 1.2 2.0 0.2 1.8 3.9 0.3 0.6 20.2 2.0 0.7 1.4 3.6 1.6 0.1 3.1 1.0 1.5 5.3 1.9 2.5 0.2 0.1 0.0 1.0 0.0 7.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.7 16.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 1.0 3.1 0.2 1.0 7.4 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 1.9 0.9 0.3 0.6 0.2 0.2 0.5 0.4 0.3 0.0 0.2 0.1 6.0 25.5 50.2 35.5 26.7 15.9 58.6 43.3 28.1 21.6 14.0 7.9 24.2 77.9 33.2 38.9 29.2 23.6 0.0 57.0 49.7 37.3 38.0 67.9 39.4 49.2 6.4 27.1 40.5 43.7 30.3 24.7 54.5 55.6 41.5 24.9 35.9 42.9 21.0 28.0 67.5 13.0 25.8 38.1 61.9 29.7 36.1 11.0 55.3 34.6 29.8 ITGAL "CD11A, LFA-1" ENSG00000005844 "Integrin subunit alpha L" P20701 16 30472658-30523185 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction, Phagocytosis" "Integrin, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.7;lymphoid tissue: 74.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 14.6;Hofbauer cells: 17.3;Kupffer cells: 16.8;T-cells: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 121.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB025011 Enhanced "Intracellular and membrane" NA NA 1100000 "CAB025011: " "unprognostic (1.10e-2)" "unprognostic (4.26e-3)" "unprognostic (3.72e-3)" "prognostic favorable (5.63e-5)" "unprognostic (2.88e-1)" "prognostic favorable (3.34e-4)" "unprognostic (1.63e-1)" "unprognostic (5.69e-3)" "prognostic favorable (5.57e-4)" "unprognostic (3.37e-2)" "unprognostic (4.98e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (2.69e-5)" "unprognostic (2.89e-1)" "unprognostic (3.05e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-2)" 2.8 1.1 1.8 29.8 2.0 15.1 1.8 0.6 1.5 1.3 3.0 2.7 0.5 2.4 1.7 1.4 2.2 2.6 4.9 1.4 1.3 1.3 2.6 6.7 16.2 29.0 3.1 1.4 1.4 1.2 0.0 1.4 1.7 1.7 2.0 3.4 1.9 6.6 0.7 0.8 1.0 12.7 1.4 4.7 44.1 3.5 0.8 2.7 74.6 2.8 2.0 41.8 4.4 1.9 2.1 7.5 7.2 36.7 9.5 22.5 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 121.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 27.3 0.0 0.0 8.1 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 7.7 2.6 0.0 0.1 0.8 0.0 3.1 8.4 6.5 22.5 16.9 11.2 2.1 8.8 16.2 7.5 1.3 4.9 11.4 7.2 9.5 36.7 3.0 6.3 11.5 1.8 2.0 0.6 1.5 1.3 1.3 3.1 1.4 1.7 2.7 6.0 14.6 8.2 0.2 0.7 0.0 1.1 0.0 12.0 3.4 1.8 0.0 0.2 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.4 0.8 0.1 4.7 3.2 17.3 0.0 0.0 4.3 16.8 0.4 0.0 5.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.4 0.1 0.2 0.3 0.6 66.0 0.0 0.1 ITGAM "CD11b, CR3A, MAC-1" ENSG00000169896 "Integrin subunit alpha M" P11215 16 31259990-31332892 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Innate immunity" "Integrin, Receptor" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 93.7" "Cell type enhanced" "Detected in many" 22 "granulocytes: 34.6;Hofbauer cells: 42.4;Kupffer cells: 152.2;Macrophages: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 29.4;classical monocyte: 19.1;eosinophil: 23.8;gdT-cell: 12.2;intermediate monocyte: 7.6;neutrophil: 21.0;NK-cell: 18.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HMC-1: 33.5;NB-4: 11.8;U-937: 14.3" "HPA002274, CAB025091, CAB072870" Enhanced NA NA 900000 "CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435" "unprognostic (1.82e-2)" "unprognostic (1.70e-2)" "unprognostic (8.78e-2)" "unprognostic (2.54e-2)" "unprognostic (2.40e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (1.86e-1)" "unprognostic (1.73e-1)" "unprognostic (3.29e-3)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.93e-5)" "unprognostic (9.89e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (3.99e-2)" "unprognostic (5.03e-2)" 19.7 5.0 6.0 14.0 7.2 93.7 6.0 2.0 4.5 2.9 3.2 9.4 0.5 1.8 2.5 3.5 2.2 4.8 4.0 6.5 4.3 3.9 3.0 3.3 14.6 22.8 10.5 1.6 2.5 2.9 1.6 1.8 4.9 5.3 3.6 2.7 3.3 3.2 2.0 1.6 1.5 4.4 6.9 8.6 29.9 2.8 1.5 7.4 2.3 2.1 1.7 6.6 4.9 4.5 1.9 3.4 29.4 19.1 18.8 12.2 8.0 0.5 1.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.5 0.9 0.6 0.0 0.2 0.1 0.0 0.2 0.0 4.8 0.0 0.6 0.0 0.0 0.0 1.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.3 0.2 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 14.3 0.0 29.4 19.1 23.8 12.2 7.6 0.7 1.9 1.3 3.6 3.4 0.3 0.3 3.0 21.0 18.8 1.1 0.2 0.5 8.0 6.0 7.2 2.0 4.5 4.3 3.9 10.5 1.6 5.3 7.4 3.0 15.6 5.1 0.1 1.0 0.0 1.5 2.5 0.0 2.3 0.0 0.0 0.3 0.0 1.1 0.3 0.6 0.0 0.0 0.0 0.4 1.0 0.5 34.6 0.8 42.4 0.0 3.5 1.8 152.2 1.5 0.3 53.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.9 0.0 0.4 0.7 0.9 0.7 5.4 0.0 0.1 ITGAX CD11c ENSG00000140678 "Integrin subunit alpha X" P20702 16 31355134-31382997 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 80.7;granulocytes: 70.6;Hofbauer cells: 46.3;Kupffer cells: 28.3;Macrophages: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HMC-1: 49.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004458, HPA004723, CAB072871" Enhanced NA NA "CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231" "unprognostic (9.75e-3)" "unprognostic (2.49e-2)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (1.89e-1)" "unprognostic (2.29e-2)" "unprognostic (1.27e-1)" "unprognostic (9.59e-2)" "unprognostic (8.06e-3)" "unprognostic (3.20e-1)" "unprognostic (7.75e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.92e-2)" "unprognostic (3.04e-2)" "unprognostic (2.82e-1)" "unprognostic (2.95e-2)" 47.9 1.9 4.4 28.1 5.7 28.6 2.9 1.4 4.4 1.8 2.1 17.1 0.6 1.7 2.1 2.5 1.9 4.3 7.7 2.5 5.3 4.6 2.3 4.6 33.2 24.4 13.6 3.8 3.0 2.1 0.8 2.4 3.3 8.1 2.5 3.2 2.5 4.3 1.3 1.1 1.6 3.8 3.3 15.6 46.3 3.3 0.9 7.5 3.8 2.2 0.9 9.7 5.1 1.9 0.8 12.4 31.7 20.3 14.9 1.8 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.1 0.0 0.0 0.1 0.0 8.3 0.0 0.0 0.1 0.1 0.0 0.5 49.2 0.0 0.0 0.8 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.5 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.8 0.1 3.9 10.1 9.2 1.8 18.1 0.1 0.8 0.0 0.3 12.4 0.4 0.0 0.2 31.7 14.9 20.3 0.2 0.0 3.2 4.4 5.7 1.4 4.4 5.3 4.6 13.6 3.8 8.1 7.5 11.9 80.7 2.9 0.2 2.5 0.0 1.4 0.0 2.7 19.4 0.0 0.0 0.3 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.2 2.1 0.2 70.6 0.0 46.3 0.0 0.0 0.0 28.3 0.0 0.0 71.4 1.7 2.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.1 1.0 0.3 5.0 0.0 0.0 ITGB1BP2 CHORDC3 ENSG00000147166 "Integrin subunit beta 1 binding protein 2" Q9UKP3 X 71301734-71305371 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 69.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA040721 Approved Cytosol NA NA Cytosol "HPA040721: AB_10805827" "unprognostic (1.87e-1)" "unprognostic (2.65e-2)" "unprognostic (6.91e-5)" "unprognostic (1.95e-2)" "unprognostic (7.92e-2)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (9.02e-2)" "unprognostic (4.69e-2)" "unprognostic (2.15e-2)" "unprognostic (4.85e-2)" "unprognostic (3.17e-1)" "unprognostic (3.08e-11)" "unprognostic (4.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-1)" 0.7 0.3 0.2 1.0 0.3 0.6 0.3 0.6 0.2 2.7 2.8 0.0 2.3 0.4 12.8 3.4 4.0 1.8 4.8 43.0 0.2 0.2 0.4 0.6 0.5 0.5 0.3 0.0 2.4 0.3 0.0 0.3 0.2 0.2 3.2 0.9 3.5 0.7 5.8 21.3 0.3 1.0 18.6 0.3 0.6 1.1 1.6 0.1 0.0 0.4 19.6 0.7 5.6 0.8 0.2 0.2 1.5 0.2 0.0 0.5 0.0 0.7 2.1 3.2 2.8 0.1 0.1 0.7 1.0 1.4 0.7 0.9 1.6 1.6 3.1 0.4 1.6 0.8 1.5 2.9 0.8 1.8 1.0 1.3 1.9 1.9 0.6 0.4 0.7 14.0 1.7 1.3 0.5 0.5 0.7 1.2 3.4 1.4 0.8 1.6 0.9 1.2 3.5 4.7 2.1 1.3 2.1 2.5 1.2 1.6 2.0 1.5 0.5 0.7 0.1 0.8 2.2 0.9 0.4 0.0 1.4 2.8 0.3 0.6 2.9 3.8 4.8 0.4 2.4 0.6 0.0 0.2 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.2 0.2 0.2 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 1.5 69.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.1 0.3 0.9 0.0 1.7 0.3 0.3 0.3 0.0 0.0 0.3 0.0 ITGB2 "CD18, LFA-1, MAC-1, MFI7" ENSG00000160255 "Integrin subunit beta 2" P05107 21 44885953-44931989 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6" "Group enriched" "Detected in many" 4 "Hofbauer cells: 620.8;Kupffer cells: 458.1;Macrophages: 428.6;T-cells: 303.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "THP-1: 117.5;U-937: 87.3" "Low region specificity" "Detected in all" "HPA008877, HPA016894" Enhanced Supported "Plasma membrane,Rods & Rings" NA NA 2500000 "Plasma membrane" "Rods & Rings" "HPA008877: AB_1846256, HPA016894: AB_1846257" "unprognostic (1.94e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (2.95e-2)" "unprognostic (9.73e-3)" "unprognostic (2.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.18e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (4.42e-2)" "unprognostic (2.65e-2)" "unprognostic (4.83e-2)" 59.1 9.8 9.0 47.5 16.8 91.4 8.4 1.7 8.0 5.6 7.4 12.2 1.2 6.3 4.9 9.0 4.8 10.7 10.3 9.7 7.2 6.4 8.1 7.0 32.9 73.8 14.3 2.9 6.6 5.1 1.1 3.3 12.7 12.1 6.9 4.2 5.2 8.8 2.7 3.0 4.1 13.2 12.3 18.3 75.6 7.6 4.2 12.2 53.5 4.5 2.2 29.0 15.7 4.2 9.5 76.0 104.6 122.9 41.0 57.4 159.7 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.5 20.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.4 0.0 0.4 0.0 15.3 4.0 0.2 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.2 1.0 0.5 17.4 18.5 0.0 0.0 0.3 0.2 3.6 9.5 0.7 0.0 0.1 0.2 0.5 0.3 0.3 0.0 0.0 117.5 0.3 0.0 1.0 0.0 0.5 0.1 0.8 0.4 0.0 87.3 0.1 10.5 122.9 85.7 57.4 84.1 25.8 6.7 28.4 39.5 76.0 9.5 19.1 32.0 104.6 41.0 81.0 11.6 20.7 159.7 9.0 16.8 1.7 8.0 7.2 6.4 14.3 2.9 12.1 12.2 14.9 42.5 86.5 0.5 4.8 0.0 3.5 15.3 5.3 19.4 5.2 0.0 3.4 0.0 2.7 0.5 5.2 0.0 0.0 0.3 3.3 5.7 0.5 23.1 4.3 620.8 0.0 0.0 11.6 458.1 2.1 0.6 428.6 5.0 109.2 0.1 0.3 0.4 0.0 1.4 3.4 0.6 6.5 3.1 0.2 1.1 4.4 4.7 303.6 0.2 0.6 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253846-47311816 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enhanced" "Detected in some" 10 "Late spermatids: 4.1;Proximal tubular cells: 3.5;Sertoli cells: 6.5" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 19 "basophil: 2.8;neutrophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 46.6;HEL: 41.2;RPTEC TERT1: 26.8;U-87 MG: 21.1;WM-115: 67.2" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 710000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 10.0 0.6 1.0 6.2 2.5 2.7 7.0 0.4 1.6 4.6 13.6 0.9 2.4 2.2 9.7 5.7 6.4 6.4 2.8 8.5 0.7 0.6 16.0 3.7 5.2 1.2 2.3 0.1 4.6 0.6 0.7 1.6 23.5 1.6 6.4 4.8 1.8 2.5 11.5 4.9 2.4 5.0 17.0 1.8 9.5 3.6 2.6 0.6 0.2 36.6 1.9 0.9 11.0 7.8 0.1 0.0 2.8 0.1 0.0 0.0 9.5 0.0 0.4 0.1 0.0 2.4 1.0 0.0 1.2 6.1 2.6 2.4 0.0 0.0 0.1 46.6 0.3 3.6 0.0 0.0 0.0 3.4 0.9 0.0 41.2 0.1 0.0 2.0 0.0 0.0 1.0 0.0 15.6 0.4 1.8 11.6 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 26.8 0.0 0.0 0.1 1.5 0.0 8.4 2.4 0.0 0.0 12.6 0.5 0.7 0.3 2.8 0.0 0.0 0.3 21.1 0.0 67.2 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 9.5 1.0 2.5 0.4 1.6 0.7 0.6 2.3 0.1 1.6 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.7 1.4 0.0 0.0 0.4 0.0 0.8 0.1 0.0 0.8 0.8 0.0 0.0 1.8 0.0 4.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 1.1 3.5 0.0 6.5 1.9 0.0 2.3 0.4 1.0 0.0 0.0 0.1 ITGB6 ENSG00000115221 "Integrin subunit beta 6" P18564 2 160099666-160200313 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Amelogenesis imperfecta, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 62.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.5;RPTEC TERT1: 74.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023626, CAB073536" Approved Approved "Nucleoplasm,Cell Junctions,Centrosome" NA NA "Nucleoplasm, Cell Junctions" Centrosome "CAB073536: , HPA023626: AB_2671267" "unprognostic (1.27e-1)" "unprognostic (1.57e-2)" "unprognostic (6.90e-2)" "unprognostic (8.22e-3)" "unprognostic (3.61e-3)" "unprognostic (1.50e-2)" "unprognostic (1.72e-3)" "unprognostic (2.04e-2)" "unprognostic (1.72e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (5.03e-6)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (4.97e-2)" "unprognostic (1.23e-1)" "unprognostic (2.16e-1)" "unprognostic (1.00e-1)" 0.3 0.3 0.3 3.1 0.3 0.0 8.7 0.3 0.3 4.1 8.3 0.1 4.5 3.5 2.1 2.5 18.7 1.2 12.0 0.7 0.3 0.3 62.1 0.3 28.8 0.1 0.3 0.1 1.5 3.8 7.0 2.2 18.7 0.2 7.5 3.0 0.1 3.8 4.8 31.5 1.9 11.7 2.0 0.3 0.3 7.9 0.6 0.1 0.1 4.9 6.8 5.9 12.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 37.5 0.0 0.2 0.0 0.0 7.7 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 2.9 0.0 74.9 12.4 0.0 0.0 0.0 11.8 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 142.9 159.2 0.0 106.9 9.3 0.0 37.4 10.2 8.1 77.3 68.0 0.0 6.6 0.0 51.3 71.2 2.2 10.3 0.0 92.6 5.2 3.3 42.3 3.5 0.8 2.0 0.0 0.0 1.8 0.8 24.4 2.6 2.5 1.7 3.6 14.1 0.8 133.9 21.0 1.1 0.2 0.0 0.0 2.7 219.5 2.4 7.4 3.9 0.0 11.2 104.4 ITGB7 ENSG00000139626 "Integrin subunit beta 7" P26010 12 53191318-53207307 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.3;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" 10 "B-cells: 35.7;granulocytes: 29.9;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 99 "Karpas-707: 295.2;RPMI-8226: 230.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042277 Approved "Nucleoplasm,Nuclear membrane,Vesicles,Plasma membrane,Cytosol" NA NA 42000 "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear membrane, Vesicles" "HPA042277: AB_10793877" "unprognostic (5.34e-2)" "unprognostic (4.47e-2)" "unprognostic (2.80e-3)" "unprognostic (1.40e-2)" "unprognostic (6.57e-4)" "unprognostic (3.51e-5)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.58e-1)" "unprognostic (2.18e-1)" "unprognostic (9.63e-3)" "unprognostic (3.36e-1)" "unprognostic (1.02e-2)" "unprognostic (2.16e-1)" "unprognostic (6.95e-2)" "unprognostic (9.34e-2)" "unprognostic (2.47e-4)" 1.8 1.4 1.4 29.1 1.8 7.5 1.5 0.6 1.2 1.8 8.7 2.9 0.8 6.7 2.3 2.8 6.6 2.0 5.6 1.4 1.5 1.0 5.4 5.1 4.9 26.4 1.9 1.0 1.1 1.3 0.7 1.7 1.8 2.4 2.7 5.6 2.1 10.7 2.2 1.0 6.4 15.1 1.5 2.0 26.7 4.3 0.9 2.0 7.8 3.6 4.4 37.6 4.6 3.0 10.1 15.4 31.3 1.9 7.5 23.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 295.2 0.0 0.0 0.0 0.4 0.0 2.4 0.0 0.1 0.0 230.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.1 0.1 22.6 1.9 31.3 19.3 0.5 14.3 10.1 19.4 23.0 15.4 8.3 16.3 17.1 0.5 7.5 0.1 4.2 22.7 5.2 1.4 1.8 0.6 1.2 1.5 1.0 1.9 1.0 2.4 2.0 3.0 8.5 35.7 0.3 1.9 0.0 0.4 2.5 0.0 0.0 7.0 3.9 0.1 6.6 0.2 0.0 0.1 0.0 0.0 0.5 0.1 1.0 0.1 29.9 1.6 13.8 0.0 0.0 0.6 3.0 0.0 0.0 7.0 6.8 7.2 0.3 6.6 0.6 0.0 0.0 4.4 0.7 0.0 0.4 0.2 1.1 3.1 0.1 27.7 0.9 1.3 ITIH1 "H1P, IATIH, ITIH" ENSG00000055957 "Inter-alpha-trypsin inhibitor heavy chain 1" P19827 3 52777592-52792068 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "liver: 321.2" "Cell type enriched" "Detected in some" 23 "Hepatocytes: 864.9" "Cancer enriched" "Detected in some" 598 "liver cancer: 329.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041639, HPA042049" Approved Approved Vesicles "Secreted to blood" NA NA 4490000 31000000000 Vesicles "HPA041639: AB_10796349, HPA042049: AB_10797379" "unprognostic (1.87e-4)" "unprognostic (1.31e-3)" "unprognostic (2.38e-1)" "unprognostic (8.55e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-3)" "prognostic favorable (1.89e-5)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-2)" "unprognostic (4.53e-4)" "unprognostic (4.02e-3)" "unprognostic (5.70e-3)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 321.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 864.9 0.1 0.0 0.0 18.4 14.8 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.5 0.0 0.0 ITIH2 H2P ENSG00000151655 "Inter-alpha-trypsin inhibitor heavy chain 2" P19823 10 7703269-7749520 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 202 "liver: 249.0" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 455.1" "Cancer enriched" "Detected in many" 279 "liver cancer: 626.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 445 "Hep G2: 155.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059150 Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 22000000000 "Golgi apparatus" "HPA059150: AB_2683930" "unprognostic (4.82e-2)" "unprognostic (6.10e-2)" "unprognostic (2.48e-2)" "unprognostic (1.21e-2)" "unprognostic (2.01e-2)" "unprognostic (2.55e-3)" "prognostic favorable (1.48e-4)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (2.28e-1)" "unprognostic (2.02e-1)" "unprognostic (2.10e-8)" "unprognostic (9.91e-3)" "unprognostic (1.70e-1)" "unprognostic (2.35e-1)" "unprognostic (4.46e-4)" 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 249.0 0.1 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.4 0.3 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 155.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.6 0.1 0.4 0.4 0.6 0.4 0.1 0.5 0.3 0.6 0.2 0.8 0.2 1.2 0.1 0.0 0.1 0.6 0.1 0.4 0.4 0.3 0.5 0.5 1.1 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.3 94.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 455.1 0.1 0.0 0.0 11.1 9.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ITIH3 H3P ENSG00000162267 "Inter-alpha-trypsin inhibitor heavy chain 3" Q06033 3 52794768-52809009 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 233 "liver: 326.9" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 931.8" "Cancer enriched" "Detected in some" 247 "liver cancer: 273.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "Hep G2: 19.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA017373 Approved "Secreted to blood" NA NA 4500000000 "HPA017373: AB_1851954" "unprognostic (2.07e-2)" "unprognostic (5.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.30e-4)" "unprognostic (4.28e-2)" "unprognostic (3.26e-2)" "unprognostic (5.97e-2)" "unprognostic (6.07e-2)" "unprognostic (1.49e-1)" "unprognostic (7.05e-2)" "unprognostic (1.04e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.49e-8)" "unprognostic (2.09e-4)" "unprognostic (1.70e-1)" "unprognostic (2.55e-2)" "unprognostic (9.31e-2)" 0.9 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.8 0.3 0.1 0.3 0.0 0.5 0.5 0.3 0.3 0.5 0.2 0.1 0.0 0.2 326.9 0.4 0.3 0.2 0.1 0.6 0.0 0.0 0.1 0.3 0.2 0.2 0.1 0.2 0.2 0.4 0.3 0.1 0.1 0.1 0.1 1.4 0.1 0.4 0.1 0.1 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 35.0 0.0 0.1 0.5 0.4 91.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.5 0.0 23.3 0.0 0.0 0.1 0.0 0.0 931.8 0.0 0.0 0.0 69.3 71.7 90.2 1.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 11.0 0.0 0.0 0.0 6.7 0.2 0.1 0.1 0.2 0.5 0.0 0.0 ITIH4 "H4P, IHRP, ITIHL1" ENSG00000055955 "Inter-alpha-trypsin inhibitor heavy chain family member 4" Q14624 3 52812975-52831479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 461.4" "Group enriched" "Detected in many" 4 "Early spermatids: 104.1;Hepatocytes: 95.7;Late spermatids: 94.2" "Cancer enriched" "Detected in single" 27 "liver cancer: 7.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 5.3;JURKAT: 4.5;U-266/70: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001835, HPA003948, CAB072872" Enhanced Approved Vesicles "Secreted to blood" NA NA 3060000 53000000000 Vesicles "CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433" "unprognostic (6.08e-2)" "unprognostic (4.45e-2)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "unprognostic (2.64e-1)" "unprognostic (1.96e-1)" "unprognostic (5.86e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-14)" "unprognostic (1.71e-3)" "unprognostic (2.96e-2)" "unprognostic (1.52e-1)" "unprognostic (4.21e-5)" 0.5 1.8 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.1 1.3 0.2 0.1 0.1 0.6 0.1 0.0 0.2 461.4 0.2 0.1 0.1 0.2 0.2 22.8 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.2 4.1 0.1 0.1 0.2 0.1 0.5 0.1 0.3 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.3 0.3 0.6 0.6 2.6 0.8 0.0 0.0 0.4 1.0 2.1 1.1 0.0 0.4 0.1 0.0 0.0 0.2 0.3 0.2 1.3 0.0 0.5 0.2 1.1 0.0 0.0 0.5 5.3 0.2 2.2 0.0 2.8 0.9 2.4 0.2 0.3 0.3 0.0 0.1 0.0 0.0 4.5 0.6 1.8 0.0 0.2 0.5 0.7 1.0 0.2 0.0 1.8 1.0 0.0 0.8 0.7 0.1 1.0 0.7 0.0 0.4 1.1 1.1 0.7 0.2 0.0 0.9 1.0 0.0 6.5 3.0 0.5 0.1 0.7 1.2 0.0 0.6 0.0 0.1 0.1 0.1 0.3 0.7 0.0 0.0 0.2 0.0 0.8 0.6 2.6 0.1 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.6 1.9 0.2 0.7 10.2 0.4 5.1 0.0 1.2 0.0 11.8 0.0 0.0 0.3 104.1 0.6 0.0 23.3 2.3 0.0 0.4 0.3 0.0 95.7 0.4 4.8 0.0 3.1 2.6 94.2 1.1 1.6 0.0 1.0 0.0 1.7 3.5 0.0 1.8 0.0 5.6 6.5 2.1 0.9 1.4 0.3 0.2 1.3 0.0 0.1 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain family member 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 58.6" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 223.5;Sertoli cells: 77.6;Smooth muscle cells: 89.6;Syncytiotrophoblasts: 185.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "WM-115: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 42.6 2.4 3.7 15.2 5.0 0.0 33.7 2.9 5.1 8.1 9.4 3.6 4.4 4.1 12.0 8.6 6.9 3.4 18.8 4.8 4.4 4.0 5.3 2.3 6.9 3.2 4.4 4.3 7.2 4.4 1.4 3.1 58.6 4.6 11.0 5.3 12.7 3.4 16.2 4.7 4.1 5.7 37.5 3.9 2.2 5.6 4.0 2.2 0.0 6.4 5.2 5.5 24.0 11.7 0.8 0.4 1.4 0.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 7.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 48.0 1.4 0.3 0.3 0.4 0.4 0.5 0.4 0.6 0.4 0.2 0.8 0.6 0.5 1.0 0.5 0.5 0.4 0.5 0.1 3.7 5.0 2.9 5.1 4.4 4.0 4.4 4.3 4.6 2.2 3.0 2.4 0.0 2.3 10.1 1.3 4.0 5.1 1.4 6.8 0.0 2.0 223.5 0.0 15.3 1.6 30.5 0.0 0.0 0.3 45.7 53.7 1.2 2.3 0.0 18.1 0.0 0.0 1.8 0.0 1.6 4.9 3.3 13.5 1.0 0.0 25.4 0.5 0.0 14.5 1.0 2.1 77.6 89.6 1.9 7.5 7.8 185.6 0.0 0.0 1.4 ITIH6 "ITIH5L, UNQ6369" ENSG00000102313 "Inter-alpha-trypsin inhibitor heavy chain family member 6" Q6UXX5 X 54748899-54798240 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.8;salivary gland: 3.5;skeletal muscle: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 7 "melanoma: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "WM-115: 34.1" HPA000506 Uncertain "Secreted to blood" NA NA "HPA000506: AB_2666007" "unprognostic (3.40e-1)" "unprognostic (1.04e-1)" "unprognostic (9.73e-3)" "unprognostic (7.24e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-3)" "unprognostic (9.81e-2)" "unprognostic (2.66e-1)" "unprognostic (1.02e-1)" "unprognostic (6.33e-2)" "unprognostic (4.14e-4)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ITK "EMT, LYK, PSCTK2" ENSG00000113263 "IL2 inducible T cell kinase" Q08881 5 157142933-157255191 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.0;lymphoid tissue: 60.5" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 10.4;granulocytes: 32.2;T-cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 28 "gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1" "Group enriched" "Detected in many" 29 "NK-cells: 9.2;T-cells: 28.0" "Group enriched" "Detected in some" 9 "JURKAT: 36.5;MOLT-4: 13.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043670 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043670: " "unprognostic (2.08e-3)" "unprognostic (6.57e-4)" "unprognostic (5.06e-3)" "unprognostic (4.96e-5)" "unprognostic (1.52e-2)" "unprognostic (1.12e-4)" "unprognostic (8.45e-4)" "unprognostic (1.56e-2)" "unprognostic (1.87e-2)" "unprognostic (5.99e-3)" "unprognostic (1.76e-1)" "unprognostic (2.52e-1)" "unprognostic (4.52e-6)" "unprognostic (3.64e-1)" "unprognostic (4.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.26e-2)" 2.3 0.7 0.5 12.2 0.6 2.5 1.3 1.9 0.5 1.4 3.3 0.0 0.0 0.5 1.2 1.1 1.8 1.4 4.3 0.9 0.5 0.5 1.4 1.2 6.6 60.5 0.9 0.0 0.7 0.7 0.0 0.9 0.1 0.3 1.1 1.3 1.5 3.5 1.1 0.5 1.0 8.9 0.4 1.2 10.7 2.3 1.4 0.0 60.3 1.6 2.7 24.3 4.1 1.3 0.0 0.0 0.4 0.6 9.2 28.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 13.8 0.0 9.1 0.0 19.5 18.9 0.0 0.0 28.0 22.8 0.4 9.2 0.6 0.0 23.1 13.6 0.5 0.6 1.9 0.5 0.5 0.5 0.9 0.0 0.3 0.0 0.0 10.4 0.0 0.6 2.4 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 32.2 0.6 0.0 0.0 0.0 1.8 0.6 5.5 0.0 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 3.0 0.1 47.3 0.0 0.4 ITLN1 "FLJ20022, hIntL, HL-1, ITLN, LFR" ENSG00000179914 "Intelectin 1" Q8WWA0 1 160876539-160885170 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1" "Cell type enriched" "Detected in many" 16 "Mucus-secreting cells: 1345.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 61.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "intermediate monocyte: 6.9;non-classical monocyte: 17.3" "Lineage enriched" "Detected in many" 15 "monocytes: 17.3" "Group enriched" "Detected in some" 4 "HEL: 3.8;HL-60: 2.8;OE19: 10.5;U-937: 10.6" "Not detected" "Not detected" "CAB012652, HPA063275, HPA067326" Enhanced "Secreted to blood" NA NA 294000000 160000000 "CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764" "unprognostic (9.69e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-3)" "unprognostic (2.28e-1)" "unprognostic (1.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.70e-1)" "unprognostic (5.22e-3)" "unprognostic (1.66e-2)" "unprognostic (4.38e-1)" "unprognostic (9.96e-2)" "unprognostic (3.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-2)" 119.2 0.0 0.2 40.1 0.2 0.0 0.2 0.2 0.2 0.4 52.5 0.2 1.0 31.9 0.5 8.8 0.7 1.2 8.7 48.6 0.2 0.0 0.5 2.6 13.9 0.2 0.2 0.3 4.3 0.2 0.0 0.4 0.4 0.3 3.0 157.9 0.2 2.6 0.6 1.5 0.1 48.6 0.8 0.2 0.6 1.9 2.7 0.2 0.4 0.2 1.4 1.5 1.6 0.8 0.0 1.1 0.1 17.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 10.5 0.0 0.0 0.0 1.5 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 10.6 0.0 0.0 0.3 0.0 0.0 6.9 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.0 17.3 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.3 0.2 0.0 6.7 0.9 0.1 0.0 0.0 6.1 2.5 1.4 3.4 3.5 0.0 0.0 0.0 0.0 0.5 0.0 20.4 0.0 3.3 0.7 0.0 0.3 1.1 0.0 0.8 0.0 17.2 81.0 86.0 0.4 13.6 0.0 0.0 0.0 1345.2 0.0 4.3 11.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 43.2 0.1 ITLN2 HL-2 ENSG00000158764 "Intelectin 2" Q8WWU7 1 160945025-160954799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 88.4" "Cell type enriched" "Detected in some" 9 "Alveolar cells type 1: 71.5" "Cancer enhanced" "Detected in many" "testis cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 15.4;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9;SuSa: 5.4" "HPA006683, HPA067326" Enhanced "Secreted to digestive system" NA NA "HPA006683: AB_2129681, HPA067326: AB_2732764" "unprognostic (1.42e-1)" "unprognostic (9.62e-3)" "unprognostic (4.61e-2)" "unprognostic (7.45e-2)" "unprognostic (2.25e-1)" "unprognostic (6.84e-4)" "unprognostic (2.47e-2)" "unprognostic (5.74e-2)" "unprognostic (1.31e-2)" "unprognostic (1.36e-1)" "unprognostic (5.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.49e-1)" "unprognostic (2.31e-1)" "unprognostic (4.91e-2)" 3.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 27.4 0.1 0.1 53.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 2.5 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 88.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 2.6 0.0 4.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.0 0.0 0.0 4.9 5.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 71.5 7.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 8.0 0.0 0.0 1.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 ITM2A "BRICD2A, E25A" ENSG00000078596 "Integral membrane protein 2A" O43736 X 79360384-79367667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 100.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 252.4;granulocytes: 190.5;Leydig cells: 310.7;Muller glia cells: 153.0;T-cells: 187.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 26.5;eosinophil: 16.8;gdT-cell: 23.2;MAIT T-cell: 17.0;memory CD4 T-cell: 44.6;memory CD8 T-cell: 36.5;naive CD4 T-cell: 48.0;naive CD8 T-cell: 22.6;NK-cell: 25.2;T-reg: 32.4" "Group enriched" "Detected in many" 7 "granulocytes: 26.5;NK-cells: 25.2;T-cells: 48.0" "Cell line enriched" "Detected in some" 5 "MOLT-4: 191.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000296 Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA Vesicles "Golgi apparatus, Plasma membrane" "HPA000296: " "unprognostic (1.05e-2)" "unprognostic (5.22e-3)" "unprognostic (2.77e-3)" "unprognostic (5.65e-2)" "unprognostic (1.73e-2)" "unprognostic (1.06e-3)" "prognostic favorable (3.66e-6)" "unprognostic (1.57e-1)" "unprognostic (4.94e-2)" "unprognostic (9.85e-2)" "unprognostic (1.33e-2)" "unprognostic (2.57e-1)" "unprognostic (1.04e-2)" "unprognostic (1.56e-1)" "unprognostic (3.31e-1)" "unprognostic (2.18e-1)" "unprognostic (4.30e-1)" 27.2 4.1 27.0 9.1 37.8 13.6 27.4 7.8 25.8 21.8 11.0 16.1 6.5 5.4 16.4 19.4 14.8 15.3 10.6 42.1 33.6 22.5 7.7 2.2 19.0 28.5 34.8 19.5 69.6 6.3 2.7 9.3 10.6 25.8 16.7 11.9 16.2 28.2 8.8 13.2 10.3 8.8 20.9 33.9 8.4 9.6 8.0 12.5 100.7 31.1 14.1 16.5 14.7 16.6 4.7 1.1 26.5 0.2 25.2 48.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.3 0.0 0.5 0.0 7.8 0.0 0.0 0.0 12.4 14.4 2.3 0.0 0.0 0.0 0.0 0.0 37.7 8.8 0.0 0.0 0.0 191.0 8.6 2.8 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.2 0.0 0.1 0.0 2.1 0.2 0.2 0.3 0.0 0.2 0.0 0.1 24.1 0.0 0.0 0.0 0.0 0.9 26.5 0.1 16.8 23.2 0.2 17.0 4.6 44.6 36.5 0.1 4.7 48.0 22.6 0.8 25.2 0.2 1.1 32.4 22.6 27.0 37.8 7.8 25.8 33.6 22.5 34.8 19.5 25.8 12.5 3.0 20.8 15.9 13.6 59.9 2.3 25.4 5.1 1.4 7.9 1.8 0.0 0.4 5.0 0.2 2.4 252.4 0.0 0.0 46.7 0.1 64.7 9.2 190.5 0.8 1.0 1.6 2.4 119.7 10.6 4.7 310.7 4.2 59.1 1.0 66.9 153.0 0.9 0.0 110.7 1.1 5.8 0.0 20.2 0.4 1.1 41.0 0.2 187.1 2.3 2.3 ITM2B "BRI, BRI2, BRICD2B, E25B, E3-16" ENSG00000136156 "Integral membrane protein 2B" Q9Y287 13 48233158-48270357 "Disease related genes, Predicted membrane proteins" "Amyloidosis, Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 346.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 236.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 236.4" "Cell line enhanced" "Detected in many" "HMC-1: 109.5;RPTEC TERT1: 155.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029292, HPA071992" Enhanced Enhanced "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2600000 "Golgi apparatus, Vesicles" "HPA029292: AB_10601917, HPA071992: AB_2686480" "unprognostic (4.66e-2)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.00e-1)" "unprognostic (4.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "unprognostic (9.88e-2)" "unprognostic (2.42e-1)" "unprognostic (5.89e-2)" "unprognostic (2.87e-2)" "prognostic favorable (3.73e-5)" "unprognostic (4.38e-2)" "unprognostic (4.09e-2)" "unprognostic (6.00e-2)" "unprognostic (1.22e-1)" 89.3 79.6 60.6 41.3 61.6 25.0 79.6 87.2 65.8 72.6 58.3 64.9 93.4 83.4 61.2 346.2 71.5 53.2 59.4 86.9 75.9 61.4 198.7 65.1 80.2 75.9 71.7 49.8 100.7 48.5 27.0 63.1 132.0 50.2 66.5 36.0 80.8 75.1 99.8 30.9 73.5 81.0 53.1 90.0 78.5 64.5 44.7 48.3 35.0 73.1 63.0 47.7 63.3 74.5 13.3 23.3 236.4 46.6 17.2 31.7 73.7 8.6 7.6 12.8 23.9 48.8 29.7 19.0 23.0 29.2 11.6 14.7 5.4 41.8 2.3 19.6 16.8 9.2 35.6 6.9 16.7 9.8 6.8 16.2 16.5 6.2 14.7 21.0 16.2 109.5 17.8 14.9 6.8 7.5 58.9 14.9 11.6 4.2 20.1 14.1 5.9 26.1 35.8 35.0 25.1 10.3 11.8 12.7 11.8 155.7 41.2 4.4 17.2 20.4 16.8 11.9 44.8 10.9 17.3 24.0 9.7 9.7 12.5 11.2 7.8 7.3 0.3 14.1 9.4 21.6 136.9 46.6 141.3 21.3 35.7 28.1 12.0 29.8 26.5 23.3 13.3 31.7 26.5 236.4 17.2 35.5 10.3 28.7 73.7 60.6 61.6 87.2 58.0 75.9 61.4 71.7 49.8 50.2 48.3 646.2 271.8 308.5 1451.5 766.1 652.6 328.8 715.9 234.2 337.8 1889.5 176.7 1011.0 462.6 652.8 18.2 997.4 807.3 186.9 609.1 1937.1 842.6 824.8 565.6 490.5 1723.2 333.7 272.1 1299.4 1392.0 32.7 1728.8 1023.4 646.2 1577.2 438.3 1662.7 462.4 719.8 1890.9 2151.3 195.5 1203.0 551.5 116.1 261.4 1004.9 1230.6 638.1 376.8 1464.7 ITM2C "BRI3, BRICD2C, E25, hRPC.1050_D_4, ITM3" ENSG00000135916 "Integral membrane protein 2C" Q9NQX7 2 230864639-230879248 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 187.0;brain: 138.3;intestine: 158.6" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 668.0;Mucus-secreting cells: 885.6;Paneth cells: 2044.1;Undifferentiated cells: 840.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 187.0" "Lineage enriched" "Detected in many" 9 "dendritic cells: 187.0" "Cell line enhanced" "Detected in many" "EFO-21: 78.4;NB-4: 84.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.50e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (3.74e-1)" "unprognostic (6.03e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.52e-2)" 9.7 21.5 113.6 23.9 138.3 21.7 6.6 15.9 122.4 18.2 158.6 41.9 3.9 18.4 19.4 9.9 20.2 12.7 12.7 11.5 81.8 96.8 29.5 7.7 8.2 15.9 97.3 63.4 19.7 18.5 23.1 39.6 24.8 51.4 24.7 124.0 26.1 17.1 27.4 5.1 4.3 41.7 22.5 68.1 18.1 18.3 4.4 44.3 29.6 12.7 1.9 16.4 27.5 10.8 14.9 187.0 21.1 0.2 3.6 4.5 3.6 4.8 9.7 32.4 25.5 4.1 2.3 10.4 25.5 28.6 14.0 21.9 13.0 6.9 0.0 78.4 18.3 14.5 2.5 19.5 3.7 8.8 48.1 16.0 6.4 5.2 16.6 14.8 11.5 27.5 20.1 3.7 12.6 1.2 5.2 0.5 11.4 6.1 16.4 5.2 7.6 8.4 84.6 39.4 27.0 8.8 12.5 5.4 68.8 18.5 28.9 1.8 50.0 12.5 1.6 29.4 35.8 2.5 66.8 0.4 6.0 17.4 10.5 7.2 0.1 1.2 0.6 18.9 10.1 49.9 4.6 0.2 21.1 1.0 0.1 2.7 14.9 3.2 2.6 5.2 6.9 3.2 2.5 0.5 3.6 0.0 187.0 4.5 3.6 113.6 138.3 15.9 93.6 81.8 96.8 97.3 63.4 51.4 44.3 6.0 6.7 71.1 42.3 21.4 377.7 20.6 58.6 24.1 22.7 130.9 237.6 89.5 23.2 90.7 0.8 14.6 668.0 0.0 34.5 56.3 95.7 68.8 181.1 12.9 61.5 95.3 392.4 20.9 5.3 2.4 50.3 12.1 192.3 116.4 885.6 180.3 43.5 2044.1 65.0 20.1 83.2 135.8 75.2 4.7 17.7 13.0 48.2 46.5 840.0 60.9 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 28.8;intestine: 19.8;stomach 1: 10.7" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 36.6;Enterocytes: 34.8;Late spermatids: 119.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2" "Cell type enriched" "Detected in single" 8 "MAIT T-cell: 4.7" "Lineage enriched" "Detected in single" 13 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 22.7;OE19: 12.5" "Group enriched" "Detected in many" 13 "amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9" "Group enriched" "Detected in many" 7 "amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6" HPA040454 Enhanced Approved Approved "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.4 3.0 12.3 1.1 21.2 0.8 0.4 3.0 28.8 0.6 8.5 0.3 0.0 19.8 0.6 0.5 0.4 0.6 0.6 0.7 10.4 0.9 0.4 0.8 0.4 0.4 1.6 8.2 0.6 2.5 1.7 0.0 0.7 0.3 0.8 3.4 0.0 2.1 0.8 1.4 0.4 19.7 0.7 0.2 0.4 10.7 3.5 0.6 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.3 4.7 0.0 4.7 1.3 0.2 5.6 0.0 1.8 10.2 3.0 2.4 2.0 2.1 11.2 0.2 0.0 2.5 0.2 4.5 0.5 2.4 0.2 0.1 4.5 3.0 6.8 3.0 22.7 9.2 2.3 0.3 0.1 0.1 1.9 0.6 1.1 0.1 0.9 8.6 1.3 0.7 3.1 0.2 4.4 0.6 12.5 4.0 1.1 1.0 0.4 0.2 0.3 0.5 1.1 2.2 0.0 0.2 0.0 0.6 3.4 0.2 4.9 5.1 5.4 8.1 0.7 7.1 0.0 9.1 9.0 1.6 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.3 21.2 3.0 28.8 10.4 0.9 1.6 8.2 0.3 0.6 0.0 0.0 0.0 0.4 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 36.6 0.0 34.8 0.0 0.6 0.4 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 119.2 2.3 0.0 0.0 0.0 12.0 7.3 0.4 19.3 1.4 0.0 0.1 6.5 0.7 1.9 3.0 0.0 0.1 0.0 14.4 0.1 ITPKB "IP3-3KB, IP3KB" ENSG00000143772 "Inositol-trisphosphate 3-kinase B" P27987 1 226631690-226739323 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.1" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 35.8;Ito cells: 27.0;Smooth muscle cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030273, HPA072923" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030273: AB_10601127, HPA072923: AB_2686558" "unprognostic (4.54e-2)" "unprognostic (3.85e-2)" "unprognostic (8.41e-3)" "unprognostic (9.37e-3)" "unprognostic (1.53e-1)" "prognostic favorable (1.72e-5)" "unprognostic (1.24e-1)" "prognostic favorable (6.65e-4)" "unprognostic (2.29e-1)" "unprognostic (9.57e-2)" "unprognostic (1.41e-2)" "unprognostic (1.75e-2)" "unprognostic (3.23e-3)" "unprognostic (2.90e-2)" "unprognostic (7.46e-2)" "unprognostic (6.54e-3)" "unprognostic (7.87e-2)" 23.8 4.2 34.7 13.0 35.1 14.8 15.2 11.1 33.6 14.3 19.7 32.4 8.5 6.0 27.1 15.6 12.6 15.3 8.9 7.8 27.9 24.8 9.7 3.2 13.4 22.7 50.4 16.3 8.8 4.8 10.1 4.2 13.5 40.0 13.1 6.3 20.8 24.9 21.3 9.8 10.5 12.5 32.6 63.1 19.0 12.4 3.2 34.0 20.0 5.9 4.3 17.1 19.6 8.5 3.1 0.9 7.7 3.5 3.0 7.9 2.6 2.8 3.0 4.9 5.7 3.9 2.5 1.3 0.8 3.4 1.6 3.7 0.5 3.6 13.1 4.7 0.7 0.3 4.2 6.3 2.5 0.8 1.8 4.3 5.8 3.4 0.0 1.5 5.4 10.3 2.8 3.7 1.7 1.6 4.4 10.7 6.7 0.0 1.8 0.2 2.7 9.9 7.3 10.9 2.1 4.9 3.8 8.9 2.9 11.5 4.6 2.9 3.8 2.3 1.7 28.6 5.1 7.3 6.1 7.4 2.1 1.6 1.8 4.6 0.1 4.6 16.0 0.5 4.9 7.5 1.2 1.4 7.7 4.4 2.1 3.9 1.9 5.3 4.5 0.9 3.1 7.9 5.7 5.4 3.0 3.5 0.8 3.0 2.6 34.7 35.1 11.1 27.9 27.9 24.8 50.4 16.3 40.0 34.0 0.0 6.1 11.1 3.8 10.9 0.3 5.6 0.0 2.7 5.7 7.0 0.0 0.5 3.3 2.0 2.0 35.8 1.3 0.0 2.0 1.1 8.5 6.5 9.3 0.9 16.4 0.0 4.1 27.0 17.7 16.5 6.6 8.6 18.6 2.8 2.6 1.4 2.3 3.2 8.9 0.5 0.0 0.0 32.0 0.9 2.3 8.8 0.3 22.3 2.9 2.1 ITPR1 "ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29" ENSG00000150995 "Inositol 1,4,5-trisphosphate receptor type 1" Q14643 3 4493348-4847840 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 46.6" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 49.5;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.0;HeLa: 25.5;HMC-1: 16.9;U-87 MG: 20.8" "Region enhanced" "Detected in all" "cerebellum: 782.1" "Low region specificity" "Detected in all" "HPA014765, HPA016487" Approved Approved Vesicles NA NA 37000 Vesicles "HPA014765: AB_1851843, HPA016487: AB_1851842" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (2.16e-2)" "unprognostic (3.61e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.92e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.40e-1)" 4.8 8.2 6.1 7.4 18.6 3.2 11.9 39.5 30.2 10.2 7.4 1.7 21.5 2.4 18.4 13.2 7.8 10.1 11.8 5.3 8.7 5.1 8.7 2.5 6.4 7.1 4.8 10.4 14.2 2.7 46.6 7.3 4.6 3.8 15.0 3.7 12.5 9.6 27.4 3.2 3.2 5.0 17.4 3.7 6.0 5.5 3.0 4.3 7.0 19.3 0.6 8.6 14.1 10.6 8.9 3.6 5.4 1.6 1.2 2.2 1.2 0.0 1.3 0.2 0.6 10.0 0.4 3.2 0.2 0.2 0.3 0.3 0.3 0.3 4.4 0.4 0.4 1.8 0.0 0.9 1.1 0.5 35.0 1.4 12.7 25.5 1.6 13.8 5.4 16.9 2.6 0.7 1.7 0.5 3.6 1.4 3.4 1.4 5.1 1.3 0.5 2.4 1.8 0.9 0.2 3.9 1.4 0.2 0.3 1.1 1.1 0.1 8.5 2.3 1.4 2.3 0.3 0.9 7.7 1.7 0.8 1.4 1.1 1.0 7.8 3.7 2.9 20.8 5.8 1.8 5.4 1.6 1.9 1.5 1.0 1.9 6.6 1.7 1.5 2.1 8.9 2.2 1.9 0.8 1.2 0.7 3.6 1.3 1.2 6.1 18.6 39.5 30.2 8.7 5.1 4.8 10.4 3.8 4.3 0.0 31.8 25.3 4.8 3.4 1.6 4.8 5.1 21.4 14.8 8.7 0.0 0.5 3.3 1.5 4.4 22.4 0.0 0.0 4.5 0.4 13.0 6.1 24.4 1.8 4.7 1.6 3.4 22.1 13.3 5.7 27.9 15.3 6.8 6.4 0.8 3.9 1.5 0.3 49.5 3.5 1.0 38.8 26.4 1.4 2.6 2.8 0.8 19.5 0.6 3.1 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26336515-26833198 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 137.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA059144: AB_2683925, HPA062260: AB_2684728" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.8 20.6 12.8 14.5 13.8 6.1 18.5 9.3 15.0 7.9 9.9 7.8 3.7 6.0 7.2 7.8 12.0 7.3 8.0 7.1 14.2 6.0 14.4 47.1 6.5 8.1 12.8 4.6 8.0 9.2 17.4 9.9 11.9 13.0 6.6 7.8 4.8 17.6 3.8 4.7 13.3 8.9 5.4 20.3 12.5 5.9 3.4 15.3 35.3 5.3 6.6 10.7 5.5 8.1 4.3 9.0 17.3 5.2 3.6 3.1 0.7 2.7 1.2 1.6 2.6 5.0 5.1 1.8 2.5 3.5 1.8 1.9 0.1 1.4 9.4 1.6 3.4 1.9 3.0 8.7 5.3 2.4 2.2 2.9 7.5 2.5 15.1 4.6 6.7 3.4 4.8 0.7 3.7 7.0 3.5 16.6 3.7 3.3 3.0 2.2 2.3 4.7 9.0 7.2 2.4 0.9 1.5 3.9 5.9 4.1 4.3 0.5 2.6 11.4 2.1 6.3 7.0 4.3 3.3 36.3 3.6 1.4 3.4 3.2 2.8 2.1 17.6 3.3 3.1 2.3 17.3 5.2 7.1 2.4 2.2 2.0 4.2 2.1 1.9 1.0 4.3 2.5 2.2 13.5 3.6 3.0 9.0 3.1 0.7 12.8 13.8 9.3 15.0 14.2 6.0 12.8 4.6 13.0 15.3 44.7 38.7 25.7 17.2 18.5 3.1 19.1 35.7 8.1 13.6 22.7 137.4 16.2 6.6 19.4 2.6 26.3 10.3 23.3 20.5 7.7 11.6 22.1 43.8 96.9 31.6 0.0 75.3 16.5 35.2 4.7 16.7 48.3 32.1 6.4 36.5 12.6 14.9 35.3 16.6 14.6 67.9 0.0 11.7 2.8 4.9 23.3 23.3 16.0 8.4 14.6 ITPRIP "bA127L20.2, DANGER, KIAA1754" ENSG00000148841 "Inositol 1,4,5-trisphosphate receptor interacting protein" Q8IWB1 10 104309698-104338404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 42.1;Ito cells: 85.3;Suprabasal keratinocytes: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 24.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.1" "Cell line enhanced" "Detected in many" "hTCEpi: 38.6" "Low region specificity" "Detected in all" HPA043626 Uncertain Vesicles NA NA Vesicles "HPA043626: AB_10963078" "unprognostic (2.45e-2)" "unprognostic (3.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.22e-2)" "unprognostic (1.08e-2)" "unprognostic (4.20e-1)" "unprognostic (7.87e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (9.74e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (4.00e-2)" "unprognostic (5.37e-3)" "unprognostic (1.01e-3)" "unprognostic (2.65e-1)" "unprognostic (2.75e-1)" "unprognostic (2.11e-3)" 23.7 5.8 3.5 7.4 3.8 81.5 20.8 0.5 4.3 13.5 5.5 4.5 6.8 1.6 8.5 6.0 29.5 5.6 9.8 33.8 3.0 1.5 6.9 7.2 20.2 9.8 4.4 1.5 19.9 4.4 4.4 7.3 24.4 4.7 8.6 2.5 21.7 6.7 7.3 7.6 26.4 3.8 8.4 3.4 8.8 5.6 8.4 5.2 12.9 14.0 14.6 14.2 13.6 17.3 2.4 4.4 24.1 5.7 3.2 3.4 9.7 2.3 5.8 7.1 3.2 12.4 12.0 4.1 13.2 27.9 9.6 12.0 0.4 1.0 4.1 3.0 8.1 19.2 7.7 2.3 6.3 10.0 3.6 2.9 2.4 9.3 1.7 24.5 5.5 4.6 11.1 38.6 20.0 16.1 11.2 17.9 4.2 10.3 7.9 11.7 0.9 1.1 6.0 5.3 0.8 6.9 5.1 3.7 2.4 3.9 1.0 4.0 2.7 2.4 2.9 5.7 4.5 0.2 4.2 30.9 19.5 5.1 12.8 12.5 3.0 3.5 2.7 14.3 10.0 9.1 3.5 5.7 9.9 3.4 4.1 3.3 1.9 1.9 1.9 4.4 2.4 2.3 2.0 24.1 3.2 3.7 3.1 1.5 9.7 3.5 3.8 0.5 4.3 3.0 1.5 4.4 1.5 4.7 5.2 3.0 8.8 7.2 17.3 33.7 0.0 5.3 0.0 2.7 5.7 3.5 0.0 5.0 0.0 3.4 4.5 42.1 0.7 23.3 2.1 16.6 10.8 4.5 20.7 1.8 9.8 0.0 0.0 85.3 15.5 0.4 4.6 14.4 8.5 1.0 2.6 2.7 2.5 0.0 5.3 0.6 0.6 12.9 13.0 2.2 1.4 63.6 4.2 13.1 1.6 16.1 ITPRIPL1 KIAA1754L ENSG00000198885 "ITPRIP like 1" Q6GPH6 2 96325331-96330517 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.5;testis: 19.4" "Group enriched" "Detected in many" 11 "Early spermatids: 133.5;Late spermatids: 110.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.5" "Lineage enriched" "Detected in many" 5 "T-cells: 12.5" "Cell line enhanced" "Detected in many" "HEK 293: 16.9;HEL: 17.1;MOLT-4: 17.9;RPMI-8226: 17.7;U-698: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (3.56e-3)" "unprognostic (4.78e-2)" "unprognostic (9.43e-2)" "unprognostic (2.22e-1)" "unprognostic (6.56e-4)" "unprognostic (3.04e-2)" "unprognostic (2.87e-1)" "unprognostic (6.50e-2)" "unprognostic (5.36e-2)" "unprognostic (8.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.41e-5)" "unprognostic (4.97e-2)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (6.39e-2)" 3.9 0.6 1.4 5.6 0.9 0.8 7.8 6.2 1.8 1.6 0.9 1.1 2.1 1.2 0.8 0.4 2.0 1.1 1.7 2.7 0.9 0.8 0.8 1.4 2.7 4.0 2.3 0.8 0.7 7.2 0.3 0.8 1.2 1.7 2.3 0.8 1.4 8.3 1.7 1.4 1.1 2.1 1.4 1.3 3.1 1.1 19.4 1.1 4.7 1.1 1.2 4.7 1.8 3.4 1.6 1.2 0.2 0.2 2.2 12.5 1.9 0.0 0.0 3.8 0.0 0.4 1.0 5.3 0.9 4.5 3.8 7.6 1.7 0.2 0.0 0.0 1.5 0.0 0.3 13.6 0.0 4.3 8.9 16.9 17.1 0.1 7.6 2.1 0.0 0.0 3.0 0.0 4.4 0.0 0.0 2.5 10.6 0.0 5.8 0.1 0.0 17.9 2.5 5.9 0.0 0.0 11.7 12.7 17.7 0.1 0.0 11.4 7.5 0.0 0.0 0.0 2.5 0.0 2.7 1.1 0.0 0.5 0.0 0.0 9.2 12.1 19.4 2.2 0.0 3.7 0.2 0.2 0.0 9.9 0.2 12.5 1.6 3.3 9.5 1.2 0.4 0.8 4.2 0.1 2.2 0.0 0.5 5.5 1.9 1.4 0.9 6.2 1.8 0.9 0.8 2.3 0.8 1.7 1.1 3.0 0.0 0.0 3.1 0.2 0.5 0.8 0.0 1.4 4.5 0.0 3.9 0.6 0.0 0.1 133.5 0.7 0.0 0.0 0.2 1.9 0.6 1.3 0.0 0.0 1.6 0.0 0.0 0.0 0.3 110.9 1.1 1.6 1.7 0.0 0.0 4.7 0.5 0.0 0.7 0.2 1.7 6.5 1.0 1.4 2.1 0.9 0.3 10.9 0.3 1.3 IVL ENSG00000163207 Involucrin P07476 1 152908545-152911886 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 97.1;tongue: 152.1" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 62.0" "Group enriched" "Detected in many" 5 "cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "HaCaT: 78.9;RT4: 20.7;SK-BR-3: 23.8" "CAB002243, HPA055211" Enhanced Supported "Nuclear bodies,Centrosome,Cytosol" NA NA 8000000 Cytosol "Nuclear bodies, Centrosome" "CAB002243: AB_563785, HPA055211: AB_2682739" "unprognostic (3.29e-4)" "unprognostic (1.91e-1)" "unprognostic (2.92e-2)" "unprognostic (2.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (4.82e-2)" "unprognostic (3.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 39.0 0.1 0.0 0.4 0.1 4.2 11.5 97.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 1.8 0.1 0.0 18.7 0.1 0.2 34.2 0.1 1.0 0.0 0.1 0.1 0.1 0.0 1.9 0.1 152.1 49.1 4.9 43.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 78.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 23.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 7.4 IVNS1ABP "HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP" ENSG00000116679 "Influenza virus NS1A binding protein" Q9Y6Y0 1 185296388-185317329 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 171.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 72.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003405 Approved Supported Cytosol NA NA Cytosol "HPA003405: AB_1079141" "unprognostic (4.11e-3)" "unprognostic (9.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.77e-1)" "unprognostic (2.03e-2)" "unprognostic (4.42e-2)" "unprognostic (4.31e-3)" "unprognostic (4.18e-1)" "unprognostic (7.04e-2)" "unprognostic (5.13e-2)" "unprognostic (4.28e-1)" "unprognostic (5.42e-3)" "unprognostic (1.85e-3)" "unprognostic (3.73e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-2)" "unprognostic (4.13e-2)" 23.7 8.7 9.9 19.8 35.8 171.2 29.0 9.9 13.8 12.5 17.0 19.2 28.5 16.2 10.2 12.9 17.1 9.0 15.9 19.3 10.9 8.6 38.7 10.2 26.5 29.9 23.0 7.8 12.7 17.1 11.6 11.9 15.8 16.8 12.6 21.5 9.2 36.2 38.8 13.5 19.5 14.3 7.9 19.3 12.8 18.3 9.0 20.8 13.1 17.3 16.0 16.3 11.5 22.5 4.6 9.1 24.5 8.1 7.4 7.9 8.1 6.8 7.6 22.2 8.9 7.9 2.6 21.0 13.5 4.2 8.5 7.8 8.0 11.0 11.0 11.2 6.6 3.8 9.6 8.1 8.9 9.2 8.1 7.8 10.4 11.4 6.4 3.1 7.2 4.1 1.9 10.1 6.5 21.0 19.1 11.0 10.8 6.8 6.2 15.4 5.2 11.9 5.0 14.0 16.6 1.7 7.0 5.9 5.9 72.8 9.2 15.6 13.3 12.0 10.0 8.1 30.6 4.5 3.5 7.5 12.0 7.3 3.0 9.6 8.9 7.1 6.5 8.8 7.4 5.3 5.1 8.1 7.7 7.9 5.9 7.0 4.6 6.0 5.7 9.1 3.3 6.7 6.3 24.5 7.4 7.2 2.5 6.1 8.1 9.9 35.8 9.9 13.8 10.9 8.6 23.0 7.8 16.8 20.8 41.7 67.3 23.9 76.0 167.8 12.2 45.1 25.5 46.8 72.8 122.1 49.1 11.2 139.3 33.5 33.7 62.5 117.0 23.3 36.8 54.3 54.5 48.7 39.4 20.2 32.0 20.6 58.0 23.4 104.1 26.3 5.5 105.9 96.2 13.6 93.0 11.3 26.3 37.4 2.5 68.4 31.5 6.5 42.2 28.1 16.2 158.7 15.3 55.8 81.7 88.9 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "thyroid gland: 212.3" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 8.5;Cholangiocytes: 20.4;Club cells: 12.5;Enterocytes: 25.8;Hepatocytes: 18.3;Mucus-secreting cells: 15.4;Paneth cells: 17.3;Proximal tubular cells: 33.8;Undifferentiated cells: 10.3" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "CACO-2: 3.0;OE19: 6.8;SK-BR-3: 7.4" "Group enriched" "Detected in some" 13 "hippocampal formation: 8.1;thalamus: 2.6" "Low region specificity" "Detected in many" HPA059627 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059627: AB_2684086" "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 8.2 0.1 0.1 3.6 0.1 0.3 0.1 0.1 6.7 0.1 0.1 0.1 5.4 6.8 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.3 0.0 0.1 0.2 13.5 0.0 0.1 0.1 0.3 0.1 0.0 0.0 212.3 0.0 0.1 0.1 0.1 1.4 1.0 5.9 1.3 2.3 0.7 2.3 0.1 0.0 0.2 0.3 0.1 0.8 0.4 0.0 0.0 0.0 0.0 3.0 0.5 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.2 0.4 0.8 0.3 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.6 0.0 0.4 0.0 0.3 0.3 6.8 0.2 0.3 0.2 0.2 0.0 0.7 0.3 0.2 0.0 7.4 0.0 0.1 0.7 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.1 0.4 0.2 0.1 3.3 1.3 0.7 0.7 1.1 0.5 0.6 0.6 0.5 0.1 1.4 0.6 0.7 5.9 2.3 0.5 1.0 0.5 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 3.0 8.5 0.0 0.5 0.1 0.0 0.5 20.4 1.4 12.5 0.0 0.0 0.0 1.7 0.1 0.0 0.0 25.8 0.0 0.2 0.0 0.0 1.0 1.1 18.3 0.1 0.0 3.5 1.3 0.0 0.0 0.0 0.5 0.0 0.0 15.4 0.0 0.2 17.3 0.0 33.8 1.1 0.0 0.0 0.0 0.2 0.4 0.2 0.0 10.3 0.7 IZUMO1 "IZUMO, MGC34799, OBF" ENSG00000182264 "Izumo sperm-egg fusion 1" Q8IYV9 19 48740852-48746909 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 17.2" "Group enriched" "Detected in some" 21 "Early spermatids: 134.8;Late spermatids: 82.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;CAPAN-2: 2.7;HaCaT: 1.8;hTCEpi: 4.4;K-562: 2.1;RT4: 2.8;U-266/84: 1.5" "Low region specificity" "Detected in many" HPA038104 Enhanced NA NA "HPA038104: AB_10670655" "unprognostic (2.03e-1)" "unprognostic (1.86e-3)" "unprognostic (3.73e-2)" "unprognostic (1.37e-2)" "unprognostic (1.17e-2)" "unprognostic (7.92e-2)" "unprognostic (3.49e-2)" "unprognostic (2.53e-4)" "unprognostic (3.61e-2)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" "unprognostic (4.83e-2)" "unprognostic (1.32e-2)" "unprognostic (3.68e-1)" "unprognostic (2.92e-1)" "unprognostic (4.31e-3)" "unprognostic (6.92e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 17.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.3 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 3.1 0.0 82.3 1.1 0.0 1.7 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.1 IZUMO1R "Folbp3, FOLR4, JUNO" ENSG00000183560 "IZUMO1 receptor, JUNO" A6ND01 11 94305592-94307721 "Predicted intracellular proteins, Transporters" Fertilization Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.0;lymphoid tissue: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.0;CACO-2: 2.1;HBEC3-KT: 2.3;U-266/84: 3.1;WM-115: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.56e-3)" "unprognostic (1.37e-1)" "unprognostic (7.22e-3)" "unprognostic (8.39e-2)" "unprognostic (2.92e-3)" "unprognostic (2.47e-1)" "unprognostic (5.08e-2)" "unprognostic (8.61e-2)" 0.2 3.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.3 0.0 0.0 0.4 0.5 1.2 0.0 0.0 1.3 0.2 0.0 2.4 0.0 1.3 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.0 0.0 0.3 0.3 0.1 0.6 0.0 0.4 0.9 1.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IZUMO2 "C19orf41, MGC33947, SCRL" ENSG00000161652 "IZUMO family member 2" Q6UXV1 19 50152548-50163195 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 33.0" "Group enriched" "Detected in some" 30 "Early spermatids: 576.2;Late spermatids: 208.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;RH-30: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042143 Uncertain NA NA "HPA042143: AB_10794078" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (4.31e-2)" "unprognostic (1.81e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (8.75e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 576.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.1 0.0 0.1 0.0 3.5 0.6 0.0 208.4 4.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 3.2 0.0 0.1 12.9 0.4 4.1 4.5 0.4 0.0 0.0 0.0 1.6 IZUMO3 "bA20A20.1, C9orf134" ENSG00000205442 "IZUMO family member 3" Q5VZ72 9 24542952-24545946 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 169 "testis: 16.9" "Group enriched" "Detected in some" 89 "Early spermatids: 185.3;Late spermatids: 58.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 IZUMO4 C19orf36 ENSG00000099840 "IZUMO family member 4" Q1ZYL8 19 2096429-2099593 "Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 108.2" "Group enriched" "Detected in many" 5 "Early spermatids: 1393.1;Late spermatids: 1780.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 11.1;RPMI-8226: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048496 Enhanced "Secreted in male reproductive system" NA NA "HPA048496: AB_2680419" "unprognostic (2.75e-3)" "unprognostic (1.10e-2)" "unprognostic (3.65e-2)" "prognostic favorable (7.08e-4)" "unprognostic (1.40e-1)" "unprognostic (2.18e-5)" "unprognostic (2.67e-2)" "unprognostic (1.02e-3)" "unprognostic (1.30e-1)" "unprognostic (2.48e-1)" "prognostic favorable (1.69e-4)" "unprognostic (2.12e-1)" "unprognostic (6.58e-5)" "unprognostic (6.38e-2)" "unprognostic (2.17e-1)" "unprognostic (5.68e-1)" "unprognostic (7.51e-3)" 1.6 1.1 4.4 0.9 5.6 0.6 0.9 1.3 4.4 1.0 0.8 2.9 1.2 0.6 0.9 1.6 1.0 1.4 1.3 1.6 4.4 2.1 1.1 2.0 0.9 1.1 10.5 3.3 3.0 8.3 0.8 2.7 0.6 4.2 1.9 0.8 0.6 1.4 1.6 0.9 1.4 0.7 0.7 3.6 0.8 1.0 108.2 6.6 0.4 1.3 0.8 1.4 0.9 0.6 5.3 2.8 3.4 3.1 1.0 5.1 2.6 0.8 0.7 0.4 3.4 1.5 1.6 0.5 0.5 0.8 0.6 0.1 0.3 0.7 0.6 0.8 0.8 0.0 0.7 0.1 3.8 0.2 1.6 0.3 0.0 1.3 1.0 4.3 0.0 0.6 0.6 1.4 1.0 1.1 1.2 0.0 2.0 0.0 11.1 1.4 0.2 1.0 0.3 0.3 1.4 0.9 0.8 0.0 13.4 1.7 0.4 0.6 0.9 0.5 1.2 0.5 0.2 0.6 1.3 0.5 0.5 0.2 0.1 0.3 1.2 1.4 1.0 1.8 1.2 0.3 0.0 1.6 1.4 1.6 2.2 3.5 5.3 5.1 3.7 2.2 1.8 4.1 1.7 3.4 1.0 3.1 2.8 4.7 2.6 4.4 5.6 1.3 4.4 4.4 2.1 10.5 3.3 4.2 6.6 0.0 0.0 0.9 3.8 2.2 3.7 1.2 2.5 0.0 0.0 8.7 7.9 0.4 5.0 2.0 1393.1 0.6 1.6 0.0 5.1 3.3 0.9 6.1 0.0 8.9 0.8 0.0 7.5 0.6 2.1 1780.5 26.4 1.6 11.8 16.2 1.9 6.0 2.5 0.0 18.7 7.2 8.7 6.5 1.3 339.6 12.2 1.5 1.4 5.1 2.6 3.7 JAG2 ENSG00000184916 "Jagged 2" Q9Y219 14 105140981-105168824 "Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.0" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 20.7;Cone photoreceptor cells: 23.6;Endothelial cells: 17.9;Horizontal cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 10.7;CAPAN-2: 10.7;HaCaT: 33.0;HBEC3-KT: 11.1;SCLC-21H: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025481, HPA030636, HPA050567" Approved Supported Vesicles,Cytosol NA NA 120000 Vesicles Cytosol "CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178" "unprognostic (6.74e-2)" "unprognostic (4.49e-2)" "unprognostic (4.28e-2)" "unprognostic (6.97e-3)" "unprognostic (3.50e-1)" "unprognostic (2.13e-2)" "unprognostic (1.01e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-2)" "unprognostic (2.62e-1)" "unprognostic (1.67e-2)" "unprognostic (9.19e-2)" "unprognostic (8.47e-3)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.39e-1)" "unprognostic (2.17e-1)" 11.5 2.5 5.4 3.5 6.3 1.3 11.4 6.4 8.4 4.2 3.0 3.5 5.2 3.2 7.5 8.4 8.1 5.0 4.4 9.5 5.6 6.4 3.0 1.5 6.6 2.4 4.5 5.3 2.7 5.8 4.3 15.9 6.8 8.7 7.1 1.7 5.9 12.2 6.9 16.8 36.0 4.3 3.2 2.9 3.7 3.8 4.2 3.0 2.7 4.2 11.0 4.1 5.2 5.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 8.5 3.5 0.2 0.9 0.0 0.0 10.7 0.1 0.1 0.0 0.0 2.9 10.7 0.0 7.4 0.0 0.0 33.0 2.1 11.1 0.0 1.1 5.1 0.0 9.5 0.0 0.1 0.0 2.1 0.1 5.4 0.0 1.2 0.1 2.7 0.4 2.1 0.0 0.0 3.9 0.0 0.0 1.1 1.0 1.2 2.7 2.1 3.7 0.1 2.3 16.9 0.5 2.9 0.7 0.1 0.2 8.4 1.3 9.1 0.0 0.9 0.0 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 5.4 6.3 6.4 8.4 5.6 6.4 4.5 5.3 8.7 3.0 6.0 2.7 0.0 7.9 20.7 1.1 5.9 0.0 5.3 7.9 0.0 23.6 1.9 0.0 3.4 0.1 17.9 4.9 0.0 2.2 0.9 1.0 2.7 0.0 0.6 0.6 25.4 0.0 5.5 0.0 0.4 1.4 1.2 6.8 1.8 2.8 0.6 3.6 2.8 0.7 0.1 4.8 0.0 2.1 0.5 13.7 5.9 1.1 2.6 2.9 1.4 JAK3 "JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK" ENSG00000105639 "Janus kinase 3" P52333 19 17824780-17848071 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 68.3" "Cell type enhanced" "Detected in many" 7 "B-cells: 18.2;Ito cells: 14.1;Peritubular cells: 13.8;T-cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.6;HEL: 9.2;HMC-1: 9.4;Karpas-707: 24.0;U-266/70: 9.3;U-266/84: 13.8;U-937: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070314 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA070314: AB_2686251" "unprognostic (5.59e-3)" "prognostic favorable (6.42e-5)" "unprognostic (5.71e-2)" "unprognostic (2.34e-1)" "unprognostic (6.13e-3)" "unprognostic (1.11e-3)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.89e-14)" "unprognostic (2.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.43e-2)" "unprognostic (7.61e-2)" 6.8 1.7 4.0 24.5 8.5 12.0 2.7 2.4 3.1 1.9 2.3 1.0 0.0 2.2 1.7 2.0 2.5 3.5 3.6 4.3 2.7 2.8 3.8 2.0 8.4 68.3 7.5 0.0 11.0 2.0 0.4 2.3 4.1 5.3 3.0 2.4 1.6 6.1 1.5 0.7 1.3 9.5 2.5 8.4 36.1 3.2 1.8 5.8 20.9 3.4 1.7 28.8 5.3 2.4 7.4 4.5 16.9 9.6 8.4 15.0 6.8 0.1 0.3 0.3 1.1 0.4 1.5 0.2 0.5 0.0 0.0 0.1 0.0 0.9 0.4 2.0 0.4 0.3 0.1 0.0 0.2 0.0 20.6 0.0 9.2 0.0 0.8 0.7 0.0 9.4 5.1 0.2 0.0 0.0 0.0 0.2 2.1 0.0 24.0 0.0 0.4 3.6 0.0 0.2 0.5 0.7 4.7 0.0 0.4 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.1 2.0 1.4 0.4 0.0 0.4 0.0 0.0 9.3 13.8 2.5 0.1 14.0 0.2 1.2 4.9 0.2 12.6 9.6 14.5 6.5 15.0 13.1 4.5 7.4 14.9 13.0 16.9 8.4 8.8 3.7 11.8 6.8 4.0 8.5 2.4 3.1 2.7 2.8 7.5 0.0 5.3 5.8 0.0 5.8 18.2 0.5 0.7 0.3 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.6 1.0 5.8 0.0 0.0 0.3 0.7 2.3 0.2 4.7 0.0 11.5 0.0 0.0 14.1 10.8 0.9 11.5 3.5 3.3 12.6 0.0 0.8 0.4 0.0 13.8 0.1 0.5 6.5 2.1 0.3 0.7 0.9 1.1 24.5 0.0 0.5 JAKMIP1 "FLJ31564, Gababrbp, JAMIP1, MARLIN1" ENSG00000152969 "Janus kinase and microtubule interacting protein 1" Q96N16 4 6026199-6200591 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.5;brain: 37.4" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 57.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "gdT-cell: 14.9;MAIT T-cell: 6.5;memory CD4 T-cell: 6.7;memory CD8 T-cell: 13.0;naive CD8 T-cell: 6.2;T-reg: 19.5" "Lineage enriched" "Detected in single" 37 "T-cells: 19.5" "Cell line enhanced" "Detected in some" "Daudi: 9.8;JURKAT: 9.1;MOLT-4: 27.3;SCLC-21H: 12.3;U-266/70: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044570 Uncertain NA NA "HPA044570: AB_2678995" "unprognostic (4.79e-2)" "unprognostic (3.46e-3)" "unprognostic (4.90e-2)" "unprognostic (1.73e-2)" "unprognostic (5.34e-2)" "unprognostic (3.86e-3)" "unprognostic (6.16e-2)" "unprognostic (6.69e-3)" "unprognostic (4.25e-4)" "unprognostic (7.14e-2)" "unprognostic (4.57e-3)" "unprognostic (1.13e-1)" "unprognostic (3.70e-8)" "unprognostic (1.85e-2)" "unprognostic (3.15e-1)" "unprognostic (4.23e-2)" "unprognostic (2.96e-3)" 1.3 8.5 15.7 2.3 35.0 2.6 1.0 2.5 37.4 1.0 1.5 2.7 0.0 1.2 1.1 1.0 1.1 1.0 1.7 1.0 15.6 14.7 1.0 1.1 1.9 4.7 10.8 13.3 1.6 1.6 1.0 3.8 1.0 7.2 7.4 1.3 0.1 2.0 1.1 1.0 1.0 1.7 1.3 4.3 2.9 1.7 5.9 7.6 0.0 1.4 0.0 1.8 2.3 0.1 0.1 0.0 0.0 0.0 0.5 19.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.2 27.3 0.0 2.2 0.0 1.7 1.4 0.0 0.7 0.0 0.0 12.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 6.5 0.1 6.7 13.0 0.0 0.1 0.5 6.2 0.0 0.5 0.0 0.0 19.5 2.5 15.7 35.0 2.5 21.2 15.6 14.7 10.8 13.3 7.2 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 3.2 0.0 0.0 1.5 2.2 0.0 0.0 0.0 0.0 0.0 57.2 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.9 3.7 0.1 0.0 8.7 0.0 0.0 JAKMIP2 "JAMIP2, KIAA0555" ENSG00000176049 "Janus kinase and microtubule interacting protein 2" Q96AA8 5 147585439-147782848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0" "Cell type enhanced" "Detected in many" 20 "Bipolar cells: 19.5;granulocytes: 27.8;Horizontal cells: 81.0;Muller glia cells: 21.8" "Cancer enriched" "Detected in some" 6 "glioma: 4.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.9;MAIT T-cell: 6.3;memory CD4 T-cell: 3.5;memory CD8 T-cell: 6.4;naive CD8 T-cell: 5.6;NK-cell: 7.4" "Group enriched" "Detected in many" 6 "NK-cells: 7.4;T-cells: 8.9" "Cell line enhanced" "Detected in many" "AF22: 11.1;Karpas-707: 26.4;RH-30: 26.7;RPMI-8226: 8.5;SCLC-21H: 12.5;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046929, HPA065023" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA046929: AB_2679867, HPA065023: AB_2685407" "unprognostic (3.69e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (3.58e-2)" "unprognostic (1.63e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.21e-4)" "unprognostic (1.28e-1)" "unprognostic (5.20e-8)" "unprognostic (1.54e-3)" "unprognostic (1.30e-1)" "unprognostic (1.33e-1)" "unprognostic (1.31e-1)" 1.3 6.5 12.0 2.5 10.4 1.7 1.1 44.0 35.0 1.8 1.7 8.7 0.0 1.6 2.6 1.4 3.1 1.1 3.2 1.2 12.4 10.0 1.3 5.1 4.2 2.3 11.4 9.0 1.2 2.2 0.9 14.8 1.0 10.2 1.7 1.9 1.0 1.4 1.6 1.0 1.3 1.9 3.4 10.8 2.1 1.9 5.3 16.5 8.7 1.0 0.0 2.3 1.6 0.3 0.8 1.2 0.7 0.2 7.4 8.9 1.6 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.6 3.8 1.1 0.0 0.0 0.2 0.0 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 26.4 0.0 0.0 2.6 0.0 6.3 0.0 0.1 1.0 26.7 8.5 0.0 0.0 12.5 8.7 0.0 0.2 0.0 1.5 0.0 0.0 0.0 2.0 2.3 0.0 0.6 1.8 1.0 2.5 5.0 0.0 0.0 0.0 0.0 0.4 8.9 0.0 6.3 0.8 3.5 6.4 0.2 0.4 0.9 5.6 0.7 7.4 0.2 1.2 1.5 1.6 12.0 10.4 44.0 16.4 12.4 10.0 11.4 9.0 10.2 16.5 0.0 1.0 0.0 0.0 0.0 19.5 0.6 0.0 2.7 2.3 0.0 2.0 0.0 0.0 0.4 8.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 27.8 2.6 1.3 81.0 1.2 0.6 1.6 4.6 0.0 1.1 0.0 0.0 0.3 21.8 0.3 0.0 0.0 0.0 7.9 0.0 0.0 1.5 1.1 0.1 0.2 9.6 0.0 0.0 JAKMIP3 "bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2" ENSG00000188385 "Janus kinase and microtubule interacting protein 3" Q5VZ66 10 132104671-132184809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 2.9;Cardiomyocytes: 5.3;Cone photoreceptor cells: 2.0;Early spermatids: 2.0;Horizontal cells: 3.2;Leydig cells: 2.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.6;GAMG: 2.5;RPMI-8226: 2.5;U-266/84: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022872 Uncertain NA NA "HPA022872: AB_2249331" "unprognostic (1.75e-1)" "unprognostic (1.76e-2)" "unprognostic (4.55e-3)" "unprognostic (8.90e-2)" "unprognostic (2.72e-1)" "unprognostic (9.39e-2)" "unprognostic (2.31e-3)" "unprognostic (1.40e-1)" "unprognostic (2.22e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-5)" "unprognostic (1.55e-2)" "unprognostic (5.71e-6)" "unprognostic (1.43e-1)" "unprognostic (2.11e-1)" "unprognostic (7.19e-4)" "unprognostic (1.59e-2)" 0.2 1.8 2.7 0.0 2.8 0.1 0.6 5.2 8.8 0.3 0.1 0.0 1.2 0.6 0.5 0.9 0.6 1.0 4.2 4.1 0.0 0.0 0.2 0.0 5.2 3.5 0.6 0.0 2.8 0.0 3.3 0.2 0.4 1.6 1.5 0.2 0.1 1.0 7.0 0.1 0.5 1.1 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.2 2.2 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 1.7 0.2 1.8 0.3 2.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 1.6 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 1.3 0.0 0.1 0.0 0.0 2.5 0.0 0.1 0.9 0.3 0.1 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.9 0.1 0.0 0.3 10.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 5.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 3.2 0.0 0.0 0.3 0.6 2.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" NA NA 17000 "Plasma membrane" Nucleoplasm "HPA028789: AB_2732443, HPA077346: AB_2732341" "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.2 0.1 0.7 0.2 0.4 0.5 11.6 1.5 5.5 0.0 0.0 0.1 0.0 0.2 7.0 0.0 1.6 0.0 3.4 11.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.3 0.0 16.2 0.0 0.4 0.0 0.2 5.6 0.1 0.3 0.1 5.7 0.1 0.0 2.1 3.7 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 0.2 0.6 0.1 0.0 13.1 1.2 0.1 1.8 1.5 0.0 0.0 9.6 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 0.0 2.9 1.4 1.4 6.6 1.5 31.9 0.0 1.4 0.0 3.5 13.7 0.3 0.0 0.3 12.9 151.0 0.0 0.0 0.2 2.2 18.5 1.2 0.0 0.0 1.0 0.0 0.0 49.7 2.2 13.2 9.2 1.4 15.1 0.0 0.0 0.9 0.1 0.0 23.0 0.0 3.6 0.0 7.6 4.8 3.9 5.8 0.7 0.0 0.0 0.7 JAM3 "JAM-C, JAMC" ENSG00000166086 "Junctional adhesion molecule 3" Q9BX67 11 134068925-134152001 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.0" "Cell type enhanced" "Detected in many" 7 "Peritubular cells: 60.5;Rod photoreceptor cells: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.2" "Group enriched" "Detected in many" 7 "B-cells: 8.2;T-cells: 4.0" "Cell line enhanced" "Detected in many" "RH-30: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003417, HPA050434" Approved Enhanced "Golgi apparatus" "Secreted to blood" NA NA 570000 "Golgi apparatus" "HPA003417: AB_1851981, HPA050434: AB_2681126" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (3.24e-1)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.32e-1)" "unprognostic (6.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.23e-3)" "unprognostic (2.17e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.68e-4)" 14.0 14.9 17.6 7.9 34.1 2.2 9.9 7.0 28.7 15.5 23.4 77.0 6.9 5.9 25.0 12.9 16.3 11.9 17.8 21.4 26.1 16.9 6.7 3.0 13.7 6.2 40.3 17.4 32.0 4.4 14.5 19.5 68.8 29.6 26.2 9.7 17.5 9.4 32.5 4.1 9.1 11.7 29.7 34.8 8.7 12.0 24.8 34.1 5.1 7.6 4.6 5.6 22.7 22.6 8.2 0.2 0.8 0.1 0.1 4.0 2.9 0.2 0.4 28.4 14.6 26.5 19.7 23.8 12.1 14.3 4.5 4.5 0.4 0.2 0.3 12.5 15.7 18.3 0.4 20.4 0.2 8.6 0.2 10.2 0.8 0.1 1.8 7.9 0.5 12.6 13.4 0.0 3.2 2.9 11.4 29.5 13.2 0.3 0.2 19.5 0.3 8.7 1.0 6.7 0.3 1.2 0.2 38.8 0.2 0.2 0.1 19.1 10.7 0.2 0.3 0.4 12.6 0.3 0.3 0.2 8.5 6.2 13.3 8.2 0.1 0.1 0.2 9.4 1.2 16.2 0.4 0.1 0.3 2.2 0.0 2.6 8.2 2.8 1.6 0.2 4.8 4.0 2.6 0.8 0.1 0.0 0.2 0.1 2.9 17.6 34.1 7.0 28.7 26.1 16.9 40.3 17.4 29.6 34.1 0.0 8.9 6.9 5.7 4.5 16.1 14.9 0.0 2.7 1.2 5.2 7.9 4.8 1.7 0.4 1.9 26.3 0.0 0.0 0.2 40.4 29.1 1.6 1.1 0.0 6.8 7.9 0.0 16.0 0.8 3.6 39.7 0.9 16.9 0.0 0.0 18.1 0.3 0.0 60.5 0.0 71.5 25.8 29.8 12.5 19.0 3.3 5.1 0.7 0.0 0.7 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.9" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 2.3 0.3 2.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 6.0 48.3 15.4 0.1 0.0 0.0 0.0 0.0 4.0 10.3 1.8 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.4 0.1 14.0 2.1 29.9 0.0 0.0 8.0 117.5 0.9 0.0 185.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 1.4 0.0 0.3 45.3 0.0 0.1 JARID2 JMJ ENSG00000008083 "Jumonji and AT-rich interaction domain containing 2" Q92833 6 15246296-15522040 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.3" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 32.2;SuSa: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063889, CAB069890" Approved Supported Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "CAB069890: AB_10000529, HPA063889: AB_2685143" "unprognostic (5.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (4.87e-3)" "unprognostic (6.35e-2)" "unprognostic (2.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (3.26e-3)" "unprognostic (7.04e-2)" "unprognostic (4.48e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-1)" 10.2 5.3 6.9 11.5 8.8 53.3 7.2 40.6 9.3 6.3 8.3 11.4 9.4 6.9 8.8 8.4 15.4 5.0 7.9 5.9 6.8 7.1 4.6 4.4 8.2 12.8 6.8 3.8 7.2 4.4 6.1 8.2 8.4 8.4 5.5 5.9 15.1 10.7 11.9 12.5 14.9 12.5 5.3 6.6 14.2 8.2 17.5 6.5 41.3 5.0 8.9 19.2 6.5 7.7 4.2 4.6 14.4 4.0 4.9 3.9 2.0 5.2 3.6 15.0 8.6 1.8 1.8 14.9 1.5 3.6 2.0 2.5 3.8 4.1 2.8 5.4 3.0 3.0 2.7 3.5 8.7 1.8 5.4 5.3 9.8 4.3 4.8 2.0 9.9 11.5 2.6 5.5 2.9 11.7 6.0 2.1 32.2 12.7 4.7 1.1 5.2 19.7 18.7 16.0 2.6 1.6 8.8 4.6 7.8 1.8 5.5 11.6 6.6 3.1 10.9 13.7 36.6 3.8 10.7 3.6 9.2 5.1 5.0 5.2 3.0 7.2 4.9 3.1 9.3 11.5 9.6 4.0 3.2 3.9 2.6 3.3 2.6 1.9 2.3 3.3 4.2 2.4 3.3 14.4 4.9 2.7 4.6 1.5 2.0 6.9 8.8 40.6 7.9 6.8 7.1 6.8 3.8 8.4 6.5 6.0 10.9 22.2 9.5 71.4 71.0 8.9 10.2 4.0 11.4 5.2 82.5 23.3 1.7 6.8 59.2 24.1 12.3 0.0 3.9 19.3 18.6 5.7 24.3 12.9 21.4 146.2 25.7 14.1 48.4 29.9 8.1 37.2 25.3 20.8 16.0 167.6 11.0 11.5 8.1 2.6 91.1 6.5 25.0 7.0 67.9 132.5 21.1 30.5 13.4 13.6 JCHAIN "IGCJ, IGJ, JCH" ENSG00000132465 "Joining chain of multimeric IgA and IgM" P01591 4 70655541-70681817 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 174.1;B-cells: 379.6;Erythroid cells: 864.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 118 "memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7" "Group enriched" "Detected in many" 142 "B-cells: 213.0;dendritic cells: 160.7" "Cell line enhanced" "Detected in some" "Daudi: 162.4;Karpas-707: 86.7;RPMI-8226: 172.1;U-266/70: 366.4;U-266/84: 142.2;U-698: 211.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034436, HPA044132" Enhanced "Secreted to blood" NA NA 4200000000 "CAB034436: AB_2233368, HPA044132: AB_2678826" "prognostic favorable (1.81e-6)" "unprognostic (1.45e-3)" "unprognostic (7.44e-3)" "unprognostic (1.82e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.56e-7)" "unprognostic (2.37e-2)" "unprognostic (2.70e-2)" "unprognostic (6.30e-2)" "unprognostic (2.64e-3)" "unprognostic (3.36e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (3.43e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.96e-1)" 4.4 1.6 0.9 209.3 0.9 0.4 69.6 0.9 0.9 27.2 403.3 2.1 0.7 132.7 1.7 1.5 29.2 9.8 79.4 2.4 0.9 1.0 19.9 12.7 62.8 111.7 0.9 0.6 14.0 8.6 0.0 1.4 0.7 0.8 5.7 142.5 8.2 220.1 30.1 1.1 1.7 361.5 4.0 1.0 161.3 124.6 7.0 0.7 8.0 7.1 36.8 96.7 42.1 5.9 213.0 160.7 1.3 0.3 0.2 0.9 52.6 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 162.4 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 86.7 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.2 0.1 172.1 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.2 0.5 0.2 0.2 366.4 142.2 211.2 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 0.9 213.0 0.1 0.2 0.3 91.6 0.1 0.1 1.3 0.2 0.1 160.7 0.1 52.6 0.9 0.9 0.9 0.9 0.9 1.0 0.9 0.6 0.8 0.7 20.8 174.1 379.6 2.5 0.0 0.0 0.3 10.2 6.7 14.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 864.3 0.0 0.1 0.0 0.5 73.2 1.5 0.3 0.0 7.0 91.4 24.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.9 0.2 0.0 0.2 10.2 0.0 0.3 JHY "C11orf63, FLJ23554, Jhy" ENSG00000109944 "Junctional cadherin complex regulator" Q6NUN7 11 122882528-122959798 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 51.0" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 11.9;Ciliated cells: 34.8;Club cells: 13.6;Proximal tubular cells: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA039612, HPA040344, HPA077658, HPA077748" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA039612: AB_10674424, HPA040344: AB_2676931, HPA077658: AB_2732355, HPA077748: AB_2732360" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (3.93e-2)" "prognostic favorable (7.94e-5)" "unprognostic (9.97e-5)" "unprognostic (1.64e-1)" "unprognostic (2.02e-3)" "unprognostic (1.94e-3)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (4.13e-2)" "unprognostic (2.97e-1)" "prognostic favorable (8.77e-4)" "unprognostic (6.46e-3)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.58e-4)" "unprognostic (7.79e-2)" 3.6 0.9 1.9 1.6 2.1 0.2 2.3 1.6 2.2 2.1 2.4 1.2 1.0 0.7 1.5 2.5 1.0 5.1 1.5 1.6 1.5 2.6 5.3 1.0 2.8 1.0 1.7 1.4 2.1 1.5 6.3 4.2 2.3 1.7 2.3 0.8 1.9 1.0 1.5 2.4 1.0 1.2 1.0 2.2 1.3 1.0 51.0 1.3 1.4 3.4 1.5 1.2 1.7 1.2 2.4 4.9 0.3 0.6 4.3 4.1 1.1 2.6 3.7 2.2 0.1 0.6 0.4 0.7 5.7 6.6 2.4 1.0 0.2 9.9 0.0 1.4 8.8 13.4 2.3 2.6 1.3 1.1 8.8 2.7 0.1 1.8 0.1 0.9 1.5 4.6 2.8 7.3 0.4 0.6 6.2 3.6 3.9 0.0 0.0 1.8 1.6 0.0 0.6 0.3 7.7 3.4 0.9 0.0 1.2 6.9 3.0 5.7 4.0 6.8 3.7 2.4 2.9 4.5 0.6 1.2 7.8 1.0 0.2 4.5 0.1 0.0 0.0 2.0 2.0 5.2 0.3 0.6 0.1 2.9 0.1 4.1 2.4 3.0 3.9 4.9 1.4 2.1 2.1 0.3 4.3 0.0 1.1 0.6 1.1 1.9 2.1 1.6 2.2 1.5 2.6 1.7 1.4 1.7 1.3 11.9 4.1 0.0 0.0 0.0 0.0 0.0 0.0 34.8 13.6 5.2 0.0 0.0 3.3 4.9 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 2.9 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 JMJD6 "KIAA0585, PTDSR, PTDSR1" ENSG00000070495 "Arginine demethylase and lysine hydroxylase" Q6NYC1 17 76712832-76726799 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 80.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004548, HPA059156" Supported Supported Nucleoplasm No No Nucleoplasm "CAB004548: AB_628185, HPA059156: AB_2683934" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (8.06e-2)" "unprognostic (9.46e-2)" "unprognostic (5.95e-2)" "unprognostic (4.14e-3)" "prognostic unfavorable (5.75e-6)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-2)" "prognostic favorable (5.71e-4)" "unprognostic (5.66e-2)" "prognostic unfavorable (7.59e-7)" "unprognostic (1.15e-1)" "unprognostic (1.31e-1)" "unprognostic (8.86e-2)" "unprognostic (3.82e-1)" 14.9 15.9 10.7 12.6 14.9 80.6 14.3 20.5 18.7 9.9 17.5 8.5 10.5 11.7 12.2 6.6 12.2 11.5 14.7 26.0 11.9 7.3 9.7 11.1 14.6 11.0 17.8 7.8 16.7 13.7 10.6 13.3 12.3 16.9 11.9 8.6 8.3 9.7 10.2 19.6 8.6 10.5 13.7 13.8 12.7 14.7 11.2 18.6 5.4 11.0 8.6 10.0 16.1 57.5 13.4 17.3 25.2 24.8 8.6 20.4 12.8 16.4 22.7 8.0 10.4 10.4 9.0 7.8 15.2 11.8 22.1 21.6 22.9 8.2 10.8 6.7 16.4 32.5 12.6 25.3 7.5 21.4 7.7 20.1 16.1 15.9 23.1 16.7 8.4 24.7 10.6 11.9 24.3 8.2 14.1 18.4 5.9 23.9 20.2 16.4 10.3 14.5 12.0 7.0 15.9 27.5 11.5 15.1 16.7 7.5 5.2 13.9 13.7 13.2 19.6 18.1 14.4 17.5 12.5 11.8 25.9 15.1 13.3 28.1 22.4 11.9 10.0 25.0 7.4 14.3 25.1 19.4 25.2 17.6 24.8 17.0 13.4 20.4 19.5 17.3 9.2 17.0 15.8 15.4 8.6 23.7 14.9 19.5 12.8 10.7 14.9 20.5 18.7 11.9 7.3 17.8 7.8 16.9 18.6 23.8 25.1 29.2 77.6 73.8 14.6 19.8 20.4 12.0 22.7 8.7 47.1 25.1 14.9 26.0 22.7 26.3 38.4 0.0 23.8 37.8 34.9 35.0 63.6 8.6 28.6 6.4 37.7 27.0 17.6 8.6 15.0 33.2 55.6 37.9 18.1 14.1 24.5 19.9 16.6 6.7 34.5 12.9 62.8 45.9 25.9 64.4 25.5 38.3 20.4 33.1 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 97.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 35.7;Basal glandular cells: 27.1;Cardiomyocytes: 31.6;Glandular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 10.1;OE19: 12.1;SK-BR-3: 24.2;T-47d: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 1.7 0.6 1.8 0.7 5.7 0.5 0.8 13.7 3.1 0.8 1.9 0.8 0.4 0.8 1.5 1.7 1.8 0.6 0.6 3.3 2.1 0.7 0.8 0.5 2.2 0.5 1.0 4.2 0.5 3.5 1.1 0.4 1.1 2.4 1.8 2.8 0.0 1.3 0.8 97.2 0.7 0.9 1.4 2.4 0.5 0.9 0.9 2.3 2.4 1.2 21.5 1.4 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.4 0.1 3.1 0.0 1.0 0.0 0.7 4.5 3.9 3.1 1.0 0.0 5.9 0.0 3.6 0.0 0.5 2.0 0.2 0.6 2.6 0.0 2.9 0.0 0.0 7.8 0.5 0.0 0.2 2.8 10.1 0.0 6.8 12.1 2.0 5.1 3.9 0.0 0.1 9.0 5.2 0.7 0.0 24.2 1.2 1.2 17.2 0.1 0.0 1.2 1.7 0.4 1.0 0.0 0.0 0.0 2.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 5.7 13.7 3.1 2.1 0.7 1.0 4.2 2.4 2.3 35.7 8.0 0.0 27.1 2.5 0.0 31.6 0.0 8.1 15.9 1.8 5.9 0.0 0.0 0.2 2.1 0.4 1.3 0.0 1.2 0.0 2.1 24.9 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.4 0.9 0.2 1.7 0.0 10.1 0.2 3.4 8.0 0.0 0.7 0.0 0.0 2.3 0.1 3.6 1.8 0.0 0.0 5.6 16.6 JPH2 JP-2 ENSG00000149596 "Junctophilin 2" Q9BR39 20 44111695-44187578 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 72.6;smooth muscle: 55.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 53.2;Smooth muscle cells: 17.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 12.9;EFO-21: 16.3;fHDF/TERT166: 16.3;HeLa: 10.7;SiHa: 10.9;T-47d: 10.6" "Low region specificity" "Detected in some" HPA052646 Approved NA NA "HPA052646: AB_2681899" "unprognostic (1.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.61e-4)" "unprognostic (4.71e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (1.06e-2)" "unprognostic (2.45e-3)" "unprognostic (6.87e-2)" "unprognostic (9.16e-2)" "unprognostic (2.57e-2)" "unprognostic (9.73e-2)" "unprognostic (4.76e-2)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "unprognostic (1.10e-2)" 3.0 0.8 0.1 5.5 0.3 0.1 2.7 0.1 0.6 13.6 21.6 0.5 10.2 1.4 20.2 6.1 13.5 11.6 14.4 24.3 0.1 0.1 0.9 0.1 1.8 0.3 1.2 0.3 5.0 0.3 0.1 0.3 2.3 1.3 11.6 2.2 5.4 2.1 14.6 72.6 1.2 4.4 55.7 0.5 0.5 7.3 1.5 0.1 0.0 0.9 11.8 1.8 22.1 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.6 0.2 0.0 0.3 0.3 1.5 2.0 3.7 4.9 2.3 12.9 5.3 0.0 16.3 16.3 5.5 9.4 0.0 0.4 2.0 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 0.8 0.9 2.5 3.7 3.7 0.0 0.0 0.0 0.0 6.8 3.8 0.0 0.1 0.2 0.0 1.2 1.7 3.3 0.0 0.3 0.0 0.0 0.0 10.9 3.2 0.0 9.5 10.6 0.0 0.2 2.1 2.4 0.3 4.3 0.0 0.0 0.0 0.2 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.6 0.1 0.1 1.2 0.3 1.3 0.1 0.0 0.0 0.0 0.2 6.0 0.0 53.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 17.3 0.0 1.2 1.8 0.5 0.0 0.2 0.1 JPH3 "CAGL237, HDL2, JP-3, JP3, TNRC22" ENSG00000154118 "Junctophilin 3" Q8WXH2 16 87601835-87698156 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 44.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 25.0;Cone photoreceptor cells: 21.6;Early spermatids: 44.0;Horizontal cells: 47.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "MCF7: 6.5;NTERA-2: 5.8;SH-SY5Y: 7.5;SiHa: 4.9;U-2 OS: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076304 Approved Nucleoplasm,Cytosol Yes No "Nucleoplasm, Cytosol" "HPA076304: AB_2686793" "unprognostic (8.97e-3)" "unprognostic (3.17e-2)" "unprognostic (1.57e-3)" "unprognostic (4.82e-3)" "unprognostic (3.43e-1)" "unprognostic (9.12e-2)" "unprognostic (1.68e-2)" "unprognostic (8.10e-2)" "unprognostic (5.53e-2)" "unprognostic (1.48e-1)" "unprognostic (5.61e-3)" "unprognostic (2.80e-2)" "unprognostic (1.28e-4)" "unprognostic (3.01e-2)" "unprognostic (2.09e-1)" "unprognostic (1.87e-2)" "unprognostic (1.36e-2)" 1.3 3.6 27.2 1.6 24.1 1.1 1.2 18.9 44.2 1.5 1.4 1.2 0.0 1.4 1.3 1.2 2.4 1.4 1.2 1.2 30.9 14.6 1.2 1.2 1.2 1.2 8.3 12.2 1.1 1.5 1.2 4.4 1.2 6.4 1.3 1.3 0.8 1.2 1.7 1.1 1.2 1.7 1.3 3.3 1.2 1.5 1.8 3.5 0.0 1.2 0.0 1.2 1.1 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.8 0.0 1.0 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 6.5 0.0 0.0 5.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 7.5 4.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 27.2 24.1 18.9 30.3 30.9 14.6 8.3 12.2 6.4 3.5 0.0 0.0 0.0 0.0 0.0 25.0 2.8 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 44.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.9 3.4 0.0 0.1 0.0 0.0 0.0 JPH4 "JPHL1, KIAA1831" ENSG00000092051 "Junctophilin 4" Q96JJ6 14 23568035-23578800 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.7;seminal vesicle: 37.8" "Group enriched" "Detected in many" 19 "Bipolar cells: 144.6;Horizontal cells: 387.7" "Cancer enhanced" "Detected in some" "glioma: 6.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.4;myeloid DC: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 5.9;monocytes: 5.4" "Group enriched" "Detected in some" 6 "SCLC-21H: 10.1;SH-SY5Y: 25.2;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013492 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB013492: " "unprognostic (3.30e-2)" "unprognostic (1.91e-3)" "unprognostic (5.05e-3)" "unprognostic (7.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.84e-1)" "unprognostic (3.77e-3)" "unprognostic (5.98e-4)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (3.89e-3)" "unprognostic (1.15e-2)" "unprognostic (3.15e-2)" "unprognostic (2.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.13e-2)" "unprognostic (4.96e-3)" 1.9 12.3 33.6 2.0 43.8 1.3 1.6 45.3 63.7 3.4 1.9 2.1 8.0 1.8 17.1 6.2 1.5 5.1 1.6 1.3 32.3 16.8 2.7 1.3 3.4 2.0 8.3 27.6 6.2 1.5 3.1 23.2 1.6 9.8 11.6 1.7 0.8 1.2 37.8 1.2 1.6 2.2 13.9 4.2 2.9 1.7 2.2 10.9 0.0 1.3 0.0 1.7 1.7 1.8 0.0 5.9 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.5 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.5 10.1 25.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 33.6 43.8 45.3 42.6 32.3 16.8 8.3 27.6 9.8 10.9 0.0 1.1 0.0 0.1 0.0 144.6 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 1.6 387.7 1.7 2.5 1.3 0.0 10.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 13.8 0.0 7.7 12.9 0.3 0.4 2.7 0.0 0.0 0.0 0.0 0.8 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Cell type enhanced" "Detected in many" 13 "Ductal cells: 365.7;Exocrine glandular cells: 382.5;Extravillous trophoblasts: 1210.3;monocytes: 655.6;Pancreatic endocrine cells: 967.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 92.5 92.3 48.6 48.2 10.3 10.6 38.8 48.7 14.5 47.9 36.9 75.5 55.6 26.1 31.3 39.0 50.4 55.4 45.3 60.7 36.2 26.0 57.0 41.9 36.7 74.7 24.2 31.4 40.5 16.2 29.1 39.0 40.1 14.1 87.1 49.7 23.6 53.7 43.8 67.0 100.7 30.7 28.3 76.6 121.7 64.4 58.0 40.4 51.2 58.2 60.4 49.1 69.8 37.0 25.9 53.6 99.1 19.3 50.1 27.5 77.6 38.5 56.6 21.0 33.9 39.0 23.9 29.5 31.3 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 23.8 17.8 0.0 0.0 0.0 0.0 0.0 0.0 30.8 33.0 233.8 0.0 95.9 84.6 365.7 0.0 0.0 0.0 0.0 382.5 1210.3 0.0 0.0 7.0 0.0 299.4 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 655.6 0.0 0.0 967.6 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 0.0 81.0 0.0 0.0 0.0 JSRP1 "FLJ32416, JP-45" ENSG00000167476 "Junctional sarcoplasmic reticulum protein 1" Q96MG2 19 2252252-2269759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "skeletal muscle: 92.0;tongue: 33.9" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 13.1;Late spermatids: 14.7;Melanocytes: 43.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "naive B-cell: 4.8" "Lineage enriched" "Detected in single" 6 "B-cells: 4.8" "Cell line enhanced" "Detected in some" "Karpas-707: 35.8;RPMI-8226: 22.4;U-266/70: 97.8;U-266/84: 11.7" "Group enriched" "Detected in many" 6 "amygdala: 8.6;basal ganglia: 11.5;cerebral cortex: 10.1;hippocampal formation: 4.9" HPA044741 Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044741: AB_10794295" "unprognostic (9.41e-3)" "unprognostic (1.52e-2)" "unprognostic (1.39e-1)" "unprognostic (5.85e-2)" "unprognostic (2.15e-1)" "unprognostic (9.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.80e-2)" "unprognostic (2.44e-2)" "unprognostic (1.87e-2)" "unprognostic (8.64e-5)" "unprognostic (3.63e-1)" "unprognostic (4.43e-1)" "unprognostic (2.07e-1)" "unprognostic (2.71e-1)" 1.1 0.1 0.0 0.9 0.1 0.2 0.1 0.0 0.1 0.4 3.0 0.0 0.0 0.9 0.1 4.5 1.7 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.2 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.1 0.0 2.7 0.0 92.0 0.0 0.6 0.0 0.0 1.4 0.6 0.3 0.0 0.0 1.8 33.9 5.0 0.6 0.1 4.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 22.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.8 11.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.5 0.3 0.8 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 0.5 0.7 0.4 0.0 2.7 0.0 0.0 2.0 0.2 0.0 1.3 13.1 0.3 0.7 0.0 0.9 0.6 0.5 0.2 5.8 0.5 0.4 0.0 5.2 1.3 1.5 14.7 0.6 1.0 43.9 0.0 1.6 0.3 0.6 0.0 0.0 0.1 0.5 0.0 0.4 4.7 2.1 0.9 0.2 3.8 0.6 0.1 JUND AP-1 ENSG00000130522 "JunD proto-oncogene, AP-1 transcription factor subunit" P17535 19 18279760-18281622 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 204.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005268, HPA063029" Supported Supported Nucleoplasm No No Nucleoplasm "CAB005268: AB_2130177, HPA063029: AB_2684925" "prognostic favorable (6.15e-5)" "unprognostic (4.18e-3)" "unprognostic (8.89e-2)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (6.39e-2)" "unprognostic (1.63e-2)" "unprognostic (6.35e-2)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (3.35e-2)" "unprognostic (1.22e-1)" "unprognostic (3.99e-1)" "unprognostic (5.37e-2)" "unprognostic (1.49e-1)" 75.7 52.7 35.4 38.9 32.4 204.7 51.5 34.7 56.5 42.4 49.5 42.6 21.1 35.7 43.4 31.0 31.7 55.7 43.5 35.9 31.5 32.1 26.9 66.5 55.7 17.2 21.6 22.6 78.1 64.3 21.7 47.8 80.3 27.0 45.5 21.0 35.2 39.0 33.3 29.2 44.5 61.8 34.4 31.5 39.3 46.2 34.9 19.2 32.0 27.2 33.7 23.1 41.7 30.8 8.6 10.7 19.0 7.8 4.5 6.3 1.7 22.3 9.5 9.5 10.6 7.5 8.4 41.9 9.4 11.3 5.3 7.2 10.2 20.2 11.6 11.1 9.6 8.9 12.2 2.3 2.2 2.7 23.0 20.6 17.1 7.8 22.2 16.8 8.0 22.3 8.1 9.6 5.7 7.4 12.8 4.2 5.2 23.3 33.9 1.4 29.8 23.5 24.9 19.7 6.2 13.7 8.7 5.9 24.4 7.7 3.5 51.6 21.2 11.6 12.8 30.5 11.2 10.7 12.0 14.6 3.2 15.4 20.7 5.7 47.5 18.8 9.3 11.5 12.1 7.6 8.0 6.4 5.8 4.9 7.8 3.8 7.4 6.3 4.4 4.6 8.6 4.7 4.9 19.0 4.5 7.4 10.7 5.1 1.7 35.4 32.4 34.7 56.5 31.5 32.1 21.6 22.6 27.0 19.2 166.7 583.1 114.2 384.1 281.7 132.7 131.9 277.7 40.2 80.8 244.3 74.6 62.1 26.6 75.1 45.5 195.4 591.7 0.0 119.6 99.8 176.3 381.2 256.9 414.0 90.7 131.9 546.1 198.2 227.2 34.1 114.2 233.6 236.2 46.9 344.1 497.9 140.1 270.0 83.4 55.0 167.8 129.4 254.4 4.4 18.5 344.5 137.4 102.3 148.5 185.6 JUP "CTNNG, DP3, DPIII, PDGB, PKGB" ENSG00000173801 "Junction plakoglobin" P14923 17 41754604-41786931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 146.3;skin 1: 126.1;tongue: 122.8" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 335.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 81.5;OE19: 288.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002139, HPA032047" Supported Supported "Vesicles,Plasma membrane,Cell Junctions" NA NA 61000000 "Plasma membrane, Cell Junctions" Vesicles "CAB002139: AB_563468, HPA032047: AB_2674124" "unprognostic (3.96e-3)" "unprognostic (3.40e-1)" "unprognostic (2.32e-1)" "unprognostic (4.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (8.11e-3)" "unprognostic (1.41e-2)" "unprognostic (9.85e-3)" "unprognostic (2.29e-3)" "unprognostic (9.60e-2)" "prognostic favorable (2.06e-10)" "unprognostic (2.50e-1)" "unprognostic (9.49e-2)" "unprognostic (9.05e-2)" "unprognostic (1.51e-2)" 12.5 2.6 2.8 9.5 4.5 3.3 13.0 6.5 3.7 34.5 17.9 8.7 12.3 15.6 12.2 9.6 146.3 13.0 19.0 34.5 3.3 1.6 31.6 11.7 13.2 4.0 5.3 2.2 12.5 12.8 3.6 5.8 42.4 4.0 14.0 8.8 8.3 34.3 14.3 17.6 126.1 36.1 4.3 3.2 4.5 15.4 3.6 4.6 10.8 27.9 122.8 84.8 12.5 55.4 7.9 7.8 14.8 20.6 0.3 0.1 2.9 19.5 16.2 1.6 1.4 0.0 0.0 25.4 1.1 6.7 0.4 0.4 24.6 21.7 0.3 12.1 0.7 0.5 81.5 2.3 18.1 0.0 0.0 5.8 0.8 12.9 5.4 2.7 0.5 8.7 0.0 41.2 0.0 3.3 4.9 7.2 0.5 7.2 7.1 0.0 25.1 0.1 7.0 3.2 288.5 2.7 22.9 0.0 14.6 12.6 50.1 4.0 2.9 2.5 49.5 0.1 7.9 41.3 0.5 11.4 0.0 1.1 0.5 0.3 0.6 2.2 0.3 0.1 0.9 0.1 1.7 7.6 14.8 0.0 12.8 0.0 7.9 0.0 0.1 7.8 7.4 0.1 0.1 0.3 0.3 20.6 2.5 0.0 2.9 2.8 4.5 6.5 3.7 3.3 1.6 5.3 2.2 4.0 4.6 56.6 33.7 8.4 158.6 174.9 1.1 80.3 53.5 18.7 43.3 125.6 3.9 81.5 23.2 189.4 28.7 23.2 158.5 0.0 119.3 141.0 19.6 196.2 10.5 29.3 12.8 0.0 64.1 28.3 5.6 6.4 4.6 9.8 11.8 6.4 91.0 16.2 237.1 128.7 0.0 33.8 4.3 6.5 14.0 2.1 4.2 335.0 155.3 5.1 94.4 236.4 KAAG1 "RU2, RU2AS" ENSG00000146049 "Kidney associated antigen 1" Q9UBP8 6 24356903-24358284 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.1;pancreas: 4.3" "Cell type enhanced" "Detected in single" 15 "Spermatocytes: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 8.7;EFO-21: 7.0;Hep G2: 8.5" HPA036021 Approved NA NA "HPA036021: AB_10601918" "unprognostic (7.57e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (2.47e-2)" "unprognostic (5.77e-2)" "unprognostic (1.87e-1)" "unprognostic (2.26e-1)" "unprognostic (2.65e-1)" "unprognostic (3.32e-2)" "unprognostic (3.58e-2)" "unprognostic (3.05e-1)" "unprognostic (3.05e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (2.23e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.4 0.0 0.0 0.0 9.1 1.3 0.0 0.0 0.0 0.1 4.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;retina: 31.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 71.2;Early spermatids: 45.5;Ito cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.3" "Lineage enriched" "Detected in single" 5 "T-cells: 4.3" "Cell line enhanced" "Detected in many" "CACO-2: 32.4;HEL: 19.8;OE19: 11.2;SH-SY5Y: 9.3" "Low region specificity" "Detected in many" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol NA NA 110000 "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 5.5 4.3 12.7 2.4 14.1 0.6 4.2 1.8 35.2 4.0 3.8 3.7 0.5 2.7 5.6 2.3 9.6 4.2 3.1 12.1 17.6 3.9 2.6 7.3 2.9 1.1 4.1 15.8 2.3 11.9 2.5 14.4 6.8 9.4 3.1 2.1 31.2 2.2 5.4 23.5 1.5 7.2 6.4 3.6 8.0 11.5 2.2 2.4 0.0 5.3 6.7 3.1 2.9 4.1 0.1 0.0 0.9 0.0 0.1 4.3 1.2 0.3 0.6 3.6 0.7 0.5 0.1 4.7 1.4 0.9 1.4 0.6 32.4 2.5 0.1 0.4 3.6 2.2 0.2 0.8 0.0 1.1 0.0 0.3 19.8 0.3 4.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.5 1.6 0.0 4.5 0.1 0.4 2.4 0.0 0.0 2.0 11.2 3.2 1.0 1.6 0.0 0.1 0.3 1.2 9.3 0.4 0.3 0.3 3.6 0.7 0.1 8.2 4.1 1.6 0.6 0.6 0.0 0.3 0.0 0.5 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.8 0.3 0.0 0.0 2.4 0.7 0.9 0.1 0.0 0.0 4.3 1.2 12.7 14.1 1.8 35.2 17.6 3.9 4.1 15.8 9.4 2.4 3.0 3.8 0.0 1.4 1.4 71.2 33.4 17.8 8.1 0.0 15.7 5.9 7.3 1.7 4.7 45.5 26.9 30.6 0.0 7.2 0.7 4.8 2.8 3.5 17.4 0.8 0.0 9.2 50.3 2.6 34.6 3.4 0.7 3.3 0.0 12.2 5.4 3.9 20.4 31.1 2.4 2.7 19.4 14.6 1.9 1.7 1.0 11.9 0.7 10.0 1.4 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236979-62319414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.6 0.7 0.9 1.0 3.1 0.1 3.1 0.5 2.2 0.6 1.2 8.9 1.0 0.4 0.3 1.0 0.4 0.7 0.6 0.6 1.9 2.7 1.7 3.6 2.9 0.1 11.1 0.1 0.4 18.4 20.4 0.4 14.4 23.2 1.8 1.2 2.6 10.4 0.8 0.5 0.8 0.6 0.2 13.4 0.8 2.4 1.0 4.9 0.1 0.7 0.8 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 23.5 0.1 0.0 0.1 0.0 3.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 9.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.7 0.4 0.0 21.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.1 0.5 2.2 1.9 2.7 11.1 0.1 23.2 4.9 0.0 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.2 0.0 0.0 0.0 7.3 14.9 0.8 0.0 0.0 0.5 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.3 0.0 3.5 0.2 0.3 0.0 1.7 0.0 0.1 0.0 4.6 0.0 0.6 0.0 KANSL1L "C2orf67, FLJ23861, FLJ32349, KIAA1267L, MSL1v2" ENSG00000144445 "KAT8 regulatory NSL complex subunit 1 like" A0AUZ9 2 210021423-210171383 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 178.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 44.2;Spermatocytes: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043102, HPA046790" Uncertain Approved Cytosol NA NA Cytosol "HPA043102: AB_2678316, HPA046790: AB_2679808" "unprognostic (3.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-3)" "unprognostic (1.45e-2)" "unprognostic (2.55e-3)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (5.99e-3)" "unprognostic (4.65e-2)" "unprognostic (5.89e-3)" "unprognostic (5.75e-2)" "unprognostic (5.95e-3)" "unprognostic (7.44e-2)" "unprognostic (4.60e-2)" "unprognostic (3.21e-2)" "unprognostic (1.30e-3)" 8.4 5.6 8.3 6.0 12.9 3.8 8.8 12.7 10.9 10.4 6.9 7.5 11.1 4.4 11.3 9.9 5.9 8.9 8.9 7.9 8.8 5.7 12.3 5.8 9.8 4.3 12.1 5.5 16.2 10.0 178.9 14.4 5.3 9.5 14.3 4.7 6.2 7.6 9.9 8.8 7.7 4.9 9.8 13.0 4.5 7.2 12.4 13.6 21.6 14.2 4.4 3.8 11.1 33.0 2.1 2.1 2.7 2.2 3.1 1.7 0.5 2.4 1.3 12.7 5.4 10.3 7.8 3.7 3.6 4.6 2.3 6.5 2.5 9.5 6.7 4.9 2.3 5.7 3.5 2.9 1.2 3.7 2.9 2.4 5.5 4.9 4.3 6.4 6.4 4.0 4.9 5.6 2.3 1.7 10.2 5.2 6.2 4.1 6.2 3.5 2.3 7.1 16.5 7.7 4.2 1.8 5.2 3.6 5.2 14.0 3.7 8.0 7.6 3.3 2.2 2.6 13.3 2.2 13.7 4.5 5.1 4.1 1.7 2.7 4.4 1.9 6.6 6.2 3.2 6.1 1.1 1.4 2.7 1.2 2.2 1.1 0.9 1.0 1.4 2.1 2.1 1.7 1.7 2.4 3.1 0.9 1.4 0.8 0.5 8.3 12.9 12.7 10.9 8.8 5.7 12.1 5.5 9.5 13.6 26.8 15.3 2.0 7.6 6.5 9.3 7.6 7.6 44.2 7.9 29.6 13.7 1.3 3.3 8.2 20.3 7.8 1.8 0.0 4.8 0.8 9.3 6.6 10.4 5.5 2.3 4.8 5.8 5.5 2.6 17.2 13.6 6.0 6.8 1.8 2.8 9.7 7.7 2.5 28.3 10.2 8.9 12.9 9.2 38.9 6.4 9.7 1.6 3.2 2.4 3.0 KANTR "LINC01155, Spasm" ENSG00000232593 "KDM5C adjacent transcript" X 53094145-53170914 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.9" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 12.8;Club cells: 6.8;Collecting duct cells: 5.2;Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 5.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.89e-1)" "unprognostic (1.66e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (5.52e-2)" "unprognostic (2.18e-2)" "unprognostic (7.30e-2)" "unprognostic (4.79e-2)" "unprognostic (2.30e-3)" "unprognostic (2.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.46e-2)" "unprognostic (3.47e-6)" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-3)" "unprognostic (1.81e-3)" 1.5 2.4 4.9 1.5 5.9 5.7 2.2 11.9 11.7 2.3 1.6 3.0 2.5 1.5 2.6 2.9 1.5 2.0 1.6 1.5 3.4 1.6 1.5 1.7 1.5 3.9 4.5 2.4 1.4 2.0 6.8 2.2 4.0 2.1 1.7 2.1 2.0 2.6 1.5 2.0 1.5 2.1 2.8 1.6 1.5 2.4 4.4 1.1 1.8 0.0 1.5 1.6 2.5 0.6 0.6 1.6 0.8 0.0 0.4 0.0 0.6 0.1 0.7 0.6 0.7 0.7 0.6 0.0 0.1 1.1 0.7 0.1 0.3 0.6 0.4 0.2 1.2 0.4 1.2 0.3 1.7 0.1 0.1 0.2 0.1 0.2 1.2 1.2 0.8 0.9 0.4 2.2 1.0 0.6 0.8 5.0 1.0 0.9 0.1 0.3 1.0 1.3 1.0 0.1 0.8 0.5 0.6 0.3 0.2 1.1 2.4 1.1 0.5 0.2 0.1 2.0 0.4 0.1 0.5 0.5 1.5 2.0 0.2 0.7 0.7 1.0 0.0 0.9 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.8 0.6 0.0 0.0 0.0 12.8 1.3 0.2 0.0 0.9 0.5 0.0 4.0 6.8 5.2 9.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.3 1.1 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.3 1.0 0.0 0.0 1.6 2.6 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 KATNAL2 "DKFZP667C165, MGC33211" ENSG00000167216 "Katanin catalytic subunit A1 like 2" Q8IYT4 18 46917492-47102243 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 30.3;testis: 33.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 46.8;Early spermatids: 59.9;Late spermatids: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040712, HPA042029" Approved Approved "Nucleoplasm,Intermediate filaments" No No "Nucleoplasm, Intermediate filaments" "HPA040712: AB_2677092, HPA042029: AB_2677807" "unprognostic (3.40e-1)" "unprognostic (7.75e-2)" "unprognostic (9.00e-3)" "unprognostic (9.28e-2)" "unprognostic (1.74e-2)" "unprognostic (6.55e-3)" "unprognostic (6.97e-2)" "unprognostic (1.28e-2)" "unprognostic (3.90e-2)" "unprognostic (5.36e-2)" "unprognostic (9.52e-6)" "unprognostic (1.28e-1)" "prognostic favorable (1.24e-7)" "unprognostic (1.64e-1)" "unprognostic (7.14e-4)" "unprognostic (1.06e-3)" "unprognostic (1.61e-1)" 5.5 2.9 8.2 4.1 9.7 2.8 7.1 4.0 7.5 2.5 2.4 11.3 2.5 1.8 2.8 7.1 2.7 8.6 5.1 4.3 8.1 7.6 9.5 5.2 4.6 3.4 9.6 6.2 3.1 3.3 30.3 7.0 2.2 9.0 3.4 3.1 6.4 3.4 3.7 6.0 8.0 1.5 2.3 8.7 3.3 2.0 33.2 6.3 2.4 15.5 1.1 3.0 2.3 2.5 3.1 0.6 2.7 1.3 0.8 1.5 0.3 1.9 4.3 2.4 15.0 4.9 5.9 1.1 1.8 1.6 1.5 1.9 0.2 5.1 19.8 1.5 2.8 1.9 0.6 4.7 0.5 1.1 2.0 2.5 0.8 1.3 0.3 2.0 1.2 1.9 12.2 1.8 2.5 0.6 3.4 0.5 9.1 0.7 1.6 8.5 1.9 1.2 2.6 5.4 2.5 2.7 5.5 1.1 0.0 4.7 0.4 5.4 6.0 1.9 0.4 0.6 8.8 11.4 11.0 1.0 5.0 0.5 2.0 1.2 1.3 1.0 13.3 2.7 12.5 9.6 1.7 0.7 0.5 1.1 1.3 0.9 2.2 0.9 0.5 0.3 3.1 1.5 1.4 2.7 0.8 0.9 0.6 0.2 0.3 8.2 9.7 4.0 7.5 8.1 7.6 9.6 6.2 9.0 6.3 0.0 1.4 0.0 2.6 1.3 10.4 2.2 0.0 46.8 6.8 3.5 5.9 0.0 11.6 0.4 59.9 1.4 0.8 0.0 0.2 0.0 1.5 1.2 0.0 3.9 2.8 11.1 0.0 3.1 1.0 47.0 1.4 0.6 3.3 1.0 0.3 2.4 0.2 0.0 2.1 5.2 2.1 0.0 0.8 11.2 4.3 1.0 0.1 0.0 1.5 1.4 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 75.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 46.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" Yes No "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: AB_2684796" "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavorable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 13.2 7.9 16.2 14.0 22.6 9.1 22.7 16.7 26.0 11.7 12.2 10.7 10.5 9.6 13.5 12.5 28.8 10.9 10.2 9.0 11.2 9.0 9.1 10.9 20.2 10.7 13.8 10.3 10.9 14.3 8.7 10.4 75.0 15.0 11.9 13.6 8.9 10.5 9.0 7.4 19.7 9.4 16.1 17.8 12.0 11.0 11.0 12.8 7.5 8.3 8.6 12.3 10.2 19.1 9.1 10.2 46.0 6.8 4.3 8.9 4.5 17.7 15.6 24.9 16.6 20.2 20.2 18.5 24.2 14.7 19.4 19.4 8.8 9.9 8.7 15.9 15.7 27.4 23.5 12.1 13.9 23.0 17.8 6.5 15.3 16.5 10.4 14.0 16.0 16.7 12.0 20.5 13.1 26.0 20.2 34.7 22.4 16.3 18.3 26.4 8.7 10.0 13.2 18.2 22.9 12.4 15.5 15.1 8.1 17.9 24.0 14.1 12.6 14.8 10.9 7.1 25.8 13.5 19.2 19.9 26.4 13.6 23.4 19.1 11.4 15.3 17.9 23.7 17.5 19.6 16.5 6.8 10.3 7.0 6.3 8.9 8.5 7.7 7.2 7.4 9.1 8.6 7.6 46.0 4.3 4.0 10.2 6.3 4.5 16.2 22.6 16.7 26.0 11.2 9.0 13.8 10.3 15.0 12.8 35.7 25.1 24.1 50.0 36.7 53.1 11.8 28.1 44.2 34.2 24.4 49.1 52.9 28.2 51.7 63.2 41.9 19.0 0.0 47.3 69.4 32.9 72.1 42.8 18.4 34.4 63.5 23.0 32.5 28.5 42.2 29.4 37.7 30.4 56.9 30.5 52.5 80.0 38.6 31.1 34.2 40.0 58.2 43.0 37.0 44.8 47.4 150.1 31.6 35.9 104.3 KAZALD1 "FKSG28, FKSG40" ENSG00000107821 "Kazal type serine peptidase inhibitor domain 1" Q96I82 10 101061841-101068131 "Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.6;prostate: 24.0;retina: 22.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 34.5;Erythroid cells: 23.3;Mucus-secreting cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 13 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 22.7;T-47d: 29.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011800 Uncertain "Secreted to extracellular matrix" NA NA "HPA011800: AB_1852082" "unprognostic (3.34e-1)" "unprognostic (8.86e-3)" "unprognostic (1.16e-2)" "unprognostic (4.43e-3)" "unprognostic (4.88e-2)" "unprognostic (1.35e-2)" "unprognostic (6.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.39e-2)" "unprognostic (1.70e-2)" "unprognostic (1.35e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-1)" "unprognostic (3.44e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (2.11e-1)" 2.6 0.6 0.8 3.2 0.5 0.1 2.6 0.3 1.0 10.3 2.3 0.4 2.9 3.3 5.2 10.6 1.6 2.0 3.0 7.7 1.0 0.4 1.9 0.4 2.4 2.8 0.6 0.3 1.9 1.1 1.6 3.6 1.1 1.5 24.0 2.0 22.5 8.3 3.0 4.8 1.7 3.7 5.6 0.5 20.6 8.7 1.8 0.3 0.6 2.5 5.7 2.3 3.0 3.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.2 1.8 22.7 1.9 6.9 1.7 4.2 4.8 1.1 1.0 4.9 1.8 0.2 2.4 4.2 0.4 0.4 1.5 0.0 0.2 2.7 0.8 0.4 5.0 4.8 0.4 0.3 2.1 0.9 0.3 0.1 0.8 0.3 0.1 0.8 0.6 2.5 0.7 3.8 0.1 1.5 0.5 5.8 9.2 9.7 8.5 0.3 0.5 1.2 0.3 1.0 0.5 0.7 1.3 0.5 29.0 0.6 0.1 0.6 1.9 0.3 1.1 0.8 2.1 2.0 1.1 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.3 1.0 1.0 0.4 0.6 0.3 1.5 0.3 0.0 1.0 0.0 0.8 1.8 1.2 0.8 2.5 0.0 0.0 0.0 2.0 0.3 1.7 0.6 0.0 3.6 34.5 23.3 1.8 0.5 12.7 7.7 0.0 0.0 0.8 0.0 2.4 2.5 3.7 0.0 9.2 0.3 1.7 0.0 45.7 0.8 1.3 10.4 0.4 0.3 1.6 0.0 3.9 3.5 1.1 2.5 0.5 0.0 6.3 0.3 KAZN "FLJ43806, KAZRIN, KIAA1026" ENSG00000189337 "Kazrin, periplakin interacting protein" Q674X7 1 13892792-15118043 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 64.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 72.8;Suprabasal keratinocytes: 79.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "neutrophil: 6.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 6.9" "Cell line enhanced" "Detected in many" "AN3-CA: 40.6;SK-BR-3: 22.0" "HPA032095, HPA032096" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA032095: AB_2674146, HPA032096: AB_10670826" "unprognostic (2.81e-1)" "unprognostic (5.82e-2)" "unprognostic (1.12e-1)" "unprognostic (2.42e-3)" "unprognostic (5.34e-2)" "unprognostic (2.15e-3)" "unprognostic (6.57e-3)" "unprognostic (7.88e-3)" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (1.10e-1)" "unprognostic (5.55e-2)" "prognostic favorable (1.20e-6)" "unprognostic (3.61e-2)" "unprognostic (7.93e-2)" "unprognostic (3.21e-1)" "unprognostic (1.06e-2)" 8.0 11.0 13.4 3.0 17.4 1.2 7.6 41.1 21.9 8.0 3.8 27.5 5.7 4.6 3.1 11.1 18.8 11.0 7.0 4.1 12.4 12.4 13.2 5.2 8.5 1.5 25.1 12.1 10.4 8.0 22.9 2.7 11.0 15.0 4.1 4.0 10.5 16.8 7.2 1.7 14.2 4.9 3.7 25.0 64.9 4.9 4.1 18.9 0.0 6.6 7.0 6.3 7.9 9.4 0.3 0.0 6.9 0.0 0.0 0.0 0.0 8.0 1.4 8.8 40.6 3.8 4.0 3.0 3.8 3.2 7.2 5.2 1.8 4.3 0.0 10.1 8.2 1.3 2.9 2.0 6.3 3.6 0.2 3.9 4.6 4.8 12.0 2.8 0.0 2.4 5.6 8.5 1.6 1.1 3.2 0.0 1.1 1.8 9.4 5.7 5.9 0.0 0.4 2.4 3.6 1.2 2.7 0.2 4.9 12.1 2.5 4.7 3.4 0.7 22.0 15.1 5.3 1.3 3.1 0.0 6.0 5.6 9.4 4.6 1.6 1.3 0.0 5.6 8.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 13.4 17.4 41.1 21.4 12.4 12.4 25.1 12.1 15.0 18.9 3.0 2.6 0.9 12.5 44.8 9.3 3.0 5.1 12.0 6.8 47.1 7.9 1.1 14.9 1.8 4.5 8.1 3.0 0.0 1.4 5.8 10.8 8.1 3.5 0.0 0.7 0.0 6.8 40.5 1.2 5.8 17.5 2.1 43.9 0.0 3.7 72.8 1.4 0.0 16.3 11.4 2.4 6.5 21.7 0.1 4.0 79.0 38.8 2.9 2.8 24.0 KBTBD11 "KIAA0711, KLHDC7C" ENSG00000176595 "Kelch repeat and BTB domain containing 11" O94819 8 1973878-2006936 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 33.4;Enterocytes: 28.4;Rod photoreceptor cells: 29.5" "Cancer enhanced" "Detected in many" "renal cancer: 14.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.6" "Group enriched" "Detected in many" 4 "granulocytes: 4.6;monocytes: 1.4" "Cell line enhanced" "Detected in some" "HDLM-2: 10.4;NB-4: 7.5;SCLC-21H: 9.1;THP-1: 14.7;U-937: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051159 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA051159: AB_2681367" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (1.20e-3)" "unprognostic (2.70e-2)" "unprognostic (2.03e-1)" "unprognostic (6.84e-2)" "unprognostic (2.76e-4)" "unprognostic (2.50e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.75e-2)" "unprognostic (9.53e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-2)" 3.2 6.8 17.6 2.6 17.7 8.7 1.8 16.3 22.4 4.5 8.2 10.9 0.0 10.9 1.6 1.7 1.7 3.8 3.8 2.1 16.1 10.8 13.9 6.7 2.3 3.1 13.2 16.7 1.9 3.2 5.1 2.0 0.8 11.4 5.0 6.6 3.1 2.1 2.9 1.8 1.0 12.7 1.7 12.4 6.4 1.9 1.6 9.3 4.7 2.4 0.0 2.0 1.4 0.7 0.0 0.4 4.6 1.4 0.0 0.6 0.4 1.5 1.0 4.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.9 0.4 0.1 0.4 0.1 0.0 2.1 0.0 0.0 10.4 1.2 0.0 0.0 0.0 1.0 4.5 0.2 0.2 0.0 0.0 0.0 0.7 0.0 4.0 0.0 0.0 2.1 0.8 4.6 7.5 1.0 1.6 0.0 1.3 0.0 0.0 2.2 0.3 9.1 4.6 0.0 0.0 0.1 0.4 0.1 14.7 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.1 20.9 0.8 0.7 1.4 4.6 0.0 0.6 0.2 0.0 0.2 0.1 0.4 0.0 0.6 0.3 0.9 0.0 0.3 0.0 0.5 0.4 17.6 17.7 16.3 21.9 16.1 10.8 13.2 16.7 11.4 9.3 0.0 7.2 0.5 0.4 0.9 21.8 4.5 10.2 2.7 0.0 12.2 33.4 0.0 21.6 1.6 0.6 4.1 28.4 0.0 3.3 0.1 1.1 2.7 0.0 10.6 3.3 19.1 5.8 4.9 9.5 0.0 4.6 2.1 1.7 3.6 13.6 6.4 7.4 10.1 9.9 22.4 29.5 0.0 1.0 0.4 3.6 0.6 0.2 0.0 14.9 0.7 KBTBD12 "FLJ46299, KLHDC6" ENSG00000187715 "Kelch repeat and BTB domain containing 12" Q3ZCT8 3 127915232-127987671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 13.1;skeletal muscle: 44.5;tongue: 16.6" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 8.5;Early spermatids: 25.7;Exocrine glandular cells: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 3.1;neutrophil: 1.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 1.8;RT4: 2.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 14.9" NA NA "unprognostic (3.60e-2)" "unprognostic (2.19e-2)" "unprognostic (3.37e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (3.01e-1)" "unprognostic (3.35e-2)" "unprognostic (4.69e-3)" "unprognostic (3.62e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-2)" "unprognostic (1.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (5.70e-2)" "unprognostic (9.49e-2)" 0.6 0.5 2.1 1.2 2.7 0.6 0.5 2.6 2.6 0.4 1.5 0.8 1.0 1.1 0.7 1.3 1.4 1.2 1.1 13.1 2.2 0.7 1.1 0.4 0.5 0.5 0.7 2.2 0.5 3.7 0.4 0.5 0.5 1.6 0.8 1.5 1.4 1.7 0.8 44.5 0.7 1.0 1.0 0.5 0.4 1.9 0.9 1.2 0.0 0.4 16.6 0.7 1.0 0.4 0.3 0.4 3.1 0.3 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.4 0.4 0.3 0.1 0.6 0.2 0.1 0.2 0.0 0.1 0.1 1.8 2.4 0.5 0.2 0.2 0.1 0.0 0.2 0.3 0.1 0.6 0.3 0.2 0.5 0.1 0.4 0.4 0.0 0.2 0.1 0.3 3.1 0.3 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.2 1.5 0.2 0.1 0.4 0.0 0.0 2.1 2.7 2.6 2.6 2.2 0.7 0.7 2.2 1.6 1.2 3.0 3.0 0.0 0.0 0.1 1.7 8.5 0.0 1.4 2.3 1.8 5.9 0.0 1.7 0.2 25.7 0.0 1.1 0.0 8.0 0.0 0.2 0.0 0.0 0.0 0.1 1.6 2.4 0.0 0.0 1.3 0.0 0.7 0.0 0.0 5.3 1.0 3.6 5.8 0.0 0.0 0.6 0.0 0.3 5.4 7.2 0.3 0.0 0.0 2.3 0.0 KBTBD13 "hCG_1645727, NEM6" ENSG00000234438 "Kelch repeat and BTB domain containing 13" C9JR72 15 65076816-65078192 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 4.6;skeletal muscle: 19.2;tongue: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HMC-1: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA062737 Uncertain NA NA "HPA062737: AB_2684856" "unprognostic (1.18e-1)" "unprognostic (7.88e-2)" "unprognostic (6.07e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.3 0.2 0.3 0.7 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 1.1 0.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 9.4 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KBTBD8 "KIAA1842, TA-KRP" ENSG00000163376 "Kelch repeat and BTB domain containing 8" Q8NFY9 3 66998307-67011210 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.7" "Cell type enhanced" "Detected in many" 8 "B-cells: 15.9;Cardiomyocytes: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 31.8;Karpas-707: 14.9;U-698: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041285, HPA069190" Approved NA NA "HPA041285: AB_10796341, HPA069190: AB_2686101" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.70e-4)" "unprognostic (1.99e-2)" "unprognostic (6.63e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-2)" "unprognostic (5.94e-3)" "unprognostic (1.93e-1)" "unprognostic (8.14e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (7.43e-2)" "unprognostic (2.96e-1)" "unprognostic (1.54e-1)" 1.6 1.4 3.4 7.3 10.3 12.5 1.2 5.1 4.7 0.9 2.5 1.0 0.0 1.9 0.9 0.3 2.3 1.0 2.0 4.4 3.6 2.5 1.2 2.2 2.9 19.8 2.5 0.6 0.8 2.0 0.4 3.5 3.7 3.6 2.6 2.2 0.5 1.9 0.5 3.5 1.1 7.0 5.9 2.8 9.9 2.2 7.9 3.0 5.4 1.4 0.4 20.7 4.1 2.1 8.9 3.2 0.5 3.8 1.5 3.0 1.6 0.6 0.7 1.3 1.5 0.9 0.5 2.8 1.6 0.6 1.2 0.9 2.9 0.3 31.8 0.4 0.4 0.7 0.8 7.5 1.7 1.9 5.3 2.4 11.6 0.3 1.5 1.2 7.4 12.6 1.0 0.8 2.4 2.1 0.4 0.8 6.4 2.8 14.9 0.8 1.2 5.9 1.2 5.5 1.2 0.5 3.4 1.3 4.3 0.3 1.0 4.6 1.6 0.6 0.5 1.2 1.7 0.3 2.1 2.5 4.1 0.9 8.8 3.0 8.7 13.4 22.1 1.1 6.0 1.3 0.0 1.5 0.5 1.5 3.8 0.9 8.9 1.8 1.6 3.2 8.8 1.8 1.2 0.0 1.5 3.2 0.4 3.0 1.6 3.4 10.3 5.1 4.7 3.6 2.5 2.5 0.6 3.6 3.0 0.0 2.6 15.9 0.4 4.6 1.3 9.2 0.0 0.0 1.2 0.0 2.0 3.3 0.0 0.5 0.7 0.6 1.5 0.0 0.8 1.0 1.0 0.4 4.6 0.4 3.4 3.2 1.2 1.8 0.3 0.4 0.0 6.5 0.0 1.0 0.7 1.6 0.8 0.8 0.4 0.4 0.3 0.0 2.1 7.2 4.8 4.8 2.1 4.1 1.1 0.5 KCNA1 "AEMK, HUK1, Kv1.1, MBK1, RBK1" ENSG00000111262 "Potassium voltage-gated channel subfamily A member 1" Q09470 12 4909893-4918256 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.1" "Group enriched" "Detected in some" 6 "Bipolar cells: 10.8;Ciliated cells: 6.7" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "LHCN-M2: 2.4;NTERA-2: 2.1;SCLC-21H: 3.9;U-2 OS: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074471 Approved NA NA "HPA074471: " "unprognostic (6.39e-3)" "unprognostic (2.64e-1)" "unprognostic (1.09e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-2)" "unprognostic (4.69e-3)" "unprognostic (2.48e-1)" "unprognostic (8.77e-5)" "unprognostic (6.30e-2)" "unprognostic (1.08e-4)" 0.8 0.7 1.5 0.7 13.7 0.7 1.3 23.8 21.1 1.6 0.9 0.9 0.0 0.9 1.0 0.7 0.7 0.7 0.9 0.7 4.6 1.1 0.7 0.7 0.8 0.7 2.2 3.5 0.7 0.7 4.0 0.6 0.7 24.1 0.7 0.9 0.0 1.9 0.8 0.7 0.8 0.8 1.1 1.1 0.7 1.0 0.7 1.4 0.2 2.0 0.0 0.7 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 23.8 21.1 4.6 1.1 2.2 3.5 24.1 1.4 0.0 0.0 0.0 0.0 0.3 10.8 1.4 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA2 "HK4, Kv1.2" ENSG00000177301 "Potassium voltage-gated channel subfamily A member 2" P16389 1 110519837-110631474 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 28.0" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 24.2" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 8 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "Karpas-707: 10.9;SCLC-21H: 2.8;U-2 OS: 2.4;U-266/70: 3.6;U-266/84: 5.4;WM-115: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001976 Enhanced NA NA "CAB001976: " "unprognostic (1.84e-2)" "unprognostic (9.70e-3)" "unprognostic (1.97e-1)" "unprognostic (2.98e-1)" "unprognostic (7.17e-3)" "unprognostic (6.68e-3)" "unprognostic (5.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (4.50e-3)" "unprognostic (3.08e-3)" "unprognostic (2.93e-4)" "unprognostic (2.15e-1)" "unprognostic (3.55e-1)" "unprognostic (6.41e-2)" "unprognostic (2.83e-1)" 3.2 1.4 7.1 2.2 13.1 0.8 1.2 17.2 28.0 1.2 1.6 3.1 0.0 1.4 1.0 1.3 1.7 1.1 1.6 1.6 7.2 6.1 0.9 0.9 1.0 1.9 7.2 14.5 1.1 1.9 0.8 1.4 0.7 21.1 1.8 2.0 1.4 1.8 2.4 2.1 1.6 1.6 1.6 2.8 1.3 1.3 2.5 3.8 0.3 5.3 0.0 3.5 1.4 0.5 0.5 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 2.8 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 2.4 0.0 0.0 3.6 5.4 0.2 0.1 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.3 0.5 1.8 1.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 4.1 0.1 7.1 13.1 17.2 26.3 7.2 6.1 7.2 14.5 21.1 3.8 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 4.9 0.0 2.9 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 KCNA3 "HLK3, HPCN3, Kv1.3, MK3" ENSG00000177272 "Potassium voltage-gated channel subfamily A member 3" P22001 1 110672465-110675033 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 59.4" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 3.4;Melanocytes: 3.3;Sertoli cells: 6.5;T-cells: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 3.3;T-cells: 11.5" "Cell line enhanced" "Detected in some" "HDLM-2: 12.7;Karpas-707: 26.1;U-266/70: 18.9;U-266/84: 16.9" "Low region specificity" "Detected in all" HPA016625 Approved NA NA "HPA016625: AB_2669407" "unprognostic (2.17e-2)" "unprognostic (5.07e-3)" "unprognostic (3.92e-3)" "unprognostic (1.20e-2)" "unprognostic (2.35e-1)" "unprognostic (1.76e-5)" "unprognostic (1.70e-4)" "unprognostic (8.48e-2)" "unprognostic (1.49e-2)" "unprognostic (5.92e-4)" "unprognostic (1.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" 1.9 1.3 4.0 7.8 5.7 5.6 1.3 5.0 5.6 1.7 3.1 0.5 0.0 3.2 1.1 0.4 1.1 1.3 2.3 1.4 3.5 4.3 1.5 1.3 7.8 14.5 1.5 3.1 1.3 0.9 0.4 1.8 0.9 3.1 1.1 2.6 0.5 3.7 0.3 0.5 0.8 5.9 0.7 1.9 7.7 5.3 1.4 1.5 59.4 2.1 0.3 10.9 5.8 1.3 3.3 1.0 0.0 0.7 0.9 11.5 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 26.1 0.0 0.0 5.4 0.0 0.5 0.0 0.0 0.0 0.0 5.2 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.0 0.0 18.9 16.9 6.5 0.0 1.5 0.0 0.0 0.7 0.0 7.2 0.0 8.2 2.3 10.8 11.5 1.0 3.3 8.5 6.4 0.0 0.9 0.1 0.5 9.5 2.9 4.0 5.7 5.0 5.6 3.5 4.3 1.5 3.1 3.1 1.5 0.0 3.4 2.2 0.0 0.3 1.3 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.6 0.0 0.0 1.6 3.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 6.5 0.0 0.9 0.2 0.5 0.0 8.7 0.0 0.0 KCNA4 "HK1, HPCN2, KCNA4L, Kv1.4" ENSG00000182255 "Potassium voltage-gated channel subfamily A member 4" P22459 11 30009741-30017023 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cataract, Disease mutation, Dystonia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 16.5;brain: 39.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 9.6;Horizontal cells: 12.7;Muller glia cells: 6.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.6;WM-115: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001977, HPA016422" Approved NA NA "CAB001977: , HPA016422: AB_1855574" "unprognostic (1.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" "unprognostic (6.71e-2)" "unprognostic (1.17e-1)" 2.2 16.5 9.8 0.6 39.0 0.6 0.6 0.2 12.2 0.6 0.6 0.8 1.8 0.7 1.1 0.9 0.6 0.8 0.6 5.9 6.1 2.7 1.2 0.6 2.4 0.6 1.6 6.2 0.6 0.6 0.6 2.8 1.2 10.5 0.6 0.6 0.0 0.6 1.7 0.6 0.8 0.6 0.8 0.6 0.6 1.0 0.7 5.9 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 39.0 0.2 12.2 6.1 2.7 1.6 6.2 10.5 5.9 0.0 0.0 0.0 0.0 0.0 9.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA5 "HK2, HPCN1, Kv1.5" ENSG00000130037 "Potassium voltage-gated channel subfamily A member 5" P22460 12 5043989-5046788 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 33.0" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 153.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 134 "plasmacytoid DC: 13.3" "Lineage enriched" "Detected in single" 134 "dendritic cells: 13.3" "Cell line enriched" "Detected in single" 12 "NTERA-2: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021516, CAB022562" Approved NA NA "CAB022562: , HPA021516: AB_2670732" "unprognostic (3.87e-1)" "unprognostic (9.91e-3)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (2.64e-1)" "unprognostic (7.06e-3)" "unprognostic (1.20e-1)" "unprognostic (4.61e-3)" "unprognostic (1.34e-1)" "unprognostic (2.14e-1)" "unprognostic (2.37e-2)" "unprognostic (5.08e-3)" "unprognostic (6.73e-4)" "unprognostic (1.92e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (3.08e-2)" 3.4 1.4 1.9 0.9 8.6 0.7 1.2 0.4 2.3 1.6 3.3 7.2 0.0 1.1 1.7 2.6 7.6 2.1 2.3 33.0 3.5 5.8 1.9 0.8 2.3 0.9 2.3 2.2 3.2 2.4 0.6 7.5 3.4 8.8 3.7 1.3 7.2 0.9 2.0 5.3 0.6 1.1 3.0 3.9 1.2 3.3 0.8 4.9 0.0 1.1 3.4 1.2 4.5 3.4 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 1.9 8.6 0.4 2.3 3.5 5.8 2.3 2.2 8.8 4.9 0.0 0.0 0.0 0.0 0.8 153.4 8.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.0 3.4 12.9 19.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 KCNA6 "HBK2, Kv1.6, PPP1R96" ENSG00000151079 "Potassium voltage-gated channel subfamily A member 6" P17658 12 4809176-4813412 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.4;JURKAT: 4.5;TIME: 1.0;U-698: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 0.7 0.8 3.8 2.7 4.7 0.8 2.0 0.7 9.6 1.0 0.7 6.8 0.0 2.2 0.8 0.6 0.8 0.8 0.6 0.7 5.8 0.7 0.8 0.9 0.9 2.1 3.9 7.2 0.9 0.8 0.6 2.0 0.7 4.3 0.8 0.6 0.0 0.8 0.6 1.2 0.7 0.8 0.7 1.7 1.5 0.8 2.0 8.4 0.0 0.8 0.0 0.6 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 2.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 4.7 0.7 9.6 5.8 0.7 3.9 7.2 4.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA7 "HAK6, Kv1.7" ENSG00000104848 "Potassium voltage-gated channel subfamily A member 7" Q96RP8 19 49067418-49072941 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 40.6" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 25.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 4.0;U-251 MG: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "unprognostic (1.68e-1)" "unprognostic (4.31e-2)" "unprognostic (3.17e-2)" "unprognostic (6.97e-2)" "unprognostic (2.94e-2)" "unprognostic (1.26e-1)" "unprognostic (2.21e-8)" "unprognostic (1.70e-1)" "unprognostic (2.62e-1)" "unprognostic (5.80e-2)" "unprognostic (5.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 40.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.6 0.3 0.0 0.0 1.1 0.9 3.3 0.8 0.9 0.8 0.2 0.7 0.3 0.4 2.0 0.0 0.2 0.7 0.4 0.0 0.1 0.0 0.5 0.9 0.4 0.2 0.2 0.7 1.3 0.1 0.2 0.0 0.4 0.6 0.2 1.5 0.4 0.2 0.6 4.0 0.1 0.3 0.1 0.1 0.4 0.0 0.4 0.5 1.1 0.1 0.5 0.3 0.7 0.5 0.3 0.3 0.4 0.2 0.5 0.2 0.5 0.4 0.4 1.5 0.3 0.1 0.6 0.5 1.1 0.7 1.4 0.5 0.9 4.0 0.7 0.3 0.3 0.6 0.4 0.5 3.3 0.8 0.7 0.8 0.4 0.5 0.5 0.7 0.7 0.2 1.1 0.7 0.8 2.6 0.9 0.7 0.9 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 25.9 0.0 1.2 0.3 0.4 3.1 0.0 1.4 5.7 0.0 5.9 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.1 0.4 0.5 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 1.6 0.0 0.1 0.1 0.7 0.3 0.9 0.0 0.0 0.3 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.1;thyroid gland: 25.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 54.8;Cone photoreceptor cells: 29.5;Sertoli cells: 77.6;Smooth muscle cells: 66.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 5.9;hTEC/SVTERT24-B: 9.2" "Region enhanced" "Detected in many" "basal ganglia: 300.5" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 12.6 5.9 7.5 1.1 41.1 1.4 3.5 10.7 16.4 5.7 2.9 4.6 2.5 1.6 3.4 11.9 2.1 2.7 2.7 4.8 12.3 4.3 1.8 2.3 3.1 0.9 3.7 10.3 2.8 3.7 1.8 1.2 1.3 3.0 21.1 1.8 7.2 3.4 17.9 1.7 1.3 1.9 2.6 2.6 4.3 1.3 2.7 12.3 0.0 25.7 1.0 0.5 2.0 3.0 1.0 4.3 2.4 1.2 0.9 2.7 0.4 0.9 0.8 1.3 0.3 0.1 0.0 2.5 2.2 0.0 0.0 0.2 1.7 0.2 0.6 1.2 0.0 0.5 0.6 0.0 0.0 0.0 0.7 1.7 5.9 1.1 2.7 0.0 1.7 0.5 0.0 0.0 9.2 0.0 2.1 3.7 0.9 0.2 0.5 0.4 0.2 0.5 1.0 1.9 2.6 0.5 0.9 1.3 4.7 0.0 0.4 1.4 1.4 0.5 1.1 1.2 0.9 1.5 0.9 3.8 1.5 0.9 2.5 2.0 3.2 0.7 0.7 4.5 1.9 1.7 2.4 0.6 0.2 1.5 0.7 2.7 0.9 1.4 1.3 0.9 1.0 1.2 1.3 0.1 0.9 1.2 4.3 1.7 0.4 7.5 41.1 10.7 16.4 12.3 4.3 3.7 10.3 3.0 12.3 0.0 0.0 0.5 0.1 0.7 54.8 4.1 0.0 0.0 1.2 0.0 29.5 0.1 0.0 0.4 11.9 1.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 3.6 0.0 0.0 1.3 9.3 4.7 0.0 1.1 1.7 0.0 0.0 1.6 0.0 0.0 2.5 0.0 6.1 77.6 66.2 0.1 0.9 0.6 0.1 0.0 0.0 0.1 KCNAB2 "AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B" ENSG00000069424 "Potassium voltage-gated channel subfamily A regulatory beta subunit 2" Q13303 1 5991466-6101193 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 57.5;brain: 54.3" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 58.5;Kupffer cells: 65.2;Macrophages: 36.4;Melanocytes: 60.8" "Cancer enriched" "Detected in all" 7 "melanoma: 29.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 67.4;JURKAT: 36.3;U-937: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001975 Enhanced NA NA "CAB001975: " "unprognostic (6.60e-2)" "unprognostic (2.33e-2)" "unprognostic (3.97e-3)" "unprognostic (2.30e-2)" "unprognostic (1.76e-2)" "unprognostic (8.18e-3)" "unprognostic (4.30e-2)" "unprognostic (1.05e-1)" "unprognostic (4.85e-2)" "unprognostic (1.58e-2)" "unprognostic (7.71e-3)" "unprognostic (8.83e-3)" "prognostic unfavorable (3.50e-5)" "unprognostic (2.88e-2)" "unprognostic (3.10e-2)" "unprognostic (2.35e-1)" "unprognostic (5.24e-2)" 6.9 4.8 37.8 21.5 34.7 57.5 2.7 13.5 54.3 2.7 4.2 4.2 0.5 3.7 3.4 2.1 4.1 6.2 8.1 8.1 44.6 13.1 10.9 3.8 13.9 31.2 16.1 24.7 3.2 2.2 1.3 6.1 4.5 28.7 2.7 4.1 10.8 3.1 2.5 4.0 9.0 7.4 5.0 5.8 21.9 5.3 3.1 4.7 13.9 2.4 0.5 17.0 9.0 1.7 6.8 19.6 11.4 21.1 9.2 19.8 22.8 2.5 7.0 0.6 0.8 0.3 1.2 2.4 1.3 8.5 1.4 1.7 2.5 1.2 14.9 4.3 0.9 1.3 0.9 0.5 0.1 0.8 17.4 2.4 18.3 7.1 4.2 1.3 67.4 0.5 1.3 0.3 0.9 1.7 1.2 1.1 36.3 0.5 28.4 0.7 2.2 12.9 29.0 0.4 1.1 3.1 2.6 2.1 17.6 0.2 0.0 4.3 1.5 1.0 1.2 22.2 0.6 1.0 26.0 0.2 0.3 2.5 2.6 1.5 21.5 25.1 21.2 2.6 71.8 0.5 2.1 21.1 11.4 19.8 17.6 18.7 6.0 13.0 19.1 19.6 6.8 13.8 14.5 9.0 9.2 15.4 8.1 13.6 22.8 37.8 34.7 13.5 54.3 44.6 13.1 16.1 24.7 28.7 4.7 0.0 10.0 20.6 1.6 4.2 16.5 12.6 7.6 9.4 2.3 1.8 5.9 0.5 0.0 0.3 4.5 3.4 0.0 0.0 1.2 1.7 3.5 0.3 8.1 0.8 58.5 6.4 0.0 4.3 65.2 3.1 3.4 36.4 60.8 5.4 0.2 4.3 0.5 0.0 2.5 35.2 11.0 0.0 3.1 3.8 3.2 2.5 0.7 34.8 0.0 0.8 KCNAB3 "AKR6A9, KCNA3B" ENSG00000170049 "Potassium voltage-gated channel subfamily A regulatory beta subunit 3" O43448 17 7921859-7929803 "Predicted intracellular proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 36.1;endometrium 1: 17.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 123.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "cerebellum: 36.1;cerebral cortex: 31.6" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 14.9;SH-SY5Y: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077993 Approved Mitochondria NA NA Mitochondria "HPA077993: AB_2686872" "unprognostic (3.02e-2)" "unprognostic (5.59e-2)" "unprognostic (6.95e-2)" "unprognostic (2.62e-2)" "unprognostic (6.13e-2)" "unprognostic (5.84e-4)" "unprognostic (2.19e-1)" "unprognostic (5.72e-2)" "unprognostic (8.50e-2)" "unprognostic (8.55e-2)" "unprognostic (3.27e-4)" "unprognostic (7.47e-3)" "unprognostic (3.03e-6)" "unprognostic (2.12e-1)" "unprognostic (5.00e-2)" "unprognostic (4.97e-2)" "unprognostic (9.54e-3)" 1.4 0.7 4.2 2.7 5.2 5.5 1.2 36.1 31.6 1.8 1.4 0.8 0.0 1.3 17.2 2.2 0.8 3.5 2.1 0.7 4.7 2.9 1.7 1.1 1.5 3.8 2.4 6.3 2.1 1.0 0.8 4.9 1.6 5.9 2.3 2.0 3.8 1.3 1.4 1.0 3.3 1.9 11.4 5.2 2.6 2.2 1.7 1.9 0.8 1.6 0.0 3.3 1.0 1.0 0.1 1.7 0.5 0.2 0.0 0.7 0.1 1.3 1.1 5.5 1.4 0.6 1.4 2.0 4.9 3.1 4.2 4.8 0.7 0.3 2.2 0.3 0.8 0.2 0.4 1.5 0.7 6.0 1.8 2.3 0.7 0.9 0.0 5.1 0.2 3.0 2.2 1.6 4.6 0.2 0.2 0.3 6.1 0.5 0.3 0.7 1.0 0.8 2.6 0.8 0.0 0.7 14.9 1.5 0.6 0.5 1.7 0.3 8.1 0.4 0.0 0.9 0.2 1.4 0.1 0.3 0.7 2.8 1.1 0.4 1.1 1.2 1.2 2.1 3.0 1.0 0.0 0.2 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.5 0.1 0.2 0.2 0.5 0.0 0.0 1.7 0.0 0.1 4.2 5.2 36.1 31.6 4.7 2.9 2.4 6.3 5.9 1.9 3.0 2.4 0.0 0.6 0.5 22.9 0.8 0.0 0.0 1.2 0.0 3.9 0.2 0.0 0.5 0.3 0.1 0.4 0.0 0.5 0.2 1.1 0.6 1.1 0.2 0.7 123.9 0.0 0.6 0.0 0.0 1.7 0.8 0.0 1.8 0.3 12.0 0.5 0.0 0.7 0.0 6.3 0.0 0.3 3.1 1.5 0.4 0.1 0.0 0.2 0.1 KCNB1 Kv2.1 ENSG00000158445 "Potassium voltage-gated channel subfamily B member 1" Q14721 20 49293394-49484297 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Exocytosis, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;retina: 22.4" "Group enriched" "Detected in some" 7 "Bipolar cells: 119.5;Cone photoreceptor cells: 200.3;Rod photoreceptor cells: 366.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.6;CACO-2: 5.1;hTCEpi: 3.2;U-2 OS: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001979, HPA042434" Enhanced NA NA "CAB001979: , HPA042434: AB_2677996" "unprognostic (4.51e-1)" "unprognostic (1.72e-1)" "unprognostic (6.54e-3)" "unprognostic (4.87e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (8.09e-2)" "unprognostic (6.22e-2)" "unprognostic (5.31e-1)" "unprognostic (8.32e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (9.35e-2)" "unprognostic (5.25e-4)" 16.9 3.6 11.4 1.3 14.6 0.8 2.4 8.1 25.9 2.3 5.1 1.8 0.7 1.2 6.8 2.3 3.9 9.0 1.9 1.9 6.6 5.3 1.3 3.5 1.2 0.8 3.3 12.5 1.2 1.2 0.9 2.5 1.0 2.5 4.8 1.9 22.4 1.7 6.5 6.2 1.1 1.8 9.6 1.2 1.2 3.9 1.5 2.4 0.0 1.0 0.1 0.8 4.0 0.9 0.4 0.3 1.2 0.2 0.3 0.7 0.0 0.0 0.1 0.8 0.0 3.6 0.3 0.1 0.0 0.4 0.4 0.0 5.1 0.0 0.0 0.0 0.1 1.3 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 2.6 0.0 0.6 3.2 0.0 0.1 0.2 0.0 0.0 0.0 1.9 1.2 0.3 0.0 2.4 0.1 0.0 0.9 0.0 1.0 0.0 0.0 0.0 2.3 1.9 1.6 2.3 0.0 0.0 1.7 0.0 0.0 2.2 4.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.7 0.2 1.2 0.3 0.1 0.3 0.1 0.0 11.4 14.6 8.1 25.9 6.6 5.3 3.3 12.5 2.5 2.4 0.0 2.1 0.0 0.1 0.7 119.5 1.2 2.5 5.3 1.2 0.0 200.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 3.5 4.7 0.1 17.5 0.0 0.0 0.0 0.4 4.0 0.1 0.0 0.0 0.0 26.9 0.1 0.0 32.5 0.0 366.4 0.0 3.4 0.2 0.3 0.3 0.1 0.0 0.0 0.0 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Cell type enriched" "Detected in some" 15 "Cone photoreceptor cells: 249.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" Yes NA "Plasma membrane" "Nucleoli, Midbody" "HPA065970: AB_2685591" "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 0.0 0.0 0.0 0.0 0.0 12.9 0.2 0.0 0.0 0.0 1.8 249.4 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 17.1 0.0 0.0 5.0 1.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.4 0.0 2.4 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 36.6" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.1 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 0.9 1.1 1.8 0.0 0.3 0.3 2.1 0.6 3.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 1.4 0.0 0.5 0.5 1.2 1.5 0.0 0.0 0.8 7.5 0.9 0.0 0.4 7.1 4.4 0.4 0.5 0.0 0.4 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 1.0 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 0.0 0.0 0.0 0.0 0.0 36.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.5 0.0 0.0 8.4 0.3 0.0 0.0 1.0 0.0 1.5 0.2 0.0 0.0 0.1 7.4 0.0 0.4 5.4 4.5 0.0 0.0 0.0 0.0 0.0 KCNC2 Kv3.2 ENSG00000166006 "Potassium voltage-gated channel subfamily C member 2" Q96PR1 12 75040077-75209868 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 39.3" "Group enriched" "Detected in some" 12 "Basal glandular cells: 1.9;Bipolar cells: 5.0;Glandular cells: 1.6;Muller glia cells: 1.9;Rod photoreceptor cells: 5.9" "Group enriched" "Detected in some" 8 "breast cancer: 1.5;prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019664, CAB022571" Uncertain NA NA "CAB022571: , HPA019664: AB_1855578" "unprognostic (2.01e-1)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "unprognostic (5.58e-3)" "unprognostic (4.46e-2)" "unprognostic (3.39e-2)" 0.7 0.7 8.7 0.7 12.9 0.7 3.3 0.4 39.3 0.7 0.8 1.9 0.0 0.7 0.9 0.9 0.7 0.7 0.7 0.7 7.4 10.4 0.7 0.9 0.7 0.7 4.7 13.5 0.7 0.7 0.7 6.0 0.7 19.1 4.4 0.8 1.3 1.1 0.7 0.7 0.7 0.8 0.7 1.0 0.7 0.7 1.0 0.6 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 12.9 0.4 27.3 7.4 10.4 4.7 13.5 19.1 0.6 0.0 0.0 0.0 1.9 0.0 5.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNC3 "Kv3.3, SCA13" ENSG00000131398 "Potassium voltage-gated channel subfamily C member 3" Q14003 19 50311937-50333515 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 9.8;Collecting duct cells: 19.2;Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 8.9;CAPAN-2: 7.8;HDLM-2: 8.0;HMC-1: 21.4;K-562: 7.9;SK-BR-3: 14.5;T-47d: 13.8;U-2 OS: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018041 Approved NA NA "HPA018041: AB_1855579" "unprognostic (8.05e-2)" "unprognostic (2.34e-2)" "unprognostic (3.01e-4)" "unprognostic (4.41e-2)" "unprognostic (3.84e-2)" "unprognostic (1.91e-2)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (3.94e-3)" "unprognostic (2.10e-5)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.68e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-2)" "unprognostic (1.19e-1)" 1.4 2.2 7.2 5.4 9.4 1.4 2.3 32.1 31.2 3.1 1.1 3.4 3.0 1.8 4.5 5.8 1.1 12.8 1.4 1.7 6.9 4.2 10.6 2.5 4.5 4.7 4.0 6.6 0.6 3.7 31.1 9.7 2.4 15.6 2.4 1.4 3.0 2.3 15.1 1.2 2.1 1.8 1.7 3.8 6.5 2.1 2.4 2.9 1.1 23.9 0.0 3.4 1.8 1.0 0.4 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 8.9 7.8 0.7 1.0 0.0 0.5 1.2 0.2 0.0 0.0 8.0 1.8 0.0 0.0 1.7 0.0 0.0 21.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 7.9 0.0 0.0 2.8 0.1 0.0 1.1 0.9 3.3 0.0 0.1 0.0 0.5 0.2 0.0 1.4 1.7 14.5 0.0 0.2 13.8 2.2 0.2 0.0 9.5 0.0 0.0 0.1 0.1 0.5 0.3 1.8 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 7.2 9.4 32.1 31.2 6.9 4.2 4.0 6.6 15.6 2.9 0.0 0.3 0.0 0.8 0.7 9.8 2.6 0.0 1.4 1.2 19.2 7.9 1.9 0.0 1.2 0.3 0.0 0.0 0.0 1.2 0.7 0.2 1.1 0.0 1.5 2.8 1.6 4.1 0.6 5.3 0.0 0.6 2.3 0.0 2.8 0.0 0.7 0.2 0.0 0.0 2.3 6.3 0.0 1.0 0.9 1.1 0.5 1.9 0.0 0.0 0.9 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 8 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Supported Uncertain Nucleoplasm Yes No Nucleoplasm "HPA000524: AB_2666013, HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favorable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 1.9 0.8 4.7 6.4 5.1 1.6 1.0 4.0 2.8 1.9 1.2 0.6 1.6 3.4 3.1 0.8 0.6 0.8 0.4 2.7 2.6 3.1 1.4 1.9 0.1 2.4 0.4 2.9 13.2 1.8 5.2 0.6 4.7 0.9 2.2 1.1 3.6 2.0 3.5 0.4 10.5 2.5 0.3 0.7 1.3 0.9 1.5 3.1 1.5 0.5 2.1 0.9 0.0 2.1 10.2 2.0 1.5 2.4 0.6 2.6 0.6 0.2 2.9 3.8 3.8 1.7 3.7 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 0.0 1.4 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 3.4 0.6 0.8 0.0 1.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 3.5 0.0 2.8 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.1 KCND2 "KIAA1044, Kv4.2, RK5" ENSG00000184408 "Potassium voltage-gated channel subfamily D member 2" Q9NZV8 7 120273668-120750331 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 41.1" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 2.9;Cholangiocytes: 5.1;Ductal cells: 2.5;Leydig cells: 3.4;Spermatocytes: 4.2;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HSkMC: 4.1;NTERA-2: 3.2;RT4: 3.3;SCLC-21H: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029068 Enhanced NA NA "HPA029068: AB_10601436" "unprognostic (4.22e-1)" "unprognostic (2.79e-4)" "unprognostic (3.79e-2)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-3)" "unprognostic (9.07e-3)" "unprognostic (1.03e-1)" "unprognostic (1.14e-1)" "unprognostic (9.77e-3)" "unprognostic (1.51e-1)" "unprognostic (4.51e-4)" "unprognostic (4.07e-5)" "unprognostic (2.71e-2)" "unprognostic (2.92e-2)" "unprognostic (1.83e-3)" 2.9 1.0 3.9 1.0 6.7 0.3 1.9 41.1 20.6 2.4 0.7 1.5 0.0 0.7 5.6 0.5 0.5 1.7 7.0 0.5 3.7 5.4 0.3 0.4 0.6 0.5 4.2 3.6 5.9 0.6 2.5 6.6 0.8 12.1 0.5 0.6 0.0 0.7 1.7 0.5 0.3 0.5 3.7 3.7 0.3 0.5 2.9 4.5 0.0 0.8 1.1 0.3 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 3.3 16.6 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.7 41.1 5.3 3.7 5.4 4.2 3.6 12.1 4.5 0.0 0.0 0.0 0.0 0.0 2.9 1.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.3 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.0 0.4 4.2 3.3 0.1 0.0 0.0 0.0 0.1 KCND3 "KSHIVB, Kv4.3, SCA19, SCA22" ENSG00000171385 "Potassium voltage-gated channel subfamily D member 3" Q9UK17 1 111770662-111989155 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 38.5;Cardiomyocytes: 34.4;Early spermatids: 29.0;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "OE19: 6.6;SCLC-21H: 15.9;U-2 OS: 2.4;WM-115: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029452 Approved NA NA "HPA029452: AB_10602239" "unprognostic (1.11e-2)" "unprognostic (1.73e-3)" "unprognostic (1.71e-1)" "unprognostic (2.60e-2)" "unprognostic (1.37e-1)" "unprognostic (2.42e-1)" "unprognostic (1.41e-1)" "unprognostic (9.48e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-2)" "unprognostic (1.40e-1)" "unprognostic (7.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-3)" "unprognostic (6.64e-3)" 3.3 0.8 6.8 3.1 6.9 0.0 2.1 25.9 11.9 1.3 2.5 1.3 1.3 0.3 4.1 9.6 3.2 3.4 4.2 5.5 5.6 5.6 1.3 11.6 1.3 1.3 8.9 5.7 1.3 2.2 4.1 1.5 1.3 1.6 9.2 1.6 1.9 1.3 10.0 2.8 5.1 1.3 7.7 1.3 2.0 1.7 1.3 1.3 1.3 1.3 2.3 1.3 3.7 1.3 0.5 0.4 1.2 0.3 0.9 0.3 0.7 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.8 0.1 0.0 1.6 0.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.3 6.6 0.0 0.0 0.1 0.0 0.0 0.3 15.9 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.5 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.4 0.5 0.3 0.2 1.2 0.9 0.3 0.3 0.1 0.7 6.8 6.9 25.9 9.3 5.6 5.6 8.9 5.7 1.6 1.3 0.0 9.4 0.0 10.7 6.6 38.5 34.4 0.0 0.0 1.2 0.0 3.9 0.1 0.0 0.7 29.0 1.8 0.0 0.0 21.1 0.1 1.4 14.3 0.0 23.7 0.2 28.6 0.0 1.8 0.6 20.3 16.7 0.0 3.3 0.0 0.2 6.1 4.4 0.3 1.8 0.2 4.2 0.0 3.1 1.1 0.7 5.8 0.0 0.0 0.0 12.3 KCNE1 "ISK, JLNS2, LQT5, minK" ENSG00000180509 "Potassium voltage-gated channel subfamily E regulatory subunit 1" P15382 21 34446688-34512275 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 17.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 32.1;Cone photoreceptor cells: 23.6;Kupffer cells: 26.3;Macrophages: 15.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "pons and medulla: 10.6" "Cell type enhanced" "Detected in some" "eosinophil: 6.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.8" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 3.0;CACO-2: 9.2;HBF TERT88: 2.3" NA NA "unprognostic (8.24e-3)" "unprognostic (9.14e-3)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.01e-3)" "unprognostic (2.98e-2)" "unprognostic (2.45e-2)" "unprognostic (1.47e-2)" "unprognostic (2.58e-1)" "unprognostic (2.06e-1)" "unprognostic (9.30e-2)" "unprognostic (7.90e-3)" "unprognostic (1.41e-2)" "unprognostic (3.27e-2)" "unprognostic (2.34e-2)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" 9.3 0.4 0.7 1.3 0.9 1.6 4.8 0.1 0.5 1.8 3.2 2.7 0.0 0.4 0.8 4.0 0.7 17.6 0.4 9.2 1.3 0.8 3.4 4.3 12.0 10.6 1.7 0.0 2.9 0.2 1.0 1.3 3.5 10.6 1.0 0.4 0.5 0.8 0.3 0.2 0.4 0.6 0.7 0.5 7.3 0.5 4.8 0.3 0.2 0.7 0.1 0.3 1.6 14.8 0.0 0.5 6.8 1.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.5 1.1 3.0 1.0 9.2 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.3 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.1 0.1 1.3 6.8 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.0 0.0 1.5 0.0 0.0 0.4 0.7 0.9 0.1 0.5 1.3 0.8 1.7 0.0 10.6 0.3 3.0 2.6 0.0 0.6 0.7 1.4 3.1 0.0 32.1 1.2 0.0 23.6 0.0 0.0 0.6 3.1 1.8 0.0 0.0 0.3 0.3 0.6 0.3 0.0 3.4 3.7 0.0 0.0 1.8 26.3 1.8 0.3 15.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.6 0.9 0.0 0.3 0.0 0.0 0.0 0.8 KCNE1B ENSG00000276289 "Potassium voltage-gated channel subfamily E regulatory subunit 1B" A0A087WTH5 21 7816675-7829926 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8" "Cell type enriched" "Detected in single" 5 "Ciliated cells: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.0;eosinophil: 4.0" "Group enriched" "Detected in many" 17 "granulocytes: 4.0;monocytes: 1.6" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;SK-MEL-30: 2.4;SuSa: 3.9" NA NA "unprognostic (5.41e-4)" "unprognostic (8.78e-2)" "unprognostic (7.14e-3)" "unprognostic (1.35e-1)" "unprognostic (3.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.08e-1)" "unprognostic (7.47e-2)" "unprognostic (3.24e-1)" "unprognostic (1.73e-3)" "unprognostic (6.59e-2)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 8.3 3.8 0.4 1.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.0 1.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.7 0.5 5.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 3.0 1.6 4.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNE2 "LQT6, MiRP1" ENSG00000159197 "Potassium voltage-gated channel subfamily E regulatory subunit 2" Q9Y6J6 21 34364024-34371389 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "stomach 1: 66.8" "Group enriched" "Detected in some" 51 "Early spermatids: 28.5;Late spermatids: 11.6" "Cancer enriched" "Detected in some" 6 "stomach cancer: 2.9" "Region enhanced" "Detected in single" "pons and medulla: 3.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 4.2;SCLC-21H: 5.0" "Region enhanced" "Detected in many" "pons and medulla: 30.5" "Not detected" "Not detected" "HPA029706, HPA051553" Enhanced NA NA "HPA029706: AB_2673159, HPA051553: AB_2681532" "unprognostic (5.29e-4)" "unprognostic (3.13e-1)" "unprognostic (6.69e-2)" "unprognostic (2.65e-5)" "unprognostic (7.45e-2)" "unprognostic (7.33e-3)" "unprognostic (5.77e-3)" "unprognostic (6.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.33e-2)" "unprognostic (9.30e-2)" "unprognostic (3.41e-2)" "unprognostic (2.19e-3)" "unprognostic (1.48e-1)" "unprognostic (3.97e-2)" "unprognostic (2.02e-1)" "unprognostic (8.81e-2)" 0.1 0.0 0.2 1.2 0.2 0.0 0.1 0.1 0.9 0.1 0.2 1.3 0.1 2.4 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.1 11.8 0.0 0.1 0.1 3.4 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 1.2 0.1 0.1 66.8 0.8 0.1 0.1 0.3 0.1 0.1 0.1 0.1 1.4 1.6 2.2 1.6 0.0 2.0 0.7 0.8 0.3 2.0 3.7 0.2 0.2 2.7 0.9 0.5 0.0 0.1 0.8 1.0 0.8 1.3 0.0 0.6 0.0 0.2 0.0 1.0 1.0 1.2 0.9 0.2 0.0 0.0 0.7 0.5 0.2 0.1 0.0 0.0 0.8 0.0 2.6 0.2 4.2 0.3 1.6 0.2 0.7 2.8 2.7 1.6 0.7 0.6 1.0 0.4 0.2 5.0 0.4 1.4 0.6 1.3 2.6 1.3 1.0 0.0 1.2 0.6 0.5 0.3 4.1 2.3 0.7 0.4 2.1 1.1 0.0 1.6 2.2 0.6 0.1 0.6 0.8 1.1 0.5 1.6 1.4 2.0 0.3 0.0 0.0 0.0 0.8 1.4 0.7 0.2 0.2 0.1 0.9 0.1 0.3 0.2 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 KCNE3 "HOKPP, MiRP2" ENSG00000175538 "Potassium voltage-gated channel subfamily E regulatory subunit 3" Q9Y6H6 11 74454841-74467729 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 63.7" "Cell type enhanced" "Detected in many" 14 "granulocytes: 33.4;Hofbauer cells: 34.3;Kupffer cells: 101.9;Undifferentiated cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 47 "basophil: 16.8;classical monocyte: 16.2;eosinophil: 9.3;intermediate monocyte: 17.4;myeloid DC: 7.6;neutrophil: 22.4;non-classical monocyte: 14.0" "Group enriched" "Detected in many" 122 "dendritic cells: 7.6;granulocytes: 22.4;monocytes: 17.4" "Cell line enhanced" "Detected in some" "HEL: 24.5;NB-4: 15.4;OE19: 55.0;THP-1: 11.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA014849 Approved NA NA "HPA014849: AB_1852112" "unprognostic (1.61e-2)" "unprognostic (2.94e-1)" "unprognostic (1.11e-1)" "unprognostic (8.69e-2)" "unprognostic (3.58e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (4.67e-3)" "unprognostic (4.89e-4)" "unprognostic (4.12e-3)" "unprognostic (2.56e-2)" "unprognostic (2.97e-2)" "unprognostic (1.45e-3)" "unprognostic (7.86e-2)" "unprognostic (1.33e-2)" "unprognostic (1.73e-1)" "unprognostic (2.00e-1)" 10.8 2.2 2.7 8.5 4.6 3.1 5.8 1.2 3.0 6.4 18.2 3.2 4.9 31.4 6.7 4.7 3.5 6.0 63.7 3.8 2.7 1.9 9.3 2.5 15.9 11.3 5.0 1.3 10.5 10.1 1.9 3.3 5.4 3.4 7.6 22.2 7.4 11.7 5.5 1.1 0.7 22.2 4.9 7.7 15.1 26.3 1.7 3.2 1.3 15.1 1.4 3.3 5.2 5.7 0.1 7.6 22.4 17.4 0.0 0.1 4.8 0.0 0.0 0.0 0.0 3.1 0.8 2.6 0.0 0.0 0.3 0.3 8.1 0.7 0.1 7.7 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 24.5 0.1 1.6 1.1 0.2 4.4 2.7 0.0 0.2 0.0 0.1 0.1 0.0 0.6 0.1 0.3 0.0 0.0 15.4 0.3 55.0 0.0 2.7 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 11.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 4.6 0.0 16.8 16.2 9.3 0.0 17.4 0.1 0.0 0.0 0.0 7.6 0.1 0.0 0.0 22.4 0.0 14.0 0.3 0.0 4.8 2.7 4.6 1.2 3.0 2.7 1.9 5.0 1.3 3.4 3.2 0.0 5.0 3.4 0.4 0.2 0.0 0.6 10.2 5.3 5.7 1.8 0.0 0.3 3.3 0.2 0.1 0.6 8.0 0.0 6.5 5.9 4.1 0.7 33.4 1.7 34.3 0.0 2.4 6.2 101.9 0.0 3.4 18.0 0.0 0.0 22.2 21.6 3.7 7.0 2.5 17.4 0.9 0.0 0.3 0.0 0.4 0.1 1.7 0.0 33.9 0.6 KCNE4 MiRP3 ENSG00000152049 "Potassium voltage-gated channel subfamily E regulatory subunit 4" Q8WWG9 2 223051814-223198399 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 27.0" "Group enriched" "Detected in many" 5 "Sertoli cells: 116.4;Smooth muscle cells: 171.0" "Cancer enhanced" "Detected in all" "breast cancer: 20.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "AN3-CA: 61.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011420 Approved Approved "Nuclear bodies,Microtubules" NA NA Microtubules "Nuclear bodies" "HPA011420: AB_1079170" "unprognostic (1.23e-1)" "unprognostic (2.02e-3)" "prognostic unfavorable (9.42e-5)" "unprognostic (2.17e-2)" "unprognostic (7.56e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.70e-3)" "unprognostic (1.20e-1)" "unprognostic (6.24e-3)" "unprognostic (9.08e-3)" 9.0 2.4 5.5 7.5 5.7 0.2 6.6 2.6 11.9 4.5 3.3 1.2 1.4 0.8 21.9 4.4 3.7 3.4 14.8 3.5 6.5 2.5 2.4 3.6 2.1 3.3 9.4 0.7 9.2 6.4 0.7 5.3 4.6 8.7 3.7 1.4 11.6 2.3 4.2 2.1 2.1 2.3 27.0 21.5 4.7 4.9 2.2 8.4 0.0 5.2 1.7 0.6 7.7 12.5 0.7 0.3 2.3 0.3 0.4 0.3 0.0 0.0 0.3 0.0 61.0 14.0 1.4 0.0 1.4 1.4 0.3 0.7 0.0 0.0 0.0 0.0 0.9 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 2.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 2.4 0.0 4.5 0.2 0.0 0.0 0.0 1.4 0.0 1.1 2.3 0.3 0.2 0.3 0.1 0.3 0.2 0.3 0.2 0.0 0.7 0.3 0.3 0.9 0.4 0.2 0.3 0.1 0.0 5.5 5.7 2.6 11.9 6.5 2.5 9.4 0.7 8.7 8.4 0.0 2.1 0.0 0.2 3.4 0.0 1.2 0.0 6.7 2.3 0.0 0.0 0.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.2 12.9 0.6 3.5 0.0 0.1 3.2 4.6 6.2 0.0 0.0 19.5 2.2 30.4 0.0 0.0 4.8 0.6 0.0 15.9 0.0 0.2 116.4 171.0 0.0 0.2 2.8 0.2 0.0 0.0 1.1 KCNE5 KCNE1L ENSG00000176076 "Potassium voltage-gated channel subfamily E regulatory subunit 5" Q9UJ90 X 109623700-109625172 "Disease related genes, Predicted membrane proteins" "Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5" "Cell type enriched" "Detected in some" 5 "monocytes: 16.2" "Group enriched" "Detected in some" 8 "glioma: 7.9;testis cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 5.6" "Group enriched" "Detected in many" 4 "dendritic cells: 5.6;monocytes: 1.7" "Cell line enhanced" "Detected in some" "HMC-1: 4.2;hTEC/SVTERT24-B: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042316 Uncertain Cytosol NA NA Cytosol "HPA042316: AB_10795397" "unprognostic (5.33e-2)" "unprognostic (2.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (1.59e-2)" "unprognostic (1.01e-1)" "unprognostic (2.14e-3)" "unprognostic (3.27e-2)" "unprognostic (9.46e-2)" "unprognostic (1.05e-1)" "unprognostic (4.62e-3)" "unprognostic (7.83e-2)" "unprognostic (5.64e-6)" "unprognostic (5.10e-2)" "unprognostic (9.06e-2)" "unprognostic (1.36e-1)" "unprognostic (5.37e-3)" 4.8 1.1 6.4 1.3 11.3 6.8 1.2 6.0 6.6 1.0 0.6 8.2 0.0 0.7 0.8 1.3 1.2 0.5 2.4 2.2 8.9 8.1 0.7 0.7 0.8 0.8 14.3 1.6 1.7 0.4 0.4 0.2 2.5 29.5 1.9 0.5 0.1 0.6 2.3 3.2 1.1 0.8 0.9 7.3 1.4 0.6 1.2 0.3 8.5 0.6 2.6 0.8 0.8 0.2 0.0 5.6 0.0 1.7 0.1 0.8 0.3 1.0 0.0 0.2 0.4 0.1 0.1 0.1 1.9 0.5 0.7 0.7 0.1 0.4 0.4 0.0 0.4 0.8 0.8 0.0 2.2 0.9 0.2 0.4 2.7 2.6 1.8 0.1 0.0 4.2 0.6 1.5 5.5 1.3 0.5 0.4 0.4 0.0 0.1 0.5 0.0 0.8 3.4 0.0 0.0 0.1 0.2 0.1 0.1 0.8 0.1 0.2 0.4 1.3 0.0 1.1 1.5 0.0 2.5 1.2 1.8 1.0 1.0 2.4 0.5 0.6 0.3 1.2 1.2 0.5 0.0 0.7 0.0 0.8 1.7 0.0 0.0 0.1 0.1 5.6 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.3 6.4 11.3 6.0 6.5 8.9 8.1 14.3 1.6 29.5 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 1.1 0.0 0.6 0.0 0.0 1.3 3.0 0.0 1.1 0.2 0.0 16.2 0.0 2.9 0.2 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911937-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 36.9" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.9;MCF7: 6.0;T-47d: 7.3" "Group enriched" "Detected in many" 4 "amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1" "Low region specificity" "Detected in all" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.9 0.9 11.5 1.0 25.5 0.8 1.2 0.8 36.9 0.9 1.2 2.4 0.0 1.2 1.9 0.8 1.6 1.1 1.0 1.1 13.1 4.7 1.1 0.9 1.0 1.0 3.1 10.5 0.9 2.2 0.8 0.2 0.9 3.6 1.0 1.2 0.0 0.8 1.4 0.8 0.8 1.1 1.0 1.0 1.5 1.1 1.0 3.1 0.5 0.8 0.0 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 16.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 2.6 0.1 1.8 0.0 0.1 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.2 7.3 0.8 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 11.5 25.5 0.8 28.5 13.1 4.7 3.1 10.5 3.6 3.1 0.0 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 KCNG1 "K13, KCNG, kH2, Kv6.1" ENSG00000026559 "Potassium voltage-gated channel modifier subfamily G member 1" Q9UIX4 20 51003656-51023129 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 25.8;endometrium 1: 48.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 45.1;Syncytiotrophoblasts: 81.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "naive B-cell: 10.8" "Lineage enriched" "Detected in single" 87 "B-cells: 10.8" "Cell line enhanced" "Detected in many" "hTCEpi: 26.7;U-138 MG: 20.3;WM-115: 17.0" "Group enriched" "Detected in many" 5 "amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7" "Group enriched" "Detected in all" 4 "amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1" "HPA039530, HPA040024" Approved Approved Vesicles NA NA Vesicles "HPA039530: AB_10795144, HPA040024: AB_10796338" "unprognostic (1.19e-1)" "unprognostic (4.47e-2)" "unprognostic (8.70e-2)" "unprognostic (3.49e-2)" "unprognostic (4.07e-2)" "unprognostic (5.05e-4)" "unprognostic (2.53e-2)" "unprognostic (3.89e-3)" "unprognostic (3.64e-2)" "unprognostic (3.43e-2)" "unprognostic (8.74e-2)" "unprognostic (8.89e-2)" "unprognostic (1.83e-9)" "unprognostic (1.52e-1)" "unprognostic (7.42e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-2)" 0.5 4.5 13.3 2.9 7.0 0.3 0.7 2.3 11.9 9.6 2.4 1.6 25.8 0.6 48.3 2.8 3.7 11.9 1.9 1.0 7.9 2.9 0.5 0.4 0.5 3.0 2.0 9.5 0.9 3.7 1.3 0.8 9.3 6.7 5.6 1.3 0.7 1.4 18.3 0.3 0.5 7.2 5.8 1.0 3.5 0.8 5.4 2.6 0.0 0.5 0.0 1.4 2.8 3.4 10.8 0.0 0.0 0.1 0.0 0.0 0.1 0.4 1.7 1.3 6.5 0.7 1.7 0.1 5.7 0.0 3.4 2.6 0.1 0.1 0.0 3.5 1.7 9.4 1.6 0.8 1.7 3.4 0.2 2.2 0.0 6.3 0.0 11.9 0.0 0.2 3.4 26.7 12.8 13.1 0.6 0.9 0.0 0.1 0.0 0.3 6.3 0.0 0.1 6.8 0.0 11.8 0.0 0.0 0.0 0.0 2.0 2.0 7.4 12.4 14.5 9.3 2.2 1.0 0.9 0.3 20.3 12.0 0.1 1.6 0.0 0.0 0.0 6.0 0.4 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.3 7.0 2.3 11.9 7.9 2.9 2.0 9.5 6.7 2.6 3.0 1.4 1.5 9.3 1.0 0.3 0.8 0.0 1.4 1.2 0.0 0.0 45.1 0.0 2.9 14.5 0.3 3.5 0.0 0.0 2.4 1.0 5.6 0.0 0.0 2.9 1.6 0.0 0.0 0.0 14.4 1.4 0.0 0.0 0.0 0.2 0.2 0.3 3.5 3.9 0.0 0.1 0.0 1.0 1.2 0.9 0.3 81.1 0.0 0.3 7.9 KCNG2 "KCNF2, Kv6.2" ENSG00000178342 "Potassium voltage-gated channel modifier subfamily G member 2" Q9UJ96 18 79863668-79900184 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 5.3" "Cell type enriched" "Detected in some" 16 "Horizontal cells: 108.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 4 "hippocampal formation: 31.7" HPA048628 Enhanced NA NA "HPA048628: AB_2680466" "unprognostic (1.07e-2)" "unprognostic (1.34e-2)" "unprognostic (8.39e-2)" "unprognostic (4.41e-1)" "unprognostic (1.99e-1)" "unprognostic (9.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (2.40e-1)" "unprognostic (3.78e-1)" "unprognostic (3.61e-3)" "unprognostic (1.09e-1)" "unprognostic (3.18e-5)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "unprognostic (4.08e-2)" "unprognostic (3.63e-2)" 0.2 0.1 1.5 0.8 2.2 0.6 0.0 0.1 2.4 0.0 0.3 1.1 0.3 0.0 0.1 0.0 0.0 0.0 5.3 1.0 0.9 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.2 0.3 0.3 1.2 0.0 0.0 0.5 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.7 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 108.1 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.3 2.1 0.0 5.3 0.0 0.0 0.0 KCNG3 Kv6.3 ENSG00000171126 "Potassium voltage-gated channel modifier subfamily G member 3" Q8TAE7 2 42442017-42494097 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.4" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 3.0;Intestinal endocrine cells: 1.7;Leydig cells: 1.7;Muller glia cells: 2.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 6 "amygdala: 9.0;basal ganglia: 11.4;cerebral cortex: 7.1;hippocampal formation: 4.4;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 5.1;HMC-1: 17.7;NTERA-2: 11.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "amygdala: 3.9;basal ganglia: 4.7;cerebral cortex: 5.3;hippocampal formation: 6.6;midbrain: 3.0" HPA041625 Approved "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA041625: " "unprognostic (1.56e-1)" "unprognostic (4.22e-3)" "unprognostic (2.48e-1)" "unprognostic (7.67e-3)" "unprognostic (7.95e-2)" "unprognostic (9.14e-3)" "unprognostic (4.83e-3)" "unprognostic (6.59e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (2.56e-1)" "unprognostic (2.17e-1)" "unprognostic (1.67e-2)" "unprognostic (2.76e-1)" "unprognostic (6.47e-2)" "unprognostic (1.23e-1)" 0.4 5.2 9.0 2.5 11.4 0.3 0.5 0.2 7.1 0.8 2.3 0.1 1.6 0.4 1.6 0.7 0.4 0.5 0.7 0.3 4.4 0.9 1.2 0.3 1.2 0.4 1.2 3.6 0.9 2.9 0.3 1.8 0.3 0.5 1.2 1.3 0.6 0.3 1.7 0.3 0.6 0.5 0.6 0.3 0.4 0.3 3.3 1.1 4.9 0.3 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 5.1 0.0 0.0 0.0 2.7 0.0 0.5 0.9 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.9 0.0 11.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.1 1.7 0.5 1.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 11.4 0.2 7.1 4.4 0.9 1.2 3.6 0.5 1.1 3.0 0.6 0.0 0.2 1.1 1.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 2.1 0.2 0.0 2.5 0.0 0.0 0.0 0.4 0.2 1.0 1.0 0.1 0.0 0.0 0.1 KCNG4 Kv6.4 ENSG00000168418 "Potassium voltage-gated channel modifier subfamily G member 4" Q8TDN1 16 84218667-84239750 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 8.8" "Cell type enriched" "Detected in some" 18 "Bipolar cells: 29.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2" "Region enhanced" "Detected in many" "cerebellum: 101.5" "Low region specificity" "Detected in many" NA NA "unprognostic (3.54e-1)" "unprognostic (6.67e-2)" 0.7 2.8 2.6 0.2 1.8 1.8 0.1 0.7 3.5 0.0 0.1 1.6 0.0 0.1 0.3 0.8 0.4 0.2 0.3 0.1 2.8 2.0 0.2 0.1 0.1 0.5 2.8 0.0 0.6 0.3 0.0 1.1 0.2 2.3 0.4 0.2 8.8 0.4 0.1 1.0 2.1 0.4 0.1 1.3 0.4 0.4 0.7 1.0 0.0 0.4 0.0 0.1 0.4 0.0 0.9 0.8 2.4 0.6 1.3 0.6 0.2 0.3 0.3 0.9 3.2 0.3 0.3 0.9 0.6 0.0 0.0 0.0 0.6 0.7 0.5 0.4 0.2 0.1 0.4 0.0 0.0 0.2 0.2 0.7 0.5 1.1 1.0 0.2 0.1 0.3 0.1 0.0 0.1 0.3 0.6 0.1 0.5 0.6 1.4 0.0 0.8 0.3 1.0 0.8 0.0 0.8 0.4 0.9 0.1 0.0 0.8 0.8 0.7 0.7 0.4 1.8 0.3 0.6 0.3 0.5 0.5 0.4 0.9 0.4 0.6 0.3 0.4 0.7 0.5 0.6 2.4 0.6 0.6 0.4 0.3 0.3 0.4 0.4 0.3 0.2 0.9 0.4 0.6 2.1 1.3 0.3 0.8 0.4 0.2 2.6 1.8 0.7 3.5 2.8 2.0 2.8 0.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 29.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNH1 "eag, eag1, h-eag, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134180 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 20.2" "Group enriched" "Detected in some" 6 "Early spermatids: 9.0;Late spermatids: 13.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.3;RH-30: 7.2;RPTEC TERT1: 4.2;SH-SY5Y: 9.2;SK-MEL-30: 8.6;T-47d: 6.5" "Low region specificity" "Detected in all" "HPA014551, HPA019445, HPA076421" Enhanced Supported Vesicles NA NA Vesicles "HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: " "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.9 2.3 6.3 1.3 13.3 0.7 0.6 19.1 20.2 1.0 1.3 3.3 0.2 1.2 1.5 1.0 0.9 1.2 1.0 0.7 3.8 1.7 1.0 0.7 0.7 0.7 1.1 7.5 0.8 0.9 0.9 0.8 1.1 1.7 1.3 1.3 0.0 0.8 0.9 0.7 0.9 1.0 1.0 2.1 0.6 1.5 2.4 1.5 0.0 0.8 0.0 0.7 0.9 0.7 0.1 0.7 0.7 0.1 0.1 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.7 0.1 1.5 1.7 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 4.2 0.0 0.3 9.2 1.6 0.1 8.6 1.2 6.5 0.0 0.0 1.1 0.1 1.4 0.8 0.0 0.0 0.0 0.2 0.0 0.6 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.7 0.1 0.0 6.3 13.3 19.1 20.2 3.8 1.7 1.1 7.5 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 KCNH2 "erg1, HERG, Kv11.1, LQT2" ENSG00000055118 "Potassium voltage-gated channel subfamily H member 2" Q12809 7 150944961-150978315 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.9" "Group enriched" "Detected in many" 5 "Bipolar cells: 199.1;Cardiomyocytes: 76.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 2.0" "Group enriched" "Detected in some" 7 "K-562: 59.8;NB-4: 29.8;SH-SY5Y: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (9.79e-3)" "unprognostic (1.95e-2)" "unprognostic (3.40e-2)" "unprognostic (3.84e-2)" "unprognostic (3.53e-2)" "unprognostic (3.52e-1)" "prognostic favorable (5.61e-4)" "unprognostic (6.08e-2)" "unprognostic (2.26e-2)" "unprognostic (4.90e-2)" "unprognostic (2.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.02e-2)" 1.1 4.9 5.0 3.2 8.3 37.9 0.7 19.3 8.0 4.3 17.3 2.8 3.1 3.5 9.3 4.6 3.4 4.1 28.5 24.9 4.8 9.3 0.8 0.7 1.7 0.9 4.7 3.9 6.6 5.1 10.5 23.8 2.2 14.1 6.8 1.8 8.0 1.8 10.2 0.8 0.7 6.9 9.4 2.2 1.6 6.8 18.0 1.6 0.1 0.7 0.0 0.7 7.5 2.4 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.9 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.1 5.7 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 59.8 0.0 0.0 0.3 0.5 29.8 0.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 1.2 25.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.5 0.0 0.0 1.7 0.0 0.6 0.0 3.7 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 8.3 19.3 8.0 4.8 9.3 4.7 3.9 14.1 1.6 0.0 0.0 0.0 0.1 0.0 199.1 76.1 0.0 0.0 0.0 0.0 3.9 0.1 0.0 1.8 0.8 0.0 0.0 23.3 0.2 1.0 0.9 0.1 26.4 0.0 0.3 15.9 15.6 2.5 0.0 2.5 2.3 0.0 0.0 0.0 0.7 2.7 0.5 0.0 12.4 0.0 9.6 0.0 1.9 0.7 2.6 0.0 0.2 0.0 0.2 0.3 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA051088: AB_2681340" "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.6 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.6 0.0 0.3 2.3 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.6 0.0 0.0 0.1 0.0 1.8 0.0 0.2 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 11.8 0.0 1.8 0.3 0.3 0.0 0.3 0.0 1.1 0.2 0.1 0.0 12.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 0.0 0.3 0.0 0.2 0.1 0.0 0.6 2.5 9.4 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 1.6 2.4 1.3 0.8 3.6 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.9 2.5 0.3 0.0 1.0 0.0 0.0 KCNH4 "elk1, Kv12.3" ENSG00000089558 "Potassium voltage-gated channel subfamily H member 4" Q9UQ05 17 42156891-42181278 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.3;K-562: 6.0;RPMI-8226: 11.4;RT4: 4.3;U-266/70: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.07e-3)" "unprognostic (1.02e-2)" "unprognostic (4.02e-2)" "unprognostic (1.70e-1)" "unprognostic (9.30e-2)" "unprognostic (2.08e-3)" "unprognostic (4.59e-3)" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (9.92e-2)" "unprognostic (4.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.36e-6)" "unprognostic (9.52e-2)" "unprognostic (2.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.72e-3)" 1.2 1.0 0.7 2.4 11.2 0.7 0.3 0.0 7.9 0.7 0.3 0.1 0.0 0.7 0.2 0.1 0.1 0.4 0.5 0.7 0.4 0.9 0.2 0.2 0.3 1.0 0.3 1.0 0.2 0.3 0.0 0.4 0.3 0.0 0.5 0.3 0.0 0.8 0.5 0.2 0.4 0.5 0.3 0.1 0.8 0.6 0.9 2.6 0.0 0.2 0.0 1.1 3.1 0.1 0.4 0.6 0.6 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 6.3 0.5 0.9 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 1.1 0.0 0.0 1.9 0.0 0.0 1.1 0.0 0.0 0.0 11.4 0.0 4.3 2.6 1.4 0.4 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.1 0.8 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.7 11.2 0.0 7.9 0.4 0.9 0.3 1.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Cell type enriched" "Detected in some" 15 "Bipolar cells: 64.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 10.1;RT4: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.1 0.0 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 0.0 0.0 0.0 0.1 0.0 64.7 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 KCNH6 "erg2, HERG2, Kv11.2" ENSG00000173826 "Potassium voltage-gated channel subfamily H member 6" Q9H252 17 63523334-63548977 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6" "Group enriched" "Detected in some" 8 "Bipolar cells: 10.0;Cardiomyocytes: 19.6;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 33.3;Proximal tubular cells: 15.4" "Cancer enhanced" "Detected in some" "prostate cancer: 5.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "SCLC-21H: 8.7;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 4.7;pons and medulla: 1.4" HPA061704 Approved NA NA "HPA061704: " "unprognostic (8.00e-2)" "unprognostic (1.80e-1)" "unprognostic (5.46e-2)" "unprognostic (5.68e-2)" "unprognostic (5.98e-5)" "unprognostic (3.39e-1)" "unprognostic (1.15e-1)" "unprognostic (3.03e-1)" "unprognostic (1.28e-2)" "unprognostic (3.25e-1)" "unprognostic (1.74e-3)" "unprognostic (3.95e-1)" "unprognostic (1.19e-1)" "unprognostic (9.80e-2)" "unprognostic (3.66e-1)" "unprognostic (8.05e-2)" "unprognostic (9.15e-2)" 0.0 0.2 0.3 0.7 1.1 0.3 0.0 0.1 1.2 0.0 4.2 0.0 0.0 3.9 0.0 0.5 0.0 0.3 0.1 0.6 0.3 2.8 15.4 0.0 0.9 0.1 1.1 0.5 0.1 2.4 0.1 7.6 0.6 1.0 6.2 0.4 7.6 0.1 0.0 0.2 0.3 8.7 0.0 0.7 0.1 1.7 1.4 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.8 0.4 1.7 0.5 0.7 0.5 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.7 0.0 0.2 0.1 0.1 0.0 0.0 0.3 8.7 3.3 0.0 0.2 0.1 0.2 0.3 0.2 0.0 0.3 1.0 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 1.2 0.5 0.4 0.4 0.3 0.1 0.6 0.2 0.2 0.2 0.8 0.5 0.4 1.7 0.7 0.3 0.4 0.2 0.4 0.3 1.1 0.1 1.2 0.3 2.8 1.1 0.5 1.0 0.3 0.0 0.0 0.0 0.2 0.2 10.0 19.6 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 33.3 0.0 0.0 2.0 0.0 0.0 1.7 0.0 1.6 0.5 0.1 0.0 0.0 15.4 2.7 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 KCNH7 "erg3, HERG3, Kv11.3" ENSG00000184611 "Potassium voltage-gated channel subfamily H member 7" Q9NS40 2 162371407-162838730 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;pituitary gland: 5.4" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 22.7;Horizontal cells: 20.6;Ito cells: 12.9;Late spermatids: 55.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;neutrophil: 3.0" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.0" "Group enriched" "Detected in some" 13 "SCLC-21H: 10.7;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018039 Uncertain NA NA "HPA018039: AB_1852125" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.66e-1)" "unprognostic (5.55e-2)" "unprognostic (3.05e-2)" "unprognostic (5.51e-2)" "unprognostic (8.12e-3)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (3.52e-2)" "unprognostic (7.55e-3)" "unprognostic (2.76e-3)" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.68e-2)" 0.4 1.0 4.4 0.9 6.8 0.8 0.4 6.0 11.0 0.4 0.4 0.0 0.7 0.7 0.4 0.6 0.4 0.5 0.4 1.0 2.6 1.8 0.6 2.7 0.5 0.5 0.7 4.6 0.4 1.0 0.3 5.4 0.6 3.1 0.4 0.3 0.4 0.4 1.5 0.3 0.4 0.5 0.4 0.7 1.1 2.5 1.6 0.3 0.0 0.4 0.0 0.3 0.4 0.4 0.1 0.1 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.7 0.7 0.0 9.6 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 4.4 6.8 6.0 11.0 2.6 1.8 0.7 4.6 3.1 0.3 0.0 0.0 0.0 0.0 0.0 8.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.6 0.0 12.9 1.6 55.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148454-19535646 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.3;pituitary gland: 16.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.7;Early spermatids: 2.7;Intestinal endocrine cells: 3.5;Melanocytes: 3.3;Muller glia cells: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 5 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "HAP1: 2.1;OE19: 4.0;SH-SY5Y: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.6 7.0 8.4 1.6 22.0 1.4 2.4 1.3 11.4 1.3 1.9 31.3 0.0 2.2 1.2 1.2 0.7 1.4 2.2 1.0 11.8 5.7 0.7 0.7 0.8 3.2 16.4 10.2 0.7 2.7 0.8 16.1 0.6 15.0 2.2 2.5 0.1 3.3 1.4 0.6 1.9 1.8 1.1 9.9 2.6 5.9 4.0 18.1 0.0 1.1 0.0 3.2 0.9 0.5 4.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.8 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.4 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.4 22.0 1.3 11.4 11.8 5.7 16.4 10.2 15.0 18.1 0.0 0.0 0.0 1.6 0.5 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.7 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 0.0 0.0 3.3 0.0 1.7 3.7 0.6 0.0 0.0 0.0 0.9 0.0 0.2 0.7 1.9 0.0 0.1 0.0 0.2 0.2 KCNIP1 KCHIP1 ENSG00000182132 "Potassium voltage-gated channel interacting protein 1" Q9NZI2 5 170353487-170736632 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2;epididymis: 27.8" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 47.7" "Cancer enriched" "Detected in some" 18 "glioma: 22.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022864, HPA066717" Uncertain Approved Vesicles NA NA Vesicles "HPA022864: AB_1858712, HPA066717: " "unprognostic (7.75e-5)" "unprognostic (2.66e-2)" "unprognostic (6.78e-2)" "unprognostic (3.22e-4)" "unprognostic (4.51e-2)" "unprognostic (3.49e-1)" "unprognostic (1.25e-2)" "unprognostic (2.69e-1)" "unprognostic (5.46e-2)" "unprognostic (6.62e-3)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.55e-1)" "unprognostic (2.58e-2)" "unprognostic (1.63e-1)" "unprognostic (2.39e-1)" "unprognostic (6.05e-2)" 1.1 5.9 20.6 1.2 27.9 0.6 1.9 6.4 31.2 4.0 1.0 6.0 5.2 0.9 2.7 27.8 1.0 2.8 2.9 1.2 11.7 20.5 4.9 0.8 1.9 1.2 12.9 7.3 0.9 2.4 5.1 0.7 2.1 11.1 2.3 1.3 0.8 1.3 7.9 0.8 0.7 1.1 2.1 6.9 2.2 1.1 5.2 5.3 0.0 1.2 0.0 1.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 27.9 6.4 14.6 11.7 20.5 12.9 7.3 11.1 5.3 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 37.5;Cardiomyocytes: 109.6;Cone photoreceptor cells: 23.6;Horizontal cells: 46.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6" "Group enriched" "Detected in many" 5 "B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2" "Cell line enhanced" "Detected in many" "HEL: 20.1;HMC-1: 12.5" "Group enriched" "Detected in many" 5 "amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles NA NA Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 86.5 3.5 15.5 2.0 54.5 0.9 10.4 8.3 26.1 1.8 2.4 2.6 0.0 1.4 2.3 2.4 1.2 2.2 1.9 74.8 19.6 5.0 1.0 1.0 1.4 3.7 4.2 11.3 5.7 1.6 1.2 3.3 1.8 4.3 1.6 2.7 1.7 4.6 2.1 3.8 3.0 1.6 1.8 2.1 2.8 1.6 4.1 9.8 0.0 1.3 0.8 3.9 1.6 0.7 4.6 0.5 1.9 1.2 0.0 0.4 0.4 1.6 2.5 2.5 3.1 1.0 1.1 0.6 1.1 1.0 0.6 0.9 3.6 3.2 1.6 1.0 0.7 0.6 1.7 0.8 0.4 0.6 2.2 1.9 20.1 2.4 1.9 0.9 1.3 12.5 2.6 1.7 1.0 1.3 3.6 1.0 4.5 5.8 1.8 1.0 1.1 0.7 3.9 0.8 0.7 0.6 0.9 0.2 1.2 1.0 1.0 7.3 1.2 0.8 0.5 2.4 1.6 2.1 0.8 2.2 1.4 2.1 0.6 1.1 1.7 1.7 1.7 1.5 5.1 0.2 0.0 0.1 1.9 0.1 1.2 0.4 2.9 0.3 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.5 0.5 0.3 0.4 15.5 54.5 8.3 26.1 19.6 5.0 4.2 11.3 4.3 9.8 0.0 0.0 1.3 0.1 0.3 37.5 109.6 0.0 0.0 0.0 1.8 23.6 0.2 0.0 0.1 5.6 0.0 0.4 0.0 0.0 0.1 0.2 0.2 0.0 0.0 1.8 46.1 0.0 0.6 0.6 5.3 1.7 0.3 0.0 0.0 0.1 6.3 0.2 0.0 0.7 0.0 4.8 0.0 0.4 1.4 5.3 0.0 0.2 0.0 0.3 0.0 KCNIP3 "CSEN, DREAM, KCHIP3" ENSG00000115041 "Potassium voltage-gated channel interacting protein 3" Q9Y2W7 2 95297304-95386083 "Predicted intracellular proteins, Transporters" "Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport" "Ion channel, Potassium channel, Repressor, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.8;parathyroid gland: 32.5" "Group enriched" "Detected in some" 5 "Leydig cells: 23.6;Peritubular cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.1;hTERT-RPE1: 15.9;RPTEC TERT1: 23.8;U-138 MG: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066717, HPA069797" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA066717: , HPA069797: AB_2686199" "unprognostic (1.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.33e-3)" "prognostic unfavorable (1.58e-5)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (2.32e-1)" "unprognostic (4.09e-1)" "unprognostic (1.44e-3)" "unprognostic (8.90e-2)" "unprognostic (6.51e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-1)" 4.2 1.8 19.8 1.5 20.1 0.7 2.8 3.7 39.8 6.0 4.6 12.9 0.6 2.1 5.8 4.9 3.5 5.3 2.4 3.4 16.7 7.8 4.6 1.2 1.5 1.1 9.1 19.5 8.8 2.5 32.5 5.6 6.5 8.2 5.7 1.8 1.4 6.9 18.6 2.2 3.9 1.9 6.4 6.3 2.2 2.9 9.2 15.9 5.4 19.5 0.0 1.3 4.5 5.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.5 4.1 3.6 2.9 0.0 4.2 12.1 6.9 6.4 0.0 0.0 0.0 0.4 5.5 3.7 0.1 2.7 0.7 2.9 0.0 0.9 0.0 1.1 0.0 1.5 0.0 0.0 2.0 2.4 1.5 6.8 15.9 0.0 0.7 0.0 0.0 0.5 5.2 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 23.8 0.0 0.4 0.1 0.2 0.2 4.6 0.0 0.2 0.0 0.2 11.2 2.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 20.1 3.7 39.8 16.7 7.8 9.1 19.5 8.2 15.9 0.0 0.6 0.0 0.7 0.3 0.6 0.9 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.3 0.3 0.6 0.2 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 23.6 0.0 6.8 1.0 0.0 0.7 0.3 0.0 40.3 0.6 0.0 0.0 2.3 0.0 0.9 0.6 0.0 0.0 0.1 0.0 KCNIP4 "CALP, KCHIP4, MGC44947" ENSG00000185774 "Potassium voltage-gated channel interacting protein 4" Q6PIL6 4 20728616-21948799 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 32.3;Distal tubular cells: 53.0;Muller glia cells: 43.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 10.1;SCLC-21H: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022862, HPA066717" Supported Approved Vesicles NA NA Vesicles "HPA022862: AB_1852654, HPA066717: " "unprognostic (8.08e-2)" "unprognostic (1.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (9.26e-2)" "unprognostic (1.49e-1)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (3.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.69e-1)" "unprognostic (4.59e-2)" "unprognostic (2.10e-2)" 1.1 3.6 15.8 2.2 28.3 1.0 0.9 22.4 38.9 15.0 4.2 1.8 0.0 2.4 9.6 1.1 5.6 3.9 2.6 1.8 11.9 16.2 7.8 0.7 1.1 1.1 11.6 19.3 1.9 1.0 0.5 5.1 1.8 16.9 1.0 5.2 3.5 1.4 0.8 1.3 2.3 5.5 7.8 3.9 1.1 1.3 1.3 3.5 0.0 8.9 0.0 0.5 2.7 1.1 0.3 0.7 0.0 0.7 0.8 0.7 0.3 1.7 1.5 2.2 2.2 0.0 0.0 1.1 1.3 0.0 0.0 0.0 1.9 1.7 3.4 1.4 0.5 1.7 0.9 0.0 0.1 0.0 0.4 2.3 1.2 2.5 1.2 0.0 3.2 0.5 0.0 0.8 0.0 1.4 2.9 0.6 1.3 2.0 1.1 0.0 0.6 2.8 1.9 2.8 1.3 1.4 0.8 4.2 1.3 10.1 1.0 7.9 4.7 1.4 1.7 2.2 2.7 0.9 1.2 2.2 1.1 1.5 2.4 3.2 1.0 0.1 1.2 3.7 2.7 1.7 0.0 0.3 0.0 0.2 0.7 0.7 0.2 0.1 0.2 0.7 0.3 0.5 0.5 0.0 0.8 0.5 0.3 0.2 0.3 15.8 28.3 22.4 33.0 11.9 16.2 11.6 19.3 16.9 3.5 0.0 0.0 0.0 0.0 0.0 32.3 0.4 0.0 0.0 0.0 14.0 0.0 0.0 53.0 0.0 6.9 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.2 0.0 0.0 3.3 1.0 0.0 43.9 0.0 7.0 0.0 4.7 11.8 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.3 0.0 KCNJ1 "Kir1.1, ROMK1" ENSG00000151704 "Potassium voltage-gated channel subfamily J member 1" P48048 11 128836315-128867373 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Bartter syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "kidney: 123.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 165.8" "Cancer enriched" "Detected in some" 7 "renal cancer: 3.4" "Region enriched" "Detected in single" 4 "basal ganglia: 2.3" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 40 "RPTEC TERT1: 51.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA026962 Enhanced NA NA "HPA026962: AB_10601934" "unprognostic (1.75e-1)" "unprognostic (4.38e-2)" "unprognostic (1.14e-1)" "unprognostic (3.19e-1)" "unprognostic (7.55e-2)" "unprognostic (1.29e-1)" "unprognostic (3.01e-2)" "unprognostic (2.69e-1)" "unprognostic (1.46e-1)" "unprognostic (2.44e-2)" "unprognostic (6.47e-2)" "unprognostic (2.78e-1)" "unprognostic (6.05e-2)" "unprognostic (4.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.28e-1)" "unprognostic (7.81e-3)" 0.1 0.0 0.5 0.2 2.3 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 123.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.3 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.9 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 36.6 0.0 0.0 165.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KCNJ10 "Kir1.2, Kir4.1" ENSG00000177807 "Potassium voltage-gated channel subfamily J member 10" P78508 1 159998651-160070483 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Deafness, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.1;kidney: 28.1" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 83.5" "Cancer enriched" "Detected in some" 6 "glioma: 27.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 6 "NK-cells: 1.7;T-cells: 2.5" "Cell line enhanced" "Detected in some" "Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078302 Enhanced NA NA "HPA078302: AB_2732378" "unprognostic (2.64e-2)" "unprognostic (3.54e-3)" "unprognostic (6.19e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (6.98e-4)" "unprognostic (1.96e-1)" "unprognostic (7.13e-2)" "unprognostic (3.43e-1)" "unprognostic (1.28e-3)" "unprognostic (5.80e-4)" "unprognostic (9.52e-2)" "unprognostic (2.09e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "unprognostic (6.70e-3)" 1.4 1.5 23.6 3.0 28.1 1.3 1.3 10.5 74.1 1.4 1.7 37.9 0.0 1.5 1.3 1.3 1.4 1.3 1.3 1.3 21.8 13.2 28.1 3.1 1.3 7.1 28.1 15.1 1.3 1.3 1.3 0.3 1.3 25.5 1.3 1.5 0.5 1.5 1.5 1.2 1.6 1.7 1.3 42.9 10.3 2.0 1.8 25.5 0.0 1.5 0.0 2.9 1.5 0.1 0.0 0.0 0.0 0.3 1.7 2.5 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.3 0.0 0.2 1.7 0.2 0.0 1.1 0.4 0.3 0.0 0.2 0.0 0.2 0.1 0.1 11.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.6 0.0 2.2 0.1 0.0 0.0 0.2 0.4 0.0 0.3 3.7 1.0 0.1 0.5 0.1 0.1 0.3 0.9 0.0 3.8 1.7 0.0 0.2 0.2 1.8 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.8 0.0 1.7 0.3 0.0 2.5 0.2 23.6 28.1 10.5 22.2 21.8 13.2 28.1 15.1 25.5 25.5 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 3.5 3.9 0.0 10.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 1.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 KCNJ11 "BIR, Kir6.2" ENSG00000187486 "Potassium voltage-gated channel subfamily J member 11" Q14654 11 17385859-17389331 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 63.1" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 11.3;Collecting duct cells: 5.2;Intestinal endocrine cells: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 7.1;HEK 293: 13.5;MCF7: 10.8;SCLC-21H: 9.2" "Low region specificity" "Detected in all" HPA048891 Approved NA NA "HPA048891: AB_2680547" "unprognostic (1.95e-2)" "unprognostic (6.18e-3)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (4.81e-5)" "unprognostic (1.83e-3)" "unprognostic (5.45e-2)" "unprognostic (8.09e-3)" "unprognostic (3.72e-3)" "unprognostic (9.23e-3)" "prognostic favorable (1.56e-4)" "unprognostic (4.05e-2)" "unprognostic (2.10e-2)" "unprognostic (1.67e-1)" "unprognostic (4.75e-2)" 2.5 1.1 2.9 1.0 7.8 0.8 2.7 13.6 7.8 1.0 1.1 0.7 4.9 1.4 1.1 2.1 1.7 1.1 1.1 6.2 3.5 2.4 1.3 0.9 1.3 1.2 2.7 5.2 0.8 8.7 2.7 3.3 0.7 3.5 2.5 1.0 0.1 1.2 7.6 63.1 1.0 1.1 0.8 1.7 1.0 4.6 0.8 1.9 0.0 4.1 4.5 1.0 0.9 1.1 0.8 0.4 1.4 0.3 0.8 0.4 0.4 1.5 2.4 0.3 4.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 2.5 0.2 7.1 0.2 0.0 0.3 0.3 4.8 0.1 0.3 1.7 13.5 3.7 0.9 0.8 0.1 0.4 0.3 0.1 0.3 0.0 0.1 0.1 0.0 6.1 3.8 3.8 0.0 10.8 0.7 0.1 1.0 4.2 0.3 1.4 1.7 2.1 0.4 0.9 9.2 0.8 0.0 3.6 0.0 0.0 4.7 0.2 0.0 0.0 1.2 0.0 0.1 0.2 6.0 0.9 0.0 1.0 0.0 1.4 0.3 0.2 0.4 0.3 0.3 0.7 0.4 0.4 0.1 0.8 0.4 0.4 1.3 0.8 0.1 0.4 0.3 0.4 2.9 7.8 13.6 7.8 3.5 2.4 2.7 5.2 3.5 1.9 0.0 2.4 0.0 0.1 0.0 2.4 11.3 0.0 0.0 1.2 5.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 1.0 0.1 0.0 4.1 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.1 KCNJ12 "hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v" ENSG00000184185 "Potassium voltage-gated channel subfamily J member 12" Q14500 17 21376197-21419872 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 39.4;skeletal muscle: 47.8" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 84.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 39.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3" "Low region specificity" "Detected in all" HPA027021 Approved Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (3.81e-3)" "unprognostic (2.69e-2)" "unprognostic (8.60e-2)" "prognostic unfavorable (7.84e-5)" "unprognostic (2.29e-1)" "unprognostic (1.73e-2)" "unprognostic (3.80e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (4.91e-2)" "unprognostic (8.12e-2)" "unprognostic (1.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-1)" "unprognostic (5.90e-2)" "unprognostic (9.70e-3)" 1.2 1.3 1.9 0.9 2.9 0.7 0.9 39.4 5.8 1.2 0.8 1.1 0.5 0.5 0.8 1.4 1.5 2.1 0.7 5.1 0.9 1.4 1.2 0.5 1.3 0.4 1.3 3.4 0.7 0.5 10.6 0.7 0.7 4.0 0.9 0.6 1.7 0.6 0.9 47.8 6.0 0.6 1.0 0.9 1.3 0.9 1.3 0.9 0.0 1.0 7.5 1.1 0.8 1.5 0.0 0.9 0.0 0.5 0.0 0.1 0.0 0.0 1.1 0.4 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 3.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.1 0.0 1.5 0.0 6.3 0.0 1.0 1.6 0.0 0.0 7.3 0.4 3.7 0.0 1.5 8.0 0.0 0.0 2.8 0.0 0.5 6.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 1.9 2.9 39.4 5.8 0.9 1.4 1.3 3.4 4.0 0.9 0.0 0.0 0.0 0.0 1.3 0.8 12.5 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.4 1.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.2 84.2 1.2 5.5 0.0 0.2 6.9 0.0 0.0 0.0 0.4 11.2 0.0 0.0 3.9 0.6 1.4 0.0 0.5 0.5 1.3 1.9 0.1 0.0 0.6 0.0 KCNJ13 "Kir1.4, Kir7.1, LCA16" ENSG00000115474 "Potassium voltage-gated channel subfamily J member 13" O60928 2 232766464-232776568 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cataract, Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 22.9;intestine: 49.5;retina: 70.3" "Group enriched" "Detected in some" 14 "Melanocytes: 20.3;Muller glia cells: 44.0" "Cancer enriched" "Detected in some" 5 "melanoma: 5.9" "Region enriched" "Detected in some" 7 "pons and medulla: 22.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051609 Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA051609: " "unprognostic (4.29e-2)" "unprognostic (2.00e-1)" "unprognostic (2.69e-1)" "unprognostic (9.03e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-2)" "unprognostic (2.26e-1)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.41e-1)" "unprognostic (4.90e-2)" "unprognostic (1.86e-2)" "unprognostic (2.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-2)" "unprognostic (1.11e-2)" 0.2 0.2 0.5 0.0 0.7 0.1 0.3 0.4 0.9 0.2 10.1 7.0 1.3 4.3 0.2 0.3 0.2 0.1 1.6 0.2 3.2 0.5 1.9 0.3 0.2 0.0 0.4 0.4 0.3 0.4 8.5 0.3 0.0 22.9 0.3 0.0 70.3 0.3 1.6 0.2 1.8 49.5 0.0 0.6 0.2 1.1 0.5 0.1 0.0 3.8 0.0 0.0 0.3 0.3 1.1 0.8 5.4 1.1 1.1 2.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.0 0.0 0.5 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.3 1.0 3.1 0.2 0.3 0.0 0.1 0.0 4.6 0.3 1.3 0.1 0.8 0.8 0.4 0.0 5.4 1.1 0.9 1.0 0.2 1.2 0.8 1.8 0.7 0.4 1.1 2.1 1.1 0.8 1.1 1.0 0.8 2.7 0.1 0.5 0.7 0.4 0.9 3.2 0.5 0.4 0.4 22.9 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.4 0.0 1.0 0.0 1.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 44.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KCNJ14 "IRK4, Kir2.4" ENSG00000182324 "Potassium voltage-gated channel subfamily J member 14" Q9UNX9 19 48455509-48466980 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 22.9" "Cell type enriched" "Detected in many" 8 "Rod photoreceptor cells: 311.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071765 Approved Nucleoli NA NA Nucleoli "HPA071765: AB_2686444" "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (1.33e-5)" "unprognostic (5.77e-2)" "unprognostic (9.41e-2)" "unprognostic (5.26e-2)" "unprognostic (7.05e-4)" "unprognostic (7.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.48e-2)" "unprognostic (4.43e-3)" "unprognostic (4.92e-2)" "unprognostic (5.02e-6)" "unprognostic (1.47e-1)" "unprognostic (4.98e-2)" "unprognostic (6.82e-3)" "unprognostic (4.41e-2)" 1.0 0.4 1.1 0.9 6.1 4.9 1.8 2.3 2.2 0.9 0.9 0.9 0.9 0.6 0.9 1.8 1.5 1.1 1.0 0.9 1.4 1.3 0.9 0.9 0.9 1.2 1.2 0.9 1.3 1.4 1.0 1.0 1.4 1.4 1.5 0.7 22.9 0.9 0.9 3.3 4.9 0.9 0.9 0.9 0.9 0.6 2.8 0.9 0.9 1.6 0.9 0.9 0.9 1.1 1.5 0.8 3.5 0.8 0.6 1.0 0.2 1.6 3.8 0.8 2.5 1.7 1.7 2.6 0.6 0.3 0.8 1.3 3.9 2.2 1.8 0.8 0.6 2.0 5.5 1.2 0.6 2.1 1.3 2.0 1.1 2.2 1.0 1.0 1.6 3.2 1.6 2.8 2.0 2.3 1.1 0.5 1.7 1.8 2.0 0.5 2.4 0.6 12.4 1.4 2.0 2.2 2.6 1.5 0.4 0.6 4.6 1.4 1.7 1.8 2.6 1.4 1.5 1.8 1.3 1.1 2.7 3.6 2.7 3.0 2.1 3.1 1.3 0.7 4.0 2.8 3.5 0.8 0.6 0.6 0.6 0.5 1.2 0.7 1.0 0.4 1.5 0.8 1.0 2.9 0.6 0.3 0.8 0.6 0.2 1.1 6.1 2.3 2.0 1.4 1.3 1.2 0.9 1.4 0.9 0.0 4.3 0.0 3.7 3.9 15.0 0.4 2.5 1.4 0.0 1.8 39.3 1.3 0.0 0.8 4.1 1.0 0.4 0.0 0.9 2.1 0.8 2.5 0.0 0.5 0.5 14.3 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.0 1.2 17.5 2.1 0.0 0.4 0.0 311.1 0.0 0.9 3.4 2.7 4.6 0.8 0.0 1.7 2.1 KCNJ15 "IRKK, Kir1.3, Kir4.2" ENSG00000157551 "Potassium voltage-gated channel subfamily J member 15" Q99712 21 38155549-38307357 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.8;kidney: 99.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 153.4;Cholangiocytes: 63.7;Proximal tubular cells: 211.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 29.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 21 "neutrophil: 74.8" "Lineage enriched" "Detected in many" 21 "granulocytes: 74.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 26.1;GAMG: 37.4;HBEC3-KT: 25.1;RPTEC TERT1: 25.0;RT4: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA016702 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA016702: AB_1855560" "unprognostic (6.34e-2)" "unprognostic (5.04e-2)" "unprognostic (7.92e-2)" "unprognostic (2.07e-3)" "unprognostic (1.21e-1)" "unprognostic (3.54e-3)" "unprognostic (2.72e-3)" "unprognostic (3.03e-2)" "unprognostic (6.79e-2)" "unprognostic (2.89e-3)" "unprognostic (3.77e-2)" "unprognostic (1.95e-2)" "prognostic favorable (4.09e-10)" "unprognostic (9.46e-3)" "unprognostic (1.82e-1)" "unprognostic (5.27e-2)" "prognostic favorable (1.95e-4)" 6.0 0.3 0.4 5.3 0.3 3.2 1.4 0.2 0.3 3.5 0.4 0.2 27.1 0.2 0.5 12.8 6.0 0.8 17.7 1.0 0.2 0.1 99.7 1.5 34.1 0.8 0.5 0.2 0.6 16.7 0.0 0.3 1.0 0.6 4.0 0.0 0.2 14.4 26.8 1.0 1.7 0.2 0.9 0.4 6.8 10.7 1.1 0.2 0.4 36.8 3.2 1.9 11.3 4.3 0.0 0.2 74.8 3.5 0.0 0.0 0.7 0.6 0.0 0.1 0.2 5.1 26.1 0.2 0.3 1.7 0.0 0.0 0.0 0.2 0.1 0.0 2.7 37.4 8.8 0.0 25.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 7.7 2.5 6.5 1.4 0.5 1.2 0.0 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 25.0 29.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 1.3 0.0 0.6 0.1 0.0 2.1 1.5 0.1 0.0 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.7 0.4 0.3 0.2 0.3 0.2 0.1 0.5 0.2 0.6 0.2 56.6 153.4 0.8 8.5 2.5 0.0 1.2 63.7 9.4 52.4 29.6 0.0 0.1 14.9 23.3 1.4 1.4 0.0 0.0 7.8 0.4 0.8 0.4 5.8 0.0 0.3 0.0 0.0 1.3 5.1 1.9 0.6 2.6 1.7 0.0 0.0 0.0 26.3 0.0 0.0 211.6 0.0 0.0 1.0 0.9 1.0 1.4 0.1 0.0 0.0 4.1 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium voltage-gated channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4" "Cell type enhanced" "Detected in some" 27 "Cholangiocytes: 43.3;Collecting duct cells: 232.1;Distal tubular cells: 34.9;Proximal tubular cells: 89.7" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles NA NA Vesicles "HPA059563: AB_2684065" "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favorable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.58e-4)" "unprognostic (3.88e-1)" 0.4 0.3 4.1 0.3 4.4 0.4 1.5 22.6 6.1 0.3 0.4 1.7 12.6 0.4 0.4 6.4 0.3 2.0 6.5 0.4 6.0 7.2 96.5 0.9 0.5 0.4 8.3 3.4 0.4 15.8 59.4 0.8 0.5 25.5 1.0 0.3 0.0 4.1 14.3 0.4 0.5 1.2 0.2 7.5 1.1 7.4 0.8 5.3 0.0 60.4 0.0 0.2 0.3 0.3 1.1 0.5 5.1 0.2 0.9 1.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 80.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.9 0.1 1.2 1.0 1.0 0.5 0.1 1.1 0.7 0.6 5.1 0.9 0.1 0.5 1.1 0.3 4.1 4.4 22.6 6.1 6.0 7.2 8.3 3.4 25.5 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 43.3 17.4 4.5 232.1 0.0 0.0 34.9 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 89.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ18 "KIR2.6, TTPP2" ENSG00000260458 "Potassium voltage-gated channel subfamily J member 18" B7U540 17 21692523-21704612 "Disease related genes, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "lymphoid tissue: 3.5;skin 1: 8.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3" "Region enhanced" "Detected in many" "cerebellum: 75.1" HPA027021 Uncertain Uncertain "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA027021: AB_10602912" "unprognostic (2.41e-1)" "unprognostic (3.90e-5)" "unprognostic (2.56e-1)" "unprognostic (1.95e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNJ2 "IRK1, Kir2.1, LQT7" ENSG00000123700 "Potassium voltage-gated channel subfamily J member 2" P63252 17 70168673-70180048 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;parathyroid gland: 34.8" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 227.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 20.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 20.8" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 7.5;HUVEC TERT2: 5.2;REH: 6.0;RH-30: 24.5;U-138 MG: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029109 Approved NA NA "HPA029109: AB_10602913" "unprognostic (1.32e-1)" "unprognostic (1.24e-1)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (3.50e-1)" "unprognostic (6.36e-3)" "unprognostic (1.22e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" "unprognostic (1.62e-1)" "unprognostic (3.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.74e-3)" "unprognostic (6.15e-3)" "unprognostic (9.60e-3)" "unprognostic (4.89e-2)" "unprognostic (5.49e-3)" 3.0 1.5 6.2 6.3 17.9 2.5 6.6 1.3 12.8 1.8 5.0 23.7 5.1 1.6 1.5 1.2 4.7 8.4 2.2 11.4 6.4 4.4 1.7 1.9 3.9 4.4 22.4 8.5 1.4 1.0 34.8 1.6 9.0 11.7 2.6 4.3 3.1 2.7 2.9 10.3 6.0 2.1 1.6 14.9 10.4 2.0 0.9 18.2 0.5 1.9 6.0 2.2 2.6 3.3 0.1 0.7 20.8 4.7 0.0 0.0 0.4 0.0 0.7 1.5 0.0 1.6 0.4 0.0 0.5 3.7 0.0 0.1 0.0 0.0 0.0 0.3 0.4 1.0 0.4 0.1 0.2 0.1 0.0 0.2 0.0 0.5 0.0 4.7 0.0 0.0 1.7 0.1 2.3 0.2 7.5 5.2 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.1 0.6 0.1 6.0 24.5 0.0 0.6 0.0 0.3 0.7 0.4 0.1 0.0 3.1 0.2 0.4 0.1 9.0 0.1 0.0 2.0 0.0 0.0 0.1 1.9 0.0 1.2 1.8 2.5 3.6 0.0 4.7 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 20.8 0.0 4.6 0.1 0.0 0.4 6.2 17.9 1.3 12.8 6.4 4.4 22.4 8.5 11.7 18.2 0.0 2.7 0.8 5.2 7.2 6.6 14.2 0.0 5.3 1.2 1.8 0.0 0.5 0.0 0.0 0.2 8.7 2.6 0.0 0.0 0.1 0.8 1.7 0.0 0.0 5.7 227.2 10.3 3.7 28.3 0.0 1.4 5.2 3.3 1.0 2.8 5.0 0.0 11.2 1.1 0.0 4.6 0.0 2.2 0.0 0.4 2.9 1.1 0.0 6.6 0.1 KCNJ3 "GIRK1, KGA, Kir3.1" ENSG00000162989 "Potassium voltage-gated channel subfamily J member 3" P48549 2 154698299-154858352 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;parathyroid gland: 22.1" "Cell type enhanced" "Detected in many" 21 "Cardiomyocytes: 43.7;Horizontal cells: 117.6;Intestinal endocrine cells: 29.9" "Group enriched" "Detected in many" 5 "breast cancer: 12.2;renal cancer: 4.4" "Region enhanced" "Detected in many" "cerebellum: 33.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 5.4;SCLC-21H: 1.7;SH-SY5Y: 3.3" "Low region specificity" "Detected in all" HPA024231 Uncertain NA NA "HPA024231: AB_1855558" "unprognostic (1.45e-1)" "unprognostic (9.42e-2)" "unprognostic (2.66e-2)" "unprognostic (4.49e-4)" "unprognostic (8.89e-2)" "unprognostic (6.81e-2)" "unprognostic (7.24e-3)" "unprognostic (1.15e-2)" "unprognostic (4.25e-3)" "unprognostic (3.72e-3)" "unprognostic (3.33e-1)" "unprognostic (8.90e-3)" "unprognostic (3.75e-2)" "unprognostic (5.59e-1)" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" 0.3 1.0 4.5 0.0 3.4 0.0 0.2 33.8 13.6 1.3 1.5 1.4 0.3 7.9 0.2 0.9 0.1 0.4 0.9 10.8 8.4 4.0 8.0 2.3 0.2 0.4 1.8 4.9 0.2 1.5 22.1 9.0 0.0 3.0 5.1 0.6 1.0 0.1 9.2 3.5 0.2 6.7 0.1 1.5 0.4 0.5 0.2 0.9 0.0 0.2 0.0 0.0 0.5 0.6 1.2 0.9 3.3 1.1 1.8 1.0 0.4 0.2 0.3 0.0 0.1 0.2 0.1 0.4 5.4 0.2 0.0 0.2 0.1 0.3 0.3 0.2 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.2 0.4 0.4 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 0.7 0.5 0.1 0.5 0.1 0.0 0.4 0.2 0.4 1.7 3.3 0.1 0.6 0.2 0.1 0.4 0.1 0.0 0.3 0.4 0.4 0.3 0.3 0.2 0.1 1.2 0.2 0.5 3.3 0.7 0.9 0.7 0.8 0.9 1.0 0.9 0.6 0.6 1.2 1.0 0.9 1.9 1.8 1.1 0.9 0.7 0.4 4.5 3.4 33.8 12.0 8.4 4.0 1.8 4.9 3.0 0.9 0.0 0.0 0.0 4.4 0.7 4.8 43.7 5.1 0.0 0.0 19.2 13.7 0.0 5.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.6 5.1 0.0 0.9 0.1 117.6 29.9 0.0 0.0 0.0 5.8 0.4 1.7 0.0 0.1 0.7 0.0 0.0 3.9 6.8 3.6 0.0 2.1 0.5 0.1 1.6 0.0 0.0 0.2 4.7 KCNJ4 "HIR, hIRK2, HRK1, IRK3, Kir2.3" ENSG00000168135 "Potassium voltage-gated channel subfamily J member 4" P48050 22 38426327-38455199 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "brain: 25.9;heart muscle: 16.9" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 3.2;Horizontal cells: 9.5;Muller glia cells: 5.4" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 16.1" "Group enriched" "Detected in many" 10 "amygdala: 105.8;basal ganglia: 143.6;cerebral cortex: 111.8;hippocampal formation: 85.7;olfactory region: 150.7" "Group enriched" "Detected in many" 14 "amygdala: 32.2;basal ganglia: 63.2;cerebral cortex: 71.1;hippocampal formation: 59.7;olfactory region: 117.2" NA NA "unprognostic (4.76e-2)" "unprognostic (2.60e-3)" "unprognostic (2.21e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (9.68e-3)" "unprognostic (3.12e-1)" "unprognostic (8.96e-2)" "unprognostic (2.07e-1)" "unprognostic (3.15e-3)" "unprognostic (1.28e-3)" "unprognostic (1.05e-1)" "unprognostic (5.41e-2)" 0.1 0.2 9.9 0.1 17.9 0.1 0.1 0.0 25.9 0.1 0.1 0.3 0.1 0.1 0.1 0.7 0.8 16.9 9.4 1.7 0.2 0.4 0.1 0.1 0.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.6 1.1 0.0 0.5 0.1 0.1 2.3 0.0 0.2 0.0 0.0 16.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.5 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 KCNJ5 "CIR, GIRK4, KATP1, Kir3.4, LQT13" ENSG00000120457 "Potassium voltage-gated channel subfamily J member 5" P48544 11 128891356-128921035 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Cancer-related genes, Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 10.6;Hofbauer cells: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 13 "HBEC3-KT: 17.5" "Group enriched" "Detected in many" 6 "basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0" "Low region specificity" "Detected in all" "HPA014722, HPA017353, CAB022569" Approved NA NA "CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135" "unprognostic (2.01e-1)" "unprognostic (2.43e-3)" "unprognostic (2.56e-3)" "unprognostic (5.81e-2)" "unprognostic (4.24e-2)" "unprognostic (3.60e-2)" "unprognostic (2.90e-1)" "unprognostic (3.54e-2)" "unprognostic (6.83e-2)" "unprognostic (1.96e-1)" "unprognostic (3.17e-1)" "unprognostic (9.29e-2)" "unprognostic (1.81e-2)" "unprognostic (6.82e-2)" "unprognostic (9.49e-2)" "unprognostic (1.88e-2)" "unprognostic (2.23e-2)" 1.8 40.7 0.8 0.3 1.9 0.2 0.9 0.3 1.2 0.8 0.8 1.9 54.6 0.4 0.3 1.1 0.6 0.6 1.3 8.7 1.6 2.5 2.0 0.3 3.4 0.8 3.7 0.8 0.8 16.6 0.7 23.4 4.3 3.4 0.8 0.4 3.3 0.9 21.7 0.3 0.4 0.5 0.7 4.5 7.7 1.5 0.7 0.9 2.3 0.7 0.4 0.3 1.1 0.5 0.9 0.4 2.9 0.7 0.6 0.4 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.3 0.1 0.4 17.5 0.0 0.2 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.4 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.5 0.2 0.1 0.1 1.3 0.0 2.2 0.7 0.6 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.9 0.3 0.4 2.9 0.6 0.4 0.4 0.2 0.4 0.8 1.9 0.3 1.2 1.6 2.5 3.7 0.8 3.4 0.9 0.0 10.6 0.0 2.3 1.3 1.7 5.8 0.0 0.0 0.0 1.8 0.0 0.7 0.0 0.0 2.1 0.6 0.0 0.0 3.2 0.6 2.1 0.4 0.0 0.0 37.1 1.6 0.0 0.6 1.8 4.5 0.9 1.9 3.3 1.8 0.0 0.3 1.3 0.0 0.7 0.0 1.4 0.0 0.1 0.2 0.7 1.5 1.0 0.0 0.0 0.5 KCNJ6 "BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2" ENSG00000157542 "Potassium voltage-gated channel subfamily J member 6" P48051 21 37607376-38121345 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Congenital generalized lipodystrophy, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0;pituitary gland: 12.2" "Cell type enriched" "Detected in some" 6 "Horizontal cells: 232.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.2" "Cell line enriched" "Detected in some" 7 "LHCN-M2: 25.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-1)" "unprognostic (1.96e-1)" "unprognostic (7.71e-2)" "unprognostic (1.26e-3)" "unprognostic (6.75e-2)" "unprognostic (3.59e-1)" "unprognostic (1.33e-1)" "unprognostic (1.25e-1)" "unprognostic (3.68e-1)" "unprognostic (8.76e-2)" "unprognostic (1.64e-2)" "unprognostic (3.49e-1)" "unprognostic (1.96e-10)" "unprognostic (2.42e-1)" "unprognostic (1.46e-1)" "unprognostic (9.87e-2)" "unprognostic (1.21e-1)" 2.0 1.2 7.7 0.9 8.4 1.0 1.1 24.0 15.6 0.9 1.4 0.8 0.0 1.1 1.4 0.6 0.7 0.7 0.8 1.2 14.6 1.1 1.2 0.9 1.0 1.4 1.3 10.8 0.8 2.7 0.7 12.2 7.4 13.5 1.5 0.9 0.0 0.8 0.6 2.2 1.1 1.1 0.5 1.5 1.6 2.7 2.0 0.4 0.0 0.8 0.0 0.6 0.8 0.8 0.3 0.3 4.2 0.3 0.3 0.2 0.0 0.0 0.0 0.6 0.3 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.8 1.4 0.0 0.0 0.0 2.9 0.1 25.6 0.1 0.0 0.0 0.3 0.0 2.5 0.0 0.1 0.8 3.6 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.3 0.0 0.1 0.2 3.8 1.0 0.0 0.0 0.0 0.0 4.2 0.3 3.6 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 2.0 0.3 0.2 0.3 0.1 0.0 7.7 8.4 24.0 15.6 14.6 1.1 1.3 10.8 13.5 0.4 0.0 0.6 0.0 0.4 0.1 31.8 21.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 232.0 39.7 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.9 1.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.1 0.1 0.2 0.0 0.1 0.3 KCNJ8 Kir6.1 ENSG00000121361 "Potassium voltage-gated channel subfamily J member 8" Q15842 12 21764955-21775581 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 60.1;pancreas: 47.6" "Group enriched" "Detected in many" 5 "Sertoli cells: 194.1;Smooth muscle cells: 65.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "eosinophil: 4.5" "Lineage enriched" "Detected in single" 45 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "CACO-2: 42.5;HSkMC: 8.6;SH-SY5Y: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031066 Uncertain NA NA "HPA031066: AB_10602240" "unprognostic (8.12e-3)" "unprognostic (1.89e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (7.81e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-2)" "unprognostic (3.90e-2)" "unprognostic (3.66e-3)" "unprognostic (2.88e-2)" "prognostic unfavorable (1.62e-6)" "unprognostic (4.70e-3)" "unprognostic (9.61e-2)" "unprognostic (1.73e-2)" "unprognostic (3.54e-3)" 14.6 12.9 3.2 2.7 3.4 0.0 14.7 1.7 5.1 7.7 6.6 2.3 3.6 2.0 10.6 4.5 6.7 5.9 6.3 60.1 2.2 1.7 6.4 29.7 12.4 3.5 2.9 3.0 12.4 47.6 1.7 3.8 4.9 3.7 10.6 1.6 8.8 2.9 15.7 15.0 2.4 3.8 13.2 2.6 3.8 6.5 3.4 2.8 0.9 8.4 7.0 1.2 11.4 5.6 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 5.2 3.4 0.0 5.7 4.6 6.6 3.4 42.5 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 1.9 0.0 2.1 1.3 0.0 0.0 0.2 0.0 0.0 8.6 0.0 2.5 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 4.2 1.9 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 3.4 1.7 5.1 2.2 1.7 2.9 3.0 3.7 2.8 3.0 19.8 0.0 0.4 1.1 0.0 24.3 0.0 0.0 1.2 1.8 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.0 6.6 0.3 0.0 22.1 0.2 0.0 1.2 1.8 1.5 0.0 0.3 0.0 1.7 0.0 0.0 12.2 2.0 0.0 0.7 0.0 1.1 194.1 65.3 0.0 0.4 0.6 0.2 0.0 0.0 0.1 KCNJ9 "GIRK3, Kir3.3" ENSG00000162728 "Potassium voltage-gated channel subfamily J member 9" Q92806 1 160081570-160090563 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 27 "brain: 52.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 12.8;Horizontal cells: 7.9" "Cancer enriched" "Detected in single" 35 "glioma: 2.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070478 Enhanced NA NA "HPA070478: AB_2686270" "unprognostic (2.35e-1)" "unprognostic (6.53e-2)" "unprognostic (2.17e-2)" "unprognostic (4.73e-1)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (1.66e-1)" "unprognostic (3.33e-2)" "unprognostic (2.64e-1)" "unprognostic (3.29e-1)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-2)" "unprognostic (2.66e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (5.24e-2)" 1.4 1.9 15.6 1.4 15.3 1.4 1.4 32.1 52.0 1.4 1.4 11.9 0.0 1.4 1.4 1.4 1.4 1.4 1.4 1.4 18.4 11.1 1.5 1.4 1.4 1.4 18.3 20.6 1.4 1.4 1.4 0.7 1.4 7.4 1.4 1.4 0.0 1.4 1.4 1.4 1.4 1.5 1.4 11.4 1.4 1.5 1.7 11.6 0.0 1.4 0.0 1.4 1.4 0.0 0.8 0.0 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.2 2.3 2.7 0.0 0.1 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.0 2.9 0.2 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.5 0.3 1.1 0.4 0.2 1.1 0.0 0.8 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 15.6 15.3 32.1 27.2 18.4 11.1 18.3 20.6 7.4 11.6 0.0 0.0 0.0 0.0 0.0 12.8 0.6 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.6 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614004-233672512 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 75.3" "Cell type enriched" "Detected in single" 98 "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in single" 98 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 236.2" "HPA016049, CAB022588" Approved Approved Vesicles NA NA Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 1.9 3.3 15.2 2.2 12.7 0.3 4.5 75.3 22.8 5.5 11.5 7.9 5.1 12.5 4.5 22.9 12.0 8.4 9.3 20.8 10.3 5.2 7.2 10.8 3.4 0.8 8.9 11.1 3.8 4.4 2.5 11.3 5.0 22.3 4.6 10.6 2.6 7.2 9.3 0.5 8.7 9.6 3.2 12.3 0.8 28.0 0.7 7.8 0.0 5.6 1.6 3.2 4.3 6.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 10.3 5.6 0.0 0.0 0.0 0.0 15.8 2.8 0.0 0.0 0.0 0.0 17.0 0.0 6.7 2.0 2.3 15.0 2.8 4.9 0.0 0.0 4.9 0.0 21.0 0.0 0.1 0.0 0.5 1.2 5.3 0.0 3.9 0.3 0.0 5.7 2.4 4.5 0.0 3.8 3.7 0.0 3.4 12.1 12.8 0.0 0.8 1.1 4.9 8.6 19.8 3.9 10.3 4.5 0.0 0.3 1.3 0.0 0.0 0.0 8.4 0.0 0.3 45.5 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 15.2 12.7 75.3 17.1 10.3 5.2 8.9 11.1 22.3 7.8 8.9 15.6 0.0 117.0 56.2 1.2 37.7 5.1 28.1 33.0 17.4 3.9 0.2 1.7 19.6 0.9 0.7 34.8 0.0 42.5 13.5 15.3 169.9 0.0 8.2 0.6 189.1 28.2 0.0 0.8 0.0 1.4 0.8 10.1 0.0 45.4 65.8 61.4 22.8 0.0 11.3 5.0 0.0 3.4 0.4 0.7 41.7 0.7 1.5 21.1 247.4 KCNK10 "K2p10.1, PPP1R97, TREK-2, TREK2" ENSG00000100433 "Potassium two pore domain channel subfamily K member 10" P57789 14 88180103-88326907 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 12.2;brain: 14.1;intestine: 11.6" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 1.3;Intestinal endocrine cells: 1.7;Mucus-secreting cells: 1.6;Proximal tubular cells: 3.6;Undifferentiated cells: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 67 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 123 "dendritic cells: 12.2" "Cell line enhanced" "Detected in some" "AF22: 2.5;OE19: 3.7;REH: 4.2;SCLC-21H: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030462 Approved NA NA "HPA030462: AB_10601919" "unprognostic (9.52e-3)" "unprognostic (1.17e-1)" "unprognostic (1.94e-2)" "unprognostic (1.08e-1)" "unprognostic (8.20e-2)" "unprognostic (1.45e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-1)" "unprognostic (4.58e-1)" "unprognostic (1.23e-2)" "unprognostic (2.70e-1)" "unprognostic (2.45e-1)" "unprognostic (6.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (4.26e-3)" 0.4 1.1 7.4 1.2 6.9 0.9 0.5 14.1 11.2 0.4 3.2 5.6 0.0 11.6 0.3 0.3 2.2 0.4 0.5 0.4 7.2 4.5 5.7 0.4 0.6 0.7 5.0 5.7 0.4 3.5 0.4 0.9 0.3 6.4 0.5 2.1 0.0 0.5 0.3 0.4 0.4 5.7 0.5 5.0 0.6 6.7 1.3 2.3 0.0 0.4 0.5 1.3 0.5 0.4 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.7 3.7 0.2 4.2 0.1 0.0 0.1 0.1 7.7 0.3 0.1 0.1 0.0 0.3 0.0 1.0 0.1 0.1 1.4 0.2 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.1 7.4 6.9 14.1 11.2 7.2 4.5 5.0 5.7 6.4 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 KCNK12 "K2p12.1, THIK-2, THIK2" ENSG00000184261 "Potassium two pore domain channel subfamily K member 12" Q9HB15 2 47516581-47570939 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 22.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 8.7;Cone photoreceptor cells: 13.7;Early spermatids: 6.7;Extravillous trophoblasts: 30.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "REH: 22.1;SCLC-21H: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.10e-2)" "unprognostic (1.24e-1)" "unprognostic (6.02e-3)" "unprognostic (3.29e-2)" "unprognostic (2.50e-1)" "unprognostic (3.77e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (2.54e-2)" "unprognostic (2.14e-1)" "unprognostic (6.55e-3)" "unprognostic (2.12e-1)" "unprognostic (1.12e-6)" "unprognostic (1.36e-1)" "unprognostic (1.34e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-1)" 1.1 1.7 9.8 5.1 4.6 1.0 0.9 22.7 16.1 0.8 1.1 2.4 0.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 5.6 3.4 1.0 0.8 1.0 1.6 7.2 4.0 1.2 0.8 0.9 5.5 1.7 8.1 1.0 0.9 0.6 0.9 0.8 1.2 1.0 0.9 0.9 10.1 1.1 1.2 1.5 2.1 0.0 1.0 0.0 1.5 1.0 0.3 0.7 0.1 0.2 0.0 0.4 1.8 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.3 0.0 0.5 22.1 0.0 1.6 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.7 1.0 1.8 0.1 0.2 1.1 1.0 0.2 0.4 0.0 0.0 1.1 0.2 9.8 4.6 22.7 16.1 5.6 3.4 7.2 4.0 8.1 2.1 0.0 0.0 1.9 0.0 0.1 8.7 0.8 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.0 30.7 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.3 4.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 5.4 0.0 0.5 0.7 1.4 0.0 0.7 2.2 0.0 0.0 KCNK13 "K2p13.1, THIK-1, THIK1" ENSG00000152315 "Potassium two pore domain channel subfamily K member 13" Q9HB14 14 90061765-90185857 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.3;parathyroid gland: 14.3;testis: 13.2" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 7 "dendritic cells: 3.8;monocytes: 1.5" "Cell line enhanced" "Detected in some" "GAMG: 2.4;RT4: 4.2;SuSa: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003514 Approved Approved "Nuclear speckles,Cell Junctions" NA NA "Nuclear speckles, Cell Junctions" "HPA003514: AB_2666978" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (6.17e-2)" "unprognostic (6.31e-2)" "unprognostic (2.56e-1)" "unprognostic (5.55e-2)" "unprognostic (3.56e-2)" "unprognostic (3.98e-2)" "unprognostic (2.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.85e-1)" "unprognostic (3.45e-2)" "unprognostic (1.97e-1)" "unprognostic (2.04e-2)" "unprognostic (6.32e-2)" "unprognostic (1.46e-1)" "unprognostic (5.65e-2)" 0.8 1.1 2.9 2.2 3.5 0.1 0.4 0.2 4.2 0.4 0.6 4.0 0.0 0.6 0.3 1.5 0.3 0.4 0.5 2.7 2.9 2.4 4.8 0.7 0.7 1.6 6.3 1.4 0.4 2.7 14.3 0.6 1.2 3.6 0.4 0.7 0.1 1.1 0.7 0.1 0.1 0.7 0.4 8.3 1.1 0.5 13.2 5.4 0.7 2.7 0.0 0.6 0.8 0.1 0.0 3.8 0.0 1.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.9 0.0 0.0 0.8 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.4 4.2 1.8 0.5 0.0 1.8 1.2 7.1 0.0 1.6 0.0 0.0 2.1 0.0 0.6 0.6 1.8 0.0 0.2 0.0 0.1 0.0 1.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 2.9 3.5 0.2 4.2 2.9 2.4 6.3 1.4 3.6 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 2.5 0.6 0.0 5.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.1 0.0 0.0 0.1 KCNK15 "dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5" ENSG00000124249 "Potassium two pore domain channel subfamily K member 15" Q9H427 20 44745780-44752313 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 24.2" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Collecting duct cells: 8.7;Exocrine glandular cells: 6.4;Leydig cells: 6.1;Urothelial cells: 7.0" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 47.5" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "MCF7: 32.2" "Region enriched" "Detected in single" 18 "olfactory region: 8.4" "Region enriched" "Detected in many" 8 "olfactory region: 9.3" HPA064861 Uncertain NA NA "HPA064861: AB_2685373" "unprognostic (8.70e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.05e-2)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.50e-2)" "unprognostic (4.22e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.11e-2)" "unprognostic (7.38e-4)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (2.21e-3)" "unprognostic (2.11e-1)" 6.0 4.5 0.4 1.3 3.4 0.5 5.9 0.0 1.2 6.2 2.3 0.0 24.2 1.1 4.3 10.6 3.2 15.1 10.7 3.8 0.6 0.4 3.5 7.0 3.0 2.2 0.6 0.0 12.6 7.4 0.6 4.2 1.1 1.1 2.7 0.8 2.1 3.4 9.6 2.6 2.0 0.9 3.8 0.3 0.6 4.1 10.6 0.0 0.0 6.5 0.5 0.9 2.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.3 0.0 0.9 0.4 3.1 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.4 0.0 1.2 0.6 0.4 0.6 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.6 5.1 0.0 0.0 8.7 0.0 0.0 0.0 3.2 0.2 0.7 0.0 0.0 6.4 0.0 1.3 2.3 0.0 0.0 0.1 0.0 1.2 0.6 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.4 0.6 0.0 0.0 0.8 7.0 KCNK16 "K2p16.1, TALK-1, TALK1" ENSG00000095981 "Potassium two pore domain channel subfamily K member 16" Q96T55 6 39314698-39322968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 22.4;stomach 1: 11.3" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 17 "pancreatic cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "basophil: 4.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.6" "Cell line enriched" "Detected in single" 406 "SCLC-21H: 55.9" "Low region specificity" "Detected in all" NA NA "unprognostic (3.29e-2)" "unprognostic (3.48e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 22.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.1 11.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.4 4.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Group enriched" "Detected in some" 4 "Exocrine glandular cells: 7.3;granulocytes: 5.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 42.5" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK18 "K2p18.1, TRESK, TRESK-2, TRESK2, TRIK" ENSG00000186795 "Potassium two pore domain channel subfamily K member 18" Q7Z418 10 117197489-117210299 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.5;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044739 Uncertain NA NA "HPA044739: AB_10795008" 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK2 "K2p2.1, TREK-1" ENSG00000082482 "Potassium two pore domain channel subfamily K member 2" O95069 1 215005775-215237093 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "adrenal gland: 49.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 1.1;Fibroblasts: 1.4;Melanocytes: 3.3;Suprabasal keratinocytes: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 31.4;fHDF/TERT166: 27.6;hTERT-RPE1: 18.9;T-47d: 42.0;U-2197: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.43e-2)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (3.81e-4)" "unprognostic (2.58e-1)" "unprognostic (3.58e-2)" "unprognostic (3.48e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (1.82e-1)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-6)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "unprognostic (7.69e-3)" "unprognostic (7.46e-3)" 2.9 49.1 4.8 1.1 7.4 0.5 6.1 1.1 6.2 2.3 1.1 2.5 0.0 0.6 0.8 2.6 1.2 1.0 1.6 0.5 5.1 4.3 1.2 0.5 0.7 0.5 2.3 7.3 3.5 2.0 0.5 0.5 0.5 3.3 1.2 1.6 0.0 0.8 3.7 1.2 3.4 2.3 1.5 4.5 0.4 3.7 1.5 3.3 0.0 8.9 2.7 0.4 2.6 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 7.9 31.4 0.0 11.0 7.3 3.5 8.3 0.0 0.4 0.0 0.0 27.6 0.0 0.0 4.9 0.0 6.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 8.1 0.0 8.4 0.8 18.9 0.0 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.9 1.5 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.8 0.2 0.1 0.0 42.0 0.0 0.0 6.1 0.2 15.0 0.6 0.6 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.8 7.4 1.1 6.2 5.1 4.3 2.3 7.3 3.3 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.2 1.3 0.0 0.0 0.0 0.0 KCNK3 "K2p3.1, TASK, TASK-1" ENSG00000171303 "Potassium two pore domain channel subfamily K member 3" O14649 2 26692690-26733420 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 69.2" "Cell type enhanced" "Detected in many" 17 "Collecting duct cells: 97.7;Exocrine glandular cells: 82.2;Pancreatic endocrine cells: 31.4" "Cancer enhanced" "Detected in many" "renal cancer: 9.7" "Group enriched" "Detected in many" 4 "basal ganglia: 4.0;cerebellum: 4.7;cerebral cortex: 6.2;hypothalamus: 4.0;pons and medulla: 13.4" "Cell type enhanced" "Detected in some" "neutrophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.7;EFO-21: 10.0;HeLa: 3.4;SCLC-21H: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.16e-3)" "unprognostic (7.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.67e-4)" "unprognostic (2.08e-1)" "unprognostic (2.91e-1)" "unprognostic (5.01e-2)" "unprognostic (2.16e-1)" "unprognostic (3.31e-1)" "unprognostic (5.48e-2)" "unprognostic (3.77e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.37e-7)" "unprognostic (3.09e-2)" "unprognostic (7.45e-2)" "unprognostic (1.44e-2)" "unprognostic (9.24e-3)" 2.4 69.2 1.3 1.9 4.0 0.6 8.3 4.7 6.2 3.5 4.0 0.8 5.7 1.3 2.4 5.6 1.9 2.0 2.3 10.3 1.0 4.0 1.8 0.7 10.0 0.6 1.5 1.5 4.6 24.7 0.7 3.6 16.6 13.4 8.2 1.1 1.9 0.6 7.7 0.6 0.6 2.6 4.7 1.1 0.9 2.2 0.9 0.0 0.0 2.1 0.0 0.5 3.2 2.3 0.7 0.5 2.5 0.4 1.2 0.4 0.0 0.0 0.6 0.2 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 10.0 0.0 1.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 23.5 2.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.4 0.3 0.4 0.2 0.4 0.3 0.3 0.3 0.2 0.7 0.4 0.4 2.5 1.2 0.2 0.5 0.2 0.0 1.3 4.0 4.7 6.2 1.0 4.0 1.5 1.5 13.4 0.0 0.0 3.2 0.0 0.2 0.0 11.5 10.0 0.0 0.0 0.0 97.7 0.0 0.2 0.0 0.8 0.4 1.0 0.0 0.0 82.2 0.2 1.9 1.6 0.0 0.0 0.3 1.6 22.5 0.6 0.0 1.3 0.9 0.0 0.0 1.0 0.4 1.2 31.4 0.0 0.0 0.0 3.9 6.5 3.1 0.0 1.3 0.1 0.5 0.0 0.0 0.3 KCNK4 "K2p4.1, TRAAK" ENSG00000182450 "Potassium two pore domain channel subfamily K member 4" Q9NYG8 11 64291302-64300031 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 12.3" "Cell type enhanced" "Detected in some" 13 "Extravillous trophoblasts: 1.7;Fibroblasts: 1.1;Horizontal cells: 3.2;Muller glia cells: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;MCF7: 1.5;SH-SY5Y: 2.9;U-2197: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.85e-1)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (2.84e-1)" 0.7 0.5 12.2 0.5 11.6 0.5 0.5 1.0 12.3 1.6 0.6 0.3 0.0 0.6 1.2 0.5 0.5 0.6 0.6 0.6 10.2 3.1 0.7 0.5 0.6 0.6 1.5 4.0 0.5 0.5 0.5 0.0 2.0 2.7 0.9 0.5 1.1 0.5 0.8 0.5 0.5 0.7 0.5 0.3 0.6 0.6 0.9 0.1 0.0 0.6 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.1 0.2 0.2 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 1.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 11.6 1.0 12.3 10.2 3.1 1.5 4.0 2.7 0.1 0.0 0.0 0.0 0.0 0.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 KCNK5 "K2p5.1, TASK-2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188973-39229450 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.4;intestine: 74.2;kidney: 46.3" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059148 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059148: AB_2683929" "unprognostic (1.46e-1)" "prognostic favorable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favorable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favorable (4.45e-4)" 2.2 1.3 0.3 4.5 0.4 4.5 3.9 0.4 0.5 4.3 25.5 0.8 2.6 16.1 5.6 4.0 4.3 1.4 48.4 1.5 0.3 0.0 46.3 12.6 3.6 1.1 0.8 0.4 4.0 15.3 1.2 1.0 15.2 0.8 2.3 4.7 3.6 16.0 1.6 0.5 15.8 74.2 1.3 0.6 1.2 9.4 0.9 0.3 2.0 9.0 2.2 4.1 2.2 3.8 0.0 0.9 0.2 0.1 0.0 1.4 0.5 3.4 3.2 4.3 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 18.8 7.8 0.0 5.7 0.0 0.4 7.2 3.3 0.1 0.0 0.0 2.4 19.3 1.5 0.1 0.0 3.9 17.8 0.0 0.0 0.1 0.0 0.0 0.0 4.3 18.0 0.0 0.0 6.1 8.7 4.3 7.9 14.7 0.0 0.0 0.8 7.3 3.0 2.9 1.0 0.8 3.1 4.0 0.0 1.7 14.3 6.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.9 1.4 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.5 0.3 0.4 0.4 0.5 0.3 0.0 0.8 0.4 0.8 0.3 0.0 19.2 0.0 1.8 3.3 0.0 0.4 43.3 0.0 6.8 1.8 0.0 22.6 5.0 13.0 0.0 0.2 50.9 0.0 10.8 3.9 1.9 1.8 0.0 23.1 1.8 0.0 0.0 0.0 0.3 0.0 0.6 0.7 1.7 1.0 10.8 0.0 7.5 10.5 0.0 29.1 0.0 0.0 0.4 0.0 0.7 2.4 38.1 1.0 6.4 10.7 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592855-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 35.0;tongue: 20.7" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 90.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6" "Group enriched" "Detected in many" 12 "B-cells: 2.9;granulocytes: 4.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077577 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077577: AB_2686845" "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 0.6 0.6 0.8 0.3 0.7 3.9 2.6 1.6 2.1 1.4 0.5 0.8 0.3 0.4 0.4 0.3 10.8 0.6 0.3 0.5 0.8 0.4 0.3 0.3 0.3 0.3 0.6 1.1 0.6 0.3 0.1 0.3 0.5 0.4 0.3 0.1 0.3 0.8 0.4 1.8 35.0 0.5 0.3 0.7 0.5 0.3 0.3 0.5 0.7 0.3 20.7 5.7 0.3 3.4 2.9 0.0 4.8 0.2 0.2 0.3 0.1 0.5 2.3 0.1 0.7 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.3 1.7 0.8 0.7 0.2 0.4 3.8 0.0 0.0 0.0 0.8 2.6 0.8 1.2 1.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.4 0.0 1.6 1.4 2.2 0.7 1.7 0.9 0.7 1.0 1.0 2.2 1.6 0.0 0.4 1.0 0.2 12.4 2.8 0.5 0.7 1.2 0.1 0.7 2.2 0.0 0.6 1.9 1.9 0.1 2.0 1.3 0.5 1.4 1.1 1.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.9 0.1 0.0 3.6 0.2 0.2 0.0 0.0 0.1 0.8 0.7 1.6 2.1 0.8 0.4 0.6 1.1 0.4 0.5 0.0 0.3 0.0 0.4 16.9 2.3 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.0 1.2 0.0 1.5 1.3 0.6 0.0 3.3 0.0 0.3 0.2 0.1 2.8 0.0 0.0 0.8 6.5 1.9 0.1 0.5 90.7 0.0 0.0 0.5 1.0 KCNK9 "K2p9.1, TASK-3, TASK3" ENSG00000169427 "Potassium two pore domain channel subfamily K member 9" Q9NPC2 8 139600838-139703056 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 9.4;brain: 15.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075842 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA075842: " "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "unprognostic (1.58e-1)" "unprognostic (8.96e-8)" "unprognostic (1.91e-1)" "unprognostic (8.17e-3)" "unprognostic (2.19e-3)" "unprognostic (1.65e-1)" "unprognostic (3.87e-1)" "unprognostic (1.69e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-1)" "unprognostic (5.12e-6)" "unprognostic (2.94e-2)" "unprognostic (1.64e-1)" "unprognostic (9.99e-3)" "unprognostic (1.76e-1)" 0.2 9.4 0.5 0.5 1.0 0.1 0.1 15.4 7.7 1.3 0.5 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.2 1.6 1.4 0.1 0.1 0.1 0.1 0.7 1.7 0.1 0.1 0.1 1.1 0.2 6.6 0.1 0.2 0.2 0.1 0.1 1.4 0.1 0.1 0.6 0.6 0.1 0.3 0.5 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 2.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 15.4 3.7 1.6 1.4 0.7 1.7 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.2 1.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 KCNMB1 hslo-beta ENSG00000145936 "Potassium calcium-activated channel subfamily M regulatory beta subunit 1" Q16558 5 170374671-170389677 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 55.5" "Cell type enriched" "Detected in many" 6 "Peritubular cells: 333.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 7.1" "Cell line enhanced" "Detected in some" "REH: 13.0;SK-BR-3: 3.2;U-937: 5.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" NA NA "unprognostic (2.06e-2)" "unprognostic (2.70e-4)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (8.88e-2)" "unprognostic (1.61e-2)" "unprognostic (3.46e-1)" "unprognostic (2.28e-1)" "unprognostic (4.68e-2)" "unprognostic (5.37e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.08e-1)" "unprognostic (2.49e-1)" "unprognostic (4.31e-2)" "unprognostic (1.04e-2)" 3.2 1.0 0.6 7.7 0.5 0.7 4.2 0.4 0.6 26.8 34.7 0.8 12.6 2.2 31.3 10.6 29.8 10.9 32.4 2.6 0.6 0.7 1.9 0.4 2.2 1.3 1.1 0.9 8.7 0.5 0.1 0.5 0.9 2.2 29.4 5.0 5.6 5.3 29.3 0.9 1.6 11.4 55.5 1.5 1.1 13.4 8.0 0.6 0.3 1.0 1.5 1.6 43.4 6.4 0.5 7.0 1.4 7.1 0.6 0.3 1.0 0.1 0.2 2.3 0.6 0.2 0.0 0.4 0.3 0.1 0.1 0.1 0.5 0.4 0.2 1.6 0.1 0.6 0.2 0.1 0.1 0.1 0.5 0.1 1.5 0.8 0.3 0.0 0.6 0.4 0.4 0.0 0.2 0.4 0.2 0.2 0.7 0.5 1.1 0.1 1.0 0.0 1.4 0.4 0.1 0.2 13.0 0.1 0.3 0.1 0.4 0.5 0.3 0.1 3.2 0.0 1.1 0.2 1.4 0.8 0.3 0.5 0.5 0.1 0.8 0.3 0.2 0.2 5.4 0.2 1.3 4.3 0.4 0.2 7.1 0.1 0.2 0.3 0.2 7.0 0.5 0.2 0.2 1.4 0.6 6.0 2.6 0.2 1.0 0.6 0.5 0.4 0.5 0.6 0.7 1.1 0.9 2.2 0.6 0.0 7.5 1.3 1.0 1.8 1.5 2.6 2.5 8.1 7.9 1.8 5.9 0.5 0.0 0.1 0.5 2.7 0.0 0.0 0.4 0.6 14.4 1.0 19.6 0.0 7.7 1.6 0.0 1.8 9.1 1.6 35.6 21.4 3.3 29.7 0.0 1.1 0.0 0.0 333.0 0.0 1.8 45.3 59.8 0.7 0.9 1.5 0.5 0.0 0.0 0.5 KCNMB2 ENSG00000197584 "Potassium calcium-activated channel subfamily M regulatory beta subunit 2" Q9Y691 3 178272932-178844429 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.8" "Group enriched" "Detected in some" 4 "Ciliated cells: 14.7;Intestinal endocrine cells: 13.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.5;fHDF/TERT166: 2.6;RPMI-8226: 1.8;SCLC-21H: 8.5" CAB022649 Uncertain NA NA "CAB022649: " "unprognostic (9.52e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (1.04e-2)" "unprognostic (2.43e-2)" "unprognostic (6.97e-2)" "unprognostic (6.74e-2)" "unprognostic (2.15e-1)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (1.71e-2)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-4)" "unprognostic (7.85e-2)" 0.7 6.3 7.8 0.5 6.2 0.4 1.3 1.8 11.2 2.5 1.9 2.2 4.4 1.0 7.2 36.8 0.9 14.3 0.9 7.4 13.2 4.5 4.1 0.6 1.6 0.4 4.7 4.9 16.3 4.5 0.4 10.2 0.5 6.2 1.1 0.9 0.5 0.6 1.9 0.6 0.7 0.9 3.0 3.2 1.9 3.6 0.6 3.2 0.0 1.1 0.0 0.4 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 6.5 0.0 0.0 0.4 0.0 0.0 1.4 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.0 1.0 8.5 0.0 0.0 0.5 0.0 0.6 1.4 0.0 0.3 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.2 1.8 11.2 13.2 4.5 4.7 4.9 6.2 3.2 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 14.7 1.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 13.3 2.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNMB4 ENSG00000135643 "Potassium calcium-activated channel subfamily M regulatory beta subunit 4" Q86W47 12 70366276-70434292 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 24.4;brain: 37.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 16.9;Collecting duct cells: 22.7;Ito cells: 24.5;Peritubular cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 8.9;RH-30: 9.5;RT4: 10.4;SuSa: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072287 Enhanced Approved Approved Cytosol NA NA Cytosol "HPA072287: AB_2686507" "unprognostic (3.90e-1)" "unprognostic (1.72e-2)" "unprognostic (2.69e-2)" "unprognostic (2.62e-2)" "unprognostic (6.98e-2)" "unprognostic (1.13e-3)" "unprognostic (1.85e-1)" "unprognostic (2.48e-2)" "unprognostic (3.50e-1)" "unprognostic (2.95e-2)" "unprognostic (3.75e-1)" "unprognostic (2.47e-2)" "unprognostic (2.19e-2)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.05e-2)" 4.4 24.4 19.8 2.6 24.6 1.3 2.6 13.8 37.7 3.5 5.0 28.4 1.0 2.5 3.2 2.8 2.6 3.3 3.2 5.9 25.9 10.4 5.8 1.8 4.6 2.8 28.6 19.3 5.4 1.5 1.3 1.4 4.9 11.6 2.9 2.9 2.0 3.8 4.5 4.2 4.9 3.0 2.8 15.2 2.8 1.8 3.8 26.0 0.8 3.3 0.0 2.6 2.4 2.1 1.7 0.6 0.3 0.3 0.2 2.8 0.5 0.0 0.3 5.6 3.1 0.3 0.3 0.6 0.6 1.0 0.3 0.9 0.2 2.1 2.7 0.3 0.0 1.2 0.1 6.0 0.9 0.2 1.3 3.5 1.4 1.3 3.2 0.0 0.1 0.1 1.6 0.1 0.0 0.0 0.6 0.2 4.0 0.0 0.0 1.1 0.7 1.9 0.4 8.9 0.1 6.4 2.8 9.5 0.2 0.2 10.4 2.7 3.4 0.8 1.1 0.1 8.9 3.1 0.1 0.1 0.4 1.5 0.1 0.3 2.0 0.0 2.8 0.5 0.0 0.9 0.3 0.3 0.0 0.3 0.3 0.3 0.6 0.6 0.6 0.6 1.7 2.2 2.8 0.3 0.2 0.1 0.2 0.6 0.5 19.8 24.6 13.8 19.1 25.9 10.4 28.6 19.3 11.6 26.0 0.0 1.1 0.0 0.1 2.9 16.9 3.1 0.0 0.0 0.0 22.7 0.0 0.2 0.0 0.0 0.9 6.0 0.0 0.0 0.0 0.2 2.2 0.4 0.0 0.2 1.1 0.0 0.0 24.5 9.5 1.8 6.1 2.0 1.7 0.0 0.0 0.4 0.0 0.0 17.0 7.8 2.7 0.0 1.7 1.5 4.9 4.8 0.2 0.5 0.0 0.0 KCNN1 "hSK1, KCa2.1" ENSG00000105642 "Potassium calcium-activated channel subfamily N member 1" Q92952 19 17951293-18000080 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "brain: 32.5" "Cell type enhanced" "Detected in some" 6 "Melanocytes: 5.0;monocytes: 3.6;Spermatogonia: 4.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.3" "Cell line enriched" "Detected in some" 12 "REH: 58.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065938 Approved "Actin filaments,Cytosol" Yes No "Actin filaments, Cytosol" "HPA065938: AB_2685582" "unprognostic (7.55e-2)" "unprognostic (4.03e-2)" "unprognostic (1.82e-1)" "unprognostic (7.80e-2)" "unprognostic (1.90e-1)" "unprognostic (8.94e-5)" "unprognostic (3.92e-3)" "unprognostic (1.01e-1)" "unprognostic (8.42e-2)" "unprognostic (3.59e-1)" "unprognostic (2.71e-3)" "unprognostic (3.38e-1)" "unprognostic (5.21e-3)" "unprognostic (2.70e-2)" "unprognostic (1.14e-1)" "unprognostic (7.24e-3)" "unprognostic (3.24e-1)" 0.8 0.9 25.8 1.5 11.3 0.9 0.8 3.3 27.0 1.6 1.0 0.5 0.1 1.0 1.7 1.0 1.0 0.9 1.0 1.3 32.5 3.3 0.9 0.8 0.8 1.0 5.0 8.7 2.6 0.9 0.7 0.2 0.8 4.1 1.2 0.8 0.0 1.5 1.3 1.0 0.9 1.2 0.9 1.2 0.9 0.9 2.8 1.6 0.0 0.9 0.0 1.0 0.9 0.0 0.2 0.2 2.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 2.1 0.0 0.1 0.1 0.9 1.9 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.0 25.8 11.3 3.3 22.4 32.5 3.3 5.0 8.7 4.1 1.6 0.0 0.0 0.0 2.5 2.3 2.2 0.8 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.0 2.3 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.9 0.9 5.0 3.6 0.0 1.3 0.2 0.0 1.8 0.0 0.9 0.0 1.9 0.4 4.3 3.3 0.1 0.7 0.0 1.4 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 15.0 2.3 0.3 0.1 0.0 0.2 0.0 0.5 0.0 2.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.1 0.0 0.2 0.0 1.2 5.7 0.0 0.0 0.1 0.0 0.7 0.3 0.1 1.8 0.0 0.0 0.2 10.6 0.3 0.2 18.7 0.2 0.0 0.4 1.7 0.0 0.1 0.0 0.1 1.8 6.7 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 0.0 0.6 0.0 0.1 0.2 6.8 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 5.2 0.0 0.0 0.8 0.0 0.9 4.5 0.0 14.7 0.0 0.0 0.0 6.2 1.0 0.0 0.0 0.0 20.3 0.0 0.5 0.3 1.4 0.0 0.0 0.5 7.2 0.0 0.5 0.5 3.2 0.3 0.0 0.0 0.4 0.1 KCNN3 "hSK3, KCa2.3, SKCA3" ENSG00000143603 "Potassium calcium-activated channel subfamily N member 3" Q9UGI6 1 154697455-154870280 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.7" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 11.9;Ciliated cells: 32.1;Endothelial cells: 16.9" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.8;memory B-cell: 4.8" "Group enriched" "Detected in many" 9 "B-cells: 4.8;granulocytes: 5.8;monocytes: 2.7" "Cell line enhanced" "Detected in some" "Daudi: 18.1;HMC-1: 12.5;Karpas-707: 31.0;RPMI-8226: 8.4;U-266/70: 29.9;U-698: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057127 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA057127: AB_2683345" "unprognostic (2.09e-1)" "unprognostic (2.91e-2)" "unprognostic (3.41e-2)" "unprognostic (1.04e-1)" "unprognostic (7.22e-2)" "unprognostic (4.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.03e-1)" "unprognostic (3.43e-2)" "unprognostic (9.51e-2)" "unprognostic (4.07e-3)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (6.93e-2)" "unprognostic (1.80e-2)" 1.7 2.5 20.6 6.5 21.7 1.0 1.8 5.7 26.7 9.3 9.1 12.4 1.1 5.4 12.6 1.7 3.5 10.3 3.1 4.0 21.6 8.0 3.5 1.0 3.1 5.8 12.0 10.9 2.1 1.0 1.5 2.6 0.7 13.3 3.4 4.6 0.1 2.7 2.7 8.5 1.1 3.9 10.6 8.1 5.0 4.4 1.3 15.5 0.2 3.7 3.5 9.2 8.3 4.9 4.8 0.4 5.8 2.7 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 1.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 31.0 0.3 0.0 0.1 0.0 0.4 0.0 1.2 0.0 7.7 8.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 29.9 3.9 10.0 0.3 0.0 2.9 5.8 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 20.6 21.7 5.7 10.3 21.6 8.0 12.0 10.9 13.3 15.5 11.9 2.4 0.0 0.5 1.1 0.2 2.2 0.0 32.1 3.4 0.0 2.0 0.0 3.3 0.2 2.6 16.9 0.0 0.0 0.2 0.0 2.3 0.4 0.0 0.0 0.4 0.0 4.1 5.5 0.0 6.2 0.3 0.8 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.5 0.1 1.5 0.0 0.0 0.0 0.1 KCNN4 "hIKCa1, hKCa4, hSK4, IK, KCa3.1" ENSG00000104783 "Potassium calcium-activated channel subfamily N member 4" O15554 19 43766533-43781257 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 45.7;salivary gland: 82.3" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 196.8;Syncytiotrophoblasts: 638.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.8;hTERT-RPE1: 24.5;SK-BR-3: 27.5;WM-115: 70.6" "Region enhanced" "Detected in single" "olfactory region: 2.3" "Not detected" "Not detected" "HPA053841, HPA059622" Approved NA NA "HPA053841: AB_2682278, HPA059622: AB_2684085" "unprognostic (1.23e-2)" "unprognostic (3.22e-2)" "unprognostic (4.29e-1)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.98e-2)" "unprognostic (7.33e-2)" "unprognostic (1.42e-2)" "unprognostic (2.48e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (9.96e-3)" "prognostic unfavorable (1.05e-14)" "unprognostic (3.70e-2)" "unprognostic (2.17e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.75e-4)" 3.0 0.1 0.5 12.2 2.5 6.5 5.6 0.4 0.5 8.0 5.7 0.7 6.4 2.0 0.9 2.9 2.6 2.6 8.8 0.6 1.4 0.5 0.8 0.3 2.6 5.7 1.7 0.6 1.3 0.3 0.0 0.3 45.7 1.5 11.0 3.8 0.8 82.3 6.8 0.7 10.8 10.0 2.0 1.1 8.4 13.6 0.9 1.0 9.1 0.7 3.6 17.3 10.3 2.4 18.7 14.4 1.9 15.8 0.0 6.9 5.2 5.1 9.6 0.0 0.0 0.0 0.8 13.5 0.2 0.7 0.5 0.1 0.1 27.8 1.5 2.2 0.2 3.2 4.1 0.0 9.8 1.4 9.3 0.0 6.8 12.5 0.2 0.0 0.0 0.1 0.0 1.2 0.6 4.4 24.5 0.0 0.0 1.5 0.8 0.1 5.0 1.5 5.2 0.0 21.9 10.3 4.6 0.1 5.1 8.5 14.4 0.0 0.0 13.8 27.5 8.1 0.6 0.0 5.5 0.3 3.8 19.7 0.1 11.1 0.0 0.3 0.6 13.1 1.2 70.6 1.9 10.2 0.0 0.3 15.8 0.4 18.7 5.1 2.6 14.4 9.4 3.4 3.2 0.5 0.0 8.6 0.4 6.9 5.2 0.5 2.5 0.4 0.5 1.4 0.5 1.7 0.6 1.5 1.0 0.0 3.4 27.2 43.3 2.5 0.1 0.4 7.6 0.0 6.8 1.8 3.9 196.8 0.0 3.0 0.7 2.8 4.2 23.3 3.5 6.8 2.8 66.7 0.0 0.0 43.0 0.0 0.0 0.0 7.5 0.0 0.0 28.3 20.3 0.0 5.9 0.0 37.2 16.9 0.0 0.0 0.3 0.0 1.0 0.0 1.3 1.9 638.3 6.5 43.7 53.5 KCNQ1 "JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1" ENSG00000053918 "Potassium voltage-gated channel subfamily Q member 1" P51787 11 2444684-2849110 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Deafness, Diabetes mellitus, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 32.7;Undifferentiated cells: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 19.9;OE19: 24.0;RPMI-8226: 13.4;U-266/70: 7.9;U-937: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB018656, HPA048553" Enhanced NA NA "CAB018656: AB_2131551, HPA048553: AB_2680438" "unprognostic (6.02e-2)" "unprognostic (2.48e-1)" "unprognostic (6.39e-3)" "unprognostic (4.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.83e-1)" "unprognostic (3.46e-2)" "unprognostic (7.36e-2)" "unprognostic (8.07e-2)" "unprognostic (8.81e-2)" "unprognostic (1.58e-1)" "unprognostic (5.39e-2)" "unprognostic (2.46e-3)" "prognostic favorable (9.85e-4)" "unprognostic (3.99e-2)" "unprognostic (4.19e-2)" "unprognostic (5.27e-2)" 3.0 78.2 1.0 5.1 1.0 3.4 3.1 0.6 1.2 5.0 13.7 4.1 88.1 14.2 1.9 15.9 1.5 2.1 12.2 10.7 1.5 1.0 13.8 1.0 11.4 5.8 1.2 0.8 1.6 25.6 5.6 2.7 1.8 1.8 7.5 4.6 2.5 9.5 83.6 0.8 1.0 18.4 1.5 1.4 5.5 31.2 3.6 1.5 1.6 36.2 0.9 4.8 5.5 3.6 1.2 5.6 5.3 4.7 0.0 1.7 1.4 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.4 0.9 3.3 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.9 0.0 2.4 0.2 0.2 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.7 24.0 0.1 0.1 0.0 13.4 5.0 1.6 0.4 3.7 0.4 0.0 0.0 0.3 0.1 5.1 0.0 0.0 0.1 0.1 0.0 7.9 0.0 0.0 0.0 7.8 0.0 1.6 4.7 4.7 0.0 2.6 0.1 1.2 0.6 0.1 5.6 0.6 1.7 1.7 5.3 0.0 3.7 1.9 0.5 1.4 1.0 1.0 0.6 1.2 1.5 1.0 1.2 0.8 1.8 1.5 3.0 11.7 6.7 6.7 0.6 0.0 15.9 17.8 2.7 5.7 27.9 0.0 1.0 13.3 16.6 1.1 2.9 32.7 0.0 18.8 1.1 1.0 6.2 19.6 0.2 13.9 0.0 6.3 9.2 24.1 0.6 0.3 10.1 1.7 1.8 21.3 0.6 17.8 17.5 0.0 1.6 0.2 6.5 1.0 0.2 0.1 0.9 1.7 1.3 44.9 14.7 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400210-63472677 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.8" "Group enriched" "Detected in some" 5 "Early spermatids: 10.8;Horizontal cells: 12.7;Late spermatids: 5.7;Spermatocytes: 6.6;Spermatogonia: 17.0" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.2;T-reg: 1.5" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Cell line enhanced" "Detected in some" "AF22: 8.5;AN3-CA: 14.0;NTERA-2: 7.8;SCLC-21H: 27.5;SH-SY5Y: 48.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: AB_2683339" "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 1.2 10.0 18.7 1.3 21.4 1.2 1.2 24.1 50.8 1.2 1.3 2.4 0.0 1.3 1.2 1.3 1.2 1.7 1.7 1.2 15.4 10.0 1.2 1.2 1.2 1.2 8.4 14.1 1.2 1.9 1.2 9.2 1.2 8.9 2.8 1.2 0.0 1.2 1.2 1.2 1.2 1.3 1.2 2.6 1.2 1.3 6.9 4.2 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.5 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 27.5 48.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 1.5 0.0 18.7 21.4 24.1 31.2 15.4 10.0 8.4 14.1 8.9 4.2 0.0 0.0 0.0 0.0 0.1 1.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 12.7 0.0 0.0 0.0 5.7 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 2.1 0.0 0.0 6.6 17.0 0.0 0.0 0.0 0.0 0.0 KCNQ3 "EBN2, Kv7.3" ENSG00000184156 "Potassium voltage-gated channel subfamily Q member 3" O43525 8 132120858-132481019 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 29.5" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 9.4;Bipolar cells: 5.7;Cardiomyocytes: 4.5;Exocrine glandular cells: 5.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.1;JURKAT: 5.6;RPMI-8226: 4.1;U-2 OS: 6.6;U-87 MG: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.90e-1)" "unprognostic (1.26e-3)" "unprognostic (1.45e-2)" "unprognostic (3.65e-5)" "unprognostic (2.32e-1)" "unprognostic (4.60e-2)" "unprognostic (5.57e-6)" "unprognostic (5.82e-2)" "unprognostic (7.32e-2)" "unprognostic (6.09e-2)" "unprognostic (7.09e-2)" "unprognostic (3.22e-1)" "unprognostic (2.71e-4)" "unprognostic (1.14e-3)" "unprognostic (3.52e-1)" "unprognostic (7.92e-2)" "unprognostic (2.50e-2)" 1.8 3.3 10.6 1.5 13.1 0.7 1.4 0.9 29.5 1.4 1.0 1.7 0.0 1.0 1.0 0.9 0.8 1.2 1.3 1.8 8.0 7.3 1.8 0.7 2.0 0.9 7.4 11.5 0.8 1.2 1.2 1.4 1.0 6.5 1.4 1.0 0.0 1.0 1.8 0.7 1.3 1.7 1.6 2.1 1.3 0.9 1.0 4.7 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.5 1.6 0.0 0.5 1.6 0.0 0.0 0.0 1.5 0.0 1.8 2.3 3.8 0.0 0.0 3.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 2.6 10.1 0.1 0.0 5.6 0.0 0.2 1.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 4.1 2.4 0.0 1.9 1.7 0.7 0.0 0.0 0.3 0.0 1.4 0.0 0.0 6.6 0.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 13.1 0.9 13.3 8.0 7.3 7.4 11.5 6.5 4.7 0.0 9.4 0.0 0.0 0.2 5.7 4.5 0.0 1.4 2.3 0.0 0.0 0.0 0.0 2.9 1.5 0.6 0.0 0.0 5.1 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.3 0.0 1.2 0.0 1.0 0.0 0.2 2.8 0.0 0.0 0.4 0.4 0.0 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 KCNQ4 "DFNA2, Kv7.4" ENSG00000117013 "Potassium voltage-gated channel subfamily Q member 4" P56696 1 40783814-40840452 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Hearing, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.1;retina: 23.0" "Cell type enhanced" "Detected in some" 12 "Muller glia cells: 4.1;Sertoli cells: 6.5;Smooth muscle cells: 2.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.0;HEK 293: 5.9;K-562: 5.9;MCF7: 3.5;REH: 3.1;THP-1: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018305 Uncertain NA NA "HPA018305: AB_1855556" "unprognostic (1.42e-2)" "unprognostic (1.56e-1)" "unprognostic (8.43e-3)" "unprognostic (4.59e-3)" "unprognostic (8.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (5.86e-2)" "unprognostic (4.34e-2)" "unprognostic (6.64e-2)" "unprognostic (1.20e-1)" "unprognostic (7.40e-2)" "unprognostic (5.18e-4)" "unprognostic (2.68e-1)" "unprognostic (1.22e-1)" "unprognostic (3.17e-2)" "unprognostic (3.44e-2)" 2.5 0.9 1.1 1.5 2.9 0.4 1.3 3.8 3.6 2.5 9.1 0.9 1.5 1.5 5.8 0.9 3.5 4.6 2.8 2.1 1.6 0.7 0.4 0.4 1.4 0.4 1.4 2.1 1.6 40.1 0.5 0.6 2.1 1.3 3.3 1.7 23.0 5.4 5.3 5.9 1.1 2.3 7.5 2.0 0.4 2.9 1.2 1.4 0.5 0.6 0.9 0.4 5.3 2.5 0.0 0.5 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.3 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 1.6 0.4 0.6 0.0 0.0 0.0 4.0 0.0 0.0 0.1 5.9 2.0 0.3 0.0 0.4 0.4 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.9 5.9 0.1 0.0 3.5 0.7 0.0 0.4 0.0 0.1 3.1 0.0 0.0 0.7 0.0 2.6 0.5 0.0 1.5 0.6 0.4 0.3 3.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.1 2.9 3.8 3.6 1.6 0.7 1.4 2.1 1.3 1.4 0.0 0.0 0.0 0.0 0.1 0.3 1.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.2 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 0.3 0.0 0.7 0.0 0.3 6.5 2.7 0.2 0.5 0.4 0.0 0.0 0.4 0.1 KCNQ5 Kv7.5 ENSG00000185760 "Potassium voltage-gated channel subfamily Q member 5" Q9NR82 6 72621792-73198851 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 3.2;Cardiomyocytes: 2.0;Horizontal cells: 1.6;Melanocytes: 1.7;Smooth muscle cells: 1.4;T-cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 20.4;HEL: 13.3;HL-60: 17.9;U-251 MG: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016655 Enhanced Approved Vesicles NA NA Vesicles "HPA016655: AB_1855557" "unprognostic (4.91e-2)" "unprognostic (1.42e-1)" "unprognostic (4.96e-2)" "unprognostic (3.78e-2)" "unprognostic (2.69e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-2)" "unprognostic (1.43e-1)" "unprognostic (6.09e-2)" "unprognostic (8.55e-2)" "unprognostic (7.96e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (1.08e-2)" "unprognostic (2.62e-1)" "unprognostic (8.16e-2)" "unprognostic (1.39e-3)" 0.7 2.8 4.2 3.0 14.9 6.6 1.1 0.6 19.6 0.6 0.9 0.0 0.0 0.8 0.7 0.6 1.7 1.0 0.9 0.6 6.9 2.7 0.6 0.8 0.8 3.4 3.0 7.5 0.7 0.6 0.6 0.5 1.0 23.0 2.4 0.9 2.2 2.1 1.9 26.1 0.6 0.9 1.7 0.9 2.0 0.8 2.0 0.7 1.6 6.9 0.4 3.1 1.2 0.7 2.7 0.5 1.2 0.0 2.2 1.7 0.2 2.5 0.6 0.0 0.1 0.0 0.9 0.0 20.4 3.0 3.0 2.6 0.0 0.0 12.2 0.0 6.9 0.3 0.4 0.1 1.2 3.6 0.1 4.3 13.3 0.0 0.0 0.5 17.9 0.0 0.2 0.5 8.7 9.1 2.0 0.0 0.0 0.7 8.4 6.0 0.1 0.0 7.7 0.8 0.0 4.3 0.0 0.7 8.4 1.2 0.0 3.4 1.6 0.0 0.0 8.3 0.1 2.5 1.3 0.0 12.7 5.6 0.1 13.5 8.8 0.2 5.6 0.1 8.6 0.7 1.2 0.0 0.0 0.2 0.0 1.1 2.7 0.5 1.5 0.5 1.4 1.7 1.2 0.0 2.2 0.0 0.0 0.0 0.2 4.2 14.9 0.6 19.6 6.9 2.7 3.0 7.5 23.0 0.7 0.0 0.0 0.8 3.2 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.2 0.3 0.2 2.2 0.0 0.3 KCNRG ENSG00000198553 "Potassium channel regulator" Q8N5I3 13 50015254-50020922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 27.7;ovary: 17.1" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 92.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001027 Uncertain Vesicles NA NA Vesicles "HPA001027: " "unprognostic (1.85e-3)" "unprognostic (1.66e-2)" "unprognostic (1.08e-2)" "prognostic favorable (2.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.39e-3)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (1.71e-1)" "unprognostic (5.91e-1)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (4.69e-2)" "unprognostic (1.52e-1)" "unprognostic (9.16e-2)" 0.4 0.2 0.3 0.3 0.3 1.1 0.6 0.9 0.3 1.8 0.3 0.5 0.3 0.3 1.0 4.8 0.6 27.7 0.3 1.0 0.3 0.5 0.6 0.3 9.1 0.3 0.3 0.3 17.1 0.3 0.4 0.4 0.3 0.5 0.5 0.8 0.3 0.3 1.7 0.4 0.8 0.4 0.4 0.3 0.4 0.3 1.7 0.3 0.3 0.4 0.3 0.6 0.3 0.3 2.7 1.2 4.4 1.1 1.3 1.4 0.4 0.9 0.9 2.9 0.9 0.9 1.4 0.4 0.1 2.3 1.9 0.1 3.4 0.9 1.8 0.6 2.8 1.2 1.2 2.2 0.8 1.4 1.3 1.4 3.8 1.4 1.6 2.7 3.1 1.1 1.9 2.1 1.4 3.5 1.6 3.7 6.8 1.5 0.4 2.3 1.1 3.4 3.1 2.0 2.3 1.3 2.5 0.0 0.0 1.7 2.4 2.5 5.3 1.0 1.8 1.7 1.5 1.4 1.0 1.2 1.7 0.7 1.1 0.7 0.2 0.4 2.0 0.6 1.3 0.4 3.2 1.1 0.7 0.5 1.1 0.7 1.5 0.7 1.0 0.9 2.7 0.8 0.9 4.4 1.3 0.8 1.2 1.4 0.4 0.3 0.3 0.9 0.3 0.3 0.5 0.3 0.3 0.5 0.3 0.0 2.4 0.0 0.7 0.1 0.6 0.5 0.0 92.3 6.8 0.0 2.0 0.6 0.0 0.5 11.5 0.1 0.5 0.0 1.2 0.4 0.8 0.6 0.0 0.2 0.5 3.2 4.1 0.0 0.0 8.9 0.6 0.0 0.0 1.0 1.1 0.8 0.4 0.0 0.7 1.5 1.0 0.0 0.3 3.4 1.5 0.1 0.6 0.0 0.6 1.0 KCNS1 Kv9.1 ENSG00000124134 "Potassium voltage-gated channel modifier subfamily S member 1" Q96KK3 20 45092310-45101112 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 27.0" "Cell type enriched" "Detected in some" 6 "Cholangiocytes: 10.2" "Cancer enhanced" "Detected in many" "cervical cancer: 6.1" "Region enhanced" "Detected in many" "cerebral cortex: 27.0" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBF TERT88: 3.2;HHSteC: 4.9;hTEC/SVTERT24-B: 2.7;THP-1: 4.1;U-87 MG: 7.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.46e-2)" "unprognostic (2.95e-3)" "unprognostic (2.03e-1)" "unprognostic (3.11e-4)" "unprognostic (8.91e-3)" "unprognostic (6.01e-3)" "unprognostic (7.47e-2)" "unprognostic (8.94e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (6.74e-2)" "unprognostic (4.65e-2)" "unprognostic (6.35e-2)" "unprognostic (5.62e-2)" "unprognostic (3.06e-2)" "unprognostic (1.15e-1)" "unprognostic (1.39e-1)" 0.3 0.8 1.4 0.2 4.6 0.4 0.7 0.4 27.0 0.6 0.3 0.0 5.9 0.2 0.2 0.2 0.4 0.3 5.2 0.4 2.1 1.1 0.5 0.3 0.7 0.3 1.0 7.2 0.2 0.3 0.1 0.4 0.3 0.0 0.9 0.2 0.0 3.4 7.0 0.2 2.6 0.3 0.2 0.4 0.3 0.3 2.0 0.0 0.0 0.3 0.0 0.5 0.4 0.6 0.6 0.2 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.1 0.5 0.0 0.3 0.3 1.0 0.9 0.1 0.4 1.4 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.2 0.9 0.0 2.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.3 1.8 0.0 2.1 0.5 0.0 4.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.2 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.4 4.6 0.4 27.0 2.1 1.1 1.0 7.2 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.9 10.2 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.1 KCNS2 Kv9.2 ENSG00000156486 "Potassium voltage-gated channel modifier subfamily S member 2" Q9ULS6 8 98427022-98432848 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.9" "Cell type enhanced" "Detected in single" 20 "Leydig cells: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HSkMC: 4.0;SCLC-21H: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051417 Uncertain NA NA "HPA051417: AB_2681478" "unprognostic (7.83e-2)" "unprognostic (9.39e-3)" "unprognostic (5.25e-2)" "unprognostic (2.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (4.27e-2)" "unprognostic (4.58e-2)" "unprognostic (1.47e-1)" "unprognostic (5.30e-5)" "unprognostic (2.43e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-3)" 1.6 1.4 2.9 0.6 6.6 0.3 0.7 0.7 20.9 2.0 1.0 0.1 0.5 0.4 1.3 1.7 0.9 1.0 1.5 0.4 1.9 2.8 0.7 0.3 0.7 0.4 0.8 6.4 1.9 0.8 0.8 1.2 4.4 3.4 0.9 0.9 0.1 0.3 3.3 0.2 0.3 0.7 0.6 0.9 0.3 1.5 1.0 0.4 0.0 0.5 0.0 0.3 2.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.3 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.6 0.7 20.9 1.9 2.8 0.8 6.4 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 KCNS3 Kv9.3 ENSG00000170745 "Potassium voltage-gated channel modifier subfamily S member 3" Q9BQ31 2 17877847-18361616 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.4" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 26.8;Intestinal endocrine cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" "Cell line enhanced" "Detected in many" "RH-30: 33.8;RPMI-8226: 13.6;RT4: 23.0;U-266/84: 15.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014864 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA Cytosol "Golgi apparatus, Plasma membrane" "HPA014864: AB_1852155" "unprognostic (5.62e-2)" "unprognostic (4.27e-3)" "unprognostic (6.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.19e-1)" "unprognostic (1.64e-2)" "unprognostic (3.30e-1)" "unprognostic (9.47e-3)" "unprognostic (9.06e-2)" "unprognostic (8.45e-2)" "unprognostic (5.82e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" 2.2 1.1 2.7 5.6 3.2 0.4 14.8 0.5 5.1 6.8 7.9 4.8 1.3 3.1 4.5 2.4 7.2 3.3 5.3 4.6 3.9 3.4 4.2 2.6 17.6 1.2 6.8 1.4 1.1 7.7 1.9 0.8 8.3 15.2 4.4 4.1 9.9 7.6 2.8 54.4 3.7 4.3 9.7 4.7 1.1 7.0 3.9 1.4 0.2 2.4 19.0 3.6 5.0 4.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.3 0.0 0.8 0.4 1.8 1.3 4.1 0.8 1.0 0.0 8.3 0.0 0.4 1.4 0.9 1.2 10.0 0.0 0.9 0.0 2.6 0.0 0.1 0.0 4.0 0.1 0.3 0.3 6.3 0.0 0.6 7.7 0.2 1.8 0.2 0.0 0.5 1.0 0.0 0.0 5.0 5.4 0.1 1.1 33.8 13.6 0.8 23.0 10.0 0.3 0.0 2.6 2.7 2.4 1.3 0.0 0.1 1.3 0.0 0.1 10.1 0.0 15.7 0.0 7.5 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.2 0.5 5.1 3.9 3.4 6.8 1.4 15.2 1.4 26.8 5.1 0.0 10.1 12.4 0.0 0.4 20.4 0.0 4.5 10.4 0.0 0.5 0.0 16.1 0.2 6.0 3.2 0.0 0.3 2.9 16.6 8.1 1.1 3.2 0.4 0.0 31.2 3.1 0.0 0.2 1.4 0.6 20.3 1.0 3.0 0.1 3.7 3.5 3.5 2.6 0.1 6.5 9.5 0.2 3.1 5.1 0.7 0.0 9.9 5.4 KCNT1 "KCa4.1, KIAA1422, SLACK, Slo2.2" ENSG00000107147 "Potassium sodium-activated channel subfamily T member 1" Q5JUK3 9 135702185-135795508 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;skeletal muscle: 19.5" "Cell type enriched" "Detected in single" 5 "Cardiomyocytes: 4.5" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 5.6;RH-30: 1.9;RPMI-8226: 4.2;SCLC-21H: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059880 Uncertain NA NA "HPA059880: AB_2684149" "unprognostic (1.50e-3)" "unprognostic (1.72e-2)" "unprognostic (2.07e-3)" "unprognostic (2.98e-13)" "unprognostic (9.26e-2)" "unprognostic (7.73e-2)" "unprognostic (9.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.30e-3)" "unprognostic (9.89e-2)" "unprognostic (6.20e-2)" "unprognostic (4.89e-7)" "unprognostic (9.15e-2)" "unprognostic (2.70e-1)" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" 1.4 0.8 7.3 1.0 12.4 1.0 0.7 29.7 29.3 0.7 0.9 0.2 0.0 1.0 0.8 0.9 1.2 0.9 1.1 1.8 5.3 4.2 0.7 0.7 0.9 0.8 1.8 12.0 7.3 0.8 0.7 4.7 1.2 6.1 0.8 0.8 0.0 0.7 0.8 19.5 0.8 0.8 0.8 2.1 9.6 1.4 1.9 3.1 0.0 0.8 0.0 0.7 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 5.6 0.0 0.0 1.9 4.2 0.0 0.0 6.3 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 7.3 12.4 29.7 29.3 5.3 4.2 1.8 12.0 6.1 3.1 0.0 0.0 0.0 0.0 0.0 0.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.7 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936128 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 15.8" "Group enriched" "Detected in some" 54 "Early spermatids: 49.4;Late spermatids: 18.0" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 13.1" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 13.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 KCNV1 Kv8.1 ENSG00000164794 "Potassium voltage-gated channel modifier subfamily V member 1" Q6PIU1 8 109963645-109975847 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 22.4" "Cell type enriched" "Detected in single" 7 "Intestinal endocrine cells: 6.8" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.41e-1)" "unprognostic (1.81e-2)" "unprognostic (5.01e-4)" "unprognostic (2.30e-1)" "unprognostic (3.76e-2)" "unprognostic (1.13e-2)" "unprognostic (3.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.17e-2)" 0.5 0.5 10.6 0.6 10.2 1.1 0.6 0.2 22.4 0.4 1.1 0.0 0.0 0.5 0.6 1.2 0.5 0.4 0.5 0.5 3.9 1.6 0.6 0.5 0.5 0.7 0.9 8.2 0.8 1.0 0.4 0.7 0.6 0.9 0.7 0.9 0.0 0.6 0.5 0.5 1.1 0.8 0.4 0.4 0.6 0.5 0.7 0.0 0.0 0.9 0.0 0.5 0.4 0.2 0.8 0.6 2.5 0.9 0.6 0.5 0.1 2.1 2.7 1.9 0.8 0.3 0.3 0.7 0.6 0.0 0.4 0.4 0.5 0.8 0.8 0.6 0.1 1.7 2.1 0.7 0.3 0.5 1.0 0.3 1.3 2.0 0.5 0.1 1.1 1.5 0.3 0.4 0.6 0.5 0.8 0.4 1.1 1.0 2.6 0.3 0.6 0.8 1.3 0.9 0.5 1.2 0.2 1.0 0.3 3.4 1.1 1.5 0.7 0.5 0.4 0.6 2.1 1.0 0.5 1.3 2.3 2.0 1.5 0.6 0.9 0.5 0.4 1.0 0.9 0.9 2.5 0.8 0.3 0.5 0.9 0.4 0.6 0.5 0.5 0.5 0.8 0.5 0.5 1.1 0.6 0.8 0.6 0.3 0.1 10.6 10.2 0.2 19.5 3.9 1.6 0.9 8.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 KCNV2 Kv8.2 ENSG00000168263 "Potassium voltage-gated channel modifier subfamily V member 2" Q8TDN2 9 2717502-2730037 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 82.3" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 485.0;Rod photoreceptor cells: 393.2" "Cancer enriched" "Detected in single" 78 "testis cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HDLM-2: 2.9;HEK 293: 1.4;HeLa: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA031131 Enhanced NA NA "HPA031131: AB_10609996" "unprognostic (5.06e-2)" "unprognostic (1.47e-3)" "unprognostic (3.45e-3)" "unprognostic (6.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "unprognostic (1.12e-3)" "unprognostic (5.38e-2)" "unprognostic (1.39e-2)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" "unprognostic (7.96e-8)" "unprognostic (3.01e-1)" "unprognostic (4.90e-2)" "unprognostic (9.90e-2)" "unprognostic (1.06e-2)" 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 82.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.6 0.0 0.2 0.7 0.2 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 1.4 0.8 2.3 0.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.7 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.1 0.1 0.6 0.0 0.0 0.7 0.4 0.6 0.3 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 0.2 0.0 0.0 0.0 0.0 485.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 19.8 0.6 0.0 0.0 0.0 0.0 36.6 0.0 0.0 1.1 0.0 393.2 12.9 0.0 5.9 11.4 0.0 0.0 0.0 0.0 0.0 KCP "CRIM2, FLJ33365, NET67" ENSG00000135253 "Kielin/chordin-like protein" 7 128862451-128910719 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "ductus deferens: 30.0;kidney: 11.2;seminal vesicle: 28.3" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 50.6;Early spermatids: 18.3;Late spermatids: 21.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.7;HMC-1: 7.7;U-87 MG: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (6.12e-2)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (6.33e-3)" "unprognostic (2.14e-1)" "unprognostic (5.24e-3)" "unprognostic (2.01e-3)" "unprognostic (3.25e-3)" "unprognostic (9.59e-2)" "unprognostic (1.52e-1)" "unprognostic (2.20e-3)" "unprognostic (6.46e-2)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.84e-2)" "unprognostic (7.64e-3)" 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 30.0 0.9 0.1 1.7 0.4 0.6 2.1 0.3 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.1 0.1 28.3 0.0 0.0 2.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 13.7 0.2 2.1 0.0 0.3 1.0 0.0 0.0 0.0 1.9 0.1 1.0 0.0 1.2 0.2 0.0 7.7 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.1 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.9 0.4 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 4.3 0.8 1.1 0.0 2.5 0.8 0.0 0.0 6.8 50.6 2.0 0.2 0.0 0.2 18.3 0.3 5.9 0.0 0.2 1.0 1.1 0.3 2.3 0.2 1.0 3.2 2.4 2.5 2.2 21.8 1.1 2.3 0.0 0.0 3.1 0.2 2.5 1.9 0.4 2.9 1.0 0.0 0.0 5.1 2.4 0.0 1.1 1.9 6.4 3.6 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 5.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.96e-5)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favorable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.63e-1)" 2.6 18.9 1.2 1.5 0.8 0.0 11.6 5.5 0.8 6.5 4.8 1.2 40.8 2.5 2.3 10.8 2.1 6.8 10.3 0.7 1.0 1.3 10.7 14.4 9.6 0.3 0.9 0.5 2.4 42.8 6.2 2.5 5.1 1.3 5.3 6.9 5.8 43.9 47.8 0.7 1.5 6.1 0.9 0.8 0.7 12.1 1.9 0.8 0.7 12.4 2.9 3.6 1.4 1.1 0.4 1.4 0.6 1.1 1.1 1.8 0.4 0.0 2.1 0.3 0.3 0.8 0.5 2.1 1.1 1.0 2.1 5.1 8.0 5.2 0.0 5.7 0.6 0.2 0.6 0.3 15.4 5.4 0.2 7.8 0.0 1.8 16.8 3.1 0.1 0.1 2.4 0.4 8.4 6.6 1.5 0.5 0.1 0.1 0.0 0.8 0.1 0.2 0.4 3.9 0.2 0.3 0.2 0.0 0.0 27.3 2.0 1.4 0.1 0.0 0.1 2.5 0.5 0.8 0.6 0.4 0.1 12.4 0.4 0.2 0.1 0.1 0.1 0.1 0.1 2.2 0.0 0.7 0.6 0.7 0.9 0.5 0.0 0.7 1.8 1.4 0.4 0.8 1.8 0.2 1.1 1.1 1.3 0.0 0.4 1.2 0.8 5.5 0.8 1.0 1.3 0.9 0.5 1.3 0.8 3.0 9.6 0.0 9.5 0.3 0.0 0.0 2.5 0.0 5.7 5.2 0.0 0.6 3.3 2.0 0.1 0.0 2.5 0.0 14.8 1.2 0.8 10.5 1.1 4.0 0.2 0.0 4.6 0.0 0.0 0.0 3.1 0.0 1.7 0.0 15.2 1.7 12.8 7.0 4.9 11.3 0.0 0.0 1.9 0.2 0.2 0.1 0.6 0.0 8.5 5.8 KCTD15 MGC25497 ENSG00000153885 "Potassium channel tetramerization domain containing 15" Q96SI1 19 33795933-33815763 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 47.3" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 14.1;Ito cells: 25.8;Suprabasal keratinocytes: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 2.5;eosinophil: 7.7;intermediate monocyte: 4.6;myeloid DC: 3.4;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.4;granulocytes: 7.7;monocytes: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050822 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA050822: AB_2681250" "unprognostic (1.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.41e-1)" "unprognostic (6.62e-3)" "unprognostic (1.67e-2)" "unprognostic (2.66e-2)" "unprognostic (3.09e-2)" "unprognostic (5.60e-2)" "unprognostic (6.33e-2)" "unprognostic (5.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.65e-8)" "unprognostic (1.40e-1)" "unprognostic (1.89e-3)" "unprognostic (6.13e-2)" "unprognostic (7.30e-2)" 8.7 4.0 10.5 7.1 7.9 3.4 7.7 7.7 11.0 15.5 13.6 8.6 4.6 4.7 20.3 6.2 14.6 12.7 9.4 6.8 13.0 5.1 6.2 7.1 13.3 4.1 5.8 8.4 14.3 15.6 1.6 3.4 7.3 9.4 9.0 4.2 12.4 3.7 13.7 4.8 47.3 5.8 13.8 9.3 8.3 8.1 10.6 8.9 1.0 8.9 5.1 4.6 9.4 13.0 0.0 3.4 7.7 6.3 0.0 1.2 0.9 5.8 13.4 12.1 18.5 4.0 2.1 9.6 7.7 1.4 4.3 2.2 7.5 4.0 0.0 17.6 10.8 2.0 6.9 8.8 6.0 1.6 6.3 15.4 24.1 8.3 7.2 11.2 4.6 4.4 4.2 25.5 1.6 9.8 0.0 8.4 3.5 5.9 0.1 0.7 14.8 0.1 13.2 11.1 9.8 22.7 11.2 6.5 2.2 4.8 2.7 9.4 32.4 15.1 21.5 28.0 5.4 15.9 12.3 13.7 20.3 18.2 0.4 1.3 15.0 0.7 9.5 0.0 8.1 24.7 0.6 2.5 7.7 0.0 4.6 0.1 0.0 1.2 0.2 3.4 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.7 0.9 10.5 7.9 7.7 9.2 13.0 5.1 5.8 8.4 9.4 8.9 0.0 1.7 0.0 3.2 14.1 2.9 2.0 0.0 0.0 3.4 0.0 9.8 0.2 3.3 0.8 0.5 8.0 0.8 0.0 7.2 0.2 4.9 2.2 8.1 1.6 1.2 1.6 1.2 25.8 3.5 1.4 4.0 4.7 5.0 0.0 2.9 2.8 3.0 0.0 8.5 0.2 10.7 0.0 5.2 0.0 0.4 16.9 0.2 0.0 0.9 2.5 KCTD16 KIAA1317 ENSG00000183775 "Potassium channel tetramerization domain containing 16" Q68DU8 5 144170832-144485686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 25.1" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 12.9;Early spermatids: 7.6;Horizontal cells: 19.1" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Group enriched" "Detected in many" 5 "amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 7.1;TIME: 13.4;U-87 MG: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044590, HPA050154" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044590: AB_2679008, HPA050154: AB_2681034" "unprognostic (7.22e-2)" "unprognostic (3.63e-1)" "unprognostic (2.54e-2)" "unprognostic (6.81e-5)" "unprognostic (9.88e-2)" "unprognostic (1.21e-1)" "unprognostic (7.74e-3)" "unprognostic (3.23e-2)" "unprognostic (1.94e-2)" "unprognostic (9.57e-2)" "unprognostic (9.38e-3)" "unprognostic (6.20e-3)" "unprognostic (2.52e-8)" "unprognostic (1.55e-3)" "unprognostic (2.34e-1)" "unprognostic (5.80e-3)" "unprognostic (1.22e-2)" 1.0 2.0 11.4 0.7 14.5 0.6 0.9 0.7 25.1 1.5 0.8 0.4 0.0 1.0 0.9 1.5 0.8 1.2 1.4 0.9 14.5 3.2 2.9 0.8 2.4 0.7 1.7 12.0 1.0 5.2 0.8 1.7 0.9 1.3 0.8 0.7 0.0 0.7 1.1 0.6 0.7 1.2 0.9 1.6 0.7 0.8 4.4 2.4 0.0 2.2 0.0 0.7 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.1 0.7 0.0 1.9 1.6 0.6 0.8 0.4 0.0 0.0 0.6 0.5 0.1 0.0 0.0 0.3 0.9 0.2 0.1 0.0 0.5 0.1 0.2 0.1 0.0 0.4 0.1 1.2 0.1 1.5 0.0 0.3 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 7.1 0.3 0.1 0.0 0.1 0.3 0.0 0.0 13.4 1.1 0.7 0.2 0.0 0.2 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 14.5 0.7 25.1 14.5 3.2 1.7 12.0 1.3 2.4 0.0 0.0 0.0 0.0 0.0 12.9 0.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 2.7 7.6 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 19.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.0 0.0 0.7 2.4 0.0 0.8 3.8 1.9 0.0 0.0 0.0 0.0 0.0 KCTD17 FLJ12242 ENSG00000100379 "Potassium channel tetramerization domain containing 17" Q8N5Z5 22 37051736-37063390 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Ubl conjugation pathway" "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 59.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018459 Uncertain NA NA "HPA018459: AB_1852169" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (1.09e-1)" "unprognostic (1.61e-2)" "unprognostic (5.38e-2)" "unprognostic (3.09e-3)" "prognostic unfavorable (3.59e-5)" "unprognostic (1.89e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-1)" "prognostic favorable (4.22e-5)" "unprognostic (8.62e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (2.32e-1)" "unprognostic (6.94e-2)" 6.1 11.8 21.7 9.6 59.0 2.5 4.2 7.0 36.3 6.2 8.3 9.2 2.7 3.8 9.6 2.6 7.7 5.9 8.9 17.1 23.1 12.9 2.3 2.1 7.1 9.6 12.6 14.7 10.8 3.0 4.0 14.5 9.5 10.5 5.1 5.8 2.3 1.8 10.3 1.9 16.9 4.3 10.0 6.8 6.8 4.4 18.7 16.0 4.1 2.8 2.3 7.1 8.7 7.9 2.9 2.7 0.0 2.9 3.8 2.8 1.0 8.4 11.1 17.6 13.0 8.4 8.5 0.7 8.8 8.6 14.5 12.5 2.3 2.5 6.5 6.1 11.3 11.3 2.3 5.5 10.3 6.1 12.6 14.7 2.8 3.0 2.6 12.6 0.0 3.4 9.8 5.1 14.8 3.2 9.8 18.5 8.7 0.6 7.3 9.0 6.8 5.7 0.1 11.2 5.0 9.6 10.5 4.6 1.9 3.7 2.2 14.7 18.3 8.2 7.8 4.0 3.8 2.1 2.3 10.6 18.8 17.6 8.8 6.4 9.9 2.8 1.1 16.6 3.9 10.2 0.0 2.3 0.0 2.7 2.9 2.6 2.9 2.0 2.8 2.7 1.5 2.5 2.0 0.0 3.8 1.3 0.6 2.8 1.0 21.7 59.0 7.0 25.4 23.1 12.9 12.6 14.7 10.5 16.0 0.0 0.3 3.2 4.4 1.3 16.5 3.5 7.6 0.0 0.0 5.2 2.0 0.4 0.0 11.4 18.5 6.8 11.8 0.0 5.6 2.2 9.7 0.7 4.6 0.5 8.6 12.7 12.6 10.4 7.8 20.3 9.8 10.5 3.3 16.2 4.4 8.6 2.8 14.4 8.5 1.7 5.6 0.0 6.2 21.6 6.6 4.3 6.3 5.1 5.4 1.8 KCTD19 FLJ40162 ENSG00000168676 "Potassium channel tetramerization domain containing 19" Q17RG1 16 67289428-67326763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 57.3" "Group enriched" "Detected in some" 8 "Early spermatids: 30.1;Spermatocytes: 63.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.6;neutrophil: 6.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 5 "dendritic cells: 5.3;granulocytes: 6.6" "Cell line enhanced" "Detected in some" "JURKAT: 10.5;U-266/70: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049310, HPA053321" Uncertain NA NA "HPA049310: AB_2680706, HPA053321: AB_2682110" "unprognostic (2.44e-1)" "unprognostic (2.14e-2)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (1.60e-2)" "unprognostic (9.01e-2)" "unprognostic (9.32e-2)" "unprognostic (1.75e-1)" "unprognostic (5.91e-2)" "unprognostic (1.88e-4)" "unprognostic (4.44e-1)" "unprognostic (2.76e-3)" "unprognostic (1.19e-2)" "unprognostic (2.91e-2)" "unprognostic (9.71e-2)" "unprognostic (8.44e-2)" 0.2 0.1 0.2 0.7 0.8 3.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.4 0.3 0.6 0.1 0.1 0.4 0.3 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.0 0.3 0.2 0.3 0.1 0.1 0.4 0.1 0.1 0.4 1.4 0.1 0.1 0.1 0.3 0.3 57.3 0.3 1.4 0.2 0.1 0.1 0.4 0.1 1.1 5.3 6.6 0.9 1.0 0.6 0.6 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.6 0.7 1.0 0.5 0.9 0.5 0.8 0.5 0.0 0.0 0.2 1.1 0.0 3.4 0.6 2.4 0.9 0.0 0.0 0.5 0.3 0.4 0.7 0.9 1.0 0.5 0.0 0.2 10.5 0.9 0.3 0.0 0.0 0.9 0.9 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.3 0.6 1.3 0.1 0.6 0.1 1.0 0.2 0.5 1.0 0.0 0.7 3.2 0.1 9.5 1.6 0.6 1.1 0.1 0.9 1.6 0.9 0.8 0.6 0.5 0.4 0.6 0.4 0.5 0.3 1.1 0.5 0.5 6.6 1.0 0.5 5.3 0.4 0.6 0.2 0.8 0.1 0.2 0.1 0.4 0.1 0.4 0.3 0.3 0.0 2.9 0.0 1.4 0.3 0.9 0.9 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 30.1 0.3 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.9 0.8 3.3 1.0 0.0 0.2 0.0 0.0 0.7 0.0 2.2 0.0 0.2 63.5 1.7 0.3 0.1 0.0 0.0 1.1 KCTD2 KIAA0176 ENSG00000180901 "Potassium channel tetramerization domain containing 2" Q14681 17 75032575-75065889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.1" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 30.4;Horizontal cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 8.0;HEK 293: 10.6;K-562: 9.2;U-266/70: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.62e-1)" "unprognostic (1.83e-1)" "unprognostic (2.66e-1)" "unprognostic (1.00e-3)" "unprognostic (1.73e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (1.83e-4)" "unprognostic (5.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.58e-2)" "prognostic favorable (1.25e-5)" "unprognostic (7.19e-2)" "unprognostic (9.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.10e-2)" "unprognostic (1.16e-2)" "unprognostic (1.60e-1)" 13.9 3.2 5.5 1.8 6.1 3.6 2.3 26.1 20.8 3.3 7.2 6.9 1.5 2.3 4.3 1.8 2.9 3.6 1.8 5.0 4.4 4.0 9.6 3.2 3.7 1.8 5.2 7.0 4.1 1.8 1.8 3.8 3.9 6.6 5.3 1.9 3.6 2.8 4.1 11.3 3.6 2.5 2.1 5.9 5.0 5.6 5.0 4.3 0.4 4.5 1.9 1.8 5.4 2.5 0.0 0.0 0.5 0.0 1.7 0.5 0.4 3.9 0.0 0.1 0.9 0.4 1.2 2.7 8.0 1.0 0.0 0.9 0.0 0.0 7.0 7.7 1.5 0.2 2.4 0.0 0.0 0.0 5.9 10.6 0.0 1.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 9.2 0.0 0.0 0.0 7.8 0.4 1.2 0.1 7.4 7.3 0.3 1.8 0.0 0.1 1.0 4.8 2.2 0.1 1.4 0.1 0.0 0.5 0.0 0.1 5.8 0.0 6.4 10.6 4.9 2.5 1.3 1.0 0.0 0.0 0.0 0.5 0.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 5.5 6.1 26.1 11.9 4.4 4.0 5.2 7.0 6.6 4.3 3.0 15.2 2.4 2.3 2.5 30.4 10.6 5.1 5.3 2.3 7.0 0.0 5.1 6.6 3.2 3.2 6.7 3.3 0.0 4.5 3.5 4.4 5.3 1.1 6.8 4.3 33.4 2.9 11.1 11.8 6.2 10.0 5.5 3.3 4.6 5.2 16.7 3.8 3.5 21.9 6.0 9.0 0.0 2.5 5.2 18.8 4.4 3.7 3.9 5.1 3.3 KCTD4 bA321C24.3 ENSG00000180332 "Potassium channel tetramerization domain containing 4" Q8WVF5 13 45192853-45194717 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 45.5" "Cell type enriched" "Detected in single" 4 "Melanocytes: 1.7" "Group enriched" "Detected in some" 5 "glioma: 1.2;renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 15.8;hTERT-RPE1: 9.6;RPTEC TERT1: 8.9;U-138 MG: 10.7;U-87 MG: 21.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040734 Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA040734: AB_10963227" "unprognostic (1.36e-1)" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.19e-2)" "unprognostic (1.70e-1)" "unprognostic (4.68e-2)" "unprognostic (1.74e-1)" "unprognostic (1.66e-3)" "unprognostic (1.63e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" 0.5 0.6 33.1 0.6 45.5 0.7 1.5 0.2 22.0 0.7 1.1 1.5 0.0 0.9 0.5 0.6 0.5 0.5 1.8 0.9 9.8 4.0 0.9 0.5 0.5 0.5 3.6 4.8 0.5 0.9 0.5 1.1 0.9 3.9 0.5 0.9 1.8 1.5 0.8 0.5 6.4 1.0 1.8 2.7 0.5 0.5 0.5 7.0 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.1 0.0 0.0 0.0 0.3 0.5 15.8 0.0 0.0 2.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.4 9.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.7 0.0 0.0 2.2 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 33.1 45.5 0.2 9.3 9.8 4.0 3.6 4.8 3.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173909-44448807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 7.6;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 16.2" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;NTERA-2: 2.9;PC-3: 1.8;SCLC-21H: 10.9;U-2 OS: 3.3" "Low region specificity" "Detected in all" HPA031562 Enhanced Approved Vesicles NA NA Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 2.0 1.4 5.4 0.9 12.2 0.7 0.9 19.5 18.9 2.2 1.0 8.5 3.5 0.8 4.2 1.3 0.8 1.1 1.5 1.1 4.8 5.2 2.8 0.7 1.0 0.7 8.9 4.0 4.3 2.4 0.7 0.2 0.7 6.8 1.5 1.1 2.3 1.7 3.1 2.6 0.8 0.9 2.3 8.0 0.7 2.6 3.8 8.3 0.0 8.6 0.4 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.2 19.5 8.5 4.8 5.2 8.9 4.0 6.8 8.3 0.0 0.0 0.0 0.6 0.0 2.7 0.2 7.6 0.0 0.0 3.5 3.9 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 1.0 16.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 KDELC2 MGC33424 ENSG00000178202 "KDEL motif containing 2" Q7Z4H8 11 108472105-108498432 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.0" "Cell type enhanced" "Detected in many" 4 "Fibroblasts: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624" "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (6.27e-5)" 20.8 7.8 4.2 12.7 4.7 2.7 19.7 3.6 3.2 27.2 11.1 4.8 9.7 4.1 21.8 21.1 16.1 17.6 18.0 13.3 4.1 4.2 11.4 13.5 12.5 10.0 4.6 2.7 25.6 9.5 19.8 5.1 65.0 4.6 20.6 8.0 13.4 13.0 14.5 8.1 6.9 7.3 24.4 5.0 9.9 8.9 9.5 4.4 10.0 9.2 8.7 6.5 19.5 20.0 0.9 2.0 0.2 1.5 4.5 4.6 1.0 3.1 3.6 14.2 14.5 24.0 27.9 13.7 14.2 13.2 20.3 22.1 17.3 23.6 0.0 8.8 18.4 22.5 2.4 10.7 0.3 21.5 5.6 8.3 5.3 4.0 8.0 9.7 13.9 0.0 16.0 4.5 10.7 0.3 12.4 17.1 0.0 11.9 0.1 30.6 2.3 8.9 8.0 6.2 3.4 10.5 0.4 22.2 0.0 3.7 8.9 3.0 9.1 26.7 1.8 3.9 6.8 12.8 5.3 17.0 39.3 7.8 3.3 14.7 0.1 0.0 0.0 10.1 14.6 31.1 0.1 0.3 0.0 4.6 1.5 3.9 0.5 2.3 3.8 1.1 0.9 2.4 3.6 0.2 4.5 0.7 2.0 1.9 1.0 4.2 4.7 3.6 3.2 4.1 4.2 4.6 2.7 4.6 4.4 3.0 10.1 3.2 5.2 10.3 9.9 5.0 2.5 10.7 9.1 15.7 5.9 21.7 1.7 2.2 0.9 11.2 1.5 0.0 6.3 13.2 35.1 7.9 3.5 9.7 14.2 0.0 1.7 14.7 2.4 0.0 26.2 6.9 5.0 3.6 8.3 3.8 4.2 3.5 29.4 5.2 6.0 12.9 16.7 0.5 1.0 8.3 17.7 8.5 6.8 2.3 KDELR3 ENSG00000100196 "KDEL endoplasmic reticulum protein retention receptor 3" O43731 22 38468062-38483447 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 48.5;salivary gland: 57.2" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 62.1;Fibroblasts: 54.4;Mucus-secreting cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 58.3;BJ: 36.7;BJ hTERT+: 37.8;fHDF/TERT166: 59.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043477, HPA076405" Uncertain Supported "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA043477: AB_10962952, HPA076405: AB_2686797" "unprognostic (1.76e-1)" "unprognostic (3.77e-2)" "unprognostic (1.81e-1)" "unprognostic (1.20e-2)" "unprognostic (2.90e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.26e-1)" "unprognostic (1.91e-1)" "unprognostic (1.23e-1)" "unprognostic (9.25e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (6.05e-10)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (8.24e-2)" "unprognostic (2.07e-2)" 10.5 4.0 1.3 3.4 1.4 0.2 11.6 0.9 1.3 15.7 7.7 1.8 5.3 6.6 6.2 14.8 5.5 5.7 20.9 14.2 1.5 1.1 10.9 44.5 8.6 5.8 1.0 1.2 7.2 48.5 9.3 12.4 11.6 1.8 9.2 10.3 5.5 57.2 7.1 2.1 3.6 15.1 6.6 2.2 3.0 15.5 4.1 0.9 1.1 6.7 6.5 16.9 6.8 6.5 1.2 4.3 0.9 0.1 0.3 2.4 0.3 7.0 2.2 1.8 7.8 30.9 58.3 1.3 36.7 37.8 9.0 22.5 4.0 9.3 0.0 7.8 59.5 3.2 1.0 1.8 2.2 10.9 0.0 4.1 0.5 1.9 11.1 13.6 0.0 4.9 21.4 1.7 11.3 1.2 12.8 10.8 0.0 1.7 0.0 14.8 11.5 0.0 0.2 0.4 30.6 6.4 0.0 0.5 2.3 10.9 0.9 0.1 0.9 9.4 0.5 4.6 0.8 2.7 0.4 8.2 9.7 6.1 33.3 3.6 0.3 0.1 0.0 15.6 0.0 13.4 0.0 0.1 0.0 0.8 0.1 2.4 1.2 0.8 0.2 0.2 0.4 0.8 0.8 0.9 0.3 0.1 4.3 0.7 0.3 1.3 1.4 0.9 1.3 1.5 1.1 1.0 1.2 1.8 0.9 0.0 3.7 1.5 4.6 6.8 1.0 2.4 7.6 8.1 7.9 14.0 2.0 4.0 6.6 16.9 0.1 8.7 9.7 0.0 28.0 62.1 54.4 28.3 1.1 5.0 4.1 0.0 4.7 22.1 1.9 0.2 30.2 1.7 15.1 1.8 58.9 5.7 29.2 3.5 15.2 0.5 1.0 0.0 7.6 0.2 1.9 6.1 6.9 0.0 9.9 4.8 KDM4D "FLJ10251, JMJD2D" ENSG00000186280 "Lysine demethylase 4D" Q6B0I6 11 94973681-94999518 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 37.5" "Group enriched" "Detected in many" 4 "Early spermatids: 69.2;Late spermatids: 28.4;Spermatocytes: 52.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA055854, HPA064037" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA055854: AB_2682944, HPA064037: AB_2685180" "unprognostic (1.98e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (9.65e-3)" "unprognostic (3.19e-1)" "unprognostic (5.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (5.62e-2)" "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" 0.6 0.8 1.2 0.4 2.0 0.1 0.8 1.4 2.1 0.6 0.3 1.2 1.7 0.2 0.6 0.9 0.4 1.0 0.5 1.0 0.7 0.7 0.6 0.4 0.4 0.7 0.6 1.3 1.3 0.4 1.4 2.1 0.5 1.1 0.6 0.4 1.2 0.7 0.7 1.0 0.7 0.5 0.6 0.9 0.7 0.4 37.5 1.0 0.3 0.8 0.6 0.6 0.6 0.4 1.3 1.2 0.0 5.1 0.1 1.4 0.2 0.9 1.4 5.6 4.1 1.2 1.4 2.6 1.9 2.1 5.2 4.6 1.5 1.8 2.1 6.1 1.6 5.0 1.7 3.6 3.9 4.0 2.3 3.7 1.8 0.6 2.1 1.1 0.9 0.6 2.7 2.1 5.2 4.7 0.8 2.0 7.4 2.0 1.0 2.0 1.7 3.1 2.1 2.5 1.4 6.8 4.3 2.4 1.5 1.2 0.6 3.3 4.0 2.2 2.0 1.5 3.2 2.1 0.6 1.5 3.6 2.1 5.5 2.8 1.3 4.1 0.3 1.2 1.1 3.9 0.0 0.3 0.0 0.3 0.2 0.2 1.3 0.6 1.0 0.0 0.2 0.8 0.1 0.0 0.1 5.1 1.2 1.4 0.2 1.2 2.0 1.4 2.1 0.7 0.7 0.6 1.3 1.1 1.0 0.0 0.0 0.0 0.2 0.0 6.6 0.8 2.5 1.4 0.0 0.0 2.0 0.8 3.3 0.6 69.2 0.4 0.0 0.0 0.5 0.7 0.3 0.1 0.0 1.0 0.5 3.2 0.0 1.8 0.3 28.4 2.0 0.7 0.0 1.0 0.0 4.3 0.2 0.0 1.1 1.0 2.9 0.0 0.9 52.0 12.4 0.0 0.2 0.0 0.2 0.1 KDM4E "JMJD2E, KDM4DL, KDM5E" ENSG00000235268 "Lysine demethylase 4E" B2RXH2 11 95025258-95027596 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.1" "HPA051740, HPA054225" Uncertain NA NA "HPA051740: AB_2681586, HPA054225: AB_2682421" "unprognostic (1.32e-1)" "unprognostic (6.31e-2)" "unprognostic (4.74e-2)" "unprognostic (3.69e-1)" "unprognostic (9.27e-2)" "unprognostic (5.54e-2)" "unprognostic (8.10e-4)" 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.5 0.3 0.0 0.8 0.8 0.5 0.0 1.8 0.0 0.1 2.0 0.3 0.0 0.2 0.7 0.0 1.7 0.7 0.0 0.7 0.3 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KDM5B "CT31, JARID1B, PLU-1, PPP1R98, RBBP2H1A" ENSG00000117139 "Lysine demethylase 5B" Q9UGL1 1 202724491-202809470 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.0" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 181.0;Spermatocytes: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027179, HPA053723, CAB068193" Enhanced Supported Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB068193: AB_2665696, HPA027179: AB_1851987, HPA053723: AB_2682241" "unprognostic (1.19e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.67e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (3.49e-3)" "unprognostic (3.02e-2)" "unprognostic (3.23e-2)" "unprognostic (6.12e-2)" "unprognostic (1.61e-2)" "unprognostic (4.79e-2)" "unprognostic (8.25e-3)" "unprognostic (2.56e-2)" "unprognostic (1.61e-1)" "unprognostic (5.56e-2)" "unprognostic (4.13e-1)" 7.7 7.1 5.9 8.2 7.8 14.8 12.3 12.7 9.0 12.9 9.6 5.1 9.7 5.0 13.6 9.4 17.6 8.6 8.4 5.7 6.1 4.5 6.0 4.6 9.0 5.4 3.7 7.3 13.3 9.0 9.8 8.6 23.1 5.0 11.3 9.0 16.0 11.1 8.8 4.3 19.5 7.3 10.1 4.9 6.9 8.2 74.0 5.2 25.8 9.1 6.2 10.4 12.2 12.6 4.1 3.0 16.0 5.2 7.3 4.4 2.6 10.6 4.3 28.9 13.9 13.7 12.4 24.4 7.3 11.3 7.7 8.2 3.6 11.3 0.0 5.0 11.4 5.7 16.4 13.6 12.0 9.9 0.1 5.2 5.8 4.1 5.8 11.7 18.0 7.7 12.9 20.0 11.0 14.5 20.8 17.1 7.2 18.0 0.0 7.7 10.8 5.0 21.5 19.6 7.4 7.6 21.2 0.0 0.0 11.1 18.4 8.8 19.5 15.5 9.5 12.9 39.6 19.5 12.9 12.6 6.8 5.1 0.8 4.2 1.1 0.7 4.5 6.0 6.7 2.8 16.0 2.9 6.4 3.7 3.4 3.1 2.8 3.3 2.7 3.0 4.1 4.2 1.8 9.5 7.3 5.2 2.1 4.4 2.6 5.9 7.8 12.7 9.0 6.1 4.5 3.7 7.3 5.0 5.2 83.4 33.4 5.4 32.8 57.2 30.9 7.3 10.2 54.9 40.9 15.7 58.9 35.8 5.0 41.9 155.3 25.3 16.1 0.0 19.5 25.5 34.2 40.2 25.5 9.6 7.0 14.3 41.9 19.0 17.8 181.0 33.6 10.8 25.3 10.0 31.3 68.3 38.0 17.3 30.8 5.9 133.9 32.3 21.7 261.1 71.6 101.6 68.9 12.5 27.0 45.7 KDM8 "FLJ13798, JMJD5" ENSG00000155666 "Lysine demethylase 8" Q8N371 16 27203495-27221768 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026545 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026545: AB_1852015" "unprognostic (1.39e-1)" "unprognostic (1.37e-3)" "unprognostic (2.80e-1)" "unprognostic (2.16e-2)" "unprognostic (3.21e-1)" "unprognostic (1.22e-2)" "unprognostic (2.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.95e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.75e-2)" "unprognostic (5.33e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (3.92e-3)" 1.9 3.2 2.7 3.6 3.5 1.4 2.1 5.9 5.9 2.2 4.2 3.7 3.2 12.0 3.1 2.2 2.1 2.5 2.5 2.0 2.7 3.2 2.3 44.9 2.0 3.3 2.3 5.1 3.0 4.5 2.8 3.3 1.7 3.7 2.9 1.9 2.1 2.6 2.5 4.0 1.9 16.8 1.9 2.2 3.7 2.3 2.2 2.2 5.9 2.9 2.0 3.7 2.8 2.2 5.6 6.5 1.3 3.4 2.2 8.2 3.5 1.6 3.7 6.4 3.3 1.6 1.9 3.4 2.1 2.4 4.8 4.3 3.1 2.9 9.6 3.7 3.5 2.4 1.9 3.7 3.2 2.8 11.0 5.5 6.1 4.1 7.3 3.4 4.3 7.3 2.5 2.6 3.2 2.1 2.8 3.7 4.6 7.7 5.9 2.9 2.8 4.3 7.7 11.1 1.3 2.2 6.3 3.9 8.6 1.8 1.9 6.0 3.8 0.9 3.0 2.3 2.2 3.2 5.7 4.1 5.7 3.0 2.1 2.2 3.7 3.8 7.7 2.3 4.0 0.5 0.4 3.2 1.3 4.2 3.4 3.6 3.2 6.2 6.0 3.0 5.6 6.0 8.2 0.1 2.2 2.9 6.5 3.6 3.5 2.7 3.5 5.9 5.9 2.7 3.2 2.3 5.1 3.7 2.2 0.0 1.7 0.5 0.2 0.2 1.0 1.0 0.0 9.4 2.3 0.0 2.0 1.3 3.3 0.9 0.4 1.0 1.6 0.0 0.6 0.4 0.8 0.4 0.0 46.0 1.6 0.0 5.2 1.3 1.3 0.0 0.3 1.2 0.0 1.0 1.3 1.6 0.7 0.0 1.1 1.2 2.5 0.0 0.8 0.9 2.5 0.0 1.1 0.5 1.1 0.1 KEL "CD238, ECE3" ENSG00000197993 "Kell blood group, metallo-endopeptidase" P23276 7 142941114-142962681 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 21.1;testis: 36.4" "Cell type enriched" "Detected in some" 14 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Group enriched" "Detected in some" 12 "HEL: 15.3;K-562: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 0.9 2.5 1.1 21.1 0.2 0.2 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.6 0.1 0.2 0.2 1.4 0.7 0.4 0.2 1.4 5.0 2.0 0.2 0.2 0.2 0.0 0.2 1.1 0.3 0.2 0.0 0.3 2.5 0.2 0.2 0.0 0.5 0.2 4.4 3.8 0.0 36.4 0.3 0.4 0.2 0.2 3.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.1 0.2 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.1 0.2 0.4 1.4 0.7 2.0 0.2 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 2.3 3.5 0.0 0.0 1.7 0.2 1.9 0.0 0.0 46.7 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 1.0 KERA "CNA2, SLRR2B" ENSG00000139330 Keratocan O60938 12 91050491-91057983 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 10.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "amygdala: 10.7;basal ganglia: 8.1;cerebral cortex: 16.0;hippocampal formation: 13.1" HPA039321 Uncertain "Secreted to extracellular matrix" NA NA "HPA039321: AB_10795248" "unprognostic (2.77e-1)" "unprognostic (2.39e-1)" "unprognostic (3.47e-1)" "unprognostic (3.70e-1)" "unprognostic (4.76e-3)" "unprognostic (3.65e-1)" "unprognostic (6.08e-2)" "unprognostic (1.19e-1)" "unprognostic (3.68e-2)" "unprognostic (5.96e-2)" "unprognostic (4.93e-3)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" 0.8 0.0 0.2 1.9 0.2 0.0 2.9 0.0 0.2 1.9 2.5 0.0 0.0 0.0 1.0 2.5 1.5 2.2 4.3 0.4 0.1 0.0 0.0 0.0 0.6 0.2 0.5 0.0 0.6 0.0 0.0 0.0 1.5 0.2 0.5 0.3 0.0 2.8 0.2 4.7 0.2 0.9 0.4 0.0 0.0 1.3 0.2 0.0 0.3 0.1 10.9 0.5 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 KHDC1L RP11-257K9.7 ENSG00000256980 "KH domain containing 1 like" Q5JSQ8 6 73223544-73225770 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.9;lymphoid tissue: 4.1;testis: 7.7" "Group enriched" "Detected in some" 8 "Early spermatids: 32.2;Late spermatids: 64.6" "Cancer enriched" "Detected in some" 9 "testis cancer: 33.6" "Region enriched" "Detected in some" 5 "basal ganglia: 8.9" "Cell type enriched" "Detected in single" 13 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enriched" "Detected in some" 4 "BEWO: 33.8" NA NA "unprognostic (1.18e-1)" "unprognostic (6.11e-5)" "unprognostic (3.06e-2)" "unprognostic (1.93e-1)" "unprognostic (3.07e-2)" "unprognostic (9.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.99e-2)" "unprognostic (1.48e-1)" "unprognostic (4.01e-2)" "unprognostic (1.31e-2)" "unprognostic (4.13e-1)" "unprognostic (6.63e-2)" "unprognostic (3.17e-3)" 0.3 0.2 1.1 0.3 8.9 0.5 0.3 1.6 1.4 0.3 0.3 0.3 0.3 0.2 0.5 0.3 0.3 0.0 0.3 0.3 0.5 0.4 0.3 0.3 2.1 0.3 0.7 0.3 0.4 0.3 0.0 1.4 2.0 0.3 0.4 0.0 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 0.0 7.7 0.3 4.1 0.3 0.3 1.5 0.3 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.3 0.0 0.0 33.8 0.1 0.2 0.2 0.1 0.3 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 8.9 1.6 0.7 0.5 0.4 0.7 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 32.2 0.0 0.0 0.0 0.3 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.6 0.3 0.0 0.0 1.0 0.0 0.2 0.2 0.0 0.7 0.0 0.5 0.0 0.0 2.2 5.7 0.0 0.1 0.0 0.0 0.0 KHDC3L "C6orf221, ECAT1" ENSG00000203908 "KH domain containing 3 like, subcortical maternal complex member" Q587J8 6 73362677-73364171 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 4.1;epididymis: 1.5;lung: 3.0;lymphoid tissue: 4.4;testis: 4.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 3155 "testis cancer: 254.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.5;NTERA-2: 2.1;SuSa: 1.1" HPA043699 Uncertain NA NA "HPA043699: AB_10960564" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (4.36e-1)" 0.2 0.5 1.2 0.2 2.1 0.0 0.2 4.1 0.9 0.2 0.2 0.2 0.2 0.1 0.2 1.5 0.3 0.1 0.2 0.2 2.1 0.6 0.2 0.2 3.0 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.6 0.3 4.9 0.2 4.4 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.2 2.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.8 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 4.1 0.9 2.1 0.6 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 KHDRBS2 "MGC26664, SLM-1, SLM1" ENSG00000112232 "KH RNA binding domain containing, signal transduction associated 2" Q5VWX1 6 61679960-62286227 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4;thyroid gland: 16.9" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 35.7;Bipolar cells: 30.6;Club cells: 11.4;Horizontal cells: 33.4;Muller glia cells: 34.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "memory B-cell: 6.8;naive B-cell: 10.4;plasmacytoid DC: 2.6" "Group enriched" "Detected in many" 13 "B-cells: 10.4;dendritic cells: 2.6" "Cell line enhanced" "Detected in some" "AF22: 12.8;NTERA-2: 3.3;SCLC-21H: 1.3;THP-1: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000500, HPA029392" Supported NA NA "HPA000500: AB_1079184, HPA029392: AB_10600816" "unprognostic (6.98e-2)" "unprognostic (1.21e-1)" "unprognostic (3.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.80e-3)" "unprognostic (4.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.25e-4)" "unprognostic (1.45e-2)" "unprognostic (2.19e-5)" "unprognostic (5.52e-2)" "unprognostic (4.54e-2)" "unprognostic (6.24e-3)" "unprognostic (1.15e-1)" 1.1 3.0 6.4 4.7 18.4 1.6 0.8 0.9 16.9 0.9 1.6 1.2 0.0 1.0 3.2 0.8 0.9 0.9 1.0 0.9 6.7 8.1 1.9 0.8 9.7 2.4 4.0 14.6 1.2 0.8 0.7 7.3 2.4 3.9 1.0 1.4 1.3 1.2 1.3 1.2 0.7 2.2 1.3 2.2 3.8 1.0 1.0 1.6 0.0 16.9 0.0 2.9 0.9 0.5 10.4 2.6 0.0 0.5 0.1 0.0 0.3 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.1 10.4 0.0 0.0 0.0 0.1 0.3 2.6 0.0 0.3 6.4 18.4 0.9 16.9 6.7 8.1 4.0 14.6 3.9 1.6 35.7 3.5 4.5 0.0 0.0 30.6 0.3 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 33.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.0 1.4 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 KHDRBS3 "Etle, etoile, SALP, SLM-2, SLM2, T-STAR" ENSG00000131773 "KH RNA binding domain containing, signal transduction associated 3" O75525 8 135457457-135656722 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4;testis: 79.1" "Group enriched" "Detected in many" 7 "Bipolar cells: 168.5;Early spermatids: 282.4;Late spermatids: 91.3;Spermatocytes: 308.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 25 "granulocytes: 4.1" "Cell line enhanced" "Detected in many" "REH: 31.4;RPTEC TERT1: 28.3;WM-115: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000275, HPA000500, HPA000981" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (6.55e-3)" "unprognostic (2.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.31e-3)" "unprognostic (9.36e-2)" "unprognostic (2.00e-2)" "unprognostic (2.66e-1)" "unprognostic (1.91e-2)" "unprognostic (1.21e-1)" "prognostic favorable (7.16e-6)" "unprognostic (6.63e-2)" "unprognostic (7.85e-2)" "unprognostic (1.07e-1)" "unprognostic (1.33e-3)" 8.0 9.6 16.4 3.3 16.6 1.7 5.8 7.1 34.4 10.3 5.3 8.0 0.9 2.7 4.3 13.4 3.9 4.2 6.8 5.6 16.7 9.8 11.0 7.0 4.5 1.9 11.1 21.7 5.8 5.4 3.5 4.2 1.6 8.7 5.2 5.4 2.6 6.4 7.6 14.7 3.1 3.6 5.1 12.5 1.9 3.7 79.1 7.9 0.9 3.1 1.5 2.7 6.8 4.5 0.1 0.0 4.1 0.0 0.0 0.1 0.0 0.1 0.6 11.5 0.6 2.4 4.6 4.6 7.5 10.5 7.2 3.7 4.0 1.6 0.0 4.1 7.2 0.1 1.0 7.2 7.6 9.8 1.5 12.4 0.0 4.2 8.2 1.9 2.0 26.2 1.0 1.0 3.9 6.0 8.7 5.8 13.5 0.9 19.0 12.7 2.6 0.7 0.4 2.3 6.1 12.5 31.4 15.7 8.1 28.3 0.2 14.8 12.5 0.5 1.6 8.1 7.6 0.5 0.6 0.4 8.9 15.3 0.1 16.2 6.7 0.0 0.0 5.4 0.0 31.3 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 16.6 7.1 34.4 16.7 9.8 11.1 21.7 8.7 7.9 26.8 4.0 1.4 11.3 13.4 168.5 11.4 5.1 1.4 6.8 7.0 0.0 0.4 21.6 11.4 282.4 14.6 2.4 0.0 19.1 1.0 19.3 16.7 4.6 16.3 0.7 6.4 22.5 6.2 2.4 91.3 15.0 2.8 13.5 2.8 7.8 5.3 25.6 2.9 8.1 21.6 13.0 0.0 26.9 308.0 29.7 8.2 1.1 0.0 5.2 6.5 KHK ENSG00000138030 Ketohexokinase P50053 2 27086747-27100772 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 60.2;kidney: 38.4;liver: 67.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 359.6;Proximal tubular cells: 948.1" "Group enriched" "Detected in all" 7 "liver cancer: 62.2;renal cancer: 32.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 18.6;Hep G2: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007040 Enhanced Approved Cytosol NA NA 320000 Cytosol "HPA007040: AB_1079185" "unprognostic (8.44e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.62e-8)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "unprognostic (3.08e-2)" "unprognostic (3.13e-2)" "unprognostic (1.67e-2)" "unprognostic (2.50e-2)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (1.68e-2)" "unprognostic (2.56e-3)" "unprognostic (2.32e-1)" "unprognostic (2.44e-1)" "unprognostic (1.02e-2)" 0.9 1.9 2.1 1.2 2.7 0.7 1.9 5.2 3.9 1.1 22.3 1.9 0.2 40.0 1.5 0.9 1.1 1.6 0.6 0.6 2.2 2.2 38.4 67.0 0.7 0.8 3.5 1.9 1.8 4.2 0.6 0.7 0.4 3.0 0.9 0.6 0.6 1.7 0.7 1.4 1.0 60.2 0.9 1.8 0.8 1.0 1.6 3.6 0.0 0.5 1.2 0.6 0.7 0.9 5.1 7.3 0.6 6.6 5.4 8.8 6.0 14.0 10.7 1.7 6.4 1.2 0.3 1.4 1.0 0.6 1.3 0.8 5.1 3.1 2.1 3.4 0.0 1.5 6.2 5.5 1.8 0.4 5.0 10.1 18.6 2.8 27.1 0.6 2.5 2.2 0.1 0.8 1.6 0.1 0.7 1.2 3.0 3.3 3.6 0.1 9.1 3.0 2.0 2.3 12.7 4.2 10.7 0.8 11.8 1.6 1.7 6.0 9.4 2.1 3.6 4.0 0.6 1.6 1.1 1.1 0.4 2.1 0.9 3.7 4.4 7.9 3.6 1.8 6.1 1.0 0.0 6.6 0.4 5.4 3.8 7.4 5.1 8.8 7.8 6.1 5.1 6.4 7.8 0.6 5.4 1.6 7.3 5.5 6.0 2.1 2.7 5.2 3.9 2.2 2.2 3.5 1.9 3.0 3.6 3.0 5.9 9.6 2.3 3.2 3.6 1.9 15.3 0.0 1.2 38.4 2.0 2.6 109.5 3.1 0.8 5.8 12.3 0.0 2.6 3.6 1.9 0.9 4.6 359.6 7.5 6.4 5.8 6.7 13.2 3.6 1.7 5.8 8.5 1.0 5.9 8.5 2.7 1.7 1.4 948.1 5.2 0.0 4.5 0.9 6.8 5.9 7.9 4.6 14.3 1.0 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646155 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.5" "Group enriched" "Detected in some" 5 "Early spermatids: 57.8;Late spermatids: 47.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 1.4;neutrophil: 5.0" "Group enriched" "Detected in many" 32 "B-cells: 1.4;granulocytes: 5.0" "Cell line enhanced" "Detected in some" "A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA015607: AB_1852299, HPA076313: AB_2732308" "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.9 1.9 9.9 1.3 10.2 0.9 1.1 10.7 23.5 0.9 1.6 4.0 0.0 0.9 0.9 0.9 0.8 4.8 1.4 0.8 9.7 7.7 0.9 0.8 2.2 0.9 5.8 12.1 0.8 3.0 0.8 3.8 1.1 10.2 1.7 1.7 0.0 0.8 0.9 0.8 2.4 1.1 1.1 1.4 1.1 3.2 3.5 2.3 0.0 0.8 0.0 1.1 0.9 0.1 1.4 0.0 5.0 0.0 0.0 0.0 0.0 3.6 4.1 0.2 2.6 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 1.5 1.1 2.0 0.0 4.3 1.7 0.7 0.0 0.0 4.8 1.8 0.0 3.5 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.3 0.0 1.9 0.0 0.2 0.0 1.2 0.1 0.0 0.5 0.2 0.3 0.2 0.0 0.8 0.1 0.2 7.8 0.5 0.1 2.2 0.0 0.1 0.8 0.0 0.0 0.0 0.6 0.4 0.8 0.6 6.3 0.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 10.2 10.7 14.9 9.7 7.7 5.8 12.1 10.2 2.3 3.0 0.3 0.0 0.0 0.0 1.8 1.2 0.0 10.7 2.3 0.0 0.0 0.0 0.0 0.2 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 47.2 0.6 0.0 0.0 1.0 0.7 0.2 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.9 1.4 0.0 0.6 0.0 0.3 0.2 KIAA0408 ENSG00000189367 KIAA0408 Q6ZU52 6 127440343-127459391 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.6;smooth muscle: 37.2" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 86.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044035, HPA053341" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044035: AB_10964274, HPA053341: AB_2732578" "unprognostic (1.06e-1)" "unprognostic (4.36e-2)" "unprognostic (3.06e-1)" "unprognostic (1.09e-1)" "unprognostic (8.56e-4)" "unprognostic (1.00e-1)" "unprognostic (4.95e-2)" "unprognostic (6.05e-3)" "unprognostic (2.29e-1)" "unprognostic (5.94e-2)" "unprognostic (3.20e-2)" 22.9 3.1 9.1 3.4 6.9 0.0 2.8 12.4 21.0 7.4 12.0 0.6 1.9 1.1 2.6 4.7 16.7 1.1 2.9 2.6 10.2 9.7 0.6 0.7 15.3 0.5 11.5 0.7 3.3 0.5 0.0 6.8 1.1 0.9 20.4 5.0 0.7 1.9 1.7 38.6 0.4 6.7 37.2 13.1 2.0 3.7 3.4 1.2 0.7 1.5 15.4 0.8 25.2 11.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 2.9 12.5 0.0 1.1 3.0 0.0 0.3 2.2 1.9 4.5 0.0 0.0 0.0 0.0 0.4 10.9 0.0 1.2 0.0 2.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.7 0.0 8.1 0.0 1.4 0.0 1.2 0.0 0.3 2.3 0.0 4.3 0.0 4.2 0.0 0.1 0.0 2.1 0.0 0.7 0.0 31.5 15.6 0.0 0.0 0.3 0.0 0.0 0.9 0.0 8.6 1.4 0.0 2.0 0.0 0.0 0.0 5.0 0.2 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.1 6.9 12.4 11.8 10.2 9.7 11.5 0.7 0.9 1.2 86.4 19.0 0.0 0.1 0.0 3.3 0.0 0.0 6.7 5.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 7.9 0.0 1.3 0.8 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.2 0.9 0.1 0.0 0.1 0.0 0.0 0.0 KIAA0513 ENSG00000135709 KIAA0513 O60268 16 85027751-85094230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 46.1;Late spermatids: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 15.9;monocytes: 13.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012866, HPA014431" Enhanced Uncertain Nucleoplasm,Cytosol NA NA 8400 "Nucleoplasm, Cytosol" "HPA012866: AB_1852321, HPA014431: AB_1852322" "unprognostic (1.98e-2)" "unprognostic (2.47e-2)" "unprognostic (2.35e-1)" "unprognostic (1.69e-2)" "unprognostic (1.49e-2)" "unprognostic (9.37e-3)" "unprognostic (2.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.38e-1)" "unprognostic (4.85e-2)" "prognostic favorable (1.72e-5)" "unprognostic (7.52e-2)" "unprognostic (1.94e-3)" "unprognostic (7.88e-2)" "unprognostic (4.00e-1)" "unprognostic (2.33e-2)" "unprognostic (2.34e-1)" 5.2 11.0 20.8 8.8 30.8 14.3 2.8 57.6 57.6 6.9 8.1 4.6 1.8 4.7 3.3 3.1 7.6 2.3 4.9 4.5 19.7 14.9 3.0 1.9 6.7 5.2 11.3 27.6 2.9 13.0 4.1 14.8 4.0 17.6 6.2 6.1 2.9 8.3 5.2 5.6 9.9 6.0 5.6 6.9 7.4 10.1 5.7 4.6 0.5 2.8 1.0 6.2 8.3 3.5 0.0 3.6 15.9 13.6 0.7 0.9 3.1 5.7 6.2 4.2 6.1 7.9 5.9 1.0 5.8 9.3 8.4 4.9 2.8 2.7 2.0 2.6 7.0 5.1 5.1 3.9 9.2 5.2 4.3 3.2 3.7 1.9 1.5 3.8 0.4 5.3 10.9 4.9 9.6 1.2 3.6 4.4 4.1 16.2 4.8 7.4 9.0 0.7 1.5 4.1 6.7 5.0 0.7 5.4 1.2 7.8 4.2 12.4 1.9 6.8 11.4 2.8 4.4 9.2 1.2 8.9 5.2 3.9 7.8 2.0 7.6 1.3 4.1 6.8 2.9 5.6 11.0 7.2 10.6 0.9 8.3 0.3 0.0 0.6 0.6 2.6 0.0 0.6 0.6 15.9 0.7 13.6 3.6 0.2 3.1 20.8 30.8 57.6 45.9 19.7 14.9 11.3 27.6 17.6 4.6 6.0 7.2 3.0 6.5 3.5 13.4 5.8 2.5 1.4 2.3 1.8 5.9 0.4 0.0 2.0 38.3 3.2 5.9 0.0 4.1 0.6 3.9 11.1 2.3 2.4 6.7 46.1 10.9 5.5 18.3 149.1 15.0 8.8 3.3 5.4 8.4 2.5 6.6 7.0 25.1 1.3 5.9 0.0 3.1 3.6 4.9 3.9 2.9 4.4 3.5 26.5 KIAA0825 "C5orf36, DKFZp686F0372, MGC34713" ENSG00000185261 KIAA0825 Q8IV33 5 94152966-94618597 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 22.4" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 47.1;Horizontal cells: 14.3;Rod photoreceptor cells: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "neutrophil: 13.4" "Lineage enriched" "Detected in single" 18 "granulocytes: 13.4" "Cell line enhanced" "Detected in many" "HeLa: 13.9" "HPA038030, HPA038031" Uncertain NA NA "HPA038030: AB_10672735, HPA038031: AB_2675794" "unprognostic (1.26e-1)" "unprognostic (7.73e-2)" "unprognostic (1.93e-4)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (7.63e-3)" "unprognostic (4.44e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-1)" "unprognostic (4.95e-3)" "unprognostic (2.14e-1)" "unprognostic (1.07e-1)" "unprognostic (9.02e-5)" "unprognostic (3.00e-2)" "unprognostic (8.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.09e-2)" 2.7 3.5 5.1 1.9 10.4 2.9 3.6 14.1 10.7 4.5 2.1 1.2 4.1 1.4 4.4 5.4 3.4 8.0 3.8 2.7 4.9 4.8 5.4 2.9 3.1 2.1 2.6 4.2 5.2 2.8 5.5 22.4 2.8 5.3 3.4 2.4 4.9 2.2 3.0 1.9 1.9 2.3 3.0 2.6 4.0 1.9 8.5 1.9 4.1 5.9 1.3 1.6 3.7 2.6 0.7 0.6 13.4 0.6 0.6 0.7 0.2 0.7 0.3 1.0 2.5 3.4 4.4 0.3 2.3 2.1 1.6 2.3 0.0 1.8 0.4 2.6 0.9 1.6 1.3 0.4 1.7 2.1 0.0 0.5 0.4 13.9 0.3 2.4 0.4 0.2 2.4 1.7 2.0 0.5 2.1 1.6 1.4 0.3 0.1 3.0 1.6 1.1 1.1 1.4 0.4 0.3 1.2 0.2 0.1 3.1 0.8 1.6 2.0 2.5 0.2 0.4 1.7 1.2 1.8 1.5 1.3 0.3 2.0 1.0 0.6 0.5 0.0 3.1 0.8 1.2 0.0 0.6 0.0 0.4 0.3 0.2 0.7 0.4 0.7 0.5 0.5 0.2 0.4 13.4 0.6 0.4 0.6 0.2 0.2 5.1 10.4 14.1 10.7 4.9 4.8 2.6 4.2 5.3 1.9 6.0 5.5 0.0 1.2 1.1 9.6 2.0 0.0 13.4 2.3 1.8 47.1 0.9 0.0 1.0 7.3 1.4 1.1 0.0 0.6 0.5 1.6 0.8 1.1 1.5 0.9 14.3 0.0 1.3 1.5 4.7 1.1 1.2 0.0 0.0 0.1 4.3 0.8 0.0 1.4 2.4 21.2 0.0 1.3 6.9 3.2 1.0 0.2 1.0 0.4 0.7 KIAA0930 "bK268H5.C22.1, C22orf9" ENSG00000100364 KIAA0930 Q6ICG6 22 45190338-45240769 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.8" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 60.5;Kupffer cells: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 9.1;eosinophil: 6.5;intermediate monocyte: 11.1;myeloid DC: 9.8;non-classical monocyte: 12.9;plasmacytoid DC: 8.2" "Group enriched" "Detected in all" 4 "dendritic cells: 9.8;granulocytes: 6.5;monocytes: 12.9" "Cell line enhanced" "Detected in many" "THP-1: 83.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038091 Uncertain Approved "Nuclear membrane,Mitochondria" No No "Nuclear membrane, Mitochondria" "HPA038091: AB_10675627" "unprognostic (4.16e-2)" "unprognostic (1.27e-2)" "unprognostic (1.99e-1)" "prognostic favorable (9.22e-5)" "unprognostic (3.16e-2)" "unprognostic (2.44e-1)" "prognostic unfavorable (6.90e-8)" "unprognostic (2.80e-1)" "unprognostic (2.03e-1)" "unprognostic (3.58e-2)" "unprognostic (2.23e-1)" "unprognostic (4.44e-1)" "prognostic unfavorable (8.95e-7)" "unprognostic (6.89e-3)" "unprognostic (5.32e-2)" "unprognostic (5.58e-2)" "unprognostic (1.15e-1)" 13.4 18.0 51.3 17.1 50.0 14.4 12.9 9.9 41.3 15.3 11.6 52.8 10.3 9.6 8.3 28.4 14.2 10.0 10.7 6.6 50.2 39.9 5.9 12.7 12.5 16.6 48.2 36.8 6.7 8.2 10.2 5.6 7.9 28.9 9.5 7.6 4.9 8.6 18.1 15.6 34.2 12.9 10.3 29.3 15.4 8.5 10.1 50.0 6.5 5.2 6.7 14.3 14.1 9.6 1.8 9.8 6.5 12.9 1.5 2.2 2.6 12.4 8.1 5.0 9.9 17.2 8.1 5.0 6.9 6.9 7.4 6.4 7.4 6.8 8.3 10.3 10.9 5.9 14.0 7.6 30.6 2.8 8.9 12.0 0.0 10.0 8.5 6.9 22.2 5.1 4.6 15.5 7.1 12.0 5.6 6.9 6.1 2.9 13.8 4.4 14.3 9.8 20.7 4.9 9.0 6.8 12.1 3.4 27.4 11.1 7.6 4.2 7.4 10.9 15.0 18.9 10.1 7.3 83.1 9.3 7.6 13.5 10.3 3.9 11.8 7.9 8.0 8.9 33.9 7.8 0.9 9.1 6.5 2.0 11.1 1.3 1.8 0.8 2.2 9.8 1.6 0.8 1.4 2.2 1.5 12.9 8.2 1.5 2.6 51.3 50.0 9.9 41.3 50.2 39.9 48.2 36.8 28.9 50.0 6.0 9.1 9.0 15.2 46.9 4.4 9.9 7.6 5.3 4.5 17.4 5.9 1.5 0.0 16.3 2.3 10.3 12.9 0.0 17.8 4.7 23.4 14.4 2.3 19.8 60.5 4.8 10.3 20.9 61.7 6.1 10.0 44.0 42.2 22.6 10.8 5.5 15.6 11.6 13.8 11.2 4.7 0.0 16.9 7.5 4.7 50.1 2.3 10.7 10.2 23.7 KIAA1024 ENSG00000169330 KIAA1024 Q9UPX6 15 79432516-79472290 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.8;brain: 10.8" "Group enriched" "Detected in some" 12 "Horizontal cells: 15.9;Muller glia cells: 22.6" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in many" 5 "cerebellum: 10.8;pons and medulla: 8.5" "Group enriched" "Detected in some" 12 "eosinophil: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 12 "granulocytes: 2.5;monocytes: 1.9" "Cell line enhanced" "Detected in many" "U-138 MG: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 16.8 0.8 0.2 0.6 0.7 0.5 10.8 2.0 0.6 0.2 0.4 0.1 0.0 0.4 0.5 0.5 0.1 0.6 0.1 0.5 1.4 0.2 0.1 0.1 0.6 1.2 1.5 0.2 3.5 0.0 0.7 0.5 8.5 1.2 0.3 0.7 4.2 0.2 0.6 0.2 0.2 0.2 1.7 0.3 0.2 1.1 1.0 0.1 0.2 0.1 0.4 0.2 0.1 0.1 0.1 2.5 1.9 0.0 0.1 0.0 0.4 0.3 0.6 0.8 1.8 1.7 0.7 0.9 1.5 0.7 0.8 0.0 0.4 1.1 0.2 1.3 1.0 0.3 1.5 0.1 0.5 1.3 1.7 3.0 0.7 0.0 1.0 4.1 1.5 0.7 0.3 1.2 0.2 1.5 0.8 1.4 0.2 0.0 0.3 0.0 0.6 1.5 0.7 0.7 0.7 0.6 0.2 0.6 0.2 0.0 3.1 1.6 0.3 2.7 1.6 1.3 0.4 2.0 0.5 14.5 0.5 0.0 3.0 1.8 2.1 0.5 1.4 2.3 1.7 0.0 0.0 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.8 0.6 10.8 2.0 0.5 1.4 1.2 1.5 8.5 1.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.3 1.5 0.0 0.0 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.1 15.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 22.6 0.3 0.6 0.0 0.0 0.5 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.1 KIAA1024L ENSG00000186367 "KIAA1024 like" P59773 5 129748079-129766732 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 26.0" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 1.5;Melanocytes: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA013760 Uncertain NA NA "HPA013760: AB_1852363" "unprognostic (1.77e-1)" "unprognostic (5.13e-1)" 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 2.8 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.1 2.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 26.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 2.8 4.1 1.1 0.8 0.8 0.1 0.6 0.1 0.1 1.9 0.2 0.1 0.5 0.3 0.2 0.3 0.4 0.1 3.1 1.0 1.3 0.2 0.1 1.7 0.0 0.3 0.2 1.6 1.3 0.5 0.7 0.9 0.0 0.2 1.4 0.6 0.4 0.1 0.4 0.1 0.2 0.8 0.4 2.1 0.5 0.4 1.5 1.7 1.2 0.2 1.6 0.3 0.5 0.6 0.5 0.9 0.8 4.7 0.2 3.1 0.5 0.3 1.3 0.4 0.2 1.6 1.2 0.9 0.3 0.2 0.8 0.5 1.3 0.1 2.5 4.1 1.1 0.6 0.8 0.6 0.8 0.6 0.6 0.5 0.3 1.6 0.6 0.8 2.6 0.8 1.0 2.8 0.3 0.1 0.1 0.9 0.0 2.8 0.1 2.0 0.3 0.0 1.9 0.0 0.0 0.3 0.0 1.5 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.4 KIAA1210 ENSG00000250423 KIAA1210 Q9ULL0 X 119078635-119150579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 24.6;seminal vesicle: 12.3;testis: 19.8" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 2.6;Late spermatids: 7.0;Leydig cells: 3.4;Peritubular cells: 5.6" "Cancer enhanced" "Detected in single" "prostate cancer: 1.3" "Group enriched" "Detected in some" 5 "basophil: 2.0;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.0" "Group enriched" "Detected in some" 8 "Daudi: 2.2;MCF7: 4.2;SK-BR-3: 2.3;U-2 OS: 2.6" "HPA000551, HPA048322" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA000551: AB_1079165, HPA048322: AB_2680358" "unprognostic (2.48e-1)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-1)" "unprognostic (2.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (5.69e-2)" "unprognostic (1.05e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-1)" "unprognostic (6.26e-4)" 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 24.6 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.7 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.1 0.0 0.2 0.2 2.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 2.3 0.2 0.3 0.1 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 1.2 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.4 1.1 0.0 0.2 0.0 0.0 0.0 KIAA1211 ENSG00000109265 KIAA1211 Q6ZU35 4 56049073-56328625 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 39.9;testis: 27.0" "Group enriched" "Detected in some" 15 "Early spermatids: 102.6;Late spermatids: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enhanced" "Detected in single" "B-cells: 1.2" "Cell line enhanced" "Detected in many" "SCLC-21H: 16.0;SH-SY5Y: 34.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043249, HPA048148" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA043249: AB_2678388, HPA048148: AB_2680286" "unprognostic (1.65e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-3)" "unprognostic (1.31e-1)" "unprognostic (6.04e-1)" "unprognostic (6.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" "unprognostic (8.05e-6)" "unprognostic (1.02e-1)" "unprognostic (6.54e-2)" "unprognostic (2.79e-2)" "unprognostic (2.93e-1)" 1.0 2.1 4.5 4.2 3.7 3.0 0.8 4.2 6.8 2.3 12.6 3.3 3.2 11.8 3.7 3.9 1.0 2.7 14.4 1.6 5.7 7.0 1.6 1.0 1.4 1.8 5.3 3.0 2.2 1.6 7.6 1.9 2.3 13.4 1.6 7.2 4.7 0.9 5.5 0.7 0.9 39.9 4.0 4.8 2.1 2.4 27.0 1.5 0.2 0.8 0.0 1.6 1.5 2.2 1.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 1.7 6.7 0.5 0.2 0.0 2.4 0.0 0.2 0.3 0.7 1.9 0.2 5.9 0.1 0.0 5.4 0.0 5.6 0.1 0.2 0.5 3.3 3.2 3.0 0.3 0.9 2.7 0.5 0.3 0.1 0.0 0.1 2.2 3.1 5.3 0.0 5.8 0.0 0.8 4.0 0.2 3.6 5.0 4.3 3.9 3.7 0.1 0.0 1.5 16.0 34.2 0.6 0.2 4.1 5.9 1.4 0.3 1.2 0.1 1.7 0.4 1.5 5.8 3.9 0.0 1.7 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 3.7 4.2 6.8 5.7 7.0 5.3 3.0 13.4 1.5 0.0 0.0 0.0 0.0 0.1 2.3 2.2 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 102.6 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 6.4 4.7 0.6 0.0 87.5 0.6 0.0 0.0 0.0 0.7 2.7 1.8 0.9 0.4 0.0 0.0 0.0 0.0 1.6 0.7 0.0 0.1 0.0 1.1 0.0 KIAA1211L "C2orf55, MGC42367" ENSG00000196872 "KIAA1211 like" Q6NV74 2 98793846-98936259 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;epididymis: 27.7" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 95.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 6 "amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 22.3;HDLM-2: 32.0;Karpas-707: 9.4;MCF7: 8.5;SiHa: 9.1;SK-BR-3: 12.2" "Group enriched" "Detected in many" 15 "amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3" "HPA051082, HPA061678" Enhanced Approved "Microtubules,Cytokinetic bridge,Centrosome" Yes No "Microtubules, Centrosome" "Cytokinetic bridge" "HPA051082: AB_2681337, HPA061678: AB_2684584" "unprognostic (3.56e-3)" "unprognostic (1.23e-3)" "unprognostic (5.88e-2)" "unprognostic (6.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.24e-1)" "unprognostic (3.67e-3)" "unprognostic (2.12e-1)" "unprognostic (5.10e-2)" "unprognostic (7.65e-2)" "unprognostic (3.23e-2)" "unprognostic (3.61e-2)" "prognostic favorable (1.13e-5)" "unprognostic (1.22e-1)" "unprognostic (3.34e-1)" "prognostic favorable (1.33e-5)" "unprognostic (2.22e-2)" 2.7 0.8 19.0 1.3 23.7 0.5 3.5 2.4 27.4 4.6 5.0 0.8 3.5 6.7 1.5 27.7 9.1 19.3 2.5 1.4 12.9 1.9 2.5 0.4 3.9 0.6 2.7 18.3 1.4 3.7 9.6 4.3 4.0 0.1 1.6 4.0 0.0 9.0 4.3 1.3 4.3 6.1 2.1 1.2 1.0 6.8 3.6 3.6 0.0 4.3 3.3 2.5 2.4 3.2 0.0 0.7 1.4 0.3 0.2 0.9 0.0 4.3 0.2 0.1 1.7 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.2 2.6 0.0 5.7 0.0 0.1 3.9 0.1 0.2 0.0 32.0 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.1 1.2 0.0 0.6 0.0 1.3 0.0 0.0 9.4 0.0 8.5 0.1 0.6 0.0 4.3 0.4 0.0 0.0 0.4 1.7 3.4 3.2 0.5 9.1 12.2 0.0 0.0 4.7 0.7 5.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.7 0.0 0.0 19.0 23.7 2.4 27.4 12.9 1.9 2.7 18.3 0.1 3.6 14.9 2.9 0.0 3.1 0.6 0.0 4.2 5.1 95.0 23.9 3.5 0.0 0.3 3.3 3.7 11.8 9.0 10.0 0.0 6.5 1.1 0.2 1.7 0.0 0.0 2.6 0.0 15.1 6.7 1.5 17.2 0.3 0.9 0.0 0.0 11.4 0.0 4.8 8.6 0.4 2.2 0.0 0.0 0.4 15.9 12.6 5.3 0.3 0.0 8.8 5.1 KIAA1217 "DKFZP761L0424, ETL4, SKT" ENSG00000120549 KIAA1217 Q5T5P2 10 23694746-24547848 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 91.1" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 107.7;Club cells: 95.5;Muller glia cells: 121.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Cell line enhanced" "Detected in many" "BEWO: 34.0;Karpas-707: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004941 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004941: AB_2130659" "unprognostic (3.60e-2)" "unprognostic (7.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.73e-2)" "unprognostic (1.27e-1)" "unprognostic (4.45e-3)" "unprognostic (1.60e-3)" "unprognostic (2.03e-3)" "unprognostic (1.87e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.69e-1)" "unprognostic (1.84e-3)" "unprognostic (5.27e-2)" "unprognostic (2.44e-1)" "unprognostic (2.97e-1)" "unprognostic (1.22e-1)" 24.9 12.7 3.3 6.6 8.7 0.0 21.6 5.5 16.2 10.2 15.1 2.7 18.0 7.5 7.2 16.5 22.6 10.4 11.9 8.6 5.1 3.7 13.5 10.4 8.6 1.4 4.3 8.1 8.4 10.1 34.1 5.5 12.2 8.8 15.1 8.9 16.9 28.8 26.6 91.1 12.0 13.7 4.1 3.8 5.7 10.1 16.8 1.8 3.3 20.5 20.4 8.8 10.1 13.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 7.6 3.9 1.5 0.0 1.0 2.8 34.0 1.5 2.4 3.5 7.6 6.6 12.3 0.4 7.7 3.0 7.2 12.8 1.9 14.5 3.9 2.8 1.4 0.1 8.9 7.7 1.7 0.0 0.1 10.7 9.4 7.8 2.1 1.6 0.0 0.7 0.0 30.9 1.8 2.7 4.2 0.2 3.5 7.5 3.5 0.3 9.1 6.3 8.3 10.1 1.0 0.5 3.8 12.9 0.0 16.6 6.2 0.0 8.1 5.4 5.9 21.7 1.9 13.8 11.6 0.0 18.1 0.2 0.2 0.0 0.0 0.0 0.5 0.0 2.8 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.3 8.7 5.5 16.2 5.1 3.7 4.3 8.1 8.8 1.8 35.7 24.2 0.8 63.7 107.7 12.4 33.1 17.8 32.1 95.5 31.4 7.9 43.5 3.3 26.0 24.9 10.8 21.2 0.0 23.1 16.7 14.6 36.0 1.1 21.2 4.6 0.0 23.0 25.8 10.5 7.0 16.4 2.7 1.7 0.0 21.3 121.7 20.1 22.0 31.1 4.5 2.7 12.9 19.6 0.5 0.7 44.5 54.5 0.7 16.6 47.2 KIAA1257 ENSG00000114656 KIAA1257 Q9ULG3 3 128909866-129002690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.3;testis: 38.5" "Group enriched" "Detected in many" 5 "Early spermatids: 154.5;Late spermatids: 157.4;Spermatocytes: 41.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 14 "neutrophil: 23.3" "Lineage enriched" "Detected in single" 47 "granulocytes: 23.3" "Cell line enhanced" "Detected in many" "AF22: 8.5;BEWO: 13.2;HL-60: 14.3;THP-1: 8.8" "HPA042811, HPA048445" Uncertain NA NA "HPA042811: AB_2678180, HPA048445: AB_2680397" "unprognostic (4.17e-2)" "unprognostic (5.16e-2)" "unprognostic (2.46e-1)" "unprognostic (2.67e-1)" "unprognostic (9.41e-3)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (4.22e-2)" "unprognostic (6.48e-3)" "unprognostic (7.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.88e-2)" "unprognostic (1.42e-2)" "unprognostic (3.38e-1)" "unprognostic (4.69e-2)" "unprognostic (2.52e-1)" "unprognostic (5.50e-2)" 0.6 0.5 1.7 0.9 7.7 1.9 0.8 0.8 3.2 0.5 0.5 2.4 0.2 0.8 0.5 1.7 1.0 4.1 1.6 0.5 2.5 1.6 0.6 0.4 1.8 0.9 0.6 1.7 1.3 0.6 1.1 3.6 3.7 2.1 0.9 0.7 0.1 0.7 0.7 0.4 5.3 0.6 0.3 0.5 1.0 0.9 38.5 0.9 0.8 0.7 0.0 0.1 0.7 0.5 0.3 0.2 23.3 0.4 0.1 0.4 0.1 1.2 1.8 8.5 1.8 0.0 0.1 13.2 0.1 0.3 0.0 0.0 2.4 1.2 2.1 0.4 0.0 1.1 1.3 2.8 0.1 0.0 0.8 1.5 4.3 1.1 1.1 0.1 14.3 0.8 0.0 1.4 0.0 0.0 0.3 0.0 4.1 1.0 2.4 0.0 1.6 1.8 3.1 1.7 2.4 1.9 1.3 0.8 1.3 0.0 1.9 1.6 0.7 0.5 0.4 0.8 1.9 2.3 8.8 0.3 0.8 1.4 0.7 0.6 2.8 2.7 3.7 0.7 5.4 0.8 0.4 0.4 1.7 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.4 23.3 0.1 0.2 0.2 0.1 0.1 1.7 7.7 0.8 3.2 2.5 1.6 0.6 1.7 2.1 0.9 3.0 1.4 0.0 0.7 0.6 0.4 0.8 0.0 21.4 1.2 0.0 3.9 0.1 0.0 0.3 154.5 1.1 0.0 0.0 0.3 0.1 0.9 0.9 0.0 0.0 0.2 1.6 8.2 2.5 0.6 157.4 2.8 0.9 0.0 0.0 1.3 1.5 0.3 0.0 0.4 0.0 1.1 0.0 0.8 41.4 10.4 0.3 0.0 0.0 0.4 0.7 KIAA1324 "EIG121, maba1" ENSG00000116299 KIAA1324 Q6UXG2 1 109113679-109206781 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8;salivary gland: 169.4" "Cell type enhanced" "Detected in many" 9 "Glandular cells: 98.1;Intestinal endocrine cells: 156.4;Mucus-secreting cells: 151.0;Undifferentiated cells: 73.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "neutrophil: 33.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 33.8" "Cell line enhanced" "Detected in some" "MCF7: 14.5;SCLC-21H: 9.3;SK-BR-3: 11.3;T-47d: 38.6;U-87 MG: 7.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029869, HPA070749" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029869: AB_10794320, HPA070749: AB_2686304" "unprognostic (2.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.99e-2)" "prognostic favorable (2.14e-7)" "unprognostic (4.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-3)" "prognostic favorable (5.69e-5)" "unprognostic (2.79e-2)" "prognostic favorable (2.16e-4)" "unprognostic (3.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.22e-16)" "unprognostic (2.46e-1)" "unprognostic (1.75e-1)" "unprognostic (5.64e-2)" "unprognostic (8.02e-2)" 0.7 0.9 3.7 3.6 7.9 0.0 16.4 0.7 5.6 23.9 11.8 0.4 0.0 14.6 5.5 5.7 1.3 7.8 19.1 0.6 3.3 2.3 0.6 0.6 2.2 0.7 1.0 2.7 1.2 79.8 6.1 46.6 0.0 1.1 15.8 10.0 0.0 169.4 0.0 0.6 2.5 16.5 0.2 0.9 0.9 27.3 9.4 1.1 0.0 3.9 5.2 11.5 0.9 0.6 0.2 0.0 33.8 0.0 0.2 4.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.8 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.3 14.5 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.5 0.2 0.0 9.3 0.2 0.0 11.3 0.0 0.0 38.6 0.0 0.2 0.0 1.4 0.0 0.1 0.8 2.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.9 0.2 3.9 1.7 0.0 0.0 1.8 0.7 33.8 0.2 0.0 0.0 4.6 1.0 3.7 7.9 0.7 5.6 3.3 2.3 1.0 2.7 1.1 1.1 14.9 43.1 0.0 6.2 0.5 5.1 1.5 0.0 34.8 62.6 0.0 3.9 0.5 0.0 0.9 32.7 0.5 13.1 0.0 33.1 0.6 1.6 98.1 22.1 0.0 0.9 1.6 156.4 1.3 1.6 12.3 4.0 2.3 3.3 0.0 151.0 1.4 16.5 24.6 2.1 0.0 2.6 0.0 1.4 13.7 1.7 1.4 0.5 4.4 73.4 8.3 KIAA1324L "EIG121L, FLJ31340" ENSG00000164659 "KIAA1324 like" A8MWY0 7 86876906-87059699 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 73.9;Early spermatids: 53.7;Horizontal cells: 31.8;Late spermatids: 70.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.8" "Group enriched" "Detected in many" 5 "B-cells: 2.7;NK-cells: 4.8;T-cells: 5.8" "Cell line enhanced" "Detected in many" "AF22: 15.4;hTERT-HME1: 17.9;HUVEC TERT2: 15.0;K-562: 23.0;SCLC-21H: 19.1;SuSa: 17.5;TIME: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044527, HPA076093" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044527: AB_10963793, HPA076093: AB_2686776" "unprognostic (2.78e-2)" "unprognostic (9.37e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-4)" "unprognostic (3.79e-1)" "unprognostic (4.00e-2)" "unprognostic (1.33e-3)" "unprognostic (1.89e-1)" "unprognostic (1.96e-1)" "unprognostic (2.16e-1)" "unprognostic (2.28e-2)" "unprognostic (6.82e-2)" "unprognostic (8.82e-3)" "unprognostic (3.86e-3)" "unprognostic (1.25e-1)" "unprognostic (4.32e-1)" "unprognostic (1.37e-1)" 11.1 4.5 7.7 2.3 17.3 1.0 6.5 15.6 15.8 4.0 5.0 28.9 1.2 1.8 4.3 1.0 4.5 3.9 5.0 5.5 10.8 8.7 2.9 1.5 24.4 3.8 22.4 10.4 2.7 5.5 11.7 13.5 9.0 22.7 7.6 6.5 2.4 3.6 6.3 3.5 3.4 2.7 6.4 23.5 6.4 4.1 3.6 21.7 0.0 6.1 1.0 4.0 5.9 2.8 2.7 0.9 0.4 0.0 4.8 5.8 0.7 0.9 0.0 15.4 0.0 0.2 0.0 4.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 3.8 0.3 0.1 0.0 1.6 0.0 0.0 3.7 0.3 11.8 4.1 1.3 0.1 0.1 1.5 1.2 0.0 0.0 17.9 0.1 15.0 5.8 23.0 0.4 1.7 4.7 0.3 0.0 8.4 0.0 3.8 0.0 1.0 2.4 1.6 6.8 19.1 14.3 4.1 5.4 1.7 17.5 1.6 0.3 17.6 0.2 6.0 0.1 0.0 8.5 5.0 0.1 4.5 0.0 0.2 0.0 0.0 0.4 0.7 0.0 5.8 0.9 2.1 1.3 0.4 2.7 2.2 1.2 0.0 4.8 0.0 0.9 0.7 0.7 7.7 17.3 15.6 15.8 10.8 8.7 22.4 10.4 22.7 21.7 11.9 73.9 0.0 1.4 1.0 11.6 2.0 0.0 6.7 3.4 3.5 9.8 0.4 3.3 1.3 53.7 10.0 1.7 0.0 1.0 0.4 3.1 3.6 2.3 0.0 0.3 31.8 8.1 0.6 0.8 70.4 2.3 1.6 0.0 0.0 2.7 1.1 1.0 1.9 2.1 0.7 3.2 6.5 6.2 0.7 2.1 1.4 0.1 0.7 2.6 1.4 KIAA1549 ENSG00000122778 KIAA1549 Q9HCM3 7 138831381-138981318 "Disease related genes, Predicted membrane proteins" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 27.5;seminal vesicle: 39.0" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 26.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.2;neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "PC-3: 20.4;SH-SY5Y: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019560 Uncertain Approved "Nuclear membrane,Intermediate filaments" NA NA "Nuclear membrane" "Intermediate filaments" "HPA019560: AB_1852418" "unprognostic (7.88e-2)" "unprognostic (2.37e-2)" "unprognostic (2.63e-1)" "unprognostic (6.85e-2)" "unprognostic (2.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.55e-2)" "unprognostic (6.40e-2)" "unprognostic (1.02e-1)" "unprognostic (2.19e-2)" "unprognostic (2.33e-2)" "unprognostic (8.30e-2)" "prognostic favorable (3.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "unprognostic (2.38e-1)" "unprognostic (1.28e-2)" 2.1 3.2 3.3 0.6 4.4 0.6 2.9 1.2 8.3 2.7 1.8 1.6 27.5 1.5 3.7 4.1 1.4 4.9 2.5 1.9 3.1 2.0 8.0 1.5 4.7 0.3 1.6 3.8 2.6 12.9 6.5 3.6 4.6 3.7 3.1 1.5 2.0 4.4 39.0 1.4 2.6 1.8 2.9 3.3 1.2 3.0 2.9 1.2 3.1 2.2 0.1 0.4 3.8 4.4 0.3 0.1 1.5 0.1 0.3 0.2 0.0 5.1 9.7 8.6 15.0 0.1 0.0 5.0 5.2 4.7 3.0 3.9 9.0 3.1 0.0 3.2 7.9 9.3 1.0 5.3 1.5 3.7 2.4 3.3 2.4 10.4 2.3 1.3 3.7 3.5 1.3 2.4 1.1 1.6 2.9 5.0 3.4 1.9 0.1 3.4 4.8 2.6 3.6 8.1 3.7 20.4 7.2 4.4 0.0 1.5 3.1 11.4 19.5 2.8 5.2 2.3 5.2 4.3 2.3 3.2 3.1 3.2 0.0 4.9 0.7 0.0 0.2 4.1 1.5 7.2 1.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.5 0.3 0.1 0.1 0.0 0.0 3.3 4.4 1.2 8.3 3.1 2.0 1.6 3.8 3.7 1.2 0.0 2.1 0.0 2.1 0.5 13.5 2.2 0.0 9.4 3.4 7.0 53.0 2.1 0.0 2.3 0.3 4.5 0.1 0.0 2.8 1.9 2.1 3.0 16.1 0.5 0.4 3.2 10.4 1.8 1.0 0.0 1.4 0.2 1.7 0.0 2.0 7.7 4.7 0.6 2.5 6.9 26.7 6.5 1.6 0.0 7.7 0.6 1.3 1.0 1.5 1.4 KIAA1549L "C11orf41, C11orf69, G2, MGC34830" ENSG00000110427 "KIAA1549 like" Q6ZVL6 11 33376466-33674102 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 30.4;parathyroid gland: 64.4" "Cell type enriched" "Detected in some" 4 "Melanocytes: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 23.0;U-138 MG: 30.4;WM-115: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010132, HPA051594" Approved Nucleoplasm,Vesicles NA NA 27000 Nucleoplasm Vesicles "HPA010132: AB_1078313, HPA051594: " "unprognostic (3.02e-1)" "unprognostic (1.18e-1)" "unprognostic (2.70e-2)" "unprognostic (1.34e-5)" "unprognostic (2.63e-1)" "unprognostic (7.92e-2)" "unprognostic (2.89e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-2)" "unprognostic (2.59e-4)" "unprognostic (8.88e-2)" "unprognostic (1.44e-1)" "unprognostic (3.62e-3)" "unprognostic (1.08e-3)" "unprognostic (8.46e-2)" "unprognostic (4.04e-1)" "unprognostic (1.09e-1)" 0.8 0.9 8.2 0.7 20.5 0.6 1.2 6.2 30.4 0.7 0.7 1.7 0.0 0.6 0.7 0.6 0.9 0.6 0.8 0.6 5.3 2.4 0.9 0.6 0.6 0.7 1.6 17.1 0.7 0.8 64.4 1.0 1.4 2.3 0.7 0.7 0.0 0.7 0.6 0.6 1.9 0.6 0.7 1.1 0.6 0.7 1.3 1.6 0.0 0.6 0.0 1.1 0.9 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 3.3 0.1 0.5 3.7 0.0 13.3 7.8 2.1 1.2 0.0 0.3 10.2 0.1 11.7 10.2 0.7 0.4 3.8 3.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 5.8 7.6 9.5 0.2 0.0 9.7 8.3 0.0 0.1 0.0 0.7 0.0 4.9 0.0 0.8 0.0 0.0 5.1 1.1 1.2 0.1 0.0 3.2 0.1 0.0 0.0 23.0 30.4 6.4 0.7 10.6 0.0 0.0 0.0 8.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.2 20.5 6.2 30.4 5.3 2.4 1.6 17.1 2.3 1.6 0.0 0.0 0.0 0.3 1.8 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.6 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.3 3.2 0.0 1.8 0.0 0.4 0.0 0.2 16.9 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.5 KIAA1551 "C12orf35, FLJ10652, FLJ20696, GET, UTA2-1" ENSG00000174718 KIAA1551 Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;lymphoid tissue: 56.3" "Cell type enhanced" "Detected in many" 7 "Urothelial cells: 190.4" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 58.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 58.8" "Cell line enhanced" "Detected in all" "SuSa: 44.6" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Nucleoli rim,Intermediate filaments,Cytosol" NA NA "Nucleoli, Nucleoli rim" "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 12.4 5.8 4.7 28.8 6.1 9.0 10.3 8.7 7.0 15.7 17.5 2.7 7.1 10.7 11.2 10.3 12.3 19.0 8.9 6.2 4.8 3.5 8.1 14.2 17.0 56.3 7.5 4.1 38.3 7.0 3.6 8.0 17.5 5.4 11.6 6.5 3.5 8.6 5.5 5.4 6.7 30.0 8.5 8.1 39.1 8.8 8.7 5.9 48.5 10.0 7.6 27.6 17.3 13.9 9.6 3.3 58.8 4.5 8.0 13.2 5.0 2.7 4.8 8.4 3.2 3.8 4.6 12.6 3.3 3.3 2.4 2.6 18.3 18.0 13.1 8.3 2.7 8.1 3.6 11.5 2.2 3.4 9.6 1.6 18.3 2.4 2.4 7.5 13.2 29.7 2.5 3.4 2.6 4.4 9.6 18.5 9.0 10.4 20.9 2.5 1.3 18.5 5.5 18.0 10.4 2.0 8.6 8.0 5.7 2.3 5.1 3.4 3.0 4.3 2.2 2.3 44.6 7.7 14.6 11.7 2.5 4.0 4.3 3.5 12.7 13.4 16.1 1.3 7.4 2.7 12.5 3.9 3.9 12.5 4.4 11.8 9.6 11.2 11.6 3.3 7.5 13.2 12.6 58.8 8.0 4.5 2.0 10.2 5.0 4.7 6.1 8.7 7.0 4.8 3.5 7.5 4.1 5.4 5.9 32.8 30.1 76.8 35.9 16.7 12.1 16.6 12.7 10.7 22.7 7.0 9.8 10.5 0.0 11.8 4.8 41.3 43.3 0.0 10.4 2.2 15.8 43.7 43.9 40.9 27.9 17.5 8.6 25.8 50.9 5.2 23.9 40.7 10.1 26.2 12.5 8.5 24.6 14.0 22.3 6.7 15.8 77.6 22.7 5.2 36.4 30.5 4.2 83.0 13.0 190.4 KIAA1614 ENSG00000135835 KIAA1614 Q5VZ46 1 180913154-180951614 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 58.8;retina: 23.8" "Group enriched" "Detected in many" 17 "Bipolar cells: 91.9;Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 171.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 5 "cerebellum: 58.8" "Cell type enhanced" "Detected in some" "basophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "RH-30: 12.3;SH-SY5Y: 31.1" "Low region specificity" "Detected in all" "HPA028227, HPA061684" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA028227: AB_10601765, HPA061684: AB_2684585" "unprognostic (3.23e-1)" "unprognostic (3.60e-2)" "unprognostic (3.17e-2)" "unprognostic (2.15e-2)" "unprognostic (1.05e-1)" "unprognostic (3.55e-2)" "unprognostic (8.76e-3)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.15e-2)" "unprognostic (1.57e-1)" "unprognostic (8.61e-5)" "unprognostic (8.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.36e-2)" "unprognostic (1.35e-2)" 4.6 1.5 2.4 1.4 2.6 0.1 2.2 58.8 11.3 4.5 4.6 1.8 0.8 3.0 5.2 1.6 4.6 3.5 3.1 7.5 2.7 1.4 3.0 0.4 3.2 1.1 1.5 3.8 6.3 2.1 0.0 1.3 3.6 3.3 3.5 0.5 23.8 4.6 2.8 2.1 3.0 2.5 4.1 1.4 2.6 2.2 1.2 2.5 0.4 7.6 0.9 0.4 4.3 5.1 0.5 0.5 4.4 0.5 0.5 0.6 0.3 1.1 0.5 0.9 2.1 3.0 7.5 3.3 2.2 2.6 1.1 0.6 1.0 1.2 0.5 2.1 2.7 0.5 2.2 0.2 0.0 0.3 0.6 0.9 1.6 0.4 1.4 4.1 1.0 1.2 3.5 0.1 0.1 0.0 1.8 1.5 1.7 1.3 0.8 1.0 0.9 1.3 0.4 2.3 0.3 0.3 0.7 12.3 1.6 1.8 1.0 8.5 31.1 0.7 0.8 4.9 1.0 0.9 1.4 3.5 2.4 1.8 2.8 0.9 1.6 2.0 1.0 0.3 0.8 1.6 4.4 0.5 1.2 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.4 0.6 0.4 0.7 0.5 0.1 0.5 0.2 0.3 2.4 2.6 58.8 11.3 2.7 1.4 1.5 3.8 3.3 2.5 0.0 2.6 0.0 0.8 0.3 91.9 2.8 0.0 0.0 2.3 1.8 123.7 0.2 1.7 0.2 3.4 1.7 0.0 0.0 0.2 0.4 2.8 0.3 1.1 0.0 1.4 3.2 0.0 2.5 0.0 1.3 7.2 0.0 3.3 1.8 0.0 7.6 1.0 0.0 5.3 1.3 171.7 6.5 1.4 0.7 0.2 0.3 0.2 0.0 0.0 0.0 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in some" 16 "Leydig cells: 3.4;Peritubular cells: 7.1;Proximal tubular cells: 2.9" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 40.9;ASC diff: 6.2;ASC TERT1: 9.4;WM-115: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA Nucleoli "Golgi apparatus, Vesicles" "HPA051064: AB_2681331" "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.2 40.9 0.0 6.2 9.4 0.0 4.0 2.3 0.0 0.0 0.2 1.2 0.0 0.2 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 1.2 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.3 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.6 0.0 1.3 3.4 0.0 1.7 0.0 0.0 0.0 0.3 0.0 7.1 2.9 0.0 0.0 0.9 0.4 0.2 0.3 0.0 0.0 0.0 0.0 KIAA2012 ENSG00000182329 KIAA2012 Q0VF49 2 202073289-202205203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.0;fallopian tube: 19.2" "Group enriched" "Detected in some" 11 "Ciliated cells: 78.9;Early spermatids: 38.5;Late spermatids: 23.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;BJ hTERT+: 1.2;CAPAN-2: 1.8;SCLC-21H: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077834 Enhanced NA NA "HPA077834: " "unprognostic (1.91e-2)" "unprognostic (3.17e-1)" "unprognostic (2.56e-1)" "unprognostic (5.35e-2)" "unprognostic (2.85e-2)" "unprognostic (3.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "unprognostic (7.35e-2)" "unprognostic (6.31e-2)" "unprognostic (7.81e-2)" "unprognostic (6.94e-5)" "unprognostic (1.60e-1)" "unprognostic (9.44e-2)" "unprognostic (3.37e-1)" "unprognostic (9.95e-3)" 0.3 0.5 6.2 0.4 10.0 0.3 0.4 0.6 8.4 1.2 0.4 5.1 0.0 0.5 0.5 2.5 0.4 19.2 0.4 0.4 6.7 3.5 0.4 2.5 2.0 0.4 0.2 4.4 3.8 0.4 0.3 2.8 0.4 6.5 0.4 0.5 0.0 0.4 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 2.6 1.0 0.0 0.4 0.0 0.3 0.4 0.1 0.6 0.5 0.9 0.6 0.5 0.8 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.1 0.7 1.2 0.1 0.0 0.4 1.8 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.1 0.9 0.3 0.6 0.2 0.2 0.5 0.5 0.2 0.6 0.8 0.4 0.3 0.5 0.5 0.5 0.0 0.0 6.2 10.0 0.6 8.4 6.7 3.5 0.2 4.4 6.5 1.0 3.0 0.0 0.0 0.3 0.0 2.6 0.8 0.0 78.9 3.4 0.0 2.0 0.1 0.0 0.0 38.5 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 4.3 0.1 3.2 0.0 1.3 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.1 1.5 0.0 0.0 0.0 0.0 0.0 KIF11 "Eg5, HKSP, KNSL1, TRIP5" ENSG00000138160 "Kinesin family member 11" P52732 10 92593286-92655395 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 74.2" "Group enriched" "Detected in many" 4 "Early spermatids: 9.6;Erythroid cells: 23.3;Extravillous trophoblasts: 11.2;Hofbauer cells: 6.7;Spermatocytes: 24.7;Spermatogonia: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006916, HPA010093, HPA010568, CAB017617" Enhanced Supported "Mitotic spindle,Cytosol" Yes Yes Cytosol "Mitotic spindle" "CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.35e-2)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (8.19e-7)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.24e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (6.59e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.35e-3)" "unprognostic (7.23e-2)" "unprognostic (9.08e-2)" "unprognostic (2.01e-1)" 2.3 1.6 1.0 20.2 2.6 14.3 1.6 0.7 1.5 2.4 4.6 0.7 0.5 3.7 1.4 1.9 11.5 0.8 2.6 2.0 1.1 1.2 1.1 1.1 2.8 12.1 1.0 1.0 1.1 1.1 0.5 0.7 3.1 1.4 1.0 5.4 0.5 2.7 0.2 0.6 4.2 4.4 1.6 1.8 5.2 2.7 10.5 1.1 74.2 1.2 7.5 13.4 2.2 3.8 2.4 0.9 2.5 1.2 3.5 3.9 1.0 31.0 13.9 31.4 29.2 2.3 3.5 7.8 22.4 19.6 24.9 24.8 12.1 20.6 34.4 11.5 10.4 10.6 22.5 22.4 11.4 29.3 20.5 12.9 21.5 13.3 12.7 0.4 34.6 20.1 1.1 1.0 19.2 18.0 5.8 15.4 14.4 15.2 40.2 18.8 12.4 29.4 19.5 12.5 12.6 9.6 31.7 31.1 12.1 6.5 9.1 9.6 13.8 17.5 7.9 9.1 11.2 21.5 11.1 8.7 11.4 16.4 11.6 29.4 11.2 17.3 35.4 9.2 25.0 15.4 2.5 0.5 0.5 0.4 1.2 1.1 2.4 1.4 1.9 0.9 1.0 0.5 0.7 1.4 3.5 0.4 0.4 3.9 1.0 1.0 2.6 0.7 1.5 1.1 1.2 1.0 1.0 1.4 1.1 0.0 1.3 0.8 0.8 2.6 1.3 1.4 0.0 4.0 3.4 1.8 0.0 1.5 1.7 0.4 9.6 0.3 0.4 23.3 0.6 11.2 1.6 0.8 0.0 0.0 6.7 0.0 0.0 2.5 2.5 3.9 0.9 2.6 0.0 1.0 1.9 0.8 0.3 0.0 0.7 0.5 0.4 0.0 1.2 24.7 25.8 2.9 1.3 3.8 2.9 0.9 KIF12 ENSG00000136883 "Kinesin family member 12" Q96FN5 9 114086126-114099291 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 33.1;kidney: 51.5;pancreas: 42.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 101.9;Collecting duct cells: 85.5;Distal tubular cells: 68.0;Intestinal endocrine cells: 61.7;Proximal tubular cells: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.5;OE19: 11.2;RPTEC TERT1: 30.9;SCLC-21H: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA020192, HPA024127" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020192: AB_1852467, HPA024127: AB_1852469" "unprognostic (5.29e-2)" "unprognostic (5.03e-2)" "unprognostic (3.34e-1)" "unprognostic (1.84e-2)" "unprognostic (5.80e-2)" "unprognostic (8.38e-2)" "unprognostic (9.81e-2)" "unprognostic (4.41e-2)" "unprognostic (1.90e-1)" "unprognostic (3.98e-2)" "unprognostic (1.69e-2)" "unprognostic (3.33e-2)" "unprognostic (1.10e-2)" "unprognostic (4.51e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" 0.4 0.0 0.8 0.8 1.2 0.0 9.1 0.8 0.6 3.3 5.8 0.4 3.3 11.8 4.7 18.0 0.5 3.8 33.1 0.4 0.4 0.2 51.5 9.8 1.0 0.4 0.4 0.5 1.1 42.1 0.0 0.6 1.3 0.4 2.4 1.7 0.8 1.8 4.2 0.4 0.4 7.3 0.4 0.4 0.4 5.5 1.5 0.4 1.0 11.6 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 3.6 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.1 11.2 0.4 0.0 0.0 0.0 30.9 0.1 4.5 0.1 0.0 0.6 0.0 0.1 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.8 0.6 0.4 0.2 0.4 0.5 0.4 0.4 0.0 4.1 0.8 0.8 0.0 0.0 0.4 101.9 0.0 0.0 85.5 0.0 0.1 68.0 28.9 5.4 0.0 7.1 0.0 10.4 6.4 0.2 2.2 0.0 7.4 0.3 0.0 61.7 0.0 0.0 9.5 0.6 0.0 0.0 1.8 22.5 0.0 8.1 20.9 0.0 57.8 0.0 0.0 0.0 1.5 4.5 0.0 0.5 0.0 23.4 0.1 KIF13B "GAKIN, KIAA0639" ENSG00000197892 "Kinesin family member 13B" Q9NQT8 8 29067279-29263124 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 40.5;parathyroid gland: 107.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025023, HPA049655" Enhanced NA NA "HPA025023: AB_1852471, HPA049655: AB_2732555" "unprognostic (1.37e-1)" "unprognostic (4.31e-1)" "prognostic favorable (8.92e-4)" "unprognostic (1.35e-3)" "unprognostic (2.27e-1)" "prognostic favorable (6.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (9.69e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (9.76e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" 7.4 10.5 12.3 8.2 21.5 4.8 8.7 3.2 13.8 8.6 15.1 40.5 15.4 13.6 6.1 9.1 6.9 7.1 10.5 4.6 16.5 10.4 16.3 12.5 7.6 4.3 25.9 7.1 7.2 9.7 107.1 10.2 4.4 22.0 10.0 12.2 4.9 12.9 8.9 3.9 15.2 18.0 7.3 29.3 7.7 15.6 6.1 25.1 4.2 8.4 5.1 7.9 9.4 5.9 2.9 5.4 4.1 3.8 2.0 4.1 1.0 9.0 9.9 3.5 2.9 5.8 3.4 5.1 0.5 2.2 3.0 4.9 6.1 5.2 1.9 5.3 0.6 5.5 6.2 2.8 1.6 3.8 2.9 2.7 4.8 1.4 6.1 5.7 1.3 14.9 3.9 3.0 6.7 2.8 6.4 13.0 3.7 6.1 7.3 9.7 2.8 7.0 2.2 1.7 12.9 1.7 4.0 8.1 3.6 13.0 9.9 1.0 6.9 1.8 6.1 8.6 3.8 4.5 2.7 17.1 2.1 5.9 0.6 4.0 5.3 7.8 3.2 12.7 2.5 10.0 0.3 3.8 4.1 4.1 2.9 2.0 2.9 1.6 2.4 1.2 2.0 1.3 1.7 2.0 2.0 1.4 5.4 1.5 1.0 12.3 21.5 3.2 13.8 16.5 10.4 25.9 7.1 22.0 25.1 41.7 19.0 8.9 14.4 3.9 12.5 4.1 22.9 33.5 30.7 33.2 56.9 4.9 10.0 19.8 4.0 10.0 53.6 0.0 22.0 0.7 8.9 33.6 38.3 14.8 7.8 15.9 24.2 11.6 18.3 2.1 7.5 8.3 6.8 8.2 34.7 8.4 28.2 39.3 19.1 13.9 25.5 6.5 5.6 5.8 7.2 5.9 4.2 10.0 22.4 26.4 KIF14 KIAA0042 ENSG00000118193 "Kinesin family member 14" Q15058 1 200551497-200620734 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 9.0;lymphoid tissue: 34.4" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 20.6;Spermatogonia: 18.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038061, HPA058220" Uncertain Supported "Midbody ring,Cytosol" NA Yes Cytosol "Midbody ring" "HPA038061: AB_10669515, HPA058220: AB_2683642" "unprognostic (1.84e-1)" "unprognostic (7.15e-2)" "unprognostic (2.00e-2)" "unprognostic (1.87e-2)" "unprognostic (2.74e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-3)" "prognostic unfavorable (8.64e-4)" "unprognostic (8.47e-3)" "unprognostic (1.02e-1)" "unprognostic (2.54e-5)" "unprognostic (2.31e-2)" "unprognostic (0.00e+0)" "unprognostic (6.28e-3)" "unprognostic (3.31e-1)" "unprognostic (8.14e-2)" "unprognostic (7.44e-2)" 0.4 0.6 0.2 2.7 0.4 9.0 2.6 0.3 0.3 0.7 2.0 0.4 0.2 1.8 0.4 0.5 3.8 0.2 0.2 0.5 0.3 0.3 0.4 0.8 1.2 4.7 0.2 0.2 0.3 0.3 0.0 0.2 2.8 0.6 0.6 1.8 0.4 0.9 0.2 0.2 1.4 2.4 0.8 0.6 2.0 1.1 4.5 0.2 34.4 0.3 0.6 4.9 0.8 1.3 0.5 0.1 2.4 0.2 0.7 1.9 0.2 15.6 9.3 14.7 8.2 0.4 1.7 8.2 10.8 6.4 10.3 9.4 5.6 8.2 9.5 3.9 5.1 6.4 12.5 11.7 7.2 14.9 11.6 6.2 15.2 13.2 5.4 0.0 23.8 8.7 0.3 0.3 11.5 9.9 2.2 7.3 14.3 22.8 12.4 12.8 6.4 13.9 7.4 12.4 4.6 8.2 12.8 19.5 12.1 3.5 4.5 7.0 7.8 15.3 5.2 6.2 11.5 7.0 6.1 6.0 8.2 9.7 8.9 18.7 4.5 4.5 13.9 4.8 12.8 16.6 2.4 0.1 0.1 0.1 0.2 0.1 0.5 0.5 0.4 0.0 0.4 0.2 0.1 0.5 0.7 0.1 0.1 1.9 0.2 0.2 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.6 0.2 0.0 0.0 1.5 0.9 2.2 2.0 0.8 0.0 1.4 1.2 0.0 2.0 1.0 0.0 0.2 2.5 0.5 0.0 0.0 0.0 6.3 1.7 0.8 2.3 0.9 4.3 0.0 0.0 1.8 2.6 1.5 0.6 1.0 0.0 0.0 0.8 0.6 0.2 0.0 0.7 0.0 0.7 6.5 0.4 20.6 18.9 0.6 1.1 0.7 1.2 1.4 KIF15 "HKLP2, KNSL7, NY-BR-62" ENSG00000163808 "Kinesin family member 15" Q9NS87 3 44761717-44873376 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 33.5;testis: 13.0" "Group enriched" "Detected in some" 4 "Early spermatids: 128.6;Erythroid cells: 46.7;Late spermatids: 55.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035516, HPA035517, HPA061469" Approved NA NA "HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: " "unprognostic (2.26e-1)" "unprognostic (1.85e-1)" "prognostic favorable (3.12e-4)" "unprognostic (3.49e-2)" "unprognostic (2.69e-1)" "unprognostic (5.17e-3)" "unprognostic (6.68e-7)" "unprognostic (1.35e-2)" "unprognostic (1.51e-2)" "unprognostic (6.94e-2)" "unprognostic (3.14e-4)" "unprognostic (2.72e-2)" "unprognostic (0.00e+0)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.58e-1)" 0.4 0.3 0.4 4.4 0.4 6.5 0.4 0.4 0.9 0.8 2.0 0.1 0.5 1.9 0.4 0.7 2.6 0.3 0.3 0.6 0.4 0.3 0.3 0.3 0.5 3.2 0.4 0.0 0.3 0.2 0.0 0.3 0.9 0.2 0.3 2.4 0.3 0.6 0.0 0.3 1.1 1.9 0.3 0.3 1.9 0.8 13.0 0.0 33.5 0.3 2.4 3.2 0.6 0.9 0.9 0.0 0.0 0.4 0.0 2.0 0.4 5.4 2.9 12.7 9.4 0.9 1.0 2.9 6.3 3.8 7.6 6.6 4.7 5.4 9.4 2.1 2.1 2.9 4.7 7.2 3.3 9.3 8.4 2.1 10.4 6.0 5.9 0.1 10.5 4.8 0.2 0.1 5.2 5.2 1.1 6.1 12.9 6.6 12.2 6.1 3.0 20.6 4.1 13.5 6.6 5.0 8.1 14.0 5.7 1.7 3.6 6.2 5.6 10.1 3.3 2.1 3.4 5.4 8.2 3.4 8.0 6.5 6.2 8.5 5.4 8.8 12.4 4.2 12.2 7.5 0.0 0.0 0.0 0.5 0.4 0.0 0.9 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.4 0.4 0.4 0.4 0.9 0.4 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.8 0.6 1.6 0.0 1.1 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.6 128.6 0.0 0.5 46.7 0.0 5.6 0.3 0.3 0.0 0.0 2.8 0.0 0.0 0.0 1.0 55.6 0.0 1.4 0.0 0.0 0.5 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.7 19.1 10.7 0.9 0.6 0.5 0.6 0.4 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.8 1.5 0.9 0.4 1.0 0.0 1.2 2.0 0.7 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.4 1.0 0.0 0.1 0.6 0.0 1.8 0.1 0.0 0.0 2.5 0.1 1.8 0.0 0.1 0.0 0.6 0.0 0.7 1.5 0.5 0.0 0.3 1.6 0.0 0.0 0.0 0.6 5.1 0.5 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 2.7 0.0 1.8 3.9 0.1 0.0 0.0 35.8 12.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 4.0 0.0 0.0 16.5 1.5 60.3 1.1 3.3 1.7 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 19.4 1.4 1.5 4.2 1.1 1.4 0.0 0.0 0.1 KIF18A "DKFZP434G2226, PPP1R99" ENSG00000121621 "Kinesin family member 18A" Q8NI77 11 28020620-28108308 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3;testis: 16.9" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 22.1;Erythroid cells: 23.3;Spermatocytes: 76.3;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA039312, HPA039484" Approved Supported "Microtubules,Cytokinetic bridge" Yes Yes "Microtubules, Cytokinetic bridge" "HPA039312: AB_10794087, HPA039484: AB_10795252" "unprognostic (3.79e-1)" "unprognostic (2.63e-1)" "unprognostic (7.09e-3)" "unprognostic (3.80e-2)" "unprognostic (6.56e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-7)" "unprognostic (2.43e-3)" "unprognostic (2.04e-3)" "unprognostic (1.23e-2)" "unprognostic (1.72e-4)" "unprognostic (4.41e-2)" "unprognostic (0.00e+0)" "unprognostic (7.88e-3)" "unprognostic (1.67e-1)" "unprognostic (1.43e-1)" "unprognostic (2.50e-1)" 0.9 0.5 0.6 3.9 0.8 7.9 0.6 0.9 0.9 0.8 2.1 0.3 0.0 1.5 0.5 0.8 3.1 0.5 0.4 0.5 0.7 0.5 1.8 0.5 1.5 4.8 0.5 0.0 0.6 0.5 0.0 0.6 3.4 0.8 0.5 2.2 1.3 0.9 1.6 0.8 1.3 1.9 0.6 0.9 2.7 1.0 16.9 0.2 31.3 2.8 2.0 4.9 1.0 1.2 2.3 0.7 6.4 0.4 2.8 2.2 0.4 12.5 12.6 12.8 8.9 0.4 1.8 4.3 13.1 6.1 20.9 22.0 4.2 5.1 10.6 4.7 6.7 11.4 12.7 10.9 5.1 29.4 10.5 6.6 6.9 8.6 5.3 1.0 10.1 6.3 3.3 0.6 7.3 8.6 3.7 8.0 8.8 10.9 9.3 11.8 6.6 10.2 7.5 6.3 8.2 5.2 8.0 30.6 5.2 5.9 3.7 7.7 5.9 10.9 5.2 3.6 8.2 11.1 3.1 4.6 16.7 13.0 15.6 17.0 3.7 8.7 10.7 10.0 7.5 11.7 6.4 0.0 0.8 0.2 0.4 0.8 2.3 0.9 0.5 0.7 1.0 0.8 0.3 0.0 2.8 0.1 0.6 2.2 0.4 0.6 0.8 0.9 0.9 0.7 0.5 0.5 0.0 0.8 0.2 3.0 0.0 6.0 1.0 2.1 0.2 0.4 0.0 2.7 3.4 0.0 5.9 2.6 0.0 0.5 22.1 0.3 0.5 23.3 0.8 6.4 0.4 0.2 4.6 0.0 1.9 0.0 1.7 1.3 1.0 4.0 0.6 1.1 0.0 1.8 0.9 0.3 0.4 0.0 0.4 0.5 1.6 0.0 0.3 76.3 16.2 0.9 1.4 3.2 1.4 0.1 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947711 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 12.3;lymphoid tissue: 34.7" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 1.6;Extravillous trophoblasts: 3.6;Hofbauer cells: 1.9;Kupffer cells: 1.8;Spermatogonia: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.7 0.6 0.5 8.2 0.4 12.3 0.4 0.4 0.5 0.9 1.6 0.3 0.7 2.9 0.5 0.6 3.2 0.3 1.3 1.5 0.5 0.5 0.5 0.7 0.8 5.9 0.6 0.1 0.6 0.4 0.0 0.4 1.9 0.2 0.5 1.5 0.1 0.7 0.1 0.4 2.9 2.5 0.8 0.4 1.7 1.5 3.8 0.1 34.7 0.4 2.7 7.6 0.7 1.1 1.1 0.8 2.0 0.6 1.0 1.4 0.4 14.4 18.8 16.2 15.1 0.4 1.4 13.6 12.4 4.6 15.6 12.3 15.6 12.5 12.8 5.3 4.7 10.0 15.9 11.1 5.0 7.9 26.3 16.6 16.5 21.2 9.6 0.0 13.6 14.5 0.3 0.2 13.5 5.4 2.1 7.9 13.3 12.4 21.8 8.0 11.2 25.3 13.4 11.9 13.1 13.0 19.4 24.7 8.5 2.5 7.9 12.2 11.8 8.3 7.5 4.6 7.8 14.1 9.7 5.2 23.3 23.1 13.7 26.0 7.0 6.9 15.7 7.5 10.4 15.0 1.8 0.6 0.4 0.5 0.3 0.4 0.8 0.7 0.5 0.3 1.1 0.4 0.5 2.0 1.0 0.3 0.8 1.4 0.4 0.5 0.4 0.4 0.4 0.5 0.5 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.3 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.4 0.1 0.0 0.0 1.9 0.0 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.5 0.4 0.7 0.5 0.6 0.1 KIF19 "FLJ37300, KIF19A" ENSG00000196169 "Kinesin family member 19" Q2TAC6 17 74326210-74355820 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;fallopian tube: 25.2" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 34.8;Intestinal endocrine cells: 22.8;Ito cells: 19.6;Mucus-secreting cells: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.5" "Lineage enriched" "Detected in single" 55 "T-cells: 5.5" "Cell line enriched" "Detected in single" 11 "SCLC-21H: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043638, HPA073303" Enhanced Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Plasma membrane" "Actin filaments, Centrosome" "HPA043638: AB_10962579, HPA073303: AB_2686593" "unprognostic (1.59e-3)" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (5.37e-3)" "unprognostic (9.64e-2)" "unprognostic (1.64e-1)" "unprognostic (2.70e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (1.05e-3)" "unprognostic (1.14e-1)" "unprognostic (1.59e-9)" "unprognostic (5.16e-5)" "unprognostic (2.72e-1)" "unprognostic (1.67e-2)" "unprognostic (1.53e-1)" 1.6 0.9 9.3 1.6 29.5 1.1 1.1 25.8 14.1 2.1 3.1 17.4 0.0 6.6 1.1 1.1 1.1 25.2 1.6 1.1 11.9 6.6 0.9 1.6 3.1 1.0 25.0 4.2 1.1 3.0 0.9 0.3 0.8 6.5 0.9 2.1 0.8 2.5 1.3 1.0 0.8 5.2 1.6 6.2 11.6 2.2 1.2 29.9 0.0 2.3 0.0 1.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 5.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.6 0.0 0.9 1.6 0.0 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.0 0.7 9.3 29.5 25.8 14.1 11.9 6.6 25.0 4.2 6.5 29.9 0.0 0.0 0.0 0.3 0.0 0.9 1.1 0.0 34.8 7.9 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 0.0 0.0 2.5 0.2 0.2 0.0 0.0 0.1 0.0 22.8 19.6 1.2 0.0 0.0 0.0 3.3 0.0 10.6 7.5 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.2 1.4 0.1 0.0 0.0 1.3 0.1 KIF1A "ATSV, C2orf20, SPG30, UNC104" ENSG00000130294 "Kinesin family member 1A" Q12756 2 240713764-240820308 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 383.7;Cone photoreceptor cells: 394.7;Horizontal cells: 506.9;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 19.2;HAP1: 34.1;K-562: 29.8;SCLC-21H: 91.8;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" HPA005442 Approved "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA005442: AB_1079210" "unprognostic (1.19e-1)" "unprognostic (2.17e-3)" "unprognostic (7.31e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (1.65e-1)" "unprognostic (4.74e-3)" "unprognostic (2.32e-2)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-2)" "unprognostic (2.06e-2)" "unprognostic (2.60e-1)" "unprognostic (2.54e-1)" "unprognostic (3.83e-2)" "unprognostic (1.96e-1)" "unprognostic (1.74e-3)" "unprognostic (3.90e-2)" 2.1 15.2 47.0 2.9 37.0 2.0 2.0 28.4 144.1 1.9 2.7 35.8 0.0 2.9 2.3 3.1 2.0 2.3 2.1 8.2 40.9 28.4 2.1 2.3 2.1 2.0 35.1 46.8 3.5 31.3 2.0 15.7 2.0 38.7 6.4 2.6 8.6 2.0 2.2 1.9 2.8 2.9 2.3 35.0 2.2 5.0 10.0 30.9 0.0 2.9 0.0 1.9 2.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 1.0 0.0 0.5 0.0 34.1 0.0 0.0 2.6 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.1 0.0 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.8 14.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 47.0 37.0 28.4 62.2 40.9 28.4 35.1 46.8 38.7 30.9 0.0 0.0 0.0 0.1 0.8 383.7 18.7 0.0 0.0 0.0 0.0 394.7 0.0 0.0 0.3 1.7 0.4 0.0 0.0 21.2 0.0 0.0 9.0 0.0 0.2 0.1 506.9 32.8 0.0 0.0 4.5 0.9 0.0 16.9 0.0 0.0 91.7 23.8 0.0 0.4 0.1 168.7 0.0 1.1 4.7 1.7 0.0 0.0 0.0 0.0 0.4 KIF1B "CMT2, CMT2A, HMSNII, KIAA0591, KLP" ENSG00000054523 "Kinesin family member 1B" O60333 1 10210805-10381603 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Motor protein" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 224.2;Cone photoreceptor cells: 545.8;Rod photoreceptor cells: 364.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015177 Approved Approved "Nucleoli fibrillar center,Microtubules" NA NA Microtubules "Nucleoli fibrillar center" "CAB015177: AB_2296564" "unprognostic (1.30e-1)" "unprognostic (6.88e-2)" "unprognostic (4.96e-2)" "unprognostic (9.82e-3)" "unprognostic (7.15e-2)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (8.72e-2)" "unprognostic (3.26e-2)" "unprognostic (1.20e-1)" "prognostic favorable (2.91e-6)" "unprognostic (1.51e-1)" "unprognostic (3.46e-2)" "unprognostic (1.10e-1)" "unprognostic (9.33e-3)" 7.8 11.0 32.9 6.2 30.2 10.3 9.0 37.0 43.2 7.4 7.6 31.0 2.0 7.1 10.0 5.7 12.9 7.4 7.8 19.3 28.3 23.7 10.8 7.4 7.4 3.5 29.2 21.5 11.7 8.9 21.2 5.8 7.5 29.9 8.9 7.2 9.5 8.2 7.5 112.9 9.1 7.7 10.9 25.2 5.3 5.4 13.1 25.6 0.3 8.2 13.0 4.2 6.2 5.4 0.8 1.1 8.0 1.8 0.8 1.2 0.7 10.8 7.8 36.7 14.3 10.2 11.4 3.1 10.6 7.4 11.2 11.4 8.5 5.4 1.5 10.7 17.1 6.0 7.9 26.3 8.3 15.7 15.1 8.7 6.4 11.6 10.0 8.2 2.2 2.0 8.8 8.5 19.1 12.2 8.2 13.8 6.8 7.1 6.4 12.4 3.2 2.5 2.2 8.1 4.7 5.8 10.7 21.3 2.8 4.7 5.3 25.2 12.3 14.9 7.2 14.8 15.9 5.1 3.0 16.0 13.3 8.5 14.9 10.1 3.5 5.9 3.4 11.5 6.9 6.6 2.9 1.4 8.0 1.1 1.4 0.5 0.7 1.1 1.2 1.1 0.8 0.7 0.6 7.5 0.8 1.8 0.8 1.2 0.7 32.9 30.2 37.0 29.5 28.3 23.7 29.2 21.5 29.9 25.6 56.6 16.3 5.6 21.4 45.2 224.2 104.1 12.7 16.0 14.8 21.0 545.8 5.7 0.0 16.6 61.9 34.4 23.8 0.0 15.5 5.0 34.2 27.1 6.9 31.1 19.1 131.9 27.6 19.6 23.7 36.2 17.3 22.4 49.0 8.2 18.0 52.7 19.9 20.1 19.4 13.4 364.1 19.4 44.3 19.6 32.1 51.7 5.6 10.1 17.7 17.0 KIF1C "SAX2, SPAX2, SPG58" ENSG00000129250 "Kinesin family member 1C" O43896 17 4997948-5028401 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.0" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 288.1;Enterocytes: 134.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024602, HPA045020" Approved NA NA "HPA024602: AB_1852480, HPA045020: AB_2679187" "unprognostic (3.89e-2)" "unprognostic (3.73e-2)" "unprognostic (2.70e-2)" "unprognostic (1.24e-2)" "unprognostic (3.74e-1)" "unprognostic (8.97e-2)" "unprognostic (1.92e-1)" "unprognostic (2.28e-1)" "unprognostic (6.69e-2)" "unprognostic (8.31e-2)" "unprognostic (1.45e-1)" "unprognostic (4.90e-3)" "prognostic favorable (2.26e-9)" "unprognostic (1.10e-1)" "unprognostic (2.28e-1)" "unprognostic (1.41e-1)" "unprognostic (7.10e-3)" 18.8 6.3 34.1 9.2 33.6 2.9 43.9 8.0 18.9 10.6 16.4 25.2 9.9 19.3 10.3 8.6 27.7 7.8 14.8 60.1 37.3 25.5 14.8 14.8 17.0 7.4 44.4 8.7 7.4 18.7 18.7 2.6 7.4 17.1 12.2 12.7 7.8 12.8 14.8 172.0 13.2 18.3 15.6 53.7 9.5 15.8 6.0 22.0 2.1 15.8 32.0 7.4 11.8 37.8 1.8 1.1 4.6 1.9 1.1 1.2 0.5 28.3 27.3 9.2 19.7 21.8 13.1 14.6 22.6 18.2 18.1 11.1 19.6 6.9 4.5 13.4 35.4 11.8 29.5 16.5 30.0 12.9 11.0 19.4 3.3 34.7 15.7 14.8 1.3 9.9 13.4 31.4 24.3 16.7 17.2 24.6 4.1 12.3 8.0 17.7 16.9 3.9 2.2 7.1 18.7 17.9 4.1 15.4 4.7 16.1 20.0 2.2 4.4 32.0 17.9 10.0 9.2 17.6 4.1 51.8 24.5 18.6 17.7 27.3 3.1 2.6 2.4 18.1 5.8 12.1 1.7 1.9 2.4 0.9 1.7 0.9 1.4 0.9 1.1 1.1 1.8 0.9 1.0 4.6 1.1 0.9 0.9 1.2 0.5 34.1 33.6 8.0 18.9 37.3 25.5 44.4 8.7 17.1 22.0 50.6 45.3 9.5 15.5 14.9 8.7 288.1 56.0 9.4 19.4 24.4 0.0 11.7 16.6 25.7 61.1 33.0 134.1 0.0 37.0 11.2 14.6 31.9 12.7 71.9 13.8 22.3 13.8 32.5 12.3 25.3 15.5 13.3 15.1 17.2 65.4 6.2 50.4 65.6 40.0 34.5 5.6 6.5 38.2 12.0 20.4 17.7 19.5 8.7 45.2 26.8 KIF20A RAB6KIFL ENSG00000112984 "Kinesin family member 20A" O95235 5 138178719-138187715 "Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.7;testis: 18.2" "Cell type enhanced" "Detected in some" 23 "Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "NK-cell: 10.0;T-reg: 3.2" "Group enriched" "Detected in many" 64 "NK-cells: 10.0;T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA036909, HPA036910" Approved Enhanced "Nucleoplasm,Cytokinetic bridge,Cleavage furrow" Yes Yes "Nucleoplasm, Cleavage furrow" "Cytokinetic bridge" "HPA036909: AB_10670245, HPA036910: AB_10671716" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (1.39e-3)" "unprognostic (1.21e-2)" "unprognostic (3.47e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (2.14e-12)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.86e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.73e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.05e-2)" "unprognostic (2.61e-1)" "unprognostic (1.09e-1)" "unprognostic (3.16e-1)" 2.3 1.7 0.3 3.6 0.4 10.4 0.7 0.3 0.7 1.7 2.7 0.4 0.3 2.7 1.6 2.2 10.7 0.3 0.3 0.8 0.3 0.3 1.2 1.2 2.3 6.7 0.6 0.4 0.8 0.5 0.0 0.3 6.6 0.5 1.0 4.2 0.4 2.0 0.3 0.5 3.5 2.7 4.4 0.5 3.8 2.1 18.2 0.3 47.7 0.5 6.1 11.7 1.8 3.0 0.1 0.0 0.0 0.0 10.0 3.2 0.4 22.2 15.0 33.2 22.0 1.7 3.3 14.3 19.3 17.7 42.1 31.8 28.2 20.8 9.6 10.4 24.3 15.8 22.1 31.1 36.1 42.2 14.0 14.7 14.2 26.8 17.9 0.1 6.9 6.6 1.2 0.6 22.4 12.9 7.1 27.2 13.7 5.9 18.4 29.1 20.4 11.6 6.8 21.0 13.1 16.4 12.8 33.3 9.9 11.5 11.0 9.9 9.8 36.5 12.4 8.5 44.5 15.8 7.2 12.9 11.0 16.4 9.9 32.2 9.5 9.1 10.7 7.1 20.5 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.2 0.4 0.3 0.4 0.3 0.7 0.3 0.3 0.6 0.4 0.5 0.3 0.0 1.7 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 46.7 0.0 10.5 0.4 0.1 4.6 0.0 4.9 0.0 0.0 3.7 1.0 1.0 0.3 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 17.9 4.6 0.4 0.8 0.0 1.6 0.0 KIF20B "CT90, KRMP1, MPHOSPH1, MPP1" ENSG00000138182 "Kinesin family member 20B" Q96Q89 10 89701610-89774939 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Spermatocytes: 149.9;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA050214 Supported Supported "Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol" Yes Yes "Nucleoplasm, Cytokinetic bridge" "Midbody, Cytosol" "HPA050214: AB_2681053" "unprognostic (2.13e-1)" "unprognostic (3.01e-2)" "unprognostic (1.72e-2)" "unprognostic (3.20e-2)" "unprognostic (2.65e-1)" "unprognostic (7.39e-2)" "unprognostic (8.95e-5)" "unprognostic (3.32e-3)" "unprognostic (2.01e-2)" "unprognostic (8.14e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (3.06e-6)" "unprognostic (4.22e-3)" "unprognostic (2.70e-1)" "unprognostic (2.51e-2)" "unprognostic (6.43e-2)" 3.9 2.3 1.3 5.9 6.6 11.1 3.2 12.8 3.0 4.1 3.8 0.7 1.1 4.3 3.4 2.2 7.0 3.3 1.5 2.2 2.1 1.3 2.4 3.2 2.8 9.5 1.6 2.6 4.3 2.0 2.1 3.2 4.0 3.6 2.3 5.1 1.5 3.4 2.0 2.1 4.9 5.5 3.0 3.0 8.0 3.0 10.2 2.6 26.2 2.8 3.9 9.1 2.8 3.8 13.3 4.8 8.3 3.9 2.4 8.6 1.9 36.0 7.4 10.8 9.6 2.1 3.7 9.0 14.8 13.6 15.6 16.4 9.7 16.7 14.0 4.7 7.5 5.8 18.4 12.0 8.3 21.0 16.8 8.2 14.2 12.9 8.4 0.6 24.1 11.8 1.5 1.2 15.0 15.4 5.5 10.0 7.4 13.5 16.2 13.8 6.2 14.1 4.6 11.1 5.9 7.1 9.8 21.3 6.1 4.8 4.8 3.4 6.2 10.6 4.8 5.6 8.1 12.6 7.0 7.8 10.0 10.1 13.0 23.8 4.5 12.2 18.8 9.5 21.5 7.4 8.3 2.3 3.7 5.5 3.9 6.7 11.5 7.4 5.9 1.2 13.3 8.6 8.0 0.1 2.4 3.8 4.8 8.6 1.9 1.3 6.6 12.8 3.0 2.1 1.3 1.6 2.6 3.6 2.6 3.0 15.7 46.6 7.4 15.8 11.8 7.1 2.5 6.7 7.9 0.0 9.8 9.8 3.3 5.1 8.6 7.8 5.9 70.0 4.0 30.5 12.7 3.4 43.8 3.8 17.2 12.7 1.2 8.6 11.6 9.6 7.5 16.4 5.0 9.0 5.4 6.4 2.9 5.7 8.1 2.4 9.1 6.5 15.5 149.9 96.9 12.3 4.3 26.1 13.0 2.2 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 235.9;Ciliated cells: 303.8;Cone photoreceptor cells: 290.6;Rod photoreceptor cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 3.1;T-cells: 8.5" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB022079: , HPA058432: AB_2683717" "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favorable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 3.4 10.1 17.7 3.1 18.5 0.8 5.1 22.1 36.7 8.4 9.2 7.7 2.9 7.1 7.7 4.7 16.0 26.8 5.1 13.4 18.0 28.7 20.9 15.6 4.8 2.2 26.4 18.0 3.2 10.1 17.4 12.3 6.4 41.5 9.3 10.6 5.9 16.4 3.5 8.0 8.5 7.9 7.2 29.2 5.0 9.6 9.5 9.6 0.0 7.1 2.5 4.1 3.6 6.0 0.7 0.0 0.1 0.0 3.1 8.5 1.1 5.9 7.6 10.7 4.5 2.0 1.0 8.6 1.5 0.7 2.0 1.4 13.7 7.4 0.0 4.8 0.6 3.2 5.3 6.1 3.7 1.8 11.7 4.9 0.0 13.4 12.5 1.6 9.9 0.0 0.6 8.2 2.5 12.0 4.6 2.6 2.6 11.2 12.3 1.6 3.5 1.2 0.0 14.4 0.0 6.7 0.0 0.0 6.8 7.6 9.9 14.7 63.8 5.8 9.3 3.5 11.4 10.8 1.2 1.8 1.1 4.7 0.3 4.2 5.6 1.9 0.0 2.8 1.4 0.9 0.0 0.0 0.0 8.4 0.0 4.1 0.7 5.2 8.5 0.0 0.0 1.3 5.9 0.1 3.1 0.0 0.0 2.3 1.1 17.7 18.5 22.1 31.6 18.0 28.7 26.4 18.0 41.5 9.6 35.7 17.4 0.8 18.1 16.5 235.9 106.3 17.8 303.8 69.4 12.2 290.6 12.6 8.3 23.9 92.2 5.8 23.8 0.0 35.7 84.3 10.0 29.0 13.8 39.9 3.5 130.3 23.1 8.0 2.4 60.6 2.8 2.1 13.5 12.6 25.5 106.4 33.2 20.1 2.5 41.7 184.9 0.0 9.8 22.7 7.2 26.8 49.4 20.8 23.4 14.6 KIF21B "DKFZP434J212, KIAA0449" ENSG00000116852 "Kinesin family member 21B" O75037 1 200969390-201023700 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.3;brain: 20.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 21.3;Cone photoreceptor cells: 55.0;Late spermatids: 57.7;Muller glia cells: 22.6;Rod photoreceptor cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.7;HMC-1: 16.8;JURKAT: 31.6;Karpas-707: 19.8;RPMI-8226: 16.8;U-266/70: 36.2;U-266/84: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027249, HPA027274" Approved Approved "Plasma membrane,Mitotic spindle,Cytosol" Yes No "Plasma membrane" "Mitotic spindle, Cytosol" "HPA027249: AB_10602241, HPA027274: AB_1852483" "unprognostic (3.49e-2)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (2.15e-1)" "unprognostic (2.28e-1)" "unprognostic (3.92e-3)" "unprognostic (1.32e-2)" "unprognostic (1.80e-1)" "unprognostic (2.18e-1)" "unprognostic (3.03e-1)" "unprognostic (1.54e-3)" "unprognostic (7.14e-2)" "unprognostic (1.41e-4)" "unprognostic (5.98e-3)" "unprognostic (2.64e-1)" "unprognostic (6.81e-2)" "unprognostic (5.81e-4)" 2.2 1.6 19.8 10.0 12.9 34.3 1.5 3.7 20.4 1.5 2.8 6.0 1.0 2.7 1.4 1.0 1.5 1.4 2.9 1.5 15.1 12.5 1.4 1.7 4.3 15.7 8.3 12.7 1.4 1.5 11.3 0.9 1.6 7.1 1.2 2.6 8.6 2.1 1.7 0.9 1.3 6.1 1.5 4.3 11.5 3.2 11.1 4.9 10.8 1.2 0.0 9.1 3.7 1.1 0.9 0.2 8.0 0.5 2.4 1.7 0.6 0.5 0.5 4.7 0.2 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.1 15.7 0.2 0.0 1.4 0.1 0.4 0.1 0.1 0.7 0.1 3.7 0.1 0.0 0.4 11.4 16.8 0.3 1.6 0.1 0.3 0.0 0.6 31.6 1.7 19.8 0.0 0.0 9.1 4.1 2.0 1.5 0.0 3.2 0.0 16.8 0.1 0.0 3.2 0.4 0.2 0.2 0.2 0.8 0.0 3.4 1.1 0.0 1.4 0.0 0.1 36.2 16.7 7.8 1.6 4.9 0.1 8.0 0.1 1.0 1.6 0.4 1.7 0.9 1.2 1.7 0.1 0.7 1.0 1.1 2.0 2.4 0.5 0.2 1.0 0.6 19.8 12.9 3.7 20.0 15.1 12.5 8.3 12.7 7.1 4.9 0.0 6.7 6.1 0.2 0.9 21.3 1.2 0.0 0.0 0.0 1.8 55.0 0.0 0.0 0.6 20.0 1.8 0.0 0.0 1.4 0.1 0.9 0.3 5.8 0.0 1.4 1.6 0.0 0.6 3.8 57.7 0.9 2.5 0.0 2.8 1.1 22.6 1.7 0.0 0.0 0.0 23.6 6.5 1.2 1.4 2.5 0.9 0.0 11.7 0.7 1.8 KIF22 "Kid, KNSL4, OBP-1, OBP-2" ENSG00000079616 "Kinesin family member 22" Q14807 16 29790719-29805385 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.2" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 228.4;Hepatocytes: 445.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA048213, HPA075670" Enhanced Supported "Nuclear speckles" NA Yes "Nuclear speckles" "HPA048213: AB_2680316, HPA075670: " "unprognostic (3.71e-2)" "prognostic favorable (3.87e-8)" "unprognostic (1.86e-1)" "unprognostic (2.21e-3)" "unprognostic (1.25e-1)" "unprognostic (6.06e-3)" "unprognostic (5.06e-3)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (4.73e-2)" "unprognostic (7.84e-2)" "unprognostic (2.10e-2)" "unprognostic (2.21e-2)" "unprognostic (3.67e-2)" "unprognostic (2.62e-1)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" 5.6 4.3 8.5 21.7 11.2 38.9 7.0 6.4 10.9 5.1 12.5 8.8 3.0 8.4 5.1 10.1 13.6 6.5 6.0 5.6 6.2 5.9 7.2 4.5 5.8 16.1 6.3 6.2 5.8 3.9 18.6 5.7 22.1 5.8 13.2 10.7 8.9 6.3 9.6 4.0 16.7 9.6 4.1 5.8 11.6 5.9 17.9 5.9 78.2 16.8 13.1 19.0 6.5 7.6 13.6 6.6 19.7 9.1 13.3 25.0 17.1 21.5 23.2 30.6 22.1 2.1 3.1 26.9 16.4 13.2 31.4 29.4 22.2 25.9 31.5 15.4 8.5 15.6 22.5 29.8 16.8 14.8 20.5 23.9 17.4 25.2 28.1 0.7 19.0 19.4 1.7 4.5 17.4 13.2 4.4 16.9 36.5 25.5 26.3 16.4 43.9 41.3 47.7 25.7 16.1 14.3 57.9 27.2 30.0 11.3 10.1 25.5 16.5 11.9 23.9 8.3 10.5 21.4 25.7 7.4 16.4 17.3 14.5 17.6 24.7 24.4 34.0 10.7 31.3 20.9 19.7 6.4 17.0 23.6 9.1 17.6 13.6 23.7 25.0 6.6 11.3 19.5 18.5 2.8 13.3 7.7 4.2 24.0 17.1 8.5 11.2 6.4 10.9 6.2 5.9 6.3 6.2 5.8 5.9 29.8 104.5 22.9 29.2 27.4 27.2 228.4 58.6 28.1 38.7 66.3 23.6 50.7 53.0 13.7 7.8 21.8 20.4 46.7 43.2 72.5 31.0 20.0 40.6 445.7 42.2 6.4 39.7 38.6 48.9 6.4 14.4 41.1 33.7 20.8 36.3 35.5 16.6 42.1 12.0 77.3 19.7 12.9 32.6 52.8 47.7 24.1 64.3 26.6 38.5 11.1 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.8;testis: 20.4" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 7.7" "Group enriched" "Detected in many" 12 "granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.8 2.6 1.8 12.7 1.3 16.3 3.2 0.3 0.9 2.2 3.3 0.3 1.4 3.5 3.3 1.2 8.8 1.8 2.4 2.2 0.7 0.5 4.9 0.8 2.5 6.7 0.9 0.5 1.6 0.9 0.0 0.3 10.8 1.3 1.9 4.3 0.6 2.1 0.9 0.3 3.0 3.9 3.4 1.4 4.5 3.1 20.4 0.2 41.8 0.6 6.3 8.8 1.8 3.3 0.3 0.1 7.7 2.2 0.1 2.1 0.6 25.2 22.0 16.3 15.6 1.0 1.9 9.9 27.7 15.0 40.2 31.3 13.3 19.8 14.8 8.4 14.3 21.4 29.2 33.6 10.3 40.9 13.7 15.7 13.9 20.6 8.2 0.6 14.3 12.9 0.9 1.1 19.2 16.2 5.1 13.6 12.0 9.2 18.5 25.2 11.1 8.0 7.7 20.2 9.4 8.8 9.1 36.3 8.2 10.6 13.1 8.3 6.9 32.2 14.2 12.1 21.4 13.5 6.5 8.8 24.3 32.4 16.8 40.7 7.2 19.5 13.3 8.6 19.3 21.4 0.0 2.2 7.7 0.0 1.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.1 1.0 0.1 2.1 0.6 1.8 1.3 0.3 0.9 0.7 0.5 0.9 0.5 1.3 0.2 0.0 0.3 0.0 2.6 1.6 0.2 0.8 7.6 1.4 6.8 7.0 2.0 5.9 3.3 1.8 6.3 0.1 1.1 0.0 0.0 31.4 3.1 0.5 2.3 0.0 6.8 0.0 1.7 6.2 3.2 3.2 0.9 2.9 0.0 10.0 2.2 0.1 0.4 0.0 1.8 0.5 0.0 6.5 2.3 47.9 18.3 0.9 2.1 0.8 2.3 1.0 KIF24 "bA571F15.4, C9orf48, FLJ10933, FLJ43884" ENSG00000186638 "Kinesin family member 24" Q5T7B8 9 34252381-34311371 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.4;testis: 12.1" "Group enriched" "Detected in some" 6 "Ciliated cells: 12.0;Early spermatids: 15.7;Late spermatids: 24.8;Spermatocytes: 13.6;Spermatogonia: 7.5" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 14 "basophil: 5.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 5.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA020643 Uncertain NA NA "HPA020643: AB_2131749" "unprognostic (2.68e-1)" "prognostic favorable (1.33e-4)" "unprognostic (9.44e-2)" "unprognostic (3.82e-3)" "unprognostic (3.11e-1)" "unprognostic (2.11e-3)" "unprognostic (1.40e-2)" "unprognostic (8.38e-3)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (1.40e-2)" "unprognostic (8.68e-3)" "unprognostic (1.17e-1)" "unprognostic (1.30e-3)" "unprognostic (2.28e-1)" "unprognostic (1.25e-1)" "unprognostic (2.50e-1)" 0.1 0.5 0.4 0.5 0.8 1.8 0.4 0.1 0.2 0.4 0.6 0.2 0.4 1.3 1.0 3.5 0.1 0.1 0.5 0.5 0.7 0.1 0.6 1.0 0.1 0.5 0.2 1.9 1.0 0.2 0.3 0.8 0.3 0.2 0.1 0.6 0.3 0.4 0.1 0.2 0.4 12.1 1.0 1.4 0.3 0.4 0.1 0.0 5.4 0.1 0.0 0.3 0.0 10.1 6.8 8.1 6.7 0.7 1.1 3.1 5.7 3.7 7.6 9.2 3.3 3.2 7.9 1.7 2.6 5.0 4.8 8.1 4.8 8.0 5.1 3.6 3.7 11.2 2.0 0.2 7.4 5.8 0.5 1.0 9.9 4.2 1.5 3.4 5.6 3.7 6.5 4.2 4.1 8.9 7.0 3.2 4.7 4.1 8.4 5.0 2.2 3.2 2.7 3.8 3.7 6.9 3.6 1.0 3.3 3.9 3.7 2.7 7.2 7.9 5.5 6.8 1.8 3.0 4.4 4.9 3.7 9.2 5.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.5 0.1 0.3 0.1 0.8 2.5 12.0 2.3 1.8 0.0 0.2 0.0 0.2 15.7 0.0 0.3 0.0 0.2 1.0 0.4 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.3 24.8 0.9 0.0 0.0 0.0 0.6 0.2 0.2 0.0 1.8 0.3 0.4 0.0 0.0 13.6 7.5 0.6 0.2 0.0 0.3 0.1 KIF25 KNSL3 ENSG00000125337 "Kinesin family member 25" Q9UIL4 6 167996241-168045089 "Predicted intracellular proteins" "Motor protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 6.2;brain: 9.9" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 3.5;granulocytes: 4.6;Horizontal cells: 3.2;Spermatogonia: 2.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 2.2;HDLM-2: 5.3;HMC-1: 2.8;SiHa: 2.2;U-266/84: 3.2;U-937: 3.1;WM-115: 2.3" "Not detected" "Not detected" HPA046153 Uncertain NA NA "HPA046153: AB_10960550" "unprognostic (1.11e-1)" "unprognostic (9.32e-3)" "unprognostic (1.39e-1)" "unprognostic (6.65e-2)" "unprognostic (1.60e-1)" "unprognostic (4.46e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-3)" "unprognostic (2.45e-1)" "unprognostic (7.08e-5)" "unprognostic (1.55e-2)" "unprognostic (5.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.77e-3)" 6.2 0.0 2.0 0.2 3.1 0.1 1.3 9.9 2.7 0.2 0.3 0.2 0.1 0.9 0.0 0.6 1.5 1.9 2.7 2.3 0.0 0.3 0.3 0.9 3.5 2.0 0.0 0.0 0.0 1.9 0.8 1.1 1.0 0.1 3.1 2.0 0.2 0.2 3.1 0.8 0.3 1.6 0.0 0.3 1.6 0.0 0.7 0.3 1.7 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 2.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.7 5.3 0.9 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.8 0.0 0.0 0.2 0.5 0.4 0.1 0.5 1.6 0.1 0.0 0.8 0.2 0.5 2.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.1 0.1 0.1 3.2 0.1 0.1 3.1 2.3 1.7 0.3 0.9 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.2 1.4 0.1 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 1.7 0.6 0.0 0.0 0.0 3.5 0.0 0.9 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.1 4.6 0.0 0.1 3.2 0.0 0.6 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 0.0 KIF27 DKFZp434D0917 ENSG00000165115 "Kinesin family member 27" Q86VH2 9 83836698-83921465 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.7" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 75.0;Early spermatids: 137.7;Late spermatids: 100.4;Spermatocytes: 55.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 15.7" "Lineage enriched" "Detected in many" 11 "granulocytes: 15.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (9.75e-2)" "unprognostic (3.86e-2)" "unprognostic (1.46e-1)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (2.83e-3)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" "unprognostic (3.86e-3)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (2.55e-1)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.65e-2)" "unprognostic (1.85e-1)" "unprognostic (2.01e-1)" 4.1 3.7 5.4 2.9 9.3 3.1 5.0 4.0 7.5 6.6 3.8 6.0 9.1 3.2 7.1 11.9 3.7 10.8 4.3 3.9 6.1 4.7 4.5 3.9 5.1 3.5 4.9 3.6 7.2 5.3 7.6 14.5 5.3 21.3 4.8 3.2 5.2 5.3 5.5 3.8 5.6 3.8 4.9 5.4 4.3 4.4 31.7 6.2 8.4 15.1 3.9 3.0 3.5 4.6 1.4 1.2 15.7 0.7 1.1 1.0 0.3 6.3 6.6 5.0 7.7 3.6 3.6 9.7 3.2 3.6 2.0 1.6 1.7 3.4 0.7 2.8 1.5 6.0 5.7 2.2 2.3 2.5 6.4 1.7 1.9 2.2 2.7 5.6 4.7 1.8 2.2 5.4 2.8 7.5 7.6 3.0 7.3 2.0 2.5 0.8 4.7 6.1 4.5 2.8 4.5 3.4 6.1 4.8 1.5 3.6 2.1 5.5 4.5 4.4 1.1 3.8 7.0 2.3 3.7 1.6 3.6 4.0 3.6 3.0 4.2 3.0 0.9 2.1 1.9 3.5 1.3 0.7 2.2 0.6 0.7 0.6 1.4 0.7 0.6 0.7 1.1 1.0 0.6 15.7 1.1 0.2 1.2 0.1 0.3 5.4 9.3 4.0 7.5 6.1 4.7 4.9 3.6 21.3 6.2 6.0 9.8 0.0 4.4 3.1 5.5 8.3 2.5 75.0 23.9 3.5 15.7 2.2 1.7 3.3 137.7 4.9 1.9 0.0 3.3 1.5 2.9 3.5 3.5 2.0 1.2 11.1 1.7 3.7 1.3 100.4 9.2 3.0 3.3 1.0 2.8 11.5 2.1 2.6 6.3 2.1 13.3 6.5 3.9 55.7 20.9 2.0 2.2 2.2 2.3 1.8 KIF2B ENSG00000141200 "Kinesin family member 2B" Q8N4N8 17 53822901-53825213 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 261 "testis: 103.6" "Group enriched" "Detected in some" 82 "Early spermatids: 638.1;Late spermatids: 419.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023081, HPA023103, HPA024795" Uncertain Supported "Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Nucleoli "HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 638.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 4.2 2.0 0.0 0.0 0.0 0.0 0.0 KIF2C "CT139, KNSL6, MCAK" ENSG00000142945 "Kinesin family member 2C" Q99661 1 44739818-44767767 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.9;testis: 61.4" "Group enriched" "Detected in many" 18 "Early spermatids: 430.2;Late spermatids: 1559.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA006219, HPA079172" Enhanced Supported Nucleoplasm,Midbody,Centrosome Yes Yes "Nucleoplasm, Centrosome" Midbody "HPA006219: AB_2667540, HPA079172: " "unprognostic (3.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.77e-1)" "unprognostic (5.17e-2)" "prognostic unfavorable (3.07e-7)" "unprognostic (7.49e-3)" "unprognostic (3.33e-3)" "unprognostic (3.66e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (4.27e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.33e-3)" "unprognostic (1.49e-1)" "unprognostic (1.86e-2)" "unprognostic (2.41e-1)" 1.1 0.7 0.4 8.7 0.4 12.7 0.8 0.5 0.5 1.2 2.4 0.4 0.2 2.1 1.3 1.4 4.6 0.6 0.7 0.9 0.6 0.5 0.7 0.6 1.6 6.7 0.4 0.2 0.7 0.4 0.3 0.6 2.2 0.6 0.6 3.2 0.4 1.1 0.2 0.4 2.3 2.2 1.1 0.4 3.3 1.4 61.4 0.2 39.9 0.8 4.7 12.0 0.9 1.7 1.3 1.5 0.0 0.2 3.9 5.8 1.0 29.0 11.3 25.3 20.2 1.4 2.9 17.0 21.8 15.6 44.7 39.0 19.1 21.1 33.5 10.5 10.7 30.9 13.9 25.7 14.7 40.9 21.6 11.1 39.6 20.0 15.9 0.1 29.2 18.4 0.7 1.4 31.8 15.6 4.1 14.4 23.8 31.2 28.8 28.2 11.3 30.7 17.7 24.7 14.3 14.2 24.7 38.2 21.0 7.5 10.6 17.4 12.4 29.0 20.7 18.3 19.1 11.9 22.2 8.5 16.2 32.3 17.6 38.2 15.2 15.5 48.3 10.4 28.5 31.2 0.0 0.0 0.0 1.9 0.0 0.1 1.3 3.4 2.6 0.3 0.2 0.7 0.5 0.0 3.9 0.2 1.5 5.8 1.0 0.4 0.4 0.5 0.5 0.6 0.5 0.4 0.2 0.6 0.2 0.0 0.3 0.8 0.5 1.5 1.0 0.8 0.0 0.0 2.3 1.8 2.0 1.1 1.7 0.3 430.2 0.1 0.0 23.3 0.3 20.1 0.7 0.6 0.0 0.0 7.4 0.0 0.0 4.3 1.0 1559.3 8.6 1.3 0.0 7.2 0.9 0.3 0.1 0.0 6.3 0.0 0.2 6.5 0.3 55.1 28.0 0.4 3.1 0.7 1.6 0.4 KIF3A "FLA10, KLP-20" ENSG00000131437 "Kinesin family member 3A" Q9Y496 5 132692628-132737638 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.5" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 131.2;Cone photoreceptor cells: 117.8;Horizontal cells: 174.8;Spermatocytes: 129.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 27.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 27.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037085 Approved Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Nucleoplasm, Intermediate filaments, Cytosol" "CAB037085: AB_477147" "unprognostic (8.22e-3)" "unprognostic (2.58e-1)" "unprognostic (2.29e-3)" "unprognostic (3.59e-2)" "unprognostic (2.51e-1)" "unprognostic (3.80e-1)" "unprognostic (8.21e-4)" "unprognostic (1.30e-1)" "unprognostic (4.71e-2)" "unprognostic (1.46e-1)" "unprognostic (1.44e-2)" "unprognostic (7.64e-2)" "unprognostic (6.08e-3)" "unprognostic (8.62e-2)" "unprognostic (1.92e-1)" "unprognostic (1.17e-1)" "unprognostic (1.23e-1)" 3.4 9.9 19.6 5.0 21.0 2.5 6.6 23.8 54.5 6.2 3.6 8.1 3.2 3.5 6.5 7.1 4.5 8.7 5.3 7.0 28.0 22.9 7.6 2.5 5.7 4.8 18.7 25.5 6.9 4.0 15.8 18.5 4.3 37.7 6.6 3.8 3.8 3.8 6.6 3.5 5.1 3.0 5.7 15.0 3.8 4.9 23.9 11.1 3.5 6.9 0.1 4.7 5.3 3.5 3.4 0.7 27.1 1.1 2.4 4.3 1.1 7.0 8.8 7.8 14.1 5.2 5.2 6.2 5.9 4.6 5.6 7.9 8.5 5.7 19.3 8.2 6.8 16.8 4.6 6.1 11.7 11.7 5.7 7.1 2.8 4.4 3.2 5.2 3.6 7.6 4.0 6.0 8.1 9.1 7.6 7.0 12.4 2.9 11.2 6.8 5.1 22.7 2.7 3.8 2.6 3.3 6.4 6.2 2.3 5.6 6.0 24.2 7.6 8.9 2.9 8.9 13.2 8.9 1.1 7.3 7.0 12.3 5.1 7.1 8.1 11.8 11.1 8.6 2.9 7.7 27.1 0.4 1.1 3.9 0.8 4.1 3.4 4.0 3.6 0.7 2.1 3.9 4.3 0.3 2.4 1.1 0.7 3.0 1.1 19.6 21.0 23.8 32.3 28.0 22.9 18.7 25.5 37.7 11.1 50.6 33.1 5.4 13.8 12.0 70.6 23.3 7.6 131.2 38.7 36.6 117.8 13.0 24.9 16.7 49.7 8.5 0.9 0.0 11.3 9.8 12.6 8.0 12.8 2.4 5.5 174.8 19.0 9.2 3.3 16.3 15.3 5.0 40.5 6.4 3.4 51.3 11.4 2.3 23.0 7.3 94.7 12.9 10.8 129.4 94.9 13.9 8.2 16.0 1.7 6.0 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926596-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 72.9" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 15.5;Horizontal cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" NA NA "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favorable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.0 7.3 22.8 2.9 21.2 2.2 2.6 22.7 72.9 3.6 2.4 3.8 0.0 2.1 3.9 2.6 3.0 3.3 4.1 3.0 21.6 18.9 2.0 1.6 2.6 2.0 17.5 20.3 7.3 2.3 4.5 4.8 2.8 22.8 3.3 2.6 1.9 1.9 4.6 2.4 2.3 2.7 4.8 6.2 2.2 2.0 3.0 5.2 0.5 2.5 0.0 2.0 3.5 1.5 0.1 0.3 2.4 0.2 0.7 2.0 1.3 13.0 19.8 10.5 8.1 6.2 7.2 8.5 6.8 3.4 4.1 4.7 3.5 2.0 0.0 5.6 6.2 12.9 1.4 8.0 4.1 2.8 2.1 3.8 4.7 1.5 7.1 3.6 1.2 4.1 5.2 1.2 12.9 2.6 15.9 13.5 3.8 1.6 1.7 4.3 0.9 3.3 1.6 10.8 0.3 5.8 5.3 5.2 0.8 9.4 3.2 12.9 29.0 2.7 1.2 14.2 9.1 0.4 1.6 10.7 7.2 7.4 3.2 6.6 0.4 2.3 1.5 16.3 6.4 6.1 0.0 0.2 0.0 0.4 0.0 1.1 0.0 1.6 1.5 0.3 0.1 0.5 0.6 2.4 0.7 0.0 0.2 2.0 1.3 22.8 21.2 22.7 40.0 21.6 18.9 17.5 20.3 22.8 5.2 0.0 0.0 0.0 1.2 0.5 15.5 3.1 2.5 1.4 1.2 0.0 5.9 0.3 0.0 7.7 2.5 3.9 0.0 0.0 1.2 3.3 1.3 0.9 6.9 0.0 2.8 39.7 2.9 9.8 2.7 3.6 1.7 1.1 3.3 2.8 0.2 6.4 8.3 0.0 4.2 0.7 5.9 6.5 2.3 0.2 1.1 0.3 1.0 2.2 0.1 0.5 KIF4A "FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100" ENSG00000090889 "Kinesin family member 4A" O95239 X 70290090-70420832 "Predicted intracellular proteins" "DNA-binding, Motor protein" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 11.1;lymphoid tissue: 19.3" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "HPA034745, HPA034746, HPA061583" Approved Supported Nucleoplasm,Midbody Yes Yes "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (8.17e-3)" "unprognostic (2.78e-2)" "unprognostic (1.02e-2)" "unprognostic (3.46e-3)" "unprognostic (3.20e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.37e-6)" "unprognostic (2.18e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.44e-6)" "unprognostic (3.79e-2)" "unprognostic (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.47e-1)" 0.9 0.6 0.8 3.3 1.0 11.1 0.5 0.4 3.4 1.2 4.1 0.4 0.4 3.4 0.8 0.4 7.4 1.5 2.5 2.0 0.8 1.3 0.7 0.7 1.5 5.8 0.5 0.9 0.4 0.4 0.0 1.3 2.4 0.8 0.7 5.2 0.4 1.2 0.4 0.8 2.3 3.6 1.2 0.5 4.9 2.1 7.5 1.1 19.3 0.4 0.4 7.2 1.1 2.0 0.7 0.0 0.0 0.2 0.2 3.2 0.3 22.5 15.8 23.9 11.7 1.1 2.0 9.4 17.2 9.2 23.5 20.5 17.7 13.3 13.9 10.8 8.4 18.2 13.6 25.8 9.3 26.6 15.9 13.0 15.7 19.3 12.5 0.2 17.4 10.9 0.7 0.5 19.5 11.2 2.8 14.3 10.7 19.9 30.9 22.1 14.5 15.9 8.6 24.1 24.1 16.8 17.7 32.3 13.0 5.6 8.9 15.8 13.2 28.0 11.9 7.3 12.6 9.5 6.8 9.9 15.6 20.3 16.7 20.4 8.9 15.3 20.1 8.2 19.1 23.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 3.2 0.3 0.8 1.0 0.4 3.4 0.8 1.3 0.5 0.9 0.8 1.1 0.0 0.3 0.0 0.2 1.5 0.0 0.4 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 46.7 0.0 10.3 1.0 0.1 0.0 0.0 4.3 0.0 1.2 1.8 0.6 0.5 0.0 0.9 0.0 0.0 1.2 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 7.2 5.8 0.3 1.5 0.5 2.1 0.3 KIF4B ENSG00000226650 "Kinesin family member 4B" Q2VIQ3 5 155013755-155018132 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 9.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Early spermatids: 4.7;Late spermatids: 3.1;Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" "HPA034745, HPA034746, HPA061583" Uncertain Uncertain Nucleoplasm,Midbody Yes NA "Nucleoplasm, Midbody" "HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564" "unprognostic (9.87e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-3)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.71e-1)" "unprognostic (4.76e-2)" "unprognostic (1.94e-1)" "unprognostic (1.06e-1)" "unprognostic (4.37e-2)" "unprognostic (6.48e-9)" "unprognostic (7.24e-2)" "unprognostic (5.10e-2)" "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.4 0.1 0.0 0.1 0.6 0.0 0.1 0.3 0.0 0.9 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.1 0.7 0.1 0.4 1.0 0.4 0.0 0.4 0.7 0.0 0.3 0.2 0.0 0.0 1.1 0.6 0.2 2.4 0.4 0.0 0.8 0.5 0.5 0.1 0.5 0.7 1.2 1.0 0.0 0.7 0.5 0.6 1.3 0.2 0.3 0.0 0.5 0.5 0.2 0.8 1.3 0.7 1.2 0.4 0.6 0.5 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 KIF5A "D12S1889, MY050, NKHC, SPG10" ENSG00000155980 "Kinesin family member 5A" Q12840 12 57549998-57586632 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "brain: 138.6" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 36.9;Horizontal cells: 25.4;Late spermatids: 11.4;Spermatogonia: 9.3" "Cancer enriched" "Detected in some" 5 "glioma: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.4;naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "HDLM-2: 20.4;K-562: 8.6;NTERA-2: 10.6;SCLC-21H: 21.8;U-87 MG: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004469, HPA073448" Enhanced Approved "Nucleoplasm,Mitotic spindle,Cytosol" Yes No "Nucleoplasm, Cytosol" "Mitotic spindle" "HPA004469: AB_1079212, HPA073448: AB_2686601" "unprognostic (7.94e-2)" "unprognostic (4.95e-3)" "unprognostic (3.87e-1)" "unprognostic (3.34e-3)" "unprognostic (7.12e-2)" "unprognostic (4.22e-2)" "unprognostic (3.22e-5)" "unprognostic (2.82e-1)" "unprognostic (2.01e-1)" "unprognostic (1.52e-2)" "prognostic favorable (5.23e-4)" "unprognostic (7.61e-2)" "unprognostic (2.26e-4)" "unprognostic (4.75e-2)" "unprognostic (1.46e-1)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" 1.8 7.6 85.4 3.0 47.6 1.9 1.9 15.2 138.6 2.1 2.8 4.0 0.0 2.4 3.4 2.1 1.9 2.0 1.9 1.7 52.4 18.3 2.0 1.7 1.8 1.8 12.9 43.6 1.8 2.3 6.0 2.5 1.7 21.6 1.9 2.8 0.6 2.0 2.0 1.7 1.7 3.0 2.8 9.0 1.8 2.1 4.4 12.9 0.0 2.8 0.0 1.8 1.8 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.8 3.3 0.0 0.0 0.1 0.2 0.7 1.3 1.7 0.0 0.0 1.6 0.0 0.7 0.6 0.1 2.0 0.0 1.0 20.4 1.5 0.1 0.1 1.6 0.6 0.0 0.1 0.2 0.1 1.0 0.0 0.0 0.2 1.8 8.6 4.5 0.0 0.0 0.3 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.8 4.9 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 2.4 0.0 0.9 2.9 3.5 0.3 8.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.4 0.8 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.3 0.0 85.4 47.6 15.2 112.0 52.4 18.3 12.9 43.6 21.6 12.9 0.0 0.0 0.0 0.1 0.0 36.9 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 5.8 0.2 0.0 0.4 0.0 8.7 0.0 0.9 2.3 9.3 0.1 0.0 0.0 0.0 0.0 KIF5C ENSG00000168280 "Kinesin family member 5C" O60282 2 148875250-149026759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.8" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 265.2;Early spermatids: 558.1;Late spermatids: 572.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 5.9" "Lineage enriched" "Detected in single" 7 "T-cells: 5.9" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 66.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035210, HPA062272" Enhanced Approved Vesicles NA NA Vesicles "HPA035210: AB_10671931, HPA062272: AB_2732678" "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (2.54e-1)" "unprognostic (4.70e-4)" "unprognostic (1.89e-1)" "unprognostic (3.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.90e-2)" "unprognostic (2.86e-1)" "unprognostic (1.41e-2)" "unprognostic (6.61e-3)" "unprognostic (1.56e-1)" "unprognostic (6.55e-6)" "unprognostic (8.34e-3)" "unprognostic (3.69e-1)" "unprognostic (3.63e-2)" "unprognostic (4.46e-2)" 1.8 10.5 32.0 2.3 31.8 1.3 1.6 33.8 95.8 2.2 2.5 21.7 0.0 1.6 1.8 11.0 1.4 1.6 1.7 1.6 25.4 13.7 1.6 1.2 1.5 1.8 15.8 25.5 3.3 2.5 1.5 12.6 1.3 27.1 21.9 3.2 0.4 1.4 7.5 1.3 1.4 2.3 2.0 20.1 1.6 2.4 13.5 18.3 0.0 3.6 0.0 1.7 2.4 1.0 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 12.9 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.6 0.0 0.1 2.8 0.0 7.5 0.0 1.5 3.8 1.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.4 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 13.0 0.0 4.0 0.0 0.1 0.0 0.0 2.7 66.9 15.4 0.0 0.3 0.2 2.7 0.0 0.0 0.0 0.0 1.1 0.0 1.9 1.3 0.2 0.0 4.7 0.2 0.4 0.0 0.0 0.0 0.3 0.0 5.9 0.5 1.1 1.4 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 32.0 31.8 33.8 40.3 25.4 13.7 15.8 25.5 27.1 18.3 0.0 0.0 1.3 5.9 1.1 265.2 12.9 7.6 0.0 0.0 17.4 102.1 0.0 0.0 0.2 558.1 2.2 0.0 0.0 0.0 0.1 2.1 48.5 0.0 0.0 0.2 93.8 124.7 1.3 0.8 572.0 7.5 0.6 5.0 1.0 1.3 6.8 1.5 2.9 12.0 0.0 12.9 6.5 8.5 11.8 9.7 0.4 0.0 5.7 0.6 1.7 KIF6 "C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317" ENSG00000164627 "Kinesin family member 6" Q6ZMV9 6 39329990-39725405 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 18.8;fallopian tube: 9.9;pituitary gland: 5.6;testis: 12.6" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 58.9;Muller glia cells: 13.8;Rod photoreceptor cells: 14.4;Spermatocytes: 18.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 20.8;RPMI-8226: 8.1;SCLC-21H: 11.4;SK-MEL-30: 4.6" "Low region specificity" "Detected in many" "HPA038811, HPA058624" Enhanced Approved Centrosome NA NA Centrosome "HPA038811: AB_10795140, HPA058624: AB_2683781" "unprognostic (4.94e-2)" "unprognostic (3.38e-2)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (1.55e-1)" "unprognostic (8.25e-4)" "unprognostic (3.12e-3)" "unprognostic (1.00e-1)" "unprognostic (3.06e-1)" "unprognostic (3.48e-2)" "unprognostic (9.12e-4)" "unprognostic (1.08e-1)" "unprognostic (3.07e-2)" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" 1.3 1.4 5.1 0.7 9.1 0.9 1.9 2.2 11.4 1.4 1.0 18.8 0.1 1.7 1.0 2.6 1.3 9.9 1.6 1.3 7.3 7.1 1.4 1.3 2.4 1.2 11.8 3.2 1.8 1.6 1.2 5.6 1.2 8.6 1.1 0.9 1.7 1.0 0.9 1.6 1.2 1.1 0.8 10.6 0.9 0.9 12.6 7.8 0.0 2.0 0.0 0.9 0.7 0.4 1.2 2.7 2.5 0.6 1.3 0.7 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.9 0.2 0.5 0.1 0.0 0.1 0.1 0.9 20.8 0.2 0.1 0.0 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.6 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.6 0.0 0.0 0.4 8.1 0.2 0.0 11.4 0.1 0.0 0.1 4.6 0.3 0.1 0.0 0.1 0.0 0.1 2.7 0.6 0.2 0.0 0.0 0.6 0.0 1.4 1.9 0.6 0.4 0.5 0.3 0.5 0.7 0.5 0.4 0.2 1.2 0.6 0.7 2.5 1.3 0.4 2.7 0.3 0.1 5.1 9.1 2.2 5.4 7.3 7.1 11.8 3.2 8.6 7.8 0.0 1.1 0.0 0.6 0.1 3.1 1.2 0.0 58.9 2.3 0.0 9.8 0.3 1.7 1.1 7.8 0.7 0.0 0.0 0.7 0.2 1.1 0.2 0.0 0.0 0.2 3.2 2.4 0.0 0.0 8.0 0.3 0.0 0.0 0.0 0.0 13.8 0.1 0.0 0.0 2.4 14.4 0.0 0.6 18.2 2.5 0.4 0.2 0.0 0.0 0.3 KIF9 MGC104186 ENSG00000088727 "Kinesin family member 9" Q9HAQ2 3 47228026-47283451 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 47.0" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 279.7;Early spermatids: 510.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022031, HPA022033, HPA030429" Approved NA NA "HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921" "unprognostic (1.93e-2)" "unprognostic (6.37e-2)" "prognostic favorable (2.26e-4)" "unprognostic (1.17e-3)" "unprognostic (8.86e-2)" "unprognostic (1.13e-1)" "unprognostic (2.80e-3)" "unprognostic (1.70e-1)" "unprognostic (2.94e-2)" "unprognostic (4.59e-2)" "unprognostic (7.47e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.95e-6)" "unprognostic (4.21e-2)" "unprognostic (2.03e-1)" "unprognostic (9.17e-2)" "unprognostic (1.23e-1)" 3.3 5.1 8.4 3.6 9.9 7.7 8.7 3.7 10.1 6.4 7.0 6.5 5.3 4.8 5.6 17.0 3.3 21.0 8.2 8.2 7.5 12.1 12.3 4.7 6.9 5.3 10.5 7.2 3.1 9.9 4.6 10.0 3.1 24.5 5.0 6.7 4.5 6.1 5.0 5.9 4.5 4.2 5.6 5.2 3.4 6.5 47.0 5.5 1.8 16.8 4.8 3.0 3.5 3.0 4.3 8.4 9.9 5.4 5.0 4.9 1.9 10.7 12.3 4.4 10.9 2.1 5.2 3.6 3.3 3.5 5.2 4.6 4.7 13.1 7.1 4.2 4.3 6.9 6.7 12.9 8.7 5.1 3.6 8.4 6.6 8.9 14.9 2.0 13.9 2.2 2.6 8.9 7.4 5.6 4.3 10.9 7.7 14.5 2.9 3.8 8.6 7.5 20.8 12.5 24.8 17.5 4.8 3.1 10.2 21.2 6.1 6.3 11.6 3.8 7.5 11.8 2.4 4.8 9.8 5.1 3.0 6.4 4.8 7.5 2.6 10.6 8.9 11.1 14.0 6.5 3.0 5.4 3.0 2.4 4.0 4.9 4.3 2.3 3.6 8.4 1.0 2.8 3.0 9.9 5.0 3.2 4.7 1.4 1.9 8.4 9.9 3.7 10.1 7.5 12.1 10.5 7.2 24.5 5.5 17.9 17.3 4.7 41.7 17.9 6.5 27.1 38.2 279.7 54.6 61.1 33.4 9.5 92.9 28.8 510.7 27.0 12.4 0.0 28.4 10.1 11.4 32.9 27.8 16.4 8.2 4.8 56.6 14.7 6.3 92.6 13.0 9.9 15.1 1.0 37.0 8.2 21.8 7.0 12.4 112.8 32.5 12.9 10.3 135.4 39.1 17.7 6.9 6.9 37.0 36.6 KIFC1 "HSET, KNSL2" ENSG00000237649 "Kinesin family member C1" Q9BW19 6 33391536-33409924 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 60.9" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 21.5;Erythroid cells: 70.0;Extravillous trophoblasts: 32.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055997, HPA062674" Enhanced Approved Centrosome NA Yes Centrosome "HPA055997: AB_2683001, HPA062674: AB_2684829" "unprognostic (7.33e-2)" "unprognostic (1.28e-2)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (1.41e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (7.07e-8)" "unprognostic (6.34e-3)" "unprognostic (9.36e-3)" "unprognostic (8.58e-2)" "prognostic unfavorable (4.21e-4)" "unprognostic (1.83e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.17e-2)" "unprognostic (6.66e-2)" "unprognostic (1.48e-1)" "unprognostic (4.52e-1)" 0.9 0.8 0.0 18.0 0.3 9.6 1.5 0.0 0.5 1.7 5.7 0.1 0.3 3.0 0.9 1.6 10.1 0.5 2.2 0.8 0.0 0.0 0.7 0.7 2.2 6.3 0.1 0.2 1.5 0.3 0.2 0.2 3.6 0.4 0.6 2.5 0.6 1.7 0.1 0.4 3.3 4.2 0.7 0.4 4.7 2.5 9.7 0.2 60.9 0.4 7.4 14.6 0.6 2.8 0.8 0.3 0.0 0.1 0.2 1.4 0.7 10.7 1.8 10.3 10.9 0.2 0.4 6.3 7.8 2.0 6.2 5.2 3.8 4.8 7.1 3.0 1.6 8.2 5.8 2.6 3.6 6.8 4.2 5.9 5.7 8.7 5.5 0.0 4.7 6.4 0.0 0.9 5.1 1.5 0.7 0.6 5.2 1.7 17.6 4.6 2.7 2.8 9.4 4.7 3.0 2.2 7.1 5.8 2.4 0.9 2.4 9.4 4.2 2.8 6.0 1.5 4.1 6.3 4.9 1.4 3.3 10.1 5.4 11.6 5.8 11.0 6.9 0.0 7.0 5.8 0.0 0.1 0.0 0.4 0.0 0.6 0.8 0.3 1.4 0.3 0.8 0.3 0.3 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.2 0.4 0.2 0.0 4.5 5.2 0.7 4.9 0.4 0.4 0.0 0.0 2.3 0.0 0.0 6.7 0.0 0.6 21.5 1.4 2.9 70.0 0.0 32.5 2.9 0.8 1.1 0.0 11.9 0.0 0.0 2.5 2.5 9.8 0.3 4.9 3.3 5.4 3.4 0.2 0.2 2.8 0.7 0.0 0.5 0.0 1.0 11.2 6.9 3.1 5.6 4.3 4.6 2.4 KIFC2 ENSG00000167702 "Kinesin family member C2" Q96AC6 8 144466043-144474202 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 36.2;skin 1: 48.2" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029264 Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA029264: AB_10609999" "unprognostic (2.03e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-3)" "unprognostic (4.12e-3)" "unprognostic (4.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-2)" "unprognostic (2.12e-1)" "unprognostic (9.95e-2)" "unprognostic (2.39e-2)" "unprognostic (4.48e-2)" "unprognostic (1.52e-1)" "unprognostic (1.06e-1)" "unprognostic (2.05e-1)" "unprognostic (8.13e-2)" "unprognostic (2.71e-2)" 4.2 5.1 18.7 4.2 28.4 4.5 3.4 36.2 35.0 3.1 6.3 2.3 6.6 8.8 2.7 5.2 7.0 2.9 4.4 2.2 13.5 7.2 4.7 2.8 3.8 4.8 4.4 16.8 2.1 7.9 9.8 7.9 2.5 8.3 7.2 4.8 2.2 7.5 6.5 2.3 48.2 7.9 2.1 2.6 8.1 8.7 5.2 6.6 1.6 4.1 1.3 3.5 5.0 4.9 0.8 0.1 0.1 0.1 0.0 0.8 0.1 8.0 6.9 3.3 7.4 4.9 2.9 7.9 4.9 3.5 2.6 2.6 2.7 10.0 8.4 2.8 2.7 4.4 16.5 3.3 4.4 1.1 8.5 2.9 5.1 17.0 3.5 6.3 1.4 15.0 3.8 15.7 2.6 3.4 12.5 1.7 8.3 5.5 8.8 2.0 13.8 6.1 4.3 0.5 8.9 10.3 15.3 0.2 5.0 11.0 12.7 10.6 9.7 3.5 10.7 3.9 2.8 28.4 2.8 4.7 5.2 15.7 5.5 4.9 4.3 2.1 2.3 10.1 7.1 2.8 0.0 0.1 0.0 0.5 0.0 0.8 0.0 0.3 0.6 0.1 0.8 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.1 18.7 28.4 36.2 35.0 13.5 7.2 4.4 16.8 8.3 6.6 8.9 9.9 2.2 2.6 5.4 8.9 0.8 7.6 2.7 6.8 14.0 5.9 1.6 1.7 3.2 5.2 0.6 17.3 0.0 1.2 1.5 2.6 3.1 8.1 5.4 2.4 14.3 22.4 2.5 6.2 6.9 7.2 4.8 3.3 1.0 9.9 7.2 2.7 14.0 2.8 4.3 3.3 0.0 1.9 5.1 5.5 9.9 2.5 5.7 9.9 2.6 KIR2DL1 "47.11, CD158A, cl-42, nkat1, p58.1" ENSG00000125498 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1" P43626 19 54769811-54784322 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.8;lung: 4.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 2: 4.5;granulocytes: 2.3;T-cells: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enriched" "Detected in single" 26 "U-266/84: 2.5" NA NA "unprognostic (2.14e-1)" "unprognostic (9.82e-2)" "unprognostic (8.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.93e-1)" "unprognostic (1.55e-2)" "unprognostic (3.19e-4)" "unprognostic (4.11e-2)" "unprognostic (6.87e-2)" "unprognostic (1.14e-2)" "unprognostic (1.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.61e-2)" 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.1 0.1 0.0 0.0 0.1 2.8 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 2.2 4.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.8 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 4.5 0.4 1.4 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 KIR2DL3 "CD158B2, cl-6, nkat2, nkat2a, nkat2b, p58" ENSG00000243772 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3" P43628 19 54738515-54753052 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 3.0;lymphoid tissue: 5.6" "Group enriched" "Detected in some" 42 "Alveolar cells type 2: 2.2;T-cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.37e-2)" "unprognostic (2.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.92e-1)" "unprognostic (7.76e-3)" "unprognostic (1.55e-2)" "unprognostic (1.99e-1)" "unprognostic (1.41e-2)" "unprognostic (2.41e-4)" "unprognostic (1.19e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (1.59e-2)" 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.1 2.1 0.1 0.1 0.2 0.1 2.2 0.0 0.0 0.1 0.4 3.0 2.4 0.0 0.0 1.0 0.1 0.1 0.0 0.8 0.1 1.3 0.1 1.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 5.6 0.1 0.1 0.8 0.6 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 KIR2DL4 "103AS, 15.212, CD158D" ENSG00000189013 "Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4" Q99706 19 54803535-54814517 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 5.6;intestine: 7.3;lymphoid tissue: 13.9" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 3.4;Collecting duct cells: 1.8;granulocytes: 2.3;T-cells: 10.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 56 "NK-cell: 5.6" "Lineage enriched" "Detected in single" 56 "NK-cells: 5.6" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.84e-2)" "unprognostic (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (5.95e-4)" "unprognostic (1.34e-1)" "unprognostic (1.49e-1)" "unprognostic (2.92e-5)" "unprognostic (5.15e-2)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.53e-8)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (6.10e-4)" "unprognostic (3.59e-3)" 0.2 0.3 0.0 2.8 0.0 0.3 0.1 0.0 0.2 0.1 3.8 0.0 0.0 0.1 1.4 0.2 0.2 0.2 0.3 0.9 0.1 0.0 0.2 0.3 1.2 0.3 0.0 0.0 1.1 0.1 0.1 0.1 1.7 0.0 0.2 0.3 0.0 0.1 0.8 0.1 0.1 7.3 0.1 0.0 13.9 0.3 0.3 0.0 0.4 0.5 0.0 1.5 0.8 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 KIR3DL1 "AMB11, CD158E1, CD158e1/2, CD158e2, cl-11, cl-2, KIR, nkat3, NKB1, NKB1B" ENSG00000167633 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1" P43629 19 54816468-54830778 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.4;bone marrow: 2.0;lymphoid tissue: 3.0" "Group enriched" "Detected in some" 9 "Alveolar cells type 2: 3.4;granulocytes: 1.1;T-cells: 4.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "gdT-cell: 5.4" "Lineage enriched" "Detected in many" 4 "T-cells: 5.4" "Not detected" "Not detected" NA NA "unprognostic (3.18e-1)" "unprognostic (8.01e-2)" "unprognostic (3.53e-2)" "unprognostic (4.85e-1)" "unprognostic (5.18e-3)" "unprognostic (6.19e-2)" "unprognostic (4.37e-2)" "unprognostic (9.97e-2)" "unprognostic (1.89e-2)" "unprognostic (3.28e-1)" "unprognostic (7.34e-2)" "unprognostic (2.07e-3)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.73e-1)" "unprognostic (2.19e-2)" 0.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 5.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.5 0.0 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 KIR3DL2 "CD158K, cl-5, nkat4, nkat4a, nkat4b" ENSG00000240403 "Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2" P43630 19 54850443-54867207 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2.0;lymphoid tissue: 5.3;salivary gland: 2.0" "Cell type enriched" "Detected in some" 4 "T-cells: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Not detected" "Not detected" NA NA "unprognostic (6.99e-2)" "unprognostic (1.83e-1)" "unprognostic (3.64e-1)" "unprognostic (4.56e-4)" "unprognostic (1.40e-1)" "unprognostic (2.99e-2)" "unprognostic (8.39e-3)" "unprognostic (5.96e-2)" "unprognostic (2.73e-1)" "unprognostic (2.12e-1)" "unprognostic (4.04e-3)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.65e-3)" "unprognostic (3.62e-2)" 0.2 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 KIR3DX1 "FLJ00060, LENG12" ENSG00000104970 "Killer cell immunoglobulin like receptor, three Ig domains X1" 19 54532692-54545771 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9;heart muscle: 3.6;lymphoid tissue: 4.6" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 13.1;Ciliated cells: 2.7;Club cells: 4.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "U-266/84: 10.0" HPA052110 Uncertain "Secreted - unknown location" NA NA "HPA052110: AB_2681731" "unprognostic (5.85e-3)" "unprognostic (4.13e-3)" "unprognostic (8.47e-2)" "unprognostic (8.90e-2)" "unprognostic (1.42e-1)" "unprognostic (4.46e-4)" "unprognostic (1.09e-1)" "unprognostic (7.51e-2)" "unprognostic (4.99e-4)" "unprognostic (1.22e-4)" "unprognostic (1.36e-1)" "unprognostic (6.40e-2)" "unprognostic (8.73e-9)" "unprognostic (1.09e-2)" "unprognostic (7.75e-2)" "unprognostic (3.62e-1)" "unprognostic (6.20e-3)" 1.9 0.0 0.0 1.3 0.6 2.2 0.3 0.0 1.2 0.6 0.2 3.9 0.0 0.0 1.0 0.0 0.5 0.1 0.4 3.6 0.1 0.1 0.2 2.2 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.1 0.5 0.6 4.6 0.0 0.5 0.1 0.0 0.2 0.0 2.7 0.0 0.0 0.4 0.3 1.7 0.2 1.2 1.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 10.0 0.0 0.0 0.8 0.0 1.7 0.2 0.0 1.1 0.2 0.2 0.2 0.2 0.2 0.0 0.4 0.1 0.2 0.6 1.2 0.0 0.3 0.3 0.0 0.0 13.1 0.9 0.5 0.6 0.0 0.2 0.0 2.7 4.5 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.0 0.0 0.0 0.3 KIRREL2 "DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1" ENSG00000126259 "Kirre like nephrin family adhesion molecule 2" Q6UWL6 19 35855861-35867109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "pancreas: 38.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 27.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "HDLM-2: 15.1;HMC-1: 24.4;JURKAT: 14.1;U-937: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA071587, HPA074326" Enhanced Supported "Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" "HPA071587: AB_2732182, HPA074326: AB_2732251" "unprognostic (1.28e-2)" "unprognostic (1.80e-1)" "unprognostic (3.29e-2)" "unprognostic (3.16e-3)" "unprognostic (2.05e-3)" "unprognostic (2.29e-1)" "unprognostic (2.00e-1)" "unprognostic (1.72e-3)" "unprognostic (3.30e-2)" "unprognostic (5.56e-2)" "unprognostic (4.85e-2)" "unprognostic (2.62e-2)" "unprognostic (2.43e-6)" "unprognostic (1.72e-1)" "unprognostic (4.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.62e-2)" 0.2 0.0 0.4 0.3 0.8 0.0 0.0 0.2 1.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.5 0.2 0.4 0.0 38.5 0.0 0.9 0.1 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.1 0.0 2.6 0.1 2.1 0.0 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 24.4 0.1 0.0 0.0 0.0 0.0 0.0 14.1 0.1 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 3.0 0.9 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.6 1.0 0.2 0.0 0.0 0.0 0.2 0.0 5.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.8 0.2 1.2 0.7 0.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 27.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 6.8 0.0 0.0 0.0 2.9 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 KIRREL3 "KIAA1867, KIRRE, NEPH2" ENSG00000149571 "Kirre like nephrin family adhesion molecule 3" Q8IZU9 11 126423359-127003460 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 10.9;brain: 28.2" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 7.4;Early spermatids: 2.6;Late spermatids: 10.7" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 10.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 10.9" "Cell line enhanced" "Detected in some" "BJ: 19.0;BJ hTERT+: 11.2;BJ hTERT+ SV40 Large T+: 7.2;BJ hTERT+ SV40 Large T+ RasG12V: 7.5;fHDF/TERT166: 13.7;U-138 MG: 8.8;U-251 MG: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053324 Enhanced "Intracellular and membrane" NA NA "HPA053324: " "unprognostic (1.92e-1)" "unprognostic (5.29e-2)" "unprognostic (1.06e-1)" "unprognostic (4.72e-2)" "unprognostic (2.50e-2)" "unprognostic (1.09e-1)" "unprognostic (4.49e-3)" "unprognostic (6.23e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (7.05e-3)" "unprognostic (3.81e-2)" "unprognostic (4.06e-6)" "unprognostic (9.91e-3)" "unprognostic (1.15e-1)" "unprognostic (2.76e-2)" "unprognostic (2.92e-1)" 1.2 4.0 12.3 1.9 20.0 1.4 1.0 13.2 28.2 1.5 2.2 23.6 0.0 1.7 1.1 1.0 1.7 1.1 1.4 2.3 9.1 7.2 1.1 1.0 1.0 2.1 7.2 11.7 1.3 1.4 0.9 0.1 1.6 9.9 1.0 1.8 0.6 3.5 3.4 1.0 1.1 1.7 1.9 8.9 2.6 1.5 1.2 12.1 0.0 1.0 0.0 1.9 1.1 0.2 0.0 10.9 0.9 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.1 0.1 19.0 11.2 7.2 7.5 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.5 0.0 0.0 1.4 0.0 3.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 4.5 0.1 0.3 0.3 0.0 0.0 0.9 0.0 0.1 2.1 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 8.8 6.1 3.4 10.4 0.0 0.0 0.0 0.0 0.0 4.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 12.3 20.0 13.2 17.4 9.1 7.2 7.2 11.7 9.9 12.1 0.0 0.0 0.0 0.0 0.0 7.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 10.7 0.0 0.0 1.7 0.0 0.1 0.3 0.1 0.3 0.0 0.0 1.5 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.1 KISS1 ENSG00000170498 "KiSS-1 metastasis suppressor" Q15726 1 204190341-204196486 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "placenta: 267.2" "Cell type enriched" "Detected in many" 41 "Syncytiotrophoblasts: 1117.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.2" "Group enriched" "Detected in some" 8 "basal ganglia: 11.3;hypothalamus: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "BJ: 55.9;U-2 OS: 22.8" "Low region specificity" "Detected in all" "CAB017775, HPA035542" Enhanced Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "CAB017775: , HPA035542: AB_2674677" "unprognostic (9.64e-2)" "unprognostic (1.78e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-1)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.63e-1)" "unprognostic (8.98e-12)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "prognostic favorable (6.29e-6)" 0.2 0.0 0.2 0.2 11.3 0.0 0.2 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 4.2 1.1 2.7 0.5 0.2 0.2 0.2 0.2 0.4 0.1 2.5 267.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.5 0.2 0.2 0.7 1.4 3.6 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 55.9 0.7 1.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 22.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.3 1.0 0.2 0.2 4.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 3.3 27.0 0.3 5.1 0.0 4.0 4.1 0.4 1.8 0.0 2.9 14.5 0.0 0.0 1.3 0.0 3.1 0.3 0.0 0.0 0.0 0.6 0.0 2.9 0.8 0.0 1.2 0.0 0.0 0.1 0.1 0.4 0.0 1117.8 0.0 1.9 2.2 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921015 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;lymphoid tissue: 12.4" "Cell type enriched" "Detected in some" 18 "Extravillous trophoblasts: 31.2" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA007156: , HPA071913: AB_2686471" "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavorable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.2 0.2 2.1 2.1 4.1 0.2 0.3 0.1 4.7 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 1.0 6.8 1.4 0.1 0.3 12.4 1.1 0.1 0.4 3.6 0.1 2.0 1.0 0.8 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.7 0.5 1.0 2.4 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.6 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 2.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.2 0.1 0.0 0.4 0.8 0.3 0.7 0.0 26.3 0.0 0.0 5.5 14.7 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.7 0.0 0.0 0.1 2.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 2.1 4.1 0.1 1.5 1.0 6.8 1.1 0.1 0.8 0.1 0.0 0.0 1.4 0.1 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 31.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.3 1.4 0.0 0.0 0.0 KIT "C-Kit, CD117, PBT, SCFR" ENSG00000157404 "KIT proto-oncogene receptor tyrosine kinase" P10721 4 54657918-54740715 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 65.5" "Group enriched" "Detected in many" 10 "granulocytes: 496.5;Melanocytes: 200.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7" "Group enriched" "Detected in many" 6 "granulocytes: 12.7;NK-cells: 9.7" "Group enriched" "Detected in some" 13 "HEL: 48.8;HMC-1: 102.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003288, HPA004471, CAB068253, CAB072867, HPA073252" Enhanced Supported Supported "Plasma membrane" NA NA 48000000 "Plasma membrane" "CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589" "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (4.04e-2)" "unprognostic (8.19e-2)" "unprognostic (3.96e-2)" "unprognostic (2.18e-2)" "unprognostic (2.33e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.20e-1)" "unprognostic (1.92e-2)" "prognostic favorable (5.63e-4)" "unprognostic (1.34e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 8.1 1.6 9.5 6.6 11.8 3.7 65.5 18.3 12.0 12.1 10.3 6.5 10.2 5.8 8.9 4.2 9.9 2.5 15.5 2.4 36.0 4.4 9.4 1.1 13.8 3.8 3.6 6.0 28.5 2.1 1.3 2.3 6.2 5.7 9.6 10.4 20.7 12.9 6.9 1.3 14.6 8.9 10.2 3.9 3.2 12.8 4.0 4.5 0.4 28.9 4.3 4.9 9.8 12.5 0.0 1.8 12.7 0.9 9.7 1.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 0.9 2.6 3.2 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.5 0.0 2.2 0.0 1.2 48.8 0.0 0.0 0.0 0.0 102.6 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.6 0.1 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.1 0.0 0.0 0.0 4.8 1.2 0.4 0.0 0.0 0.0 3.0 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 12.7 0.0 10.0 0.1 0.0 1.9 0.0 0.3 0.7 1.8 0.0 0.0 0.0 0.8 9.7 0.9 0.0 0.0 0.1 9.5 11.8 18.3 12.0 36.0 4.4 3.6 6.0 5.7 4.5 6.0 34.8 1.4 1.1 12.7 0.0 0.4 5.1 0.0 5.7 3.5 0.0 0.0 3.3 0.8 0.0 2.4 0.0 0.0 0.0 0.1 1.3 0.5 496.5 0.0 0.3 0.0 5.2 1.8 0.3 0.0 1.1 3.1 200.8 0.0 0.3 2.4 0.0 0.0 0.0 0.6 0.3 0.0 0.5 0.0 8.2 3.3 0.2 2.2 0.3 0.3 KL ENSG00000133116 Klotho Q9UEF7 13 33016433-33066145 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Glycosidase, Hormone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 99.7" "Group enriched" "Detected in many" 6 "prostate cancer: 5.9;renal cancer: 17.8" "Region enhanced" "Detected in some" "pons and medulla: 11.6" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HMC-1: 5.1;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 510000 "unprognostic (1.32e-1)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.73e-3)" "unprognostic (3.37e-1)" "unprognostic (1.15e-4)" "unprognostic (3.06e-2)" "unprognostic (6.50e-2)" "unprognostic (2.22e-2)" "unprognostic (2.60e-1)" "prognostic favorable (4.44e-4)" "unprognostic (9.46e-2)" "prognostic favorable (1.29e-9)" "unprognostic (4.76e-3)" "unprognostic (1.91e-1)" "unprognostic (2.86e-2)" "unprognostic (1.07e-1)" 4.8 0.6 0.8 0.9 4.3 0.1 7.4 0.0 0.8 0.7 2.1 3.3 0.2 1.0 1.0 3.2 0.8 0.7 0.9 0.9 2.4 0.8 64.3 0.2 10.4 0.9 0.5 0.3 0.4 1.6 76.9 0.3 25.5 11.6 3.3 0.4 0.3 0.7 1.0 0.9 0.4 3.2 0.7 0.4 3.1 1.9 0.6 0.3 0.0 1.4 1.3 0.3 1.5 1.1 0.0 0.0 0.0 1.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 4.3 0.0 0.8 2.4 0.8 0.5 0.3 11.6 0.3 0.0 0.3 0.0 0.1 0.1 0.0 0.8 0.0 1.4 1.2 12.2 0.0 0.1 5.0 0.0 1.7 1.8 0.9 0.0 0.0 0.1 0.7 4.4 0.0 0.0 2.1 0.0 15.6 0.0 0.8 0.0 0.3 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.4 99.7 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.0 0.6 0.1 KLB ENSG00000134962 "Klotho beta" Q86Z14 4 39406853-39451536 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adipose tissue: 17.3;liver: 49.2;pancreas: 21.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 12.1;Hepatocytes: 28.7;Intestinal endocrine cells: 16.7;Spermatocytes: 11.1" "Cancer enriched" "Detected in some" 16 "liver cancer: 11.6" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 23 "ASC diff: 6.5;Hep G2: 23.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA021136 Uncertain NA NA 290000 "HPA021136: AB_1852616" "unprognostic (1.03e-2)" "unprognostic (1.61e-2)" "unprognostic (4.67e-2)" "unprognostic (2.69e-1)" "unprognostic (4.30e-2)" "unprognostic (7.02e-3)" "unprognostic (2.46e-1)" "unprognostic (9.92e-2)" "unprognostic (6.99e-3)" "unprognostic (4.51e-3)" "unprognostic (3.02e-3)" "unprognostic (8.90e-3)" "unprognostic (1.73e-1)" "unprognostic (5.03e-2)" "unprognostic (4.53e-2)" "unprognostic (3.87e-2)" "unprognostic (3.09e-2)" 17.3 0.0 0.2 1.9 1.0 0.2 3.9 0.4 0.2 0.0 1.6 0.0 0.0 0.2 0.1 0.5 0.3 0.1 1.3 0.5 1.0 0.2 0.1 49.2 1.4 0.5 0.1 0.0 0.2 21.4 0.2 0.2 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.4 0.5 0.6 0.3 0.0 0.0 1.5 2.5 0.2 0.0 0.1 0.4 0.0 0.3 0.2 0.5 2.5 2.3 0.7 0.4 0.4 0.2 0.0 0.2 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 23.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.7 0.2 0.3 0.4 0.2 0.4 0.2 0.2 0.1 0.5 0.2 0.4 2.3 0.4 0.5 2.5 0.1 0.2 0.2 1.0 0.4 0.2 1.0 0.2 0.1 0.0 0.4 0.2 3.0 12.1 0.0 0.9 0.5 2.1 0.9 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.9 5.9 0.3 1.4 0.0 3.7 1.1 0.4 1.0 0.0 28.7 0.2 1.6 16.7 0.0 0.3 1.1 1.4 0.2 1.7 0.0 6.7 0.3 1.4 3.5 0.7 0.8 1.6 0.0 0.0 11.1 0.7 0.6 1.1 0.0 0.6 0.7 KLC1 "hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A" ENSG00000126214 "Kinesin light chain 1" Q07866 14 103561896-103714249 "Predicted intracellular proteins" "Host-virus interaction" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 117.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB009798, HPA044617, HPA052450" Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "CAB009798: AB_2280879, HPA044617: AB_2679024, HPA052450: AB_2681838" "unprognostic (6.93e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (7.94e-2)" "unprognostic (2.60e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-3)" "unprognostic (2.67e-2)" "unprognostic (9.21e-2)" "unprognostic (5.62e-2)" "prognostic favorable (6.75e-4)" "unprognostic (6.84e-3)" "prognostic unfavorable (7.17e-4)" "unprognostic (6.58e-2)" "unprognostic (8.69e-2)" "unprognostic (4.05e-1)" "unprognostic (1.49e-1)" 19.5 20.4 61.3 15.7 45.6 17.6 16.6 103.0 117.9 15.2 14.8 22.4 11.5 10.5 21.1 18.7 19.7 16.0 15.7 27.1 61.0 65.1 8.6 8.9 20.0 15.9 66.2 47.9 19.8 14.8 25.2 17.0 17.9 50.7 16.3 14.1 14.1 16.9 19.7 28.2 22.4 12.8 23.1 56.0 18.3 13.8 14.3 23.2 7.9 13.8 13.0 18.1 15.7 14.9 7.3 10.4 12.4 8.6 4.1 10.9 3.1 16.4 22.1 42.7 23.3 28.9 31.6 19.7 38.8 31.9 36.5 24.9 18.9 18.0 21.8 20.2 41.8 16.2 27.5 26.0 20.5 34.6 26.3 13.1 12.2 26.1 19.1 32.9 23.9 24.3 22.9 33.3 27.5 33.5 38.9 31.3 15.5 18.2 25.1 31.7 27.7 16.0 21.1 13.7 26.3 40.9 15.4 18.0 10.7 22.7 36.5 50.4 28.2 31.5 16.0 25.6 27.6 14.1 11.8 45.5 27.1 13.4 37.1 21.5 20.1 14.0 24.2 31.0 13.8 29.0 7.6 5.8 12.4 10.3 6.0 9.5 6.4 9.3 10.9 6.8 7.3 7.9 7.2 7.0 4.1 8.6 10.4 8.4 3.1 61.3 45.6 103.0 90.3 61.0 65.1 66.2 47.9 50.7 23.2 41.7 27.5 24.9 39.0 23.1 133.1 34.0 22.9 16.0 14.8 19.2 49.1 19.5 8.3 42.1 4.2 42.8 13.0 0.0 26.7 27.4 32.1 34.5 32.4 15.6 26.3 130.3 43.0 31.9 18.1 11.4 35.6 24.1 37.1 46.9 20.2 42.5 49.1 14.4 45.3 3.4 89.3 25.8 40.6 36.8 78.0 15.4 35.2 28.9 14.7 31.8 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.7" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 7.5 12.5 15.9 7.9 20.7 2.9 6.6 51.7 49.4 7.4 7.8 7.5 6.5 8.5 11.3 6.0 8.8 9.0 8.0 15.3 20.0 17.4 6.7 2.4 6.6 7.5 13.8 26.0 11.3 11.2 15.4 15.4 6.4 29.0 13.6 4.4 8.2 8.4 15.5 23.8 9.3 7.7 10.1 8.6 6.6 9.8 17.4 10.0 13.5 6.3 4.5 5.6 8.8 8.5 4.7 4.1 0.8 0.4 2.3 6.2 1.5 20.4 25.1 12.2 7.3 7.4 6.0 9.5 14.5 10.4 14.9 11.5 13.6 6.1 9.3 14.0 10.7 19.2 17.3 12.5 14.0 5.0 14.8 15.8 1.8 19.8 9.2 14.3 4.1 9.9 6.0 18.6 17.4 14.2 9.6 6.9 11.2 9.9 12.5 11.8 28.8 23.2 6.2 12.1 5.9 20.9 8.9 6.3 12.6 11.6 11.5 33.4 16.1 10.6 9.5 17.3 7.1 15.7 2.8 11.3 24.5 21.9 29.6 19.0 13.1 10.9 5.0 17.3 2.8 9.8 0.0 0.4 0.8 4.6 0.1 6.2 3.6 2.2 3.1 0.6 4.7 2.2 2.7 0.7 2.3 0.3 4.1 0.6 1.5 15.9 20.7 51.7 49.4 20.0 17.4 13.8 26.0 29.0 10.0 3.0 1.0 5.6 8.0 7.9 32.1 1.4 0.0 5.3 1.2 12.2 11.8 8.8 11.6 15.0 8.9 4.5 2.9 0.0 7.2 16.4 4.8 12.0 0.0 2.1 2.7 52.4 35.6 4.3 4.6 3.4 8.1 2.8 11.8 10.0 5.8 14.1 13.4 3.6 13.1 9.1 26.5 0.0 16.2 24.4 25.6 8.4 10.6 3.3 3.7 7.1 KLC3 "KLC2L, KLCt, KNS2B" ENSG00000104892 "Kinesin light chain 3" Q6P597 19 45333434-45351520 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5;tongue: 25.3" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 126.0;Ductal cells: 38.6;Suprabasal keratinocytes: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 25.8;HaCaT: 12.0;HBEC3-KT: 7.7;hTCEpi: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052797, HPA056508" Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Actin filaments" "Nucleoplasm, Cytosol" "HPA052797: AB_2681954, HPA056508: AB_2683159" "unprognostic (4.11e-2)" "unprognostic (3.71e-1)" "unprognostic (3.07e-4)" "prognostic unfavorable (1.46e-4)" "unprognostic (3.47e-3)" "unprognostic (1.13e-1)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.53e-1)" "unprognostic (1.75e-2)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (4.79e-3)" "unprognostic (1.94e-1)" "unprognostic (3.55e-3)" "unprognostic (4.14e-1)" "unprognostic (2.37e-1)" 0.1 0.2 0.0 0.2 1.2 1.9 1.9 0.0 0.5 4.0 0.1 0.0 0.0 0.1 0.6 2.9 10.6 0.1 0.2 0.1 0.2 0.0 1.9 0.1 0.7 0.2 0.0 0.0 0.3 4.5 1.5 1.1 0.9 0.5 1.7 0.2 4.0 7.8 2.2 0.6 39.5 0.3 0.0 0.0 0.2 0.2 2.8 0.2 0.3 1.1 25.3 9.2 0.2 7.9 1.5 1.0 3.3 0.9 1.0 1.3 0.6 25.8 0.2 0.1 0.3 0.1 0.1 2.1 0.2 0.0 0.0 0.1 2.6 4.8 0.2 2.1 0.0 2.8 12.0 1.7 7.7 0.1 0.6 3.9 0.1 0.7 0.5 0.0 0.2 1.7 0.0 9.8 0.1 1.9 0.3 0.0 0.4 0.4 0.3 0.1 3.4 0.1 0.4 0.6 0.4 0.8 4.0 0.0 0.2 0.2 0.9 3.4 0.6 0.2 5.5 0.7 0.3 4.8 0.1 0.0 0.3 2.8 0.2 0.3 0.6 0.5 0.2 0.1 0.1 0.3 3.3 0.7 0.6 0.8 0.5 0.7 0.9 1.0 0.9 0.3 1.5 1.0 1.3 2.6 1.0 0.9 1.0 0.8 0.6 0.0 1.2 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.2 0.0 3.7 0.0 35.4 126.0 0.9 0.4 2.5 2.7 2.3 1.8 0.0 0.2 8.3 38.6 3.0 0.0 0.0 0.0 2.6 0.4 1.2 9.3 0.0 0.0 0.3 1.6 0.0 0.6 0.0 8.5 1.7 1.4 13.5 1.0 0.0 0.8 11.5 0.0 0.4 1.4 1.9 0.0 4.1 0.5 8.3 160.2 0.6 0.0 0.0 19.7 KLC4 "bA387M24.3, KNSL8" ENSG00000137171 "Kinesin light chain 4" Q9NSK0 6 43040777-43075099 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.7" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 103.2;Paneth cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030168, HPA030169" Enhanced Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA030168: AB_10599285, HPA030169: AB_10601105" "unprognostic (2.96e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-2)" "unprognostic (1.08e-2)" "unprognostic (3.67e-2)" "unprognostic (5.63e-3)" "unprognostic (6.36e-3)" "unprognostic (1.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.30e-1)" "unprognostic (1.47e-2)" "unprognostic (9.22e-2)" "prognostic favorable (6.99e-6)" "unprognostic (2.08e-1)" "unprognostic (3.93e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" 6.1 9.7 13.1 8.5 11.5 5.3 6.9 25.0 15.2 7.6 35.0 10.2 8.1 35.1 8.5 12.3 5.6 9.3 15.2 12.2 13.8 10.8 13.6 47.2 8.2 5.8 12.2 13.7 11.2 9.1 17.6 13.3 5.9 12.1 8.6 17.4 9.0 11.4 8.4 9.9 8.7 55.7 7.4 9.2 6.6 16.0 22.6 13.2 6.7 10.9 4.5 5.4 10.2 9.9 5.6 12.2 9.0 3.7 6.1 7.0 3.3 3.5 3.2 8.7 10.4 8.6 8.5 7.7 2.9 4.8 5.3 8.2 5.3 6.3 5.3 10.7 7.0 7.0 6.3 8.7 8.2 4.3 5.3 10.6 6.2 9.2 23.4 8.3 3.0 4.9 11.1 10.3 6.4 6.3 16.8 6.7 11.0 4.2 7.1 4.4 7.2 7.9 6.5 3.4 35.5 4.4 6.4 4.9 10.2 8.1 3.6 14.3 7.0 5.7 5.0 11.1 8.3 9.1 7.6 4.8 6.1 7.2 3.0 3.0 14.1 5.0 12.9 3.3 4.5 2.1 2.6 3.7 4.4 4.0 3.6 5.1 5.6 5.5 3.9 4.2 4.3 7.0 4.8 9.0 6.1 3.6 12.2 6.4 3.3 13.1 11.5 25.0 15.2 13.8 10.8 12.2 13.7 12.1 13.2 14.9 11.8 3.9 8.3 3.3 20.8 10.2 22.9 21.4 5.7 14.0 27.5 9.4 16.6 6.6 6.1 4.4 103.2 0.0 8.7 4.1 5.1 5.1 6.9 51.3 5.8 11.1 21.5 5.5 3.7 6.8 9.5 2.5 3.3 6.4 36.2 15.8 6.6 59.6 6.3 20.0 25.7 12.9 4.4 20.9 15.5 4.0 11.3 4.9 35.1 5.0 KLF1 EKLF ENSG00000105610 "Kruppel like factor 1" Q13351 19 12884422-12887199 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0" "Cell type enriched" "Detected in some" 146 "Erythroid cells: 350.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9" "Lineage enriched" "Detected in single" 8 "monocytes: 4.7" "Group enriched" "Detected in some" 28 "HEL: 23.1;K-562: 55.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051850 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051850: AB_2616460" "unprognostic (1.17e-1)" "unprognostic (1.38e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-3)" "unprognostic (7.13e-2)" "unprognostic (3.90e-4)" "unprognostic (3.25e-2)" "unprognostic (3.19e-2)" "unprognostic (1.97e-1)" "unprognostic (1.08e-2)" "unprognostic (6.51e-2)" "unprognostic (7.71e-2)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (2.44e-1)" 0.0 0.0 0.5 0.0 0.3 30.6 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 9.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 7.0 0.0 0.1 0.0 0.0 0.8 1.2 0.0 0.6 0.0 0.3 0.5 0.5 4.7 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 23.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.2 4.7 0.0 0.3 0.0 0.1 0.5 0.1 0.1 0.2 0.5 0.0 2.9 0.0 0.0 1.6 0.5 0.3 0.1 0.4 0.2 0.1 0.2 0.0 0.3 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 350.4 0.0 1.2 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 KLF14 BTEB5 ENSG00000266265 "Kruppel like factor 14" 7 130731235-130734061 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.3;pancreas: 1.8;placenta: 2.9" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.4;Early spermatids: 3.2;Late spermatids: 3.0" "Cancer enriched" "Detected in single" 6 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;BJ hTERT+: 4.0;RH-30: 4.4;SK-MEL-30: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044729 Uncertain NA NA "HPA044729: AB_10960356" "unprognostic (4.49e-2)" "unprognostic (2.62e-1)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (1.92e-1)" "unprognostic (9.90e-3)" "unprognostic (7.98e-2)" "unprognostic (5.30e-3)" "unprognostic (7.14e-2)" "unprognostic (1.60e-1)" "unprognostic (1.95e-2)" "unprognostic (7.03e-3)" "unprognostic (3.63e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 2.9 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.5 0.5 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 3.0 0.8 4.0 1.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 4.4 0.0 0.0 0.0 0.8 0.0 0.4 0.0 1.7 0.0 0.5 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 KLF17 "FLJ40160, Zfp393, ZNF393" ENSG00000171872 "Kruppel like factor 17" Q5JT82 1 44118850-44135140 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 31.5" "Group enriched" "Detected in some" 73 "Early spermatids: 110.1;Late spermatids: 32.3" "Cancer enriched" "Detected in single" 25 "testis cancer: 4.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 3.2;HBF TERT88: 4.0;U-138 MG: 6.6" HPA024629 Enhanced NA NA "HPA024629: AB_1668927" "unprognostic (1.73e-2)" "unprognostic (1.18e-4)" "unprognostic (4.02e-4)" "unprognostic (2.38e-1)" "unprognostic (4.64e-2)" "unprognostic (5.17e-2)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (9.70e-3)" "unprognostic (5.30e-3)" "unprognostic (8.35e-2)" "unprognostic (5.54e-2)" "unprognostic (6.60e-2)" "unprognostic (8.04e-3)" 0.1 0.8 0.2 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 1.6 0.1 1.2 0.3 0.4 0.1 0.1 0.0 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 2.5 0.2 0.1 0.1 31.5 0.1 0.1 0.1 0.1 0.1 1.8 0.1 0.3 0.3 2.5 0.4 0.8 0.9 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.9 2.1 3.8 3.2 0.2 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 4.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 1.1 0.1 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.7 0.1 0.1 0.0 6.6 0.8 0.2 1.9 0.0 0.0 0.1 0.6 0.2 0.2 1.2 0.4 0.9 0.3 0.3 0.2 0.3 0.4 0.4 0.0 0.3 0.9 0.6 2.5 0.8 0.3 0.3 0.8 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.1 KLF18 ENSG00000283039 "Kruppel like factor 18" 1 44137821-44141631 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLF4 "EZF, GKLF" ENSG00000136826 "Kruppel like factor 4" O43474 9 107484852-107490482 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 92.1" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 685.3;Suprabasal keratinocytes: 589.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "classical monocyte: 5.2;intermediate monocyte: 7.4;myeloid DC: 4.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 12 "dendritic cells: 4.4;monocytes: 7.4" "Cell line enhanced" "Detected in many" "hTCEpi: 32.8;hTERT-HME1: 20.3;OE19: 17.5;U-2197: 49.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA002926 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA002926: AB_1852541" "unprognostic (2.06e-1)" "unprognostic (1.42e-2)" "unprognostic (1.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.55e-1)" "unprognostic (6.58e-3)" "unprognostic (3.44e-2)" "unprognostic (6.49e-2)" "unprognostic (3.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.93e-5)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (8.13e-2)" "unprognostic (8.32e-2)" 29.2 8.5 2.7 23.8 3.9 14.4 23.7 1.8 3.5 39.1 28.9 5.6 5.5 10.2 17.8 18.6 34.9 22.0 32.4 18.6 2.4 2.2 4.8 5.1 35.6 4.4 2.7 2.2 18.6 2.3 2.7 2.8 41.0 6.2 11.3 29.6 11.7 11.9 6.5 13.6 92.1 39.4 16.0 3.3 21.8 22.2 11.2 2.0 1.9 7.8 81.1 30.7 16.8 24.1 0.0 4.4 0.4 7.4 0.1 0.0 1.3 5.7 2.3 0.2 0.0 6.0 15.5 2.2 2.0 10.6 2.7 3.2 0.8 7.3 0.0 0.3 2.6 9.4 4.2 2.6 1.5 1.0 0.0 1.1 0.0 4.0 0.1 9.0 0.0 0.0 2.0 32.8 5.5 20.3 0.6 0.2 0.1 0.2 0.0 1.5 3.7 0.0 0.7 1.8 17.5 11.5 0.1 0.6 0.1 0.8 1.6 0.1 0.1 1.6 4.8 6.0 4.8 0.7 2.5 1.2 1.6 0.0 49.8 0.8 0.0 0.0 0.0 1.6 1.0 2.8 0.0 5.2 0.0 0.0 7.4 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.1 2.9 0.4 0.0 1.3 2.7 3.9 1.8 3.5 2.4 2.2 2.7 2.2 6.2 2.0 11.9 47.4 12.3 228.3 387.3 0.4 56.5 17.8 18.7 29.6 1.8 7.9 33.0 1.7 21.1 201.9 242.7 430.0 0.0 34.8 55.7 240.7 170.1 55.2 3.9 80.6 0.0 118.8 142.4 148.1 123.4 133.2 214.3 195.7 12.6 685.3 1.7 32.1 447.5 57.0 1.2 1.8 38.8 108.2 4.1 15.1 589.1 90.3 5.3 253.4 169.8 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077542 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 88.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 22.2" "Cell type enriched" "Detected in single" 18 "basophil: 16.3" "Lineage enriched" "Detected in single" 106 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0" "Group enriched" "Detected in many" 4 "amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3" "Low region specificity" "Detected in some" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 2.3 1.5 4.1 24.3 22.2 12.9 8.1 0.7 1.2 19.6 74.4 0.4 4.3 28.7 4.8 3.7 88.4 8.3 48.4 1.3 1.4 1.2 3.9 1.2 12.8 0.1 0.9 1.1 5.0 3.5 0.0 7.3 22.8 4.3 17.6 32.9 1.8 26.4 5.4 10.0 59.4 88.1 4.1 2.4 0.8 17.9 12.2 1.4 3.0 20.7 64.4 61.8 23.4 34.1 0.0 0.0 16.3 0.0 0.0 0.1 0.0 5.3 7.4 0.0 0.1 0.2 0.4 8.5 3.1 7.3 1.4 1.7 6.9 27.5 0.1 16.7 2.7 0.5 31.5 9.6 27.5 2.2 0.2 2.5 0.1 15.7 0.6 2.0 2.5 0.4 2.0 39.3 0.4 15.4 1.4 0.0 0.9 0.3 0.5 6.3 1.8 0.5 0.1 0.3 59.4 10.6 0.4 7.0 0.6 21.8 33.2 0.7 0.3 28.0 4.5 1.9 3.6 0.6 0.6 0.0 1.9 5.7 0.0 1.3 0.9 0.4 0.9 2.7 0.5 2.3 16.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 22.2 0.7 1.2 1.4 1.2 0.9 1.1 4.3 1.4 151.8 97.6 0.5 1017.1 460.9 0.4 5.6 79.0 128.5 151.2 34.9 2.0 57.7 18.3 30.8 305.6 1.1 308.2 0.0 40.2 87.3 46.1 522.9 3.5 2.9 5.4 9.5 195.2 0.6 0.0 162.5 6.1 6.1 55.6 5.4 327.8 0.0 63.9 284.0 1.4 2.6 0.0 0.0 28.8 7.2 25.9 599.6 48.5 0.7 397.9 1225.4 KLHDC3 "dJ20C7.3, hPeas, PEAS" ENSG00000124702 "Kelch domain containing 3" Q9BQ90 6 43014103-43021298 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.7" "Group enriched" "Detected in all" 9 "Early spermatids: 436.9;Late spermatids: 1305.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030131, HPA030132, HPA030133, HPA030134" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350" "unprognostic (3.85e-2)" "prognostic favorable (9.15e-4)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (9.97e-3)" "unprognostic (2.80e-1)" "unprognostic (2.09e-3)" "unprognostic (1.05e-2)" "unprognostic (5.09e-2)" "unprognostic (1.58e-3)" "prognostic favorable (9.08e-4)" "unprognostic (6.34e-2)" "unprognostic (2.88e-2)" "unprognostic (8.73e-2)" "unprognostic (9.78e-2)" "unprognostic (2.88e-1)" "unprognostic (1.52e-1)" 16.1 19.0 37.2 11.6 41.6 14.7 17.6 38.0 68.2 15.2 16.7 14.6 15.4 14.4 12.8 21.2 16.1 19.9 13.6 34.0 34.2 25.7 14.8 20.2 14.4 14.4 26.7 41.6 20.3 15.2 15.6 17.6 20.9 29.6 16.3 15.0 13.5 21.3 18.5 122.7 15.1 14.7 15.9 14.6 14.1 15.4 47.0 15.3 17.4 19.3 17.6 15.6 13.7 11.2 19.5 39.4 41.6 36.3 21.6 31.5 29.8 26.4 8.2 27.3 45.6 18.8 14.2 19.6 12.0 15.5 23.5 25.8 23.5 13.9 26.3 13.7 17.5 8.8 14.1 29.0 15.5 16.1 14.0 39.5 32.7 23.6 24.4 18.5 19.2 23.4 22.8 15.6 18.1 10.6 18.3 22.7 30.1 39.7 18.8 8.8 32.9 31.4 33.1 35.5 66.8 8.8 30.6 20.0 31.5 14.4 15.4 50.6 39.5 12.7 14.6 20.4 18.5 25.4 55.7 13.4 10.7 20.0 11.8 11.8 20.6 25.8 38.2 4.7 27.6 9.0 14.9 36.3 41.6 28.5 33.8 24.0 19.2 23.8 25.8 39.4 19.5 31.5 24.5 17.7 21.6 25.8 21.8 25.1 29.8 37.2 41.6 38.0 68.2 34.2 25.7 26.7 41.6 29.6 15.3 11.9 17.1 31.9 30.7 16.7 29.1 32.5 30.6 5.3 6.8 17.4 13.7 84.7 72.9 52.9 436.9 20.2 33.8 23.3 48.1 97.9 40.2 39.5 13.8 24.5 56.1 30.2 50.3 24.5 35.6 1305.6 41.4 26.0 32.1 61.3 43.7 33.2 40.4 43.6 55.5 45.1 21.9 51.8 26.8 102.4 30.2 18.1 89.5 30.2 50.7 28.0 KLHDC7A FLJ38753 ENSG00000179023 "Kelch domain containing 7A" Q5VTJ3 1 18480982-18486126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 36.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 7.6;Ciliated cells: 6.7;Collecting duct cells: 8.7;Hepatocytes: 5.7;Proximal tubular cells: 8.4" "Cancer enhanced" "Detected in many" "renal cancer: 10.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.3;CAPAN-2: 10.4;EFO-21: 5.4;NTERA-2: 5.8;RPTEC TERT1: 11.9;RT4: 9.4;T-47d: 10.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA056616 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA056616: AB_2683193" "unprognostic (4.63e-1)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (5.25e-2)" "unprognostic (1.68e-3)" "unprognostic (2.02e-1)" "unprognostic (1.31e-2)" "unprognostic (1.80e-3)" "unprognostic (2.94e-2)" "unprognostic (1.91e-1)" "unprognostic (9.01e-2)" "unprognostic (2.79e-1)" "prognostic favorable (7.81e-9)" "unprognostic (4.64e-3)" "unprognostic (1.37e-1)" "unprognostic (3.44e-1)" "prognostic favorable (1.88e-4)" 0.6 0.0 0.0 0.3 0.2 0.0 5.0 0.5 0.5 2.5 0.6 0.7 2.6 0.3 0.0 2.6 1.8 0.8 7.4 0.3 0.0 0.0 36.4 6.9 1.4 0.0 0.1 0.6 0.2 5.7 0.0 0.3 0.3 2.9 0.5 0.7 2.8 2.2 1.2 0.0 0.1 0.4 1.0 0.1 0.0 4.8 0.2 0.0 0.0 1.6 0.3 0.8 5.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 5.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.1 10.4 0.0 5.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.1 0.0 0.2 0.0 0.0 11.9 9.4 2.9 0.0 0.0 0.8 0.0 1.1 10.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.5 0.5 0.0 0.0 0.1 0.6 2.9 0.0 0.0 2.7 0.0 0.1 0.1 0.0 1.2 7.6 6.7 1.2 8.7 0.0 0.0 1.7 2.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 KLHDC7B MGC16635 ENSG00000130487 "Kelch domain containing 7B" Q96G42 22 50548033-50551022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.4;parathyroid gland: 12.5" "Cell type enriched" "Detected in some" 5 "monocytes: 30.7" "Cancer enhanced" "Detected in many" "cervical cancer: 42.3;urothelial cancer: 40.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA000518, HPA076540" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA000518: AB_1079213, HPA076540: " "prognostic favorable (1.30e-4)" "unprognostic (3.18e-2)" "unprognostic (2.74e-2)" "unprognostic (2.21e-1)" "unprognostic (3.96e-2)" "unprognostic (6.04e-3)" "unprognostic (3.91e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (7.13e-2)" "unprognostic (3.33e-3)" "unprognostic (2.48e-1)" "unprognostic (2.09e-3)" "unprognostic (2.89e-1)" "unprognostic (4.69e-2)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" 0.4 0.4 0.3 3.9 1.2 1.2 0.7 0.3 1.5 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.2 0.3 0.3 0.3 0.1 8.4 1.1 1.1 4.0 0.3 0.3 0.8 0.3 12.5 2.2 0.3 0.9 0.7 0.0 0.8 3.0 0.3 0.3 0.3 2.0 0.3 0.3 5.4 0.5 0.3 0.3 6.5 2.9 0.3 1.7 3.0 0.3 3.8 2.0 2.4 4.0 1.4 5.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.1 47.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.4 2.2 0.2 4.5 4.0 3.3 3.8 4.7 5.7 2.0 3.1 5.2 4.3 0.4 1.4 2.8 0.7 4.1 2.5 0.3 1.2 0.3 1.5 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.1 3.7 0.0 0.1 0.0 0.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 5.7 0.0 1.6 0.0 0.0 0.0 4.7 0.0 0.0 1.7 0.0 30.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 4.4 0.0 0.1 KLHDC8A FLJ10748 ENSG00000162873 "Kelch domain containing 8A" Q8IYD2 1 205336065-205357090 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 12 "ovary: 93.4" "Group enriched" "Detected in some" 5 "Bipolar cells: 46.6;Erythroid cells: 46.7;Muller glia cells: 17.4;Peritubular cells: 19.8" "Cancer enhanced" "Detected in many" "glioma: 45.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.7;HAP1: 11.5;NTERA-2: 2.8;SCLC-21H: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (4.18e-2)" "unprognostic (4.80e-2)" "unprognostic (3.43e-2)" "unprognostic (3.21e-1)" "unprognostic (2.63e-2)" "unprognostic (2.97e-1)" "unprognostic (4.92e-1)" "unprognostic (8.37e-3)" "unprognostic (7.39e-3)" "unprognostic (4.03e-2)" "unprognostic (1.84e-7)" "unprognostic (4.53e-3)" "unprognostic (5.83e-2)" "prognostic favorable (8.01e-4)" "unprognostic (1.20e-2)" 0.3 8.0 2.2 0.4 6.0 2.3 0.5 7.8 2.4 0.7 0.5 2.3 0.1 0.6 1.2 1.7 1.4 5.7 0.5 0.4 3.6 5.0 0.3 0.3 0.4 0.3 2.2 1.8 93.4 1.1 0.3 6.5 0.3 8.0 0.4 0.5 3.0 2.2 0.3 0.3 0.5 0.5 1.2 1.3 0.4 1.4 1.8 0.8 0.0 1.5 1.7 1.4 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 11.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 11.7 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 6.0 7.8 2.4 3.6 5.0 2.2 1.8 8.0 0.8 0.0 0.0 0.0 0.0 0.0 46.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.8 0.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 17.4 0.5 0.0 19.8 0.0 4.6 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 KLHDC9 KARCA1 ENSG00000162755 "Kelch domain containing 9" Q8NEP7 1 161098361-161100346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Group enriched" "Detected in many" 6 "Early spermatids: 336.6;Late spermatids: 352.6;Spermatocytes: 259.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 5.0;HDLM-2: 3.5;HEK 293: 3.7;MCF7: 3.4;T-47d: 3.3;U-266/70: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032058, HPA043197" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes NA "Nucleoplasm, Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA032058: AB_10601439, HPA043197: AB_2678359" "unprognostic (1.79e-1)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "unprognostic (1.04e-3)" "unprognostic (2.53e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-1)" "unprognostic (4.87e-3)" "unprognostic (6.31e-2)" "prognostic favorable (4.20e-6)" "unprognostic (1.81e-3)" "unprognostic (1.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.53e-1)" "unprognostic (5.51e-2)" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" 1.0 3.7 4.0 1.0 8.4 0.9 1.4 3.1 9.5 1.8 2.4 2.3 5.6 1.6 2.4 3.9 1.1 5.7 2.4 1.7 3.3 4.9 5.9 2.6 1.7 1.0 3.6 7.4 2.5 3.6 4.1 4.8 1.0 5.6 3.2 1.6 3.5 2.9 2.4 2.5 0.8 1.6 1.1 1.6 1.1 2.4 24.3 2.2 0.0 5.0 0.0 1.1 1.5 0.6 0.9 0.1 0.0 0.2 0.0 1.1 0.1 0.4 2.7 1.0 2.9 0.0 0.3 0.3 0.0 0.7 0.1 0.0 0.0 0.2 0.0 5.0 0.0 0.0 1.6 0.0 0.0 0.0 3.5 3.7 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.5 0.0 1.5 0.5 2.4 2.6 0.0 1.9 0.6 0.0 2.5 1.1 0.0 1.0 0.0 0.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 4.0 8.4 3.1 9.5 3.3 4.9 3.6 7.4 5.6 2.2 0.0 4.1 0.0 11.1 0.8 13.0 8.5 7.6 53.5 9.1 27.9 2.0 2.3 48.0 6.8 336.6 3.3 3.2 0.0 4.9 2.8 3.5 10.5 1.1 7.3 0.5 3.2 5.2 1.8 0.3 352.6 7.5 0.3 6.8 1.0 12.5 27.9 4.2 7.0 7.8 29.8 16.9 12.9 1.9 259.8 11.1 0.6 0.7 0.0 7.6 5.6 KLHL1 "FLJ30047, KIAA1490, MRP2" ENSG00000150361 "Kelch like family member 1" Q9NR64 13 69700594-70108493 "Predicted intracellular proteins" Actin-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 17.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HeLa: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021196 Uncertain NA NA "HPA021196: AB_1852567" "unprognostic (5.81e-2)" "unprognostic (7.40e-3)" "unprognostic (2.43e-1)" "unprognostic (1.41e-1)" 0.3 1.4 2.0 0.5 5.0 0.3 0.3 3.5 6.9 0.3 0.5 0.0 0.0 0.4 0.3 0.3 0.4 0.3 0.3 0.3 1.8 7.6 0.8 0.3 0.3 0.3 17.6 2.3 0.3 0.7 0.5 1.9 0.3 16.2 2.1 0.4 1.0 0.3 0.4 0.3 0.3 0.6 0.4 5.3 0.3 0.7 1.5 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.0 3.5 4.2 1.8 7.6 17.6 2.3 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL10 FLJ32662 ENSG00000161594 "Kelch like family member 10" Q6JEL2 17 41835685-41848384 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 33.4" "Group enriched" "Detected in some" 37 "Early spermatids: 293.4;Late spermatids: 411.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.6;HBF TERT88: 2.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA067538 Enhanced NA NA "HPA067538: AB_2685859" "unprognostic (3.46e-4)" "unprognostic (1.95e-1)" "unprognostic (3.23e-1)" "unprognostic (1.52e-1)" "unprognostic (5.18e-3)" "unprognostic (1.22e-2)" "unprognostic (3.20e-1)" "unprognostic (5.08e-3)" "unprognostic (1.90e-1)" "unprognostic (3.82e-2)" "unprognostic (4.07e-2)" "unprognostic (8.58e-2)" "unprognostic (1.35e-3)" "unprognostic (1.90e-2)" "unprognostic (2.65e-2)" "unprognostic (1.96e-1)" "unprognostic (5.17e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.2 1.0 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.4 0.1 0.1 0.2 33.4 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.7 0.0 1.2 0.3 0.7 0.0 0.7 0.0 3.6 0.5 1.1 0.8 0.7 0.8 0.4 0.3 0.1 0.9 0.4 0.3 0.5 0.0 1.0 0.7 2.4 0.5 0.3 0.1 0.4 0.3 0.8 0.2 0.0 1.6 0.5 1.2 0.1 0.5 0.1 0.4 0.3 0.0 0.9 0.8 0.0 0.6 0.0 0.0 0.9 0.1 0.6 1.1 0.1 0.8 0.1 0.1 0.1 0.8 0.1 1.1 1.0 0.9 1.5 0.0 0.3 1.2 0.3 0.1 1.1 0.7 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.2 0.2 0.2 0.3 0.1 0.1 0.6 0.2 0.0 0.0 0.3 0.0 0.8 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 293.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 411.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 2.0 0.0 0.0 9.4 1.9 0.0 0.1 0.0 0.0 0.0 KLHL13 "BKLHD2, FLJ10262, KIAA1309" ENSG00000003096 "Kelch like family member 13" Q9P2N7 X 117897813-118117340 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 35.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 25.4;Distal tubular cells: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;granulocytes: 9.3" "Cell line enhanced" "Detected in many" "HAP1: 12.8;HeLa: 22.7;RH-30: 14.3;RPTEC TERT1: 40.8;SH-SY5Y: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046039, HPA059901" Approved Approved Cytosol NA NA Cytosol "HPA046039: AB_2679514, HPA059901: AB_2684155" "unprognostic (1.11e-1)" "unprognostic (2.20e-1)" "unprognostic (1.03e-1)" "unprognostic (6.09e-2)" "unprognostic (1.07e-2)" "unprognostic (9.54e-2)" "unprognostic (7.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-1)" "unprognostic (2.54e-1)" "unprognostic (6.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.09e-3)" "unprognostic (1.24e-2)" "unprognostic (3.90e-2)" "unprognostic (1.53e-1)" "unprognostic (2.31e-1)" 2.4 5.5 3.4 3.9 11.9 0.2 19.0 2.5 3.7 24.9 5.3 3.1 6.6 2.2 35.6 5.6 5.4 8.1 10.1 9.0 2.3 4.0 15.4 3.3 1.4 0.4 4.7 2.1 7.7 3.3 3.5 5.0 1.7 6.6 7.3 3.0 5.6 2.6 9.7 2.3 1.5 4.9 22.2 3.5 1.1 3.5 2.8 4.9 3.6 1.4 3.1 1.2 8.2 5.0 0.0 5.6 9.3 0.1 1.4 0.9 0.4 0.4 0.1 2.6 5.5 0.0 0.0 0.1 0.2 0.0 0.1 0.0 3.4 0.0 0.0 6.3 0.0 0.2 6.3 12.8 2.1 0.0 0.0 4.9 0.1 22.7 0.0 0.3 0.4 0.8 0.7 0.9 0.0 0.2 2.7 9.7 0.0 0.0 0.0 0.0 0.5 2.1 0.5 5.1 0.0 3.6 0.0 14.3 0.0 40.8 1.5 0.0 36.4 0.1 0.4 0.3 1.1 7.9 0.0 0.2 0.9 1.1 0.7 3.2 0.1 0.0 0.0 3.9 0.0 1.5 3.2 0.1 9.3 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.9 0.8 0.0 1.4 0.0 5.6 0.4 0.4 3.4 11.9 2.5 3.5 2.3 4.0 4.7 2.1 6.6 4.9 0.0 0.0 0.0 5.5 0.7 3.9 5.8 0.0 25.4 5.7 1.8 0.0 0.1 24.9 1.1 0.3 0.7 1.6 0.0 2.9 0.1 2.6 1.5 0.0 1.0 0.5 0.0 1.2 4.3 0.0 0.7 5.8 0.0 1.7 0.0 2.0 8.4 1.2 3.5 1.8 8.5 1.1 6.5 3.2 1.2 12.0 0.4 0.0 0.0 2.3 1.7 KLHL14 KIAA1384 ENSG00000197705 "Kelch like family member 14" Q9P2G3 18 32672671-32773062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 14.6;seminal vesicle: 19.3" "Cell type enhanced" "Detected in some" 23 "B-cells: 6.0;Collecting duct cells: 7.0;Muller glia cells: 21.8" "Group enriched" "Detected in many" 10 "endometrial cancer: 6.8;ovarian cancer: 15.5;thyroid cancer: 7.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 97 "memory B-cell: 10.7;naive B-cell: 8.5" "Lineage enriched" "Detected in single" 108 "B-cells: 10.7" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;Hep G2: 16.8;REH: 4.5;RPTEC TERT1: 9.4;SCLC-21H: 3.6;U-698: 4.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "hippocampal formation: 22.7;olfactory region: 20.4" HPA024777 Uncertain Supported "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA024777: AB_1852576" "unprognostic (3.93e-2)" "unprognostic (7.87e-2)" "unprognostic (7.09e-2)" "unprognostic (5.61e-3)" "unprognostic (1.87e-1)" "unprognostic (2.16e-6)" "unprognostic (2.14e-1)" "unprognostic (4.30e-2)" "unprognostic (4.81e-2)" "unprognostic (2.32e-3)" "unprognostic (2.32e-1)" "unprognostic (7.64e-2)" "unprognostic (8.91e-2)" "unprognostic (8.03e-2)" "unprognostic (1.97e-1)" "unprognostic (2.65e-2)" "unprognostic (1.43e-2)" 0.6 0.1 0.4 1.0 0.4 1.5 0.6 0.4 1.0 2.4 0.4 0.4 14.6 0.0 1.5 1.4 0.4 6.3 0.4 0.4 0.4 0.3 4.3 0.4 0.4 5.1 0.4 0.4 1.1 0.4 10.3 1.1 0.4 1.5 1.6 0.0 1.0 0.4 19.3 0.4 0.1 2.3 0.4 0.4 9.5 0.1 2.8 0.4 0.4 11.7 0.4 3.8 0.4 0.7 10.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 16.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 4.5 1.5 0.0 9.4 0.0 3.6 0.4 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.4 1.0 0.4 0.3 0.4 0.4 1.5 0.4 0.0 0.0 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 3.3 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 KLHL15 KIAA1677 ENSG00000174010 "Kelch like family member 15" Q96M94 X 23983720-24027186 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 25.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065730 Uncertain Approved Aggresome,Cytosol NA NA Cytosol Aggresome "HPA065730: AB_2685547" "unprognostic (5.89e-2)" "unprognostic (6.98e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.13e-1)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (7.37e-3)" "unprognostic (7.42e-2)" "unprognostic (9.39e-2)" "unprognostic (1.95e-2)" "unprognostic (3.09e-1)" "unprognostic (2.57e-2)" "unprognostic (1.29e-1)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (8.40e-2)" 2.9 6.1 1.7 1.3 2.3 25.1 1.3 2.8 1.8 1.9 2.0 1.0 2.3 4.0 4.3 3.8 1.9 2.1 1.6 1.9 2.2 6.4 1.6 1.4 1.3 4.6 2.9 4.3 2.6 1.2 2.8 1.2 1.3 1.8 2.6 1.0 1.5 2.2 1.6 1.5 3.4 9.0 2.3 1.2 1.3 1.1 1.4 2.1 2.8 2.6 1.6 2.8 1.3 4.3 4.2 4.7 6.8 7.0 5.0 4.8 7.0 6.1 3.2 3.9 3.8 3.9 11.3 2.5 4.5 5.1 3.3 7.4 3.8 7.9 4.4 15.3 7.2 11.3 2.0 4.4 9.4 5.1 5.2 2.0 5.5 5.5 2.9 2.3 6.8 4.6 16.0 6.0 1.5 8.4 9.2 8.8 2.2 5.2 6.7 8.5 7.0 3.0 3.8 12.4 5.8 9.7 2.4 8.0 6.2 3.2 8.4 2.9 5.0 3.0 9.8 4.5 8.9 8.9 13.1 3.9 6.1 3.9 1.5 1.1 2.8 2.0 2.6 2.8 1.0 1.8 2.3 2.1 1.4 2.4 2.4 1.5 1.6 2.6 1.7 1.8 1.3 6.0 6.4 7.5 3.7 16.0 7.7 9.8 2.5 1.4 6.8 3.5 11.8 0.4 0.0 1.2 1.8 4.4 2.6 0.0 1.2 0.7 6.1 5.3 8.1 11.5 3.2 19.1 8.1 6.2 9.8 1.7 3.1 7.2 11.8 1.8 2.9 11.8 1.7 0.0 3.9 2.1 7.4 0.0 19.6 3.0 13.5 8.7 1.1 5.0 4.0 2.5 KLHL2 MAV ENSG00000109466 "Kelch like family member 2" O95198 4 165207618-165323156 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051637 Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA051637: " "unprognostic (1.14e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" "unprognostic (8.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.56e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (4.42e-2)" "unprognostic (2.06e-1)" "unprognostic (4.67e-1)" "unprognostic (4.88e-2)" "prognostic favorable (3.77e-4)" "unprognostic (4.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-2)" "unprognostic (1.81e-1)" 10.5 11.2 25.1 10.4 36.0 16.4 12.1 9.7 41.6 6.1 5.8 19.6 4.0 5.0 7.0 13.4 15.8 8.9 9.5 5.0 37.2 17.7 13.3 23.8 10.6 9.4 25.7 14.7 3.8 6.6 5.3 18.4 6.9 15.1 7.8 6.5 4.0 16.3 9.7 3.2 4.7 5.6 9.6 25.7 11.1 7.4 5.4 25.0 1.6 11.3 3.4 8.4 10.9 7.2 1.3 1.2 10.8 1.9 0.3 1.6 0.6 8.7 8.1 5.6 5.8 8.7 7.8 6.0 11.9 9.4 6.2 6.7 4.8 6.6 9.1 3.0 6.0 11.0 6.1 9.1 6.3 8.0 14.8 3.5 7.6 7.2 7.5 7.6 7.8 11.1 6.5 18.0 5.6 21.2 10.9 14.8 3.4 3.4 19.2 9.5 3.3 0.2 2.5 3.4 5.0 3.6 3.1 4.2 2.8 11.3 8.5 28.8 4.8 7.5 2.7 7.2 10.9 1.8 8.9 20.4 4.9 10.1 5.6 8.0 12.5 8.7 7.3 6.0 5.6 9.6 1.9 1.4 1.9 0.8 1.4 0.5 0.4 0.6 0.5 1.2 1.3 1.4 1.6 10.8 0.3 1.9 0.7 0.7 0.6 25.1 36.0 9.7 24.7 37.2 17.7 25.7 14.7 15.1 25.0 6.0 14.1 5.6 11.1 5.4 8.3 4.0 7.6 5.3 7.9 21.0 13.7 3.5 23.2 6.7 1.1 13.4 4.1 0.0 11.3 8.3 5.4 10.1 9.2 30.8 7.4 30.2 14.9 17.2 40.5 1.3 3.7 20.7 5.0 4.6 4.7 3.2 8.8 4.8 4.2 14.7 6.4 0.0 6.8 2.1 7.1 6.6 3.1 7.0 3.1 16.1 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759323-85795030 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 31.5" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 12.1;Horizontal cells: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebral cortex: 36.7;hippocampal formation: 25.8" HPA023450 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 10.6 4.2 5.2 6.8 12.1 1.5 12.7 3.9 21.5 4.7 4.8 7.5 7.7 9.9 7.9 7.2 8.2 6.2 5.2 4.2 5.7 5.9 4.3 18.3 4.8 4.0 5.3 5.8 4.4 3.6 4.4 4.6 2.8 5.4 5.7 2.9 3.8 6.2 7.6 7.8 9.7 7.0 6.2 3.0 2.6 7.5 16.3 4.3 3.7 4.7 2.5 3.9 4.1 31.5 0.6 1.2 0.5 6.1 5.1 3.5 1.0 2.3 7.2 10.5 5.1 2.1 1.2 5.4 3.0 1.4 4.3 3.2 9.6 4.0 1.5 1.6 2.5 2.7 5.9 11.3 5.7 0.9 1.4 5.2 0.4 3.0 7.3 2.5 0.4 1.9 2.2 1.9 4.1 1.4 1.9 2.3 5.2 0.6 1.4 1.8 4.4 3.7 2.3 9.5 4.1 3.8 7.6 6.3 2.4 1.6 5.0 14.7 10.2 4.4 5.1 1.9 4.5 9.3 0.6 1.9 4.5 8.2 2.9 5.4 1.5 3.1 1.5 2.0 2.6 2.5 0.0 0.2 0.5 2.0 2.3 1.1 0.1 2.1 1.5 0.5 0.6 3.5 2.2 0.0 5.1 6.1 1.2 1.8 1.0 5.2 12.1 3.9 11.1 5.7 5.9 5.3 5.8 5.4 4.3 0.0 3.4 0.0 4.2 2.4 1.9 2.5 2.5 1.4 1.2 0.0 0.0 0.7 1.7 1.8 12.1 2.1 3.8 0.0 2.3 1.2 1.9 3.4 0.0 9.6 0.7 12.7 10.3 3.1 1.5 3.1 0.9 0.7 6.8 1.0 6.6 2.2 3.8 2.9 1.4 1.7 0.9 6.5 2.3 3.2 3.9 4.1 1.5 1.5 2.8 3.5 KLHL3 KIAA1129 ENSG00000146021 "Kelch like family member 3" Q9UH77 5 137617500-137736090 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 64.2" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 27.8;Early spermatids: 44.2;Late spermatids: 47.8;Muller glia cells: 46.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 64.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 6.3;RT4: 6.7;TIME: 14.8;U-266/70: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051291 Approved NA NA "HPA051291: AB_2681423" "unprognostic (4.31e-2)" "unprognostic (5.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.41e-1)" "unprognostic (6.39e-3)" "unprognostic (3.28e-1)" "unprognostic (9.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.71e-1)" "unprognostic (5.20e-3)" "unprognostic (1.50e-4)" 4.1 5.8 9.1 3.2 11.9 1.2 2.7 64.2 12.0 5.3 2.1 0.8 1.7 2.6 5.0 2.7 2.2 5.1 5.8 14.7 6.2 4.2 10.2 1.8 2.8 5.2 4.7 9.3 9.0 2.2 1.3 5.9 3.3 5.0 2.3 2.4 10.4 1.6 2.2 2.2 3.1 1.9 3.6 4.2 3.5 5.1 5.5 1.7 3.7 12.1 1.3 4.0 3.0 3.4 0.1 1.2 1.6 0.0 2.2 3.2 0.6 0.4 0.3 1.5 0.0 0.9 1.2 1.0 0.3 0.4 0.2 0.2 0.5 5.8 1.4 3.2 0.0 0.0 0.2 0.3 2.7 0.2 1.5 0.7 0.6 1.0 0.0 0.3 0.0 1.2 1.1 0.2 0.7 0.0 2.5 6.3 4.1 0.3 1.3 0.2 0.0 3.1 0.9 2.7 0.0 0.9 2.5 0.0 0.0 1.1 6.7 1.9 1.0 0.4 0.0 0.5 4.5 0.0 0.6 14.8 0.4 0.4 0.0 0.4 8.9 5.0 0.0 5.7 0.1 0.7 0.0 0.0 1.6 0.7 0.0 0.8 0.0 3.0 1.1 0.1 0.1 3.2 1.8 0.0 2.2 0.0 1.2 1.3 0.6 9.1 11.9 64.2 12.0 6.2 4.2 4.7 9.3 5.0 1.7 0.0 2.1 0.8 1.4 1.0 14.7 27.8 2.5 1.4 1.2 7.0 21.6 0.6 1.7 0.6 44.2 10.9 0.4 0.0 0.8 0.1 1.6 0.7 1.1 2.5 0.5 4.8 15.0 20.9 2.6 47.8 2.3 0.3 1.7 0.0 1.1 46.3 1.0 0.0 1.8 0.1 6.4 0.0 1.9 8.8 7.5 0.6 0.1 4.1 1.6 0.7 KLHL30 FLJ43374 ENSG00000168427 "Kelch like family member 30" Q0D2K2 2 238138722-238152947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 62.8" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 11.5;Smooth muscle cells: 5.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.1;CAPAN-2: 3.2;EFO-21: 3.1;REH: 2.6;RH-30: 8.8;THP-1: 4.3" "Region enriched" "Detected in single" 35 "olfactory region: 11.6" "Low region specificity" "Detected in all" HPA062095 Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA062095: AB_2684680" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (2.07e-4)" "unprognostic (6.02e-5)" "unprognostic (1.29e-1)" "unprognostic (1.22e-2)" "unprognostic (1.31e-1)" "unprognostic (4.54e-3)" "unprognostic (1.07e-1)" "unprognostic (1.63e-1)" "unprognostic (5.57e-3)" "unprognostic (2.24e-1)" "unprognostic (1.93e-1)" "unprognostic (8.17e-4)" "unprognostic (2.75e-2)" "unprognostic (2.30e-1)" "unprognostic (2.06e-1)" 4.4 0.1 0.1 0.3 0.1 0.1 2.4 0.1 0.1 1.2 0.5 0.1 0.1 0.2 1.2 2.3 1.3 0.4 0.4 6.1 0.1 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.7 0.3 1.4 0.1 0.8 1.7 0.6 62.8 0.2 0.3 1.5 0.1 0.1 0.3 0.4 0.0 0.0 0.9 8.7 0.2 1.6 1.4 0.7 1.4 1.1 2.5 0.5 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.0 6.1 0.0 0.1 0.1 0.0 0.2 3.2 0.0 3.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.5 0.0 0.3 2.2 0.2 0.0 0.0 2.6 8.8 1.4 0.7 0.0 0.1 0.2 0.1 0.8 0.3 0.5 0.0 4.3 0.0 0.1 0.5 0.2 0.0 0.3 0.3 0.1 0.2 0.5 0.1 0.5 2.5 0.3 0.2 0.5 0.2 0.7 0.1 0.1 1.4 0.6 0.2 0.3 1.1 0.5 0.3 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL31 "bA345L23.2, BKLHD6, KBTBD1" ENSG00000124743 "Kelch like family member 31" Q9H511 6 53647901-53665708 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9" "Cell type enriched" "Detected in single" 284 "Cardiomyocytes: 217.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 2.8;SCLC-21H: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (7.27e-2)" "unprognostic (6.18e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" "unprognostic (7.67e-4)" "unprognostic (2.23e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (3.98e-2)" "unprognostic (5.50e-2)" "unprognostic (4.24e-1)" "unprognostic (1.09e-4)" "unprognostic (8.73e-2)" "unprognostic (2.88e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" 13.1 0.5 0.1 0.3 0.3 0.0 2.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 1.2 1.3 0.6 0.1 77.7 0.2 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.6 0.1 0.0 1.6 0.0 57.7 0.6 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 40.9 2.2 0.3 0.2 0.7 0.0 0.0 0.1 0.9 0.6 0.0 1.0 0.7 0.2 0.2 0.0 0.0 0.5 0.0 0.2 0.2 0.1 1.2 2.5 0.0 0.2 0.0 0.7 1.9 0.8 0.4 0.1 0.1 1.3 0.4 1.7 1.6 0.1 0.6 0.0 2.1 2.6 0.0 0.5 0.5 0.0 1.4 0.0 0.2 0.0 0.8 0.9 0.0 0.3 1.3 0.8 0.1 2.8 0.1 0.8 0.9 3.7 0.4 0.2 0.6 0.0 0.3 1.2 0.0 0.0 0.1 0.5 0.0 0.2 0.5 0.1 0.0 0.3 2.1 0.1 0.0 0.0 0.0 0.4 0.0 0.6 0.7 0.0 0.2 0.0 0.3 0.2 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.6 0.3 217.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.2 0.2 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.0 0.0 0.4 KLHL32 "BKLHD5, KIAA1900" ENSG00000186231 "Kelch like family member 32" Q96NJ5 6 96924620-97140754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 47.1;fallopian tube: 12.8" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 24.1;Horizontal cells: 17.5;Intestinal endocrine cells: 10.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.2;T-cells: 5.5" "Cell line enhanced" "Detected in some" "Daudi: 6.0;HDLM-2: 8.2;JURKAT: 3.1;RPMI-8226: 3.7;SCLC-21H: 3.5;U-266/70: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039150 Enhanced NA NA "HPA039150: AB_2676367" "unprognostic (1.75e-1)" "unprognostic (7.99e-2)" "unprognostic (6.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (5.22e-2)" "unprognostic (5.00e-1)" "unprognostic (3.12e-3)" "unprognostic (5.88e-3)" "unprognostic (1.01e-1)" "unprognostic (1.51e-5)" "unprognostic (5.82e-2)" "unprognostic (6.04e-2)" "unprognostic (7.01e-2)" "unprognostic (1.86e-2)" "unprognostic (7.48e-2)" "unprognostic (4.49e-4)" 1.0 2.6 14.2 1.5 47.1 1.1 1.5 8.8 36.9 1.5 2.0 19.4 0.0 2.3 1.3 1.8 1.0 12.8 1.5 2.1 16.2 11.1 4.3 2.0 2.2 1.6 31.0 14.7 2.7 3.2 2.6 3.0 1.0 22.0 1.2 2.5 0.1 1.8 1.3 2.9 1.1 2.9 1.2 30.6 1.4 1.7 3.7 32.2 0.0 2.3 0.0 1.6 1.1 0.5 2.2 0.1 0.1 0.0 0.7 5.5 1.5 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.5 6.0 0.2 0.0 0.0 0.2 0.6 0.2 0.0 8.2 1.3 0.4 0.1 0.2 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.9 3.0 0.0 0.0 1.5 0.4 0.4 0.3 0.3 0.2 0.0 3.7 0.0 0.0 3.5 1.2 0.0 0.0 0.8 0.2 0.2 0.2 0.4 0.0 0.1 0.0 0.0 4.4 0.7 2.4 0.2 0.3 0.4 0.0 0.0 0.0 0.9 0.0 2.1 2.2 3.6 1.3 0.1 1.5 4.2 5.5 0.1 0.7 0.0 0.0 2.5 1.5 14.2 47.1 8.8 36.9 16.2 11.1 31.0 14.7 22.0 32.2 3.0 0.0 0.0 0.2 0.0 0.1 2.2 0.0 24.1 0.0 5.2 0.0 0.0 3.3 0.1 4.6 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 17.5 10.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.4 0.0 KLHL33 ENSG00000185271 "Kelch like family member 33" A6NCF5 14 20425852-20436158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 39.2" "Cell type enriched" "Detected in single" 215 "Cardiomyocytes: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 9.3" "Lineage enriched" "Detected in single" 24 "dendritic cells: 9.3" "Cell line enriched" "Detected in some" 9 "REH: 9.5" "Low region specificity" "Detected in many" "HPA049985, HPA056560" Enhanced NA NA "HPA049985: , HPA056560: AB_2683174" "unprognostic (6.92e-2)" "unprognostic (6.39e-2)" "unprognostic (2.07e-1)" "unprognostic (4.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.26e-1)" "unprognostic (2.38e-3)" "unprognostic (1.60e-1)" "unprognostic (9.77e-2)" "unprognostic (1.25e-1)" "unprognostic (7.39e-2)" "unprognostic (4.15e-2)" "unprognostic (4.60e-2)" "unprognostic (7.43e-3)" "unprognostic (4.88e-3)" "unprognostic (3.32e-5)" "unprognostic (2.32e-1)" 1.2 0.1 0.1 0.1 0.1 0.0 0.3 0.6 0.6 0.6 0.4 0.3 0.1 0.0 0.8 0.7 0.4 0.4 0.3 0.5 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.6 0.1 0.7 0.1 0.1 0.4 0.5 0.0 0.1 0.8 0.5 39.2 0.0 0.3 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.2 8.5 0.6 0.3 0.8 0.3 9.3 0.3 0.1 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.3 0.3 0.1 0.2 0.2 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.3 0.3 0.1 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.5 0.0 0.0 0.2 0.3 0.4 0.1 0.0 9.5 0.1 0.2 0.0 0.2 0.2 0.3 0.0 0.1 0.1 0.1 0.2 0.4 0.2 1.0 0.5 0.1 0.1 0.3 0.3 0.2 0.1 0.7 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.3 0.2 0.1 0.0 9.3 0.0 0.2 0.1 0.1 0.6 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL34 "FLJ34960, RP11-450P7.3" ENSG00000185915 "Kelch like family member 34" Q8N239 X 21654690-21658330 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 31.1" "Cell type enhanced" "Detected in some" 27 "Cone photoreceptor cells: 13.7;Horizontal cells: 15.9;Rod photoreceptor cells: 62.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Lineage enriched" "Detected in single" 4 "T-cells: 3.0" "Cell line enhanced" "Detected in some" "NTERA-2: 1.1;PC-3: 1.1;SCLC-21H: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA060287 Uncertain NA NA "HPA060287: AB_2684243" "unprognostic (2.00e-2)" "unprognostic (8.73e-2)" "unprognostic (1.79e-1)" "unprognostic (3.02e-1)" "unprognostic (3.14e-2)" "unprognostic (8.68e-2)" "unprognostic (9.17e-2)" "unprognostic (3.24e-1)" "unprognostic (3.40e-2)" "unprognostic (3.74e-1)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (8.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.64e-1)" "unprognostic (2.46e-1)" "unprognostic (3.29e-1)" 0.3 0.1 0.7 0.1 0.9 0.0 0.0 1.7 0.8 0.0 0.3 0.1 0.0 1.1 0.0 0.0 0.3 0.0 0.0 1.8 0.5 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 3.1 0.6 0.0 31.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 2.8 0.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.5 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 1.1 0.0 1.1 0.1 0.8 0.2 0.0 0.2 1.0 0.5 0.0 0.1 0.0 0.9 0.1 0.1 0.8 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.3 3.0 0.9 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.9 1.7 0.8 0.5 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 6.5 7.8 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 2.0 0.0 0.0 62.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 KLHL35 FLJ33790 ENSG00000149243 "Kelch like family member 35" Q6PF15 11 75422394-75430629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;testis: 11.2" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 33.0;Early spermatids: 21.7;Late spermatids: 21.4;Spermatogonia: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Group enriched" "Detected in many" 4 "granulocytes: 5.4;T-cells: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 14.2;HMC-1: 9.5;PC-3: 8.2;SiHa: 16.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039864, HPA070736" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nucleoli fibrillar center" "HPA039864: AB_10794204, HPA070736: " "unprognostic (3.53e-2)" "prognostic favorable (4.63e-4)" "unprognostic (5.40e-2)" "unprognostic (1.97e-1)" "unprognostic (6.88e-2)" "unprognostic (4.15e-3)" "unprognostic (4.98e-2)" "unprognostic (3.92e-2)" "unprognostic (6.52e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (4.39e-2)" "unprognostic (8.68e-3)" "unprognostic (1.59e-1)" "unprognostic (1.05e-1)" "unprognostic (3.11e-2)" "unprognostic (1.28e-1)" 1.1 3.4 4.5 0.7 14.1 0.7 3.5 1.8 8.2 3.2 1.0 3.0 0.2 0.7 0.5 1.0 1.0 2.0 1.1 1.1 3.7 6.2 0.6 0.6 2.7 0.7 3.1 3.3 0.5 4.5 0.5 0.8 0.8 6.2 0.7 0.6 0.7 1.3 1.0 0.9 1.2 0.5 1.1 4.3 1.0 2.3 11.2 2.4 0.0 1.4 0.0 0.7 0.7 0.2 0.2 0.8 5.4 0.3 0.0 2.1 1.2 0.0 0.3 0.1 0.0 0.2 1.3 0.0 0.8 0.0 0.8 0.1 14.2 1.2 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.8 3.6 9.5 0.2 0.2 0.0 0.0 0.1 0.4 2.5 0.0 0.0 1.0 0.6 0.3 0.1 0.1 2.8 8.2 0.0 0.0 0.8 0.7 0.1 1.1 0.9 16.7 3.1 0.0 0.0 3.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 2.1 0.0 0.5 0.0 1.2 0.7 0.8 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.0 1.2 4.5 14.1 1.8 7.1 3.7 6.2 3.1 3.3 6.2 2.4 8.9 4.3 0.0 1.5 1.1 33.0 0.8 0.0 2.7 4.5 3.5 7.9 1.3 3.3 1.7 21.7 1.0 0.2 0.0 2.7 1.4 2.5 0.9 4.6 0.0 1.1 1.6 4.1 3.7 0.0 21.4 2.6 2.1 1.7 2.8 1.0 2.0 2.6 0.0 1.1 0.1 11.0 6.5 1.4 7.5 37.1 1.9 2.1 0.0 0.6 0.7 KLHL38 C8ORFK36 ENSG00000175946 "Kelch like family member 38" Q2WGJ6 8 123645527-123652950 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 72.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.5;SK-MEL-30: 1.7;U-2197: 9.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024770, HPA027115" Uncertain Approved Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA024770: AB_10599286, HPA027115: AB_10599950" "unprognostic (8.62e-3)" "unprognostic (3.86e-3)" "unprognostic (1.02e-2)" "unprognostic (8.94e-2)" "unprognostic (4.68e-1)" "unprognostic (2.09e-2)" "unprognostic (8.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-2)" "unprognostic (5.73e-6)" "unprognostic (8.46e-3)" "unprognostic (3.82e-2)" "unprognostic (6.52e-2)" "unprognostic (2.84e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.7 0.6 0.1 0.1 16.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.2 0.1 72.0 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.8 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.7 0.0 1.0 0.0 0.0 0.0 0.2 9.7 0.1 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLHL4 "DKELCHL, KHL4, KIAA1687" ENSG00000102271 "Kelch like family member 4" Q9C0H6 X 87517749-87670050 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 34.4;brain: 16.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 4.0;Cone photoreceptor cells: 7.9;Endothelial cells: 5.7;Ito cells: 9.8;Rod photoreceptor cells: 4.2" "Cancer enriched" "Detected in some" 8 "glioma: 9.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.1;T-reg: 2.0" "Lineage enriched" "Detected in single" 10 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "AF22: 9.5;GAMG: 13.0;hTERT-RPE1: 9.2;HUVEC TERT2: 20.2;NTERA-2: 15.2;SuSa: 11.3;TIME: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029192 Approved Supported "Microtubules,Centriolar satellite" NA NA Microtubules "Centriolar satellite" "HPA029192: AB_10602341" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (8.74e-2)" "unprognostic (2.84e-3)" "unprognostic (1.48e-2)" "unprognostic (5.90e-2)" "unprognostic (1.71e-2)" "unprognostic (1.89e-2)" "unprognostic (5.21e-2)" "unprognostic (2.63e-1)" "unprognostic (5.98e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (8.08e-5)" "unprognostic (2.40e-4)" "unprognostic (1.05e-1)" "unprognostic (5.87e-2)" "unprognostic (7.25e-4)" 2.3 34.4 6.8 1.0 12.1 0.5 1.9 1.1 11.2 2.4 1.0 16.3 0.9 0.7 4.8 1.4 1.3 3.7 2.5 1.5 7.0 4.0 2.1 1.4 1.8 1.0 15.9 7.4 11.7 0.9 0.6 0.6 0.6 11.9 1.1 1.1 0.0 0.5 2.8 0.8 0.6 0.9 8.0 12.7 2.4 0.9 9.7 16.2 0.0 1.4 0.2 0.7 1.9 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.2 0.0 2.8 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.7 0.0 0.9 0.2 0.0 1.9 0.0 8.0 0.1 0.0 1.3 3.8 4.1 1.0 9.2 20.2 0.0 0.1 1.7 5.4 0.0 0.0 0.0 15.2 0.1 3.9 0.0 8.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 11.3 0.0 0.0 22.1 0.0 4.7 0.0 0.3 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.2 6.8 12.1 1.1 11.2 7.0 4.0 15.9 7.4 11.9 16.2 0.0 0.0 0.0 0.0 0.1 2.2 1.4 0.0 4.0 0.0 0.0 7.9 0.0 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 9.8 0.3 0.9 0.9 0.0 0.0 0.0 0.0 1.4 0.1 0.0 1.4 2.8 4.2 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 KLHL40 "KBTBD5, NEM8, SRYP" ENSG00000157119 "Kelch like family member 40" Q2TBA0 3 42685519-42692544 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 132.0" "Group enriched" "Detected in some" 13 "Early spermatids: 3.9;Late spermatids: 6.7" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "HSkMC: 3.2;RH-30: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024463, HPA052201" Enhanced NA NA "HPA024463: AB_1852095, HPA052201: AB_2681759" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (2.50e-1)" "unprognostic (4.04e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.0 132.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 19.6 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 KLHL41 "KBTBD10, Krp1, SARCOSIN" ENSG00000239474 "Kelch like family member 41" O60662 2 169509702-169526262 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "skeletal muscle: 564.4;tongue: 157.3" "Cell type enriched" "Detected in some" 12 "Cardiomyocytes: 97.4" "Group enriched" "Detected in some" 9 "head and neck cancer: 10.8;prostate cancer: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HSkMC: 12.8;LHCN-M2: 20.3;RH-30: 32.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA021165, HPA021753, HPA021760" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091" "unprognostic (2.44e-2)" "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (2.94e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-3)" "unprognostic (2.05e-1)" "unprognostic (5.46e-3)" "unprognostic (1.88e-1)" "unprognostic (5.38e-2)" "unprognostic (6.65e-4)" "unprognostic (9.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (1.52e-1)" 12.0 0.1 0.2 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.1 17.8 9.8 0.2 0.6 10.2 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.5 0.1 0.0 3.9 0.1 0.0 6.6 0.1 564.4 0.2 0.1 2.3 0.2 0.1 0.2 0.5 0.0 0.0 2.0 157.3 5.0 2.1 0.1 0.2 0.5 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.1 0.0 12.8 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 2.2 97.4 0.0 4.0 3.4 0.0 7.9 0.0 0.0 0.4 3.7 0.0 0.0 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.2 0.0 1.2 0.6 0.0 2.1 0.9 0.0 0.0 0.0 0.0 0.7 0.7 0.0 1.1 0.2 5.7 0.0 0.6 3.3 0.5 0.0 0.0 0.0 0.0 0.0 KLHL6 FLJ00029 ENSG00000172578 "Kelch like family member 6" Q8WZ60 3 183487531-183555689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.2" "Cell type enhanced" "Detected in many" 12 "B-cells: 16.2;Ciliated cells: 18.7;granulocytes: 47.6;Hofbauer cells: 22.0;Kupffer cells: 16.7;Macrophages: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.4;HEL: 9.8;HMC-1: 10.3;U-266/70: 31.6;U-266/84: 16.4;U-698: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024512 Uncertain Approved "Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite" Yes NA "Centriolar satellite" "Plasma membrane, Microtubules, Mitotic spindle" "HPA024512: AB_2131015" "unprognostic (8.46e-2)" "unprognostic (3.67e-4)" "unprognostic (1.48e-2)" "unprognostic (6.03e-4)" "unprognostic (5.15e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (9.62e-2)" "unprognostic (8.24e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (1.81e-1)" "unprognostic (3.68e-2)" "unprognostic (2.42e-1)" "unprognostic (5.73e-2)" 4.4 1.2 1.4 43.2 3.3 2.9 2.2 0.5 1.8 1.7 4.1 2.4 0.5 2.3 1.1 0.3 1.7 4.2 2.3 1.9 1.8 1.3 1.4 1.4 8.0 23.8 4.4 0.0 0.7 0.8 0.2 1.0 1.8 2.8 1.4 2.2 0.8 4.6 0.6 0.7 0.8 9.9 0.7 8.8 15.1 3.5 0.7 2.3 21.4 1.6 0.5 34.5 2.8 2.7 4.4 5.2 13.3 3.3 2.8 4.8 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 9.8 0.0 0.0 0.0 2.6 10.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.1 7.0 0.0 0.0 3.2 1.5 0.0 0.0 0.0 5.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.0 31.6 16.4 46.4 0.0 2.9 0.0 7.1 3.3 13.3 0.8 2.7 0.9 4.4 3.0 1.3 2.3 3.3 3.6 2.2 3.1 2.8 3.0 5.2 4.8 2.7 1.4 3.3 0.5 1.8 1.8 1.3 4.4 0.0 2.8 2.3 6.0 9.2 16.2 1.5 1.0 0.6 3.2 0.0 18.7 9.1 0.0 2.0 0.2 0.0 0.0 1.5 2.9 0.0 0.0 0.0 0.2 1.1 1.1 47.6 0.0 22.0 0.0 0.0 1.8 16.7 0.0 0.3 17.0 8.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.4 0.5 0.5 10.8 0.0 1.0 KLHL8 KIAA1378 ENSG00000145332 "Kelch like family member 8" Q9P2G9 4 87160103-87240314 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 56.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 205.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013856, HPA017762" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA013856: AB_1852594, HPA017762: AB_2669660" "unprognostic (2.93e-2)" "unprognostic (4.91e-3)" "unprognostic (3.44e-2)" "unprognostic (4.66e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (2.12e-1)" "unprognostic (4.46e-3)" "unprognostic (3.27e-2)" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "prognostic favorable (1.53e-5)" "unprognostic (4.24e-3)" "unprognostic (3.05e-1)" "unprognostic (3.57e-3)" "unprognostic (1.57e-3)" 6.8 7.3 6.9 5.6 8.1 3.0 12.0 10.0 10.7 9.2 7.5 5.3 3.8 7.3 8.3 56.2 5.3 5.4 5.0 7.4 7.7 7.2 11.4 10.3 9.0 8.1 6.3 5.6 6.1 6.3 7.1 14.2 6.6 7.3 5.7 8.5 4.6 6.5 7.7 23.4 4.8 8.2 6.6 8.0 6.9 5.5 4.2 6.5 7.0 17.3 2.9 4.7 6.8 10.9 3.8 10.3 8.6 12.1 8.7 4.9 5.0 6.5 5.8 10.5 4.7 9.6 7.0 5.6 8.4 4.5 5.6 6.6 9.2 5.0 9.5 6.8 6.2 4.6 2.8 11.1 8.3 12.2 9.1 7.0 11.6 4.4 5.4 8.2 19.0 7.3 8.8 6.0 8.6 8.7 5.5 6.7 7.3 14.9 8.7 5.8 7.2 22.7 9.6 2.6 14.8 2.3 8.6 9.0 5.8 9.5 6.8 22.0 7.7 5.5 13.5 6.2 4.1 4.7 14.1 6.2 7.2 8.8 7.6 7.0 13.1 8.5 16.9 5.4 9.1 7.8 1.9 12.1 7.3 3.0 9.2 4.9 3.3 2.4 2.5 10.3 3.8 4.4 4.3 8.6 8.7 9.0 2.7 0.9 5.0 6.9 8.1 10.0 10.7 7.7 7.2 6.3 5.6 7.3 6.5 3.0 18.5 11.3 9.5 12.2 18.4 11.7 5.1 6.7 10.3 41.8 39.3 3.2 10.0 4.5 2.8 9.5 12.2 0.0 3.9 4.6 8.6 10.5 7.0 17.1 8.6 22.3 8.6 5.5 30.8 2.4 8.9 13.4 10.1 2.8 12.0 205.6 5.0 8.6 7.8 16.5 44.7 12.9 9.2 11.2 19.4 12.9 19.9 7.7 13.3 9.8 KLK1 Klk6 ENSG00000167748 "Kallikrein 1" P06870 19 50819148-50823787 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 56 "pancreas: 742.6;salivary gland: 473.0" "Cell type enhanced" "Detected in many" 19 "Exocrine glandular cells: 663.7;Mucus-secreting cells: 890.7;Pancreatic endocrine cells: 205.3" "Group enriched" "Detected in many" 6 "colorectal cancer: 20.0;pancreatic cancer: 50.9;renal cancer: 84.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "memory B-cell: 10.9;naive B-cell: 3.8" "Lineage enriched" "Detected in single" 14 "B-cells: 10.9" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 29.2" "Secreted to digestive system" NA NA 4300000 "unprognostic (1.51e-3)" "unprognostic (1.23e-2)" "unprognostic (4.20e-1)" "unprognostic (1.73e-2)" "unprognostic (1.10e-1)" "unprognostic (8.72e-2)" "unprognostic (1.92e-2)" "unprognostic (7.47e-3)" "unprognostic (1.66e-1)" "unprognostic (2.49e-2)" "unprognostic (8.06e-2)" "unprognostic (2.12e-1)" "unprognostic (1.42e-2)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.23e-2)" 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.2 2.5 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 3.8 0.1 0.1 0.1 0.1 0.1 0.1 742.6 0.0 0.1 0.1 0.1 0.2 1.9 0.1 473.0 0.1 0.1 1.8 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 1.2 0.2 0.2 0.1 0.1 10.9 0.7 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.2 0.2 0.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 10.9 0.0 0.0 0.2 3.8 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.1 17.9 1.4 17.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 38.1 2.8 0.4 0.1 46.5 0.0 663.7 0.0 1.6 15.7 9.2 0.0 0.6 0.0 112.7 0.0 0.8 0.0 5.8 2.9 5.0 9.0 890.7 0.0 205.3 113.2 0.0 0.2 0.0 0.0 0.1 0.3 0.7 47.2 0.0 0.0 128.7 3.4 KLK10 "NES1, PRSSL1" ENSG00000129451 "Kallikrein related peptidase 10" O43240 19 51012739-51020175 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Cell cycle" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 29.8;Club cells: 77.3;Glandular cells: 41.6;Pancreatic endocrine cells: 43.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 50.7;HaCaT: 76.9;OE19: 49.9" "Region enriched" "Detected in single" 4 "hippocampal formation: 1.7" "Not detected" "Not detected" "Secreted in other tissues" NA NA 670000 "prognostic favorable (8.32e-4)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (4.26e-3)" "unprognostic (3.81e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-2)" "unprognostic (2.10e-2)" "unprognostic (3.94e-1)" "unprognostic (3.38e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (2.71e-2)" "unprognostic (2.46e-6)" "unprognostic (9.34e-2)" "unprognostic (7.81e-2)" "unprognostic (2.66e-3)" "unprognostic (1.52e-2)" 1.5 0.5 0.2 1.7 0.3 0.3 2.4 0.7 0.4 20.8 0.9 0.3 0.5 0.2 2.9 0.8 78.6 7.8 36.0 0.7 0.2 0.5 0.2 0.3 4.3 0.2 0.2 0.3 7.2 0.2 0.0 0.2 0.8 0.6 1.6 0.4 0.3 11.0 0.6 0.4 17.7 0.4 0.4 0.4 0.2 0.5 1.6 0.2 1.0 0.3 136.3 58.6 0.5 33.4 0.4 0.5 2.1 0.4 0.4 0.3 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 50.7 0.0 2.8 0.0 0.0 76.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 49.9 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.3 2.1 0.4 0.4 0.5 0.3 0.1 0.2 0.3 0.7 0.4 0.2 0.5 0.2 0.3 0.6 0.2 29.8 1.6 0.0 13.6 6.6 0.6 0.4 7.6 10.7 77.3 0.0 0.0 0.0 0.0 3.4 0.2 0.3 0.0 0.0 14.1 0.0 0.5 41.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 10.6 1.1 0.0 1.0 0.0 0.2 43.5 0.0 5.6 0.0 0.4 0.0 0.9 0.9 1.2 3.8 0.0 0.0 0.0 18.7 KLK11 "PRSS20, TLSP" ENSG00000167757 "Kallikrein related peptidase 11" Q9UBX7 19 51022216-51028039 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 141.1;Glandular cells: 237.5;Late spermatids: 257.5;Suprabasal keratinocytes: 189.7;Urothelial cells: 143.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 11 "pons and medulla: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 9.6;HaCaT: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB026340 Approved "Secreted in other tissues" NA NA 320000 "CAB026340: " "unprognostic (4.23e-2)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.78e-4)" "unprognostic (2.08e-2)" "unprognostic (4.67e-1)" "unprognostic (5.32e-2)" "unprognostic (3.72e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.92e-2)" "unprognostic (4.16e-6)" "unprognostic (3.90e-2)" "unprognostic (2.73e-1)" "unprognostic (4.40e-2)" "unprognostic (2.53e-1)" 5.5 0.0 0.2 1.1 0.2 0.0 4.9 0.2 0.6 24.5 1.7 2.0 0.4 0.0 5.1 2.7 103.4 9.7 61.8 0.4 0.9 0.0 0.2 0.6 12.3 0.2 0.2 0.2 2.3 25.0 0.0 2.1 0.4 10.7 18.8 0.0 5.1 96.5 1.6 0.3 49.8 0.6 0.3 0.2 0.2 18.7 7.7 0.2 0.9 0.2 65.2 88.5 0.7 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 9.6 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.9 0.0 0.2 0.2 10.7 0.2 80.4 7.2 0.0 141.1 94.9 0.0 0.4 63.7 26.8 108.1 0.0 0.0 0.0 0.0 2.9 105.3 2.2 0.0 0.0 118.6 0.0 8.9 237.5 1.1 0.0 0.3 0.0 19.4 0.0 0.0 257.5 2.6 2.6 8.5 0.0 2.8 0.0 49.0 0.0 0.4 0.0 1.4 0.0 0.3 2.1 2.5 189.7 0.0 0.0 0.3 143.9 KLK12 KLK-L5 ENSG00000186474 "Kallikrein related peptidase 12" Q9UKR0 19 51029092-51035230 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 22.9;Intestinal endocrine cells: 38.5;Late spermatids: 21.2;Mucus-secreting cells: 8.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;HaCaT: 2.0;U-698: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB025473 Uncertain "Secreted in other tissues" NA NA "CAB025473: " "unprognostic (2.84e-1)" "unprognostic (1.41e-1)" "unprognostic (1.08e-3)" "unprognostic (1.15e-1)" "unprognostic (5.80e-3)" "unprognostic (4.99e-3)" "unprognostic (3.18e-1)" "unprognostic (1.41e-1)" "unprognostic (4.64e-2)" "unprognostic (1.51e-1)" "unprognostic (1.56e-1)" "prognostic favorable (8.01e-4)" "unprognostic (8.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.6 2.0 0.0 0.0 3.6 1.2 0.2 53.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.7 0.0 16.6 0.0 0.0 0.4 4.3 0.1 0.2 0.0 0.4 0.5 0.0 0.2 0.0 33.3 24.7 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 38.5 0.0 0.0 21.2 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 1.8 KLK13 KLK-L4 ENSG00000167759 "Kallikrein related peptidase 13" Q9UKR3 19 51056206-51065114 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 100.5" "Cell type enriched" "Detected in some" 7 "Late spermatids: 184.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 42.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "HaCaT: 20.8" "Not detected" "Not detected" HPA062136 Enhanced "Secreted in other tissues" NA NA "HPA062136: AB_2684694" "unprognostic (1.99e-3)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (3.66e-2)" "unprognostic (3.43e-1)" "unprognostic (2.99e-2)" "unprognostic (1.69e-1)" "unprognostic (6.76e-2)" "unprognostic (2.18e-2)" "unprognostic (8.30e-2)" "unprognostic (7.07e-6)" "unprognostic (7.33e-2)" "unprognostic (2.53e-1)" "unprognostic (6.38e-2)" "unprognostic (7.06e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.2 15.7 0.4 0.2 0.1 0.2 0.3 0.1 100.5 0.2 0.9 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.4 1.7 0.0 0.5 0.1 0.2 0.1 0.0 0.3 12.4 0.1 1.2 2.1 0.4 0.1 0.1 0.1 0.2 6.1 0.1 0.1 0.1 17.9 12.8 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 20.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 1.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.6 1.8 0.0 0.4 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 27.9 0.1 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 184.3 0.3 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.7 1.1 0.0 0.0 0.0 2.0 KLK14 KLK-L6 ENSG00000129437 "Kallikrein related peptidase 14" Q9P0G3 19 51077495-51084245 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 14.2" "Group enriched" "Detected in some" 29 "Ciliated cells: 1.4;Club cells: 4.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 14.0;HEK 293: 4.0;U-266/84: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB026228 Uncertain "Secreted in other tissues" NA NA "CAB026228: " "unprognostic (2.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.44e-2)" "unprognostic (2.60e-2)" "unprognostic (1.23e-1)" "unprognostic (6.12e-2)" "unprognostic (4.91e-2)" "unprognostic (5.79e-2)" "unprognostic (7.84e-2)" "unprognostic (1.38e-1)" "unprognostic (7.60e-2)" "unprognostic (8.87e-2)" "unprognostic (2.04e-8)" "unprognostic (1.93e-1)" "unprognostic (3.74e-3)" "unprognostic (1.94e-2)" "unprognostic (8.08e-2)" 0.2 0.0 0.4 0.2 1.2 0.1 2.7 2.1 0.9 3.8 0.6 1.8 0.4 0.9 1.2 0.8 0.3 1.1 0.6 0.5 0.1 0.1 0.5 0.4 0.3 0.9 0.4 0.0 0.3 0.0 0.7 0.4 1.1 0.7 0.3 14.2 1.0 0.0 0.3 0.4 0.8 0.7 0.1 0.6 0.2 3.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.8 0.8 0.1 1.0 0.7 0.6 0.8 0.2 0.0 0.0 0.2 1.7 2.1 0.8 0.6 0.3 0.4 14.0 0.2 0.3 0.0 0.5 4.0 0.3 1.0 0.0 0.2 0.3 0.3 0.4 0.4 0.5 0.6 0.2 0.2 0.6 0.3 0.5 0.0 1.2 0.2 0.8 0.8 1.6 1.5 0.2 0.1 0.8 0.0 0.7 0.1 0.0 0.3 1.3 0.4 0.4 0.6 0.0 0.0 0.2 0.6 0.9 0.2 3.7 7.3 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLK15 "ACO, HSRNASPH, prostinogen" ENSG00000174562 "Kallikrein related peptidase 15" Q9H2R5 19 50825289-50837213 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 5.7;salivary gland: 9.7" "Cell type enhanced" "Detected in some" 19 "Late spermatids: 6.7;Mucus-secreting cells: 21.9;Spermatocytes: 14.7;Spermatogonia: 7.0" "Cancer enhanced" "Detected in some" "prostate cancer: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 7.3" "Not detected" "Not detected" HPA019802 Uncertain "Secreted to blood" NA NA "HPA019802: AB_1852601" "unprognostic (6.06e-2)" "unprognostic (2.85e-1)" "unprognostic (8.13e-2)" "unprognostic (2.90e-1)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 2.1 9.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 6.7 0.9 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 7.0 0.0 0.0 0.0 0.6 0.0 KLK2 ENSG00000167751 "Kallikrein related peptidase 2" P20151 19 50861568-50880567 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "prostate: 163.5" "Cell type enriched" "Detected in some" 36 "Glandular cells: 729.8" "Cancer enriched" "Detected in some" 1666 "prostate cancer: 989.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 5.0;NB-4: 10.2" HPA000764 Supported "Secreted in male reproductive system" NA NA "HPA000764: AB_1079700" "unprognostic (3.05e-2)" "unprognostic (2.40e-1)" "unprognostic (1.69e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (3.22e-1)" "unprognostic (6.44e-2)" "unprognostic (8.06e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-3)" "unprognostic (7.56e-2)" "unprognostic (8.10e-2)" "unprognostic (1.68e-1)" "unprognostic (2.04e-1)" 0.0 0.1 0.0 0.1 0.0 1.1 0.2 0.0 0.6 0.0 0.0 0.0 0.6 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.5 0.0 0.1 2.3 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.2 0.0 2.2 1.9 5.7 2.2 1.6 1.3 0.5 1.7 1.1 0.6 1.6 0.0 0.9 5.0 0.5 0.3 0.2 0.2 0.6 0.8 1.8 0.2 0.0 0.8 2.0 0.2 0.0 0.3 1.7 1.1 0.0 1.3 0.4 0.0 0.3 3.1 0.5 0.3 0.3 0.4 0.5 0.0 1.1 1.5 2.0 0.3 1.8 1.2 10.2 1.1 1.7 0.0 0.9 0.0 2.9 0.0 1.7 0.9 1.6 0.3 1.4 1.3 0.2 1.3 0.4 0.8 1.3 1.9 4.9 1.7 1.8 3.2 0.8 1.9 1.7 1.4 0.9 2.2 1.6 1.2 1.0 1.0 1.0 0.8 1.0 0.5 2.2 0.8 1.3 5.7 1.6 0.8 1.9 0.4 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 13.7 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 729.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 5.0 0.6 0.0 0.0 0.0 9.2 KLK3 "APS, PSA" ENSG00000142515 "Kallikrein related peptidase 3" P07288 19 50854915-50860764 "Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 115 "prostate: 447.4" "Cell type enriched" "Detected in some" 62 "Glandular cells: 3142.6" "Cancer enriched" "Detected in some" 3905 "prostate cancer: 4241.6" "Region enriched" "Detected in single" 8 "cerebral cortex: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 138 "BEWO: 22.4;NB-4: 18.9;RPMI-8226: 12.5;SH-SY5Y: 7.4;U-2197: 7.6" "CAB000070, HPA000764" Enhanced "Secreted in male reproductive system" NA NA "CAB000070: , HPA000764: AB_1079700" "unprognostic (5.06e-3)" "unprognostic (5.60e-2)" "unprognostic (9.93e-2)" "unprognostic (3.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.13e-3)" "unprognostic (1.94e-1)" "unprognostic (4.64e-1)" "unprognostic (3.15e-1)" 0.1 0.3 0.0 0.1 0.0 0.0 0.7 0.0 1.0 0.1 0.1 0.0 0.2 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 447.4 0.0 0.1 3.8 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 50.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3142.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 KLK4 "EMSP, EMSP1, KLK-L1, PRSS17, PSTS" ENSG00000167749 "Kallikrein related peptidase 4" Q9Y5K2 19 50906352-50910738 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Hydrolase, Protease, Serine protease" "Amelogenesis imperfecta, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "prostate: 79.3" "Cell type enriched" "Detected in some" 23 "Glandular cells: 120.1" "Cancer enriched" "Detected in many" 55 "prostate cancer: 463.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.0;HaCaT: 9.8;OE19: 8.8;SK-BR-3: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA051839 Enhanced "Secreted in male reproductive system" NA NA "HPA051839: AB_2681632" "unprognostic (3.58e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-3)" "unprognostic (1.66e-3)" "unprognostic (3.11e-2)" "unprognostic (4.35e-1)" "unprognostic (3.18e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-2)" "unprognostic (8.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.20e-3)" "unprognostic (3.27e-3)" "unprognostic (2.21e-2)" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" 0.2 0.8 0.1 0.3 0.1 0.1 0.7 0.2 0.5 2.0 1.2 0.0 3.8 1.8 1.5 7.7 0.4 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.5 79.3 0.8 0.2 3.2 2.1 0.7 2.4 1.2 0.6 0.1 0.1 0.3 0.6 0.1 0.0 8.7 0.0 0.0 0.2 0.2 0.1 0.4 0.6 0.1 0.0 0.3 0.0 4.9 2.0 0.2 0.3 0.0 0.0 4.4 0.1 0.0 0.0 0.0 4.5 8.0 0.5 0.4 0.1 0.2 9.8 0.0 5.3 0.0 1.3 1.3 1.5 3.6 1.7 0.0 1.6 2.2 0.0 2.5 0.0 0.0 0.3 0.0 0.4 0.9 4.1 0.0 1.2 0.1 2.4 0.1 8.8 0.4 0.3 0.5 1.1 0.0 3.2 0.0 0.6 0.3 6.3 0.0 0.2 5.1 0.4 1.1 0.3 0.3 1.3 0.3 2.6 1.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.5 0.3 0.2 0.2 0.0 0.5 0.1 0.0 0.0 0.0 2.9 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 120.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 1.7 KLK5 "KLK-L2, SCTE" ENSG00000167754 "Kallikrein related peptidase 5" Q9Y337 19 50943303-50953093 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skin 1: 69.2;tongue: 67.3" "Group enriched" "Detected in some" 5 "Early spermatids: 88.7;Late spermatids: 144.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 112.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "A-431: 87.4;HaCaT: 85.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014343, CAB025503, CAB026341" Enhanced "Secreted in other tissues" NA NA "CAB025503: , CAB026341: , HPA014343: AB_1852603" "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (4.30e-4)" "unprognostic (3.01e-1)" "prognostic unfavorable (9.79e-4)" "unprognostic (3.04e-1)" "unprognostic (3.05e-1)" "unprognostic (1.70e-3)" "unprognostic (2.21e-1)" "unprognostic (2.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.16e-3)" "prognostic unfavorable (3.85e-6)" 1.1 0.0 0.7 0.4 0.2 0.0 12.1 0.2 0.5 3.8 0.3 0.2 0.2 0.1 1.4 0.9 6.5 0.2 0.3 0.2 0.2 0.1 0.6 0.2 2.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.3 7.0 0.2 0.4 69.2 0.2 0.2 0.2 0.2 0.0 3.3 0.2 0.4 0.3 67.3 4.4 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 85.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.5 0.2 0.1 0.2 0.2 0.4 0.2 14.9 0.0 0.0 1.9 23.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 144.1 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.5 9.5 0.0 0.0 0.0 0.0 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 70.0;CAPAN-2: 167.5" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" Yes No 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 167.5 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 15.4 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.2 0.0 0.1 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 2.7 KLK7 "PRSS6, SCCE" ENSG00000169035 "Kallikrein related peptidase 7" P49862 19 50976482-50984099 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 29.1;skin 1: 77.5;tongue: 90.2" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 139.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 6.7;HaCaT: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018994, CAB026342, HPA062126" Enhanced Supported "Nuclear membrane,Plasma membrane" "Secreted in other tissues" NA NA 960000 "Plasma membrane" "Nuclear membrane" "CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691" "unprognostic (1.88e-2)" "unprognostic (6.41e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (8.06e-5)" "unprognostic (4.33e-3)" "unprognostic (2.28e-1)" "unprognostic (4.44e-3)" "unprognostic (2.99e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.10e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-1)" "unprognostic (4.47e-2)" "unprognostic (1.12e-2)" "unprognostic (5.60e-3)" 2.1 0.3 5.4 0.3 4.3 0.4 5.6 0.5 11.3 5.4 0.3 0.0 0.0 0.5 0.7 0.3 29.1 7.8 3.3 0.2 4.8 0.5 2.6 0.2 1.6 0.3 0.3 3.5 1.0 0.2 0.2 0.1 0.5 4.2 0.3 0.2 0.0 7.4 0.3 0.6 77.5 0.3 0.4 0.3 0.5 0.4 0.3 0.0 0.0 0.4 90.2 15.3 0.2 9.0 1.1 0.4 1.3 0.8 2.1 1.0 0.6 2.7 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 6.7 0.0 1.0 0.0 0.1 26.6 0.0 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 1.3 0.8 0.4 0.4 0.4 0.7 0.6 0.6 0.4 0.4 1.1 1.0 0.9 0.9 2.1 0.4 0.4 0.7 0.6 5.4 4.3 0.5 11.3 4.8 0.5 0.3 3.5 4.2 0.0 6.0 0.6 0.0 0.1 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.0 0.0 0.0 1.8 KLK8 "HNP, neuropsin, ovasin, PRSS19, TADG14" ENSG00000129455 "Kallikrein related peptidase 8" O60259 19 50996007-51002711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.6;skin 1: 40.4;tongue: 46.9" "Group enriched" "Detected in some" 13 "Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 29.9;ovarian cancer: 30.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2" "Region enriched" "Detected in many" 5 "hippocampal formation: 39.6" "CAB019393, HPA035761" Enhanced Approved Vesicles "Secreted in other tissues" NA NA 950000 Vesicles "CAB019393: , HPA035761: AB_2674769" "unprognostic (4.27e-3)" "unprognostic (2.59e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (5.46e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.10e-4)" "unprognostic (4.29e-2)" "unprognostic (4.66e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (6.17e-4)" 1.6 0.0 0.1 0.4 0.1 0.0 4.5 1.0 0.3 8.1 0.7 0.1 0.1 0.0 1.1 0.7 43.6 6.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.4 0.6 0.3 0.0 0.3 6.0 0.1 0.3 40.4 0.1 0.1 0.6 0.3 0.0 0.7 0.1 0.5 0.3 46.9 11.1 0.3 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.6 42.3 0.0 0.8 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 58.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 1.7 0.0 8.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.4 157.5 0.0 0.0 0.0 0.1 KLK9 KLK-L3 ENSG00000213022 "Kallikrein related peptidase 9" Q9UKQ9 19 51003111-51009634 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "tongue: 37.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "HaCaT: 1.2;HBEC3-KT: 4.2" CAB025049 Enhanced "Secreted to digestive system" NA NA "CAB025049: " "unprognostic (3.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 37.6 3.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLKB1 KLK3 ENSG00000164344 "Kallikrein B1" P03952 4 186208979-186258471 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 76 "liver: 102.9" "Cell type enriched" "Detected in some" 11 "Hepatocytes: 203.0" "Cancer enriched" "Detected in some" 17 "liver cancer: 27.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 7 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 8 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "NTERA-2: 7.3;SCLC-21H: 5.0;SK-MEL-30: 2.2;U-937: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 28900000000 4900000000 "unprognostic (4.80e-2)" "unprognostic (4.53e-3)" "unprognostic (4.36e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-2)" "unprognostic (1.90e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-1)" "unprognostic (8.14e-2)" "unprognostic (1.35e-1)" "unprognostic (1.38e-2)" "unprognostic (1.15e-1)" "unprognostic (1.45e-2)" "unprognostic (6.01e-2)" "unprognostic (7.30e-2)" "unprognostic (1.20e-1)" "unprognostic (1.59e-2)" 0.3 0.3 0.8 0.3 1.2 0.0 0.3 0.7 0.5 0.3 0.4 0.3 0.3 0.7 0.4 0.4 0.3 0.2 0.7 0.5 0.6 0.5 1.3 102.9 0.3 0.3 0.5 0.5 0.3 1.3 0.5 1.0 0.4 0.4 0.3 0.3 0.5 0.3 0.3 0.5 0.1 0.6 0.3 0.3 0.5 0.0 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.0 7.3 0.1 0.0 0.1 0.0 0.2 1.3 0.0 5.0 0.4 0.2 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 1.2 0.7 0.5 0.6 0.5 0.5 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 4.2 3.9 17.8 1.4 0.0 1.8 15.7 0.0 0.0 1.1 2.2 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 203.0 0.2 0.0 2.9 5.5 3.2 0.8 0.6 0.0 0.0 0.0 0.3 14.6 0.7 0.3 0.0 0.9 3.6 0.0 0.2 1.4 0.9 0.0 0.0 0.0 0.4 0.0 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859161-87863437 "Disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 6.3;skeletal muscle: 7.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 5.7;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 8.1;Karpas-707: 8.4" "Low region specificity" "Detected in many" HPA074502 Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "HPA074502: AB_2686695" "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.7 1.5 1.2 0.8 1.9 0.6 1.4 2.0 1.4 1.3 1.6 0.7 1.2 2.0 0.6 2.9 0.6 0.7 1.0 1.8 1.7 1.7 0.5 1.3 1.1 0.7 0.6 1.3 1.9 0.9 0.6 1.6 0.4 0.8 7.4 0.4 0.7 0.8 0.9 1.7 0.9 2.4 1.3 1.4 0.9 0.9 1.7 1.4 6.3 1.6 1.7 1.2 0.5 1.4 1.6 1.9 1.4 1.0 0.6 1.5 1.2 1.5 0.9 1.2 0.9 4.3 3.3 0.6 0.5 0.9 1.6 1.2 1.3 0.6 0.8 0.5 1.1 2.5 1.0 1.1 2.4 0.9 1.1 1.4 1.1 1.5 1.6 0.5 8.1 0.7 8.4 0.9 2.8 6.4 2.6 0.8 1.0 0.8 4.2 0.3 4.1 0.8 1.4 0.8 1.6 1.4 1.1 0.2 1.4 2.7 1.9 0.5 1.0 0.5 1.6 0.6 4.9 5.0 4.7 1.7 4.7 1.0 3.1 1.0 1.5 0.7 1.4 1.1 1.2 0.9 0.9 0.8 1.7 1.2 1.1 6.3 1.7 1.6 1.4 0.7 0.5 0.0 0.0 0.0 0.1 0.1 1.5 2.0 0.0 2.7 2.3 0.0 0.0 0.6 0.0 0.2 2.7 0.5 1.6 0.0 0.2 0.3 0.5 0.2 5.7 0.4 0.3 3.2 0.0 0.6 0.3 1.1 0.0 0.0 0.0 0.0 1.6 2.4 0.2 0.9 0.0 1.3 1.1 6.5 0.5 0.2 1.4 0.4 0.5 0.0 1.0 0.1 KLRB1 "CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A" ENSG00000111796 "Killer cell lectin like receptor B1" Q12918 12 9594551-9607886 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 178.9" "Cell type enriched" "Detected in many" 21 "T-cells: 765.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "MAIT T-cell: 178.9" "Group enriched" "Detected in many" 133 "NK-cells: 53.0;T-cells: 178.9" "Cell line enhanced" "Detected in some" "HEL: 3.0;Karpas-707: 2.2" "Low region specificity" "Detected in all" HPA039113 Approved Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039113: AB_10674979" "prognostic favorable (3.51e-5)" "unprognostic (1.23e-3)" "unprognostic (7.03e-3)" "prognostic favorable (1.42e-5)" "unprognostic (1.69e-1)" "prognostic favorable (6.99e-5)" "unprognostic (1.54e-3)" "unprognostic (7.15e-3)" "unprognostic (4.12e-1)" "unprognostic (8.23e-3)" "unprognostic (3.57e-2)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (5.61e-4)" "unprognostic (1.17e-2)" 3.8 0.8 0.8 22.8 0.8 18.6 2.1 0.5 0.6 2.9 9.1 0.0 1.3 5.0 1.8 3.7 2.6 1.8 7.3 1.3 0.7 0.8 3.8 4.9 11.8 23.7 1.1 0.2 2.0 1.0 0.0 0.9 2.1 0.8 1.8 3.9 0.9 4.8 1.4 0.9 0.8 20.4 0.6 1.8 25.2 4.4 1.3 0.2 6.2 1.9 2.9 17.7 5.5 2.0 0.1 0.3 0.8 0.2 53.0 178.9 18.5 0.1 0.0 1.5 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.1 0.0 0.9 0.2 1.9 0.0 0.0 0.2 0.0 3.0 0.0 0.4 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.2 2.2 0.0 0.8 0.8 0.6 0.5 0.5 0.0 1.1 0.3 0.9 0.0 0.5 0.4 0.6 0.6 0.7 0.1 1.7 0.3 0.2 0.0 1.6 0.0 0.4 0.7 0.6 0.4 1.5 0.0 1.8 1.0 0.5 0.1 0.0 43.1 0.1 178.9 0.1 25.6 28.1 0.1 0.1 1.5 8.7 0.8 53.0 0.2 0.3 5.7 18.5 0.8 0.8 0.5 0.6 0.7 0.8 1.1 0.2 0.8 0.2 0.0 12.8 14.5 0.6 8.7 0.0 0.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 5.1 1.3 0.0 5.5 0.9 0.0 0.0 35.6 22.5 0.0 0.0 3.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.5 0.0 0.0 7.8 0.8 765.3 0.3 1.3 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 64.3;lymphoid tissue: 22.1" "Cell type enriched" "Detected in some" 22 "T-cells: 112.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 45.7;NK-cell: 64.3" "Group enriched" "Detected in many" 42 "NK-cells: 64.3;T-cells: 45.7" "Cell line enhanced" "Detected in some" "HeLa: 9.3;Karpas-707: 3.8;SuSa: 3.7" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 2.4 0.5 1.2 5.8 1.4 5.6 2.3 1.0 2.7 1.7 3.3 0.7 1.2 1.5 5.5 3.9 1.7 2.5 2.4 2.6 1.6 1.3 1.9 2.0 5.9 10.3 2.3 0.6 1.2 1.4 0.3 1.3 3.6 1.5 1.9 2.5 2.0 3.1 0.3 0.5 1.0 5.0 2.1 2.6 22.1 5.2 1.4 0.5 3.5 1.9 3.0 2.9 2.9 1.8 0.1 0.0 1.2 0.1 64.3 45.7 5.1 0.4 1.6 0.1 0.1 0.5 0.4 0.8 0.0 0.0 0.8 1.7 0.0 1.3 0.2 0.1 0.4 3.3 0.3 0.6 2.8 1.1 0.9 0.4 2.1 9.3 0.0 0.1 0.6 0.4 1.0 0.0 0.3 0.0 0.0 0.8 0.7 1.3 3.8 0.8 0.0 0.2 2.8 0.0 0.1 0.0 0.9 0.2 0.3 0.2 0.0 0.5 0.1 0.8 0.0 0.3 3.7 0.3 0.0 2.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 2.1 0.8 0.0 0.2 0.0 0.0 45.7 0.0 5.8 0.1 0.0 7.9 0.0 0.0 0.0 6.9 1.2 64.3 0.1 0.0 0.0 5.1 1.2 1.4 1.0 0.9 1.6 1.3 2.3 0.6 1.5 0.5 0.0 1.1 0.0 0.2 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.1 1.6 1.7 1.3 3.2 0.0 0.6 0.0 5.0 0.0 1.9 0.0 0.0 0.3 1.1 0.6 1.5 0.0 0.3 0.5 0.2 0.1 0.1 112.3 0.0 0.4 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;brain: 16.2" "Group enriched" "Detected in some" 20 "Intestinal endocrine cells: 9.2;T-cells: 36.2" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 10.7;NK-cell: 32.8" "Group enriched" "Detected in many" 92 "NK-cells: 32.8;T-cells: 10.7" "Cell line enhanced" "Detected in some" "GAMG: 17.9;HEL: 5.3;HeLa: 16.4;HSkMC: 4.0" HPA058052 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058052: AB_2683589" "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.5 0.2 8.2 0.6 4.6 2.8 1.1 1.2 16.2 0.4 1.9 2.3 0.1 1.0 1.4 1.0 0.8 0.6 1.7 0.2 6.1 5.4 0.1 1.1 1.4 1.5 6.2 2.6 1.5 0.1 0.0 0.1 0.6 3.7 0.3 1.3 0.1 0.5 0.3 0.1 0.2 1.8 0.1 4.1 8.1 3.2 0.5 1.7 2.2 0.2 0.1 2.0 1.2 0.1 0.0 0.0 0.2 0.0 32.8 10.7 1.7 0.0 0.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 17.9 0.0 0.0 2.0 0.0 0.0 0.0 5.3 16.4 0.3 0.0 0.5 0.0 4.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.1 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.5 2.7 0.1 0.1 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 3.7 0.2 32.8 0.0 0.0 0.0 1.7 8.2 4.6 1.2 3.6 6.1 5.4 6.2 2.6 3.7 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in some" 19 "Club cells: 1.2;Intestinal endocrine cells: 1.7;T-cells: 1.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;GAMG: 5.1;HEL: 2.2;HeLa: 11.6;HSkMC: 2.2;SuSa: 2.8;U-698: 3.2" "HPA039910, HPA062570" Approved Uncertain Vesicles NA NA Vesicles "HPA039910: , HPA062570: AB_2684795" "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.6 0.1 0.0 0.2 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 KLRC4 NKG2-F ENSG00000183542 "Killer cell lectin like receptor C4" O43908 12 10407382-10409757 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 9.3;lymphoid tissue: 11.8" "Cell type enriched" "Detected in some" 4 "T-cells: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 20 "gdT-cell: 9.3;memory CD8 T-cell: 6.5;naive CD8 T-cell: 7.5;NK-cell: 5.4" "Group enriched" "Detected in many" 67 "NK-cells: 5.4;T-cells: 9.3" "Cell line enhanced" "Detected in some" "HeLa: 9.7;HSkMC: 1.9;SuSa: 3.9;U-698: 3.5" NA NA "unprognostic (3.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.60e-1)" "unprognostic (7.00e-2)" "unprognostic (1.55e-4)" "unprognostic (1.89e-2)" "unprognostic (1.52e-1)" "unprognostic (3.32e-1)" "unprognostic (2.92e-1)" "unprognostic (4.36e-1)" "unprognostic (3.44e-7)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (5.51e-3)" 1.6 0.8 2.3 2.5 1.6 1.6 1.7 1.3 3.9 5.0 2.6 0.6 0.6 1.4 0.9 0.6 0.8 1.0 2.8 0.6 2.6 1.5 3.7 1.9 3.5 5.6 1.9 0.6 0.6 0.6 0.0 0.6 1.3 1.5 1.1 1.6 2.1 1.2 3.8 0.6 0.3 4.2 0.6 2.0 11.8 2.6 0.6 0.6 1.2 1.5 0.6 6.9 2.1 1.1 0.0 0.0 0.1 0.0 5.4 9.3 1.5 0.0 0.2 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.5 9.7 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.3 0.0 0.0 6.5 0.0 0.0 0.0 7.5 0.1 5.4 0.0 0.0 0.0 1.5 2.3 1.6 1.3 1.4 2.6 1.5 1.9 0.6 1.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 KLRD1 CD94 ENSG00000134539 "Killer cell lectin like receptor D1" Q13241 12 10226058-10329600 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 85.5;lymphoid tissue: 31.0;pituitary gland: 44.6" "Cell type enriched" "Detected in many" 26 "T-cells: 450.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 67.2;memory CD8 T-cell: 28.0;naive CD8 T-cell: 30.3;NK-cell: 85.5" "Group enriched" "Detected in many" 63 "NK-cells: 85.5;T-cells: 67.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA069688 Uncertain NA NA "HPA069688: AB_2686170" "unprognostic (3.75e-2)" "unprognostic (2.15e-3)" "unprognostic (4.95e-2)" "unprognostic (2.48e-3)" "unprognostic (2.13e-2)" "unprognostic (2.60e-3)" "unprognostic (2.26e-2)" "unprognostic (1.13e-1)" "unprognostic (8.94e-3)" "unprognostic (4.53e-3)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.47e-3)" "unprognostic (1.78e-1)" "unprognostic (3.07e-1)" "unprognostic (3.06e-1)" "unprognostic (1.37e-2)" 5.2 1.3 0.9 6.4 1.1 6.9 1.7 0.8 0.9 1.4 2.7 0.6 0.2 1.5 3.3 1.9 2.0 1.1 1.5 1.7 1.0 1.0 1.5 3.7 12.3 10.2 3.8 0.7 0.9 1.9 0.0 44.6 2.3 0.8 2.0 0.9 2.1 1.2 0.5 1.1 0.8 10.6 0.5 2.6 31.0 1.8 1.4 0.4 2.2 1.3 0.3 3.6 6.3 1.3 0.1 0.2 1.2 0.2 85.5 67.2 16.2 0.9 0.7 1.1 1.5 1.5 0.6 0.9 2.3 0.1 0.2 0.7 1.4 1.0 1.3 1.1 1.9 0.8 1.1 0.5 1.3 0.2 2.2 2.8 1.7 2.6 0.6 2.7 1.1 2.2 0.7 1.7 0.4 1.2 1.3 0.3 1.2 1.0 4.9 0.3 1.9 1.0 1.3 1.8 0.8 1.4 0.6 1.6 1.2 0.7 2.1 2.4 1.2 1.1 2.2 0.5 3.1 0.8 2.1 1.7 1.8 3.1 1.5 0.7 2.0 1.8 1.1 2.6 1.6 1.6 0.1 0.1 0.1 67.2 0.2 7.6 0.1 0.4 28.0 0.2 0.1 0.1 30.3 1.2 85.5 0.1 0.2 0.1 16.2 0.9 1.1 0.8 0.9 1.0 1.0 3.8 0.7 0.8 0.4 0.0 14.6 0.8 1.0 0.5 0.7 2.0 5.1 2.7 3.4 0.0 5.9 1.2 0.0 0.2 5.9 3.4 0.0 0.0 0.0 0.8 1.9 1.2 2.3 2.1 0.7 1.6 0.0 13.5 17.1 9.8 0.3 1.7 5.0 0.0 0.0 0.6 0.0 0.0 0.7 1.0 0.9 0.0 0.9 1.2 3.4 0.5 0.7 450.1 0.0 1.0 KLRF1 "CLEC5C, NKp80" ENSG00000150045 "Killer cell lectin like receptor F1" Q9NZS2 12 9827481-9845007 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 95.2;lymphoid tissue: 24.7" "Cell type enriched" "Detected in many" 10 "T-cells: 119.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "NK-cell: 95.2" "Lineage enriched" "Detected in many" 6 "NK-cells: 95.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;CAPAN-2: 1.9;HAP1: 3.0;U-937: 9.5" "Low region specificity" "Detected in some" HPA054038 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054038: " "unprognostic (2.96e-1)" "unprognostic (8.59e-2)" "unprognostic (3.18e-2)" "unprognostic (2.95e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-4)" "unprognostic (6.06e-2)" "unprognostic (3.68e-2)" "unprognostic (9.95e-3)" "unprognostic (3.00e-1)" "unprognostic (2.90e-1)" "unprognostic (4.43e-2)" "unprognostic (6.53e-2)" "unprognostic (4.64e-2)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (8.89e-3)" 3.3 0.7 0.9 3.0 1.2 8.8 1.4 0.6 0.8 1.0 0.6 0.3 0.1 0.0 0.7 3.3 0.8 1.1 0.9 1.0 1.0 0.8 0.8 5.8 10.0 4.0 0.9 0.7 0.7 1.1 0.0 0.9 1.7 0.4 1.5 0.5 0.9 1.5 0.8 1.3 0.8 1.0 0.5 1.0 24.7 0.7 1.0 0.4 2.0 0.8 0.5 2.8 1.0 0.7 0.4 0.3 0.9 0.2 95.2 14.9 11.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 3.3 0.0 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.1 0.1 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.5 1.4 0.0 0.1 0.1 11.6 0.2 14.9 0.4 0.6 5.5 0.2 0.1 0.2 5.8 0.9 95.2 0.1 0.3 0.1 11.1 0.9 1.2 0.6 0.8 1.0 0.8 0.9 0.7 0.4 0.4 0.0 2.1 0.0 1.1 1.3 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.8 8.3 0.2 0.4 1.2 0.0 0.0 0.2 0.5 0.7 0.6 1.1 0.9 1.2 0.0 0.0 8.0 10.1 0.9 0.0 1.4 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.1 1.5 1.0 0.5 119.3 0.2 2.1 KLRF2 NKp65 ENSG00000256797 "Killer cell lectin like receptor F2" D3W0D1 12 9881489-9895833 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.0;skin 1: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 56 "NK-cell: 5.2;plasmacytoid DC: 6.0" "Group enriched" "Detected in many" 56 "dendritic cells: 6.0;NK-cells: 5.2" "Cell line enriched" "Detected in single" 47 "U-937: 26.5" NA NA "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (6.24e-2)" "unprognostic (1.63e-1)" "unprognostic (5.57e-2)" "unprognostic (3.40e-5)" "unprognostic (9.03e-2)" "unprognostic (3.16e-1)" 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.9 0.3 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.6 3.9 0.0 0.0 0.1 0.0 0.0 0.1 2.2 0.0 0.6 0.2 0.5 2.9 0.0 0.0 16.7 2.4 0.0 0.1 0.7 0.1 0.4 0.0 0.0 0.5 0.0 1.2 0.1 0.1 0.0 6.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 83.1" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 23.3;granulocytes: 113.5;T-cells: 58.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 71.3;MAIT T-cell: 83.1" "Lineage enriched" "Detected in many" 28 "T-cells: 83.1" "Group enriched" "Detected in many" 5 "HEL: 23.6;HUVEC TERT2: 8.3;NTERA-2: 16.2;U-937: 14.8" "Low region specificity" "Detected in some" "HPA051403, HPA076494" Approved Enhanced Vesicles NA NA Vesicles "HPA051403: , HPA076494: AB_2686800" "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 15.4 3.9 4.4 7.3 5.8 5.6 5.7 12.3 5.0 3.2 3.5 7.1 0.8 1.7 5.6 4.2 2.2 2.6 7.7 5.1 4.4 5.8 3.2 6.4 5.5 17.3 8.3 3.4 2.7 1.9 1.5 5.6 1.5 5.5 4.8 4.7 5.6 3.5 1.8 3.1 2.2 5.0 3.9 5.5 19.0 3.6 2.2 6.8 6.8 2.9 2.3 11.1 8.3 2.6 0.5 1.3 2.4 0.6 2.9 83.1 14.0 0.1 2.2 1.2 1.7 2.0 0.4 1.1 0.3 0.3 0.2 0.7 0.8 0.7 3.1 0.1 0.3 1.6 0.2 2.9 0.3 0.3 2.3 1.5 23.6 0.3 1.2 0.6 0.8 1.2 1.4 0.3 0.4 0.0 0.4 8.3 1.8 1.0 0.3 0.2 0.5 0.5 1.6 16.2 0.8 1.5 0.9 0.7 0.0 0.3 0.3 0.4 3.2 0.7 0.4 0.9 3.1 0.2 1.1 0.6 0.5 0.7 0.4 1.0 1.0 2.8 1.8 1.4 14.8 0.2 2.4 0.3 0.2 71.3 0.4 83.1 0.5 15.8 43.4 1.3 0.5 4.3 29.9 0.9 2.9 0.6 0.5 1.2 14.0 4.4 5.8 12.3 5.0 4.4 5.8 8.3 3.4 5.5 6.8 0.0 7.0 4.7 0.4 0.3 4.1 2.5 0.0 0.0 0.0 0.0 7.9 0.8 1.7 0.5 1.7 1.6 0.0 23.3 0.2 0.3 0.4 0.2 113.5 1.8 3.0 4.8 1.2 16.0 5.9 2.0 0.6 1.7 1.7 1.0 0.0 1.5 0.2 0.0 0.0 2.2 3.5 0.0 0.5 1.6 4.3 0.0 0.2 58.9 0.6 0.0 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 9.7;thyroid gland: 22.1" "Group enriched" "Detected in some" 6 "Collecting duct cells: 7.0;Extravillous trophoblasts: 1.8;Syncytiotrophoblasts: 6.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 11.2;HAP1: 11.8;NTERA-2: 6.2;SCLC-21H: 5.6;SK-BR-3: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favorable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.2 0.1 0.0 0.0 0.3 0.0 2.4 0.0 0.8 1.0 0.0 0.2 0.0 0.0 0.2 0.7 7.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 6.2 0.0 0.1 0.0 0.0 0.2 6.5 0.9 0.7 0.3 0.2 0.1 0.3 9.7 0.3 0.1 4.7 0.0 1.5 1.4 0.0 0.2 2.3 0.0 0.9 22.1 2.6 2.3 0.8 2.4 0.4 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.3 0.0 0.0 1.7 11.8 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.1 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.0 1.8 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.4 0.1 5.6 0.3 1.7 23.9 0.0 4.8 5.3 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.3 0.0 0.0 0.0 7.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 6.4 0.0 0.0 0.3 KLRK1 "CD314, D12S2489E, KLR, NKG2-D, NKG2D" ENSG00000213809 "Killer cell lectin like receptor K1" P26718 12 10372353-10391874 "Cancer-related genes, CD markers, Predicted membrane proteins, Transporters" "Adaptive immunity, Differentiation, Immunity, Innate immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;lymphoid tissue: 30.7" "Cell type enriched" "Detected in some" 9 "T-cells: 20.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 39 "gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8" "Group enriched" "Detected in many" 47 "NK-cells: 50.8;T-cells: 49.4" "Cell line enriched" "Detected in some" 8 "U-698: 36.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB021896, HPA068877" Enhanced Supported "Plasma membrane" NA NA 33000 "Plasma membrane" "CAB021896: , HPA068877: AB_2686052" "unprognostic (3.34e-4)" "unprognostic (2.65e-4)" "unprognostic (3.25e-1)" "unprognostic (2.59e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-5)" "unprognostic (5.61e-4)" "unprognostic (1.00e-3)" "unprognostic (1.33e-1)" "unprognostic (9.22e-2)" "unprognostic (1.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-10)" "unprognostic (1.24e-2)" "unprognostic (6.32e-2)" "unprognostic (7.59e-2)" "unprognostic (7.08e-10)" 4.1 0.9 1.3 18.3 1.1 10.6 2.1 0.4 0.8 2.8 4.5 1.2 0.6 2.0 2.4 2.7 3.1 2.0 7.7 1.3 1.3 1.1 2.4 3.6 13.6 22.2 2.1 0.1 1.5 3.3 0.0 1.2 1.6 1.2 2.2 2.1 2.4 7.0 0.6 0.5 1.1 13.1 1.3 2.1 30.7 3.3 1.9 0.6 6.0 2.9 2.8 11.4 11.3 2.5 1.0 0.2 0.8 0.1 50.8 49.4 16.7 0.2 0.0 0.4 1.9 0.1 4.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.4 0.7 0.0 0.2 0.0 0.2 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.2 0.0 0.0 0.0 49.4 0.1 18.5 0.8 0.3 44.0 0.1 1.0 0.4 44.3 0.8 50.8 0.1 0.2 0.1 16.7 1.3 1.1 0.4 0.8 1.3 1.1 2.1 0.1 1.2 0.6 0.0 2.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.3 0.0 0.0 KMO ENSG00000117009 "Kynurenine 3-monooxygenase" O15229 1 241532134-241595642 "Enzymes, Predicted membrane proteins" "Pyridine nucleotide biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;liver: 58.6;placenta: 26.0" "Cell type enhanced" "Detected in many" 23 "Hepatocytes: 43.2;Proximal tubular cells: 45.1;Syncytiotrophoblasts: 150.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 79 "classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1" "Group enriched" "Detected in many" 97 "B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7" "Cell line enhanced" "Detected in some" "Daudi: 5.4;RPMI-8226: 7.8;RPTEC TERT1: 20.0;SK-BR-3: 10.4;U-698: 8.3" "Region enriched" "Detected in single" 4 "thalamus: 1.3" "Not detected" "Not detected" "HPA031115, HPA056942" Enhanced NA NA "HPA031115: AB_10601924, HPA056942: AB_2683281" "unprognostic (4.27e-2)" "unprognostic (3.35e-2)" "unprognostic (3.95e-2)" "unprognostic (7.48e-3)" "unprognostic (8.37e-3)" "unprognostic (2.63e-1)" "unprognostic (9.79e-2)" "unprognostic (3.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.75e-3)" "unprognostic (8.07e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.49e-8)" "unprognostic (1.60e-2)" "unprognostic (3.65e-2)" "unprognostic (3.36e-2)" "unprognostic (6.81e-2)" 3.7 0.6 0.5 3.3 0.6 0.3 2.4 0.2 0.9 0.3 0.4 0.2 0.0 0.0 2.7 0.1 0.3 0.4 0.5 0.4 0.8 0.4 14.2 58.6 6.5 3.2 0.3 0.3 0.4 0.3 0.0 0.4 26.0 0.3 0.4 0.3 0.3 0.5 0.0 0.2 0.3 1.0 0.1 0.5 8.0 0.4 0.6 0.1 0.7 0.4 0.1 4.5 1.4 0.3 20.3 11.1 0.1 14.7 0.0 0.0 2.8 0.1 1.6 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.4 0.0 0.2 5.4 0.4 0.0 0.1 2.2 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.2 0.7 0.1 0.1 0.5 0.0 0.4 0.1 0.8 0.0 0.2 0.0 2.3 0.9 0.8 0.4 1.4 0.1 7.8 20.0 4.1 0.3 0.1 0.0 10.4 0.0 2.1 4.0 1.7 0.0 0.0 0.1 0.1 1.4 0.3 0.5 8.3 0.2 2.0 1.6 0.0 5.2 0.1 0.0 14.7 0.0 16.1 0.0 0.0 5.3 20.3 0.0 0.0 0.1 0.0 14.7 11.1 0.0 2.8 0.5 0.6 0.2 0.9 0.8 0.4 0.3 0.3 0.3 0.1 0.0 0.3 22.3 0.0 0.9 0.0 0.4 2.5 0.0 0.0 0.0 0.0 3.0 5.0 2.2 3.5 0.0 0.0 0.0 0.2 1.6 0.5 0.3 0.0 43.2 7.1 0.0 0.0 1.3 17.4 0.4 0.0 18.4 0.0 3.6 0.0 0.0 2.5 0.0 0.0 45.1 0.0 0.0 0.0 0.5 0.1 1.3 150.6 0.0 0.0 0.0 KNCN "FLJ32011, KINO, L5" ENSG00000162456 Kinocilin A6PVL3 1 46545644-46551527 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.9;pituitary gland: 1.0;testis: 2.5" "Group enriched" "Detected in some" 41 "Early spermatids: 10.4;Late spermatids: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (6.99e-3)" "unprognostic (2.28e-2)" "unprognostic (2.80e-2)" 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160447-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 7.0;Ciliated cells: 22.7;Club cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.4;non-classical monocyte: 3.1" "Lineage enriched" "Detected in single" 10 "monocytes: 3.1" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;EFO-21: 2.9;MCF7: 2.6;NTERA-2: 3.6;RPMI-8226: 5.0;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039624, HPA056143" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" Vesicles "HPA039624: AB_10671045, HPA056143: " "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 1.1 11.4 14.7 1.2 13.2 1.0 1.2 23.9 26.2 2.1 1.1 5.4 0.0 1.1 3.9 2.7 1.0 14.6 1.5 1.2 11.3 12.1 1.5 5.5 4.2 1.1 8.3 13.2 10.9 2.1 1.0 13.2 1.9 8.5 2.0 1.1 0.7 2.5 3.2 1.2 1.2 1.2 1.9 3.2 1.7 1.4 2.8 3.5 0.0 2.4 0.0 1.1 1.1 0.3 0.3 0.0 0.0 3.1 0.0 0.0 0.1 0.6 0.9 0.5 4.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 1.5 0.6 0.0 2.9 0.3 1.4 0.6 0.1 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 3.6 0.1 0.0 0.0 0.1 5.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 4.9 0.4 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 14.7 13.2 23.9 25.2 11.3 12.1 8.3 13.2 8.5 3.5 0.0 7.0 0.0 0.0 0.0 0.8 2.0 2.5 22.7 6.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 4.3 0.2 1.6 2.9 0.0 1.0 0.8 3.4 0.4 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 KNG1 "BDK, BK, KNG" ENSG00000113889 "Kininogen 1" P01042 3 186717276-186744410 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis, Inflammatory response" "Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 323.8" "Group enriched" "Detected in some" 22 "Distal tubular cells: 555.4;Hepatocytes: 1509.4" "Cancer enriched" "Detected in some" 126 "liver cancer: 608.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 5.2;Hep G2: 4.5;HL-60: 2.4;RH-30: 4.0;SiHa: 2.7" "Low region specificity" "Detected in some" "HPA001616, HPA001645, CAB009809" Enhanced "Secreted to blood" NA NA 90000000000 64000000000 "CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215" "unprognostic (3.88e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-1)" "unprognostic (3.27e-1)" "unprognostic (8.30e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.28e-6)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (9.96e-2)" "unprognostic (1.65e-1)" "unprognostic (3.45e-3)" "unprognostic (5.20e-2)" "unprognostic (2.46e-1)" "unprognostic (4.52e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 41.9 323.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.4 2.3 0.2 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 1.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.1 4.5 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.7 0.1 0.0 0.1 4.0 0.0 0.2 0.0 0.5 0.1 2.7 0.4 0.0 1.5 0.1 0.0 0.9 0.0 0.2 0.0 0.0 1.0 0.0 1.9 0.0 2.0 0.0 2.3 0.2 0.3 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.5 0.1 0.2 1.6 0.7 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 23.2 0.0 0.0 0.0 0.4 38.2 0.0 0.0 31.4 0.0 0.0 555.4 0.0 0.3 0.0 0.5 46.7 0.0 0.0 0.0 0.0 0.0 1509.4 0.1 0.0 0.0 25.2 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 54.7;testis: 35.6" "Cell type enhanced" "Detected in some" 12 "Club cells: 3.4;Extravillous trophoblasts: 9.3;Hofbauer cells: 5.6;Proximal tubular cells: 8.4;Syncytiotrophoblasts: 3.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.7 0.5 0.3 7.1 0.4 5.4 0.7 0.3 0.3 0.6 4.0 0.1 0.0 1.5 0.4 0.8 3.9 0.4 0.9 0.5 0.4 0.4 0.9 1.0 1.3 4.7 0.3 0.0 0.5 0.5 0.0 0.4 2.8 0.1 0.5 1.5 0.0 0.8 0.0 0.4 0.8 3.9 0.5 0.4 3.3 0.8 35.6 0.0 54.7 0.5 4.1 3.7 0.7 0.9 2.9 1.2 0.7 0.5 0.7 2.5 0.0 10.9 5.6 11.5 8.3 0.3 1.7 5.1 12.8 5.2 10.0 8.5 6.9 4.4 7.3 4.1 5.5 7.6 13.7 10.8 6.0 10.6 12.6 3.0 21.4 9.6 2.0 0.0 16.3 10.8 0.3 0.2 6.7 4.2 1.3 8.5 13.0 13.7 12.2 11.7 3.7 13.9 3.3 5.6 6.6 6.0 12.7 16.5 3.6 1.5 9.7 9.9 4.6 11.1 6.3 1.3 3.8 6.8 5.0 7.9 11.7 10.4 13.4 7.1 4.7 15.9 14.2 4.7 11.1 11.1 0.4 0.2 0.1 0.1 0.1 0.0 2.9 1.1 0.1 1.2 2.2 0.0 0.7 0.7 0.7 0.5 0.1 2.5 0.0 0.3 0.4 0.3 0.3 0.4 0.4 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 3.4 1.8 0.0 2.4 1.7 0.2 0.0 0.0 0.0 0.0 0.5 9.3 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin/SPAG5 binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8" "Group enriched" "Detected in many" 4 "Early spermatids: 321.9;Late spermatids: 423.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes Yes "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 5.5 4.4 6.7 5.5 6.3 7.3 9.0 8.1 7.0 3.3 4.5 4.0 8.0 5.3 3.9 7.8 6.2 3.4 2.5 4.1 6.0 5.3 4.2 7.0 4.1 8.0 4.6 7.1 3.4 3.5 6.0 4.2 7.4 6.8 4.4 6.3 2.5 6.4 5.0 7.5 4.2 4.1 5.9 4.3 4.8 6.2 40.1 4.5 18.4 59.8 6.0 9.1 3.8 3.7 5.9 11.0 10.0 26.2 5.5 5.5 4.0 31.2 14.7 29.4 19.2 6.5 10.1 15.3 21.7 16.9 44.9 39.7 31.5 13.8 12.1 11.1 14.6 35.8 36.2 31.3 20.1 40.7 21.5 15.3 35.9 33.0 19.8 6.1 19.2 18.8 5.2 11.6 22.6 22.7 11.0 25.1 30.5 25.8 21.0 37.7 15.8 16.6 15.5 18.5 26.8 22.4 17.1 22.1 14.0 15.6 13.0 28.7 19.9 18.1 20.0 4.8 18.6 20.9 13.8 12.9 21.7 22.2 22.1 30.0 18.0 29.1 21.8 13.4 25.8 17.7 4.8 10.3 10.0 4.8 14.5 4.4 5.9 3.6 4.4 11.0 5.4 3.5 3.6 5.9 5.5 26.2 7.5 5.5 4.0 6.7 6.3 8.1 7.0 6.0 5.3 4.6 7.1 6.8 4.5 8.9 0.6 0.8 3.1 1.9 7.8 4.7 2.5 9.4 5.7 0.0 7.9 14.3 3.3 9.5 321.9 1.7 1.6 46.7 8.1 35.4 6.2 3.8 1.1 5.7 18.4 4.8 2.4 3.1 7.5 423.6 8.3 7.6 3.3 8.2 3.6 7.0 8.7 0.0 6.7 4.4 7.4 0.0 2.7 83.7 18.1 1.3 17.6 3.2 3.0 2.8 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 23.5;Erythroid cells: 23.3;Spermatocytes: 24.6;Spermatogonia: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favorable (8.69e-4)" "prognostic unfavorable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 5.6 5.6 4.5 15.3 5.4 28.9 5.8 7.5 5.6 5.2 6.4 2.7 3.9 7.0 5.4 5.5 9.6 4.9 2.9 2.9 4.6 1.8 4.9 4.5 5.8 11.8 4.0 3.8 6.7 4.9 3.5 5.9 8.1 3.6 5.3 9.7 3.9 6.1 2.8 1.6 11.7 10.9 7.7 3.1 14.1 5.5 23.2 2.8 39.6 4.0 7.0 15.6 4.4 6.6 4.8 2.1 5.0 2.6 2.2 3.6 0.8 13.1 11.0 31.7 7.3 2.5 4.5 14.3 12.2 7.9 12.1 11.5 10.4 11.1 15.8 6.4 5.9 8.0 18.2 13.7 7.6 16.1 11.2 9.5 19.4 20.5 10.6 0.8 19.0 13.4 2.4 1.7 12.5 8.3 6.3 8.2 20.2 19.3 11.9 9.1 9.7 15.7 44.1 16.0 6.4 13.9 21.6 15.4 17.5 7.2 14.1 9.8 12.7 22.2 4.7 6.5 19.7 17.9 11.0 6.0 13.9 13.3 13.5 14.2 16.1 16.1 24.3 8.3 12.4 15.8 5.0 1.4 4.6 2.0 1.9 1.8 4.8 3.3 3.6 1.3 3.0 2.5 2.9 4.4 2.2 2.6 2.1 1.4 0.8 4.5 5.4 7.5 5.6 4.6 1.8 4.0 3.8 3.6 2.8 0.0 1.6 6.0 1.2 3.8 2.5 1.2 0.0 6.7 2.3 5.2 3.9 5.0 0.0 1.2 23.5 2.1 1.0 23.3 0.3 5.0 2.1 0.8 1.1 0.9 4.0 0.0 0.0 1.3 2.4 13.7 4.4 3.1 1.7 1.8 1.2 0.9 0.7 0.0 2.8 0.3 3.6 6.5 1.4 24.6 35.8 1.9 2.4 3.3 5.2 0.6 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421949-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.4" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 145.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053627: AB_2682211, HPA063426: AB_2685013" "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 15.4 16.9 15.1 14.4 15.5 7.6 17.8 14.6 19.3 11.8 13.6 12.0 9.0 9.9 14.4 12.3 17.2 10.8 9.6 18.7 13.9 11.6 13.1 24.6 12.5 11.2 14.4 16.8 10.8 14.5 19.6 13.8 13.6 16.5 12.3 12.3 8.6 13.2 15.1 89.4 13.1 11.3 17.7 15.8 10.9 12.3 15.2 13.5 12.4 14.1 10.9 15.3 14.5 13.6 11.4 17.3 29.3 18.2 13.5 13.9 10.9 29.9 17.8 30.7 15.5 20.0 22.1 9.7 23.2 19.7 25.5 23.1 21.4 14.7 21.9 21.4 25.5 20.2 15.8 24.0 19.8 37.7 5.9 9.1 26.9 16.0 11.9 11.7 23.8 12.4 15.3 25.8 18.3 25.8 12.5 27.8 11.9 18.8 12.7 23.1 14.0 17.2 5.7 13.3 21.2 19.2 17.7 25.5 14.0 11.1 21.1 21.2 12.8 24.9 13.6 20.2 25.1 18.0 14.1 23.7 16.0 17.6 7.8 17.9 12.2 12.3 40.7 22.4 16.7 16.2 15.7 13.1 12.5 12.6 13.4 13.5 11.4 11.2 13.9 17.3 8.8 11.6 11.8 29.3 13.5 18.2 5.5 11.8 10.9 15.1 15.5 14.6 16.7 13.9 11.6 14.4 16.8 16.5 13.5 14.9 28.5 15.2 21.0 36.9 27.4 26.5 25.5 46.8 42.1 14.0 29.5 18.8 11.6 21.1 89.9 29.2 15.5 46.7 28.8 20.9 21.6 27.0 38.1 43.9 20.5 19.1 15.6 26.4 29.7 145.2 20.8 25.2 16.9 25.2 17.0 23.9 27.4 17.5 23.3 16.7 47.9 12.9 33.5 30.1 16.6 39.6 20.8 27.3 10.7 24.2 KPNA2 "IPOA1, QIP2, RCH1, SRP1alpha" ENSG00000182481 "Karyopherin subunit alpha 2" P52292 17 68035519-68046842 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.9" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 663.6;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015460, HPA041270" Enhanced Enhanced Nucleoplasm,Cytosol Yes Yes 38000 Nucleoplasm Cytosol "CAB015460: AB_831493, HPA041270: AB_2677385" "unprognostic (2.78e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.83e-4)" "unprognostic (2.14e-2)" "unprognostic (1.64e-1)" "unprognostic (5.16e-3)" "prognostic unfavorable (2.12e-10)" "prognostic unfavorable (5.77e-4)" "unprognostic (3.34e-2)" "unprognostic (7.59e-2)" "unprognostic (3.72e-3)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.26e-13)" "unprognostic (3.07e-2)" "unprognostic (1.78e-1)" "unprognostic (9.50e-2)" "prognostic unfavorable (2.19e-4)" 10.6 8.3 10.2 19.5 12.0 38.6 11.9 6.1 13.2 7.4 11.5 6.6 4.3 10.1 8.3 10.4 21.1 6.3 7.9 8.9 11.6 13.2 10.9 11.8 9.1 25.5 10.3 10.3 5.3 4.7 4.5 8.4 16.4 11.4 4.6 14.5 4.0 8.2 4.7 7.2 8.7 10.2 13.2 8.5 14.8 9.7 103.9 9.0 56.6 5.9 20.3 36.8 10.0 8.3 24.6 28.1 16.4 22.6 20.3 17.7 15.0 62.2 81.9 78.2 31.3 11.6 11.3 49.7 55.0 42.7 88.9 69.4 56.3 29.2 58.5 17.4 31.7 44.3 34.5 86.4 42.9 102.4 23.5 50.9 51.8 39.6 53.7 12.2 44.5 35.7 7.0 8.1 51.1 31.5 12.5 85.5 25.0 41.1 42.3 78.8 58.1 55.5 28.7 52.8 50.8 42.5 30.7 71.4 32.0 35.0 29.2 31.1 34.6 30.9 99.8 32.3 74.7 58.1 22.4 33.3 49.3 61.0 34.7 73.9 35.1 50.2 58.4 24.0 38.3 52.9 16.4 16.1 6.6 14.1 22.6 10.9 24.6 10.3 14.4 28.1 19.7 7.9 12.3 1.2 20.3 18.9 21.4 17.7 15.0 10.2 12.0 6.1 13.2 11.6 13.2 10.3 10.3 11.4 9.0 11.9 32.3 47.6 33.0 97.4 19.1 12.6 7.6 8.1 18.2 17.4 7.9 59.0 13.3 31.3 663.6 49.2 9.8 70.0 22.3 244.0 94.4 18.1 43.8 15.3 104.7 30.2 41.1 16.0 36.5 186.9 17.8 52.4 50.6 104.6 9.7 29.4 18.3 10.5 13.8 26.9 17.8 32.3 72.6 296.7 211.0 77.3 99.4 34.5 15.8 20.4 KPNA3 "hSRP1, IPOA4, SRP1gamma, SRP4" ENSG00000102753 "Karyopherin subunit alpha 3" O00505 13 49699307-49792921 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 71.8" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 254.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046852, HPA077643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA046852: AB_2679840, HPA077643: " "unprognostic (4.20e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (3.69e-2)" "unprognostic (1.23e-1)" "prognostic favorable (2.03e-4)" "unprognostic (6.27e-3)" "unprognostic (6.79e-2)" "unprognostic (9.40e-3)" "unprognostic (1.56e-2)" "unprognostic (4.57e-3)" "unprognostic (3.93e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.78e-2)" "unprognostic (7.83e-2)" "unprognostic (5.68e-3)" "unprognostic (4.60e-3)" 12.4 8.0 15.2 9.1 11.8 14.1 12.4 10.9 14.4 8.5 11.4 7.5 8.1 7.0 9.5 6.8 14.5 7.3 8.4 17.2 12.3 11.4 8.0 13.6 9.6 9.4 11.1 11.4 8.1 6.3 9.1 8.1 8.3 13.0 9.4 9.7 5.9 8.3 11.4 71.8 9.0 8.5 14.3 13.2 8.1 8.3 15.1 11.8 11.4 10.9 14.6 10.8 15.0 16.3 6.0 5.0 7.6 6.8 8.1 12.1 4.1 14.1 9.8 18.9 15.8 19.4 21.3 9.5 25.8 21.4 22.7 16.6 29.8 13.2 30.6 5.3 30.0 15.3 16.7 22.5 20.7 38.0 18.3 15.8 22.4 9.7 34.6 18.9 33.4 14.6 15.6 15.1 19.0 25.1 15.0 28.0 12.9 12.3 8.3 31.2 6.5 17.9 18.2 21.8 19.8 6.9 23.5 18.6 9.3 13.9 11.8 7.9 12.6 9.4 11.8 10.2 16.4 7.0 13.5 25.4 16.8 13.7 15.3 17.1 6.7 9.4 27.0 10.2 15.5 16.6 7.6 4.6 4.3 8.6 5.5 12.1 6.0 8.8 8.4 5.0 4.0 8.8 7.9 2.8 8.1 6.8 2.9 10.1 4.1 15.2 11.8 10.9 14.4 12.3 11.4 11.1 11.4 13.0 11.8 62.5 29.8 19.7 23.8 38.2 22.9 70.2 10.2 37.5 25.0 12.2 31.4 13.2 14.9 42.7 254.1 35.9 17.7 23.3 46.6 15.0 28.3 24.7 32.3 33.4 29.7 49.3 29.2 35.0 34.0 136.0 20.4 32.3 18.6 37.9 17.6 46.9 45.4 10.5 47.0 20.9 62.4 25.8 29.3 52.1 29.9 43.5 8.8 27.7 20.2 28.7 KPNA4 "IPOA3, MGC12217, MGC26703, QIP1, SRP3" ENSG00000186432 "Karyopherin subunit alpha 4" O00629 3 160494995-160565588 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034336, HPA043154, HPA045500" Enhanced Enhanced Nucleoplasm NA NA 250000 Nucleoplasm "CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351" "unprognostic (1.58e-1)" "unprognostic (7.65e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (8.59e-4)" "unprognostic (7.56e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.24e-7)" "unprognostic (7.71e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.20e-1)" "unprognostic (1.21e-1)" "unprognostic (3.98e-2)" "unprognostic (2.21e-1)" "unprognostic (2.17e-3)" "unprognostic (1.48e-1)" 18.0 9.4 12.6 12.9 12.7 15.2 25.1 13.1 14.1 14.8 14.4 8.6 11.1 7.3 13.1 10.8 22.1 8.9 13.9 45.0 12.0 12.1 11.0 12.6 11.4 12.4 11.6 10.8 15.0 10.7 12.5 6.9 17.5 11.1 11.0 9.7 7.1 10.9 13.1 66.1 10.6 9.5 20.4 10.4 12.1 10.8 13.5 6.3 13.8 11.4 22.2 10.2 21.8 25.2 2.9 2.9 6.8 11.5 8.3 5.6 3.2 33.8 12.0 12.4 16.7 14.3 13.2 16.3 21.1 15.1 15.5 13.2 15.3 17.8 18.0 25.3 21.6 23.2 15.8 13.9 13.6 23.4 22.3 7.8 15.2 10.7 9.1 18.6 21.2 13.7 13.5 14.4 15.0 30.6 12.5 20.4 8.9 11.4 14.6 22.0 9.5 19.1 8.8 25.2 15.3 11.2 12.8 18.5 18.2 12.5 13.0 10.1 9.8 20.4 20.5 29.3 14.4 17.8 11.6 22.7 17.8 15.3 17.7 33.9 26.8 17.7 41.3 16.2 22.2 15.7 6.8 3.6 6.0 3.1 6.7 5.6 2.9 4.5 4.5 2.7 2.5 3.6 4.7 5.4 8.3 11.5 2.9 4.2 3.2 12.6 12.7 13.1 13.3 12.0 12.1 11.6 10.8 11.1 6.3 35.7 24.3 27.5 63.0 109.9 56.4 153.2 20.4 40.2 43.3 10.4 74.6 22.7 29.9 33.3 19.9 45.0 51.2 0.0 32.4 20.6 50.3 69.0 30.1 26.1 35.0 50.9 27.5 29.4 41.9 14.3 31.4 45.8 42.2 26.2 29.9 52.1 57.1 33.4 32.5 31.4 60.8 32.3 42.2 40.3 21.8 110.2 34.0 29.9 30.5 94.6 KPNA5 "IPOA6, SRP6" ENSG00000196911 "Karyopherin subunit alpha 5" O15131 6 116681187-116741866 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 211.4;Alveolar cells type 2: 181.5;Ciliated cells: 240.9;Club cells: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026464, HPA054037" Enhanced Supported Cytosol NA NA Cytosol "CAB026464: , HPA054037: AB_2682351" "unprognostic (9.64e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-2)" "unprognostic (3.56e-1)" "unprognostic (6.60e-3)" "unprognostic (6.98e-2)" "unprognostic (1.75e-3)" "unprognostic (5.19e-2)" "unprognostic (1.10e-1)" "unprognostic (6.12e-2)" "unprognostic (1.51e-3)" "unprognostic (3.02e-1)" "unprognostic (6.12e-2)" "unprognostic (8.00e-2)" "unprognostic (4.79e-1)" "unprognostic (7.89e-2)" "unprognostic (1.43e-1)" 5.7 6.5 11.9 5.9 12.8 7.5 7.6 24.1 21.2 8.6 6.0 4.3 3.4 4.0 11.2 5.3 6.1 9.8 6.5 5.8 11.0 8.1 6.6 3.6 7.2 10.7 9.0 13.5 22.3 4.4 9.5 19.7 5.6 14.1 8.4 4.5 5.7 4.7 7.1 14.0 4.7 5.6 8.5 12.0 7.4 4.8 46.6 8.2 10.9 12.2 3.9 7.3 6.4 7.4 18.0 10.5 11.9 4.0 6.3 16.6 2.9 2.5 1.5 11.0 6.8 4.2 7.9 4.5 3.8 10.6 6.7 9.5 7.1 2.6 9.2 5.0 4.1 7.6 4.2 5.8 3.4 8.7 5.8 15.8 8.8 4.6 4.0 5.2 6.8 5.5 7.0 2.1 8.2 4.8 7.9 7.6 9.3 12.9 4.0 7.4 3.4 10.5 4.7 4.9 1.7 4.1 8.7 3.6 2.6 5.1 5.0 11.5 11.0 2.9 2.3 3.6 7.5 4.6 6.7 6.0 2.8 5.7 2.9 6.6 10.4 11.3 10.7 3.1 4.8 5.8 11.9 3.1 3.7 8.8 3.2 10.9 14.9 10.0 10.3 1.6 18.0 16.6 12.1 0.8 6.3 4.0 10.5 7.3 2.9 11.9 12.8 24.1 21.2 11.0 8.1 9.0 13.5 14.1 8.2 211.4 181.5 19.3 7.0 12.0 45.3 13.6 10.2 240.9 211.5 8.7 27.5 3.3 8.3 5.3 34.2 15.8 1.4 0.0 4.7 1.5 10.8 7.1 119.7 4.2 3.8 44.5 32.4 16.0 5.4 5.9 16.4 10.4 10.1 4.6 6.8 34.6 4.2 0.0 15.6 4.2 36.7 12.9 7.2 60.3 9.8 7.9 2.7 12.5 3.5 2.6 KPNA7 IPOA8 ENSG00000185467 "Karyopherin subunit alpha 7" A9QM74 7 99173574-99207506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "stomach 1: 9.0" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 4.0;Ductal cells: 4.8;Exocrine glandular cells: 2.8;Pancreatic endocrine cells: 7.3;Urothelial cells: 8.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.7;CAPAN-2: 3.6;HaCaT: 2.0;OE19: 4.4;SK-BR-3: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA031395 Uncertain NA NA "HPA031395: AB_10601584" "unprognostic (7.38e-2)" "unprognostic (7.99e-2)" "unprognostic (2.23e-1)" "unprognostic (8.44e-2)" "unprognostic (8.37e-2)" "unprognostic (9.35e-2)" "unprognostic (9.77e-2)" "unprognostic (2.25e-2)" "unprognostic (2.30e-1)" "unprognostic (3.23e-1)" "unprognostic (7.94e-3)" "unprognostic (5.89e-2)" "unprognostic (2.28e-13)" "unprognostic (2.21e-2)" "unprognostic (1.23e-1)" "unprognostic (3.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.2 0.0 0.0 2.4 1.6 0.6 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.1 0.2 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.3 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.4 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.8 0.5 0.0 0.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.4 0.0 2.8 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 8.5 KPRP C1orf45 ENSG00000203786 "Keratinocyte proline rich protein" Q5T749 1 152759561-152762052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 72.4" "Cell type enriched" "Detected in some" 10 "Suprabasal keratinocytes: 17.6" "Group enriched" "Detected in some" 22 "head and neck cancer: 6.9;melanoma: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.0;hTEC/SVTERT24-B: 5.8;LHCN-M2: 1.9;U-2197: 3.5;U-87 MG: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031988, HPA031990" Enhanced NA NA 2700000 "HPA031988: AB_10671582, HPA031990: AB_2674102" "unprognostic (1.03e-1)" "unprognostic (2.67e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 72.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.8 0.9 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 30.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 8.9;Muller glia cells: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: AB_2681129" "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 3.8 4.6 5.6 6.2 8.1 4.7 5.6 8.7 12.8 5.2 5.2 7.6 11.0 2.2 7.8 4.9 5.5 5.2 5.8 30.6 6.7 5.2 5.3 2.2 4.5 5.7 6.3 9.0 7.9 7.0 9.7 16.9 3.1 7.1 6.0 1.9 9.4 17.2 9.5 7.4 6.4 3.6 8.5 5.1 6.4 5.0 5.7 6.5 2.5 4.3 5.5 4.8 5.0 5.3 4.1 3.7 1.3 3.7 0.3 4.2 1.7 6.2 3.9 7.8 16.2 3.5 3.5 6.8 3.3 4.2 5.4 6.2 0.4 1.7 1.9 7.1 4.2 11.0 6.2 5.8 11.2 2.7 8.7 11.0 3.5 5.0 3.6 4.4 0.0 9.8 7.7 5.3 3.7 2.0 6.4 4.9 10.5 14.1 2.0 2.7 2.4 9.0 5.3 9.3 2.9 3.8 9.5 3.1 1.0 4.1 5.0 6.2 10.4 5.1 14.9 3.5 3.7 2.6 5.4 5.0 6.6 2.9 0.0 4.6 9.6 3.1 8.4 3.9 6.0 6.8 0.0 1.8 0.4 3.8 1.7 2.6 1.8 1.9 2.2 2.6 4.1 3.4 2.9 1.3 0.3 3.7 3.7 4.2 1.7 5.6 8.1 8.7 12.8 6.7 5.2 6.3 9.0 7.1 6.5 0.0 2.7 1.5 2.1 1.5 6.3 8.9 0.0 0.0 0.0 3.5 3.9 0.9 0.0 4.5 0.5 0.9 0.0 0.0 2.3 1.9 2.3 2.2 0.0 0.8 4.2 7.9 0.0 0.6 3.0 0.9 3.7 1.1 0.0 1.0 0.0 11.2 1.2 0.0 3.2 1.5 4.4 6.5 1.7 0.7 3.6 1.6 1.0 1.0 0.0 1.5 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "placenta: 78.4;testis: 68.5" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 1048.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 9.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 9.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8" HPA046901 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA046901: AB_2797232" "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 1.1 1.8 1.6 0.3 2.1 0.3 1.4 2.1 2.3 1.9 1.6 1.8 1.2 0.8 2.6 5.4 2.1 1.9 1.2 2.3 1.4 1.2 1.4 0.3 0.7 0.7 1.4 1.2 3.2 2.3 0.3 1.9 78.4 1.6 1.6 1.0 2.3 2.1 2.7 0.5 2.5 1.0 2.3 1.8 0.7 1.1 68.5 0.6 0.2 2.5 1.1 0.8 1.2 1.1 0.8 1.7 1.2 1.2 9.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 10.6 0.0 0.0 0.0 22.9 0.0 11.2 0.8 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.5 0.0 16.1 10.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 8.2 0.0 31.8 0.0 3.4 1.1 0.0 1.7 0.0 0.6 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.9 0.0 9.0 1.2 1.7 0.5 0.2 1.6 2.1 2.1 2.3 1.4 1.2 1.4 1.2 1.6 0.6 0.0 1.6 0.0 2.5 0.0 6.5 4.8 5.1 1.4 3.4 5.2 2.0 9.4 16.6 4.1 134.8 0.4 0.7 0.0 10.5 8.6 1.6 1.5 0.0 0.5 2.0 1.6 0.0 1.3 0.0 72.9 18.7 0.0 0.0 0.0 0.8 12.4 6.2 1.9 12.7 1.7 7.4 12.9 3.3 1048.9 159.2 0.0 7.6 0.0 1.7 0.8 KREMEN2 "KRM2, MGC10791" ENSG00000131650 "Kringle containing transmembrane protein 2" Q8NCW0 16 2963944-2968383 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1;skin 1: 12.5" "Cell type enhanced" "Detected in some" 9 "Basal keratinocytes: 12.6;Cone photoreceptor cells: 5.9;Mucus-secreting cells: 9.5;Rod photoreceptor cells: 10.0;Spermatogonia: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 6 "B-cells: 3.2;monocytes: 1.4" "Cell line enhanced" "Detected in many" "HMC-1: 20.3;MCF7: 10.2;RPMI-8226: 19.1;T-47d: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA003223 Uncertain Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA003223: AB_1079217" "unprognostic (8.36e-2)" "unprognostic (4.65e-1)" "unprognostic (6.24e-3)" "unprognostic (4.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (4.02e-3)" "prognostic unfavorable (8.98e-4)" "unprognostic (3.34e-2)" "unprognostic (1.57e-2)" "unprognostic (8.03e-2)" "unprognostic (8.57e-2)" "unprognostic (7.79e-12)" "unprognostic (6.69e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-2)" "unprognostic (6.58e-3)" 0.2 0.1 1.6 2.0 0.7 1.7 0.2 0.2 3.0 1.8 0.4 0.2 4.5 0.3 0.3 0.8 3.8 0.6 0.3 0.2 1.9 0.3 0.2 0.2 0.2 0.8 0.7 0.2 0.2 0.4 0.0 0.2 0.2 0.3 1.6 0.0 1.9 1.6 0.2 0.6 12.5 0.6 0.2 1.7 0.9 0.5 2.1 0.2 13.1 0.2 1.8 6.8 0.2 0.6 3.2 0.3 0.0 1.4 0.0 0.0 0.0 1.2 0.8 0.3 7.3 0.0 0.0 1.1 0.4 0.0 0.0 0.0 2.9 1.1 5.3 1.5 0.0 0.8 6.0 0.9 0.5 0.0 0.8 0.8 0.3 1.7 1.7 0.0 0.4 20.3 0.2 0.0 0.0 0.1 0.6 0.0 0.6 2.1 2.1 0.0 10.2 1.2 2.4 2.0 2.1 1.5 3.2 8.3 19.1 0.0 0.2 2.1 1.2 1.4 3.3 3.3 0.2 10.3 1.9 0.1 0.6 8.9 0.7 0.5 3.8 0.8 3.2 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.7 0.2 2.3 1.9 0.3 0.7 0.2 0.3 0.2 0.0 0.0 0.0 0.6 12.6 0.4 0.8 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.4 0.0 0.5 0.0 2.4 1.6 0.0 2.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.3 0.0 9.5 0.2 0.2 0.2 0.0 0.0 10.0 0.0 0.0 0.5 5.9 4.8 0.1 0.0 0.2 0.3 KRT1 "EHK1, KRT1A" ENSG00000167768 "Keratin 1" P04264 12 52674736-52680407 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 606.8" "Cell type enriched" "Detected in some" 6 "Suprabasal keratinocytes: 8767.9" "Group enriched" "Detected in many" 5 "head and neck cancer: 313.8;melanoma: 478.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "memory CD4 T-cell: 5.8;memory CD8 T-cell: 2.1;naive CD4 T-cell: 1.8" "Lineage enriched" "Detected in single" 59 "T-cells: 5.8" "Group enriched" "Detected in some" 14 "HaCaT: 44.9;hTCEpi: 19.0" "CAB002153, HPA017917, HPA062908" Enhanced NA NA 65000000000 "CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: AB_2684901" "unprognostic (8.05e-2)" "unprognostic (8.49e-3)" "unprognostic (5.06e-3)" "unprognostic (6.44e-2)" "unprognostic (1.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (3.24e-1)" "unprognostic (1.30e-1)" "unprognostic (2.16e-1)" "unprognostic (9.24e-2)" "unprognostic (6.63e-2)" "unprognostic (3.23e-4)" "unprognostic (1.58e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (1.09e-2)" 0.3 0.0 0.1 0.1 0.1 0.4 24.2 0.1 0.3 63.4 0.1 0.1 0.1 0.0 38.6 0.1 2.5 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.0 0.1 16.2 0.1 2.0 606.8 0.1 0.1 0.2 0.1 0.0 0.1 0.1 24.1 0.1 114.6 0.4 0.1 46.2 0.0 0.0 0.0 0.0 0.0 5.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 19.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 2.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.2 0.0 0.0 1493.7 0.0 0.2 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 239.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 251.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8767.9 0.0 0.0 0.0 0.1 KRT10 "CK10, K10, KPP" ENSG00000186395 "Keratin 10" P13645 17 40818117-40822595 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 20 "skin 1: 1236.8" "Cell type enriched" "Detected in all" 5 "Suprabasal keratinocytes: 10939.8" "Cancer enhanced" "Detected in all" "melanoma: 562.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 131.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB000132, HPA012014" Enhanced "Intracellular and membrane" NA NA 34000000000 "CAB000132: , HPA012014: AB_1852195" "unprognostic (3.07e-1)" "unprognostic (5.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.37e-2)" "unprognostic (2.00e-2)" "unprognostic (2.60e-1)" "unprognostic (3.02e-2)" "unprognostic (1.29e-2)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (1.00e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (9.32e-5)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-2)" "unprognostic (8.10e-2)" 4.1 4.4 5.3 3.7 6.0 3.9 41.4 7.2 6.4 37.3 3.7 1.4 8.2 4.0 14.9 5.4 7.4 3.0 3.7 9.3 6.4 2.9 5.9 7.6 3.0 5.3 5.2 3.2 3.3 9.2 2.6 8.1 5.7 4.9 5.6 2.9 2.4 17.4 8.3 12.2 1236.8 4.9 3.0 4.0 3.7 4.3 9.6 6.1 11.6 5.5 21.7 5.8 3.3 62.7 17.5 15.4 21.7 5.7 13.2 13.4 3.4 17.9 22.9 6.7 7.2 8.3 7.4 6.2 16.2 10.0 6.7 6.1 8.7 6.8 5.0 24.4 7.1 8.8 36.3 2.8 6.1 8.6 11.9 18.0 4.7 29.9 15.9 9.6 10.0 13.9 5.8 131.9 4.4 9.6 8.7 4.6 5.9 25.3 9.6 7.7 13.5 13.0 9.7 8.6 12.4 14.6 9.7 9.8 10.6 6.8 19.5 5.9 6.9 11.5 27.7 21.1 10.0 21.5 13.6 5.2 11.3 16.7 13.9 20.0 0.2 12.1 14.1 15.3 6.5 14.1 21.7 4.7 19.1 9.8 4.2 11.1 17.5 10.8 13.4 7.7 10.1 12.1 11.8 1.6 13.2 5.7 15.4 10.3 3.4 5.3 6.0 7.2 6.4 6.4 2.9 5.2 3.2 4.9 6.1 32.8 40.2 140.7 245.9 1989.5 42.2 180.5 168.2 18.7 37.5 106.4 19.6 108.0 258.6 178.2 67.5 155.9 127.9 70.0 325.5 259.5 164.5 278.2 74.8 191.4 95.0 20.6 173.9 148.0 93.7 31.5 200.5 149.2 372.8 55.1 172.8 131.5 192.1 133.3 164.4 188.8 57.0 103.5 208.9 225.9 128.5 10939.8 133.9 135.5 151.3 432.6 KRT12 K12 ENSG00000187242 "Keratin 12" Q99456 17 40861303-40867210 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Corneal dystrophy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.3;retina: 3.6;skin 1: 1.9" "Cell type enriched" "Detected in some" 5 "Paneth cells: 7.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "HeLa: 3.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA055217, HPA055835" Enhanced NA NA "HPA055217: AB_2682742, HPA055835: AB_2682935" "unprognostic (1.89e-1)" "unprognostic (2.40e-2)" "unprognostic (1.01e-1)" "unprognostic (4.82e-1)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.74e-2)" "unprognostic (5.52e-2)" "unprognostic (9.41e-3)" "unprognostic (3.49e-1)" "unprognostic (1.73e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-4)" "unprognostic (6.31e-3)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.9 0.1 3.3 0.1 0.1 1.3 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 3.6 0.1 0.1 0.1 1.9 3.3 0.1 0.1 0.1 0.4 0.7 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 KRT13 "CK13, K13, MGC161462, MGC3781" ENSG00000171401 "Keratin 13" P13646 17 41500981-41505705 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8" "Cell type enriched" "Detected in some" 11 "Urothelial cells: 2979.9" "Group enriched" "Detected in many" 5 "cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Group enriched" "Detected in some" 100 "A-431: 216.9;HaCaT: 144.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000133, HPA030877, HPA069771" Enhanced Enhanced "Intermediate filaments" NA NA 1100000000 "Intermediate filaments" "CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141" "unprognostic (1.45e-1)" "unprognostic (6.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (9.30e-5)" "unprognostic (7.30e-3)" "unprognostic (1.95e-1)" "unprognostic (1.77e-1)" "unprognostic (5.81e-3)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-1)" "prognostic unfavorable (1.45e-6)" "unprognostic (1.80e-1)" "unprognostic (2.76e-1)" "unprognostic (3.04e-2)" "unprognostic (4.33e-1)" 0.3 0.3 0.0 0.3 0.0 0.5 0.3 0.0 0.3 250.9 0.3 0.0 0.0 0.3 13.7 0.3 1075.6 0.3 0.6 0.5 0.0 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 2.4 0.3 0.1 134.9 0.4 0.4 0.3 0.3 1.7 0.0 0.3 0.3 0.4 0.0 0.6 0.3 499.8 404.8 14.9 222.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 216.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 144.9 0.0 0.0 0.0 0.1 0.0 0.3 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.5 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.6 1.3 250.4 2.5 0.0 0.6 0.0 1.4 14.8 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.2 66.7 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 51.8 0.0 0.0 0.0 0.4 0.0 0.1 2.5 269.4 0.0 0.0 0.0 0.2 0.2 0.4 1.4 0.3 0.0 0.2 2979.9 KRT14 "EBS3, EBS4" ENSG00000186847 "Keratin 14" P02533 17 41582279-41586921 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skin 1: 439.2;tongue: 363.5" "Group enriched" "Detected in some" 11 "Basal keratinocytes: 31612.6;Suprabasal keratinocytes: 10207.3" "Group enriched" "Detected in many" 6 "cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 265.9;HBEC3-KT: 131.1;hTCEpi: 164.0;hTERT-HME1: 53.6;U-2197: 46.3" "Not detected" "Not detected" "CAB000134, HPA000452, HPA000539, HPA023040" Enhanced Enhanced "Intermediate filaments" NA NA 2200000000 "Intermediate filaments" "CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201" "prognostic favorable (2.66e-4)" "unprognostic (1.64e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-1)" "unprognostic (1.02e-2)" "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (1.35e-1)" "unprognostic (1.00e-2)" "unprognostic (5.74e-3)" "unprognostic (1.49e-8)" "unprognostic (8.91e-2)" "unprognostic (2.00e-1)" "unprognostic (8.80e-3)" "unprognostic (1.22e-2)" 0.2 0.1 0.2 0.2 0.2 0.2 23.1 0.2 0.2 27.0 0.2 0.2 0.2 0.1 0.3 0.2 69.3 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 7.6 0.2 2.1 0.1 0.2 30.8 0.3 1.0 439.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 4.6 0.2 363.5 47.6 0.2 37.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.9 0.0 131.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 164.0 0.2 53.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 46.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 999.3 31612.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 6.8 0.0 0.0 56.3 2.6 68.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1887.9 0.0 0.0 0.0 0.3 3.5 0.0 0.0 0.0 0.0 75.4 0.0 0.0 10207.3 2.1 0.0 0.2 106.7 KRT15 "CK15, K15, K1CO" ENSG00000171346 "Keratin 15" P19012 17 41513743-41522529 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6" "Cell type enhanced" "Detected in many" 19 "Basal glandular cells: 1816.1;Basal keratinocytes: 1163.5;Urothelial cells: 567.2" "Cancer enhanced" "Detected in many" "cervical cancer: 178.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HaCaT: 123.1;hTCEpi: 95.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023910, HPA024554" Enhanced Supported "Nucleoplasm,Intermediate filaments" No No 580000000 "Intermediate filaments" Nucleoplasm "HPA023910: AB_1852205, HPA024554: AB_1852207" "prognostic favorable (4.50e-4)" "unprognostic (9.14e-2)" "unprognostic (3.28e-2)" "unprognostic (1.19e-3)" "unprognostic (3.57e-2)" "unprognostic (8.84e-2)" "unprognostic (6.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.13e-1)" "unprognostic (8.65e-3)" "unprognostic (9.91e-3)" "unprognostic (2.09e-1)" "unprognostic (2.24e-11)" "unprognostic (6.91e-3)" "unprognostic (2.62e-1)" "unprognostic (1.33e-5)" "unprognostic (5.35e-2)" 0.6 0.0 1.4 0.6 1.5 0.0 37.4 0.6 1.1 14.6 1.1 0.6 0.6 0.0 0.6 0.6 115.3 2.7 10.6 0.6 1.3 0.0 1.1 0.6 2.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 3.0 1.1 16.4 0.0 1.4 15.1 0.6 0.6 119.3 3.5 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 1.9 6.2 0.8 38.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.1 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.6 2.2 0.0 0.2 0.0 1.3 123.1 0.0 4.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.4 0.0 95.2 0.2 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.6 0.0 0.0 10.4 0.3 0.7 0.2 0.0 0.1 1.8 0.1 0.0 2.3 0.0 2.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 1.5 0.6 1.1 1.3 0.0 0.6 0.6 1.1 0.6 11.9 10.1 0.0 1816.1 1163.5 0.6 0.7 7.6 22.7 230.9 1.8 0.0 0.4 1.7 6.9 90.0 0.5 4.7 0.0 6.8 6.5 13.4 221.8 2.3 0.0 0.3 0.0 4.6 0.0 0.0 35.8 1.4 5.1 303.7 0.0 10.4 0.0 8.6 9.7 0.4 0.0 0.6 0.0 22.7 0.6 0.7 169.3 1.0 0.5 6.0 567.2 KRT16 NEPPK ENSG00000186832 "Keratin 16" P08779 17 41609778-41615899 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 503.5" "Group enriched" "Detected in some" 8 "Basal glandular cells: 391.0;Basal keratinocytes: 804.9;Suprabasal keratinocytes: 1178.6;Urothelial cells: 555.3" "Group enriched" "Detected in many" 7 "cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "hTCEpi: 137.6" "Not detected" "Not detected" "CAB000136, HPA000539" Approved Approved "Intermediate filaments" NA NA 2200000000 "Intermediate filaments" "CAB000136: , HPA000539: " "unprognostic (3.95e-3)" "unprognostic (6.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (1.41e-2)" "unprognostic (1.00e-2)" "unprognostic (7.14e-3)" "unprognostic (1.03e-3)" "unprognostic (2.05e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (8.23e-2)" "unprognostic (6.53e-8)" "unprognostic (3.81e-1)" "unprognostic (1.83e-1)" "unprognostic (7.40e-2)" "unprognostic (3.61e-2)" 1.6 0.2 0.2 0.2 0.2 0.0 2.1 0.2 0.2 32.4 0.2 0.2 0.2 0.0 1.1 0.2 112.4 0.1 0.6 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.6 0.2 0.7 0.0 0.3 15.5 9.9 0.4 41.4 0.2 0.2 0.2 0.2 0.1 0.6 0.2 3.0 0.2 503.5 26.4 0.6 50.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 4.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 137.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.1 0.0 0.0 15.6 0.1 1.0 0.0 0.0 9.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 391.0 804.9 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.2 2.5 20.6 95.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 60.8 0.0 0.0 0.0 48.1 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 1178.6 0.1 0.0 0.0 555.3 KRT17 PCHC1 ENSG00000128422 "Keratin 17" Q04695 17 41619437-41624842 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 109.0;tongue: 144.0" "Group enriched" "Detected in many" 8 "Basal glandular cells: 10709.5;Urothelial cells: 6883.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 3317.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTCEpi: 653.9;SiHa: 272.2" "Not detected" "Not detected" "CAB000029, HPA000452, HPA000453, HPA000539, HPA045062" Enhanced Enhanced "Intermediate filaments" Yes No 750000000 "Intermediate filaments" "CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204" "prognostic favorable (4.44e-4)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (3.65e-3)" "unprognostic (4.46e-2)" "unprognostic (4.34e-1)" "unprognostic (4.36e-3)" "unprognostic (1.32e-2)" "unprognostic (2.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.86e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.82e-1)" "unprognostic (1.77e-1)" "unprognostic (2.20e-1)" "unprognostic (3.89e-1)" 0.7 0.0 0.7 0.7 0.7 0.1 52.3 0.7 0.8 12.6 0.8 0.7 1.2 0.0 1.0 3.1 38.6 0.9 0.9 0.7 0.7 0.0 0.8 0.7 3.7 0.7 0.7 1.0 0.8 0.7 0.0 0.9 4.1 0.8 15.0 0.0 0.7 26.8 33.4 0.7 109.0 0.7 1.2 0.7 0.7 0.0 0.8 0.7 5.1 0.8 144.0 19.7 55.6 25.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 6.5 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 66.1 0.0 67.6 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 653.9 0.0 50.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 0.0 24.8 0.0 0.0 272.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.7 0.7 0.8 0.7 0.0 0.7 1.0 0.8 0.7 20.8 7.4 0.0 10709.5 124.0 0.0 0.0 0.0 112.4 563.0 34.9 0.0 2.0 0.0 285.1 0.3 2.9 0.0 0.0 180.6 118.1 9.3 924.1 3.5 0.0 3.5 19.1 1.7 0.0 0.0 1.3 2.0 7.9 10.1 11.8 0.1 0.0 1050.1 0.0 199.8 0.0 0.0 0.0 5.7 0.4 0.2 108.7 4.8 0.5 0.6 6883.0 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 268.7" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 6515.6;Exocrine glandular cells: 4232.0;Extravillous trophoblasts: 4401.0;Pancreatic endocrine cells: 4358.9;Syncytiotrophoblasts: 6392.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 10.0" "Cell type enriched" "Detected in many" 5 "basophil: 28.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.6" "Cell line enhanced" "Detected in many" "A549: 228.6;BEWO: 144.3;CACO-2: 251.4;CAPAN-2: 182.6;MCF7: 334.7;SK-BR-3: 185.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 23.3 4.8 1.0 31.0 1.1 0.0 24.1 2.9 1.2 28.6 45.4 1.3 66.3 35.0 6.6 55.3 22.4 21.7 147.4 6.8 1.1 2.5 61.9 181.0 39.6 2.8 1.2 1.0 13.7 162.9 8.2 39.8 268.7 10.0 29.3 57.0 14.1 121.1 49.9 1.3 6.5 83.6 3.9 1.4 4.4 36.0 9.5 0.8 4.2 83.4 10.8 20.9 21.5 10.8 4.1 1.0 28.6 0.1 1.0 5.9 1.6 76.6 228.6 0.0 0.3 0.0 0.0 144.3 11.6 14.2 15.1 4.3 251.4 182.6 0.0 32.5 12.6 7.9 18.8 3.2 88.6 9.1 0.0 5.4 0.7 37.4 69.1 39.1 0.0 0.0 0.5 8.3 13.2 18.2 43.2 16.1 0.1 18.5 0.0 0.0 334.7 0.1 1.4 18.6 107.6 17.3 0.1 0.0 8.7 73.6 46.3 2.6 0.1 18.9 185.1 0.7 116.4 97.7 0.2 5.1 0.2 17.6 0.2 2.6 0.0 0.2 0.1 0.0 0.0 1.4 28.6 0.1 1.1 0.2 0.1 1.1 2.1 2.3 0.6 1.0 4.1 5.9 2.1 1.5 1.0 0.0 0.0 0.2 1.6 1.0 1.1 2.9 1.2 1.1 2.5 1.2 1.0 10.0 0.8 801.0 239.7 47.5 1382.6 13.2 0.0 4.9 1332.4 459.0 466.3 591.5 0.0 2872.9 233.8 6515.6 0.9 56.4 1517.2 0.0 4232.0 4401.0 68.2 910.9 48.4 492.5 270.7 1.6 616.3 87.8 9.9 2.3 9.8 37.0 197.4 71.3 2268.9 5.8 4358.9 1644.8 0.0 407.9 0.5 0.0 45.3 1.6 5.9 5.8 6392.2 10.7 1202.1 1262.3 KRT19 "CK19, K19, K1CS, MGC15366" ENSG00000171345 "Keratin 19" P08727 17 41523617-41528308 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 205.3;intestine: 184.9;placenta: 179.4" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 4255.4;Enterocytes: 4014.8;Extravillous trophoblasts: 5684.1;Pancreatic endocrine cells: 4513.8;Urothelial cells: 5295.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.7" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 102.7;HBEC3-KT: 154.6;MCF7: 114.1;RT4: 164.2;SK-BR-3: 290.2;T-47d: 195.5" "Not detected" "Not detected" "CAB000031, HPA002465" Enhanced Supported "Intermediate filaments" NA NA 330000000 "Intermediate filaments" "CAB000031: AB_2234418, HPA002465: AB_1079179" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.86e-2)" "unprognostic (1.59e-2)" "unprognostic (2.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (3.14e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (6.82e-5)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (3.52e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.35e-2)" 9.8 1.6 0.7 22.8 0.9 0.0 50.1 2.9 0.8 37.4 126.7 1.0 38.0 37.8 9.9 53.0 102.1 19.5 205.3 2.3 0.8 0.2 35.0 2.1 50.6 0.7 0.8 0.8 16.7 7.5 1.2 2.6 179.4 1.3 39.2 40.1 1.8 103.0 46.3 0.7 15.8 184.9 11.7 0.6 0.6 69.1 6.4 0.7 33.3 4.9 21.2 89.2 77.0 35.4 0.0 0.0 0.0 0.0 2.7 0.6 0.2 0.1 18.0 0.0 0.3 0.0 0.1 62.8 21.6 0.0 0.6 0.1 51.6 102.7 0.0 21.2 10.3 0.0 55.0 0.0 154.6 0.1 0.0 0.5 0.0 11.6 35.3 1.6 0.0 4.4 0.0 28.1 0.4 0.0 0.0 1.3 0.0 7.4 0.1 0.0 114.1 0.2 0.1 0.9 68.3 26.1 0.1 0.0 0.3 70.9 164.2 2.1 0.0 0.1 290.2 0.0 15.0 195.5 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.7 0.9 2.9 0.8 0.8 0.2 0.8 0.8 1.3 0.7 625.3 180.1 0.5 3332.5 4.6 0.0 1.4 746.5 641.1 757.5 846.2 0.0 833.1 1.7 4255.4 0.1 5.4 4014.8 0.0 2348.9 5684.1 55.9 1574.4 94.4 0.0 159.5 0.0 348.1 0.6 1.8 0.7 35.1 13.4 180.5 52.3 1103.8 0.6 4513.8 2781.1 83.4 4.2 0.0 0.0 4.6 0.2 0.7 1.0 1779.2 1.0 1201.4 5295.6 KRT2 "KRT2A, KRTE" ENSG00000172867 "Keratin 2" P35908 12 52644558-52652164 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 289.9" "Cell type enriched" "Detected in some" 15 "Suprabasal keratinocytes: 232.0" "Group enriched" "Detected in some" 35 "head and neck cancer: 4.7;melanoma: 23.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Group enriched" "Detected in some" 4 "HEL: 6.3;HMC-1: 2.7;JURKAT: 2.4;OE19: 2.9" "Group enriched" "Detected in some" 6 "amygdala: 1.8;hippocampal formation: 2.9" "Not detected" "Not detected" "HPA006299, CAB037321" Enhanced Approved "Golgi apparatus,Intermediate filaments,Cytosol" NA NA 14000000000 "Intermediate filaments, Cytosol" "Golgi apparatus" "CAB037321: , HPA006299: AB_1079180" "unprognostic (1.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.56e-1)" "unprognostic (8.47e-3)" "unprognostic (1.69e-2)" "unprognostic (1.84e-1)" "unprognostic (3.59e-1)" "unprognostic (2.12e-1)" "unprognostic (4.76e-2)" "unprognostic (3.56e-7)" "unprognostic (6.43e-2)" "unprognostic (5.98e-3)" "unprognostic (6.69e-2)" "unprognostic (3.46e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 9.5 0.1 0.1 18.3 0.1 0.1 0.1 0.0 2.0 0.1 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.4 289.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 6.8 0.1 19.2 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 4.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 4.4 2.1 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 15.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.2 0.6 0.8 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.0 0.1 0.0 0.1 0.0 KRT20 "CK20, K20, MGC35423" ENSG00000171431 "Keratin 20" P35900 17 40875941-40885227 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 232.0" "Cell type enhanced" "Detected in some" 29 "Enterocytes: 974.5;Mucus-secreting cells: 369.1;Paneth cells: 1841.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.4;BEWO: 2.7;NB-4: 2.4;RPMI-8226: 2.8;RT4: 7.4;SH-SY5Y: 2.3" "Region enhanced" "Detected in single" "basal ganglia: 0.7" "Not detected" "Not detected" "CAB000032, HPA024309, HPA024684, HPA027236" Enhanced Supported Cytosol NA NA 34000000 Cytosol "CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224" "unprognostic (3.49e-1)" "unprognostic (3.13e-1)" "unprognostic (1.71e-1)" "unprognostic (6.38e-3)" "unprognostic (5.12e-2)" "unprognostic (2.66e-3)" "prognostic unfavorable (7.05e-4)" "unprognostic (2.63e-2)" "unprognostic (4.87e-3)" "unprognostic (2.37e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.71e-2)" "unprognostic (6.30e-2)" "unprognostic (7.27e-2)" 0.2 0.1 0.2 38.0 0.2 0.0 0.2 0.2 0.2 0.2 75.5 0.2 0.2 40.4 0.2 0.2 0.3 0.3 3.9 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.3 45.0 0.2 0.3 0.2 0.2 0.2 232.0 2.7 0.2 0.2 13.6 0.2 0.2 0.2 0.2 0.3 0.2 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.2 0.1 0.0 0.0 2.8 0.0 7.4 0.4 2.3 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 974.5 0.0 0.0 0.0 0.0 1.4 13.8 0.0 0.1 0.0 42.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 369.1 0.0 0.0 1841.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 43.8 1.7 KRT222 "KA21, KRT222P, MGC45562" ENSG00000213424 "Keratin 222" Q8N1A0 17 40654665-40665181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 22.0;Cholangiocytes: 12.7;Horizontal cells: 27.0;Muller glia cells: 33.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 16.3" "HPA054586, HPA068724, HPA069774" Enhanced Approved "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA054586: AB_2682532, HPA068724: , HPA069774: AB_2686195" "unprognostic (2.72e-2)" "unprognostic (4.08e-2)" "unprognostic (1.92e-1)" "unprognostic (2.43e-1)" "unprognostic (1.26e-2)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.12e-2)" "unprognostic (5.59e-1)" "unprognostic (2.04e-1)" "unprognostic (1.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-1)" "unprognostic (7.41e-2)" 3.8 5.0 9.6 0.7 18.3 0.6 1.3 15.6 21.7 2.3 1.8 0.2 0.9 1.2 1.9 11.8 1.2 1.2 8.3 1.0 10.0 10.0 1.3 9.4 1.4 1.1 8.6 13.4 0.9 1.7 1.6 5.2 0.6 14.3 3.2 2.3 0.8 0.7 4.6 0.6 0.8 2.3 3.1 3.3 3.4 1.0 1.4 3.3 0.0 1.2 0.3 1.1 2.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 18.3 15.6 21.7 10.0 10.0 8.6 13.4 14.3 3.3 0.0 0.3 0.0 0.5 0.1 22.0 0.4 12.7 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.3 1.4 0.0 0.0 0.2 0.1 0.0 0.1 2.3 2.9 0.0 27.0 0.0 0.6 0.0 0.0 6.1 0.0 0.0 0.0 0.0 33.2 0.1 0.0 0.7 1.2 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRT23 "CK23, DKFZP434G032, HAIK1, K23, MGC26158" ENSG00000108244 "Keratin 23" Q9C075 17 40922696-40937634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.3;salivary gland: 99.8;skin 1: 48.2" "Cell type enhanced" "Detected in many" 24 "Basal glandular cells: 835.0;Cytotrophoblasts: 634.9;Glandular cells: 639.4;Syncytiotrophoblasts: 3253.9;Urothelial cells: 1153.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 12 "neutrophil: 30.1" "Lineage enriched" "Detected in single" 70 "granulocytes: 30.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.1;Hep G2: 13.1;SuSa: 7.6;T-47d: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012050, HPA016959, CAB017091" Approved Approved "Intermediate filaments,Cytosol" NA NA 170000 "Intermediate filaments" Cytosol "CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228" "unprognostic (1.62e-1)" "unprognostic (5.29e-2)" "unprognostic (4.35e-2)" "unprognostic (6.18e-3)" "unprognostic (1.45e-2)" "unprognostic (2.83e-1)" "unprognostic (5.22e-2)" "unprognostic (6.84e-3)" "unprognostic (2.74e-1)" "unprognostic (2.15e-2)" "unprognostic (8.96e-2)" "unprognostic (1.56e-1)" "unprognostic (8.22e-2)" "unprognostic (6.78e-2)" "unprognostic (1.40e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.26e-4)" 0.3 0.0 0.2 0.5 0.2 0.5 10.0 0.3 0.3 9.8 0.2 0.2 2.1 0.0 1.1 1.2 2.5 1.5 4.5 0.2 0.2 0.0 0.3 0.6 1.1 0.6 0.2 0.2 0.6 1.2 0.0 0.9 128.3 0.2 6.9 0.0 0.3 99.8 2.8 0.3 48.2 0.2 0.3 0.2 1.0 0.0 9.1 0.2 2.0 0.3 11.7 9.5 2.3 3.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.3 0.0 0.0 0.6 0.0 21.1 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 7.6 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 2.2 0.0 835.0 4.0 0.0 0.3 20.4 21.4 10.3 3.5 0.0 634.9 1.7 211.1 47.4 0.7 0.0 0.0 0.7 68.7 0.5 639.4 0.0 0.0 56.0 0.0 6.8 0.0 0.0 5.4 0.6 0.7 5.0 7.2 0.0 11.8 19.4 0.0 0.7 0.0 0.2 0.0 0.4 29.7 0.7 7.0 3253.9 0.0 0.0 1153.1 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703750 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Extravillous trophoblasts: 1.2;Leydig cells: 2.8;Syncytiotrophoblasts: 3.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 15.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "T-reg: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 12.8" "Region enriched" "Detected in single" 18 "cerebellum: 1.1" "Not detected" "Not detected" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" No NA "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 9.2 4.1 0.0 0.0 0.0 0.7 9.3 62.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 48.6 0.0 0.1 3.1 0.0 1.2 0.8 0.1 0.1 0.2 3.4 0.1 0.1 1.1 0.1 0.0 0.0 0.1 1.4 68.9 0.6 3.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 KRT25 KRT25A ENSG00000204897 "Keratin 25" Q7Z3Z0 17 40748021-40755332 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 44.5" "Group enriched" "Detected in some" 9 "Early spermatids: 8.0;Late spermatids: 6.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 5.6" "Region enriched" "Detected in single" 7 "cerebellum: 9.7" "Group enriched" "Detected in some" 5 "cerebral cortex: 8.3;hippocampal formation: 6.1" "HPA053977, HPA058943" Enhanced Approved Vesicles NA NA Vesicles "HPA053977: AB_2682329, HPA058943: AB_2683859" "unprognostic (8.19e-2)" "unprognostic (5.89e-8)" "unprognostic (1.79e-1)" 1.6 0.0 0.0 0.0 0.9 0.0 8.6 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.1 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 KRT26 KRT25B ENSG00000186393 "Keratin 26" Q7Z3Y9 17 40766238-40772162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "blood: 7.1;skin 1: 10.7;testis: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "basophil: 2.8;neutrophil: 7.1" "Lineage enriched" "Detected in single" 32 "granulocytes: 7.1" "Cell line enhanced" "Detected in single" "BEWO: 1.0" HPA026890 Enhanced NA NA "HPA026890: AB_2672042" 0.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 10.7 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.5 0.3 0.0 0.7 0.0 0.0 0.7 0.4 2.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 KRT27 KRT25C ENSG00000171446 "Keratin 27" Q7Z3Y8 17 40776808-40782534 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 37.4" "Cell type enhanced" "Detected in some" 24 "Ito cells: 1.8;Melanocytes: 8.5;Muller glia cells: 2.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.9" "Region enriched" "Detected in single" 9 "basal ganglia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "EFO-21: 5.7;SK-BR-3: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "hippocampal formation: 104.2" HPA055114 Enhanced NA NA "HPA055114: AB_2682700" "unprognostic (1.13e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (5.75e-4)" "unprognostic (5.11e-2)" "unprognostic (3.08e-2)" "unprognostic (8.41e-2)" "unprognostic (4.16e-1)" "unprognostic (1.53e-1)" "unprognostic (4.90e-1)" "unprognostic (1.56e-1)" "unprognostic (5.64e-3)" 1.1 0.0 0.1 0.1 1.2 0.0 4.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 37.4 0.2 0.1 0.1 0.1 0.0 1.0 0.1 2.8 0.5 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.3 0.0 8.5 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.4 0.4 0.2 0.0 0.0 0.0 KRT28 KRT25D ENSG00000173908 "Keratin 28" Q7Z3Y7 17 40792203-40799959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "breast: 4.6;skin 1: 14.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "cervical cancer: 0.6;endometrial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.4" "Region enriched" "Detected in single" 6 "cerebellum: 3.6" "Low region specificity" "Detected in single" HPA066890 Enhanced NA NA "HPA066890: AB_2685742" 0.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 KRT3 "CK3, K3" ENSG00000186442 "Keratin 3" P12035 12 52789685-52796117 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "salivary gland: 15.9;tongue: 58.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 13.6;HMC-1: 8.2" "Not detected" "Not detected" NA NA 350000000 "unprognostic (1.03e-1)" "unprognostic (2.68e-2)" "unprognostic (2.42e-2)" "unprognostic (2.75e-1)" "unprognostic (9.68e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (3.89e-2)" "unprognostic (2.54e-1)" "unprognostic (3.08e-2)" "unprognostic (1.73e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.9 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 58.7 0.9 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 KRT31 "Ha-1, KRTHA1" ENSG00000094796 "Keratin 31" Q15323 17 41393724-41397592 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 21.2;skin 1: 72.1" "Cell type enriched" "Detected in some" 5 "Basal keratinocytes: 34.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 22 "cerebellum: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.7" "HPA049550, HPA055194" Enhanced NA NA 560000000 "HPA049550: AB_2680813, HPA055194: AB_2682733" "unprognostic (3.92e-2)" "unprognostic (3.50e-1)" "unprognostic (3.30e-1)" "unprognostic (5.51e-2)" "unprognostic (7.71e-2)" "unprognostic (4.60e-1)" "unprognostic (6.98e-2)" "unprognostic (1.84e-1)" "unprognostic (4.07e-1)" "unprognostic (4.26e-2)" "unprognostic (1.65e-1)" 1.5 0.0 0.0 0.0 0.2 0.0 1.0 21.2 1.2 0.6 0.0 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.5 0.0 5.5 72.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 21.2 0.9 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.2 34.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 KRT32 "Ha-2, KRTHA2" ENSG00000108759 "Keratin 32" Q14532 17 41459811-41467429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "esophagus: 12.8;skin 1: 18.0" "Cell type enhanced" "Detected in single" 25 "Peritubular cells: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.8;HaCaT: 1.3;hTERT-RPE1: 4.4;MCF7: 1.4;PC-3: 2.1;U-2197: 1.1;U-87 MG: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 230000000 "unprognostic (1.39e-2)" "unprognostic (3.29e-1)" "unprognostic (1.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.13e-1)" "unprognostic (3.46e-1)" "unprognostic (2.32e-2)" "unprognostic (2.67e-3)" "unprognostic (2.72e-9)" "unprognostic (1.31e-2)" "unprognostic (1.77e-1)" 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.7 0.2 0.0 0.1 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 KRT33A "Ha-3I, Krt1-3, KRTHA3A" ENSG00000006059 "Keratin 33A" O76009 17 41346092-41350812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 30.4" "Group enriched" "Detected in some" 6 "Early spermatids: 2.1;Late spermatids: 1.6" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 5.5" HPA055194 Supported NA NA 160000000 "HPA055194: AB_2682733" "unprognostic (1.93e-1)" "unprognostic (1.30e-2)" "unprognostic (4.58e-2)" "unprognostic (4.34e-1)" "unprognostic (2.16e-1)" 0.5 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 5.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 30.4 0.1 0.1 0.1 0.1 0.0 3.3 0.1 2.8 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT33B "Ha-3II, KRTHA3B" ENSG00000131738 "Keratin 33B" Q14525 17 41363494-41369800 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 40.6" "Cell type enhanced" "Detected in single" 37 "Extravillous trophoblasts: 2.2" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 9.0;BJ hTERT+ SV40 Large T+: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;hTEC/SVTERT24-B: 3.5;U-2197: 2.4;U-87 MG: 1.6" HPA055194 Supported NA NA 460000000 "HPA055194: AB_2682733" "unprognostic (3.34e-2)" "unprognostic (5.19e-2)" "unprognostic (3.04e-1)" "unprognostic (1.55e-2)" "unprognostic (6.28e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.5 0.0 0.0 0.0 1.0 0.0 2.7 0.0 7.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.7 2.0 2.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 KRT34 "Ha-4, KRTHA4" ENSG00000131737 "Keratin 34" O76011 17 41377650-41382403 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2" "Group enriched" "Detected in some" 17 "Early spermatids: 4.5;Late spermatids: 11.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BJ: 66.1" "HPA055194, HPA072208" Enhanced Approved Nucleoplasm,Vesicles NA NA 170000000 "Nucleoplasm, Vesicles" "HPA055194: AB_2682733, HPA072208: AB_2686494" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (9.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.86e-3)" "unprognostic (5.12e-7)" "unprognostic (3.84e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 18.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 66.1 2.9 7.9 15.6 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 8.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 KRT35 "Ha-5, KRTHA5" ENSG00000197079 "Keratin 35" Q92764 17 41476689-41481140 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025750, HPA078713" Enhanced Approved "Intermediate filaments" NA NA 270000000 "Intermediate filaments" "HPA025750: , HPA078713: " 1.8 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 2.1 0.1 0.1 33.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT36 KRTHA6 ENSG00000126337 "Keratin 36" O76013 17 41486136-41492546 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "tongue: 109.3" "Cell type enhanced" "Detected in some" 9 "Glandular cells: 1.6;Intestinal endocrine cells: 1.7;Spermatogonia: 1.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.3;intermediate monocyte: 1.0" "Lineage enhanced" "Detected in single" "monocytes: 2.3" "Cell line enriched" "Detected in single" 15 "Karpas-707: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 150000000 "unprognostic (4.39e-2)" "unprognostic (2.24e-3)" "unprognostic (9.85e-2)" "unprognostic (4.66e-1)" "unprognostic (1.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.34e-1)" "unprognostic (5.36e-2)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (7.19e-2)" "unprognostic (8.24e-2)" "unprognostic (8.50e-2)" "unprognostic (3.74e-1)" "unprognostic (6.66e-2)" "unprognostic (1.49e-1)" "unprognostic (7.11e-2)" 0.3 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.3 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.6 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.5 0.1 0.1 5.6 0.3 0.1 0.1 1.6 0.0 0.6 0.1 1.9 0.1 109.3 5.1 0.1 1.4 0.0 0.8 0.0 2.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.4 0.0 1.7 0.0 0.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.7 KRT37 KRTHA7 ENSG00000108417 "Keratin 37" O76014 17 41420753-41424523 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 2.5" NA NA "unprognostic (1.15e-1)" "unprognostic (4.54e-1)" "unprognostic (8.63e-2)" "unprognostic (5.15e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT38 KRTHA8 ENSG00000171360 "Keratin 38" O76015 17 41436446-41440921 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 18.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "head and neck cancer: 1.1;urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.1;fHDF/TERT166: 1.3;hTERT-RPE1: 1.9" NA NA 170000000 "unprognostic (1.37e-1)" "unprognostic (4.05e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.1 0.4 0.8 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT39 KA35 ENSG00000196859 "Keratin 39" Q6A163 17 40958417-40966892 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "skin 1: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 270000 "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (4.92e-1)" "unprognostic (3.85e-1)" "unprognostic (9.03e-3)" "unprognostic (9.89e-3)" "unprognostic (5.00e-2)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (9.42e-10)" "unprognostic (3.95e-1)" "unprognostic (3.04e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 KRT4 "CK4, CYK4, K4" ENSG00000170477 "Keratin 4" P19013 12 52806549-52814551 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 20.8;Ciliated cells: 56.2;Club cells: 112.6;Urothelial cells: 43.0" "Group enriched" "Detected in many" 5 "cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "HaCaT: 96.5;SK-BR-3: 39.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002154, HPA034881" Enhanced Supported "Intermediate filaments" NA NA 540000000 "Intermediate filaments" "CAB002154: AB_563803, HPA034881: AB_2674370" "unprognostic (4.04e-1)" "unprognostic (3.22e-3)" "unprognostic (5.16e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "unprognostic (2.64e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.85e-3)" "unprognostic (2.84e-2)" "unprognostic (2.58e-11)" "unprognostic (1.64e-1)" "unprognostic (6.97e-2)" "unprognostic (1.16e-1)" "prognostic unfavorable (6.26e-4)" 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 25.5 0.1 0.0 0.0 0.1 2.5 0.1 637.8 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 48.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 174.6 403.6 0.2 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 96.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 3.5 0.0 4.5 0.0 0.0 0.3 0.0 56.2 112.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.0 KRT40 "FLJ36600, KA36" ENSG00000204889 "Keratin 40" Q6A162 17 40977716-40987135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 9.5;skin 1: 5.2" "Group enriched" "Detected in some" 133 "Intestinal endocrine cells: 21.2;Muller glia cells: 25.9" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SK-BR-3: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075961 Supported NA NA "HPA075961: " "unprognostic (2.33e-2)" "unprognostic (9.35e-4)" "unprognostic (8.90e-2)" "unprognostic (1.73e-2)" "unprognostic (1.87e-1)" "unprognostic (1.92e-1)" "unprognostic (9.09e-3)" "unprognostic (2.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.08e-1)" "unprognostic (2.01e-4)" "unprognostic (1.47e-2)" "unprognostic (9.60e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.2 1.0 0.1 0.1 1.5 0.1 0.1 1.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.6 0.0 9.5 0.1 0.4 0.1 0.4 1.8 0.7 0.2 0.1 5.2 0.9 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 4.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT5 "EBS2, KRT5A" ENSG00000186081 "Keratin 5" P13647 12 52514575-52520687 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 463.1;skin 1: 338.1;tongue: 522.3" "Cell type enhanced" "Detected in some" 30 "Basal glandular cells: 909.3;Basal keratinocytes: 5214.3;Suprabasal keratinocytes: 1765.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 3340.4" "Region enriched" "Detected in single" 7 "pons and medulla: 1.7" "Cell type enriched" "Detected in single" 197 "plasmacytoid DC: 19.6" "Lineage enriched" "Detected in single" 197 "dendritic cells: 19.6" "Cell line enhanced" "Detected in some" "HaCaT: 120.8;HBEC3-KT: 216.3;hTCEpi: 494.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000027, CAB000129, HPA059479" Enhanced Approved "Intermediate filaments" NA NA 6500000000 "Intermediate filaments" "CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034" "prognostic favorable (1.27e-4)" "unprognostic (9.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (1.84e-1)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "unprognostic (2.82e-1)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.73e-1)" "unprognostic (6.01e-7)" "unprognostic (3.46e-2)" "unprognostic (5.56e-2)" "unprognostic (7.96e-2)" "unprognostic (2.81e-3)" 0.3 0.0 0.1 0.3 0.2 0.2 15.9 0.1 0.2 74.2 0.2 0.3 6.2 0.0 4.9 6.4 463.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 4.4 1.7 5.8 0.0 0.4 46.9 7.8 0.5 338.1 0.1 0.3 0.1 0.1 0.1 0.7 0.1 31.7 0.1 522.3 128.9 4.0 96.8 0.0 19.6 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 120.8 0.0 216.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 494.5 0.0 43.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.2 1.7 0.1 0.0 0.6 0.0 909.3 5214.3 0.0 0.6 0.0 30.8 153.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 28.8 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 271.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 66.8 0.0 0.0 1765.9 0.0 0.0 0.0 372.4 KRT6A "CK6C, CK6D, K6C, K6D, KRT6C, KRT6D" ENSG00000205420 "Keratin 6A" P02538 12 52487174-52493257 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Allergen, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 93.8;Suprabasal keratinocytes: 132.4;Urothelial cells: 329.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 3892.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 470.1" "HPA045697, HPA061168" Supported Enhanced "Intermediate filaments" NA NA 7200000000 "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (8.10e-3)" "unprognostic (2.11e-1)" "unprognostic (2.78e-2)" "unprognostic (1.06e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.45e-4)" "unprognostic (2.43e-1)" "unprognostic (3.73e-2)" "unprognostic (1.31e-3)" "unprognostic (1.29e-1)" "unprognostic (2.89e-9)" "unprognostic (8.80e-2)" "unprognostic (7.20e-2)" "unprognostic (1.72e-1)" "unprognostic (2.13e-2)" 0.2 0.2 0.0 0.4 0.0 0.2 0.8 0.0 0.3 209.2 0.2 0.0 0.0 0.2 6.8 0.2 422.1 0.3 0.3 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 19.8 0.0 0.3 0.2 0.0 37.6 0.2 0.2 19.0 0.2 0.3 0.0 0.2 0.2 0.2 0.0 2.7 0.2 620.2 86.8 0.5 179.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 53.9 0.0 113.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 470.1 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.7 93.8 0.0 0.0 0.0 2.7 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 132.4 0.0 0.0 0.0 329.0 KRT6B KRTL1 ENSG00000185479 "Keratin 6B" P04259 12 52446651-52452126 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 135.3;tongue: 232.4" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 18.3;Ductal cells: 33.5;Suprabasal keratinocytes: 28.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 1424.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "OE19: 57.1" "CAB000130, HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "CAB000130: , HPA045697: AB_2679422, HPA061168: AB_2684440" "prognostic favorable (9.44e-4)" "unprognostic (3.27e-2)" "unprognostic (1.93e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-2)" "unprognostic (2.07e-3)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (5.77e-2)" "unprognostic (9.63e-2)" "unprognostic (3.29e-1)" "prognostic unfavorable (9.52e-4)" 0.2 0.1 0.1 0.5 0.1 0.1 3.9 0.1 0.1 33.3 0.1 0.1 0.1 0.1 0.7 0.1 135.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 17.8 0.1 0.1 34.9 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 232.4 15.4 0.1 26.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.4 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.8 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 1.5 0.0 0.0 0.0 1.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.5 0.0 0.0 0.0 4.8 KRT6C KRT6E ENSG00000170465 "Keratin 6C" P48668 12 52468516-52473785 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 3.1;Suprabasal keratinocytes: 2.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 564.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 46.0" "HPA045697, HPA061168" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA045697: AB_2679422, HPA061168: AB_2684440" "unprognostic (3.18e-2)" "unprognostic (6.26e-3)" "unprognostic (6.63e-2)" "unprognostic (1.54e-3)" "unprognostic (6.97e-2)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.83e-1)" "unprognostic (1.87e-2)" "unprognostic (3.25e-2)" "unprognostic (2.24e-1)" "unprognostic (2.84e-1)" "unprognostic (4.50e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 109.4 0.2 0.0 0.0 0.2 1.1 0.2 125.8 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 16.3 0.2 0.2 2.7 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.1 0.2 244.2 6.7 0.2 40.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 KRT7 "CK7, K2C7, K7, SCL" ENSG00000135480 "Keratin 7" P08729 12 52232520-52252186 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 3055.9;Exocrine glandular cells: 1910.6;Extravillous trophoblasts: 3534.8;Pancreatic endocrine cells: 3941.8;Urothelial cells: 1796.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 560.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 3.8" "Lineage enriched" "Detected in single" 5 "monocytes: 3.8" "Cell line enhanced" "Detected in some" "BEWO: 120.3;HBEC3-KT: 267.7;hTERT-HME1: 108.0;RT4: 319.2;SiHa: 251.7;SK-BR-3: 147.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000028, HPA007272, HPA007315" Enhanced Supported "Intermediate filaments,Cytosol" NA NA 350000000 "Intermediate filaments" Cytosol "CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: " "unprognostic (2.71e-3)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (1.27e-1)" "unprognostic (5.44e-3)" "unprognostic (2.74e-1)" "prognostic unfavorable (9.42e-5)" "prognostic unfavorable (7.78e-5)" "unprognostic (4.54e-2)" "prognostic favorable (2.77e-9)" "unprognostic (2.82e-1)" "unprognostic (1.43e-2)" "unprognostic (3.28e-1)" "unprognostic (3.98e-3)" 3.5 0.2 0.2 0.6 0.2 0.0 43.1 0.2 0.2 7.8 0.5 0.1 18.0 0.0 1.7 9.6 14.4 11.7 27.1 1.2 0.2 0.2 35.0 4.3 63.2 0.0 0.2 0.2 3.3 15.1 1.7 2.1 156.6 0.6 23.1 0.0 0.1 142.6 67.3 0.4 10.7 0.3 4.3 0.3 0.2 2.3 4.3 0.0 0.4 199.7 6.1 16.3 58.2 22.3 0.0 0.8 0.0 3.8 0.0 0.0 0.2 0.1 101.9 0.0 0.0 0.1 0.0 120.3 21.9 0.0 11.5 1.0 0.3 72.7 0.0 0.0 7.5 0.0 80.2 0.0 267.7 0.5 0.1 0.0 0.0 54.7 0.3 2.5 0.0 0.0 0.0 16.7 0.0 108.0 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.1 0.0 0.2 1.6 66.1 319.2 0.1 0.1 251.7 147.0 0.0 1.2 5.6 0.0 87.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 607.4 92.0 0.0 937.0 3.2 0.0 0.8 743.9 127.2 357.2 342.0 0.0 1328.4 114.4 3055.9 12.2 11.7 0.2 0.0 1910.6 3534.8 10.3 851.4 3.5 0.9 166.7 0.0 6.3 7.4 5.2 97.2 3.4 6.2 124.9 61.3 2.1 0.0 3941.8 0.0 0.4 2.8 0.0 0.0 7.2 0.7 0.5 1.9 1206.3 1.8 0.6 1796.1 KRT71 "K6IRS1, KRT6IRS, KRT6IRS1" ENSG00000139648 "Keratin 71" Q3SY84 12 52543909-52553147 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "epididymis: 10.8;skin 1: 42.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "CACO-2: 11.9" HPA049404 Enhanced NA NA 180000000 "HPA049404: AB_2680748" "unprognostic (9.12e-2)" "unprognostic (2.38e-1)" "unprognostic (1.21e-1)" "unprognostic (1.04e-1)" "unprognostic (1.51e-1)" "unprognostic (2.18e-1)" "unprognostic (1.47e-1)" "unprognostic (3.14e-1)" "unprognostic (1.69e-2)" 1.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRT72 "K6irs, K6IRS2, KRT6, KRT6IRS2" ENSG00000170486 "Keratin 72" Q14CN4 12 52585589-52601538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skin 1: 8.9;testis: 32.6" "Group enriched" "Detected in some" 23 "Early spermatids: 19.8;Late spermatids: 46.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive CD4 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;JURKAT: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA065523 Enhanced NA NA "HPA065523: AB_2685504" "unprognostic (3.36e-1)" "unprognostic (7.20e-2)" "unprognostic (3.41e-2)" "unprognostic (1.02e-1)" "unprognostic (6.97e-2)" "unprognostic (4.38e-3)" "unprognostic (4.82e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" 0.2 0.0 0.2 0.6 0.2 1.1 0.2 0.4 0.3 0.2 0.2 0.2 0.2 1.9 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.0 0.2 0.2 0.5 3.1 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 8.9 1.7 0.2 0.2 1.8 0.0 32.6 0.2 0.6 0.2 0.2 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.3 0.4 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.4 0.0 0.0 0.0 0.0 KRT73 "K6IRS3, KRT6IRS3" ENSG00000186049 "Keratin 73" Q86Y46 12 52607570-52618559 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 11.4;skin 1: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "naive CD4 T-cell: 11.4;naive CD8 T-cell: 3.9" "Lineage enriched" "Detected in single" 15 "T-cells: 11.4" "Group enriched" "Detected in some" 4 "HMC-1: 1.4;JURKAT: 4.2" "Region enhanced" "Detected in some" "hippocampal formation: 5.3" "Not detected" "Not detected" HPA044031 Enhanced NA NA "HPA044031: AB_10963434" "unprognostic (2.23e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (2.12e-3)" "unprognostic (2.11e-3)" "unprognostic (4.94e-1)" 0.5 0.0 0.0 0.8 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 17.7 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 11.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.3 0.0 0.0 11.4 3.9 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT74 "K6IRS4, KRT5C, KRT6IRS4" ENSG00000170484 "Keratin 74" Q7RTS7 12 52565782-52573825 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "epididymis: 11.9;skin 1: 17.2" "Cell type enriched" "Detected in single" 4 "Late spermatids: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in single" "HaCaT: 2.6" "Not detected" "Not detected" HPA048596 Enhanced NA NA "HPA048596: AB_2680457" "unprognostic (6.75e-3)" "unprognostic (3.93e-1)" "unprognostic (1.60e-1)" "unprognostic (2.49e-2)" "unprognostic (9.46e-2)" "unprognostic (2.29e-1)" "unprognostic (8.54e-2)" "unprognostic (1.02e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 11.9 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 17.2 0.1 0.1 0.4 0.1 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 KRT75 K6HF ENSG00000170454 "Keratin 75" O95678 12 52424070-52434525 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skin 1: 22.9;tongue: 18.8" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 2.5;Ductal cells: 1.2;Early spermatids: 2.0;Late spermatids: 1.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "PC-3: 22.2;U-2 OS: 29.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019367, HPA076201" Enhanced Approved "Plasma membrane,Cytosol" NA NA 2200000000 Cytosol "Plasma membrane" "HPA019367: AB_1852239, HPA076201: AB_2686786" "unprognostic (2.83e-2)" "unprognostic (2.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (8.85e-3)" "unprognostic (2.67e-1)" "unprognostic (2.17e-2)" "unprognostic (1.72e-1)" "unprognostic (6.60e-2)" "unprognostic (9.20e-2)" "unprognostic (5.19e-2)" "unprognostic (2.45e-1)" "unprognostic (8.98e-2)" "unprognostic (1.94e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 3.5 0.0 18.8 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 KRT76 "HUMCYT2A, KRT2B, KRT2P" ENSG00000185069 "Keratin 76" Q01546 12 52768155-52777345 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "tongue: 81.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 12 "head and neck cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 2.4" "Not detected" "Not detected" HPA019696 Approved NA NA 430000000 "HPA019696: AB_1852243" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.4 7.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.7" "Cell type enriched" "Detected in some" 9 "Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "HaCaT: 9.1" "Group enriched" "Detected in many" 5 "amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" NA NA 2100000000 "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 77.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 KRT78 K5B ENSG00000170423 "Keratin 78" Q8N1N4 12 52837804-52849092 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 166.3;lymphoid tissue: 128.7;tongue: 53.1" "Group enriched" "Detected in some" 6 "Spermatogonia: 4.3;Suprabasal keratinocytes: 3.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 11 "monocytes: 1.0" "Group enriched" "Detected in some" 7 "EFO-21: 9.9;RT4: 2.7;SK-BR-3: 7.0;U-87 MG: 5.4" "Not detected" "Not detected" HPA039724 Enhanced NA NA 71000000 "HPA039724: AB_10795255" "unprognostic (5.36e-2)" "unprognostic (5.89e-2)" "unprognostic (2.95e-2)" "unprognostic (3.25e-2)" "unprognostic (1.88e-1)" "unprognostic (2.18e-2)" "unprognostic (3.01e-3)" "unprognostic (8.88e-16)" "unprognostic (3.50e-2)" "unprognostic (6.92e-1)" "unprognostic (7.55e-2)" "unprognostic (1.25e-1)" 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.1 26.8 0.1 0.1 0.1 0.0 0.6 0.1 166.3 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 18.3 0.1 0.3 15.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 53.1 128.7 0.2 25.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 0.3 2.7 0.1 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 3.9 0.2 0.0 0.0 0.4 KRT79 "K6L, KRT6L" ENSG00000185640 "Keratin 79" Q5XKE5 12 52821410-52834295 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 11.3;skin 1: 34.3" "Group enriched" "Detected in some" 5 "granulocytes: 4.6;Melanocytes: 3.3" "Group enriched" "Detected in some" 5 "breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HMC-1: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA059347 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA 950000000 "Nucleoplasm, Nuclear membrane, Cytosol" "HPA059347: AB_2683986" "unprognostic (5.19e-3)" "unprognostic (1.56e-3)" "unprognostic (5.24e-2)" "unprognostic (2.38e-2)" "unprognostic (6.85e-2)" "unprognostic (6.36e-2)" "unprognostic (3.17e-1)" "unprognostic (7.92e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-2)" "unprognostic (1.32e-1)" "unprognostic (2.72e-1)" "unprognostic (3.99e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 4.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 34.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 11.3 0.1 0.1 0.2 0.1 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.9 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 KRT8 "CARD2, CK8, CYK8, K2C8, K8, KO" ENSG00000170421 "Keratin 8" P05787 12 52897187-52949954 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 102.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 5778.2;Enterocytes: 4471.9;Exocrine glandular cells: 4777.1;Extravillous trophoblasts: 4560.4;Pancreatic endocrine cells: 3911.0;Syncytiotrophoblasts: 4406.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 13.7" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 4 "dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6" "Cell line enhanced" "Detected in many" "A549: 228.5;BEWO: 153.1;CACO-2: 284.3;CAPAN-2: 179.6;MCF7: 383.7;SK-BR-3: 195.0;T-47d: 164.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000131, CAB001696, HPA049866" Enhanced Supported "Intermediate filaments" NA NA 920000000 "Intermediate filaments" "CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923" "unprognostic (5.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "unprognostic (2.76e-2)" "unprognostic (4.86e-3)" "unprognostic (3.10e-2)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (8.99e-2)" "unprognostic (2.08e-2)" "unprognostic (2.83e-2)" "unprognostic (3.18e-1)" "unprognostic (3.68e-1)" "unprognostic (1.19e-2)" 13.4 4.8 2.0 11.0 1.5 0.0 13.9 2.7 1.3 15.1 90.2 2.1 29.8 87.2 11.1 18.3 19.3 10.4 20.3 17.6 1.1 0.2 28.8 55.8 20.1 18.4 1.4 1.2 10.6 75.9 4.0 31.8 28.9 13.7 25.2 45.0 12.1 36.9 46.0 3.7 5.0 102.9 5.2 3.3 14.3 61.8 5.1 1.2 2.9 27.6 9.2 11.6 27.1 10.5 0.7 4.9 3.2 0.7 1.6 0.6 0.5 101.4 228.5 0.0 0.3 0.0 0.1 153.1 0.4 1.8 0.2 0.2 284.3 179.6 0.0 43.4 0.5 0.2 35.5 0.6 28.1 0.2 0.1 4.9 0.1 47.6 81.3 8.3 0.0 0.0 0.3 0.4 0.5 1.9 16.2 0.6 0.0 17.4 0.0 0.0 383.7 0.2 0.3 15.9 100.9 5.0 0.1 0.0 0.5 45.2 50.4 4.9 0.1 39.7 195.0 0.3 50.7 164.0 0.3 0.7 0.2 17.2 0.3 0.3 0.0 0.2 0.2 0.1 0.0 0.5 3.2 0.5 0.6 0.6 0.7 0.4 0.3 0.4 0.3 2.1 0.7 0.4 0.5 1.4 1.6 0.3 4.9 0.5 0.5 2.0 1.5 2.7 1.3 1.1 0.2 1.4 1.2 13.7 1.2 372.2 157.7 26.9 1665.1 5.4 2.4 26.3 1065.0 434.9 350.3 465.9 0.0 1661.4 252.0 5778.2 13.8 28.9 4471.9 0.0 4777.1 4560.4 56.5 694.5 77.0 253.1 223.9 1.6 905.1 28.3 8.4 52.9 7.5 27.5 124.9 94.6 2325.6 3.9 3911.0 3583.7 1.8 388.7 3.8 0.0 11.3 1.1 4.1 1.5 4406.3 7.5 1775.0 1380.2 KRT80 KB20 ENSG00000167767 "Keratin 80" Q6KB66 12 52168996-52192000 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8" "Cell type enhanced" "Detected in some" 13 "Ductal cells: 70.7;Pancreatic endocrine cells: 32.8;Suprabasal keratinocytes: 32.6;Syncytiotrophoblasts: 48.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 44.6;MCF7: 63.7;SK-BR-3: 29.5;U-2 OS: 41.3" "Region enhanced" "Detected in single" "cerebral cortex: 5.7" "Low region specificity" "Detected in all" "HPA077836, HPA077918" Enhanced "Intermediate filaments" No No 290000000 "Intermediate filaments" "HPA077836: AB_2686857, HPA077918: AB_2686871" "prognostic unfavorable (1.05e-4)" "unprognostic (5.45e-3)" "unprognostic (5.35e-2)" "unprognostic (9.19e-3)" "unprognostic (2.85e-4)" "unprognostic (6.68e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-3)" "unprognostic (5.60e-2)" "unprognostic (4.06e-2)" "unprognostic (7.06e-3)" "unprognostic (1.02e-1)" "unprognostic (8.79e-3)" "unprognostic (8.85e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.98e-2)" 0.2 1.9 0.1 0.0 0.2 0.0 3.9 0.0 0.1 5.7 0.5 0.0 1.5 0.0 0.5 4.2 20.4 1.4 1.8 0.2 0.0 0.1 2.7 0.2 1.5 0.0 0.0 0.0 0.6 9.0 7.3 0.2 17.5 0.0 1.8 0.0 0.1 22.1 1.6 0.9 64.0 0.5 0.0 0.1 0.1 0.2 0.5 0.0 0.8 0.4 41.8 43.9 3.2 10.7 0.1 0.9 0.3 0.9 0.0 0.1 0.0 44.6 15.0 0.0 0.0 0.0 0.0 12.5 0.6 0.4 3.5 1.0 1.0 19.6 0.0 22.0 0.5 23.2 22.3 0.0 0.3 1.2 0.0 0.0 0.0 23.4 0.5 2.4 0.0 0.0 0.2 2.7 0.8 5.4 16.4 5.3 0.0 0.0 0.0 1.2 63.7 0.0 0.0 0.0 13.0 2.3 0.0 18.4 0.6 20.1 8.0 5.7 0.3 11.3 29.5 0.2 1.3 5.5 0.2 3.0 0.0 41.3 0.0 16.0 0.0 0.0 0.1 4.2 1.6 0.2 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.5 5.6 0.0 0.3 10.2 6.7 1.2 10.4 0.0 19.7 0.0 70.7 0.6 0.0 0.0 0.0 17.4 0.6 0.7 4.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 32.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 32.6 48.7 0.0 0.0 7.8 KRT81 "Hb-1, KRTHB1" ENSG00000205426 "Keratin 81" Q14533 12 52285913-52291534 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 43.2;skin 1: 53.9" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 22.1;Pancreatic endocrine cells: 15.9;Urothelial cells: 7.3" "Cancer enhanced" "Detected in many" "breast cancer: 46.1;cervical cancer: 49.2" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 43 "basophil: 43.2" "Lineage enriched" "Detected in many" 43 "granulocytes: 43.2" "Cell line enhanced" "Detected in some" "A-431: 215.5;A549: 164.5;MCF7: 49.1;PC-3: 79.1;U-251 MG: 151.5" HPA049778 Supported NA NA 220000000 "HPA049778: AB_2680877" "unprognostic (1.69e-2)" "unprognostic (5.61e-2)" "unprognostic (6.57e-2)" "unprognostic (2.90e-1)" "unprognostic (5.64e-2)" "unprognostic (1.77e-1)" "unprognostic (2.00e-1)" "unprognostic (3.64e-3)" "unprognostic (1.87e-1)" "unprognostic (5.10e-2)" "unprognostic (4.89e-2)" "unprognostic (2.21e-1)" "unprognostic (2.64e-4)" "unprognostic (5.98e-2)" "unprognostic (1.86e-1)" "unprognostic (2.25e-1)" "unprognostic (7.31e-2)" 0.8 0.0 0.2 0.2 0.2 0.4 7.4 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.5 0.4 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.3 0.2 0.5 0.0 0.2 4.6 0.4 0.2 53.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 2.4 0.7 0.2 0.2 0.2 0.2 0.0 0.0 43.2 0.0 1.0 0.0 0.0 215.5 164.5 0.0 0.0 0.0 0.0 0.0 1.3 0.2 1.7 0.1 0.4 0.0 0.0 0.2 0.0 0.1 3.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 49.1 0.0 0.4 0.0 0.0 79.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 13.0 0.8 0.0 0.0 0.9 0.0 0.0 41.6 0.0 151.5 0.0 0.3 0.2 0.0 0.5 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.0 0.0 0.0 22.1 0.6 0.0 0.0 0.0 1.1 1.5 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 2.4 4.1 0.0 7.3 KRT82 "Hb-2, KRTHB2" ENSG00000161850 "Keratin 82" Q9NSB4 12 52393931-52406355 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-87 MG: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058715, HPA067230" Enhanced NA NA 20000000 "HPA058715: AB_2683798, HPA067230: AB_2685807" "unprognostic (3.04e-1)" "unprognostic (3.59e-3)" 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 14.9 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRT83 "Hb-3, KRTHB3" ENSG00000170523 "Keratin 83" P78385 12 52314301-52321398 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 36.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.1" "Group enriched" "Detected in many" 5 "amygdala: 1.2;cerebral cortex: 1.2;pons and medulla: 3.3;thalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPMI-8226: 17.0" HPA049778 Supported NA NA 170000000 "HPA049778: AB_2680877" "unprognostic (7.03e-2)" "unprognostic (2.17e-1)" "unprognostic (2.99e-1)" "unprognostic (3.30e-5)" "unprognostic (3.08e-1)" "unprognostic (1.41e-1)" "unprognostic (1.76e-2)" "unprognostic (2.43e-1)" "unprognostic (1.12e-3)" "unprognostic (7.49e-3)" "unprognostic (2.16e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" 0.8 0.0 1.2 0.0 0.0 0.0 1.5 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.6 0.1 0.0 36.3 0.0 0.0 2.1 0.0 0.0 0.8 2.7 0.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.4 0.0 3.3 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT84 "Hb-4, KRTHB4" ENSG00000161849 "Keratin 84" Q9NSB2 12 52377812-52385652 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 86.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "gdT-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 1.2;HaCaT: 1.7;U-251 MG: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA039714 Supported NA NA 79000000 "HPA039714: AB_2676641" "unprognostic (1.08e-1)" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.4 0.0 86.0 3.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRT85 "Hb-5, KRTHB5" ENSG00000135443 "Keratin 85" P78386 12 52360006-52367481 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skin 1: 57.5;tongue: 16.1" "Group enriched" "Detected in some" 15 "Early spermatids: 5.2;Late spermatids: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "basophil: 2.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 2.0" "Cell line enriched" "Detected in some" 5 "A549: 7.0" "Not detected" "Not detected" HPA049778 Supported NA NA 160000000 "HPA049778: AB_2680877" "unprognostic (1.36e-2)" "unprognostic (3.93e-1)" "unprognostic (7.27e-3)" "unprognostic (5.71e-2)" "unprognostic (2.36e-1)" "unprognostic (4.72e-2)" "unprognostic (9.22e-4)" "unprognostic (1.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.38e-1)" 2.1 0.1 0.1 0.1 0.1 0.2 2.1 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.3 0.1 0.0 0.1 0.1 0.4 0.2 57.5 0.1 0.1 0.1 0.1 0.0 2.9 0.1 0.3 1.1 16.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.2 0.0 0.0 1.4 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 KRT86 "Hb6, KRTHB6, MNX" ENSG00000170442 "Keratin 86" O43790 12 52249300-52309163 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 31.5;skin 1: 60.4;testis: 23.0" "Group enriched" "Detected in some" 5 "Early spermatids: 21.8;Late spermatids: 19.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "basophil: 31.5" "Lineage enriched" "Detected in many" 8 "granulocytes: 31.5" "Cell line enhanced" "Detected in some" "A-431: 13.9;A549: 14.7;hTERT-RPE1: 7.5;MCF7: 28.9;RPMI-8226: 18.2;U-251 MG: 8.1" "HPA039798, HPA049778" Supported Approved Cytosol NA NA 240000000 Cytosol "HPA039798: AB_10674986, HPA049778: AB_2680877" "unprognostic (4.52e-2)" "unprognostic (6.83e-2)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (2.61e-2)" "unprognostic (6.49e-2)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.22e-2)" 0.8 0.3 0.2 0.1 0.2 3.5 0.9 0.5 1.1 0.4 0.3 0.1 1.0 0.6 0.6 2.4 0.3 1.1 1.0 0.1 0.2 0.3 3.8 0.2 1.0 0.1 0.3 0.1 0.6 7.9 0.0 0.2 0.6 0.3 0.5 0.0 0.3 6.3 0.4 1.5 60.4 0.2 0.1 0.7 0.1 0.2 23.0 0.1 0.1 7.6 0.1 0.3 1.2 0.2 0.0 0.0 31.5 0.0 3.8 0.0 0.2 13.9 14.7 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.2 0.0 0.1 0.7 0.0 0.6 0.0 0.3 0.9 0.0 2.6 0.0 6.1 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 7.5 0.0 0.0 0.0 1.0 0.0 28.9 0.0 1.6 0.0 0.1 3.5 0.0 0.0 18.2 0.2 1.8 1.7 0.0 2.6 1.1 1.1 0.0 0.8 0.0 0.4 0.0 0.7 0.0 8.1 0.0 0.0 0.0 0.0 3.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.5 0.2 0.3 0.3 0.1 0.3 0.1 0.0 1.1 0.0 3.2 0.6 0.2 0.4 2.5 0.0 1.2 0.0 0.0 0.1 0.0 2.0 21.8 0.0 0.0 0.0 4.2 1.4 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.3 0.0 1.7 0.0 0.0 0.2 2.9 0.0 0.0 0.5 0.1 0.0 0.3 0.7 0.3 0.1 1.0 3.2 0.0 3.1 KRT9 "CK-9, EPPK, K9" ENSG00000171403 "Keratin 9" P35527 17 41565841-41572058 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "lymphoid tissue: 25.7;skin 1: 7.6" "Cell type enhanced" "Detected in some" 20 "Basal keratinocytes: 3.1;Extravillous trophoblasts: 1.5" "Cancer enriched" "Detected in some" 6 "melanoma: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.8;HaCaT: 18.4;U-2197: 3.3;U-937: 5.7" "HPA007261, CAB037322" Supported NA NA 42000000000 "CAB037322: , HPA007261: AB_1079182" "unprognostic (2.13e-2)" "unprognostic (5.08e-2)" "unprognostic (4.97e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (5.92e-7)" "unprognostic (1.28e-1)" "unprognostic (3.02e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" 0.1 1.7 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.9 0.1 7.6 0.5 0.2 0.1 0.1 0.0 0.7 0.1 25.7 0.1 0.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 7.8 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.1 0.6 0.0 0.0 0.0 0.1 KRTAP1-1 "HB2A, KAP1.1, KAP1.1A, KAP1.1B" ENSG00000188581 "Keratin associated protein 1-1" Q07627 17 41040559-41041461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skin 1: 38.7" "Cell type enhanced" "Detected in some" 21 "Basal glandular cells: 5.4;Ductal cells: 3.9;Glandular cells: 1.2;Urothelial cells: 1.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 14 "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.3;fHDF/TERT166: 1.9;LHCN-M2: 2.3;U-2197: 1.3" NA NA "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 KRTAP1-3 KAP1.3 ENSG00000221880 "Keratin associated protein 1-3" Q8IUG1 17 41033884-41034855 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 88 "skin 1: 40.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 2.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 40.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-4 KAP1.4 ENSG00000204887 "Keratin associated protein 1-4" P0C5Y4 17 41029697-41030104 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skin 1: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HDLM-2: 1.7;HeLa: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP1-5 KAP1.5 ENSG00000221852 "Keratin associated protein 1-5" Q9BYS1 17 41026026-41027202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 37.4" "Group enriched" "Detected in some" 8 "Basal glandular cells: 2.3;Syncytiotrophoblasts: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ: 18.9;BJ hTERT+: 8.2;fHDF/TERT166: 24.5;LHCN-M2: 12.2" NA NA "unprognostic (1.76e-1)" "unprognostic (2.96e-2)" "unprognostic (2.24e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (9.98e-2)" "unprognostic (1.80e-2)" "unprognostic (5.60e-2)" 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 18.9 8.2 1.8 0.7 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 1.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 KRTAP10-1 "KAP10.1, KAP18.1, KRTAP18-1" ENSG00000215455 "Keratin associated protein 10-1" P60331 21 44538981-44540195 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 13.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.3" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 13.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-10 "KAP10.10, KAP18.10, KRTAP18-10" ENSG00000221859 "Keratin associated protein 10-10" P60014 21 44637356-44638455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "skin 1: 18.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.7" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-11 "KAP10.11, KAP18.11, KRTAP18-11, KRTAP18.11" ENSG00000243489 "Keratin associated protein 10-11" P60412 21 44646414-44647650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "skin 1: 12.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.7" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-12 "KAP10.12, KRTAP18-12, KRTAP18.12" ENSG00000189169 "Keratin associated protein 10-12" P60413 21 44697172-44698044 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "skin 1: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.8;SCLC-21H: 1.0" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-2 "KAP10.2, KAP18.2, KRTAP18-2" ENSG00000205445 "Keratin associated protein 10-2" P60368 21 44550357-44551505 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "skin 1: 16.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enhanced" "Detected in single" "granulocytes: 1.5" "Cell line enriched" "Detected in single" 6 "U-266/84: 3.6" NA NA "unprognostic (1.26e-1)" 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-3 "KAP10.3, KAP18.3, KRTAP18-3" ENSG00000212935 "Keratin associated protein 10-3" P60369 21 44557790-44558760 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "skin 1: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "SCLC-21H: 2.0" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-4 "KAP10.4, KRTAP18-4, KRTAP18.4" ENSG00000215454 "Keratin associated protein 10-4" P60372 21 44573724-44638284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "RPMI-8226: 1.4;SCLC-21H: 1.6" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-5 "KAP10.5, KAP18.5, KRTAP18-5" ENSG00000241123 "Keratin associated protein 10-5" P60370 21 44579455-44580604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "skin 1: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "SCLC-21H: 1.8" NA NA 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-6 "KAP10.6, KAP18.6, KRTAP18-6, KRTAP18.6" ENSG00000188155 "Keratin associated protein 10-6" P60371 21 44591268-44592505 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "skin 1: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "SCLC-21H: 2.6" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-8 "KAP10.8, KRTAP18-8, KRTAP18.8" ENSG00000187766 "Keratin associated protein 10-8" P60410 21 44612079-44612954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 79 "skin 1: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SCLC-21H: 1.0" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP10-9 "KAP10.9, KAP18.9, KRTAP18-9" ENSG00000221837 "Keratin associated protein 10-9" P60411 21 44627123-44628293 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "skin 1: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "SCLC-21H: 1.2" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP11-1 KAP11.1 ENSG00000182591 "Keratin associated protein 11-1" Q8IUC1 21 30880644-30881555 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "skin 1: 60.7;tongue: 18.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "endometrial cancer: 1.3;urothelial cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA054008 Enhanced NA NA 3800000 "HPA054008: AB_2682341" 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.3 0.0 60.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP12-1 "KAP12.1, KRTAP12.1" ENSG00000187175 "Keratin associated protein 12-1" P59990 21 44681576-44682163 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 20.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SCLC-21H: 3.6" NA NA "unprognostic (4.04e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP12-2 "KAP12.2, KRTAP12.2" ENSG00000221864 "Keratin associated protein 12-2" P59991 21 44666189-44666927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 1.0" NA NA 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP12-3 KRTAP12.3 ENSG00000205439 "Keratin associated protein 12-3" P60328 21 44657932-44658341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "blood: 3.3;skin 1: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.3" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP12-4 KRTAP12.4 ENSG00000212933 "Keratin associated protein 12-4" P60329 21 44654213-44654659 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skin 1: 3.2;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP13-1 KAP13.1 ENSG00000198390 "Keratin associated protein 13-1" Q8IUC0 21 30396074-30396822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "skin 1: 13.0;tongue: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 2000000 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP13-2 KAP13-2 ENSG00000182816 "Keratin associated protein 13-2" Q52LG2 21 30371391-30372257 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "intestine: 5.9;skin 1: 14.9;tongue: 19.7" "Group enriched" "Detected in some" 5 "Glandular cells: 14.8;Urothelial cells: 5.1" "Cancer enhanced" "Detected in single" "prostate cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 2.0" NA NA 1300000 "unprognostic (2.44e-2)" "unprognostic (5.68e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 5.9 0.0 0.0 0.0 0.0 14.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.1 KRTAP13-4 KAP13.4 ENSG00000186971 "Keratin associated protein 13-4" Q3LI77 21 30430230-30431026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.3;adrenal gland: 1.5;parathyroid gland: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "NTERA-2: 3.1" NA NA 200000 2.3 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP16-1 KAP16.1 ENSG00000212657 "Keratin associated protein 16-1" A8MUX0 17 41307700-41309253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 16.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "cerebral cortex: 1.4" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "HDLM-2: 1.1;SCLC-21H: 1.6;U-87 MG: 1.7;U-937: 2.1" "Not detected" "Not detected" HPA070954 Enhanced NA NA "HPA070954: AB_2686327" "unprognostic (3.65e-5)" "unprognostic (4.61e-2)" 0.6 0.0 0.0 2.5 0.0 3.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 16.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.9 0.0 1.9 0.3 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.8 0.0 0.9 0.3 0.2 1.9 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP17-1 KAP17.1 ENSG00000186860 "Keratin associated protein 17-1" Q9BYP8 17 41314917-41315695 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 9 "skin 1: 20.6" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Intestinal endocrine cells: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 48 "HDLM-2: 12.9;SCLC-21H: 8.2" NA NA 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-1 KAP19.1 ENSG00000184351 "Keratin associated protein 19-1" Q8IUB9 21 30479699-30480344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "skin 1: 17.6" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 19 "melanoma: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "HEK 293: 22.3" NA NA "unprognostic (2.36e-2)" "unprognostic (8.67e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 KRTAP19-3 KAP19.3 ENSG00000244025 "Keratin associated protein 19-3" Q7Z4W3 21 30491464-30491985 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 279 "skeletal muscle: 39.3;skin 1: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.3 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-4 KAP19.4 ENSG00000186967 "Keratin associated protein 19-4" Q3LI73 21 30496824-30497133 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 15 "skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-5 KAP19.5 ENSG00000186977 "Keratin associated protein 19-5" Q3LI72 21 30501657-30502117 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "skin 1: 23.5" "Cell type enriched" "Detected in single" 18 "Syncytiotrophoblasts: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEK 293: 10.3" NA NA 2100000 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 KRTAP19-6 KAP19.6 ENSG00000186925 "Keratin associated protein 19-6" Q3LI70 21 30541535-30541864 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.4;HMC-1: 1.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-7 KAP19.7 ENSG00000244362 "Keratin associated protein 19-7" Q3SYF9 21 30560875-30561314 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "skin 1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP19-8 ENSG00000206102 "Keratin associated protein 19-8" Q3LI54 21 31038159-31038476 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 1.4;skin 1: 1.4;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "JURKAT: 3.3;NTERA-2: 1.4;U-937: 2.3" NA NA "unprognostic (1.94e-1)" 0.0 0.0 0.1 0.0 0.0 1.4 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-1 KAP2.1A ENSG00000212725 "Keratin associated protein 2-1" Q9BYU5 17 41046541-41047316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 62 "skin 1: 34.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.1;SCLC-21H: 2.5" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRTAP2-2 KAP2.2 ENSG00000214518 "Keratin associated protein 2-2" Q9BYT5 17 41054498-41055230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 305 "skin 1: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-3 KAP2.3 ENSG00000212724 "Keratin associated protein 2-3" P0C7H8 17 41059240-41060114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 19.5" "Cell type enriched" "Detected in some" 4 "Ductal cells: 25.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 21.3;fHDF/TERT166: 12.7;HBF TERT88: 19.0;LHCN-M2: 23.9;U-2 OS: 9.2" HPA059203 Supported NA NA "HPA059203: AB_2683947" "unprognostic (2.22e-1)" "unprognostic (2.58e-2)" "unprognostic (3.79e-3)" "unprognostic (3.25e-3)" "unprognostic (2.78e-2)" "unprognostic (6.91e-2)" "unprognostic (1.38e-1)" "unprognostic (6.41e-4)" "unprognostic (7.83e-6)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.7 5.3 4.5 0.2 0.2 0.0 0.0 12.7 1.3 0.0 0.0 0.3 19.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.4 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 3.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 9.2 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 25.6 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP2-4 KAP2.4 ENSG00000213417 "Keratin associated protein 2-4" Q9BYR9 17 41065116-41065879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 55 "skin 1: 27.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.2" HPA059203 Supported NA NA "HPA059203: AB_2683947" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-1 KAP20.1 ENSG00000244624 "Keratin associated protein 20-1" Q3LI63 21 30616425-30616699 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 21 "skin 1: 2.7;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP20-2 KAP20.2 ENSG00000184032 "Keratin associated protein 20-2" Q3LI61 21 30635236-30635619 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "skin 1: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "ASC diff: 3.3;U-2 OS: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 KRTAP20-4 KAP20.4 ENSG00000206105 "Keratin associated protein 20-4" Q3LI62 21 30620627-30620850 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 41 "testis: 6.8" "Cell type enriched" "Detected in single" 6 "Spermatogonia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-2 OS: 11.1" NA NA "unprognostic (1.31e-1)" "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 KRTAP21-1 KAP21.1 ENSG00000187005 "Keratin associated protein 21-1" Q3LI58 21 30754830-30755428 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "breast: 15.0;testis: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SK-MEL-30: 4.0;SuSa: 8.3" NA NA 0.1 0.0 0.0 0.1 0.1 0.0 15.0 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.9 0.0 0.2 1.2 0.0 1.7 0.0 0.1 0.4 0.1 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 8.3 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP21-2 KAP21.2 ENSG00000187026 "Keratin associated protein 21-2" Q3LI59 21 30746794-30747233 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 45 "skin 1: 3.4;testis: 5.7" "Cell type enriched" "Detected in single" 21 "Early spermatids: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HEK 293: 6.6" NA NA 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.4 0.1 0.1 0.1 0.1 0.0 5.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 KRTAP22-1 KAP22.1 ENSG00000186924 "Keratin associated protein 22-1" Q3MIV0 21 30601087-30601382 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "urinary bladder: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "K-562: 2.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP22-2 KAP22.2 ENSG00000206106 "Keratin associated protein 22-2" Q3LI68 21 30590105-30590397 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-2 OS: 1.3" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP23-1 KAP23.1 ENSG00000186980 "Keratin associated protein 23-1" A1A580 21 30348399-30348609 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "skin 1: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP24-1 KAP24.1 ENSG00000188694 "Keratin associated protein 24-1" Q3LI83 21 30281309-30282958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "skin 1: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA017604 Enhanced NA NA "HPA017604: AB_2669625" 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP26-1 ENSG00000197683 "Keratin associated protein 26-1" Q6PEX3 21 30319124-30320316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 56 "placenta: 59.4;skin 1: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP29-1 KAP29.2 ENSG00000212658 "Keratin associated protein 29-1" A8MX34 17 41301826-41302851 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.5;lymphoid tissue: 1.3;skin 1: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 21 "HDLM-2: 7.0" "Not detected" "Not detected" NA NA "unprognostic (1.15e-2)" "unprognostic (2.18e-3)" "unprognostic (9.76e-2)" 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.2 0.0 0.9 0.0 0.0 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.5 0.2 0.0 0.9 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP3-1 KAP3.1 ENSG00000212901 "Keratin associated protein 3-1" Q9BYR8 17 41008521-41019324 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 64.5" "Cell type enhanced" "Detected in some" 33 "Basal glandular cells: 268.6;Glandular cells: 74.1;Urothelial cells: 59.6" "Cancer enhanced" "Detected in some" "stomach cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.0;BJ: 4.2;CACO-2: 11.0;HaCaT: 3.0;Hep G2: 5.5;T-47d: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.24e-1)" "unprognostic (3.00e-2)" "unprognostic (7.37e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 1.7 0.0 0.0 64.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 11.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.4 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 268.6 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 59.6 KRTAP3-2 KAP3.2 ENSG00000212900 "Keratin associated protein 3-2" Q9BYR7 17 40999193-40999894 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "esophagus: 22.1;skin 1: 42.9" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 1.3;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 1.2;HeLa: 2.3;SCLC-21H: 1.1;U-2197: 2.3" HPA042992 Approved NA NA "HPA042992: AB_2678258" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.1 KRTAP3-3 KAP3.3 ENSG00000212899 "Keratin associated protein 3-3" Q9BYR6 17 40993430-40994133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "skin 1: 50.5;tongue: 29.5" "Cell type enriched" "Detected in single" 17 "Intestinal endocrine cells: 1.7" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.1;SCLC-21H: 2.3" HPA042992 Supported NA NA "HPA042992: AB_2678258" 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.0 0.3 0.0 0.0 50.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-1 "KAP4.1, KAP4.10, KRTAP4-10" ENSG00000198443 "Keratin associated protein 4-1" Q9BYQ7 17 41184102-41185342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 14.8" "Cell type enriched" "Detected in single" 6 "Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.2;A549: 3.5;CAPAN-2: 2.6;HDLM-2: 9.8;SCLC-21H: 2.4;SK-BR-3: 2.0" "Not detected" "Not detected" NA NA "unprognostic (1.21e-1)" "unprognostic (3.57e-1)" "unprognostic (1.64e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (2.49e-2)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 1.3 0.1 0.1 0.2 0.1 14.8 1.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 1.4 0.0 0.0 2.4 0.0 0.0 2.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 KRTAP4-11 "KAP4.11, KAP4.14, KRTAP4-14" ENSG00000212721 "Keratin associated protein 4-11" Q9BYQ6 17 41117181-41118360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ: 1.0" NA NA 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-12 KAP4.12 ENSG00000213416 "Keratin associated protein 4-12" Q9BQ66 17 41123091-41124167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 21.4" "Group enriched" "Detected in some" 15 "Basal glandular cells: 1.4;Urothelial cells: 1.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "pons and medulla: 1.5" "Cell type enhanced" "Detected in single" "naive B-cell: 2.9" "Lineage enhanced" "Detected in single" "B-cells: 2.9" "Cell line enriched" "Detected in single" 5 "BJ: 4.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 2.9 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 KRTAP4-16 "KAP4A, KRTAP4-16P, KRTAP4P1" ENSG00000241241 "Keratin associated protein 4-16" 17 41101502-41102209 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "pancreas: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "PC-3: 2.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-2 KAP4.2 ENSG00000244537 "Keratin associated protein 4-2" Q9BYR5 17 41177446-41178208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "skin 1: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.2" NA NA 1200000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-3 KAP4.3 ENSG00000196156 "Keratin associated protein 4-3" Q9BYR4 17 41167231-41168194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 17.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "memory CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enriched" "Detected in single" 52 "HDLM-2: 5.2" NA NA 390000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-4 "KAP4.13, KAP4.4, KRTAP4-13" ENSG00000171396 "Keratin associated protein 4-4" Q9BYR3 17 41159651-41160731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1300000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-5 KAP4.5 ENSG00000198271 "Keratin associated protein 4-5" Q9BYR2 17 41148924-41149802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "skin 1: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-6 "KAP4.15, KAP4.6, KRTAP4-15" ENSG00000198090 "Keratin associated protein 4-6" Q9BYQ5 17 41139433-41140487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "skin 1: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.5" "Lineage enriched" "Detected in single" 13 "B-cells: 1.5" "Group enriched" "Detected in some" 13 "CACO-2: 1.2;HaCaT: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-7 KAP4.7 ENSG00000240871 "Keratin associated protein 4-7" Q9BYR0 17 41084150-41085141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "skin 1: 30.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "fHDF/TERT166: 3.1;SCLC-21H: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-8 KAP4.8 ENSG00000204880 "Keratin associated protein 4-8" Q9BYQ9 17 41096981-41098141 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 20.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.1;BJ hTERT+ SV40 Large T+: 1.2;HBF TERT88: 4.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP4-9 KAP4.9 ENSG00000212722 "Keratin associated protein 4-9" Q9BYQ8 17 41105332-41106488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "skin 1: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.9;BJ hTERT+ SV40 Large T+: 1.4;U-138 MG: 1.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-1 "KRN1L, KRTAP5.1" ENSG00000205869 "Keratin associated protein 5-1" Q6L8H4 11 1584342-1585283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.4;SCLC-21H: 5.1;TIME: 1.1" NA NA "unprognostic (2.68e-1)" "unprognostic (2.97e-1)" "prognostic unfavorable (2.37e-4)" "unprognostic (1.04e-1)" "unprognostic (8.08e-2)" "unprognostic (3.36e-3)" "unprognostic (2.41e-1)" "unprognostic (7.87e-2)" "unprognostic (1.43e-1)" "unprognostic (6.71e-2)" "unprognostic (9.66e-2)" "unprognostic (2.75e-2)" "unprognostic (6.32e-3)" "unprognostic (3.88e-2)" "unprognostic (1.25e-1)" "unprognostic (2.71e-2)" "unprognostic (3.10e-1)" 0.4 0.8 0.6 0.2 1.7 0.3 0.1 11.5 1.3 0.1 0.6 0.5 0.5 0.1 0.1 0.2 0.3 1.2 0.6 0.8 0.4 0.2 0.5 0.5 0.2 0.1 3.9 0.1 3.6 0.2 0.2 0.1 1.9 0.1 0.8 1.8 1.2 0.1 0.2 0.7 1.0 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.5 0.0 0.7 0.0 0.1 0.3 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-10 KRTAP5.10 ENSG00000204572 "Keratin associated protein 5-10" Q6L8G5 11 71565563-71566738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 5.6;skin 1: 8.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 1.4;Club cells: 1.2;Early spermatids: 1.7" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "RT4: 8.9" NA NA "unprognostic (4.05e-2)" "unprognostic (5.64e-3)" "unprognostic (1.39e-2)" "unprognostic (6.47e-2)" "unprognostic (7.81e-2)" "unprognostic (4.70e-2)" "unprognostic (5.55e-2)" "unprognostic (1.68e-1)" "unprognostic (3.53e-1)" "unprognostic (9.81e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (8.39e-4)" "unprognostic (9.43e-2)" "unprognostic (1.37e-1)" "unprognostic (6.21e-2)" "unprognostic (2.27e-4)" 0.3 0.0 0.2 0.0 0.7 0.1 0.6 0.4 0.1 0.1 0.1 0.0 0.0 5.6 0.1 0.9 0.2 0.0 0.2 0.1 0.4 0.4 0.1 0.0 0.1 0.1 1.8 0.0 0.2 0.0 0.4 0.3 0.1 1.1 0.7 8.3 0.3 0.0 0.2 0.2 0.1 0.8 0.2 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.5 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 KRTAP5-11 "KRTAP5-6, KRTAP5.11" ENSG00000204571 "Keratin associated protein 5-11" Q6L8G4 11 71579714-71603353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.08e-1)" 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.6 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-2 "KRTAP5-8, KRTAP5.2" ENSG00000205867 "Keratin associated protein 5-2" Q701N4 11 1597177-1598294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 6.3;pancreas: 5.2;skin 1: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;memory CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "B-cells: 1.1;T-cells: 1.0" "Group enriched" "Detected in some" 7 "HDLM-2: 1.7;MCF7: 6.0;SCLC-21H: 6.8;SH-SY5Y: 3.0;SK-BR-3: 1.8" NA NA "unprognostic (6.31e-2)" 0.0 0.8 0.8 0.2 1.3 0.0 0.0 5.4 6.3 0.0 0.6 1.2 0.2 0.9 0.0 0.0 1.5 0.3 0.7 1.4 0.0 0.0 0.3 0.1 0.4 0.0 5.2 0.0 0.4 0.0 0.0 0.0 1.6 0.0 0.1 10.2 1.5 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.8 3.0 0.0 1.8 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-3 "KRTAP5-9, KRTAP5.3" ENSG00000196224 "Keratin associated protein 5-3" Q6L8H2 11 1607565-1608463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "RT4: 1.5" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 11.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-4 KRTAP5.4 ENSG00000241598 "Keratin associated protein 5-4" 11 1620958-1622138 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "skeletal muscle: 2.4;skin 1: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.1" NA NA "unprognostic (6.52e-2)" "unprognostic (4.04e-4)" "unprognostic (1.80e-1)" "unprognostic (7.83e-2)" "unprognostic (2.00e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 8.7 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-5 "KRTAP5-11, KRTAP5.5" ENSG00000185940 "Keratin associated protein 5-5" Q701N2 11 1629775-1630707 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skin 1: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.45e-2)" "unprognostic (1.00e-2)" "unprognostic (7.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.7 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-6 KRTAP5.6 ENSG00000205864 "Keratin associated protein 5-6" Q6L8G9 11 1697195-1697755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 6.7;placenta: 2.6;skin 1: 2.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 21 "liver cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.4;SK-BR-3: 1.8" NA NA "prognostic favorable (6.04e-5)" "unprognostic (3.70e-1)" "unprognostic (2.93e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.0 1.8 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-7 "KRTAP5-3, KRTAP5.7" ENSG00000244411 "Keratin associated protein 5-7" Q6L8G8 11 71527267-71528674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 9.2;testis: 4.8" "Group enriched" "Detected in some" 6 "Early spermatids: 1.1;Late spermatids: 1.5;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "basophil: 2.6" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.6" "Cell line enriched" "Detected in single" 9 "RT4: 6.3" NA NA "unprognostic (3.69e-1)" "unprognostic (2.49e-4)" "unprognostic (1.64e-1)" "unprognostic (1.82e-2)" "unprognostic (3.40e-2)" "unprognostic (7.48e-2)" "unprognostic (2.10e-2)" "unprognostic (3.83e-1)" "unprognostic (2.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.35e-1)" "unprognostic (5.68e-3)" 0.0 0.1 0.8 0.3 1.2 0.3 0.7 0.5 0.9 0.1 0.2 0.6 0.0 2.2 0.1 0.1 0.2 0.0 1.1 1.3 0.6 0.6 0.0 0.1 1.5 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.3 0.2 0.5 9.2 0.0 0.1 1.1 0.0 0.1 4.8 0.0 0.1 0.2 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-8 "KRTAP5-2, KRTAP5.8, UHSKerB" ENSG00000241233 "Keratin associated protein 5-8" O75690 11 71538025-71539207 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "epididymis: 3.4;kidney: 7.1;skin 1: 8.7;testis: 2.7" "Cell type enriched" "Detected in single" 8 "Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;RT4: 4.2" NA NA "unprognostic (9.72e-2)" "unprognostic (8.49e-2)" "unprognostic (9.79e-2)" "unprognostic (1.52e-1)" "unprognostic (1.66e-1)" "unprognostic (2.58e-2)" "unprognostic (1.99e-1)" "unprognostic (6.92e-2)" "unprognostic (2.89e-2)" "unprognostic (2.42e-2)" "unprognostic (2.08e-1)" "unprognostic (3.02e-2)" "unprognostic (1.14e-1)" "unprognostic (3.62e-2)" "unprognostic (2.21e-3)" 0.0 0.1 0.2 0.1 0.6 0.0 0.3 0.3 0.4 0.0 0.2 0.3 0.0 3.4 0.0 0.1 0.2 0.0 0.2 0.3 7.1 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.4 8.7 0.4 0.0 0.1 0.1 0.0 2.7 0.1 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.7 0.5 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.8 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 KRTAP5-9 "KRN1, KRTAP5-1, KRTAP5.9" ENSG00000254997 "Keratin associated protein 5-9" P26371 11 71548418-71549553 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 5.1;testis: 4.6;urinary bladder: 4.6" "Cell type enriched" "Detected in single" 5 "Late spermatids: 4.9" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Cell type enriched" "Detected in single" 11 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.0" "Cell line enriched" "Detected in single" 20 "RT4: 14.4" NA NA "unprognostic (1.72e-3)" "unprognostic (2.20e-1)" "unprognostic (2.22e-2)" "unprognostic (2.16e-1)" "unprognostic (4.13e-1)" "unprognostic (6.53e-2)" "unprognostic (8.10e-2)" "unprognostic (2.09e-1)" "unprognostic (1.06e-1)" "unprognostic (7.76e-2)" "unprognostic (7.23e-2)" "unprognostic (2.56e-1)" "unprognostic (3.29e-1)" "unprognostic (2.05e-2)" "unprognostic (2.01e-1)" "unprognostic (4.82e-4)" "prognostic favorable (9.25e-4)" 0.4 0.4 1.1 0.1 2.8 0.5 0.5 1.3 1.3 0.1 0.9 0.3 0.1 5.1 0.5 0.8 0.9 0.1 1.0 2.0 0.4 0.8 0.3 0.3 0.8 0.2 0.0 1.5 1.1 0.2 0.9 0.7 0.8 1.4 0.4 1.4 0.7 0.1 1.0 0.7 0.4 4.6 0.4 0.4 4.6 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.6 0.0 0.4 0.1 0.5 0.0 0.1 0.0 0.0 0.0 14.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP6-1 "C21orf103, KAP6.1" ENSG00000184724 "Keratin associated protein 6-1" Q3LI64 21 30613431-30613930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP7-1 KAP7.1 ENSG00000274749 "Keratin associated protein 7-1 (gene/pseudogene)" Q8IUC3 21 30829039-30829759 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.3;skin 1: 1.6;tongue: 3.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 16 "urothelial cancer: 1.2" "Cell type enriched" "Detected in single" 13 "T-reg: 2.3" "Lineage enriched" "Detected in single" 13 "T-cells: 2.3" "Group enriched" "Detected in some" 5 "SiHa: 3.4;SK-MEL-30: 2.0;WM-115: 2.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP8-1 KAP8.1 ENSG00000183640 "Keratin associated protein 8-1" Q8IUC2 21 30812697-30813252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skin 1: 33.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 21 "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "U-937: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-1 "KAP9.1, KRTAP9L3" ENSG00000240542 "Keratin associated protein 9-1" A8MXZ3 17 41189887-41190639 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 101 "HDLM-2: 10.0" NA NA 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-2 KAP9.2 ENSG00000239886 "Keratin associated protein 9-2" Q9BYQ4 17 41226648-41227652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "skin 1: 23.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-3 KAP9.3 ENSG00000204873 "Keratin associated protein 9-3" Q9BYQ3 17 41232463-41233454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "skin 1: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "SCLC-21H: 1.4" NA NA 150000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-4 KAP9.4 ENSG00000241595 "Keratin associated protein 9-4" Q9BYQ2 17 41249687-41250653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "skin 1: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-6 "KAP9.6, KRTAP9L2" ENSG00000212659 "Keratin associated protein 9-6" A8MVA2 17 41265339-41266641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "skin 1: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" NA NA 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 6.9 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.7 0.3 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 1.0 0.0 0.4 0.1 0.3 0.3 0.0 0.4 0.5 0.7 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.3 0.1 0.1 0.0 0.0 0.5 0.2 0.7 0.3 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.4 0.0 0.5 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 KRTAP9-7 "KAP9.7, KRTAP9L1" ENSG00000180386 "Keratin associated protein 9-7" A8MTY7 17 41275659-41276697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 47 "skin 1: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "HDLM-2: 2.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-8 KAP9.8 ENSG00000187272 "Keratin associated protein 9-8" Q9BYQ0 17 41238045-41239004 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 60 "HDLM-2: 6.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP9-9 "KAP9.5, KAP9.9, KRTAP9-5" ENSG00000198083 "Keratin associated protein 9-9" Q9BYP9 17 41255384-41256364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 208 "skin 1: 20.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.8" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 157.5;Undifferentiated cells: 162.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8" "Group enriched" "Detected in many" 19 "B-cells: 5.4;T-cells: 7.0" "Cell line enhanced" "Detected in some" "A-431: 28.1;CAPAN-2: 32.2;HaCaT: 10.3;OE19: 14.3;SCLC-21H: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: AB_2684221" "prognostic favorable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 0.9 1.0 0.5 10.0 0.8 0.5 6.3 1.3 1.7 4.6 24.4 0.7 13.3 16.2 1.5 3.2 8.5 9.8 16.5 1.7 0.7 0.3 4.8 6.5 11.8 1.9 0.7 1.4 2.7 28.8 3.3 6.9 1.5 1.5 9.7 6.2 1.9 17.4 22.6 1.0 4.9 34.8 0.9 0.9 1.0 16.7 1.8 0.8 2.3 12.3 6.9 5.4 7.6 4.5 5.4 0.0 0.1 0.0 0.3 7.0 1.8 28.1 0.2 0.7 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.1 9.0 32.2 0.2 0.2 0.0 0.0 10.3 0.2 7.3 0.0 0.2 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.1 0.0 0.7 0.3 0.1 0.0 7.5 0.3 1.9 6.1 14.3 0.1 0.1 0.2 0.7 0.0 0.0 15.1 0.5 0.4 9.4 0.6 0.5 0.2 0.2 0.0 0.3 0.7 0.3 0.2 1.6 1.1 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.6 0.0 6.9 5.4 6.2 3.2 0.0 4.6 7.0 3.3 0.0 0.3 0.0 0.0 4.8 1.8 0.5 0.8 1.3 1.7 0.7 0.3 0.7 1.4 1.5 0.8 20.8 18.0 3.7 106.9 20.7 2.6 0.2 86.6 56.2 43.3 40.1 7.9 15.0 5.0 85.6 4.7 0.8 81.3 0.0 157.5 26.3 1.5 101.7 4.6 12.1 1.8 1.6 59.7 1.3 0.6 3.6 0.3 1.8 6.8 4.6 108.5 1.5 121.7 98.2 0.0 4.9 5.9 0.0 1.0 2.7 33.8 13.6 6.6 1.0 162.2 123.8 KRTDAP "KDAP, UNQ467" ENSG00000188508 "Keratinocyte differentiation associated protein" P60985 19 35487324-35495558 "Plasma proteins, Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9" "Cell type enriched" "Detected in some" 15 "Suprabasal keratinocytes: 4612.7" "Group enriched" "Detected in many" 7 "head and neck cancer: 486.4;melanoma: 207.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 55 "hTCEpi: 42.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA063474 Enhanced "Secreted in other tissues" NA NA 62000000 "HPA063474: AB_2685019" "unprognostic (4.55e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-1)" "unprognostic (6.11e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-2)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (3.80e-2)" "unprognostic (1.50e-1)" "unprognostic (2.76e-1)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (1.16e-2)" 0.2 0.0 0.2 0.2 0.2 0.1 29.4 0.2 0.2 110.5 0.2 0.2 0.2 0.0 8.2 0.2 5.7 0.1 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.6 0.2 0.2 0.0 0.2 11.3 0.2 1.4 326.3 0.2 0.2 0.2 0.2 0.0 0.2 0.2 3.5 0.2 234.9 5.5 0.2 77.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.2 309.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.2 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.9 0.0 40.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 38.6 16.1 4612.7 0.0 0.0 0.0 0.3 KSR1 "KSR, RSU2" ENSG00000141068 "Kinase suppressor of ras 1" Q8IVT5 17 27456470-27626438 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 57.7" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 68.7;Late spermatids: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 89.7;HEL: 32.2;HMC-1: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009623, HPA011215" Uncertain NA NA "CAB009623: AB_2265455, HPA011215: AB_1852649" "unprognostic (2.03e-2)" "unprognostic (2.74e-1)" "unprognostic (2.60e-1)" "unprognostic (3.48e-3)" "unprognostic (2.90e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-5)" "unprognostic (8.36e-3)" "unprognostic (1.32e-1)" "unprognostic (3.15e-2)" "unprognostic (1.12e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (1.00e-1)" "unprognostic (7.55e-2)" "unprognostic (1.74e-2)" "unprognostic (9.61e-2)" 10.5 9.3 15.3 12.5 16.0 9.5 7.7 20.5 18.5 15.5 6.1 20.5 7.0 5.4 17.9 7.0 15.5 9.3 21.2 7.0 17.5 7.0 12.4 3.8 12.4 8.6 18.3 12.5 14.4 57.7 7.3 8.9 29.4 16.2 7.9 5.9 19.8 4.7 13.4 17.5 13.8 7.6 13.7 12.0 12.2 5.1 11.5 19.9 5.2 16.3 3.3 9.4 8.9 13.5 0.9 1.1 7.0 4.1 1.5 1.1 0.7 1.0 4.2 2.6 1.3 2.2 1.6 15.4 0.9 2.1 1.4 1.7 12.7 0.1 1.0 2.2 1.8 9.8 0.6 2.6 0.5 0.9 89.7 2.8 32.2 4.1 5.2 3.9 0.4 22.2 1.9 0.9 4.2 0.1 6.1 8.1 1.4 16.8 0.1 0.8 1.0 0.4 1.2 1.9 0.9 0.7 2.0 14.6 0.7 6.0 0.7 4.1 2.7 5.2 1.2 1.4 7.3 0.1 1.7 7.6 0.4 2.0 1.2 0.7 0.1 0.0 0.0 0.4 1.8 2.4 0.0 1.9 7.0 0.7 4.1 0.7 0.9 0.3 0.4 1.1 0.4 0.2 0.2 2.2 1.5 2.0 0.1 1.1 0.7 15.3 16.0 20.5 18.5 17.5 7.0 18.3 12.5 16.2 19.9 6.0 4.3 1.4 3.5 2.7 12.4 1.1 0.0 17.4 14.8 14.0 68.7 15.9 3.3 1.4 26.8 7.0 4.9 0.0 4.5 17.5 9.9 1.2 0.0 1.0 5.7 9.5 6.3 12.3 6.5 33.8 1.4 5.3 8.5 5.4 1.3 7.1 2.4 3.5 2.1 2.5 28.7 0.0 3.4 2.1 5.3 5.3 16.2 5.7 0.6 7.1 KSR2 FLJ25965 ENSG00000171435 "Kinase suppressor of ras 2" Q6VAB6 12 117453012-117968983 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 27.4;pituitary gland: 24.6" "Cell type enhanced" "Detected in many" 21 "Bipolar cells: 48.8;Collecting duct cells: 153.5;Cone photoreceptor cells: 37.3;Horizontal cells: 44.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 7.3;SCLC-21H: 5.4;TIME: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035536 Enhanced NA NA "HPA035536: AB_10673485" "unprognostic (1.74e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (2.29e-2)" "unprognostic (9.11e-2)" "unprognostic (8.42e-2)" "unprognostic (6.91e-3)" "unprognostic (1.10e-2)" "unprognostic (5.78e-2)" "unprognostic (5.80e-2)" "unprognostic (2.05e-4)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (5.02e-2)" "unprognostic (5.68e-2)" "unprognostic (8.14e-3)" "unprognostic (5.74e-2)" 0.9 5.0 13.2 1.1 13.8 1.1 1.7 27.4 17.2 1.0 1.9 1.3 2.2 1.0 0.8 2.6 0.9 1.7 1.0 0.8 12.9 4.8 3.5 0.8 1.2 1.6 2.2 10.8 0.8 3.0 0.9 24.6 0.9 7.7 1.3 2.3 0.2 1.2 3.4 0.9 1.0 1.0 0.9 2.9 1.0 1.7 3.2 3.0 0.0 3.8 0.0 1.5 2.3 0.5 0.1 0.2 0.8 0.1 0.2 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.1 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 2.2 0.0 0.0 0.0 1.6 0.1 0.0 0.5 0.1 1.2 0.0 0.0 0.1 0.7 1.5 5.4 0.1 0.0 0.0 0.0 0.1 1.1 0.0 11.0 0.0 0.8 0.0 0.2 0.9 1.5 0.0 0.5 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.2 0.1 0.2 0.0 0.0 13.2 13.8 27.4 17.2 12.9 4.8 2.2 10.8 7.7 3.0 0.0 0.0 0.5 1.1 0.2 48.8 2.0 2.5 0.0 0.0 153.5 37.3 0.5 0.0 1.6 8.4 0.3 0.0 0.0 1.4 0.3 0.0 1.3 0.0 0.0 0.1 44.5 19.7 0.0 0.0 9.4 0.0 0.0 0.0 0.0 8.2 2.3 0.4 1.1 0.0 0.5 28.3 0.0 0.0 0.2 1.7 0.3 0.2 0.0 2.8 1.0 KY FLJ33207 ENSG00000174611 "Kyphoscoliosis peptidase" Q8NBH2 3 134603138-134651636 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 19.5;tongue: 36.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 3.0;Late spermatids: 5.2;Muller glia cells: 2.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 7.4" "Lineage enriched" "Detected in single" 75 "granulocytes: 7.4" "Cell line enhanced" "Detected in some" "Karpas-707: 3.4;U-2197: 4.6;U-87 MG: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036492, HPA036668" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036492: AB_10672222, HPA036668: AB_2675239" "unprognostic (1.40e-2)" "unprognostic (2.05e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-2)" "unprognostic (2.72e-2)" "unprognostic (1.65e-2)" "unprognostic (2.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-1)" "unprognostic (3.86e-2)" "unprognostic (9.87e-2)" "unprognostic (2.83e-2)" "unprognostic (3.82e-1)" "unprognostic (4.62e-2)" "unprognostic (2.29e-1)" "unprognostic (8.98e-2)" "unprognostic (1.47e-1)" 0.3 5.7 3.5 0.4 2.3 0.5 1.4 2.5 4.6 2.2 1.7 2.1 1.7 0.9 3.9 2.3 3.1 3.7 0.9 4.8 4.9 2.1 0.7 0.2 0.3 0.2 1.7 6.9 1.7 0.2 8.5 6.8 0.2 3.2 3.6 0.6 3.3 1.7 2.8 19.5 12.6 0.5 7.4 2.0 0.3 1.7 0.7 3.6 0.5 5.2 36.2 1.1 1.3 1.4 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 13.9 0.7 0.0 7.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.5 2.3 2.5 4.6 4.9 2.1 1.7 6.9 3.2 3.6 0.0 0.0 0.0 0.0 0.6 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 KYNU ENSG00000115919 Kynureninase Q16719 2 142877498-143055832 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;liver: 41.1;placenta: 34.3" "Cell type enhanced" "Detected in many" 18 "Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 21 "B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9" "Cell line enhanced" "Detected in some" "A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA031686 Enhanced Supported Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA031686: AB_2673995" "unprognostic (2.58e-2)" "unprognostic (3.39e-3)" "unprognostic (1.21e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.36e-3)" "unprognostic (3.58e-3)" "unprognostic (4.88e-2)" "unprognostic (3.35e-2)" "unprognostic (2.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-3)" "unprognostic (3.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.64e-1)" 9.0 3.7 2.2 11.0 3.7 3.9 15.4 0.6 1.7 3.0 1.2 1.3 0.8 0.2 1.1 2.6 5.6 1.5 4.4 3.8 1.4 1.1 8.4 41.1 12.7 13.7 2.9 0.4 1.7 1.0 0.2 1.6 34.3 2.7 1.9 1.2 1.5 3.0 0.8 0.7 1.5 2.7 2.0 6.3 16.0 2.4 7.0 2.6 2.7 2.2 1.7 13.0 12.4 2.6 19.7 28.4 1.3 35.9 0.4 0.1 11.1 0.0 37.9 0.1 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.6 0.5 2.2 0.1 0.0 62.8 0.1 0.0 0.0 0.0 0.1 0.0 0.8 42.3 25.7 0.5 0.1 0.2 3.6 3.1 22.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 19.3 0.0 2.3 0.1 0.0 0.1 0.0 0.2 0.1 0.6 19.6 0.1 0.0 21.0 3.1 0.2 0.2 10.5 5.4 0.3 1.2 0.1 18.5 0.0 0.1 0.0 0.0 66.4 4.4 0.1 0.1 28.7 0.5 0.1 35.9 0.1 19.7 0.1 0.1 28.4 12.7 0.1 0.0 1.3 0.4 29.2 19.9 0.1 11.1 2.2 3.7 0.6 1.7 1.4 1.1 2.9 0.4 2.7 2.6 3.0 2.4 22.6 0.5 3.5 0.1 1.2 5.1 2.7 10.3 3.5 3.9 2.8 5.0 12.1 34.6 2.9 0.0 0.0 7.8 1.5 3.3 0.8 0.0 44.8 38.5 9.5 0.0 3.1 59.7 39.6 1.7 94.5 1.7 360.7 0.0 0.2 37.4 0.0 0.4 23.0 0.5 6.5 1.3 40.0 8.0 2.8 87.5 0.0 0.0 4.2 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 59000000 "Nucleoplasm, Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.9 1.4 5.4 0.0 0.0 0.0 2.3 25.5 73.5 24.6 40.4 7.3 0.1 0.0 24.3 0.1 20.6 0.7 0.6 0.4 12.9 0.0 0.1 0.0 53.0 1.1 0.0 0.0 4.0 0.1 0.3 3.7 2.5 0.0 0.0 0.0 0.0 0.0 0.1 24.4 0.0 0.5 1.2 0.0 0.9 0.0 32.2 0.1 43.2 0.3 16.2 10.6 14.3 12.7 10.3 12.7 1.3 0.3 0.0 0.0 10.8 1.1 12.1 0.2 0.3 0.1 0.1 0.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 0.0 0.0 0.8 0.0 1.0 8.5 0.8 0.0 0.0 0.0 80.3 3.9 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 31.8 0.0 1.8 0.0 0.0 0.9 0.0 42.2 0.0 0.0 0.8 0.0 0.0 0.0 0.2 8.6 0.0 0.4 0.0 0.1 1.1 0.1 0.0 0.0 0.1 L1TD1 "ECAT11, FLJ10884" ENSG00000240563 "LINE1 type transposase domain containing 1" Q5T7N2 1 62194831-62212328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.2;placenta: 34.0" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 82.1;Syncytiotrophoblasts: 23.6" "Cancer enriched" "Detected in some" 14 "testis cancer: 120.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "non-classical monocyte: 8.1" "Lineage enriched" "Detected in single" 17 "monocytes: 8.1" "Group enriched" "Detected in some" 22 "NTERA-2: 68.4;SuSa: 53.8" "HPA028501, HPA030064" Enhanced Vesicles NA NA Vesicles "HPA028501: AB_10599287, HPA030064: AB_10600538" "unprognostic (2.03e-2)" "unprognostic (7.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.51e-1)" "unprognostic (2.29e-1)" "unprognostic (2.46e-1)" "unprognostic (4.03e-1)" "unprognostic (1.09e-1)" "unprognostic (9.23e-2)" "unprognostic (4.04e-2)" "unprognostic (4.61e-2)" "unprognostic (1.52e-5)" "unprognostic (3.49e-2)" "unprognostic (2.43e-1)" "unprognostic (5.75e-2)" "unprognostic (1.95e-1)" 0.6 0.8 0.2 18.2 0.4 0.0 0.7 0.4 0.2 1.6 6.9 0.0 0.3 0.1 0.3 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.4 0.2 3.1 1.6 0.2 0.1 1.3 0.3 0.0 0.4 34.0 0.7 2.4 1.6 1.5 0.7 0.1 0.6 0.3 0.6 0.5 0.2 2.9 0.4 8.5 0.0 0.4 2.4 0.1 0.1 1.6 1.3 0.4 0.3 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.7 0.0 6.0 15.4 0.0 0.5 0.3 2.5 0.3 0.0 10.7 13.6 0.0 5.9 82.1 0.0 0.0 0.3 0.7 0.2 0.0 0.3 20.0 2.1 0.3 1.1 0.0 6.6 3.2 10.2 0.0 0.8 0.4 1.7 2.0 0.0 0.0 4.4 0.3 0.4 0.9 17.3 0.0 3.9 0.0 0.9 0.7 13.2 0.1 23.6 1.9 0.6 0.2 L34079.1 ENSG00000268361 19 43554692-43593036 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;brain: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "basophil: 3.0" "Lineage enriched" "Detected in single" 30 "granulocytes: 3.0" "Cell line enhanced" "Detected in some" "HaCaT: 1.5;hTERT-RPE1: 1.0;SK-BR-3: 1.7;U-266/70: 3.3" NA NA 0.2 0.8 0.1 0.7 0.2 0.0 0.2 4.3 0.5 0.3 0.4 0.0 0.6 0.0 1.4 0.4 0.0 0.3 0.4 0.2 0.0 0.0 0.2 0.0 0.3 1.5 0.0 2.3 0.2 0.3 0.0 0.0 0.0 0.0 1.7 1.1 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LACC1 "C13orf31, FAMIN, FLJ38725" ENSG00000179630 "Laccase domain containing 1" Q8IV20 13 43879284-43893932 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 9.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 15.9;TIME: 49.9" "CAB034228, HPA040150, HPA044211" Uncertain NA NA "CAB034228: AB_1564163, HPA040150: AB_10963540, HPA044211: AB_10961258" "unprognostic (2.48e-1)" "unprognostic (3.27e-2)" "unprognostic (4.54e-2)" "unprognostic (3.31e-3)" "unprognostic (1.17e-2)" "unprognostic (3.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.43e-2)" "unprognostic (3.03e-3)" "unprognostic (1.78e-2)" "unprognostic (6.06e-3)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (3.30e-1)" "unprognostic (9.36e-3)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" 6.6 7.1 13.1 11.0 28.2 1.5 5.1 2.1 12.2 4.8 9.8 12.2 2.7 10.0 4.4 4.7 7.1 4.6 9.9 9.6 18.5 10.5 7.6 8.2 7.8 7.3 31.0 9.1 4.5 4.7 9.8 6.2 6.4 10.9 5.7 13.2 2.2 6.1 4.6 2.5 4.6 14.2 7.8 16.5 8.3 6.6 9.2 21.5 4.8 3.6 4.3 7.6 12.2 4.4 1.7 3.5 4.1 9.6 0.5 1.2 1.3 1.9 1.1 0.6 0.0 1.1 4.8 4.1 4.3 11.1 1.2 1.6 2.2 4.5 4.0 1.0 5.9 2.6 2.9 0.1 1.1 1.9 2.7 0.7 5.1 1.1 0.7 5.3 1.2 15.9 7.3 3.5 4.5 5.0 1.5 2.5 0.5 0.0 2.9 2.7 0.9 0.1 1.5 0.4 1.0 0.9 0.9 0.0 2.1 3.2 2.3 0.7 1.1 1.5 0.5 2.1 3.0 0.6 2.5 49.9 1.5 0.4 8.1 0.0 0.0 0.0 1.0 4.2 1.4 3.4 1.3 4.1 4.1 1.0 6.8 1.2 1.2 0.9 0.9 3.5 1.7 0.3 0.5 0.2 0.5 9.6 0.8 1.2 1.3 13.1 28.2 2.1 12.2 18.5 10.5 31.0 9.1 10.9 21.5 11.9 5.0 5.0 6.5 5.0 0.1 19.6 0.0 1.4 3.4 10.4 0.0 4.6 1.7 4.5 1.1 5.2 6.3 0.0 3.3 3.7 4.7 9.0 8.1 4.7 14.1 0.0 5.2 4.9 13.4 1.7 2.0 11.5 1.7 5.4 4.3 2.1 5.3 7.2 1.4 7.3 0.3 6.5 4.7 6.2 15.6 8.9 7.7 2.9 5.6 7.6 LACRT LACRITIN ENSG00000135413 Lacritin Q9GZZ8 12 54630811-54634895 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 72 "salivary gland: 67.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 304 "breast cancer: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 460000 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669174 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.1;liver: 58.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 194.5;Proximal tubular cells: 262.2;Spermatocytes: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 99.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 24000 Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 9.3 31.4 6.8 6.7 10.0 1.2 8.9 2.0 7.1 5.5 13.5 9.0 5.3 17.8 5.7 8.3 7.6 5.2 14.6 19.3 7.2 7.2 70.1 58.8 9.7 8.9 11.5 7.5 5.5 10.6 6.2 12.6 6.3 10.1 7.5 10.0 6.2 7.8 8.6 12.0 6.1 19.1 7.2 11.6 8.0 7.7 45.7 11.7 6.0 9.8 10.9 5.9 8.2 7.4 14.0 18.2 13.4 17.3 11.0 13.8 6.4 14.3 15.0 4.7 1.9 8.3 12.7 2.9 8.0 4.7 8.7 6.6 7.1 16.2 0.0 3.3 3.9 17.5 10.3 5.7 8.5 6.9 8.6 6.4 6.7 2.0 3.9 17.4 6.5 5.8 15.3 10.4 4.3 6.5 4.1 2.2 5.3 11.6 13.6 11.4 4.3 3.7 1.2 5.1 19.4 14.2 3.3 2.8 3.0 33.2 7.6 6.8 2.4 17.9 99.3 8.9 6.4 16.6 8.8 3.6 0.6 4.8 15.4 6.5 11.1 8.3 0.0 4.9 11.2 6.4 11.1 15.2 13.4 9.9 17.3 12.5 14.0 10.4 9.7 18.2 13.2 10.1 10.6 6.4 11.0 16.4 12.8 13.8 6.4 6.8 10.0 2.0 7.1 7.2 7.2 11.5 7.5 10.1 11.7 53.6 33.1 13.5 17.8 14.5 13.8 31.9 25.5 20.1 30.7 17.4 7.9 19.6 64.6 43.6 194.5 15.3 25.3 0.0 101.8 11.7 10.3 12.0 9.2 70.0 40.7 7.9 11.6 22.1 31.8 14.1 19.0 23.7 15.1 11.8 21.3 33.2 68.2 19.2 14.2 262.2 14.8 6.5 11.3 198.5 24.5 14.6 16.2 23.0 26.4 8.1 LACTBL1 ENSG00000215906 "Lactamase beta like 1" A8MY62 1 22953043-22965338 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 2.2" "Cell type enriched" "Detected in single" 7 "Bipolar cells: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "Hep G2: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA066810 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA066810: " 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAD1 ENSG00000159166 "Ladinin 1" O00515 1 201373244-201399915 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 83.9;tongue: 66.9" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 171.5;monocytes: 433.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.8" "Cell line enhanced" "Detected in some" "A-431: 36.7;CAPAN-2: 32.6;HaCaT: 47.4;HBEC3-KT: 36.0;hTCEpi: 35.0;MCF7: 40.2;OE19: 50.5;RT4: 34.6;SK-BR-3: 56.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007256, HPA028732" Enhanced Enhanced "Actin filaments" "Secreted to extracellular matrix" NA NA "Actin filaments" "HPA007256: AB_1852681, HPA028732: AB_10602916" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (3.82e-1)" "unprognostic (7.55e-3)" "unprognostic (4.66e-2)" "unprognostic (7.41e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.06e-1)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (9.11e-2)" "unprognostic (2.31e-2)" "unprognostic (3.71e-2)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (3.28e-1)" 0.3 0.2 0.3 10.7 0.3 0.0 3.0 0.3 0.3 15.9 17.5 0.3 22.1 17.4 2.9 4.4 83.9 2.8 56.9 2.0 0.3 0.2 17.2 5.4 3.6 1.5 0.3 0.3 1.5 29.5 0.0 0.4 16.0 0.4 6.9 12.1 0.5 17.1 25.0 1.3 49.7 39.1 1.5 0.3 0.4 13.8 0.6 0.3 3.0 1.6 66.9 42.5 8.9 29.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 36.7 0.3 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.0 23.8 32.6 0.0 2.1 0.0 0.0 47.4 0.0 36.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 35.0 0.0 7.2 0.0 0.0 0.0 0.0 0.1 0.0 40.2 0.0 0.1 0.9 50.5 0.4 0.0 1.6 0.4 24.4 34.6 1.9 0.0 0.0 56.7 0.6 1.5 8.5 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.4 0.3 3.0 27.8 1.5 72.1 78.6 0.0 1.8 89.2 4.0 28.4 29.6 0.0 2.9 38.1 140.9 1.0 0.2 171.5 0.0 107.2 4.6 4.1 25.8 0.0 8.5 0.4 0.0 17.4 0.0 0.3 2.4 0.0 2.5 10.1 433.8 49.1 0.0 149.1 89.0 0.4 54.9 0.0 0.0 5.2 0.0 0.0 133.5 8.7 0.0 93.8 117.6 LAG3 CD223 ENSG00000089692 "Lymphocyte activating 3" P18627 12 6772512-6778455 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.1;ovary: 28.4" "Cell type enhanced" "Detected in many" 13 "Intestinal endocrine cells: 20.8;Leydig cells: 36.2;Peritubular cells: 65.0;T-cells: 29.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "pons and medulla: 2.7" "Cell type enhanced" "Detected in many" "gdT-cell: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0" "Lineage enriched" "Detected in single" 56 "T-cells: 11.3" "Cell line enriched" "Detected in single" 144 "HDLM-2: 57.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002301, HPA013967" Enhanced "Secreted - unknown location" NA NA "CAB002301: AB_564101, HPA013967: AB_1846277" "unprognostic (9.39e-2)" "prognostic favorable (3.89e-4)" "unprognostic (8.88e-2)" "unprognostic (7.00e-3)" "unprognostic (1.08e-1)" "unprognostic (6.74e-3)" "unprognostic (8.85e-2)" "unprognostic (4.63e-3)" "unprognostic (1.94e-2)" "unprognostic (1.97e-3)" "unprognostic (8.71e-2)" "unprognostic (9.93e-2)" "prognostic unfavorable (4.62e-11)" "unprognostic (3.07e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" "unprognostic (8.19e-3)" 1.7 0.4 0.3 33.2 0.3 1.0 1.0 0.8 0.7 7.7 4.4 0.5 2.7 2.9 6.4 3.3 2.4 3.8 3.0 2.2 0.3 0.4 1.2 5.9 3.8 12.4 0.4 0.0 28.4 0.4 0.1 1.0 1.3 2.7 2.8 1.8 1.1 2.0 6.8 0.8 0.6 9.6 1.7 0.9 58.1 2.0 6.1 0.1 4.1 1.0 1.3 23.5 2.6 3.6 0.0 0.2 0.0 0.0 0.0 11.3 0.8 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 9.2 0.0 2.2 10.0 0.0 0.0 0.6 4.0 0.0 0.0 0.0 0.2 1.7 0.8 0.3 0.3 0.8 0.7 0.3 0.4 0.4 0.0 2.7 0.1 0.0 3.5 0.9 0.8 4.5 4.0 1.2 0.0 0.0 5.7 0.0 9.8 0.2 0.0 0.1 0.3 1.9 1.1 0.0 0.0 0.2 2.1 1.9 0.0 2.5 8.7 0.0 20.8 5.5 3.5 1.1 36.2 0.3 1.7 4.6 4.5 1.3 0.3 0.0 65.0 0.2 6.2 6.5 2.5 0.3 2.0 2.6 0.1 29.6 2.5 0.3 LAIR1 CD305 ENSG00000167613 "Leukocyte associated immunoglobulin like receptor 1" Q6GTX8 19 54351384-54370558 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.0" "Cell type enhanced" "Detected in many" 12 "granulocytes: 103.2;Hofbauer cells: 178.5;Kupffer cells: 84.4;Macrophages: 142.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HMC-1: 6.6;Karpas-707: 17.1;THP-1: 19.4" HPA011155 Enhanced Supported "Plasma membrane" NA NA 130000 "Plasma membrane" "HPA011155: AB_1852685" "unprognostic (1.91e-1)" "unprognostic (1.12e-2)" "unprognostic (2.81e-2)" "unprognostic (1.25e-2)" "unprognostic (2.03e-2)" "unprognostic (4.38e-2)" "unprognostic (2.16e-2)" "unprognostic (1.74e-1)" "unprognostic (5.00e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (5.01e-5)" "unprognostic (1.72e-1)" "unprognostic (2.72e-3)" "unprognostic (3.52e-2)" "unprognostic (5.22e-2)" 12.7 7.0 4.5 10.9 9.9 13.5 6.9 0.5 4.5 2.7 5.1 6.7 0.2 2.7 2.2 6.8 2.5 3.6 4.4 3.9 5.2 4.2 3.8 2.9 16.5 33.1 10.2 1.9 2.0 2.4 1.4 2.8 7.0 7.0 3.0 2.0 3.1 3.9 2.2 2.3 2.3 7.6 7.8 11.9 28.6 2.9 3.1 7.4 39.0 2.0 0.5 6.1 3.7 1.7 6.0 10.3 12.4 8.8 5.8 8.0 5.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 17.1 0.0 0.0 2.2 1.5 0.0 0.0 0.0 2.2 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 19.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 2.7 0.2 12.4 4.2 10.0 8.0 8.3 4.6 2.3 2.4 4.3 0.1 6.0 3.8 4.9 0.6 5.8 8.8 10.3 1.6 5.7 4.5 9.9 0.5 4.5 5.2 4.2 10.2 1.9 7.0 7.4 14.9 34.1 29.8 0.5 0.6 5.5 1.3 0.0 20.1 20.5 0.0 35.3 4.4 0.0 0.0 15.9 0.7 0.0 0.0 0.0 4.1 1.9 0.5 103.2 0.8 178.5 1.6 0.0 4.3 84.4 20.4 0.3 142.0 0.0 1.0 0.0 1.1 0.1 0.0 0.0 0.1 14.8 0.0 0.9 1.4 1.0 1.0 8.4 33.0 0.0 0.8 LAIR2 CD306 ENSG00000167618 "Leukocyte associated immunoglobulin like receptor 2" Q6ISS4 19 54497879-54510687 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 233.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "T-reg: 12.8" "Lineage enriched" "Detected in single" 21 "T-cells: 12.8" "Group enriched" "Detected in some" 5 "BEWO: 6.9;Hep G2: 3.3" "Secreted - unknown location" NA NA "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (4.19e-2)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (4.86e-4)" "unprognostic (1.06e-2)" "unprognostic (8.37e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (2.21e-1)" "unprognostic (9.52e-2)" "unprognostic (3.68e-9)" "unprognostic (1.21e-2)" "unprognostic (3.15e-3)" "unprognostic (3.40e-5)" "unprognostic (6.71e-2)" 0.9 0.5 0.6 5.9 1.7 1.6 0.5 0.2 1.3 0.4 0.6 1.3 0.0 0.4 0.5 1.3 0.7 0.5 1.3 0.4 1.4 3.0 0.6 0.8 3.2 12.3 0.6 0.5 0.2 0.9 0.1 7.1 15.5 1.3 0.8 1.3 0.4 0.5 0.4 0.6 0.5 1.2 0.5 1.5 6.6 1.0 1.2 0.4 19.6 0.5 0.0 2.0 0.3 0.3 0.0 0.0 0.1 0.1 0.6 12.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 3.0 2.0 0.0 0.0 0.8 2.7 0.1 0.6 0.1 0.0 12.8 1.8 0.6 1.7 0.2 1.3 1.4 3.0 0.6 0.5 1.3 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 233.4 0.5 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 26.9 24.5 0.0 0.0 LALBA LYZL7 ENSG00000167531 "Lactalbumin alpha" P00709 12 48567684-48570066 "Cancer-related genes, Predicted secreted proteins" "Lactose biosynthesis" "Milk protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 194 "breast: 217.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 599 "breast cancer: 29.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;MCF7: 1.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB026343, HPA029855, HPA029856" Enhanced "Secreted in female reproductive system" NA NA "CAB026343: , HPA029855: AB_2673222, HPA029856: AB_10671362" "unprognostic (7.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 217.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 LAMA1 LAMA ENSG00000101680 "Laminin subunit alpha 1" P25391 18 6941744-7117814 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.9" "Group enriched" "Detected in many" 5 "Enterocytes: 39.1;Mucus-secreting cells: 37.7;Paneth cells: 37.4;Undifferentiated cells: 12.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.2;ASC diff: 13.6;BEWO: 65.1;hTEC/SVTERT24-B: 13.5;SK-MEL-30: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB010179 Enhanced "Secreted to extracellular matrix" NA NA "CAB010179: AB_2133741" "unprognostic (2.75e-1)" "unprognostic (3.66e-4)" "unprognostic (2.08e-1)" "unprognostic (3.56e-1)" "unprognostic (4.97e-3)" "unprognostic (3.66e-2)" "unprognostic (1.72e-2)" "unprognostic (7.94e-2)" "unprognostic (2.23e-2)" "unprognostic (3.43e-2)" "unprognostic (3.02e-1)" "unprognostic (6.80e-2)" "unprognostic (1.92e-1)" "unprognostic (1.78e-2)" "unprognostic (4.85e-1)" "unprognostic (3.47e-2)" "unprognostic (7.34e-3)" 3.2 0.4 2.2 0.9 4.4 0.4 4.2 0.7 3.3 2.7 0.5 7.3 0.6 0.4 2.8 4.0 0.5 0.7 0.6 0.6 5.2 1.7 5.5 0.5 0.9 0.4 3.6 1.9 4.4 1.4 0.4 3.4 0.8 5.4 0.7 0.6 0.2 3.6 2.0 0.4 0.7 0.4 1.3 5.7 0.7 0.4 20.9 4.7 0.0 6.7 0.0 0.4 1.4 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 13.6 12.2 65.1 0.6 3.1 3.2 7.0 7.7 0.0 0.0 0.1 1.1 2.6 0.0 0.0 2.3 1.3 0.0 1.0 0.0 3.6 0.0 1.6 0.0 0.0 10.3 0.3 13.5 7.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.0 0.0 12.7 4.0 0.0 0.0 0.0 2.4 6.8 1.3 0.0 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.4 0.7 2.4 5.2 1.7 3.6 1.9 5.4 4.7 6.0 0.0 0.0 0.6 0.0 0.0 1.7 5.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.1 0.0 39.1 0.0 0.4 2.2 0.4 0.7 0.0 0.0 0.7 0.0 1.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 37.7 2.5 0.0 37.4 0.0 1.1 0.3 0.0 0.0 0.5 1.7 0.0 4.0 0.0 12.1 0.3 LAMA2 LAMM ENSG00000196569 "Laminin subunit alpha 2" P24043 6 128883141-129516569 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.7;placenta: 71.2" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 76.7;Leydig cells: 170.6;Peritubular cells: 210.7;Sertoli cells: 116.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Group enriched" "Detected in many" 15 "NK-cells: 2.2;T-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC diff: 66.7;ASC TERT1: 48.6;HHSteC: 14.5;HSkMC: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB040310, CAB078182" Enhanced "Secreted to extracellular matrix" NA NA 38000000 "CAB040310: , CAB078182: AB_2665829" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (2.17e-2)" "unprognostic (3.17e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.65e-2)" "unprognostic (9.73e-2)" "unprognostic (3.67e-2)" "unprognostic (2.44e-3)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (4.04e-2)" "unprognostic (1.24e-3)" "unprognostic (6.16e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (3.65e-5)" 35.3 7.4 1.7 3.5 8.1 0.9 38.9 6.4 3.8 22.0 10.4 1.7 6.3 2.0 13.3 12.8 17.1 17.7 13.6 65.7 2.1 1.5 3.6 3.8 17.1 8.8 4.7 3.3 33.0 5.4 2.1 7.0 71.2 6.2 8.2 4.2 3.5 9.4 7.5 26.1 8.2 7.2 26.8 6.9 7.3 10.2 16.7 5.4 0.0 9.6 9.2 1.4 18.5 22.1 0.1 0.1 0.0 0.0 2.2 2.2 0.1 0.0 0.0 0.7 0.0 66.7 48.6 0.0 6.5 2.4 0.1 0.1 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 40.8 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.2 11.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.7 0.3 0.0 0.0 2.2 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.2 0.0 1.0 1.1 0.1 0.1 0.0 0.5 0.0 2.2 0.0 0.0 0.5 0.1 1.7 8.1 6.4 3.8 2.1 1.5 4.7 3.3 6.2 5.4 0.0 0.3 0.0 2.3 3.3 0.8 76.7 0.0 5.3 1.2 0.0 0.0 1.9 0.0 1.4 6.0 5.7 0.0 0.0 0.2 1.5 36.3 0.1 0.0 0.0 2.7 0.0 0.0 5.5 0.0 4.7 170.6 1.3 1.7 0.0 0.0 14.2 0.6 0.0 210.7 0.4 1.0 116.4 8.2 1.4 0.7 2.5 3.2 1.3 0.0 0.7 LAMA3 "BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa" ENSG00000053747 "Laminin subunit alpha 3" Q16787 18 23689443-23955066 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 70.8" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 107.2;Pancreatic endocrine cells: 340.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "HBEC3-KT: 154.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009309, CAB010757" Uncertain Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 810000 "Endoplasmic reticulum" "CAB010757: AB_477162, HPA009309: AB_1079224" "unprognostic (1.49e-2)" "unprognostic (2.14e-2)" "unprognostic (6.36e-2)" "unprognostic (3.82e-3)" "unprognostic (2.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-3)" "unprognostic (1.59e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (3.58e-6)" "unprognostic (1.98e-1)" "unprognostic (2.36e-1)" "unprognostic (3.15e-1)" "unprognostic (9.91e-3)" "unprognostic (3.98e-2)" "unprognostic (1.13e-1)" 8.2 0.9 2.9 8.2 1.9 0.0 16.7 0.6 2.3 18.2 13.3 2.4 5.4 11.2 19.1 9.5 12.4 7.8 8.1 2.7 1.8 1.5 3.1 1.3 26.2 7.0 2.4 0.9 5.8 3.1 10.3 2.3 70.8 1.6 8.7 5.2 5.7 14.9 9.1 2.2 20.7 27.8 10.2 1.3 0.8 19.7 3.8 0.5 3.3 1.8 9.7 8.0 11.5 15.2 0.0 0.0 0.8 0.0 0.0 1.3 0.2 17.3 2.2 0.0 0.0 0.9 0.2 0.0 0.3 0.2 0.1 0.2 0.7 20.1 0.0 2.3 0.2 0.0 31.7 0.0 154.2 0.1 0.0 1.2 0.0 0.6 0.3 0.1 0.0 0.0 0.2 17.3 0.1 18.3 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 5.4 2.0 0.3 0.0 0.0 6.8 2.0 0.0 0.3 0.7 0.3 0.0 0.0 0.6 0.2 1.6 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 2.9 1.9 0.6 2.3 1.8 1.5 2.4 0.9 1.6 0.5 107.2 23.7 0.5 53.6 27.8 3.8 2.0 5.1 13.4 23.9 1.8 0.0 0.1 0.0 30.0 3.7 2.8 50.4 0.0 30.6 0.2 2.0 16.7 5.7 0.8 0.2 0.0 7.9 1.8 0.0 2.8 5.5 1.1 1.7 1.0 11.0 0.0 340.7 31.6 3.2 0.0 1.9 6.5 19.6 3.1 1.9 8.7 0.1 0.7 6.6 15.4 LAMB4 ENSG00000091128 "Laminin subunit beta 4" A4D0S4 7 108023548-108130356 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6" "Cell type enhanced" "Detected in some" 22 "Basal keratinocytes: 31.0;Early spermatids: 8.6;Late spermatids: 7.6;Suprabasal keratinocytes: 12.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 6.1;HMC-1: 3.6" "Low region specificity" "Detected in many" "HPA020242, HPA024247" Approved "Secreted to extracellular matrix" NA NA "HPA020242: AB_2670388, HPA024247: AB_2671496" "unprognostic (7.41e-2)" "unprognostic (1.79e-1)" "unprognostic (4.85e-2)" "unprognostic (1.77e-1)" "unprognostic (3.79e-2)" "unprognostic (6.29e-4)" "unprognostic (8.90e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.27e-2)" "unprognostic (1.23e-4)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.2 13.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 31.1 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 21.6 2.0 0.1 0.1 0.6 0.5 1.6 0.3 1.0 0.4 0.2 0.0 0.9 0.3 0.1 0.6 0.5 6.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.8 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.1 0.0 3.6 1.0 0.2 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.3 0.4 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 1.6 0.3 0.1 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.6 0.3 0.2 1.6 1.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 5.0 0.0 8.6 0.1 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 2.2 0.3 12.0 1.1 0.0 0.0 0.0 LAMC3 DKFZp434E202 ENSG00000050555 "Laminin subunit gamma 3" Q9Y6N6 9 131009082-131094473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.8;testis: 32.5" "Group enriched" "Detected in some" 5 "Leydig cells: 109.6;Peritubular cells: 342.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 5.2;EFO-21: 20.5;Hep G2: 7.4;SiHa: 7.6;U-2 OS: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022814 Enhanced "Secreted to extracellular matrix" NA NA 240000 "HPA022814: AB_2670960" "unprognostic (9.77e-2)" "unprognostic (1.90e-1)" "unprognostic (9.55e-3)" "unprognostic (2.09e-1)" "unprognostic (2.15e-1)" "unprognostic (1.22e-2)" "unprognostic (1.38e-2)" "unprognostic (2.28e-3)" "unprognostic (6.27e-2)" "unprognostic (1.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.38e-1)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (1.63e-1)" "unprognostic (3.34e-1)" "unprognostic (7.83e-2)" 1.3 9.5 1.0 0.9 2.0 0.6 1.6 0.8 3.0 23.5 1.3 2.4 2.2 1.0 6.0 5.1 1.2 1.2 9.1 0.9 1.4 1.0 8.8 3.7 15.6 0.6 1.7 2.1 1.3 3.3 0.9 8.8 50.8 3.6 7.0 0.7 7.5 1.8 4.9 0.7 6.2 0.6 10.7 1.9 17.0 1.0 32.5 0.8 0.0 1.1 2.4 0.5 13.8 12.4 0.7 0.2 1.7 0.3 0.3 0.8 0.1 0.0 0.7 5.2 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 20.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.5 0.0 0.8 7.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.5 0.1 7.6 0.0 3.3 0.6 0.0 0.6 0.0 0.0 6.4 0.2 0.0 0.0 0.1 0.4 0.0 0.1 0.0 1.2 0.3 0.3 0.2 0.0 0.2 0.7 0.5 0.1 0.2 0.4 0.8 0.5 1.7 0.3 0.1 0.2 0.5 0.1 1.0 2.0 0.8 3.0 1.4 1.0 1.7 2.1 3.6 0.8 0.0 0.0 0.0 0.0 6.1 0.0 1.1 0.0 0.0 0.0 1.8 0.0 0.8 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.6 36.3 0.0 0.0 0.0 1.3 0.0 0.0 3.7 0.0 3.4 109.6 0.0 10.1 0.0 0.0 0.0 0.1 0.0 342.3 0.0 0.0 45.3 6.6 0.6 3.2 3.9 0.8 0.0 0.0 0.0 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122213-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 123.9" "Group enriched" "Detected in many" 7 "Alveolar cells type 2: 374.8;monocytes: 592.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Group enriched" "Detected in many" 8 "granulocytes: 7.6;T-cells: 6.6" "Cell line enhanced" "Detected in some" "EFO-21: 57.7;HDLM-2: 14.6;HHSteC: 21.4;hTCEpi: 19.5;JURKAT: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB025133, HPA051467" Enhanced Enhanced Vesicles NA NA 47000 Vesicles "CAB025133: , HPA051467: AB_2681495" "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.5 0.7 0.4 14.1 0.4 0.0 0.5 0.3 0.4 1.0 0.6 0.1 0.6 0.4 0.4 1.0 2.5 0.5 0.8 0.4 0.4 0.4 0.8 0.6 123.9 11.2 0.4 0.1 0.4 8.3 0.0 0.6 1.0 0.6 1.0 1.7 0.2 6.8 1.9 0.4 1.9 1.4 0.8 0.5 2.0 0.8 8.4 0.0 21.3 8.3 3.1 11.3 3.3 0.9 0.4 0.0 7.6 0.1 0.8 6.6 1.1 3.5 0.1 0.0 0.5 0.0 0.0 2.8 0.0 0.9 0.6 0.1 0.8 1.8 0.0 57.7 0.3 6.5 0.5 1.2 2.2 0.1 14.6 1.7 0.0 0.1 0.1 21.4 0.0 0.5 0.3 19.5 0.0 2.6 0.0 2.6 17.7 0.1 3.4 0.1 0.0 0.8 0.1 0.1 0.3 0.8 0.0 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.1 1.5 0.7 1.1 0.1 2.7 0.0 1.0 0.1 0.0 1.2 4.3 0.1 0.0 0.0 0.0 0.4 0.1 7.6 0.4 0.0 3.2 0.1 2.7 1.7 0.0 0.4 3.5 2.0 1.9 0.8 0.1 0.0 6.6 1.1 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.6 0.0 59.6 374.8 0.5 3.2 5.4 0.0 1.2 2.5 9.4 15.9 1.8 0.0 1.9 0.0 0.6 26.0 0.5 0.0 0.0 5.3 0.2 0.2 1.2 17.4 0.0 1.3 0.0 0.0 0.0 0.0 69.6 0.6 3.1 1.7 592.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 5.0 1.0 0.5 0.3 2.0 LAMP5 "BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46" ENSG00000125869 "Lysosomal associated membrane protein family member 5" Q9UJQ1 20 9514358-9530524 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.1;brain: 105.2" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 57.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "basal ganglia: 105.2" "Cell type enriched" "Detected in some" 15 "plasmacytoid DC: 42.1" "Lineage enriched" "Detected in many" 30 "dendritic cells: 42.1" "Cell line enhanced" "Detected in some" "Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004802, HPA070765" Enhanced Uncertain "Mitotic spindle,Centriolar satellite,Cytosol" NA NA Cytosol "Mitotic spindle, Centriolar satellite" "HPA004802: AB_10603682, HPA070765: AB_2686309" "unprognostic (2.78e-2)" "unprognostic (3.90e-3)" "unprognostic (5.73e-4)" "unprognostic (5.47e-2)" "unprognostic (7.89e-2)" "unprognostic (2.67e-1)" "unprognostic (3.80e-3)" "unprognostic (1.45e-1)" "unprognostic (1.54e-2)" "unprognostic (1.91e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (6.46e-6)" "unprognostic (5.12e-3)" "unprognostic (3.74e-2)" "unprognostic (1.08e-2)" "unprognostic (4.49e-3)" 0.5 4.1 21.6 1.5 105.2 2.0 1.0 2.3 28.6 9.1 1.3 0.6 1.8 1.3 4.6 6.0 0.6 9.7 2.9 0.6 18.7 4.1 0.9 0.5 1.1 4.8 4.5 7.7 21.2 1.3 0.3 2.0 0.4 23.2 2.3 1.4 2.6 1.4 3.6 0.3 0.5 1.4 3.8 6.7 1.4 1.6 1.1 4.8 0.0 1.1 0.0 4.7 1.2 0.6 1.4 42.1 0.9 0.5 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.1 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.1 0.0 0.0 42.1 0.0 0.7 21.6 105.2 2.3 19.1 18.7 4.1 4.5 7.7 23.2 4.8 0.0 1.4 2.2 0.0 0.1 7.5 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.6 5.8 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 1.1 57.2 0.0 0.0 1.2 5.6 0.6 0.2 3.3 8.2 0.0 4.0 0.2 0.0 0.0 0.0 4.9 0.0 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 LAMTOR4 C7orf59 ENSG00000188186 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4" Q0VGL1 7 100148907-100155944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 206.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 206.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020998 Enhanced Supported Vesicles NA NA Vesicles "HPA020998: AB_1845762" "prognostic favorable (2.48e-4)" "prognostic favorable (6.08e-4)" "unprognostic (1.29e-2)" "unprognostic (1.14e-1)" "unprognostic (8.21e-3)" "unprognostic (6.11e-2)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (6.17e-2)" "unprognostic (1.57e-1)" "unprognostic (2.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.45e-1)" "unprognostic (1.68e-2)" 31.0 30.7 43.8 36.0 40.2 54.7 43.2 20.9 70.6 28.5 41.8 27.9 26.5 28.6 25.0 35.3 32.9 35.9 36.0 42.2 39.5 35.1 36.3 24.9 32.0 44.7 49.5 30.7 30.0 36.9 19.3 28.5 26.8 38.7 30.8 34.5 31.2 35.4 27.5 44.4 84.7 27.2 31.3 47.8 41.5 29.7 21.3 35.2 15.7 37.3 33.1 26.6 31.3 39.6 31.4 35.1 206.0 53.2 17.6 26.5 46.2 19.2 46.9 24.8 31.3 26.4 30.5 20.2 11.6 28.6 21.6 26.8 21.6 31.1 31.1 39.3 17.5 39.5 20.4 23.5 29.9 9.3 31.4 66.4 24.8 44.4 37.2 24.9 19.2 35.9 36.5 29.6 22.6 28.0 24.2 33.0 29.2 23.3 50.2 29.4 91.9 18.6 77.5 26.3 53.5 37.7 19.6 20.4 55.4 24.5 23.6 17.5 32.4 21.4 50.4 38.4 19.8 20.2 38.2 22.0 20.7 30.8 42.6 18.6 30.5 40.6 57.6 33.0 54.0 29.3 52.0 53.2 183.0 19.6 46.9 16.3 31.4 24.8 20.2 35.1 27.7 25.5 20.5 206.0 17.6 43.4 29.7 26.5 46.2 43.8 40.2 20.9 70.6 39.5 35.1 49.5 30.7 38.7 35.2 86.4 157.1 194.3 153.1 244.3 54.7 157.4 145.2 139.2 85.3 207.6 11.8 217.7 452.6 149.0 26.3 183.1 559.6 0.0 283.4 159.4 191.6 159.9 180.0 212.1 461.4 55.6 287.5 220.4 484.9 36.2 135.4 342.4 411.7 182.1 346.6 148.8 173.2 634.8 113.1 406.9 51.3 142.3 219.3 71.5 128.6 579.4 168.4 176.8 418.7 161.9 LANCL1 "GPR69A, p40" ENSG00000115365 "LanC like 1" O43813 2 210431249-210477652 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.1" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 104.6;Late spermatids: 88.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034994 Enhanced Uncertain Microtubules NA NA 13000 Microtubules "HPA034994: AB_10601936" "unprognostic (2.34e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (2.67e-2)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.10e-2)" "unprognostic (9.76e-2)" "unprognostic (2.82e-2)" "unprognostic (2.08e-1)" "unprognostic (2.13e-3)" "unprognostic (1.23e-1)" "unprognostic (9.27e-2)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 10.7 11.5 26.2 5.7 43.8 6.6 14.0 24.0 48.7 10.3 8.5 66.1 3.5 8.6 12.2 8.4 12.4 10.0 9.4 16.6 36.6 23.0 16.1 9.5 8.5 10.0 43.5 21.5 14.0 9.9 34.9 9.4 8.9 47.3 14.3 9.5 6.6 7.8 14.1 10.4 17.3 8.2 13.9 73.1 8.9 7.3 21.2 37.1 8.7 10.1 5.9 10.9 9.1 7.1 8.6 8.0 6.1 7.4 7.5 13.0 6.0 9.9 11.3 18.2 18.4 20.8 29.5 12.7 15.3 19.8 14.2 18.7 12.6 11.5 8.6 20.1 17.4 23.1 10.4 11.8 24.7 24.0 9.9 12.7 15.1 39.5 22.2 17.3 19.1 5.4 21.2 20.4 18.6 15.2 32.2 20.5 26.7 18.8 14.1 18.3 8.8 25.6 10.6 12.1 12.2 7.9 11.6 25.4 12.7 26.0 9.8 17.4 24.2 17.9 38.5 20.0 28.1 13.1 10.3 20.8 25.0 16.8 13.0 16.0 8.7 16.3 12.0 23.5 14.9 28.8 5.8 2.4 6.1 12.1 5.1 11.8 7.8 10.8 12.1 8.0 8.6 11.5 13.0 0.9 7.5 7.4 7.1 11.1 6.0 26.2 43.8 24.0 48.7 36.6 23.0 43.5 21.5 47.3 37.1 11.9 13.9 9.0 6.7 23.4 26.4 32.3 5.1 13.4 12.5 19.2 17.7 8.7 13.3 8.5 104.6 11.9 5.3 0.0 10.4 4.5 11.0 7.2 5.8 14.3 7.6 47.7 6.4 6.7 8.3 88.3 12.0 4.9 15.1 2.8 7.5 20.4 5.1 3.5 18.0 13.9 22.8 19.4 17.5 30.4 17.7 29.0 4.2 10.7 13.4 5.6 LANCL2 "GPR69B, TASP" ENSG00000132434 "LanC like 2" Q9NS86 7 55365448-55433742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 38.4;Late spermatids: 42.1" "Cancer enhanced" "Detected in all" "glioma: 52.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 7 "A-431: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019711, HPA029535" Uncertain Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019711: AB_1852699, HPA029535: AB_10602342" "unprognostic (1.11e-1)" "unprognostic (6.89e-2)" "unprognostic (7.28e-2)" "unprognostic (1.28e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (1.01e-1)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.89e-4)" "unprognostic (1.35e-3)" "unprognostic (5.58e-2)" "prognostic favorable (1.03e-6)" "unprognostic (4.58e-3)" "unprognostic (1.04e-2)" "unprognostic (3.94e-1)" "unprognostic (1.45e-1)" 3.1 4.9 20.4 2.3 17.0 3.1 5.9 9.9 28.5 6.1 4.6 19.8 1.8 5.0 9.6 5.3 3.5 5.6 3.8 3.9 17.2 11.3 6.0 4.8 3.0 4.0 12.9 21.1 9.6 3.4 10.4 4.2 3.9 10.1 5.9 4.7 2.4 3.3 6.9 5.7 5.3 4.2 7.0 10.8 2.8 3.5 5.7 13.1 3.3 6.6 0.3 2.7 2.8 2.7 2.7 4.7 0.7 4.5 3.6 6.0 2.6 58.4 2.0 4.1 2.7 1.2 2.2 2.3 2.7 3.2 4.1 3.5 2.0 1.7 4.1 2.5 3.8 4.1 2.6 2.2 1.5 2.5 1.8 4.3 1.4 1.6 2.0 2.2 4.5 2.7 3.9 1.6 3.1 1.0 2.1 2.0 1.9 2.5 2.7 3.8 1.7 1.1 2.1 7.9 1.6 2.5 1.7 1.9 2.0 2.7 4.7 7.2 6.8 3.8 5.7 1.5 1.6 2.3 4.8 3.3 2.6 3.5 4.9 5.1 2.6 3.1 4.4 2.0 1.0 4.9 0.4 3.6 0.7 2.6 4.5 4.5 2.7 3.4 3.9 4.7 2.6 3.1 2.7 0.5 3.6 3.0 3.7 6.0 2.6 20.4 17.0 9.9 28.5 17.2 11.3 12.9 21.1 10.1 13.1 3.0 6.2 7.6 5.5 3.5 8.0 7.5 7.6 8.1 4.5 10.4 5.9 10.6 5.0 6.7 38.4 4.8 6.6 23.3 10.4 11.1 9.3 4.3 11.5 7.3 6.6 14.3 12.1 9.2 6.3 42.1 8.3 5.0 0.0 9.0 8.6 10.6 6.7 7.0 7.1 19.5 8.2 0.0 3.1 12.0 10.9 3.3 15.9 4.4 10.3 4.7 LANCL3 FLJ42925 ENSG00000147036 "LanC like 3" Q6ZV70 X 37571569-37684463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.1;lung: 6.8" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 7.8;Suprabasal keratinocytes: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 7.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 17.2;HMC-1: 5.6;K-562: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005470, HPA076575" Approved Approved Mitochondria NA NA Mitochondria "HPA005470: AB_2134886, HPA076575: AB_2732315" "unprognostic (6.76e-2)" "unprognostic (4.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.85e-1)" "unprognostic (5.20e-2)" "unprognostic (5.26e-2)" "unprognostic (3.60e-1)" "unprognostic (1.21e-3)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.81e-2)" "unprognostic (2.88e-1)" "unprognostic (7.90e-5)" "unprognostic (4.01e-3)" "unprognostic (7.93e-3)" "unprognostic (1.11e-2)" "unprognostic (2.08e-2)" 1.2 0.8 0.7 0.3 2.3 0.9 0.4 2.5 2.4 1.2 3.8 0.7 0.2 0.6 0.5 0.3 4.6 0.2 0.9 0.7 1.1 2.8 0.4 0.2 6.8 0.4 1.3 1.3 1.3 0.2 0.1 1.7 0.2 2.2 0.6 2.8 2.5 1.1 0.9 1.0 2.6 1.1 1.9 1.8 0.2 2.2 1.8 0.9 0.2 1.2 1.7 1.2 1.8 2.9 0.3 0.2 7.1 0.2 1.1 1.8 0.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 1.1 2.5 0.3 0.0 0.0 0.3 17.2 1.8 0.0 0.0 0.0 5.6 0.0 0.5 0.0 0.1 0.0 0.3 0.0 3.9 0.0 1.2 0.0 0.2 0.3 0.4 0.2 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 1.2 0.0 0.0 1.6 0.7 0.0 0.0 2.9 0.0 0.4 7.1 0.2 0.9 1.0 0.2 0.8 0.2 0.4 1.8 0.1 0.3 0.1 1.0 1.1 1.1 0.2 0.2 0.6 0.7 0.7 2.3 2.5 2.4 1.1 2.8 1.3 1.3 2.2 0.9 3.0 2.6 0.0 1.1 7.8 0.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.6 0.0 0.2 0.1 0.4 0.5 1.1 0.0 0.1 3.2 1.7 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.5 1.3 0.9 1.4 0.0 1.4 0.0 1.7 0.2 1.7 3.9 0.1 1.0 0.6 2.2 LAPTM5 ENSG00000162511 "Lysosomal protein transmembrane 5" Q13571 1 30732469-30757820 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5" "Group enriched" "Detected in many" 5 "B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051293 Approved Approved Cytosol NA NA Cytosol "HPA051293: AB_2681424" "unprognostic (3.12e-2)" "prognostic favorable (3.40e-4)" "unprognostic (6.86e-2)" "unprognostic (4.05e-3)" "unprognostic (1.63e-1)" "unprognostic (8.45e-2)" "unprognostic (1.43e-1)" "unprognostic (3.76e-1)" "unprognostic (1.22e-3)" "unprognostic (2.30e-1)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (9.47e-2)" "unprognostic (8.18e-3)" "unprognostic (5.98e-2)" "unprognostic (3.94e-2)" 56.0 15.5 11.5 59.1 17.8 157.5 15.0 2.2 10.4 8.2 11.2 20.7 1.8 9.5 7.5 6.8 8.3 13.7 19.9 9.2 11.2 12.7 14.0 18.2 60.8 144.5 19.0 3.3 7.7 6.3 2.0 6.8 20.1 14.6 8.2 13.2 7.4 11.7 4.7 4.0 5.5 37.1 12.9 33.8 130.9 9.5 6.7 15.8 75.2 10.1 5.2 91.2 21.4 6.4 98.2 69.1 145.1 109.3 26.0 55.4 166.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.1 4.9 0.1 0.1 0.1 0.0 0.0 0.0 5.2 0.0 89.3 0.0 0.1 0.0 56.6 211.5 0.0 0.1 0.0 0.3 0.0 10.8 6.1 1.1 2.9 0.7 0.0 9.7 11.9 0.0 0.0 0.0 66.3 8.7 32.9 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 36.0 12.5 0.0 0.2 0.0 0.2 0.2 0.0 76.8 0.2 46.2 0.1 73.5 109.3 115.3 47.7 87.9 55.4 70.2 43.7 44.6 69.1 98.2 44.2 43.1 145.1 26.0 83.9 33.2 53.7 166.6 11.5 17.8 2.2 10.1 11.2 12.7 19.0 3.3 14.6 15.8 23.8 148.6 749.7 1.1 21.2 0.0 5.6 10.2 18.7 25.0 3.5 0.0 5.6 0.0 0.4 1.5 31.3 0.7 0.0 0.6 5.1 16.6 0.8 621.6 4.2 1099.3 0.0 1.2 36.2 831.6 1.7 1.4 787.9 47.2 70.3 0.6 0.2 0.9 0.0 0.4 2.2 1.3 0.0 6.8 0.3 0.3 17.6 7.4 409.7 0.3 1.6 LARGE1 "KIAA0609, LARGE" ENSG00000133424 "LARGE xylosyl- and glucuronyltransferase 1" O95461 22 33162226-33922841 "Disease related genes, Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 2: 5.1;Club cells: 4.5;Ductal cells: 6.3;Exocrine glandular cells: 6.9;Hofbauer cells: 4.6;Pancreatic endocrine cells: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 5.8" "Group enriched" "Detected in many" 4 "B-cells: 5.8;granulocytes: 1.9" "Cell line enhanced" "Detected in many" "U-266/84: 19.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.16e-1)" "unprognostic (7.77e-3)" "unprognostic (3.79e-1)" "unprognostic (1.74e-3)" "unprognostic (1.63e-1)" "unprognostic (1.48e-2)" "unprognostic (4.90e-2)" "unprognostic (1.39e-2)" "unprognostic (5.21e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-2)" "unprognostic (1.35e-2)" "unprognostic (7.12e-3)" "unprognostic (1.19e-1)" "unprognostic (3.68e-2)" "unprognostic (2.93e-1)" "unprognostic (3.96e-3)" 3.2 2.8 4.4 3.2 6.9 0.0 3.2 4.7 10.6 5.1 7.7 3.2 3.2 2.9 7.2 3.2 3.2 3.5 3.3 16.6 6.8 2.0 3.2 3.2 3.2 3.2 3.2 3.2 9.2 3.9 2.0 3.2 3.2 3.2 7.0 4.5 3.2 3.2 10.7 18.0 2.0 3.2 7.6 3.2 3.2 4.8 43.1 3.2 3.2 3.2 3.2 3.2 6.8 3.3 5.8 0.3 1.9 0.2 0.4 0.8 0.1 3.0 8.1 11.9 5.1 2.8 0.9 5.6 9.6 4.4 1.4 0.0 2.2 0.4 11.8 1.9 10.9 3.3 1.5 7.6 0.0 0.3 0.2 6.0 0.0 0.1 7.3 3.8 0.0 1.3 1.4 0.7 0.2 0.0 0.1 0.0 0.2 0.2 2.0 3.1 9.1 0.1 6.0 5.0 8.9 0.6 7.5 11.6 2.1 3.2 12.1 4.9 2.0 4.9 6.5 7.7 10.6 9.5 0.7 0.2 5.8 9.3 4.2 2.1 15.1 19.2 0.4 10.3 0.0 0.1 0.3 0.2 0.1 0.4 0.1 0.8 2.0 0.3 0.3 0.0 5.8 0.1 0.3 1.9 0.4 0.1 0.3 0.1 0.1 4.4 6.9 4.7 8.0 6.8 2.0 3.2 3.2 3.2 3.2 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 1.8 0.0 0.1 0.0 6.3 0.0 0.0 0.0 0.0 6.9 0.6 0.0 0.0 1.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 LARGE2 "FLJ35207, GYLTL1B, PP5656" ENSG00000165905 "LARGE xylosyl- and glucuronyltransferase 2" Q8N3Y3 11 45921621-45929096 "Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 38.9;placenta: 29.6" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 128.7;Syncytiotrophoblasts: 97.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "pons and medulla: 2.1" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5;naive B-cell: 5.8" "Lineage enriched" "Detected in many" 5 "B-cells: 5.8" "Cell line enhanced" "Detected in some" "BEWO: 17.8;NTERA-2: 16.7;SK-BR-3: 12.0;T-47d: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA056621 Approved "Intracellular and membrane" NA NA "HPA056621: AB_2683194" "unprognostic (9.82e-2)" "unprognostic (3.63e-2)" "unprognostic (3.65e-2)" "unprognostic (2.43e-2)" "unprognostic (6.20e-2)" "unprognostic (4.46e-3)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.30e-2)" "unprognostic (6.94e-2)" "prognostic favorable (3.04e-12)" "unprognostic (2.31e-1)" "unprognostic (9.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-2)" 0.2 1.4 0.2 2.8 0.2 0.1 2.8 0.2 0.4 3.5 0.8 0.8 16.0 0.6 1.6 8.3 10.5 2.5 0.4 0.4 0.4 0.1 12.2 1.7 2.5 2.8 0.2 0.2 1.8 38.9 9.5 6.6 29.6 2.1 5.8 0.2 14.8 20.7 12.7 0.2 11.1 2.3 0.7 0.2 1.6 5.2 1.2 0.2 2.0 8.1 3.9 8.1 1.3 3.7 5.8 0.0 0.1 0.0 0.8 1.1 0.2 0.6 0.8 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 4.2 0.3 0.0 0.4 0.0 0.4 4.0 0.0 7.6 0.0 0.0 2.4 0.0 0.5 4.6 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 4.8 0.0 0.0 1.3 0.1 0.0 16.7 6.0 0.5 0.4 0.0 1.5 0.2 0.3 4.9 0.5 0.1 12.0 0.0 1.0 36.4 0.0 0.0 0.1 5.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 3.5 0.3 0.9 0.0 5.8 0.2 0.4 0.1 0.8 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.4 0.4 0.1 0.2 0.2 2.1 0.2 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.0 0.0 128.7 3.3 3.5 0.0 0.0 0.0 0.0 5.5 5.5 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 LASP1 "Lasp-1, MLN50" ENSG00000002834 "LIM and SH3 protein 1" Q14847 17 38869859-38921770 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 124.5" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 467.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012072, CAB022049" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 26000000 "Plasma membrane, Cytosol" "Focal adhesion sites" "CAB022049: , HPA012072: AB_1852714" "unprognostic (1.23e-1)" "unprognostic (2.09e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (4.57e-4)" "unprognostic (1.47e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (2.41e-4)" "unprognostic (1.06e-3)" "unprognostic (2.24e-1)" "unprognostic (9.60e-2)" "unprognostic (9.87e-3)" "unprognostic (1.01e-1)" "unprognostic (9.65e-3)" "unprognostic (1.29e-3)" "unprognostic (3.95e-2)" "unprognostic (1.60e-3)" "unprognostic (4.53e-2)" 51.2 20.0 23.8 40.3 22.4 45.4 35.5 15.5 25.7 23.6 57.4 16.3 18.7 54.4 23.4 24.1 22.4 20.8 48.3 15.2 18.4 23.3 33.1 47.5 33.3 44.2 20.0 14.3 28.4 30.1 10.1 17.6 40.0 16.1 18.9 38.6 24.2 22.4 24.1 10.7 18.3 124.5 21.3 12.2 43.1 39.5 13.9 12.9 40.5 18.3 18.7 33.7 22.0 28.3 6.4 13.9 34.0 19.9 17.3 16.5 13.1 35.4 73.9 21.6 19.1 31.8 34.5 37.3 44.6 43.6 47.0 34.6 22.0 38.6 16.2 37.3 68.9 26.7 56.5 9.8 33.9 41.2 11.8 5.3 7.7 21.4 38.3 30.2 17.8 23.4 30.6 11.9 39.8 11.3 29.4 31.5 10.0 13.1 5.4 65.4 11.7 21.1 27.5 10.8 31.2 18.5 11.9 11.5 20.4 57.7 31.2 3.2 7.9 26.5 27.9 23.1 41.8 44.0 21.8 55.0 28.2 41.2 33.0 27.0 14.0 18.4 12.6 29.8 16.0 33.9 9.9 14.8 16.8 16.5 17.1 11.3 6.4 8.4 11.0 13.9 6.3 7.2 10.9 34.0 17.3 19.9 10.7 10.7 13.1 23.8 22.4 15.5 25.7 18.4 23.3 20.0 14.3 16.1 12.9 38.7 25.9 38.3 19.5 37.2 55.7 0.8 66.2 32.1 19.4 69.8 9.8 4.3 14.9 58.2 85.5 48.9 225.0 0.0 65.7 33.5 47.6 22.3 51.8 85.9 75.8 25.4 83.1 70.6 116.7 467.6 48.1 58.0 33.7 52.3 91.2 21.1 95.7 106.3 37.4 62.1 22.0 64.7 29.7 2.1 4.1 24.8 5.4 60.9 75.9 23.8 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990783 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "blood: 58.1;lymphoid tissue: 193.6" "Group enriched" "Detected in many" 5 "granulocytes: 73.2;T-cells: 103.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1" "Group enriched" "Detected in many" 134 "granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1" "Cell line enhanced" "Detected in some" "HEL: 31.0;HMC-1: 131.1;MOLT-4: 44.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002223, HPA011157, CAB012978" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 75000 "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 4.8 1.8 1.6 27.6 3.0 8.5 2.5 6.6 2.3 3.9 10.8 2.0 2.0 4.9 7.7 3.1 4.3 4.2 5.8 3.1 1.9 1.9 6.0 3.3 7.8 33.2 1.7 1.7 3.0 2.7 1.4 6.0 2.8 1.8 8.5 2.8 3.1 12.2 5.4 2.0 5.8 9.0 3.1 1.9 13.9 5.1 2.3 1.7 193.6 7.3 4.6 50.3 6.4 5.4 0.2 0.2 38.2 0.2 15.7 58.1 26.8 0.1 0.3 0.2 0.4 0.6 0.3 0.8 0.8 0.2 0.2 0.3 0.3 0.5 0.1 1.1 0.3 0.1 0.4 0.4 0.2 0.1 0.2 0.5 31.0 0.7 0.5 0.1 0.9 131.1 0.3 0.6 0.2 0.1 0.4 0.1 10.5 0.4 3.7 0.1 0.8 44.6 6.1 0.5 0.0 0.4 0.5 0.1 3.9 0.3 0.2 0.8 0.1 0.1 0.3 0.3 0.2 0.4 5.1 0.6 0.6 3.0 0.6 0.2 1.2 1.0 0.4 7.9 0.4 0.5 38.2 0.2 0.1 47.9 0.2 33.5 0.2 46.9 47.9 0.1 0.2 44.6 42.6 2.3 15.7 0.1 0.2 58.1 26.8 1.6 3.0 6.6 2.3 1.9 1.9 1.7 1.7 1.8 1.7 0.0 19.1 1.9 1.7 6.4 10.4 0.4 7.6 0.0 4.5 8.7 5.9 1.9 1.7 1.3 0.1 2.4 0.7 0.0 0.5 0.8 2.7 1.8 73.2 2.6 14.9 6.4 0.0 8.6 6.5 0.0 1.4 9.0 10.1 1.8 1.5 5.7 0.7 0.0 0.7 0.4 10.7 0.0 3.4 1.4 2.4 4.5 2.3 103.8 1.3 0.7 LAT2 "HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5" ENSG00000086730 "Linker for activation of T cells family member 2" Q9GZY6 7 74199652-74229834 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 98.4;lymphoid tissue: 36.7" "Cell type enhanced" "Detected in many" 12 "B-cells: 89.1;granulocytes: 165.4;Hofbauer cells: 75.1;Kupffer cells: 75.9;Macrophages: 83.0;monocytes: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 98.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 46.6;REH: 53.0;RPMI-8226: 19.0;THP-1: 48.0;U-937: 46.8" "Low region specificity" "Detected in all" HPA003462 Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA003462: AB_1079238" "unprognostic (1.24e-2)" "unprognostic (1.14e-2)" "unprognostic (1.32e-2)" "unprognostic (3.55e-3)" "unprognostic (1.09e-1)" "unprognostic (3.30e-3)" "unprognostic (2.79e-2)" "unprognostic (1.33e-1)" "unprognostic (9.27e-2)" "unprognostic (1.19e-1)" "unprognostic (6.34e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (4.10e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (6.10e-4)" "unprognostic (7.44e-2)" "unprognostic (2.03e-1)" 4.6 3.7 10.3 21.4 19.3 32.8 2.5 2.7 9.6 2.8 3.9 11.6 0.5 3.3 2.5 2.4 2.5 3.8 5.9 2.4 8.8 6.5 3.0 3.8 11.6 29.3 21.9 2.5 1.4 2.8 1.0 2.8 4.4 15.7 4.5 4.7 2.3 3.6 2.2 2.7 1.8 9.9 5.0 19.3 36.7 3.6 1.6 17.6 3.2 2.4 1.0 32.7 5.8 4.6 26.8 32.5 98.4 39.5 10.0 1.3 24.7 0.4 0.2 0.2 0.8 0.0 0.0 0.3 0.3 0.3 0.2 0.2 0.5 8.1 5.3 0.1 0.1 1.6 0.2 0.0 0.3 0.1 8.5 0.3 2.1 0.3 0.3 0.0 15.5 15.6 0.1 0.2 0.5 0.1 0.3 0.0 0.2 0.3 2.4 0.2 0.3 0.3 46.6 0.2 1.3 0.5 53.0 0.2 19.0 0.0 0.4 0.2 0.2 0.1 0.3 0.2 0.2 0.2 48.0 0.6 0.6 5.6 0.2 0.4 0.2 1.5 8.3 2.7 46.8 0.3 98.4 39.5 5.9 1.3 22.3 0.1 24.4 0.3 0.1 32.5 26.8 0.1 0.4 69.1 10.0 12.4 1.2 0.6 24.7 10.3 19.3 2.7 9.6 8.8 6.5 21.9 2.5 15.7 17.6 3.0 23.9 89.1 0.6 3.1 0.0 0.8 7.6 10.7 5.7 3.5 0.0 0.5 0.0 0.0 2.3 1.0 0.0 0.0 0.2 0.9 1.4 1.0 165.4 3.2 75.1 0.0 7.5 4.9 75.9 1.9 0.0 83.0 1.7 54.1 0.2 0.3 0.6 0.0 0.7 0.0 1.3 0.0 0.7 0.4 1.1 2.3 1.0 51.6 0.4 0.5 LAX1 "FLJ20340, LAX" ENSG00000122188 "Lymphocyte transmembrane adaptor 1" Q8IWV1 1 203765176-203776233 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.7" "Group enriched" "Detected in some" 5 "granulocytes: 78.7;T-cells: 27.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0" "Group enriched" "Detected in many" 19 "B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9" "Group enriched" "Detected in some" 4 "Karpas-707: 11.7;U-266/70: 14.4;U-266/84: 32.4;U-698: 12.3" "Low region specificity" "Detected in all" "HPA002461, HPA003887, CAB025358" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Golgi apparatus" "CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240" "unprognostic (2.85e-3)" "unprognostic (3.83e-3)" "unprognostic (3.90e-4)" "unprognostic (3.65e-2)" "unprognostic (5.22e-2)" "unprognostic (1.03e-5)" "unprognostic (2.99e-2)" "unprognostic (4.91e-2)" "unprognostic (4.36e-2)" "unprognostic (3.31e-3)" "unprognostic (4.77e-1)" "unprognostic (4.36e-1)" "unprognostic (4.23e-4)" "unprognostic (3.07e-1)" "unprognostic (1.12e-1)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" 1.6 0.6 0.4 19.9 0.4 1.3 1.3 0.4 0.4 1.8 3.4 0.0 0.2 2.1 1.2 1.1 4.5 1.1 3.8 0.6 0.4 0.4 1.0 0.8 6.3 17.4 0.4 0.0 0.7 0.6 0.0 0.5 0.1 0.0 2.2 2.6 1.1 5.7 1.5 0.5 1.0 5.5 1.1 0.5 11.7 3.4 1.0 0.0 22.7 1.1 0.7 26.7 6.3 2.8 6.5 0.0 0.3 0.0 4.6 9.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 11.7 0.0 0.0 3.8 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 32.4 12.3 0.0 0.9 0.0 0.0 0.0 0.3 9.9 0.0 7.4 6.5 5.7 7.3 0.0 1.5 4.5 5.9 0.0 4.6 0.0 0.0 6.0 2.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 3.4 11.5 0.3 1.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 78.7 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.9 10.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 27.9 0.0 0.4 LBHD1 "C11orf48, MGC2477" ENSG00000162194 "LBH domain containing 1" Q9BQE6 11 62662817-62672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 67.7" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 16.0;Club cells: 4.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.1;JURKAT: 33.3" "HPA012127, HPA023592" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012127: AB_1845527, HPA023592: AB_1845528" "unprognostic (4.34e-4)" "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (7.90e-3)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.18e-8)" "unprognostic (2.75e-1)" "unprognostic (1.03e-1)" "unprognostic (1.52e-2)" "unprognostic (2.81e-1)" "unprognostic (6.79e-2)" "unprognostic (2.78e-8)" "unprognostic (3.69e-2)" "unprognostic (1.62e-1)" "unprognostic (5.79e-2)" "unprognostic (4.72e-3)" 4.7 14.7 1.7 6.2 3.9 6.9 4.2 3.4 3.6 3.8 4.0 3.9 7.6 4.0 2.3 5.4 4.0 4.1 5.3 67.7 3.4 2.1 4.1 8.3 4.4 8.3 1.8 3.3 3.3 4.1 7.5 4.4 2.3 3.7 4.6 4.1 4.5 4.2 10.0 4.8 2.6 6.0 2.5 3.1 10.4 4.6 6.7 2.3 6.2 4.6 3.0 6.5 4.8 2.6 4.9 7.1 5.7 6.2 8.0 7.0 4.3 1.6 2.8 1.7 1.3 2.7 5.1 3.9 2.2 3.3 3.7 2.9 2.3 19.1 5.7 4.9 2.7 3.8 7.4 1.9 5.2 2.9 7.7 5.9 4.8 7.8 1.6 4.0 4.4 6.3 7.0 0.6 6.5 2.0 4.1 2.0 33.3 4.9 5.2 2.3 2.8 2.8 6.7 2.2 3.9 2.5 6.8 4.3 10.4 4.8 3.3 1.9 2.9 2.5 3.5 7.1 2.5 6.3 6.7 1.5 2.3 1.4 2.3 2.4 8.6 7.4 5.4 2.1 4.5 2.4 2.2 6.2 5.7 6.6 4.5 5.7 4.6 3.7 7.0 5.4 4.9 5.1 4.1 1.8 8.0 3.4 7.1 2.2 4.3 1.7 3.9 3.4 3.6 3.4 2.1 1.8 3.3 3.7 2.3 3.0 2.4 0.0 0.1 0.0 1.9 0.8 0.0 16.0 4.5 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 2.3 0.2 0.2 1.6 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 1.3 0.2 0.0 0.4 0.3 7.3 0.0 0.0 0.6 0.9 0.0 0.2 0.0 0.0 0.3 LBHD2 ENSG00000283071 "LBH domain containing 2" 14 103084210-103090027 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 1.9;brain: 1.6;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;HeLa: 2.2;Hep G2: 1.2;K-562: 1.0;PC-3: 1.5;RT4: 1.2;SiHa: 1.1" "Region enhanced" "Detected in many" "basal ganglia: 134.1" NA NA 1.9 0.0 1.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.3 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LBP BPIFD2 ENSG00000129988 "Lipopolysaccharide binding protein" P18428 20 38346356-38377023 "Plasma proteins, Predicted secreted proteins, Transporters" "Immunity, Innate immunity, Lipid transport, Transport" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "liver: 429.7" "Cell type enriched" "Detected in some" 15 "Hepatocytes: 356.7" "Cancer enriched" "Detected in many" 20 "liver cancer: 356.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "ASC diff: 12.4;HSkMC: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001508, CAB025905" Approved "Secreted to blood" NA NA 25000000000 910000000 "CAB025905: , HPA001508: AB_1079241" "unprognostic (4.20e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (4.54e-2)" "unprognostic (2.47e-1)" "unprognostic (3.80e-2)" "unprognostic (2.53e-2)" "unprognostic (5.50e-2)" "unprognostic (2.48e-3)" "unprognostic (6.15e-2)" "unprognostic (2.12e-1)" "unprognostic (7.93e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.62e-12)" "prognostic unfavorable (5.76e-4)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" 12.8 0.0 0.1 4.7 0.1 0.0 0.7 0.1 0.1 0.6 0.4 0.1 0.1 0.0 0.4 0.2 0.1 0.0 0.1 0.4 0.1 0.0 3.1 429.7 0.1 0.5 0.1 0.1 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 4.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 1.4 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 12.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.7 0.0 0.0 0.0 0.0 0.1 6.6 0.3 0.6 0.0 0.0 23.3 9.1 0.1 0.0 0.0 0.0 356.7 0.3 0.0 0.0 11.1 8.6 0.0 0.6 0.0 0.0 1.0 0.0 0.0 8.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LBR "DHCR14B, TDRD18" ENSG00000143815 "Lamin B receptor" Q14739 1 225401502-225428925 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" "DNA-binding, Oxidoreductase, Receptor" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 88.7" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049840, HPA062236" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "HPA049840: AB_2680908, HPA062236: AB_2684721" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (2.14e-3)" "unprognostic (1.32e-2)" "unprognostic (7.96e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.60e-2)" "unprognostic (1.11e-2)" "unprognostic (3.43e-2)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (6.42e-2)" "unprognostic (2.08e-1)" "unprognostic (5.45e-1)" "unprognostic (8.32e-2)" "unprognostic (2.78e-1)" 16.7 4.2 5.6 22.9 7.8 37.0 14.6 5.5 7.2 23.4 37.7 14.5 10.8 16.8 31.4 19.5 17.2 21.8 11.1 7.2 6.5 6.1 15.4 18.9 12.3 31.0 9.9 4.2 14.3 11.8 2.4 5.0 11.2 9.4 19.6 19.7 6.2 8.2 16.6 6.8 7.3 20.4 32.8 9.9 25.4 21.5 8.0 8.9 88.7 8.7 6.9 28.1 28.8 16.2 14.1 13.1 70.9 15.0 12.2 19.9 20.2 25.1 9.9 33.5 14.9 14.1 8.8 16.9 6.6 8.4 13.9 14.9 19.8 43.4 51.9 14.8 6.9 8.3 19.2 23.9 7.0 21.0 30.2 24.8 12.9 9.6 16.9 8.7 56.1 22.9 7.6 4.5 12.6 11.2 7.2 17.6 25.7 39.1 35.3 9.3 3.5 51.4 31.7 30.2 24.7 3.4 34.7 30.5 48.3 15.9 11.8 9.0 11.9 11.3 8.4 5.5 15.2 11.5 37.0 11.5 3.8 20.0 10.7 23.8 12.7 17.3 58.0 5.2 25.4 13.0 22.2 15.0 21.1 15.3 10.1 17.1 13.8 14.6 16.2 13.1 14.1 14.7 17.4 70.9 12.2 7.8 6.6 19.9 20.2 5.6 7.8 5.5 7.2 6.5 6.1 9.9 4.2 9.4 8.9 26.8 31.3 74.4 22.1 24.0 4.2 5.1 50.9 28.1 45.5 29.6 5.9 27.8 5.0 20.9 0.7 42.7 17.2 163.5 17.2 18.7 25.9 27.1 9.3 64.4 38.4 11.1 25.9 44.2 84.0 2.3 31.4 51.1 25.3 15.4 30.9 12.0 18.1 21.0 30.4 22.5 9.8 38.8 33.0 14.0 27.7 31.0 9.3 46.3 62.8 28.9 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 76 "brain: 11.8;skeletal muscle: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 7 "cerebellum: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6" "Group enriched" "Detected in some" 24 "cerebellum: 1.8;pons and medulla: 3.2" "Group enriched" "Detected in some" 21 "cerebellum: 2.9;pons and medulla: 2.8" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.4 0.0 0.0 0.0 13.6 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LBX2 ENSG00000179528 "Ladybird homeobox 2" Q6XYB7 2 74497517-74503316 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 13.8" "Cell type enhanced" "Detected in some" 11 "Hepatocytes: 2.8;Ito cells: 2.5;Proximal tubular cells: 6.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 9.3;Hep G2: 19.3;SK-MEL-30: 8.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.3;olfactory region: 0.9" HPA044257 Uncertain Approved Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA044257: AB_2678880" "unprognostic (5.24e-2)" "unprognostic (7.97e-2)" "unprognostic (2.35e-5)" "unprognostic (8.22e-4)" "unprognostic (2.95e-1)" "unprognostic (2.94e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (1.85e-1)" "unprognostic (3.25e-2)" "unprognostic (1.43e-5)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (1.87e-2)" 4.4 0.4 1.5 1.0 0.5 0.3 1.3 0.5 0.5 1.1 6.8 0.0 1.5 8.3 2.2 2.6 0.5 0.6 3.9 1.8 0.3 0.3 1.9 13.8 3.7 0.4 0.3 0.6 0.6 3.4 0.0 0.3 2.6 0.5 0.6 0.0 0.2 1.5 0.4 0.8 1.3 7.3 0.1 0.4 1.9 4.9 1.3 0.0 0.3 1.1 1.7 2.1 0.8 0.6 0.2 2.1 1.6 4.8 2.5 1.0 1.5 3.8 1.4 0.0 0.1 1.7 1.4 6.5 0.3 0.2 0.4 0.4 9.3 5.7 0.2 1.6 0.7 0.6 1.5 0.0 0.3 0.0 8.0 1.7 4.1 0.5 19.3 1.3 0.2 2.6 1.8 1.4 1.4 0.3 0.2 1.6 0.1 2.7 2.0 0.3 2.0 0.1 0.8 0.4 1.6 0.2 0.4 0.4 0.2 0.2 1.2 0.2 1.1 2.3 0.3 8.4 0.1 0.2 0.3 3.6 1.4 6.1 7.4 0.1 2.6 2.0 0.2 1.4 0.7 4.3 0.8 4.0 0.3 0.8 1.9 0.5 0.2 0.2 1.0 2.1 0.2 0.2 0.7 1.6 2.5 4.8 0.6 0.1 1.5 1.5 0.5 0.5 0.5 0.3 0.3 0.3 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.5 0.0 0.0 1.6 0.0 0.6 0.4 0.3 0.0 0.0 2.8 0.9 0.0 2.4 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 6.3 0.0 6.5 0.2 0.0 0.0 0.1 0.5 0.0 0.8 0.1 LCA5 C6orf152 ENSG00000135338 "LCA5, lebercilin" Q86VQ0 6 79484991-79537458 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 42.4" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 121.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029053, HPA029055" Supported NA NA "HPA029053: AB_10602020, HPA029055: AB_2672889" "unprognostic (8.96e-2)" "unprognostic (1.04e-1)" "unprognostic (3.06e-2)" "unprognostic (2.65e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.58e-2)" "unprognostic (1.34e-3)" "unprognostic (6.83e-2)" "unprognostic (2.73e-2)" "unprognostic (4.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (7.09e-3)" "unprognostic (1.39e-1)" "unprognostic (5.39e-2)" "unprognostic (3.21e-2)" 5.2 3.4 8.8 2.9 9.9 4.7 7.4 16.4 9.7 7.6 4.3 5.7 9.1 2.2 8.2 6.0 4.9 13.9 4.9 3.9 9.1 7.8 4.8 2.4 6.2 2.6 7.4 7.7 11.0 4.3 42.4 11.4 5.1 17.2 7.5 3.0 4.4 7.6 9.3 2.7 2.0 2.5 6.6 13.6 2.9 2.9 9.5 8.0 0.1 13.4 2.1 2.2 7.6 8.8 0.3 0.1 0.0 0.6 0.0 1.0 0.2 1.8 1.4 4.3 2.4 5.3 6.0 1.9 3.1 3.8 2.0 4.0 10.4 2.0 0.5 4.3 2.5 3.7 2.0 3.2 1.9 3.6 0.0 2.4 15.3 2.1 1.4 5.6 0.3 1.3 5.6 2.2 3.4 4.4 7.7 5.9 0.1 2.3 0.9 3.2 0.0 0.0 0.0 1.2 1.1 1.6 0.0 7.4 0.7 4.2 0.6 3.2 3.8 2.9 0.5 2.0 5.5 0.3 0.9 4.1 2.1 2.5 0.6 2.7 4.0 1.4 0.0 1.0 0.0 1.6 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.2 0.0 0.1 0.3 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 8.8 9.9 16.4 9.7 9.1 7.8 7.4 7.7 17.2 8.0 14.9 7.8 0.5 10.9 0.9 11.4 4.6 7.6 121.8 26.1 10.4 21.6 6.6 0.0 12.2 7.7 12.2 0.0 0.0 4.3 3.1 6.9 4.6 1.1 0.0 0.9 9.5 2.4 8.6 1.3 3.6 16.7 0.9 3.3 0.0 0.0 12.8 6.3 0.0 14.9 2.2 28.0 6.5 9.2 14.0 2.9 0.9 10.3 0.0 0.0 9.0 LCA5L "C21orf13, MGC33295" ENSG00000157578 "LCA5L, lebercilin like" O95447 21 39405844-39445805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 57.2" "Cell type enhanced" "Detected in many" 28 "Early spermatids: 967.3;Late spermatids: 347.9;Spermatocytes: 191.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 6.9;T-47d: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019790, HPA032010" Enhanced Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019790: AB_1845690, HPA032010: AB_2674110" "unprognostic (1.02e-1)" "unprognostic (3.81e-1)" "unprognostic (2.43e-1)" "unprognostic (2.54e-3)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (6.34e-2)" "unprognostic (1.27e-2)" "unprognostic (1.85e-2)" "unprognostic (5.50e-2)" "unprognostic (2.37e-1)" "unprognostic (7.53e-3)" "unprognostic (1.40e-1)" "unprognostic (1.04e-2)" "unprognostic (9.68e-3)" "unprognostic (1.95e-1)" 0.4 1.3 1.4 0.3 3.7 0.3 1.2 1.1 1.6 1.2 0.6 2.3 2.7 0.4 0.9 4.6 0.4 4.4 1.0 0.5 1.9 1.2 1.6 1.3 1.0 0.3 0.7 1.2 0.8 1.1 1.7 9.1 0.3 3.1 0.7 0.4 2.2 0.8 1.8 1.7 0.7 0.4 0.5 0.7 0.4 0.6 57.2 1.1 0.3 2.9 0.4 0.3 0.5 0.5 0.3 0.7 0.2 0.5 0.0 1.1 0.0 1.7 1.8 1.0 3.2 1.6 1.4 0.2 0.5 0.8 1.0 0.1 1.0 1.9 1.2 1.5 1.7 0.4 0.5 0.1 1.0 0.6 0.6 1.5 0.9 1.9 0.2 1.3 2.0 0.0 1.2 4.2 3.0 3.4 2.2 0.6 1.9 3.1 1.2 1.1 6.9 0.6 0.7 6.2 1.3 1.9 0.4 0.4 1.2 3.3 0.6 2.1 0.9 3.8 1.6 2.5 0.6 7.4 0.3 0.1 0.6 0.4 1.8 0.5 3.7 1.9 0.4 2.8 0.7 1.2 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.5 0.6 0.2 0.3 0.0 1.1 0.2 0.0 0.5 0.7 0.0 0.0 1.4 3.7 1.1 1.6 1.9 1.2 0.7 1.2 3.1 1.1 3.0 0.3 0.0 0.8 0.5 2.0 1.7 2.5 84.3 27.3 7.0 5.9 0.8 16.6 2.7 967.3 1.0 0.0 0.0 2.0 0.1 1.5 0.5 0.0 1.5 0.5 1.6 4.1 1.8 0.6 347.9 6.1 1.0 1.7 1.0 1.3 3.1 1.7 0.0 7.4 9.1 15.3 19.4 0.9 191.0 27.7 0.5 0.2 0.0 0.8 0.5 LCAT ENSG00000213398 "Lecithin-cholesterol acyltransferase" P04180 16 67939750-67944131 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Hydrolase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "brain: 64.4;liver: 154.2" "Cell type enriched" "Detected in many" 16 "Hepatocytes: 204.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 64.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 35.6;Hep G2: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044767 Approved Nucleoplasm "Secreted to blood" NA NA 6470000000 9500000000 Nucleoplasm "HPA044767: AB_2756312" "unprognostic (3.34e-2)" "unprognostic (3.56e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.43e-3)" "unprognostic (1.25e-2)" "unprognostic (2.16e-1)" "prognostic favorable (4.21e-8)" "unprognostic (6.42e-2)" "unprognostic (4.26e-1)" "unprognostic (4.12e-1)" "unprognostic (1.50e-2)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (9.93e-2)" "unprognostic (1.83e-1)" "unprognostic (2.85e-1)" "unprognostic (1.90e-3)" 4.4 3.6 6.3 2.2 3.7 0.9 4.3 64.4 9.6 4.5 4.4 7.3 1.4 1.3 5.3 3.0 1.8 3.5 3.5 4.5 8.4 1.8 3.9 154.2 5.6 1.9 5.5 6.3 4.7 2.5 5.9 2.7 5.5 9.2 6.4 1.3 1.8 2.4 6.2 3.4 9.9 2.4 3.8 7.5 3.9 2.3 2.2 6.1 1.4 7.6 1.6 1.4 2.6 4.5 1.8 0.8 5.0 1.1 1.3 1.4 0.1 2.5 4.0 6.0 6.8 5.2 7.4 35.6 9.9 4.3 6.7 4.7 13.3 3.1 1.3 1.9 14.3 2.4 8.8 1.4 13.6 4.2 0.6 3.6 1.7 8.9 27.7 7.2 0.3 4.7 12.8 12.9 13.9 4.8 9.1 4.9 4.0 3.8 0.6 4.7 4.1 1.6 4.2 3.9 0.4 2.2 1.7 6.5 1.4 1.9 4.3 0.2 3.1 15.0 0.7 1.7 12.9 8.5 2.7 9.3 8.7 13.6 9.5 3.5 8.2 2.2 3.7 4.1 1.1 7.5 2.4 1.1 5.0 0.9 0.1 1.3 1.2 0.7 0.8 0.2 1.8 1.4 0.4 2.8 1.3 0.5 0.8 0.0 0.1 6.3 3.7 64.4 9.6 8.4 1.8 5.5 6.3 9.2 6.1 8.9 4.5 0.0 4.1 8.4 0.2 4.2 7.6 2.7 3.4 3.5 2.0 6.0 0.0 1.6 0.0 4.3 0.0 0.0 0.9 2.7 7.1 2.9 1.1 204.0 2.1 0.0 1.2 12.3 3.2 0.5 8.1 1.6 6.8 2.8 0.0 7.5 1.4 0.0 8.1 0.0 0.5 12.9 7.1 1.0 1.5 2.3 10.2 0.0 0.0 1.4 LCE1A LEP1 ENSG00000186844 "Late cornified envelope 1A" Q5T7P2 1 152827473-152827894 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 97.7" "Cell type enriched" "Detected in some" 26 "Suprabasal keratinocytes: 35.3" "Cancer enriched" "Detected in some" 6 "melanoma: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.82e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 97.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 LCE1B "LEP2, SPRL2A" ENSG00000196734 "Late cornified envelope 1B" Q5T7P3 1 152811971-152813109 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 59.7" "Cell type enriched" "Detected in single" 18 "Suprabasal keratinocytes: 16.6" "Cancer enriched" "Detected in some" 10 "melanoma: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HBEC3-KT: 1.7;hTCEpi: 6.7" NA NA "unprognostic (1.79e-1)" "unprognostic (1.24e-2)" "unprognostic (6.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 59.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 LCE1C LEP3 ENSG00000197084 "Late cornified envelope 1C" Q5T751 1 152804835-152806628 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "skin 1: 100.1" "Cell type enriched" "Detected in some" 4 "Suprabasal keratinocytes: 72.5" "Cancer enriched" "Detected in some" 6 "melanoma: 17.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 2.5;HBEC3-KT: 5.3;hTEC/SVTERT24-B: 2.8;hTERT-HME1: 7.1" NA NA "unprognostic (3.35e-2)" "unprognostic (5.95e-2)" "unprognostic (3.46e-2)" "unprognostic (3.35e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 8.6 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.7 100.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 3.1 0.1 8.8 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.9 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.1 0.0 0.0 72.5 0.0 0.0 0.0 0.0 LCE1D LEP4 ENSG00000172155 "Late cornified envelope 1D" Q5T752 1 152796751-152798181 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 46.0" "Cell type enriched" "Detected in single" 48 "Suprabasal keratinocytes: 11.0" "Cancer enriched" "Detected in single" 8 "melanoma: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "HaCaT: 1.7;Karpas-707: 1.5" NA NA "unprognostic (7.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 LCE1E LEP5 ENSG00000186226 "Late cornified envelope 1E" Q5T753 1 152786214-152788426 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 39.5" "Cell type enriched" "Detected in some" 9 "Suprabasal keratinocytes: 15.9" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Region enriched" "Detected in single" 15 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HaCaT: 14.9" NA NA "unprognostic (9.92e-2)" "unprognostic (9.50e-2)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.3 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 2.7 0.0 0.0 0.0 14.9 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 LCE1F LEP6 ENSG00000240386 "Late cornified envelope 1F" Q5T754 1 152776372-152776728 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "skin 1: 69.5" "Cell type enriched" "Detected in some" 11 "Suprabasal keratinocytes: 15.9" "Group enriched" "Detected in some" 13 "head and neck cancer: 5.5;melanoma: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+: 11.7;hTERT-HME1: 5.4" NA NA "unprognostic (2.21e-1)" "unprognostic (8.43e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 69.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 LCE2A LEP9 ENSG00000187173 "Late cornified envelope 2A" Q5TA79 1 152698364-152699442 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "skin 1: 54.2;tongue: 14.1" "Cell type enriched" "Detected in single" 7 "Melanocytes: 1.7" "Cancer enriched" "Detected in some" 5 "melanoma: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.0;SK-MEL-30: 3.9;U-138 MG: 2.0;U-2197: 2.8;U-87 MG: 1.4" NA NA "unprognostic (3.45e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 54.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.0 0.0 2.8 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 LCE2B "LEP10, SPRL1B, XP5" ENSG00000159455 "Late cornified envelope 2B" O14633 1 152686123-152687401 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 101.7" "Cell type enriched" "Detected in some" 16 "Suprabasal keratinocytes: 27.6" "Cancer enriched" "Detected in some" 5 "melanoma: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+: 2.1" NA NA "unprognostic (3.04e-2)" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 101.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 LCE2C LEP11 ENSG00000187180 "Late cornified envelope 2C" Q5TA81 1 152675295-152676574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 75.3" "Cell type enriched" "Detected in single" 54 "Suprabasal keratinocytes: 12.4" "Group enriched" "Detected in some" 30 "head and neck cancer: 2.0;melanoma: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.0;CACO-2: 2.0" NA NA "unprognostic (1.47e-2)" "unprognostic (7.00e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 75.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 LCE2D "LEP12, SPRL1A" ENSG00000187223 "Late cornified envelope 2D" Q5TA82 1 152663396-152664659 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 52.0" "Group enriched" "Detected in some" 29 "Melanocytes: 1.7;Suprabasal keratinocytes: 4.1" "Group enriched" "Detected in some" 42 "head and neck cancer: 1.2;melanoma: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.5;U-2197: 1.0" NA NA "unprognostic (3.94e-2)" "unprognostic (5.63e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 3.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 52.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 6.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 LCE3A LEP13 ENSG00000185962 "Late cornified envelope 3A" Q5TA76 1 152622834-152623103 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 50.6" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 3.0;Late spermatids: 1.0;Spermatogonia: 1.3" "Group enriched" "Detected in some" 9 "head and neck cancer: 26.6;melanoma: 9.8" "Cell type enriched" "Detected in single" 33 "plasmacytoid DC: 3.3" "Lineage enriched" "Detected in single" 33 "dendritic cells: 3.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.1;LHCN-M2: 3.5;U-138 MG: 4.1;U-87 MG: 1.5" NA NA "unprognostic (7.47e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 50.6 0.0 10.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 LCE3B LEP14 ENSG00000187238 "Late cornified envelope 3B" Q5TA77 1 152613811-152614098 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 23 "lymphoid tissue: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE3C "LEP15, SPRL3A" ENSG00000244057 "Late cornified envelope 3C" Q5T5A8 1 152600662-152601086 "Predicted intracellular proteins" Keratinization Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "lymphoid tissue: 24.2;tongue: 17.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "head and neck cancer: 3.8;melanoma: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "hTCEpi: 1.3;hTERT-HME1: 4.8" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 17.3 24.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE3D "LEP16, SPRL6A, SPRL6B" ENSG00000163202 "Late cornified envelope 3D" Q9BYE3 1 152579381-152580504 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5" "Cell type enriched" "Detected in single" 36 "Pancreatic endocrine cells: 5.0" "Group enriched" "Detected in many" 9 "head and neck cancer: 126.9;melanoma: 47.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTCEpi: 8.7;hTERT-HME1: 8.1" NA NA "unprognostic (1.34e-1)" "unprognostic (1.09e-1)" "unprognostic (2.87e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 53.2 0.1 0.1 0.1 0.0 3.7 0.1 7.8 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 8.5 0.1 0.1 17.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 96.6 48.6 0.1 48.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE3E LEP17 ENSG00000185966 "Late cornified envelope 3E" Q5T5B0 1 152565654-152566772 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 35.6;lymphoid tissue: 21.3;tongue: 38.9;vagina: 19.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "head and neck cancer: 40.7;melanoma: 18.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTCEpi: 5.0" NA NA "unprognostic (1.33e-1)" "unprognostic (7.76e-2)" "unprognostic (2.51e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 35.6 0.1 0.1 0.1 0.0 1.9 0.1 9.9 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 3.5 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 38.9 21.3 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE4A "LEP8, SPRL4A" ENSG00000187170 "Late cornified envelope 4A" Q5TA78 1 152708160-152709491 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 10.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BJ: 1.2;BJ hTERT+: 1.0;THP-1: 1.0" NA NA "unprognostic (1.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCE5A "LEP18, SPRL5A" ENSG00000186207 "Late cornified envelope 5A" Q5TCM9 1 152510844-152512177 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 42.7" "Group enriched" "Detected in some" 6 "Melanocytes: 1.7;Suprabasal keratinocytes: 6.5" "Cancer enhanced" "Detected in single" "melanoma: 0.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "NK-cell: 1.4" "Lineage enriched" "Detected in single" 14 "NK-cells: 1.4" "Cell line enhanced" "Detected in some" "A549: 1.6;hTERT-HME1: 1.1" NA NA "unprognostic (2.51e-1)" "unprognostic (7.27e-3)" "unprognostic (9.27e-2)" "unprognostic (1.89e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 7.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 42.7 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 4.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 LCE6A C1orf44 ENSG00000235942 "Late cornified envelope 6A" A0A183 1 152842868-152843983 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.1" "Cell type enriched" "Detected in single" 11 "Suprabasal keratinocytes: 2.3" "Cancer enriched" "Detected in some" 5 "melanoma: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "RPMI-8226: 1.5" HPA046376 Enhanced NA NA "HPA046376: AB_10965998" "unprognostic (4.25e-2)" "unprognostic (8.73e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.2 0.0 0.1 0.1 0.1 0.2 77.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.8 0.1 6.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 LCK ENSG00000182866 "LCK proto-oncogene, Src family tyrosine kinase" P06239 1 32251239-32286165 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 112.2;lymphoid tissue: 153.0" "Cell type enriched" "Detected in many" 10 "T-cells: 207.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 14 "gdT-cell: 83.4;MAIT T-cell: 77.5;memory CD4 T-cell: 86.1;memory CD8 T-cell: 90.2;naive CD4 T-cell: 97.0;naive CD8 T-cell: 91.3;NK-cell: 42.8;T-reg: 112.2" "Group enriched" "Detected in many" 13 "NK-cells: 42.8;T-cells: 112.2" "Group enriched" "Detected in some" 6 "JURKAT: 66.9;MOLT-4: 93.9;U-698: 54.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003494, CAB003816" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB003816: AB_562158, HPA003494: AB_1852751" "unprognostic (6.38e-3)" "unprognostic (5.45e-3)" "unprognostic (8.39e-2)" "prognostic favorable (2.96e-6)" "unprognostic (2.20e-2)" "prognostic favorable (2.91e-4)" "unprognostic (4.78e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.65e-5)" "unprognostic (3.07e-2)" "unprognostic (3.80e-2)" "unprognostic (2.83e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (8.15e-2)" "unprognostic (4.05e-2)" "unprognostic (7.39e-2)" "unprognostic (1.17e-2)" 2.6 0.7 0.4 28.2 0.5 3.8 1.3 0.3 0.5 1.7 3.9 0.5 0.9 2.2 1.1 4.5 2.3 1.6 3.8 1.0 0.4 0.4 3.0 2.3 6.6 34.9 0.9 0.5 1.2 0.8 0.0 0.8 0.7 0.6 2.2 1.9 1.3 8.4 1.3 0.9 1.0 16.5 0.7 1.0 28.9 3.5 0.7 0.5 153.0 2.9 1.5 27.1 5.8 2.1 6.1 0.5 2.5 0.3 42.8 112.2 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 11.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 0.0 0.0 0.0 0.0 93.9 0.0 1.0 0.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 54.1 0.0 0.0 0.0 0.6 0.3 0.4 83.4 0.3 77.5 4.0 86.1 90.2 0.3 6.1 97.0 91.3 2.5 42.8 0.3 0.5 112.2 109.3 0.4 0.5 0.3 0.5 0.4 0.4 0.9 0.5 0.6 0.5 0.0 16.0 20.4 0.9 4.0 0.0 1.1 2.5 2.7 2.3 3.5 0.0 0.2 0.0 0.3 0.1 1.6 0.0 0.0 0.4 0.1 2.0 0.8 4.7 1.0 0.3 0.0 2.4 3.7 4.9 0.0 0.0 0.6 3.3 0.0 0.0 0.0 2.7 0.0 0.4 1.1 0.0 0.0 0.9 3.7 1.9 2.8 0.3 207.5 0.4 1.0 LCN1 "MGC71975, PMFA, TLC, TP, VEGP" ENSG00000160349 "Lipocalin 1" P31025 9 135521438-135526532 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Sensory transduction, Taste, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "tongue: 204.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.1" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;U-2 OS: 1.0;U-87 MG: 2.0" "Not detected" "Not detected" "Secreted in other tissues" NA NA 20000000 "unprognostic (5.50e-3)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (3.99e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-4)" "unprognostic (1.22e-1)" "unprognostic (7.84e-2)" "unprognostic (9.47e-2)" "unprognostic (3.94e-8)" "unprognostic (2.07e-3)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 16.8 3.3 0.0 0.7 2.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.3 0.0 2.2 0.4 0.0 0.1 0.0 0.0 0.4 15.8 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 204.2 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 2.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCN10 ENSG00000187922 "Lipocalin 10" Q6JVE6 9 136738167-136743356 "Predicted secreted proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 21.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 8 "thyroid cancer: 1.2" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 21 "memory B-cell: 5.5;naive B-cell: 6.2" "Lineage enriched" "Detected in single" 22 "B-cells: 6.2" "Cell line enhanced" "Detected in some" "HeLa: 3.8;Hep G2: 1.3;REH: 2.1;RPMI-8226: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA055919 Approved "Secreted in male reproductive system" NA NA "HPA055919: AB_2682969" "unprognostic (2.02e-1)" "unprognostic (1.35e-2)" "unprognostic (2.62e-1)" "unprognostic (1.89e-1)" "unprognostic (5.85e-2)" "unprognostic (6.54e-3)" "unprognostic (2.22e-4)" "unprognostic (4.54e-2)" "unprognostic (3.97e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (2.96e-1)" "unprognostic (2.77e-2)" "unprognostic (3.11e-2)" "unprognostic (2.52e-1)" "unprognostic (8.32e-2)" "unprognostic (3.86e-1)" 2.8 0.0 0.5 1.4 0.5 0.2 2.2 0.5 1.0 6.2 0.9 0.7 3.2 0.2 7.2 21.8 0.8 7.8 1.2 4.5 0.5 0.0 0.5 0.5 0.5 0.8 0.5 0.5 1.8 1.5 0.0 0.5 0.5 0.5 2.1 0.6 0.5 1.2 0.8 0.6 0.2 2.0 2.5 0.5 1.4 1.5 2.1 0.5 0.5 4.3 0.5 0.9 2.1 2.6 6.2 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.5 0.7 0.6 0.0 0.0 2.1 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 6.2 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.5 0.5 0.5 1.0 0.5 0.0 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCN12 MGC48935 ENSG00000184925 "Lipocalin 12" Q6JVE5 9 136949551-136955497 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 131.5" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 47.1;Distal tubular cells: 16.6;Intestinal endocrine cells: 15.7;Muller glia cells: 26.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 44.8" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 21 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 21 "dendritic cells: 2.0" "Cell line enhanced" "Detected in some" "A549: 2.8;BEWO: 1.4;Daudi: 1.0;EFO-21: 1.7;HEL: 1.5;SH-SY5Y: 1.1" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (7.27e-3)" "unprognostic (5.72e-3)" "unprognostic (2.45e-2)" "unprognostic (7.14e-2)" "unprognostic (4.53e-4)" "unprognostic (9.33e-3)" "unprognostic (1.97e-3)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (7.33e-3)" "unprognostic (2.18e-1)" "unprognostic (5.73e-2)" "unprognostic (5.21e-3)" "unprognostic (3.06e-1)" "unprognostic (5.00e-2)" "unprognostic (7.91e-4)" 0.3 0.4 0.9 0.3 1.8 0.3 0.3 0.2 0.9 0.9 0.3 0.4 24.4 0.4 0.5 131.5 0.3 2.4 0.3 0.3 0.8 0.8 2.3 1.2 0.3 0.3 1.0 0.7 0.6 0.7 0.3 1.9 0.3 1.2 0.3 0.3 1.6 0.3 10.9 0.3 0.3 0.4 0.3 0.9 0.6 0.4 1.1 0.9 0.0 8.6 0.0 0.3 0.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.9 1.8 0.2 0.9 0.8 0.8 1.0 0.7 1.2 0.9 0.0 2.1 0.5 0.3 0.0 0.2 6.9 0.0 1.4 2.3 47.1 2.0 0.1 16.6 1.0 0.6 0.0 2.9 0.0 1.1 0.0 0.2 0.9 0.0 10.2 0.2 0.0 15.7 0.0 0.3 0.8 13.8 0.0 0.0 0.0 2.6 26.1 0.7 0.0 10.3 5.9 0.9 0.0 0.0 1.4 0.2 0.0 0.2 0.0 4.7 0.2 LCN15 "PRO6093, UNQ2541" ENSG00000177984 "Lipocalin 15" Q6UWW0 9 136759634-136766255 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3" "Cell type enriched" "Detected in some" 54 "Intestinal endocrine cells: 377.4" "Cancer enriched" "Detected in some" 19 "colorectal cancer: 23.0" "Group enriched" "Detected in some" 6 "amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "Hep G2: 19.7" "Low region specificity" "Detected in all" HPA060584 Enhanced "Secreted in other tissues" NA NA "HPA060584: AB_2684327" "unprognostic (5.24e-1)" "unprognostic (2.61e-1)" "unprognostic (2.14e-1)" "unprognostic (3.67e-1)" "unprognostic (3.45e-2)" "unprognostic (3.28e-2)" "unprognostic (2.39e-1)" "unprognostic (1.83e-1)" 0.1 0.0 2.4 0.1 0.4 0.0 0.1 0.1 4.9 0.1 12.8 0.1 12.0 16.5 0.1 2.0 0.1 0.0 0.1 1.9 1.7 0.1 0.1 0.1 2.0 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 2.6 0.1 0.1 5.3 1.3 0.0 5.2 0.1 0.7 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.1 4.9 1.7 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 377.4 0.0 0.8 1.7 0.0 0.0 1.7 0.0 0.7 0.0 0.0 7.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.3 LCN2 "24p3, NGAL" ENSG00000148346 "Lipocalin 2" P80188 9 128149071-128153455 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7" "Cell type enhanced" "Detected in many" 16 "Ductal cells: 4866.3;Exocrine glandular cells: 1633.7;Pancreatic endocrine cells: 4295.8;Urothelial cells: 1384.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5" "Group enriched" "Detected in many" 72 "granulocytes: 11.4;monocytes: 4.5" "Group enriched" "Detected in some" 11 "CAPAN-2: 277.6;EFO-21: 113.7" "HPA002695, CAB016549, CAB016550" Enhanced Supported "Endoplasmic reticulum" "Secreted in other tissues" NA NA 297000000 870000000 "Endoplasmic reticulum" "CAB016549: , CAB016550: , HPA002695: AB_1852758" "prognostic favorable (9.61e-4)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (7.38e-3)" "unprognostic (1.01e-2)" "unprognostic (4.66e-2)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-1)" "unprognostic (1.79e-1)" "unprognostic (2.36e-2)" "unprognostic (2.83e-2)" "unprognostic (1.10e-3)" "unprognostic (6.15e-2)" "unprognostic (2.37e-1)" "unprognostic (3.15e-2)" "unprognostic (1.11e-2)" 0.3 0.5 0.2 24.6 0.3 199.7 2.7 0.2 0.5 78.7 19.4 1.0 0.5 2.4 7.9 9.1 77.0 4.0 173.3 20.4 0.2 0.2 12.7 12.8 32.6 0.2 0.2 0.1 6.7 17.4 0.0 5.4 7.1 0.8 17.0 10.5 1.0 168.7 0.9 1.0 3.1 17.0 0.7 0.2 8.1 35.1 5.8 0.1 5.0 3.8 142.0 178.1 68.9 48.5 0.0 0.0 11.4 4.5 0.0 0.1 9.6 8.7 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 277.6 0.0 113.7 0.0 0.2 18.1 0.0 0.5 0.0 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 5.1 0.0 0.0 0.6 0.1 0.0 0.2 1.2 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 4.5 0.0 0.0 9.6 0.2 0.3 0.2 0.5 0.2 0.2 0.2 0.1 0.8 0.1 0.0 17.3 2.4 352.2 0.2 0.0 0.2 932.5 180.7 184.2 130.9 0.0 0.3 0.0 4866.3 1.9 0.1 78.8 23.3 1633.7 0.3 0.2 349.2 13.8 18.3 0.5 0.0 55.6 2.5 0.6 10.5 3.1 0.6 0.0 103.6 135.4 0.0 4295.8 131.2 0.0 0.7 0.0 0.0 3.1 0.0 0.2 0.0 0.2 0.7 262.6 1384.7 LCN6 ENSG00000267206 "Lipocalin 6" P62502 9 136744011-136748528 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "epididymis: 261.0" "Cell type enhanced" "Detected in some" 21 "Endothelial cells: 16.9;Ito cells: 3.7;Leydig cells: 5.2;Sertoli cells: 6.5" "Cancer enriched" "Detected in some" 10 "thyroid cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 4.7;REH: 14.9" "Secreted in male reproductive system" NA NA "unprognostic (4.05e-2)" "unprognostic (1.01e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (3.23e-1)" "unprognostic (1.26e-1)" "unprognostic (3.83e-4)" "unprognostic (3.41e-2)" "unprognostic (7.47e-2)" "unprognostic (1.08e-2)" "unprognostic (2.89e-3)" "unprognostic (1.78e-1)" "unprognostic (5.55e-2)" "unprognostic (2.96e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-2)" "unprognostic (1.45e-1)" 4.5 0.5 0.4 1.3 0.6 1.1 4.4 0.4 0.6 5.1 1.6 0.4 13.9 0.5 10.1 261.0 1.5 6.5 1.8 8.3 0.4 0.0 0.8 0.5 1.1 0.6 0.6 0.5 2.6 1.0 0.6 0.3 0.5 0.6 3.4 0.6 0.6 2.0 1.2 1.5 0.5 3.1 1.4 0.7 1.0 3.1 3.2 0.4 0.3 2.2 0.4 0.5 2.9 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 14.9 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.4 0.6 0.4 0.0 0.6 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.3 LCN8 LCN5 ENSG00000204001 "Lipocalin 8" Q6JVE9 9 136754386-136758543 "Predicted intracellular proteins, Predicted secreted proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "epididymis: 72.1" "Cell type enriched" "Detected in single" 8 "B-cells: 2.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Region enriched" "Detected in single" 7 "cerebellum: 5.3" "Group enriched" "Detected in some" 57 "memory B-cell: 5.3;naive B-cell: 9.3" "Lineage enriched" "Detected in single" 72 "B-cells: 9.3" "Cell line enriched" "Detected in some" 6 "REH: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.64e-2)" "unprognostic (1.00e-1)" "unprognostic (6.71e-2)" "unprognostic (2.11e-2)" "unprognostic (2.92e-1)" "unprognostic (2.89e-1)" "unprognostic (2.00e-1)" 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.3 0.7 0.1 0.0 0.0 2.5 0.0 0.2 72.1 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.5 0.0 0.0 0.9 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 7.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 5.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCN9 ENSG00000148386 "Lipocalin 9" Q8WX39 9 135663322-135666422 "Predicted secreted proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 19.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA060941 Enhanced "Secreted in male reproductive system" NA NA "HPA060941: AB_2732654" "unprognostic (7.64e-4)" 0.3 0.0 0.5 0.0 0.5 0.0 0.0 0.2 2.1 0.2 0.0 0.1 17.2 0.0 0.0 5.0 0.0 0.5 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 7.7 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.4 0.5 0.3 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCNL1 FLJ45224 ENSG00000214402 "Lipocalin like 1" Q6ZST4 9 136981904-136986410 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.1;seminal vesicle: 3.7;testis: 2.5" "Group enriched" "Detected in some" 30 "Leydig cells: 49.5;Muller glia cells: 41.0;Peritubular cells: 119.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 2.0;fHDF/TERT166: 1.4;HSkMC: 1.0;TIME: 1.3" NA NA "unprognostic (1.39e-1)" "unprognostic (4.60e-3)" "unprognostic (1.08e-3)" "unprognostic (5.14e-2)" "unprognostic (3.39e-1)" "unprognostic (2.03e-5)" "unprognostic (6.46e-2)" "unprognostic (6.67e-2)" "unprognostic (7.79e-2)" "unprognostic (9.51e-2)" "unprognostic (2.16e-1)" "unprognostic (9.82e-2)" "unprognostic (1.34e-9)" "unprognostic (4.31e-2)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "unprognostic (1.93e-1)" 0.1 0.0 2.2 0.0 1.8 0.0 0.1 0.4 1.9 1.0 0.1 0.0 0.3 1.6 0.0 0.4 0.2 0.5 2.0 1.3 0.3 0.0 0.2 0.7 3.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 3.7 1.0 0.0 0.2 0.1 2.6 0.3 0.1 2.5 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 49.5 0.0 0.0 0.0 0.0 41.0 0.0 0.0 119.9 0.0 1.4 0.0 0.4 0.3 0.7 0.0 0.1 0.0 0.0 0.0 LCP1 "CP64, L-PLASTIN, LC64P, PLS2" ENSG00000136167 "Lymphocyte cytosolic protein 1" P13796 13 46125920-46211871 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 188.6;lymphoid tissue: 118.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 106.9;B-cells: 102.2;Early spermatids: 108.1;granulocytes: 292.1;Hofbauer cells: 246.0;Kupffer cells: 369.7;Late spermatids: 220.3;Macrophages: 303.2;monocytes: 275.9;T-cells: 260.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 82.8;HDLM-2: 75.7;HL-60: 80.4;HMC-1: 85.3;JURKAT: 76.6;THP-1: 75.0;U-698: 106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019493, CAB020673" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA 2200000000 "Plasma membrane, Cytosol" "Actin filaments" "CAB020673: , HPA019493: AB_1855457" "unprognostic (2.79e-2)" "unprognostic (8.20e-3)" "unprognostic (1.19e-2)" "unprognostic (3.95e-3)" "unprognostic (1.19e-1)" "unprognostic (2.84e-2)" "unprognostic (2.70e-1)" "unprognostic (4.99e-2)" "unprognostic (6.70e-3)" "unprognostic (2.54e-1)" "unprognostic (5.47e-2)" "unprognostic (3.63e-1)" "unprognostic (3.32e-3)" "unprognostic (2.51e-1)" "unprognostic (1.02e-1)" "unprognostic (7.50e-2)" "unprognostic (2.92e-1)" 57.1 10.0 5.6 44.3 9.4 71.2 8.7 3.9 4.6 3.6 6.2 4.5 5.0 4.5 5.3 43.1 6.2 8.3 8.9 5.5 4.3 3.8 7.2 12.2 33.7 59.1 12.0 1.0 5.7 3.9 0.1 2.8 24.7 7.7 21.5 8.1 5.5 9.5 2.5 3.5 6.8 21.7 6.5 11.9 112.9 6.1 8.2 9.2 118.2 4.5 4.1 68.7 14.0 7.1 25.4 79.3 133.5 127.6 43.2 67.2 188.6 3.3 0.0 0.1 0.0 0.0 0.0 40.2 0.0 0.1 0.3 0.2 22.2 0.1 82.8 17.6 0.0 24.6 0.1 0.0 0.0 0.3 75.7 19.7 17.9 0.0 0.0 0.0 80.4 85.3 0.2 0.0 0.1 0.1 0.0 0.0 76.6 9.3 55.1 0.0 0.1 56.9 55.7 0.0 0.0 0.8 42.4 0.1 59.2 0.0 22.9 0.1 0.7 0.1 8.8 0.6 2.5 0.4 75.0 0.2 2.1 1.3 0.1 2.4 13.2 27.4 106.5 1.6 49.0 0.3 57.1 96.6 54.3 67.2 127.6 60.8 25.4 40.4 55.5 79.3 18.3 25.2 42.3 133.5 43.2 118.1 20.8 40.5 188.6 5.6 9.4 3.9 4.6 4.3 3.8 12.0 1.0 7.7 9.2 29.8 106.9 102.2 0.8 10.6 0.4 3.1 2.5 25.4 33.0 3.5 0.0 8.6 0.0 19.4 108.1 6.6 0.0 23.3 14.4 53.7 6.6 52.4 292.1 26.8 246.0 0.0 1.2 14.1 369.7 220.3 1.1 303.2 21.9 275.9 0.0 19.2 4.7 0.6 1.8 1.4 0.9 0.0 7.9 1.8 1.7 10.3 11.3 260.3 0.1 2.2 LCP2 "SLP-76, SLP76" ENSG00000043462 "Lymphocyte cytosolic protein 2" Q13094 5 170246237-170298227 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.1;lymphoid tissue: 95.2" "Cell type enhanced" "Detected in many" 10 "granulocytes: 122.8;Hofbauer cells: 51.0;Kupffer cells: 121.6;Macrophages: 65.3;T-cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 34.3;HL-60: 35.3;HMC-1: 91.1;Karpas-707: 19.5;MOLT-4: 21.2;THP-1: 18.8;U-937: 23.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004574, HPA036396, HPA036397" Enhanced NA NA 3600000 "CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436" "unprognostic (1.33e-2)" "unprognostic (3.88e-2)" "unprognostic (7.52e-3)" "prognostic favorable (5.08e-4)" "unprognostic (1.43e-1)" "unprognostic (1.30e-2)" "unprognostic (2.03e-1)" "unprognostic (8.84e-2)" "unprognostic (1.44e-1)" "unprognostic (4.87e-2)" "unprognostic (1.37e-1)" "unprognostic (3.10e-1)" "prognostic unfavorable (6.22e-5)" "unprognostic (1.87e-1)" "unprognostic (3.56e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" 18.9 5.8 4.6 26.6 5.8 51.1 6.8 1.2 6.3 5.4 7.5 5.2 0.7 5.7 4.2 5.0 3.6 5.4 10.8 4.3 3.7 3.6 5.4 9.4 22.0 25.3 8.4 1.7 3.6 3.0 0.9 3.3 8.0 5.6 7.3 6.1 4.6 5.3 2.3 2.7 4.0 14.3 5.9 7.9 46.8 6.1 4.0 6.7 95.2 4.6 2.4 25.8 9.7 4.3 1.3 11.3 31.1 26.1 18.0 18.4 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 34.3 0.0 0.0 0.0 35.3 91.1 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.2 19.5 0.0 0.0 21.2 12.0 0.1 0.0 0.0 3.2 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 0.0 23.2 0.4 23.2 8.6 31.1 18.3 18.4 18.4 1.3 15.0 17.5 11.3 0.4 14.2 14.5 30.6 18.0 26.1 2.3 16.8 8.7 4.6 5.8 1.2 6.3 3.7 3.6 8.4 1.7 5.6 6.7 14.9 43.0 14.1 0.2 2.9 0.0 2.0 2.5 5.3 10.3 1.8 0.0 0.4 0.0 0.1 1.3 10.5 0.0 0.0 0.0 0.6 4.5 0.4 122.8 1.3 51.0 0.0 0.0 22.1 121.6 0.2 2.3 65.3 1.7 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 25.8 2.5 0.0 0.1 1.6 0.7 60.9 0.0 0.3 LCT ENSG00000115850 Lactase P09848 2 135787840-135837180 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "intestine: 255.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Group enriched" "Detected in some" 4 "JURKAT: 3.6;MOLT-4: 6.9;RPMI-8226: 13.7" "Region enriched" "Detected in single" 16 "hippocampal formation: 17.3" NA NA "unprognostic (2.21e-2)" "unprognostic (1.65e-4)" "unprognostic (2.54e-1)" "unprognostic (2.06e-1)" "unprognostic (3.39e-2)" "unprognostic (8.03e-4)" "unprognostic (3.55e-3)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (3.57e-1)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (1.64e-4)" "unprognostic (4.90e-2)" "unprognostic (8.92e-2)" "unprognostic (8.97e-2)" "unprognostic (1.02e-1)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.1 209.8 0.0 0.0 67.7 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 255.5 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 6.9 1.1 0.0 0.0 0.0 1.6 0.0 13.7 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.1 0.2 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Group enriched" "Detected in some" 4 "Early spermatids: 5.0;Late spermatids: 7.5;Spermatogonia: 2.7" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;hTERT-RPE1: 7.5;NTERA-2: 5.8;SuSa: 7.0;U-2 OS: 16.2;U-251 MG: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" NA NA "Plasma membrane" "Endoplasmic reticulum" "HPA071640: AB_2686428" "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.0 0.3 0.4 0.4 0.4 6.3 0.2 0.6 0.6 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.5 0.0 0.2 0.4 0.4 0.0 0.3 0.0 7.5 0.0 0.2 0.4 0.4 0.2 0.1 0.2 0.4 5.8 0.4 0.1 0.2 3.4 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 7.0 0.4 0.5 0.4 1.6 16.2 0.6 6.9 0.2 0.2 0.2 2.1 0.7 2.9 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 0.0 0.0 0.0 0.5 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 7.5 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.1 0.0 0.4 1.2 2.7 0.3 0.2 0.0 0.0 0.3 LDB3 "CMD1C, KIAA0613, PDLIM6, ZASP" ENSG00000122367 "LIM domain binding 3" O75112 10 86668449-86736068 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 21 "heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3" "Cell type enriched" "Detected in some" 41 "Cardiomyocytes: 1579.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6" "Low region specificity" "Detected in all" HPA048955 Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA 450000 "Focal adhesion sites, Cytosol" Nucleoplasm "HPA048955: AB_2680568" "unprognostic (1.60e-1)" "unprognostic (9.01e-2)" "unprognostic (4.87e-2)" "unprognostic (6.92e-2)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (2.57e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-2)" "unprognostic (7.61e-2)" "unprognostic (2.54e-3)" "unprognostic (3.55e-2)" "unprognostic (4.72e-4)" "unprognostic (3.07e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-2)" "unprognostic (3.16e-1)" 6.4 0.4 0.9 1.3 1.6 0.2 0.5 0.1 1.3 2.8 2.3 0.0 4.9 0.4 4.2 9.9 9.9 1.3 1.0 213.9 1.7 1.0 0.3 0.2 0.4 0.2 2.6 0.0 1.5 0.3 0.3 0.1 0.5 0.0 4.4 0.8 4.7 7.6 3.1 329.7 0.3 1.2 3.6 6.7 0.2 0.7 0.5 0.0 0.0 2.8 110.3 10.2 1.9 0.9 0.9 0.6 1.8 0.4 0.6 0.6 0.0 0.3 0.2 0.4 3.1 0.4 0.1 0.3 0.4 0.3 0.1 0.2 0.3 0.3 0.2 0.6 0.0 0.7 0.4 0.2 0.0 0.1 0.9 0.7 0.7 0.9 0.1 0.1 0.1 1.6 5.9 0.5 0.1 0.0 5.8 0.0 0.7 0.2 1.8 0.3 1.5 0.4 0.2 0.4 0.4 0.3 0.0 2.0 0.1 0.0 1.1 9.6 1.8 0.3 0.2 4.6 1.4 0.3 0.2 0.0 0.3 0.5 0.4 0.1 0.2 0.6 0.4 0.7 0.3 0.5 1.8 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.9 0.5 0.6 1.4 0.6 0.4 0.6 0.3 0.0 0.9 1.6 0.1 0.6 1.7 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.7 1579.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 18.3 0.7 0.0 0.0 1.0 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.2 10.3 0.4 1.7 0.0 0.0 1.0 0.1 0.0 6.3 0.0 3.4 38.8 33.0 0.6 1.0 0.0 0.0 0.0 0.0 0.1 LDHA ENSG00000134333 "Lactate dehydrogenase A" P00338 11 18394388-18408425 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 249.1" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 1952.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015336, CAB069404" Uncertain Supported Vesicles,Cytosol NA NA 300000000 Cytosol Vesicles "CAB015336: AB_2134947, CAB069404: " "unprognostic (8.83e-2)" "prognostic unfavorable (2.78e-5)" "unprognostic (3.81e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (4.66e-3)" "prognostic unfavorable (3.26e-8)" "prognostic unfavorable (2.27e-6)" "unprognostic (1.08e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (8.09e-6)" "unprognostic (1.76e-2)" "prognostic unfavorable (9.69e-9)" "unprognostic (4.15e-2)" "unprognostic (1.89e-1)" "unprognostic (3.07e-1)" "unprognostic (1.05e-2)" 84.2 56.4 24.5 52.6 32.5 64.0 56.0 22.3 40.2 38.1 53.5 13.5 9.1 60.5 24.9 36.2 77.7 29.0 31.6 59.4 24.4 33.0 100.1 249.1 37.1 59.4 29.7 25.7 49.7 34.1 10.5 16.4 49.7 44.3 33.3 51.2 45.9 46.3 37.0 199.6 70.2 128.3 50.7 35.5 45.0 31.2 25.9 23.9 45.0 56.4 90.6 60.1 81.9 44.8 27.6 76.5 29.1 61.2 32.8 52.2 72.1 131.7 82.0 3.1 46.2 72.2 49.3 44.0 127.5 135.5 112.0 166.7 36.6 21.7 99.7 41.9 128.8 80.8 106.6 82.0 195.4 242.9 34.0 48.5 34.5 74.9 62.8 17.8 85.1 25.9 49.2 90.1 44.0 44.1 189.0 66.1 31.6 48.6 48.0 131.1 34.9 70.0 53.9 19.8 43.8 102.6 45.4 32.7 83.5 178.0 30.6 24.6 30.4 69.1 57.0 23.6 50.2 26.8 20.3 59.5 140.3 50.9 122.1 1.5 38.2 55.9 95.9 200.8 44.1 47.2 28.9 53.1 29.1 38.1 61.2 42.6 27.6 50.2 40.1 76.5 19.2 32.8 33.3 18.1 32.8 59.5 25.8 52.2 72.1 24.5 32.5 22.3 40.2 24.4 33.0 29.7 25.7 44.3 23.9 68.5 191.6 171.4 331.5 1952.6 415.5 222.7 142.7 85.6 187.7 293.1 137.4 475.1 368.1 1059.9 147.3 475.2 671.1 0.0 1350.8 1780.5 725.6 281.3 256.4 438.3 607.6 486.3 43.8 182.3 215.4 106.3 266.3 427.9 1116.8 1462.6 176.8 316.6 1380.9 487.5 192.7 408.8 354.8 187.5 1239.9 102.9 38.5 1506.3 419.6 213.6 251.8 384.9 LDHAL6A "LDH6A, MGC23940" ENSG00000166800 "Lactate dehydrogenase A like 6A" Q6ZMR3 11 18455824-18479600 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.9" "Group enriched" "Detected in some" 6 "Early spermatids: 7.5;Late spermatids: 5.6;Spermatocytes: 4.6;Spermatogonia: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HL-60: 15.6" NA NA "unprognostic (1.41e-1)" "unprognostic (4.84e-2)" "unprognostic (8.95e-2)" "unprognostic (5.35e-2)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" "unprognostic (7.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.23e-1)" "unprognostic (1.60e-1)" "unprognostic (2.35e-2)" "unprognostic (3.58e-1)" "unprognostic (2.22e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" 0.2 0.7 0.6 0.4 0.6 1.4 0.2 2.4 1.9 0.1 0.2 0.4 0.0 0.9 0.2 0.4 0.4 0.2 0.3 1.1 0.4 0.5 0.4 0.2 0.2 0.6 0.3 0.7 0.7 0.4 0.0 0.4 0.2 2.2 0.2 0.1 1.9 0.3 0.3 0.2 1.5 0.8 0.0 0.3 0.4 0.4 18.9 0.0 0.1 0.8 0.0 0.1 0.2 0.2 1.3 0.7 3.5 0.5 1.6 1.9 0.2 0.2 0.4 1.0 0.8 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.5 0.5 0.9 0.3 0.0 0.2 0.6 0.1 0.3 0.4 0.7 1.0 0.6 0.9 0.5 0.0 15.6 0.7 0.1 0.3 0.0 0.2 0.2 0.0 1.0 0.4 1.2 0.1 0.3 0.4 1.1 0.4 0.2 0.7 0.8 0.4 1.5 0.1 1.1 0.6 0.5 0.5 0.3 0.2 0.5 0.4 2.2 0.8 0.6 0.2 1.0 0.3 2.7 0.6 0.2 0.3 0.6 0.3 2.1 0.4 0.4 1.9 0.3 0.3 0.9 0.5 0.5 0.7 1.3 1.1 1.0 3.5 1.6 0.5 0.5 1.3 0.2 0.6 0.6 2.4 1.9 0.4 0.5 0.3 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.6 0.0 0.0 4.6 3.6 0.0 0.2 0.0 0.0 0.0 LDHAL6B "LDH6B, LDHAL6, LDHL" ENSG00000171989 "Lactate dehydrogenase A like 6B" Q9BYZ2 15 59206823-59208515 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 56.6" "Cell type enriched" "Detected in some" 20 "Spermatocytes: 103.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4" "Region enriched" "Detected in single" 6 "olfactory region: 1.7" HPA053962 Enhanced NA NA "HPA053962: AB_2682324" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (2.37e-1)" "unprognostic (4.46e-2)" "unprognostic (6.59e-2)" "unprognostic (2.23e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (2.29e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-3)" "unprognostic (1.64e-1)" "unprognostic (3.12e-7)" "unprognostic (3.47e-2)" "unprognostic (1.49e-2)" "unprognostic (8.53e-2)" "unprognostic (7.80e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 56.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.8 0.0 0.4 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 1.5 0.4 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.5 0.1 0.0 0.0 0.4 0.4 0.8 0.3 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 103.7 0.6 0.0 0.0 0.0 0.0 0.0 LDHB ENSG00000111716 "Lactate dehydrogenase B" P07195 12 21635342-21757857 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 255.8;kidney: 233.1" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "T-cells: 145.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004641, HPA019007" Enhanced Supported Cytosol No No 780000000 Cytosol "CAB004641: AB_425525, HPA019007: AB_2670008" "unprognostic (2.93e-1)" "unprognostic (9.20e-3)" "unprognostic (6.10e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-3)" "unprognostic (1.36e-3)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (5.34e-2)" "unprognostic (8.40e-2)" "unprognostic (2.91e-1)" "unprognostic (6.41e-2)" "prognostic favorable (2.51e-4)" "unprognostic (1.31e-1)" "unprognostic (1.71e-1)" "unprognostic (2.55e-1)" "unprognostic (9.32e-2)" 70.9 60.2 79.5 33.3 79.6 40.8 33.4 52.4 80.1 24.9 31.8 30.6 13.2 11.8 38.7 27.3 25.6 34.4 32.3 255.8 58.8 69.9 233.1 9.8 27.7 52.3 91.6 62.3 68.0 54.8 41.8 19.4 40.1 84.9 34.9 39.4 26.8 21.8 42.2 29.7 8.6 18.0 42.9 52.9 23.8 47.5 16.4 47.6 59.1 48.5 56.3 58.7 49.7 21.8 28.1 32.9 33.0 15.3 33.7 145.1 93.2 32.6 87.5 77.0 50.6 55.2 61.5 89.5 45.6 45.6 63.8 63.2 138.5 0.1 115.5 29.9 30.7 62.2 16.4 105.9 84.5 81.3 29.6 73.7 118.8 83.7 0.1 52.8 110.9 51.4 70.3 30.3 55.9 76.1 75.5 72.7 83.7 64.9 17.4 70.1 0.1 94.2 134.3 222.1 53.5 38.0 85.1 107.5 93.1 316.6 145.6 24.8 57.4 20.9 32.5 78.6 213.4 0.2 87.0 28.3 43.0 56.4 30.5 85.8 15.4 20.8 151.7 47.6 53.2 51.0 33.0 15.3 1.8 28.5 9.4 47.5 28.1 110.7 59.4 28.3 17.7 145.1 92.2 2.5 33.7 6.7 32.9 105.4 93.2 79.5 79.6 52.4 80.1 58.8 69.9 91.6 62.3 84.9 47.6 131.0 259.8 264.1 356.5 64.9 144.4 2212.6 252.3 329.2 235.4 450.1 64.8 1548.4 2801.9 8.8 8.2 201.1 10.6 163.5 278.5 675.2 313.9 183.2 261.1 6.8 514.5 133.5 88.8 124.0 155.9 19.6 254.3 185.3 170.4 154.1 114.8 173.5 149.2 14.4 390.3 2766.7 85.3 232.8 418.6 17.7 95.7 56.1 1371.1 274.1 316.8 307.0 LDHC CT32 ENSG00000166796 "Lactate dehydrogenase C" P07864 11 18412307-18452058 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 143.9" "Group enriched" "Detected in some" 11 "Early spermatids: 838.5;Spermatocytes: 827.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-BR-3: 3.5;U-2197: 8.7;U-266/70: 7.8;U-266/84: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA045442 Enhanced NA NA "HPA045442: AB_10966720" "unprognostic (2.32e-2)" "unprognostic (3.42e-3)" "unprognostic (1.87e-1)" "unprognostic (2.83e-2)" "unprognostic (2.19e-1)" "unprognostic (8.56e-4)" "unprognostic (1.35e-1)" "unprognostic (5.74e-2)" "unprognostic (6.65e-2)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" "unprognostic (1.08e-1)" "unprognostic (9.30e-2)" "unprognostic (3.00e-1)" "unprognostic (4.25e-1)" "unprognostic (1.93e-1)" 0.1 0.1 0.7 0.0 0.9 0.1 0.1 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.5 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.3 0.0 0.4 0.1 0.0 0.2 0.1 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.0 143.9 0.3 0.0 0.2 0.1 0.2 0.0 0.0 2.4 2.7 3.6 1.1 0.2 3.8 1.2 0.0 0.0 0.3 2.0 1.5 1.6 2.0 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.1 0.4 0.1 0.2 0.0 0.0 0.1 0.2 2.8 0.2 1.1 0.0 0.0 0.2 0.3 0.0 0.4 0.1 0.1 0.2 1.0 0.2 0.1 0.6 0.0 0.4 0.2 0.5 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.9 0.0 2.2 3.5 0.5 0.1 0.2 0.1 0.9 0.4 2.8 8.7 0.1 7.8 6.8 0.3 0.1 0.0 0.1 1.3 0.7 1.0 0.6 1.0 2.3 0.8 1.8 2.2 0.0 2.4 3.8 2.6 3.6 0.2 1.1 2.7 1.7 1.2 0.7 0.9 0.6 0.4 0.2 0.1 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 1.4 1.2 1.8 0.0 0.0 3.3 0.3 838.5 0.6 0.0 0.0 5.5 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.6 0.0 78.1 21.6 0.0 0.0 0.0 0.0 1.0 1.2 0.0 17.0 2.9 0.6 19.4 0.0 827.5 26.0 0.5 0.0 0.0 0.0 0.1 LDHD ENSG00000166816 "Lactate dehydrogenase D" Q86WU2 16 75111860-75116771 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.3;skeletal muscle: 39.7" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 33.6;Enterocytes: 38.8;Hepatocytes: 81.8;Proximal tubular cells: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7" "Group enriched" "Detected in many" 31 "granulocytes: 8.9;monocytes: 5.7" "Cell line enhanced" "Detected in many" "Hep G2: 8.7;HMC-1: 12.0;T-47d: 23.5;U-266/70: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041766, HPA048639, HPA066148" Enhanced Approved Cytosol No NA Cytosol "HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626" "unprognostic (8.75e-2)" "unprognostic (3.68e-3)" "unprognostic (1.27e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (1.53e-1)" "prognostic favorable (5.61e-4)" "unprognostic (2.49e-3)" "unprognostic (1.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.74e-1)" "unprognostic (4.01e-1)" "prognostic favorable (2.95e-14)" "unprognostic (4.10e-3)" "unprognostic (4.49e-2)" "unprognostic (7.00e-2)" "unprognostic (2.20e-1)" 15.3 5.5 6.8 1.6 6.7 0.8 3.7 4.9 11.7 4.1 12.5 7.6 4.5 6.1 1.5 3.0 3.8 2.1 3.6 25.3 6.6 5.8 21.5 44.3 2.8 0.9 8.1 9.7 7.9 7.7 8.5 4.4 2.1 9.9 4.4 6.8 5.1 14.2 4.5 39.7 1.8 2.5 1.2 4.5 0.7 11.2 1.0 4.0 0.0 4.3 14.4 2.7 1.1 1.2 0.0 0.2 8.9 5.7 0.1 0.1 0.9 0.6 1.6 0.0 0.3 1.3 1.1 5.1 0.1 0.1 0.1 0.2 2.1 2.2 0.0 1.8 0.7 0.8 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.5 8.7 2.1 0.0 12.0 1.6 0.3 0.0 0.0 0.4 0.1 0.3 0.6 1.9 0.0 4.0 0.0 0.6 1.1 2.1 1.0 0.0 0.0 6.0 1.1 0.1 0.0 0.0 0.0 4.1 0.3 0.6 23.5 2.6 0.0 0.0 0.2 0.0 0.0 9.3 0.5 0.0 1.6 0.0 0.0 8.9 2.7 0.8 0.0 4.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.9 6.8 6.7 4.9 11.7 6.6 5.8 8.1 9.7 9.9 4.0 0.0 7.9 2.2 2.1 0.6 0.0 33.6 10.2 1.4 1.2 10.4 0.0 1.6 31.5 1.3 0.3 0.6 38.8 0.0 5.5 1.1 0.5 1.6 10.3 81.8 6.2 1.6 2.9 4.3 5.3 0.2 0.0 1.6 5.0 1.0 9.4 11.0 3.7 19.9 0.0 75.5 1.0 0.0 0.4 0.0 0.3 0.3 2.6 1.3 11.0 1.7 LDLRAD1 ENSG00000203985 "Low density lipoprotein receptor class A domain containing 1" Q5T700 1 54007299-54018186 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 64.2;lung: 16.1;ovary: 20.5" "Cell type enriched" "Detected in some" 15 "Ciliated cells: 499.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 3.7;Hep G2: 15.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052489 Enhanced Uncertain "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA052489: AB_2681850" "unprognostic (6.53e-3)" "unprognostic (2.05e-2)" "unprognostic (2.51e-1)" "prognostic favorable (9.21e-4)" "unprognostic (1.59e-2)" "unprognostic (1.67e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-1)" "unprognostic (8.07e-3)" "unprognostic (2.43e-1)" "unprognostic (2.86e-1)" "unprognostic (5.23e-1)" "unprognostic (4.27e-2)" 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.1 0.1 0.0 0.0 0.6 2.1 0.4 64.2 1.1 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 20.5 0.1 0.0 1.5 0.1 0.2 0.5 0.0 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.8 4.8 0.0 0.0 0.7 0.5 2.1 0.4 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 3.7 0.0 1.9 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.3 0.8 15.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.6 0.3 0.0 0.1 1.0 0.0 0.1 0.8 0.1 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.1 0.3 0.0 0.2 2.1 0.4 0.3 0.4 0.2 0.3 0.5 0.3 0.4 0.1 0.7 0.4 0.5 2.1 0.4 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.0 7.4 0.0 0.2 0.0 0.0 0.0 0.0 499.2 34.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 4.7 0.0 0.1 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 LDLRAD3 LRAD3 ENSG00000179241 "Low density lipoprotein receptor class A domain containing 3" Q86YD5 11 35943981-36232136 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.5" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 19.0;Peritubular cells: 23.3;Suprabasal keratinocytes: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.1;non-classical monocyte: 7.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 28.5;RH-30: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038251 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA038251: AB_10675790" "unprognostic (1.59e-3)" "prognostic unfavorable (2.24e-4)" "unprognostic (3.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.81e-1)" "unprognostic (1.93e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (9.34e-6)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (1.68e-2)" "unprognostic (6.93e-2)" "prognostic unfavorable (5.05e-8)" "unprognostic (3.32e-2)" "unprognostic (9.21e-3)" "unprognostic (9.33e-2)" "prognostic unfavorable (2.14e-5)" 12.0 5.0 9.5 6.0 13.7 2.0 23.4 32.5 17.9 9.3 2.8 20.7 1.7 2.9 8.2 4.7 8.8 5.0 6.5 3.6 10.8 7.2 3.0 2.6 3.3 4.4 18.0 4.0 15.0 5.1 1.5 9.2 3.4 18.1 14.8 3.2 5.3 23.9 6.0 5.5 17.0 3.3 7.2 24.4 2.9 3.4 4.8 13.5 0.1 3.0 2.6 4.8 5.3 6.5 0.0 4.1 1.9 7.7 0.0 0.0 2.0 4.8 4.6 14.4 8.7 11.5 12.6 11.0 2.8 2.5 6.4 5.7 3.4 3.0 0.0 2.1 3.0 9.6 2.5 4.4 6.3 9.0 0.4 9.3 15.7 3.0 1.0 15.2 3.4 1.9 15.1 28.5 2.9 25.2 2.6 10.7 0.0 4.0 0.6 11.7 2.7 0.0 0.8 5.9 0.5 8.1 0.0 26.9 1.5 1.1 0.7 4.9 11.1 4.9 5.4 15.8 5.8 7.5 4.6 10.7 7.7 6.9 0.6 9.3 0.3 0.0 0.0 3.8 4.2 13.7 1.9 6.1 0.6 0.0 6.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 0.0 7.7 0.3 0.0 2.0 9.5 13.7 32.5 9.1 10.8 7.2 18.0 4.0 18.1 13.5 0.0 5.6 0.5 6.7 13.7 0.2 0.4 0.0 0.0 1.2 0.0 0.0 2.1 0.0 3.6 12.5 5.5 0.0 0.0 0.9 11.4 4.4 19.0 0.0 0.6 3.8 0.0 0.0 9.8 13.5 11.9 8.9 5.1 6.8 1.0 0.0 0.5 1.2 0.0 23.3 1.6 0.0 12.9 8.2 0.5 3.0 22.7 1.1 0.0 0.4 2.2 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 112.3;Late spermatids: 181.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.6;JURKAT: 15.5;MOLT-4: 47.7;REH: 14.4;U-698: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles NA NA Vesicles "HPA047633: , HPA065246: AB_2685444" "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 8.3 6.6 9.6 11.5 22.0 11.9 7.5 10.3 22.9 8.6 6.1 45.4 4.3 9.8 12.9 5.2 5.6 11.0 7.8 17.8 14.6 10.7 3.9 10.4 5.9 11.6 19.9 12.5 3.6 6.2 4.6 8.3 8.0 23.5 10.4 3.3 3.7 4.8 8.3 19.0 4.8 10.9 7.5 30.7 8.9 7.6 8.9 21.2 49.2 5.2 2.5 8.5 7.9 6.7 8.2 8.2 17.2 11.0 12.5 14.5 6.2 0.1 0.2 0.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.4 0.2 0.0 0.0 0.0 7.8 0.8 15.6 3.2 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 15.5 0.2 0.6 0.0 1.2 47.7 0.6 1.2 0.2 5.5 14.4 0.1 0.6 0.0 0.8 1.1 1.6 0.2 1.1 0.0 0.7 2.1 4.8 1.4 0.8 5.6 0.1 1.0 2.2 0.2 12.0 0.0 3.5 3.2 12.7 10.3 3.4 10.2 10.3 8.9 7.2 9.7 8.8 5.1 8.2 14.5 12.6 17.2 12.5 11.0 8.2 5.2 6.2 9.6 22.0 10.3 20.6 14.6 10.7 19.9 12.5 23.5 21.2 3.0 6.6 34.6 2.1 9.3 4.2 15.4 0.0 6.7 7.9 1.8 66.8 0.6 1.7 5.0 112.3 18.0 7.1 0.0 3.3 0.4 27.0 21.2 23.1 21.7 18.5 0.0 56.4 18.4 18.9 181.4 10.3 35.0 13.5 6.4 7.9 4.3 0.5 3.5 23.0 2.1 17.0 6.5 9.2 2.3 5.3 6.8 1.4 16.6 6.7 3.0 LDLRAP1 "ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705" ENSG00000157978 "Low density lipoprotein receptor adaptor protein 1" Q5SW96 1 25543580-25568886 "Disease related genes, Predicted intracellular proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Atherosclerosis, Disease mutation, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 60.6" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 36.7" "Group enriched" "Detected in all" 7 "NK-cells: 11.3;T-cells: 36.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB003705, HPA050358" Uncertain Approved Microtubules NA NA Microtubules "CAB003705: AB_425923, HPA050358: AB_2681103" "unprognostic (2.52e-2)" "unprognostic (5.39e-3)" "unprognostic (7.49e-3)" "unprognostic (4.12e-2)" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.70e-2)" "unprognostic (7.27e-3)" "unprognostic (4.79e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-3)" "unprognostic (9.96e-2)" "unprognostic (6.49e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.74e-2)" "unprognostic (4.24e-1)" 5.9 10.9 5.4 11.0 16.7 4.7 8.1 60.6 10.4 6.4 11.7 31.8 9.7 7.2 5.9 6.2 10.5 6.2 6.3 6.0 9.3 5.7 8.3 14.0 10.2 21.3 23.4 6.9 6.7 26.1 8.5 11.1 15.8 16.4 11.4 10.8 9.9 22.6 7.6 7.4 13.6 8.8 6.8 34.3 31.1 8.7 3.2 15.8 2.8 11.0 8.0 13.8 6.2 8.3 3.5 2.9 1.0 2.1 11.3 36.7 15.0 13.4 5.3 7.6 8.0 4.8 5.6 6.2 8.6 8.4 13.2 9.2 2.1 11.2 3.0 6.3 11.7 9.2 14.3 5.2 8.7 6.7 3.6 8.0 4.8 6.3 4.1 7.7 5.4 7.2 6.0 12.5 10.6 4.0 3.2 11.3 3.1 6.6 29.7 4.3 7.8 0.1 9.3 9.6 10.9 5.7 0.8 8.6 24.2 4.9 2.8 3.8 2.1 11.9 19.1 13.6 6.5 8.7 9.4 6.7 5.8 8.5 10.9 5.9 28.5 33.2 8.6 19.6 4.6 7.0 0.0 2.1 0.0 7.7 1.7 9.1 3.5 18.2 14.3 2.9 1.8 36.7 29.4 1.0 11.3 1.7 0.4 14.9 15.0 5.4 16.7 60.6 10.4 9.3 5.7 23.4 6.9 16.4 15.8 0.0 14.1 13.7 18.3 7.3 3.3 3.2 7.6 2.7 13.6 7.0 17.7 29.3 3.3 9.2 0.2 9.2 14.7 0.0 15.7 6.3 8.4 16.3 2.3 18.3 9.4 66.7 6.4 13.5 5.7 0.0 9.5 4.6 16.9 0.0 21.5 3.8 11.3 24.6 8.1 4.4 13.2 25.8 7.2 1.2 7.5 5.0 19.8 13.1 17.8 17.1 LEAP2 LEAP-2 ENSG00000164406 "Liver enriched antimicrobial peptide 2" Q969E1 5 132872322-132875046 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "liver: 52.4" "Cell type enriched" "Detected in many" 19 "Hepatocytes: 1416.7" "Cancer enriched" "Detected in many" 17 "liver cancer: 40.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 1300000 "unprognostic (2.14e-2)" "unprognostic (8.78e-2)" "unprognostic (4.75e-1)" "unprognostic (2.16e-1)" "unprognostic (2.82e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-3)" "unprognostic (6.53e-2)" "unprognostic (3.86e-2)" "unprognostic (1.62e-1)" "unprognostic (7.08e-3)" "unprognostic (2.91e-2)" "unprognostic (1.02e-1)" "unprognostic (2.39e-1)" "unprognostic (3.97e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.68e-4)" 0.1 0.1 0.0 0.2 0.1 0.0 0.2 1.5 0.0 0.2 0.3 1.5 0.1 0.1 0.3 0.2 0.4 0.2 0.1 0.0 1.4 52.4 0.2 0.3 0.1 0.2 0.5 0.5 0.2 0.0 0.7 0.5 0.3 0.1 0.9 0.4 2.6 0.0 0.1 0.7 0.5 0.1 0.6 0.5 1.8 0.4 1.6 0.9 4.2 1.3 0.9 2.0 0.3 0.5 2.3 2.4 4.8 2.7 1.3 1.8 1.0 0.2 0.7 1.6 2.4 2.8 2.0 0.4 0.3 0.8 4.2 3.8 1.1 0.5 3.6 1.7 1.7 5.7 1.7 0.7 0.9 1.3 1.1 1.9 0.7 1.3 2.0 0.7 3.5 1.4 4.9 0.7 1.2 1.6 3.9 1.4 1.9 1.1 1.4 1.6 1.5 1.0 2.0 1.6 1.1 1.0 1.0 0.8 1.1 1.5 1.2 0.4 2.7 1.6 1.2 0.6 5.8 4.3 1.7 0.7 2.7 1.1 4.2 1.3 0.2 1.3 0.9 1.4 1.5 0.9 0.6 0.9 1.6 1.1 1.2 3.2 0.9 0.5 0.8 2.0 0.3 0.0 1.6 16.9 9.6 9.0 15.8 1.2 76.5 1.4 1.2 0.0 31.4 2.7 8.3 2.3 3.7 3.8 75.4 0.0 8.7 4.9 6.7 7.2 6.9 1416.7 1.2 12.7 4.6 21.5 19.4 0.2 1.4 3.4 5.0 0.0 3.4 4.6 2.5 34.5 1.8 36.3 23.1 0.0 6.2 4.1 1.9 6.8 6.1 10.0 4.4 7.8 LECT2 "chm-II, chm2" ENSG00000145826 "Leukocyte cell derived chemotaxin 2" O14960 5 135922279-135955034 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 100.7" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 116.8;Erythroid cells: 23.3;Hepatocytes: 93.6;Late spermatids: 39.1" "Cancer enriched" "Detected in single" 216 "liver cancer: 35.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043883, HPA058246" Enhanced Supported Vesicles,Cytosol "Secreted to blood" NA NA 26500000 820000 Cytosol Vesicles "HPA043883: AB_2678714, HPA058246: " "prognostic favorable (4.16e-5)" "unprognostic (2.57e-2)" "unprognostic (3.52e-1)" 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 100.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.5 2.5 1.2 0.1 0.8 0.3 1.0 1.2 1.5 2.5 0.6 2.2 2.3 0.5 0.2 0.0 0.0 0.9 1.4 2.4 1.9 1.0 1.1 1.5 0.2 0.7 0.2 0.9 3.2 2.4 3.3 4.1 1.0 3.0 0.5 0.8 0.7 1.1 1.1 2.0 1.1 2.6 0.9 2.0 2.0 1.5 1.2 1.3 1.7 0.8 1.9 1.6 1.4 0.7 1.6 2.7 1.0 1.9 0.0 0.6 0.1 3.3 0.3 1.6 2.5 0.9 1.5 1.3 0.4 3.6 1.7 1.0 1.1 2.8 2.4 2.4 1.2 0.4 0.7 0.8 0.5 1.3 0.8 0.8 0.2 1.0 0.7 0.5 2.5 0.1 0.6 0.5 0.7 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.8 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 93.6 0.0 0.0 0.0 3.7 2.2 39.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 6.5 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 LEF1 "TCF10, TCF1ALPHA, TCF7L3" ENSG00000138795 "Lymphoid enhancer binding factor 1" Q9UJU2 4 108047545-108168956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 231.5" "Cell type enhanced" "Detected in many" 12 "Distal tubular cells: 11.6;Melanocytes: 32.1;Spermatocytes: 21.3;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 42.2" "Lineage enriched" "Detected in many" 5 "T-cells: 42.2" "Group enriched" "Detected in many" 5 "JURKAT: 98.3;MOLT-4: 93.3;REH: 72.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002087, CAB019405" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB019405: AB_823558, HPA002087: AB_1079245" "unprognostic (1.03e-3)" "unprognostic (7.36e-3)" "unprognostic (2.97e-2)" "prognostic favorable (1.37e-5)" "unprognostic (9.08e-2)" "unprognostic (5.24e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (1.77e-1)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.47e-6)" "unprognostic (1.12e-1)" "unprognostic (5.22e-2)" "unprognostic (7.88e-2)" "unprognostic (8.91e-2)" 0.9 13.5 3.5 9.3 5.4 7.6 2.0 1.6 3.4 3.6 1.0 2.9 0.8 0.4 6.0 3.5 3.4 5.0 2.8 0.5 4.7 5.2 2.7 0.3 2.4 25.3 4.9 1.9 1.8 0.8 0.0 1.1 7.8 3.1 2.8 1.0 1.6 3.1 0.7 0.5 2.4 3.9 2.9 4.4 7.0 0.9 8.2 2.3 231.5 2.7 1.3 20.6 4.8 3.2 0.3 0.1 0.5 0.0 8.9 42.2 9.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.7 4.1 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.5 0.0 2.9 1.0 0.0 0.0 0.0 3.6 0.5 0.0 0.1 0.0 0.1 0.6 0.0 98.3 2.1 0.0 0.4 0.1 93.3 0.0 0.2 1.0 0.2 72.0 1.4 0.0 0.3 0.2 0.4 0.8 0.0 0.0 13.8 1.1 0.3 0.0 0.0 1.9 1.6 0.0 2.4 6.0 2.5 16.5 1.2 0.0 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.1 19.7 8.8 0.0 0.3 42.2 29.2 0.5 8.9 0.0 0.1 25.7 9.5 3.5 5.4 1.6 3.4 4.7 5.2 4.9 1.9 3.1 2.3 3.0 3.4 0.0 1.1 3.0 0.0 1.2 0.0 4.0 1.2 0.0 0.0 0.1 11.6 0.0 3.1 3.6 0.0 0.0 0.0 0.1 1.8 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.9 0.6 0.8 32.1 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.0 5.9 21.3 9.6 1.1 0.3 13.1 0.1 0.3 LEFTY1 "LEFTB, LEFTYB" ENSG00000243709 "Left-right determination factor 1" O75610 1 225886282-225911382 "Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5" "Cell type enriched" "Detected in many" 4 "Undifferentiated cells: 330.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.8" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 35 "basophil: 12.1" "Lineage enriched" "Detected in single" 35 "granulocytes: 12.1" "Cell line enriched" "Detected in some" 6 "NTERA-2: 34.0" "HPA047883, HPA056210" Approved "Secreted in other tissues" NA NA "HPA047883: AB_2680200, HPA056210: AB_2683067" "unprognostic (2.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.26e-2)" "unprognostic (1.18e-2)" "unprognostic (1.83e-2)" "unprognostic (3.50e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" "unprognostic (2.19e-1)" "unprognostic (1.28e-1)" "unprognostic (7.76e-2)" "unprognostic (6.13e-2)" "prognostic unfavorable (2.48e-6)" "unprognostic (2.78e-2)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (2.61e-2)" 0.2 0.0 0.6 4.5 1.1 0.0 0.2 1.2 0.9 0.6 26.6 0.2 1.5 0.0 0.7 19.0 0.4 0.1 0.2 0.2 0.6 0.7 3.6 0.2 0.3 0.2 0.2 0.2 2.0 46.5 0.0 0.3 0.3 0.2 0.6 15.1 0.3 0.5 1.6 0.2 0.0 0.8 0.4 0.2 0.2 0.4 2.1 0.2 0.3 0.2 0.2 0.2 0.9 0.2 0.0 0.0 12.1 0.0 0.3 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.0 3.6 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.7 0.6 1.1 1.2 0.9 0.6 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 14.5 1.5 0.0 6.7 0.0 27.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 2.1 1.4 0.0 0.0 0.0 45.3 0.8 0.5 73.7 1.8 4.8 1.3 0.0 0.3 1.6 1.5 0.0 0.0 0.0 330.1 1.3 LEFTY2 "EBAF, LEFTA, LEFTYA, TGFB4" ENSG00000143768 "Left-right determination factor 2" O00292 1 225936598-225941489 "Disease related genes, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "endometrium 1: 61.1;ovary: 80.0" "Group enriched" "Detected in some" 10 "Early spermatids: 16.3;Late spermatids: 27.4;Leydig cells: 16.7;Peritubular cells: 11.3" "Cancer enriched" "Detected in many" 8 "testis cancer: 41.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NTERA-2: 24.3;RPMI-8226: 26.2;SuSa: 15.6" "CAB025801, HPA047883, HPA056210" Approved "Secreted in other tissues" NA NA "CAB025801: , HPA047883: AB_2680200, HPA056210: AB_2683067" "unprognostic (3.78e-2)" "unprognostic (4.10e-3)" "unprognostic (5.79e-3)" "unprognostic (5.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-1)" "unprognostic (4.87e-2)" "unprognostic (9.75e-4)" "unprognostic (2.91e-1)" "unprognostic (3.84e-1)" "unprognostic (7.98e-2)" "unprognostic (9.14e-3)" "unprognostic (1.15e-1)" "unprognostic (4.69e-2)" "unprognostic (1.90e-4)" "unprognostic (1.64e-3)" 0.5 0.4 0.1 0.3 0.2 0.0 0.5 0.1 0.2 15.2 0.5 0.7 0.1 0.0 61.1 4.5 0.2 1.1 0.1 0.8 0.4 0.0 0.4 0.1 0.7 0.1 0.2 0.1 80.0 0.1 0.0 8.5 16.3 0.6 0.9 0.0 0.9 0.1 4.4 0.2 0.0 0.2 14.7 0.1 0.1 0.0 1.8 0.1 0.3 0.1 0.1 0.1 0.3 0.5 0.5 0.0 0.9 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 24.3 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 1.3 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.7 0.8 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.1 0.2 0.4 0.0 0.2 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 16.3 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 27.4 16.7 0.0 1.7 0.0 0.1 0.3 0.0 0.0 11.3 0.0 0.1 0.0 1.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" Q6ZMV7 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 29.8" "Group enriched" "Detected in many" 10 "Ciliated cells: 34.8;Early spermatids: 63.2;Late spermatids: 32.2;Spermatocytes: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.6;U-266/70: 6.2" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 1.4 1.7 1.4 2.5 4.6 0.6 2.7 1.4 2.2 1.5 1.0 1.6 3.5 1.7 1.3 8.2 0.9 6.3 1.7 1.4 1.5 2.0 2.8 1.3 3.0 1.6 1.1 1.4 2.9 2.7 4.8 4.5 0.5 2.2 1.7 1.1 2.5 1.6 4.9 0.7 0.9 1.6 0.8 1.9 1.8 1.5 29.8 0.7 4.4 4.0 0.7 1.4 1.2 1.8 3.2 1.9 2.5 0.3 2.5 2.0 0.4 6.6 2.7 0.1 1.6 1.2 0.6 0.4 0.4 1.0 1.4 1.1 0.3 3.8 0.1 2.0 1.1 2.6 2.5 0.0 0.5 2.7 1.2 0.6 2.5 0.5 0.0 0.0 2.1 0.6 3.1 1.6 0.5 1.9 0.8 0.6 0.1 1.5 1.6 2.4 2.4 0.0 1.9 2.2 1.9 1.5 0.0 1.8 1.5 2.1 0.6 4.2 1.7 2.2 1.5 0.1 0.5 4.6 3.6 0.0 0.4 0.7 0.5 1.0 6.2 1.0 0.0 1.2 1.5 2.3 2.5 0.3 0.3 0.7 0.1 1.4 3.1 1.6 0.6 1.2 3.2 1.8 0.9 0.3 2.5 0.2 1.9 2.0 0.4 1.4 4.6 1.4 2.2 1.5 2.0 1.1 1.4 2.2 0.7 0.0 1.4 0.0 1.1 1.1 1.3 0.8 2.5 34.8 3.4 3.5 2.0 0.2 3.3 0.6 63.2 0.4 1.3 0.0 1.4 0.1 0.5 0.7 1.1 1.6 0.2 3.2 0.0 0.0 1.8 32.2 1.4 1.1 1.7 1.8 0.6 1.4 0.7 0.0 1.8 3.3 4.5 0.0 0.3 49.4 3.2 0.6 0.1 1.3 0.8 0.8 LELP1 ENSG00000203784 "Late cornified envelope like proline rich 1" Q5T871 1 153203443-153205120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 65 "testis: 147.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 16141.9" "Cancer enriched" "Detected in single" 10 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.6" HPA070231 Enhanced NA NA "HPA070231: AB_2686237" "unprognostic (1.77e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 147.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3232.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16141.9 82.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.8 0.0 0.0 45.3 0.0 103.7 46.9 0.0 0.0 0.0 0.0 0.0 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205457091 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.1;testis: 34.8" "Group enriched" "Detected in some" 129 "Early spermatids: 869.0;Late spermatids: 3077.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in some" 13 "cerebellum: 2.6;pons and medulla: 5.3" "Cell type enhanced" "Detected in single" "NK-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 29.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045425 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.2 0.2 0.2 0.0 0.3 0.0 0.3 2.6 0.2 0.4 1.4 0.0 3.8 0.6 1.0 13.1 1.0 1.5 0.7 0.2 0.2 0.3 0.9 0.2 0.4 0.0 0.3 0.0 0.6 0.6 0.0 0.6 4.7 5.3 0.3 0.0 0.3 3.2 0.4 0.2 0.3 1.4 0.1 0.2 0.2 0.3 34.8 0.0 0.0 4.8 2.2 2.6 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.7 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 29.9 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.2 0.3 2.6 0.2 0.2 0.3 0.3 0.0 5.3 0.0 0.0 1.6 0.0 1.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 869.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3077.5 11.8 0.0 0.0 0.0 0.0 0.9 4.0 0.0 13.1 1.5 0.7 6.5 0.0 15.3 7.2 0.0 0.3 0.0 0.0 2.2 LENEP LEP503 ENSG00000163352 "Lens epithelial protein" Q9Y5L5 1 154993586-154994315 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.0" "Cell type enhanced" "Detected in single" 35 "Muller glia cells: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 1.7;hippocampal formation: 3.0;pons and medulla: 2.5" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 1.8;BEWO: 1.1;Daudi: 1.1;HaCaT: 1.6;HAP1: 1.6;Karpas-707: 1.2;MCF7: 1.1;PC-3: 1.4" "Not detected" "Not detected" NA NA "unprognostic (1.03e-1)" "unprognostic (3.60e-2)" "unprognostic (4.71e-2)" "unprognostic (1.16e-1)" "unprognostic (2.04e-2)" "unprognostic (9.50e-3)" "unprognostic (2.72e-2)" "unprognostic (4.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.79e-1)" "unprognostic (9.51e-2)" "unprognostic (8.04e-2)" "unprognostic (1.32e-5)" "unprognostic (5.26e-2)" "unprognostic (4.50e-3)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" 0.1 0.4 1.7 0.1 0.2 0.0 0.2 0.4 0.2 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 3.0 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.3 0.0 0.3 0.2 2.5 0.6 0.3 0.1 1.9 0.1 0.5 1.4 1.3 0.1 1.8 0.1 0.3 0.3 0.1 0.1 1.6 0.1 0.1 0.1 0.2 0.2 0.8 0.0 0.1 0.0 1.0 0.0 0.9 1.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.4 1.2 0.0 1.1 0.0 0.0 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.8 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.2 0.4 0.2 3.0 0.2 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LENG9 ENSG00000275183 "Leukocyte receptor cluster member 9" 19 54461796-54463711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.3" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 25.9;Mucus-secreting cells: 25.8;Rod photoreceptor cells: 25.8;Undifferentiated cells: 21.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 8.0;OE19: 9.7;RPMI-8226: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051671, HPA053556" Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA051671: AB_2681568, HPA053556: AB_2682187" "unprognostic (8.38e-2)" "unprognostic (8.60e-2)" "unprognostic (1.18e-1)" "prognostic favorable (9.99e-5)" "unprognostic (2.43e-2)" "unprognostic (2.21e-3)" "unprognostic (1.09e-1)" "unprognostic (4.88e-2)" "unprognostic (5.73e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (2.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.63e-3)" "unprognostic (2.96e-1)" "unprognostic (9.12e-2)" "unprognostic (2.76e-2)" 2.9 0.6 0.0 2.6 0.9 0.2 1.8 0.0 1.0 1.4 5.7 0.9 0.7 6.8 1.3 0.3 3.0 0.7 5.0 1.9 0.4 0.5 6.4 2.1 2.0 0.8 0.2 2.2 19.3 0.1 0.0 0.2 0.7 3.4 1.5 0.0 7.0 2.2 2.6 0.2 5.8 1.0 0.5 1.7 4.7 0.7 0.2 0.2 0.7 2.8 2.6 0.7 0.4 0.5 0.0 1.9 0.4 0.0 0.7 0.0 4.8 1.5 0.1 0.1 2.1 2.0 0.0 0.7 1.9 0.3 0.3 0.6 4.5 0.0 2.3 1.8 0.0 8.0 0.5 1.4 0.0 4.8 0.0 1.1 0.0 0.2 2.7 0.0 0.0 2.8 2.4 0.0 1.6 1.3 0.9 0.8 0.0 6.8 0.6 4.4 2.1 2.9 1.1 9.7 0.0 4.1 0.4 8.4 0.8 0.0 0.8 0.3 0.0 2.8 1.3 0.5 4.6 0.0 2.1 0.2 0.1 0.0 1.6 0.6 0.0 0.6 1.3 2.9 4.0 1.9 0.4 0.1 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 10.3 0.8 4.0 0.2 0.0 1.4 0.0 1.8 2.0 0.2 0.0 2.5 1.1 2.2 25.9 0.0 3.7 2.5 2.7 11.2 0.0 2.1 3.3 4.8 5.2 3.7 7.2 0.0 6.1 2.1 1.7 0.0 25.8 9.2 2.9 17.8 1.8 2.8 25.8 0.0 6.6 0.5 2.5 2.8 0.3 3.8 21.4 13.7 LEP "OB, OBS" ENSG00000174697 Leptin P41159 7 128241284-128257628 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "adipose tissue: 85.2;breast: 63.7;placenta: 24.3" "Cell type enriched" "Detected in some" 28 "Syncytiotrophoblasts: 361.5" "Cancer enhanced" "Detected in some" "breast cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.8" "Group enriched" "Detected in some" 11 "BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB010490 Approved "Secreted to blood" NA NA 17000000 26000000 "CAB010490: AB_2296951" "unprognostic (8.19e-3)" "unprognostic (5.33e-1)" "unprognostic (1.60e-4)" "unprognostic (1.19e-1)" "unprognostic (7.99e-3)" "unprognostic (1.83e-1)" "unprognostic (6.56e-3)" "unprognostic (1.98e-2)" "unprognostic (1.42e-2)" "unprognostic (2.45e-2)" "unprognostic (2.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.23e-2)" "unprognostic (6.84e-2)" 85.2 0.3 0.0 1.5 0.0 0.0 63.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.1 0.0 0.4 2.0 0.0 0.0 0.1 0.7 0.0 0.0 24.3 0.0 0.0 0.1 0.0 0.4 0.0 0.6 1.1 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 1.5 2.1 0.4 0.4 3.8 0.5 0.5 0.3 0.2 0.0 0.2 0.1 0.3 0.2 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.3 0.1 7.1 0.2 0.1 0.0 0.2 0.2 0.4 0.2 0.2 0.1 0.2 0.3 0.1 0.3 0.9 0.5 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.4 0.2 0.3 3.8 0.5 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.2 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 361.5 0.0 0.0 0.1 LEPR "CD295, OBR" ENSG00000116678 "Leptin receptor" P48357 1 65420652-65641559 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 82.8" "Cell type enhanced" "Detected in many" 18 "Endothelial cells: 59.1;Hepatocytes: 196.4" "Cancer enriched" "Detected in many" 7 "liver cancer: 13.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.7;K-562: 46.5;RPTEC TERT1: 22.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030899 Approved Supported "Secreted to blood" NA NA 8240000 8300000 "HPA030899: AB_10610003" "unprognostic (1.59e-2)" "unprognostic (1.09e-3)" "unprognostic (3.09e-1)" "unprognostic (8.95e-2)" "unprognostic (2.32e-1)" "unprognostic (2.64e-1)" "unprognostic (2.58e-1)" "unprognostic (2.30e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-3)" "unprognostic (1.79e-1)" "unprognostic (2.41e-1)" "unprognostic (7.53e-2)" "unprognostic (1.11e-1)" "unprognostic (2.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.73e-1)" 15.9 5.5 3.8 3.7 4.3 3.3 23.5 2.5 3.9 15.0 9.2 5.6 5.4 3.2 20.6 7.3 10.9 11.7 10.1 9.2 4.3 4.9 14.6 82.8 20.3 9.0 4.9 3.3 18.4 16.7 3.9 13.1 12.8 8.2 10.8 4.1 18.1 12.0 5.7 5.6 10.2 7.3 12.9 7.0 6.4 11.9 6.6 3.1 1.9 13.1 11.2 6.9 13.6 8.6 0.6 1.8 6.9 1.9 1.1 2.3 1.8 1.3 0.8 1.1 1.2 5.0 4.7 3.9 5.9 3.4 2.0 1.9 0.6 3.2 0.5 4.4 7.5 0.5 1.1 0.9 5.2 5.5 7.0 1.5 7.7 3.6 0.1 3.0 0.5 0.6 13.2 3.0 1.2 4.7 15.7 5.9 0.6 46.5 0.9 9.5 0.3 0.6 0.1 1.8 0.8 0.1 0.1 0.9 0.3 22.5 0.6 0.7 11.4 1.4 0.6 1.6 6.7 2.1 2.1 2.2 2.1 4.4 0.4 3.2 1.3 0.9 0.2 4.5 2.2 2.0 6.9 1.9 2.8 1.3 1.5 1.3 0.6 1.1 1.1 1.8 0.3 0.9 1.5 1.1 1.1 1.7 1.2 2.3 1.8 3.8 4.3 2.5 3.9 4.3 4.9 4.9 3.3 8.2 3.1 0.0 16.5 3.0 1.9 31.4 4.9 3.5 10.2 2.7 4.5 8.7 0.0 1.2 3.3 1.5 1.0 59.1 0.4 0.0 0.9 2.3 20.2 3.3 1.1 196.4 1.9 1.6 0.0 27.6 6.5 1.5 31.9 5.8 33.7 2.8 0.9 0.0 1.6 1.7 7.1 6.8 0.9 0.0 17.7 1.1 0.6 25.7 2.2 0.5 0.8 1.4 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.8;testis: 28.6" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 41.6;Late spermatids: 34.7;Pancreatic endocrine cells: 29.9;Spermatocytes: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.8;hTERT-HME1: 15.3" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 50.6" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 2.3 1.3 3.3 1.7 7.9 6.8 1.5 9.9 6.6 2.6 1.3 2.9 0.5 1.5 2.1 2.1 2.1 2.1 2.0 1.4 4.3 4.1 3.5 1.4 3.2 1.7 3.1 4.2 2.6 1.4 3.6 5.5 6.7 3.3 1.9 1.5 3.0 1.4 1.4 0.8 1.8 1.1 1.2 3.2 2.3 4.1 28.6 1.6 3.8 1.6 1.0 2.2 3.1 1.7 1.4 1.3 16.8 3.8 1.2 4.0 1.2 13.8 2.5 1.9 1.8 1.5 4.3 1.4 4.7 5.6 6.7 4.1 1.0 5.5 1.7 11.1 1.0 2.0 1.5 3.8 16.8 7.0 0.8 1.6 2.0 1.9 2.5 1.9 0.3 1.9 1.2 4.7 7.1 15.3 3.6 7.0 2.2 1.7 2.7 5.9 2.9 5.0 1.2 0.4 1.0 11.8 1.7 3.1 1.0 11.0 0.6 1.6 1.6 1.6 0.3 0.5 1.3 1.6 0.8 12.1 2.1 14.8 3.8 1.1 1.8 1.0 1.3 3.3 2.2 1.6 0.9 3.4 0.5 0.9 1.3 1.5 1.4 0.8 1.3 1.3 1.4 1.6 1.5 16.8 1.2 3.8 0.6 4.0 1.2 3.3 7.9 9.9 6.6 4.3 4.1 3.1 4.2 3.3 1.6 3.0 5.4 0.5 11.6 0.5 7.0 1.6 5.1 4.0 2.3 5.2 5.9 1.4 1.7 3.5 41.6 2.6 0.2 0.0 17.9 4.8 2.2 2.1 9.2 0.0 1.3 6.4 0.0 1.3 1.5 34.7 2.0 2.5 1.7 1.0 1.4 3.5 29.9 0.0 1.4 2.2 8.2 0.0 2.8 24.4 1.5 0.6 6.8 3.8 1.0 4.4 LEXM "C1orf177, FLJ40201, LEM" ENSG00000162398 "Lymphocyte expansion molecule" Q3ZCV2 1 54806063-54842252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.0;esophagus: 14.2;testis: 5.2" "Group enriched" "Detected in some" 22 "Early spermatids: 34.6;Late spermatids: 32.5" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "gdT-cell: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.1;CAPAN-2: 2.5;HaCaT: 1.6;Karpas-707: 1.9;U-266/84: 2.0;U-87 MG: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035889, HPA035890" Uncertain NA NA "HPA035889: AB_2674844, HPA035890: AB_10669535" "unprognostic (1.61e-1)" "unprognostic (2.18e-2)" "unprognostic (5.01e-2)" "unprognostic (3.69e-2)" "unprognostic (1.50e-2)" "unprognostic (8.32e-2)" "unprognostic (7.28e-2)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (5.13e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (2.11e-1)" "unprognostic (1.38e-1)" "unprognostic (3.64e-1)" "unprognostic (1.81e-1)" 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.5 0.5 2.3 0.0 0.0 14.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 1.3 1.7 0.0 0.0 0.0 0.2 5.2 0.0 0.6 0.0 3.8 0.0 0.2 1.6 0.0 3.0 7.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.1 0.2 0.0 0.2 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.2 0.0 0.2 0.8 1.1 0.2 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.7 0.0 1.0 2.0 0.0 1.2 0.3 0.1 0.0 0.0 1.6 7.0 0.0 0.4 0.0 1.5 3.4 0.0 0.0 0.3 4.6 0.0 3.0 0.0 0.2 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.1 LFNG SCDO3 ENSG00000106003 "LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" Q8NES3 7 2512529-2529177 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 55.0" "Cell type enhanced" "Detected in many" 12 "Intestinal endocrine cells: 84.0;Kupffer cells: 31.7;Mucus-secreting cells: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.5;OE19: 22.3;RH-30: 23.0;U-2 OS: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069130 Approved "Intracellular and membrane" NA NA 620000 "HPA069130: AB_2686091" "unprognostic (4.58e-2)" "unprognostic (1.17e-2)" "unprognostic (2.52e-2)" "prognostic favorable (6.36e-4)" "unprognostic (1.85e-2)" "unprognostic (8.34e-2)" "unprognostic (4.15e-1)" "unprognostic (7.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (5.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.09e-1)" "unprognostic (1.97e-2)" "unprognostic (2.28e-2)" 10.4 4.9 8.3 12.6 13.5 6.5 15.7 8.3 12.0 10.9 17.3 11.2 0.8 11.9 15.0 5.9 7.9 4.1 16.9 10.1 7.1 11.8 6.6 1.9 15.6 18.1 15.0 6.6 3.0 55.0 1.7 2.6 6.2 19.4 13.0 9.6 8.4 16.5 7.3 3.7 43.0 11.6 6.0 10.2 13.2 28.4 3.4 5.2 5.8 4.4 10.4 19.8 9.0 8.3 2.6 2.5 12.8 7.7 1.3 4.5 1.5 0.7 6.9 9.1 1.2 1.0 0.9 0.6 2.6 1.4 2.4 3.0 2.9 18.5 0.5 8.4 7.2 4.1 13.3 1.4 2.5 1.2 4.1 0.3 2.1 3.6 1.5 0.0 2.9 3.8 1.7 6.3 3.8 0.4 1.6 0.9 0.1 0.3 0.1 1.8 16.4 0.0 4.1 11.1 22.3 5.1 0.8 23.0 1.4 0.9 2.1 8.4 2.1 3.0 0.7 0.1 2.5 5.0 3.5 2.2 5.3 25.4 0.2 7.2 0.1 0.0 0.7 5.8 7.9 1.0 5.3 5.9 12.8 2.0 7.7 2.4 1.3 2.0 1.0 2.5 2.6 2.2 2.0 3.2 1.3 7.0 0.6 4.5 1.5 8.3 13.5 8.3 12.0 7.1 11.8 15.0 6.6 19.4 5.2 6.0 8.9 9.3 2.7 6.1 1.0 2.8 7.6 1.4 4.5 0.0 0.0 0.1 0.0 1.1 0.1 12.7 6.6 0.0 5.5 0.2 2.6 2.0 17.3 0.0 6.9 0.0 84.0 12.9 31.7 0.0 1.7 12.3 3.3 9.0 36.6 26.9 14.2 0.0 0.0 0.3 0.7 0.0 2.1 0.2 3.3 3.4 0.0 10.9 11.5 0.3 LGALS12 GRIP1 ENSG00000133317 "Galectin 12" Q96DT0 11 63506084-63516774 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 45.1;blood: 90.2;breast: 28.6" "Cell type enriched" "Detected in some" 8 "granulocytes: 18.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enriched" "Detected in some" 19 "eosinophil: 90.2" "Lineage enriched" "Detected in many" 19 "granulocytes: 90.2" "Group enriched" "Detected in some" 14 "ASC diff: 11.8;HL-60: 20.4;NB-4: 40.2;U-937: 43.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA021124 Approved Cytosol NA NA Cytosol "HPA021124: " "unprognostic (3.89e-2)" "unprognostic (4.40e-2)" "unprognostic (5.17e-2)" "unprognostic (1.79e-1)" "unprognostic (6.26e-2)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.31e-2)" "unprognostic (1.01e-1)" "unprognostic (2.13e-3)" "unprognostic (4.69e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (4.60e-7)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (6.22e-2)" "unprognostic (8.60e-2)" 45.1 0.5 0.1 5.8 1.1 10.1 28.6 0.0 0.1 0.1 10.6 0.0 0.0 0.3 0.2 1.1 0.1 0.7 7.7 2.2 0.1 0.1 0.4 0.2 1.4 5.3 0.1 0.0 0.5 0.5 0.0 0.1 0.1 0.2 0.7 0.4 0.1 5.9 1.6 1.6 0.6 1.4 0.6 0.2 0.8 0.4 0.1 0.0 0.1 0.5 2.4 0.2 0.9 0.2 0.0 1.2 90.2 4.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 20.4 1.3 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 43.1 0.0 1.8 4.7 90.2 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 2.8 0.1 1.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LGALS13 "PLAC8, PP13" ENSG00000105198 "Galectin 13" Q9UHV8 19 39602501-39607476 "Predicted intracellular proteins" Apoptosis Hemagglutinin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 58.9" "Cell type enriched" "Detected in some" 19 "Syncytiotrophoblasts: 267.5" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Group enriched" "Detected in some" 7 "cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 73 "SuSa: 7.3" HPA046803 Supported Nucleoplasm NA NA Nucleoplasm "HPA046803: AB_10965990" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.2 0.0 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 14.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 267.5 0.0 0.0 0.0 LGALS14 "CLC2, PPL13" ENSG00000006659 "Galectin 14" Q8TCE9 19 39704306-39709444 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "placenta: 110.8" "Cell type enriched" "Detected in some" 72 "Syncytiotrophoblasts: 74.1" "Cancer enriched" "Detected in single" 16 "liver cancer: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Group enriched" "Detected in some" 5 "EFO-21: 5.5;U-266/70: 12.8" HPA065180 Supported Nucleoplasm NA NA Nucleoplasm "HPA065180: " "unprognostic (1.95e-1)" 0.0 0.2 0.1 0.1 0.1 0.2 1.1 0.1 0.3 1.5 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.2 110.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.2 0.0 0.3 0.3 0.1 1.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.6 0.0 0.0 3.2 0.6 0.3 0.0 0.4 0.7 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.3 0.5 0.0 5.5 0.1 0.1 0.8 0.1 0.0 0.3 1.9 0.2 0.1 1.0 0.4 0.0 0.2 1.2 0.0 0.3 0.3 0.4 0.7 0.0 0.5 0.1 1.4 0.0 0.5 0.2 0.3 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.2 0.8 0.1 0.2 0.0 0.6 0.8 1.0 0.3 12.8 0.7 0.1 0.4 0.3 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.1 3.2 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.0 LGALS16 ENSG00000249861 "Galectin 16" A8MUM7 19 39655894-39660647 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 14.2" "Cell type enriched" "Detected in some" 76 "Syncytiotrophoblasts: 852.8" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Region enhanced" "Detected in some" "cerebellum: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 105 "BEWO: 5.5;SuSa: 16.1" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.6 0.5 0.1 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 852.8 0.0 0.0 0.0 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570246-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 800.0;Enterocytes: 838.5;Pancreatic endocrine cells: 476.7;Proximal tubular cells: 1320.5;Undifferentiated cells: 571.4" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5" "Group enriched" "Detected in many" 51 "dendritic cells: 100.5;monocytes: 129.0" "Group enriched" "Detected in some" 4 "CACO-2: 46.8;Hep G2: 26.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 3.1 0.4 0.6 4.3 0.5 1.8 0.6 0.4 0.5 0.5 12.6 0.5 0.4 6.1 1.0 1.9 0.8 0.6 91.7 0.7 0.4 0.4 35.3 1.0 2.3 7.9 0.5 0.4 0.6 87.3 0.0 0.4 0.9 0.5 0.5 13.0 0.5 1.8 0.4 0.4 0.9 43.0 0.4 0.5 8.3 1.5 0.6 0.4 4.5 0.5 1.0 9.6 0.7 0.6 0.6 100.5 2.2 129.0 0.1 0.2 70.1 1.1 0.6 0.4 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.0 46.8 0.0 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 26.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.4 0.2 9.0 0.1 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.7 0.8 1.1 0.2 0.7 0.7 2.7 0.9 0.4 1.9 0.3 0.0 0.1 0.1 1.2 0.0 0.5 0.6 129.0 0.6 0.1 47.0 0.2 0.6 0.1 0.2 100.5 0.2 0.2 0.1 2.2 0.1 2.9 0.8 0.2 70.1 0.6 0.5 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.4 6.0 4.6 32.7 0.1 15.1 0.0 0.1 800.0 1.4 2.3 27.9 0.0 0.1 107.8 20.9 0.0 0.1 838.5 0.0 175.0 0.2 3.5 0.1 2.3 0.6 27.7 0.0 70.9 0.6 23.7 0.0 0.6 71.1 23.6 13.6 374.8 0.0 476.7 354.2 0.0 1320.5 0.0 0.0 6.2 0.0 0.2 10.8 0.2 2.5 571.4 0.1 LGALS4 GAL4 ENSG00000171747 "Galectin 4" P56470 19 38801671-38813364 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "gallbladder: 157.1;intestine: 326.8;lymphoid tissue: 83.5" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 3138.6;Mucus-secreting cells: 3717.7;Paneth cells: 2896.2;Undifferentiated cells: 2134.6" "Group enriched" "Detected in many" 21 "colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "basophil: 1.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.7" "Cell line enriched" "Detected in single" 239 "OE19: 123.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025653, HPA031184, HPA031185, HPA031186" Enhanced Uncertain "Plasma membrane" NA NA 92000 "Plasma membrane" "CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (2.57e-3)" "unprognostic (7.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.69e-1)" "unprognostic (3.38e-1)" "unprognostic (9.71e-2)" "prognostic favorable (3.21e-4)" 0.3 0.2 0.2 83.5 0.2 0.0 0.3 0.3 0.2 0.3 190.6 0.3 0.3 65.5 0.3 0.5 0.6 0.5 157.1 0.2 0.2 0.2 0.4 20.3 1.5 0.2 0.2 0.2 0.3 8.3 0.0 0.2 0.2 0.2 0.8 75.8 0.3 0.3 0.4 0.3 0.3 326.8 4.9 0.2 0.6 10.5 0.2 0.2 0.3 0.4 0.3 0.2 2.7 0.3 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 123.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 3.0 6.2 9.0 1.9 1.0 0.8 0.8 820.4 0.0 1.2 0.0 0.0 0.6 0.0 145.0 0.1 0.1 3138.6 0.0 92.9 0.6 0.2 1.5 50.5 28.7 0.1 1.6 624.2 2.5 2.1 0.0 0.0 0.0 0.0 4.6 3717.7 0.9 292.6 2896.2 0.4 1.6 1.8 0.0 0.3 0.0 0.2 2.4 0.5 0.7 2134.6 28.2 LGALS7 "GAL7, LGALS7A, PIG1, TP53I1" ENSG00000205076 "Galectin 7" P47929 19 38770971-38773492 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 45.1;skin 1: 97.9" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 244.4;Suprabasal keratinocytes: 634.4" "Group enriched" "Detected in many" 7 "cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 12.3;OE19: 3.8" "HPA001549, CAB032606" Enhanced "Intracellular and membrane" NA NA 3700000 "CAB032606: AB_640852, HPA001549: AB_1078938" "unprognostic (1.56e-2)" "unprognostic (1.30e-2)" "unprognostic (1.18e-2)" "unprognostic (4.86e-2)" "unprognostic (2.39e-1)" "unprognostic (2.38e-1)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.01e-2)" "unprognostic (3.37e-1)" "unprognostic (1.93e-1)" "unprognostic (3.31e-2)" "unprognostic (3.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 8.3 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 7.6 97.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 17.8 0.3 0.5 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.8 244.4 0.0 0.2 0.0 9.4 59.1 0.0 0.0 0.0 3.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 634.4 0.0 0.0 0.0 1.8 LGALS7B GAL7 ENSG00000178934 "Galectin 7B" P47929 19 38789211-38791749 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 260.5" "Group enriched" "Detected in some" 41 "Basal keratinocytes: 1358.8;Suprabasal keratinocytes: 4489.9" "Group enriched" "Detected in many" 7 "cervical cancer: 142.7;head and neck cancer: 185.0;melanoma: 42.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 18 "HaCaT: 8.3;OE19: 8.0" "HPA001549, CAB025100" Supported "Intracellular and membrane" NA NA 3700000 "CAB025100: , HPA001549: AB_1078938" "unprognostic (4.20e-2)" "unprognostic (2.15e-1)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.81e-1)" "unprognostic (3.54e-2)" "unprognostic (2.78e-2)" "unprognostic (1.01e-1)" "unprognostic (5.92e-2)" "unprognostic (3.66e-3)" "unprognostic (6.17e-2)" "unprognostic (2.93e-2)" "unprognostic (1.60e-1)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (1.29e-3)" 0.3 0.1 0.3 0.3 0.3 0.2 10.3 0.3 0.3 20.7 0.3 0.3 0.3 0.1 1.6 0.6 61.8 0.2 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 0.3 6.7 0.3 11.6 260.5 0.3 0.3 0.3 0.5 0.1 0.3 0.3 0.8 0.3 21.4 2.1 0.3 33.4 0.1 0.7 0.0 0.2 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 4.6 1358.8 0.0 0.2 0.0 6.7 71.7 1.8 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.2 0.1 1.0 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 7.0 0.0 0.0 42.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 5.6 0.6 4489.9 0.0 0.0 0.0 11.2 LGALS9 LGALS9A ENSG00000168961 "Galectin 9" O00182 17 27629798-27649560 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 273.5;Kupffer cells: 189.6;Paneth cells: 182.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 11.4;HMC-1: 29.7;MOLT-4: 14.7;REH: 10.4;THP-1: 26.6;U-937: 22.8" "HPA046876, HPA047218" Approved Approved Cytosol "Secreted to blood" NA NA 448000 Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (2.62e-2)" "prognostic favorable (2.35e-5)" "unprognostic (1.16e-2)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (2.46e-3)" "unprognostic (1.58e-2)" "unprognostic (8.60e-2)" "unprognostic (4.79e-1)" "unprognostic (1.80e-1)" "unprognostic (8.13e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.52e-5)" "unprognostic (4.76e-2)" "unprognostic (3.02e-2)" "unprognostic (2.23e-2)" "unprognostic (2.24e-3)" 25.7 3.9 6.4 15.6 11.2 22.2 6.1 2.0 5.3 5.7 26.9 12.6 0.2 8.6 4.3 6.1 6.0 8.5 13.9 4.6 5.6 3.4 5.0 9.0 14.7 29.6 9.7 2.7 5.9 6.0 0.5 2.9 8.5 8.7 4.2 26.0 10.9 5.7 2.1 2.5 3.7 15.0 5.1 13.2 48.9 20.2 2.2 7.9 22.1 3.8 2.0 17.1 14.8 3.6 6.6 28.7 12.0 35.2 4.2 7.0 10.9 0.4 0.3 0.2 0.1 0.0 0.1 0.5 0.2 0.4 3.4 11.4 0.0 2.3 0.4 2.5 0.5 0.3 1.2 0.1 0.0 0.2 3.4 0.4 3.6 0.4 0.0 0.1 7.5 29.7 0.1 0.0 0.2 0.0 0.1 4.0 2.1 0.2 0.2 0.0 0.0 14.7 3.6 0.1 5.3 0.0 10.4 0.0 0.3 1.6 0.3 0.1 0.3 0.0 1.0 0.0 0.2 0.1 26.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 22.8 0.1 5.6 16.4 12.0 1.0 35.2 0.6 4.5 2.6 1.3 28.7 6.6 1.5 0.7 7.2 4.2 31.2 4.5 7.0 10.9 6.4 11.2 2.0 5.3 5.6 3.4 9.7 2.7 8.7 7.9 8.9 7.5 29.3 6.0 2.9 0.1 0.8 25.5 10.7 12.5 7.0 0.0 2.0 3.3 99.7 1.1 23.3 125.2 0.0 111.9 2.5 6.8 2.9 31.1 0.8 273.5 0.0 38.8 18.4 189.6 1.5 4.0 133.7 1.7 127.2 146.3 0.4 119.4 182.0 2.8 0.4 0.5 19.4 3.1 0.1 0.7 1.5 3.1 24.5 106.1 25.8 LGALS9B ENSG00000170298 "Galectin 9B" Q3B8N2 17 20449395-20467539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.4;esophagus: 13.6;stomach 1: 23.2" "Cell type enhanced" "Detected in some" 26 "Enterocytes: 7.8;Mucus-secreting cells: 17.2;Paneth cells: 43.5" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 15 "NK-cell: 13.4" "Lineage enriched" "Detected in single" 15 "NK-cells: 13.4" "Group enriched" "Detected in some" 7 "CAPAN-2: 13.6;U-937: 4.5" "HPA046876, HPA047218" Approved Uncertain Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.69e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.05e-1)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (3.93e-3)" "unprognostic (2.72e-1)" "unprognostic (2.26e-2)" "unprognostic (6.85e-2)" "unprognostic (1.32e-2)" "unprognostic (3.20e-1)" "unprognostic (3.79e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (5.27e-2)" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 1.2 5.7 2.3 0.0 0.0 13.6 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.4 1.8 0.0 0.0 0.3 2.6 0.0 0.0 0.4 23.2 0.0 0.0 1.0 0.0 3.4 0.3 0.4 0.2 0.3 13.4 0.9 1.7 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.9 0.2 0.0 0.2 0.2 0.0 0.4 0.3 0.2 0.4 0.2 13.4 0.3 0.2 0.0 1.7 0.0 1.1 0.0 0.1 2.1 0.0 0.0 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.5 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 5.1 0.1 LGALS9C ENSG00000171916 "Galectin 9C" Q6DKI2 17 18476737-18494945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 16.8;Mucus-secreting cells: 22.5;Paneth cells: 54.7;Undifferentiated cells: 11.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 3.2;NK-cell: 8.9" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 8.9" "Cell line enhanced" "Detected in some" "A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.6;U-937: 2.9" "HPA046876, HPA047218" Approved Approved Cytosol NA NA Cytosol "HPA046876: AB_2679852, HPA047218: AB_2679988" "unprognostic (4.47e-2)" "unprognostic (1.43e-3)" "unprognostic (3.17e-2)" "unprognostic (4.30e-2)" "unprognostic (5.92e-1)" "unprognostic (3.02e-2)" "unprognostic (2.52e-1)" "unprognostic (5.16e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.04e-2)" "unprognostic (5.85e-2)" "unprognostic (4.27e-3)" "unprognostic (9.84e-2)" 0.1 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 2.1 8.3 0.2 0.0 1.6 0.0 0.0 15.8 0.0 4.7 1.0 0.0 0.0 0.0 0.8 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.9 0.0 1.6 1.0 0.0 0.2 5.1 0.1 0.0 1.5 15.4 0.0 0.0 0.4 0.0 3.0 7.5 0.0 2.1 0.0 0.4 3.2 1.2 8.9 0.6 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.9 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.5 0.5 0.6 1.2 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.2 3.2 8.9 1.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 7.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.3 54.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 11.0 0.1 LGALSL "GRP, HSPC159" ENSG00000119862 "Galectin like" Q3ZCW2 2 64453969-64461381 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 50.8;tongue: 90.3" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 124.1;Suprabasal keratinocytes: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1" "Group enriched" "Detected in many" 8 "granulocytes: 4.1;T-cells: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 25.0;HAP1: 36.4" "Low region specificity" "Detected in all" HPA046079 Approved Approved Nucleoplasm NA NA 9700000 Nucleoplasm "HPA046079: AB_10967075" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "unprognostic (7.18e-2)" "unprognostic (3.77e-2)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.25e-2)" "unprognostic (8.43e-2)" "unprognostic (3.57e-3)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (4.34e-2)" "unprognostic (6.57e-2)" "unprognostic (6.20e-2)" "unprognostic (9.19e-2)" "unprognostic (2.77e-2)" 6.5 9.2 4.8 3.4 6.2 3.5 12.0 11.0 7.2 6.9 11.5 2.7 2.4 5.0 4.2 6.4 12.7 3.5 4.9 8.1 4.6 5.0 5.6 4.8 18.0 2.9 3.8 3.9 5.7 5.5 10.0 6.3 5.3 4.3 8.2 6.1 14.7 6.4 3.9 30.7 50.8 13.4 5.2 2.8 4.0 4.4 4.0 1.2 0.8 3.1 90.3 13.6 5.1 6.2 0.3 0.1 4.1 0.3 0.0 1.9 3.8 5.8 3.7 10.6 25.0 0.3 0.1 3.1 1.6 4.0 3.1 3.0 17.4 1.2 0.0 2.4 0.8 6.1 7.0 36.4 6.7 2.5 6.6 9.5 0.1 1.9 8.5 3.2 1.6 2.4 1.6 4.3 1.3 4.8 2.8 1.9 3.9 0.0 1.7 0.0 4.5 2.4 0.3 8.3 3.4 4.4 2.7 6.5 1.9 3.7 4.2 1.7 7.0 5.2 3.5 3.0 6.6 2.5 0.2 0.8 2.0 6.4 1.3 3.1 7.4 3.5 4.9 0.0 1.0 2.7 0.0 0.3 3.7 0.0 0.0 1.9 0.3 0.4 0.4 0.1 0.2 0.0 0.0 4.1 0.0 0.0 0.0 0.0 3.8 4.8 6.2 11.0 7.2 4.6 5.0 3.8 3.9 4.3 1.2 20.8 55.7 0.8 19.8 60.0 27.5 11.8 5.1 0.0 3.4 10.4 31.4 1.2 13.3 5.6 9.7 11.7 35.4 0.0 11.7 2.3 9.3 20.9 1.1 9.5 0.9 12.7 8.7 12.9 4.8 1.5 7.5 2.8 10.1 1.8 29.0 68.8 14.0 20.1 4.2 10.2 124.1 19.4 32.3 4.7 1.3 119.7 1.3 0.0 16.6 28.5 LGI1 "EPITEMPIN, EPT, ETL1, IB1099" ENSG00000108231 "Leucine rich glioma inactivated 1" O95970 10 93757809-93806272 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 45.1" "Group enriched" "Detected in some" 4 "Early spermatids: 5.9;Hepatocytes: 5.9" "Group enriched" "Detected in some" 7 "glioma: 1.8;testis cancer: 0.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.3;CACO-2: 2.4;NTERA-2: 8.9;SuSa: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (1.26e-1)" "unprognostic (4.68e-2)" "unprognostic (2.45e-2)" "unprognostic (1.01e-1)" "unprognostic (8.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.24e-3)" "unprognostic (1.85e-1)" "unprognostic (4.07e-3)" "unprognostic (8.71e-2)" "unprognostic (2.21e-1)" "unprognostic (5.93e-2)" "unprognostic (4.65e-1)" 1.4 4.5 15.3 1.4 30.6 1.1 1.5 18.1 45.1 1.4 4.4 7.3 0.0 1.3 1.3 1.2 7.2 1.2 2.6 1.5 16.3 10.1 1.2 5.4 1.2 1.2 9.6 17.3 1.3 1.5 1.1 6.5 1.1 35.6 2.2 5.2 10.9 1.1 1.9 9.2 1.2 2.3 2.1 7.3 1.1 2.4 1.5 10.4 0.0 1.2 0.0 1.3 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 30.6 18.1 20.7 16.3 10.1 9.6 17.3 35.6 10.4 0.0 0.0 0.0 0.2 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 5.9 0.0 0.0 0.0 0.6 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Cell line enhanced" "Detected in some" "AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Uncertain Centrosome "Secreted to blood" NA NA Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.8 0.0 0.9 10.4 0.4 0.0 14.7 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 0.0 0.0 0.0 0.1 0.1 0.4 2.6 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.8 1.6 0.0 1.3 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 LGI3 ENSG00000168481 "Leucine rich repeat LGI family member 3" Q8N145 8 22146825-22157084 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 20.3;Melanocytes: 38.8" "Cancer enhanced" "Detected in many" "melanoma: 14.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;GAMG: 2.1;SCLC-21H: 4.6;SK-MEL-30: 4.6;U-2 OS: 2.6;WM-115: 3.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024826 Approved Cytosol "Secreted in brain" NA NA Cytosol "HPA024826: AB_10601131" "unprognostic (4.41e-2)" "unprognostic (1.78e-1)" "unprognostic (3.28e-1)" "unprognostic (8.11e-3)" "unprognostic (1.14e-1)" "unprognostic (7.45e-2)" "unprognostic (3.38e-1)" "unprognostic (2.43e-2)" "unprognostic (9.64e-2)" "unprognostic (1.64e-2)" "unprognostic (6.25e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-5)" "unprognostic (1.36e-2)" "unprognostic (9.41e-2)" "unprognostic (4.80e-2)" "unprognostic (4.14e-2)" 1.2 4.8 13.1 1.1 26.4 1.1 1.2 7.7 52.2 2.6 1.2 35.5 0.0 1.4 1.5 1.3 6.1 2.0 1.1 1.5 20.7 15.7 1.1 1.0 17.7 1.0 24.2 10.4 1.1 1.5 0.9 0.7 1.0 24.9 2.3 1.1 4.6 1.2 4.2 1.0 16.3 1.4 1.7 29.8 1.1 1.3 1.4 14.8 0.0 14.9 0.0 1.3 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.0 0.2 0.0 2.1 1.1 0.8 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.3 0.0 4.6 0.6 0.0 0.0 4.6 0.0 0.5 0.0 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 26.4 7.7 32.1 20.7 15.7 24.2 10.4 24.9 14.8 0.0 20.3 0.0 0.0 2.1 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 38.8 0.0 0.0 1.0 0.1 0.0 6.7 0.0 2.3 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 LGI4 ENSG00000153902 "Leucine rich repeat LGI family member 4" Q8N135 19 35124513-35142451 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.3;skeletal muscle: 59.4" "Group enriched" "Detected in many" 7 "Muller glia cells: 88.9;Sertoli cells: 77.6;Smooth muscle cells: 120.2" "Group enriched" "Detected in many" 6 "glioma: 4.5;melanoma: 11.5;renal cancer: 13.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.2" "Cell line enriched" "Detected in single" 30 "WM-115: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042116, HPA043556" Approved Approved "Golgi apparatus" "Secreted in brain" NA NA "Golgi apparatus" "HPA042116: AB_2677855, HPA043556: AB_2678550" "unprognostic (3.79e-1)" "unprognostic (6.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-2)" "unprognostic (3.71e-2)" "unprognostic (2.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.57e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.84e-7)" "unprognostic (1.71e-2)" "unprognostic (4.47e-1)" "unprognostic (7.73e-2)" "unprognostic (7.13e-2)" 35.6 10.7 31.7 7.9 18.5 2.0 9.9 16.3 36.5 22.3 26.9 17.1 6.3 7.4 13.2 8.9 9.0 12.2 9.4 12.2 23.3 7.9 3.4 4.7 5.3 4.5 15.4 31.5 5.8 4.5 4.4 1.0 7.6 26.0 10.4 8.1 8.7 8.7 24.7 59.4 5.9 11.7 9.6 50.3 3.5 8.5 3.1 15.1 0.0 5.6 4.8 2.4 9.6 24.4 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 26.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 31.7 18.5 16.3 36.5 23.3 7.9 15.4 31.5 26.0 15.1 0.0 0.0 0.0 0.4 2.3 0.8 10.4 0.0 1.4 1.2 1.8 2.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 0.0 0.2 8.0 0.6 0.0 1.7 0.1 0.0 1.7 12.9 0.0 0.0 13.6 1.1 10.1 0.0 0.1 88.9 0.1 2.5 6.7 0.0 2.8 77.6 120.2 0.6 0.9 2.0 0.0 0.0 0.2 0.7 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439770-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 10 "B-cells: 1.1" "Group enriched" "Detected in some" 5 "Hep G2: 16.2;SH-SY5Y: 47.7" "Region enriched" "Detected in some" 8 "olfactory region: 41.8" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 2.3 2.2 3.5 0.8 18.1 0.4 2.1 0.9 9.5 2.2 4.2 24.5 0.0 6.1 4.9 1.7 0.6 19.9 0.8 0.8 5.0 3.4 0.9 1.4 1.4 0.4 32.3 5.1 1.5 0.6 1.0 2.0 21.6 10.8 1.8 4.6 0.9 3.1 9.0 26.6 4.0 6.5 0.7 15.0 0.6 2.9 0.7 25.7 0.0 0.9 0.9 2.1 0.7 1.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.4 16.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 5.3 0.7 1.0 0.0 0.0 0.0 6.5 0.1 47.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 18.1 0.9 9.5 5.0 3.4 32.3 5.1 10.8 25.7 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.3 0.1 0.4 0.0 0.0 1.7 1.7 0.0 0.0 0.4 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 22.1 0.0 11.5 0.0 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193901-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 41 "T-cells: 14.3" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0" "Region enriched" "Detected in some" 9 "olfactory region: 30.0" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.1 0.1 0.9 0.8 3.2 1.8 7.9 6.0 2.4 2.6 2.2 1.5 0.5 0.2 1.6 7.3 4.4 13.8 49.6 12.3 0.7 3.3 0.9 1.4 6.9 1.1 6.8 0.2 2.2 0.5 0.1 15.9 0.9 9.3 6.7 1.1 0.8 8.5 2.5 0.3 3.2 1.6 2.6 1.6 5.3 0.7 4.9 3.9 0.2 4.1 2.6 3.4 3.2 2.9 0.0 0.0 0.0 0.0 0.3 14.3 2.5 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 1.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.9 0.0 1.7 8.3 0.0 0.0 0.7 4.7 0.0 0.3 0.0 0.0 0.4 2.5 0.9 3.2 6.0 2.4 0.7 3.3 6.8 0.2 9.3 3.9 0.0 0.0 0.0 2.8 1.1 0.0 8.3 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.0 3.3 0.1 0.7 0.5 1.7 0.3 LGSN "GLULD1, LGS" ENSG00000146166 "Lengsin, lens protein with glutamine synthetase domain" Q5TDP6 6 63275951-63319977 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.2;liver: 9.3" "Cell type enhanced" "Detected in some" 9 "Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4" "Cancer enhanced" "Detected in some" "lung cancer: 2.2" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030957, HPA039983" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA030957: AB_10670149, HPA039983: AB_2676784" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (1.12e-1)" "unprognostic (9.03e-2)" "unprognostic (2.81e-1)" "unprognostic (1.01e-1)" "unprognostic (5.05e-4)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (2.13e-1)" "unprognostic (2.53e-2)" "unprognostic (4.51e-3)" "unprognostic (1.64e-3)" "unprognostic (1.31e-1)" "unprognostic (2.19e-1)" 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 5.2 9.3 0.7 0.2 0.4 0.2 0.2 0.5 0.0 0.2 2.3 2.9 0.5 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 1.6 0.3 0.8 0.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.0 3.4 0.7 0.3 0.5 0.1 0.1 10.6 0.1 0.1 0.0 0.0 5.7 0.1 0.1 0.0 0.0 3.4 0.1 0.1 0.0 0.0 0.3 0.1 0.6 0.4 0.0 0.0 0.0 0.1 3.9 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 2.6 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.1 1.9 0.1 0.4 0.1 0.1 0.4 0.1 0.0 0.2 0.3 0.2 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 1.6 0.7 0.3 0.5 0.3 0.2 0.7 0.5 0.3 0.1 0.7 0.4 0.5 3.4 0.3 0.3 1.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.4 0.2 2.9 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 4.0 3.4 0.0 0.0 1.7 1.7 0.0 0.8 0.0 0.2 0.0 0.2 0.3 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.3 2.2 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.5 0.0 LHB "CGB4, hLHB, LSH-B" ENSG00000104826 "Luteinizing hormone beta polypeptide" P01229 19 49015980-49017081 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pituitary gland: 301.4" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 2.3;Late spermatids: 3.3;Pancreatic endocrine cells: 4.8;Syncytiotrophoblasts: 8.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.8;T-reg: 1.3" "Lineage enriched" "Detected in single" 12 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 6.6;U-266/84: 7.1" "CAB022241, CAB022707, HPA038925" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB022241: , CAB022707: , HPA038925: AB_2676272" "unprognostic (8.12e-2)" "unprognostic (3.59e-1)" "unprognostic (2.34e-3)" "unprognostic (1.41e-2)" "unprognostic (8.89e-2)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (5.69e-2)" "unprognostic (7.04e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.47e-2)" "unprognostic (1.68e-3)" "unprognostic (1.38e-1)" "unprognostic (4.46e-1)" "unprognostic (9.52e-2)" "unprognostic (4.86e-2)" 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.1 23.1 0.0 301.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.5 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 1.8 0.1 1.3 6.6 0.3 1.3 0.0 0.0 1.8 0.5 0.0 1.0 0.5 5.4 1.9 1.8 0.1 0.0 0.3 0.5 0.0 0.4 0.0 1.7 5.2 0.3 1.7 2.5 0.3 0.4 1.8 0.0 0.0 0.3 0.0 0.0 0.3 1.1 4.8 2.9 0.3 0.4 0.1 0.6 0.7 0.3 0.5 2.8 1.2 1.3 0.0 1.4 3.0 1.2 2.0 0.4 2.2 0.0 2.0 0.0 0.0 2.7 2.8 0.3 3.3 2.5 7.1 1.8 1.4 3.1 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.3 0.0 0.0 0.0 0.7 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.5 0.0 8.6 0.0 0.0 0.1 LHCGR "HHG, LCGR, LGR2, LHR, ULG5" ENSG00000138039 "Luteinizing hormone/choriogonadotropin receptor" P22888 2 48686775-48755730 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3;testis: 18.8" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 1.1;Leydig cells: 1.1;Suprabasal keratinocytes: 1.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.8;HSkMC: 1.0;NTERA-2: 1.6;SuSa: 1.0" CAB009814 Uncertain NA NA "CAB009814: AB_2135467" "unprognostic (8.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.97e-2)" "unprognostic (2.24e-2)" "unprognostic (5.22e-2)" 3.6 2.9 0.3 1.4 6.1 0.0 1.6 0.3 0.4 0.2 0.5 0.2 0.0 0.2 0.4 0.3 2.1 0.2 1.8 0.6 0.7 0.4 0.9 0.1 0.4 0.1 2.6 0.0 5.0 0.1 0.0 2.7 0.1 1.4 0.4 0.2 0.3 1.0 0.1 0.2 0.6 0.3 1.0 10.3 0.1 0.6 18.8 0.0 0.4 2.2 0.1 0.1 0.4 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 6.1 0.3 0.4 0.7 0.4 2.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LHFPL1 ENSG00000182508 "LHFPL tetraspan subfamily member 1" Q86WI0 X 112630648-112680054 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 13.7;pituitary gland: 15.9;salivary gland: 8.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.9;SK-MEL-30: 5.4;SuSa: 8.6" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 6.1" HPA003029 Uncertain NA NA "HPA003029: AB_1079248" "unprognostic (2.23e-2)" "unprognostic (2.78e-3)" "unprognostic (2.49e-1)" "unprognostic (1.36e-1)" "unprognostic (2.65e-1)" "unprognostic (1.54e-1)" "unprognostic (5.31e-3)" "unprognostic (1.29e-1)" "unprognostic (4.41e-3)" "unprognostic (5.19e-5)" "unprognostic (1.33e-1)" "unprognostic (7.63e-3)" "unprognostic (4.83e-2)" "unprognostic (1.21e-1)" "unprognostic (6.98e-2)" "unprognostic (1.92e-1)" 0.2 0.6 3.1 0.4 13.7 0.1 2.0 0.1 3.8 1.5 0.3 0.6 0.9 0.3 0.6 0.9 0.5 1.3 0.2 2.2 2.8 2.5 0.6 0.2 0.2 0.4 4.5 1.5 1.1 0.1 0.3 15.9 0.5 3.8 1.2 0.4 0.0 8.2 3.3 0.5 0.3 0.5 0.3 0.5 0.4 0.2 0.4 1.6 0.3 6.1 0.1 0.5 0.5 0.2 0.7 0.0 0.0 0.0 0.8 2.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 1.2 0.2 0.7 0.1 0.3 0.1 0.2 0.0 0.0 5.4 8.6 0.0 0.0 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.7 1.0 2.6 0.0 0.6 0.2 0.8 0.0 0.8 0.0 0.0 0.1 0.4 3.1 13.7 0.1 2.7 2.8 2.5 4.5 1.5 3.8 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328656-104907232 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 36.5" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 7.0" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;K-562: 2.2;SCLC-21H: 4.1;SH-SY5Y: 5.5;SK-BR-3: 4.6;SK-MEL-30: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles No NA Vesicles "HPA069691: AB_2686171" "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.5 0.6 6.4 0.6 7.7 0.5 0.5 2.3 36.5 4.3 0.8 6.1 0.0 2.0 0.7 0.5 0.5 0.9 0.5 0.5 4.9 5.6 1.4 0.5 2.2 0.5 4.8 4.2 0.7 1.5 0.5 0.1 0.5 5.6 0.7 0.6 3.8 0.5 0.5 0.5 0.7 1.4 0.5 6.0 0.9 0.8 0.7 6.7 0.0 0.5 0.0 0.6 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.2 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 4.1 5.5 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 7.7 2.3 7.1 4.9 5.6 4.8 4.2 5.6 6.7 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.0 1.4 0.0 0.0 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LHFPL4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.1;pituitary gland: 9.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 39.8;Cone photoreceptor cells: 17.7;Horizontal cells: 14.3;Rod photoreceptor cells: 16.4" "Group enriched" "Detected in some" 13 "glioma: 6.8;pancreatic cancer: 1.3;testis cancer: 5.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.3;SCLC-21H: 10.1;SH-SY5Y: 12.5;U-266/84: 10.5;WM-115: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.9 4.9 8.0 1.0 11.4 0.9 0.9 16.0 29.1 0.9 1.4 1.5 0.0 1.2 0.9 0.8 0.9 0.9 0.9 0.8 8.4 8.5 0.9 0.8 1.0 0.8 4.2 8.6 0.8 1.8 1.2 9.0 0.8 9.2 0.9 1.4 1.7 0.9 0.9 0.8 0.9 1.3 0.9 4.2 0.8 1.3 1.6 1.8 0.0 0.9 0.0 0.8 0.8 0.1 0.0 1.2 0.6 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 10.1 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.8 0.0 10.5 0.0 0.5 0.0 3.8 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.0 0.0 8.0 11.4 16.0 15.6 8.4 8.5 4.2 8.6 9.2 1.8 0.0 0.0 0.0 2.6 0.0 39.8 0.6 0.0 0.0 0.0 0.0 17.7 0.5 0.0 0.3 0.4 0.0 0.5 0.0 0.2 0.8 0.3 1.5 1.1 0.0 0.2 14.3 1.2 4.9 0.3 0.4 0.0 0.0 0.0 0.0 0.6 1.3 0.3 1.4 0.0 0.1 16.4 0.0 0.1 1.7 1.0 0.0 1.1 0.0 1.0 2.5 LHFPL5 "DFNB67, dJ510O8.8, MGC33835, Tmhs" ENSG00000197753 "LHFPL tetraspan subfamily member 5" Q8TAF8 6 35805293-35833874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 13.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055110 Uncertain NA NA "HPA055110: AB_2682697" "unprognostic (2.35e-1)" "unprognostic (6.45e-2)" "unprognostic (2.41e-2)" "unprognostic (1.22e-3)" "unprognostic (1.96e-1)" "unprognostic (1.78e-1)" "unprognostic (4.89e-3)" "unprognostic (2.96e-3)" "unprognostic (2.46e-2)" "unprognostic (1.47e-8)" "unprognostic (5.53e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.41e-1)" 0.5 0.5 3.9 1.2 4.1 7.4 0.5 0.4 5.8 0.4 0.4 0.2 0.0 0.9 0.9 12.0 0.3 0.3 0.7 0.3 3.5 2.8 0.4 0.4 0.3 1.5 1.2 6.7 0.6 12.3 0.0 2.2 0.6 2.0 0.6 0.3 0.2 1.1 0.1 0.6 2.3 0.8 0.1 0.6 1.0 0.5 0.8 0.0 0.0 0.8 0.0 0.4 0.3 0.4 1.0 0.3 1.0 0.8 0.5 0.9 0.0 1.5 1.9 3.6 2.2 0.6 1.7 3.2 2.5 0.9 0.4 1.1 2.1 2.2 3.6 1.9 1.3 2.3 2.0 0.6 1.4 0.9 1.8 2.9 3.8 5.6 1.9 0.1 1.7 2.6 1.4 0.7 0.7 1.0 3.1 0.5 3.4 2.0 7.2 2.0 1.2 2.3 1.8 2.4 0.9 1.5 2.0 1.6 1.0 1.2 3.3 3.3 2.2 1.6 1.9 1.1 2.5 3.0 1.3 3.6 2.4 2.1 3.3 1.0 4.1 3.4 2.8 1.1 2.4 1.5 1.0 0.3 0.2 0.9 0.6 0.5 0.5 0.5 0.3 0.0 1.0 0.6 0.8 0.9 0.5 0.8 0.3 0.4 0.0 3.9 4.1 0.4 5.8 3.5 2.8 1.2 6.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LHPP HDHD2B ENSG00000107902 "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase" Q9H008 10 124461834-124617888 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 106.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 103.7;Late spermatids: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009163, HPA009269" Enhanced Supported "Nuclear speckles,Cytosol" NA NA 880000 "Nuclear speckles, Cytosol" "HPA009163: AB_1079250, HPA009269: AB_1079249" "unprognostic (3.46e-2)" "unprognostic (1.23e-2)" "unprognostic (4.78e-2)" "unprognostic (3.89e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-1)" "unprognostic (5.77e-3)" "unprognostic (2.02e-2)" "unprognostic (3.58e-1)" "unprognostic (1.93e-1)" "unprognostic (6.42e-2)" "unprognostic (5.55e-2)" "unprognostic (1.79e-3)" "unprognostic (2.52e-1)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" 9.6 14.2 37.3 6.0 34.0 6.9 7.9 11.9 34.2 12.3 13.6 29.7 8.2 17.9 7.5 11.0 12.7 8.1 8.3 9.8 43.0 31.5 18.6 33.8 6.6 8.2 62.7 19.3 5.5 12.2 6.6 5.6 7.2 20.5 6.9 6.7 6.7 13.3 10.6 6.5 8.9 15.7 8.1 106.0 8.2 12.4 14.2 19.5 7.1 20.5 3.6 11.2 8.7 5.7 24.7 20.0 13.3 16.1 3.9 17.2 12.9 14.8 7.4 3.0 7.6 11.7 9.6 8.0 5.5 11.2 3.5 6.4 1.3 13.8 14.7 12.8 8.2 3.8 16.2 0.9 2.9 3.6 3.3 10.6 10.8 2.4 6.8 12.0 2.1 17.5 7.1 12.6 3.4 8.3 10.2 5.5 13.3 5.3 5.9 4.3 14.7 7.1 6.9 5.3 6.3 4.2 7.6 3.3 18.8 7.5 1.9 1.7 9.1 3.8 14.1 5.0 4.3 10.7 0.3 2.6 5.4 8.0 4.5 1.4 4.9 1.5 4.7 4.9 4.2 1.2 4.6 16.1 13.3 9.5 13.5 12.4 23.7 11.1 10.1 20.0 24.7 13.7 9.6 2.7 3.9 14.9 7.5 17.2 12.9 37.3 34.0 11.9 25.0 43.0 31.5 62.7 19.3 20.5 19.5 3.0 15.0 15.6 9.1 6.5 6.2 12.0 15.3 18.7 12.5 7.0 0.0 44.1 28.2 4.0 103.7 1.6 23.3 0.0 2.1 20.7 9.3 7.6 10.4 53.3 22.8 11.1 9.1 7.4 13.2 124.0 5.5 9.2 16.9 14.4 17.3 6.9 3.5 25.9 9.9 58.6 6.4 12.9 5.1 28.8 10.2 4.6 20.3 7.2 19.6 11.1 LHX1 "LIM-1, LIM1" ENSG00000273706 "LIM homeobox 1" P48742 17 36936785-36944612 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 15.0;kidney: 5.7;seminal vesicle: 7.1" "Cell type enriched" "Detected in some" 9 "Horizontal cells: 341.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 8.1" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in some" "HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7" "Region enhanced" "Detected in many" "cerebellum: 21.5" "Region enriched" "Detected in many" 4 "cerebellum: 20.4" "HPA044307, HPA073521, HPA074382" Enhanced Supported "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA Nucleoplasm "Nuclear membrane, Golgi apparatus" "HPA044307: , HPA073521: AB_2732226, HPA074382: " "unprognostic (3.86e-5)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.85e-2)" "unprognostic (1.06e-4)" "unprognostic (2.67e-2)" "unprognostic (2.72e-1)" "unprognostic (1.52e-1)" "unprognostic (4.20e-3)" "unprognostic (1.74e-5)" "unprognostic (1.33e-1)" "unprognostic (8.62e-2)" "unprognostic (3.05e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 15.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.2 0.0 6.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.1 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 1.9 0.0 1.5 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 1.7 0.0 0.0 0.9 1.2 0.0 0.3 0.0 0.0 0.0 LHX2 "hLhx2, LH-2" ENSG00000106689 "LIM homeobox 2" P50458 9 124001670-124033301 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 44.7;retina: 17.0" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 245.9" "Group enriched" "Detected in many" 5 "cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5" "Group enriched" "Detected in many" 6 "amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2" "Group enriched" "Detected in many" 5 "amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7" "Group enriched" "Detected in many" 6 "amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5" HPA000838 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA000838: AB_2666109" "unprognostic (3.60e-3)" "prognostic favorable (9.52e-4)" "unprognostic (3.52e-1)" "unprognostic (9.97e-2)" "unprognostic (1.29e-1)" "unprognostic (1.12e-2)" "unprognostic (6.37e-3)" "unprognostic (1.07e-1)" "unprognostic (4.59e-2)" "unprognostic (3.24e-1)" "unprognostic (2.96e-1)" "unprognostic (1.32e-2)" "unprognostic (4.66e-15)" "unprognostic (1.72e-1)" "unprognostic (2.92e-1)" "unprognostic (2.46e-2)" "unprognostic (1.77e-1)" 0.9 1.0 30.7 1.1 20.5 0.9 1.1 0.0 44.7 0.8 0.9 4.7 0.0 1.0 0.8 0.8 0.8 0.8 1.0 0.8 23.6 2.4 0.8 6.1 0.9 1.1 1.5 16.1 1.1 0.8 0.8 4.6 5.1 0.0 0.8 1.1 17.0 1.1 0.8 0.8 2.2 0.9 0.8 0.2 0.9 0.9 4.0 4.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 4.9 0.1 15.7 0.0 0.2 1.6 0.4 0.2 1.2 0.1 4.9 0.0 0.1 2.1 0.9 12.3 0.1 15.7 0.0 0.6 0.0 3.4 0.0 10.9 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 7.8 0.0 0.1 19.5 0.0 4.6 4.2 0.0 0.0 0.0 0.0 6.4 0.0 4.0 0.0 0.0 0.1 5.6 2.0 0.0 10.2 0.4 2.9 0.7 0.2 3.2 0.0 0.6 2.2 1.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 30.7 20.5 0.0 26.6 23.6 2.4 1.5 16.1 0.0 4.2 0.0 0.0 0.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 3.0 7.9 0.0 6.7 0.0 16.0 0.0 0.0 0.0 0.0 0.0 245.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 1.0 0.6 0.0 0.1 0.0 0.0 0.0 LHX3 ENSG00000107187 "LIM homeobox 3" Q9UBR4 9 136196250-136205128 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "pituitary gland: 33.4" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;U-266/70: 5.2;U-698: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.17e-2)" "unprognostic (4.72e-1)" "unprognostic (1.33e-1)" "unprognostic (2.57e-1)" "unprognostic (3.31e-2)" "unprognostic (6.18e-2)" 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.2 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 13.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 LHX4 Gsh4 ENSG00000121454 "LIM homeobox 4" Q969G2 1 180230286-180278982 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 21.0" "Group enriched" "Detected in some" 9 "Bipolar cells: 48.5;Cone photoreceptor cells: 49.1;Early spermatids: 42.7;Late spermatids: 55.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 6.1;BEWO: 14.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA055705 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA055705: AB_2682892" "unprognostic (2.83e-2)" "unprognostic (3.23e-2)" "unprognostic (1.94e-1)" "unprognostic (2.86e-2)" "unprognostic (9.38e-2)" "unprognostic (5.76e-5)" "unprognostic (9.39e-4)" "unprognostic (1.47e-1)" "unprognostic (2.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.77e-3)" "unprognostic (2.72e-3)" "unprognostic (4.07e-8)" "unprognostic (3.63e-1)" "unprognostic (1.43e-1)" "unprognostic (6.44e-3)" "unprognostic (7.83e-3)" 0.8 1.4 0.8 2.3 0.8 1.5 0.9 4.3 1.4 0.9 1.2 0.8 0.8 2.5 1.3 0.8 1.2 1.3 1.2 0.8 0.8 0.4 4.6 0.8 1.0 2.2 0.8 0.8 2.2 2.5 0.0 2.4 2.8 2.1 1.2 1.1 21.0 1.4 0.8 1.3 3.4 2.4 0.8 1.4 2.2 1.4 3.6 0.8 0.8 1.9 0.8 0.8 1.3 1.5 0.6 0.1 0.6 0.7 0.2 0.7 0.0 1.4 6.1 1.6 3.3 0.0 0.0 14.7 1.6 0.4 0.4 0.1 1.2 2.7 1.5 0.4 0.0 0.6 2.6 2.9 0.0 0.7 0.8 2.4 1.0 5.8 0.6 0.0 1.7 1.8 0.0 0.0 0.0 0.0 0.6 0.0 1.6 1.7 0.6 0.0 3.1 0.9 3.0 1.3 0.5 0.3 1.0 3.9 0.6 0.0 1.2 1.5 1.3 1.7 1.3 0.5 1.4 3.4 0.3 1.9 1.4 2.6 1.5 1.0 1.1 0.4 1.4 0.5 1.3 1.5 0.0 0.7 0.0 0.6 0.2 0.4 0.6 0.3 0.4 0.0 0.5 0.6 0.3 0.6 0.2 0.5 0.1 0.7 0.0 0.8 0.8 4.3 0.8 0.8 0.4 0.8 0.8 2.1 0.8 0.0 0.0 0.0 0.0 0.1 48.5 0.3 0.0 0.0 0.0 0.0 49.1 0.1 0.0 0.0 42.7 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 55.3 0.6 0.0 0.0 0.0 0.5 2.4 0.0 0.0 0.0 0.8 5.3 0.0 0.0 0.3 0.7 0.0 0.1 0.0 0.2 0.0 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462034-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.0;stomach 1: 2.1;testis: 2.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 5 "cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;HMC-1: 4.6;K-562: 1.2;SiHa: 3.3;U-2 OS: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053908 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Cytosol "Nucleoplasm, Nuclear bodies" "HPA053908: AB_2682304" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.8 4.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 2.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 6.7 1.2 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 LHX6 LHX6.1 ENSG00000106852 "LIM homeobox 6" Q9UPM6 9 122202577-122229626 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4" "Group enriched" "Detected in some" 9 "Early spermatids: 64.4;Late spermatids: 142.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 11.7;K-562: 8.5;NB-4: 16.1;PC-3: 11.1;U-87 MG: 8.9" "Group enriched" "Detected in many" 5 "amygdala: 11.3;basal ganglia: 16.2;cerebral cortex: 8.5;hippocampal formation: 9.5;hypothalamus: 10.7" "Group enriched" "Detected in many" 7 "amygdala: 13.1;basal ganglia: 12.2;cerebral cortex: 13.3;hippocampal formation: 13.4;hypothalamus: 4.9" "HPA047854, HPA058319" Approved Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA047854: AB_2680183, HPA058319: " "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (8.06e-2)" "unprognostic (6.18e-2)" "unprognostic (7.72e-2)" "unprognostic (4.49e-2)" "unprognostic (5.83e-2)" "unprognostic (3.47e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" "unprognostic (9.14e-2)" "unprognostic (5.64e-6)" "unprognostic (1.77e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" 14.4 1.2 7.3 4.2 11.5 0.5 10.6 0.4 17.4 3.6 3.0 0.9 0.9 2.6 3.8 2.5 4.1 2.6 6.1 6.4 12.3 3.5 1.9 0.9 5.2 2.2 2.0 12.4 2.1 1.1 2.3 0.3 6.0 1.1 2.4 3.2 1.4 2.3 2.3 4.3 2.5 3.1 7.4 1.5 0.6 2.3 7.8 2.2 0.0 3.2 4.6 2.5 5.3 7.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 2.4 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 11.7 3.0 0.0 2.6 0.0 1.0 0.0 1.3 3.3 0.0 0.0 1.9 0.1 0.8 0.5 0.0 2.2 0.6 0.0 0.8 0.0 0.2 0.0 4.3 0.6 8.5 0.0 0.0 2.4 0.0 16.1 2.6 0.4 11.1 0.0 5.6 0.0 2.0 0.0 1.7 0.4 3.0 0.9 3.0 0.5 2.5 0.0 0.7 0.8 1.2 0.0 0.2 0.3 0.1 0.2 8.9 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.3 11.5 0.4 17.4 12.3 3.5 2.0 12.4 1.1 2.2 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 64.4 11.9 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 142.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 2.3 6.9 0.3 0.0 0.0 0.0 0.1 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Cell type enhanced" "Detected in single" 26 "Spermatogonia: 2.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.8;U-266/70: 8.0" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA071806: AB_2686449" "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 8.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 LHX9 ENSG00000143355 "LIM homeobox 9" Q9NQ69 1 197911902-197935478 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ovary: 22.1;retina: 24.3;testis: 17.5" "Group enriched" "Detected in some" 10 "Leydig cells: 145.9;Peritubular cells: 47.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "fHDF/TERT166: 78.9" "Group enriched" "Detected in many" 4 "hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3" "Group enriched" "Detected in many" 5 "midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4" HPA009695 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA009695: AB_1079251" "unprognostic (8.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.38e-4)" "unprognostic (1.43e-1)" "unprognostic (5.68e-3)" "unprognostic (3.55e-1)" "unprognostic (1.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.63e-2)" "unprognostic (3.26e-2)" "unprognostic (5.15e-2)" "unprognostic (2.62e-3)" "unprognostic (6.35e-3)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" 0.3 0.2 1.7 0.1 1.0 0.1 0.1 0.1 0.5 1.1 0.3 0.7 0.4 0.2 0.8 4.1 0.1 0.4 0.2 1.5 0.7 2.6 0.1 1.2 2.7 0.1 0.8 0.0 22.1 0.1 0.1 1.4 0.1 3.1 0.1 0.2 24.3 0.1 0.2 0.9 0.1 0.2 0.1 0.5 0.1 0.1 17.5 0.5 0.0 0.1 0.0 0.1 0.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 1.2 2.2 0.1 0.0 0.0 0.0 0.0 78.9 0.0 0.0 1.9 0.0 0.6 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 2.4 2.3 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.7 0.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.1 0.5 0.7 2.6 0.8 0.0 3.1 0.5 3.0 9.6 0.0 0.0 0.0 0.0 1.4 0.0 1.4 1.2 0.0 0.0 0.0 1.7 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.8 145.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 47.4 0.0 0.3 0.0 0.0 2.3 0.3 0.0 0.1 0.0 0.0 0.0 LIF "CDF, DIA, HILDA" ENSG00000128342 "LIF, interleukin 6 family cytokine" P15018 22 30240447-30246851 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 58.9;granulocytes: 63.7;Smooth muscle cells: 39.8" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 11.7" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "GAMG: 27.0;hTEC/SVTERT24-B: 34.3;hTERT-RPE1: 31.7;U-138 MG: 38.2;U-251 MG: 27.6;U-87 MG: 30.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA018844, CAB025985" Uncertain Supported Cytosol "Secreted in other tissues" NA NA Cytosol "CAB025985: , HPA018844: AB_1852814" "unprognostic (1.28e-2)" "prognostic unfavorable (9.01e-4)" "unprognostic (8.79e-2)" "unprognostic (4.61e-2)" "unprognostic (7.36e-3)" "unprognostic (4.18e-3)" "unprognostic (1.17e-2)" "unprognostic (1.41e-2)" "unprognostic (3.18e-3)" "unprognostic (1.22e-1)" "unprognostic (8.10e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (6.78e-8)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (8.99e-2)" "unprognostic (4.71e-3)" 20.3 1.7 1.4 21.6 3.3 0.6 5.2 0.9 4.3 4.4 3.9 1.8 1.6 3.7 6.9 2.6 2.0 7.3 28.7 14.2 1.2 0.6 5.7 3.4 17.4 3.8 2.2 0.5 7.9 7.5 0.2 7.3 1.3 11.7 8.6 4.7 3.5 3.2 1.2 1.9 6.0 5.2 4.6 4.3 1.6 4.1 2.0 1.8 0.9 3.4 2.2 5.4 20.8 1.7 0.0 0.0 0.0 0.0 1.2 0.2 0.1 8.4 14.2 0.4 3.1 0.0 1.2 5.2 1.2 5.1 1.5 3.7 2.3 13.8 0.0 3.1 0.0 27.0 2.1 0.3 3.8 2.1 2.0 0.6 1.0 4.8 3.1 1.4 0.0 11.1 1.3 0.7 34.3 1.0 31.7 0.0 0.0 0.2 0.0 6.6 6.3 0.1 0.0 0.5 7.7 8.8 0.2 4.8 0.0 12.2 3.2 0.0 0.1 1.4 0.1 2.5 1.6 0.3 0.1 0.1 38.2 14.1 14.4 27.6 0.0 0.0 0.0 30.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.4 3.3 0.9 4.3 1.2 0.6 2.2 0.5 11.7 1.8 20.8 58.9 0.0 12.0 3.1 0.0 0.2 17.8 4.0 13.6 5.2 0.0 0.1 0.0 27.7 0.1 0.5 3.5 0.0 3.0 0.4 11.3 13.8 63.7 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 2.9 1.2 24.9 0.0 0.0 0.6 0.1 0.0 39.8 0.0 0.2 2.5 0.2 0.5 5.5 18.0 LILRA1 "CD85i, LIR-6, LIR6" ENSG00000104974 "Leukocyte immunoglobulin like receptor A1" O75019 19 54593582-54602090 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "blood: 22.2;lymphoid tissue: 21.0" "Cell type enriched" "Detected in some" 4 "Kupffer cells: 35.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 17.9;non-classical monocyte: 22.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "REH: 1.3;THP-1: 2.4" NA NA "unprognostic (4.52e-2)" "unprognostic (1.12e-1)" "unprognostic (6.30e-2)" "unprognostic (1.59e-1)" "unprognostic (2.34e-1)" "unprognostic (9.46e-3)" "unprognostic (1.17e-1)" "unprognostic (4.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.90e-2)" "unprognostic (8.72e-2)" "unprognostic (1.13e-1)" "unprognostic (8.28e-3)" "unprognostic (8.82e-2)" "unprognostic (3.79e-4)" "unprognostic (2.53e-1)" "unprognostic (9.83e-2)" 0.7 0.9 1.0 3.7 1.7 1.0 0.6 0.2 1.3 0.5 0.3 1.1 0.0 0.4 0.2 1.7 0.6 0.5 1.0 0.6 0.9 0.8 0.5 2.1 2.4 18.8 1.5 0.5 0.4 0.4 0.6 0.3 0.8 1.6 0.4 0.7 0.8 1.0 0.3 0.5 0.3 1.0 0.5 2.2 21.0 0.5 0.3 1.1 0.1 0.4 0.4 0.9 0.9 0.2 0.0 5.4 6.1 22.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 7.4 6.1 0.0 17.9 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 5.3 0.0 22.2 0.7 0.0 4.2 1.0 1.7 0.2 1.3 0.9 0.8 1.5 0.5 1.6 1.1 0.0 3.4 0.5 0.0 0.0 0.0 0.0 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 35.6 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LILRA2 "CD85h, ILT1, LIR-7, LIR7" ENSG00000239998 "Leukocyte immunoglobulin like receptor A2" Q8N149 19 54572920-54590287 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 21.6;bone marrow: 21.7;lymphoid tissue: 39.9" "Group enriched" "Detected in some" 8 "Hofbauer cells: 21.6;Kupffer cells: 82.8;Macrophages: 28.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.6" "Group enriched" "Detected in many" 7 "granulocytes: 21.6;monocytes: 7.1" "Cell line enhanced" "Detected in some" "NB-4: 2.5;REH: 3.0;THP-1: 6.1;U-937: 13.6" "Secreted to blood" NA NA 130000000 "unprognostic (2.04e-1)" "unprognostic (7.72e-2)" "unprognostic (6.94e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-2)" "unprognostic (2.65e-2)" "unprognostic (8.45e-2)" "unprognostic (3.56e-2)" "unprognostic (1.22e-1)" "unprognostic (3.53e-5)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (5.43e-2)" "unprognostic (5.58e-2)" "unprognostic (3.30e-4)" "unprognostic (4.21e-2)" "unprognostic (6.59e-2)" 2.8 1.5 1.4 4.7 1.1 21.7 0.9 0.1 2.0 0.6 0.8 3.0 0.0 0.6 0.5 1.0 0.5 2.3 1.0 3.7 1.1 1.1 1.2 3.8 6.8 14.6 2.9 0.4 1.1 0.6 0.5 0.4 1.7 1.4 0.6 0.6 1.1 0.8 0.5 0.6 0.7 0.7 1.0 3.7 39.9 0.7 0.7 2.3 0.7 0.6 0.0 0.8 0.9 1.8 0.2 2.1 21.6 7.1 0.3 0.1 3.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 2.5 0.0 0.1 0.0 3.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 6.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 13.6 0.1 2.4 4.9 1.8 0.1 7.1 0.0 0.1 0.1 0.1 2.1 0.2 0.1 0.1 21.6 0.3 6.8 0.4 0.0 3.0 1.4 1.1 0.1 2.0 1.1 1.1 2.9 0.4 1.4 2.3 3.0 4.8 0.0 0.7 0.2 0.4 0.4 2.5 2.7 3.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.3 0.9 5.8 0.0 21.6 0.0 0.0 0.6 82.8 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.4 LILRA4 "CD85g, ILT7" ENSG00000239961 "Leukocyte immunoglobulin like receptor A4" P59901 19 54333185-54339150 "CD markers, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "blood: 49.7;brain: 12.5;lymphoid tissue: 16.8" "Cell type enhanced" "Detected in some" 23 "B-cells: 8.5;Hofbauer cells: 3.1;Kupffer cells: 3.2;Macrophages: 2.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 21 "plasmacytoid DC: 49.7" "Lineage enriched" "Detected in many" 21 "dendritic cells: 49.7" "Cell line enriched" "Detected in single" 31 "RPMI-8226: 3.0" HPA049418 Approved NA NA "HPA049418: AB_2680756" "unprognostic (5.11e-2)" "unprognostic (1.21e-4)" "unprognostic (2.65e-2)" "unprognostic (5.94e-2)" "unprognostic (1.44e-1)" "unprognostic (1.19e-3)" "unprognostic (7.62e-2)" "unprognostic (1.36e-3)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "unprognostic (4.90e-2)" "unprognostic (9.30e-2)" "unprognostic (8.28e-7)" "unprognostic (2.12e-2)" "unprognostic (1.17e-3)" "unprognostic (4.53e-1)" "unprognostic (5.86e-2)" 0.7 0.4 2.1 2.3 2.5 0.6 0.7 1.1 4.3 0.4 0.9 12.5 0.0 0.7 0.4 0.4 0.6 0.4 0.8 0.4 3.5 1.4 0.4 0.7 1.4 5.3 12.2 1.2 0.4 0.4 0.4 0.3 0.4 7.6 0.5 0.5 0.0 0.7 0.5 0.4 0.6 2.0 0.6 7.4 16.8 0.5 0.5 6.7 2.3 0.4 0.0 10.1 0.7 0.2 2.4 49.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.1 0.0 49.7 0.0 0.1 2.1 2.5 1.1 4.3 3.5 1.4 12.2 1.2 7.6 6.7 0.0 1.1 8.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 3.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LILRA5 "CD85, CD85f, ILT11, LILRB7, LIR9" ENSG00000187116 "Leukocyte immunoglobulin like receptor A5" A6NI73 19 54307070-54313139 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.2;lymphoid tissue: 67.3" "Group enriched" "Detected in some" 4 "Kupffer cells: 84.9;Macrophages: 23.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "classical monocyte: 10.6;intermediate monocyte: 27.0;neutrophil: 14.5;non-classical monocyte: 30.2" "Group enriched" "Detected in many" 8 "granulocytes: 14.5;monocytes: 30.2" "Cell line enriched" "Detected in single" 11 "RPMI-8226: 4.1" "Secreted to blood" NA NA 370000 "unprognostic (8.52e-2)" "unprognostic (3.61e-1)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "unprognostic (1.57e-2)" "unprognostic (6.56e-2)" "unprognostic (2.90e-1)" "unprognostic (1.86e-1)" "unprognostic (3.11e-1)" "unprognostic (6.61e-3)" "unprognostic (2.01e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (3.61e-2)" "unprognostic (6.51e-3)" "unprognostic (4.68e-2)" "unprognostic (6.21e-2)" 3.4 0.6 0.3 9.9 0.3 19.1 0.7 0.1 0.3 0.4 0.6 0.1 0.0 0.8 0.4 2.0 0.6 2.0 0.9 7.0 0.2 0.2 1.7 10.8 14.4 24.2 0.5 0.0 1.5 0.4 0.1 0.4 1.3 0.6 0.6 0.7 0.6 0.5 0.3 0.9 0.1 1.8 1.3 0.7 67.3 1.0 0.6 0.0 0.1 1.4 0.4 0.4 2.7 2.8 0.0 2.6 14.5 30.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.6 0.0 0.0 27.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 14.5 0.0 30.2 2.1 0.0 5.1 0.3 0.3 0.1 0.3 0.2 0.2 0.5 0.0 0.6 0.0 0.0 13.3 1.4 0.1 0.1 0.0 0.0 0.0 4.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 10.5 0.2 6.5 0.0 0.0 0.6 84.9 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LILRA6 "CD85b, ILT8, LILRB6" ENSG00000244482 "Leukocyte immunoglobulin like receptor A6" Q6PI73 19 54236592-54242791 "Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.4;lymphoid tissue: 16.0" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 6.2;Hofbauer cells: 12.4;Kupffer cells: 34.4;Macrophages: 12.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.5;neutrophil: 9.4" "Group enriched" "Detected in many" 23 "granulocytes: 9.4;monocytes: 4.5" "Cell line enhanced" "Detected in single" "PC-3: 1.5" NA NA 18000000 "unprognostic (1.00e-1)" "unprognostic (8.38e-2)" "unprognostic (5.60e-2)" "unprognostic (3.31e-1)" "unprognostic (2.95e-2)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (2.51e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-1)" "unprognostic (9.11e-2)" "unprognostic (1.51e-1)" "unprognostic (7.47e-5)" "unprognostic (7.76e-2)" "unprognostic (4.01e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-2)" 4.9 1.1 0.2 4.0 0.2 4.4 0.8 0.2 0.6 0.2 0.5 0.2 0.2 0.3 0.2 2.2 1.9 1.3 1.4 0.8 0.2 0.0 0.4 5.5 6.0 0.2 0.2 0.2 1.1 0.2 0.0 0.2 1.9 0.7 1.1 0.0 0.2 0.8 0.2 0.8 0.1 1.1 4.0 0.2 16.0 0.5 0.8 0.2 0.2 0.6 0.2 0.2 1.3 0.2 0.0 0.3 9.4 4.5 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.5 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.4 0.0 1.0 0.0 0.0 1.2 0.2 0.2 0.2 0.6 0.2 0.0 0.2 0.2 0.7 0.2 0.0 6.2 0.0 0.0 0.2 0.0 0.4 5.1 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.5 0.2 12.4 0.0 0.0 1.3 34.4 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 LILRB1 "CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB" ENSG00000104972 "Leukocyte immunoglobulin like receptor B1" 19 54617158-54637528 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "blood: 26.7;lymphoid tissue: 52.5" "Group enriched" "Detected in some" 7 "B-cells: 16.2;Hofbauer cells: 16.3;Kupffer cells: 58.9;Macrophages: 35.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "intermediate monocyte: 19.1;non-classical monocyte: 26.7" "Lineage enriched" "Detected in many" 10 "monocytes: 26.7" "Group enriched" "Detected in some" 19 "Daudi: 10.6;THP-1: 5.5" "Intracellular and membrane" NA NA "unprognostic (9.23e-2)" "unprognostic (4.20e-2)" "unprognostic (4.95e-2)" "unprognostic (3.29e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (1.24e-1)" "unprognostic (3.89e-2)" "unprognostic (3.58e-1)" "unprognostic (9.64e-2)" "unprognostic (1.24e-1)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (6.57e-2)" "unprognostic (1.62e-2)" "unprognostic (7.06e-2)" "unprognostic (8.03e-2)" 2.6 1.5 2.5 11.9 4.5 2.5 0.9 0.4 2.5 1.1 1.8 3.1 0.5 0.6 0.5 1.8 0.8 1.4 0.7 2.5 2.2 1.6 1.5 3.2 5.6 18.7 4.7 0.9 1.7 0.7 0.3 1.1 2.7 3.7 1.4 1.1 0.8 1.2 0.8 0.3 0.3 4.8 5.4 5.8 52.5 1.0 0.5 4.6 0.8 0.8 0.1 3.0 4.9 0.6 1.2 2.5 0.1 26.7 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 3.1 0.0 0.6 19.1 0.0 1.2 0.0 0.5 2.5 1.1 0.0 0.4 0.1 0.0 26.7 1.0 0.0 1.7 2.5 4.5 0.4 2.5 2.2 1.6 4.7 0.9 3.7 4.6 0.0 2.1 16.2 0.3 0.2 0.0 0.6 2.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.2 2.3 0.4 16.3 0.0 0.0 3.7 58.9 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 1.4 LILRB2 "CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10" ENSG00000131042 "Leukocyte immunoglobulin like receptor B2" Q8N423 19 54273821-54281184 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9;bone marrow: 30.3;lymphoid tissue: 31.9" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 26.7;Kupffer cells: 133.7;Macrophages: 59.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 15.9;intermediate monocyte: 33.8;neutrophil: 16.7;non-classical monocyte: 37.9" "Group enriched" "Detected in many" 5 "granulocytes: 16.7;monocytes: 37.9" "Cell line enhanced" "Detected in single" "THP-1: 1.2" NA NA 52000000 "unprognostic (1.23e-1)" "unprognostic (1.12e-2)" "unprognostic (3.21e-2)" "unprognostic (3.51e-2)" "unprognostic (6.21e-3)" "unprognostic (1.70e-2)" "unprognostic (1.44e-2)" "unprognostic (2.94e-1)" "unprognostic (1.08e-2)" "unprognostic (2.98e-2)" "unprognostic (2.64e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.45e-7)" "unprognostic (1.90e-2)" "unprognostic (4.68e-3)" "unprognostic (3.72e-1)" "unprognostic (9.73e-2)" 3.2 1.4 0.4 6.8 0.6 30.3 1.0 0.3 1.9 0.5 1.1 0.6 0.4 3.3 0.6 0.9 0.5 2.3 6.6 1.5 1.6 0.4 1.5 3.6 18.4 4.9 2.6 0.0 0.4 0.7 0.2 0.7 0.7 1.8 0.9 1.0 1.1 7.4 2.6 0.5 0.4 1.5 0.6 3.4 31.9 1.0 0.3 0.8 0.8 0.6 5.0 0.7 0.6 1.9 0.0 5.3 16.7 37.9 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 15.9 4.2 0.0 33.8 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.0 16.7 0.0 37.9 2.2 0.1 8.1 0.4 0.6 0.3 1.9 1.6 0.4 2.6 0.0 1.8 0.8 3.0 17.0 3.4 0.0 1.3 0.0 0.6 2.5 4.0 5.7 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.8 0.0 4.7 0.8 26.7 0.0 0.0 3.1 133.7 0.0 0.0 59.3 3.3 5.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.5 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 LILRB3 "CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB" ENSG00000204577 "Leukocyte immunoglobulin like receptor B3" O75022 19 54216278-54223506 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.4;bone marrow: 15.3;lymphoid tissue: 23.4" "Cell type enhanced" "Detected in many" 14 "Hofbauer cells: 57.4;Kupffer cells: 90.9;Macrophages: 66.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 24.4" "Group enriched" "Detected in many" 4 "granulocytes: 24.4;monocytes: 9.4" "Cell line enhanced" "Detected in some" "BJ: 1.7;HaCaT: 1.9;HEK 293: 2.6" NA NA "unprognostic (7.51e-2)" "unprognostic (3.52e-2)" "unprognostic (9.59e-2)" "unprognostic (4.53e-1)" "unprognostic (1.83e-3)" "unprognostic (5.28e-3)" "unprognostic (2.91e-2)" "unprognostic (2.55e-1)" "unprognostic (5.58e-2)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.92e-8)" "unprognostic (2.18e-1)" "unprognostic (2.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.75e-1)" 5.1 0.8 0.4 8.9 1.0 15.3 0.8 0.4 0.5 0.7 1.6 0.0 0.2 0.2 0.6 2.5 0.7 1.3 1.1 7.8 1.5 0.6 0.7 1.5 10.9 19.7 0.5 0.0 3.0 1.7 0.0 0.5 2.0 0.6 0.9 0.0 1.0 0.8 0.0 1.7 0.6 0.9 0.9 2.2 23.4 0.8 0.7 0.0 0.3 1.5 0.0 0.1 6.4 1.1 0.1 4.0 24.4 9.4 0.0 0.1 4.5 1.5 0.6 0.4 0.8 0.0 0.0 0.5 1.7 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.4 1.9 0.0 0.0 0.0 0.4 2.6 1.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.4 0.0 1.1 0.2 0.5 0.6 0.2 0.0 0.0 1.0 1.7 0.0 0.0 0.6 0.1 0.0 1.6 0.0 0.0 0.7 0.8 0.0 0.0 0.5 0.3 0.0 0.3 1.0 0.0 0.4 9.4 0.3 0.0 7.5 0.1 0.1 0.1 0.0 4.0 0.1 0.0 0.0 24.4 0.0 3.3 0.4 0.0 4.5 0.4 1.0 0.4 0.5 1.5 0.6 0.5 0.0 0.6 0.0 8.9 18.3 3.0 1.2 2.2 0.7 0.4 5.1 8.1 11.4 1.8 0.0 1.4 0.0 0.3 0.9 0.6 0.0 0.0 0.5 2.6 1.3 0.8 7.0 2.1 57.4 0.0 0.0 2.5 90.9 2.6 0.3 66.5 1.7 2.8 0.7 0.9 0.2 0.6 0.7 0.3 3.0 6.5 1.2 0.5 1.6 2.6 1.0 1.8 1.2 0.3 LILRB4 "CD85k, HM18, ILT3, LIR-5, LIR5" ENSG00000186818 "Leukocyte immunoglobulin like receptor B4" Q8NHJ6 19 54643889-54670359 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.8;lymphoid tissue: 33.1" "Group enriched" "Detected in some" 6 "Hofbauer cells: 134.1;Kupffer cells: 95.5;Macrophages: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 22.8" "Group enriched" "Detected in many" 69 "dendritic cells: 22.8;monocytes: 6.2" "Cell line enriched" "Detected in some" 35 "Karpas-707: 97.2" HPA052807 Approved NA NA 9900 "HPA052807: AB_2681958" "unprognostic (4.09e-2)" "unprognostic (5.75e-3)" "unprognostic (6.06e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.55e-1)" "unprognostic (5.03e-2)" "unprognostic (3.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.52e-1)" "unprognostic (5.43e-1)" "unprognostic (2.79e-1)" "unprognostic (1.91e-2)" "unprognostic (1.08e-1)" "unprognostic (4.42e-2)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" 15.4 4.3 5.1 20.1 7.4 4.5 3.1 0.8 5.9 1.6 3.6 12.8 0.0 4.0 1.0 4.7 2.1 4.2 4.4 3.9 5.3 5.3 3.1 3.9 12.3 33.1 10.8 1.9 1.7 1.6 1.5 2.4 4.2 6.6 1.7 5.5 2.9 3.8 1.4 0.8 0.9 5.4 2.1 15.1 18.0 2.8 1.3 6.9 3.1 2.3 0.7 6.1 13.8 0.8 0.2 22.8 0.1 6.2 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 6.2 0.0 0.1 0.0 0.0 7.0 0.2 0.0 0.0 0.1 0.1 4.8 22.8 0.0 1.8 5.1 7.4 0.8 4.5 5.3 5.3 10.8 1.9 6.6 6.9 0.0 5.5 16.7 0.0 0.3 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.0 1.1 0.2 134.1 0.0 0.0 2.5 95.5 0.0 0.0 56.7 1.7 12.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.5 0.3 0.0 0.4 0.1 0.7 0.0 0.0 0.0 LILRB5 "CD85c, LIR-8, LIR8" ENSG00000105609 "Leukocyte immunoglobulin like receptor B5" O75023 19 54249431-54257301 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 31.0;lymphoid tissue: 35.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 46.1;Kupffer cells: 83.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SiHa: 2.3" HPA012069 Approved NA NA 36000000 "HPA012069: AB_1852873" "unprognostic (3.55e-3)" "unprognostic (5.38e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-2)" "unprognostic (8.86e-2)" "unprognostic (5.44e-2)" "unprognostic (3.02e-5)" "unprognostic (6.80e-2)" "unprognostic (2.23e-1)" "unprognostic (2.33e-1)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (4.14e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" 23.6 8.3 0.7 5.4 0.8 0.8 31.0 0.6 0.6 2.1 11.9 0.5 1.6 5.2 1.2 16.2 5.8 4.9 6.2 10.0 0.7 0.8 2.1 22.8 8.6 13.3 0.8 0.0 4.1 2.7 0.7 1.0 5.6 0.7 4.0 5.5 3.6 2.9 1.1 6.1 2.0 9.0 5.9 0.9 35.1 2.4 3.9 0.0 1.2 2.6 4.9 1.3 10.6 1.8 0.9 0.7 3.1 0.9 0.9 0.5 0.3 0.4 0.0 0.8 0.5 0.2 0.1 1.0 1.1 0.3 0.4 0.0 0.3 0.6 0.2 0.4 0.1 0.5 1.4 0.3 0.6 0.0 0.5 0.9 1.1 1.8 0.4 0.5 0.6 0.7 0.5 0.3 0.1 0.3 0.1 0.5 0.7 0.6 1.0 0.2 0.0 0.3 0.3 0.7 0.2 0.0 0.6 0.7 0.6 0.2 0.8 0.5 0.9 2.3 0.8 0.7 0.8 0.8 0.1 0.3 0.8 0.7 0.5 0.6 0.4 1.1 0.1 0.4 0.3 0.2 3.1 0.9 0.4 0.4 0.6 0.3 0.4 0.5 0.3 0.3 0.9 0.4 0.4 2.3 0.9 0.8 0.7 0.3 0.3 0.7 0.8 0.6 0.6 0.7 0.8 0.8 0.0 0.7 0.0 0.0 0.6 0.8 0.0 0.9 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 1.0 46.1 0.0 0.0 12.9 83.3 1.6 0.0 7.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.0 0.0 LIM2 "MP17, MP19" ENSG00000105370 "Lens intrinsic membrane protein 2" P55344 19 51379909-51387960 "Disease related genes, Predicted membrane proteins" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "testis cancer: 18.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "gdT-cell: 12.9" "Lineage enriched" "Detected in many" 8 "T-cells: 12.9" "Cell line enhanced" "Detected in single" "SuSa: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.25e-2)" "unprognostic (1.09e-3)" "unprognostic (1.21e-1)" 0.1 0.1 0.1 0.1 0.1 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.4 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.5 12.9 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.2 1.6 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 LIMCH1 "DKFZP686A01247, LIMCH1A, LMO7B" ENSG00000064042 "LIM and calponin homology domains 1" Q9UPQ0 4 41359607-41700044 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 87.1" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 604.5;Cardiomyocytes: 206.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "myeloid DC: 4.4" "Lineage enriched" "Detected in single" 9 "dendritic cells: 4.4" "Cell line enhanced" "Detected in many" "EFO-21: 27.6;HeLa: 47.6;hTERT-RPE1: 38.2;RT4: 45.4;SiHa: 25.8;WM-115: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004184, HPA063840" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA004184: AB_1078673, HPA063840: AB_2685133" "prognostic unfavorable (5.55e-6)" "unprognostic (3.63e-2)" "unprognostic (1.67e-1)" "unprognostic (5.42e-3)" "unprognostic (8.30e-2)" "unprognostic (1.27e-1)" "unprognostic (7.70e-2)" "unprognostic (3.73e-3)" "unprognostic (2.05e-1)" "unprognostic (7.00e-2)" "unprognostic (1.95e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.82e-7)" "unprognostic (2.84e-1)" "unprognostic (6.77e-2)" "unprognostic (2.01e-2)" "unprognostic (2.24e-3)" 19.4 18.7 24.9 3.1 27.6 0.9 11.7 13.8 24.6 6.7 4.3 30.2 8.4 3.0 4.0 6.5 8.8 9.3 11.2 45.0 29.1 21.3 15.0 6.4 58.2 1.9 34.4 18.2 19.1 5.8 59.6 8.6 15.8 23.3 28.7 4.5 13.6 32.5 13.6 87.1 6.6 4.2 7.2 43.3 49.1 5.4 5.1 25.2 0.2 20.6 23.5 2.4 12.4 9.4 0.0 4.4 0.0 0.4 0.0 0.0 0.1 0.6 6.7 10.4 0.6 0.0 0.0 1.0 8.5 4.3 8.6 4.3 1.0 2.6 0.0 27.6 22.6 0.2 4.7 5.8 3.9 9.7 0.0 0.8 0.0 47.6 0.0 8.8 0.0 0.0 0.1 11.5 0.0 2.7 38.2 0.8 0.0 0.0 0.0 2.4 3.7 0.0 0.0 0.7 1.4 0.7 0.0 12.7 0.1 7.2 45.4 9.8 19.9 25.8 10.3 0.1 8.7 0.7 0.0 0.0 0.1 10.2 2.3 6.5 0.0 0.0 0.0 0.6 0.0 36.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.9 27.6 13.8 21.6 29.1 21.3 34.4 18.2 23.3 25.2 604.5 166.2 0.0 43.2 34.7 24.7 206.0 17.8 105.7 147.9 90.7 35.3 12.1 18.3 32.7 54.1 58.8 4.2 0.0 12.0 30.0 23.8 134.4 4.7 9.3 10.2 0.0 9.2 108.6 17.8 20.9 1.7 5.5 13.5 33.3 5.1 100.0 7.4 8.6 7.1 9.3 73.0 0.0 6.2 5.1 12.0 26.7 38.6 5.4 5.1 49.4 LIMD2 MGC10986 ENSG00000136490 "LIM domain containing 2" Q9BT23 17 63695902-63701172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 175.1;lymphoid tissue: 98.4" "Cell type enhanced" "Detected in many" 13 "B-cells: 358.9;Hofbauer cells: 123.5;Kupffer cells: 178.4;T-cells: 223.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 54.7;NB-4: 38.1;SH-SY5Y: 38.1;THP-1: 28.6;U-698: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062432, HPA075172" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA062432: , HPA075172: " "unprognostic (2.90e-3)" "unprognostic (2.89e-3)" "unprognostic (6.34e-2)" "unprognostic (6.53e-2)" "unprognostic (8.72e-2)" "unprognostic (2.00e-3)" "unprognostic (1.81e-1)" "unprognostic (2.67e-2)" "unprognostic (6.68e-2)" "unprognostic (2.01e-2)" "unprognostic (1.20e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.36e-11)" "unprognostic (1.21e-1)" "unprognostic (2.21e-1)" "unprognostic (2.26e-2)" "unprognostic (6.08e-2)" 3.6 2.0 6.5 54.8 14.8 28.7 2.3 1.2 8.5 2.7 2.9 3.0 1.3 3.9 2.6 3.2 3.0 2.6 5.1 2.7 9.6 3.3 3.7 5.1 8.1 63.5 3.6 3.7 2.8 1.7 0.8 3.5 6.4 2.8 4.1 2.8 5.0 11.3 1.7 1.1 1.8 12.9 2.6 3.0 51.1 5.5 6.1 1.7 98.4 2.5 2.2 79.7 7.4 2.6 81.9 55.1 175.1 65.1 46.6 67.5 73.0 0.1 1.7 21.6 5.3 0.2 0.5 0.5 0.5 0.3 2.2 1.5 0.9 0.4 54.7 4.8 2.6 2.2 0.8 4.7 0.2 0.6 18.8 1.9 16.2 0.3 4.6 4.2 21.0 1.7 5.4 0.2 2.2 0.0 2.5 5.8 3.8 1.4 3.2 2.4 0.2 18.5 38.1 11.6 0.0 1.0 7.7 8.7 9.6 3.0 0.2 26.0 38.1 2.7 0.0 5.0 5.8 0.1 28.6 7.3 3.0 6.6 0.1 0.7 0.6 0.2 57.0 0.3 3.0 5.2 175.1 54.6 122.9 35.7 63.3 35.1 64.6 49.4 41.5 55.1 81.9 67.5 48.1 112.7 46.6 65.1 20.8 58.1 73.0 6.5 14.8 1.2 8.5 9.6 3.3 3.6 3.7 2.8 1.7 0.0 5.8 358.9 7.5 6.6 0.8 0.8 2.5 1.4 3.4 10.4 3.9 1.3 5.0 15.9 14.6 16.3 0.5 0.0 8.0 2.7 7.3 13.6 53.0 1.5 123.5 3.2 21.4 27.0 178.4 36.6 3.1 84.5 35.4 24.4 2.0 5.0 22.0 5.9 4.6 1.7 1.0 6.5 7.3 4.9 6.8 5.3 1.3 223.7 2.1 3.1 LIME1 "dJ583P15.4, FLJ20406, LIME" ENSG00000203896 "Lck interacting transmembrane adaptor 1" Q9H400 20 63736283-63739103 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 87.5;liver: 43.7;lymphoid tissue: 80.4" "Cell type enriched" "Detected in single" 11 "Hepatocytes: 2.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 39.4;MAIT T-cell: 35.4;memory CD4 T-cell: 54.9;memory CD8 T-cell: 51.2;naive CD4 T-cell: 37.5;naive CD8 T-cell: 40.6;plasmacytoid DC: 87.5;T-reg: 77.8" "Group enriched" "Detected in many" 9 "dendritic cells: 87.5;T-cells: 77.8" "Cell line enhanced" "Detected in some" "Karpas-707: 13.4;MOLT-4: 14.0;RPMI-8226: 51.4;U-266/70: 27.8" CAB015363 Approved "Intracellular and membrane" NA NA "CAB015363: AB_629890" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.95e-3)" "unprognostic (3.01e-1)" "unprognostic (1.34e-1)" "unprognostic (3.85e-3)" "unprognostic (3.06e-2)" "unprognostic (1.46e-1)" "unprognostic (1.36e-1)" "unprognostic (1.94e-1)" "unprognostic (1.05e-3)" "unprognostic (1.51e-3)" "prognostic unfavorable (5.04e-5)" "unprognostic (2.39e-2)" "unprognostic (4.25e-2)" "unprognostic (1.67e-1)" "prognostic favorable (6.92e-6)" 1.9 0.6 2.1 17.9 4.9 4.0 0.7 4.4 2.1 2.0 5.2 0.4 0.5 2.2 0.9 0.3 4.2 0.7 8.4 0.8 2.0 1.8 13.6 43.7 5.0 20.3 1.4 1.1 1.2 0.5 0.4 1.8 0.6 0.4 2.3 0.6 1.1 9.9 0.7 0.9 4.9 3.7 0.7 1.7 10.0 16.9 0.7 0.5 80.4 1.6 2.4 22.8 2.5 1.1 9.6 87.5 1.3 0.1 9.2 77.8 22.3 0.7 0.2 0.0 0.1 0.0 0.0 1.8 0.9 0.0 0.1 0.0 0.4 0.8 2.2 1.4 0.0 0.0 1.9 0.0 0.1 0.1 0.9 1.7 0.4 0.7 8.6 0.0 0.6 0.8 0.1 0.2 0.0 0.0 0.0 0.0 6.4 0.8 13.4 0.0 0.4 14.0 3.8 0.7 0.6 2.4 9.7 0.3 51.4 0.2 0.1 0.7 1.1 0.5 0.5 1.0 0.0 0.4 0.3 0.2 0.7 1.0 0.7 0.5 27.8 1.0 4.4 0.6 0.4 0.2 0.1 0.1 0.2 39.4 0.1 35.4 9.6 54.9 51.2 0.2 3.7 37.5 40.6 1.3 9.2 0.1 87.5 77.8 22.3 2.1 4.9 4.4 2.1 2.0 1.8 1.4 1.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 LIMK1 LIMK ENSG00000106683 "LIM domain kinase 1" P53667 7 74082933-74122525 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.2" "Cell type enhanced" "Detected in many" 6 "B-cells: 22.9;Hofbauer cells: 25.0;Horizontal cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028516, HPA073571" Approved Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA028516: AB_10601751, HPA073571: " "unprognostic (1.45e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (4.95e-5)" "unprognostic (2.77e-2)" "unprognostic (1.40e-3)" "unprognostic (3.35e-2)" "prognostic unfavorable (7.79e-6)" "unprognostic (1.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (6.63e-8)" "unprognostic (4.14e-2)" "unprognostic (7.00e-2)" "unprognostic (3.84e-2)" "unprognostic (5.79e-2)" 8.8 8.6 31.6 18.2 18.6 6.3 7.4 14.3 44.1 11.5 6.6 7.1 6.6 6.9 7.3 5.3 6.4 6.0 10.8 6.3 26.8 32.9 5.2 2.6 12.5 22.0 33.4 22.2 12.1 8.1 4.0 7.2 8.0 45.2 6.1 4.7 4.8 18.1 9.6 10.9 6.8 7.2 7.6 10.8 18.4 7.8 10.4 6.5 4.3 7.5 3.7 18.1 14.1 7.2 4.6 8.6 3.8 7.7 6.9 2.4 3.1 17.0 13.3 10.2 16.9 13.5 18.3 7.4 10.6 10.2 8.6 9.6 7.7 16.9 10.6 4.8 13.0 28.9 10.3 3.8 6.5 3.3 18.3 6.7 7.8 4.5 8.8 15.5 5.9 28.7 18.1 5.9 6.9 3.6 26.0 12.8 7.7 5.2 3.4 10.7 14.9 5.1 10.7 19.3 6.0 8.4 7.4 15.8 6.6 9.6 3.7 4.0 9.3 6.8 16.4 8.5 11.7 5.2 5.4 15.2 13.7 12.8 35.4 17.0 3.8 4.3 19.4 50.9 4.3 9.3 0.1 6.5 3.8 2.4 7.7 1.8 4.6 0.6 1.5 8.6 2.4 0.2 0.7 0.7 6.9 4.7 0.8 0.4 3.1 31.6 18.6 14.3 44.1 26.8 32.9 33.4 22.2 45.2 6.5 3.0 2.4 22.9 4.6 2.6 5.6 2.7 7.6 2.7 3.4 1.8 2.0 2.2 0.0 6.6 0.6 3.0 0.9 0.0 5.6 5.4 7.5 5.1 5.7 1.1 25.0 33.4 2.4 2.5 10.7 1.5 6.6 14.1 3.3 10.0 2.1 3.1 10.2 2.9 5.6 1.5 3.1 0.0 2.1 1.9 12.4 2.8 3.1 10.1 2.5 6.2 LIMS2 "PINCH-2, PINCH2" ENSG00000072163 "LIM zinc finger domain containing 2" Q7Z4I7 2 127638381-127681786 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 114.4" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 67.6;Endothelial cells: 62.4;Ito cells: 124.0;Peritubular cells: 46.7;Smooth muscle cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 17.1" "Group enriched" "Detected in many" 14 "B-cells: 17.1;T-cells: 8.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.1;fHDF/TERT166: 13.2;HHSteC: 15.9;MOLT-4: 18.0;TIME: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058340 Enhanced Supported "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA058340: AB_2683683" "unprognostic (2.51e-2)" "unprognostic (1.25e-1)" "unprognostic (5.82e-3)" "unprognostic (4.51e-2)" "unprognostic (9.25e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.53e-7)" "unprognostic (3.98e-2)" "unprognostic (3.73e-1)" "unprognostic (2.29e-1)" "unprognostic (3.78e-2)" "unprognostic (8.86e-2)" "unprognostic (3.33e-1)" "unprognostic (4.60e-3)" "unprognostic (3.64e-2)" "unprognostic (1.77e-1)" "unprognostic (4.00e-2)" 21.9 4.4 3.4 16.7 4.5 0.2 17.9 1.5 5.8 31.7 83.5 4.6 18.1 6.5 49.9 17.4 28.3 23.8 31.8 40.2 4.2 1.8 11.7 8.0 20.1 4.9 3.7 4.3 8.2 2.9 2.6 2.8 11.6 6.4 30.6 6.6 20.4 8.0 45.1 12.5 5.7 16.9 114.4 4.0 21.6 25.6 6.8 2.7 11.5 9.3 6.5 4.5 65.1 44.9 17.1 0.8 0.3 0.2 0.0 8.2 1.9 0.3 0.7 0.2 0.0 2.1 0.5 0.2 8.8 12.1 9.4 8.8 2.3 0.0 0.0 5.1 13.2 0.5 0.0 0.1 0.0 2.0 0.0 0.3 0.0 5.6 1.6 15.9 0.0 0.0 0.1 0.0 3.6 0.1 5.2 6.6 7.2 0.0 0.0 4.4 0.0 18.0 0.4 0.6 0.0 1.1 4.1 0.8 0.4 0.6 0.0 0.0 0.1 1.6 0.8 0.3 3.3 0.3 0.0 37.8 0.0 6.4 8.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.2 0.0 10.7 3.9 0.8 0.1 17.1 8.2 3.3 0.3 0.0 0.1 0.8 5.2 1.9 3.4 4.5 1.5 5.8 4.2 1.8 3.7 4.3 6.4 2.7 20.8 9.6 4.9 0.2 8.4 0.0 67.6 2.5 1.4 2.3 0.0 0.0 0.5 0.0 0.8 1.3 62.4 0.0 0.0 0.2 10.4 16.2 0.1 2.3 14.0 0.9 0.0 0.0 124.0 7.2 1.4 18.4 3.4 10.1 0.0 0.0 0.1 0.7 0.0 46.7 0.0 1.0 25.8 49.1 0.5 1.4 5.8 0.8 1.3 0.0 0.3 LIMS3 ENSG00000256977 "LIM zinc finger domain containing 3" P0CW19 2 109898428-109924868 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 11.9;endometrium 1: 9.7" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 1.7;Club cells: 1.2;Distal tubular cells: 1.7;Exocrine glandular cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 11.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 9.8;HMC-1: 29.8" HPA058455 Uncertain Approved "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.23e-2)" 1.2 2.8 0.5 2.2 0.5 0.0 1.0 0.8 0.5 1.0 0.7 0.3 4.2 0.2 9.7 2.8 1.2 7.1 0.9 2.6 0.5 0.5 2.6 0.6 0.8 2.8 0.6 0.3 2.2 0.7 0.3 2.4 5.6 0.3 1.0 0.8 0.6 2.2 0.6 3.0 0.8 0.5 1.2 0.6 0.6 0.7 3.7 0.3 0.3 1.0 0.3 0.3 2.6 0.7 0.7 2.5 11.9 5.5 1.1 6.2 8.0 0.0 0.1 1.3 1.5 0.5 0.4 0.0 1.5 0.0 0.2 0.7 1.5 0.0 0.0 4.7 0.3 3.1 0.8 0.0 1.8 1.3 2.4 0.0 9.8 0.5 0.9 1.4 1.7 29.8 2.2 1.1 1.1 1.3 0.0 2.4 0.0 2.0 1.6 3.3 0.1 0.0 0.2 1.6 0.9 0.6 1.8 3.1 1.0 0.8 1.5 0.4 3.6 4.0 0.0 0.8 0.0 0.0 0.5 7.3 6.4 5.9 3.3 0.3 0.0 0.0 1.9 0.8 0.0 1.9 4.7 3.3 11.9 0.9 5.5 1.5 0.7 5.0 1.7 2.5 0.2 0.9 0.3 0.7 1.1 5.2 0.2 6.2 8.0 0.5 0.5 0.8 0.5 0.5 0.5 0.6 0.3 0.3 0.3 0.0 0.3 0.0 0.1 0.1 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410778-26429722 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 9.8" "Group enriched" "Detected in some" 42 "Early spermatids: 24.2;Late spermatids: 49.8" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "NTERA-2: 136.8;SuSa: 50.5" "Not detected" "Not detected" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" NA NA Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.5 0.1 0.1 0.1 0.2 0.3 9.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.6 2.3 0.5 1.0 0.8 0.1 0.0 0.0 13.5 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.7 0.7 0.3 0.4 1.0 0.5 0.6 0.2 1.3 0.8 0.7 2.2 1.0 0.3 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.4 0.1 0.0 0.0 0.0 0.1 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 14.1 2.8 0.0 0.0 73.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.8 0.0 8.8 0.0 0.0 0.0 6.8 10.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 1.5 1.7 12.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 13.5 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.3 6.0 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 5.9 66.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 8.0 1.6 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 6.5 0.0 5.8 9.2 0.0 46.7 0.0 0.0 0.0 LIN7A "LIN-7A, MALS-1, TIP-33, VELI1" ENSG00000111052 "Lin-7 homolog A, crumbs cell polarity complex component" O14910 12 80792520-80937925 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.5" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 60.0;Early spermatids: 76.0;Late spermatids: 59.9" "Cancer enhanced" "Detected in many" "renal cancer: 8.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 10.1;eosinophil: 9.6;neutrophil: 18.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 18.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;ASC TERT1: 19.1;HAP1: 14.7;HDLM-2: 16.7;HL-60: 16.3;NB-4: 15.2;RH-30: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071562 Approved NA NA "HPA071562: AB_2732181" "unprognostic (7.11e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.02e-1)" "unprognostic (2.52e-3)" "unprognostic (3.04e-2)" "unprognostic (8.24e-2)" "unprognostic (4.24e-2)" "unprognostic (1.46e-2)" "unprognostic (8.83e-2)" "unprognostic (2.27e-2)" "unprognostic (2.41e-1)" "prognostic favorable (1.63e-11)" "unprognostic (5.01e-5)" "unprognostic (7.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" 6.5 5.0 12.8 3.8 13.1 32.9 8.5 56.5 18.2 7.2 2.4 1.1 1.4 1.4 12.1 1.6 2.1 3.1 6.1 7.7 10.6 7.4 12.5 23.9 6.6 6.6 6.4 11.3 5.5 1.3 1.4 28.9 7.6 7.0 2.5 1.6 4.5 1.8 1.9 1.5 1.2 2.6 7.2 2.7 5.3 1.7 8.9 3.0 0.0 6.5 0.7 2.4 4.2 6.7 0.0 0.0 18.9 3.4 0.0 0.1 0.8 0.0 0.3 2.9 0.0 12.9 19.1 0.0 7.4 3.4 3.0 0.6 5.6 0.0 0.0 0.0 2.8 0.0 0.0 14.7 0.0 0.9 16.7 4.5 0.0 0.1 8.8 1.6 16.3 0.1 4.7 0.0 0.3 0.3 0.7 2.4 0.0 0.0 0.0 1.3 0.2 0.0 15.2 2.7 0.1 0.0 0.0 11.0 0.0 1.7 2.3 6.1 0.0 0.0 0.0 0.0 0.2 0.6 8.8 0.0 2.4 0.9 1.2 0.0 2.6 0.0 0.0 0.2 0.0 0.1 10.1 3.4 9.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.1 0.0 0.1 0.8 12.8 13.1 56.5 18.2 10.6 7.4 6.4 11.3 7.0 3.0 20.8 4.3 0.0 3.5 0.7 60.0 19.4 15.3 1.4 1.2 24.4 2.0 0.5 8.3 0.6 76.0 1.3 1.3 0.0 0.2 0.1 3.6 1.8 0.0 18.8 2.7 28.6 1.7 2.5 8.9 59.9 4.4 1.6 0.0 0.0 0.0 34.3 0.0 0.0 1.4 21.4 10.5 12.9 11.3 13.9 1.1 0.4 0.6 0.0 0.0 1.4 LIN7B "LIN-7B, MALS-2, VELI2" ENSG00000104863 "Lin-7 homolog B, crumbs cell polarity complex component" Q9HAP6 19 49114324-49118460 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 51.7" "Cell type enhanced" "Detected in many" 6 "Spermatogonia: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.01e-1)" "unprognostic (1.55e-2)" "unprognostic (3.70e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.02e-1)" "unprognostic (5.59e-3)" "unprognostic (2.15e-2)" "unprognostic (4.33e-2)" "unprognostic (9.72e-2)" "unprognostic (3.94e-2)" "unprognostic (1.05e-3)" "unprognostic (1.10e-1)" "unprognostic (3.35e-2)" "unprognostic (4.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.23e-1)" "unprognostic (5.69e-2)" 3.7 3.4 19.4 2.3 20.4 2.6 3.2 8.3 19.6 3.4 4.7 3.9 4.8 6.0 3.2 3.4 4.5 3.7 3.4 15.9 15.2 19.2 3.1 2.6 3.7 2.8 13.2 10.6 3.1 6.3 1.5 9.6 2.1 10.0 6.9 3.3 3.8 5.6 5.1 51.7 11.3 5.5 2.5 7.6 4.0 4.7 6.3 4.7 1.4 4.2 6.7 3.0 3.8 2.5 4.8 12.5 1.5 5.6 1.5 8.5 4.4 3.1 7.2 3.7 6.8 1.0 1.4 3.2 3.8 1.8 2.4 5.7 3.9 0.6 1.3 3.8 4.8 4.6 5.8 4.3 0.4 1.2 7.5 16.5 1.1 7.3 5.2 5.0 1.3 0.9 1.4 3.0 2.2 0.4 4.5 0.8 4.8 2.2 3.9 3.7 4.3 2.9 4.8 1.9 3.9 7.7 4.7 4.7 3.3 2.5 5.5 5.2 4.6 5.4 3.1 3.6 1.6 4.2 0.7 2.6 9.4 4.0 4.9 2.2 6.7 12.8 2.0 3.4 3.0 2.8 0.0 5.6 1.5 7.4 2.7 5.8 4.8 6.0 5.2 3.6 4.8 8.5 7.2 0.9 1.5 4.6 12.5 3.2 4.4 19.4 20.4 8.3 19.6 15.2 19.2 13.2 10.6 10.0 4.7 3.0 4.5 3.7 5.1 6.0 31.8 18.6 5.1 5.3 4.5 8.7 11.8 0.8 18.3 4.2 3.4 6.7 15.1 0.0 4.1 2.8 6.3 9.6 4.7 4.9 7.6 15.9 16.3 11.1 11.8 3.6 6.9 6.4 16.9 1.8 10.9 11.3 2.7 17.5 8.9 13.5 22.5 25.8 13.7 5.2 59.2 11.4 1.8 2.2 8.9 6.0 LINC00483 "C17orf73, FLJ20694" ENSG00000167117 "Long intergenic non-protein coding RNA 483" 17 50761029-50767557 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "intestine: 73.0" "Cell type enriched" "Detected in single" 20 "Intestinal endocrine cells: 3.4" "Group enriched" "Detected in some" 12 "colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0" "Cell type enhanced" "Detected in some" "neutrophil: 6.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.5" "Cell line enhanced" "Detected in some" "CACO-2: 12.8;HDLM-2: 9.6" "Region enhanced" "Detected in single" "basal ganglia: 0.4" "Low region specificity" "Detected in many" NA NA "unprognostic (2.98e-1)" "unprognostic (1.96e-2)" "unprognostic (2.02e-3)" "unprognostic (2.76e-1)" "unprognostic (4.52e-1)" "unprognostic (1.95e-1)" "unprognostic (2.09e-2)" "unprognostic (8.37e-2)" "unprognostic (1.57e-2)" "unprognostic (6.81e-2)" "unprognostic (1.67e-1)" "unprognostic (1.05e-3)" 0.1 0.0 0.1 4.6 0.1 0.7 0.1 0.1 0.1 0.1 28.3 0.1 0.1 27.1 0.1 0.1 0.1 0.0 2.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 9.7 0.1 0.1 0.1 0.1 0.2 73.0 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.8 6.5 1.5 0.9 0.9 0.4 0.6 1.1 0.6 1.4 0.0 0.6 1.3 0.5 0.0 0.0 0.0 12.8 0.8 0.3 0.4 0.3 0.2 0.8 0.0 0.2 0.1 9.6 0.8 0.8 2.1 1.6 0.0 0.7 2.0 0.6 0.1 0.2 0.0 0.6 0.0 1.1 0.2 0.9 0.0 0.5 0.4 1.3 0.2 2.8 0.6 0.9 0.6 0.5 0.2 2.1 0.4 1.1 0.5 1.0 0.1 0.7 1.2 0.0 1.0 1.2 0.8 0.8 0.5 0.6 0.4 1.0 0.4 0.4 0.5 4.6 1.5 0.8 0.7 0.8 0.4 0.7 0.7 0.7 0.2 1.1 0.9 0.6 6.5 0.9 0.8 0.8 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINC00672 ENSG00000263874 "Long intergenic non-protein coding RNA 672" 17 38925168-38929384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 16.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 29.3;granulocytes: 35.6;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 11.7" NA NA "unprognostic (3.28e-1)" "unprognostic (9.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.06e-1)" "unprognostic (4.15e-2)" "unprognostic (8.81e-2)" "unprognostic (7.08e-2)" "unprognostic (2.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.68e-6)" "unprognostic (7.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.44e-2)" "unprognostic (2.59e-4)" 0.7 2.5 4.6 1.0 9.6 3.5 0.9 5.1 16.8 0.4 1.1 4.0 0.0 1.0 2.5 3.1 0.7 1.5 1.8 1.1 5.0 0.3 0.2 1.4 1.4 2.8 7.5 2.7 0.3 0.4 0.4 1.0 7.1 1.5 1.7 2.1 0.6 3.1 0.6 2.3 1.8 2.3 3.5 1.9 1.6 0.3 3.7 0.0 0.2 0.0 0.9 0.8 0.0 1.3 1.0 4.0 1.2 1.4 2.8 0.5 0.7 1.0 2.1 1.4 1.2 1.5 0.3 0.9 0.7 0.2 0.6 0.4 3.8 0.7 0.8 1.3 0.2 2.0 0.0 0.5 0.7 0.4 0.6 1.1 1.1 0.1 0.8 1.4 2.7 1.6 0.8 0.7 0.3 1.6 0.3 1.0 0.2 0.8 0.5 0.8 0.7 1.5 11.7 0.7 0.0 3.3 0.2 1.0 1.2 1.0 0.2 4.5 1.2 1.3 0.7 1.0 1.5 1.3 2.2 0.6 0.9 0.8 0.4 1.1 1.6 0.8 1.1 1.5 0.4 1.6 1.2 1.9 1.1 0.5 0.5 0.7 0.8 0.8 0.5 1.3 0.9 2.8 4.0 1.4 0.7 1.0 0.7 0.5 11.9 4.3 0.0 1.4 1.0 29.3 2.6 0.0 5.3 2.3 0.0 2.0 0.1 0.0 1.5 0.5 2.1 2.1 0.0 1.2 0.6 2.5 2.1 35.6 0.8 1.4 28.6 1.7 6.2 3.7 0.2 3.4 2.6 3.3 2.8 2.9 6.6 2.8 3.4 3.9 0.0 8.1 0.0 2.1 0.0 0.4 0.5 0.2 6.9 3.9 0.9 LINC00854 TMEM106A-AS1 ENSG00000236383 "Long intergenic non-protein coding RNA 854" 17 43216941-43305397 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 10.4;testis: 18.1" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.4;Ciliated cells: 4.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 8.9;Hep G2: 9.3;HMC-1: 7.0" NA NA "unprognostic (3.14e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-3)" "unprognostic (4.29e-2)" "unprognostic (3.95e-2)" "unprognostic (7.19e-4)" "unprognostic (1.41e-3)" "unprognostic (1.73e-1)" "unprognostic (1.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.17e-1)" "unprognostic (2.10e-1)" "unprognostic (2.88e-4)" "unprognostic (2.11e-1)" "unprognostic (3.88e-2)" "unprognostic (5.95e-2)" "unprognostic (3.08e-2)" 0.0 0.0 1.2 1.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.1 1.3 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.7 1.4 0.0 0.0 1.6 0.3 18.1 0.9 0.0 0.0 2.7 2.3 7.4 1.4 10.4 1.0 0.4 1.2 4.6 0.9 1.4 0.1 0.1 2.1 1.4 0.0 0.4 0.0 4.1 1.2 2.3 1.3 0.7 0.7 1.4 0.1 0.0 0.0 1.5 3.4 1.7 8.9 9.3 0.8 1.2 7.0 0.0 0.5 0.1 0.0 0.7 0.0 2.3 0.6 1.5 0.0 4.0 2.1 5.6 0.7 1.7 0.6 3.5 1.2 0.4 0.0 0.4 3.1 0.1 0.9 1.4 1.0 1.0 0.8 2.6 3.8 1.8 1.3 1.7 0.9 1.8 0.5 0.5 1.0 2.8 1.6 7.4 1.4 1.4 1.0 1.1 0.5 1.1 0.5 0.5 0.5 2.7 0.6 0.6 4.2 10.4 0.5 2.3 0.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINC02203 ENSG00000280709 "Long intergenic non-protein coding RNA 2203" 15 21552795-21653276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-2 OS: 11.9" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINC02210-CRHR1 ENSG00000263715 "LINC02210-CRHR1 readthrough" 17 45620344-45835826 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "U-2 OS: 1.8" NA NA 0.9 0.9 0.8 0.9 2.6 0.9 0.9 2.1 7.3 1.4 0.9 1.8 1.0 0.9 4.0 0.9 0.9 1.6 0.9 0.9 7.5 0.9 0.9 0.9 0.9 0.0 2.7 0.9 2.2 0.9 2.1 1.0 4.2 1.2 0.9 0.9 3.3 0.9 1.2 0.9 0.9 1.4 0.0 0.9 0.9 2.6 0.4 1.1 0.9 0.9 1.3 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 1.7 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 67.2" "Cell type enhanced" "Detected in some" 22 "Horizontal cells: 125.5;Muller glia cells: 49.3;Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.2;AN3-CA: 11.0;HAP1: 16.7;HEK 293: 11.7;NTERA-2: 31.4;SuSa: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Supported "Plasma membrane" NA NA 8400 "Plasma membrane" "HPA074653: AB_2686706" "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.0 1.6 27.4 1.7 21.8 0.8 1.3 9.1 67.2 3.8 2.0 5.9 0.0 2.0 3.3 2.7 1.4 3.1 2.5 9.7 29.8 12.2 2.2 1.1 1.1 1.3 10.3 21.8 1.7 2.7 1.1 0.5 6.1 6.8 1.7 1.5 1.8 3.4 2.5 1.0 3.0 1.5 4.5 6.8 3.3 2.0 3.7 3.9 0.0 1.7 0.0 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 13.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.0 16.7 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 7.2 0.0 0.0 31.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.7 0.0 1.3 2.8 13.1 0.2 0.2 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 21.8 9.1 47.5 29.8 12.2 10.3 21.8 6.8 3.9 0.0 0.0 0.0 0.1 0.2 14.5 6.1 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.5 8.3 0.9 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.2 125.5 0.0 3.7 0.0 13.7 0.3 0.0 3.3 0.0 0.0 49.3 0.3 8.6 0.4 0.0 15.9 25.8 5.7 0.1 2.5 0.1 0.2 0.0 0.0 0.0 LINGO2 "LERN3, LRRN6C" ENSG00000174482 "Leucine rich repeat and Ig domain containing 2" Q7L985 9 27948078-28670286 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 10.5;smooth muscle: 11.4" "Group enriched" "Detected in some" 6 "Bipolar cells: 7.3;Early spermatids: 12.0;Late spermatids: 11.5" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 8 "NK-cells: 3.4" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;hTERT-HME1: 2.3;SH-SY5Y: 13.7;U-87 MG: 2.4;WM-115: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016633, CAB025361" Approved NA NA "CAB025361: , HPA016633: AB_1853362" "unprognostic (1.27e-1)" "unprognostic (3.58e-1)" "unprognostic (1.20e-2)" "unprognostic (1.98e-4)" "unprognostic (9.86e-4)" "unprognostic (7.55e-3)" "unprognostic (2.67e-6)" "unprognostic (1.08e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-2)" "unprognostic (3.74e-2)" "unprognostic (8.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.08e-2)" "unprognostic (2.30e-2)" "unprognostic (1.95e-4)" 0.0 0.3 1.8 0.0 1.7 0.0 0.0 1.0 3.4 0.3 0.0 0.0 10.5 1.0 0.0 0.4 1.0 0.0 1.4 4.1 0.6 0.0 0.0 0.0 0.6 0.0 0.0 2.7 0.6 1.8 0.6 0.0 0.0 1.9 0.0 0.0 0.0 11.4 0.3 0.0 0.4 1.8 3.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.4 1.7 0.0 0.5 0.3 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 1.1 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.4 0.0 6.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.2 0.0 1.7 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.2 0.6 0.0 0.0 1.2 0.9 0.0 0.2 0.0 0.0 0.0 LINGO3 "LERN2, LRRN6B" ENSG00000220008 "Leucine rich repeat and Ig domain containing 3" P0C6S8 19 2289784-2292024 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.9;brain: 15.7;lymphoid tissue: 7.1" "Cell type enriched" "Detected in some" 7 "Bipolar cells: 32.9" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Cell type enhanced" "Detected in some" "eosinophil: 6.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 6.9" "Cell line enriched" "Detected in some" 4 "HMC-1: 19.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 7 "basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5" "HPA043781, HPA059558" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043781: AB_2678668, HPA059558: AB_2684062" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (7.16e-3)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (3.61e-3)" "unprognostic (3.53e-1)" "unprognostic (7.45e-3)" "unprognostic (1.11e-2)" "unprognostic (3.19e-2)" "unprognostic (4.03e-4)" "unprognostic (2.35e-2)" "unprognostic (1.36e-2)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" 0.1 0.2 2.2 3.1 15.7 2.8 0.0 4.6 2.9 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.2 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 1.2 0.0 0.4 7.1 1.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 6.9 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 2.1 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.6 0.2 0.0 0.1 1.9 0.0 4.8 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1.9 0.1 6.9 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.0 0.1 0.0 2.9 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 32.9 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.2 3.2 0.0 0.0 2.1 0.0 0.0 0.2 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 LINGO4 LRRN6D ENSG00000213171 "Leucine rich repeat and Ig domain containing 4" Q6UY18 1 151800264-151806154 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;skeletal muscle: 17.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.4;Ciliated cells: 1.4;Club cells: 1.2;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.0;JURKAT: 1.5;Karpas-707: 1.1;SH-SY5Y: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA060781 Uncertain NA NA "HPA060781: AB_2684361" "unprognostic (2.71e-2)" "unprognostic (1.98e-1)" "unprognostic (1.33e-3)" "unprognostic (1.96e-1)" "unprognostic (8.65e-2)" "unprognostic (3.16e-2)" "unprognostic (1.49e-5)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (2.39e-1)" "unprognostic (1.94e-4)" "unprognostic (6.92e-2)" "unprognostic (3.94e-4)" "unprognostic (3.84e-1)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.60e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.3 0.0 0.1 0.3 0.7 0.1 0.1 0.0 0.0 0.3 0.4 1.2 0.0 0.8 0.0 0.4 0.1 17.7 0.3 0.0 0.0 0.3 0.0 0.3 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 LIPA "CESD, LAL" ENSG00000107798 "Lipase A, lysosomal acid type" P38571 10 89213569-89414557 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.0" "Group enriched" "Detected in many" 7 "Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6" "Group enriched" "Detected in all" 5 "dendritic cells: 23.3;monocytes: 68.4" "Cell line enhanced" "Detected in many" "AN3-CA: 61.6;ASC TERT1: 77.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034892, HPA057052" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" "Intracellular and membrane" NA NA 150000 "Vesicles, Cytosol" "Nucleoplasm, Nucleoli fibrillar center" "CAB034892: AB_784329, HPA057052: AB_2683322" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (7.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (4.28e-2)" "unprognostic (1.08e-1)" "unprognostic (7.30e-3)" "unprognostic (1.39e-2)" "unprognostic (1.40e-1)" "unprognostic (4.42e-2)" "unprognostic (3.42e-2)" "unprognostic (5.71e-2)" 139.0 16.3 15.8 14.4 22.7 7.8 19.9 8.8 21.4 13.4 28.1 61.3 3.4 37.4 10.2 5.2 9.5 9.0 19.4 8.7 22.5 13.8 10.8 49.3 38.5 45.7 41.6 13.4 10.4 9.5 17.5 6.3 17.8 28.4 7.4 16.7 5.7 11.0 8.8 4.1 6.8 65.8 11.3 55.1 87.3 7.9 3.1 37.2 7.0 8.3 4.7 10.0 15.1 8.6 7.0 23.3 3.2 68.4 5.5 8.3 25.5 55.0 8.5 5.6 61.6 58.1 77.3 1.6 29.2 34.2 12.2 21.9 3.2 29.7 10.2 5.7 45.7 13.1 55.2 2.4 15.8 9.1 14.3 5.7 4.2 3.6 13.1 15.3 8.1 8.4 34.3 11.4 13.0 7.0 14.8 2.4 7.7 0.0 19.0 9.5 4.6 7.0 5.5 3.6 9.8 9.6 4.6 6.6 9.4 11.3 8.7 1.9 3.9 7.1 9.2 21.5 3.9 10.5 10.5 4.4 10.4 2.7 22.2 7.1 9.9 10.5 4.2 12.4 18.0 13.0 0.8 31.8 3.2 8.2 68.4 8.2 6.5 7.3 7.8 23.3 7.0 7.7 8.3 1.4 5.5 35.6 4.7 7.1 25.5 15.8 22.7 8.8 21.4 22.5 13.8 41.6 13.4 28.4 37.2 38.7 42.2 50.6 22.0 15.8 5.2 8.5 45.9 14.7 13.6 31.4 0.0 28.4 18.3 29.7 4.4 53.1 3.9 23.3 31.7 28.0 34.8 15.2 27.7 46.5 503.3 15.9 20.9 52.8 514.1 1.8 10.6 167.0 45.5 27.9 9.4 29.4 17.5 5.9 20.5 14.6 1.3 6.5 21.8 4.8 10.9 10.9 16.7 33.0 8.7 20.1 LIPC "HL, HTGL" ENSG00000166035 "Lipase C, hepatic type" P11150 15 58410569-58569843 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 91.7" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 125.3" "Group enriched" "Detected in some" 14 "liver cancer: 20.4;renal cancer: 10.4" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5" "Cell line enhanced" "Detected in some" "CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 3200000 "unprognostic (1.76e-2)" "unprognostic (9.15e-3)" "unprognostic (7.89e-2)" "unprognostic (7.15e-4)" "unprognostic (1.40e-1)" "unprognostic (1.33e-2)" "unprognostic (9.93e-3)" "unprognostic (6.25e-2)" "unprognostic (3.79e-2)" "unprognostic (1.10e-2)" "unprognostic (3.06e-1)" "unprognostic (2.31e-1)" "unprognostic (2.82e-2)" "unprognostic (1.41e-1)" "unprognostic (2.87e-2)" "unprognostic (1.80e-2)" "unprognostic (2.27e-2)" 0.2 0.1 0.4 1.1 0.7 0.0 0.7 0.1 0.4 0.3 0.2 0.6 0.0 0.7 0.1 0.4 0.2 0.4 0.3 0.3 0.4 0.2 3.0 91.7 0.3 0.2 1.2 0.2 0.3 1.0 0.0 1.0 0.1 1.5 0.3 0.3 0.5 0.1 1.5 0.1 0.3 0.3 0.1 1.2 0.4 0.2 0.1 0.5 2.7 0.5 0.0 0.1 1.1 0.2 0.1 0.2 3.7 0.4 3.0 4.5 2.5 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.7 0.0 0.0 7.0 0.0 0.0 5.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 2.5 0.0 20.0 0.4 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.1 4.5 0.6 0.0 0.0 0.0 0.9 0.3 0.0 2.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 15.8 0.0 0.0 0.0 0.1 0.1 0.4 0.0 3.7 0.3 0.0 3.0 0.2 4.5 0.0 0.8 2.2 0.2 0.1 1.0 3.2 0.4 3.0 0.4 0.1 2.1 2.5 0.4 0.7 0.1 0.4 0.4 0.2 1.2 0.2 1.5 0.5 0.0 0.0 5.1 0.0 0.2 0.0 0.8 12.7 0.0 1.2 3.5 0.0 0.0 5.0 3.7 0.0 0.0 0.0 0.0 3.3 0.0 1.2 0.2 0.0 125.3 0.1 0.0 0.0 5.5 4.0 0.0 0.3 0.0 1.7 1.0 0.0 0.0 0.3 0.0 0.0 9.6 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 LIPE HSL ENSG00000079435 "Lipase E, hormone sensitive type" Q05469 19 42401507-42427426 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism" Hydrolase "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 207.4;breast: 65.1" "Group enriched" "Detected in many" 6 "Early spermatids: 123.5;Late spermatids: 188.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "ASC diff: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA006567, CAB017700" Enhanced Supported Cytosol NA NA Cytosol "CAB017700: AB_2135504, HPA006567: AB_2667618" "unprognostic (4.24e-2)" "unprognostic (2.46e-2)" "unprognostic (8.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.77e-1)" "unprognostic (3.38e-3)" "unprognostic (5.68e-2)" "unprognostic (2.84e-1)" "unprognostic (3.11e-1)" "unprognostic (9.44e-2)" "prognostic favorable (1.15e-4)" "unprognostic (1.52e-1)" "unprognostic (3.63e-10)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (3.76e-2)" "unprognostic (2.34e-3)" 207.4 6.0 3.2 2.9 9.4 2.1 65.1 2.0 6.8 1.2 6.7 19.6 0.8 2.4 1.7 1.3 2.2 1.6 3.6 4.8 6.2 4.2 1.5 1.1 1.4 2.7 18.0 2.3 1.5 2.2 2.2 0.8 1.7 9.9 1.7 1.3 3.7 5.4 1.7 3.7 2.9 3.4 1.7 19.2 3.1 1.6 9.0 10.8 1.7 1.5 1.8 1.9 2.0 3.7 6.1 4.8 10.8 12.1 4.1 5.2 4.0 4.9 3.8 2.5 0.9 57.3 0.5 0.0 2.3 1.3 3.7 3.5 0.9 1.9 8.2 2.6 0.7 1.8 2.2 1.5 4.6 0.4 1.5 2.4 2.3 1.8 0.1 1.1 0.0 5.6 0.5 4.4 0.6 0.8 0.5 1.0 3.4 1.0 5.2 0.5 0.0 5.7 0.2 0.3 3.8 1.1 4.7 0.4 2.7 1.0 5.2 3.5 3.6 2.0 2.3 2.1 0.1 0.6 3.0 1.9 1.0 3.2 0.4 2.1 3.9 3.2 6.1 2.6 0.2 3.5 10.8 12.1 4.7 3.6 6.0 3.3 4.8 4.6 5.2 4.8 6.1 4.1 3.7 2.0 4.1 3.3 3.9 3.9 4.0 3.2 9.4 2.0 6.8 6.2 4.2 18.0 2.3 9.9 10.8 0.0 3.5 1.3 10.1 3.7 8.1 2.2 0.0 0.0 0.0 1.8 9.8 0.0 1.7 6.4 123.5 4.5 3.2 23.3 2.4 0.1 1.7 5.2 0.0 0.0 0.6 7.9 0.0 17.8 1.8 188.1 2.8 1.2 5.0 0.0 1.1 3.3 1.4 0.0 1.4 1.1 12.3 0.0 1.0 26.8 12.4 2.0 0.0 6.9 2.7 9.0 LIPF "HGL, HLAL" ENSG00000182333 "Lipase F, gastric type" P07098 10 88664441-88678814 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "stomach 1: 762.9" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 75 "stomach cancer: 278.5" "Region enhanced" "Detected in single" "cerebral cortex: 1.9" "Cell type enriched" "Detected in single" 16 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9" "Region enriched" "Detected in single" 51 "olfactory region: 9.9" HPA045930 Enhanced "Secreted to digestive system" NA NA "HPA045930: AB_10959518" "unprognostic (1.53e-1)" "unprognostic (1.83e-1)" 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.1 1.9 0.1 0.2 28.2 0.1 8.2 0.1 0.1 31.6 0.1 0.6 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 9.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 762.9 0.1 0.1 0.2 0.1 1.1 0.1 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 5.3 0.0 0.0 3.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 3.6 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 1.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LIPG EDL ENSG00000101670 "Lipase G, endothelial type" Q9Y5X9 18 49560699-49599182 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.0;placenta: 44.7;thyroid gland: 84.3" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 56.9;Extravillous trophoblasts: 60.0;Hepatocytes: 66.8" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 20.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 31.4;HaCaT: 48.1;RPTEC TERT1: 32.0;TIME: 62.4" "Group enriched" "Detected in many" 5 "amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9" "Low region specificity" "Detected in many" HPA016966 Uncertain "Secreted to blood" NA NA 657000000 170000 "HPA016966: AB_1852893" "unprognostic (2.20e-2)" "unprognostic (3.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.25e-3)" "unprognostic (6.38e-2)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" "unprognostic (4.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.44e-1)" "unprognostic (6.44e-2)" "unprognostic (8.74e-2)" "unprognostic (2.98e-1)" "unprognostic (8.68e-2)" "unprognostic (5.64e-2)" "unprognostic (1.54e-1)" "unprognostic (1.35e-1)" 1.5 0.4 0.8 4.7 0.7 0.1 0.8 2.0 0.7 0.4 5.6 3.9 15.0 1.9 0.4 3.1 1.0 0.5 4.3 1.2 1.1 0.9 5.2 37.0 4.4 0.7 1.1 0.1 0.5 1.0 0.0 0.6 44.7 1.4 1.0 2.2 8.3 0.6 24.6 2.6 1.1 7.6 2.2 1.4 0.4 1.4 5.8 0.4 0.3 84.3 2.1 0.5 2.0 0.6 1.2 0.6 2.1 0.6 1.7 0.8 0.1 0.5 0.0 13.8 31.4 0.1 0.0 0.2 0.1 1.4 0.0 0.0 13.6 4.9 0.0 7.6 0.0 9.6 48.1 2.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 1.4 11.1 4.9 9.6 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.1 0.0 0.0 0.7 32.0 3.7 0.2 0.0 0.2 0.3 0.0 1.8 0.0 0.0 62.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.4 0.7 0.4 0.4 0.8 0.5 0.5 0.2 1.2 0.8 0.7 2.1 1.7 0.4 0.6 0.4 0.1 0.8 0.7 2.0 0.5 1.1 0.9 1.1 0.1 1.4 0.4 0.0 1.4 0.0 4.8 1.5 0.8 1.7 25.5 0.0 3.4 14.0 56.9 4.7 0.0 3.2 8.0 1.4 9.5 0.0 1.2 60.0 1.0 8.4 0.0 66.8 1.6 0.0 13.3 4.9 1.9 6.0 0.3 0.0 1.7 1.0 3.4 1.0 7.7 2.9 0.0 1.0 2.4 0.0 0.7 1.0 0.8 2.3 16.2 0.7 6.2 9.9 LIPH "LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B" ENSG00000163898 "Lipase H" Q8WWY8 3 185506262-185552613 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 28.8;lung: 28.5;stomach 1: 27.0" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 134.0;Enterocytes: 247.9;Mucus-secreting cells: 115.8;Urothelial cells: 130.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 37.9;OE19: 8.6;RPTEC TERT1: 19.2;T-47d: 9.1;U-266/84: 9.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA049079 Approved "Secreted to blood" NA NA "HPA049079: AB_2680623" "unprognostic (4.50e-3)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (3.38e-1)" "unprognostic (1.01e-1)" "unprognostic (8.59e-2)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (7.88e-2)" "prognostic favorable (9.20e-5)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "prognostic favorable (4.21e-4)" "unprognostic (1.15e-1)" 0.3 0.5 0.5 5.1 1.2 0.0 2.1 0.3 1.4 2.5 20.4 0.6 3.1 6.2 0.2 5.1 12.9 0.5 16.5 0.6 0.4 0.7 8.5 0.5 28.5 0.0 0.3 0.0 0.7 13.6 0.0 2.1 0.9 1.8 10.7 21.9 2.1 15.7 3.0 0.3 6.1 28.8 1.6 0.3 0.5 27.0 6.2 0.0 0.2 0.4 4.1 14.9 8.8 5.0 0.9 0.4 2.4 0.9 0.6 0.7 1.7 5.1 6.8 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.1 0.1 0.6 37.9 0.0 3.9 0.1 1.5 1.8 2.8 0.0 0.2 0.0 0.8 0.9 0.9 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.3 8.6 0.5 0.0 0.0 0.5 19.2 4.6 0.0 0.0 0.5 6.3 0.1 0.3 9.1 0.1 0.0 0.0 0.5 0.0 0.1 0.6 9.0 0.0 0.0 0.0 0.0 2.2 0.9 0.4 0.5 0.2 0.3 0.4 0.5 0.4 0.2 0.9 0.7 0.6 2.4 0.6 0.4 0.4 0.3 1.7 0.5 1.2 0.3 1.4 0.4 0.7 0.3 0.0 1.8 0.0 134.0 29.7 0.0 12.6 0.7 0.4 0.4 68.8 45.5 54.6 64.6 0.0 0.2 1.7 42.3 0.0 0.2 247.9 0.0 22.4 0.1 0.4 71.5 6.9 0.0 0.0 0.0 21.4 1.3 0.0 0.0 0.0 0.1 15.1 1.0 115.8 0.3 39.8 89.6 0.0 1.6 0.7 0.0 0.2 0.5 0.0 1.8 0.2 0.0 61.8 130.6 LIPI "CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5" ENSG00000188992 "Lipase I" Q6XZB0 21 14108813-14210891 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "epididymis: 113.2" "Cell type enriched" "Detected in single" 7 "Early spermatids: 1.1" "Cancer enriched" "Detected in single" 6 "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 3.1;REH: 2.0;SH-SY5Y: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in male reproductive system" NA NA "unprognostic (2.60e-2)" "unprognostic (3.49e-1)" "unprognostic (1.12e-3)" "unprognostic (1.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.68e-1)" "unprognostic (4.53e-2)" "unprognostic (2.90e-1)" "unprognostic (3.64e-13)" "unprognostic (2.82e-1)" "unprognostic (4.14e-2)" "unprognostic (2.90e-1)" "unprognostic (7.87e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 1.0 0.0 0.6 0.0 1.2 113.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 1.4 0.0 0.0 4.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.9 0.0 0.0 1.5 0.9 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.7 0.2 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.0 0.0 0.0 0.5 3.1 1.4 0.0 0.4 2.0 0.5 1.0 0.0 0.0 0.3 1.9 0.7 0.1 0.1 1.8 0.1 0.1 0.0 0.5 0.3 0.8 0.2 0.3 0.0 0.3 0.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 LIPJ "bA425M17.2, LIPL1" ENSG00000204022 "Lipase family member J" Q5W064 10 88586753-88606976 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 32.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.7;NB-4: 1.0;SK-MEL-30: 2.4;U-2197: 1.0" HPA048594 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA048594: AB_2680456" "unprognostic (4.79e-3)" "unprognostic (6.77e-2)" "unprognostic (4.80e-2)" "unprognostic (2.36e-1)" "unprognostic (2.70e-2)" "unprognostic (9.33e-2)" "unprognostic (2.90e-3)" "unprognostic (7.50e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.73e-2)" "unprognostic (1.73e-2)" "unprognostic (6.21e-4)" "unprognostic (9.87e-2)" "unprognostic (9.57e-2)" "unprognostic (1.85e-1)" "unprognostic (1.88e-1)" 0.2 0.0 0.3 0.0 0.3 0.0 0.2 1.0 0.3 0.1 0.0 0.4 0.2 1.6 0.0 1.1 0.1 0.1 0.4 0.5 0.2 0.7 0.0 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.3 0.2 0.6 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.3 11.5 0.9 0.4 0.5 0.1 0.7 0.0 1.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.1 0.7 1.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 LIPK "bA186O14.2, LIPL2" ENSG00000204021 "Lipase family member K" Q5VXJ0 10 88724544-88752786 "Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "skin 1: 27.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.65e-2)" "unprognostic (8.64e-2)" "unprognostic (3.57e-2)" "unprognostic (3.19e-7)" "unprognostic (1.25e-1)" "unprognostic (1.60e-2)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 LIPM "bA304I5.1, LIPL3" ENSG00000173239 "Lipase family member M" Q5VYY2 10 88802730-88820546 "Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 14 "skin 1: 30.1" "Cell type enriched" "Detected in single" 9 "Suprabasal keratinocytes: 1.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.0" "Lineage enhanced" "Detected in single" "monocytes: 1.0" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 6.9;HL-60: 3.9;NB-4: 3.3;OE19: 6.1;RT4: 2.9;T-47d: 3.3;U-937: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.72e-2)" "unprognostic (8.49e-4)" "unprognostic (1.42e-2)" "unprognostic (2.23e-4)" "unprognostic (6.70e-3)" "unprognostic (3.01e-3)" "unprognostic (5.75e-2)" "unprognostic (6.63e-2)" "unprognostic (5.61e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (6.47e-4)" "unprognostic (1.59e-2)" "unprognostic (5.93e-2)" "unprognostic (7.05e-3)" "unprognostic (4.17e-2)" "unprognostic (9.02e-2)" "unprognostic (9.70e-6)" 0.0 0.0 0.0 0.8 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 1.0 0.0 0.1 0.1 2.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 6.1 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.3 3.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.8 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 LIPN "bA186O14.3, LIPL4" ENSG00000204020 "Lipase family member N" Q5VXI9 10 88761406-88778242 "Disease related genes, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase Ichthyosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 12.5;skin 1: 25.5" "Cell type enhanced" "Detected in single" 23 "Kupffer cells: 1.2" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.6" "Group enriched" "Detected in many" 5 "classical monocyte: 4.8;eosinophil: 12.5;intermediate monocyte: 10.7;neutrophil: 7.7;non-classical monocyte: 11.3" "Group enriched" "Detected in many" 6 "granulocytes: 12.5;monocytes: 11.3" "Group enriched" "Detected in some" 7 "Daudi: 3.3;HL-60: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.27e-1)" "unprognostic (1.07e-1)" "unprognostic (2.03e-2)" "unprognostic (9.75e-2)" "unprognostic (2.54e-2)" "unprognostic (4.40e-2)" "unprognostic (5.77e-3)" "unprognostic (1.65e-1)" 1.5 0.1 0.0 2.8 0.0 3.7 1.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 25.5 0.0 0.3 0.1 1.2 0.0 0.0 0.0 0.0 0.4 1.1 0.0 1.8 12.5 11.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 9.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 1.1 4.8 12.5 0.0 10.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 7.7 0.0 11.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LITAF "FLJ38636, PIG7, SIMPLE, TP53I7" ENSG00000189067 "Lipopolysaccharide induced TNF factor" Q99732 16 11547722-11636381 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 202.5" "Cell type enhanced" "Detected in many" 5 "monocytes: 551.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 202.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 202.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006960 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA006960: AB_1079254" "unprognostic (2.26e-1)" "unprognostic (4.96e-2)" "unprognostic (2.32e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (4.07e-2)" "unprognostic (8.75e-3)" "unprognostic (3.60e-1)" "unprognostic (6.15e-3)" "unprognostic (1.04e-1)" "unprognostic (4.61e-2)" "unprognostic (5.01e-1)" "unprognostic (1.85e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.57e-2)" "unprognostic (1.60e-1)" 55.0 14.1 18.0 49.2 42.4 53.3 65.7 5.0 18.5 50.4 36.4 45.2 20.2 13.9 42.7 28.8 19.6 34.0 35.3 31.5 20.7 15.7 48.9 66.3 73.0 80.6 28.6 13.2 43.1 26.3 15.9 17.1 46.2 42.8 36.2 36.7 26.0 57.3 32.2 18.6 28.5 24.1 41.6 52.1 57.9 26.3 11.0 19.0 18.7 53.3 18.8 36.4 47.4 41.6 14.1 16.9 202.5 10.3 20.2 37.6 35.6 13.9 26.1 16.5 7.9 2.5 1.9 16.7 18.2 56.1 17.4 25.9 10.8 37.7 7.0 23.3 15.3 20.2 17.3 6.9 30.5 16.6 53.6 7.2 0.5 22.7 54.7 38.7 2.1 2.4 5.8 59.3 14.2 38.9 15.6 0.0 0.4 4.3 27.3 0.2 13.3 0.3 32.3 26.8 18.6 0.1 2.1 3.6 40.3 14.5 19.8 4.1 12.4 31.5 40.3 32.4 26.6 22.5 11.9 0.1 7.2 12.2 4.2 4.2 10.7 23.5 18.0 8.3 17.1 41.3 32.2 10.3 20.8 37.6 9.8 22.8 14.1 23.5 33.5 13.6 13.9 26.8 31.7 202.5 20.2 5.7 16.9 26.2 35.6 18.0 42.4 5.0 18.5 20.7 15.7 28.6 13.2 42.8 19.0 41.7 81.4 104.3 281.2 139.8 1.8 51.2 129.9 133.8 114.9 155.3 0.0 57.9 411.1 191.6 1.7 48.8 46.4 0.0 64.4 335.4 125.8 223.3 202.9 35.5 219.5 0.0 16.8 61.4 140.8 7.9 52.0 294.8 148.5 551.0 130.0 207.3 91.3 203.2 64.3 66.5 3.5 51.8 174.1 0.0 4.7 115.6 31.0 220.6 89.7 303.0 LIX1 "C5orf11, Lft" ENSG00000145721 "Limb and CNS expressed 1" Q8N485 5 97091867-97142872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 35.9" "Cell type enriched" "Detected in some" 16 "Muller glia cells: 199.8" "Cancer enhanced" "Detected in many" "glioma: 13.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.9" "Lineage enriched" "Detected in single" 9 "B-cells: 5.9" "Group enriched" "Detected in some" 11 "RPTEC TERT1: 24.5;SuSa: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058426 Uncertain Approved "Vesicles,Cytokinetic bridge,Cytosol" Yes NA Cytosol "Vesicles, Cytokinetic bridge" "HPA058426: AB_2683715" "unprognostic (3.18e-1)" "unprognostic (4.53e-2)" "unprognostic (9.46e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (8.96e-2)" "unprognostic (6.60e-2)" "unprognostic (1.34e-1)" "unprognostic (4.70e-1)" "unprognostic (7.63e-2)" "unprognostic (1.58e-2)" "unprognostic (3.52e-1)" "unprognostic (2.01e-1)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" "unprognostic (9.61e-2)" 1.0 1.2 14.9 1.3 16.9 1.4 1.1 6.1 35.9 1.0 1.3 19.2 1.0 1.2 1.2 1.2 1.0 1.2 1.1 1.1 24.6 10.7 4.9 1.0 1.1 1.6 11.7 13.2 1.0 1.0 1.0 1.2 1.4 12.4 3.0 1.4 3.3 1.1 8.3 1.1 1.1 1.2 1.2 10.1 1.2 1.2 1.1 13.0 0.0 6.5 0.0 1.0 1.0 0.2 5.9 0.1 0.6 0.1 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 1.2 0.1 0.0 0.0 5.9 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 14.9 16.9 6.1 11.9 24.6 10.7 11.7 13.2 12.4 13.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 199.8 0.0 0.0 0.0 1.4 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LKAAEAR1 C20orf201 ENSG00000171695 "LKAAEAR motif containing 1" Q8TD35 20 64083380-64084359 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.5;testis: 18.0" "Group enriched" "Detected in some" 36 "Early spermatids: 401.3;Late spermatids: 525.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 12.5" "Lineage enriched" "Detected in many" 11 "monocytes: 12.5" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 9.6" "Low region specificity" "Detected in many" HPA056463 Approved Nucleoplasm NA NA Nucleoplasm "HPA056463: AB_2683139" "unprognostic (5.47e-3)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-1)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.19e-1)" "unprognostic (2.58e-1)" "unprognostic (7.93e-2)" "unprognostic (3.78e-3)" "unprognostic (6.74e-2)" "unprognostic (3.16e-4)" "unprognostic (3.07e-2)" "unprognostic (1.41e-1)" "unprognostic (3.12e-1)" "unprognostic (2.30e-2)" 0.5 0.0 3.4 0.3 2.9 0.6 0.1 1.5 2.9 0.0 0.2 0.6 0.1 0.0 0.0 1.8 0.0 0.0 1.7 3.1 0.1 0.0 0.3 0.2 1.2 0.0 0.7 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.5 0.3 18.0 0.1 0.0 0.0 0.0 0.1 1.0 0.8 12.5 0.0 0.8 0.8 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.3 1.8 0.7 0.3 0.0 1.5 9.3 0.0 0.2 0.0 0.0 9.6 2.3 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.8 0.1 7.9 0.6 0.1 0.7 0.2 1.0 0.0 0.8 0.2 0.0 0.0 12.5 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.5 0.0 0.0 1.3 2.4 525.6 3.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.8 0.0 0.7 12.9 0.5 3.7 5.5 0.0 0.1 0.0 0.0 0.0 LLCFC1 "C7orf34, CTM-1" ENSG00000165131 "LLLL and CFNLAS motif containing 1" Q96L11 7 142939343-142940868 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 21 "testis: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Group enriched" "Detected in some" 5 "K-562: 3.2;RT4: 3.4;SiHa: 1.5" "Intracellular and membrane" NA NA "unprognostic (5.05e-2)" "unprognostic (9.94e-2)" "unprognostic (5.49e-3)" "unprognostic (2.76e-2)" "unprognostic (1.13e-1)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.85e-3)" "unprognostic (3.54e-1)" "unprognostic (2.02e-1)" 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.5 0.0 31.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 3.2 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 3.4 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LLGL1 "DLG4, HUGL, HUGL-1, Lgl1, LLGL, Mgl1" ENSG00000131899 "LLGL1, scribble cell polarity complex component" Q15334 17 18225587-18244875 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 53.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022924 Enhanced NA NA "HPA022924: AB_1852926" "unprognostic (1.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (1.88e-2)" "unprognostic (2.94e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.72e-4)" "unprognostic (7.71e-2)" "unprognostic (3.06e-1)" "unprognostic (7.18e-2)" "unprognostic (3.27e-3)" "unprognostic (8.99e-3)" "unprognostic (1.40e-1)" "unprognostic (6.02e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-2)" "unprognostic (2.40e-2)" 5.6 10.0 15.0 5.1 21.2 3.5 3.7 7.3 24.1 6.0 3.7 53.5 3.1 3.6 8.1 4.6 10.3 8.0 6.1 6.0 18.4 11.9 3.4 1.4 4.5 5.7 30.4 12.5 10.6 5.1 3.8 4.4 8.2 17.3 5.2 2.4 3.0 6.6 6.5 8.5 8.8 4.2 5.6 32.5 6.1 4.3 6.8 24.2 3.9 3.9 2.9 4.5 6.9 4.8 0.6 0.2 1.0 0.5 1.2 1.6 0.2 11.4 7.6 18.9 18.3 7.3 6.7 7.8 5.1 8.2 10.1 9.1 16.8 2.2 6.9 8.9 4.5 5.6 10.6 5.6 6.7 3.0 11.5 15.1 3.2 5.5 5.9 3.5 1.2 7.3 8.3 3.7 5.2 2.4 7.7 6.4 9.0 2.3 1.5 3.9 8.2 8.2 1.9 8.0 5.5 4.2 10.5 13.6 3.8 3.0 4.3 5.0 10.7 6.2 2.9 4.8 17.0 3.5 2.0 8.9 8.0 10.3 10.6 7.9 2.4 1.7 2.2 15.9 3.0 7.0 1.0 0.3 0.0 0.4 0.5 0.3 0.5 0.4 0.3 0.1 0.6 0.3 0.1 1.0 1.2 0.1 0.2 1.6 0.2 15.0 21.2 7.3 17.2 18.4 11.9 30.4 12.5 17.3 24.2 0.0 1.7 1.4 1.1 2.4 1.0 1.7 2.5 1.4 0.0 3.5 0.0 2.0 0.0 5.1 7.9 1.7 0.5 0.0 3.8 5.4 5.0 1.3 0.0 1.5 2.5 4.8 3.5 1.8 2.1 1.5 6.4 1.0 1.7 0.0 2.4 2.4 4.8 0.0 7.4 1.4 2.2 0.0 6.7 4.6 7.8 2.6 1.7 1.9 2.9 2.0 LMAN1L "ERGIC-53L, ERGL" ENSG00000140506 "Lectin, mannose binding 1 like" Q9HAT1 15 74812716-74825758 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3" "Group enriched" "Detected in some" 4 "Glandular cells: 9.7;Spermatocytes: 6.5" "Cancer enriched" "Detected in single" 45 "prostate cancer: 2.2" "Region enriched" "Detected in some" 22 "cerebellum: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.8;HEK 293: 2.4;SCLC-21H: 2.5;SK-BR-3: 2.5;U-698: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.51e-1)" "unprognostic (2.44e-1)" "unprognostic (4.26e-2)" "unprognostic (3.09e-1)" 0.1 1.1 0.2 4.8 0.2 0.0 0.1 45.5 0.9 0.3 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.0 0.5 18.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 2.0 37.0 0.0 0.1 17.3 0.1 0.1 0.0 0.2 0.1 0.3 13.5 2.5 0.7 0.1 0.1 0.1 0.3 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.1 0.0 0.9 0.3 0.0 1.1 0.0 0.5 2.5 0.1 0.0 2.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.6 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 45.5 0.9 0.1 0.0 0.1 0.3 2.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.5 1.1 0.0 0.0 0.0 0.0 0.1 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501707-8574673 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 189.9" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "T-reg: 17.0" "Lineage enriched" "Detected in many" 6 "T-cells: 17.0" "Cell line enhanced" "Detected in many" "HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 38.6 3.3 1.6 10.1 1.8 0.0 36.4 3.9 1.9 11.7 4.4 3.8 5.2 1.9 22.3 20.8 8.3 11.9 15.4 15.9 2.3 1.7 5.5 2.2 25.9 3.8 2.4 1.7 17.9 8.5 5.8 2.0 14.1 4.5 16.1 1.6 4.6 19.2 7.0 189.9 5.7 3.3 72.9 3.7 14.3 10.6 9.3 1.3 0.8 4.6 34.3 7.1 29.4 15.7 1.8 2.7 0.0 0.3 0.0 17.0 0.2 2.9 16.9 2.8 2.1 21.1 11.9 2.9 12.4 6.4 6.8 16.9 12.5 3.8 0.0 1.4 14.3 2.9 0.2 1.6 3.2 2.8 5.1 1.1 3.7 1.1 2.4 30.4 0.0 0.3 42.6 0.0 31.3 0.2 4.0 3.3 0.0 0.0 0.0 8.8 2.1 0.0 0.0 5.5 3.8 0.7 0.0 9.4 0.0 6.3 1.1 0.1 7.1 2.0 10.3 6.4 8.4 13.4 0.0 1.6 6.9 13.8 27.6 8.3 1.7 1.9 0.8 1.4 0.9 8.8 0.0 0.0 0.0 0.0 0.3 0.1 1.8 2.6 0.5 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.9 17.0 0.2 1.6 1.8 3.9 1.9 2.3 1.7 2.4 1.7 4.5 1.3 8.9 15.4 0.0 47.6 28.0 13.3 13.7 20.4 20.1 15.9 5.2 9.8 2.6 3.3 99.6 0.9 70.2 0.5 0.0 42.3 3.5 58.2 6.1 10.3 11.3 3.1 92.2 11.6 36.2 0.6 1.5 10.6 4.0 50.6 15.4 2.2 34.8 83.3 0.0 30.4 29.2 7.9 0.0 171.0 5.0 7.0 23.7 3.7 2.2 3.3 5.2 LMF1 "C16orf26, FLJ12681, FLJ22302, JFP11, TMEM112, TMEM112A" ENSG00000103227 "Lipase maturation factor 1" Q96S06 16 853634-981318 "Disease related genes, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.42e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-2)" "unprognostic (1.16e-3)" "unprognostic (5.58e-3)" "unprognostic (1.20e-2)" "unprognostic (5.24e-3)" "unprognostic (1.41e-2)" "unprognostic (6.22e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (4.01e-3)" "prognostic favorable (7.95e-8)" "unprognostic (2.00e-1)" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (2.03e-3)" 8.5 12.5 40.0 6.4 66.1 6.6 8.8 7.3 37.2 7.2 6.4 30.0 5.3 7.2 8.1 22.9 7.3 9.3 7.6 6.8 27.4 10.5 8.6 12.4 7.3 6.7 23.6 23.9 9.5 33.2 23.5 8.0 5.8 23.5 11.1 5.7 8.6 22.5 9.5 6.5 10.6 7.5 8.2 31.4 9.5 10.1 5.8 42.1 3.0 13.6 3.2 6.2 8.7 7.8 3.6 10.1 2.5 7.2 8.2 9.0 4.8 0.7 9.0 6.4 11.5 8.1 8.3 2.8 4.4 14.4 1.6 2.9 1.8 12.0 1.9 6.8 11.4 4.3 3.4 2.4 0.0 0.9 5.9 3.2 0.6 0.5 2.2 4.2 1.6 2.3 4.8 0.0 0.3 3.8 7.2 3.4 3.3 1.4 7.8 5.3 10.3 3.4 0.9 3.3 7.2 5.0 3.5 6.4 12.5 5.8 2.1 0.0 3.5 2.2 2.4 8.1 3.6 5.5 5.4 3.6 0.9 1.5 3.6 0.6 9.6 1.3 2.7 2.4 1.7 7.3 2.5 6.4 1.4 9.0 7.2 5.2 3.6 5.1 6.2 10.1 3.2 5.2 4.1 0.3 8.2 4.3 9.5 4.8 4.8 40.0 66.1 7.3 37.2 27.4 10.5 23.6 23.9 23.5 42.1 11.9 11.3 3.0 5.5 3.7 10.5 3.6 2.5 13.4 6.8 5.2 13.7 1.1 3.3 11.8 0.5 6.3 8.0 0.0 15.1 1.2 7.4 6.1 2.3 7.9 6.1 12.7 8.1 7.4 6.0 2.9 13.6 4.5 15.1 1.8 5.3 19.7 15.0 5.1 9.2 7.7 8.7 6.5 5.1 1.5 3.8 1.8 0.9 4.4 5.4 4.6 LMF2 "TMEM112B, TMEM153" ENSG00000100258 "Lipase maturation factor 2" Q9BU23 22 50502949-50507691 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 122.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062626 Approved Approved Centrosome NA NA Centrosome "HPA062626: AB_2684812" "unprognostic (2.69e-1)" "prognostic favorable (3.47e-4)" "unprognostic (8.67e-2)" "unprognostic (2.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.13e-2)" "unprognostic (1.21e-2)" "unprognostic (2.70e-2)" "unprognostic (5.11e-2)" "unprognostic (2.90e-1)" "unprognostic (2.97e-2)" "unprognostic (3.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.08e-1)" "unprognostic (2.54e-2)" "unprognostic (8.75e-2)" 18.2 13.7 7.7 14.3 10.1 20.9 16.9 14.6 16.6 16.9 20.0 16.1 11.0 18.7 14.7 19.3 17.5 13.0 19.0 11.2 8.1 8.7 18.5 34.7 14.2 15.3 10.7 10.1 18.0 122.0 8.7 20.8 14.2 11.3 15.8 5.3 16.9 27.3 16.4 10.8 17.8 21.3 11.3 7.8 19.0 12.9 12.0 7.8 12.8 20.4 13.9 19.9 13.3 14.1 10.8 25.3 16.1 17.7 12.1 21.0 12.6 18.0 13.6 7.8 14.8 11.3 9.7 18.2 32.4 17.2 20.9 23.5 13.4 9.4 8.0 8.8 17.0 9.3 21.8 2.6 10.2 2.9 6.3 28.5 4.4 25.0 14.1 14.2 8.2 17.6 14.3 9.5 14.2 3.5 9.0 11.6 6.3 5.2 27.1 9.0 13.0 5.8 9.7 4.6 4.6 17.0 13.3 12.5 21.8 8.4 9.8 7.0 10.3 22.1 19.2 14.9 3.9 11.0 5.8 16.8 29.6 16.8 21.1 1.6 10.5 3.4 4.8 21.5 5.1 24.1 10.3 13.2 16.1 21.0 17.7 15.9 10.8 17.5 19.4 14.0 7.3 10.4 10.9 12.4 12.1 14.5 25.3 15.9 12.6 7.7 10.1 14.6 16.6 8.1 8.7 10.7 10.1 11.3 7.8 11.9 9.6 31.3 14.9 16.6 13.7 8.1 35.7 5.3 12.5 14.0 21.6 50.7 3.3 33.0 7.3 17.9 48.5 0.0 65.4 89.5 42.9 11.0 15.1 31.6 38.4 11.1 14.5 23.4 17.3 14.8 27.0 23.9 23.6 19.0 25.4 24.6 31.0 59.6 24.1 19.5 14.1 19.4 19.4 11.2 20.1 15.2 23.8 34.6 24.4 13.1 LMLN2 ENSG00000283654 "Leishmanolysin like peptidase 2" 14 23099065-23104992 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 12 "HSkMC: 7.7" "Not detected" "Not detected" NA NA 0.3 0.5 0.0 0.4 2.5 1.2 0.3 1.1 2.0 0.2 0.7 3.7 0.0 0.4 0.4 1.4 0.2 0.2 1.4 0.1 0.0 0.0 0.0 0.1 1.0 0.9 1.1 0.7 0.0 0.7 0.0 0.0 3.9 0.3 0.7 0.9 0.4 0.0 0.1 1.3 0.6 1.7 0.9 0.6 0.1 1.1 0.7 0.0 1.4 0.0 1.0 0.1 0.0 0.7 0.3 1.0 0.5 0.4 0.7 0.2 0.2 0.2 0.6 0.5 0.1 0.2 0.3 0.2 0.2 0.0 0.2 0.5 0.2 0.4 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.6 0.3 0.3 0.1 0.3 7.7 0.1 0.1 0.0 0.4 0.3 0.4 0.1 0.4 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.2 0.2 0.6 0.2 0.0 0.2 0.6 0.1 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.8 0.5 0.2 0.7 0.1 0.3 0.0 0.1 0.3 0.2 0.7 0.5 0.3 1.0 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMNB1 ENSG00000113368 "Lamin B1" P20700 5 126776623-126837020 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Leukodystrophy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 93.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 61.8;Extravillous trophoblasts: 58.3;granulocytes: 89.2;Late spermatids: 58.6;monocytes: 77.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebellum: 23.4;pons and medulla: 6.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005269, HPA050524, CAB079757" Supported Supported "Nuclear membrane" NA NA 3300000 "Nuclear membrane" "CAB005269: AB_648156, CAB079757: AB_2665863, HPA050524: AB_2681156" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" "unprognostic (4.96e-3)" "unprognostic (3.70e-2)" "unprognostic (1.61e-1)" "unprognostic (8.65e-3)" "prognostic unfavorable (3.08e-6)" "unprognostic (2.06e-2)" "unprognostic (6.62e-3)" "unprognostic (5.28e-2)" "unprognostic (2.13e-3)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.33e-16)" "unprognostic (1.33e-2)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" 3.9 2.0 2.5 36.8 3.5 21.1 7.0 23.4 2.5 3.1 10.6 0.5 3.9 8.2 2.2 3.2 15.8 2.4 4.3 3.3 3.0 2.7 2.4 5.0 9.7 25.4 2.1 1.7 2.9 2.9 1.0 3.4 5.2 6.3 1.9 9.9 1.7 4.1 5.7 1.8 6.2 11.1 2.6 8.8 15.3 5.7 2.5 2.3 93.1 2.0 9.3 20.3 4.1 5.1 3.8 13.2 8.5 12.2 1.9 10.5 4.9 25.3 8.4 26.3 25.1 0.6 1.9 34.1 11.9 3.5 13.2 14.3 21.9 21.2 44.1 20.7 4.1 6.3 14.2 17.9 8.1 14.6 30.9 22.0 28.3 10.0 12.8 0.2 33.6 19.1 0.5 0.1 6.9 3.2 2.5 10.8 18.1 16.4 17.2 9.2 20.9 60.8 66.7 19.8 10.4 11.9 29.1 52.0 17.8 7.2 11.6 30.5 16.1 19.2 8.3 7.2 9.5 15.1 38.9 9.1 9.9 26.9 7.3 25.4 11.4 8.7 38.7 5.0 47.8 14.6 1.2 12.2 4.0 1.9 5.0 1.5 3.8 4.0 2.5 13.2 2.9 2.9 2.6 8.5 1.9 1.2 4.0 10.5 4.9 2.5 3.5 23.4 2.5 3.0 2.7 2.1 1.7 6.3 2.3 0.0 7.0 22.9 2.4 4.4 6.1 0.8 7.6 2.7 4.5 0.0 7.9 14.6 1.7 1.9 61.8 3.8 2.3 0.0 0.7 58.3 2.9 1.0 89.2 2.4 18.5 4.8 5.8 1.8 18.2 58.6 2.0 12.5 1.7 77.5 13.5 2.8 0.9 10.5 0.4 1.7 16.5 0.0 4.2 2.8 8.1 4.6 3.9 20.8 25.7 0.4 LMNTD1 "FLJ36004, IFLTD1, Pas1c1" ENSG00000152936 "Lamin tail domain containing 1" Q8N9Z9 12 25409307-25648579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;fallopian tube: 19.0;pituitary gland: 21.3;testis: 15.0" "Group enriched" "Detected in some" 15 "Ciliated cells: 26.8;Early spermatids: 38.5;Late spermatids: 35.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.5;RT4: 6.7;SH-SY5Y: 6.9;U-2197: 24.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038640 Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA038640: AB_2676127" "unprognostic (8.92e-3)" "unprognostic (3.21e-1)" "unprognostic (2.41e-1)" "unprognostic (1.19e-2)" "unprognostic (9.57e-2)" "unprognostic (1.68e-1)" "unprognostic (6.18e-2)" "unprognostic (2.42e-1)" "unprognostic (7.80e-2)" "unprognostic (3.89e-2)" 0.4 0.3 4.3 0.7 6.7 0.4 1.1 3.3 1.6 1.4 3.9 7.1 0.0 1.5 0.8 6.0 0.3 19.0 0.9 0.5 8.5 2.8 0.8 0.2 4.1 0.4 1.1 3.0 4.0 0.7 0.1 21.3 0.3 13.4 0.4 3.8 1.3 0.2 0.3 0.2 0.6 0.6 1.2 4.1 0.6 0.6 15.0 6.5 0.0 1.1 0.0 0.2 0.4 0.3 2.6 2.2 2.7 0.9 0.7 1.6 0.6 0.3 0.3 0.1 0.2 0.2 1.6 2.4 3.1 5.5 1.2 0.2 0.0 0.3 0.2 0.1 0.0 3.5 0.1 0.2 0.1 0.3 0.9 0.1 1.0 0.8 2.0 0.3 0.1 0.1 0.5 0.2 1.6 0.4 0.1 0.1 0.1 1.9 0.3 0.0 0.4 0.0 0.3 1.7 0.1 0.5 0.4 0.2 0.2 0.2 6.7 0.1 6.9 0.2 0.4 3.9 0.8 0.3 1.5 0.3 0.2 0.9 24.0 0.2 0.8 1.3 1.7 0.3 1.6 2.6 1.9 0.9 0.6 1.4 0.3 0.5 2.1 1.0 1.3 0.4 2.6 1.4 1.6 2.7 0.7 0.4 2.2 0.5 0.6 4.3 6.7 3.3 1.6 8.5 2.8 1.1 3.0 13.4 6.5 0.0 0.0 0.5 1.1 0.0 0.0 0.4 0.0 26.8 2.3 0.0 0.0 0.2 1.7 0.0 38.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.7 LMO1 "RBTN1, RHOM1, TTG1" ENSG00000166407 "LIM domain only 1" P25800 11 8224304-8268716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 29.4;skeletal muscle: 29.1" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 16.5;Distal tubular cells: 23.2;Early spermatids: 35.8;Horizontal cells: 38.1" "Cancer enriched" "Detected in many" 6 "glioma: 6.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 21.7;SCLC-21H: 8.5;SH-SY5Y: 26.0;SiHa: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.74e-3)" "unprognostic (1.45e-1)" "unprognostic (4.75e-6)" "unprognostic (9.34e-2)" "unprognostic (2.37e-1)" "unprognostic (1.98e-1)" "unprognostic (7.06e-3)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (9.05e-2)" "unprognostic (4.36e-12)" "unprognostic (1.76e-2)" "unprognostic (8.88e-2)" "unprognostic (2.58e-2)" "unprognostic (3.13e-2)" 0.3 1.7 2.5 0.3 2.1 0.2 0.6 0.4 3.0 0.2 0.2 1.5 0.1 0.4 0.3 2.1 0.6 0.3 0.2 0.5 2.3 5.9 1.0 0.2 0.2 0.2 3.5 0.6 0.2 1.6 0.2 2.1 0.3 2.1 0.3 0.2 29.4 0.2 0.2 29.1 6.4 0.3 0.5 1.2 0.6 0.6 1.6 2.0 0.1 0.2 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.9 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.0 3.1 0.0 0.0 0.0 0.4 0.9 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 26.0 5.2 2.9 0.1 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.1 0.4 3.0 2.3 5.9 3.5 0.6 2.1 2.0 0.0 0.0 0.0 0.0 16.5 1.1 1.0 0.0 4.0 0.0 0.0 0.0 0.1 23.2 0.2 35.8 0.1 0.0 0.0 1.1 4.9 0.2 0.0 1.1 0.0 0.2 38.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.4 0.0 3.7 0.0 0.0 0.5 1.2 3.0 0.2 0.0 0.0 0.0 LMO3 "DAT1, RBTNL2, Rhom-3" ENSG00000048540 "LIM domain only 3" Q8TAP4 12 16548373-16610594 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.5" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 160.8;Alveolar cells type 2: 154.4;Ciliated cells: 111.1;Club cells: 110.3;Collecting duct cells: 50.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "ASC diff: 70.7;LHCN-M2: 31.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.67e-2)" "unprognostic (2.84e-1)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.10e-7)" "unprognostic (3.62e-2)" "unprognostic (5.44e-2)" "unprognostic (6.56e-3)" "unprognostic (4.91e-2)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.39e-5)" "unprognostic (4.41e-2)" "unprognostic (1.61e-1)" "unprognostic (2.13e-3)" "unprognostic (4.83e-2)" 15.9 8.3 38.1 3.1 43.9 1.2 8.2 5.2 87.5 13.1 22.6 5.8 6.4 2.0 8.7 3.4 3.1 2.1 6.3 3.6 20.8 9.4 4.0 1.3 30.0 1.3 14.5 27.6 9.6 29.6 2.1 7.9 2.1 12.9 11.2 9.9 0.9 4.1 25.7 1.2 1.3 4.3 16.9 4.2 1.4 2.6 1.7 8.6 0.3 30.4 0.0 1.2 15.9 6.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.1 43.9 5.2 42.5 20.8 9.4 14.5 27.6 12.9 8.6 160.8 154.4 0.0 0.2 0.2 0.2 0.8 0.0 111.1 110.3 50.6 17.7 0.2 3.3 0.0 2.6 0.0 0.0 0.0 3.0 0.0 3.1 0.2 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 3.3 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.5 0.0 1.9 1.7 0.7 0.1 0.2 0.0 0.0 0.1 LMO4 ENSG00000143013 "LIM domain only 4" P61968 1 87328468-87348923 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 105.3;T-47d: 67.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022345, HPA045877, HPA061638" Approved Supported "Nucleoplasm,Midbody ring" Yes No Nucleoplasm "Midbody ring" "CAB022345: , HPA045877: AB_2679480, HPA061638: AB_2684572" "unprognostic (5.39e-2)" "unprognostic (4.62e-3)" "unprognostic (2.67e-2)" "unprognostic (4.33e-3)" "unprognostic (1.37e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.97e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.47e-4)" "unprognostic (3.46e-2)" "unprognostic (6.82e-2)" "unprognostic (1.14e-2)" "unprognostic (2.86e-2)" "unprognostic (2.87e-2)" "prognostic favorable (1.42e-4)" "unprognostic (1.70e-1)" 19.3 7.5 39.8 11.7 36.4 8.0 13.9 10.3 102.4 22.7 16.2 9.8 10.9 11.5 19.4 18.1 22.2 13.7 21.0 17.2 62.3 18.0 12.8 14.5 16.6 11.5 21.0 50.9 18.4 10.4 11.6 13.3 27.5 13.0 26.0 14.3 11.2 36.2 37.9 18.4 17.1 21.1 15.3 16.5 15.8 38.6 12.0 11.0 4.4 14.2 12.5 36.3 15.4 21.4 7.8 7.2 18.9 8.2 15.3 6.9 3.6 9.4 7.4 5.8 105.3 17.9 21.3 14.8 8.6 6.8 8.1 9.1 18.2 6.0 22.2 11.0 10.0 13.2 7.9 2.3 6.0 8.1 11.8 5.8 20.2 16.2 5.6 17.2 10.9 27.5 11.1 13.9 12.6 7.2 14.7 5.5 8.6 4.5 19.7 4.3 3.8 0.3 7.1 21.3 10.2 7.0 12.6 8.1 4.8 10.0 36.4 4.8 0.3 34.6 5.1 25.5 11.6 67.0 30.0 3.5 38.2 7.2 9.1 28.1 18.1 11.9 5.0 4.7 2.4 5.4 18.9 6.8 13.0 6.0 8.2 6.9 7.8 5.4 6.1 5.0 4.4 1.4 3.5 10.9 15.3 7.7 7.2 1.4 3.6 39.8 36.4 10.3 102.4 62.3 18.0 21.0 50.9 13.0 11.0 41.7 27.4 50.6 46.8 87.3 192.0 49.2 163.1 29.4 48.9 34.9 68.7 270.0 53.0 48.7 1.6 54.7 57.7 23.3 112.7 251.2 186.2 38.4 292.9 75.1 64.5 104.9 29.9 81.6 115.9 4.5 88.1 61.6 62.4 25.2 66.7 78.4 77.9 34.8 221.3 42.6 34.0 32.3 148.3 3.9 34.7 81.2 214.1 67.1 38.3 32.9 LMO7 "FBX20, FBXO20, KIAA0858" ENSG00000136153 "LIM domain 7" Q8WWI1 13 75620434-75859870 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 1563.3;Club cells: 396.9;Urothelial cells: 377.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 14.1" "Lineage enriched" "Detected in many" 5 "T-cells: 14.1" "Cell line enhanced" "Detected in many" "BJ: 55.4;fHDF/TERT166: 91.4;LHCN-M2: 86.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2" "HPA020923, HPA050184" Enhanced Supported "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA020923: AB_1852963, HPA050184: AB_2681045" "unprognostic (2.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.57e-2)" "unprognostic (1.97e-1)" "unprognostic (1.52e-2)" "unprognostic (3.42e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.14e-1)" "prognostic favorable (7.75e-12)" "unprognostic (2.49e-1)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (8.33e-2)" 2.2 2.2 10.1 6.3 32.6 0.9 2.5 2.7 13.2 6.7 24.3 0.5 2.4 17.5 2.3 7.8 42.5 4.0 16.3 65.6 9.8 2.5 21.7 19.9 57.0 2.6 2.3 8.8 5.5 6.8 6.2 3.1 10.9 1.1 7.6 8.9 2.7 14.3 7.0 44.4 8.6 55.0 2.1 2.0 1.5 16.7 4.7 4.1 16.2 25.7 36.3 23.7 4.6 15.4 2.4 1.1 3.0 0.5 0.5 14.1 2.6 12.2 7.0 0.2 0.2 14.6 10.4 2.4 55.4 27.4 14.1 15.3 17.1 15.9 1.0 4.2 91.4 3.5 11.9 3.0 2.6 16.3 16.5 0.7 7.5 37.2 16.0 4.2 2.4 3.9 7.1 5.2 6.1 7.0 34.6 5.9 2.4 0.2 0.1 86.0 4.8 1.8 1.0 0.3 19.0 10.6 1.1 25.9 0.2 6.0 2.8 0.9 1.9 10.1 1.7 2.2 1.5 2.3 1.8 9.0 34.9 6.5 4.1 13.5 3.7 2.7 4.4 10.2 2.7 15.8 3.0 0.2 2.4 0.7 0.5 0.9 1.1 3.2 1.0 0.4 2.4 14.1 8.5 0.1 0.5 0.3 1.1 1.2 2.6 10.1 32.6 2.7 13.2 9.8 2.5 2.3 8.8 1.1 4.1 1563.3 242.1 2.7 51.2 21.3 5.2 309.1 48.4 234.2 396.9 59.3 2.0 38.6 13.3 56.6 4.7 11.3 219.0 0.0 32.9 6.2 66.8 251.0 19.7 61.7 5.1 6.4 68.3 6.7 3.7 5.6 38.9 4.9 15.1 1.8 69.4 1.7 146.0 64.9 40.0 13.6 10.9 12.9 19.1 8.1 3.2 39.5 14.2 7.0 44.1 377.1 LMO7DN C13orf45 ENSG00000178734 "LMO7 downstream neighbor" F2Z398 13 75871038-75883811 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 3.4" "Cell type enhanced" "Detected in single" 26 "Leydig cells: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 1.5;fHDF/TERT166: 2.5;LHCN-M2: 5.2;U-2197: 1.4" HPA052013 Uncertain NA NA "HPA052013: AB_2681693" "unprognostic (2.85e-2)" "unprognostic (2.83e-2)" "unprognostic (2.37e-2)" "unprognostic (1.51e-2)" "unprognostic (3.08e-4)" "unprognostic (1.38e-1)" "unprognostic (3.86e-1)" "unprognostic (1.04e-1)" "unprognostic (2.43e-3)" "unprognostic (1.91e-2)" "unprognostic (2.95e-1)" "unprognostic (8.72e-3)" "unprognostic (6.19e-2)" 0.6 0.1 0.1 0.0 0.8 0.2 1.8 0.0 0.8 0.0 0.1 1.2 0.3 0.6 2.7 0.8 3.4 0.2 0.3 0.5 0.3 0.0 1.6 0.4 0.3 0.6 0.0 0.1 3.0 0.2 0.1 0.1 0.7 0.0 0.4 0.3 1.3 0.6 0.3 0.0 0.6 1.4 0.7 0.0 0.4 0.4 0.2 0.1 0.0 0.0 1.0 0.3 0.1 0.3 0.3 0.3 0.4 0.6 0.5 0.3 1.5 0.3 0.0 0.6 1.3 0.2 0.1 0.0 2.5 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.2 0.0 0.3 0.1 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.0 1.4 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 LMOD1 "1D, 64kD, D1" ENSG00000163431 "Leiomodin 1" P29536 1 201896452-201946588 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 199.7;urinary bladder: 165.5" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 127.6;Leydig cells: 116.2;Peritubular cells: 258.9;Rod photoreceptor cells: 66.8;Sertoli cells: 194.1;Smooth muscle cells: 158.8" "Cancer enhanced" "Detected in all" "prostate cancer: 43.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 9.2;BJ: 11.9;BJ hTERT+: 19.3;fHDF/TERT166: 9.6;HSkMC: 8.5;hTERT-RPE1: 31.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028325, HPA028435, HPA030097" Enhanced Approved Cytosol No No Cytosol "HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223" "unprognostic (3.84e-2)" "unprognostic (5.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (5.64e-1)" "unprognostic (6.35e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.27e-1)" "unprognostic (6.10e-2)" "unprognostic (1.73e-2)" "unprognostic (3.51e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.30e-2)" "unprognostic (2.72e-1)" "unprognostic (4.44e-3)" "unprognostic (1.15e-2)" 27.4 12.7 1.9 26.7 6.2 0.0 20.5 2.2 1.9 65.6 83.5 1.8 42.7 6.0 84.9 29.0 94.6 33.2 80.7 8.3 1.6 1.6 5.3 1.0 11.0 5.5 2.3 3.2 38.1 1.6 7.4 1.3 10.2 4.1 77.1 12.0 28.9 6.8 63.8 29.5 7.4 20.9 199.7 1.8 6.3 47.0 23.3 0.7 0.0 7.9 12.3 2.7 165.5 39.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 9.2 1.1 0.7 11.9 19.3 0.7 0.9 0.0 0.1 0.0 0.4 9.6 0.1 0.2 0.3 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 8.5 0.0 0.5 0.0 31.2 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.2 5.6 0.4 0.0 0.0 0.1 0.4 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.9 6.2 2.2 1.9 1.6 1.6 2.3 3.2 4.1 0.7 0.0 1.4 0.0 0.7 1.1 4.9 22.4 0.0 1.4 0.0 0.0 127.6 1.1 0.0 0.0 1.9 2.1 0.0 0.0 0.5 0.2 13.9 0.6 0.0 0.0 0.8 3.2 0.0 13.5 0.0 3.6 116.2 0.0 3.3 0.0 0.0 4.5 0.0 0.0 258.9 0.0 66.8 194.1 158.8 1.4 0.2 1.9 1.0 0.0 0.0 0.3 LMOD2 ENSG00000170807 "Leiomodin 2" Q6P5Q4 7 123655807-123664290 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1" "Cell type enriched" "Detected in some" 1164 "Cardiomyocytes: 1233.0" "Group enriched" "Detected in some" 20 "head and neck cancer: 3.5;prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HSkMC: 5.7;SuSa: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046370, HPA051039" Enhanced Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "HPA046370: , HPA051039: AB_2681321" "unprognostic (2.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-3)" "unprognostic (1.18e-1)" "unprognostic (5.50e-1)" "unprognostic (5.69e-2)" "unprognostic (6.98e-2)" "unprognostic (2.13e-2)" "unprognostic (1.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.82e-3)" 3.3 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.2 3.8 0.0 0.0 117.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.0 2.6 0.0 297.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.4 100.1 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1233.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LMOD3 ENSG00000163380 "Leiomodin 3" Q0VAK6 3 69106872-69123032 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 28.3;skeletal muscle: 121.1;tongue: 53.1" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 241.3" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "HSkMC: 8.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA036034 Uncertain NA NA "HPA036034: AB_10673494" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.32e-2)" "unprognostic (1.93e-1)" "unprognostic (2.50e-3)" "unprognostic (1.96e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (6.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.33e-1)" "unprognostic (2.98e-4)" "unprognostic (3.67e-3)" "unprognostic (1.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.96e-1)" 0.8 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 4.8 1.9 0.1 0.0 28.3 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.9 0.0 0.0 4.4 0.1 121.1 0.1 0.1 0.3 0.1 0.2 0.2 0.1 0.1 0.0 1.4 53.1 0.7 0.6 0.1 0.9 0.3 4.1 1.1 0.4 1.0 0.2 0.3 0.1 0.9 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 0.2 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.7 0.6 0.0 0.2 0.7 8.2 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.6 1.8 0.1 0.0 0.3 0.1 0.0 0.2 0.1 0.6 0.1 0.0 0.8 0.2 0.3 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.3 0.1 0.3 0.1 0.4 0.5 0.2 0.3 0.2 0.3 4.1 0.6 0.8 0.5 0.4 0.6 0.6 0.9 0.7 0.1 0.9 0.6 0.7 0.8 0.4 1.1 0.3 1.0 0.2 0.1 0.2 0.1 0.3 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 3.7 1.4 2.1 4.5 241.3 10.2 0.0 0.0 0.0 37.3 0.7 0.0 0.8 0.7 0.7 2.4 0.0 0.0 1.6 2.2 1.9 18.4 1.0 0.7 6.4 0.0 1.3 1.0 0.2 0.3 1.7 11.8 1.8 1.5 1.6 1.0 0.0 1.1 0.3 14.1 0.0 1.9 0.4 0.1 1.3 0.3 7.5 0.6 1.8 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513189 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.1" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Supported Uncertain "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: AB_2732330" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 1.3 4.4 19.8 2.3 28.6 2.0 2.0 20.0 38.1 2.0 1.5 6.0 0.2 6.2 1.4 1.5 2.3 1.6 1.9 1.7 17.2 11.1 2.5 1.3 3.2 2.2 6.5 23.8 1.3 2.1 8.5 6.1 2.1 12.5 3.5 1.2 1.6 5.2 3.1 1.2 2.4 4.0 1.2 6.6 1.8 2.9 1.5 10.3 0.0 2.3 0.0 2.2 1.6 1.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 4.6 3.1 0.4 0.0 0.0 0.0 4.5 0.0 0.3 0.0 0.1 2.2 3.7 1.7 1.3 0.0 1.2 2.2 0.3 1.6 0.0 0.0 1.2 0.2 0.3 0.7 0.0 0.0 8.6 0.2 0.9 0.0 0.0 2.0 0.1 2.8 1.4 2.9 0.0 3.1 0.6 0.8 1.1 2.4 0.9 3.9 0.0 1.3 1.1 0.8 0.7 2.9 0.1 10.2 0.0 0.6 3.9 0.2 0.1 0.0 0.8 0.1 0.0 9.5 7.7 0.4 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 19.8 28.6 20.0 38.1 17.2 11.1 6.5 23.8 12.5 10.3 3.0 1.7 0.8 9.2 0.5 16.4 2.2 2.5 4.0 4.5 7.0 0.0 4.3 21.6 19.4 0.1 0.0 0.7 0.0 0.4 2.5 0.9 15.7 0.0 0.0 1.0 17.5 0.0 1.3 0.3 0.0 0.6 0.3 3.3 0.0 1.0 7.3 10.7 0.0 0.0 0.6 1.9 0.0 0.7 2.4 1.3 1.6 5.7 0.0 0.6 44.3 LMX1A "LMX1, LMX1.1" ENSG00000162761 "LIM homeobox transcription factor 1 alpha" Q8TE12 1 165201867-165356715 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3;pituitary gland: 8.0" "Group enriched" "Detected in some" 33 "Early spermatids: 29.1;Intestinal endocrine cells: 40.3;Late spermatids: 14.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "SCLC-21H: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA028051, HPA030088" Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA028051: AB_10599731, HPA030088: AB_10601106" "unprognostic (1.73e-1)" "unprognostic (9.57e-2)" "unprognostic (7.58e-2)" "unprognostic (1.59e-1)" "unprognostic (2.17e-1)" "unprognostic (2.82e-1)" "unprognostic (2.63e-1)" "unprognostic (3.22e-2)" "unprognostic (2.10e-3)" "unprognostic (1.51e-1)" "unprognostic (9.82e-3)" 2.2 0.0 0.0 2.0 0.0 0.0 1.2 2.6 0.5 0.5 1.7 3.4 3.1 4.0 0.1 1.3 1.1 0.5 0.2 0.2 0.9 1.5 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.1 8.0 0.0 7.3 0.2 2.1 0.5 1.5 0.3 1.4 0.3 2.2 0.9 0.1 0.0 0.2 4.3 0.3 0.0 0.3 3.5 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.5 2.2 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LMX1B NPS1 ENSG00000136944 "LIM homeobox transcription factor 1 beta" O60663 9 126614443-126701032 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 16.5;salivary gland: 35.3" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.4;Early spermatids: 1.1" "Cancer enriched" "Detected in some" 14 "breast cancer: 12.9" "Region enriched" "Detected in single" 4 "pons and medulla: 2.9" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 17.2;OE19: 10.9;T-47d: 10.6" "Region enhanced" "Detected in some" "pons and medulla: 2.4" "Region enhanced" "Detected in some" "midbrain: 7.9" HPA073716 Approved Nucleoplasm NA NA Nucleoplasm "HPA073716: AB_2686630" "unprognostic (4.17e-1)" "unprognostic (4.72e-2)" "unprognostic (2.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.73e-1)" "unprognostic (1.50e-4)" "unprognostic (1.86e-1)" "unprognostic (2.20e-2)" "unprognostic (3.41e-1)" "unprognostic (2.26e-1)" "unprognostic (1.34e-2)" "unprognostic (3.51e-3)" "unprognostic (1.63e-5)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-6)" "unprognostic (1.13e-2)" 1.3 0.1 0.0 0.1 0.0 0.1 7.5 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 1.9 0.1 0.2 1.4 0.0 0.1 0.0 0.6 0.0 0.1 0.8 0.0 0.6 0.0 2.9 0.1 0.0 16.5 35.3 0.0 0.4 1.5 0.2 0.0 2.4 0.0 0.1 3.1 0.0 0.0 0.9 0.1 0.0 0.2 0.1 0.6 0.4 1.2 0.3 0.9 0.5 0.0 2.4 1.1 0.4 3.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.2 1.3 0.0 0.5 0.0 2.8 1.2 3.8 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.5 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 17.2 0.0 0.0 0.0 10.9 0.2 0.0 3.2 0.0 0.0 0.3 0.0 1.5 0.3 0.1 0.4 0.1 10.6 0.2 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.3 0.3 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.5 0.4 1.2 0.9 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401193-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.9" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 107.8;Horizontal cells: 243.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 9.4;cerebral cortex: 11.0;hippocampal formation: 10.1;olfactory region: 9.4" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 3.1 2.8 6.5 1.7 11.4 0.6 2.7 7.9 9.7 3.4 2.3 1.5 3.4 1.2 4.6 8.4 1.9 4.0 2.7 9.5 5.3 7.2 4.8 7.4 3.8 1.4 5.7 5.6 6.3 4.5 3.0 17.0 3.7 7.4 2.8 2.2 9.0 2.4 3.3 4.3 1.0 1.5 4.5 4.2 1.8 1.9 31.9 3.5 1.6 5.3 0.8 1.7 3.1 1.8 0.9 0.2 0.0 0.4 0.2 2.7 0.8 2.9 1.6 8.5 1.2 5.5 2.4 0.7 2.3 5.6 1.9 2.2 0.6 0.7 2.6 1.0 1.6 3.0 1.9 2.2 2.0 2.2 2.6 2.3 6.2 0.8 2.8 1.7 3.6 0.7 2.6 0.7 1.0 4.8 2.5 0.4 1.3 2.4 9.7 1.7 2.1 5.0 3.6 5.8 1.7 12.8 3.8 4.7 5.1 1.7 0.3 8.8 4.4 1.7 2.5 3.5 2.5 0.6 0.4 0.6 0.9 9.0 0.8 2.0 11.4 12.2 7.5 2.6 3.1 1.6 0.0 0.4 0.0 1.1 0.2 2.5 0.9 1.1 0.6 0.2 0.9 1.0 1.1 0.0 0.2 0.0 0.0 2.7 0.8 6.5 11.4 7.9 9.7 5.3 7.2 5.7 5.6 7.4 3.5 0.0 0.3 4.2 1.2 0.9 32.6 9.6 0.0 5.3 2.3 1.8 47.1 1.2 6.6 0.4 107.8 0.7 0.4 23.3 0.8 1.6 3.1 0.9 0.0 1.6 0.6 243.1 2.4 0.0 0.3 17.2 3.1 0.0 20.3 1.0 1.0 9.4 0.6 0.0 1.1 3.1 35.6 0.0 2.2 31.5 2.7 0.5 0.3 0.0 0.6 0.1 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037515 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 104.4" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" NA NA 390000 "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 9.8 4.7 5.6 12.0 7.3 13.2 7.7 23.3 12.9 6.3 7.6 6.9 7.8 4.2 8.2 4.4 10.2 6.6 4.3 10.1 5.2 5.6 7.6 4.3 6.9 15.9 7.7 8.8 8.2 5.9 13.8 9.7 104.4 9.1 7.9 6.8 3.9 7.8 7.7 13.2 14.0 9.0 6.6 7.5 10.0 8.5 3.3 7.7 23.6 7.2 2.9 15.8 8.9 7.7 4.1 3.5 5.0 12.8 11.2 7.9 4.3 5.3 6.2 2.8 2.9 17.1 8.2 3.3 5.5 7.3 6.5 9.9 5.2 8.7 26.5 10.4 7.4 18.3 7.1 3.6 10.4 6.8 9.4 2.0 6.6 4.5 3.6 4.4 7.6 9.1 6.3 6.4 9.4 6.9 7.0 6.8 5.9 2.8 17.6 7.4 4.7 9.0 5.3 0.6 1.7 3.3 6.5 10.6 4.0 23.2 11.1 5.5 1.4 6.7 5.9 3.3 2.8 18.1 10.0 13.5 9.5 5.3 7.5 8.3 3.8 8.8 24.2 8.4 7.2 4.3 5.0 3.3 4.4 7.9 5.5 6.8 3.1 5.9 6.1 3.5 4.1 5.9 6.4 4.1 11.2 12.8 3.3 5.1 4.3 5.6 7.3 23.3 12.9 5.2 5.6 7.7 8.8 9.1 7.7 32.8 42.4 53.7 16.7 52.8 57.3 58.2 17.8 22.7 20.5 34.9 117.8 9.5 5.0 14.0 2.4 31.5 15.8 0.0 12.3 21.8 30.1 24.6 24.4 14.1 14.7 22.3 24.6 33.7 46.5 3.8 30.5 38.3 20.3 12.6 27.8 43.8 15.9 14.0 43.9 9.1 35.8 25.8 24.7 21.4 23.1 41.3 22.9 70.5 21.5 19.9 LONP1 "hLON, LonHS, PIM1, PRSS15" ENSG00000196365 "Lon peptidase 1, mitochondrial" P36776 19 5691834-5720572 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA-binding, Hydrolase, Protease, Serine protease" "Cataract, Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002034, HPA002192" Supported Enhanced Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA002034: AB_2756304, HPA002192: AB_1079695" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (2.43e-1)" "unprognostic (2.43e-2)" "unprognostic (2.84e-1)" "unprognostic (2.38e-1)" "unprognostic (1.66e-3)" "unprognostic (5.56e-2)" "unprognostic (2.71e-1)" "unprognostic (7.57e-2)" "unprognostic (4.04e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (2.11e-1)" 15.8 78.3 16.4 12.8 19.8 12.5 13.9 16.1 22.8 11.3 13.6 15.8 13.3 13.7 10.5 13.8 12.7 12.7 15.7 27.3 15.4 15.3 19.9 49.6 10.3 14.5 17.7 14.9 15.5 17.7 17.6 16.8 16.6 16.2 11.7 8.5 12.7 18.5 14.7 38.0 14.7 13.9 11.5 12.7 15.5 13.5 9.8 13.3 13.8 21.2 15.3 11.8 14.7 12.5 6.7 6.5 6.0 6.2 4.0 7.2 3.0 23.0 23.9 7.9 25.3 9.4 6.7 24.7 14.7 11.7 15.9 19.5 20.4 8.3 28.9 20.6 15.4 15.3 9.8 20.4 17.8 7.7 17.1 16.8 16.0 20.9 26.7 43.7 36.4 16.8 12.6 25.6 15.1 29.9 7.7 12.7 40.6 42.3 57.8 7.3 15.3 18.0 21.7 28.3 9.4 31.6 19.0 11.4 31.2 8.8 13.7 21.1 21.1 12.9 18.9 51.6 5.8 11.1 45.7 8.9 8.1 8.9 22.5 21.4 60.9 37.5 25.7 36.5 39.9 14.6 6.0 4.1 0.8 6.4 6.2 4.1 6.0 5.6 6.1 4.3 6.7 7.2 4.8 0.5 4.0 2.4 6.5 4.0 3.0 16.4 19.8 16.1 22.8 15.4 15.3 17.7 14.9 16.2 13.3 6.0 13.3 13.7 8.7 7.3 24.7 17.9 15.3 9.4 10.3 26.2 5.9 24.8 39.7 28.3 5.3 9.8 24.8 0.0 23.9 27.0 10.5 12.9 5.7 44.0 28.2 20.6 10.9 14.1 11.3 4.0 11.8 15.2 13.5 24.4 21.6 20.9 25.6 14.4 16.3 36.0 22.0 19.4 10.3 9.1 13.4 9.4 29.3 9.2 22.2 9.4 LONRF2 "FLJ45273, RNF192" ENSG00000170500 "LON peptidase N-terminal domain and ring finger 2" Q1L5Z9 2 100273291-100322733 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.9;epididymis: 32.6" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 74.2;Cardiomyocytes: 34.4;Horizontal cells: 104.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 6.5;GAMG: 8.1;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057366 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA057366: AB_2683420" "unprognostic (9.81e-2)" "unprognostic (4.97e-2)" "unprognostic (2.68e-2)" "unprognostic (3.20e-2)" "unprognostic (7.10e-2)" "unprognostic (7.72e-2)" "unprognostic (9.50e-2)" "unprognostic (9.86e-3)" "unprognostic (6.33e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.42e-5)" "unprognostic (1.14e-1)" "unprognostic (6.06e-2)" "unprognostic (3.45e-2)" "unprognostic (2.50e-2)" "unprognostic (2.66e-3)" "unprognostic (6.34e-2)" 1.6 23.0 8.4 0.6 32.9 0.2 2.2 21.1 15.4 5.1 1.7 1.3 2.3 0.5 19.0 32.6 2.0 17.8 1.7 4.3 5.6 9.9 1.3 0.7 1.5 0.5 3.9 7.0 10.5 4.4 9.6 7.8 0.6 6.4 3.2 0.7 1.6 1.5 3.2 4.6 0.4 0.5 19.8 4.5 0.5 1.5 1.8 4.3 0.4 3.5 0.8 0.4 1.4 1.3 0.7 0.5 1.7 0.4 0.7 0.5 0.1 0.0 6.5 2.0 2.4 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 1.2 0.0 1.1 0.0 8.1 0.0 6.4 0.0 0.0 0.5 6.9 0.0 0.4 0.0 0.2 0.1 5.7 0.0 0.0 0.3 0.0 0.4 0.0 1.8 3.7 0.1 0.0 4.2 0.0 0.3 0.4 1.2 5.9 0.0 0.0 0.0 1.6 0.2 14.0 3.8 0.0 0.0 1.0 2.3 3.5 0.1 0.1 0.1 0.8 0.0 0.4 0.0 0.0 0.0 2.8 0.0 0.3 1.1 0.4 0.4 0.3 0.3 0.3 0.4 0.3 0.3 0.2 0.7 0.4 0.5 1.7 0.7 0.3 0.5 0.2 0.1 8.4 32.9 21.1 9.7 5.6 9.9 3.9 7.0 6.4 4.3 0.0 13.2 0.0 1.2 0.7 74.2 34.4 5.1 5.3 5.7 5.2 29.5 1.7 5.0 2.4 0.4 1.0 0.0 0.0 1.8 0.2 1.5 5.8 5.7 0.5 0.4 104.9 10.9 0.0 0.0 1.5 3.1 0.3 1.7 0.0 0.1 10.0 2.1 0.0 11.0 0.3 18.2 6.5 3.3 0.5 0.2 0.1 2.4 0.0 0.4 0.5 LOR ENSG00000203782 Loricrin P23490 1 153259700-153262122 "Disease related genes, Predicted intracellular proteins" Keratinization "Ichthyosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 181.8" "Cell type enriched" "Detected in some" 7 "Suprabasal keratinocytes: 164.2" "Cancer enriched" "Detected in some" 11 "melanoma: 45.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 89 "HDLM-2: 28.2" "HPA076123, HPA077266" Enhanced NA NA "HPA076123: AB_2732302, HPA077266: AB_2732338" "unprognostic (1.97e-2)" "unprognostic (1.93e-2)" "unprognostic (4.16e-2)" "prognostic favorable (8.53e-4)" "unprognostic (1.65e-1)" "unprognostic (2.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.41e-1)" "unprognostic (1.47e-1)" "unprognostic (3.03e-1)" "unprognostic (1.02e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.9 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.3 181.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 15.7 0.1 31.2 2.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 164.2 0.0 0.0 0.0 0.0 LOXHD1 "DFNB77, FLJ32670, LH2D1" ENSG00000167210 "Lipoxygenase homology domains 1" Q8IVV2 18 46476972-46657220 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.5;epididymis: 9.7;testis: 22.0" "Group enriched" "Detected in some" 84 "Early spermatids: 168.6;Late spermatids: 330.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 5 "basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "THP-1: 3.5;WM-115: 1.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "olfactory region: 1.0" HPA077128 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077128: " "unprognostic (6.95e-2)" "unprognostic (1.88e-2)" "unprognostic (4.81e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (7.75e-4)" "unprognostic (9.53e-2)" "unprognostic (7.91e-2)" "unprognostic (7.61e-2)" "unprognostic (9.44e-2)" "unprognostic (1.26e-2)" "unprognostic (1.93e-2)" "unprognostic (7.43e-3)" "unprognostic (6.48e-5)" "unprognostic (2.30e-1)" "unprognostic (8.10e-3)" "unprognostic (1.66e-3)" 1.7 0.0 0.4 0.0 2.4 2.7 0.4 0.1 1.9 0.0 0.1 0.2 15.5 0.0 0.0 9.7 0.1 1.7 0.1 0.5 0.2 0.1 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.4 4.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.2 0.1 0.0 0.0 0.7 0.1 22.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.4 2.4 0.1 1.9 0.2 0.1 0.0 0.0 0.0 1.1 3.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 1.7 0.0 168.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 330.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 LOXL4 "FLJ21889, LOXC" ENSG00000138131 "Lysyl oxidase like 4" Q96JB6 10 98247690-98268250 "Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.1" "Cell type enhanced" "Detected in many" 15 "Club cells: 9.1;Collecting duct cells: 29.6;Ductal cells: 8.6" "Cancer enhanced" "Detected in all" "melanoma: 44.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.3;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BJ hTERT+: 60.1;CAPAN-2: 72.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033876, HPA037609" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "CAB033876: AB_2135101, HPA037609: AB_2675579" "unprognostic (9.91e-3)" "unprognostic (3.97e-2)" "unprognostic (1.81e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (7.71e-2)" "unprognostic (1.75e-2)" "unprognostic (8.38e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (2.51e-1)" "unprognostic (4.97e-2)" "unprognostic (5.25e-2)" "unprognostic (5.77e-3)" "unprognostic (1.28e-1)" "unprognostic (6.10e-2)" "unprognostic (7.40e-3)" 6.3 1.8 1.1 1.1 4.2 0.1 10.7 1.0 1.7 20.7 7.3 4.6 1.4 1.4 8.0 4.6 2.3 7.4 4.6 1.8 1.6 0.3 4.4 29.1 3.1 0.6 1.1 1.2 6.1 14.5 1.7 1.4 5.1 8.2 5.1 1.5 3.2 15.7 10.7 14.7 3.1 2.5 7.1 3.0 1.8 2.3 10.8 1.0 1.4 5.7 1.9 1.7 3.1 6.0 0.8 1.2 0.1 0.2 2.3 0.0 0.0 0.0 0.4 0.0 0.0 1.7 7.4 0.2 7.6 60.1 0.6 6.5 1.2 72.2 0.0 6.9 5.9 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 3.1 1.6 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.1 0.1 0.0 13.6 0.8 0.2 0.0 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.3 0.0 1.2 0.0 0.0 1.1 4.2 1.0 1.7 1.6 0.3 1.1 1.2 8.2 1.0 6.0 1.0 0.0 1.9 0.8 0.2 1.1 5.1 4.0 9.1 29.6 0.0 0.2 0.0 8.6 0.2 0.6 0.0 0.0 0.5 0.3 5.1 2.0 1.1 0.2 0.2 0.0 0.0 3.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 4.9 3.3 0.0 1.4 0.5 0.0 0.0 1.6 0.0 0.2 0.6 0.3 0.0 0.0 1.6 LPA "LP, Lp(a)" ENSG00000198670 Lipoprotein(a) P08519 6 160531483-160664259 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid transport, Transport" "Hydrolase, Protease, Serine protease" Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 71 "liver: 43.4" "Cell type enriched" "Detected in some" 32 "Hepatocytes: 79.7" "Cancer enriched" "Detected in single" 38 "liver cancer: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "RT4: 4.7" "CAB016072, HPA060604" Supported "Secreted to blood" NA NA 78800000000 2900000000 "CAB016072: AB_2135240, HPA060604: AB_2684330" "unprognostic (2.16e-1)" "unprognostic (5.10e-1)" "unprognostic (7.75e-3)" "unprognostic (6.70e-2)" "unprognostic (1.60e-1)" "unprognostic (4.17e-3)" "unprognostic (1.59e-1)" "unprognostic (6.38e-3)" "unprognostic (3.63e-2)" "unprognostic (3.18e-1)" "unprognostic (7.45e-3)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (3.72e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.2 43.4 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.7 0.0 0.0 0.0 1.3 2.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.2 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 45.6;Leydig cells: 35.9;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.5;eosinophil: 15.6" "Group enriched" "Detected in many" 6 "granulocytes: 15.6;monocytes: 7.5" "Cell line enhanced" "Detected in many" "ASC diff: 98.3;ASC TERT1: 57.4;BJ hTERT+: 69.5;HSkMC: 41.7" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 16.3 9.5 55.8 12.0 56.2 0.3 14.8 4.7 30.9 43.7 12.3 71.4 3.4 9.4 12.1 12.3 10.6 10.1 9.8 8.5 55.6 30.6 5.7 1.9 7.3 10.5 59.4 17.0 8.9 4.6 1.1 2.3 25.7 29.1 9.4 12.8 3.5 5.6 17.2 3.3 6.9 10.2 14.0 69.8 9.5 6.5 4.8 49.4 0.1 6.2 3.2 11.3 15.4 17.8 0.0 1.9 15.6 7.5 1.8 0.0 1.6 1.8 3.5 5.0 0.0 98.3 57.4 0.0 24.5 69.5 17.2 7.8 0.4 0.3 0.0 0.0 25.3 3.1 7.3 0.0 19.1 14.2 0.0 0.6 0.0 0.2 0.0 26.6 0.0 0.0 41.7 1.1 8.5 16.2 10.3 0.3 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.9 0.0 19.8 0.0 3.7 0.0 3.9 3.3 0.1 1.2 0.5 0.0 0.0 1.0 1.7 0.0 0.0 8.1 0.2 5.8 0.0 0.2 0.0 0.0 1.2 0.0 8.9 0.9 7.5 15.6 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 1.8 1.1 0.1 0.0 1.6 55.8 56.2 4.7 29.5 55.6 30.6 59.4 17.0 29.1 49.4 0.0 0.6 0.0 10.4 11.6 0.0 0.8 0.0 2.7 10.3 0.0 0.0 0.5 1.7 1.3 1.0 1.7 5.1 0.0 2.5 0.3 45.6 9.6 0.0 0.0 3.3 0.0 0.0 3.1 3.3 1.5 35.9 2.5 13.5 12.6 3.7 1.1 1.7 0.0 66.4 0.0 0.0 0.0 7.2 0.0 2.4 8.2 0.7 0.0 4.0 5.5 LPAR2 "EDG-4, EDG4, LPA2" ENSG00000064547 "Lysophosphatidic acid receptor 2" Q9HBW0 19 19623668-19628930 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 32.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA019616 Approved NA NA "HPA019616: AB_1847988" "unprognostic (1.60e-2)" "unprognostic (1.83e-3)" "unprognostic (6.39e-2)" "unprognostic (1.19e-2)" "unprognostic (1.05e-1)" "unprognostic (2.29e-3)" "unprognostic (1.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.32e-1)" "unprognostic (1.05e-3)" "unprognostic (8.07e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.61e-7)" "prognostic favorable (1.43e-4)" "unprognostic (2.40e-1)" "unprognostic (5.87e-2)" "unprognostic (2.29e-2)" 3.4 1.2 2.2 12.6 1.9 26.1 4.6 1.3 2.4 6.5 7.9 1.4 13.8 5.1 2.4 3.9 10.5 4.4 17.9 1.9 2.2 4.0 7.0 2.4 11.0 17.7 2.4 1.1 6.1 27.3 7.4 4.0 4.2 2.7 8.2 4.3 7.4 12.3 12.3 1.6 7.2 16.4 1.1 2.8 31.4 19.2 43.7 1.1 18.5 23.2 10.0 21.1 4.9 4.1 3.8 1.1 6.7 1.0 1.7 15.9 4.1 12.8 1.4 15.3 3.4 4.0 2.0 13.2 0.8 1.2 0.6 1.1 9.2 12.4 8.3 8.6 1.2 0.8 13.6 2.3 4.6 0.6 3.5 3.9 1.9 2.6 0.7 0.5 3.1 32.0 2.1 11.6 0.6 0.9 2.1 0.3 4.1 1.8 3.3 0.5 21.0 1.8 5.1 15.2 17.4 5.9 8.2 1.2 3.7 9.4 19.0 5.4 10.2 3.4 2.8 2.0 8.8 7.2 19.6 3.8 3.0 2.5 5.3 1.2 1.5 4.3 2.8 0.6 22.4 1.4 0.1 0.6 2.2 6.1 0.7 11.2 3.8 14.0 8.0 0.4 2.0 12.8 9.2 6.7 1.7 1.0 1.1 15.9 4.1 2.2 1.9 1.3 2.4 2.2 4.0 2.4 1.1 2.7 1.1 3.0 11.1 4.2 8.9 5.6 0.4 1.2 7.6 4.0 5.7 7.0 2.0 0.7 3.3 12.1 0.3 0.7 9.3 0.0 17.2 5.0 1.3 10.5 3.5 0.4 2.3 1.6 2.4 1.8 5.4 1.3 0.6 4.7 0.0 6.4 10.0 5.8 13.8 6.8 0.4 0.6 1.3 0.0 0.9 1.1 3.7 4.4 0.1 13.8 7.8 9.5 LPAR3 "Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3" ENSG00000171517 "Lysophosphatidic acid receptor 3" Q9UBY5 1 84811602-84893213 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 32.0" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 13.1;Cardiomyocytes: 24.9;Ciliated cells: 25.4;Glandular cells: 15.0;Urothelial cells: 10.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 24.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 13.3;HBEC3-KT: 16.3;hTCEpi: 17.6;NTERA-2: 14.8;PC-3: 16.6;SK-MEL-30: 15.6" "Region enhanced" "Detected in some" "olfactory region: 3.5" "Low region specificity" "Detected in some" HPA013421 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA013421: AB_1847990" "unprognostic (2.85e-2)" "unprognostic (1.67e-1)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (2.72e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-1)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.31e-5)" "unprognostic (1.11e-2)" "unprognostic (7.52e-2)" "unprognostic (1.13e-4)" "unprognostic (4.11e-2)" "unprognostic (1.19e-1)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" 0.0 1.2 2.4 0.5 1.9 0.3 0.7 0.2 3.5 8.8 0.4 2.2 2.9 0.1 2.4 11.8 7.2 32.0 0.5 12.4 3.7 0.9 0.0 0.1 4.2 0.1 0.1 2.6 5.1 8.6 0.3 0.4 1.1 6.8 11.5 0.5 0.7 5.0 4.7 0.3 4.0 0.5 0.5 0.3 0.1 0.2 14.7 0.2 0.7 0.2 3.3 4.3 4.8 6.9 0.6 0.4 1.1 0.1 1.8 0.5 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.5 0.2 1.2 1.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 13.3 16.3 1.0 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.1 17.6 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 16.6 0.0 0.0 0.0 0.0 3.8 0.9 0.7 0.0 0.3 15.6 1.0 0.0 1.3 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.2 0.3 0.0 0.2 0.4 0.5 0.5 0.3 0.6 0.4 0.3 1.1 1.8 0.1 0.4 0.1 0.1 2.4 1.9 0.2 3.5 3.7 0.9 0.1 2.6 6.8 0.2 0.0 0.3 0.0 13.1 3.1 0.0 24.9 0.0 25.4 7.9 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 1.1 0.0 0.2 15.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.6 0.6 1.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 4.4 8.0 0.1 0.0 0.0 10.8 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;ovary: 10.0" "Cell type enriched" "Detected in some" 7 "Leydig cells: 18.7" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "basophil: 7.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.4" "Cell line enhanced" "Detected in some" "AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853" "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 1.5 0.2 6.0 1.0 2.1 0.6 2.0 4.9 3.7 1.8 0.9 7.4 0.7 0.2 2.9 0.8 1.8 1.1 2.1 1.9 15.8 1.4 0.3 0.3 0.3 0.2 2.4 4.0 10.0 0.7 0.1 0.7 0.2 3.6 0.6 1.2 0.5 1.0 1.6 0.2 1.6 0.9 1.3 3.8 0.4 1.5 0.8 5.6 0.0 0.6 0.8 1.2 1.4 0.9 0.0 0.5 7.4 0.0 0.0 0.0 0.1 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.6 1.1 1.4 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.7 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.1 2.3 0.0 0.5 1.8 16.7 0.0 0.2 0.9 7.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 2.7 0.0 0.0 0.2 0.0 0.7 1.4 0.0 0.7 0.7 4.0 1.6 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 6.0 2.1 4.9 3.5 15.8 1.4 2.4 4.0 3.6 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.7 0.0 1.7 1.0 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 LPAR5 "GPR92, GPR93, KPG_010, LPA5" ENSG00000184574 "Lysophosphatidic acid receptor 5" Q9H1C0 12 6618835-6636447 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 28.4;brain: 20.3;esophagus: 21.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;Enterocytes: 15.1;granulocytes: 16.1;Hofbauer cells: 29.9;Paneth cells: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 28.4;T-cells: 23.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HEL: 13.9;HMC-1: 20.2;K-562: 10.3;U-698: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013170 Approved NA NA "HPA013170: AB_1849314" "unprognostic (1.94e-1)" "unprognostic (6.43e-2)" "unprognostic (1.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (1.37e-1)" "unprognostic (5.95e-2)" "unprognostic (3.45e-1)" "unprognostic (1.41e-2)" "unprognostic (3.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.27e-2)" "unprognostic (7.99e-3)" "unprognostic (5.43e-1)" "prognostic favorable (6.56e-5)" "unprognostic (7.43e-2)" 2.1 3.2 11.2 5.6 12.4 1.1 1.6 1.3 8.9 5.8 10.2 20.3 0.5 11.2 0.7 3.2 21.1 2.0 1.9 3.6 10.9 4.0 1.3 1.5 2.1 9.2 9.3 4.0 0.9 0.8 0.9 1.4 7.2 9.2 1.7 9.7 1.7 6.3 1.6 0.3 6.8 9.3 1.3 11.7 10.6 8.3 1.7 13.6 2.2 2.0 1.1 13.5 3.4 9.0 28.4 5.5 2.5 1.8 1.3 23.9 6.5 4.1 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 7.6 3.2 1.0 0.0 0.1 5.3 0.0 2.2 0.0 0.0 0.0 13.9 0.4 0.3 0.0 0.0 20.2 0.0 2.6 0.1 1.1 0.0 0.0 3.0 10.3 0.0 0.0 0.3 0.4 4.3 0.0 6.7 0.7 3.6 0.0 0.0 0.0 2.4 0.1 0.1 2.1 0.0 0.0 0.8 0.0 1.6 0.1 0.0 3.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 2.5 0.1 0.0 23.9 1.0 18.0 28.4 4.0 14.1 5.5 27.8 4.0 8.9 0.2 1.3 1.8 0.3 5.4 6.5 11.2 12.4 1.3 8.9 10.9 4.0 9.3 4.0 9.2 13.6 0.0 0.0 17.5 0.5 1.3 0.0 1.6 0.0 0.0 2.3 1.8 0.0 0.2 0.0 0.4 2.2 0.0 15.1 0.0 0.8 0.2 0.6 0.6 16.1 0.0 29.9 0.0 1.2 0.6 10.7 13.0 0.0 3.7 0.0 6.4 10.6 0.0 5.5 15.8 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.1 0.5 6.9 9.1 1.7 LPAR6 "P2RY5, P2Y5" ENSG00000139679 "Lysophosphatidic acid receptor 6" P43657 13 48389567-48444704 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 54.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 329.7;Late spermatids: 239.9;Macrophages: 212.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.4;HUVEC TERT2: 21.7;MOLT-4: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028934 Approved NA NA "HPA028934: AB_2672833" "unprognostic (1.19e-1)" "unprognostic (4.10e-1)" "unprognostic (8.82e-2)" "unprognostic (9.30e-3)" "unprognostic (2.31e-1)" "unprognostic (5.57e-2)" "unprognostic (7.40e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.07e-2)" "unprognostic (8.00e-2)" "unprognostic (2.63e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.60e-4)" "unprognostic (6.54e-2)" "unprognostic (3.81e-2)" "unprognostic (2.09e-2)" "unprognostic (1.94e-2)" 10.9 6.0 7.6 5.3 10.0 0.3 11.0 5.4 10.6 8.7 4.5 11.1 2.9 2.7 6.5 9.7 25.6 4.9 8.0 5.6 8.4 4.1 7.6 4.7 9.6 9.4 7.9 10.9 3.7 2.9 2.0 4.8 18.7 14.1 17.7 6.3 5.9 18.3 7.8 3.4 7.5 5.5 6.0 17.4 9.4 4.4 54.2 12.6 2.9 7.3 2.9 9.1 9.6 21.3 0.3 7.3 1.6 31.0 1.8 23.0 16.3 0.0 1.2 13.4 0.0 4.4 5.5 0.1 2.7 7.8 0.5 1.6 0.0 4.0 0.0 0.0 2.9 0.0 7.8 0.4 4.3 0.2 0.0 2.6 0.1 0.1 9.6 3.0 0.0 0.1 7.3 7.8 0.4 4.4 0.0 21.7 4.2 0.0 0.2 2.6 0.0 11.8 3.7 5.3 0.2 3.6 10.2 0.0 0.1 3.7 8.0 0.0 0.0 0.0 0.0 2.6 8.6 1.4 0.1 5.6 1.5 0.0 0.1 0.7 0.0 0.0 0.0 0.4 0.6 4.8 0.3 20.8 0.0 7.6 31.0 4.1 0.3 21.5 9.0 7.3 0.1 15.5 4.8 1.6 1.8 26.6 0.3 23.0 16.3 7.6 10.0 5.4 10.6 8.4 4.1 7.9 10.9 14.1 12.6 3.0 11.9 12.6 163.9 107.2 1.5 3.6 17.8 32.1 33.0 5.2 0.0 0.9 0.0 7.7 329.7 100.6 4.1 0.0 3.6 0.9 17.8 82.2 7.0 2.4 67.9 0.0 20.5 130.8 61.7 239.9 21.0 212.7 47.2 78.5 4.5 8.8 4.9 0.0 14.9 21.8 1.1 12.9 15.6 2.7 1.7 125.0 0.7 58.9 7.3 144.8 LPCAT1 "AGPAT10, AGPAT9, AYTL2, FLJ12443" ENSG00000153395 "Lysophosphatidylcholine acyltransferase 1" Q8NF37 5 1456480-1523977 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 35.6" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 286.5;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 34.9;EFO-21: 33.5;PC-3: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012501, HPA022268" Enhanced Supported "Endoplasmic reticulum,Lipid droplets" NA NA "Endoplasmic reticulum" "Lipid droplets" "HPA012501: AB_1845224, HPA022268: AB_1845225" "unprognostic (5.33e-3)" "prognostic unfavorable (7.11e-5)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.67e-4)" "unprognostic (3.13e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (1.88e-8)" "unprognostic (5.90e-2)" "unprognostic (6.37e-2)" "unprognostic (2.08e-2)" "prognostic favorable (4.90e-5)" "unprognostic (4.89e-2)" "prognostic unfavorable (2.64e-7)" "unprognostic (2.60e-1)" "unprognostic (3.13e-1)" "unprognostic (1.52e-1)" "unprognostic (4.03e-1)" 9.8 5.6 5.2 9.0 5.7 5.1 7.4 9.2 9.5 5.4 7.5 2.9 4.5 3.9 7.0 3.2 3.2 5.9 5.8 4.3 5.3 5.2 4.9 3.1 35.6 8.5 3.2 3.7 5.0 5.4 3.1 5.6 10.0 4.6 5.2 2.3 13.6 4.5 4.4 3.5 3.2 5.9 5.5 3.3 28.8 9.4 3.0 2.9 5.8 4.7 1.4 8.1 6.6 10.6 0.9 0.7 2.4 1.7 1.7 3.6 0.6 2.0 3.0 0.5 3.3 0.3 0.5 34.9 7.8 0.4 0.4 0.3 1.1 0.9 6.8 33.5 0.2 1.4 5.8 0.6 0.2 0.2 16.5 14.2 1.6 4.9 2.0 0.6 1.7 4.6 0.6 0.1 0.3 0.1 0.5 0.4 2.3 3.7 1.3 0.0 4.3 6.4 2.6 12.3 0.1 23.3 12.3 0.6 4.9 1.4 2.8 4.4 4.3 6.2 5.7 1.8 0.3 2.6 2.7 3.9 0.6 7.7 2.3 2.8 4.4 4.2 1.6 1.4 2.8 2.1 0.0 0.6 0.8 3.6 1.7 3.6 0.9 0.8 1.8 0.7 0.7 0.1 1.0 2.4 1.7 1.2 0.2 0.8 0.6 5.2 5.7 9.2 8.0 5.3 5.2 3.2 3.7 4.6 2.9 80.4 286.5 25.1 1.9 5.6 52.2 3.2 7.6 5.3 21.6 14.0 137.4 5.1 0.0 16.9 1.5 10.3 2.6 0.0 11.7 67.8 9.3 5.6 8.1 4.0 21.8 22.3 14.3 18.4 26.3 1.5 10.0 16.2 6.8 10.8 9.0 28.2 22.2 0.0 14.5 4.4 124.0 0.0 12.3 1.7 9.8 3.4 26.5 26.7 2.5 1.6 LPCAT3 "C3F, MBOAT5, nessy, OACT5" ENSG00000111684 "Lysophosphatidylcholine acyltransferase 3" Q6P1A2 12 6976186-7018510 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 85.5;liver: 78.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.74e-1)" "unprognostic (3.33e-2)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (6.72e-2)" "unprognostic (3.86e-1)" "unprognostic (2.40e-2)" "unprognostic (6.90e-2)" "unprognostic (1.88e-1)" "unprognostic (5.00e-3)" "unprognostic (2.06e-1)" "unprognostic (2.58e-2)" "prognostic favorable (4.89e-5)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (6.49e-3)" "unprognostic (1.23e-1)" 16.4 24.4 4.2 8.8 5.0 8.1 15.1 15.7 5.4 7.9 37.5 6.1 8.1 43.4 8.2 7.8 13.6 9.1 11.3 20.2 4.1 2.7 37.3 78.2 20.3 17.9 5.2 5.3 13.9 38.7 4.6 9.4 29.0 4.8 13.7 17.2 8.3 22.2 8.2 19.4 13.3 85.5 12.4 4.9 11.3 22.8 7.6 4.0 14.1 14.6 10.3 13.7 15.7 8.5 5.3 13.9 32.3 33.7 11.5 10.8 12.4 6.2 11.6 5.0 14.1 35.4 16.7 10.8 3.6 15.5 10.0 17.1 24.7 32.7 6.8 2.1 5.8 21.4 15.8 6.0 13.4 7.8 16.7 7.3 13.7 10.3 22.1 7.6 7.0 14.7 26.3 7.8 9.6 4.8 6.4 9.3 10.5 7.3 4.9 6.5 9.5 8.6 8.7 16.8 22.4 6.8 9.1 7.1 7.0 12.3 48.9 4.4 4.2 21.9 33.9 2.4 16.5 3.4 9.9 3.8 6.2 9.3 10.9 2.6 6.2 4.4 10.0 7.7 7.4 5.4 13.9 20.8 32.3 8.6 30.0 10.0 5.0 9.0 9.7 13.9 5.3 8.5 8.7 20.0 11.5 33.7 7.9 10.8 12.4 4.2 5.0 15.7 5.4 4.1 2.7 5.2 5.3 4.8 4.0 65.5 29.7 4.5 32.1 20.9 5.2 0.4 15.3 13.4 23.9 19.2 0.0 71.1 10.0 25.0 1.5 9.8 66.7 0.0 29.4 45.9 18.4 22.1 13.9 52.5 36.0 11.1 41.5 14.1 18.0 1.2 17.0 13.7 6.8 16.2 22.8 12.3 18.9 24.6 6.0 34.4 3.9 19.4 9.4 14.6 30.6 19.4 55.5 13.8 32.4 25.1 LPGAT1 "FAM34A, FAM34A1, KIAA0205, NET8" ENSG00000123684 "Lysophosphatidylglycerol acyltransferase 1" Q92604 1 211743457-211830772 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 75.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 288.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.60e-2)" "unprognostic (1.04e-1)" "unprognostic (3.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.36e-1)" "unprognostic (1.66e-1)" "unprognostic (9.47e-3)" "unprognostic (1.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (3.70e-2)" 15.9 17.4 11.8 10.7 20.3 14.9 16.5 12.3 22.7 10.5 13.3 25.9 9.9 19.5 7.9 9.4 6.7 7.5 10.4 9.7 15.1 13.6 8.6 75.6 9.6 13.8 19.0 11.9 6.1 13.1 15.1 9.0 7.7 15.5 9.5 9.0 21.8 9.0 15.6 8.3 5.2 39.8 10.3 16.0 13.3 6.4 17.5 18.9 5.1 22.1 3.9 8.0 9.2 6.9 1.6 2.7 13.4 2.3 4.5 1.2 0.7 14.7 16.3 5.4 12.8 9.7 13.7 7.7 10.6 16.9 9.9 9.2 4.8 12.4 6.0 6.2 16.4 11.1 8.1 18.0 9.5 12.6 11.8 6.1 6.3 13.7 11.0 11.7 15.6 10.9 8.0 11.7 9.1 12.0 18.3 11.9 8.8 7.2 0.1 13.1 4.6 5.9 5.8 5.9 6.4 2.7 14.3 21.3 1.8 11.0 12.3 31.2 16.2 17.4 18.5 18.1 8.7 9.4 10.2 11.4 18.1 8.0 16.6 17.2 8.9 10.9 16.3 9.0 13.3 12.4 9.5 2.3 13.4 1.2 1.9 1.0 1.6 0.8 0.9 2.7 1.0 0.2 0.7 10.4 4.5 1.3 2.1 0.2 0.7 11.8 20.3 12.3 22.7 15.1 13.6 19.0 11.9 15.5 18.9 26.8 18.9 11.0 47.5 10.9 140.9 25.4 73.9 37.5 18.2 12.2 58.9 1.6 1.7 53.5 288.3 27.4 28.8 0.0 50.8 3.5 14.7 35.8 12.7 49.1 18.6 33.4 13.2 21.5 35.6 39.3 43.7 26.7 28.7 19.8 12.2 31.9 50.2 16.9 52.3 18.6 121.2 19.4 20.6 61.8 32.6 6.6 0.9 16.6 19.1 57.7 LPIN1 KIAA0188 ENSG00000134324 "Lipin 1" Q14693 2 11677595-11827409 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.4" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1310.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024591, HPA038021" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA024591: , HPA038021: AB_10669514" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (9.17e-2)" "unprognostic (2.69e-2)" "unprognostic (8.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (2.45e-3)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.58e-3)" "unprognostic (1.25e-1)" "unprognostic (9.60e-2)" "unprognostic (4.02e-1)" 18.1 10.1 13.0 10.7 18.3 6.0 22.1 20.0 16.4 10.5 8.6 10.9 7.3 8.9 11.0 15.0 20.0 7.0 10.4 12.8 11.6 11.9 7.6 13.2 8.0 15.4 13.2 11.2 19.3 7.5 17.2 32.0 9.0 17.9 9.6 7.1 9.0 14.4 11.6 88.4 6.5 9.2 11.0 10.3 8.4 7.6 39.0 13.2 8.3 8.1 14.0 19.2 10.4 21.7 6.5 9.6 11.6 2.8 8.0 11.1 3.2 5.5 6.6 5.5 12.3 25.5 28.4 2.8 7.8 13.4 5.0 8.7 2.4 5.5 2.7 1.0 6.6 14.8 6.0 6.2 17.0 4.6 11.4 3.4 6.8 3.7 3.5 9.0 4.7 32.1 25.6 7.7 20.8 7.9 14.7 9.7 6.7 9.4 24.7 3.7 2.1 4.4 4.1 5.7 1.8 6.7 6.1 10.1 17.3 12.7 3.6 15.3 12.1 2.8 6.8 17.5 5.5 1.7 2.6 6.8 8.0 7.2 5.1 6.7 38.8 30.0 5.2 11.3 8.4 5.9 9.5 2.8 11.6 10.3 2.1 11.1 6.5 9.6 9.7 2.5 5.0 8.4 7.1 1.1 8.0 2.1 9.6 10.5 3.2 13.0 18.3 20.0 14.4 11.6 11.9 13.2 11.2 17.9 13.2 20.8 49.1 22.9 38.9 16.9 40.6 49.5 25.5 61.6 63.7 10.4 80.5 7.3 6.6 18.7 314.7 24.6 9.7 0.0 24.2 5.3 24.6 29.2 33.6 21.9 8.1 46.1 34.7 15.4 15.7 1310.7 110.1 27.2 16.9 7.2 23.9 16.4 25.5 11.6 169.0 3.4 47.2 32.3 20.6 18.4 17.8 10.5 10.3 57.5 13.6 26.8 LPIN2 KIAA0249 ENSG00000101577 "Lipin 2" Q92539 18 2916994-3013315 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 83.9" "Cell type enhanced" "Detected in all" 5 "Cholangiocytes: 140.1;Hepatocytes: 111.5;Horizontal cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015223, HPA017857, HPA030550" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" Yes No Cytosol "Plasma membrane, Actin filaments" "CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519" "unprognostic (7.03e-2)" "unprognostic (1.05e-1)" "unprognostic (2.88e-1)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "prognostic favorable (8.01e-4)" "unprognostic (9.85e-3)" "unprognostic (1.89e-2)" "unprognostic (1.03e-2)" "unprognostic (3.44e-3)" "unprognostic (3.19e-1)" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (4.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.49e-1)" "unprognostic (7.11e-2)" 6.8 5.6 13.0 10.5 18.4 9.2 7.7 11.9 16.5 6.6 25.2 10.4 2.4 31.6 6.7 3.9 5.9 6.3 14.3 5.1 11.0 14.5 20.7 83.9 11.8 11.8 11.2 9.8 8.8 9.0 9.7 8.2 16.3 15.3 5.8 7.4 6.8 4.4 5.3 2.2 2.7 43.3 6.1 9.6 10.7 15.6 13.5 9.6 6.3 7.5 1.5 10.0 6.8 6.7 1.2 1.1 20.8 2.0 10.1 9.5 2.1 4.9 6.7 10.6 3.7 18.4 17.1 6.3 12.0 14.6 11.9 11.6 8.7 4.2 3.6 7.3 18.3 18.6 0.2 8.7 3.7 9.4 7.0 1.8 9.2 5.2 9.9 17.2 7.3 10.2 17.2 2.5 11.8 10.3 17.3 14.8 8.8 8.3 1.9 16.7 3.7 9.1 6.3 3.4 7.4 9.6 16.1 9.2 13.4 9.5 11.1 9.0 6.2 11.2 5.3 3.8 6.4 0.0 10.1 20.8 15.4 18.7 19.7 8.8 3.5 5.3 7.8 13.6 7.5 5.4 6.5 2.0 6.1 9.3 1.3 9.5 0.9 7.1 5.3 0.8 1.2 7.3 4.7 20.8 10.1 0.6 1.1 6.3 2.1 13.0 18.4 11.9 16.5 11.0 14.5 11.2 9.8 15.3 9.6 62.5 38.2 16.9 8.2 4.9 31.9 10.4 140.1 21.4 35.2 36.6 13.7 17.4 14.9 9.7 2.1 17.5 52.0 46.7 16.6 9.6 15.9 14.5 11.6 111.5 19.6 109.7 14.3 20.3 21.0 6.9 21.0 19.9 8.5 24.4 30.3 16.0 18.6 10.5 29.4 40.8 14.8 6.5 9.9 28.8 59.6 1.8 41.4 39.9 11.9 3.4 LPIN3 "LIPN3L, SMP2" ENSG00000132793 "Lipin 3" Q9BQK8 20 41340920-41360582 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 49.9;Late spermatids: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 6.3" "Group enriched" "Detected in many" 4 "granulocytes: 1.8;NK-cells: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" "HPA051466, HPA052667, HPA070640" Approved Supported Cytosol NA NA Cytosol "HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288" "unprognostic (2.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (6.91e-3)" "unprognostic (4.26e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.74e-4)" "unprognostic (4.29e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (5.60e-3)" "unprognostic (2.02e-1)" "unprognostic (1.35e-1)" "unprognostic (3.37e-3)" 11.6 3.7 3.0 8.1 5.2 0.1 23.4 1.5 3.0 10.9 29.2 2.8 13.5 26.8 12.8 21.6 16.3 7.5 11.2 8.8 3.6 0.7 28.2 14.4 4.5 1.6 2.8 3.7 7.9 7.4 8.1 6.7 4.4 4.2 10.1 8.8 8.7 11.0 15.1 1.8 26.1 49.1 5.5 2.4 2.7 7.4 2.5 1.5 1.2 14.2 10.6 9.0 8.0 12.5 0.9 0.7 1.8 0.9 6.3 0.8 0.2 6.9 6.8 0.4 4.1 11.2 17.5 5.3 4.3 6.0 5.3 7.2 12.7 6.2 0.3 5.4 9.4 5.6 17.7 2.1 11.2 3.3 0.1 4.0 0.3 9.6 6.4 1.8 0.0 4.8 12.6 14.3 8.9 3.5 6.2 1.3 0.1 1.8 0.2 6.6 14.9 0.0 0.1 0.6 4.3 7.1 0.0 0.1 0.5 18.4 8.8 0.5 0.1 5.7 7.4 3.6 3.5 8.6 3.5 0.4 0.3 1.7 5.9 0.0 3.4 1.8 0.0 0.1 0.1 0.3 1.8 0.5 0.7 0.5 0.5 0.8 0.6 0.7 0.4 0.3 0.9 0.7 0.6 1.8 6.3 0.9 0.7 0.5 0.2 3.0 5.2 1.5 3.0 3.6 0.7 2.8 3.7 4.2 1.5 6.0 10.5 0.8 8.2 12.8 0.0 0.6 10.2 1.4 4.5 10.4 0.0 2.3 5.0 7.4 10.4 2.1 49.9 0.0 3.3 2.2 7.7 3.5 1.1 33.7 2.7 0.0 14.3 4.3 1.3 82.8 2.8 1.5 10.1 0.0 16.6 7.5 5.5 21.6 2.5 5.9 0.3 32.3 6.4 0.9 2.1 11.0 2.2 1.3 16.2 3.9 LPL LIPD ENSG00000175445 "Lipoprotein lipase" P06858 8 19901717-19967258 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation, FDA approved drug targets, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8" "Cancer enhanced" "Detected in all" "glioma: 39.2" "Region enhanced" "Detected in many" "basal ganglia: 16.3" "Cell type enhanced" "Detected in some" "non-classical monocyte: 7.1" "Lineage enriched" "Detected in many" 5 "monocytes: 7.1" "Cell line enriched" "Detected in some" 5 "AF22: 91.4" "Region enhanced" "Detected in many" "basal ganglia: 40.6" "Region enriched" "Detected in many" 4 "basal ganglia: 64.0" HPA048749 Supported Vesicles "Secreted to blood" NA NA 880000 Vesicles "HPA048749: AB_2680511" "unprognostic (5.52e-2)" "unprognostic (3.16e-1)" "unprognostic (6.41e-2)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-4)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (8.20e-2)" "unprognostic (2.54e-2)" "unprognostic (5.28e-1)" "unprognostic (1.18e-1)" "unprognostic (4.20e-3)" "unprognostic (4.16e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.07e-4)" 178.6 4.3 2.0 11.4 16.3 0.6 146.2 3.9 8.0 1.0 16.9 0.3 27.3 0.8 1.3 1.1 1.1 0.7 8.2 121.4 2.8 2.3 4.8 0.6 20.7 7.0 4.5 0.7 2.7 1.8 32.6 0.9 7.1 1.7 0.9 1.8 8.4 9.2 85.1 53.8 1.8 3.1 1.3 2.8 0.8 1.8 0.7 3.4 0.0 2.7 9.7 1.0 3.2 6.1 0.0 0.7 1.3 7.1 0.0 0.1 0.4 0.0 0.0 91.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 14.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.4 0.0 1.6 1.3 0.0 2.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.4 2.0 16.3 3.9 2.3 2.8 2.3 4.5 0.7 1.7 3.4 11.9 93.6 0.0 0.1 1.3 1.0 482.3 0.0 5.3 1.2 0.0 2.0 0.3 13.3 0.0 0.6 5.4 0.0 0.0 0.0 0.6 3.1 0.3 5.8 0.0 114.1 195.5 0.0 4.3 13.4 1.0 1.1 23.8 13.5 2.8 0.0 1.7 0.0 0.0 0.0 0.0 2.2 232.8 19.1 0.3 0.2 0.5 0.3 0.0 0.0 0.1 LPO SPO ENSG00000167419 Lactoperoxidase P22079 17 58218548-58268518 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrogen peroxide" "Antimicrobial, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 262 "salivary gland: 345.7" "Group enriched" "Detected in some" 5 "Early spermatids: 5.0;Late spermatids: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "THP-1: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA028688 Enhanced Supported "Secreted to digestive system" NA NA "HPA028688: AB_10601909" "unprognostic (2.74e-1)" "unprognostic (5.12e-2)" "unprognostic (4.14e-3)" "unprognostic (1.56e-3)" "unprognostic (2.41e-2)" "unprognostic (9.71e-2)" "unprognostic (2.06e-2)" "unprognostic (1.53e-1)" "unprognostic (2.40e-2)" "unprognostic (6.27e-3)" "unprognostic (6.32e-2)" "unprognostic (2.56e-1)" "unprognostic (0.00e+0)" "unprognostic (3.41e-2)" "unprognostic (3.15e-1)" "unprognostic (2.72e-2)" "unprognostic (1.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.2 0.0 0.0 1.2 0.8 1.3 0.7 0.8 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.0 1.5 0.0 0.9 0.7 0.4 0.6 0.3 0.5 0.9 0.7 0.6 0.2 1.2 0.6 0.9 1.3 0.8 0.3 0.8 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.7 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 1.1 0.0 0.2 1.6 0.0 0.6 0.0 10.6 0.3 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.4 LPP ENSG00000145012 "LIM domain containing preferred translocation partner in lipoma" Q93052 3 188153284-188890671 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 127.8;urinary bladder: 105.1" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 514.4;Late spermatids: 1329.9;Smooth muscle cells: 529.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 18.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.5;EFO-21: 36.6;U-698: 61.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011133, HPA017342" Enhanced Enhanced "Focal adhesion sites,Cytosol" NA NA 520000 "Focal adhesion sites, Cytosol" "HPA011133: AB_1853247, HPA017342: AB_1853249" "unprognostic (1.50e-1)" "unprognostic (4.97e-3)" "unprognostic (1.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.86e-1)" "unprognostic (4.05e-1)" "unprognostic (2.43e-3)" "unprognostic (7.97e-2)" "unprognostic (2.17e-1)" "unprognostic (5.56e-2)" "unprognostic (3.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.57e-3)" "unprognostic (2.25e-2)" "unprognostic (6.86e-2)" "unprognostic (2.82e-3)" "unprognostic (1.48e-1)" 19.6 4.2 2.7 29.5 2.8 3.1 12.5 3.0 2.7 42.2 29.9 2.1 19.6 5.0 68.6 14.9 59.7 10.0 37.9 9.3 2.6 2.8 10.9 5.3 11.4 6.0 2.8 1.6 26.1 4.4 4.7 3.2 5.2 3.0 37.7 12.8 8.5 7.0 28.4 11.6 5.9 17.2 127.8 3.2 9.5 12.1 30.7 1.5 5.1 5.4 4.2 7.8 105.1 38.3 5.9 4.9 18.0 4.5 4.3 5.0 1.4 7.7 7.1 5.2 3.5 11.3 11.7 5.6 5.1 6.5 3.7 2.5 12.9 3.7 29.5 36.6 11.4 4.6 3.3 1.5 3.4 9.4 3.2 1.7 1.4 5.5 3.4 4.8 0.6 1.7 8.3 4.8 8.3 7.2 5.4 6.2 1.6 0.0 0.6 6.5 2.4 1.5 0.6 2.1 4.9 2.3 1.9 3.9 0.1 4.1 8.2 0.3 0.0 10.9 3.6 6.1 9.0 2.8 2.4 13.4 8.6 6.6 6.1 12.5 0.0 1.1 61.0 4.3 1.3 7.7 0.8 4.5 1.9 5.0 4.2 3.2 2.9 4.3 3.6 2.4 5.9 2.3 2.9 18.0 4.3 4.0 4.9 1.6 1.4 2.7 2.8 3.0 2.7 2.6 2.8 2.8 1.6 3.0 1.5 83.4 55.0 41.3 72.1 69.3 7.7 101.6 99.3 40.2 83.0 66.3 13.7 35.7 24.9 114.3 514.4 83.0 142.7 23.3 78.6 20.6 102.9 124.2 17.4 84.7 36.8 4.8 74.4 114.2 61.5 1329.9 208.5 76.2 75.9 36.1 86.3 27.1 104.6 158.4 448.3 61.0 7.4 329.8 529.6 8.1 6.6 59.6 15.6 39.5 123.5 109.3 LPXN LDPL ENSG00000110031 Leupaxin O60711 11 58526871-58578220 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.0;lymphoid tissue: 75.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 51.8;Kupffer cells: 53.4;Macrophages: 67.3;T-cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 40.0;HMC-1: 67.0;Karpas-707: 57.4;U-2197: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043741, CAB046478, HPA061441" Enhanced Supported "Nuclear speckles,Focal adhesion sites,Cytosol" No No "Focal adhesion sites" "Nuclear speckles, Cytosol" "CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518" "unprognostic (1.61e-3)" "unprognostic (6.91e-2)" "unprognostic (6.54e-2)" "prognostic favorable (8.81e-4)" "unprognostic (5.16e-2)" "unprognostic (2.07e-3)" "unprognostic (2.16e-2)" "unprognostic (8.87e-3)" "unprognostic (5.18e-2)" "unprognostic (3.96e-2)" "unprognostic (2.39e-2)" "unprognostic (3.05e-1)" "unprognostic (3.60e-3)" "unprognostic (1.91e-1)" "unprognostic (5.25e-2)" "unprognostic (2.55e-1)" "unprognostic (2.41e-3)" 16.3 5.6 5.1 34.2 4.7 4.2 5.1 3.5 4.9 4.4 6.7 9.0 4.1 5.1 6.5 5.9 3.8 4.7 7.2 3.9 5.2 5.1 6.3 7.1 19.7 37.2 6.3 2.5 6.6 5.6 3.9 4.8 2.6 5.0 5.7 9.6 6.2 7.6 5.1 2.1 3.7 16.0 4.7 11.4 32.2 5.7 5.9 4.9 75.1 6.8 4.4 52.9 11.2 3.9 19.9 36.5 3.8 19.1 20.1 42.0 20.9 0.3 0.4 0.4 0.7 1.5 1.9 0.2 10.0 40.0 2.5 4.5 0.0 1.0 29.2 0.4 12.1 1.8 0.3 0.3 27.2 10.5 12.7 0.1 1.3 0.2 0.1 2.6 7.9 67.0 1.5 0.6 34.5 4.5 2.4 16.1 17.9 0.3 57.4 20.2 0.2 27.6 9.9 0.3 0.4 9.1 0.4 0.5 25.1 1.6 14.0 0.2 0.3 0.4 0.6 3.9 0.6 0.5 2.3 15.7 6.3 1.8 40.3 8.9 3.7 3.5 28.7 14.6 7.1 14.2 1.7 19.1 3.1 28.2 11.0 42.0 19.9 29.0 32.4 36.5 11.5 22.6 26.8 3.8 20.1 5.6 33.1 38.7 20.9 5.1 4.7 3.5 4.9 5.2 5.1 6.3 2.5 5.0 4.9 0.0 7.0 47.0 4.0 8.7 3.4 1.6 0.0 4.0 2.3 0.0 3.9 2.3 3.3 2.2 22.9 8.0 4.7 0.0 4.9 1.1 4.5 3.3 51.8 6.7 46.1 1.6 5.8 2.5 53.4 6.2 1.7 67.3 18.6 36.9 2.9 4.1 2.8 4.9 3.5 4.2 4.7 6.5 4.1 7.4 4.1 8.4 2.1 74.6 5.2 26.4 LRAT LCA14 ENSG00000121207 "Lecithin retinol acyltransferase" O95237 4 154626945-154753118 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "Acyltransferase, Transferase" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 82.4" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 7.6;Early spermatids: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "NTERA-2: 16.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA070726 Uncertain "Endoplasmic reticulum,Golgi apparatus" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA070726: " "unprognostic (3.64e-3)" "unprognostic (1.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (4.75e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (2.65e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-4)" "unprognostic (4.49e-6)" "unprognostic (6.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.98e-1)" 0.9 0.8 2.2 0.8 3.2 1.8 1.4 0.7 1.1 0.9 4.2 3.0 0.8 3.7 0.5 1.2 0.5 0.9 2.3 0.6 3.1 4.2 0.6 3.3 1.0 0.5 2.9 2.4 1.0 2.9 0.3 1.0 0.3 8.9 1.6 0.4 82.4 0.5 1.6 2.3 1.4 11.1 0.3 7.0 0.7 0.9 2.9 3.1 0.0 4.9 0.2 0.6 0.5 0.7 0.9 3.7 2.0 4.5 0.6 0.3 3.9 0.7 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.2 0.0 0.0 0.1 0.8 0.6 0.1 0.1 0.2 0.5 0.4 0.3 0.1 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.3 16.5 0.0 0.0 0.1 0.0 0.1 2.0 0.5 0.1 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.0 0.4 0.2 0.6 0.1 0.1 0.0 0.0 0.0 0.2 0.5 1.0 4.5 0.4 0.3 1.6 0.3 0.5 0.3 0.3 3.7 0.9 0.3 0.3 2.0 0.6 0.5 0.5 0.2 3.9 2.2 3.2 0.7 1.1 3.1 4.2 2.9 2.4 8.9 3.1 0.0 4.1 0.0 4.2 1.0 0.8 0.2 7.6 0.0 1.2 0.0 0.0 0.1 3.3 0.8 7.2 0.2 2.0 0.0 0.7 0.1 0.3 2.4 0.0 2.0 0.1 0.0 0.0 1.8 0.0 1.6 0.0 0.0 5.0 0.0 0.7 3.7 1.4 0.0 0.0 0.3 0.9 0.0 0.1 4.8 4.5 1.0 0.2 0.7 0.3 0.6 LRCOL1 ENSG00000204583 "Leucine rich colipase like 1" A6NCL2 12 132603150-132610543 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "epididymis: 54.8" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 39.8" "Cancer enhanced" "Detected in some" "liver cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0" "Secreted in male reproductive system" NA NA "unprognostic (5.09e-3)" "unprognostic (7.83e-3)" "unprognostic (3.26e-1)" "unprognostic (6.94e-2)" "unprognostic (3.15e-2)" "unprognostic (2.38e-2)" "prognostic favorable (7.04e-4)" "unprognostic (4.54e-2)" "unprognostic (6.08e-2)" "unprognostic (5.29e-2)" "unprognostic (4.66e-3)" "unprognostic (1.52e-1)" "unprognostic (6.50e-6)" "unprognostic (1.46e-3)" "unprognostic (9.63e-2)" "unprognostic (3.31e-1)" "unprognostic (4.00e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.4 0.1 0.0 54.8 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.5 1.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 0.0 3.1 1.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 LRFN1 "KIAA1484, SALM2" ENSG00000128011 "Leucine rich repeat and fibronectin type III domain containing 1" Q9P244 19 39306568-39315336 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.5" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 22.8;Cone photoreceptor cells: 7.9;Muller glia cells: 7.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.9;HEK 293: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.92e-3)" "unprognostic (2.00e-1)" "unprognostic (6.36e-4)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.87e-2)" "unprognostic (6.75e-2)" "unprognostic (4.25e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.45e-3)" "unprognostic (1.08e-1)" "unprognostic (0.00e+0)" "unprognostic (1.89e-3)" "unprognostic (2.10e-2)" "unprognostic (1.31e-3)" "unprognostic (1.78e-1)" 1.6 0.3 5.5 1.3 3.4 1.1 0.6 9.5 9.0 0.4 0.6 1.0 1.2 1.4 0.2 0.6 0.3 0.2 5.2 6.6 0.3 0.5 0.9 1.0 2.9 0.3 2.0 0.2 0.1 0.5 1.1 0.4 2.0 0.3 0.2 1.4 1.5 0.7 1.0 3.8 0.7 0.6 0.3 0.6 0.2 0.0 0.3 0.4 3.2 0.8 1.8 1.0 0.0 1.1 4.7 0.1 4.1 0.0 0.0 5.1 0.1 0.0 0.3 0.1 14.9 0.6 0.4 2.0 0.0 1.2 0.2 1.9 0.1 0.1 0.4 18.2 0.8 0.7 0.6 0.1 0.3 3.9 0.3 0.2 0.1 0.0 0.4 0.1 5.5 7.5 0.4 0.0 2.4 1.9 2.3 2.0 1.5 5.0 6.4 0.0 1.6 0.0 0.2 1.4 7.3 1.6 3.1 1.2 0.4 1.5 1.5 0.3 1.7 5.9 1.4 0.1 0.7 0.2 1.8 0.1 0.9 0.5 1.7 0.3 3.2 1.0 0.2 0.9 0.1 0.4 1.0 0.0 0.3 0.5 0.7 2.6 1.8 0.8 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.7 22.8 0.8 2.5 0.0 0.0 0.0 7.9 0.4 0.0 0.2 0.0 1.0 0.0 0.0 0.6 0.4 1.0 0.4 0.0 0.8 0.8 3.2 0.0 2.5 4.0 0.0 0.0 0.7 0.0 1.0 0.0 7.5 0.2 0.0 2.5 0.0 2.3 0.0 0.1 0.9 0.7 0.4 0.7 3.1 0.0 0.1 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391586-40587465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.7" "Cell type enriched" "Detected in some" 5 "Cone photoreceptor cells: 58.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;T-cells: 1.8" "Group enriched" "Detected in some" 5 "REH: 3.5;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076660 Enhanced Supported Vesicles NA NA Vesicles "HPA076660: AB_2686812" "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.5 1.4 5.9 0.5 7.6 1.3 0.6 4.5 21.7 0.5 0.8 0.0 0.0 0.5 0.6 0.4 1.8 0.6 0.6 0.4 5.0 5.2 0.5 0.4 0.4 0.5 2.3 7.4 2.1 0.7 0.4 0.6 0.5 0.9 0.5 0.7 2.7 0.4 0.4 0.4 0.5 0.5 0.5 0.8 3.1 0.7 2.5 0.5 0.0 0.7 0.0 0.6 0.5 0.2 0.0 1.3 0.0 0.0 0.3 1.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 3.5 0.0 0.0 0.0 0.3 1.4 10.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 1.3 0.0 0.2 5.9 7.6 4.5 21.7 5.0 5.2 2.3 7.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 LRFN5 "C14orf146, FIGLER8, SALM5" ENSG00000165379 "Leucine rich repeat and fibronectin type III domain containing 5" Q96NI6 14 41607570-41904549 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;parathyroid gland: 38.4" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 4.1;Fibroblasts: 3.3;Leydig cells: 7.8;Peritubular cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 17.7;HSkMC: 3.6;RPTEC TERT1: 6.0;SCLC-21H: 9.3;U-138 MG: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001177 Uncertain "Intracellular and membrane" NA NA "HPA001177: AB_1079274" "unprognostic (5.23e-3)" "unprognostic (1.37e-1)" "unprognostic (5.10e-1)" "unprognostic (6.24e-2)" "unprognostic (2.39e-1)" "unprognostic (3.54e-1)" "unprognostic (1.31e-1)" "unprognostic (6.38e-3)" "unprognostic (2.61e-2)" "unprognostic (5.78e-2)" "unprognostic (2.70e-2)" "unprognostic (9.27e-2)" "unprognostic (6.02e-3)" "unprognostic (3.79e-3)" "unprognostic (1.98e-1)" "unprognostic (6.07e-3)" "unprognostic (2.92e-3)" 1.5 3.3 7.9 1.7 9.3 0.5 2.4 3.1 19.1 13.7 2.2 0.8 1.3 0.8 3.8 1.5 1.2 5.0 1.9 0.9 12.2 9.5 0.9 0.6 1.2 0.6 4.3 11.9 2.7 0.9 38.4 1.0 1.8 8.7 3.7 1.9 0.9 0.8 9.3 0.8 1.0 0.9 9.3 1.6 1.2 1.0 1.7 1.2 0.0 1.0 0.0 0.8 7.8 6.3 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.5 0.1 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 9.3 3.1 19.1 12.2 9.5 4.3 11.9 8.7 1.2 0.0 0.0 0.0 0.0 0.2 4.1 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.8 7.8 0.0 1.7 0.0 0.0 0.2 0.2 0.0 3.9 0.0 1.0 0.0 1.0 0.0 1.5 0.3 0.1 0.0 0.0 0.0 LRG1 LRG ENSG00000171236 "Leucine rich alpha-2-glycoprotein 1" P02750 19 4536409-4540474 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 636.5" "Cell type enriched" "Detected in many" 9 "Hepatocytes: 728.6" "Cancer enriched" "Detected in many" 9 "liver cancer: 160.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 19 "neutrophil: 58.9" "Lineage enriched" "Detected in many" 42 "granulocytes: 58.9" "Cell line enhanced" "Detected in some" "Hep G2: 8.2;HMC-1: 8.3;SK-BR-3: 8.8;THP-1: 14.8;U-937: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA001888, HPA001889" Enhanced Approved Vesicles "Secreted to blood" NA NA 21000000000 74000000000 Vesicles "HPA001888: AB_1079276, HPA001889: AB_1079275" "unprognostic (5.54e-3)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.46e-3)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.66e-6)" "unprognostic (4.06e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.49e-4)" "unprognostic (2.60e-2)" 1.7 0.9 0.2 3.3 0.4 5.4 0.9 0.2 0.3 1.7 1.3 0.2 2.2 1.1 0.3 1.1 4.5 1.9 3.0 0.9 0.4 0.2 3.5 636.5 2.2 5.7 0.7 0.1 1.5 8.1 0.0 0.7 0.4 0.4 1.1 0.8 0.3 4.1 3.0 0.5 0.8 0.6 0.2 0.3 4.3 2.3 0.5 0.3 0.3 0.9 1.7 3.4 1.4 1.3 0.1 0.3 58.9 1.4 0.0 0.2 0.4 5.9 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.6 4.3 2.1 7.7 0.0 0.3 0.8 0.0 1.0 0.0 7.7 0.2 0.1 0.1 8.2 0.0 0.2 8.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.3 0.0 6.0 0.1 4.7 0.0 0.0 0.1 6.2 0.6 1.1 0.0 0.0 0.0 8.8 0.1 0.8 2.6 14.8 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 27.4 0.0 0.5 1.4 3.0 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 58.9 0.0 0.2 0.0 0.2 0.4 0.2 0.4 0.2 0.3 0.4 0.2 0.7 0.1 0.4 0.3 11.9 51.2 16.5 26.9 7.1 0.0 0.4 58.6 78.9 39.8 14.0 0.0 0.5 1.7 54.6 0.0 8.3 25.4 0.0 54.4 10.6 1.4 2.9 11.5 728.6 5.4 1.6 4.7 42.4 17.4 0.0 0.0 7.6 1.7 10.0 20.0 0.0 55.9 7.0 0.0 3.6 0.0 0.0 2.1 0.0 0.2 5.1 1.1 2.9 16.7 29.6 LRGUK "CFAP246, FLJ32786" ENSG00000155530 "Leucine rich repeats and guanylate kinase domain containing" Q96M69 7 134127299-134264591 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.5;pituitary gland: 11.5;testis: 22.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 26.8;Early spermatids: 14.4;Spermatocytes: 8.3" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 5.1;SH-SY5Y: 4.9;SK-MEL-30: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029505, HPA029506" Uncertain NA NA "HPA029505: AB_10599606, HPA029506: AB_10601752" "unprognostic (4.08e-3)" "unprognostic (1.87e-1)" "unprognostic (6.94e-2)" "unprognostic (1.01e-2)" "unprognostic (2.31e-2)" "unprognostic (2.64e-2)" "unprognostic (7.85e-4)" "unprognostic (6.92e-2)" "unprognostic (2.43e-1)" "unprognostic (4.28e-2)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (1.27e-3)" "unprognostic (2.22e-3)" "unprognostic (3.83e-2)" "unprognostic (3.01e-3)" "unprognostic (2.10e-2)" 0.7 0.6 2.3 0.6 6.4 1.3 1.2 0.5 1.4 1.2 0.5 4.1 0.3 0.5 1.5 4.0 0.4 9.1 0.7 0.4 2.4 1.2 1.2 0.9 3.4 0.4 0.3 0.6 2.4 1.9 0.4 11.5 0.4 12.5 1.6 0.7 2.2 1.3 0.5 0.2 1.2 0.5 0.5 1.6 1.3 0.6 22.4 0.9 0.0 2.2 0.0 0.6 0.5 0.4 0.5 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.4 0.7 1.1 0.1 0.3 0.3 0.0 0.1 0.5 0.4 0.0 1.0 0.2 0.3 0.1 1.0 0.3 0.4 0.1 0.8 0.5 0.5 0.1 0.3 0.2 0.1 0.2 0.6 0.3 0.7 0.9 0.0 0.1 0.2 0.7 0.2 0.8 0.8 0.2 0.3 0.6 5.1 0.2 1.2 0.7 0.1 0.0 0.8 0.4 1.6 4.9 1.5 0.0 5.1 0.7 0.2 1.1 0.0 0.3 0.6 0.3 0.6 1.2 1.7 1.5 1.4 0.2 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 6.4 0.5 1.4 2.4 1.2 0.3 0.6 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 26.8 2.3 0.0 0.0 0.0 0.0 0.2 14.4 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 1.4 0.0 0.0 0.4 0.0 1.8 0.0 0.0 8.3 0.7 0.4 0.2 0.0 0.0 0.1 LRIG1 "DKFZP586O1624, LIG-1, LIG1" ENSG00000144749 "Leucine rich repeats and immunoglobulin like domains 1" Q96JA1 3 66378797-66501263 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 64.0" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 48.2;Muller glia cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enhanced" "Detected in single" "T-cells: 2.7" "Cell line enhanced" "Detected in many" "Daudi: 23.8;hTEC/SVTERT24-B: 18.7;U-698: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011846 Approved Approved Cytosol NA NA 21000 Cytosol "HPA011846: AB_2668545" "unprognostic (6.41e-2)" "unprognostic (4.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.58e-2)" "unprognostic (2.12e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.01e-5)" "unprognostic (5.12e-1)" "unprognostic (7.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.18e-1)" "unprognostic (2.12e-1)" "unprognostic (8.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.50e-4)" 12.6 1.7 22.3 8.1 21.1 2.4 13.4 9.6 31.8 15.5 24.6 20.3 0.7 8.2 12.7 2.6 6.9 13.3 13.8 16.8 24.6 7.1 2.5 15.8 8.6 4.1 19.8 12.4 8.8 64.0 4.2 6.7 2.8 18.9 12.2 7.6 4.8 9.4 4.3 16.6 6.6 7.5 14.5 10.9 2.4 21.2 6.4 19.8 0.2 8.1 5.0 5.0 5.1 5.4 0.3 0.0 0.7 0.0 0.0 2.7 0.4 0.4 0.4 9.5 0.1 2.6 1.7 0.8 1.5 8.9 1.5 4.8 7.4 0.0 23.8 4.1 0.7 2.1 0.0 1.8 3.2 3.4 0.0 4.9 0.0 1.4 0.6 0.6 0.2 5.4 2.1 1.8 18.7 3.1 6.5 8.2 0.1 0.0 0.0 0.3 1.1 0.0 0.0 7.1 0.7 0.0 4.3 2.8 1.2 1.8 0.0 1.2 0.3 1.4 1.4 0.0 1.7 8.5 2.1 2.5 4.7 2.0 9.2 3.9 1.9 0.9 18.2 8.3 0.0 1.6 0.0 0.0 0.7 0.4 0.0 1.4 0.3 1.1 1.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 2.7 0.4 22.3 21.1 9.6 20.2 24.6 7.1 19.8 12.4 18.9 19.8 35.7 42.0 2.7 7.5 10.1 1.7 28.8 7.6 48.2 30.7 0.0 7.9 0.2 1.7 5.5 1.5 9.8 7.1 0.0 14.9 0.1 9.4 18.3 1.1 17.4 1.5 7.9 25.4 4.3 1.0 1.3 10.6 3.1 10.1 1.8 24.4 47.3 6.2 7.0 16.3 1.0 6.5 0.0 9.2 1.5 18.1 10.0 0.1 9.6 19.5 3.7 LRIT1 "DKFZP434K091, FIGLER9, LRRC21, PAL" ENSG00000148602 "Leucine rich repeat, Ig-like and transmembrane domains 1" Q9P2V4 10 84231593-84241461 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 67 "retina: 20.7;testis: 10.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 13.8;Early spermatids: 21.9;Late spermatids: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 LRIT2 "AC022389.4, LRRC22" ENSG00000204033 "Leucine rich repeat, Ig-like and transmembrane domains 2" A6NDA9 10 84220495-84225589 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 25.4;skin 1: 8.5" "Group enriched" "Detected in some" 6 "Bipolar cells: 5.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037788 Enhanced NA NA "HPA037788: AB_10672393" "unprognostic (3.12e-1)" "unprognostic (1.09e-3)" "unprognostic (3.99e-1)" "unprognostic (9.44e-2)" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" 0.1 0.2 0.2 0.1 3.4 0.0 0.1 0.1 2.2 0.1 1.6 0.1 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 25.4 0.1 0.1 0.1 8.5 0.7 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.1 0.5 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.2 0.1 1.3 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.8 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.3 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 31.4 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LRMP JAW1 ENSG00000118308 "Lymphoid restricted membrane protein" Q12912 12 25004342-25108334 "Predicted intracellular proteins, Predicted membrane proteins" "Fertilization, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 9 "B-cells: 52.5;granulocytes: 24.4;Kupffer cells: 29.4;T-cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.8" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Daudi: 96.3;REH: 33.5;U-698: 110.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA002967, HPA018505" Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA002967: AB_1079161, HPA018505: AB_1851988" "unprognostic (3.78e-2)" "unprognostic (2.59e-3)" "unprognostic (7.54e-2)" "unprognostic (7.08e-3)" "unprognostic (2.36e-1)" "unprognostic (1.48e-3)" "unprognostic (7.98e-2)" "unprognostic (4.08e-2)" "unprognostic (7.32e-2)" "unprognostic (1.15e-1)" "unprognostic (3.59e-2)" "unprognostic (7.97e-2)" "unprognostic (7.25e-3)" "unprognostic (7.72e-2)" "unprognostic (9.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.59e-2)" 5.5 1.4 15.1 51.7 2.9 19.2 4.6 0.4 5.6 1.9 3.6 2.1 0.9 3.2 1.4 1.8 3.9 2.3 3.0 1.7 8.1 1.8 5.5 2.3 5.6 57.8 3.5 4.7 2.3 15.1 0.4 2.1 1.7 7.4 2.8 3.5 1.3 4.1 2.1 0.8 2.7 13.2 1.8 5.3 27.6 3.6 0.7 2.8 67.0 3.6 1.7 69.5 10.4 5.7 17.4 5.7 51.8 12.2 12.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 96.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 5.7 0.0 0.0 0.0 7.4 8.5 0.0 0.0 0.1 0.0 0.0 0.0 4.9 1.1 6.4 0.0 0.0 8.1 13.7 0.0 0.0 0.0 33.5 0.0 9.5 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.2 0.0 0.0 6.3 1.1 110.1 0.0 3.3 0.0 17.0 5.4 51.8 6.5 10.5 5.4 17.4 4.1 6.6 5.7 13.3 7.1 6.9 39.3 12.0 12.2 5.4 0.7 4.7 15.1 2.9 0.4 5.6 8.1 1.8 3.5 4.7 7.4 2.8 0.0 7.4 52.5 2.5 0.8 0.2 0.4 0.0 9.4 15.9 0.0 0.0 0.1 0.0 0.2 1.5 2.1 0.0 0.0 7.5 0.1 0.5 0.2 24.4 1.0 11.5 0.0 8.5 4.9 29.4 0.4 0.9 20.0 5.0 1.8 0.0 0.0 1.6 3.5 4.6 13.0 0.2 0.0 0.2 0.2 0.0 4.8 0.1 40.3 0.2 14.4 LRP1B "LRP-DIT, LRPDIT" ENSG00000168702 "LDL receptor related protein 1B" Q9NZR2 2 140231423-142131701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;thyroid gland: 14.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 15.8;Early spermatids: 4.6;Late spermatids: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "myeloid DC: 1.4;plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;HEK 293: 4.5;HeLa: 2.3;HSkMC: 2.2;U-138 MG: 4.9;U-87 MG: 2.6" "Low region specificity" "Detected in all" "HPA069094, HPA074788" Approved Approved Vesicles NA NA 63000 Vesicles "HPA069094: AB_2686082, HPA074788: AB_2797273" "unprognostic (5.31e-4)" "unprognostic (3.68e-2)" "unprognostic (2.61e-1)" "unprognostic (7.36e-4)" "unprognostic (5.19e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-2)" "unprognostic (3.49e-1)" "unprognostic (3.75e-1)" "unprognostic (7.02e-3)" "unprognostic (1.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.94e-3)" "unprognostic (4.85e-3)" "unprognostic (1.52e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-1)" 4.8 4.5 17.6 1.3 14.1 1.2 2.6 23.2 25.7 1.4 1.3 6.5 0.0 1.2 1.3 6.8 1.3 1.9 1.4 1.6 18.3 9.3 2.2 1.6 1.4 1.2 10.8 16.7 3.0 1.2 1.1 12.7 1.2 12.8 3.5 1.3 0.1 2.5 3.8 10.5 1.7 1.3 1.3 8.2 1.2 1.5 1.9 10.6 0.0 14.9 0.0 1.3 1.2 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.0 0.2 0.2 0.6 4.5 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.4 1.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 17.6 14.1 23.2 21.3 18.3 9.3 10.8 16.7 12.8 10.6 0.0 0.0 0.0 0.3 0.2 15.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 0.8 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.6 LRP2 "DBS, gp330" ENSG00000081479 "LDL receptor related protein 2" P98164 2 169127109-169362685 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Endocytosis, Hearing, Neurogenesis, Transport" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 61.7;parathyroid gland: 61.4" "Cell type enhanced" "Detected in many" 23 "Cone photoreceptor cells: 82.5;Cytotrophoblasts: 52.4;Proximal tubular cells: 250.3" "Group enriched" "Detected in many" 6 "breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 21.9;CACO-2: 36.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA005980, HPA064792" Enhanced Approved Vesicles,Mitochondria No NA "Vesicles, Mitochondria" "HPA005980: AB_1079278, HPA064792: AB_2685353" "unprognostic (1.87e-1)" "unprognostic (1.04e-3)" "unprognostic (1.32e-3)" "unprognostic (3.65e-3)" "unprognostic (3.18e-2)" "unprognostic (1.60e-2)" "unprognostic (1.64e-3)" "unprognostic (2.99e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (4.09e-2)" "unprognostic (4.38e-1)" "prognostic favorable (3.43e-5)" "unprognostic (1.37e-1)" "unprognostic (4.21e-1)" "unprognostic (2.44e-2)" "unprognostic (1.62e-2)" 1.7 0.4 2.7 0.4 12.9 0.5 7.4 0.7 5.7 0.6 0.4 18.5 0.0 0.4 0.5 4.8 0.4 0.4 0.6 0.5 6.2 3.4 61.7 0.6 1.8 0.4 20.7 1.9 0.4 0.4 61.4 0.4 10.5 8.5 0.5 0.4 7.9 1.1 0.5 0.5 0.5 0.4 0.4 17.2 0.4 0.5 0.6 17.0 0.0 18.2 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.7 12.9 0.7 5.7 6.2 3.4 20.7 1.9 8.5 17.0 6.0 39.5 0.0 0.1 0.2 1.9 1.7 2.5 4.0 4.5 3.5 82.5 52.4 14.9 0.0 1.4 0.0 0.0 0.0 0.0 1.9 0.8 0.0 2.3 0.0 4.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 250.3 18.0 0.0 0.0 0.0 0.5 0.0 19.3 0.0 0.0 0.1 LRP2BP DKFZp761O0113 ENSG00000109771 "LRP2 binding protein" Q9P2M1 4 185363879-185395899 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 19.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 28.6;Cone photoreceptor cells: 31.4;Early spermatids: 52.8;Horizontal cells: 25.4;Late spermatids: 29.3;Rod photoreceptor cells: 36.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036664, HPA036665" Approved NA NA "HPA036664: AB_10672361, HPA036665: AB_10673660" "unprognostic (2.50e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-3)" "unprognostic (3.15e-5)" "unprognostic (2.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (9.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.84e-2)" "unprognostic (4.35e-4)" "unprognostic (2.17e-2)" "unprognostic (9.76e-3)" "unprognostic (2.15e-1)" "unprognostic (5.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.54e-4)" 2.8 3.9 7.0 1.9 6.9 1.4 2.7 10.7 8.8 2.1 2.3 8.7 0.9 1.1 3.2 6.5 1.8 15.1 2.5 3.3 6.9 7.3 2.6 1.4 5.1 1.8 8.8 4.0 6.5 3.3 1.1 15.5 1.7 5.5 2.6 1.4 3.4 2.7 2.0 4.6 3.1 1.7 1.9 9.5 2.3 2.1 19.9 10.7 0.4 4.8 1.4 1.0 3.4 2.4 2.4 2.3 1.0 0.6 0.8 2.6 0.4 1.1 0.8 1.0 2.2 0.5 0.4 2.0 2.8 0.9 0.3 0.7 1.0 1.1 3.3 0.3 0.3 1.1 0.7 0.7 0.5 0.6 3.3 1.8 0.9 2.6 2.9 0.5 0.6 1.1 0.6 0.7 1.5 0.6 2.9 1.1 3.0 1.5 2.8 1.0 0.2 1.2 2.5 1.2 0.2 0.4 0.5 0.6 0.8 0.9 0.6 2.5 2.0 0.8 0.8 1.8 1.5 0.8 0.2 2.7 1.6 1.2 0.6 1.5 11.5 1.2 0.6 3.0 0.7 1.1 0.3 0.4 0.4 1.2 0.2 1.2 2.1 1.7 1.3 0.1 2.4 2.6 1.4 1.0 0.8 0.6 2.3 1.6 0.4 7.0 6.9 10.7 8.8 6.9 7.3 8.8 4.0 5.5 10.7 8.9 1.6 0.8 3.4 2.2 28.6 3.9 0.0 18.7 2.3 0.0 31.4 0.9 0.0 1.3 52.8 3.1 1.4 0.0 0.8 1.9 1.8 3.6 0.0 0.0 0.4 25.4 7.5 1.8 0.0 29.3 2.6 1.2 5.0 1.0 1.7 10.3 0.9 0.0 3.5 1.3 36.6 0.0 3.4 3.5 1.4 2.8 1.4 1.7 1.1 1.7 LRP3 "hLRp105, LRP-3" ENSG00000130881 "LDL receptor related protein 3" O75074 19 33177603-33208867 "Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.0" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 28.5;Hepatocytes: 25.9;Leydig cells: 24.2;Peritubular cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.8;non-classical monocyte: 2.6" "Lineage enriched" "Detected in single" 4 "monocytes: 2.8" "Cell line enhanced" "Detected in many" "THP-1: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041658 Approved "Lipid droplets" NA NA "Lipid droplets" "HPA041658: " "unprognostic (3.10e-1)" "unprognostic (2.55e-2)" "unprognostic (3.25e-2)" "unprognostic (1.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (1.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.07e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.12e-7)" "unprognostic (1.34e-1)" "unprognostic (2.71e-3)" "unprognostic (4.36e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (1.32e-1)" 23.5 16.6 28.3 5.1 33.1 15.3 15.6 14.2 41.2 12.1 7.8 6.6 4.4 7.1 11.2 8.8 7.4 12.4 8.2 10.9 27.6 13.0 4.2 15.5 5.3 3.2 15.4 19.4 50.0 16.8 9.8 10.3 3.8 11.0 15.5 3.4 10.0 14.4 12.7 21.9 5.0 6.6 10.6 6.3 4.8 7.0 5.6 7.7 0.0 9.5 4.7 3.1 9.0 9.1 0.0 0.0 0.6 2.8 0.5 0.1 0.7 0.0 20.7 5.7 20.6 14.4 5.4 4.3 5.3 5.2 4.9 1.9 5.9 0.2 0.0 13.9 6.5 6.9 0.0 5.5 0.5 0.4 0.0 11.2 0.0 4.6 20.7 5.5 7.4 0.7 8.2 4.9 1.3 0.7 0.8 4.0 0.0 0.0 0.0 6.2 19.1 0.0 8.4 11.7 4.1 1.0 0.0 2.6 0.0 0.0 8.3 12.6 19.0 8.6 0.0 1.5 0.6 8.7 26.2 0.0 10.2 9.1 15.1 3.0 0.0 0.0 0.1 0.0 12.5 3.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 2.6 0.0 0.0 0.7 28.3 33.1 14.2 41.2 27.6 13.0 15.4 19.4 11.0 7.7 0.0 2.2 0.9 2.1 3.0 28.5 0.4 10.2 0.0 3.4 5.2 3.9 0.1 0.0 5.8 2.2 1.8 0.9 0.0 6.5 0.6 7.0 8.2 0.0 25.9 8.2 22.3 1.7 6.2 10.0 5.2 24.2 2.3 3.3 1.8 6.6 23.0 8.9 0.0 30.8 0.5 3.6 6.5 5.2 0.2 0.4 2.3 0.0 0.0 4.9 1.4 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRP8 "APOER2, HSZ75190, LRP-8, MCI1" ENSG00000157193 "LDL receptor related protein 8" Q14114 1 53242364-53328070 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.5;thyroid gland: 48.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 39.8;Ciliated cells: 14.7;Horizontal cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 6 "dendritic cells: 3.2;T-cells: 1.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073031 Enhanced "Secreted in other tissues" NA NA 240000 "HPA073031: AB_2732217" "unprognostic (3.83e-2)" "unprognostic (6.06e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (3.46e-1)" "unprognostic (6.13e-2)" "unprognostic (1.03e-3)" "prognostic unfavorable (7.02e-4)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (8.88e-16)" "unprognostic (7.73e-3)" "unprognostic (5.47e-2)" "unprognostic (6.98e-2)" "unprognostic (3.00e-2)" 2.6 1.9 7.0 5.5 7.1 5.8 1.9 13.0 15.1 1.8 1.8 2.7 0.3 1.4 2.0 2.8 6.1 3.6 2.3 1.9 7.6 8.0 1.4 0.8 3.2 5.6 5.8 7.9 1.3 0.9 0.8 4.2 5.0 6.6 1.5 2.4 11.9 1.4 1.6 0.8 1.5 1.5 2.9 3.8 2.3 1.3 22.5 3.4 1.7 48.7 2.4 4.9 1.7 2.0 0.3 3.2 0.0 0.4 0.0 1.6 0.2 10.0 21.4 8.4 12.1 5.8 5.6 10.8 12.4 10.3 18.8 13.1 5.8 12.0 16.4 14.4 8.3 27.9 17.1 6.6 14.2 8.9 12.0 6.5 9.2 24.4 10.2 6.0 16.6 16.6 1.6 1.6 20.5 11.2 2.9 14.7 12.7 3.6 7.2 2.7 12.5 10.2 7.8 15.6 9.8 15.6 18.2 12.3 14.2 7.3 8.5 19.2 7.3 5.9 33.5 7.9 5.3 4.0 11.3 11.8 4.9 7.9 10.7 24.7 11.5 17.8 6.8 24.5 23.1 28.1 0.0 0.4 0.0 1.0 0.0 1.6 0.3 0.6 0.4 0.5 0.2 0.2 0.2 0.0 0.0 0.0 3.2 1.4 0.2 7.0 7.1 13.0 12.7 7.6 8.0 5.8 7.9 6.6 3.4 0.0 6.7 3.0 1.7 1.3 39.8 2.3 0.0 14.7 6.8 0.0 0.0 2.0 0.0 2.3 2.1 1.9 0.0 0.0 2.1 1.6 0.9 5.1 1.1 0.0 1.7 25.4 2.4 0.0 6.2 3.8 0.6 2.0 0.0 10.0 1.2 1.4 2.9 0.0 2.5 0.0 1.8 0.0 2.7 3.2 0.9 1.3 8.1 2.5 0.5 4.6 LRR1 "LRR-1, MGC20689, PPIL5" ENSG00000165501 "Leucine rich repeat protein 1" Q96L50 14 49598697-49614672 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 43.9" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 77.7;Erythroid cells: 70.0;Spermatocytes: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA065703, HPA069364" Approved Approved "Nucleoplasm,Nuclear membrane,Vesicles" No No "Nucleoplasm, Nuclear membrane" Vesicles "HPA065703: AB_2685537, HPA069364: AB_2686129" "unprognostic (2.73e-2)" "unprognostic (1.21e-2)" "unprognostic (3.17e-2)" "unprognostic (2.26e-2)" "unprognostic (2.85e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (7.34e-2)" "unprognostic (2.50e-2)" "unprognostic (8.30e-2)" "unprognostic (4.64e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.90e-7)" "unprognostic (6.86e-2)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" "unprognostic (4.04e-2)" 5.7 6.0 1.7 7.8 2.5 14.2 5.0 2.4 2.8 3.2 8.5 2.5 2.6 7.8 4.2 2.8 7.2 3.7 4.6 6.9 1.5 1.1 4.3 5.6 4.5 9.6 2.5 1.6 3.1 6.5 1.3 1.6 4.8 2.3 3.3 6.2 4.3 6.0 5.5 7.5 4.8 7.9 3.5 3.3 8.1 4.9 43.9 2.0 28.0 3.8 7.7 9.2 4.7 4.6 12.5 14.6 20.3 18.8 7.3 12.7 8.5 22.3 16.0 12.8 12.7 2.9 2.1 14.8 12.1 11.1 27.6 24.9 14.3 18.8 20.3 8.4 7.2 8.0 14.6 15.3 11.0 19.4 20.7 12.1 9.8 11.6 9.1 2.3 23.2 12.9 2.2 3.8 12.3 5.6 1.9 13.0 17.5 9.9 13.7 13.6 20.1 27.0 19.4 7.7 10.7 20.9 19.1 21.6 14.6 9.3 9.2 12.8 7.2 11.6 13.9 8.3 3.4 17.9 15.1 5.0 19.1 31.7 8.4 14.9 7.5 10.7 22.2 9.8 16.3 14.3 16.9 12.3 20.3 9.3 18.8 11.8 12.5 11.9 12.6 12.7 9.2 9.5 10.7 6.6 7.3 13.1 14.6 12.7 8.5 1.7 2.5 2.4 2.8 1.5 1.1 2.5 1.6 2.3 2.0 3.0 6.2 3.0 4.9 13.9 3.6 2.8 10.2 2.7 7.9 3.5 2.0 8.3 1.7 11.3 77.7 8.4 10.5 70.0 19.7 27.5 7.5 7.5 13.9 5.6 18.9 1.6 4.6 6.2 11.1 26.3 6.9 12.4 10.1 14.4 8.4 4.5 10.8 0.0 3.2 6.2 5.0 6.5 7.1 63.9 10.0 13.0 6.4 6.4 12.4 5.9 LRRC10 "HRLRRP, LRRC10A" ENSG00000198812 "Leucine rich repeat containing 10" Q5BKY1 12 69608564-69611162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "heart muscle: 42.5" "Cell type enriched" "Detected in single" 323 "Cardiomyocytes: 32.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.76e-4)" "unprognostic (4.59e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.1 1.0 0.5 0.4 0.8 0.1 0.1 0.5 0.6 0.6 0.0 0.0 0.5 0.2 0.0 1.0 0.4 0.3 0.3 1.0 0.3 0.1 0.2 0.7 0.0 0.1 0.0 2.5 0.7 0.5 0.7 0.6 0.1 0.0 0.8 0.2 0.7 0.6 0.0 0.9 0.4 0.5 0.6 0.1 0.1 0.0 0.8 0.4 0.2 0.0 0.4 0.9 0.1 0.1 0.8 1.3 0.8 0.9 0.0 0.1 0.0 0.7 0.3 0.1 0.4 0.2 0.8 0.5 0.4 0.6 0.4 0.8 1.0 1.3 0.1 0.4 0.5 0.4 0.6 0.2 0.5 0.7 0.5 0.6 0.1 1.3 0.8 0.7 1.0 0.4 0.3 1.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508800-61511018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8" "Region enriched" "Detected in many" 7 "basal ganglia: 202.0" "Group enriched" "Detected in many" 5 "basal ganglia: 39.3;hippocampal formation: 35.0" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli No NA Nucleoplasm Nucleoli "HPA047619: AB_2680106" "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 2.4 1.6 4.8 0.9 27.8 0.5 1.9 0.2 5.8 3.4 1.6 1.2 1.0 0.9 2.2 3.7 1.1 36.2 0.8 1.2 5.2 1.9 0.9 0.6 3.7 0.5 1.1 4.3 3.0 1.5 2.1 14.8 1.2 1.2 0.9 1.0 0.0 1.1 1.2 0.7 0.5 0.9 2.5 0.2 0.6 1.0 2.4 8.3 0.9 0.8 0.2 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.9 0.0 0.3 0.0 0.0 0.0 13.2 0.0 0.0 0.0 6.8 0.6 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 27.8 0.2 5.8 5.2 1.9 1.1 4.3 1.2 8.3 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 20.1 4.5 1.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 7.8 0.1 0.0 0.0 0.0 0.0 19.4 11.8 0.5 0.9 0.3 0.1 0.0 0.0 0.0 LRRC14B ENSG00000185028 "Leucine rich repeat containing 14B" A6NHZ5 5 191511-195353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 30.6;skeletal muscle: 45.2;tongue: 14.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.8" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.8" "Cell line enriched" "Detected in some" 4 "U-266/84: 29.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038046, HPA038047" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA038046: AB_10672504, HPA038047: AB_2675806" "unprognostic (7.63e-4)" "unprognostic (4.25e-3)" "unprognostic (8.50e-3)" "unprognostic (7.63e-4)" "unprognostic (4.95e-2)" "unprognostic (3.79e-2)" "unprognostic (6.07e-3)" "unprognostic (9.68e-2)" "unprognostic (6.43e-2)" "unprognostic (6.43e-3)" "unprognostic (2.78e-2)" "unprognostic (6.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.19e-1)" 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 30.6 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.9 0.4 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.2 14.3 0.7 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 3.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 7.1 29.2 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 48.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.5 1.6 1.2 0.0 0.0 0.0 0.0 26.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LRRC17 "H_RG318M05.3, P37NB" ENSG00000128606 "Leucine rich repeat containing 17" Q8N6Y2 7 102912991-102944949 "Predicted secreted proteins" Osteogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 39.0" "Group enriched" "Detected in some" 4 "Leydig cells: 94.3;Peritubular cells: 29.7;Sertoli cells: 64.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 17 "eosinophil: 12.0" "Lineage enriched" "Detected in single" 75 "granulocytes: 12.0" "Cell line enriched" "Detected in some" 5 "LHCN-M2: 172.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073458 Approved "Vesicles,Cytokinetic bridge" "Secreted in other tissues" NA NA Vesicles "Cytokinetic bridge" "HPA073458: " "unprognostic (1.77e-1)" "unprognostic (7.73e-2)" "unprognostic (4.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.48e-1)" "unprognostic (4.46e-1)" "unprognostic (1.18e-1)" "unprognostic (9.76e-4)" "unprognostic (6.09e-3)" "unprognostic (2.26e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.12e-6)" "unprognostic (8.57e-3)" "unprognostic (4.48e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (6.30e-4)" 5.1 1.3 1.1 0.5 1.2 0.0 6.2 1.4 2.0 15.0 1.4 1.5 5.6 0.5 8.3 17.1 5.2 8.9 13.5 6.4 1.2 1.3 1.5 1.4 1.6 1.6 1.1 2.1 39.0 2.6 1.2 1.7 1.8 2.5 7.8 1.4 2.7 2.8 2.5 5.3 2.0 2.6 5.1 1.2 1.2 3.5 5.1 0.2 2.2 2.6 6.7 1.3 6.7 4.2 0.1 0.1 12.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.8 4.3 0.0 0.2 2.5 0.0 0.4 0.0 0.0 0.0 0.4 0.2 1.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 4.0 0.1 3.0 0.0 20.0 19.6 0.0 0.0 0.0 172.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.2 2.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.4 2.0 1.2 1.3 1.1 2.1 2.5 0.2 0.0 0.6 0.0 0.1 0.8 3.7 0.8 0.0 0.0 0.0 1.8 2.0 0.2 0.0 1.5 2.4 3.6 0.0 0.0 0.3 0.1 11.8 0.2 1.1 0.6 0.3 0.0 0.0 9.2 0.0 0.7 94.3 0.0 5.0 1.0 0.0 0.2 0.2 0.0 29.7 0.0 1.9 64.7 14.3 0.6 0.3 0.5 0.0 0.0 0.1 0.1 LRRC18 "MGC34773, UNQ933, UNQ9338, VKGE9338" ENSG00000165383 "Leucine rich repeat containing 18" Q8N456 10 48909483-48914232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.1;testis: 15.5" "Cell type enriched" "Detected in some" 4 "Early spermatids: 174.5" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.4;naive B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.3;HDLM-2: 1.4;HL-60: 2.1;JURKAT: 3.1;NB-4: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039256 Enhanced NA NA "HPA039256: AB_10671873" "unprognostic (1.31e-2)" "unprognostic (3.66e-2)" "unprognostic (9.83e-4)" "unprognostic (3.10e-1)" "unprognostic (4.82e-2)" "unprognostic (1.98e-1)" "unprognostic (2.00e-1)" "unprognostic (8.11e-2)" "unprognostic (1.11e-1)" "unprognostic (3.16e-2)" "unprognostic (8.57e-3)" "unprognostic (4.08e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.3 0.2 0.7 0.2 0.2 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 9.1 0.1 0.2 0.8 0.9 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.8 0.3 0.0 0.1 0.0 0.0 15.5 0.0 0.0 0.3 0.0 1.4 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.4 0.1 1.3 0.0 0.1 0.0 0.2 0.1 0.0 0.0 1.4 0.0 0.4 0.2 0.0 0.0 2.1 0.6 0.4 0.4 0.0 0.2 0.3 0.7 3.1 0.2 0.0 0.0 0.0 0.1 3.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.2 0.1 0.4 0.0 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.2 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 2.3 0.0 0.0 0.0 0.0 0.0 174.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 LRRC19 FLJ21302 ENSG00000184434 "Leucine rich repeat containing 19" Q9H756 9 26993136-27005693 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "intestine: 61.3;kidney: 50.0" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 22.7;Enterocytes: 78.3;Paneth cells: 39.5;Proximal tubular cells: 50.0;Undifferentiated cells: 24.0" "Group enriched" "Detected in some" 5 "colorectal cancer: 6.0;renal cancer: 5.8;stomach cancer: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 2.4;RPTEC TERT1: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 96000 "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (6.30e-2)" "unprognostic (5.20e-2)" "unprognostic (2.30e-1)" "unprognostic (4.05e-2)" "unprognostic (1.85e-2)" "unprognostic (4.16e-2)" "unprognostic (9.21e-5)" "unprognostic (1.87e-2)" "unprognostic (4.48e-2)" "prognostic favorable (7.08e-8)" "unprognostic (2.46e-2)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (3.32e-2)" 0.2 0.2 0.2 5.9 0.2 0.0 0.2 0.2 0.2 0.2 23.4 0.1 0.1 11.9 0.2 1.3 0.2 0.2 2.9 0.1 0.2 0.2 50.0 0.8 0.2 0.1 0.2 0.1 0.2 0.6 0.0 0.2 0.1 0.1 0.2 17.0 0.1 0.2 0.1 0.1 0.2 61.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.2 2.0 0.9 1.1 0.7 0.4 0.8 0.0 2.4 0.6 0.3 0.4 0.0 0.4 0.9 0.7 0.0 0.0 0.0 0.6 0.3 0.3 0.8 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.3 0.6 1.0 0.5 0.0 0.6 0.8 0.1 0.5 0.0 0.3 1.0 0.0 0.2 0.3 1.0 0.0 0.3 0.5 1.5 1.7 0.3 1.1 0.5 0.5 0.6 4.2 0.4 0.6 0.3 1.7 0.3 0.1 0.6 0.3 0.5 1.2 0.8 0.4 1.6 0.5 0.3 0.3 0.1 0.2 0.6 0.2 1.0 0.7 0.6 0.5 0.6 0.4 0.6 0.8 0.4 0.5 2.0 0.8 0.7 1.1 0.4 0.6 0.9 0.6 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.4 20.4 0.0 0.0 22.7 0.0 0.0 8.3 0.1 0.0 0.0 78.3 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.5 0.1 0.1 39.5 0.4 50.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515423-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0" "Cell type enriched" "Detected in many" 17 "Cardiomyocytes: 175.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 1.8 0.5 1.9 0.4 1.4 0.4 1.0 1.4 3.0 2.6 1.1 0.2 0.0 0.4 3.9 1.4 1.1 1.1 1.4 53.9 1.3 0.4 2.2 2.5 0.6 0.3 0.5 2.3 2.8 0.7 0.1 2.2 0.5 1.0 1.2 0.8 0.4 1.4 0.2 70.3 1.2 0.6 2.3 0.4 1.3 1.0 0.4 0.0 1.4 10.1 20.0 1.2 1.7 1.8 1.2 0.8 2.6 0.7 1.1 2.5 0.3 0.2 0.1 0.2 0.3 1.0 2.3 0.1 0.8 1.5 0.6 0.8 0.0 0.2 0.3 0.2 10.8 0.1 0.2 3.8 0.0 1.4 0.5 0.1 6.2 0.4 0.2 0.3 0.2 0.1 0.2 0.1 4.3 0.0 3.6 0.2 0.8 0.1 0.4 6.2 0.1 0.8 0.1 1.5 0.5 0.2 0.1 0.1 0.3 0.1 0.3 0.5 1.2 0.8 0.2 1.6 1.3 0.2 0.8 4.9 0.3 0.6 2.5 1.6 0.4 0.3 2.9 0.2 0.1 1.4 2.2 0.7 0.6 0.6 0.4 0.4 0.7 1.6 0.3 0.2 1.2 0.8 0.6 2.6 1.1 0.5 0.8 2.5 0.3 1.9 1.4 1.4 3.0 1.3 0.4 0.5 2.3 1.0 0.0 8.9 0.6 0.0 0.8 1.6 0.0 175.7 2.5 1.4 0.0 1.8 0.0 0.1 8.3 0.2 2.0 1.5 0.0 0.0 0.8 0.0 4.3 0.4 10.3 8.9 1.5 0.0 2.9 5.5 0.0 1.7 0.6 1.1 10.1 0.0 1.5 0.3 1.5 0.0 0.0 0.5 0.1 0.0 3.9 0.6 0.2 2.0 0.1 0.7 1.7 0.4 LRRC20 "FLJ10751, FLJ10844" ENSG00000172731 "Leucine rich repeat containing 20" Q8TCA0 10 70298970-70382650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 111.8" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 28.5;Early spermatids: 20.2;Hepatocytes: 14.5;Late spermatids: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2 OS: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039630 Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA039630: AB_10795467" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-2)" "unprognostic (3.18e-1)" "unprognostic (2.16e-1)" "unprognostic (9.43e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.41e-4)" "unprognostic (1.50e-3)" "unprognostic (1.60e-1)" "unprognostic (1.32e-1)" "unprognostic (1.30e-1)" 1.3 2.5 5.6 1.4 7.2 1.6 1.4 5.2 11.2 3.3 3.2 2.5 0.0 1.4 2.7 3.1 7.1 2.4 2.1 15.8 5.0 3.9 1.2 8.3 2.2 1.7 3.7 6.3 2.2 1.3 2.1 3.6 1.1 4.9 2.6 2.0 1.8 1.8 2.4 111.8 1.6 1.4 3.5 2.0 1.4 1.6 3.5 1.9 1.6 2.6 14.3 3.1 2.2 4.8 0.9 2.6 0.0 1.0 1.1 4.1 1.1 14.6 11.3 7.3 15.6 4.1 3.3 0.0 1.9 6.6 5.0 4.7 9.6 15.3 2.9 7.8 1.4 15.6 5.3 7.1 10.6 3.5 8.2 2.3 1.7 2.5 22.0 4.5 4.2 1.4 1.3 3.2 6.9 2.3 4.9 9.7 19.4 2.1 4.7 4.6 2.3 16.0 3.5 2.4 11.0 25.7 13.4 4.2 8.3 6.5 1.5 18.5 8.0 1.2 1.3 5.1 1.9 1.9 4.3 5.9 4.0 34.6 5.3 4.5 7.6 13.4 4.8 6.5 17.4 0.8 0.0 0.9 0.0 1.7 1.0 1.4 0.9 1.3 1.9 2.6 0.0 4.1 1.5 0.0 1.1 0.7 0.4 0.2 1.1 5.6 7.2 5.2 11.2 5.0 3.9 3.7 6.3 4.9 1.9 0.0 5.8 0.0 0.5 1.3 8.0 28.5 2.5 0.0 1.2 0.0 3.9 0.1 0.0 3.5 20.2 2.7 0.4 0.0 4.2 0.1 2.0 0.7 0.0 14.5 0.4 1.6 5.2 1.3 0.3 32.8 2.8 0.0 1.7 1.0 1.3 7.8 4.1 1.7 1.4 1.4 1.7 0.0 1.7 4.3 4.5 0.5 0.0 0.8 1.9 0.6 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "fallopian tube: 94.2" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 279.7;Rod photoreceptor cells: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA037766: AB_10672609, HPA057533: AB_2683459" "prognostic favorable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 3.6 4.2 11.4 2.4 12.8 3.4 4.8 10.5 10.9 5.8 3.1 10.8 6.9 2.2 6.0 13.1 2.9 94.2 4.2 4.7 12.2 12.9 6.9 3.7 9.4 2.9 7.3 9.6 5.9 2.5 9.3 9.0 3.4 9.9 4.8 3.3 9.4 4.0 5.0 5.5 3.5 2.1 4.8 7.0 3.5 4.5 21.1 8.4 2.2 7.1 2.4 3.7 3.1 3.1 7.8 5.9 9.0 4.4 5.3 4.7 2.2 5.2 10.1 1.7 3.8 7.6 5.9 6.0 2.1 7.2 3.5 6.7 2.1 10.7 4.6 2.3 5.5 10.1 1.3 3.1 4.4 7.5 3.6 1.5 3.2 4.0 4.1 6.2 1.7 3.1 4.1 8.2 6.7 6.1 9.1 4.7 11.3 1.9 2.6 4.0 5.8 4.0 1.2 1.1 7.7 3.0 3.7 8.4 5.3 7.1 1.5 2.8 6.6 3.3 4.5 6.3 11.2 2.3 4.1 2.0 3.5 9.2 3.9 2.3 2.5 1.7 3.8 8.5 2.3 5.0 1.3 4.4 9.0 3.7 4.2 4.7 7.8 3.6 3.1 4.0 4.8 4.1 4.0 0.7 5.3 3.8 5.9 0.2 2.2 11.4 12.8 10.5 10.9 12.2 12.9 7.3 9.6 9.9 8.4 0.0 28.5 7.0 9.6 5.8 17.2 7.5 22.9 279.7 46.6 12.2 47.1 7.2 31.5 10.7 32.5 6.2 4.2 23.3 15.1 9.4 10.8 6.9 5.7 6.4 11.8 12.7 17.2 9.2 8.6 32.8 7.8 8.7 8.5 8.2 7.9 28.7 13.0 3.5 11.7 28.1 113.4 12.9 10.0 62.1 12.6 5.1 3.8 9.6 6.5 6.3 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522377-144527032 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 100.1;Cone photoreceptor cells: 68.7;Late spermatids: 50.7;Rod photoreceptor cells: 63.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 4.2;SCLC-21H: 4.5;SH-SY5Y: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles NA NA Vesicles "HPA028171: AB_2672504, HPA052250: AB_2681774" "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.5 4.0 5.1 1.4 9.3 1.7 1.5 12.3 16.9 2.3 2.1 1.6 0.6 2.0 2.5 1.7 1.7 2.8 1.3 1.5 4.5 7.9 2.2 1.6 2.0 1.4 4.5 8.4 4.5 3.2 9.3 8.4 1.5 5.9 11.4 1.1 10.3 2.8 3.2 2.3 1.7 2.0 1.6 2.1 2.2 1.9 1.5 1.3 0.6 1.6 1.0 1.1 1.4 1.6 0.0 0.5 0.0 0.1 0.1 0.5 0.0 0.4 0.8 0.6 1.6 0.8 0.5 1.8 0.5 0.6 0.7 0.6 0.2 1.6 0.8 3.5 0.2 0.3 0.1 0.0 0.0 0.1 1.2 2.3 0.5 1.0 0.3 0.6 0.0 1.0 0.7 0.4 0.5 0.1 0.4 0.3 0.9 0.9 0.1 0.1 4.2 1.2 1.7 0.2 0.2 0.8 1.8 0.1 0.6 0.1 0.5 4.5 12.4 0.4 0.1 0.4 0.0 3.8 1.3 0.0 0.1 1.2 0.5 0.2 1.0 0.1 0.1 0.6 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 9.3 12.3 16.9 4.5 7.9 4.5 8.4 5.9 1.3 0.0 2.9 0.0 0.5 0.8 100.1 0.0 2.5 0.0 1.2 1.8 68.7 0.4 3.3 0.2 19.3 0.0 1.8 0.0 0.2 0.4 0.8 1.5 0.0 2.4 0.4 28.6 10.3 0.0 1.5 50.7 2.6 0.8 5.0 0.0 1.7 12.1 0.4 1.9 2.8 3.0 63.8 0.0 1.4 4.8 2.9 0.4 0.3 0.0 1.6 0.5 LRRC25 "FLJ38116, MAPA" ENSG00000175489 "Leucine rich repeat containing 25" Q8N386 19 18391144-18397617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 79.9;lymphoid tissue: 50.7" "Group enriched" "Detected in some" 6 "Hofbauer cells: 45.4;Kupffer cells: 107.3;Macrophages: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "classical monocyte: 37.6;eosinophil: 41.2;intermediate monocyte: 61.8;myeloid DC: 27.9;neutrophil: 70.3;non-classical monocyte: 79.9" "Group enriched" "Detected in many" 50 "dendritic cells: 27.9;granulocytes: 70.3;monocytes: 79.9" "Cell line enhanced" "Detected in some" "HMC-1: 5.2;THP-1: 4.8;U-937: 3.9" "Low region specificity" "Detected in all" HPA029459 Approved NA NA 250000 "HPA029459: AB_10610005" "unprognostic (2.72e-2)" "unprognostic (6.08e-2)" "unprognostic (1.76e-2)" "unprognostic (2.07e-1)" "unprognostic (3.77e-2)" "unprognostic (9.15e-2)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.20e-2)" "unprognostic (4.63e-2)" "unprognostic (2.02e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-3)" "unprognostic (5.77e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.74e-1)" "unprognostic (1.14e-1)" 12.7 7.0 2.1 14.6 3.0 19.5 5.2 0.6 1.2 1.6 3.4 2.7 0.4 2.3 1.6 5.4 1.5 3.4 3.5 6.4 1.6 1.3 4.1 10.0 10.5 30.7 2.6 0.4 3.2 1.7 0.1 1.3 5.5 2.5 3.5 1.7 2.7 2.5 0.6 2.0 1.1 3.9 4.3 2.7 50.7 2.1 2.2 1.7 2.5 1.4 0.6 3.0 4.5 2.8 1.1 27.9 70.3 79.9 0.6 0.2 21.2 0.2 0.0 0.3 0.4 0.1 0.2 0.7 0.3 0.3 0.1 0.3 0.4 0.5 0.5 0.2 0.1 0.1 0.3 0.3 0.1 0.2 0.1 0.2 2.0 0.8 2.6 2.6 1.1 5.2 1.5 0.1 0.0 0.1 0.7 0.0 0.2 0.2 1.4 0.0 0.5 0.1 1.2 0.7 0.2 0.1 0.2 0.1 1.3 0.3 0.1 0.2 0.2 0.0 0.1 0.3 0.2 0.5 4.8 1.1 0.6 0.4 0.4 0.3 0.3 0.2 0.2 0.6 3.9 0.2 5.8 37.6 41.2 0.1 61.8 0.2 0.9 0.0 0.1 27.9 1.1 0.0 0.0 70.3 0.6 79.9 3.9 0.1 21.2 2.1 3.0 0.6 1.2 1.6 1.3 2.6 0.4 2.5 1.7 0.0 2.2 9.7 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 5.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.4 0.0 10.3 0.4 45.4 0.0 0.0 2.5 107.3 0.0 0.0 46.0 1.7 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.1 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 173.1" "Cell type enriched" "Detected in some" 9 "Mucus-secreting cells: 513.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 408 "plasmacytoid DC: 40.8" "Lineage enriched" "Detected in single" 408 "dendritic cells: 40.8" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 52.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: AB_2683098" "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favorable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favorable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.1 0.0 0.0 1.3 0.0 0.0 2.1 0.7 0.1 0.3 6.8 0.0 11.2 1.2 0.3 0.1 0.7 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.4 0.0 173.1 20.0 0.0 1.3 4.0 0.0 0.0 0.1 1.0 0.0 0.0 0.7 0.0 10.3 4.6 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.3 8.7 0.0 52.8 0.0 0.0 0.4 0.1 0.2 2.6 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 13.9 0.0 0.4 0.0 0.1 45.8 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.6 0.0 0.0 54.0 1.0 513.0 0.0 0.2 12.5 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.3 0.0 0.0 16.2 3.3 LRRC27 KIAA1674 ENSG00000148814 "Leucine rich repeat containing 27" Q9C0I9 10 132332154-132379918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "testis: 52.9" "Group enriched" "Detected in many" 8 "Early spermatids: 394.8;Late spermatids: 739.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 14.5;hTERT-RPE1: 18.9" "Low region specificity" "Detected in all" "HPA037595, HPA067395" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA037595: , HPA067395: AB_2732766" "unprognostic (1.97e-1)" "unprognostic (5.76e-4)" "unprognostic (1.48e-3)" "unprognostic (1.94e-3)" "unprognostic (6.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.41e-1)" "unprognostic (1.04e-2)" "unprognostic (8.26e-2)" "unprognostic (1.75e-2)" "unprognostic (5.94e-3)" "unprognostic (1.47e-1)" "unprognostic (2.18e-1)" "unprognostic (5.74e-2)" "unprognostic (1.72e-1)" "unprognostic (4.49e-2)" "unprognostic (9.27e-4)" 2.1 2.8 8.1 1.5 8.4 1.0 4.1 2.2 8.9 3.6 2.1 6.1 7.5 2.0 3.8 5.6 1.6 10.5 3.5 2.2 6.6 5.4 4.4 2.4 3.1 1.9 4.3 7.3 5.4 3.1 7.5 5.8 2.1 6.5 4.1 2.1 4.8 3.1 4.0 1.2 2.1 2.6 3.4 3.5 3.3 3.0 52.9 4.5 0.7 5.1 1.0 1.2 2.5 1.8 4.7 7.8 4.4 6.8 3.1 2.8 2.7 2.5 4.7 10.3 14.5 9.1 9.3 1.0 2.5 8.1 4.2 3.8 0.8 5.2 1.4 1.5 5.8 3.2 1.8 2.3 1.2 2.6 2.9 2.0 0.3 3.3 2.4 6.5 1.1 1.7 4.0 8.0 4.2 5.7 18.9 3.0 3.6 0.8 1.0 3.2 4.3 2.2 3.2 2.9 1.8 1.6 1.9 1.7 0.8 7.5 0.6 1.8 5.2 1.2 0.8 3.3 2.2 2.3 2.6 3.9 1.7 2.1 3.8 1.5 0.7 0.3 0.8 7.7 2.2 1.0 4.4 6.8 1.1 1.7 5.7 1.3 3.4 1.1 1.0 7.3 4.7 2.8 1.6 0.5 3.1 3.6 7.8 0.7 2.7 8.1 8.4 2.2 8.9 6.6 5.4 4.3 7.3 6.5 4.5 8.9 10.9 1.3 2.4 2.5 7.8 4.4 7.6 48.2 7.9 3.5 9.8 3.1 16.6 5.9 394.8 4.5 1.7 0.0 4.6 1.0 5.2 2.9 8.1 2.1 6.6 7.9 5.2 14.7 8.0 739.5 4.4 7.1 6.8 7.2 1.9 8.9 3.3 0.0 11.0 11.9 17.7 6.5 2.3 75.2 20.4 2.8 1.1 4.9 3.3 1.4 LRRC3 C21orf102 ENSG00000160233 "Leucine rich repeat containing 3" Q9BY71 21 44455486-44462196 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 35.3;liver: 19.1" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.2;U-2 OS: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017975 Uncertain NA NA "HPA017975: AB_1853307" "unprognostic (1.36e-2)" "unprognostic (5.48e-3)" "unprognostic (1.49e-2)" "unprognostic (2.10e-4)" "unprognostic (1.55e-1)" "unprognostic (1.74e-2)" "unprognostic (7.20e-3)" "unprognostic (2.59e-1)" "unprognostic (4.61e-1)" "unprognostic (7.43e-2)" "unprognostic (1.37e-1)" "unprognostic (1.38e-2)" "unprognostic (1.74e-5)" "unprognostic (6.44e-2)" "unprognostic (2.01e-1)" "unprognostic (7.51e-2)" "unprognostic (6.66e-3)" 3.7 2.7 1.1 2.5 1.6 1.0 3.9 0.3 1.0 4.5 7.6 1.1 2.5 3.1 2.1 3.3 3.7 1.9 35.3 2.8 1.2 1.4 1.1 19.1 3.8 3.7 0.5 0.2 5.7 2.3 0.1 2.0 1.8 0.9 4.1 1.6 2.1 2.6 1.3 1.0 3.3 3.0 5.2 0.8 1.9 5.4 5.4 0.0 2.2 1.0 2.2 1.6 4.5 5.8 0.9 0.5 2.1 0.8 0.5 1.1 0.1 0.7 0.5 4.5 3.7 0.0 0.0 11.2 1.9 0.0 0.2 0.0 1.7 1.5 0.0 3.4 0.9 2.5 0.2 2.1 0.0 0.1 0.3 4.9 0.0 0.5 5.0 0.8 0.0 2.9 1.4 1.8 0.0 0.0 0.0 1.8 0.7 0.4 5.7 0.0 1.6 0.7 0.2 1.2 5.5 1.8 2.4 0.0 1.8 0.1 0.2 3.7 4.1 1.7 0.3 0.7 2.6 1.1 2.3 3.5 0.0 8.4 0.0 0.0 3.2 6.2 0.0 0.0 2.0 0.6 1.8 0.8 0.2 0.3 0.7 1.1 0.6 0.5 0.2 0.3 0.9 0.4 0.4 2.1 0.5 0.6 0.5 0.2 0.1 1.1 1.6 0.3 1.0 1.2 1.4 0.5 0.2 0.9 0.0 0.0 1.0 1.4 0.5 0.6 0.7 1.5 2.5 0.0 0.0 1.8 0.0 0.2 0.0 0.4 0.2 0.2 1.3 0.0 0.3 4.7 1.3 1.1 1.1 26.8 2.2 0.0 4.1 0.0 2.1 1.4 0.6 1.1 0.0 5.4 2.2 1.5 1.2 0.0 0.7 0.0 0.0 0.0 1.0 0.5 1.3 0.5 0.2 0.0 1.5 0.7 LRRC30 ENSG00000206422 "Leucine rich repeat containing 30" A6NM36 18 7231125-7232047 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 30 "skeletal muscle: 18.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "SH-SY5Y: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA041039 Uncertain NA NA "HPA041039: AB_2677270" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC31 FLJ23259 ENSG00000114248 "Leucine rich repeat containing 31" Q6UY01 3 169839179-169869930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.3;salivary gland: 7.0;stomach 1: 7.6" "Cell type enhanced" "Detected in some" 22 "Intestinal endocrine cells: 9.9;Mucus-secreting cells: 20.2;Paneth cells: 6.6;Undifferentiated cells: 4.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.15e-2)" "unprognostic (5.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.90e-2)" "unprognostic (4.40e-2)" "unprognostic (7.90e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-2)" "unprognostic (3.20e-4)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (2.27e-1)" "unprognostic (5.96e-3)" 0.3 0.0 0.3 1.2 0.3 0.0 0.3 0.3 0.3 0.9 14.2 0.3 0.3 6.4 0.3 0.3 0.3 0.0 1.0 0.3 0.3 0.0 0.3 3.9 0.6 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.5 17.3 0.3 7.0 0.3 0.3 0.0 10.5 0.3 0.3 0.3 7.6 0.3 0.3 0.3 0.3 0.3 1.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 6.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.1 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793428-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 13.7;testis: 23.8" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 144.6;Cone photoreceptor cells: 35.3;Early spermatids: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 7 "B-cells: 2.2;dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "HEK 293: 7.4;HEL: 9.3;HL-60: 9.8;JURKAT: 8.1;NTERA-2: 9.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Cell Junctions, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 2.8 1.1 4.8 1.2 9.6 2.7 2.3 1.1 4.0 2.3 0.9 4.2 1.4 1.0 1.9 3.9 1.0 13.7 1.1 2.0 4.1 3.8 2.1 0.9 3.4 1.9 3.5 5.6 2.2 0.5 1.0 7.9 0.9 11.8 2.0 0.7 2.6 1.3 2.4 0.9 1.0 1.1 2.0 3.6 1.8 1.1 23.8 4.8 1.7 2.7 0.5 1.2 1.0 0.9 2.2 4.6 0.1 0.3 0.0 0.5 0.4 2.7 0.4 0.8 0.0 1.1 4.1 0.0 1.2 2.4 2.8 2.7 0.1 0.0 1.6 0.0 0.7 3.8 0.0 2.5 0.0 1.0 0.4 7.4 9.3 0.1 0.0 0.7 9.8 2.4 1.4 0.4 1.1 0.0 0.1 1.7 8.1 0.2 0.0 1.0 0.0 0.9 1.9 9.9 0.0 3.1 4.9 0.0 0.5 2.3 0.2 4.9 3.8 0.8 0.1 0.0 0.3 0.0 4.7 0.4 0.6 0.0 0.3 0.0 0.0 0.0 2.3 4.5 0.1 2.6 0.0 0.2 0.0 0.0 0.3 0.2 2.2 0.0 0.0 1.4 1.5 0.0 0.0 0.1 0.0 0.0 4.6 0.5 0.4 4.8 9.6 1.1 4.0 4.1 3.8 3.5 5.6 11.8 4.8 3.0 1.6 0.0 0.9 0.3 5.3 2.8 0.0 144.6 15.9 5.2 35.3 0.2 1.7 0.5 74.2 1.5 0.0 0.0 0.2 0.2 3.2 0.7 1.1 0.0 2.2 11.1 4.1 11.1 0.3 23.5 9.8 1.7 0.0 6.4 0.5 6.0 0.2 0.0 9.9 3.2 18.6 0.0 1.7 29.6 8.6 0.3 0.5 0.7 0.1 0.3 LRRC36 FLJ11004 ENSG00000159708 "Leucine rich repeat containing 36" Q1X8D7 16 67326798-67385203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 11.7;placenta: 9.3;testis: 31.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 68.2;Early spermatids: 152.0;Late spermatids: 96.7;Spermatocytes: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 11.7" "Lineage enriched" "Detected in many" 10 "dendritic cells: 11.7" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.5;hTEC/SVTERT24-B: 4.7;JURKAT: 4.3;TIME: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058479 Enhanced NA NA "HPA058479: AB_2683728" "unprognostic (4.59e-2)" "unprognostic (6.84e-2)" "unprognostic (2.17e-2)" "unprognostic (2.26e-5)" "unprognostic (5.27e-2)" "unprognostic (4.32e-2)" "unprognostic (5.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.65e-1)" "unprognostic (3.32e-3)" "unprognostic (4.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.26e-1)" "unprognostic (3.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.88e-2)" 0.2 0.1 0.3 0.0 1.5 0.0 0.2 0.5 0.4 0.3 0.1 0.0 0.0 0.0 0.4 2.3 0.1 2.6 0.3 0.1 1.2 0.4 0.3 0.1 4.3 0.2 0.2 0.0 0.3 2.0 0.0 1.2 9.3 2.5 0.1 0.4 0.5 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.4 31.9 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.0 11.7 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.7 0.0 0.0 0.1 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.3 1.5 0.5 0.4 1.2 0.4 0.2 0.0 2.5 0.2 3.0 68.2 0.0 0.4 0.2 0.4 0.8 0.0 18.7 1.2 0.0 0.0 0.0 0.0 0.4 152.0 0.5 0.4 0.0 0.0 0.1 0.6 0.1 8.1 0.0 0.2 0.0 2.4 0.0 0.0 96.7 2.0 0.8 6.8 0.0 0.7 1.9 0.1 0.0 1.4 1.1 0.1 0.0 0.0 48.3 10.6 0.3 0.2 0.0 1.3 0.1 LRRC37A KIAA0563 ENSG00000176681 "Leucine rich repeat containing 37A" A6NMS7 17 46292733-46337794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 9.4;testis: 15.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 18.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 8.0" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.22e-2)" "unprognostic (3.75e-2)" "unprognostic (6.02e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-2)" "unprognostic (5.23e-2)" "unprognostic (5.20e-2)" "unprognostic (8.22e-2)" "unprognostic (2.05e-1)" "unprognostic (2.65e-3)" "unprognostic (3.37e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-2)" "unprognostic (4.30e-2)" 0.9 0.4 1.4 2.0 1.8 1.4 1.7 2.6 1.7 0.7 0.9 0.5 1.1 0.4 1.1 1.0 0.5 1.1 1.5 1.2 0.9 0.6 0.9 1.5 0.6 1.2 0.9 0.5 2.1 0.7 1.3 1.0 1.0 0.9 9.4 1.8 1.3 0.6 0.8 1.2 0.8 15.2 1.2 0.9 1.1 1.1 1.4 1.7 2.1 1.4 2.1 1.5 0.2 0.2 0.2 1.6 0.2 0.3 0.0 0.5 0.1 0.4 0.1 0.2 3.6 0.3 8.0 0.3 0.3 2.5 0.3 0.0 0.0 0.0 0.5 1.2 0.4 4.0 2.7 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.5 0.3 0.2 0.6 0.9 0.0 0.3 0.7 1.2 0.0 0.0 2.7 2.9 1.8 0.0 1.9 0.5 1.1 0.2 0.6 0.1 0.0 0.5 3.6 1.2 1.4 2.4 0.4 0.2 3.6 2.5 0.5 1.3 2.4 2.3 2.1 1.1 1.0 1.0 1.0 0.9 0.8 0.8 1.5 1.1 1.4 1.3 1.1 1.9 2.1 1.4 1.7 1.0 0.2 3.0 0.3 0.0 0.3 0.1 0.6 3.6 0.0 1.4 0.0 0.0 0.0 0.1 1.7 0.2 18.2 0.0 1.3 0.0 0.4 0.0 0.2 0.1 1.1 0.0 0.3 0.0 1.2 0.0 2.7 1.0 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.7 0.2 0.1 0.1 0.5 1.0 0.0 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Early spermatids: 32.7" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "Daudi: 4.0;THP-1: 4.3;U-138 MG: 2.5" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.5 0.0 0.3 0.4 0.7 0.9 0.8 0.9 0.4 0.1 0.4 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.4 0.4 0.5 0.4 0.7 0.5 0.1 0.3 0.1 0.1 1.2 0.1 0.4 0.9 0.4 0.7 0.6 0.9 0.4 0.5 0.2 0.0 0.5 13.5 0.4 0.5 0.6 0.3 0.2 0.3 2.9 0.1 0.1 0.4 0.0 0.5 0.7 0.4 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 4.0 0.1 0.3 0.8 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.8 0.0 0.3 0.0 2.0 0.1 0.0 0.8 2.0 0.0 0.3 0.1 0.2 0.0 0.1 1.8 0.8 0.4 0.0 1.4 0.2 0.4 0.3 0.0 0.3 0.0 1.4 4.3 0.8 2.5 1.9 0.0 0.8 1.4 1.1 0.5 0.2 1.0 1.6 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 20.8 10.5 0.8 3.8 1.3 7.1 2.0 2.5 14.7 7.9 0.0 11.8 1.0 0.0 1.9 32.7 1.9 1.0 0.0 0.8 0.8 1.9 1.9 10.5 0.4 1.2 12.7 1.7 1.3 1.5 7.5 3.1 3.2 0.0 0.0 1.7 2.8 0.9 1.4 1.8 0.3 8.4 12.9 2.0 6.8 2.5 1.9 0.6 4.4 1.0 2.7 LRRC37B ENSG00000185158 "Leucine rich repeat containing 37B" Q96QE4 17 32007872-32053504 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 71.2;Spermatocytes: 37.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;NK-cells: 6.4;T-cells: 4.9" "Low cell line specificity" "Detected in all" HPA015135 Approved Approved Cytosol NA NA Cytosol "HPA015135: AB_1853309" "unprognostic (5.46e-3)" "unprognostic (2.56e-2)" "unprognostic (5.08e-2)" "unprognostic (5.30e-2)" "unprognostic (2.39e-1)" "unprognostic (1.04e-1)" "unprognostic (3.60e-2)" "unprognostic (9.65e-3)" "unprognostic (5.06e-2)" "unprognostic (3.19e-2)" "unprognostic (1.72e-4)" "unprognostic (6.99e-2)" "unprognostic (5.72e-3)" "unprognostic (6.94e-2)" "unprognostic (3.35e-2)" "unprognostic (4.97e-2)" "unprognostic (1.36e-3)" 4.7 5.0 13.7 4.8 15.0 28.5 6.4 35.5 14.4 5.9 5.2 7.2 5.0 4.5 8.3 6.5 4.6 8.2 4.8 2.7 10.7 8.5 3.7 3.0 6.7 5.5 8.6 10.2 12.1 4.3 7.4 13.8 4.6 8.9 5.3 6.4 6.1 6.5 4.2 3.5 11.7 6.3 7.2 8.5 7.6 6.6 24.5 10.3 8.3 4.4 1.8 5.8 5.3 10.2 0.8 1.1 2.8 0.5 6.4 4.9 0.5 2.1 3.9 12.5 7.1 3.2 4.0 3.9 1.9 7.1 5.5 7.1 5.4 2.1 5.6 4.0 4.3 6.9 2.8 7.4 1.5 4.4 1.6 6.3 2.6 5.8 2.0 4.7 10.1 4.8 4.2 4.7 5.0 12.8 5.3 4.6 9.6 6.1 5.4 2.1 1.9 17.6 15.6 3.8 1.9 2.7 12.4 2.9 4.5 3.1 5.2 2.4 4.0 4.8 3.1 6.5 4.3 8.2 16.3 3.9 3.9 2.7 8.6 4.6 5.4 7.7 5.6 2.8 10.2 2.8 0.0 0.4 2.8 1.1 0.5 2.1 0.2 2.2 3.0 0.8 0.8 3.0 0.8 1.1 6.4 0.2 1.1 4.9 0.5 13.7 15.0 35.5 14.4 10.7 8.5 8.6 10.2 8.9 10.3 6.0 7.8 2.7 6.4 3.7 7.8 4.4 10.2 8.1 10.3 1.8 0.0 1.8 8.3 8.5 71.2 5.0 2.9 23.3 9.0 1.9 5.0 8.3 3.5 2.9 8.3 3.2 1.7 7.4 7.9 11.8 6.4 8.3 8.5 7.2 5.5 9.2 8.3 0.0 6.7 6.9 8.7 0.0 9.6 37.1 10.6 4.4 1.8 10.1 5.4 6.5 LRRC38 ENSG00000162494 "Leucine rich repeat containing 38" Q5VT99 1 13474977-13514048 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 16.0;skeletal muscle: 60.8" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 1.4;Cardiomyocytes: 1.9;Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 7 "cerebellum: 4.1;cerebral cortex: 3.0;pons and medulla: 1.1" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.8" "Cell line enhanced" "Detected in some" "EFO-21: 3.9;MOLT-4: 14.6;PC-3: 10.5;U-138 MG: 17.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038778 Approved NA NA "HPA038778: AB_10673294" "unprognostic (5.13e-2)" "unprognostic (3.98e-1)" "unprognostic (3.12e-1)" "unprognostic (3.88e-1)" "unprognostic (5.49e-2)" "unprognostic (1.45e-3)" "unprognostic (1.72e-1)" "unprognostic (2.70e-1)" "unprognostic (9.70e-2)" "unprognostic (4.23e-1)" "unprognostic (7.81e-2)" "unprognostic (4.47e-2)" "unprognostic (1.05e-1)" 0.4 16.0 0.1 0.1 0.3 0.2 0.7 4.1 3.0 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.4 0.2 0.2 1.0 0.2 0.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.1 0.2 0.1 0.7 1.1 0.4 0.2 0.8 0.5 0.2 60.8 0.8 0.2 0.2 6.8 0.2 0.2 0.5 0.0 5.7 0.2 10.0 0.3 0.2 0.5 0.1 1.8 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 10.5 0.0 0.1 1.6 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 17.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.1 0.3 4.1 3.0 0.2 0.1 0.4 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 LRRC39 MGC14816 ENSG00000122477 "Leucine rich repeat containing 39" Q96DD0 1 100148449-100178273 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 30.7;skeletal muscle: 113.7;tongue: 28.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 83.0;Cone photoreceptor cells: 56.9;Early spermatids: 72.5;Hofbauer cells: 57.5;Rod photoreceptor cells: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 12.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA077159 Enhanced NA NA "HPA077159: AB_2732333" "unprognostic (7.68e-2)" "unprognostic (3.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.91e-1)" "unprognostic (6.40e-2)" "unprognostic (1.27e-1)" "unprognostic (4.07e-3)" "unprognostic (1.58e-2)" "unprognostic (1.87e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (8.17e-2)" "unprognostic (1.79e-1)" "unprognostic (3.38e-4)" 1.8 3.2 1.6 0.4 1.3 0.4 0.5 0.6 3.0 0.2 0.3 0.5 0.0 0.3 0.4 2.6 1.3 0.3 0.4 30.7 0.8 0.5 0.3 0.5 0.3 0.6 0.8 1.3 0.3 0.3 0.3 0.5 1.3 0.5 1.3 0.3 9.5 1.1 0.3 113.7 1.1 0.3 0.3 0.7 0.5 0.3 1.7 0.6 0.1 0.5 28.5 1.2 0.3 0.1 1.1 0.4 0.2 0.6 0.2 0.9 0.0 0.6 0.9 3.1 4.3 0.7 1.8 2.5 1.3 0.6 0.6 1.5 0.2 1.9 3.4 1.5 0.6 0.6 1.9 0.3 0.4 1.4 0.4 2.8 1.5 3.2 0.6 0.5 1.0 1.8 3.3 0.7 0.7 0.3 0.9 0.7 2.6 1.5 2.9 1.1 0.6 1.7 4.1 1.3 0.8 1.1 1.5 1.4 1.4 0.6 1.1 1.3 4.3 1.1 1.1 12.0 1.1 1.0 2.2 0.9 1.6 1.7 2.5 2.7 5.8 2.8 1.1 3.1 2.2 0.4 0.0 0.4 0.2 0.4 0.6 0.6 0.9 0.4 0.4 0.1 1.1 0.9 0.9 0.2 0.2 0.3 0.4 0.4 0.0 1.6 1.3 0.6 3.0 0.8 0.5 0.8 1.3 0.5 0.6 0.0 2.2 0.0 0.1 0.1 11.4 83.0 0.0 1.4 0.0 0.0 56.9 0.3 0.0 0.1 72.5 0.3 0.0 0.0 0.5 0.4 0.2 0.0 1.1 0.0 57.5 17.5 0.0 1.3 0.8 5.0 2.0 0.7 0.0 1.0 0.0 5.5 0.2 0.0 0.4 0.0 63.1 0.0 0.9 1.7 1.1 0.1 0.6 0.0 0.0 0.0 LRRC3B LRP15 ENSG00000179796 "Leucine rich repeat containing 3B" Q96PB8 3 26622806-26710776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 21.3;skeletal muscle: 17.4;testis: 12.0" "Cell type enriched" "Detected in some" 28 "Early spermatids: 56.9" "Group enriched" "Detected in some" 9 "endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 3.8;REH: 1.8;SuSa: 9.0;THP-1: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015568 Approved NA NA "HPA015568: AB_1853282" "unprognostic (1.22e-2)" "unprognostic (2.94e-1)" "unprognostic (1.87e-1)" "unprognostic (7.42e-2)" "unprognostic (8.82e-4)" "unprognostic (2.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.91e-4)" "unprognostic (3.31e-2)" "unprognostic (2.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.82e-1)" 0.8 0.9 15.5 0.7 13.6 0.6 1.6 18.5 21.3 0.8 1.2 2.2 0.0 0.8 2.3 0.7 1.5 1.6 0.7 1.4 9.5 7.3 0.8 0.8 0.8 0.6 8.7 5.6 2.9 0.6 0.7 0.8 0.7 5.7 0.8 1.9 3.0 1.9 1.1 17.4 0.7 1.2 2.0 4.9 0.8 1.5 12.0 1.7 0.0 0.7 0.1 0.7 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.5 13.6 18.5 10.1 9.5 7.3 8.7 5.6 5.7 1.7 0.0 0.0 0.0 0.0 0.1 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.5 0.1 0.0 0.0 0.0 0.0 LRRC3C ENSG00000204913 "Leucine rich repeat containing 3C" A6NJW4 17 39941474-39944747 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 1.9;testis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HDLM-2: 2.2;Karpas-707: 3.9;U-266/70: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA071271 Uncertain NA NA "HPA071271: AB_2686378" "unprognostic (1.59e-1)" "unprognostic (6.57e-2)" "unprognostic (6.17e-2)" "unprognostic (2.81e-1)" "unprognostic (3.16e-4)" "unprognostic (9.20e-2)" "unprognostic (4.27e-1)" "unprognostic (6.00e-2)" "unprognostic (1.24e-1)" "unprognostic (2.14e-1)" "unprognostic (1.90e-2)" 0.2 0.0 0.3 0.3 0.2 0.1 0.2 0.0 0.2 0.6 0.1 0.0 0.4 0.3 0.0 0.8 0.0 0.6 0.2 0.0 0.2 0.5 0.2 0.0 0.1 0.3 0.1 1.9 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.4 0.1 0.1 0.2 0.0 0.2 3.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.4 0.1 0.0 0.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC4 NAG14 ENSG00000128594 "Leucine rich repeat containing 4" Q9HBW1 7 128027071-128032107 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 57.6;Club cells: 43.3;Horizontal cells: 52.4;Rod photoreceptor cells: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 14.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 14.3" "Group enriched" "Detected in some" 6 "AF22: 10.7;NTERA-2: 23.8;REH: 21.9;SCLC-21H: 12.2;SH-SY5Y: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051100 Approved "Golgi apparatus" NA NA 1100000 "Golgi apparatus" "HPA051100: AB_2797241" "unprognostic (7.98e-2)" "unprognostic (6.15e-3)" "unprognostic (2.85e-2)" "prognostic favorable (8.19e-4)" "unprognostic (2.33e-1)" "unprognostic (1.34e-3)" "unprognostic (3.43e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (7.63e-2)" "unprognostic (3.23e-2)" "unprognostic (1.72e-1)" "prognostic favorable (6.98e-4)" "unprognostic (4.79e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-1)" "unprognostic (5.84e-3)" 2.6 7.7 11.6 2.9 13.1 10.0 0.8 22.3 33.2 2.3 1.1 3.2 0.7 0.9 3.4 0.5 4.0 7.3 3.4 2.0 10.1 6.6 4.6 2.2 6.3 1.9 5.1 15.5 5.5 0.6 8.6 1.5 4.7 3.1 0.9 0.8 1.7 1.5 3.5 1.0 0.5 1.0 1.9 3.4 4.7 1.5 6.3 2.9 0.8 0.8 3.6 2.4 1.5 2.0 0.0 0.0 14.3 0.6 0.0 0.1 0.1 0.0 0.1 10.7 0.0 0.4 0.0 0.0 0.6 0.0 0.9 0.3 0.0 0.0 0.0 0.8 0.9 0.0 1.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.1 0.0 23.8 0.0 0.0 21.9 0.0 0.2 0.1 0.0 12.2 7.6 0.0 0.0 0.9 1.8 0.0 2.4 0.3 0.7 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.3 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.6 0.0 0.0 0.1 11.6 13.1 22.3 28.4 10.1 6.6 5.1 15.5 3.1 2.9 14.9 14.7 0.0 1.1 0.1 12.7 1.1 0.0 57.6 43.3 1.8 25.5 0.1 0.0 0.0 4.3 1.6 0.0 0.0 0.0 0.2 0.4 2.5 1.1 0.0 14.9 52.4 0.0 15.4 7.6 0.0 0.0 0.6 1.7 0.0 0.0 1.2 0.0 0.0 0.7 0.3 40.6 0.0 0.4 4.7 4.8 0.0 0.3 0.0 0.1 16.9 LRRC43 MGC35140 ENSG00000158113 "Leucine rich repeat containing 43" Q8N309 12 122167738-122203471 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.6" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 40.2;Early spermatids: 18.7;Late spermatids: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 2.9;HSkMC: 3.3;HUVEC TERT2: 6.5;SCLC-21H: 5.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA039425 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA039425: AB_2676501" "unprognostic (6.42e-3)" "unprognostic (1.33e-1)" "unprognostic (2.71e-1)" "unprognostic (2.83e-3)" "unprognostic (2.48e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.56e-2)" "unprognostic (6.03e-5)" "unprognostic (1.19e-1)" "unprognostic (4.52e-3)" "unprognostic (2.61e-1)" "unprognostic (6.21e-4)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.39e-1)" "unprognostic (2.49e-1)" 0.9 0.9 3.0 0.3 5.0 0.8 0.7 1.2 4.6 1.5 0.7 4.1 1.3 1.0 1.4 6.6 0.4 26.6 1.6 1.5 4.5 3.0 3.1 0.5 2.5 0.4 3.1 1.5 3.3 1.2 3.5 3.4 0.5 6.4 1.3 0.5 2.9 1.8 2.2 0.4 0.8 0.5 0.6 1.0 0.8 0.7 10.8 1.8 0.0 2.5 0.0 0.4 0.7 0.3 0.0 0.9 0.0 0.6 2.9 1.9 0.8 0.0 0.0 0.3 0.0 0.3 0.7 0.4 0.0 1.8 0.5 0.5 0.6 0.1 0.0 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 2.9 0.1 0.7 3.3 0.0 1.0 0.0 0.0 6.5 0.6 0.0 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.3 5.3 1.2 0.0 0.2 0.3 0.0 0.8 1.6 0.5 0.0 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.9 0.8 0.0 0.0 1.9 0.0 2.9 0.6 0.9 0.0 0.8 3.0 5.0 1.2 4.6 4.5 3.0 3.1 1.5 6.4 1.8 6.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 40.2 3.4 1.8 3.9 0.0 1.7 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.6 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 8.3 0.0 0.0 0.0 8.4 1.1 0.0 0.1 0.0 0.0 0.0 LRRC46 MGC16309 ENSG00000141294 "Leucine rich repeat containing 46" Q96FV0 17 47831627-47837713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 51.2;testis: 94.4" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 239.6;Early spermatids: 97.9;Late spermatids: 46.8;Spermatocytes: 76.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.4" "Region enriched" "Detected in many" 4 "pons and medulla: 14.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 6.4;T-47d: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA021882, HPA074893" Enhanced Approved Cytosol NA NA Cytosol "HPA021882: AB_1853320, HPA074893: AB_2732271" "unprognostic (1.06e-1)" "unprognostic (6.01e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.40e-1)" "unprognostic (2.81e-2)" "unprognostic (4.27e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.21e-3)" "unprognostic (3.63e-2)" "unprognostic (2.98e-3)" "unprognostic (1.10e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (2.14e-1)" 0.3 0.4 1.8 0.3 3.3 0.6 0.5 0.4 0.5 2.3 0.3 5.2 1.6 0.4 1.5 13.8 0.4 51.2 0.5 0.5 2.0 2.4 0.7 0.4 11.8 0.5 0.3 0.1 8.8 0.5 0.3 4.2 0.4 14.0 0.5 0.3 1.8 0.4 1.3 0.3 0.3 0.3 0.3 0.6 0.5 0.3 94.4 1.1 1.2 1.4 0.0 0.4 0.3 0.1 0.6 2.5 4.4 1.6 2.4 1.0 0.5 1.5 6.4 0.8 3.2 0.5 1.4 1.8 0.2 1.7 1.7 3.3 3.0 1.4 0.7 4.1 0.8 1.7 1.4 0.8 1.1 2.6 2.8 2.8 1.3 1.8 1.0 0.3 0.1 1.5 0.0 1.0 3.5 1.3 0.5 0.3 1.1 1.2 0.8 2.3 2.4 2.1 0.3 0.2 0.5 1.3 2.0 0.2 1.3 2.8 1.1 2.7 2.0 0.7 0.0 0.9 0.3 7.6 0.2 0.5 3.5 1.3 0.6 0.4 1.4 1.3 1.3 2.4 0.5 0.3 4.4 1.3 2.0 0.2 1.6 0.0 0.6 0.1 1.0 2.5 0.4 0.7 0.0 1.6 2.4 1.5 1.3 0.2 0.5 1.8 3.3 0.4 0.5 2.0 2.4 0.3 0.1 14.0 1.1 0.0 2.9 0.0 0.3 0.0 0.6 0.3 0.0 239.6 27.3 5.2 2.0 0.1 0.0 0.3 97.9 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 46.8 2.6 0.7 0.0 1.0 0.1 0.9 0.5 0.0 1.8 1.0 5.4 0.0 0.1 76.7 4.0 0.0 0.1 0.0 0.0 0.1 LRRC49 FLJ20156 ENSG00000137821 "Leucine rich repeat containing 49" Q8IUZ0 15 70853239-71053657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 50.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 138.5;Ciliated cells: 62.9;Cone photoreceptor cells: 58.9;Early spermatids: 63.6;Late spermatids: 73.7;Spermatocytes: 70.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015596 Uncertain NA NA "HPA015596: AB_2669230" "unprognostic (9.74e-2)" "unprognostic (7.94e-2)" "unprognostic (3.25e-3)" "unprognostic (1.15e-2)" "unprognostic (6.10e-2)" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (1.72e-1)" "unprognostic (3.36e-2)" "unprognostic (9.43e-2)" "unprognostic (7.66e-4)" "unprognostic (3.02e-1)" "unprognostic (5.29e-2)" "unprognostic (7.60e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.09e-2)" 2.1 5.0 9.1 2.0 17.8 1.1 3.6 27.4 17.9 6.0 3.1 5.6 2.9 1.8 9.2 28.8 2.7 10.7 4.7 50.3 10.3 11.1 4.8 1.3 3.7 1.4 11.6 10.8 12.8 2.3 14.3 27.3 2.1 23.0 6.5 2.9 6.1 2.1 6.1 1.6 2.3 2.1 6.7 5.9 1.6 2.8 13.2 7.2 0.1 5.3 1.1 1.5 5.7 3.5 1.0 0.6 0.6 2.4 0.9 1.7 0.6 2.0 3.7 7.6 11.8 2.8 4.6 0.0 2.6 6.1 2.2 4.4 1.1 1.6 0.0 2.9 2.5 6.2 3.1 9.0 4.7 2.3 0.0 3.4 0.6 3.2 0.1 23.4 0.0 1.0 2.7 1.1 7.3 12.6 10.1 5.5 0.0 0.1 0.0 3.1 0.7 0.0 0.6 4.3 0.3 2.2 0.0 4.8 0.0 5.4 3.3 13.5 13.0 4.2 1.4 3.2 3.4 3.5 1.0 3.8 2.2 8.2 5.2 5.5 1.3 3.7 0.0 5.9 0.1 2.3 0.6 0.2 0.1 1.5 2.4 1.7 1.0 1.1 0.1 0.6 0.4 0.1 0.7 0.4 0.9 0.8 0.2 0.0 0.6 9.1 17.8 27.4 17.9 10.3 11.1 11.6 10.8 23.0 7.2 3.0 3.0 0.0 18.3 2.1 53.2 138.5 2.5 62.9 17.0 7.0 58.9 0.0 5.0 5.1 63.6 8.6 1.1 0.0 0.8 0.1 4.9 9.4 0.0 0.0 0.1 28.6 17.7 3.7 0.0 73.7 5.2 0.3 0.0 0.0 1.9 9.1 1.3 1.5 9.2 2.2 36.1 0.0 4.3 70.7 6.4 1.4 0.2 0.0 1.2 7.4 LRRC4B "DKFZp761A179, HSM, LRIG4" ENSG00000131409 "Leucine rich repeat containing 4B" Q9NT99 19 50516892-50568045 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.9" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 18.8;Horizontal cells: 9.5;Peritubular cells: 4.2;Spermatogonia: 5.3" "Group enriched" "Detected in many" 9 "glioma: 36.5;testis cancer: 9.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 6.0;HMC-1: 22.2;REH: 6.1;SH-SY5Y: 19.4;U-2 OS: 18.2;WM-115: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058986 Uncertain NA NA 2300000 "HPA058986: AB_2683871" "unprognostic (1.52e-2)" "unprognostic (1.14e-1)" "unprognostic (4.46e-2)" "unprognostic (4.48e-2)" "unprognostic (3.56e-1)" "unprognostic (5.39e-4)" "unprognostic (2.70e-2)" "unprognostic (1.11e-1)" "unprognostic (5.28e-2)" "unprognostic (4.61e-3)" "unprognostic (1.11e-3)" "unprognostic (3.41e-1)" "unprognostic (3.15e-5)" "unprognostic (4.29e-2)" "unprognostic (2.61e-1)" "unprognostic (3.64e-1)" "unprognostic (2.17e-1)" 3.0 8.8 28.7 2.3 24.6 1.2 1.3 21.7 52.9 13.4 2.3 4.0 0.0 2.3 9.4 1.4 3.3 3.6 2.8 2.5 23.4 22.9 1.7 1.7 3.6 2.7 17.8 20.6 2.8 1.7 1.3 8.8 6.9 12.8 2.2 1.4 2.2 2.3 2.8 1.7 1.7 3.2 3.1 15.0 1.9 2.4 2.3 8.5 0.0 1.8 0.0 1.9 3.2 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.5 0.1 0.1 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.6 0.1 0.0 5.7 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.0 19.4 0.0 0.0 3.8 0.1 0.0 0.2 0.0 0.0 18.2 0.0 0.0 0.4 0.0 0.0 0.1 0.2 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 28.7 24.6 21.7 31.9 23.4 22.9 17.8 20.6 12.8 8.5 0.0 0.0 0.0 0.0 0.0 18.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 9.5 0.0 1.3 0.0 1.6 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.2 0.0 1.0 0.0 2.1 3.9 5.3 0.0 0.1 0.0 0.0 0.0 LRRC4C "KIAA1580, NGL-1" ENSG00000148948 "Leucine rich repeat containing 4C" Q9HCJ2 11 40114203-41459773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 31.5" "Group enriched" "Detected in some" 12 "Muller glia cells: 106.3;Rod photoreceptor cells: 97.7" "Cancer enhanced" "Detected in some" "glioma: 3.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 18 "B-cells: 1.7" "Group enriched" "Detected in some" 6 "AF22: 17.3;U-2 OS: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054800, HPA075816" Supported Approved Cytosol NA NA Cytosol "HPA054800: AB_2682603, HPA075816: " "unprognostic (4.86e-3)" "unprognostic (3.43e-2)" "unprognostic (7.62e-3)" "unprognostic (4.87e-3)" "unprognostic (6.48e-2)" "unprognostic (1.42e-1)" "unprognostic (2.84e-1)" "unprognostic (4.64e-2)" "unprognostic (1.93e-1)" "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (4.90e-13)" "unprognostic (5.05e-4)" "unprognostic (5.21e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-3)" 1.6 5.7 20.2 1.6 23.7 0.5 2.6 3.6 31.5 5.3 1.9 3.3 0.0 1.1 2.3 1.0 1.2 1.3 1.8 2.6 16.7 8.7 0.9 2.1 1.6 1.4 7.5 10.3 1.6 1.0 4.3 3.2 0.5 8.7 1.5 1.6 1.3 1.4 3.0 0.7 0.7 1.3 2.4 6.0 1.3 0.9 0.9 7.9 0.0 4.0 0.0 1.6 1.1 1.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 19.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 23.7 3.6 16.4 16.7 8.7 7.5 10.3 8.7 7.9 0.0 2.2 0.0 0.0 0.1 8.7 1.0 0.0 0.0 1.2 0.0 5.9 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.1 7.9 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 0.0 106.3 0.2 0.0 1.4 0.6 97.7 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 LRRC52 FLJ25811 ENSG00000162763 "Leucine rich repeat containing 52" Q8N7C0 1 165544007-165563961 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 31.9" "Cell type enriched" "Detected in some" 5 "Early spermatids: 118.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-937: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.09e-2)" "unprognostic (1.76e-2)" "unprognostic (6.48e-2)" "unprognostic (3.79e-2)" "unprognostic (8.45e-2)" "unprognostic (6.70e-4)" "unprognostic (6.05e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 LRRC53 ENSG00000162621 "Leucine rich repeat containing 53" A6NM62 1 74469878-74512614 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 2.9" "Cell type enriched" "Detected in single" 11 "Intestinal endocrine cells: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "SCLC-21H: 3.6" HPA054062 Uncertain NA NA "HPA054062: AB_2682364" "unprognostic (3.67e-1)" 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.6 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.5 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC55 FLJ45686 ENSG00000183908 "Leucine rich repeat containing 55" Q6ZSA7 11 57181747-57191717 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 9.2;lymphoid tissue: 24.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "glioma: 9.0;ovarian cancer: 2.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 4 "AF22: 21.0" "Low region specificity" "Detected in many" HPA014053 Uncertain NA NA "HPA014053: AB_2137630" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (3.68e-2)" "unprognostic (3.03e-2)" "unprognostic (2.78e-3)" "unprognostic (2.29e-3)" "unprognostic (2.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (9.43e-2)" "unprognostic (2.11e-2)" "unprognostic (3.32e-2)" "unprognostic (7.17e-4)" "unprognostic (6.66e-2)" "unprognostic (3.59e-1)" "unprognostic (3.79e-2)" 0.8 1.0 2.2 3.4 2.3 0.0 0.1 0.8 9.2 0.1 0.9 0.4 0.1 0.6 3.1 0.1 1.2 0.7 0.6 0.5 2.7 7.3 0.6 2.5 1.5 24.4 6.9 0.5 0.6 0.4 0.0 0.1 2.9 1.7 0.1 1.0 0.1 3.4 0.1 0.6 0.1 0.9 2.2 7.3 2.6 0.1 0.2 0.1 2.2 0.2 2.1 1.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 2.3 0.8 3.7 2.7 7.3 6.9 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRC56 "DKFZp761L1518, FLJ00101" ENSG00000161328 "Leucine rich repeat containing 56" Q8IYG6 11 537527-554916 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 15.5;testis: 20.8" "Group enriched" "Detected in many" 5 "Early spermatids: 54.0;Late spermatids: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.2;Daudi: 3.0;Karpas-707: 5.9;SK-BR-3: 3.7;T-47d: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038728 Approved NA NA "HPA038728: AB_10671864" "unprognostic (2.77e-2)" "unprognostic (9.54e-3)" "unprognostic (1.28e-2)" "prognostic favorable (7.39e-4)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (2.29e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.32e-4)" "unprognostic (1.17e-1)" "unprognostic (7.89e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-3)" 0.6 0.7 2.4 2.9 9.6 1.1 0.6 3.2 1.7 1.6 1.7 1.2 8.1 0.9 1.2 9.1 2.1 4.6 5.0 0.5 2.1 1.6 1.7 0.8 7.8 3.0 0.5 1.3 3.4 4.5 0.4 15.5 0.6 2.8 1.9 0.8 1.7 2.2 2.0 1.1 4.8 2.8 0.5 0.4 1.0 3.6 20.8 0.7 0.3 1.8 0.1 5.3 1.0 0.8 0.5 0.1 0.2 0.3 0.3 1.2 0.7 0.0 0.0 0.1 4.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.5 0.0 3.0 0.0 0.0 0.1 1.0 0.1 0.4 0.0 0.0 0.0 0.0 1.5 0.1 1.7 1.0 2.6 1.0 1.9 0.0 0.3 0.0 0.0 1.1 0.0 5.9 0.0 0.0 0.3 1.5 0.0 1.5 1.7 0.0 0.0 1.2 0.5 0.0 0.8 0.5 0.0 3.7 0.0 0.2 4.6 0.1 0.1 0.7 0.1 0.2 0.2 0.8 0.2 0.1 0.0 0.0 1.0 0.2 0.2 0.0 0.2 0.3 0.1 0.5 0.1 0.6 0.1 0.1 0.1 0.6 0.0 0.3 0.1 0.0 1.2 0.7 2.4 9.6 3.2 1.7 2.1 1.6 0.5 1.3 2.8 0.7 0.0 4.3 1.7 1.5 1.4 1.5 0.4 2.5 5.3 2.3 3.5 15.7 0.1 0.0 0.8 54.0 0.0 1.3 0.0 0.4 0.1 0.3 1.7 0.0 0.0 0.2 6.4 12.0 0.6 0.8 96.6 1.1 0.0 1.7 0.0 2.2 2.5 0.5 0.9 1.1 0.7 6.6 0.0 0.0 4.4 2.1 0.6 0.5 1.5 0.5 0.6 LRRC6 "CILD19, LRTP, TSLRP" ENSG00000129295 "Leucine rich repeat containing 6" Q86X45 8 132571953-132675617 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 22.9;testis: 27.6" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 176.7;Early spermatids: 152.3;Spermatocytes: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.5;RPTEC TERT1: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028058 Approved NA NA "HPA028058: AB_1853337" "unprognostic (1.53e-1)" "unprognostic (2.77e-1)" "unprognostic (6.91e-3)" "unprognostic (3.56e-2)" "unprognostic (2.50e-2)" "unprognostic (8.04e-3)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (7.39e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-1)" "unprognostic (9.51e-2)" "unprognostic (3.38e-2)" "unprognostic (8.42e-3)" "unprognostic (3.95e-2)" "prognostic unfavorable (5.98e-4)" "unprognostic (4.17e-2)" 3.1 4.2 7.8 2.4 18.2 4.2 3.6 2.0 10.6 6.5 2.7 4.5 2.4 1.5 4.2 8.2 1.6 22.9 4.6 2.1 6.5 7.3 14.0 1.8 4.2 1.3 3.7 8.1 4.6 2.9 7.8 10.6 2.4 17.6 2.0 2.2 5.4 1.9 3.2 0.8 1.9 3.3 3.3 3.8 3.6 1.4 27.6 4.1 0.4 8.0 0.0 1.1 3.9 2.1 0.2 0.7 6.3 0.5 0.0 0.6 0.7 0.4 2.4 3.5 0.0 3.1 5.1 7.8 0.3 0.5 1.7 1.6 0.4 8.5 0.0 2.6 3.2 2.5 0.0 0.6 1.1 1.8 0.3 0.0 0.0 0.6 0.1 1.3 0.0 3.9 4.4 2.2 3.9 0.1 4.1 0.8 3.6 0.3 0.0 2.2 2.8 0.0 0.1 5.6 2.6 2.2 0.0 0.1 1.1 16.1 0.0 1.8 2.7 0.3 0.0 0.4 5.8 0.9 0.5 0.0 2.0 7.5 6.4 0.7 0.0 0.9 0.2 5.5 0.4 0.2 1.3 0.5 0.0 0.1 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.7 0.0 0.7 7.8 18.2 2.0 10.6 6.5 7.3 3.7 8.1 17.6 4.1 6.0 0.3 0.0 3.2 1.1 2.5 2.9 2.5 176.7 25.0 8.7 7.9 0.0 18.3 4.5 152.3 1.8 2.0 0.0 1.5 0.1 2.4 0.8 0.0 0.8 2.0 1.6 1.2 3.7 1.5 38.6 3.4 1.4 0.0 0.0 0.9 6.5 0.7 0.8 4.2 25.9 13.1 0.0 1.7 47.6 9.5 1.0 0.0 0.0 1.6 1.4 LRRC61 "FLJ31392, HSPC295, MGC3036" ENSG00000127399 "Leucine rich repeat containing 61" Q9BV99 7 150322639-150338150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 41.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 31.1;Hep G2: 20.7;NTERA-2: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019355 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA019355: AB_1853339" "unprognostic (4.05e-2)" "unprognostic (9.50e-2)" "unprognostic (1.61e-3)" "unprognostic (5.91e-3)" "prognostic unfavorable (1.11e-5)" "unprognostic (1.46e-2)" "unprognostic (4.43e-3)" "unprognostic (1.82e-1)" "unprognostic (1.76e-2)" "unprognostic (4.22e-2)" "unprognostic (2.53e-2)" "unprognostic (1.56e-1)" "unprognostic (1.66e-2)" "prognostic favorable (2.85e-4)" "unprognostic (1.21e-1)" "unprognostic (3.27e-1)" "unprognostic (1.69e-3)" 2.8 14.7 6.7 9.0 9.3 2.3 4.1 7.5 7.3 6.7 6.0 3.5 4.5 5.8 7.0 4.0 6.4 20.8 8.0 3.3 5.4 13.1 10.8 18.3 4.8 9.1 5.0 3.4 18.5 12.7 12.2 10.9 7.3 5.1 6.4 2.9 10.6 6.2 6.7 3.0 5.4 7.9 3.8 3.0 10.1 6.6 6.6 3.9 41.0 16.4 3.0 11.8 4.2 9.0 9.5 15.1 11.6 2.4 6.5 10.5 4.2 7.8 0.2 0.2 0.0 0.0 0.0 3.7 0.0 0.0 1.0 3.2 14.8 7.8 2.4 3.3 0.1 0.0 7.1 0.0 0.0 0.5 31.1 10.1 2.8 9.5 20.7 5.7 0.0 1.5 0.6 3.2 0.0 0.0 0.2 0.0 16.2 9.8 4.6 0.0 14.2 14.3 1.2 27.3 5.3 0.0 0.0 0.0 6.4 2.3 5.1 14.1 13.8 13.2 2.9 5.4 2.3 2.2 1.7 0.0 0.0 0.0 0.0 0.0 5.1 1.6 0.0 0.0 0.0 0.0 2.3 2.4 6.7 9.5 1.0 7.6 8.0 6.8 7.3 2.6 9.5 6.7 7.7 11.6 6.5 1.0 15.1 10.5 4.2 6.7 9.3 7.5 7.3 5.4 13.1 5.0 3.4 5.1 3.9 6.0 1.0 6.5 4.0 1.0 7.7 2.1 10.2 20.1 4.5 15.7 0.0 22.6 16.6 22.1 4.7 2.1 9.6 0.0 24.7 21.2 2.4 4.0 1.1 18.3 5.5 12.7 18.6 1.3 1.3 12.9 9.5 1.8 3.3 24.4 7.6 13.0 27.0 13.9 5.3 27.2 4.7 0.0 0.8 20.4 22.8 2.4 22.5 8.7 9.5 2.6 LRRC63 RP11-139H14.4 ENSG00000173988 "Leucine rich repeat containing 63" 13 46211943-46277366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.3;epididymis: 7.2" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 8.1;Cone photoreceptor cells: 5.9;Early spermatids: 23.3;Late spermatids: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 3.6;JURKAT: 6.4;MOLT-4: 1.6;THP-1: 1.9" "HPA039318, HPA039763" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA039318: AB_10796224, HPA039763: AB_10795408" "unprognostic (3.40e-2)" "unprognostic (2.81e-1)" "unprognostic (5.33e-1)" "unprognostic (2.12e-3)" "unprognostic (1.96e-1)" "unprognostic (3.99e-1)" "unprognostic (1.06e-2)" "unprognostic (7.28e-2)" "unprognostic (3.05e-2)" "unprognostic (1.11e-1)" "unprognostic (5.39e-2)" "unprognostic (7.61e-2)" "unprognostic (1.18e-6)" "unprognostic (1.27e-1)" "unprognostic (2.98e-1)" "unprognostic (4.57e-2)" "unprognostic (7.31e-2)" 0.6 1.3 1.5 1.0 9.9 1.0 0.7 0.7 5.0 1.2 0.7 11.9 0.0 0.6 0.5 7.2 0.5 1.3 0.4 0.5 3.0 1.8 0.8 0.7 1.1 1.3 16.3 2.3 0.5 0.5 0.7 0.5 0.7 10.0 1.1 0.7 0.7 0.7 0.8 0.5 0.6 0.6 0.4 15.9 0.8 0.8 6.2 10.0 3.6 0.6 0.0 0.4 0.8 0.5 0.0 0.9 0.2 0.1 0.0 1.8 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.3 3.6 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.2 0.7 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.8 0.3 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.4 0.4 0.1 0.0 1.8 1.7 0.2 0.0 0.0 0.9 0.0 0.5 1.5 9.9 0.7 5.0 3.0 1.8 16.3 2.3 10.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.1 0.0 0.0 5.9 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 1.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.0 LRRC66 ENSG00000188993 "Leucine rich repeat containing 66" Q68CR7 4 51993702-52017620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 50.2" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 11.9;Mucus-secreting cells: 4.0;Paneth cells: 2.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.0;CAPAN-2: 5.1;OE19: 6.5" "Low region specificity" "Detected in all" "HPA014549, HPA027839" Uncertain NA NA "HPA014549: AB_1853062, HPA027839: AB_10602705" "unprognostic (1.10e-1)" "unprognostic (4.87e-2)" "unprognostic (8.62e-2)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-1)" "unprognostic (2.57e-2)" "unprognostic (4.83e-3)" "unprognostic (2.93e-1)" "unprognostic (4.09e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (6.31e-3)" "unprognostic (1.71e-1)" "unprognostic (1.19e-1)" "unprognostic (3.05e-1)" "unprognostic (4.06e-1)" 0.5 0.1 0.8 2.6 1.0 0.0 0.5 1.4 0.9 0.5 11.3 0.5 0.5 19.6 0.5 0.5 0.5 0.5 1.6 0.6 0.8 0.8 0.9 0.5 0.5 0.5 0.8 0.5 0.5 0.5 0.5 3.1 0.5 0.5 0.5 5.2 0.5 0.5 0.5 6.7 0.0 50.2 0.5 0.6 0.5 4.6 0.7 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.2 0.4 0.6 1.7 4.0 0.1 0.6 1.0 0.3 0.7 0.2 5.1 0.0 0.1 0.9 0.1 0.0 0.3 0.2 0.3 1.6 0.6 0.0 0.2 0.0 0.2 0.1 0.1 1.6 0.8 0.8 0.2 1.3 0.4 0.3 0.0 0.0 2.0 0.0 0.1 0.0 0.0 6.5 0.9 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.4 1.1 0.0 0.7 0.5 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.4 0.9 0.8 0.8 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 11.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.0 4.0 0.0 0.3 2.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.6" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 38.9;Late spermatids: 11.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 6.8;SuSa: 6.1;U-266/70: 17.7;U-266/84: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA046337: AB_2679626" "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.8 0.9 0.2 1.5 0.2 0.0 1.0 0.0 0.1 0.7 0.5 0.1 0.5 1.9 0.7 0.4 0.5 1.1 0.1 0.1 0.9 0.7 0.7 1.9 0.3 0.4 0.7 0.3 0.6 0.5 1.0 1.5 1.1 0.3 0.6 3.5 0.6 1.4 0.3 1.2 0.6 6.6 1.3 1.1 1.0 0.8 1.9 2.0 1.5 1.1 0.4 2.3 0.1 0.6 0.7 0.2 0.5 0.7 1.5 1.2 0.4 0.1 0.3 0.3 1.1 0.9 1.0 0.5 0.2 0.1 0.6 0.7 1.2 0.3 0.3 6.8 1.5 1.8 0.5 0.2 0.5 1.1 0.4 1.1 0.4 0.8 0.4 0.1 1.2 1.1 0.6 0.4 0.2 0.3 0.5 0.7 1.1 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 6.1 1.6 1.2 0.2 0.3 0.7 0.2 0.9 17.7 9.8 4.0 0.1 2.2 0.9 1.3 0.6 1.5 1.5 1.1 1.5 1.2 1.6 0.6 0.1 1.9 2.3 1.2 0.1 0.4 0.6 2.0 2.1 0.1 0.0 0.6 0.8 2.4 4.1 1.8 2.4 0.0 6.7 1.2 3.5 3.9 1.9 3.3 1.3 38.9 2.1 0.5 0.0 1.0 1.5 2.2 3.1 0.0 0.8 0.8 0.0 2.4 3.7 2.1 11.9 2.6 1.7 6.8 4.6 1.4 1.1 1.5 0.9 1.1 0.2 3.2 0.0 2.1 2.3 2.5 4.5 0.8 0.0 1.4 2.0 LRRC7 "densin-180, KIAA1365" ENSG00000033122 "Leucine rich repeat containing 7" Q96NW7 1 69568398-70151945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 29.1" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 37.9;Early spermatids: 20.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3" "Group enriched" "Detected in many" 14 "granulocytes: 1.4;T-cells: 1.7" "Group enriched" "Detected in some" 6 "HaCaT: 10.5;HEL: 31.3" "Low region specificity" "Detected in many" HPA005625 Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA005625: AB_1853340" "unprognostic (2.81e-2)" "unprognostic (1.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.98e-3)" "unprognostic (2.47e-1)" "unprognostic (1.73e-1)" "unprognostic (1.04e-1)" "unprognostic (3.50e-2)" "unprognostic (4.84e-3)" "unprognostic (2.92e-2)" "unprognostic (1.06e-3)" "unprognostic (1.46e-1)" "unprognostic (5.64e-6)" "unprognostic (1.31e-2)" "unprognostic (1.74e-2)" "unprognostic (5.13e-3)" "unprognostic (2.08e-3)" 1.0 1.3 20.2 1.0 29.1 1.0 0.8 0.5 21.9 1.2 1.9 5.0 0.0 1.0 1.2 1.0 1.3 0.8 3.2 2.8 15.4 5.8 2.8 1.2 0.8 0.9 4.4 17.6 1.0 2.7 0.7 0.4 1.2 2.4 1.5 2.4 0.2 0.9 1.1 2.8 1.1 1.3 1.2 2.5 0.8 0.8 5.8 7.6 0.0 6.7 0.0 0.8 0.9 0.5 0.0 0.1 1.4 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 3.3 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.5 31.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 3.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.1 20.2 29.1 0.5 19.2 15.4 5.8 4.4 17.6 2.4 7.6 0.0 0.0 5.1 0.5 0.7 37.9 5.8 2.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 20.2 1.4 0.0 0.0 0.0 0.4 2.1 0.7 0.0 5.5 0.3 6.4 0.0 1.8 1.5 4.6 0.6 0.7 5.0 0.0 0.0 0.5 0.0 0.0 2.8 1.3 7.9 0.0 1.4 7.4 2.7 1.1 0.1 2.5 0.0 0.1 LRRC71 "C1orf92, FLJ32884" ENSG00000160838 "Leucine rich repeat containing 71" Q8N4P6 1 156920650-156933094 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;fallopian tube: 16.9;testis: 26.4" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 96.4;Early spermatids: 207.3;Late spermatids: 442.9" "Cancer enriched" "Detected in single" 7 "endometrial cancer: 3.3" "Region enhanced" "Detected in many" "pons and medulla: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 8.4;PC-3: 3.8;TIME: 3.4;U-2 OS: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (8.91e-2)" "unprognostic (4.21e-2)" "unprognostic (6.13e-2)" "unprognostic (1.95e-3)" "unprognostic (5.43e-2)" "unprognostic (3.98e-2)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (8.02e-2)" "unprognostic (5.07e-3)" "unprognostic (5.18e-1)" "unprognostic (1.68e-7)" "unprognostic (2.29e-1)" "unprognostic (5.18e-2)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" 0.3 0.8 1.1 0.1 4.0 0.1 0.1 0.0 0.3 1.1 0.1 5.6 0.0 0.1 0.5 5.6 0.1 16.9 0.1 0.1 1.7 1.8 0.1 0.1 3.0 0.1 0.2 0.4 3.6 0.1 0.1 0.0 0.3 9.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 26.4 1.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 4.0 0.0 0.3 1.7 1.8 0.2 0.4 9.5 1.2 0.0 2.6 0.0 0.0 0.0 0.2 0.4 0.0 96.4 18.2 0.0 0.0 0.0 0.0 0.0 207.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 442.9 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 10.9 2.3 0.0 0.0 0.0 0.0 0.0 LRRC72 ENSG00000205858 "Leucine rich repeat containing 72" A6NJI9 7 16526880-16581568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 15.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 117.7" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020554 Uncertain NA NA "HPA020554: AB_1859508" "unprognostic (1.58e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 LRRC73 "C6orf154, dJ337H4.2" ENSG00000204052 "Leucine rich repeat containing 73" Q5JTD7 6 43506969-43510686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5;testis: 31.6" "Cell type enriched" "Detected in many" 7 "Early spermatids: 299.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 5.7;MCF7: 5.7;OE19: 8.0;T-47d: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046698 Enhanced Approved Cytosol NA NA Cytosol "HPA046698: AB_10959526" "unprognostic (3.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (4.42e-3)" "unprognostic (1.04e-2)" "unprognostic (3.52e-1)" "unprognostic (6.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.25e-1)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.81e-1)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-3)" "unprognostic (1.89e-2)" 1.2 6.1 10.4 0.9 19.4 0.8 1.1 2.3 23.5 1.4 1.3 2.3 0.9 2.1 1.4 1.5 1.0 11.3 1.8 1.8 8.9 5.2 3.0 1.2 1.6 0.9 3.1 12.1 2.0 2.8 7.5 4.1 1.2 6.2 1.9 1.1 0.6 1.4 2.1 1.0 1.1 1.2 1.5 1.1 1.2 1.8 31.6 1.8 0.0 1.6 0.0 0.9 1.4 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.3 0.8 5.7 0.9 2.9 0.2 0.2 1.6 0.5 0.3 0.0 0.3 0.2 0.1 1.0 0.8 2.2 0.7 0.7 0.0 0.1 0.9 0.0 0.4 0.2 0.9 0.0 0.1 0.5 1.1 1.8 0.3 2.8 0.1 0.3 0.3 0.5 1.0 5.7 0.0 0.0 0.1 8.0 0.7 0.0 0.0 0.1 1.5 0.0 2.1 2.5 0.5 0.4 0.2 0.0 5.8 0.0 0.2 0.4 0.6 2.1 0.2 0.5 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 19.4 2.3 23.5 8.9 5.2 3.1 12.1 6.2 1.8 0.0 0.0 0.0 2.4 0.3 4.9 0.8 0.0 8.1 2.3 3.5 0.0 0.1 6.6 0.6 299.6 0.1 1.3 0.0 0.7 0.1 0.6 2.3 0.0 0.4 0.1 27.0 5.2 0.0 0.0 27.3 4.0 0.0 1.7 0.0 2.0 8.3 0.2 0.0 3.9 5.1 6.6 6.5 1.1 41.7 9.7 0.0 0.2 0.0 0.6 0.6 LRRC74A "C14orf166B, LRRC74" ENSG00000100565 "Leucine rich repeat containing 74A" Q0VAA2 14 76826372-76870302 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 19.8" "Group enriched" "Detected in some" 88 "Early spermatids: 50.3;Late spermatids: 81.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "NTERA-2: 1.1;RH-30: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA035094 Uncertain NA NA "HPA035094: AB_10600793" "unprognostic (7.71e-3)" "unprognostic (1.77e-1)" "unprognostic (2.77e-1)" "unprognostic (6.38e-2)" "unprognostic (3.44e-1)" "unprognostic (5.29e-3)" "unprognostic (3.22e-1)" "unprognostic (1.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.11e-2)" "unprognostic (5.21e-4)" "unprognostic (1.72e-1)" "unprognostic (9.96e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 81.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 LRRC74B ENSG00000187905 "Leucine rich repeat containing 74B" Q6ZQY2 22 21045960-21064168 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.1;epididymis: 5.6;fallopian tube: 11.4" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 132.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "pons and medulla: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 1.7;U-87 MG: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049947 Uncertain NA NA "HPA049947: AB_2680966" "unprognostic (3.43e-2)" "unprognostic (1.76e-1)" "unprognostic (3.28e-4)" "unprognostic (1.06e-1)" "unprognostic (6.44e-3)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (1.64e-2)" "unprognostic (1.18e-1)" "unprognostic (7.57e-9)" "unprognostic (4.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-2)" "unprognostic (4.92e-2)" 0.2 0.2 2.1 0.2 2.3 0.2 0.2 0.4 1.6 1.5 0.2 3.7 0.0 0.4 0.3 5.6 0.2 11.4 0.2 0.2 1.5 1.2 0.2 0.2 1.9 0.2 0.1 0.7 1.9 0.2 0.2 0.9 0.2 17.1 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.5 0.2 0.2 3.6 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 0.4 1.6 1.5 1.2 0.1 0.7 17.1 0.3 0.0 2.6 0.0 0.6 0.0 1.0 0.4 0.0 132.5 22.7 0.0 3.9 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 1.6 0.0 0.6 0.0 0.4 0.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.7 2.1 0.0 0.2 0.0 0.0 0.0 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 12.0;HUVEC TERT2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.2 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.8 2.3 1.1 0.3 0.0 0.8 0.1 0.5 0.4 0.3 0.2 0.1 0.4 0.9 12.0 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 0.4 3.9 1.3 0.5 0.2 0.0 2.0 1.9 0.8 0.2 2.8 0.1 0.7 0.7 0.1 0.6 0.2 2.3 0.6 0.0 0.2 2.8 0.5 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 38.7 51.3 11.9 7.2 0.0 8.7 0.3 7.6 16.0 36.4 1.8 5.9 13.7 16.6 3.8 5.3 6.0 49.1 23.3 6.1 16.9 3.9 6.4 27.8 8.1 10.5 3.2 23.7 9.2 10.7 5.9 15.3 6.7 0.0 1.8 44.8 16.7 5.7 23.0 10.6 15.2 16.4 12.9 2.3 3.8 6.7 0.0 14.0 8.9 47.2 6.2 LRRC8B "KIAA0231, TA-LRRP" ENSG00000197147 "Leucine rich repeat containing 8 VRAC subunit B" Q6P9F7 1 89524836-89597864 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 81.5;Late spermatids: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017950 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA017950: AB_1853346" "unprognostic (2.50e-2)" "unprognostic (3.93e-2)" "prognostic favorable (7.15e-4)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.22e-1)" "unprognostic (5.24e-2)" "unprognostic (3.97e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (1.72e-1)" "unprognostic (8.80e-3)" "unprognostic (2.30e-2)" "unprognostic (1.85e-1)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" 8.1 18.0 13.0 4.4 19.3 3.0 6.6 2.5 27.8 3.8 5.6 15.4 0.5 7.4 2.6 6.9 5.0 4.3 6.2 3.3 15.3 6.5 4.9 4.8 5.8 4.9 8.8 17.1 2.6 8.5 12.4 5.1 2.4 8.3 5.6 6.8 4.4 5.0 1.6 5.9 6.9 4.9 3.6 16.2 4.3 6.4 17.4 8.2 3.1 6.1 2.7 5.9 3.3 3.3 3.0 2.4 1.5 2.2 0.9 3.7 1.6 8.5 3.3 2.4 8.4 12.2 7.3 9.7 0.2 2.5 1.1 1.6 5.2 5.2 0.7 3.5 1.2 3.3 4.5 22.3 1.9 1.4 4.1 4.5 16.6 2.2 4.5 1.2 7.9 11.8 4.0 7.1 0.9 3.7 0.4 11.9 6.7 18.5 5.7 1.3 4.6 3.9 3.8 13.8 3.5 4.8 8.8 1.1 3.0 2.7 10.7 7.0 11.2 4.7 11.4 8.1 3.0 6.9 3.8 3.9 1.0 5.7 2.6 2.7 4.2 3.4 4.2 1.4 2.0 2.0 1.4 2.2 1.5 1.1 1.1 1.7 3.0 2.1 1.7 2.4 2.3 3.7 2.9 0.7 0.9 1.2 2.1 3.4 1.6 13.0 19.3 2.5 27.5 15.3 6.5 8.8 17.1 8.3 8.2 14.9 11.5 5.6 11.4 29.3 34.9 3.4 12.7 20.1 14.8 7.0 45.2 2.6 1.7 12.0 81.5 8.4 5.1 0.0 16.2 9.6 1.5 17.3 2.3 6.7 6.1 0.0 25.8 19.6 13.2 55.3 2.3 7.7 1.7 3.6 13.0 5.5 12.8 3.5 2.5 4.5 21.5 6.5 14.7 6.9 4.1 24.1 2.1 2.5 11.0 8.9 LRRC8D "FLJ10470, LRRC5" ENSG00000171492 "Leucine rich repeat containing 8 VRAC subunit D" Q7L1W4 1 89821014-89936611 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA No "unprognostic (2.92e-3)" "unprognostic (9.50e-2)" "unprognostic (1.06e-3)" "prognostic unfavorable (3.21e-5)" "unprognostic (4.98e-2)" "unprognostic (7.03e-2)" "unprognostic (7.71e-3)" "unprognostic (7.74e-2)" "unprognostic (9.67e-2)" "unprognostic (1.01e-2)" "unprognostic (1.42e-1)" "unprognostic (2.77e-1)" "unprognostic (4.91e-2)" "unprognostic (9.52e-3)" "unprognostic (1.23e-1)" "unprognostic (2.65e-2)" "unprognostic (9.61e-2)" 4.4 26.3 15.7 11.0 24.0 9.6 9.7 8.8 21.3 9.7 13.1 46.2 4.3 14.1 7.7 8.1 6.7 5.9 6.0 5.5 24.5 16.9 19.8 17.6 7.1 17.0 34.7 20.3 4.6 9.6 6.8 16.2 7.5 24.5 4.3 14.0 7.5 17.8 4.6 7.8 5.0 13.6 8.6 38.5 16.8 8.3 7.5 31.6 11.8 12.1 4.3 14.8 8.9 3.4 5.8 7.8 3.0 8.8 10.5 14.3 8.4 24.7 16.2 6.6 15.6 11.9 10.1 22.5 17.0 25.7 9.7 12.2 6.9 6.3 19.6 19.4 28.2 11.0 32.7 15.2 20.4 12.3 15.3 8.4 23.0 14.7 14.6 23.3 26.2 7.3 6.3 17.0 8.2 18.0 13.4 16.4 11.4 12.5 6.2 10.5 7.4 10.8 17.0 11.5 5.6 14.9 14.7 9.6 14.0 24.4 8.8 12.4 8.7 21.1 21.9 47.0 12.0 5.2 26.1 7.2 10.4 3.5 21.1 12.8 7.6 12.9 11.8 4.0 33.1 9.1 0.0 7.1 1.2 6.2 8.8 10.3 5.8 14.3 7.4 6.8 5.3 13.8 10.2 3.0 10.5 6.6 7.8 13.8 8.4 15.7 24.0 8.8 21.3 24.5 16.9 34.7 20.3 24.5 31.6 3.0 1.7 6.5 1.5 5.4 6.1 2.1 10.2 6.7 4.5 12.2 2.0 3.5 6.6 5.0 0.6 5.8 17.1 23.3 7.4 7.9 1.8 2.0 5.7 26.3 10.8 3.2 7.5 9.2 20.6 0.0 1.1 16.3 10.1 20.8 11.2 6.5 5.7 10.5 3.5 9.7 7.1 6.5 1.4 0.1 0.6 1.0 1.5 8.7 9.8 1.4 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.4;pituitary gland: 13.9;testis: 14.3" "Group enriched" "Detected in some" 9 "Early spermatids: 98.5;Late spermatids: 64.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 7.3;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.6 0.4 0.6 0.1 7.3 0.2 0.1 0.2 1.1 0.3 0.1 3.2 0.0 0.1 0.2 1.4 0.1 3.4 0.1 0.1 1.4 1.2 0.2 0.2 0.1 0.1 0.5 1.3 1.0 0.2 4.8 13.9 0.1 16.4 1.3 0.1 0.0 0.1 0.2 0.1 0.1 0.7 0.1 0.9 0.1 0.2 14.3 2.2 0.0 0.1 0.0 0.1 0.2 0.1 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 7.3 0.2 1.1 1.4 1.2 0.5 1.3 16.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 64.1 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 8.8 0.9 0.0 0.1 0.0 0.0 0.0 LRRCC1 "CLERC, KIAA1764, VFL1" ENSG00000133739 "Leucine rich repeat and coiled-coil centrosomal protein 1" Q9C099 8 85107147-85146076 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.1" "Group enriched" "Detected in many" 4 "Early spermatids: 124.2;Late spermatids: 120.8;Spermatocytes: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012893, HPA075880" Uncertain Supported Centrosome NA NA Centrosome "HPA012893: AB_1852434, HPA075880: " "unprognostic (1.01e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-3)" "unprognostic (2.37e-2)" "unprognostic (7.67e-2)" "unprognostic (7.76e-2)" "unprognostic (1.47e-2)" "unprognostic (1.05e-1)" "unprognostic (2.01e-1)" "unprognostic (1.31e-1)" "unprognostic (4.45e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-2)" "unprognostic (2.43e-2)" "unprognostic (2.67e-2)" "unprognostic (7.37e-2)" "unprognostic (1.52e-1)" 5.2 5.6 10.8 9.8 10.7 7.0 7.3 2.3 7.2 7.0 10.8 5.6 5.1 7.3 7.1 7.3 6.1 5.2 4.8 5.3 10.4 9.0 9.7 4.4 6.1 4.9 12.7 6.0 9.4 4.8 6.0 2.7 2.5 8.8 8.9 10.1 3.4 3.6 6.8 2.0 6.5 10.0 11.7 15.0 5.3 6.5 33.1 9.9 11.4 10.1 3.4 3.9 8.0 22.1 1.3 2.9 0.1 1.2 2.5 3.6 0.6 4.3 0.9 8.1 1.8 4.0 3.5 6.4 4.6 2.9 1.0 1.8 2.1 6.2 3.2 0.7 2.7 5.4 6.0 9.6 2.7 1.6 25.1 0.8 12.6 2.4 3.2 1.2 4.8 3.4 2.0 0.7 2.8 0.6 1.8 1.1 8.4 14.1 2.9 5.1 1.5 14.4 3.8 2.8 16.6 2.1 10.6 5.1 2.2 2.8 3.3 1.1 2.8 2.2 4.3 1.6 5.5 9.7 10.4 1.4 3.9 5.4 4.1 6.1 4.0 4.0 6.3 3.2 12.4 7.6 0.0 0.8 0.0 1.8 1.2 0.9 1.3 1.4 1.9 2.9 1.2 1.6 2.8 0.1 2.5 0.9 1.9 3.6 0.6 10.8 10.7 2.3 7.2 10.4 9.0 12.7 6.0 8.8 9.9 29.8 26.2 0.8 8.8 8.2 6.7 12.5 5.1 30.8 34.2 24.4 11.8 4.5 28.2 5.8 124.2 9.9 7.7 0.0 6.6 9.2 8.6 8.9 15.0 5.7 5.8 23.8 7.5 6.7 2.4 120.8 9.5 7.7 5.0 5.4 13.2 9.4 2.6 7.0 13.4 5.4 4.9 19.4 9.9 208.1 36.4 5.6 0.9 4.5 16.6 6.4 LRRD1 IMAGE:4798971 ENSG00000240720 "Leucine rich repeats and death domain containing 1" A4D1F6 7 92112159-92179531 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 19.1" "Group enriched" "Detected in some" 82 "Early spermatids: 257.1;Late spermatids: 670.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055670, HPA079440" Enhanced Approved Vesicles,Mitochondria NA NA Mitochondria Vesicles "HPA055670: , HPA079440: " "unprognostic (1.11e-1)" "unprognostic (1.49e-1)" "unprognostic (3.72e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (1.12e-1)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.27e-2)" "unprognostic (1.56e-2)" "unprognostic (1.81e-3)" "unprognostic (1.77e-1)" "unprognostic (7.67e-2)" "unprognostic (2.02e-1)" "unprognostic (3.13e-3)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 19.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.7 3.8 0.6 0.7 0.8 0.1 0.9 0.2 0.9 0.9 0.4 1.7 0.6 0.8 0.0 0.5 0.4 0.3 1.3 0.9 0.2 0.0 0.5 0.7 0.1 0.0 0.7 0.9 0.9 0.6 1.0 0.3 0.4 3.3 1.1 0.2 0.4 0.7 0.3 0.9 0.5 1.3 1.2 2.4 0.9 2.0 0.8 2.5 0.4 0.1 0.7 0.5 0.9 0.5 0.1 0.7 0.7 0.6 0.1 0.3 0.1 0.7 0.5 0.4 1.3 1.0 1.2 1.0 0.7 1.2 0.3 1.3 0.4 0.9 0.4 3.8 0.6 0.4 0.5 0.3 0.4 0.5 0.5 0.4 0.1 1.0 0.4 0.5 1.9 0.7 0.4 0.7 0.8 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.3 0.2 0.7 0.2 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 257.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.1 0.0 0.1 1.6 0.0 0.0 0.0 670.8 4.4 0.3 0.0 0.0 0.0 0.5 0.0 0.0 2.8 0.0 0.4 0.0 0.1 5.6 2.7 0.3 0.0 0.0 0.0 0.3 LRRIQ1 "FLJ12303, KIAA1801" ENSG00000133640 "Leucine rich repeats and IQ motif containing 1" Q96JM4 12 85036314-85263224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 24.9;testis: 20.1" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 433.6;Cone photoreceptor cells: 174.7;Early spermatids: 267.1;Late spermatids: 186.4;Rod photoreceptor cells: 250.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "pons and medulla: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 6.5;SH-SY5Y: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046162 Uncertain NA NA "HPA046162: AB_10963055" "unprognostic (3.55e-2)" "unprognostic (7.81e-2)" "unprognostic (1.91e-1)" "unprognostic (4.37e-3)" "unprognostic (1.01e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" "unprognostic (4.05e-3)" "unprognostic (1.52e-1)" "unprognostic (1.22e-1)" "unprognostic (1.97e-2)" "unprognostic (6.98e-2)" "unprognostic (1.25e-3)" "unprognostic (3.35e-2)" "unprognostic (6.10e-3)" "unprognostic (1.64e-1)" 0.4 1.2 2.4 0.5 8.2 0.3 1.5 0.4 3.1 2.0 0.5 2.2 2.0 0.2 1.9 8.2 0.3 13.4 0.9 0.5 4.7 3.7 5.3 0.3 4.6 0.3 1.0 3.4 4.7 0.7 3.1 24.9 0.3 21.5 1.8 0.3 1.0 0.6 1.0 0.2 0.3 0.3 1.0 1.0 0.4 0.6 20.1 3.4 0.0 2.8 0.2 0.3 0.3 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.8 0.0 1.0 2.0 0.4 0.6 0.6 1.7 0.4 0.0 0.1 0.0 0.2 0.4 2.3 0.1 1.4 1.7 0.4 0.0 2.5 0.6 0.2 0.0 0.0 0.0 0.0 1.0 2.7 1.3 1.9 2.0 0.3 3.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.4 0.0 0.6 0.0 6.5 0.0 2.4 4.3 0.2 0.2 0.2 0.7 1.9 0.0 0.0 3.6 1.0 1.4 0.2 0.0 1.1 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 8.2 0.4 3.1 4.7 3.7 1.0 3.4 21.5 3.4 3.0 4.5 0.0 1.3 0.3 9.6 0.8 2.5 433.6 76.2 15.7 174.7 0.0 8.3 7.9 267.1 0.7 0.0 0.0 1.1 0.0 0.7 5.8 1.1 0.0 0.1 0.0 11.1 0.0 0.0 186.4 4.0 0.5 3.3 0.0 0.0 15.1 2.3 0.0 3.9 4.4 250.0 12.9 0.3 126.2 42.6 0.0 0.1 0.0 0.0 0.3 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 34.1" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 144.3;Late spermatids: 74.3;Spermatocytes: 156.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 12.2;JURKAT: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.8 1.3 0.9 0.9 2.7 0.2 0.9 0.3 1.5 0.8 0.4 1.1 0.1 0.3 0.4 1.2 0.6 2.8 0.6 0.6 1.0 1.1 3.5 1.7 1.6 0.9 2.5 1.4 2.5 0.6 2.1 7.2 0.3 2.4 0.6 0.3 0.6 0.8 0.6 0.4 0.3 0.4 0.2 1.3 1.6 0.5 34.1 1.0 1.4 1.9 0.0 0.8 0.5 0.4 3.9 1.1 1.9 1.1 1.1 4.0 0.9 0.3 1.5 0.2 0.6 1.6 0.6 1.0 0.9 0.6 1.3 1.4 0.2 2.1 2.1 1.9 0.2 12.2 0.2 3.3 3.0 1.6 5.2 0.0 1.9 0.5 1.0 0.2 3.4 1.1 1.1 1.6 2.2 0.8 0.5 0.6 7.3 1.6 3.0 2.1 0.0 1.3 0.5 1.7 3.7 1.0 1.6 1.2 2.1 1.9 0.2 1.6 1.1 0.2 0.2 4.6 0.3 1.3 1.9 0.2 0.2 1.1 0.8 1.8 3.1 1.1 1.7 2.3 0.3 1.6 0.0 0.2 1.9 2.3 1.1 2.9 3.9 2.6 2.9 0.3 2.0 2.5 3.5 0.0 1.1 0.3 1.1 4.0 0.9 0.9 2.7 0.3 1.5 1.0 1.1 2.5 1.4 2.4 1.0 0.0 1.0 0.0 1.0 1.0 0.8 0.4 0.0 36.1 1.2 0.0 3.9 1.4 11.6 1.4 144.3 0.1 0.0 0.0 1.6 1.5 0.2 1.2 0.0 1.0 1.1 0.0 2.9 0.0 0.6 74.3 1.7 0.4 0.0 1.0 0.9 1.1 0.7 0.0 1.4 4.2 0.6 0.0 0.4 156.8 22.6 0.1 0.2 0.7 0.6 0.7 LRRIQ4 LRRC64 ENSG00000188306 "Leucine rich repeats and IQ motif containing 4" A6NIV6 3 169821922-169837775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 7.1" "Group enriched" "Detected in some" 51 "Early spermatids: 39.4;Late spermatids: 18.7" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 13 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "HEL: 2.6;JURKAT: 2.3;RT4: 4.8;T-47d: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036271, HPA036706" Uncertain Approved Mitochondria NA NA Mitochondria "HPA036271: , HPA036706: AB_2675264" "unprognostic (5.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-4)" "unprognostic (5.26e-3)" "unprognostic (2.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (9.72e-2)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "unprognostic (7.47e-2)" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (4.56e-3)" 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.1 1.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.6 7.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.3 0.0 0.3 0.2 0.0 0.4 0.0 0.0 1.7 0.3 0.2 1.6 0.0 0.7 0.0 0.4 2.0 0.1 2.6 0.0 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.2 0.0 0.1 0.5 0.4 1.1 0.7 1.0 0.0 0.0 0.1 4.8 1.9 0.6 0.1 0.4 0.0 0.0 4.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 LRRK1 "FLJ23119, KIAA1790, RIPK6, Roco1" ENSG00000154237 "Leucine rich repeat kinase 1" Q38SD2 15 100919215-101078254 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 26.3" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 30.0;monocytes: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.2;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.5;Karpas-707: 17.3;U-266/84: 15.6;U-698: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010537 Uncertain Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA010537: AB_1079283" "unprognostic (3.74e-2)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (3.72e-1)" "unprognostic (6.68e-2)" "unprognostic (6.35e-2)" "unprognostic (1.94e-1)" "unprognostic (4.75e-2)" "unprognostic (3.43e-2)" "unprognostic (3.34e-2)" "unprognostic (2.95e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-2)" "unprognostic (3.13e-1)" "unprognostic (5.25e-2)" 6.1 1.9 4.5 26.3 3.9 6.5 5.0 2.1 8.1 6.4 8.0 5.9 2.2 2.9 7.9 6.0 5.4 7.1 4.2 3.4 4.0 1.5 2.7 1.0 4.7 15.0 4.5 4.0 6.3 5.3 2.8 2.3 4.4 2.5 7.1 6.5 2.8 7.7 6.8 1.6 7.3 8.5 5.7 3.7 11.1 3.9 5.1 3.4 1.2 3.5 2.1 17.4 7.5 6.7 2.3 3.3 3.2 1.1 0.0 0.0 0.1 0.8 4.8 0.0 0.0 7.4 7.6 0.0 2.9 2.1 2.7 1.9 0.8 2.1 23.5 1.1 7.8 0.0 4.8 0.7 0.5 1.4 0.4 1.1 7.1 1.1 0.0 0.5 3.8 5.5 6.0 1.0 1.7 1.5 0.7 4.7 0.0 1.2 17.3 0.5 0.0 0.0 2.4 0.2 4.3 2.0 1.7 0.4 6.4 0.0 0.0 0.0 1.7 1.8 2.7 5.4 0.0 0.3 4.6 5.4 0.0 0.8 1.0 0.0 8.8 15.6 15.2 0.3 0.5 4.4 0.0 0.7 3.2 0.0 0.3 0.0 2.3 0.0 0.0 0.9 1.5 0.0 0.0 0.8 0.0 1.1 3.3 0.0 0.1 4.5 3.9 2.1 8.1 4.0 1.5 4.5 4.0 2.5 3.4 14.9 12.8 11.9 6.5 2.9 0.6 2.8 2.5 8.1 7.9 0.0 5.9 8.4 0.0 3.6 3.0 5.7 12.0 0.0 2.7 3.1 3.5 6.3 1.1 0.0 9.5 0.0 13.2 12.3 14.3 2.4 30.0 14.0 3.3 32.5 12.8 0.8 6.7 10.5 20.1 0.3 0.4 6.5 2.1 5.2 1.1 3.0 3.0 0.5 10.8 9.3 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 40.4;lung: 50.4" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 391.0" "Group enriched" "Detected in many" 7 "lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 40.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 40.4" "Cell line enhanced" "Detected in some" "A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Supported Vesicles NA NA Vesicles "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 3.7 3.4 2.3 7.0 3.9 8.6 3.0 1.7 5.0 5.1 4.5 1.7 2.6 0.7 5.3 2.9 5.3 3.8 4.5 4.0 1.8 1.4 10.6 4.5 50.4 6.8 2.2 3.6 5.8 3.3 10.9 2.5 1.0 1.9 3.6 1.6 3.3 4.2 2.0 5.6 2.6 3.4 6.7 4.9 8.6 2.7 1.2 2.4 0.5 3.9 2.7 4.9 4.6 6.8 0.9 1.5 40.4 5.8 0.0 0.0 0.8 0.0 9.9 0.1 0.0 3.9 10.2 0.1 2.1 5.7 0.4 0.3 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.3 0.0 0.4 0.0 0.8 0.3 0.2 0.0 0.7 0.5 0.1 2.5 0.7 0.0 0.2 3.8 0.6 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.0 0.1 0.0 0.0 0.0 10.9 0.0 0.1 0.6 0.0 0.2 2.8 0.3 2.8 2.2 1.4 1.2 1.1 1.2 0.7 0.0 0.0 0.0 2.4 0.0 0.5 0.0 5.8 1.2 0.0 3.1 0.0 0.9 0.0 0.0 1.5 0.9 0.0 0.0 40.4 0.0 3.0 0.2 0.0 0.8 2.3 3.9 1.7 5.0 1.8 1.4 2.2 3.6 1.9 2.4 29.8 391.0 17.5 1.5 2.2 7.5 6.9 5.1 5.3 30.7 26.2 0.0 0.0 1.7 0.8 0.4 4.5 0.0 0.0 2.3 0.1 9.4 0.6 12.8 7.8 4.6 44.5 0.0 9.2 74.8 0.0 17.5 19.9 11.8 10.8 0.0 11.0 1.1 0.0 11.3 15.2 0.9 0.0 3.9 0.2 0.4 2.8 0.3 0.8 0.0 0.5 LRRN1 FIGLER3 ENSG00000175928 "Leucine rich repeat neuronal 1" Q6UXK5 3 3799437-3847703 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 10.2;Muller glia cells: 4.3;Pancreatic endocrine cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;memory B-cell: 1.0;neutrophil: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 1.0;granulocytes: 2.6" "Cell line enhanced" "Detected in some" "AF22: 48.6;CAPAN-2: 17.2;HAP1: 14.5;NTERA-2: 28.8;SuSa: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011071 Enhanced NA NA 1400000 "HPA011071: AB_1853355" "unprognostic (1.27e-2)" "unprognostic (4.87e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-3)" "unprognostic (2.01e-2)" "unprognostic (3.02e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.34e-1)" "unprognostic (2.96e-1)" "unprognostic (2.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-3)" "unprognostic (1.86e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (7.25e-2)" 1.4 0.8 12.5 1.1 19.0 2.4 7.6 13.8 32.5 7.1 0.9 5.0 0.3 1.9 4.7 2.5 1.9 2.9 4.6 0.7 11.1 9.4 1.3 0.7 2.1 0.9 8.5 6.1 10.0 3.8 14.2 2.7 0.9 22.2 7.7 1.0 11.5 8.9 8.2 9.2 2.2 2.6 3.2 8.3 1.8 1.8 10.3 10.7 8.7 4.8 0.7 1.7 10.6 1.5 1.0 0.0 2.6 0.0 0.1 0.2 0.0 0.0 0.0 48.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 14.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 9.2 0.0 2.1 0.0 3.6 0.0 0.0 0.4 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 50.0 1.8 0.0 0.0 0.0 5.9 0.0 0.5 5.0 10.1 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.3 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.0 12.5 19.0 13.8 10.3 11.1 9.4 8.5 6.1 22.2 10.7 3.0 0.0 0.8 1.2 1.9 2.7 0.3 10.2 0.0 1.2 0.0 0.0 0.2 0.0 0.7 2.1 0.2 0.0 0.0 2.0 0.1 0.8 2.2 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.8 2.3 0.0 1.7 0.0 0.3 4.3 6.7 0.0 0.7 0.3 0.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.7 LRRN2 "FIGLER7, GAC1, LRANK1, LRRN5" ENSG00000170382 "Leucine rich repeat neuronal 2" O75325 1 204617170-204685733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 49.3" "Group enriched" "Detected in many" 6 "breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029124 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029124: AB_10601545" "unprognostic (2.16e-2)" "unprognostic (1.93e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.59e-7)" "unprognostic (1.40e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" "unprognostic (1.21e-1)" "unprognostic (4.63e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (1.68e-2)" "unprognostic (1.43e-2)" "unprognostic (7.33e-2)" "unprognostic (1.88e-1)" "unprognostic (1.59e-3)" 4.9 6.6 11.8 3.7 16.5 2.4 3.3 9.7 20.3 1.9 7.9 5.3 1.0 1.9 3.9 0.8 2.4 10.2 6.1 6.0 11.7 12.8 7.3 0.7 2.5 2.9 6.3 13.8 3.3 1.4 19.1 9.7 1.3 8.1 1.6 7.5 12.2 2.8 3.7 2.2 0.7 3.3 9.9 3.1 6.3 1.4 3.8 6.1 3.2 2.8 0.0 1.3 2.1 1.5 0.4 0.1 1.7 0.3 0.7 0.8 0.2 0.0 3.3 2.7 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 7.1 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 1.1 0.0 14.3 0.0 0.1 0.2 0.0 22.2 0.0 0.1 1.9 0.3 4.4 0.1 0.0 8.2 7.9 0.0 0.0 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.1 0.2 0.7 0.7 0.0 0.1 0.8 0.2 11.8 16.5 9.7 15.7 11.7 12.8 6.3 13.8 8.1 6.1 0.0 0.0 0.0 0.5 0.3 4.6 1.0 0.0 0.0 0.0 1.8 2.0 0.1 0.0 2.7 0.0 0.7 1.7 0.0 0.8 0.1 1.1 0.3 0.0 0.0 5.3 49.3 10.9 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.9 3.3 0.3 0.0 2.7 0.9 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.7 0.3 LRRN3 "FIGLER5, FLJ11129, NLRR3" ENSG00000173114 "Leucine rich repeat neuronal 3" Q9H3W5 7 111091006-111125454 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.5;brain: 23.8" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 33.5;Leydig cells: 52.0;Peritubular cells: 15.2" "Group enriched" "Detected in many" 7 "glioma: 17.5;thyroid cancer: 4.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 20.3;naive CD8 T-cell: 18.4" "Lineage enriched" "Detected in single" 98 "T-cells: 20.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BJ: 8.3;BJ hTERT+: 18.2;GAMG: 9.3;SH-SY5Y: 26.4;SuSa: 8.5;T-47d: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043820, HPA046792" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA043820: AB_2678687, HPA046792: AB_2679810" "unprognostic (4.93e-2)" "unprognostic (4.55e-2)" "unprognostic (5.92e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-2)" "unprognostic (4.78e-3)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.51e-1)" "unprognostic (5.84e-2)" "unprognostic (4.85e-3)" "unprognostic (1.08e-2)" "unprognostic (3.29e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (7.23e-2)" 7.8 26.5 12.7 1.6 21.2 1.1 2.1 20.0 23.8 3.6 1.4 1.9 0.8 1.0 1.0 3.1 1.9 1.3 1.6 9.0 10.4 10.7 0.9 2.7 8.7 3.6 7.7 13.0 7.9 1.5 0.7 4.9 6.7 9.0 4.7 1.6 0.8 1.9 6.4 4.0 0.8 2.1 1.0 2.9 2.0 0.9 16.4 6.3 8.8 22.3 0.0 4.4 1.6 1.3 0.2 0.0 0.1 0.0 0.0 20.3 4.0 0.0 0.0 14.7 1.8 6.8 2.9 0.0 8.3 18.2 0.8 0.7 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.9 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 26.4 0.0 0.0 0.0 8.5 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.0 20.3 18.4 0.1 0.0 0.0 0.0 0.2 4.0 12.7 21.2 20.0 23.8 10.4 10.7 7.7 13.0 9.0 6.3 0.0 7.0 0.0 0.0 0.0 33.5 12.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.3 9.6 0.0 1.1 0.0 0.7 3.2 1.7 1.3 0.0 3.4 52.0 0.0 1.7 0.0 0.0 10.8 0.0 0.0 15.2 0.0 3.9 0.0 1.2 0.9 0.5 0.1 0.3 3.2 0.0 0.1 LRRN4 "C20orf75, dJ1056H1.1, NLRR4" ENSG00000125872 "Leucine rich repeat neuronal 4" Q8WUT4 20 6040778-6054049 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 9.5;kidney: 13.0;lung: 36.4" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2" "Group enriched" "Detected in many" 7 "lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 1.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 40.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA075974 Uncertain "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 32000 "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA075974: AB_2686770" "unprognostic (6.16e-2)" "unprognostic (1.69e-3)" "unprognostic (2.40e-3)" "unprognostic (9.04e-3)" "unprognostic (5.95e-2)" "unprognostic (1.32e-2)" "unprognostic (2.59e-1)" "unprognostic (8.94e-2)" "unprognostic (2.73e-1)" "unprognostic (2.44e-2)" "unprognostic (2.79e-2)" "unprognostic (4.83e-3)" "unprognostic (1.15e-3)" "unprognostic (2.33e-2)" "unprognostic (6.88e-2)" "unprognostic (2.31e-1)" "unprognostic (9.84e-3)" 9.5 0.1 0.0 2.4 1.1 0.1 0.1 0.0 0.2 0.7 2.2 0.0 0.0 0.1 0.1 2.8 0.1 1.5 0.1 1.1 0.0 0.2 13.0 0.4 36.4 0.1 0.0 0.0 1.6 2.6 0.1 0.0 3.4 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 40.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.8 0.4 0.2 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.9 3.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 1.8 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 LRRTM1 FLJ32082 ENSG00000162951 "Leucine rich repeat transmembrane neuronal 1" Q86UE6 2 80288351-80304749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.8;salivary gland: 19.8" "Group enriched" "Detected in some" 4 "Distal tubular cells: 1.7;Sertoli cells: 6.5" "Group enriched" "Detected in many" 11 "endometrial cancer: 8.8;ovarian cancer: 16.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.2;CAPAN-2: 3.2;NTERA-2: 2.1;SH-SY5Y: 4.7;U-266/70: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062660 Approved NA NA "HPA062660: AB_2684824" "unprognostic (2.47e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (5.63e-2)" "unprognostic (6.67e-2)" "unprognostic (4.35e-1)" "unprognostic (2.66e-1)" "unprognostic (8.16e-2)" "unprognostic (6.03e-3)" "unprognostic (7.10e-4)" "unprognostic (3.16e-2)" "unprognostic (1.90e-1)" "unprognostic (4.96e-4)" 0.7 2.2 8.1 1.0 17.8 0.5 0.6 0.5 17.6 1.5 2.2 2.7 0.1 1.7 1.7 1.2 1.1 2.8 0.9 1.3 10.7 6.3 0.9 0.7 0.7 0.5 2.5 7.8 0.9 0.5 0.5 1.3 0.5 1.8 0.9 1.1 1.7 19.8 2.8 0.5 0.7 1.9 1.1 2.1 0.5 0.9 0.7 2.4 0.0 2.9 0.0 0.6 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 17.8 0.5 17.6 10.7 6.3 2.5 7.8 1.8 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.4 0.1 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRRTM2 KIAA0416 ENSG00000146006 "Leucine rich repeat transmembrane neuronal 2" O43300 5 138868923-138875368 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 33.1" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 6.0;Bipolar cells: 9.8;Cone photoreceptor cells: 3.9;Horizontal cells: 6.4;Ito cells: 3.7" "Cancer enriched" "Detected in single" 11 "glioma: 4.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "HDLM-2: 18.3;SCLC-21H: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.77e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (2.85e-1)" "unprognostic (3.58e-1)" "unprognostic (8.72e-2)" "unprognostic (4.31e-2)" "unprognostic (4.48e-1)" "unprognostic (4.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.13e-2)" "unprognostic (3.13e-2)" "unprognostic (2.86e-2)" "unprognostic (8.11e-2)" "unprognostic (1.08e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" 2.3 4.1 11.0 1.1 15.7 1.1 1.5 15.6 33.1 1.3 1.4 5.1 0.0 1.3 1.1 1.0 1.0 1.1 1.4 1.1 9.7 9.1 1.2 1.3 1.1 1.2 5.4 17.7 1.2 1.4 0.9 0.7 4.5 8.4 1.0 1.4 1.0 1.0 0.9 1.1 1.2 1.5 1.4 5.8 1.9 1.0 0.9 9.9 0.0 1.1 0.0 1.0 1.2 0.3 0.5 0.0 1.0 0.8 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.5 18.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 1.5 0.0 0.8 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 11.0 15.7 15.6 20.8 9.7 9.1 5.4 17.7 8.4 9.9 6.0 1.0 0.8 0.2 0.0 9.8 0.6 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.1 6.4 0.0 3.7 0.3 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926006-67099830 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.5;Late spermatids: 100.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;Daudi: 2.3;HAP1: 10.8;NTERA-2: 2.3;RPMI-8226: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.9 7.3 12.9 1.0 18.7 0.9 0.9 19.7 29.1 1.7 0.9 3.2 0.0 1.0 1.2 0.9 1.4 0.9 0.9 0.9 7.0 6.5 1.0 0.9 1.4 0.9 3.7 16.0 8.0 3.7 0.9 26.6 0.9 4.5 1.2 0.9 0.0 1.0 1.2 1.0 0.9 1.1 1.0 2.8 0.9 0.9 1.9 5.9 0.0 0.9 0.0 0.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 18.7 19.7 21.3 7.0 6.5 3.7 16.0 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 100.5 8.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 11.3 0.0 0.3 0.0 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 LRRTM4 FLJ12568 ENSG00000176204 "Leucine rich repeat transmembrane neuronal 4" Q86VH4 2 76747719-77593319 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 12.7;Cone photoreceptor cells: 3.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "Karpas-707: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.00e-1)" "unprognostic (4.40e-2)" "unprognostic (3.13e-1)" "unprognostic (4.72e-4)" "unprognostic (7.20e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-2)" "unprognostic (9.15e-2)" "unprognostic (3.93e-1)" "unprognostic (5.84e-2)" "unprognostic (4.22e-2)" "unprognostic (1.40e-1)" "unprognostic (2.64e-1)" "unprognostic (5.77e-3)" "unprognostic (3.54e-2)" "unprognostic (7.99e-2)" 1.2 1.5 13.7 1.2 15.7 4.5 0.8 1.8 25.4 1.0 1.5 1.6 0.8 2.1 1.3 3.7 2.4 1.2 2.3 1.3 8.9 8.0 0.9 3.4 1.9 1.9 4.1 16.4 2.4 1.2 0.2 7.9 2.3 5.5 1.7 1.2 1.0 1.9 3.1 2.8 2.1 1.2 0.8 3.1 1.5 1.8 1.2 5.1 0.0 2.2 0.0 0.8 1.6 1.6 0.0 0.4 3.3 0.6 0.9 1.2 0.2 0.8 1.3 0.5 0.5 0.1 0.0 0.8 0.1 0.0 0.0 0.0 1.1 0.3 0.5 1.3 0.5 0.4 0.4 0.0 0.0 0.1 0.3 1.1 0.2 1.9 1.7 0.2 0.6 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 54.3 0.1 1.1 0.2 0.5 5.5 0.1 0.5 0.7 0.0 1.2 0.0 2.3 2.0 0.6 0.3 0.4 0.5 0.9 0.8 0.4 0.0 1.6 2.0 0.2 0.2 0.3 1.2 0.1 1.2 0.1 1.5 0.0 0.6 0.9 0.3 0.4 0.1 0.0 1.0 0.9 0.0 0.0 1.2 0.7 3.3 0.9 0.3 0.4 0.4 0.2 13.7 15.7 1.8 25.4 8.9 8.0 4.1 16.4 5.5 5.1 0.0 0.3 0.0 0.0 0.0 12.7 0.3 0.0 1.4 0.0 0.0 3.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.4 0.0 2.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRTM1 HT017 ENSG00000144771 "Leucine rich repeats and transmembrane domains 1" Q9HBL6 3 54918237-54967088 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3" "Cell type enriched" "Detected in many" 14 "Bipolar cells: 403.4" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Region enriched" "Detected in single" 7 "pons and medulla: 2.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (9.56e-2)" "unprognostic (2.16e-1)" "unprognostic (1.87e-3)" 0.3 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.3 3.6 0.1 0.4 0.1 0.3 0.2 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.1 0.3 0.1 0.4 2.9 1.2 0.0 18.8 2.1 0.4 22.5 0.1 0.3 0.0 1.0 12.2 0.1 0.3 0.0 0.0 0.1 15.3 0.5 0.1 0.1 0.7 1.0 2.3 1.9 0.7 0.9 0.5 0.5 0.3 1.7 0.2 0.2 0.0 1.8 0.0 0.5 0.9 1.6 0.3 1.3 0.0 0.8 0.8 0.0 1.0 0.4 1.5 0.6 1.0 0.2 4.3 1.1 0.9 0.2 0.5 1.1 1.8 0.4 0.7 0.2 0.1 0.1 0.3 0.1 1.6 0.3 0.2 0.4 2.3 1.5 0.0 0.5 0.1 0.3 1.3 0.2 0.7 0.5 0.7 0.5 2.3 0.3 0.7 1.2 0.3 0.0 0.7 0.9 0.7 0.1 0.0 1.0 0.1 0.4 0.6 0.9 2.3 0.5 0.6 0.7 0.6 0.9 0.7 0.6 0.3 1.0 0.3 0.8 0.6 1.5 0.7 1.9 0.6 0.7 0.5 0.3 0.3 0.1 0.2 0.3 0.2 0.3 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.3 403.4 0.4 0.0 0.0 0.0 1.8 15.7 7.8 0.0 0.0 2.0 0.2 0.0 0.0 0.3 1.1 0.8 0.4 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 16.2 1.4 0.0 4.2 0.0 28.5 0.0 1.0 3.0 2.2 0.4 18.5 0.0 0.0 0.4 LRTM2 ENSG00000166159 "Leucine rich repeats and transmembrane domains 2" Q8N967 12 1820267-1836752 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "brain: 18.7" "Cell type enhanced" "Detected in some" 29 "Bipolar cells: 3.7;Cone photoreceptor cells: 2.0;Horizontal cells: 11.1;Rod photoreceptor cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 9.2;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055094, HPA062745" Uncertain Approved Cytosol NA NA Cytosol "HPA055094: AB_2682693, HPA062745: " "unprognostic (1.84e-3)" "unprognostic (4.83e-2)" "unprognostic (1.97e-1)" "unprognostic (1.90e-1)" "unprognostic (5.49e-2)" "unprognostic (1.60e-1)" "unprognostic (1.34e-3)" "unprognostic (2.25e-1)" "unprognostic (1.24e-1)" "unprognostic (6.20e-4)" "unprognostic (2.21e-1)" "unprognostic (8.02e-2)" 0.7 0.7 5.1 0.7 12.3 0.7 0.7 0.8 18.7 0.7 0.7 1.7 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 3.3 5.0 0.7 0.7 0.7 0.7 1.7 10.5 0.7 0.7 0.7 0.1 0.7 4.7 0.7 0.7 0.1 0.7 0.8 0.7 0.7 0.7 0.7 1.7 0.7 0.8 0.9 4.3 0.0 0.7 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 12.3 0.8 18.7 3.3 5.0 1.7 10.5 4.7 4.3 0.0 0.0 0.0 0.0 0.0 3.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRTOMT "CFAP111, COMT2, DFNB63, LRRC51" ENSG00000184154 "Leucine rich transmembrane and O-methyltransferase domain containing" "Q8WZ04, Q96E66" 11 72080331-72110782 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 49.8;testis: 47.8" "Group enriched" "Detected in many" 10 "Early spermatids: 522.5;Late spermatids: 1781.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 27.7" HPA039949 Approved Uncertain Microtubules NA NA Microtubules "HPA039949: AB_10960708" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (1.85e-2)" "prognostic favorable (7.70e-4)" "unprognostic (8.09e-2)" "unprognostic (9.07e-2)" "unprognostic (1.42e-1)" "unprognostic (1.90e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.36e-4)" "unprognostic (6.12e-2)" "unprognostic (8.43e-2)" "unprognostic (2.64e-2)" "unprognostic (1.58e-1)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" 3.5 3.7 10.6 2.0 11.1 2.1 7.1 3.7 8.9 7.1 4.2 14.0 6.1 3.2 6.0 13.6 3.5 49.8 5.3 2.6 8.8 7.6 9.0 6.2 6.2 2.6 7.7 8.5 8.5 7.0 7.1 8.9 4.4 10.6 7.5 6.2 7.3 4.3 4.7 5.2 4.5 2.5 4.8 7.7 3.2 3.6 47.8 8.9 3.1 9.3 2.4 3.5 3.5 2.6 4.3 4.2 9.2 2.9 10.1 6.2 2.0 2.6 9.8 6.2 5.0 5.4 4.8 1.5 3.1 2.5 2.8 2.5 4.7 14.3 3.4 4.7 5.3 6.9 5.3 4.4 7.4 3.2 6.4 4.3 2.5 4.5 3.3 0.9 2.0 2.7 2.1 3.8 4.3 3.3 4.6 1.0 7.2 2.7 5.3 4.1 9.3 6.0 4.0 3.1 15.4 2.6 7.3 6.3 5.2 11.0 3.2 5.8 4.5 6.1 14.0 7.5 4.5 27.7 2.4 4.6 3.0 4.2 8.0 2.1 5.7 6.2 3.9 2.9 1.7 3.3 2.3 2.9 5.0 3.1 2.8 3.2 4.2 3.3 2.6 1.7 4.3 3.0 3.0 9.2 10.1 1.8 4.2 6.2 2.0 10.6 11.1 3.7 8.9 8.8 7.6 7.7 8.5 10.6 8.9 0.0 1.0 6.1 6.6 2.1 3.7 1.7 5.1 115.1 9.1 3.5 11.8 11.0 10.0 6.1 522.5 4.5 3.1 0.0 2.1 6.7 4.1 11.4 0.0 5.6 2.7 6.4 1.2 3.1 1.0 1781.2 13.8 2.2 1.7 1.8 8.8 12.6 1.8 2.9 9.6 14.6 12.6 6.5 7.1 69.5 22.8 2.0 11.0 2.6 4.3 4.7 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Group enriched" "Detected in many" 8 "Early spermatids: 733.2;Spermatocytes: 397.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles" NA NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favorable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.4 10.3 5.6 15.7 4.3 3.2 8.7 7.9 5.2 13.6 9.4 9.9 4.3 18.4 11.4 6.0 16.0 7.9 8.2 7.1 4.0 6.4 15.9 3.8 4.7 6.1 5.7 7.1 7.4 3.0 4.3 15.7 3.3 4.6 7.1 14.4 17.8 5.7 7.3 22.4 21.3 16.9 11.9 9.4 15.0 11.3 5.2 19.8 4.0 4.7 7.4 21.1 8.7 8.4 7.7 6.8 4.8 5.9 4.1 7.5 16.1 23.2 12.6 20.9 36.0 17.6 8.3 6.6 13.0 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 0.0 0.6 5.2 5.8 9.3 11.7 0.7 2.5 16.0 6.8 12.2 2.0 7.7 6.6 12.2 733.2 5.8 7.9 0.0 9.2 9.8 5.7 3.5 0.0 6.8 7.8 4.8 7.5 5.5 5.7 71.5 17.5 3.9 5.0 10.0 6.3 8.6 9.9 6.0 14.9 11.5 8.1 0.0 5.1 397.6 39.9 8.5 5.1 7.0 6.3 3.3 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system-associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 208.2;Leydig cells: 116.8;Muller glia cells: 166.8;Peritubular cells: 86.3" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.0;SH-SY5Y: 14.2;WM-115: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol NA NA 200000000 Cytosol "HPA054051: AB_2682358, HPA076122: AB_2686779" "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 2.3 12.7 21.9 4.3 23.7 1.1 1.6 43.4 48.4 17.8 5.5 16.6 0.0 1.9 4.4 2.8 3.4 2.9 11.3 2.1 23.7 18.8 2.5 1.0 8.5 4.0 17.6 21.5 4.8 11.1 0.6 3.1 1.2 18.3 21.1 3.5 1.2 1.7 6.2 0.7 4.6 1.9 3.3 13.1 1.7 3.2 3.9 21.3 0.0 4.2 0.0 5.2 7.3 3.4 1.6 0.4 3.0 0.8 0.3 1.0 0.3 0.2 2.2 7.0 0.2 0.7 2.2 0.7 0.6 0.3 0.2 0.7 0.2 0.4 0.5 0.2 3.6 0.2 0.1 0.1 0.1 0.3 0.5 0.1 0.2 0.8 0.3 0.1 0.5 0.4 1.7 0.0 0.8 0.1 0.2 0.0 0.9 0.3 2.3 0.0 0.2 0.8 0.6 2.7 0.3 0.8 0.2 0.1 0.1 1.7 1.6 1.6 14.2 0.0 0.1 2.2 3.2 0.2 0.8 0.1 1.5 1.3 1.7 0.4 1.5 1.9 0.2 0.5 0.2 34.6 3.0 0.8 1.4 0.9 0.5 1.0 0.7 0.6 0.5 0.2 1.6 1.0 0.7 2.8 0.3 0.6 0.4 0.5 0.3 21.9 23.7 43.4 23.7 23.7 18.8 17.6 21.5 18.3 21.3 0.0 0.6 0.5 0.2 6.8 47.9 18.9 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 15.9 2.5 0.0 0.0 3.0 0.0 16.0 17.5 0.0 0.0 0.3 208.2 0.0 1.8 0.0 18.1 116.8 1.8 54.0 0.0 0.0 166.8 0.6 0.0 86.3 0.0 9.7 0.0 1.3 0.9 0.2 4.4 0.0 0.0 0.0 0.5 LSM10 MGC15749 ENSG00000181817 "LSM10, U7 small nuclear RNA associated" Q969L4 1 36391238-36397892 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048469 Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA048469: AB_2756307" "unprognostic (2.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (6.21e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.84e-1)" "unprognostic (2.80e-1)" "unprognostic (3.59e-2)" "unprognostic (8.54e-2)" 15.0 11.9 19.8 17.7 20.2 12.6 21.1 11.1 20.9 12.3 20.8 9.5 16.7 11.9 14.2 19.1 15.0 11.4 15.7 28.2 18.6 19.7 17.3 21.3 11.8 27.3 17.7 14.4 14.6 18.6 12.1 16.4 13.2 17.0 16.2 11.0 13.8 16.9 19.5 82.0 10.1 13.0 17.8 12.5 21.1 14.5 12.1 10.3 10.3 18.9 22.0 26.8 19.1 25.0 73.8 45.9 66.7 50.5 19.1 31.0 49.9 18.9 29.0 10.9 29.2 25.8 25.3 11.3 17.1 25.1 27.5 21.1 12.9 18.2 44.9 23.7 23.1 20.4 10.5 18.5 22.2 18.3 30.4 22.1 22.5 17.2 30.3 31.4 16.9 33.1 21.2 19.8 24.7 17.6 15.0 28.1 25.8 20.7 22.0 19.3 33.7 18.8 19.3 28.1 23.6 30.1 14.3 10.5 30.3 26.5 11.6 14.0 10.5 13.9 17.8 41.5 18.4 9.2 14.6 18.6 12.6 17.4 32.7 26.6 29.1 39.1 35.1 25.2 26.0 28.3 35.7 50.5 61.4 25.6 48.7 27.8 70.6 25.5 26.5 36.0 73.8 23.1 25.0 66.7 19.1 44.9 45.9 31.0 49.9 19.8 20.2 11.1 20.9 18.6 19.7 17.7 14.4 17.0 10.3 11.9 15.6 88.7 31.6 28.6 15.4 45.2 15.3 5.3 11.4 43.6 5.9 48.1 119.3 34.9 7.6 35.4 23.8 46.7 41.3 51.7 42.8 37.2 40.4 54.6 93.0 17.5 27.1 30.1 72.9 16.5 35.9 85.7 49.0 44.1 20.4 20.9 37.9 34.5 44.2 91.1 12.7 12.9 49.5 8.4 23.0 35.0 33.4 57.3 25.4 24.3 LSMEM1 "C7orf53, FLJ39575" ENSG00000181016 "Leucine rich single-pass membrane protein 1" Q8N8F7 7 112480853-112491062 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "skeletal muscle: 51.3;tongue: 19.2" "Group enriched" "Detected in many" 6 "Early spermatids: 43.6;Late spermatids: 47.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebellum: 3.6" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "HeLa: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA013753, HPA047988" Uncertain Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA013753: AB_1848926, HPA047988: AB_2680229" "unprognostic (6.87e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-2)" "unprognostic (2.77e-2)" "unprognostic (1.38e-1)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (6.68e-2)" "unprognostic (3.54e-2)" "unprognostic (2.80e-3)" "unprognostic (1.47e-6)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.25e-2)" "unprognostic (3.42e-2)" 1.1 0.7 0.6 0.6 0.6 0.8 0.9 3.6 0.7 0.6 0.6 0.6 0.6 1.3 0.6 1.7 0.7 0.4 0.6 2.1 0.7 0.8 1.4 3.5 1.8 0.6 0.7 0.6 0.6 2.8 0.3 0.9 0.6 0.6 0.9 0.8 0.6 1.9 0.6 51.3 0.8 0.8 0.6 0.6 1.9 0.8 1.1 0.6 0.6 0.9 19.2 1.5 0.6 0.6 0.0 0.1 2.7 0.1 0.0 0.2 2.2 0.8 1.3 0.7 2.8 2.9 3.2 0.1 1.3 0.9 0.6 0.5 2.2 1.9 1.2 1.9 0.3 1.9 0.7 0.8 1.0 1.2 0.6 0.8 0.8 12.5 2.3 1.3 1.2 0.7 2.2 3.8 0.8 0.8 2.7 0.8 1.1 0.9 2.8 0.4 1.1 1.0 3.7 0.6 1.1 0.9 0.4 0.2 0.6 2.4 1.5 2.7 1.4 2.3 1.1 1.5 3.4 0.4 0.5 0.5 2.8 1.0 0.8 1.1 0.9 1.7 1.1 0.8 0.8 0.9 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 2.2 0.6 0.6 3.6 0.7 0.7 0.8 0.7 0.6 0.6 0.6 0.0 3.2 0.8 2.4 4.8 2.2 7.7 5.1 1.4 2.3 1.8 2.0 1.2 0.0 0.6 43.6 2.9 7.1 0.0 0.8 0.7 2.8 7.4 0.0 1.0 3.2 0.0 2.9 1.8 2.7 47.7 0.9 1.3 1.7 2.8 4.0 0.3 1.0 4.3 0.4 0.1 3.4 0.0 6.6 0.5 0.6 4.1 1.6 0.7 3.2 2.2 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279027-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2" "Cell type enriched" "Detected in some" 5 "Late spermatids: 197.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 3.7;WM-115: 3.5" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.6 0.3 1.2 0.2 2.1 0.4 0.2 0.7 1.9 1.1 0.3 2.1 0.1 0.4 1.4 0.4 0.7 0.8 0.4 26.6 1.4 0.7 0.3 0.1 0.3 0.1 1.3 0.6 0.9 0.3 0.1 0.1 0.2 1.3 0.4 0.3 1.6 1.4 0.5 16.3 0.1 0.5 0.5 1.6 0.2 0.2 3.0 0.9 0.1 0.2 7.2 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.4 0.4 0.4 0.2 0.3 0.5 0.1 0.1 0.0 0.5 0.1 0.1 1.1 0.1 0.0 0.5 0.2 3.7 0.2 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.5 0.0 1.1 0.0 1.0 0.0 0.2 0.1 0.7 0.5 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.1 0.5 0.0 0.8 1.0 0.4 0.0 0.0 0.0 0.2 1.3 0.4 0.4 0.9 0.6 0.6 0.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 0.7 1.9 1.4 0.7 1.3 0.6 1.3 0.9 0.0 1.1 0.0 0.1 0.9 0.1 3.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 41.7 0.0 0.9 0.0 0.2 0.1 0.3 0.3 4.7 0.0 0.1 0.0 0.0 0.0 0.0 197.4 1.1 0.0 1.7 0.0 0.4 0.5 0.1 0.0 0.7 0.0 0.2 0.0 0.7 1.6 1.0 1.1 0.1 0.0 0.6 0.1 LSP1 WP34 ENSG00000130592 "Lymphocyte-specific protein 1" P33241 11 1852970-1892267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.7" "Cell type enriched" "Detected in many" 5 "monocytes: 2353.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 42.9;HDLM-2: 148.4;Karpas-707: 27.5;RPMI-8226: 61.8;U-937: 26.5" "Low region specificity" "Detected in all" "CAB017781, HPA019693" Enhanced NA NA 1600000 "CAB017781: , HPA019693: AB_1853387" "unprognostic (7.53e-3)" "prognostic favorable (3.56e-4)" "unprognostic (4.35e-2)" "prognostic favorable (2.54e-4)" "prognostic unfavorable (5.35e-4)" "unprognostic (1.43e-3)" "unprognostic (3.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.13e-1)" "unprognostic (1.14e-1)" "unprognostic (6.10e-2)" "unprognostic (1.72e-1)" "unprognostic (1.03e-3)" "unprognostic (3.29e-1)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.20e-2)" 58.6 61.2 2.1 81.9 3.0 46.5 15.4 0.6 2.5 20.5 11.6 2.8 7.2 8.0 11.4 19.8 18.3 11.7 20.2 10.2 1.9 1.4 3.3 5.8 25.9 61.0 4.5 1.8 8.7 3.9 0.0 2.5 10.4 3.3 11.2 4.9 29.4 25.3 3.7 9.2 27.3 21.4 12.9 6.2 87.3 13.2 7.5 3.4 81.9 7.6 26.7 84.9 19.7 16.1 42.7 80.3 157.7 79.6 25.4 45.5 90.6 0.0 0.2 0.0 0.0 5.6 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 148.4 0.0 0.0 0.0 0.0 1.2 0.1 0.1 5.0 0.1 0.0 0.1 0.1 0.0 0.4 0.1 27.5 3.2 0.0 3.2 3.7 0.0 0.0 0.0 0.1 2.5 61.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.0 0.1 0.1 0.0 6.7 0.0 26.5 0.0 34.1 72.9 75.9 38.0 79.6 22.7 42.7 25.7 34.1 80.3 27.9 17.6 26.6 157.7 25.4 78.1 58.8 45.5 90.6 2.1 3.0 0.6 2.5 1.9 1.4 4.5 1.8 3.3 3.4 14.9 12.2 247.3 5.2 105.0 0.8 1.4 7.6 6.7 7.9 3.5 0.0 3.7 1.7 0.8 2.3 4.5 0.7 46.7 7.4 3.7 48.0 1.0 11.6 1.0 518.4 1.6 1.2 11.1 97.0 4.9 83.1 393.7 62.4 2353.5 0.7 0.1 1.1 0.9 28.3 11.0 0.8 0.0 14.6 0.2 1.1 100.2 5.4 315.4 1.1 19.0 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.3;pancreas: 98.6" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 229.3;Exocrine glandular cells: 243.9;Pancreatic endocrine cells: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 88.1;CACO-2: 38.6;CAPAN-2: 41.0;HaCaT: 37.0;OE19: 53.1;RT4: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007270, HPA075309" Approved Supported "Plasma membrane" NA NA 2100000 "Plasma membrane" "HPA007270: AB_1079253, HPA075309: " "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favorable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 5.0 11.2 2.9 20.9 4.0 0.9 12.4 2.0 4.5 8.7 32.8 4.0 24.4 29.5 6.5 21.4 20.3 10.6 58.2 2.6 3.4 3.1 15.7 106.3 21.1 17.0 4.1 2.6 4.8 98.6 6.2 13.4 36.6 7.1 11.2 15.4 40.9 26.2 33.8 1.9 16.8 39.5 1.8 3.8 9.1 46.7 21.0 1.9 3.4 24.0 20.1 20.9 9.9 9.5 5.3 0.3 5.9 0.2 6.1 7.1 3.2 88.1 1.4 0.1 0.1 0.2 0.1 16.0 0.2 0.3 0.4 0.3 38.6 41.0 3.5 13.6 0.2 1.3 37.0 8.2 13.5 0.0 5.3 14.9 0.0 1.2 17.0 0.3 0.0 0.1 0.2 15.1 0.3 4.5 0.1 0.1 0.1 13.9 3.1 0.2 31.3 0.1 0.1 12.7 53.1 0.5 0.7 0.1 9.5 8.5 35.7 7.0 0.2 7.4 24.1 6.6 4.2 20.6 0.4 0.0 0.7 8.4 0.5 0.4 5.0 8.9 8.0 0.6 0.1 2.2 5.9 0.2 0.2 3.3 0.0 3.3 5.3 7.1 6.7 0.1 4.1 5.5 6.0 0.1 6.1 0.0 0.3 4.8 3.2 2.9 4.0 2.0 4.5 3.4 3.1 4.1 2.6 7.1 1.9 14.9 17.1 13.9 106.8 45.9 1.4 3.2 79.0 12.0 27.3 34.9 15.7 183.2 10.0 229.3 8.5 29.2 159.2 0.0 243.9 80.3 15.6 94.1 31.1 77.6 19.8 0.0 54.2 17.2 1.5 2.1 6.1 3.7 13.5 11.8 103.4 9.1 273.3 171.7 3.2 20.3 11.0 0.0 24.6 5.4 13.4 45.2 207.4 8.6 101.9 201.4 LST1 "B144, D6S49E, LST-1" ENSG00000204482 "Leukocyte specific transcript 1" O00453 6 31586124-31588909 "Predicted intracellular proteins, Predicted membrane proteins" "Cell shape, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 115.3;bone marrow: 60.9;lymphoid tissue: 72.4" "Group enriched" "Detected in many" 6 "Hofbauer cells: 354.0;Kupffer cells: 1112.1;Macrophages: 1026.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 38.4;eosinophil: 60.8;intermediate monocyte: 95.8;myeloid DC: 34.1;neutrophil: 99.1;non-classical monocyte: 115.3" "Group enriched" "Detected in all" 12 "dendritic cells: 34.1;granulocytes: 99.1;monocytes: 115.3" "Cell line enhanced" "Detected in some" "HEL: 11.9;HMC-1: 23.3;MOLT-4: 11.7;NB-4: 24.2;THP-1: 58.1;U-937: 30.9" NA NA "unprognostic (1.08e-2)" "prognostic favorable (7.89e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-3)" "unprognostic (3.13e-1)" "unprognostic (3.92e-2)" "unprognostic (3.65e-1)" "unprognostic (7.06e-3)" "unprognostic (2.81e-3)" "unprognostic (2.12e-1)" "unprognostic (1.70e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (5.97e-5)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (1.03e-1)" "unprognostic (1.95e-1)" 4.6 3.1 5.2 14.9 7.3 60.9 2.4 1.0 4.0 1.5 3.3 7.7 0.2 4.2 1.3 3.9 1.9 2.2 2.8 3.2 4.9 5.4 2.8 11.9 16.2 25.7 9.7 1.9 2.3 1.6 0.7 2.2 7.0 6.2 2.7 2.6 2.6 3.0 1.7 1.0 2.3 4.1 4.2 13.6 72.4 2.8 0.9 6.6 12.6 1.5 1.2 5.8 4.1 1.7 1.9 34.1 99.1 115.3 1.6 7.0 35.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.1 0.1 0.1 3.8 0.0 11.9 0.0 0.0 0.2 8.7 23.3 0.0 0.1 0.0 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 11.7 24.2 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 30.9 0.0 8.6 38.4 60.8 0.8 95.8 7.0 1.9 1.3 1.7 34.1 1.8 0.9 0.8 99.1 1.6 115.3 6.0 0.9 35.7 5.2 7.3 1.0 4.0 4.9 5.4 9.7 1.9 6.2 6.6 32.8 129.2 43.8 0.3 31.3 0.0 1.7 7.6 20.1 23.9 10.4 0.0 2.5 0.0 0.6 0.9 11.7 0.0 0.0 0.2 2.3 12.2 0.3 68.2 2.6 354.0 0.0 0.0 27.0 1112.1 3.2 3.4 1026.6 42.2 27.9 0.0 0.5 0.1 0.0 1.1 2.2 0.2 25.8 3.6 0.6 2.2 24.7 4.5 39.9 0.0 0.3 LTA "LT, TNFB, TNFSF1" ENSG00000226979 "Lymphotoxin alpha" P01374 6 31572054-31574324 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 25.3" "Group enriched" "Detected in some" 4 "B-cells: 13.7;T-cells: 7.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.2;MOLT-4: 3.6;U-266/84: 1.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA007729 Uncertain "Secreted to blood" NA NA 8150 "HPA007729: AB_1852906" "unprognostic (3.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.36e-3)" "unprognostic (8.99e-5)" "unprognostic (3.22e-1)" "unprognostic (5.13e-3)" "unprognostic (2.07e-1)" "unprognostic (4.71e-2)" "unprognostic (3.10e-2)" "unprognostic (3.39e-4)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (8.72e-12)" "unprognostic (2.59e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-1)" 0.4 0.1 0.2 25.3 0.6 1.1 0.1 1.3 0.2 0.2 0.5 0.1 0.0 0.1 0.1 0.1 0.9 0.2 0.1 0.1 0.2 0.1 0.3 0.4 2.0 7.2 0.1 0.0 0.3 0.1 0.1 0.1 0.3 0.0 0.6 0.4 0.2 2.4 0.5 0.3 0.2 2.8 0.2 0.3 10.0 0.4 6.0 0.0 11.2 0.2 0.5 17.5 0.7 0.1 0.2 0.0 0.5 0.6 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.6 0.5 0.1 0.6 0.0 0.1 0.0 0.2 0.6 1.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.6 13.7 0.0 0.1 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 2.1 0.5 0.4 0.0 7.5 0.0 0.0 LTB "p33, TNFC, TNFSF3" ENSG00000227507 "Lymphotoxin beta" Q06643 6 31580525-31582522 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.1;lymphoid tissue: 81.5" "Cell type enriched" "Detected in many" 4 "B-cells: 1026.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.1;Daudi: 19.8;HDLM-2: 11.2;HMC-1: 5.8;NB-4: 12.8;REH: 12.2;U-698: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048884 Approved Approved Centrosome NA NA Centrosome "HPA048884: AB_2680543" "unprognostic (1.43e-2)" "unprognostic (3.89e-2)" "unprognostic (7.29e-2)" "prognostic favorable (2.36e-6)" "unprognostic (2.91e-3)" "prognostic favorable (1.74e-4)" "unprognostic (1.45e-1)" "unprognostic (9.49e-3)" "unprognostic (1.42e-3)" "unprognostic (4.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.31e-7)" "unprognostic (8.91e-2)" "unprognostic (4.92e-2)" "unprognostic (6.56e-3)" "unprognostic (1.99e-1)" 1.0 0.2 0.2 35.9 0.2 3.4 0.5 0.1 0.1 0.2 1.5 0.0 0.0 1.3 0.2 0.3 2.7 0.4 0.7 1.9 0.2 0.1 4.2 1.3 4.2 27.8 0.2 0.0 0.5 0.8 0.0 0.2 0.3 0.1 0.7 0.6 0.5 6.1 0.3 0.1 0.6 18.0 0.3 0.3 69.7 2.0 0.2 0.0 81.5 1.1 0.8 41.6 1.6 0.5 44.1 15.6 17.8 3.6 5.2 39.3 10.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 19.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 12.8 0.0 0.0 0.0 12.2 0.0 2.7 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 2.5 0.4 17.8 3.7 2.0 26.8 42.5 39.3 17.3 0.6 44.1 33.5 14.2 14.5 5.2 3.6 15.6 22.2 10.7 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 13.6 1026.5 0.2 14.4 0.2 0.4 0.0 0.0 4.5 85.5 0.0 0.3 1.7 211.4 1.9 3.8 0.0 0.0 97.9 0.2 5.6 1.2 13.9 2.8 8.9 0.0 0.0 6.7 27.5 0.0 0.6 21.2 40.5 10.0 0.3 1.0 243.4 1.5 0.0 8.6 0.1 6.5 10.8 0.1 1.1 10.8 0.2 247.3 0.4 0.3 LTB4R "BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7" ENSG00000213903 "Leukotriene B4 receptor" Q15722 14 24311450-24318036 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;skin 1: 47.0" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 21.3;Kupffer cells: 41.4;Macrophages: 20.5;Suprabasal keratinocytes: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 13.8;eosinophil: 13.9;neutrophil: 36.8" "Group enriched" "Detected in many" 6 "granulocytes: 36.8;monocytes: 13.8" "Cell line enhanced" "Detected in many" "HaCaT: 17.6;Karpas-707: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA003873 Approved NA NA "HPA003873: AB_1078288" "unprognostic (4.07e-2)" "unprognostic (7.67e-2)" "unprognostic (3.67e-3)" "unprognostic (2.40e-3)" "unprognostic (4.90e-2)" "unprognostic (9.00e-3)" "unprognostic (1.15e-2)" "unprognostic (8.63e-2)" "unprognostic (3.68e-1)" "unprognostic (2.06e-1)" "prognostic favorable (1.85e-4)" "unprognostic (7.25e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (2.88e-1)" "unprognostic (2.97e-1)" "unprognostic (6.59e-2)" "unprognostic (7.45e-2)" 7.8 2.7 0.4 3.5 1.7 9.8 2.9 1.7 2.2 8.4 2.8 0.9 0.4 3.0 2.4 4.0 27.0 2.5 2.6 6.5 1.0 0.2 3.1 10.8 9.2 27.7 1.4 0.4 3.6 3.5 0.6 2.5 2.3 1.2 3.9 1.3 2.9 5.9 2.0 2.6 47.0 2.6 1.3 2.1 23.9 1.6 1.7 1.0 2.4 2.3 14.3 7.2 2.5 11.6 0.1 4.0 36.8 13.8 0.7 1.2 4.3 2.1 4.9 1.7 1.4 1.1 1.1 7.4 1.0 0.7 1.1 1.3 3.6 2.6 3.6 1.6 0.9 1.9 17.6 1.5 2.8 1.5 9.4 5.5 3.8 5.9 2.3 0.6 5.1 5.0 0.6 5.0 2.2 2.6 1.5 2.0 6.0 3.0 14.9 0.5 4.8 2.1 8.7 1.3 0.2 3.8 7.7 1.6 6.1 0.6 3.5 3.9 1.4 5.2 2.5 2.3 3.2 4.1 5.2 1.1 3.6 3.6 3.7 1.3 8.4 1.9 5.8 0.7 13.6 2.4 4.9 13.8 13.9 1.2 1.7 0.9 0.0 0.9 1.0 4.0 0.1 0.4 0.3 36.8 0.7 0.3 0.4 0.2 4.3 0.4 1.7 1.7 2.2 1.0 0.2 1.4 0.4 1.2 1.0 0.0 1.1 0.9 8.4 21.3 3.0 1.2 5.1 2.7 3.4 0.0 5.9 0.7 0.0 2.1 0.2 3.6 2.6 0.0 5.5 0.6 2.6 2.1 1.1 3.6 12.9 0.0 0.0 8.0 41.4 0.4 3.1 20.5 3.3 0.0 2.3 0.6 3.6 2.9 1.4 0.5 11.0 6.5 1.7 1.2 1.3 41.0 0.7 10.1 2.6 2.4 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.5 4.4 1.9 1.8 0.4 0.6 7.7 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 1.9 15.9 1.3 2.7 1.0 4.0 4.9 2.2 3.5 1.6 0.5 3.6 4.2 0.5 3.6 2.0 2.3 1.2 0.6 5.8 2.8 3.6 0.6 4.8 1.9 3.8 1.0 0.1 5.4 7.9 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 2.1 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.3 5.2 0.5 6.1 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 0.0 0.0 0.0 3.0 0.2 0.2 0.0 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.0 1.2 0.1 0.0 0.2 0.0 0.8 0.6 3.2 1.7 1.3 2.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.6 0.9 LTC4S MGC33147 ENSG00000213316 "Leukotriene C4 synthase" Q16873 5 179793980-179796647 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Leukotriene biosynthesis, Lipid biosynthesis, Lipid metabolism" "Lyase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.3" "Cell type enriched" "Detected in many" 6 "granulocytes: 332.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 8.5;eosinophil: 31.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 31.3" "Cell line enriched" "Detected in some" 10 "HMC-1: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044688 Approved "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA Nucleoplasm "Endoplasmic reticulum, Cytosol" "HPA044688: " "unprognostic (8.94e-2)" "unprognostic (2.40e-2)" "unprognostic (9.35e-3)" "unprognostic (3.57e-2)" "unprognostic (1.24e-2)" "unprognostic (9.40e-2)" "unprognostic (4.53e-5)" "unprognostic (2.27e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (2.65e-1)" "unprognostic (1.98e-2)" "unprognostic (4.62e-1)" 9.0 6.7 3.5 2.8 3.5 8.6 4.6 1.7 5.0 6.9 5.0 9.4 5.4 3.6 8.7 10.4 4.2 13.0 15.7 11.3 3.9 3.1 6.2 2.3 28.3 8.0 6.8 4.2 5.8 2.4 2.0 3.2 2.9 4.3 5.6 1.9 3.3 7.4 11.6 2.7 3.5 5.7 4.5 6.3 6.7 5.0 3.3 3.9 0.8 5.3 5.6 3.2 3.6 3.9 0.1 4.5 31.3 0.3 2.2 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 5.3 0.0 0.2 0.2 0.3 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 8.5 0.2 31.3 0.5 0.3 1.7 0.1 1.2 0.8 4.5 0.1 0.2 0.5 0.1 2.2 0.0 0.2 0.1 0.3 3.5 3.5 1.7 5.0 3.9 3.1 6.8 4.2 4.3 3.9 0.0 5.6 2.2 7.5 8.9 0.2 0.0 12.7 4.0 3.4 14.0 0.0 6.9 1.7 4.1 0.3 11.3 0.4 0.0 2.1 1.5 4.7 3.1 332.3 0.8 33.8 0.0 2.9 53.4 8.9 0.0 15.3 23.5 1.7 1.0 1.6 0.0 2.1 0.0 44.6 40.2 0.3 0.0 0.9 0.0 0.7 6.0 2.5 5.0 2.6 5.0 LTF HLF2 ENSG00000012223 Lactotransferrin P02788 3 46435645-46485234 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport" "Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1" "Group enriched" "Detected in many" 4 "Club cells: 55.7;Collecting duct cells: 68.0;Glandular cells: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 27 "neutrophil: 4.0;non-classical monocyte: 13.5" "Group enriched" "Detected in many" 27 "granulocytes: 4.0;monocytes: 13.5" "Group enriched" "Detected in some" 10 "RPMI-8226: 29.8;TIME: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB008646, CAB016201, HPA057177, HPA059976" Enhanced "Secreted in other tissues" NA NA 600000000 "CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185" "unprognostic (7.24e-3)" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (3.41e-2)" "unprognostic (7.14e-3)" "unprognostic (3.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (3.43e-1)" "unprognostic (1.04e-1)" "prognostic favorable (6.30e-5)" "unprognostic (1.66e-2)" "unprognostic (3.53e-1)" "unprognostic (2.05e-1)" "unprognostic (9.09e-3)" 1.0 0.3 0.4 8.8 0.5 277.8 23.0 0.3 0.3 53.1 0.3 3.2 108.0 0.0 0.7 39.3 3.8 0.9 2.2 2.5 0.6 0.6 20.8 0.6 10.8 1.3 0.6 0.0 0.3 2.7 0.0 1.2 0.8 1.5 13.0 0.0 0.2 181.9 177.1 0.4 1.2 0.9 0.1 0.7 9.1 22.6 2.8 0.1 4.0 1.6 13.4 30.7 2.3 1.0 0.0 0.3 4.0 13.5 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.5 29.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.2 0.9 0.1 0.5 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 13.5 0.3 0.0 14.7 0.4 0.5 0.3 0.3 0.6 0.6 0.6 0.0 1.5 0.1 0.0 3.2 0.0 7.7 1.0 0.0 1.2 5.1 12.0 55.7 68.0 0.0 0.0 0.0 0.3 0.7 2.3 0.0 0.0 0.8 0.1 0.5 88.7 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.7 4.6 0.9 0.0 0.0 0.0 0.0 5.0 0.0 0.0 10.8 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 16.6 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503638-41513887 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 13.4;Ito cells: 14.7;Mucus-secreting cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "MAIT T-cell: 8.3;plasmacytoid DC: 7.0" "Group enriched" "Detected in many" 10 "dendritic cells: 7.0;T-cells: 8.3" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 10.5;RH-30: 5.1;THP-1: 16.1" "Low region specificity" "Detected in many" HPA059545 Approved Vesicles NA NA Vesicles "HPA059545: AB_2684057" "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 1.0 0.5 0.5 5.1 1.6 3.1 0.5 2.0 3.2 0.6 8.2 0.5 1.9 10.6 1.3 1.1 1.2 0.3 2.0 2.2 0.5 0.1 3.5 4.3 15.1 0.6 0.5 0.5 1.0 0.5 1.0 0.7 8.9 0.5 0.7 4.8 4.3 11.7 0.5 2.0 0.9 10.7 0.5 0.5 5.5 8.3 2.4 0.8 0.5 0.7 0.5 2.2 0.6 0.7 0.7 7.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.6 1.0 1.3 2.4 0.0 0.0 0.1 0.7 0.0 0.0 2.9 0.0 0.4 0.2 1.4 5.4 0.0 0.0 2.4 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.0 10.5 0.4 2.0 0.2 0.2 5.1 0.2 0.0 0.0 0.5 3.4 0.1 0.2 0.0 3.0 0.2 16.1 0.0 0.0 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.0 8.3 0.7 0.5 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.2 0.5 1.6 2.0 3.2 0.5 0.1 0.5 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 5.1 4.0 1.2 0.0 0.0 0.2 0.0 0.0 2.1 0.1 13.4 0.0 0.2 1.1 0.2 0.0 0.0 0.2 0.1 0.0 1.7 14.7 3.2 1.7 0.0 0.0 3.3 0.0 7.8 0.0 0.5 3.5 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.1 0.3 1.3 2.8 0.0 LUM "LDC, SLRR2D" ENSG00000139329 Lumican P51884 12 91102629-91111831 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 344.8" "Group enriched" "Detected in many" 8 "Fibroblasts: 1406.2;Leydig cells: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 103 "basophil: 10.2" "Lineage enriched" "Detected in single" 103 "granulocytes: 10.2" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 186.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001522, CAB025783" Supported "Secreted to extracellular matrix" NA NA 59000000000 "CAB025783: , HPA001522: AB_1079285" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "unprognostic (3.32e-1)" "unprognostic (2.75e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.19e-1)" "unprognostic (1.65e-2)" "unprognostic (2.20e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (5.25e-3)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (2.06e-2)" 44.8 25.3 0.8 15.1 0.7 0.0 19.7 0.7 0.7 56.7 26.9 0.7 28.1 5.1 64.8 77.8 28.1 12.2 76.6 48.8 0.8 0.7 26.9 6.4 77.1 32.0 0.9 0.6 73.0 9.1 0.7 2.7 344.8 2.8 77.4 13.3 1.4 5.6 9.9 9.1 8.3 24.0 48.7 4.0 1.3 8.2 30.9 0.3 1.7 18.1 32.3 11.5 65.3 20.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.0 11.3 0.0 37.8 186.6 1.5 2.3 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 18.0 0.0 0.0 15.6 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.0 1.6 0.0 0.0 0.0 1.6 0.4 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.7 0.7 0.8 0.7 0.9 0.6 2.8 0.3 11.9 51.4 0.0 1.2 86.7 0.0 10.1 0.0 1.4 9.1 0.0 2.0 47.4 0.0 0.8 2.4 11.6 0.0 0.0 0.0 27.5 1406.2 2.2 17.4 0.4 58.5 0.0 0.0 93.9 0.8 2.9 371.9 3.6 111.3 1.8 0.0 75.5 3.0 0.0 42.1 0.2 2.8 0.0 68.4 0.2 0.9 87.6 70.3 0.0 0.0 4.2 LURAP1L "bA3L8.2, C9orf150, FLJ38505, MGC46502" ENSG00000153714 "Leucine rich adaptor protein 1 like" Q8IV03 9 12775021-12822131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 48.7" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 80.1;Glandular cells: 116.6;Paneth cells: 77.2;Urothelial cells: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "HHSteC: 45.3;hTERT-HME1: 36.3;T-47d: 52.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024407 Uncertain Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA024407: AB_10603780" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (7.45e-2)" "unprognostic (1.73e-2)" "unprognostic (2.08e-2)" "unprognostic (5.61e-3)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (5.68e-3)" "unprognostic (4.38e-1)" "unprognostic (5.67e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-2)" 10.6 7.2 2.9 7.9 9.2 0.1 13.0 23.4 5.5 11.5 13.7 7.1 2.9 4.0 5.0 7.9 8.5 4.1 14.7 3.5 3.5 3.3 4.1 48.7 17.8 5.3 7.7 4.0 4.5 19.9 0.2 7.3 21.0 5.9 8.0 9.6 4.7 21.6 7.3 2.4 8.8 6.6 13.2 8.1 11.0 9.9 3.7 7.9 0.9 8.6 2.8 5.3 10.3 9.4 0.0 0.1 1.2 0.0 0.0 0.0 1.6 0.9 3.2 0.0 1.0 4.9 6.8 0.0 1.7 9.1 2.2 2.5 0.0 1.1 0.0 0.6 8.7 10.8 1.3 0.0 0.1 1.7 0.0 0.4 0.4 3.0 1.7 45.3 0.0 0.0 2.6 4.3 8.1 36.3 3.8 1.5 0.0 0.0 11.9 1.2 0.7 0.0 0.0 0.0 4.1 3.5 0.0 0.6 0.0 8.9 0.5 6.9 0.6 1.9 1.2 1.5 0.8 52.1 0.1 0.5 2.0 0.3 5.0 1.2 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 9.2 23.4 5.5 3.5 3.3 7.7 4.0 5.9 7.9 8.9 17.3 0.0 29.2 80.1 4.1 5.3 15.3 5.3 17.0 1.8 2.0 0.4 6.6 56.6 2.6 6.3 32.8 0.0 10.3 1.2 27.7 116.6 10.4 28.7 0.5 17.5 25.6 1.8 0.0 0.8 8.6 0.6 25.3 0.0 8.9 3.6 22.9 77.2 2.8 4.1 9.3 38.8 40.0 0.1 0.3 56.2 0.9 0.0 13.4 93.3 LUZP2 ENSG00000187398 "Leucine zipper protein 2" Q86TE4 11 24496970-25082631 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.1;brain: 32.7" "Group enriched" "Detected in some" 4 "Early spermatids: 18.8;Paneth cells: 21.8" "Group enriched" "Detected in some" 7 "glioma: 3.5;prostate cancer: 4.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1" "Low region specificity" "Detected in all" "HPA039007, HPA046161" Enhanced Supported Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted in brain" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA039007: AB_2676307, HPA046161: AB_2679564" "unprognostic (4.49e-2)" "unprognostic (2.74e-2)" "unprognostic (8.63e-2)" "unprognostic (3.50e-1)" "unprognostic (5.22e-3)" "unprognostic (3.38e-1)" "unprognostic (4.88e-2)" "unprognostic (5.67e-4)" "unprognostic (2.40e-1)" "unprognostic (5.66e-2)" "unprognostic (6.16e-3)" "unprognostic (4.09e-2)" "unprognostic (5.18e-3)" "unprognostic (9.41e-3)" "unprognostic (4.18e-2)" "unprognostic (2.17e-1)" "unprognostic (9.64e-2)" 1.2 11.1 14.5 0.9 10.8 0.9 1.6 2.6 32.7 0.9 2.1 5.9 0.0 0.9 1.0 0.8 0.9 0.8 1.0 1.0 10.3 13.8 1.0 2.3 1.1 0.8 13.7 5.6 0.8 0.8 0.7 1.9 0.8 26.7 4.5 1.7 0.0 1.0 0.9 0.8 0.9 1.1 1.2 30.0 0.9 0.9 1.6 14.5 0.0 0.8 0.9 0.8 1.6 0.3 0.5 0.4 1.9 0.3 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 14.2 7.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.2 0.2 0.0 1.5 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.5 0.3 0.4 0.2 0.1 0.2 0.2 0.1 0.3 0.1 0.5 0.3 0.2 1.9 0.3 0.2 0.4 0.1 0.0 14.5 10.8 2.6 9.3 10.3 13.8 13.7 5.6 26.7 14.5 0.0 0.0 0.0 0.1 0.6 2.3 0.4 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.6 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 1.8 0.2 0.1 21.8 0.0 0.6 0.6 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.9 0.7 LUZP4 "CT-8, CT28, HOM-TES-85" ENSG00000102021 "Leucine zipper protein 4" Q9P127 X 115289727-115307556 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 142 "testis: 21.2" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 24.3" "Cancer enriched" "Detected in some" 9 "testis cancer: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 2.4;U-266/70: 1.1" "HPA046436, HPA051999" Enhanced NA NA "HPA046436: AB_10964168, HPA051999: AB_2681688" "unprognostic (1.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.1 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.0 24.3 0.0 0.0 0.0 0.0 0.0 LVRN "APQ, AQPEP, FLJ90650, TAQPEP" ENSG00000172901 Laeverin Q6Q4G3 5 115962454-116027619 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 75.1" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 25.5;Extravillous trophoblasts: 21.0;Late spermatids: 42.0;Syncytiotrophoblasts: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 3.9;CAPAN-2: 1.8;SiHa: 1.5;U-266/70: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053254 Enhanced "Intracellular and membrane" NA NA "HPA053254: AB_2682092" "unprognostic (1.47e-1)" "unprognostic (3.38e-3)" "unprognostic (5.81e-2)" "unprognostic (2.97e-3)" "unprognostic (5.38e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-3)" "unprognostic (1.88e-2)" "unprognostic (2.23e-1)" "unprognostic (2.23e-2)" "unprognostic (3.83e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-7)" "unprognostic (1.05e-2)" "unprognostic (5.94e-2)" "unprognostic (6.53e-2)" "unprognostic (3.31e-2)" 10.6 0.1 0.0 0.5 0.0 0.1 3.9 0.0 0.0 0.3 1.4 0.0 0.4 0.1 0.0 0.0 1.8 0.2 0.4 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.1 75.1 0.0 0.7 0.4 0.0 0.6 1.2 1.3 1.0 1.7 0.5 0.0 0.0 0.4 0.3 0.0 0.0 0.3 1.7 0.1 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 2.4 3.9 0.9 0.2 0.3 0.1 0.3 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.1 0.0 0.9 0.0 0.0 0.2 0.3 1.3 0.4 0.0 0.0 0.3 0.1 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.3 0.0 0.6 1.6 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 25.5 0.0 0.0 0.0 0.0 21.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 42.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 8.9 0.0 0.0 0.0 LY6D E48 ENSG00000167656 "Lymphocyte antigen 6 family member D" Q14210 8 142784880-142786592 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 236.9;skin 1: 111.6;tongue: 316.2" "Group enriched" "Detected in some" 14 "Basal keratinocytes: 1040.7;Suprabasal keratinocytes: 3379.4" "Group enriched" "Detected in many" 7 "cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "A-431: 57.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024755, HPA064317" Enhanced NA NA 92000 "HPA024755: AB_1853410, HPA064317: AB_2685244" "unprognostic (2.13e-2)" "unprognostic (7.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-2)" "unprognostic (8.97e-2)" "unprognostic (1.51e-2)" "unprognostic (3.84e-1)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (8.68e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.50e-1)" "unprognostic (3.97e-1)" "unprognostic (5.40e-4)" "unprognostic (1.06e-1)" 0.2 3.7 0.2 0.2 0.2 0.1 3.7 0.2 0.2 23.0 0.2 0.2 0.2 0.1 2.1 0.2 236.9 0.1 0.5 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 1.3 0.2 1.2 0.1 0.2 18.1 0.2 0.4 111.6 0.2 0.9 0.2 0.2 2.0 0.2 0.2 0.9 0.2 316.2 61.8 6.3 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 1.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.0 0.0 6.9 1040.7 0.0 0.0 0.0 1.4 39.8 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 4.6 0.5 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 155.3 0.0 0.0 0.0 4.1 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 3379.4 6.9 0.0 0.0 148.4 LY6G5C "C6orf20, G5c, NG33" ENSG00000204428 "Lymphocyte antigen 6 family member G5C" Q5SRR4 6 31676684-31684040 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 17.4;Spermatocytes: 12.9;Spermatogonia: 13.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HDLM-2: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038690 Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Nucleoplasm Cytosol "HPA038690: AB_10673286" "unprognostic (1.51e-2)" "unprognostic (7.26e-2)" "unprognostic (7.19e-2)" "prognostic favorable (1.07e-4)" "unprognostic (4.83e-1)" "unprognostic (6.91e-2)" "unprognostic (1.33e-1)" "unprognostic (1.57e-2)" "unprognostic (4.27e-2)" "unprognostic (5.63e-2)" "unprognostic (3.74e-5)" "unprognostic (5.84e-2)" "unprognostic (3.78e-4)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.88e-2)" "unprognostic (1.39e-2)" 0.4 0.0 0.5 2.1 2.5 1.1 0.3 4.6 3.8 0.0 0.0 0.2 0.3 0.4 0.0 0.5 2.0 0.8 0.4 0.7 0.0 0.9 0.5 1.2 0.3 0.4 2.5 0.0 1.0 0.4 0.1 0.0 0.2 0.0 1.3 0.3 0.3 0.0 0.4 0.8 1.2 2.1 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.4 2.1 3.1 0.1 0.1 0.1 0.3 0.3 0.8 0.0 2.4 1.5 0.1 0.1 0.0 0.6 0.0 0.0 0.9 2.7 1.4 1.1 0.0 0.5 0.0 0.3 1.2 0.0 0.0 0.7 1.7 0.1 0.0 0.9 0.0 1.5 0.1 0.0 2.3 0.4 0.1 0.1 0.0 1.0 0.4 0.8 0.1 0.5 0.3 0.2 0.9 0.0 0.5 0.0 0.1 1.8 0.0 0.2 1.1 1.8 0.1 0.4 0.5 0.5 2.3 1.5 0.6 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.8 0.0 0.0 3.0 1.0 0.0 1.7 1.4 3.1 0.8 2.5 17.4 1.2 1.8 2.0 0.4 3.3 1.5 9.4 4.3 2.9 0.0 4.3 0.1 1.2 2.4 4.7 1.7 5.2 0.0 3.4 7.4 6.5 4.4 1.1 2.2 1.7 1.8 1.7 5.7 3.7 2.5 1.4 3.8 0.9 0.0 1.9 12.9 13.4 0.6 0.2 4.4 2.5 0.9 LY6G6C "C6orf24, G6c, NG24" ENSG00000204421 "Lymphocyte antigen 6 family member G6C" O95867 6 31718648-31721845 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 10.2;Late spermatids: 8.8;Suprabasal keratinocytes: 56.1;Syncytiotrophoblasts: 17.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HaCaT: 1.9;MCF7: 2.4;OE19: 1.2;SuSa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-1)" "unprognostic (3.05e-2)" "unprognostic (1.68e-1)" "unprognostic (4.85e-3)" "unprognostic (2.59e-3)" "unprognostic (1.35e-1)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (4.13e-1)" "unprognostic (1.76e-3)" "unprognostic (2.85e-1)" "unprognostic (8.80e-7)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (6.09e-2)" "unprognostic (9.38e-2)" 0.1 0.1 0.0 0.1 0.1 0.1 1.9 0.0 0.1 2.5 0.1 0.0 0.0 0.1 0.4 0.1 5.4 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 26.5 0.0 0.1 0.1 0.0 2.4 0.1 0.2 89.7 0.0 0.1 0.0 0.1 0.1 0.2 0.0 1.8 0.1 56.1 24.8 0.1 4.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 0.4 0.1 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.0 0.2 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.2 0.0 0.4 0.1 0.0 0.0 2.4 0.1 0.9 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.6 0.0 0.0 10.2 0.1 0.7 0.0 0.0 1.0 0.6 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 2.1 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 56.1 17.0 0.0 1.7 2.3 LY6G6D "C6orf23, G6D, Ly6-D, MEGT1, NG25" ENSG00000244355 "Lymphocyte antigen 6 family member G6D" O95868 6 31715356-31717804 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "seminal vesicle: 7.4;skin 1: 21.4" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 22 "colorectal cancer: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HEL: 6.2" "Region enhanced" "Detected in some" "cerebellum: 6.8" HPA054412 Uncertain "Intracellular and membrane" NA NA "HPA054412: AB_2682480" "unprognostic (5.48e-2)" "unprognostic (1.25e-1)" "unprognostic (2.81e-2)" "unprognostic (2.13e-1)" 0.6 0.2 0.1 0.0 0.7 0.2 0.1 0.0 0.6 5.1 2.7 0.3 1.7 0.1 0.5 0.0 0.3 0.2 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.4 5.6 0.6 0.3 0.3 7.4 0.1 21.4 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.7 0.0 0.6 0.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 LY6G6E "C6orf22, G6e" ENSG00000255552 "Lymphocyte antigen 6 family member G6E" 6 31711771-31714065 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 111 "HEL: 23.1" HPA056234 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA056234: AB_2732601" "unprognostic (1.77e-1)" "unprognostic (1.58e-2)" "unprognostic (2.25e-1)" "unprognostic (6.88e-2)" 0.3 0.0 2.9 0.0 0.5 4.3 0.0 0.0 5.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.3 0.2 1.7 0.1 0.0 0.3 3.9 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.6 0.7 0.2 0.0 0.0 0.3 0.0 0.0 4.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.6 2.2 0.0 0.1 0.2 0.4 0.4 0.8 1.1 0.4 0.1 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.6 0.2 0.4 0.4 0.4 0.7 0.4 0.0 0.2 0.3 0.4 1.1 0.1 0.3 0.8 0.7 1.0 2.9 0.5 0.0 5.2 1.7 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6G6F "C6orf21, G6f, LY6G6D, NG32" ENSG00000204424 "Lymphocyte antigen 6 family member G6F" Q5SQ64 6 31706885-31710595 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enriched" "Detected in single" 141 "HEL: 14.0" HPA008053 Uncertain NA NA 12000000 "HPA008053: AB_1840160" "unprognostic (3.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.66e-3)" 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 1.1 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.3 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6G6F-LY6G6D ENSG00000250641 "LY6G6F-LY6G6D readthrough" 6 31706904-31717918 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 9.3;testis: 4.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.7" HPA008053 Uncertain NA NA "HPA008053: AB_1840160" "unprognostic (5.02e-2)" "unprognostic (1.31e-1)" "unprognostic (3.47e-1)" "unprognostic (5.90e-2)" "unprognostic (1.07e-2)" "unprognostic (2.66e-1)" "unprognostic (2.42e-1)" 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.7 0.1 0.0 0.0 0.4 0.0 9.3 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY6H NMLY6 ENSG00000176956 "Lymphocyte antigen 6 family member H" O94772 8 143157914-143160711 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 58.2" "Group enriched" "Detected in some" 8 "Intestinal endocrine cells: 52.7;Spermatogonia: 16.2" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MOLT-4: 6.8;NTERA-2: 1.3;SCLC-21H: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077218 Enhanced "Intracellular and membrane" NA NA "HPA077218: " "unprognostic (8.76e-2)" "unprognostic (2.76e-1)" "unprognostic (1.41e-2)" "unprognostic (9.45e-4)" "unprognostic (3.34e-3)" "unprognostic (1.82e-1)" "unprognostic (1.71e-4)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-3)" "unprognostic (3.76e-3)" "unprognostic (5.97e-2)" "unprognostic (2.20e-5)" "unprognostic (6.43e-3)" "unprognostic (1.54e-1)" "unprognostic (8.98e-2)" "unprognostic (9.89e-3)" 1.4 1.4 46.7 1.6 26.3 1.3 1.3 0.0 42.8 1.3 2.8 3.2 0.0 5.6 1.5 1.4 1.5 2.6 1.4 1.2 58.2 53.4 1.3 1.2 1.4 1.4 10.9 32.5 1.2 1.3 1.2 8.4 1.3 7.1 1.3 1.3 0.0 1.3 1.4 1.4 1.2 2.2 1.8 4.0 1.2 4.3 2.3 1.9 0.0 1.3 0.0 1.2 1.4 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 46.7 26.3 0.0 36.9 58.2 53.4 10.9 32.5 7.1 1.9 0.0 0.0 0.0 0.1 0.6 1.3 4.2 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.1 0.0 52.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.9 0.1 0.0 0.0 0.0 3.4 0.0 0.0 1.1 16.2 0.0 0.0 0.0 0.0 0.5 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2" "HPA017770, CAB075742, CAB075743" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.8 0.5 0.0 1.5 0.6 1.9 0.3 31.3 3.7 9.7 5.9 0.0 0.2 0.0 2.6 3.5 3.4 2.6 0.0 1.7 8.2 0.3 0.0 0.0 34.1 0.0 0.4 0.0 0.0 2.9 5.1 7.2 9.3 0.0 0.8 0.0 0.0 0.1 18.2 0.2 0.0 0.0 1.0 0.9 0.5 0.0 0.1 0.0 1.6 0.4 0.9 0.1 49.0 0.6 9.5 1.7 0.1 0.0 1.2 0.4 2.8 66.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 3.0 0.3 0.0 65.7 34.6 0.3 0.1 10.2 1.4 7.9 24.4 0.0 11.3 0.0 0.5 5.0 3.3 0.0 0.0 0.0 132.9 2.9 88.0 0.0 0.0 5.3 0.0 0.0 1.3 0.0 10.1 3.7 2.8 11.8 0.0 0.0 0.5 3.9 0.0 2.8 0.0 0.7 0.0 13.3 359.5 76.0 39.3 21.2 0.0 0.0 76.5 LY6L ENSG00000261667 "Lymphocyte antigen 6 family member L" H3BQJ8 8 143080457-143083001 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "epididymis: 48.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "prostate cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "BEWO: 1.2" NA NA "unprognostic (5.25e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY75 "CD205, CLEC13B, DEC-205" ENSG00000054219 "Lymphocyte antigen 75" O60449 2 159803355-159904749 "CD markers, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 28.8;lymphoid tissue: 61.9" "Cell type enriched" "Detected in many" 7 "monocytes: 150.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.5;HDLM-2: 9.9;Karpas-707: 42.2;RT4: 14.3;THP-1: 10.6" "CAB001450, HPA049108, HPA054073" Enhanced Approved "Golgi apparatus" NA NA 960000 "Golgi apparatus" "CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370" "unprognostic (7.29e-3)" "unprognostic (1.92e-3)" "unprognostic (3.15e-1)" "unprognostic (1.52e-2)" "unprognostic (4.60e-3)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.80e-1)" "unprognostic (2.36e-1)" "unprognostic (8.74e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (2.39e-5)" "unprognostic (2.66e-1)" "unprognostic (4.89e-2)" "unprognostic (1.94e-2)" "prognostic favorable (3.86e-4)" 3.5 1.8 1.9 21.4 2.6 4.9 6.1 1.2 1.8 4.5 9.3 2.0 1.0 10.8 2.1 1.9 4.5 5.0 10.7 2.8 1.8 1.7 2.8 1.2 10.3 33.9 2.5 1.1 1.6 2.3 0.2 1.9 0.8 2.4 2.0 7.2 1.3 7.2 1.3 0.8 6.5 28.8 1.3 3.4 17.2 3.8 1.1 3.0 61.9 10.7 3.6 17.1 6.9 3.8 5.8 4.3 5.9 2.6 7.5 8.0 2.3 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 10.5 7.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 9.9 0.0 2.1 0.0 0.0 0.2 1.6 0.0 0.2 0.0 0.2 0.1 0.0 5.4 0.0 0.0 42.2 0.0 0.0 0.0 2.7 0.2 0.2 0.0 2.7 0.0 1.8 3.2 14.3 0.0 0.0 3.4 2.4 0.0 0.1 0.0 10.6 8.1 0.0 0.0 0.0 0.0 6.5 1.1 1.4 0.0 3.6 0.0 3.4 2.0 3.5 6.5 2.6 7.1 5.8 5.9 7.5 4.3 4.5 6.7 8.0 5.9 7.5 1.0 1.5 4.3 2.3 1.9 2.6 1.2 1.8 1.8 1.7 2.5 1.1 2.4 3.0 0.0 4.3 8.8 1.9 6.6 0.0 0.4 5.1 6.7 4.5 22.7 2.0 0.1 0.0 0.9 0.3 2.2 20.2 0.0 4.9 0.1 1.5 1.1 11.5 0.0 4.2 0.0 1.7 3.1 7.9 0.0 2.3 11.0 5.0 150.5 11.0 0.5 3.2 10.5 0.4 1.2 0.2 0.0 0.7 0.0 0.7 5.8 0.2 8.7 12.4 4.3 LY75-CD302 ENSG00000248672 "LY75-CD302 readthrough" 2 159771851-159904710 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 17.0;lymphoid tissue: 37.5" "Cell type enhanced" "Detected in some" 20 "Ciliated cells: 2.7;Club cells: 2.3;granulocytes: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;HDLM-2: 6.0;Karpas-707: 22.7;RT4: 9.6;TIME: 5.5" HPA049108 Uncertain NA NA "HPA049108: AB_2680635" "unprognostic (2.53e-1)" "unprognostic (1.55e-1)" "unprognostic (2.33e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (1.68e-4)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (3.32e-1)" "unprognostic (4.47e-2)" "unprognostic (1.88e-1)" 1.1 1.2 0.9 12.5 1.0 5.9 2.1 1.0 1.0 1.1 5.0 0.5 0.0 4.5 0.9 0.4 1.3 1.1 5.8 1.1 1.0 1.1 1.0 1.0 5.6 20.2 0.9 0.0 1.0 1.1 0.0 1.0 0.4 0.7 1.0 3.6 0.0 2.7 0.0 1.0 1.3 17.0 0.2 1.2 9.9 1.1 1.0 1.1 37.5 4.6 1.5 9.8 1.5 1.2 1.7 10.0 6.9 4.2 0.9 2.7 3.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.7 2.7 0.7 0.2 0.1 0.0 0.0 0.0 0.1 0.0 6.0 0.0 3.3 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.0 0.0 22.7 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 9.6 0.0 0.0 2.4 0.5 0.0 0.1 0.0 0.7 5.5 0.0 0.0 0.0 0.0 1.9 0.4 0.7 0.0 1.3 0.0 3.0 3.7 4.4 1.7 4.2 2.7 1.5 1.6 2.0 10.0 1.7 1.9 1.4 6.9 0.9 1.8 2.0 1.8 3.1 0.9 1.0 1.0 1.0 1.0 1.1 0.9 0.0 0.7 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LY86 "dJ80N2.1, MD-1" ENSG00000112799 "Lymphocyte antigen 86" O95711 6 6588108-6654983 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 58.7;lymphoid tissue: 44.6" "Group enriched" "Detected in many" 8 "B-cells: 109.7;Hofbauer cells: 173.4;Kupffer cells: 183.5;Macrophages: 157.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 58.2;myeloid DC: 58.7" "Group enriched" "Detected in many" 43 "B-cells: 47.7;dendritic cells: 58.7;monocytes: 58.2" "Cell line enhanced" "Detected in some" "Daudi: 20.9;NB-4: 11.3;RPMI-8226: 67.8;THP-1: 27.2;U-698: 9.4;U-937: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025000, HPA044895" Approved "Secreted to blood" NA NA 83000 "CAB025000: , HPA044895: AB_2679138" "unprognostic (1.82e-1)" "unprognostic (2.49e-3)" "unprognostic (2.01e-2)" "unprognostic (7.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.93e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-3)" "unprognostic (3.52e-2)" "unprognostic (3.17e-1)" "unprognostic (1.69e-1)" "unprognostic (1.16e-1)" "unprognostic (5.82e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.11e-1)" "unprognostic (4.20e-2)" 10.2 5.0 9.9 18.2 12.9 11.5 2.9 1.6 5.3 3.9 3.2 15.4 0.0 1.5 1.8 1.5 2.0 2.8 7.4 2.5 8.9 7.0 2.8 5.2 13.3 31.2 16.5 4.1 2.1 2.0 0.8 2.8 6.3 9.3 2.5 4.3 2.3 4.5 3.0 0.9 1.5 13.0 4.6 19.9 44.6 2.5 1.1 12.7 2.9 1.7 0.3 32.7 8.4 1.7 47.7 58.7 1.2 58.2 0.7 0.7 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.3 0.0 0.0 0.0 2.4 0.0 67.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 12.7 0.0 0.5 58.2 0.4 0.1 32.1 0.1 47.7 0.1 0.1 58.7 35.6 0.7 0.4 1.2 0.7 11.6 2.3 0.2 25.7 9.9 12.9 1.6 5.3 8.9 7.0 16.5 4.1 9.3 12.7 0.0 19.6 109.7 0.0 1.8 0.0 0.5 2.5 1.4 2.3 0.0 0.0 1.2 0.0 0.0 2.9 0.6 0.0 0.0 0.0 1.6 2.8 0.0 1.1 0.8 173.4 0.0 0.0 5.5 183.5 12.8 0.3 157.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.5 0.3 0.9 0.0 2.0 1.6 1.3 0.0 0.1 LY9 "CD229, hly9, mLY9, SLAMF3" ENSG00000122224 "Lymphocyte antigen 9" Q9HBG7 1 160796074-160828261 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.8;intestine: 11.3;lymphoid tissue: 43.7;urinary bladder: 28.6" "Group enriched" "Detected in some" 19 "B-cells: 55.0;Erythroid cells: 23.3;Melanocytes: 67.4;T-cells: 45.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 30.6;MAIT T-cell: 30.7;memory B-cell: 15.2;memory CD4 T-cell: 26.8;memory CD8 T-cell: 29.6;naive B-cell: 13.9;naive CD4 T-cell: 30.5;naive CD8 T-cell: 30.8;plasmacytoid DC: 18.6;T-reg: 19.7" "Group enriched" "Detected in many" 4 "B-cells: 15.2;dendritic cells: 18.6;T-cells: 30.8" "Cell line enhanced" "Detected in some" "Daudi: 7.3;JURKAT: 7.4;Karpas-707: 14.9;U-266/70: 37.8;U-266/84: 14.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050917 Approved NA NA 23000 "HPA050917: AB_2681272" "unprognostic (8.04e-4)" "unprognostic (2.31e-5)" "unprognostic (8.08e-3)" "unprognostic (1.20e-3)" "unprognostic (9.83e-3)" "unprognostic (1.87e-5)" "unprognostic (1.16e-2)" "unprognostic (3.84e-3)" "unprognostic (1.23e-2)" "unprognostic (2.89e-3)" "unprognostic (1.64e-1)" "unprognostic (2.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.69e-2)" "unprognostic (9.47e-2)" "unprognostic (3.49e-2)" "unprognostic (6.88e-2)" 2.8 0.5 0.4 20.9 0.4 6.9 2.7 0.4 0.4 1.4 3.7 0.2 0.4 2.4 0.9 0.8 3.5 1.0 2.0 0.9 0.4 0.4 1.7 1.3 6.1 35.3 0.4 0.0 1.1 0.5 0.0 0.5 0.2 0.1 1.0 2.3 1.0 6.5 0.4 0.4 0.8 11.3 0.1 0.7 25.3 3.4 1.1 0.0 35.7 1.6 1.8 43.7 28.6 1.2 15.2 18.6 0.6 0.2 5.2 30.8 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 14.9 0.0 0.0 1.1 0.2 0.0 0.4 0.0 0.8 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 37.8 14.6 0.1 0.0 2.1 0.0 0.2 0.2 0.1 30.6 0.2 30.7 15.2 26.8 29.6 1.3 13.9 30.5 30.8 0.6 5.2 0.2 18.6 19.7 12.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.1 0.0 0.0 2.6 55.0 0.5 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 23.3 0.2 0.0 0.5 0.2 0.0 0.4 2.0 0.0 1.2 2.5 2.4 0.0 0.0 2.2 67.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.9 0.1 45.3 0.0 0.4 LY96 MD-2 ENSG00000154589 "Lymphocyte antigen 96" Q9Y6Y9 8 73991352-74029087 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.6" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 473.5;Kupffer cells: 449.9;Macrophages: 173.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 92.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 92.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.0;GAMG: 21.8;Karpas-707: 52.3;RPMI-8226: 25.2;U-87 MG: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053060 Approved Vesicles "Secreted to blood" NA NA 95000 Vesicles "HPA053060: AB_2682029" "unprognostic (2.96e-1)" "unprognostic (2.64e-2)" "unprognostic (2.11e-1)" "unprognostic (1.85e-1)" "unprognostic (1.64e-2)" "unprognostic (2.87e-1)" "unprognostic (2.12e-3)" "unprognostic (1.42e-1)" "unprognostic (8.29e-2)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.38e-11)" "unprognostic (2.87e-2)" "unprognostic (1.29e-2)" "unprognostic (1.60e-2)" "unprognostic (5.90e-2)" 23.4 9.6 5.7 20.9 9.6 7.3 12.6 1.6 7.8 7.5 10.3 2.5 2.7 6.0 6.2 12.3 9.6 7.6 17.1 18.8 11.2 5.8 7.4 10.9 17.3 36.3 11.6 1.9 12.7 3.2 0.7 7.2 21.8 9.2 9.6 7.4 3.9 9.0 3.4 6.0 3.5 7.0 10.0 19.6 47.3 4.9 7.2 6.6 5.3 6.5 5.2 18.4 15.3 16.1 4.0 6.8 92.6 14.2 0.0 3.1 4.6 0.4 0.0 0.1 0.0 10.1 21.0 0.0 14.0 17.0 3.7 8.8 0.0 0.1 4.3 4.8 8.9 21.8 0.1 0.0 0.2 9.8 4.6 0.1 0.1 0.0 0.5 5.0 0.7 0.2 6.1 0.1 6.1 1.2 0.6 18.6 2.7 0.0 52.3 13.4 0.0 1.7 0.6 0.0 0.0 0.3 1.7 0.0 25.2 0.7 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.0 0.9 14.4 9.7 0.7 5.1 3.3 13.8 6.4 2.6 27.0 0.2 4.1 1.6 14.2 0.0 0.0 12.3 0.2 4.0 2.0 0.3 6.8 1.8 1.3 0.4 92.6 0.0 9.8 5.6 3.1 4.6 5.7 9.6 1.6 7.8 11.2 5.8 11.6 1.9 9.2 6.6 14.9 15.4 42.6 1.0 12.2 0.1 0.7 0.0 4.0 13.6 3.5 0.0 2.4 0.0 3.2 22.0 45.8 0.0 0.0 6.3 2.6 16.0 0.6 3.5 2.0 473.5 0.0 0.0 102.5 449.9 2.0 13.3 173.5 72.6 46.9 0.0 0.0 13.2 0.0 6.3 0.6 0.1 6.5 14.7 0.5 0.1 10.2 5.4 15.9 0.0 1.0 LYAR "ZC2HC2, ZLYAR" ENSG00000145220 "Ly1 antibody reactive" Q9NX58 4 4267701-4290169 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035880, HPA035881" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA035880: , HPA035881: AB_10669980" "unprognostic (2.81e-1)" "unprognostic (3.79e-1)" "unprognostic (2.64e-2)" "unprognostic (6.22e-3)" "unprognostic (1.44e-1)" "unprognostic (2.97e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (1.08e-3)" "unprognostic (2.92e-2)" "prognostic favorable (8.82e-4)" "unprognostic (5.05e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (4.36e-10)" "unprognostic (4.94e-2)" "unprognostic (1.61e-1)" "unprognostic (5.90e-2)" "unprognostic (2.72e-1)" 11.1 5.7 6.8 11.9 10.1 10.9 8.2 7.3 8.0 6.6 6.9 4.3 4.1 5.7 6.9 5.5 11.2 7.1 5.4 10.1 7.0 4.6 5.0 9.9 7.7 13.8 10.9 4.5 11.1 6.3 4.4 15.6 7.1 8.4 7.8 6.8 3.7 5.4 6.4 15.1 5.9 6.2 9.1 7.9 18.2 5.8 60.2 12.0 10.0 6.3 11.9 10.9 10.1 10.4 7.3 7.1 8.9 12.9 10.7 32.8 10.3 13.3 7.0 6.3 9.2 5.5 6.3 10.8 12.2 4.2 12.7 8.8 22.0 17.6 35.9 8.8 5.2 20.5 8.5 23.5 12.7 16.7 6.4 17.3 36.0 6.7 24.6 9.4 41.5 9.8 4.9 8.1 14.6 24.9 3.3 10.9 20.5 48.1 12.0 8.8 13.5 14.1 53.5 31.3 14.2 23.0 21.7 11.5 17.3 5.7 9.3 15.0 6.4 6.6 7.3 12.4 8.4 7.5 12.4 10.2 12.7 10.1 16.5 38.4 8.5 12.8 57.4 8.6 35.1 10.2 8.9 9.7 8.5 28.6 9.6 32.8 7.3 18.9 30.8 7.1 5.7 8.9 19.0 2.8 10.7 12.9 5.3 8.8 10.3 6.8 10.1 7.3 8.0 7.0 4.6 10.9 4.5 8.4 12.0 14.9 30.0 19.7 34.4 106.7 9.4 21.6 12.7 26.8 36.4 1.8 7.9 43.0 8.3 15.1 74.2 29.5 2.8 0.0 17.0 43.6 29.4 25.4 20.8 10.6 32.5 14.3 10.3 8.6 30.8 61.9 31.7 32.1 20.3 19.0 16.0 9.6 22.6 13.9 25.1 5.1 28.7 38.8 35.0 435.9 39.2 101.3 16.9 130.7 24.0 62.3 LYG1 SALW1939 ENSG00000144214 "Lysozyme g1" Q8N1E2 2 99284238-99304742 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "kidney: 22.5" "Group enriched" "Detected in some" 6 "Distal tubular cells: 18.3;Proximal tubular cells: 70.3" "Cancer enriched" "Detected in many" 15 "renal cancer: 31.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted - unknown location" NA NA "unprognostic (1.53e-2)" "unprognostic (3.13e-2)" "unprognostic (1.53e-2)" "unprognostic (3.73e-1)" "unprognostic (9.74e-2)" "unprognostic (3.76e-4)" "unprognostic (6.94e-4)" "unprognostic (2.58e-2)" "unprognostic (4.72e-2)" "unprognostic (9.74e-3)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "prognostic favorable (8.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.58e-1)" "unprognostic (1.07e-1)" "unprognostic (2.31e-3)" 1.0 0.4 1.0 1.1 1.0 0.7 2.1 2.3 1.0 1.1 1.0 1.0 1.0 1.2 1.4 1.9 1.0 0.7 1.0 1.0 1.0 0.4 22.5 3.1 1.0 1.5 1.0 1.0 1.1 1.0 0.0 1.0 1.0 1.0 1.6 1.1 1.0 1.0 1.0 2.0 1.5 1.2 1.0 1.0 2.6 0.6 2.9 1.0 1.0 1.2 1.0 1.2 1.0 1.0 1.0 0.4 1.2 0.9 0.0 2.4 0.5 0.5 3.9 3.0 4.9 6.9 4.1 3.4 1.5 1.7 1.6 2.7 0.8 3.5 0.8 2.7 0.7 0.4 1.7 4.0 0.6 1.9 2.7 2.4 2.2 2.9 1.3 1.4 0.8 5.4 3.2 4.3 2.6 1.0 3.6 0.8 5.2 1.2 2.6 1.8 0.8 2.0 6.7 0.7 2.0 3.8 4.9 1.7 1.3 6.9 1.5 1.7 1.0 0.6 1.2 1.1 3.8 0.5 0.7 2.2 2.0 2.5 3.6 1.7 3.0 1.8 0.6 0.6 4.0 1.0 0.0 0.9 1.2 1.5 0.1 1.4 0.2 0.2 0.6 0.4 1.0 1.2 0.7 0.0 0.0 0.0 0.0 2.4 0.5 1.0 1.0 2.3 1.0 1.0 0.4 1.0 1.0 1.0 1.0 0.0 0.0 0.0 0.2 0.0 1.0 0.3 0.0 0.0 2.3 1.8 2.0 0.2 18.3 0.5 7.8 0.3 0.3 0.0 0.2 0.1 0.4 0.5 4.6 0.0 0.3 0.0 0.0 1.3 0.3 3.6 0.3 0.4 0.0 1.0 0.3 0.3 0.6 0.0 0.4 70.3 0.5 0.0 0.4 1.8 0.2 0.0 0.5 0.5 0.2 0.1 LYG2 LYGH ENSG00000185674 "Lysozyme g2" Q86SG7 2 99242246-99255282 "Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 4.0;skin 1: 13.0;testis: 4.8" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 12.8;Cone photoreceptor cells: 13.7;Horizontal cells: 14.3;Rod photoreceptor cells: 24.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;dendritic cells: 2.9;T-cells: 2.5" "Cell line enhanced" "Detected in many" "THP-1: 4.3;U-937: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039179 Uncertain "Secreted in other tissues" NA NA "HPA039179: AB_10794633" "unprognostic (5.12e-2)" "unprognostic (8.70e-3)" "unprognostic (6.29e-2)" "unprognostic (3.91e-2)" "unprognostic (1.47e-1)" "unprognostic (7.29e-2)" "unprognostic (1.86e-2)" "unprognostic (1.78e-2)" "unprognostic (1.90e-1)" "unprognostic (1.30e-2)" "unprognostic (1.30e-5)" "unprognostic (1.40e-3)" "unprognostic (1.08e-13)" "unprognostic (9.98e-2)" "unprognostic (1.44e-1)" "unprognostic (1.19e-2)" "unprognostic (9.24e-3)" 0.5 0.5 0.1 0.4 0.7 1.7 0.0 0.7 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.1 0.0 0.9 13.0 0.2 0.0 0.0 0.5 0.5 4.8 0.3 0.0 0.0 0.0 4.0 2.9 0.3 0.7 0.5 2.5 0.0 0.8 1.1 1.0 1.2 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.9 0.7 2.2 0.5 0.0 2.7 0.5 0.0 0.0 0.3 1.1 0.2 0.5 1.2 0.3 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.6 0.2 0.0 2.6 0.5 1.6 0.8 0.0 3.2 0.6 1.5 1.2 2.9 0.8 1.2 0.3 0.2 0.2 0.0 1.0 0.9 4.3 1.6 1.8 1.2 0.2 1.0 0.6 2.1 0.3 0.8 6.1 1.2 0.0 0.7 0.3 1.2 0.2 0.6 1.9 2.5 1.4 0.2 4.0 1.0 0.9 0.3 0.5 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.2 0.6 12.8 0.3 2.5 0.0 0.0 0.0 13.7 0.7 0.0 0.2 5.9 0.6 0.0 0.0 0.0 0.1 0.9 0.6 0.0 0.0 0.2 14.3 0.0 1.3 0.8 1.3 0.0 0.0 1.7 0.0 0.0 6.8 0.1 0.0 0.7 0.0 24.2 0.0 0.6 1.4 1.3 0.4 0.2 0.0 0.2 0.1 LYL1 bHLHa18 ENSG00000104903 "LYL1, basic helix-loop-helix family member" P12980 19 13099033-13103161 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.4;lymphoid tissue: 25.4" "Group enriched" "Detected in many" 4 "Early spermatids: 274.5;Late spermatids: 496.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 33.0;HL-60: 23.1;HMC-1: 55.7;K-562: 25.9;NB-4: 33.8;REH: 24.8;THP-1: 22.4;U-937: 22.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA075004 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA075004: AB_2686728" "unprognostic (8.62e-2)" "unprognostic (1.58e-1)" "unprognostic (1.27e-2)" "unprognostic (3.29e-3)" "unprognostic (2.76e-1)" "unprognostic (3.64e-3)" "unprognostic (2.46e-1)" "unprognostic (1.05e-2)" "unprognostic (1.90e-2)" "unprognostic (5.87e-2)" "unprognostic (1.78e-3)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.89e-4)" "unprognostic (1.18e-1)" "unprognostic (6.54e-2)" "unprognostic (1.33e-1)" "unprognostic (4.28e-1)" 6.3 3.0 3.4 19.9 5.8 37.4 8.0 1.1 3.8 4.0 3.7 5.5 1.3 3.0 5.3 3.9 5.9 3.8 3.5 4.9 4.5 2.9 3.9 2.0 8.1 24.0 7.1 1.6 3.2 1.6 0.8 1.7 8.0 5.1 6.2 1.4 4.4 6.4 2.4 3.5 2.0 8.8 3.3 6.0 25.4 4.2 11.9 4.1 3.6 3.5 1.4 18.9 3.3 7.0 4.6 1.4 8.8 3.6 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 6.4 2.2 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 33.0 0.0 0.3 0.3 23.1 55.7 0.1 0.0 0.0 0.0 0.0 8.5 0.0 25.9 1.1 0.0 0.0 0.1 33.8 0.0 0.1 0.8 24.8 0.0 2.8 0.0 0.0 0.0 2.4 0.7 0.0 1.5 0.0 0.0 22.4 13.6 0.0 0.0 0.9 0.0 0.0 0.0 5.2 0.0 22.3 0.0 2.5 2.3 8.8 0.1 2.9 0.2 2.8 0.3 0.2 1.4 4.6 0.2 0.2 3.6 0.0 3.6 0.4 0.5 0.6 3.4 5.8 1.1 3.7 4.5 2.9 7.1 1.6 5.1 4.1 0.0 0.3 46.4 0.5 2.3 0.0 2.0 2.5 1.4 0.0 1.8 0.0 0.6 0.0 0.2 274.5 27.4 1.1 70.0 0.0 0.8 4.7 0.2 44.9 0.8 92.6 0.0 1.7 20.9 52.2 496.4 7.5 33.5 6.8 2.8 1.1 1.4 1.2 1.5 11.3 0.2 0.1 12.9 1.8 39.2 5.5 1.6 1.3 2.2 0.8 0.4 LYN JTK8 ENSG00000254087 "LYN proto-oncogene, Src family tyrosine kinase" P07948 8 55879813-56014168 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.9" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 110.4;Kupffer cells: 161.3;Macrophages: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 36.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 57.7;HMC-1: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001231, CAB004492" Enhanced Supported "Golgi apparatus,Vesicles,Plasma membrane" NA NA 11000000 "Golgi apparatus, Plasma membrane" Vesicles "CAB004492: AB_627897, HPA001231: AB_1079286" "unprognostic (7.87e-2)" "unprognostic (4.89e-2)" "unprognostic (9.04e-2)" "unprognostic (3.74e-1)" "unprognostic (8.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.70e-2)" "unprognostic (1.11e-1)" "unprognostic (2.79e-1)" "unprognostic (8.80e-2)" "unprognostic (3.68e-2)" "unprognostic (7.15e-2)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.13e-1)" "unprognostic (2.72e-3)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" 8.8 6.8 4.5 34.0 6.3 33.6 11.1 9.5 4.1 5.3 10.5 5.8 7.2 15.6 3.4 7.8 7.2 6.7 13.7 8.9 4.8 3.6 6.1 13.8 34.6 70.9 7.7 2.1 5.3 9.8 3.1 4.9 19.1 5.6 5.7 6.6 6.3 14.9 8.5 2.7 3.4 16.2 6.6 8.5 69.4 7.4 3.6 5.1 3.8 9.4 5.3 25.8 10.7 7.5 8.4 9.2 36.8 26.5 1.9 0.9 2.7 12.8 7.7 1.8 0.3 0.1 0.0 13.9 9.8 14.5 6.2 4.4 5.3 4.4 12.4 4.4 3.9 4.8 6.0 7.2 7.3 5.3 20.1 7.2 57.7 2.3 1.9 1.9 5.8 58.6 0.3 2.5 0.1 4.5 3.6 8.3 0.0 30.5 26.9 0.9 0.7 0.0 6.1 11.1 20.2 0.9 0.9 2.8 1.5 4.0 6.1 1.2 22.3 4.9 0.0 2.0 13.8 1.1 13.6 9.7 0.0 2.9 0.0 4.4 9.0 3.3 28.1 0.6 11.5 0.4 2.1 7.2 12.3 0.9 16.8 0.7 8.2 0.2 0.3 6.4 8.4 0.1 0.4 36.8 1.9 26.5 9.2 0.0 2.7 4.5 6.3 9.5 4.1 4.8 3.6 7.7 2.1 5.6 5.1 32.8 35.7 89.3 18.6 4.7 2.1 1.4 17.8 22.7 31.8 8.7 2.0 2.5 0.0 18.6 0.6 18.5 14.9 0.0 44.9 61.3 8.4 36.9 70.5 10.9 110.4 0.0 5.8 25.8 161.3 1.7 3.1 122.4 5.0 73.1 13.5 61.7 37.6 13.5 1.1 1.3 1.5 19.4 4.3 0.2 1.2 5.1 32.4 24.5 12.3 92.1 LYNX1 SLURP2 ENSG00000180155 "Ly6/neurotoxin 1" P0DP58 8 142771197-142777810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.2" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 62.8;Hepatocytes: 25.9;Horizontal cells: 20.6;Suprabasal keratinocytes: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "intermediate monocyte: 5.7;non-classical monocyte: 15.0" "Lineage enriched" "Detected in single" 16 "monocytes: 15.0" "Cell line enhanced" "Detected in many" "BJ: 8.0;fHDF/TERT166: 10.1;GAMG: 11.7;HHSteC: 8.5;HSkMC: 7.7;OE19: 7.5;T-47d: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.67e-2)" "unprognostic (6.96e-2)" "unprognostic (1.31e-2)" "unprognostic (2.79e-3)" "unprognostic (1.04e-3)" "unprognostic (5.13e-3)" "unprognostic (1.33e-1)" "unprognostic (5.55e-3)" "unprognostic (1.12e-1)" "unprognostic (3.61e-3)" "unprognostic (7.21e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.82e-4)" "unprognostic (2.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.64e-2)" "unprognostic (1.85e-1)" 6.5 15.5 15.0 2.2 26.7 0.3 5.7 18.8 55.2 7.2 7.2 13.3 0.9 2.5 7.2 3.3 13.4 7.6 5.5 37.7 32.8 4.8 5.3 16.4 5.0 1.2 7.9 24.4 7.1 6.2 23.4 6.0 1.9 38.5 8.1 1.7 6.1 10.9 9.0 3.5 14.3 3.0 7.2 8.9 8.5 5.1 2.1 10.2 0.0 5.2 1.3 1.4 7.1 8.8 0.0 0.9 0.0 15.0 0.0 0.3 0.3 0.1 5.6 0.3 0.0 2.3 0.3 0.1 8.0 0.6 1.1 1.4 0.3 1.3 0.0 3.9 10.1 11.7 1.5 0.2 0.0 0.3 0.0 0.2 0.0 0.2 1.3 8.5 0.0 3.9 7.7 1.3 2.3 0.0 0.2 0.9 0.0 0.0 0.3 0.8 0.0 0.0 0.1 1.9 7.5 0.1 0.0 0.0 0.0 3.1 0.0 0.7 4.3 0.6 6.2 0.0 3.8 7.2 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 0.2 5.7 0.1 0.0 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 15.0 0.0 0.0 0.3 15.0 26.7 18.8 55.2 32.8 4.8 7.9 24.4 38.5 10.2 0.0 0.0 0.0 0.9 5.0 8.7 62.8 2.5 2.7 2.3 0.0 0.0 0.2 3.3 0.8 0.2 3.0 0.0 0.0 0.3 0.2 3.2 0.9 1.1 25.9 2.7 20.6 0.0 14.1 2.2 0.4 4.6 1.0 5.0 0.0 0.0 12.8 0.2 0.0 7.8 2.1 4.5 6.5 6.1 0.6 1.5 29.1 0.5 0.0 0.0 2.8 LYNX1-SLURP2 ENSG00000284505 "LYNX1-SLURP2 readthrough" 8 142764334-142778224 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.1;esophagus: 13.6" "Cell type enriched" "Detected in single" 9 "Pancreatic endocrine cells: 5.9" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.7;non-classical monocyte: 4.1" "Lineage enriched" "Detected in single" 6 "monocytes: 4.1" "Cell line enhanced" "Detected in some" "A549: 2.3;BJ: 3.6;EFO-21: 3.0;HaCaT: 2.6;SH-SY5Y: 1.7;TIME: 1.7" "Intracellular and membrane" NA NA 3.8 2.4 3.7 0.8 4.1 0.3 1.1 1.2 13.1 1.1 1.4 2.1 0.0 1.1 1.9 1.4 13.6 2.1 1.2 7.0 3.0 1.6 6.5 1.1 0.6 2.3 4.2 1.6 1.0 1.2 0.0 0.7 6.7 3.6 0.9 1.9 2.0 5.0 2.0 8.6 1.5 3.5 1.2 1.5 1.2 0.8 1.4 0.0 0.5 0.5 1.1 4.2 0.8 0.0 0.2 0.0 4.1 0.0 0.6 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.1 0.4 0.3 0.0 0.0 3.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.4 0.2 0.0 0.1 1.1 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.7 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.2 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LYPD1 "LYPDC1, MGC29643" ENSG00000150551 "LY6/PLAUR domain containing 1" Q8N2G4 2 132644853-132671579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 74.6" "Group enriched" "Detected in many" 5 "Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 57.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 10.9" "Lineage enriched" "Detected in single" 36 "granulocytes: 10.9" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068333 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA068333: " "unprognostic (9.25e-2)" "unprognostic (7.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.07e-2)" "unprognostic (6.40e-3)" "unprognostic (5.60e-2)" "unprognostic (8.36e-3)" "unprognostic (1.05e-2)" "unprognostic (6.70e-2)" "unprognostic (2.86e-2)" "unprognostic (1.51e-2)" "unprognostic (1.43e-2)" "unprognostic (1.55e-1)" "unprognostic (1.03e-1)" "unprognostic (6.78e-2)" 1.5 2.5 16.4 1.7 27.8 1.2 1.4 3.8 16.8 1.3 2.5 4.6 0.0 1.4 2.5 1.8 1.4 74.6 3.6 1.8 18.9 19.0 3.2 1.6 1.4 3.5 16.9 5.4 8.4 3.5 2.0 12.4 1.2 11.8 1.4 1.4 5.4 21.7 1.4 1.2 1.5 1.4 1.8 7.0 1.3 1.4 1.5 3.4 1.2 1.3 1.1 2.5 1.4 0.0 0.3 0.0 10.9 0.0 0.0 0.0 0.0 0.2 4.8 5.4 0.0 0.0 0.0 0.0 1.1 0.6 2.4 0.5 0.4 0.6 0.0 10.1 2.0 1.6 5.2 0.0 0.0 1.2 0.0 1.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 1.0 14.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.3 0.1 2.1 0.0 0.0 0.0 7.1 0.1 0.7 1.3 0.6 0.0 15.2 13.7 0.0 0.1 0.7 0.3 7.6 3.2 31.7 0.0 0.0 0.0 6.2 0.0 63.9 1.3 0.0 10.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.8 3.8 11.0 18.9 19.0 16.9 5.4 11.8 3.4 0.0 0.0 0.0 0.0 0.1 0.8 0.2 5.1 0.0 0.0 5.2 0.0 0.0 1.7 49.4 4.4 0.0 0.0 0.0 65.7 0.0 0.1 0.1 0.0 0.0 0.1 14.3 1.7 0.6 0.3 6.3 3.7 0.0 0.0 108.2 0.0 1.5 67.6 0.0 0.0 2.2 0.8 0.0 5.3 1.1 1.8 0.0 0.0 0.0 0.0 0.0 LYPD2 "LYPDC2, RGTR430, UNQ430" ENSG00000197353 "LY6/PLAUR domain containing 2" Q6UXB3 8 142750150-142752534 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9" "Cell type enriched" "Detected in single" 13 "Ito cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 13 "non-classical monocyte: 76.5" "Lineage enriched" "Detected in many" 20 "monocytes: 76.5" "Cell line enhanced" "Detected in some" "EFO-21: 15.1;HaCaT: 4.1;OE19: 2.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA028599 Uncertain "Intracellular and membrane" NA NA "HPA028599: AB_10603777" "prognostic favorable (2.00e-4)" "unprognostic (3.10e-2)" "prognostic favorable (2.63e-4)" "unprognostic (3.85e-3)" "unprognostic (3.75e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-2)" "unprognostic (3.11e-3)" "unprognostic (1.53e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.12e-1)" "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 6.7 0.0 0.0 0.1 0.0 0.3 0.0 77.5 0.2 0.1 1.2 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 7.7 0.0 0.5 6.5 0.0 0.0 0.0 0.1 11.6 0.0 0.0 5.7 0.0 37.9 69.2 0.0 10.1 0.2 3.7 0.0 76.5 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 15.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 76.5 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6" "Cell type enhanced" "Detected in many" 25 "Basal keratinocytes: 448.4;Suprabasal keratinocytes: 2015.9;Syncytiotrophoblasts: 598.6;Urothelial cells: 616.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 235.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.9" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.8;HaCaT: 30.1;MCF7: 33.6;RT4: 32.3;SK-BR-3: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA 9700000 "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 0.3 0.4 0.3 0.4 0.3 0.8 5.8 0.3 0.3 28.0 0.3 0.3 0.3 0.0 2.1 0.7 110.5 0.5 0.3 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.0 0.3 7.4 0.3 1.4 0.0 0.5 21.7 0.3 0.6 86.4 0.4 0.8 0.3 0.3 0.1 0.3 0.3 1.9 0.3 70.6 75.2 4.1 48.3 0.2 3.5 3.0 0.4 0.1 7.9 1.9 11.2 0.1 0.0 0.2 0.1 0.0 4.7 0.4 1.2 0.4 0.5 0.1 12.8 0.0 0.5 0.3 1.7 30.1 0.0 1.3 0.2 0.0 0.1 0.2 1.5 0.2 0.1 0.0 0.2 0.5 11.4 0.0 0.1 0.5 0.0 0.9 0.0 0.0 0.0 33.6 0.2 0.0 0.0 7.2 2.5 0.1 0.0 0.0 0.3 32.3 0.0 0.1 0.1 48.4 0.5 1.5 5.3 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.6 0.2 4.2 1.6 3.5 0.0 7.9 6.7 3.0 0.1 0.0 0.4 1.2 1.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.6 0.5 55.8 448.4 0.6 0.5 5.1 0.0 1.2 14.0 0.0 74.6 1.7 1.6 0.0 2.2 0.3 0.0 0.2 59.2 26.8 34.6 5.7 0.0 12.7 3.2 0.0 0.0 0.0 0.0 0.6 2.7 140.0 1.0 1.0 3.2 2.8 0.0 0.4 0.6 0.2 0.0 18.6 0.0 0.9 2015.9 598.6 2.5 0.7 616.2 LYPD4 MGC42718 ENSG00000273111 "LY6/PLAUR domain containing 4" Q6UWN0 19 41837074-41844697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "testis: 120.3" "Group enriched" "Detected in some" 55 "Early spermatids: 232.6;Late spermatids: 649.6;Spermatocytes: 177.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "BEWO: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (4.07e-2)" "unprognostic (2.92e-1)" "unprognostic (3.21e-1)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.8 1.2 1.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.7 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.8 0.3 0.5 0.6 0.4 0.9 0.6 0.5 0.5 0.5 0.5 0.6 0.8 1.5 1.7 1.2 0.7 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 649.6 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.0 177.4 5.0 0.0 0.0 0.0 0.0 0.0 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.8;Late spermatids: 48.7;Melanocytes: 16.9;Syncytiotrophoblasts: 18.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 5.9;BEWO: 9.1;HaCaT: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: AB_2682567" "unprognostic (4.27e-3)" "prognostic favorable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.9 0.0 0.3 0.0 0.1 0.0 9.1 0.5 0.0 0.8 1.0 0.7 2.1 0.3 1.1 0.7 2.3 9.5 0.0 1.1 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.9 2.6 0.4 1.1 0.0 0.3 0.2 0.1 0.3 0.0 0.3 0.2 0.1 0.6 3.1 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 1.9 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 0.0 0.0 0.0 2.6 3.2 1.5 0.6 0.0 1.4 0.0 0.0 0.0 0.9 3.3 0.4 25.8 1.7 0.0 0.0 0.8 7.4 0.2 1.4 0.0 0.0 2.0 0.0 0.0 0.6 0.0 48.7 0.3 0.7 16.9 0.0 1.8 1.0 0.4 0.2 1.1 0.0 0.6 0.0 0.1 1.1 2.6 2.5 18.1 0.0 0.4 5.1 LYPD6 MGC52057 ENSG00000187123 "LY6/PLAUR domain containing 6" Q86Y78 2 149329985-149474148 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 17.7;placenta: 22.7" "Group enriched" "Detected in many" 33 "Early spermatids: 54.3;Late spermatids: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042805 Enhanced Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA042805: AB_10794159" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (7.23e-3)" "unprognostic (1.64e-2)" "unprognostic (3.25e-1)" "unprognostic (6.49e-3)" "unprognostic (6.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.73e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.14e-3)" "unprognostic (6.75e-2)" "unprognostic (7.33e-4)" "unprognostic (1.39e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.72e-4)" 2.6 1.0 8.7 1.8 7.9 0.4 14.6 3.3 8.2 2.0 4.4 4.3 1.1 2.8 4.0 1.0 1.2 2.9 17.7 1.4 6.2 11.5 3.4 0.8 1.3 0.8 6.2 5.3 1.4 3.2 2.6 0.9 22.7 7.2 2.5 4.1 2.8 0.8 2.6 0.7 1.4 5.6 4.7 5.1 1.3 6.2 4.5 2.6 0.0 0.6 0.0 2.3 4.4 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 18.6 0.0 0.0 0.2 7.6 3.3 9.6 6.1 0.1 1.5 0.0 0.4 23.9 4.7 1.9 2.7 0.0 13.1 0.0 0.9 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.8 0.1 0.1 0.0 0.0 0.0 23.7 3.0 0.0 1.7 2.7 1.6 2.2 0.0 10.3 0.0 1.2 19.5 0.7 3.4 5.1 5.8 0.6 6.3 0.7 0.3 0.0 0.2 3.0 0.2 4.1 0.0 0.0 0.0 1.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 8.7 7.9 3.3 8.2 6.2 11.5 6.2 5.3 7.2 2.6 0.0 0.0 0.0 0.5 0.1 1.9 0.3 2.5 1.4 3.4 0.0 0.0 0.0 3.3 2.2 54.3 0.2 1.0 0.0 0.7 0.2 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 174.5 2.8 0.0 0.0 0.0 2.5 3.5 3.3 0.0 0.4 0.0 3.2 0.0 0.1 0.7 1.1 0.0 0.2 0.0 1.9 1.1 LYPD6B "CT116, LYPD7" ENSG00000150556 "LY6/PLAUR domain containing 6B" Q8NI32 2 149038107-149215262 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 38.9" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 202.8;Late spermatids: 80.2;Suprabasal keratinocytes: 60.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.0;LHCN-M2: 41.7;NB-4: 13.6;RT4: 22.0;SK-BR-3: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA049239 Uncertain "Intracellular and membrane" NA NA "HPA049239: AB_2680688" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (8.42e-2)" "unprognostic (3.12e-3)" "unprognostic (1.64e-1)" "unprognostic (3.37e-1)" "unprognostic (2.01e-2)" "unprognostic (6.27e-2)" "unprognostic (3.64e-2)" "unprognostic (7.95e-3)" "unprognostic (2.59e-2)" "unprognostic (4.40e-2)" "unprognostic (1.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-1)" "unprognostic (2.68e-1)" "unprognostic (1.32e-3)" 0.2 0.2 1.4 0.1 1.5 0.0 8.9 0.7 2.4 1.4 2.3 0.6 21.8 1.1 1.1 0.5 2.1 12.2 27.3 0.1 5.0 2.4 4.0 0.4 2.7 2.4 0.7 0.6 1.7 13.2 9.8 0.6 0.6 0.9 5.0 1.5 2.5 11.9 26.6 0.1 38.9 2.9 1.8 0.6 1.3 20.3 16.9 0.7 0.2 0.2 0.6 2.3 9.1 3.7 2.8 0.0 14.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.6 2.7 1.0 0.3 0.0 0.0 0.0 26.0 0.0 5.6 0.6 0.6 8.6 0.0 3.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 9.4 0.0 13.6 0.8 5.8 0.1 0.0 0.1 1.7 1.3 22.0 1.5 0.0 0.1 13.2 0.0 2.7 1.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 14.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.5 0.7 2.4 5.0 2.4 0.7 0.6 0.9 0.7 0.0 1.3 2.0 20.2 26.6 0.0 1.1 50.9 22.7 6.8 43.6 0.0 0.0 6.6 10.6 202.8 0.8 3.6 0.0 16.3 0.5 0.8 26.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 80.2 2.0 1.1 5.0 1.0 3.1 0.0 23.2 6.5 0.0 0.0 0.0 0.0 0.9 1.5 1.5 60.3 0.2 0.0 2.5 35.1 LYPD8 ENSG00000259823 "LY6/PLAUR domain containing 8" Q6UX82 1 248718649-248755739 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 60.0;lymphoid tissue: 40.9" "Cell type enriched" "Detected in some" 7 "Paneth cells: 701.4" "Cancer enriched" "Detected in some" 7 "colorectal cancer: 15.2" "Group enriched" "Detected in some" 6 "classical monocyte: 1.0;intermediate monocyte: 1.1;MAIT T-cell: 1.7;neutrophil: 2.3;plasmacytoid DC: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 1.2;THP-1: 2.5" "Not detected" "Not detected" "Secreted to digestive system" NA NA "unprognostic (6.69e-3)" "unprognostic (3.53e-2)" "unprognostic (1.08e-5)" "unprognostic (1.42e-2)" "unprognostic (1.35e-1)" "unprognostic (2.16e-4)" "unprognostic (8.62e-2)" "unprognostic (7.28e-2)" "unprognostic (3.22e-1)" "unprognostic (9.73e-2)" "unprognostic (1.87e-1)" "unprognostic (1.19e-4)" "unprognostic (2.57e-1)" "unprognostic (2.89e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.1 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 36.8 0.0 0.0 0.0 0.0 0.0 8.1 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.1 2.3 1.1 0.0 1.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 1.1 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 3.4 0.0 57.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 30.2 0.0 0.0 7.5 0.0 0.0 0.0 0.0 104.6 0.0 0.0 701.4 0.0 1.7 0.0 0.0 0.0 0.2 0.7 0.0 0.2 0.0 16.3 0.0 LYRM1 A211C6.1 ENSG00000102897 "LYR motif containing 1" O43325 16 20899868-20925006 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 101.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 144.2;Late spermatids: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059840 Supported Nucleoplasm,Midbody Yes No Nucleoplasm Midbody "HPA059840: AB_2684137" "unprognostic (4.44e-2)" "unprognostic (1.03e-1)" "unprognostic (1.66e-2)" "prognostic favorable (7.48e-7)" "unprognostic (3.04e-1)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (8.60e-2)" "unprognostic (1.20e-1)" "unprognostic (1.04e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (1.57e-1)" "unprognostic (6.18e-2)" "unprognostic (3.86e-1)" "prognostic favorable (9.50e-4)" 25.4 18.9 19.1 15.0 17.4 12.8 25.5 12.6 17.8 17.5 16.6 9.6 14.0 9.5 17.1 21.1 16.2 24.9 17.0 34.2 15.4 18.2 30.6 101.6 11.2 19.2 18.8 13.8 25.3 26.1 20.5 13.9 9.0 24.9 21.1 14.0 13.1 14.1 19.1 28.7 10.6 12.6 27.6 17.9 11.5 15.7 22.9 9.0 16.2 19.4 14.9 12.9 25.3 19.7 12.7 7.2 47.4 10.2 8.4 14.2 10.1 12.1 13.0 12.1 9.6 32.9 26.2 4.0 10.1 16.9 5.8 8.8 14.6 15.2 8.5 39.5 12.1 8.5 8.5 5.3 10.6 9.5 15.9 8.3 3.9 3.6 37.6 24.5 12.7 7.7 19.0 9.4 16.3 46.8 16.5 24.1 12.7 8.5 15.1 25.2 16.1 12.5 8.6 12.6 18.1 6.9 17.2 6.7 10.2 21.0 7.1 11.9 11.4 6.3 10.5 16.8 7.0 10.8 7.4 6.4 8.4 6.1 13.2 6.9 14.9 20.9 13.3 21.9 13.7 7.3 47.4 7.2 23.3 8.6 9.1 11.8 12.7 13.2 10.6 5.9 11.2 10.7 10.8 26.8 8.4 10.2 7.2 14.2 10.1 19.1 17.4 12.6 17.8 15.4 18.2 18.8 13.8 24.9 9.0 17.9 13.9 29.7 49.4 18.7 29.4 53.1 25.5 24.1 10.3 22.7 13.7 23.9 64.6 36.2 144.2 28.7 7.0 0.0 38.2 7.9 24.2 36.6 15.1 41.4 13.8 14.3 28.8 11.1 11.6 327.6 26.7 12.7 16.9 55.9 15.3 26.4 29.5 14.0 35.7 98.2 27.2 12.9 22.0 66.8 24.3 18.2 12.5 26.1 25.2 44.5 LYSMD2 MGC35274 ENSG00000140280 "LysM domain containing 2" Q8IV50 15 51723011-51751585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 122.7;monocytes: 101.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040460 Approved Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA040460: AB_10794874" "unprognostic (7.71e-3)" "unprognostic (2.69e-1)" "unprognostic (3.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.11e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.60e-1)" "unprognostic (1.85e-1)" "unprognostic (3.98e-1)" "unprognostic (4.17e-3)" "unprognostic (6.86e-2)" "unprognostic (1.58e-2)" "unprognostic (5.03e-1)" "unprognostic (4.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" 5.3 13.4 17.7 13.8 26.2 7.9 5.1 19.9 35.8 6.5 6.1 7.9 7.2 10.0 6.1 7.5 4.6 6.9 7.6 3.6 17.9 19.1 6.7 13.9 9.3 17.2 14.6 17.6 5.8 8.6 7.1 15.2 6.1 25.2 6.2 6.5 4.1 4.3 9.8 10.9 2.7 8.1 7.8 8.2 12.9 7.7 15.6 5.9 6.1 4.9 2.3 16.7 7.4 4.6 17.0 18.2 38.7 20.4 11.9 16.3 12.2 6.0 4.5 0.8 6.0 2.0 3.5 0.0 7.2 4.2 9.2 11.9 0.5 5.5 23.7 1.0 4.0 10.7 8.6 4.9 4.8 6.5 20.0 2.3 7.0 4.2 0.1 4.4 16.3 3.0 3.9 9.8 3.6 3.9 4.1 5.4 9.1 0.3 0.0 2.8 9.1 6.1 20.5 1.9 0.2 5.1 9.3 0.1 8.8 8.9 5.0 18.2 4.5 6.7 0.1 12.1 1.2 5.1 12.5 3.2 9.0 4.6 9.4 10.0 0.0 0.0 0.1 4.5 33.3 6.7 0.0 13.2 24.4 10.9 15.9 16.3 17.0 11.0 13.1 11.1 16.2 13.3 11.0 38.7 11.9 20.4 18.2 6.4 12.2 17.7 26.2 19.9 35.8 17.9 19.1 14.6 17.6 25.2 5.9 3.0 7.4 58.5 17.6 17.2 14.3 1.8 17.8 2.7 5.7 14.0 0.0 1.0 21.6 16.6 122.7 22.4 5.2 23.3 16.1 0.8 13.6 16.4 12.7 13.4 37.2 30.2 76.7 23.4 39.6 55.5 15.0 28.8 6.8 101.8 13.3 5.6 9.7 15.9 14.9 23.3 3.6 25.8 20.0 3.5 3.8 14.2 0.7 47.3 20.3 17.2 LYST "CHS, CHS1" ENSG00000143669 "Lysosomal trafficking regulator" Q99698 1 235661041-235883640 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.8" "Cell type enhanced" "Detected in many" 6 "monocytes: 236.3;Rod photoreceptor cells: 167.4" "Cancer enhanced" "Detected in all" "melanoma: 11.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Group enriched" "Detected in all" 5 "granulocytes: 13.0;monocytes: 5.9" "Cell line enhanced" "Detected in many" "HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053366, HPA055725" Supported "Nucleoplasm,Plasma membrane,Centriolar satellite" Yes No Nucleoplasm "Plasma membrane, Centriolar satellite" "HPA053366: AB_2682129, HPA055725: AB_2682898" "unprognostic (1.56e-2)" "unprognostic (1.54e-1)" "unprognostic (9.92e-2)" "unprognostic (8.85e-2)" "unprognostic (1.96e-2)" "unprognostic (4.32e-2)" "unprognostic (4.11e-2)" "unprognostic (7.79e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.27e-5)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" "unprognostic (6.29e-2)" "unprognostic (1.99e-1)" 10.3 5.2 6.4 9.0 8.8 31.3 10.6 10.5 7.1 8.8 5.3 3.8 3.4 3.4 6.8 4.3 6.6 5.6 5.8 4.7 4.3 2.4 5.0 6.1 10.9 7.8 4.2 6.0 6.2 5.0 9.1 12.6 5.5 5.3 6.0 5.0 9.6 8.2 4.8 3.9 11.7 6.3 9.8 9.2 11.3 8.4 6.4 6.3 38.8 8.5 4.0 7.6 9.3 10.6 1.6 1.7 13.0 5.9 1.7 1.0 0.7 3.8 0.9 0.4 0.9 6.0 6.9 0.6 1.4 5.7 1.5 1.4 0.0 1.0 0.5 0.6 3.1 3.6 1.8 0.5 0.7 1.3 13.7 1.2 1.2 0.8 0.3 1.1 1.8 1.7 2.3 3.6 1.9 4.7 2.2 1.2 0.6 0.1 0.8 1.2 0.2 2.3 3.9 0.1 0.7 0.4 0.1 0.5 0.0 4.4 4.2 2.5 0.5 1.5 0.0 12.7 0.5 0.5 44.9 2.6 1.1 0.5 1.3 1.2 0.9 0.0 0.0 1.9 17.2 3.2 0.4 3.1 5.7 0.6 3.5 1.0 1.1 0.3 0.7 1.7 1.6 0.2 0.5 13.0 1.7 5.9 0.2 0.2 0.7 6.4 8.8 10.5 7.1 4.3 2.4 4.2 6.0 5.3 6.3 17.9 50.4 48.0 71.9 63.1 61.8 9.2 10.2 24.1 39.8 10.4 88.4 5.4 10.0 5.6 9.9 41.7 11.5 0.0 10.7 4.0 23.9 49.0 106.6 14.5 28.2 49.3 9.2 15.4 73.1 13.4 25.9 70.4 114.7 236.3 11.3 23.7 24.4 14.2 20.5 9.0 167.4 12.9 28.6 79.6 22.6 57.0 7.3 65.4 6.3 82.9 LYVE1 "LYVE-1, XLKD1" ENSG00000133800 "Lymphatic vessel endothelial hyaluronan receptor 1" Q9Y5Y7 11 10556966-10611689 "Plasma proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 87.6" "Group enriched" "Detected in many" 26 "Hofbauer cells: 604.0;Ito cells: 335.7;Kupffer cells: 258.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.0;neutrophil: 1.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 12 "HUVEC TERT2: 43.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB025860, HPA042953" Supported NA NA 3000000000 "CAB025860: , HPA042953: AB_2678238" "unprognostic (9.83e-2)" "unprognostic (1.52e-1)" "unprognostic (1.87e-1)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "unprognostic (1.94e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.53e-2)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.98e-5)" "unprognostic (1.67e-2)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.43e-3)" 51.8 28.6 3.3 7.4 4.2 0.4 23.0 2.8 2.8 7.9 26.4 2.4 2.9 5.3 5.3 20.8 17.7 17.2 8.0 19.8 3.8 2.0 18.0 31.1 15.7 47.7 3.2 1.6 11.0 5.4 1.6 3.6 56.6 6.2 15.2 8.0 6.0 4.8 4.7 15.4 5.1 17.8 25.5 2.9 87.6 8.4 11.9 2.5 0.0 21.4 9.1 2.7 25.9 10.9 0.7 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 43.2 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 4.2 2.8 1.8 3.8 2.0 3.2 1.6 6.2 2.5 0.0 3.2 7.0 0.0 3.3 0.0 3.1 15.3 2.7 0.0 0.0 0.0 4.6 0.0 0.0 0.7 11.4 0.0 0.0 0.0 4.4 4.4 0.1 1.1 1.5 604.0 0.0 0.0 335.7 258.9 0.8 3.4 8.5 6.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 12.9 5.1 0.0 0.0 2.9 9.3 0.0 0.0 0.1 LYZ ENSG00000090382 Lysozyme P61626 12 69348341-69354234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 490.0;salivary gland: 1017.8" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 3040.5;Macrophages: 4386.3;Pancreatic endocrine cells: 1930.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 490.0;myeloid DC: 308.1" "Group enriched" "Detected in all" 18 "dendritic cells: 308.1;monocytes: 490.0" "Cell line enriched" "Detected in some" 13 "OE19: 521.4" "Not detected" "Not detected" "CAB000055, HPA048284, HPA066182" Enhanced Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Secreted to blood" NA NA 1500000000 2600000000 "Golgi apparatus, Actin filaments" Nucleoplasm "CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741" "unprognostic (8.52e-2)" "unprognostic (6.12e-3)" "unprognostic (2.83e-1)" "unprognostic (7.29e-2)" "unprognostic (7.91e-2)" "prognostic favorable (7.45e-4)" "unprognostic (1.21e-1)" "unprognostic (7.40e-2)" "unprognostic (1.41e-1)" "unprognostic (2.08e-2)" "unprognostic (1.44e-1)" "unprognostic (3.13e-1)" "unprognostic (2.50e-1)" "unprognostic (2.37e-1)" "unprognostic (3.65e-2)" "unprognostic (5.78e-2)" "unprognostic (3.62e-2)" 19.1 2.4 1.7 42.1 1.8 187.0 2.9 1.6 1.6 2.9 52.5 2.0 0.1 72.4 2.3 6.9 3.9 3.4 105.0 15.4 1.8 1.8 4.8 4.8 81.0 57.2 2.1 0.0 4.5 5.0 0.0 1.8 8.3 0.9 2.4 5.0 2.7 1017.8 2.8 1.8 2.1 95.0 1.8 2.5 34.2 212.1 1.6 0.5 24.5 2.4 207.7 75.7 6.6 2.4 1.6 308.1 21.9 490.0 2.3 1.1 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 39.8 0.0 4.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 4.5 0.1 521.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 22.3 0.0 7.5 490.0 5.9 0.7 102.3 1.1 1.6 0.4 0.5 308.1 0.4 0.4 0.4 21.9 2.3 17.6 6.5 0.6 407.9 1.7 1.8 1.6 1.6 1.8 1.8 2.1 0.0 0.9 0.5 80.4 424.7 79.8 2.3 50.8 0.1 0.0 815.3 52.2 87.6 26.2 0.0 4.1 0.0 46.7 1.4 10.8 19.6 0.0 484.8 7.4 19.7 4.1 113.9 7.3 924.7 0.0 12.0 37.4 3040.5 3.7 3.7 4386.3 50.6 757.4 61.5 0.0 1930.3 401.2 2.1 5.0 1.1 38.8 3.9 0.6 2.3 33.4 7.1 13.8 38.3 2.2 LYZL1 "LYC2, MGC33408" ENSG00000120563 "Lysozyme like 1" Q6UWQ5 10 29289061-29318328 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 371 "testis: 39.5" "Group enriched" "Detected in some" 48 "Early spermatids: 474.4;Late spermatids: 148.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.0;SuSa: 2.9" "Secreted in male reproductive system" NA NA "unprognostic (1.88e-1)" "unprognostic (8.40e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 474.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.5 0.0 4.2 1.9 0.0 0.0 0.0 0.0 0.0 LYZL2 ENSG00000151033 "Lysozyme like 2" Q7Z4W2 10 30611779-30629762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 84 "testis: 34.2" "Group enriched" "Detected in some" 53 "Early spermatids: 605.6;Late spermatids: 151.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 8.2" "Secreted in male reproductive system" NA NA "unprognostic (2.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 605.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 2.6 1.6 0.0 0.0 0.0 0.0 0.0 LYZL4 "LYC4, MGC26768" ENSG00000157093 "Lysozyme like 4" Q96KX0 3 42397078-42410600 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 29.0" "Group enriched" "Detected in some" 72 "Early spermatids: 297.8;Late spermatids: 112.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "OE19: 9.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA038806 Approved "Secreted in male reproductive system" NA NA "HPA038806: AB_10674841" "unprognostic (4.03e-1)" "unprognostic (5.68e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 297.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.4 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.3 0.0 0.0 1.9 2.1 0.0 0.0 0.0 0.0 0.0 LYZL6 "LYC1, PRO1485, TKAL754" ENSG00000275722 "Lysozyme like 6" O75951 17 35934518-35943699 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 33.2" "Cell type enriched" "Detected in some" 10 "Early spermatids: 287.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "NB-4: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA025734, HPA053073" Enhanced "Secreted in male reproductive system" NA NA "HPA025734: AB_1853444, HPA053073: AB_2682034" 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 287.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 2.5 0.0 0.0 0.0 0.0 0.0 LZTFL1 BBS17 ENSG00000163818 "Leucine zipper transcription factor like 1" Q9NQ48 3 45823316-45916042 "Disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.7" "Cell type enhanced" "Detected in all" 11 "Ciliated cells: 188.7;Spermatocytes: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043466, HPA048447" Enhanced Supported Cytosol NA NA Cytosol "HPA043466: AB_2678491, HPA048447: AB_2680398" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-2)" "unprognostic (2.65e-2)" "unprognostic (5.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.26e-2)" "unprognostic (4.20e-2)" "unprognostic (2.94e-2)" "unprognostic (7.83e-2)" "unprognostic (5.32e-2)" "unprognostic (1.30e-3)" "unprognostic (6.27e-3)" "unprognostic (8.31e-2)" "unprognostic (4.27e-3)" "unprognostic (4.19e-1)" 5.8 7.2 12.3 5.0 14.9 4.8 13.6 9.3 21.6 14.5 6.9 4.4 10.4 6.0 14.4 16.6 6.1 20.8 7.3 5.3 10.2 11.6 12.9 10.1 9.7 4.4 6.9 13.4 12.8 8.6 14.6 30.7 6.2 10.1 9.0 6.8 5.6 7.5 10.4 3.6 6.4 6.8 8.7 6.1 5.8 6.3 27.7 5.6 55.7 20.4 4.3 5.7 7.3 6.4 7.2 4.6 1.9 2.5 2.3 4.0 2.7 6.8 3.5 5.5 3.6 5.2 12.7 2.6 3.7 6.1 7.6 9.9 1.0 5.2 2.1 2.2 4.6 9.8 3.2 6.0 6.1 10.6 0.0 4.2 1.3 4.9 2.9 6.9 6.7 2.0 6.8 21.1 9.5 6.2 5.6 4.3 10.8 6.3 4.4 4.1 1.1 18.3 6.4 5.8 4.5 3.0 2.5 0.5 7.2 10.5 2.6 3.8 7.8 4.5 4.1 8.9 6.3 5.0 11.7 6.9 3.2 2.2 8.6 4.7 12.4 6.5 0.0 10.2 7.9 2.6 0.0 1.9 0.7 2.8 2.5 3.9 7.2 2.5 2.4 4.6 3.7 4.0 3.3 1.9 2.3 1.6 4.5 3.5 2.7 12.3 14.9 9.3 21.6 10.2 11.6 6.9 13.4 10.1 5.6 26.8 18.5 8.8 8.3 11.9 7.7 6.9 10.2 188.7 33.0 14.0 13.7 2.5 13.3 10.7 53.9 7.3 2.6 23.3 6.1 4.3 11.0 7.6 8.1 11.6 5.9 22.3 10.9 8.6 3.7 8.6 9.2 5.8 8.5 13.6 11.3 15.2 5.6 3.5 12.7 16.7 14.1 12.9 6.1 140.9 20.0 8.7 1.7 15.3 8.8 4.1 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 19.0;parathyroid gland: 64.9" "Cell type enhanced" "Detected in some" 21 "Horizontal cells: 19.1;Melanocytes: 18.6;Rod photoreceptor cells: 17.9;Sertoli cells: 64.7" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 36.7;U-698: 11.2;WM-115: 24.8" "Group enriched" "Detected in many" 5 "amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1" "Group enriched" "Detected in many" 9 "amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 2.4 2.1 13.3 1.8 19.0 0.8 1.9 0.6 19.0 1.6 1.1 2.2 0.4 1.1 2.2 1.5 3.5 1.4 3.5 2.3 8.9 2.6 1.9 1.1 4.0 1.5 2.5 8.8 1.7 1.6 64.9 1.4 5.8 1.9 1.7 1.1 10.3 1.3 1.7 1.6 4.2 1.2 2.7 0.8 1.1 1.3 6.6 1.5 0.3 2.0 0.9 1.1 1.9 1.0 0.2 0.1 0.7 0.1 0.1 2.2 0.5 0.0 0.0 4.8 4.0 0.0 0.0 0.6 2.4 0.0 2.1 1.8 0.1 0.0 5.3 1.7 1.5 0.8 0.1 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.8 0.0 0.3 0.0 5.7 0.0 0.0 7.0 0.0 9.2 0.0 6.0 0.0 0.0 0.0 7.7 0.0 1.3 0.2 7.4 6.4 0.0 0.0 36.7 4.2 0.0 0.2 0.0 2.5 1.7 0.0 0.7 0.0 0.0 11.2 0.0 0.5 24.8 0.2 0.1 0.0 2.2 0.0 0.8 0.0 0.7 0.4 0.0 0.2 0.2 0.3 0.7 0.1 0.0 0.1 0.0 0.5 13.3 19.0 0.6 19.0 8.9 2.6 2.5 8.8 1.9 1.5 0.0 0.0 0.0 0.6 1.1 1.5 1.0 0.0 0.0 0.0 0.0 3.9 6.1 1.7 0.0 0.4 0.7 0.0 0.0 0.0 1.6 1.0 0.1 0.0 0.0 0.8 19.1 0.0 0.0 0.0 0.4 1.1 0.0 18.6 0.0 0.0 0.9 0.0 0.0 0.4 0.2 17.9 64.7 10.5 0.2 1.1 0.1 0.7 0.0 0.0 0.0 LZTS3 "KIAA0552, ProSAPiP1" ENSG00000088899 "Leucine zipper tumor suppressor family member 3" O60299 20 3162617-3173592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.9;salivary gland: 36.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 9.3;Cardiomyocytes: 12.0;Club cells: 11.4;Collecting duct cells: 10.4;Distal tubular cells: 10.0;Proximal tubular cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031008, HPA031009" Approved Approved Vesicles NA NA Vesicles "HPA031008: AB_10601610, HPA031009: AB_10670162" "unprognostic (4.09e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (1.15e-1)" "unprognostic (6.19e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.98e-4)" "unprognostic (3.31e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (9.69e-3)" "prognostic favorable (5.92e-8)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (8.47e-2)" "unprognostic (1.38e-1)" 2.4 5.3 17.6 1.4 31.1 1.7 3.5 51.9 45.7 11.5 2.4 4.2 2.1 8.6 4.6 3.7 1.7 6.4 6.8 5.4 16.4 10.7 11.9 2.7 5.6 1.2 7.1 17.4 9.0 17.0 11.8 4.1 2.2 10.5 5.0 2.2 7.4 36.2 7.9 5.1 1.4 6.5 2.7 4.5 1.7 7.7 1.9 6.0 0.0 7.1 0.4 1.0 2.6 1.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 2.8 2.7 3.8 4.2 5.3 1.5 2.6 2.8 6.1 4.8 7.1 15.3 8.0 4.8 1.6 5.5 6.3 1.4 2.1 3.0 3.7 0.1 2.7 0.2 0.5 12.5 12.0 0.2 1.3 1.9 6.6 6.7 2.6 1.8 0.7 4.5 2.7 1.5 2.3 1.2 0.3 0.6 8.5 6.5 2.6 1.3 1.3 5.1 6.0 1.0 15.0 4.6 2.3 3.3 2.3 5.8 7.7 0.1 4.3 5.2 9.8 2.0 0.8 3.0 0.4 1.4 2.5 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.8 0.5 0.0 17.6 31.1 51.9 45.7 16.4 10.7 7.1 17.4 10.5 6.0 17.9 9.3 2.2 0.0 1.3 0.0 12.0 0.0 4.0 11.4 10.4 0.0 1.1 10.0 4.9 0.0 0.7 0.0 0.0 4.3 0.3 0.7 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 8.1 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.0 M1AP "C2orf65, D6Mm5e, SPATA37" ENSG00000159374 "Meiosis 1 associated protein" Q8TC57 2 74557883-74648338 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.8;testis: 13.2" "Group enriched" "Detected in some" 4 "Spermatocytes: 8.7;Spermatogonia: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "NTERA-2: 6.1;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045420, HPA059302" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045420: AB_10961177, HPA059302: AB_2683972" "unprognostic (1.76e-1)" "unprognostic (6.58e-3)" "unprognostic (1.26e-2)" "unprognostic (2.87e-1)" "unprognostic (9.15e-2)" "unprognostic (1.35e-3)" "unprognostic (1.86e-1)" "unprognostic (2.17e-3)" "unprognostic (3.42e-1)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (6.11e-2)" "unprognostic (7.74e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" 0.7 0.6 5.2 0.2 1.5 3.7 3.7 1.2 3.4 4.6 0.2 0.3 1.0 0.2 2.1 0.5 0.3 4.6 0.5 0.1 0.9 1.8 1.5 0.1 0.6 0.1 0.5 1.6 0.3 0.4 1.7 8.8 1.2 0.9 0.2 0.0 2.0 1.5 1.0 0.1 0.2 0.2 0.2 0.7 0.4 0.7 13.2 0.2 1.0 3.6 0.0 0.5 0.9 0.5 0.0 0.9 0.2 1.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.2 0.5 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 6.1 0.8 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 5.2 1.5 1.2 3.4 0.9 1.8 0.5 1.6 0.9 0.2 0.0 1.4 0.0 0.0 0.1 0.3 0.3 0.0 2.7 0.0 3.5 0.0 0.3 0.0 0.2 2.5 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 3.5 0.0 0.0 0.0 1.0 3.1 0.0 2.3 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.0 1.3 0.0 0.0 8.7 22.0 0.0 0.2 0.0 0.0 0.1 MAATS1 "AAT1, AAT1alpha, C3orf15, CaM-IP2, SPATA26" ENSG00000183833 "MYCBP associated and testis expressed 1" Q7Z4T9 3 119703022-119767102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 31.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 158.0;Early spermatids: 481.0;Late spermatids: 243.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;hTERT-RPE1: 2.8;RPTEC TERT1: 4.7;SCLC-21H: 7.0;SH-SY5Y: 5.0;T-47d: 3.6;U-87 MG: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074084 Enhanced NA NA "HPA074084: " "unprognostic (6.70e-2)" "unprognostic (3.54e-2)" "unprognostic (3.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.40e-2)" "unprognostic (1.89e-2)" "unprognostic (1.36e-1)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (4.07e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (4.46e-2)" 1.1 3.4 2.6 0.8 7.7 0.5 3.5 1.8 3.8 5.8 2.1 4.4 10.5 0.7 6.7 12.0 1.1 23.1 3.5 0.8 3.0 4.7 4.8 1.2 3.8 0.6 1.5 3.2 6.7 7.8 7.6 31.6 0.8 17.1 4.4 1.5 7.2 2.6 12.8 0.6 0.7 1.1 3.4 1.5 4.0 2.9 19.5 2.2 0.0 7.9 0.4 0.9 2.2 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 3.3 0.0 0.4 0.0 0.0 0.0 0.4 0.5 2.5 0.0 2.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.1 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 4.7 0.0 7.0 5.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 3.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 7.7 1.8 3.8 3.0 4.7 1.5 3.2 17.1 2.2 3.0 2.7 0.0 1.8 0.8 3.2 1.4 7.6 158.0 20.5 7.0 41.2 0.0 0.0 2.6 481.0 1.5 0.0 0.0 2.4 0.0 0.9 1.5 1.1 0.5 0.1 11.1 3.5 0.6 0.3 243.3 6.6 1.5 3.3 1.0 0.0 4.1 0.9 0.0 8.5 2.1 26.5 0.0 1.4 33.8 4.2 0.6 0.1 0.0 0.0 0.5 MAB21L1 CAGR1 ENSG00000180660 "Mab-21 like 1" Q13394 13 35474182-35477209 "Predicted intracellular proteins" "Developmental protein, Nucleotidyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 24.0;skeletal muscle: 8.5" "Group enriched" "Detected in some" 38 "Bipolar cells: 51.8;Cone photoreceptor cells: 47.1;Horizontal cells: 82.6;Muller glia cells: 136.9;Rod photoreceptor cells: 120.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.9;BJ hTERT+: 10.5;BJ hTERT+ SV40 Large T+: 14.9;HBF TERT88: 16.2;hTERT-RPE1: 31.2;SH-SY5Y: 48.0" "Group enriched" "Detected in some" 9 "cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9" "Low region specificity" "Detected in all" "HPA049324, HPA059864" Approved Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (4.44e-2)" "unprognostic (2.82e-2)" "unprognostic (2.79e-3)" "unprognostic (3.87e-4)" "unprognostic (5.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-3)" "unprognostic (1.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (3.19e-2)" "unprognostic (6.93e-3)" "unprognostic (1.14e-1)" "unprognostic (3.72e-1)" "unprognostic (2.86e-1)" 2.9 6.4 0.3 0.5 0.0 0.0 6.3 24.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.8 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.5 3.7 0.2 8.5 1.2 1.1 0.0 0.8 0.0 0.3 0.0 0.6 0.2 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 10.5 14.9 8.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 16.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.2 48.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 51.8 0.3 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.2 2.3 0.0 0.1 82.6 0.0 1.3 0.0 0.0 0.3 0.0 1.7 0.0 0.0 136.9 0.0 0.0 0.4 0.0 120.3 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.2 MAB21L2 ENSG00000181541 "Mab-21 like 2" Q9Y586 4 150581922-150584693 "Disease related genes, Predicted intracellular proteins" "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.2;intestine: 59.8;smooth muscle: 15.2" "Cell type enhanced" "Detected in some" 24 "Cholangiocytes: 12.7;Horizontal cells: 23.8;Muller glia cells: 5.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Region enriched" "Detected in some" 18 "pons and medulla: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTERT-RPE1: 46.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049324, HPA059864" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA049324: AB_2680712, HPA059864: AB_2684147" "unprognostic (1.12e-1)" "unprognostic (3.67e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-1)" "unprognostic (2.32e-1)" "unprognostic (3.85e-2)" "unprognostic (8.99e-2)" "unprognostic (2.76e-2)" "unprognostic (2.75e-1)" "unprognostic (6.60e-2)" "unprognostic (4.78e-3)" "unprognostic (1.18e-1)" "unprognostic (6.81e-2)" "unprognostic (1.68e-1)" 0.6 3.1 0.2 8.6 0.4 0.0 0.1 0.2 0.2 0.2 59.8 0.1 0.0 6.8 0.1 0.9 0.9 0.2 0.5 0.7 0.2 0.6 0.1 0.5 0.1 0.6 1.0 0.0 0.1 0.2 0.0 0.3 0.0 19.2 0.2 8.1 9.0 2.2 0.0 0.3 0.2 14.7 15.2 4.5 0.1 0.3 0.1 0.0 0.2 1.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.6 1.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.8 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAB21L3 "C1orf161, FLJ38716" ENSG00000173212 "Mab-21 like 3" Q8N8X9 1 116111755-116135240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.9;skin 1: 8.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 41.7;Alveolar cells type 2: 51.9;Ciliated cells: 24.1;Club cells: 33.0;granulocytes: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 15.7;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039551 Approved Nucleoplasm NA NA Nucleoplasm "HPA039551: AB_2676565" "unprognostic (9.25e-3)" "unprognostic (3.47e-3)" "unprognostic (1.44e-3)" "unprognostic (5.23e-5)" "unprognostic (2.22e-1)" "unprognostic (2.06e-2)" "unprognostic (5.36e-2)" "unprognostic (3.75e-3)" "unprognostic (1.21e-1)" "unprognostic (7.01e-2)" "unprognostic (2.49e-1)" "unprognostic (4.84e-2)" "unprognostic (1.16e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (4.61e-2)" 0.3 0.0 0.3 2.7 0.3 0.8 0.5 0.3 0.3 2.8 2.1 0.3 0.3 0.2 0.3 0.3 9.9 0.0 0.3 0.3 0.3 0.2 2.0 3.1 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 2.2 0.3 1.1 1.8 0.3 1.3 0.7 0.6 8.7 3.4 0.3 0.3 0.3 0.4 0.7 0.3 0.3 0.3 2.5 1.7 2.1 4.2 2.6 1.3 5.5 1.2 4.4 0.7 0.0 3.4 0.1 0.8 0.6 0.1 0.0 5.3 0.6 0.2 0.0 0.0 0.3 1.3 2.1 15.7 0.1 0.3 2.9 0.1 0.1 0.1 0.7 0.1 0.9 0.4 2.8 0.0 0.9 0.5 0.0 0.4 0.1 0.3 0.1 0.0 0.5 0.9 2.4 0.0 0.3 0.5 0.5 2.2 0.7 1.0 0.8 0.8 0.4 0.6 15.1 0.5 0.8 2.4 2.0 0.6 2.5 2.5 0.4 0.5 1.0 2.5 0.7 0.6 2.3 4.0 1.0 0.5 0.3 1.0 2.6 1.2 0.3 0.6 0.6 0.5 0.8 0.4 0.5 0.3 2.6 0.7 0.7 5.5 4.4 0.7 1.3 0.2 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 41.7 51.9 0.0 2.3 0.6 0.0 0.4 0.0 24.1 33.0 3.5 0.0 3.8 1.7 0.0 0.1 0.0 0.7 0.0 0.2 0.5 0.0 0.7 16.3 0.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.5 11.4 0.0 1.0 0.6 MACC1 "7A5, SH3BP4L" ENSG00000183742 "MACC1, MET transcriptional regulator" Q6ZN28 7 20134655-20217404 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.5;kidney: 23.9" "Cell type enhanced" "Detected in many" 11 "Club cells: 103.5;Pancreatic endocrine cells: 96.6;Urothelial cells: 233.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 41.3;CAPAN-2: 9.7;HaCaT: 29.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020081, HPA020103, HPA029476, CAB068194" Supported Approved Mitochondria NA NA Mitochondria "CAB068194: AB_2665682, HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136" "unprognostic (1.59e-2)" "unprognostic (1.88e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (2.26e-1)" "unprognostic (1.42e-2)" "unprognostic (7.01e-2)" "unprognostic (2.52e-2)" "unprognostic (2.05e-1)" "unprognostic (2.43e-2)" "unprognostic (2.43e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.71e-9)" "unprognostic (4.49e-2)" "unprognostic (2.91e-1)" "unprognostic (1.78e-1)" "unprognostic (6.93e-3)" 4.8 2.6 0.5 5.6 0.4 0.7 4.5 0.4 0.5 8.3 13.7 0.0 4.4 10.1 0.7 6.1 14.1 0.9 9.6 0.5 0.5 0.5 23.9 1.0 13.3 1.1 0.4 0.0 1.3 11.3 0.1 4.0 1.6 0.1 3.9 3.3 0.1 11.4 6.0 0.5 4.5 29.5 0.1 0.8 6.0 5.0 0.8 0.0 1.7 1.5 16.0 13.6 4.0 5.1 2.3 1.0 1.4 1.0 0.8 0.6 0.5 41.3 0.1 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 9.2 9.7 5.8 0.4 0.0 0.0 29.1 0.1 0.4 0.0 0.0 0.1 5.5 0.1 0.0 0.0 2.3 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 5.9 2.8 0.0 3.4 0.0 0.5 0.4 8.1 0.0 0.0 0.3 4.4 7.3 2.8 0.1 0.2 0.0 3.3 0.0 0.2 1.7 0.1 0.1 0.1 0.0 0.0 0.1 8.9 0.4 2.2 0.0 0.3 0.0 1.0 0.6 0.3 0.3 0.7 0.6 2.3 0.2 0.5 0.3 2.0 0.3 0.3 1.4 0.8 1.0 1.0 0.2 0.5 0.5 0.4 0.4 0.5 0.5 0.5 0.4 0.0 0.1 0.0 65.5 63.4 1.4 71.9 2.5 2.1 0.6 22.9 58.9 103.5 38.4 2.0 0.5 6.6 49.2 2.2 0.7 25.7 0.0 55.2 0.1 2.3 64.3 11.6 1.0 4.6 1.6 37.1 3.7 2.4 0.8 2.0 4.4 1.7 13.6 15.0 0.5 96.6 14.0 2.5 12.9 1.0 0.0 0.4 0.2 0.4 3.4 0.2 3.9 13.3 233.0 MACROD1 LRP16 ENSG00000133315 "MACRO domain containing 1" Q9BQ69 11 63998558-64166106 "Disease related genes, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 142.5" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 116.0;Proximal tubular cells: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 27.0;RPMI-8226: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041031, HPA071075" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA041031: AB_10794435, HPA071075: AB_2686341" "unprognostic (1.19e-2)" "unprognostic (2.15e-1)" "unprognostic (1.38e-1)" "unprognostic (3.14e-2)" "unprognostic (3.88e-2)" "unprognostic (6.03e-2)" "unprognostic (1.95e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.15e-1)" "prognostic favorable (4.68e-6)" "unprognostic (2.45e-2)" "unprognostic (9.92e-2)" "unprognostic (2.36e-1)" "unprognostic (2.86e-2)" 4.9 3.0 2.9 2.8 3.3 2.5 3.9 6.2 4.6 3.6 6.9 2.8 7.0 4.3 3.4 6.5 7.8 3.2 3.9 29.0 2.2 3.4 10.6 10.4 3.0 1.8 3.0 3.1 5.2 16.6 2.5 2.7 2.1 3.1 6.1 1.9 4.6 16.4 8.1 142.5 5.5 3.9 6.2 2.4 2.7 5.6 1.9 2.7 0.8 12.7 25.0 3.3 4.6 4.5 0.6 0.7 0.0 1.2 0.0 2.0 0.4 4.0 2.1 0.6 3.8 0.6 0.4 3.7 2.3 1.1 1.9 1.8 2.0 11.0 15.4 8.5 0.2 0.6 10.4 0.5 0.0 0.1 1.1 7.2 5.5 8.8 10.9 2.3 4.6 0.6 0.9 1.2 0.2 0.5 1.3 0.7 4.8 5.0 3.1 0.3 27.0 6.4 15.9 1.8 1.4 8.2 5.7 4.3 51.0 0.6 0.2 5.3 11.0 2.1 15.9 14.5 0.0 11.4 0.1 1.0 1.7 2.6 2.6 0.2 6.2 0.9 2.5 1.2 4.7 1.6 0.0 0.2 0.0 2.0 1.2 1.9 0.6 1.8 1.1 0.4 0.4 0.9 0.8 0.0 0.0 0.0 0.7 0.0 0.4 2.9 3.3 6.2 4.6 2.2 3.4 3.0 3.1 3.1 2.7 0.0 5.8 10.9 30.6 24.8 13.1 30.8 30.6 0.0 4.5 40.1 0.0 25.1 116.0 16.5 5.8 9.0 17.2 0.0 34.7 10.9 13.7 23.2 0.0 42.3 9.7 11.1 22.0 7.4 2.5 15.9 23.0 1.8 37.1 2.8 52.9 14.3 17.6 28.8 13.4 164.4 15.8 19.4 18.4 2.9 28.5 32.4 20.0 6.1 65.5 30.1 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "MACRO domain containing 2" A1Z1Q3 20 13995369-16053197 "Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 151.9;Bipolar cells: 89.0;Club cells: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8" "Group enriched" "Detected in many" 5 "B-cells: 14.1;granulocytes: 3.8" "Cell line enhanced" "Detected in many" "EFO-21: 14.7;Karpas-707: 18.2;RT4: 8.0;SCLC-21H: 10.0" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 2.8 5.1 15.2 3.0 47.5 2.0 4.2 20.8 13.6 6.4 2.7 3.7 2.0 1.4 12.1 3.9 2.3 10.3 4.1 1.9 10.5 8.2 5.6 2.7 15.7 5.5 7.6 8.9 4.5 4.2 5.4 12.0 1.8 10.5 7.1 2.1 4.0 2.4 14.9 3.1 3.9 1.8 5.8 6.9 6.9 3.4 7.9 9.9 0.0 4.1 0.1 7.2 10.6 3.1 14.1 0.5 3.8 1.8 0.3 0.6 0.5 1.0 0.6 2.8 0.9 0.9 0.8 0.5 0.5 2.0 1.1 0.6 1.0 0.7 1.9 14.7 1.4 2.6 1.4 0.4 0.7 1.9 1.0 0.9 1.1 1.1 1.9 3.6 0.3 0.3 1.6 1.1 0.0 0.8 1.0 1.1 0.3 1.3 18.2 3.1 0.4 0.5 0.7 1.0 6.3 0.4 1.1 0.5 3.5 2.1 8.0 10.0 4.3 1.5 0.1 0.7 1.3 1.0 1.6 0.8 1.5 3.1 0.2 0.1 1.5 0.5 1.8 0.9 1.0 1.8 0.3 0.6 0.6 0.4 1.3 0.4 7.4 0.3 0.4 0.5 14.1 0.4 0.6 3.8 0.3 1.8 0.2 0.2 0.5 15.2 47.5 20.8 12.8 10.5 8.2 7.6 8.9 10.5 9.9 47.6 151.9 14.5 37.6 3.9 89.0 4.0 12.7 12.0 67.1 12.2 37.3 4.4 8.3 9.1 28.4 2.1 1.1 0.0 1.4 0.2 2.6 4.4 1.1 3.9 0.8 7.9 1.2 2.5 0.3 46.6 3.1 1.0 3.3 0.0 3.7 9.3 4.6 1.1 16.6 5.1 18.6 6.5 4.1 17.9 16.4 5.8 1.7 0.0 2.4 3.8 MAD2L1 "HSMAD2, MAD2" ENSG00000164109 "Mitotic arrest deficient 2 like 1" Q13257 4 120055608-120067074 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 100.5;Spermatocytes: 142.5;Spermatogonia: 91.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003348 Uncertain Approved Nucleoplasm NA Yes Nucleoplasm "HPA003348: AB_10603014" "unprognostic (4.08e-3)" "unprognostic (7.31e-2)" "unprognostic (5.17e-3)" "unprognostic (1.10e-2)" "unprognostic (1.27e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (5.15e-5)" "prognostic unfavorable (2.17e-4)" "unprognostic (6.74e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "unprognostic (3.87e-3)" "prognostic unfavorable (3.07e-11)" "unprognostic (3.06e-2)" "unprognostic (4.05e-1)" "unprognostic (1.03e-1)" "unprognostic (9.70e-2)" 1.4 1.8 2.4 4.2 5.7 10.3 2.4 4.4 4.1 1.9 4.4 1.2 0.3 3.8 1.7 1.4 6.5 2.9 1.1 1.7 2.7 2.7 1.2 1.2 1.5 7.6 2.3 3.6 1.7 1.2 0.7 1.0 3.5 2.4 1.6 5.5 0.7 2.4 1.2 1.2 2.3 4.2 1.8 2.8 3.8 1.9 13.7 1.2 27.3 1.2 8.2 7.3 2.1 2.4 1.8 2.2 2.0 0.8 2.5 3.9 1.7 14.7 6.4 15.2 9.9 1.6 2.0 6.5 11.7 6.6 12.2 9.5 8.6 9.1 21.7 3.9 4.2 5.4 4.0 15.1 8.9 17.2 10.2 10.6 12.0 6.3 8.1 0.5 19.5 6.9 1.1 1.3 8.3 5.2 3.1 7.0 9.3 14.3 12.4 6.4 6.5 18.7 8.5 10.4 7.7 7.4 9.7 20.4 8.9 5.0 5.7 16.2 11.5 5.8 7.2 3.6 7.8 4.8 7.2 4.4 8.3 9.4 8.3 14.7 11.6 12.4 14.2 7.7 10.1 10.8 2.0 0.5 0.4 1.6 0.5 2.1 1.8 3.8 3.0 0.4 1.4 3.5 3.5 1.3 2.5 0.8 2.2 3.9 1.7 2.4 5.7 4.4 4.1 2.7 2.7 2.3 3.6 2.4 1.2 0.0 2.2 6.0 6.3 15.3 8.5 3.0 2.5 6.7 2.3 7.0 2.0 18.3 0.0 2.9 1.8 3.1 2.9 23.3 1.4 100.5 6.1 4.5 15.0 1.6 23.3 19.1 1.7 2.5 6.3 3.6 4.4 6.2 8.5 4.6 8.1 10.6 1.7 2.9 1.4 4.3 3.6 12.9 6.6 142.5 91.0 7.9 9.0 17.9 16.2 4.5 MADCAM1 MACAM1 ENSG00000099866 "Mucosal vascular addressin cell adhesion molecule 1" Q13477 19 489176-505342 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.9;lymphoid tissue: 27.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.6;Collecting duct cells: 3.5;Muller glia cells: 6.5;Rod photoreceptor cells: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "neutrophil: 10.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 10.3" "Cell line enhanced" "Detected in some" "HEK 293: 3.7;Hep G2: 4.4;U-266/70: 4.9" "CAB075699, HPA077998" Enhanced NA NA 41000000 "CAB075699: , HPA077998: " "unprognostic (2.30e-1)" "unprognostic (7.81e-2)" "unprognostic (5.52e-2)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (6.26e-4)" "unprognostic (1.68e-2)" "unprognostic (2.17e-4)" "unprognostic (2.00e-1)" "unprognostic (1.12e-2)" "unprognostic (2.44e-2)" "unprognostic (1.09e-1)" "unprognostic (2.54e-4)" "unprognostic (2.42e-1)" "unprognostic (4.95e-3)" "unprognostic (9.80e-2)" "unprognostic (2.07e-2)" 1.4 0.9 4.6 27.2 5.2 0.9 1.1 6.8 6.3 0.7 5.6 0.9 1.2 5.1 0.9 3.3 1.6 0.6 19.9 0.7 3.6 2.9 0.7 0.9 0.8 3.2 2.4 3.1 0.7 3.3 2.9 2.9 0.9 2.7 0.9 5.0 0.5 1.3 0.7 1.5 0.9 12.1 0.8 2.4 13.7 5.0 1.6 3.2 1.0 2.3 0.0 0.8 0.7 1.5 1.0 0.4 10.3 0.4 0.4 1.2 0.1 0.8 0.1 0.3 1.2 1.1 0.1 1.5 0.3 0.2 0.4 0.1 0.8 0.5 0.5 2.5 0.2 0.5 1.3 0.2 0.0 0.1 2.8 3.7 0.0 2.3 4.4 0.1 0.1 2.8 1.2 0.2 0.3 0.0 0.4 0.0 0.8 0.8 2.0 0.4 2.7 0.2 1.4 0.4 0.1 2.1 0.7 0.0 0.2 0.0 0.6 1.8 0.4 0.2 0.3 0.2 0.2 0.1 0.0 0.0 1.5 0.3 1.0 0.2 4.9 1.7 0.9 0.2 1.2 0.1 0.0 0.4 1.0 0.5 0.4 0.6 0.6 0.4 0.3 0.1 1.0 1.2 1.2 10.3 0.4 0.3 0.4 0.0 0.1 4.6 5.2 6.8 6.3 3.6 2.9 2.4 3.1 2.7 3.2 0.0 0.0 0.0 0.4 0.5 6.6 0.8 0.0 1.4 0.0 3.5 0.0 0.5 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.7 0.6 0.0 0.0 0.4 1.6 0.0 2.5 0.0 0.0 0.9 0.0 0.0 0.0 0.6 6.5 0.1 0.0 0.7 0.7 5.1 0.0 0.9 2.2 2.5 0.4 0.2 0.0 0.0 0.4 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 72.8;Cone photoreceptor cells: 117.8;Horizontal cells: 125.5;Rod photoreceptor cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favorable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favorable (8.25e-4)" 7.7 18.2 18.3 11.5 27.6 16.9 8.7 66.3 46.5 9.2 10.8 15.5 13.1 8.6 9.4 8.9 6.9 9.4 8.6 13.8 20.2 18.4 9.8 7.7 11.0 13.2 15.5 19.8 14.0 12.2 18.8 26.7 11.2 20.7 12.5 12.0 16.0 10.2 14.0 16.1 14.0 9.8 10.5 11.3 12.3 13.2 19.4 11.0 14.6 8.4 6.0 12.2 11.0 7.8 3.5 4.1 20.8 5.8 4.5 5.7 4.4 6.5 13.6 14.9 13.3 10.2 7.1 3.3 9.2 12.3 11.7 12.7 9.9 6.2 13.8 2.9 10.0 15.2 12.9 12.0 6.4 10.2 15.3 12.3 24.5 25.2 8.4 7.4 16.6 33.8 6.9 6.9 6.2 7.8 8.0 10.7 8.9 15.7 10.2 10.3 9.1 7.8 17.9 8.9 15.3 9.4 10.8 24.0 9.1 6.1 31.1 23.6 15.3 11.8 14.0 8.1 9.2 11.0 12.7 9.1 11.0 7.0 15.6 6.1 12.1 12.5 7.9 10.2 11.8 10.3 20.8 2.6 4.8 4.8 4.6 4.2 3.5 3.4 4.0 4.1 3.3 4.0 3.1 0.7 4.5 5.8 2.2 5.7 4.4 18.3 27.6 66.3 44.6 20.2 18.4 15.5 19.8 20.7 11.0 11.9 8.6 9.0 3.5 9.5 72.8 22.6 10.2 1.4 3.4 7.0 117.8 3.9 0.0 7.0 11.4 9.5 12.1 0.0 4.2 1.9 6.1 7.5 26.5 5.0 10.1 125.5 15.6 17.8 18.3 4.0 6.6 10.6 10.1 9.0 17.0 13.7 8.8 10.5 12.0 4.2 106.1 6.5 6.2 14.6 21.5 7.2 3.7 6.9 11.2 4.8 MAEL "CT128, FLJ14904, SPATA35" ENSG00000143194 "Maelstrom spermatogenic transposon silencer" Q96JY0 1 166975582-167022214 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 90.7" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 1028.7;Late spermatids: 292.6;Spermatocytes: 368.4" "Cancer enhanced" "Detected in many" "testis cancer: 3.9" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Cell line enriched" "Detected in some" 8 "NTERA-2: 8.8" "Region enriched" "Detected in single" 5 "thalamus: 1.2" "Not detected" "Not detected" HPA078602 Approved NA NA "HPA078602: AB_2732386" "unprognostic (1.36e-1)" "unprognostic (7.01e-2)" "unprognostic (5.81e-2)" "unprognostic (3.15e-1)" "unprognostic (9.78e-2)" "unprognostic (3.08e-1)" "unprognostic (2.68e-3)" "unprognostic (4.99e-2)" "unprognostic (1.42e-1)" "unprognostic (9.00e-3)" "unprognostic (3.04e-1)" "unprognostic (8.88e-2)" "unprognostic (5.49e-2)" "unprognostic (1.26e-1)" "unprognostic (3.32e-1)" "unprognostic (8.67e-2)" "unprognostic (1.85e-1)" 0.1 0.0 0.8 0.1 0.2 0.0 0.1 0.6 1.3 0.1 0.3 0.1 0.1 0.0 0.1 0.7 0.2 0.0 0.2 2.1 0.7 0.5 0.6 0.3 0.1 0.1 0.4 0.1 0.1 0.6 0.0 0.2 3.5 0.2 0.2 0.0 0.2 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.1 0.0 90.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 8.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.8 0.2 0.6 1.3 0.7 0.5 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.4 0.1 1.3 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1028.7 0.1 0.0 0.0 0.2 0.4 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 292.6 10.0 0.0 0.0 0.0 0.0 42.7 0.0 0.0 9.6 4.3 1.3 0.0 0.3 368.4 143.2 0.0 0.2 0.0 0.0 0.1 MAFA "hMafA, RIPE3b1" ENSG00000182759 "MAF bZIP transcription factor A" Q8NHW3 8 143419182-143430406 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 25.6" "Cell type enriched" "Detected in some" 8 "Intestinal endocrine cells: 41.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "amygdala: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.8;MCF7: 4.5;RH-30: 2.7;SCLC-21H: 6.5;T-47d: 6.2;U-2 OS: 4.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (5.92e-3)" "unprognostic (9.89e-3)" "unprognostic (2.81e-3)" "unprognostic (1.42e-8)" "unprognostic (1.75e-2)" "unprognostic (8.67e-2)" "unprognostic (6.08e-2)" "unprognostic (5.67e-2)" "unprognostic (4.41e-1)" "unprognostic (3.71e-1)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.00e-1)" "unprognostic (3.36e-1)" "unprognostic (3.38e-2)" 0.2 0.1 2.5 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.2 0.0 0.0 0.1 0.1 0.3 0.6 0.1 0.1 2.1 0.4 0.2 0.3 0.1 0.7 0.1 0.1 0.2 0.1 2.2 0.2 0.5 1.8 0.9 0.3 0.1 0.7 0.4 0.1 25.6 0.1 0.1 0.1 0.7 0.1 0.1 3.4 0.0 0.4 2.5 5.5 0.4 0.1 0.1 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 2.8 0.9 0.0 0.0 0.1 1.9 1.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 4.5 0.1 0.6 0.6 0.0 0.4 0.6 2.7 0.4 0.0 0.0 6.5 0.2 1.6 0.0 0.0 1.2 6.2 0.1 0.0 0.2 4.3 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 2.5 0.2 0.0 0.6 0.4 0.2 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.4 0.5 1.2 4.9 0.0 0.0 0.0 3.5 2.0 0.2 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.6 0.0 0.0 2.2 0.0 0.9 0.6 2.3 1.0 0.2 0.0 0.4 0.1 MAFB KRML ENSG00000204103 "MAF bZIP transcription factor B" Q9Y5Q3 20 40685848-40689240 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.6;parathyroid gland: 154.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 27.4;non-classical monocyte: 36.7" "Lineage enriched" "Detected in many" 14 "monocytes: 36.7" "Cell line enhanced" "Detected in some" "HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005653 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Cytosol" "HPA005653: AB_1079293" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.16e-3)" "prognostic unfavorable (5.64e-4)" "unprognostic (9.16e-2)" "unprognostic (3.92e-2)" "unprognostic (1.10e-1)" "unprognostic (2.10e-1)" "unprognostic (2.57e-2)" "unprognostic (6.09e-2)" "unprognostic (5.45e-3)" "unprognostic (9.92e-2)" "unprognostic (3.95e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-3)" "unprognostic (3.49e-2)" "unprognostic (2.30e-2)" 38.3 7.9 3.2 13.0 4.0 17.0 19.5 1.0 9.7 10.6 6.9 3.0 1.2 3.3 5.6 8.9 16.8 7.0 9.2 12.4 3.6 2.3 10.9 14.0 21.9 28.9 4.7 3.4 7.0 6.1 154.1 2.3 9.4 5.0 7.6 3.3 5.6 10.4 2.7 11.0 41.6 7.6 5.5 7.7 87.6 4.7 7.5 3.8 6.9 18.2 20.5 11.4 8.2 10.9 0.0 2.5 0.7 36.7 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.8 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.1 0.5 0.0 0.1 16.2 34.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 3.9 1.4 3.3 0.0 0.0 0.0 0.0 0.3 0.2 9.3 0.7 8.4 0.8 2.0 3.1 0.8 0.1 0.2 9.2 0.1 13.4 0.0 0.0 0.0 0.0 8.9 0.3 0.0 0.1 7.3 0.0 0.0 27.4 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.7 0.0 36.7 0.0 0.0 2.5 3.2 4.0 1.0 9.7 3.6 2.3 4.7 3.4 5.0 3.8 20.8 32.3 6.7 25.3 60.9 14.6 153.6 7.6 0.0 13.6 48.8 23.6 7.5 1.7 2.0 0.6 19.9 50.9 0.0 3.0 2.1 61.9 37.1 10.4 32.6 322.7 3.2 55.5 34.4 488.8 0.7 27.3 252.1 20.3 0.0 13.7 25.8 5.4 24.6 23.0 0.8 8.2 12.9 44.3 0.5 0.9 77.0 10.4 4.4 8.1 17.7 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "CAB025341: , HPA055371: AB_2682797" "prognostic favorable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.5 1.2 1.7 2.6 2.7 8.7 7.9 15.3 21.2 7.8 8.4 2.2 6.2 0.2 1.5 6.5 11.8 5.1 0.4 6.1 13.3 1.4 0.2 0.8 0.8 1.9 7.3 0.5 2.7 3.7 10.2 31.3 17.4 7.0 16.4 0.8 1.5 7.3 6.1 1.7 0.3 2.0 1.2 8.4 6.2 0.5 1.4 1.5 7.9 11.6 0.9 1.4 2.3 6.1 37.2 4.4 1.3 0.6 21.4 9.9 7.3 7.3 5.1 2.7 2.8 0.3 15.0 0.6 6.2 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 50.6 43.7 7.5 289.5 111.8 2.2 13.7 33.1 29.4 33.0 10.4 0.0 30.6 6.6 37.6 0.4 35.0 98.6 0.0 21.5 52.9 80.2 257.7 21.9 5.0 23.2 0.0 100.5 14.7 7.8 0.0 9.2 26.4 55.6 17.2 43.3 16.8 51.3 62.0 3.5 2.4 2.0 19.4 116.4 0.9 1.0 90.2 400.7 27.7 35.7 321.4 MAFIP "FLJ00219, FLJ35473, FLJ39633, MIP, pp5644, TEKT4P4" ENSG00000274847 "MAFF interacting protein (pseudogene)" Unmapped 53594-115055 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.5" "Cell type enhanced" "Detected in some" 8 "Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.3;Proximal tubular cells: 1.4;Syncytiotrophoblasts: 1.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 15.7" HPA053929 Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA053929: AB_2682314" 2.9 5.1 0.5 0.0 0.2 0.9 0.4 0.3 0.7 1.1 0.1 2.0 1.0 1.2 1.4 1.6 1.2 1.0 2.3 2.4 1.6 0.0 0.5 1.7 0.0 2.5 0.3 1.1 0.0 1.5 1.4 2.0 0.0 0.2 1.3 0.3 1.9 5.4 10.5 2.5 5.6 4.5 4.8 3.5 0.2 3.6 0.0 1.4 0.0 0.0 4.0 3.6 1.8 1.1 1.4 6.5 8.2 0.1 7.4 4.8 5.5 0.9 2.8 3.9 0.7 0.3 3.5 5.8 3.8 6.6 0.3 0.1 9.3 0.6 5.5 3.3 0.0 4.4 3.5 0.0 15.7 8.4 2.4 7.1 5.1 1.1 0.2 4.7 3.0 0.0 4.7 3.7 3.9 1.0 3.1 5.8 0.0 5.3 6.4 2.7 11.7 0.4 9.0 2.3 6.5 3.0 2.9 8.0 6.1 0.0 9.9 0.0 2.3 2.4 4.8 2.5 3.7 5.6 3.1 5.3 3.7 3.5 6.0 5.4 4.6 4.6 0.3 4.5 2.9 10.5 4.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.7 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 MAFK "NFE2U, P18" ENSG00000198517 "MAF bZIP transcription factor K" O60675 7 1530714-1543043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 62.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026820, HPA060841" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB026820: , HPA060841: AB_2684377" "unprognostic (6.82e-2)" "unprognostic (3.71e-3)" "unprognostic (1.49e-2)" "unprognostic (2.55e-1)" "unprognostic (6.44e-3)" "unprognostic (1.19e-1)" "unprognostic (9.44e-2)" "unprognostic (2.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" 15.7 14.3 12.6 12.4 20.1 16.3 13.0 4.2 12.5 9.3 18.0 13.5 6.7 18.2 14.7 5.0 10.1 10.2 12.7 30.9 13.2 11.8 10.5 10.9 18.7 8.7 19.7 11.0 7.2 34.9 6.0 8.7 62.4 14.5 16.1 5.1 6.7 11.0 12.0 26.8 12.8 16.8 26.1 12.1 11.3 13.2 4.1 13.1 22.8 9.1 9.7 7.5 13.7 19.0 1.9 5.1 3.6 1.7 1.5 2.6 1.4 20.0 14.4 0.5 2.1 1.6 2.0 11.0 13.3 7.6 3.2 2.3 10.3 5.5 4.7 4.9 3.3 21.9 15.6 1.2 3.8 1.4 7.2 10.5 2.7 18.4 7.5 3.7 6.4 8.7 2.0 5.0 5.4 4.1 4.0 2.9 14.8 7.0 2.6 1.5 13.2 7.2 23.1 4.6 4.9 14.6 10.9 0.5 7.9 3.0 8.3 6.2 2.3 8.0 23.8 5.8 3.3 9.2 8.6 6.9 5.0 34.8 25.0 7.2 5.0 1.5 7.8 6.6 8.9 7.0 1.7 1.6 3.6 2.1 0.8 2.3 1.4 1.2 2.5 0.7 1.9 2.6 2.0 2.2 1.5 1.7 5.1 2.2 1.4 12.6 20.1 4.2 12.5 13.2 11.8 19.7 11.0 14.5 13.1 38.7 21.2 5.1 38.8 56.7 1.8 2.4 12.7 9.4 15.9 29.6 2.0 7.9 1.7 12.6 2.8 17.5 32.5 0.0 12.9 7.1 20.6 51.3 9.2 11.6 9.5 11.1 22.2 10.4 16.3 3.8 4.4 14.9 18.6 5.4 21.7 7.5 30.7 26.8 2.8 2.1 0.6 12.9 22.7 0.5 4.7 50.4 65.2 8.6 13.4 64.3 MAG "GMA, S-MAG, SIGLEC-4A, SIGLEC4A" ENSG00000105695 "Myelin associated glycoprotein" P20916 19 35292125-35313804 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 113.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.8;Distal tubular cells: 1.7;Extravillous trophoblasts: 2.5;granulocytes: 4.6;Ito cells: 1.8;Leydig cells: 1.7;Spermatogonia: 1.9" "Cancer enriched" "Detected in some" 7 "glioma: 20.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 15 "dendritic cells: 6.4" "Cell line enriched" "Detected in some" 22 "WM-115: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009345, HPA012499" Enhanced NA NA "CAB009345: AB_670104, HPA012499: AB_1854238" "unprognostic (2.70e-3)" "unprognostic (2.70e-2)" "unprognostic (8.06e-3)" "unprognostic (1.23e-1)" "unprognostic (6.93e-2)" "unprognostic (3.74e-1)" "unprognostic (1.50e-1)" "unprognostic (2.39e-1)" "unprognostic (1.06e-1)" "unprognostic (2.00e-1)" "unprognostic (5.62e-2)" "unprognostic (5.18e-4)" "unprognostic (6.29e-2)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-1)" 1.5 2.3 19.5 1.4 29.9 1.4 1.5 3.6 90.8 1.5 1.4 97.0 0.0 1.4 1.6 1.4 1.5 5.1 1.4 1.4 36.7 19.1 1.5 1.6 1.7 1.5 48.9 18.0 21.8 1.4 1.4 0.1 1.7 38.0 1.5 1.4 0.0 1.4 1.7 1.4 1.4 1.5 1.4 113.6 1.6 1.4 1.7 38.1 0.0 1.8 0.0 1.5 1.4 0.1 0.4 6.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 28.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 6.4 0.0 0.1 19.5 29.9 3.6 38.5 36.7 19.1 48.9 18.0 38.0 38.1 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.3 0.0 4.6 0.0 1.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 MAGEA1 "CT1.1, MAGE1, MGC9326" ENSG00000198681 "MAGE family member A1" P43355 X 153179285-153183880 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.5" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 29.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 17.8;HMC-1: 31.0;RPMI-8226: 15.3;U-2 OS: 29.6;U-266/70: 44.3;U-266/84: 70.5" CAB002620 Enhanced Supported Cytosol NA NA Cytosol "CAB002620: " "unprognostic (8.65e-2)" "unprognostic (1.33e-1)" "unprognostic (6.40e-3)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.18e-1)" "unprognostic (2.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 17.8 3.2 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.1 0.0 0.0 29.6 0.1 0.1 44.3 70.5 0.0 2.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 29.0 0.0 0.0 0.0 0.0 0.0 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 48.7" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Sertoli cells: 6.5;Spermatocytes: 12.1;Spermatogonia: 8.9;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "GAMG: 42.1" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: AB_2686310" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 48.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.8 2.6 0.8 1.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.9 0.0 0.2 0.0 7.0 2.6 0.8 0.7 0.4 0.7 0.4 0.7 0.5 0.4 0.3 0.9 0.6 0.7 2.6 1.2 0.5 0.8 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 12.1 8.9 0.0 9.4 0.0 0.0 0.0 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717266 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 36.5;testis: 9.3" "Cell type enhanced" "Detected in some" 22 "Spermatocytes: 9.3;Spermatogonia: 14.3;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 23.4" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: AB_2681915" "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 36.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 23.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 14.3 0.0 4.9 0.0 0.0 0.0 MAGEA12 "CT1.12, MAGE12" ENSG00000213401 "MAGE family member A12" P43365 X 152733779-152737669 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 4.1;testis: 8.3" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 19.4" "Cancer enhanced" "Detected in many" "melanoma: 10.8" "Region enhanced" "Detected in some" "cerebral cortex: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 45.5;HMC-1: 18.4;K-562: 26.7;OE19: 34.5;SH-SY5Y: 15.3;U-2 OS: 27.9;U-266/70: 22.0" NA NA "unprognostic (3.47e-2)" "unprognostic (4.54e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.82e-1)" "unprognostic (3.25e-1)" "unprognostic (1.60e-3)" "unprognostic (8.57e-4)" "unprognostic (4.61e-2)" "unprognostic (1.78e-1)" "unprognostic (4.06e-2)" 0.2 0.0 0.7 0.0 1.1 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 34.5 13.1 0.0 0.0 0.3 0.0 0.0 1.0 15.3 0.0 7.6 3.9 0.0 0.2 0.0 0.1 0.0 27.9 4.0 1.9 22.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.1 4.1 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 19.4 0.0 0.0 0.0 0.0 0.0 MAGEA2 "CT1.2, MAGE2, MAGEA2A" ENSG00000268606 "MAGE family member A2" P43356 X 152749863-152753884 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 25.0;HMC-1: 15.0;K-562: 20.2;OE19: 39.0;SH-SY5Y: 16.2;SK-BR-3: 15.8;U-266/70: 39.6;U-266/84: 26.7" NA NA "unprognostic (3.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 8.7 0.0 0.0 0.0 0.0 0.0 39.0 1.0 0.0 0.0 0.0 0.0 0.0 6.4 16.2 0.0 15.8 4.3 0.0 0.0 1.7 0.0 0.1 1.2 0.3 0.1 39.6 26.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA2B "MAGE2, MAGEA2, MAGEA2b, MGC16973" ENSG00000183305 "MAGE family member A2B" P43356 X 152714586-152718607 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "testis: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 13.4;GAMG: 58.4;HMC-1: 14.0;K-562: 11.8;SH-SY5Y: 18.9;U-266/70: 9.9;U-266/84: 14.9" NA NA "unprognostic (1.20e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 58.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 3.7 0.0 0.0 0.0 0.0 0.0 5.6 1.2 0.0 0.0 0.0 0.0 0.0 4.3 18.9 0.0 5.7 0.6 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.2 9.9 14.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEA3 "CT1.3, HIP8, HYPD, MAGE3, MGC14613" ENSG00000221867 "MAGE family member A3" P43357 X 152698752-152702347 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 12.8" "Cell type enriched" "Detected in some" 5 "Spermatogonia: 46.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 53.9;K-562: 31.5;OE19: 70.3;PC-3: 29.4;SH-SY5Y: 29.2;SK-BR-3: 33.3;U-266/70: 46.6;U-266/84: 51.9" NA NA "unprognostic (1.29e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (3.58e-4)" "unprognostic (4.20e-2)" "unprognostic (2.48e-1)" "unprognostic (2.53e-3)" "unprognostic (3.95e-2)" "unprognostic (2.92e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 3.2 0.0 0.0 0.0 0.0 0.0 70.3 29.4 0.0 0.0 0.5 0.0 0.0 6.3 29.2 0.0 33.3 1.6 0.0 0.3 1.9 0.1 2.0 3.9 1.9 2.7 46.6 51.9 0.0 0.2 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.6 46.4 0.0 0.1 0.0 0.0 0.0 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "placenta: 12.1;testis: 23.5" "Cell type enriched" "Detected in some" 7 "Spermatogonia: 190.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 62.8;AN3-CA: 39.2;HMC-1: 74.8;U-2 OS: 20.0;U-266/84: 116.4" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.8 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 20.0 0.0 0.3 15.9 116.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 23.4 190.5 0.0 27.6 0.0 0.0 0.0 MAGEA6 "CT1.6, MAGE-3b, MAGE3B, MAGE6" ENSG00000197172 "MAGE family member A6" P43360 X 152766136-152769747 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 11.7" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 45.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 46.4;HMC-1: 35.0;K-562: 28.4;OE19: 58.2;PC-3: 32.3;SK-BR-3: 30.6;U-266/70: 39.1;U-266/84: 24.3" NA NA "unprognostic (3.09e-1)" "unprognostic (5.94e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (3.50e-2)" "unprognostic (1.74e-1)" "unprognostic (5.33e-2)" "unprognostic (8.33e-2)" "unprognostic (6.00e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.7 0.2 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 16.5 0.0 0.0 0.0 0.0 0.0 58.2 32.3 0.0 0.0 1.8 0.0 0.0 1.7 12.8 0.0 30.6 4.2 0.0 0.4 2.1 0.1 14.3 22.5 0.8 4.2 39.1 24.3 0.0 0.2 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 7.0 45.4 0.0 0.1 0.0 0.0 0.0 MAGEA8 "CT1.8, MAGE8, MGC2182" ENSG00000156009 "MAGE family member A8" P43361 X 149881141-149885835 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 24.6" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 61.9;Extravillous trophoblasts: 27.4;Syncytiotrophoblasts: 65.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "U-2 OS: 19.5;U-266/70: 36.3" HPA003998 Enhanced NA NA "HPA003998: AB_10965020" "unprognostic (6.81e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.27e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-2)" "unprognostic (2.49e-2)" "unprognostic (5.07e-3)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 36.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.5 3.0 0.0 65.0 0.0 0.0 0.0 MAGEA9 "CT1.9, MAGE9, MGC8421" ENSG00000123584 "MAGE family member A9" P43362 X 149781930-149787737 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "U-266/70: 29.6;U-266/84: 20.1" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 MAGEA9B ENSG00000267978 "MAGE family member A9B" P43362 X 149581653-149587453 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 14.2" "Group enriched" "Detected in some" 22 "Sertoli cells: 6.5;Spermatocytes: 10.7;Spermatogonia: 4.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "OE19: 29.3;RT4: 47.2;U-266/70: 20.4;U-266/84: 25.2" "HPA045401, HPA051687" Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045401: AB_2679315, HPA051687: " "unprognostic (6.12e-3)" "unprognostic (3.26e-1)" 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 2.2 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 20.4 25.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 10.7 4.8 0.0 0.1 0.0 0.0 0.0 MAGEB1 "CT3.1, DAM10, MAGE-Xp, MAGEL1, MGC9322" ENSG00000214107 "MAGE family member B1" P43366 X 30243730-30252038 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 23.9" "Group enriched" "Detected in some" 8 "Spermatocytes: 4.9;Spermatogonia: 10.1" "Cancer enriched" "Detected in some" 9 "testis cancer: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "K-562: 13.7;U-266/70: 31.4;U-266/84: 21.8" "HPA001193, HPA002820" Enhanced NA NA "HPA001193: AB_1079296, HPA002820: AB_1079295" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 31.4 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.9 10.1 0.0 0.0 0.0 0.0 0.0 MAGEB10 FLJ32965 ENSG00000177689 "MAGE family member B10" Q96LZ2 X 27807990-27823014 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 1.9;testis: 7.1" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 12.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2 OS: 4.2" "Not detected" "Not detected" HPA000611 Uncertain NA NA "HPA000611: AB_2138307" "unprognostic (2.77e-1)" 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 7.1 0.0 0.0 0.1 0.0 0.7 0.5 1.9 0.4 0.6 0.5 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.2 0.5 0.5 0.0 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.1 0.9 1.0 0.0 0.0 0.3 0.9 0.2 0.0 0.1 0.1 0.1 0.4 0.3 1.1 0.8 0.0 0.4 0.3 0.3 0.1 0.0 0.1 0.5 0.4 0.7 0.0 0.1 0.2 1.3 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.4 4.2 0.4 0.0 0.3 0.1 0.2 0.3 0.4 0.5 1.9 0.4 0.5 0.4 0.3 0.2 0.3 0.3 0.5 0.1 0.7 0.4 0.3 1.7 0.6 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 12.1 0.4 0.0 0.0 0.0 0.1 MAGEB16 ENSG00000189023 "MAGE family member B16" A2A368 X 35798342-35803735 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 44 "testis: 9.0" "Group enriched" "Detected in some" 25 "Spermatocytes: 4.7;Spermatogonia: 9.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/70: 37.0" "HPA055743, HPA076456" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA055743: AB_2682902, HPA076456: " "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 9.7 0.0 0.0 0.0 0.0 0.0 MAGEB17 ENSG00000182798 "MAGE family member B17" A8MXT2 X 16167481-16171464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 4.4;testis: 5.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 3.3;U-2 OS: 7.2;U-266/70: 17.8" HPA003756 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA003756: AB_2250114" "unprognostic (1.94e-2)" "unprognostic (2.23e-1)" "unprognostic (3.57e-1)" "unprognostic (4.04e-4)" "unprognostic (2.75e-1)" "unprognostic (5.11e-1)" "unprognostic (3.56e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (1.88e-2)" "unprognostic (2.49e-2)" "unprognostic (1.50e-1)" "unprognostic (7.05e-2)" "unprognostic (2.88e-1)" "unprognostic (5.45e-2)" "unprognostic (6.44e-2)" 0.1 0.0 0.1 0.4 0.0 0.0 0.6 0.1 0.0 0.6 0.4 0.0 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 1.2 5.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.3 7.2 0.0 0.2 17.8 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB18 MGC33889 ENSG00000176774 "MAGE family member B18" Q96M61 X 26138343-26140735 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 4.2" "Cell type enriched" "Detected in single" 9 "Spermatocytes: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "Karpas-707: 10.0" "Not detected" "Not detected" HPA046141 Enhanced NA NA "HPA046141: AB_2679554" "unprognostic (1.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.0 0.0 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215560-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 35.8" "Group enriched" "Detected in some" 11 "Sertoli cells: 12.9;Spermatocytes: 16.1;Spermatogonia: 45.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 26.1;K-562: 18.8;Karpas-707: 22.8;U-2 OS: 27.2;U-266/70: 44.8;U-266/84: 46.8" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol NA Yes Cytosol "HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 27.2 0.0 0.0 44.8 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 16.1 45.1 0.0 0.0 0.0 0.0 0.0 MAGEB3 CT3.5 ENSG00000198798 "MAGE family member B3" O15480 X 30230436-30237492 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "epididymis: 20.5;testis: 7.8" "Cell type enhanced" "Detected in some" 23 "Late spermatids: 1.1;Spermatocytes: 4.6;Spermatogonia: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SuSa: 4.3;U-266/70: 6.4" "Not detected" "Not detected" HPA072203 Approved NA NA "HPA072203: AB_2686492" "unprognostic (3.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 6.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.1 0.0 0.0 0.0 0.0 0.0 MAGEB4 "CT3.6, MGC33144" ENSG00000120289 "MAGE family member B4" O15481 X 30242052-30244193 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "epididymis: 26.3;testis: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" HPA030456 Enhanced NA NA "HPA030456: AB_10602707" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB5 "CT3.3, MAGE-B5" ENSG00000188408 "MAGE family member B5" Q9BZ81 X 26216169-26218270 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 10 "testis: 3.3" "Group enriched" "Detected in some" 7 "Early spermatids: 3.2;Late spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA052627 Uncertain NA NA "HPA052627: AB_2681890" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 MAGEB6 "CT3.4, FLJ40242, MAGE-B6, MAGEB6A" ENSG00000176746 "MAGE family member B6" Q8N7X4 X 26192440-26195646 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 87 "testis: 8.6" "Group enriched" "Detected in some" 10 "Spermatocytes: 7.2;Spermatogonia: 11.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "K-562: 10.0" "HPA041853, HPA076711" Enhanced NA NA "HPA041853: AB_10796785, HPA076711: " "unprognostic (2.05e-1)" "unprognostic (1.31e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 11.7 0.0 0.0 0.0 0.0 0.0 MAGEB6B MAGEB6P1 ENSG00000232030 "MAGE family member B6B" X 26160601-26161824 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 34 "testis: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 2.4;U-2197: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEC1 "CT7, CT7.1, MAGE-C1, MGC39366" ENSG00000155495 "MAGE family member C1" O60732 X 141903894-141909388 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 23.5" "Group enriched" "Detected in some" 7 "Sertoli cells: 6.5;Spermatocytes: 5.9;Spermatogonia: 14.9" "Cancer enhanced" "Detected in many" "melanoma: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 22.9;Karpas-707: 22.9;U-2 OS: 15.4;U-2197: 29.1;U-266/70: 20.9;U-266/84: 18.4" "HPA004622, CAB015452" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB015452: AB_784404, HPA004622: AB_1853495" "unprognostic (5.63e-2)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (4.52e-2)" "unprognostic (9.96e-2)" "unprognostic (3.47e-1)" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 15.4 29.1 0.0 20.9 18.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 5.9 14.9 0.0 0.0 0.0 0.0 0.0 MAGEC2 "CT10, HCA587, MAGE-C2, MAGEE1" ENSG00000046774 "MAGE family member C2" Q9UBF1 X 142202345-142205290 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 319 "testis: 31.8" "Group enriched" "Detected in some" 9 "Spermatocytes: 30.7;Spermatogonia: 86.6" "Cancer enhanced" "Detected in many" "melanoma: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "K-562: 35.8;U-266/84: 40.4" HPA062230 Enhanced Supported Nucleoplasm,Cytosol Yes NA Nucleoplasm Cytosol "HPA062230: AB_2684718" "unprognostic (1.25e-1)" "unprognostic (5.68e-2)" "unprognostic (3.99e-1)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 1.5 0.0 0.0 0.0 0.1 2.5 0.4 4.9 0.0 0.0 40.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 30.7 86.6 0.0 0.0 0.0 0.0 0.0 MAGEC3 "CT7.2, HCA2, MAGE-C3" ENSG00000165509 "MAGE family member C3" Q8TD91 X 141838316-141897832 "Cancer-related genes, Predicted intracellular proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;epididymis: 3.0;testis: 3.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.2;U-2197: 1.9;U-266/70: 2.9;U-266/84: 6.4" HPA052067 Approved NA NA "HPA052067: AB_2681717" "unprognostic (3.45e-1)" "unprognostic (2.39e-1)" "unprognostic (4.01e-1)" "unprognostic (2.95e-1)" "unprognostic (2.10e-2)" "unprognostic (3.45e-2)" "unprognostic (2.35e-11)" "unprognostic (3.21e-2)" "unprognostic (4.29e-2)" 0.1 0.1 1.6 0.0 2.5 0.1 0.5 0.5 2.5 0.2 0.0 0.0 0.2 3.0 0.1 0.4 0.2 0.0 3.3 2.0 0.1 0.1 0.2 0.0 2.8 0.4 0.0 0.0 0.7 0.0 0.3 0.0 0.5 0.3 0.0 0.1 0.2 0.3 4.9 1.1 0.1 3.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.9 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 1.9 0.3 2.9 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 MAGED4 "KIAA1859, MAGE-E1, MAGE1, MGC3210" ENSG00000154545 "MAGE family member D4" Q96JG8 X 52184823-52192268 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.1;pituitary gland: 7.5" "Cell type enhanced" "Detected in single" 26 "Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Group enriched" "Detected in many" 21 "B-cells: 3.1;dendritic cells: 1.3;T-cells: 1.6" "Cell line enhanced" "Detected in some" "A549: 4.8;ASC TERT1: 4.5;Hep G2: 12.3" HPA003554 Uncertain NA NA "HPA003554: AB_1853497" "unprognostic (7.71e-2)" "unprognostic (8.21e-2)" "unprognostic (4.07e-4)" "unprognostic (6.15e-2)" 1.3 2.1 5.5 1.3 6.1 0.4 3.1 0.8 4.6 2.0 1.0 2.4 0.0 0.4 1.9 0.4 0.4 0.4 1.9 1.6 5.1 4.8 1.1 0.6 0.4 0.4 3.7 5.5 1.2 1.0 0.4 7.5 1.7 3.7 1.2 1.2 0.3 1.1 1.4 0.9 0.4 0.4 2.0 5.2 0.8 0.5 0.6 1.2 0.0 0.4 0.0 0.4 0.4 0.4 3.1 1.3 0.0 0.0 0.0 1.6 0.3 0.0 4.8 0.9 0.8 0.0 4.5 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.1 0.0 1.7 0.0 1.2 0.0 0.0 0.0 0.9 0.0 0.0 12.3 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 1.6 0.0 3.1 0.5 0.2 0.0 0.0 0.0 1.3 1.5 0.3 5.5 6.1 0.8 4.6 5.1 4.8 3.7 5.5 3.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGED4B ENSG00000187243 "MAGE family member D4B" Q96JG8 X 52061827-52069248 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell type enhanced" "Detected in single" 29 "Club cells: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 8.1" "Group enriched" "Detected in many" 30 "B-cells: 8.1;dendritic cells: 5.4;T-cells: 5.0" "Cell line enhanced" "Detected in many" "AF22: 23.8;NTERA-2: 19.6;SuSa: 21.8" HPA003554 Approved NA NA "HPA003554: AB_1853497" "unprognostic (7.75e-2)" "unprognostic (2.19e-1)" "unprognostic (2.37e-2)" "unprognostic (7.01e-6)" "unprognostic (6.45e-2)" 0.5 2.8 7.4 1.6 13.5 0.0 1.2 1.9 19.3 5.5 1.4 1.2 7.2 0.5 0.4 3.1 2.9 0.1 5.2 18.1 0.2 0.0 0.3 0.5 5.6 5.7 2.5 0.0 7.2 2.3 3.6 0.7 2.9 1.6 0.0 0.5 1.9 3.8 6.9 0.3 2.4 0.3 1.7 0.5 1.6 1.0 8.1 5.4 0.0 0.0 0.2 5.0 0.8 0.0 1.0 23.8 7.8 6.7 5.1 7.9 13.4 9.4 3.5 6.9 0.0 1.6 0.0 2.7 14.9 8.4 0.0 9.7 0.0 2.0 0.0 1.6 0.0 0.0 10.9 5.4 0.0 3.2 11.7 0.0 7.6 0.2 9.4 6.7 6.4 0.0 0.0 6.2 1.0 2.6 0.0 19.6 0.0 0.7 0.0 14.0 0.0 2.6 0.0 1.0 14.8 0.0 0.0 1.9 21.8 0.0 0.0 0.8 6.6 9.9 0.0 0.0 0.0 0.0 0.5 8.6 0.0 11.6 0.0 0.0 0.0 0.2 0.0 0.5 2.7 2.4 1.3 0.0 8.1 0.0 0.5 0.0 0.2 0.0 5.4 5.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEE1 "DAMAGE, KIAA1587" ENSG00000198934 "MAGE family member E1" Q9HCI5 X 76427724-76431353 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 9.4;Horizontal cells: 27.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4" "Cell line enhanced" "Detected in many" "GAMG: 9.4" "Low region specificity" "Detected in all" HPA003047 Approved Approved "Cytokinetic bridge,Cytosol" Yes No Cytosol "Cytokinetic bridge" "HPA003047: AB_1079298" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-3)" "unprognostic (1.76e-1)" "unprognostic (3.94e-2)" "unprognostic (5.61e-3)" "unprognostic (8.72e-3)" "unprognostic (2.41e-3)" "unprognostic (1.43e-1)" "prognostic favorable (3.95e-4)" "unprognostic (7.91e-2)" "prognostic favorable (6.86e-6)" "unprognostic (4.60e-3)" "unprognostic (2.71e-1)" "unprognostic (6.03e-3)" "unprognostic (5.99e-3)" 2.6 5.8 13.8 3.0 23.5 1.1 3.3 18.7 33.9 4.7 1.9 3.2 0.5 1.5 5.4 3.5 2.3 4.8 2.3 3.9 18.9 20.3 4.1 1.1 2.6 4.1 10.2 22.0 8.4 4.1 15.1 5.1 0.8 19.8 5.9 2.1 2.3 3.4 7.4 2.2 3.3 2.0 4.8 5.4 4.5 2.6 1.3 4.9 1.1 4.0 0.1 3.6 2.4 1.8 1.0 0.0 0.0 0.0 1.5 2.4 0.4 0.2 4.5 4.7 8.9 3.3 1.9 4.1 3.4 3.4 2.9 1.6 1.0 0.7 0.9 1.7 3.0 9.4 3.4 6.9 6.4 2.4 2.2 0.1 0.0 0.0 2.9 0.7 1.8 0.6 1.4 2.9 0.8 0.8 0.1 1.1 4.9 0.3 0.0 4.4 0.6 4.9 0.2 5.6 0.0 6.9 3.9 3.5 0.0 3.7 0.0 0.0 2.4 0.0 0.4 0.6 5.0 2.1 0.1 0.6 4.4 5.6 4.6 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.8 1.1 2.3 0.0 1.0 1.4 1.3 0.0 1.5 0.0 0.0 0.0 0.4 13.8 23.5 18.7 33.9 18.9 20.3 10.2 22.0 19.8 4.9 3.0 1.6 0.0 0.6 0.5 9.4 1.6 0.0 0.0 1.2 1.8 3.9 0.1 1.7 1.5 0.0 1.0 0.0 0.0 1.3 0.4 0.7 0.2 1.1 0.0 0.1 27.0 0.0 0.6 0.3 0.0 1.4 0.0 0.0 0.0 0.2 4.3 0.8 0.0 4.2 0.9 5.1 19.4 1.4 0.2 0.2 0.1 0.1 4.3 0.0 0.1 MAGEE2 HCA3 ENSG00000186675 "MAGE family member E2" Q8TD90 X 75782988-75785236 "Predicted intracellular proteins" "Tumor antigen" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 8.8" "Cell type enhanced" "Detected in single" 39 "Bipolar cells: 1.5" "Cancer enriched" "Detected in single" 9 "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030625 Uncertain NA NA "HPA030625: AB_10601863" "unprognostic (5.92e-2)" "unprognostic (9.33e-2)" "unprognostic (2.24e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (3.01e-3)" "unprognostic (5.79e-3)" "unprognostic (3.47e-2)" "unprognostic (6.43e-2)" 0.5 3.6 2.6 0.5 6.4 0.3 0.7 8.1 8.8 0.9 1.0 0.3 0.0 0.8 1.2 1.2 0.8 0.6 1.0 0.8 2.5 6.7 1.0 0.4 0.9 0.3 2.0 3.8 1.6 0.3 0.3 1.9 0.3 4.1 1.1 1.4 0.4 0.8 1.1 0.3 0.9 1.1 1.3 2.0 0.4 0.4 0.5 0.9 0.0 0.5 0.0 0.4 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 6.4 8.1 7.2 2.5 6.7 2.0 3.8 4.1 0.9 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452105-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "epididymis: 207.1" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011324, HPA011971" Uncertain Supported "Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" "HPA011324: AB_1853499, HPA011971: " "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favorable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 8.3 13.2 21.5 7.6 21.6 3.0 8.1 19.9 29.7 13.5 7.5 14.4 13.8 5.2 13.3 207.1 5.2 19.2 8.3 10.2 22.8 32.1 11.4 8.7 10.2 9.0 19.8 20.6 16.1 11.9 9.0 22.5 9.2 17.9 20.8 5.9 11.4 8.9 19.6 5.7 5.6 6.3 11.8 17.2 8.1 9.3 18.2 15.3 10.8 12.4 5.2 7.5 8.5 10.0 9.4 14.0 9.5 8.5 8.3 26.0 9.4 0.0 2.6 15.0 0.0 24.3 14.7 0.2 16.2 15.0 4.5 12.1 0.0 3.4 0.0 22.3 16.3 8.5 2.2 5.6 6.1 7.1 18.7 0.9 5.0 0.0 2.0 8.0 0.2 6.5 12.2 0.5 2.6 1.9 4.2 6.8 5.4 2.8 20.1 4.9 9.6 13.3 4.3 4.2 0.0 3.1 8.4 1.9 10.5 8.2 0.0 0.1 11.4 0.0 4.4 6.7 11.8 2.1 3.8 7.9 6.2 7.2 3.7 0.8 12.0 15.1 2.1 11.5 7.0 7.8 5.0 4.4 9.5 11.3 6.8 10.1 9.4 18.7 12.9 6.7 8.8 26.0 16.1 0.6 8.3 8.5 14.0 24.7 9.4 21.5 21.6 19.9 28.4 22.8 32.1 19.8 20.6 17.9 15.3 6.0 11.8 20.4 7.1 7.1 37.4 7.9 22.9 9.4 18.2 12.2 9.8 2.2 11.6 27.6 0.8 20.5 1.0 0.0 9.3 1.3 39.5 9.9 12.7 13.6 12.7 35.0 15.2 30.7 2.5 2.1 43.7 7.1 20.3 10.8 6.4 51.7 5.9 7.0 60.1 14.4 15.4 25.8 37.6 1.2 1.7 5.5 1.4 10.7 4.5 3.0 MAGEL2 "NDNL1, nM15" ENSG00000254585 "MAGE family member L2" Q9UJ55 15 23643544-23647841 "Disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" Repressor "Autism spectrum disorder, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6;pituitary gland: 13.0" "Cell type enhanced" "Detected in some" 12 "Horizontal cells: 3.2;Ito cells: 1.3;Leydig cells: 2.6;Muller glia cells: 1.9;Peritubular cells: 1.1" "Cancer enhanced" "Detected in some" "testis cancer: 4.3" "Group enriched" "Detected in many" 5 "basal ganglia: 20.6;cerebral cortex: 6.4;hypothalamus: 19.4;pons and medulla: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 7.2;JURKAT: 2.7;NTERA-2: 4.4;SuSa: 5.4;U-2 OS: 2.3" "Region enhanced" "Detected in many" "hypothalamus: 20.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.18e-1)" "unprognostic (2.63e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-3)" "unprognostic (1.65e-2)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "unprognostic (5.38e-3)" "unprognostic (3.51e-3)" "unprognostic (8.61e-2)" "unprognostic (1.31e-2)" "unprognostic (9.55e-2)" "unprognostic (2.96e-9)" "unprognostic (1.66e-4)" "unprognostic (3.30e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-2)" 1.5 1.3 3.0 0.9 20.6 0.3 0.7 0.3 6.8 6.7 0.5 1.0 0.2 0.3 4.9 1.2 0.5 1.6 1.2 0.6 2.9 19.4 0.5 0.4 0.5 0.4 2.1 1.6 7.2 2.2 0.3 13.0 4.3 8.9 1.0 0.4 2.5 0.6 1.9 0.5 0.7 0.6 2.2 0.9 1.0 0.5 4.2 1.4 0.0 2.5 0.0 0.4 1.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.9 0.0 0.5 0.0 4.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 20.6 0.3 6.4 2.9 19.4 2.1 1.6 8.9 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.2 0.0 1.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.3 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAGI2 "ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2" ENSG00000187391 "Membrane associated guanylate kinase, WW and PDZ domain containing 2" Q86UL8 7 78017057-79453574 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.7;parathyroid gland: 31.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 30.1;Horizontal cells: 44.5;Muller glia cells: 24.9" "Cancer enhanced" "Detected in many" "glioma: 7.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "Karpas-707: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013650 Approved NA NA "HPA013650: AB_1853501" "unprognostic (4.32e-2)" "unprognostic (2.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-4)" "unprognostic (5.04e-2)" "unprognostic (3.33e-1)" "unprognostic (6.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.17e-1)" "unprognostic (8.80e-3)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "prognostic favorable (1.08e-4)" "unprognostic (4.34e-4)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (3.01e-2)" 5.4 8.3 21.0 2.2 20.5 1.8 3.9 43.7 36.8 5.5 3.2 17.7 2.5 3.1 5.6 5.6 3.6 4.8 4.6 3.9 21.8 12.7 7.6 2.5 4.4 1.6 13.6 19.5 11.5 5.1 31.8 7.7 2.3 16.5 11.9 3.0 3.5 2.8 11.6 2.9 2.3 3.2 4.1 15.1 3.1 2.9 5.1 24.4 0.0 9.0 0.0 1.4 4.1 2.9 2.0 1.4 3.8 0.9 1.0 0.9 0.2 0.0 0.3 10.3 0.2 2.1 3.4 0.1 1.8 3.4 0.4 0.5 0.0 0.1 0.0 0.0 1.1 1.4 0.1 0.6 0.0 0.5 0.5 0.4 0.1 0.2 0.6 3.2 0.2 0.5 2.5 0.1 0.2 0.1 1.9 0.4 0.3 0.3 43.1 0.9 0.4 0.1 0.2 2.3 0.3 0.1 0.1 0.1 0.7 0.1 0.1 1.6 2.6 0.4 0.1 1.0 1.6 0.2 0.3 0.6 1.5 0.5 4.2 0.2 0.2 0.0 0.1 0.9 0.1 0.6 2.7 0.7 0.8 0.9 0.6 0.6 1.1 0.6 0.5 0.4 2.0 0.6 0.8 3.8 1.0 0.9 1.4 0.6 0.2 21.0 20.5 43.7 34.5 21.8 12.7 13.6 19.5 16.5 24.4 8.9 8.4 0.0 1.1 0.9 30.1 5.2 5.1 2.7 5.7 1.8 19.6 0.3 5.0 0.4 21.7 2.0 0.9 0.0 0.8 0.1 4.4 3.0 0.0 1.6 0.2 44.5 2.4 3.1 0.0 22.8 6.1 0.1 1.7 0.0 1.1 24.9 0.3 1.1 18.7 1.4 21.2 12.9 4.7 2.4 1.2 0.9 0.3 0.0 1.2 0.7 MAGI3 MAGI-3 ENSG00000081026 "Membrane associated guanylate kinase, WW and PDZ domain containing 3" Q5TCQ9 1 113390749-113685923 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 50.7" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 247.1;Bipolar cells: 91.7;Club cells: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008444 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA008444: AB_2668069" "unprognostic (4.07e-1)" "unprognostic (3.59e-2)" "unprognostic (1.54e-3)" "unprognostic (2.32e-2)" "unprognostic (2.31e-2)" "unprognostic (5.21e-3)" "unprognostic (2.23e-1)" "unprognostic (7.06e-2)" "unprognostic (2.80e-2)" "prognostic favorable (4.29e-4)" "unprognostic (1.09e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.60e-8)" "unprognostic (1.71e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-2)" 4.4 4.3 9.5 9.0 6.2 0.4 11.6 11.3 11.9 4.9 15.3 1.3 1.7 7.4 6.2 8.7 10.0 4.8 6.3 4.2 6.6 9.5 9.6 8.0 50.7 2.6 8.0 7.9 8.0 13.3 7.1 8.2 9.2 5.2 5.5 10.5 5.9 7.8 3.6 2.4 3.1 25.1 5.9 5.4 3.6 14.6 4.9 3.9 3.9 16.5 9.1 9.0 4.5 9.8 0.1 0.7 1.1 0.2 0.8 1.8 0.2 8.1 9.4 9.0 4.0 4.2 6.1 2.7 5.8 2.7 4.4 5.0 8.3 2.4 0.3 4.3 5.1 3.7 3.6 8.1 4.3 5.5 8.8 8.7 3.5 8.2 3.8 1.0 2.8 5.3 3.2 2.2 4.6 10.3 5.3 6.0 3.7 4.4 7.8 5.9 5.3 4.6 0.7 3.3 13.8 5.9 6.6 14.4 1.0 5.2 3.6 8.3 8.6 6.7 11.3 2.0 11.9 5.8 1.5 10.6 7.3 9.2 6.6 7.9 3.1 2.5 0.0 3.8 1.4 5.8 0.4 0.2 0.0 0.5 0.0 0.5 0.0 1.3 0.2 0.7 0.1 1.8 0.1 1.1 0.8 0.2 0.2 0.0 0.2 9.5 6.2 11.3 11.9 6.6 9.5 8.0 7.9 5.2 3.9 247.1 72.0 0.0 7.8 9.6 91.7 7.5 15.3 21.4 97.8 12.2 47.1 12.8 6.6 8.8 20.1 12.0 41.6 0.0 9.3 1.7 11.3 11.7 5.8 12.2 3.3 38.1 13.2 9.8 1.8 21.6 9.5 2.8 11.8 0.0 19.0 36.6 11.9 26.6 10.6 4.3 46.3 12.9 6.9 15.9 10.1 6.6 4.6 1.8 25.9 8.9 MAJIN C11orf85 ENSG00000168070 "Membrane anchored junction protein" Q3KP22 11 64937517-64972085 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 43.7" "Group enriched" "Detected in some" 15 "Distal tubular cells: 3.3;Proximal tubular cells: 4.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebellum: 4.9" "Cell type enhanced" "Detected in some" "memory B-cell: 4.1;naive B-cell: 1.7" "Lineage enriched" "Detected in single" 5 "B-cells: 4.1" "Group enriched" "Detected in some" 9 "CAPAN-2: 12.5;SiHa: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.37e-1)" "unprognostic (6.43e-3)" "unprognostic (3.69e-2)" "unprognostic (7.05e-2)" "unprognostic (9.64e-3)" "unprognostic (2.92e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" "unprognostic (9.11e-2)" "unprognostic (4.11e-2)" "unprognostic (1.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.48e-2)" "unprognostic (2.43e-1)" "unprognostic (2.79e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-2)" 0.2 0.2 0.2 1.2 0.7 0.0 0.2 4.9 0.4 0.3 0.2 0.1 0.7 0.0 0.2 2.2 0.2 1.1 2.9 0.4 0.1 0.1 1.4 1.0 0.2 1.5 0.2 0.0 0.1 1.7 0.0 1.5 0.0 0.7 0.3 0.1 0.5 0.3 0.6 0.1 1.2 0.6 0.0 0.2 1.6 0.2 43.7 0.0 0.0 0.8 0.1 1.2 0.3 0.5 4.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.3 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 1.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 4.9 0.4 0.1 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAK "dJ417M14.2, RP62" ENSG00000111837 "Male germ cell associated kinase" P20794 6 10762723-10838555 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 38.1;testis: 19.3" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 347.5;Early spermatids: 112.5;Rod photoreceptor cells: 298.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "pons and medulla: 10.6" "Cell type enriched" "Detected in single" 13 "neutrophil: 11.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 11.7" "Cell line enhanced" "Detected in some" "HDLM-2: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.23e-3)" "unprognostic (8.77e-3)" "unprognostic (2.44e-1)" "unprognostic (3.81e-2)" "unprognostic (6.62e-2)" "unprognostic (1.35e-3)" "unprognostic (1.97e-2)" "unprognostic (2.53e-1)" "unprognostic (3.21e-2)" "unprognostic (2.42e-2)" "unprognostic (1.13e-3)" "unprognostic (6.73e-2)" "unprognostic (6.59e-5)" "unprognostic (1.55e-1)" "unprognostic (8.40e-2)" "unprognostic (7.71e-3)" "unprognostic (4.59e-2)" 0.6 0.3 0.7 0.7 1.5 1.4 0.7 0.4 0.4 0.8 0.2 3.5 0.3 0.2 0.6 2.9 0.3 8.6 1.0 0.3 1.1 1.2 0.3 0.2 1.8 3.7 0.2 0.1 2.2 0.5 9.3 3.6 0.2 10.6 0.5 0.0 38.1 0.5 0.4 0.2 1.1 0.4 0.1 0.7 1.4 0.5 19.3 0.7 0.0 0.6 0.4 0.2 0.2 1.2 0.6 0.4 11.7 0.8 0.3 0.7 0.1 3.0 0.9 1.8 1.8 0.1 0.0 1.7 0.0 0.2 1.0 1.0 1.3 1.7 0.9 0.7 0.0 2.9 0.5 0.6 0.3 0.4 4.7 1.9 0.7 0.7 1.2 0.0 3.2 2.9 0.1 0.0 0.2 0.3 0.6 0.0 0.6 1.6 0.6 0.1 0.4 0.4 1.9 0.8 0.1 0.4 0.6 0.8 0.3 0.1 0.4 1.9 0.9 0.1 0.5 0.1 1.4 1.1 0.3 0.2 0.7 1.1 0.2 1.1 0.5 0.1 0.4 0.5 0.6 1.0 0.5 0.8 0.9 0.4 0.5 0.4 0.2 0.4 0.3 0.4 0.6 0.4 0.7 11.7 0.3 0.8 0.4 0.1 0.1 0.7 1.5 0.4 0.4 1.1 1.2 0.2 0.1 10.6 0.7 0.0 5.4 0.0 2.4 0.3 11.3 0.6 0.0 57.6 7.9 3.5 347.5 0.4 0.0 0.3 112.5 1.1 0.0 0.0 0.2 0.7 0.4 1.2 2.3 0.0 0.2 4.8 0.0 1.3 0.0 27.7 0.6 0.9 1.7 0.0 0.0 15.7 0.1 0.0 0.4 0.0 298.8 0.0 1.0 7.0 6.0 0.4 0.7 0.0 0.0 0.8 MAL ENSG00000172005 "Mal, T cell differentiation protein" P21145 2 95025677-95053996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "esophagus: 447.4" "Cell type enhanced" "Detected in many" 24 "Collecting duct cells: 354.2;Distal tubular cells: 200.6;Muller glia cells: 85.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1" "Lineage enriched" "Detected in many" 44 "T-cells: 57.9" "Cell line enhanced" "Detected in some" "HDLM-2: 45.9;MOLT-4: 64.2;RPMI-8226: 22.7;RPTEC TERT1: 232.7" "Low region specificity" "Detected in all" HPA065691 Approved "Golgi apparatus,Centrosome" NA NA "Golgi apparatus" Centrosome "HPA065691: AB_2685533" "unprognostic (1.57e-3)" "unprognostic (2.64e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (5.18e-6)" "unprognostic (1.67e-1)" "unprognostic (2.30e-2)" "unprognostic (5.13e-2)" "unprognostic (2.35e-2)" "unprognostic (1.06e-1)" "unprognostic (3.59e-1)" "unprognostic (4.61e-2)" "unprognostic (3.89e-2)" "prognostic favorable (3.96e-9)" "unprognostic (1.91e-1)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.57e-1)" 2.3 2.0 14.3 3.5 21.8 3.7 2.0 1.8 20.6 35.8 3.7 43.2 0.4 2.0 1.8 3.4 447.4 3.4 2.2 3.3 18.2 8.3 53.1 1.7 4.3 5.9 27.4 13.2 2.0 1.9 1.6 0.2 2.2 11.8 2.5 2.9 2.8 42.5 3.9 2.0 3.7 2.4 2.1 27.6 3.2 9.3 1.7 27.2 35.0 5.8 56.1 90.1 2.6 64.8 0.6 0.2 0.4 0.1 1.3 57.9 13.7 4.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 64.2 0.0 0.0 0.0 0.0 0.0 0.0 22.7 232.7 5.8 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.4 0.6 42.0 7.5 0.0 0.5 57.9 26.4 0.4 1.3 0.0 0.2 40.1 13.7 14.3 21.8 1.8 20.6 18.2 8.3 27.4 13.2 11.8 27.2 0.0 0.0 0.0 0.1 1.0 1.1 8.1 0.0 0.0 0.0 354.2 3.9 0.1 200.6 0.1 5.3 0.1 0.0 0.0 0.0 0.0 1.9 0.2 1.1 0.0 0.1 4.8 0.0 4.3 0.0 16.2 0.9 0.5 16.9 0.0 0.0 85.5 0.1 0.0 0.0 2.8 2.5 6.5 1.5 0.0 0.4 0.9 0.2 17.0 0.0 0.7 MAL2 ENSG00000147676 "Mal, T cell differentiation protein 2 (gene/pseudogene)" Q969L2 8 119165034-119245673 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.4" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 369.9;Suprabasal keratinocytes: 398.5;Urothelial cells: 421.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 104.3;HaCaT: 46.6;OE19: 114.7;RPTEC TERT1: 40.4;SK-BR-3: 150.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043831 Uncertain NA NA "HPA043831: " "prognostic unfavorable (4.57e-6)" "unprognostic (3.12e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (2.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.03e-2)" "unprognostic (7.20e-2)" "unprognostic (5.86e-2)" "unprognostic (2.00e-3)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.09e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.48e-2)" "unprognostic (1.34e-1)" "unprognostic (3.33e-1)" "unprognostic (9.27e-3)" 3.3 1.3 7.8 5.5 21.1 0.0 17.4 17.4 26.4 13.1 25.5 1.6 19.2 16.0 1.5 5.4 70.4 13.9 16.2 1.9 8.6 4.0 22.8 11.5 20.4 0.0 2.2 11.8 1.3 19.0 9.3 22.7 6.6 1.2 6.8 24.3 0.6 21.1 16.9 1.1 31.0 18.3 0.5 1.8 1.2 33.8 3.3 1.6 0.5 43.8 30.4 31.5 13.3 28.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 104.3 0.0 0.1 0.0 0.0 0.0 9.7 0.0 0.2 0.1 0.1 8.9 34.0 0.0 5.9 0.0 0.0 46.6 0.0 3.3 0.0 0.0 0.2 0.0 1.5 8.6 0.0 0.0 0.0 0.0 23.7 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.8 114.7 32.1 0.0 0.0 0.0 40.4 26.2 5.9 0.0 1.8 150.4 0.3 0.7 19.9 0.3 0.0 0.0 0.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 21.1 17.4 26.4 8.6 4.0 2.2 11.8 1.2 1.6 104.2 103.7 5.7 58.8 102.0 1.8 1.4 79.0 52.2 76.2 369.9 0.0 18.2 92.9 208.4 0.4 0.6 183.7 0.0 156.8 18.1 7.3 197.7 14.9 43.1 2.4 4.8 40.2 0.6 0.3 1.1 0.6 4.4 15.1 6.4 101.9 0.3 231.3 126.8 0.0 14.7 1.0 0.0 2.8 1.1 5.5 398.5 7.8 2.5 89.8 421.4 MALL BENE ENSG00000144063 "Mal, T cell differentiation protein like" Q13021 2 110083870-110116566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 107.7;intestine: 142.1;lung: 72.9" "Cell type enhanced" "Detected in many" 14 "Ductal cells: 224.3;Enterocytes: 724.1;Pancreatic endocrine cells: 223.5;Urothelial cells: 444.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 9.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.3" "Cell line enhanced" "Detected in some" "A-431: 40.7;A549: 39.9;CAPAN-2: 55.2;fHDF/TERT166: 60.6;HaCaT: 43.0;PC-3: 24.4" "Low region specificity" "Detected in single" HPA051410 Uncertain NA NA "HPA051410: AB_2681474" "unprognostic (5.17e-1)" "unprognostic (4.15e-2)" "unprognostic (2.92e-1)" "unprognostic (3.53e-1)" "unprognostic (1.92e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (4.46e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (2.37e-1)" "unprognostic (7.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.84e-1)" "unprognostic (2.80e-1)" "unprognostic (6.50e-3)" 5.5 1.0 0.9 11.1 2.1 0.1 7.7 0.4 1.1 22.5 46.4 0.2 1.3 41.2 6.0 2.7 107.7 2.8 6.7 10.8 1.7 1.0 1.9 1.1 72.9 3.7 1.1 0.2 1.6 2.9 49.8 1.0 3.7 3.6 5.5 19.0 1.6 11.2 1.5 2.1 11.1 142.1 5.1 4.2 2.0 1.8 2.2 0.4 0.6 5.6 45.8 63.8 7.8 35.4 0.9 0.7 9.3 0.7 2.1 1.0 0.5 40.7 39.9 0.0 0.1 0.0 0.0 0.1 7.9 0.4 0.0 0.0 6.6 55.2 0.1 20.1 60.6 0.0 43.0 0.0 2.3 0.0 0.1 0.0 0.3 1.1 0.0 0.3 0.0 0.1 0.9 2.2 0.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 19.1 24.4 0.0 0.0 0.1 5.2 2.3 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.2 20.3 0.0 0.1 0.1 0.1 0.0 0.0 4.7 0.0 0.0 0.0 9.3 0.7 1.0 0.4 0.4 0.4 0.7 0.8 0.7 0.3 0.9 0.5 1.0 4.4 2.1 0.2 0.7 0.6 0.5 0.9 2.1 0.4 1.1 1.7 1.0 1.1 0.2 3.6 0.4 38.7 157.7 0.0 55.9 14.5 0.0 2.8 5.1 10.7 42.1 1.8 0.0 0.1 0.0 224.3 19.6 50.2 724.1 0.0 57.6 0.1 7.4 142.5 6.9 0.6 6.2 0.0 16.8 27.6 1.2 5.6 2.3 1.8 13.5 1.8 39.1 0.0 223.5 112.2 1.1 11.3 0.0 0.0 5.0 7.7 0.9 11.5 0.5 1.3 52.5 444.9 MALRD1 "bA265G8.2, C10orf112, Diet1" ENSG00000204740 "MAM and LDL receptor class A domain containing 1" Q5VYJ5 10 19048771-19790401 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "intestine: 60.5" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 2.6;Early spermatids: 6.8;Spermatocytes: 6.3" "Cancer enhanced" "Detected in some" "stomach cancer: 1.1" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 3.6" "Cell line enriched" "Detected in some" 10 "Karpas-707: 31.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035732, HPA038106, HPA046848" Uncertain Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837" "unprognostic (9.03e-3)" "unprognostic (1.38e-1)" "unprognostic (2.40e-2)" "unprognostic (4.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.77e-1)" "unprognostic (2.74e-2)" "unprognostic (5.57e-2)" "unprognostic (5.01e-1)" "unprognostic (1.00e-1)" "unprognostic (3.55e-1)" "unprognostic (7.69e-2)" "unprognostic (3.16e-2)" "unprognostic (9.80e-2)" "unprognostic (8.90e-2)" "unprognostic (3.13e-2)" "unprognostic (3.78e-4)" 0.5 0.8 2.0 0.3 2.0 0.4 0.6 0.3 0.9 0.8 19.4 0.6 0.1 25.2 1.3 2.3 0.3 0.3 0.4 1.3 1.6 0.8 1.3 0.3 0.9 0.2 0.8 0.0 1.1 0.3 0.1 4.7 0.4 0.8 0.9 0.2 1.4 0.5 0.4 0.5 0.4 60.5 1.3 0.7 0.3 0.5 1.7 0.7 2.6 0.6 0.3 0.1 0.5 0.5 0.0 3.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 31.9 0.0 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.0 3.6 0.0 0.0 2.0 2.0 0.3 0.9 1.6 0.8 0.8 0.0 0.8 0.7 0.0 2.6 0.0 0.2 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.7 0.0 0.0 0.0 0.4 6.3 2.1 0.1 0.2 0.0 0.0 0.0 MAMDC4 "AEGP, DKFZp434M1411" ENSG00000177943 "MAM domain containing 4" Q6UXC1 9 136850943-136860799 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;liver: 48.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 10 "cerebellum: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 18.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB026377, HPA059977" Approved Nucleoplasm,Cytosol NA Yes Nucleoplasm Cytosol "CAB026377: , HPA059977: AB_2684186" "unprognostic (2.79e-1)" "unprognostic (7.90e-2)" "unprognostic (4.09e-3)" "unprognostic (6.86e-2)" "unprognostic (8.33e-2)" "unprognostic (2.66e-4)" "unprognostic (3.20e-2)" "unprognostic (2.39e-1)" "unprognostic (1.31e-1)" "unprognostic (7.37e-2)" "prognostic favorable (1.88e-6)" "unprognostic (8.22e-3)" "unprognostic (1.58e-2)" "unprognostic (1.22e-3)" "unprognostic (9.22e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" 2.0 1.6 1.2 1.9 1.5 1.4 1.2 14.9 1.2 1.2 2.3 1.2 1.2 5.0 1.2 1.2 1.2 1.7 1.2 1.6 1.2 0.4 2.6 48.9 1.2 2.5 1.2 1.2 1.2 3.4 0.5 7.2 1.2 1.2 3.2 0.9 1.2 3.5 1.4 1.7 1.5 6.1 1.2 1.2 5.1 2.3 6.5 1.2 1.2 5.1 1.2 1.2 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 1.6 2.6 1.5 2.9 0.6 0.1 18.9 2.7 0.3 0.3 0.6 2.0 1.6 1.4 0.6 0.7 0.8 2.2 0.3 1.3 0.0 2.1 0.9 0.8 5.3 2.3 1.2 0.2 4.9 0.8 1.7 1.4 0.6 1.4 0.6 2.5 2.7 1.2 0.2 4.2 1.0 3.7 1.4 1.1 0.7 1.6 0.4 2.5 0.9 1.4 1.7 2.1 0.6 1.3 1.1 1.0 4.4 0.9 0.8 7.6 4.8 1.5 0.4 3.1 1.6 0.4 1.7 2.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.5 14.9 1.2 1.2 0.4 1.2 1.2 1.2 1.2 0.0 4.3 0.0 0.8 0.7 5.4 6.2 12.7 2.7 0.0 1.8 0.0 2.2 1.7 0.8 1.7 1.4 19.8 0.0 4.4 2.8 2.6 1.3 0.0 16.6 2.4 15.9 0.0 2.5 2.4 1.9 1.7 2.2 0.0 1.0 19.5 2.6 0.9 12.5 1.4 2.1 7.4 0.0 1.4 1.2 2.2 0.4 1.9 1.3 10.3 0.7 MAMSTR "FLJ36070, MASTR" ENSG00000176909 "MEF2 activating motif and SAP domain containing transcriptional regulator" Q6ZN01 19 48712742-48719721 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.9" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 6.8;Peritubular cells: 5.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 7.6;RH-30: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049765 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049765: AB_2680870" "unprognostic (6.00e-2)" "unprognostic (3.20e-2)" "unprognostic (5.98e-2)" "unprognostic (6.07e-2)" "unprognostic (1.65e-1)" "unprognostic (6.50e-3)" "unprognostic (4.34e-4)" "unprognostic (2.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (4.65e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (2.79e-1)" "unprognostic (4.84e-2)" "unprognostic (1.39e-2)" 2.4 14.7 1.8 1.0 1.9 0.5 0.9 8.0 4.3 7.9 1.0 2.2 1.1 0.7 13.5 3.5 2.7 4.8 1.0 2.7 1.6 1.0 0.7 0.4 0.9 0.7 1.0 4.3 9.5 1.0 2.7 2.7 1.4 0.7 4.7 0.8 3.3 1.5 1.7 53.9 1.7 0.9 3.6 0.8 2.9 0.7 7.7 1.1 0.0 0.9 9.2 1.1 1.4 2.4 4.1 2.9 1.1 0.9 0.7 4.0 0.6 0.6 1.4 1.5 3.8 3.0 5.2 1.5 5.1 4.1 2.5 4.0 1.5 1.0 0.7 0.3 4.8 1.5 1.1 0.2 0.9 1.0 0.5 1.7 0.3 0.5 7.6 1.6 0.1 1.1 3.1 1.0 3.5 0.5 3.5 0.9 1.5 0.3 1.0 1.6 0.7 1.2 0.6 0.1 1.2 1.1 1.4 18.3 0.4 0.3 0.3 1.7 3.1 0.8 0.4 0.3 0.4 0.6 0.0 0.3 5.2 0.9 4.2 0.7 1.1 0.7 0.5 1.9 0.6 1.0 0.0 0.5 1.1 3.9 0.9 2.5 3.1 4.0 3.8 1.0 4.1 4.0 3.5 0.4 0.7 0.9 2.9 1.7 0.6 1.8 1.9 8.0 4.3 1.6 1.0 1.0 4.3 0.7 1.1 0.0 0.0 0.0 1.5 0.8 1.7 2.8 0.0 0.0 2.3 1.8 2.0 0.8 5.0 1.4 0.4 1.6 0.4 0.0 0.9 2.4 2.5 0.5 0.0 0.0 1.0 0.0 0.0 2.5 0.0 1.4 5.2 1.6 6.8 1.8 0.3 4.8 0.5 0.0 5.6 0.6 2.5 0.0 2.2 0.5 1.7 0.6 0.8 0.9 0.6 1.0 MAN1A1 ENSG00000111885 "Mannosidase alpha class 1A member 1" P33908 6 119177209-119349761 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.2" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 149.9;Hepatocytes: 232.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 60.3;Hep G2: 42.3;Karpas-707: 47.2;U-266/70: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037058, HPA053198, HPA063561" Uncertain Supported "Golgi apparatus" NA NA 390000000 "Golgi apparatus" "CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042" "unprognostic (1.50e-1)" "unprognostic (7.36e-3)" "unprognostic (4.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.95e-2)" "unprognostic (2.19e-1)" "unprognostic (3.33e-3)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" "unprognostic (5.11e-2)" "unprognostic (1.68e-3)" "unprognostic (4.62e-1)" "unprognostic (2.37e-2)" "unprognostic (3.49e-2)" "unprognostic (2.25e-1)" "unprognostic (6.89e-2)" "unprognostic (3.40e-1)" 41.8 19.8 5.8 10.5 17.4 8.1 32.2 1.5 7.9 12.3 23.3 3.2 3.6 17.4 11.3 12.0 10.6 9.5 22.0 10.4 5.0 3.3 23.4 74.2 16.4 16.8 2.8 5.7 10.3 22.0 3.4 6.4 26.1 3.7 14.7 9.9 10.5 41.0 5.3 7.1 9.6 36.3 19.7 3.5 20.9 10.0 8.7 3.7 8.8 15.2 10.3 9.1 21.2 36.4 1.4 5.5 6.0 1.1 1.9 4.7 0.6 0.0 0.0 0.7 0.0 60.3 26.7 1.4 1.4 8.8 1.1 2.7 4.1 0.5 9.0 0.0 5.5 14.2 0.1 1.6 0.0 1.4 13.3 4.1 7.5 0.8 42.3 6.0 0.0 3.8 18.2 1.1 9.0 5.5 4.8 0.7 2.6 26.0 47.2 8.5 1.2 0.3 0.0 0.5 4.1 2.1 2.5 0.9 13.6 2.9 7.4 3.0 4.5 0.0 0.1 0.0 1.9 2.2 1.0 5.2 3.7 3.4 6.9 3.3 63.8 9.0 17.8 10.9 0.1 2.2 6.0 0.6 2.0 2.4 1.1 4.7 1.4 1.3 1.3 0.6 0.9 0.8 1.9 3.8 1.9 0.9 5.5 1.4 0.6 5.8 17.4 1.5 7.9 5.0 3.3 2.8 5.7 3.7 3.7 8.9 36.6 18.6 5.7 28.2 18.6 3.9 45.9 8.1 11.4 101.2 0.0 4.7 5.0 5.1 149.9 42.5 42.8 23.3 32.8 8.0 90.1 5.0 3.5 232.5 81.6 0.0 46.1 103.7 76.4 24.4 24.5 57.9 27.0 6.4 55.5 1.3 20.9 14.4 3.9 32.2 4.7 6.5 18.1 2.1 3.9 24.3 5.1 26.1 11.5 7.6 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 122.4" "Cell type enhanced" "Detected in all" 7 "Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" NA NA 1100000 "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: AB_2683419" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favorable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 11.1 9.7 13.9 9.1 15.8 3.8 9.7 11.9 15.2 14.4 10.7 8.5 9.4 8.1 15.8 10.7 11.5 12.2 9.2 11.0 11.2 9.2 11.8 16.4 8.1 9.9 12.0 13.9 11.2 27.4 21.7 9.6 122.4 11.3 11.2 9.5 8.3 11.1 10.5 10.5 7.5 9.0 13.7 10.4 10.4 10.3 10.1 14.4 16.1 19.4 6.9 9.8 13.6 9.8 3.7 4.4 4.0 2.7 6.0 9.8 2.4 14.4 6.3 10.8 9.3 14.2 17.1 34.6 12.0 18.8 5.4 5.1 4.8 8.3 10.8 22.3 15.4 5.1 8.6 5.0 10.2 12.2 13.5 7.6 6.4 8.9 5.3 8.6 10.0 14.8 11.5 11.0 8.3 7.3 10.0 16.1 7.6 10.3 16.7 11.3 28.1 6.1 3.2 5.5 7.3 6.6 5.5 23.5 7.4 7.5 19.7 5.9 8.6 11.9 12.8 9.4 14.7 6.3 6.4 15.3 12.2 10.1 8.6 12.2 11.4 7.7 7.3 16.2 8.0 29.0 1.3 2.7 4.0 5.2 2.1 6.2 3.3 4.3 4.3 2.3 3.7 3.6 5.2 2.1 6.0 1.7 4.4 9.8 2.4 13.9 15.8 11.9 15.2 11.2 9.2 12.0 13.9 11.3 14.4 35.7 30.2 42.7 29.6 27.5 59.3 85.6 35.7 42.8 40.9 41.8 21.6 40.9 14.9 26.4 27.9 33.3 25.6 23.3 52.0 201.3 31.7 37.6 15.1 78.0 25.6 41.3 20.8 34.4 30.7 15.9 49.8 22.8 38.8 12.6 32.4 40.2 36.9 21.0 61.5 21.5 39.0 38.8 29.1 63.9 52.5 30.2 318.2 30.5 26.4 37.2 MAN2A1 "GOLIM7, MANA2" ENSG00000112893 "Mannosidase alpha class 2A member 1" Q16706 5 109689366-109869625 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 88.9;Hepatocytes: 113.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022377, HPA026896" Enhanced Supported "Golgi apparatus" NA NA 70000000 "Golgi apparatus" "CAB022377: , HPA026896: AB_1853512" "unprognostic (1.62e-2)" "unprognostic (4.06e-2)" "unprognostic (1.25e-2)" "unprognostic (6.96e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-2)" "unprognostic (4.20e-2)" "unprognostic (3.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.73e-2)" "unprognostic (1.23e-1)" "unprognostic (6.77e-3)" "unprognostic (2.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.11e-3)" "unprognostic (5.31e-3)" 7.6 17.5 10.9 7.7 21.8 5.7 7.4 1.9 13.2 8.4 11.2 46.8 2.4 17.2 9.2 1.8 7.7 6.2 10.6 4.2 11.7 4.8 9.5 20.7 8.5 7.8 29.9 10.4 7.5 16.7 20.1 3.4 8.7 19.8 4.7 11.9 5.6 9.0 6.0 8.7 7.0 14.4 11.2 23.1 6.9 8.9 7.5 30.6 15.0 9.0 1.8 7.8 10.9 6.2 3.3 2.7 5.8 6.7 0.9 5.5 1.6 7.3 6.8 8.5 3.6 16.4 14.5 32.0 16.4 27.1 9.3 16.9 8.0 11.9 5.3 10.6 21.3 6.5 8.7 4.5 17.0 20.5 5.7 3.5 10.8 5.1 7.3 9.2 4.9 5.9 12.3 7.0 14.9 19.9 11.5 18.4 5.4 2.9 31.1 22.0 3.6 9.1 1.3 6.1 4.9 2.5 3.6 13.3 23.5 7.5 11.7 1.2 1.1 7.7 6.9 4.6 9.6 6.8 4.3 19.6 18.5 8.2 10.0 10.6 16.6 21.5 4.5 14.2 6.3 10.2 5.8 2.9 0.9 3.0 3.8 1.9 3.3 4.5 4.9 2.7 2.9 5.5 4.8 2.1 0.9 6.7 2.5 4.1 1.6 10.9 21.8 1.9 13.2 11.7 4.8 29.9 10.4 19.8 30.6 6.0 6.7 28.2 9.3 15.9 0.2 5.9 40.8 9.4 7.9 29.6 0.0 16.0 1.7 21.5 7.3 22.4 45.5 23.3 30.1 88.9 21.8 26.3 14.0 113.4 16.8 0.0 23.7 41.7 62.5 4.9 9.2 22.8 25.3 25.2 37.1 7.5 30.3 28.1 6.3 21.4 0.3 19.4 16.0 5.5 19.1 20.7 19.8 15.8 41.2 17.8 MANEA "FLJ12838, mandaselin" ENSG00000172469 "Mannosidase endo-alpha" Q5SRI9 6 95577543-95609457 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 53.1;Ito cells: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011046, HPA011069" Enhanced Supported "Golgi apparatus" NA NA 87000 "Golgi apparatus" "HPA011046: AB_1079303, HPA011069: AB_1079304" "unprognostic (6.00e-2)" "unprognostic (7.81e-2)" "prognostic favorable (3.04e-4)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (5.03e-2)" "unprognostic (2.98e-3)" "unprognostic (2.74e-1)" "unprognostic (5.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.44e-1)" "unprognostic (9.07e-2)" "unprognostic (2.86e-3)" "unprognostic (5.18e-2)" "unprognostic (3.08e-1)" "unprognostic (9.68e-2)" "unprognostic (7.47e-2)" 18.0 8.1 6.0 6.7 6.9 2.4 14.4 8.3 6.0 9.6 9.5 5.0 5.8 7.7 7.5 8.2 11.5 7.2 7.1 9.3 6.5 6.2 14.6 44.9 9.8 12.3 8.9 6.7 10.4 8.0 10.9 13.5 7.4 7.8 9.2 8.0 4.5 8.1 7.6 3.8 5.9 9.5 6.0 11.6 13.2 10.7 7.1 6.9 17.9 11.7 5.9 9.7 11.2 7.5 6.6 3.4 8.5 5.7 3.8 10.4 3.3 3.8 3.3 12.5 10.1 20.8 24.5 4.8 10.8 9.9 6.3 9.5 3.7 9.7 7.4 13.5 7.0 9.5 6.4 8.6 7.2 14.5 12.7 7.7 10.0 3.1 6.0 7.2 13.1 8.9 24.2 8.4 7.5 5.3 9.1 14.7 7.7 15.4 17.2 13.4 2.7 7.6 5.6 1.8 10.2 3.3 9.2 12.5 11.0 9.6 6.7 10.1 5.4 6.1 4.4 3.8 9.3 7.0 12.3 13.3 6.3 4.5 11.3 10.6 12.9 7.5 9.2 11.3 11.5 14.3 8.5 3.3 1.9 4.8 5.7 6.8 6.6 5.9 5.5 3.4 3.3 6.9 4.6 0.7 3.8 4.9 1.3 10.4 3.3 6.0 6.9 8.3 6.0 6.5 6.2 8.9 6.7 7.8 6.9 11.9 6.7 4.5 4.6 6.5 8.3 3.2 7.6 10.7 7.9 12.2 3.9 4.5 5.0 3.3 12.0 6.3 2.5 0.0 6.2 4.6 5.2 3.2 2.3 53.1 9.2 11.1 1.7 36.8 9.1 10.0 5.5 6.9 8.5 2.8 4.7 9.1 3.3 3.5 14.9 8.6 4.8 12.9 5.3 6.8 12.5 6.0 1.1 6.4 5.2 3.0 MANEAL FLJ31434 ENSG00000185090 "Mannosidase endo-alpha like" Q5VSG8 1 37793802-37801137 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.6;Horizontal cells: 25.4;Intestinal endocrine cells: 29.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 6 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063423 Approved "Golgi apparatus" "Intracellular and membrane" NA NA 24000 "Golgi apparatus" "HPA063423: AB_2685011" "unprognostic (8.07e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (7.92e-2)" "prognostic favorable (5.28e-4)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.02e-1)" "unprognostic (1.03e-2)" "unprognostic (7.67e-2)" "unprognostic (6.27e-3)" "unprognostic (1.08e-1)" "unprognostic (1.17e-3)" "unprognostic (8.29e-3)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (2.26e-1)" 1.6 9.5 12.3 2.6 15.2 0.4 6.4 11.2 21.7 4.1 7.6 6.6 2.4 4.5 2.6 8.8 4.8 3.8 2.4 1.5 12.0 20.3 3.8 11.4 3.9 1.5 10.4 9.6 1.8 12.8 6.2 16.2 1.3 15.4 5.6 8.2 4.1 4.4 3.8 4.6 5.2 4.4 3.1 6.2 1.9 6.3 3.5 3.8 0.8 7.3 1.8 2.4 2.7 2.1 0.6 0.3 0.1 0.4 0.0 3.6 0.6 8.1 10.4 1.9 20.1 2.6 0.9 18.2 1.5 9.0 7.8 3.4 17.2 19.3 13.5 6.7 1.0 9.3 1.8 3.8 2.0 2.8 16.0 8.2 10.0 9.4 13.7 0.2 14.2 8.3 0.3 10.8 0.4 0.3 11.0 0.2 2.4 5.8 10.8 1.2 16.0 3.9 0.0 6.3 19.4 11.0 6.2 13.8 15.8 4.6 21.6 50.0 15.1 21.9 0.7 8.1 0.4 9.6 1.5 1.2 11.1 6.8 10.7 13.9 15.6 14.7 4.5 1.8 4.7 8.2 0.0 0.0 0.0 1.5 0.1 3.6 0.6 0.7 0.8 0.0 0.6 0.0 1.2 0.1 0.0 0.4 0.3 0.6 0.6 12.3 15.2 11.2 21.7 12.0 20.3 10.4 9.6 15.4 3.8 3.0 2.4 0.8 0.9 0.5 15.6 0.7 2.5 0.0 0.0 3.5 3.9 0.1 0.0 1.5 0.2 0.4 1.1 0.0 5.0 1.3 0.3 1.2 0.0 2.9 0.8 25.4 29.2 0.0 0.3 0.0 0.3 0.2 3.3 0.0 4.5 4.1 3.2 0.0 0.0 0.2 8.4 0.0 0.4 0.0 1.4 0.0 0.1 0.0 3.0 1.1 MANSC4 ENSG00000205693 "MANSC domain containing 4" A6NHS7 12 27762738-27771276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 3.3;testis: 5.9" "Cell type enhanced" "Detected in single" 26 "Cytotrophoblasts: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 13 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "HaCaT: 2.2;HUVEC TERT2: 5.2;PC-3: 2.6;U-2 OS: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039454, HPA039682" Uncertain NA NA "HPA039454: AB_2676515, HPA039682: AB_10805483" "unprognostic (1.13e-1)" "unprognostic (4.74e-2)" "unprognostic (2.34e-2)" "unprognostic (2.75e-2)" "unprognostic (6.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-4)" "unprognostic (1.96e-1)" "unprognostic (2.49e-2)" "unprognostic (2.87e-3)" "unprognostic (2.50e-3)" "unprognostic (7.15e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.21e-1)" "unprognostic (2.10e-2)" 0.1 0.0 0.2 0.6 0.5 0.1 0.5 3.3 0.2 0.2 0.0 0.2 0.5 0.0 0.0 0.2 0.0 0.0 0.2 1.2 0.7 0.0 0.8 1.9 0.1 0.7 0.6 0.0 2.0 2.0 0.2 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.2 0.1 0.1 5.9 0.2 1.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 1.7 0.2 0.1 0.8 0.0 0.1 0.7 0.2 0.8 0.4 0.0 0.0 0.3 1.7 0.3 0.1 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 5.2 0.4 0.3 0.1 0.0 0.0 0.1 0.0 0.5 0.0 2.6 0.2 0.1 0.0 0.0 1.1 0.1 0.0 0.2 0.7 0.0 0.5 0.4 1.0 1.2 0.2 1.9 0.4 0.2 0.5 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 MAOB ENSG00000069535 "Monoamine oxidase B" P27338 X 43766611-43882447 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 104.9" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 111.3;granulocytes: 138.1;Hepatocytes: 197.3;Peritubular cells: 89.5;Proximal tubular cells: 130.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Group enriched" "Detected in some" 7 "Hep G2: 20.6;SiHa: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002328, CAB037200" Enhanced NA NA 3600000 "CAB037200: AB_1841012, HPA002328: AB_1854062" "unprognostic (1.19e-2)" "unprognostic (1.36e-1)" "unprognostic (5.16e-2)" "unprognostic (1.85e-2)" "unprognostic (4.39e-2)" "unprognostic (2.69e-2)" "unprognostic (5.61e-2)" "unprognostic (4.37e-2)" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-2)" "unprognostic (9.74e-2)" "unprognostic (5.35e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (1.90e-3)" 25.0 18.2 24.8 3.9 34.8 0.5 16.5 5.5 24.5 12.0 18.9 20.3 15.6 24.9 38.0 20.0 11.4 34.9 15.4 32.4 21.2 46.9 41.8 104.9 10.9 2.3 24.4 19.9 56.0 4.1 15.6 8.9 9.4 26.8 30.1 6.3 3.0 38.0 55.9 34.8 3.0 30.5 35.9 39.1 1.3 8.4 5.2 21.3 0.2 1.8 8.2 2.8 12.1 8.5 0.0 0.0 0.0 0.1 0.0 1.0 1.2 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 2.7 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 20.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.6 39.9 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.2 24.8 34.8 5.5 24.5 21.2 46.9 24.4 19.9 26.8 21.3 0.0 5.5 0.0 0.4 4.8 1.0 111.3 38.2 21.4 3.4 5.2 3.9 0.3 53.0 15.6 0.1 11.3 8.0 0.0 2.5 0.7 11.2 0.6 138.1 197.3 1.4 14.3 0.0 4.9 4.7 0.4 42.6 1.3 6.8 0.0 2.9 25.5 4.7 8.0 89.5 130.3 0.7 12.9 15.6 0.0 0.1 3.4 0.3 4.3 3.9 0.3 MAP1A MAP1L ENSG00000166963 "Microtubule associated protein 1A" P78559 15 43510958-43531620 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 103.6" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 71.0;Horizontal cells: 282.9;Peritubular cells: 71.8" "Cancer enhanced" "Detected in many" "glioma: 18.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 74 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in single" 74 "dendritic cells: 12.3" "Cell line enhanced" "Detected in many" "ASC diff: 21.8;BJ hTERT+: 21.4;fHDF/TERT166: 32.0;hTEC/SVTERT24-B: 20.4;U-87 MG: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039063, HPA039064, HPA066488" Enhanced Approved Cytosol No No Cytosol "HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-2)" "unprognostic (5.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.65e-2)" "unprognostic (1.13e-3)" "unprognostic (8.36e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (6.59e-5)" "unprognostic (5.83e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (1.09e-5)" "prognostic unfavorable (1.66e-5)" 5.2 7.9 43.6 5.4 42.8 2.5 4.3 24.5 103.6 10.5 5.4 18.3 1.0 3.0 5.6 4.3 4.8 9.1 5.9 14.8 40.9 30.2 2.8 1.9 3.4 2.7 34.7 31.3 7.1 2.7 4.1 4.4 4.4 56.2 6.7 5.3 3.1 2.5 9.6 4.5 3.1 3.2 14.5 21.4 2.6 2.7 5.4 12.6 6.5 3.7 0.1 2.7 6.3 2.8 0.0 12.3 0.0 0.0 0.0 0.1 0.2 0.1 0.8 3.9 2.2 21.8 15.0 0.0 12.5 21.4 3.7 3.6 1.5 0.0 0.0 5.4 32.0 1.1 0.1 5.2 0.0 2.1 1.8 0.5 4.8 1.2 0.1 2.1 0.1 2.0 11.2 0.0 20.4 0.1 5.6 2.7 14.2 7.9 0.1 14.8 0.1 8.7 0.2 2.8 0.0 0.3 2.4 11.3 0.0 0.0 0.0 12.2 3.7 0.4 0.0 0.1 5.4 0.8 0.2 0.5 11.9 4.0 3.9 0.1 0.0 0.5 1.7 43.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.1 0.2 43.6 42.8 24.5 63.1 40.9 30.2 34.7 31.3 56.2 12.6 3.0 0.6 0.0 1.1 4.8 35.3 48.5 0.0 71.0 12.5 3.5 23.6 0.3 0.0 0.4 10.6 4.3 0.0 0.0 0.0 0.6 30.1 0.7 6.9 0.0 1.9 282.9 10.9 4.9 0.8 5.2 47.2 1.4 8.5 0.0 0.0 15.3 1.2 0.0 71.8 0.3 20.6 32.3 49.5 9.2 27.3 3.6 0.9 0.7 0.0 0.5 MAP1B "MAP5, PPP1R102" ENSG00000131711 "Microtubule associated protein 1B" P46821 5 72107234-72209570 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 102.5" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 675.4;Horizontal cells: 611.8;Muller glia cells: 420.2;Rod photoreceptor cells: 440.1;Sertoli cells: 756.7;Smooth muscle cells: 465.8" "Cancer enriched" "Detected in all" 5 "glioma: 48.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "TIME: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009792, HPA022275" Enhanced Supported Enhanced Cytosol NA NA 140000 Cytosol "CAB009792: AB_2137420, HPA022275: AB_1853944" "unprognostic (9.96e-2)" "unprognostic (3.97e-2)" "unprognostic (1.57e-2)" "unprognostic (3.70e-1)" "unprognostic (4.67e-3)" "unprognostic (2.98e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (1.42e-1)" "unprognostic (7.00e-2)" "unprognostic (4.78e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-2)" "unprognostic (1.13e-2)" "unprognostic (1.90e-1)" "unprognostic (1.75e-2)" "prognostic unfavorable (8.22e-5)" 20.3 18.1 27.5 10.2 39.6 1.6 9.3 52.3 101.9 15.3 6.1 21.6 3.5 3.2 9.2 9.8 12.8 7.7 10.7 17.1 37.6 40.7 4.4 3.3 3.7 3.2 42.4 42.5 7.8 4.5 3.0 7.0 9.5 102.5 19.0 6.2 9.4 7.6 24.0 3.6 10.2 3.9 22.9 45.7 2.4 7.2 11.0 11.3 0.0 5.7 0.1 2.6 13.4 5.9 0.2 0.4 0.6 0.0 0.0 0.3 2.1 0.3 12.2 30.7 11.1 19.1 33.5 0.0 6.6 5.1 6.7 8.0 0.1 0.4 0.0 15.8 24.3 20.2 0.1 16.7 0.6 10.1 0.0 2.4 1.3 4.3 4.0 10.2 0.0 1.0 33.6 2.1 26.8 9.9 6.0 20.7 0.0 1.9 0.0 11.3 0.1 0.0 0.0 8.3 0.0 3.9 0.1 3.6 0.0 0.6 0.0 19.9 13.8 6.5 0.0 3.4 26.6 0.0 1.3 64.6 21.2 10.0 15.4 29.6 1.4 0.0 0.0 22.9 0.0 16.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.1 0.2 0.6 0.0 0.0 0.4 0.2 2.1 27.5 39.6 52.3 59.1 37.6 40.7 42.4 42.5 102.5 11.3 0.0 1.3 1.7 41.3 28.0 193.6 258.0 2.5 68.3 19.4 8.7 675.4 1.8 0.0 9.0 10.7 79.8 0.0 0.0 2.9 1.2 236.1 19.8 1.1 0.8 5.2 611.8 74.5 53.4 2.2 10.5 286.8 2.8 75.9 0.0 0.2 420.2 9.6 0.0 361.7 0.8 440.1 756.7 465.8 7.7 4.4 44.3 3.3 0.0 0.0 9.8 MAP1LC3B2 ATG8G ENSG00000258102 "Microtubule associated protein 1 light chain 3 beta 2" A6NCE7 12 116548105-116576448 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "blood: 33.1" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 31.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 11.2" "HPA042824, HPA052474, HPA052484, HPA053767" Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253" "unprognostic (1.50e-1)" "unprognostic (6.94e-2)" "unprognostic (9.14e-2)" "unprognostic (3.89e-3)" "unprognostic (1.62e-1)" "unprognostic (1.22e-1)" "unprognostic (2.43e-3)" "unprognostic (3.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (1.11e-3)" "unprognostic (6.66e-3)" "unprognostic (1.65e-1)" "unprognostic (1.53e-2)" "unprognostic (3.42e-1)" 0.4 3.5 0.4 0.4 0.4 2.0 0.4 0.4 1.8 0.4 0.7 0.4 0.4 2.2 1.0 0.4 0.5 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.0 0.4 0.4 2.6 0.4 0.2 0.4 0.8 0.4 3.9 1.1 0.8 0.6 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.7 0.4 7.0 8.0 33.1 10.1 7.2 11.4 8.5 2.7 0.0 0.7 3.0 0.4 1.5 1.6 3.0 0.6 0.2 0.4 3.7 2.6 0.2 3.7 0.7 2.2 1.6 1.1 0.8 1.2 0.7 0.0 0.0 0.6 3.2 2.3 1.9 1.8 0.4 1.0 2.3 1.9 0.7 0.5 0.3 1.6 4.7 0.7 0.9 1.4 2.9 1.7 0.1 0.7 2.0 0.4 0.6 0.4 1.4 0.9 4.4 1.2 1.1 11.2 0.4 1.5 0.2 0.9 4.1 1.1 3.6 2.6 3.8 3.0 4.7 4.7 1.2 2.4 22.7 9.3 25.1 6.6 8.9 6.2 7.0 7.4 6.3 7.7 6.1 5.1 5.6 33.1 7.2 10.1 8.0 11.4 8.5 0.0 1.7 1.4 17.3 21.5 1.1 31.3 0.0 1.4 3.4 0.0 0.0 2.2 6.6 0.2 9.2 8.2 3.5 0.0 0.0 1.9 8.9 10.1 6.9 1.5 3.9 12.7 1.7 3.1 8.1 13.4 4.4 10.2 10.1 0.0 1.0 0.5 0.3 3.5 3.5 1.3 1.2 0.0 14.4 20.0 8.4 18.7 9.5 6.9 0.8 18.6 MAP1LC3C ATG8J ENSG00000197769 "Microtubule associated protein 1 light chain 3 gamma" Q9BXW4 1 241995490-241999073 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.9" "Cell type enhanced" "Detected in single" 17 "granulocytes: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SuSa: 26.1" "Low region specificity" "Detected in all" HPA072670 Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA072670: AB_2686546" "unprognostic (2.27e-2)" "unprognostic (1.74e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (1.34e-7)" "unprognostic (1.08e-1)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.04e-1)" "unprognostic (2.42e-1)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (2.89e-3)" "unprognostic (6.17e-3)" "unprognostic (1.26e-1)" "unprognostic (8.65e-2)" "unprognostic (7.73e-2)" 12.2 0.8 0.5 1.4 0.7 0.1 13.4 0.5 0.9 0.3 4.4 0.2 0.7 0.4 0.5 1.9 8.9 3.5 1.5 1.8 0.3 0.1 0.7 0.4 9.0 5.4 0.5 0.3 4.4 0.4 0.5 2.0 17.9 0.6 0.7 0.5 4.7 7.8 0.2 5.7 5.5 2.6 0.9 0.9 1.4 4.3 1.2 0.5 0.1 2.3 7.1 5.0 6.5 3.5 1.0 0.8 2.6 2.5 0.4 0.5 0.1 0.1 0.0 5.2 0.0 0.2 5.0 3.3 0.1 0.0 0.2 0.2 0.4 0.0 0.0 3.0 1.4 0.3 0.0 0.1 0.1 0.1 0.0 0.9 0.2 0.2 0.1 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.1 1.6 0.1 0.0 0.0 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 26.1 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.6 0.4 0.4 1.2 0.3 0.6 0.3 0.5 0.2 1.0 0.2 0.4 1.2 0.4 2.5 0.8 0.1 0.1 0.5 0.7 0.5 0.9 0.3 0.1 0.5 0.3 0.6 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 MAP2 "MAP2A, MAP2B, MAP2C" ENSG00000078018 "Microtubule associated protein 2" P11137 2 209424058-209734118 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 122.3" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 824.7;Rod photoreceptor cells: 453.2" "Cancer enhanced" "Detected in many" "glioma: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.6;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 15 "B-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 76.3;NTERA-2: 27.3;SCLC-21H: 38.4;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001984, HPA008273, HPA012558, HPA012828" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946" "unprognostic (2.47e-2)" "unprognostic (2.81e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (1.98e-6)" "unprognostic (2.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (6.06e-2)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (1.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-1)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (7.28e-2)" "unprognostic (4.10e-5)" 4.6 9.2 62.1 2.1 63.1 1.5 4.9 24.7 122.3 4.4 2.5 3.8 0.0 2.0 2.9 4.0 5.6 2.8 6.3 6.2 73.6 53.8 3.9 3.7 9.3 2.4 31.0 48.8 6.4 8.2 12.5 14.7 1.9 35.4 6.5 2.5 7.6 4.9 4.7 2.2 12.1 2.0 3.2 19.9 2.4 2.6 5.4 11.4 0.0 12.2 0.4 2.9 2.8 1.5 3.4 0.1 0.0 0.0 0.0 0.2 0.3 0.6 0.1 76.3 0.0 1.0 0.5 0.0 0.4 0.5 0.1 0.5 0.0 4.0 0.0 0.4 0.9 3.6 1.0 5.9 0.4 0.2 0.0 0.3 0.2 2.4 0.0 9.7 0.0 0.0 0.8 2.4 0.0 1.5 4.4 2.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 27.3 0.1 0.1 0.0 0.1 0.0 1.0 0.0 38.4 21.5 1.6 0.2 0.9 9.4 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.5 0.0 0.0 4.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 62.1 63.1 24.7 79.6 73.6 53.8 31.0 48.8 35.4 11.4 89.3 2.7 0.0 3.1 5.3 111.0 3.6 30.6 1.4 4.5 5.2 824.7 0.3 3.3 19.1 16.8 7.1 0.0 0.0 9.4 0.0 1.9 10.4 1.1 0.0 0.5 31.8 31.2 16.0 3.0 7.5 26.4 0.8 18.6 0.0 0.0 125.4 13.7 0.0 14.5 0.4 453.2 32.3 17.6 3.3 19.9 5.6 0.2 0.0 0.0 0.6 MAP2K6 "MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3" ENSG00000108984 "Mitogen-activated protein kinase kinase 6" P52564 17 69414698-69553861 "Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.9;skeletal muscle: 55.6" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 43.8;Muller glia cells: 32.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 9.3;neutrophil: 19.3;plasmacytoid DC: 31.9" "Group enriched" "Detected in all" 9 "dendritic cells: 31.9;granulocytes: 19.3;monocytes: 9.3" "Cell line enhanced" "Detected in many" "A549: 24.4;AN3-CA: 13.3;HUVEC TERT2: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007744, HPA031134" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB007744: AB_562318, HPA031134: AB_10603016" "prognostic favorable (2.27e-6)" "unprognostic (2.24e-1)" "unprognostic (8.46e-2)" "unprognostic (4.10e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.61e-3)" "unprognostic (9.52e-2)" "unprognostic (3.67e-1)" "unprognostic (4.09e-3)" "prognostic favorable (7.52e-4)" "unprognostic (3.61e-2)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (9.43e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-2)" 4.5 2.0 3.2 8.6 5.9 10.1 14.0 13.7 7.5 19.8 21.5 6.2 4.7 7.2 4.7 3.1 3.4 3.3 5.1 2.5 3.9 3.5 4.1 8.6 2.6 10.3 5.4 4.1 2.7 8.5 0.0 3.2 1.1 5.3 2.8 22.8 5.3 4.0 4.6 55.6 2.3 7.3 2.3 6.2 5.9 5.4 2.1 5.4 13.7 2.8 4.8 5.1 3.0 2.5 2.3 31.9 19.3 9.3 1.8 2.1 2.6 0.1 24.4 11.0 13.3 4.7 2.6 1.6 0.1 3.6 1.0 1.5 0.7 1.1 0.6 9.0 0.5 0.8 1.2 3.8 0.5 0.3 0.8 2.0 0.1 6.9 6.8 4.7 1.0 1.0 12.1 0.3 0.3 0.0 1.0 17.5 3.3 0.0 1.7 0.0 0.1 12.7 0.5 7.8 0.5 4.5 4.6 1.1 0.3 4.9 3.4 4.9 7.4 1.0 0.9 2.2 6.1 3.4 1.3 3.1 1.3 1.6 1.1 0.4 1.2 1.3 0.3 1.0 1.5 1.0 0.8 9.3 1.6 1.2 1.1 2.1 1.6 1.4 1.5 2.9 2.3 1.6 1.5 19.3 1.8 0.4 31.9 1.9 2.6 3.2 5.9 13.7 7.5 3.9 3.5 5.4 4.1 5.3 5.4 3.0 7.9 4.7 3.2 2.4 4.9 1.4 2.5 6.7 5.7 0.0 2.0 7.5 19.9 1.2 8.5 2.4 17.0 0.0 3.6 5.4 2.8 1.9 1.1 2.0 5.1 3.2 43.8 4.9 8.9 1.9 4.0 7.0 3.3 0.0 22.4 32.9 1.2 8.6 3.5 1.1 3.8 0.0 3.1 0.0 0.2 3.8 0.7 11.5 23.7 2.3 MAP3K10 "MEKK10, MLK2, MST" ENSG00000130758 "Mitogen-activated protein kinase kinase kinase 10" Q02779 19 40191744-40215575 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 13.9;Horizontal cells: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007039 Approved Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Actin filaments, Cytosol" "HPA007039: AB_1079357" "unprognostic (2.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-3)" "unprognostic (2.03e-2)" "unprognostic (2.04e-1)" "prognostic favorable (8.69e-4)" "unprognostic (4.50e-3)" "unprognostic (1.80e-1)" "unprognostic (3.94e-2)" "unprognostic (6.13e-2)" "unprognostic (1.34e-3)" "unprognostic (4.62e-3)" "unprognostic (6.88e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-2)" "unprognostic (4.77e-3)" "prognostic favorable (2.13e-4)" 7.7 7.0 29.6 4.7 22.8 3.7 2.2 14.3 32.0 3.3 3.4 5.3 1.8 4.4 4.5 1.8 3.7 3.1 4.0 8.2 28.2 11.2 4.7 2.1 4.2 4.6 11.5 9.4 4.3 8.1 4.7 5.2 3.7 9.0 4.6 2.0 2.4 6.9 4.8 22.9 5.6 5.0 4.0 5.3 6.7 6.2 6.6 7.1 2.3 3.3 2.6 2.4 3.8 5.4 0.8 0.0 0.0 0.2 0.0 0.9 0.0 6.3 7.6 2.4 5.6 2.2 1.3 6.5 4.4 2.2 2.0 2.1 1.7 1.8 5.8 4.6 1.5 5.1 2.1 0.9 2.3 0.3 11.0 7.2 1.5 3.2 1.7 4.2 1.3 3.7 1.2 5.5 2.2 1.5 2.3 1.9 8.2 5.5 9.9 0.6 3.8 4.8 2.3 2.8 2.1 5.0 5.9 2.5 3.4 1.8 4.0 7.9 11.4 5.1 1.9 10.4 1.5 2.5 2.3 3.1 5.4 5.2 7.8 8.5 13.1 7.5 2.6 6.2 2.4 7.8 0.0 0.1 0.0 0.4 0.2 0.0 0.8 0.2 0.9 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 29.6 22.8 14.3 28.7 28.2 11.2 11.5 9.4 9.0 7.1 0.0 0.0 2.2 1.5 1.3 13.9 2.4 0.0 0.0 0.0 7.0 7.9 0.6 0.0 2.3 2.6 2.3 2.6 0.0 3.6 0.7 1.9 2.0 0.0 2.6 2.2 22.3 4.1 3.7 2.2 6.5 2.8 1.1 1.7 1.0 1.9 5.2 3.4 1.9 4.6 3.7 7.3 6.5 2.6 2.6 1.7 2.4 1.1 1.9 2.1 1.7 MAP3K11 "MEKK11, MLK3, PTK1, SPRK" ENSG00000173327 "Mitogen-activated protein kinase kinase kinase 11" Q16584 11 65597755-65615382 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 75.8" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 120.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010165 Approved Supported "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "CAB010165: AB_631936" "unprognostic (8.36e-2)" "unprognostic (1.17e-2)" "unprognostic (1.06e-1)" "unprognostic (9.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.87e-1)" "unprognostic (7.56e-3)" "unprognostic (3.10e-2)" "unprognostic (4.50e-2)" "unprognostic (4.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.77e-2)" "unprognostic (3.13e-2)" "unprognostic (2.01e-2)" "unprognostic (7.62e-2)" "unprognostic (1.95e-1)" "unprognostic (8.27e-3)" 23.2 10.8 11.4 23.7 21.2 14.2 27.4 7.9 13.8 8.6 15.8 29.8 6.1 31.9 11.0 8.1 14.7 11.6 12.0 11.6 13.3 8.1 16.1 31.2 21.1 14.4 30.9 8.2 8.4 12.5 8.3 10.3 14.7 16.7 13.4 8.2 15.4 13.5 9.5 11.9 13.7 31.9 8.6 17.7 28.8 16.9 8.6 19.0 8.9 13.6 7.6 12.7 8.9 75.8 2.3 7.6 13.8 12.0 1.8 3.5 5.6 16.7 14.8 8.0 8.5 2.6 3.2 8.2 6.5 4.6 7.8 5.3 14.8 16.3 6.3 24.1 5.1 11.4 14.7 4.8 7.0 2.9 13.9 6.1 17.8 10.1 17.7 7.1 10.2 26.9 5.1 6.8 5.8 5.3 8.3 21.8 7.3 7.7 12.7 4.1 20.8 11.9 19.2 8.8 11.2 19.0 19.8 5.2 12.8 7.4 14.6 7.3 8.2 7.7 22.2 38.1 4.2 17.7 16.6 24.4 12.0 13.0 17.5 11.5 8.1 9.2 5.6 14.0 11.8 27.8 4.3 7.7 9.2 2.4 12.0 2.4 2.0 2.6 3.5 7.6 2.3 2.0 1.5 13.8 1.8 11.7 2.3 1.4 5.6 11.4 21.2 7.9 13.8 13.3 8.1 30.9 8.2 16.7 19.0 20.8 19.7 19.7 21.8 18.7 22.9 9.6 17.8 5.3 6.8 10.4 23.6 21.6 16.6 18.8 9.8 69.5 120.7 23.3 23.8 13.7 11.6 23.2 25.4 45.6 44.4 17.5 40.3 49.7 42.7 44.8 8.9 39.8 20.3 37.9 41.8 14.5 24.8 77.2 6.0 21.1 53.6 32.3 11.2 11.4 13.6 26.2 28.7 21.2 36.5 30.8 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039936: AB_10795239, HPA071996: AB_2686481" "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favorable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavorable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.0 4.4 6.8 26.4 14.1 0.5 4.7 8.9 5.2 5.3 0.1 0.8 1.5 2.7 5.1 4.2 0.0 2.0 3.1 2.1 2.3 2.4 1.7 3.6 0.0 25.2 0.0 1.7 25.1 2.3 7.1 3.7 33.3 8.1 3.5 0.0 7.5 4.9 3.0 1.7 0.3 1.5 0.0 2.6 2.4 2.9 0.4 2.6 0.0 4.4 6.0 2.5 3.2 6.7 1.0 2.2 4.4 5.9 5.0 5.4 2.3 1.2 3.0 3.4 0.0 8.1 3.0 4.9 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 6.0 13.4 5.6 1.9 0.7 26.7 0.7 10.2 8.1 11.4 1.8 35.3 1.6 8.3 5.4 1.2 3.7 4.6 0.0 1.6 1.8 3.8 2.7 12.7 7.7 3.6 28.6 3.4 7.4 12.7 1.4 7.5 5.9 0.0 7.2 2.5 17.4 4.5 2.6 7.8 7.0 81.9 6.5 4.9 2.3 1.9 0.9 1.8 7.5 3.5 2.0 MAP3K15 "ASK3, bA723P2.3, FLJ16518" ENSG00000180815 "Mitogen-activated protein kinase kinase kinase 15" Q6ZN16 X 19360056-19515261 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 17.3;brain: 13.2" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.9;Cardiomyocytes: 2.5;Collecting duct cells: 5.2;Cone photoreceptor cells: 3.9;Distal tubular cells: 3.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "pons and medulla: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;HAP1: 7.9;HEK 293: 6.7;JURKAT: 3.9;REH: 4.1;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA004006 Approved Vesicles NA NA Vesicles "HPA004006: AB_1079358" "unprognostic (2.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.21e-2)" "unprognostic (6.56e-8)" "unprognostic (3.47e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-3)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-2)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (2.77e-3)" "unprognostic (4.00e-1)" "unprognostic (2.37e-1)" "unprognostic (3.98e-2)" "unprognostic (8.20e-2)" 0.1 17.3 0.5 0.4 0.3 0.5 0.1 2.3 0.1 0.1 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.5 3.6 0.1 0.5 0.0 0.1 0.0 1.3 4.1 0.4 5.7 0.0 13.2 0.1 0.0 4.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.6 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.4 0.0 7.9 0.0 0.0 1.3 6.7 2.7 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.0 0.2 0.0 2.1 2.0 0.0 0.8 4.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.3 0.1 0.4 0.5 0.1 0.0 13.2 0.0 0.0 1.9 0.0 0.6 0.1 0.6 2.5 0.0 0.0 0.0 5.2 3.9 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.6 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 MAP3K19 "FLJ23074, RCK, YSK4" ENSG00000176601 "Mitogen-activated protein kinase kinase kinase 19" Q56UN5 2 134964491-135047468 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.3;fallopian tube: 23.9" "Group enriched" "Detected in some" 5 "Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.8" "Region enhanced" "Detected in many" "pons and medulla: 18.3" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 6 "dendritic cells: 1.5" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.1;U-266/70: 2.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 20.2" HPA011388 Uncertain Cytosol NA NA Cytosol "HPA011388: AB_1848822" "unprognostic (7.12e-3)" "unprognostic (6.55e-3)" "unprognostic (6.96e-2)" "unprognostic (3.90e-3)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (1.96e-1)" "unprognostic (9.38e-2)" "unprognostic (1.09e-1)" "unprognostic (4.33e-1)" "unprognostic (2.02e-2)" "unprognostic (1.32e-1)" "unprognostic (4.04e-6)" "unprognostic (1.50e-1)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (2.83e-4)" 0.1 0.2 1.7 0.2 6.2 0.1 0.1 0.0 0.5 1.1 0.2 7.3 0.0 0.2 1.0 6.7 0.2 23.9 0.1 0.1 2.9 3.8 0.2 0.2 5.6 0.2 0.5 1.5 7.3 0.1 0.1 1.0 0.1 18.3 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.2 7.6 3.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 4.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.7 6.2 0.0 0.5 2.9 3.8 0.5 1.5 18.3 3.1 0.0 0.6 0.0 0.0 0.0 0.2 0.4 0.0 151.3 17.0 0.0 9.8 0.0 0.0 0.0 55.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.0 0.0 0.0 0.0 0.1 MAP3K20 "MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK" ENSG00000091436 "Mitogen-activated protein kinase kinase kinase 20" Q9NYL2 2 173075435-173268010 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 96.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 35.7;Alveolar cells type 2: 51.9;Cytotrophoblasts: 48.5;Ductal cells: 34.2;Pancreatic endocrine cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 13.7" "Group enriched" "Detected in many" 5 "dendritic cells: 13.7;monocytes: 8.0" "Cell line enhanced" "Detected in many" "hTERT-HME1: 44.9;U-138 MG: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017205 Approved Supported Cytosol NA NA Cytosol "HPA017205: AB_1858933" "unprognostic (2.90e-2)" "unprognostic (9.99e-3)" "unprognostic (4.63e-3)" "unprognostic (1.98e-1)" "unprognostic (7.63e-2)" "unprognostic (5.02e-2)" "unprognostic (2.34e-2)" "unprognostic (3.89e-3)" "unprognostic (2.83e-2)" "unprognostic (9.27e-2)" "unprognostic (4.54e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.41e-6)" "unprognostic (2.34e-1)" "unprognostic (1.86e-1)" "unprognostic (2.23e-1)" "unprognostic (1.19e-2)" 21.7 5.0 2.9 7.4 3.3 0.8 9.2 2.8 3.1 25.7 24.8 2.1 10.7 3.1 30.2 15.4 26.2 13.1 14.9 52.5 3.5 3.0 2.4 8.5 7.5 2.5 4.5 3.0 21.7 4.4 22.6 3.1 6.9 4.2 25.6 5.4 11.5 6.7 15.8 96.1 5.8 8.0 68.4 4.7 3.7 15.8 6.6 3.5 2.8 6.7 38.0 4.9 46.7 24.0 2.1 13.7 2.3 8.0 0.4 1.6 2.7 8.9 7.5 5.9 7.8 17.3 25.8 3.7 32.3 25.3 15.1 16.3 5.1 5.9 6.9 8.5 32.3 13.3 6.1 8.8 17.1 34.1 13.4 5.9 11.2 8.5 1.0 6.9 10.0 11.9 20.7 7.4 28.4 44.9 12.6 10.0 7.6 5.0 1.3 9.9 3.8 6.3 5.0 3.3 7.5 4.3 9.3 12.1 0.0 3.7 5.1 3.5 3.4 12.4 3.0 5.3 10.1 3.4 5.4 10.0 48.3 19.8 14.3 7.3 0.0 0.0 1.4 34.7 2.7 5.0 0.1 8.0 0.0 0.9 7.5 0.9 1.5 0.8 1.6 13.7 2.1 0.0 0.8 2.3 0.4 6.6 0.3 0.7 2.7 2.9 3.3 2.8 3.1 3.5 3.0 4.5 3.0 4.2 3.5 35.7 51.9 0.0 0.0 0.0 0.0 0.0 0.0 24.1 13.6 10.4 0.0 48.5 1.7 34.2 0.0 0.0 0.0 0.0 23.2 22.4 0.0 0.0 4.7 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 27.1 0.0 0.0 31.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 MAP3K21 "KIAA1804, MLK4" ENSG00000143674 "Mitogen-activated protein kinase kinase kinase 21" Q5TCX8 1 233327768-233385148 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 28.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.0" "Cell line enhanced" "Detected in many" "HEK 293: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007636 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007636: AB_1079392" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.42e-3)" "unprognostic (4.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.82e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (8.21e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (1.71e-1)" "unprognostic (9.22e-2)" "unprognostic (4.84e-2)" 0.6 3.2 2.0 3.4 2.2 1.3 2.2 10.0 3.3 1.5 11.4 0.6 9.1 9.9 0.8 5.2 2.4 3.9 3.9 0.7 1.3 2.1 12.5 13.3 5.6 0.5 0.9 1.7 0.8 28.9 4.4 2.6 1.0 1.2 1.3 6.0 1.0 3.7 2.5 0.4 2.7 17.2 0.3 0.9 0.7 10.1 12.4 0.6 0.5 2.4 0.8 1.3 1.1 1.6 0.5 0.8 0.1 0.3 5.0 0.2 0.1 7.4 12.7 0.2 0.0 0.0 0.0 6.4 0.2 0.0 0.3 0.5 7.0 6.5 0.7 5.2 0.1 2.4 4.0 9.5 3.9 0.8 13.8 18.3 0.1 7.1 0.0 0.5 12.1 2.9 0.1 5.2 0.2 7.4 1.4 0.4 5.8 0.1 2.4 0.0 1.6 3.8 4.3 9.1 8.7 5.6 0.0 0.0 13.3 8.8 3.1 9.4 2.5 4.3 0.2 0.0 1.0 3.7 3.9 0.0 0.0 1.2 0.0 7.4 2.3 2.9 0.0 1.2 3.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.8 0.5 0.0 0.0 0.1 5.0 0.0 0.2 0.2 0.1 2.0 2.2 10.0 3.3 1.3 2.1 0.9 1.7 1.2 0.6 32.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 14.0 0.0 0.0 3.3 9.7 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 7.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAP3K5 "ASK1, MAPKKK5, MEKK5" ENSG00000197442 "Mitogen-activated protein kinase kinase kinase 5" Q99683 6 136557047-136792518 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007824, HPA063245" Supported Supported Cytosol NA NA Cytosol "CAB007824: AB_598175, HPA063245: AB_2684969" "unprognostic (1.37e-1)" "unprognostic (3.21e-2)" "unprognostic (2.85e-2)" "unprognostic (1.38e-1)" "unprognostic (3.19e-1)" "prognostic favorable (6.08e-4)" "unprognostic (8.76e-2)" "unprognostic (1.41e-2)" "unprognostic (2.84e-1)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.91e-4)" "unprognostic (3.97e-1)" "unprognostic (3.75e-2)" "unprognostic (1.37e-1)" "unprognostic (2.72e-1)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 7.7 55.6 13.0 7.5 17.6 7.6 5.5 12.9 12.7 4.0 5.4 6.9 3.6 4.6 7.2 5.1 6.4 6.1 4.9 7.3 11.8 6.8 6.8 5.5 7.7 8.8 8.2 6.4 32.4 28.2 1.5 9.9 3.4 7.9 11.6 6.2 5.8 4.2 4.9 3.7 5.0 4.6 4.3 7.5 9.8 8.7 7.3 8.6 2.0 10.0 3.4 9.0 10.8 18.9 2.5 2.5 8.5 3.0 4.1 7.0 1.4 2.9 1.8 0.0 0.0 4.2 11.3 1.0 4.2 22.7 2.2 2.1 0.1 3.0 1.7 6.2 5.8 1.6 4.0 7.2 2.1 5.7 2.3 5.7 15.0 4.0 0.0 20.1 6.9 0.0 14.8 2.8 3.4 9.8 8.4 7.3 2.1 3.7 16.8 15.3 5.6 0.1 5.9 0.7 5.7 2.4 3.9 4.8 6.8 8.8 18.6 5.3 3.5 3.5 3.4 0.9 0.8 0.7 6.2 6.3 3.6 1.1 0.2 3.9 13.7 9.1 0.0 2.8 9.8 3.2 5.7 3.0 3.3 2.7 2.3 4.9 2.0 4.3 3.7 2.5 2.5 0.4 1.4 8.5 4.1 2.1 2.4 7.0 1.4 13.0 17.6 12.9 9.4 11.8 6.8 8.2 6.4 7.9 8.6 6.0 22.4 10.4 17.9 4.4 17.5 21.8 2.5 16.0 34.2 10.4 5.9 0.7 3.3 2.1 4.9 3.8 7.7 0.0 19.7 0.9 5.1 22.3 5.7 9.6 7.1 0.0 33.5 9.8 22.1 2.3 21.9 18.4 0.0 1.0 12.1 42.4 18.9 5.8 13.4 6.8 2.5 12.9 8.0 1.4 15.0 8.8 2.3 6.9 10.0 19.3 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27355184-27366892 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 63.9" "Cell type enhanced" "Detected in many" 4 "Ito cells: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: AB_2681380" "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.13e-4)" "prognostic favorable (7.26e-4)" "prognostic unfavorable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 37.5 6.3 7.4 6.9 8.6 1.3 22.1 12.6 8.3 19.9 9.0 2.7 8.9 3.3 13.1 10.3 25.7 12.8 12.4 14.9 6.2 2.6 13.6 5.0 21.7 5.5 11.4 1.9 11.7 8.3 8.2 15.8 7.3 9.8 13.9 5.9 15.7 11.5 9.7 6.3 63.9 6.2 16.0 11.7 8.7 9.0 6.7 7.0 0.6 12.0 16.1 14.3 14.3 18.3 2.7 3.3 5.1 6.9 1.1 7.6 2.4 7.5 7.0 6.3 7.0 8.8 15.4 1.6 9.4 5.4 7.1 5.4 2.1 10.2 0.1 8.4 14.2 2.8 11.9 2.1 6.5 3.6 6.2 5.2 0.5 16.2 3.1 2.7 0.5 0.6 12.4 16.1 7.4 2.6 7.9 4.8 0.5 2.3 4.1 11.3 18.7 0.3 8.6 2.0 7.5 5.8 2.7 4.2 1.7 10.6 7.9 2.3 3.5 9.9 8.7 7.4 2.7 4.6 6.4 9.9 17.9 7.5 19.9 4.9 3.4 4.2 0.1 15.8 6.1 5.2 1.8 1.5 5.1 5.3 3.3 7.6 2.7 5.5 5.9 3.3 2.3 4.4 3.6 2.4 1.1 6.9 0.0 5.6 2.4 7.4 8.6 12.6 8.3 6.2 2.6 11.4 1.9 9.8 7.0 17.9 16.2 4.7 10.4 11.1 0.5 8.9 10.2 1.4 11.4 3.5 0.0 0.9 3.3 2.3 0.4 15.8 1.7 0.0 3.8 1.7 7.7 7.3 2.3 0.8 2.5 4.8 0.0 28.8 12.5 1.1 15.0 5.1 5.0 13.6 4.9 5.2 8.9 0.0 14.2 1.5 0.4 6.5 10.5 8.7 2.1 12.9 0.1 10.2 4.3 14.4 MAP3K7CL "C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4" ENSG00000156265 "MAP3K7 C-terminal like" P57077 21 29077471-29175889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.9;skeletal muscle: 50.4;tongue: 28.8" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 17.1;Sertoli cells: 19.4;Smooth muscle cells: 26.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 7.6;granulocytes: 12.0;monocytes: 5.7" "Cell line enhanced" "Detected in many" "HBF TERT88: 17.4;LHCN-M2: 18.5;RH-30: 74.0" "HPA030079, HPA042439" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030079: AB_2673299, HPA042439: AB_10794422" "unprognostic (2.23e-1)" "unprognostic (2.06e-1)" "unprognostic (9.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.98e-2)" "unprognostic (7.00e-3)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.93e-2)" "unprognostic (1.28e-3)" "unprognostic (4.39e-3)" "prognostic unfavorable (8.31e-6)" "unprognostic (2.68e-3)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (8.10e-2)" 6.9 5.1 1.6 4.6 2.2 1.4 2.5 1.2 1.7 4.0 4.6 2.4 1.7 0.9 8.6 11.7 3.4 3.0 5.2 16.2 1.4 1.9 4.4 3.2 6.6 5.2 1.8 1.9 4.7 4.3 2.5 2.9 1.7 2.7 4.4 1.8 2.4 1.8 2.6 50.4 2.7 3.1 3.8 3.1 3.9 1.7 3.2 1.4 2.3 2.7 28.8 7.8 3.6 2.1 7.6 0.8 12.0 5.7 0.6 1.5 37.9 0.9 0.2 0.1 0.3 0.1 5.7 0.1 1.3 3.7 3.4 9.3 1.5 0.4 8.0 0.5 5.3 0.1 0.0 0.1 4.2 17.4 1.6 0.0 0.8 0.6 0.1 0.8 0.0 0.0 2.0 8.1 11.9 11.3 1.7 0.6 0.2 0.5 3.3 18.5 0.2 0.1 0.0 0.4 0.7 0.3 0.0 74.0 0.2 0.5 0.2 0.5 0.3 0.0 0.0 0.4 1.5 0.0 0.4 0.6 7.3 6.2 1.6 0.2 1.4 0.2 0.3 1.1 0.6 1.5 12.0 5.7 1.1 0.6 4.2 1.5 7.6 0.4 0.6 0.7 5.3 0.7 1.1 8.6 0.6 1.9 0.8 1.1 37.9 1.6 2.2 1.2 1.7 1.4 1.9 1.8 1.9 2.7 1.4 0.0 4.0 3.7 5.5 7.6 2.3 1.4 2.5 1.4 0.0 0.0 2.0 0.2 0.0 1.1 1.1 3.6 1.3 0.0 1.4 0.2 3.4 3.0 1.1 4.0 3.3 0.0 4.6 1.3 17.1 0.6 0.6 5.5 5.0 1.8 2.2 1.3 2.6 2.9 4.2 2.1 1.2 19.4 26.7 1.1 1.4 8.3 0.3 2.6 1.3 2.1 MAP3K8 "c-COT, COT, EST, ESTF, MEKK8, Tpl-2" ENSG00000107968 "Mitogen-activated protein kinase kinase kinase 8" P41279 10 30433937-30461833 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 104.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 133.3;Urothelial cells: 168.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005120, HPA017962" Supported Supported Cytosol NA NA Cytosol "CAB005120: AB_2140669, HPA017962: AB_1853776" "unprognostic (1.91e-2)" "unprognostic (2.94e-1)" "unprognostic (3.07e-1)" "unprognostic (9.29e-2)" "unprognostic (6.73e-2)" "unprognostic (1.00e-2)" "unprognostic (1.44e-1)" "unprognostic (3.36e-2)" "unprognostic (1.41e-2)" "unprognostic (8.04e-3)" "unprognostic (8.23e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (8.76e-7)" "unprognostic (1.88e-1)" "unprognostic (1.49e-1)" "unprognostic (1.63e-2)" "unprognostic (5.98e-3)" 28.0 7.6 3.6 15.6 4.1 104.6 26.1 1.5 2.6 8.2 8.4 2.7 11.3 3.4 11.5 16.5 13.8 19.5 15.3 20.1 4.3 2.9 6.3 7.6 29.0 33.7 4.3 2.0 9.8 3.6 2.8 4.1 27.5 8.3 7.9 6.8 9.4 6.1 18.4 8.6 15.3 9.6 23.4 9.7 25.6 10.7 6.7 3.6 2.4 7.0 13.2 17.2 13.2 15.6 19.6 13.8 23.7 16.8 12.4 7.8 4.0 8.0 7.2 2.0 4.2 10.5 8.8 9.3 2.0 12.1 4.5 5.4 5.0 18.8 5.3 5.2 4.3 4.4 15.2 4.5 1.9 1.6 12.3 2.3 9.9 12.3 16.0 8.9 3.1 24.4 11.0 1.1 4.5 0.9 4.5 2.0 0.1 4.4 8.0 0.7 4.6 0.1 11.8 0.7 4.3 2.6 0.6 1.6 3.0 4.4 16.4 0.2 0.8 7.2 6.2 0.9 5.7 2.1 6.6 0.1 2.8 2.4 9.9 0.3 12.1 11.3 1.6 4.0 13.4 0.1 17.9 7.0 23.7 7.8 12.0 4.3 9.6 1.7 4.9 6.6 19.6 0.1 3.0 16.7 12.4 16.8 13.8 0.4 4.0 3.6 4.1 1.5 2.6 4.3 2.9 4.3 2.0 8.3 3.6 35.7 41.7 14.7 46.9 103.8 13.9 7.1 5.1 25.4 13.6 3.5 0.0 23.9 1.7 25.2 0.4 36.9 5.2 0.0 9.8 71.1 77.1 32.5 71.4 3.0 109.0 0.0 11.5 14.1 86.6 0.0 7.8 94.5 40.5 78.5 5.3 5.0 17.6 17.5 3.9 2.4 1.1 6.5 75.4 0.0 0.7 74.2 133.3 52.3 5.8 168.4 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 28.6;Urothelial cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.5 2.2 5.8 2.0 9.2 1.4 2.8 20.1 16.5 2.4 3.1 1.8 0.4 3.0 1.1 3.4 10.1 2.2 1.5 1.2 5.7 7.1 3.1 2.4 3.9 2.6 5.9 5.9 1.4 4.3 6.8 4.7 2.8 12.8 2.0 3.1 3.1 3.2 1.3 1.9 7.8 2.9 0.7 1.6 1.9 3.4 10.1 1.8 0.6 5.3 3.2 6.8 2.0 3.9 2.3 0.5 1.3 0.2 1.1 1.4 0.3 18.1 8.4 1.6 2.0 0.0 0.0 5.6 0.4 0.2 1.7 1.6 6.0 7.0 3.7 2.5 0.1 3.7 8.6 5.3 10.2 1.9 2.4 1.5 0.2 2.9 4.0 0.3 0.4 0.8 0.1 5.6 1.2 10.6 3.1 0.0 3.3 1.3 0.8 0.4 7.3 2.8 0.4 3.5 7.2 3.9 1.0 3.2 0.7 3.9 8.3 11.6 2.5 5.2 6.2 1.0 3.2 5.6 0.6 0.0 0.0 7.4 0.0 2.8 1.9 4.4 1.9 2.8 0.3 1.1 0.5 0.2 0.8 0.6 0.1 0.1 1.0 0.6 1.0 0.0 2.3 1.0 0.7 1.3 1.1 0.2 0.5 1.4 0.3 5.8 9.2 20.1 16.5 5.7 7.1 5.9 5.9 12.8 1.8 6.0 14.9 0.9 10.9 7.7 15.8 1.8 15.3 0.0 10.3 7.0 11.8 2.5 1.7 5.5 13.2 0.7 3.1 0.0 4.0 1.3 0.8 9.0 1.1 4.9 1.0 28.6 8.1 0.6 0.8 15.9 0.6 1.4 3.3 0.0 3.4 3.4 7.4 3.5 0.0 1.9 12.3 0.0 1.0 5.4 8.5 8.0 3.3 2.9 5.0 25.4 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 131.5;skeletal muscle: 197.9" "Group enriched" "Detected in many" 6 "Bipolar cells: 398.9;Cardiomyocytes: 855.4;Cone photoreceptor cells: 589.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Enhanced "Plasma membrane,Microtubules,Cytosol" NA NA 120000 "Plasma membrane, Microtubules, Cytosol" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 39.3 14.8 60.5 18.2 50.9 6.3 16.4 29.3 56.0 26.9 26.4 80.8 15.8 13.6 25.8 27.4 27.0 24.6 20.1 110.2 63.7 57.5 20.8 13.8 22.7 12.4 86.8 26.1 26.8 18.9 14.6 9.3 24.0 59.5 21.8 18.8 25.2 14.0 34.9 197.9 25.1 15.2 35.0 131.5 18.3 16.2 21.2 41.8 7.3 15.4 31.3 14.2 24.3 18.1 9.9 8.9 6.3 19.7 10.7 13.4 6.7 22.2 17.9 22.4 17.0 33.1 59.1 9.5 41.8 45.7 35.4 39.8 15.0 14.0 18.9 9.8 63.0 33.3 14.9 28.6 37.9 39.8 27.2 12.1 12.7 20.0 19.4 45.0 8.8 10.4 49.4 47.4 43.0 52.7 32.3 46.4 13.3 16.4 22.0 27.8 12.6 12.5 10.8 13.5 11.0 37.0 6.7 21.1 23.4 22.7 18.7 8.9 13.9 32.1 13.0 22.1 32.8 9.5 8.2 62.6 33.5 25.9 35.0 26.7 15.4 11.9 8.9 43.1 10.9 31.6 6.3 5.3 2.8 13.4 9.0 6.5 9.9 9.0 10.9 5.7 9.4 4.3 6.7 2.2 10.7 19.7 8.9 10.2 6.7 60.5 50.9 29.3 51.8 63.7 57.5 86.8 26.1 59.5 41.8 65.5 44.5 28.6 38.3 66.4 398.9 855.4 48.4 45.5 70.5 76.8 589.0 27.7 23.2 85.7 90.1 78.7 34.2 0.0 56.1 64.5 84.5 58.1 26.6 49.9 34.2 44.5 27.6 41.1 23.5 28.8 71.4 40.8 74.2 101.8 29.5 77.6 76.7 23.0 96.9 27.0 86.7 71.1 108.8 53.1 49.0 60.9 18.8 48.4 33.0 40.0 MAP4K1 HPK1 ENSG00000104814 "Mitogen-activated protein kinase kinase kinase kinase 1" Q92918 19 38587641-38618882 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2" "Cell type enhanced" "Detected in many" 14 "B-cells: 29.0;Rod photoreceptor cells: 58.2;T-cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 20.8;HDLM-2: 20.6;Karpas-707: 21.4;REH: 11.4;RPMI-8226: 12.9;U-266/70: 16.9;U-266/84: 16.6;U-698: 26.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA007419, CAB007754" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB007754: AB_562299, HPA007419: AB_1853778" "unprognostic (1.99e-3)" "prognostic favorable (6.17e-5)" "unprognostic (9.50e-3)" "unprognostic (3.27e-1)" "unprognostic (6.03e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.88e-3)" "unprognostic (5.32e-3)" "unprognostic (2.79e-1)" "unprognostic (2.51e-1)" "unprognostic (3.92e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (7.99e-10)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (3.18e-2)" "unprognostic (1.50e-2)" 1.6 0.9 1.2 31.4 2.3 6.3 1.1 1.0 1.2 1.0 3.1 1.7 0.1 2.1 0.9 1.4 2.6 1.2 2.9 0.9 1.1 1.4 2.2 1.6 3.9 23.0 2.3 0.7 0.8 1.2 0.2 1.2 1.4 2.1 1.6 1.9 2.0 4.4 0.8 0.5 1.2 16.9 0.7 3.4 34.4 2.3 0.9 1.3 19.1 1.9 1.4 39.2 3.1 1.3 16.2 15.9 1.3 6.2 3.7 14.6 7.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 20.6 0.1 4.4 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.1 21.4 0.0 0.1 4.9 5.2 0.6 0.1 0.0 11.4 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 4.7 0.0 0.0 0.1 0.0 0.0 16.9 16.6 26.2 0.0 5.9 0.0 1.3 3.2 1.2 13.4 6.2 12.4 16.2 11.2 14.0 15.9 10.7 6.2 8.7 0.3 3.7 3.4 14.0 14.6 7.3 1.2 2.3 1.0 1.2 1.1 1.4 2.3 0.7 2.1 1.3 3.0 8.2 29.0 0.1 2.1 6.1 0.6 0.0 0.0 1.2 0.0 11.8 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.2 1.0 0.3 15.1 0.0 2.5 1.6 0.0 1.3 7.1 0.0 0.0 11.7 3.3 2.8 0.0 6.7 0.0 0.0 0.0 0.2 58.2 0.0 0.4 0.6 4.3 0.9 0.1 33.2 0.2 0.1 MAP4K4 "FLH21957, HGK, NIK" ENSG00000071054 "Mitogen-activated protein kinase kinase kinase kinase 4" O95819 2 101696850-101894689 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 81.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008476 Uncertain NA NA "HPA008476: AB_1079362" "unprognostic (6.40e-2)" "unprognostic (1.09e-2)" "unprognostic (4.01e-1)" "unprognostic (1.89e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-2)" "unprognostic (2.83e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (4.29e-2)" "unprognostic (9.79e-2)" "unprognostic (2.22e-3)" "unprognostic (8.65e-2)" "prognostic unfavorable (3.62e-6)" "unprognostic (6.67e-3)" "unprognostic (8.98e-2)" "unprognostic (3.15e-1)" "unprognostic (7.14e-3)" 27.0 5.0 68.3 21.1 56.3 32.1 35.2 14.5 50.4 13.2 7.8 47.5 2.1 5.4 14.6 6.7 18.5 8.6 18.0 22.2 70.5 40.5 6.3 16.8 13.2 25.8 65.3 21.5 12.6 8.3 9.5 4.3 25.1 40.2 7.6 9.6 6.1 7.7 5.7 16.1 8.7 6.5 14.8 81.2 11.7 11.0 20.3 49.1 13.2 8.3 6.6 29.6 13.5 16.3 4.6 6.3 14.4 3.4 1.1 3.7 1.5 19.1 14.6 31.2 14.9 29.6 53.1 39.2 24.4 20.1 21.8 18.0 24.0 25.5 27.9 21.2 36.4 6.4 7.9 9.8 21.5 21.9 37.4 6.7 20.9 11.0 62.8 25.0 9.9 0.9 47.6 9.8 53.8 24.1 21.9 56.7 15.8 13.5 0.0 57.3 10.4 23.1 6.2 15.8 7.3 23.2 28.0 21.3 0.1 14.5 6.7 12.2 20.4 16.8 0.0 18.2 30.1 3.9 18.1 71.2 43.4 18.6 12.5 29.0 0.0 0.0 17.0 28.0 12.7 31.7 6.9 3.3 0.0 2.4 3.4 1.8 3.5 3.3 1.7 1.1 4.6 2.5 2.7 14.4 1.1 3.0 6.3 3.7 1.5 68.3 56.3 14.5 38.9 70.5 40.5 65.3 21.5 40.2 49.1 17.9 22.9 29.6 34.7 26.7 120.4 66.8 25.5 14.7 36.4 17.4 47.1 11.0 0.0 53.8 23.8 54.9 6.3 0.0 45.6 16.9 45.6 49.1 22.1 38.2 32.1 33.4 16.7 59.5 23.4 28.3 50.9 37.5 18.6 87.4 12.9 60.6 85.8 13.1 16.3 4.4 7.3 51.8 51.5 20.6 82.8 21.5 6.5 25.3 12.4 35.8 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669120 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.9" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 77.0;Cone photoreceptor cells: 149.2;Horizontal cells: 47.7" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 24 "B-cells: 2.4" "Group enriched" "Detected in some" 6 "AF22: 19.5;CACO-2: 19.0;HDLM-2: 10.6;SCLC-21H: 32.4;SH-SY5Y: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326" "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favorable (3.41e-4)" "prognostic favorable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 3.0 16.6 23.7 2.1 26.4 0.6 2.6 14.9 35.9 6.9 6.4 10.0 6.1 1.9 10.0 18.6 4.2 34.6 5.8 5.4 21.3 26.6 7.3 1.3 6.5 1.1 17.0 19.9 7.1 3.4 28.7 24.9 1.8 33.2 12.9 3.6 7.5 2.9 18.7 1.1 2.4 2.0 11.5 13.7 1.7 3.6 12.4 9.9 0.0 6.2 0.0 1.0 2.6 3.1 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 19.5 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.0 19.0 0.0 0.3 0.7 3.1 0.6 0.0 1.7 0.2 0.0 10.6 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.2 0.0 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 32.4 16.4 2.3 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.7 26.4 14.9 29.1 21.3 26.6 17.0 19.9 33.2 9.9 3.0 3.0 0.0 1.3 0.7 77.0 7.6 2.5 28.1 4.5 10.4 149.2 0.1 1.7 0.1 21.3 0.7 0.0 0.0 0.2 0.0 0.8 1.6 0.0 0.4 0.1 47.7 12.6 0.6 0.0 31.1 6.9 0.0 5.0 0.0 0.0 16.8 0.3 0.0 17.3 0.8 8.8 0.0 2.3 20.6 1.9 0.4 0.0 0.0 0.0 0.5 MAP6D1 "FLJ12748, SL21" ENSG00000180834 "MAP6 domain containing 1" Q9H9H5 3 183815876-183825594 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 48.1;skeletal muscle: 33.5" "Cell type enhanced" "Detected in some" 5 "Early spermatids: 2.4;Glandular cells: 2.6;Intestinal endocrine cells: 2.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 2.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.7" "Cell line enriched" "Detected in many" 5 "T-47d: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037991 Enhanced Supported Approved Cytosol NA NA Cytosol "HPA037991: AB_10672503" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-1)" "unprognostic (1.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (8.81e-12)" "unprognostic (1.08e-1)" "unprognostic (2.96e-3)" "unprognostic (1.86e-1)" "unprognostic (5.72e-2)" 1.1 1.2 11.8 1.5 16.0 1.1 2.0 30.9 32.1 1.5 1.4 48.1 0.0 1.9 1.4 2.0 1.1 1.5 1.3 1.9 18.8 9.2 1.2 1.3 1.4 1.7 24.7 8.7 1.7 6.0 1.8 0.5 1.3 18.4 2.7 1.4 0.0 1.6 2.0 33.5 4.6 1.5 1.4 37.7 1.5 1.2 1.3 20.4 2.2 1.1 0.0 1.4 1.1 0.2 0.5 0.3 0.2 0.2 0.0 2.7 0.3 1.9 1.4 2.2 0.4 0.5 0.7 1.7 2.4 0.4 4.6 3.1 1.8 0.1 0.2 3.1 3.6 2.3 1.4 4.5 1.2 3.1 1.3 6.8 0.2 0.0 0.0 1.3 2.4 0.8 0.3 0.3 1.1 0.4 0.6 0.9 3.6 0.3 0.0 0.6 8.4 5.9 3.4 2.0 1.1 3.9 2.9 3.4 0.0 0.2 0.0 7.2 1.3 1.8 1.3 2.5 1.6 39.9 2.4 0.4 1.1 1.6 1.6 3.5 1.5 0.9 1.1 0.3 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.5 2.7 0.3 0.0 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.3 11.8 16.0 30.9 19.9 18.8 9.2 24.7 8.7 18.4 20.4 0.0 0.0 0.0 0.5 1.0 2.2 1.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.4 0.5 2.6 0.0 0.0 0.8 1.6 2.4 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.4 1.7 1.3 0.6 0.0 0.3 0.6 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.4" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 301.8;Early spermatids: 212.6;Horizontal cells: 287.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 21.8;HeLa: 26.0;MCF7: 32.0;OE19: 20.1;RT4: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favorable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.2 6.8 24.1 3.6 41.3 3.4 10.4 36.9 29.3 5.2 18.5 49.8 6.0 21.8 2.1 15.7 11.9 7.9 6.5 1.5 30.7 18.3 25.3 13.3 5.5 1.3 47.6 16.5 1.5 19.0 18.9 13.8 5.3 26.2 15.8 18.0 6.6 14.0 8.2 1.1 13.0 19.7 2.1 55.4 1.5 14.4 17.1 52.7 0.4 12.6 4.3 3.9 6.3 6.0 1.6 5.9 13.0 2.8 0.7 0.6 0.7 9.2 14.4 0.1 0.0 0.1 0.1 15.3 0.2 0.4 0.1 0.2 21.8 9.8 0.0 2.0 0.3 2.5 14.1 4.1 12.8 0.2 0.0 9.1 9.6 26.0 0.1 0.1 9.3 1.1 0.0 11.9 0.0 0.9 0.3 0.1 0.7 6.5 0.2 0.0 32.0 0.1 0.9 1.9 20.1 2.1 0.0 0.3 1.7 8.9 25.1 9.2 1.9 10.1 19.4 0.2 3.6 7.7 0.9 0.2 0.0 0.7 0.1 0.6 1.7 2.2 0.0 0.2 3.7 0.2 3.0 2.6 0.0 0.0 1.7 0.3 1.6 0.6 0.0 5.9 1.2 0.1 0.0 13.0 0.7 2.8 0.0 0.2 0.7 24.1 41.3 36.9 29.3 30.7 18.3 47.6 16.5 26.2 52.7 53.6 37.7 2.9 34.7 25.0 301.8 2.2 22.9 77.6 53.4 17.4 137.4 27.7 26.6 30.3 212.6 2.8 55.1 0.0 42.3 19.5 2.8 61.3 0.0 30.9 12.9 287.6 112.9 1.3 3.2 27.4 6.4 5.9 16.9 1.8 75.1 52.0 32.2 46.0 3.2 70.8 107.3 19.4 5.2 36.1 19.0 26.6 63.7 2.1 55.9 54.6 MAP7D1 "FLJ10350, FLJ39022, PARCC1, RPRC1" ENSG00000116871 "MAP7 domain containing 1" Q3KQU3 1 36155579-36180849 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 144.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028075 Approved Approved Microtubules,Cytosol NA NA "Microtubules, Cytosol" "HPA028075: AB_10603778" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (5.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.49e-6)" "unprognostic (6.00e-3)" "unprognostic (2.05e-1)" "unprognostic (3.57e-2)" "unprognostic (1.88e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (8.56e-6)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (9.32e-3)" 39.4 12.8 25.4 24.4 27.8 19.4 17.4 26.4 44.7 11.2 24.0 32.4 4.6 12.4 16.6 5.5 25.9 10.6 18.4 51.7 25.1 22.5 7.4 4.9 21.3 14.7 31.2 24.1 10.2 10.0 8.3 12.2 15.4 30.8 18.4 7.1 10.2 11.0 19.5 144.7 20.9 10.9 21.1 40.7 17.8 14.2 6.7 22.8 14.9 10.5 18.6 11.5 22.8 12.4 0.4 0.8 4.7 1.4 0.4 1.9 0.2 29.2 17.2 27.1 17.1 16.6 12.6 20.0 29.4 29.9 31.0 27.4 9.6 30.2 12.3 25.3 26.6 17.0 32.2 11.1 39.9 10.2 20.9 9.9 8.3 12.9 3.6 26.2 12.3 21.5 22.0 11.4 41.8 26.0 24.1 21.1 17.3 8.0 19.0 17.1 5.9 22.6 10.4 24.7 4.1 9.7 23.5 20.0 11.6 15.7 10.1 10.5 20.2 16.9 9.4 22.8 15.3 6.2 8.7 39.6 36.6 27.9 30.9 39.7 18.9 5.6 14.3 31.4 8.4 21.9 0.5 1.4 1.4 1.1 0.7 1.5 0.1 1.0 0.8 0.6 0.4 1.9 0.6 4.7 0.4 0.5 0.8 0.3 0.2 25.4 27.8 26.4 43.8 25.1 22.5 31.2 24.1 30.8 22.8 41.7 15.6 16.1 127.0 127.2 31.7 140.8 17.8 0.0 13.6 22.7 9.8 41.0 14.9 35.7 29.9 48.9 40.4 0.0 23.7 93.6 61.5 85.8 12.7 8.6 62.7 46.1 9.7 27.0 38.3 58.1 28.4 52.1 30.4 27.9 12.4 29.4 46.9 17.5 44.9 9.2 38.5 19.4 64.5 7.6 15.3 124.0 108.9 52.3 17.2 165.9 MAP7D2 FLJ14503 ENSG00000184368 "MAP7 domain containing 2" Q96T17 X 20006713-20116917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.8;epididymis: 38.7" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 80.1;Spermatocytes: 34.1;Spermatogonia: 117.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "basophil: 5.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 8.8;CACO-2: 12.7;HEK 293: 17.4;HeLa: 15.1;Hep G2: 7.5;SCLC-21H: 20.0;SiHa: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051508, HPA059537" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051508: AB_2681513, HPA059537: AB_2684054" "unprognostic (1.51e-1)" "unprognostic (9.19e-2)" "unprognostic (3.76e-1)" "unprognostic (1.45e-5)" "unprognostic (5.65e-2)" "unprognostic (9.77e-3)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (5.95e-2)" "unprognostic (7.77e-3)" "unprognostic (3.58e-4)" "unprognostic (2.21e-2)" "prognostic unfavorable (7.27e-5)" "unprognostic (9.12e-3)" "unprognostic (3.60e-2)" "unprognostic (2.54e-3)" "unprognostic (3.19e-1)" 0.7 3.6 11.1 0.9 18.5 1.3 1.0 12.9 30.8 0.7 1.3 0.8 0.7 1.3 1.2 38.7 0.9 3.0 1.1 0.9 16.5 10.3 4.1 0.7 0.9 0.8 10.4 15.0 0.8 1.7 0.7 3.0 8.1 24.2 1.5 1.5 0.8 0.8 2.8 1.0 1.5 1.8 1.0 7.1 0.7 8.9 9.7 2.1 0.0 0.6 0.0 0.9 0.7 0.5 0.0 0.8 5.5 0.1 0.0 0.3 0.0 0.0 8.8 0.8 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.1 12.7 0.3 1.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 17.4 0.0 15.1 7.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.5 0.6 0.0 0.2 0.0 0.0 1.0 0.0 20.0 3.4 8.5 3.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 1.0 0.0 0.9 5.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 11.1 18.5 12.9 21.7 16.5 10.3 10.4 15.0 24.2 2.1 3.0 0.0 0.0 0.4 1.5 29.4 1.1 0.0 9.4 1.2 0.0 2.0 80.1 3.3 1.1 10.2 0.5 2.0 0.0 0.7 5.5 1.0 0.6 0.0 0.0 5.1 17.5 9.2 0.0 0.0 16.3 0.6 0.7 0.0 0.0 0.3 1.9 0.6 3.2 1.8 13.3 7.3 0.0 0.1 34.1 117.0 1.4 25.6 0.0 1.4 0.4 MAP9 "ASAP, FLJ21159" ENSG00000164114 "Microtubule associated protein 9" Q49MG5 4 155342658-155376970 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3;parathyroid gland: 43.5" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 153.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 25.3" "Low region specificity" "Detected in all" NA NA "unprognostic (8.00e-2)" "unprognostic (1.60e-1)" "unprognostic (6.53e-2)" "unprognostic (6.11e-2)" "unprognostic (2.11e-1)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.01e-1)" "unprognostic (7.58e-2)" "unprognostic (2.98e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-1)" "unprognostic (4.39e-2)" "unprognostic (2.48e-2)" "unprognostic (1.04e-1)" "unprognostic (4.05e-2)" "unprognostic (9.54e-2)" 3.5 5.1 8.9 3.3 16.3 1.6 3.9 7.5 19.0 5.4 3.8 2.2 7.2 1.1 6.5 6.7 2.8 8.3 6.8 5.7 8.9 13.3 8.4 0.9 4.3 2.7 11.2 10.3 5.5 4.8 43.5 25.7 4.4 31.3 10.9 1.8 3.3 2.5 8.0 0.6 0.8 1.9 5.1 7.6 2.1 5.2 10.2 4.8 1.6 12.9 0.4 2.2 3.7 2.4 6.7 4.1 0.2 0.6 1.3 4.6 0.9 0.0 5.9 6.5 5.6 7.0 8.4 1.3 6.5 5.9 3.9 3.4 0.0 0.0 4.2 8.8 4.8 14.8 0.0 6.7 7.0 6.4 0.0 5.6 2.7 0.0 0.0 5.2 0.0 0.0 7.0 3.9 5.4 3.4 11.9 0.0 1.7 0.0 0.0 4.4 2.6 4.9 0.0 5.0 2.1 7.7 0.0 0.0 0.1 13.1 5.1 9.0 25.3 0.0 11.3 0.3 4.4 9.2 0.0 0.9 5.3 9.7 0.1 4.8 5.3 0.0 4.7 15.3 0.0 8.4 0.0 0.0 0.0 4.6 0.6 3.7 5.1 2.6 4.1 0.1 6.7 2.4 3.1 0.2 1.3 0.0 4.1 1.5 0.9 8.9 16.3 7.5 19.0 8.9 13.3 11.2 10.3 31.3 4.8 14.9 34.9 7.3 12.6 1.1 63.8 29.9 12.7 153.9 33.0 24.4 74.6 6.3 28.2 28.3 18.9 1.8 0.0 0.0 14.0 3.1 16.6 12.2 2.3 0.4 0.9 68.3 20.3 3.1 0.0 9.8 42.3 1.5 5.0 1.8 0.5 56.8 16.1 0.0 46.3 28.0 88.8 12.9 21.6 66.1 49.5 1.0 1.9 11.4 0.6 2.2 MAPK1 "ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2" ENSG00000100030 "Mitogen-activated protein kinase 1" P28482 22 21754500-21867680 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003995, CAB004229, HPA005700, HPA030069" Approved NA NA 250000 "CAB004229: AB_627547, HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035" "unprognostic (9.41e-3)" "unprognostic (2.68e-1)" "unprognostic (2.50e-3)" "unprognostic (4.17e-1)" "unprognostic (4.44e-3)" "unprognostic (1.72e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (2.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.58e-1)" "unprognostic (8.43e-3)" "unprognostic (1.04e-1)" "unprognostic (1.35e-2)" "unprognostic (2.08e-1)" "unprognostic (1.94e-1)" "unprognostic (1.41e-1)" "unprognostic (6.49e-2)" 16.1 21.1 32.9 18.3 80.3 20.2 13.6 31.0 54.5 18.6 18.5 23.2 9.6 13.7 17.4 10.6 25.7 16.9 14.9 22.8 32.4 23.4 21.7 16.4 19.9 16.6 18.4 23.6 16.0 19.8 27.4 10.9 17.2 27.6 16.4 19.9 14.2 15.8 17.8 28.2 17.5 15.1 22.8 20.4 19.8 17.2 24.2 21.5 19.5 23.0 11.1 21.4 17.7 15.3 2.5 3.2 13.5 4.9 7.0 13.7 2.5 19.7 12.5 16.1 9.2 19.1 19.2 6.1 21.8 20.4 19.6 19.0 9.9 10.5 10.9 10.9 29.2 18.0 18.8 18.9 17.4 25.6 44.0 17.7 19.8 11.7 11.6 15.7 27.8 20.6 14.3 14.0 23.7 21.9 15.4 26.7 11.9 81.1 12.5 23.9 8.1 18.0 6.1 6.1 26.8 12.3 19.8 39.7 2.9 11.2 16.2 13.1 7.3 23.6 14.2 12.7 16.7 10.7 9.4 23.3 16.4 21.4 18.8 13.8 12.0 14.6 17.0 15.5 13.6 17.7 1.0 4.0 5.8 13.7 4.6 3.9 2.0 2.9 4.9 3.2 2.5 2.8 5.1 13.5 7.0 4.9 3.2 2.7 2.5 32.9 80.3 31.0 54.5 32.4 23.4 18.4 23.6 27.6 21.5 44.7 30.2 28.0 22.1 53.3 23.8 34.6 63.7 21.4 33.0 48.8 51.1 18.0 16.6 24.0 33.2 31.2 46.6 23.3 33.6 18.2 31.5 37.5 93.2 59.4 47.7 27.0 57.3 57.7 88.6 9.9 30.2 59.7 38.8 15.4 44.2 32.3 39.5 28.8 41.8 37.6 21.0 32.3 32.2 70.0 47.7 54.1 16.0 95.8 30.7 34.8 MAPK10 "JNK3, p493F12, p54bSAPK, PRKM10" ENSG00000109339 "Mitogen-activated protein kinase 10" P53779 4 85990007-86594625 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.3" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 92.3;Early spermatids: 179.3;Late spermatids: 303.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "AF22: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022625 Approved NA NA "CAB022625: " "unprognostic (2.46e-2)" "unprognostic (4.36e-2)" "unprognostic (1.13e-1)" "unprognostic (4.05e-2)" "unprognostic (5.17e-2)" "unprognostic (2.03e-1)" "unprognostic (4.59e-2)" "unprognostic (4.82e-2)" "unprognostic (3.81e-2)" "unprognostic (4.45e-2)" "unprognostic (1.18e-3)" "unprognostic (3.02e-2)" "prognostic favorable (3.11e-4)" "unprognostic (1.92e-2)" "unprognostic (1.44e-1)" "unprognostic (6.22e-3)" "prognostic favorable (5.57e-4)" 17.2 11.9 31.6 3.7 34.5 9.7 6.2 26.1 58.3 11.4 4.0 12.6 8.1 3.2 11.0 14.2 7.4 11.9 10.4 5.1 36.0 28.6 15.0 2.7 6.5 3.9 31.5 36.4 11.3 5.6 10.9 31.5 3.4 37.9 16.6 4.3 5.4 3.4 18.9 2.0 3.5 3.9 11.4 23.1 5.3 4.3 18.2 15.8 0.0 15.3 0.4 3.6 11.1 10.2 3.7 3.0 6.9 1.8 3.3 3.6 2.3 1.1 2.0 60.3 1.9 1.7 1.4 2.3 1.2 1.1 1.0 0.5 1.1 1.8 2.6 2.0 0.7 1.5 3.7 0.6 1.6 1.7 3.8 1.6 2.2 2.4 1.9 1.4 1.0 1.2 1.6 0.8 1.4 1.9 2.1 1.3 1.8 1.9 9.9 0.7 1.6 1.7 1.1 3.5 0.3 1.2 1.9 1.5 0.9 4.3 6.4 3.6 3.3 1.2 4.9 0.8 2.0 3.5 1.3 2.8 2.6 2.7 1.1 1.0 3.2 1.9 1.7 3.8 1.3 1.4 6.9 1.8 3.3 2.3 1.6 2.4 3.7 1.9 2.5 1.6 3.3 2.7 3.6 6.2 3.3 1.5 3.0 2.7 2.3 31.6 34.5 26.1 58.3 36.0 28.6 31.5 36.4 37.9 15.8 20.8 26.0 0.0 12.6 0.7 19.8 0.8 12.7 92.3 15.9 21.0 5.9 0.3 10.0 2.1 179.3 1.1 0.0 0.0 0.0 0.5 1.5 10.1 2.3 0.0 0.2 36.5 2.4 1.8 0.3 303.7 24.5 2.5 1.7 0.0 0.0 16.4 1.7 0.0 51.6 16.2 10.2 6.5 2.0 8.8 2.2 0.9 0.1 0.0 0.0 17.9 MAPK12 "ERK6, p38gamma, PRKM12, SAPK-3, SAPK3" ENSG00000188130 "Mitogen-activated protein kinase 12" P53778 22 50245450-50261825 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "skeletal muscle: 104.2" "Cell type enhanced" "Detected in many" 8 "Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "NK-cell: 3.0" "Lineage enriched" "Detected in single" 31 "NK-cells: 3.0" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 35.4" "Low region specificity" "Detected in all" "CAB025483, HPA054562" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB025483: , HPA054562: AB_2682524" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (4.53e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (6.35e-3)" "unprognostic (3.90e-3)" "unprognostic (3.16e-2)" "unprognostic (6.02e-2)" "unprognostic (5.70e-2)" "unprognostic (3.48e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.00e-6)" "unprognostic (2.57e-1)" "unprognostic (8.88e-2)" "unprognostic (1.11e-2)" "unprognostic (4.28e-3)" 3.0 1.6 4.5 2.1 4.5 1.0 1.8 9.0 7.0 2.1 1.4 2.1 1.6 2.0 5.4 5.1 3.3 2.9 2.4 5.1 3.9 3.6 2.5 1.0 2.1 2.0 3.5 5.7 3.0 1.4 1.2 7.0 2.3 2.6 2.9 1.1 2.2 1.4 3.7 104.2 0.9 1.5 4.2 2.6 1.6 1.5 1.6 2.4 0.0 1.3 10.8 1.1 2.4 1.9 0.0 0.0 0.0 0.0 3.0 0.0 0.0 10.4 6.4 2.5 7.5 5.7 6.3 3.5 8.0 6.9 13.4 8.5 9.3 3.3 19.6 10.9 8.8 8.0 7.0 11.1 1.6 2.6 5.6 15.6 12.8 19.5 11.5 18.1 12.0 25.4 13.5 2.9 3.0 0.0 7.3 15.2 1.8 11.3 18.2 6.2 5.7 0.0 16.0 7.5 3.5 10.5 18.3 6.7 19.9 7.9 1.4 8.6 2.9 6.2 0.2 9.9 1.9 3.4 14.0 7.9 13.9 12.5 3.0 5.0 4.2 3.2 10.5 3.5 11.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 4.5 4.5 9.0 7.0 3.9 3.6 3.5 5.7 2.6 2.4 0.0 5.6 1.3 0.4 0.7 5.1 7.8 2.5 1.4 0.0 0.0 0.0 0.3 1.7 0.4 0.3 9.5 0.0 0.0 0.0 1.8 2.8 3.0 10.4 1.0 4.9 1.6 1.7 22.1 2.8 1.3 6.1 0.8 0.0 1.0 0.0 5.1 0.6 0.0 3.5 6.5 1.7 6.5 2.4 0.2 9.7 0.5 0.3 1.0 0.2 0.0 MAPK15 "ERK7, ERK8" ENSG00000181085 "Mitogen-activated protein kinase 15" Q8TD08 8 143716259-143722458 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;epididymis: 27.6;fallopian tube: 29.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 85.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA002704 Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA002704: AB_1079307" "unprognostic (9.11e-2)" "unprognostic (1.38e-1)" "unprognostic (8.04e-3)" "unprognostic (2.94e-1)" "unprognostic (2.54e-2)" "unprognostic (1.14e-2)" "unprognostic (1.22e-1)" "unprognostic (6.09e-2)" "unprognostic (2.59e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-1)" "unprognostic (9.51e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (5.78e-1)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" 0.6 0.1 3.6 0.3 8.1 0.1 1.1 0.2 2.1 4.5 0.4 8.7 5.2 0.5 2.2 27.6 1.3 29.5 0.4 1.1 5.4 4.6 3.9 0.2 7.4 0.5 0.2 1.5 4.7 2.0 9.1 4.2 0.6 26.9 0.9 0.4 1.6 3.0 2.4 0.2 4.9 0.7 0.5 0.4 0.5 0.9 7.3 2.4 0.1 8.4 0.5 0.4 0.5 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.7 0.0 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.2 7.2 0.0 1.3 0.0 0.0 5.4 0.1 0.2 0.0 1.1 1.6 0.0 14.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.3 2.7 0.0 0.0 13.9 0.0 0.0 2.0 1.2 1.1 0.0 3.0 0.4 0.9 1.3 4.0 4.0 0.0 2.8 0.0 0.2 12.5 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 8.1 0.2 2.1 5.4 4.6 0.2 1.5 26.9 2.4 0.0 8.3 0.0 0.2 0.3 0.0 0.8 0.0 85.6 13.6 0.0 0.0 0.0 0.0 0.6 12.6 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.7 0.3 0.1 0.0 0.1 0.0 MAPK4 "Erk3-related, Erk4, PRKM4" ENSG00000141639 "Mitogen-activated protein kinase 4" P31152 18 50560078-50731824 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 20.1;Early spermatids: 20.2;Late spermatids: 42.4;Muller glia cells: 55.0" "Group enriched" "Detected in many" 5 "glioma: 15.2;melanoma: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.0;HeLa: 4.5;NTERA-2: 3.0;SCLC-21H: 15.7;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007461 Approved "Nucleoplasm,Golgi apparatus,Midbody" NA NA "Nucleoplasm, Golgi apparatus" Midbody "HPA007461: AB_1079308" "unprognostic (4.12e-2)" "unprognostic (3.24e-2)" "unprognostic (3.60e-1)" "unprognostic (1.42e-3)" "unprognostic (5.17e-2)" "unprognostic (1.84e-2)" "unprognostic (6.32e-2)" "unprognostic (2.08e-2)" "unprognostic (8.24e-2)" "unprognostic (1.61e-1)" "unprognostic (4.38e-3)" "unprognostic (2.16e-1)" "unprognostic (3.44e-7)" "unprognostic (1.96e-4)" "unprognostic (5.99e-4)" "unprognostic (2.31e-2)" "unprognostic (1.82e-1)" 1.9 26.4 16.9 1.1 33.4 0.9 1.8 15.9 23.9 1.4 2.6 9.5 3.8 1.6 1.8 4.5 3.5 1.5 3.0 16.9 13.0 14.3 4.5 7.0 3.5 0.9 17.1 9.1 4.2 2.5 43.5 8.3 3.7 20.5 5.3 1.8 4.1 1.8 12.4 1.7 1.0 1.9 5.2 11.8 1.1 1.3 3.5 12.4 1.7 7.8 0.0 0.9 2.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 1.5 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.9 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 15.7 3.8 0.1 1.1 2.6 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 33.4 15.9 14.5 13.0 14.3 17.1 9.1 20.5 12.4 8.9 0.0 0.0 0.1 0.0 11.0 20.1 2.5 0.0 0.0 0.0 0.0 3.6 5.0 1.0 20.2 0.0 0.0 0.0 0.0 0.3 0.4 0.8 0.0 0.8 0.3 4.8 0.0 0.0 0.0 42.4 0.9 0.0 0.0 0.0 0.0 55.0 0.5 0.0 1.4 0.0 0.6 0.0 1.0 0.6 0.6 0.0 1.5 0.0 0.0 0.0 MAPK8IP1 "IB1, JIP-1, JIP1, PRKM8IP" ENSG00000121653 "Mitogen-activated protein kinase 8 interacting protein 1" Q9UQF2 11 45885651-45906465 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.5" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 38.7;Horizontal cells: 63.5;Intestinal endocrine cells: 38.7" "Cancer enhanced" "Detected in all" "glioma: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058921, HPA070332, HPA079657" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: " "unprognostic (3.96e-2)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (6.88e-2)" "unprognostic (5.59e-2)" "unprognostic (2.82e-1)" "unprognostic (8.25e-3)" "unprognostic (3.42e-3)" "unprognostic (1.27e-2)" "unprognostic (9.54e-2)" "unprognostic (3.22e-3)" "unprognostic (2.20e-2)" "prognostic favorable (1.23e-11)" "unprognostic (7.19e-2)" "unprognostic (4.01e-2)" "unprognostic (4.46e-2)" "unprognostic (1.80e-3)" 3.0 12.8 33.3 2.1 29.6 1.4 2.7 24.9 73.5 3.1 1.9 4.6 0.1 1.6 4.9 3.1 2.1 6.6 3.0 2.9 38.1 22.3 5.1 2.7 2.6 1.0 28.0 18.9 4.4 26.4 14.7 24.8 1.6 23.5 4.9 1.5 4.5 4.8 5.0 1.7 1.7 2.0 4.4 44.4 1.7 3.8 10.8 4.8 0.0 3.9 0.5 0.9 2.0 0.4 0.4 0.4 2.1 0.9 2.6 0.2 0.0 0.0 3.6 4.8 13.3 1.8 0.9 0.1 2.6 2.3 5.1 3.7 3.1 0.5 0.2 1.3 2.9 8.7 2.9 5.1 2.4 2.3 1.9 6.6 0.0 4.5 2.0 1.6 0.3 2.3 1.3 0.5 3.3 0.7 3.4 1.1 0.5 5.5 0.8 1.4 1.9 0.2 0.3 12.7 1.6 5.3 0.3 7.9 0.1 2.3 0.1 39.4 14.7 4.2 3.5 4.8 1.9 5.6 0.2 1.0 6.5 10.0 9.7 4.6 0.5 0.6 0.2 4.1 0.1 1.9 2.1 0.9 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.4 0.1 0.2 1.8 2.6 0.0 0.4 0.1 0.0 33.3 29.6 24.9 41.7 38.1 22.3 28.0 18.9 23.5 4.8 6.0 2.6 0.0 5.9 2.2 33.1 1.1 5.1 2.7 3.4 10.4 21.6 1.2 11.6 5.6 38.7 2.2 1.3 0.0 24.7 0.4 3.9 7.7 0.0 4.0 0.4 63.5 38.7 0.0 0.6 29.6 5.8 1.7 3.3 2.8 1.1 30.4 17.1 0.0 6.0 7.0 15.7 0.0 5.8 12.5 5.5 0.9 4.8 1.0 0.9 5.4 MAPK8IP2 "IB2, JIP2, PRKM8IPL" ENSG00000008735 "Mitogen-activated protein kinase 8 interacting protein 2" Q13387 22 50600685-50613981 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 48.9" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 49.4;Horizontal cells: 93.8;Intestinal endocrine cells: 31.0;Rod photoreceptor cells: 23.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 22.4;HEK 293: 7.7;SCLC-21H: 15.4;SH-SY5Y: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034780 Uncertain NA NA "HPA034780: AB_10670283" "unprognostic (7.82e-2)" "unprognostic (7.62e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (5.80e-2)" "unprognostic (6.72e-2)" "unprognostic (1.18e-1)" "unprognostic (2.90e-1)" "unprognostic (5.23e-2)" "unprognostic (9.19e-2)" "unprognostic (8.57e-3)" "unprognostic (8.78e-3)" "unprognostic (6.33e-3)" "unprognostic (6.77e-2)" "unprognostic (1.72e-1)" "unprognostic (5.29e-2)" "unprognostic (4.75e-2)" 1.9 8.4 12.2 0.9 14.5 0.6 1.9 13.4 48.9 3.0 2.0 2.1 0.0 1.3 1.6 0.8 2.3 1.7 0.7 2.0 12.0 1.3 2.0 1.8 1.8 0.7 1.4 19.0 4.7 3.1 2.4 4.1 1.2 20.1 1.9 0.9 0.9 4.3 1.1 1.7 1.6 2.0 1.0 3.1 2.1 2.4 3.5 3.8 0.0 2.2 0.0 0.7 3.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 3.9 3.5 0.5 0.0 4.0 0.0 0.0 1.2 0.6 2.3 0.7 0.5 1.0 0.0 22.4 0.0 4.9 0.0 0.0 0.2 7.7 0.0 0.2 1.4 0.4 0.0 0.8 0.2 4.9 0.0 0.1 0.0 0.0 0.0 1.1 1.9 0.0 0.1 0.0 0.0 2.5 0.8 2.1 0.7 0.5 0.0 0.0 0.0 15.4 13.9 4.1 4.5 0.2 0.9 0.9 0.0 0.0 0.1 0.2 0.4 0.0 1.0 2.4 0.2 0.3 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 14.5 13.4 29.7 12.0 1.3 1.4 19.0 20.1 3.8 3.0 1.3 0.0 1.5 0.3 49.4 2.0 0.0 0.0 4.5 0.0 15.7 0.1 0.0 1.8 0.5 0.5 0.4 0.0 2.2 0.9 0.3 1.3 0.0 0.0 0.1 93.8 31.0 0.0 0.0 0.9 5.5 0.2 6.8 0.0 0.1 10.6 0.8 0.0 0.7 0.6 23.0 0.0 0.1 2.3 2.5 0.5 0.9 0.0 0.2 0.1 MAPK8IP3 "JIP3, JSAP1, KIAA1066, syd" ENSG00000138834 "Mitogen-activated protein kinase 8 interacting protein 3" Q9UPT6 16 1706183-1770317 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005580, HPA041785, HPA069311" Approved Approved Vesicles NA NA Vesicles "CAB005580: AB_627840, HPA041785: AB_2677671, HPA069311: AB_2686116" "unprognostic (1.49e-1)" "unprognostic (2.22e-1)" "unprognostic (8.28e-3)" "unprognostic (8.32e-2)" "unprognostic (3.90e-1)" "unprognostic (6.83e-3)" "unprognostic (3.66e-2)" "unprognostic (2.41e-2)" "unprognostic (1.55e-1)" "unprognostic (8.67e-2)" "unprognostic (1.57e-2)" "unprognostic (6.91e-3)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (2.45e-1)" "prognostic favorable (3.95e-4)" 9.6 13.8 29.3 14.0 35.7 24.7 6.7 54.9 56.8 8.4 7.7 25.8 5.7 14.9 10.4 5.4 5.5 7.2 9.2 15.1 24.4 19.4 9.1 7.5 8.5 16.4 20.3 35.7 14.6 21.8 12.0 21.3 9.8 32.9 11.1 5.1 8.8 18.1 9.5 12.8 25.1 13.8 8.0 15.3 20.6 13.8 11.1 22.0 4.6 10.0 2.4 7.7 9.8 7.6 1.5 1.6 2.4 1.3 0.0 1.4 0.4 3.7 7.3 7.7 6.9 3.8 6.5 6.1 6.3 2.4 3.2 2.8 10.2 12.6 4.4 4.0 4.0 2.2 7.2 1.9 4.2 1.0 6.9 8.5 5.8 16.6 7.8 5.3 3.8 10.3 12.9 5.6 4.6 2.3 14.1 4.2 8.5 4.9 8.5 3.3 9.6 5.9 16.6 5.2 1.8 4.1 25.8 3.8 7.4 3.9 5.0 16.2 12.9 7.6 7.2 3.0 3.7 3.8 5.4 13.0 13.5 7.5 5.7 5.0 19.2 3.3 5.7 3.5 4.0 6.7 0.0 1.3 2.4 1.4 0.3 0.8 1.5 0.3 0.5 0.4 1.4 0.4 0.4 1.1 0.0 0.3 1.6 0.8 0.4 29.3 35.7 54.9 53.1 24.4 19.4 20.3 35.7 32.9 22.0 3.0 8.5 6.2 4.0 8.8 36.3 5.9 10.2 4.0 7.9 3.5 35.3 4.4 1.7 4.2 19.9 6.3 12.0 0.0 3.2 4.9 6.4 4.9 1.1 7.8 6.1 82.6 9.8 8.0 11.3 15.6 7.2 7.5 6.8 8.2 9.6 7.2 6.0 10.4 8.5 0.7 17.5 6.5 2.1 14.2 3.1 8.4 4.7 6.1 8.9 5.1 MAPK9 "JNK2, p54a, PRKM9, SAPK" ENSG00000050748 "Mitogen-activated protein kinase 9" P45984 5 180233143-180292099 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "basophil: 13.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 13.2" "Cell line enhanced" "Detected in all" "HDLM-2: 69.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB008910 Enhanced NA NA "CAB008910: " "unprognostic (5.04e-3)" "unprognostic (2.06e-2)" "prognostic favorable (1.11e-4)" "unprognostic (8.53e-2)" "unprognostic (1.75e-1)" "unprognostic (5.06e-3)" "unprognostic (6.83e-3)" "unprognostic (3.16e-1)" "unprognostic (4.93e-2)" "unprognostic (3.76e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "unprognostic (2.13e-1)" "unprognostic (2.29e-1)" "unprognostic (9.38e-3)" "unprognostic (2.40e-1)" 10.3 12.4 22.9 9.6 31.8 10.3 11.4 48.7 41.4 10.8 12.4 10.6 4.7 10.1 8.7 9.5 8.7 8.8 7.8 14.0 24.3 25.0 12.2 9.7 10.8 10.0 22.0 21.0 8.5 25.9 16.3 8.8 10.9 29.4 11.7 15.3 7.0 9.9 13.1 20.5 6.3 10.4 11.4 16.8 8.6 12.3 9.4 10.3 7.1 15.4 5.1 11.3 9.9 7.3 1.4 1.4 13.2 2.4 1.3 3.1 0.3 17.2 14.3 12.6 15.8 12.5 14.1 27.2 16.6 14.8 14.0 14.1 18.7 12.3 18.5 28.7 17.6 30.8 13.3 13.0 27.9 16.5 69.4 12.5 7.7 15.9 13.3 9.5 15.9 13.5 10.3 12.5 13.6 13.2 14.6 16.6 14.5 8.4 13.4 19.0 22.6 15.8 6.6 8.8 21.4 8.5 15.3 21.5 8.8 10.6 16.5 14.6 10.3 19.5 19.0 13.2 16.4 19.3 13.8 11.9 16.8 16.9 23.6 24.8 9.7 11.4 12.6 17.8 14.9 11.1 13.2 0.6 2.5 2.0 1.3 2.0 1.0 1.5 1.8 1.0 1.4 1.0 1.2 0.9 1.3 2.4 1.4 3.1 0.3 22.9 31.8 48.7 41.4 24.3 25.0 22.0 21.0 29.4 10.3 29.8 11.8 11.5 6.1 9.0 18.3 20.7 10.2 5.3 10.3 8.7 15.7 12.1 5.0 7.1 0.9 15.7 13.5 0.0 13.9 18.8 9.9 10.0 11.5 15.3 10.3 12.7 16.0 13.5 17.2 2.3 9.8 12.8 5.0 10.0 17.1 10.4 10.9 11.5 12.7 9.2 14.2 12.9 7.2 15.9 17.0 9.9 14.9 8.6 14.5 7.3 MAPKAPK3 "3pK, MAPKAP3" ENSG00000114738 "Mitogen-activated protein kinase-activated protein kinase 3" Q16644 3 50611520-50649297 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 86.7;skeletal muscle: 70.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 193.9;Hofbauer cells: 91.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 30.2;eosinophil: 23.0;intermediate monocyte: 50.0;myeloid DC: 27.1;neutrophil: 20.5;non-classical monocyte: 61.4;plasmacytoid DC: 16.9" "Group enriched" "Detected in all" 5 "dendritic cells: 27.1;granulocytes: 23.0;monocytes: 61.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058275 Supported Nucleoplasm NA NA Nucleoplasm "HPA058275: AB_2683663" "unprognostic (6.46e-3)" "unprognostic (1.84e-1)" "prognostic favorable (8.08e-5)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (9.96e-2)" "unprognostic (8.77e-3)" "unprognostic (7.68e-3)" "unprognostic (1.11e-1)" "unprognostic (5.87e-2)" "unprognostic (2.19e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.90e-8)" "unprognostic (2.15e-2)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.69e-1)" 8.9 16.1 5.6 9.3 7.2 30.4 6.3 1.9 6.2 5.5 9.5 7.1 7.5 9.9 5.5 8.6 16.8 5.1 8.5 86.7 4.8 3.7 17.9 11.9 11.0 15.1 7.2 4.1 8.7 24.2 11.2 9.0 9.0 6.0 7.6 6.7 10.9 12.4 9.2 70.1 17.6 12.0 5.2 5.9 12.5 9.0 4.0 5.2 25.9 22.6 40.9 14.3 6.1 7.5 3.0 27.1 23.0 61.4 7.3 6.4 19.5 23.4 7.3 3.0 8.6 4.6 11.7 6.9 5.7 8.2 8.8 7.5 11.3 21.9 9.4 5.8 19.1 21.9 8.4 20.9 22.5 7.9 20.8 5.0 49.5 10.3 10.2 9.3 35.6 26.4 9.3 14.0 20.5 28.0 8.8 7.8 16.8 13.9 6.2 18.5 9.5 15.1 35.9 11.4 8.2 30.0 6.7 7.3 14.2 41.0 13.5 5.7 4.0 5.1 14.5 6.5 5.3 9.1 22.1 5.6 7.0 16.0 36.0 14.1 4.2 7.7 7.8 37.0 56.1 2.8 6.4 30.2 23.0 5.5 50.0 5.4 3.0 6.2 6.4 27.1 1.8 4.9 5.5 20.5 7.3 61.4 16.9 5.2 19.5 5.6 7.2 1.9 6.2 4.8 3.7 7.2 4.1 6.0 5.2 8.9 9.4 7.5 19.5 10.1 0.9 193.9 10.2 6.7 6.8 10.4 0.0 5.0 54.7 35.3 28.4 6.7 23.1 0.0 26.4 5.7 11.0 21.5 35.7 10.9 91.5 0.0 5.8 4.9 48.9 60.2 6.6 40.9 6.8 46.9 13.9 10.8 54.8 8.6 3.2 28.5 2.3 25.8 11.7 3.4 4.3 17.7 4.2 18.7 27.9 30.1 MAPKBP1 KIAA0596 ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.1" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 48.5;Cone photoreceptor cells: 192.4;Suprabasal keratinocytes: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 4.7 6.0 10.6 5.0 13.8 4.4 5.7 48.1 13.9 6.1 5.7 8.8 4.4 10.6 9.3 5.4 12.5 8.0 5.3 4.2 8.6 6.7 3.9 2.3 4.7 4.0 8.6 9.2 15.4 4.3 5.8 9.5 6.1 9.3 5.9 4.3 7.0 5.1 7.1 4.9 26.3 10.5 10.2 6.8 5.7 5.4 19.5 10.7 4.4 8.7 5.2 7.4 8.4 6.6 1.9 1.9 4.3 2.1 2.2 3.3 1.6 4.9 2.6 7.1 6.7 7.9 7.8 4.8 7.1 17.7 6.4 4.7 5.2 1.8 1.2 5.8 5.7 8.9 12.0 6.8 19.7 4.6 4.5 2.0 5.0 8.1 1.7 3.4 3.2 10.3 4.0 15.8 10.2 18.5 10.6 9.4 8.3 3.1 2.3 9.0 1.0 2.6 2.8 0.8 2.9 5.4 2.9 5.1 0.5 3.7 5.6 8.0 4.6 4.1 4.1 3.1 7.6 4.9 2.5 7.4 9.2 4.5 8.9 6.9 5.2 8.5 2.9 6.2 4.3 7.7 4.3 1.3 1.1 3.3 0.7 2.4 1.9 1.9 1.4 1.9 1.8 2.4 2.0 0.7 2.2 2.1 0.7 0.8 1.6 10.6 13.8 48.1 13.9 8.6 6.7 8.6 9.2 9.3 10.7 6.0 13.0 2.2 7.6 48.5 11.4 2.8 2.5 10.7 9.1 3.5 192.4 5.0 0.0 2.7 11.7 7.0 4.0 0.0 3.0 3.5 5.5 3.6 1.1 1.8 3.3 14.3 4.6 4.9 2.1 19.1 6.6 4.6 8.5 4.6 1.4 6.1 3.3 1.5 7.4 0.3 8.2 12.9 3.9 8.1 4.1 46.9 4.5 4.4 2.0 12.1 MAPRE2 "EB1, EB2, RP1" ENSG00000166974 "Microtubule associated protein RP/EB family member 2" Q15555 18 34976928-35143470 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.4" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016738, HPA016739" Enhanced Uncertain Nucleoplasm NA NA 24000000 Nucleoplasm "HPA016738: AB_1853571, HPA016739: AB_1853570" "unprognostic (2.01e-1)" "unprognostic (3.48e-1)" "unprognostic (2.55e-2)" "unprognostic (5.30e-3)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-2)" "unprognostic (8.53e-2)" "unprognostic (1.09e-2)" "unprognostic (2.29e-1)" "unprognostic (2.93e-2)" "unprognostic (5.40e-2)" "unprognostic (2.22e-3)" "unprognostic (5.83e-2)" "unprognostic (1.34e-1)" "unprognostic (3.16e-2)" "unprognostic (3.99e-3)" 12.3 33.8 38.9 15.3 35.5 10.4 9.6 34.6 61.8 11.6 13.4 30.4 3.1 8.3 8.1 11.3 10.1 6.5 22.7 47.9 43.7 29.8 10.6 18.5 15.1 18.4 39.0 43.3 14.8 7.3 7.6 8.6 15.7 32.1 9.4 14.0 8.7 10.5 10.2 24.6 12.8 10.7 14.4 71.4 14.6 16.7 3.8 22.1 31.9 12.3 8.6 17.5 15.7 8.4 27.4 23.1 25.1 22.8 34.0 32.8 32.8 0.2 8.8 9.9 5.2 6.0 5.6 0.7 6.3 15.0 7.5 13.0 0.6 3.3 28.9 7.4 13.8 8.1 11.9 7.7 5.1 13.9 16.9 7.2 29.4 9.6 16.9 4.4 16.1 24.7 6.7 1.4 10.5 3.6 7.1 42.1 20.8 9.1 13.0 9.8 0.5 34.1 5.4 7.7 9.6 1.7 13.7 12.1 6.6 3.9 0.1 12.4 8.2 4.7 0.2 5.2 9.7 1.0 9.5 7.0 8.3 4.7 4.9 4.2 6.8 16.2 17.0 14.4 21.7 12.9 25.1 14.7 22.2 32.8 18.2 25.4 27.4 23.2 29.8 16.0 25.9 26.8 32.6 10.6 34.0 22.8 23.1 23.5 32.8 38.9 35.5 34.6 41.2 43.7 29.8 39.0 43.3 32.1 22.1 20.8 19.4 20.7 4.8 21.1 74.9 93.6 17.8 9.4 6.8 5.2 23.6 0.4 5.0 7.3 8.0 22.0 9.6 0.0 11.4 8.9 21.6 2.9 26.5 22.2 22.9 49.3 28.2 36.2 41.5 5.5 17.8 20.3 28.7 4.6 27.1 43.5 8.6 19.2 19.8 4.6 10.1 77.6 52.6 1.5 11.3 24.1 0.7 35.5 9.9 3.0 MAPRE3 "EB3, RP3" ENSG00000084764 "Microtubule associated protein RP/EB family member 3" Q9UPY8 2 26970612-27027196 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 77.1;skeletal muscle: 62.3" "Group enriched" "Detected in many" 5 "Early spermatids: 413.8;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 7.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009263 Uncertain NA NA "HPA009263: AB_1078716" "unprognostic (1.24e-1)" "unprognostic (1.10e-1)" "unprognostic (8.31e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-2)" "unprognostic (3.40e-2)" "unprognostic (2.22e-2)" "unprognostic (1.35e-3)" "unprognostic (1.75e-2)" "unprognostic (3.49e-1)" "unprognostic (4.77e-3)" "unprognostic (2.37e-1)" "unprognostic (1.22e-2)" "unprognostic (3.84e-2)" "unprognostic (3.43e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" 14.4 17.3 38.5 5.7 46.6 1.7 10.0 39.5 77.1 7.3 9.7 13.4 6.5 5.8 12.0 8.4 7.3 30.2 9.6 22.2 34.6 40.9 9.3 11.3 9.2 4.5 27.7 46.0 22.1 9.6 17.9 25.9 8.2 32.8 12.0 7.8 8.8 7.7 11.8 62.3 17.2 4.5 9.9 15.7 5.7 10.3 25.4 15.9 0.5 9.8 6.3 5.2 6.6 6.0 1.4 1.7 7.0 3.2 1.0 1.5 1.3 9.2 7.2 6.7 11.6 12.2 6.8 1.9 7.3 5.9 6.2 6.4 2.6 12.4 0.0 7.1 9.0 16.5 4.8 3.6 7.8 3.7 7.7 9.0 1.4 3.9 0.6 11.2 1.0 17.9 5.6 14.0 3.1 5.8 17.1 1.5 0.8 8.9 7.3 3.7 4.2 0.0 0.5 2.9 32.6 11.6 0.0 0.1 0.9 4.3 6.2 16.9 8.3 5.0 3.7 5.1 4.5 3.9 0.6 1.5 5.5 5.6 7.8 6.4 5.6 2.0 0.0 19.7 0.7 10.9 0.2 2.8 0.5 1.5 2.9 1.0 1.4 0.8 0.5 1.7 0.7 1.3 0.3 7.0 1.0 3.2 0.0 0.2 1.3 38.5 46.6 39.5 57.3 34.6 40.9 27.7 46.0 32.8 15.9 3.0 3.2 0.0 18.3 7.8 43.0 5.3 0.0 30.8 3.4 3.5 23.6 1.2 14.9 10.0 413.8 4.3 10.4 0.0 4.1 3.3 9.0 8.5 38.0 6.6 1.8 55.6 24.1 11.6 2.6 191.7 11.8 4.1 6.8 0.0 1.5 62.2 9.3 1.9 11.0 4.6 44.0 32.3 8.5 20.0 12.8 12.0 15.8 1.3 1.5 14.4 MAPT "DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau" ENSG00000186868 "Microtubule associated protein tau" P10636 17 45894382-46028334 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 89.9;skeletal muscle: 43.7" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 300.5;Early spermatids: 153.8;Horizontal cells: 341.7;Late spermatids: 194.8;Muller glia cells: 139.1" "Group enriched" "Detected in many" 11 "breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 27.9;SCLC-21H: 10.1;T-47d: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000151, HPA048895, HPA069524, HPA069570, CAB072344" Enhanced Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155" "unprognostic (1.78e-3)" "unprognostic (7.51e-2)" "unprognostic (3.71e-2)" "unprognostic (8.40e-5)" "unprognostic (1.40e-1)" "unprognostic (1.31e-2)" "unprognostic (4.06e-5)" "unprognostic (6.04e-2)" "unprognostic (2.19e-2)" "unprognostic (3.49e-2)" "unprognostic (3.88e-3)" "unprognostic (2.65e-1)" "unprognostic (1.72e-3)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" 3.8 7.1 28.9 2.4 31.2 2.1 8.8 40.1 89.9 2.4 2.7 21.4 1.7 2.5 2.6 2.3 6.4 2.5 2.8 6.5 28.7 29.7 15.3 2.2 2.4 2.3 22.6 35.2 2.3 2.8 8.5 8.8 5.2 29.1 5.1 2.5 2.2 8.1 5.3 43.7 4.6 2.8 2.5 13.6 2.2 2.3 6.5 27.7 0.0 2.3 3.1 2.3 3.2 0.8 0.0 0.0 0.3 0.1 0.5 1.7 0.1 0.8 0.3 0.2 2.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 1.3 0.1 0.0 27.9 1.4 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 1.6 0.2 1.4 0.0 4.2 0.5 0.1 0.0 0.4 1.1 0.0 2.3 2.8 0.0 3.6 10.1 4.7 1.0 0.0 1.0 0.6 12.7 0.0 0.0 0.2 0.3 0.6 0.1 0.5 0.2 0.0 0.2 0.5 0.3 0.0 0.1 0.3 0.8 0.0 0.6 0.0 0.4 1.2 0.0 0.0 0.9 0.9 0.0 0.5 0.1 0.0 1.7 0.1 28.9 31.2 40.1 46.3 28.7 29.7 22.6 35.2 29.1 27.7 0.0 9.8 0.8 1.1 0.9 300.5 32.3 0.0 0.0 0.0 1.8 60.9 0.1 6.6 0.4 153.8 1.3 0.0 0.0 0.4 8.0 1.9 2.9 4.6 0.5 0.3 341.7 0.0 0.6 0.3 194.8 2.6 1.3 5.0 1.0 0.0 139.1 0.6 0.0 2.5 44.6 24.8 0.0 4.1 11.4 5.9 2.9 0.2 0.0 0.1 0.5 MARC1 "FLJ22390, MOSC1" ENSG00000186205 "Mitochondrial amidoxime reducing component 1" Q5VT66 1 220786759-220819657 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 71.3;breast: 81.3" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 94.8;Extravillous trophoblasts: 36.6;Syncytiotrophoblasts: 62.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 12.0;classical monocyte: 20.6;eosinophil: 8.1;neutrophil: 28.5" "Group enriched" "Detected in many" 32 "granulocytes: 28.5;monocytes: 20.6" "Cell line enhanced" "Detected in many" "BEWO: 51.6;HeLa: 22.0;Hep G2: 25.3;NTERA-2: 21.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028702 Approved Supported Mitochondria NA NA Mitochondria "HPA028702: AB_10601135" "unprognostic (3.15e-2)" "unprognostic (1.27e-1)" "unprognostic (2.16e-2)" "unprognostic (5.04e-2)" "unprognostic (2.90e-1)" "unprognostic (2.31e-1)" "unprognostic (3.71e-3)" "unprognostic (1.39e-1)" "unprognostic (7.51e-2)" "unprognostic (7.71e-3)" "unprognostic (3.71e-1)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.85e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (1.50e-1)" 71.3 3.0 4.6 7.5 6.1 7.3 81.3 3.1 4.0 3.4 7.8 2.1 18.7 3.3 1.4 5.5 3.4 2.8 6.4 6.7 3.7 4.6 3.4 33.6 4.3 4.3 4.0 3.3 2.5 4.0 4.0 3.3 9.7 4.3 14.9 6.8 4.4 27.8 10.5 4.2 1.4 3.8 2.6 2.6 4.3 3.2 0.6 1.4 0.1 22.0 2.7 1.4 3.9 7.5 0.2 0.7 28.5 20.6 0.0 0.1 4.9 5.7 3.1 2.0 0.0 0.4 0.1 51.6 0.5 0.4 0.3 0.5 17.0 0.3 0.0 2.1 0.5 0.0 0.0 10.7 1.0 0.7 0.0 10.9 0.0 22.0 25.3 1.3 0.1 0.1 2.0 0.6 0.0 0.0 0.0 0.3 0.0 1.6 0.1 0.3 5.6 0.0 10.9 21.8 16.8 9.5 0.0 0.0 0.1 2.4 6.4 6.1 14.2 3.1 3.8 0.0 6.0 14.4 13.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.0 20.6 8.1 0.1 1.5 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 28.5 0.0 0.4 0.2 0.0 4.9 4.6 6.1 3.1 4.0 3.7 4.6 4.0 3.3 4.3 1.4 0.0 12.8 0.9 0.0 0.8 5.7 5.1 0.0 2.7 0.0 8.7 0.0 94.8 1.7 0.0 4.4 2.9 6.3 0.0 0.0 36.6 1.0 0.0 2.3 22.1 10.4 0.0 4.1 3.1 22.0 2.6 0.6 0.2 0.0 0.0 22.2 12.4 0.0 9.5 5.6 2.5 1.4 0.0 3.1 0.0 0.7 0.5 62.8 0.0 9.5 0.0 MARC2 "FLJ20605, MOSC2" ENSG00000117791 "Mitochondrial amidoxime reducing component 2" Q969Z3 1 220748225-220784815 "Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.3;parathyroid gland: 63.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 81.6;Proximal tubular cells: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 14.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 14.1" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.4;T-47d: 21.9;TIME: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015085, HPA017572" Enhanced NA NA "HPA015085: AB_1848780, HPA017572: AB_1848778" "unprognostic (8.17e-2)" "unprognostic (1.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.40e-10)" "unprognostic (4.78e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-1)" "unprognostic (1.90e-1)" "unprognostic (2.05e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (2.39e-2)" "unprognostic (6.23e-2)" 8.1 8.2 5.5 4.6 5.9 0.1 9.5 2.7 5.6 4.4 19.4 3.7 5.0 16.7 4.8 6.6 6.7 3.8 10.3 10.2 5.0 3.7 38.2 73.3 12.5 2.2 4.0 5.7 9.2 12.7 63.3 4.3 3.5 8.0 6.4 5.9 6.9 24.3 3.9 8.8 2.0 36.4 8.1 1.9 4.5 9.1 7.4 2.7 0.4 19.6 6.2 2.9 5.5 9.0 2.2 0.0 14.1 0.1 0.0 0.0 0.1 5.6 4.7 2.5 3.3 6.3 2.9 1.9 4.1 7.1 4.9 5.0 3.1 7.2 0.0 2.8 3.8 2.7 0.7 0.0 5.6 4.6 0.0 9.7 0.0 9.2 6.5 5.9 2.6 0.0 5.0 8.7 1.9 0.0 7.5 13.5 0.0 3.6 0.0 3.1 1.4 0.0 9.2 4.0 1.9 4.7 0.0 8.0 0.1 17.4 6.1 1.4 3.7 6.4 0.0 8.7 2.9 21.9 3.4 20.3 0.0 3.0 6.5 7.1 1.2 0.0 0.0 1.1 0.0 0.1 14.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 5.9 2.7 5.6 5.0 3.7 4.0 5.7 8.0 2.7 35.7 26.1 3.9 0.0 0.8 0.6 22.0 20.4 5.3 6.8 17.4 0.0 0.7 10.0 0.0 0.4 8.2 18.8 0.0 0.0 0.4 5.2 0.0 5.7 81.6 0.7 0.0 0.0 9.2 3.2 1.3 19.2 1.0 13.5 0.0 13.0 10.2 0.0 11.6 23.0 51.6 0.5 12.9 8.2 0.5 0.5 1.1 4.7 0.0 14.4 0.0 MARCH1 "FLJ20668, MARCH-I, RNF171" ENSG00000145416 "Membrane associated ring-CH-type finger 1" Q8TCQ1 4 163524298-164384050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.4;lymphoid tissue: 32.4" "Cell type enhanced" "Detected in many" 11 "B-cells: 128.6;Cone photoreceptor cells: 184.6;Kupffer cells: 192.5;Macrophages: 105.3;Rod photoreceptor cells: 172.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 95 "classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 9.6;U-266/70: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014600 Uncertain NA NA "HPA014600: AB_1853573" "unprognostic (7.29e-2)" "unprognostic (5.82e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" "unprognostic (8.25e-2)" "unprognostic (2.98e-2)" "unprognostic (4.79e-3)" "unprognostic (9.00e-2)" "unprognostic (3.00e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-1)" "unprognostic (2.20e-1)" "unprognostic (1.24e-1)" "unprognostic (7.00e-2)" "unprognostic (2.48e-2)" "unprognostic (2.70e-1)" "unprognostic (2.91e-2)" 7.7 4.2 11.6 20.5 19.7 3.9 4.0 3.1 14.5 3.7 3.9 8.5 0.1 4.4 3.9 4.6 3.6 4.2 5.9 2.6 12.6 10.1 3.0 4.5 8.3 28.5 17.3 6.3 4.2 4.1 1.5 4.1 10.2 13.5 3.5 5.1 2.4 4.6 1.8 1.6 4.9 9.0 6.5 24.4 32.4 4.1 2.3 17.9 2.6 3.2 1.4 24.6 9.0 4.2 18.5 18.1 9.9 17.2 0.1 0.0 6.6 0.8 0.7 2.9 1.7 0.0 0.0 1.9 1.2 0.1 0.0 0.0 1.6 3.3 9.6 3.6 0.0 0.4 1.4 0.0 0.0 0.0 1.0 1.0 6.8 3.7 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.2 4.0 0.0 1.9 2.5 5.0 3.3 1.0 2.3 2.6 3.6 0.3 1.3 2.7 0.5 0.7 0.1 1.6 1.5 1.3 0.9 1.5 0.5 2.2 4.0 0.7 3.1 1.1 2.0 0.7 2.3 9.8 3.3 2.7 1.4 2.1 1.5 0.0 16.8 9.9 0.0 17.0 0.0 18.5 0.0 0.0 18.1 15.7 0.0 0.0 0.1 0.1 17.2 6.8 0.0 6.6 11.6 19.7 3.1 12.5 12.6 10.1 17.3 6.3 13.5 17.9 0.0 2.7 128.6 0.0 1.5 24.7 2.4 0.0 1.4 4.5 3.5 184.6 0.3 0.0 0.0 4.6 1.1 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.9 43.0 11.1 0.0 3.1 192.5 1.7 0.0 105.3 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.1 172.3 12.9 0.0 0.6 1.5 0.9 0.7 0.8 0.0 0.0 MARCH10 "FLJ35757, MARCH-X, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 80.2" "Group enriched" "Detected in some" 7 "Early spermatids: 371.3;Late spermatids: 1043.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 3.9;EFO-21: 7.3;HSkMC: 3.2;SCLC-21H: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.2 0.1 0.7 0.2 1.6 0.0 0.1 0.1 0.3 0.5 0.1 1.9 0.6 0.0 0.3 4.8 0.1 7.9 0.1 0.1 1.0 1.0 0.6 0.1 1.4 0.1 0.2 0.5 1.0 0.1 0.3 4.5 0.1 1.8 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 80.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.6 3.4 0.3 0.1 0.0 0.2 0.0 0.0 0.2 3.9 1.7 0.2 1.2 0.3 0.0 0.1 0.0 7.3 0.5 0.1 0.0 0.0 0.4 1.4 0.0 0.0 1.3 0.7 0.0 1.5 0.0 0.0 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.2 1.1 0.0 12.7 0.0 0.0 0.7 0.1 0.5 0.2 0.0 0.0 0.0 0.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.7 0.3 0.7 0.1 0.6 1.8 0.0 0.6 0.0 0.0 0.7 0.3 0.7 1.6 0.1 0.3 1.0 1.0 0.2 0.5 1.8 0.3 3.0 1.0 0.0 0.0 0.1 0.0 0.3 0.0 105.7 15.9 3.5 0.0 0.1 44.7 0.0 371.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1043.9 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.0 42.4 10.6 0.0 0.1 0.5 0.0 0.0 MARCH11 "MARCH-XI, RNF226" ENSG00000183654 "Membrane associated ring-CH-type finger 11" A6NNE9 5 16067139-16180762 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 42.1" "Group enriched" "Detected in some" 7 "Early spermatids: 83.9;Spermatocytes: 30.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 44.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (9.91e-3)" "unprognostic (1.08e-1)" "unprognostic (2.98e-1)" "unprognostic (1.50e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-1)" "unprognostic (3.55e-2)" 0.4 1.1 1.8 0.3 3.4 0.3 0.4 3.7 3.7 0.3 0.4 0.0 0.0 0.3 0.4 0.3 0.3 0.3 0.3 2.2 2.0 3.2 0.5 0.5 0.4 0.3 1.5 2.0 0.5 1.0 0.3 6.8 0.4 2.1 0.6 0.4 0.6 1.4 0.3 0.3 0.3 0.4 0.3 0.5 0.3 0.4 42.1 0.0 0.0 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 44.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.4 3.7 3.7 2.0 3.2 1.5 2.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 5.9 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 2.4 6.5 0.0 30.3 1.4 0.0 0.0 0.0 0.0 0.0 MARCH4 "KIAA1399, MARCH-IV, RNF174" ENSG00000144583 "Membrane associated ring-CH-type finger 4" Q9P2E8 2 216257865-216372027 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 16.6;pituitary gland: 13.1" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 33.8;fHDF/TERT166: 21.5;TIME: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014348 Approved NA NA "HPA014348: AB_1853578" "unprognostic (4.84e-2)" "unprognostic (1.02e-4)" "unprognostic (1.63e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (6.49e-2)" "unprognostic (5.55e-3)" "unprognostic (1.07e-1)" "unprognostic (6.81e-5)" "unprognostic (4.82e-2)" "unprognostic (2.06e-1)" "unprognostic (1.23e-1)" "unprognostic (1.09e-3)" 0.7 2.9 7.0 0.7 11.9 0.7 0.6 1.0 16.6 0.6 1.1 0.3 0.0 1.5 0.7 0.7 0.6 2.5 0.6 0.6 5.8 5.6 0.6 0.6 0.8 0.6 2.0 4.8 0.6 1.5 0.6 13.1 3.1 3.4 0.7 1.2 0.1 0.6 0.6 0.6 0.7 1.4 0.6 1.6 0.6 5.1 0.7 1.1 0.0 0.6 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 5.6 1.2 0.0 0.0 0.1 0.8 0.0 33.8 11.6 7.3 2.6 0.0 0.5 0.0 5.2 21.5 12.2 0.0 0.0 13.3 7.2 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 6.6 10.0 4.7 9.5 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.9 0.0 0.0 0.0 1.1 0.0 0.0 15.9 11.3 11.8 0.0 9.0 0.0 0.0 0.0 2.6 0.0 8.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.0 11.9 1.0 16.6 5.8 5.6 2.0 4.8 3.4 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MARCKSL1 "F52, MacMARCKS, MLP, MLP1" ENSG00000175130 "MARCKS like 1" P49006 1 32333832-32336379 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 166.5" "Cell type enhanced" "Detected in many" 9 "monocytes: 1596.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "eosinophil: 54.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 54.9" "Cell line enhanced" "Detected in many" "AF22: 108.3;NTERA-2: 104.4" "Low region specificity" "Detected in all" "CAB020787, HPA030528" Enhanced Supported "Nucleoplasm,Actin filaments,Cytosol" NA Yes 120000 Cytosol "Nucleoplasm, Actin filaments" "CAB020787: , HPA030528: AB_2673514" "unprognostic (8.08e-2)" "unprognostic (1.28e-1)" "unprognostic (1.11e-1)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (3.16e-3)" "prognostic unfavorable (1.78e-6)" "unprognostic (3.65e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-3)" "unprognostic (2.91e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.50e-1)" "unprognostic (8.16e-3)" "unprognostic (1.08e-1)" "unprognostic (3.22e-2)" 9.9 12.7 59.9 22.1 45.4 10.9 27.7 22.0 58.0 22.3 27.5 126.3 5.3 15.9 25.8 42.3 3.6 15.9 24.9 10.7 64.2 47.2 6.4 9.7 9.0 41.5 83.6 35.4 74.1 4.8 1.3 4.9 11.0 56.6 22.5 30.7 5.2 19.9 14.2 2.0 5.3 13.9 11.3 166.5 12.5 34.8 30.3 52.3 41.4 29.0 2.2 49.2 17.0 5.5 6.4 2.2 54.9 6.7 0.2 3.9 1.2 8.4 7.6 108.3 44.2 2.4 0.9 19.2 3.5 2.2 10.6 7.0 18.0 6.2 19.0 13.3 2.4 0.0 4.5 34.9 0.4 7.8 0.4 25.8 1.0 2.9 39.7 7.5 4.9 0.1 12.4 1.4 7.9 0.2 16.5 30.9 32.8 29.1 0.2 14.2 20.0 61.7 20.9 104.4 27.4 17.6 77.1 11.6 9.0 15.9 16.8 67.2 63.9 18.6 20.6 58.5 46.0 14.3 8.8 9.1 4.5 26.3 0.4 6.7 2.9 0.2 49.9 0.5 7.5 23.7 0.7 1.0 54.9 0.9 5.4 0.3 4.6 1.9 1.2 1.5 6.4 3.9 1.6 4.4 0.2 6.7 2.2 1.0 1.2 59.9 45.4 22.0 54.9 64.2 47.2 83.6 35.4 56.6 52.3 0.0 2.2 147.6 95.4 83.2 17.7 7.3 163.1 2.7 4.5 57.6 5.9 9.9 69.6 353.9 21.7 181.6 54.0 0.0 269.1 98.8 68.7 341.5 23.0 3.8 20.1 9.5 716.9 486.2 57.0 35.8 567.8 77.4 285.1 1596.0 443.0 406.9 517.8 228.0 602.9 1.2 12.4 129.4 72.9 6.2 129.4 72.6 11.2 47.2 387.2 506.2 MARCO "SCARA2, SR-A6" ENSG00000019169 "Macrophage receptor with collagenous structure" Q9UEW3 2 118942166-118994660 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.3;lung: 65.6;lymphoid tissue: 58.7" "Cell type enriched" "Detected in some" 6 "Kupffer cells: 829.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 15.8;intermediate monocyte: 26.7" "Lineage enriched" "Detected in many" 5 "monocytes: 26.7" "Cell line enhanced" "Detected in some" "HaCaT: 4.0;THP-1: 5.7;U-2 OS: 6.2;U-266/70: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063793 Enhanced Approved "Golgi apparatus,Vesicles" NA NA 24000000 "Golgi apparatus" Vesicles "HPA063793: AB_2685123" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" "unprognostic (5.96e-3)" "unprognostic (3.36e-2)" "unprognostic (1.71e-2)" "unprognostic (3.58e-2)" "unprognostic (3.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (6.27e-3)" "unprognostic (5.13e-2)" "unprognostic (2.24e-3)" "unprognostic (1.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (6.55e-2)" 22.8 11.7 0.8 29.6 1.1 0.9 3.3 2.3 1.3 0.3 2.8 0.9 0.0 0.6 0.3 12.9 5.2 13.8 0.8 10.8 0.6 0.4 1.6 66.3 65.6 29.3 1.3 3.1 4.7 0.4 0.2 0.8 2.3 2.7 4.5 0.7 1.0 2.9 0.8 6.8 1.1 1.3 9.6 1.7 58.7 2.2 2.8 0.6 0.0 3.0 0.5 0.4 8.8 1.1 0.0 5.0 0.3 26.7 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.9 4.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 5.7 0.0 0.0 6.2 0.9 0.0 3.6 0.0 0.2 0.0 1.3 0.0 0.0 15.8 0.0 0.0 26.7 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 3.2 0.4 0.0 3.4 0.8 1.1 2.3 1.3 0.6 0.4 1.3 3.1 2.7 0.6 23.8 42.6 0.0 0.0 1.0 0.0 0.4 0.0 24.1 30.7 3.5 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.7 1.5 0.1 11.6 0.8 145.4 0.0 0.0 13.5 829.9 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.6 1.3 0.0 0.0 MARCOL ENSG00000248109 "MARCO like" 5 148221650-148243580 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ductus deferens: 3.8;epididymis: 5.7;seminal vesicle: 3.1;skeletal muscle: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HeLa: 127.7" NA NA 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 0.0 3.8 0.0 0.7 5.7 0.0 0.0 0.0 0.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.1 2.9 0.0 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MARVELD3 MRVLDC3 ENSG00000140832 "MARVEL domain containing 3" Q96A59 16 71626161-71642114 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.9;pancreas: 34.5" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 154.2;Paneth cells: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 11.7;BEWO: 17.6;CACO-2: 13.0;CAPAN-2: 12.6;HaCaT: 11.9;MCF7: 22.2;RT4: 10.4;SK-BR-3: 10.5;T-47d: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043514, HPA045471" Approved "Vesicles,Intermediate filaments" No NA Vesicles "Intermediate filaments" "HPA043514: AB_10959475, HPA045471: " "unprognostic (1.18e-1)" "unprognostic (3.92e-1)" "unprognostic (9.92e-2)" "unprognostic (5.56e-2)" "unprognostic (1.03e-1)" "unprognostic (6.16e-3)" "unprognostic (2.04e-1)" "unprognostic (3.22e-2)" "unprognostic (2.54e-1)" "unprognostic (8.75e-3)" "unprognostic (3.29e-1)" "unprognostic (5.16e-2)" "prognostic favorable (6.80e-10)" "unprognostic (2.63e-3)" "unprognostic (4.76e-1)" "unprognostic (3.59e-2)" "unprognostic (2.43e-1)" 0.4 0.3 0.4 12.5 0.3 0.0 5.0 0.7 1.2 2.0 35.7 0.3 5.2 17.3 1.3 8.6 4.1 2.1 15.4 0.5 0.5 0.4 14.2 4.3 3.3 0.5 0.3 0.1 1.0 34.5 5.4 1.2 5.3 2.4 6.5 10.5 2.4 10.4 4.3 0.3 3.0 52.9 0.7 0.4 0.4 2.1 1.2 0.1 1.3 8.3 2.3 4.6 3.0 3.4 1.5 1.4 4.1 0.8 1.5 0.8 0.2 11.7 0.4 0.2 0.5 0.0 0.1 17.6 0.0 0.0 0.0 0.0 13.0 12.6 0.1 1.3 0.0 0.0 11.9 1.1 5.7 0.0 0.0 6.8 0.0 0.1 3.4 0.0 0.1 0.1 0.5 7.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 22.2 0.1 0.2 2.0 7.4 0.1 0.0 0.0 4.7 0.2 10.4 2.1 0.1 0.2 10.5 0.0 1.5 14.9 0.2 0.0 0.0 0.2 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 4.1 0.8 0.8 0.7 0.5 0.4 0.8 0.8 0.6 0.3 1.5 0.7 0.7 4.0 1.5 0.5 1.4 0.7 0.2 0.4 0.3 0.7 0.5 0.5 0.4 0.3 0.1 2.4 0.1 8.9 5.9 0.0 25.0 7.0 5.9 0.4 38.2 20.1 12.5 8.7 0.0 31.8 1.7 23.0 4.2 0.0 154.2 0.0 29.6 0.7 1.0 32.3 0.0 5.0 2.5 0.0 59.0 0.6 1.2 2.2 0.3 1.0 0.0 1.0 62.0 0.8 24.0 84.2 0.7 20.2 19.7 0.0 1.0 7.7 4.3 3.1 4.0 1.3 44.3 38.8 MAS1 ENSG00000130368 "MAS1 proto-oncogene, G protein-coupled receptor" P04201 6 159906690-159916530 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.5;cervix, uterine: 1.9" "Cell type enhanced" "Detected in some" 7 "Alveolar cells type 1: 3.0;Cone photoreceptor cells: 2.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "HMC-1: 13.3" "Group enriched" "Detected in many" 25 "amygdala: 40.1;basal ganglia: 26.8;cerebral cortex: 31.9;hippocampal formation: 71.0" "Group enriched" "Detected in many" 7 "amygdala: 8.6;cerebral cortex: 13.2;hippocampal formation: 26.9" HPA079325 Approved NA NA "HPA079325: " "unprognostic (3.31e-1)" "unprognostic (2.25e-3)" "unprognostic (2.91e-1)" "unprognostic (2.22e-3)" "unprognostic (8.15e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (6.52e-2)" "unprognostic (1.48e-5)" "unprognostic (1.69e-1)" "unprognostic (7.67e-2)" "unprognostic (6.28e-1)" 0.1 0.0 0.9 0.0 0.0 0.8 0.0 0.0 4.5 1.9 0.0 0.0 0.3 0.7 0.0 0.3 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.0 0.5 0.3 1.5 0.2 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.6 0.1 1.5 0.2 0.3 0.2 0.1 0.2 0.3 0.2 0.2 0.1 0.5 0.3 0.3 1.5 0.3 0.1 0.3 0.1 0.1 3.0 1.1 0.5 1.1 0.0 1.2 0.7 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.5 0.2 0.0 0.0 1.3 1.5 0.0 0.9 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.0 1.6 0.0 0.1 0.4 0.7 0.0 0.2 0.0 0.0 1.4 MAS1L "dJ994E9.2, MAS-L, MRG" ENSG00000204687 "MAS1 proto-oncogene like, G protein-coupled receptor" P35410 6 29486697-29487956 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 7.5;epididymis: 4.0" "Cell type enriched" "Detected in single" 58 "granulocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 40 "HEL: 3.9" HPA017983 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA017983: AB_1849332" "unprognostic (3.66e-2)" "unprognostic (2.51e-1)" "unprognostic (2.30e-2)" "unprognostic (5.22e-2)" "unprognostic (1.65e-1)" 2.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 7.5 1.3 0.4 1.2 4.0 2.1 0.2 1.2 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 1.1 1.5 0.3 0.2 1.7 1.5 1.1 0.0 0.0 0.5 0.3 0.0 0.5 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MASP1 "CRARF, MASP, PRSS5" ENSG00000127241 "Mannan binding lectin serine peptidase 1" P48740 3 187217285-187292022 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 43.4;liver: 80.1" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7" "Group enriched" "Detected in some" 9 "glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BJ: 27.1;BJ hTERT+: 103.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001617, HPA009641" Supported Enhanced Nucleoplasm,Cytosol "Secreted to blood" No NA 8670000000 1800000000 "Nucleoplasm, Cytosol" "HPA001617: AB_1079314, HPA009641: AB_1079313" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (1.99e-1)" "unprognostic (5.20e-2)" "unprognostic (1.02e-2)" "unprognostic (1.25e-6)" "prognostic favorable (2.20e-4)" "unprognostic (9.92e-2)" "unprognostic (3.22e-1)" "unprognostic (2.29e-1)" "unprognostic (4.18e-1)" "unprognostic (1.29e-1)" "unprognostic (2.82e-3)" "unprognostic (3.56e-3)" "unprognostic (1.97e-1)" "unprognostic (7.85e-2)" "unprognostic (4.29e-1)" 2.1 1.4 3.6 1.2 3.8 0.1 1.2 1.9 10.2 43.4 19.1 14.8 2.4 0.8 34.9 7.1 4.1 6.7 3.3 39.6 6.1 2.5 1.6 80.1 2.2 0.4 6.4 3.0 1.7 0.2 0.2 0.5 3.2 13.0 17.4 2.1 0.1 0.9 19.4 12.2 2.5 2.6 17.1 21.8 0.4 0.6 1.5 6.7 0.0 1.3 6.3 3.5 4.4 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 3.7 0.0 27.1 103.4 0.4 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.8 1.9 3.5 6.1 2.5 6.4 3.0 13.0 6.7 0.0 2.6 0.0 0.1 2.6 0.0 32.5 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.2 11.0 0.0 0.0 57.1 0.4 0.0 0.0 30.7 2.4 3.8 2.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 5.9 0.0 0.0 1.5 0.1 0.5 0.0 0.1 MASP2 MASP1P1 ENSG00000009724 "Mannan binding lectin serine peptidase 2" O00187 1 11026523-11047233 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Complement pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 98 "liver: 185.1" "Cell type enriched" "Detected in some" 68 "Hepatocytes: 541.9" "Cancer enriched" "Detected in some" 71 "liver cancer: 41.9" "Region enriched" "Detected in single" 4 "cerebellum: 1.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 7 "Hep G2: 20.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029313, HPA029314" Uncertain Supported "Golgi apparatus" "Secreted to blood" NA NA 340000000 880000000 "Golgi apparatus" "HPA029313: AB_10669654, HPA029314: AB_10670029" "unprognostic (7.00e-2)" "unprognostic (8.37e-2)" "unprognostic (2.75e-2)" "unprognostic (2.89e-1)" "unprognostic (1.86e-1)" "unprognostic (3.26e-3)" "prognostic favorable (1.60e-4)" "unprognostic (2.92e-3)" "unprognostic (3.13e-2)" "unprognostic (4.04e-2)" "unprognostic (6.90e-3)" "unprognostic (8.30e-4)" "unprognostic (7.14e-2)" "unprognostic (3.91e-1)" "unprognostic (2.62e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-4)" 0.3 0.2 0.3 0.4 0.3 1.8 0.3 1.7 0.5 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.3 0.1 0.3 185.1 0.3 0.6 0.3 0.3 0.5 0.4 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.7 0.3 1.4 1.4 0.5 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.4 1.2 1.2 0.2 0.8 1.3 0.0 0.5 0.3 2.9 1.6 0.0 0.1 0.5 0.8 0.0 0.0 0.0 1.3 1.1 2.4 0.7 0.0 0.6 0.7 0.0 0.0 0.0 0.6 2.3 1.4 2.6 20.5 0.0 2.2 1.7 0.0 0.0 0.1 0.0 2.0 0.0 1.9 0.8 0.5 0.0 0.6 0.6 1.2 0.4 0.2 0.6 1.8 1.0 0.5 0.0 1.4 1.8 0.7 0.9 0.5 0.5 1.8 0.6 1.3 1.2 0.9 0.6 1.0 0.6 0.8 1.1 1.7 0.6 1.9 0.4 1.2 0.2 1.1 0.7 0.1 1.0 0.7 0.9 0.8 0.5 1.4 1.3 1.3 0.2 0.8 0.2 1.2 0.1 0.0 0.3 0.3 1.7 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 3.4 0.2 0.8 0.0 0.4 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 541.9 0.1 0.0 0.0 8.0 7.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 MAST1 "KIAA0973, SAST" ENSG00000105613 "Microtubule associated serine/threonine kinase 1" Q9Y2H9 19 12833951-12874951 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 51.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 22.6;Cone photoreceptor cells: 41.2;Early spermatids: 13.0;Horizontal cells: 14.3;Rod photoreceptor cells: 18.7" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 3.6;T-reg: 2.0" "Lineage enriched" "Detected in single" 8 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "AN3-CA: 15.0;SCLC-21H: 26.5;SH-SY5Y: 13.2;U-266/70: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028181, HPA073106" Enhanced Supported Vesicles,Cytosol NA NA Vesicles Cytosol "HPA028181: AB_10603872, HPA073106: AB_2732218" "unprognostic (6.32e-2)" "unprognostic (3.66e-2)" "unprognostic (3.93e-2)" "unprognostic (2.83e-5)" "unprognostic (1.72e-1)" "unprognostic (4.19e-2)" "unprognostic (2.38e-1)" "unprognostic (8.72e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "unprognostic (8.89e-3)" "unprognostic (3.43e-2)" "unprognostic (3.84e-3)" "unprognostic (1.19e-1)" "unprognostic (7.04e-2)" "unprognostic (2.49e-2)" "unprognostic (1.96e-1)" 1.2 5.2 20.4 1.7 13.6 1.6 1.5 51.0 40.1 1.1 1.5 1.4 0.0 1.7 1.3 1.2 1.3 1.2 1.6 1.3 16.1 16.3 1.2 1.3 1.2 1.3 8.8 19.5 1.5 1.6 1.2 10.4 1.2 19.9 1.2 1.3 1.6 1.3 1.2 1.2 4.1 1.6 1.3 4.2 1.2 1.5 3.9 2.7 0.0 1.2 0.0 1.3 1.2 0.2 0.4 0.0 0.0 0.2 0.0 3.6 0.1 2.2 1.0 1.0 15.0 0.0 0.0 1.2 0.1 0.1 0.2 0.6 0.5 0.9 3.6 1.7 0.0 2.5 0.0 4.4 0.0 0.0 2.5 2.9 0.3 3.6 1.6 0.0 0.8 0.8 0.3 0.0 0.5 0.5 0.8 0.0 9.8 3.1 1.9 0.0 0.5 1.5 0.4 4.5 0.4 4.6 9.9 3.0 5.1 0.2 0.1 26.5 13.2 0.5 0.9 2.7 0.8 2.4 1.3 0.0 1.8 2.8 2.0 0.5 10.8 8.6 2.1 3.3 2.0 0.1 0.0 0.2 0.0 0.0 0.2 3.6 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 2.0 0.1 20.4 13.6 51.0 34.3 16.1 16.3 8.8 19.5 19.9 2.7 0.0 3.7 0.0 1.9 0.8 22.6 0.8 0.0 1.4 0.0 0.0 41.2 0.4 0.0 0.1 13.0 1.0 0.7 0.0 0.4 0.4 0.7 0.9 1.1 0.8 0.2 14.3 0.0 0.6 1.2 6.5 0.6 1.0 5.0 0.0 0.0 3.6 0.3 2.9 1.1 0.1 18.7 0.0 0.8 2.8 4.1 1.3 0.2 1.0 0.4 0.6 MAST2 "KIAA0807, MAST205" ENSG00000086015 "Microtubule associated serine/threonine kinase 2" Q6P0Q8 1 45786987-46036124 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.3" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 43.3;Cone photoreceptor cells: 51.1;Enterocytes: 45.1;Late spermatids: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039722, HPA040155" Approved Approved Cytosol NA NA Cytosol "HPA039722: AB_10795294, HPA040155: AB_10793957" "unprognostic (7.80e-2)" "unprognostic (3.02e-2)" "unprognostic (5.77e-2)" "unprognostic (1.52e-1)" "unprognostic (3.82e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (4.31e-8)" "unprognostic (8.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.98e-1)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (6.85e-13)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (9.73e-2)" "unprognostic (4.90e-1)" 8.9 4.3 7.0 9.9 8.1 3.7 7.1 7.1 11.8 13.6 15.2 8.4 6.6 11.2 16.7 7.7 8.8 9.5 9.9 25.5 5.0 7.6 4.8 6.1 5.9 4.4 8.9 7.3 19.8 3.6 9.1 10.5 5.5 10.1 13.9 13.9 7.2 8.3 8.6 83.3 5.5 21.3 14.9 5.8 2.5 9.0 24.8 4.8 3.5 5.7 27.4 7.5 16.3 10.6 0.5 1.9 1.4 4.3 1.4 1.4 0.5 14.9 12.1 12.3 9.4 16.1 23.1 13.6 16.0 11.6 14.8 16.5 13.9 4.9 23.4 7.5 19.5 30.0 7.4 14.8 9.1 15.7 11.2 8.0 10.6 13.7 12.7 14.0 5.6 13.6 17.7 11.8 24.8 19.8 18.6 13.8 6.1 8.1 7.2 17.6 10.2 8.2 5.8 10.1 10.1 13.9 12.2 20.6 4.4 7.7 8.1 17.1 10.1 18.8 24.6 8.0 14.1 11.2 5.6 13.4 28.7 18.5 14.9 15.8 9.7 8.7 8.5 19.1 7.7 11.8 0.0 1.1 1.4 1.4 0.6 1.4 0.2 0.7 1.4 1.9 0.5 0.5 1.0 0.0 1.4 4.3 0.1 0.0 0.5 7.0 8.1 7.1 11.8 5.0 7.6 8.9 7.3 10.1 4.8 0.0 1.3 0.0 4.2 3.8 14.9 43.3 2.5 1.4 7.9 3.5 51.1 4.4 1.7 4.2 27.6 5.3 45.1 0.0 5.4 4.0 6.6 7.8 0.0 5.6 5.5 4.8 11.6 3.1 1.6 44.9 8.3 6.4 6.8 1.0 18.3 3.0 6.7 26.6 9.6 4.2 12.7 6.5 6.1 28.4 11.7 2.4 4.6 1.9 18.1 6.0 MAST3 KIAA0561 ENSG00000099308 "Microtubule associated serine/threonine kinase 3" O60307 19 18097793-18151692 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 72.5" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 21.5;Late spermatids: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035061, HPA035062" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA035061: AB_10670585, HPA035062: AB_10671508" "unprognostic (5.94e-3)" "unprognostic (4.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.02e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (1.93e-1)" "unprognostic (4.63e-2)" "unprognostic (1.43e-1)" "unprognostic (3.21e-1)" "prognostic favorable (7.01e-4)" "unprognostic (2.58e-1)" "unprognostic (1.64e-3)" "unprognostic (1.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.58e-3)" "unprognostic (1.26e-3)" 4.6 3.5 20.7 8.3 36.1 12.3 1.8 1.1 72.5 3.8 5.3 19.0 0.2 9.1 3.6 4.9 2.2 4.9 3.1 2.1 19.7 9.3 3.6 6.4 4.6 9.9 13.0 33.6 4.6 14.3 7.1 7.7 2.6 13.0 2.7 4.4 0.7 4.6 4.2 2.6 6.9 8.8 3.0 7.9 11.4 3.9 2.1 12.5 1.8 2.4 0.3 9.4 3.3 2.4 4.4 10.3 23.2 9.7 5.8 8.4 3.1 3.3 5.0 2.3 10.1 6.8 5.5 5.5 3.4 2.2 2.4 3.5 5.0 4.7 8.7 5.2 3.4 2.6 1.8 3.3 1.9 1.7 7.4 4.1 4.0 5.2 7.9 5.8 2.1 13.3 6.3 5.7 3.6 1.4 3.3 1.1 6.0 4.0 5.7 2.7 6.0 4.4 7.0 2.4 7.4 6.2 12.1 2.0 6.4 1.8 1.5 3.8 6.2 4.8 2.8 2.0 1.7 3.2 4.9 4.0 3.1 3.3 13.0 1.4 6.2 8.4 8.0 6.8 11.2 2.8 0.1 4.5 9.4 8.4 5.6 6.2 4.1 4.7 3.3 2.1 4.4 3.7 6.4 23.2 5.8 9.7 10.3 5.0 3.1 20.7 36.1 1.1 72.5 19.7 9.3 13.0 33.6 13.0 12.5 6.0 10.3 7.8 0.7 0.5 3.2 1.1 7.6 0.0 3.4 8.7 2.0 0.5 3.3 2.8 9.1 1.6 20.0 0.0 9.2 1.2 2.2 0.8 2.3 12.5 6.9 0.0 2.4 7.4 21.5 24.6 3.7 7.9 5.0 6.4 6.9 0.8 6.1 8.6 6.3 8.7 0.6 0.0 1.8 0.6 2.8 1.9 0.3 9.6 8.6 0.6 MAT1A "MAT, MATA1, SAMS, SAMS1" ENSG00000151224 "Methionine adenosyltransferase 1A" Q00266 10 80271820-80289684 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "liver: 178.8" "Cell type enriched" "Detected in many" 51 "Hepatocytes: 4835.7" "Cancer enriched" "Detected in many" 54 "liver cancer: 209.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA048627 Supported NA NA 530000 "HPA048627: AB_2680465" "unprognostic (6.92e-2)" "unprognostic (2.63e-1)" "unprognostic (2.88e-2)" "unprognostic (9.43e-2)" "unprognostic (3.79e-2)" "unprognostic (2.49e-2)" "unprognostic (2.03e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.66e-2)" "unprognostic (1.11e-16)" "unprognostic (8.59e-3)" "unprognostic (9.90e-2)" "unprognostic (3.58e-1)" "unprognostic (5.98e-2)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 12.5 0.1 0.2 0.2 0.1 0.0 0.0 0.3 178.8 0.1 0.1 0.1 0.0 0.7 9.9 0.0 0.6 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 45.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 14.0 0.0 1.8 0.0 0.5 76.5 8.1 1.2 1.8 0.0 0.0 1.7 0.0 22.5 0.0 0.0 46.7 3.8 0.0 0.0 0.0 0.0 4835.7 0.1 0.0 0.0 88.4 94.8 4.2 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.1 2.4 0.0 0.0 0.0 0.0 MAT2A "MATA2, MATII, SAMS2" ENSG00000168906 "Methionine adenosyltransferase 2A" P31153 2 85539165-85545280 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 205.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009968, HPA043028" Approved Approved Nucleoplasm,Cytosol NA NA 950000 Nucleoplasm Cytosol "CAB009968: AB_675710, HPA043028: AB_10960707" "unprognostic (1.38e-3)" "unprognostic (2.58e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (5.29e-5)" "unprognostic (9.89e-3)" "unprognostic (5.90e-3)" "prognostic unfavorable (4.87e-4)" "prognostic favorable (8.94e-4)" "prognostic unfavorable (5.94e-5)" "unprognostic (4.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.59e-2)" "unprognostic (9.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (1.77e-2)" 55.9 68.9 37.4 35.3 54.1 20.4 30.3 37.5 50.0 28.6 35.3 74.5 39.7 33.6 35.8 59.8 33.5 44.9 51.6 35.0 41.7 28.5 52.3 26.4 32.9 27.0 74.8 37.6 44.2 205.8 38.8 60.5 29.3 48.9 40.6 36.8 35.0 28.2 31.3 51.4 33.7 35.8 47.6 57.7 24.7 44.6 34.9 69.4 22.7 94.0 34.1 30.8 46.9 33.4 13.8 15.3 4.9 17.2 16.9 22.8 14.9 30.0 44.6 52.4 32.5 36.1 44.1 31.0 37.8 34.9 39.8 42.5 36.4 101.4 70.5 24.9 45.9 32.5 46.9 65.9 56.4 51.2 35.7 48.4 42.1 64.6 31.5 66.0 62.4 47.1 39.9 57.2 42.9 30.0 50.7 37.7 41.0 47.3 55.5 90.3 25.8 56.9 68.8 34.8 25.9 57.5 60.6 49.6 45.7 60.1 47.7 41.3 38.1 34.2 33.0 60.9 27.7 27.9 33.5 36.6 48.9 29.5 26.9 45.1 34.3 27.2 51.0 31.9 78.4 25.6 4.8 15.2 4.9 15.4 17.2 22.8 13.8 17.5 16.2 15.3 12.2 16.4 14.3 1.6 16.9 13.7 10.9 15.3 14.9 37.4 54.1 37.5 50.0 41.7 28.5 74.8 37.6 48.9 69.4 44.7 76.0 36.8 172.0 127.5 81.9 4.5 86.6 34.8 63.7 68.0 64.8 30.7 16.6 50.4 46.3 49.1 61.0 23.3 49.9 34.3 63.9 55.3 83.1 40.6 57.5 25.4 79.9 36.2 106.8 20.7 66.7 92.6 64.1 35.1 55.5 59.7 55.5 42.1 78.8 119.6 80.9 109.9 101.9 51.4 57.7 103.4 31.9 36.2 51.7 86.6 MATK "CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101" ENSG00000007264 "Megakaryocyte-associated tyrosine kinase" P42679 19 3777970-3802129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.3;bone marrow: 19.1;brain: 27.4" "Group enriched" "Detected in many" 6 "granulocytes: 44.9;Hofbauer cells: 58.6;T-cells: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 19.4;NK-cell: 29.3" "Group enriched" "Detected in many" 54 "NK-cells: 29.3;T-cells: 19.4" "Cell line enhanced" "Detected in some" "HL-60: 41.6;HMC-1: 12.8;K-562: 18.5;MCF7: 13.5;NB-4: 29.0;SCLC-21H: 12.7;THP-1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004847, HPA066547" Approved Approved "Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol" "HPA004847: AB_1079316, HPA066547: " "prognostic favorable (5.27e-4)" "unprognostic (1.28e-2)" "unprognostic (1.84e-1)" "unprognostic (3.54e-2)" "unprognostic (3.36e-1)" "unprognostic (3.39e-2)" "unprognostic (9.50e-2)" "unprognostic (1.23e-1)" "unprognostic (7.91e-2)" "unprognostic (3.19e-3)" "unprognostic (2.07e-2)" "unprognostic (4.51e-2)" "unprognostic (1.16e-2)" "unprognostic (7.59e-2)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (2.33e-2)" 11.2 1.6 22.1 6.8 18.1 19.1 2.2 1.5 27.4 1.5 2.3 1.7 0.0 7.0 1.2 0.4 1.1 4.7 5.1 1.7 25.1 10.0 1.1 2.8 7.3 9.6 7.0 11.0 1.0 1.6 0.1 1.4 1.4 6.1 1.2 1.4 0.6 3.8 1.0 0.8 1.6 6.7 1.1 2.8 14.8 4.1 2.1 1.3 3.5 0.9 0.0 4.5 2.4 0.7 0.4 0.3 0.4 0.0 29.3 19.4 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.4 4.2 5.5 0.1 0.0 0.0 7.2 4.6 0.5 1.1 0.0 41.6 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.5 0.0 0.0 13.5 0.1 29.0 3.4 3.5 0.1 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.4 0.0 10.9 1.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 13.2 0.0 2.5 12.2 0.3 0.4 1.2 7.1 0.4 29.3 0.0 0.1 0.1 2.7 22.1 18.1 1.5 27.4 25.1 10.0 7.0 11.0 6.1 1.3 0.0 1.4 2.4 0.0 0.3 1.7 1.1 0.0 1.4 0.0 0.0 11.8 0.2 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.3 0.5 0.1 44.9 0.8 58.6 0.0 6.8 11.6 3.5 4.0 0.0 7.2 1.7 1.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.3 2.7 1.0 0.2 105.8 0.1 0.0 MATN1 "CMP, CRTM" ENSG00000162510 "Matrilin 1, cartilage matrix protein" P21941 1 30711277-30723587 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 6.6" "Cell type enhanced" "Detected in some" 14 "B-cells: 2.7;Club cells: 1.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 3.0" "Group enriched" "Detected in many" 10 "B-cells: 3.0;T-cells: 2.3" "Cell line enhanced" "Detected in some" "EFO-21: 3.5;Karpas-707: 3.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA028580 Supported "Secreted to extracellular matrix" NA NA "HPA028580: AB_10601913" "unprognostic (4.71e-2)" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (3.75e-6)" "unprognostic (9.93e-2)" "unprognostic (4.10e-1)" "unprognostic (1.31e-3)" "unprognostic (2.63e-1)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (7.31e-2)" "unprognostic (5.22e-2)" "unprognostic (4.01e-13)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-2)" "unprognostic (3.42e-2)" 0.4 0.4 1.1 1.0 0.7 2.6 0.4 0.4 1.7 2.0 0.4 0.4 0.4 0.3 1.7 0.6 0.4 0.9 0.7 0.4 1.2 1.1 0.4 0.4 6.6 2.0 1.1 0.4 2.9 0.6 0.0 1.1 1.1 0.4 0.5 0.0 0.4 1.4 0.4 0.4 0.9 0.5 0.4 1.4 1.4 0.5 1.0 0.4 0.4 1.4 0.4 0.4 0.5 1.2 3.0 0.1 0.2 0.1 0.0 2.3 0.6 0.9 0.5 0.2 1.0 0.2 0.0 0.3 0.5 0.2 0.1 0.0 0.1 1.5 0.7 3.5 0.1 0.7 1.3 0.2 0.1 0.2 1.5 0.4 1.3 1.0 0.1 0.0 0.4 1.0 0.0 0.0 0.0 0.9 0.6 0.0 0.4 2.0 3.5 0.0 1.4 0.1 0.2 0.2 0.3 1.0 0.5 1.4 0.5 0.0 0.4 0.4 0.6 0.5 0.4 0.8 0.6 0.4 1.2 0.6 0.3 0.8 0.2 0.8 0.9 0.1 0.3 0.0 0.6 2.1 0.0 0.1 0.0 0.5 0.0 0.9 0.9 0.6 0.5 0.0 3.0 2.3 1.2 0.2 0.0 0.0 0.1 0.8 0.6 1.1 0.7 0.4 1.7 1.2 1.1 1.1 0.4 0.4 0.4 0.0 0.3 2.7 0.5 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 0.5 0.1 0.2 0.0 0.0 0.1 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992111-20012694 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.5;placenta: 16.6" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 35.7;Sertoli cells: 25.8;Smooth muscle cells: 11.4" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "Hep G2: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA051250: AB_2681406" "unprognostic (3.47e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.4 1.3 6.6 1.0 5.1 0.3 3.4 1.8 7.9 4.1 1.0 2.4 2.6 0.9 2.7 1.8 1.4 2.6 3.4 0.9 6.2 4.9 4.1 0.4 19.5 0.7 8.6 3.7 1.1 1.3 0.4 0.3 16.6 7.4 2.7 1.0 1.9 0.8 7.2 0.5 0.9 0.8 2.8 7.9 0.7 2.8 1.6 6.0 0.0 1.7 0.0 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 1.9 6.5 0.0 1.9 4.1 0.4 0.8 0.4 2.6 3.4 1.8 1.1 0.0 0.3 0.6 2.5 0.4 0.1 5.0 3.8 0.0 0.1 0.0 0.4 56.1 0.4 0.0 0.0 8.8 0.3 2.9 0.7 1.8 3.5 0.0 0.0 0.0 5.5 0.9 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 7.9 1.7 0.0 0.8 4.2 0.7 2.4 11.6 7.7 0.0 1.9 3.9 4.8 0.1 0.4 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.1 1.8 7.9 6.2 4.9 8.6 3.7 7.4 6.0 35.7 2.1 0.0 0.3 0.2 0.0 0.2 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.2 1.6 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.7 0.0 4.2 0.3 0.0 25.8 11.4 0.0 1.5 0.1 0.1 0.0 0.0 0.1 MATN4 ENSG00000124159 "Matrilin 4" O95460 20 45293445-45308529 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 5.7;Exocrine glandular cells: 2.3;Spermatogonia: 3.8;Suprabasal keratinocytes: 3.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.1;NB-4: 7.0;SK-MEL-30: 2.3;U-937: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (1.54e-1)" "unprognostic (2.39e-2)" "unprognostic (2.22e-2)" "unprognostic (3.60e-2)" "unprognostic (8.38e-2)" "unprognostic (9.67e-2)" "unprognostic (1.84e-1)" "unprognostic (6.79e-2)" "unprognostic (6.27e-2)" "unprognostic (6.74e-3)" "unprognostic (5.53e-1)" "unprognostic (6.19e-3)" "unprognostic (3.63e-6)" "unprognostic (2.38e-1)" "unprognostic (4.69e-2)" "unprognostic (4.27e-1)" "unprognostic (5.38e-2)" 0.6 0.0 0.1 0.0 0.2 0.1 2.4 0.0 0.2 1.4 0.0 0.0 21.5 0.0 0.6 0.6 0.2 0.1 0.1 1.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.3 0.0 0.1 0.2 0.0 1.9 1.5 17.7 0.0 4.1 0.0 0.0 0.3 0.0 0.4 1.6 0.0 0.2 0.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.4 0.4 3.1 0.4 0.1 0.3 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.0 0.4 0.0 7.0 0.3 0.0 1.0 0.0 0.1 0.0 0.3 0.2 0.5 0.0 0.1 0.3 2.3 0.0 0.1 0.6 0.0 0.2 1.0 0.0 0.1 0.1 0.6 0.2 0.2 3.5 0.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 5.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 2.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.4 3.8 3.8 0.2 0.0 0.0 0.9 MB PVALB ENSG00000198125 Myoglobin P02144 22 35606764-35637951 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7" "Cell type enriched" "Detected in many" 38 "Cardiomyocytes: 4117.3" "Group enriched" "Detected in many" 7 "breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "NK-cell: 4.4" "Lineage enriched" "Detected in single" 6 "NK-cells: 4.4" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 62.9" "Not detected" "Not detected" "CAB000060, HPA003123" Enhanced NA NA 13500000 190000000 "CAB000060: , HPA003123: AB_1079442" "unprognostic (7.51e-2)" "unprognostic (3.92e-3)" "unprognostic (1.07e-1)" "unprognostic (7.71e-2)" "unprognostic (2.35e-1)" "unprognostic (4.66e-3)" "unprognostic (5.78e-3)" "unprognostic (1.18e-1)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (2.74e-3)" "unprognostic (1.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.51e-2)" "unprognostic (2.35e-1)" "unprognostic (3.44e-3)" "unprognostic (1.19e-2)" 3.6 0.1 0.2 0.1 0.2 0.0 1.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 13.0 19.6 0.4 0.0 366.6 0.2 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.1 0.7 0.0 0.3 0.1 0.0 5.0 0.3 0.0 13.0 0.0 871.2 0.3 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.0 4.6 310.7 14.4 0.3 0.1 0.1 0.4 0.1 0.0 4.4 0.7 0.0 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 6.4 0.0 0.2 0.0 0.6 0.9 0.3 0.2 2.7 0.0 2.2 0.5 0.0 6.7 62.9 0.0 0.1 14.0 0.0 0.1 0.2 0.4 0.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 4117.3 0.0 20.1 3.4 0.0 0.0 0.0 0.0 3.6 20.4 0.0 1.6 0.0 0.2 0.0 0.0 28.6 0.0 0.0 0.0 0.0 11.1 0.0 0.0 52.6 0.0 0.0 11.8 0.0 109.2 0.0 0.4 2.9 0.7 0.0 0.0 0.0 1.9 0.4 0.6 0.1 0.2 0.0 2.6 8.4 MB21D2 C3orf59 ENSG00000180611 "Mab-21 domain containing 2" Q8IYB1 3 192796815-192918161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 34.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 55.7;Syncytiotrophoblasts: 92.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 6.6;T-reg: 5.5" "Lineage enriched" "Detected in single" 10 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "HDLM-2: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044026 Approved Approved Cytosol NA NA Cytosol "HPA044026: AB_10962840" "unprognostic (3.52e-2)" "unprognostic (1.02e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (3.74e-5)" "unprognostic (2.42e-2)" "prognostic unfavorable (9.94e-4)" "unprognostic (2.76e-2)" "unprognostic (3.50e-2)" "unprognostic (1.53e-1)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-3)" "unprognostic (5.94e-3)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (3.28e-2)" 5.7 6.0 4.4 4.4 6.9 1.6 5.1 11.1 10.9 5.8 6.9 5.6 2.7 12.0 7.3 2.9 3.2 5.3 10.1 7.6 3.9 5.0 5.8 2.3 5.9 3.1 4.4 3.5 6.5 2.8 5.6 8.6 34.9 4.6 4.9 4.3 4.0 3.1 3.9 4.9 8.6 15.7 7.8 3.5 3.0 5.1 11.4 3.3 1.2 3.3 2.5 2.5 8.7 5.0 0.3 0.6 0.0 0.6 0.0 6.6 1.8 9.9 1.4 2.4 7.3 1.5 2.3 4.4 7.2 6.7 13.0 7.8 6.4 1.6 0.0 4.3 17.6 5.4 4.4 5.6 1.8 14.2 43.0 3.1 1.2 0.7 0.7 2.9 0.1 0.6 3.0 2.8 3.6 2.2 1.0 2.5 1.2 0.0 0.6 2.2 7.3 0.1 0.0 5.1 5.4 17.8 0.2 4.0 2.0 3.0 5.7 3.8 1.9 1.5 4.9 0.7 5.2 7.7 0.1 0.8 2.4 7.3 4.3 13.7 19.1 15.1 0.0 1.7 1.5 3.3 0.0 0.3 0.0 0.3 0.6 2.9 0.3 6.6 1.7 0.6 0.0 4.2 1.2 0.0 0.0 0.0 0.0 5.5 1.8 4.4 6.9 11.1 10.9 3.9 5.0 4.4 3.5 4.6 3.3 6.0 0.3 0.9 0.8 8.1 10.6 1.0 0.0 1.4 1.2 0.0 2.0 55.7 0.0 5.2 0.1 4.8 2.9 0.0 0.2 7.2 7.6 0.7 0.0 0.0 5.0 7.9 9.8 9.8 4.3 1.3 2.8 10.7 13.5 22.6 2.4 1.0 1.6 5.8 5.6 8.4 0.7 12.9 4.7 2.1 19.4 7.5 92.3 1.3 2.5 0.9 MBD3L1 MBD3L ENSG00000170948 "Methyl-CpG binding domain protein 3 like 1" Q8WWY6 19 8832398-8843340 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.8" "Group enriched" "Detected in some" 29 "Early spermatids: 297.0;Late spermatids: 80.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.4;U-266/84: 1.3" "Not detected" "Not detected" "HPA043121, HPA046753" Supported NA NA "HPA043121: AB_2678327, HPA046753: AB_2679786" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.4 1.4 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 297.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 80.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 1.9 1.9 0.0 0.0 0.0 0.0 0.0 MBD3L2 ENSG00000230522 "Methyl-CpG binding domain protein 3 like 2" Q8NHZ7 19 7049321-7051735 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 2.9" HPA060924 Uncertain Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L2B ENSG00000196589 "Methyl-CpG binding domain protein 3 like 2B" A0A1B0GVZ6 19 7018969-7021450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 18 "testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "U-2 OS: 2.7" HPA060924 Uncertain Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L3 ENSG00000182315 "Methyl-CpG binding domain protein 3 like 3" A6NE82 19 7056209-7058640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HUVEC TERT2: 1.3" HPA060924 Approved Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L4 ENSG00000205718 "Methyl-CpG binding domain protein 3 like 4" A6NDZ8 19 7037748-7040179 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.6" HPA060924 Approved Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBD3L5 ENSG00000237247 "Methyl-CpG binding domain protein 3 like 5" A6NJ08 19 7030578-7033011 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "smooth muscle: 1.0;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060924 Approved Mitochondria NA NA Mitochondria "HPA060924: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 218.5;Club cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favorable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favorable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.6 8.7 18.7 18.8 18.8 18.2 14.1 14.3 17.8 19.0 20.0 17.8 16.8 15.8 21.9 18.4 10.0 12.8 19.6 13.2 23.4 22.8 14.7 9.2 8.7 30.3 20.5 18.8 10.3 18.6 20.4 12.4 16.1 19.7 11.8 22.2 15.8 19.8 14.0 16.0 18.0 15.3 15.8 14.3 26.0 8.7 16.3 11.0 21.4 12.9 28.0 11.1 11.8 11.4 18.9 16.7 18.6 12.3 9.2 21.2 13.8 15.5 14.7 16.4 18.9 24.8 8.1 9.7 14.6 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 202.5 218.5 10.4 31.7 80.1 24.3 9.4 2.5 50.9 169.5 24.4 2.0 20.7 49.7 17.7 2.7 17.7 14.6 0.0 16.6 17.7 24.9 20.7 12.7 21.2 15.9 87.4 30.2 15.4 9.9 2.5 29.7 14.5 20.3 9.0 12.1 23.6 16.8 17.5 25.5 38.3 22.5 12.9 21.2 42.9 36.4 57.2 16.6 14.9 17.7 12.9 MBL2 "COLEC1, MBL" ENSG00000165471 "Mannose binding lectin 2" P11226 10 52765380-52771700 "Plasma proteins, Predicted secreted proteins" "Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 825 "liver: 82.5" "Cell type enriched" "Detected in some" 62 "Hepatocytes: 190.6" "Cancer enriched" "Detected in single" 275 "liver cancer: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "Hep G2: 7.0" "Region enriched" "Detected in single" 5 "pons and medulla: 0.5" "Not detected" "Not detected" "HPA002027, CAB016782" Enhanced "Secreted to blood" NA NA 1220000000 1700000000 "CAB016782: , HPA002027: AB_1079324" "unprognostic (1.72e-2)" "unprognostic (3.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.6 0.0 0.0 0.0 3.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.0" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 253.9;Hepatocytes: 109.0;Syncytiotrophoblasts: 287.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 39.8;Hep G2: 54.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.6 10.4 1.8 14.7 1.9 5.1 7.5 0.9 1.6 3.8 5.9 2.8 10.8 4.0 4.8 25.8 9.6 4.6 4.6 14.2 1.6 1.9 5.6 23.5 12.0 16.2 3.0 1.1 5.5 10.4 2.4 6.3 67.0 1.8 5.4 4.7 2.8 5.5 6.1 1.6 5.5 9.7 6.7 3.5 15.2 5.2 23.8 1.9 18.6 3.5 7.9 10.8 8.3 8.3 18.1 12.3 7.2 14.0 13.4 12.5 6.2 2.2 0.0 2.8 0.4 0.5 1.2 5.2 0.1 1.0 0.3 0.0 39.8 7.4 10.4 0.2 0.4 0.3 2.5 6.5 2.6 0.2 1.0 2.5 9.3 8.6 54.6 0.5 10.3 3.4 0.5 2.4 0.0 1.2 0.0 0.3 6.6 0.8 3.0 0.5 6.1 17.6 3.9 0.4 8.8 0.5 16.8 3.5 5.9 1.9 6.0 1.0 3.5 4.8 2.8 1.4 5.2 1.0 2.7 1.2 2.1 0.4 2.7 2.1 6.0 4.0 15.3 0.4 7.0 6.6 7.2 5.9 3.7 12.5 6.9 11.1 15.0 7.7 8.6 6.2 18.1 7.8 8.7 0.9 13.4 14.0 12.3 1.5 6.2 1.8 1.9 0.9 1.6 1.6 1.9 3.0 1.1 1.8 1.9 3.0 5.0 11.9 1.8 7.8 0.3 8.9 45.9 6.7 6.8 10.4 0.0 253.9 3.3 1.3 4.2 2.4 8.8 46.7 4.7 36.5 5.1 1.2 8.1 109.0 25.7 0.0 6.4 6.7 23.7 6.2 21.3 5.6 6.8 1.0 11.4 0.3 1.2 0.0 47.7 5.9 1.8 0.0 1.2 0.9 1.2 7.4 287.8 10.0 8.3 3.3 MBOAT2 "FLJ14415, FLJ90298, OACT2" ENSG00000143797 "Membrane bound O-acyltransferase domain containing 2" Q6ZWT7 2 8852690-9003813 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.7" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 133.5;Muller glia cells: 95.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014836 Uncertain Approved Vesicles NA NA Vesicles "HPA014836: AB_1854745" "unprognostic (2.49e-1)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.13e-9)" "unprognostic (1.30e-1)" "unprognostic (2.32e-2)" "unprognostic (2.38e-1)" "unprognostic (3.97e-3)" "unprognostic (3.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.03e-3)" "unprognostic (1.70e-1)" "unprognostic (5.90e-2)" "unprognostic (2.23e-1)" "unprognostic (3.04e-2)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.32e-4)" 2.3 2.9 12.8 2.9 18.0 24.2 10.1 10.1 20.2 6.0 8.2 16.6 1.2 3.1 5.3 3.5 14.2 3.7 4.3 5.1 14.7 12.4 8.0 1.3 10.9 2.9 23.3 10.3 6.8 2.1 34.7 5.5 3.8 16.2 16.1 9.3 6.4 5.6 4.1 1.2 12.3 4.3 4.6 18.5 2.5 6.9 2.7 17.8 1.9 5.3 16.1 10.3 4.4 7.5 0.0 0.8 6.7 0.7 0.0 0.2 0.3 8.4 2.6 7.9 3.4 3.6 8.0 4.6 4.1 1.5 5.3 3.5 0.7 13.5 2.4 4.9 9.7 4.2 6.5 7.0 8.2 8.0 7.5 12.1 10.1 3.7 0.0 4.4 0.0 3.2 5.8 4.9 5.0 3.5 11.7 2.8 3.5 8.6 1.9 4.6 2.2 3.0 0.2 3.1 3.8 10.0 4.5 12.5 0.1 7.8 1.2 4.7 14.5 4.2 25.5 4.0 4.1 4.8 2.9 1.5 9.4 5.0 7.2 11.6 0.7 0.2 2.7 14.7 1.4 3.1 6.3 0.7 2.8 0.0 0.2 0.0 0.0 0.2 0.1 0.8 0.0 0.2 0.1 6.7 0.0 0.2 0.1 0.0 0.3 12.8 18.0 10.1 15.8 14.7 12.4 23.3 10.3 16.2 17.8 17.9 10.1 4.5 2.9 3.0 18.3 10.6 5.1 16.0 19.4 38.4 7.9 2.5 5.0 4.5 7.3 8.8 10.3 46.7 1.4 1.3 9.8 21.0 8.1 0.0 1.7 133.5 36.0 4.3 2.1 7.8 4.9 4.3 13.5 44.1 49.8 95.3 52.2 20.4 7.1 8.4 7.2 6.5 12.0 10.7 23.7 4.4 1.6 2.1 11.9 29.8 MBOAT4 "FKSG89, GOAT, OACT4" ENSG00000177669 "Membrane bound O-acyltransferase domain containing 4" Q96T53 8 30131824-30144686 "Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 23.9;stomach 1: 7.7" "Cell type enhanced" "Detected in some" 22 "Cholangiocytes: 5.1;Ductal cells: 1.6;Early spermatids: 1.0;Intestinal endocrine cells: 3.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;Hep G2: 6.9;OE19: 7.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044509 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA044509: AB_2678966" "unprognostic (4.35e-3)" "unprognostic (2.08e-1)" "unprognostic (2.55e-1)" "unprognostic (3.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.76e-2)" "unprognostic (1.85e-3)" "unprognostic (4.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.07e-1)" "unprognostic (6.30e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-6)" "unprognostic (9.87e-3)" "unprognostic (1.58e-1)" "unprognostic (2.18e-1)" "unprognostic (3.66e-2)" 0.4 1.8 0.3 0.5 0.6 1.0 0.3 0.3 0.3 0.3 0.5 0.3 0.3 0.8 0.9 0.3 0.3 3.9 2.1 0.4 0.3 0.1 0.4 1.5 0.9 0.8 0.3 0.3 0.5 23.9 0.0 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.1 1.3 0.3 0.3 1.4 7.7 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.8 0.7 2.6 1.5 2.8 4.1 0.6 0.4 1.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 1.9 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.3 0.3 0.1 6.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.6 0.0 0.1 0.5 0.3 0.0 7.7 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.2 1.3 0.0 0.2 0.1 0.0 0.0 1.1 0.8 0.4 0.6 0.6 2.1 0.5 1.5 2.4 0.0 1.6 2.0 0.7 1.8 2.4 4.1 2.6 2.8 0.2 0.4 0.5 0.6 0.3 0.6 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBP ENSG00000197971 "Myelin basic protein" P02686 18 76978827-77133683 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autoimmune encephalomyelitis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 1297.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 9 "glioma: 47.5;melanoma: 20.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 29.0;SK-MEL-30: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002300, HPA049222, HPA064368" Enhanced Supported Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002300: AB_563893, HPA049222: AB_2680679, HPA064368: AB_2685247" "unprognostic (9.36e-2)" "unprognostic (7.60e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" "unprognostic (6.93e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (3.31e-1)" "unprognostic (9.87e-2)" "unprognostic (2.90e-2)" "unprognostic (5.25e-2)" "unprognostic (1.95e-1)" "prognostic favorable (4.48e-12)" "unprognostic (2.90e-1)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" 4.0 3.4 271.6 6.1 244.9 10.1 4.5 28.7 418.9 5.6 5.5 487.7 0.0 5.9 4.4 3.6 6.4 9.0 5.7 6.8 355.0 247.6 6.2 5.9 6.2 7.1 645.5 43.4 3.7 6.8 16.4 0.7 2.7 242.9 4.5 5.6 0.4 5.0 4.9 29.9 7.9 6.2 3.8 1297.7 7.6 5.1 2.9 224.3 0.0 6.8 0.0 7.7 6.0 0.6 3.4 6.8 23.7 4.7 15.4 17.1 5.6 7.5 6.6 0.0 0.2 11.2 16.7 2.6 0.2 0.2 0.2 0.1 0.9 11.8 4.7 1.3 0.5 0.0 15.0 1.1 6.6 0.2 18.2 1.6 3.0 1.1 1.5 7.0 29.0 20.2 2.4 5.6 6.0 9.3 5.0 1.9 11.4 0.0 1.0 0.0 0.9 1.1 14.9 0.6 4.5 5.3 0.4 0.1 10.5 10.6 10.3 0.5 0.1 0.9 0.0 60.4 1.9 0.2 17.8 0.0 0.0 0.1 0.0 0.8 0.0 0.1 5.0 1.8 18.3 0.7 11.0 4.7 17.8 13.2 4.6 8.0 3.4 9.4 17.1 5.3 3.3 5.7 10.5 23.7 15.4 4.4 6.8 7.9 5.6 271.6 244.9 28.7 127.7 355.0 247.6 645.5 43.4 242.9 224.3 44.7 33.2 33.8 46.5 105.6 50.2 38.2 38.2 56.2 44.3 97.7 2.0 0.6 34.9 38.1 4.8 9.9 40.8 46.7 31.6 0.6 21.8 82.0 69.4 25.5 41.0 1.6 47.8 11.1 60.5 4.5 26.2 83.3 87.7 24.4 45.4 26.0 43.3 23.0 13.4 28.1 6.2 0.0 6.6 4.8 0.7 135.3 0.6 123.7 33.3 87.7 MC2R ACTHR ENSG00000185231 "Melanocortin 2 receptor" Q01718 18 13882044-13915707 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 31.7;pituitary gland: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "HeLa: 1.7;MCF7: 3.6;SuSa: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA079148 Enhanced NA NA "HPA079148: " "unprognostic (2.09e-1)" "unprognostic (3.63e-2)" "unprognostic (1.85e-2)" 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 14.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.1 1.3 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.3 0.1 0.3 1.1 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.4 0.1 0.3 0.1 0.9 0.1 0.0 0.5 0.0 1.7 0.2 0.0 0.2 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.2 0.1 0.4 0.0 3.6 0.0 0.0 0.6 0.0 0.1 0.2 0.5 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 1.8 0.1 0.3 0.0 0.2 0.3 0.5 0.0 0.2 0.2 0.0 0.1 0.4 0.0 1.3 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MC3R MC3 ENSG00000124089 "Melanocortin 3 receptor" P41968 20 56248732-56249815 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "hTERT-HME1: 2.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 4.8;hypothalamus: 3.3;thalamus: 2.6" HPA074739 Uncertain NA NA "HPA074739: " 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MC4R ENSG00000166603 "Melanocortin 4 receptor" P32245 18 60371110-60372775 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.8;fallopian tube: 10.3" "Group enriched" "Detected in some" 11 "Bipolar cells: 1.1;Rod photoreceptor cells: 1.1" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 69 "fHDF/TERT166: 47.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA016719 Uncertain NA NA "HPA016719: AB_1853617" "unprognostic (2.29e-1)" "unprognostic (5.31e-3)" "unprognostic (5.78e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (3.33e-1)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (2.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.59e-1)" 0.4 1.1 4.0 0.3 9.8 0.2 0.9 0.7 6.4 0.5 0.5 0.3 0.0 0.6 0.4 1.3 0.4 10.3 0.4 0.4 3.0 7.8 0.4 0.2 0.3 0.4 1.1 7.6 0.6 0.2 0.2 0.3 0.2 3.3 0.4 0.5 0.1 2.5 0.5 0.2 0.3 0.4 0.2 0.8 0.8 0.6 0.6 5.1 0.0 0.2 0.0 1.4 0.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.8 0.7 6.4 3.0 7.8 1.1 7.6 3.3 5.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MC5R ENSG00000176136 "Melanocortin 5 receptor" P33032 18 13824149-13827323 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 7.9;esophagus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;OE19: 1.6;SiHa: 1.7;U-138 MG: 6.2;U-2 OS: 1.4;U-2197: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA042365, HPA058088" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA042365: AB_2677961, HPA058088: " "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (8.77e-2)" "unprognostic (7.10e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-2)" "unprognostic (9.04e-3)" "unprognostic (1.54e-1)" 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 0.0 7.9 2.7 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.4 0.1 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 6.2 1.4 1.2 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCC ENSG00000171444 "Mutated in colorectal cancers" P23508 5 113022099-113488830 "Predicted intracellular proteins" "Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 49.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 97.8;Cone photoreceptor cells: 53.0;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.2;hTCEpi: 19.0;RT4: 17.6" "Low region specificity" "Detected in all" "HPA037390, HPA037391" Approved Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytosol" "Cytoplasmic bodies" "HPA037390: AB_2675451, HPA037391: AB_10671248" "unprognostic (6.60e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (8.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (5.21e-2)" "unprognostic (9.59e-2)" "unprognostic (8.02e-3)" "unprognostic (1.56e-1)" "unprognostic (1.74e-1)" "prognostic favorable (6.19e-4)" "unprognostic (1.70e-3)" "unprognostic (3.34e-1)" "unprognostic (2.47e-2)" "unprognostic (2.90e-1)" 7.1 2.3 6.9 3.2 6.1 0.5 7.8 11.4 8.1 11.8 3.2 3.4 5.9 1.7 12.5 4.7 9.1 7.4 4.4 8.4 9.2 5.0 3.9 12.7 4.6 3.0 7.6 5.1 49.4 4.5 28.9 5.2 7.1 7.8 7.7 2.4 15.1 6.7 9.5 5.0 13.9 2.6 9.1 5.8 3.4 3.6 6.5 5.2 1.3 3.2 6.1 4.3 9.3 11.8 0.2 6.3 1.3 0.2 0.1 1.6 0.1 0.4 0.1 7.2 0.7 6.2 5.8 7.9 1.2 3.2 1.3 1.6 0.2 6.5 0.0 7.6 0.5 3.6 8.7 4.3 28.2 0.6 2.3 2.7 0.0 2.5 1.9 1.8 0.3 0.1 7.7 19.0 3.5 13.4 7.2 8.4 0.9 0.0 10.7 2.9 0.6 0.1 0.1 3.9 0.0 0.5 0.1 6.3 1.9 0.1 17.6 3.1 6.8 5.8 0.0 15.4 2.6 2.3 0.0 10.0 4.9 4.6 7.6 2.2 3.1 0.0 0.0 13.1 0.0 5.1 0.0 0.2 0.1 0.5 0.2 1.6 0.2 0.5 0.6 0.0 0.2 0.4 0.5 1.3 0.1 0.1 6.3 1.5 0.1 6.9 6.1 11.4 8.1 9.2 5.0 7.6 5.1 7.8 5.2 0.0 0.6 0.5 24.4 33.4 97.8 13.9 7.6 0.0 3.4 3.5 53.0 0.7 0.0 2.9 10.6 23.9 0.0 0.0 1.2 1.7 27.7 5.4 0.0 50.6 2.0 35.0 4.6 25.2 4.0 24.2 19.5 0.5 15.1 5.4 0.2 7.4 3.0 0.2 25.5 1.4 8.2 0.0 10.3 8.2 8.5 41.3 1.0 2.9 0.0 14.9 MCCC2 MCCB ENSG00000131844 "Methylcrotonoyl-CoA carboxylase 2" Q9HCC0 5 71587288-71658704 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 74.3" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038300, HPA038301, HPA061546" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557" "unprognostic (2.39e-1)" "unprognostic (6.89e-3)" "prognostic favorable (3.62e-4)" "unprognostic (1.79e-2)" "unprognostic (1.89e-2)" "unprognostic (8.07e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (5.39e-2)" "unprognostic (2.90e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.43e-8)" "unprognostic (1.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" 12.4 29.4 9.2 11.8 13.6 2.7 30.5 7.9 10.0 11.2 15.3 12.2 15.1 13.0 9.7 20.0 14.5 9.1 12.3 74.3 7.6 8.1 35.6 61.9 8.4 11.6 7.8 8.0 9.6 18.9 14.1 10.3 15.1 13.4 24.6 18.1 12.8 20.6 29.4 17.6 10.8 14.1 7.8 17.0 11.0 13.6 6.9 6.9 9.4 22.2 13.3 14.3 15.7 8.5 8.8 16.7 1.7 11.5 12.9 10.2 6.7 11.9 16.5 7.1 27.1 7.6 7.8 12.1 5.7 9.6 11.8 8.5 28.9 15.2 27.7 21.0 8.3 9.2 9.9 12.3 19.0 14.8 14.7 15.7 15.0 8.5 31.7 13.3 7.4 14.3 10.0 10.0 10.8 8.6 5.3 10.3 8.0 18.9 10.4 8.1 32.6 0.1 13.6 9.3 10.5 9.3 14.5 20.4 40.7 30.6 21.6 11.2 12.4 24.9 36.9 12.1 3.5 30.6 18.9 7.5 4.8 7.5 8.7 15.3 7.5 13.8 17.2 7.9 20.7 11.9 1.7 7.4 1.6 6.1 11.5 7.9 8.8 7.9 6.9 16.7 8.6 8.0 8.7 1.2 12.9 6.8 7.4 10.2 6.7 9.2 13.6 7.9 10.0 7.6 8.1 7.8 8.0 13.4 6.9 14.9 23.4 22.9 14.2 11.7 12.8 60.9 17.8 16.0 18.2 15.7 5.9 40.3 18.3 18.3 3.1 14.2 19.6 0.0 16.1 19.0 8.9 25.3 12.7 79.8 15.6 3.2 28.4 8.0 10.8 7.4 12.7 12.2 11.8 19.0 22.7 19.0 14.2 17.5 19.1 48.4 11.4 6.5 9.1 3.9 13.3 12.0 53.2 12.9 28.8 18.5 MCCD1 ENSG00000204511 "Mitochondrial coiled-coil domain 1" P59942 6 31528717-31530232 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 188 "kidney: 63.6" "Group enriched" "Detected in some" 34 "Distal tubular cells: 339.8;Proximal tubular cells: 251.4" "Cancer enhanced" "Detected in some" "liver cancer: 2.4;renal cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (2.71e-1)" "unprognostic (3.22e-2)" "prognostic favorable (1.73e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 63.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 339.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 251.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCEMP1 "C19orf59, MGC132456" ENSG00000183019 "Mast cell expressed membrane protein 1" Q8IX19 19 7676628-7679826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 34.6;Club cells: 20.5;Hofbauer cells: 30.0;Kupffer cells: 41.3;Macrophages: 51.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 2.9" "Group enriched" "Detected in some" 5 "classical monocyte: 36.5;neutrophil: 16.6" "Group enriched" "Detected in many" 5 "granulocytes: 16.6;monocytes: 36.5" "Group enriched" "Detected in some" 6 "THP-1: 19.2;U-937: 59.8" HPA014731 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014731: AB_1845619" "unprognostic (4.84e-2)" "unprognostic (9.81e-4)" "unprognostic (2.41e-1)" "unprognostic (4.36e-2)" "unprognostic (8.85e-3)" "unprognostic (2.62e-3)" "unprognostic (5.57e-3)" "unprognostic (1.42e-1)" "unprognostic (2.19e-1)" "unprognostic (4.36e-2)" "unprognostic (1.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.69e-5)" "unprognostic (1.15e-2)" "unprognostic (7.37e-2)" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" 2.2 0.3 0.3 10.0 0.5 30.9 0.5 0.4 0.9 0.1 0.3 0.0 0.0 0.1 0.1 0.2 0.3 1.2 0.2 4.8 0.2 0.2 0.6 1.3 66.4 11.8 2.9 0.0 0.4 0.4 0.0 0.1 0.8 0.6 0.4 0.0 0.1 0.6 0.0 0.2 0.1 0.3 2.4 0.9 24.2 0.6 0.7 0.3 0.3 0.7 0.0 0.1 0.5 2.9 0.0 5.3 16.6 36.5 0.2 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.8 0.0 0.0 36.5 0.9 0.1 2.1 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.1 16.6 0.2 0.1 0.3 0.1 11.6 0.3 0.5 0.4 0.9 0.2 0.2 2.9 0.0 0.6 0.3 17.9 34.6 1.4 0.0 0.0 0.0 0.3 0.0 9.4 20.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 7.0 0.0 30.0 0.0 0.0 0.0 41.3 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 MCF2 "ARHGEF21, DBL" ENSG00000101977 "MCF.2 cell line derived transforming sequence" P10911 X 139581770-139708227 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 30.7;brain: 23.1;seminal vesicle: 18.8;testis: 18.2" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 92.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "U-251 MG: 28.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.42e-1)" "unprognostic (2.18e-2)" "unprognostic (1.46e-2)" "unprognostic (5.11e-4)" "unprognostic (8.95e-2)" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (1.80e-1)" "unprognostic (1.28e-1)" "unprognostic (2.63e-2)" "unprognostic (7.77e-2)" "unprognostic (2.33e-3)" "unprognostic (3.68e-2)" "unprognostic (2.92e-2)" "unprognostic (4.62e-4)" "unprognostic (4.02e-2)" 0.7 30.7 5.2 0.8 8.1 1.0 0.5 3.3 12.4 0.5 0.5 0.9 12.5 0.5 0.5 13.4 0.5 1.2 1.1 1.4 7.1 11.3 2.0 0.6 0.5 1.0 8.9 5.7 11.5 0.7 0.5 3.3 0.5 23.1 1.8 0.5 2.8 1.3 18.8 0.6 0.6 0.5 0.5 6.3 1.3 0.6 18.2 2.4 0.0 1.6 0.0 0.6 0.6 0.1 0.1 0.3 0.6 0.1 1.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 2.5 0.0 0.4 0.4 2.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.4 28.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.6 1.0 0.0 0.3 0.0 0.0 5.2 8.1 3.3 12.4 7.1 11.3 8.9 5.7 23.1 2.4 0.0 0.0 0.0 0.4 0.1 1.3 1.7 0.0 0.0 0.0 0.0 92.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.8 1.1 0.0 0.0 1.8 0.0 0.8 0.1 0.0 7.8 0.6 1.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 MCF2L "ARHGEF14, DBS, KIAA0362, OST" ENSG00000126217 "MCF.2 cell line derived transforming sequence like" O15068 13 112894378-113099739 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 77.5" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 59.3;Cone photoreceptor cells: 119.8;Mucus-secreting cells: 47.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "B-cells: 2.3;granulocytes: 1.8;T-cells: 2.1" "Cell line enhanced" "Detected in many" "OE19: 16.0;SCLC-21H: 30.5;SH-SY5Y: 13.5;SK-BR-3: 20.2;WM-115: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (1.56e-1)" "unprognostic (2.53e-2)" "unprognostic (8.86e-3)" "prognostic favorable (6.01e-4)" "unprognostic (9.07e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.02e-2)" "unprognostic (1.94e-1)" "unprognostic (2.11e-1)" "prognostic favorable (4.36e-5)" "unprognostic (1.17e-1)" "prognostic favorable (9.14e-6)" "unprognostic (2.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.24e-1)" "prognostic favorable (2.63e-5)" 24.2 6.4 21.2 4.6 37.5 0.8 10.9 77.5 37.2 9.4 13.2 20.9 2.6 8.7 7.3 4.3 11.0 6.9 10.4 19.0 20.1 15.7 10.3 3.7 7.0 4.9 49.0 11.5 2.4 14.7 7.7 20.7 6.7 28.6 11.2 10.9 5.7 24.5 7.2 11.4 19.0 12.4 5.7 23.0 2.9 13.7 1.4 46.2 0.3 11.5 4.0 4.7 8.8 12.0 2.3 0.2 1.8 0.1 0.3 2.1 2.0 0.0 0.7 7.0 2.2 0.2 0.4 1.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 1.7 0.6 1.1 0.1 1.7 0.0 0.0 0.0 3.5 1.9 0.0 4.1 0.2 0.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 6.5 2.5 0.2 1.1 1.9 16.0 0.0 0.1 6.9 3.7 2.8 10.6 30.5 13.5 0.0 20.2 0.0 1.1 11.9 0.0 0.2 0.0 6.0 2.4 0.0 3.4 0.1 1.0 11.2 0.4 27.3 0.2 0.1 0.3 0.5 0.1 0.6 0.5 0.6 0.7 0.0 2.3 2.1 0.7 1.8 0.3 0.1 0.2 0.2 2.0 21.2 37.5 77.5 37.2 20.1 15.7 49.0 11.5 28.6 46.2 0.0 6.7 1.5 3.2 4.8 59.3 23.5 10.2 12.0 5.7 8.7 119.8 0.0 6.6 5.0 0.3 29.2 5.6 0.0 2.3 0.1 1.5 6.7 1.1 2.6 1.0 36.5 25.4 16.0 1.5 1.0 0.6 1.1 8.5 0.0 47.9 4.5 1.9 11.2 1.1 7.9 21.6 0.0 4.1 0.4 2.8 8.0 0.1 0.7 6.5 3.0 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.4;brain: 23.7" "Group enriched" "Detected in many" 11 "Bipolar cells: 64.6;Cone photoreceptor cells: 208.1;Early spermatids: 86.7;Rod photoreceptor cells: 135.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "T-reg: 4.6" "Lineage enriched" "Detected in single" 8 "T-cells: 4.6" "Cell line enhanced" "Detected in many" "HDLM-2: 9.4;Karpas-707: 8.2;REH: 5.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655" "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.9 16.4 12.8 1.4 14.9 1.1 1.1 11.3 23.7 1.3 1.4 3.6 0.0 0.9 1.3 1.3 1.3 1.0 1.5 1.1 12.2 7.6 1.4 0.8 1.2 1.7 5.6 13.0 1.2 1.2 10.5 8.9 0.8 7.3 2.1 1.4 7.5 0.8 1.6 1.4 1.0 1.2 1.4 4.5 5.3 1.2 5.5 4.3 0.0 0.9 0.0 2.1 1.6 0.4 0.1 0.0 0.6 0.0 0.1 4.6 0.2 0.1 0.6 0.2 1.8 0.1 0.2 0.4 0.0 0.1 0.3 0.0 1.2 0.2 1.5 0.2 0.1 1.9 0.0 0.3 0.2 0.1 9.4 1.4 4.0 0.3 0.0 0.3 1.2 0.8 0.3 0.0 0.0 0.7 0.0 0.7 2.5 1.2 8.2 0.5 1.2 1.2 0.9 1.3 0.0 1.6 5.4 0.0 1.5 0.4 0.2 2.6 0.9 1.0 0.0 2.1 0.6 0.5 0.9 0.6 0.0 0.9 0.1 0.1 3.3 3.5 1.7 0.8 1.4 0.1 0.1 0.0 0.1 0.4 0.0 1.0 0.0 1.0 0.6 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.0 4.6 0.2 12.8 14.9 11.3 23.7 12.2 7.6 5.6 13.0 7.3 4.3 0.0 2.1 0.0 0.4 0.3 64.6 1.2 0.0 4.0 0.0 5.2 208.1 0.2 0.0 0.1 86.7 0.7 0.3 0.0 0.2 0.1 0.7 0.2 1.1 0.0 0.4 7.9 0.0 3.1 0.6 11.7 0.9 1.0 1.7 2.8 0.0 3.0 0.2 0.0 0.4 0.0 135.4 0.0 0.4 0.7 3.4 0.4 1.1 2.1 0.0 0.6 MCHR1 "GPR24, MCH1R, SLC1" ENSG00000128285 "Melanin concentrating hormone receptor 1" Q99705 22 40678750-40682814 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Group enriched" "Detected in some" 5 "Leydig cells: 2.6;Melanocytes: 8.5" "Group enriched" "Detected in some" 7 "glioma: 4.9;liver cancer: 1.5;melanoma: 3.1;renal cancer: 2.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 2.5;RH-30: 3.4;SuSa: 10.1;T-47d: 2.8;U-87 MG: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (2.45e-3)" "unprognostic (2.68e-1)" "unprognostic (2.84e-3)" "unprognostic (4.92e-3)" "unprognostic (4.51e-3)" "unprognostic (1.19e-2)" "unprognostic (1.58e-2)" "unprognostic (9.35e-4)" "unprognostic (3.05e-1)" "unprognostic (2.26e-1)" "prognostic unfavorable (1.49e-6)" "unprognostic (3.07e-2)" "unprognostic (5.40e-2)" "unprognostic (2.42e-1)" "unprognostic (3.91e-2)" 0.7 0.8 3.4 1.1 4.7 0.4 0.4 1.0 14.4 1.2 0.5 0.2 0.0 0.7 4.8 1.5 0.4 1.2 0.4 3.1 4.6 7.3 0.4 2.6 0.5 0.8 3.4 4.9 5.1 0.5 0.3 2.8 0.6 2.5 0.4 0.5 0.8 0.4 0.5 0.5 1.7 0.5 2.4 1.2 0.4 0.5 0.6 0.1 0.0 0.3 0.0 0.7 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 2.5 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.1 2.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.7 1.0 11.6 4.6 7.3 3.4 4.9 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.6 0.0 0.0 2.6 0.0 8.5 0.0 0.0 1.2 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MCHR2 "GPR145, MCH2, MCH2R, SLT" ENSG00000152034 "Melanin concentrating hormone receptor 2" Q969V1 6 99919910-99994247 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 14.9;testis: 5.5" "Cell type enriched" "Detected in single" 5 "Early spermatids: 1.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 6.3;cerebral cortex: 14.9;olfactory region: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HMC-1: 1.9;U-266/70: 1.8" "Region enhanced" "Detected in single" "cerebral cortex: 0.9" NA NA "unprognostic (5.76e-2)" 0.2 0.2 1.9 0.3 6.3 0.3 0.2 0.2 14.9 0.2 0.5 0.0 0.0 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.7 0.6 0.2 0.2 0.2 0.3 0.5 4.4 0.3 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.3 0.5 0.2 0.2 0.2 0.3 5.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.3 0.2 0.6 0.2 0.5 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 2.1 0.2 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.2 0.2 1.8 0.9 0.3 0.0 0.1 0.0 0.6 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.3 0.1 0.1 0.3 0.5 0.0 0.2 0.2 0.1 1.9 6.3 0.2 14.9 0.7 0.6 0.5 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MCIDAS "IDAS, MCI, MCIN" ENSG00000234602 "Multiciliate differentiation and DNA synthesis associated cell cycle protein" D6RGH6 5 55219614-55227315 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation" Activator "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 2.6;stomach 1: 1.6" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;Collecting duct cells: 1.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.0;CACO-2: 5.9;HEK 293: 4.9;U-2 OS: 3.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA049981, HPA058073" Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA049981: , HPA058073: AB_2683596" "unprognostic (3.11e-2)" "unprognostic (7.50e-4)" "unprognostic (2.48e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (2.41e-3)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (3.17e-2)" "unprognostic (4.67e-1)" "unprognostic (2.90e-3)" "unprognostic (4.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "unprognostic (2.70e-2)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 2.6 0.5 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.8 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.1 0.5 5.9 2.8 0.0 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.1 4.9 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.4 0.0 0.0 0.3 0.1 1.5 0.2 0.9 0.1 0.0 0.5 0.6 0.0 1.8 0.0 1.6 0.0 2.2 0.6 0.0 0.0 3.4 0.6 0.2 1.9 2.4 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.3 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161554-13211104 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.8;lymphoid tissue: 31.4" "Cell type enhanced" "Detected in many" 13 "Erythroid cells: 23.3;Extravillous trophoblasts: 17.2;Spermatogonia: 14.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 3.0 0.5 0.3 5.6 0.3 10.8 2.1 0.3 0.5 1.4 2.6 0.4 0.3 1.8 1.1 0.6 5.9 0.2 0.7 0.7 0.3 0.3 0.6 0.9 1.4 6.0 0.3 0.6 0.7 0.3 0.3 0.4 3.6 0.5 0.6 2.9 0.4 1.1 0.3 1.5 1.3 1.8 0.9 0.7 2.9 1.1 4.3 0.3 31.4 0.9 3.3 6.9 0.9 1.8 0.5 1.0 1.5 0.4 0.8 3.4 1.5 13.7 15.5 18.4 13.9 0.6 1.1 8.0 14.4 2.2 16.2 16.9 15.1 9.8 20.7 6.5 3.6 6.0 16.1 25.8 8.5 15.0 10.8 12.3 25.8 6.9 10.0 0.0 13.2 11.7 0.2 0.3 16.4 1.5 1.3 5.2 16.8 30.4 14.2 8.8 12.3 31.3 5.7 10.9 13.2 3.8 24.8 16.3 12.8 3.7 5.0 3.7 14.0 11.6 8.3 2.2 10.0 10.4 9.1 3.2 10.3 19.4 15.5 15.5 4.4 17.1 27.2 6.6 14.6 8.0 0.2 0.3 0.2 1.1 0.1 0.2 0.5 1.6 3.4 1.0 0.4 0.4 2.8 1.5 0.8 0.4 0.2 1.6 1.5 0.3 0.3 0.3 0.5 0.3 0.3 0.3 0.6 0.5 0.3 0.0 0.0 1.5 0.2 1.4 0.0 1.2 0.0 0.0 1.2 0.0 0.0 4.1 0.0 0.4 1.1 0.1 0.0 23.3 0.2 17.2 1.0 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 1.9 5.9 14.0 0.4 2.9 1.0 1.8 0.0 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598223-127622436 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 69.9" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 8600 Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 2.9 3.7 2.1 24.3 4.0 32.5 3.5 6.7 3.2 4.7 7.1 3.3 2.2 4.7 4.7 5.9 11.2 4.8 5.4 3.6 2.0 2.3 3.9 3.4 3.4 14.6 2.2 3.5 5.1 3.0 2.4 2.4 26.4 3.0 3.2 6.0 2.5 4.7 1.9 7.0 6.0 7.1 2.9 2.9 13.3 3.8 20.3 3.9 69.9 4.1 16.6 20.7 3.4 5.1 10.4 3.6 0.9 1.4 5.8 10.6 3.4 25.1 21.4 23.5 20.5 1.4 3.0 23.0 13.2 8.5 26.6 29.0 35.5 16.7 27.1 12.9 6.5 22.8 20.3 41.9 15.2 16.6 22.4 26.2 44.9 28.7 25.8 0.9 41.9 19.6 1.6 1.7 18.0 2.7 3.2 8.3 29.6 22.3 24.9 9.8 33.3 38.8 30.7 34.4 21.6 18.9 43.6 33.7 38.8 5.5 19.5 29.3 22.2 33.9 10.1 3.5 9.9 21.7 32.9 4.2 20.7 17.7 25.5 17.8 25.8 29.2 67.4 14.3 31.7 7.9 0.0 0.6 0.2 4.7 1.4 5.9 10.4 4.1 5.5 2.8 9.2 3.9 5.0 0.9 5.8 0.3 3.6 10.6 3.4 2.1 4.0 6.7 3.2 2.0 2.3 2.2 3.5 3.0 3.9 3.0 1.3 6.7 1.7 4.0 2.2 7.6 0.0 10.7 5.7 0.0 0.0 45.7 0.0 4.1 0.7 1.7 1.0 0.0 1.6 22.4 3.3 0.7 1.1 1.7 15.2 0.0 3.5 1.3 1.6 0.7 1.7 1.6 1.7 15.4 5.1 1.5 1.7 0.0 1.4 0.5 1.7 0.0 2.8 6.2 27.1 2.6 28.0 3.2 12.0 0.6 MCM3 ENSG00000112118 "Minichromosome maintenance complex component 3" P25205 6 52264009-52284881 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 82.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002162, HPA004789, HPA004790" Supported Supported Nucleoplasm NA Yes 29000 Nucleoplasm "CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335" "unprognostic (9.14e-2)" "prognostic favorable (1.89e-4)" "unprognostic (2.37e-1)" "unprognostic (1.53e-2)" "unprognostic (2.14e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.40e-5)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (1.16e-2)" "unprognostic (1.00e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.34e-2)" 17.3 10.9 8.5 29.7 10.5 22.3 15.3 10.7 9.7 15.9 17.2 9.5 20.2 9.0 21.2 13.0 21.7 15.5 15.8 15.4 7.4 6.6 16.1 12.6 13.7 30.1 8.9 5.8 20.0 13.8 16.0 7.4 24.7 10.0 15.9 19.2 12.7 12.6 23.4 12.1 15.0 17.8 17.7 9.5 23.2 15.3 16.1 10.5 82.5 12.9 20.1 35.7 19.1 15.3 21.1 12.9 11.4 13.3 22.2 29.4 18.6 30.2 20.1 35.1 33.0 7.6 6.8 23.0 22.5 17.3 38.4 39.4 41.1 16.5 33.0 22.6 13.1 25.1 24.1 46.2 27.5 38.8 37.1 43.7 62.4 40.4 57.9 2.0 61.2 25.6 4.1 6.4 28.2 7.9 9.4 19.5 40.0 50.7 76.2 19.7 19.9 61.6 47.3 29.1 60.3 14.2 54.7 53.7 44.1 17.0 32.2 35.6 27.3 23.6 13.6 20.4 51.4 26.8 43.4 10.0 26.2 28.2 27.1 33.5 22.6 25.8 58.8 22.5 53.1 30.7 11.1 8.0 11.4 22.9 13.3 19.7 21.1 23.3 23.0 12.9 19.2 22.6 24.0 1.1 22.2 7.4 8.3 29.4 18.6 8.5 10.5 10.7 9.7 7.4 6.6 8.9 5.8 10.0 10.5 20.8 10.5 30.5 14.0 17.1 13.8 13.9 12.7 22.7 20.5 21.0 3.9 85.3 11.6 21.3 0.6 24.8 4.9 23.3 17.7 53.2 16.0 7.5 36.9 9.3 30.8 0.0 7.0 14.7 8.9 2.3 25.0 13.8 6.8 10.8 16.7 19.0 13.0 10.5 19.8 6.5 11.2 6.5 24.7 21.7 59.4 8.8 22.9 27.7 31.0 11.2 MCM4 "CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21" ENSG00000104738 "Minichromosome maintenance complex component 4" P33991 8 47960185-47978160 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 117.9;Late spermatids: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004497, HPA004873, HPA031052" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712" "unprognostic (4.55e-2)" "unprognostic (3.16e-3)" "prognostic favorable (2.19e-4)" "prognostic unfavorable (2.84e-5)" "unprognostic (7.71e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.12e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (2.65e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (2.90e-1)" "unprognostic (1.70e-2)" "unprognostic (1.40e-1)" 4.9 8.7 6.7 18.4 12.6 33.1 9.3 13.9 14.8 6.7 11.9 6.9 3.6 8.3 4.7 7.8 21.6 5.9 6.8 8.3 6.6 7.1 8.0 6.6 4.4 20.3 5.9 7.7 5.3 5.5 4.3 4.1 29.2 7.7 4.2 13.2 5.3 9.0 3.1 8.7 16.2 10.3 5.9 6.4 10.1 6.3 39.0 4.1 56.6 4.0 21.8 23.7 8.0 9.5 5.1 4.9 3.4 4.3 4.9 12.9 4.5 34.5 21.5 39.9 14.6 3.9 6.9 17.6 26.4 17.3 33.3 37.7 22.8 31.5 37.5 14.8 13.1 25.0 25.5 50.3 21.4 37.6 11.8 33.2 64.3 25.8 25.3 1.1 34.3 14.1 4.1 4.3 26.5 9.5 5.1 11.7 25.3 35.4 31.2 22.9 21.4 75.8 25.0 43.3 41.1 9.3 48.2 31.3 24.4 12.0 31.0 38.4 18.4 53.4 22.3 7.9 23.8 26.6 18.1 7.8 25.4 24.7 28.5 24.2 10.3 24.6 76.5 20.4 31.9 22.7 3.4 2.1 1.5 5.5 3.7 2.7 5.1 5.0 6.8 4.9 2.1 4.6 3.4 0.1 4.9 4.3 1.7 12.9 4.5 6.7 12.6 13.9 14.8 6.6 7.1 5.9 7.7 7.7 4.1 0.0 4.6 3.0 9.5 19.3 11.6 22.4 0.0 17.4 10.3 5.2 9.8 26.7 3.3 6.0 117.9 5.2 5.0 46.7 5.2 33.9 7.4 4.3 1.1 3.4 10.4 15.9 6.4 1.3 3.5 57.7 4.9 9.9 3.3 2.8 9.6 6.5 4.1 3.5 2.8 2.2 15.3 0.0 8.0 45.2 31.3 16.7 24.9 3.8 20.2 8.2 MCM5 CDC46 ENSG00000100297 "Minichromosome maintenance complex component 5" P33992 22 35400063-35425430 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.0;lymphoid tissue: 60.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 115.2;monocytes: 225.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000101, HPA000845, HPA052880" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979" "unprognostic (6.71e-2)" "prognostic favorable (2.81e-6)" "unprognostic (5.29e-3)" "unprognostic (7.94e-2)" "unprognostic (1.83e-2)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.78e-4)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" "unprognostic (1.37e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (3.26e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-3)" "unprognostic (1.53e-1)" 12.1 4.9 6.1 27.5 9.0 57.0 9.1 6.7 5.7 10.4 11.5 12.3 5.0 9.5 10.8 10.8 15.8 8.7 9.4 5.2 4.4 3.4 6.8 8.0 9.3 31.1 8.8 3.7 17.9 10.8 6.2 3.6 19.3 5.8 7.2 8.3 6.5 8.9 5.1 8.8 10.3 16.7 6.0 7.8 31.2 8.4 16.4 8.8 60.6 9.0 17.7 33.0 8.7 9.6 46.8 30.9 19.0 26.0 21.3 32.9 24.0 39.3 28.6 22.6 23.0 2.2 4.5 19.9 26.3 14.0 39.4 37.5 19.0 19.7 26.1 15.3 13.4 16.3 19.7 22.6 20.9 12.6 21.0 41.5 37.2 28.7 38.0 0.8 76.8 33.7 2.4 1.9 23.5 6.4 3.6 17.4 23.9 23.0 39.0 14.9 32.5 62.5 25.6 30.1 26.9 17.0 70.8 32.1 32.8 7.7 22.9 17.5 18.6 36.2 14.5 8.1 12.4 15.2 29.4 10.3 39.8 30.2 24.7 27.1 21.7 26.8 49.1 25.8 29.1 30.3 19.0 20.7 14.5 18.4 24.1 13.1 46.8 16.1 19.4 27.1 37.0 13.1 14.8 9.9 21.3 26.0 30.9 32.9 24.0 6.1 9.0 6.7 5.7 4.4 3.4 8.8 3.7 5.8 8.8 6.0 8.2 53.6 8.0 9.4 1.5 3.4 12.7 5.3 4.5 7.0 0.0 115.2 5.0 14.8 1.9 7.5 3.8 70.0 11.1 61.5 6.2 3.3 15.0 5.1 47.1 1.6 3.4 13.5 21.1 3.6 10.0 25.5 6.8 225.4 9.2 4.5 9.4 7.0 5.6 3.7 3.2 19.4 6.4 11.2 52.2 5.5 68.8 20.8 32.2 4.7 MCM6 Mis5 ENSG00000076003 "Minichromosome maintenance complex component 6" Q14566 2 135839626-135876426 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 66.3" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 46.7;Spermatogonia: 41.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004818, CAB009577" Enhanced Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB009577: AB_2266309, HPA004818: AB_1079339" "unprognostic (6.73e-2)" "unprognostic (6.68e-3)" "unprognostic (1.22e-3)" "unprognostic (3.60e-3)" "unprognostic (8.98e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (5.70e-7)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.09e-5)" "unprognostic (2.36e-2)" "unprognostic (1.36e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (8.29e-12)" "unprognostic (2.84e-1)" "unprognostic (9.02e-2)" "unprognostic (7.42e-2)" "unprognostic (1.68e-1)" 11.3 6.3 7.2 17.7 8.4 23.1 9.5 12.3 9.4 9.1 11.9 5.1 2.9 8.7 10.4 8.8 12.6 8.7 7.6 6.0 5.0 5.5 6.8 7.0 8.5 23.9 4.9 8.0 10.9 4.3 6.2 3.4 10.9 5.9 8.6 12.2 6.2 6.9 6.7 8.2 8.9 16.7 10.4 7.2 14.1 8.0 13.2 3.7 66.3 5.1 11.4 27.5 10.8 9.8 5.5 9.4 5.3 4.0 7.0 13.9 5.6 23.3 14.3 31.3 19.9 6.7 8.8 12.3 17.0 12.9 19.8 22.1 29.3 17.9 40.8 12.5 12.3 8.7 13.9 31.6 15.5 21.2 20.9 21.8 40.5 21.3 9.2 3.1 48.5 18.1 5.2 2.0 14.4 4.4 4.0 13.4 32.2 28.9 34.5 14.5 23.8 59.2 35.7 28.2 20.6 14.4 29.4 37.5 37.3 9.9 20.6 19.7 16.8 22.4 10.7 10.7 23.4 12.3 30.6 6.6 13.8 11.5 14.8 12.8 20.7 33.7 53.7 19.3 37.2 16.4 5.3 1.4 0.9 7.6 4.0 7.1 5.5 10.5 9.2 4.6 3.2 9.6 11.8 0.8 7.0 3.6 9.4 13.9 5.6 7.2 8.4 12.3 9.4 5.0 5.5 4.9 8.0 5.9 3.7 0.0 2.4 2.2 3.8 6.0 2.2 3.2 2.5 4.0 6.8 3.5 0.0 26.1 0.0 4.4 2.1 7.1 1.3 46.7 5.8 20.9 11.3 1.5 9.2 3.0 20.4 3.2 2.4 9.8 4.0 1.6 8.6 5.8 5.0 3.6 9.2 2.3 2.8 3.5 15.9 1.0 0.5 0.0 4.2 15.6 41.4 3.6 8.9 17.5 9.7 1.0 MCMDC2 "C8orf45, FLJ25692" ENSG00000178460 "Minichromosome maintenance domain containing 2" Q4G0Z9 8 66870749-66922048 "Predicted intracellular proteins" "DNA damage, DNA repair, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 32.8" "Group enriched" "Detected in many" 5 "Early spermatids: 30.9;Spermatocytes: 53.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA026522 Approved "Actin filaments" NA NA "Actin filaments" "HPA026522: AB_10603453" "unprognostic (6.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.42e-1)" "unprognostic (9.46e-2)" "unprognostic (9.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.79e-3)" "unprognostic (7.87e-2)" "unprognostic (3.06e-2)" "unprognostic (8.49e-2)" "unprognostic (2.31e-5)" 1.2 2.0 1.1 1.2 2.2 3.9 1.2 0.9 2.1 1.1 1.0 3.7 0.7 1.4 1.2 1.9 1.7 1.0 1.0 3.0 1.3 1.2 1.6 1.1 2.0 2.7 1.2 0.3 3.6 1.8 1.6 7.0 0.7 3.0 1.0 0.5 2.0 1.3 0.7 6.1 2.3 1.3 0.3 2.1 1.1 1.1 32.8 1.6 0.4 1.4 1.3 0.3 1.4 1.2 3.1 3.4 1.9 1.4 3.6 4.7 1.6 2.9 6.3 3.2 3.8 0.4 1.5 1.7 2.8 0.4 0.2 0.2 5.2 4.0 4.5 1.1 0.2 1.7 2.5 0.0 0.2 0.9 2.3 7.8 5.6 9.1 6.3 0.8 2.5 3.0 1.0 0.9 0.1 0.0 4.7 0.2 4.3 3.5 4.3 1.3 5.8 6.2 7.8 4.0 4.9 5.8 2.2 1.2 2.0 0.6 4.5 2.2 4.0 0.9 1.1 12.7 1.9 4.0 6.6 1.3 2.1 3.1 3.6 3.4 3.5 1.9 4.2 2.4 5.3 2.2 1.9 1.4 0.6 2.6 1.0 3.3 2.9 4.2 3.3 3.0 3.1 4.7 3.8 0.6 3.6 0.9 3.4 3.0 1.6 1.1 2.2 0.9 1.8 1.3 1.2 1.2 0.3 3.0 1.6 0.0 0.3 0.0 0.4 0.3 1.7 2.0 0.0 4.0 0.0 1.8 5.9 0.9 0.0 0.1 30.9 0.2 0.0 0.0 0.2 0.6 0.2 0.3 0.0 0.0 0.4 1.6 0.0 0.0 1.8 8.5 1.7 0.0 1.7 0.0 0.2 2.0 0.1 0.0 0.7 0.7 1.7 0.0 0.0 53.3 6.1 0.9 0.0 0.0 1.2 0.7 MCOLN2 "FLJ36691, TRP-ML2, TRPML2" ENSG00000153898 "Mucolipin 2" Q8IZK6 1 84925583-84997113 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 18.9" "Group enriched" "Detected in many" 12 "B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9" "Cell line enhanced" "Detected in many" "Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5" "Region enriched" "Detected in single" 5 "amygdala: 0.4" "Low region specificity" "Detected in all" HPA019114 Uncertain NA NA "HPA019114: AB_1853645" "unprognostic (3.02e-2)" "unprognostic (5.67e-2)" "unprognostic (3.07e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.38e-1)" "prognostic favorable (2.56e-4)" "unprognostic (8.92e-2)" "unprognostic (1.48e-2)" "unprognostic (6.84e-2)" "unprognostic (2.21e-2)" "unprognostic (3.12e-4)" "unprognostic (3.68e-2)" "unprognostic (4.69e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-2)" 1.3 12.5 0.4 31.9 0.4 2.2 1.1 0.2 0.4 1.7 8.5 0.5 1.6 1.2 1.4 18.4 1.3 2.9 3.8 2.0 0.6 0.4 1.4 0.6 7.5 18.4 0.6 0.0 1.0 1.8 0.0 1.2 2.1 1.5 1.5 14.0 1.6 3.2 0.9 0.6 1.8 7.5 0.5 1.7 9.7 1.7 2.7 0.4 4.1 1.0 2.8 27.5 2.3 1.3 6.6 18.9 0.2 0.8 0.4 5.9 1.4 1.0 1.1 0.1 3.0 0.6 0.2 0.4 0.7 3.8 0.9 1.2 0.0 0.1 14.1 0.4 0.0 1.8 0.1 10.1 1.2 1.1 16.8 7.5 1.4 0.4 0.0 0.8 0.3 1.3 0.2 0.0 0.9 0.8 0.1 0.1 3.7 0.0 0.3 0.2 0.4 0.2 0.1 1.1 0.0 1.9 0.1 2.3 0.0 0.1 0.3 0.7 0.0 0.1 0.2 6.2 0.2 1.8 20.1 0.1 1.0 1.6 0.1 2.6 0.1 0.0 12.5 0.9 0.1 2.4 0.1 0.2 0.0 4.1 0.8 1.3 6.6 3.3 5.9 4.5 1.9 0.5 3.4 0.2 0.4 0.1 18.9 0.2 1.4 0.4 0.4 0.2 0.4 0.6 0.4 0.6 0.0 1.5 0.4 0.0 1.1 9.8 0.5 3.9 0.0 0.5 0.0 2.7 2.3 1.8 0.0 0.1 0.0 0.0 34.6 0.1 6.0 0.0 1.2 0.1 2.1 0.7 0.0 0.0 0.7 0.0 2.4 1.3 0.6 14.2 0.0 15.1 8.5 53.3 4.1 0.0 0.4 5.8 0.0 0.3 0.0 0.0 0.1 0.2 3.7 2.9 0.2 8.2 2.3 0.1 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048499 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.2;pituitary gland: 38.3" "Group enriched" "Detected in many" 8 "Intestinal endocrine cells: 109.0;Melanocytes: 143.4" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 1.7" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: AB_2684695" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 4.7 29.2 1.5 0.8 0.8 0.0 3.0 0.2 0.4 6.1 2.8 0.9 2.1 3.2 5.4 15.6 0.8 1.1 0.6 5.1 3.4 0.3 4.5 0.2 4.1 0.0 0.5 0.0 2.2 6.5 17.9 38.3 1.8 2.7 0.5 0.5 4.5 8.1 0.4 1.9 2.5 1.9 1.1 0.3 0.9 1.6 0.4 0.3 2.6 1.5 0.9 0.4 0.7 2.8 0.0 0.0 0.0 0.0 0.0 2.9 0.7 6.5 1.5 0.0 0.0 5.3 4.8 1.7 0.1 10.1 2.5 7.0 0.5 1.2 0.0 0.7 0.1 2.3 0.0 10.0 3.2 1.6 2.6 5.9 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.2 2.1 1.2 2.6 0.0 0.0 0.0 0.0 4.9 0.6 0.0 0.0 0.7 0.0 0.6 0.0 12.2 0.0 0.3 0.0 0.4 0.0 0.3 0.0 21.6 0.8 4.1 5.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.2 0.4 3.4 0.3 0.5 0.0 2.7 0.3 14.9 1.7 0.0 3.6 7.7 0.0 6.9 10.2 0.0 1.2 3.5 0.0 6.4 0.0 1.9 0.3 0.5 1.3 0.0 8.4 0.1 5.1 1.1 0.0 0.0 3.4 0.0 109.0 0.0 0.0 0.0 1.7 0.8 143.4 2.8 0.6 0.0 4.9 7.8 0.0 2.2 0.0 6.5 1.2 0.9 1.6 3.0 2.2 0.0 0.6 0.3 MCTP1 FLJ22344 ENSG00000175471 "Multiple C2 and transmembrane domain containing 1" Q6DN14 5 94703741-95284575 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 49.2;brain: 42.4" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 41 "basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 52 "dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2" "Cell line enhanced" "Detected in many" "Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019018 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019018: AB_1853665" "unprognostic (1.20e-2)" "unprognostic (6.70e-4)" "unprognostic (1.77e-2)" "unprognostic (1.03e-2)" "unprognostic (1.16e-4)" "unprognostic (1.88e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" "unprognostic (1.86e-1)" "unprognostic (6.99e-2)" "unprognostic (5.31e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-6)" "unprognostic (5.38e-2)" "unprognostic (3.65e-2)" "unprognostic (2.89e-3)" "unprognostic (4.43e-2)" 49.2 2.7 6.5 11.4 42.4 36.9 18.3 18.3 16.5 6.9 7.2 0.3 4.4 5.0 11.1 9.2 6.5 4.1 16.7 4.6 8.5 7.4 3.0 3.8 11.3 5.5 4.1 3.8 3.3 3.4 3.1 5.2 7.1 3.9 5.9 7.3 1.0 4.3 2.7 5.1 4.5 4.8 10.9 5.7 8.2 5.3 4.0 8.1 5.5 5.0 21.2 4.3 17.3 12.6 0.3 10.1 18.7 19.2 0.2 0.2 3.3 0.1 2.0 1.3 0.0 20.0 8.0 0.0 0.1 9.8 0.9 3.2 0.0 5.2 7.2 7.7 0.0 20.5 0.0 0.1 0.1 1.1 0.0 1.4 4.3 4.9 0.0 2.6 8.9 5.8 2.9 0.0 3.6 13.1 8.5 20.7 3.0 0.1 28.3 7.4 0.2 0.5 6.8 1.6 0.1 8.2 0.3 0.0 28.0 21.3 11.3 4.0 0.2 0.6 0.0 14.6 0.6 0.0 8.4 0.1 3.6 5.6 0.1 1.6 2.0 0.0 0.0 16.9 14.9 3.6 11.5 12.9 5.8 0.0 19.2 0.0 0.3 0.0 0.1 10.1 0.1 0.2 0.0 18.7 0.2 17.6 5.3 0.0 3.3 6.5 42.4 18.3 12.2 8.5 7.4 4.1 3.8 3.9 8.1 3.0 9.6 0.0 0.1 16.1 2.0 2.5 0.0 4.0 6.8 3.5 0.0 0.3 0.0 0.0 20.6 29.9 0.0 0.0 0.2 0.1 3.0 0.6 61.2 0.5 10.7 3.2 0.0 1.8 33.5 12.2 0.6 35.3 11.8 0.0 0.0 3.6 0.8 0.0 0.0 0.0 3.7 0.0 2.2 1.4 1.4 11.7 0.2 2.2 0.0 0.4 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 41.6" "Cell type enhanced" "Detected in many" 5 "granulocytes: 35.7;Mucus-secreting cells: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;HMC-1: 12.0;U-698: 15.9;U-87 MG: 18.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA051176: AB_2681373, HPA070541: AB_2686277" "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 5.3 4.1 0.8 19.7 1.7 12.6 2.7 0.7 1.5 5.4 12.3 0.0 6.9 5.6 4.0 9.5 5.7 4.5 10.3 4.6 1.0 2.2 3.6 2.3 12.4 18.4 2.5 0.8 3.8 10.0 5.3 24.4 17.1 0.6 6.8 10.2 2.5 16.8 9.6 0.8 4.0 10.9 4.0 0.9 41.6 3.7 1.7 0.4 3.0 8.7 4.1 12.9 6.2 14.8 2.7 0.1 21.2 0.5 6.8 4.4 1.1 2.5 0.0 0.0 0.0 0.0 0.0 1.8 1.3 0.8 0.2 0.1 1.7 3.1 7.3 0.3 0.0 0.0 5.7 0.1 4.7 0.0 1.4 0.5 14.5 2.0 0.8 1.0 3.0 12.0 0.8 5.8 0.1 6.0 0.0 0.0 2.5 0.5 4.1 0.0 0.0 1.4 8.0 0.6 2.4 2.6 3.3 0.1 2.7 0.3 7.6 1.4 0.3 0.1 2.4 0.9 0.5 0.0 0.2 0.0 0.0 1.2 0.0 0.0 8.7 0.1 15.9 18.0 7.9 0.9 3.2 0.5 7.7 4.4 0.1 2.1 2.2 1.2 1.9 0.0 2.7 0.5 1.9 21.2 6.8 0.5 0.1 0.0 1.1 0.8 1.7 0.7 1.5 1.0 2.2 2.5 0.8 0.6 0.4 3.0 24.7 20.4 10.8 3.8 0.8 0.8 5.1 5.3 15.9 3.5 0.0 13.2 0.0 2.7 3.2 2.1 18.6 0.0 4.1 5.9 7.2 13.7 35.7 1.3 7.5 0.0 15.0 1.3 12.7 3.9 0.3 2.1 1.7 0.0 42.4 0.2 4.0 21.0 0.0 1.7 0.5 0.0 0.8 0.1 2.0 1.9 20.5 19.7 18.7 14.9 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: AB_2680518" "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.4 4.5 2.5 12.8 2.8 7.4 9.7 9.0 5.5 9.9 8.9 0.2 8.5 36.7 1.9 7.7 5.5 3.0 9.4 5.5 8.8 23.3 7.4 4.4 5.0 0.6 4.9 8.9 0.1 4.7 1.5 6.0 5.1 7.0 13.2 13.6 1.3 23.4 7.5 12.8 20.4 0.1 11.6 1.8 6.5 7.8 19.4 4.1 11.6 4.6 10.3 4.5 9.7 28.9 3.0 2.1 3.6 0.4 9.4 3.9 5.1 20.6 15.6 9.1 6.3 8.9 12.0 1.9 2.7 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 8.9 6.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 5.2 0.0 107.3 0.0 22.4 0.0 0.0 0.0 0.0 99.3 82.0 0.0 0.0 1.1 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 25.2 0.0 0.0 50.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 MDFIC2 ENSG00000242120 "MyoD family inhibitor domain containing 2" A0A1B0GVS7 3 70196894-70312726 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.5;salivary gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HeLa: 2.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 94.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 31.7;Cone photoreceptor cells: 47.1;Horizontal cells: 54.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 17 "cerebellum: 94.7" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 3.1" "Group enriched" "Detected in many" 22 "B-cells: 1.1;T-cells: 3.1" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;HaCaT: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031235, HPA050382" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 490000 "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: AB_2681108" "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 1.5 3.7 3.4 3.1 2.4 0.0 1.0 94.7 5.1 3.0 1.3 1.5 1.0 0.0 3.0 1.5 1.8 2.1 3.4 1.2 5.0 2.0 0.8 0.5 3.5 3.4 1.7 2.4 8.4 2.6 6.6 2.6 0.5 5.4 1.5 1.1 3.4 0.7 1.2 0.9 6.7 1.5 2.6 4.1 3.9 1.2 1.4 1.3 0.6 1.1 1.7 2.7 1.1 3.1 1.1 0.0 0.0 0.0 0.0 3.1 0.4 0.1 3.8 6.9 2.6 13.8 5.6 3.0 2.7 2.7 3.4 3.9 0.7 0.0 0.9 0.6 1.7 3.6 8.9 0.5 0.0 1.1 6.9 4.0 0.0 0.5 0.0 0.6 0.0 0.9 1.0 0.1 1.4 0.0 8.0 0.0 0.1 0.1 0.0 1.2 0.1 0.0 0.5 0.0 0.1 0.4 7.3 2.4 0.0 0.8 4.2 6.3 0.0 1.5 0.4 3.3 0.2 3.2 0.6 0.5 3.7 1.2 1.3 5.0 0.0 0.1 0.0 5.8 1.1 2.4 0.0 0.0 0.0 1.4 0.0 0.4 1.1 1.2 0.8 0.0 1.0 3.1 0.8 0.0 0.0 0.0 0.0 1.8 0.4 3.4 2.4 94.7 2.7 5.0 2.0 1.7 2.4 5.4 1.3 8.9 0.3 0.0 1.7 2.1 31.7 5.2 0.0 2.7 1.2 3.5 47.1 0.1 0.0 0.6 1.9 1.0 0.0 0.0 0.0 1.2 2.4 1.5 0.0 0.0 0.1 54.0 1.7 1.8 0.0 0.0 9.5 0.0 1.7 0.0 0.0 2.3 0.6 0.0 4.6 0.1 1.3 0.0 3.4 2.3 1.0 2.6 0.6 0.5 0.0 3.8 MDGA2 MAMDC1 ENSG00000139915 "MAM domain containing glycosylphosphatidylinositol anchor 2" Q7Z553 14 46840092-47674954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 8.6;testis: 7.9" "Group enriched" "Detected in some" 7 "Bipolar cells: 39.5;Early spermatids: 31.0" "Cancer enhanced" "Detected in single" "melanoma: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.0;T-47d: 4.0;U-138 MG: 8.8;U-2 OS: 6.3;U-87 MG: 3.4;WM-115: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003084 Uncertain NA NA "HPA003084: AB_1079302" "unprognostic (3.27e-1)" "unprognostic (5.38e-2)" "unprognostic (9.13e-2)" "unprognostic (8.92e-3)" "unprognostic (6.36e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.49e-3)" "unprognostic (3.62e-3)" "unprognostic (3.06e-2)" "unprognostic (5.89e-1)" 0.2 0.3 1.4 0.0 1.5 0.0 0.2 0.4 8.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.2 0.2 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 3.3 0.0 0.5 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.7 4.0 0.0 0.0 8.8 6.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 39.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 5.0 0.0 0.0 0.5 0.1 0.0 0.7 0.0 1.8 0.0 0.2 3.9 3.6 0.0 0.0 0.0 0.0 0.0 MDH1 ENSG00000014641 "Malate dehydrogenase 1" P40925 2 63588609-63607197 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 155.8" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 1859.7;Proximal tubular cells: 683.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027296, CAB047333, HPA054276" Uncertain Supported Centrosome,Cytosol NA NA 63000000 "Centrosome, Cytosol" "CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434" "unprognostic (1.01e-1)" "unprognostic (6.52e-3)" "unprognostic (1.61e-2)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.83e-1)" "unprognostic (8.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.79e-2)" "unprognostic (9.52e-2)" "unprognostic (2.05e-1)" "unprognostic (3.26e-1)" "unprognostic (8.80e-2)" "prognostic favorable (9.95e-4)" "unprognostic (6.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.97e-2)" "unprognostic (3.05e-1)" 32.0 28.6 28.0 10.5 58.1 9.2 18.4 38.0 69.5 12.4 21.4 12.5 9.0 19.3 13.4 22.6 16.7 14.7 11.5 155.8 33.6 37.5 47.6 33.2 11.2 14.7 33.4 40.1 10.9 8.9 26.0 18.3 11.4 65.9 16.1 24.9 13.8 15.4 19.9 91.1 11.1 17.1 21.5 18.6 9.4 22.4 8.6 12.2 14.1 15.6 47.1 20.2 15.6 10.2 61.7 57.1 50.7 61.5 46.7 74.5 67.8 44.2 36.3 49.1 32.1 69.7 51.7 50.8 34.9 51.6 53.1 53.9 42.9 39.4 55.8 20.7 45.7 66.4 39.0 55.2 64.6 76.3 33.7 42.6 52.3 33.9 68.2 38.3 60.2 41.5 51.2 44.2 49.8 29.4 43.3 40.5 56.8 28.9 40.6 69.9 26.6 52.7 60.8 28.7 66.4 45.2 42.1 57.8 54.7 88.0 42.0 45.5 27.1 29.2 47.2 66.8 39.1 34.4 62.9 23.6 40.8 40.0 33.9 43.8 50.7 44.4 68.3 50.4 54.5 33.7 50.7 45.8 45.8 52.7 61.5 55.0 61.7 61.3 57.6 57.1 56.4 60.5 57.5 7.0 46.7 55.7 43.3 74.5 67.8 28.0 58.1 38.0 69.5 33.6 37.5 33.4 40.1 65.9 12.2 56.6 41.7 76.8 91.9 72.5 153.0 1859.7 86.6 136.5 79.6 127.4 66.8 222.4 533.9 152.0 8.3 50.1 143.7 70.0 94.8 211.6 90.4 54.0 78.5 143.3 336.7 116.0 60.3 41.1 68.1 11.1 92.6 78.1 168.7 212.0 97.2 112.7 85.3 103.5 102.6 683.5 120.0 58.2 87.6 48.3 49.0 73.4 125.1 76.2 138.8 88.5 MDH1B "FLJ25341, RP11-95H11" ENSG00000138400 "Malate dehydrogenase 1B" Q5I0G3 2 206737763-206765547 "Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.7;testis: 27.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 121.8;Early spermatids: 123.3;Spermatocytes: 50.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 7.2;SCLC-21H: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073761 Approved NA NA "HPA073761: AB_2732241" "unprognostic (1.03e-2)" "unprognostic (9.44e-2)" "unprognostic (1.58e-1)" "unprognostic (9.84e-2)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (2.55e-2)" "unprognostic (8.21e-2)" "unprognostic (2.01e-1)" "unprognostic (3.66e-2)" "unprognostic (3.23e-3)" "unprognostic (3.08e-1)" "unprognostic (6.10e-3)" "unprognostic (1.15e-1)" "unprognostic (3.09e-2)" "unprognostic (7.84e-3)" "unprognostic (3.01e-1)" 0.9 2.3 3.1 0.7 9.0 0.6 1.9 1.5 5.7 2.0 1.1 5.0 3.6 0.5 2.5 6.6 1.1 26.7 1.5 1.9 3.4 4.2 4.2 0.6 3.6 0.8 2.4 3.5 4.5 1.1 6.3 15.1 0.5 9.5 1.3 1.1 2.8 1.7 2.2 0.9 1.0 0.6 1.5 1.6 0.6 1.1 27.6 1.8 0.1 5.2 0.0 0.7 0.9 0.5 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.7 2.4 1.8 4.9 0.4 2.3 0.7 0.0 0.9 1.0 0.7 0.2 1.6 1.1 1.1 0.2 2.2 1.1 0.1 1.4 1.0 0.1 0.1 0.5 0.4 1.5 1.1 0.8 2.5 1.4 0.5 0.1 0.3 1.1 1.4 2.3 0.1 1.4 0.7 2.9 1.5 0.6 3.2 0.3 2.9 3.1 1.8 0.1 7.2 0.3 6.9 1.5 2.2 1.1 0.6 1.1 2.2 0.0 0.1 1.2 1.2 0.3 0.6 0.7 2.9 0.4 2.6 0.2 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 3.1 9.0 1.5 5.7 3.4 4.2 2.4 3.5 9.5 1.8 6.0 1.0 0.0 1.2 0.7 3.0 1.2 2.5 121.8 6.8 0.0 0.0 0.1 11.6 0.7 123.3 0.2 0.0 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.1 3.2 1.2 0.0 0.0 17.1 1.7 0.2 1.7 0.0 0.0 7.7 0.1 0.0 2.8 5.1 9.9 0.0 1.0 50.4 4.0 0.3 0.0 0.0 0.0 0.4 MDH2 ENSG00000146701 "Malate dehydrogenase 2" P40926 7 76048051-76067508 "Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 175.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019714, HPA019716, HPA019848, HPA026720" Enhanced Enhanced Mitochondria No No 47000000 Mitochondria "HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685" "unprognostic (3.20e-2)" "unprognostic (2.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.43e-2)" "unprognostic (5.55e-3)" "unprognostic (8.94e-2)" "unprognostic (6.45e-2)" "unprognostic (3.77e-2)" "unprognostic (3.60e-1)" "unprognostic (2.02e-2)" "unprognostic (1.40e-1)" "unprognostic (9.70e-2)" "prognostic favorable (1.49e-5)" "unprognostic (8.57e-2)" "unprognostic (9.64e-2)" "unprognostic (5.68e-2)" "unprognostic (2.66e-1)" 18.1 39.1 17.4 15.4 20.6 18.3 22.2 15.3 34.4 14.9 27.0 13.5 16.9 32.5 16.6 13.5 31.8 19.4 17.6 103.1 17.1 18.8 29.1 101.9 13.8 26.6 17.4 21.9 17.3 35.5 16.8 16.9 17.5 20.5 17.9 24.3 15.0 26.8 21.5 175.8 24.6 26.7 21.9 12.8 21.1 22.3 17.6 9.5 22.4 20.1 76.2 23.8 19.9 17.8 37.1 52.8 22.1 45.3 30.1 45.6 44.7 29.0 47.7 17.3 43.2 19.7 21.7 29.7 19.5 25.2 28.0 25.4 41.9 35.0 44.0 8.8 25.7 30.3 29.7 44.3 29.2 20.0 31.3 64.1 24.4 25.6 38.6 24.3 38.0 25.3 27.4 26.1 27.2 40.6 22.0 26.0 27.4 76.9 25.7 25.9 65.8 32.9 67.0 38.5 51.5 60.2 26.9 21.3 63.2 26.2 38.4 43.3 39.4 19.6 98.1 40.3 23.0 55.7 42.9 20.1 28.1 26.6 30.5 38.8 28.9 23.8 48.7 24.4 48.7 42.7 22.1 38.9 18.2 32.7 43.5 34.2 37.1 36.9 35.3 52.8 32.1 36.0 33.1 10.2 30.1 45.3 47.1 45.6 44.7 17.4 20.6 15.3 34.4 17.1 18.8 17.4 21.9 20.5 9.5 47.6 54.0 113.9 144.7 120.7 61.8 448.3 122.3 80.3 48.9 109.9 17.7 283.1 379.7 210.0 208.8 86.2 316.5 0.0 291.5 257.6 93.5 138.9 53.1 240.8 220.1 68.3 162.9 73.1 117.9 127.9 92.0 117.1 172.1 171.3 226.5 63.6 223.7 228.0 93.3 301.0 48.8 84.1 129.5 71.9 69.5 145.2 246.6 109.1 306.4 194.4 MDK "FLJ27379, MK, NEGF2" ENSG00000110492 Midkine P21741 11 46380756-46383837 "Cancer-related genes, Predicted secreted proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 115.9" "Cell type enhanced" "Detected in many" 11 "Intestinal endocrine cells: 971.2;Paneth cells: 1226.4;Urothelial cells: 439.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6;neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0" "Cell line enhanced" "Detected in many" "NTERA-2: 89.4;REH: 130.0;SH-SY5Y: 111.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010055, HPA057126" Uncertain Approved Vesicles "Secreted to blood" NA NA 158000 1200000 Vesicles "CAB010055: AB_627949, HPA057126: AB_2683344" "unprognostic (8.87e-3)" "unprognostic (6.65e-2)" "unprognostic (4.02e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.11e-2)" "unprognostic (4.01e-2)" "unprognostic (4.15e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (8.78e-2)" "unprognostic (1.31e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" 8.0 16.2 4.7 11.9 5.6 1.7 13.5 5.3 5.9 62.5 36.3 5.3 13.9 50.6 41.0 33.9 6.5 34.6 35.0 6.4 4.0 5.9 6.1 2.0 8.0 3.6 4.9 4.4 115.9 13.1 8.9 64.8 11.5 5.5 47.7 7.4 59.0 22.2 24.5 4.7 4.1 58.4 16.6 4.0 13.9 21.0 9.3 2.1 22.5 5.2 5.5 12.4 15.3 23.0 3.6 0.2 4.9 0.6 0.2 2.0 1.5 4.9 6.5 76.3 0.2 0.5 6.4 1.8 3.8 7.7 14.7 13.1 49.5 21.8 0.3 53.8 5.6 0.6 42.5 43.0 0.0 1.3 15.1 9.0 2.1 0.6 67.8 34.8 0.1 0.3 10.3 1.3 8.9 0.0 3.1 21.4 2.9 36.6 0.3 8.2 33.8 1.8 0.9 89.4 26.7 38.8 130.0 2.9 0.4 0.1 0.1 42.4 111.0 12.7 1.1 1.0 70.5 34.8 34.3 5.8 22.6 54.3 0.3 2.6 0.2 1.0 0.4 0.6 1.3 19.6 0.0 0.1 0.0 0.3 0.5 0.0 3.6 0.2 0.5 0.1 1.1 0.2 0.0 4.9 0.2 0.6 0.2 2.0 1.5 4.7 5.6 5.3 5.9 4.0 5.9 4.9 4.4 5.5 2.1 0.0 4.8 2.4 142.7 9.8 0.1 5.8 40.8 41.5 46.6 45.4 0.0 140.1 1.7 217.8 16.4 56.2 413.9 0.0 92.4 97.9 99.4 135.8 4.6 5.9 43.2 0.0 971.2 77.3 4.0 90.5 101.5 7.1 35.4 16.2 245.7 23.8 203.6 1226.4 17.7 13.5 0.7 84.1 56.5 14.9 29.0 7.0 128.0 3.2 126.6 439.7 MEA1 MEA ENSG00000124733 "Male-enhanced antigen 1" Q16626 6 43011143-43016868 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 109.4" "Group enriched" "Detected in many" 5 "Early spermatids: 615.5;Late spermatids: 1508.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017921, HPA073087" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017921: AB_1853708, HPA073087: " "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (1.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.74e-2)" "prognostic favorable (3.37e-4)" "unprognostic (8.56e-2)" "unprognostic (2.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (2.07e-1)" "unprognostic (8.62e-2)" "unprognostic (1.89e-2)" "unprognostic (5.58e-2)" 16.8 17.4 26.6 13.9 23.4 11.8 17.4 13.1 29.9 16.2 14.3 17.2 14.0 12.7 20.1 25.2 16.8 20.5 17.2 12.5 20.9 25.4 16.5 18.7 15.2 14.2 21.9 20.8 22.7 26.7 13.2 17.7 17.3 17.5 20.9 17.0 19.6 16.6 20.3 14.6 15.2 13.1 19.5 15.7 12.8 13.0 109.4 8.7 19.1 15.8 13.4 21.2 21.5 14.1 61.2 40.9 70.6 51.0 46.6 51.7 59.9 38.7 22.4 33.6 26.6 30.8 20.6 13.4 26.0 27.7 32.5 35.7 33.3 10.2 20.3 27.3 31.7 47.5 19.7 25.9 35.3 30.6 23.2 35.1 37.7 24.5 35.9 15.9 27.4 19.8 16.4 17.6 43.1 28.2 33.1 19.5 33.3 25.4 22.8 35.5 74.3 36.7 31.8 15.8 110.3 19.8 18.0 20.0 20.2 22.4 36.8 32.5 22.8 20.0 17.2 29.5 28.3 26.2 30.0 14.4 35.9 28.9 23.2 44.8 26.0 21.5 33.9 18.0 20.6 29.1 64.5 39.2 70.6 46.7 44.5 42.9 61.2 42.9 45.6 40.9 56.8 43.2 45.8 35.9 46.6 51.0 40.0 51.7 59.9 26.6 23.4 13.1 29.9 20.9 25.4 21.9 20.8 17.5 8.7 23.8 11.8 43.2 62.1 58.8 20.2 24.9 43.3 58.9 39.8 52.4 3.9 94.6 142.6 74.9 615.5 56.2 55.4 0.0 80.2 87.3 55.2 61.8 46.1 39.4 95.1 15.9 28.7 41.7 31.9 1508.8 58.7 50.6 64.1 93.8 42.8 52.2 71.4 49.1 56.3 121.5 14.8 116.4 68.9 194.8 94.1 60.9 71.1 58.2 45.3 74.3 MED12L "KIAA1635, TNRC11L, TRALP, TRALPUSH" ENSG00000144893 "Mediator complex subunit 12 like" Q86YW9 3 151085697-151437072 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 14.2;Horizontal cells: 31.8;Muller glia cells: 35.7;Syncytiotrophoblasts: 22.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 15.8;HEL: 17.1;JURKAT: 10.9;MOLT-4: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036807 Enhanced Approved Nucleoli NA NA Nucleoli "HPA036807: AB_10670242" "unprognostic (1.01e-2)" "unprognostic (5.82e-2)" "unprognostic (5.12e-2)" "unprognostic (8.14e-4)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (1.23e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (1.38e-3)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (4.36e-3)" "unprognostic (3.84e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" 2.8 5.2 6.4 1.2 11.1 5.5 0.5 4.9 23.1 1.6 0.6 4.4 0.0 2.2 0.9 3.0 0.9 0.6 1.8 1.7 5.5 5.1 0.4 0.4 0.7 4.4 5.8 2.6 1.0 1.7 0.5 5.4 2.0 3.9 1.2 0.3 1.9 1.7 0.7 0.5 0.4 1.6 0.6 6.1 2.1 0.8 6.1 5.7 0.6 1.0 0.0 1.5 1.3 0.8 1.0 5.1 3.1 2.8 0.1 0.4 0.8 0.7 0.3 2.5 0.2 0.1 0.0 15.8 0.0 0.2 0.6 0.7 0.8 0.3 0.0 0.2 0.1 1.8 0.1 3.2 0.2 0.7 0.0 1.5 17.1 0.1 0.1 0.0 0.5 6.1 0.0 0.1 0.1 0.1 0.1 0.0 10.9 0.0 2.6 0.0 2.5 7.9 0.0 2.9 0.1 0.5 0.1 0.9 0.4 0.2 2.5 4.2 0.6 0.4 0.2 0.0 4.6 0.8 0.1 0.0 0.0 1.9 0.0 1.3 5.0 0.0 6.1 0.2 1.5 0.9 3.1 0.3 0.0 0.1 2.8 0.4 0.1 0.1 0.2 1.6 1.0 0.0 0.0 0.3 0.1 0.8 5.1 0.0 0.8 6.4 11.1 4.9 6.9 5.5 5.1 5.8 2.6 3.9 5.7 0.0 0.0 0.0 1.2 1.0 9.0 1.2 0.0 1.4 2.3 1.8 3.9 14.2 0.0 0.1 9.9 0.1 0.0 0.0 0.5 0.6 0.6 1.0 0.0 0.0 1.6 31.8 0.0 0.6 1.0 4.5 0.9 0.9 0.0 1.8 0.0 35.7 0.2 0.0 0.4 0.1 1.8 0.0 0.1 7.5 1.5 0.1 22.5 0.0 0.0 0.1 MED26 "CRSP7, CRSP70" ENSG00000105085 "Mediator complex subunit 26" O95402 19 16574907-16629062 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 45.5;Late spermatids: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA057997, HPA071835" Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No Nucleoplasm "Vesicles, Cytosol" "HPA057997: AB_2732618, HPA071835: AB_2686455" "unprognostic (2.02e-2)" "prognostic favorable (2.46e-4)" "unprognostic (2.47e-2)" "unprognostic (2.57e-3)" "unprognostic (1.42e-1)" "unprognostic (3.60e-3)" "unprognostic (5.03e-2)" "unprognostic (3.77e-2)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (2.99e-3)" "unprognostic (2.60e-2)" "prognostic unfavorable (5.50e-5)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (5.14e-2)" "unprognostic (5.98e-3)" 5.5 4.6 5.9 8.3 6.2 14.0 7.3 8.7 6.2 6.0 5.1 4.2 5.2 4.0 5.7 6.0 6.2 4.3 4.4 4.0 5.1 4.5 3.7 5.9 9.0 7.6 4.8 4.5 6.2 6.8 6.8 5.4 7.9 4.9 5.4 3.3 3.8 7.2 7.9 9.9 7.1 4.8 4.2 4.5 6.8 5.1 34.7 4.6 8.5 5.0 6.0 6.9 4.8 5.7 2.6 4.4 2.3 1.0 1.2 2.3 0.4 9.1 3.6 3.3 7.1 4.3 3.4 9.7 5.4 3.8 5.8 5.3 5.3 5.5 14.7 5.7 3.4 1.9 6.9 5.1 5.4 4.0 10.8 10.5 5.8 3.3 4.2 4.2 6.5 5.5 4.1 5.3 4.9 5.2 3.5 3.1 7.8 9.4 17.8 3.6 9.1 6.9 6.2 7.8 4.4 11.5 7.2 5.0 16.0 3.4 3.6 8.8 4.6 4.7 4.6 5.3 2.4 3.4 8.6 3.7 7.4 5.9 9.0 7.1 12.4 10.0 11.8 5.2 8.7 4.3 2.3 0.4 0.4 1.6 1.0 0.3 1.4 0.2 0.7 0.8 2.6 1.0 0.2 1.2 1.2 0.4 4.4 2.3 0.4 5.9 6.2 8.7 6.2 5.1 4.5 4.8 4.5 4.9 4.6 3.0 10.1 12.7 3.9 12.6 3.9 0.7 2.5 1.4 1.2 5.2 9.8 5.8 3.3 3.7 45.5 4.7 4.3 0.0 3.4 8.8 6.2 4.9 1.1 4.0 4.3 4.8 2.4 3.7 9.4 52.0 6.1 4.7 1.7 2.8 4.3 5.2 5.1 3.5 3.5 1.9 5.7 0.0 6.4 21.0 16.9 9.4 14.1 4.9 5.0 7.6 MEDAG "AWMS3, C13orf33, FLJ14834, MEDA-4" ENSG00000102802 "Mesenteric estrogen dependent adipogenesis" Q5VYS4 13 30906191-30925572 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 63.0" "Cell type enhanced" "Detected in some" 16 "Fibroblasts: 43.8;Leydig cells: 17.5;Smooth muscle cells: 18.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.6" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC diff: 77.9;ASC TERT1: 21.9;U-2197: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.44e-2)" "unprognostic (3.42e-2)" "unprognostic (6.06e-3)" "unprognostic (8.80e-2)" "unprognostic (1.07e-1)" "unprognostic (3.71e-3)" "unprognostic (1.37e-1)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (8.69e-3)" "unprognostic (2.48e-1)" "unprognostic (5.41e-3)" "unprognostic (7.52e-2)" 63.0 1.9 0.1 7.4 0.3 0.2 43.8 0.1 0.4 9.0 10.0 0.3 7.5 1.2 10.2 24.8 13.3 14.5 7.2 18.6 0.4 0.4 2.0 0.4 5.3 7.3 0.4 0.5 17.9 6.8 0.5 2.2 6.4 2.6 3.6 3.2 4.6 6.0 1.7 27.1 8.0 3.5 10.8 2.4 0.4 5.2 9.5 0.1 0.0 15.3 12.7 3.6 21.5 10.5 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 77.9 21.9 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 9.2 0.0 11.1 0.0 0.0 10.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 9.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 11.1 0.0 0.0 42.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.4 0.4 0.4 0.5 2.6 0.1 0.0 0.3 0.0 0.0 10.2 0.0 4.2 0.0 1.4 2.3 0.0 0.0 0.1 0.0 1.2 1.0 6.7 0.0 0.0 0.0 0.4 43.8 1.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 1.3 17.5 0.6 10.1 0.0 0.0 0.0 0.3 0.0 9.2 0.1 0.0 0.0 18.8 0.0 0.0 9.2 0.2 0.0 0.0 0.5 MEF2B RSRFR2 ENSG00000213999 "Myocyte enhancer factor 2B" Q02080 19 19145568-19170289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "lymphoid tissue: 81.2" "Cell type enriched" "Detected in single" 16 "Sertoli cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "Daudi: 50.9;U-266/70: 51.2;U-698: 67.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004734 Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Nucleoplasm, Cytosol" "Cell Junctions" "HPA004734: AB_10963939" "unprognostic (7.31e-3)" "unprognostic (4.06e-2)" "unprognostic (9.44e-5)" "unprognostic (5.07e-2)" "unprognostic (2.01e-1)" "unprognostic (7.19e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-1)" "unprognostic (2.76e-1)" "unprognostic (1.98e-2)" "unprognostic (8.66e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-11)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (3.68e-1)" "unprognostic (8.98e-3)" 2.0 1.0 0.8 81.2 1.2 1.4 1.9 0.6 1.4 2.7 3.0 0.9 0.6 1.5 2.2 1.1 1.5 2.3 2.2 1.9 1.0 0.6 1.8 2.9 2.0 32.3 1.1 0.9 3.7 0.8 0.8 2.1 0.8 1.0 3.7 1.0 1.8 3.5 1.1 1.4 2.3 3.1 1.1 1.2 6.7 1.7 1.7 0.8 1.6 3.0 3.5 58.7 1.9 2.9 0.1 0.2 1.1 0.9 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 50.9 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.2 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.2 0.3 0.3 0.0 0.0 0.9 0.4 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.5 0.1 51.2 4.7 67.3 0.1 0.3 0.0 0.0 0.9 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.6 1.4 1.0 0.6 1.1 0.9 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEF2C ENSG00000081189 "Myocyte enhancer factor 2C" Q06413 5 88717117-88904257 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 154.8" "Cell type enhanced" "Detected in many" 6 "B-cells: 255.0;Ito cells: 239.4;Sertoli cells: 329.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8" "Group enriched" "Detected in many" 5 "B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5" "Cell line enhanced" "Detected in many" "Daudi: 24.2;HEL: 53.4;Karpas-707: 29.4;REH: 60.8;U-266/70: 22.3;WM-115: 34.8" "Group enriched" "Detected in many" 7 "amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3" "Group enriched" "Detected in all" 4 "amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8" "HPA005533, CAB068196, CAB068197" Enhanced Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352" "unprognostic (2.74e-1)" "unprognostic (1.64e-2)" "unprognostic (2.37e-2)" "unprognostic (8.78e-2)" "unprognostic (9.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.06e-1)" "unprognostic (3.19e-2)" "unprognostic (3.52e-2)" "unprognostic (8.73e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (7.18e-3)" "unprognostic (1.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.42e-2)" 13.9 10.8 17.0 15.0 26.7 3.8 10.7 4.3 52.8 8.2 6.8 6.1 1.5 2.8 10.9 5.4 5.0 6.4 9.8 11.2 11.1 6.8 4.5 4.0 8.3 19.3 6.6 28.0 12.3 2.9 5.2 6.5 14.8 4.8 7.1 5.7 4.6 6.6 6.6 154.8 3.9 7.4 10.8 8.3 16.0 4.5 3.6 4.4 1.6 9.6 3.5 24.0 8.9 5.8 48.2 23.8 5.8 19.5 4.0 0.1 7.2 0.3 0.0 1.7 0.0 1.9 1.1 0.0 0.5 1.0 0.0 0.2 0.0 0.2 24.2 0.1 2.8 0.6 0.7 2.3 2.1 0.0 7.3 3.0 53.4 3.2 0.0 0.6 2.3 0.1 5.3 0.0 0.0 0.0 0.3 8.4 0.0 2.8 29.4 2.1 0.0 0.0 0.0 0.5 0.0 2.0 60.8 15.3 11.6 0.0 0.3 0.0 2.0 0.0 0.1 7.0 1.0 0.0 13.5 9.6 1.3 0.2 0.1 1.2 22.3 2.5 14.6 0.3 16.5 34.8 0.1 17.2 0.0 0.0 19.5 0.0 32.6 0.0 0.0 22.3 48.2 0.0 0.0 5.8 4.0 15.9 23.8 0.1 7.2 17.0 26.7 4.3 52.8 11.1 6.8 6.6 28.0 4.8 4.4 29.8 48.3 255.0 4.7 9.5 22.0 80.9 12.7 6.7 39.8 1.8 202.2 0.8 23.2 0.8 6.9 155.1 1.6 70.0 11.1 1.1 13.9 1.6 4.7 3.0 134.1 4.8 1.2 239.4 207.6 5.3 27.6 138.9 64.1 28.9 0.3 65.1 0.4 2.9 67.5 0.5 196.7 329.8 171.0 1.2 16.6 7.3 1.4 7.9 1.9 1.6 MEF2D ENSG00000116604 "Myocyte enhancer factor 2D" Q14814 1 156463727-156500828 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.8" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 163.0;Sertoli cells: 97.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 55.0;U-266/70: 48.3;U-266/84: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004807, HPA007114" Enhanced Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA004807: AB_1079354, HPA007114: AB_1079353" "unprognostic (3.17e-2)" "unprognostic (7.31e-2)" "unprognostic (3.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.95e-1)" "unprognostic (8.99e-2)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (9.96e-2)" "unprognostic (1.96e-2)" "unprognostic (1.97e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (9.27e-2)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.45e-1)" 18.1 19.6 14.9 15.7 27.5 47.6 15.5 27.0 40.3 23.8 21.1 12.1 10.5 11.0 28.6 12.9 13.8 19.5 16.6 26.3 11.8 9.6 10.4 10.6 20.0 13.9 8.6 21.1 26.7 22.4 21.4 15.0 16.2 11.6 17.2 10.6 22.3 11.3 18.8 97.8 17.5 14.8 22.0 8.4 17.2 16.1 9.9 9.9 17.2 14.7 19.4 15.6 21.9 19.3 1.7 8.5 8.1 2.0 1.5 2.3 0.8 4.6 8.6 1.8 2.8 4.4 6.1 2.8 6.1 8.0 3.2 3.5 2.7 6.3 10.8 7.1 8.2 3.2 4.6 2.1 3.5 1.9 14.7 2.8 2.6 10.7 1.5 5.4 6.3 8.6 6.8 5.9 5.6 7.7 6.8 6.1 3.4 1.9 19.1 5.1 4.4 4.2 14.6 2.6 2.6 4.4 20.8 3.9 12.4 2.8 2.3 3.0 4.7 5.9 12.9 10.2 3.7 3.5 55.0 10.2 7.7 7.2 5.6 4.5 48.3 49.9 20.7 6.5 5.0 4.1 1.3 2.0 2.3 1.9 1.1 2.3 1.7 1.4 1.7 1.4 1.7 0.7 1.3 8.1 1.5 1.9 8.5 1.6 0.8 14.9 27.5 27.0 40.3 11.8 9.6 8.6 21.1 11.6 9.9 6.0 18.1 14.4 10.3 33.1 78.1 35.2 20.4 2.7 15.9 1.8 163.0 3.9 0.0 7.0 1.3 21.1 33.9 0.0 9.7 4.3 21.3 16.3 3.5 11.3 15.8 66.7 20.6 18.4 22.5 4.6 29.1 18.3 13.5 10.0 29.7 16.8 18.5 28.1 30.4 2.6 80.6 97.0 38.1 5.1 9.8 33.2 12.8 12.9 11.0 14.9 MEFV "FMF, MEF, TRIM20" ENSG00000103313 "MEFV, pyrin innate immunity regulator" O15553 16 3242028-3256627 "Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" Actin-binding "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 23.3" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 7.0;Kupffer cells: 14.8;Macrophages: 7.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "THP-1: 12.1" HPA077497 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077497: " "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (4.96e-2)" "unprognostic (2.01e-1)" "unprognostic (2.49e-2)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "unprognostic (3.35e-2)" "unprognostic (2.97e-2)" "unprognostic (1.09e-1)" "unprognostic (8.89e-2)" "unprognostic (3.27e-1)" "unprognostic (7.58e-7)" "unprognostic (1.08e-1)" "unprognostic (7.16e-4)" "unprognostic (1.73e-3)" "unprognostic (1.48e-1)" 4.2 1.2 0.5 9.8 1.0 9.7 0.9 0.4 0.9 1.1 1.4 0.3 0.0 1.0 0.6 2.7 1.2 1.6 1.8 4.2 0.5 0.5 1.3 1.5 11.4 14.8 2.8 0.1 1.2 1.8 0.2 0.7 1.8 0.8 0.9 0.6 1.7 0.8 0.7 1.7 0.6 1.3 1.6 2.2 23.3 1.0 2.2 1.3 1.2 1.7 0.2 1.4 2.7 4.1 0.4 2.1 10.0 6.5 0.5 0.3 1.3 0.1 0.1 0.1 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.2 1.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.1 12.1 0.1 0.3 0.1 0.1 0.1 0.5 0.4 0.2 0.4 2.1 0.0 2.5 3.8 0.2 0.1 4.2 0.1 0.2 0.2 0.1 2.1 0.4 0.1 0.3 10.0 0.5 6.5 0.3 0.1 1.3 0.5 1.0 0.4 0.9 0.5 0.5 2.8 0.1 0.8 1.3 0.0 2.2 0.0 0.0 0.2 0.0 7.0 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.9 0.0 0.0 0.6 14.8 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 MEGF10 KIAA1780 ENSG00000145794 "Multiple EGF like domains 10" Q96KG7 5 127290831-127465737 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis, Phagocytosis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 48.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 21.6;RH-30: 26.5" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 27000000 "unprognostic (7.02e-2)" "unprognostic (4.50e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-3)" "unprognostic (8.91e-3)" "unprognostic (1.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.16e-1)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.76e-4)" "unprognostic (5.28e-3)" "unprognostic (2.59e-1)" "unprognostic (9.36e-4)" "unprognostic (1.17e-1)" 1.3 5.1 9.8 1.2 12.9 0.9 2.8 3.3 24.6 1.8 1.4 25.8 0.0 1.2 2.8 2.0 1.2 1.2 1.1 1.5 11.6 5.6 1.1 1.8 1.0 1.0 21.7 10.4 1.2 0.9 0.9 2.4 1.2 12.2 2.8 1.5 2.4 5.0 3.7 7.3 1.1 1.3 1.6 14.8 1.2 1.0 1.9 23.1 0.0 1.1 2.0 1.5 1.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.7 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.8 12.9 3.3 10.8 11.6 5.6 21.7 10.4 12.2 23.1 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 7.9 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 MEGF11 "DKFZp434L121, KIAA1781" ENSG00000157890 "Multiple EGF like domains 11" A6BM72 15 65895079-66253747 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.7;fallopian tube: 16.3" "Group enriched" "Detected in many" 6 "Early spermatids: 136.6;Horizontal cells: 119.2;Late spermatids: 159.9" "Cancer enhanced" "Detected in some" "glioma: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 4.6;HEK 293: 3.6;RPTEC TERT1: 12.7;SCLC-21H: 9.9" "Region enriched" "Detected in many" 4 "cerebellum: 39.2" "Region enriched" "Detected in all" 7 "cerebellum: 62.2" NA NA "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.95e-2)" "unprognostic (1.84e-2)" "unprognostic (9.02e-3)" "unprognostic (6.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.08e-2)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" "unprognostic (6.79e-3)" "unprognostic (6.81e-3)" "unprognostic (5.71e-5)" "unprognostic (7.94e-2)" "unprognostic (9.78e-3)" "unprognostic (2.03e-1)" "unprognostic (4.89e-2)" 0.6 0.8 8.7 0.9 5.4 1.3 0.6 34.7 17.1 0.6 0.7 5.3 0.0 0.6 0.8 2.3 0.7 16.3 0.7 0.6 11.6 5.7 4.6 0.6 1.6 0.9 6.5 2.5 0.7 1.0 0.5 1.5 0.6 9.2 0.7 0.6 3.4 0.6 0.8 0.6 3.2 0.7 0.6 9.2 0.9 1.0 2.6 5.5 0.0 0.7 0.0 0.7 0.6 0.2 0.3 0.1 0.5 0.2 0.0 1.5 0.0 0.0 0.1 0.5 4.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.8 0.0 0.3 0.1 0.3 0.0 0.1 0.2 3.6 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.5 0.0 0.1 12.7 0.3 9.9 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.4 1.5 0.5 0.0 0.0 0.1 0.1 0.0 8.7 5.4 34.7 4.7 11.6 5.7 6.5 2.5 9.2 5.5 0.0 3.0 0.0 0.5 1.9 4.9 0.6 0.0 1.4 0.0 3.5 7.9 0.2 0.0 0.0 136.6 0.7 0.0 0.0 0.2 0.1 1.1 0.3 0.0 0.0 0.1 119.2 0.0 1.3 0.3 159.9 2.3 0.9 0.0 0.0 0.0 3.5 0.1 0.0 1.4 0.8 25.0 0.0 0.5 2.1 2.0 3.3 0.5 0.0 0.0 0.4 MEGF6 EGFL3 ENSG00000162591 "Multiple EGF like domains 6" O75095 1 3489920-3611495 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;T-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052129 Uncertain Approved "Microtubules,Cytokinetic bridge" "Secreted - unknown location" Yes No 580000 Microtubules "Cytokinetic bridge" "HPA052129: AB_2681739" "unprognostic (1.95e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "prognostic favorable (6.57e-4)" "unprognostic (1.19e-1)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (3.09e-3)" "unprognostic (1.60e-1)" "unprognostic (1.64e-1)" "unprognostic (9.51e-2)" "unprognostic (3.43e-2)" 15.0 2.3 0.5 8.5 1.0 9.2 13.4 0.8 2.0 8.1 5.9 1.8 7.5 2.3 5.1 13.1 6.6 14.6 21.0 6.1 1.4 0.5 2.7 1.9 12.6 12.6 0.7 1.9 8.8 4.8 0.8 1.5 2.8 2.3 12.0 0.9 11.0 8.7 5.5 6.1 37.8 4.2 3.0 0.8 5.7 4.2 4.6 1.4 5.0 5.2 12.0 12.0 6.7 10.1 0.8 0.3 4.8 0.1 0.0 1.9 0.2 4.5 7.2 1.6 3.1 0.1 0.1 0.5 22.5 6.3 1.9 0.6 1.5 5.3 0.0 7.2 7.7 1.3 2.8 0.0 0.2 0.2 0.0 0.1 0.0 20.3 1.3 0.0 0.1 0.4 0.0 0.2 0.1 0.2 26.6 2.4 0.0 0.0 0.0 0.0 2.5 0.0 4.1 1.0 1.0 0.4 0.9 0.9 2.7 0.4 1.4 1.6 1.5 8.1 0.5 2.8 2.3 2.2 0.4 1.0 8.2 0.8 20.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 4.8 0.1 0.0 0.4 0.0 0.4 0.4 0.3 0.8 0.8 0.1 2.2 0.0 0.0 0.0 1.9 0.2 0.5 1.0 0.8 2.0 1.4 0.5 0.7 1.9 2.3 1.4 20.8 19.4 0.0 7.5 16.4 0.8 3.0 5.1 0.0 6.8 1.8 0.0 0.1 0.0 3.0 0.2 8.7 0.3 0.0 1.2 1.0 6.4 3.4 1.1 0.9 1.0 0.0 0.0 16.5 0.8 0.0 10.6 2.8 18.6 0.0 1.3 9.5 3.6 0.0 3.2 1.7 1.0 0.0 2.1 0.5 0.6 9.9 0.3 0.0 0.7 3.0 MEI1 "MGC40042, SPATA38" ENSG00000167077 "Meiotic double-stranded break formation protein 1" Q5TIA1 22 41699499-41799456 "Predicted intracellular proteins, Predicted secreted proteins" Meiosis "Disease mutation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 26.8;lymphoid tissue: 20.3;testis: 34.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 50.5;Late spermatids: 37.4;monocytes: 22.6;T-cells: 22.5" "Cancer enhanced" "Detected in many" "cervical cancer: 5.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 7.9;HMC-1: 6.4;Karpas-707: 21.4;U-266/70: 22.7" "Group enriched" "Detected in many" 17 "amygdala: 1.6;basal ganglia: 1.7;cerebral cortex: 2.6;hippocampal formation: 1.7;olfactory region: 1.9" "Region enriched" "Detected in single" 4 "olfactory region: 4.2" HPA049240 Approved "Secreted in male reproductive system" NA NA "HPA049240: AB_2680689" "unprognostic (1.95e-3)" "prognostic favorable (1.59e-6)" "unprognostic (6.13e-3)" "unprognostic (1.86e-2)" "unprognostic (9.70e-2)" "unprognostic (2.97e-3)" "unprognostic (9.04e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (5.96e-2)" "unprognostic (9.65e-2)" "unprognostic (2.62e-1)" "unprognostic (2.45e-10)" "unprognostic (2.82e-1)" "unprognostic (3.02e-1)" "unprognostic (1.85e-1)" "unprognostic (7.39e-2)" 2.1 0.9 1.4 7.7 1.4 12.4 3.1 1.7 3.3 1.6 6.3 0.5 0.9 2.6 0.8 3.6 1.6 1.2 1.9 1.5 1.2 1.8 2.2 1.3 3.5 20.3 1.1 0.4 0.9 1.0 0.0 1.0 1.6 1.6 1.2 3.3 3.3 6.0 1.0 0.7 1.1 6.5 0.6 1.1 15.5 4.5 34.7 0.3 3.8 1.9 1.8 17.1 4.0 1.3 11.0 3.2 7.3 3.7 7.8 26.8 8.8 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 1.7 0.0 0.2 0.4 0.1 0.4 0.4 0.1 0.2 0.1 0.0 0.0 0.0 5.0 0.0 1.4 7.9 0.9 1.3 1.0 6.4 0.1 0.1 0.0 0.0 0.3 0.3 0.6 0.2 21.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.7 0.7 0.4 0.0 0.0 0.0 22.7 3.6 0.9 0.3 2.1 0.1 6.2 3.7 7.3 15.8 2.7 15.2 11.0 15.8 13.3 3.2 7.3 11.7 12.8 0.7 7.8 1.1 1.2 26.8 8.8 1.4 1.4 1.7 3.3 1.2 1.8 1.1 0.4 1.6 0.3 0.0 5.6 14.9 0.2 0.8 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 50.5 1.0 0.0 0.0 0.0 0.1 1.4 0.2 13.9 0.8 7.4 0.0 0.0 1.8 1.9 37.4 0.6 6.3 16.9 22.6 0.3 0.0 3.2 0.0 1.1 0.3 0.6 0.0 2.5 19.7 19.0 0.9 0.0 22.5 0.0 0.2 MEI4 ENSG00000269964 "Meiotic double-stranded break formation protein 4" A8MW99 6 77690658-77926974 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "kidney: 8.5;pancreas: 4.1;testis: 4.7;thyroid gland: 4.6" "Group enriched" "Detected in some" 9 "Early spermatids: 59.5;Late spermatids: 15.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 3.5;NTERA-2: 1.5;TIME: 2.6;U-266/70: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.47e-1)" "unprognostic (9.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (1.88e-1)" "unprognostic (4.62e-2)" "unprognostic (9.70e-4)" "unprognostic (3.16e-1)" "unprognostic (2.86e-4)" "unprognostic (3.35e-2)" "unprognostic (4.17e-2)" "unprognostic (4.85e-2)" 0.0 1.3 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.0 0.2 0.9 8.5 1.7 0.0 0.0 0.8 0.0 4.1 0.0 2.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 4.7 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.6 0.4 0.7 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 15.6 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 3.5 0.0 0.0 0.0 4.3 2.5 0.0 0.0 0.0 0.0 0.0 MEIG1 "bA2K17.3, SPATA39" ENSG00000197889 "Meiosis/spermiogenesis associated 1" Q5JSS6 10 14959439-14988050 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 9.6;testis: 18.9" "Group enriched" "Detected in some" 4 "Ciliated cells: 30.8;Early spermatids: 97.5;Spermatocytes: 33.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 9.7;SK-MEL-30: 5.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (1.08e-1)" "unprognostic (2.42e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (5.51e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (3.75e-6)" "unprognostic (6.89e-2)" "unprognostic (1.36e-5)" "unprognostic (2.97e-1)" "unprognostic (3.74e-3)" "unprognostic (8.40e-3)" "unprognostic (3.15e-1)" 0.7 0.7 2.9 0.3 3.1 0.4 0.6 2.9 4.3 0.8 0.6 1.3 0.0 0.3 0.6 1.0 0.3 9.6 0.4 0.3 3.5 1.9 0.8 0.7 1.4 0.8 3.3 1.5 0.9 0.9 0.7 4.5 0.7 3.8 0.6 0.7 0.5 0.8 0.7 0.3 0.5 0.7 0.4 1.3 0.8 0.4 18.9 2.1 1.8 0.4 0.0 0.7 0.3 0.2 3.8 0.5 0.0 1.3 1.6 2.1 0.1 1.6 1.3 2.3 1.1 0.7 0.4 0.0 0.4 0.7 0.9 0.9 0.0 2.2 0.5 0.0 0.4 1.2 0.1 1.5 0.3 0.3 9.7 0.4 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 1.3 0.0 0.3 0.7 0.3 0.5 1.0 1.1 2.2 0.3 0.1 1.3 1.2 1.8 2.2 0.3 0.8 1.1 0.0 1.5 3.4 0.4 0.2 5.8 0.5 1.2 0.2 0.0 0.1 0.0 0.6 0.0 3.8 3.0 3.1 1.3 1.5 0.0 0.0 0.4 0.0 0.4 0.0 1.0 3.8 0.7 0.4 0.5 0.6 0.3 0.2 0.0 1.6 1.3 0.1 2.1 0.1 2.9 3.1 2.9 4.3 3.5 1.9 3.3 1.5 3.8 2.1 0.0 0.3 0.0 0.5 0.0 0.1 0.8 0.0 30.8 3.4 1.8 0.0 0.7 1.7 0.3 97.5 0.0 0.0 0.0 0.8 0.2 0.2 0.7 0.0 0.8 0.5 0.0 0.0 0.0 0.0 12.6 2.0 0.0 0.0 0.0 0.6 2.3 0.2 0.0 0.0 0.5 0.1 0.0 0.0 33.9 3.6 0.4 0.2 1.3 0.0 0.3 MEIKIN ENSG00000239642 "Meiotic kinetochore factor" A0A087WXM9 5 131806993-131945698 "Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 16.3" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 16.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.7;non-classical monocyte: 3.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "SuSa: 2.3;U-2 OS: 5.9" "Low region specificity" "Detected in all" NA NA "unprognostic (3.21e-1)" "unprognostic (2.30e-1)" "unprognostic (2.64e-2)" "unprognostic (5.27e-2)" "unprognostic (4.31e-1)" "unprognostic (4.64e-6)" "unprognostic (2.38e-1)" "unprognostic (3.81e-1)" 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.5 0.0 3.2 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 2.7 0.4 0.5 0.1 0.1 1.5 0.5 1.0 0.0 0.0 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 4.1 0.0 0.0 0.0 0.0 0.0 MEIOB "C16orf73, MGC35212" ENSG00000162039 "Meiosis specific with OB domains" Q8N635 16 1833987-1884294 "Disease related genes, Predicted intracellular proteins" Meiosis "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 44 "testis: 41.2" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 383.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 12.5;K-562: 40.4;THP-1: 34.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (7.18e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-2)" "unprognostic (9.73e-2)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (2.00e-2)" "unprognostic (2.68e-2)" "unprognostic (7.30e-3)" "unprognostic (1.34e-1)" "unprognostic (3.80e-1)" "unprognostic (2.18e-3)" 0.1 0.1 0.8 0.0 0.9 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.6 0.3 0.9 0.3 0.0 0.0 0.1 0.8 0.3 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.3 0.0 0.1 41.2 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 4.2 0.4 0.0 0.2 0.4 34.5 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.9 0.0 0.7 0.6 0.3 0.1 0.8 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 37.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 4.6 0.0 0.1 3.2 0.0 0.0 0.0 10.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 2.3 0.2 6.5 0.0 383.1 43.7 0.4 0.0 0.0 0.0 0.4 MEIOC "C17orf104, FLJ35848" ENSG00000180336 "Meiosis specific with coiled-coil domain" A2RUB1 17 44656404-44690308 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 59.6" "Group enriched" "Detected in some" 5 "Early spermatids: 263.1;Late spermatids: 392.6;Spermatocytes: 236.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 13.4;HMC-1: 20.5;NTERA-2: 7.1;SiHa: 7.5;SuSa: 10.2;THP-1: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA027266 Enhanced Uncertain "Cell Junctions" NA NA "Cell Junctions" "HPA027266: AB_1848900" "unprognostic (5.82e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.96e-2)" "unprognostic (9.12e-2)" "unprognostic (2.31e-1)" "unprognostic (2.13e-1)" "unprognostic (3.63e-2)" "unprognostic (8.89e-2)" "unprognostic (7.58e-2)" "unprognostic (6.83e-4)" "unprognostic (1.85e-1)" "unprognostic (6.24e-3)" "unprognostic (1.72e-1)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (8.89e-3)" 0.2 0.2 0.4 0.2 0.8 0.6 0.2 2.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.2 0.3 0.7 0.6 1.4 0.3 0.2 0.3 0.4 0.2 0.2 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.2 1.5 0.7 0.2 0.2 0.3 0.2 0.1 59.6 0.2 0.2 0.3 0.2 0.3 0.2 0.2 1.8 1.9 2.2 0.8 0.8 1.0 0.1 0.2 6.2 0.9 1.0 0.2 0.0 0.5 0.8 0.0 0.5 1.7 0.4 0.2 0.7 1.5 0.3 0.2 0.2 13.4 0.0 0.2 0.6 5.4 0.5 0.8 0.3 0.0 0.5 20.5 0.0 0.0 0.8 0.0 1.4 0.0 1.3 0.4 0.6 0.1 1.2 0.4 1.2 7.1 0.2 0.6 0.3 0.7 0.4 0.0 0.2 1.5 2.0 7.5 0.2 0.1 10.2 0.9 10.2 0.2 0.4 0.2 1.5 0.7 0.5 0.8 0.3 0.5 0.7 1.2 1.9 0.8 0.7 0.9 0.5 0.5 0.9 0.8 0.5 0.2 1.8 1.0 0.9 2.2 0.8 0.6 1.9 0.5 0.1 0.4 0.8 2.5 0.9 0.7 0.6 0.4 0.2 0.3 0.2 0.0 0.6 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 0.2 3.3 0.2 263.1 0.0 0.0 0.0 0.2 0.4 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 1.0 392.6 4.4 0.5 0.0 0.0 0.0 1.0 0.3 0.0 3.5 1.1 2.2 19.4 0.0 236.7 55.3 0.0 0.2 0.0 0.0 0.5 MEIS3 "DKFZp547H236, MRG2" ENSG00000105419 "Meis homeobox 3" Q99687 19 47403124-47419523 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 35.3;endometrium 1: 28.8" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 22.3;Horizontal cells: 42.9;Late spermatids: 47.6;Muller glia cells: 18.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;HMC-1: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046699 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA046699: AB_2616456" "unprognostic (3.27e-3)" "unprognostic (2.98e-1)" "unprognostic (2.13e-2)" "unprognostic (4.49e-1)" "unprognostic (3.16e-1)" "unprognostic (4.67e-2)" "unprognostic (2.12e-2)" "unprognostic (5.93e-3)" "unprognostic (1.21e-1)" "unprognostic (2.73e-2)" "unprognostic (1.58e-2)" "unprognostic (9.76e-2)" "prognostic unfavorable (1.78e-6)" "unprognostic (9.29e-3)" "unprognostic (9.21e-3)" "unprognostic (4.36e-2)" "unprognostic (3.80e-3)" 5.6 3.9 35.3 4.7 10.6 0.0 5.0 11.0 25.3 8.4 4.7 2.4 3.8 3.5 28.8 2.2 6.0 14.2 6.0 3.7 23.2 11.6 1.5 1.1 3.1 1.2 2.6 14.6 7.4 1.7 1.1 4.9 7.4 3.8 7.0 2.1 4.1 3.6 6.4 1.4 1.6 3.8 22.5 1.7 2.4 2.6 3.3 2.0 0.5 3.4 1.6 1.4 6.1 4.7 0.0 0.2 0.5 0.7 0.0 0.1 0.4 0.3 12.1 28.4 0.1 15.4 13.3 0.4 12.7 19.4 9.9 17.5 1.1 1.9 0.0 1.4 20.8 8.2 1.4 2.9 3.5 3.4 18.9 4.3 0.0 4.4 0.1 10.0 0.2 24.6 9.8 0.7 3.9 2.1 3.5 0.0 0.0 0.2 2.8 1.1 11.5 0.0 0.1 8.3 0.3 0.7 0.0 2.1 0.3 0.6 0.9 1.1 23.0 10.9 0.9 5.2 11.8 0.6 3.5 0.0 7.6 19.3 5.5 1.7 0.0 0.0 0.0 21.2 1.1 15.2 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.1 0.4 35.3 10.6 11.0 25.3 23.2 11.6 2.6 14.6 3.8 2.0 0.0 2.7 0.0 1.0 0.7 4.8 0.8 0.0 2.7 3.4 3.5 5.9 0.1 0.0 0.0 22.3 0.5 0.0 0.0 0.0 0.2 9.9 3.2 0.0 0.0 0.5 42.9 0.0 1.8 0.0 47.6 10.6 1.1 6.8 0.0 0.0 18.0 0.1 0.0 3.9 0.0 2.7 12.9 6.9 2.6 4.7 0.9 0.7 0.0 0.0 0.7 MELK KIAA0175 ENSG00000165304 "Maternal embryonic leucine zipper kinase" Q14680 9 36572862-36677683 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.4" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 36.8;Spermatocytes: 10.2;Spermatogonia: 19.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 4.8" "Lineage enriched" "Detected in many" 5 "T-cells: 4.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA017214 Uncertain NA Yes "HPA017214: AB_1853798" "unprognostic (5.03e-2)" "unprognostic (9.57e-2)" "unprognostic (2.27e-2)" "unprognostic (3.42e-3)" "unprognostic (2.16e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.91e-7)" "prognostic unfavorable (3.99e-4)" "unprognostic (1.26e-2)" "unprognostic (1.60e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (4.69e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (8.86e-3)" "unprognostic (1.37e-1)" "unprognostic (2.40e-1)" "unprognostic (1.35e-1)" 1.5 1.1 0.3 11.4 0.6 7.7 2.6 0.2 0.8 2.1 5.9 0.3 0.1 4.5 1.2 1.5 12.2 0.4 1.6 1.3 0.5 0.4 1.2 1.3 2.0 8.3 0.4 0.1 0.7 0.8 0.0 0.3 6.3 0.5 0.7 7.8 0.4 2.3 0.1 0.9 2.8 4.6 1.9 1.0 5.2 2.9 11.3 0.4 42.4 0.5 7.2 12.6 1.5 3.3 0.1 0.6 1.0 0.1 0.4 4.8 0.5 35.6 18.4 24.8 14.6 3.4 5.9 14.4 26.5 18.7 37.2 45.9 14.0 14.1 11.9 8.5 13.0 32.5 12.3 21.6 16.6 41.1 32.5 8.6 9.4 21.8 14.0 1.3 14.5 11.9 2.1 3.0 28.6 16.3 4.8 18.7 18.6 11.9 19.1 30.4 11.9 18.0 6.8 19.8 16.1 14.4 16.7 16.7 7.6 11.4 12.0 16.8 12.5 14.1 13.6 8.6 14.4 11.4 6.9 9.2 20.1 25.4 16.9 24.1 3.8 13.6 17.9 12.7 10.8 27.2 0.0 0.0 1.0 0.2 0.0 0.0 0.1 0.8 1.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.6 4.8 0.5 0.3 0.6 0.2 0.8 0.5 0.4 0.4 0.1 0.5 0.4 0.0 0.0 0.0 0.4 4.0 0.0 0.3 0.0 1.4 2.3 0.0 0.0 4.2 0.0 0.8 1.8 0.0 1.2 0.0 1.0 36.8 2.1 0.2 0.0 0.2 8.4 0.0 0.0 1.3 0.6 1.8 1.1 2.3 0.0 5.4 1.3 0.0 1.1 2.9 0.0 0.0 0.0 0.0 0.9 10.2 19.0 1.5 7.4 0.0 3.7 1.4 MELTF "CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1" ENSG00000163975 Melanotransferrin P08582 3 196988621-197029816 "CD markers, Plasma proteins, Predicted intracellular proteins" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 65.7" "Group enriched" "Detected in some" 5 "Collecting duct cells: 14.0;Ductal cells: 23.5;Hofbauer cells: 16.2;Pancreatic endocrine cells: 42.2" "Cancer enhanced" "Detected in all" "melanoma: 32.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 3.3" "Group enriched" "Detected in many" 5 "dendritic cells: 1.9;monocytes: 2.1;T-cells: 3.3" "Cell line enhanced" "Detected in many" "A-431: 47.1;SK-MEL-30: 58.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA004880 Approved "Intracellular and membrane" NA NA 230000000 "HPA004880: AB_1853844" "unprognostic (8.68e-3)" "unprognostic (3.68e-2)" "unprognostic (1.75e-2)" "unprognostic (7.68e-3)" "unprognostic (1.06e-2)" "unprognostic (1.08e-2)" "unprognostic (5.53e-2)" "unprognostic (1.64e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-1)" "unprognostic (3.68e-3)" "unprognostic (8.14e-2)" "prognostic unfavorable (6.99e-11)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.09e-2)" 6.0 1.6 1.9 3.5 2.0 1.8 7.5 2.7 2.8 4.4 5.1 3.3 3.5 2.1 4.9 4.8 2.4 6.4 2.5 3.3 1.8 1.1 5.1 1.4 1.6 1.7 1.0 1.0 1.3 4.3 15.9 1.8 4.4 2.9 3.7 1.9 2.9 65.7 4.7 1.4 10.5 8.7 3.1 1.1 1.0 1.1 2.6 0.9 3.6 2.0 1.3 2.4 2.0 5.4 0.2 1.9 0.2 2.1 0.5 3.3 0.6 47.1 10.3 0.1 0.3 1.5 1.9 1.2 0.8 0.4 1.6 1.9 2.9 7.1 1.3 10.2 1.6 1.4 14.8 0.5 0.0 0.7 2.1 3.3 1.6 2.2 1.2 9.6 0.2 9.4 10.3 1.3 1.3 0.1 0.0 0.2 2.7 1.2 9.3 0.9 2.8 2.7 0.0 1.1 2.0 6.8 3.9 1.6 0.5 0.2 0.4 0.9 3.5 9.8 0.8 58.2 1.2 2.9 1.4 0.3 0.3 8.3 1.7 5.8 1.6 13.1 1.3 1.2 2.8 0.0 0.1 0.3 0.0 1.2 1.0 3.3 0.2 1.0 1.0 1.9 0.2 0.3 0.1 0.2 0.5 2.1 0.0 0.1 0.6 1.9 2.0 2.7 2.8 1.8 1.1 1.0 1.0 2.9 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 14.0 0.0 0.2 0.0 23.5 0.0 0.0 0.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 42.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 MEOX2 "GAX, MOX2" ENSG00000106511 "Mesenchyme homeobox 2" P50222 7 15611212-15686812 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 45.3" "Cell type enhanced" "Detected in some" 13 "Leydig cells: 37.4;Peritubular cells: 23.7;Sertoli cells: 25.8;Smooth muscle cells: 32.1" "Cancer enriched" "Detected in many" 8 "glioma: 15.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 72.3;U-138 MG: 18.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 4.4" HPA053793 Enhanced NA NA "HPA053793: AB_2682264" "unprognostic (1.10e-1)" "unprognostic (4.72e-2)" "unprognostic (9.82e-3)" "unprognostic (4.22e-2)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (3.12e-2)" "unprognostic (1.21e-1)" "unprognostic (5.56e-2)" "unprognostic (1.47e-3)" "unprognostic (4.44e-1)" "unprognostic (2.34e-1)" "unprognostic (1.65e-5)" "unprognostic (3.67e-3)" "unprognostic (1.13e-1)" "unprognostic (5.86e-2)" "unprognostic (1.46e-4)" 45.3 0.9 0.7 6.0 0.6 0.0 22.7 0.4 0.6 6.9 5.4 0.0 3.9 0.3 8.1 13.3 9.8 3.2 4.4 10.5 0.5 0.8 0.6 1.4 12.0 6.1 0.7 0.0 4.5 1.5 0.9 1.2 33.8 1.5 7.5 1.5 0.6 6.7 3.1 16.5 5.5 2.1 6.3 3.2 0.6 2.3 7.6 0.0 1.1 7.4 19.4 7.0 14.2 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.3 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.4 0.6 0.5 0.8 0.7 0.0 1.5 0.0 0.0 0.3 0.0 0.0 7.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 8.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 37.4 0.3 3.3 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 25.8 32.1 0.0 0.2 6.0 0.1 0.0 0.0 0.0 MEP1A PPHA ENSG00000112818 "Meprin A subunit alpha" Q16819 6 46793390-46839782 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "intestine: 243.0" "Group enriched" "Detected in some" 4 "Enterocytes: 391.5;Paneth cells: 129.6" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 38.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 3.1;CACO-2: 7.1;Hep G2: 1.9;NB-4: 3.1;RPMI-8226: 3.5;SH-SY5Y: 2.2;U-2197: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025163, HPA029416" Enhanced NA NA 990000 "CAB025163: , HPA029416: AB_10600823" "unprognostic (1.83e-1)" "unprognostic (2.81e-4)" "unprognostic (2.03e-1)" "unprognostic (8.53e-2)" "unprognostic (8.73e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-2)" "unprognostic (5.27e-4)" "unprognostic (2.05e-1)" "unprognostic (2.35e-2)" "unprognostic (1.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.11e-3)" "unprognostic (1.45e-1)" "unprognostic (1.91e-2)" "unprognostic (4.70e-3)" "unprognostic (1.68e-1)" 0.1 0.1 0.1 4.7 0.1 0.0 0.1 0.1 0.1 0.1 100.5 0.1 0.1 51.7 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 19.8 0.1 0.2 0.1 0.1 0.1 243.0 0.2 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 391.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.9 0.0 0.0 4.7 0.0 0.0 0.0 0.0 61.3 0.0 0.0 129.6 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 28.3 0.0 MEP1B ENSG00000141434 "Meprin A subunit beta" Q16820 18 32185069-32220404 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 167 "intestine: 241.5" "Group enriched" "Detected in some" 6 "Early spermatids: 2.1;Enterocytes: 6.3" "Group enriched" "Detected in some" 5 "pancreatic cancer: 3.0;stomach cancer: 0.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA029119 Enhanced "Secreted to digestive system" NA NA 120000 "HPA029119: AB_2672913" "unprognostic (1.33e-1)" "unprognostic (6.72e-2)" "unprognostic (2.79e-2)" "unprognostic (1.00e-1)" "unprognostic (3.50e-4)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (4.30e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.55e-1)" "unprognostic (8.31e-4)" "unprognostic (4.74e-2)" "unprognostic (3.39e-1)" "unprognostic (2.71e-1)" "unprognostic (3.39e-2)" "unprognostic (3.75e-2)" 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.1 0.1 78.8 0.0 0.0 54.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 241.5 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.4 0.3 0.3 0.0 1.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 2.1 1.0 0.3 0.3 0.1 0.6 1.4 1.7 0.5 0.0 0.8 0.2 0.0 0.0 0.0 0.8 1.0 1.1 0.7 0.6 0.4 1.3 0.3 0.0 0.7 0.0 0.1 0.7 0.5 1.6 1.1 0.2 0.0 1.9 1.3 4.1 1.3 0.5 0.0 1.8 1.8 2.9 0.0 0.7 10.6 2.4 0.8 0.2 0.3 0.3 0.4 3.1 0.9 1.4 0.8 3.4 0.0 0.6 2.3 0.5 2.6 0.0 0.5 0.0 0.3 0.3 1.0 0.1 1.3 1.1 0.7 1.4 0.4 0.1 1.2 0.3 0.2 0.0 0.1 0.2 0.5 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 MEPE ENSG00000152595 "Matrix extracellular phosphoglycoprotein" Q9NQ76 4 87821411-87846817 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 43 "brain: 34.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 34.2;cerebral cortex: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.0" "Group enriched" "Detected in some" 4 "amygdala: 1.3;basal ganglia: 0.7" "HPA038003, HPA038004" Uncertain "Secreted to extracellular matrix" NA NA 24000000 "HPA038003: AB_2675780, HPA038004: AB_10670537" "unprognostic (2.88e-1)" "unprognostic (8.15e-2)" "unprognostic (3.62e-1)" "unprognostic (1.91e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.14e-2)" "unprognostic (1.98e-1)" "unprognostic (2.41e-1)" "unprognostic (5.64e-4)" 0.2 0.2 34.2 0.2 5.2 0.3 0.5 0.0 10.0 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 2.4 1.7 0.3 0.2 0.3 0.2 0.5 5.4 0.2 0.2 0.2 0.1 0.3 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 5.2 0.0 10.0 2.4 1.7 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 14.1;prostate: 10.9" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 37.0;Glandular cells: 36.0;Spermatocytes: 42.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 6.3;prostate cancer: 26.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.7;HDLM-2: 5.0;HEK 293: 5.0;PC-3: 9.5;SCLC-21H: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA069981: AB_2686225" "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 14.1 1.6 6.8 1.4 4.3 1.1 3.8 7.3 8.8 2.5 1.9 1.1 0.1 1.3 1.0 1.0 0.9 1.0 2.9 3.9 4.9 5.0 1.3 1.2 1.1 1.1 3.3 4.3 1.0 1.2 1.1 1.1 0.8 2.4 10.9 1.0 1.3 3.0 1.2 7.0 0.9 1.1 0.9 1.4 0.9 1.0 1.4 1.9 0.0 1.0 2.2 0.9 0.9 0.4 0.0 0.1 0.0 0.1 0.0 0.8 0.1 5.7 2.1 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.3 0.0 2.3 0.0 0.7 0.0 0.4 0.0 0.0 5.0 5.0 0.2 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.1 0.8 1.4 0.0 0.0 9.5 0.2 0.0 1.3 0.1 0.0 4.4 0.1 1.1 1.9 1.2 0.0 0.1 0.7 0.0 0.0 0.3 3.4 1.1 2.3 0.8 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.8 4.3 7.3 8.8 4.9 5.0 3.3 4.3 2.4 1.9 0.0 0.6 0.8 2.6 0.2 10.5 5.2 12.7 0.0 0.0 1.8 9.8 1.8 10.0 16.5 3.7 0.7 17.0 0.0 37.0 0.1 1.0 36.0 4.6 11.5 2.0 7.9 5.8 3.1 2.2 1.0 1.1 2.1 6.8 2.8 4.6 12.7 7.1 10.5 0.0 11.1 15.3 0.0 1.0 42.6 14.3 0.3 0.2 4.4 11.0 5.0 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.8;placenta: 193.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 680.5;Syncytiotrophoblasts: 836.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 18.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "AN3-CA: 525.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 44.9 26.0 7.8 4.7 12.9 3.4 63.8 2.6 22.7 2.4 7.5 3.4 1.1 7.9 7.3 4.6 2.6 5.2 6.6 3.7 7.9 8.0 6.7 13.7 18.8 4.1 3.3 9.0 7.8 13.0 2.5 15.4 193.5 15.5 4.1 6.1 8.4 7.0 2.5 2.2 2.1 7.2 5.3 3.2 22.4 3.0 10.1 3.3 2.0 4.3 2.5 1.9 4.5 3.7 3.1 6.7 8.6 2.0 2.7 18.8 5.3 3.2 1.7 8.5 525.5 0.1 0.0 0.0 3.5 1.6 3.7 1.7 10.1 4.9 1.6 1.2 0.1 3.2 0.4 0.1 0.0 1.4 0.0 0.0 2.8 2.7 1.6 14.5 0.1 0.0 0.2 0.1 2.7 0.0 18.9 1.4 0.0 3.1 0.0 7.1 4.5 0.3 3.5 5.3 4.8 0.8 0.0 94.6 1.0 4.0 3.0 30.0 0.0 3.1 10.2 0.0 9.0 0.3 2.4 1.4 1.2 0.0 11.7 0.2 0.1 0.3 0.0 4.5 0.0 0.4 8.6 1.9 6.2 0.7 2.0 1.7 3.1 2.0 1.4 6.7 2.8 7.6 18.8 1.1 2.7 1.2 0.3 0.1 5.3 7.8 12.9 2.6 22.7 7.9 8.0 3.3 9.0 15.5 3.3 6.0 3.8 2.4 36.0 3.9 9.1 0.6 17.8 4.0 5.7 15.7 3.9 680.5 10.0 19.8 53.5 3.4 10.9 0.0 35.4 99.2 31.1 18.0 0.0 15.8 79.5 1.6 28.4 35.6 7.7 27.3 78.6 1.9 1.7 1.0 19.5 40.4 28.9 28.1 12.7 9.2 19.9 19.4 5.2 33.9 38.5 0.5 836.0 0.0 33.2 16.5 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715115-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.9" "Cell type enriched" "Detected in many" 8 "Muller glia cells: 554.6" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 53.4;PC-3: 41.3" "Region enriched" "Detected in all" 5 "cerebellum: 549.1" "Low region specificity" "Detected in all" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 7.7 14.9 44.7 5.1 58.9 2.6 4.6 14.2 45.4 4.1 7.0 24.1 19.8 5.6 5.3 7.8 3.1 27.4 6.4 12.4 39.6 31.6 10.5 8.5 6.0 4.2 45.7 15.1 2.7 43.1 5.2 15.1 5.3 15.3 7.4 2.5 9.2 27.3 16.8 21.5 3.9 5.9 4.4 39.5 5.4 8.3 4.6 19.0 2.5 6.6 3.4 3.0 3.9 5.0 3.2 0.9 0.8 1.0 1.7 2.9 0.5 2.6 22.5 4.4 22.5 7.9 4.4 7.2 5.3 2.7 2.1 1.4 3.3 6.6 0.4 12.5 3.7 8.2 9.9 0.6 5.2 0.3 1.4 9.9 0.9 4.1 17.0 4.8 1.9 2.9 10.7 5.7 0.6 1.3 6.7 0.7 6.3 1.5 0.5 1.6 53.4 0.7 6.5 1.6 2.9 41.3 7.3 5.1 7.3 5.5 0.7 7.0 8.9 2.1 5.9 27.4 0.5 8.9 3.8 2.4 6.1 11.7 7.1 4.6 3.4 0.9 0.4 9.6 1.4 14.4 0.0 0.3 0.8 2.9 1.0 1.7 3.2 1.5 2.7 0.2 0.5 0.9 1.9 0.0 1.7 1.0 0.9 2.8 0.5 44.7 58.9 14.2 27.4 39.6 31.6 45.7 15.1 15.3 19.0 0.0 2.1 4.2 14.7 3.4 38.6 14.0 50.9 2.7 0.0 15.7 13.7 0.6 43.1 6.3 6.5 12.6 15.0 0.0 4.2 1.8 8.7 28.3 0.0 27.2 5.2 66.7 26.2 19.0 5.1 14.5 10.3 4.8 10.1 0.0 8.1 554.6 5.4 14.7 8.9 43.5 29.1 25.8 15.3 3.9 11.3 2.6 0.3 6.4 8.6 14.2 METTL11B "C1orf184, HOMT1B" ENSG00000203740 "Methyltransferase like 11B" Q5VVY1 1 170146001-170167790 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "heart muscle: 7.0;skeletal muscle: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "NTERA-2: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028049 Uncertain NA NA "HPA028049: AB_10610139" "unprognostic (1.12e-1)" "unprognostic (2.57e-1)" "unprognostic (5.62e-2)" "unprognostic (7.59e-2)" "unprognostic (7.25e-2)" "unprognostic (1.19e-1)" "unprognostic (8.68e-2)" "unprognostic (5.24e-2)" "unprognostic (2.76e-3)" "unprognostic (5.43e-2)" "unprognostic (4.56e-1)" "unprognostic (5.79e-4)" 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 METTL21C "C13orf39, LOC196541" ENSG00000139780 "Methyltransferase like 21C" Q5VZV1 13 102685744-102694504 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 28.8;skeletal muscle: 8.5" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 1.9;Early spermatids: 1.9;Late spermatids: 3.6;Syncytiotrophoblasts: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;CACO-2: 1.6;HSkMC: 3.1;NB-4: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.07e-1)" "unprognostic (1.63e-6)" "unprognostic (2.64e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.0 0.0 0.0 0.8 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 1.8 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.5 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 METTL7A DKFZP586A0522 ENSG00000185432 "Methyltransferase like 7A" Q9H8H3 12 50923472-50932517 "Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 126.5;thyroid gland: 120.3" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 780.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 29.7;classical monocyte: 12.7;eosinophil: 25.8;intermediate monocyte: 14.2;memory B-cell: 13.6;myeloid DC: 11.5;naive B-cell: 14.7;non-classical monocyte: 20.2;plasmacytoid DC: 10.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 77.1;Karpas-707: 77.0;RPMI-8226: 42.5" HPA017434 Supported "Lipid droplets" NA NA 140000 "Lipid droplets" "HPA017434: AB_1853835" "unprognostic (2.31e-2)" "unprognostic (2.82e-2)" "unprognostic (9.85e-3)" "unprognostic (9.43e-2)" "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.09e-3)" "unprognostic (2.68e-3)" "unprognostic (5.48e-2)" "unprognostic (9.94e-2)" "unprognostic (2.57e-2)" "unprognostic (4.49e-2)" "prognostic favorable (0.00e+0)" "unprognostic (8.64e-2)" "unprognostic (5.94e-2)" "unprognostic (1.39e-1)" "unprognostic (1.22e-2)" 38.3 35.2 25.3 10.3 32.1 4.4 44.8 22.7 21.5 21.4 36.6 17.8 15.6 18.3 16.1 13.0 19.9 29.1 25.2 12.8 27.1 12.6 43.0 126.5 26.4 24.5 29.3 22.2 29.0 35.6 11.9 10.5 7.9 26.5 13.6 20.0 13.0 19.0 14.2 16.1 10.9 22.3 19.4 32.2 16.0 28.1 17.3 25.9 3.6 120.3 9.4 16.0 29.1 15.8 14.7 11.5 29.7 20.2 3.8 3.7 5.4 0.2 0.0 1.9 11.2 77.1 22.2 24.3 0.2 1.9 0.1 0.3 0.9 1.0 13.1 1.0 0.8 0.2 1.5 1.2 1.3 0.0 1.4 2.9 3.2 2.3 7.4 16.8 0.8 6.7 23.0 0.1 0.1 0.0 0.4 5.1 0.5 1.8 77.0 0.7 0.0 0.6 3.4 9.1 0.3 0.0 0.7 0.1 42.5 3.6 13.8 4.3 7.1 0.2 7.6 0.2 2.5 22.0 0.7 2.9 0.1 0.2 0.9 0.0 3.9 0.7 5.9 1.5 1.5 0.0 29.7 12.7 25.8 1.0 14.2 0.6 13.6 0.4 0.8 11.5 14.7 0.1 0.7 0.8 3.8 20.2 10.1 3.7 5.4 25.3 32.1 22.7 20.0 27.1 12.6 29.3 22.2 26.5 25.9 187.6 116.7 62.3 43.3 7.7 1.4 8.5 221.7 247.6 86.4 68.0 0.0 69.2 36.5 5.5 1.6 39.3 112.5 70.0 33.4 24.6 39.1 44.0 31.3 780.7 32.3 7.9 65.3 120.3 246.1 3.2 200.5 33.3 11.8 8.2 68.5 143.2 5.5 67.6 140.0 124.1 4.6 51.8 27.8 1.6 1.0 8.2 32.0 25.4 61.7 44.6 METTL7B "ALDI, MGC17301" ENSG00000170439 "Methyltransferase like 7B" Q6UX53 12 55681546-55684611 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 50.8;Hepatocytes: 89.3;Hofbauer cells: 55.0;Proximal tubular cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0" "Group enriched" "Detected in many" 56 "B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4" "Cell line enhanced" "Detected in many" "CACO-2: 11.9;CAPAN-2: 24.1;EFO-21: 18.1;LHCN-M2: 19.9;OE19: 13.5;THP-1: 17.6;U-87 MG: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038644 Enhanced Approved Vesicles,Microtubules NA NA Microtubules Vesicles "HPA038644: AB_2676130" "unprognostic (7.54e-2)" "unprognostic (7.15e-2)" "unprognostic (5.55e-2)" "unprognostic (3.07e-3)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (2.00e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-2)" "unprognostic (5.33e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-2)" "unprognostic (7.10e-2)" "prognostic favorable (2.37e-4)" "unprognostic (2.43e-1)" 1.3 0.9 1.2 2.1 0.9 0.1 0.5 0.5 2.2 0.4 15.2 3.0 0.0 15.2 0.4 35.7 0.3 0.7 8.1 46.1 4.6 0.6 12.6 82.4 0.8 0.8 1.8 1.5 0.3 1.2 0.0 1.3 4.3 3.2 0.3 6.0 1.4 0.4 0.1 2.7 0.5 44.7 0.4 1.0 3.1 1.0 0.4 0.6 0.0 1.0 0.1 0.0 0.3 0.3 2.5 8.6 0.0 5.4 0.0 0.0 0.4 0.2 9.2 0.0 0.2 1.9 6.8 0.1 0.3 1.4 0.1 0.6 11.9 24.1 4.8 18.1 0.5 0.5 0.0 1.7 0.1 0.3 0.0 2.3 0.4 1.5 11.7 0.0 0.2 0.0 1.7 0.0 0.4 0.0 1.8 0.0 0.0 0.1 0.0 19.9 8.3 0.0 0.1 2.4 13.5 1.1 0.0 0.6 1.1 0.2 0.0 0.0 0.1 0.9 0.0 1.6 0.1 1.6 17.6 0.0 1.3 1.6 0.2 1.2 0.0 0.2 1.4 18.3 4.1 0.1 0.0 1.0 0.0 0.0 5.4 0.0 0.7 0.0 0.0 8.6 2.5 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.4 1.2 0.9 0.5 2.2 4.6 0.6 1.8 1.5 3.2 0.6 0.0 1.0 0.0 0.1 0.0 0.0 14.9 25.5 0.0 1.2 0.0 0.0 0.4 3.3 3.3 0.0 0.0 50.8 0.0 4.6 0.4 0.4 0.0 0.0 89.3 55.0 0.0 1.2 1.8 14.6 0.0 0.0 0.0 0.0 0.0 8.5 0.5 3.8 17.3 1.1 31.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 17.2 0.1 MEX3A "RKHD4, RNF162" ENSG00000254726 "Mex-3 RNA binding family member A" A1L020 1 156072013-156081998 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 7.2;ovary: 10.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 9.8;Ductal cells: 9.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 13 "B-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 25.4;NTERA-2: 23.1;SCLC-21H: 24.1;SH-SY5Y: 43.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062703 Supported Cytosol NA NA Cytosol "HPA062703: AB_2684840" "unprognostic (8.63e-2)" "unprognostic (2.28e-1)" "unprognostic (1.39e-1)" "unprognostic (2.55e-3)" "unprognostic (6.18e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (9.23e-8)" "unprognostic (4.25e-2)" "unprognostic (1.79e-1)" "unprognostic (2.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (1.08e-3)" "unprognostic (4.73e-2)" "unprognostic (3.21e-2)" "unprognostic (1.75e-1)" "unprognostic (4.96e-2)" 0.4 0.2 1.8 1.0 1.8 0.8 2.5 3.3 5.1 2.5 1.3 1.4 0.2 0.7 7.2 0.7 1.4 1.7 1.1 0.2 3.5 1.0 1.1 1.8 0.6 3.4 1.9 2.1 10.1 0.6 0.4 0.4 0.8 2.2 1.7 1.0 1.0 2.0 0.6 0.2 0.7 0.6 1.7 1.0 1.4 0.5 3.1 2.0 3.6 1.5 0.2 1.1 1.9 1.4 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 25.4 6.3 0.3 0.4 3.0 0.6 0.1 1.0 0.9 1.4 0.3 0.8 3.0 0.3 0.6 0.5 11.0 0.4 1.2 1.2 3.0 0.6 1.1 2.5 0.5 0.3 0.5 0.7 0.8 0.5 0.4 2.6 4.8 5.8 5.7 0.0 1.4 1.6 2.9 0.4 23.1 1.0 3.3 9.3 2.0 0.1 0.8 1.1 24.1 43.9 0.7 2.8 1.5 11.1 4.9 1.9 1.6 1.6 3.9 0.4 1.4 0.6 0.4 1.3 0.1 0.7 3.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 3.3 2.0 3.5 1.0 1.9 2.1 2.2 2.0 0.0 0.3 0.0 2.6 3.5 1.6 0.8 0.0 2.7 0.0 0.0 9.8 0.6 1.7 9.9 0.1 6.0 0.0 0.0 1.3 1.8 2.8 2.1 0.0 5.6 1.7 3.2 5.8 7.4 1.5 0.0 4.6 0.0 5.0 0.0 0.5 1.4 4.2 0.0 1.1 7.5 2.7 0.0 2.7 0.0 2.7 3.0 0.2 0.0 2.2 1.1 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046141 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 15.6;testis: 33.3" "Group enriched" "Detected in many" 21 "Early spermatids: 185.8;Late spermatids: 144.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 33.5;HEL: 24.6;SH-SY5Y: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.0 0.6 1.5 1.8 1.6 2.0 1.6 3.8 4.5 15.6 2.8 1.6 2.5 0.8 7.9 0.6 1.1 1.2 2.8 2.0 2.0 1.4 1.0 1.0 1.4 2.8 2.2 3.3 6.8 0.7 0.2 0.9 3.3 1.0 3.7 0.9 1.2 3.0 3.8 1.6 1.1 1.1 4.0 1.0 1.2 1.0 33.3 0.7 8.4 1.0 1.8 1.2 3.1 4.2 0.0 1.3 0.0 0.1 0.4 0.1 0.0 0.1 1.2 8.8 33.5 0.7 1.0 2.5 1.0 0.5 1.8 1.6 0.2 0.2 1.5 0.6 1.9 0.5 0.2 4.1 0.1 1.3 0.3 2.7 24.6 1.4 1.1 1.4 0.3 7.8 0.5 0.7 1.0 2.0 4.3 3.8 3.1 1.2 0.0 3.1 0.8 4.0 2.1 11.4 0.0 0.3 5.6 5.4 0.8 0.0 0.0 7.0 13.7 1.7 0.3 1.1 2.6 0.1 0.4 3.5 4.6 5.4 2.5 1.5 3.2 1.6 1.8 1.5 2.4 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 1.6 3.8 4.5 2.0 1.4 2.2 3.3 1.0 0.7 0.0 1.1 0.0 0.4 2.5 3.3 3.7 0.0 0.0 0.0 0.0 2.0 7.7 0.0 0.8 185.8 1.9 0.0 0.0 0.2 7.2 4.3 0.9 1.1 0.0 1.5 0.0 1.2 3.7 1.0 144.1 6.1 3.6 6.8 0.0 1.6 5.7 0.6 0.0 4.2 0.0 2.8 6.5 4.0 2.6 4.3 1.8 2.1 0.0 1.1 0.3 MFAP2 "MAGP, MAGP-1" ENSG00000117122 "Microfibril associated protein 2" P55001 1 16974502-16980835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.7" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 148.9;Fibroblasts: 84.5;Leydig cells: 49.8;Peritubular cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 7 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC diff: 48.7;ASC TERT1: 50.2;HUVEC TERT2: 51.4;SH-SY5Y: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007354 Enhanced "Secreted to extracellular matrix" NA NA "HPA007354: AB_1079365" "unprognostic (5.10e-2)" "unprognostic (3.81e-2)" "unprognostic (2.62e-1)" "unprognostic (2.92e-2)" "unprognostic (4.86e-1)" "unprognostic (1.53e-3)" "unprognostic (3.72e-3)" "unprognostic (2.21e-1)" "unprognostic (1.85e-2)" "unprognostic (1.98e-1)" "unprognostic (9.45e-3)" "unprognostic (9.12e-2)" "prognostic unfavorable (2.52e-8)" "unprognostic (2.18e-3)" "unprognostic (1.34e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" 13.1 1.6 0.2 6.0 0.4 0.0 20.8 0.4 0.8 24.8 5.0 0.5 6.7 1.6 28.7 14.0 5.7 6.6 29.7 29.6 0.6 0.3 3.4 0.8 12.5 1.2 0.3 1.0 23.6 33.9 0.0 4.7 51.7 1.8 16.9 1.7 15.4 6.9 5.0 4.6 10.9 4.3 18.3 2.9 1.3 3.5 10.4 0.3 0.7 3.8 7.4 3.3 10.3 13.2 0.3 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.0 19.0 0.0 48.7 50.2 1.2 4.8 20.0 7.5 14.7 4.3 0.2 0.0 16.6 16.7 0.0 0.0 1.3 1.5 3.0 0.0 14.8 0.0 7.0 0.4 4.6 0.0 0.0 20.5 3.7 21.1 8.4 23.3 51.4 0.0 0.0 3.1 3.7 2.3 0.0 0.0 22.1 0.1 0.1 0.2 0.0 0.6 0.2 0.0 1.0 43.1 1.6 7.2 1.8 15.6 2.4 2.5 14.2 13.1 27.4 10.6 0.5 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.8 0.6 0.3 0.3 1.0 1.8 0.3 0.0 1.7 0.0 5.7 6.0 0.0 0.4 2.5 1.4 7.9 3.5 0.0 3.9 0.0 0.9 13.1 0.6 0.0 0.0 0.7 148.9 84.5 1.0 0.0 0.0 6.7 0.0 9.7 1.8 0.0 4.5 49.8 0.9 16.9 0.0 0.3 26.5 3.2 0.0 60.1 0.0 0.8 0.0 4.1 1.1 8.1 5.5 24.3 0.0 0.0 0.8 MFAP3L "KIAA0626, NYD-sp9" ENSG00000198948 "Microfibril associated protein 3 like" O75121 4 169986597-170033031 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.9" "Group enriched" "Detected in many" 20 "Early spermatids: 409.5;Late spermatids: 1347.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 7.9" "Cell line enhanced" "Detected in many" "HMC-1: 14.4;RT4: 23.5;SK-BR-3: 21.6;SuSa: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017986, HPA062306, HPA077490" Enhanced Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA Nucleoplasm "Cell Junctions" "HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842" "unprognostic (8.04e-3)" "unprognostic (8.67e-3)" "unprognostic (3.74e-1)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (3.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-1)" "unprognostic (7.58e-2)" "prognostic favorable (1.42e-8)" "unprognostic (6.59e-3)" "unprognostic (2.12e-1)" "unprognostic (1.62e-4)" "unprognostic (2.40e-3)" 2.1 3.4 15.0 1.3 19.6 2.7 10.2 4.9 19.4 11.4 2.1 21.1 4.2 1.0 4.9 32.9 1.2 4.0 2.6 1.9 15.4 11.1 25.6 29.5 2.7 1.2 21.8 10.0 1.1 1.6 5.7 3.3 5.5 21.1 2.9 2.2 17.5 2.0 11.7 4.2 19.7 1.1 3.9 16.4 1.7 1.3 30.6 20.8 0.0 2.8 0.2 1.0 11.9 1.5 0.0 0.7 7.9 0.8 0.0 0.8 6.9 0.2 3.5 1.9 2.0 1.6 0.8 0.7 3.8 0.5 1.8 1.6 1.2 0.2 0.0 0.1 5.9 3.4 1.8 6.9 0.8 0.8 0.0 2.6 0.0 3.7 1.4 0.9 0.0 14.4 1.2 2.1 0.2 0.6 1.0 0.2 2.2 0.5 0.7 3.6 2.0 0.6 0.5 2.0 0.4 3.0 0.0 1.1 0.0 5.2 23.5 1.6 3.5 3.2 21.6 6.9 12.8 1.2 0.0 0.1 1.9 7.1 3.5 7.3 0.3 0.0 0.0 4.8 0.7 7.1 7.9 0.2 2.1 0.8 0.8 0.4 0.0 0.7 0.2 0.3 0.0 0.3 0.1 4.9 0.0 0.0 0.7 0.1 6.9 15.0 19.6 4.9 15.4 15.4 11.1 21.8 10.0 21.1 20.8 0.0 6.4 0.0 0.2 2.3 9.2 2.5 0.0 0.0 0.0 34.9 19.6 2.9 5.0 0.4 409.5 2.3 0.4 23.3 1.0 0.9 0.5 0.5 4.6 43.3 0.9 3.2 2.4 4.9 1.0 1347.3 4.9 0.6 6.8 0.0 0.1 2.3 1.3 0.0 8.5 17.3 14.7 19.4 3.4 18.0 13.6 7.3 7.9 0.0 0.4 2.1 MFAP5 "MAGP2, MP25" ENSG00000197614 "Microfibril associated protein 5" Q13361 12 8637346-8662888 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.1" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 937.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 50.0;BJ: 18.1;EFO-21: 43.9;HeLa: 16.6;SuSa: 42.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010553 Enhanced "Secreted to extracellular matrix" NA NA 3800000 "HPA010553: AB_1853843" "unprognostic (1.80e-1)" "unprognostic (1.11e-2)" "unprognostic (4.25e-2)" "unprognostic (4.84e-2)" "unprognostic (1.44e-1)" "unprognostic (6.05e-2)" "unprognostic (2.15e-3)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (8.79e-2)" "unprognostic (8.63e-3)" "unprognostic (3.05e-1)" "unprognostic (4.41e-7)" "prognostic unfavorable (6.87e-4)" "unprognostic (8.81e-2)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.81e-4)" 44.3 3.2 0.6 3.3 0.7 0.3 21.8 0.5 0.5 71.5 11.2 0.5 18.2 1.4 78.4 34.0 31.3 9.0 6.8 16.5 0.7 0.6 1.9 3.0 3.3 3.3 0.6 0.4 4.7 1.4 0.2 1.7 128.1 0.7 7.6 11.0 0.9 6.0 13.5 19.6 13.0 9.0 37.0 3.4 1.0 7.9 12.3 0.3 1.0 13.1 35.0 4.5 46.3 21.1 1.1 1.2 5.3 2.4 0.6 1.2 0.8 0.4 1.6 0.4 0.7 8.7 3.7 50.0 18.1 0.3 0.2 0.3 0.6 0.3 0.1 43.9 5.6 0.4 2.5 0.1 3.7 0.0 0.1 0.1 0.4 16.6 0.5 0.1 0.3 0.2 2.5 1.3 2.1 0.0 0.9 0.0 0.5 0.7 1.0 15.1 0.2 0.5 0.2 0.9 0.2 0.8 0.3 0.4 1.8 1.8 0.7 0.2 0.2 0.5 0.2 0.3 42.1 6.9 0.2 0.6 3.2 6.3 13.2 0.8 0.6 0.5 0.5 1.7 0.2 0.0 5.3 2.4 2.0 0.7 1.9 1.2 0.4 0.4 0.4 1.2 1.1 1.2 0.5 3.1 0.6 1.4 1.0 0.1 0.8 0.6 0.7 0.5 0.5 0.7 0.6 0.6 0.4 0.7 0.3 11.9 4.3 0.0 0.4 20.5 0.2 5.2 0.0 2.7 3.4 0.0 0.0 70.9 0.0 0.0 0.3 4.4 0.0 0.0 0.0 937.0 96.1 0.0 0.0 0.0 24.9 0.0 0.0 7.4 1.9 0.2 56.7 3.6 11.8 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.6 0.0 20.2 0.0 0.0 15.7 210.9 0.0 0.0 0.1 MFN2 "CMT2A2, CPRP1, KIAA0214, MARF" ENSG00000116688 "Mitofusin 2" O95140 1 11980181-12013514 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.9;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 308.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030554, CAB079902" Uncertain Supported Mitochondria NA NA Mitochondria "CAB079902: AB_2724683, HPA030554: AB_10603018" "unprognostic (9.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-1)" "unprognostic (4.38e-2)" "unprognostic (8.36e-2)" "unprognostic (9.71e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (3.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.43e-1)" "unprognostic (3.55e-1)" "prognostic favorable (2.36e-8)" "unprognostic (4.69e-2)" "unprognostic (2.76e-1)" "unprognostic (8.84e-3)" "unprognostic (2.12e-1)" 12.8 10.1 16.4 8.9 20.3 17.2 10.1 15.9 32.1 8.7 17.0 17.0 11.2 16.5 12.1 8.7 20.1 9.0 9.0 100.9 17.9 16.0 14.8 20.4 10.6 8.0 18.8 19.3 10.2 9.0 22.0 9.3 12.9 20.8 14.1 13.2 16.5 10.7 23.7 111.1 18.8 25.7 22.9 15.7 10.2 14.0 11.3 10.9 7.3 18.7 28.5 12.1 16.3 10.6 7.3 8.9 18.5 16.9 5.8 10.2 13.4 26.0 15.9 18.1 23.8 18.3 13.8 21.0 20.6 19.1 28.3 22.1 26.3 17.4 19.1 22.4 24.9 18.6 27.9 29.9 47.8 25.4 69.2 22.7 27.3 25.6 20.4 19.0 27.7 17.2 17.4 36.9 39.8 36.9 12.2 19.9 10.3 28.2 16.8 20.9 13.1 16.8 12.7 12.5 17.5 23.5 19.7 26.4 17.8 17.0 17.4 21.1 13.8 24.2 25.8 23.9 14.2 13.9 16.7 19.9 19.0 19.0 28.8 21.5 20.1 21.1 31.3 22.5 31.2 20.5 8.5 10.3 7.1 9.6 13.5 10.2 7.3 7.2 8.6 8.9 6.6 6.3 8.0 18.5 5.8 16.9 4.6 8.0 13.4 16.4 20.3 15.9 32.1 17.9 16.0 18.8 19.3 20.8 10.9 20.8 18.6 11.5 8.2 20.3 24.8 308.6 12.7 12.0 14.8 14.0 11.8 12.2 18.3 12.7 3.6 12.0 31.1 23.3 17.3 13.2 9.3 12.5 10.4 39.2 14.2 28.6 17.3 13.5 18.1 4.4 6.6 11.8 16.9 10.0 20.9 11.6 13.9 14.0 14.2 13.3 18.6 12.9 14.4 27.7 16.8 26.3 21.1 9.6 22.1 12.9 MFNG ENSG00000100060 "MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" O00587 22 37469063-37486401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.7;lymphoid tissue: 42.1" "Group enriched" "Detected in many" 5 "B-cells: 44.1;Endothelial cells: 25.5;granulocytes: 30.1;Hofbauer cells: 28.8;Ito cells: 45.4;Kupffer cells: 36.8;Macrophages: 23.4;monocytes: 20.8;T-cells: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.8;HEL: 25.3;HL-60: 41.3;HMC-1: 54.8;HUVEC TERT2: 44.2;U-698: 31.7;U-937: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048936, HPA056479" Approved Approved Vesicles "Intracellular and membrane" NA NA 28000 Vesicles "HPA048936: AB_2680564, HPA056479: " "unprognostic (1.21e-1)" "unprognostic (4.17e-3)" "prognostic unfavorable (5.12e-4)" "prognostic favorable (1.65e-4)" "unprognostic (6.41e-3)" "unprognostic (1.00e-2)" "unprognostic (2.64e-1)" "unprognostic (2.36e-2)" "unprognostic (4.64e-2)" "unprognostic (2.91e-2)" "unprognostic (5.44e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (2.67e-1)" "unprognostic (4.03e-2)" "unprognostic (3.86e-2)" "unprognostic (1.43e-1)" 10.0 4.5 2.6 16.6 5.1 14.4 13.4 1.0 3.3 6.0 6.5 3.0 2.0 3.7 6.5 3.5 4.4 7.1 6.3 6.7 2.8 2.6 6.1 5.6 14.9 42.1 5.6 1.2 3.6 3.7 0.8 2.2 14.0 8.3 5.6 3.7 4.4 5.7 2.5 3.4 3.0 14.1 5.1 4.4 37.6 4.1 2.6 3.6 33.9 6.3 4.5 19.3 8.8 4.2 24.1 40.5 72.7 40.8 40.9 53.3 53.2 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.6 32.8 0.1 0.0 0.1 2.3 9.6 1.9 0.0 12.9 0.2 25.3 0.1 0.3 0.1 41.3 54.8 0.0 0.5 0.3 0.7 0.2 44.2 11.4 0.1 15.7 0.0 0.1 4.7 0.5 0.1 1.2 0.1 12.1 0.4 24.7 0.1 0.0 19.8 0.2 0.1 0.0 0.0 0.2 0.3 2.8 24.6 0.0 1.2 4.9 0.1 0.0 0.1 31.7 0.2 37.2 0.5 36.8 40.1 72.7 41.3 38.8 45.1 21.8 48.0 43.3 40.5 24.1 52.9 45.5 25.5 40.9 40.8 10.1 53.3 53.2 2.6 5.1 1.0 3.3 2.8 2.6 5.6 1.2 8.3 3.6 0.0 6.7 44.1 0.2 3.3 0.6 1.4 5.1 0.0 5.7 0.0 0.0 0.3 0.0 3.0 0.1 25.5 1.1 0.0 0.8 0.2 1.1 0.4 30.1 1.0 28.8 0.0 1.2 45.4 36.8 0.0 0.0 23.4 3.3 20.8 2.2 0.0 2.1 0.6 0.0 0.3 0.3 0.0 1.0 0.0 0.5 2.0 0.6 53.8 0.6 0.3 MFRP "C1QTNF5, FLJ30570, NNO2, rd6" ENSG00000235718 "Membrane frizzled-related protein" Q9BY79 11 119338942-119346673 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Microphthalmia, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 40 "brain: 54.9;retina: 112.9" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in some" 10 "pons and medulla: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.5;JURKAT: 1.0;NB-4: 1.8" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9" "Low region specificity" "Detected in some" NA NA 0.9 0.3 0.6 0.0 0.4 0.1 0.1 0.2 2.8 0.2 0.1 14.6 0.0 0.2 0.3 0.0 0.1 0.2 0.1 0.2 5.5 0.5 0.2 0.1 0.3 0.2 0.8 0.0 0.1 0.1 2.0 0.5 0.6 54.9 0.1 0.0 112.9 0.1 0.1 0.5 0.1 0.2 0.4 0.4 0.3 0.2 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.4 0.2 2.8 5.5 0.5 0.8 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MFSD14B "FLJ14753, HIATL1" ENSG00000148110 "Major facilitator superfamily domain containing 14B" Q5SR56 9 94374551-94461042 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.0" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017978 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017978: AB_2116836" "unprognostic (3.03e-2)" "unprognostic (2.28e-1)" "unprognostic (3.96e-3)" "unprognostic (5.95e-3)" "unprognostic (1.39e-1)" "unprognostic (3.29e-2)" "unprognostic (4.13e-3)" "unprognostic (3.27e-2)" "unprognostic (1.01e-1)" "unprognostic (9.64e-2)" "unprognostic (1.16e-2)" "unprognostic (3.11e-3)" "unprognostic (1.15e-1)" "unprognostic (9.12e-2)" "unprognostic (6.63e-2)" "unprognostic (1.93e-1)" "unprognostic (9.01e-2)" 15.1 18.9 13.3 14.3 14.7 9.0 20.2 11.6 12.8 14.9 14.2 19.7 15.5 9.9 18.6 16.1 28.1 14.4 12.5 13.4 13.3 12.4 14.7 9.0 25.7 21.5 14.6 7.8 15.9 21.5 86.0 9.2 24.2 28.3 14.5 15.4 21.6 15.9 14.2 7.3 21.8 16.0 12.8 19.1 19.3 13.0 9.2 13.2 24.0 16.7 14.2 23.9 14.1 18.8 4.6 7.8 10.4 11.4 3.6 7.1 3.6 25.9 16.7 13.1 10.2 28.8 20.7 20.9 25.3 22.0 22.5 22.1 8.4 31.1 31.3 15.1 21.7 26.1 57.4 15.6 16.1 22.0 22.3 8.4 10.7 16.1 12.6 20.5 33.8 20.0 18.9 24.4 23.8 18.3 12.6 19.2 17.2 20.3 18.6 29.9 19.7 24.7 19.4 19.2 38.0 13.5 12.4 30.1 10.1 24.0 20.0 12.6 16.6 21.5 25.5 26.7 16.4 11.6 20.0 20.6 23.6 16.7 36.2 23.3 20.6 25.5 8.6 21.0 16.6 21.1 0.6 7.9 5.9 5.6 11.4 5.1 4.6 5.1 5.6 7.8 2.9 5.1 7.1 10.4 3.6 7.7 7.7 5.1 3.6 13.3 14.7 11.6 12.8 13.3 12.4 14.6 7.8 28.3 13.2 6.0 21.9 13.7 20.2 0.0 11.2 0.0 17.8 13.4 12.5 41.8 3.9 12.4 6.6 15.2 2.6 11.3 7.1 0.0 16.4 22.4 13.2 30.5 3.5 10.4 25.8 4.8 7.0 27.0 63.5 2.1 15.5 18.5 0.0 10.8 26.6 18.1 22.0 15.8 15.2 5.7 9.1 12.9 0.0 10.4 17.5 0.0 16.0 13.8 14.9 41.4 MFSD2A "FLJ14490, MFSD2" ENSG00000168389 "Major facilitator superfamily domain containing 2A" Q8NA29 1 39955112-39969968 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Symport, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 11 "dendritic cells: 16.7;monocytes: 9.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.9;THP-1: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043107 Uncertain Approved "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "HPA043107: AB_10794387" "unprognostic (2.20e-1)" "unprognostic (1.15e-1)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (6.92e-2)" "unprognostic (2.61e-2)" "unprognostic (2.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.33e-1)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (9.26e-2)" "unprognostic (4.11e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.33e-4)" 2.0 0.9 6.0 1.6 7.2 3.3 6.2 2.4 6.5 1.6 5.6 4.3 96.9 6.4 4.3 45.0 5.0 1.5 1.2 0.7 7.6 6.1 7.2 87.9 15.8 1.1 7.5 2.6 0.8 0.5 0.3 3.0 111.3 7.8 1.0 2.5 2.0 1.7 121.2 0.3 27.0 20.4 1.8 7.3 0.8 1.0 17.7 2.3 0.2 2.9 4.7 1.7 2.6 4.6 1.1 16.7 0.9 9.3 0.1 0.1 2.3 2.1 0.9 4.5 6.8 3.2 0.6 0.0 2.0 4.0 4.6 5.5 0.2 1.2 13.3 1.2 1.0 3.2 5.3 4.4 7.7 3.6 1.7 2.1 1.6 0.0 0.0 10.7 2.3 7.9 3.6 4.8 18.9 7.8 0.8 1.1 4.1 0.0 3.4 2.0 0.2 3.6 3.6 3.6 7.4 1.6 2.5 6.6 3.0 0.7 6.3 1.6 2.4 1.6 11.4 1.1 0.4 0.5 59.5 0.7 1.0 2.0 3.4 8.7 0.6 1.2 2.9 10.6 9.0 3.3 0.0 9.3 0.9 0.1 4.6 0.1 1.1 0.0 0.1 10.3 0.2 0.0 0.0 0.5 0.1 0.8 16.7 0.0 2.3 6.0 7.2 2.4 6.5 7.6 6.1 7.5 2.6 7.8 2.3 17.9 112.2 11.5 13.4 46.9 1.9 0.6 12.7 12.0 31.8 15.7 0.0 0.3 0.0 3.2 0.6 6.7 112.9 0.0 22.5 6.5 9.7 5.7 17.3 268.3 6.4 0.0 1.2 10.4 12.4 0.9 0.6 11.4 0.0 2.8 16.4 41.8 16.3 3.5 0.4 3.7 1.8 0.0 3.4 1.1 1.0 47.9 43.9 2.2 10.0 23.0 MFSD2B ENSG00000205639 "Major facilitator superfamily domain containing 2B" A6NFX1 2 24010081-24063321 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.4;brain: 7.5;placenta: 7.5" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Glandular cells: 24.5;Urothelial cells: 32.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 7.5" "Cell type enriched" "Detected in some" 4 "basophil: 5.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 5.5" "Group enriched" "Detected in some" 14 "HEL: 13.1;K-562: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044145 Enhanced NA NA "HPA044145: AB_2678833" "unprognostic (5.67e-2)" "unprognostic (1.25e-3)" "unprognostic (1.84e-1)" "unprognostic (5.35e-5)" "unprognostic (2.82e-1)" "unprognostic (1.74e-1)" "unprognostic (4.26e-2)" "unprognostic (7.47e-2)" "unprognostic (2.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.21e-3)" "unprognostic (1.90e-2)" "unprognostic (6.87e-6)" "unprognostic (7.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.72e-1)" 0.2 0.1 0.1 0.6 7.5 17.4 0.2 0.1 0.3 0.3 0.4 0.0 1.1 0.3 0.5 0.3 0.1 0.2 0.2 0.5 0.1 0.4 0.1 0.4 3.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 7.5 0.3 1.2 0.2 0.2 1.0 0.1 0.5 0.2 0.2 0.1 0.3 2.3 0.2 2.0 0.0 0.1 0.1 0.0 0.4 0.8 1.8 0.0 0.2 5.5 0.0 0.2 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 5.6 0.0 0.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.0 3.4 0.1 7.5 0.1 0.3 0.1 0.4 0.3 0.0 0.3 0.0 0.0 2.2 1.5 12.3 9.0 0.6 3.9 2.5 0.0 0.0 0.0 3.9 5.7 3.3 1.2 0.5 1.4 0.9 46.7 1.6 3.6 1.8 24.5 4.7 0.0 2.8 0.0 1.2 0.0 0.8 0.2 0.0 1.1 0.0 0.0 3.3 0.2 6.3 2.9 0.0 0.0 1.3 0.0 0.9 0.6 2.5 9.8 6.3 1.5 4.7 32.0 MFSD4A "DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064" ENSG00000174514 "Major facilitator superfamily domain containing 4A" Q8N468 1 205568885-205602918 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;kidney: 37.6;stomach 1: 60.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.0;Ciliated cells: 5.3;Club cells: 11.4;Collecting duct cells: 8.7;Distal tubular cells: 11.6;Exocrine glandular cells: 5.6;Proximal tubular cells: 6.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;HAP1: 2.7;HMC-1: 4.6;SCLC-21H: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0" NA NA "unprognostic (7.15e-4)" "prognostic favorable (7.54e-4)" "unprognostic (5.60e-2)" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic favorable (4.59e-4)" "unprognostic (2.73e-2)" "unprognostic (1.65e-2)" "unprognostic (3.20e-2)" "unprognostic (6.97e-3)" "prognostic favorable (2.27e-13)" "unprognostic (1.58e-1)" "unprognostic (4.44e-2)" "unprognostic (5.75e-3)" "unprognostic (8.78e-2)" 1.7 0.6 17.3 0.8 10.6 0.3 2.1 18.8 24.9 4.9 7.3 1.3 0.0 1.2 0.8 5.2 1.0 1.6 11.1 0.8 11.9 4.3 37.6 0.5 3.8 0.5 3.6 13.3 0.6 1.0 0.4 3.2 3.5 8.4 1.1 9.5 2.4 8.6 0.6 0.6 3.3 1.1 0.7 2.8 0.6 60.0 0.5 0.2 0.0 0.7 0.8 2.8 0.9 0.8 1.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.8 0.1 0.8 0.0 0.1 2.1 2.7 0.0 0.0 0.0 1.1 0.0 0.0 0.9 0.0 0.0 4.6 0.2 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.2 0.5 5.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.3 0.1 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 17.3 10.6 18.8 24.9 11.9 4.3 3.6 13.3 8.4 0.2 6.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 5.3 11.4 8.7 0.0 0.5 11.6 1.2 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MFSD6L FLJ35773 ENSG00000185156 "Major facilitator superfamily domain containing 6 like" Q8IWD5 17 8797162-8799349 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 8.5;testis: 20.1" "Group enriched" "Detected in some" 6 "Early spermatids: 104.1;Late spermatids: 27.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enriched" "Detected in some" 6 "HMC-1: 14.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA023164 Uncertain NA NA "HPA023164: AB_2142777" "prognostic favorable (1.84e-4)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (3.64e-2)" "unprognostic (1.07e-4)" "unprognostic (3.31e-1)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" "unprognostic (7.26e-2)" "unprognostic (3.98e-3)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (7.68e-3)" "unprognostic (1.25e-1)" 0.5 0.0 0.5 3.2 0.5 0.0 0.5 0.5 0.5 1.4 2.1 0.5 0.5 1.8 0.5 0.9 0.5 1.6 0.5 0.5 0.5 0.0 1.1 0.5 2.2 0.5 0.5 0.5 0.5 8.5 4.8 4.3 0.5 0.5 0.5 2.6 0.5 5.5 1.8 0.5 0.2 1.0 0.5 0.5 0.5 3.4 20.1 0.5 0.5 3.1 0.5 0.5 0.7 0.5 0.0 0.3 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.1 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.0 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 2.3 0.0 6.0 104.1 0.0 0.0 0.0 6.7 0.1 0.0 0.6 0.0 0.0 0.6 0.0 1.2 0.0 0.8 27.4 0.9 0.0 0.0 0.0 5.8 0.0 3.0 0.0 1.1 0.0 0.0 0.0 0.1 10.7 0.2 0.0 1.3 0.0 3.7 0.6 MGAM MGA ENSG00000257335 Maltase-glucoamylase O43451 7 141907813-142106747 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 155.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 50.7;Late spermatids: 90.5;Proximal tubular cells: 18.9" "Cancer enriched" "Detected in some" 7 "renal cancer: 4.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "neutrophil: 14.1" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.1" "Cell line enhanced" "Detected in some" "A549: 3.7;BJ hTERT+: 3.3;HL-60: 5.5;U-937: 8.7;WM-115: 2.1" "Region enriched" "Detected in single" 12 "olfactory region: 3.1" HPA002270 Enhanced NA NA 68000 "HPA002270: AB_1079366" "unprognostic (1.02e-2)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (6.95e-3)" "unprognostic (2.80e-1)" "unprognostic (7.81e-2)" "unprognostic (7.32e-3)" "unprognostic (3.83e-2)" "unprognostic (4.97e-1)" "unprognostic (2.17e-2)" "unprognostic (6.86e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.16e-5)" "unprognostic (1.82e-1)" "unprognostic (2.82e-1)" "unprognostic (1.34e-3)" "unprognostic (3.03e-1)" 0.9 0.2 0.3 0.8 0.2 6.9 0.3 0.2 0.2 0.2 59.4 0.1 7.6 25.2 0.2 36.0 0.2 1.0 0.1 0.3 0.2 0.2 8.7 0.4 2.1 0.1 0.3 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.6 0.0 0.1 0.2 3.2 0.2 0.1 155.5 0.1 0.3 8.3 0.7 4.3 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.5 0.1 3.3 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.4 0.1 0.3 0.0 0.1 0.0 8.7 2.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.1 0.1 0.0 4.5 0.0 0.0 0.0 0.0 1.1 0.0 2.7 2.3 12.2 0.0 0.0 1.7 0.0 50.7 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 90.5 0.6 1.8 0.0 0.0 0.4 0.5 0.2 0.0 0.4 18.9 0.0 0.0 0.0 1.6 1.2 0.0 0.0 0.0 0.2 0.2 MGAM2 ENSG00000257743 "Maltase-glucoamylase 2 (putative)" Q2M2H8 7 142111749-142222324 "Enzymes, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 61.2;pancreas: 15.6;salivary gland: 35.4" "Group enriched" "Detected in some" 10 "Early spermatids: 21.0;Late spermatids: 12.0" "Group enriched" "Detected in some" 11 "colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Group enriched" "Detected in some" 8 "OE19: 5.5;RH-30: 4.0" "Low region specificity" "Detected in many" HPA055697 Enhanced Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA055697: AB_2682890" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-3)" "unprognostic (5.65e-2)" "unprognostic (2.19e-2)" "unprognostic (1.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-2)" "unprognostic (5.93e-2)" "unprognostic (2.43e-1)" "unprognostic (2.05e-1)" "unprognostic (5.50e-4)" "unprognostic (7.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.71e-2)" "unprognostic (9.33e-2)" 0.2 0.1 0.1 2.5 0.1 0.2 1.3 0.1 0.1 0.1 28.8 0.0 0.0 15.0 0.1 0.4 0.1 0.3 7.0 0.1 0.1 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.1 15.6 0.0 0.1 0.0 0.1 0.1 1.4 0.7 35.4 0.0 0.1 0.2 61.2 0.0 0.5 1.5 0.7 1.0 0.0 0.0 0.1 1.7 0.8 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 0.0 4.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4" "Low region specificity" "Detected in some" "HPA015994, HPA070835" Enhanced Supported Mitochondria NA NA Mitochondria "HPA015994: AB_2630370, HPA070835: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.7 0.0 1.6 0.0 0.0 0.1 0.0 0.1 15.9 4.6 0.2 2.3 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.9 0.1 0.1 3.9 0.3 1.7 0.1 3.8 32.4 0.1 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 4.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 0.0 0.0 0.0 0.7 1.4 140.5 2.5 0.0 0.0 0.0 0.0 7.9 0.2 1.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 2.4 0.3 0.0 0.0 0.5 197.0 0.0 0.6 0.0 0.0 15.8 0.0 0.0 0.0 0.0 424.1 0.1 0.0 23.3 7.6 28.7 0.0 0.4 0.7 0.3 0.6 0.2 0.0 0.0 0.3 MGAT3 GNT-III ENSG00000128268 "Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase" Q09327 22 39457344-39492194 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0;intestine: 27.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 41.7;Bipolar cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2" "Group enriched" "Detected in many" 9 "B-cells: 1.7;granulocytes: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 28.1;HMC-1: 24.3;OE19: 24.3;U-266/70: 31.6;U-266/84: 12.8;U-698: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017598 Approved "Intracellular and membrane" NA NA 78000 "HPA017598: AB_1853853" "unprognostic (1.41e-3)" "unprognostic (5.98e-3)" "unprognostic (4.79e-2)" "unprognostic (2.96e-1)" "unprognostic (2.76e-1)" "unprognostic (5.71e-3)" "unprognostic (8.92e-2)" "unprognostic (2.17e-1)" "unprognostic (4.35e-3)" "unprognostic (6.77e-2)" "unprognostic (8.12e-3)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.04e-8)" "unprognostic (6.73e-2)" "unprognostic (1.46e-1)" "unprognostic (5.89e-2)" "unprognostic (4.92e-2)" 5.3 1.2 17.1 3.9 18.7 9.2 3.6 29.0 24.6 7.1 11.9 8.9 0.0 21.1 3.4 1.2 1.4 4.0 7.9 3.0 18.1 14.9 3.3 0.4 14.9 7.2 13.1 13.4 1.0 3.1 0.9 1.4 10.5 10.7 1.0 4.9 1.7 2.1 1.4 1.6 2.5 27.1 3.2 10.4 3.3 7.8 4.9 9.0 0.2 1.1 0.0 8.9 3.0 2.7 1.7 0.1 3.5 0.2 0.0 0.2 0.1 0.1 0.1 4.6 0.4 0.0 0.0 28.1 0.2 0.3 0.2 0.0 6.2 1.5 9.7 3.4 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.2 7.8 0.0 0.0 0.1 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 6.4 1.2 0.0 0.1 0.2 0.6 1.3 24.3 0.0 0.4 0.0 1.6 0.2 0.2 2.6 1.9 0.0 0.0 0.0 8.4 0.3 0.4 0.0 0.0 3.7 0.0 0.0 31.6 12.8 13.7 0.0 0.0 0.7 3.5 0.1 3.3 0.1 0.2 0.1 1.7 0.0 0.0 0.1 1.2 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.1 17.1 18.7 29.0 24.6 18.1 14.9 13.1 13.4 10.7 9.0 41.7 4.0 3.7 0.1 0.3 30.0 1.2 2.5 2.7 1.2 0.0 5.9 4.6 0.0 0.0 11.0 2.3 5.2 0.0 0.2 10.1 0.6 0.0 2.3 0.0 1.3 12.7 7.5 0.0 0.0 16.2 4.0 0.7 0.0 0.0 3.2 1.5 1.3 3.4 3.5 1.3 2.3 6.5 1.4 0.7 1.0 0.5 3.1 0.9 3.4 1.3 MGAT4A "GnT-4a, GnT-Iva" ENSG00000071073 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A" Q9UM21 2 98619106-98731126 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 49.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 46.0;HUVEC TERT2: 17.2;JURKAT: 30.7;TIME: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007608 Enhanced Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA007608: AB_10602008" "prognostic unfavorable (4.30e-4)" "unprognostic (1.15e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.48e-8)" "unprognostic (1.35e-1)" "unprognostic (2.28e-2)" "unprognostic (3.82e-3)" "unprognostic (1.89e-1)" "unprognostic (3.76e-1)" "unprognostic (3.58e-1)" "unprognostic (2.80e-2)" "unprognostic (2.32e-2)" "unprognostic (4.17e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-2)" "unprognostic (4.04e-2)" "unprognostic (2.04e-1)" 8.1 5.1 11.3 11.9 15.6 49.2 8.2 28.5 14.3 6.1 14.6 8.3 6.8 17.6 5.2 4.1 4.1 6.2 8.0 5.1 11.3 10.4 17.1 6.0 13.7 16.7 9.9 8.3 2.9 26.7 33.3 14.1 11.9 10.4 6.6 15.8 5.6 14.5 4.4 3.3 3.4 38.5 7.2 16.1 7.0 8.4 3.9 14.3 20.3 6.4 3.1 11.6 8.3 5.0 2.0 9.3 7.6 2.9 7.7 19.7 7.4 3.0 0.6 1.2 2.6 0.0 0.0 46.0 0.0 0.0 0.3 0.0 7.3 3.7 0.0 6.9 0.0 0.9 0.1 2.5 0.3 0.0 3.6 2.8 0.1 0.0 12.7 0.0 6.1 2.3 0.0 1.7 0.0 0.2 0.1 17.2 30.7 0.5 3.3 0.0 5.9 13.3 10.7 0.4 2.6 0.5 3.3 0.0 3.6 8.9 6.2 3.7 1.2 0.8 11.5 1.6 3.4 2.7 8.3 27.8 0.0 1.4 0.0 0.9 1.1 2.5 0.7 0.0 9.2 0.2 3.3 2.9 6.6 12.3 0.5 15.9 2.0 14.9 13.7 2.0 1.1 19.7 16.1 7.6 7.7 1.1 9.3 8.4 7.4 11.3 15.6 28.5 14.3 11.3 10.4 9.9 8.3 10.4 14.3 50.6 31.3 18.2 18.4 8.9 20.9 11.7 10.2 5.3 13.6 21.0 3.9 3.9 18.3 15.5 10.0 32.8 84.5 0.0 25.8 66.5 5.4 17.8 12.7 8.5 53.2 46.1 50.8 20.3 30.7 13.9 2.3 33.8 10.1 10.0 34.5 13.6 22.1 48.9 2.1 25.6 4.8 6.5 5.1 2.8 3.4 9.3 12.5 74.0 30.1 20.1 MGAT4B GnT-Ivb ENSG00000161013 "Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B" Q9UQ53 5 179797597-179806952 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 125.6;liver: 100.0" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 212.8;Paneth cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "eosinophil: 8.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 8.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012804, HPA052134" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus, Vesicles, Cytosol" "HPA012804: , HPA052134: AB_2681741" "unprognostic (2.01e-2)" "unprognostic (8.68e-3)" "unprognostic (1.40e-1)" "unprognostic (3.83e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (3.61e-3)" "unprognostic (7.57e-3)" "unprognostic (1.22e-2)" "unprognostic (2.02e-1)" "unprognostic (5.13e-2)" "unprognostic (2.26e-2)" "unprognostic (2.27e-2)" "prognostic favorable (5.78e-4)" "unprognostic (1.52e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-2)" "unprognostic (1.42e-1)" 13.2 22.8 9.1 19.5 8.2 9.5 18.7 15.3 13.5 8.7 77.3 5.9 10.1 61.7 9.2 10.4 16.8 10.7 26.0 20.6 9.5 5.4 31.9 100.0 17.1 15.6 6.3 5.2 9.1 13.4 10.3 8.3 14.4 6.3 8.8 30.9 10.1 19.2 8.2 8.4 12.1 125.6 7.5 4.9 12.5 22.3 11.2 5.6 7.0 16.6 14.6 10.0 9.5 13.7 0.9 0.6 8.5 0.7 0.0 0.6 0.2 20.8 21.1 10.4 24.1 32.0 17.2 18.1 12.4 24.9 11.3 8.9 23.1 58.2 3.5 31.9 28.6 50.4 15.8 15.2 27.9 8.6 29.2 8.1 10.7 19.2 20.1 22.6 13.5 3.3 18.6 19.6 11.5 14.3 44.4 23.2 4.2 6.9 9.6 19.0 23.3 2.0 11.2 6.4 31.9 8.5 5.2 8.3 9.9 33.9 40.6 17.2 10.1 18.6 19.3 33.4 9.2 13.2 13.7 28.3 28.6 12.7 16.0 19.8 8.2 9.4 8.8 34.3 17.0 20.6 0.0 0.7 8.5 0.3 0.1 0.1 0.0 0.5 0.2 0.6 0.9 0.4 0.6 0.3 0.0 0.5 0.5 0.0 0.2 9.1 8.2 15.3 13.5 9.5 5.4 6.3 5.2 6.3 5.6 11.9 8.6 8.5 16.0 11.1 15.5 21.6 25.5 0.0 5.7 26.2 3.9 6.8 3.3 60.0 0.5 14.3 212.8 0.0 46.0 9.9 10.4 29.2 4.7 75.0 15.1 28.6 22.0 31.9 17.0 1.6 14.1 11.7 10.1 18.0 64.6 23.5 79.0 114.3 15.9 20.7 10.4 12.9 8.6 1.6 4.8 10.5 11.7 5.0 102.6 39.7 MGAT4C HGNT-IV-H ENSG00000182050 "MGAT4 family member C" Q9UBM8 12 85955666-86838904 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0" "Group enriched" "Detected in some" 6 "Early spermatids: 99.1;Late spermatids: 74.0" "Cancer enriched" "Detected in single" 19 "thyroid cancer: 2.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "NTERA-2: 11.0;SCLC-21H: 4.8;SuSa: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016418 Approved Approved "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Vesicles, Plasma membrane" "Centriolar satellite" "HPA016418: AB_2732416" "unprognostic (5.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.32e-4)" "unprognostic (1.07e-1)" "unprognostic (9.64e-2)" "unprognostic (5.94e-3)" "unprognostic (1.88e-1)" "unprognostic (8.05e-2)" "unprognostic (1.89e-1)" "unprognostic (6.32e-3)" "unprognostic (3.51e-2)" "unprognostic (6.85e-10)" "unprognostic (3.15e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" "unprognostic (4.74e-3)" 1.0 3.0 5.5 1.0 12.3 1.1 0.9 4.9 12.8 1.3 1.2 2.5 0.4 0.9 1.0 10.9 1.1 1.1 1.2 3.6 9.4 3.9 1.0 0.9 1.0 0.9 3.0 9.3 0.9 0.9 0.9 25.9 0.8 10.6 1.1 1.2 0.0 0.9 2.4 0.8 1.0 1.0 1.0 4.3 0.9 1.0 7.8 5.1 0.0 18.0 0.0 0.8 0.9 0.6 0.5 0.3 0.8 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.0 11.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.1 0.8 0.2 0.1 0.3 0.2 0.0 5.5 12.3 4.9 12.8 9.4 3.9 3.0 9.3 10.6 5.1 6.0 0.6 0.0 0.1 0.1 9.7 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 74.0 15.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 3.9 0.0 1.6 0.0 0.0 1.7 0.6 0.1 0.0 0.0 0.0 0.3 MGAT4D GnT1IP ENSG00000205301 "MGAT4 family member D" A6NG13 4 140442262-140498377 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 56 "testis: 33.8" "Cell type enhanced" "Detected in some" 33 "Early spermatids: 12.4;Late spermatids: 20.4;Spermatocytes: 70.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA036523 Enhanced NA NA "HPA036523: AB_10670110" "unprognostic (2.70e-1)" "unprognostic (3.16e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 70.7 1.0 0.0 0.0 0.0 0.0 0.0 MGAT5B "FLJ25132, GnT-IX, GnT-VB" ENSG00000167889 "Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B" Q3V5L5 17 76868456-76950393 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 28.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.1;Early spermatids: 6.3;Extravillous trophoblasts: 2.8;Late spermatids: 6.8" "Group enriched" "Detected in many" 5 "glioma: 2.6;melanoma: 7.1;testis cancer: 2.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 21.8;SCLC-21H: 11.2;U-138 MG: 13.2;U-2 OS: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011082 Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes No "Nucleoplasm, Mitotic spindle" "Cytokinetic bridge" "HPA011082: AB_2668423" "unprognostic (6.37e-2)" "unprognostic (9.16e-3)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (5.68e-3)" "unprognostic (1.33e-1)" "unprognostic (2.28e-3)" "unprognostic (1.52e-3)" "unprognostic (5.30e-2)" "unprognostic (3.89e-2)" "unprognostic (1.68e-1)" "unprognostic (5.67e-2)" "unprognostic (1.46e-7)" "unprognostic (1.66e-1)" "unprognostic (8.09e-3)" "unprognostic (1.04e-1)" "unprognostic (3.01e-1)" 1.1 1.2 9.3 1.1 13.4 1.0 0.9 4.4 28.1 1.0 0.9 1.1 0.0 0.8 1.1 0.7 0.9 1.0 0.9 0.8 5.5 2.8 0.9 0.7 1.0 0.9 2.3 8.1 1.2 0.8 1.0 0.6 1.1 2.6 0.8 0.8 1.1 0.8 0.8 0.7 0.9 0.9 0.8 0.7 1.4 1.0 2.3 1.7 0.0 0.8 0.0 0.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 21.8 4.4 2.2 0.0 0.0 2.3 0.3 0.9 8.0 4.7 0.0 0.5 0.0 1.7 1.0 9.4 0.1 1.0 0.2 2.1 0.0 0.3 0.0 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 1.3 3.6 1.4 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.5 2.3 3.0 3.9 4.5 6.2 0.0 11.2 4.3 3.8 1.7 3.4 0.2 0.1 0.1 4.0 13.2 14.3 0.2 4.1 0.0 0.0 0.5 0.4 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 13.4 4.4 27.4 5.5 2.8 2.3 8.1 2.6 1.7 0.0 0.0 0.0 0.1 0.1 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 6.8 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 2.1 0.0 0.2 0.9 2.2 0.0 0.1 0.0 0.0 0.0 MGST1 "GST12, MGST-I" ENSG00000008394 "Microsomal glutathione S-transferase 1" P10620 12 16347142-16609259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 382.8" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 3471.1;Proximal tubular cells: 978.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 46.1;myeloid DC: 34.1" "Group enriched" "Detected in many" 15 "dendritic cells: 34.1;monocytes: 46.1" "Cell line enhanced" "Detected in many" "ASC diff: 342.0;ASC TERT1: 132.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044840 Enhanced Approved "Endoplasmic reticulum,Mitochondria" NA NA Mitochondria "Endoplasmic reticulum" "HPA044840: AB_10965550" "unprognostic (4.57e-2)" "unprognostic (4.80e-3)" "unprognostic (5.82e-2)" "unprognostic (2.92e-3)" "unprognostic (3.97e-3)" "unprognostic (1.03e-1)" "unprognostic (8.19e-2)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (3.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (7.45e-4)" "unprognostic (9.90e-2)" "unprognostic (4.61e-1)" "prognostic favorable (1.97e-4)" "unprognostic (4.19e-1)" 127.9 106.0 18.5 10.8 32.6 9.5 116.8 10.3 14.0 9.3 39.7 9.6 2.6 17.0 4.1 6.4 19.5 6.9 26.6 12.1 19.6 13.9 56.9 382.8 42.0 2.7 18.9 8.9 3.1 12.4 0.8 5.3 8.7 18.4 23.5 28.3 3.0 14.7 8.2 8.9 7.0 15.5 11.5 20.1 0.9 10.3 6.8 12.0 0.0 69.9 13.9 3.6 32.6 37.2 0.2 34.1 2.7 46.1 0.0 0.2 13.0 0.0 30.6 7.3 8.5 342.0 132.0 0.0 25.1 25.7 13.7 21.3 11.6 51.3 0.0 3.0 32.1 43.1 0.1 19.0 40.2 12.4 0.0 2.5 10.4 17.0 40.7 79.9 20.2 0.0 85.6 44.8 41.8 44.1 34.0 24.0 0.0 7.3 0.0 29.4 6.2 0.0 8.1 60.9 0.0 24.3 0.0 4.3 13.8 30.8 60.5 1.3 1.1 39.2 25.2 1.0 41.3 27.1 11.4 15.1 14.1 1.9 27.7 32.3 0.0 0.0 0.0 46.4 32.3 0.4 2.7 46.1 0.4 0.0 7.0 0.1 0.2 0.0 0.0 34.1 0.0 0.0 0.0 1.5 0.0 1.5 9.6 0.2 13.0 18.5 32.6 10.3 14.0 19.6 13.9 18.9 8.9 18.4 12.0 247.1 493.0 46.4 120.5 22.8 0.0 5.3 738.8 293.1 502.7 68.0 0.0 2.3 154.2 22.7 20.8 14.2 262.1 46.7 371.4 189.8 162.1 379.2 32.4 3471.1 168.6 0.0 43.8 78.5 223.7 10.9 30.8 51.0 37.1 187.6 224.9 0.0 374.3 135.3 106.4 978.0 1.0 0.0 12.2 0.5 2.2 15.4 6.6 37.4 362.2 564.6 MIA CD-RAP ENSG00000261857 "Melanoma inhibitory activity" Q16674 19 40771648-40777490 "Cancer-related genes, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9" "Group enriched" "Detected in some" 10 "Melanocytes: 97.8;monocytes: 52.3;Pancreatic endocrine cells: 38.8" "Cancer enriched" "Detected in many" 5 "melanoma: 58.6" "Region enriched" "Detected in some" 8 "midbrain: 16.1" "Cell type enhanced" "Detected in some" "basophil: 1.6;neutrophil: 3.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.0" "Group enriched" "Detected in some" 31 "AN3-CA: 21.8;CAPAN-2: 18.3;SK-MEL-30: 63.5;WM-115: 60.2" HPA042369 Approved "Secreted to blood" NA NA 8270000 "HPA042369: AB_10794420" "prognostic favorable (2.08e-4)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (9.02e-3)" "unprognostic (2.27e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-3)" "unprognostic (3.67e-2)" "unprognostic (1.61e-1)" "unprognostic (9.37e-2)" "unprognostic (1.17e-1)" "unprognostic (3.19e-1)" "unprognostic (3.29e-8)" "unprognostic (5.88e-2)" "unprognostic (2.44e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-1)" 0.7 1.5 0.6 3.5 0.6 1.4 28.7 0.9 0.4 3.7 6.1 0.5 2.2 0.8 2.8 3.2 4.0 1.0 3.2 4.1 0.4 0.4 0.9 0.8 1.4 0.7 16.1 0.4 2.6 0.4 0.0 33.5 0.9 2.1 2.2 1.9 6.0 22.7 1.7 0.8 4.5 2.2 3.4 3.1 2.4 28.9 1.0 0.4 0.5 1.1 5.9 4.4 2.0 1.5 0.7 0.0 3.0 0.1 0.0 0.3 0.1 0.0 0.1 0.2 21.8 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 18.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 63.5 0.8 0.1 0.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.2 0.0 0.1 60.2 1.6 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.1 0.0 0.0 0.1 0.6 0.6 0.9 0.4 0.4 0.4 16.1 0.4 2.1 0.4 0.0 0.3 0.0 0.1 4.6 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.7 0.0 0.4 0.0 0.6 0.7 0.0 2.7 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.6 0.0 97.8 52.3 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.6 0.0 0.5 0.4 MIB2 "FLJ39787, skeletrophin, ZZANK1, ZZZ5" ENSG00000197530 "Mindbomb E3 ubiquitin protein ligase 2" Q96AX9 1 1615415-1630610 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" "Actin-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 72.5" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 116.3;Late spermatids: 190.0;Suprabasal keratinocytes: 110.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 13.4;SCLC-21H: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068322 Enhanced NA NA "HPA068322: AB_2685973" "unprognostic (3.93e-2)" "unprognostic (6.02e-2)" "unprognostic (2.34e-2)" "unprognostic (6.60e-2)" "unprognostic (2.08e-1)" "unprognostic (1.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.61e-1)" "unprognostic (1.54e-1)" "unprognostic (6.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.17e-2)" "unprognostic (2.22e-3)" "unprognostic (1.29e-1)" "unprognostic (3.58e-2)" "unprognostic (2.49e-1)" "unprognostic (1.01e-2)" 6.4 3.9 8.7 6.4 10.0 4.5 4.7 8.8 11.5 4.8 6.9 7.1 4.7 5.3 5.1 5.4 11.4 4.1 3.7 6.1 9.1 7.9 5.5 6.2 5.1 3.7 5.3 7.1 5.8 7.0 3.7 9.4 4.0 5.7 4.7 3.7 6.6 5.4 6.5 72.5 9.6 4.6 5.4 3.4 9.0 8.5 5.2 5.8 7.4 5.9 9.7 4.1 4.5 4.1 2.9 9.2 1.9 0.1 7.3 4.7 1.0 6.6 0.9 0.4 1.5 1.8 0.6 9.3 3.1 1.4 1.0 2.3 1.3 1.7 0.7 4.5 0.9 0.4 13.4 0.5 2.1 0.0 3.5 5.7 0.5 1.9 1.3 2.4 0.8 2.2 1.4 1.4 0.6 0.2 0.6 0.5 3.1 2.7 1.2 0.3 1.0 3.6 8.4 1.2 1.7 10.6 6.2 1.9 9.1 0.1 0.8 14.3 5.2 5.3 0.8 5.1 0.3 1.0 3.3 0.6 1.0 2.2 5.2 0.9 6.9 2.0 1.8 2.4 2.7 1.1 0.0 0.1 1.9 4.3 0.1 4.3 2.6 3.3 4.7 0.0 2.9 3.9 2.9 0.5 7.3 0.0 9.2 2.3 1.0 8.7 10.0 8.8 11.5 9.1 7.9 5.3 7.1 5.7 5.8 0.0 9.6 13.2 14.2 116.3 32.0 9.8 12.7 4.0 7.9 22.7 11.8 8.6 8.3 6.8 52.0 10.0 36.6 0.0 1.1 7.0 10.3 10.7 20.7 9.2 5.8 25.4 14.5 13.5 6.2 190.0 19.5 6.4 16.9 3.6 25.0 25.0 5.9 42.1 14.9 18.1 35.7 0.0 16.8 22.9 43.2 110.2 12.6 52.2 28.9 15.9 MICAL2 KIAA0750 ENSG00000133816 "Microtubule associated monooxygenase, calponin and LIM domain containing 2" "O94851, Q6ZW33" 11 12094008-12359144 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 138.4" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebellum: 138.4;cerebral cortex: 39.8" "Cell type enhanced" "Detected in many" "neutrophil: 12.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030437, HPA039895, HPA040438" Approved Uncertain "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Cytosol" "Nucleoplasm, Plasma membrane" "HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896" "unprognostic (2.68e-2)" "unprognostic (1.77e-2)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (6.88e-4)" "unprognostic (2.20e-2)" "unprognostic (3.60e-2)" "unprognostic (9.32e-2)" "unprognostic (2.86e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (4.61e-2)" "unprognostic (1.97e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-1)" 4.1 3.3 15.4 7.3 15.1 6.8 2.9 138.4 39.8 6.6 14.7 2.7 2.9 7.2 14.7 7.7 11.5 5.4 11.1 24.8 22.0 6.9 2.9 3.9 12.8 2.3 5.6 17.9 3.9 4.4 0.7 2.4 5.0 5.5 3.3 15.1 2.8 2.9 8.4 14.6 9.3 10.8 22.7 7.6 2.6 5.9 24.6 0.6 0.0 4.5 1.9 2.2 7.8 3.2 0.2 5.5 12.2 6.7 3.7 3.5 2.1 11.8 6.3 0.3 1.4 1.6 3.0 7.5 18.9 21.4 7.4 11.6 13.2 8.5 0.3 4.1 13.2 21.2 8.4 2.3 30.4 18.4 13.7 1.5 11.2 1.2 0.9 14.2 2.1 1.4 5.3 5.4 32.6 31.9 13.8 16.9 0.8 19.5 0.5 11.9 0.7 0.1 1.0 0.4 8.4 5.9 0.1 7.5 7.9 1.5 14.9 6.1 0.5 6.2 17.3 1.2 4.7 1.7 0.6 30.1 40.3 15.2 6.6 16.4 0.4 0.9 0.4 24.5 3.0 0.8 0.1 6.7 0.5 2.8 1.7 3.5 0.2 1.7 1.7 5.5 0.2 0.2 0.9 12.2 3.7 0.5 1.0 2.1 2.1 15.4 15.1 138.4 39.8 22.0 6.9 5.6 17.9 5.5 0.6 38.7 29.6 4.2 6.7 9.0 2.8 28.1 7.6 5.3 11.4 3.5 0.0 2.1 0.0 9.6 73.9 7.1 31.5 23.3 12.4 9.5 4.5 7.0 1.1 17.8 3.0 0.0 21.7 11.1 11.1 128.9 19.5 8.9 5.0 8.2 10.0 0.2 29.0 14.1 106.1 0.6 1.6 12.9 27.6 0.9 0.9 8.3 1.9 9.2 9.9 9.7 MICB PERB11.2 ENSG00000204516 "MHC class I polypeptide-related sequence B" Q29980 6 31494881-31511124 "Disease related genes, Predicted membrane proteins" "Adaptive immunity, Cytolysis, Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 26.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Hofbauer cells: 9.9;Kupffer cells: 12.9;monocytes: 10.0;T-cells: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 11.6;U-266/84: 26.5" HPA064618 Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" Nucleoplasm "HPA064618: AB_2685301" "unprognostic (3.63e-3)" "unprognostic (8.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.51e-2)" "unprognostic (8.44e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (7.04e-5)" "unprognostic (2.05e-1)" "unprognostic (2.61e-1)" "unprognostic (1.67e-3)" "unprognostic (2.28e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.94e-9)" "unprognostic (1.91e-3)" "unprognostic (2.80e-2)" "unprognostic (9.72e-2)" "unprognostic (1.21e-2)" 3.3 1.2 0.8 9.1 0.8 6.1 3.5 3.0 1.0 1.8 1.6 0.9 0.0 1.0 2.1 1.3 2.1 1.1 1.7 2.2 1.0 0.6 2.9 1.3 6.9 7.8 1.2 0.8 1.3 2.9 0.2 0.6 0.8 1.2 1.1 1.9 1.1 1.9 0.7 0.8 1.0 5.0 1.7 1.5 11.7 1.4 2.3 1.1 8.1 2.4 0.7 8.1 3.2 26.5 2.2 2.1 4.1 4.8 1.9 4.4 1.9 2.4 0.8 0.0 0.0 1.5 2.5 0.0 1.7 1.7 2.2 2.9 0.0 0.3 2.8 6.2 3.2 7.1 0.6 0.7 2.9 0.8 2.4 2.6 3.2 0.5 1.1 0.5 1.0 2.7 3.1 0.6 3.8 2.2 2.3 1.4 4.4 3.3 5.9 2.6 0.0 0.9 4.2 0.3 0.0 0.4 3.4 0.0 5.9 2.6 0.1 0.0 0.0 1.1 0.0 0.5 0.9 1.5 1.2 1.4 1.7 0.0 1.5 0.0 11.6 26.5 6.2 0.4 8.7 3.7 4.1 3.1 4.0 2.9 3.6 3.6 2.2 2.9 3.9 2.1 2.0 1.6 3.1 3.1 1.9 4.8 1.3 4.4 1.9 0.8 0.8 3.0 1.0 1.0 0.6 1.2 0.8 1.2 1.1 3.0 1.0 5.1 0.6 2.6 0.0 0.3 2.5 0.0 1.2 0.0 0.0 0.1 1.7 1.2 0.0 1.9 0.3 23.3 0.6 0.2 3.3 1.7 0.0 0.0 9.9 0.0 0.0 3.1 12.9 0.0 0.3 8.1 1.7 10.0 0.7 0.0 1.5 2.0 0.4 0.3 0.0 0.0 3.9 0.7 1.5 1.0 0.1 10.0 1.7 1.1 MICU3 "DKFZp313A0139, EFHA2" ENSG00000155970 "Mitochondrial calcium uptake family member 3" Q86XE3 8 17027238-17122644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 76.0;Horizontal cells: 69.9;Rod photoreceptor cells: 78.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.0;HBF TERT88: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024048, HPA024771, HPA024779" Uncertain NA NA "HPA024048: AB_1848021, HPA024771: AB_1848022, HPA024779: AB_1848023" "unprognostic (2.99e-2)" "unprognostic (7.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.80e-2)" "unprognostic (1.19e-1)" "unprognostic (7.49e-2)" "unprognostic (2.25e-2)" "unprognostic (9.01e-5)" "unprognostic (9.82e-2)" "unprognostic (2.80e-1)" "unprognostic (1.11e-3)" "unprognostic (8.45e-2)" "unprognostic (2.32e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (4.65e-2)" 9.1 11.7 13.7 3.3 18.7 1.4 7.0 34.1 32.3 8.6 4.1 7.7 1.9 2.0 10.4 7.0 5.1 5.4 6.0 6.6 15.4 12.0 7.3 14.8 5.5 4.1 10.5 15.1 12.9 4.6 13.9 13.3 22.1 19.8 9.5 3.5 5.8 5.2 7.5 5.4 2.4 2.7 9.1 10.2 6.9 3.5 7.9 6.3 1.8 7.9 1.3 3.2 6.1 7.5 1.4 0.0 0.1 0.0 0.8 0.9 0.0 0.0 1.1 5.7 2.2 4.4 6.6 1.5 8.4 12.0 6.5 5.3 0.0 0.2 0.1 1.7 4.4 4.6 0.0 2.5 1.7 12.3 0.0 1.5 0.0 0.0 2.1 7.6 0.0 0.3 4.9 0.0 5.5 5.5 6.0 2.5 4.3 0.3 1.6 6.0 0.0 0.7 1.0 4.0 0.0 1.4 0.0 2.6 0.0 4.5 0.0 9.4 4.4 0.0 0.0 3.3 2.6 0.0 0.0 3.1 2.8 1.1 0.4 1.5 1.6 1.2 2.9 5.3 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.4 0.0 0.0 1.4 0.9 0.7 0.0 0.8 0.0 0.0 0.0 0.0 13.7 18.7 34.1 24.3 15.4 12.0 10.5 15.1 19.8 6.3 6.0 5.9 3.9 6.9 0.8 76.0 14.4 5.1 2.7 3.4 5.2 39.3 1.6 6.6 4.2 4.0 4.5 0.0 0.0 2.6 1.1 11.2 5.0 8.1 13.2 0.5 69.9 0.0 4.3 2.1 5.8 25.3 1.0 1.7 2.8 0.0 25.8 3.2 0.0 22.6 3.3 78.8 38.8 26.4 23.6 12.0 1.4 6.1 1.0 0.0 2.0 MID1IP1 "FLJ10386, G12-like, MIG12, STRAIT11499, THRSPL" ENSG00000165175 "MID1 interacting protein 1" Q9NPA3 X 38801432-38806537 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.2;skeletal muscle: 86.1" "Cell type enhanced" "Detected in all" 5 "Alveolar cells type 2: 162.1;monocytes: 180.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 3.7;eosinophil: 14.0;neutrophil: 8.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 14.0" "Cell line enhanced" "Detected in all" "U-266/70: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038816 Uncertain NA NA "HPA038816: AB_10670908" "unprognostic (5.35e-2)" "unprognostic (1.75e-1)" "unprognostic (1.24e-1)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (8.08e-2)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.62e-2)" "unprognostic (3.10e-1)" "unprognostic (1.26e-2)" "unprognostic (2.88e-1)" "unprognostic (2.31e-3)" "prognostic favorable (1.15e-4)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (1.18e-2)" "prognostic favorable (8.06e-4)" 20.3 9.3 26.9 9.4 59.5 58.4 8.9 5.4 33.3 5.0 9.3 33.7 7.2 11.6 5.5 5.9 7.7 8.7 5.6 6.7 29.1 21.0 8.9 13.9 21.9 7.2 69.2 12.3 13.1 30.6 3.6 3.6 6.5 42.3 8.7 4.3 5.1 7.7 10.3 86.1 6.2 8.7 7.0 31.6 5.8 19.7 9.7 62.9 3.0 4.0 7.1 4.7 9.4 10.5 0.7 1.3 14.0 1.8 0.8 1.5 0.8 18.3 16.9 4.6 3.5 21.6 10.2 4.9 10.4 7.1 2.2 4.2 5.5 14.0 17.9 9.2 3.2 1.9 17.2 14.8 12.1 1.4 12.2 5.8 15.2 14.7 4.4 16.5 7.0 11.7 14.9 9.8 8.7 7.5 6.0 2.2 21.6 14.1 19.5 3.1 15.1 12.3 19.3 15.8 5.3 30.1 34.0 5.7 35.1 5.8 9.1 11.0 13.2 5.5 10.7 26.8 9.1 8.9 21.7 3.1 6.4 7.2 8.1 7.6 50.0 19.2 16.4 19.7 11.6 7.0 3.7 1.8 14.0 1.0 1.3 1.1 0.5 1.5 1.0 1.3 0.7 1.4 1.3 8.2 0.8 1.8 1.3 0.5 0.8 26.9 59.5 5.4 33.3 29.1 21.0 69.2 12.3 42.3 62.9 74.5 162.1 18.4 32.8 21.1 12.0 38.0 35.7 41.5 17.0 19.2 3.9 3.4 31.5 28.9 6.2 17.1 17.4 93.5 60.7 15.8 31.1 29.5 47.4 32.7 38.5 14.3 24.8 19.6 44.9 5.1 36.5 57.0 25.3 180.3 29.1 20.1 58.3 20.1 46.7 30.5 11.5 38.8 80.2 2.5 2.7 14.3 4.1 31.0 18.0 80.4 MILR1 "Allergin-1, C17orf60, MCA-32" ENSG00000271605 "Mast cell immunoglobulin like receptor 1" Q7Z6M3 17 64449037-64468643 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.0" "Group enriched" "Detected in many" 8 "granulocytes: 33.5;Hofbauer cells: 64.4;Kupffer cells: 28.0;Macrophages: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.9;CAPAN-2: 46.9;Daudi: 23.0;REH: 18.3;U-698: 24.6" "Low region specificity" "Detected in all" HPA014347 Enhanced NA NA 130000 "HPA014347: AB_2732408" "unprognostic (8.40e-2)" "unprognostic (9.77e-2)" "unprognostic (9.28e-3)" "unprognostic (3.27e-1)" "unprognostic (1.17e-1)" "unprognostic (1.21e-2)" "unprognostic (1.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.25e-1)" "unprognostic (3.31e-2)" "unprognostic (5.99e-3)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.07e-6)" "unprognostic (2.51e-2)" "unprognostic (7.12e-3)" "unprognostic (1.09e-1)" "unprognostic (5.99e-2)" 8.4 6.7 6.6 22.3 12.6 13.1 5.0 1.5 6.7 6.8 3.9 11.8 0.6 3.7 3.0 6.9 3.4 4.2 7.3 6.2 7.4 5.4 4.3 3.2 11.4 24.6 13.9 2.3 3.9 2.9 2.5 3.1 13.6 9.8 4.4 7.7 5.6 5.0 2.0 1.6 1.9 7.1 6.7 18.6 24.2 3.1 2.2 11.2 2.2 3.8 3.1 17.7 7.1 3.4 9.4 21.5 28.0 18.7 0.6 0.4 5.2 2.8 0.6 0.0 0.1 1.7 17.9 0.3 0.0 1.9 0.3 3.9 0.1 46.9 23.0 1.0 0.2 9.1 0.5 0.0 0.8 1.1 0.1 0.0 0.5 0.3 0.0 0.3 1.5 15.3 1.7 0.1 5.7 0.7 2.2 1.7 0.2 1.6 2.8 11.1 0.0 0.2 3.0 0.1 0.2 3.2 18.3 3.1 9.5 0.6 0.3 0.1 0.0 1.5 0.2 3.0 0.0 0.1 12.8 6.0 0.2 0.6 0.1 1.1 0.2 0.0 24.6 12.4 2.6 0.0 28.0 18.7 1.0 0.4 15.4 0.3 9.4 0.2 0.3 11.9 6.5 0.3 0.4 5.7 0.6 9.6 21.5 0.2 5.2 6.6 12.6 1.5 6.7 7.4 5.4 13.9 2.3 9.8 11.2 0.0 0.3 4.2 2.3 0.5 0.1 0.4 2.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.6 0.0 0.0 0.0 2.1 1.9 2.0 33.5 0.0 64.4 0.0 4.7 1.8 28.0 0.0 3.7 28.9 0.0 1.0 0.2 0.5 0.0 0.3 1.4 0.0 0.6 0.0 2.0 0.2 0.2 1.5 1.0 0.5 1.5 2.2 MINDY4B "C3orf76, FAM188B2" ENSG00000214237 "MINDY family member 4B" 3 150871045-150905439 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.5;endometrium 1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;T-47d: 3.8" "Low region specificity" "Detected in single" NA NA "unprognostic (1.91e-4)" "unprognostic (6.32e-3)" "unprognostic (6.09e-3)" "unprognostic (3.14e-1)" "unprognostic (3.96e-1)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-3)" "unprognostic (3.36e-1)" "unprognostic (8.66e-3)" "unprognostic (1.43e-1)" "unprognostic (2.22e-1)" "unprognostic (4.70e-1)" "unprognostic (2.54e-1)" "unprognostic (4.77e-1)" "unprognostic (2.16e-1)" 0.0 0.9 0.0 0.0 7.5 0.2 0.0 0.0 0.6 0.0 0.0 0.2 2.8 0.0 0.4 0.7 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MIOS "FLJ20323, MIO, Sea4" ENSG00000164654 "Meiosis regulator for oocyte development" Q9NXC5 7 7566872-7608929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042928, HPA052223" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042928: AB_10795610, HPA052223: AB_2681768" "unprognostic (8.09e-3)" "unprognostic (1.25e-2)" "unprognostic (6.93e-2)" "prognostic favorable (6.51e-4)" "unprognostic (3.42e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (1.44e-2)" "unprognostic (2.27e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.28e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-2)" "unprognostic (7.67e-3)" "unprognostic (2.72e-1)" 9.9 7.8 6.7 14.4 9.5 10.3 9.6 11.7 10.3 9.9 7.0 7.3 10.3 5.5 8.8 8.7 17.1 8.1 6.4 8.0 7.3 5.6 12.0 11.2 7.4 13.9 5.7 7.2 9.0 16.2 24.6 14.9 11.0 16.8 14.7 8.7 10.9 12.3 14.3 67.7 15.3 8.9 8.0 8.8 15.2 10.6 11.9 7.8 14.0 6.8 14.6 19.0 9.3 12.2 10.5 8.3 8.9 11.0 6.4 7.5 4.2 18.9 8.5 10.3 12.3 8.1 17.5 8.6 14.9 11.9 9.5 9.6 10.5 7.5 16.8 4.7 8.8 25.6 17.2 10.4 10.9 12.7 6.8 9.1 4.1 10.2 7.0 11.4 18.0 4.7 14.5 13.7 8.5 21.4 9.4 8.5 5.7 20.9 13.8 40.2 13.2 4.0 8.2 20.8 9.6 9.1 12.5 15.7 16.1 8.6 9.7 10.8 17.5 7.9 22.7 8.8 19.8 12.3 16.2 7.4 14.9 16.0 8.2 12.6 12.3 13.5 15.0 13.0 10.5 17.3 0.0 5.9 8.9 5.1 11.0 4.3 10.5 5.5 4.7 8.3 9.5 7.5 5.8 0.6 6.4 5.3 5.0 5.4 4.2 6.7 9.5 11.7 10.3 7.3 5.6 5.7 7.2 16.8 7.8 8.9 11.0 15.3 12.4 10.8 7.9 16.5 10.2 12.0 9.1 7.0 11.8 14.7 14.9 11.0 29.5 6.4 6.3 0.0 15.2 7.3 5.7 25.8 9.2 15.1 13.8 11.1 4.1 6.7 20.9 40.8 5.5 13.5 6.8 5.4 8.1 7.8 11.3 9.0 7.1 8.4 15.6 12.9 6.6 24.4 28.0 16.6 17.7 12.5 9.3 16.5 MIOX ALDRL6 ENSG00000100253 "Myo-inositol oxygenase" Q9UGB7 22 50486784-50490648 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "kidney: 136.7" "Cell type enriched" "Detected in some" 5 "Proximal tubular cells: 1814.0" "Cancer enriched" "Detected in many" 16 "renal cancer: 56.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 21.8;Hep G2: 4.9;Karpas-707: 11.6;U-266/70: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039451, HPA039562" Enhanced NA NA "HPA039451: AB_2676513, HPA039562: AB_2676574" "unprognostic (2.11e-1)" "unprognostic (4.32e-2)" "unprognostic (2.22e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (5.25e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-3)" "unprognostic (2.84e-1)" "unprognostic (4.72e-2)" "unprognostic (1.85e-2)" "unprognostic (9.83e-2)" "prognostic favorable (2.60e-6)" "unprognostic (1.77e-1)" "unprognostic (1.50e-1)" "unprognostic (1.36e-2)" "unprognostic (2.23e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 136.7 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 2.7 0.1 0.1 0.1 0.1 1.3 0.6 3.1 0.7 0.4 1.4 0.4 0.0 0.0 0.1 0.3 0.2 0.1 1.8 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.6 0.4 0.0 0.1 0.1 0.0 0.0 21.8 0.0 0.1 0.3 4.9 2.9 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 1.0 0.1 11.6 0.0 1.1 0.0 0.1 0.2 0.5 0.4 0.1 0.1 0.1 2.3 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.0 1.2 0.0 0.0 0.5 0.1 0.0 7.0 0.6 0.3 0.1 0.0 0.2 3.1 0.4 0.6 0.5 0.3 0.2 1.3 0.5 1.4 0.1 0.9 0.5 0.6 1.8 0.4 0.7 0.6 0.4 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.7 2.4 0.8 0.7 0.5 0.0 0.0 0.0 0.0 94.2 0.0 0.0 359.8 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.1 0.0 1.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1814.0 0.2 0.0 0.2 0.1 0.4 0.1 0.2 0.9 0.0 0.6 MIP "AQP0, LIM1, MP26" ENSG00000135517 "Major intrinsic protein of lens fiber" P30301 12 56449502-56469166 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Transport, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 2.9;retina: 2.1;testis: 3.3" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 1.9;Horizontal cells: 1.6;Late spermatids: 2.4;Spermatocytes: 6.0;Spermatogonia: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 2.8;SK-BR-3: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA014940 Supported NA NA "HPA014940: AB_2669122" "unprognostic (6.48e-2)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (7.14e-2)" "unprognostic (3.96e-2)" "unprognostic (2.90e-3)" "unprognostic (1.72e-1)" "unprognostic (3.47e-1)" "unprognostic (1.51e-5)" "unprognostic (4.56e-3)" "unprognostic (6.75e-2)" "unprognostic (1.16e-2)" "unprognostic (2.83e-2)" "unprognostic (3.27e-1)" "unprognostic (2.62e-1)" "unprognostic (8.82e-2)" 0.2 0.4 0.4 0.2 0.5 0.1 0.2 0.3 0.7 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.4 0.5 0.8 0.2 2.9 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 2.1 0.2 0.2 0.2 0.1 0.2 0.2 0.6 0.2 0.0 3.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.1 1.3 1.0 1.4 0.3 0.6 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.6 0.1 0.0 0.3 0.8 0.0 0.2 0.9 0.1 0.1 0.2 0.2 0.2 0.0 0.0 0.6 0.4 2.8 0.2 0.0 0.1 0.9 1.8 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.4 1.7 0.4 0.4 0.0 0.9 0.6 0.0 0.6 0.0 0.1 0.7 0.4 0.4 1.5 0.5 0.9 2.6 0.8 0.2 0.5 1.8 0.2 0.4 0.3 0.0 0.0 0.1 0.2 0.9 0.0 0.8 0.3 1.0 1.4 0.1 0.6 0.8 0.3 0.7 0.6 0.2 0.0 1.1 0.2 0.4 0.6 0.3 0.3 1.3 0.5 0.0 0.4 0.5 0.3 0.5 0.5 0.8 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 6.0 1.3 0.0 0.2 0.0 0.0 0.0 MISP "C19orf21, Caprice, DKFZp686H18209, MISP1" ENSG00000099812 "Mitotic spindle positioning" Q8IVT2 19 751126-764318 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "gallbladder: 24.6;intestine: 63.8" "Group enriched" "Detected in many" 5 "Enterocytes: 892.4;Paneth cells: 434.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 133.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 37.2;HaCaT: 27.6;hTCEpi: 25.9;MCF7: 19.0;OE19: 23.2;SK-BR-3: 42.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049511, HPA062232" Enhanced Enhanced "Plasma membrane,Focal adhesion sites" No No "Plasma membrane, Focal adhesion sites" "HPA049511: AB_2680798, HPA062232: AB_2684719" "unprognostic (7.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" "unprognostic (6.50e-2)" "unprognostic (1.78e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.49e-1)" "unprognostic (2.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.78e-3)" "unprognostic (2.29e-1)" "unprognostic (4.80e-1)" "unprognostic (5.27e-2)" 0.5 0.1 0.3 7.9 0.3 0.0 0.7 0.2 0.2 1.5 42.8 0.2 0.2 45.9 0.7 0.8 0.4 2.4 24.6 0.2 0.5 0.2 6.9 0.4 6.8 0.2 0.3 0.3 2.2 2.0 0.0 4.2 2.1 0.2 2.2 13.0 0.2 0.5 0.5 0.2 0.3 63.8 0.7 0.2 0.2 5.8 0.2 0.2 0.3 0.2 0.8 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 37.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 12.8 13.7 3.2 3.6 0.0 0.0 27.6 0.0 11.6 0.0 0.0 0.0 0.0 14.6 3.9 0.0 0.0 0.5 0.0 25.9 0.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 19.0 0.0 0.2 0.0 23.2 7.6 0.0 0.1 0.3 9.3 10.3 0.4 0.1 13.2 42.0 0.0 0.0 9.1 0.0 0.0 0.0 4.7 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 35.7 10.1 2.2 4.0 0.1 0.0 0.4 2.5 26.8 15.9 10.4 0.0 0.3 1.7 48.8 0.4 0.0 892.4 0.0 41.8 2.6 0.3 34.5 9.2 0.0 0.1 0.0 55.7 0.0 0.0 0.7 0.0 0.8 0.0 1.0 139.5 0.0 94.0 434.9 0.0 21.7 0.0 0.0 0.0 0.0 1.5 0.3 1.7 0.0 93.0 40.9 MIXL1 "MILD1, MIXL" ENSG00000185155 "Mix paired-like homeobox" Q9H2W2 1 226223618-226227054 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 23.9;lymphoid tissue: 8.9" "Cell type enhanced" "Detected in single" 17 "Melanocytes: 1.7" "Cancer enriched" "Detected in some" 9 "testis cancer: 6.3" "Group enriched" "Detected in some" 5 "cerebellum: 5.1;cerebral cortex: 1.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HAP1: 2.7;Hep G2: 13.3;SuSa: 3.1;U-698: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA005662 Approved Nucleoplasm NA NA Nucleoplasm "HPA005662: AB_2667382" "unprognostic (4.09e-2)" "unprognostic (2.84e-2)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (6.34e-2)" "unprognostic (1.03e-2)" "unprognostic (3.18e-2)" "unprognostic (5.66e-2)" "unprognostic (5.05e-2)" "unprognostic (7.40e-3)" "unprognostic (2.78e-2)" "unprognostic (2.70e-1)" "unprognostic (2.71e-13)" "unprognostic (1.54e-1)" "unprognostic (1.29e-2)" "unprognostic (1.67e-1)" "unprognostic (8.47e-2)" 0.6 0.2 0.6 8.9 0.4 0.3 0.3 5.1 1.8 0.7 1.4 0.4 0.0 2.7 0.4 0.1 0.6 0.3 0.2 0.4 0.6 0.6 0.3 0.6 0.5 8.2 0.6 0.0 1.2 0.2 2.3 0.3 0.3 0.6 1.0 1.1 0.2 4.9 0.4 0.2 0.3 1.3 0.0 0.5 7.8 1.4 2.2 0.0 1.0 0.4 0.7 7.0 2.6 0.3 7.5 7.7 23.9 12.2 14.6 9.5 4.0 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 2.7 0.0 0.2 0.0 0.1 0.2 0.2 13.3 0.7 0.0 0.1 0.2 0.1 0.7 0.0 0.0 0.2 1.9 0.0 0.1 0.1 0.0 0.1 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 3.1 0.1 0.7 0.2 0.1 0.0 0.1 0.0 0.4 0.0 3.5 0.0 0.0 0.0 23.9 4.7 8.4 4.8 7.1 9.5 7.5 5.6 5.4 4.8 7.2 7.4 7.3 12.9 14.6 12.2 7.7 7.1 4.0 0.6 0.4 5.1 1.8 0.6 0.6 0.6 0.0 0.6 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 MKI67 "MIB-, PPP1R105" ENSG00000148773 "Marker of proliferation Ki-67" P46013 10 128096659-128126385 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.2;lymphoid tissue: 81.5" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 163.5;Extravillous trophoblasts: 71.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.4;T-reg: 1.3" "Group enriched" "Detected in many" 13 "NK-cells: 1.1;T-cells: 1.4" "Low cell line specificity" "Detected in many" "CAB000058, HPA000451, HPA001164, CAB068198" Enhanced Enhanced "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes Yes "Nucleoplasm, Nucleoli rim" "Mitotic chromosome" "CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187" "unprognostic (2.54e-1)" "unprognostic (1.29e-1)" "unprognostic (3.37e-1)" "unprognostic (9.92e-3)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.61e-6)" "unprognostic (7.16e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (9.47e-5)" "unprognostic (2.45e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (4.61e-1)" 1.8 1.2 0.2 9.9 0.5 25.2 1.8 0.3 0.5 1.5 5.0 0.6 0.2 3.6 0.7 1.4 13.4 0.3 1.2 1.3 0.2 0.2 1.2 1.0 1.9 8.8 0.2 0.2 0.5 0.4 0.0 0.4 2.9 0.5 0.7 5.8 0.5 2.2 0.6 0.5 3.9 6.2 1.3 0.8 6.5 3.5 2.5 0.2 81.5 0.4 5.2 10.0 1.3 3.5 0.0 0.0 0.0 0.0 1.1 1.4 0.4 48.1 24.5 25.5 18.0 1.0 2.2 7.9 18.3 13.5 17.4 15.6 20.0 20.0 36.3 5.3 12.5 11.5 29.4 26.7 13.7 26.2 38.2 12.9 31.1 18.1 12.5 0.0 43.6 16.9 0.5 0.6 17.8 18.3 4.3 17.0 16.9 14.2 34.9 17.2 19.1 26.0 13.3 10.1 12.5 11.2 19.4 33.4 4.8 6.3 13.5 8.9 9.6 25.9 9.3 4.4 8.8 7.7 9.3 15.7 9.2 18.5 13.0 49.4 15.9 12.6 44.0 7.7 20.0 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.4 1.0 0.0 1.1 0.0 0.0 1.3 0.4 0.2 0.5 0.3 0.5 0.2 0.2 0.2 0.2 0.5 0.2 0.0 4.8 10.7 0.5 5.7 0.0 1.2 2.5 2.7 7.9 0.0 0.0 2.7 0.0 0.4 2.5 0.0 2.7 163.5 0.0 71.7 3.4 1.4 1.1 1.0 34.1 0.0 6.4 3.7 8.0 0.5 0.3 12.7 3.3 0.0 4.8 0.0 0.1 2.9 0.4 0.0 0.0 0.0 0.4 8.8 14.6 2.6 6.5 13.4 20.7 4.1 MKNK1 MNK1 ENSG00000079277 "MAP kinase interacting serine/threonine kinase 1" Q9BUB5 1 46557408-46616843 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 72.3" "Cell type enhanced" "Detected in all" 6 "Hofbauer cells: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB027355, CAB037310, HPA071293" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382" "unprognostic (4.05e-3)" "prognostic favorable (7.05e-4)" "unprognostic (5.28e-2)" "unprognostic (3.47e-2)" "unprognostic (1.64e-1)" "unprognostic (7.38e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (3.50e-2)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (1.50e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.51e-5)" "unprognostic (7.02e-2)" "unprognostic (3.19e-2)" "unprognostic (4.67e-1)" "unprognostic (5.67e-3)" 17.6 12.0 10.7 16.2 10.5 16.8 12.1 13.7 12.3 9.2 12.6 11.0 9.6 9.7 11.9 13.3 12.2 11.1 11.4 12.3 10.8 7.0 9.4 10.8 16.1 16.3 9.9 9.8 10.7 72.3 8.6 11.3 15.4 11.0 9.9 13.3 11.9 10.6 7.7 12.8 10.2 12.7 13.3 8.1 25.6 11.7 7.6 8.7 12.5 8.8 15.8 10.9 10.9 14.5 4.9 6.0 33.3 12.1 5.0 22.0 6.1 19.5 13.2 8.8 9.7 7.9 11.7 11.7 9.9 9.9 12.0 16.4 15.3 8.0 12.9 12.2 9.9 13.5 23.7 14.7 16.2 12.9 22.2 13.0 27.3 15.2 13.0 12.3 14.6 22.2 15.4 11.2 15.6 8.6 6.5 14.0 15.9 14.2 9.5 6.5 12.8 10.4 13.0 6.0 11.3 15.7 9.6 18.4 12.9 12.9 20.5 6.2 5.5 19.1 17.3 16.0 18.3 11.7 16.3 11.4 4.4 0.9 13.6 11.0 8.1 13.5 11.0 8.5 18.8 8.0 3.9 12.1 14.3 7.5 11.5 22.0 4.6 6.6 6.8 6.0 4.9 4.8 7.0 33.3 5.0 8.1 4.4 4.4 6.1 10.7 10.5 13.7 12.3 10.8 7.0 9.9 9.8 11.0 8.7 11.9 22.1 17.5 15.7 12.4 17.9 15.5 15.3 10.7 18.2 21.0 2.0 19.4 6.6 16.1 13.0 14.3 23.5 23.3 32.1 29.7 19.5 15.8 11.5 20.2 113.5 17.5 16.1 18.4 71.2 17.5 19.8 58.2 10.1 16.2 11.9 6.5 28.0 14.0 34.3 10.2 4.6 6.5 14.4 16.8 15.5 9.7 15.4 24.9 14.7 19.5 MKNK2 "GPRK7, MNK2" ENSG00000099875 "MAP kinase interacting serine/threonine kinase 2" Q9HBH9 19 2037465-2051244 "Enzymes, Predicted intracellular proteins" "Apoptosis, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 207.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 80.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021875, CAB037253, HPA070499" Supported Supported "Nuclear bodies" No No "Nuclear bodies" "CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157" "unprognostic (8.76e-2)" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "prognostic favorable (4.86e-5)" "unprognostic (3.08e-1)" "unprognostic (1.59e-2)" "unprognostic (6.42e-3)" "unprognostic (1.35e-1)" "unprognostic (4.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.08e-1)" "unprognostic (6.56e-2)" "unprognostic (4.07e-2)" "prognostic favorable (4.01e-4)" "unprognostic (1.63e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-1)" 30.3 15.6 7.6 24.2 8.5 31.9 31.1 16.6 9.7 12.5 22.7 6.5 21.4 13.1 9.3 18.4 42.1 11.0 21.7 33.3 7.5 5.7 10.3 22.0 24.5 16.9 10.3 3.3 13.8 53.1 8.3 13.4 16.7 9.2 18.8 8.4 14.2 35.2 32.5 207.5 19.3 15.1 13.0 7.0 27.8 16.7 9.1 9.1 16.0 32.3 47.1 32.8 21.2 63.6 10.7 5.9 26.9 8.0 6.1 7.5 2.2 13.4 15.1 6.4 14.1 47.8 17.4 14.4 7.9 5.7 5.7 5.8 9.7 23.5 19.0 11.0 16.0 5.9 16.6 8.1 23.2 2.6 25.8 7.5 7.7 12.7 10.3 80.4 15.0 13.8 18.4 56.5 10.8 23.0 13.3 13.5 12.8 13.1 34.0 3.9 7.8 8.9 12.5 16.8 10.2 16.5 17.2 1.8 23.9 10.1 8.7 8.9 10.6 18.7 27.6 34.0 7.5 11.4 18.6 20.2 2.1 8.2 8.4 9.5 55.3 21.4 18.5 16.8 11.3 3.8 2.7 6.1 5.7 5.6 6.3 5.1 10.7 5.8 6.2 4.8 10.2 3.7 4.5 26.9 6.1 8.0 5.9 7.5 2.2 7.6 8.5 16.6 9.7 7.5 5.7 10.3 3.3 9.2 9.1 35.7 53.3 43.1 91.9 73.3 45.8 46.4 30.6 16.0 11.4 34.9 23.6 21.3 8.3 25.3 6.2 35.4 94.0 23.3 48.2 31.0 32.0 121.4 28.8 50.0 30.9 39.7 144.2 58.3 34.6 10.0 18.7 27.4 54.0 19.8 92.4 38.7 46.8 69.1 19.1 18.2 43.0 19.4 34.0 15.5 21.8 102.4 47.3 39.5 64.3 110.6 MKRN2OS "C3orf83, MKRN2-AS1" ENSG00000225526 "MKRN2 opposite strand" H3BPM6 3 12514934-12561059 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.1;epididymis: 8.8" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 5.1;Ciliated cells: 8.1;Collecting duct cells: 3.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.4;CAPAN-2: 16.7;HBEC3-KT: 4.3;MCF7: 3.8;RT4: 7.0;T-47d: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA065586, HPA065753" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA065586: AB_2685514, HPA065753: AB_2685553" "unprognostic (2.53e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (2.03e-3)" "unprognostic (3.81e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.29e-1)" "unprognostic (5.26e-2)" "unprognostic (3.86e-2)" "unprognostic (1.58e-2)" "unprognostic (4.29e-3)" "unprognostic (2.53e-5)" "unprognostic (1.02e-1)" "unprognostic (2.48e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-3)" 0.0 0.0 0.0 0.0 0.6 0.0 0.9 10.1 0.5 1.4 3.7 7.0 0.2 8.8 5.5 1.5 1.7 1.4 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.1 5.1 1.1 1.9 0.0 0.6 4.3 5.8 1.5 0.3 2.0 6.6 0.0 0.0 0.0 4.5 0.0 0.1 0.3 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 16.7 0.0 0.4 0.0 0.0 0.7 0.0 4.3 0.0 0.0 1.1 0.0 0.3 0.4 0.0 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.1 0.1 0.1 0.9 0.0 0.0 0.0 0.2 2.7 7.0 0.3 0.0 0.0 1.1 0.0 0.1 3.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.7 0.6 5.1 8.1 1.2 3.5 0.0 2.1 0.0 1.1 1.3 0.0 2.1 0.0 2.0 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 2.6 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.9 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565678-23630075 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 12.6;Cone photoreceptor cells: 23.6;Horizontal cells: 6.4;Rod photoreceptor cells: 6.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 4 "T-cells: 5.7" "Cell line enhanced" "Detected in many" "JURKAT: 16.0;K-562: 17.1" "Low region specificity" "Detected in many" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 1.0 0.7 5.1 1.2 10.4 4.0 1.2 1.0 11.1 0.5 1.1 8.4 0.0 1.3 1.3 3.2 5.6 0.9 0.8 0.8 6.4 3.4 1.1 0.7 1.0 1.9 14.4 3.0 1.2 1.7 0.5 3.8 8.5 5.1 1.2 0.8 3.1 5.2 1.0 1.4 1.2 1.9 0.8 8.2 1.5 0.9 5.7 13.3 5.0 0.9 1.1 1.7 0.7 0.6 1.0 0.9 1.3 0.5 0.4 5.7 0.7 4.6 3.3 3.0 3.1 0.0 0.0 7.0 0.3 0.0 2.8 1.9 8.3 0.0 0.2 0.1 0.0 6.2 8.0 1.3 0.0 0.7 0.0 0.3 6.7 8.9 0.3 0.1 7.8 6.0 0.1 0.0 5.8 0.0 1.2 0.0 16.0 17.1 7.3 0.8 0.0 8.2 3.4 0.0 4.4 10.1 5.9 1.1 4.1 0.0 0.1 0.7 2.4 0.0 3.4 0.0 0.2 2.6 2.3 0.0 7.8 6.6 0.4 5.5 9.2 11.3 5.5 4.5 0.1 0.1 1.3 0.5 0.4 1.8 0.2 1.0 1.0 0.6 1.4 0.2 0.9 2.0 5.7 1.3 0.4 0.3 0.9 0.4 0.7 5.1 10.4 1.0 6.8 6.4 3.4 14.4 3.0 5.1 13.3 0.0 0.0 0.0 1.1 0.5 12.6 0.4 0.0 0.0 0.0 0.0 23.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 3.4 0.0 0.0 0.4 0.0 6.4 0.0 1.2 2.4 1.0 0.0 0.5 0.0 0.0 0.4 MKX "C10orf48, IRXL1, MGC39616" ENSG00000150051 "Mohawk homeobox" Q8IYA7 10 27672875-27746060 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 21.3;prostate: 24.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 3.4;Ciliated cells: 6.7;Club cells: 2.3;Peritubular cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "BJ: 19.3;BJ hTERT+: 11.1;BJ hTERT+ SV40 Large T+: 12.7;BJ hTERT+ SV40 Large T+ RasG12V: 8.7;fHDF/TERT166: 55.2;SiHa: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006927 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA006927: AB_1853981" "unprognostic (2.04e-1)" "unprognostic (2.59e-2)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.23e-2)" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (8.37e-2)" "unprognostic (2.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-2)" "unprognostic (7.62e-2)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (6.38e-3)" 3.7 3.2 1.6 1.4 2.1 0.3 3.0 2.6 5.9 4.9 4.3 1.4 0.9 0.5 1.8 3.4 1.8 7.1 2.7 0.8 1.4 2.5 0.6 1.9 1.2 0.5 2.7 1.4 21.3 1.0 0.3 13.9 0.3 6.7 24.3 1.5 2.9 0.9 7.7 0.5 1.0 0.7 10.6 2.7 0.8 3.4 1.3 0.1 0.0 4.5 0.5 0.3 8.7 1.6 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.3 11.1 12.7 8.7 0.0 0.0 0.0 0.0 55.2 0.5 0.0 0.1 0.0 3.4 0.0 1.2 0.0 3.5 0.0 0.5 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 1.2 0.0 2.4 0.3 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.0 8.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.1 2.6 5.9 1.4 2.5 2.7 1.4 6.7 0.1 0.0 3.4 0.0 0.0 0.0 0.1 1.4 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 MLANA MART1 ENSG00000120215 Melan-A Q16655 9 5890802-5910606 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 191.5" "Cell type enriched" "Detected in some" 25 "Melanocytes: 1629.7" "Cancer enriched" "Detected in single" 556 "melanoma: 277.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 385 "SK-MEL-30: 123.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000057, HPA048662" Enhanced NA NA "CAB000057: AB_442107, HPA048662: AB_2680485" "unprognostic (2.52e-2)" "unprognostic (6.87e-2)" "unprognostic (5.20e-2)" "unprognostic (5.61e-2)" "unprognostic (2.58e-2)" "unprognostic (1.46e-1)" "unprognostic (4.53e-1)" "unprognostic (3.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-3)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (8.01e-2)" "unprognostic (5.78e-2)" "unprognostic (9.43e-2)" 0.1 0.1 0.1 0.2 0.1 0.6 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 191.5 1.2 0.1 0.2 31.5 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.3 2.1 1.6 3.5 1.2 1.8 1.5 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.5 1.2 0.8 1.4 0.8 1.1 1.4 1.3 1.2 0.4 2.1 1.4 1.5 2.9 1.8 1.1 1.6 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 65.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1629.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.0 0.0 0.0 MLC1 "KIAA0027, LVM, MLC, VL" ENSG00000100427 "Megalencephalic leukoencephalopathy with subcortical cysts 1" Q15049 22 50059391-50085902 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.0;brain: 95.3" "Cell type enhanced" "Detected in some" 23 "Hofbauer cells: 2.6;Muller glia cells: 12.6;T-cells: 4.5" "Cancer enriched" "Detected in some" 69 "glioma: 122.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 15.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 46.8;NB-4: 43.3;THP-1: 82.0;U-266/70: 28.7;U-266/84: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003040 Enhanced Supported Cytosol NA NA Cytosol "HPA003040: AB_1079387" "unprognostic (2.68e-2)" "unprognostic (5.46e-6)" "unprognostic (5.41e-3)" "unprognostic (1.51e-1)" "unprognostic (1.47e-1)" "unprognostic (2.42e-3)" "unprognostic (9.54e-3)" "unprognostic (7.21e-2)" "unprognostic (2.24e-1)" "unprognostic (1.90e-1)" "unprognostic (1.31e-1)" "unprognostic (1.51e-3)" "unprognostic (8.39e-4)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (3.66e-2)" "unprognostic (2.92e-1)" 1.6 1.4 42.3 1.9 45.4 27.0 1.4 17.6 95.3 2.5 1.5 25.9 0.0 1.8 1.5 2.3 1.4 2.8 2.1 1.6 30.9 19.6 1.4 1.6 2.3 1.6 22.5 28.9 1.4 1.4 1.4 0.1 3.2 18.4 2.9 1.4 0.0 1.5 2.6 1.4 2.2 1.5 1.6 18.9 2.8 1.5 2.8 17.3 0.0 1.4 0.0 1.8 1.8 2.6 0.1 0.7 0.1 7.1 15.8 3.3 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 46.8 15.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 43.3 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 82.0 0.0 0.0 0.0 0.0 0.0 28.7 24.5 0.0 0.0 7.2 0.4 0.0 0.7 0.0 3.3 5.7 0.1 0.1 0.2 1.4 0.7 0.0 0.1 1.6 0.1 15.8 7.1 0.1 0.1 2.7 42.3 45.4 17.6 29.8 30.9 19.6 22.5 28.9 18.4 17.3 0.0 0.3 0.0 0.0 0.2 0.2 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 2.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.2 4.5 0.0 0.0 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.4;skeletal muscle: 53.6;testis: 101.1" "Group enriched" "Detected in many" 15 "Early spermatids: 4250.8;Late spermatids: 9284.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in single" 12 "T-cells: 10.4" "Cell line enhanced" "Detected in many" "A-431: 33.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA069479, HPA079339" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA069479: AB_2686140, HPA079339: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 3.5 2.6 6.0 1.8 11.9 0.9 5.3 3.4 7.1 3.1 2.7 6.5 0.5 0.8 4.9 5.6 3.5 18.3 4.9 41.4 6.3 6.3 5.7 1.2 5.2 1.0 4.9 6.3 6.2 3.1 5.2 10.4 1.0 20.1 2.0 1.7 2.8 2.2 1.6 53.6 1.8 1.3 4.5 4.7 1.2 1.9 101.1 5.7 0.0 5.3 18.9 1.4 4.2 1.5 0.6 0.3 0.4 0.3 0.8 10.4 2.3 33.7 4.4 11.4 0.0 6.0 7.1 3.4 3.5 3.3 12.8 11.7 0.0 19.2 0.0 13.4 6.0 18.7 6.6 0.1 5.9 17.1 0.0 7.4 2.0 3.3 0.3 4.1 0.0 2.5 4.4 8.7 6.1 3.4 13.4 3.0 0.0 2.5 0.0 8.4 4.9 0.0 0.1 2.7 18.0 9.9 0.0 6.4 0.4 9.8 2.4 14.7 8.7 15.9 5.6 16.7 11.7 16.2 3.4 1.1 12.0 12.2 14.1 13.6 6.1 3.8 0.0 8.7 0.0 8.6 0.0 0.0 0.0 3.6 0.0 1.6 0.6 8.3 8.7 0.3 0.3 2.1 4.4 0.4 0.8 0.3 0.2 10.4 2.3 6.0 11.9 3.4 7.1 6.3 6.3 4.9 6.3 20.1 5.7 23.8 26.2 2.2 109.9 39.8 12.6 168.2 0.0 238.3 60.3 19.2 31.4 0.6 61.3 22.4 4250.8 23.3 4.2 0.0 6.9 3.5 36.8 26.1 43.8 0.0 6.4 9.5 32.5 8.0 2.7 9284.2 64.7 13.2 21.9 1.8 14.3 25.9 7.6 14.4 47.4 27.5 58.5 19.4 36.9 440.7 150.0 29.9 1.4 8.9 10.3 65.9 MLIP "C6orf142, CIP, MGC18257" ENSG00000146147 "Muscular LMNA interacting protein" Q5VWP3 6 53929982-54266280 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 190.6" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HUVEC TERT2: 18.1;SK-MEL-30: 17.4" "Low region specificity" "Detected in many" "HPA029252, HPA046654" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA029252: AB_2732446, HPA046654: " "unprognostic (7.95e-3)" "unprognostic (4.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.06e-4)" "unprognostic (2.38e-2)" "unprognostic (1.26e-2)" "unprognostic (5.60e-2)" "unprognostic (2.74e-2)" "unprognostic (1.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.91e-5)" "unprognostic (7.49e-2)" "unprognostic (2.65e-2)" "unprognostic (5.27e-2)" "unprognostic (3.29e-3)" 5.7 1.9 4.2 0.2 5.2 0.1 1.6 0.8 11.5 0.8 0.5 0.0 0.0 0.3 0.4 3.5 4.9 0.5 0.8 61.7 1.8 0.8 0.5 47.4 0.4 0.2 7.2 8.3 0.4 0.6 0.3 0.5 0.2 1.8 0.8 0.4 1.3 2.6 0.3 101.9 6.5 1.1 0.3 2.9 0.3 0.4 0.5 0.0 0.0 2.7 31.6 2.2 0.6 1.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 0.0 18.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.2 0.0 0.1 0.6 1.3 0.0 0.0 0.5 17.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 5.2 0.8 11.5 1.8 0.8 7.2 8.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 190.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 11.7 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.0 18.3 0.0 12.7 0.0 0.6 1.5 8.2 0.3 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.2 0.1 1.8 0.0 0.0 0.0 0.1 MLKL FLJ34389 ENSG00000168404 "Mixed lineage kinase domain like pseudokinase" Q8NB16 16 74671855-74700960 "Enzymes, Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 50.4" "Cell type enhanced" "Detected in many" 6 "granulocytes: 27.8;Macrophages: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA078638 Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane" "Cell Junctions, Cytosol" "HPA078638: " "unprognostic (7.53e-2)" "unprognostic (1.74e-2)" "unprognostic (2.57e-1)" "prognostic favorable (2.16e-4)" "unprognostic (1.23e-1)" "unprognostic (3.07e-1)" "unprognostic (5.69e-2)" "unprognostic (3.67e-3)" "unprognostic (1.90e-1)" "unprognostic (6.64e-3)" "unprognostic (1.37e-1)" "unprognostic (2.74e-1)" "unprognostic (1.60e-3)" "unprognostic (5.30e-2)" "unprognostic (1.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.53e-3)" 18.5 4.7 5.2 15.1 8.9 21.6 13.2 2.9 7.9 6.4 8.0 3.2 5.3 8.5 7.5 3.8 11.5 5.2 9.1 6.8 6.4 3.5 7.4 6.7 17.3 14.8 10.5 1.8 2.8 8.2 1.6 3.0 7.1 8.1 6.3 9.2 6.5 12.6 4.3 2.3 3.6 10.0 6.0 11.2 26.2 8.2 1.9 8.4 4.3 6.5 4.9 10.4 9.2 50.4 4.2 9.2 25.2 17.7 1.7 8.1 7.1 6.5 12.2 0.1 0.1 3.2 6.7 0.1 8.5 7.4 8.0 11.9 7.0 13.2 0.1 9.8 7.2 6.9 10.5 2.2 12.2 3.0 4.1 0.3 9.2 9.1 8.0 2.3 6.0 9.6 4.5 1.2 8.5 3.0 4.7 19.3 10.7 1.3 1.3 6.2 10.9 3.4 12.0 1.1 14.3 15.0 6.7 0.9 11.7 11.4 4.8 0.5 0.4 6.7 4.5 3.7 0.0 3.2 6.3 21.0 4.0 2.4 3.6 5.8 5.7 19.2 1.6 7.3 21.2 1.9 8.3 17.7 21.7 5.8 10.6 7.9 4.2 6.5 6.0 9.2 2.8 3.6 5.5 25.2 1.7 10.2 0.5 8.1 7.1 5.2 8.9 2.9 7.9 6.4 3.5 10.5 1.8 8.1 8.4 3.0 15.4 8.1 4.8 3.1 0.0 1.6 2.5 2.7 7.9 1.8 0.0 0.2 1.7 4.0 2.6 17.9 5.8 0.0 4.6 0.5 3.8 2.0 27.8 0.9 14.2 1.6 1.2 14.7 15.5 3.8 0.9 24.1 6.8 1.0 5.6 0.0 4.1 9.1 0.4 0.3 0.4 0.0 3.3 0.0 0.2 2.5 0.2 10.0 6.4 5.1 MLLT10 AF10 ENSG00000078403 "MLLT10, histone lysine methyltransferase DOT1L cofactor" P55197 10 21524675-21743630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 158.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005747 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA005747: AB_1079393" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (7.32e-2)" "unprognostic (1.47e-2)" "unprognostic (1.31e-2)" "prognostic favorable (8.75e-4)" "unprognostic (1.03e-3)" "unprognostic (9.56e-3)" "unprognostic (9.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.69e-2)" "unprognostic (7.85e-2)" "unprognostic (6.57e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" 16.3 12.1 11.7 18.4 14.3 21.9 12.8 25.4 13.6 19.0 17.0 12.0 13.6 8.5 26.3 12.8 14.7 14.5 13.7 15.8 10.2 8.5 12.3 13.5 12.3 11.6 10.5 9.9 21.4 12.3 16.6 23.2 20.3 11.8 12.6 11.3 14.6 13.2 16.3 13.4 18.7 12.1 18.7 11.2 10.6 11.4 71.2 14.3 14.6 18.1 9.7 15.2 18.5 19.6 5.5 6.9 12.0 6.8 5.3 7.2 2.8 14.5 12.4 19.1 13.2 12.1 15.3 21.0 9.2 5.8 11.6 11.3 13.1 15.5 17.4 5.1 10.2 10.0 13.7 21.0 12.4 11.6 12.0 12.2 27.0 10.8 18.9 15.0 0.6 17.4 11.4 14.8 9.6 11.1 11.8 15.3 18.3 28.8 13.6 9.1 11.3 20.9 12.6 7.8 8.1 3.9 18.3 10.2 14.6 11.1 6.9 6.7 18.6 12.2 14.7 20.7 17.7 6.9 18.7 13.8 7.3 12.7 14.5 9.1 11.8 13.6 19.5 8.4 10.4 5.6 10.6 6.8 12.0 5.3 4.6 5.2 5.0 6.2 5.7 5.6 5.5 7.2 6.7 5.8 5.3 5.2 6.9 4.6 2.8 11.7 14.3 25.4 13.6 10.2 8.5 10.5 9.9 11.8 14.3 26.8 36.0 13.7 13.7 33.5 31.4 23.5 20.4 17.4 20.5 17.4 41.2 28.7 11.6 12.4 52.7 20.3 15.5 0.0 11.2 48.3 23.9 18.2 23.3 17.8 25.1 28.6 3.4 27.0 30.5 78.0 36.5 23.5 45.5 20.8 15.6 19.7 11.6 14.0 45.3 17.5 50.9 38.8 19.4 158.1 57.1 38.3 42.0 23.5 18.3 10.1 MLLT11 AF1Q ENSG00000213190 "MLLT11, transcription factor 7 cofactor" Q13015 1 151057758-151068497 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.1" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 72.1;Late spermatids: 161.6;monocytes: 56.9" "Cancer enhanced" "Detected in all" "glioma: 29.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 38.6;EFO-21: 29.3;SH-SY5Y: 42.4;U-698: 36.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000540 Uncertain Supported Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA000540: AB_2666024" "unprognostic (2.96e-2)" "unprognostic (1.98e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.26e-5)" "unprognostic (1.69e-1)" "unprognostic (1.96e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.49e-2)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.25e-12)" "unprognostic (5.66e-3)" "unprognostic (1.42e-1)" "unprognostic (1.29e-1)" "unprognostic (3.94e-3)" 1.9 7.5 13.6 3.4 9.1 1.1 1.2 16.3 42.1 1.9 2.1 5.1 1.2 0.8 3.7 1.2 1.3 0.8 11.1 11.8 11.3 16.4 1.2 1.2 5.3 2.3 10.3 1.2 4.2 1.3 8.4 1.8 1.2 3.2 1.3 1.1 1.2 1.5 1.2 2.6 1.0 2.0 4.2 5.8 2.1 0.9 1.2 1.2 2.0 1.2 1.2 2.6 3.2 1.2 2.4 1.0 6.5 1.0 4.2 9.2 2.8 1.2 5.3 38.6 6.1 0.6 1.0 0.6 2.4 2.6 2.3 4.2 0.5 2.5 1.9 29.3 1.8 6.5 1.5 9.3 2.2 1.3 11.3 2.6 5.0 3.8 0.1 1.2 0.3 0.8 1.7 0.3 12.7 0.5 8.0 17.0 7.6 5.3 0.9 7.4 0.4 17.7 3.3 16.8 0.1 0.8 16.9 5.1 0.1 4.4 1.1 23.3 42.4 0.2 0.4 1.2 26.5 1.4 0.6 11.8 5.0 5.5 1.8 4.4 0.9 0.8 36.0 12.5 0.3 9.4 1.6 0.6 1.6 5.9 0.7 2.7 2.4 3.9 6.0 0.8 2.1 5.3 9.2 6.5 4.2 1.0 1.0 3.6 2.8 13.6 9.1 16.3 21.0 11.3 16.4 10.3 1.2 3.2 1.2 0.0 0.6 1.5 4.0 3.2 38.5 10.1 0.0 0.0 0.0 3.5 7.9 2.0 14.9 2.6 72.1 3.6 0.0 0.0 1.1 2.1 12.7 1.7 4.6 0.0 5.6 35.0 10.3 5.5 4.8 161.6 2.0 7.6 5.0 56.9 0.0 12.4 2.9 0.0 3.5 1.1 18.5 0.0 35.9 4.7 8.8 3.0 6.2 7.5 0.1 4.1 MLN ENSG00000096395 Motilin P12872 6 33794673-33804011 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 175 "intestine: 76.0" "Cell type enriched" "Detected in single" 34 "Intestinal endocrine cells: 3.4" "Cancer enriched" "Detected in some" 6 "testis cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.3;RPMI-8226: 1.7;SuSa: 3.1;TIME: 3.4" "Not detected" "Not detected" HPA069392 Enhanced "Secreted to blood" NA NA 450000 "HPA069392: AB_2686136" "unprognostic (7.70e-2)" "unprognostic (6.70e-2)" "unprognostic (4.44e-2)" "unprognostic (3.14e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 58.4 0.0 0.0 76.0 0.1 0.0 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 30.6 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.8 0.0 0.0 0.0 3.1 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MLNR GPR38 ENSG00000102539 "Motilin receptor" O43193 13 49220338-49222377 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 3.9;stomach 1: 2.8;thyroid gland: 5.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.5;NTERA-2: 3.0;THP-1: 9.2" "Low region specificity" "Detected in many" NA NA "unprognostic (9.75e-2)" "unprognostic (2.13e-2)" "unprognostic (2.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.03e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-2)" "unprognostic (7.79e-2)" "unprognostic (1.88e-2)" "unprognostic (3.74e-1)" "unprognostic (2.61e-4)" "unprognostic (3.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.38e-1)" 0.1 0.1 0.2 0.0 0.2 3.9 0.0 0.0 0.1 0.3 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.1 2.8 0.4 5.6 0.0 0.0 0.1 0.0 0.0 0.7 0.6 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.1 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.3 0.0 0.8 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MLPH "exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a" ENSG00000115648 Melanophilin Q9BV36 2 237485428-237555318 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 79.5" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 116.1;Alveolar cells type 2: 367.5;granulocytes: 179.4;Mucus-secreting cells: 189.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 31.0;MCF7: 53.5;SK-BR-3: 51.2;SK-MEL-30: 37.7;U-87 MG: 52.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA014685 Enhanced NA NA "HPA014685: AB_1853997" "unprognostic (3.32e-3)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "prognostic favorable (5.14e-6)" "unprognostic (2.26e-4)" "unprognostic (1.36e-2)" "unprognostic (5.44e-2)" "unprognostic (2.66e-1)" "unprognostic (3.74e-3)" "unprognostic (8.16e-2)" "unprognostic (5.73e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.34e-1)" "unprognostic (9.37e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-3)" 5.9 0.3 0.2 4.4 0.8 0.0 22.1 0.5 0.6 19.3 8.0 0.5 40.0 3.0 9.1 7.4 2.3 6.3 54.1 21.8 0.3 0.3 1.0 15.5 27.8 0.1 1.2 0.4 3.6 10.5 2.3 0.8 5.8 1.2 39.4 7.8 36.4 79.5 41.7 3.1 3.4 7.2 4.3 1.8 0.1 35.3 2.1 0.1 0.2 35.0 7.3 9.4 10.1 15.8 1.0 0.7 1.2 0.5 0.6 1.0 0.0 0.0 28.6 0.0 0.0 13.2 8.9 0.0 5.7 6.8 3.2 4.1 0.2 21.8 0.0 0.0 10.6 11.2 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.1 10.8 3.2 9.5 12.5 16.7 0.0 0.0 0.0 0.0 31.0 53.5 0.0 0.1 0.0 22.3 16.5 0.1 0.0 0.0 0.1 0.6 0.3 0.0 0.0 51.2 37.7 0.1 13.4 0.3 5.7 17.8 0.5 0.2 8.0 0.0 0.0 0.0 52.4 0.0 13.6 0.8 0.5 0.4 0.5 0.2 0.6 0.4 0.6 0.5 0.2 1.0 1.0 0.5 1.2 0.6 0.4 0.7 0.3 0.0 0.2 0.8 0.5 0.6 0.3 0.3 1.2 0.4 1.2 0.1 116.1 367.5 0.0 14.1 3.7 0.0 53.3 45.9 53.5 78.5 12.2 0.0 0.3 1.7 10.8 0.2 2.5 11.5 0.0 37.0 0.2 3.3 78.0 179.4 22.1 1.3 0.0 13.8 1.3 0.3 0.4 7.8 2.2 28.7 1.0 189.7 0.0 40.7 17.3 2.8 0.3 0.0 0.0 3.7 0.4 0.4 2.0 0.6 0.0 29.3 30.6 MLXIPL "bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH" ENSG00000009950 "MLX interacting protein like" Q9NP71 7 73593194-73624543 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 103.6" "Group enriched" "Detected in many" 6 "Cholangiocytes: 71.4;Hepatocytes: 220.3;Intestinal endocrine cells: 86.4" "Cancer enriched" "Detected in many" 6 "liver cancer: 60.9" "Region enhanced" "Detected in many" "cerebellum: 20.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 30.1;K-562: 9.0;SCLC-21H: 16.2;T-47d: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064640 Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA064640: AB_2685309" "unprognostic (1.11e-1)" "unprognostic (1.14e-1)" "unprognostic (2.18e-2)" "unprognostic (4.86e-2)" "unprognostic (5.04e-1)" "unprognostic (1.06e-3)" "unprognostic (3.46e-3)" "unprognostic (9.12e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (6.13e-3)" "unprognostic (4.91e-2)" "unprognostic (2.25e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-2)" "unprognostic (2.46e-2)" "unprognostic (7.72e-3)" 30.0 18.0 4.2 0.8 3.9 0.5 10.9 20.4 6.8 1.1 16.5 0.4 2.6 33.2 0.4 22.1 1.0 3.5 5.5 1.8 3.2 1.7 11.6 103.6 0.9 0.4 1.2 4.0 2.0 6.5 4.0 3.9 0.4 5.0 0.9 1.3 1.1 2.7 0.9 24.7 1.2 27.1 0.7 1.2 0.4 3.5 5.7 0.0 0.0 2.0 7.7 0.4 0.8 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 3.7 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.1 4.6 0.0 2.5 30.1 0.8 0.1 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 3.5 0.0 0.0 0.4 4.8 0.7 0.0 0.0 0.7 0.0 0.0 16.2 0.4 0.5 2.5 0.0 0.0 7.3 3.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.2 3.9 20.4 6.8 3.2 1.7 1.2 4.0 5.0 0.0 0.0 14.4 0.0 4.4 1.0 3.5 2.1 71.4 5.3 7.9 3.5 19.6 0.1 1.7 1.8 1.7 1.5 5.2 0.0 0.9 0.1 2.5 2.1 0.0 220.3 0.4 1.6 86.4 12.3 11.6 0.2 2.6 1.7 6.8 0.0 7.7 2.8 2.2 4.2 1.1 9.9 7.4 0.0 1.9 3.6 0.9 0.6 0.5 2.9 10.3 2.5 MLYCD "hMCD, MCD" ENSG00000103150 "Malonyl-CoA decarboxylase" O95822 16 83899126-83927026 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 39.1" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 72.8;Cone photoreceptor cells: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA031625 Enhanced NA NA "HPA031625: AB_10602028" "unprognostic (6.23e-2)" "unprognostic (1.94e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.26e-1)" "unprognostic (2.36e-2)" "unprognostic (1.28e-1)" "unprognostic (6.23e-2)" "unprognostic (1.84e-4)" "unprognostic (2.33e-1)" "prognostic favorable (2.61e-7)" "unprognostic (2.39e-1)" "unprognostic (3.19e-1)" "unprognostic (9.56e-2)" "unprognostic (1.51e-3)" 6.6 10.1 3.3 3.7 4.2 2.3 4.6 2.4 5.4 4.1 6.9 6.3 6.2 4.6 4.4 4.4 5.1 4.9 7.0 39.1 3.7 3.3 6.7 17.4 4.1 3.6 6.9 3.1 6.2 21.5 6.9 5.1 3.1 4.6 5.6 4.4 8.0 6.4 4.1 31.0 4.0 5.1 5.8 3.3 3.8 6.7 7.1 5.7 3.3 5.6 5.7 4.6 6.4 5.4 0.7 0.7 2.3 0.8 0.1 0.9 0.2 0.5 2.3 1.6 2.7 5.0 2.4 3.7 1.2 1.8 1.1 0.5 2.3 1.7 0.4 2.8 2.1 2.1 2.5 2.8 0.8 1.0 1.9 2.1 1.7 0.9 1.4 2.8 1.5 3.2 3.0 2.8 0.7 1.1 1.9 1.2 2.3 2.1 0.8 1.3 4.4 1.5 4.5 2.0 2.2 1.0 3.5 1.4 2.2 3.0 2.7 2.5 2.3 4.5 0.7 2.1 2.5 4.3 1.9 1.6 1.8 0.4 1.4 0.5 2.7 2.6 3.2 1.8 2.1 1.9 0.8 0.7 2.3 0.5 0.5 0.3 0.7 0.8 0.7 0.7 0.3 0.8 0.9 0.3 0.1 0.8 0.3 0.0 0.2 3.3 4.2 2.4 5.4 3.7 3.3 6.9 3.1 4.6 5.7 6.0 5.3 15.6 6.1 1.8 25.1 72.8 20.4 0.0 7.9 22.7 117.8 16.1 26.6 5.6 3.6 6.7 14.8 0.0 4.7 8.7 5.6 8.5 5.7 35.5 10.9 15.9 9.8 9.2 5.6 4.7 13.6 6.9 3.3 1.8 15.8 17.7 5.9 10.5 18.4 18.0 48.9 6.5 7.2 10.5 12.4 1.8 6.9 9.2 16.6 6.8 MMAA cblA ENSG00000151611 "Methylmalonic aciduria (cobalamin deficiency) cblA type" Q8IVH4 4 145618263-145660035 "Disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 14.7" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 28.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037361, HPA058187" Supported Approved Cytosol No No Cytosol "HPA037361: AB_10672107, HPA058187: " "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "prognostic favorable (3.38e-4)" "unprognostic (1.97e-3)" "unprognostic (1.44e-1)" "unprognostic (4.83e-3)" "unprognostic (1.31e-3)" "unprognostic (3.98e-1)" "unprognostic (7.03e-2)" "unprognostic (7.26e-2)" "unprognostic (3.19e-3)" "unprognostic (1.46e-1)" "prognostic favorable (2.23e-5)" "unprognostic (3.40e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.21e-4)" 1.7 3.3 1.4 1.4 1.7 0.5 2.6 2.3 1.5 1.5 3.1 4.2 1.4 2.6 2.3 1.5 2.0 1.8 1.2 1.5 4.3 14.7 1.7 1.3 1.4 1.3 2.5 1.4 0.9 1.1 1.3 3.5 2.0 1.3 5.2 2.3 3.4 1.2 1.2 1.6 1.9 2.0 2.2 1.7 1.6 1.6 4.2 4.2 4.1 10.0 5.8 7.8 2.9 2.3 1.3 4.3 2.2 10.4 10.4 0.9 5.9 4.7 2.4 1.4 1.8 4.7 7.9 2.0 3.9 1.2 1.9 2.1 4.5 1.6 5.5 1.0 3.5 0.9 1.4 7.5 4.2 3.2 6.5 6.4 2.5 6.6 4.1 7.4 9.5 1.0 5.4 5.1 2.9 7.6 1.6 1.6 6.1 2.2 3.6 1.5 1.5 14.1 1.8 2.1 1.7 3.4 7.2 3.2 2.2 3.7 2.0 6.1 3.8 1.6 4.6 1.5 3.0 1.9 3.6 4.0 4.2 3.4 4.1 3.8 3.2 6.3 8.4 5.8 4.2 7.8 6.4 3.6 3.3 5.9 7.8 0.0 5.8 10.0 4.2 6.1 2.9 11.9 3.5 2.2 7.3 2.6 2.9 7.0 12.7 4.0 15.9 10.4 2.0 6.9 13.3 8.5 7.0 3.3 8.8 0.0 10.8 2.8 3.8 5.2 8.1 28.6 4.5 0.0 2.4 7.4 2.7 4.7 4.4 2.6 1.7 3.6 4.9 2.2 7.8 7.0 2.8 15.3 1.5 0.0 3.1 6.7 4.9 1.0 6.4 1.7 5.9 9.5 MMACHC "cblC, DKFZP564I122" ENSG00000132763 "Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria" Q9Y4U1 1 45500053-45513382 "Disease related genes, Predicted intracellular proteins" "Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.1" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027394, HPA027399, HPA027402" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255" "unprognostic (3.34e-1)" "unprognostic (1.63e-1)" "unprognostic (7.03e-3)" "unprognostic (3.14e-2)" "unprognostic (4.05e-1)" "unprognostic (1.16e-2)" "unprognostic (9.04e-2)" "unprognostic (1.03e-2)" "unprognostic (1.90e-1)" "unprognostic (1.05e-2)" "unprognostic (3.88e-2)" "unprognostic (6.81e-2)" "unprognostic (2.61e-3)" "unprognostic (2.08e-3)" "unprognostic (8.83e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" 3.5 7.4 5.8 3.3 10.2 2.2 6.1 3.6 12.2 5.4 6.3 11.8 3.2 5.6 4.1 5.6 4.0 6.2 2.9 11.1 6.2 5.1 7.6 30.1 2.7 3.1 7.3 6.9 6.4 9.8 9.5 5.4 2.9 8.5 3.9 7.6 4.0 11.9 7.5 14.7 3.8 4.1 4.2 6.7 3.6 4.5 7.3 5.7 4.1 4.4 3.7 3.6 3.9 3.1 2.1 3.6 5.0 6.1 2.6 3.9 1.1 6.8 3.5 6.1 9.2 5.8 3.5 7.6 5.3 3.5 9.7 8.8 7.3 4.2 10.7 6.9 4.4 1.8 5.7 11.2 12.7 8.9 2.9 10.2 8.3 5.9 8.2 5.5 11.8 3.0 5.0 7.2 10.7 11.8 3.5 4.6 11.3 9.4 6.1 7.4 7.3 7.9 3.8 10.0 7.8 8.3 9.8 2.5 11.9 5.6 5.4 9.8 5.0 8.0 13.3 17.3 4.8 7.6 4.3 2.1 6.8 9.3 7.6 2.8 9.2 7.4 6.2 4.9 5.7 6.3 5.0 1.6 1.6 1.7 2.4 2.8 2.0 2.0 1.4 1.7 2.1 3.9 2.0 3.5 2.6 6.1 3.6 1.4 1.1 5.8 10.2 3.6 12.2 6.2 5.1 7.3 6.9 8.5 5.7 3.0 5.6 1.5 1.7 0.1 0.9 8.7 2.5 1.4 3.4 1.8 0.0 3.1 5.0 1.1 0.6 0.7 1.6 0.0 1.2 3.7 1.8 1.3 2.3 21.9 2.9 3.2 4.1 2.5 3.1 0.0 1.7 0.9 0.0 0.0 2.6 1.0 1.8 0.0 1.4 3.2 4.4 0.0 1.7 8.1 2.0 0.1 2.3 1.3 6.0 1.6 MMD "MMA, PAQR11" ENSG00000108960 "Monocyte to macrophage differentiation associated" Q15546 17 55392613-55421992 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.1;brain: 40.5;breast: 46.0" "Cell type enhanced" "Detected in many" 6 "monocytes: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;HSkMC: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026978 Approved Vesicles NA NA Vesicles "HPA026978: AB_2672068" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.52e-5)" "prognostic unfavorable (3.88e-4)" "unprognostic (2.48e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (8.07e-3)" "unprognostic (6.67e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (3.71e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.12e-2)" 61.1 6.6 33.4 7.1 40.5 5.3 46.0 2.0 23.7 2.6 5.6 4.1 1.7 5.0 3.2 4.9 3.6 1.8 4.7 5.0 26.9 7.5 3.2 6.0 4.7 9.0 11.2 5.1 1.5 1.6 0.9 2.1 13.4 4.6 3.2 6.5 3.2 2.2 4.1 2.5 2.5 4.7 5.4 6.5 8.7 2.4 7.8 5.0 1.4 3.3 1.2 5.6 5.7 4.1 4.1 3.6 9.6 1.6 2.2 4.2 15.9 5.1 13.2 19.5 3.8 32.8 25.9 9.6 3.2 1.5 2.0 3.0 2.0 15.3 7.4 9.4 1.1 5.8 0.3 5.4 4.1 4.3 9.7 1.9 2.7 0.7 23.9 8.8 2.6 0.8 59.3 1.3 2.9 3.3 4.6 2.6 7.2 0.9 5.9 4.3 0.7 7.3 1.9 5.3 0.9 3.4 2.9 12.6 2.7 5.7 1.4 1.8 18.6 1.1 2.0 2.9 12.7 4.3 4.7 2.4 5.4 6.5 4.3 3.6 2.6 1.3 10.4 7.8 2.2 4.3 9.6 1.3 1.5 1.4 1.6 4.2 3.6 1.6 2.9 3.6 4.1 2.7 2.9 3.8 2.2 1.5 1.1 1.7 15.9 33.4 40.5 2.0 16.9 26.9 7.5 11.2 5.1 4.6 5.0 3.0 1.1 10.5 17.0 4.7 24.9 4.3 7.6 0.0 1.2 7.0 3.9 8.1 13.3 22.9 2.1 11.3 2.6 46.7 1.2 13.7 8.0 18.3 0.0 17.0 32.6 15.9 7.5 10.4 35.9 2.5 1.7 28.4 6.8 74.9 5.8 11.5 12.0 0.0 3.2 7.1 9.3 19.4 5.2 15.6 16.0 15.3 16.7 12.5 7.9 4.0 MMD2 PAQR10 ENSG00000136297 "Monocyte to macrophage differentiation associated 2" Q8IY49 7 4905989-4959213 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "brain: 38.5;testis: 10.1" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 2.0;Muller glia cells: 2.4;Rod photoreceptor cells: 2.3" "Cancer enriched" "Detected in single" 59 "glioma: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.9;SH-SY5Y: 2.0;U-87 MG: 1.0" "Low region specificity" "Detected in all" NA NA "unprognostic (2.32e-1)" "unprognostic (1.53e-2)" "unprognostic (5.03e-2)" "unprognostic (2.03e-1)" 0.9 1.2 10.6 0.9 16.2 0.8 0.8 2.4 38.5 0.9 0.9 4.0 0.0 0.9 0.8 0.9 0.9 0.8 0.9 0.8 7.4 6.5 0.9 0.8 0.8 0.9 7.4 6.8 1.0 0.8 0.8 1.9 0.8 7.9 0.9 0.9 1.4 1.0 1.0 0.8 0.8 1.0 0.9 16.7 0.8 0.9 10.1 3.7 0.0 0.9 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.6 16.2 2.4 9.8 7.4 6.5 7.4 6.8 7.9 3.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 MME "CALLA, CD10, NEP" ENSG00000196549 "Membrane metalloendopeptidase" P08473 3 155024124-155183729 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.1;intestine: 136.0;kidney: 64.9" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 62.4;Cytotrophoblasts: 71.6;Proximal tubular cells: 101.6;Syncytiotrophoblasts: 105.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 129 "neutrophil: 61.1" "Lineage enriched" "Detected in single" 129 "granulocytes: 61.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 97.1;BJ hTERT+: 146.1;HSkMC: 94.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 26.8" "CAB000013, HPA052583, HPA056072" Enhanced NA NA 99000 "CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027" "unprognostic (1.36e-1)" "unprognostic (1.02e-3)" "unprognostic (8.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.78e-2)" "unprognostic (6.52e-3)" "unprognostic (1.20e-1)" "unprognostic (1.67e-2)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (7.30e-3)" "unprognostic (1.31e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-1)" "unprognostic (7.29e-2)" "unprognostic (1.06e-2)" "unprognostic (1.37e-2)" 26.5 0.4 0.4 3.4 7.4 1.9 14.7 0.4 0.7 4.8 65.6 0.1 18.4 74.0 2.8 8.1 0.7 0.9 8.5 1.8 0.3 0.4 64.9 11.5 13.7 3.0 2.1 0.2 0.9 0.6 0.0 0.6 35.0 8.6 18.3 0.4 1.3 3.7 11.3 11.7 1.4 136.0 0.6 0.9 2.7 0.7 1.0 1.2 13.2 1.0 5.3 2.3 3.4 4.9 0.1 0.4 61.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 39.4 97.1 0.2 21.7 146.1 11.1 28.7 0.0 0.0 23.9 0.0 19.2 15.1 0.0 0.7 0.8 26.7 0.0 0.1 0.0 0.0 0.0 31.6 0.0 0.0 94.2 0.1 5.9 42.5 12.3 8.4 0.0 0.0 0.0 17.7 0.1 0.0 0.1 0.9 0.0 0.1 39.7 18.7 0.1 0.6 0.2 0.0 0.2 0.0 0.0 4.2 8.9 0.0 0.0 23.8 47.7 0.1 16.3 3.7 0.0 0.0 31.5 5.7 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 61.1 0.0 0.0 0.4 0.0 0.0 0.4 7.4 0.4 0.7 0.3 0.4 2.1 0.2 8.6 1.2 8.9 18.3 0.9 62.4 0.7 0.0 1.1 17.8 2.7 19.4 21.0 0.0 71.6 8.3 0.1 0.3 0.6 0.0 0.0 0.0 48.9 19.2 29.2 2.3 48.9 8.1 0.0 0.0 3.1 1.8 0.2 3.7 2.7 0.0 0.0 0.2 0.0 0.3 0.0 1.1 101.6 0.0 0.0 3.1 0.2 0.4 0.3 105.4 0.0 0.0 29.2 MMEL1 "MMEL2, NEPII, NL1, NL2, SEP" ENSG00000142606 "Membrane metalloendopeptidase like 1" Q495T6 1 2590639-2632990 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 30.2" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 28.1;Early spermatids: 82.5;Late spermatids: 27.3;Paneth cells: 37.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 8.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007876, HPA008205, CAB020786" Uncertain "Intracellular and membrane" NA NA "CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011" "unprognostic (5.80e-2)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (4.27e-2)" "unprognostic (1.33e-1)" "unprognostic (2.71e-2)" "unprognostic (1.45e-1)" "unprognostic (7.96e-2)" "unprognostic (1.36e-2)" "unprognostic (2.37e-1)" "unprognostic (4.54e-3)" "unprognostic (2.44e-2)" "unprognostic (4.79e-2)" "unprognostic (3.18e-1)" "unprognostic (2.82e-1)" "unprognostic (2.18e-3)" "unprognostic (7.01e-4)" 1.5 0.5 0.8 1.8 8.5 0.6 1.8 0.4 0.6 4.3 4.2 0.4 1.9 3.2 0.8 10.3 3.0 3.0 9.6 1.3 1.0 2.6 1.4 0.4 1.4 1.4 1.7 0.4 1.1 7.3 0.3 0.4 0.7 0.5 4.2 1.4 0.4 2.0 2.0 0.4 0.3 2.6 0.9 0.7 1.4 7.9 30.2 0.9 0.8 1.1 0.8 0.8 3.7 1.6 0.6 1.1 6.6 5.1 2.3 6.1 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.5 0.0 17.8 0.0 0.1 1.7 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 1.5 6.6 0.5 3.9 0.3 0.6 1.7 0.7 1.1 0.0 4.5 2.2 1.0 2.3 5.1 0.2 6.1 2.2 0.8 8.5 0.4 0.6 1.0 2.6 1.7 0.4 0.5 0.9 0.0 0.0 0.0 4.6 0.0 0.0 0.8 28.1 10.7 2.3 17.4 0.0 0.0 0.0 7.1 82.5 0.6 15.7 0.0 3.1 0.0 0.3 12.4 0.0 0.0 1.3 0.0 1.2 0.6 1.5 27.3 1.7 0.5 0.0 0.0 14.9 0.5 2.7 37.7 1.1 0.0 0.0 0.0 0.4 0.5 0.9 0.0 0.0 0.0 9.7 10.9 MMP1 CLG ENSG00000196611 "Matrix metallopeptidase 1" P03956 11 102789920-102798160 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation, Host-virus interaction" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 62.4;stomach 1: 27.2" "Cell type enriched" "Detected in some" 7 "Pancreatic endocrine cells: 1303.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 344.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7" HPA004920 Approved Vesicles "Secreted to extracellular matrix" NA NA 7730000 430000 Vesicles "HPA004920: AB_2667293" "unprognostic (4.11e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (4.20e-3)" "unprognostic (1.19e-3)" "unprognostic (6.46e-2)" "unprognostic (6.50e-2)" "prognostic unfavorable (4.22e-6)" "unprognostic (7.83e-3)" "unprognostic (2.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.86e-10)" "unprognostic (1.67e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-2)" "unprognostic (5.11e-2)" 0.2 0.1 0.3 12.3 0.3 0.0 0.9 0.3 0.3 0.3 2.7 0.3 0.2 3.2 4.8 0.2 3.3 0.1 62.4 0.4 0.2 0.1 0.7 1.3 4.7 0.2 0.2 0.2 0.2 1.6 0.0 0.2 8.6 0.5 0.7 3.0 0.3 2.0 0.2 0.2 0.3 8.8 0.2 0.4 1.8 27.2 2.2 0.2 0.4 0.3 1.3 0.9 11.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 90.2 36.9 9.6 0.7 0.0 0.0 0.4 21.6 14.2 0.3 0.0 12.6 89.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.9 3.2 0.0 234.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.1 30.6 0.0 1.3 0.1 0.0 0.0 0.0 0.7 0.0 115.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.3 0.3 0.3 0.2 0.1 0.2 0.2 0.5 0.2 3.0 1.6 0.0 14.4 2.1 0.0 0.0 35.7 0.0 23.9 3.5 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 184.0 0.0 0.2 5.4 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 7.2 0.0 0.0 1303.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 25.0 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770503-102780628 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "endometrium 1: 89.4" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 102.2" "Region enriched" "Detected in single" 9 "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2" "Not detected" "Not detected" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 765000 Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favorable (7.12e-4)" 0.1 0.1 0.0 2.6 0.2 0.1 0.1 0.0 0.3 1.7 0.5 0.0 0.0 0.4 89.4 0.1 0.2 0.1 0.5 0.1 0.0 0.1 0.1 3.6 11.0 0.1 0.0 0.0 0.5 0.3 0.1 0.9 19.8 2.8 3.2 0.2 0.0 2.9 0.1 0.1 0.1 0.7 0.1 0.0 0.2 3.3 0.5 0.0 1.2 0.1 0.0 1.9 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.2 12.6 0.7 0.1 0.1 0.3 0.0 0.0 3.7 1.9 0.2 2.9 0.0 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 0.0 16.2 0.0 0.7 0.0 0.0 0.0 0.0 0.3 3.0 0.5 1.7 0.0 0.0 0.0 0.0 0.7 5.2 0.0 2.5 0.0 0.0 0.9 0.0 0.0 2.0 3.9 1.3 0.4 0.5 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 38.9 0.7 0.0 0.0 0.0 5.3 70.5 27.9 0.0 0.0 0.0 9.8 5.0 0.0 0.0 0.0 12.9 0.0 0.2 5.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 2.8 0.0 0.0 62.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 7.4 MMP11 STMY3 ENSG00000099953 "Matrix metallopeptidase 11" P24347 22 23768226-23784316 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 44.1;placenta: 119.6" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 34.6;Syncytiotrophoblasts: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 7.8" "Group enriched" "Detected in many" 5 "B-cells: 2.4;dendritic cells: 7.8" "Cell line enhanced" "Detected in some" "AN3-CA: 18.7;hTERT-RPE1: 9.7;REH: 7.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002593, HPA068864" Approved "Secreted to extracellular matrix" NA NA "CAB002593: , HPA068864: AB_2686051" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (1.83e-1)" "unprognostic (1.84e-3)" "unprognostic (2.77e-2)" "unprognostic (6.73e-2)" "unprognostic (2.14e-2)" "unprognostic (5.15e-1)" "unprognostic (2.73e-2)" "unprognostic (2.20e-1)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.05e-2)" "unprognostic (6.78e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-2)" 1.7 0.6 0.2 1.0 0.6 0.1 1.6 1.0 0.5 13.4 1.8 0.4 0.4 1.9 44.1 1.1 0.8 2.2 2.0 3.1 0.5 0.0 1.7 0.5 0.7 1.8 0.4 0.2 7.7 1.1 0.2 0.3 119.6 0.5 1.4 1.0 0.8 2.5 0.4 0.5 2.0 4.0 2.7 0.3 0.9 0.7 3.4 0.2 2.6 0.5 0.6 0.9 1.6 2.1 2.4 7.8 0.0 0.0 0.0 1.0 0.1 0.1 0.0 2.3 18.7 2.8 4.2 0.0 0.2 5.0 0.6 0.4 0.0 0.6 0.6 3.5 1.3 0.9 0.1 1.0 0.0 0.2 0.0 0.3 0.0 0.0 1.0 2.1 0.0 0.0 2.7 0.4 0.5 0.0 9.7 2.9 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.6 0.5 0.1 7.8 0.0 0.2 0.3 0.0 2.9 5.0 1.9 0.3 0.0 3.0 1.7 0.0 1.3 0.3 0.0 0.7 0.0 0.1 0.0 2.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.4 1.0 0.3 0.0 0.0 0.0 7.8 0.0 0.1 0.2 0.6 1.0 0.5 0.5 0.0 0.4 0.2 0.5 0.2 0.0 4.5 0.8 0.8 0.9 0.4 4.3 2.5 1.4 0.0 0.0 0.0 0.3 1.7 5.9 6.6 0.2 0.0 0.0 0.6 34.6 5.7 0.4 1.1 0.0 0.7 0.0 1.7 1.3 0.0 8.0 0.6 0.0 1.7 0.0 0.8 0.5 1.6 0.0 0.4 2.2 0.6 0.0 2.0 1.1 2.7 0.5 15.6 0.0 0.8 0.3 MMP12 HME ENSG00000262406 "Matrix metallopeptidase 12" P39900 11 102862736-102875034 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 42.4;urinary bladder: 13.2" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 80.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BJ: 4.2;fHDF/TERT166: 14.6;hTEC/SVTERT24-B: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.74e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (1.42e-4)" "unprognostic (1.69e-2)" "unprognostic (7.31e-2)" "unprognostic (1.52e-2)" "unprognostic (1.52e-3)" "unprognostic (5.45e-2)" "unprognostic (3.05e-6)" "unprognostic (1.08e-2)" "unprognostic (4.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.92e-2)" 2.7 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.3 6.9 0.0 0.0 3.3 0.0 5.9 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.6 18.9 0.0 0.0 0.1 0.0 0.0 0.0 9.7 0.0 0.3 8.4 0.0 0.9 0.0 0.0 0.0 3.8 4.6 0.0 42.4 1.3 0.1 0.0 5.5 0.0 1.5 9.9 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.4 0.2 0.0 0.1 0.0 0.0 0.0 14.6 0.1 0.5 0.0 0.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 17.0 80.4 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 1.4 MMP13 CLG3 ENSG00000137745 "Matrix metallopeptidase 13" P45452 11 102942995-102955734 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 12.6;vagina: 10.8" "Group enriched" "Detected in some" 8 "Club cells: 30.7;Urothelial cells: 14.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 70.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HaCaT: 19.5;PC-3: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" CAB002742 Supported "Secreted to extracellular matrix" NA NA "CAB002742: " "unprognostic (8.98e-3)" "unprognostic (1.54e-1)" "unprognostic (4.75e-2)" "unprognostic (4.57e-2)" "unprognostic (3.05e-2)" "unprognostic (1.59e-3)" "unprognostic (1.32e-1)" "unprognostic (6.35e-3)" "unprognostic (1.69e-1)" "unprognostic (7.55e-3)" "unprognostic (2.24e-1)" "unprognostic (1.73e-8)" "unprognostic (2.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.14e-2)" "unprognostic (4.33e-2)" 0.5 0.1 0.0 0.8 0.0 1.3 0.4 0.0 0.2 1.3 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 12.6 0.1 0.0 0.0 0.1 0.0 0.0 3.1 0.1 0.1 1.2 0.0 0.0 0.6 0.0 0.0 1.0 0.5 0.0 0.0 0.1 0.1 1.9 0.0 1.4 0.0 0.0 0.1 4.6 10.8 1.0 0.7 2.7 0.5 1.9 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 19.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 7.4 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.6 1.3 0.4 1.0 0.5 0.7 0.8 0.3 1.0 0.6 1.1 1.9 1.9 0.3 0.7 0.4 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 2.7 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025566-58046901 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.2" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 56.0;Enterocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 30 "plasmacytoid DC: 2.9" "Lineage enriched" "Detected in single" 30 "dendritic cells: 2.9" "Cell line enhanced" "Detected in many" "BEWO: 37.1;Hep G2: 19.3;SK-BR-3: 18.6;WM-115: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 5.9 2.3 2.0 5.5 3.0 0.1 7.7 3.7 7.2 3.3 19.5 4.2 16.3 22.6 2.9 1.7 2.5 3.6 15.9 17.6 2.3 3.7 8.4 26.4 6.1 2.0 2.5 2.2 2.1 10.3 7.3 5.2 28.5 10.4 3.6 8.2 9.5 4.7 14.7 3.4 2.3 43.2 3.4 3.4 5.2 14.7 28.0 2.1 1.1 26.8 2.5 2.2 3.3 4.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 5.7 4.4 2.3 11.9 2.4 0.1 37.1 0.5 0.3 2.1 0.5 3.5 14.9 0.0 7.0 0.6 1.6 8.1 2.0 1.7 0.6 0.0 3.9 0.0 1.9 19.3 3.1 0.1 7.7 1.2 3.1 0.3 0.9 3.3 1.4 3.3 4.8 0.0 0.7 2.9 0.2 0.9 6.8 17.0 1.2 2.9 0.3 3.1 6.5 2.1 0.6 4.1 7.7 18.6 3.5 5.5 2.0 3.1 1.3 0.1 3.7 1.4 0.5 0.0 0.0 0.1 0.7 0.9 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 2.0 3.0 3.7 7.2 2.3 3.7 2.5 2.2 10.4 2.1 17.9 11.8 0.9 1.0 2.3 1.9 19.3 56.0 5.3 9.1 17.4 15.7 33.4 1.7 33.5 2.2 6.0 81.1 0.0 10.5 19.6 2.8 1.6 0.0 29.0 10.2 1.6 10.9 19.6 3.5 4.8 0.9 0.1 1.7 0.0 31.8 1.7 13.5 40.7 3.2 5.4 1.4 0.0 0.8 0.9 4.9 1.9 40.5 1.5 28.3 1.4 MMP16 "C8orf57, DKFZp761D112, MT3-MMP" ENSG00000156103 "Matrix metallopeptidase 16" P51512 8 88032009-88328025 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 3.9;Early spermatids: 4.9;Fibroblasts: 9.9;Late spermatids: 4.7" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;HUVEC TERT2: 8.8;SH-SY5Y: 11.4;U-138 MG: 9.7;WM-115: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023693 Uncertain Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA Cytosol Vesicles "HPA023693: AB_1854025" "unprognostic (2.58e-1)" "unprognostic (2.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.31e-2)" "unprognostic (2.39e-3)" "unprognostic (1.45e-3)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "unprognostic (9.42e-2)" "unprognostic (2.92e-1)" "unprognostic (2.09e-8)" "unprognostic (6.90e-3)" "unprognostic (1.16e-1)" "unprognostic (3.62e-1)" "unprognostic (2.19e-3)" 2.4 1.3 11.0 1.4 6.8 0.5 4.9 8.3 15.9 5.3 2.2 2.9 0.7 0.8 4.9 2.1 1.7 2.1 7.3 2.7 8.7 6.9 0.8 0.9 1.0 1.0 5.5 9.1 3.3 2.1 1.5 1.7 3.0 6.3 3.2 1.7 0.6 1.2 2.4 0.7 1.1 1.3 4.0 4.6 1.5 1.4 1.5 5.5 0.0 3.2 0.7 1.0 2.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 20.4 0.7 1.4 0.0 7.5 1.1 2.1 1.3 0.0 0.0 0.0 0.0 3.3 1.2 0.0 4.0 0.0 2.6 0.0 2.4 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.0 3.1 0.9 3.8 8.8 0.0 0.0 0.7 1.1 0.0 0.0 0.0 1.2 0.0 2.0 0.2 0.4 0.0 0.4 0.0 0.1 11.4 0.0 0.0 0.1 1.6 0.8 0.0 4.9 9.7 5.5 0.1 2.8 0.0 0.0 0.0 3.9 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 6.8 8.3 14.1 8.7 6.9 5.5 9.1 6.3 5.5 0.0 0.0 0.0 0.0 1.0 3.9 0.6 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 4.9 2.9 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.3 1.6 0.0 0.6 0.0 4.7 0.9 0.6 1.7 0.0 0.0 3.2 0.2 0.0 1.1 0.0 0.3 0.0 1.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 MMP17 MT4-MMP ENSG00000198598 "Matrix metallopeptidase 17" Q9ULZ9 12 131828393-131851783 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3" "Cell type enriched" "Detected in some" 7 "Melanocytes: 27.0" "Cancer enriched" "Detected in many" 10 "melanoma: 29.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 2.2;intermediate monocyte: 2.1;memory B-cell: 1.4;myeloid DC: 1.2;naive B-cell: 1.7;non-classical monocyte: 2.7" "Group enriched" "Detected in many" 9 "B-cells: 1.7;dendritic cells: 1.2;monocytes: 2.7" "Group enriched" "Detected in many" 4 "REH: 17.3;SK-MEL-30: 42.1;WM-115: 62.3" "Group enriched" "Detected in many" 5 "amygdala: 51.6;basal ganglia: 52.2;cerebral cortex: 70.8;hippocampal formation: 73.1;hypothalamus: 21.6" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (9.11e-2)" "unprognostic (1.27e-2)" "unprognostic (1.69e-2)" "unprognostic (3.71e-3)" "unprognostic (5.62e-2)" "unprognostic (1.85e-2)" "unprognostic (8.90e-3)" "unprognostic (2.14e-2)" "unprognostic (2.60e-1)" "unprognostic (2.66e-4)" "unprognostic (7.68e-2)" "unprognostic (5.88e-2)" "unprognostic (9.26e-10)" "unprognostic (1.15e-2)" "unprognostic (2.65e-1)" "unprognostic (1.21e-3)" "unprognostic (2.81e-2)" 4.6 2.0 12.6 3.0 23.3 6.2 2.5 1.4 21.5 5.6 3.0 3.1 0.0 1.4 4.2 0.9 2.1 2.1 7.0 1.1 22.5 10.1 0.5 0.5 1.8 5.5 3.7 7.6 9.0 5.0 3.1 0.7 1.1 2.2 1.6 0.8 1.6 8.5 2.5 1.6 9.7 1.9 1.7 1.6 4.8 1.4 2.9 3.5 0.0 0.8 1.5 1.6 2.8 2.8 1.7 1.2 0.2 2.7 0.1 0.0 1.1 0.1 5.3 0.2 0.5 4.3 1.7 0.1 2.7 6.7 2.6 2.7 0.0 1.5 0.0 2.2 4.2 1.6 2.3 2.2 2.5 0.5 0.0 0.3 0.9 1.9 0.0 5.3 0.0 3.8 2.6 0.7 3.7 0.9 1.0 3.5 0.0 1.0 0.1 3.3 4.7 0.1 4.0 2.4 1.6 3.2 17.3 0.0 2.0 0.0 0.0 2.3 0.7 0.3 0.9 42.1 0.7 4.9 10.0 2.7 0.7 0.7 3.8 0.3 0.0 0.0 0.0 1.4 0.5 62.3 0.1 2.2 0.0 0.0 2.1 0.0 1.4 0.0 0.0 1.2 1.7 0.0 0.0 0.2 0.1 2.7 0.0 0.0 1.1 12.6 23.3 1.4 17.9 22.5 10.1 3.7 7.6 2.2 3.5 0.0 0.0 0.0 0.1 2.3 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 1.0 0.2 0.0 0.0 0.6 3.2 0.0 1.3 4.0 0.0 0.9 0.4 27.0 0.0 0.0 0.2 0.0 0.0 1.8 0.3 0.0 0.0 1.0 0.5 0.4 1.0 0.0 0.0 0.0 0.1 MMP19 "MMP18, RASI-1" ENSG00000123342 "Matrix metallopeptidase 19" Q99542 12 55835433-55842966 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Angiogenesis, Collagen degradation, Differentiation" "Developmental protein, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.7" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 16 "classical monocyte: 3.2;myeloid DC: 1.0" "Group enriched" "Detected in many" 16 "dendritic cells: 1.0;monocytes: 3.2" "Cell line enriched" "Detected in many" 6 "BEWO: 57.2" "Region enriched" "Detected in single" 6 "olfactory region: 8.8" "Low region specificity" "Detected in all" HPA070804 Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 800000 "Endoplasmic reticulum, Vesicles" "HPA070804: AB_2686315" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (2.28e-2)" "unprognostic (2.42e-1)" "unprognostic (4.77e-3)" "unprognostic (4.77e-3)" "unprognostic (2.01e-2)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (8.56e-9)" "unprognostic (5.06e-3)" "unprognostic (1.28e-3)" "unprognostic (2.73e-2)" "unprognostic (4.00e-2)" 60.7 1.9 0.2 10.9 0.7 0.0 9.9 0.2 0.5 7.6 3.9 0.4 1.4 0.8 12.7 6.0 3.6 11.8 30.3 4.7 0.6 0.1 4.1 3.0 14.0 15.5 0.5 0.2 7.4 8.1 0.0 0.5 24.5 1.0 2.9 2.8 3.1 2.0 3.5 2.1 2.7 4.1 7.7 0.8 27.4 5.0 2.9 0.2 2.7 3.3 1.8 7.1 5.9 3.5 0.0 1.0 0.1 3.2 0.0 0.0 0.6 0.8 0.0 0.0 0.0 6.3 8.1 57.2 6.0 7.1 2.5 2.9 0.3 0.2 0.0 0.0 8.4 0.1 0.0 0.0 1.8 3.4 0.3 0.0 0.0 0.0 0.1 5.2 0.0 0.2 8.4 0.2 1.5 1.6 3.0 0.4 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 1.1 2.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 9.7 1.5 3.3 0.0 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.7 0.2 0.5 0.6 0.1 0.5 0.2 1.0 0.2 0.0 5.8 0.9 0.2 6.4 0.5 0.6 5.1 2.7 5.7 0.0 3.9 14.4 0.0 0.3 0.4 2.1 0.0 0.0 0.4 42.0 24.0 0.4 2.3 0.5 31.2 0.0 0.0 4.9 30.5 0.4 5.5 48.2 11.8 38.7 0.0 0.3 0.1 0.0 4.9 0.0 1.7 0.0 9.6 0.0 0.2 3.8 15.7 0.0 0.0 0.1 MMP20 ENSG00000137674 "Matrix metallopeptidase 20" O60882 11 102576835-102625332 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Amelogenesis imperfecta, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.0;testis: 3.5" "Cell type enriched" "Detected in some" 10 "Early spermatids: 66.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (4.62e-3)" "unprognostic (2.61e-2)" "unprognostic (1.68e-3)" "unprognostic (1.75e-1)" "unprognostic (2.13e-1)" "unprognostic (3.06e-1)" "unprognostic (2.97e-2)" "unprognostic (6.75e-2)" "unprognostic (9.58e-5)" "unprognostic (6.10e-2)" "unprognostic (2.35e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.5 MMP21 ENSG00000154485 "Matrix metallopeptidase 21" Q8N119 10 125766453-125775821 "Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets, Heterotaxy" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "epididymis: 37.6" "Cell type enhanced" "Detected in single" 32 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.8" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (1.32e-2)" "unprognostic (1.28e-1)" "unprognostic (8.51e-2)" "unprognostic (2.19e-2)" "unprognostic (4.02e-2)" "unprognostic (2.21e-2)" "unprognostic (4.22e-3)" "unprognostic (1.01e-1)" "unprognostic (2.12e-1)" "unprognostic (1.48e-1)" "unprognostic (2.89e-2)" "unprognostic (3.62e-2)" "unprognostic (9.70e-8)" "unprognostic (1.30e-2)" "unprognostic (7.69e-2)" "unprognostic (7.00e-2)" "unprognostic (2.18e-1)" 0.2 0.1 0.1 0.1 0.4 0.1 0.3 0.7 0.0 0.1 0.2 0.1 0.1 37.6 0.1 0.4 0.2 0.9 0.0 0.4 0.1 1.0 0.1 0.1 0.0 2.8 0.8 0.0 0.3 0.0 0.6 0.1 0.5 0.1 0.0 0.1 0.5 0.1 0.0 0.7 0.2 0.1 0.6 0.1 0.2 0.0 1.1 0.0 0.0 0.1 0.5 0.6 0.0 0.1 0.0 0.0 0.8 0.3 0.0 1.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.5 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.7 0.0 2.1 1.8 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.6 0.0 0.0 1.1 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMP23B "MIFR, MIFR-1, MMP22" ENSG00000189409 "Matrix metallopeptidase 23B" O75900 1 1632095-1635263 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 51.8" "Group enriched" "Detected in many" 6 "Fibroblasts: 124.0;Leydig cells: 90.9;Peritubular cells: 167.3" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 12.3" "Lineage enriched" "Detected in many" 5 "dendritic cells: 12.3" "Cell line enhanced" "Detected in some" "AN3-CA: 3.4;HHSteC: 8.3;NTERA-2: 3.6;PC-3: 3.6;U-266/70: 6.5" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Not detected" "Not detected" NA NA "unprognostic (2.19e-2)" "unprognostic (6.31e-2)" "unprognostic (6.70e-3)" "unprognostic (1.29e-1)" "unprognostic (3.99e-2)" "unprognostic (9.31e-2)" "unprognostic (6.94e-2)" "unprognostic (1.20e-1)" "unprognostic (8.06e-2)" "unprognostic (8.37e-2)" "unprognostic (2.22e-1)" "unprognostic (2.33e-1)" "unprognostic (2.26e-11)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-2)" "unprognostic (6.66e-2)" 4.7 2.4 0.3 3.9 0.3 2.1 2.3 0.5 0.4 19.6 3.2 0.1 4.2 3.9 17.3 20.1 4.7 6.4 28.5 14.4 0.2 0.3 3.6 2.3 11.0 3.3 0.1 0.0 51.8 0.7 0.0 3.1 10.5 0.1 32.1 0.2 1.2 1.4 6.3 0.9 2.5 2.7 11.7 0.2 4.1 4.3 13.5 0.0 0.4 1.2 0.9 2.8 13.9 7.0 0.2 12.3 0.1 0.2 2.2 1.8 1.3 1.0 0.0 0.3 3.4 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.7 1.0 0.2 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.7 2.6 1.0 0.3 2.2 8.3 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.3 0.0 0.9 0.0 0.6 3.6 0.0 3.6 1.3 0.1 1.6 0.0 0.1 0.6 0.2 0.5 0.0 0.2 0.1 1.0 0.0 0.7 0.5 0.3 0.7 0.0 6.5 0.3 1.1 0.1 0.4 0.3 0.0 0.2 0.0 1.8 0.0 1.1 0.0 0.4 1.1 0.0 0.2 0.1 0.9 0.1 2.2 0.1 12.3 0.2 1.3 0.3 0.3 0.5 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.9 11.8 1.1 9.0 2.5 0.0 0.0 1.8 0.0 2.7 0.0 0.8 0.8 1.5 1.7 0.0 0.5 1.6 124.0 0.4 0.0 1.0 5.1 3.2 2.9 20.9 1.5 3.2 90.9 1.0 18.6 1.0 1.7 0.8 3.4 0.0 167.3 0.6 5.7 0.0 8.2 1.6 10.7 13.8 8.6 9.2 1.2 0.7 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MMP25 "MMP20, MMPL1, MT6-MMP" ENSG00000008516 "Matrix metallopeptidase 25" Q9NPA2 16 3046681-3060726 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 10.7;Kupffer cells: 5.9;monocytes: 23.4" "Cancer enhanced" "Detected in many" "testis cancer: 7.1" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 6 "basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 17.6" "Cell line enriched" "Detected in some" 12 "HMC-1: 50.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB025177, HPA055640" Uncertain Supported "Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" "CAB025177: , HPA055640: " "unprognostic (4.51e-3)" "unprognostic (9.28e-3)" "unprognostic (7.57e-2)" "unprognostic (2.95e-3)" "unprognostic (2.26e-1)" "prognostic favorable (1.09e-5)" "unprognostic (1.36e-1)" "unprognostic (7.39e-3)" "unprognostic (7.63e-3)" "unprognostic (2.29e-2)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (2.37e-3)" "unprognostic (1.17e-2)" "unprognostic (8.30e-2)" "unprognostic (4.01e-1)" "unprognostic (2.02e-1)" 4.0 0.3 0.6 12.3 0.4 25.6 0.8 0.5 0.6 0.8 1.1 0.2 0.0 1.0 0.4 0.5 0.8 3.8 1.1 2.8 0.5 0.4 0.7 2.5 10.7 54.1 1.8 0.0 0.6 0.8 0.0 0.5 2.0 1.1 0.6 1.0 1.0 0.9 0.0 2.4 0.6 1.8 0.5 0.4 43.9 1.1 0.7 0.5 4.1 0.7 0.9 4.2 1.5 2.5 0.0 0.3 17.6 0.2 1.7 0.5 0.1 0.2 0.1 0.7 1.5 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.3 0.6 0.3 0.0 0.0 4.0 0.8 0.1 0.1 0.0 0.0 0.1 50.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.5 0.2 3.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.3 3.6 0.1 0.1 0.4 0.1 0.0 1.2 0.1 0.1 0.0 1.0 0.1 10.2 0.2 6.0 0.3 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.3 0.2 17.6 1.7 0.0 0.3 0.3 0.1 0.6 0.4 0.5 0.6 0.5 0.4 1.8 0.0 1.1 0.5 3.0 10.7 0.0 0.2 0.3 0.6 0.4 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.1 0.2 0.5 1.1 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.0 2.0 0.0 23.4 0.0 0.1 1.1 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 3.1 0.1 0.1 MMP26 "endometase, MGC126590, MGC126592" ENSG00000167346 "Matrix metallopeptidase 26" Q9NRE1 11 4704927-4992429 "Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "endometrium 1: 19.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "endometrial cancer: 8.8;prostate cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (4.21e-3)" "unprognostic (2.63e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMP27 ENSG00000137675 "Matrix metallopeptidase 27" Q9H306 11 102691487-102705806 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 10.4;tongue: 10.0" "Cell type enriched" "Detected in single" 5 "Suprabasal keratinocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA069097 Approved "Intracellular and membrane" NA NA "HPA069097: AB_2686085" "unprognostic (3.99e-2)" "unprognostic (2.37e-4)" "unprognostic (1.25e-3)" "unprognostic (1.63e-1)" "unprognostic (4.60e-1)" 3.2 0.0 0.0 0.0 0.5 2.4 10.4 0.0 0.0 1.5 0.8 0.0 0.0 0.3 0.9 4.7 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 5.1 0.0 0.8 5.4 2.6 2.0 0.0 0.1 0.4 0.4 0.0 0.9 0.1 10.0 2.2 0.4 0.3 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 MMP3 "STMY, STMY1" ENSG00000149968 "Matrix metallopeptidase 3" P08254 11 102835801-102843803 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 177.5;salivary gland: 73.4" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 11.5;Basal keratinocytes: 7.4;Club cells: 11.4;Early spermatids: 14.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 59.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BJ: 101.3;BJ hTERT+: 275.6;fHDF/TERT166: 119.3" "Low region specificity" "Detected in many" HPA007875 Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA 2540000 170000 Vesicles "HPA007875: AB_1079396" "unprognostic (2.27e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.63e-3)" "unprognostic (5.11e-3)" "unprognostic (3.78e-1)" "unprognostic (5.11e-2)" "unprognostic (5.26e-6)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (3.26e-2)" "unprognostic (1.22e-15)" "unprognostic (3.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (2.34e-1)" 19.1 0.0 0.2 14.4 0.3 0.0 6.9 0.2 0.5 0.2 1.5 0.3 0.2 1.8 28.3 177.5 0.2 0.0 1.4 0.2 0.2 0.0 0.3 0.5 0.4 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 1.2 1.7 0.2 73.4 1.5 7.3 12.6 0.7 5.9 0.2 0.2 2.8 1.4 0.2 0.2 0.6 1.5 0.9 7.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 275.6 1.8 0.5 0.0 0.0 0.0 0.0 119.3 6.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.8 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.0 0.0 11.5 7.4 0.0 0.2 5.1 0.0 11.4 0.0 0.0 0.1 0.0 0.7 14.6 0.0 0.0 0.0 1.2 2.2 1.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.9 3.0 0.2 0.0 0.1 5.2 MMP7 "MPSL1, PUMP-1" ENSG00000137673 "Matrix metallopeptidase 7" P09237 11 102520508-102530753 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3" "Cell type enriched" "Detected in many" 6 "Ductal cells: 5335.6" "Cancer enhanced" "Detected in all" "pancreatic cancer: 352.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025869, HPA051358" Supported Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA 2810000 "Nucleoplasm, Vesicles" "CAB025869: , HPA051358: AB_2681452" "unprognostic (1.06e-3)" "unprognostic (9.51e-2)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (7.70e-3)" "unprognostic (7.28e-2)" "prognostic unfavorable (2.53e-4)" "prognostic unfavorable (3.38e-4)" "unprognostic (3.96e-2)" "unprognostic (5.63e-2)" "unprognostic (6.59e-3)" "unprognostic (1.51e-1)" "unprognostic (6.36e-3)" "unprognostic (1.42e-2)" "unprognostic (5.54e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" 6.8 0.2 0.2 1.2 0.2 0.0 28.8 0.2 0.2 5.2 0.2 0.2 2.1 0.0 17.2 12.3 3.3 16.4 93.0 0.2 0.2 0.2 129.5 1.4 5.0 0.9 0.2 0.2 3.9 23.5 0.0 0.7 2.7 1.3 42.0 0.0 0.2 79.3 6.7 0.2 7.8 0.3 0.5 0.2 0.2 0.9 9.4 0.2 1.2 0.3 1.4 4.5 19.9 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 129.5 0.0 30.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 56.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 80.4 30.5 0.0 310.5 0.9 0.0 0.6 119.8 113.8 646.0 964.8 0.0 0.3 0.0 5335.6 3.9 0.3 0.0 0.0 184.1 0.2 0.4 323.2 2.3 0.0 103.8 0.0 0.0 0.0 0.0 6.5 10.9 7.3 0.0 113.6 0.0 0.0 723.2 0.0 0.0 6.0 0.0 0.0 0.4 0.0 0.1 2.0 0.7 0.0 0.0 640.3 MMP8 CLG1 ENSG00000118113 "Matrix metallopeptidase 8" P22894 11 102711795-102727050 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "bone marrow: 119.3" "Cell type enriched" "Detected in single" 32 "Hofbauer cells: 4.3" "Cancer enriched" "Detected in single" 17 "melanoma: 5.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.7" "Group enriched" "Detected in some" 32 "neutrophil: 1.4;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 32 "granulocytes: 1.4;monocytes: 4.9" "Cell line enriched" "Detected in some" 8 "WM-115: 40.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021221, HPA022935" Enhanced "Secreted to extracellular matrix" NA NA 83000 "HPA021221: AB_1854043, HPA022935: AB_1854044" "unprognostic (3.03e-1)" "unprognostic (8.49e-5)" "unprognostic (1.08e-2)" "unprognostic (3.95e-3)" "unprognostic (1.80e-1)" "unprognostic (1.01e-2)" "unprognostic (7.68e-3)" "unprognostic (1.27e-1)" "unprognostic (4.92e-2)" "unprognostic (6.64e-3)" "unprognostic (2.45e-6)" "unprognostic (2.33e-4)" "unprognostic (1.33e-1)" "unprognostic (4.97e-1)" "unprognostic (2.30e-2)" 1.9 0.1 0.2 0.2 0.4 119.3 0.3 0.1 1.7 0.1 0.2 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.1 9.0 0.2 0.3 0.4 0.8 12.6 2.6 0.3 0.0 0.9 0.9 0.1 0.6 1.4 0.2 0.1 0.1 0.1 0.3 0.1 0.6 0.3 0.1 0.2 0.3 18.7 0.2 0.1 0.1 5.2 1.9 0.0 0.1 0.2 7.6 0.0 0.0 1.4 4.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.9 0.0 0.0 1.7 0.2 0.4 0.1 1.7 0.2 0.3 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MMP9 CLG4B ENSG00000100985 "Matrix metallopeptidase 9" P14780 20 46008908-46016561 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1" "Cell type enhanced" "Detected in many" 25 "Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 141 "neutrophil: 63.2" "Lineage enriched" "Detected in single" 339 "granulocytes: 63.2" "Cell line enriched" "Detected in some" 12 "NB-4: 89.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201" Enhanced Approved Cytosol "Secreted to blood" NA NA 43300000 57000000 Cytosol "CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150" "unprognostic (4.62e-2)" "unprognostic (1.64e-1)" "unprognostic (2.85e-2)" "prognostic favorable (2.55e-4)" "unprognostic (6.65e-3)" "unprognostic (2.82e-1)" "prognostic unfavorable (7.19e-4)" "unprognostic (1.54e-1)" "unprognostic (8.57e-2)" "unprognostic (3.21e-2)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.05e-5)" "unprognostic (4.65e-1)" "unprognostic (9.85e-3)" "unprognostic (2.48e-2)" "unprognostic (2.17e-3)" 64.0 0.5 0.6 38.6 0.7 89.4 4.3 0.4 0.6 0.8 1.2 0.1 0.0 2.8 0.6 0.2 0.9 1.5 0.6 4.0 0.5 0.6 1.4 2.0 13.3 80.1 0.6 0.0 2.7 1.4 0.0 0.8 2.6 0.5 0.6 0.8 0.5 12.5 0.0 1.3 1.3 4.2 0.3 0.5 53.7 2.5 2.7 0.0 23.6 1.3 2.3 44.5 4.5 2.9 0.0 0.0 63.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 7.5 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 89.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 1.0 0.0 0.3 0.0 2.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.2 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.6 0.5 0.6 0.6 0.0 0.5 0.0 0.0 8.5 0.0 0.0 30.5 1.6 0.4 0.0 0.0 0.0 0.0 7.9 0.9 0.0 0.8 0.6 0.5 0.0 0.0 1.5 2.0 1.7 0.1 1.1 0.0 273.8 3.2 0.0 0.0 1.9 0.0 0.0 115.1 54.0 3.6 0.0 0.5 1.6 0.0 0.0 0.3 4.3 0.0 12.3 5.4 5.5 24.6 1.6 0.0 0.0 0.0 MMS22L "C6orf167, dJ39B17.2" ENSG00000146263 "MMS22 like, DNA repair protein" Q6ZRQ5 6 97142161-97283217 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 21.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 39.3;Early spermatids: 45.4;Spermatocytes: 34.8;Spermatogonia: 44.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067042 Supported Nucleoplasm NA NA Nucleoplasm "HPA067042: AB_2685768" "unprognostic (3.61e-2)" "unprognostic (2.80e-1)" "unprognostic (2.26e-2)" "unprognostic (1.97e-3)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.00e-5)" "unprognostic (9.63e-2)" "unprognostic (5.81e-3)" "unprognostic (8.21e-3)" "unprognostic (9.39e-2)" "unprognostic (6.58e-2)" "unprognostic (1.34e-6)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" 3.1 3.3 3.0 8.0 4.6 12.7 7.1 2.0 3.2 4.2 3.4 5.5 3.6 2.7 5.2 2.8 4.9 3.1 3.0 3.7 3.6 3.3 2.7 2.1 6.0 11.0 5.1 1.8 3.7 3.2 5.0 4.3 4.1 4.0 4.6 5.0 4.6 3.9 3.5 1.6 5.9 5.1 3.9 8.1 4.5 2.8 13.1 3.1 21.4 2.5 4.0 6.8 3.5 4.0 3.0 4.1 3.1 4.8 2.1 3.9 1.4 4.9 5.6 9.4 10.2 1.5 2.9 7.4 10.2 4.7 9.7 14.2 7.7 5.9 11.0 6.3 3.8 11.2 9.1 11.8 5.6 19.3 9.4 8.8 11.1 8.1 4.8 0.9 17.0 7.9 1.5 3.0 13.6 6.3 2.0 4.1 10.4 15.1 17.7 9.0 5.9 6.2 6.9 3.6 8.1 4.2 10.5 8.9 3.9 4.1 6.6 5.3 4.6 6.7 3.4 2.8 5.5 5.2 10.5 3.1 9.8 9.4 8.1 13.9 2.2 6.6 12.4 5.6 10.8 10.8 1.6 1.5 3.1 2.4 2.4 3.6 1.8 3.2 3.5 3.6 3.0 3.0 3.9 1.5 2.1 4.8 4.1 2.8 1.4 3.0 4.6 2.0 3.2 3.6 3.3 5.1 1.8 4.0 3.1 3.0 7.5 10.7 4.6 8.1 10.7 3.6 5.1 4.0 9.1 3.5 39.3 7.5 1.7 2.3 45.4 5.3 2.6 0.0 3.6 9.4 6.4 2.3 7.0 2.6 5.3 3.2 1.2 11.1 8.7 11.8 9.2 5.2 6.8 1.8 7.5 6.9 2.1 0.0 5.3 0.3 29.7 6.5 3.1 34.8 44.9 7.2 3.0 12.1 7.0 1.8 MN1 "MGCR, MGCR1, MGCR1-PEN" ENSG00000169184 "MN1 proto-oncogene, transcriptional regulator" Q10571 22 27748277-27801498 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Developmental protein" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 62.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 9.8;Early spermatids: 22.6;Fibroblasts: 10.0;Late spermatids: 12.6;Peritubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 8 "monocytes: 1.7" "Cell line enhanced" "Detected in some" "AF22: 22.1;HeLa: 8.9;hTERT-RPE1: 9.9;RH-30: 8.9;TIME: 14.0;U-2 OS: 12.1;U-2197: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003072 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003072: AB_1079399" "unprognostic (5.64e-2)" "unprognostic (2.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (2.88e-2)" "unprognostic (2.52e-2)" "unprognostic (7.01e-2)" "unprognostic (3.03e-2)" "unprognostic (4.17e-2)" "unprognostic (1.64e-1)" "unprognostic (4.00e-2)" "unprognostic (7.33e-2)" "unprognostic (5.13e-7)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (5.28e-3)" "unprognostic (2.21e-4)" 3.7 2.0 3.4 4.2 17.3 2.4 1.9 1.3 5.6 5.9 4.2 2.6 2.5 2.1 3.0 9.0 7.0 3.4 11.1 5.1 2.5 2.7 1.6 1.4 4.3 1.3 3.3 3.5 12.4 1.5 1.3 2.3 2.6 4.5 3.1 2.2 10.8 2.1 2.7 62.7 2.9 2.1 5.8 1.0 1.5 3.5 2.0 5.4 0.0 1.8 14.8 2.1 5.0 4.7 0.0 0.2 0.0 1.7 0.0 0.1 0.0 0.0 1.0 22.1 0.6 0.4 0.9 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 2.2 3.9 0.9 1.8 1.1 1.3 0.0 0.0 0.6 0.0 8.9 0.0 0.5 0.0 0.2 0.0 2.5 0.5 2.2 9.9 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.2 2.9 0.0 2.0 3.6 8.9 0.0 0.3 0.0 0.0 0.3 1.9 0.0 0.0 5.6 0.2 0.0 14.0 0.7 12.1 12.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 3.4 17.3 1.3 4.2 2.5 2.7 3.3 3.5 4.5 5.4 3.0 2.9 0.5 0.1 3.8 9.8 3.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 22.6 4.1 0.0 0.0 0.9 0.1 10.0 0.1 0.0 0.4 0.2 0.0 0.0 0.6 0.3 12.6 4.6 0.7 0.0 0.0 0.0 4.3 1.7 0.0 9.6 0.0 0.6 0.0 2.1 0.5 0.9 2.4 0.0 0.0 0.0 0.1 MND1 GAJ ENSG00000121211 "Meiotic nuclear divisions 1" Q9BWT6 4 153344649-153415118 "Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.5;testis: 15.7" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 46.7;Spermatocytes: 52.9;Spermatogonia: 77.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.5;T-reg: 4.4" "Group enriched" "Detected in many" 5 "dendritic cells: 3.5;NK-cells: 1.2;T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA043499 Enhanced NA NA "HPA043499: AB_2732506" "unprognostic (2.21e-2)" "unprognostic (6.46e-3)" "unprognostic (9.79e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (2.72e-4)" "unprognostic (6.21e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (5.28e-2)" "unprognostic (1.28e-2)" "unprognostic (9.43e-2)" "unprognostic (2.71e-8)" "unprognostic (7.65e-2)" "unprognostic (5.70e-2)" "unprognostic (9.84e-2)" "unprognostic (7.64e-2)" 0.8 0.9 1.5 10.5 1.4 9.4 3.0 0.9 1.3 1.0 3.6 0.4 0.3 2.5 1.2 1.0 5.3 0.3 0.9 1.1 1.8 1.7 1.0 0.9 1.2 9.5 1.8 0.6 1.0 2.0 0.0 0.7 3.7 0.8 0.9 4.4 0.3 1.4 0.6 1.5 1.5 2.3 1.3 1.9 4.0 1.7 15.7 0.3 28.5 0.7 4.2 11.1 1.4 1.7 0.6 3.5 0.0 0.0 1.2 4.4 0.6 11.6 5.4 17.8 10.1 0.2 2.4 6.5 11.1 4.7 9.9 8.1 10.4 8.6 22.7 2.2 2.8 9.4 4.8 18.0 5.0 12.8 14.6 6.7 12.2 5.3 12.7 0.4 26.8 6.1 0.7 1.1 7.7 6.7 2.5 3.3 26.8 21.2 29.8 8.2 6.4 37.7 34.8 12.3 5.7 5.6 23.7 6.1 10.9 6.6 2.9 8.6 7.8 5.0 5.7 9.1 9.1 4.5 21.9 0.8 7.8 11.4 8.8 10.5 25.1 29.0 18.8 7.8 21.4 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.6 1.6 0.1 3.5 0.1 1.4 0.1 0.0 1.2 0.0 0.3 4.4 0.6 1.5 1.4 0.9 1.3 1.8 1.7 1.8 0.6 0.8 0.3 0.0 0.3 0.0 0.8 2.5 0.0 0.6 5.1 1.4 0.0 0.0 0.0 3.4 1.7 0.4 16.4 0.2 0.5 46.7 0.5 16.2 1.6 0.5 0.0 0.8 10.0 0.0 0.0 1.8 2.2 13.3 0.9 1.1 3.3 0.0 1.7 0.0 0.5 0.9 2.1 0.0 0.0 6.5 0.7 52.9 77.3 1.3 2.1 1.3 6.8 1.8 MNDA PYHIN3 ENSG00000163563 "Myeloid cell nuclear differentiation antigen" P41218 1 158831317-158849506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 289.8;bone marrow: 83.3" "Group enriched" "Detected in many" 4 "Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 289.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 289.8" "Group enriched" "Detected in some" 15 "NB-4: 36.7;THP-1: 69.4;U-937: 45.4" "Low region specificity" "Detected in all" "HPA034532, HPA073215" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol" NA NA 110000 Nucleoplasm "Nucleoli, Nucleoli rim, Vesicles, Cytosol" "HPA034532: AB_10669677, HPA073215: AB_2686582" "unprognostic (1.53e-2)" "unprognostic (7.84e-3)" "unprognostic (2.45e-2)" "unprognostic (1.03e-1)" "unprognostic (1.42e-1)" "unprognostic (1.41e-2)" "unprognostic (2.02e-2)" "unprognostic (7.99e-3)" "unprognostic (1.58e-2)" "unprognostic (1.46e-1)" "unprognostic (1.65e-1)" "unprognostic (9.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-2)" "unprognostic (2.81e-2)" "unprognostic (1.02e-1)" 17.6 6.3 5.4 24.4 7.9 83.3 3.0 1.4 5.8 2.1 2.1 3.2 0.2 1.1 1.7 3.4 2.3 4.7 8.4 6.3 4.9 3.2 3.9 4.2 31.3 32.2 10.7 2.6 3.4 2.4 1.1 2.2 9.9 6.8 2.6 2.5 5.0 3.6 1.2 2.0 1.9 3.6 6.2 18.6 57.3 2.6 4.0 6.3 5.5 2.1 1.4 4.2 9.1 4.9 1.6 29.7 289.8 60.9 0.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 7.1 60.9 11.1 0.1 25.4 0.1 1.6 0.0 0.1 29.7 0.6 0.0 0.0 289.8 0.1 12.0 0.4 0.0 40.2 5.4 7.9 1.4 5.8 4.9 3.2 10.7 2.6 6.8 6.3 32.8 82.3 20.5 0.0 2.2 0.6 0.7 10.2 14.7 17.0 0.0 0.0 0.8 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.9 2.3 0.0 40.7 1.3 203.8 0.0 0.0 6.2 493.3 0.9 1.1 520.9 1.7 25.2 0.0 130.5 0.0 0.0 0.0 1.1 4.7 12.9 9.2 0.3 0.2 1.9 0.8 1.0 0.0 0.0 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;testis: 36.4" "Group enriched" "Detected in many" 5 "Ciliated cells: 285.0;Early spermatids: 279.9;Spermatocytes: 128.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.6 1.4 3.2 2.7 4.9 3.2 2.6 35.2 6.7 4.3 2.0 2.1 0.6 2.0 3.2 5.4 2.4 17.6 2.9 2.1 4.1 4.0 7.9 1.8 2.9 1.2 2.1 4.9 4.0 2.1 0.8 10.7 1.4 11.4 3.8 1.9 1.1 1.8 1.7 1.2 1.3 1.8 1.9 3.2 1.3 1.9 36.4 2.4 3.3 2.6 1.4 1.1 1.6 2.2 0.1 0.8 0.0 0.4 0.0 0.0 0.0 19.2 4.5 2.4 7.1 2.0 4.3 0.4 4.7 2.7 5.6 11.9 6.4 9.3 10.8 6.0 2.0 8.1 7.6 2.9 2.7 11.4 0.0 1.2 13.9 5.0 1.1 0.7 4.7 1.5 1.7 0.1 11.3 1.6 2.3 1.0 4.2 3.1 0.0 4.7 2.5 0.1 5.9 0.7 10.0 2.7 9.0 14.2 0.1 5.4 3.8 18.7 5.7 7.8 2.4 8.2 0.6 5.7 7.3 0.4 7.6 8.7 7.3 11.4 2.2 7.1 0.2 8.5 11.2 8.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 3.2 4.9 35.2 6.7 4.1 4.0 2.1 4.9 11.4 2.4 0.0 6.6 0.8 7.2 3.0 9.7 5.2 5.1 285.0 42.1 33.2 23.6 0.5 10.0 7.1 279.9 1.4 0.0 0.0 1.7 3.1 10.3 2.0 0.0 0.0 5.6 14.3 1.2 7.4 1.0 16.7 11.8 3.0 0.0 1.0 0.7 12.0 1.2 0.0 8.1 9.1 31.9 0.0 3.6 128.6 20.6 1.3 0.5 0.0 3.7 0.9 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell type enhanced" "Detected in some" 15 "Intestinal endocrine cells: 24.1;Mucus-secreting cells: 18.0;Paneth cells: 9.0;Undifferentiated cells: 12.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 11.8;BEWO: 8.8;EFO-21: 11.3;HEK 293: 9.0;RPMI-8226: 24.7;SCLC-21H: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol No NA Nucleoplasm "Nucleoli, Cytosol" "HPA071717: AB_2686437" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 3.9 0.0 11.8 0.0 0.0 8.8 0.0 0.0 0.1 0.0 5.1 1.7 0.9 11.3 0.0 0.3 0.2 2.0 1.6 0.9 1.4 9.0 0.0 0.8 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 1.9 0.0 6.6 0.6 0.1 0.0 1.1 0.7 0.0 1.7 24.7 4.4 0.4 13.3 0.0 1.7 1.5 0.2 0.1 3.7 2.9 0.0 0.0 0.0 0.0 0.0 3.7 1.9 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.7 0.0 4.3 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 24.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 18.0 0.0 2.5 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.4 0.0 MOAP1 "MAP-1, PNMA4" ENSG00000165943 "Modulator of apoptosis 1" Q96BY2 14 93182196-93184928 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000939, HPA076948" Enhanced Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA000939: AB_1079402, HPA076948: " "unprognostic (9.40e-3)" "unprognostic (1.26e-1)" "unprognostic (1.57e-1)" "unprognostic (7.52e-2)" "unprognostic (1.21e-1)" "unprognostic (8.75e-2)" "unprognostic (1.01e-1)" "prognostic favorable (7.37e-9)" "unprognostic (1.98e-1)" "unprognostic (6.52e-2)" "unprognostic (1.05e-3)" "unprognostic (1.58e-2)" "prognostic favorable (3.15e-6)" "unprognostic (6.93e-2)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 6.9 14.5 21.9 5.7 30.0 15.9 8.6 30.5 69.5 12.8 10.1 7.1 7.7 7.1 9.3 12.0 8.0 11.1 8.2 23.9 24.2 35.9 14.2 9.0 9.7 7.9 22.9 27.8 8.6 9.0 25.0 12.0 7.1 27.8 15.0 7.4 10.1 8.2 14.9 13.9 5.2 7.0 10.1 11.2 7.8 8.3 4.4 7.8 5.9 10.6 3.6 7.5 8.4 3.8 6.3 4.2 16.4 4.4 8.8 14.3 7.5 3.8 3.0 7.3 9.8 6.3 2.4 4.9 4.5 5.2 4.7 5.3 3.2 3.8 11.6 8.3 5.2 3.3 6.0 5.2 4.5 5.2 5.3 6.6 6.5 6.1 4.3 8.2 5.8 11.8 4.3 6.8 2.8 5.7 11.2 5.7 14.1 2.3 7.1 5.3 15.9 9.1 5.5 3.4 7.7 3.9 5.6 9.9 7.0 11.9 10.9 16.9 14.6 4.6 6.5 18.4 6.1 10.0 4.3 6.2 1.8 2.9 4.2 2.2 13.4 13.7 7.0 4.8 3.7 3.2 16.4 4.0 10.3 11.3 4.4 12.6 6.0 10.5 11.5 4.2 6.3 14.3 12.2 3.7 8.8 4.4 4.0 9.8 7.5 21.9 30.0 30.5 69.5 24.2 35.9 22.9 27.8 27.8 7.8 29.8 27.2 31.3 16.6 14.3 94.0 64.3 12.7 6.7 12.5 19.2 47.1 23.2 34.9 26.8 3.8 15.8 10.7 0.0 13.3 4.8 12.5 23.4 26.6 6.4 14.5 79.4 46.6 11.6 10.8 0.9 16.4 10.1 11.8 18.0 18.8 76.4 16.9 10.2 25.8 13.9 85.3 19.4 26.1 9.6 21.3 13.6 39.9 31.9 13.1 18.6 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favorable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.5 16.6 8.7 11.0 16.1 21.2 16.8 9.7 19.2 10.3 8.5 25.9 13.2 17.1 14.5 24.7 13.0 13.8 21.7 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.3 17.1 22.5 13.4 12.6 10.7 10.7 9.9 13.2 17.4 11.6 26.7 14.2 9.6 9.6 10.7 17.7 13.3 17.6 18.7 13.7 17.1 13.2 12.5 7.9 10.2 18.5 13.0 6.6 4.2 6.9 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 6.0 7.7 13.7 25.1 73.0 17.7 11.3 12.7 6.7 5.7 7.0 11.8 26.7 23.2 29.5 22.2 55.0 43.9 70.0 33.6 25.8 27.0 36.5 25.3 7.4 23.5 41.3 20.1 25.8 15.2 9.0 22.2 20.7 54.0 32.5 29.1 18.0 31.2 63.1 48.1 18.3 17.2 84.1 54.6 22.2 39.4 71.6 49.7 45.0 24.3 28.6 MOB3A "MOB-LAK, MOB1C, MOBKL2A, moblak" ENSG00000172081 "MOB kinase activator 3A" Q96BX8 19 2071038-2096673 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.3" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (2.05e-2)" "unprognostic (3.58e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.33e-6)" "unprognostic (3.40e-2)" "unprognostic (3.53e-3)" "unprognostic (3.12e-3)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (2.16e-2)" "unprognostic (7.74e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.93e-4)" "unprognostic (5.90e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" 19.6 9.5 9.8 31.9 10.0 27.4 11.9 11.1 9.2 15.5 19.2 12.7 7.7 7.7 19.9 9.2 14.3 16.7 14.1 10.6 10.0 6.9 10.7 5.7 14.9 39.6 9.4 6.4 15.6 8.2 6.7 7.0 15.9 8.8 15.3 9.2 13.4 11.6 13.1 7.9 12.0 18.2 17.0 7.6 37.3 12.5 8.3 10.0 39.3 11.7 6.7 42.2 17.1 13.1 11.6 14.5 69.3 22.0 13.0 16.5 17.1 14.1 5.8 6.9 6.6 16.5 18.2 5.4 8.9 5.6 6.1 4.9 2.3 5.1 36.3 3.2 15.3 4.9 6.0 3.8 19.7 4.9 12.7 1.9 7.9 4.1 3.1 16.3 12.3 40.9 10.7 13.1 16.6 7.1 7.0 11.3 7.0 4.0 36.5 8.8 5.6 6.4 12.5 2.1 1.7 4.2 3.9 2.0 28.2 7.5 3.5 4.4 5.9 4.5 4.8 4.9 5.4 5.1 20.1 19.2 7.4 4.1 13.7 5.2 7.2 25.6 28.7 19.9 8.3 8.8 18.0 20.6 23.9 16.5 20.8 14.2 11.6 12.3 13.6 14.5 10.7 9.4 11.8 69.3 13.0 22.0 8.3 14.7 17.1 9.8 10.0 11.1 9.2 10.0 6.9 9.4 6.4 8.8 10.0 3.0 5.0 50.6 9.8 13.4 3.1 3.2 2.5 8.1 7.9 10.4 19.6 7.9 3.3 9.5 1.2 10.7 14.2 0.0 8.2 48.6 12.6 10.3 27.6 4.0 28.8 1.6 14.3 14.7 70.3 4.0 17.0 36.1 15.1 49.5 10.5 6.2 9.2 8.6 15.9 6.8 6.6 6.5 12.0 6.6 6.4 13.9 23.0 40.6 7.6 10.1 MOB3B "C9orf35, FLJ13204, MOB1D, MOBKL2B" ENSG00000120162 "MOB kinase activator 3B" Q86TA1 9 27325209-27529781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.2;ovary: 29.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 47.8;Muller glia cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.1;HAP1: 10.4;K-562: 29.7;SK-BR-3: 12.5" "Low region specificity" "Detected in many" HPA057744 Uncertain "Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "HPA057744: " "unprognostic (6.96e-3)" "unprognostic (9.60e-2)" "unprognostic (5.10e-3)" "unprognostic (1.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.02e-1)" "unprognostic (1.87e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (7.57e-3)" "unprognostic (1.28e-1)" "unprognostic (9.45e-2)" "prognostic favorable (2.33e-10)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (7.99e-2)" 6.0 2.3 6.2 4.2 18.0 1.0 7.0 5.0 13.9 7.8 13.2 32.6 2.8 19.0 10.9 6.1 4.3 9.4 5.8 2.0 9.8 6.4 8.6 1.9 7.5 4.2 19.7 6.2 29.9 4.5 0.9 1.8 5.3 17.2 2.8 14.9 5.7 3.9 3.8 8.5 7.1 16.6 7.5 33.2 8.6 6.2 3.7 17.5 0.6 7.0 2.9 6.2 4.0 5.2 5.9 4.6 0.0 1.4 0.0 0.1 0.5 2.0 1.5 4.8 0.0 1.2 0.1 10.1 0.0 0.1 0.1 0.1 1.1 0.0 0.0 2.1 0.0 0.0 6.8 10.4 8.2 0.0 4.6 1.6 3.0 6.3 0.0 0.0 0.0 0.6 2.2 8.7 0.0 1.6 0.0 0.0 0.0 29.7 0.1 0.0 0.0 0.0 0.0 6.1 3.8 0.5 2.0 0.5 0.0 2.9 3.9 0.0 1.5 1.7 12.5 2.9 6.6 0.8 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.4 0.0 4.8 0.0 0.0 4.6 5.9 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.5 6.2 18.0 5.0 12.0 9.8 6.4 19.7 6.2 17.2 17.5 3.0 5.5 18.6 6.8 20.1 1.2 1.2 30.6 1.4 4.5 10.4 0.0 18.9 8.3 13.5 0.7 4.3 47.8 0.0 18.5 45.9 11.2 4.0 1.1 2.6 4.6 1.6 2.4 6.2 11.6 1.7 14.7 22.9 15.1 8.2 27.2 68.7 10.1 17.5 15.2 9.1 1.3 0.0 12.2 1.4 1.7 8.3 9.8 1.0 31.1 6.2 MOBP ENSG00000168314 "Myelin-associated oligodendrocyte basic protein" Q13875 3 39467198-39529479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 32 "brain: 194.3" "Group enriched" "Detected in some" 8 "Early spermatids: 82.2;Late spermatids: 87.8" "Cancer enriched" "Detected in single" 63 "glioma: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "HAP1: 20.7" "Low region specificity" "Detected in all" HPA035152 Enhanced Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA035152: AB_10603020" "unprognostic (1.76e-2)" "unprognostic (2.34e-1)" "unprognostic (3.53e-2)" "unprognostic (7.35e-2)" "unprognostic (5.67e-2)" "unprognostic (3.60e-2)" "unprognostic (7.47e-2)" "unprognostic (2.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.04e-5)" "unprognostic (2.28e-1)" "unprognostic (8.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" 1.7 1.8 35.0 1.7 58.5 1.7 1.7 3.8 101.8 1.7 2.3 102.1 0.0 1.6 1.8 1.7 1.7 2.7 1.7 1.7 51.4 33.4 1.7 1.6 2.3 1.6 84.8 14.7 2.1 1.6 6.0 0.0 1.6 68.2 1.6 1.8 0.0 1.6 1.7 1.8 1.7 1.7 1.8 194.3 1.6 1.7 5.0 64.2 0.0 1.7 0.0 1.6 1.7 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 35.0 58.5 3.8 29.1 51.4 33.4 84.8 14.7 68.2 64.2 0.0 0.0 0.0 0.1 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 87.8 1.4 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.3 0.0 0.4 8.6 4.9 0.4 0.0 0.0 0.0 0.0 MOCOS "FLJ20733, HMCS, MOS" ENSG00000075643 "Molybdenum cofactor sulfurase" Q96EN8 18 36187519-36272157 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 33.0;liver: 36.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 30.1;monocytes: 20.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 20.8;hTERT-HME1: 25.6;SiHa: 27.4;SK-MEL-30: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039412, HPA047958" Uncertain Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039412: AB_2676496, HPA047958: AB_2680225" "unprognostic (3.07e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (3.18e-3)" "unprognostic (2.55e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.84e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.91e-2)" "prognostic unfavorable (3.03e-12)" "unprognostic (8.98e-2)" "unprognostic (2.37e-1)" "unprognostic (4.09e-1)" "unprognostic (6.35e-2)" 3.7 12.7 0.6 1.6 0.5 0.2 6.4 0.4 0.4 1.4 10.4 0.7 8.0 6.7 1.3 4.6 4.8 1.9 5.8 1.3 0.4 0.5 1.7 36.6 1.8 0.2 0.4 0.1 17.2 3.2 1.1 9.4 11.2 2.2 2.8 1.8 2.1 2.5 7.2 1.3 2.6 33.0 1.0 0.4 0.7 1.7 1.3 0.2 0.0 1.2 2.9 3.5 2.6 1.7 0.4 0.3 1.9 0.3 1.1 0.3 0.1 6.9 2.4 0.1 0.0 2.2 2.9 1.5 4.1 2.3 2.0 5.1 1.5 2.2 0.0 1.3 6.6 0.5 4.3 1.5 6.5 2.8 1.2 1.2 0.1 6.9 5.7 7.6 0.0 2.0 4.5 20.8 7.7 25.6 0.2 0.3 0.0 2.3 0.0 3.2 1.8 0.0 0.0 0.4 1.6 2.0 0.0 0.0 0.0 2.8 9.1 0.0 0.6 27.4 1.7 19.1 0.4 1.3 0.1 1.3 1.6 1.9 3.4 0.7 0.0 0.0 0.0 4.0 0.0 0.7 1.7 0.3 0.3 0.3 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.2 0.3 1.9 1.1 0.2 0.3 0.1 0.1 0.6 0.5 0.4 0.4 0.4 0.5 0.4 0.1 2.2 0.2 11.9 5.3 3.4 1.2 0.6 0.2 0.4 0.0 2.7 6.8 0.0 2.0 0.4 0.0 2.7 5.7 0.9 2.6 0.0 10.9 3.3 1.5 1.2 0.0 30.1 0.5 0.0 2.9 0.0 0.6 1.7 1.7 1.4 3.3 20.8 2.3 7.6 4.3 2.8 8.5 0.0 0.3 0.0 0.5 0.1 0.2 1.1 1.9 0.0 2.8 2.2 MOG "BTN6, BTNL11" ENSG00000204655 "Myelin oligodendrocyte glycoprotein" Q16653 6 29656981-29672372 "Disease related genes, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "brain: 106.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 45 "glioma: 15.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 3.4;HEK 293: 2.1;SuSa: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021873 Enhanced NA NA "HPA021873: AB_1854055" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (3.00e-4)" "unprognostic (4.89e-2)" "unprognostic (4.90e-2)" 1.9 1.7 22.1 1.7 35.1 1.7 1.7 3.1 30.0 1.7 1.9 79.5 0.0 1.7 1.7 1.7 1.7 1.7 1.7 1.7 40.2 19.6 2.0 1.7 1.8 1.7 49.2 17.1 2.0 1.7 1.7 0.0 1.8 39.8 1.8 2.1 0.0 1.7 2.2 1.7 1.7 2.0 1.7 106.4 1.7 1.7 2.0 46.4 0.0 1.7 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 22.1 35.1 3.1 30.0 40.2 19.6 49.2 17.1 39.8 46.4 0.0 0.6 0.0 0.3 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 MOGAT1 "DGAT2L, DGAT2L1, MGAT1" ENSG00000124003 "Monoacylglycerol O-acyltransferase 1" Q96PD6 2 222671786-222709930 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "gallbladder: 40.9" "Cell type enhanced" "Detected in some" 13 "Cholangiocytes: 5.1;Exocrine glandular cells: 4.5;Hepatocytes: 2.1;Muller glia cells: 2.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 0.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.4" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.4" "Cell line enhanced" "Detected in single" "Hep G2: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049944 Uncertain NA NA "HPA049944: AB_2680964" "unprognostic (6.32e-2)" "unprognostic (2.38e-1)" "unprognostic (1.15e-1)" "unprognostic (1.41e-1)" "unprognostic (4.28e-3)" "unprognostic (4.39e-2)" "unprognostic (4.32e-2)" "unprognostic (9.44e-2)" "unprognostic (1.91e-1)" "unprognostic (8.59e-2)" "unprognostic (3.07e-3)" "unprognostic (4.99e-2)" "unprognostic (3.89e-1)" "unprognostic (9.03e-3)" 2.3 0.1 0.6 0.1 0.5 0.1 1.3 0.2 0.9 0.3 0.6 0.5 0.2 0.0 1.0 1.1 0.5 0.1 40.9 0.8 0.5 0.2 5.7 7.6 1.1 0.3 0.2 0.9 0.1 1.5 2.3 0.4 0.0 0.9 0.2 0.1 0.0 1.4 2.6 0.5 1.6 0.2 0.1 0.3 0.1 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.5 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.6 0.5 0.2 0.9 0.5 0.2 0.2 0.9 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 2.2 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 MOGAT2 "DGAT2L5, FLJ22644, MGAT2" ENSG00000166391 "Monoacylglycerol O-acyltransferase 2" Q3SYC2 11 75717819-75732958 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 90.2;liver: 40.5" "Cell type enhanced" "Detected in some" 19 "Enterocytes: 91.9;Hepatocytes: 64.7;Mucus-secreting cells: 33.4;Undifferentiated cells: 25.8" "Cancer enhanced" "Detected in many" "liver cancer: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 8.6;RPMI-8226: 5.8" "Not detected" "Not detected" HPA028834 Uncertain NA NA "HPA028834: AB_10601865" "unprognostic (5.63e-2)" "unprognostic (2.71e-2)" "unprognostic (6.37e-2)" "unprognostic (6.88e-3)" "unprognostic (1.15e-4)" "unprognostic (2.66e-3)" "unprognostic (1.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.42e-2)" "unprognostic (1.12e-1)" "unprognostic (4.21e-2)" "unprognostic (3.02e-1)" "unprognostic (1.24e-5)" "unprognostic (2.13e-3)" "unprognostic (1.84e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-3)" 0.1 0.0 0.1 4.8 0.1 0.0 2.1 0.1 0.1 0.2 34.0 0.1 1.4 22.3 0.1 0.1 0.2 0.0 2.6 0.1 0.1 0.0 0.2 40.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 7.0 0.1 0.4 2.2 0.4 0.9 90.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.1 5.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.9 0.0 0.5 0.0 0.0 0.8 0.0 64.7 0.0 0.0 2.4 0.6 0.6 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 18.7 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.1 MOGAT3 "DC7, DGAT2L2, MGAT3" ENSG00000106384 "Monoacylglycerol O-acyltransferase 3" Q86VF5 7 101195007-101201021 "Enzymes, Predicted membrane proteins" "Glycerol metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 61.6;liver: 16.0" "Cell type enhanced" "Detected in some" 22 "Enterocytes: 76.6;Paneth cells: 56.1;Undifferentiated cells: 21.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.0;liver cancer: 11.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CACO-2: 4.8;Hep G2: 16.2" HPA011940 Approved Approved Centrosome NA NA Centrosome "HPA011940: AB_1854057" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (7.14e-2)" "unprognostic (6.11e-2)" "unprognostic (3.20e-1)" "unprognostic (9.54e-3)" "unprognostic (9.36e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-3)" "unprognostic (1.87e-1)" "unprognostic (1.23e-1)" "unprognostic (9.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.59e-2)" 0.2 0.1 0.2 2.6 0.2 0.4 0.2 0.2 0.2 0.2 17.3 0.2 0.2 19.7 0.2 0.5 0.2 0.1 0.2 0.2 0.2 0.1 0.9 16.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.1 61.6 0.4 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.2 5.3 0.9 1.9 1.2 0.3 0.6 0.2 0.2 0.5 0.0 0.2 0.4 0.6 0.0 0.0 0.0 4.8 1.1 0.4 0.6 0.1 0.6 0.4 0.2 0.1 0.1 0.1 0.2 0.6 0.6 16.2 0.2 0.5 0.6 0.1 0.1 0.0 0.1 0.4 0.1 0.3 0.2 0.7 0.1 0.3 0.3 0.5 0.2 0.5 0.6 0.3 0.1 0.4 0.7 0.6 0.3 0.3 0.3 0.6 0.1 0.8 0.3 0.3 0.8 0.9 0.2 1.0 0.5 0.4 0.2 0.1 1.7 0.6 1.4 2.2 0.9 1.1 1.0 0.7 0.7 1.0 0.8 0.7 0.5 1.7 0.9 1.2 5.3 1.9 0.6 1.2 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 76.6 0.0 0.0 0.0 0.2 0.2 0.0 5.5 0.0 0.0 1.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.1 56.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.5 0.4 MOK "RAGE, RAGE1, STK30" ENSG00000080823 "MOK protein kinase" Q9UQ07 14 102224500-102305200 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 45.0" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 214.2;Cone photoreceptor cells: 174.7;Early spermatids: 171.0;Rod photoreceptor cells: 441.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBF TERT88: 28.6;hTEC/SVTERT24-B: 72.8;NB-4: 90.6;U-138 MG: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA027292 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA027292: AB_10600989" "unprognostic (8.16e-2)" "unprognostic (1.82e-1)" "unprognostic (6.68e-2)" "unprognostic (6.05e-3)" "unprognostic (1.34e-2)" "unprognostic (1.81e-2)" "unprognostic (4.43e-2)" "unprognostic (3.49e-4)" "unprognostic (2.19e-1)" "unprognostic (2.03e-2)" "unprognostic (2.93e-1)" "unprognostic (3.01e-3)" "unprognostic (5.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.17e-1)" "unprognostic (1.26e-2)" "unprognostic (2.48e-1)" 5.9 6.8 12.9 2.7 17.3 3.7 7.8 9.7 15.9 7.6 3.6 8.7 6.2 4.7 7.6 10.2 3.9 26.4 6.4 8.3 13.5 10.2 7.7 3.6 6.1 2.5 6.0 13.7 12.4 8.6 9.4 22.1 3.6 16.6 5.1 3.0 15.2 6.1 5.4 1.9 8.6 4.1 5.9 6.2 3.8 11.7 45.0 6.2 0.4 11.7 2.3 2.2 6.2 3.9 0.7 3.9 0.9 1.1 10.6 2.4 1.3 3.4 3.0 0.4 1.7 0.7 2.5 0.7 7.0 2.0 10.1 12.2 0.2 8.4 2.6 0.5 1.3 2.2 0.7 0.6 3.6 28.6 2.9 2.6 0.6 0.4 2.3 3.1 0.3 3.4 2.1 0.9 72.8 6.7 7.9 0.3 0.5 0.6 0.1 6.6 2.3 0.2 90.6 0.1 1.5 7.4 0.4 0.2 0.0 4.1 0.1 1.1 0.7 1.2 0.4 19.6 0.1 2.1 0.2 0.2 38.5 1.9 1.4 2.2 0.2 0.4 0.2 7.7 0.2 17.4 0.0 1.1 0.0 0.7 0.7 1.2 0.0 0.5 1.9 3.9 0.7 1.1 2.4 0.9 10.6 0.1 0.0 0.0 1.3 12.9 17.3 9.7 15.9 13.5 10.2 6.0 13.7 16.6 6.2 17.9 17.4 0.5 6.5 9.5 36.2 12.2 10.2 214.2 43.3 12.2 174.7 1.0 5.0 7.0 171.0 6.7 3.8 0.0 14.2 2.1 7.6 3.6 3.5 1.7 2.0 15.9 4.6 7.4 1.8 130.3 28.1 4.2 75.9 0.0 2.0 58.0 5.6 0.0 15.2 8.1 441.5 25.8 12.1 81.9 27.2 5.1 1.0 6.7 3.8 3.0 MORC1 "CT33, MORC, ZCW6" ENSG00000114487 "MORC family CW-type zinc finger 1" Q86VD1 3 108958239-109118142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 21.0" "Group enriched" "Detected in some" 5 "Early spermatids: 45.5;Late spermatids: 21.8;Spermatocytes: 37.7;Spermatogonia: 41.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.0" "Group enriched" "Detected in some" 10 "Karpas-707: 4.4;RPMI-8226: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA036413 Enhanced NA NA "HPA036413: AB_10669989" "unprognostic (1.66e-1)" "unprognostic (4.30e-2)" "unprognostic (2.17e-2)" "unprognostic (2.63e-1)" "unprognostic (7.45e-6)" "unprognostic (4.80e-2)" "unprognostic (2.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 2.2 21.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 37.7 41.6 0.0 0.0 0.0 0.0 0.1 MORC2 "AC004542.C22.1, KIAA0852, ZCW3, ZCWCC1" ENSG00000133422 "MORC family CW-type zinc finger 2" Q9Y6X9 22 30925130-30968298 "Disease related genes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 10.3;MAIT T-cell: 9.1;memory CD4 T-cell: 14.3;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 8.9;T-reg: 17.7" "Lineage enriched" "Detected in many" 8 "T-cells: 17.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000436 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA000436: AB_1079404" "unprognostic (3.43e-2)" "unprognostic (1.71e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-2)" "unprognostic (6.15e-2)" "unprognostic (3.56e-3)" "unprognostic (2.89e-3)" "unprognostic (4.63e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-1)" "unprognostic (5.46e-3)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.54e-8)" "unprognostic (5.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.02e-2)" "unprognostic (6.66e-3)" 6.7 5.3 4.6 6.0 7.0 5.2 16.9 6.4 7.5 6.8 7.1 6.5 14.8 4.7 7.4 5.9 6.1 6.3 4.7 7.7 4.7 5.0 5.3 9.6 6.3 8.8 4.8 4.1 8.1 7.5 9.4 8.1 7.7 7.7 8.0 4.5 7.7 11.0 7.9 9.8 10.4 5.6 6.7 5.3 7.3 5.9 50.5 5.0 5.5 6.6 6.1 6.6 6.8 9.7 1.7 2.2 0.8 2.0 1.2 17.7 3.9 18.6 17.0 20.2 22.3 21.1 15.7 15.3 13.8 10.8 14.2 14.6 22.2 9.0 16.7 12.4 12.0 10.0 16.0 18.1 8.6 11.8 13.1 21.9 17.4 13.6 26.0 18.2 14.2 18.0 14.9 12.6 14.9 19.3 11.8 14.2 9.8 22.8 17.3 14.8 30.3 15.1 29.0 18.7 22.0 12.6 29.0 11.8 21.5 13.7 17.0 18.0 14.2 14.6 23.9 10.5 16.9 12.8 24.2 14.2 17.2 17.0 12.1 12.2 15.5 19.1 18.8 12.6 10.1 12.2 0.5 1.1 0.8 10.3 1.9 9.1 1.5 14.3 8.3 1.2 1.7 14.7 8.9 0.3 1.2 2.0 2.2 17.7 3.9 4.6 7.0 6.4 7.5 4.7 5.0 4.8 4.1 7.7 5.0 0.0 2.9 5.2 6.2 6.5 7.0 4.5 2.5 2.7 6.8 10.4 9.8 7.0 3.3 6.4 23.5 7.1 4.0 0.0 7.0 9.6 6.6 7.4 1.1 7.8 4.5 12.7 8.6 4.9 4.0 7.4 7.2 3.7 6.8 2.8 5.8 3.5 9.1 3.5 9.6 2.8 9.9 19.4 6.2 20.9 18.8 8.2 5.3 4.4 6.4 4.9 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000244 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 94.5" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 122.1;Alveolar cells type 2: 98.4;Ciliated cells: 111.1;Club cells: 109.2;Cytotrophoblasts: 213.9;granulocytes: 61.5;Syncytiotrophoblasts: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 44.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063" "prognostic unfavorable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 8.7 20.0 3.2 6.0 4.8 5.1 6.2 4.9 3.6 8.0 5.3 4.6 12.7 4.6 8.8 8.5 6.8 7.3 6.7 5.3 4.3 2.8 4.9 9.7 6.0 2.2 4.9 2.2 12.3 9.1 6.0 4.9 94.5 5.8 7.7 4.9 4.2 8.7 8.8 9.4 8.6 4.9 7.4 5.4 2.6 5.6 12.5 5.0 2.3 7.6 7.5 5.2 6.3 15.1 6.0 4.6 10.5 3.8 2.8 4.0 0.7 11.0 44.0 4.4 10.1 13.4 15.5 22.9 10.7 11.4 5.4 7.0 23.3 5.0 1.7 5.6 11.0 9.3 8.7 14.7 9.4 6.5 2.5 8.5 2.7 14.9 9.8 9.9 1.9 5.6 8.2 9.1 7.4 10.8 32.3 4.8 1.7 1.5 16.7 12.1 9.7 4.0 2.7 3.9 29.5 16.7 1.9 8.8 1.9 17.5 8.8 3.8 4.8 13.0 12.8 8.4 6.5 7.6 1.9 5.0 8.7 8.8 17.2 5.9 4.7 6.1 4.3 9.3 1.7 6.3 10.5 3.8 3.1 3.7 3.0 3.2 3.3 3.6 2.8 1.6 6.0 4.0 3.4 8.2 2.8 3.6 4.6 2.6 0.7 3.2 4.8 4.9 3.6 4.3 2.8 4.9 2.2 5.8 5.0 122.1 98.4 2.2 12.9 15.5 4.5 2.2 7.6 111.1 109.2 5.2 3.9 213.9 18.3 8.8 0.8 5.0 3.9 0.0 6.4 21.9 23.8 19.4 61.5 16.2 20.2 1.6 1.7 8.6 1.3 0.9 10.3 4.8 11.8 0.0 8.8 5.8 6.7 4.9 11.0 9.0 7.5 25.8 8.6 5.4 24.3 14.1 215.6 6.4 8.4 11.7 MORN2 MOPT ENSG00000188010 "MORN repeat containing 2" Q502X0 2 38875962-38929072 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 88.7" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 638.4;Early spermatids: 1599.5;Late spermatids: 2860.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057815 Approved Nucleoplasm NA NA Nucleoplasm "HPA057815: AB_2683537" "unprognostic (7.28e-3)" "unprognostic (3.84e-2)" "unprognostic (8.65e-2)" "unprognostic (1.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.48e-1)" "unprognostic (1.24e-3)" "unprognostic (1.66e-2)" "unprognostic (6.01e-2)" "unprognostic (2.60e-2)" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" "unprognostic (8.37e-3)" "unprognostic (2.35e-1)" "unprognostic (1.09e-2)" "unprognostic (3.55e-1)" "unprognostic (8.80e-2)" 5.9 14.4 20.5 3.1 22.7 4.1 10.2 6.8 14.8 14.9 6.5 10.3 13.8 3.4 8.3 34.6 5.0 43.7 9.1 10.7 16.4 18.6 31.4 8.6 8.6 2.9 16.5 12.7 9.6 9.5 22.7 27.1 4.0 30.1 8.4 6.8 8.3 11.4 9.7 7.1 3.6 3.3 5.7 11.1 3.1 6.9 88.7 9.5 2.0 21.9 7.2 2.9 6.1 4.4 3.6 7.5 2.0 11.0 3.1 4.8 4.8 23.4 12.4 15.2 18.5 16.7 25.2 8.5 10.9 17.2 17.5 16.9 7.2 13.4 1.5 9.2 16.2 17.5 6.5 6.8 14.1 26.0 9.9 13.1 5.1 14.0 19.1 14.6 8.2 3.7 15.0 17.4 21.4 7.8 22.0 16.0 4.7 8.7 3.5 14.3 23.5 3.7 15.8 11.6 15.6 13.0 2.0 16.0 5.3 32.6 14.1 15.3 20.1 16.2 10.8 23.1 9.2 14.8 11.4 10.7 12.2 12.2 19.3 17.3 6.9 9.9 0.9 28.2 2.4 21.9 2.0 11.0 1.5 2.2 8.4 4.1 3.4 2.6 3.3 7.5 3.6 4.4 4.6 0.9 3.1 6.9 3.8 4.8 4.8 20.5 22.7 6.8 14.8 16.4 18.6 16.5 12.7 30.1 9.5 14.9 16.4 6.4 23.2 8.7 14.8 36.7 38.2 638.4 66.0 57.6 9.8 13.2 228.8 53.3 1599.5 11.8 8.3 0.0 38.9 19.6 23.9 32.1 9.2 17.9 21.0 15.9 22.0 14.1 7.8 2860.4 49.5 14.9 21.9 5.4 18.5 60.4 35.0 28.8 48.4 323.7 28.1 25.8 13.4 365.9 74.1 9.3 6.4 4.1 23.9 21.4 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 30.1;testis: 51.5" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1766.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "BEWO: 12.6;CACO-2: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favorable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.3 0.2 1.2 0.5 1.4 0.9 0.3 0.3 1.6 0.4 0.3 0.3 0.3 0.2 0.3 1.4 0.3 5.6 0.4 0.3 1.4 1.2 0.4 0.3 1.0 1.4 0.3 0.3 0.3 0.4 3.4 0.7 30.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 2.5 0.3 0.3 0.3 0.8 0.8 51.5 0.3 0.3 0.5 0.3 0.6 0.3 0.3 1.2 1.2 3.1 0.6 2.2 2.3 0.6 0.1 0.2 0.4 0.2 0.0 0.3 12.6 0.2 0.0 0.1 0.1 6.8 0.3 0.2 0.2 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.4 0.3 0.4 0.9 0.1 0.3 0.3 0.0 0.1 0.2 0.8 0.2 0.3 0.1 0.2 0.8 0.6 0.2 0.0 0.1 0.3 0.0 0.1 0.4 0.2 1.1 1.1 0.1 0.2 0.0 0.5 0.9 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.1 0.4 0.9 0.3 0.1 2.3 0.6 0.4 2.1 0.3 2.0 0.8 2.3 1.3 0.2 1.2 2.1 1.4 3.1 2.2 0.5 1.2 2.0 0.6 1.2 1.4 0.3 1.2 1.4 1.2 0.3 0.3 0.3 0.3 3.0 2.2 0.5 1.1 2.9 1.1 1.1 5.1 50.9 11.4 1.8 0.0 0.2 6.6 3.3 357.0 1.5 0.0 0.0 1.2 0.4 1.3 0.3 2.3 0.0 0.8 0.0 0.0 0.6 0.0 1766.8 8.6 0.1 0.0 1.8 0.0 3.7 1.7 0.0 8.9 0.8 1.7 0.0 0.0 7.0 5.6 3.4 6.1 3.3 0.1 1.0 MORN5 "C9orf113, C9orf18, FLJ46909" ENSG00000185681 "MORN repeat containing 5" Q5VZ52 9 122159908-122200088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "fallopian tube: 56.9;testis: 52.1" "Group enriched" "Detected in many" 6 "Ciliated cells: 386.8;Early spermatids: 358.0;Late spermatids: 462.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;HHSteC: 3.2;JURKAT: 1.4;NB-4: 5.0;RPTEC TERT1: 1.3;U-87 MG: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.24e-3)" "unprognostic (7.30e-3)" "unprognostic (1.12e-1)" "prognostic favorable (4.86e-4)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (7.80e-3)" "unprognostic (1.91e-3)" "unprognostic (3.25e-3)" "unprognostic (2.64e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (2.95e-1)" 0.2 0.2 2.8 0.5 4.1 0.1 0.3 0.3 2.1 1.8 10.7 4.5 2.1 0.6 2.9 5.3 1.3 56.9 2.2 0.2 3.1 3.4 0.8 0.1 5.4 0.2 1.1 2.7 4.1 0.4 1.8 3.8 0.2 9.2 0.6 3.1 0.7 0.9 2.2 0.1 0.1 1.2 8.8 0.9 0.1 2.1 52.1 1.3 0.0 0.2 0.0 0.2 2.4 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 1.4 0.1 0.0 0.0 0.0 0.0 5.0 0.0 1.1 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 4.1 0.3 2.1 3.1 3.4 1.1 2.7 9.2 1.3 0.0 2.2 0.0 0.1 0.0 0.9 0.0 0.0 386.8 28.4 3.5 2.0 0.0 0.0 0.1 358.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 1.6 0.0 0.0 0.0 462.5 6.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.9 2.2 4.7 0.0 0.0 68.8 4.5 0.0 0.0 0.0 0.0 0.0 MOS ENSG00000172680 "MOS proto-oncogene, serine/threonine kinase" P00540 8 56112942-56113982 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 3.5" "Cell type enriched" "Detected in single" 8 "Early spermatids: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HAP1: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.28e-1)" 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 MOV10L1 "CHAMP, DJ402G11.8, DKFZp434B0717" ENSG00000073146 "Mov10 RISC complex RNA helicase like 1" Q9BXT6 22 50089879-50161690 "Enzymes, Predicted intracellular proteins" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 27.7" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 110.5;Late spermatids: 224.1;Spermatocytes: 68.2;Spermatogonia: 38.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 3.3;HUVEC TERT2: 16.1;TIME: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019034 Approved NA NA "HPA019034: AB_1854070" "unprognostic (1.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.88e-2)" "unprognostic (7.91e-2)" "unprognostic (4.29e-2)" "unprognostic (4.05e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (9.43e-2)" "unprognostic (7.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.03e-1)" "unprognostic (8.02e-3)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (1.37e-1)" 0.4 0.1 0.7 0.2 1.5 0.3 0.2 1.3 1.3 0.9 0.8 0.6 0.2 0.1 3.0 2.0 0.4 1.0 1.2 0.3 0.9 0.6 0.3 1.0 0.3 0.2 0.5 1.5 1.8 0.2 0.1 0.4 0.6 2.1 1.0 0.2 0.6 0.2 0.2 0.2 0.3 0.4 1.9 0.7 0.2 0.1 27.7 0.2 0.2 0.5 0.2 0.3 0.4 2.0 0.0 0.0 0.0 0.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 0.5 1.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 3.3 0.0 1.5 0.2 0.0 0.0 0.0 0.2 16.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.5 1.3 1.3 0.9 0.6 0.5 1.5 2.1 0.2 0.0 0.0 0.0 0.1 0.2 2.4 1.4 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 110.5 1.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 0.0 1.4 4.8 0.0 0.0 0.0 224.1 1.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.8 0.8 3.8 12.9 0.0 68.2 38.5 0.0 0.1 0.0 0.0 0.0 MOXD1 "dJ248E1.1, DKFZP564G202, MOX" ENSG00000079931 "Monooxygenase DBH like 1" Q6UVY6 6 132296055-132401545 "Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 57.2;smooth muscle: 41.1" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.8;Early spermatids: 36.8;Muller glia cells: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 47 "memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8" "Group enriched" "Detected in many" 58 "B-cells: 4.9;dendritic cells: 7.8" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;ASC TERT1: 31.0;BJ: 23.4;fHDF/TERT166: 43.5;HBF TERT88: 28.1;U-2197: 69.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035740 Approved Approved Cytosol NA NA Cytosol "HPA035740: AB_10610141" "unprognostic (1.74e-1)" "unprognostic (1.28e-1)" "unprognostic (8.05e-2)" "unprognostic (9.87e-3)" "unprognostic (5.62e-2)" "prognostic favorable (7.09e-5)" "unprognostic (5.77e-2)" "unprognostic (2.48e-1)" "unprognostic (6.55e-2)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" "unprognostic (9.54e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (2.92e-2)" "unprognostic (6.24e-2)" "unprognostic (1.73e-2)" 1.9 19.5 13.4 3.8 12.5 0.2 1.4 0.3 16.0 17.2 7.7 6.7 7.3 2.7 57.2 7.8 17.4 1.9 15.1 3.2 9.8 1.1 21.4 1.2 15.3 2.9 1.0 6.4 2.4 1.7 0.1 4.3 3.3 0.2 17.6 4.9 0.9 10.6 21.5 0.4 7.4 4.5 41.1 0.8 3.2 3.1 3.1 4.6 0.8 1.5 7.7 7.7 9.4 8.6 4.9 7.8 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.9 0.0 38.5 31.0 0.0 23.4 15.9 8.6 15.1 0.0 0.2 0.1 0.0 43.5 7.1 0.0 0.3 0.1 28.1 0.0 4.3 0.0 0.0 0.0 0.3 0.0 0.0 7.3 0.0 17.3 0.5 10.7 0.0 0.0 0.0 1.7 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.1 0.0 10.5 0.0 0.6 0.0 0.0 0.1 0.5 2.3 0.0 1.3 0.1 3.9 3.7 69.7 12.2 0.9 0.0 0.0 10.0 0.0 11.5 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.3 13.4 12.5 0.3 16.0 9.8 1.1 1.0 6.4 0.2 4.6 0.0 2.2 3.4 0.4 24.8 0.2 0.6 0.0 0.0 4.5 1.8 0.0 0.6 0.0 0.4 36.8 0.0 0.0 0.0 0.0 1.0 9.6 0.2 3.5 0.0 0.4 0.0 0.0 0.0 0.0 6.8 0.3 0.6 6.8 0.0 0.0 14.0 0.4 0.0 0.4 0.0 0.8 0.0 0.4 0.5 0.4 5.9 0.0 0.0 0.0 0.0 MPC1 "BRP44L, CGI-129, dJ68L15.3, SLC54A1" ENSG00000060762 "Mitochondrial pyruvate carrier 1" Q9Y5U8 6 166364919-166383013 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.8;liver: 129.7" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 875.4;Distal tubular cells: 1458.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045119, HPA055790" Enhanced Enhanced Mitochondria NA NA Mitochondria "HPA045119: AB_10960421, HPA055790: AB_2682923" "unprognostic (3.30e-2)" "prognostic favorable (1.45e-4)" "unprognostic (5.24e-3)" "unprognostic (1.68e-1)" "unprognostic (3.17e-2)" "unprognostic (2.85e-2)" "unprognostic (7.61e-2)" "prognostic favorable (1.29e-4)" "unprognostic (3.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.11e-3)" "unprognostic (5.64e-2)" "prognostic favorable (4.79e-11)" "unprognostic (4.13e-2)" "unprognostic (1.03e-1)" "unprognostic (7.48e-2)" "unprognostic (8.45e-2)" 13.1 9.4 27.1 7.2 28.5 10.9 12.2 12.3 21.6 12.4 21.1 26.1 8.3 18.8 8.4 10.5 16.0 8.3 9.5 149.8 27.6 21.5 56.1 129.7 10.0 8.7 39.2 18.3 10.5 14.9 12.4 9.4 5.4 23.8 10.3 19.9 11.5 23.0 10.5 63.3 9.2 16.9 11.0 43.3 9.2 19.7 5.0 25.8 9.0 18.6 43.9 9.9 10.6 8.1 12.2 26.5 32.2 43.7 13.9 24.5 17.1 6.5 1.9 8.1 27.9 23.6 13.6 12.0 7.5 12.2 11.8 11.5 9.9 4.6 13.7 13.6 11.6 9.5 6.2 12.1 9.5 8.3 9.3 20.8 6.8 10.1 32.9 9.8 26.2 8.9 10.9 13.4 9.6 6.9 3.6 9.5 21.3 23.6 21.9 7.3 10.4 18.2 48.6 4.1 37.3 9.2 10.0 13.5 34.2 22.0 5.2 25.5 22.6 8.7 38.0 8.6 7.0 9.0 39.4 6.6 6.9 7.1 24.2 7.7 15.0 10.3 11.4 6.3 32.4 10.9 18.6 23.0 32.2 16.4 35.3 15.4 12.2 19.4 17.6 26.5 9.2 18.2 17.4 20.4 13.9 43.7 15.7 24.5 17.1 27.1 28.5 12.3 21.6 27.6 21.5 39.2 18.3 23.8 25.8 110.2 37.1 53.6 36.9 40.5 51.2 875.4 183.4 44.2 47.8 101.2 9.8 19.1 1458.9 78.7 46.1 45.8 147.2 23.3 122.5 67.4 59.4 34.7 70.3 365.8 104.2 46.1 35.7 38.6 74.2 5.6 61.5 76.9 123.2 111.8 87.8 137.3 56.8 120.7 84.5 301.3 55.1 90.5 90.6 126.5 39.4 48.8 20.4 54.3 110.8 45.7 MPC1L SLC54A3 ENSG00000238205 "Mitochondrial pyruvate carrier 1 like" P0DKB6 X 40623566-40624136 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 26.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.1;BJ hTERT+: 1.1;PC-3: 1.9;U-2197: 1.4" "Not detected" "Not detected" NA NA "unprognostic (8.47e-4)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPC2 "BRP44, DKFZP564B167, SLC54A2" ENSG00000143158 "Mitochondrial pyruvate carrier 2" O95563 1 167916729-167937040 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 111.7" "Cell type enhanced" "Detected in all" 13 "Early spermatids: 1811.9;Late spermatids: 3927.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 94.3" "Low region specificity" "Detected in all" HPA056091 Uncertain NA NA "HPA056091: AB_2683035" "unprognostic (3.25e-1)" "unprognostic (6.82e-2)" "unprognostic (8.79e-3)" "unprognostic (4.15e-2)" "unprognostic (3.47e-1)" "unprognostic (1.02e-1)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-3)" "unprognostic (1.44e-3)" "unprognostic (1.08e-2)" "unprognostic (9.13e-2)" "unprognostic (2.39e-1)" "unprognostic (6.95e-2)" "unprognostic (5.43e-2)" "unprognostic (1.67e-1)" 13.5 22.5 22.6 11.5 21.6 33.5 23.0 15.0 25.3 11.7 26.8 12.1 10.2 27.1 7.8 12.5 12.2 9.9 25.2 46.2 19.0 17.7 46.4 92.9 9.9 11.4 18.8 16.7 9.6 14.7 9.6 18.4 9.9 13.5 34.4 24.8 11.9 20.6 10.8 45.0 9.3 26.3 13.1 16.5 7.4 29.6 111.7 11.4 12.7 11.9 23.5 10.9 11.2 8.1 23.4 28.7 45.3 18.5 27.4 40.2 37.2 18.3 17.6 7.8 17.7 19.5 18.1 1.7 30.1 16.9 14.2 16.6 40.8 10.3 31.9 21.9 17.2 11.6 14.9 10.5 16.3 14.7 40.8 15.7 13.9 18.0 32.4 13.1 15.0 10.3 11.6 14.9 25.5 14.7 12.4 12.4 23.7 17.1 18.7 25.3 8.5 22.2 15.5 12.9 42.3 22.1 11.7 14.2 25.3 94.3 16.1 12.4 12.6 17.3 20.6 16.6 18.9 37.0 19.3 11.4 15.3 11.3 22.2 13.9 24.9 28.3 35.1 39.4 13.6 8.0 41.0 16.6 45.3 23.7 14.6 25.3 23.4 29.3 25.0 28.7 20.6 27.7 26.5 31.8 27.4 18.5 20.7 40.2 37.2 22.6 21.6 15.0 25.3 19.0 17.7 18.8 16.7 13.5 11.4 32.8 46.1 92.5 122.7 112.0 55.3 407.2 440.8 125.8 42.1 123.9 21.6 444.8 868.7 156.5 1811.9 78.2 261.8 93.5 128.1 44.4 116.0 241.3 87.6 688.4 140.6 42.9 318.3 49.7 62.2 3927.7 98.4 101.0 114.7 412.0 246.3 79.1 95.6 240.2 106.1 749.3 55.3 64.7 116.9 623.0 121.0 100.0 287.0 99.6 339.8 130.5 MPDU1 "CDGIf, Lec35, PQLC5, SL15" ENSG00000129255 "Mannose-P-dolichol utilization defect 1" O75352 17 7583529-7592789 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Transport "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014845 Uncertain Supported "Endoplasmic reticulum,Mitochondria" NA NA "Endoplasmic reticulum" Mitochondria "HPA014845: AB_1854072" "unprognostic (1.96e-1)" "unprognostic (8.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.36e-2)" "unprognostic (5.00e-2)" "unprognostic (5.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" "unprognostic (4.70e-2)" "unprognostic (3.37e-1)" "unprognostic (1.22e-1)" "unprognostic (1.95e-1)" "unprognostic (2.34e-3)" "unprognostic (9.00e-2)" "unprognostic (2.60e-1)" "unprognostic (2.48e-3)" "unprognostic (2.93e-1)" 15.4 24.6 12.6 10.3 16.5 16.6 16.7 9.1 26.2 16.0 27.3 22.8 4.6 18.5 8.2 15.3 20.5 14.2 16.4 9.1 11.6 10.3 36.0 80.1 15.4 12.3 12.9 8.4 10.8 24.3 21.0 9.3 27.4 15.7 15.1 30.0 17.3 17.2 9.6 11.0 14.7 39.0 11.8 13.3 23.8 20.3 9.1 10.9 17.6 21.4 12.5 17.5 15.5 11.3 7.5 19.7 5.5 26.8 6.4 10.0 8.7 12.5 26.3 19.2 12.6 24.3 22.4 11.6 20.8 30.6 39.5 29.0 13.7 21.2 7.5 15.1 36.0 17.0 24.4 29.1 35.7 33.7 15.6 26.6 13.6 17.4 23.4 30.4 11.3 21.2 22.8 29.5 36.8 21.8 18.3 29.8 21.0 22.2 9.7 42.7 18.0 7.4 7.0 20.7 29.3 12.5 17.2 14.8 12.7 39.6 12.3 12.1 22.0 27.1 18.9 7.2 17.9 22.1 9.2 20.0 16.3 8.4 9.5 25.9 4.9 9.0 6.2 23.3 14.7 23.2 5.5 16.2 4.8 6.7 26.8 5.5 7.5 6.5 9.0 19.7 7.5 6.7 7.6 2.6 6.4 24.2 18.5 10.0 8.7 12.6 16.5 9.1 26.2 11.6 10.3 12.9 8.4 15.7 10.9 8.9 26.0 42.4 30.9 9.5 15.5 4.3 40.8 17.4 12.5 22.7 11.8 99.2 29.9 56.7 2.3 16.3 81.1 0.0 66.5 77.5 25.4 35.1 13.9 42.4 70.3 15.9 35.7 27.0 31.6 3.6 15.8 35.1 23.6 39.7 56.4 28.4 60.1 66.6 6.0 39.4 20.1 25.8 11.3 19.7 30.4 11.0 131.8 21.8 53.6 36.1 MPDZ MUPP1 ENSG00000107186 "Multiple PDZ domain crumbs cell polarity complex component" O75970 9 13105704-13279590 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 94.2;Hepatocytes: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 26.2;HUVEC TERT2: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013512, HPA020255, HPA026686" Enhanced NA NA "CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074" "unprognostic (1.55e-1)" "unprognostic (4.21e-3)" "unprognostic (4.09e-3)" "unprognostic (1.68e-1)" "unprognostic (4.28e-2)" "unprognostic (1.03e-1)" "prognostic favorable (8.68e-4)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.50e-1)" "prognostic favorable (7.40e-4)" "unprognostic (1.54e-1)" "unprognostic (2.59e-3)" "unprognostic (1.32e-3)" "unprognostic (2.50e-1)" "unprognostic (1.58e-1)" "unprognostic (9.74e-2)" 17.6 9.2 16.7 5.1 14.4 1.0 18.7 20.4 18.8 13.4 12.5 12.8 8.0 3.1 15.1 13.3 6.9 15.4 10.2 23.6 14.7 12.8 16.0 68.7 9.5 3.5 14.5 12.4 22.3 4.5 11.4 21.7 20.0 14.8 16.9 5.2 9.6 5.4 20.3 14.7 3.2 5.3 21.0 18.6 9.2 7.3 9.5 17.0 0.0 10.2 6.5 2.3 12.1 24.3 0.0 0.8 0.0 0.0 0.0 0.3 0.0 6.9 9.3 26.2 11.5 17.9 16.5 5.3 7.0 7.3 6.2 5.9 0.0 0.0 0.0 2.0 17.3 6.4 0.1 7.6 3.8 10.1 0.0 4.5 4.6 9.5 1.6 9.3 0.0 2.5 12.0 1.6 4.4 2.9 15.9 23.7 0.0 0.1 0.0 5.4 1.8 0.0 0.1 11.1 0.0 3.8 0.0 6.4 0.0 6.2 3.8 3.2 12.1 5.5 1.2 6.7 18.5 3.5 0.0 18.9 6.4 1.2 2.1 5.4 0.0 0.0 0.0 3.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 16.7 14.4 20.4 15.1 14.7 12.8 14.5 12.4 14.8 17.0 29.8 6.4 0.0 8.1 4.5 26.0 94.2 0.0 45.5 22.7 7.0 37.3 11.0 1.7 3.9 3.5 46.7 0.0 0.0 1.7 19.9 22.4 13.4 1.1 66.0 4.6 25.4 1.7 39.9 0.6 2.7 22.5 1.6 16.9 1.0 0.0 42.9 2.8 0.0 31.8 14.4 26.0 38.8 27.8 4.8 8.9 3.4 9.0 0.0 0.0 3.2 MPEG1 MPG1 ENSG00000197629 "Macrophage expressed 1" Q2M385 11 59208510-59212951 "Predicted membrane proteins, Transporters" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.3;lymphoid tissue: 108.6" "Cell type enriched" "Detected in many" 5 "Kupffer cells: 355.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3" "Group enriched" "Detected in many" 6 "dendritic cells: 38.3;monocytes: 47.3" "Cell line enhanced" "Detected in some" "Daudi: 2.8;HMC-1: 1.3;THP-1: 3.8" HPA046801 Approved NA NA "HPA046801: AB_2679814" "unprognostic (1.24e-1)" "unprognostic (2.17e-3)" "unprognostic (1.05e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-2)" "unprognostic (2.79e-3)" "unprognostic (7.82e-2)" "unprognostic (1.41e-2)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (5.48e-2)" "unprognostic (3.51e-1)" "unprognostic (1.48e-1)" "unprognostic (9.38e-2)" "unprognostic (2.48e-2)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" 17.6 6.4 2.2 27.7 2.1 3.6 5.9 1.3 1.8 3.3 9.5 4.9 0.9 9.0 3.2 13.2 3.7 4.9 8.2 7.7 2.2 2.3 7.0 17.3 13.1 51.3 2.6 1.0 4.2 2.7 0.8 2.3 13.4 2.5 5.6 10.0 8.9 7.5 2.4 2.9 2.6 20.6 6.0 3.9 108.6 4.0 3.2 1.7 18.5 3.7 5.5 23.0 11.0 2.7 2.9 38.3 7.0 47.3 0.2 0.1 29.1 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.5 0.5 0.1 0.0 0.5 0.4 0.7 0.0 0.5 0.3 0.5 0.2 0.0 0.0 0.0 0.0 3.8 0.5 0.0 0.2 0.4 0.0 0.9 0.1 0.5 0.0 0.2 0.1 0.0 47.3 1.4 0.1 38.9 0.1 2.4 0.0 0.0 26.6 2.9 0.0 0.0 7.0 0.2 41.6 38.3 0.1 29.1 2.2 2.1 1.3 1.8 2.2 2.3 2.6 1.0 2.5 1.7 0.0 12.2 29.3 0.0 1.0 0.0 1.2 2.5 1.4 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.9 0.0 2.3 1.7 41.8 0.0 0.0 6.2 355.6 0.0 0.0 71.1 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 6.5 0.3 0.0 0.0 1.4 0.2 0.0 0.0 0.0 MPHOSPH9 MPP9 ENSG00000051825 "M-phase phosphoprotein 9" Q99550 12 123152320-123244014 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 108.0;Rod photoreceptor cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037485 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA037485: AB_10672792" "unprognostic (2.98e-2)" "unprognostic (5.00e-1)" "unprognostic (4.36e-3)" "unprognostic (1.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.81e-1)" "unprognostic (5.81e-3)" "unprognostic (1.64e-1)" "unprognostic (1.58e-2)" "unprognostic (1.88e-1)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.53e-3)" "unprognostic (1.31e-2)" "unprognostic (2.75e-1)" "unprognostic (5.14e-3)" "unprognostic (1.17e-1)" 5.3 9.8 11.0 10.5 14.6 24.8 5.6 21.6 14.9 5.5 6.7 7.7 4.9 7.9 6.4 12.8 5.9 6.1 4.0 8.8 8.8 6.0 7.1 12.7 6.1 12.0 7.1 8.0 6.9 6.3 9.9 20.4 5.7 9.9 5.8 7.6 7.7 5.9 5.2 7.2 5.4 8.0 5.9 9.1 10.2 5.9 14.4 11.0 48.9 6.2 3.2 10.8 5.5 5.0 6.2 4.9 8.3 3.7 8.5 12.1 3.0 8.5 9.1 14.6 16.4 6.5 6.1 5.5 8.8 4.5 11.1 8.9 8.6 4.2 16.8 6.5 5.8 10.6 6.1 18.8 7.2 15.5 10.7 12.2 17.1 10.1 8.4 5.0 15.9 14.9 6.6 2.7 10.5 10.5 9.8 11.3 25.6 11.8 7.4 10.1 7.2 18.1 25.2 10.0 5.6 9.9 16.2 14.7 10.9 8.6 8.4 18.7 8.8 13.7 5.5 8.6 15.3 10.3 12.0 6.4 9.1 13.1 10.5 12.5 11.6 18.7 14.0 7.3 15.3 18.8 8.3 3.7 5.1 10.9 3.6 7.7 5.6 8.6 9.8 3.5 6.2 12.1 11.8 0.7 8.5 3.1 4.9 7.4 3.0 11.0 14.6 21.6 14.9 8.8 6.0 7.1 8.0 9.9 11.0 8.9 7.4 13.8 3.9 3.9 36.9 12.6 10.2 14.7 9.1 7.0 108.0 8.9 5.0 4.1 46.8 4.5 3.3 0.0 1.6 5.6 8.1 2.8 2.3 27.6 7.3 50.9 13.7 5.5 12.0 48.4 6.6 7.2 3.3 14.4 5.1 17.7 1.6 0.0 10.6 7.1 64.2 0.0 4.1 30.0 19.6 1.9 1.4 22.3 7.5 2.4 MPIG6B "C6orf25, G6b, G6b-B, NG31" ENSG00000204420 "Megakaryocyte and platelet inhibitory receptor G6b" O95866 6 31718594-31726714 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heparin-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.2" "Cell type enriched" "Detected in single" 30 "granulocytes: 9.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NK-cell: 3.0;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 4 "dendritic cells: 1.8;NK-cells: 3.0" "Cell line enriched" "Detected in single" 17 "HEL: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA054404, HPA073017" Approved "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 7400000 "Golgi apparatus" "Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA054404: , HPA073017: AB_2686566" "unprognostic (1.45e-1)" "unprognostic (1.25e-1)" "unprognostic (2.93e-1)" "unprognostic (1.77e-2)" "unprognostic (1.23e-1)" "unprognostic (6.53e-2)" "unprognostic (3.53e-2)" "unprognostic (2.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (1.82e-2)" "unprognostic (1.02e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-2)" "unprognostic (1.71e-2)" 0.8 0.2 0.0 1.2 0.5 5.3 0.7 0.1 0.4 1.0 0.9 0.0 0.0 0.9 1.0 0.8 2.0 0.7 1.5 7.4 0.2 0.0 0.4 0.5 7.6 2.8 1.0 0.0 2.7 0.2 0.2 0.2 1.4 0.7 0.9 0.2 1.1 1.8 0.3 1.2 10.5 0.8 1.9 0.6 33.2 0.4 2.7 0.1 1.2 1.0 1.4 0.8 1.6 1.6 0.2 1.8 0.5 0.1 3.0 0.1 5.7 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.5 3.0 0.1 1.8 0.0 5.7 0.0 0.5 0.1 0.4 0.2 0.0 1.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MPL "CD110, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337849-43352772 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enriched" "Detected in single" 78 "HEL: 41.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.4" "Low region specificity" "Detected in all" HPA007619 Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 1.1 0.3 0.9 0.5 0.8 2.0 0.9 0.5 2.2 0.6 0.6 0.5 0.5 0.3 0.9 1.7 0.9 2.1 0.5 3.9 0.8 0.6 0.5 0.5 2.0 0.5 0.9 0.5 6.6 1.1 0.6 0.6 2.2 0.5 1.5 0.7 0.5 0.5 0.7 0.6 0.4 1.2 2.1 2.5 8.6 0.5 2.1 0.5 0.5 2.2 2.4 0.5 0.9 0.5 0.0 0.0 1.6 0.3 0.0 0.0 4.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 41.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.0 0.9 0.8 0.5 2.2 0.8 0.6 0.9 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPO ENSG00000005381 Myeloperoxidase P05164 17 58269856-58280935 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "bone marrow: 315.2" "Cell type enhanced" "Detected in some" 11 "Distal tubular cells: 1.7;Kupffer cells: 1.2" "Cancer enhanced" "Detected in single" "stomach cancer: 1.1" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0" "Group enriched" "Detected in many" 30 "dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6" "Group enriched" "Detected in some" 93 "HL-60: 218.1;NB-4: 285.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000059, HPA021147, HPA061464" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" No NA 576000000 15000000 Vesicles Nucleoplasm "CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531" "unprognostic (1.91e-1)" "unprognostic (9.08e-2)" "unprognostic (4.62e-2)" "unprognostic (2.90e-2)" "unprognostic (2.13e-3)" "unprognostic (2.78e-1)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (2.56e-1)" "unprognostic (1.68e-1)" "unprognostic (6.92e-2)" "unprognostic (8.34e-3)" "unprognostic (4.91e-2)" "unprognostic (3.07e-3)" "unprognostic (2.83e-1)" "unprognostic (1.14e-2)" "unprognostic (8.05e-2)" 0.2 0.1 0.5 0.1 0.8 315.2 0.1 0.4 1.0 0.1 0.1 1.4 0.0 0.1 0.2 0.2 0.1 0.1 0.1 21.5 0.6 0.8 0.1 1.4 6.9 0.8 0.6 0.0 0.6 0.1 0.1 1.0 2.9 0.4 0.2 0.1 0.2 6.3 0.1 0.7 0.5 0.1 0.1 0.4 17.8 0.1 0.4 0.2 19.7 0.6 0.0 0.5 0.1 0.0 0.0 3.2 2.0 7.6 0.0 0.1 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 285.8 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 3.8 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.1 7.2 0.5 0.8 0.4 1.0 0.6 0.8 0.6 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 1.2 0.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 MPP2 "DKFZp761D0712, DLG2" ENSG00000108852 "Membrane palmitoylated protein 2" Q14168 17 43875357-43909711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 89.3;Early spermatids: 63.3;Horizontal cells: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Lineage enriched" "Detected in single" 14 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "T-47d: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026486, HPA073483" Enhanced Approved Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA026486: AB_1854085, HPA073483: " "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (1.30e-5)" "prognostic unfavorable (1.87e-4)" "unprognostic (4.37e-2)" "unprognostic (2.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.34e-1)" "unprognostic (1.25e-1)" "unprognostic (3.69e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.72e-2)" "unprognostic (4.93e-2)" "unprognostic (1.85e-1)" "unprognostic (7.23e-2)" "unprognostic (6.89e-4)" 2.1 5.0 12.1 2.1 11.8 1.1 3.1 19.5 26.3 3.5 5.1 19.8 2.7 1.9 4.6 31.0 4.1 3.3 3.0 9.0 13.8 14.2 2.0 0.9 2.0 1.2 15.3 14.4 2.8 4.4 31.1 8.4 3.4 11.5 7.1 2.0 6.5 2.3 10.7 1.7 2.0 2.0 6.5 20.3 1.3 2.5 13.8 12.3 0.0 4.5 0.0 1.4 3.6 2.8 0.1 0.0 0.0 0.1 0.0 1.9 0.7 4.9 7.2 7.8 11.3 1.1 0.7 4.3 1.7 0.2 6.8 6.4 2.5 3.3 7.1 4.0 1.7 8.7 2.0 10.5 4.1 5.3 0.0 8.0 0.6 6.7 0.1 0.2 0.0 2.1 1.1 0.3 4.9 0.0 3.8 0.4 11.6 2.6 0.0 2.0 1.9 1.0 0.5 14.0 0.6 4.5 5.0 11.2 0.5 0.1 0.1 8.4 7.8 2.1 0.7 2.9 7.3 17.2 3.4 0.1 7.5 9.6 2.9 3.1 2.4 4.9 0.0 11.4 4.8 1.4 0.0 0.1 0.0 1.4 0.0 0.2 0.0 0.5 1.2 0.0 0.1 1.6 1.9 0.0 0.0 0.0 0.0 0.1 0.7 12.1 11.8 19.5 22.5 13.8 14.2 15.3 14.4 11.5 12.3 0.0 0.0 0.0 1.5 0.3 89.3 8.5 0.0 0.0 0.0 0.0 2.0 4.5 0.0 0.5 63.3 0.5 0.0 0.0 0.3 0.3 2.4 0.0 0.0 0.0 0.6 33.4 0.0 0.0 0.0 16.0 3.4 0.0 0.0 0.0 0.0 15.3 0.8 0.0 5.3 0.0 6.4 0.0 2.8 18.2 18.0 0.1 2.3 0.0 0.0 0.0 MPP3 DLG3 ENSG00000161647 "Membrane palmitoylated protein 3" Q13368 17 43800799-43833170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 24.5;Early spermatids: 39.4;Late spermatids: 56.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 46.7;pons and medulla: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 6.6;SCLC-21H: 13.3;T-47d: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021818, HPA024742" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021818: AB_1854086, HPA024742: AB_1854087" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (2.30e-2)" "unprognostic (2.23e-5)" "unprognostic (4.59e-3)" "unprognostic (5.63e-2)" "unprognostic (5.07e-6)" "unprognostic (2.01e-1)" "unprognostic (1.03e-2)" "unprognostic (3.43e-2)" "unprognostic (1.77e-1)" "unprognostic (1.84e-3)" "unprognostic (8.02e-11)" "unprognostic (9.98e-3)" "unprognostic (1.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.75e-2)" 5.1 2.0 4.8 2.1 2.9 0.6 5.1 46.7 5.2 3.3 1.7 2.2 4.5 1.4 3.5 4.0 3.0 2.7 5.4 12.3 2.7 5.0 2.1 1.2 7.4 1.3 3.0 1.5 1.7 5.9 3.0 2.6 2.1 13.0 3.0 1.1 1.7 1.6 4.3 1.5 2.4 1.3 3.5 2.5 2.2 4.3 3.7 1.1 0.0 1.7 0.9 1.4 1.6 4.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.6 3.1 0.8 0.8 1.8 1.4 0.0 1.6 0.6 1.2 0.7 1.2 1.9 0.0 0.6 1.3 0.8 1.5 1.2 2.3 1.8 0.0 1.6 1.5 3.7 0.7 0.1 0.0 0.1 0.9 3.1 2.1 6.6 3.7 1.6 0.3 0.9 0.0 0.6 0.9 0.0 0.0 0.8 0.7 1.2 0.0 1.0 0.4 4.4 0.6 13.3 3.5 0.8 2.8 0.5 1.1 7.1 1.6 1.4 3.5 3.3 0.9 3.0 0.9 0.4 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 2.9 46.7 3.3 2.7 5.0 3.0 1.5 13.0 1.1 11.9 2.6 0.0 5.5 3.5 1.9 24.5 7.6 0.0 6.8 1.8 0.0 0.1 0.0 3.4 39.4 2.7 0.7 0.0 1.2 0.5 2.6 4.8 1.1 0.9 0.9 9.5 1.2 1.3 0.0 56.6 3.4 2.8 1.7 2.8 0.9 0.8 2.2 3.1 2.5 0.3 1.9 6.5 4.1 0.7 1.9 2.4 0.1 0.0 1.7 2.5 MPP4 DLG6 ENSG00000082126 "Membrane palmitoylated protein 4" Q96JB8 2 201644870-201698694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 78.2" "Group enriched" "Detected in many" 41 "Cone photoreceptor cells: 1494.2;Rod photoreceptor cells: 807.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBF TERT88: 11.2;hTEC/SVTERT24-B: 10.5;LHCN-M2: 42.4;TIME: 8.4;U-87 MG: 11.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 8.1" HPA057393 Supported "Actin filaments,Cytosol" No No Cytosol "Actin filaments" "HPA057393: AB_2732612" "unprognostic (1.42e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-1)" "unprognostic (2.50e-2)" "unprognostic (2.22e-2)" "unprognostic (6.66e-2)" "unprognostic (1.09e-2)" "unprognostic (9.42e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-1)" "unprognostic (1.19e-1)" "unprognostic (9.20e-2)" "unprognostic (3.33e-16)" "unprognostic (1.82e-2)" "unprognostic (8.23e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-2)" 0.4 1.7 0.3 0.5 0.6 0.0 0.3 4.9 1.1 1.2 0.2 0.2 0.2 0.0 0.8 0.4 0.3 0.1 0.4 0.2 0.5 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.0 0.7 0.7 0.3 0.3 0.3 78.2 0.2 0.5 0.6 4.1 0.2 0.3 0.2 3.8 0.1 2.2 0.2 0.2 0.6 0.6 0.2 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 5.5 1.3 3.4 3.3 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.4 11.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 10.5 0.0 1.6 6.2 0.0 0.0 0.0 42.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.4 4.3 1.3 0.9 3.8 0.0 0.0 0.0 11.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 4.9 0.6 0.5 0.4 0.2 0.2 0.3 0.2 3.0 10.4 0.0 0.0 0.3 13.4 0.3 2.5 12.0 11.4 1.8 1494.2 0.1 0.0 0.2 2.9 0.1 0.0 0.0 0.2 0.0 0.3 0.0 3.5 0.0 0.1 17.5 0.0 0.0 0.3 2.1 0.0 0.3 1.7 0.0 0.0 28.2 0.1 0.0 0.0 0.0 807.6 0.0 1.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 MPP6 "p55T, PALS2, VAM-1" ENSG00000105926 "Membrane palmitoylated protein 6" Q9NZW5 7 24573268-24694193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 41.2;Spermatocytes: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 9.4" "Group enriched" "Detected in many" 4 "B-cells: 9.4;dendritic cells: 4.0;T-cells: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019085, HPA020456" Enhanced NA NA "HPA019085: AB_1858713, HPA020456: AB_1858714" "unprognostic (2.79e-1)" "unprognostic (3.49e-1)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.10e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (2.18e-3)" "unprognostic (3.80e-2)" "unprognostic (4.07e-2)" "unprognostic (2.84e-1)" "unprognostic (1.29e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.94e-1)" "unprognostic (8.51e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.88e-3)" 4.5 3.7 12.2 4.1 17.9 3.5 4.7 10.2 11.4 2.2 1.9 3.1 0.5 4.4 2.8 1.8 3.8 3.6 22.5 2.4 13.2 5.8 10.5 11.1 2.5 5.6 4.9 11.0 11.7 9.3 0.6 1.9 1.4 5.9 3.5 2.1 1.3 3.3 2.0 10.3 2.8 5.4 4.0 6.8 2.5 3.1 27.3 7.8 2.6 7.5 2.1 5.8 2.6 3.2 9.4 4.0 0.3 1.2 1.4 3.4 0.8 9.8 5.7 6.5 9.6 7.3 5.2 4.7 7.5 4.2 5.3 6.7 17.5 7.6 17.3 6.1 4.6 13.8 6.2 11.3 9.1 10.6 6.9 8.7 2.9 9.8 4.3 5.7 11.4 2.1 5.3 3.9 6.3 11.4 3.9 8.3 10.7 18.6 7.0 6.1 4.0 7.6 3.0 35.7 4.7 9.3 9.3 11.0 9.4 7.4 13.6 5.0 20.6 8.6 8.6 2.5 13.7 4.4 1.7 7.7 3.4 14.6 10.6 14.3 26.2 2.7 35.0 6.1 4.4 12.7 0.2 0.1 0.1 2.9 1.2 1.8 6.3 1.3 2.9 0.2 9.4 3.4 2.9 0.3 1.4 0.1 4.0 1.0 0.8 12.2 17.9 10.2 11.4 13.2 5.8 4.9 11.0 5.9 7.8 6.0 2.7 12.0 9.5 9.8 2.1 3.6 28.1 0.0 6.8 5.2 41.2 1.8 3.3 27.1 22.4 2.2 1.3 0.0 15.7 1.7 14.6 12.0 0.0 15.6 1.3 3.2 2.9 3.1 2.2 24.7 4.9 1.1 1.7 1.0 7.6 1.4 14.5 14.1 6.7 25.8 5.5 0.0 5.0 58.5 23.7 7.8 0.5 6.9 4.9 8.9 MPP7 FLJ32798 ENSG00000150054 "Membrane palmitoylated protein 7" Q5T2T1 10 28050993-28334486 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.2" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 55.2;Suprabasal keratinocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 11.0;CACO-2: 20.7;CAPAN-2: 12.9;T-47d: 41.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037597, HPA037598" Approved Supported "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "HPA037597: AB_2675569, HPA037598: AB_10696941" "unprognostic (1.12e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-3)" "unprognostic (1.49e-1)" "unprognostic (6.64e-2)" "unprognostic (7.78e-2)" "unprognostic (9.31e-3)" "prognostic favorable (5.88e-4)" "unprognostic (2.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "prognostic favorable (2.79e-14)" "unprognostic (2.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.66e-2)" "unprognostic (1.03e-2)" 1.9 1.2 1.9 3.2 1.9 2.6 3.7 3.2 3.0 2.3 6.3 1.9 1.9 1.8 1.9 3.7 16.3 4.6 2.0 2.0 1.9 0.6 4.9 1.9 3.7 4.6 1.9 1.9 1.9 11.3 1.8 7.8 4.2 2.2 2.8 3.5 2.6 5.0 1.9 4.7 11.2 3.3 3.0 1.9 2.4 5.9 33.2 1.9 1.9 5.7 1.9 3.0 3.4 5.4 0.7 8.1 9.0 8.2 4.9 9.2 5.3 2.6 0.0 0.2 0.0 0.0 0.0 11.0 0.5 0.4 2.2 3.5 20.7 12.9 0.0 0.1 1.5 1.6 4.8 1.8 3.4 5.2 0.0 3.5 0.0 0.6 1.2 0.0 0.0 0.0 0.1 5.5 0.3 0.2 0.0 0.0 1.0 0.5 0.0 2.9 4.9 1.0 0.0 0.6 4.0 1.0 0.5 6.2 0.0 0.2 8.7 0.5 0.0 1.1 5.3 0.0 1.8 41.8 0.5 0.0 0.8 6.0 0.0 0.4 0.1 0.0 0.0 0.0 4.9 0.0 0.0 8.2 9.0 4.3 2.7 6.3 0.7 4.7 2.9 8.1 0.6 9.2 6.4 3.3 4.9 1.4 0.1 1.1 5.3 1.9 1.9 3.2 3.0 1.9 0.6 1.9 1.9 2.2 1.9 41.7 38.7 0.0 9.3 20.5 1.2 9.0 12.7 16.0 23.9 14.0 15.7 38.9 8.3 3.5 55.2 2.8 10.9 0.0 10.9 2.0 2.1 11.1 1.1 2.6 4.7 3.2 6.4 1.8 5.6 13.5 0.9 2.5 6.8 0.0 8.9 22.1 7.6 7.0 0.4 7.3 7.0 0.0 4.7 2.5 9.3 53.3 38.9 8.7 10.7 12.8 MPPED1 "239AB, C22orf1, FAM1A" ENSG00000186732 "Metallophosphoesterase domain containing 1" O15442 22 43411196-43507848 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "brain: 33.0;liver: 11.0" "Group enriched" "Detected in some" 6 "Hepatocytes: 8.9;Peritubular cells: 7.1" "Cancer enhanced" "Detected in some" "liver cancer: 1.6" "Group enriched" "Detected in many" 4 "amygdala: 9.3;basal ganglia: 11.0;cerebral cortex: 32.1;hippocampal formation: 16.2;olfactory region: 17.4" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;plasmacytoid DC: 1.8" "Group enriched" "Detected in many" 16 "dendritic cells: 1.8;granulocytes: 1.3" "Group enriched" "Detected in some" 5 "HaCaT: 11.9;SCLC-21H: 4.9" "Group enriched" "Detected in many" 5 "amygdala: 108.6;basal ganglia: 66.9;cerebral cortex: 165.8;hippocampal formation: 190.7" "Group enriched" "Detected in all" 5 "cerebral cortex: 131.1;hippocampal formation: 116.7" NA NA "unprognostic (1.15e-1)" "unprognostic (4.29e-1)" "unprognostic (8.17e-2)" "unprognostic (4.81e-2)" "unprognostic (9.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.47e-2)" "unprognostic (2.04e-1)" "unprognostic (3.19e-1)" "unprognostic (4.46e-4)" "unprognostic (1.09e-1)" "unprognostic (4.32e-3)" "unprognostic (1.30e-1)" "unprognostic (2.87e-1)" "unprognostic (6.92e-3)" 0.5 0.8 9.3 0.6 11.0 0.5 0.8 0.5 33.0 0.6 0.6 0.8 0.0 0.7 1.2 1.2 0.5 0.7 0.5 0.7 16.2 2.2 0.6 11.0 0.5 0.6 3.8 17.4 1.9 0.5 0.5 0.9 0.5 0.7 1.2 0.6 0.0 0.6 0.6 0.5 1.4 0.7 0.6 2.9 0.6 0.9 2.1 0.1 0.0 0.5 0.0 0.6 0.6 0.1 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 9.3 11.0 0.5 32.1 16.2 2.2 3.8 17.4 0.7 0.1 0.0 0.0 0.0 0.0 0.5 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 31.0;thyroid gland: 30.0" "Cell type enhanced" "Detected in many" 21 "Cone photoreceptor cells: 269.0;Horizontal cells: 77.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 19.2;HAP1: 11.4;JURKAT: 10.0;RT4: 8.0;SH-SY5Y: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria NA NA Nucleoli "Vesicles, Mitochondria" "HPA062575: AB_2684797" "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.9 7.0 6.3 1.7 19.3 1.1 5.5 4.6 8.9 31.0 4.2 1.8 4.4 1.5 8.3 7.9 1.6 11.1 1.9 4.6 8.5 9.7 12.2 1.2 1.1 0.9 7.0 6.7 1.2 2.5 5.0 10.7 2.5 11.2 15.6 1.4 7.1 12.1 10.1 5.7 1.0 1.4 5.1 4.6 3.1 1.9 3.8 3.4 9.1 30.0 1.2 1.0 4.7 4.9 1.3 0.7 0.3 0.2 2.0 4.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 11.4 0.0 0.0 0.0 2.1 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.8 0.0 0.2 3.2 0.1 0.0 0.0 3.1 0.2 0.0 8.0 0.1 6.1 0.0 0.0 3.1 1.3 1.7 0.0 0.1 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.9 0.0 4.8 0.0 0.0 0.6 0.4 1.3 1.3 0.2 0.2 2.0 0.0 0.7 0.1 0.2 6.3 19.3 4.6 8.8 8.5 9.7 7.0 6.7 11.2 3.4 0.0 2.1 0.0 47.3 0.9 23.4 3.1 0.0 5.3 0.0 43.6 269.0 0.2 21.6 2.9 1.6 5.0 0.0 0.0 0.0 0.1 4.1 21.0 4.7 0.2 3.2 77.9 0.0 0.6 15.9 0.5 0.3 2.3 5.0 0.0 0.0 40.1 0.1 0.0 3.2 2.2 17.1 0.0 1.4 0.1 0.7 1.0 0.5 0.0 0.0 18.4 MPST "MST, TST2, TUM1" ENSG00000128309 "Mercaptopyruvate sulfurtransferase" P25325 22 37019635-37029822 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 106.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 780.2;Hepatocytes: 473.7;Paneth cells: 550.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001240 Enhanced Approved Mitochondria,Cytosol NA NA 2800000 Mitochondria Cytosol "HPA001240: AB_1079408" "unprognostic (7.18e-3)" "unprognostic (4.45e-1)" "unprognostic (1.80e-1)" "unprognostic (1.30e-3)" "unprognostic (1.73e-3)" "unprognostic (1.43e-1)" "unprognostic (7.07e-2)" "unprognostic (2.15e-1)" "unprognostic (2.22e-1)" "unprognostic (1.35e-1)" "unprognostic (2.25e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-3)" "unprognostic (3.98e-2)" "unprognostic (3.51e-1)" "unprognostic (2.52e-1)" "prognostic favorable (5.89e-4)" 8.7 7.2 4.5 6.8 6.4 10.5 22.7 2.6 5.4 8.8 39.1 8.0 2.8 36.8 6.1 3.0 19.8 4.3 15.3 14.1 4.6 2.3 14.1 106.2 10.3 5.4 8.8 3.8 12.6 20.7 0.7 2.7 4.2 5.6 6.6 5.7 3.8 13.4 3.9 11.5 15.9 33.7 4.8 4.8 4.1 12.8 24.9 7.1 2.1 6.3 6.2 5.1 8.7 11.6 9.6 37.1 18.5 26.5 28.8 16.1 12.5 14.3 17.0 8.3 17.1 9.8 6.1 13.2 7.8 7.1 8.6 11.5 16.2 6.4 22.6 11.4 5.6 5.7 10.1 7.2 11.4 1.2 13.6 40.3 8.7 7.4 38.0 31.0 9.4 12.2 10.6 22.2 5.6 5.2 7.9 17.3 11.2 15.5 6.6 2.3 11.1 0.8 32.0 15.7 18.8 17.7 24.3 9.9 16.8 8.6 4.7 4.2 32.0 5.2 8.3 14.9 4.4 8.9 15.2 13.3 7.4 21.0 8.1 5.3 11.6 5.3 6.8 2.6 11.5 3.7 15.3 26.5 18.5 11.8 9.4 16.1 9.6 7.7 9.9 37.1 9.6 1.1 4.1 7.9 28.8 4.3 6.0 15.2 12.5 4.5 6.4 2.6 5.4 4.6 2.3 8.8 3.8 5.6 7.1 32.8 55.2 24.6 70.3 72.5 4.6 26.6 188.5 1.4 19.4 57.6 0.0 50.1 112.7 124.1 138.8 35.9 780.2 116.8 129.7 102.0 53.0 67.5 17.3 473.7 65.5 3.2 104.3 84.7 67.1 60.3 84.3 59.9 55.6 57.7 299.4 16.4 119.7 550.6 79.5 318.0 2.6 45.3 28.3 7.9 12.0 133.6 41.9 42.6 311.7 103.6 MPV17L "FLJ39599, MLPH1, MLPH2, MPV17L1" ENSG00000156968 "MPV17 mitochondrial inner membrane protein like" Q2QL34 16 15395754-15413268 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 33.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HMC-1: 30.3" HPA041180 Approved Supported Vesicles NA NA Vesicles "HPA041180: AB_10794266" "unprognostic (9.65e-2)" "unprognostic (8.74e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (2.73e-1)" "unprognostic (4.38e-3)" "unprognostic (8.41e-2)" "unprognostic (8.99e-3)" "unprognostic (8.70e-2)" "unprognostic (6.36e-3)" "prognostic favorable (1.48e-11)" "unprognostic (2.84e-1)" "unprognostic (7.60e-2)" "unprognostic (6.61e-3)" "unprognostic (3.87e-2)" 3.1 4.9 6.2 3.7 8.7 8.3 16.0 6.8 8.0 7.1 4.5 10.5 1.6 7.1 4.5 3.1 2.5 3.3 5.7 3.7 7.4 5.4 8.2 12.2 2.3 4.7 5.8 6.1 4.8 33.1 10.6 11.7 1.4 6.3 3.7 2.9 9.7 10.1 5.0 16.0 9.1 5.6 9.4 7.2 3.7 4.1 2.7 7.0 0.0 5.2 1.3 1.6 4.8 2.4 4.0 2.2 5.7 3.6 3.6 2.5 1.2 0.8 1.6 0.6 0.6 0.1 0.1 1.0 0.4 0.0 0.0 0.0 1.5 2.9 1.2 1.2 0.5 0.4 1.2 2.9 0.0 0.0 0.9 0.8 5.9 3.6 3.0 0.3 2.8 30.3 0.2 0.3 0.1 0.2 0.4 0.0 1.2 1.8 2.7 0.0 1.6 0.9 1.7 1.5 0.2 1.0 1.5 0.5 1.1 0.5 0.6 4.8 1.7 2.5 7.0 0.2 0.7 1.5 2.0 2.0 1.1 0.6 0.9 0.8 1.1 0.4 1.3 0.6 1.3 0.4 3.9 3.6 0.6 2.3 2.7 1.9 2.1 1.5 2.4 1.2 4.0 1.5 2.5 5.7 3.6 1.0 2.2 1.2 1.2 6.2 8.7 6.8 8.0 7.4 5.4 5.8 6.1 6.3 7.0 6.0 9.1 2.9 11.2 7.0 12.3 5.0 10.2 22.7 14.8 0.0 9.8 0.4 13.3 6.8 2.5 4.5 2.6 0.0 11.2 0.4 10.3 5.6 5.8 26.3 0.9 7.9 1.2 5.5 8.3 0.4 6.6 6.9 20.3 0.0 6.2 5.7 8.5 14.8 13.4 14.6 14.8 0.0 11.3 4.1 2.1 10.0 0.5 3.1 10.5 8.4 MPZ "CMT1, CMT1B, CMT2I, CMT2J, HMSNIB" ENSG00000158887 "Myelin protein zero" P25189 1 161304735-161309972 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.7;retina: 60.6" "Cell type enhanced" "Detected in many" 5 "monocytes: 5.4;Sertoli cells: 6.5" "Cancer enriched" "Detected in many" 11 "melanoma: 83.9" "Region enriched" "Detected in many" 4 "midbrain: 118.7" "Group enriched" "Detected in some" 6 "eosinophil: 1.9;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.9" "Cell line enriched" "Detected in some" 5 "WM-115: 68.2" "Group enriched" "Detected in some" 5 "olfactory region: 3.6;pons and medulla: 1.4" "Region enriched" "Detected in single" 58 "midbrain: 262.7" HPA068925 Enhanced NA NA "HPA068925: AB_2732123" "unprognostic (6.77e-2)" "unprognostic (2.98e-1)" "unprognostic (9.27e-2)" "unprognostic (1.46e-1)" "unprognostic (3.35e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "unprognostic (7.88e-3)" "unprognostic (1.51e-1)" "unprognostic (6.62e-8)" "unprognostic (6.75e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (8.32e-2)" 14.3 12.6 2.2 3.4 2.9 1.3 4.7 6.0 2.2 4.5 6.1 2.6 9.9 2.6 1.7 7.5 8.7 1.5 4.3 7.2 2.4 4.3 3.2 7.9 3.1 1.3 118.7 0.7 1.9 2.2 0.5 7.4 0.8 28.4 7.3 5.0 60.6 6.4 15.6 4.2 2.3 6.3 5.6 40.9 6.8 2.1 2.7 0.8 0.2 2.8 26.3 3.0 9.3 3.3 0.1 0.0 1.9 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.4 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.7 0.5 0.1 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.3 0.1 12.6 0.4 1.5 1.2 1.4 0.0 2.1 0.1 0.0 0.9 0.6 3.2 0.0 1.4 0.0 0.2 2.5 0.5 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 6.5 0.3 0.0 3.1 0.9 0.1 0.1 0.9 0.0 0.3 0.3 0.4 1.6 5.7 68.2 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.2 0.1 2.2 2.9 6.0 2.2 2.4 4.3 118.7 0.7 28.4 0.8 3.0 1.1 0.0 2.3 0.5 2.8 0.2 0.0 0.0 0.0 3.5 2.0 0.4 0.0 0.1 4.2 0.8 0.0 0.0 1.0 0.5 0.2 1.3 0.0 0.8 1.6 1.6 1.7 3.1 2.7 1.1 1.4 1.2 3.3 5.4 0.4 0.7 0.1 0.0 0.4 0.3 1.1 6.5 0.8 0.5 0.7 0.4 0.2 0.5 0.4 1.4 MPZL2 "EVA, EVA1" ENSG00000149573 "Myelin protein zero like 2" O60487 11 118253403-118264536 "Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 405.2;Basal keratinocytes: 295.4;Suprabasal keratinocytes: 408.6;Urothelial cells: 416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9" "Group enriched" "Detected in many" 10 "dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 25.3;EFO-21: 27.9;HaCaT: 34.9;RT4: 66.3;TIME: 72.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060740 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA060740: AB_2684352" "unprognostic (1.74e-1)" "unprognostic (6.02e-2)" "unprognostic (8.23e-2)" "unprognostic (3.28e-3)" "unprognostic (9.95e-3)" "unprognostic (1.56e-1)" "unprognostic (2.11e-3)" "unprognostic (3.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.62e-4)" "unprognostic (2.08e-2)" 11.7 1.7 1.5 2.8 1.5 0.0 17.1 1.5 1.6 31.0 8.5 1.0 26.3 4.4 6.8 17.8 103.8 13.4 12.3 4.7 2.4 1.5 11.7 7.9 21.7 1.8 2.4 0.6 7.4 4.6 10.2 9.2 1.5 4.0 17.8 8.7 6.2 21.6 32.8 7.8 11.4 4.4 5.6 4.3 1.3 10.0 3.7 1.3 5.7 21.7 52.3 41.1 29.4 37.4 0.0 13.4 10.9 9.3 0.3 1.0 2.8 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 25.3 0.0 27.9 0.0 0.1 34.9 0.0 8.0 0.0 0.0 2.0 0.0 0.3 7.3 0.0 0.0 0.0 0.0 19.2 0.0 0.6 0.0 18.2 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.3 7.0 0.0 0.0 0.0 1.3 3.1 66.3 0.0 0.0 1.2 12.9 0.0 0.1 5.5 0.1 72.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.3 2.3 0.1 7.2 1.0 0.0 0.5 0.4 13.4 0.0 0.6 0.7 10.9 0.3 1.0 0.2 0.2 2.8 1.5 1.5 1.5 1.6 2.4 1.5 2.4 0.6 4.0 1.3 77.4 91.1 0.0 405.2 295.4 0.0 3.4 28.1 46.8 146.7 122.1 0.0 1.0 0.0 32.1 0.0 28.8 29.1 0.0 45.6 0.1 7.2 133.5 6.9 13.6 0.8 0.0 5.1 23.4 4.0 0.0 0.0 11.0 20.3 0.0 3.3 0.0 45.3 14.8 0.0 5.6 0.0 0.0 7.1 0.0 0.6 408.6 14.9 2.6 32.4 416.5 MRAP "B27, C21orf61, FALP" ENSG00000170262 "Melanocortin 2 receptor accessory protein" Q8TCY5 21 32291813-32314784 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 41.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "basal ganglia: 2.6" "Cell type enhanced" "Detected in many" "NK-cell: 5.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Hep G2: 4.7;HSkMC: 5.4" "HPA011024, HPA011093" Uncertain Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA011024: AB_10599292, HPA011093: AB_10600889" "unprognostic (1.38e-1)" "unprognostic (1.55e-3)" "unprognostic (1.53e-1)" "unprognostic (1.11e-1)" "unprognostic (9.53e-2)" "unprognostic (1.31e-1)" "unprognostic (1.38e-1)" "unprognostic (2.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.80e-2)" "unprognostic (4.12e-1)" "unprognostic (6.30e-6)" "unprognostic (3.32e-2)" "unprognostic (2.37e-1)" "unprognostic (1.18e-1)" "unprognostic (5.76e-2)" 28.3 52.7 0.0 1.6 2.6 0.0 68.6 0.3 0.1 0.0 3.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.4 1.6 0.0 0.0 0.1 0.6 0.2 1.8 0.2 0.1 0.8 0.1 0.0 0.0 1.1 0.3 0.1 0.1 0.2 1.7 0.0 0.9 0.2 1.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.1 0.6 4.3 1.8 1.5 0.0 0.5 5.5 1.8 0.1 0.0 0.4 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.9 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.9 0.5 0.7 1.8 0.7 1.2 0.5 1.4 0.8 1.6 0.0 5.5 0.3 1.5 1.8 0.1 0.0 2.6 0.3 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.3 0.1 41.3 0.0 0.0 0.0 4.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 MRAP2 "bA51G5.2, C6orf117" ENSG00000135324 "Melanocortin 2 receptor accessory protein 2" Q96G30 6 84033756-84090881 "Disease related genes, Predicted membrane proteins" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 12.2;Mucus-secreting cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Lineage enhanced" "Detected in single" "B-cells: 2.3" "Group enriched" "Detected in some" 6 "K-562: 43.5;SCLC-21H: 15.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.82e-4)" "unprognostic (7.11e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.66e-4)" "unprognostic (8.80e-3)" "unprognostic (3.15e-1)" "unprognostic (9.85e-2)" "unprognostic (7.43e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-3)" "unprognostic (1.41e-2)" "unprognostic (4.47e-1)" "unprognostic (6.02e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (4.50e-3)" "unprognostic (9.12e-2)" 1.4 9.6 7.8 1.5 11.6 0.2 2.1 14.5 19.0 3.6 6.8 3.5 4.2 4.7 3.5 1.5 2.0 10.8 3.5 1.2 5.2 16.3 4.6 0.4 1.2 0.6 5.8 14.5 6.4 5.4 0.2 3.7 0.3 8.4 8.2 6.6 4.7 7.4 10.3 1.5 2.5 5.0 1.5 3.0 8.0 10.0 3.2 1.9 0.1 0.8 2.0 2.1 1.2 2.1 2.3 0.1 0.6 0.0 0.0 0.1 0.1 0.0 1.2 0.4 0.0 0.1 0.7 0.0 0.4 0.0 0.7 0.1 0.5 0.0 0.1 0.0 4.7 1.6 0.0 0.8 0.1 0.0 0.4 0.4 1.5 0.1 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 0.0 2.8 0.0 43.5 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.2 0.0 2.5 0.0 2.6 0.7 15.2 5.1 0.1 0.0 0.7 0.6 0.1 1.3 0.2 0.2 0.2 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 2.3 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.1 7.8 11.6 14.5 19.0 5.2 16.3 5.8 14.5 8.4 1.9 0.0 0.3 0.0 6.7 1.5 0.6 0.3 0.0 2.7 2.3 12.2 0.0 0.0 1.7 2.7 2.2 0.7 2.8 0.0 4.8 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.2 3.7 0.0 0.0 0.0 12.4 0.0 0.6 7.0 4.9 0.0 0.2 0.0 1.4 0.2 2.7 0.9 0.0 0.0 3.7 2.4 MRAS "M-RAs, R-RAS3, RRAS3" ENSG00000158186 "Muscle RAS oncogene homolog" O14807 3 138347648-138405534 "Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 69.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 103.5;Distal tubular cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 18.9" "Lineage enriched" "Detected in many" 9 "monocytes: 18.9" "Cell line enhanced" "Detected in many" "ASC diff: 29.2;BJ: 31.3;EFO-21: 39.0;fHDF/TERT166: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042728 Approved Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA042728: AB_10796582" "unprognostic (1.96e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.69e-1)" "unprognostic (5.32e-2)" "unprognostic (8.96e-2)" "unprognostic (3.85e-3)" "unprognostic (1.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (3.18e-3)" "unprognostic (1.78e-2)" "unprognostic (6.25e-2)" "unprognostic (2.21e-1)" "unprognostic (4.23e-2)" 49.3 32.6 32.0 6.4 37.6 1.3 17.7 12.3 37.3 6.4 5.4 9.4 1.7 2.3 11.9 5.2 5.1 6.8 8.6 69.1 29.0 23.9 8.9 3.7 8.9 3.3 31.3 18.0 17.2 3.4 7.6 4.7 6.9 25.2 7.6 3.4 8.2 8.0 12.0 22.5 2.7 2.7 16.9 21.5 7.3 3.4 5.9 19.3 0.0 12.1 2.4 2.8 10.0 6.4 0.0 2.1 0.3 18.9 0.6 0.0 0.5 0.2 2.5 6.7 8.8 29.2 13.4 13.9 31.3 7.9 3.2 3.9 1.1 1.0 0.1 39.0 30.6 8.3 0.0 3.3 0.7 2.5 2.7 1.0 0.1 1.6 6.4 7.4 0.0 0.6 19.2 3.0 0.2 0.5 5.9 0.5 0.0 3.5 0.2 14.4 1.1 0.0 7.6 7.3 0.0 0.9 0.3 12.2 0.0 14.1 0.6 7.0 15.5 20.5 0.2 16.4 5.0 6.0 15.2 0.1 8.2 9.3 8.9 0.8 0.0 0.3 0.3 8.3 0.0 4.5 0.1 1.6 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.6 18.9 0.1 0.0 0.5 32.0 37.6 12.3 28.9 29.0 23.9 31.3 18.0 25.2 19.3 8.9 1.0 0.5 2.6 1.9 4.1 103.5 5.1 1.4 4.5 8.7 9.8 16.8 49.7 8.5 9.6 16.3 0.0 0.0 2.7 2.0 11.9 1.9 5.8 1.5 26.7 27.0 1.7 8.6 13.8 26.2 21.6 13.8 27.0 15.4 0.0 15.8 4.3 0.0 32.2 23.1 10.4 6.5 19.8 4.6 11.9 0.9 12.0 0.0 0.0 0.5 MRC1 "bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1" ENSG00000260314 "Mannose receptor C-type 1" P22897 10 17809344-17911170 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 44.8;lymphoid tissue: 37.8" "Group enriched" "Detected in many" 6 "Hofbauer cells: 135.5;Ito cells: 511.3;Kupffer cells: 324.4;Macrophages: 182.8" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "myeloid DC: 8.2" "Lineage enriched" "Detected in single" 15 "dendritic cells: 8.2" "Group enriched" "Detected in some" 19 "MOLT-4: 17.7;TIME: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004114, HPA045134, CAB068203" Enhanced NA NA 130000000 "CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.03e-2)" "unprognostic (2.58e-1)" "unprognostic (5.62e-2)" "unprognostic (4.30e-1)" "unprognostic (6.36e-3)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (6.05e-2)" "unprognostic (5.61e-2)" "unprognostic (4.12e-1)" "unprognostic (2.94e-2)" "unprognostic (4.97e-2)" "unprognostic (3.05e-2)" "unprognostic (1.74e-2)" "unprognostic (7.02e-2)" 34.8 8.3 0.3 6.2 1.2 0.0 19.8 0.7 0.6 5.2 11.2 0.6 0.9 2.2 4.5 10.4 4.2 1.3 7.9 13.4 0.9 12.4 16.4 44.8 37.8 1.0 0.0 3.6 5.1 1.8 2.4 15.4 3.1 5.5 5.1 7.0 0.7 1.9 5.1 0.0 6.5 8.2 1.4 30.6 2.2 7.1 0.8 0.8 6.5 3.5 0.7 7.5 5.1 0.0 8.2 0.1 0.5 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 17.7 0.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.2 29.8 47.4 11.5 0.0 0.3 0.0 3.6 5.1 10.7 13.6 0.0 0.0 0.8 0.0 0.0 26.7 4.8 1.3 0.0 0.3 1.1 1.0 0.0 12.8 2.5 135.5 0.0 0.0 511.3 324.4 7.9 1.4 182.8 0.0 0.0 0.4 0.0 0.1 1.1 0.0 0.0 0.0 32.3 0.0 0.3 1.2 0.4 1.7 4.9 0.8 0.0 MRGBP "C20orf20, Eaf7, FLJ10914, MRG15BP" ENSG00000101189 "MRG domain binding protein" Q9NV56 20 62796453-62801738 "Plasma proteins, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 55.3" "Group enriched" "Detected in many" 8 "Early spermatids: 101.9;Late spermatids: 283.4;Spermatocytes: 115.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017012 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA017012: AB_1845679" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (8.56e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.02e-2)" "unprognostic (3.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.17e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (2.48e-6)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "unprognostic (2.25e-1)" "unprognostic (6.01e-3)" 5.7 6.7 6.3 6.1 6.6 6.6 5.8 7.8 9.1 5.4 7.7 6.8 4.4 9.2 5.7 4.6 6.2 5.2 5.4 8.9 5.6 5.3 6.5 9.4 5.6 8.0 6.5 5.5 10.5 10.6 5.9 6.6 8.4 5.1 5.7 4.9 6.5 8.4 7.3 8.5 6.3 9.7 8.4 4.0 8.5 6.7 55.3 6.0 8.3 6.2 6.2 6.1 6.6 7.5 1.7 2.0 2.8 3.7 0.6 3.8 1.2 14.3 9.1 7.5 11.5 4.1 6.3 7.3 8.3 10.8 32.5 14.2 32.4 11.5 13.2 16.7 6.4 16.1 12.2 8.5 14.1 18.4 4.1 7.3 9.6 9.8 18.6 6.5 11.2 18.2 5.4 10.4 8.8 9.4 6.9 7.7 12.8 13.0 7.3 8.1 21.8 21.1 21.3 6.3 15.1 16.5 19.0 14.3 9.8 4.9 5.9 10.6 8.6 11.9 10.7 15.0 4.3 13.1 16.4 7.9 20.3 21.2 13.7 17.6 9.8 6.0 15.7 20.0 11.2 11.3 0.0 2.2 2.8 2.0 3.7 2.7 1.5 2.5 2.7 1.5 1.7 1.9 3.8 2.4 0.6 1.5 2.0 2.7 1.2 6.3 6.6 7.8 9.1 5.6 5.3 6.5 5.5 5.1 6.0 0.0 2.1 8.2 13.4 13.1 10.5 8.1 7.6 1.4 3.4 12.2 7.9 9.6 16.6 19.6 101.9 10.3 9.8 0.0 19.2 21.5 10.4 13.1 1.1 12.7 12.6 12.7 2.4 7.4 8.4 283.4 11.2 12.2 6.8 14.4 10.2 10.6 18.6 7.0 7.4 13.8 12.6 0.0 8.9 115.6 17.2 11.4 12.2 10.9 11.8 16.5 MRGPRD mrgD ENSG00000172938 "MAS related GPR family member D" Q8TDS7 11 68980021-68980986 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "JURKAT: 4.7" "Not detected" "Not detected" HPA031346 Uncertain NA NA "HPA031346: AB_10602710" "unprognostic (1.92e-1)" "unprognostic (7.14e-2)" "unprognostic (1.72e-1)" 0.4 0.4 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.9 2.5 0.0 1.8 0.0 0.9 0.9 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.2 0.0 0.1 0.8 1.1 0.0 0.0 0.5 0.3 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRE "GPR167, mrgE" ENSG00000184350 "MAS related GPR family member E" Q86SM8 11 3227698-3232386 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 34.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Region enriched" "Detected in many" 14 "pons and medulla: 34.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NB-4: 2.6;RPMI-8226: 5.0;SCLC-21H: 8.2" "Low region specificity" "Detected in many" HPA046556 Uncertain NA NA "HPA046556: AB_10961404" "unprognostic (1.18e-1)" "unprognostic (7.52e-4)" "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (6.65e-2)" "unprognostic (1.77e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-1)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" 0.1 0.8 0.1 0.1 0.3 2.1 0.8 1.5 2.0 3.5 0.8 0.0 0.0 0.0 2.0 0.7 0.6 1.7 0.5 1.1 0.6 2.3 0.1 0.0 0.3 0.0 2.5 0.0 0.1 0.3 0.0 0.5 1.8 34.9 1.1 0.0 3.9 1.6 1.3 0.1 0.3 0.3 0.5 1.5 1.9 0.1 0.2 0.1 0.0 0.9 0.2 0.0 0.6 1.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 8.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.1 0.3 1.5 2.0 0.6 2.3 2.5 0.0 34.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRG "GPR169, mrgG" ENSG00000182170 "MAS related GPR family member G" Q86SM5 11 3217944-3218813 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NB-4: 1.1;REH: 2.6;SCLC-21H: 4.0" "Not detected" "Not detected" HPA058909 Uncertain NA NA "HPA058909: AB_2683852" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRX2 MRGX2 ENSG00000183695 "MAS related GPR family member X2" Q96LB1 11 19054455-19060681 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 9.2" "Cell type enriched" "Detected in single" 9 "Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 2.0" "Lineage enriched" "Detected in single" 21 "T-cells: 2.0" "Cell line enriched" "Detected in single" 4 "U-266/84: 1.9" HPA055220 Approved NA NA "HPA055220: AB_2682743" "unprognostic (1.56e-2)" "unprognostic (1.79e-1)" 5.2 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 2.8 0.5 0.0 0.0 0.0 2.0 1.0 0.7 0.1 2.9 0.1 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.7 1.1 0.0 1.3 0.0 0.3 4.3 0.5 9.2 0.0 0.3 0.4 0.8 0.0 0.0 0.0 1.6 0.4 2.8 2.2 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRGPRX3 MRGX3 ENSG00000179826 "MAS related GPR family member X3" Q96LB0 11 18120955-18138480 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 10.3;salivary gland: 7.9;tongue: 4.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 7 "HBEC3-KT: 18.2" NA NA "unprognostic (1.54e-3)" "unprognostic (5.07e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (2.09e-1)" 0.1 0.0 0.1 0.8 0.1 0.4 10.3 0.1 0.3 0.3 0.1 0.1 0.1 0.3 0.1 0.1 3.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.1 0.9 0.1 0.1 0.1 4.4 1.4 0.1 0.5 0.1 0.2 1.6 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 2.6 0.4 0.0 18.2 0.0 0.1 0.3 0.0 0.1 0.6 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.7 0.4 0.2 0.3 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.7 0.1 0.0 0.8 0.2 0.2 0.5 0.4 0.2 0.1 1.9 1.2 0.4 0.2 0.7 0.2 0.1 0.2 0.3 0.5 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 MRLN "Linc-RAM, LINC00948, M1, MLN, MUSER1" ENSG00000227877 Myoregulin P0DMT0 10 59736692-59756041 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.1;skeletal muscle: 59.2;tongue: 22.0" "Group enriched" "Detected in some" 5 "Ciliated cells: 65.6;Rod photoreceptor cells: 27.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 10 "RH-30: 22.7" "Region enriched" "Detected in single" 11 "cerebellum: 24.2" "Low region specificity" "Detected in some" NA NA "unprognostic (2.32e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (4.54e-1)" "unprognostic (3.17e-3)" "unprognostic (9.77e-2)" "unprognostic (1.09e-2)" "unprognostic (8.49e-2)" "unprognostic (1.23e-1)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (6.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" 0.8 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 2.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 4.4 0.0 0.9 0.4 0.0 1.2 0.1 0.0 59.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.9 22.0 0.7 0.0 0.0 2.5 1.7 4.2 1.4 1.7 2.4 0.4 0.0 0.8 0.4 0.9 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.8 0.6 1.1 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.7 0.2 1.9 0.3 0.1 0.0 1.1 1.9 0.0 0.6 0.0 0.1 0.0 0.1 0.1 1.3 0.0 2.1 0.0 0.9 0.2 0.2 1.6 0.5 22.7 0.0 0.0 0.1 0.6 0.2 0.3 0.1 0.1 0.1 0.4 0.7 0.0 0.3 0.8 0.9 0.6 1.1 0.1 0.1 0.4 0.3 0.0 4.2 1.4 1.6 2.4 1.0 1.7 2.0 1.7 1.5 1.2 2.5 1.2 2.1 4.2 1.7 1.0 1.7 1.5 0.4 0.0 0.3 0.0 0.0 0.0 2.2 0.9 0.0 65.6 3.4 0.0 2.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 4.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 3.3 0.4 0.0 0.4 10.2 27.6 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 MRO "B29, C18orf3, FLJ30140" ENSG00000134042 Maestro Q9BYG7 18 50795120-50825402 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.5;kidney: 24.3;testis: 30.9" "Group enriched" "Detected in some" 4 "Ito cells: 55.9;Kupffer cells: 14.2" "Cancer enriched" "Detected in some" 7 "glioma: 6.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 4.6;ASC TERT1: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022011 Approved NA NA "HPA022011: AB_2670880" "unprognostic (9.21e-5)" "unprognostic (5.22e-2)" "unprognostic (7.87e-3)" "unprognostic (1.45e-2)" "unprognostic (2.47e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-2)" "unprognostic (5.11e-2)" "unprognostic (3.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.32e-1)" "unprognostic (4.71e-1)" "unprognostic (5.15e-3)" "unprognostic (1.14e-1)" "unprognostic (3.99e-3)" "unprognostic (6.06e-4)" 2.7 3.2 12.2 0.9 13.9 0.6 1.0 4.5 17.5 0.7 0.7 13.9 1.0 8.3 0.5 4.1 0.9 0.7 1.7 4.4 15.4 5.9 24.3 7.7 0.7 0.7 9.1 10.3 3.8 2.2 3.8 1.3 1.2 11.1 0.7 0.6 1.6 0.7 2.7 2.4 0.5 5.3 0.7 10.7 2.5 1.8 30.9 12.4 0.0 6.6 0.0 0.5 0.8 0.6 0.8 0.9 2.1 1.2 0.5 0.4 0.0 0.0 0.0 0.1 0.3 4.6 14.0 1.1 0.0 0.0 0.0 0.0 0.2 0.2 0.4 2.2 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.6 0.1 0.4 0.2 0.4 0.1 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.2 1.0 0.5 0.2 0.3 0.9 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.1 0.5 1.2 0.9 0.2 0.0 12.2 13.9 4.5 11.2 15.4 5.9 9.1 10.3 11.1 12.4 0.0 0.0 2.2 0.1 0.0 0.0 5.3 2.5 0.0 0.0 0.0 2.0 0.0 5.0 0.0 0.5 0.0 0.0 0.0 0.9 0.6 0.2 0.1 0.0 4.3 8.7 0.0 0.0 55.9 14.2 2.2 1.1 0.1 0.0 0.0 0.0 3.9 0.1 0.0 0.7 7.5 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 MROH2A HEATR7B1 ENSG00000185038 "Maestro heat like repeat family member 2A" A6NES4 2 233775679-233833423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 1.8;testis: 5.0;thyroid gland: 5.1" "Cell type enhanced" "Detected in single" 13 "Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RT4: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA052107 Uncertain Uncertain Cytosol NA NA Cytosol "HPA052107: AB_2681729" "unprognostic (7.00e-2)" "unprognostic (3.37e-3)" "unprognostic (4.77e-1)" "unprognostic (1.65e-2)" "unprognostic (4.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.87e-1)" "unprognostic (4.41e-2)" "unprognostic (2.69e-1)" "unprognostic (1.67e-1)" "unprognostic (4.32e-2)" "unprognostic (5.05e-2)" "unprognostic (4.06e-9)" "unprognostic (5.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 5.0 5.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 11.6 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.0 0.0 0.0 0.1 MROH2B "DKFZp781F0822, FLJ40243, HEATR7B2" ENSG00000171495 "Maestro heat like repeat family member 2B" Q7Z745 5 40998017-41071342 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 107 "testis: 46.4" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 16.6;Late spermatids: 26.6;Spermatocytes: 5.6" "Cancer enriched" "Detected in single" 6 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059457 Enhanced NA NA "HPA059457: AB_2684026" "unprognostic (1.81e-1)" "unprognostic (3.54e-2)" "unprognostic (1.08e-1)" "unprognostic (3.41e-2)" "unprognostic (2.35e-1)" "unprognostic (8.91e-5)" "unprognostic (2.51e-3)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.6 0.7 0.0 0.0 0.0 0.0 0.0 MROH7 "C1orf175, FLJ46354, HEATR8" ENSG00000184313 "Maestro heat like repeat family member 7" Q68CQ1 1 54641754-54710266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 54.2" "Group enriched" "Detected in many" 59 "Early spermatids: 146.5;Late spermatids: 448.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 29 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;SH-SY5Y: 1.6" HPA071840 Enhanced NA NA "HPA071840: AB_2732187" "unprognostic (1.52e-3)" "unprognostic (1.51e-3)" "unprognostic (1.65e-2)" "unprognostic (2.77e-4)" "unprognostic (1.81e-1)" "unprognostic (9.88e-4)" "unprognostic (1.09e-1)" "unprognostic (2.84e-1)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (4.16e-2)" "unprognostic (1.79e-2)" "unprognostic (7.93e-2)" "unprognostic (7.40e-3)" "unprognostic (2.38e-1)" "unprognostic (5.83e-2)" "unprognostic (4.15e-2)" 0.3 0.0 0.5 0.3 0.4 0.5 0.3 0.3 0.4 0.3 1.0 0.3 0.8 0.1 0.3 0.9 0.5 0.4 0.3 0.7 0.3 0.4 0.7 0.3 0.3 0.3 0.3 0.3 1.3 0.3 0.7 1.8 0.3 0.3 0.8 0.3 0.3 1.4 0.6 0.6 0.9 0.4 0.3 0.3 0.3 0.5 54.2 0.3 0.3 2.3 0.3 0.3 0.8 0.3 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.0 2.2 0.0 0.6 0.8 1.7 1.8 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 146.5 0.1 3.9 0.0 0.3 0.0 0.4 0.2 4.7 0.4 0.4 0.0 2.4 0.6 1.0 448.4 4.0 0.0 0.0 1.0 2.6 4.3 0.1 3.1 4.2 0.0 0.2 0.0 0.0 5.0 2.5 0.4 0.1 0.0 1.7 0.5 MROH8 "C20orf131, C20orf132, dJ621N11.3, dJ621N11.4" ENSG00000101353 "Maestro heat like repeat family member 8" Q9H579 20 37101226-37179588 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 27.0;Late spermatids: 25.0;Spermatocytes: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA060298 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060298: AB_2684246" "unprognostic (1.16e-2)" "unprognostic (6.65e-3)" "unprognostic (5.88e-3)" "unprognostic (1.04e-2)" "unprognostic (2.17e-2)" "unprognostic (6.92e-2)" "unprognostic (3.31e-3)" "unprognostic (2.50e-4)" "unprognostic (1.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (9.70e-3)" "unprognostic (5.00e-9)" "unprognostic (1.39e-1)" "unprognostic (1.01e-1)" "unprognostic (3.10e-2)" "unprognostic (1.62e-1)" 3.6 3.1 4.0 1.8 5.9 2.7 2.9 6.6 7.7 3.4 3.4 4.6 2.4 2.1 4.3 9.5 2.0 4.0 2.2 4.9 3.6 5.0 3.6 4.0 1.7 5.5 3.8 5.0 3.7 4.5 4.8 7.3 1.9 4.1 3.4 2.1 6.2 4.7 5.9 12.0 3.4 1.9 4.1 3.4 2.6 2.5 33.7 2.7 3.1 4.8 2.4 3.7 2.8 2.0 2.6 7.2 8.0 2.2 1.0 2.0 1.1 1.3 3.6 8.9 2.2 3.5 3.6 1.4 1.3 5.0 3.1 3.8 2.3 1.8 7.7 0.4 1.3 5.8 2.2 2.3 1.0 2.5 1.3 0.2 2.4 1.9 1.9 3.1 2.5 3.8 2.1 2.2 1.2 0.1 2.6 2.4 3.6 3.2 1.6 2.0 0.7 6.9 7.0 1.0 1.0 2.2 5.9 1.9 1.5 1.7 1.4 3.1 4.2 2.3 0.9 1.5 2.5 2.2 2.7 2.8 9.5 1.5 0.5 0.6 2.9 2.2 4.8 3.2 1.6 3.1 1.9 2.1 0.7 1.8 2.2 2.0 2.6 1.2 2.0 1.0 2.5 0.6 1.4 8.0 1.0 1.0 7.2 0.7 1.1 4.0 5.9 6.6 7.7 3.6 5.0 3.8 5.0 4.1 2.7 3.0 1.1 0.0 0.8 0.6 5.7 2.8 0.0 1.4 0.0 0.0 7.9 3.5 0.0 0.1 27.0 2.4 1.3 0.0 0.2 0.9 3.1 0.8 0.0 3.4 2.4 0.0 1.2 1.3 2.6 25.0 1.4 0.2 1.7 1.0 1.0 3.3 0.1 0.8 2.8 1.7 4.2 0.0 1.0 18.2 3.7 0.4 1.1 0.7 1.3 0.3 MROH9 "ARMC11, C1orf129, FLJ23550" ENSG00000117501 "Maestro heat like repeat family member 9" Q5TGP6 1 170935471-171064765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.1;testis: 4.7" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 17.4;Club cells: 4.5;Early spermatids: 2.7;granulocytes: 3.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "pons and medulla: 1.9" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "BJ: 1.3;BJ hTERT+: 1.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;Daudi: 2.2;SK-MEL-30: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.16e-1)" "unprognostic (1.04e-1)" "unprognostic (7.94e-3)" "unprognostic (3.67e-2)" "unprognostic (9.73e-2)" "unprognostic (7.62e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (8.07e-5)" "unprognostic (3.66e-8)" "unprognostic (5.96e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 7.1 0.1 0.1 0.1 0.0 0.1 0.1 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 4.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 1.0 0.7 1.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.9 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 17.4 4.5 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 MRPL15 "HSPC145, L15mt, MRP-L15, MRP-L7, RPML7" ENSG00000137547 "Mitochondrial ribosomal protein L15" Q9P015 8 54135210-54147901 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.5" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 210.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044425 Enhanced Supported Mitochondria NA NA Mitochondria "HPA044425: AB_10969629" "unprognostic (5.67e-3)" "unprognostic (8.89e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (9.30e-2)" "unprognostic (1.90e-2)" "unprognostic (2.57e-2)" "unprognostic (3.10e-3)" "unprognostic (1.39e-1)" "unprognostic (3.39e-2)" "unprognostic (1.94e-3)" "unprognostic (1.57e-2)" "unprognostic (2.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (1.06e-1)" "unprognostic (1.06e-2)" 13.7 15.2 16.2 10.2 17.7 6.7 16.1 10.7 28.0 11.6 21.8 8.7 7.4 18.4 11.3 10.2 16.9 11.8 10.9 54.2 14.4 16.3 31.2 32.3 9.1 14.5 17.5 15.4 10.1 14.9 16.8 9.0 20.9 18.7 9.9 22.1 12.3 15.2 10.8 77.5 16.2 16.5 13.9 10.2 12.7 14.2 5.4 8.1 11.3 12.4 25.0 16.7 15.8 10.9 28.2 38.5 8.2 32.2 13.6 21.2 21.9 30.3 25.4 19.2 22.2 15.2 22.6 24.6 25.7 18.1 32.6 28.8 27.2 35.0 46.3 32.9 20.1 30.7 30.5 37.5 30.5 38.7 21.7 28.1 32.6 13.6 35.0 22.3 17.1 32.4 21.4 33.6 30.1 32.0 15.7 66.2 18.7 37.6 14.9 47.5 32.8 44.5 38.8 38.9 59.0 16.1 31.2 12.3 24.1 42.7 28.7 11.1 17.2 13.0 36.7 29.9 20.5 36.0 17.3 24.7 17.5 22.5 27.3 27.3 18.9 23.5 38.0 17.3 26.5 27.3 8.2 25.9 7.4 15.4 32.2 18.6 28.2 19.4 20.1 38.5 21.6 18.4 17.2 1.0 13.6 28.9 24.1 21.2 21.9 16.2 17.7 10.7 28.0 14.4 16.3 17.5 15.4 18.7 8.1 23.8 11.8 46.2 33.1 20.9 28.0 114.6 56.0 24.1 19.4 34.9 27.5 128.1 210.5 90.3 14.2 23.7 36.5 23.3 61.2 122.6 25.7 20.9 25.3 57.8 93.7 23.8 17.3 29.4 48.6 3.2 23.0 37.9 32.1 61.3 48.9 22.6 78.0 35.1 21.2 95.0 46.9 12.9 17.9 7.9 32.5 30.1 166.4 20.2 75.9 40.0 MRPL33 "C2orf1, RPL33L" ENSG00000243147 "Mitochondrial ribosomal protein L33" O75394 2 27771717-27988087 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 127.3" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 1278.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066872 Approved NA NA "HPA066872: AB_2685739" "unprognostic (5.13e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-2)" "unprognostic (7.92e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.68e-4)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.78e-2)" "unprognostic (9.67e-2)" "unprognostic (2.48e-1)" "unprognostic (1.70e-3)" "unprognostic (1.54e-1)" "unprognostic (8.20e-2)" 21.6 96.5 27.3 12.6 36.7 16.7 27.3 18.1 35.4 24.3 29.6 11.3 26.2 15.4 22.4 31.9 14.8 19.1 20.3 75.4 21.7 16.5 37.3 26.9 18.8 14.8 27.1 22.6 19.7 40.0 13.6 32.6 14.7 26.5 26.5 20.2 14.2 20.9 26.0 127.3 10.4 15.3 35.9 24.7 17.5 24.1 20.9 21.7 8.7 18.4 41.0 15.6 19.6 16.3 29.5 62.2 85.8 47.2 25.7 37.5 25.0 60.1 27.3 50.6 20.6 31.9 36.4 23.5 38.3 48.5 38.5 50.5 24.1 46.7 17.4 48.5 40.0 58.4 18.5 28.2 30.4 55.3 27.3 54.0 33.9 27.2 43.5 48.5 33.9 20.2 46.3 27.0 34.8 61.5 62.8 49.1 26.9 26.3 29.7 50.6 19.9 23.2 37.1 28.3 61.3 39.8 11.9 57.4 24.2 117.8 24.4 29.0 41.9 26.5 33.8 41.0 48.9 15.2 35.1 41.6 24.5 52.9 23.9 60.1 34.5 53.2 51.1 33.7 56.3 22.4 85.8 47.2 44.9 30.2 34.4 32.1 29.5 34.3 31.6 62.2 25.7 29.5 35.2 34.1 25.7 32.9 40.3 37.5 25.0 27.3 36.7 18.1 35.4 21.7 16.5 27.1 22.6 26.5 21.7 166.7 134.3 134.0 88.7 49.7 47.5 1278.2 150.3 178.0 149.0 305.4 23.6 119.3 601.8 170.7 51.0 206.0 108.3 0.0 299.1 109.6 96.8 108.3 181.7 220.0 131.4 39.7 147.1 142.4 177.4 33.6 157.9 127.5 146.8 136.1 152.3 68.2 229.6 126.3 186.0 269.1 46.7 161.7 186.2 188.3 139.1 49.9 87.0 119.3 158.1 104.6 MRPL36 "BRIP1, L36mt, MRP-L36, PRPL36, RPMJ" ENSG00000171421 "Mitochondrial ribosomal protein L36" Q9P0J6 5 1798386-1801366 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 90.2" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 359.0;Late spermatids: 373.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047238 Approved Supported "Nuclear bodies,Mitochondria" No No "Nuclear bodies, Mitochondria" "HPA047238: AB_10965331" "unprognostic (2.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-2)" "unprognostic (7.83e-3)" "unprognostic (2.03e-2)" "unprognostic (2.01e-2)" "unprognostic (1.09e-3)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (5.39e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.53e-2)" "unprognostic (9.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" 16.8 20.7 14.3 12.9 14.8 8.2 17.9 9.3 15.4 12.3 15.9 9.0 13.7 14.1 13.5 15.1 20.8 12.7 19.0 32.4 13.5 13.0 22.4 44.6 11.6 13.6 14.2 8.6 16.5 28.9 9.0 10.1 13.9 12.3 17.0 10.5 9.6 27.3 12.3 52.5 11.7 16.2 16.1 11.9 11.5 14.4 46.0 11.1 14.1 18.1 35.8 15.3 16.3 14.4 24.5 90.2 12.9 20.3 18.4 25.8 24.1 23.2 34.6 16.1 30.4 29.8 24.7 21.2 20.4 18.0 24.4 23.4 25.0 19.0 31.4 37.1 21.8 35.9 25.5 36.2 33.6 17.7 34.1 40.3 15.2 76.9 39.6 38.2 19.7 12.0 21.7 26.0 27.2 35.3 21.4 23.6 18.6 23.1 20.3 34.6 42.7 23.0 44.5 15.6 25.8 42.6 18.5 12.0 37.8 22.0 19.1 18.0 12.3 44.4 34.7 21.2 15.5 20.3 21.4 14.2 21.2 23.0 14.3 22.5 19.5 24.3 41.3 26.6 36.5 28.8 12.9 20.3 12.5 18.6 19.4 22.1 24.5 21.0 22.4 24.3 17.9 18.6 22.1 5.8 18.4 16.5 90.2 25.8 24.1 14.3 14.8 9.3 15.4 13.5 13.0 14.2 8.6 12.3 11.1 29.8 25.3 33.5 68.7 94.2 19.7 152.3 53.5 38.8 42.1 55.8 5.9 78.6 260.2 71.7 359.0 51.5 50.4 0.0 65.2 52.4 60.6 90.8 27.6 108.3 76.3 14.3 25.3 34.4 38.0 373.3 69.3 34.3 57.3 73.9 47.9 48.5 78.1 49.2 56.3 144.3 22.1 64.7 83.4 78.8 62.6 109.2 73.1 35.2 55.9 94.5 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19431902-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 28.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favorable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 4.0 6.6 5.5 2.5 6.6 1.3 3.9 5.1 5.4 4.3 2.6 2.9 3.0 5.0 3.7 5.0 2.9 11.8 4.6 4.7 6.1 10.3 2.2 3.0 5.1 4.7 7.0 6.4 4.9 2.5 4.6 2.2 8.7 4.2 14.8 3.6 2.3 2.4 5.0 2.7 3.1 2.8 8.2 2.8 3.7 2.5 28.1 21.6 10.3 15.1 10.9 16.4 16.6 13.2 9.2 2.2 8.4 13.7 12.7 7.0 10.0 11.6 14.1 17.6 10.8 7.7 11.6 10.4 11.0 8.1 13.1 13.9 15.9 11.9 11.8 21.3 10.5 6.6 13.3 20.2 15.0 7.0 13.1 15.5 10.4 18.6 9.5 9.4 4.4 42.5 11.1 13.6 10.1 7.8 8.9 3.6 18.7 12.5 7.4 14.5 5.3 16.8 5.6 7.6 7.0 15.3 12.9 19.2 5.2 11.4 8.8 11.8 18.8 17.4 7.4 9.7 10.6 14.2 16.9 12.3 10.2 13.6 5.9 13.8 10.3 13.0 15.1 14.0 28.1 13.2 13.5 15.0 25.5 16.4 14.3 1.6 10.9 12.0 21.6 15.0 16.6 41.7 33.6 52.8 60.0 35.8 28.7 83.9 76.5 109.7 53.4 45.4 11.8 118.0 220.5 67.0 81.1 33.6 39.3 0.0 84.9 110.0 43.1 49.9 33.4 122.0 116.9 20.6 33.6 40.5 35.4 118.1 67.0 37.7 81.0 100.0 42.0 80.3 63.8 42.4 67.8 201.9 38.4 45.3 58.7 83.7 70.0 33.6 52.6 34.6 45.0 39.2 MRPL41 "BMRP, MRP-L27, MRPL27, PIG3, RPML27" ENSG00000182154 "Mitochondrial ribosomal protein L41" Q8IXM3 9 137551199-137552555 "Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 55.8;skeletal muscle: 60.6" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 826.6;Distal tubular cells: 824.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 49.0;PC-3: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024550, HPA027160" Supported Supported Mitochondria NA NA Mitochondria "HPA024550: AB_1854112, HPA027160: AB_1854113" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (6.92e-2)" "unprognostic (1.22e-3)" "unprognostic (5.86e-3)" "unprognostic (8.04e-2)" "unprognostic (2.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "unprognostic (4.83e-3)" "unprognostic (3.24e-2)" "unprognostic (2.06e-3)" "unprognostic (3.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" 15.3 8.0 12.8 3.5 14.4 3.1 2.8 4.1 10.7 2.4 8.3 7.1 2.3 1.0 1.7 2.1 1.5 16.4 10.3 7.7 6.8 10.7 2.6 3.3 8.5 4.2 6.3 1.8 2.9 1.6 9.5 2.2 10.8 3.8 60.6 5.3 6.2 1.5 4.0 6.2 10.5 2.1 2.0 1.5 2.7 2.1 38.3 55.8 43.7 42.5 21.8 42.2 42.8 10.0 17.0 2.9 6.8 4.3 3.6 13.2 12.9 3.3 5.9 4.8 11.8 5.7 7.4 16.9 3.1 8.9 21.4 3.8 6.1 0.6 10.8 21.1 6.8 9.3 18.4 9.9 11.0 31.4 7.1 8.4 5.3 1.9 2.6 5.4 6.5 14.8 3.2 3.1 49.0 3.7 35.8 10.9 12.8 48.0 4.6 4.9 10.3 5.0 6.7 9.4 10.2 8.5 15.8 20.9 1.7 15.0 10.0 10.6 10.3 14.3 18.5 16.7 9.6 13.3 13.1 11.9 10.9 7.8 43.7 42.5 31.5 31.2 34.1 29.5 38.3 33.8 35.9 34.6 28.5 32.2 30.2 5.1 21.8 31.1 55.8 42.2 42.8 26.8 28.1 87.8 111.7 124.4 47.8 826.6 188.5 41.5 37.5 249.5 9.8 105.5 824.0 135.5 238.0 93.7 424.6 0.0 166.2 127.5 105.3 182.0 54.1 733.3 213.4 27.0 257.8 98.2 123.7 565.6 112.8 114.0 212.6 190.2 235.6 66.7 187.8 270.0 98.3 497.0 34.2 109.9 97.6 90.9 72.6 145.2 68.8 110.7 282.5 152.7 MRPS18A "FLJ10548, MRPS18-3" ENSG00000096080 "Mitochondrial ribosomal protein S18A" Q9NVS2 6 43671303-43687791 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 90.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 95.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035450, HPA035451" Approved NA NA "HPA035450: AB_10670701, HPA035451: AB_10602029" "unprognostic (9.85e-2)" "unprognostic (3.08e-1)" "unprognostic (2.04e-1)" "unprognostic (7.35e-3)" "unprognostic (2.00e-1)" "unprognostic (1.15e-2)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (5.16e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (9.15e-2)" "unprognostic (2.14e-2)" "unprognostic (2.42e-1)" "unprognostic (1.96e-1)" "prognostic favorable (4.03e-5)" "unprognostic (9.35e-2)" 16.4 20.9 17.5 14.5 19.1 10.7 16.3 12.1 22.9 15.1 24.6 14.6 12.4 21.8 16.1 13.7 25.8 19.4 17.9 28.1 15.6 14.0 22.8 34.8 12.1 15.1 16.4 15.4 17.1 21.8 14.7 9.7 22.4 14.7 20.8 28.7 17.4 20.7 18.7 90.1 18.6 20.4 17.0 13.4 19.5 24.9 13.6 11.7 20.4 21.0 27.3 20.2 18.2 15.4 55.1 37.7 35.2 30.1 35.3 35.0 32.3 17.6 15.2 11.7 16.6 12.2 8.5 13.6 8.4 13.4 21.2 21.1 30.6 7.5 7.6 14.4 12.0 17.0 14.7 17.0 24.5 11.1 11.5 20.2 14.1 11.8 26.8 21.7 19.5 8.6 11.4 19.9 17.7 27.6 10.8 16.1 19.3 24.6 16.3 12.6 29.6 14.4 16.0 8.5 95.9 12.2 12.1 9.2 24.6 16.0 20.7 19.1 10.1 8.6 17.0 30.1 8.9 17.2 27.4 8.2 13.2 15.0 10.4 15.3 17.7 14.5 27.6 17.8 13.6 34.8 35.2 30.1 30.6 34.9 25.0 32.9 55.1 32.7 32.9 34.1 38.8 32.9 30.5 13.7 35.3 17.2 37.7 35.0 32.3 17.5 19.1 12.1 22.9 15.6 14.0 16.4 15.4 14.7 11.7 29.8 23.2 46.9 35.5 29.8 13.5 1.2 22.9 21.4 19.4 31.4 2.0 61.5 84.6 68.4 12.6 21.8 67.9 23.3 58.9 52.1 21.3 38.8 26.5 43.9 44.0 7.9 31.0 25.2 14.2 29.2 21.0 22.1 38.8 72.1 48.5 19.2 59.0 84.2 19.8 91.3 12.1 32.3 26.4 20.1 34.8 23.8 56.3 24.5 66.0 69.2 MRPS24 "HSPC335, MRP-S24" ENSG00000062582 "Mitochondrial ribosomal protein S24" Q96EL2 7 43866558-43869893 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 136.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 38.8;Club cells: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073947 Approved NA NA "HPA073947: " "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (1.30e-1)" "unprognostic (3.44e-1)" "unprognostic (7.32e-2)" "unprognostic (8.63e-3)" "unprognostic (9.42e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (2.03e-1)" "unprognostic (6.86e-3)" "unprognostic (9.58e-3)" "unprognostic (1.71e-2)" "prognostic favorable (9.89e-4)" "unprognostic (2.87e-1)" "unprognostic (9.08e-2)" "unprognostic (7.37e-2)" "unprognostic (1.95e-1)" 17.9 31.6 23.0 15.1 21.1 26.8 42.8 17.4 34.9 16.6 21.7 8.5 19.3 24.5 16.5 15.5 27.9 19.3 21.3 63.4 18.8 17.1 26.6 38.7 16.6 29.3 19.7 19.1 22.7 50.1 12.7 13.9 17.3 13.0 19.1 16.4 13.3 33.3 18.6 136.5 17.3 21.3 22.9 12.3 15.3 23.1 25.0 11.7 16.9 25.3 54.7 17.4 20.4 19.5 50.2 55.7 20.6 41.9 26.4 47.7 36.8 28.3 46.0 14.3 29.6 15.0 25.8 23.8 27.5 67.5 36.7 36.4 41.0 27.0 24.3 33.2 27.6 50.2 36.3 20.3 24.8 28.8 22.7 51.0 14.8 51.6 48.7 22.4 23.9 19.4 24.3 25.2 28.6 34.4 23.5 21.1 24.2 47.7 18.4 22.9 44.9 29.0 53.9 36.0 31.9 46.3 23.8 20.5 92.8 26.4 24.1 28.6 32.7 27.8 69.1 27.6 19.3 46.7 44.0 17.0 34.8 48.5 20.9 39.2 56.4 42.6 30.6 42.2 32.2 54.4 8.4 41.9 20.6 28.2 40.0 30.6 50.2 41.3 33.6 55.7 44.8 41.6 35.6 3.4 26.4 38.6 37.5 47.7 36.8 23.0 21.1 17.4 34.9 18.8 17.1 19.7 19.1 13.0 11.7 6.0 11.8 2.2 2.3 3.9 4.8 0.4 7.6 38.8 22.7 5.2 5.9 1.2 3.3 4.9 1.5 1.6 1.3 0.0 0.6 2.8 3.3 1.2 3.5 18.1 1.1 0.0 4.1 12.9 11.8 0.9 0.3 5.1 3.3 3.6 1.3 0.8 4.3 0.0 0.7 1.4 7.1 0.0 4.7 1.0 1.4 5.1 1.6 7.5 2.0 2.6 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455752-60470760 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1" "Cell type enriched" "Detected in some" 61 "B-cells: 527.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 105 "memory B-cell: 77.7;naive B-cell: 77.7" "Lineage enriched" "Detected in single" 105 "B-cells: 77.7" "Group enriched" "Detected in some" 25 "Daudi: 122.9;U-698: 61.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favorable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 1.6 0.3 0.3 79.0 0.3 3.6 0.6 0.3 0.3 0.5 2.0 0.0 0.0 0.2 0.4 0.5 7.0 0.4 1.3 0.7 0.3 0.3 2.0 0.9 2.7 81.2 0.3 0.1 0.3 0.4 0.0 0.4 0.4 0.1 1.1 1.7 0.6 14.5 0.2 0.3 0.3 46.1 0.1 0.4 90.7 2.6 0.6 0.0 15.7 2.5 2.7 134.1 6.4 0.8 77.7 0.0 0.2 0.0 0.7 0.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 122.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 77.7 0.3 0.6 0.0 77.7 0.0 0.2 0.2 0.7 0.0 0.0 0.0 3.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.0 0.0 6.7 527.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.6 1.8 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 MS4A10 "CD20L7, MS4A9" ENSG00000172689 "Membrane spanning 4-domains A10" Q96PG2 11 60785348-60801305 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "intestine: 115.7" "Cell type enhanced" "Detected in single" 26 "Enterocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.3;NB-4: 2.4" "Low region specificity" "Detected in all" HPA014778 Uncertain NA NA "HPA014778: AB_2669089" "unprognostic (7.67e-3)" "unprognostic (1.28e-1)" "unprognostic (8.73e-3)" "unprognostic (1.27e-1)" "unprognostic (5.21e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 28.3 0.0 0.0 33.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 115.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 3.5 0.5 0.9 0.5 0.1 0.3 0.9 0.4 0.2 0.2 0.0 2.3 0.2 0.1 0.1 0.0 0.8 0.2 0.4 0.3 0.1 0.0 0.7 0.2 0.3 0.2 0.0 0.3 2.1 0.7 0.3 0.1 0.6 1.9 0.0 0.0 0.6 0.3 0.2 0.0 0.3 0.5 1.4 0.7 0.3 0.5 2.4 0.0 0.4 0.3 0.2 0.0 1.7 0.1 0.4 1.0 1.0 0.4 0.6 0.0 0.8 0.4 0.2 1.5 0.7 0.2 1.5 0.3 0.2 0.2 0.4 0.4 0.7 0.2 3.5 0.4 0.7 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.8 0.5 0.5 1.4 0.9 0.5 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 MS4A12 "FLJ20217, Ms4a10" ENSG00000071203 "Membrane spanning 4-domains A12" Q9NXJ0 11 60492778-60507430 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "intestine: 64.7;lymphoid tissue: 28.6" "Group enriched" "Detected in some" 6 "Enterocytes: 108.9;Paneth cells: 59.6" "Cancer enriched" "Detected in some" 8 "colorectal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6;LHCN-M2: 2.2;NTERA-2: 3.1;RH-30: 4.3;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048616, HPA057657" Enhanced Approved "Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "Nucleoli, Endoplasmic reticulum, Golgi apparatus" "HPA048616: , HPA057657: AB_2683491" "unprognostic (2.64e-2)" "unprognostic (2.33e-1)" "unprognostic (1.49e-1)" "unprognostic (3.26e-1)" "unprognostic (2.83e-1)" "unprognostic (9.20e-3)" 0.1 0.0 0.1 28.6 0.1 0.0 0.1 0.1 0.1 0.1 57.7 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 64.7 0.1 0.1 0.1 0.1 0.0 0.2 1.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 1.8 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 108.9 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 59.6 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 13.2 0.0 MS4A13 ENSG00000204979 "Membrane spanning 4-domains A13" Q5J8X5 11 60515413-60542721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 85 "testis: 8.4" "Group enriched" "Detected in some" 6 "Early spermatids: 20.4;Late spermatids: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "U-2 OS: 2.1;U-266/70: 6.4;U-266/84: 2.0" "HPA045017, HPA063626" Uncertain NA NA "HPA045017: AB_10962976, HPA063626: AB_2685065" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.1 0.7 0.0 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.8 2.1 0.0 0.0 0.0 0.0 0.0 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Group enriched" "Detected in some" 41 "Early spermatids: 207.0;Late spermatids: 514.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" "Cell line enriched" "Detected in single" 24 "THP-1: 14.6" HPA058973 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 207.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.5 514.6 3.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 5.7 2.4 0.3 0.1 0.0 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MS4A18 ENSG00000214782 "Membrane spanning 4-domains A18" Q3C1V0 11 60729304-60744212 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 7.8;intestine: 21.9;testis: 4.3" "Group enriched" "Detected in some" 41 "Early spermatids: 3.9;Late spermatids: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.4" HPA045121 Approved NA NA "HPA045121: AB_10969456" "unprognostic (1.02e-1)" "unprognostic (8.87e-2)" "unprognostic (2.51e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A2 "APY, FCER1B, IGER, MS4A1" ENSG00000149534 "Membrane spanning 4-domains A2" Q01362 11 60088261-60098466 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "IgE-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 72.0" "Cell type enriched" "Detected in some" 18 "granulocytes: 912.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 720 "basophil: 72.0" "Lineage enriched" "Detected in single" 720 "granulocytes: 72.0" "Cell line enhanced" "Detected in some" "HEL: 7.1;NB-4: 2.6;THP-1: 4.2;U-937: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059967 Enhanced NA NA "HPA059967: AB_2684183" "unprognostic (7.28e-2)" "unprognostic (9.21e-2)" "unprognostic (2.50e-4)" "unprognostic (4.97e-2)" "unprognostic (4.47e-1)" "unprognostic (2.40e-6)" "unprognostic (1.88e-2)" "unprognostic (6.21e-3)" "unprognostic (3.96e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (6.63e-3)" "unprognostic (6.49e-3)" "unprognostic (9.95e-2)" "unprognostic (4.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.74e-1)" 4.9 0.5 0.4 5.1 0.4 0.2 2.1 0.4 0.4 11.9 4.6 0.1 4.5 4.7 14.3 11.2 5.9 1.1 14.6 2.1 0.4 0.4 1.5 0.9 12.9 0.5 0.4 0.1 1.1 1.2 0.2 0.6 0.6 0.1 17.5 5.6 4.5 3.2 5.4 1.5 4.3 7.4 15.9 0.4 0.6 4.5 2.7 0.2 1.2 0.6 6.7 3.4 5.1 4.1 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.2 0.0 0.3 0.0 0.0 0.1 0.3 0.2 0.4 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.0 7.1 0.5 0.2 0.3 0.9 0.4 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.9 0.3 0.0 0.1 0.0 2.6 0.1 0.0 0.1 0.1 0.0 0.2 0.0 1.0 0.2 0.1 0.1 0.2 0.0 0.0 0.3 4.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.2 1.9 0.2 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.1 0.1 0.2 0.0 51.4 0.0 0.6 0.0 0.4 0.4 0.0 1.4 12.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 912.4 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MS4A3 "CD20L, HTM4" ENSG00000149516 "Membrane spanning 4-domains A3" Q96HJ5 11 60056587-60071128 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 196.2;bone marrow: 105.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 1061 "basophil: 196.2" "Lineage enriched" "Detected in single" 1963 "granulocytes: 196.2" "Group enriched" "Detected in some" 4 "HEL: 37.1;K-562: 31.7;NB-4: 25.7;THP-1: 75.0;U-937: 29.6" "Not detected" "Not detected" HPA019210 Supported Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus" "Vesicles, Cytosol" "HPA019210: AB_1854134" "unprognostic (6.37e-3)" "unprognostic (1.25e-1)" "unprognostic (2.67e-1)" "unprognostic (3.77e-1)" 0.2 0.0 0.1 0.1 0.3 105.4 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 14.7 0.1 0.1 0.1 0.5 6.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.1 8.6 0.0 1.0 0.0 7.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 196.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 9.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 196.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A4A "CD20L1, MS4A4, MS4A7" ENSG00000110079 "Membrane spanning 4-domains A4A" Q96JQ5 11 60280541-60308972 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.2" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 321.0;Kupffer cells: 359.4;Macrophages: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 26.4;myeloid DC: 11.9;non-classical monocyte: 31.6;plasmacytoid DC: 11.7" "Group enriched" "Detected in many" 27 "dendritic cells: 11.9;monocytes: 31.6" "Cell line enriched" "Detected in some" 18 "K-562: 54.8" HPA029323 Approved NA NA "HPA029323: AB_10601866" "unprognostic (7.93e-2)" "unprognostic (2.05e-2)" "unprognostic (1.37e-3)" "unprognostic (1.98e-1)" "unprognostic (4.46e-2)" "unprognostic (2.31e-1)" "unprognostic (9.66e-2)" "unprognostic (1.59e-1)" "unprognostic (4.56e-1)" "unprognostic (6.65e-2)" "unprognostic (8.10e-2)" "unprognostic (2.11e-1)" "unprognostic (5.02e-3)" "unprognostic (3.32e-2)" "unprognostic (4.66e-2)" "unprognostic (4.89e-2)" "unprognostic (4.21e-2)" 47.2 13.9 3.8 10.2 5.3 1.3 18.8 1.4 3.1 8.5 9.8 2.8 2.5 2.6 4.4 18.9 6.2 10.6 14.8 13.7 4.1 3.0 12.6 9.9 20.4 28.2 4.9 1.5 4.4 3.1 1.6 5.0 32.7 6.7 8.3 9.5 8.7 7.7 2.7 3.9 2.6 9.9 12.1 7.4 30.7 5.7 5.6 3.6 2.8 5.0 3.4 4.0 13.1 3.1 0.2 11.9 0.3 31.6 0.8 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 26.4 0.0 0.2 0.0 0.0 11.9 0.0 0.0 0.0 0.3 0.8 31.6 11.7 0.0 2.3 3.8 5.3 1.4 3.1 4.1 3.0 4.9 1.5 6.7 3.6 0.0 9.3 9.5 0.1 1.5 0.0 3.6 5.1 0.0 4.5 0.0 0.0 1.5 0.0 0.0 0.6 2.1 0.0 0.0 0.0 1.3 2.6 0.0 7.0 2.6 321.0 0.0 0.0 74.9 359.4 0.8 0.9 124.2 3.3 3.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.9 0.9 0.0 0.1 1.6 3.0 4.1 0.0 0.0 MS4A4E ENSG00000214787 "Membrane spanning 4-domains A4E" Q96PG1 11 60201253-60243088 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.1" "Cell type enhanced" "Detected in some" 21 "Club cells: 1.2;Kupffer cells: 2.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in some" 7 "basophil: 17.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 17.1" "Cell line enhanced" "Detected in some" "K-562: 5.2;NB-4: 1.7;THP-1: 7.5;U-937: 1.0" HPA040075 Uncertain NA NA "HPA040075: AB_10793915" "unprognostic (1.90e-1)" "unprognostic (2.64e-2)" "unprognostic (7.05e-2)" "unprognostic (9.42e-2)" "unprognostic (5.99e-2)" "unprognostic (1.45e-2)" "unprognostic (8.97e-2)" "unprognostic (1.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.74e-1)" "unprognostic (1.28e-3)" "unprognostic (4.16e-2)" "unprognostic (9.88e-3)" "unprognostic (4.97e-2)" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (4.05e-2)" 4.7 2.2 0.2 1.2 0.2 7.1 3.4 0.1 0.2 0.5 1.6 1.0 0.8 1.1 1.2 0.9 2.9 1.2 0.3 0.3 1.0 0.8 1.9 1.6 0.2 0.8 0.8 0.8 0.7 1.0 0.9 1.2 1.9 0.1 0.6 1.0 2.8 3.3 0.5 3.1 1.6 0.5 0.7 0.4 2.1 0.9 0.0 2.4 17.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.6 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 17.1 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 1.3 1.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MS4A5 CD20L2 ENSG00000166930 "Membrane spanning 4-domains A5" Q9H3V2 11 60429589-60455214 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 54 "testis: 46.6" "Group enriched" "Detected in some" 89 "Early spermatids: 541.0;Late spermatids: 817.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 2.1;U-2 OS: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA043732 Uncertain NA NA "HPA043732: AB_10959759" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 541.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 817.7 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.5 0.0 7.6 2.0 0.0 0.0 0.0 0.0 0.0 MS4A6A "CD20L3, MS4A6" ENSG00000110077 "Membrane spanning 4-domains A6A" Q9H2W1 11 60172014-60184666 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 112.4;lymphoid tissue: 89.5" "Group enriched" "Detected in many" 14 "Hofbauer cells: 335.3;Ito cells: 767.3;Kupffer cells: 1329.9;Macrophages: 569.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3" "Group enriched" "Detected in many" 96 "dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4" "Cell line enriched" "Detected in some" 9 "THP-1: 32.6" "HPA011391, HPA076623" Approved Approved Vesicles NA NA Vesicles "HPA011391: AB_10603876, HPA076623: AB_2686809" "unprognostic (1.17e-1)" "prognostic favorable (6.33e-4)" "unprognostic (2.35e-2)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" "unprognostic (8.51e-2)" "unprognostic (2.33e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (3.20e-1)" "unprognostic (4.75e-3)" "unprognostic (1.06e-1)" "unprognostic (4.66e-2)" "unprognostic (3.94e-2)" "unprognostic (2.97e-2)" 29.3 17.8 12.3 18.3 26.7 9.1 18.1 2.8 14.6 10.2 14.9 4.7 4.0 9.0 7.0 28.3 8.7 11.3 21.0 23.1 10.7 6.9 18.0 35.6 23.0 89.5 22.2 2.4 7.7 6.0 2.4 8.8 21.5 20.5 9.6 19.0 10.2 11.8 6.3 6.0 5.1 20.4 17.2 32.0 78.1 8.5 8.3 19.4 8.5 7.0 6.7 15.4 21.5 6.3 0.7 65.3 32.4 112.4 0.2 0.3 61.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.8 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 32.4 112.4 0.7 0.1 35.6 0.3 0.7 0.2 0.1 65.3 0.1 0.1 0.1 7.4 0.2 2.3 46.3 0.1 61.3 12.3 26.7 2.8 14.6 10.7 6.9 22.2 2.4 20.5 19.4 6.0 31.7 53.0 0.4 8.2 0.0 2.4 30.6 2.7 4.5 3.5 0.0 1.6 0.0 0.0 2.0 8.5 0.0 0.0 0.0 1.7 7.3 0.2 12.8 6.0 335.3 0.0 0.0 767.3 1329.9 1.1 1.4 569.3 13.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 45.3 7.2 0.3 1.0 6.9 1.7 27.7 0.0 0.1 MS4A6E ENSG00000166926 "Membrane spanning 4-domains A6E" Q96DS6 11 60334831-60396596 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.2" "Cell type enriched" "Detected in some" 21 "Early spermatids: 1123.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 6 "monocytes: 1.2" "Group enriched" "Detected in some" 7 "K-562: 2.1;SuSa: 4.2" HPA076623 Approved Vesicles NA NA Vesicles "HPA076623: AB_2686809" "unprognostic (2.58e-1)" "unprognostic (3.35e-1)" "unprognostic (3.47e-1)" "unprognostic (6.81e-3)" "unprognostic (4.55e-4)" "unprognostic (1.08e-1)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" 2.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 28.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 53.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 5.1 2.5 0.0 0.0 0.0 0.0 0.0 MS4A7 "CD20L4, CFFM4, MS4A8" ENSG00000166927 "Membrane spanning 4-domains A7" Q9GZW8 11 60378482-60395951 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in all" 4 "blood: 132.8;lymphoid tissue: 126.7" "Group enriched" "Detected in many" 12 "Hofbauer cells: 291.6;Kupffer cells: 748.0;Macrophages: 338.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 71.2;non-classical monocyte: 132.8" "Lineage enriched" "Detected in many" 11 "monocytes: 132.8" "Cell line enriched" "Detected in some" 24 "THP-1: 51.2" "Low region specificity" "Detected in all" "HPA017418, CAB026387" Approved NA NA "CAB026387: , HPA017418: AB_1854137" "unprognostic (1.43e-1)" "unprognostic (2.60e-3)" "unprognostic (3.24e-2)" "unprognostic (9.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-1)" "unprognostic (9.51e-2)" "unprognostic (3.02e-2)" "unprognostic (4.85e-2)" "unprognostic (5.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-2)" "unprognostic (4.59e-2)" "unprognostic (3.90e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" 24.2 11.9 4.4 15.1 4.9 2.0 9.7 1.3 3.5 5.9 7.4 4.2 2.9 5.2 4.2 11.0 4.0 4.8 15.2 11.3 5.1 3.9 6.8 22.3 29.7 19.1 4.6 1.3 3.2 3.4 2.3 6.2 13.3 5.0 5.9 7.5 8.4 5.3 3.4 2.2 2.3 8.1 4.8 9.9 126.7 4.3 6.0 3.5 7.0 3.3 2.3 5.6 9.7 3.9 2.0 11.9 0.9 132.8 0.1 0.1 10.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 51.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.2 0.0 1.6 0.0 0.5 18.8 0.2 0.1 71.2 0.1 2.0 0.0 0.0 11.9 1.8 0.0 0.0 0.9 0.1 132.8 0.3 0.0 10.9 4.4 4.9 1.3 3.5 5.1 3.9 4.6 1.3 5.0 3.5 11.9 38.5 23.0 0.6 2.4 0.8 1.9 0.0 13.4 6.8 8.7 0.0 1.0 0.0 0.0 2.0 2.1 0.0 0.0 0.2 1.2 3.1 1.2 12.8 0.9 291.6 0.0 0.0 16.0 748.0 0.5 1.1 338.5 1.7 15.4 0.0 0.3 0.1 0.0 0.0 0.6 0.5 19.4 1.2 0.0 0.3 1.6 1.6 4.1 0.0 0.8 MS4A8 "CD20L5, MS4A4, MS4A8B" ENSG00000166959 "Membrane spanning 4-domains A8" Q9BY19 11 60699574-60715811 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "fallopian tube: 36.8;intestine: 123.9" "Group enriched" "Detected in many" 6 "Ciliated cells: 681.3;Intestinal endocrine cells: 454.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;CAPAN-2: 1.5;HDLM-2: 1.4;NB-4: 2.2;OE19: 5.3;RPMI-8226: 3.9;SCLC-21H: 2.8;SH-SY5Y: 1.5" "Not detected" "Not detected" HPA007319 Enhanced NA NA "HPA007319: AB_1854138" "unprognostic (7.28e-3)" "unprognostic (2.11e-1)" "unprognostic (9.03e-2)" "unprognostic (1.91e-2)" "unprognostic (2.52e-2)" "unprognostic (9.41e-2)" "unprognostic (4.89e-3)" "unprognostic (9.33e-2)" "unprognostic (7.97e-3)" "unprognostic (2.40e-1)" "unprognostic (2.40e-9)" "unprognostic (2.46e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-3)" 0.1 0.2 1.4 2.0 0.2 0.0 0.1 0.2 0.6 7.1 43.9 0.4 0.6 46.6 2.5 5.9 0.3 36.8 8.9 0.3 0.6 0.3 0.2 0.1 8.6 0.1 0.1 0.5 4.2 1.2 0.0 4.7 0.1 1.0 2.3 4.0 0.2 0.4 10.9 0.8 0.1 123.9 0.1 0.1 0.1 12.7 0.7 0.1 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 5.3 0.0 0.0 0.0 3.9 0.0 0.0 2.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.2 0.6 0.6 0.3 0.1 0.5 1.0 0.1 6.0 5.4 0.0 0.1 0.0 0.0 0.3 20.4 681.3 94.4 1.8 0.0 0.0 0.0 0.2 1.1 0.0 24.2 0.0 2.3 0.0 0.0 1.9 1.1 0.0 0.0 0.0 454.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 10.5 0.0 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 MSANTD1 "C4orf44, LOC345222" ENSG00000188981 "Myb/SANT DNA binding domain containing 1" Q6ZTZ1 4 3244369-3271738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.7;testis: 6.3" "Group enriched" "Detected in some" 5 "Early spermatids: 34.1;Late spermatids: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enhanced" "Detected in single" "T-cells: 1.0" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (7.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-3)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (3.99e-1)" "unprognostic (5.50e-2)" "unprognostic (2.34e-3)" "unprognostic (6.36e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-2)" "unprognostic (8.57e-2)" "unprognostic (5.96e-2)" "unprognostic (1.24e-1)" 0.7 0.8 3.3 1.0 9.4 1.0 0.7 2.0 9.7 0.5 0.7 1.3 0.0 0.8 0.7 1.6 0.5 0.6 0.5 0.5 6.9 4.7 1.0 0.5 1.3 0.8 0.8 5.8 0.8 1.5 0.5 1.4 0.7 1.4 1.0 0.5 0.3 1.5 0.8 2.4 0.8 0.8 0.6 0.4 1.3 1.1 6.3 1.0 0.0 1.2 0.0 0.7 0.3 0.4 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.3 0.5 1.7 0.4 0.1 0.7 0.3 0.2 0.1 0.4 0.9 0.8 0.7 0.6 0.3 1.8 0.4 0.3 0.1 0.3 0.5 0.4 0.8 1.2 1.2 0.0 0.1 2.2 0.7 0.5 0.3 0.5 0.3 0.3 1.0 0.4 1.0 0.0 0.7 0.6 2.0 1.4 0.5 1.5 0.4 0.1 0.5 0.2 0.8 2.3 0.5 0.3 0.1 0.5 1.2 0.6 0.3 0.5 0.7 1.4 0.9 0.9 1.6 1.3 0.4 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 9.4 2.0 9.7 6.9 4.7 0.8 5.8 1.4 1.0 0.0 0.0 0.0 0.1 0.9 1.4 1.1 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 34.1 0.0 0.0 0.0 6.2 0.2 0.2 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.4 0.0 1.9 0.0 0.0 3.8 1.2 0.3 0.0 0.0 0.0 0.0 MSANTD3-TMEFF1 C9orf30-TMEFF1 ENSG00000251349 "MSANTD3-TMEFF1 readthrough" 9 100442271-100577636 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 21.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 40.5;NTERA-2: 20.5;SCLC-21H: 21.8;SuSa: 30.2" "Low region specificity" "Detected in all" NA NA "unprognostic (8.53e-3)" "unprognostic (1.95e-3)" "unprognostic (5.92e-2)" "unprognostic (5.32e-2)" "unprognostic (8.87e-2)" "unprognostic (3.00e-1)" "unprognostic (3.39e-4)" "unprognostic (6.34e-2)" "unprognostic (2.19e-1)" "unprognostic (8.88e-3)" "unprognostic (1.46e-1)" "unprognostic (9.55e-3)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" 0.6 0.6 7.7 1.1 4.9 0.0 0.5 7.1 21.4 2.3 0.8 0.0 3.5 1.0 0.6 0.6 1.1 0.7 5.5 3.9 0.4 0.0 0.5 0.0 2.9 1.2 0.0 0.1 0.0 1.1 1.1 0.6 0.0 2.0 0.3 0.0 0.3 2.8 3.5 0.0 0.2 3.3 3.7 0.2 0.9 0.1 0.2 1.0 1.0 0.0 0.0 1.0 0.7 1.1 1.8 40.5 3.3 5.0 2.8 6.7 4.4 3.1 3.3 3.5 0.2 1.2 0.8 2.2 3.9 9.3 0.7 12.7 1.3 7.6 3.1 2.4 0.2 1.3 0.6 2.5 0.8 0.7 1.2 1.1 3.2 3.8 7.4 8.2 7.7 0.8 0.5 6.5 0.7 5.0 0.7 20.5 3.4 1.7 6.0 17.2 0.1 3.2 0.4 21.8 10.2 1.4 0.9 2.1 30.2 0.4 2.5 2.9 3.5 3.6 4.0 3.9 1.9 4.3 3.7 5.3 0.5 3.3 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.4 0.3 1.0 0.2 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSC "ABF-1, bHLHa22" ENSG00000178860 Musculin O60682 8 71841549-71844468 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 56.3" "Cell type enhanced" "Detected in many" 12 "Exocrine glandular cells: 35.3;Leydig cells: 39.4;monocytes: 88.4;Peritubular cells: 38.9;Smooth muscle cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 18.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "HDLM-2: 132.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062878 Supported Nucleoplasm NA NA Nucleoplasm "HPA062878: AB_2684891" "unprognostic (2.58e-2)" "unprognostic (1.62e-1)" "unprognostic (1.86e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (5.21e-4)" "unprognostic (3.70e-2)" "prognostic unfavorable (4.83e-5)" "unprognostic (3.95e-2)" "unprognostic (7.92e-2)" "unprognostic (3.75e-2)" "unprognostic (3.73e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.07e-13)" "unprognostic (1.65e-2)" "unprognostic (1.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.40e-2)" 9.9 7.6 2.0 10.1 1.3 2.8 56.3 0.6 4.4 4.8 1.6 0.8 0.4 1.9 4.8 2.9 3.3 3.4 10.5 16.3 5.5 0.2 5.2 3.0 6.6 14.1 0.8 1.2 7.3 4.7 0.0 2.6 15.1 1.9 4.8 0.9 15.9 3.7 3.1 2.6 3.0 3.8 3.8 0.9 5.6 3.8 3.1 0.6 1.8 3.6 3.4 4.8 10.3 6.5 5.0 4.3 0.1 0.2 0.0 18.5 2.1 0.0 1.0 0.0 0.0 4.8 0.8 0.0 0.2 3.9 0.1 0.2 0.0 0.0 0.0 0.0 0.7 4.8 0.2 0.0 0.2 0.0 132.2 0.0 0.0 0.0 0.0 8.6 0.0 0.4 1.9 0.0 8.3 5.1 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.1 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.2 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.0 3.5 0.0 5.7 0.0 0.0 0.0 3.9 0.0 5.2 5.0 6.8 18.5 0.1 2.8 0.1 6.4 0.1 0.0 0.2 4.3 8.6 2.1 2.0 1.3 0.6 4.4 5.5 0.2 0.8 1.2 1.9 0.6 0.0 0.0 1.5 0.1 4.5 0.0 1.6 0.0 0.0 0.0 1.8 0.0 0.1 0.0 14.0 0.3 2.2 0.0 0.0 35.3 0.1 17.8 0.4 0.0 0.0 1.9 0.0 0.0 1.8 0.8 0.6 39.4 3.8 25.3 88.4 0.0 0.0 22.7 0.0 38.9 0.8 0.0 25.8 40.6 0.2 0.2 2.9 0.0 5.0 0.0 0.2 MSGN1 pMesogenin1 ENSG00000151379 "Mesogenin 1" A6NI15 2 17816496-17817101 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.2;esophagus: 2.9;tongue: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "cerebral cortex: 2.0;hippocampal formation: 2.2" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "hTCEpi: 1.3;REH: 1.1;RH-30: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.63e-2)" "unprognostic (3.25e-2)" "unprognostic (1.66e-1)" 0.0 0.0 0.1 0.3 0.0 0.0 0.4 0.0 2.0 0.3 0.2 0.0 0.0 0.0 0.0 1.0 2.9 0.6 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.1 0.1 0.0 1.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.1 0.4 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 2.0 2.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSH4 ENSG00000057468 "MutS homolog 4" O15457 1 75796882-75913238 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 33.0" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 19.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.7;HDLM-2: 2.7;JURKAT: 3.0" "Not detected" "Not detected" NA NA "unprognostic (6.64e-2)" "unprognostic (2.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (1.99e-2)" "unprognostic (6.88e-3)" "unprognostic (1.74e-2)" "unprognostic (4.37e-2)" "unprognostic (3.00e-1)" "unprognostic (3.58e-3)" "unprognostic (9.72e-2)" "unprognostic (6.88e-8)" "unprognostic (5.33e-2)" "unprognostic (4.90e-2)" "unprognostic (5.08e-2)" "unprognostic (4.63e-2)" 0.3 0.2 0.3 0.3 0.6 0.1 0.5 2.6 0.4 0.3 0.8 0.3 0.3 0.1 0.6 4.8 0.3 0.6 0.3 0.6 0.3 0.0 0.3 0.3 0.4 0.3 0.3 0.3 1.0 0.3 0.0 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.5 0.4 0.7 0.7 1.2 0.2 33.0 0.3 0.3 0.3 0.3 0.3 0.5 0.5 0.7 0.4 0.0 0.1 0.0 0.5 0.0 0.8 0.1 0.0 5.7 1.1 0.4 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.2 0.0 0.3 0.0 2.7 0.6 0.2 0.2 0.0 0.0 0.1 0.4 1.1 1.7 0.5 0.0 0.7 0.1 3.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.1 1.1 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.9 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.6 2.6 0.4 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 1.2 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.3 0.0 0.0 19.1 1.3 0.0 0.0 0.0 0.0 0.0 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369180 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.3;skeletal muscle: 23.2" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favorable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.8 6.8 8.7 0.6 7.4 0.4 1.2 3.9 14.2 1.9 1.5 8.6 2.2 7.8 4.3 2.7 1.5 3.1 1.4 4.0 11.3 5.9 0.7 1.0 1.0 0.6 4.7 6.1 2.9 7.3 1.3 12.8 1.4 4.6 4.5 1.5 27.3 1.3 2.5 23.2 0.5 5.2 2.2 4.7 0.7 3.1 12.5 5.4 0.0 1.3 0.0 0.4 0.9 0.9 0.1 0.4 0.6 0.2 0.2 0.3 0.0 0.0 0.5 43.8 11.1 0.0 0.0 5.6 0.0 0.0 0.3 0.5 7.7 0.2 0.0 0.6 0.0 0.2 0.1 20.0 0.0 0.1 0.2 4.5 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.1 22.8 0.2 0.2 0.1 0.0 0.1 0.0 0.0 32.5 15.8 0.0 0.3 0.3 4.4 6.7 0.0 0.0 0.1 6.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.6 0.2 0.2 0.4 0.1 0.0 8.7 7.4 3.9 7.2 11.3 5.9 4.7 6.1 4.6 5.4 0.0 0.0 0.0 1.0 0.9 20.9 2.6 0.0 0.0 0.0 0.0 51.1 0.0 1.7 1.0 46.0 0.3 0.5 0.0 4.5 0.5 0.5 5.5 0.0 0.0 0.1 3.2 9.7 0.0 0.0 40.7 0.3 0.0 0.0 1.0 0.7 68.3 2.0 5.5 0.4 0.0 92.6 12.9 2.1 7.0 1.3 0.0 0.3 0.0 2.5 0.3 MSLN "CAK1, MPF" ENSG00000102854 Mesothelin Q13421 16 760762-768865 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 85.5;lung: 88.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 343.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 9.0" "Group enriched" "Detected in many" 59 "dendritic cells: 9.0;monocytes: 2.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3" "Low region specificity" "Detected in many" "CAB002216, HPA017172" Enhanced Supported Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 14000000 Vesicles Nucleoplasm "CAB002216: AB_563874, HPA017172: AB_1853819" "unprognostic (1.73e-1)" "unprognostic (1.77e-1)" "unprognostic (2.06e-2)" "unprognostic (1.33e-1)" "unprognostic (3.43e-2)" "unprognostic (3.95e-2)" "unprognostic (2.46e-1)" "unprognostic (9.47e-2)" "unprognostic (8.57e-2)" "unprognostic (4.69e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.63e-1)" "prognostic favorable (5.91e-4)" "unprognostic (2.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.14e-2)" "unprognostic (3.35e-2)" 36.5 0.0 0.4 6.7 0.5 0.7 0.3 0.1 0.4 5.4 5.4 0.8 26.8 2.1 4.8 18.9 3.1 85.5 9.6 4.3 0.4 0.3 2.6 0.2 88.5 0.4 0.6 0.0 22.3 0.4 0.0 0.6 13.7 0.9 1.9 1.2 0.2 14.4 33.1 0.0 0.5 0.7 1.0 0.8 0.1 3.7 2.1 0.0 0.1 0.1 0.6 7.8 1.4 1.3 0.0 9.0 0.0 2.6 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.5 1.8 0.4 1.5 104.2 0.0 16.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 31.8 1.2 0.9 0.0 0.0 0.0 23.1 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 19.3 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.4 0.4 0.5 0.1 0.4 0.4 0.3 0.6 0.0 0.9 0.0 175.7 67.0 0.0 1.3 0.2 1.3 1.2 50.9 25.4 66.0 24.4 0.0 0.1 0.0 1.6 1.1 0.0 1.9 0.0 0.7 0.0 0.6 1.2 0.0 0.0 2.9 0.0 2.9 0.0 0.6 4.5 4.4 2.6 1.7 7.2 1.3 0.0 19.2 190.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.1 0.0 2.5 37.2 MSLNL "C16orf37, MPFL" ENSG00000162006 Mesothelin-like Q96KJ4 16 769428-783370 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 2.4;epididymis: 4.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CAPAN-2: 14.9;HeLa: 8.7" "Not detected" "Not detected" NA NA "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (5.26e-4)" "unprognostic (3.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.38e-2)" "unprognostic (1.54e-1)" "unprognostic (3.73e-3)" "unprognostic (6.50e-2)" "unprognostic (2.09e-1)" "unprognostic (5.36e-2)" "unprognostic (2.16e-1)" 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.1 2.4 0.0 0.0 0.2 0.3 4.1 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MSMB "IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94" ENSG00000263639 "Microseminoprotein beta" P08118 10 46033307-46046269 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "prostate: 437.8" "Cell type enriched" "Detected in some" 25 "Glandular cells: 8376.6" "Cancer enriched" "Detected in many" 42 "prostate cancer: 3435.3" "Cell type enriched" "Detected in single" 5 "eosinophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "BEWO: 20.5;NB-4: 16.5;RPMI-8226: 8.6;SH-SY5Y: 4.7;SK-BR-3: 4.8;U-2197: 9.7" "CAB026357, HPA051257" Enhanced "Secreted in male reproductive system" NA NA 3700000 "CAB026357: , HPA051257: AB_2681410" "unprognostic (6.47e-2)" "unprognostic (7.21e-3)" "unprognostic (1.37e-2)" "unprognostic (8.18e-3)" "unprognostic (4.28e-3)" "unprognostic (9.24e-3)" "unprognostic (1.66e-1)" "unprognostic (8.66e-2)" "unprognostic (2.01e-1)" "unprognostic (4.55e-2)" "unprognostic (2.01e-1)" "unprognostic (7.04e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.19e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.0 0.8 0.0 0.1 0.1 0.0 1.8 0.1 0.0 7.2 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 437.8 0.0 0.0 14.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 26.8 0.6 0.0 0.0 0.0 0.1 0.7 0.7 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.5 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.3 16.5 0.2 0.1 0.0 0.0 0.0 8.6 0.0 1.2 0.9 4.7 0.0 4.8 0.0 0.2 0.4 0.0 0.0 0.0 0.0 9.7 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 273.5 0.0 0.0 0.0 7.6 333.3 236.6 0.0 0.0 1.9 0.0 0.0 43.1 0.0 0.0 0.0 0.2 0.2 0.0 8376.6 1.1 1.0 0.2 0.0 0.0 0.0 0.0 49.8 0.3 0.0 3.3 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 1.3 0.0 0.0 190.4 MSMO1 "DESP4, ERG25, SC4MOL" ENSG00000052802 "Methylsterol monooxygenase 1" Q15800 4 165327623-165343160 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 171.6" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 234.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 69.5;Karpas-707: 68.2;RPTEC TERT1: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056127 Enhanced NA NA "HPA056127: AB_2683045" "unprognostic (5.76e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.35e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" "unprognostic (1.20e-2)" "unprognostic (7.14e-2)" "unprognostic (1.75e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.28e-1)" "prognostic favorable (9.21e-4)" "unprognostic (2.39e-1)" "unprognostic (1.56e-2)" "unprognostic (3.54e-1)" "unprognostic (1.40e-1)" 5.0 26.5 17.1 6.7 23.7 3.5 21.5 7.7 29.6 15.6 12.6 22.8 4.0 22.6 6.1 31.5 44.9 7.1 7.4 5.8 18.8 20.8 16.3 171.6 30.0 6.4 13.1 18.6 18.0 7.5 10.9 7.0 7.4 41.1 19.1 10.8 12.1 10.6 4.7 2.2 22.5 20.7 5.7 33.5 4.3 10.3 15.8 12.5 4.3 7.5 17.6 12.9 8.6 17.7 21.2 10.1 6.2 9.8 12.1 20.8 15.8 14.0 3.4 33.1 6.0 16.4 52.8 6.2 5.7 25.9 7.4 20.5 6.6 60.4 7.0 3.4 6.9 69.5 11.6 16.6 59.9 8.2 5.9 10.2 3.1 3.6 20.3 33.1 5.6 4.4 32.6 39.4 27.1 16.8 10.1 9.5 9.1 5.5 68.2 12.1 7.2 5.0 9.2 19.0 7.4 3.4 2.6 3.6 21.0 65.8 16.5 6.6 4.9 8.9 12.7 5.3 21.2 5.9 7.1 10.9 3.4 6.1 3.0 3.9 12.6 13.2 9.2 7.3 5.7 4.6 6.2 4.6 4.5 19.0 5.9 14.2 21.2 18.3 17.6 7.8 18.9 20.0 20.8 3.4 12.1 9.8 10.1 15.8 15.8 17.1 23.7 7.7 29.6 18.8 20.8 13.1 18.6 41.1 12.5 47.6 144.4 35.8 51.9 32.1 27.2 5.8 45.9 68.3 60.3 66.3 25.5 47.4 29.9 52.5 2.8 17.5 70.9 0.0 62.6 72.4 27.9 84.9 48.3 234.0 24.0 33.4 58.1 29.4 29.7 4.5 23.0 15.0 30.4 36.1 42.1 22.3 58.7 24.6 17.7 36.0 46.7 19.4 20.2 7.4 14.4 100.6 102.9 22.4 21.1 123.4 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;pituitary gland: 6.0;placenta: 5.7" "Group enriched" "Detected in some" 67 "Early spermatids: 95.5;Late spermatids: 142.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.9" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 35.1;PC-3: 44.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in male reproductive system" No No Vesicles Cytosol "HPA055174: AB_2682726" 0.5 0.0 1.2 1.1 0.6 0.0 0.8 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.1 0.1 0.4 0.0 0.4 0.9 3.9 0.0 0.0 0.0 0.0 6.0 5.7 0.8 0.7 0.5 0.0 0.0 0.3 1.3 0.5 1.5 0.3 2.2 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 3.2 0.3 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 1.2 0.3 0.1 0.3 0.4 1.2 0.6 0.0 0.6 0.1 0.1 3.9 0.0 0.8 0.0 0.0 0.6 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 95.5 0.3 0.0 0.0 1.8 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 142.6 0.3 0.0 1.7 0.0 0.0 0.8 1.3 0.0 0.7 0.2 0.6 0.0 0.0 0.7 0.4 0.1 0.2 0.0 0.0 1.1 MSR1 "CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII" ENSG00000038945 "Macrophage scavenger receptor 1" P21757 8 16107878-16567490 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 88.1;lung: 70.4" "Group enriched" "Detected in many" 4 "Hofbauer cells: 144.7;Kupffer cells: 246.5;Macrophages: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 16.0" "Lineage enriched" "Detected in many" 5 "monocytes: 16.0" "Group enriched" "Detected in many" 7 "BJ hTERT+: 48.2;REH: 18.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000272, CAB032491" Enhanced NA NA 25000 "CAB032491: AB_672722, HPA000272: AB_1846269" "unprognostic (8.19e-3)" "unprognostic (4.87e-2)" "unprognostic (1.93e-2)" "unprognostic (2.10e-1)" "unprognostic (9.24e-2)" "unprognostic (1.32e-2)" "unprognostic (5.85e-3)" "unprognostic (2.89e-1)" "unprognostic (9.70e-2)" "unprognostic (1.62e-2)" "unprognostic (7.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.76e-2)" "unprognostic (9.16e-2)" "unprognostic (7.39e-2)" "unprognostic (6.85e-2)" "unprognostic (4.69e-2)" 88.1 9.0 2.2 6.1 4.5 3.7 6.9 10.4 3.3 4.5 3.1 1.8 1.0 2.1 3.1 6.2 2.4 4.5 11.4 8.0 3.8 3.1 9.5 13.6 70.4 6.9 4.3 0.8 6.7 3.8 1.2 2.6 10.4 7.7 3.2 3.9 4.5 6.2 2.3 3.2 1.6 4.0 6.5 11.9 10.9 2.5 4.9 3.1 1.5 2.2 1.7 0.7 10.8 1.8 1.5 1.0 3.0 16.0 0.3 1.3 0.5 0.6 0.9 1.3 0.6 0.6 0.6 0.6 0.3 48.2 0.1 0.2 1.6 0.1 1.5 2.4 0.4 0.3 0.3 0.3 0.4 0.9 0.2 2.0 2.0 1.8 1.9 0.4 1.0 1.1 0.3 0.4 0.4 0.7 0.8 0.0 0.8 0.7 1.4 0.9 1.9 0.6 0.6 0.2 0.7 0.6 18.3 1.0 0.4 0.9 2.8 1.0 0.5 0.4 1.3 0.1 2.4 0.2 0.5 1.1 1.3 0.5 5.0 1.3 4.9 3.8 3.3 0.5 0.7 1.0 1.1 3.1 0.5 0.9 16.0 0.4 0.9 0.7 0.7 1.0 1.5 1.3 0.9 3.0 0.3 7.8 0.5 0.6 0.5 2.2 4.5 10.4 2.7 3.8 3.1 4.3 0.8 7.7 3.1 20.8 40.5 8.2 0.0 2.4 0.0 1.7 5.1 12.0 14.8 3.5 23.6 0.5 1.7 0.0 2.2 1.3 0.0 0.0 0.0 0.4 0.9 0.0 16.3 0.9 144.7 0.0 0.0 7.4 246.5 2.1 1.7 103.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 19.4 0.9 3.3 1.4 1.8 0.7 1.3 0.0 0.1 MSRA ENSG00000175806 "Methionine sulfoxide reductase A" Q9UJ68 8 10054268-10428891 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 597.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 78.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Group enriched" "Detected in many" 4 "dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2" "Cell line enhanced" "Detected in many" "HMC-1: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023804, HPA075766" Approved Supported "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" No No 25000 "Nucleoplasm, Plasma membrane, Cytosol" "Actin filaments" "HPA023804: AB_1853826, HPA075766: " "unprognostic (1.55e-1)" "unprognostic (4.30e-3)" "unprognostic (1.45e-3)" "unprognostic (1.00e-2)" "unprognostic (4.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.49e-2)" "unprognostic (6.40e-2)" "unprognostic (9.69e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.07e-3)" "unprognostic (6.43e-3)" "unprognostic (4.02e-1)" "unprognostic (6.36e-3)" "unprognostic (3.07e-1)" 7.0 8.1 8.0 5.2 7.5 36.1 5.9 78.4 13.7 3.6 5.9 4.3 2.2 5.9 4.8 3.7 5.5 4.2 4.4 8.5 8.9 5.5 32.4 22.9 5.7 6.8 6.8 9.5 4.2 10.2 2.9 3.4 4.6 8.1 3.4 4.0 3.9 6.0 5.0 4.7 3.8 12.7 4.9 6.7 7.2 4.9 8.5 5.5 3.5 4.4 2.6 3.8 3.9 2.7 1.1 2.3 9.0 3.2 1.1 0.8 0.3 0.1 1.1 1.8 5.4 1.6 1.8 0.6 3.3 0.7 0.5 2.2 0.7 2.7 0.0 0.8 3.0 7.2 2.9 0.5 0.2 1.7 0.4 0.0 0.5 1.7 2.5 5.3 1.0 15.2 0.5 3.9 0.4 0.0 1.8 0.9 0.3 0.5 0.3 5.9 0.2 0.0 0.3 0.8 3.9 1.0 1.8 1.7 2.3 1.3 1.3 3.1 2.0 5.4 0.2 0.7 0.6 2.8 3.3 3.2 2.2 2.6 0.5 1.6 0.2 0.1 0.9 5.9 1.0 4.1 0.8 3.2 9.0 0.7 2.2 0.6 1.1 0.8 0.5 2.3 0.4 0.6 0.5 3.8 1.1 1.6 0.3 0.5 0.3 8.0 7.5 78.4 13.7 8.9 5.5 6.8 9.5 8.1 5.5 0.0 9.0 10.0 24.1 14.5 10.7 18.1 17.8 5.3 4.5 24.4 29.5 5.8 77.9 27.0 64.1 26.4 29.0 0.0 41.4 4.5 11.3 16.9 81.6 82.9 42.3 15.9 9.2 16.5 31.0 107.2 8.6 33.1 28.7 14.4 19.7 13.4 40.7 28.8 9.2 597.4 5.8 12.9 17.6 27.7 18.8 12.3 7.0 15.3 17.4 28.6 MSRB1 "SelR, SelX, SepR, SEPX1" ENSG00000198736 "Methionine sulfoxide reductase B1" Q9NZV6 16 1938210-1943326 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 195.6;liver: 94.8;pancreas: 107.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 236.4;monocytes: 165.9;Proximal tubular cells: 237.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 85.8;neutrophil: 195.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 195.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008650, HPA043463, HPA069557" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153" "unprognostic (3.93e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.88e-2)" "unprognostic (4.90e-2)" "unprognostic (5.29e-2)" "unprognostic (3.60e-1)" "unprognostic (4.27e-2)" "unprognostic (8.46e-2)" "unprognostic (4.92e-2)" "unprognostic (7.31e-2)" "unprognostic (4.59e-3)" 7.9 4.0 5.2 9.0 6.3 27.3 5.1 3.2 6.1 5.2 13.1 5.6 7.5 8.7 7.9 13.5 16.9 9.6 13.5 13.7 4.7 4.1 24.9 94.8 9.6 15.6 5.5 4.1 7.3 107.2 2.9 3.9 11.6 4.1 11.0 5.1 6.2 4.7 9.4 20.5 8.0 17.0 14.3 4.3 18.2 9.6 8.1 3.6 3.7 5.5 19.8 4.5 14.8 4.8 1.7 10.9 195.6 26.2 2.4 2.8 12.2 6.8 17.3 6.4 15.2 12.0 5.3 11.0 8.4 10.6 12.3 10.7 27.7 7.5 6.6 27.5 9.7 10.8 11.2 10.7 7.4 3.8 37.0 12.2 5.1 6.4 44.1 11.0 14.4 12.2 9.8 6.5 8.9 1.7 3.9 12.3 8.6 8.0 3.7 6.5 37.5 8.1 23.6 8.8 12.3 9.9 11.8 8.9 31.0 19.2 11.4 6.2 8.2 9.5 10.6 5.1 4.3 11.5 25.5 7.3 3.7 10.4 7.4 4.9 9.8 15.5 12.6 3.9 13.6 6.5 26.0 26.2 85.8 2.2 12.0 2.1 1.7 1.8 1.8 10.9 1.7 1.4 1.6 195.6 2.4 10.7 4.6 2.8 12.2 5.2 6.3 3.2 6.1 4.7 4.1 5.5 4.1 4.1 3.6 8.9 14.9 11.5 10.5 5.8 6.0 32.4 38.2 20.1 3.4 31.4 3.9 30.0 79.6 56.2 3.3 12.0 75.5 23.3 97.0 102.6 13.1 12.7 4.6 236.4 55.0 7.9 57.8 19.0 79.6 10.4 8.6 26.2 15.1 165.9 31.9 17.1 66.7 63.3 21.5 237.9 3.0 0.0 19.8 35.7 9.1 8.3 32.3 20.3 27.8 18.7 MSRB2 "CBS-1, CBS1, CGI-131, MSRB, PILB" ENSG00000148450 "Methionine sulfoxide reductase B2" Q9Y3D2 10 23095506-23122013 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 72.3" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 249.2;Proximal tubular cells: 323.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027933 Enhanced "Intracellular and membrane" NA NA "HPA027933: AB_10601867" "unprognostic (4.89e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-3)" "unprognostic (3.47e-3)" "unprognostic (4.51e-1)" "unprognostic (9.26e-3)" "unprognostic (1.62e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-1)" "unprognostic (6.07e-3)" "unprognostic (3.47e-2)" "unprognostic (1.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.82e-2)" "unprognostic (6.74e-2)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" 13.2 11.6 16.4 6.8 16.2 6.0 9.9 6.5 11.4 10.7 14.4 8.0 14.3 8.2 10.6 15.2 14.1 10.5 15.8 72.3 13.9 14.5 16.0 25.7 7.9 6.3 14.2 8.2 11.3 7.0 11.5 9.4 12.4 9.3 16.3 10.2 10.6 7.7 18.0 31.5 3.6 13.5 25.1 10.8 8.2 7.5 5.6 6.1 6.0 16.7 11.0 5.5 19.0 10.3 0.4 3.1 6.7 2.6 0.3 1.3 0.5 4.0 5.9 11.0 6.6 11.4 10.3 3.3 6.5 3.6 4.2 4.8 4.0 8.9 3.3 5.8 13.8 6.3 2.6 3.6 4.8 3.5 22.2 4.0 2.4 9.8 2.2 16.1 0.5 2.9 13.1 8.2 4.9 1.2 9.2 5.9 6.5 3.2 5.9 9.1 12.1 3.8 3.0 6.0 23.0 3.4 4.5 6.3 0.8 5.2 1.5 2.2 15.1 8.0 7.1 13.1 9.6 4.8 9.5 4.3 3.6 3.4 8.1 3.8 7.7 2.4 0.1 5.2 7.1 3.0 1.6 2.6 4.1 0.7 2.1 0.6 0.4 0.7 0.5 1.6 0.1 1.3 0.9 6.7 0.3 1.5 3.1 0.7 0.5 16.4 16.2 6.5 11.4 13.9 14.5 14.2 8.2 9.3 6.1 0.0 16.0 12.3 46.9 16.3 63.8 249.2 76.5 14.7 6.8 85.5 21.6 88.5 149.2 108.6 0.9 27.2 64.2 0.0 56.2 49.9 58.5 35.8 29.9 158.3 94.8 106.5 53.5 38.6 53.9 3.3 46.1 29.8 69.2 18.0 46.4 85.9 76.4 76.4 58.7 323.7 43.6 58.2 52.8 1.1 5.4 15.3 58.2 10.7 59.3 40.6 MSRB3 "DFNB74, DKFZp686C1178, FLJ36866" ENSG00000174099 "Methionine sulfoxide reductase B3" Q8IXL7 12 65278643-65491430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 75.9" "Cell type enriched" "Detected in many" 16 "Cardiomyocytes: 2030.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 23.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 37.2;hTERT-RPE1: 33.8;U-937: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014432 Enhanced "Intracellular and membrane" NA NA "HPA014432: AB_1854146" "unprognostic (1.40e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (2.86e-3)" "unprognostic (1.94e-1)" "unprognostic (2.74e-2)" "unprognostic (1.74e-2)" "unprognostic (2.63e-2)" "unprognostic (1.23e-1)" "unprognostic (1.84e-2)" "unprognostic (5.33e-2)" "unprognostic (8.28e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (8.85e-8)" "unprognostic (3.29e-3)" "unprognostic (7.80e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (2.17e-4)" 15.2 3.8 4.5 11.6 5.3 6.4 26.8 5.1 5.2 19.0 39.4 3.6 20.4 4.0 40.3 15.0 23.0 16.1 23.4 30.9 4.8 4.3 4.1 1.4 11.7 4.4 5.0 5.0 13.3 2.5 0.8 3.1 8.7 4.7 19.8 10.2 11.8 4.7 38.4 32.2 3.8 10.0 75.9 5.0 6.5 17.2 6.1 4.8 0.4 6.0 11.2 2.5 33.9 20.9 0.2 6.5 23.4 0.6 4.4 0.1 0.8 2.5 5.6 4.9 22.8 22.2 19.7 0.1 25.8 27.8 10.1 6.1 0.2 0.3 0.0 5.6 37.2 3.2 0.5 2.3 6.5 9.2 0.0 4.7 0.0 5.0 0.2 14.5 13.5 0.1 10.3 3.6 8.5 11.9 33.8 20.4 0.0 0.1 0.1 23.0 0.8 0.0 3.1 1.6 0.0 3.1 0.0 6.7 0.1 2.3 0.3 0.1 2.4 8.9 0.5 6.3 5.3 4.2 13.0 23.4 12.9 7.0 5.8 10.0 2.4 1.8 0.0 3.5 31.3 8.0 6.3 0.3 23.4 0.1 0.6 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 4.0 4.4 0.2 6.5 0.0 0.8 4.5 5.3 5.1 5.2 4.8 4.3 5.0 5.0 4.7 4.8 11.9 4.3 0.5 13.0 5.7 20.7 2030.9 7.6 10.7 1.2 3.5 0.0 0.4 0.0 8.7 4.5 40.9 0.0 0.0 0.8 0.3 27.9 2.8 2.3 0.0 0.5 20.6 0.0 23.4 0.0 1.3 11.5 3.9 10.1 1.0 0.0 36.4 1.5 0.0 109.6 0.3 10.3 103.5 126.0 4.1 1.4 4.0 0.6 0.0 0.0 2.6 MSS51 "FLJ39565, ZMYND17" ENSG00000166343 "MSS51 mitochondrial translational activator" Q4VC12 10 73423579-73433561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "parathyroid gland: 34.4;skeletal muscle: 66.9" "Cell type enhanced" "Detected in some" 7 "Cardiomyocytes: 3.9;granulocytes: 4.7;Leydig cells: 2.8;Paneth cells: 2.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 6 "cerebellum: 2.7" "Cell type enhanced" "Detected in some" "gdT-cell: 1.7;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA038564 Uncertain Vesicles,Cytosol NA NA Vesicles Cytosol "HPA038564: AB_10674687" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.40e-3)" "unprognostic (2.06e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-3)" "unprognostic (3.05e-3)" "unprognostic (7.88e-3)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (1.50e-4)" "unprognostic (1.22e-1)" "unprognostic (1.78e-7)" "unprognostic (1.51e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-2)" 2.8 0.3 0.4 0.4 0.4 0.3 0.4 2.7 0.4 0.5 0.5 0.4 0.4 0.2 0.6 0.4 0.9 0.6 0.4 3.9 0.4 0.1 0.4 0.4 0.6 0.4 0.4 0.4 1.1 0.5 34.4 0.7 0.4 0.4 0.8 0.3 0.4 2.3 0.4 66.9 0.8 0.8 0.4 0.4 1.4 0.4 0.4 0.4 0.6 0.4 1.2 0.4 0.5 0.6 0.1 0.0 0.0 0.5 0.0 1.7 0.4 1.2 1.3 3.0 4.7 4.2 6.0 2.6 1.5 1.1 0.6 1.3 0.7 1.5 3.8 0.5 1.5 0.2 2.3 1.9 0.4 1.7 1.8 1.5 3.3 2.0 1.1 1.5 2.2 3.1 4.7 1.5 1.3 3.5 4.3 0.6 1.5 1.1 2.0 2.5 0.5 1.9 3.0 0.9 1.0 1.6 1.1 7.8 0.2 1.8 1.9 0.6 1.2 1.0 2.2 1.7 3.2 1.9 1.8 2.7 2.3 1.4 0.9 3.0 1.2 3.4 2.0 1.0 3.8 0.6 0.0 0.4 0.0 1.7 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.3 1.2 0.0 0.0 0.5 0.0 0.0 0.4 0.4 0.4 2.7 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 2.2 2.2 0.0 0.5 1.4 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.7 0.4 0.0 0.3 0.1 0.5 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.6 0.0 2.8 0.1 0.0 0.0 0.6 0.9 0.1 2.9 1.4 0.0 1.2 0.0 0.4 0.5 0.2 0.0 0.1 0.7 0.6 0.1 MST1 "D3F15S2, DNF15S2, HGFL, MSP, NF15S2" ENSG00000173531 "Macrophage stimulating 1" 3 49683947-49689501 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "liver: 117.0" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 361.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 42.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;memory B-cell: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 42.3;NB-4: 8.6;U-266/70: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024036 Approved "Secreted to blood" NA NA "HPA024036: AB_1854147" "unprognostic (5.13e-3)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (1.16e-2)" "unprognostic (9.42e-3)" "unprognostic (8.24e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.14e-4)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.7 3.5 4.0 0.3 4.8 1.4 1.0 4.9 5.4 0.9 1.4 2.5 1.9 14.4 1.2 3.3 0.8 1.7 1.9 0.5 6.5 1.1 8.8 117.0 1.6 0.7 2.0 2.9 1.7 1.9 3.8 4.8 1.5 4.8 1.5 0.5 1.6 3.4 3.7 2.8 4.0 8.2 1.3 4.2 1.7 0.8 9.9 2.3 0.9 5.0 0.3 1.1 0.8 0.7 1.2 0.9 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.6 1.0 1.9 4.1 1.9 0.5 0.7 0.3 0.4 2.0 0.6 0.1 1.3 0.6 0.3 0.4 0.3 0.8 0.3 0.6 0.3 0.3 0.9 42.3 3.1 0.0 0.8 5.5 1.3 0.3 1.1 7.5 0.7 1.8 0.3 5.2 1.0 0.3 0.2 8.6 0.1 0.5 0.5 0.2 0.2 1.1 2.3 0.3 0.1 1.5 0.0 0.9 0.2 1.3 0.7 2.8 0.5 1.0 0.3 0.0 0.1 11.5 1.4 0.2 1.1 1.6 0.7 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.2 4.0 4.8 4.9 5.4 6.5 1.1 2.0 2.9 4.8 2.3 6.0 3.8 6.0 4.8 2.6 7.2 1.7 38.2 5.3 4.5 26.2 7.9 3.6 53.0 5.4 4.2 2.1 4.6 46.7 3.3 13.8 3.3 1.1 1.1 361.8 1.2 1.6 7.9 11.6 9.5 0.5 2.8 1.4 3.3 0.0 7.3 7.7 2.3 7.0 1.8 54.1 6.9 0.0 2.0 18.7 4.4 4.1 4.2 2.1 12.1 2.7 MST1R "CD136, CDw136, PTK8, RON" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 34.3;skin 1: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 23.8;Enterocytes: 29.1;Mucus-secreting cells: 21.5;Pancreatic endocrine cells: 19.7;Paneth cells: 20.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Lineage enhanced" "Detected in single" "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 35.9;HaCaT: 19.8;HBEC3-KT: 21.6;hTCEpi: 30.3;RT4: 23.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol NA NA Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favorable (2.33e-5)" 1.7 0.1 0.4 7.5 0.6 0.0 2.4 0.5 0.7 1.8 20.5 0.7 2.0 11.2 1.2 1.3 6.1 0.6 27.7 0.9 0.5 0.1 1.4 0.4 5.0 1.1 0.4 0.6 0.5 4.1 0.0 1.3 0.8 0.9 1.7 9.7 2.5 2.1 0.4 0.5 28.7 34.3 0.7 0.4 0.6 19.1 1.9 0.4 7.7 1.3 6.0 4.5 4.3 3.5 0.2 0.0 0.0 0.0 0.6 2.1 0.0 12.9 5.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.2 35.9 0.5 3.1 0.2 0.0 19.8 0.0 21.6 0.0 0.3 0.3 0.0 8.5 0.3 0.3 0.0 0.4 0.1 30.3 0.1 4.3 0.1 0.0 0.0 0.2 0.1 0.0 1.8 0.0 0.0 0.1 11.6 10.5 0.9 0.0 0.3 13.3 23.1 0.3 0.0 3.6 8.4 0.0 0.0 6.6 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.4 0.6 0.5 0.7 0.5 0.1 0.4 0.6 0.9 0.4 23.8 10.1 0.0 2.2 7.8 0.0 1.2 0.0 2.7 9.1 0.0 0.0 0.1 0.0 5.2 13.7 0.0 29.1 0.0 8.7 0.4 0.4 1.7 0.0 0.0 0.1 0.0 4.1 0.0 0.0 7.9 0.3 0.0 0.0 1.0 21.5 0.0 19.7 20.4 0.0 0.0 0.0 0.0 0.4 1.6 0.8 4.1 0.0 0.0 12.4 4.6 MSTN GDF8 ENSG00000138379 Myostatin O14793 2 190055697-190062729 "Disease related genes, Predicted secreted proteins" "Cytokine, Growth factor, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 17.2;tongue: 15.8" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 3.9;Early spermatids: 13.2;Late spermatids: 4.3;Muller glia cells: 16.9" "Cancer enriched" "Detected in some" 9 "glioma: 6.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "LHCN-M2: 16.2;RH-30: 33.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" CAB009963 Approved "Secreted in other tissues" NA NA 4800000 "CAB009963: AB_2148798" "unprognostic (8.45e-2)" "unprognostic (2.84e-2)" "unprognostic (3.52e-2)" "unprognostic (2.54e-1)" "prognostic favorable (2.86e-4)" "unprognostic (7.59e-3)" "unprognostic (2.95e-1)" "unprognostic (4.09e-2)" "unprognostic (1.91e-1)" "unprognostic (2.19e-1)" "unprognostic (1.24e-3)" "unprognostic (7.72e-3)" "unprognostic (1.12e-4)" "unprognostic (1.06e-1)" "unprognostic (3.94e-1)" "unprognostic (6.53e-2)" "unprognostic (5.67e-4)" 3.3 1.9 1.7 0.7 1.4 0.2 0.8 4.1 1.8 4.8 1.1 2.2 0.0 0.7 1.8 1.2 2.3 0.5 0.6 0.7 3.5 1.6 1.1 0.3 0.3 0.3 1.3 0.0 0.7 0.4 0.4 1.4 0.2 3.4 1.0 1.1 0.9 1.0 0.5 17.2 1.2 2.1 0.9 1.1 0.3 0.6 0.7 4.0 0.0 0.7 15.8 0.4 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 4.1 1.0 3.5 1.6 1.3 0.0 3.4 4.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.4 0.0 1.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MSX1 "HOX7, HYD1, OFC5" ENSG00000163132 "Msh homeobox 1" P28360 4 4859666-4863936 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 47.2" "Cell type enhanced" "Detected in some" 11 "Endothelial cells: 14.6;Fibroblasts: 22.2;Melanocytes: 15.1;Smooth muscle cells: 26.1" "Cancer enriched" "Detected in all" 17 "endometrial cancer: 246.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 29.5;EFO-21: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026198, HPA063895, HPA073604" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617" "unprognostic (1.12e-1)" "unprognostic (1.93e-2)" "unprognostic (3.39e-2)" "prognostic favorable (1.64e-7)" "unprognostic (9.13e-2)" "unprognostic (1.16e-3)" "unprognostic (4.07e-3)" "unprognostic (3.81e-2)" "unprognostic (1.48e-2)" "unprognostic (2.21e-3)" "unprognostic (4.78e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.18e-5)" "unprognostic (4.35e-2)" "unprognostic (2.06e-1)" "unprognostic (2.34e-3)" "unprognostic (1.33e-2)" 9.0 3.8 4.6 1.5 2.9 1.0 11.4 1.4 8.6 47.2 1.4 6.0 1.0 1.4 17.9 1.2 1.5 4.5 2.2 2.5 8.7 2.2 1.4 1.3 2.1 1.4 4.2 1.6 2.5 2.0 1.2 11.5 5.1 14.0 3.9 0.9 1.7 3.7 4.9 18.3 2.5 1.2 4.3 3.6 3.3 1.3 1.4 3.8 0.0 4.7 2.6 1.2 5.9 18.8 0.5 0.4 1.9 0.8 0.7 0.6 0.2 1.5 0.9 0.3 1.8 5.2 3.3 5.6 3.8 1.8 2.2 1.1 29.5 9.6 0.1 13.7 2.7 10.9 0.0 6.6 0.0 0.8 1.2 7.7 0.0 5.1 10.5 0.4 0.1 0.9 0.6 0.5 1.7 0.5 0.7 0.5 2.5 4.7 0.2 1.1 0.7 0.8 1.5 0.1 0.4 7.0 3.9 4.1 0.3 0.1 0.9 0.3 0.1 3.4 0.1 2.3 0.5 0.6 1.3 1.2 2.6 5.8 8.3 6.0 0.6 0.5 3.4 1.7 1.9 2.5 1.9 0.4 0.5 0.3 0.5 0.4 0.5 0.3 0.4 0.3 0.4 0.6 0.4 1.4 0.7 0.8 0.4 0.5 0.2 4.6 2.9 1.4 8.6 8.7 2.2 4.2 1.6 14.0 3.8 0.0 0.0 0.0 1.9 6.4 0.7 4.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.2 0.4 14.6 0.7 0.0 0.8 0.1 22.2 3.2 0.0 0.0 0.4 0.0 0.0 6.7 0.6 0.0 1.1 0.9 15.1 0.0 0.1 0.3 0.4 0.0 0.4 0.4 0.8 0.0 26.1 0.7 1.5 4.1 0.2 0.0 1.5 1.5 MSX2 "CRS2, FPP, HOX8, MSH, PFM, PFM1" ENSG00000120149 "Msh homeobox 2" P35548 5 174724533-174730893 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.7;urinary bladder: 18.2" "Group enriched" "Detected in many" 16 "Cytotrophoblasts: 123.2;Syncytiotrophoblasts: 195.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "BEWO: 84.9" "Region enriched" "Detected in single" 7 "cerebellum: 6.9" "Low region specificity" "Detected in some" HPA005652 Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA005652: AB_1079418" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "prognostic favorable (8.43e-5)" "unprognostic (2.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.08e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (1.36e-4)" "unprognostic (7.64e-3)" "unprognostic (5.06e-2)" "unprognostic (2.12e-6)" "unprognostic (1.43e-2)" 2.0 0.4 0.3 0.4 0.5 0.0 7.6 6.3 1.6 2.6 0.9 2.0 0.0 0.3 6.2 0.2 0.9 1.1 1.5 1.7 2.5 0.5 0.3 0.1 0.9 0.1 1.5 1.2 0.4 0.6 9.4 0.5 44.7 7.2 6.3 0.1 6.6 0.9 0.8 2.1 6.4 0.9 10.4 6.6 1.1 2.6 5.2 1.3 0.0 0.8 0.2 0.3 18.2 2.4 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 1.0 0.3 0.8 0.0 0.0 84.9 0.5 0.9 0.2 0.0 14.4 5.9 0.0 2.2 0.0 5.2 1.6 4.5 1.6 0.0 0.0 2.8 0.0 0.3 0.0 0.6 0.0 0.8 1.0 1.2 0.8 0.9 0.0 0.0 0.0 0.0 0.0 1.2 6.9 0.0 0.1 0.6 9.6 2.2 0.0 2.3 0.0 1.0 9.0 0.0 0.6 0.0 11.2 0.7 19.3 6.7 0.0 0.0 0.2 1.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.5 6.3 1.6 2.5 0.5 1.5 1.2 7.2 1.3 0.0 0.0 0.0 2.4 8.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 123.2 0.0 0.6 0.1 0.5 0.5 0.0 0.0 7.6 5.0 2.6 4.6 0.0 9.9 0.0 0.0 0.6 0.6 0.2 0.0 0.0 1.7 0.0 1.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 3.1 1.1 4.9 9.9 195.5 0.0 0.4 8.3 MT-ATP6 "ATP6, ATPase-6, MTATP6, RP, Su6m" ENSG00000198899 "Mitochondrially encoded ATP synthase membrane subunit 6" P00846 MT 8527-9207 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 419.0;skeletal muscle: 475.3" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 108059.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 419.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 1186.6" "Low region specificity" "Detected in all" NA NA "unprognostic (2.97e-1)" "unprognostic (4.16e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" "unprognostic (8.45e-3)" "unprognostic (1.66e-1)" "prognostic favorable (3.79e-4)" "unprognostic (6.47e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-2)" "prognostic favorable (7.64e-4)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.37e-1)" "unprognostic (3.56e-1)" "unprognostic (2.52e-3)" 85.2 89.2 126.0 25.1 159.3 20.1 29.6 45.2 81.2 20.1 60.3 75.6 23.5 30.9 42.8 19.8 24.6 309.5 122.3 90.2 154.4 166.8 18.0 19.3 102.8 26.5 54.7 36.2 22.0 34.1 37.6 59.4 66.8 35.6 475.3 62.5 52.6 27.9 61.3 20.7 58.4 27.7 22.4 18.6 23.0 15.7 110.2 58.9 419.0 88.2 72.3 90.5 35.3 100.8 166.4 116.2 182.2 221.8 50.9 75.9 148.7 27.1 20.1 34.0 195.6 110.9 179.7 63.2 80.2 31.2 219.8 12.1 116.0 37.3 128.3 105.3 157.3 1186.6 338.6 37.7 93.1 203.9 83.0 102.9 36.1 34.9 141.5 35.7 100.8 103.4 131.1 78.3 284.0 57.3 247.9 30.5 77.4 68.9 72.2 49.5 110.7 208.9 256.0 66.4 85.2 53.3 113.7 107.5 199.3 121.6 319.6 188.2 82.0 121.2 135.4 106.1 58.0 76.5 124.6 71.6 198.7 45.8 419.0 88.2 156.1 56.6 66.3 71.6 106.0 64.7 71.1 47.5 110.2 76.5 90.5 100.1 72.3 67.8 58.9 47.6 35.3 1381.7 1526.0 11633.9 5315.5 2578.7 0.0 108059.0 10741.3 2731.6 2651.3 6092.6 0.0 0.0 1593.2 1756.2 808.5 1505.8 13591.3 14997.7 2949.2 0.0 1371.6 3985.7 1952.8 21340.2 0.0 0.0 3847.9 7623.7 10387.2 3622.6 7103.8 2816.3 2404.1 3082.2 11928.5 0.0 2519.5 9780.9 4668.2 10316.3 0.0 6202.4 2943.8 6022.8 4841.7 2653.0 0.0 6498.2 11027.9 6485.3 MT-ATP8 "A6L, ATP8, MTATP8" ENSG00000228253 "Mitochondrially encoded ATP synthase membrane subunit 8" P03928 MT 8366-8572 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 959.7" "Cell type enriched" "Detected in many" 31 "Cardiomyocytes: 20663.1" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 352.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 352.9" "Cell line enhanced" "Detected in all" "HeLa: 805.0" NA NA "unprognostic (1.54e-1)" "unprognostic (4.12e-2)" "unprognostic (3.95e-2)" "unprognostic (2.56e-1)" "unprognostic (3.07e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.56e-5)" "unprognostic (5.17e-2)" "unprognostic (6.61e-2)" "unprognostic (2.52e-3)" "unprognostic (8.26e-2)" "unprognostic (1.30e-2)" "unprognostic (1.10e-1)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (2.62e-1)" "unprognostic (1.63e-2)" 257.8 128.5 111.1 33.5 124.1 20.5 31.2 42.1 82.1 14.9 78.9 115.5 23.9 11.6 31.6 14.4 19.9 203.6 108.7 78.8 151.5 165.2 16.9 18.5 88.8 24.3 56.4 22.8 21.1 27.7 44.2 38.7 65.2 25.7 959.7 33.1 91.5 14.2 52.0 19.3 67.4 26.1 23.2 11.8 19.6 15.4 87.7 58.0 352.9 78.1 75.9 79.1 24.2 189.4 69.9 228.3 43.4 248.7 39.8 112.1 398.9 23.6 18.1 31.7 81.2 127.3 485.5 99.6 85.8 69.2 326.0 14.0 131.5 28.5 214.5 91.1 367.2 805.0 183.1 45.4 213.8 314.4 85.5 69.8 40.2 34.6 254.6 25.8 193.9 194.4 154.0 55.5 101.3 125.2 315.4 50.2 106.8 50.5 103.4 111.0 102.1 133.6 189.5 71.8 129.8 151.3 140.3 147.4 378.1 136.9 449.1 377.2 88.4 195.8 194.6 182.8 104.4 174.8 277.5 87.1 380.3 53.6 352.9 78.1 97.9 49.4 68.6 73.5 87.7 55.9 58.5 47.2 87.3 68.9 79.1 49.0 75.9 68.0 58.0 44.0 24.2 175.7 127.6 194.5 6.6 10.3 0.0 20663.1 265.0 662.5 619.9 12.2 0.0 0.0 3.3 11.5 6.0 7.1 98.6 420.4 26.4 0.0 6.7 3.9 274.2 625.8 0.0 0.0 28.0 241.2 345.1 31.7 37.7 12.6 11.8 11.8 48.6 0.0 16.1 47.0 23.7 20.3 0.0 38.8 11.3 24.7 22.2 8.0 0.0 192.9 46.4 6.2 MT-CO1 "COI, COX1, MTCO1" ENSG00000198804 "Mitochondrially encoded cytochrome c oxidase I" P00395 MT 5904-7445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 81405.0;Enterocytes: 59874.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 872.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016241, HPA069328" Enhanced Supported Mitochondria NA NA Mitochondria "CAB016241: AB_2229888, HPA069328: AB_2686122" "unprognostic (4.39e-1)" "unprognostic (2.45e-1)" "unprognostic (1.39e-1)" "unprognostic (2.21e-1)" "unprognostic (1.59e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.29e-4)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (1.20e-2)" "unprognostic (6.60e-2)" "unprognostic (2.83e-2)" "unprognostic (5.06e-3)" "unprognostic (4.50e-2)" "unprognostic (2.15e-2)" "unprognostic (2.44e-2)" 57.6 82.5 184.1 22.2 164.2 26.4 37.4 40.6 117.1 31.5 80.8 78.1 25.7 42.7 43.5 24.8 32.4 345.0 161.8 111.7 151.0 150.5 20.9 22.6 126.3 23.7 42.5 62.3 10.1 29.0 35.8 84.4 65.6 54.2 380.7 68.9 60.0 38.2 61.2 28.1 65.5 27.8 23.8 21.9 31.6 15.3 292.2 232.9 177.4 396.5 182.8 192.4 130.5 114.5 173.2 235.7 256.3 540.3 247.5 249.9 261.4 87.1 66.0 110.6 208.4 373.6 302.7 125.7 198.6 65.0 435.2 26.9 231.6 94.6 143.0 165.0 181.7 872.7 389.9 74.8 104.9 230.2 288.6 241.1 65.3 145.0 306.7 79.4 172.7 115.3 217.3 195.5 277.4 85.7 469.5 59.9 156.0 141.8 112.3 70.4 181.6 334.7 303.0 112.7 150.2 90.6 351.3 163.0 296.6 201.5 352.9 316.5 264.7 180.2 259.8 131.1 103.0 98.6 68.6 130.7 276.7 128.6 177.4 396.5 169.3 156.6 236.0 176.4 255.6 154.9 171.8 163.0 292.2 159.7 192.4 93.5 182.8 260.1 232.9 138.6 130.5 2694.8 3022.9 23660.6 9171.4 8678.3 0.0 81405.0 28094.1 4463.5 5243.5 18590.0 0.0 0.0 3606.0 6482.3 1224.4 4243.1 59874.1 34807.7 4485.9 0.0 3116.3 8181.6 3594.1 45857.2 0.0 0.0 7240.0 18002.1 27410.8 6497.0 10830.0 8032.7 6539.1 13021.9 32338.6 0.0 5722.6 29051.7 7980.9 24852.9 0.0 13394.3 6634.5 9840.4 12887.5 10030.7 0.0 18830.6 25753.2 17251.8 MT-CO2 "CO2, COX2, MTCO2" ENSG00000198712 "Mitochondrially encoded cytochrome c oxidase II" P00403 MT 7586-8269 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 489.9;skeletal muscle: 343.4" "Cell type enriched" "Detected in many" 10 "Cardiomyocytes: 412590.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 1073.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016243, HPA051505, HPA054758" Enhanced NA NA 1300000 "CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (2.77e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.89e-4)" "unprognostic (1.06e-1)" "unprognostic (3.39e-1)" "unprognostic (2.72e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.25e-1)" "unprognostic (9.30e-2)" "unprognostic (3.05e-1)" "unprognostic (1.70e-1)" "unprognostic (9.50e-2)" "unprognostic (3.72e-3)" 54.6 64.8 149.7 21.7 194.8 30.2 45.5 48.9 99.5 27.0 106.9 73.6 23.8 46.3 35.8 25.1 23.7 252.1 151.9 112.4 158.4 173.8 22.7 22.8 154.6 21.2 46.4 50.4 22.5 41.4 38.2 106.4 61.7 56.0 343.4 56.4 51.1 40.0 77.8 25.9 68.5 28.2 23.3 29.5 29.9 16.2 379.8 278.1 489.9 409.1 220.4 273.9 181.4 111.2 179.1 238.3 230.3 487.6 188.0 175.6 145.1 117.7 82.5 124.6 192.6 251.5 232.6 121.5 213.4 84.9 422.7 31.5 298.5 111.8 180.1 161.5 166.8 1073.7 370.2 106.1 140.2 187.4 275.7 441.7 42.5 152.4 270.3 91.3 232.4 155.7 226.9 226.0 240.8 102.5 404.1 62.3 220.6 114.0 107.2 72.6 194.8 336.5 310.9 89.2 147.6 119.5 294.8 209.6 367.9 205.2 568.6 225.1 200.0 173.5 188.5 102.0 115.3 114.6 131.1 106.4 283.3 131.3 489.9 409.1 476.0 194.9 292.9 236.6 379.8 217.1 218.8 205.5 378.1 227.9 273.9 180.3 220.4 308.7 278.1 170.3 181.4 1343.0 1746.9 18282.0 6995.6 5999.6 0.0 412590.4 19500.5 2813.3 2462.5 17642.7 0.0 0.0 3143.4 3272.8 866.0 2789.7 27604.7 22029.3 4281.1 0.0 1817.5 4991.0 2029.2 43011.4 0.0 0.0 6162.7 12438.4 17929.8 4401.0 7095.7 4687.5 4875.7 4595.3 21499.4 0.0 3881.8 14501.3 4815.7 15512.8 0.0 6946.2 3920.2 6682.3 8100.4 5859.1 0.0 11198.1 21247.6 11593.6 MT-CO3 "CO3, COIII, COX3, MTCO3" ENSG00000198938 "Mitochondrially encoded cytochrome c oxidase III" P00414 MT 9207-9990 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 319.5" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 76804.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 810.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042788 Approved NA NA "HPA042788: AB_10793985" "unprognostic (2.38e-1)" "unprognostic (5.24e-2)" "unprognostic (1.71e-1)" "unprognostic (1.88e-1)" "unprognostic (3.04e-1)" "unprognostic (2.93e-1)" "prognostic favorable (2.01e-4)" "unprognostic (1.18e-1)" "unprognostic (1.45e-2)" "unprognostic (1.05e-2)" "prognostic favorable (1.04e-4)" "unprognostic (1.05e-1)" "unprognostic (8.80e-3)" "unprognostic (2.75e-2)" "unprognostic (1.20e-1)" "unprognostic (9.29e-2)" "unprognostic (1.33e-2)" 56.5 83.7 174.1 20.5 149.4 34.8 55.5 47.4 106.2 30.5 90.9 76.1 27.5 46.0 40.4 26.3 28.7 290.4 159.6 111.4 190.3 143.1 21.0 22.8 120.2 27.9 38.9 60.5 26.7 32.5 37.3 95.5 79.0 64.3 319.5 70.0 55.3 39.0 61.9 21.7 60.5 36.5 31.0 31.0 26.9 18.7 247.1 126.7 244.3 245.3 141.7 181.1 106.8 130.8 155.4 238.8 339.1 475.8 196.3 130.7 170.6 101.1 67.4 104.1 208.0 195.6 292.9 73.9 141.6 73.7 359.5 37.6 204.9 119.5 99.3 164.3 155.7 810.6 345.5 96.2 92.6 205.1 188.5 291.4 74.1 110.5 238.7 124.6 168.0 123.3 296.8 222.5 267.4 94.0 540.0 53.0 208.4 112.2 100.6 75.3 211.0 420.2 231.5 107.0 148.6 79.5 87.1 164.8 347.1 182.0 408.6 199.6 113.0 193.8 211.0 111.3 122.2 78.6 163.5 112.8 302.0 74.2 132.0 245.3 121.5 110.0 128.3 137.4 198.7 119.5 127.0 126.7 247.1 153.2 181.1 244.3 141.7 122.3 107.8 79.5 106.8 1774.7 2343.8 18268.7 8249.8 7411.8 0.0 76804.5 19304.4 3075.6 3885.5 15697.2 0.0 0.0 3702.1 4549.9 1673.9 3293.3 31596.9 21118.2 5876.9 0.0 3002.6 5473.3 1979.3 30765.6 0.0 0.0 6556.1 11050.6 17592.2 7669.6 10722.1 5677.4 5267.0 6541.2 23740.6 0.0 4985.0 16907.1 7340.6 25199.2 0.0 11945.6 6322.1 9983.2 10814.8 7412.6 0.0 11568.9 24590.7 11079.5 MT-CYB "COB, CYTB, MTCYB, UQCR3" ENSG00000198727 "Mitochondrially encoded cytochrome b" P00156 MT 14747-15887 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 324.2;skeletal muscle: 302.1" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 61379.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 490.3;HeLa: 493.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032215, HPA068400, HPA074796" Approved Supported Mitochondria NA NA Mitochondria "CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: " "unprognostic (4.50e-1)" "unprognostic (2.56e-1)" "unprognostic (9.12e-2)" "unprognostic (3.88e-2)" "unprognostic (9.22e-2)" "unprognostic (3.50e-1)" "prognostic favorable (5.96e-4)" "unprognostic (1.63e-2)" "unprognostic (8.53e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-3)" "unprognostic (6.09e-2)" "unprognostic (1.40e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (4.09e-2)" "unprognostic (1.54e-2)" 78.0 52.4 98.5 14.7 143.5 14.4 32.3 38.4 59.6 30.9 54.0 55.6 25.0 43.6 28.0 25.0 21.2 222.5 93.9 68.0 128.7 144.7 19.6 13.7 83.6 25.3 51.4 33.6 23.7 32.6 32.9 57.7 59.2 49.5 302.1 63.5 37.2 37.4 44.3 15.7 55.2 20.2 20.9 20.6 23.6 14.7 183.7 78.7 324.2 155.7 90.0 146.7 57.6 73.4 99.2 123.0 131.3 490.3 78.9 99.1 84.7 35.1 22.2 38.5 97.6 162.5 188.2 41.5 100.3 26.6 231.5 18.2 104.1 54.5 91.9 81.5 105.1 493.3 174.0 92.4 59.0 128.5 170.3 155.3 42.0 90.5 150.2 56.2 76.8 53.7 118.5 113.1 202.8 54.8 121.7 27.3 71.8 67.4 64.8 48.4 117.8 176.2 171.6 43.9 77.6 59.0 111.5 83.4 192.8 162.6 203.7 176.1 77.9 101.9 141.8 65.0 32.5 43.6 80.6 46.8 92.0 48.9 324.2 155.7 235.1 102.8 94.4 135.3 150.5 118.7 132.0 78.0 183.7 128.3 146.7 148.0 90.0 96.8 78.7 79.8 57.6 1101.8 1182.9 10535.1 6605.8 2949.0 0.0 61379.6 10280.2 2941.7 2205.5 7087.1 0.0 0.0 1833.6 2297.4 679.0 1928.7 15168.1 14904.3 3076.0 0.0 1463.9 4337.7 1777.7 14746.0 0.0 0.0 2756.0 7288.5 8580.4 3048.7 7355.0 2431.1 2478.3 3811.6 11241.0 0.0 2672.3 10113.2 5078.0 11513.5 0.0 5704.4 3210.7 4468.4 3767.8 2992.1 0.0 6827.7 9828.0 8723.5 MT-ND1 "MTND1, NAD1, ND1" ENSG00000198888 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1" P03886 MT 3307-4262 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 314.4;skeletal muscle: 398.2" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 72531.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 314.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 314.4" "Cell line enhanced" "Detected in all" "HeLa: 673.1" "Low region specificity" "Detected in all" "CAB033779, HPA066847" Approved NA NA "CAB033779: AB_2149736, HPA066847: " "prognostic favorable (3.63e-4)" "unprognostic (3.55e-1)" "unprognostic (3.77e-2)" "unprognostic (3.65e-1)" "unprognostic (3.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.95e-3)" "unprognostic (5.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.05e-2)" "prognostic favorable (3.26e-4)" "unprognostic (8.67e-2)" "unprognostic (8.66e-2)" "unprognostic (3.24e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-2)" "unprognostic (2.85e-2)" 83.5 48.0 118.0 15.2 136.1 17.7 31.8 45.0 85.9 19.6 58.3 40.2 16.3 43.4 30.7 16.7 17.6 223.1 106.1 74.3 96.0 104.7 20.5 12.1 101.8 14.2 48.2 35.1 14.3 32.2 26.6 58.6 71.2 48.4 398.2 75.4 33.3 24.6 55.2 16.7 45.0 29.8 13.8 17.1 19.9 9.4 60.8 32.2 314.4 54.4 35.8 46.4 19.5 101.9 104.3 85.6 77.9 325.0 59.2 110.1 88.0 26.0 24.4 25.8 181.3 111.3 125.2 56.0 66.3 24.8 68.2 9.4 53.0 49.0 89.2 73.5 139.3 673.1 257.0 69.8 65.9 137.7 140.2 144.8 37.8 54.6 99.7 26.2 36.7 64.0 78.3 72.4 140.2 53.0 273.1 22.9 64.3 78.6 55.9 38.9 67.2 135.5 165.5 35.6 56.7 48.8 78.1 85.3 108.9 69.7 228.7 137.9 81.8 73.9 104.2 73.1 86.9 53.5 58.0 55.0 116.9 22.3 314.4 54.4 103.0 25.7 31.4 37.3 54.3 30.8 34.0 20.6 60.8 41.1 46.4 157.8 35.8 32.0 32.2 22.0 19.5 1256.6 1138.7 6703.3 2831.5 2012.7 0.0 72531.4 10000.0 1801.4 2082.6 4374.0 0.0 0.0 875.4 1190.4 925.4 1519.1 10706.5 9881.7 3135.3 0.0 1058.8 2565.3 1330.0 13675.3 0.0 0.0 3018.7 7368.9 9328.1 4287.1 6527.3 2029.2 1420.6 1887.4 12938.3 0.0 1718.0 6638.7 3334.2 5210.0 0.0 6305.8 2437.5 5090.3 4626.8 1812.2 0.0 3284.5 11055.0 4223.0 MT-ND2 "MTND2, NAD2, ND2" ENSG00000198763 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2" P03891 MT 4470-5511 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Alzheimer disease, Amyloidosis, Disease mutation, Leber hereditary optic neuropathy, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 432.3" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 49093.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "basophil: 432.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 432.3" "Cell line enhanced" "Detected in all" "HeLa: 612.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.82e-3)" "unprognostic (1.58e-2)" "unprognostic (1.53e-2)" "unprognostic (1.36e-1)" "unprognostic (4.77e-1)" "unprognostic (4.79e-2)" "unprognostic (9.56e-3)" "unprognostic (3.74e-2)" "unprognostic (2.18e-1)" "unprognostic (3.38e-3)" "unprognostic (4.55e-3)" "unprognostic (3.79e-2)" "unprognostic (4.35e-2)" "unprognostic (3.94e-2)" "unprognostic (2.11e-1)" "unprognostic (5.92e-2)" "unprognostic (4.35e-2)" 93.0 57.2 116.0 16.9 169.9 15.6 33.9 40.1 73.5 22.6 53.7 50.1 21.5 59.8 29.0 22.1 19.3 262.4 112.2 85.2 125.9 128.9 20.9 14.7 113.0 25.1 62.0 24.3 20.3 37.0 28.1 59.0 85.3 41.0 263.4 72.7 39.2 24.6 72.4 15.2 49.2 27.3 18.2 17.7 23.8 13.1 66.1 43.5 432.3 54.8 43.0 57.9 21.8 94.6 104.2 93.3 157.4 337.2 60.2 88.3 88.4 22.1 23.6 29.9 131.2 128.0 135.9 84.1 63.4 38.9 170.0 14.6 110.5 51.2 118.3 75.9 156.8 612.6 211.5 69.1 152.0 182.5 99.4 202.0 58.1 57.6 84.5 34.7 75.0 114.3 133.2 56.7 111.9 86.3 246.1 46.8 99.5 68.3 75.8 52.3 113.9 175.1 146.5 58.4 70.0 38.2 117.4 140.8 155.7 180.7 175.9 109.6 88.9 110.1 125.0 111.9 87.1 74.6 114.4 57.7 131.3 39.7 432.3 54.8 93.1 34.1 39.7 54.7 58.6 39.5 42.5 23.0 66.1 48.5 57.9 88.6 43.0 45.7 43.5 25.9 21.8 854.6 571.9 9056.6 6978.7 2368.7 0.0 49093.4 9352.8 2568.3 1610.6 5912.8 0.0 0.0 1531.9 1483.8 1182.4 1676.0 12590.8 16329.3 3187.2 0.0 1222.0 4063.7 1766.1 15003.8 0.0 0.0 3057.2 8326.4 10199.3 4945.8 8393.1 2380.5 1572.4 3231.9 13237.7 0.0 2288.2 10285.9 4266.6 9047.2 0.0 7166.1 2550.6 5515.5 4332.8 2146.6 0.0 6221.6 10985.9 6668.6 MT-ND3 "MTND3, NAD3, ND3" ENSG00000198840 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3" P03897 MT 10059-10404 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 357.8" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 33020.6;Erythroid cells: 20674.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 644.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063296 Enhanced Uncertain Cytosol NA NA Cytosol "HPA063296: AB_2684978" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (8.10e-2)" "unprognostic (3.07e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "prognostic favorable (4.63e-5)" "unprognostic (2.45e-2)" "unprognostic (7.13e-2)" "unprognostic (8.85e-2)" "unprognostic (1.76e-3)" "unprognostic (1.74e-1)" "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-1)" "unprognostic (5.65e-3)" 102.1 73.9 117.3 17.6 137.2 17.9 59.3 33.7 70.5 31.2 76.3 64.0 25.9 49.2 21.7 24.7 19.7 256.8 110.3 81.7 138.1 145.8 19.7 17.4 92.0 27.5 77.8 14.6 22.2 34.6 39.1 59.1 67.6 50.7 357.8 42.2 48.9 28.4 66.8 19.1 60.6 21.0 25.0 20.3 24.2 15.9 84.8 32.6 159.6 48.5 48.6 75.3 24.4 85.5 139.7 93.3 91.5 644.7 129.2 77.7 72.1 42.4 39.1 44.3 210.2 133.3 89.1 111.9 92.5 70.8 178.3 40.1 157.5 67.3 127.7 192.1 87.6 465.1 346.0 100.6 129.0 132.7 223.4 292.0 65.5 73.9 233.9 60.8 102.4 69.0 104.2 73.7 279.5 67.7 172.2 47.9 245.4 129.3 58.7 91.7 82.0 237.9 236.2 38.5 83.7 34.8 69.8 142.5 254.3 161.5 208.4 103.2 60.5 91.9 105.1 77.0 40.5 53.1 192.1 49.1 78.4 34.2 159.6 48.5 36.6 36.7 36.4 49.8 73.1 42.6 44.8 32.6 84.8 63.1 75.3 100.7 48.6 32.7 32.3 27.6 24.4 652.1 738.1 6543.7 1904.3 1765.5 0.0 33020.6 8848.3 2785.1 1856.3 4782.3 0.0 0.0 986.5 1173.3 880.9 872.1 11850.5 20674.5 2500.6 0.0 790.1 1401.0 1375.6 14769.6 0.0 0.0 2746.0 8921.3 11655.5 4356.4 8457.2 1642.1 1763.0 2463.5 12873.7 0.0 1918.1 9893.1 4573.5 7467.5 0.0 6887.9 1962.1 6063.0 3539.9 1651.0 0.0 4305.8 10869.3 1952.0 MT-ND4 "LHON, MTND4, NAD4, ND4" ENSG00000198886 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4" P03905 MT 10760-12137 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 392.9" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 130137.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 821.0" "Low region specificity" "Detected in all" HPA053928 Approved Supported Mitochondria NA NA Mitochondria "HPA053928: AB_2682313" "unprognostic (8.39e-2)" "unprognostic (1.83e-1)" "unprognostic (7.29e-2)" "unprognostic (9.54e-2)" "unprognostic (5.41e-2)" "unprognostic (3.78e-2)" "unprognostic (2.50e-3)" "unprognostic (8.16e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.76e-4)" "unprognostic (1.01e-2)" "unprognostic (7.23e-2)" "unprognostic (2.79e-2)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (3.14e-2)" "unprognostic (4.24e-2)" 82.5 72.4 124.2 19.8 138.2 14.9 34.5 43.8 78.5 34.1 68.7 56.5 27.8 37.1 32.9 25.2 23.7 292.7 122.4 90.3 129.8 178.5 20.8 17.4 101.6 25.5 58.3 37.8 19.7 39.1 37.3 82.1 61.7 65.6 288.4 61.1 41.0 37.8 63.6 21.7 67.7 29.6 24.3 23.4 26.0 15.3 164.7 87.6 392.9 119.5 87.1 129.7 53.0 102.6 106.9 138.9 205.1 326.5 82.3 97.3 104.6 40.0 24.3 47.5 162.1 117.7 182.9 92.3 89.1 35.8 192.5 12.4 169.4 43.6 105.5 67.2 112.6 821.0 271.8 49.3 113.1 134.0 139.2 179.5 35.8 128.4 229.8 58.7 92.3 93.8 226.5 87.5 231.7 44.5 257.0 39.3 89.7 72.7 60.6 43.6 110.2 177.8 222.1 51.2 69.3 60.8 202.4 104.6 257.3 141.7 267.4 162.8 99.5 96.8 133.1 81.0 135.9 55.1 81.4 64.9 196.6 52.9 392.9 119.5 268.8 82.9 91.3 115.5 148.0 93.0 98.9 65.9 164.7 109.6 129.7 105.7 87.1 89.0 87.6 67.6 53.0 1179.2 1324.7 15760.8 7514.4 3912.5 0.0 130137.0 15452.1 2295.3 2103.1 12148.5 0.0 0.0 2064.1 2636.7 917.0 2449.9 17720.8 23127.3 3538.6 0.0 2017.3 5309.0 2067.8 31565.1 0.0 0.0 4902.7 11944.3 15339.0 4282.8 8180.5 3605.2 3603.6 4879.3 17860.7 0.0 3353.9 12846.0 5441.2 13683.6 0.0 6208.8 3859.5 7259.5 5529.7 4316.1 0.0 9799.9 18174.2 10097.1 MT-ND4L "MTND4L, NAD4L, ND4L" ENSG00000212907 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L" P03901 MT 10470-10766 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 434.4;skeletal muscle: 294.4" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 16050.3;Hepatocytes: 4100.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 885.9" "Low region specificity" "Detected in all" HPA075648 Approved Centrosome,Mitochondria NA NA Mitochondria Centrosome "HPA075648: AB_2686760" "unprognostic (5.81e-2)" "unprognostic (3.46e-2)" "unprognostic (2.76e-2)" "unprognostic (7.91e-2)" "unprognostic (5.64e-2)" "unprognostic (1.05e-1)" "prognostic favorable (4.47e-4)" "unprognostic (1.97e-1)" "unprognostic (4.04e-2)" "unprognostic (4.63e-3)" "unprognostic (6.61e-2)" "unprognostic (7.38e-3)" "unprognostic (1.39e-1)" "unprognostic (3.09e-1)" "unprognostic (3.73e-1)" "unprognostic (2.97e-2)" "unprognostic (5.68e-2)" 101.1 71.9 102.4 20.3 114.5 13.2 39.4 41.5 73.3 39.4 83.8 48.0 26.1 34.1 30.7 23.9 23.4 187.5 102.7 79.1 123.5 185.7 20.2 13.1 88.6 26.2 43.4 29.7 18.5 30.9 34.2 80.0 43.2 75.4 294.4 31.8 38.4 38.6 59.2 16.1 62.5 27.5 24.6 24.4 25.8 14.3 200.8 111.2 434.4 139.9 112.1 153.0 66.8 97.1 90.4 163.1 166.1 571.6 120.3 71.9 208.6 52.3 32.7 59.8 150.2 89.8 241.1 85.5 140.9 53.6 185.3 25.3 223.3 65.2 94.9 104.4 173.3 885.9 279.0 83.9 178.2 155.8 210.6 228.8 62.4 218.5 246.4 65.5 125.0 95.5 172.9 119.9 173.6 67.7 228.6 41.1 103.4 109.2 39.3 70.3 107.2 174.1 205.2 49.5 67.0 102.3 162.1 69.9 366.4 115.3 224.3 209.4 86.0 107.1 125.8 79.8 156.5 73.2 128.4 61.7 242.4 40.1 434.4 139.9 290.0 102.4 110.6 140.6 166.9 110.0 117.5 86.1 200.8 132.4 153.0 78.4 112.1 99.4 111.2 79.0 66.8 208.4 153.9 1221.6 193.7 203.1 0.0 16050.3 1630.6 940.9 684.7 307.1 0.0 0.0 76.3 127.4 46.0 141.8 949.6 2499.6 297.1 0.0 116.0 126.2 448.0 4100.6 0.0 0.0 246.6 1665.3 1966.8 217.5 386.3 249.3 243.0 242.5 657.8 0.0 237.0 573.3 217.1 415.7 0.0 342.8 211.1 226.8 167.2 211.8 0.0 631.2 458.3 137.0 MT-ND5 "MTND5, NAD5, ND5" ENSG00000198786 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5" P03915 MT 12337-14148 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 193.9;heart muscle: 190.3;skeletal muscle: 223.2" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 21708.1;Hepatocytes: 6052.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 367.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.87e-1)" "unprognostic (3.18e-2)" "unprognostic (3.00e-1)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (1.30e-1)" "unprognostic (1.07e-3)" "unprognostic (5.09e-3)" "unprognostic (1.06e-2)" "unprognostic (3.01e-1)" "unprognostic (3.29e-3)" "unprognostic (4.78e-2)" "prognostic favorable (7.31e-5)" "unprognostic (9.93e-3)" "unprognostic (8.75e-2)" "unprognostic (1.26e-2)" "unprognostic (3.68e-2)" 47.2 30.4 71.2 14.8 94.5 11.3 16.5 23.2 45.8 13.6 30.3 38.9 16.6 24.9 26.2 21.4 19.1 190.3 65.0 52.8 56.3 66.6 19.3 9.4 56.1 18.6 22.9 23.1 7.9 15.1 27.5 28.0 25.7 21.5 223.2 63.9 29.5 25.3 37.9 12.6 41.4 14.6 12.8 13.2 24.9 8.0 124.1 89.3 193.9 123.4 79.6 99.3 33.7 70.0 74.7 91.4 88.3 276.3 72.4 49.3 144.0 22.1 16.2 27.1 109.7 92.4 170.5 73.1 67.2 18.2 150.6 8.5 75.6 27.0 95.4 58.2 124.9 367.2 185.3 31.9 87.3 130.0 108.0 60.5 18.3 44.0 89.3 32.6 55.4 45.4 81.7 55.2 132.9 32.7 107.8 18.0 40.1 41.0 62.8 42.9 73.1 98.0 139.7 27.3 41.8 67.1 120.3 40.1 144.3 87.4 131.2 227.9 93.3 65.1 109.9 55.7 31.2 53.9 47.5 49.9 79.8 40.5 193.9 123.4 79.9 81.3 100.2 99.3 99.4 79.3 87.3 73.4 124.1 78.5 86.6 45.3 79.6 95.9 89.3 62.1 33.7 583.6 431.9 2723.9 906.1 795.2 0.0 21708.1 2619.1 1640.9 1064.6 1097.4 0.0 0.0 240.4 680.7 99.3 666.5 2590.2 4134.9 811.9 0.0 364.3 748.8 814.8 6052.2 0.0 0.0 752.3 2617.9 3186.6 403.9 979.2 872.2 577.0 1484.2 1582.7 0.0 1038.2 1813.1 797.6 2081.7 0.0 685.6 570.5 650.3 492.1 851.0 0.0 1584.2 1461.9 1233.6 MT-ND6 "MTND6, NAD6, ND6" ENSG00000198695 "Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6" P03923 MT 14149-14673 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 395.3;skeletal muscle: 593.2" "Cell type enriched" "Detected in many" 16 "Cardiomyocytes: 10763.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 524.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.96e-1)" "unprognostic (3.27e-1)" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.03e-3)" "unprognostic (6.02e-3)" "unprognostic (1.68e-2)" "unprognostic (1.48e-1)" "unprognostic (6.06e-3)" "unprognostic (2.91e-1)" "prognostic favorable (8.91e-6)" "unprognostic (3.64e-2)" "unprognostic (1.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.92e-2)" 79.2 43.1 55.5 34.4 78.5 30.7 9.6 14.7 76.1 5.9 30.2 90.3 19.2 0.0 69.5 23.2 40.2 395.3 50.7 41.2 65.5 42.8 28.5 25.9 41.9 23.2 48.0 0.0 3.5 10.3 28.0 0.3 48.1 0.0 593.2 176.3 63.8 0.0 24.8 19.9 53.2 22.7 17.5 0.0 32.3 5.7 127.3 91.2 164.8 108.2 88.8 104.3 29.7 99.5 80.8 71.5 90.8 12.0 1.1 51.3 134.7 0.2 0.4 0.4 109.8 101.1 214.8 91.6 3.6 13.5 149.0 0.7 2.4 0.7 126.9 62.0 128.7 524.8 313.8 0.9 81.4 121.6 2.0 3.3 3.3 2.7 68.1 0.7 45.0 55.3 84.4 2.9 212.8 25.0 112.4 15.5 57.2 39.8 60.9 45.7 92.3 1.9 293.8 29.5 47.4 70.1 123.5 55.6 118.8 95.7 158.8 273.9 79.6 67.2 112.6 53.9 28.9 77.1 51.5 54.0 83.1 46.2 164.8 108.2 68.3 89.1 103.5 104.3 118.4 94.5 96.1 66.2 127.3 94.7 102.4 53.7 88.8 103.7 91.2 71.8 29.7 77.4 48.1 340.3 38.0 14.9 0.0 10763.4 298.1 156.6 138.8 122.1 0.0 0.0 14.9 22.5 5.1 82.2 98.6 584.0 30.5 0.0 11.3 44.8 92.7 656.7 0.0 0.0 29.0 406.4 492.6 24.4 57.8 31.8 32.1 42.3 60.4 0.0 23.3 63.7 42.5 111.6 0.0 58.2 27.7 25.6 53.0 17.9 0.0 156.7 77.0 76.6 MT1A "MT1, MT1S" ENSG00000205362 "Metallothionein 1A" P04731 16 56638666-56640087 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 108.5;liver: 146.5;skeletal muscle: 111.3" "Group enriched" "Detected in many" 8 "Hepatocytes: 251.4;Smooth muscle cells: 534.6" "Cancer enhanced" "Detected in all" "liver cancer: 33.3" "Group enriched" "Detected in many" 7 "basal ganglia: 35.4;cerebral cortex: 14.5;hippocampal formation: 15.3;pons and medulla: 37.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 9.1;ASC TERT1: 14.0;HHSteC: 9.8;HMC-1: 14.4;hTEC/SVTERT24-B: 38.9;NTERA-2: 19.3" "CAB002161, CAB013056" Approved NA NA "CAB002161: AB_563878, CAB013056: " "unprognostic (1.36e-1)" "unprognostic (4.91e-3)" "unprognostic (1.22e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-3)" "unprognostic (9.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (6.67e-3)" "unprognostic (3.10e-2)" "unprognostic (1.86e-1)" "unprognostic (9.43e-2)" "unprognostic (1.35e-2)" 108.5 14.2 2.7 8.0 35.4 1.0 35.2 0.6 14.5 11.3 10.2 0.7 0.2 4.8 1.8 4.1 17.4 11.0 16.1 16.2 15.3 1.8 20.7 146.5 16.1 14.2 3.6 0.0 7.1 46.1 1.2 11.0 1.4 37.2 4.4 7.8 3.8 3.0 2.6 111.3 4.4 12.4 9.2 16.9 4.6 6.1 2.0 2.1 0.0 18.6 4.1 1.7 10.7 7.1 0.4 0.6 0.0 0.1 0.3 1.1 0.2 0.0 2.9 0.0 0.0 9.1 14.0 0.1 0.9 3.8 0.6 0.7 1.1 2.2 0.0 1.2 0.5 0.0 0.2 0.0 0.2 1.4 0.0 0.0 0.0 1.3 4.6 9.8 0.1 14.4 4.1 0.0 38.9 0.0 0.0 3.7 0.0 0.3 0.0 2.6 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.1 2.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.6 0.0 0.6 0.4 0.8 1.1 0.6 0.0 0.5 0.9 0.0 0.3 0.0 0.3 1.0 0.2 2.7 35.4 0.6 14.5 15.3 1.8 3.6 0.0 37.2 2.1 8.9 1.7 0.8 9.7 24.4 0.0 5.1 0.0 5.3 9.1 0.0 0.0 1.1 11.6 2.4 0.0 13.5 9.5 23.3 1.5 6.5 29.1 30.8 3.5 251.4 0.3 0.0 3.5 13.5 3.8 0.4 50.9 10.0 32.1 0.0 25.8 0.0 3.9 14.4 12.0 13.9 0.0 25.8 534.6 0.0 0.2 16.9 0.5 5.7 23.0 12.6 MT1B "MT1, MT1Q" ENSG00000169688 "Metallothionein 1B" P07438 16 56651899-56653204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 21.2" "Cell type enhanced" "Detected in some" 20 "Extravillous trophoblasts: 2.0;Proximal tubular cells: 1.2" "Cancer enriched" "Detected in single" 209 "liver cancer: 57.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;EFO-21: 2.2" NA NA "unprognostic (2.66e-1)" 0.5 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.3 0.9 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 MT1E "MT1, MTD" ENSG00000169715 "Metallothionein 1E" P04732 16 56625475-56627112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 248.5" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 3009.6;Hepatocytes: 2806.6;Mucus-secreting cells: 2755.2;Paneth cells: 3720.3;Proximal tubular cells: 4546.8;Undifferentiated cells: 2435.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 3.9;T-cells: 14.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 124.0;LHCN-M2: 94.5;RPTEC TERT1: 107.0;U-2 OS: 60.4" HPA041152 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA041152: AB_2732490" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (3.59e-1)" "unprognostic (1.55e-1)" "unprognostic (2.77e-2)" "unprognostic (1.19e-2)" "unprognostic (3.63e-1)" "unprognostic (9.80e-2)" "unprognostic (7.85e-2)" "unprognostic (3.45e-2)" "unprognostic (2.78e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.06e-5)" "unprognostic (1.86e-1)" "unprognostic (9.53e-2)" "unprognostic (1.97e-1)" "unprognostic (3.78e-2)" 68.4 71.5 38.0 18.4 104.6 2.5 47.7 13.8 42.3 10.1 75.3 20.0 10.7 36.2 7.3 18.4 27.1 33.1 44.2 19.6 40.0 27.0 66.1 248.5 21.1 13.7 66.0 27.4 13.4 145.0 4.5 5.1 7.8 94.3 22.6 64.3 13.9 9.1 9.1 28.0 16.4 114.5 29.8 58.6 5.4 47.0 4.1 24.5 0.0 110.7 21.3 4.9 9.4 11.8 0.3 3.9 0.0 2.0 0.1 14.2 1.9 11.2 0.0 0.0 0.0 18.2 21.1 0.1 29.8 32.0 8.2 9.6 0.1 15.1 0.0 2.3 10.3 1.2 24.5 27.5 124.0 11.3 11.3 0.0 0.4 16.4 1.9 8.2 0.0 0.0 14.5 42.1 21.4 24.7 49.8 4.9 0.0 0.0 0.0 94.5 0.0 0.0 7.4 10.8 0.0 0.1 0.0 0.0 0.3 107.0 0.0 1.6 0.0 0.0 0.0 0.1 2.1 0.0 13.8 12.2 0.0 60.4 9.5 5.7 0.0 0.2 0.2 34.7 18.9 0.1 0.0 2.0 0.0 10.5 1.4 3.7 0.3 5.9 14.2 3.9 0.0 2.7 10.7 0.0 0.1 1.2 0.2 13.7 1.9 38.0 104.6 13.8 42.3 40.0 27.0 66.0 27.4 94.3 24.5 366.3 115.6 55.5 220.6 158.7 0.0 67.5 448.4 238.3 298.0 471.1 0.0 12.9 1188.7 375.5 1.5 49.3 3009.6 93.5 167.4 775.1 142.5 750.7 27.7 2806.6 30.0 0.0 233.0 171.2 56.5 2.4 138.4 87.0 104.6 99.2 2755.2 0.0 423.2 3720.3 48.1 4546.8 0.0 213.4 278.2 0.2 2.7 129.5 66.7 38.7 2435.9 51.9 MT1F MT1 ENSG00000198417 "Metallothionein 1F" P04733 16 56657694-56660698 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 84.1;liver: 98.0;thyroid gland: 152.5" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 4487.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 14.7;classical monocyte: 10.2;gdT-cell: 14.0;MAIT T-cell: 12.7;memory B-cell: 7.4;memory CD4 T-cell: 15.3;memory CD8 T-cell: 23.9;naive CD4 T-cell: 15.2;naive CD8 T-cell: 25.4;T-reg: 23.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 18.4;NB-4: 29.8;NTERA-2: 19.1;RPTEC TERT1: 82.7;THP-1: 17.9;U-937: 16.0" NA NA "unprognostic (4.15e-2)" "unprognostic (3.60e-2)" "unprognostic (6.78e-2)" "unprognostic (2.78e-2)" "unprognostic (1.95e-3)" "unprognostic (1.88e-3)" "unprognostic (2.70e-1)" "unprognostic (4.08e-2)" "unprognostic (3.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.14e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.02e-7)" "unprognostic (2.78e-1)" "unprognostic (3.50e-2)" "unprognostic (2.65e-2)" "unprognostic (2.85e-1)" 6.4 12.1 14.8 5.8 22.9 2.4 3.1 5.9 18.6 2.2 24.6 9.7 4.9 15.9 2.3 13.5 2.2 3.7 10.6 1.9 16.0 13.7 84.1 98.0 2.5 6.5 27.5 15.7 1.3 55.7 1.4 4.5 1.5 37.0 11.6 17.6 8.3 3.9 4.3 1.1 2.0 37.9 3.3 23.8 3.9 15.1 1.6 9.2 0.0 152.5 0.0 2.8 3.3 1.1 7.4 2.5 14.7 10.2 2.3 25.4 14.4 1.3 0.8 0.0 0.0 0.0 0.0 1.6 0.9 1.9 0.6 1.1 0.3 5.0 0.0 3.2 0.1 1.3 4.6 5.8 0.9 0.7 18.4 0.8 1.3 0.2 0.6 0.4 0.0 15.3 0.1 0.2 0.7 0.2 0.4 0.0 0.4 0.0 0.0 0.0 2.5 0.0 29.8 19.1 0.3 1.8 0.0 0.0 0.7 82.7 0.8 9.6 1.2 1.2 0.4 0.5 2.8 0.6 17.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 13.9 16.0 0.1 14.7 10.2 2.8 14.0 0.9 12.7 7.4 15.3 23.9 2.5 3.0 15.2 25.4 1.5 2.3 0.4 0.8 23.9 14.4 14.8 22.9 5.9 18.6 16.0 13.7 27.5 15.7 37.0 9.2 0.0 9.4 25.5 29.5 7.6 0.0 6.1 137.6 38.8 21.6 310.6 0.0 3.4 948.3 194.8 0.4 5.4 802.3 23.3 105.7 281.1 9.2 83.9 11.5 847.0 26.2 0.0 164.4 28.3 35.5 0.0 29.1 28.8 87.7 79.4 549.3 0.0 152.7 997.7 4.9 4487.9 0.0 6.5 36.6 0.2 1.7 6.9 16.2 34.8 560.8 18.8 MT1G "MT1, MT1K" ENSG00000125144 "Metallothionein 1G" P13640 16 56666731-56668065 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4" "Cell type enhanced" "Detected in many" 22 "Distal tubular cells: 5804.3;Hepatocytes: 13716.6;Paneth cells: 6754.7;Proximal tubular cells: 31723.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "U-937: 156.0" "Intracellular and membrane" NA NA "unprognostic (1.62e-1)" "unprognostic (4.21e-1)" "unprognostic (2.77e-2)" "unprognostic (3.15e-1)" "unprognostic (1.32e-2)" "unprognostic (1.73e-3)" "unprognostic (1.26e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-1)" "unprognostic (5.97e-2)" "unprognostic (2.49e-2)" "unprognostic (4.21e-1)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.42e-1)" "unprognostic (3.50e-2)" "unprognostic (7.92e-2)" "unprognostic (2.26e-2)" 10.1 1.0 11.7 10.4 50.7 0.7 2.8 1.1 27.4 1.0 78.1 3.1 1.9 49.6 1.5 15.9 21.7 4.6 23.2 0.9 25.1 7.6 210.7 396.4 2.4 7.0 23.6 11.3 0.6 217.1 0.4 1.0 0.6 46.9 21.6 48.9 22.4 2.4 1.0 0.6 2.9 101.1 7.9 7.7 0.5 47.4 0.6 3.6 0.0 278.4 1.9 1.8 2.4 1.2 0.1 1.1 0.7 1.1 0.3 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.2 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.5 0.6 0.1 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 35.6 0.0 0.0 0.0 0.0 0.1 10.2 6.0 0.0 3.2 0.4 0.0 0.2 0.1 1.6 0.0 15.3 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 156.0 0.0 0.7 1.1 0.3 1.5 1.1 1.4 0.1 1.7 2.6 1.1 0.0 1.6 2.9 0.1 0.3 0.5 0.3 2.8 1.5 11.7 50.7 1.1 27.4 25.1 7.6 23.6 11.3 46.9 3.6 26.8 5.4 164.5 23.0 51.4 0.0 9.4 145.2 6.7 15.9 2184.4 0.0 2.9 5804.3 77.4 0.3 3.5 4202.6 140.2 238.0 320.8 7.8 355.3 17.3 13716.6 22.8 0.0 237.6 129.5 169.9 0.2 21.6 83.6 28.7 18.0 3803.0 0.0 432.8 6754.7 2.1 31723.3 0.0 0.0 18.1 0.3 0.9 68.1 111.0 37.1 2367.7 10.9 MT1H MT1 ENSG00000205358 "Metallothionein 1H" P80294 16 56669814-56671129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3" "Cell type enhanced" "Detected in many" 21 "Distal tubular cells: 1414.2;Hepatocytes: 2756.5;Paneth cells: 1455.4;Proximal tubular cells: 6160.6" "Cancer enhanced" "Detected in many" "testis cancer: 173.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "EFO-21: 5.5;SuSa: 14.2" NA NA "unprognostic (1.32e-1)" "unprognostic (1.09e-1)" "unprognostic (3.51e-1)" "unprognostic (8.65e-2)" "prognostic unfavorable (2.37e-7)" "unprognostic (8.48e-3)" "unprognostic (6.26e-2)" "unprognostic (7.44e-2)" "unprognostic (3.31e-1)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.44e-5)" "unprognostic (5.77e-2)" "unprognostic (3.50e-2)" "unprognostic (2.37e-2)" "unprognostic (1.34e-1)" 0.6 0.0 1.4 1.1 20.1 0.0 0.2 0.2 4.7 0.3 21.7 0.6 0.2 9.4 0.8 3.1 4.1 0.2 2.8 0.2 7.4 0.9 88.1 134.0 0.3 1.3 4.4 1.6 0.3 50.2 0.0 0.2 0.3 8.3 2.3 11.0 1.6 0.5 0.2 0.3 0.7 53.9 1.4 1.9 0.2 6.7 0.4 1.5 0.2 60.3 0.9 0.4 1.0 0.2 0.2 0.1 0.0 1.6 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 1.9 0.2 0.0 0.0 0.2 0.0 1.0 0.4 0.0 1.4 0.9 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 1.4 20.1 0.2 4.7 7.4 0.9 4.4 1.6 8.3 1.5 0.0 0.0 30.6 1.2 10.9 0.0 2.0 17.8 0.0 1.2 507.7 0.0 2.4 1414.2 1.6 0.0 0.7 931.8 0.0 39.8 466.6 1.5 11.5 4.6 2756.5 16.3 0.0 42.0 27.6 30.2 0.0 0.3 40.9 0.0 1.0 787.0 0.0 66.2 1455.4 0.0 6160.6 0.0 0.0 2.9 0.0 0.4 16.6 56.0 4.9 264.0 0.4 MT1HL1 MT1P2 ENSG00000244020 "Metallothionein 1H like 1" P0DM35 1 237004103-237004418 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "heart muscle: 10.5;liver: 4.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 6.6;Hepatocytes: 7.3;Paneth cells: 8.6;Proximal tubular cells: 14.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;U-2 OS: 1.7;U-266/84: 3.5;U-87 MG: 1.2" NA NA "unprognostic (5.79e-2)" "unprognostic (2.78e-1)" "unprognostic (2.65e-1)" "unprognostic (3.77e-2)" 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 1.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 10.5 0.1 0.0 1.7 4.3 0.1 0.2 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.0 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.7 0.1 0.2 0.6 0.8 0.2 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.5 0.0 3.5 0.0 1.2 0.0 0.0 0.8 0.2 0.2 0.2 0.2 0.4 0.1 0.8 0.9 0.6 0.2 0.8 0.5 0.0 0.1 0.2 0.0 1.6 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.5 0.0 7.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 8.6 0.0 14.0 0.0 0.0 1.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 MT1M "MT1, MT1K" ENSG00000205364 "Metallothionein 1M" Q8N339 16 56632233-56633986 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 78.0;brain: 80.1;liver: 85.1" "Group enriched" "Detected in many" 5 "Enterocytes: 365.6;Hepatocytes: 1085.7;Mucus-secreting cells: 419.9;Paneth cells: 859.9;Smooth muscle cells: 334.7;Undifferentiated cells: 352.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 33.4" NA NA "unprognostic (1.83e-2)" "unprognostic (2.49e-1)" "unprognostic (2.10e-2)" "unprognostic (3.10e-2)" "unprognostic (4.19e-3)" "unprognostic (7.73e-2)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (4.67e-2)" "unprognostic (3.10e-1)" "unprognostic (3.55e-1)" "unprognostic (3.68e-2)" "unprognostic (1.25e-1)" "unprognostic (3.50e-2)" "unprognostic (1.34e-2)" "unprognostic (4.71e-2)" 78.0 10.3 16.5 12.7 80.1 1.6 25.5 4.7 31.0 5.1 33.7 6.1 0.4 8.1 2.8 4.9 20.5 16.9 12.4 9.5 39.3 13.6 38.9 85.1 17.5 15.7 28.7 9.6 4.4 40.8 2.5 1.4 2.2 54.5 11.6 35.3 3.5 5.0 3.7 16.6 7.4 35.6 12.6 37.1 3.5 13.1 2.0 13.1 0.0 12.2 3.2 2.2 5.4 5.1 0.1 0.0 2.3 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.7 4.9 0.1 0.3 1.7 0.4 0.4 0.0 0.2 0.0 1.9 1.2 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 4.6 0.0 5.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 3.4 0.0 0.2 0.0 0.0 0.0 33.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.7 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.2 0.0 0.4 0.3 0.1 0.0 0.3 0.5 0.0 0.1 0.0 0.2 2.3 0.0 0.1 0.0 0.4 0.0 16.5 80.1 4.7 31.0 39.3 13.6 28.7 9.6 54.5 13.1 11.9 7.4 11.5 16.3 24.5 0.0 5.6 68.8 8.1 10.3 14.0 0.0 0.3 31.5 58.0 0.1 32.2 365.6 23.3 100.5 50.9 75.8 118.0 16.1 1085.7 1.5 0.0 31.5 59.5 27.2 0.4 44.3 29.4 84.4 42.3 419.9 0.0 70.9 859.9 11.3 76.7 0.0 77.6 334.7 0.0 0.3 17.7 0.8 10.0 352.6 4.7 MT1X "MT-1l, MT1" ENSG00000187193 "Metallothionein 1X" P80297 16 56682424-56684196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 351.9;skeletal muscle: 474.1" "Group enriched" "Detected in many" 5 "Hepatocytes: 10383.8;Proximal tubular cells: 10901.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 96.7;HBEC3-KT: 170.2;NTERA-2: 61.7;U-87 MG: 66.9" NA NA "unprognostic (8.15e-2)" "unprognostic (9.02e-2)" "unprognostic (8.27e-2)" "unprognostic (1.18e-3)" "unprognostic (7.05e-3)" "unprognostic (7.26e-3)" "unprognostic (9.49e-3)" "unprognostic (9.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.40e-2)" "unprognostic (4.85e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-10)" "unprognostic (1.56e-1)" "unprognostic (4.25e-2)" "unprognostic (4.11e-1)" "unprognostic (1.37e-3)" 130.2 18.6 18.1 15.0 86.0 4.3 59.8 14.5 55.7 23.3 39.0 7.3 7.1 15.9 5.4 30.6 120.9 18.3 18.8 72.4 42.3 13.0 98.8 351.9 23.5 43.3 34.6 18.6 10.2 216.6 2.5 20.4 3.2 70.7 20.6 28.2 8.2 49.7 8.3 474.1 78.4 29.3 17.5 78.1 3.2 29.9 4.7 16.8 1.3 130.3 82.5 15.4 10.9 34.1 4.8 17.0 17.0 17.1 6.6 30.3 13.4 4.0 4.1 0.1 8.7 96.7 21.2 3.5 12.8 7.8 3.4 3.8 0.7 3.7 3.1 3.5 3.0 4.3 36.1 11.5 170.2 4.0 12.3 7.0 4.1 2.5 1.3 13.8 26.2 9.8 21.5 32.4 8.3 8.7 3.3 0.7 3.0 0.6 1.2 11.5 10.4 5.3 28.4 61.7 0.2 27.5 5.5 0.5 8.0 34.0 0.4 8.9 3.1 39.0 9.9 2.8 3.3 1.1 6.8 1.9 7.5 9.1 7.6 9.0 1.3 0.9 1.2 66.9 42.2 4.3 17.0 17.1 5.4 23.2 7.7 26.4 4.8 26.1 28.8 17.0 3.0 24.8 30.3 0.8 6.6 3.1 5.9 25.7 13.4 18.1 86.0 14.5 55.7 42.3 13.0 34.6 18.6 70.7 16.8 62.5 16.6 113.1 789.9 1552.5 0.0 124.8 229.3 144.6 320.8 551.3 0.0 5.0 1788.9 114.2 2.2 128.9 1230.1 303.7 87.5 573.1 299.7 789.4 38.1 10383.8 60.6 0.0 138.4 289.7 291.2 3.9 458.8 118.2 229.5 43.3 1281.9 0.0 205.8 1833.6 111.0 10901.2 0.0 71.1 282.2 0.7 2.9 2096.3 57.2 90.0 876.8 143.1 MT2A MT2 ENSG00000125148 "Metallothionein 2A" P02795 16 56608199-56609497 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 626.9" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 13602.7;Proximal tubular cells: 7840.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 119.8;HBEC3-KT: 433.2;LHCN-M2: 174.3;U-138 MG: 121.8;U-87 MG: 143.4" NA NA "unprognostic (1.14e-1)" "unprognostic (8.90e-2)" "unprognostic (2.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.76e-1)" "unprognostic (4.89e-3)" "unprognostic (1.02e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (5.69e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (9.52e-4)" "unprognostic (8.59e-2)" "prognostic unfavorable (2.92e-9)" "unprognostic (4.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.42e-1)" "unprognostic (1.03e-2)" 177.1 215.4 27.7 49.6 66.6 16.3 58.2 10.3 41.7 23.1 48.1 20.8 12.4 26.0 10.7 37.5 35.8 33.6 48.0 30.8 31.6 23.4 74.6 626.9 53.0 38.7 51.0 13.9 23.3 129.1 2.9 11.4 21.8 95.2 30.4 20.2 15.9 19.5 10.8 184.6 29.6 62.8 21.2 63.4 29.7 30.6 7.6 26.5 0.6 69.6 29.8 15.6 24.6 20.5 3.8 13.1 25.3 26.3 10.5 33.6 18.0 14.2 6.0 0.1 5.0 41.2 60.4 0.8 119.8 62.1 23.5 21.5 0.0 25.2 2.2 16.7 9.6 7.8 15.4 5.3 433.2 9.7 23.0 3.6 2.7 6.1 2.2 19.6 17.3 1.8 37.6 20.2 54.4 21.2 25.0 29.5 0.9 0.1 0.2 174.3 10.2 1.9 23.0 11.5 0.0 56.4 2.0 7.1 0.1 111.2 0.1 2.7 0.6 29.4 10.5 7.9 0.4 1.6 2.2 37.7 121.8 47.3 19.9 34.2 0.1 0.2 0.1 143.4 21.3 7.4 25.3 16.3 21.3 31.9 24.8 21.2 3.8 18.7 33.6 13.1 2.2 13.0 25.8 9.6 10.5 26.3 2.1 30.4 18.0 27.7 66.6 10.3 41.7 31.6 23.4 51.0 13.9 95.2 26.5 276.9 184.4 357.1 1299.4 1628.5 0.0 101.0 481.6 536.7 844.0 1059.0 0.0 515.1 2379.1 658.7 59.6 1015.9 5012.0 654.1 300.4 669.8 642.1 4438.7 248.5 13602.7 257.7 0.0 233.1 1138.6 1133.4 9.2 315.5 831.1 593.9 428.4 2564.2 0.0 802.3 3748.0 69.6 7840.0 0.0 1073.6 3753.4 1.4 12.1 637.9 375.9 600.6 1750.7 336.8 MT3 GIF ENSG00000087250 "Metallothionein 3" P25713 16 56589074-56591088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 243.8" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 19.7;Ciliated cells: 29.4;Distal tubular cells: 38.1" "Cancer enriched" "Detected in many" 58 "glioma: 392.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive CD8 T-cell: 8.0" "Lineage enriched" "Detected in single" 81 "T-cells: 8.0" "Cell line enhanced" "Detected in some" "JURKAT: 2.8;RPMI-8226: 5.3;SCLC-21H: 9.2;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004011, CAB017779" Enhanced NA NA "CAB017779: , HPA004011: AB_1854158" "unprognostic (6.63e-3)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (4.34e-2)" "unprognostic (8.11e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "unprognostic (2.45e-2)" "unprognostic (7.99e-2)" "unprognostic (1.66e-1)" "unprognostic (8.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.55e-1)" "unprognostic (2.03e-1)" "unprognostic (9.26e-2)" 2.7 19.8 168.7 2.6 140.5 2.3 2.4 42.2 243.8 2.5 3.6 20.2 0.0 2.4 2.4 2.3 3.2 2.5 2.4 3.8 107.2 80.5 3.1 2.3 2.5 2.5 129.1 53.2 2.6 2.3 2.3 1.1 2.7 37.0 2.6 3.1 0.0 17.4 2.5 2.8 2.5 2.8 2.4 53.7 2.4 2.4 5.9 48.6 0.0 2.4 0.0 5.9 2.4 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 5.3 0.0 0.0 9.2 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 1.7 8.0 0.0 0.0 0.0 0.0 0.0 0.9 168.7 140.5 42.2 102.1 107.2 80.5 129.1 53.2 37.0 48.6 0.0 0.3 0.0 0.1 0.2 0.0 19.7 0.0 29.4 4.5 0.0 0.0 0.0 38.1 1.4 6.1 0.1 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 9.9 1.3 0.0 7.9 1.1 0.0 0.0 0.0 6.5 0.0 0.0 2.9 0.4 0.3 0.0 0.0 0.9 0.1 0.2 0.0 0.0 0.0 6.2 0.0 MT4 MTIV ENSG00000102891 "Metallothionein 4" P47944 16 56565049-56568957 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skin 1: 42.3" "Cell type enriched" "Detected in some" 4 "Suprabasal keratinocytes: 17.2" "Group enriched" "Detected in many" 6 "cervical cancer: 6.7;endometrial cancer: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "HaCaT: 2.5;K-562: 1.2" "Region enhanced" "Detected in single" "thalamus: 0.4" "Not detected" "Not detected" NA NA "unprognostic (8.81e-2)" 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 1.5 0.1 0.1 0.1 0.0 0.1 0.1 1.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.7 42.3 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.6 0.1 8.5 0.1 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.2 0.0 0.0 0.0 0.0 MTA3 KIAA1266 ENSG00000057935 "Metastasis associated 1 family member 3" Q9BTC8 2 42494569-42756947 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 74.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039433 Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA039433: AB_10794747" "unprognostic (5.40e-2)" "unprognostic (4.89e-2)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.30e-4)" "unprognostic (4.13e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (5.43e-2)" "unprognostic (2.27e-1)" "unprognostic (1.58e-1)" "unprognostic (2.64e-2)" "unprognostic (9.03e-2)" "unprognostic (2.05e-1)" "unprognostic (3.47e-1)" "unprognostic (1.28e-2)" 8.8 35.0 19.2 16.7 21.0 1.6 14.6 11.4 23.7 14.5 12.5 10.2 16.8 9.0 17.2 25.0 16.7 14.1 11.3 11.1 18.3 14.0 14.5 7.6 8.3 11.5 12.3 14.6 33.3 15.0 18.3 15.8 16.1 12.5 15.0 14.1 12.6 10.6 20.8 9.8 15.4 8.7 14.3 10.4 6.4 12.5 21.0 9.3 74.3 13.0 7.7 15.0 13.5 13.4 2.9 3.2 7.7 1.9 3.3 8.8 3.3 7.6 8.0 12.0 7.2 9.6 13.4 23.8 4.8 8.7 10.8 9.3 10.1 13.3 25.1 8.3 10.4 8.2 4.8 25.4 11.4 15.9 9.3 8.6 4.5 4.7 15.9 10.4 2.7 15.3 14.2 12.8 7.3 7.9 14.8 14.5 12.7 8.2 2.9 11.8 11.3 17.5 8.4 42.9 10.2 4.9 10.1 10.5 0.0 10.8 6.3 6.4 20.8 7.4 23.3 9.8 32.7 12.6 3.4 9.0 5.2 8.5 3.8 4.6 6.0 2.8 36.8 6.9 2.8 6.6 7.7 1.9 0.0 4.1 0.7 5.7 2.5 4.4 6.2 3.2 2.9 8.8 5.9 0.3 3.3 1.2 1.0 2.2 3.3 19.2 21.0 11.4 23.7 18.3 14.0 12.3 14.6 12.5 9.3 11.9 12.2 9.0 18.9 13.6 0.0 10.6 10.2 9.4 12.5 21.0 0.0 48.3 14.9 20.3 8.2 11.1 20.0 0.0 24.6 35.3 15.4 16.9 11.5 12.3 10.4 0.0 9.2 16.0 7.3 17.2 31.4 5.9 16.9 8.2 20.7 0.0 18.5 23.5 37.4 26.2 0.0 12.9 14.4 20.0 42.4 15.9 50.1 6.9 19.7 15.3 MTCH2 SLC25A50 ENSG00000109919 "Mitochondrial carrier 2" Q9Y6C9 11 47617315-47642623 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 432.9;Proximal tubular cells: 398.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038390 Approved Approved Mitochondria NA NA 55000 Mitochondria "HPA038390: AB_10669723" "unprognostic (4.94e-2)" "unprognostic (3.29e-1)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (4.27e-1)" "unprognostic (7.63e-3)" "unprognostic (1.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "prognostic favorable (9.05e-6)" "unprognostic (1.12e-2)" "unprognostic (8.75e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" 13.6 19.6 15.6 12.8 20.3 8.3 12.5 14.1 21.3 10.4 22.3 19.3 8.7 28.3 12.6 15.1 21.6 9.9 11.6 15.0 14.0 13.8 40.8 74.8 9.1 13.9 15.2 12.2 9.3 14.4 16.8 9.3 9.5 15.4 11.8 24.7 13.6 13.4 10.0 31.4 12.1 33.9 16.1 11.4 11.4 10.1 44.2 10.2 15.1 15.5 24.9 16.4 11.6 10.7 13.7 25.7 7.9 21.3 12.1 13.6 17.5 18.9 20.8 17.8 24.0 21.1 19.6 13.2 20.6 18.9 27.8 26.4 16.5 19.4 26.2 11.2 25.2 30.1 23.9 31.9 27.1 33.9 13.1 29.8 15.0 29.7 32.9 29.1 31.2 15.1 22.1 21.4 18.5 27.7 16.2 25.1 22.6 27.7 15.8 33.9 27.6 23.9 23.5 19.3 37.2 31.6 22.4 27.1 18.8 32.2 24.6 21.2 14.9 28.2 28.5 14.5 17.6 41.0 14.7 20.8 25.7 22.4 42.5 26.4 16.8 19.1 29.6 21.2 27.2 22.9 5.9 19.8 7.9 12.7 21.3 12.0 13.7 11.1 11.7 25.7 10.9 9.7 11.2 1.9 12.1 17.0 16.9 13.6 17.5 15.6 20.3 14.1 21.3 14.0 13.8 15.2 12.2 15.4 10.2 20.8 33.9 37.2 43.0 41.8 0.0 61.0 81.5 46.8 37.5 50.6 0.0 75.5 154.2 136.5 432.9 25.1 133.4 0.0 95.3 101.6 32.1 64.6 35.9 265.9 146.4 0.0 76.7 35.0 64.2 110.8 26.7 50.7 77.6 112.8 82.5 0.0 85.1 63.1 54.8 398.6 0.0 32.3 38.1 327.5 81.0 47.3 106.9 37.6 134.8 50.4 MTCL1 "CCDC165, KIAA0802, SOGA2" ENSG00000168502 "Microtubule crosslinking factor 1" Q9Y4B5 18 8705661-8832778 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 61.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 7.6;Early spermatids: 18.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 61.5" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" HPA046245 Uncertain NA NA "HPA046245: AB_10962580" "unprognostic (2.64e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.35e-1)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-1)" "unprognostic (4.41e-4)" "unprognostic (1.30e-2)" "unprognostic (7.19e-2)" "unprognostic (9.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.82e-1)" "unprognostic (3.67e-1)" "unprognostic (7.17e-3)" "unprognostic (1.08e-2)" 1.4 1.2 1.8 3.2 3.4 0.4 1.4 61.5 10.0 5.5 8.5 2.4 4.1 2.3 3.4 2.0 3.8 1.3 12.5 3.8 1.7 2.4 1.4 1.3 1.4 0.9 2.4 3.8 1.3 3.4 4.8 2.7 3.0 5.2 1.7 2.3 8.4 1.5 4.4 2.4 1.6 2.7 7.0 3.3 1.1 4.9 8.2 1.2 1.4 1.1 1.1 0.6 9.9 4.8 0.6 1.1 0.0 0.0 0.0 0.0 0.0 8.7 18.8 9.4 5.5 4.2 7.9 0.3 12.2 9.1 10.2 7.4 5.5 3.1 5.5 7.0 8.5 7.6 1.3 2.9 5.0 4.7 1.1 2.4 2.7 5.0 4.9 6.1 0.0 4.0 4.6 3.7 5.7 4.0 6.6 7.9 4.7 0.6 9.6 4.7 2.6 0.3 1.3 4.3 21.1 8.2 7.3 6.8 2.0 14.6 15.9 21.5 4.8 5.6 1.6 1.4 8.2 0.5 0.3 15.0 18.7 9.8 14.9 12.5 1.8 1.4 2.7 4.6 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.8 3.4 61.5 10.0 1.7 2.4 2.4 3.8 5.2 1.2 0.0 0.6 0.0 2.4 0.0 0.0 5.7 7.6 0.0 1.2 1.8 0.0 3.7 1.7 4.6 18.9 0.5 0.1 0.0 3.1 0.4 0.9 1.3 2.3 0.9 0.5 0.0 1.2 5.5 1.2 6.3 1.1 0.0 0.0 0.0 1.1 0.0 6.4 0.0 0.4 1.0 0.0 0.0 0.6 1.0 6.6 0.0 0.8 0.0 1.0 1.0 MTF2 "M96, PCL2, TDRD19A" ENSG00000143033 "Metal response element binding transcription factor 2" Q9Y483 1 93079235-93139081 "Predicted intracellular proteins" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.4" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069047, HPA069066" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA069047: AB_2686073, HPA069066: AB_2686078" "unprognostic (1.84e-2)" "unprognostic (1.45e-1)" "unprognostic (5.56e-2)" "unprognostic (7.88e-3)" "unprognostic (7.12e-2)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.90e-7)" "unprognostic (1.26e-2)" "unprognostic (9.22e-3)" "unprognostic (3.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (1.05e-4)" "prognostic unfavorable (2.47e-7)" "unprognostic (7.19e-3)" "unprognostic (2.48e-1)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" 6.8 8.0 8.5 19.7 18.4 21.9 10.3 24.3 12.2 9.8 8.0 8.6 4.9 8.0 9.0 8.5 7.2 7.6 7.4 5.3 9.0 8.2 7.6 7.3 8.6 19.9 8.1 9.8 12.0 7.0 6.7 13.9 13.0 9.2 7.0 8.4 6.7 6.7 6.8 7.1 8.1 9.5 6.8 8.5 12.7 7.2 17.3 9.2 43.4 9.6 7.1 19.4 7.9 8.3 11.7 12.0 14.7 10.6 13.0 14.3 6.2 7.4 3.6 12.5 8.2 2.2 2.1 14.5 4.8 3.8 8.3 10.4 6.1 4.1 24.1 8.8 3.0 7.1 4.0 11.5 5.0 12.3 9.3 8.4 16.6 5.5 8.2 3.3 21.6 7.1 2.6 2.7 7.8 4.7 3.8 7.9 18.8 18.7 7.6 5.1 3.1 31.0 18.0 21.3 3.3 4.8 25.2 15.4 6.5 7.7 8.1 7.8 9.5 7.9 9.4 9.6 13.8 5.6 15.3 4.5 5.5 8.2 5.2 7.1 5.9 6.7 42.8 1.1 12.9 3.5 9.4 9.4 14.7 11.3 10.6 12.9 10.0 11.7 14.3 12.0 11.7 13.9 12.4 7.2 13.0 6.3 11.4 12.9 6.2 8.5 18.4 24.3 12.2 9.0 8.2 8.1 9.8 9.2 9.2 26.8 27.2 56.4 25.5 41.3 0.0 11.7 7.6 17.4 28.4 36.6 0.0 60.2 6.6 29.9 3.7 39.3 25.4 23.3 16.9 56.8 29.0 28.2 57.8 13.4 30.0 0.0 30.9 35.0 26.7 5.0 30.2 40.6 16.9 42.3 29.2 0.0 27.2 31.6 22.3 12.9 0.0 38.8 23.6 122.6 74.3 37.8 50.8 48.4 30.8 32.0 MTFR2 "DUFD1, FAM54A" ENSG00000146410 "Mitochondrial fission regulator 2" Q6P444 6 136231024-136250335 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Extravillous trophoblasts: 18.8;Spermatocytes: 11.8;Spermatogonia: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029792, HPA029794" Approved Uncertain Vesicles NA Yes Vesicles "HPA029792: AB_10600210, HPA029794: AB_10600535" "unprognostic (6.49e-3)" "unprognostic (6.29e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.64e-4)" "unprognostic (3.93e-1)" "unprognostic (1.75e-2)" "unprognostic (4.60e-6)" "prognostic unfavorable (8.28e-4)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.27e-2)" "unprognostic (6.54e-2)" "unprognostic (1.11e-16)" "unprognostic (8.82e-3)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (3.64e-2)" 1.7 0.9 0.6 5.1 1.5 15.2 0.9 0.9 1.1 0.8 2.9 0.8 0.4 2.8 0.7 0.9 4.5 0.5 1.7 1.0 0.6 0.6 2.5 0.7 1.5 6.4 0.8 0.4 0.9 0.7 0.0 0.7 3.2 1.2 0.7 4.1 0.6 1.3 0.4 1.4 1.9 3.2 0.9 1.1 3.8 1.9 13.5 0.4 16.8 0.4 3.2 5.8 1.1 1.4 1.6 3.0 0.1 2.9 0.0 2.6 1.1 7.2 5.6 4.8 9.0 0.8 1.4 8.6 9.6 6.7 11.4 15.9 9.9 5.9 18.8 5.9 3.8 15.1 11.3 10.9 7.1 17.0 10.5 8.4 14.8 4.1 9.0 0.5 27.1 14.0 1.1 1.5 12.6 8.1 1.3 6.1 16.5 15.9 14.6 8.5 9.6 15.2 22.7 4.8 9.7 6.9 14.0 7.7 9.4 4.9 5.6 3.8 3.8 6.0 10.6 5.5 6.2 4.5 18.7 3.3 5.7 5.9 19.9 14.6 5.6 13.1 12.4 3.3 18.5 8.6 0.0 0.6 0.0 1.2 2.9 0.4 1.6 1.6 2.6 3.0 1.3 0.2 1.3 0.1 0.0 2.3 2.2 2.2 1.1 0.6 1.5 0.9 1.1 0.6 0.6 0.8 0.4 1.2 0.4 0.0 0.6 6.2 0.3 0.9 0.0 0.3 0.0 1.4 1.2 0.0 0.0 4.9 0.0 0.8 6.5 0.3 0.9 23.3 2.2 18.8 0.4 0.8 1.1 0.5 5.6 0.0 0.0 1.3 4.3 4.2 0.3 1.8 0.0 2.8 1.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.3 11.8 9.9 0.3 2.5 1.5 1.4 0.9 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" P11586 14 64388031-64463457 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis" "Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 121.6" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 125.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes 250000 Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 18.9 9.0 8.1 8.4 18.1 9.7 12.2 5.7 15.9 7.1 9.3 9.0 4.0 7.5 8.5 6.9 12.0 6.7 6.4 10.6 8.4 6.5 20.5 121.6 6.8 9.2 8.0 10.4 10.1 13.4 13.1 5.6 5.6 10.0 5.5 11.4 9.3 11.6 5.6 26.5 7.6 7.3 8.8 6.9 8.3 7.9 2.3 7.4 15.6 8.6 14.0 12.5 8.7 7.3 21.1 12.8 0.5 13.2 12.8 14.9 8.4 72.5 41.3 15.7 34.2 16.9 13.8 25.5 28.5 19.6 37.0 36.7 40.1 33.4 30.5 13.5 16.9 18.6 35.7 48.4 28.3 43.3 30.3 31.9 37.8 41.4 30.4 12.5 29.0 20.6 10.7 9.2 33.0 17.9 15.3 23.0 30.9 28.1 25.1 28.0 60.2 46.7 17.0 28.7 46.2 43.8 37.3 54.6 27.6 27.8 42.5 34.0 13.2 47.6 25.9 14.3 15.3 40.3 14.7 14.1 27.9 48.4 25.7 34.1 16.8 20.6 53.8 25.6 33.5 31.6 0.2 8.2 0.1 8.1 13.2 10.9 21.1 9.0 9.9 12.8 11.6 7.6 10.1 0.5 12.8 10.3 3.2 14.9 8.4 8.1 18.1 5.7 15.9 8.4 6.5 8.0 10.4 10.0 7.4 17.9 26.3 11.5 9.9 12.2 0.0 38.1 17.8 12.0 20.5 15.7 0.0 20.0 34.9 15.4 0.9 9.9 5.2 0.0 9.0 24.2 10.6 8.3 49.7 125.3 21.6 0.0 2.9 7.4 11.3 0.9 12.0 10.9 13.5 14.4 11.9 0.0 10.8 2.9 12.4 49.9 0.0 19.4 18.6 0.9 7.5 9.4 8.2 20.0 21.3 9.9 MTHFS HsT19268 ENSG00000136371 "Methenyltetrahydrofolate synthetase" P49914 15 79833585-79897379 "Enzymes, Predicted intracellular proteins" Ligase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.7;liver: 120.9" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 163.6;monocytes: 231.8;Proximal tubular cells: 140.3;Syncytiotrophoblasts: 212.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 88.7" "Group enriched" "Detected in all" 5 "granulocytes: 88.7;monocytes: 25.4" "Low cell line specificity" "Detected in many" "HPA008067, HPA054177" Approved Supported Cytosol NA NA Cytosol "HPA008067: AB_1078882, HPA054177: AB_2682405" "unprognostic (4.57e-2)" "unprognostic (9.76e-2)" "unprognostic (6.11e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (9.13e-3)" "prognostic favorable (1.29e-6)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "unprognostic (6.18e-3)" "unprognostic (2.91e-2)" "unprognostic (2.76e-1)" "prognostic favorable (2.04e-4)" "unprognostic (1.36e-1)" "unprognostic (2.85e-1)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" 10.0 6.6 4.5 7.6 4.4 2.5 5.7 3.9 2.8 4.4 12.4 3.7 6.8 8.3 4.3 6.2 4.5 4.0 7.9 5.2 4.1 5.0 27.9 120.9 6.4 5.4 5.5 1.7 3.3 18.8 11.4 9.4 13.9 3.9 8.6 3.7 6.5 10.6 7.6 6.0 1.9 18.3 4.4 6.1 7.6 6.3 5.9 3.3 5.3 12.0 3.1 5.7 4.0 9.9 9.7 9.3 88.7 25.4 12.4 12.6 13.8 10.9 27.7 2.5 1.4 9.8 8.3 11.2 7.7 10.1 13.5 10.3 21.5 21.6 13.8 23.4 9.5 12.1 17.7 23.6 7.5 10.3 14.3 15.7 11.8 16.1 25.5 17.0 5.5 0.4 12.5 22.1 5.6 14.1 12.6 5.0 12.2 26.1 11.3 10.7 23.6 8.5 23.0 11.8 34.2 10.4 9.3 13.6 20.9 24.6 20.6 6.8 3.2 21.4 12.8 28.2 12.5 16.4 10.2 3.3 5.2 11.0 2.4 5.1 5.7 18.4 13.9 2.6 21.8 4.0 9.8 16.6 43.5 7.7 19.0 9.9 9.7 10.8 9.0 9.3 8.7 12.6 9.7 88.7 12.4 25.4 7.0 11.2 13.8 4.5 4.4 3.9 2.8 4.1 5.0 5.5 1.7 3.9 3.3 17.9 35.3 18.8 8.6 9.5 0.0 0.6 40.8 25.4 18.2 21.0 0.0 57.2 54.7 50.9 1.1 8.4 11.9 0.0 65.9 31.6 13.1 11.4 8.1 163.6 41.2 0.0 16.9 16.5 21.5 1.7 12.7 29.7 20.3 231.8 22.7 0.0 65.8 29.8 14.9 140.3 0.0 12.9 5.1 7.5 7.3 7.0 212.2 35.2 30.5 7.4 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991607 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: AB_2667508" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favorable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 13.9 7.3 19.9 7.8 22.8 12.0 16.3 8.4 19.3 10.0 8.4 32.9 4.2 9.6 7.4 8.1 17.1 6.4 7.5 10.2 22.5 13.3 25.9 19.2 10.6 9.6 30.9 11.9 9.5 9.8 14.8 4.3 32.7 29.4 9.2 8.5 9.5 11.1 10.0 24.3 7.6 8.9 8.3 84.0 10.7 10.0 6.6 24.9 8.9 11.7 6.0 8.3 9.5 7.2 3.4 3.8 14.1 6.9 1.4 1.6 1.6 5.5 6.3 5.8 3.1 12.9 7.0 4.2 8.0 16.8 6.8 6.7 4.0 1.9 2.3 11.0 10.7 6.7 8.2 4.5 4.8 6.4 8.3 1.2 2.9 4.1 5.9 7.5 5.5 5.9 9.4 3.8 4.3 4.8 8.0 16.7 6.8 3.1 6.5 6.1 1.6 5.8 1.6 2.9 6.9 2.6 4.4 5.0 13.1 25.3 8.8 2.1 5.4 3.8 4.6 1.6 8.4 2.9 10.4 7.9 7.9 5.0 4.1 4.9 5.9 5.0 6.0 4.6 2.0 8.8 3.3 3.2 3.0 0.8 4.2 0.8 2.1 0.9 0.6 3.2 3.4 1.6 1.3 14.1 1.4 6.9 3.8 1.3 1.6 19.9 22.8 8.4 19.3 22.5 13.3 30.9 11.9 29.4 24.9 23.8 14.6 5.9 3.7 7.9 0.0 20.2 5.1 4.0 7.9 31.4 0.0 14.7 1.7 2.9 11.5 11.7 10.0 0.0 3.2 2.6 7.6 7.4 16.2 28.7 10.3 0.0 5.8 10.4 21.9 17.8 9.8 17.2 8.5 2.8 9.0 0.0 4.2 8.6 7.1 13.3 0.0 0.0 5.3 12.1 6.6 9.7 32.2 5.7 6.8 5.2 MTMR11 CRA ENSG00000014914 "Myotubularin related protein 11" A4FU01 1 149928651-149936869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 49.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 108.3;Mucus-secreting cells: 58.0;Paneth cells: 72.4;Undifferentiated cells: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0" "Group enriched" "Detected in many" 37 "dendritic cells: 4.2;monocytes: 3.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.7;OE19: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030351, HPA072906" Enhanced Approved Centrosome NA NA Centrosome "HPA030351: AB_10602185, HPA072906: " "unprognostic (1.14e-1)" "unprognostic (3.01e-3)" "unprognostic (1.42e-1)" "unprognostic (1.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.37e-2)" "unprognostic (5.81e-2)" "unprognostic (7.94e-2)" "unprognostic (2.98e-1)" "unprognostic (2.88e-2)" "unprognostic (1.22e-1)" "unprognostic (5.83e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (1.80e-2)" "unprognostic (9.12e-2)" 3.2 12.0 4.9 15.0 8.4 0.0 5.4 1.5 3.9 9.5 36.8 2.7 5.8 15.9 10.0 6.2 4.4 7.2 17.0 3.1 2.6 2.8 9.7 1.8 3.4 1.5 2.0 2.8 14.5 2.2 5.8 6.3 9.6 5.2 5.5 20.8 4.5 2.1 6.5 1.1 7.4 49.9 11.4 5.0 1.8 4.0 4.9 2.5 0.0 1.6 4.0 1.5 5.8 6.8 0.0 4.2 0.0 3.2 0.0 0.0 0.5 2.3 5.7 2.5 2.1 7.4 8.4 4.7 2.4 8.2 3.2 4.0 0.1 10.3 0.0 5.6 8.4 4.0 3.3 0.3 4.1 1.8 0.1 0.0 0.0 1.7 0.7 1.9 0.0 0.0 5.2 1.3 3.2 5.3 13.7 3.8 0.0 0.1 0.1 6.3 7.7 0.0 0.0 0.5 16.5 2.0 0.0 0.9 0.1 4.8 0.7 0.1 0.2 1.4 2.3 0.8 1.2 2.5 0.0 2.6 3.5 4.3 2.9 1.9 0.2 0.9 0.0 3.3 0.0 0.3 0.0 1.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.5 4.9 8.4 1.5 3.9 2.6 2.8 2.0 2.8 5.2 2.5 0.0 1.1 0.0 2.5 3.7 0.0 1.6 10.2 1.4 3.4 14.0 0.0 11.9 1.7 12.5 0.5 2.1 108.3 0.0 15.3 9.0 8.1 2.6 0.0 1.1 4.9 0.0 15.1 4.9 13.3 0.0 5.2 6.4 1.7 3.6 58.0 0.0 28.8 72.4 11.3 15.3 0.0 6.5 6.2 0.3 0.2 5.6 23.8 1.3 48.1 3.7 MTMR7 ENSG00000003987 "Myotubularin related protein 7" Q9Y216 8 17298030-17413528 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;parathyroid gland: 17.9" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 9.5;Intestinal endocrine cells: 3.5;Late spermatids: 3.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 5.4;SCLC-21H: 14.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" HPA075682 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA075682: " "unprognostic (1.01e-1)" "unprognostic (6.10e-2)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-1)" "unprognostic (1.31e-2)" "unprognostic (4.15e-2)" "unprognostic (1.41e-2)" "unprognostic (1.92e-1)" "unprognostic (2.45e-1)" "unprognostic (2.07e-4)" "unprognostic (1.46e-2)" "unprognostic (1.97e-7)" "unprognostic (1.12e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (2.66e-3)" 1.4 4.9 10.9 1.9 16.7 3.4 0.9 16.2 25.8 1.2 1.3 16.0 0.0 2.0 1.8 0.8 1.5 1.5 1.6 1.7 7.5 7.8 2.4 2.2 1.4 1.7 9.2 9.5 3.5 2.6 17.9 10.3 1.8 19.5 1.2 1.3 4.7 1.4 1.1 2.1 2.6 1.9 1.1 11.2 1.4 1.8 2.9 9.4 0.0 6.5 0.0 0.8 1.4 0.7 0.7 0.2 0.8 0.2 0.3 1.4 0.1 0.8 0.7 1.2 1.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.9 0.2 0.9 0.5 0.0 0.8 0.4 4.1 0.1 0.0 0.1 3.0 1.2 1.6 0.5 1.0 0.7 0.9 0.2 0.0 0.1 0.0 0.8 0.2 0.4 0.6 0.7 0.0 0.6 1.3 1.7 5.4 0.7 0.6 0.4 1.8 0.5 0.0 3.4 14.3 8.3 0.6 0.8 0.9 2.0 0.4 0.9 1.5 0.9 0.5 2.0 1.1 0.4 0.4 0.7 2.6 1.3 0.7 0.0 0.1 0.7 0.2 0.2 0.1 0.7 0.1 0.2 0.1 0.0 0.5 0.3 0.8 0.3 0.2 0.2 1.4 0.1 10.9 16.7 16.2 15.2 7.5 7.8 9.2 9.5 19.5 9.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.5 0.5 0.6 1.6 0.1 1.1 0.0 0.0 0.0 MTMR8 FLJ20126 ENSG00000102043 "Myotubularin related protein 8" Q96EF0 X 64268081-64395431 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.4" "Cell type enhanced" "Detected in single" 5 "Urothelial cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 6.8;JURKAT: 7.0;NTERA-2: 6.4;U-2197: 5.6" "Low region specificity" "Detected in all" NA NA "unprognostic (1.73e-2)" "unprognostic (2.53e-2)" "unprognostic (2.95e-3)" "unprognostic (1.87e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-2)" "unprognostic (3.41e-3)" "unprognostic (1.41e-2)" "unprognostic (2.67e-1)" "unprognostic (2.08e-1)" "unprognostic (8.00e-2)" "unprognostic (2.96e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-2)" "unprognostic (1.52e-1)" "unprognostic (9.22e-2)" "unprognostic (8.20e-2)" 2.8 2.6 1.2 3.1 2.2 1.9 2.2 6.1 2.0 4.2 4.0 2.5 4.1 1.7 6.0 2.9 3.8 8.1 2.0 1.8 1.5 1.7 3.2 1.4 2.1 3.0 2.4 0.7 6.6 2.5 2.7 6.8 0.5 2.0 3.4 4.9 16.4 2.8 6.5 1.5 2.1 5.3 6.7 2.4 4.3 4.1 1.3 3.0 5.5 2.4 1.6 6.1 4.9 3.1 3.2 0.2 0.7 1.4 0.8 4.0 1.6 0.0 1.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 1.4 6.8 1.0 0.0 0.0 0.0 3.9 0.8 1.7 0.0 1.6 2.2 0.3 0.0 0.0 4.7 3.0 0.0 1.0 0.1 0.3 0.0 0.0 7.0 4.9 5.0 0.0 0.3 2.5 0.8 6.4 1.9 0.6 3.8 0.0 1.7 0.4 1.1 0.0 0.7 0.0 0.1 0.0 1.3 1.3 2.4 0.0 0.0 1.6 5.6 0.0 0.0 0.5 4.3 0.0 0.0 0.0 0.4 0.4 0.1 3.2 1.2 3.1 3.0 3.3 2.0 0.2 3.2 4.0 3.5 0.7 0.8 1.4 0.2 1.7 1.6 1.2 2.2 6.1 2.0 1.5 1.7 2.4 0.7 2.0 3.0 0.0 0.0 0.5 0.8 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.4 0.3 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.7 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.4 1.0 MTNR1A MEL-1A-R ENSG00000168412 "Melatonin receptor 1A" P48039 4 186533655-186555567 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;EFO-21: 2.0;HEK 293: 2.1;NTERA-2: 1.8;SCLC-21H: 1.6;SH-SY5Y: 3.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (7.99e-2)" "unprognostic (2.27e-1)" "unprognostic (2.16e-1)" "unprognostic (3.67e-1)" "unprognostic (2.14e-1)" "unprognostic (9.88e-2)" "unprognostic (9.20e-2)" "unprognostic (8.81e-2)" 0.0 0.0 0.1 1.2 0.1 0.0 0.0 3.8 0.2 0.0 3.1 0.3 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 5.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTNR1B ENSG00000134640 "Melatonin receptor 1B" P49286 11 92969720-92985066 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "GAMG: 10.6;SuSa: 2.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "midbrain: 0.8;pons and medulla: 1.2" HPA074024 Supported NA NA "HPA074024: " "unprognostic (3.61e-1)" "unprognostic (1.43e-1)" 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MTRNR2L1 ENSG00000256618 "MT-RNR2-like 1" P0CJ68 17 22523111-22524663 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 4 "blood: 249.5" "Cell type enriched" "Detected in many" 13 "Cardiomyocytes: 14115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 249.5" "Lineage enriched" "Detected in all" 7 "granulocytes: 249.5" "Cell line enhanced" "Detected in all" "HeLa: 188.9;Hep G2: 129.8" "Secreted to blood" NA NA "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.41e-3)" "unprognostic (2.99e-2)" "unprognostic (9.82e-3)" "prognostic favorable (8.99e-4)" "unprognostic (2.14e-1)" "unprognostic (2.59e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-2)" "unprognostic (1.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (5.21e-3)" 9.4 16.2 7.9 3.7 10.0 2.3 3.0 4.0 8.4 2.5 8.9 3.3 4.8 4.5 2.6 6.8 4.8 2.6 3.3 34.3 8.1 6.1 17.8 12.8 4.2 5.6 8.9 3.0 4.1 15.0 1.5 3.4 2.5 4.6 3.5 7.7 3.3 5.9 5.0 55.5 5.3 5.2 7.5 5.9 3.3 5.6 4.4 4.0 1.8 2.7 6.8 1.8 3.3 2.6 29.4 21.6 249.5 34.3 15.0 18.3 28.7 20.6 48.2 18.6 62.5 29.5 12.2 23.6 19.5 4.6 4.5 5.3 29.6 33.5 28.1 21.3 10.0 3.2 55.0 1.4 7.0 5.6 16.5 34.6 25.7 188.9 129.8 9.6 6.0 31.0 27.3 15.1 5.0 12.2 32.8 4.8 18.4 20.8 17.2 13.4 16.7 9.3 41.3 5.3 16.1 10.8 15.3 11.8 14.6 25.7 29.5 9.9 17.6 9.4 17.9 28.7 18.7 16.8 43.0 9.3 24.9 21.0 29.6 12.0 16.0 5.1 13.3 14.2 38.0 5.4 74.4 34.3 62.1 10.9 16.7 13.5 28.7 13.9 11.8 12.1 29.4 18.3 15.9 249.5 15.0 16.1 21.6 12.1 28.7 7.9 10.0 4.0 6.8 8.1 6.1 8.9 3.0 4.6 4.0 122.1 126.9 16.9 1081.8 75.0 0.0 14115.0 2.5 184.7 263.9 73.3 0.0 0.7 94.5 0.5 4.6 52.2 1.1 0.0 0.6 0.6 57.9 106.8 153.5 10.2 0.7 0.0 1.7 4.9 6.9 6.9 14.4 92.3 59.1 0.0 1.3 0.0 0.2 1.4 3.9 12.2 0.0 0.0 31.1 6.6 18.6 149.7 0.8 7.5 1.2 234.3 MTRNR2L10 ENSG00000256045 "MT-RNR2-like 10" P0CJ77 X 55181391-55182920 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.2" "Cell type enriched" "Detected in many" 21 "Cardiomyocytes: 8067.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2" "Lineage enriched" "Detected in all" 9 "granulocytes: 60.2" "Group enriched" "Detected in many" 4 "A549: 22.8;HeLa: 83.8;Hep G2: 71.6" "Secreted to blood" NA NA "unprognostic (4.42e-1)" "unprognostic (3.04e-2)" "unprognostic (1.15e-1)" "unprognostic (5.10e-4)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-2)" "unprognostic (8.42e-2)" "unprognostic (1.58e-2)" "unprognostic (9.01e-2)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (6.28e-2)" "unprognostic (2.97e-2)" "unprognostic (4.99e-2)" "unprognostic (3.97e-4)" 4.2 3.8 3.2 0.6 4.6 0.0 1.0 1.3 4.4 1.2 4.5 1.2 0.6 0.6 1.0 4.7 2.2 1.5 1.5 19.8 4.1 2.2 14.3 8.5 2.0 5.1 2.6 0.6 1.2 2.4 0.0 2.5 1.0 2.7 1.1 8.4 0.6 3.0 0.6 16.9 1.1 1.0 2.6 2.1 1.0 1.1 3.7 1.0 0.6 1.0 1.6 1.7 1.0 1.0 6.1 3.9 60.2 6.9 3.5 3.4 7.4 1.3 22.8 0.3 6.5 0.5 0.3 1.6 2.0 0.1 0.1 0.0 1.4 3.3 3.1 0.4 0.1 0.2 4.8 0.0 0.1 0.0 0.9 4.7 1.5 83.8 71.6 0.1 0.5 0.8 0.8 0.3 0.0 0.2 5.6 0.0 2.4 2.7 1.8 0.2 8.4 0.4 3.6 0.1 0.1 1.8 1.2 1.3 1.4 0.5 13.9 0.3 1.3 0.6 0.5 2.2 3.2 1.9 2.7 3.3 2.4 0.5 0.8 0.2 0.6 0.3 0.2 1.5 0.6 0.5 16.9 6.9 19.1 1.5 3.8 1.8 5.8 2.4 2.0 3.2 6.1 3.1 3.4 60.2 3.5 3.5 3.9 2.4 7.4 3.2 4.6 1.3 4.4 4.1 2.2 2.6 0.6 2.7 1.0 0.0 0.0 8.0 376.7 7.2 0.0 8067.8 0.0 0.0 0.0 40.1 0.0 0.2 71.3 0.0 0.2 2.2 0.0 0.0 0.0 0.2 13.1 232.2 0.0 4.9 0.5 0.0 0.0 1.8 3.2 0.4 0.6 10.6 15.1 0.0 0.0 0.0 0.0 0.0 1.1 4.3 0.0 0.0 22.6 0.5 0.7 8.0 0.2 0.0 0.0 338.2 MTRNR2L11 ENSG00000270188 "MT-RNR2-like 11" S4R3Y5 1 237943724-237945275 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 64.8;skeletal muscle: 46.5" "Cell type enriched" "Detected in many" 26 "Cardiomyocytes: 1023.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 64.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 64.8" "Cell line enhanced" "Detected in many" "HeLa: 66.8;Hep G2: 42.8" "Secreted to blood" NA NA "unprognostic (1.07e-1)" "unprognostic (9.70e-2)" "unprognostic (4.49e-2)" "unprognostic (5.26e-2)" 9.9 11.8 3.7 0.9 3.8 1.4 5.5 2.1 8.5 2.0 7.0 1.4 3.7 2.9 2.0 3.1 2.0 2.0 0.2 12.4 4.2 2.3 11.1 7.2 3.0 2.8 2.2 2.6 2.0 3.3 0.0 2.0 1.3 4.6 2.1 3.1 0.9 4.4 6.5 46.5 2.0 3.5 0.7 3.3 2.0 4.3 4.0 3.0 0.8 2.0 7.4 0.3 2.0 2.0 5.9 3.4 64.8 7.0 2.9 3.1 8.2 7.1 16.9 7.9 22.1 6.8 1.7 6.3 12.0 0.9 0.7 0.9 7.1 10.4 12.3 7.7 2.3 1.3 21.8 0.2 1.6 0.6 5.3 11.8 12.3 66.8 42.8 2.2 3.4 9.9 6.8 2.3 0.8 3.0 15.5 1.0 8.0 8.6 7.4 2.0 6.1 3.4 11.7 2.1 8.9 3.1 6.5 6.4 5.0 4.6 9.9 3.0 5.3 4.7 5.5 8.7 8.1 6.7 10.8 19.3 8.9 6.3 7.2 3.4 5.6 1.8 5.0 4.9 12.1 2.1 14.8 7.0 16.1 1.4 3.2 1.7 5.5 2.2 1.9 2.7 5.9 3.1 3.1 64.8 2.9 3.1 3.4 2.0 8.2 3.7 3.8 2.1 5.1 4.2 2.3 2.2 2.6 4.6 3.0 0.0 0.0 0.0 22.2 3.5 0.0 1023.1 0.0 0.0 0.0 12.2 0.0 0.1 39.7 0.0 0.0 2.2 0.0 0.0 0.0 0.1 2.4 23.0 0.0 1.3 0.1 0.0 0.0 1.3 0.3 0.0 0.0 2.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.1 0.3 0.2 3.4 0.0 0.0 0.0 20.9 MTRNR2L12 ENSG00000269028 "MT-RNR2-like 12" P0DMP1 3 96617188-96618236 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "blood: 603.3" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 31937.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 603.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 603.3" "Cell line enhanced" "Detected in all" "HeLa: 496.6" "Secreted to blood" NA NA "unprognostic (3.79e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (9.76e-3)" "unprognostic (1.69e-3)" "unprognostic (1.81e-2)" "unprognostic (7.77e-2)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.90e-2)" "unprognostic (9.59e-3)" "unprognostic (1.81e-2)" "unprognostic (2.61e-1)" "unprognostic (2.08e-1)" "unprognostic (1.85e-2)" 18.0 29.1 32.5 5.2 31.0 4.5 7.5 8.8 19.2 5.1 20.2 6.4 5.7 8.1 5.1 75.3 10.9 3.8 40.2 114.2 26.3 19.8 32.9 29.8 5.4 7.8 26.2 7.5 4.9 9.7 4.3 6.6 5.0 10.4 6.9 16.5 6.8 10.8 9.3 101.3 10.6 9.3 6.9 15.3 5.3 13.3 9.7 8.7 72.1 5.1 11.0 5.3 6.0 8.5 69.1 53.1 603.3 81.8 37.9 45.5 57.6 99.3 122.4 91.7 329.0 142.5 76.9 84.3 129.6 26.5 25.0 32.3 67.2 160.7 219.2 105.6 48.9 14.5 274.9 6.4 54.7 34.2 64.2 118.4 232.2 496.6 283.0 54.2 46.0 128.5 139.1 65.6 26.3 72.2 153.1 27.8 99.1 164.5 75.6 84.7 52.0 39.7 145.5 26.7 60.3 36.9 63.6 88.2 67.6 149.9 74.0 41.8 81.5 84.4 85.9 111.3 85.1 88.3 134.4 122.9 103.5 86.0 115.6 36.6 40.2 25.1 108.9 64.2 290.2 27.9 183.7 81.8 153.2 28.1 44.0 37.0 65.7 35.7 29.9 31.2 69.1 45.5 40.8 603.3 37.9 42.3 53.1 31.4 57.6 32.5 31.0 8.8 19.0 26.3 19.8 26.2 7.5 10.4 8.7 2513.2 2660.0 61.6 386.4 99.9 0.0 31937.7 112.1 2625.9 2640.0 80.3 0.0 6.1 53.0 0.7 11.2 82.6 5.6 163.5 1.6 7.5 167.2 335.7 1581.1 147.2 10.6 0.0 4.7 79.2 93.4 36.3 39.7 230.1 183.9 1.0 7.8 0.0 1.3 7.0 21.5 70.0 0.0 45.3 270.2 25.4 36.6 70.6 8.8 96.9 2.4 333.1 MTRNR2L13 ENSG00000270394 "MT-RNR2-like 13" S4R3P1 4 116298876-116300320 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "skeletal muscle: 11.5" "Cell type enriched" "Detected in some" 39 "Cardiomyocytes: 161.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 4.9" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.9" "Group enriched" "Detected in some" 5 "HeLa: 8.3;Hep G2: 4.4" "Secreted - unknown location" NA NA "unprognostic (6.40e-2)" "unprognostic (2.88e-1)" "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" 1.7 2.5 0.6 0.2 1.1 0.4 0.6 0.6 1.8 0.6 1.2 0.0 2.9 0.5 0.6 1.0 0.6 0.6 0.4 3.3 0.6 0.6 2.3 1.4 0.9 1.7 0.6 0.5 0.6 0.6 0.0 0.6 0.4 2.7 0.6 1.1 0.2 1.2 0.4 11.5 0.6 1.0 1.1 2.6 0.6 0.6 2.0 1.2 0.0 0.6 1.4 0.2 1.0 0.6 0.4 0.2 4.9 0.4 0.3 0.2 0.3 0.3 1.1 0.1 1.1 0.1 0.1 0.4 0.9 0.0 0.0 0.0 0.1 0.5 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.1 8.3 4.4 0.1 0.1 0.4 0.4 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.4 0.0 0.2 0.1 0.2 0.1 0.4 0.3 1.2 0.1 0.4 0.2 0.1 0.5 0.2 0.2 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.0 0.4 1.0 0.1 0.3 0.1 0.3 0.2 0.1 0.2 0.4 0.2 0.2 4.9 0.3 0.2 0.2 0.0 0.3 0.6 1.1 0.6 1.8 0.6 0.6 0.6 0.5 2.7 1.2 0.0 0.0 0.0 4.2 0.1 0.0 161.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.5 MTRNR2L3 ENSG00000256222 "MT-RNR2-like 3" P0CJ70 20 57358442-57359980 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 13.3" "Cell type enriched" "Detected in many" 94 "Cardiomyocytes: 2712.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 5.0;Hep G2: 1.6" "Secreted - unknown location" NA NA "unprognostic (1.55e-4)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (8.34e-2)" "unprognostic (2.64e-1)" "unprognostic (1.80e-2)" "unprognostic (9.44e-6)" "unprognostic (2.56e-1)" "unprognostic (6.68e-2)" "unprognostic (5.35e-3)" "unprognostic (1.52e-3)" "unprognostic (7.52e-2)" "unprognostic (5.36e-2)" "unprognostic (4.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (2.94e-3)" 0.8 1.0 2.9 0.3 2.4 2.4 0.5 1.0 3.6 0.7 0.9 0.0 2.5 0.6 0.5 1.4 0.7 0.5 1.0 1.3 2.5 0.7 1.2 1.1 0.4 0.5 2.1 2.7 0.8 1.2 0.2 0.5 0.3 2.4 0.5 0.9 0.0 2.4 1.1 13.3 1.1 0.5 0.5 1.7 0.4 0.9 1.2 2.7 0.0 0.6 0.0 0.3 0.3 0.6 1.0 0.8 3.7 0.7 0.1 1.3 0.4 0.3 0.0 0.2 0.9 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 5.0 1.6 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.6 0.1 0.2 0.1 0.5 0.3 0.6 0.2 0.0 0.2 0.4 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.2 0.6 0.2 0.3 0.5 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.7 0.7 1.1 0.8 0.2 0.6 0.4 0.5 0.5 0.8 1.0 1.3 0.5 3.7 0.1 0.6 0.2 0.7 0.4 2.9 2.4 1.0 3.6 2.5 0.7 2.1 2.7 2.4 2.7 0.0 0.0 0.9 28.7 2.9 0.0 2712.0 2.5 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 1.3 0.0 0.0 0.0 0.3 5.1 15.0 0.0 2.4 0.6 0.0 0.0 1.8 1.6 0.4 1.4 0.4 6.8 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 8.5 0.2 0.8 2.8 0.5 0.0 0.0 16.2 MTRNR2L4 ENSG00000232196 "MT-RNR2-like 4" P0CJ71 16 3370979-3372740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 49.5;skeletal muscle: 52.2" "Cell type enriched" "Detected in some" 24 "Cardiomyocytes: 125.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 49.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 49.5" "Cell line enhanced" "Detected in many" "AN3-CA: 22.3;HaCaT: 23.3;HeLa: 31.2" "Secreted to blood" NA NA "unprognostic (8.53e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-1)" "unprognostic (1.05e-1)" "unprognostic (3.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (6.81e-3)" "unprognostic (1.65e-1)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (9.27e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" 2.5 10.3 3.5 1.3 4.4 0.9 1.2 2.7 6.6 1.5 2.2 0.5 0.3 3.4 1.6 0.9 1.5 2.0 1.7 11.7 2.3 1.2 5.8 2.5 1.0 0.3 6.3 4.8 5.8 9.7 0.0 3.1 1.0 2.5 1.7 1.1 1.2 2.7 3.3 52.2 1.2 3.6 2.1 1.5 1.1 3.1 2.3 3.1 0.3 2.6 1.1 0.8 1.5 1.3 5.4 3.8 49.5 6.4 2.5 2.5 5.0 6.0 4.0 1.2 22.3 0.5 0.7 6.9 3.3 0.1 0.4 0.3 1.8 13.1 4.5 6.7 0.2 0.1 23.3 0.0 0.2 0.2 3.4 2.2 4.0 31.2 16.2 0.1 1.3 10.9 0.4 0.3 0.1 0.2 0.5 0.0 0.5 3.0 6.3 0.7 1.3 2.8 10.5 1.8 0.2 0.8 5.2 3.2 4.1 0.9 4.6 2.7 6.0 2.1 5.3 8.0 0.4 7.4 10.1 2.9 7.2 6.4 8.3 2.3 3.3 1.1 4.2 4.9 10.3 1.6 12.1 6.4 19.1 1.4 3.7 1.7 4.2 1.9 1.9 3.1 5.4 2.1 2.5 49.5 2.5 3.6 3.8 2.1 5.0 3.5 4.4 2.7 5.5 2.3 1.2 6.3 4.8 2.5 3.1 0.0 0.0 0.0 2.4 0.1 0.0 125.1 5.1 0.0 0.0 1.8 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 1.7 0.5 0.2 0.3 0.1 0.0 0.0 1.4 MTRNR2L5 ENSG00000249860 "MT-RNR2-like 5" P0CJ72 10 55599303-55600041 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6" "Cell type enriched" "Detected in single" 42 "Cardiomyocytes: 23.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "HeLa: 1.7;Hep G2: 2.5;HL-60: 1.0" "Secreted - unknown location" NA NA "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" 0.4 1.8 1.5 1.2 2.5 0.2 0.4 0.4 2.3 0.4 0.6 0.4 0.0 0.5 0.4 1.3 0.4 0.4 0.6 0.5 1.0 0.5 0.9 0.4 0.4 0.3 1.4 0.6 0.4 0.7 0.1 0.8 0.1 0.6 0.4 0.3 0.0 4.7 7.0 16.4 0.4 0.8 0.5 0.4 0.4 0.5 0.5 0.9 0.0 0.4 6.6 0.3 1.0 0.4 0.2 0.1 1.8 0.4 0.1 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.5 0.0 1.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 1.0 0.4 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 1.8 0.1 0.1 0.1 0.0 0.1 1.5 2.5 0.4 2.3 1.0 0.5 1.4 0.6 0.6 0.9 0.0 0.0 0.0 0.1 0.6 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MTRNR2L6 ENSG00000270672 "MT-RNR2-like 6" P0CJ73 7 142666272-142667718 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.7;skeletal muscle: 39.1" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 849.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 81.7" "Lineage enriched" "Detected in all" 10 "granulocytes: 81.7" "Cell line enhanced" "Detected in many" "HeLa: 50.0;Hep G2: 44.1" "Secreted to blood" NA NA "unprognostic (5.34e-2)" "unprognostic (1.34e-3)" "unprognostic (3.80e-1)" "unprognostic (4.45e-3)" "unprognostic (1.33e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-2)" "unprognostic (3.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-2)" "unprognostic (6.02e-2)" "unprognostic (1.04e-1)" "unprognostic (3.69e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-3)" 3.4 8.2 1.4 0.8 2.3 0.1 1.1 1.2 5.5 1.1 3.9 1.5 0.8 1.1 1.1 0.8 1.7 1.1 0.8 17.9 6.1 1.4 7.3 4.7 1.1 5.9 2.2 3.9 1.1 2.2 0.0 1.1 0.8 4.5 1.1 2.3 0.8 2.5 0.8 39.1 1.5 2.6 0.8 3.5 1.1 2.2 1.7 1.8 0.8 1.5 0.8 0.8 1.8 1.1 8.4 4.2 81.7 8.2 4.7 3.9 9.5 5.6 9.6 3.3 22.6 3.8 2.0 5.5 6.0 0.5 0.6 1.0 3.1 10.3 4.9 8.2 1.1 0.5 19.9 0.1 1.1 0.5 3.1 3.7 6.8 50.0 44.1 1.2 1.4 7.3 3.4 1.4 0.5 1.6 12.7 0.5 6.1 5.8 7.3 1.8 3.1 2.8 15.2 1.2 3.1 1.1 4.5 2.8 3.7 3.9 8.3 2.2 8.2 1.6 3.8 11.5 4.9 5.3 9.6 6.9 6.5 6.6 7.8 2.0 2.9 1.3 3.1 3.9 8.7 1.6 20.0 8.2 21.6 2.4 4.9 2.4 8.4 2.9 2.9 4.1 7.7 3.2 3.9 81.7 4.7 4.4 4.2 3.1 9.5 1.4 2.3 1.2 2.9 6.1 1.4 2.2 3.9 4.5 1.8 35.7 50.8 1.4 7.4 5.7 0.0 849.8 0.0 75.0 127.4 31.4 0.0 0.5 38.1 0.0 0.3 1.5 0.0 23.3 0.0 0.6 7.1 3.3 51.1 1.9 0.5 0.0 0.0 0.6 0.6 0.6 2.3 14.5 3.3 0.0 0.0 0.0 0.0 0.0 0.4 4.9 0.0 0.0 4.7 0.3 2.0 3.9 0.2 1.0 0.0 3.7 MTRNR2L7 ENSG00000256892 "MT-RNR2-like 7" P0CJ74 10 37601440-37602974 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9" "Cell type enriched" "Detected in single" 277 "Cardiomyocytes: 171.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "HeLa: 3.2;Hep G2: 1.6" "Secreted - unknown location" NA NA "unprognostic (2.28e-1)" "unprognostic (5.87e-2)" 0.3 0.6 0.1 0.0 0.1 0.2 0.1 0.1 0.4 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.0 1.6 0.1 0.1 0.9 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.1 0.5 0.1 0.0 1.9 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.3 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.3 0.0 0.3 0.2 0.0 0.1 0.0 0.7 0.0 0.6 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 3.2 1.6 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.0 0.5 0.0 0.1 0.3 0.5 0.4 0.3 0.0 0.2 0.8 0.1 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.1 0.8 0.0 1.2 0.2 0.6 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.3 0.2 0.2 2.1 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.6 0.1 0.0 171.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 MTRNR2L8 ENSG00000255823 "MT-RNR2-like 8" P0CJ75 11 10507887-10509189 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 329.5;skeletal muscle: 107.4" "Cell type enriched" "Detected in many" 28 "Cardiomyocytes: 28256.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 329.5" "Cell line enhanced" "Detected in many" "HeLa: 192.6;Hep G2: 140.8" "Secreted to blood" NA NA "unprognostic (6.19e-2)" "unprognostic (1.43e-1)" "unprognostic (6.66e-2)" "unprognostic (3.26e-2)" "unprognostic (3.71e-2)" "unprognostic (3.52e-2)" "unprognostic (2.81e-2)" "unprognostic (3.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (4.59e-2)" "unprognostic (4.59e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-2)" 35.7 33.4 22.5 4.2 22.8 6.6 4.3 7.3 17.5 6.5 15.6 3.6 19.3 10.2 3.8 6.1 12.7 4.6 14.1 73.2 20.1 14.7 30.7 21.7 6.3 4.0 22.0 7.3 7.0 10.9 1.9 6.9 7.0 9.0 7.7 15.5 3.3 12.3 14.8 107.4 12.0 12.9 8.8 16.1 9.7 10.2 28.4 6.5 2.2 4.4 32.3 4.3 10.0 5.8 35.3 24.5 329.5 42.7 16.6 19.0 36.2 30.8 55.6 21.8 97.9 21.9 12.0 30.1 29.2 4.3 4.1 5.2 33.8 47.5 43.4 34.3 6.3 3.2 87.4 0.6 6.6 4.4 18.4 48.1 40.4 192.6 140.8 8.5 7.4 39.0 21.3 10.4 3.3 10.0 43.4 4.0 24.4 34.1 22.6 12.6 19.7 11.3 55.8 7.2 14.6 15.5 19.5 18.7 20.8 24.9 31.3 12.3 28.0 14.6 21.4 44.5 21.4 25.1 56.1 26.1 28.8 25.6 30.4 11.4 12.7 6.0 23.0 18.9 66.2 6.9 89.7 42.7 97.5 11.6 21.0 14.3 33.7 14.8 13.0 16.3 35.3 19.0 17.5 329.5 16.6 20.1 24.5 14.9 36.2 22.5 22.8 7.3 16.7 20.1 14.7 22.0 7.3 9.0 6.5 771.2 760.8 62.0 993.3 419.0 0.0 28256.5 137.6 867.3 881.5 54.1 0.0 5.8 61.3 0.0 12.2 397.4 0.0 140.2 0.0 5.0 628.6 627.3 501.1 277.9 11.0 0.0 0.0 103.2 108.7 41.9 60.7 803.5 686.7 0.0 0.3 0.0 0.1 0.0 42.1 73.2 0.0 64.7 701.4 22.4 27.9 427.3 9.4 68.2 0.6 948.0 MTSS1L "ABBA, ABBA-1, LOC92154" ENSG00000132613 "MTSS1L, I-BAR domain containing" Q765P7 16 70661204-70686066 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 105.5" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 36.3;Hepatocytes: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 2.4;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 7 "dendritic cells: 2.3;T-cells: 2.4" "Cell line enhanced" "Detected in many" "Hep G2: 62.0;HHSteC: 61.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048531, HPA066469" Approved Supported "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA048531: AB_2680430, HPA066469: AB_2685671" "prognostic unfavorable (2.85e-4)" "unprognostic (8.85e-2)" "unprognostic (7.01e-2)" "unprognostic (5.99e-2)" "unprognostic (3.21e-1)" "unprognostic (2.98e-1)" "unprognostic (1.86e-1)" "unprognostic (1.82e-1)" "unprognostic (5.30e-2)" "unprognostic (1.31e-1)" "unprognostic (5.59e-3)" "unprognostic (3.88e-1)" "unprognostic (2.92e-3)" "unprognostic (9.87e-2)" "unprognostic (9.92e-2)" "unprognostic (6.74e-2)" "unprognostic (2.25e-2)" 17.2 13.4 61.9 11.1 47.6 4.9 6.4 68.3 105.5 22.5 15.5 59.5 4.1 8.1 29.5 4.1 27.4 17.5 15.8 16.8 70.3 45.6 6.8 21.7 12.9 5.5 50.2 38.7 14.5 7.9 7.7 5.2 19.0 40.7 15.5 5.2 11.8 16.1 21.6 37.2 15.8 7.8 31.6 53.5 19.2 6.7 6.2 53.3 8.2 4.5 5.2 4.8 20.8 10.0 0.3 2.3 0.2 0.1 0.0 2.4 0.4 13.8 33.4 8.4 8.6 7.0 7.0 31.7 20.9 26.2 18.0 15.0 13.4 8.9 0.1 7.5 32.7 7.1 29.0 9.0 9.1 6.9 0.2 12.1 4.8 28.4 62.0 61.7 7.1 0.2 28.6 20.0 8.3 29.0 7.8 5.9 7.4 18.1 0.3 15.9 34.4 6.8 36.7 7.3 4.7 7.1 14.6 15.6 0.0 15.7 20.8 19.8 13.2 44.7 19.5 5.8 8.3 15.0 14.0 8.8 14.1 16.0 12.7 13.0 5.0 1.2 0.2 12.8 0.2 4.8 0.0 0.1 0.2 0.1 0.0 2.4 0.2 0.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.4 61.9 47.6 68.3 52.3 70.3 45.6 50.2 38.7 40.7 53.3 0.0 1.3 0.0 3.4 5.4 0.0 6.7 0.0 2.7 1.2 1.8 0.0 2.5 3.3 4.3 3.5 2.1 0.0 0.0 0.5 36.3 4.0 4.6 1.1 24.1 7.1 0.0 2.9 13.5 1.6 5.2 4.0 0.0 5.0 0.0 4.5 0.0 0.9 0.0 3.2 1.7 0.0 0.0 5.9 0.5 1.1 5.6 5.1 0.0 1.2 3.9 MTTP "ABL, MTP" ENSG00000138823 "Microsomal triglyceride transfer protein" P55157 4 99563761-99623999 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 49 "intestine: 211.4;liver: 60.8" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 201.1" "Cancer enriched" "Detected in many" 13 "liver cancer: 28.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 6 "AF22: 12.8;Hep G2: 14.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA051170, HPA054862" Uncertain Uncertain Cytosol "Intracellular and membrane" NA NA 450000 Cytosol "HPA051170: , HPA054862: AB_2682628" "unprognostic (1.66e-2)" "unprognostic (1.14e-1)" "unprognostic (5.64e-2)" "unprognostic (5.33e-2)" "unprognostic (3.49e-3)" "unprognostic (7.38e-2)" "unprognostic (1.05e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (3.66e-2)" "unprognostic (1.00e-2)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (2.02e-2)" "unprognostic (3.64e-1)" "unprognostic (1.53e-2)" "unprognostic (1.31e-1)" 0.1 0.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.0 53.2 0.2 0.1 53.4 0.0 0.0 0.2 0.2 0.4 0.4 0.3 0.4 2.7 60.8 0.1 0.0 0.4 0.1 1.1 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.1 211.4 0.7 0.4 0.1 0.2 1.8 0.2 0.1 0.1 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.8 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.3 0.5 0.0 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.2 0.3 0.1 14.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.7 0.6 0.0 0.3 0.3 0.2 1.3 0.0 0.0 0.8 1.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.3 0.4 0.4 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.6 0.0 0.0 1.8 0.0 0.1 0.0 0.0 25.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 201.1 0.1 0.0 0.0 5.5 3.3 7.9 0.9 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.4 18.6 0.0 6.5 0.0 21.9 1.5 0.0 0.0 0.0 0.0 0.0 MTURN "C7orf41, Ells1, FLJ25903" ENSG00000180354 "Maturin, neural progenitor differentiation regulator homolog" Q8N3F0 7 30134810-30162762 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 189.2" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 9.9" "Group enriched" "Detected in many" 4 "granulocytes: 9.9;NK-cells: 3.0" "Cell line enhanced" "Detected in many" "ASC diff: 23.1;HEL: 40.2;SCLC-21H: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029507 Enhanced Approved Cytosol NA NA Cytosol "HPA029507: AB_10601149" "unprognostic (1.99e-1)" "unprognostic (1.38e-2)" "unprognostic (3.70e-1)" "unprognostic (7.14e-2)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-1)" "unprognostic (1.89e-3)" "unprognostic (9.80e-2)" "unprognostic (1.94e-1)" "unprognostic (1.11e-3)" "unprognostic (8.11e-3)" "prognostic favorable (7.64e-13)" "unprognostic (9.50e-2)" "unprognostic (7.64e-2)" "unprognostic (4.64e-1)" "unprognostic (3.26e-1)" 35.9 5.7 113.5 4.8 86.7 9.3 14.2 21.7 100.8 12.9 5.2 97.0 3.3 3.0 7.9 45.6 9.6 8.2 5.3 11.2 122.8 79.5 24.7 2.3 10.1 2.8 162.4 26.2 16.5 6.2 9.7 2.7 4.0 54.2 9.2 5.3 2.9 14.9 12.0 14.3 7.8 3.4 8.5 189.2 4.1 10.0 4.5 49.4 0.0 6.7 2.4 3.0 6.0 6.5 0.7 1.4 9.9 0.4 3.0 0.8 2.4 5.1 0.9 3.0 3.2 23.1 15.8 2.7 2.5 2.9 0.8 1.2 0.4 2.1 0.3 2.1 5.5 4.8 1.0 6.8 9.8 2.8 2.2 5.5 40.2 6.4 2.8 1.8 2.0 13.3 7.8 4.6 2.6 4.7 3.7 1.3 5.5 2.5 2.1 5.8 1.9 2.3 0.9 2.1 4.8 3.2 0.2 7.1 8.6 10.3 2.1 29.7 7.9 1.6 8.1 8.1 3.0 5.7 3.0 6.5 3.4 3.7 7.1 3.5 3.6 5.1 0.4 4.5 4.3 1.7 9.9 0.4 4.8 0.5 0.2 0.1 0.7 0.3 0.2 0.6 0.5 0.2 0.5 3.1 3.0 0.0 1.4 0.8 2.4 113.5 86.7 21.7 51.7 122.8 79.5 162.4 26.2 54.2 49.4 14.9 18.3 2.9 13.7 33.3 0.0 22.0 17.8 22.7 9.1 41.8 0.0 1.8 132.6 7.5 10.1 17.9 0.4 0.0 7.6 5.5 12.8 24.6 5.8 4.4 4.8 0.0 52.0 18.4 18.2 26.7 15.8 6.5 52.3 10.8 9.2 0.0 8.6 5.7 11.7 9.1 0.0 6.5 31.2 1.4 3.4 32.1 1.8 6.9 3.0 16.5 MTUS2 "CAZIP, ICIS, KIAA0774, TIP150" ENSG00000132938 "Microtubule associated scaffold protein 2" Q5JR59 13 28820348-29505947 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 46.8;pituitary gland: 19.3" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 122.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.9;intermediate monocyte: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7" "Group enriched" "Detected in some" 4 "HaCaT: 16.7;HeLa: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031473, HPA031474, HPA031475" Enhanced Supported "Microtubules,Cytokinetic bridge" Yes NA "Microtubules, Cytokinetic bridge" "HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442" "unprognostic (1.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.96e-1)" "unprognostic (3.33e-3)" "unprognostic (1.00e-1)" "unprognostic (1.22e-2)" "unprognostic (2.79e-1)" "unprognostic (1.35e-1)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (1.30e-3)" "unprognostic (3.45e-2)" "unprognostic (3.91e-5)" "unprognostic (2.51e-2)" "unprognostic (5.46e-2)" "unprognostic (5.93e-2)" "unprognostic (9.62e-2)" 0.6 0.8 2.3 0.7 6.1 0.7 0.6 12.2 8.8 1.1 0.8 0.1 0.0 0.7 2.1 0.6 0.8 1.4 0.7 46.8 3.4 1.9 0.6 1.1 0.7 1.0 1.2 4.6 8.2 4.7 0.5 19.3 0.5 2.3 0.8 0.8 2.0 1.0 0.7 0.6 0.7 0.9 1.7 0.7 1.0 1.5 1.6 0.9 0.0 1.1 0.0 0.6 2.6 0.7 0.0 1.3 1.9 1.7 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 16.7 0.5 0.0 0.0 0.1 0.7 0.0 7.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.2 0.0 2.9 2.1 0.1 0.6 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.3 0.1 0.4 0.0 0.0 0.0 0.2 1.9 0.0 1.7 0.1 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 2.3 6.1 12.2 8.8 3.4 1.9 1.2 4.6 2.3 0.9 0.0 0.3 0.0 0.5 0.5 0.0 122.0 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.5 0.0 1.0 0.2 0.0 0.6 0.1 0.0 0.0 0.6 0.0 2.5 0.9 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.1 0.2 0.0 0.0 0.9 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "Group enriched" "Detected in many" 6 "CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" NA NA 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.4 0.7 1.9 0.0 139.4 0.0 10.1 1.1 0.3 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 1.5 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 65.3 0.2 0.2 0.0 3.4 107.0 0.1 0.6 0.2 3.3 5.9 0.1 0.5 47.0 0.6 0.2 0.4 0.8 1.3 0.1 2.1 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 402.0 1308.2 0.9 16.1 0.6 1.0 0.4 384.7 92.3 252.5 465.9 3.9 0.1 29.9 144.7 27.3 3.5 49.2 0.0 994.6 1.2 3.1 11.6 45.2 0.5 0.2 1.6 29.4 1.3 3.4 68.9 2.3 2.6 5.0 42.3 249.7 1.1 807.2 66.2 1.4 0.9 0.2 0.0 1.9 6.2 0.8 1.0 0.2 0.0 132.5 164.3 MUC12 MUC11 ENSG00000205277 "Mucin 12, cell surface associated" Q9UKN1 7 100969623-101018949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 35.6" "Group enriched" "Detected in many" 5 "Enterocytes: 444.8;Mucus-secreting cells: 128.0;Paneth cells: 173.4;Undifferentiated cells: 234.4" "Cancer enriched" "Detected in some" 7 "colorectal cancer: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.8" HPA023835 Enhanced NA NA "HPA023835: AB_1854199" "unprognostic (1.38e-1)" "unprognostic (2.09e-1)" "unprognostic (2.80e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-4)" "unprognostic (4.40e-2)" "unprognostic (1.30e-3)" "unprognostic (1.84e-2)" "unprognostic (1.40e-1)" "unprognostic (6.52e-2)" "unprognostic (3.72e-1)" "unprognostic (1.92e-1)" "unprognostic (3.33e-7)" "unprognostic (8.42e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-1)" "unprognostic (7.54e-2)" 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 35.6 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 10.9 3.4 0.0 2.0 0.0 6.7 2.3 1.8 0.0 0.2 0.0 4.6 2.9 1.3 444.8 0.0 2.3 1.2 14.1 7.1 9.2 0.0 2.0 0.0 45.6 1.3 0.6 4.0 0.9 4.8 3.3 0.0 128.0 0.0 7.9 173.4 3.2 0.0 0.0 0.0 5.9 2.4 1.3 2.6 0.5 1.0 234.4 4.3 MUC13 DRCC1 ENSG00000173702 "Mucin 13, cell surface associated" Q9H3R2 3 124905442-124953819 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 334.4" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 474.6;Intestinal endocrine cells: 147.6;Mucus-secreting cells: 321.7;Paneth cells: 299.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 198.4;stomach cancer: 152.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "OE19: 70.4" HPA045163 Enhanced "Secreted to digestive system" NA NA "HPA045163: AB_10960396" "unprognostic (8.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.55e-3)" "unprognostic (2.93e-1)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.48e-2)" "unprognostic (2.94e-1)" "unprognostic (5.10e-2)" "unprognostic (2.02e-1)" "unprognostic (9.64e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (2.05e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.42e-1)" 0.5 0.6 0.5 16.4 0.5 0.0 0.5 0.5 0.5 0.5 83.1 0.0 0.0 79.9 0.5 0.3 0.5 0.5 16.7 0.5 0.5 0.5 3.3 8.7 0.5 0.0 0.5 0.0 0.5 1.8 0.0 0.5 0.1 0.1 0.5 40.6 0.1 0.5 0.0 0.5 0.5 334.4 1.0 0.5 0.5 4.1 0.5 0.0 0.1 0.5 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.0 4.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.0 70.4 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.1 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.6 0.1 474.6 0.0 28.4 0.0 0.0 2.1 9.2 0.0 0.0 0.0 147.6 0.0 0.3 2.7 0.0 0.0 0.0 0.0 321.7 0.0 14.3 299.5 0.7 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 111.9 0.1 MUC15 ENSG00000169550 "Mucin 15, cell surface associated" Q8N387 11 26559033-26572233 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8" "Cell type enhanced" "Detected in many" 25 "Alveolar cells type 1: 101.3;Ciliated cells: 164.6;Syncytiotrophoblasts: 556.9" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 56.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.8;K-562: 9.7;SK-BR-3: 16.6;SuSa: 11.3;U-266/70: 6.5;U-266/84: 17.4" "Group enriched" "Detected in some" 4 "cerebellum: 1.3;thalamus: 1.5" "Low region specificity" "Detected in many" "HPA026110, HPA073304" Enhanced "Intracellular and membrane" NA NA "HPA026110: AB_1854200, HPA073304: " "unprognostic (1.49e-1)" "unprognostic (2.08e-3)" "unprognostic (7.71e-5)" "unprognostic (5.09e-3)" "unprognostic (2.77e-2)" "unprognostic (3.04e-2)" "unprognostic (6.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.98e-1)" "unprognostic (7.27e-3)" "unprognostic (4.96e-3)" "unprognostic (1.09e-1)" "unprognostic (5.70e-2)" "unprognostic (4.54e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.9 0.0 0.0 9.3 0.0 0.1 265.1 11.0 1.0 0.1 0.1 0.0 0.0 5.2 0.1 4.8 0.1 0.0 0.0 0.1 1.8 0.0 2.1 56.8 0.0 0.8 0.0 0.0 14.4 1.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 1.1 77.8 8.1 1.7 3.0 6.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.6 0.0 16.6 0.0 11.3 0.1 0.0 0.0 0.0 2.5 0.0 0.0 6.5 17.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 20.9 0.0 12.3 3.1 0.0 0.0 0.0 164.6 64.8 47.1 0.0 52.1 26.6 3.0 0.4 0.0 0.0 0.0 0.0 15.5 0.5 0.6 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 26.0 556.9 0.0 0.0 10.5 MUC16 "CA125, FLJ14303" ENSG00000181143 "Mucin 16, cell surface associated" Q8WXI7 19 8848844-8981342 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 49.5;Club cells: 10.3;Early spermatids: 11.7;Late spermatids: 12.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.9;CAPAN-2: 5.6;HaCaT: 5.4;HeLa: 27.6;SK-BR-3: 3.5" "CAB055172, HPA065600" Enhanced "Secreted in other tissues" NA NA "CAB055172: AB_2148831, HPA065600: AB_2732736" "unprognostic (8.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.37e-2)" "unprognostic (3.07e-1)" "unprognostic (1.76e-2)" "unprognostic (3.01e-3)" "unprognostic (3.83e-3)" "unprognostic (1.31e-2)" "unprognostic (1.00e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-3)" "unprognostic (1.81e-1)" "unprognostic (2.60e-8)" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (1.43e-1)" "unprognostic (3.68e-3)" 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.3 0.0 0.0 2.4 0.0 0.2 6.7 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.4 2.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 2.2 0.0 49.5 10.3 0.0 0.0 1.4 0.0 0.2 11.7 0.0 0.0 0.0 0.0 0.7 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 2.7 0.0 0.0 0.6 MUC17 ENSG00000169876 "Mucin 17, cell surface associated" Q685J3 7 101020072-101058745 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 299 "intestine: 125.2" "Cell type enriched" "Detected in some" 5 "Enterocytes: 59.0" "Group enriched" "Detected in some" 29 "colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.2;OE19: 1.0" HPA031634 Enhanced "Intracellular and membrane" NA NA "HPA031634: AB_10603021" "unprognostic (2.37e-2)" "unprognostic (2.41e-1)" "unprognostic (8.17e-3)" "unprognostic (5.57e-3)" "unprognostic (6.07e-2)" "unprognostic (8.79e-8)" "unprognostic (1.28e-1)" "unprognostic (2.47e-2)" 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 64.7 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 2.5 0.0 0.1 0.0 0.1 0.1 125.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 3.5 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 MUC19 FLJ35746 ENSG00000205592 "Mucin 19, oligomeric" 12 40393395-40570832 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "salivary gland: 22.6" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-937: 8.9" "Intracellular and membrane" NA NA "unprognostic (7.80e-3)" "unprognostic (2.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.53e-1)" "unprognostic (4.25e-3)" "unprognostic (8.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.45e-2)" "unprognostic (8.63e-2)" "unprognostic (6.99e-2)" "unprognostic (8.64e-3)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-1)" "unprognostic (7.35e-3)" 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC2 ENSG00000198788 "Mucin 2, oligomeric mucus/gel-forming" 11 1074875-1110511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "intestine: 28.1" "Group enriched" "Detected in some" 38 "Cardiomyocytes: 14.8;granulocytes: 9.2;Intestinal endocrine cells: 13.6" "Group enriched" "Detected in many" 13 "colorectal cancer: 93.2;pancreatic cancer: 27.7;stomach cancer: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.0;RPMI-8226: 1.0;RT4: 2.6;U-2197: 1.0" CAB016275 Enhanced "Intracellular and membrane" NA NA "CAB016275: AB_627970" "unprognostic (6.37e-2)" "unprognostic (8.32e-2)" "unprognostic (5.76e-3)" "unprognostic (5.09e-2)" "unprognostic (6.18e-3)" "unprognostic (3.39e-2)" "unprognostic (1.71e-2)" "unprognostic (5.76e-3)" "unprognostic (7.87e-2)" "unprognostic (2.04e-1)" "unprognostic (7.37e-3)" "unprognostic (4.20e-2)" "unprognostic (3.64e-5)" "unprognostic (1.38e-1)" "unprognostic (1.22e-1)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720882-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 50.6" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 60.2;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 25.3" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 11000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 1.7 1.2 1.1 3.4 2.1 1.2 1.8 2.5 1.2 6.3 15.2 1.1 4.7 3.2 1.5 5.2 15.9 5.7 8.7 1.1 1.1 0.7 50.6 4.8 6.4 1.1 1.1 1.1 4.6 7.6 1.0 4.6 13.3 1.1 4.9 7.6 1.2 10.6 1.8 2.5 2.1 4.1 2.0 1.1 1.6 2.3 1.8 1.1 3.0 3.9 1.9 14.9 10.6 26.6 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.2 0.6 0.2 0.0 0.6 0.0 0.1 0.0 0.0 0.0 3.0 0.1 0.5 0.0 0.2 1.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.4 0.0 0.5 3.4 0.1 0.8 0.1 0.8 0.0 1.9 1.0 0.3 0.0 25.3 0.2 0.4 0.1 0.0 0.0 0.2 0.7 0.9 0.1 1.1 1.3 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.1 2.5 1.2 1.1 0.7 1.1 1.1 1.1 1.1 32.8 14.7 0.0 8.8 1.5 20.2 0.5 10.2 60.2 37.5 21.0 33.4 0.0 1.7 32.3 0.0 1.3 15.6 0.0 8.7 0.1 1.5 12.8 1.1 6.4 0.4 11.1 13.3 1.8 0.6 0.0 4.9 0.9 3.3 0.0 7.2 5.6 13.7 18.6 6.0 1.4 22.0 0.0 1.6 1.1 0.7 1.6 0.0 0.5 13.5 102.7 MUC21 "bCX31G15.2, C6orf205" ENSG00000204544 "Mucin 21, cell surface associated" Q5SSG8 6 30983718-30989903 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 251.5;lymphoid tissue: 126.1" "Group enriched" "Detected in some" 17 "Alveolar cells type 2: 4.8;Club cells: 9.1;Urothelial cells: 11.2" "Group enriched" "Detected in many" 9 "cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.0" "Cell line enriched" "Detected in single" 14 "Karpas-707: 4.3" HPA052028 Enhanced NA NA "HPA052028: AB_2681700" "unprognostic (2.27e-2)" "unprognostic (4.85e-3)" "unprognostic (5.24e-3)" "unprognostic (1.68e-2)" "unprognostic (2.68e-2)" "unprognostic (2.98e-3)" "unprognostic (1.32e-4)" "unprognostic (1.05e-1)" "unprognostic (1.53e-1)" "unprognostic (3.24e-2)" "unprognostic (7.81e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 34.7 0.2 0.0 0.0 0.2 1.3 0.2 251.5 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.7 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 16.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.2 33.7 126.1 0.2 33.2 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.5 0.0 0.0 0.2 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 MUC22 PBMUCL1 ENSG00000261272 "Mucin 22" E2RYF6 6 31010474-31035402 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.38e-1)" "unprognostic (1.57e-1)" "unprognostic (1.46e-1)" "unprognostic (1.91e-1)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (9.88e-2)" "unprognostic (1.14e-1)" "unprognostic (3.65e-1)" "unprognostic (1.35e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 MUC3A MUC3 ENSG00000169894 "Mucin 3A, cell surface associated" Q02505 7 100949555-100968346 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 84.4;intestine: 138.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 181.0;Mucus-secreting cells: 104.0;Paneth cells: 136.8;Undifferentiated cells: 104.3" "Cancer enhanced" "Detected in many" "stomach cancer: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 11.8;CAPAN-2: 3.9;MCF7: 2.6;OE19: 5.9" HPA010871 Uncertain "Intracellular and membrane" NA NA "HPA010871: AB_1854201" "unprognostic (1.12e-2)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (4.22e-3)" "unprognostic (2.91e-1)" "unprognostic (5.16e-2)" "unprognostic (2.06e-1)" "unprognostic (5.29e-3)" "unprognostic (2.87e-1)" "unprognostic (1.33e-1)" "unprognostic (7.01e-2)" "unprognostic (2.99e-1)" "unprognostic (6.50e-3)" "unprognostic (8.73e-2)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" "unprognostic (4.51e-2)" 0.1 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 31.4 0.0 0.0 23.3 0.0 0.0 0.0 0.0 84.4 0.8 0.0 0.0 2.8 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.5 6.7 0.0 0.0 0.0 2.4 0.0 138.0 0.1 0.0 0.0 1.4 0.0 0.0 19.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 11.8 3.9 0.0 0.1 0.0 0.1 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 2.6 0.0 0.0 1.7 5.9 0.0 0.0 0.0 0.3 0.6 0.0 0.9 0.0 0.0 1.2 0.0 1.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 1.2 33.1 0.0 0.0 1.8 0.0 0.3 0.0 12.0 0.4 0.0 181.0 0.0 25.0 0.6 0.0 42.1 0.0 5.1 0.2 0.0 9.9 0.6 1.5 0.0 0.3 0.0 0.0 1.8 104.0 0.0 34.7 136.8 0.0 0.1 0.0 0.0 1.3 0.5 3.4 0.1 0.2 0.0 104.3 12.8 MUC4 ENSG00000145113 "Mucin 4, cell surface associated" Q99102 3 195746765-195812277 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.5;lymphoid tissue: 57.2" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 85.6;Club cells: 86.4;Mucus-secreting cells: 154.7;Undifferentiated cells: 114.6;Urothelial cells: 276.8" "Cancer enhanced" "Detected in many" "cervical cancer: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.6" "HPA005895, CAB013536" Approved "Secreted in other tissues" NA NA "CAB013536: , HPA005895: AB_1079427" "unprognostic (4.16e-3)" "unprognostic (1.00e-2)" "unprognostic (6.79e-2)" "unprognostic (1.11e-2)" "unprognostic (3.03e-2)" "unprognostic (5.16e-2)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (3.19e-1)" "unprognostic (4.22e-3)" "unprognostic (6.68e-3)" "unprognostic (5.30e-2)" "unprognostic (2.43e-3)" "unprognostic (3.19e-1)" "unprognostic (6.78e-2)" "unprognostic (3.46e-3)" "unprognostic (9.97e-3)" 0.4 0.4 0.0 28.7 0.0 0.4 0.4 0.0 0.4 13.4 21.5 0.0 0.0 0.4 1.4 0.4 13.0 1.7 0.4 0.4 0.0 0.0 0.4 0.4 10.3 0.4 0.0 0.0 0.5 0.4 0.4 0.0 6.2 0.2 10.0 1.9 0.0 5.5 0.4 0.4 0.4 1.7 0.4 0.0 0.4 2.4 0.5 0.0 0.5 0.4 6.1 57.2 6.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.0 14.1 0.0 11.3 0.0 0.0 2.0 0.0 85.6 86.4 0.0 0.0 0.1 0.0 0.2 2.4 0.0 53.1 0.0 4.7 4.0 0.0 10.6 2.3 0.0 0.1 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.7 0.0 22.6 40.3 0.4 0.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.0 114.6 276.8 MUC5AC MUC5 ENSG00000215182 "Mucin 5AC, oligomeric mucus/gel-forming" P98088 11 1157953-1201138 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "gallbladder: 70.3;lung: 87.0;stomach 1: 68.3" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 6.7;Club cells: 25.0;Pancreatic endocrine cells: 5.3" "Cancer enhanced" "Detected in many" "stomach cancer: 61.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "A549: 19.5;OE19: 13.0" "CAB002774, CAB009395, HPA040615" Enhanced "Secreted to digestive system" NA NA "CAB002774: , CAB009395: AB_2146854, HPA040615: AB_2677042" "unprognostic (2.10e-2)" "unprognostic (1.11e-1)" "unprognostic (1.27e-1)" "unprognostic (3.14e-2)" "unprognostic (1.72e-2)" "unprognostic (2.51e-2)" "unprognostic (4.56e-2)" "unprognostic (6.49e-2)" "unprognostic (2.44e-2)" "unprognostic (1.30e-3)" "unprognostic (8.46e-2)" "unprognostic (5.83e-4)" "unprognostic (1.84e-1)" "unprognostic (9.21e-3)" "unprognostic (4.07e-1)" "unprognostic (1.37e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 70.3 0.0 0.0 0.0 0.0 87.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 68.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 13.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 2.2 0.0 6.7 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 MUC5B "MG1, MUC5" ENSG00000117983 "Mucin 5B, oligomeric mucus/gel-forming" Q9HC84 11 1223066-1262172 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8" "Cell type enriched" "Detected in some" 4 "Cholangiocytes: 591.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "OE19: 41.8;PC-3: 45.1" "HPA008246, CAB009396" Enhanced Supported Vesicles "Secreted in other tissues" NA NA 590000 Vesicles "CAB009396: AB_2282256, HPA008246: AB_1854203" "unprognostic (2.01e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (2.76e-3)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (4.89e-2)" "unprognostic (7.80e-3)" "unprognostic (3.75e-1)" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (8.95e-2)" "unprognostic (2.57e-7)" "unprognostic (2.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (8.13e-2)" 0.1 0.1 0.1 0.7 0.1 0.0 0.2 0.1 0.1 67.4 8.4 0.0 0.0 0.0 1.9 0.0 11.6 0.2 301.7 0.1 0.1 0.1 0.1 0.6 2.0 0.0 0.1 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.1 4.6 0.0 192.8 0.0 0.7 0.1 0.3 0.1 0.1 0.1 1.5 0.1 0.0 0.0 0.1 31.6 155.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 41.8 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 32.8 0.9 0.0 0.0 0.0 10.5 591.1 34.8 46.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 1.2 4.6 0.0 0.2 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.5 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 131.5 0.3 MUC6 ENSG00000184956 "Mucin 6, oligomeric mucus/gel-forming" Q6W4X9 11 1012821-1036706 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 426.4;seminal vesicle: 478.2" "Cell type enhanced" "Detected in some" 27 "Cholangiocytes: 79.0;Exocrine glandular cells: 17.2;Pancreatic endocrine cells: 34.6" "Cancer enhanced" "Detected in many" "stomach cancer: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "OE19: 6.1" "Not detected" "Not detected" CAB002165 Enhanced "Secreted to digestive system" NA NA "CAB002165: AB_442114" "unprognostic (1.90e-2)" "unprognostic (1.00e-1)" "unprognostic (5.21e-3)" "unprognostic (1.56e-3)" "unprognostic (1.04e-1)" "unprognostic (5.17e-3)" "unprognostic (2.17e-1)" "unprognostic (1.48e-1)" "unprognostic (1.65e-2)" "unprognostic (2.63e-1)" "unprognostic (9.46e-2)" "unprognostic (8.62e-2)" "unprognostic (3.17e-3)" "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (4.72e-2)" "unprognostic (5.23e-2)" 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.4 5.3 0.1 0.3 426.4 13.1 0.5 3.1 2.1 0.5 118.1 0.1 0.0 0.0 0.4 1.3 0.1 0.1 0.0 0.0 0.1 36.5 0.1 0.0 0.1 0.0 5.2 0.1 0.0 0.1 478.2 0.2 0.2 0.1 0.1 0.0 0.2 76.6 0.2 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 6.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 79.0 0.0 0.0 8.7 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUC7 "FLJ27047, MG2" ENSG00000171195 "Mucin 7, secreted" Q8TAX7 4 70430492-70482997 "Disease related genes, Predicted secreted proteins" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "salivary gland: 1562.5" "Cell type enriched" "Detected in single" 60 "Melanocytes: 11.8" "Group enriched" "Detected in some" 12 "head and neck cancer: 8.1;melanoma: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.2;GAMG: 1.4" HPA006411 Enhanced "Secreted to digestive system" NA NA "HPA006411: AB_1854204" "unprognostic (5.49e-2)" "unprognostic (3.20e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1562.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 265.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUCL1 SBEM ENSG00000172551 "Mucin like 1" Q96DR8 12 54830519-54858393 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 75 "breast: 283.5;salivary gland: 277.2;skin 1: 99.4" "Cell type enriched" "Detected in some" 6 "Melanocytes: 1005.5" "Cancer enriched" "Detected in many" 30 "breast cancer: 298.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;naive CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;hTCEpi: 2.2;MCF7: 3.7;SK-BR-3: 9.2;SuSa: 6.2" HPA039093 Enhanced "Secreted in other tissues" NA NA "HPA039093: AB_10795577" "unprognostic (2.26e-1)" "unprognostic (3.38e-1)" "unprognostic (1.90e-1)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (8.34e-3)" "unprognostic (5.55e-2)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (9.90e-2)" 2.9 0.0 0.1 0.1 0.1 0.0 283.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.0 0.1 277.2 0.1 0.2 99.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 9.2 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.0 1.1 0.0 0.9 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.4 167.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1005.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.8 0.0 0.0 0.0 0.6 MUM1L1 FLJ33516 ENSG00000157502 "MUM1 like 1" Q5H9M0 X 106168305-106208956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 79.4;thyroid gland: 26.9" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 25.5;Leydig cells: 42.0;Peritubular cells: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.1;HHSteC: 2.8;HSkMC: 5.3;LHCN-M2: 9.5;NTERA-2: 3.6;SuSa: 2.9;T-47d: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000168, HPA020464" Enhanced NA NA "HPA000168: AB_1079431, HPA020464: AB_1854209" "unprognostic (2.79e-1)" "unprognostic (1.08e-2)" "unprognostic (3.83e-2)" "unprognostic (6.08e-2)" "unprognostic (5.06e-2)" "unprognostic (4.12e-6)" "unprognostic (3.48e-2)" "unprognostic (1.31e-1)" "unprognostic (3.86e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-1)" "unprognostic (8.43e-3)" "unprognostic (2.11e-5)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.53e-2)" 1.5 1.8 5.2 0.2 1.3 0.2 0.6 0.1 8.8 7.3 0.2 0.0 2.0 0.2 7.3 4.2 0.3 6.7 0.7 1.9 2.9 2.3 1.0 0.8 0.4 0.2 0.5 4.9 79.4 11.4 0.2 12.8 4.8 4.8 2.3 0.2 0.0 0.2 1.7 4.1 0.2 0.2 1.5 0.3 0.2 0.6 17.0 0.8 0.0 26.9 1.5 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.1 0.0 0.0 2.8 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.1 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.0 2.9 3.3 0.0 0.0 0.4 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 1.3 0.1 8.8 2.9 2.3 0.5 4.9 4.8 0.8 3.0 0.0 0.0 1.6 0.0 0.2 11.4 25.5 6.7 2.3 0.0 0.0 1.3 1.7 5.5 1.1 0.3 0.0 0.0 1.0 0.4 0.3 0.9 0.0 0.0 0.2 0.0 0.0 2.5 0.0 1.8 42.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 67.5 2.1 0.0 12.9 0.6 1.4 1.0 0.0 3.0 0.0 0.0 0.5 MUSK ENSG00000030304 "Muscle associated receptor tyrosine kinase" O15146 9 110668771-110801620 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "skeletal muscle: 50.0" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 2.7;Late spermatids: 3.3;Leydig cells: 4.9;Peritubular cells: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "LHCN-M2: 19.8;RH-30: 20.1" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Not detected" "Not detected" NA NA "unprognostic (6.12e-2)" "unprognostic (9.01e-2)" "unprognostic (5.39e-2)" "unprognostic (3.66e-1)" "unprognostic (3.14e-1)" "unprognostic (1.20e-2)" "unprognostic (1.50e-2)" "unprognostic (2.46e-1)" "unprognostic (3.13e-1)" "unprognostic (7.58e-2)" "unprognostic (6.03e-5)" "unprognostic (4.58e-2)" "unprognostic (1.62e-1)" "unprognostic (9.67e-2)" "unprognostic (5.11e-2)" 7.5 0.3 0.6 5.8 0.7 0.0 0.2 0.1 0.2 0.3 6.8 0.0 0.0 2.3 0.2 4.0 3.8 0.1 2.1 3.2 0.9 0.7 0.2 0.5 4.2 0.9 0.2 0.1 0.3 0.3 0.0 0.2 0.6 0.3 1.9 5.3 0.0 0.4 0.0 50.0 0.3 5.0 3.0 0.3 0.2 2.6 5.9 0.0 0.0 0.3 1.4 3.9 3.6 2.9 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.4 0.0 0.2 0.0 20.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.1 0.2 0.9 0.7 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 MUSTN1 Mustang ENSG00000272573 "Musculoskeletal, embryonic nuclear protein 1" Q8IVN3 3 52833114-52835219 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "skeletal muscle: 252.5" "Cell type enriched" "Detected in single" 7 "Alveolar cells type 2: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "Hep G2: 9.5;HSkMC: 6.0;RH-30: 8.5" NA NA "unprognostic (2.79e-2)" "unprognostic (3.73e-2)" "unprognostic (4.11e-1)" "unprognostic (2.60e-2)" "unprognostic (2.34e-2)" "unprognostic (6.21e-3)" "unprognostic (2.78e-1)" "unprognostic (1.13e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-3)" "unprognostic (6.00e-2)" "unprognostic (1.79e-1)" "unprognostic (8.11e-2)" "unprognostic (1.88e-2)" 12.1 1.8 2.5 1.8 5.2 1.3 6.1 1.5 5.7 16.0 4.6 2.6 2.4 1.7 11.1 18.9 7.9 6.4 10.6 15.5 2.6 2.2 1.8 0.8 3.2 1.4 4.3 3.9 5.1 1.6 0.8 1.1 1.3 5.2 11.6 3.4 3.8 5.9 8.9 252.5 2.7 2.6 6.1 2.2 0.9 2.3 6.4 0.2 0.0 5.4 26.9 3.6 8.1 7.9 0.0 0.0 2.1 0.6 0.0 0.3 0.2 0.1 0.2 3.0 0.0 0.8 2.1 3.5 0.2 0.9 0.4 0.3 0.4 0.5 0.0 0.0 1.4 0.1 1.3 0.7 0.6 0.5 0.1 0.9 0.0 1.6 9.5 1.4 1.9 0.6 6.0 1.0 0.9 0.0 1.4 1.2 0.4 0.2 0.0 0.1 0.6 0.7 2.8 0.4 0.4 2.2 1.0 8.5 0.0 0.6 0.0 0.3 0.3 0.6 0.7 1.5 3.2 0.0 0.7 0.0 0.4 0.7 1.2 0.6 0.0 0.1 0.0 0.3 2.4 0.3 0.0 0.4 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.0 0.2 2.5 5.2 1.5 5.7 2.6 2.2 4.3 3.9 5.2 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MUT ENSG00000146085 "Methylmalonyl-CoA mutase" P22033 6 49430360-49463191 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Isomerase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.5" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035971, HPA035972" Enhanced Approved Mitochondria,Cytosol NA NA 110000 Cytosol Mitochondria "HPA035971: AB_10696648, HPA035972: AB_2674895" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.17e-2)" "unprognostic (3.72e-2)" "unprognostic (3.18e-3)" "unprognostic (1.20e-1)" "unprognostic (1.16e-2)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (1.89e-2)" "unprognostic (6.57e-2)" "unprognostic (9.89e-2)" "prognostic favorable (8.71e-13)" "unprognostic (5.38e-2)" "unprognostic (3.78e-1)" "unprognostic (6.01e-3)" "unprognostic (1.91e-1)" 10.7 14.3 10.9 5.7 13.4 4.1 9.7 10.0 12.1 8.9 12.7 8.6 9.0 13.6 8.7 8.6 13.2 8.4 7.5 16.6 10.1 10.0 25.5 96.5 7.8 5.7 11.8 9.5 13.1 15.7 15.8 13.5 7.5 12.0 11.2 11.2 8.0 9.3 9.2 13.7 9.0 14.7 11.8 9.7 6.4 10.9 9.1 9.9 8.2 11.2 9.1 5.8 12.8 8.1 9.4 8.9 14.0 15.2 14.2 12.0 6.7 13.4 4.8 14.5 16.9 28.9 27.5 8.0 12.1 16.0 12.8 19.0 5.5 7.0 12.5 9.7 12.9 19.4 7.7 16.1 8.6 18.1 10.6 11.7 6.6 11.0 14.4 21.1 8.5 6.4 16.6 12.8 13.0 15.2 11.5 12.3 13.6 12.0 15.0 15.0 8.4 9.9 8.4 6.2 14.2 3.5 8.9 18.2 17.2 14.8 12.9 13.5 9.4 13.3 9.6 20.0 15.9 8.3 13.6 8.8 11.9 8.8 16.1 16.3 5.9 6.7 10.7 16.8 10.0 10.4 14.0 7.5 12.5 7.9 9.9 9.9 9.4 9.5 9.9 8.9 8.3 12.0 9.0 4.3 14.2 15.2 6.3 11.9 6.7 10.9 13.4 10.0 12.1 10.1 10.0 11.8 9.5 12.0 9.9 17.9 17.4 10.4 16.2 17.7 16.5 60.2 22.9 18.7 21.6 31.4 2.0 21.2 24.9 14.4 5.7 10.0 27.4 0.0 12.8 11.2 13.8 13.3 10.4 117.7 10.8 19.1 50.0 14.1 10.0 2.1 22.2 9.4 8.5 2.8 23.1 28.2 10.5 23.0 26.2 34.2 15.2 32.3 12.2 18.6 14.3 17.6 27.9 7.9 21.2 11.5 MVB12B "C9orf28, FAM125B, FLJ00001" ENSG00000196814 "Multivesicular body subunit 12B" Q9H7P6 9 126326849-126507041 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 1.5;gdT-cell: 3.1;MAIT T-cell: 5.7;memory CD4 T-cell: 1.4;memory CD8 T-cell: 5.0;myeloid DC: 2.0;naive CD8 T-cell: 2.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.0;monocytes: 1.5;T-cells: 5.7" "Cell line enhanced" "Detected in many" "AF22: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043683, HPA049383" Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA043683: AB_2678616, HPA049383: AB_2680737" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (6.82e-2)" "unprognostic (9.59e-3)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-2)" "unprognostic (4.45e-3)" "unprognostic (4.33e-1)" "unprognostic (1.05e-1)" "prognostic favorable (7.89e-4)" "unprognostic (2.82e-1)" "unprognostic (1.66e-3)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (5.79e-2)" "unprognostic (1.12e-3)" 5.6 5.5 15.2 4.3 21.2 10.7 5.0 7.3 22.9 6.3 6.1 52.0 2.4 3.7 5.9 3.3 4.3 10.2 3.9 4.6 22.8 15.3 3.4 4.0 17.7 5.9 31.1 9.8 6.6 3.3 8.8 5.3 14.8 28.2 5.9 6.4 5.8 3.1 9.0 21.4 3.3 4.2 6.6 62.2 10.3 4.0 5.4 28.8 4.8 5.7 1.5 2.6 6.9 3.2 0.4 2.0 0.2 1.5 0.1 5.7 1.4 2.9 4.0 21.9 12.0 0.7 0.2 13.0 2.4 2.0 4.4 0.8 3.4 0.1 0.0 1.5 2.3 6.5 1.3 6.7 1.1 2.7 4.8 4.2 1.0 0.7 14.9 1.8 1.9 0.9 1.7 2.2 0.9 0.0 3.7 3.4 15.9 0.0 0.0 3.2 2.3 3.1 6.1 4.8 0.5 5.5 4.6 12.0 0.0 0.2 12.0 5.5 10.1 4.0 2.9 2.5 9.6 2.9 11.7 4.9 5.0 3.7 2.8 5.0 0.0 0.0 1.2 1.4 8.7 2.6 0.0 1.5 0.2 3.1 0.4 5.7 0.2 1.4 5.0 2.0 0.4 0.3 2.2 0.1 0.1 0.4 0.1 0.0 1.4 15.2 21.2 7.3 15.9 22.8 15.3 31.1 9.8 28.2 28.8 6.0 5.3 0.0 2.8 3.2 8.8 3.1 5.1 9.4 1.2 1.8 3.9 10.2 0.0 1.1 0.5 4.8 1.3 0.0 1.2 1.8 3.8 1.2 6.9 5.0 1.4 9.5 2.4 1.3 18.0 1.7 2.6 4.0 0.0 1.8 2.1 8.8 0.9 5.9 6.0 0.0 5.5 0.0 1.8 1.4 3.3 2.3 2.9 4.4 2.3 1.4 MX2 MXB ENSG00000183486 "MX dynamin like GTPase 2" P20592 21 41361943-41409390 "Plasma proteins, Predicted intracellular proteins, Transporters" "Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.2;lymphoid tissue: 35.9" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 26.3;Macrophages: 27.1;Sertoli cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in all" 5 "neutrophil: 61.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 61.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 43.1;BJ hTERT+ SV40 Large T+ RasG12V: 42.1;MOLT-4: 26.9;U-266/84: 44.7;U-937: 46.2" "Low region specificity" "Detected in all" HPA030235 Uncertain NA NA "HPA030235: AB_10601970" "unprognostic (1.88e-1)" "unprognostic (2.26e-1)" "unprognostic (7.90e-3)" "prognostic unfavorable (3.71e-5)" "unprognostic (2.50e-1)" "unprognostic (2.30e-1)" "unprognostic (7.77e-2)" "unprognostic (3.36e-1)" "unprognostic (2.63e-1)" "unprognostic (6.64e-2)" "unprognostic (2.01e-2)" "unprognostic (9.48e-2)" "unprognostic (3.38e-14)" "unprognostic (6.31e-2)" "unprognostic (1.59e-3)" "unprognostic (5.61e-2)" "unprognostic (1.16e-2)" 21.6 1.4 1.6 14.3 7.6 12.5 11.5 0.7 2.3 9.2 4.7 3.0 2.5 5.5 9.2 7.4 5.7 5.6 12.4 7.1 2.3 2.2 4.9 3.0 6.1 34.7 2.2 2.8 3.9 2.8 0.2 1.7 5.7 6.1 4.4 2.8 5.7 6.7 1.8 4.5 4.8 8.9 4.9 5.5 24.3 11.2 3.9 2.1 35.9 4.6 2.4 14.9 12.3 6.7 5.2 7.4 61.2 11.7 2.5 8.3 6.3 0.2 0.0 0.0 0.0 1.0 2.3 0.0 0.0 5.9 43.1 42.1 0.0 14.7 0.0 0.0 0.7 8.4 0.0 0.0 0.0 1.4 0.5 0.0 17.7 0.0 7.7 0.3 0.3 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.4 0.7 9.1 0.0 0.0 26.9 10.7 16.8 2.3 0.2 3.8 0.0 1.4 0.0 1.1 0.0 0.0 0.9 0.0 1.2 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.6 1.3 46.2 4.6 2.3 10.5 9.0 4.4 11.7 5.7 5.2 7.1 5.2 7.4 4.7 8.3 5.4 61.2 2.5 10.3 4.2 4.8 6.3 1.6 7.6 0.7 2.3 2.3 2.2 2.2 2.8 6.1 2.1 6.0 10.3 18.5 2.2 3.7 0.0 2.8 0.0 10.7 15.9 1.8 0.0 0.3 1.7 0.9 0.3 9.7 2.6 0.0 2.6 0.9 8.0 2.7 11.6 0.0 15.0 0.0 2.9 4.3 26.3 1.2 6.4 27.1 10.1 0.0 1.0 0.3 3.9 0.0 3.9 0.1 0.2 25.8 9.5 1.4 6.4 1.3 0.2 13.1 0.0 4.9 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.5 1.5 2.2 1.6 5.0 2.5 8.4 3.9 2.2 1.9 1.3 4.9 2.8 2.0 2.0 1.5 1.9 12.6 4.2 7.8 2.0 1.1 5.1 4.2 4.5 4.9 16.8 5.0 4.2 2.8 13.3 4.4 20.4 2.4 2.4 2.1 7.3 8.1 1.2 2.8 2.4 10.1 0.6 5.2 2.5 1.1 2.3 5.0 2.5 4.2 7.3 3.1 5.2 7.0 2.7 2.7 1.0 3.0 9.6 2.8 0.8 3.0 3.7 5.5 9.3 0.8 2.9 8.9 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 35.7 30.8 18.2 23.9 22.9 27.8 4.8 7.6 10.7 11.4 1.8 51.1 7.9 6.6 10.8 12.4 9.0 212.1 0.0 14.8 5.1 13.6 61.3 26.5 6.7 26.9 9.5 93.4 6.2 48.3 15.3 4.4 71.5 15.1 20.8 115.5 40.4 44.4 91.2 2.5 5.1 17.8 0.0 28.7 8.1 2.0 49.3 88.6 20.8 26.6 110.0 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.1;lymphoid tissue: 59.4" "Cell type enriched" "Detected in many" 7 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 14.1" "Group enriched" "Detected in many" 6 "granulocytes: 14.1;monocytes: 8.7" "Cell line enhanced" "Detected in many" "HDLM-2: 59.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli NA Yes "Nucleoplasm, Nucleoli" "HPA070111: AB_2686228" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 2.5 1.8 1.3 28.2 1.9 32.1 5.4 1.2 3.4 2.4 6.8 1.2 2.8 6.9 2.7 6.2 6.6 3.6 2.8 2.4 1.6 0.8 2.7 6.6 5.4 7.3 2.2 1.2 2.6 5.8 0.7 4.3 4.5 2.1 5.0 0.9 1.1 4.7 2.1 3.6 10.3 5.6 1.4 1.3 10.3 3.8 3.1 2.9 59.4 3.5 3.7 13.5 2.7 3.6 2.0 1.6 14.1 8.7 0.7 0.8 1.1 8.1 5.6 3.5 9.5 0.2 0.5 5.8 10.6 3.5 4.8 4.6 3.7 8.5 4.3 4.4 1.4 2.6 4.0 0.4 1.2 0.2 59.2 7.2 2.4 8.1 5.4 0.5 2.3 7.5 0.3 0.6 0.3 0.2 0.4 4.4 19.2 1.5 13.6 0.9 10.4 21.6 6.5 1.2 2.5 9.8 10.6 10.8 6.2 1.0 1.1 8.6 7.1 6.8 6.9 3.7 0.5 10.9 6.2 3.2 5.8 15.0 4.6 5.6 18.0 5.9 4.7 4.5 8.1 3.3 3.5 2.6 7.7 0.7 7.2 0.0 1.6 0.1 0.1 1.6 2.0 0.0 0.3 14.1 0.7 8.7 1.0 0.8 1.1 1.3 1.9 1.2 3.4 1.6 0.8 2.2 1.2 2.1 2.9 3.0 2.2 0.0 1.5 4.9 2.8 1.2 5.1 5.3 4.5 5.2 0.0 4.5 0.0 1.3 16.3 2.3 4.0 116.8 3.5 7.2 3.4 2.4 9.2 3.9 8.8 3.2 1.7 4.3 4.9 1.9 1.7 5.1 3.3 1.0 5.0 1.0 1.9 3.1 1.4 0.3 2.2 0.0 3.1 0.7 5.9 5.0 11.0 5.1 6.9 1.8 MXRA5 DKFZp564I1922 ENSG00000101825 "Matrix remodeling associated 5" Q9NR99 X 3308565-3346641 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 49.4;pancreas: 46.6" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 34.2;Collecting duct cells: 29.6;Exocrine glandular cells: 53.2;Pancreatic endocrine cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 12.8;BJ hTERT+: 49.0;fHDF/TERT166: 23.0;HaCaT: 20.3;HSkMC: 9.9" "HPA000508, HPA076518" Uncertain Uncertain Mitochondria "Secreted - unknown location" NA NA 1700000 Mitochondria "HPA000508: AB_2147995, HPA076518: " "unprognostic (7.51e-2)" "unprognostic (6.45e-2)" "unprognostic (8.00e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (7.05e-2)" "unprognostic (7.25e-2)" "unprognostic (1.35e-2)" "unprognostic (1.13e-1)" "unprognostic (2.53e-2)" "unprognostic (6.32e-3)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.94e-4)" 6.5 12.1 0.5 10.4 1.2 0.0 7.5 0.4 0.8 49.4 4.4 0.6 18.8 2.1 11.4 6.0 8.7 4.2 5.8 9.2 0.6 0.5 8.0 4.5 5.9 0.9 0.6 0.7 7.9 46.6 0.5 1.4 7.9 0.8 11.0 5.9 10.2 11.5 29.5 1.1 16.6 7.8 8.8 0.5 7.7 5.1 4.0 0.3 5.7 15.0 11.7 6.2 12.7 9.6 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 12.8 0.0 7.6 49.0 0.0 0.0 0.0 0.2 0.0 0.6 23.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 2.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.4 0.8 0.6 0.5 0.6 0.7 0.8 0.3 0.0 0.0 0.0 3.9 34.2 0.0 1.6 0.0 1.4 5.7 29.6 0.0 0.0 0.0 1.7 0.0 2.2 0.0 0.0 53.2 0.2 19.5 0.1 0.0 0.0 0.3 0.0 0.0 17.2 0.8 0.0 0.0 0.0 16.9 1.0 0.0 0.0 47.4 0.0 1.4 0.0 0.1 0.0 9.2 0.0 0.0 19.1 0.2 0.0 0.0 1.4 MYADML2 LOC255275 ENSG00000185105 "Myeloid associated differentiation marker like 2" A6NDP7 17 81939645-81947233 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 20 "skeletal muscle: 44.5" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 4.8;Early spermatids: 1.4;Horizontal cells: 1.6" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 8.4" "Low region specificity" "Detected in all" "HPA041856, HPA048476" Uncertain NA NA "HPA041856: AB_2677709, HPA048476: AB_2680410" "unprognostic (1.83e-1)" "unprognostic (1.71e-2)" "unprognostic (7.07e-2)" "unprognostic (2.90e-4)" "unprognostic (2.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (1.44e-2)" "unprognostic (3.37e-2)" "unprognostic (4.16e-7)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.4 2.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 1.5 0.6 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 44.5 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.3 1.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.7 0.0 0.6 0.0 0.1 0.6 0.1 0.5 0.0 0.4 0.1 0.0 0.2 8.4 0.7 0.2 0.2 0.6 0.0 0.2 0.0 0.0 0.3 0.7 0.2 0.0 1.5 1.1 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 MYB c-myb ENSG00000118513 "MYB proto-oncogene, transcription factor" P10242 6 135181315-135219173 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 104.9" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5" "Cancer enhanced" "Detected in many" "breast cancer: 17.7" "Region enhanced" "Detected in some" "basal ganglia: 4.7" "Group enriched" "Detected in some" 4 "basophil: 5.6;eosinophil: 10.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 10.0" "Cell line enhanced" "Detected in many" "HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB017704, HPA071605" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB017704: , HPA071605: " "unprognostic (1.69e-1)" "unprognostic (5.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.37e-2)" "unprognostic (4.06e-1)" "unprognostic (8.35e-3)" "unprognostic (1.13e-3)" "unprognostic (2.48e-2)" "unprognostic (6.44e-2)" "unprognostic (1.00e-1)" "unprognostic (3.71e-2)" "prognostic favorable (9.65e-4)" "unprognostic (2.41e-11)" "prognostic favorable (9.87e-4)" "unprognostic (8.35e-2)" "unprognostic (3.04e-2)" "unprognostic (9.40e-2)" 0.5 0.7 1.3 9.1 4.7 18.9 13.2 0.3 0.6 1.4 15.4 0.5 0.3 6.5 0.9 1.0 3.7 5.0 1.7 0.6 0.7 0.7 0.4 0.5 1.8 3.3 0.3 0.5 1.0 0.3 0.4 0.3 0.6 0.5 1.6 16.7 0.5 0.8 1.5 1.0 3.5 5.9 0.7 0.4 1.4 0.9 2.0 0.6 104.9 0.4 2.0 4.7 0.7 1.5 0.1 1.7 10.0 0.8 0.0 0.5 0.1 0.3 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.2 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.1 3.1 0.4 25.2 0.1 0.0 0.0 39.5 20.0 0.0 0.0 0.1 0.0 0.0 0.0 24.8 20.4 3.8 0.2 2.0 72.0 37.5 0.2 3.5 0.3 44.5 1.0 6.1 0.0 0.2 1.9 1.2 0.0 2.0 0.0 0.1 1.5 62.8 0.0 0.0 0.3 1.5 0.4 4.8 1.2 12.2 0.0 34.2 0.4 5.6 0.8 10.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.5 0.1 1.3 4.7 0.3 0.6 0.7 0.7 0.3 0.5 0.5 0.6 0.0 2.2 2.9 1.1 2.4 0.6 0.4 2.5 44.2 10.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 2.9 0.0 0.7 0.6 0.4 2.7 25.4 0.0 0.9 0.0 16.9 0.0 1.2 0.0 0.0 1.5 8.5 0.0 26.5 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 6.0 0.2 1.9 37.5 2.0 MYBL1 "A-myb, AMYB" ENSG00000185697 "MYB proto-oncogene like 1" P10243 8 66562175-66614247 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.6" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 23.3;Spermatocytes: 32.1;T-cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.9;MAIT T-cell: 3.5" "Group enriched" "Detected in many" 32 "NK-cells: 1.4;T-cells: 4.9" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 29.1;BJ hTERT+ SV40 Large T+ RasG12V: 24.7;Daudi: 29.7;HBF TERT88: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008791 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008791: AB_1078540" "unprognostic (1.11e-1)" "unprognostic (2.47e-2)" "unprognostic (2.57e-1)" "unprognostic (7.23e-4)" "unprognostic (2.26e-1)" "unprognostic (1.89e-2)" "unprognostic (6.67e-3)" "unprognostic (2.38e-1)" "unprognostic (1.25e-1)" "unprognostic (3.78e-2)" "unprognostic (1.13e-2)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.03e-8)" "unprognostic (2.04e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (5.87e-2)" 2.1 1.1 2.6 25.6 5.1 2.5 2.2 6.5 3.8 1.6 2.1 4.0 2.6 1.7 1.6 2.9 1.5 1.8 3.3 3.9 3.4 2.2 1.4 2.4 4.5 21.7 6.4 2.8 1.2 0.7 1.3 1.2 4.1 6.3 2.6 1.9 1.8 1.2 2.2 1.3 1.6 3.9 2.7 6.5 11.0 2.2 12.7 4.4 4.7 1.5 1.0 18.0 2.2 1.9 0.0 0.0 0.0 0.0 1.4 4.9 0.3 11.8 4.1 1.3 3.5 0.3 0.7 0.9 16.4 7.6 29.1 24.7 0.5 12.1 29.7 1.5 13.8 10.9 3.4 1.2 1.3 40.3 3.5 1.9 0.6 4.5 0.5 0.0 0.2 1.2 0.2 0.1 8.0 6.7 5.2 0.9 2.2 0.1 9.9 17.7 1.0 1.9 0.4 1.0 1.1 5.5 0.6 4.9 0.7 6.8 0.4 2.9 1.1 2.9 1.0 2.9 2.1 17.6 0.8 5.0 17.5 4.0 3.9 15.0 2.9 3.9 8.8 4.6 1.8 6.9 0.0 0.0 0.0 4.9 0.0 3.5 0.0 0.9 2.0 0.0 0.0 0.1 0.8 0.0 1.4 0.0 0.0 0.0 0.3 2.6 5.1 6.5 3.8 3.4 2.2 6.4 2.8 6.3 4.4 0.0 2.9 0.9 0.4 1.5 9.2 8.1 0.0 2.7 0.0 0.0 2.0 1.2 0.0 0.6 3.0 0.7 0.0 23.3 0.0 0.6 1.3 0.2 0.0 0.8 0.5 4.8 0.0 3.1 0.6 3.2 0.9 1.4 1.7 1.0 0.1 10.3 0.1 0.0 0.0 0.6 9.3 0.0 2.1 32.1 5.7 0.4 1.3 50.3 0.2 0.1 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716496 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 93.5;Extravillous trophoblasts: 28.3;Spermatogonia: 25.7" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 30 "plasmacytoid DC: 35.9" "Lineage enriched" "Detected in many" 30 "dendritic cells: 35.9" "Cell line enhanced" "Detected in many" "MCF7: 103.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.7 0.7 0.2 48.3 0.2 33.0 1.0 0.2 0.2 1.0 4.4 0.2 0.1 2.7 1.1 1.1 8.4 0.3 1.7 0.9 0.2 0.2 1.0 1.2 1.8 22.3 0.3 0.1 0.8 9.4 0.0 0.4 4.0 0.2 0.7 2.7 0.3 2.9 0.1 0.3 1.8 6.4 0.6 0.3 43.9 2.9 12.6 0.1 49.2 0.6 6.4 33.8 1.9 2.1 1.1 35.9 0.0 0.0 0.0 0.4 0.3 26.3 16.8 14.9 15.4 0.1 0.5 19.3 11.9 4.0 37.8 27.9 82.4 16.6 53.3 6.9 5.2 7.9 16.1 26.9 8.2 14.2 9.9 17.2 24.9 16.8 22.2 0.0 22.7 17.3 0.3 0.7 14.4 3.2 0.8 10.1 26.5 24.8 66.3 3.3 103.7 46.1 32.0 17.1 21.2 14.7 32.1 30.6 30.5 7.0 5.4 13.7 20.0 35.5 35.7 3.6 16.4 23.5 24.9 4.7 2.3 38.0 16.7 20.5 23.0 47.4 83.8 4.9 19.5 14.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 35.9 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.0 13.4 0.2 3.8 0.0 1.7 2.5 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.3 0.0 0.5 93.5 0.8 28.3 0.4 0.1 0.0 0.0 11.2 0.0 0.0 1.3 1.6 10.0 0.0 0.5 1.7 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.4 25.7 2.0 3.1 2.1 2.2 0.9 MYBPC1 ENSG00000196091 "Myosin binding protein C, slow type" Q00872 12 101568353-101686018 "Disease related genes, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 739.9" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 26.0;Early spermatids: 7.8;Glandular cells: 14.9;Late spermatids: 16.0" "Cancer enhanced" "Detected in many" "prostate cancer: 33.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Cell line enhanced" "Detected in some" "AF22: 2.6;HSkMC: 3.4;SCLC-21H: 1.0" "Group enriched" "Detected in some" 9 "cerebellum: 41.6;olfactory region: 12.2" "Not detected" "Not detected" "HPA021004, HPA027614" Enhanced NA NA "HPA021004: AB_1854232, HPA027614: AB_10602711" "prognostic favorable (4.76e-5)" "unprognostic (7.72e-2)" "unprognostic (1.09e-1)" "unprognostic (1.81e-2)" "unprognostic (3.33e-2)" "unprognostic (4.63e-2)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (9.98e-3)" "unprognostic (2.56e-1)" "unprognostic (2.55e-1)" "unprognostic (1.19e-2)" "unprognostic (4.10e-2)" "unprognostic (7.96e-2)" "unprognostic (6.13e-2)" "unprognostic (5.55e-3)" 10.4 0.1 0.2 0.1 0.2 0.1 3.3 0.1 0.6 0.2 0.3 0.0 0.0 0.1 0.1 20.1 6.2 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.0 4.5 0.1 0.0 8.1 0.1 739.9 0.2 0.5 0.1 0.2 0.1 0.2 0.3 0.0 0.0 2.7 164.9 9.7 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.7 1.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.6 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 16.0 0.6 0.1 1.7 0.0 0.2 0.0 0.1 1.4 0.4 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.2 3.1 MYBPC2 "MGC163408, MYBPC, MYBPCF" ENSG00000086967 "Myosin binding protein C, fast type" Q14324 19 50432903-50466321 "Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skeletal muscle: 311.8;tongue: 133.8" "Cell type enhanced" "Detected in some" 18 "Distal tubular cells: 1.7;Spermatogonia: 1.3" "Cancer enriched" "Detected in some" 9 "head and neck cancer: 9.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 1.5;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 6 "B-cells: 3.3" "Group enriched" "Detected in some" 17 "HDLM-2: 21.9;Karpas-707: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA042991 Enhanced NA NA "HPA042991: AB_2678257" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" "unprognostic (6.25e-2)" "unprognostic (3.26e-3)" "unprognostic (1.91e-3)" "unprognostic (2.15e-2)" "unprognostic (6.22e-3)" "unprognostic (2.46e-1)" "unprognostic (5.38e-2)" "unprognostic (9.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.30e-1)" "unprognostic (2.19e-8)" "unprognostic (1.85e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-3)" "unprognostic (2.73e-1)" 9.6 0.1 0.2 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 42.6 1.6 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.3 0.2 0.0 0.1 0.2 50.3 0.1 0.0 0.0 0.5 0.0 0.0 4.5 0.0 311.8 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.1 1.3 133.8 4.0 0.1 0.1 3.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.5 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 MYBPC3 "CMH4, FHC, MYBP-C" ENSG00000134571 "Myosin binding protein C, cardiac" Q14896 11 47331397-47352702 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 108 "heart muscle: 199.6" "Cell type enriched" "Detected in some" 61 "Cardiomyocytes: 1683.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enriched" "Detected in single" 17 "U-937: 12.0" "Region enriched" "Detected in single" 33 "cerebellum: 38.5" "Not detected" "Not detected" "HPA040147, HPA043898" Enhanced NA NA 44000 "HPA040147: AB_2676861, HPA043898: AB_2678720" "unprognostic (1.06e-1)" "unprognostic (1.47e-6)" "unprognostic (2.17e-1)" "unprognostic (6.16e-2)" "unprognostic (3.00e-3)" "unprognostic (1.40e-4)" "unprognostic (7.47e-2)" "unprognostic (2.72e-2)" "unprognostic (2.53e-1)" "unprognostic (1.62e-1)" "unprognostic (9.53e-2)" "unprognostic (4.22e-2)" "unprognostic (1.11e-3)" "unprognostic (2.11e-1)" "unprognostic (1.96e-1)" "unprognostic (4.15e-1)" "unprognostic (3.21e-2)" 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 199.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1683.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 14.7 0.3 0.8 0.0 1.8 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.6 0.0 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Cell type enhanced" "Detected in single" 33 "Alveolar cells type 2: 2.2" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Group enriched" "Detected in some" 5 "CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYBPHL ENSG00000221986 "Myosin binding protein H like" A2RUH7 1 109292365-109307041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "heart muscle: 64.6" "Cell type enriched" "Detected in some" 14 "Cardiomyocytes: 139.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;Daudi: 1.5;Hep G2: 6.7;K-562: 1.7;RH-30: 3.9;THP-1: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077633 Approved Vesicles NA NA Vesicles "HPA077633: " "unprognostic (6.07e-3)" "unprognostic (1.43e-1)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.24e-2)" "unprognostic (5.53e-2)" "unprognostic (5.89e-1)" "unprognostic (5.22e-3)" "unprognostic (4.10e-1)" "unprognostic (7.05e-9)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (5.81e-2)" "unprognostic (2.64e-1)" 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.3 1.3 0.0 64.6 0.4 0.1 0.0 0.0 0.7 0.0 1.4 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.4 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.8 0.5 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.6 0.4 0.1 1.4 0.1 0.4 0.9 0.0 3.2 0.0 0.1 0.0 1.1 139.3 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.7 0.0 9.8 0.0 0.3 0.3 0.3 0.1 0.0 0.0 0.0 0.5 MYCBPAP "AMAP-1, DKFZp434N1415" ENSG00000136449 "MYCBP associated protein" Q8TBZ2 17 50508384-50531501 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 81.2" "Group enriched" "Detected in some" 8 "Ciliated cells: 56.2;Early spermatids: 173.4;Late spermatids: 100.2;Spermatocytes: 52.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.5;JURKAT: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023257, HPA024405" Enhanced Approved Vesicles NA NA Vesicles "HPA023257: AB_2671126, HPA024405: " "unprognostic (2.05e-2)" "unprognostic (1.79e-2)" "unprognostic (9.13e-3)" "unprognostic (3.98e-5)" "unprognostic (8.62e-4)" "unprognostic (3.65e-2)" "unprognostic (1.52e-3)" "unprognostic (1.61e-1)" "unprognostic (2.38e-3)" "unprognostic (1.11e-1)" "unprognostic (7.32e-4)" "unprognostic (2.52e-1)" "unprognostic (1.39e-4)" "unprognostic (7.15e-2)" "unprognostic (1.97e-1)" "unprognostic (7.37e-2)" "unprognostic (2.02e-2)" 0.5 0.6 1.1 0.4 1.6 0.9 0.4 1.3 1.4 0.9 0.4 1.6 0.8 0.1 1.3 2.2 0.6 3.5 1.0 0.4 1.2 0.8 0.4 0.2 1.1 0.6 0.4 0.9 1.9 0.2 0.4 0.7 0.2 3.5 0.8 0.2 0.6 0.7 1.2 0.6 0.8 0.3 0.7 0.9 0.5 0.3 81.2 0.4 0.3 0.6 0.0 0.4 0.4 0.5 0.3 0.2 2.8 0.4 1.0 1.0 0.3 0.3 1.5 0.8 0.6 1.9 1.2 1.5 0.7 0.4 0.5 0.7 1.3 3.2 0.5 0.2 0.3 1.6 0.8 0.4 2.3 0.3 7.5 0.7 2.6 2.5 0.7 1.7 0.1 0.6 2.7 0.6 1.2 4.0 1.9 1.4 7.1 0.9 0.8 1.5 0.9 0.3 0.7 0.2 0.2 1.1 0.4 0.7 0.4 0.1 0.8 1.5 3.3 0.9 0.5 0.5 1.2 0.7 1.5 4.1 0.9 1.2 0.3 0.2 4.6 1.5 0.4 1.1 0.5 2.3 1.2 0.4 0.7 0.3 0.3 0.4 0.1 0.4 0.3 0.1 0.3 0.9 0.4 2.8 1.0 0.1 0.2 1.0 0.3 1.1 1.6 1.3 1.4 1.2 0.8 0.4 0.9 3.5 0.4 0.0 1.7 0.0 1.4 0.1 3.6 0.5 0.0 56.2 11.4 1.8 0.0 1.4 0.0 0.0 173.4 0.6 0.4 0.0 0.3 0.2 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.6 100.2 6.4 0.6 0.0 0.0 1.5 6.5 0.1 0.0 3.5 0.0 0.4 0.0 0.3 52.0 5.5 0.4 0.1 0.9 0.1 0.9 MYCL "bHLHe38, LMYC, MYCL1" ENSG00000116990 "MYCL proto-oncogene, bHLH transcription factor" P12524 1 39895426-39902256 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 46.4;skin 1: 26.0" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 21.7;Hepatocytes: 21.9;Mucus-secreting cells: 22.7;Urothelial cells: 22.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 28.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4" "Group enriched" "Detected in many" 75 "dendritic cells: 15.4;monocytes: 11.5" "Group enriched" "Detected in some" 7 "U-266/70: 96.4;U-266/84: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA063132, HPA074515" Enhanced "Nucleoplasm,Mitotic chromosome" NA NA Nucleoplasm "Mitotic chromosome" "HPA063132: AB_2684946, HPA074515: " "unprognostic (7.45e-2)" "unprognostic (6.91e-2)" "unprognostic (7.36e-2)" "unprognostic (1.83e-3)" "unprognostic (1.61e-2)" "unprognostic (2.92e-3)" "unprognostic (6.72e-3)" "prognostic favorable (4.49e-4)" "unprognostic (1.24e-1)" "unprognostic (1.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.12e-1)" "unprognostic (5.01e-3)" "unprognostic (2.75e-2)" "unprognostic (5.21e-2)" "unprognostic (1.53e-2)" "unprognostic (5.80e-2)" 0.3 0.3 1.2 4.4 2.1 0.1 1.7 0.8 1.7 3.6 7.5 1.8 8.5 2.6 1.0 4.0 17.8 1.6 2.3 0.7 1.1 0.9 0.8 6.4 1.9 2.9 0.6 1.4 0.5 46.4 0.0 2.1 11.2 1.8 5.3 3.6 1.8 4.6 16.6 0.6 26.0 7.3 1.2 1.1 4.0 3.3 1.5 0.6 6.4 4.2 3.1 6.0 18.4 7.3 0.0 15.4 0.1 11.5 0.0 0.1 3.8 0.2 0.0 2.9 0.7 0.0 0.0 7.1 0.1 0.0 0.2 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.7 2.0 0.5 0.1 0.4 1.1 0.1 0.0 0.1 0.0 0.0 1.7 0.2 2.4 0.0 0.2 0.0 0.2 1.1 0.7 0.0 0.1 0.2 0.0 0.0 2.8 0.4 0.1 0.2 3.4 0.6 0.2 11.6 0.5 0.7 0.2 0.4 0.1 1.1 0.7 3.7 0.0 0.0 1.1 1.3 0.1 96.4 70.7 0.2 0.0 0.4 0.0 0.0 11.5 0.0 0.0 5.5 0.0 0.0 0.0 0.1 12.9 0.0 0.0 0.0 0.1 0.0 2.3 15.4 0.0 3.8 1.2 2.1 0.8 1.7 1.1 0.9 0.6 1.4 1.8 0.6 0.0 0.6 0.0 9.0 6.0 0.2 3.3 0.0 1.4 4.5 8.7 0.0 21.7 0.0 1.1 0.1 0.5 9.5 0.0 5.1 11.3 0.7 4.8 0.0 21.9 4.9 0.0 16.6 2.5 6.9 0.2 0.0 9.6 1.7 0.0 22.7 1.1 2.4 8.5 0.0 0.0 0.0 0.0 0.3 0.0 0.7 10.3 14.6 0.0 10.5 22.1 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940564-15947007 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.8" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 75.4" "Cancer enhanced" "Detected in many" "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA057420: AB_2683434" "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.9 1.9 5.1 1.8 5.5 1.6 1.2 1.4 8.4 3.1 1.2 12.1 0.0 3.0 1.9 0.8 1.3 1.4 2.6 2.3 7.0 4.7 6.0 1.5 1.6 2.9 6.0 2.2 10.3 0.7 0.4 0.7 16.8 6.8 0.6 1.3 1.1 6.6 0.7 1.0 2.4 1.7 0.9 8.9 0.9 8.5 6.5 4.0 5.7 5.1 2.3 3.5 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 26.6 0.6 0.0 0.0 18.6 3.5 0.0 0.9 0.2 4.7 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 1.4 7.0 7.0 4.7 6.0 2.2 6.8 4.0 0.0 0.0 0.0 0.1 0.5 2.6 0.7 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.2 0.2 0.0 0.0 0.0 75.4 0.6 0.0 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.2 0.0 0.4 2.1 0.1 0.0 0.0 0.5 3.6 0.0 9.6 0.0 0.2 0.0 MYD88 ENSG00000172936 "Myeloid differentiation primary response 88" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.0" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 75.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favorable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 25.0 11.3 5.9 19.5 6.9 18.1 14.7 5.2 4.6 10.0 13.4 5.8 5.0 15.1 9.5 12.3 25.5 9.8 12.4 10.4 5.3 3.2 15.1 47.9 25.6 40.1 6.2 3.5 13.3 10.3 5.4 10.4 17.8 6.7 11.3 14.3 8.8 13.9 5.4 3.9 12.5 30.4 10.7 7.0 39.0 12.5 5.8 5.1 28.5 10.4 17.5 30.8 13.9 13.7 7.8 34.7 49.0 68.0 8.3 14.3 34.6 8.1 12.2 1.8 10.8 8.6 11.2 3.8 8.1 13.2 22.8 24.3 7.6 10.0 17.6 4.8 14.5 5.2 10.3 14.4 8.1 7.6 13.6 3.0 9.5 6.2 11.5 7.1 12.1 24.8 12.9 8.6 12.9 4.8 4.3 13.0 13.5 4.1 7.2 12.0 8.3 19.8 3.9 7.7 17.2 12.1 8.5 2.3 7.5 11.7 19.3 0.8 4.0 11.5 55.1 7.1 1.5 8.6 13.7 12.0 4.5 2.7 20.7 7.7 10.7 11.8 13.1 8.7 21.1 9.7 38.3 37.6 48.1 12.2 56.5 10.4 7.8 11.0 12.2 34.7 6.7 7.7 10.9 49.0 8.3 68.0 16.6 14.3 34.6 5.9 6.9 5.2 4.6 5.3 3.2 6.2 3.5 6.7 5.1 6.0 14.6 17.4 10.4 12.8 0.9 1.5 7.6 10.7 11.4 5.2 0.0 12.2 6.6 22.7 0.7 10.5 25.9 0.0 24.0 20.1 9.1 11.9 24.2 27.6 30.3 0.0 9.2 9.8 75.0 0.6 12.7 48.3 3.3 18.0 16.3 3.5 43.6 34.5 9.9 9.2 0.0 12.9 7.0 2.1 0.4 15.1 10.1 20.3 13.1 37.7 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell type enriched" "Detected in some" 8 "Pancreatic endocrine cells: 116.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1" HPA012949 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 59.2 28.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.7 0.2 2.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.0 2.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.0 0.1 0.8 0.0 13.1 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 15.5 10.5 0.0 0.4 0.0 8.4 0.2 0.2 1.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 4.7 0.3 0.0 0.0 0.0 1.0 0.0 116.0 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.1 0.1 0.0 0.5 6.8 MYF5 bHLHc2 ENSG00000111049 "Myogenic factor 5" P13349 12 80716912-80719673 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "skeletal muscle: 23.1;tongue: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "LHCN-M2: 104.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041691 Supported Nucleoplasm NA NA Nucleoplasm "HPA041691: AB_10796780" "unprognostic (2.65e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 13.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYF6 "bHLHc4, MRF4" ENSG00000111046 "Myogenic factor 6" P23409 12 80707498-80709474 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 175.1" "Cell type enhanced" "Detected in single" 34 "Proximal tubular cells: 2.2" "Group enriched" "Detected in some" 11 "head and neck cancer: 3.0;prostate cancer: 0.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enriched" "Detected in some" 17 "LHCN-M2: 23.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.20e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.88e-2)" "unprognostic (6.64e-1)" 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 175.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 17.1 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH1 "MGC133384, MYHa, MyHC-2X/D, MYHSA1" ENSG00000109061 "Myosin heavy chain 1" P12882 17 10492307-10518543 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "skeletal muscle: 428.9" "Cell type enhanced" "Detected in some" 32 "Cardiomyocytes: 1.2;Early spermatids: 6.3;Late spermatids: 2.0" "Cancer enriched" "Detected in single" 45 "head and neck cancer: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4;OE19: 1.3;SuSa: 1.5;U-2 OS: 2.0" "Not detected" "Not detected" "HPA001349, CAB010759" Enhanced NA NA 49000000 "CAB010759: AB_477248, HPA001349: AB_1079437" "unprognostic (2.87e-2)" "unprognostic (3.27e-3)" "unprognostic (1.91e-1)" "unprognostic (8.95e-3)" "unprognostic (4.49e-2)" "unprognostic (7.31e-2)" "unprognostic (5.63e-3)" "unprognostic (9.85e-4)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" 5.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 428.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MYH11 "SMHC, SMMHC" ENSG00000133392 "Myosin heavy chain 11" P35749 16 15703172-15857033 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 507.4;urinary bladder: 394.5" "Group enriched" "Detected in many" 29 "Peritubular cells: 1569.5;Sertoli cells: 614.4;Smooth muscle cells: 1327.8" "Cancer enhanced" "Detected in many" "prostate cancer: 173.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.6;NB-4: 3.9;U-698: 9.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 54.5" "CAB002302, HPA014539, HPA015310" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 130000000 "Plasma membrane, Cytosol" "CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (4.18e-2)" "unprognostic (9.21e-3)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "prognostic favorable (1.10e-5)" "unprognostic (1.41e-2)" "unprognostic (1.87e-1)" "unprognostic (3.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-3)" "unprognostic (4.06e-2)" "unprognostic (9.53e-2)" "unprognostic (5.00e-2)" "unprognostic (5.45e-3)" 13.2 3.0 0.6 31.5 1.2 0.0 5.9 0.5 1.7 90.3 227.5 1.3 100.0 11.6 102.0 38.4 233.0 43.8 94.3 6.2 0.6 0.7 4.7 0.7 8.5 1.5 1.4 2.6 45.5 1.3 0.0 1.0 5.3 3.6 164.7 22.2 37.0 8.8 127.2 6.4 5.0 50.6 507.4 1.4 3.7 77.7 22.3 0.2 0.1 3.7 6.2 3.0 394.5 57.5 1.5 0.9 6.0 0.9 1.1 1.5 0.4 0.1 0.4 0.2 0.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.4 0.2 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 1.5 0.0 0.3 0.3 3.9 0.4 0.1 0.1 0.4 0.2 1.9 0.0 0.2 0.7 1.4 0.2 0.5 1.2 0.2 0.5 0.0 0.3 0.1 0.3 2.0 0.1 0.5 0.4 9.9 0.4 0.4 0.4 3.1 0.9 2.7 1.2 0.6 1.2 1.5 1.5 1.4 0.5 1.2 1.4 1.4 6.0 1.1 0.6 0.9 1.4 0.4 0.6 1.2 0.5 1.7 0.6 0.7 1.4 2.6 3.6 0.2 0.0 2.6 4.5 1.6 11.7 1.5 38.7 0.0 1.4 2.3 0.0 7.9 0.2 0.0 0.0 36.6 5.7 0.0 0.0 0.3 0.2 8.0 5.1 0.0 0.0 1.1 0.0 1.2 4.3 0.0 30.8 39.7 3.8 11.8 2.8 0.3 0.3 0.2 0.0 1569.5 0.0 1.6 614.4 1327.8 3.2 7.5 16.3 0.0 4.9 0.4 2.5 MYH13 MyHC-eo ENSG00000006788 "Myosin heavy chain 13" Q9UKX3 17 10300865-10373130 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 1.9;skeletal muscle: 5.2;stomach 1: 4.8" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 7.2;Spermatogonia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" NA NA "unprognostic (8.86e-2)" "unprognostic (2.45e-2)" "unprognostic (7.81e-2)" "unprognostic (3.95e-1)" "unprognostic (8.35e-2)" "unprognostic (1.42e-2)" "unprognostic (7.50e-3)" "unprognostic (3.15e-2)" "unprognostic (1.08e-1)" "unprognostic (8.74e-2)" "unprognostic (3.40e-9)" "unprognostic (2.44e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.9 0.1 0.1 0.0 0.1 0.1 0.1 5.2 0.0 0.8 0.1 0.1 0.4 4.8 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 MYH14 "DFNA4, FLJ13881, KIAA2034, MHC16, MYH17" ENSG00000105357 "Myosin heavy chain 14" Q7Z406 19 50188186-50310544 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;skeletal muscle: 53.1" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 373.2;Paneth cells: 214.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.2;CAPAN-2: 19.2;HaCaT: 38.2;MCF7: 18.5;OE19: 19.5;RT4: 47.4;SK-BR-3: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062391, HPA067889, HPA070260" Enhanced Approved Nucleoplasm NA NA 59000000 Nucleoplasm "HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243" "unprognostic (2.52e-1)" "unprognostic (5.81e-2)" "unprognostic (9.63e-2)" "unprognostic (3.73e-3)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "unprognostic (1.71e-1)" "unprognostic (3.48e-2)" "unprognostic (1.93e-2)" "unprognostic (1.01e-1)" "prognostic favorable (3.97e-8)" "prognostic favorable (7.83e-4)" "unprognostic (8.50e-2)" "unprognostic (3.12e-1)" "unprognostic (2.77e-1)" 5.5 0.5 6.1 8.4 6.1 0.1 2.7 4.6 9.4 3.4 63.9 10.5 3.5 38.7 1.1 4.6 14.7 7.5 9.2 16.2 6.4 5.4 4.3 8.7 11.5 0.2 8.5 3.9 1.1 7.5 7.3 4.5 0.7 7.8 3.2 9.4 4.6 12.0 3.1 53.1 20.3 78.6 0.8 11.1 0.2 21.0 0.7 4.2 0.4 16.7 11.4 9.5 4.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 1.6 0.0 8.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 10.5 19.2 0.0 9.9 0.0 1.2 38.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 8.0 0.0 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 18.5 0.0 0.1 0.2 19.5 0.2 0.0 9.6 0.2 0.0 47.4 0.0 0.0 0.9 16.9 0.0 0.0 3.1 0.5 0.0 0.0 3.9 0.0 0.0 0.3 3.4 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 6.1 4.6 9.4 6.4 5.4 8.5 3.9 7.8 4.2 74.5 32.2 4.7 15.0 3.0 4.6 18.6 50.9 42.8 37.5 54.1 2.0 0.0 0.0 46.2 0.9 0.7 373.2 0.0 24.4 0.1 0.9 28.7 14.9 41.5 0.1 15.9 49.7 3.7 1.2 0.4 0.3 1.7 5.0 0.0 88.8 19.2 45.9 214.0 0.0 6.4 10.8 0.0 2.8 0.4 4.1 18.3 0.0 0.8 86.0 79.7 MYH15 KIAA1000 ENSG00000144821 "Myosin heavy chain 15" Q9Y2K3 3 108380369-108529322 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.6" "Cell type enhanced" "Detected in some" 13 "Muller glia cells: 7.0;Rod photoreceptor cells: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.4;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "GAMG: 7.9;Karpas-707: 4.1;PC-3: 8.9;SH-SY5Y: 3.2;U-87 MG: 3.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034871, HPA057915" Uncertain Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA034871: AB_10669996, HPA057915: " "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.62e-1)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (7.84e-3)" "unprognostic (7.32e-2)" "unprognostic (1.89e-2)" "unprognostic (5.67e-2)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (8.41e-2)" "unprognostic (3.57e-2)" 0.1 0.9 2.9 0.3 2.4 0.1 0.1 1.1 4.6 0.3 1.4 1.5 0.0 1.1 0.0 0.5 0.8 1.3 2.8 2.3 0.0 0.0 1.1 0.2 3.3 0.0 0.1 0.0 1.5 0.0 0.7 1.0 0.0 0.0 0.7 1.2 2.3 0.0 3.3 0.6 0.5 1.4 0.3 0.1 0.0 0.0 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.8 1.7 0.2 0.4 0.1 0.7 0.0 0.2 0.0 7.9 0.1 0.2 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.3 2.3 0.0 0.1 0.0 0.5 0.3 0.4 0.5 0.3 0.0 4.1 2.1 0.0 0.0 0.0 0.1 0.0 8.9 0.2 0.1 0.0 0.0 0.0 0.5 3.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.8 0.9 0.0 0.9 2.2 0.3 0.0 3.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 1.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 7.0 0.3 0.0 0.0 0.0 5.3 0.0 0.0 1.2 0.2 0.1 0.0 0.0 1.0 0.0 MYH2 "IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2" ENSG00000125414 "Myosin heavy chain 2" Q9UKX2 17 10521148-10549957 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "skeletal muscle: 559.4;tongue: 232.5" "Cell type enriched" "Detected in single" 38 "Cardiomyocytes: 3.8" "Cancer enriched" "Detected in single" 60 "head and neck cancer: 27.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 6.1;HSkMC: 3.0;NTERA-2: 13.0;SuSa: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001349, CAB010760" Enhanced NA NA 42000000 "CAB010760: AB_477190, HPA001349: AB_1079437" "unprognostic (6.50e-2)" "unprognostic (1.86e-2)" "unprognostic (4.76e-2)" "unprognostic (1.92e-2)" "unprognostic (1.05e-4)" "unprognostic (2.89e-1)" "unprognostic (9.51e-2)" "unprognostic (2.03e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" 10.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 11.6 0.1 559.4 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 232.5 11.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 13.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH3 "HEMHC, MYHC-EMB, MYHSE1, SMHCE" ENSG00000109063 "Myosin heavy chain 3" P11055 17 10628526-10657309 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.1;prostate: 25.6;skeletal muscle: 18.5" "Cell type enriched" "Detected in many" 17 "Early spermatids: 325.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 28 "HSkMC: 37.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.7" "Not detected" "Not detected" HPA021808 Enhanced NA NA 17000000 "HPA021808: AB_1854242" "unprognostic (1.70e-2)" "unprognostic (1.10e-3)" "unprognostic (4.19e-4)" "unprognostic (3.35e-1)" "unprognostic (7.66e-2)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (1.67e-2)" "unprognostic (3.54e-1)" "unprognostic (7.84e-4)" "unprognostic (1.29e-1)" "unprognostic (3.24e-4)" "unprognostic (1.91e-2)" "unprognostic (6.17e-3)" "unprognostic (3.40e-2)" "unprognostic (3.49e-1)" 1.0 0.5 0.7 0.8 1.0 0.6 0.8 1.9 0.8 2.2 4.1 0.6 3.5 0.9 1.9 13.2 21.1 1.0 0.6 0.6 0.9 0.6 0.8 1.8 0.6 1.0 0.9 0.6 1.4 1.3 0.5 0.7 1.1 0.6 25.6 0.9 0.6 0.7 16.2 18.5 1.5 1.4 16.5 1.2 1.6 0.8 2.8 0.6 1.8 2.3 1.7 2.0 8.5 2.6 1.0 0.1 0.0 0.1 0.9 0.7 0.0 0.1 0.6 0.4 0.7 0.6 0.2 0.6 0.4 0.2 0.3 0.3 0.6 0.1 0.4 0.2 0.2 0.1 0.6 0.3 0.1 0.6 0.4 0.6 0.6 0.1 1.0 0.2 0.3 0.9 37.9 0.2 0.4 0.5 0.1 0.0 0.8 0.2 0.0 0.1 0.4 0.5 1.3 0.6 0.1 0.4 0.5 0.5 0.1 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.0 0.6 0.1 0.0 0.8 0.6 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.7 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.9 0.0 0.1 0.6 0.0 0.7 1.0 1.9 0.8 0.9 0.6 0.9 0.6 0.6 0.6 0.0 12.7 0.0 0.8 2.6 3.8 2.6 2.5 0.0 1.2 0.0 5.9 0.4 0.0 0.4 325.0 0.5 0.9 0.0 0.5 0.6 0.4 0.7 7.0 0.6 0.1 0.0 0.0 0.6 1.2 18.6 2.6 1.2 1.7 0.0 0.5 2.9 0.5 0.0 2.5 0.0 3.9 0.0 0.1 7.7 3.6 1.4 0.5 0.9 0.8 0.1 MYH4 "MYH2B, MyHC-2B, MyHC-IIb" ENSG00000264424 "Myosin heavy chain 4" Q9Y623 17 10443290-10469559 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 29 "skeletal muscle: 15.1" "Cell type enriched" "Detected in single" 25 "Cardiomyocytes: 2.5" "Cancer enriched" "Detected in single" 115 "liver cancer: 9.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 25 "OE19: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA001349 Supported NA NA 34000000 "HPA001349: AB_1079437" "unprognostic (3.27e-2)" "unprognostic (2.94e-2)" "unprognostic (4.94e-2)" "unprognostic (1.69e-2)" "unprognostic (4.72e-1)" "unprognostic (1.37e-1)" "unprognostic (3.32e-2)" "unprognostic (1.21e-3)" "unprognostic (3.52e-4)" "unprognostic (9.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH6 ENSG00000197616 "Myosin heavy chain 6" P13533 14 23381990-23408277 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Atrial septal defect, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "heart muscle: 313.7" "Cell type enriched" "Detected in some" 1060 "Cardiomyocytes: 5369.5" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 23 "NTERA-2: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001239, HPA001349, CAB075723, CAB075724, CAB075725" Enhanced NA NA 20000000 "CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (2.09e-2)" "unprognostic (8.53e-4)" "unprognostic (1.80e-2)" "unprognostic (2.99e-1)" "unprognostic (1.66e-1)" "unprognostic (2.09e-1)" "unprognostic (1.66e-1)" "unprognostic (5.73e-2)" "unprognostic (1.44e-2)" "unprognostic (5.34e-3)" "unprognostic (6.90e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (1.22e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.2 0.2 0.0 0.1 313.7 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 8.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5369.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 MYH7 "CMD1S, CMH1, MPD1" ENSG00000092054 "Myosin heavy chain 7" P12883 14 23412738-23435718 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 644.7;skeletal muscle: 596.4" "Cell type enriched" "Detected in some" 2697 "Cardiomyocytes: 8327.1" "Group enriched" "Detected in some" 9 "head and neck cancer: 12.2;prostate cancer: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "HSkMC: 16.4" "Low region specificity" "Detected in many" "HPA001239, HPA001349, CAB015384" Enhanced NA NA 31000000 "CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437" "unprognostic (6.49e-2)" "unprognostic (8.27e-5)" "unprognostic (1.56e-1)" "unprognostic (3.04e-3)" "unprognostic (4.30e-1)" "unprognostic (7.33e-3)" "unprognostic (8.60e-2)" "unprognostic (1.55e-1)" "unprognostic (1.31e-1)" "unprognostic (1.22e-1)" "unprognostic (3.79e-1)" "unprognostic (5.38e-3)" "unprognostic (2.32e-1)" "unprognostic (1.20e-1)" "unprognostic (1.41e-1)" "unprognostic (2.28e-2)" 5.4 0.1 0.2 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 11.7 7.2 0.0 0.1 644.7 0.2 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 3.3 0.0 0.0 11.8 0.0 596.4 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 2.9 109.6 16.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8327.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYH7B "dJ756N5.1, KIAA1512, MHC14, MYH14" ENSG00000078814 "Myosin heavy chain 7B" A7E2Y1 20 34975403-35002437 "Predicted intracellular proteins" "Actin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 48.1;skeletal muscle: 63.0" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 73.8;Early spermatids: 27.3;Late spermatids: 53.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 4.5;U-138 MG: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.05e-4)" "unprognostic (1.64e-1)" "unprognostic (1.66e-2)" "unprognostic (2.71e-1)" "unprognostic (5.36e-2)" "unprognostic (1.46e-2)" "unprognostic (3.89e-2)" "unprognostic (5.44e-2)" "unprognostic (4.87e-1)" "unprognostic (4.72e-2)" "unprognostic (4.41e-3)" "unprognostic (1.92e-1)" "unprognostic (1.02e-4)" "unprognostic (8.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.44e-5)" 0.4 0.4 2.2 0.4 2.6 0.3 0.4 1.8 3.5 0.4 0.4 1.1 0.4 0.7 0.7 0.8 0.9 0.4 0.4 48.1 2.8 2.3 0.4 0.4 0.4 0.4 3.2 0.4 0.8 0.4 0.1 0.4 0.4 1.0 1.1 0.2 0.8 3.4 0.4 63.0 0.6 0.4 0.4 2.9 0.5 0.3 5.1 0.9 0.4 1.0 8.5 1.1 0.4 0.4 0.3 0.1 2.0 0.4 1.1 0.7 0.0 2.5 0.8 0.7 1.1 0.2 0.6 2.0 0.1 0.0 0.0 0.0 4.5 1.4 0.6 1.7 0.0 0.7 1.5 0.1 0.0 0.3 0.3 0.8 1.5 1.3 2.1 0.4 0.6 0.9 0.8 0.4 0.1 0.0 1.7 0.0 2.2 0.8 1.6 0.4 1.1 0.5 2.7 0.5 0.1 0.4 0.5 0.8 0.4 0.3 0.8 0.9 1.1 0.2 0.7 0.6 0.7 3.7 0.8 1.1 4.6 2.0 0.7 0.5 2.7 0.5 1.0 1.2 0.5 1.0 1.6 0.4 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.3 0.3 0.7 2.0 1.1 0.1 0.1 0.2 0.0 2.2 2.6 1.8 3.5 2.8 2.3 3.2 0.4 1.0 0.9 0.0 6.4 2.0 1.4 3.2 9.3 73.8 0.0 0.0 1.2 5.2 7.9 0.9 0.0 0.4 27.3 1.5 0.5 0.0 0.6 0.6 2.1 0.8 1.1 0.0 0.3 9.5 0.0 1.3 0.8 53.0 2.0 1.7 0.0 0.0 0.2 3.9 0.5 0.0 3.2 0.3 15.1 6.5 2.3 8.2 6.3 4.6 0.7 2.2 0.5 0.8 MYH8 "MyHC-peri, MyHC-pn" ENSG00000133020 "Myosin heavy chain 8" P13535 17 10390322-10421950 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "esophagus: 16.5;skeletal muscle: 18.3;tongue: 10.0" "Cell type enriched" "Detected in some" 4 "Proximal tubular cells: 29.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 0.7;renal cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HSkMC: 13.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA001349, CAB016527" Enhanced NA NA "CAB016527: AB_2147291, HPA001349: AB_1079437" "unprognostic (5.87e-2)" "unprognostic (5.13e-3)" "unprognostic (4.12e-2)" "unprognostic (1.25e-2)" "unprognostic (2.29e-3)" "unprognostic (1.08e-1)" "unprognostic (5.02e-3)" "unprognostic (7.87e-2)" "unprognostic (1.61e-1)" "unprognostic (3.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 18.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.8 0.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.5 0.0 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 MYL1 ENSG00000168530 "Myosin light chain 1" P05976 2 210290150-210315190 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "skeletal muscle: 743.1;tongue: 350.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "head and neck cancer: 36.0;prostate cancer: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HSkMC: 34.6" "Not detected" "Not detected" "HPA046859, HPA063034, HPA073827" Enhanced "Intracellular and membrane" NA NA 20000000 "HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: " "prognostic unfavorable (6.59e-4)" "unprognostic (1.88e-1)" 12.9 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 16.1 9.9 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 6.1 0.0 0.0 13.4 0.0 743.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 2.4 350.7 9.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 7.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 MYL10 "MGC3479, MYLC2PL, PLRLC" ENSG00000106436 "Myosin light chain 10" Q9BUA6 7 101613325-101629296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.5;skeletal muscle: 9.1" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 1.4;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "melanoma: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "PC-3: 12.3;RH-30: 7.1;SuSa: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA019763 Uncertain Uncertain Microtubules NA NA Microtubules "HPA019763: AB_1854243" "unprognostic (2.32e-2)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-2)" "unprognostic (2.78e-3)" "unprognostic (5.04e-3)" "unprognostic (8.93e-2)" "unprognostic (1.10e-2)" 0.2 0.1 0.2 0.2 0.2 1.5 0.2 0.2 0.3 1.9 0.2 0.2 0.2 0.1 0.9 0.4 0.2 0.4 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 2.7 2.0 0.2 2.9 0.9 0.2 0.3 0.2 9.1 1.1 0.2 0.2 0.2 0.2 0.1 0.9 0.2 0.2 0.2 2.9 0.6 1.0 0.2 1.4 1.0 4.5 0.9 1.4 1.3 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.9 0.0 0.3 0.1 0.5 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.8 0.1 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.5 0.0 0.2 0.3 0.0 12.3 0.0 7.1 0.0 0.1 0.5 0.2 0.0 0.1 0.1 1.2 3.7 0.2 0.1 0.3 0.6 1.3 0.0 0.2 0.4 0.2 1.2 0.1 0.3 0.0 4.5 0.9 0.8 0.4 0.5 0.4 0.9 0.6 0.8 0.3 1.4 0.9 0.7 3.4 1.4 0.5 1.0 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL12A "MLCB, MRCL3, MRLC3, MYL2B" ENSG00000101608 "Myosin light chain 12A" P19105 18 3247481-3256236 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 245.4;heart muscle: 248.0;skeletal muscle: 423.8" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 5937.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004503, HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes 70000000 "Nucleoplasm, Nucleoli fibrillar center" "CAB004503: AB_2282358, HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (2.14e-3)" "unprognostic (5.30e-2)" "unprognostic (1.80e-1)" "unprognostic (5.31e-2)" "unprognostic (3.03e-2)" "unprognostic (7.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.57e-3)" "unprognostic (2.02e-1)" "unprognostic (2.53e-2)" "unprognostic (1.49e-3)" "unprognostic (2.30e-1)" "unprognostic (9.86e-2)" "unprognostic (1.30e-1)" "unprognostic (4.98e-2)" "unprognostic (4.58e-3)" "unprognostic (7.13e-2)" 60.9 19.9 7.1 31.1 13.1 21.7 63.9 5.1 7.6 25.1 31.2 7.4 22.5 15.6 24.1 29.0 43.6 22.8 32.4 248.0 8.2 6.8 52.7 43.1 58.3 58.4 14.6 5.7 28.6 24.8 24.9 11.1 49.5 18.9 24.3 27.2 14.7 26.5 18.6 423.8 24.2 41.5 27.9 22.1 68.6 22.5 20.4 10.3 40.3 38.6 80.1 42.0 30.6 31.2 103.4 166.8 173.4 91.9 104.2 168.7 245.4 31.3 20.0 45.6 19.1 53.9 56.8 27.9 71.6 94.5 68.1 74.3 30.2 39.8 15.2 18.9 103.9 47.6 13.7 26.4 44.9 61.1 21.4 9.4 15.5 23.8 26.5 90.3 44.1 30.3 88.8 63.7 52.8 32.0 62.5 106.8 20.4 19.4 53.2 139.6 53.7 20.5 44.4 18.7 36.4 14.8 11.9 23.9 26.7 149.3 50.9 6.4 15.6 56.6 24.4 49.5 44.0 17.2 65.2 114.2 16.9 38.5 46.2 56.5 12.1 17.5 24.6 50.7 17.7 60.4 173.4 74.5 154.6 166.4 77.4 166.7 103.4 156.8 168.7 109.0 80.4 142.5 167.0 122.8 104.2 91.9 166.8 133.2 245.4 7.1 13.1 5.1 7.6 8.2 6.8 14.6 5.7 18.9 10.3 684.9 287.2 341.2 723.8 564.8 28.8 5937.2 466.2 370.7 324.2 485.1 11.8 673.0 399.6 1177.4 18.9 908.8 703.7 0.0 1306.6 996.1 418.1 441.5 501.9 258.7 758.2 54.0 101.2 852.6 651.0 20.6 309.8 806.5 420.1 2189.4 519.0 67.5 1678.2 662.9 372.7 509.4 40.9 562.7 473.8 61.2 173.0 476.5 557.0 1044.7 325.5 594.7 MYL2 CMH10 ENSG00000111245 "Myosin light chain 2" P10916 12 110910819-110920722 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "heart muscle: 656.7;skeletal muscle: 672.9" "Cell type enriched" "Detected in some" 10238 "Cardiomyocytes: 17552.7" "Group enriched" "Detected in some" 46 "head and neck cancer: 31.5;prostate cancer: 25.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 31 "memory B-cell: 3.8;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 38 "B-cells: 3.8" "Cell line enhanced" "Detected in some" "EFO-21: 4.3;HSkMC: 9.4;U-2 OS: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019763, HPA039262" Supported Uncertain Microtubules NA NA 190000 Microtubules "HPA019763: AB_1854243, HPA039262: AB_2676418" "unprognostic (2.07e-2)" "unprognostic (1.37e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.32e-1)" "unprognostic (4.05e-2)" "unprognostic (4.82e-2)" "unprognostic (2.05e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "unprognostic (3.55e-1)" 3.6 0.0 0.1 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 6.4 8.9 0.0 0.2 656.7 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 6.1 0.0 0.0 7.7 0.0 672.9 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 2.4 59.4 10.5 0.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 4.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.4 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.1 0.0 0.0 1.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 17552.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 MYL3 "CMH8, MLC1SB, MLC1V, VLC1" ENSG00000160808 "Myosin light chain 3" P08590 3 46857872-46882169 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "heart muscle: 398.1;skeletal muscle: 319.8" "Cell type enriched" "Detected in some" 65 "Cardiomyocytes: 3031.1" "Cancer enhanced" "Detected in many" "renal cancer: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 28.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016564, CAB018662, HPA046859, HPA063034" Enhanced Approved Nucleoli,Mitochondria NA NA 15000000 "Nucleoli, Mitochondria" "CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (3.11e-1)" "unprognostic (2.64e-2)" "unprognostic (5.55e-2)" "unprognostic (1.51e-1)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "unprognostic (9.67e-3)" "unprognostic (3.37e-2)" "unprognostic (4.72e-3)" "unprognostic (3.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.88e-2)" "prognostic favorable (1.22e-8)" "unprognostic (1.16e-3)" "unprognostic (9.45e-3)" "unprognostic (7.18e-5)" "unprognostic (2.53e-3)" 0.9 0.2 0.5 0.2 0.4 0.0 0.6 0.2 0.4 0.5 0.1 0.3 0.0 0.0 0.2 10.1 10.5 0.1 0.2 398.1 0.7 0.4 2.3 0.1 0.2 0.1 0.7 0.3 0.3 0.1 0.0 0.0 0.3 0.3 1.6 0.0 0.3 5.5 0.0 319.8 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.4 0.0 1.1 30.1 3.1 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 1.6 0.3 0.1 0.0 0.1 5.9 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.4 0.7 0.4 0.7 0.3 0.3 0.4 0.0 0.0 0.0 0.1 0.7 0.1 3031.1 0.0 0.0 0.0 1.8 0.0 0.4 46.4 0.0 2.0 0.3 0.0 0.0 0.0 5.0 7.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.5 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.7 46.2 0.4 6.5 1.3 0.0 0.4 0.4 0.7 0.0 0.0 0.0 MYL4 "ALC1, AMLC, GT1, PRO1957" ENSG00000198336 "Myosin light chain 4" P12829 17 47200446-47223679 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Atrial fibrillation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "heart muscle: 712.3" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 2384.1" "Group enriched" "Detected in some" 7 "testis cancer: 2.4;thyroid cancer: 11.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.2" "Cell line enriched" "Detected in some" 4 "HEL: 109.9" "Group enriched" "Detected in many" 6 "amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8" "Not detected" "Not detected" "HPA046859, HPA051884, HPA063034" Enhanced Approved "Plasma membrane" NA NA 140000 "Plasma membrane" "HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927" "unprognostic (2.43e-2)" "unprognostic (9.57e-2)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.33e-1)" "unprognostic (4.12e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.52e-2)" "unprognostic (2.10e-2)" "unprognostic (7.37e-2)" "unprognostic (1.00e-6)" "unprognostic (1.92e-4)" "unprognostic (2.54e-1)" "unprognostic (6.51e-3)" "unprognostic (1.50e-1)" 0.1 0.0 0.0 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 712.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.8 3.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.1 0.6 4.6 0.1 0.1 0.2 0.2 5.2 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 109.9 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.2 0.3 26.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.7 4.5 2384.1 0.0 0.0 0.0 0.0 60.9 0.4 0.0 0.0 16.3 3.0 0.3 443.9 0.0 2.6 2.1 0.0 0.0 0.0 1.8 1.6 0.0 1.3 0.0 42.1 3.1 0.0 11.8 0.0 0.0 4.9 0.1 0.0 1.4 0.0 17.0 0.0 2.0 1.5 0.4 0.6 1.1 0.0 0.0 0.0 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 61.5" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 71.2;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.0;ASC TERT1: 23.4" "Low region specificity" "Detected in many" "HPA037381, HPA039262" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: AB_2676418" "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 9.9 11.4 14.5 10.1 12.7 8.5 12.6 13.4 14.6 6.1 10.9 14.7 14.6 18.0 7.1 19.5 10.6 7.1 8.0 4.9 13.9 11.4 9.7 11.3 7.8 19.5 10.8 10.0 7.5 15.4 13.2 7.7 5.3 10.5 9.8 11.8 10.0 61.5 10.7 18.6 16.2 15.4 10.1 9.3 8.8 7.3 15.5 3.9 7.5 7.5 24.2 9.9 6.5 6.9 11.0 12.6 8.2 9.5 15.4 6.5 4.5 2.2 3.7 13.6 7.2 34.0 23.4 6.5 5.5 7.4 5.6 5.2 4.5 9.6 2.6 2.6 8.9 4.0 3.3 2.1 3.7 1.6 4.8 2.7 3.9 5.1 4.1 11.9 5.9 3.6 17.6 3.6 4.4 4.7 8.2 3.4 5.6 4.0 3.5 6.9 4.2 3.1 4.1 2.8 4.7 5.7 2.8 2.9 1.5 9.2 10.6 6.2 3.5 1.8 4.6 3.7 4.6 7.4 5.4 5.6 4.8 0.9 4.1 3.1 13.6 2.6 1.6 5.3 5.3 2.4 8.2 7.4 1.1 3.1 4.7 3.9 7.9 5.1 1.8 6.6 11.0 6.5 6.3 5.0 15.4 9.5 12.6 2.3 4.5 14.5 12.7 13.4 14.6 13.9 11.4 10.8 10.0 10.5 3.9 0.0 11.0 9.5 6.0 10.6 5.7 1.2 7.6 6.7 2.3 7.0 19.6 5.7 10.0 8.8 16.6 4.5 31.5 0.0 4.0 4.3 6.6 7.4 12.8 14.9 18.5 11.1 5.2 9.2 16.2 71.2 6.6 7.5 6.8 20.8 8.8 16.6 6.2 10.5 3.5 30.0 78.4 6.5 5.0 14.4 3.1 11.7 4.6 6.1 13.3 8.9 MYL6B MLC1SA ENSG00000196465 "Myosin light chain 6B" P14649 12 56152256-56159647 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Cell type enhanced" "Detected in many" 13 "Late spermatids: 863.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.6" "Group enriched" "Detected in all" 5 "B-cells: 5.3;dendritic cells: 15.6;T-cells: 12.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038887, HPA046859, HPA063034" Enhanced Approved Vesicles NA NA Vesicles "HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (5.25e-2)" "unprognostic (3.18e-1)" "unprognostic (6.29e-3)" "unprognostic (7.39e-2)" "unprognostic (5.37e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (1.02e-3)" "unprognostic (3.48e-1)" "unprognostic (1.53e-1)" "unprognostic (3.56e-3)" "unprognostic (3.42e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-2)" 5.6 10.0 32.0 4.8 33.1 5.4 8.7 11.9 26.7 13.9 4.1 8.0 8.5 3.0 9.8 12.8 8.4 13.2 9.7 13.6 24.1 21.8 9.3 6.2 4.5 6.9 20.7 21.6 20.0 4.8 17.4 14.1 5.1 13.4 12.6 4.0 11.0 7.3 8.3 129.0 5.1 4.1 8.4 10.7 3.9 5.1 24.9 10.2 11.5 9.9 10.7 8.8 5.6 5.0 5.3 15.6 1.8 2.3 2.0 12.0 3.1 7.5 13.0 35.4 33.8 7.5 27.0 24.7 8.8 39.1 35.3 34.5 9.3 12.6 12.7 19.6 19.0 13.5 4.3 16.6 21.5 19.1 22.9 24.1 13.3 13.4 16.3 23.8 9.7 9.3 45.2 8.7 32.6 12.7 75.2 38.1 30.9 14.0 13.1 29.0 9.9 26.5 32.2 29.7 7.2 22.5 28.0 21.9 16.7 26.8 5.1 32.6 47.9 9.8 12.0 17.8 27.1 9.9 16.6 21.1 20.8 17.8 10.7 18.9 18.6 10.6 10.5 22.2 9.8 22.7 0.7 2.3 0.7 1.8 2.2 1.0 5.3 3.7 3.0 5.4 3.5 2.7 2.2 1.8 2.0 0.9 15.6 12.0 3.1 32.0 33.1 11.9 26.7 24.1 21.8 20.7 21.6 13.4 10.2 62.5 29.6 26.0 41.8 29.5 53.0 14.1 30.6 21.4 20.5 104.7 23.6 31.3 127.6 41.5 257.0 40.5 19.3 0.0 17.8 53.4 50.7 40.2 12.7 25.5 36.1 31.8 151.1 46.1 17.2 863.2 74.8 25.0 38.8 73.9 31.3 69.7 27.9 20.1 62.6 129.3 46.7 51.8 46.7 90.0 52.8 22.2 18.9 13.8 36.0 36.2 MYL7 "MYL2A, MYLC2A" ENSG00000106631 "Myosin light chain 7" Q01449 7 44138864-44141332 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 822 "heart muscle: 639.9" "Cell type enriched" "Detected in single" 8987 "Cardiomyocytes: 8328.0" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "BEWO: 14.8;CACO-2: 50.4;SuSa: 20.8" "Not detected" "Not detected" "HPA013331, CAB033884, HPA039262" Enhanced NA NA "CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418" "unprognostic (1.00e-2)" "unprognostic (7.99e-2)" "unprognostic (4.36e-3)" "unprognostic (2.31e-1)" "unprognostic (2.51e-1)" "unprognostic (1.28e-1)" "unprognostic (7.85e-2)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 639.9 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.1 0.0 50.4 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.1 0.0 20.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8328.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL9 "LC20, MLC2, MRLC1, MYRL2" ENSG00000101335 "Myosin light chain 9" P24844 20 36541484-36551447 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 717.2;urinary bladder: 496.7" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 1565.8;Peritubular cells: 1778.4;Sertoli cells: 2108.4;Smooth muscle cells: 1718.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.6;neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 85.3;BJ: 110.6;fHDF/TERT166: 87.8;hTERT-RPE1: 70.2" "Low region specificity" "Detected in single" "HPA039262, HPA045244, HPA059197" Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA 92000000 "Nucleoplasm, Nucleoli fibrillar center" "HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944" "unprognostic (1.15e-1)" "unprognostic (5.05e-2)" "unprognostic (2.67e-3)" "unprognostic (5.38e-2)" "unprognostic (7.17e-2)" "unprognostic (5.06e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (9.06e-2)" "unprognostic (8.90e-2)" "prognostic unfavorable (7.92e-7)" "unprognostic (1.90e-2)" "unprognostic (8.41e-2)" "unprognostic (1.20e-1)" "unprognostic (1.92e-2)" 61.9 46.0 2.0 58.1 5.8 0.2 64.8 1.4 6.4 123.3 361.6 6.0 162.9 22.7 278.8 102.0 242.7 80.3 199.0 169.8 1.9 2.1 27.7 6.8 36.0 14.9 4.7 8.7 107.8 5.4 2.8 4.8 31.7 10.5 218.9 30.4 71.8 22.6 203.9 22.2 14.7 70.3 717.2 5.2 22.8 120.7 55.1 1.4 1.4 48.8 21.9 8.7 496.7 107.7 1.2 0.5 2.7 0.2 0.3 0.1 10.8 8.0 0.1 6.4 0.1 85.3 32.8 28.4 110.6 47.9 58.0 37.6 63.8 0.9 0.0 58.0 87.8 12.7 3.0 0.0 0.2 13.7 0.0 0.0 1.6 12.5 5.9 55.1 0.0 1.9 45.9 5.8 38.3 0.1 70.2 2.0 0.0 0.2 2.9 48.6 0.0 0.0 0.8 2.5 1.6 0.5 0.0 0.0 0.5 0.4 0.6 0.0 0.4 1.1 2.8 0.0 29.2 24.7 1.6 14.2 55.4 23.4 8.0 0.1 0.0 0.4 0.2 21.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.1 1.2 0.0 0.1 0.3 0.2 0.0 0.0 2.7 0.3 0.0 0.5 0.0 10.8 2.0 5.8 1.4 6.4 1.9 2.1 4.7 8.7 10.5 1.4 366.3 53.6 10.5 235.7 53.9 0.8 1565.8 30.6 20.1 50.0 85.5 0.0 24.0 23.2 211.4 5.9 105.7 0.0 0.0 105.2 66.4 237.6 45.8 15.0 1.1 29.4 1.6 0.0 219.1 4.8 25.6 307.2 19.2 69.2 26.2 0.1 179.9 56.1 0.0 1778.4 24.0 5.5 2108.4 1718.3 4.2 6.9 46.7 22.4 10.2 0.6 57.0 MYLIP "IDOL, MIR" ENSG00000007944 "Myosin regulatory light chain interacting protein" Q8WY64 6 16129125-16148248 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 84.0" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 294.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 33.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.54e-1)" "unprognostic (4.84e-3)" "unprognostic (2.79e-1)" "unprognostic (9.65e-3)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (1.11e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.75e-2)" "unprognostic (2.67e-2)" "unprognostic (5.44e-3)" "unprognostic (1.03e-2)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "prognostic favorable (4.11e-5)" 23.4 12.5 7.3 10.3 10.6 44.2 19.5 5.4 11.4 28.5 14.4 18.9 16.4 7.5 31.8 16.1 12.1 22.2 19.1 9.0 8.6 6.1 13.1 3.5 19.0 19.4 12.9 8.8 22.3 10.5 9.8 6.1 84.0 7.4 20.1 9.7 20.2 16.2 20.9 20.6 16.7 15.7 18.0 7.0 23.5 14.8 15.2 12.2 8.8 39.1 10.9 15.7 19.0 33.7 4.9 1.4 14.2 2.3 3.2 8.4 1.5 2.0 4.1 1.7 2.0 17.3 4.6 4.5 1.4 3.4 3.5 7.6 11.5 2.1 9.2 7.4 2.2 2.4 5.1 8.1 2.5 3.0 3.3 8.4 6.2 4.3 2.1 2.5 4.2 6.1 7.4 3.3 1.8 1.4 1.7 8.0 2.0 17.8 10.9 1.3 7.7 0.1 20.8 4.9 4.9 3.7 2.1 7.9 33.8 3.7 24.6 8.6 3.7 1.8 18.8 9.5 14.8 3.5 10.4 2.3 1.6 4.0 1.2 3.6 10.1 4.4 4.9 1.0 12.3 5.5 8.5 2.3 11.1 8.4 2.2 7.3 4.9 5.3 5.9 1.4 4.9 5.9 5.4 14.2 3.2 2.0 0.7 3.2 1.5 7.3 10.6 5.4 11.4 8.6 6.1 12.9 8.8 7.4 12.2 20.8 36.3 30.2 28.3 87.0 7.3 74.2 35.7 21.4 18.2 21.0 0.0 113.9 8.3 14.9 36.7 33.1 32.6 0.0 16.2 65.2 75.2 27.4 35.7 1.0 27.7 11.1 80.9 34.4 42.6 12.5 35.6 21.9 75.9 26.2 35.2 15.3 8.1 32.3 58.0 18.8 6.6 135.8 92.6 59.7 17.5 73.4 294.6 88.3 34.8 26.9 MYLK "MLCK, MLCK1, MYLK1, smMLCK" ENSG00000065534 "Myosin light chain kinase" Q15746 3 123610049-123884331 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 191.1" "Cell type enhanced" "Detected in many" 16 "Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3" "Cell line enhanced" "Detected in many" "BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020789, HPA031677, HPA048055" Enhanced Enhanced "Plasma membrane,Actin filaments" NA NA 3000000 "Actin filaments" "Plasma membrane" "CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543" "unprognostic (2.80e-2)" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (2.85e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.40e-1)" "unprognostic (8.21e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (2.04e-6)" "unprognostic (5.26e-3)" "unprognostic (9.60e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.46e-4)" 14.9 4.9 4.5 19.8 10.9 0.0 14.4 0.8 5.8 77.1 107.3 22.0 93.2 9.4 111.2 48.3 96.0 56.3 40.6 6.6 4.7 3.2 8.3 5.4 13.2 6.5 25.8 2.8 50.2 1.6 0.5 1.1 8.0 16.0 85.1 27.6 6.0 17.6 158.6 1.6 4.8 33.3 191.1 28.8 7.4 38.7 17.4 13.0 0.2 4.1 2.5 3.4 137.1 21.3 0.2 2.8 4.5 1.3 0.0 0.2 17.3 2.5 7.7 2.0 1.3 2.1 0.4 0.9 36.4 55.1 23.6 16.9 1.6 1.4 0.1 8.2 45.0 11.2 0.9 0.9 0.3 29.0 0.0 0.1 20.3 0.2 5.0 10.9 0.1 1.9 6.8 0.7 4.6 6.9 38.5 1.8 0.2 0.2 0.1 17.4 0.3 0.0 0.5 2.2 0.1 1.0 2.3 1.2 6.6 59.6 1.4 0.3 1.1 3.7 0.4 0.6 5.0 0.2 0.0 6.7 7.2 2.6 1.7 5.9 0.6 0.7 0.0 18.5 0.2 1.8 3.6 1.3 0.3 0.1 0.2 0.0 0.2 0.0 0.0 2.8 0.1 0.2 0.1 4.5 0.0 0.0 2.7 0.1 17.3 4.5 10.9 0.8 5.8 4.7 3.2 25.8 2.8 16.0 13.0 14.9 34.7 2.9 24.1 18.2 2.5 16.5 33.1 5.3 6.8 26.2 117.8 0.6 3.3 4.5 38.5 34.3 13.8 0.0 3.6 0.6 23.4 4.9 2.3 169.4 4.0 3.2 10.9 66.9 9.2 26.0 97.0 8.0 18.6 0.0 3.0 4.8 2.7 24.0 649.2 9.6 18.7 271.7 829.4 3.0 3.3 17.7 2.1 0.5 3.7 1.6 MYLK2 "KMLC, MLCK2, skMLCK" ENSG00000101306 "Myosin light chain kinase 2" Q9H1R3 20 31819308-31834689 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 176.1" "Cell type enhanced" "Detected in single" 29 "Hofbauer cells: 1.4" "Cancer enhanced" "Detected in some" "glioma: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.3;RH-30: 13.5;RPMI-8226: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA059704, HPA059890" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA059704: AB_2684108, HPA059890: AB_2684153" "unprognostic (1.74e-2)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (5.27e-2)" "prognostic favorable (4.00e-4)" "unprognostic (5.58e-2)" "unprognostic (1.38e-7)" "unprognostic (2.29e-1)" "unprognostic (2.60e-3)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (4.73e-2)" "unprognostic (7.25e-11)" "unprognostic (2.01e-1)" "unprognostic (3.15e-1)" "unprognostic (2.60e-2)" "unprognostic (2.70e-2)" 1.4 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.4 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.3 176.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.1 18.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.8 0.0 0.0 0.5 0.1 0.0 0.4 0.1 0.3 0.3 0.6 0.4 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.2 0.7 0.3 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.0 1.7 1.0 0.7 0.2 5.3 0.1 0.8 0.7 0.4 0.7 0.0 0.4 0.8 13.5 10.9 0.1 0.1 0.7 0.6 3.4 0.1 0.0 0.1 0.1 0.1 2.7 0.3 1.0 0.6 3.0 0.1 1.0 0.2 0.2 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 MYLK3 "caMLCK, MLCK" ENSG00000140795 "Myosin light chain kinase 3" Q32MK0 16 46703369-46790407 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 162.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1" "Group enriched" "Detected in some" 7 "cerebral cortex: 9.8;hippocampal formation: 5.7" "Region enriched" "Detected in single" 5 "hippocampal formation: 5.2" HPA073447 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA073447: AB_2732225" "unprognostic (6.01e-4)" "unprognostic (2.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.77e-2)" "unprognostic (1.84e-1)" "unprognostic (2.94e-3)" "unprognostic (2.60e-1)" "unprognostic (4.73e-2)" "unprognostic (3.33e-2)" "unprognostic (2.41e-2)" "unprognostic (6.58e-3)" "unprognostic (1.83e-1)" "unprognostic (4.16e-2)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (1.08e-2)" "unprognostic (2.97e-1)" 0.0 0.1 0.7 0.0 1.7 0.1 0.0 0.1 0.2 0.2 0.0 3.8 0.0 0.0 0.1 3.4 2.0 0.8 0.1 62.2 1.5 1.4 0.4 0.0 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.5 0.2 6.6 1.0 0.0 0.0 1.3 0.0 20.8 0.0 0.0 0.0 0.3 0.0 0.0 2.9 0.3 0.0 0.1 31.1 1.1 0.1 0.0 1.2 0.9 2.6 0.7 1.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 1.6 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 6.1 0.2 2.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.5 0.7 0.6 0.6 0.4 0.4 0.7 0.5 0.5 0.3 1.2 0.7 0.7 2.6 1.2 0.5 0.9 0.3 0.2 0.7 1.7 0.1 0.2 1.5 1.4 0.1 0.4 6.6 0.3 0.0 3.5 0.0 0.7 0.0 0.5 162.4 0.0 16.0 6.8 0.0 2.0 1.4 0.0 0.0 7.4 0.0 0.0 0.0 0.2 0.4 1.4 0.6 1.1 0.0 0.4 0.0 0.0 0.6 0.0 3.2 0.6 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.0 0.2 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell type enhanced" "Detected in some" 6 "Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Proximal tubular cells: 2.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "HEL: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.2 0.6 1.2 1.0 1.2 0.6 0.7 1.6 0.5 0.4 0.5 1.1 1.1 1.6 0.8 0.2 1.9 0.2 0.5 0.7 0.2 0.6 12.7 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.6 0.5 0.2 0.1 0.1 0.3 0.5 0.1 1.4 0.2 0.4 0.0 0.9 0.0 0.0 0.9 0.3 1.0 0.6 0.3 0.2 0.5 1.1 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.3 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 3.0 0.6 0.0 0.1 0.1 0.8 1.2 2.5 0.0 1.2 0.0 0.0 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 1.6 1.2 0.0 0.3 0.0 0.3 1.0 0.0 1.8 0.0 0.2 0.0 0.0 1.4 2.9 0.2 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.1 MYLPF "HUMMLC2B, MRLC2, MYL11" ENSG00000180209 "Myosin light chain, phosphorylatable, fast skeletal muscle" Q96A32 16 30370934-30377991 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "skeletal muscle: 689.9;tongue: 215.7" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 18.9;Early spermatids: 13.3;Late spermatids: 16.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 71 "plasmacytoid DC: 16.5" "Lineage enriched" "Detected in single" 71 "dendritic cells: 16.5" "Group enriched" "Detected in some" 18 "BEWO: 26.1;HSkMC: 58.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039262, HPA055059" Enhanced NA NA 28000 "HPA039262: AB_2676418, HPA055059: AB_2732591" "unprognostic (8.81e-3)" "unprognostic (7.55e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (2.07e-2)" "unprognostic (1.18e-2)" "unprognostic (1.53e-1)" "unprognostic (1.37e-3)" "unprognostic (8.26e-4)" "unprognostic (1.28e-1)" "unprognostic (1.16e-2)" "unprognostic (5.52e-2)" "unprognostic (4.14e-4)" "unprognostic (1.84e-1)" "unprognostic (3.88e-1)" "unprognostic (7.07e-3)" "unprognostic (1.44e-2)" 16.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 2.1 5.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 10.4 0.0 689.9 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 215.7 5.8 0.0 0.0 0.1 16.5 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 26.1 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 16.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 2.9 3.0 1.5 0.8 0.9 1.6 2.5 5.3 0.0 7.0 0.0 18.9 0.0 0.5 13.3 0.7 1.1 0.0 0.8 8.3 1.3 1.2 8.1 0.9 3.7 0.0 3.5 4.3 6.6 16.9 1.1 1.7 1.7 1.8 2.5 1.0 0.4 5.8 0.4 2.6 1.8 0.0 1.8 0.7 1.6 1.0 5.5 3.1 1.8 2.2 MYMK "TMEM226, TMEM8C" ENSG00000187616 "Myomaker, myoblast fusion factor" A6NI61 9 133514586-133528612 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Myogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 34 "HSkMC: 18.4;RH-30: 8.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA051846, HPA055785" Uncertain NA NA "HPA051846: AB_2681636, HPA055785: AB_2682920" "unprognostic (9.17e-3)" "unprognostic (8.63e-2)" "unprognostic (3.76e-1)" "unprognostic (1.13e-1)" "unprognostic (1.03e-1)" "unprognostic (5.37e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-1)" 0.6 0.2 0.5 0.0 3.3 0.2 0.0 0.7 2.6 0.0 0.0 0.8 0.0 0.0 0.0 3.1 0.6 0.1 0.0 0.3 1.0 0.4 1.7 0.2 0.3 0.0 0.9 2.1 0.0 0.0 0.0 0.1 2.0 1.6 0.6 0.0 0.0 0.2 0.0 8.0 0.2 0.0 0.0 0.4 0.1 0.0 1.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.3 0.7 2.6 1.0 0.4 0.9 2.1 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYMX MINION ENSG00000262179 "Myomixer, myoblast fusion factor" A0A1B0GTQ4 6 44216939-44218236 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "adipose tissue: 27.4;blood: 12.2;pancreas: 9.0" "Cell type enhanced" "Detected in some" 24 "Distal tubular cells: 3.3;Exocrine glandular cells: 2.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 121 "dendritic cells: 12.2" "Cell line enriched" "Detected in some" 31 "RH-30: 56.5" "Not detected" "Not detected" HPA051451 Supported Approved Vesicles,Mitochondria,Cytosol NA NA Vesicles "Mitochondria, Cytosol" "HPA051451: " "unprognostic (1.24e-1)" "unprognostic (8.55e-2)" "unprognostic (6.86e-2)" "unprognostic (6.51e-3)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-2)" "unprognostic (2.10e-3)" "unprognostic (4.32e-1)" "unprognostic (1.77e-1)" "unprognostic (8.71e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-4)" "unprognostic (1.63e-2)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.67e-1)" 27.4 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.8 0.0 1.1 0.0 0.5 1.4 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.7 0.0 2.2 0.0 0.1 0.0 0.0 1.8 3.2 0.6 0.0 2.8 0.4 0.0 0.4 0.5 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 56.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYO15A "DFNB3, MYO15" ENSG00000091536 "Myosin XVA" Q9UKN7 17 18108706-18179806 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 46.1" "Group enriched" "Detected in many" 6 "Early spermatids: 72.6;Late spermatids: 42.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;EFO-21: 2.7;HSkMC: 2.1;RPMI-8226: 3.2;SuSa: 3.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "hippocampal formation: 2.7" HPA078501 Enhanced NA NA "HPA078501: AB_2732383" "unprognostic (2.48e-3)" "unprognostic (5.31e-2)" "unprognostic (2.87e-3)" "unprognostic (7.35e-3)" "unprognostic (4.92e-3)" "unprognostic (2.33e-1)" "unprognostic (8.32e-4)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-3)" "unprognostic (8.38e-2)" "unprognostic (4.18e-3)" "unprognostic (5.69e-3)" "unprognostic (9.89e-2)" "unprognostic (1.47e-1)" "unprognostic (2.21e-2)" 0.5 0.0 0.5 0.6 0.7 0.0 0.5 2.3 1.6 0.5 0.5 0.5 0.5 0.2 1.7 3.4 0.5 1.0 0.5 0.5 0.5 1.2 0.5 0.8 1.5 0.5 0.5 0.5 3.0 0.5 2.2 46.1 0.5 0.7 0.5 0.4 0.5 0.5 1.6 0.5 0.1 0.9 0.5 0.5 0.5 0.6 7.4 0.5 0.5 0.9 0.5 0.5 0.5 0.5 0.7 0.4 3.8 0.9 0.6 0.3 0.1 0.1 0.0 1.4 0.0 0.8 2.5 0.4 0.1 0.8 0.0 0.0 0.5 0.3 0.1 2.7 0.8 0.1 0.4 0.0 0.7 0.0 1.3 0.6 0.0 0.3 0.0 0.4 0.0 0.0 2.1 0.0 0.4 0.6 0.4 0.0 0.4 0.0 0.4 0.0 0.5 0.1 0.5 0.1 1.0 0.0 0.2 0.4 3.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 3.4 1.4 0.3 0.2 0.0 0.1 0.0 0.0 0.9 1.4 0.1 0.0 0.1 0.4 3.8 0.5 0.5 0.2 0.9 0.3 0.7 0.1 0.1 0.2 0.4 0.2 0.3 1.4 0.6 0.2 0.4 0.1 0.1 0.5 0.7 2.3 1.5 0.5 1.2 0.5 0.5 0.7 0.5 0.0 1.4 0.0 2.0 1.3 1.8 2.5 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.5 72.6 0.7 0.0 0.0 0.7 0.2 0.9 1.5 5.8 1.6 0.5 9.5 4.1 0.6 0.3 42.1 1.1 1.1 3.3 1.0 0.3 3.1 0.4 0.0 1.1 0.4 2.7 0.0 1.0 4.8 8.1 1.1 0.6 0.0 0.4 1.0 MYO15B MYO15BP ENSG00000266714 "Myosin XVB" 17 75588058-75626501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "intestine: 155.3" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 148.8;Paneth cells: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 26.0;HEL: 10.9;HMC-1: 14.9;THP-1: 21.5" "Not detected" "Not detected" "HPA022857, HPA023105" Approved Cytosol No No Cytosol "HPA022857: AB_1848813, HPA023105: AB_1859526" "prognostic favorable (9.34e-4)" "unprognostic (7.55e-2)" "unprognostic (6.99e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (5.59e-4)" "unprognostic (7.29e-3)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-3)" "unprognostic (1.04e-2)" "unprognostic (1.49e-1)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.90e-5)" 7.5 2.8 4.2 7.3 5.3 13.8 8.9 1.6 4.3 8.0 58.9 8.1 5.4 48.9 13.6 4.5 2.8 10.8 13.5 5.8 4.5 1.7 13.0 2.0 10.7 5.0 6.5 5.5 14.9 3.6 1.8 3.7 4.0 5.1 7.1 5.9 6.5 5.2 4.5 3.1 3.9 155.3 5.9 4.0 13.2 4.8 3.1 5.9 5.5 14.0 2.3 4.0 4.9 7.2 2.8 2.0 6.2 1.5 1.9 1.4 1.1 0.3 26.0 0.3 1.0 0.2 0.4 0.4 0.1 0.0 0.0 0.0 3.4 7.4 0.4 1.0 0.0 0.3 0.4 0.0 0.0 0.0 0.3 2.0 10.9 5.0 6.4 0.7 0.0 14.9 0.7 0.5 0.0 0.0 0.5 0.1 4.6 0.6 2.9 0.0 3.5 0.2 4.3 0.5 7.2 6.5 6.8 0.2 1.1 0.1 0.5 1.0 2.0 0.2 0.4 0.8 0.9 2.3 21.5 0.5 0.1 1.1 0.1 0.1 1.4 0.8 0.1 0.6 5.3 0.4 2.4 1.5 1.2 1.4 1.4 0.9 1.5 0.7 0.5 0.8 2.8 0.5 1.0 6.2 1.9 1.5 2.0 0.2 1.1 4.2 5.3 1.6 4.3 4.5 1.7 6.5 5.5 5.1 5.9 0.0 3.5 8.0 2.1 2.2 3.8 5.6 10.2 6.7 2.3 8.7 15.7 0.1 1.7 1.5 0.5 9.8 148.8 0.0 1.4 0.1 5.1 1.7 13.9 1.6 4.7 1.6 30.4 25.2 9.1 0.4 5.2 10.2 3.3 1.8 31.9 6.1 5.2 56.1 4.6 12.7 14.2 6.5 3.8 3.5 3.6 2.6 0.1 4.3 11.1 1.6 MYO16 "KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107" ENSG00000041515 "Myosin XVI" Q9Y6X6 13 108596152-109208007 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 8.0;Hepatocytes: 4.7;Late spermatids: 8.9;Muller glia cells: 3.9;Spermatocytes: 4.2;Spermatogonia: 6.8" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 10 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 1.6;SH-SY5Y: 6.7;U-2197: 4.0" "Group enriched" "Detected in all" 4 "basal ganglia: 21.9;olfactory region: 88.9" "Low region specificity" "Detected in all" "HPA040110, HPA058769, HPA071948" Uncertain Approved Vesicles NA NA Vesicles "HPA040110: AB_10796339, HPA058769: AB_2683814, HPA071948: AB_2686475" "unprognostic (7.55e-3)" "unprognostic (7.74e-3)" "unprognostic (4.52e-4)" "unprognostic (5.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.53e-1)" "unprognostic (6.50e-2)" "unprognostic (9.01e-3)" "unprognostic (5.29e-2)" "unprognostic (4.68e-4)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "unprognostic (7.06e-2)" "unprognostic (2.34e-2)" 3.4 2.2 4.0 0.9 3.7 0.4 0.8 2.4 9.2 0.9 0.6 1.5 0.0 0.6 0.5 0.5 1.0 0.5 0.5 2.4 7.5 3.2 0.6 4.8 0.8 0.9 1.8 4.5 0.5 0.7 0.3 5.7 0.6 5.7 1.1 0.6 0.7 0.6 2.0 0.4 0.7 0.5 1.4 5.1 0.5 0.6 3.0 0.0 0.0 0.5 0.0 1.1 0.5 1.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 4.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 3.7 2.4 9.2 7.5 3.2 1.8 4.5 5.7 0.0 0.0 1.1 0.0 0.0 0.2 3.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 1.1 4.7 0.1 0.0 0.0 0.0 0.0 8.9 0.9 0.0 1.7 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 4.2 6.8 0.0 0.2 0.0 0.0 0.0 MYO18A "KIAA0216, MysPDZ" ENSG00000196535 "Myosin XVIIIA" Q92614 17 29071124-29180412 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 179.7" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 31.3;Club cells: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 29.3" "Low region specificity" "Detected in all" HPA019646 Supported NA NA 80000 "HPA019646: AB_1854249" "unprognostic (2.54e-2)" "unprognostic (1.08e-1)" "unprognostic (5.36e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.48e-1)" "unprognostic (1.72e-1)" "unprognostic (3.31e-2)" "unprognostic (8.70e-2)" "prognostic unfavorable (3.28e-4)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "prognostic favorable (3.18e-4)" "unprognostic (6.94e-2)" "unprognostic (2.12e-2)" "unprognostic (6.95e-3)" "unprognostic (1.95e-1)" 8.3 3.6 11.9 5.8 15.5 7.7 8.6 23.1 18.7 6.1 6.7 15.9 3.6 9.0 6.5 5.4 11.8 4.4 7.2 24.6 15.2 9.4 4.0 9.2 5.2 4.8 13.6 9.9 5.1 9.3 7.4 3.4 4.0 11.4 6.0 4.8 4.4 7.4 5.1 179.7 11.7 9.0 6.3 15.7 4.8 9.0 4.3 12.9 8.0 5.7 14.5 9.1 4.8 5.9 2.2 2.3 2.9 1.8 2.1 3.0 0.7 14.3 20.2 7.8 4.0 2.1 3.6 12.5 6.9 6.8 6.0 4.2 5.0 10.2 1.5 7.7 4.9 8.8 16.5 3.0 11.4 2.4 16.6 5.7 1.3 6.0 5.5 3.1 1.7 1.8 4.2 6.7 3.6 1.6 9.9 2.1 6.2 17.6 2.6 2.9 4.9 5.1 1.4 1.6 29.3 4.5 18.1 8.7 4.4 4.6 10.7 4.1 4.2 6.8 22.9 5.0 5.4 5.3 2.1 2.5 3.9 4.8 2.6 4.7 5.1 8.5 2.9 4.9 1.3 10.4 2.5 1.6 2.4 2.3 1.8 3.0 0.9 1.7 1.8 1.8 2.2 2.4 1.4 2.9 2.1 1.7 2.3 1.3 0.7 11.9 15.5 23.1 18.7 15.2 9.4 13.6 9.9 11.4 12.9 11.9 6.5 0.5 0.8 0.9 7.1 31.3 5.1 2.7 14.8 1.8 9.8 0.4 0.0 2.1 1.0 4.3 7.3 0.0 1.2 2.4 0.8 0.6 1.1 3.4 0.9 1.6 2.4 1.8 0.8 0.2 2.0 1.8 0.0 1.8 3.9 2.5 3.1 4.0 2.8 0.8 4.0 0.0 1.3 1.0 1.6 0.6 0.2 1.3 2.4 0.7 MYO18B BK125H2.1 ENSG00000133454 "Myosin XVIIIB" 22 25742144-26031041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 141.2" "Group enriched" "Detected in some" 45 "Cardiomyocytes: 88.1;Early spermatids: 50.3;Late spermatids: 28.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;REH: 11.2;RH-30: 23.8;U-2 OS: 10.5;U-266/70: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA000953 Uncertain Supported Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA000953: AB_1079440" "unprognostic (3.28e-2)" "unprognostic (1.79e-1)" "unprognostic (1.86e-2)" "unprognostic (1.23e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-2)" "unprognostic (5.93e-4)" "unprognostic (2.46e-1)" "unprognostic (1.22e-1)" "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (2.96e-3)" "unprognostic (3.93e-7)" "unprognostic (1.14e-1)" "unprognostic (3.12e-1)" "unprognostic (5.06e-2)" "unprognostic (1.65e-1)" 3.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.4 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 1.0 0.0 141.2 0.1 0.0 1.5 0.0 0.0 0.3 2.4 0.0 0.3 1.1 16.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.7 2.9 0.0 0.3 1.2 0.0 0.0 0.0 11.2 23.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 7.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 28.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 MYO1A "DFNA48, MYHL" ENSG00000166866 "Myosin IA" Q9UBC5 12 57028517-57051198 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "intestine: 148.0" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 221.7;Mucus-secreting cells: 59.5;Paneth cells: 51.8;Undifferentiated cells: 76.4" "Group enriched" "Detected in many" 13 "colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8" "Region enhanced" "Detected in single" "pons and medulla: 1.3" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;monocytes: 1.2" "Cell line enriched" "Detected in some" 5 "OE19: 30.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA053490 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA053490: AB_2682168" "unprognostic (2.77e-2)" "unprognostic (2.00e-3)" "unprognostic (1.04e-1)" "unprognostic (1.20e-1)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (6.04e-2)" "unprognostic (4.26e-2)" "unprognostic (8.96e-2)" "unprognostic (2.14e-1)" "unprognostic (2.38e-2)" "unprognostic (6.89e-2)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (8.72e-2)" 0.1 0.1 0.1 5.2 0.2 0.0 0.1 0.1 0.2 0.1 57.2 0.3 0.1 70.0 0.1 0.1 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.2 1.3 0.1 14.1 0.1 0.2 0.1 0.1 0.1 148.0 0.4 4.7 0.1 3.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 2.9 0.0 1.2 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 1.1 0.0 30.9 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 221.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 23.7 0.0 0.3 0.2 0.0 0.9 0.0 0.0 59.5 0.0 0.2 51.8 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.0 0.0 76.4 0.0 MYO1B myr1 ENSG00000128641 "Myosin IB" O43795 2 191245185-191425389 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 92.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 306.7;Hepatocytes: 373.0;Sertoli cells: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.7;naive B-cell: 2.7;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 4 "B-cells: 2.7;T-cells: 1.2" "Cell line enhanced" "Detected in many" "hTERT-HME1: 75.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013607, HPA060144" Approved Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA013607: AB_1854251, HPA060144: AB_2684211" "unprognostic (4.11e-3)" "unprognostic (7.36e-3)" "unprognostic (1.21e-1)" "unprognostic (4.83e-3)" "unprognostic (2.78e-1)" "unprognostic (1.59e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-2)" "unprognostic (3.25e-3)" "unprognostic (5.85e-2)" "unprognostic (4.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" 18.8 2.5 3.3 5.9 4.3 0.2 21.8 1.4 4.7 8.2 8.0 2.1 21.6 4.2 11.8 8.2 9.0 4.9 8.9 11.6 3.6 3.1 12.2 92.7 34.5 6.6 3.6 2.3 7.8 34.3 15.0 3.1 15.7 4.4 8.5 7.4 5.8 7.5 18.6 9.3 7.5 5.4 6.7 2.7 6.6 5.0 3.6 2.0 3.6 9.3 10.4 4.8 10.3 9.9 2.7 0.4 0.0 0.0 0.0 1.2 0.0 20.3 10.5 17.2 5.1 4.7 20.4 15.5 38.9 19.3 27.0 26.9 12.9 1.8 0.0 6.5 44.7 10.9 45.2 5.6 33.5 34.0 0.0 4.9 0.0 4.9 16.4 11.1 0.4 0.1 8.2 23.2 28.1 75.9 10.0 4.9 8.7 0.0 0.0 24.8 8.6 7.7 2.4 11.2 1.3 16.7 10.0 10.9 1.5 10.6 8.6 8.7 22.8 13.1 2.3 11.7 15.3 2.1 0.6 5.9 25.9 12.9 15.6 4.5 0.2 0.0 0.2 15.7 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 4.3 1.4 4.7 3.6 3.1 3.6 2.3 4.4 2.0 306.7 93.9 10.0 37.0 68.2 1.1 4.8 48.4 32.1 87.6 66.3 0.0 4.5 0.0 92.7 2.8 24.0 13.9 0.0 38.3 21.2 34.0 35.8 3.5 373.0 3.5 0.0 56.1 3.7 8.6 3.2 4.6 4.7 25.3 1.8 23.5 69.7 41.1 49.5 8.5 1.3 1.5 200.5 74.6 1.4 18.9 24.6 2.9 4.3 30.4 41.7 MYO1F ENSG00000142347 "Myosin IF" O00160 19 8520790-8577577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 69.4;Kupffer cells: 191.9;Macrophages: 117.9;T-cells: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 15.5;HL-60: 15.3;HMC-1: 27.2;NB-4: 60.4;THP-1: 45.0;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055242, HPA056036" Enhanced Enhanced Cytosol NA NA 8800 Cytosol "HPA055242: AB_2682754, HPA056036: " "unprognostic (4.86e-2)" "unprognostic (5.86e-3)" "unprognostic (1.39e-2)" "unprognostic (1.04e-3)" "unprognostic (1.76e-2)" "unprognostic (2.12e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (7.47e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (3.23e-1)" "unprognostic (2.64e-2)" "unprognostic (1.57e-1)" "unprognostic (9.35e-2)" 7.6 3.7 4.8 22.9 9.1 50.6 3.6 1.0 4.6 2.2 4.3 7.5 0.4 4.6 2.1 4.7 2.7 5.4 6.5 4.0 5.2 3.1 3.7 6.2 17.1 24.8 9.0 1.7 2.5 2.3 0.6 2.3 4.8 6.9 3.3 2.3 3.5 3.3 1.3 1.2 1.8 8.5 3.9 9.9 56.1 3.9 1.3 7.0 4.2 2.7 1.8 11.1 6.8 2.5 1.5 15.4 64.9 23.7 7.5 14.9 18.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 15.5 0.0 11.2 0.0 0.0 0.0 15.3 27.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 60.4 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 45.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 24.8 0.0 14.4 23.7 24.5 14.9 19.6 11.6 1.5 5.9 10.2 15.4 0.7 0.4 4.6 64.9 7.5 22.4 1.9 8.1 18.6 4.8 9.1 1.0 4.6 5.2 3.1 9.0 1.7 6.9 7.0 3.0 20.1 25.2 1.9 3.0 0.7 2.1 7.6 0.0 4.5 1.8 2.0 4.1 1.7 1.2 5.2 2.7 2.1 23.3 0.8 6.0 3.1 1.2 30.1 5.6 69.4 6.4 1.2 14.1 191.9 3.6 2.3 117.9 6.8 53.3 1.7 1.4 1.7 1.9 1.1 2.1 0.3 0.0 2.8 2.7 2.1 4.6 4.2 142.2 2.4 1.4 MYO1G HA-2 ENSG00000136286 "Myosin IG" B0I1T2 7 44962662-44979098 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8" "Cell type enriched" "Detected in many" 7 "monocytes: 573.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.2;HEL: 24.5;HL-60: 14.0;JURKAT: 30.5;MOLT-4: 31.0;NB-4: 13.1;THP-1: 27.5;U-937: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021252 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 120000 "Plasma membrane" Nucleoplasm "HPA021252: AB_1854254" "unprognostic (2.74e-2)" "prognostic favorable (8.26e-4)" "unprognostic (5.20e-3)" "unprognostic (9.91e-3)" "unprognostic (1.27e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (4.54e-3)" "unprognostic (6.47e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (8.71e-8)" "unprognostic (3.20e-1)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (7.92e-2)" 2.5 1.2 1.6 11.0 3.0 27.4 1.5 0.4 2.0 1.0 1.9 0.7 0.0 1.8 1.2 2.1 2.4 1.9 3.6 3.2 1.0 0.9 1.9 1.9 13.0 18.6 4.5 0.0 0.9 0.8 0.0 0.9 1.5 2.7 1.5 1.1 1.5 5.8 0.5 0.6 1.2 8.3 1.9 2.6 22.3 2.1 0.9 1.8 46.8 2.1 2.2 26.6 4.7 1.3 9.9 14.0 9.4 37.9 6.7 24.4 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 24.5 0.8 0.0 0.0 14.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 31.0 13.1 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 20.2 0.0 9.4 17.0 5.2 19.9 29.6 12.6 9.9 12.7 17.4 14.0 6.6 4.6 9.0 1.7 6.7 37.9 1.2 24.4 19.3 1.6 3.0 0.4 2.0 1.0 0.9 4.5 0.0 2.7 1.8 3.0 11.4 56.6 0.3 2.5 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.9 0.2 1.7 0.4 30.0 0.9 10.8 3.2 0.0 2.5 71.9 1.2 0.0 51.5 3.3 573.5 0.0 0.2 0.2 0.0 0.4 0.3 0.0 6.5 1.6 0.4 0.2 1.5 0.1 86.3 0.0 0.1 MYO1H FLJ37587 ENSG00000174527 "Myosin IH" Q8N1T3 12 109347903-109455523 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 4.7" "Group enriched" "Detected in some" 4 "Early spermatids: 4.6;Ito cells: 1.3;Late spermatids: 3.0;Spermatogonia: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-BR-3: 1.3;U-266/70: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA039516 Uncertain NA NA "HPA039516: AB_10794198" "unprognostic (1.92e-1)" "unprognostic (8.00e-3)" "unprognostic (1.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (4.07e-7)" "unprognostic (7.13e-2)" "unprognostic (6.26e-4)" "unprognostic (1.51e-1)" "unprognostic (2.09e-1)" "unprognostic (7.90e-2)" "unprognostic (2.88e-1)" "unprognostic (1.12e-3)" "unprognostic (2.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (1.52e-1)" 0.6 0.0 0.0 0.2 0.2 0.1 0.4 0.0 0.0 0.4 0.1 0.2 0.2 0.2 0.7 0.1 0.2 0.7 0.0 0.5 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 4.7 0.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.8 0.1 1.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 2.6 0.1 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.0 0.1 MYO3A DFNB30 ENSG00000095777 "Myosin IIIA" Q8NEV4 10 25934071-26212536 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.1;testis: 12.5" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 12 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051893, HPA075413" Enhanced Supported "Plasma membrane,Actin filaments,Cytoplasmic bodies" No No "Actin filaments, Cytoplasmic bodies" "Plasma membrane" "HPA051893: , HPA075413: " "unprognostic (5.00e-3)" "unprognostic (3.36e-2)" "unprognostic (1.53e-1)" "unprognostic (3.20e-3)" "unprognostic (2.96e-1)" "unprognostic (4.37e-2)" "unprognostic (5.29e-2)" "unprognostic (2.74e-1)" "unprognostic (4.31e-2)" "unprognostic (1.03e-1)" "unprognostic (5.66e-3)" "unprognostic (7.96e-3)" "unprognostic (6.34e-2)" "unprognostic (1.46e-2)" "unprognostic (6.62e-2)" "unprognostic (9.69e-2)" 0.8 0.7 0.4 0.3 5.0 0.5 1.5 0.3 1.9 2.1 0.6 0.1 0.7 0.4 0.3 3.2 0.9 1.1 0.3 0.3 0.5 1.3 0.9 0.2 1.0 0.3 0.2 0.0 0.5 2.1 0.2 8.1 0.2 5.4 0.5 1.1 3.8 0.2 0.6 0.3 2.2 0.6 1.0 0.4 0.3 0.9 12.5 0.8 0.0 1.3 1.4 0.9 0.5 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 1.5 0.0 0.0 1.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.0 0.3 1.9 0.5 1.3 0.2 0.0 5.4 0.8 0.0 0.3 0.0 0.3 1.5 0.9 0.6 0.0 0.0 4.5 0.0 0.0 0.0 1.7 0.5 127.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 34.5 1.1 0.0 0.0 0.0 0.2 68.5 0.3 0.0 1.1 1.4 3.4 0.0 0.0 20.0 5.8 0.9 0.0 0.0 0.0 0.1 MYO3B ENSG00000071909 "Myosin IIIB" Q8WXR4 2 170178145-170655171 "Enzymes, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6" "Cell type enhanced" "Detected in some" 20 "Cone photoreceptor cells: 80.5;Early spermatids: 23.6;Late spermatids: 18.5;Rod photoreceptor cells: 57.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Group enriched" "Detected in some" 10 "HDLM-2: 11.3;HEL: 10.4;RT4: 11.7" "Region enriched" "Detected in single" 5 "basal ganglia: 4.7" "Not detected" "Not detected" HPA045483 Approved NA NA "HPA045483: AB_2679344" "unprognostic (1.65e-1)" "unprognostic (7.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.67e-1)" "unprognostic (7.15e-3)" "unprognostic (5.07e-2)" "unprognostic (2.61e-2)" "unprognostic (5.84e-3)" "unprognostic (2.12e-1)" "unprognostic (7.99e-3)" "unprognostic (2.59e-1)" "unprognostic (4.25e-5)" "unprognostic (2.34e-1)" "unprognostic (8.12e-3)" "unprognostic (1.18e-1)" "unprognostic (1.07e-1)" 0.2 0.2 0.3 0.0 0.3 0.0 0.2 0.2 0.3 0.6 0.2 0.0 4.6 0.0 0.3 20.0 0.3 0.5 0.0 0.3 0.3 0.5 8.5 0.2 0.3 0.5 0.3 0.3 0.4 2.2 12.6 1.0 0.0 0.3 0.3 0.0 21.6 1.4 1.1 0.2 0.5 0.2 0.5 0.2 0.3 0.2 4.2 0.0 0.0 2.2 0.0 0.8 4.4 0.3 0.1 0.3 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.3 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.2 0.3 0.3 0.5 0.3 0.3 0.3 0.0 0.0 0.3 0.0 0.3 0.6 2.9 0.4 0.0 0.0 0.0 3.5 80.5 0.0 11.6 0.3 23.6 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.3 18.5 0.3 0.2 0.0 0.0 0.2 1.6 0.1 0.0 0.4 0.1 57.8 0.0 0.1 0.9 0.2 0.4 0.1 0.0 0.0 0.1 MYO5A "GS1, MYH12, MYO5, MYR12" ENSG00000197535 "Myosin VA" Q9Y4I1 15 52307283-52529050 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.5;parathyroid gland: 47.6" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 82.8;Melanocytes: 92.8" "Cancer enhanced" "Detected in all" "melanoma: 25.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 60.0;RPMI-8226: 40.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001356 Enhanced Approved "Focal adhesion sites,Centriolar satellite" NA NA "Focal adhesion sites, Centriolar satellite" "HPA001356: AB_1079441" "unprognostic (1.54e-1)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (2.29e-2)" "unprognostic (1.97e-2)" "unprognostic (3.91e-2)" "unprognostic (2.30e-2)" "unprognostic (6.65e-2)" "unprognostic (7.89e-2)" "unprognostic (4.74e-2)" "unprognostic (9.36e-3)" "unprognostic (1.71e-1)" "unprognostic (5.63e-3)" "unprognostic (3.79e-3)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (4.22e-4)" 8.4 7.1 16.6 9.5 27.5 15.7 5.5 27.4 34.5 6.2 4.4 7.8 0.4 3.3 4.2 3.2 5.0 3.6 7.3 4.6 15.9 15.4 4.6 2.7 7.3 11.2 15.6 17.6 5.4 4.3 47.6 10.5 5.2 29.3 4.5 5.2 9.9 4.0 3.4 4.1 10.4 3.9 7.7 10.1 7.3 4.1 4.6 7.1 3.1 6.8 2.7 10.3 7.3 4.2 2.3 5.2 6.3 4.4 0.7 4.5 1.9 5.5 9.8 5.2 6.3 5.3 6.5 5.6 10.1 9.1 5.4 4.2 0.9 2.2 5.3 2.6 12.0 7.9 4.6 12.0 10.4 6.7 30.0 2.8 4.9 2.5 1.2 2.7 2.6 4.8 4.3 6.5 7.9 15.8 5.3 31.4 3.5 0.1 60.0 10.4 9.8 2.3 0.3 2.4 0.1 7.8 4.2 8.4 40.7 4.4 4.0 3.8 2.3 9.4 7.8 18.3 4.0 4.1 2.9 15.0 10.9 4.7 5.1 9.8 6.2 13.8 6.4 11.9 7.5 15.7 0.9 4.4 5.4 2.9 3.6 4.5 2.3 2.9 1.9 5.2 1.6 0.5 1.0 6.3 0.7 2.6 3.1 4.1 1.9 16.6 27.5 27.4 34.5 15.9 15.4 15.6 17.6 29.3 7.1 11.9 10.7 12.3 8.4 18.4 82.8 8.7 5.1 9.4 29.6 14.0 37.3 0.5 0.0 4.8 16.0 9.0 0.0 0.0 5.4 0.4 6.0 6.8 22.0 1.0 21.3 25.4 1.2 1.8 24.4 6.4 3.4 39.4 92.8 27.9 0.0 4.5 5.0 0.8 1.8 2.2 27.1 6.5 4.7 8.7 7.0 10.2 0.9 12.9 0.0 7.4 MYO5B KIAA1119 ENSG00000167306 "Myosin VB" Q9ULV0 18 49822813-50195093 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 92.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 114.3;Pancreatic endocrine cells: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 21.0;HaCaT: 33.2;RH-30: 51.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040593, HPA040902, HPA069773" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194" "unprognostic (2.51e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (6.17e-3)" "unprognostic (2.14e-1)" "unprognostic (8.84e-3)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (4.13e-2)" "unprognostic (3.46e-1)" "prognostic unfavorable (2.26e-5)" "unprognostic (4.48e-2)" "prognostic favorable (1.45e-11)" "unprognostic (2.17e-3)" "unprognostic (1.50e-1)" "unprognostic (6.56e-2)" "unprognostic (3.28e-1)" 2.0 1.2 1.1 12.7 1.3 0.0 5.2 0.4 2.5 7.5 56.9 1.0 13.7 23.5 1.8 10.4 20.3 4.6 20.6 2.0 1.8 1.2 19.1 13.9 9.4 0.6 0.7 1.5 1.7 16.4 9.3 10.5 13.5 2.1 6.0 17.5 8.4 21.6 8.7 0.6 14.5 92.2 0.8 0.7 0.9 13.1 5.5 0.3 2.4 16.3 14.9 17.4 4.0 11.8 1.0 0.1 0.0 0.0 2.4 0.6 0.0 21.0 5.7 0.1 0.1 0.0 0.0 11.5 0.1 0.8 0.4 0.0 14.9 9.0 0.0 5.3 0.0 1.7 33.2 7.5 9.0 0.4 0.0 2.3 0.0 2.5 10.5 0.0 0.0 0.1 0.0 7.9 0.2 5.5 1.7 0.7 0.1 0.1 8.3 0.9 8.1 0.0 0.0 1.5 12.3 2.3 0.0 51.4 3.5 19.0 4.3 11.4 0.2 8.0 9.5 0.0 3.0 5.6 0.0 0.5 0.0 11.6 0.1 2.2 5.6 3.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 1.0 0.4 0.1 0.0 0.0 0.2 0.4 0.0 2.4 0.0 0.1 0.1 0.0 1.1 1.3 0.4 2.5 1.8 1.2 0.7 1.5 2.1 0.3 50.6 12.0 0.8 8.3 0.3 8.2 1.9 15.3 24.1 19.4 7.0 9.8 3.2 5.0 40.6 14.7 0.6 114.3 0.0 41.1 1.1 0.5 42.9 0.0 15.3 0.7 0.0 6.4 0.0 0.3 1.5 0.9 0.9 3.3 3.6 33.5 29.9 76.1 53.7 0.7 13.0 29.0 0.0 0.2 9.5 3.8 5.6 3.9 0.0 38.0 58.3 MYO7A "DFNA11, DFNB2, NSRD2, USH1B" ENSG00000137474 "Myosin VIIA" Q13402 11 77128264-77215241 "Disease related genes, Predicted intracellular proteins" Hearing "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Deafness, Disease mutation, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 26.3;retina: 30.9" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 45.2;Cytotrophoblasts: 34.1;Hofbauer cells: 24.3;Ito cells: 21.5;Kupffer cells: 20.9;Rod photoreceptor cells: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 5.6;intermediate monocyte: 4.0;NK-cell: 1.4" "Group enriched" "Detected in many" 10 "monocytes: 5.6;NK-cells: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 11.6;CACO-2: 7.1;RH-30: 15.9;RPMI-8226: 10.4;SK-BR-3: 8.7;U-937: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA028918, CAB034059" Uncertain Approved Cytosol NA NA Cytosol "CAB034059: AB_2148626, HPA028918: AB_10603022" "unprognostic (1.14e-3)" "unprognostic (2.58e-2)" "unprognostic (2.94e-2)" "unprognostic (1.61e-1)" "unprognostic (9.66e-2)" "unprognostic (4.02e-3)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (3.65e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (3.03e-2)" 5.8 26.3 3.6 3.7 5.6 1.1 5.0 0.7 3.0 1.3 1.7 3.5 0.9 2.2 1.3 2.9 1.2 2.3 2.8 1.7 4.0 3.8 5.3 14.8 1.6 4.5 5.2 1.7 4.4 3.8 1.2 25.1 16.9 7.2 13.6 1.4 30.9 1.1 0.9 1.0 0.6 2.4 2.4 3.9 11.2 2.0 22.9 4.7 0.5 1.5 0.3 1.1 1.9 4.4 0.0 0.3 0.0 5.6 1.4 0.1 1.8 0.0 1.1 0.1 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 7.1 2.0 0.0 1.6 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.3 4.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.3 0.0 15.9 10.4 0.0 0.2 2.5 0.8 0.1 8.7 0.1 1.9 1.2 1.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 5.6 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.8 3.6 5.6 0.7 3.0 4.0 3.8 5.2 1.7 7.2 4.7 0.0 0.0 0.0 0.2 0.2 7.3 3.6 7.6 0.0 0.0 0.0 45.2 34.1 0.0 0.6 1.5 0.7 0.0 0.0 1.5 7.0 0.8 0.1 0.0 12.4 24.3 0.0 1.2 21.5 20.9 3.7 2.8 1.1 0.0 0.0 0.5 15.1 1.0 0.0 0.4 2.2 31.8 0.0 0.3 0.3 0.4 0.3 13.5 0.0 0.4 0.1 MYO7B ENSG00000169994 "Myosin VIIB" Q6PIF6 2 127535802-127637729 "Predicted intracellular proteins" Differentiation "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 124.3" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 127.0;Mucus-secreting cells: 44.2;Paneth cells: 49.5;Undifferentiated cells: 36.3" "Group enriched" "Detected in many" 8 "colorectal cancer: 17.2;pancreatic cancer: 5.4;renal cancer: 3.7;stomach cancer: 9.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "classical monocyte: 7.2;naive B-cell: 9.1" "Group enriched" "Detected in many" 24 "B-cells: 9.1;dendritic cells: 3.3;monocytes: 7.2" "Cell line enriched" "Detected in some" 10 "MOLT-4: 79.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA039131 Enhanced NA NA "HPA039131: AB_10672771" "unprognostic (4.10e-3)" "unprognostic (3.81e-2)" "unprognostic (3.80e-2)" "unprognostic (2.23e-4)" "unprognostic (1.14e-2)" "unprognostic (2.23e-1)" "unprognostic (2.07e-1)" "unprognostic (8.51e-2)" "unprognostic (3.76e-1)" "unprognostic (3.86e-2)" "unprognostic (2.32e-1)" "unprognostic (1.03e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.80e-2)" "unprognostic (8.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.88e-1)" 0.2 0.2 0.2 8.4 0.3 2.0 0.2 0.2 0.3 0.2 67.2 0.0 0.7 41.3 0.2 7.2 0.3 0.3 21.0 0.2 0.3 0.3 8.9 0.4 0.5 2.0 0.5 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.2 9.2 0.0 0.2 0.0 0.3 0.2 124.3 0.2 0.4 7.3 0.2 0.9 0.0 3.0 0.2 0.0 0.5 0.2 0.2 9.1 3.3 0.2 7.2 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.2 1.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 79.2 0.2 0.0 0.1 0.5 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.1 2.5 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.1 0.0 2.7 0.0 1.2 0.0 0.0 3.3 9.1 0.0 0.2 0.2 0.0 1.7 0.8 0.0 2.7 0.2 0.3 0.2 0.3 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.4 15.3 0.0 0.0 5.2 0.0 0.0 1.7 0.1 0.0 0.0 127.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 0.0 24.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 44.2 0.0 0.9 49.5 0.0 9.6 0.0 0.0 0.0 0.5 0.9 0.1 0.2 0.0 36.3 0.0 MYOC "GLC1A, JOAG1, TIGR" ENSG00000034971 Myocilin Q99972 1 171635417-171652683 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 100.8" "Cell type enriched" "Detected in some" 4 "Peritubular cells: 35.3" "Cancer enriched" "Detected in many" 6 "melanoma: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027364 Uncertain "Secreted to extracellular matrix" NA NA 12000000 "HPA027364: AB_10602036" "unprognostic (2.02e-2)" "unprognostic (4.65e-2)" "unprognostic (4.44e-2)" "unprognostic (6.29e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.42e-2)" "unprognostic (3.02e-2)" "unprognostic (2.82e-2)" "unprognostic (2.54e-1)" "unprognostic (1.94e-4)" "unprognostic (5.35e-2)" "unprognostic (1.87e-1)" "unprognostic (3.87e-2)" "unprognostic (1.24e-1)" 26.9 0.8 0.0 0.5 0.0 0.0 8.4 0.0 0.0 5.4 6.0 0.0 5.3 2.4 8.1 7.6 40.7 7.4 8.3 12.6 0.1 0.0 0.2 0.1 3.7 0.0 0.0 0.0 3.9 2.1 0.2 0.1 0.1 0.2 9.0 2.5 100.8 10.5 4.8 21.7 2.4 2.6 39.4 0.3 0.1 29.9 2.8 0.0 0.6 14.9 28.2 5.0 26.1 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 MYOCD MYCD ENSG00000141052 Myocardin Q8IZQ8 17 12665890-12768949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 63.4" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 26.6;Peritubular cells: 94.7;Sertoli cells: 25.8;Smooth muscle cells: 30.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 6.3;BJ hTERT+: 6.4;HBF TERT88: 10.6;hTEC/SVTERT24-B: 11.7;REH: 8.0;SuSa: 13.5" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 6.4" "CAB046485, HPA071528, HPA072582" Approved Approved Nucleoplasm NA NA Nucleoplasm "CAB046485: AB_10600720, HPA071528: , HPA072582: " "unprognostic (2.82e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (1.90e-1)" "unprognostic (3.79e-2)" "unprognostic (5.33e-2)" "unprognostic (2.15e-4)" "unprognostic (2.71e-2)" "unprognostic (1.61e-2)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (4.83e-2)" "unprognostic (1.01e-4)" "unprognostic (2.88e-2)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.91e-2)" 3.1 0.8 0.6 5.1 1.0 0.0 1.9 0.3 0.5 19.6 19.9 0.2 17.6 2.1 16.6 10.9 14.4 7.4 12.2 18.6 0.4 0.4 0.9 0.4 2.5 0.0 0.5 0.8 10.6 0.4 0.0 0.5 2.6 0.6 17.2 4.2 5.1 0.4 18.7 1.2 1.5 6.6 63.4 0.6 0.5 6.7 3.7 0.1 0.0 1.0 1.2 0.0 33.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.3 6.4 2.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.3 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 13.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.3 0.5 0.4 0.4 0.5 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 1.1 0.1 0.0 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.7 0.0 0.0 25.8 30.6 0.2 0.7 0.6 0.5 0.0 0.0 0.0 MYOCOS ENSG00000283683 "Myocilin opposite strand" A0A1B0GUC4 1 171600621-171638799 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "cervix, uterine: 8.1;epididymis: 4.8;fallopian tube: 3.9" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 3.0;Club cells: 1.2;Proximal tubular cells: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HEL: 24.6" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 0.0 1.3 4.8 0.0 3.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.8 0.0 0.3 0.9 0.6 1.6 0.3 0.1 1.3 0.0 0.0 0.4 0.3 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.1 3.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 24.6 0.4 0.4 0.1 0.1 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.4 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.1 0.9 1.8 0.2 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.6 0.1 0.4 0.1 0.1 0.1 0.3 0.3 0.2 0.3 0.2 1.0 0.9 0.4 1.1 0.1 0.9 0.5 0.4 1.6 0.1 0.0 0.6 1.3 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYOD1 "bHLHc1, MYF3, MYOD, PUM" ENSG00000129152 "Myogenic differentiation 1" P15172 11 17719568-17722131 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 31.8" "Cell type enriched" "Detected in single" 7 "Spermatogonia: 3.0" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RH-30: 103.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055436, HPA078647" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055436: , HPA078647: " "unprognostic (1.07e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 4.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 0.0 MYOG "bHLHc3, MYF4" ENSG00000122180 Myogenin P15173 1 203083132-203086036 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 60.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "head and neck cancer: 3.9;testis cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 200 "HSkMC: 18.0;RH-30: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA028336 Supported Nucleoplasm NA NA Nucleoplasm "HPA028336: AB_2672562" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (2.22e-1)" "unprognostic (2.79e-9)" "unprognostic (3.96e-1)" "unprognostic (2.56e-1)" 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 2.4 0.0 60.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 1.7 13.3 1.7 0.0 0.0 0.8 0.8 2.3 1.3 1.8 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.4 0.8 0.4 0.7 1.0 0.8 0.5 0.6 0.3 0.6 0.9 1.0 1.4 1.8 1.3 0.8 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYOM1 ENSG00000101605 "Myomesin 1" P52179 18 3066807-3220108 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 111.4;skeletal muscle: 153.1;tongue: 51.6" "Cell type enriched" "Detected in many" 17 "Cardiomyocytes: 1033.7" "Cancer enhanced" "Detected in many" "liver cancer: 6.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "HAP1: 16.6;HMC-1: 4.5;HSkMC: 8.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA014305, HPA049193" Enhanced NA NA 32000 "HPA014305: AB_1854257, HPA049193: AB_2680670" "unprognostic (2.51e-1)" "unprognostic (2.08e-3)" "unprognostic (2.19e-3)" "unprognostic (8.01e-3)" "unprognostic (8.94e-2)" "unprognostic (4.31e-2)" "unprognostic (9.10e-2)" "unprognostic (1.59e-1)" "unprognostic (9.27e-2)" "unprognostic (1.87e-1)" "unprognostic (2.38e-1)" "unprognostic (1.63e-2)" "unprognostic (2.01e-1)" "unprognostic (9.15e-2)" "unprognostic (4.90e-2)" "unprognostic (1.73e-1)" "unprognostic (2.62e-1)" 6.2 0.6 1.3 0.9 1.2 0.3 0.8 0.6 0.7 1.0 2.4 0.3 0.4 0.5 2.9 10.1 6.0 1.3 3.0 111.4 1.1 1.3 0.4 16.6 0.4 0.4 2.2 0.1 0.9 6.4 0.3 0.3 0.5 0.9 2.6 0.7 3.4 4.6 1.1 153.1 0.3 0.9 9.3 2.0 0.3 0.7 1.2 0.1 0.0 1.6 51.6 4.6 5.0 0.5 0.7 3.0 0.6 0.4 0.8 2.1 1.1 0.0 0.1 0.3 0.0 0.9 1.0 0.4 0.5 0.6 0.0 0.0 0.1 0.1 0.5 0.1 0.2 0.2 0.0 16.6 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.0 4.5 8.1 0.4 0.3 0.1 0.4 0.1 0.3 0.0 0.5 0.3 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.6 0.0 0.1 0.4 0.0 0.2 0.3 0.0 0.7 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.6 0.9 0.4 0.5 0.7 0.6 0.5 0.5 0.6 1.0 2.1 0.5 0.8 0.0 3.0 0.2 1.1 1.3 1.2 0.6 0.7 1.1 1.3 2.2 0.1 0.9 0.1 0.0 0.3 4.6 2.1 1.4 1.7 1033.7 30.6 1.4 1.2 0.0 2.0 0.4 0.0 0.7 10.2 0.9 0.6 0.0 5.6 0.0 0.9 0.7 0.0 6.0 0.2 1.6 0.0 3.7 0.6 8.9 2.0 1.0 0.0 1.0 0.9 0.0 2.0 62.6 3.9 0.0 1.3 6.5 6.6 2.3 1.9 1.1 1.8 1.3 0.6 0.6 MYOM2 ENSG00000036448 "Myomesin 2" P54296 8 2045040-2165552 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "heart muscle: 170.7;skeletal muscle: 75.9" "Cell type enriched" "Detected in many" 15 "Cardiomyocytes: 554.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 8 "HEK 293: 10.1;SCLC-21H: 4.3;U-266/84: 5.3" "Not detected" "Not detected" "HPA001765, HPA005953" Enhanced Approved Mitochondria NA NA 120000 Mitochondria "HPA001765: AB_1079443, HPA005953: AB_1854258" "unprognostic (2.81e-2)" "unprognostic (1.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.86e-2)" "unprognostic (2.30e-5)" "unprognostic (1.10e-1)" "unprognostic (5.17e-2)" "unprognostic (1.34e-2)" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (3.89e-2)" "unprognostic (2.71e-2)" "unprognostic (9.01e-2)" "unprognostic (3.22e-1)" "unprognostic (1.14e-1)" 2.0 0.0 0.3 0.1 0.4 0.0 1.7 0.9 0.9 0.2 0.2 0.0 0.2 0.0 0.5 2.7 1.2 0.1 0.1 170.7 0.3 0.1 0.7 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.2 1.2 1.0 75.9 0.2 0.1 0.3 0.1 0.4 0.0 0.2 0.0 0.0 0.6 8.9 1.2 0.3 0.1 1.9 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 10.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.4 0.2 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 0.4 0.9 0.9 0.3 0.1 0.2 0.0 0.1 0.0 6.0 4.0 0.0 2.3 3.2 2.8 554.8 17.8 6.7 0.0 3.5 0.0 0.0 11.6 3.4 5.4 2.3 1.0 0.0 1.5 0.0 1.4 1.0 5.7 6.4 1.4 6.4 0.0 5.5 2.8 6.2 0.6 2.3 3.3 3.6 2.5 7.0 2.5 0.0 1.4 21.4 4.1 0.0 17.0 36.9 22.7 2.5 0.1 8.7 1.1 1.4 MYOM3 FLJ35961 ENSG00000142661 "Myomesin 3" Q5VTT5 1 24056035-24112175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 168.2" "Cancer enhanced" "Detected in some" "renal cancer: 6.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 5.2;Hep G2: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028132, HPA028340" Approved "Golgi apparatus,Vesicles,Cytokinetic bridge" Yes No 680000 Vesicles "Golgi apparatus, Cytokinetic bridge" "HPA028132: AB_10599293, HPA028340: " "unprognostic (8.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.39e-1)" "unprognostic (8.60e-3)" "unprognostic (1.52e-2)" "unprognostic (7.31e-2)" "unprognostic (3.00e-2)" "unprognostic (1.40e-2)" "unprognostic (4.66e-1)" "unprognostic (2.21e-1)" "unprognostic (2.73e-4)" "unprognostic (2.09e-1)" "prognostic favorable (4.28e-6)" "unprognostic (2.77e-2)" "unprognostic (1.60e-3)" "unprognostic (7.75e-2)" "unprognostic (1.68e-1)" 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 6.3 2.7 0.2 0.0 59.5 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 2.7 0.0 104.6 0.4 1.5 0.0 0.0 0.0 0.0 1.9 0.1 0.0 2.7 39.7 2.8 0.2 0.1 0.8 0.4 2.3 0.4 0.2 0.4 0.0 0.1 5.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 1.5 0.0 2.2 0.6 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.8 19.8 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.2 0.1 1.1 0.2 0.6 0.7 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.8 0.4 0.1 0.3 0.4 0.1 0.4 0.2 0.2 0.0 0.8 0.3 0.4 2.3 0.2 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 168.2 0.0 0.0 0.0 3.5 0.0 0.0 1.7 0.1 15.5 0.1 4.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.6 0.6 0.0 0.0 0.0 0.0 0.0 1.4 2.9 0.0 25.9 2.8 6.5 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.3 MYORG "KIAA1161, NET37" ENSG00000164976 "Myogenesis regulating glycosidase (putative)" Q6NSJ0 9 34366670-34376853 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 56.1" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 41.5;Exocrine glandular cells: 10.3;Syncytiotrophoblasts: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 17.6;SK-BR-3: 29.4;T-47d: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060533, HPA067487" Enhanced Approved Mitochondria NA NA Mitochondria "HPA060533: AB_2684311, HPA067487: AB_2685848" "unprognostic (6.56e-2)" "unprognostic (1.51e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (2.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (4.68e-3)" "unprognostic (1.91e-3)" "unprognostic (3.20e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.08e-3)" "unprognostic (3.68e-1)" "unprognostic (3.09e-1)" "unprognostic (1.00e-3)" 6.3 5.6 16.7 4.7 20.5 2.1 3.5 6.9 16.0 2.0 19.9 9.8 1.3 20.9 2.2 2.8 4.8 3.6 11.6 2.9 11.1 8.7 11.7 31.8 3.1 1.7 11.2 12.6 1.6 16.6 2.0 4.0 15.4 10.7 3.2 13.1 0.5 4.7 4.9 56.1 3.6 26.7 4.8 7.0 1.7 9.9 1.7 6.9 0.0 2.2 6.4 2.1 3.5 1.9 1.1 0.8 1.9 0.8 1.9 3.3 0.6 4.1 2.9 4.9 2.9 2.0 0.7 10.4 0.8 0.6 0.4 0.7 7.1 4.3 2.3 8.4 0.7 2.1 8.4 3.4 7.8 0.6 0.7 1.9 0.4 13.0 17.6 0.3 0.4 1.4 1.0 3.8 1.3 1.6 2.3 1.9 1.7 0.5 2.4 1.1 6.8 1.3 0.7 2.9 13.7 2.3 2.1 2.5 0.7 2.6 1.5 0.7 6.8 5.8 29.4 0.5 4.3 27.3 0.7 1.7 1.1 6.0 0.9 1.8 1.5 3.2 0.9 0.9 1.6 0.9 1.9 0.6 1.2 3.3 0.6 2.6 0.8 2.0 1.9 0.3 1.1 1.3 1.6 1.6 1.9 0.8 0.8 2.6 0.6 16.7 20.5 6.9 16.0 11.1 8.7 11.2 12.6 10.7 6.9 8.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 3.5 0.0 41.5 1.7 5.6 0.0 0.0 0.0 0.0 10.3 1.9 0.0 0.0 1.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 9.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 MYOT "LGMD1, LGMD1A, TTID" ENSG00000120729 Myotilin Q9UBF9 5 137867791-137887851 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 30 "skeletal muscle: 297.3;tongue: 85.1" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 25.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.7" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 1.6;HeLa: 2.4;U-266/70: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037733, HPA037734" Enhanced NA NA "HPA037733: AB_10697082, HPA037734: AB_2675638" "unprognostic (5.85e-2)" "unprognostic (2.38e-2)" "unprognostic (6.93e-2)" "unprognostic (3.08e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (8.03e-2)" "unprognostic (1.17e-2)" "unprognostic (1.54e-2)" "unprognostic (2.02e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (7.56e-4)" "unprognostic (1.72e-2)" "unprognostic (2.42e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" 2.8 0.3 0.6 0.2 1.4 0.1 0.1 0.1 0.4 0.3 1.0 0.0 0.0 0.3 0.1 6.0 6.2 0.1 0.2 6.2 0.7 0.4 0.2 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.0 0.1 0.1 2.4 0.3 0.0 3.6 0.6 297.3 0.1 0.4 0.2 0.7 0.1 0.2 0.1 0.6 0.0 2.2 85.1 6.0 0.2 0.4 0.8 1.0 0.0 0.1 0.4 0.6 0.0 0.5 0.3 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.2 1.1 1.1 0.0 0.0 0.1 0.0 0.3 0.0 0.5 1.6 0.4 2.4 0.0 0.0 0.0 0.3 1.4 0.4 0.0 0.0 0.4 0.0 1.1 0.2 1.1 1.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.7 0.0 0.8 0.0 0.0 0.2 0.6 0.1 0.5 0.0 0.0 1.7 0.7 0.0 0.7 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.8 0.5 0.2 0.0 0.4 0.1 1.0 0.0 0.0 0.6 1.4 0.1 0.4 0.7 0.4 0.9 0.0 0.1 0.6 0.0 0.0 0.0 0.5 0.2 0.0 25.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 MYOZ1 "CS-2, FATZ, MYOZ" ENSG00000177791 "Myozenin 1" Q9NP98 10 73631654-73641757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "skeletal muscle: 387.8;tongue: 133.0" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 5.6;Collecting duct cells: 5.2;Distal tubular cells: 6.6;Hofbauer cells: 6.6;Peritubular cells: 7.1;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BEWO: 30.4" "Region enriched" "Detected in single" 17 "olfactory region: 4.9" "Low region specificity" "Detected in all" "HPA037848, HPA038437" Enhanced NA NA "HPA037848: AB_10670156, HPA038437: AB_2676009" "unprognostic (4.55e-2)" "unprognostic (2.23e-1)" "unprognostic (4.90e-2)" "unprognostic (3.91e-2)" "unprognostic (1.14e-1)" "unprognostic (5.08e-2)" "unprognostic (2.76e-2)" "unprognostic (1.22e-4)" "unprognostic (1.18e-1)" "unprognostic (9.25e-2)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (5.14e-2)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" "unprognostic (7.17e-2)" "unprognostic (1.09e-1)" 8.1 0.1 0.2 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 10.9 4.2 0.1 0.1 4.1 0.2 0.2 0.2 0.1 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.4 0.0 1.3 0.1 0.0 5.6 0.3 387.8 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 1.4 133.0 5.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 30.4 0.3 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.1 5.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.3 0.7 0.2 0.0 0.8 0.8 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 2.3 5.6 0.0 0.0 2.3 5.2 0.0 0.1 6.6 0.1 0.1 0.0 0.0 0.0 0.2 1.7 0.5 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 3.5 0.0 0.0 7.1 0.2 0.4 12.9 5.0 0.3 1.4 0.3 0.1 0.0 0.0 0.3 MYOZ2 "C4orf5, CS-1" ENSG00000172399 "Myozenin 2" Q9NPC6 4 119135784-119187789 "Disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 219.1;skeletal muscle: 188.6" "Cell type enriched" "Detected in some" 343 "Cardiomyocytes: 2214.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035763, HPA035764" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035763: AB_2674770, HPA035764: AB_10696509" "unprognostic (2.53e-1)" "unprognostic (9.20e-2)" "unprognostic (6.94e-2)" "unprognostic (2.14e-1)" "unprognostic (2.57e-1)" "unprognostic (2.34e-2)" "unprognostic (5.71e-1)" "unprognostic (2.18e-1)" "unprognostic (4.77e-2)" "unprognostic (4.04e-1)" "unprognostic (8.25e-2)" "unprognostic (5.07e-2)" "unprognostic (6.19e-7)" "unprognostic (6.66e-4)" "unprognostic (2.43e-1)" "unprognostic (3.06e-1)" "unprognostic (2.83e-2)" 3.7 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 2.4 2.6 0.2 0.1 219.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.9 0.1 188.6 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.0 2.0 13.9 3.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.4 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.7 0.0 0.6 0.0 0.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.5 1.7 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 10.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2214.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.9 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.7 0.7 0.0 6.5 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 MYOZ3 "CS-3, CS3, FRP3" ENSG00000164591 "Myozenin 3" Q8TDC0 5 150660874-150679365 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "skeletal muscle: 81.2;tongue: 79.7" "Cell type enriched" "Detected in some" 15 "Peritubular cells: 41.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "HAP1: 5.9;NTERA-2: 10.5;REH: 16.1;SuSa: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA039166 Enhanced NA NA "HPA039166: AB_10671871" "unprognostic (2.74e-1)" "unprognostic (2.46e-3)" "unprognostic (9.57e-3)" "unprognostic (1.41e-2)" "unprognostic (1.26e-1)" "unprognostic (3.46e-2)" "unprognostic (2.59e-2)" "unprognostic (8.77e-2)" "unprognostic (9.19e-4)" "unprognostic (6.99e-2)" "unprognostic (5.19e-2)" "unprognostic (7.21e-3)" "unprognostic (7.31e-9)" "unprognostic (2.19e-2)" "unprognostic (2.79e-1)" "unprognostic (8.46e-2)" "unprognostic (4.20e-2)" 0.7 0.3 0.3 0.1 1.4 0.4 0.2 0.2 0.9 0.8 0.2 0.1 0.0 0.2 0.6 3.4 2.3 0.4 0.6 2.0 0.3 2.1 0.2 0.1 0.4 0.1 1.1 0.7 0.4 0.1 0.1 0.7 0.1 0.8 1.7 0.1 1.3 3.8 0.5 81.2 0.1 0.4 0.4 1.9 0.1 0.3 1.8 0.1 0.0 0.3 79.7 4.3 0.2 0.2 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.2 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.5 0.8 0.0 0.0 0.1 0.0 0.6 1.5 10.5 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.3 1.4 0.2 0.9 0.3 2.1 1.1 0.7 0.8 0.1 0.0 0.0 0.0 0.2 0.3 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.3 1.0 0.3 0.0 0.0 0.2 0.0 0.0 2.5 0.3 1.1 2.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 41.8 0.0 0.0 0.0 0.1 0.3 1.7 0.4 0.6 0.0 0.4 0.0 MYPN MYOP ENSG00000138347 Myopalladin Q86TC9 10 68106117-68212017 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 94.6" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "BJ: 16.6;fHDF/TERT166: 46.6;GAMG: 9.2;HBF TERT88: 11.0;LHCN-M2: 20.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA036299, HPA061494" Enhanced Approved Nucleoplasm,Vesicles,Cytosol No No "Nucleoplasm, Vesicles" Cytosol "HPA036299: , HPA061494: AB_2684539" "unprognostic (4.75e-2)" "unprognostic (2.20e-1)" "unprognostic (8.14e-3)" "unprognostic (8.62e-3)" "unprognostic (3.91e-1)" "unprognostic (3.36e-3)" "unprognostic (4.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "unprognostic (2.26e-3)" "unprognostic (3.94e-3)" "unprognostic (3.10e-1)" "unprognostic (2.88e-8)" "unprognostic (4.63e-5)" "unprognostic (9.94e-2)" "unprognostic (2.01e-1)" "unprognostic (3.47e-1)" 4.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 2.1 0.0 0.0 23.6 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.5 0.0 0.1 2.1 0.0 114.9 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.9 46.3 3.4 0.0 0.0 0.3 0.1 3.8 0.1 0.2 0.1 0.0 1.2 0.5 0.0 0.0 0.3 1.8 0.0 16.6 8.3 6.3 2.3 0.0 0.0 0.0 0.0 46.6 9.2 0.3 0.0 0.1 11.0 0.1 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.8 0.0 3.3 0.4 1.5 0.1 0.0 0.0 0.1 20.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.0 0.0 0.0 2.0 0.0 1.8 3.8 0.1 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 94.6 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MYPOP P42pop ENSG00000176182 "Myb related transcription factor, partner of profilin" Q86VE0 19 45890020-45902604 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 36.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 19.2;NB-4: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065307 Approved Nucleoplasm NA NA Nucleoplasm "HPA065307: AB_2685460" "unprognostic (5.13e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.87e-3)" "prognostic unfavorable (1.21e-4)" "unprognostic (1.94e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (8.67e-5)" "unprognostic (1.28e-3)" "unprognostic (1.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.19e-3)" "unprognostic (3.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.10e-3)" 7.6 9.4 15.7 7.9 14.3 4.2 8.0 15.1 25.9 6.5 7.5 6.8 5.9 11.4 7.2 7.0 6.4 6.1 7.1 8.0 15.9 9.2 9.5 6.1 5.9 8.3 8.5 7.7 6.5 8.5 7.0 12.9 6.1 11.3 7.7 6.0 6.3 9.5 8.2 36.4 10.1 10.1 6.5 9.0 12.3 8.5 6.8 8.7 5.3 5.0 4.3 7.0 6.8 10.7 1.0 1.5 2.7 1.4 0.6 1.1 0.4 4.2 6.8 2.6 5.3 3.4 2.2 5.2 3.2 3.3 3.5 4.6 2.7 2.7 4.1 3.1 1.6 3.4 3.6 1.9 1.4 2.5 19.2 11.1 1.9 3.8 4.4 3.7 1.9 6.2 2.1 4.1 1.9 1.8 3.7 2.8 7.0 2.6 3.7 2.2 1.8 10.1 26.2 2.9 5.5 6.9 8.1 1.1 2.3 2.0 2.4 5.4 4.1 3.1 3.4 3.3 2.0 2.3 7.1 3.6 3.3 5.5 3.0 5.0 10.9 7.8 2.7 4.8 5.2 3.9 0.0 1.4 2.7 1.1 0.6 0.3 1.0 0.8 0.6 1.5 0.3 0.6 0.7 1.6 0.6 0.7 1.0 0.7 0.4 15.7 14.3 15.1 25.9 15.9 9.2 8.5 7.7 11.3 8.7 3.0 1.3 3.7 4.4 10.2 10.1 11.8 5.1 1.4 0.0 5.2 7.9 4.5 19.9 7.0 5.2 3.8 7.8 0.0 7.9 14.2 6.6 2.9 0.0 3.2 5.1 6.4 8.6 3.7 4.9 1.0 6.6 5.3 3.3 6.4 4.5 3.2 6.0 5.9 7.1 5.1 11.4 19.4 4.5 2.4 4.9 8.5 4.5 6.9 4.6 2.0 MYRF "C11orf9, MRF, Ndt80, pqn-47" ENSG00000124920 "Myelin regulatory factor" Q9Y2G1 11 61752642-61788518 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.7;stomach 1: 57.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 44.7;Cholangiocytes: 58.6;Ductal cells: 29.2;Exocrine glandular cells: 31.5;Pancreatic endocrine cells: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 17.5;CACO-2: 29.3;CAPAN-2: 16.9;EFO-21: 22.9;Hep G2: 12.4;HHSteC: 13.1;OE19: 25.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018310 Approved Nucleoplasm,Cytosol NA NA 550000 Nucleoplasm Cytosol "HPA018310: AB_1845534" "unprognostic (3.51e-2)" "unprognostic (3.34e-1)" "unprognostic (1.56e-1)" "unprognostic (5.39e-2)" "unprognostic (1.54e-1)" "unprognostic (3.65e-2)" "unprognostic (1.34e-1)" "unprognostic (9.34e-3)" "unprognostic (2.44e-1)" "unprognostic (1.27e-1)" "unprognostic (1.01e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.91e-3)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" 4.6 1.3 16.4 2.1 42.9 1.4 1.5 3.3 38.5 3.7 4.3 96.7 0.0 12.8 6.9 1.6 2.0 8.0 22.4 1.5 29.2 13.9 4.5 5.8 15.8 1.2 54.3 19.9 5.8 19.7 1.2 0.2 2.6 35.7 1.2 4.0 11.6 1.7 1.6 1.0 1.4 11.4 5.4 53.8 1.3 57.2 3.0 51.4 0.0 1.2 0.0 1.2 1.3 0.3 0.0 0.0 0.2 0.3 0.5 2.1 0.5 1.3 17.5 3.1 1.0 0.0 0.0 0.1 0.1 0.0 0.6 0.7 29.3 16.9 0.6 22.9 0.0 0.8 0.7 1.0 0.1 1.2 0.0 0.3 0.1 0.3 12.4 13.1 0.0 0.3 0.3 0.1 0.4 0.0 7.7 0.1 0.9 5.4 0.2 0.1 0.3 0.0 0.6 0.8 25.8 2.3 0.0 0.1 1.1 7.8 0.1 0.1 0.6 0.1 1.2 0.3 10.9 0.3 0.1 0.6 0.2 10.2 0.2 0.3 0.3 0.1 0.1 0.1 1.2 0.2 0.0 0.0 0.2 2.1 0.3 1.2 0.0 0.7 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.5 16.4 42.9 3.3 29.3 29.2 13.9 54.3 19.9 35.7 51.4 44.7 6.1 0.0 0.0 0.1 0.1 0.8 58.6 0.0 2.3 3.5 0.0 0.2 0.0 29.2 0.3 0.0 8.4 0.0 31.5 0.2 4.9 0.2 0.0 5.3 0.8 0.0 1.2 0.6 0.0 0.2 5.5 0.6 3.3 1.8 3.2 3.7 47.6 11.5 3.5 1.0 0.0 0.0 0.3 1.0 3.2 0.0 0.7 0.0 5.2 0.7 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor-like" Q96LU7 12 69825304-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "intestine: 56.1" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 5.2;Early spermatids: 12.4;Late spermatids: 22.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 7.0;SK-BR-3: 3.5;T-47d: 15.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" NA NA Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.3 0.3 0.5 0.0 0.6 0.0 0.5 3.6 0.6 0.1 20.7 0.0 0.4 21.4 0.1 0.9 0.1 0.1 0.7 0.2 0.4 0.2 2.0 0.3 0.2 0.2 0.5 0.2 0.0 0.8 0.0 1.0 0.3 0.7 0.6 0.1 0.3 1.3 0.4 0.0 1.6 56.1 0.1 1.0 0.1 0.1 2.4 0.5 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.0 0.1 0.0 0.1 0.0 1.1 1.0 0.0 0.3 0.1 0.0 3.5 0.0 1.2 15.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.5 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 3.6 0.6 0.4 0.2 0.5 0.2 0.7 0.5 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 5.2 0.0 0.2 3.3 0.8 12.4 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 22.2 0.9 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.4 0.5 0.0 0.0 0.0 0.7 0.4 1.0 0.0 0.0 0.0 0.0 MYRIP "DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 36.3" "Cell type enhanced" "Detected in many" 17 "Hepatocytes: 14.7;Ito cells: 44.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.5;HUVEC TERT2: 17.0;REH: 3.9;SCLC-21H: 3.6;SH-SY5Y: 10.5;T-47d: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.8 2.0 31.0 2.2 7.8 0.5 3.4 23.7 19.4 9.0 4.2 3.9 1.3 2.9 6.0 3.8 2.4 3.3 4.3 2.8 13.9 9.6 2.7 16.7 1.7 2.6 8.5 11.0 5.3 13.1 2.1 8.4 0.6 10.8 3.4 4.4 36.3 16.0 1.8 2.7 1.8 2.8 3.9 5.5 10.2 7.7 1.7 4.2 0.0 2.1 1.6 2.9 2.8 2.7 0.8 0.1 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 1.1 0.0 0.1 3.9 0.0 0.0 0.4 2.2 3.6 10.5 0.0 0.0 0.0 0.0 4.2 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 31.0 7.8 23.7 18.4 13.9 9.6 8.5 11.0 10.8 4.2 0.0 5.6 0.0 0.1 0.7 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 9.9 0.0 0.0 2.3 0.0 0.2 1.7 2.3 14.7 0.0 4.8 0.0 44.8 4.3 3.6 0.9 0.0 0.0 0.0 9.6 6.3 1.0 0.0 0.0 0.8 4.3 0.0 0.5 2.7 0.2 0.5 0.0 0.0 0.6 0.0 MYT1 "MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A" ENSG00000196132 "Myelin transcription factor 1" Q01538 20 64102394-64242253 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 69.5" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 28.8;Cone photoreceptor cells: 56.9;Horizontal cells: 25.4;Rod photoreceptor cells: 27.0" "Cancer enhanced" "Detected in some" "glioma: 3.2" "Region enriched" "Detected in all" 13 "cerebellum: 69.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.8;REH: 13.3;SCLC-21H: 16.6;SH-SY5Y: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006303 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006303: AB_1079446" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.05e-7)" "unprognostic (1.28e-1)" "unprognostic (8.34e-2)" "unprognostic (1.20e-1)" "unprognostic (7.10e-2)" "unprognostic (9.33e-3)" "unprognostic (2.28e-2)" "unprognostic (8.45e-4)" "unprognostic (9.73e-2)" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (9.68e-2)" "unprognostic (2.91e-3)" "unprognostic (1.23e-1)" 0.4 7.4 4.3 0.5 5.0 2.4 0.4 69.5 11.0 0.3 0.7 2.7 0.0 0.9 0.4 0.5 0.3 0.6 0.5 0.8 4.2 5.3 0.6 0.4 0.4 0.4 3.7 2.2 0.4 4.7 0.4 3.7 0.4 5.1 0.6 0.6 3.7 0.3 0.4 0.3 0.4 0.6 0.4 2.0 0.5 1.0 2.1 4.8 0.0 1.4 0.0 0.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.6 0.0 0.5 0.0 4.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 1.0 0.0 0.0 1.4 0.0 0.7 0.0 0.3 13.3 0.0 0.0 0.0 0.0 16.6 4.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.9 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.3 5.0 69.5 3.1 4.2 5.3 3.7 2.2 5.1 4.8 0.0 0.0 0.0 0.2 0.0 28.8 1.1 5.1 0.0 0.0 0.0 56.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 25.4 2.4 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.5 9.8 0.0 0.0 0.0 0.0 0.0 MYT1L "KIAA1106, NZF1, ZC2H2C2, ZC2HC4B" ENSG00000186487 "Myelin transcription factor 1 like" Q9UL68 2 1789113-2331348 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.2" "Cell type enhanced" "Detected in many" 20 "Bipolar cells: 49.9;Horizontal cells: 111.2;Spermatocytes: 36.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 8 "granulocytes: 2.3;T-cells: 1.6" "Group enriched" "Detected in some" 9 "SCLC-21H: 11.3;SH-SY5Y: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060245 Approved Vesicles NA NA Vesicles "HPA060245: AB_2732643" "unprognostic (9.90e-3)" "unprognostic (3.74e-1)" "unprognostic (1.30e-1)" "unprognostic (9.61e-3)" "unprognostic (7.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.44e-1)" "unprognostic (2.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.93e-2)" "unprognostic (2.46e-1)" "unprognostic (7.96e-2)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" 1.2 3.4 11.0 1.4 20.0 1.1 1.1 19.5 50.2 1.1 1.2 0.5 0.0 1.1 1.2 1.1 1.3 1.1 1.1 1.1 15.6 10.3 1.1 1.1 1.1 1.2 5.1 14.5 1.1 1.5 1.0 10.7 1.1 6.8 1.3 1.3 0.4 1.1 1.1 1.1 1.1 1.2 1.1 1.5 1.0 1.1 4.6 2.0 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.2 2.3 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.6 0.1 0.0 0.0 11.3 8.4 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.2 0.0 0.6 11.0 20.0 19.5 26.7 15.6 10.3 5.1 14.5 6.8 2.0 6.0 6.7 0.0 0.5 1.5 49.9 3.6 0.0 2.7 5.7 1.8 2.0 0.1 0.0 0.0 3.4 0.8 0.0 0.0 0.0 0.1 0.8 0.2 5.8 0.4 0.1 111.2 0.0 1.3 0.3 2.9 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.0 1.4 0.0 6.8 6.5 0.3 36.2 17.4 0.9 0.2 0.0 0.0 0.5 MYZAP "GCOM1, Gup, Gup1, MYOZAP" ENSG00000263155 "Myocardial zonula adherens protein" P0CAP1 15 57591941-57685364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 132.6;smooth muscle: 52.2" "Cell type enriched" "Detected in many" 16 "Cardiomyocytes: 451.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 6.9;pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "naive B-cell: 6.7;naive CD4 T-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 52.3;hTERT-HME1: 9.6;HUVEC TERT2: 11.5;OE19: 18.4;RT4: 10.1;TIME: 12.3" "Not detected" "Not detected" HPA039827 Approved NA NA "HPA039827: AB_10673364" "unprognostic (1.30e-2)" "unprognostic (1.25e-1)" "unprognostic (2.44e-1)" "unprognostic (1.66e-1)" "unprognostic (9.26e-3)" "unprognostic (1.49e-1)" "unprognostic (6.10e-3)" "unprognostic (5.19e-2)" "unprognostic (8.92e-2)" "unprognostic (2.30e-2)" "unprognostic (1.26e-1)" "unprognostic (9.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-1)" "unprognostic (3.86e-2)" "unprognostic (1.77e-2)" 11.8 12.3 0.6 1.4 1.2 0.5 13.0 6.9 1.0 5.5 5.6 0.6 3.3 3.3 6.1 1.9 12.6 1.1 3.2 132.6 0.6 0.9 1.4 0.4 9.8 2.1 0.9 0.5 1.5 7.4 0.0 1.0 11.7 6.1 13.0 2.4 0.0 6.1 8.4 3.3 2.2 9.1 52.2 0.5 2.4 4.9 1.6 0.2 0.4 1.0 6.6 6.4 31.4 12.1 6.7 0.1 1.0 1.3 0.0 3.6 5.0 2.3 0.7 0.0 4.2 1.0 0.0 1.2 0.3 3.5 0.5 0.7 2.9 1.6 0.0 0.2 0.0 3.5 0.9 0.0 1.6 0.7 0.0 0.1 52.3 0.6 0.0 0.1 0.0 0.0 0.0 1.3 0.1 9.6 0.0 11.5 0.0 0.7 0.0 0.3 0.8 0.0 0.0 0.0 18.4 1.0 0.0 4.4 0.1 0.0 10.1 0.0 1.5 0.2 2.4 0.0 0.5 3.1 0.0 12.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.7 0.6 0.0 0.1 6.7 3.6 0.0 1.0 0.0 1.3 0.0 0.3 5.0 0.6 1.2 6.9 1.0 0.6 0.9 0.9 0.5 6.1 0.2 8.9 1.1 0.0 8.9 0.0 0.1 451.1 7.6 1.4 1.2 24.4 0.0 3.6 6.6 28.1 0.1 3.6 13.7 0.0 16.8 2.3 0.0 6.0 0.0 0.0 1.3 0.0 1.7 4.9 5.9 0.4 4.4 0.0 0.0 5.4 6.1 0.1 17.9 21.0 15.9 0.0 0.0 0.0 0.9 0.0 0.9 0.0 1.0 0.0 6.0 4.9 MZB1 "HSPC190, MEDA-7, MGC29506, PACAP, pERp1" ENSG00000170476 "Marginal zone B and B1 cell specific protein" Q8WU39 5 139387480-139390081 "Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 97.7;lymphoid tissue: 152.6" "Group enriched" "Detected in many" 6 "Erythroid cells: 280.4;Melanocytes: 512.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 29.5;plasmacytoid DC: 97.7" "Group enriched" "Detected in many" 115 "B-cells: 29.5;dendritic cells: 97.7" "Group enriched" "Detected in some" 5 "Karpas-707: 66.2;RPMI-8226: 234.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA043745, HPA052694" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 670000 "Golgi apparatus" "HPA043745: AB_10960359, HPA052694: AB_2681919" "unprognostic (4.97e-3)" "unprognostic (1.75e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.27e-4)" "unprognostic (2.21e-2)" "prognostic favorable (4.60e-5)" "unprognostic (6.57e-2)" "unprognostic (1.35e-1)" "unprognostic (6.45e-3)" "unprognostic (7.10e-3)" "unprognostic (2.57e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.15e-8)" "unprognostic (7.22e-2)" "unprognostic (3.14e-1)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" 2.2 1.9 0.6 37.8 0.6 6.2 4.4 0.5 0.6 5.7 25.5 0.4 0.3 21.6 1.2 0.6 13.6 2.9 5.6 0.8 0.6 0.6 4.2 2.6 6.7 54.7 0.6 0.3 1.7 2.1 0.0 0.8 0.4 0.4 2.4 9.8 2.0 30.2 7.1 0.7 0.7 13.3 0.5 0.6 92.6 15.0 3.7 0.3 152.6 3.3 3.1 54.3 26.6 2.0 29.5 97.7 0.5 0.0 0.3 0.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 66.2 0.0 0.0 25.6 0.2 0.0 0.0 0.0 10.6 0.0 234.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 31.7 1.8 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 29.5 0.1 0.1 0.0 11.0 0.0 0.0 0.5 0.3 0.0 97.7 0.0 4.5 0.6 0.6 0.5 0.6 0.6 0.6 0.6 0.3 0.4 0.3 6.0 18.0 63.0 0.6 2.3 0.0 0.8 5.1 1.4 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 280.4 0.0 0.0 1.0 2.4 2.3 1.6 0.1 0.0 1.2 12.3 4.7 0.7 0.0 0.7 512.8 0.0 0.7 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.1 2.0 1.8 7.9 0.8 0.3 MZT1 "C13orf37, FLJ21869, LOC440145, MGC150539, MOZART1, RP11-11C5.2" ENSG00000204899 "Mitotic spindle organizing protein 1" Q08AG7 13 72708357-72727687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 44.6" "Cell type enhanced" "Detected in many" 4 "Erythroid cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063299, HPA066715" Approved NA Yes "HPA063299: AB_2684980, HPA066715: AB_2685709" "unprognostic (1.52e-1)" "unprognostic (3.38e-2)" "unprognostic (1.48e-1)" "unprognostic (4.89e-1)" "unprognostic (2.46e-1)" "unprognostic (2.38e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (2.65e-2)" "unprognostic (6.88e-2)" "unprognostic (5.28e-2)" "unprognostic (7.09e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.01e-5)" "unprognostic (9.01e-3)" "unprognostic (5.23e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" 7.5 14.1 19.8 9.7 44.6 19.9 10.6 26.9 24.1 8.3 7.6 4.4 7.3 7.2 7.6 8.5 8.9 5.4 5.4 10.3 17.3 16.6 10.1 4.6 8.6 14.1 11.3 14.8 6.8 6.1 5.3 7.2 9.3 9.2 9.5 9.1 5.3 8.0 10.7 15.5 8.4 6.4 7.0 9.1 8.1 7.9 5.3 8.2 12.1 10.9 7.8 11.2 9.2 6.2 9.6 7.5 13.8 8.6 9.0 11.5 4.8 30.7 4.9 17.6 12.9 3.6 6.1 14.4 25.0 10.4 15.8 18.4 9.3 20.3 21.4 19.2 9.9 10.0 10.0 17.5 9.3 28.9 25.5 17.9 27.7 10.5 13.9 5.1 46.3 22.7 3.3 9.5 9.5 19.9 9.6 16.0 25.0 15.2 16.8 31.2 5.5 23.4 25.9 13.4 18.8 9.4 16.7 20.1 10.5 14.1 7.7 20.7 19.0 10.6 15.7 15.1 10.1 11.8 23.0 10.8 14.0 16.0 19.7 30.2 15.5 23.8 16.8 32.9 28.4 28.6 13.8 4.7 9.9 6.2 8.3 7.7 9.6 8.4 7.7 5.8 8.5 11.1 8.8 2.4 9.0 8.6 7.5 11.5 4.8 19.8 44.6 26.9 24.1 17.3 16.6 11.3 14.8 9.2 8.2 0.0 17.5 49.1 23.0 48.9 27.5 16.1 10.2 5.3 11.4 29.6 13.7 37.4 49.7 24.7 2.4 23.0 7.8 116.8 21.2 78.8 23.9 23.9 18.4 6.6 36.9 60.4 20.8 18.4 23.5 3.1 18.4 31.4 57.3 36.1 14.4 16.2 20.9 17.5 15.6 27.5 22.1 32.3 21.7 45.4 41.0 50.2 25.3 38.3 17.5 28.1 N4BP2 B3BP ENSG00000078177 "NEDD4 binding protein 2" Q86UW6 4 40056826-40158252 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036770, HPA042607, HPA072549" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA036770: AB_10672477, HPA042607: AB_2678074, HPA072549: " "unprognostic (5.03e-2)" "unprognostic (3.42e-1)" "unprognostic (7.94e-3)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-3)" "unprognostic (2.88e-1)" "unprognostic (1.01e-1)" "unprognostic (3.66e-2)" "unprognostic (2.65e-2)" "unprognostic (9.55e-3)" "unprognostic (4.49e-2)" "unprognostic (2.14e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (6.85e-3)" "unprognostic (1.45e-1)" 3.5 3.1 3.4 7.4 5.1 7.0 5.8 6.1 3.2 5.5 4.3 1.2 7.1 4.7 7.0 6.6 5.2 4.8 3.8 3.5 2.5 3.6 3.2 11.3 7.5 9.2 1.9 1.6 7.0 13.1 2.5 14.3 11.9 2.8 4.9 4.5 4.3 10.7 11.0 2.9 5.4 5.3 3.2 3.1 4.3 3.8 3.5 2.1 35.6 7.2 3.5 7.8 5.6 5.2 2.4 8.1 5.7 1.2 10.6 4.5 1.2 1.5 1.6 9.4 1.5 0.6 3.1 7.7 1.8 1.9 1.0 2.2 3.0 3.1 8.3 3.5 1.7 1.7 1.2 6.0 1.9 2.5 2.6 1.9 3.7 1.4 1.4 1.6 10.0 8.9 3.5 2.7 1.7 3.7 0.3 2.7 7.9 8.2 3.6 2.0 1.5 20.2 4.3 4.7 1.2 1.3 11.8 11.1 1.9 0.8 3.7 3.8 6.7 1.6 1.3 1.5 6.3 1.1 2.7 3.7 1.1 5.9 0.7 1.3 5.9 6.0 5.7 1.2 3.6 2.3 5.7 1.1 0.5 2.3 1.2 2.4 1.7 3.0 1.7 1.7 2.4 4.5 2.5 0.3 10.6 1.0 8.1 1.3 1.2 3.4 5.1 6.1 3.2 2.5 3.6 1.9 1.6 2.8 2.1 20.8 19.5 2.9 12.0 10.6 30.6 12.3 12.7 6.7 18.2 21.0 25.5 34.4 0.0 5.4 2.6 6.6 6.0 23.3 10.7 11.4 12.3 12.2 4.7 15.5 10.4 68.3 18.6 4.9 16.3 2.7 9.2 17.8 6.8 9.0 15.0 11.8 9.7 8.6 3.5 3.1 20.2 12.9 5.7 13.6 27.0 11.4 22.5 13.8 8.0 8.4 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113443-178126087 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.5" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 120.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4" "Group enriched" "Detected in many" 18 "B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favorable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 6.6 1.3 1.9 2.6 2.1 3.5 13.9 6.5 4.3 2.5 1.8 0.7 0.5 0.8 1.1 0.6 16.2 1.5 1.3 3.2 1.8 2.6 2.5 0.2 8.4 4.0 2.1 1.2 1.4 1.1 10.1 2.5 31.5 3.1 2.0 0.6 1.5 9.5 1.3 5.7 7.8 1.9 1.3 1.2 5.9 3.1 1.4 1.3 0.4 2.0 4.7 11.2 4.9 3.8 4.0 4.4 0.0 0.0 0.2 2.6 0.5 0.0 0.0 1.2 0.9 0.1 0.0 8.0 0.0 0.0 0.0 0.0 1.7 0.6 0.7 1.1 0.0 0.1 2.5 0.2 0.0 0.0 1.2 0.4 2.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 6.4 0.7 1.3 0.5 0.0 10.9 0.1 0.1 6.0 1.8 0.0 6.0 10.9 2.7 0.6 1.2 0.9 0.4 0.3 38.8 2.5 1.6 1.4 0.0 1.2 0.0 0.9 0.0 0.0 1.7 1.2 6.8 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 4.0 0.2 0.2 0.0 4.0 0.9 2.6 0.0 0.2 0.0 4.4 0.0 0.5 1.9 2.1 6.5 4.3 1.8 2.6 2.1 1.2 3.1 1.3 3.0 1.1 5.9 11.5 8.4 27.3 1.5 2.5 0.0 0.0 1.8 11.8 1.7 11.6 3.4 0.1 4.0 2.6 0.0 0.7 120.1 0.9 9.9 4.6 0.0 2.0 1.6 4.1 0.0 0.0 0.4 0.6 1.1 11.8 1.8 1.8 1.9 4.7 5.3 1.8 0.3 8.9 0.0 0.9 0.1 6.9 5.9 19.3 1.0 1.9 10.6 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N(alpha)-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326050 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 166 "placenta: 32.1;testis: 30.5" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 32.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 30.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 25.1 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 21.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 20.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 14.4 15.0 0.0 11.1 0.0 0.0 0.0 NAA50 "FLJ13194, MAK3, NAT13, NAT5, San" ENSG00000121579 "N(alpha)-acetyltransferase 50, NatE catalytic subunit" Q9GZZ1 3 113716460-113746300 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 86.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074489 Approved NA NA "HPA074489: " "unprognostic (9.74e-2)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.32e-4)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.62e-3)" "unprognostic (6.82e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.92e-5)" "unprognostic (2.97e-3)" "unprognostic (1.09e-1)" "unprognostic (2.25e-2)" "unprognostic (9.59e-2)" "unprognostic (7.13e-3)" "unprognostic (2.43e-1)" 23.4 23.6 15.9 18.0 19.8 19.7 25.6 17.1 16.5 14.7 16.2 9.3 12.9 12.7 18.4 13.3 32.6 14.7 13.6 17.0 14.1 10.8 17.6 31.8 17.3 20.7 13.8 13.7 17.8 20.7 18.4 14.1 14.9 15.6 14.5 14.7 10.7 21.6 13.8 86.5 17.7 14.0 16.1 15.7 17.7 16.9 19.0 12.9 22.5 18.3 37.0 23.2 19.9 19.8 32.3 24.7 28.7 22.6 17.4 27.3 26.2 90.0 39.4 21.7 25.2 29.5 24.0 45.3 48.5 27.3 30.0 34.6 56.5 32.5 62.4 30.1 25.7 23.7 37.3 37.7 33.2 55.1 13.0 19.3 67.2 29.7 34.0 27.1 70.0 21.9 20.4 26.3 33.5 48.5 19.8 26.7 26.4 42.2 25.2 30.9 42.7 46.2 15.2 48.5 35.3 58.0 47.6 33.3 49.3 22.8 68.8 33.4 19.3 35.2 26.2 35.3 19.6 36.3 23.3 24.6 41.5 41.2 17.5 36.5 28.0 46.4 115.8 32.5 39.5 25.4 8.5 22.5 11.9 27.3 22.6 24.3 32.3 20.6 25.5 24.7 20.5 18.2 24.0 28.7 17.4 19.8 14.4 21.9 26.2 15.9 19.8 17.1 16.5 14.1 10.8 13.8 13.7 15.6 12.9 44.7 29.9 65.7 72.5 149.5 21.5 41.9 22.9 25.4 42.1 34.9 7.9 37.5 66.3 50.5 52.7 36.5 37.5 0.0 47.8 76.9 38.8 84.6 46.2 63.8 57.0 38.1 19.1 26.4 50.8 39.9 28.4 52.5 59.1 42.3 31.3 30.1 51.1 34.9 29.4 56.1 16.9 19.4 85.8 52.4 57.5 155.5 52.3 62.5 39.8 140.8 NAAA ASAHL ENSG00000138744 "N-acylethanolamine acid amidase" Q02083 4 75913657-75941051 "Predicted intracellular proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 89.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 97.1;Kupffer cells: 106.0" "Cancer enhanced" "Detected in all" "prostate cancer: 31.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "intermediate monocyte: 89.9" "Lineage enriched" "Detected in all" 5 "monocytes: 89.9" "Cell line enhanced" "Detected in many" "U-2197: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB026135 Approved "Intracellular and membrane" NA NA "CAB026135: " "unprognostic (5.30e-3)" "unprognostic (1.23e-2)" "unprognostic (1.41e-2)" "prognostic favorable (1.93e-4)" "unprognostic (1.10e-1)" "unprognostic (2.17e-2)" "unprognostic (2.92e-2)" "unprognostic (2.34e-2)" "unprognostic (2.24e-1)" "unprognostic (2.87e-2)" "prognostic favorable (4.90e-4)" "unprognostic (1.63e-1)" "unprognostic (2.15e-2)" "unprognostic (2.54e-1)" "unprognostic (3.20e-2)" "unprognostic (3.42e-3)" "unprognostic (6.21e-2)" 11.2 6.7 5.8 12.3 10.3 6.5 16.9 10.2 10.5 10.8 26.4 6.0 6.0 13.1 9.8 7.1 12.5 8.4 6.8 9.5 7.0 8.2 18.2 29.6 10.0 52.2 11.8 5.3 6.1 6.9 5.5 9.0 8.2 9.1 32.4 31.2 16.6 19.8 5.1 6.2 11.2 34.0 10.2 11.2 44.9 9.8 3.4 6.9 10.2 11.2 8.0 19.5 10.3 12.6 8.1 19.7 14.3 89.9 4.5 15.1 25.9 4.4 10.1 0.4 0.3 24.6 25.0 0.4 6.6 4.4 4.6 1.5 3.4 15.7 0.4 3.5 16.3 0.1 8.8 13.2 5.1 2.8 6.3 0.5 3.1 7.5 8.3 5.7 11.5 11.5 6.3 3.9 4.0 1.4 7.1 7.3 7.1 3.4 13.8 4.0 16.2 7.3 7.5 5.1 19.8 4.0 5.0 0.1 20.5 4.8 2.5 6.1 0.9 6.8 21.6 1.9 0.7 24.3 20.1 10.8 0.2 0.6 30.4 0.3 3.4 1.3 2.2 5.8 16.6 2.8 5.5 37.2 14.3 9.0 89.9 9.7 8.1 11.5 8.9 19.7 5.3 9.7 8.1 12.5 4.5 74.4 7.3 15.1 25.9 5.8 10.3 10.2 10.5 7.0 8.2 11.8 5.3 9.1 6.9 0.0 8.2 28.2 16.1 10.1 9.6 3.9 28.1 24.1 6.8 5.2 17.7 21.0 11.6 4.6 0.4 11.7 97.1 0.0 7.4 16.3 27.2 69.0 14.0 30.2 35.4 11.1 46.1 17.8 106.0 0.0 9.8 77.1 16.9 16.2 28.2 6.5 3.9 28.5 7.1 9.2 78.9 0.0 18.4 0.7 0.9 16.6 11.1 36.2 21.4 12.1 NAALAD2 "GCPIII, NAALADASE2" ENSG00000077616 "N-acetylated alpha-linked acidic dipeptidase 2" Q9Y3Q0 11 90131515-90192894 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 44.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 15.8;Early spermatids: 37.5;Horizontal cells: 66.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "non-classical monocyte: 2.4" "Lineage enriched" "Detected in single" 12 "monocytes: 2.4" "Cell line enhanced" "Detected in some" "CACO-2: 20.0;SH-SY5Y: 6.7;SuSa: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060820, HPA065419" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060820: AB_2684373, HPA065419: AB_2685487" "unprognostic (1.68e-1)" "unprognostic (2.66e-3)" "unprognostic (1.49e-1)" "unprognostic (4.52e-3)" "unprognostic (4.73e-3)" "unprognostic (2.97e-1)" "unprognostic (3.82e-3)" "unprognostic (1.77e-2)" "unprognostic (2.44e-1)" "unprognostic (2.30e-1)" "unprognostic (3.30e-2)" "unprognostic (8.00e-2)" "unprognostic (9.97e-4)" "unprognostic (1.52e-2)" "unprognostic (2.54e-1)" "unprognostic (1.63e-2)" "unprognostic (2.93e-1)" 7.7 13.0 5.3 1.8 9.9 1.1 3.1 2.1 9.8 7.8 2.1 3.7 2.8 1.3 10.3 5.4 1.8 4.7 3.7 2.5 5.5 7.4 2.7 1.7 2.8 1.6 6.5 5.0 12.9 2.5 0.9 44.1 8.8 11.9 5.2 2.2 5.8 1.9 3.7 2.1 1.5 2.1 3.5 6.2 4.4 1.8 16.6 7.4 0.0 1.7 1.7 1.2 1.8 3.8 0.0 0.1 0.0 2.4 0.0 0.1 0.1 0.1 0.2 1.9 0.1 0.6 0.1 2.4 0.1 0.1 0.1 0.0 20.0 0.7 0.3 0.2 0.0 0.3 0.3 1.4 0.0 0.0 0.0 0.4 1.9 0.4 1.8 0.2 0.1 0.1 2.3 0.0 0.0 0.0 0.6 0.4 0.2 0.1 0.0 0.0 0.0 0.3 0.3 1.9 0.5 0.2 0.3 0.0 0.2 0.0 0.0 0.2 6.7 0.0 0.2 0.0 4.9 0.2 0.4 2.6 0.1 1.6 0.4 0.3 1.1 0.3 0.3 0.7 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.1 0.1 5.3 9.9 2.1 9.8 5.5 7.4 6.5 5.0 11.9 7.4 0.0 0.0 0.0 0.1 0.2 15.8 0.8 2.5 0.0 1.2 0.0 0.0 0.8 0.0 0.0 37.5 0.7 0.0 0.0 0.0 0.5 3.4 0.2 0.0 0.0 0.3 66.7 0.0 1.3 5.4 13.2 10.3 0.2 0.0 0.0 0.0 10.1 0.0 0.0 13.8 0.0 2.3 0.0 4.7 0.3 4.4 0.0 0.7 0.0 0.0 0.0 NAALADL1 ENSG00000168060 "N-acetylated alpha-linked acidic dipeptidase like 1" Q9UQQ1 11 65044818-65058549 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "blood: 49.5;intestine: 123.4" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 39.3;monocytes: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 49.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.4;fHDF/TERT166: 6.8;HHSteC: 19.0;HSkMC: 12.5;SCLC-21H: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047123 Enhanced Uncertain Cytosol NA NA Cytosol "HPA047123: AB_2679942" "unprognostic (2.98e-2)" "unprognostic (2.06e-1)" "unprognostic (1.58e-1)" "unprognostic (8.76e-2)" "unprognostic (1.70e-1)" "unprognostic (1.28e-3)" "unprognostic (1.36e-1)" "unprognostic (1.40e-1)" "unprognostic (1.89e-2)" "unprognostic (1.38e-1)" "unprognostic (3.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.75e-4)" "unprognostic (2.10e-3)" "unprognostic (3.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.80e-2)" 4.1 0.9 1.4 3.3 1.6 7.0 4.1 1.9 1.4 6.0 54.3 1.2 2.6 7.8 7.2 1.8 2.7 4.4 3.4 3.5 1.3 0.6 2.3 1.2 3.4 5.2 1.5 1.5 6.2 1.0 0.9 2.0 1.5 1.6 4.6 2.6 3.1 2.3 4.8 2.0 1.6 123.4 4.3 1.4 5.0 2.8 1.8 1.2 1.8 1.8 2.3 2.9 3.1 5.4 8.8 4.9 49.5 6.3 22.2 12.9 7.0 0.0 0.0 0.1 0.2 0.5 5.4 0.9 2.0 0.0 2.5 1.1 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 0.1 3.1 19.0 0.0 0.0 12.5 0.0 2.5 0.0 0.0 3.2 0.1 0.0 0.2 0.0 0.2 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.8 0.2 0.0 9.8 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.7 0.0 0.1 0.1 49.5 6.3 10.3 9.5 4.3 4.9 8.0 7.6 4.8 4.9 8.8 8.8 4.9 1.1 22.2 2.5 0.2 12.9 7.0 1.4 1.6 1.9 1.4 1.3 0.6 1.5 1.5 1.6 1.2 0.0 0.0 8.2 3.2 3.2 1.1 1.1 2.5 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.6 9.0 39.3 0.0 0.7 0.2 5.7 0.5 19.6 0.0 2.8 9.5 1.2 16.5 7.6 1.7 10.9 6.4 15.1 22.6 0.7 10.8 0.3 14.4 17.0 0.0 0.9 0.0 13.7 1.6 2.6 2.9 0.3 11.7 0.4 0.3 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810552 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.3" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 60.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5" "Low region specificity" "Detected in many" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 4.9 2.3 2.2 4.6 3.7 0.8 7.0 1.9 2.7 8.3 8.3 5.4 23.8 2.4 9.7 10.5 2.3 5.0 8.9 5.4 2.5 1.8 7.0 3.7 3.3 1.3 2.3 2.0 5.4 3.9 20.6 3.0 6.4 4.0 9.6 3.3 4.4 17.0 29.3 1.8 3.2 6.6 6.0 3.6 2.6 4.5 1.9 2.9 4.9 3.5 2.6 1.7 8.7 5.0 0.1 1.7 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.2 0.0 3.5 11.7 0.1 2.3 4.2 0.6 0.7 0.2 1.3 0.0 0.5 4.9 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 3.2 0.6 0.1 0.0 3.0 0.4 0.0 0.0 0.1 2.3 0.4 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.1 1.7 0.2 0.0 0.0 0.2 0.2 0.9 0.3 3.1 0.1 0.5 2.3 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.0 4.5 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.1 0.0 1.7 0.0 0.0 2.2 3.7 1.9 2.7 2.5 1.8 2.3 2.0 4.0 2.9 0.0 11.5 0.0 7.2 2.1 7.6 2.8 10.2 18.7 6.8 12.2 11.8 16.3 6.6 6.8 60.1 2.1 11.1 0.0 2.3 1.5 7.8 18.3 4.6 2.4 1.6 0.0 8.6 3.1 0.3 28.0 14.1 0.7 3.3 0.0 1.1 7.7 2.5 3.5 11.3 1.7 6.6 0.0 2.3 3.2 1.9 1.6 10.3 0.0 14.9 13.7 NABP1 "DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2" ENSG00000173559 "Nucleic acid binding protein 1" Q96AH0 2 191678068-191696659 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.0" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 620.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054978, HPA067802" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA054978: AB_2682660, HPA067802: AB_2685899" "unprognostic (5.43e-2)" "unprognostic (5.33e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.48e-1)" "unprognostic (6.89e-2)" "unprognostic (8.07e-4)" "unprognostic (1.33e-1)" "unprognostic (2.89e-2)" "unprognostic (2.99e-1)" "unprognostic (2.82e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (8.20e-7)" "unprognostic (5.64e-2)" "unprognostic (7.50e-2)" "unprognostic (1.48e-1)" "unprognostic (6.02e-2)" 20.8 4.9 2.4 26.0 2.3 4.2 22.2 1.1 2.1 4.4 14.1 1.9 1.6 13.3 6.7 9.2 12.1 4.9 8.1 6.9 4.7 2.0 8.8 8.7 18.6 39.6 3.9 1.3 4.9 6.3 0.8 4.4 28.0 6.1 4.7 5.2 2.6 6.2 3.9 3.1 4.3 30.6 4.7 5.3 40.0 4.6 18.4 1.5 7.4 3.6 12.1 23.0 8.7 8.8 3.8 2.2 18.6 7.7 1.6 14.2 1.9 14.8 2.3 0.3 0.4 11.3 13.7 3.9 23.2 19.0 14.4 8.7 12.3 8.4 0.8 18.4 14.0 11.7 4.2 2.1 9.9 16.0 7.7 1.9 7.4 4.7 3.1 8.2 3.4 8.4 18.0 12.5 20.7 14.9 17.2 5.4 2.2 10.4 32.9 22.5 1.2 1.1 4.0 1.3 3.1 11.7 2.5 2.6 7.0 21.6 11.0 0.5 0.1 8.0 2.8 6.5 14.1 0.7 2.2 13.8 12.1 10.2 6.3 14.5 10.9 4.5 3.1 10.0 4.1 2.1 2.5 4.0 1.9 6.4 6.7 8.7 3.8 8.6 6.6 2.2 0.6 2.2 3.8 18.6 1.6 7.7 1.4 14.2 1.9 2.4 2.3 1.1 1.9 4.7 2.0 3.9 1.3 6.1 1.5 199.5 620.7 29.6 104.4 47.2 3.0 6.7 12.7 85.6 168.4 10.4 2.0 20.0 3.3 17.5 161.5 9.3 94.3 0.0 4.6 34.8 18.6 41.1 131.1 6.7 49.8 3.2 4.1 11.6 96.8 54.0 9.5 125.6 38.8 147.9 15.3 1.1 20.2 31.6 3.5 17.7 3.8 6.5 28.6 21.1 18.0 39.5 122.3 52.2 21.7 106.4 NACA2 "MGC71999, NACAL" ENSG00000253506 "Nascent polypeptide associated complex alpha subunit 2" Q9H009 17 61590426-61591202 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 76.7" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 120.7;Early spermatids: 304.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 7.7;SK-MEL-30: 4.4" "HPA073152, HPA073648" Approved Cytosol NA NA Cytosol "HPA073152: AB_2686575, HPA073648: AB_2686621" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (9.59e-2)" "unprognostic (5.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.45e-1)" "unprognostic (8.14e-3)" "unprognostic (4.91e-2)" "unprognostic (3.51e-2)" "unprognostic (1.18e-2)" "unprognostic (7.80e-2)" "unprognostic (2.08e-1)" "unprognostic (1.80e-2)" "unprognostic (6.88e-2)" "unprognostic (7.53e-3)" "unprognostic (5.45e-3)" "unprognostic (3.09e-3)" 2.5 2.5 2.4 2.7 2.8 2.2 5.6 2.2 2.8 6.6 2.4 1.0 0.8 2.2 2.1 2.6 5.0 2.2 1.9 3.7 2.2 2.0 4.7 5.5 3.3 6.5 2.2 2.1 9.5 14.3 2.3 2.1 3.6 1.3 3.3 2.1 1.3 2.2 2.0 7.2 2.8 4.1 5.4 2.9 4.2 2.2 76.7 2.8 4.8 4.1 3.2 2.7 6.3 2.4 2.1 1.9 0.7 3.2 1.7 2.0 2.9 0.8 0.0 0.8 0.8 0.3 0.6 2.3 0.2 0.8 0.3 0.5 0.7 0.4 0.0 1.3 0.0 0.3 0.2 0.2 0.2 0.6 0.6 0.2 0.2 0.8 0.8 0.2 0.3 0.8 0.0 0.9 0.0 0.0 0.3 0.4 0.1 0.2 2.6 0.2 0.2 1.1 7.7 1.9 0.1 0.2 1.0 0.5 2.5 0.3 0.1 1.0 1.9 0.5 1.2 4.4 0.0 2.0 2.8 0.0 0.4 1.0 1.5 0.8 0.9 0.7 0.8 1.0 0.5 0.7 0.4 1.4 0.7 1.2 3.2 1.4 2.1 1.6 1.6 1.9 1.8 2.0 1.8 0.4 1.7 3.0 1.8 1.9 2.9 2.4 2.8 2.2 2.8 2.2 2.0 2.2 2.1 1.3 2.8 0.0 0.0 26.2 34.9 61.6 0.7 120.7 33.1 0.0 0.0 1.8 0.0 16.5 72.9 0.3 304.8 29.2 2.8 0.0 0.7 19.1 22.7 38.5 0.0 16.2 12.6 0.0 3.5 22.7 59.5 103.0 31.4 21.0 43.9 0.0 6.5 1.2 0.5 10.5 10.6 5.1 0.8 12.9 44.3 61.4 10.7 69.4 20.1 27.7 11.9 38.7 NACAD KIAA0363 ENSG00000136274 "NAC alpha domain containing" O15069 7 45080438-45088914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.0" "Cell type enhanced" "Detected in many" 16 "Horizontal cells: 30.2;Peritubular cells: 11.3" "Group enriched" "Detected in many" 7 "glioma: 12.1;testis cancer: 16.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 12 "monocytes: 1.8;T-cells: 1.4" "Cell line enhanced" "Detected in many" "GAMG: 24.1;SCLC-21H: 18.5;SH-SY5Y: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020981, HPA079208" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA020981: AB_2670549, HPA079208: " "unprognostic (5.54e-6)" "unprognostic (1.89e-1)" "unprognostic (8.55e-4)" "unprognostic (7.06e-3)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.61e-1)" "unprognostic (6.91e-2)" "unprognostic (1.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.17e-2)" "unprognostic (8.17e-3)" "unprognostic (2.76e-2)" "unprognostic (7.72e-3)" "unprognostic (2.72e-3)" "unprognostic (9.22e-2)" "unprognostic (1.54e-1)" "unprognostic (2.87e-2)" 4.7 8.9 11.5 2.7 19.4 1.1 2.1 16.7 45.0 4.8 3.5 43.1 0.1 2.1 6.9 2.3 3.9 4.8 3.7 5.1 16.7 15.9 2.2 1.2 3.0 1.9 30.2 12.9 10.4 2.4 3.2 11.7 3.8 26.7 4.7 2.3 1.1 3.2 5.7 2.0 2.1 2.7 7.4 30.8 2.7 2.5 4.5 21.5 0.0 1.4 0.0 1.5 3.2 2.3 0.1 0.0 0.0 1.8 0.0 1.4 0.1 0.0 0.0 1.8 0.0 1.1 0.5 0.0 2.0 2.5 5.6 3.5 0.1 0.1 0.0 1.6 3.6 24.1 0.1 1.6 1.3 2.0 0.0 0.5 0.0 1.2 0.0 1.3 0.0 0.0 1.2 0.0 2.4 0.2 2.9 1.7 0.0 0.0 2.5 1.4 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.7 0.0 0.2 0.0 18.5 12.8 0.0 0.0 0.1 5.0 0.0 0.0 0.6 0.0 0.0 0.1 0.3 1.3 0.7 0.0 1.1 0.0 3.7 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.1 11.5 19.4 16.7 24.1 16.7 15.9 30.2 12.9 26.7 21.5 0.0 0.0 0.0 2.7 0.6 5.1 4.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.4 2.0 1.0 0.0 0.0 0.2 0.0 3.8 1.7 1.1 0.0 0.1 30.2 1.2 0.6 0.0 3.6 6.4 0.0 1.7 1.8 0.0 1.9 0.1 0.0 11.3 0.0 1.4 6.5 2.2 1.5 0.6 0.1 0.1 0.0 0.0 0.6 NADK2 "C5orf33, FLJ30596, MNADK, NADKD1" ENSG00000152620 "NAD kinase 2, mitochondrial" Q4G0N4 5 36192592-36242279 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 128.6" "Group enriched" "Detected in many" 7 "Early spermatids: 231.1;Hepatocytes: 160.3;Late spermatids: 119.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038366, HPA038367, HPA061492" Enhanced Supported Mitochondria NA NA 28000 Mitochondria "HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538" "unprognostic (1.15e-2)" "unprognostic (2.63e-2)" "unprognostic (3.01e-2)" "unprognostic (3.10e-3)" "unprognostic (1.64e-1)" "unprognostic (1.97e-2)" "unprognostic (4.06e-3)" "unprognostic (8.84e-2)" "unprognostic (3.32e-2)" "unprognostic (1.93e-3)" "unprognostic (1.09e-1)" "unprognostic (1.76e-1)" "unprognostic (9.73e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.54e-2)" "unprognostic (1.75e-2)" 5.7 10.2 13.7 4.1 12.5 4.4 6.8 6.7 13.4 6.6 6.0 13.3 5.9 7.0 5.9 4.1 4.9 6.0 5.5 8.3 14.3 8.5 10.0 128.6 4.0 4.2 11.6 12.0 8.8 12.2 4.8 3.1 7.2 11.6 9.5 6.2 3.9 5.6 7.7 11.1 3.3 5.5 24.8 20.3 3.8 7.6 7.3 11.4 2.5 7.6 3.5 5.1 15.2 5.9 5.1 3.3 9.1 4.2 9.5 3.2 1.7 9.1 6.0 9.2 10.5 14.1 12.0 12.6 8.6 5.7 7.9 5.9 16.8 11.5 32.9 6.4 9.8 9.8 6.4 8.6 6.3 11.1 9.1 7.6 8.8 17.8 9.8 10.4 19.1 3.5 13.2 9.7 8.7 13.2 9.8 8.3 12.8 23.2 11.8 7.9 3.6 17.8 7.3 5.1 7.4 8.7 17.3 22.8 7.0 10.1 7.8 4.1 9.3 44.4 14.1 4.6 7.6 10.0 16.8 6.2 15.4 8.4 11.6 10.2 10.8 13.0 9.7 6.5 24.9 6.0 9.1 2.0 1.9 2.1 2.0 2.7 2.2 3.2 2.5 3.3 5.1 2.7 2.2 0.1 9.5 4.2 1.5 2.9 1.7 13.7 12.5 6.7 11.4 14.3 8.5 11.6 12.0 11.6 11.4 3.0 5.8 6.7 5.9 6.1 5.5 25.5 22.9 8.1 7.9 5.2 7.9 6.8 21.6 3.9 231.1 6.8 5.2 0.0 8.0 6.9 11.2 12.7 1.1 160.3 7.5 3.2 6.9 13.5 8.9 119.7 18.4 4.9 13.5 2.8 11.7 15.3 8.4 7.0 21.5 19.6 5.0 0.0 13.0 16.7 10.5 5.0 6.1 5.7 12.3 8.1 NAGS "AGAS, ARGA, NAT7" ENSG00000161653 "N-acetylglutamate synthase" Q8N159 17 44004546-44009063 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Urea cycle" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.4;liver: 30.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 12.2;Hepatocytes: 18.8;Proximal tubular cells: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;HHSteC: 6.6;TIME: 8.1;U-87 MG: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA027300 Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA027300: AB_2672207" "unprognostic (1.51e-3)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (8.67e-2)" "unprognostic (1.44e-2)" "unprognostic (1.30e-3)" "unprognostic (2.38e-2)" "unprognostic (1.98e-1)" "unprognostic (3.14e-2)" "unprognostic (2.73e-2)" "unprognostic (2.53e-3)" "unprognostic (1.46e-1)" "unprognostic (5.19e-2)" "unprognostic (6.99e-2)" "unprognostic (1.29e-2)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" 0.6 0.6 0.5 0.4 2.4 0.0 1.0 0.7 1.5 0.3 7.2 0.5 5.6 16.4 0.5 2.6 0.9 0.3 0.3 0.9 0.7 1.5 4.4 30.2 2.5 0.2 1.8 0.6 0.5 0.3 3.6 0.4 0.4 1.2 0.8 0.4 0.1 0.9 6.5 0.1 0.6 13.4 0.3 2.0 0.5 0.3 0.4 1.1 0.2 2.9 0.0 0.1 0.8 0.8 1.5 2.0 2.3 2.7 1.0 3.5 1.3 3.4 0.2 0.0 0.5 0.0 6.4 0.1 0.6 0.0 0.2 0.0 2.2 0.8 0.0 1.4 0.0 0.1 1.5 0.0 1.2 0.1 0.3 0.8 0.1 0.2 2.7 6.6 0.0 0.0 2.8 0.1 0.2 0.0 0.6 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 1.7 2.7 0.1 0.2 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.0 0.1 0.2 0.1 8.1 3.0 0.8 0.2 0.7 0.2 0.2 0.2 12.1 0.1 0.4 1.8 1.4 2.3 3.5 1.5 2.8 1.2 2.2 2.9 2.0 1.5 1.1 1.7 0.8 1.0 2.7 0.3 1.7 1.3 0.5 2.4 0.7 1.5 0.7 1.5 1.8 0.6 1.2 1.1 3.0 3.4 0.5 0.8 1.3 0.4 2.4 5.1 1.4 4.5 12.2 0.0 0.9 6.6 1.6 4.4 0.9 10.4 0.0 3.6 1.6 0.6 0.4 0.0 18.8 1.0 0.0 6.9 1.3 2.6 2.2 1.4 4.2 0.0 9.0 2.6 0.9 3.7 3.2 0.7 14.6 0.5 0.0 1.0 5.5 1.5 0.6 0.3 1.5 3.3 0.6 NAIP "BIRC1, NLRB1" ENSG00000249437 "NLR family apoptosis inhibitory protein" Q13075 5 70968483-71025114 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.1;lymphoid tissue: 17.5" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 56.4;Kupffer cells: 123.5;Macrophages: 49.1" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 6.4" "Group enriched" "Detected in some" 10 "classical monocyte: 8.1;intermediate monocyte: 2.9;myeloid DC: 6.9;neutrophil: 5.9" "Group enriched" "Detected in many" 14 "dendritic cells: 6.9;granulocytes: 5.9;monocytes: 8.1" "Cell line enhanced" "Detected in some" "MOLT-4: 8.0;SiHa: 4.6;T-47d: 5.0" HPA042438 Approved NA NA "HPA042438: AB_10796578" "unprognostic (9.03e-2)" "unprognostic (6.03e-2)" "unprognostic (1.31e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (1.12e-3)" "unprognostic (1.12e-1)" "unprognostic (2.23e-2)" "unprognostic (4.36e-2)" "unprognostic (1.86e-1)" "unprognostic (2.54e-2)" "unprognostic (5.13e-1)" "unprognostic (1.69e-3)" "unprognostic (1.17e-1)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (9.96e-2)" 2.4 1.0 0.8 4.7 0.8 2.4 0.8 0.8 2.6 0.8 0.8 0.8 0.8 0.1 0.9 1.2 0.8 1.6 1.6 0.8 0.8 0.6 0.8 0.8 3.9 3.4 1.2 0.8 0.8 0.8 0.2 0.8 0.8 6.4 0.8 0.7 0.8 0.8 0.8 1.0 0.4 2.3 1.1 2.3 17.5 3.0 0.8 0.8 0.8 0.9 0.8 0.8 3.6 0.8 0.3 6.9 5.9 8.1 0.4 0.2 2.0 0.0 0.0 1.1 0.5 0.4 0.0 0.3 0.0 0.0 0.3 0.0 0.8 0.8 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.8 0.7 1.6 0.2 1.5 0.5 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.3 0.6 0.2 0.0 8.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.3 0.1 0.3 0.0 4.6 0.0 0.3 0.9 5.0 0.0 0.0 1.2 0.3 0.2 0.0 0.9 0.0 0.6 0.2 0.1 0.9 0.2 8.1 0.0 0.2 2.9 0.1 0.1 0.0 0.1 6.9 0.3 0.2 0.1 5.9 0.4 0.5 0.3 0.1 2.0 0.8 0.8 0.8 2.6 0.8 0.6 1.2 0.8 6.4 0.8 17.9 8.9 0.8 2.3 3.2 15.4 2.7 17.8 9.4 12.5 5.2 21.6 2.9 0.0 1.6 40.1 7.1 2.0 23.3 1.9 1.7 4.3 2.3 4.7 4.5 56.4 15.9 10.3 9.8 123.5 10.1 10.0 49.1 1.7 1.0 6.0 6.5 1.6 0.0 6.7 0.6 35.7 6.5 2.6 15.2 4.3 3.3 2.4 3.1 3.4 1.4 NALCN "bA430M15.1, CanIon, VGCNL1" ENSG00000102452 "Sodium leak channel, non-selective" Q8IZF0 13 101053776-101416492 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 14.4;Cone photoreceptor cells: 5.9;Horizontal cells: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 7.8;HaCaT: 11.8;HHSteC: 12.7;hTERT-RPE1: 9.4;TIME: 15.3;U-87 MG: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031889, HPA031890, HPA031958" Approved NA NA "HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039" "unprognostic (4.66e-1)" "unprognostic (6.55e-3)" "unprognostic (1.86e-3)" "unprognostic (6.78e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-3)" "unprognostic (8.11e-2)" "unprognostic (2.60e-1)" "unprognostic (7.72e-2)" "unprognostic (5.92e-2)" "unprognostic (1.25e-1)" "unprognostic (2.18e-1)" "unprognostic (1.58e-5)" "unprognostic (1.77e-3)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" 1.5 8.3 9.8 1.4 18.3 1.6 5.2 13.4 29.4 3.6 1.3 18.6 0.0 1.1 1.5 3.4 1.1 2.6 4.6 6.0 10.8 11.4 1.2 2.3 2.7 1.0 11.0 13.1 5.6 2.1 4.2 13.0 5.6 17.0 1.3 1.7 4.3 1.6 2.5 1.0 1.6 1.4 1.3 12.7 1.3 1.8 2.0 14.1 0.0 4.8 0.0 0.8 1.6 0.6 1.4 0.8 5.4 0.5 0.9 0.9 0.3 0.1 6.6 1.3 0.2 0.6 0.3 0.1 0.7 0.6 1.6 0.4 0.1 7.8 0.0 0.4 3.1 0.8 11.8 0.0 1.8 4.2 0.0 0.8 0.4 3.8 0.1 12.7 0.2 0.2 0.2 0.5 1.4 3.9 9.4 6.9 0.0 0.1 0.4 5.0 0.0 0.1 0.0 0.3 1.1 1.4 0.0 0.0 0.0 3.9 1.6 1.0 0.2 0.1 0.1 0.6 0.7 0.2 0.1 15.3 0.4 0.1 0.3 1.6 0.0 0.1 0.0 9.7 0.0 0.3 5.4 0.5 0.8 0.9 0.3 0.4 0.7 0.5 0.5 0.1 1.4 0.6 0.5 1.8 0.9 0.2 0.8 0.4 0.3 9.8 18.3 13.4 18.2 10.8 11.4 11.0 13.1 17.0 14.1 0.0 0.0 0.0 0.0 0.2 14.4 4.5 0.0 0.0 0.0 0.0 5.9 0.9 0.0 0.5 3.5 0.3 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.1 25.4 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.8 0.0 2.4 0.0 0.3 0.2 0.7 0.1 0.5 0.0 0.0 0.0 NANOG "FLJ12581, FLJ40451" ENSG00000111704 "Nanog homeobox" Q9H9S0 12 7787794-7799141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.9;testis: 3.8" "Cell type enhanced" "Detected in some" 12 "Cone photoreceptor cells: 7.9;Spermatocytes: 5.7" "Cancer enriched" "Detected in single" 1164 "testis cancer: 58.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 52.1" "CAB019380, HPA072117" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB019380: , HPA072117: " "unprognostic (1.76e-1)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (8.59e-3)" "unprognostic (3.50e-1)" "unprognostic (3.46e-2)" "unprognostic (6.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.87e-1)" "unprognostic (4.51e-7)" "unprognostic (3.46e-2)" "unprognostic (2.09e-1)" "unprognostic (1.51e-1)" "unprognostic (3.85e-2)" 0.4 0.9 0.4 0.4 1.0 1.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.4 0.4 0.6 0.4 0.4 0.4 0.1 0.5 0.7 1.7 0.5 0.4 0.4 0.5 0.5 0.0 0.6 0.4 0.4 0.5 0.0 0.4 0.4 0.4 1.1 1.7 0.4 0.4 0.4 1.0 0.7 3.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.1 4.9 3.2 0.7 1.1 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.7 0.5 0.6 0.4 0.4 0.6 0.5 0.4 0.2 1.1 0.7 0.8 2.3 1.1 0.5 4.9 0.3 0.2 0.4 1.0 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.5 1.6 1.4 1.9 0.4 0.0 0.0 0.0 0.0 7.9 1.2 0.0 0.3 1.0 0.3 0.0 0.0 0.3 0.2 0.4 0.8 0.0 0.5 0.4 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.2 1.2 0.0 0.0 5.7 0.4 0.5 0.6 0.0 0.3 1.4 NANOGNB ENSG00000205857 "NANOG neighbor homeobox" Q7Z5D8 12 7765216-7774121 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.0;testis: 2.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 18 "testis cancer: 1.2" "Group enriched" "Detected in some" 4 "basophil: 1.8;neutrophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "A549: 2.0;HL-60: 1.7;HSkMC: 1.7;U-2197: 3.0" HPA060371 Uncertain NA NA "HPA060371: AB_2684266" "unprognostic (2.76e-1)" 0.1 0.3 0.1 0.7 0.1 1.4 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 1.2 0.6 0.1 0.0 0.1 0.0 0.1 0.3 0.9 0.5 0.1 0.0 0.1 0.2 0.1 2.0 0.1 0.0 0.1 0.1 0.4 0.2 2.0 0.4 0.3 0.4 0.1 0.1 2.0 0.2 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.8 0.5 0.4 1.0 0.0 0.0 1.7 0.0 1.7 0.0 0.4 0.0 0.6 0.0 0.2 0.7 0.0 0.0 0.0 0.2 0.9 0.2 0.2 0.0 0.1 0.4 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.3 1.0 0.4 1.3 3.0 0.2 0.9 0.5 0.1 0.8 0.2 0.0 1.8 0.3 0.3 0.4 0.4 0.4 0.2 0.3 0.3 0.0 0.4 0.4 0.3 2.0 0.3 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 NANOGP8 ENSG00000255192 "Nanog homeobox retrogene P8" 15 35084193-35085110 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.5;skin 1: 1.7;testis: 2.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 415 "testis cancer: 20.7" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Group enriched" "Detected in some" 85 "NTERA-2: 32.7;SuSa: 15.4" HPA072117 Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA072117: " "unprognostic (1.58e-1)" "unprognostic (9.05e-3)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 1.7 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NANOS1 "NOS1, ZC2HC12A" ENSG00000188613 "Nanos C2HC-type zinc finger 1" Q8WY41 10 119029716-119033732 "Disease related genes, Predicted intracellular proteins" "Translation regulation" "Repressor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.9;Cone photoreceptor cells: 9.8;Muller glia cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 39.6;SK-BR-3: 22.7;SK-MEL-30: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012219 Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB012219: " "prognostic unfavorable (1.52e-4)" "unprognostic (1.17e-1)" "unprognostic (1.50e-3)" "unprognostic (1.59e-3)" "unprognostic (7.07e-3)" "unprognostic (2.01e-1)" "unprognostic (2.19e-2)" "unprognostic (4.76e-3)" "unprognostic (1.97e-1)" "unprognostic (2.70e-1)" "unprognostic (8.22e-3)" "unprognostic (8.79e-2)" "unprognostic (2.64e-4)" "unprognostic (7.89e-2)" "unprognostic (6.99e-2)" "unprognostic (2.78e-2)" "unprognostic (2.52e-3)" 8.5 10.5 8.1 1.0 7.1 1.0 6.4 6.5 4.8 4.9 2.1 4.5 1.3 1.2 2.1 4.4 2.1 1.5 1.0 16.7 5.0 6.7 3.5 1.0 1.3 1.1 3.4 2.4 0.9 3.3 0.9 2.2 8.2 6.0 3.5 1.2 8.8 1.5 2.5 40.7 1.7 1.4 3.4 6.7 0.9 3.1 2.9 3.0 0.1 9.3 0.3 1.0 3.3 9.8 0.6 0.5 3.2 0.3 0.6 0.3 0.1 7.6 0.6 1.1 0.2 3.7 0.5 4.7 0.1 0.2 0.2 0.1 0.9 2.7 4.1 1.0 0.0 0.0 2.8 1.3 1.3 0.3 1.2 3.2 0.1 1.9 0.8 1.7 0.4 0.0 0.7 5.7 0.0 0.8 1.2 0.2 1.4 0.7 0.5 0.2 1.1 1.0 1.3 3.5 1.6 0.6 0.0 1.3 2.7 1.5 0.6 3.0 39.6 2.2 22.7 17.2 6.2 3.6 2.2 0.2 0.0 1.7 0.0 0.3 1.2 3.9 1.4 0.3 1.0 0.0 3.2 0.3 0.4 0.2 0.1 0.1 0.2 0.2 0.2 0.0 0.6 0.3 0.2 1.3 0.6 0.2 0.5 0.1 0.1 8.1 7.1 6.5 4.8 5.0 6.7 3.4 2.4 6.0 3.0 6.0 0.6 0.0 3.5 0.7 3.3 10.9 0.0 0.0 1.2 1.8 9.8 5.3 0.0 0.5 0.1 0.6 0.4 0.0 0.2 0.2 4.1 3.2 0.0 0.0 0.5 1.6 2.9 0.6 0.0 0.0 1.7 0.0 0.0 0.0 1.0 8.5 0.2 0.0 0.7 0.2 1.7 0.0 0.5 0.2 0.7 1.1 0.8 0.0 0.6 0.9 NANOS2 "NOS2, ZC2HC12B" ENSG00000188425 "Nanos C2HC-type zinc finger 2" P60321 19 45913214-45914870 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "BEWO: 4.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA014190 Approved NA NA "HPA014190: AB_2668950" "unprognostic (2.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.69e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NANOS3 "NANOS1L, NOS3, ZC2HC12C" ENSG00000187556 "Nanos C2HC-type zinc finger 3" P60323 19 13862063-13880757 "Predicted intracellular proteins" "Differentiation, Oogenesis, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;testis: 9.4" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 3.7;monocytes: 4.6;Spermatogonia: 4.5" "Cancer enriched" "Detected in many" 34 "testis cancer: 132.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;MCF7: 3.2;MOLT-4: 1.8;REH: 2.9;RPMI-8226: 2.2;SH-SY5Y: 2.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062989 Enhanced NA NA "HPA062989: AB_2684916" "unprognostic (9.42e-3)" "unprognostic (3.17e-2)" "unprognostic (1.58e-1)" "unprognostic (8.58e-2)" "unprognostic (2.69e-1)" "unprognostic (6.89e-3)" "unprognostic (3.23e-3)" "unprognostic (4.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-3)" "unprognostic (5.17e-2)" "unprognostic (4.60e-2)" "unprognostic (3.12e-1)" "unprognostic (1.73e-1)" "unprognostic (2.16e-1)" "unprognostic (2.06e-1)" 0.3 0.0 1.7 0.3 0.4 0.0 0.3 5.1 4.4 0.3 0.3 0.3 0.3 2.2 0.3 0.3 0.3 0.0 0.3 0.3 1.3 1.7 0.3 0.3 1.1 0.3 0.8 0.3 0.3 0.5 0.0 0.4 0.4 0.3 0.3 0.0 0.3 0.3 0.4 0.3 0.4 1.3 0.3 0.3 0.4 0.5 9.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 2.0 0.7 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 3.2 1.8 1.5 0.3 0.0 0.0 2.9 0.0 2.2 0.0 0.0 0.4 2.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.8 1.2 0.0 0.3 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 5.1 4.4 1.3 1.7 0.8 0.3 0.3 0.3 0.0 3.7 0.0 0.6 1.5 0.8 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.6 0.8 0.2 0.0 0.0 1.0 0.2 0.7 1.7 1.1 0.0 0.4 0.0 1.2 0.0 1.0 1.4 0.0 0.4 3.3 4.6 0.7 1.2 2.2 0.0 0.7 0.0 0.5 0.0 1.9 0.2 4.5 1.1 0.1 0.0 0.4 0.8 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 24.8;Horizontal cells: 17.5;Muller glia cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.1;Karpas-707: 10.2;NTERA-2: 13.0;U-2197: 10.5;U-266/84: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054050: AB_2682357, HPA057065: AB_2797258" "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.3 5.8 15.7 2.2 20.0 0.9 3.2 37.5 49.8 4.5 2.8 2.0 0.2 1.3 4.9 8.0 2.8 4.2 2.5 7.2 21.0 22.8 8.0 1.3 2.5 2.9 15.7 28.7 8.6 2.6 10.5 10.2 0.5 20.5 10.4 3.1 2.6 3.1 5.9 1.1 4.9 1.7 4.6 8.3 3.9 2.0 2.2 4.9 0.0 8.0 0.0 1.8 2.6 2.5 0.9 0.0 0.0 0.0 1.2 3.6 1.4 0.0 3.4 0.1 6.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 12.1 0.0 6.5 0.7 2.4 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.9 0.1 1.8 0.0 0.2 4.7 0.2 10.2 0.0 1.2 4.0 0.0 13.0 0.0 6.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.8 0.0 2.7 1.2 0.0 0.1 0.0 7.6 10.5 0.8 4.8 21.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.9 3.4 2.3 0.0 0.1 1.6 3.6 0.0 1.2 0.0 0.0 2.6 1.4 15.7 20.0 37.5 42.1 21.0 22.8 15.7 28.7 20.5 4.9 0.0 4.0 0.0 4.6 5.7 24.8 10.9 5.1 0.0 1.2 12.2 0.0 0.0 11.6 0.8 0.0 2.2 0.0 0.0 0.2 0.0 0.5 2.4 4.6 0.8 0.1 17.5 6.9 2.5 0.8 0.0 0.3 0.0 0.0 0.0 0.2 12.4 1.1 0.0 0.4 3.1 8.7 0.0 3.3 0.2 0.0 2.6 0.0 3.2 0.2 0.8 NAP1L3 "MB20, MGC26312, NPL3" ENSG00000186310 "Nucleosome assembly protein 1 like 3" Q99457 X 93670930-93673568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.2" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 38.8;Horizontal cells: 58.8;Peritubular cells: 18.4" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.9" "Group enriched" "Detected in many" 24 "NK-cells: 4.5;T-cells: 6.9" "Cell line enhanced" "Detected in some" "AF22: 9.9;HAP1: 9.5;NTERA-2: 17.4;SuSa: 15.8;U-2197: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026075 Approved Vesicles NA NA Vesicles "HPA026075: AB_1854301" "unprognostic (7.18e-2)" "unprognostic (1.81e-2)" "unprognostic (9.26e-2)" "unprognostic (4.83e-4)" "unprognostic (3.06e-1)" "unprognostic (1.28e-2)" "unprognostic (5.10e-2)" "unprognostic (1.76e-1)" "unprognostic (3.31e-2)" "unprognostic (9.29e-2)" "unprognostic (2.75e-3)" "unprognostic (5.01e-2)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.75e-1)" "unprognostic (5.23e-4)" 2.3 10.4 24.4 2.4 25.7 1.2 2.4 44.9 60.2 16.0 2.4 5.3 0.0 1.6 9.5 4.7 1.5 8.1 4.4 8.4 22.0 42.3 2.9 1.4 1.8 2.1 18.5 31.0 13.1 1.5 1.1 7.9 1.6 20.9 3.9 2.3 2.4 1.6 4.6 0.8 1.7 2.0 6.5 13.1 3.6 1.4 11.9 7.0 0.0 4.6 0.0 1.5 3.3 1.2 0.0 0.0 0.2 0.0 4.5 6.9 1.6 0.0 0.1 9.9 7.2 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.4 0.2 0.0 9.5 0.0 0.0 0.0 0.2 4.5 0.0 0.1 0.5 0.0 0.3 4.5 0.0 0.5 4.6 0.0 0.0 4.9 0.0 0.0 0.5 0.0 0.0 0.0 17.4 0.0 4.1 0.0 7.7 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.1 15.8 0.0 0.5 0.0 5.5 8.0 11.7 0.4 7.5 3.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.1 0.0 4.3 1.6 0.0 0.0 6.9 4.8 0.2 4.5 0.0 0.0 1.3 1.6 24.4 25.7 44.9 60.2 22.0 42.3 18.5 31.0 20.9 7.0 0.0 0.0 0.0 0.2 0.6 38.8 7.3 0.0 2.7 1.2 0.0 5.9 0.2 14.9 0.0 0.8 0.7 0.0 0.0 0.0 0.1 6.6 0.0 5.7 0.0 0.3 58.8 0.0 1.8 0.0 1.7 10.9 0.0 5.0 0.0 0.0 14.5 0.3 0.0 18.4 0.3 11.1 0.0 3.4 2.2 6.9 0.4 0.2 0.0 0.0 0.0 NAP1L5 DRLM ENSG00000177432 "Nucleosome assembly protein 1 like 5" Q96NT1 4 88695915-88697829 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 32.4;granulocytes: 31.1;Muller glia cells: 32.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 29.5" "Low region specificity" "Detected in all" HPA058227 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058227: AB_2683644" "unprognostic (1.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.33e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (8.54e-3)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (2.57e-2)" "unprognostic (1.39e-1)" 7.3 21.8 24.5 3.6 23.3 4.9 4.9 25.8 53.4 6.2 3.1 4.2 2.1 1.9 6.4 10.5 4.1 4.9 5.4 5.6 23.9 52.8 6.1 5.0 3.1 3.0 28.4 33.6 8.2 2.8 7.9 12.9 4.7 35.6 6.7 3.1 3.6 2.5 8.7 1.8 1.7 2.4 6.4 11.5 3.5 2.8 4.9 5.4 0.5 9.3 1.3 2.4 5.2 2.0 0.7 0.9 0.6 0.8 1.5 3.9 1.0 0.0 1.1 7.3 4.4 10.7 6.9 0.0 7.8 4.8 4.0 6.3 0.0 0.9 0.0 3.2 4.5 1.7 1.5 12.9 3.1 7.3 2.4 0.0 13.5 4.7 1.1 9.3 6.9 8.9 10.8 1.0 4.7 0.7 5.2 7.1 7.6 3.8 0.0 11.8 0.1 8.5 0.5 3.0 3.7 0.0 4.6 2.1 0.8 2.7 3.3 9.7 29.5 0.0 1.4 5.7 8.2 0.0 2.0 5.1 4.6 1.1 2.9 3.9 2.0 0.0 0.0 9.8 0.0 3.5 0.0 0.2 0.4 3.9 0.4 2.6 0.0 1.9 3.0 0.9 0.7 3.5 3.3 0.6 1.5 0.8 0.7 1.7 1.0 24.5 23.3 25.8 41.9 23.9 52.8 28.4 33.6 35.6 5.4 3.0 7.0 2.4 3.4 1.5 32.4 4.8 0.0 1.4 6.8 5.2 13.7 12.6 13.3 1.7 0.6 5.4 0.0 0.0 2.2 1.6 8.5 2.9 31.1 2.9 4.8 14.3 16.6 10.4 0.0 0.4 10.0 1.2 5.0 2.8 1.4 32.8 1.0 0.2 17.0 3.4 17.3 19.4 9.8 5.6 2.1 1.3 18.5 7.9 0.9 1.7 NAPB "SNAP-BETA, SNAPB" ENSG00000125814 "NSF attachment protein beta" Q9H115 20 23374519-23421519 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 110.9" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 176.7;Cone photoreceptor cells: 62.8;Horizontal cells: 63.5;Rod photoreceptor cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 24.5;U-937: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037225, CAB037227, HPA046149, HPA050196" Supported Uncertain Cytosol NA NA Cytosol "CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: AB_2679557, HPA050196: AB_2681048" "unprognostic (3.89e-1)" "unprognostic (2.71e-1)" "unprognostic (5.95e-2)" "unprognostic (1.05e-1)" "unprognostic (2.54e-2)" "unprognostic (3.92e-2)" "unprognostic (1.32e-3)" "unprognostic (1.25e-1)" "unprognostic (4.71e-2)" "unprognostic (6.37e-2)" "unprognostic (4.46e-3)" "unprognostic (7.52e-3)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.42e-1)" "unprognostic (2.31e-1)" "unprognostic (1.12e-1)" "unprognostic (4.60e-2)" 3.2 15.5 32.7 3.8 32.7 6.0 4.4 46.0 110.9 4.0 4.0 4.4 2.6 3.8 4.7 6.3 3.7 4.6 3.8 3.7 30.5 32.0 4.4 3.8 3.9 4.0 26.1 40.1 6.4 3.4 6.1 4.6 5.9 50.2 4.0 5.0 6.1 4.0 4.6 3.4 5.0 5.5 4.5 9.7 4.5 4.3 5.3 4.0 0.7 5.1 0.1 3.4 3.6 2.3 2.4 1.9 6.0 2.1 1.5 5.1 2.1 4.3 2.8 4.6 4.8 5.2 4.8 6.5 5.6 3.0 4.5 4.0 3.3 3.8 6.3 6.7 3.3 3.3 5.5 5.9 3.8 5.5 2.0 4.4 6.9 3.7 7.7 6.1 5.1 4.1 4.8 5.0 3.2 4.0 4.1 3.3 6.5 5.8 8.4 7.2 2.9 5.2 4.7 2.0 3.5 5.1 3.5 3.7 4.7 5.9 4.7 24.5 7.8 3.2 3.1 5.2 7.0 3.2 3.2 3.9 4.3 3.2 4.8 3.9 6.2 4.8 2.9 2.2 24.4 4.3 6.0 1.2 0.0 5.1 1.3 1.5 1.7 2.0 2.4 1.9 2.4 2.0 3.3 1.5 1.5 2.1 1.5 2.5 2.1 32.7 32.7 46.0 57.7 30.5 32.0 26.1 40.1 50.2 4.0 11.9 6.2 5.1 4.4 7.7 176.7 4.9 7.6 2.7 6.8 14.0 62.8 5.6 0.0 2.9 39.1 7.7 3.5 0.0 1.2 4.4 8.4 3.3 10.5 4.9 4.4 63.5 9.8 10.4 7.2 45.5 8.3 3.6 10.1 4.6 2.3 15.7 2.7 0.0 8.5 2.2 78.5 6.5 6.2 9.7 9.8 7.3 5.1 5.7 4.5 3.3 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552761 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favorable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.0 14.0 20.5 9.1 31.2 6.1 12.1 24.0 40.2 11.6 11.6 17.8 4.9 9.3 11.0 12.7 12.3 11.3 13.5 19.3 26.3 20.8 16.9 13.3 9.6 8.7 24.1 21.4 7.6 12.4 12.8 10.5 13.7 54.1 14.3 14.1 10.1 10.7 11.6 9.0 8.8 10.3 12.5 25.2 8.5 13.4 7.1 11.9 6.9 14.8 8.2 10.6 12.6 8.7 8.4 4.7 15.2 7.1 6.6 7.1 3.6 5.0 3.0 5.3 4.6 15.2 10.5 7.7 10.7 15.4 10.5 13.4 6.6 7.6 6.7 8.6 14.6 9.6 4.9 7.0 9.7 15.1 5.7 4.3 4.9 5.3 6.8 14.6 13.5 9.2 11.0 11.2 12.0 9.0 6.9 9.8 8.7 7.9 16.0 15.3 7.0 10.4 5.8 4.1 38.5 4.5 4.6 8.8 11.2 12.3 11.9 21.2 5.6 8.7 9.3 12.3 9.0 4.2 9.0 11.0 16.6 8.0 15.2 11.3 10.3 10.5 7.4 11.1 9.5 7.6 11.3 5.7 15.2 6.5 7.1 5.8 8.4 5.2 6.3 4.2 4.1 7.1 6.1 9.7 6.6 6.9 4.7 5.1 3.6 20.5 31.2 24.0 40.2 26.3 20.8 24.1 21.4 54.1 11.9 26.8 26.7 24.1 23.8 21.6 62.1 30.5 22.9 17.4 22.7 26.2 11.8 20.2 34.9 43.8 12.0 21.5 22.5 0.0 37.3 25.1 18.2 29.7 43.9 18.8 22.3 42.9 22.5 17.2 23.1 2.1 7.2 19.7 25.3 19.8 17.1 28.2 53.8 34.5 19.8 31.9 31.3 25.8 21.7 12.7 37.9 18.4 37.8 20.1 14.3 46.1 NAPSA "KAP, Kdap, NAP1, NAPA" ENSG00000131400 "Napsin A aspartic peptidase" O96009 19 50358477-50365830 "Enzymes, Plasma proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 47.5;lung: 153.3" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 2552.8" "Cancer enriched" "Detected in many" 18 "lung cancer: 249.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 10.5" "Group enriched" "Detected in many" 9 "B-cells: 5.1;dendritic cells: 10.5" "Cell line enriched" "Detected in some" 24 "U-698: 29.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB009591, HPA045280, HPA047236, HPA047744" Enhanced "Secreted in other tissues" NA NA 380000 "CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143" "unprognostic (5.36e-2)" "unprognostic (4.77e-2)" "unprognostic (1.64e-3)" "unprognostic (1.78e-1)" "unprognostic (1.93e-1)" "unprognostic (4.65e-2)" "unprognostic (1.02e-1)" "unprognostic (8.30e-3)" "unprognostic (2.29e-1)" "unprognostic (2.23e-2)" "unprognostic (1.76e-3)" "unprognostic (7.67e-3)" "prognostic favorable (1.21e-4)" "unprognostic (4.08e-4)" "unprognostic (3.29e-1)" "unprognostic (9.83e-3)" "unprognostic (7.26e-5)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 5.0 0.1 0.1 0.1 0.1 0.1 0.0 47.5 0.1 153.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 5.1 10.5 0.5 0.9 0.5 0.6 1.1 0.2 0.4 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.2 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.3 1.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.6 0.1 0.3 0.2 0.3 0.3 0.6 0.0 0.1 0.9 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.8 0.0 0.2 0.4 29.8 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.9 0.0 5.1 0.2 0.4 3.0 1.9 0.6 0.5 0.5 0.5 0.9 10.5 0.0 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 485.3 2552.8 8.0 0.4 0.1 1.3 0.4 0.0 29.4 84.2 43.6 3.9 0.4 8.3 0.4 34.9 0.1 0.9 0.0 0.7 0.2 0.2 0.6 64.0 0.0 0.3 0.0 0.0 0.0 0.3 4.5 0.9 4.0 0.0 0.0 0.9 1.3 0.1 2.8 0.4 230.9 0.7 0.0 0.3 0.5 0.7 0.5 0.1 0.0 0.8 0.0 NAT1 AAC1 ENSG00000171428 "N-acetyltransferase 1" P18440 8 18170477-18223689 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 23.4" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 34.8;Paneth cells: 25.9" "Cancer enriched" "Detected in all" 14 "breast cancer: 47.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB017782, HPA043704" Approved NA NA "CAB017782: , HPA043704: AB_2678625" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.07e-4)" "unprognostic (2.09e-1)" "unprognostic (2.53e-2)" "unprognostic (8.25e-2)" "unprognostic (5.20e-2)" "unprognostic (6.53e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-2)" "unprognostic (9.51e-2)" "unprognostic (6.60e-2)" "unprognostic (7.44e-2)" "unprognostic (2.30e-1)" "unprognostic (3.28e-2)" "unprognostic (8.15e-2)" 3.7 3.2 1.5 8.5 1.5 1.9 7.9 1.3 1.5 5.4 15.6 1.0 5.1 9.3 4.4 13.0 4.8 3.5 5.9 2.9 1.7 1.0 8.6 14.3 6.2 6.6 2.5 1.0 3.3 4.2 1.1 4.6 6.0 3.1 7.4 10.3 4.5 3.6 5.4 2.0 1.6 23.4 2.6 2.3 9.8 4.8 4.1 0.5 10.8 2.6 4.3 6.2 3.1 3.0 6.3 8.1 12.3 7.1 8.6 8.5 3.9 18.5 2.3 2.1 2.8 5.6 5.6 4.5 6.8 7.1 7.6 8.7 3.1 4.0 9.0 5.4 4.3 7.0 2.9 3.8 4.4 7.7 8.4 2.0 6.1 2.6 2.3 5.4 2.7 8.4 4.6 5.7 5.1 0.4 1.9 6.6 8.0 5.3 2.5 8.3 3.3 8.0 8.6 2.0 14.6 2.9 4.0 2.0 3.8 8.0 10.7 1.1 1.4 0.3 8.0 4.6 4.7 6.5 8.1 6.6 4.5 2.7 6.9 1.1 1.7 3.2 7.8 4.0 6.2 2.0 5.3 6.4 12.3 4.8 7.1 3.5 6.3 5.0 4.8 8.1 5.4 4.8 5.8 11.2 8.6 6.8 4.7 8.5 3.9 1.5 1.5 1.3 1.5 1.7 1.0 2.5 1.0 3.1 0.5 0.0 2.2 3.0 0.6 0.3 0.0 1.1 0.0 34.8 5.7 5.2 0.0 5.2 1.7 5.3 3.9 1.5 12.6 0.0 6.1 6.9 2.1 1.8 2.3 11.9 6.4 0.0 3.5 2.5 8.4 1.6 3.7 4.6 3.3 2.8 8.8 2.4 4.3 25.9 5.3 10.6 0.0 0.0 4.1 1.4 0.5 0.5 9.2 4.9 7.8 1.2 NAT14 KLP1 ENSG00000090971 "N-acetyltransferase 14 (putative)" Q8WUY8 19 55485004-55487568 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 60.2;Horizontal cells: 139.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047187 Approved Mitochondria NA NA Mitochondria "HPA047187: AB_2679974" "unprognostic (5.96e-2)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (5.43e-2)" "unprognostic (1.32e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-2)" "unprognostic (7.01e-2)" "unprognostic (1.94e-1)" "unprognostic (2.97e-1)" "unprognostic (9.12e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (3.61e-4)" "unprognostic (7.00e-2)" "unprognostic (6.74e-2)" "unprognostic (9.85e-2)" "unprognostic (1.58e-1)" 3.6 10.1 15.8 5.7 19.6 4.5 5.5 25.8 25.8 8.2 7.0 8.9 3.1 3.5 12.6 10.1 2.9 24.1 6.5 5.9 15.4 16.7 9.2 2.5 7.8 4.6 10.8 15.5 14.1 5.6 11.2 19.2 8.5 10.6 6.8 3.1 7.8 5.0 10.5 2.9 4.1 3.4 11.1 6.5 3.7 5.6 4.9 9.5 42.2 9.8 1.3 3.8 6.0 4.3 1.8 1.8 2.3 0.3 0.3 1.0 0.6 2.4 8.9 9.8 18.1 4.1 5.1 6.2 9.2 10.7 10.1 14.4 3.1 7.9 1.0 3.2 5.9 5.0 3.3 6.4 5.6 6.2 9.9 55.3 8.0 11.9 6.7 7.4 5.9 8.1 7.3 2.1 7.4 1.9 19.9 7.3 14.5 9.9 2.8 5.8 3.0 9.9 9.0 14.0 4.7 4.9 9.8 6.3 3.6 23.0 4.6 30.3 20.6 3.7 5.4 8.1 3.8 4.4 5.7 8.8 3.7 10.2 0.5 7.3 5.7 2.3 4.2 8.2 1.0 9.2 0.0 0.3 0.2 0.5 0.3 1.0 0.6 0.4 0.3 0.0 1.8 0.7 0.7 2.3 0.3 0.3 1.8 0.0 0.6 15.8 19.6 25.8 25.8 15.4 16.7 10.8 15.5 10.6 9.5 6.0 2.7 7.3 6.1 2.6 60.2 4.5 2.5 14.7 2.3 27.9 33.4 10.6 13.3 14.0 1.4 4.3 0.7 0.0 1.0 6.9 8.2 4.4 0.0 2.9 2.6 139.8 12.2 4.9 0.8 1.7 10.9 0.7 5.0 3.6 1.8 34.9 4.7 0.0 9.9 3.5 34.0 0.0 9.2 4.1 2.9 0.5 5.0 1.3 0.9 1.4 NAT16 "C7orf52, FLJ39237" ENSG00000167011 "N-acetyltransferase 16 (putative)" Q8N8M0 7 101170493-101180276 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6" "Cell type enriched" "Detected in some" 45 "Horizontal cells: 276.5" "Cancer enhanced" "Detected in some" "melanoma: 2.1" "Group enriched" "Detected in many" 4 "amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4" HPA021918 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA021918: AB_1848922" "unprognostic (4.32e-2)" "unprognostic (1.75e-1)" "unprognostic (2.69e-3)" "unprognostic (4.58e-3)" "unprognostic (2.93e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" "unprognostic (1.40e-2)" "unprognostic (2.25e-3)" "unprognostic (2.35e-2)" "unprognostic (4.23e-2)" "unprognostic (2.62e-2)" "unprognostic (5.53e-5)" "unprognostic (7.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.02e-5)" "unprognostic (1.59e-1)" 0.2 0.4 3.1 0.2 9.1 0.7 0.1 0.4 8.2 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.2 0.1 0.1 0.9 4.8 0.1 0.5 0.1 0.2 0.7 0.6 0.1 6.0 0.2 5.8 0.1 0.8 0.2 0.3 0.5 0.3 0.1 0.3 0.4 0.2 0.2 0.4 0.3 1.2 0.4 1.2 0.0 4.6 0.0 0.0 0.1 0.0 1.2 0.7 2.2 0.6 1.3 0.8 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.3 0.5 0.5 0.1 0.1 0.8 0.0 0.6 0.2 0.1 4.6 0.1 0.5 0.1 6.9 0.0 0.3 5.2 0.5 0.3 0.0 0.0 0.4 6.1 0.5 0.1 0.1 0.0 0.1 3.4 0.0 1.6 0.4 0.6 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.2 1.2 0.8 0.4 2.2 1.3 0.3 0.7 0.3 0.0 3.1 9.1 0.4 2.9 0.9 4.8 0.7 0.6 0.8 1.2 0.0 0.0 0.0 0.0 0.0 1.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 276.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NAT2 AAC2 ENSG00000156006 "N-acetyltransferase 2" P11245 8 18391245-18401218 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "intestine: 28.4;liver: 75.5" "Cell type enhanced" "Detected in some" 25 "Enterocytes: 16.0;Hepatocytes: 52.3;Paneth cells: 10.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.0;liver cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.8;RT4: 4.2;SCLC-21H: 5.8;SK-BR-3: 3.6" HPA043704 Uncertain NA NA "HPA043704: AB_2678625" "unprognostic (2.74e-3)" "unprognostic (4.03e-1)" "prognostic favorable (4.61e-5)" "unprognostic (1.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" "unprognostic (2.52e-2)" "unprognostic (2.67e-2)" "unprognostic (1.27e-1)" "unprognostic (1.33e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-3)" "unprognostic (1.02e-1)" "unprognostic (3.40e-1)" "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" 0.2 0.1 0.2 2.3 0.3 0.0 0.3 0.1 0.2 0.3 14.0 0.1 0.1 13.0 0.4 0.4 0.1 0.2 0.3 0.4 0.1 0.1 0.6 75.5 0.2 0.1 0.2 0.2 0.2 0.1 0.0 0.2 0.2 0.3 0.3 5.1 0.1 0.1 0.1 0.1 0.1 28.4 0.4 0.2 0.6 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.3 0.0 1.8 0.0 0.2 0.0 1.4 0.0 0.0 0.3 0.3 0.1 0.5 0.1 0.5 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.9 0.0 2.8 4.2 5.8 0.1 0.1 3.6 0.0 0.5 1.0 0.6 1.5 1.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.2 0.1 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.0 0.0 0.1 0.0 16.0 0.0 0.0 0.8 0.0 0.1 0.0 52.3 0.2 0.0 0.0 0.6 0.6 0.0 0.6 0.0 0.0 0.0 7.5 0.0 0.1 10.1 2.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 4.2 0.0 NAT6 FUS2 ENSG00000243477 "N-acetyltransferase 6" Q93015 3 50296402-50299421 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.3" "Group enriched" "Detected in many" 21 "Early spermatids: 179.7;Late spermatids: 391.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "eosinophil: 29.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.0" "Cell line enhanced" "Detected in all" "HMC-1: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039576 Approved NA NA "HPA039576: AB_10794750" "prognostic favorable (3.62e-4)" "unprognostic (1.02e-2)" "unprognostic (6.04e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-1)" "unprognostic (7.78e-2)" "unprognostic (7.49e-2)" "unprognostic (4.62e-2)" "unprognostic (1.89e-1)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (4.38e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.88e-1)" "unprognostic (1.01e-1)" "unprognostic (9.16e-2)" "unprognostic (2.55e-1)" 7.9 6.9 9.3 7.7 17.5 30.6 8.6 15.4 24.8 9.6 7.0 8.8 12.9 6.8 10.7 11.1 9.7 10.6 11.6 10.9 11.5 9.9 8.9 8.8 9.8 10.1 8.8 12.1 13.4 8.8 14.5 8.8 6.3 22.3 10.6 8.7 8.5 13.2 12.6 12.0 15.5 7.9 7.6 8.9 9.9 10.0 59.3 6.7 7.2 8.8 11.1 10.4 8.0 9.3 6.1 2.8 29.0 2.3 5.3 6.1 2.8 4.0 3.1 4.8 5.0 5.8 6.8 3.1 3.9 7.8 6.2 5.3 2.7 7.8 12.6 2.9 6.7 5.0 5.2 2.9 12.7 2.6 8.0 5.0 25.2 18.0 6.3 5.2 4.2 32.3 8.1 9.0 10.3 7.2 9.4 7.4 7.0 2.3 12.0 5.5 4.3 4.9 19.3 2.6 1.8 10.6 3.2 1.7 15.1 10.5 2.1 3.4 4.8 4.4 9.2 1.8 3.2 4.0 12.3 6.0 5.0 5.0 6.0 3.7 8.2 4.3 3.1 8.6 7.9 4.6 6.7 1.6 29.0 4.2 2.3 6.1 6.1 5.7 5.0 2.8 4.3 4.6 3.7 0.5 5.3 1.4 1.4 5.1 2.8 9.3 17.5 15.4 24.8 11.5 9.9 8.8 12.1 22.3 6.7 6.0 5.1 2.2 7.5 3.0 5.0 0.0 0.0 5.3 3.4 0.0 3.9 4.7 0.0 0.0 179.7 7.1 3.0 0.0 0.0 4.3 4.1 5.5 12.7 4.7 4.1 0.0 8.7 8.6 4.0 391.0 7.8 2.6 5.0 0.0 2.4 3.7 0.0 3.5 8.5 0.0 2.7 12.9 5.7 13.6 10.2 3.4 4.2 7.2 3.3 8.1 NAT8 "ATase2, GLA, Hcml1, TSC501" ENSG00000144035 "N-acetyltransferase 8 (putative)" Q9UHE5 2 73640832-73642393 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 140.4" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 1951.9" "Cancer enriched" "Detected in some" 5 "renal cancer: 242.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "Hep G2: 16.9" "Low region specificity" "Detected in all" "HPA067855, HPA074519" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA067855: AB_2732774, HPA074519: AB_2686699" "unprognostic (4.51e-2)" "unprognostic (6.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (4.95e-3)" "unprognostic (2.46e-1)" "unprognostic (1.90e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (8.60e-2)" "unprognostic (1.37e-3)" "unprognostic (2.07e-2)" "unprognostic (4.11e-3)" "unprognostic (2.13e-2)" "unprognostic (8.36e-5)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 140.4 15.8 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 1.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 16.9 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 159.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.0 22.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1951.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NAT8L "FLJ37478, Hcml3" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059512-2069089 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 45.9;brain: 45.9;testis: 11.8" "Group enriched" "Detected in some" 5 "Horizontal cells: 76.3;Muller glia cells: 25.6" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "NB-4: 14.7;SCLC-21H: 19.0;SK-MEL-30: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria NA NA Mitochondria "HPA040677: AB_2732486" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 45.9 2.0 23.5 1.3 28.3 1.2 7.9 16.4 45.9 1.2 1.5 7.4 0.3 1.3 1.6 2.8 1.3 2.4 1.3 2.1 20.8 12.9 8.2 1.2 1.2 1.4 16.4 12.6 1.4 3.9 1.2 5.6 1.3 12.8 2.4 1.3 1.2 3.8 3.2 7.3 2.4 1.5 1.4 6.5 1.5 1.6 11.8 8.2 0.0 1.6 0.0 1.2 1.2 0.1 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 6.6 3.6 7.3 0.7 0.0 4.2 0.1 0.0 0.2 0.0 2.9 0.2 0.0 1.3 0.0 1.1 0.1 8.2 0.0 0.1 0.0 9.6 0.1 1.4 4.7 1.2 10.1 5.0 0.0 0.1 0.0 0.0 1.4 0.0 2.5 7.8 0.0 0.3 4.4 0.1 14.7 10.3 0.0 3.0 0.5 1.7 0.2 0.1 0.3 19.0 6.3 4.8 0.0 15.1 0.6 0.5 5.9 0.0 0.0 2.5 0.1 3.9 0.0 0.0 0.1 0.0 4.3 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 23.5 28.3 16.4 32.7 20.8 12.9 16.4 12.6 12.8 8.2 0.0 0.0 0.0 0.0 0.2 7.1 2.0 0.0 0.0 0.0 1.8 5.9 0.0 0.0 4.2 0.8 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.7 76.3 1.7 0.0 0.0 3.1 0.0 0.1 10.1 0.0 0.0 25.6 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 NATD1 "C17orf103, Gtlf3b, MGC33894" ENSG00000274180 "N-acetyltransferase domain containing 1" Q8N6N6 17 21238870-21253410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 22.0" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 38.4;Late spermatids: 45.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "BEWO: 14.5;HSkMC: 10.6;SuSa: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.16e-1)" "unprognostic (9.40e-2)" "unprognostic (4.69e-2)" "unprognostic (3.17e-2)" "unprognostic (8.22e-3)" "unprognostic (3.99e-2)" "unprognostic (1.32e-1)" "unprognostic (1.86e-1)" "unprognostic (5.93e-2)" "unprognostic (6.81e-2)" "unprognostic (2.48e-2)" "unprognostic (2.51e-1)" "prognostic favorable (3.55e-6)" "unprognostic (2.18e-1)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (3.98e-2)" 8.3 1.9 2.7 1.2 2.2 10.1 4.5 5.0 3.3 3.1 3.2 2.2 3.5 2.3 3.2 5.0 3.8 2.6 5.2 7.7 3.4 3.7 3.5 4.4 1.7 1.7 1.2 2.3 4.0 6.1 1.0 5.4 2.8 5.1 0.9 3.2 4.0 4.6 22.0 4.1 2.4 4.2 0.8 3.2 1.7 4.6 1.5 3.7 12.1 6.6 2.8 4.3 5.6 0.6 0.9 9.0 2.1 0.4 1.3 1.1 0.8 1.3 1.7 2.1 7.6 7.1 14.5 2.2 3.0 1.6 2.6 3.7 0.6 0.0 3.7 3.2 2.6 1.1 1.1 1.0 0.8 1.0 4.0 0.3 0.7 0.6 6.5 0.1 1.4 10.6 2.2 2.0 1.4 4.9 3.3 3.3 2.0 0.0 2.1 0.6 0.1 1.0 3.7 0.6 0.4 1.8 1.4 0.5 2.8 1.1 0.5 3.7 1.7 0.2 3.0 33.2 0.9 1.0 2.0 0.8 1.1 1.2 0.5 3.0 1.2 0.8 1.0 0.6 1.3 1.1 2.1 2.6 1.3 0.7 0.4 0.3 0.8 1.0 0.4 0.6 0.5 0.5 9.0 0.4 0.6 0.9 1.3 1.1 6.0 4.5 0.0 0.8 0.0 2.7 9.0 12.7 1.4 3.4 5.2 0.0 5.1 0.0 2.9 38.4 2.9 3.8 0.0 0.6 2.5 1.3 3.9 1.1 3.9 2.4 1.6 3.5 4.9 10.1 45.6 9.5 1.5 0.0 0.0 3.3 2.1 4.3 2.8 14.9 4.2 2.9 12.9 1.4 0.5 6.8 0.0 8.5 0.0 1.2 1.6 NAV2 "FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1" ENSG00000166833 "Neuron navigator 2" Q8IVL1 11 19350724-20121598 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.6" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-HME1: 34.8;SH-SY5Y: 31.8;TIME: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011755, HPA011891" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA011755: AB_1854319, HPA011891: AB_1854318" "unprognostic (7.71e-2)" "unprognostic (2.37e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.76e-3)" "unprognostic (3.01e-2)" "unprognostic (3.86e-2)" "unprognostic (1.54e-1)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (1.84e-1)" "unprognostic (2.83e-2)" "unprognostic (3.85e-2)" "unprognostic (1.08e-1)" "unprognostic (6.43e-2)" "unprognostic (3.28e-2)" 14.8 3.1 7.9 4.7 12.5 3.1 13.8 13.8 16.1 10.2 17.6 16.1 8.6 5.1 9.3 13.4 7.8 5.7 3.2 64.6 9.9 7.0 12.3 18.7 11.2 3.0 16.5 11.5 4.7 10.8 10.1 6.6 16.2 23.5 7.9 6.3 8.6 16.5 11.8 3.4 7.9 4.7 13.0 32.2 2.5 9.9 2.1 12.6 0.0 20.1 1.8 5.3 6.0 8.6 0.3 1.9 0.0 0.5 0.0 0.3 0.0 5.9 1.7 3.9 0.4 13.2 8.5 4.2 5.0 8.6 6.6 5.0 6.7 0.8 0.0 0.2 7.5 10.8 0.7 0.2 3.9 7.8 1.0 0.4 0.1 8.8 7.6 2.4 0.0 0.2 5.5 10.2 3.1 34.8 4.9 8.8 0.0 0.7 3.0 19.1 6.3 0.0 0.0 9.2 1.6 5.0 0.0 18.0 0.9 5.7 1.7 6.8 31.8 3.8 3.0 5.7 21.5 0.1 0.0 24.5 15.5 2.3 18.3 4.7 1.0 0.5 0.0 5.3 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 7.9 12.5 13.8 16.1 9.9 7.0 16.5 11.5 23.5 12.6 59.6 16.9 0.8 19.9 3.8 1.7 12.3 10.2 25.4 25.0 19.2 0.0 22.2 11.6 17.9 2.4 10.8 1.0 0.0 18.3 18.1 14.6 23.3 1.1 33.0 8.6 25.4 10.4 11.1 1.5 5.6 0.9 2.3 15.1 1.8 7.7 32.7 26.8 0.0 3.9 0.4 2.1 0.0 9.0 1.5 0.5 3.1 12.2 0.0 8.0 15.2 NAV3 "KIAA0938, POMFIL1" ENSG00000067798 "Neuron navigator 3" Q8IVL0 12 77324641-78213008 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2;ovary: 29.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 47.7;Leydig cells: 22.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 3.8" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.8" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 23.8;THP-1: 20.9;U-138 MG: 16.0;WM-115: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA032111, HPA061392" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane" Cytosol "HPA032111: AB_10603881, HPA061392: " "unprognostic (3.51e-1)" "unprognostic (6.72e-2)" "unprognostic (1.09e-2)" "unprognostic (1.79e-1)" "unprognostic (8.98e-2)" "unprognostic (2.14e-1)" "unprognostic (2.78e-1)" "unprognostic (3.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.06e-2)" "unprognostic (2.99e-1)" "unprognostic (1.90e-1)" "unprognostic (5.68e-7)" "unprognostic (6.86e-3)" "unprognostic (1.23e-1)" "unprognostic (1.58e-2)" "unprognostic (2.29e-3)" 6.2 8.5 17.8 2.4 14.2 1.5 7.1 14.7 25.2 2.8 2.1 9.7 2.6 1.2 4.1 5.8 3.8 3.6 8.6 3.7 14.2 7.5 1.4 2.3 3.8 1.6 7.8 13.0 29.6 1.4 2.2 9.3 4.3 7.1 4.5 2.0 12.3 2.2 5.1 2.6 4.1 1.3 4.6 10.6 12.7 1.6 5.0 8.3 0.0 1.7 0.0 1.4 3.9 2.3 0.3 0.1 3.8 0.2 0.1 0.0 0.0 1.8 4.4 0.3 0.1 4.6 9.5 0.1 13.4 10.5 5.5 2.9 1.2 0.3 0.1 1.0 10.7 3.8 1.4 3.9 2.0 9.8 0.0 0.0 0.0 1.8 0.1 3.6 0.0 0.1 3.5 0.0 23.8 6.0 4.9 8.2 0.0 0.0 0.0 13.5 0.1 0.1 6.0 1.5 0.1 1.2 0.6 1.1 0.0 0.9 0.0 0.4 0.0 0.9 0.1 1.9 0.5 0.0 20.9 7.1 16.0 4.5 6.8 9.1 0.7 0.0 0.4 4.8 0.2 19.8 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.1 0.2 0.1 0.0 0.0 17.8 14.2 14.7 20.5 14.2 7.5 7.8 13.0 7.1 8.3 17.9 7.7 0.0 7.4 3.2 3.1 2.1 0.0 16.0 13.6 0.0 0.0 0.1 0.0 1.7 7.6 3.5 0.0 0.0 1.3 0.1 8.7 1.8 10.5 0.0 5.4 47.7 15.7 2.5 0.0 3.6 22.2 1.3 11.8 0.0 0.0 19.9 11.8 0.0 7.1 0.0 2.1 0.0 2.8 0.2 0.5 1.3 0.2 0.0 0.0 2.8 NBDY "LINC01420, NoBody" ENSG00000204272 "Negative regulator of P-body association" A0A0U1RRE5 X 56729241-56818380 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.7" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 285.1;Extravillous trophoblasts: 200.0;monocytes: 159.7;Proximal tubular cells: 180.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (8.38e-3)" "unprognostic (2.46e-1)" "unprognostic (1.96e-3)" "prognostic unfavorable (3.14e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.01e-2)" "unprognostic (2.23e-1)" "unprognostic (2.83e-1)" "unprognostic (2.59e-2)" "unprognostic (2.77e-1)" "unprognostic (2.09e-1)" "unprognostic (2.01e-2)" "unprognostic (2.18e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-2)" 7.2 16.7 8.2 7.3 12.5 5.9 7.8 11.5 14.8 12.1 7.8 11.3 12.2 6.7 11.5 20.5 10.4 13.4 11.1 10.5 8.5 15.0 5.1 9.4 9.8 7.4 9.4 12.7 9.7 10.8 21.8 15.0 10.4 11.0 9.1 12.8 8.8 12.6 3.3 9.9 7.2 12.4 8.9 12.0 8.4 6.6 7.9 16.2 18.7 7.4 10.0 14.6 6.0 26.1 52.7 16.4 18.2 28.7 28.8 19.4 11.1 17.0 21.7 18.3 26.7 24.2 5.2 15.3 26.1 9.0 14.6 8.0 22.7 4.9 37.6 18.6 18.3 7.5 20.3 20.0 11.7 0.0 25.0 14.4 17.8 2.0 27.9 16.1 14.8 28.8 24.5 15.9 28.6 26.9 23.6 16.0 5.7 12.7 17.8 19.7 19.6 4.6 28.2 18.5 30.5 9.9 14.3 17.4 24.0 16.1 9.5 14.9 34.1 15.7 14.4 40.5 20.7 7.7 19.7 14.8 12.1 25.5 9.5 13.7 8.4 12.9 12.7 8.9 11.8 16.4 16.9 1.6 22.6 18.1 23.0 26.1 28.8 24.8 29.4 24.5 28.1 26.5 1.5 28.7 18.2 52.7 26.5 19.4 26.8 28.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 33.0 111.7 0.0 121.8 285.1 97.1 0.0 0.0 0.0 0.0 84.8 200.0 0.0 0.0 36.0 0.0 123.1 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 159.7 0.0 0.0 103.2 0.0 0.0 180.6 0.0 0.0 0.0 0.0 0.0 0.0 124.5 0.0 0.0 0.0 NBEAL2 KIAA0540 ENSG00000160796 "Neurobeachin like 2" Q6ZNJ1 3 46979683-47009703 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "neutrophil: 8.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 8.1" "Cell line enhanced" "Detected in many" "HEL: 31.3;SK-BR-3: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051969 Approved NA NA 490000 "HPA051969: " "unprognostic (3.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-1)" "unprognostic (3.37e-2)" "unprognostic (5.99e-3)" "prognostic favorable (4.60e-4)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (6.27e-2)" "unprognostic (5.29e-2)" "unprognostic (1.06e-3)" "unprognostic (3.75e-1)" "unprognostic (6.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.34e-2)" 7.6 5.5 3.5 14.8 4.2 53.4 7.0 5.5 3.9 11.6 10.5 2.8 17.0 7.5 7.1 5.7 36.2 5.6 20.9 3.8 3.7 1.8 11.4 3.9 19.4 10.7 5.6 2.4 3.0 15.0 4.2 4.8 3.3 4.2 7.6 6.6 5.2 14.2 10.3 2.7 26.5 14.2 6.9 3.8 26.3 16.2 2.7 3.8 11.5 5.4 22.1 39.0 6.7 18.7 0.1 0.2 8.1 1.2 0.7 1.1 0.4 8.5 9.4 2.1 5.1 1.3 0.4 5.6 1.1 0.7 1.7 1.2 8.5 6.2 7.4 3.4 1.2 1.8 5.9 3.8 4.2 1.0 6.7 5.7 31.3 11.4 5.1 0.9 5.3 22.6 0.8 7.1 1.8 3.4 2.3 15.7 16.3 6.3 13.0 0.7 13.4 8.6 14.2 4.8 13.9 4.5 9.5 0.2 9.5 4.5 18.3 2.8 4.4 1.1 28.6 2.4 3.3 13.9 8.5 11.5 0.1 5.3 2.3 3.9 9.1 8.5 7.2 2.2 24.9 1.2 0.4 1.2 0.6 1.1 1.1 0.3 0.1 0.4 1.1 0.2 0.1 0.2 0.2 8.1 0.7 0.8 0.2 0.5 0.4 3.5 4.2 5.5 3.9 3.7 1.8 5.6 2.4 4.2 3.8 11.9 10.3 5.6 4.6 3.0 1.3 4.2 5.1 0.0 7.9 31.4 17.7 1.8 1.7 19.4 1.3 6.3 4.0 0.0 20.2 1.0 1.6 6.3 5.8 1.0 9.7 0.0 6.9 11.6 14.0 0.9 1.1 8.8 0.0 5.4 10.6 1.5 22.3 3.5 0.0 1.0 1.7 12.9 1.6 0.2 2.3 6.9 1.6 10.2 9.3 12.2 NBPF12 "COAS1, KIAA1245" ENSG00000268043 "NBPF member 12" 1 146938744-146996202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 29.8" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.48e-2)" "unprognostic (3.97e-1)" "unprognostic (1.74e-1)" "unprognostic (8.96e-3)" "unprognostic (4.57e-2)" "unprognostic (5.00e-3)" "unprognostic (2.03e-2)" "unprognostic (5.76e-3)" "unprognostic (4.57e-2)" "unprognostic (2.90e-1)" "prognostic favorable (9.01e-7)" "unprognostic (2.23e-1)" "unprognostic (1.69e-3)" "unprognostic (2.96e-2)" "unprognostic (2.86e-1)" "unprognostic (2.08e-1)" "prognostic favorable (2.47e-5)" 2.7 1.7 2.2 4.0 3.9 5.1 3.2 4.4 4.7 2.6 1.9 5.8 2.2 2.4 6.0 3.6 1.5 2.4 3.1 0.9 2.3 1.7 6.1 2.8 3.4 4.2 4.2 4.3 29.8 4.2 5.0 1.8 3.8 2.5 1.8 4.2 3.5 4.0 0.9 2.5 1.9 3.0 3.2 3.1 5.3 7.0 1.1 3.3 2.9 0.9 2.9 1.2 3.9 3.8 2.6 6.1 2.3 0.9 3.5 0.8 6.7 5.4 11.4 9.8 5.4 5.0 7.4 7.0 5.3 5.0 5.1 4.9 6.4 15.1 4.4 6.0 5.3 5.0 8.1 4.0 4.8 5.6 5.7 6.6 11.7 4.2 4.5 4.9 9.8 5.3 7.2 4.9 11.4 6.5 4.5 10.9 10.4 2.6 4.0 10.3 10.6 6.2 6.6 8.2 7.1 10.3 4.2 3.6 3.8 14.9 5.7 12.0 9.2 8.2 4.6 17.8 6.9 14.9 5.3 4.4 7.3 10.0 9.7 9.2 6.8 6.3 4.8 3.5 5.0 6.1 2.3 1.8 3.5 1.1 2.0 3.4 2.3 1.9 1.0 3.8 2.6 2.0 0.7 0.9 1.4 2.6 2.2 0.8 29.8 20.0 11.1 2.6 3.4 16.0 7.2 0.0 9.4 11.4 5.2 43.2 3.3 0.0 9.6 5.2 4.5 6.5 0.0 7.5 3.0 5.0 1.4 23.2 11.3 3.3 9.5 10.3 8.6 14.3 2.5 5.2 7.1 1.7 9.0 9.9 9.5 10.0 14.0 9.9 0.8 17.2 6.5 5.0 12.2 5.7 3.8 1.6 10.9 11.5 0.9 NBPF14 DJ328E19.C1.1 ENSG00000270629 "NBPF member 14" 1 148531385-148679751 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.2" "Cell type enhanced" "Detected in many" 9 "Paneth cells: 190.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basophil: 9.8;classical monocyte: 17.2;eosinophil: 25.2;intermediate monocyte: 11.5;memory B-cell: 21.8;myeloid DC: 14.9;naive B-cell: 15.1;neutrophil: 22.9;non-classical monocyte: 13.1;plasmacytoid DC: 16.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.28e-2)" "unprognostic (3.88e-2)" "unprognostic (7.92e-3)" "unprognostic (7.13e-2)" "unprognostic (2.46e-1)" "unprognostic (1.37e-3)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (2.02e-2)" "unprognostic (7.69e-4)" "unprognostic (7.23e-3)" "unprognostic (5.20e-2)" "unprognostic (5.15e-4)" "unprognostic (2.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.73e-1)" "unprognostic (2.52e-2)" 4.4 0.7 2.5 3.2 4.6 6.7 4.3 2.1 4.3 5.4 2.4 2.1 0.9 0.4 4.3 11.2 3.9 3.4 2.9 6.7 4.2 3.4 3.4 3.4 4.0 2.6 2.8 7.7 6.3 3.1 0.9 1.8 4.6 3.6 2.7 6.9 3.2 1.9 1.2 8.5 1.9 4.1 3.8 4.5 0.8 5.2 5.1 2.8 2.6 9.1 4.7 1.8 4.7 21.8 16.5 25.2 17.2 3.4 3.1 3.5 26.7 5.1 10.1 7.4 21.1 29.5 5.0 10.0 10.2 6.9 8.0 4.1 8.9 5.0 2.6 10.3 9.5 8.1 6.7 10.5 10.1 9.8 7.6 13.2 16.4 1.0 8.3 10.4 5.4 29.5 8.7 18.5 24.7 32.9 10.7 4.6 4.4 27.1 16.4 16.0 2.7 7.5 4.3 5.6 12.3 4.3 9.1 15.8 8.6 11.1 0.1 0.1 20.4 11.3 4.8 10.1 14.1 9.0 42.8 7.9 8.8 9.5 16.6 47.8 15.3 12.3 14.3 9.1 11.8 9.8 17.2 25.2 2.3 11.5 1.7 21.8 2.4 2.1 14.9 15.1 3.1 2.6 22.9 3.4 13.1 16.5 3.1 3.5 83.4 73.1 16.4 35.4 1.9 2.0 17.3 10.2 16.0 27.3 12.2 3.9 1.1 0.0 29.4 29.3 0.8 7.7 0.0 13.9 12.6 12.9 19.5 49.9 8.1 12.9 0.0 3.5 3.7 40.0 30.3 26.2 27.4 1.7 20.8 5.3 17.1 21.9 190.4 15.9 4.4 9.8 12.9 11.4 57.2 10.2 5.5 1.3 6.9 16.2 27.9 NBPF20 ENSG00000162825 "NBPF member 20" 1 145289900-145405778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.3" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 27.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (6.25e-3)" "unprognostic (4.74e-2)" "unprognostic (1.23e-1)" "unprognostic (8.05e-2)" "unprognostic (1.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.25e-2)" "unprognostic (5.37e-2)" "unprognostic (3.22e-3)" "unprognostic (3.54e-1)" "unprognostic (4.26e-4)" "unprognostic (1.69e-1)" "unprognostic (1.45e-4)" "unprognostic (9.74e-2)" "unprognostic (5.21e-2)" "unprognostic (1.00e-1)" "unprognostic (1.70e-1)" 1.1 1.2 1.1 1.2 1.2 1.0 1.5 2.5 1.2 1.4 1.1 0.0 1.3 1.8 1.1 1.2 0.7 1.1 1.1 1.1 1.1 2.6 1.1 1.2 1.0 2.2 1.3 5.9 1.1 0.0 1.5 1.1 1.6 2.1 1.1 2.4 1.1 1.7 1.0 1.1 1.1 3.6 1.1 1.5 1.4 1.1 4.0 13.3 1.0 1.8 2.9 1.0 0.3 14.7 7.5 2.1 5.9 13.2 23.2 5.4 7.2 1.8 2.6 2.7 8.1 1.8 3.5 2.8 7.4 4.1 4.5 7.3 8.5 7.3 7.0 9.0 2.3 9.4 5.9 2.7 4.0 4.0 6.9 6.6 14.2 12.1 4.8 6.8 1.9 9.2 5.2 10.5 9.6 0.6 1.8 2.0 3.3 12.0 3.5 6.1 2.2 3.8 2.7 3.8 6.7 14.7 7.6 4.1 5.7 5.8 5.6 12.4 12.7 15.9 6.7 16.7 3.1 2.6 8.0 6.9 1.7 1.8 0.5 1.5 0.5 1.0 0.9 0.8 1.5 0.7 1.0 0.4 4.0 1.0 0.9 1.0 2.9 1.8 13.3 0.9 0.3 20.8 27.1 1.9 1.4 2.6 4.3 3.3 0.0 8.1 3.4 0.0 17.7 1.2 0.0 6.7 13.7 2.4 0.6 0.0 9.6 4.0 3.1 1.1 7.0 14.5 1.6 1.6 5.8 2.5 3.7 1.1 5.2 3.8 3.3 5.4 2.8 1.3 8.9 10.5 3.5 0.0 7.5 0.0 2.2 12.7 9.8 2.8 0.6 0.7 4.0 0.9 NBPF26 ENSG00000273136 "NBPF member 26" 1 120723923-120841481 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 50.6;Alveolar cells type 2: 23.7;granulocytes: 15.1;Paneth cells: 23.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in all" "neutrophil: 17.7" "Group enriched" "Detected in all" 4 "granulocytes: 17.7;monocytes: 10.0" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (2.24e-1)" "unprognostic (7.64e-3)" "unprognostic (4.21e-1)" "unprognostic (1.34e-3)" "unprognostic (1.69e-1)" "unprognostic (1.26e-2)" "unprognostic (6.31e-5)" "unprognostic (9.78e-3)" "unprognostic (3.01e-1)" "unprognostic (1.27e-1)" "unprognostic (2.82e-5)" "unprognostic (1.05e-1)" "unprognostic (2.08e-1)" "unprognostic (8.11e-2)" "unprognostic (1.65e-1)" 2.7 0.8 2.3 4.3 2.2 2.1 1.8 1.1 2.5 3.2 1.9 1.1 1.1 0.0 3.0 5.6 4.8 2.4 3.1 1.1 1.1 3.5 1.7 2.3 2.0 1.1 1.1 3.6 1.1 1.1 1.1 1.1 2.0 2.5 1.4 1.7 1.6 1.3 1.1 9.9 1.1 6.0 2.4 10.6 0.5 3.4 1.1 1.1 1.8 3.3 1.8 2.0 1.1 3.4 2.8 17.7 10.0 2.4 2.1 1.0 27.0 0.1 8.1 8.9 11.5 9.4 0.6 9.6 4.9 6.0 6.5 5.8 1.0 1.9 9.1 11.1 10.7 8.0 13.1 13.8 8.4 12.8 0.5 18.5 2.9 2.3 5.2 7.6 5.6 5.7 6.0 15.7 17.4 19.4 0.3 4.9 1.5 16.7 15.8 15.1 2.1 12.3 2.9 1.0 11.0 3.0 9.2 4.9 4.7 11.0 0.8 0.5 11.2 16.4 8.4 9.6 0.6 3.4 8.2 7.2 19.2 23.8 7.6 7.4 2.0 7.9 6.8 11.5 1.0 7.7 6.4 7.2 1.9 5.2 1.7 1.2 2.0 1.9 2.8 3.4 1.7 2.1 17.7 2.4 10.0 2.1 1.1 1.0 50.6 23.7 1.4 1.3 0.0 0.6 1.4 0.0 6.7 6.8 0.0 0.0 0.4 3.3 3.5 2.2 0.0 0.0 0.0 2.6 1.7 1.0 0.7 15.1 1.3 0.2 0.0 0.0 1.3 3.7 0.0 6.1 1.8 0.0 1.0 0.6 0.8 3.2 23.2 4.2 0.6 1.6 0.0 0.5 4.3 2.6 0.0 0.3 0.0 2.5 0.4 NBPF3 AE2 ENSG00000142794 "NBPF member 3" Q9H094 1 21440128-21485005 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 29.5" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 9.4;Early spermatids: 10.3;Spermatocytes: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.4;HHSteC: 14.9" "HPA042595, HPA043692, HPA044023, HPA046971, HPA058050" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA042595: , HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (5.49e-2)" "unprognostic (1.19e-2)" "unprognostic (5.09e-3)" "unprognostic (2.57e-2)" "unprognostic (3.11e-1)" "unprognostic (2.01e-1)" "unprognostic (2.82e-2)" "unprognostic (2.10e-1)" "unprognostic (2.22e-3)" "unprognostic (1.09e-1)" "unprognostic (3.11e-3)" "unprognostic (1.63e-1)" "unprognostic (5.31e-5)" "unprognostic (8.35e-2)" "unprognostic (1.23e-2)" "unprognostic (2.69e-2)" "unprognostic (1.66e-2)" 3.2 5.1 4.5 2.6 4.6 2.3 6.5 12.7 5.3 4.1 3.5 3.7 4.2 1.5 3.7 4.6 3.7 3.6 2.9 2.8 4.7 3.5 4.0 4.6 3.0 3.0 5.0 3.8 4.7 4.3 2.6 9.4 11.7 4.5 4.5 3.6 3.3 4.9 4.0 2.2 6.2 4.0 5.3 4.6 3.2 4.7 29.5 4.9 2.4 4.8 1.3 4.5 5.1 5.6 1.1 0.3 2.3 0.7 1.1 5.3 1.6 1.8 2.5 0.2 5.7 3.8 1.3 4.8 3.2 15.4 4.5 3.8 3.4 5.8 2.9 1.3 8.4 1.3 0.2 2.7 3.8 0.5 1.5 2.9 2.0 0.1 1.2 14.9 1.2 2.0 1.0 1.1 4.1 0.7 2.2 0.4 0.0 0.8 1.0 1.0 6.4 0.0 2.8 0.8 2.6 3.6 0.0 0.0 2.7 0.7 2.4 3.9 4.1 5.0 1.3 3.9 1.4 1.8 2.4 3.7 1.9 2.2 5.6 1.3 0.0 1.6 4.5 0.4 2.5 2.5 0.0 0.5 2.3 3.8 0.7 5.3 1.1 1.6 3.0 0.3 0.5 2.8 3.5 0.2 1.1 0.0 0.0 1.5 1.6 4.5 4.6 12.7 5.3 4.7 3.5 5.0 3.8 4.5 4.9 0.0 3.0 0.8 2.2 1.1 1.4 2.6 2.5 9.4 1.2 1.8 5.9 2.5 0.0 1.0 10.3 1.4 0.0 0.0 2.2 1.0 3.1 1.5 2.3 1.0 0.8 0.0 0.0 3.7 0.6 1.6 2.6 2.2 0.0 0.0 3.3 1.0 2.0 0.0 1.8 1.6 1.8 0.0 1.0 14.4 7.0 2.6 2.1 1.3 1.2 1.6 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 3.1;testis: 8.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 8.2;K-562: 11.8;Karpas-707: 3.5;MCF7: 13.9;THP-1: 4.2" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.8 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.8 3.5 0.0 13.9 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 1.7 0.0 0.2 4.2 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF6 ENSG00000186086 "NBPF member 6" Q5VWK0 1 108450282-108471002 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;testis: 7.1" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.9;K-562: 14.0;SK-BR-3: 3.3;SK-MEL-30: 2.5" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (4.36e-2)" "unprognostic (5.87e-2)" "unprognostic (4.62e-2)" "unprognostic (2.39e-1)" "unprognostic (2.61e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 1.4 0.0 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 1.5 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 3.3 2.5 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NBPF9 AE01 ENSG00000269713 "NBPF member 9" 1 149054027-149103561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.25e-2)" "unprognostic (1.02e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (1.94e-1)" "unprognostic (2.15e-2)" "unprognostic (2.93e-1)" "unprognostic (2.10e-1)" "unprognostic (6.90e-2)" "unprognostic (9.42e-6)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (6.63e-3)" "unprognostic (8.80e-2)" 3.3 2.0 5.6 6.5 5.3 2.4 2.6 12.3 5.0 4.2 3.3 2.1 4.5 1.7 4.9 7.2 2.8 2.9 4.7 3.8 5.3 3.6 5.4 8.3 4.6 2.8 1.8 4.9 6.3 4.4 1.9 2.2 4.3 3.0 3.1 6.8 2.2 2.4 1.7 4.5 3.2 4.4 2.0 2.7 1.8 2.9 2.0 1.8 5.2 2.5 4.0 2.3 0.0 4.2 5.2 21.9 7.6 5.6 1.8 0.8 22.2 9.8 12.2 16.5 11.1 13.5 9.7 20.6 15.0 10.9 11.8 7.3 9.7 5.3 5.7 10.5 13.1 6.7 8.5 9.6 18.7 13.5 8.9 1.7 16.5 4.4 12.9 2.2 6.5 13.3 7.2 11.9 20.9 20.1 9.5 4.1 6.2 14.0 13.3 17.6 0.7 3.6 4.6 4.0 13.4 6.0 7.6 8.1 8.9 10.3 7.9 16.5 6.7 16.6 9.1 8.0 12.3 4.2 22.2 24.6 7.2 17.9 31.6 17.2 9.1 10.6 9.0 1.6 8.6 21.9 7.6 0.3 0.4 3.6 0.7 1.9 1.3 0.4 1.3 4.2 1.8 1.0 5.8 5.6 1.2 5.2 1.6 0.8 35.7 13.6 5.4 6.7 4.8 4.3 3.9 7.6 8.1 19.4 5.2 5.9 2.3 0.0 2.9 2.8 2.4 0.7 0.0 1.6 3.4 9.1 4.1 17.4 24.5 3.2 0.0 1.7 2.5 9.5 2.1 6.6 14.0 3.3 1.8 0.4 3.7 2.5 7.8 3.9 0.4 11.4 6.5 3.9 9.7 4.1 12.4 1.1 2.2 0.6 5.8 NCALD ENSG00000104490 "Neurocalcin delta" P61601 8 101686543-102124907 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;salivary gland: 48.5" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 37.5;Melanocytes: 97.8;Muller glia cells: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 32.8" "Group enriched" "Detected in many" 13 "NK-cells: 32.8;T-cells: 17.1" "Group enriched" "Detected in some" 4 "AF22: 44.4;HDLM-2: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043245 Approved NA NA "HPA043245: AB_2678385" "unprognostic (3.49e-1)" "unprognostic (1.55e-1)" "unprognostic (4.85e-2)" "unprognostic (4.97e-2)" "unprognostic (5.48e-3)" "unprognostic (2.60e-3)" "unprognostic (1.25e-1)" "unprognostic (5.63e-3)" "unprognostic (1.54e-1)" "unprognostic (2.48e-1)" "prognostic favorable (5.30e-4)" "unprognostic (2.79e-1)" "unprognostic (6.24e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-1)" "unprognostic (7.87e-2)" "unprognostic (1.00e-2)" 9.6 3.4 21.2 5.6 26.8 0.7 21.2 2.7 57.2 6.9 8.8 7.3 1.3 2.7 3.7 2.0 6.1 18.6 5.8 5.1 25.1 16.4 7.0 7.0 9.4 5.6 7.2 18.4 18.2 4.3 0.6 6.6 4.6 7.8 5.9 4.2 20.8 48.5 7.4 6.4 7.3 4.6 5.7 4.4 3.6 5.7 3.4 2.8 0.3 2.6 3.1 4.9 5.4 2.1 0.3 1.9 0.5 0.1 32.8 17.1 4.6 2.1 3.2 44.4 0.2 0.4 7.8 0.0 0.7 0.1 0.0 0.0 0.0 0.0 2.8 1.0 3.3 0.1 0.0 0.3 0.0 0.0 54.8 0.3 0.2 0.0 0.1 0.0 1.8 0.3 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.3 0.7 0.5 0.0 0.0 1.0 0.0 0.0 7.3 0.1 0.2 4.3 0.0 1.0 1.8 7.7 0.3 1.5 0.0 0.7 0.1 0.0 0.1 12.1 1.7 0.0 0.1 0.0 0.7 0.1 0.1 0.1 17.1 0.1 15.4 0.3 6.6 10.1 1.9 0.2 1.6 8.5 0.5 32.8 0.1 0.1 6.5 4.6 21.2 26.8 2.7 57.2 25.1 16.4 7.2 18.4 7.8 2.8 0.0 1.6 0.0 0.4 3.8 13.0 3.6 7.6 37.5 4.5 0.0 23.6 2.6 6.6 4.8 9.8 6.4 0.0 0.0 1.0 7.7 16.2 1.7 2.3 13.1 1.6 12.7 20.2 14.7 2.7 5.0 2.6 2.4 97.8 0.0 2.7 42.7 2.3 0.0 1.4 14.6 4.4 25.8 10.3 0.5 0.9 2.8 2.5 22.3 0.4 0.9 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 108.7;Cardiomyocytes: 109.4;Horizontal cells: 165.3;Muller glia cells: 263.9;Rod photoreceptor cells: 95.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Cell line enhanced" "Detected in some" "HEL: 19.5;RH-30: 44.0;SCLC-21H: 35.8;SH-SY5Y: 17.6;U-138 MG: 24.5;WM-115: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1200000 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705" "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favorable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.9 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 1.0 6.1 6.5 0.2 0.1 0.0 0.0 0.0 0.1 3.9 19.5 0.0 0.0 0.7 0.0 3.1 4.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 6.8 0.0 0.0 1.6 0.6 0.0 0.1 0.0 44.0 3.1 0.0 0.0 35.8 17.6 0.0 0.1 0.0 0.7 0.0 0.2 0.0 24.5 11.4 0.1 10.2 0.0 0.1 0.0 2.7 9.2 25.9 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 0.0 0.0 0.0 0.4 1.4 108.7 109.4 0.0 1.4 0.0 0.0 35.3 0.5 1.7 14.4 4.5 0.3 0.0 0.0 0.0 0.2 7.6 0.3 1.1 0.5 0.4 165.3 5.2 6.7 5.1 3.9 14.1 1.7 0.0 0.0 0.0 263.9 1.7 0.0 9.6 0.0 95.4 0.0 3.8 0.5 2.3 1.5 0.1 11.4 0.0 0.1 NCAM2 "MGC51008, NCAM21" ENSG00000154654 "Neural cell adhesion molecule 2" O15394 21 20998315-21543329 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.9;brain: 52.7" "Group enriched" "Detected in some" 4 "Early spermatids: 44.1;Late spermatids: 20.9" "Cancer enhanced" "Detected in some" "glioma: 5.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030900, HPA030901" Enhanced Supported Supported "Nuclear bodies,Plasma membrane" No No 100000000 "Nuclear bodies, Plasma membrane" "HPA030900: AB_10602037, HPA030901: AB_2673650" "unprognostic (9.70e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (1.37e-2)" "unprognostic (3.01e-2)" "unprognostic (5.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-1)" "unprognostic (5.61e-1)" "unprognostic (3.07e-4)" "unprognostic (2.47e-4)" "unprognostic (1.62e-1)" "unprognostic (8.05e-2)" "unprognostic (1.35e-3)" 2.0 15.9 25.8 2.0 22.3 1.1 3.1 7.0 52.7 3.3 2.1 14.7 0.0 1.3 2.3 1.8 1.7 1.8 2.6 3.1 18.7 13.9 1.3 9.1 4.4 1.2 21.6 19.4 1.4 1.3 1.1 1.0 1.7 17.9 2.2 2.4 0.5 1.8 2.3 1.5 2.0 1.9 2.7 17.3 2.0 1.3 8.3 26.6 0.0 1.5 0.0 1.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.6 0.0 1.1 0.0 0.0 5.7 0.0 1.7 0.0 0.2 0.0 0.0 5.3 1.2 0.1 7.2 0.1 0.0 0.2 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 2.6 0.0 0.4 0.3 0.0 45.2 3.4 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 1.2 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 22.3 7.0 22.4 18.7 13.9 21.6 19.4 17.9 26.6 3.0 2.2 0.0 0.2 0.5 0.2 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.4 2.4 0.8 0.0 0.0 0.3 0.0 0.0 3.7 0.0 20.9 0.9 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 3.3 8.0 0.1 0.2 0.0 0.0 0.1 NCAN CSPG3 ENSG00000130287 Neurocan O14594 19 19211973-19252233 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "brain: 88.4" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 1.6;Spermatocytes: 1.0;Spermatogonia: 1.7" "Cancer enriched" "Detected in some" 57 "glioma: 71.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;NTERA-2: 1.4;SCLC-21H: 6.5;SH-SY5Y: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036814 Enhanced "Secreted in brain" NA NA 340000 "HPA036814: AB_10673666" "unprognostic (1.02e-2)" "unprognostic (2.84e-3)" "unprognostic (1.92e-1)" "unprognostic (1.56e-2)" "unprognostic (2.35e-2)" "unprognostic (1.65e-2)" "unprognostic (1.70e-2)" "unprognostic (1.03e-3)" "unprognostic (1.76e-1)" "unprognostic (2.12e-1)" "unprognostic (4.58e-3)" "unprognostic (4.38e-2)" "unprognostic (9.09e-6)" "unprognostic (1.10e-2)" "unprognostic (2.79e-2)" "unprognostic (2.91e-1)" "unprognostic (2.58e-2)" 1.1 1.2 21.2 1.1 23.2 1.1 1.1 5.4 88.4 1.1 1.1 12.9 0.0 1.1 1.1 1.1 1.1 1.1 1.1 1.1 16.8 8.3 1.1 1.2 1.1 1.1 7.8 15.2 1.1 1.1 1.1 0.1 1.1 12.3 1.1 1.1 0.0 1.2 1.1 1.1 1.1 1.1 1.1 4.0 1.1 1.1 1.8 5.6 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.5 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 23.2 5.4 22.8 16.8 8.3 7.8 15.2 12.3 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.1 0.0 0.0 0.0 0.0 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavorable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 22.1 20.5 22.1 16.0 5.8 6.0 25.8 15.3 12.3 24.8 20.1 18.5 23.6 23.3 4.6 10.0 21.0 19.6 36.4 17.9 47.4 42.2 20.4 21.3 23.5 10.5 2.4 26.4 15.4 3.8 6.7 19.3 19.8 11.4 16.3 15.0 13.5 9.5 21.9 11.0 29.9 17.4 34.5 20.9 16.0 25.6 50.3 12.4 8.3 12.4 9.1 9.6 22.8 10.8 8.1 36.0 4.7 16.6 10.2 16.3 26.8 11.0 29.7 7.4 10.0 33.2 9.6 15.3 20.2 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 6.0 6.1 13.0 3.2 3.2 3.6 2.9 7.6 5.3 3.4 1.8 7.9 6.8 0.0 4.1 14.9 2.6 5.2 46.7 3.3 16.2 3.1 2.8 3.5 2.6 8.6 4.8 1.2 9.2 10.8 20.4 5.5 5.4 0.0 5.4 6.3 10.0 4.5 5.7 5.6 2.0 7.6 0.0 3.6 17.7 10.0 3.0 5.3 6.9 8.0 3.0 NCAPD3 "CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056" ENSG00000151503 "Non-SMC condensin II complex subunit D3" P42695 11 134150119-134225454 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 82.1" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 8 "prostate cancer: 50.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040286 Supported Nucleoplasm NA NA Nucleoplasm "HPA040286: AB_2676918" "unprognostic (4.27e-2)" "unprognostic (6.05e-2)" "unprognostic (7.78e-3)" "unprognostic (8.22e-3)" "unprognostic (2.79e-1)" "unprognostic (4.29e-2)" "unprognostic (2.15e-3)" "unprognostic (2.56e-1)" "unprognostic (4.32e-2)" "unprognostic (4.75e-1)" "unprognostic (2.79e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.93e-2)" "unprognostic (3.35e-2)" "unprognostic (3.94e-1)" "unprognostic (3.48e-1)" 4.9 6.4 4.9 8.3 7.4 13.7 5.4 8.9 6.2 4.0 5.4 8.5 5.0 5.4 4.7 5.9 7.8 4.2 5.4 4.5 5.5 4.3 4.3 12.1 5.3 7.6 9.0 3.3 4.1 5.9 6.8 9.2 6.0 6.1 82.1 6.1 4.9 6.0 6.6 3.8 9.0 5.6 5.4 6.8 8.5 5.3 14.8 7.1 30.7 6.6 5.3 9.8 4.5 5.4 6.9 11.2 2.6 5.6 5.8 10.4 3.8 13.1 11.7 12.9 19.4 5.2 3.9 8.5 15.5 9.9 14.3 15.8 22.8 20.8 24.4 20.9 7.9 14.8 22.0 24.0 13.4 15.6 22.1 20.8 41.9 11.8 10.1 2.5 25.9 22.8 2.7 2.2 18.9 6.2 4.1 9.3 23.2 22.3 14.5 10.7 11.0 29.8 16.8 8.8 24.7 20.7 17.5 15.2 14.1 5.5 16.9 25.8 12.1 22.5 18.0 3.6 10.5 28.5 14.8 7.4 18.5 7.8 12.5 19.3 6.2 6.2 23.0 5.3 30.9 15.5 1.7 5.6 2.6 9.5 5.0 5.6 3.7 6.4 7.2 5.1 6.9 8.9 10.4 2.2 5.8 4.1 11.2 9.4 3.8 4.9 7.4 8.9 6.2 5.5 4.3 9.0 3.3 6.1 7.1 3.0 7.2 9.0 3.7 8.1 18.5 7.0 5.1 4.0 9.1 12.2 9.8 8.7 0.0 2.5 5.0 4.2 2.4 0.0 2.3 8.8 5.9 9.1 2.3 8.9 7.6 11.1 7.5 4.9 5.1 7.5 4.4 7.7 1.7 20.8 4.3 10.6 2.7 0.0 3.9 2.8 22.1 0.0 6.4 17.4 13.7 8.0 3.8 7.9 7.1 2.5 NCAPG "CAP-G, FLJ12450, hCAP-G, YCG1" ENSG00000109805 "Non-SMC condensin I complex subunit G" Q9BPX3 4 17810902-17844862 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 65.4" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 23.3;Extravillous trophoblasts: 22.2;Spermatocytes: 40.4;Spermatogonia: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.9" "Lineage enriched" "Detected in single" 5 "T-cells: 2.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039613 Uncertain NA Yes "HPA039613: AB_10805481" "unprognostic (5.23e-2)" "unprognostic (3.37e-1)" "unprognostic (1.59e-3)" "prognostic unfavorable (8.28e-4)" "unprognostic (4.22e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (1.18e-3)" "unprognostic (1.63e-2)" "unprognostic (6.70e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.44e-2)" "unprognostic (0.00e+0)" "unprognostic (1.94e-2)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" 1.4 1.1 0.3 18.0 0.4 12.5 2.5 0.7 0.5 1.4 2.9 0.3 0.2 3.7 0.8 1.2 7.1 0.3 0.7 1.6 0.4 0.7 0.9 1.1 1.8 8.3 2.0 0.3 0.6 0.5 0.0 0.4 3.7 0.5 0.7 2.4 0.3 1.6 0.9 0.6 3.4 3.3 0.7 1.0 6.4 1.9 11.8 0.3 65.4 0.5 6.7 8.6 1.6 2.0 0.5 0.5 0.0 0.4 0.3 2.9 1.7 16.4 10.6 24.3 15.9 1.5 3.0 8.9 21.4 8.4 21.1 21.7 13.4 10.1 24.7 4.3 5.9 18.3 7.5 20.6 8.2 29.1 11.2 10.1 19.6 14.5 10.9 0.1 13.8 7.7 0.5 0.5 15.6 7.2 3.3 10.5 10.8 19.1 28.2 20.9 4.9 15.8 13.4 12.5 9.6 10.5 15.6 22.0 10.3 6.4 5.1 19.2 11.4 19.2 4.1 6.1 10.9 9.7 7.8 8.6 20.3 9.2 11.4 29.1 8.8 8.3 21.0 8.4 14.4 13.4 0.0 0.0 0.0 0.5 0.2 0.0 0.5 1.0 0.6 0.5 0.2 0.1 0.7 0.0 0.3 0.4 0.0 2.9 1.7 0.3 0.4 0.7 0.5 0.4 0.7 2.0 0.3 0.5 0.3 0.0 1.4 1.5 0.2 2.2 0.0 0.1 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.0 12.5 0.0 0.2 23.3 0.0 22.2 0.6 0.3 1.1 0.0 7.7 0.0 1.7 3.1 2.2 8.4 0.6 2.2 1.7 1.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 40.4 29.7 1.0 1.8 1.5 2.3 0.1 NCAPG2 "CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB" ENSG00000146918 "Non-SMC condensin II complex subunit G2" Q86XI2 7 158631311-158704829 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.1" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026631, HPA049637" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA026631: AB_1845983, HPA049637: " "unprognostic (2.73e-2)" "unprognostic (1.77e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.91e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (5.33e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.79e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.19e-2)" "prognostic unfavorable (4.06e-5)" "unprognostic (2.58e-3)" "unprognostic (1.28e-1)" "unprognostic (8.21e-2)" "unprognostic (7.37e-2)" 5.9 4.0 4.4 8.6 4.2 20.1 5.4 9.0 5.1 4.4 6.6 5.8 3.5 4.2 5.1 5.1 9.9 3.7 3.1 4.0 4.3 3.5 3.3 3.9 4.4 11.4 6.2 4.2 4.4 4.4 6.0 5.8 6.9 4.9 4.5 7.7 3.9 5.3 4.2 4.5 6.5 5.5 4.6 6.2 6.1 5.3 14.6 5.1 39.1 3.6 7.6 13.0 4.8 5.5 1.8 2.8 6.9 5.4 6.1 9.3 2.5 30.0 16.0 19.5 12.5 2.9 4.8 7.7 22.0 14.2 27.3 30.6 14.1 15.8 18.6 13.8 9.0 29.0 15.5 16.2 10.1 36.5 19.8 12.0 16.8 19.9 11.1 1.3 20.7 19.0 2.0 1.1 22.2 6.4 5.0 15.1 21.8 20.6 28.0 25.0 32.0 34.4 14.0 19.2 17.1 13.0 20.2 20.5 17.7 6.7 13.5 21.3 16.5 27.2 10.6 6.0 13.0 9.6 13.5 7.9 18.7 14.3 50.4 35.3 18.5 13.6 22.6 19.8 26.5 35.4 6.9 1.0 1.2 6.5 1.4 9.3 1.8 6.6 4.5 2.8 1.2 2.2 2.4 0.6 6.1 5.4 1.4 8.3 2.5 4.4 4.2 9.0 5.1 4.3 3.5 6.2 4.2 4.9 5.1 6.0 1.0 1.5 1.1 3.5 3.8 3.4 2.5 8.1 6.8 1.8 0.0 2.6 0.0 2.3 9.3 2.2 0.4 0.0 2.9 8.4 2.7 0.9 1.1 2.1 6.1 7.9 0.0 4.3 2.7 4.0 2.6 4.7 1.7 2.8 1.7 1.9 1.6 0.0 3.9 1.1 2.8 6.5 4.1 40.1 15.6 1.8 2.2 5.1 1.8 2.3 NCAPH "BRRN1, CAP-H, hCAP-H" ENSG00000121152 "Non-SMC condensin I complex subunit H" Q15003 2 96335787-96373845 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4" "Cell type enhanced" "Detected in many" 22 "Spermatocytes: 77.0;Spermatogonia: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 5.6;T-reg: 8.7" "Group enriched" "Detected in many" 5 "granulocytes: 5.6;T-cells: 8.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA002647, HPA003008" Enhanced Supported Nucleoplasm,Cytosol Yes Yes Cytosol Nucleoplasm "HPA002647: AB_1078300, HPA003008: AB_1078301" "unprognostic (5.52e-2)" "unprognostic (7.37e-2)" "unprognostic (2.93e-2)" "unprognostic (2.85e-3)" "unprognostic (1.92e-1)" "unprognostic (7.51e-2)" "prognostic unfavorable (9.53e-6)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.50e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (3.16e-2)" "unprognostic (0.00e+0)" "unprognostic (3.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.14e-1)" "unprognostic (2.30e-2)" 1.3 1.1 0.8 13.2 0.9 17.2 1.7 0.7 1.2 1.5 3.9 0.7 0.4 2.9 0.7 1.1 7.4 0.4 1.0 0.8 0.8 0.7 0.9 0.9 1.5 10.6 1.0 0.6 0.8 0.6 0.1 0.5 3.4 1.0 0.7 5.1 0.6 1.9 0.4 0.6 2.7 3.5 1.4 1.2 6.7 2.1 60.4 0.8 41.3 0.6 6.4 12.2 1.7 2.2 1.3 0.5 5.6 1.0 0.1 8.7 0.8 31.2 11.9 30.2 15.6 1.1 1.6 20.0 14.8 10.4 28.7 30.3 21.9 17.5 29.2 10.5 6.5 26.2 14.1 25.8 10.1 30.8 25.6 17.1 30.1 12.4 19.8 0.2 27.8 25.7 0.5 1.1 22.2 9.4 2.7 11.3 23.4 20.8 21.6 13.6 14.7 40.7 29.0 21.6 13.8 15.1 31.7 27.5 23.7 5.7 12.1 17.9 13.7 8.6 12.1 5.2 11.9 8.9 20.6 6.5 21.2 32.4 19.8 23.9 11.6 16.5 31.0 9.1 27.9 23.9 5.6 0.0 0.3 1.3 1.0 0.2 1.3 1.9 1.5 0.5 0.9 0.0 0.7 0.3 0.1 0.0 0.0 8.7 0.8 0.8 0.9 0.7 1.2 0.8 0.7 1.0 0.6 1.0 0.8 0.0 0.0 0.8 0.2 0.6 0.4 0.4 0.0 2.7 2.3 0.0 7.9 1.1 0.0 0.4 3.9 0.5 0.0 0.0 0.0 14.1 0.4 0.5 1.1 0.5 6.8 0.0 0.0 0.6 3.2 4.0 0.9 3.0 1.7 0.0 1.0 4.7 0.2 0.0 0.4 0.0 2.3 0.0 0.9 77.0 26.2 0.6 1.6 5.4 1.2 0.6 NCBP2-AS2 ENSG00000270170 "NCBP2 antisense RNA 2 (head to head)" Q69YL0 3 196942623-196943540 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (3.48e-1)" "unprognostic (4.33e-3)" "unprognostic (4.51e-2)" "unprognostic (1.74e-3)" "unprognostic (4.77e-2)" "unprognostic (2.49e-1)" "unprognostic (2.61e-3)" "unprognostic (1.30e-1)" "unprognostic (1.71e-1)" "unprognostic (2.67e-1)" "unprognostic (5.07e-2)" "unprognostic (3.21e-2)" "prognostic favorable (8.92e-4)" "unprognostic (4.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (8.66e-3)" 5.0 5.1 6.2 3.5 9.8 14.5 6.2 4.4 12.4 4.2 9.6 4.5 3.8 6.7 3.8 5.8 3.8 4.4 5.8 7.1 5.1 6.5 5.1 4.1 5.0 5.1 5.8 3.9 11.9 5.1 2.5 3.7 7.1 5.6 7.3 5.4 6.8 5.9 16.2 4.4 6.0 4.3 2.8 4.9 6.1 2.4 5.5 3.9 5.3 8.6 4.7 2.5 5.3 41.4 46.6 40.4 45.5 41.4 56.0 37.7 17.7 5.2 9.2 10.9 7.4 6.7 17.6 8.4 5.8 11.7 7.8 10.1 6.5 16.7 31.3 6.2 9.2 14.2 14.9 7.4 9.2 5.9 22.3 13.2 6.3 16.4 8.3 12.2 8.3 11.1 13.8 6.8 8.5 5.4 7.6 15.9 13.2 13.4 5.0 31.5 15.3 22.1 20.1 20.0 25.7 13.8 8.0 20.5 9.7 10.1 21.2 24.1 9.0 13.9 19.9 9.9 28.4 14.1 5.7 5.5 16.1 8.6 17.7 20.3 23.2 40.0 6.4 21.2 7.2 25.0 45.5 40.4 36.1 34.1 37.8 35.2 45.3 41.0 39.9 41.4 56.0 45.7 17.6 41.4 29.9 46.6 40.9 37.7 14.9 8.8 33.7 40.9 44.0 22.6 36.4 33.1 6.7 18.2 45.4 11.8 43.8 101.2 32.4 4.9 40.9 47.7 70.0 48.5 33.2 35.1 44.2 13.9 38.1 37.7 17.5 48.6 35.0 33.2 5.8 30.8 29.6 45.5 27.1 55.7 34.4 47.8 37.4 26.5 64.0 23.4 25.8 40.6 12.6 25.3 57.6 28.7 40.2 57.9 59.3 NCBP2L ENSG00000170935 "Nuclear cap binding protein subunit 2 like" A6PVI3 X 107774899-107795829 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 8.7;testis: 6.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 5.3;Early spermatids: 19.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 39 "basophil: 8.7" "Lineage enriched" "Detected in single" 39 "granulocytes: 8.7" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;MCF7: 1.4;SK-BR-3: 2.8" "Not detected" "Not detected" HPA010664 Uncertain NA NA "HPA010664: AB_1079451" "unprognostic (3.22e-1)" "unprognostic (8.00e-2)" "unprognostic (5.64e-2)" "unprognostic (7.29e-2)" "unprognostic (2.64e-1)" 0.0 3.1 0.3 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.0 0.2 1.9 1.6 0.0 0.1 0.0 0.3 0.0 0.9 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 8.7 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.0 1.8 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 NCCRP1 "FBXO50, LOC342897, NCCRP-1" ENSG00000188505 "Non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)" Q6ZVX7 19 39196961-39201884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 101.7;lymphoid tissue: 113.1;skin 1: 49.6" "Cell type enriched" "Detected in some" 23 "monocytes: 983.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 26.8" "Region enhanced" "Detected in single" "olfactory region: 2.0" "Low region specificity" "Detected in single" HPA052812 Approved NA NA 1200000 "HPA052812: AB_2681960" "unprognostic (3.56e-3)" "unprognostic (3.69e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (4.59e-3)" "unprognostic (3.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.37e-3)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (2.04e-2)" "unprognostic (1.90e-1)" "unprognostic (6.37e-6)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" 0.1 0.1 0.0 3.1 0.0 0.3 2.1 0.0 0.4 21.5 0.8 0.0 0.4 0.6 2.1 0.3 101.7 0.4 0.3 0.1 0.0 0.0 0.9 0.1 0.8 2.4 0.0 0.0 0.1 2.9 0.1 0.0 7.5 0.0 0.4 0.6 20.2 10.5 0.4 0.3 49.6 2.4 0.2 0.0 0.4 0.1 0.1 0.0 4.3 0.2 42.7 113.1 1.2 31.2 0.7 0.8 3.4 0.6 0.9 0.6 0.1 0.2 0.2 1.0 0.2 0.1 0.7 2.1 0.1 0.0 0.1 0.1 0.5 0.5 0.6 2.0 0.4 0.2 0.9 1.5 0.6 0.5 0.0 0.4 0.2 0.8 0.2 0.1 0.4 0.3 0.5 0.4 0.1 0.3 0.3 0.2 0.5 0.3 0.3 0.3 0.1 0.2 0.1 0.6 0.1 0.2 0.2 0.4 0.4 0.1 0.6 0.6 1.0 2.6 26.8 0.2 0.8 0.3 0.9 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.6 0.5 0.2 0.5 3.4 0.6 0.5 0.6 0.4 0.3 0.5 0.4 0.3 0.2 0.7 0.5 0.4 2.0 0.9 0.5 0.8 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.4 0.2 0.0 0.0 0.0 3.5 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 2.0 2.5 0.4 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 983.8 0.0 0.2 6.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 6.1 9.3 0.0 0.0 42.6 NCDN "NCDN-1, NCDN-2" ENSG00000020129 Neurochondrin Q9UBB6 1 35557473-35567274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 144.3" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 21.4;Club cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023676 Enhanced Supported Supported Cytosol NA NA Cytosol "HPA023676: AB_1854325" "unprognostic (1.15e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.91e-5)" "unprognostic (4.66e-2)" "unprognostic (1.41e-1)" "unprognostic (4.36e-2)" "prognostic favorable (3.73e-4)" "unprognostic (5.91e-3)" "unprognostic (5.34e-3)" "unprognostic (5.88e-3)" "unprognostic (2.87e-1)" "unprognostic (3.24e-2)" "unprognostic (2.23e-2)" 5.2 11.3 33.4 6.0 144.3 3.4 3.6 28.7 104.9 9.9 3.5 8.7 1.2 3.9 6.2 4.8 4.5 8.1 6.5 12.0 45.4 25.0 4.0 2.5 4.5 5.9 15.8 32.3 9.2 6.1 6.2 5.5 4.7 26.4 7.1 2.9 3.6 6.7 8.0 5.3 5.6 3.2 6.5 10.7 5.0 4.7 5.8 15.6 0.8 6.5 0.6 4.6 6.0 2.4 5.9 2.7 0.8 4.5 3.0 6.5 5.5 8.8 10.7 9.0 14.1 13.1 16.2 6.2 11.7 12.2 12.3 9.9 10.7 13.1 10.1 11.4 10.8 8.9 13.6 8.8 14.2 4.5 9.8 18.2 12.5 15.7 5.5 18.1 11.3 14.5 15.5 12.0 21.8 8.8 10.2 6.5 6.1 13.5 16.2 10.0 15.9 10.3 7.3 40.3 9.8 18.9 8.5 5.0 13.0 8.3 9.9 11.2 16.1 13.3 12.3 16.5 7.5 11.8 7.4 8.9 15.8 11.3 11.5 16.0 22.8 16.1 7.5 19.6 18.2 14.3 0.0 4.5 0.8 3.1 2.6 3.8 5.9 4.8 4.8 2.7 2.7 6.5 5.3 0.7 3.0 4.2 1.6 2.7 5.5 33.4 144.3 28.7 61.4 45.4 25.0 15.8 32.3 26.4 15.6 3.0 11.8 0.8 0.5 3.1 3.4 12.0 5.1 21.4 15.9 7.0 0.0 5.0 1.7 3.2 2.2 2.8 1.0 0.0 3.7 2.2 5.0 0.4 3.5 3.6 3.3 6.4 3.5 3.1 7.0 0.7 6.1 1.9 5.0 1.0 2.8 1.6 3.5 2.8 3.9 3.0 2.4 0.0 4.1 3.2 2.2 2.6 4.7 3.2 2.1 0.4 NCEH1 "AADACL1, KIAA1363, NCEH" ENSG00000144959 "Neutral cholesterol ester hydrolase 1" Q6PIU2 3 172630249-172711218 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 70.8;LHCN-M2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026888, HPA043873" Enhanced Approved "Endoplasmic reticulum" No No "Endoplasmic reticulum" "HPA026888: AB_10601557, HPA043873: " "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (5.74e-2)" "unprognostic (1.27e-1)" "unprognostic (6.88e-3)" "unprognostic (5.41e-2)" "unprognostic (3.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (5.29e-2)" "unprognostic (2.96e-2)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (2.81e-2)" "unprognostic (2.28e-1)" 17.0 14.8 6.5 7.1 23.8 6.0 5.1 14.3 30.1 4.1 9.8 2.3 1.4 3.5 3.9 2.9 4.4 3.5 6.0 14.6 13.2 9.6 18.8 4.2 17.0 11.2 6.6 11.4 2.5 4.0 6.3 4.2 5.7 17.7 6.0 10.7 4.3 8.2 4.2 6.6 2.7 4.1 2.9 5.0 9.1 10.9 2.0 4.0 1.9 3.9 3.1 9.3 5.1 3.4 3.0 10.6 4.8 15.1 2.8 2.3 4.8 23.3 13.6 0.4 0.7 0.8 0.9 1.9 17.6 11.7 11.7 6.8 3.4 70.8 1.9 26.5 10.6 11.2 4.7 0.5 8.6 27.2 6.5 1.1 1.3 2.2 2.6 1.0 3.5 4.9 0.4 0.8 8.0 12.0 11.0 7.8 1.0 0.3 1.7 33.1 1.9 0.5 1.2 0.6 6.6 11.2 0.5 1.3 2.4 20.9 3.1 0.4 0.2 10.6 11.2 2.3 0.8 3.8 1.6 21.1 18.0 2.7 8.4 31.8 2.0 3.8 1.6 13.4 3.4 13.6 4.8 15.1 0.5 2.3 9.6 1.5 3.0 1.5 1.6 10.6 1.9 1.5 1.8 0.5 2.8 6.2 0.6 1.3 4.8 6.5 23.8 14.3 30.1 13.2 9.6 6.6 11.4 17.7 4.0 44.7 19.9 6.4 16.9 6.1 12.9 27.7 25.5 30.8 28.4 15.7 21.6 6.2 3.3 54.9 4.5 8.7 13.1 46.7 26.6 3.8 6.1 23.2 4.7 1.6 48.4 4.8 7.5 5.5 34.7 2.6 0.9 14.5 5.0 1.8 9.7 4.9 50.0 10.5 2.5 25.4 19.2 6.5 5.8 0.0 0.9 3.0 8.8 3.8 6.0 22.8 NCF1 "NCF1A, NOXO2, p47phox, SH3PXD1A" ENSG00000158517 "Neutrophil cytosolic factor 1" P14598 7 74773962-74789315 "Disease related genes, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 166.6;lymphoid tissue: 42.1" "Cell type enhanced" "Detected in many" 14 "B-cells: 168.1;Kupffer cells: 142.9;Macrophages: 51.2;monocytes: 81.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 75.1;classical monocyte: 49.6;eosinophil: 106.8;neutrophil: 166.6" "Group enriched" "Detected in many" 5 "granulocytes: 166.6;monocytes: 49.6" "Group enriched" "Detected in some" 6 "Daudi: 36.1;HMC-1: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004524, HPA047836, HPA052095" Enhanced NA NA "CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721" "unprognostic (4.93e-2)" "unprognostic (8.34e-3)" "unprognostic (1.23e-1)" "unprognostic (1.25e-2)" "unprognostic (8.67e-2)" "unprognostic (3.55e-3)" "unprognostic (7.60e-2)" "unprognostic (4.75e-2)" "unprognostic (6.23e-3)" "unprognostic (9.99e-2)" "unprognostic (6.61e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-3)" "unprognostic (3.16e-1)" "unprognostic (4.17e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-1)" 2.4 0.9 0.7 11.9 0.5 25.9 0.7 0.0 0.2 0.4 2.0 1.9 0.3 0.0 1.2 1.2 1.2 0.7 0.7 0.8 1.3 1.4 6.6 17.1 1.3 0.2 0.3 0.0 0.4 1.0 0.7 0.9 1.3 0.0 0.1 0.1 10.0 0.7 2.5 42.1 1.4 0.0 0.9 11.8 3.2 0.6 21.2 21.2 166.6 49.6 0.7 1.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 1.1 0.3 0.3 0.0 0.3 51.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.5 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.0 0.2 0.1 6.2 0.1 3.0 0.0 75.1 49.6 106.8 0.3 18.6 0.7 18.2 0.7 0.4 5.9 21.2 1.0 0.6 166.6 0.7 4.1 21.2 0.7 29.3 0.0 3.2 168.1 1.0 2.7 0.0 0.5 7.6 0.0 1.2 3.5 0.0 0.5 0.0 0.9 6.5 1.0 0.0 23.3 0.6 9.6 1.1 0.9 13.9 0.8 34.7 3.2 0.0 4.3 142.9 4.8 0.0 51.2 10.1 81.2 0.2 0.3 0.9 1.1 0.4 1.4 0.3 0.0 0.3 0.0 0.2 1.5 3.8 25.9 0.2 1.6 NCF2 "NOXA2, p67phox" ENSG00000116701 "Neutrophil cytosolic factor 2" P19878 1 183555563-183590876 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 6 "Ductal cells: 59.6;Hofbauer cells: 199.3;Kupffer cells: 138.6;Macrophages: 192.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 125.2;neutrophil: 80.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 13.4;HMC-1: 11.7;hTERT-HME1: 28.0;U-2 OS: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002327, HPA006040, CAB022160" Enhanced Supported Cytosol NA NA Cytosol "CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906" "unprognostic (4.97e-2)" "unprognostic (3.48e-2)" "unprognostic (2.40e-2)" "unprognostic (1.22e-3)" "unprognostic (5.83e-3)" "unprognostic (4.04e-2)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.29e-1)" "unprognostic (2.45e-1)" "unprognostic (2.33e-1)" "unprognostic (5.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-2)" "unprognostic (8.24e-2)" "unprognostic (2.36e-2)" 15.3 3.1 2.0 23.0 4.5 53.0 3.9 0.7 2.8 2.9 2.8 3.7 0.2 2.3 1.8 6.1 4.1 5.2 7.2 6.4 2.0 1.8 2.9 5.4 39.5 42.7 6.8 0.4 3.5 4.2 0.6 1.9 11.5 3.8 3.4 3.7 4.2 4.4 0.8 3.5 7.1 3.8 5.8 5.5 45.4 2.6 3.9 3.2 4.2 2.0 5.6 5.5 7.3 3.5 1.4 24.3 125.2 45.7 0.2 1.0 22.7 13.4 0.4 0.0 0.0 0.0 0.0 0.1 1.0 1.2 1.8 0.8 0.1 0.4 1.6 2.3 0.4 0.3 7.6 0.0 9.9 1.6 8.4 0.0 0.0 3.4 3.1 0.0 1.0 11.7 0.0 2.2 1.8 28.0 1.1 0.0 0.0 0.0 3.0 3.1 0.1 0.1 0.5 0.2 0.8 0.8 3.6 1.2 10.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 1.0 1.5 4.7 0.6 0.0 27.2 0.0 2.5 0.5 0.7 0.3 0.2 5.4 0.0 15.5 45.7 125.2 0.1 34.4 0.1 1.4 0.4 0.1 24.3 0.8 0.2 0.1 80.6 0.2 29.7 1.3 1.0 22.7 2.0 4.5 0.7 2.8 2.0 1.8 6.8 0.4 3.8 3.2 8.9 17.8 4.8 0.1 4.8 0.4 1.1 10.2 26.8 13.6 0.0 0.0 0.8 3.3 59.6 1.0 0.7 0.0 0.0 3.3 0.8 2.1 0.3 7.0 0.4 199.3 0.0 0.0 4.3 138.6 2.1 0.6 192.4 6.8 20.8 0.0 0.0 18.4 1.1 0.0 0.1 0.6 12.9 3.4 0.0 0.2 3.8 1.6 1.3 0.0 0.8 NCF4 "p40phox, SH3PXD4" ENSG00000100365 "Neutrophil cytosolic factor 4" Q15080 22 36860988-36878015 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Chronic granulomatous disease, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0" "Cell type enhanced" "Detected in many" 14 "B-cells: 49.2;granulocytes: 71.7;Hofbauer cells: 162.7;Kupffer cells: 83.9;Macrophages: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 130.3" "Cell line enhanced" "Detected in some" "HEL: 18.6;HMC-1: 88.9;NB-4: 31.5;REH: 16.2;RPMI-8226: 31.3;THP-1: 29.6;U-937: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010146, HPA036156, HPA057975" Enhanced Enhanced Cytosol NA NA Cytosol "CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568" "unprognostic (3.27e-2)" "unprognostic (1.55e-2)" "unprognostic (2.68e-2)" "unprognostic (1.36e-3)" "unprognostic (1.35e-1)" "unprognostic (2.78e-3)" "unprognostic (4.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.03e-2)" "unprognostic (2.70e-1)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "prognostic unfavorable (7.06e-8)" "unprognostic (3.60e-1)" "unprognostic (2.23e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-1)" 10.4 5.8 4.4 24.8 5.6 69.0 5.6 0.7 2.8 3.4 7.4 2.5 1.2 5.0 2.2 8.1 4.4 5.9 7.2 8.0 3.9 2.2 4.4 4.2 17.5 21.2 8.0 1.0 3.3 2.1 0.6 2.6 10.3 4.6 5.1 5.3 4.2 6.5 2.2 2.6 2.3 16.0 4.3 7.7 66.0 3.9 3.0 5.4 5.0 3.5 2.8 22.2 9.0 7.1 12.6 10.0 130.3 19.5 0.4 10.8 10.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 18.6 0.0 0.0 0.0 2.7 88.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 31.5 0.0 0.0 0.0 16.2 0.0 31.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.0 16.5 0.0 58.0 19.5 76.4 0.2 9.6 1.1 12.6 3.9 0.8 9.1 8.9 0.2 0.2 130.3 0.4 6.4 10.0 10.8 10.2 4.4 5.6 0.7 2.8 3.9 2.2 8.0 1.0 4.6 5.4 3.0 28.4 49.2 2.2 2.5 0.0 0.8 0.0 1.4 9.1 1.8 0.0 2.5 0.0 0.6 0.3 1.4 0.4 0.0 2.7 14.2 2.5 0.3 71.7 0.6 162.7 0.0 0.0 0.6 83.9 1.0 0.6 82.4 13.5 17.2 0.3 0.0 1.2 17.3 0.0 0.2 0.2 0.0 0.4 0.0 0.2 1.9 10.9 17.0 1.2 3.8 NCKAP1L HEM1 ENSG00000123338 "NCK associated protein 1 like" P55160 12 54497711-54548238 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.1;lymphoid tissue: 56.7" "Group enriched" "Detected in many" 5 "B-cells: 52.5;granulocytes: 53.3;Hofbauer cells: 98.9;Kupffer cells: 144.7;Macrophages: 81.9;monocytes: 90.2;T-cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 33.5;HMC-1: 35.4;NB-4: 24.7;REH: 17.7;THP-1: 36.7;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039490, HPA040772" Approved Uncertain "Plasma membrane,Cytosol" NA NA 52000 Cytosol "Plasma membrane" "HPA039490: AB_2676540, HPA040772: AB_2677129" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (1.61e-2)" "unprognostic (1.22e-3)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (3.69e-1)" "unprognostic (2.95e-2)" "unprognostic (6.53e-3)" "unprognostic (4.80e-1)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (1.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.76e-2)" "unprognostic (3.63e-2)" "unprognostic (4.74e-2)" 18.1 5.0 5.9 22.0 10.5 16.9 7.2 1.2 5.8 3.1 15.0 8.1 0.6 4.0 3.1 4.3 4.8 4.0 5.1 6.5 4.1 3.5 3.9 6.5 19.7 56.7 9.3 2.5 2.2 2.4 4.4 2.3 7.3 6.6 4.8 6.9 3.0 4.3 4.0 1.5 2.8 15.4 7.0 13.9 44.7 4.7 1.7 7.9 47.2 2.8 1.8 30.0 22.2 3.3 11.2 25.4 18.4 39.1 12.3 15.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.1 14.4 0.0 0.0 0.0 33.5 35.4 0.0 0.0 0.0 0.0 0.0 0.2 12.4 2.3 13.6 0.0 0.0 14.1 24.7 0.0 0.0 0.0 17.7 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 11.8 0.0 21.5 0.0 8.6 23.3 18.4 11.9 36.4 9.8 11.2 10.7 12.1 25.4 11.0 6.9 10.0 5.9 12.3 39.1 14.4 15.2 19.2 5.9 10.5 1.2 5.8 4.1 3.5 9.3 2.5 6.6 7.9 0.0 15.2 52.5 0.4 1.1 0.9 1.3 7.6 1.4 3.4 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.3 0.7 1.7 0.1 53.3 0.9 98.9 0.0 0.0 9.2 144.7 1.5 1.1 81.9 5.0 90.2 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 1.4 0.5 1.0 0.5 1.1 53.6 0.0 0.3 NCKAP5 "ERIH1, ERIH2, NAP5" ENSG00000176771 "NCK associated protein 5" O14513 2 132671799-133568463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 18.3;lung: 19.2" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 244.2;Bipolar cells: 119.6;Muller glia cells: 83.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "basophil: 3.1" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 6 "AF22: 32.3" "Low region specificity" "Detected in all" "HPA034639, HPA044859" Uncertain Approved "Nucleoli,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoli "Golgi apparatus, Plasma membrane, Cytosol" "HPA034639: AB_10669678, HPA044859: AB_2679114" "unprognostic (2.54e-1)" "unprognostic (1.95e-2)" "unprognostic (2.30e-2)" "unprognostic (2.58e-2)" "unprognostic (2.49e-2)" "unprognostic (3.13e-1)" "unprognostic (7.07e-2)" "unprognostic (1.90e-1)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.46e-1)" "unprognostic (2.93e-1)" "unprognostic (1.06e-11)" "unprognostic (4.56e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.03e-1)" 3.6 2.0 6.6 1.5 6.3 0.2 5.4 5.2 5.6 3.1 5.8 6.2 0.9 3.8 3.6 6.2 6.9 1.0 1.5 4.6 6.0 3.9 16.3 6.7 19.2 2.2 6.6 4.7 4.5 1.8 2.2 1.3 4.6 4.2 1.6 1.9 7.5 7.8 1.0 1.1 3.7 18.3 1.0 6.3 2.9 3.0 2.1 6.6 0.3 2.1 5.4 2.3 1.3 3.1 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 1.5 32.3 0.0 0.0 0.3 0.1 0.5 5.7 0.5 0.6 0.0 0.0 2.4 0.0 0.3 0.3 0.1 0.2 0.4 1.8 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.3 2.7 3.1 0.4 5.3 0.5 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.7 0.2 1.0 0.3 0.0 1.3 0.7 0.7 0.1 1.0 0.0 1.2 1.6 0.3 0.5 0.0 1.6 0.2 0.2 4.7 0.0 0.1 0.0 0.9 0.3 0.0 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 6.3 5.2 5.6 6.0 3.9 6.6 4.7 4.2 6.6 244.2 14.1 0.0 0.4 7.9 119.6 16.1 0.0 1.4 51.2 1.8 39.3 0.0 3.3 0.4 5.4 0.8 11.0 0.0 0.2 0.1 5.2 0.9 1.1 5.3 0.5 31.8 3.5 0.6 5.1 2.7 24.5 6.8 1.7 6.4 3.3 83.1 0.9 4.9 7.1 9.0 5.6 6.5 8.1 0.1 0.7 2.5 0.0 0.0 0.9 1.6 NCKIPSD "AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH" ENSG00000213672 "NCK interacting protein with SH3 domain" Q9NZQ3 3 48673844-48686364 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 39.6;parathyroid gland: 123.9" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019267, HPA050005" Enhanced "Plasma membrane" NA NA 42000 "Plasma membrane" "CAB019267: , HPA050005: AB_2680988" "unprognostic (1.55e-2)" "unprognostic (2.02e-1)" "unprognostic (2.15e-1)" "unprognostic (1.79e-1)" "unprognostic (9.64e-3)" "unprognostic (5.50e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (2.40e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.20e-5)" "unprognostic (1.60e-2)" "unprognostic (1.55e-1)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" 11.7 11.9 14.4 4.9 18.5 4.4 7.8 17.9 39.6 7.0 7.9 10.3 3.5 7.3 7.8 8.6 7.8 9.6 9.3 17.8 12.9 16.0 8.7 6.8 7.4 5.9 11.1 17.8 17.7 8.5 123.9 10.0 8.0 16.9 8.1 7.4 9.6 8.9 11.7 6.4 9.8 7.3 8.7 9.2 5.7 6.2 8.4 10.9 2.9 7.7 1.9 5.4 7.7 6.5 4.9 8.5 1.0 5.3 4.8 6.4 4.7 11.8 10.5 10.7 11.0 14.6 8.9 14.9 11.9 13.4 13.3 17.0 15.4 7.3 8.8 6.5 7.0 15.2 8.0 13.6 15.8 7.7 9.8 16.6 15.7 38.9 12.2 12.8 10.6 17.7 8.5 13.8 18.4 11.6 15.1 7.5 11.2 5.3 11.8 10.6 8.7 9.6 9.0 12.4 11.8 18.6 4.9 4.9 14.6 7.2 12.3 11.2 9.1 12.5 11.8 10.0 10.2 10.5 13.0 4.1 11.5 12.9 13.6 15.7 10.6 7.7 9.8 13.1 14.2 17.5 1.0 4.6 0.2 3.5 5.3 2.6 4.9 4.2 4.1 5.8 2.6 6.4 4.1 0.3 4.8 2.8 8.5 4.6 4.7 14.4 18.5 17.9 39.6 12.9 16.0 11.1 17.8 16.9 10.9 0.0 8.6 0.0 3.2 2.3 8.9 7.5 7.6 1.4 1.2 1.8 11.8 8.9 5.0 5.5 1.9 4.0 10.6 0.0 4.0 8.8 5.1 2.4 5.7 5.5 7.7 11.1 8.1 24.5 6.3 1.7 17.0 6.9 1.7 4.6 6.4 3.6 7.3 8.0 44.6 5.7 5.9 12.9 5.6 4.1 17.4 1.5 6.9 2.2 9.0 1.8 NCMAP "C1orf130, FLJ42528, MP11" ENSG00000184454 "Non-compact myelin associated protein" Q5T1S8 1 24556111-24609328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 28.8;placenta: 21.2" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 2: 15.3;Ductal cells: 15.9;Exocrine glandular cells: 41.1;Pancreatic endocrine cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.1;RPTEC TERT1: 3.4;T-47d: 8.1;U-266/70: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013656 Uncertain NA NA "HPA013656: AB_2275006" "unprognostic (3.38e-2)" "unprognostic (3.52e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.83e-6)" "unprognostic (3.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.73e-1)" "unprognostic (2.41e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-3)" "unprognostic (9.88e-2)" "unprognostic (9.53e-2)" "unprognostic (1.63e-2)" "unprognostic (7.27e-3)" 0.6 0.2 0.6 0.5 0.7 0.6 4.6 0.2 0.7 1.3 7.0 1.3 0.0 6.3 0.5 1.8 0.5 1.1 15.0 0.5 0.8 0.6 2.2 5.8 4.7 0.2 1.0 0.1 0.2 28.8 0.0 9.1 21.2 0.8 2.1 0.2 1.3 13.4 0.0 0.6 0.6 7.5 0.2 2.2 0.3 5.7 0.2 1.1 0.2 5.3 0.7 1.4 0.9 0.3 1.4 1.0 2.7 0.9 0.7 0.8 0.1 0.2 4.1 0.1 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 1.8 0.4 1.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 0.1 0.4 0.3 1.9 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.3 0.0 0.3 0.2 0.5 0.0 0.4 0.2 0.4 0.2 1.5 0.0 0.4 0.1 1.1 3.4 1.1 0.4 0.3 0.2 0.3 0.0 1.1 8.1 0.2 0.5 0.2 0.3 0.5 0.2 6.4 0.8 0.1 0.1 0.2 0.3 2.7 0.9 0.6 0.5 0.3 0.4 0.8 0.5 0.4 0.2 1.4 0.7 0.8 2.0 0.7 0.4 1.0 0.3 0.1 0.6 0.7 0.2 0.7 0.8 0.6 1.0 0.1 0.8 1.1 3.0 15.3 0.0 1.7 0.0 0.0 1.1 0.0 1.4 2.3 3.5 3.9 1.0 0.0 15.9 0.0 0.0 0.7 0.0 41.1 0.2 0.4 2.8 1.1 1.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 1.8 0.6 3.2 14.2 1.4 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.1 7.8 0.0 0.8 1.7 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030714 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" NA NA Nucleoli "Golgi apparatus, Cytosol" "HPA051260: AB_2681412, HPA065208: AB_2685432" "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favorable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 18.5 6.9 5.5 9.5 10.0 17.4 10.0 5.5 11.3 10.8 22.5 13.6 5.9 27.0 9.9 9.4 17.0 6.3 9.0 16.6 5.7 20.8 40.9 11.6 11.6 8.7 7.1 11.0 9.1 9.3 9.6 28.4 13.5 14.7 12.4 9.9 12.6 8.5 15.5 6.8 36.4 11.2 9.7 23.8 8.9 6.4 8.1 26.8 13.2 13.9 16.3 13.0 6.4 7.3 30.2 100.1 40.4 13.4 10.9 53.9 31.8 13.5 15.9 16.3 42.1 38.2 39.8 29.3 47.4 28.9 28.4 20.8 23.6 36.0 35.3 47.8 16.2 32.6 16.6 32.3 32.3 25.4 17.1 24.3 18.6 59.4 29.5 61.8 54.3 37.1 32.4 24.6 41.4 30.9 42.5 18.2 26.4 21.7 39.4 14.2 30.0 23.2 9.6 24.6 8.0 17.8 23.1 21.5 34.6 27.1 16.0 10.8 29.6 33.8 29.3 32.9 24.4 30.4 39.1 17.9 21.5 18.9 19.7 16.2 17.3 35.8 22.4 52.1 9.5 69.1 40.4 70.7 10.0 26.8 10.9 7.3 9.4 9.5 30.2 6.6 10.2 8.6 100.1 13.4 30.4 9.3 10.8 53.9 47.6 78.0 32.8 33.2 44.0 13.3 136.0 38.2 50.9 59.1 41.8 27.5 85.3 68.0 41.7 72.4 47.2 113.4 186.9 45.2 92.9 44.2 51.5 191.6 148.1 148.2 19.1 25.8 53.4 209.6 51.8 34.5 96.2 49.0 73.1 41.3 37.9 41.1 57.5 44.6 100.4 11.3 12.9 47.2 22.7 15.1 49.4 132.3 41.5 50.4 45.0 NCR1 "CD335, LY94, NK-p46, NKP46" ENSG00000189430 "Natural cytotoxicity triggering receptor 1" O76036 19 54906150-54916140 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 5.5;lymphoid tissue: 13.9" "Cell type enriched" "Detected in some" 9 "T-cells: 10.9" "Cancer enhanced" "Detected in single" "testis cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049311 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049311: AB_2680707" "unprognostic (3.92e-2)" "unprognostic (2.21e-3)" "unprognostic (1.67e-1)" "unprognostic (2.87e-4)" "unprognostic (2.89e-1)" "unprognostic (6.32e-4)" "unprognostic (2.22e-2)" "unprognostic (3.29e-1)" "unprognostic (1.07e-1)" "unprognostic (1.89e-2)" "unprognostic (1.45e-1)" "unprognostic (1.36e-1)" "unprognostic (1.15e-5)" "unprognostic (1.82e-2)" "unprognostic (5.92e-2)" "unprognostic (3.81e-3)" "unprognostic (6.05e-3)" 1.4 0.2 0.1 3.7 0.4 2.1 0.3 0.1 0.3 0.3 2.1 0.0 0.5 0.1 1.2 1.3 0.3 0.2 2.1 1.9 0.2 0.2 0.3 2.5 5.5 3.8 0.2 0.0 0.2 0.1 0.1 0.2 0.4 0.0 0.6 0.2 1.0 0.4 0.1 0.3 0.5 3.4 1.2 0.2 13.9 0.3 0.4 0.0 2.0 0.3 0.1 2.6 0.7 0.3 0.2 0.2 1.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.1 NCR2 "CD336, LY95, NK-p44" ENSG00000096264 "Natural cytotoxicity triggering receptor 2" O95944 6 41335655-41350887 "CD markers, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.5;intestine: 3.3;lymphoid tissue: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "NK-cell: 2.5;plasmacytoid DC: 8.5" "Group enriched" "Detected in many" 13 "dendritic cells: 8.5;NK-cells: 2.5" "Cell line enhanced" "Detected in some" "HMC-1: 1.6;JURKAT: 1.7;MOLT-4: 1.9" HPA067249 Uncertain NA NA "HPA067249: AB_2685811" "unprognostic (5.81e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (1.65e-1)" 0.1 0.1 0.1 1.9 0.1 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.1 0.2 0.0 0.1 2.5 0.1 0.0 0.6 0.1 0.3 0.0 1.2 0.1 1.7 3.7 0.0 0.1 0.0 8.5 0.0 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 8.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 NCR3 "1C7, CD337, LY117, NKp30" ENSG00000204475 "Natural cytotoxicity triggering receptor 3" O14931 6 31588895-31592985 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 28.5;lymphoid tissue: 18.5" "Group enriched" "Detected in some" 5 "B-cells: 22.0;T-cells: 69.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 28.5" "Lineage enriched" "Detected in many" 4 "T-cells: 28.5" "Cell line enriched" "Detected in some" 4 "NB-4: 9.5" NA NA "unprognostic (3.99e-3)" "unprognostic (9.23e-4)" "unprognostic (1.23e-3)" "unprognostic (2.49e-4)" "unprognostic (2.15e-1)" "unprognostic (2.57e-4)" "unprognostic (5.99e-2)" "unprognostic (1.15e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-1)" "unprognostic (1.81e-1)" "unprognostic (2.21e-4)" "unprognostic (1.72e-1)" "unprognostic (1.83e-1)" "unprognostic (8.17e-2)" "unprognostic (1.43e-1)" 1.8 0.1 0.2 10.5 0.2 4.3 0.3 0.1 0.1 0.1 0.4 0.0 0.0 0.2 0.3 0.5 0.9 0.2 0.3 1.2 0.6 0.1 0.5 1.3 3.9 11.4 0.2 0.0 0.5 1.1 0.0 0.1 0.8 0.1 0.3 0.3 0.1 8.4 0.4 0.1 0.3 5.8 0.2 0.2 18.5 0.4 0.8 0.0 3.6 0.4 0.1 12.8 1.0 0.3 6.1 0.0 0.1 0.2 6.4 28.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 10.5 0.0 28.5 6.1 1.2 5.2 0.0 4.4 0.5 3.3 0.1 6.4 0.2 0.0 1.7 2.5 0.2 0.2 0.1 0.1 0.6 0.1 0.2 0.0 0.1 0.0 0.0 3.4 22.0 0.0 3.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 9.2 0.2 0.3 0.0 0.0 1.8 1.2 0.0 0.3 0.4 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.5 0.6 1.5 0.1 69.1 0.0 0.0 NCR3LG1 "B7-H6, DKFZp686O24166" ENSG00000188211 "Natural killer cell cytotoxicity receptor 3 ligand 1" Q68D85 11 17351726-17377341 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9;parathyroid gland: 15.4" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 8.1;Early spermatids: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.5" "Lineage enriched" "Detected in single" 4 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HL-60: 29.3;K-562: 16.6" HPA024137 Uncertain NA NA 7300 "HPA024137: AB_1859534" "unprognostic (1.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.52e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.05e-1)" "unprognostic (7.03e-5)" "unprognostic (6.24e-2)" "unprognostic (1.09e-1)" "unprognostic (3.59e-1)" "unprognostic (2.62e-1)" "unprognostic (2.36e-1)" "prognostic favorable (4.21e-12)" "unprognostic (7.88e-3)" "unprognostic (1.72e-1)" "unprognostic (3.52e-3)" "unprognostic (1.36e-1)" 2.4 1.4 1.6 2.2 9.4 3.1 1.4 14.9 14.1 1.7 6.2 1.1 0.0 8.1 2.1 1.1 2.0 3.5 2.4 2.4 1.9 2.9 5.0 1.3 2.7 1.1 1.5 5.3 3.2 2.2 15.4 7.9 0.9 4.3 1.5 9.6 3.6 2.0 1.4 1.2 2.0 10.1 2.1 1.2 1.3 2.4 4.2 0.4 0.4 4.9 1.0 1.4 1.6 2.1 0.0 0.3 0.0 0.6 0.0 2.5 0.1 2.1 0.7 5.0 0.7 1.8 4.8 0.3 1.6 3.0 2.2 5.2 4.0 0.8 12.4 0.2 1.7 0.6 2.2 8.1 2.0 1.8 2.1 13.5 11.3 5.2 3.9 7.4 29.3 0.5 3.9 1.0 3.0 7.4 0.9 2.4 4.6 16.6 0.0 0.7 0.2 2.8 2.6 0.3 7.9 1.2 0.9 2.6 0.1 1.8 0.7 5.4 2.0 1.7 0.4 1.5 0.0 1.2 6.6 3.4 0.4 0.7 1.3 0.8 1.4 2.4 14.3 2.2 9.9 1.0 0.0 0.6 0.0 0.6 0.3 2.5 0.0 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 9.4 14.9 14.1 1.9 2.9 1.5 5.3 4.3 0.4 0.0 1.3 0.0 1.9 2.3 6.0 0.7 2.5 8.1 2.3 1.8 2.0 0.0 0.0 2.0 12.5 0.3 4.1 0.0 0.7 0.0 1.3 1.4 0.0 0.4 1.0 4.8 1.7 5.5 0.6 1.0 0.6 2.6 3.3 0.0 5.0 1.1 0.9 3.5 0.4 0.6 1.1 0.0 2.1 0.7 1.1 3.1 1.3 1.0 7.2 1.0 NCS1 "FREQ, NCS-1" ENSG00000107130 "Neuronal calcium sensor 1" P62166 9 130172578-130237304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.8" "Cell type enriched" "Detected in many" 5 "Horizontal cells: 106.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018587, HPA019713" Enhanced Supported Enhanced "Plasma membrane" NA NA "Plasma membrane" "CAB018587: AB_649907, HPA019713: AB_1854404" "prognostic unfavorable (5.40e-4)" "unprognostic (1.57e-1)" "unprognostic (4.64e-3)" "prognostic unfavorable (8.69e-4)" "unprognostic (1.29e-1)" "unprognostic (9.23e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.61e-3)" "unprognostic (4.27e-1)" "unprognostic (1.21e-2)" "unprognostic (8.45e-2)" "unprognostic (1.58e-1)" "unprognostic (3.71e-3)" "unprognostic (8.59e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.65e-1)" 5.8 12.6 76.8 7.9 56.6 4.6 2.8 18.6 66.2 7.7 20.1 6.4 5.0 3.6 12.6 4.1 24.9 13.5 8.7 4.6 74.3 25.7 8.7 1.6 2.5 1.6 20.6 28.1 4.6 3.5 1.5 2.7 1.6 17.7 14.9 6.8 4.2 5.3 41.6 0.9 10.0 4.3 34.3 6.8 1.1 5.1 2.2 7.1 0.0 20.1 0.7 2.7 16.4 4.6 0.0 0.0 0.0 0.0 0.0 1.2 0.1 7.8 16.0 8.3 16.6 5.2 11.7 4.0 20.3 9.4 15.6 10.4 7.6 4.0 0.0 7.4 25.6 18.3 14.2 13.5 17.8 7.0 23.2 4.1 0.0 10.6 8.1 8.0 0.7 9.8 13.6 9.1 17.6 11.2 13.9 14.7 3.1 5.7 0.1 22.5 22.6 1.4 7.8 12.7 4.2 6.7 0.0 26.3 5.4 15.2 5.0 22.0 20.7 12.5 6.0 12.0 6.6 11.1 5.0 11.5 30.3 24.7 24.3 26.0 0.0 0.0 0.0 35.4 2.2 32.6 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 76.8 56.6 18.6 59.9 74.3 25.7 20.6 28.1 17.7 7.1 0.0 0.0 0.0 8.5 8.7 2.7 3.6 0.0 5.3 7.9 10.4 3.9 0.0 5.0 6.6 0.3 0.0 0.0 0.0 2.5 1.5 7.1 4.5 3.5 0.0 3.6 106.5 1.2 1.3 0.0 0.0 1.1 2.3 5.0 17.2 0.5 18.7 4.9 0.0 1.4 12.4 3.1 0.0 20.2 0.0 0.9 6.0 0.5 0.0 0.0 2.6 NDC80 "HEC, HEC1, hsNDC80, KNTC2, TID3" ENSG00000080986 "NDC80, kinetochore complex component" O14777 18 2571511-2616635 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 51.3" "Cell type enhanced" "Detected in many" 15 "Erythroid cells: 23.3;Spermatocytes: 84.6;Spermatogonia: 25.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 7.9;granulocytes: 9.3;T-cells: 11.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066330 Supported Nucleoplasm,Centrosome NA Yes Nucleoplasm Centrosome "HPA066330: AB_2685661" "unprognostic (1.96e-1)" "unprognostic (5.38e-2)" "unprognostic (2.96e-1)" "unprognostic (2.21e-3)" "unprognostic (1.87e-1)" "unprognostic (3.63e-2)" "prognostic unfavorable (2.53e-8)" "unprognostic (1.16e-2)" "unprognostic (2.58e-3)" "unprognostic (2.86e-2)" "unprognostic (3.19e-3)" "unprognostic (7.74e-2)" "unprognostic (0.00e+0)" "unprognostic (9.69e-3)" "unprognostic (1.69e-1)" "unprognostic (3.50e-2)" "unprognostic (1.71e-1)" 2.9 1.3 0.8 15.3 0.8 14.6 0.9 0.7 0.9 2.9 3.8 0.8 0.6 2.7 4.2 3.8 8.3 1.3 1.8 2.7 0.6 0.4 1.6 1.4 2.9 10.1 0.6 0.8 1.2 0.8 0.0 0.6 6.0 1.1 4.3 5.1 0.8 1.9 7.6 0.6 4.0 4.8 2.2 0.6 7.9 3.0 15.9 0.6 51.3 0.9 8.1 9.9 2.2 6.7 7.9 1.6 9.3 0.7 2.2 11.5 1.4 21.9 5.0 24.8 11.0 1.3 3.0 12.8 25.8 13.9 33.8 28.9 13.6 12.5 24.0 11.7 10.0 14.3 13.6 27.7 11.1 35.8 9.0 7.0 18.9 14.2 10.4 0.5 36.2 15.9 1.5 1.0 19.4 13.8 3.5 15.3 14.9 15.4 30.6 29.5 9.9 17.6 15.8 12.8 14.2 7.3 19.5 25.4 19.2 8.8 10.6 20.1 9.0 23.6 6.2 9.4 10.3 10.4 14.5 9.3 22.1 49.2 17.4 34.0 13.4 21.1 32.2 9.7 16.8 18.6 3.7 0.7 2.8 2.2 0.6 2.0 7.9 3.7 4.3 0.3 5.7 2.4 2.4 9.3 2.2 0.5 1.6 11.5 1.4 0.8 0.8 0.7 0.9 0.6 0.4 0.6 0.8 1.1 0.6 0.0 1.1 3.7 0.8 2.1 0.0 17.3 0.0 1.4 3.4 0.0 0.0 1.7 0.0 0.9 9.7 0.3 0.2 23.3 0.3 20.1 1.9 0.1 0.0 0.0 9.3 0.0 0.0 6.2 2.5 3.6 6.9 2.2 0.0 0.0 0.9 0.0 0.2 0.0 21.9 0.1 0.0 19.4 3.1 84.6 25.0 0.5 1.7 6.9 2.3 0.9 NDNF "C4orf31, FLJ23191" ENSG00000173376 "Neuron derived neurotrophic factor" Q8TB73 4 121035613-121073021 "Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.6;retina: 41.0" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 229.3;Early spermatids: 225.6;Late spermatids: 164.5" "Cancer enhanced" "Detected in many" "lung cancer: 12.6" "Region enriched" "Detected in many" 4 "pons and medulla: 7.6" "Cell type enriched" "Detected in single" 11 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 23.2;U-266/70: 10.3;U-266/84: 39.6" "Group enriched" "Detected in many" 4 "basal ganglia: 11.4;olfactory region: 41.7" "Low region specificity" "Detected in all" HPA048881 Supported Vesicles "Secreted in other tissues" NA NA Vesicles "HPA048881: " "unprognostic (2.84e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" "unprognostic (6.65e-4)" "unprognostic (2.18e-3)" "unprognostic (6.27e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.38e-3)" "unprognostic (1.20e-1)" "unprognostic (1.18e-4)" "unprognostic (1.74e-1)" 3.8 1.3 1.2 0.4 1.0 0.0 14.2 0.6 1.5 7.2 3.5 1.2 1.7 1.3 3.1 2.2 5.7 10.0 6.9 4.9 1.2 1.5 12.5 0.5 91.6 0.1 1.8 1.2 21.3 0.6 0.4 8.2 28.0 7.6 26.1 4.0 41.0 2.1 2.2 7.5 1.8 3.9 2.6 5.5 0.4 2.2 8.0 0.8 7.0 1.6 9.0 1.4 8.9 11.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 7.0 5.7 0.1 0.1 0.2 0.1 0.2 0.7 0.0 0.0 0.0 23.2 0.4 0.0 0.0 0.0 0.5 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 6.9 0.4 0.0 0.0 0.0 0.4 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.3 0.1 0.0 0.0 5.7 0.0 0.1 0.2 10.3 39.6 0.0 1.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.6 1.5 1.2 1.5 1.8 1.2 7.6 0.8 229.3 38.7 0.0 0.0 1.0 69.0 1.6 15.3 22.7 52.4 12.2 17.7 0.2 0.0 0.0 225.6 11.7 0.0 0.0 0.2 0.0 3.1 0.0 2.3 0.0 0.1 1.6 1.7 4.3 0.0 164.5 3.1 0.4 5.0 0.0 0.2 15.1 0.1 0.0 0.7 0.0 18.7 0.0 3.3 7.5 4.7 0.6 0.5 0.0 1.2 0.0 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 100.6" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Cell line enriched" "Detected in some" 17 "U-87 MG: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" NA NA Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.1 1.1 0.7 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 41.2 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 12.4 0.0 0.0 0.0 0.0 100.6 0.7 0.0 9.2 0.0 3.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NDRG2 "KIAA1248, SYLD" ENSG00000165795 "NDRG family member 2" Q9UN36 14 21016763-21070872 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 310.5;skeletal muscle: 253.0" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 411.1;Leydig cells: 322.7;Muller glia cells: 402.9;Sertoli cells: 588.6" "Cancer enhanced" "Detected in all" "glioma: 78.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 10 "myeloid DC: 54.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 54.5" "Cell line enhanced" "Detected in many" "Hep G2: 27.9;HMC-1: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002896, HPA003590, CAB017491" Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA 150000 "Centriolar satellite" "Nucleoplasm, Cytosol" "CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458" "unprognostic (9.27e-3)" "unprognostic (2.97e-3)" "unprognostic (1.26e-2)" "unprognostic (5.09e-3)" "unprognostic (2.00e-2)" "unprognostic (2.92e-2)" "prognostic favorable (6.71e-4)" "unprognostic (1.85e-3)" "unprognostic (5.57e-2)" "unprognostic (3.46e-2)" "unprognostic (1.69e-1)" "unprognostic (5.10e-2)" "prognostic favorable (1.43e-12)" "unprognostic (1.46e-1)" "unprognostic (5.56e-2)" "unprognostic (6.11e-2)" "unprognostic (4.19e-2)" 19.3 45.3 140.2 4.8 135.1 1.4 50.3 93.5 110.0 35.5 21.0 89.6 23.8 12.2 30.7 44.4 37.3 29.5 21.5 45.2 103.6 86.1 24.3 84.8 13.7 7.7 128.9 73.5 79.7 15.5 35.6 6.0 8.1 95.4 23.7 18.8 8.9 310.5 37.3 253.0 18.9 12.0 22.0 73.0 21.1 11.2 5.2 71.2 0.4 13.6 53.4 16.1 13.9 19.3 1.8 54.5 0.4 1.8 0.7 5.4 4.0 5.3 1.1 3.4 6.4 0.5 0.0 0.5 0.1 2.2 2.0 1.1 7.4 10.0 0.3 2.0 0.1 3.2 8.8 15.3 3.1 2.7 0.0 5.5 6.9 1.2 27.9 0.7 0.6 20.0 6.1 6.7 0.4 0.9 3.2 0.0 6.3 13.9 0.6 0.3 4.5 2.4 1.9 9.1 17.3 0.4 7.1 0.3 1.6 3.8 13.6 0.0 9.9 1.5 1.7 7.0 9.3 13.5 4.0 0.0 0.6 10.9 0.2 0.2 3.1 2.2 0.1 0.9 0.1 2.3 0.0 1.8 0.2 2.4 0.4 3.2 1.8 3.6 3.3 54.5 1.3 5.4 4.0 0.4 0.7 0.0 1.9 2.4 4.0 140.2 135.1 93.5 110.0 103.6 86.1 128.9 73.5 95.4 71.2 0.0 14.8 8.5 70.8 25.4 6.7 160.9 140.1 20.1 13.6 38.4 9.8 8.0 411.1 69.3 4.7 52.6 25.5 0.0 18.9 0.6 20.1 71.2 47.4 183.0 19.8 3.2 32.1 116.6 25.7 5.9 322.7 43.4 305.4 6.4 71.2 402.9 14.6 28.8 156.3 32.0 12.8 588.6 188.5 1.1 3.4 26.6 18.1 10.1 86.6 132.0 NDRG3 ENSG00000101079 "NDRG family member 3" Q9UGV2 20 36651766-36746078 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.1" "Group enriched" "Detected in many" 10 "Early spermatids: 834.6;Late spermatids: 275.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017851, HPA018256" Enhanced NA NA "HPA017851: AB_1854340, HPA018256: AB_1854341" "unprognostic (4.59e-2)" "unprognostic (9.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.34e-2)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.56e-1)" "unprognostic (1.30e-2)" "unprognostic (5.42e-3)" "unprognostic (2.48e-3)" "unprognostic (3.52e-1)" "unprognostic (9.57e-2)" "unprognostic (2.66e-2)" "unprognostic (3.39e-1)" "unprognostic (3.98e-2)" "unprognostic (1.61e-1)" 6.4 16.6 24.6 6.7 31.9 3.6 9.5 62.1 59.7 12.2 8.9 11.3 6.4 9.6 11.7 8.5 8.8 10.1 8.0 15.5 26.2 22.2 9.6 4.0 8.5 8.4 20.3 19.8 14.8 6.6 18.5 14.3 5.8 62.1 29.5 11.3 11.3 8.4 9.4 9.3 8.7 8.3 12.8 15.6 8.9 6.9 33.1 12.6 4.3 8.0 5.2 10.6 8.0 6.8 10.5 8.7 11.3 8.5 21.2 14.7 7.9 17.9 10.2 13.4 7.9 14.2 15.6 4.4 7.6 9.2 13.0 12.8 19.6 9.4 9.2 8.9 15.4 20.5 16.9 17.2 26.7 14.8 6.8 12.8 25.6 14.5 21.8 7.4 6.6 8.1 14.6 15.5 11.0 3.2 14.9 16.3 16.5 9.9 19.8 11.5 6.7 9.1 9.3 4.0 22.9 17.9 8.0 21.1 6.7 15.3 8.4 11.9 10.2 11.8 52.1 11.3 11.3 24.2 5.9 7.1 12.7 8.3 5.0 9.4 9.3 7.7 5.9 23.7 11.6 6.7 5.1 5.4 11.3 13.9 7.4 14.6 10.5 14.7 13.2 8.7 7.6 12.6 13.0 8.5 21.2 8.5 4.4 14.0 7.9 24.6 31.9 62.1 59.7 26.2 22.2 20.3 19.8 62.1 12.6 20.8 5.8 13.3 13.1 9.8 50.4 21.4 12.7 10.7 5.7 7.0 47.1 8.2 23.2 12.8 834.6 12.2 11.2 0.0 12.2 10.4 8.2 14.4 5.7 4.4 22.2 20.6 7.0 12.3 23.7 275.8 25.6 10.3 11.8 5.4 6.6 19.8 11.9 7.0 26.2 9.5 57.7 25.8 21.1 24.2 20.4 6.8 5.7 15.3 12.1 10.0 NDRG4 "KIAA1180, SMAP-8" ENSG00000103034 "NDRG family member 4" Q9ULP0 16 58462846-58513628 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 389.7;Horizontal cells: 487.8" "Cancer enriched" "Detected in many" 6 "glioma: 23.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015313, HPA017587" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015313: AB_1854343, HPA017587: AB_1854344" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" "unprognostic (9.03e-3)" "unprognostic (1.59e-2)" "unprognostic (3.97e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-3)" "unprognostic (1.56e-1)" "unprognostic (6.07e-2)" "unprognostic (1.02e-1)" "unprognostic (4.84e-3)" "unprognostic (5.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.22e-2)" "unprognostic (8.51e-2)" "unprognostic (4.45e-2)" "unprognostic (7.17e-2)" 3.6 59.2 28.7 2.9 49.4 1.6 2.3 65.4 134.1 3.8 3.5 11.0 15.6 3.4 10.2 5.1 10.0 3.9 3.4 112.6 30.5 32.0 2.3 1.9 6.5 3.4 33.7 35.4 2.1 2.6 10.8 11.6 2.6 81.2 2.1 3.2 8.7 2.9 18.2 5.3 3.9 3.2 8.7 11.7 11.7 2.6 19.9 7.4 0.0 2.6 0.3 3.5 2.7 8.0 1.5 0.1 0.2 0.0 0.1 0.9 0.2 0.1 9.3 8.9 1.7 0.2 1.7 0.7 2.9 4.5 1.4 0.9 3.5 2.4 0.2 18.4 2.2 16.2 0.8 0.7 0.5 1.2 0.0 1.8 0.4 1.5 2.5 2.5 0.1 0.1 2.1 0.2 0.9 0.0 15.2 11.7 0.0 0.1 0.1 1.3 2.3 0.9 0.1 0.8 0.3 6.8 0.2 2.5 0.2 0.4 5.8 27.8 10.4 0.3 0.8 0.1 1.1 0.3 0.1 4.2 1.2 3.5 0.3 0.4 0.5 0.2 3.0 6.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.2 28.7 49.4 65.4 63.4 30.5 32.0 33.7 35.4 81.2 7.4 0.0 3.4 0.0 4.0 1.8 38.9 389.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 3.6 4.6 13.5 0.0 0.0 0.2 0.1 1.5 1.4 0.0 0.2 0.0 487.8 1.7 23.9 1.0 6.2 4.0 0.7 6.8 0.0 0.0 74.2 3.2 0.0 2.5 0.0 22.6 6.5 5.7 3.9 3.6 5.1 0.0 0.0 0.0 7.5 NDST3 HSST3 ENSG00000164100 "N-deacetylase and N-sulfotransferase 3" O95803 4 118033618-118258648 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 20.2;Horizontal cells: 6.4;Kupffer cells: 27.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7" "Cell type enhanced" "Detected in some" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "MOLT-4: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056189 Uncertain NA NA "HPA056189: AB_2683061" "unprognostic (1.95e-2)" "unprognostic (7.58e-2)" "unprognostic (4.34e-3)" "unprognostic (2.55e-7)" "unprognostic (4.05e-2)" "unprognostic (2.18e-2)" "unprognostic (2.86e-3)" "unprognostic (2.32e-2)" "unprognostic (1.87e-1)" "unprognostic (1.46e-2)" "unprognostic (7.43e-2)" "unprognostic (1.99e-2)" "unprognostic (1.09e-3)" "unprognostic (1.37e-1)" "unprognostic (4.39e-3)" "unprognostic (6.83e-2)" "unprognostic (8.85e-2)" 0.3 2.0 3.2 0.3 17.0 0.6 0.3 22.2 6.9 2.1 0.4 0.0 0.0 0.3 0.4 0.2 0.3 1.3 0.4 0.3 2.3 2.0 0.9 4.6 0.4 0.6 0.9 1.7 0.6 0.2 0.2 7.6 0.4 1.7 0.5 0.4 1.3 0.2 1.2 0.3 0.4 0.4 0.4 0.6 6.8 1.0 0.5 2.4 6.8 0.6 0.0 0.4 0.3 0.3 0.3 0.4 1.3 0.2 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.9 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.9 1.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 1.3 0.4 0.1 0.4 0.0 0.0 3.2 17.0 22.2 5.7 2.3 2.0 0.9 1.7 1.7 2.4 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 6.4 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NDST4 ENSG00000138653 "N-deacetylase and N-sulfotransferase 4" Q9H3R1 4 114827763-115113876 "Enzymes, Predicted intracellular proteins" "Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 17 "pons and medulla: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011129 Uncertain NA NA "HPA011129: AB_1079460" "unprognostic (5.58e-2)" "unprognostic (5.90e-2)" "unprognostic (4.82e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (6.55e-2)" 0.1 0.0 1.3 0.0 1.7 0.0 0.1 0.2 3.4 1.4 0.3 0.3 0.3 0.1 1.5 0.0 0.1 0.1 0.3 0.1 0.7 1.9 0.1 0.0 0.1 0.0 1.3 1.4 5.7 0.1 0.0 0.6 0.0 34.6 1.5 0.1 0.0 0.5 0.6 0.1 0.2 0.1 1.6 1.0 2.5 1.1 0.7 0.0 0.0 0.1 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 0.2 1.7 0.7 1.9 1.3 1.4 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NDUFA1 "CI-MWFE, MWFE" ENSG00000125356 "NADH:ubiquinone oxidoreductase subunit A1" O15239 X 119871487-119876662 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 144.8;skeletal muscle: 138.8" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3052.5;Distal tubular cells: 1856.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029768, HPA054359" Enhanced Approved Mitochondria,Cytosol No No "Mitochondria, Cytosol" "HPA029768: AB_2673192, HPA054359: AB_2682461" "unprognostic (1.72e-1)" "unprognostic (3.00e-3)" "unprognostic (3.12e-2)" "unprognostic (1.17e-1)" "unprognostic (1.74e-1)" "unprognostic (7.34e-3)" "unprognostic (1.56e-1)" "unprognostic (8.20e-3)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (8.11e-3)" "unprognostic (4.77e-2)" "prognostic favorable (3.48e-4)" "unprognostic (1.16e-1)" "unprognostic (3.62e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-3)" 24.5 30.1 37.9 20.1 42.5 25.2 23.8 27.9 37.8 19.7 38.4 8.7 27.3 41.0 13.5 25.8 21.6 15.9 24.8 144.8 30.1 28.5 46.0 40.2 21.1 22.2 34.6 32.8 14.6 40.4 22.7 21.7 15.4 29.5 17.9 31.1 15.5 38.4 29.6 138.8 12.1 34.6 19.3 31.5 17.1 28.1 7.7 21.1 9.2 16.2 67.4 16.7 14.0 14.9 66.3 90.5 96.3 85.7 49.8 75.5 73.8 33.6 36.4 26.0 27.7 31.4 19.9 32.6 26.6 24.3 18.7 23.4 20.3 28.2 27.5 41.1 27.8 40.0 32.5 36.5 25.6 21.5 37.9 50.4 28.5 66.4 45.5 24.4 43.5 31.7 32.4 34.8 19.9 15.5 30.6 23.2 28.1 15.5 42.7 25.7 59.6 30.9 41.2 38.4 87.9 65.0 31.3 24.8 82.5 56.4 48.0 19.0 25.1 54.7 67.9 36.5 36.6 17.2 51.3 29.9 16.0 16.2 33.2 51.9 39.4 48.8 35.9 29.0 51.7 19.7 96.3 79.0 91.6 60.2 80.4 57.1 66.3 67.1 62.8 84.0 52.7 56.1 65.7 94.6 49.8 85.7 90.5 75.5 73.8 37.9 42.5 27.9 37.8 30.1 28.5 34.6 32.8 29.5 21.1 148.9 173.3 221.0 195.7 189.9 139.0 3052.5 636.9 330.6 205.9 533.9 74.6 331.6 1856.9 408.0 28.1 249.5 1244.9 256.9 444.8 351.6 251.4 215.4 204.5 881.4 567.3 77.9 441.2 254.8 408.9 27.3 272.7 346.6 541.6 587.1 745.3 168.3 446.0 706.9 268.0 1089.7 161.0 213.4 269.6 46.1 78.8 217.9 318.3 243.7 663.1 282.7 NDUFA12 "B17.2, DAP13" ENSG00000184752 "NADH:ubiquinone oxidoreductase subunit A12" Q9UI09 12 94897055-95003770 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Group enriched" "Detected in all" 5 "Cardiomyocytes: 2083.1;Distal tubular cells: 525.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039903 Supported Supported Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA039903: AB_10795516" "unprognostic (2.76e-1)" "unprognostic (5.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.56e-2)" "unprognostic (2.85e-1)" "unprognostic (4.03e-2)" "unprognostic (3.05e-2)" "unprognostic (6.68e-2)" "unprognostic (1.67e-1)" "unprognostic (2.47e-2)" "unprognostic (1.89e-1)" "unprognostic (1.64e-1)" "unprognostic (3.13e-3)" "unprognostic (2.32e-1)" "unprognostic (1.65e-1)" "unprognostic (6.13e-2)" "unprognostic (3.27e-2)" 24.0 24.8 36.0 17.9 36.8 19.7 19.7 27.2 36.5 17.9 35.5 12.5 20.0 27.4 17.0 21.9 23.3 19.4 14.4 82.8 31.2 32.0 33.2 34.6 18.1 20.1 37.0 29.9 17.0 18.4 22.3 22.4 21.1 31.3 19.1 35.7 13.1 18.7 20.7 129.0 17.4 26.7 24.0 24.2 23.9 20.9 14.2 23.5 21.0 27.9 40.0 28.1 21.9 21.4 60.8 78.4 69.7 67.9 59.1 93.8 100.6 41.6 45.3 37.9 26.9 31.1 29.0 28.2 19.9 29.3 43.5 39.5 55.9 21.5 47.9 11.8 30.4 24.1 31.5 38.9 45.9 49.4 41.3 46.7 40.1 37.8 56.3 32.0 56.8 49.0 31.1 58.0 36.4 44.7 45.5 35.6 41.7 37.4 22.3 42.1 60.4 39.3 87.8 28.7 51.2 78.9 30.1 32.8 54.6 42.6 62.6 36.1 21.9 33.7 49.2 25.8 34.2 48.6 37.4 40.6 23.1 23.5 33.5 33.8 36.4 54.0 73.1 13.9 47.6 35.2 69.7 59.5 29.8 52.1 67.9 48.2 60.8 71.6 62.5 78.4 50.7 93.8 68.6 8.6 59.1 63.3 48.0 74.8 100.6 36.0 36.8 27.2 36.5 31.2 32.0 37.0 29.9 31.3 23.5 68.5 58.6 79.6 121.2 96.5 65.8 2083.1 160.5 77.6 45.5 102.9 60.9 215.5 525.6 141.2 192.8 157.8 177.2 46.7 143.2 214.5 94.4 120.9 56.6 123.1 168.7 35.0 81.9 98.8 95.5 70.6 90.3 125.9 151.8 218.2 146.8 79.4 169.8 188.7 125.5 242.6 113.4 103.5 149.9 130.8 119.2 111.7 175.3 96.5 189.4 182.6 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.3;testis: 140.2" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 2344.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria NA NA Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 17.9 16.9 20.0 11.7 23.9 15.4 14.4 20.7 25.2 11.0 19.2 8.7 16.5 16.5 9.7 19.6 12.2 11.7 12.9 68.0 16.4 13.9 18.9 20.8 8.4 11.9 19.9 22.3 10.6 17.8 10.6 12.1 12.1 20.0 12.9 11.9 9.8 15.2 15.5 79.7 9.5 14.9 12.1 13.4 10.1 15.0 140.2 16.2 7.6 11.3 28.1 8.4 9.6 10.2 73.7 74.9 61.4 76.8 44.8 72.7 116.3 33.1 24.5 45.3 45.0 46.2 37.5 42.5 39.5 43.8 44.6 43.5 39.7 49.8 44.1 93.0 47.6 27.8 27.0 32.0 42.9 18.4 26.9 72.4 33.7 39.1 48.6 41.3 63.3 47.6 50.3 39.0 31.2 36.0 31.5 32.0 51.6 37.2 63.2 35.4 65.9 75.1 62.9 46.1 85.3 68.2 43.1 29.4 67.4 65.0 47.6 43.0 54.4 40.2 47.4 39.3 26.4 29.3 87.2 33.3 43.7 14.8 50.9 49.0 45.0 35.4 47.5 38.5 49.2 31.9 61.4 76.8 57.8 51.2 72.9 45.5 73.7 58.9 56.0 74.9 60.5 56.9 51.1 26.9 44.8 60.8 61.2 72.7 116.3 20.0 23.9 20.7 25.2 16.4 13.9 19.9 22.3 20.0 16.2 122.1 153.3 217.5 53.6 114.6 57.3 436.5 216.6 210.1 204.8 237.3 23.6 341.6 517.3 485.5 369.3 147.4 952.4 140.2 502.5 299.6 215.0 71.6 253.9 389.3 292.2 39.7 534.5 181.7 314.3 2344.2 142.1 234.7 249.7 531.2 516.2 105.2 438.1 641.8 121.3 667.2 59.7 90.5 183.3 59.7 92.9 111.0 416.8 195.8 508.5 65.7 NDUFA4 "CI-9k, MLRQ" ENSG00000189043 "NDUFA4, mitochondrial complex associated" O00483 7 10931951-10940256 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 149.9;skeletal muscle: 151.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 3966.4;Distal tubular cells: 3355.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055323, HPA078265" Approved Approved Mitochondria NA NA 18000 Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favorable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 21.9 22.0 72.8 13.6 55.3 19.8 27.0 33.1 74.4 20.5 18.3 12.0 16.8 25.1 16.9 29.6 15.8 20.2 16.7 149.9 56.1 32.1 46.2 46.7 15.9 13.5 47.6 48.9 17.1 23.7 18.9 5.6 11.4 33.0 23.1 20.4 14.1 36.0 31.1 151.6 12.1 17.3 21.4 26.3 13.6 23.6 7.4 23.2 6.8 20.4 60.1 15.6 15.8 11.6 29.0 41.1 52.8 39.6 21.7 37.5 48.0 11.4 19.7 33.6 38.7 19.1 18.0 15.5 14.5 13.8 13.7 12.1 24.7 31.5 22.4 13.9 20.9 37.5 20.3 22.3 17.3 15.0 11.0 16.3 18.7 23.2 23.0 16.7 25.8 18.5 19.3 17.4 16.7 14.8 26.1 19.0 20.2 27.8 30.5 28.5 22.1 11.5 22.7 36.8 78.1 40.0 15.6 24.0 25.1 34.7 24.9 21.1 21.9 23.1 66.5 13.1 49.0 42.0 31.7 16.6 16.3 22.6 23.4 24.0 18.5 23.6 25.7 22.6 27.9 50.7 52.8 32.5 44.4 23.4 38.6 27.4 29.0 32.7 29.3 41.1 22.0 34.1 29.7 7.4 21.7 39.6 38.5 37.5 48.0 72.8 55.3 33.1 74.4 56.1 32.1 47.6 48.9 33.0 23.2 455.6 386.9 389.1 472.6 361.6 472.0 3966.4 996.2 704.0 533.5 903.7 251.3 756.7 3355.6 748.9 115.7 549.6 532.5 186.9 833.3 599.3 543.2 716.7 552.0 1498.2 844.7 149.4 201.3 748.3 552.8 81.7 457.0 587.9 868.9 625.8 610.1 384.0 636.5 584.4 737.2 2069.7 472.4 329.8 932.8 105.9 274.8 422.2 550.9 350.3 618.2 678.3 NDUFA4L2 "FLJ26118, NUOMS" ENSG00000185633 "NDUFA4, mitochondrial complex associated like 2" Q9NRX3 12 57234903-57240715 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 82.5;skin 1: 93.4" "Group enriched" "Detected in many" 4 "Muller glia cells: 315.5;Sertoli cells: 1112.4;Smooth muscle cells: 398.4" "Cancer enhanced" "Detected in all" "renal cancer: 356.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4;T-reg: 2.8" "Group enriched" "Detected in many" 24 "B-cells: 2.4;T-cells: 2.8" "Cell line enriched" "Detected in many" 7 "AN3-CA: 55.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA055323, HPA078265" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.25e-1)" "unprognostic (1.60e-1)" "unprognostic (2.11e-3)" "unprognostic (3.23e-3)" "unprognostic (5.06e-2)" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (3.53e-1)" "unprognostic (6.67e-2)" "unprognostic (5.79e-2)" "unprognostic (2.13e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.10e-3)" "unprognostic (1.31e-1)" "unprognostic (6.41e-2)" "unprognostic (2.74e-2)" 24.5 9.6 8.3 4.9 15.5 1.3 11.5 7.7 10.4 19.1 4.4 8.3 1.1 4.6 4.6 5.4 82.5 3.6 11.0 30.9 9.8 7.3 5.4 4.2 12.7 4.6 10.9 10.7 6.1 6.7 4.6 6.2 42.7 13.2 6.8 2.4 13.7 10.3 7.4 19.0 93.4 4.7 5.6 5.6 29.9 4.3 3.0 8.9 0.7 12.0 14.8 11.9 10.2 31.4 2.4 0.1 0.0 0.0 0.0 2.8 0.3 0.3 0.5 0.1 55.4 2.3 1.3 0.1 0.8 0.6 0.2 0.5 0.0 0.6 2.2 2.3 0.8 0.0 0.4 0.3 0.4 0.0 1.2 0.1 0.2 0.1 0.0 7.9 1.6 0.8 5.1 1.0 0.1 2.0 0.3 0.0 3.1 0.2 2.9 0.1 1.1 0.4 0.0 0.1 0.2 1.0 0.8 0.4 4.2 0.0 0.0 3.0 1.0 0.1 0.1 1.8 0.0 0.6 5.8 0.2 0.5 0.0 0.4 0.2 4.2 1.3 1.0 2.0 3.9 0.3 0.0 0.0 0.0 0.6 0.0 0.0 2.4 0.7 0.0 0.1 0.4 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.3 8.3 15.5 7.7 10.4 9.8 7.3 10.9 10.7 13.2 8.9 0.0 0.3 0.9 0.7 134.3 28.0 0.8 0.0 0.0 0.0 0.0 17.7 0.8 0.0 1.0 1.0 3.6 0.0 0.0 0.0 0.8 18.6 1.5 9.2 0.0 1.5 11.1 0.0 4.9 0.0 1.3 2.8 1.4 28.7 1.8 0.0 315.5 7.7 0.0 2.1 0.0 17.5 1112.4 398.4 8.1 0.9 141.0 0.9 0.0 0.0 0.9 NDUFA7 B14.5a ENSG00000267855 "NADH:ubiquinone oxidoreductase subunit A7" O95182 19 8308768-8321396 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.6" "Cell type enhanced" "Detected in many" 4 "monocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA059251, HPA071866" Enhanced Supported Mitochondria NA NA Mitochondria "HPA059251: AB_2683960, HPA071866: AB_2686465" "unprognostic (6.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (3.85e-1)" "unprognostic (2.18e-1)" "unprognostic (5.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.43e-2)" "unprognostic (3.40e-1)" "unprognostic (1.13e-3)" "unprognostic (1.81e-2)" "unprognostic (1.43e-1)" "unprognostic (1.09e-2)" "unprognostic (5.53e-2)" "unprognostic (1.29e-2)" "unprognostic (2.59e-2)" "unprognostic (9.35e-3)" 17.7 30.0 28.0 15.5 30.5 15.3 18.9 15.4 32.0 9.0 17.2 11.3 15.7 12.6 9.9 32.1 18.9 26.2 16.1 69.1 22.1 21.0 26.5 30.9 20.3 22.1 25.9 19.7 10.1 28.5 11.9 30.2 13.0 26.7 20.5 17.6 16.7 23.0 20.7 110.6 16.2 16.0 13.1 18.5 14.7 19.3 13.8 11.1 19.3 22.0 47.5 16.8 14.3 9.1 30.6 65.5 25.1 39.7 24.9 33.5 26.7 15.4 13.2 16.8 8.7 11.5 6.1 9.5 4.4 5.7 16.6 11.1 13.9 13.1 8.7 6.8 10.6 9.5 13.4 7.6 23.2 7.8 22.8 48.1 6.4 20.3 33.0 17.9 9.7 8.9 12.4 15.1 8.9 8.2 13.4 19.3 42.1 11.0 45.4 20.6 16.8 18.5 48.1 13.6 30.4 50.4 10.3 3.1 18.9 33.7 9.2 14.1 10.8 6.4 19.8 11.0 9.9 7.5 16.0 5.7 9.3 7.5 13.0 12.5 17.8 13.7 10.4 13.3 16.8 14.6 14.2 38.9 25.1 22.6 39.7 24.4 29.9 24.7 22.2 47.9 30.6 24.1 23.4 9.7 24.9 34.4 65.5 33.5 26.7 28.0 30.5 15.4 32.0 22.1 21.0 25.9 19.7 26.7 11.1 41.7 57.7 13.4 8.7 0.0 12.0 0.0 28.1 129.8 37.5 50.6 5.9 55.6 84.6 128.2 25.6 8.7 82.6 23.3 137.5 37.8 2.0 14.6 19.8 58.9 45.6 7.9 84.3 27.6 40.8 12.2 12.4 28.3 0.0 190.2 132.6 19.5 142.9 146.3 12.4 67.1 13.2 6.5 0.0 18.4 23.7 0.0 39.2 27.7 136.7 10.8 NDUFA8 "MGC793, PGIV" ENSG00000119421 "NADH:ubiquinone oxidoreductase subunit A8" P51970 9 122144058-122159819 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 105.4" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 528.1;Distal tubular cells: 520.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041510, HPA041600" Enhanced Supported Mitochondria NA NA 14000 Mitochondria "HPA041510: AB_10794379, HPA041600: AB_10796778" "unprognostic (2.90e-1)" "unprognostic (2.27e-3)" "unprognostic (3.58e-1)" "unprognostic (3.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-2)" "unprognostic (2.33e-2)" "unprognostic (6.98e-2)" "unprognostic (1.46e-2)" "unprognostic (4.12e-2)" "prognostic favorable (4.17e-6)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (4.62e-2)" 15.4 20.0 35.9 9.5 40.5 7.3 16.5 18.8 36.8 14.2 23.4 12.4 19.6 19.4 12.6 26.9 17.0 18.9 16.9 105.4 32.3 27.5 29.0 23.6 10.9 11.2 31.3 30.3 11.3 16.8 21.8 15.3 14.1 22.4 17.9 26.6 14.6 25.1 19.7 68.3 11.1 17.4 22.0 19.1 10.9 18.0 25.1 16.8 10.0 18.5 30.9 15.8 15.6 15.3 29.7 39.7 22.2 34.3 25.5 30.8 24.3 17.9 33.3 22.1 29.1 23.9 22.0 27.4 21.0 24.9 28.8 24.3 42.2 17.9 26.3 20.8 24.5 52.6 45.3 41.8 45.3 28.4 25.8 28.9 20.7 55.9 36.4 25.8 36.5 21.4 24.0 44.3 28.8 18.5 26.5 41.2 29.5 31.5 19.8 32.8 45.7 22.6 23.8 20.2 81.0 64.2 18.2 34.9 38.3 41.4 25.0 38.3 15.1 32.9 39.1 26.0 23.6 41.4 17.6 26.7 16.0 16.1 30.0 23.4 22.4 36.1 26.0 33.3 23.7 26.4 5.1 29.4 22.2 29.1 34.3 27.8 29.7 27.0 28.4 38.1 29.3 29.0 30.5 4.8 25.5 28.8 39.7 30.8 24.3 35.9 40.5 18.8 36.8 32.3 27.5 31.3 30.3 22.4 16.8 26.8 30.2 50.6 59.9 42.8 43.3 528.1 56.0 69.6 48.9 78.5 27.5 106.7 520.6 91.1 282.6 89.5 102.7 46.7 88.4 95.7 43.5 75.0 19.7 93.1 108.4 42.9 74.3 58.3 41.0 68.2 52.3 46.0 89.4 88.4 92.7 52.1 87.8 87.7 70.7 161.2 38.8 25.8 56.7 227.6 125.0 49.7 105.8 45.0 118.7 71.0 NDUFA9 "CI-39k, NDUFS2L, SDR22E1" ENSG00000139180 "NADH:ubiquinone oxidoreductase subunit A9" Q16795 12 4649095-4694317 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 66.6" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042268, HPA073212" Supported Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA042268: AB_2677922, HPA073212: AB_2686581" "unprognostic (2.26e-1)" "unprognostic (7.85e-3)" "unprognostic (3.67e-2)" "unprognostic (1.84e-1)" "unprognostic (2.41e-2)" "unprognostic (7.58e-2)" "unprognostic (9.64e-3)" "unprognostic (3.02e-1)" "unprognostic (2.06e-1)" "unprognostic (1.25e-1)" "unprognostic (3.45e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.57e-7)" "unprognostic (7.80e-2)" "unprognostic (1.71e-1)" "unprognostic (1.93e-2)" "prognostic favorable (5.75e-4)" 10.7 13.2 11.0 10.1 17.8 21.2 11.7 15.3 20.7 9.2 22.1 12.0 8.6 20.9 10.1 11.0 13.4 8.4 8.5 41.3 11.6 11.0 23.7 22.1 8.5 11.8 12.7 9.9 8.4 10.4 10.4 12.2 9.5 16.2 9.9 22.7 12.1 13.3 10.1 66.6 10.6 18.9 11.7 8.3 11.5 13.6 5.8 9.3 14.4 10.2 30.7 12.8 8.2 8.8 36.8 43.5 14.6 41.5 25.8 35.9 59.6 10.9 19.8 9.8 13.0 7.2 7.2 28.3 8.4 8.5 16.3 12.4 42.9 22.1 12.4 4.5 9.1 18.4 18.5 14.1 12.4 10.6 24.0 24.8 12.1 21.1 32.4 15.8 17.6 13.1 9.2 12.1 11.1 15.1 10.1 12.2 17.8 8.4 23.5 12.0 21.3 17.6 20.3 25.2 20.7 16.5 24.9 14.4 12.9 22.4 25.1 7.1 8.0 10.6 28.5 14.7 22.2 5.9 16.9 8.5 12.4 25.2 11.3 19.4 4.6 5.4 20.5 13.0 11.0 13.6 14.6 35.8 13.3 27.7 41.5 28.0 36.8 29.0 30.2 42.3 26.2 25.3 26.2 3.1 25.8 32.2 43.5 35.9 59.6 11.0 17.8 15.3 20.7 11.6 11.0 12.7 9.9 16.2 9.3 26.8 28.0 46.2 52.9 43.0 46.1 165.0 50.9 41.5 36.4 61.1 55.0 100.9 140.9 108.0 102.8 42.7 83.0 23.3 114.3 98.5 39.0 37.2 56.6 65.2 101.8 31.8 45.5 34.4 33.6 461.4 26.2 46.0 52.3 57.7 92.6 40.4 94.0 94.8 34.6 133.6 48.3 19.4 42.6 28.8 28.1 41.3 83.5 45.7 120.3 64.7 NDUFAB1 "ACP, ACP1, FASN2A, SDAP" ENSG00000004779 "NADH:ubiquinone oxidoreductase subunit AB1" O14561 16 23581002-23596356 "Predicted intracellular proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 118.2;skeletal muscle: 112.0" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 1253.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054364, HPA076020" Approved Supported Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA054364: AB_2682463, HPA076020: " "unprognostic (3.33e-3)" "unprognostic (9.38e-2)" "unprognostic (1.14e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-1)" "unprognostic (5.71e-2)" "unprognostic (1.22e-1)" "unprognostic (5.97e-2)" "unprognostic (1.97e-1)" "unprognostic (7.57e-2)" "unprognostic (3.89e-1)" "unprognostic (5.60e-2)" "prognostic favorable (1.94e-7)" "unprognostic (1.77e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (3.16e-1)" 21.6 25.5 29.4 14.8 28.0 15.1 20.4 21.2 37.7 13.4 31.2 11.4 16.2 30.2 13.7 15.5 19.4 16.2 17.4 118.2 24.1 25.6 32.5 38.8 12.0 15.2 27.0 21.6 10.9 29.1 21.9 18.6 15.2 23.3 16.0 26.5 15.3 24.3 19.2 112.0 12.4 25.7 18.1 15.5 14.0 20.1 11.4 11.5 14.5 15.8 54.3 16.7 13.4 12.7 39.3 61.8 17.4 49.3 25.0 39.5 43.1 28.2 20.9 26.2 23.3 18.7 20.2 36.4 21.8 16.2 22.0 18.1 18.1 23.0 46.8 35.8 15.7 27.4 23.4 45.5 25.9 17.5 26.5 52.6 25.1 37.5 88.9 19.6 46.6 20.9 18.8 36.0 16.2 17.5 20.7 27.9 42.3 52.6 23.8 23.8 42.8 36.0 70.9 68.0 42.2 48.6 49.6 29.5 63.7 20.2 25.4 36.0 28.1 24.4 44.7 40.7 30.1 36.1 39.0 21.9 20.2 21.2 19.5 29.9 30.4 44.2 52.5 22.6 37.7 22.8 15.1 43.1 17.4 31.7 49.3 34.6 39.3 37.7 35.0 55.2 34.6 35.2 36.5 8.9 25.0 38.0 61.8 39.5 43.1 29.4 28.0 21.2 37.7 24.1 25.6 27.0 21.6 23.3 11.5 92.3 83.8 96.1 105.6 108.4 80.0 1253.7 109.5 175.3 81.9 106.4 43.2 246.2 600.2 140.5 81.4 113.0 204.9 70.0 182.7 251.9 115.6 117.8 83.1 281.9 233.1 49.3 194.3 96.3 110.6 24.0 89.8 100.2 148.5 155.9 210.6 118.9 192.1 168.4 114.2 541.1 90.3 90.5 123.0 114.6 115.3 124.3 187.8 90.6 317.0 150.7 NDUFAF5 "C20orf7, dJ842G6.1" ENSG00000101247 "NADH:ubiquinone oxidoreductase complex assembly factor 5" Q5TEU4 20 13784950-13821582 "Disease related genes, Predicted intracellular proteins" "Methyltransferase, Oxidoreductase, Transferase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.3" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051184 Uncertain NA NA "HPA051184: AB_2681377" "unprognostic (3.81e-1)" "unprognostic (1.27e-2)" "unprognostic (4.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.32e-1)" "unprognostic (8.22e-2)" "unprognostic (1.68e-2)" "unprognostic (3.14e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-1)" "unprognostic (1.74e-3)" "unprognostic (2.41e-2)" "prognostic favorable (2.27e-6)" "unprognostic (5.38e-2)" "unprognostic (5.89e-2)" "unprognostic (6.88e-2)" "unprognostic (1.58e-2)" 6.8 6.4 8.3 4.2 11.1 10.4 4.5 10.0 13.8 3.6 6.3 4.4 3.5 7.8 4.8 4.3 5.2 3.7 3.8 15.0 6.1 6.1 8.1 7.8 3.8 3.5 6.0 7.4 3.4 5.8 3.7 5.1 5.0 8.6 5.0 6.0 4.4 4.4 5.0 34.3 5.3 6.7 6.8 5.5 3.8 6.2 6.0 6.8 4.2 3.5 9.4 4.1 5.5 4.1 5.2 7.3 7.5 5.4 6.9 5.6 2.5 5.9 5.9 7.2 4.9 5.7 1.7 3.6 4.5 3.4 5.9 4.9 13.1 4.5 10.1 4.5 4.5 11.0 8.2 13.3 8.6 4.8 4.7 7.6 9.0 3.9 16.3 7.3 7.9 4.5 3.4 6.2 7.1 4.7 2.6 5.0 9.7 7.0 5.0 5.6 7.8 11.2 7.2 2.5 6.8 6.4 7.5 8.8 6.2 6.6 8.0 7.2 7.3 4.8 13.1 13.8 2.4 6.5 5.6 5.3 7.0 3.6 5.9 6.9 5.6 8.4 8.2 3.0 3.4 7.1 2.3 4.4 7.5 5.6 5.4 3.7 5.2 4.5 3.5 6.0 5.1 5.1 5.0 1.3 6.9 3.9 7.3 4.8 2.5 8.3 11.1 10.0 13.8 6.1 6.1 6.0 7.4 8.6 6.8 0.0 12.8 8.0 9.4 5.6 42.1 36.2 5.1 8.1 2.3 10.4 25.5 13.9 24.9 10.7 58.7 7.0 9.3 0.0 4.9 6.7 8.3 6.8 7.0 9.4 11.8 11.1 12.0 4.9 10.0 6.8 6.4 8.8 1.7 6.4 10.4 12.6 9.0 7.0 11.7 24.9 23.2 0.0 9.5 25.0 25.0 6.5 12.2 10.1 10.1 11.0 NDUFAF7 "C2orf56, MidA, PRO1853" ENSG00000003509 "NADH:ubiquinone oxidoreductase complex assembly factor 7" Q7L592 2 37231631-37253403 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.4" "Group enriched" "Detected in many" 4 "Early spermatids: 139.4;Late spermatids: 75.9;Spermatocytes: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045217 Uncertain NA NA "HPA045217: AB_10960395" "unprognostic (6.38e-2)" "unprognostic (2.92e-2)" "unprognostic (2.13e-1)" "unprognostic (1.38e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.48e-4)" "prognostic favorable (3.08e-4)" "unprognostic (5.44e-2)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (8.12e-3)" "unprognostic (5.94e-2)" "unprognostic (3.48e-2)" "unprognostic (1.03e-1)" "unprognostic (5.73e-2)" "unprognostic (8.67e-3)" 7.1 14.3 10.1 7.5 15.9 7.3 8.3 24.1 17.0 9.3 12.6 7.7 6.1 6.4 10.0 11.0 6.7 6.4 8.1 18.3 9.4 9.7 12.2 13.5 6.6 8.3 9.4 10.5 8.8 7.6 9.4 15.2 7.9 14.5 7.7 8.1 7.8 7.0 7.9 21.0 5.8 7.3 9.8 7.2 7.8 7.1 44.4 10.5 8.2 6.4 6.5 7.5 7.8 7.2 8.9 9.9 5.3 8.1 6.9 8.3 4.1 15.8 8.5 10.7 9.6 6.9 14.8 6.0 5.1 8.5 9.1 11.7 18.1 6.8 13.5 6.7 4.9 15.5 11.9 13.2 6.7 10.8 9.2 9.7 9.9 10.6 16.4 8.6 9.7 5.1 11.5 11.3 7.6 4.7 9.8 14.2 5.0 12.1 9.1 5.3 5.9 9.8 10.7 14.2 12.4 7.3 8.9 8.4 11.3 12.8 6.0 11.3 9.1 6.7 11.4 11.3 16.0 6.9 4.0 2.8 7.7 10.3 9.4 9.6 8.0 4.6 15.2 11.2 13.5 6.5 4.6 8.1 4.5 8.3 7.0 3.8 8.9 7.4 7.1 9.9 7.8 7.4 6.4 5.3 6.9 4.9 8.1 8.3 4.1 10.1 15.9 24.1 17.0 9.4 9.7 9.4 10.5 14.5 10.5 8.9 7.7 11.5 8.2 4.2 17.7 12.0 2.5 13.4 6.8 10.4 21.6 12.3 14.9 9.1 139.4 7.1 4.5 0.0 5.6 8.6 8.0 5.2 7.0 5.9 8.4 11.1 2.4 8.0 8.6 75.9 12.4 11.2 3.3 10.8 5.0 8.1 7.9 0.0 15.6 11.1 20.9 6.5 8.9 47.1 14.2 3.4 9.6 10.0 6.4 5.3 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 161.6" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 2033.2;Hepatocytes: 1436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 38.3 48.3 47.8 22.4 43.1 30.2 22.1 30.9 53.6 12.4 39.7 13.4 28.1 36.4 14.8 39.2 23.2 15.9 20.0 142.2 38.4 35.7 51.2 64.6 28.1 24.9 40.6 36.0 16.5 48.5 9.9 30.6 13.2 41.8 19.3 26.9 22.9 54.1 35.9 161.6 12.6 32.9 25.9 31.3 19.3 29.4 10.0 26.4 11.9 21.6 48.9 21.3 17.1 16.3 61.7 98.6 116.1 93.9 45.1 70.1 95.0 27.1 55.1 44.7 28.8 29.3 21.9 20.5 33.5 18.9 19.9 18.4 33.2 46.3 24.5 31.2 18.7 29.1 34.0 25.6 27.2 18.0 38.6 58.5 47.5 86.5 39.5 23.3 37.5 27.2 27.0 16.5 20.8 18.4 47.1 17.7 47.1 25.8 50.5 27.2 102.8 37.0 33.6 22.6 103.1 67.5 33.1 42.5 36.4 49.6 67.3 29.9 21.7 65.6 40.0 42.6 39.3 59.8 58.6 39.5 12.7 24.1 25.3 22.3 40.0 62.3 54.5 38.2 27.8 26.2 58.1 93.9 67.8 43.7 63.5 50.2 61.7 64.7 49.8 82.6 52.0 65.4 60.4 116.1 45.1 58.1 98.6 70.1 95.0 47.8 43.1 30.9 53.6 38.4 35.7 40.6 36.0 41.8 26.4 154.9 246.4 237.3 88.1 114.4 72.8 2033.2 565.6 282.4 178.6 369.9 37.3 225.4 988.2 197.4 98.7 145.0 655.0 280.4 371.9 86.0 164.5 117.3 207.1 1436.2 359.0 52.4 305.2 426.6 707.7 29.0 243.1 282.3 315.5 296.6 433.5 108.9 268.5 512.0 226.7 864.5 130.9 219.9 185.4 133.6 144.5 153.9 172.1 204.2 467.2 90.1 NDUFB10 PDSW ENSG00000140990 "NADH:ubiquinone oxidoreductase subunit B10" O96000 16 1959508-1961975 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 280.4" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1107.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073189 Supported NA NA "HPA073189: AB_2686579" "unprognostic (3.56e-1)" "prognostic favorable (7.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.22e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (7.84e-2)" "unprognostic (1.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.44e-1)" "prognostic favorable (9.43e-6)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (4.43e-1)" "unprognostic (8.76e-2)" 21.6 20.3 29.0 18.3 30.9 15.6 23.5 21.0 32.2 18.2 31.3 17.0 22.2 32.3 18.8 22.9 22.1 18.9 22.0 97.1 26.9 20.1 28.8 33.9 13.0 22.3 27.7 28.7 15.4 29.8 26.3 13.3 15.1 20.1 18.9 28.2 17.9 32.0 24.2 280.4 16.8 27.8 27.5 18.9 15.7 25.2 19.2 15.6 16.6 20.0 73.7 17.3 20.1 17.7 64.6 84.7 66.6 75.5 51.8 84.8 80.2 17.4 51.4 24.7 29.6 24.9 23.7 25.6 21.8 26.4 25.3 17.4 37.8 23.7 35.6 37.3 27.9 13.5 37.3 27.2 33.3 19.1 32.6 101.2 27.5 40.7 42.8 32.0 44.3 26.6 26.6 30.2 24.4 27.4 27.3 29.3 31.9 25.6 35.0 32.1 72.9 52.2 46.2 31.7 46.6 58.6 61.7 26.4 76.3 36.8 18.1 56.1 36.0 41.0 66.7 28.7 15.2 40.5 30.1 25.1 23.6 22.3 33.5 23.7 58.0 44.5 46.6 16.6 22.2 24.7 54.8 75.5 66.6 57.7 63.2 55.8 64.6 71.2 72.1 79.0 58.0 56.9 59.5 41.3 51.8 53.2 84.7 84.8 80.2 29.0 30.9 21.0 32.2 26.9 20.1 27.7 28.7 20.1 15.6 107.2 71.6 131.7 132.1 151.5 82.2 1107.2 300.7 160.6 76.2 207.6 17.7 313.5 832.3 248.3 262.3 175.5 627.2 163.5 362.2 264.7 185.2 120.1 110.6 343.0 279.7 74.7 195.8 149.8 199.0 686.6 146.4 164.2 263.2 256.9 319.4 135.9 259.6 427.8 146.7 623.8 82.2 187.5 259.7 198.1 121.6 159.6 167.3 149.5 388.8 110.0 NDUFB11 "ESSS, Np15, NP17.3" ENSG00000147123 "NADH:ubiquinone oxidoreductase subunit B11" Q9NX14 X 47142216-47145504 "Disease related genes, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Cardiomyopathy, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030367 Supported Approved Mitochondria NA NA Mitochondria "HPA030367: AB_10603882" "unprognostic (2.20e-1)" "unprognostic (6.77e-3)" "unprognostic (1.39e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (8.84e-2)" "unprognostic (3.31e-2)" "unprognostic (2.05e-1)" "unprognostic (5.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (3.27e-1)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (8.46e-3)" 16.9 33.4 26.1 21.2 24.8 25.2 29.2 18.9 29.7 17.6 23.3 10.5 24.7 24.2 14.3 25.1 23.3 18.8 24.0 64.4 22.4 20.6 24.4 48.8 18.1 36.5 22.5 22.0 14.9 50.9 15.6 24.5 14.2 24.4 18.1 21.2 13.0 37.0 30.2 164.0 17.3 22.8 16.0 18.3 19.2 22.8 9.7 12.3 30.4 38.5 53.6 21.2 14.3 20.5 58.9 69.0 22.2 44.7 27.7 54.6 59.5 19.9 29.7 23.5 27.1 20.3 17.5 25.0 14.5 16.9 23.8 23.1 31.6 24.5 24.6 12.6 15.8 25.1 25.6 26.4 15.4 16.0 23.7 70.6 14.1 40.6 26.1 20.4 23.6 21.7 19.1 14.1 20.6 13.7 15.3 17.7 32.1 16.8 32.4 13.3 45.1 27.8 65.3 36.7 23.8 54.6 30.3 23.2 55.8 24.1 21.3 43.3 32.0 27.6 31.8 22.0 31.3 45.6 30.9 13.5 16.7 22.8 31.0 17.0 32.0 27.9 27.5 18.2 14.8 22.2 22.2 44.7 19.8 34.0 32.0 42.2 58.9 48.4 39.0 52.8 52.8 54.6 43.6 9.5 27.7 23.7 69.0 51.0 59.5 26.1 24.8 18.9 29.7 22.4 20.6 22.5 22.0 24.4 12.3 98.3 106.3 255.4 204.6 230.6 88.2 209.9 272.6 84.3 121.7 275.7 35.3 385.7 494.0 274.0 3.3 148.1 318.7 303.7 319.8 368.1 203.9 216.1 191.4 557.4 340.7 52.4 317.3 186.6 292.7 7.4 168.2 251.5 251.4 301.2 382.3 151.0 288.4 321.1 165.9 606.1 75.5 161.7 184.4 17.2 37.7 253.9 377.1 200.3 398.2 277.3 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 153.5" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3102.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Uncertain Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA051377: AB_2681460" "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favorable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 25.1 31.2 45.1 19.9 52.5 20.2 27.3 29.1 43.3 21.5 39.0 26.0 25.1 28.3 20.1 29.5 27.7 22.0 25.7 105.5 37.0 36.0 46.6 41.2 18.4 23.8 46.0 35.6 14.5 47.0 26.5 23.9 17.7 33.3 20.7 30.8 28.1 37.6 27.4 127.2 17.2 28.1 38.1 37.7 19.7 26.9 14.3 25.2 15.6 57.6 48.1 21.1 25.5 17.5 94.7 116.5 55.2 108.5 75.9 87.8 153.5 41.1 67.0 24.0 52.4 38.6 39.2 34.9 29.9 26.2 31.0 29.6 51.7 41.1 31.3 44.8 36.2 58.7 20.4 21.4 42.1 24.7 52.2 73.6 22.9 57.3 58.1 30.6 35.3 30.9 43.6 36.5 29.4 18.1 26.6 46.1 44.5 38.7 37.9 42.9 122.0 55.3 91.1 55.6 84.7 76.6 31.9 23.4 72.2 62.1 81.8 48.9 48.3 41.0 67.2 35.9 28.6 29.2 40.5 38.4 41.0 24.1 48.4 51.5 36.2 67.2 54.9 62.4 56.8 51.3 55.2 108.5 48.1 83.5 107.8 71.3 94.7 82.1 81.4 116.5 72.9 87.8 87.7 9.0 75.9 97.1 92.8 73.9 153.5 45.1 52.5 29.1 43.3 37.0 36.0 46.0 35.6 33.3 25.2 175.7 232.0 217.4 229.1 201.1 175.8 3102.3 435.7 235.5 197.9 638.6 92.3 489.8 1692.7 343.0 795.3 237.8 727.9 70.0 273.3 377.8 291.6 360.2 272.6 944.1 632.0 131.9 411.8 215.5 261.6 154.7 206.2 385.8 411.7 381.5 493.4 197.7 268.8 531.3 229.1 1640.6 200.8 194.1 278.2 77.7 190.5 245.3 430.7 214.4 506.9 369.0 NDUFB3 B12 ENSG00000119013 "NADH:ubiquinone oxidoreductase subunit B3" O43676 2 201071433-201085750 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.9" "Cell type enhanced" "Detected in all" 10 "Cardiomyocytes: 1805.8;Distal tubular cells: 901.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034596 Enhanced NA NA "HPA034596: AB_10602712" "unprognostic (5.38e-2)" "unprognostic (2.90e-1)" "unprognostic (4.46e-2)" "unprognostic (6.85e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (7.24e-4)" "unprognostic (1.41e-3)" "unprognostic (6.29e-2)" "unprognostic (8.81e-3)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-1)" "unprognostic (1.37e-2)" "unprognostic (9.40e-3)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.27e-2)" 16.9 19.9 23.4 13.9 23.6 10.1 14.7 13.5 33.3 10.4 27.1 8.2 16.8 23.8 8.4 18.9 21.1 8.6 13.0 57.5 24.2 19.9 35.2 25.8 10.4 12.6 25.6 29.7 6.8 13.0 15.3 13.2 10.9 20.8 11.7 23.8 8.8 21.8 11.7 113.9 8.6 21.2 10.8 19.2 13.4 17.5 17.2 17.8 10.8 11.6 39.1 16.9 9.4 12.0 40.5 55.8 66.2 52.9 36.4 47.3 27.2 25.1 20.6 31.1 17.6 26.6 22.9 26.7 29.4 18.6 21.7 23.8 46.1 31.2 18.1 36.5 24.1 34.8 23.9 25.4 35.8 33.2 37.3 59.5 42.1 49.9 54.3 17.2 60.6 24.7 22.3 27.1 25.4 15.1 25.9 27.9 33.3 38.3 35.8 34.3 29.3 43.4 67.3 20.7 48.1 68.3 31.8 25.9 55.9 46.2 38.4 31.1 22.7 22.5 23.7 36.8 47.5 22.1 54.0 27.9 20.8 27.8 22.0 31.6 27.3 54.2 61.4 37.7 35.5 24.1 43.5 37.7 40.0 32.7 51.7 36.3 40.5 38.5 37.8 45.8 31.4 33.8 41.2 66.2 36.4 52.9 55.8 47.3 27.2 23.4 23.6 13.5 33.3 24.2 19.9 25.6 29.7 20.8 17.8 74.5 43.1 110.7 86.1 69.4 45.6 1805.8 155.4 131.2 79.6 177.9 11.8 229.3 901.9 200.3 116.7 76.5 387.2 23.3 176.3 165.0 71.9 72.2 76.2 207.9 250.1 30.2 140.6 86.5 115.2 32.2 88.3 118.4 160.3 347.2 205.2 105.4 170.7 284.0 95.5 609.5 64.6 90.5 95.2 200.4 91.8 80.4 131.8 87.3 261.2 108.6 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NDUFB7 "B18, CI-B18, MGC2480" ENSG00000099795 "NADH:ubiquinone oxidoreductase subunit B7" P17568 19 14566078-14572062 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 182.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002817 Enhanced NA NA "HPA002817: AB_1079462" "unprognostic (2.80e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.03e-1)" "unprognostic (4.09e-2)" "unprognostic (4.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.95e-1)" "unprognostic (1.45e-3)" "unprognostic (2.07e-1)" "unprognostic (1.87e-2)" "unprognostic (2.02e-2)" "unprognostic (4.14e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.40e-1)" "unprognostic (1.69e-1)" "unprognostic (1.59e-1)" "unprognostic (9.25e-3)" 35.5 34.0 42.1 24.1 37.3 26.0 34.6 25.1 50.3 24.7 36.2 19.4 28.5 36.6 22.2 31.6 28.3 27.2 31.9 110.4 32.6 32.3 36.2 44.9 22.6 26.8 40.7 29.6 21.3 55.1 20.4 23.9 21.8 29.3 24.5 17.0 24.9 58.1 30.8 182.0 22.6 32.7 28.7 26.4 18.9 30.3 20.9 20.0 20.4 27.6 65.5 19.7 19.3 23.6 64.2 82.6 48.7 77.5 67.3 83.1 90.6 37.0 37.4 15.2 32.3 13.2 13.3 26.9 17.3 19.4 32.4 30.8 49.7 20.6 16.9 52.1 16.1 14.1 29.1 10.0 37.9 4.3 26.1 50.9 32.7 61.6 51.3 23.4 21.1 22.7 21.6 31.7 17.0 8.0 9.1 25.9 30.8 20.1 31.1 14.9 70.1 34.3 47.2 38.6 35.2 122.9 26.8 18.1 40.9 22.6 39.7 32.9 35.1 18.1 42.3 46.0 4.1 27.8 38.1 19.1 41.2 20.0 52.0 31.8 42.5 43.5 21.1 39.5 41.2 27.6 48.7 77.5 23.8 83.1 68.5 77.1 64.2 56.8 70.0 74.7 56.9 47.6 62.2 21.9 67.3 64.7 82.6 63.8 90.6 42.1 37.3 25.1 50.3 32.6 32.3 40.7 29.6 29.3 20.0 71.5 82.9 160.0 137.4 118.5 101.4 590.7 285.3 140.5 116.0 246.0 53.0 296.5 978.2 260.6 63.3 159.0 823.9 93.5 394.9 276.1 228.8 165.8 101.4 537.7 331.0 68.3 319.0 192.8 231.2 180.8 192.1 159.9 359.4 312.8 436.8 150.4 310.7 547.1 188.1 778.8 103.1 232.8 265.0 103.0 228.5 140.9 188.7 143.4 440.9 144.9 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539103-124568510 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 221.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 254.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria NA NA Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 26.9 20.8 61.0 19.6 45.1 43.7 33.3 26.9 63.7 20.7 40.4 15.0 25.4 35.5 17.4 30.0 27.9 19.4 23.8 125.1 44.2 39.0 50.1 52.9 23.8 38.2 60.0 49.1 16.8 51.7 20.6 16.3 15.8 46.7 20.6 37.5 13.4 39.9 24.0 221.3 18.0 26.1 31.3 44.8 15.3 28.9 44.1 31.1 13.5 27.7 80.7 19.3 16.7 16.5 53.8 52.7 52.1 54.4 37.5 71.2 64.2 28.8 26.7 20.5 27.7 21.3 18.2 17.2 14.2 16.2 25.9 19.6 35.1 27.9 28.6 36.9 16.3 13.5 32.9 29.7 22.6 24.5 33.2 40.5 69.5 19.0 42.0 28.4 21.6 19.0 21.2 32.9 23.7 51.3 14.1 23.5 20.8 42.9 24.1 20.7 90.1 34.0 43.3 20.6 104.1 59.4 23.0 15.6 39.0 34.0 24.4 28.6 22.4 30.9 254.6 30.4 12.9 35.0 29.3 18.7 15.1 39.4 14.1 33.4 31.1 41.4 32.8 26.3 43.3 19.9 52.1 54.4 27.5 48.3 37.2 47.9 53.8 64.0 53.9 52.7 42.5 63.4 52.2 11.2 37.5 27.2 39.6 71.2 64.2 61.0 45.1 26.9 63.7 44.2 39.0 60.0 49.1 46.7 31.1 116.1 101.5 163.0 206.1 193.5 71.0 877.9 259.9 172.6 153.6 272.2 92.3 413.9 678.1 287.5 321.0 148.3 490.6 46.7 353.1 228.0 195.3 239.3 136.2 450.4 353.4 35.0 224.5 179.2 208.1 585.5 147.0 181.9 234.5 201.0 282.2 86.2 298.7 372.2 143.5 593.2 52.3 168.1 258.4 306.2 277.3 164.6 437.4 148.2 397.6 262.6 NDUFC1 KFYI ENSG00000109390 "NADH:ubiquinone oxidoreductase subunit C1" O43677 4 139266880-139302551 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 164.1" "Cell type enhanced" "Detected in all" 8 "Cardiomyocytes: 1810.7;Distal tubular cells: 963.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044556, HPA062427" Enhanced Approved Mitochondria No No Mitochondria "HPA044556: AB_10794402, HPA062427: " "unprognostic (6.07e-2)" "unprognostic (4.61e-3)" "unprognostic (1.76e-2)" "prognostic favorable (8.23e-5)" "unprognostic (7.11e-2)" "unprognostic (1.74e-1)" "unprognostic (1.23e-1)" "unprognostic (1.40e-1)" "unprognostic (7.62e-2)" "unprognostic (3.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.17e-2)" "prognostic favorable (9.96e-4)" "unprognostic (2.33e-1)" "unprognostic (1.07e-1)" "unprognostic (1.66e-1)" "prognostic favorable (7.25e-4)" 7.4 17.0 15.2 6.4 15.8 5.6 8.3 12.2 15.7 8.5 13.1 11.8 7.0 15.2 6.6 12.0 11.7 8.3 7.7 55.5 12.4 14.6 20.3 17.1 8.4 6.7 13.0 12.1 9.7 13.1 11.4 14.3 8.9 10.0 8.1 12.6 11.3 10.9 10.5 164.1 9.1 16.4 7.2 10.4 10.5 11.9 27.1 8.5 6.1 11.6 57.6 9.4 7.0 7.3 32.7 40.0 40.8 24.4 12.8 31.4 26.1 8.7 3.7 10.7 13.3 7.7 8.4 8.6 10.8 7.2 8.0 6.1 6.5 11.0 3.8 3.9 7.6 7.9 5.2 20.9 7.1 6.3 5.5 6.7 6.1 7.1 10.4 9.7 5.0 3.3 12.1 10.7 7.6 11.2 10.3 7.9 8.8 14.0 16.4 5.5 6.2 7.4 12.4 8.2 16.4 5.0 6.3 6.6 29.1 12.8 5.7 9.1 6.9 7.7 9.5 4.9 9.0 10.4 9.9 3.9 7.9 3.7 5.5 6.1 13.2 23.2 9.6 8.5 13.3 6.3 16.0 24.4 40.8 21.7 17.3 17.3 28.3 24.4 23.2 24.0 32.7 31.4 23.1 15.4 12.8 18.8 40.0 28.3 26.1 15.2 15.8 12.2 15.7 12.4 14.6 13.0 12.1 10.0 8.5 83.4 126.2 85.5 146.6 124.6 118.7 1810.7 239.5 211.5 137.6 417.0 31.4 127.4 963.3 232.9 260.2 150.4 371.3 93.5 293.9 141.6 109.0 170.1 69.5 334.5 190.8 112.8 212.7 108.1 87.2 30.8 156.8 98.4 253.1 220.0 288.1 223.0 228.9 313.4 194.1 826.9 103.1 97.0 148.0 386.4 224.2 156.7 98.7 62.3 275.8 158.3 NDUFS1 CI-75k ENSG00000023228 "NADH:ubiquinone oxidoreductase core subunit S1" P28331 2 206114817-206159603 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.5" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 534.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064605, CAB070844" Enhanced Supported Mitochondria NA NA Mitochondria "CAB070844: , HPA064605: AB_2685297" "prognostic unfavorable (3.85e-4)" "unprognostic (1.76e-1)" "unprognostic (9.22e-3)" "unprognostic (5.01e-2)" "unprognostic (8.63e-3)" "unprognostic (3.75e-1)" "unprognostic (3.72e-2)" "unprognostic (6.18e-2)" "unprognostic (2.30e-2)" "unprognostic (3.28e-1)" "unprognostic (2.00e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.47e-12)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" "unprognostic (4.73e-2)" 13.9 29.0 12.1 8.3 22.1 7.6 10.3 11.6 26.4 9.1 17.4 16.4 9.2 18.3 9.1 7.7 15.7 7.7 7.3 62.6 11.3 11.7 29.5 30.7 8.3 7.7 13.3 13.8 8.2 9.3 22.1 11.6 10.8 24.2 10.7 18.9 13.5 12.8 10.9 99.5 11.0 19.9 11.1 10.8 8.4 14.9 8.8 11.1 11.2 10.8 34.7 10.5 11.6 9.4 10.7 15.3 15.7 21.4 12.5 16.1 8.9 12.9 12.9 18.8 13.6 17.6 14.3 21.9 19.1 20.6 31.9 23.2 33.5 15.2 14.7 16.9 23.8 31.7 18.2 25.1 18.5 28.4 6.7 11.8 29.3 32.1 30.0 18.3 21.1 13.3 17.4 10.9 25.0 19.7 14.3 24.8 18.6 31.7 14.9 20.7 16.2 17.4 14.0 17.4 21.9 23.1 17.6 26.3 25.4 26.4 23.7 18.4 14.4 22.0 21.6 31.2 26.9 19.0 20.5 18.9 17.6 15.7 17.2 18.1 14.4 17.3 21.9 17.6 17.5 17.9 12.0 13.3 15.7 13.6 15.4 10.8 10.7 12.2 13.0 15.3 9.5 10.9 12.4 9.6 12.5 21.4 8.2 16.1 8.9 12.1 22.1 11.6 26.4 11.3 11.7 13.3 13.8 24.2 11.1 56.6 24.1 13.7 19.6 14.3 94.7 534.9 63.7 60.2 35.2 36.6 113.9 40.2 79.6 36.7 9.9 33.7 63.8 0.0 24.5 26.7 24.7 17.4 35.9 83.9 29.8 111.2 49.0 33.7 34.6 5.2 31.1 25.2 28.7 27.1 47.3 60.7 29.2 35.1 42.1 80.9 78.2 32.3 27.8 28.6 37.3 14.4 43.8 18.7 52.8 23.9 NDUFS2 CI-49 ENSG00000158864 "NADH:ubiquinone oxidoreductase core subunit S2" O75306 1 161197104-161214395 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 104.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055140, HPA061953" Enhanced Supported Mitochondria NA NA 16000 Mitochondria "HPA055140: AB_2682713, HPA061953: AB_2684646" "unprognostic (2.13e-2)" "unprognostic (2.24e-2)" "unprognostic (8.47e-2)" "unprognostic (7.78e-2)" "unprognostic (9.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.10e-2)" "unprognostic (1.51e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-2)" "unprognostic (3.17e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.32e-4)" "unprognostic (2.35e-1)" "unprognostic (2.80e-1)" "unprognostic (1.13e-1)" "unprognostic (1.82e-1)" 14.6 30.7 16.6 8.0 25.4 10.2 15.5 23.4 25.4 13.0 25.6 17.9 11.7 23.6 12.3 11.2 16.7 14.5 10.6 75.4 17.6 14.8 37.4 52.6 12.8 9.2 28.0 25.0 14.1 14.3 25.6 10.7 11.5 24.1 12.7 27.2 11.4 14.6 14.5 104.9 14.0 22.1 15.7 16.1 13.0 19.4 8.8 25.3 10.4 12.3 37.1 15.1 13.2 10.5 18.9 47.3 26.6 42.2 20.3 29.2 32.4 17.2 27.8 17.6 20.4 25.9 23.0 15.2 15.7 23.1 31.1 24.5 30.5 18.0 22.0 29.6 24.2 17.1 23.2 28.1 28.1 27.5 14.6 23.6 21.4 20.9 26.6 26.9 23.2 19.9 33.1 24.8 25.1 28.7 20.6 35.5 23.0 27.4 12.0 29.2 19.9 14.7 12.4 32.1 60.6 25.7 12.7 18.2 30.9 36.9 20.7 18.7 27.8 19.0 46.9 26.8 26.3 42.1 60.8 22.7 15.1 12.9 10.6 21.2 16.9 26.7 18.4 23.1 19.6 19.4 26.6 35.9 18.9 20.5 42.2 19.9 18.9 20.9 20.7 47.3 15.7 21.6 21.8 20.2 20.3 37.0 31.8 29.2 32.4 16.6 25.4 23.4 25.4 17.6 14.8 28.0 25.0 24.1 25.3 32.8 43.7 52.8 39.4 34.6 72.7 193.6 76.5 68.3 35.2 73.3 29.5 125.8 281.8 158.0 7.1 61.2 199.4 23.3 126.2 94.3 73.7 24.9 68.1 177.0 131.6 87.4 69.2 58.9 83.7 4.7 40.3 64.2 79.2 127.2 94.1 51.2 124.2 89.2 31.5 226.7 49.8 45.3 68.0 36.7 32.1 37.9 132.5 50.1 138.8 41.7 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004484, CAB034894" Enhanced Supported "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "CAB034894: AB_2151118, HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favorable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 13.4 22.9 29.7 13.2 46.3 25.5 18.1 23.9 35.0 16.6 28.4 16.5 16.1 31.4 12.7 16.0 19.1 17.3 16.3 45.8 26.0 24.8 34.1 32.0 12.0 13.9 29.4 24.9 12.2 23.0 21.4 17.0 12.0 26.0 13.9 30.9 14.4 20.1 17.4 100.9 15.1 28.9 15.9 17.1 14.2 18.9 15.1 15.4 20.5 16.1 51.6 18.8 14.5 11.7 25.0 36.1 18.7 31.2 16.4 23.8 31.5 11.5 22.0 18.6 19.4 16.1 16.7 15.9 11.0 18.8 27.2 25.9 32.3 20.4 25.8 11.0 15.7 19.3 21.4 26.3 19.8 22.2 13.8 42.5 15.6 30.9 31.2 16.6 38.1 20.3 16.3 14.3 10.3 17.0 11.6 17.1 21.3 22.7 17.8 17.6 35.4 26.1 49.4 26.4 32.0 31.2 31.8 26.9 21.2 23.3 18.1 20.9 15.1 14.1 24.2 24.9 11.6 27.0 36.4 11.9 16.3 18.3 18.9 24.8 20.5 27.1 28.5 16.5 29.3 16.1 12.2 28.6 18.7 18.7 31.2 19.8 25.0 19.7 20.3 33.7 23.1 18.8 20.1 7.5 16.4 25.0 36.1 23.8 31.5 29.7 46.3 23.9 35.0 26.0 24.8 29.4 24.9 26.0 15.4 50.6 35.2 47.4 60.2 58.3 41.3 154.2 96.8 75.0 45.5 66.3 39.3 103.3 343.2 99.0 93.6 59.9 204.6 23.3 97.2 97.6 64.9 43.1 56.6 108.3 166.7 57.2 81.3 52.8 54.3 46.0 62.5 73.9 113.1 83.8 120.8 100.0 80.5 103.7 65.0 231.7 51.0 103.5 79.3 76.9 75.2 66.4 74.5 62.9 167.5 58.5 NDUFS6 CI-13kA ENSG00000145494 "NADH:ubiquinone oxidoreductase subunit S6" O75380 5 1801400-1816605 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 146.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 104.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064221 Supported NA NA 27000 "HPA064221: AB_2685217" "unprognostic (2.34e-1)" "unprognostic (1.43e-3)" "unprognostic (4.04e-1)" "unprognostic (9.74e-2)" "unprognostic (5.91e-2)" "unprognostic (6.27e-2)" "unprognostic (1.13e-2)" "unprognostic (5.67e-2)" "unprognostic (3.22e-1)" "unprognostic (9.99e-3)" "unprognostic (1.68e-3)" "unprognostic (8.57e-2)" "unprognostic (2.14e-2)" "unprognostic (1.16e-3)" "unprognostic (2.46e-1)" "unprognostic (9.08e-2)" "unprognostic (1.02e-1)" 25.0 20.6 19.8 18.9 20.9 23.7 23.9 13.3 26.8 10.6 26.2 11.5 13.6 34.2 13.6 14.4 20.3 10.9 18.8 59.8 17.6 16.5 28.1 43.1 13.5 26.2 19.9 12.9 13.0 29.7 10.5 13.6 17.1 16.1 15.4 12.6 14.7 22.3 19.0 146.4 13.0 27.1 17.8 16.5 16.4 25.4 13.3 9.3 25.5 14.7 36.6 14.1 15.5 12.7 38.7 55.7 35.8 52.8 32.4 40.2 36.7 20.7 28.6 14.0 21.2 5.1 4.6 38.4 17.7 6.3 9.6 8.3 31.5 20.3 28.7 49.1 7.3 18.3 20.7 10.5 14.1 5.2 32.4 34.6 22.1 104.2 26.5 10.3 26.0 19.6 6.5 9.1 9.1 6.5 5.7 9.3 17.2 27.1 22.0 10.3 34.6 37.2 47.6 18.5 23.0 40.3 27.7 18.2 33.6 9.8 23.2 17.3 17.4 57.5 36.9 22.2 8.0 24.6 30.9 18.7 15.2 35.3 15.6 28.7 26.6 40.8 36.7 19.2 37.9 17.2 31.4 46.5 35.8 35.1 52.8 34.9 38.7 37.2 35.5 55.7 31.0 31.5 35.2 20.2 32.4 45.7 54.5 40.2 36.7 19.8 20.9 13.3 26.8 17.6 16.5 19.9 12.9 16.1 9.3 62.5 105.5 111.7 113.4 111.5 87.6 652.0 214.0 129.8 83.0 197.1 45.2 314.0 824.0 224.3 170.3 151.7 605.8 93.5 294.9 176.7 145.1 148.1 103.7 453.3 357.1 62.0 256.5 163.9 217.4 213.8 143.2 152.8 207.5 168.7 287.4 119.2 250.9 375.2 147.8 647.4 112.5 161.7 147.6 204.0 175.7 146.4 205.0 122.2 358.9 170.2 NDUFS7 "CI-20, FLJ45860, FLJ46880, PSST" ENSG00000115286 "NADH:ubiquinone oxidoreductase core subunit S7" O75251 19 1383527-1395589 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 198.0" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 688.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.36e-2)" "prognostic favorable (2.03e-4)" "unprognostic (5.30e-2)" "unprognostic (3.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.28e-2)" "unprognostic (2.41e-2)" "unprognostic (5.85e-2)" "unprognostic (4.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.99e-3)" "unprognostic (8.12e-2)" "prognostic favorable (4.90e-7)" "unprognostic (2.95e-1)" "unprognostic (2.82e-1)" "unprognostic (1.57e-1)" "unprognostic (2.34e-2)" 22.4 17.6 15.3 10.1 17.6 9.9 7.0 16.6 22.7 6.1 18.7 20.6 7.6 34.5 7.1 9.6 13.3 6.7 10.0 35.9 16.1 15.1 20.7 20.7 7.1 9.1 19.6 11.9 7.2 28.7 5.0 12.0 6.8 17.6 11.9 4.0 12.0 23.6 10.2 198.0 8.3 25.2 7.5 20.1 11.5 18.2 14.2 14.6 9.7 8.0 39.2 10.0 6.7 7.9 29.1 41.8 19.8 39.1 17.2 29.2 20.8 18.3 18.7 0.6 4.3 0.6 1.7 9.6 11.1 1.1 2.4 2.6 30.5 4.5 27.2 11.4 0.6 0.3 9.6 0.8 2.2 0.1 30.3 21.4 8.6 19.9 18.9 2.9 14.8 9.5 1.4 3.8 0.4 0.0 0.4 3.2 10.0 17.0 10.7 0.6 19.2 14.7 6.1 6.7 1.6 23.1 14.3 7.1 27.6 1.1 14.2 10.5 10.6 9.8 9.3 18.0 0.0 7.3 9.3 13.9 4.5 6.2 9.7 14.3 42.9 37.5 18.4 11.2 20.0 6.2 19.8 33.6 16.1 21.3 39.1 18.1 29.1 20.1 20.0 41.8 27.1 19.7 19.1 9.1 17.2 31.7 31.6 29.2 20.8 15.3 17.6 16.6 22.7 16.1 15.1 19.6 11.9 17.6 14.6 74.5 95.4 131.8 86.9 79.8 72.1 67.4 168.2 78.9 51.2 137.9 47.1 192.7 688.1 137.5 357.3 76.0 544.6 46.7 141.5 160.0 98.8 68.4 110.7 228.2 287.0 49.3 168.3 69.3 190.4 312.5 77.6 125.3 248.0 122.6 224.8 92.8 114.3 256.1 69.6 490.7 62.6 71.1 129.1 207.7 148.4 92.6 156.2 96.4 322.1 105.1 NDUFS8 "CI-23k, TYKY" ENSG00000110717 "NADH:ubiquinone oxidoreductase core subunit S8" O00217 11 68030617-68036644 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.6" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 706.2;Proximal tubular cells: 686.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018524, HPA067429" Enhanced Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA018524: AB_1854355, HPA067429: " "unprognostic (2.90e-1)" "unprognostic (1.41e-3)" "unprognostic (2.41e-1)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-1)" "unprognostic (7.75e-2)" "unprognostic (3.15e-1)" "unprognostic (1.77e-2)" "unprognostic (3.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (3.27e-8)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (9.45e-2)" 26.0 62.0 29.9 16.9 40.5 21.0 19.1 18.4 50.1 18.6 24.7 19.7 24.3 34.7 18.2 15.1 28.3 19.0 22.7 82.4 26.5 27.5 50.3 47.6 16.3 19.1 28.3 22.4 20.8 41.3 25.4 26.7 18.0 25.9 22.9 18.3 30.1 41.3 32.2 156.6 17.3 26.7 19.8 18.2 20.3 25.0 21.1 15.7 29.6 29.2 53.9 24.2 19.1 14.8 37.3 66.6 23.6 46.1 59.0 39.6 42.6 26.4 65.7 18.2 24.7 13.6 12.2 23.9 18.8 16.3 29.1 22.7 61.1 28.3 20.5 34.3 16.3 26.2 32.7 20.8 22.8 10.5 24.5 48.0 18.6 41.9 32.1 32.5 17.4 20.5 15.4 23.7 21.4 24.5 16.1 19.5 28.9 19.1 22.2 19.0 62.7 38.3 37.3 22.3 70.4 55.7 26.7 17.7 66.2 36.6 21.5 22.9 18.6 13.7 31.7 66.4 13.6 43.5 19.1 15.1 28.3 24.9 40.9 25.9 30.5 32.0 17.4 45.5 21.0 19.7 15.8 46.1 23.6 39.6 45.1 37.0 37.3 34.2 36.0 63.3 30.2 33.0 36.7 4.4 59.0 24.9 66.6 39.6 42.6 29.9 40.5 18.4 50.1 26.5 27.5 28.3 22.4 25.9 15.7 83.4 69.0 76.7 81.4 75.9 80.5 251.3 155.4 84.3 69.4 202.4 51.1 253.0 706.2 176.2 170.4 79.8 264.8 0.0 174.1 132.3 109.2 89.4 94.6 216.5 241.0 47.7 197.0 64.4 119.9 632.4 93.2 101.9 155.3 202.8 173.3 94.1 168.6 178.9 101.5 686.8 98.3 58.2 128.2 84.2 59.4 101.6 144.2 120.4 242.9 99.3 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67606852-67612535 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 150.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 23.3 28.9 27.3 20.7 33.9 20.3 18.9 32.9 48.8 18.5 33.0 23.1 19.2 40.6 19.4 21.5 25.5 22.5 23.4 93.0 26.5 24.1 39.0 41.5 15.9 20.6 31.5 40.5 24.6 38.3 49.2 18.8 15.7 34.8 16.1 25.1 17.6 27.3 27.0 150.8 28.4 30.3 22.7 23.1 21.5 28.2 30.2 24.3 18.3 23.4 67.9 20.3 18.7 18.6 23.8 41.2 13.5 30.7 36.2 28.2 24.3 25.9 27.9 14.2 28.5 17.8 17.9 26.6 16.2 15.6 25.4 17.0 52.8 31.5 48.0 34.2 13.9 20.7 35.0 30.0 25.3 8.0 24.4 23.7 19.6 37.9 26.0 25.2 26.7 22.0 26.5 24.6 20.6 18.5 16.1 22.5 35.2 35.7 39.3 15.4 39.0 31.2 52.9 13.9 59.1 35.2 36.3 27.6 77.9 20.6 19.5 22.7 21.4 20.5 71.8 54.1 9.9 36.4 27.2 17.8 24.7 18.4 35.1 17.0 38.4 21.8 23.9 28.7 28.3 23.7 12.6 26.7 13.5 25.9 30.7 28.2 23.2 21.7 24.5 41.2 23.8 20.2 25.1 4.8 36.2 17.4 26.5 27.8 24.3 27.3 33.9 32.9 48.8 26.5 24.1 31.5 40.5 34.8 24.3 56.6 80.9 64.0 70.8 71.3 67.0 408.9 66.2 72.3 67.1 82.0 47.1 180.6 336.5 96.7 57.0 53.7 205.0 23.3 97.8 127.6 79.5 47.7 59.0 122.2 121.6 60.4 94.7 53.4 67.1 159.3 60.7 67.5 108.0 83.8 141.7 63.1 68.4 126.7 55.5 398.9 60.4 45.3 98.9 77.2 78.1 70.4 158.1 71.2 225.4 78.9 NDUFV3 CI-10k ENSG00000160194 "NADH:ubiquinone oxidoreductase subunit V3" P56181 21 42879644-42913304 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.5" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 701.2;Late spermatids: 1042.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019791, HPA020463, HPA030427, CAB034142" Enhanced Enhanced Mitochondria NA NA Mitochondria "CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024" "unprognostic (1.62e-1)" "unprognostic (2.17e-3)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.11e-2)" "unprognostic (4.69e-1)" "unprognostic (2.97e-2)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (3.85e-3)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (6.56e-2)" "unprognostic (9.30e-3)" "unprognostic (2.14e-1)" "unprognostic (1.94e-1)" 18.1 14.1 16.9 11.1 17.2 15.8 14.6 11.8 23.2 12.0 15.9 11.9 14.6 15.2 15.1 15.7 15.6 12.7 15.4 54.9 14.2 11.0 15.1 24.3 10.8 12.5 14.0 18.6 16.0 17.7 13.2 13.1 11.6 19.2 13.6 11.4 12.2 19.4 21.8 129.5 15.4 13.5 16.9 16.0 13.3 14.3 20.3 13.3 6.6 11.6 18.5 10.6 13.3 11.8 9.9 22.9 16.0 22.8 10.5 8.8 10.3 9.6 11.4 11.0 18.0 13.6 11.9 13.6 19.2 11.0 11.5 9.6 20.7 11.9 10.7 15.2 7.2 15.6 10.5 12.8 16.9 7.5 6.1 15.5 35.3 13.3 16.2 21.4 12.0 18.5 13.3 14.7 11.6 18.4 10.4 14.4 7.4 27.9 14.0 13.1 18.9 8.0 18.2 14.4 21.5 22.4 13.9 8.0 33.4 15.4 12.8 8.1 8.4 19.3 22.8 12.7 6.2 19.6 15.9 16.9 10.8 7.5 13.8 13.6 20.8 13.7 12.2 14.1 21.6 16.2 3.7 21.4 16.0 8.0 22.8 8.1 8.1 7.6 6.7 22.9 9.9 8.8 7.7 3.8 10.5 19.6 11.3 8.8 10.3 16.9 17.2 11.8 23.2 14.2 11.0 14.0 18.6 19.2 13.3 50.6 37.7 43.0 46.0 17.6 69.1 701.2 89.2 92.3 27.3 85.5 64.8 46.1 195.6 69.0 416.9 34.9 128.4 140.2 87.3 49.8 41.1 75.6 30.1 285.4 97.8 54.0 75.1 62.0 81.5 1042.9 61.5 68.7 35.4 67.7 73.4 56.3 83.6 77.2 58.7 265.4 102.6 71.1 47.2 216.7 86.2 20.6 75.2 34.6 82.9 49.3 NEB "NEB177D, NEM2" ENSG00000183091 Nebulin P20929 2 151485336-151734487 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 505.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 32.0;Cholangiocytes: 22.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.8;RH-30: 27.2;U-266/70: 10.2" "Group enriched" "Detected in some" 7 "cerebellum: 7.4;olfactory region: 4.9" "Region enriched" "Detected in single" 7 "cerebellum: 25.3" HPA016601 Enhanced NA NA "HPA016601: AB_1854361" "unprognostic (2.40e-2)" "unprognostic (6.71e-2)" "unprognostic (2.13e-2)" "unprognostic (2.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-3)" "unprognostic (2.54e-2)" "unprognostic (1.45e-1)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-13)" "unprognostic (6.80e-2)" "unprognostic (2.22e-2)" "unprognostic (4.07e-3)" "unprognostic (4.06e-2)" 9.6 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.2 4.0 0.0 0.8 1.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.0 0.0 3.8 0.0 505.8 0.3 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 3.0 65.9 2.6 0.1 0.0 1.3 0.5 1.7 0.6 0.8 0.9 0.3 0.3 0.4 0.6 0.5 0.1 0.1 1.7 0.3 0.0 0.0 0.0 4.7 0.5 1.2 1.0 0.1 0.1 1.0 0.1 0.0 0.0 0.6 0.7 0.4 0.7 1.5 0.0 0.8 1.1 4.1 0.2 0.0 0.0 0.2 0.7 0.4 0.9 6.8 0.4 0.5 0.4 0.7 1.1 2.3 0.8 1.2 27.2 0.1 0.1 0.9 1.5 0.2 0.2 0.3 0.1 1.1 0.7 0.8 0.6 0.7 0.9 0.1 0.9 10.2 1.5 0.3 0.1 0.6 1.1 1.2 0.6 1.7 0.9 0.0 0.9 1.2 0.8 0.5 0.0 1.3 0.3 0.4 1.1 0.8 0.0 0.5 0.4 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.9 0.8 0.7 2.0 32.0 22.9 0.0 1.2 0.0 0.0 0.3 0.0 0.3 5.7 0.0 0.0 0.0 0.0 0.4 1.0 1.7 1.1 1.9 0.7 3.2 1.7 0.6 1.3 1.8 0.6 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 1.7 0.0 0.4 1.6 0.9 1.1 0.7 0.0 0.0 0.1 NEBL "LASP2, LNEBL" ENSG00000078114 Nebulette O76041 10 20779973-21174187 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 123.6" "Cell type enriched" "Detected in many" 10 "Cardiomyocytes: 2193.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HSkMC: 13.9;hTCEpi: 12.9;SCLC-21H: 28.1;SH-SY5Y: 17.0;SK-BR-3: 26.5" "Low region specificity" "Detected in all" "HPA013994, HPA013995" Approved NA NA "HPA013994: AB_1854359, HPA013995: AB_1854360" "unprognostic (3.79e-2)" "unprognostic (1.92e-3)" "unprognostic (3.44e-2)" "unprognostic (3.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (6.25e-2)" "unprognostic (1.05e-1)" "unprognostic (6.20e-3)" "unprognostic (2.36e-2)" "unprognostic (8.42e-2)" "prognostic favorable (2.77e-8)" "unprognostic (3.51e-1)" "unprognostic (8.11e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (5.56e-4)" 1.3 6.9 16.4 1.0 17.2 0.7 13.2 21.1 16.1 2.6 2.9 9.8 0.1 1.0 1.3 1.0 10.8 1.1 1.7 123.6 16.5 12.7 12.0 1.7 14.1 0.9 12.7 13.3 1.5 6.0 6.6 16.0 5.1 12.6 7.3 4.0 2.2 18.8 8.1 0.8 16.2 1.3 1.4 10.6 0.8 4.0 2.8 12.5 0.5 30.8 3.9 3.8 2.1 4.4 0.0 0.0 1.4 0.8 0.0 0.5 0.2 0.6 5.2 8.0 0.3 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.6 0.7 1.6 8.2 0.0 0.4 4.8 0.5 0.0 0.0 0.0 3.3 0.0 2.5 0.0 12.5 0.0 0.0 13.9 12.9 0.0 1.3 0.0 0.3 0.2 0.3 2.2 0.0 12.2 0.1 0.0 5.8 5.3 3.1 0.0 0.1 0.0 2.0 1.1 28.1 17.0 1.5 26.5 0.0 2.8 8.9 0.0 11.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.0 0.5 0.2 16.4 17.2 21.1 14.1 16.5 12.7 12.7 13.3 12.6 12.5 202.5 60.0 0.0 11.7 16.4 72.9 2193.2 7.6 18.7 13.6 31.4 37.3 11.0 24.9 2.6 229.1 5.5 3.9 0.0 6.5 9.5 13.9 18.2 0.0 0.0 1.9 138.2 17.2 0.0 0.3 35.8 3.4 0.9 11.8 0.0 23.7 3.1 9.9 27.7 4.6 4.4 10.2 0.0 4.1 1.7 0.9 40.4 30.8 1.3 10.2 24.3 NECAB1 EFCBP1 ENSG00000123119 "N-terminal EF-hand calcium binding protein 1" Q8N987 8 90791550-90959408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 56.4" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 54.2;Cardiomyocytes: 55.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 6.1;hTERT-RPE1: 6.4;MOLT-4: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210" Enhanced Supported Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815" "unprognostic (8.09e-3)" "unprognostic (3.78e-1)" "unprognostic (8.17e-3)" "unprognostic (5.96e-5)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-3)" "unprognostic (8.38e-2)" "unprognostic (1.78e-3)" "unprognostic (2.60e-1)" "unprognostic (2.25e-2)" "unprognostic (2.57e-2)" "unprognostic (2.19e-3)" "unprognostic (4.45e-3)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (5.39e-3)" 2.7 4.9 19.7 2.0 27.3 3.2 1.5 0.5 56.4 1.4 3.7 12.1 0.3 1.7 4.1 4.4 3.6 1.6 3.1 10.9 19.5 9.8 3.4 1.1 6.8 1.4 16.0 30.7 3.8 1.3 1.9 1.9 2.8 10.8 2.6 1.1 4.1 2.5 2.0 1.3 1.9 1.8 1.3 18.7 2.4 2.1 5.2 17.4 0.0 2.9 0.0 1.0 4.2 1.2 0.5 1.8 0.3 0.0 0.7 0.9 0.2 0.1 0.1 2.3 0.4 0.0 0.1 0.1 2.5 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 2.3 0.0 1.0 0.0 0.1 0.0 4.6 6.1 2.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 6.4 0.0 1.7 4.0 4.4 0.0 4.9 6.3 3.1 0.8 0.0 0.1 0.0 3.9 0.0 0.0 0.0 4.1 4.3 0.1 0.0 2.1 2.9 0.0 0.2 1.5 3.8 3.8 0.0 1.6 6.0 3.6 3.1 3.8 0.0 1.8 0.0 0.0 0.1 0.6 0.0 0.4 0.2 0.4 0.6 0.1 0.5 0.6 0.9 0.3 0.7 0.0 1.8 0.9 0.2 19.7 27.3 0.5 37.1 19.5 9.8 16.0 30.7 10.8 17.4 17.9 54.2 0.0 0.2 0.5 3.9 55.7 0.0 0.0 4.5 12.2 0.0 0.0 0.0 0.0 3.5 0.7 0.0 0.0 0.2 0.0 1.3 0.1 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1.0 2.3 0.7 3.3 0.0 0.0 0.3 0.1 0.0 2.1 5.6 0.5 6.5 2.7 4.3 1.7 0.6 0.0 0.0 0.0 0.0 NECAB2 EFCBP2 ENSG00000103154 "N-terminal EF-hand calcium binding protein 2" Q7Z6G3 16 83968632-84002776 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 30.6;brain: 42.5;kidney: 12.4;liver: 15.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 13.3;Hepatocytes: 10.0;Late spermatids: 36.4;Muller glia cells: 10.2;Proximal tubular cells: 19.6" "Cancer enhanced" "Detected in many" "liver cancer: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 68 "neutrophil: 30.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 30.6" "Cell line enhanced" "Detected in some" "AF22: 7.6;SCLC-21H: 29.2;U-87 MG: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA013998, HPA014144, CAB068211" Enhanced Supported NA NA "CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017" "unprognostic (5.27e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (3.48e-5)" "unprognostic (3.45e-2)" "unprognostic (4.20e-2)" "unprognostic (6.74e-2)" "unprognostic (8.79e-2)" "unprognostic (4.15e-1)" "unprognostic (2.59e-1)" "unprognostic (5.75e-3)" "unprognostic (2.14e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (8.89e-3)" "unprognostic (3.48e-1)" "unprognostic (8.61e-3)" "unprognostic (3.75e-2)" 1.8 1.1 34.1 1.3 42.5 1.3 0.9 0.2 35.2 0.7 1.1 2.2 0.0 1.9 2.2 0.9 0.7 0.7 1.3 1.0 9.5 21.7 12.4 15.1 1.0 0.8 5.0 14.0 0.7 2.1 1.6 3.3 0.9 7.4 0.8 0.9 0.1 0.6 0.8 0.5 0.7 1.7 1.2 1.9 1.1 2.8 5.4 5.9 0.0 0.8 0.0 0.5 1.1 0.0 0.0 0.0 30.6 0.4 0.0 0.0 0.0 0.1 3.8 7.6 0.0 0.0 1.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 1.3 0.2 0.5 0.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.1 0.0 1.2 0.4 0.1 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.0 4.4 0.0 0.0 4.0 0.3 0.5 0.0 0.0 0.4 0.0 0.0 29.2 1.2 0.0 0.1 2.3 1.1 3.9 1.3 0.2 0.1 2.3 0.3 0.0 0.1 0.0 0.0 10.4 0.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 34.1 42.5 0.2 21.2 9.5 21.7 5.0 14.0 7.4 5.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 2.5 0.0 6.9 0.0 0.0 36.4 0.3 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.7 19.6 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 NECAB3 "APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51" ENSG00000125967 "N-terminal EF-hand calcium binding protein 3" Q96P71 20 33657087-33674463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 49.7" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044785, HPA070595, HPA071786" Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186" "unprognostic (8.95e-2)" "unprognostic (1.45e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.44e-1)" "unprognostic (4.05e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.19e-5)" "unprognostic (3.13e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (6.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-1)" 7.7 29.1 13.9 5.6 10.5 2.3 6.4 3.8 30.0 5.7 8.1 7.1 9.4 14.6 4.9 8.4 6.5 6.9 5.5 30.5 13.2 10.0 6.4 6.3 11.9 2.9 11.3 15.0 22.4 13.6 10.9 5.5 4.9 15.5 23.8 5.4 6.9 13.7 9.7 49.7 3.3 8.3 7.4 6.8 3.4 13.6 6.5 5.5 0.4 10.6 10.8 3.3 7.7 7.8 1.2 2.6 3.5 6.5 2.4 3.0 1.2 4.4 3.9 2.9 5.9 2.3 4.6 14.2 6.3 2.4 4.1 3.6 18.4 3.0 5.0 15.1 3.7 9.6 5.4 3.0 1.8 1.5 1.7 4.4 4.7 16.6 21.4 6.2 1.1 4.6 5.8 2.7 3.8 1.2 4.4 2.7 2.7 6.8 2.7 5.2 6.9 1.7 4.7 1.2 4.8 10.0 5.3 7.6 8.6 3.7 3.4 18.6 5.2 14.6 16.3 6.4 3.3 20.7 5.7 2.2 5.0 7.1 6.5 7.0 10.2 4.2 9.1 9.8 2.2 2.1 0.0 2.7 3.5 0.8 2.5 1.9 0.5 1.3 0.7 2.6 1.2 1.0 0.3 0.1 2.4 6.5 0.1 3.0 1.2 13.9 10.5 3.8 30.0 13.2 10.0 11.3 15.0 15.5 5.5 14.9 39.2 3.4 5.1 2.7 16.0 27.9 5.1 4.0 5.7 5.2 7.9 16.1 28.2 3.2 75.4 2.9 30.8 0.0 6.5 21.8 7.5 16.3 3.5 6.6 7.6 7.9 19.1 2.5 4.0 41.0 24.5 5.4 11.8 1.8 16.2 17.7 5.0 13.3 22.3 9.2 15.9 6.5 14.7 14.0 14.7 2.8 17.3 5.1 19.1 8.2 NECAP1 DKFZP566B183 ENSG00000089818 "NECAP endocytosis associated 1" Q8NC96 12 8076939-8097859 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053980, HPA063300" Uncertain Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA053980: AB_2682331, HPA063300: AB_2684981" "unprognostic (1.73e-2)" "unprognostic (6.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-3)" "unprognostic (1.03e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (5.79e-3)" "unprognostic (5.72e-3)" "unprognostic (1.03e-1)" "unprognostic (1.72e-2)" "unprognostic (1.89e-2)" "unprognostic (2.64e-1)" "unprognostic (2.06e-1)" "unprognostic (5.94e-2)" 7.5 19.1 25.5 9.2 34.1 6.5 10.5 45.9 53.2 11.9 13.1 9.6 5.1 12.1 8.4 8.1 9.3 12.0 7.8 9.4 27.6 36.8 12.5 11.1 8.5 6.0 19.2 22.1 13.1 17.4 16.3 17.9 11.6 32.5 12.7 13.3 11.1 10.9 10.1 5.0 5.9 11.8 9.0 9.6 7.0 12.0 10.0 7.5 5.3 9.6 4.4 8.0 8.9 5.8 7.0 8.9 25.4 14.3 6.8 12.0 8.5 10.3 9.4 6.8 9.4 15.8 12.0 15.3 22.4 13.6 18.8 18.9 20.4 11.9 5.3 3.9 10.6 14.1 7.2 18.2 11.7 16.1 14.2 14.3 5.8 12.1 10.2 14.4 5.4 17.1 15.3 14.2 20.6 25.8 14.4 13.5 7.9 13.4 7.9 19.9 12.7 9.1 1.8 18.6 29.1 8.7 3.6 16.5 4.9 13.0 15.7 11.0 8.5 11.1 15.8 8.8 22.4 5.3 4.7 13.2 9.1 18.4 10.7 15.4 5.2 9.2 10.8 15.9 6.0 13.2 18.5 11.5 25.4 8.4 11.5 9.4 6.6 7.9 8.6 8.9 7.0 9.5 8.8 18.8 6.8 14.3 4.8 12.0 8.5 25.5 34.1 45.9 47.0 27.6 36.8 19.2 22.1 32.5 7.5 35.7 20.0 25.7 18.8 22.7 49.9 10.1 7.6 12.0 15.9 22.7 25.5 13.2 21.6 14.6 19.8 16.3 20.6 0.0 14.6 12.1 18.7 18.9 28.8 12.1 12.4 27.0 15.5 12.9 12.3 10.2 21.6 22.0 27.0 6.4 14.2 29.7 14.4 14.7 13.8 16.1 43.1 6.5 22.7 14.7 23.0 18.6 18.8 28.0 11.7 17.3 NECTIN1 "CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12" ENSG00000110400 "Nectin cell adhesion molecule 1" Q15223 11 119623408-119729084 "CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.3;skin 1: 73.5" "Cell type enhanced" "Detected in some" 10 "Club cells: 7.9;Ductal cells: 6.5;Exocrine glandular cells: 10.7;Pancreatic endocrine cells: 12.5;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 59.2;hTCEpi: 36.9;RT4: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016135, HPA026846" Approved "Secreted in other tissues" NA NA 97000000 "CAB016135: AB_626865, HPA026846: AB_1846226" "unprognostic (1.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.11e-1)" "unprognostic (3.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.20e-2)" "unprognostic (2.25e-3)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (3.42e-1)" "unprognostic (3.58e-2)" "unprognostic (3.28e-1)" "unprognostic (3.59e-3)" "unprognostic (2.13e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (9.62e-2)" 3.1 3.0 7.7 3.0 11.1 11.9 5.3 8.4 20.8 6.6 7.3 27.3 2.4 9.6 2.3 2.0 55.3 2.9 2.5 3.0 16.1 8.2 3.0 2.4 2.5 1.7 12.7 10.6 1.8 10.8 2.4 4.1 8.2 10.1 5.9 7.8 6.3 8.7 4.4 1.6 73.5 6.9 3.1 14.3 2.2 3.2 1.3 12.4 2.5 1.8 25.3 20.8 17.3 14.8 0.1 4.8 1.0 1.5 0.1 0.1 0.2 4.1 3.4 3.3 4.7 1.7 0.5 23.2 1.6 1.5 1.4 1.0 7.3 14.2 5.5 6.9 1.9 2.8 59.2 8.4 30.2 0.6 12.9 1.3 0.7 1.1 3.3 0.7 3.7 9.3 0.5 36.9 4.4 16.5 0.5 4.2 1.6 0.1 29.4 1.8 10.8 0.0 2.2 10.8 14.0 4.8 0.3 19.8 6.6 1.3 40.1 8.0 18.0 5.6 14.9 0.5 5.2 13.5 0.5 2.3 1.2 4.7 10.2 1.5 5.4 6.8 0.0 0.4 3.0 2.8 0.0 0.3 0.2 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 1.0 0.1 1.5 4.8 0.0 0.2 7.7 11.1 8.4 20.8 16.1 8.2 12.7 10.6 10.1 12.4 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 7.9 1.8 0.0 3.5 0.0 6.5 0.0 0.0 0.0 0.0 10.7 0.9 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 12.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 94.2" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "AF22: 33.5;TIME: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Cell Junctions,Cytosol" NA NA 20000000 Cytosol "Cell Junctions" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favorable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 5.6 4.0 5.4 4.4 6.0 0.0 4.5 1.3 8.9 4.6 12.6 6.5 2.8 17.8 5.0 2.2 3.5 5.4 4.4 4.8 6.3 5.0 6.9 16.4 5.6 1.9 6.0 4.1 9.2 4.7 1.9 1.9 94.2 5.5 6.9 12.6 10.7 3.4 4.8 2.3 1.8 18.9 7.2 8.9 1.8 13.2 27.6 4.5 0.4 24.1 2.0 1.4 5.4 7.7 0.1 0.0 0.3 0.0 0.2 1.7 0.7 0.0 10.1 33.5 2.2 13.6 25.2 2.0 22.0 23.3 13.7 11.7 9.3 4.7 0.0 7.3 31.3 7.6 0.1 9.3 3.2 25.2 0.2 2.5 0.0 3.6 0.7 23.0 1.6 0.3 12.7 1.4 9.0 8.7 12.3 11.5 0.4 0.0 8.8 29.5 0.0 2.2 0.0 9.4 3.1 3.6 0.0 16.6 0.0 8.5 5.3 0.8 6.1 0.4 0.0 4.6 11.7 0.3 0.1 47.5 17.4 7.2 3.1 13.1 4.9 0.0 0.0 11.0 0.0 16.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 1.7 1.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.7 5.4 6.0 1.3 8.9 6.3 5.0 6.0 4.1 5.5 4.5 23.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.7 12.2 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 16.4 7.6 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 13.3 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 98.1 0.0 0.0 0.0 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070995-161089599 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;placenta: 46.6;skin 1: 39.3" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 321.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" No No 11000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.2 0.1 0.1 0.8 0.1 0.1 7.7 0.1 0.1 9.8 0.6 0.1 5.4 0.2 1.5 3.7 40.1 1.4 5.6 0.1 0.1 0.1 1.3 0.2 3.1 0.0 0.1 0.0 0.5 4.4 0.0 0.3 46.6 0.1 7.8 0.7 0.1 13.5 5.5 0.1 39.3 0.4 2.0 0.1 0.1 4.5 0.2 0.0 0.5 0.1 22.7 23.1 12.6 18.5 0.2 0.3 3.6 0.1 0.1 0.2 0.0 5.2 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.1 0.0 0.0 18.2 0.0 0.6 0.1 0.0 0.2 0.0 0.4 5.3 0.0 0.0 0.3 0.0 7.2 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.1 23.7 0.0 3.3 15.3 0.0 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 1.2 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 6.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 24.1 0.0 34.7 0.0 0.0 0.0 0.0 26.2 43.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.3 0.0 0.0 0.0 NEDD4 "KIAA0093, MGC176705, NEDD4-1, RPF1" ENSG00000069869 "Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase" P46934 15 55826922-55993746 "Enzymes, Predicted intracellular proteins, Transporters" "Host-virus interaction, Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 86.4;Alveolar cells type 2: 87.7;Ciliated cells: 135.1;Club cells: 79.6;granulocytes: 67.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001991, HPA039883, CAB072833" Approved Approved Cytosol NA NA Cytosol "CAB001991: , CAB072833: , HPA039883: AB_10795683" "unprognostic (1.18e-1)" "unprognostic (2.10e-2)" "unprognostic (5.66e-3)" "unprognostic (1.15e-1)" "unprognostic (6.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.18e-3)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (6.38e-3)" "unprognostic (2.98e-1)" "unprognostic (2.22e-1)" "unprognostic (2.35e-2)" 14.1 4.1 2.5 3.1 3.3 4.5 8.7 1.5 2.7 9.9 9.4 2.8 3.4 3.4 10.1 4.1 8.2 3.8 4.5 4.1 2.9 2.4 8.6 21.5 7.2 2.1 3.5 1.3 6.6 2.8 6.5 6.7 20.1 3.5 8.4 3.4 5.4 4.0 6.4 57.7 7.1 15.2 10.9 6.0 5.9 4.4 2.6 3.1 9.4 5.7 9.0 3.3 11.9 8.9 0.1 1.6 1.2 2.8 1.2 2.9 0.9 7.3 11.5 3.1 3.0 4.1 6.8 5.1 14.1 22.3 10.5 10.5 5.1 2.2 1.8 3.7 5.4 25.5 12.2 3.4 9.3 17.2 4.1 2.1 9.1 2.7 2.6 21.9 4.0 0.9 11.6 23.1 12.5 21.1 5.1 8.6 5.4 3.9 0.0 30.6 3.8 5.3 0.0 0.8 3.9 1.7 3.9 24.8 1.0 4.3 14.6 0.3 2.0 6.3 4.5 5.6 5.9 5.6 3.0 29.6 23.3 7.7 4.9 22.9 1.2 2.7 4.8 15.7 8.6 5.5 0.6 1.0 0.0 1.3 2.8 2.9 0.1 1.5 1.2 0.8 0.0 1.4 1.6 1.2 1.2 1.9 1.6 1.3 0.9 2.5 3.3 1.5 2.7 2.9 2.4 3.5 1.3 3.5 3.1 86.4 87.7 2.0 3.3 10.8 0.3 4.8 7.6 135.1 79.6 0.0 21.6 16.5 1.7 3.2 1.3 16.8 6.9 0.0 4.8 6.4 6.3 3.4 67.4 17.9 4.0 0.0 0.0 15.4 1.8 1.0 5.2 3.8 1.7 0.0 4.2 8.4 3.3 0.0 6.7 10.8 6.0 0.0 8.2 1.2 5.9 9.2 11.6 2.2 2.9 1.6 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 72.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 437.7;Basal glandular cells: 247.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 49.8;HSkMC: 24.9" "Low region specificity" "Detected in all" "HPA009689, CAB009720, HPA038768, HPA039270, HPA072955" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 72.8 4.7 4.5 14.9 5.6 3.3 35.7 2.2 5.9 14.0 16.6 5.1 14.2 7.1 17.3 21.7 10.3 11.5 15.3 17.3 4.6 4.1 34.6 9.5 58.4 15.0 4.9 3.9 11.1 7.9 4.2 6.1 32.6 6.6 13.4 14.7 12.8 15.4 15.4 22.4 12.3 17.9 12.4 5.3 25.7 10.9 12.2 4.3 18.8 15.8 6.8 18.6 17.6 9.9 5.8 6.0 34.8 19.8 5.1 8.3 6.3 1.5 10.2 9.5 0.1 6.5 0.8 10.0 2.3 2.9 4.4 8.1 3.2 0.6 3.2 49.8 5.1 0.5 4.4 12.7 4.7 5.7 1.4 0.3 0.3 1.5 21.4 3.0 3.4 0.2 24.9 1.4 2.8 0.5 1.6 7.4 0.2 0.0 2.7 9.8 0.4 1.9 1.3 1.4 11.9 1.0 0.5 0.2 1.8 2.2 13.9 0.2 1.7 0.4 11.2 19.3 11.0 0.8 2.6 18.8 3.0 5.3 0.3 5.7 2.8 11.5 3.9 0.0 2.7 12.9 9.1 5.5 15.4 8.3 12.2 6.8 5.0 5.6 8.0 6.0 5.8 3.0 4.7 34.8 5.1 19.8 3.7 5.0 6.3 4.5 5.6 2.2 5.9 4.6 4.1 4.9 3.9 6.6 4.3 437.7 110.8 20.8 247.6 53.8 4.8 7.3 53.5 97.7 139.9 41.8 23.6 41.8 8.3 54.6 6.0 101.8 77.5 0.0 17.3 34.2 31.7 54.5 61.4 16.3 13.3 9.5 103.9 91.4 24.8 2.9 6.9 22.9 23.6 1.8 90.0 104.5 46.5 35.1 27.3 20.3 12.2 25.8 25.0 1.1 0.5 18.1 35.8 41.5 37.6 69.7 NEFH ENSG00000100285 "Neurofilament heavy" P12036 22 29480230-29491390 "Disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 87.6;prostate: 116.0" "Group enriched" "Detected in many" 5 "Glandular cells: 29.5;monocytes: 59.5;Spermatogonia: 28.8" "Group enriched" "Detected in many" 7 "prostate cancer: 130.0;testis cancer: 31.8" "Region enhanced" "Detected in many" "pons and medulla: 87.6" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.4" "Lineage enriched" "Detected in many" 5 "monocytes: 7.4" "Cell line enriched" "Detected in some" 5 "SiHa: 63.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007786, HPA061615" Enhanced NA NA "CAB007786: AB_598179, HPA061615: AB_2684568" "prognostic favorable (2.33e-6)" "unprognostic (6.17e-3)" "unprognostic (9.74e-2)" "unprognostic (3.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.19e-3)" "unprognostic (2.63e-4)" "unprognostic (2.95e-2)" "unprognostic (1.68e-1)" "unprognostic (6.42e-2)" "unprognostic (5.85e-2)" "unprognostic (6.64e-3)" "unprognostic (1.57e-3)" "unprognostic (1.54e-1)" "unprognostic (2.59e-1)" "unprognostic (1.31e-2)" "unprognostic (1.47e-1)" 1.0 8.4 3.3 1.4 5.4 1.0 1.4 7.1 31.6 0.9 0.9 2.2 0.0 0.9 1.0 1.1 0.8 0.8 0.9 0.8 8.3 17.1 1.2 0.9 0.9 1.1 34.8 2.3 10.0 0.8 0.8 3.9 1.0 87.6 116.0 1.0 4.0 1.1 1.0 0.8 0.8 1.0 1.2 17.9 1.2 0.8 3.6 0.1 0.0 0.8 0.0 1.2 0.8 0.0 0.2 1.1 0.0 7.4 0.4 1.6 1.2 0.0 0.0 0.8 0.2 0.0 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 3.4 0.0 0.0 0.0 0.0 3.0 12.0 0.0 8.8 0.0 0.5 0.0 3.7 1.3 0.0 0.1 0.0 0.0 0.4 0.0 9.3 0.0 4.1 0.0 4.0 0.4 6.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 6.9 63.4 0.0 0.0 2.2 0.0 3.4 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.8 4.8 1.6 0.2 0.9 0.7 1.1 0.1 0.3 1.0 0.0 0.4 7.4 0.3 0.4 1.2 3.3 5.4 7.1 31.6 8.3 17.1 34.8 2.3 87.6 0.1 0.0 0.0 0.0 1.2 0.1 2.8 0.7 0.0 0.0 0.0 1.8 2.0 1.0 0.0 0.1 0.3 0.7 0.0 0.0 0.3 0.8 0.6 29.5 1.1 0.0 5.0 7.9 0.0 0.0 1.3 0.6 5.5 3.1 1.7 59.5 0.0 3.3 0.2 0.0 2.8 1.0 6.5 6.5 1.0 2.9 28.8 0.1 0.3 0.0 0.0 0.7 NEFL "CMT1F, CMT2E, NF68, NFL, PPP1R110" ENSG00000277586 "Neurofilament light" P07196 8 24950955-24957110 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 95.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 32.2;Distal tubular cells: 87.9;Horizontal cells: 28.6;Intestinal endocrine cells: 32.1;Muller glia cells: 29.9;Rod photoreceptor cells: 73.4" "Cancer enhanced" "Detected in many" "renal cancer: 24.0" "Cell type enriched" "Detected in some" 5 "memory CD4 T-cell: 13.7" "Lineage enriched" "Detected in single" 138 "T-cells: 13.7" "Group enriched" "Detected in some" 5 "HEK 293: 114.9;PC-3: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014850, HPA015021" Enhanced Supported Approved "Nucleoplasm,Intermediate filaments,Midbody" NA NA "Nucleoplasm, Intermediate filaments" Midbody "HPA014850: AB_1854397, HPA015021: AB_2669135" "unprognostic (7.63e-2)" "unprognostic (1.36e-2)" "unprognostic (9.53e-2)" "unprognostic (6.81e-2)" "unprognostic (2.82e-2)" "unprognostic (6.69e-2)" "unprognostic (3.69e-2)" "unprognostic (3.78e-3)" "unprognostic (3.06e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.91e-4)" "unprognostic (5.76e-3)" "unprognostic (7.88e-2)" "unprognostic (3.97e-3)" "unprognostic (3.17e-3)" 0.7 12.0 10.3 1.4 20.1 0.6 0.6 2.3 92.1 1.8 1.8 3.0 0.0 1.0 0.7 0.8 3.8 0.7 0.6 0.6 14.1 3.5 0.6 0.6 0.7 0.0 23.8 0.7 0.7 0.6 0.0 0.6 95.1 1.6 1.5 5.0 0.6 9.5 0.6 0.7 1.7 1.2 18.0 0.7 1.1 1.6 2.1 0.0 1.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 13.7 2.1 0.0 0.1 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.1 0.0 0.0 114.9 0.0 0.0 0.0 5.1 0.0 0.1 1.9 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.9 0.0 30.8 0.0 0.0 0.0 7.1 1.0 6.4 6.5 2.6 0.0 0.4 0.5 0.0 0.0 0.0 0.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 1.5 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.0 32.2 0.4 0.0 0.0 0.0 0.0 7.9 0.0 87.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 8.9 0.0 73.4 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 NEFM "NEF3, NF-M, NFM" ENSG00000104722 "Neurofilament medium" P07197 8 24913012-24919098 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 144.7" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 26.9;Early spermatids: 68.8;Late spermatids: 86.3;Rod photoreceptor cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enriched" "Detected in some" 23 "HEK 293: 292.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010900, CAB012976, HPA022845, HPA023138" Enhanced Enhanced "Intermediate filaments" Yes NA "Intermediate filaments" "CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398" "unprognostic (1.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.59e-2)" "unprognostic (9.38e-2)" "unprognostic (5.17e-2)" "unprognostic (6.32e-3)" "unprognostic (6.10e-3)" "unprognostic (2.57e-1)" "unprognostic (8.55e-3)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-2)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (4.76e-2)" "unprognostic (2.61e-2)" 1.5 18.9 20.3 2.0 24.2 1.3 1.3 10.9 87.6 9.7 2.0 5.6 0.0 1.3 3.8 1.3 4.7 1.3 1.4 1.3 36.1 25.0 2.2 1.2 1.3 1.3 52.2 22.4 2.0 2.5 1.2 3.3 1.4 144.7 2.5 1.9 3.4 1.3 26.9 1.9 1.3 1.5 3.3 26.7 1.3 1.5 12.4 4.9 0.0 1.3 0.0 1.6 1.3 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 292.9 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 24.2 10.9 71.9 36.1 25.0 52.2 22.4 144.7 4.9 0.0 0.0 0.0 0.1 1.1 26.9 2.0 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 68.8 0.6 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.1 19.1 3.4 0.0 0.0 86.3 0.9 0.0 1.7 0.0 0.0 20.8 0.0 0.0 4.2 0.4 46.9 0.0 1.3 2.2 1.3 0.3 0.0 0.0 0.0 0.3 NEGR1 "IGLON4, KILON, MGC46680, Ntra" ENSG00000172260 "Neuronal growth regulator 1" Q7Z3B1 1 71395940-72282734 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Cell type enhanced" "Detected in many" 20 "Bipolar cells: 41.5;Leydig cells: 194.8;Peritubular cells: 42.1;Rod photoreceptor cells: 57.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1;plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 16.0;TIME: 16.3;U-2 OS: 13.6;U-251 MG: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011894 Uncertain Approved "Vesicles,Actin filaments,Cytosol" NA NA 390000000 "Vesicles, Actin filaments, Cytosol" "HPA011894: AB_1854363" "unprognostic (2.60e-1)" "unprognostic (1.89e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (7.99e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.94e-2)" "unprognostic (8.15e-2)" "unprognostic (8.73e-2)" "unprognostic (3.38e-2)" "unprognostic (1.36e-1)" "unprognostic (3.31e-5)" "unprognostic (5.89e-3)" "unprognostic (1.31e-1)" "unprognostic (1.43e-3)" "unprognostic (2.11e-4)" 17.5 7.8 18.1 7.6 16.3 2.2 7.3 24.1 41.5 8.0 14.7 2.6 2.4 3.8 7.1 5.9 13.6 5.9 13.5 10.7 11.2 14.8 8.8 1.1 5.4 2.4 8.7 26.3 8.4 6.0 1.5 4.6 4.1 5.9 9.9 10.3 3.2 3.6 7.6 5.9 5.5 6.3 25.5 10.2 1.5 7.6 4.4 3.0 0.3 3.8 1.5 1.6 20.1 9.1 0.5 3.3 1.1 0.4 0.4 0.4 0.1 0.2 0.1 0.5 0.2 16.0 12.7 0.1 11.1 4.2 6.1 7.5 0.1 0.1 0.2 0.1 12.2 0.2 0.3 0.0 0.0 13.3 0.2 0.1 0.1 2.2 0.1 1.3 0.2 0.3 6.1 0.0 5.2 0.9 9.1 7.2 0.2 0.1 0.5 11.3 0.1 0.1 0.2 1.8 0.2 6.4 7.7 11.9 0.2 1.0 0.2 0.9 1.0 3.9 0.1 0.1 0.3 0.1 0.2 16.3 1.4 13.6 0.6 13.8 0.3 0.2 0.1 3.1 7.4 4.8 1.1 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.3 3.1 0.5 0.3 0.3 0.8 0.4 0.4 3.3 0.2 0.1 18.1 16.3 24.1 31.8 11.2 14.8 8.7 26.3 5.9 3.0 0.0 0.3 0.0 0.5 4.4 41.5 4.0 0.0 12.0 4.5 0.0 25.5 0.0 0.0 1.5 4.9 2.9 0.0 0.0 0.0 0.0 29.4 1.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 7.1 194.8 2.2 8.5 0.0 0.0 10.8 0.6 0.0 42.1 1.4 57.5 32.3 6.6 0.7 1.5 3.0 0.0 0.0 0.0 0.7 NEIL3 "FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3" ENSG00000109674 "Nei like DNA glycosylase 3" Q8TAT5 4 177309836-177362943 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lymphoid tissue: 70.8" "Cell type enhanced" "Detected in some" 8 "Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065761 Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA065761: AB_2685555" "unprognostic (6.03e-2)" "unprognostic (5.79e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (5.45e-4)" "unprognostic (4.91e-2)" "unprognostic (2.05e-1)" "unprognostic (3.64e-7)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (6.51e-4)" "unprognostic (2.82e-3)" "unprognostic (0.00e+0)" "unprognostic (3.25e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (1.04e-2)" 0.5 0.4 0.2 7.4 0.2 9.3 0.7 0.1 0.2 0.8 1.5 0.1 0.1 1.5 0.5 0.1 5.6 0.2 0.3 0.5 0.2 0.2 0.4 0.4 0.9 5.1 0.2 0.1 0.3 0.2 0.0 0.2 1.6 0.2 0.2 2.1 0.2 0.8 0.1 0.2 3.4 1.7 0.5 0.7 1.5 0.8 3.5 0.3 70.8 0.2 1.1 5.0 0.7 1.3 0.2 0.3 0.8 0.0 1.6 1.6 0.2 7.1 5.9 6.3 3.1 0.7 1.3 3.1 8.8 3.3 9.8 5.8 2.1 6.3 7.9 1.3 2.3 9.7 3.3 6.6 3.5 14.3 26.6 4.3 5.4 4.7 5.6 0.2 29.0 3.7 0.1 0.2 10.1 2.2 2.0 3.7 20.5 5.6 38.1 6.3 3.1 29.3 11.1 2.9 2.1 4.4 6.0 4.3 2.5 2.5 0.9 5.0 3.4 4.4 5.1 2.4 2.9 4.2 7.6 1.7 5.9 4.6 3.0 8.9 2.6 1.7 12.5 3.9 10.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 0.2 0.0 1.1 0.8 1.6 0.0 0.3 1.6 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.6 2.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.9 3.0 1.1 0.2 0.5 0.4 0.1 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 31.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 97.7;Cone photoreceptor cells: 82.5;Early spermatids: 98.7;Late spermatids: 45.8" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ: 7.7;LHCN-M2: 10.6;U-2 OS: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favorable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.4 0.5 4.5 0.5 14.6 0.4 14.2 0.6 6.8 1.6 2.0 1.1 2.0 2.5 0.9 8.3 2.0 10.5 2.1 3.1 8.4 3.8 1.4 2.5 4.5 0.6 0.8 6.7 2.7 0.8 0.5 9.0 0.3 3.4 1.9 0.7 1.3 0.5 1.4 10.5 0.4 1.0 1.2 0.8 0.6 1.1 31.4 1.3 0.3 0.8 0.3 0.7 1.4 0.4 0.4 0.2 1.9 0.1 0.1 0.6 0.1 1.0 2.1 1.1 1.2 0.9 2.1 0.4 7.7 1.2 2.1 1.9 0.0 0.5 0.7 1.9 3.2 1.5 0.1 0.5 0.5 2.3 1.4 0.8 0.2 4.1 3.7 0.2 0.4 1.0 2.5 0.5 3.3 0.1 2.7 1.5 4.4 0.1 0.7 10.6 0.1 0.8 0.5 0.7 0.2 0.3 1.0 0.4 0.3 4.1 0.6 0.2 0.2 1.2 0.5 0.6 0.8 6.2 0.4 0.9 5.7 9.0 0.3 0.8 0.3 0.2 0.5 4.8 0.9 2.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.5 0.4 0.0 0.4 0.1 0.5 1.9 0.1 0.0 0.2 0.0 0.1 4.5 14.6 0.6 6.8 8.4 3.8 0.8 6.7 3.4 1.3 6.0 0.0 0.0 0.2 0.2 4.0 10.2 2.5 97.7 13.6 1.8 82.5 0.0 0.0 0.3 98.7 0.7 0.7 0.0 0.0 0.2 2.9 1.5 0.0 0.5 0.2 0.0 0.0 0.6 1.3 45.8 1.7 0.4 0.0 0.0 0.1 1.4 0.2 0.6 1.1 0.0 19.6 0.0 1.1 25.4 1.7 0.4 0.0 0.0 0.1 0.1 NEK11 FLJ23495 ENSG00000114670 "NIMA related kinase 11" Q8NG66 3 131026850-131350465 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.9" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 148.5;Early spermatids: 122.2;Late spermatids: 80.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016908 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA016908: AB_1854364" "unprognostic (9.15e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (4.85e-3)" "unprognostic (2.48e-5)" "unprognostic (5.38e-2)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "prognostic favorable (5.92e-6)" "unprognostic (2.46e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" 3.9 5.8 9.3 2.7 11.1 0.5 8.7 2.7 7.6 7.3 2.8 11.2 8.4 2.0 6.5 16.0 3.2 26.9 6.0 2.9 9.1 10.0 8.2 1.1 5.5 1.7 7.8 5.4 8.7 2.8 5.0 9.3 4.6 17.3 4.0 3.3 3.0 3.8 6.7 1.7 2.8 2.6 4.3 7.3 1.8 2.3 17.8 5.5 0.2 12.3 2.5 1.7 4.2 3.0 0.9 1.0 1.1 1.3 0.3 2.9 0.3 5.9 2.4 1.8 5.2 7.0 10.5 1.0 2.9 5.5 4.5 3.4 2.2 8.3 0.3 2.1 5.2 4.3 3.3 0.5 5.1 6.3 0.6 0.7 0.8 0.4 1.0 2.3 0.6 1.5 4.4 8.5 4.8 2.2 4.8 0.9 2.6 0.2 0.9 7.5 4.2 0.1 0.5 0.5 0.9 2.3 0.0 0.2 0.1 10.3 2.3 2.2 2.5 1.4 0.1 2.0 0.8 4.9 0.1 0.9 4.7 2.3 3.6 1.4 1.4 2.3 0.1 3.2 0.2 0.8 0.0 0.3 1.1 0.6 1.3 1.2 0.9 2.9 2.6 0.5 0.6 1.0 0.8 0.9 0.3 0.9 1.0 1.5 0.3 9.3 11.1 2.7 7.6 9.1 10.0 7.8 5.4 17.3 5.5 14.9 2.7 0.0 3.4 3.8 2.7 1.1 2.5 148.5 29.6 1.8 5.9 0.5 5.0 4.7 122.2 2.4 1.7 0.0 2.2 1.0 5.4 1.4 0.0 0.0 1.8 0.0 2.4 2.5 0.0 80.8 6.4 1.4 0.0 1.0 2.7 5.7 2.9 3.7 5.6 8.4 6.9 6.5 2.2 30.5 4.9 1.8 1.4 0.0 1.7 1.8 NEK2 "NEK2A, NLK1, PPP1R111, RP67" ENSG00000117650 "NIMA related kinase 2" P51955 1 211658657-211675630 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.0;testis: 41.0" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 44.4;Erythroid cells: 93.5;Spermatocytes: 191.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.2" "Not detected" "Not detected" "CAB017530, HPA064967" Enhanced Supported Nucleoplasm,Centrosome NA Yes "Nucleoplasm, Centrosome" "CAB017530: AB_1126558, HPA064967: AB_2685393" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (1.83e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (9.47e-6)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.95e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-3)" "unprognostic (8.49e-2)" "unprognostic (0.00e+0)" "unprognostic (8.21e-2)" "unprognostic (4.11e-2)" "unprognostic (1.25e-2)" "unprognostic (2.71e-1)" 1.1 0.7 0.6 6.7 0.5 7.4 1.3 0.3 0.9 0.9 2.5 0.3 0.3 3.4 0.3 1.2 4.2 0.7 1.4 0.9 1.0 0.3 0.6 0.6 1.0 3.9 0.3 0.3 0.6 0.3 0.0 0.3 1.2 0.4 0.9 3.6 0.4 1.0 0.3 0.3 1.8 3.0 0.6 0.6 1.6 1.1 41.0 0.4 14.0 0.3 1.5 4.8 0.6 1.6 1.8 0.9 2.7 0.5 3.9 4.3 0.9 30.7 22.2 17.0 12.2 1.0 1.7 18.8 11.9 11.2 21.0 18.1 11.8 30.3 16.4 5.7 9.2 13.3 16.5 14.8 8.9 26.5 25.0 12.3 7.8 19.4 15.9 0.1 15.4 10.7 0.5 1.1 16.1 17.4 5.1 13.5 16.7 21.4 28.8 21.0 8.6 16.8 10.4 16.1 19.9 11.4 16.6 26.1 24.9 7.3 8.8 15.4 17.1 17.2 19.2 14.9 15.2 29.6 9.2 7.0 10.5 20.8 20.6 31.9 11.9 22.0 21.7 9.1 11.9 17.4 2.7 0.5 0.4 0.5 0.3 0.2 1.5 0.6 0.3 0.1 1.8 1.1 0.7 2.4 3.9 0.4 0.9 4.3 0.9 0.6 0.5 0.3 0.9 1.0 0.3 0.3 0.3 0.4 0.4 0.0 0.3 0.8 0.5 2.6 0.7 0.4 0.0 2.7 3.4 0.0 0.0 0.9 0.0 0.1 44.4 0.1 1.1 93.5 0.2 11.4 0.2 0.3 0.0 0.0 4.7 3.2 0.0 2.5 2.8 28.5 2.3 1.1 0.0 0.0 1.2 0.8 0.0 0.8 0.7 0.0 1.9 6.5 0.0 191.1 25.4 1.5 1.1 0.7 2.3 0.9 NEK4 "NRK2, pp12301, STK2" ENSG00000114904 "NIMA related kinase 4" P51957 3 52708449-52770949 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 47.7" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 58.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015750, HPA058543" Enhanced Supported Cytosol NA NA Cytosol "HPA015750: AB_1854367, HPA058543: AB_2732623" "unprognostic (1.32e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.69e-5)" "unprognostic (9.65e-3)" "unprognostic (3.42e-1)" "unprognostic (6.64e-2)" "unprognostic (8.75e-3)" "unprognostic (2.27e-1)" "unprognostic (7.85e-2)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.74e-3)" "unprognostic (5.11e-2)" "unprognostic (2.85e-1)" "unprognostic (1.51e-2)" "unprognostic (8.39e-2)" 7.2 10.7 15.5 9.1 15.7 7.3 11.0 20.2 16.1 10.6 8.4 10.6 9.6 7.6 10.3 10.7 8.1 15.8 7.5 7.4 12.5 14.2 11.6 12.4 7.7 8.8 12.7 8.6 15.8 10.2 13.4 17.6 8.7 11.9 9.4 9.7 9.1 8.5 11.3 10.8 5.3 6.6 9.5 10.7 7.9 11.0 47.7 12.4 11.1 15.5 5.0 10.4 9.3 10.7 5.1 6.4 12.4 11.8 4.6 5.2 5.5 12.9 10.1 13.9 10.9 12.7 9.2 15.1 9.2 12.5 17.3 17.5 8.8 9.7 13.3 4.3 9.0 19.1 6.1 16.9 10.9 23.2 13.3 7.1 10.4 12.3 11.2 7.9 25.4 10.5 5.6 10.1 22.1 14.8 9.2 6.4 11.7 12.9 10.9 10.9 11.1 13.7 9.3 12.0 13.7 10.0 12.0 12.1 9.8 9.8 18.7 10.3 6.1 19.4 11.9 9.1 11.2 11.1 15.3 5.9 11.6 11.8 18.5 17.0 12.2 17.7 13.1 13.3 12.0 12.5 12.4 11.8 5.8 4.6 7.3 5.2 3.6 4.0 4.8 6.4 5.1 4.9 4.2 1.8 4.6 4.8 3.2 3.1 5.5 15.5 15.7 20.2 16.1 12.5 14.2 12.7 8.6 11.9 12.4 11.9 5.1 9.5 4.6 3.7 12.7 3.5 0.0 21.4 15.9 5.2 11.8 6.1 8.3 6.4 16.2 5.3 5.1 0.0 8.4 6.8 4.6 6.5 7.0 13.4 7.2 6.4 4.6 4.9 14.9 16.1 13.6 7.0 1.7 5.4 9.6 16.2 7.8 0.0 11.7 14.6 17.4 6.5 5.9 58.3 31.9 3.6 5.6 5.3 8.2 4.1 NEK5 ENSG00000197168 "NIMA related kinase 5" Q6P3R8 13 52033611-52129078 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.8;fallopian tube: 12.7;testis: 15.7" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 172.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 3.5;OE19: 6.4;T-47d: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035565, HPA041399" Enhanced NA NA "HPA035565: AB_10672095, HPA041399: AB_2677453" "unprognostic (4.14e-2)" "unprognostic (1.49e-1)" "unprognostic (1.89e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-2)" "unprognostic (2.47e-1)" "unprognostic (3.57e-2)" "unprognostic (6.50e-2)" "unprognostic (8.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.94e-1)" "unprognostic (2.06e-3)" "unprognostic (1.83e-3)" "unprognostic (1.10e-1)" "unprognostic (1.19e-3)" "unprognostic (9.44e-3)" 0.6 0.3 3.2 1.4 3.2 0.7 0.9 0.4 2.6 0.9 0.4 5.4 0.3 0.5 2.5 3.0 0.4 12.7 0.5 1.3 3.2 1.6 0.9 0.3 4.9 0.5 0.7 1.3 2.8 0.5 0.9 5.3 0.8 11.8 1.5 0.4 0.3 0.5 0.3 0.6 0.5 0.4 0.5 0.9 0.4 0.3 15.7 2.1 0.0 0.7 0.0 0.3 0.4 0.4 0.9 1.1 2.5 0.5 0.6 0.4 0.0 0.4 0.5 0.3 1.7 0.2 1.1 2.2 0.0 0.0 0.0 0.2 0.1 1.1 0.5 0.2 0.0 0.1 0.4 0.2 0.4 0.0 0.1 0.3 0.6 0.6 0.4 0.3 1.1 1.3 0.3 0.8 0.1 0.6 0.4 0.2 3.5 1.2 0.8 0.0 1.3 0.6 0.8 0.5 6.4 0.6 0.2 0.1 0.0 1.9 0.5 0.6 0.8 0.4 0.0 1.0 1.0 3.3 1.3 0.4 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.1 0.2 0.3 2.5 0.5 0.1 0.3 0.3 0.4 0.5 0.2 0.2 0.1 0.9 0.3 0.3 0.9 0.6 0.1 1.1 0.2 0.0 3.2 3.2 0.4 2.6 3.2 1.6 0.7 1.3 11.8 2.1 0.0 1.3 2.2 1.7 0.0 8.0 1.6 2.5 172.6 21.6 7.0 13.7 2.2 1.7 1.1 43.0 1.7 0.8 0.0 2.6 1.5 1.1 3.2 2.3 0.9 1.0 12.7 1.7 0.6 0.0 24.4 2.0 0.8 0.0 1.0 0.3 2.4 0.7 0.0 2.1 1.0 11.4 6.5 0.3 21.1 12.0 0.1 1.6 0.0 1.0 0.8 NELL1 "FLJ45906, IDH3GL" ENSG00000165973 "Neural EGFL like 1" Q92832 11 20669551-21575681 "Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6;kidney: 24.2" "Cell type enhanced" "Detected in some" 20 "Distal tubular cells: 5.0;Early spermatids: 20.1;Late spermatids: 16.1" "Cancer enhanced" "Detected in many" "melanoma: 5.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051535 Approved "Secreted in other tissues" NA NA 120000 "HPA051535: AB_2681524" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.29e-2)" "unprognostic (5.35e-4)" "unprognostic (3.78e-4)" "unprognostic (1.67e-2)" "unprognostic (3.91e-1)" "unprognostic (4.38e-2)" "unprognostic (4.65e-2)" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" "unprognostic (4.23e-2)" "unprognostic (1.83e-1)" "unprognostic (2.29e-1)" 0.6 0.6 5.5 0.6 10.3 0.4 0.5 1.8 19.6 0.9 0.8 0.5 0.1 0.5 0.9 2.8 1.3 0.6 1.0 0.4 8.8 6.9 24.2 0.4 1.1 0.4 2.0 13.3 0.6 0.4 0.5 4.5 0.4 4.1 7.9 1.0 0.0 1.1 4.2 0.4 0.9 0.6 0.7 0.9 0.6 1.3 1.8 0.5 0.0 0.4 0.0 1.3 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.6 0.0 0.0 0.6 0.0 0.0 0.1 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 10.3 1.8 18.7 8.8 6.9 2.0 13.3 4.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.6 5.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.5 0.0 0.1 0.0 0.0 0.0 0.0 16.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.6 0.0 0.0 0.0 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;brain: 73.3;fallopian tube: 35.1" "Group enriched" "Detected in many" 6 "Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8" "Lineage enriched" "Detected in many" 11 "T-cells: 36.8" "Cell line enhanced" "Detected in some" "AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" NA NA 4700000 Vesicles "HPA035714: AB_2674746, HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favorable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.0 10.5 22.4 6.1 24.8 4.2 1.6 15.7 73.3 14.9 2.9 3.6 0.0 15.3 1.9 0.8 1.3 35.1 1.7 0.8 40.2 20.4 1.2 1.1 3.4 11.2 6.6 27.0 1.0 1.1 0.6 18.4 0.8 7.5 18.8 1.8 9.3 1.5 1.8 0.7 5.0 8.6 2.2 2.6 3.8 2.1 2.2 2.4 0.4 4.4 0.0 9.1 2.3 2.0 0.0 0.0 0.1 0.0 3.3 36.8 8.5 0.1 0.0 41.8 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 5.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 10.9 0.1 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.1 16.4 0.0 5.4 0.0 5.0 0.0 0.0 0.0 30.4 0.7 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 1.5 0.0 0.7 11.1 11.1 15.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 0.0 8.5 0.0 10.3 18.1 0.0 0.0 24.5 36.8 0.1 3.3 0.0 0.0 0.1 8.5 22.4 24.8 15.7 50.4 40.2 20.4 6.6 27.0 7.5 2.4 0.0 2.2 0.0 0.0 1.0 38.4 0.4 0.0 40.2 11.4 0.0 31.4 0.1 0.0 0.0 0.2 0.5 5.4 0.0 0.2 0.2 1.4 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 5.2 0.3 0.0 0.4 0.1 43.8 0.0 1.4 1.5 3.4 1.0 0.1 5.3 0.6 0.0 NEMP2 TMEM194B ENSG00000189362 "Nuclear envelope integral membrane protein 2" A6NFY4 2 190504342-190534722 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.3" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" HPA057719 Approved Nucleoplasm NA NA Nucleoplasm "HPA057719: AB_2683510" "unprognostic (3.51e-1)" "unprognostic (9.99e-2)" "unprognostic (1.11e-3)" "unprognostic (1.05e-2)" "unprognostic (2.06e-2)" "unprognostic (1.03e-1)" "unprognostic (8.65e-3)" "unprognostic (5.70e-2)" "unprognostic (1.06e-1)" "unprognostic (5.61e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (5.82e-2)" "unprognostic (7.76e-3)" "unprognostic (4.75e-3)" "unprognostic (1.32e-1)" 7.8 4.9 2.9 14.5 2.9 4.5 4.3 7.5 3.6 6.0 3.6 4.3 2.2 2.5 8.5 6.8 4.4 3.3 3.0 4.3 3.5 2.9 5.7 5.7 9.3 11.3 3.8 3.2 5.6 3.2 2.6 4.0 3.7 3.4 3.9 2.6 6.6 9.3 4.8 1.7 5.1 4.5 3.4 3.4 12.3 5.1 8.1 2.4 27.3 5.4 3.5 15.8 4.4 4.3 3.6 3.4 0.2 0.8 2.4 5.6 2.2 5.2 2.8 1.9 2.4 1.1 3.0 5.1 3.8 3.3 3.8 4.7 4.2 7.3 7.6 2.5 1.9 2.7 9.3 3.0 8.1 7.6 5.6 2.6 5.5 2.8 2.9 2.9 5.9 1.9 3.1 3.4 17.3 4.5 3.5 1.7 8.5 4.7 9.0 7.3 2.4 6.4 2.8 2.1 2.9 3.1 2.7 4.2 3.5 3.4 3.9 3.5 3.0 5.9 0.6 5.7 3.4 1.5 6.4 3.1 8.5 6.6 1.6 4.1 4.9 5.3 4.1 6.5 6.2 6.1 0.1 0.8 0.1 3.0 0.7 3.9 2.7 3.3 2.7 0.9 3.6 5.4 4.6 0.2 2.4 0.6 3.4 5.6 2.2 2.9 2.9 7.5 3.6 3.5 2.9 3.8 3.2 3.4 2.4 0.0 1.1 2.4 1.3 0.0 4.5 1.6 0.0 0.0 0.0 1.8 0.0 2.1 0.0 1.5 2.5 3.8 0.0 0.0 1.7 2.8 1.3 1.5 1.1 2.5 2.6 3.2 0.0 3.1 5.4 4.2 2.6 2.3 0.0 1.8 1.2 3.3 0.6 1.5 1.1 2.1 2.1 0.0 2.5 16.7 5.9 0.0 1.0 5.7 1.8 1.3 NES FLJ21841 ENSG00000132688 Nestin P48681 1 156668763-156677397 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.9" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 191.0;Endothelial cells: 67.1;Sertoli cells: 103.5;Smooth muscle cells: 44.2" "Group enriched" "Detected in all" 6 "glioma: 147.0;melanoma: 101.4;testis cancer: 34.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 92.5;HUVEC TERT2: 46.8;LHCN-M2: 74.7;RH-30: 76.5;SuSa: 52.8;WM-115: 36.1" "Low region specificity" "Detected in all" "CAB005889, HPA006286, HPA007007, HPA026111, CAB058692" Enhanced Enhanced "Intermediate filaments" No No "Intermediate filaments" "CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382" "unprognostic (7.73e-2)" "unprognostic (2.05e-1)" "unprognostic (2.80e-2)" "unprognostic (1.36e-1)" "unprognostic (6.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" "unprognostic (4.40e-2)" "unprognostic (7.56e-2)" "unprognostic (9.84e-2)" "unprognostic (4.49e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.02e-7)" "unprognostic (2.87e-1)" "unprognostic (2.48e-1)" "unprognostic (6.67e-2)" "unprognostic (8.11e-3)" 22.1 4.2 6.2 7.1 7.6 0.4 13.8 6.0 13.3 16.9 5.9 13.0 7.5 3.1 23.4 12.3 10.0 12.5 8.9 77.9 6.5 5.1 15.7 4.5 16.0 4.2 8.2 5.1 13.2 2.2 7.5 5.6 8.9 12.8 14.6 4.0 12.2 3.8 20.0 25.3 3.2 4.9 16.1 12.0 26.8 4.2 5.3 6.2 0.4 8.0 16.8 3.5 12.7 17.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 92.5 19.7 0.2 5.1 0.0 22.3 17.6 0.3 0.5 14.6 0.2 0.0 5.3 2.1 0.0 0.4 9.3 0.0 0.2 0.0 0.1 0.1 1.3 6.6 0.8 0.0 5.5 4.3 0.0 0.8 0.0 0.7 46.8 0.0 0.6 0.0 74.7 0.6 0.0 0.0 15.0 0.8 12.8 0.1 76.5 0.0 0.0 0.0 0.2 14.9 0.5 0.6 17.2 52.8 0.2 0.1 33.8 0.1 5.2 0.6 1.2 0.0 3.3 0.0 2.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 7.6 6.0 6.3 6.5 5.1 8.2 5.1 12.8 6.2 0.0 7.9 0.0 0.4 2.2 0.3 191.0 0.0 0.0 1.2 17.4 0.0 0.2 0.0 1.4 0.4 67.1 0.0 0.0 0.0 1.9 14.4 0.4 0.0 0.0 1.5 0.0 0.0 23.4 0.6 0.0 7.5 1.1 1.7 1.8 0.0 13.2 0.4 0.0 3.9 0.0 1.1 103.5 44.2 0.5 3.1 2.0 0.1 0.0 0.0 0.3 NETO1 "BCTL1, BTCL1" ENSG00000166342 "Neuropilin and tolloid like 1" Q8TDF5 18 72742314-72868146 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 47.9" "Cell type enriched" "Detected in some" 38 "Bipolar cells: 163.9" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 27 "memory B-cell: 1.6;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Cell line enhanced" "Detected in some" "MOLT-4: 15.1;NTERA-2: 6.9;REH: 14.9;RPMI-8226: 23.7;RT4: 15.7;SCLC-21H: 20.9;U-2 OS: 7.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA064630 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA064630: AB_2685305" "unprognostic (4.02e-2)" "unprognostic (4.08e-3)" "unprognostic (2.75e-1)" "unprognostic (1.55e-2)" "unprognostic (6.04e-2)" "unprognostic (1.35e-5)" "unprognostic (4.05e-1)" "unprognostic (4.73e-2)" "unprognostic (3.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.63e-2)" "unprognostic (1.20e-1)" "unprognostic (1.73e-2)" "unprognostic (3.70e-2)" "unprognostic (3.35e-2)" "unprognostic (1.59e-1)" "unprognostic (9.13e-3)" 2.0 0.8 9.1 1.3 18.3 1.0 1.7 0.4 47.9 0.9 0.9 0.7 0.0 0.8 0.9 0.9 1.0 0.8 0.9 1.4 15.9 3.9 1.0 0.8 0.9 3.8 3.0 15.1 0.8 0.8 1.0 0.3 0.8 5.0 0.9 1.1 3.9 1.1 0.8 0.8 1.2 0.8 0.8 1.1 4.0 0.9 2.0 2.8 0.8 2.3 0.0 2.7 1.2 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 6.9 0.0 0.0 14.9 0.0 23.7 3.7 15.7 20.9 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 18.3 0.4 22.8 15.9 3.9 3.0 15.1 5.0 2.8 0.0 0.0 0.0 0.0 0.0 163.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 NETO2 "FLJ10430, NEOT2" ENSG00000171208 "Neuropilin and tolloid like 2" Q8NC67 16 47077703-47143997 "Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6;lymphoid tissue: 23.8" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 40.0;Spermatogonia: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013180 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA013180: AB_1854383" "unprognostic (2.67e-2)" "unprognostic (3.46e-2)" "unprognostic (3.90e-1)" "unprognostic (1.51e-3)" "unprognostic (2.25e-1)" "unprognostic (5.26e-3)" "unprognostic (1.10e-2)" "unprognostic (5.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (5.53e-6)" "unprognostic (3.48e-2)" "unprognostic (1.66e-1)" "unprognostic (6.79e-2)" "unprognostic (1.32e-1)" 3.3 6.7 6.9 6.9 23.6 2.4 3.4 11.8 15.8 1.8 9.5 2.1 0.6 1.9 2.8 0.9 5.6 1.1 5.5 2.4 8.3 5.9 2.5 0.9 5.3 6.6 4.9 7.1 2.0 9.8 11.6 1.4 3.8 13.5 1.4 2.8 10.1 2.6 1.6 4.5 1.7 2.7 1.9 2.5 23.8 1.9 8.6 4.7 1.9 10.0 3.1 6.8 4.2 2.5 1.0 2.1 0.9 3.3 0.3 2.2 0.7 25.0 28.0 40.6 0.1 6.0 35.0 6.7 25.0 4.0 22.2 12.1 5.8 16.1 6.2 15.4 5.3 21.4 11.3 25.9 24.8 27.3 0.1 16.7 5.0 10.0 6.2 7.4 16.0 13.3 21.0 16.6 8.9 12.6 21.6 14.7 15.0 7.4 7.7 14.2 6.8 9.1 8.8 19.5 7.5 20.6 0.0 7.9 12.6 15.6 5.4 26.7 19.4 33.0 2.6 3.7 6.9 0.5 11.8 7.1 0.0 0.0 0.0 0.1 8.3 6.8 13.8 18.1 11.4 17.8 0.9 3.3 0.1 0.1 1.6 1.3 1.0 1.3 0.1 2.1 0.4 0.0 0.1 0.9 0.3 1.5 0.2 2.2 0.7 6.9 23.6 11.8 15.8 8.3 5.9 4.9 7.1 13.5 4.7 0.0 5.0 0.0 0.6 6.9 0.7 1.2 0.0 2.7 3.4 0.0 0.0 0.7 0.0 0.4 2.5 4.4 3.5 0.0 2.6 0.4 2.6 2.0 2.3 0.0 6.3 0.0 10.4 0.6 9.4 4.2 0.6 11.3 3.3 6.4 1.3 40.0 1.1 1.1 0.0 0.0 0.8 6.5 2.5 7.7 22.0 2.9 0.7 1.9 1.6 0.9 NEU2 SIAL2 ENSG00000115488 "Neuraminidase 2" Q9Y3R4 2 233032672-233035057 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "skin 1: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 1.1;BEWO: 1.6;PC-3: 3.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebral cortex: 2.2;hippocampal formation: 1.1" CAB022336 Uncertain NA NA 9000 "CAB022336: " "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEU3 ENSG00000162139 "Neuraminidase 3" Q9UQ49 11 74988134-75018893 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 58.9;Spermatocytes: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038729, HPA070381" Approved Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA038729: AB_2676179, HPA070381: " "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (2.55e-2)" "unprognostic (1.13e-3)" "unprognostic (2.95e-2)" "unprognostic (5.42e-2)" "unprognostic (1.63e-1)" "unprognostic (5.11e-2)" "unprognostic (3.91e-3)" "unprognostic (8.50e-2)" "prognostic favorable (5.98e-4)" "unprognostic (3.57e-3)" "unprognostic (3.80e-2)" "unprognostic (3.79e-1)" "unprognostic (2.38e-1)" "unprognostic (3.73e-1)" "unprognostic (1.84e-1)" 5.4 13.4 3.7 10.5 6.9 17.0 5.4 7.9 9.1 4.0 3.9 3.0 4.1 3.6 5.4 4.8 3.9 4.4 3.6 5.9 4.0 4.5 4.3 6.7 8.7 9.0 3.8 6.6 7.2 7.3 15.1 11.2 3.1 4.2 9.7 5.4 5.6 4.8 4.6 19.1 6.7 4.7 4.0 3.5 5.5 5.1 44.6 3.0 19.0 6.8 3.5 7.5 4.5 3.1 3.2 3.8 5.8 6.4 1.2 4.2 2.2 4.6 4.0 3.4 6.6 2.6 2.5 3.8 4.5 2.9 5.2 4.0 13.7 3.9 13.3 4.6 3.6 6.6 4.3 8.2 5.8 7.9 7.0 4.4 10.9 7.4 5.6 2.9 17.2 10.6 3.0 4.9 5.2 8.1 3.4 3.7 19.0 17.7 10.0 5.9 5.0 16.9 8.9 4.2 9.1 5.4 14.8 9.0 11.7 6.4 4.9 6.3 4.0 6.9 4.6 20.2 4.2 9.8 4.4 5.6 6.5 6.5 4.3 4.5 8.2 8.0 26.6 1.9 8.9 5.5 2.1 6.4 5.8 4.1 3.7 3.0 2.8 3.2 3.9 3.8 3.2 3.5 4.2 3.3 1.2 4.6 2.7 2.3 2.2 3.7 6.9 7.9 9.1 4.0 4.5 3.8 6.6 4.2 3.0 3.0 5.8 2.2 1.8 0.5 7.2 7.3 2.5 2.7 4.5 1.8 58.9 1.8 0.0 1.0 5.7 1.6 1.3 0.0 2.6 1.2 1.5 2.7 1.1 7.2 4.8 11.1 6.9 4.3 8.6 5.3 1.4 4.5 0.0 4.6 2.9 2.9 2.7 0.0 1.8 3.3 5.8 0.0 2.2 32.5 1.7 0.5 1.1 3.5 3.2 0.4 NEU4 ENSG00000204099 "Neuraminidase 4" Q8WWR8 2 241808825-241817413 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 27.1;liver: 42.9" "Cell type enhanced" "Detected in some" 14 "Enterocytes: 65.6;Hepatocytes: 117.5;Intestinal endocrine cells: 33.1;Mucus-secreting cells: 40.3;Paneth cells: 66.2;Undifferentiated cells: 40.1" "Group enriched" "Detected in some" 7 "colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "Hep G2: 22.5;HMC-1: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037394 Enhanced NA NA "HPA037394: AB_2675455" "unprognostic (1.50e-1)" "unprognostic (2.39e-3)" "unprognostic (1.85e-1)" "unprognostic (3.68e-4)" "unprognostic (3.76e-2)" "unprognostic (1.57e-1)" "unprognostic (8.70e-2)" "unprognostic (8.62e-2)" "unprognostic (1.74e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-2)" "unprognostic (2.92e-1)" "unprognostic (8.11e-4)" "unprognostic (2.00e-2)" "unprognostic (3.82e-1)" "unprognostic (6.64e-3)" "unprognostic (1.55e-2)" 0.6 0.5 6.5 0.7 5.3 5.7 0.3 1.9 7.0 0.6 13.9 4.9 0.0 9.3 0.3 0.3 0.7 1.1 2.6 0.6 6.4 5.8 1.4 42.9 0.4 0.5 6.9 4.4 0.4 0.3 0.3 0.4 0.4 3.8 0.5 6.1 0.0 0.4 0.4 3.6 0.3 27.1 0.4 4.1 0.5 0.5 0.6 2.3 0.0 0.4 2.8 0.3 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.5 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 5.3 1.9 4.0 6.4 5.8 6.9 4.4 3.8 2.3 0.0 0.0 0.9 0.0 0.0 0.7 0.5 0.0 0.0 0.0 1.8 0.0 0.0 3.3 0.0 0.0 0.0 65.6 0.0 0.0 0.0 0.2 0.0 1.1 117.5 1.2 0.0 33.1 0.6 3.2 0.0 0.6 0.7 0.0 0.0 40.3 26.2 0.0 66.2 0.7 8.6 1.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 40.1 0.1 NEURL1 "h-neu, neu-1, NEURL, RNF67" ENSG00000107954 "Neuralized E3 ubiquitin protein ligase 1" O76050 10 103493979-103592552 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Translation regulation, Ubl conjugation pathway" Transferase "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.1;skeletal muscle: 83.5" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 105.4;Late spermatids: 383.1;Paneth cells: 157.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "intermediate monocyte: 16.0;non-classical monocyte: 37.1" "Lineage enriched" "Detected in many" 17 "monocytes: 37.1" "Cell line enhanced" "Detected in some" "BEWO: 13.0;HeLa: 7.7;HMC-1: 6.6;JURKAT: 6.9;SCLC-21H: 16.4;SiHa: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044204 Enhanced NA NA "HPA044204: AB_10959383" "unprognostic (1.21e-2)" "unprognostic (8.14e-2)" "unprognostic (1.18e-3)" "unprognostic (1.58e-4)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (5.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (4.31e-2)" "unprognostic (1.32e-3)" "unprognostic (1.08e-1)" "unprognostic (8.61e-3)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.91e-4)" "unprognostic (3.23e-1)" 1.1 3.9 18.5 3.0 17.5 2.0 1.0 28.2 27.2 6.1 8.6 0.6 1.2 7.7 13.2 11.0 3.6 2.1 2.0 1.1 12.0 7.6 1.3 1.1 1.3 1.3 4.5 18.9 2.1 12.8 2.9 6.5 13.3 6.1 2.8 7.3 7.8 1.5 1.7 83.5 1.9 11.7 11.7 1.2 2.0 4.4 7.5 2.1 0.0 1.2 8.5 1.1 9.2 1.7 0.4 2.1 1.0 37.1 0.2 0.4 1.2 0.8 0.2 1.3 0.0 0.4 0.1 13.0 0.5 0.8 0.2 0.1 0.3 0.3 0.4 0.7 0.1 0.9 0.7 0.4 0.2 0.1 0.3 0.7 0.2 7.7 0.6 0.0 0.3 6.6 0.2 0.5 0.1 0.6 0.2 0.0 6.9 2.1 0.4 0.2 1.1 1.3 0.8 0.0 0.5 3.9 0.2 0.6 1.4 0.0 0.5 16.4 5.6 8.2 0.0 0.4 2.5 0.7 1.5 0.0 0.1 0.9 0.2 0.2 0.9 0.2 0.3 0.5 0.0 0.3 0.2 1.0 0.2 0.3 16.0 0.4 0.4 0.4 0.4 2.1 0.3 0.4 0.3 1.0 0.2 37.1 1.7 0.1 1.2 18.5 17.5 28.2 27.2 12.0 7.6 4.5 18.9 6.1 2.1 0.0 1.1 1.4 1.3 0.5 42.1 1.2 0.0 0.0 0.0 0.0 88.4 3.4 0.0 9.1 105.4 1.0 6.9 0.0 0.6 10.0 1.9 0.5 0.0 0.0 4.2 3.2 75.1 0.0 4.1 383.1 5.2 2.0 0.0 0.0 92.0 6.4 0.9 157.0 4.9 0.0 83.3 6.5 0.6 47.6 28.8 1.6 94.9 3.9 7.8 0.5 NEURL3 "Lincr, LOC93082, RNF132" ENSG00000163121 "Neuralized E3 ubiquitin protein ligase 3" Q96EH8 2 96497643-96508109 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 26.3;salivary gland: 22.4;seminal vesicle: 10.8" "Cell type enhanced" "Detected in many" 21 "Ductal cells: 94.8;Exocrine glandular cells: 31.1;monocytes: 20.8;Pancreatic endocrine cells: 20.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.1;CAPAN-2: 16.7;GAMG: 6.0;RPMI-8226: 10.5;RT4: 5.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (4.97e-2)" "unprognostic (6.07e-2)" "unprognostic (7.22e-2)" "unprognostic (1.42e-2)" "unprognostic (2.49e-2)" "unprognostic (4.35e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.29e-1)" "unprognostic (9.55e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (8.14e-3)" "unprognostic (1.23e-2)" "unprognostic (5.83e-2)" "unprognostic (6.57e-2)" "unprognostic (2.44e-1)" "unprognostic (6.57e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.0 0.9 0.9 0.0 0.1 0.0 0.0 1.3 0.0 0.0 5.3 0.6 1.8 0.0 0.0 0.1 0.0 26.3 0.0 0.0 0.0 0.2 1.4 0.1 0.0 22.4 10.8 0.4 0.0 1.2 0.0 0.2 0.0 0.1 0.2 0.0 6.4 0.0 0.5 0.1 0.4 0.0 0.3 0.2 0.7 0.1 0.1 0.1 3.0 1.0 0.5 0.0 0.3 0.0 0.0 4.1 0.0 0.4 0.3 0.2 2.4 16.7 0.0 1.3 0.0 6.0 2.5 0.2 0.0 0.0 0.6 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.4 0.0 0.0 10.5 2.2 5.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.5 0.3 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.1 0.0 0.7 0.1 0.0 0.0 0.1 3.0 0.0 1.0 1.3 10.0 0.0 0.0 0.4 2.5 0.0 1.2 8.7 0.0 0.1 3.3 94.8 0.0 0.0 7.9 0.0 31.1 0.0 0.0 13.5 0.0 0.0 1.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.5 0.7 20.7 2.3 0.0 3.6 0.0 0.0 0.3 0.4 1.1 0.0 0.0 0.0 0.6 4.3 NEUROD1 "BETA2, BHF-1, bHLHa3, MODY6, NeuroD" ENSG00000162992 "Neuronal differentiation 1" Q13562 2 181673088-181680876 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 101.9" "Cell type enhanced" "Detected in some" 26 "Cone photoreceptor cells: 141.4;Intestinal endocrine cells: 408.1;Rod photoreceptor cells: 170.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.3" "Region enriched" "Detected in many" 16 "cerebellum: 101.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 72 "SCLC-21H: 81.2" "Region enriched" "Detected in many" 14 "cerebellum: 242.4" "Region enriched" "Detected in many" 20 "cerebellum: 447.6" "HPA003278, CAB022450" Approved NA NA "CAB022450: , HPA003278: AB_1845331" "unprognostic (1.29e-1)" "prognostic favorable (1.34e-4)" "unprognostic (6.92e-3)" "unprognostic (1.27e-1)" 0.2 0.2 6.3 0.2 0.8 0.1 0.2 101.9 5.6 0.2 3.1 0.0 0.0 8.9 0.2 0.1 0.2 0.2 0.0 0.2 4.7 0.4 0.2 0.2 0.2 0.0 0.4 1.2 0.2 13.3 0.0 0.8 0.0 3.9 0.2 1.9 14.4 0.2 0.0 0.2 0.2 5.8 0.0 1.4 0.2 7.6 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.1 1.0 3.5 1.8 1.4 1.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.6 1.0 0.8 1.1 1.5 1.1 1.1 0.8 0.8 1.0 1.3 1.4 1.8 1.4 1.8 1.0 1.0 0.7 6.3 0.8 101.9 2.5 4.7 0.4 0.4 1.2 3.9 0.0 0.0 0.0 0.0 0.1 0.0 61.1 0.3 0.0 0.0 0.0 0.0 141.4 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 408.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 17.4 2.8 0.2 0.0 0.0 170.4 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.1 NEUROD2 "bHLHa1, NDRF" ENSG00000171532 "Neuronal differentiation 2" Q15784 17 39603536-39609777 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "brain: 51.4" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 7.7;Cone photoreceptor cells: 3.9;Intestinal endocrine cells: 22.8" "Cancer enhanced" "Detected in some" "cervical cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 245 "SCLC-21H: 24.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "amygdala: 28.0;cerebellum: 127.9;cerebral cortex: 45.1;hippocampal formation: 107.5" NA NA "unprognostic (5.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.87e-1)" "unprognostic (3.51e-3)" "unprognostic (2.44e-2)" "unprognostic (3.04e-1)" "unprognostic (4.69e-1)" "unprognostic (1.72e-1)" "unprognostic (2.16e-1)" "unprognostic (3.96e-1)" "unprognostic (6.15e-2)" "unprognostic (4.09e-2)" "unprognostic (3.21e-6)" "unprognostic (4.20e-1)" "unprognostic (2.66e-1)" "unprognostic (2.52e-2)" "unprognostic (2.57e-3)" 0.7 0.7 10.9 0.7 8.3 0.7 0.7 51.4 22.1 0.7 0.7 0.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 18.8 0.6 0.7 0.7 0.7 0.7 1.1 18.3 0.7 0.7 0.7 0.2 0.7 12.3 0.7 0.7 0.0 0.7 0.7 0.7 0.8 0.7 0.7 1.1 0.7 0.9 0.7 0.0 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 8.3 51.4 18.8 18.8 0.6 1.1 18.3 12.3 0.0 0.0 0.0 0.0 0.7 0.2 7.7 1.2 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.2 0.0 22.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.5 0.3 0.0 0.7 0.0 0.0 1.0 NEUROD4 "ATH-3, Atoh3, bHLHa4, MATH-3" ENSG00000123307 "Neuronal differentiation 4" Q9HD90 12 55019945-55030014 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pituitary gland: 54.8" "Cell type enriched" "Detected in some" 16 "Bipolar cells: 170.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 3.7;SCLC-21H: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA015545 Enhanced NA NA "HPA015545: AB_2669215" "unprognostic (1.78e-2)" 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 54.8 0.0 0.7 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 170.1 2.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEUROD6 "Atoh2, bHLHa2, Math-2, Nex1, NEX1M" ENSG00000164600 "Neuronal differentiation 6" Q96NK8 7 31337461-31340894 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "brain: 30.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 119 "SCLC-21H: 11.8" "Group enriched" "Detected in many" 5 "cerebral cortex: 99.2;hippocampal formation: 246.6" "Group enriched" "Detected in many" 9 "cerebral cortex: 26.0;hippocampal formation: 108.7" HPA074530 Enhanced NA NA "HPA074530: AB_2732257" "unprognostic (3.68e-2)" 0.5 0.5 8.3 0.5 10.7 0.5 0.5 3.9 25.5 0.5 0.5 0.7 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 30.6 0.5 0.5 0.5 0.5 0.5 1.3 17.4 0.5 0.5 0.5 0.1 0.5 0.4 0.5 0.5 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 10.7 3.9 25.5 30.6 0.5 1.3 17.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEUROG1 "AKA, bHLHa6, Math4C, NEUROD3, ngn1" ENSG00000181965 "Neurogenin 1" Q92886 5 135534282-135535949 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.1;retina: 7.7;testis: 2.3" "Cell type enhanced" "Detected in single" 24 "Bipolar cells: 1.3" "Cancer enriched" "Detected in single" 12 "testis cancer: 1.1" "Region enhanced" "Detected in single" "midbrain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 1.3;SCLC-21H: 1.1;THP-1: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA072232 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA072232: " "unprognostic (3.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NEUROG2 "Atoh4, bHLHa8, Math4A, ngn-2, NGN2" ENSG00000178403 "Neurogenin 2" Q9H2A3 4 112513516-112516172 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 5.1" "Cell type enriched" "Detected in some" 5 "Muller glia cells: 8.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 68.9" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 18 "hippocampal formation: 17.3" CAB012342 Uncertain NA NA "CAB012342: " "unprognostic (1.09e-1)" "unprognostic (2.52e-2)" "unprognostic (7.51e-2)" "unprognostic (4.10e-1)" "unprognostic (1.62e-1)" "unprognostic (7.75e-2)" "unprognostic (1.04e-1)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (3.30e-1)" 0.4 0.1 3.0 0.0 3.6 0.1 1.2 4.1 1.6 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 3.9 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 68.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.6 4.1 0.8 3.9 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 NEUROG3 "Atoh5, bHLHa7, Math4B, ngn3" ENSG00000122859 "Neurogenin 3" Q9Y4Z2 10 69571698-69573238 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.5;intestine: 8.4" "Group enriched" "Detected in some" 49 "Cardiomyocytes: 4.8;Intestinal endocrine cells: 5.1" "Cancer enhanced" "Detected in some" "stomach cancer: 1.4" "Region enriched" "Detected in single" 20 "hippocampal formation: 7.5" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;memory B-cell: 1.1" "Group enriched" "Detected in many" 7 "B-cells: 1.1;T-cells: 2.1" "Cell line enriched" "Detected in some" 5 "THP-1: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA039785 Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA039785: AB_10795114" "unprognostic (1.22e-2)" "unprognostic (7.33e-2)" "unprognostic (3.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.10e-1)" "unprognostic (1.65e-2)" "unprognostic (5.85e-5)" "unprognostic (4.58e-2)" "unprognostic (4.19e-1)" 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 7.6 0.0 0.0 8.0 0.0 0.0 0.9 0.0 1.8 0.0 7.5 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.1 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.3 7.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEXMIF "KIAA2022, KIDLIA, MRX98, XPN" ENSG00000050030 "Neurite extension and migration factor" Q5QGS0 X 74732856-74925485 "Disease related genes, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.2;parathyroid gland: 9.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 2.2;Ciliated cells: 5.3;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HAP1: 6.7;Karpas-707: 10.8;SiHa: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA000407 Uncertain Supported "Nucleoplasm,Midbody,Mitotic spindle,Cytosol" Yes NA Nucleoplasm "Midbody, Mitotic spindle, Cytosol" "HPA000407: AB_2665984" "unprognostic (1.04e-3)" "unprognostic (6.07e-5)" "unprognostic (1.81e-2)" "unprognostic (2.07e-5)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (3.71e-1)" "unprognostic (1.79e-2)" "unprognostic (1.64e-3)" "unprognostic (8.25e-2)" "unprognostic (7.58e-3)" "unprognostic (1.37e-2)" "unprognostic (3.80e-2)" "unprognostic (2.79e-4)" "unprognostic (6.94e-4)" 0.6 3.0 5.4 0.7 6.2 0.4 1.3 10.2 9.4 1.7 1.9 0.7 1.0 0.6 1.7 0.9 1.8 1.3 0.5 0.3 5.0 6.2 2.4 0.2 0.9 0.5 1.8 5.0 1.7 4.4 9.0 7.5 0.5 1.9 3.2 1.1 1.1 2.5 2.5 0.4 1.8 1.1 2.6 1.2 0.6 1.6 0.9 1.5 0.0 1.5 0.0 0.5 0.7 2.8 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.8 0.0 0.2 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 9.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 6.2 10.2 6.8 5.0 6.2 1.8 5.0 1.9 1.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NEXN "NELIN, nexilin" ENSG00000162614 "Nexilin F-actin binding protein" Q0ZGT2 1 77888513-77943895 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 110.8;skeletal muscle: 198.5" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 2090.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 43.5;LHCN-M2: 40.0;RH-30: 31.7" "Low region specificity" "Detected in many" "HPA011185, HPA011904" Approved Supported "Plasma membrane,Actin filaments" NA NA 12000000 "Plasma membrane, Actin filaments" "HPA011185: AB_1854409, HPA011904: " "unprognostic (9.73e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.46e-1)" "unprognostic (3.25e-1)" "unprognostic (5.41e-2)" "unprognostic (5.60e-2)" "unprognostic (2.48e-1)" "unprognostic (9.65e-3)" "unprognostic (3.68e-2)" 8.9 4.3 0.4 10.4 0.8 0.0 5.0 0.5 0.4 14.1 17.0 0.2 12.5 1.9 16.6 12.5 24.1 9.9 8.7 110.8 0.4 0.5 4.0 1.2 6.2 3.8 0.6 0.5 8.2 2.0 0.3 0.5 2.6 0.7 13.1 3.2 0.9 4.1 14.8 198.5 1.4 5.5 45.8 0.8 3.9 10.6 4.2 1.2 0.0 5.1 40.1 1.0 29.7 10.3 1.4 1.7 2.9 3.4 0.6 0.6 7.0 7.1 0.4 1.3 0.0 23.5 22.8 3.5 43.5 19.3 8.9 6.0 1.2 0.0 0.0 2.5 15.8 10.1 0.9 0.9 4.1 16.0 0.2 0.9 1.7 2.2 0.4 17.6 0.3 0.0 17.0 0.9 12.3 6.9 19.0 6.7 1.7 0.0 0.0 40.0 0.0 8.1 0.5 6.9 0.0 5.3 6.8 31.7 0.0 10.4 0.3 0.0 0.3 3.8 0.0 0.2 9.1 0.0 0.9 6.8 21.3 15.6 9.0 21.6 0.0 0.0 0.0 1.2 0.8 0.0 0.0 3.4 0.0 0.4 2.0 0.1 1.4 0.3 0.4 1.7 1.1 0.6 0.2 2.9 0.6 1.4 1.2 0.0 7.0 0.4 0.8 0.5 0.4 0.4 0.5 0.6 0.5 0.7 1.2 98.3 8.2 0.0 0.8 1.5 2.8 2090.8 0.0 0.0 9.1 0.0 3.9 0.3 1.7 15.9 15.1 11.3 0.9 0.0 27.4 2.8 19.0 0.9 1.1 0.8 1.1 1.6 0.0 53.4 2.6 5.4 67.9 5.3 0.0 0.0 0.0 0.2 23.5 0.0 325.3 0.5 2.6 213.4 98.6 0.7 2.1 0.6 0.2 2.2 0.3 0.2 NFAM1 CNAIP ENSG00000235568 "NFAT activating protein with ITAM motif 1" Q8NET5 22 42380410-42432395 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.0;bone marrow: 28.0;lymphoid tissue: 35.2" "Cell type enhanced" "Detected in some" 20 "granulocytes: 11.5;Hofbauer cells: 15.6;Kupffer cells: 46.1;Macrophages: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 34.0" "Group enriched" "Detected in many" 4 "granulocytes: 34.0;monocytes: 17.5" "Cell line enriched" "Detected in some" 4 "THP-1: 28.6" "Group enriched" "Detected in many" 4 "basal ganglia: 2.9;hypothalamus: 3.7;midbrain: 7.4;pons and medulla: 7.8;thalamus: 8.3" HPA031812 Uncertain NA NA "HPA031812: AB_10603121" "unprognostic (9.77e-3)" "unprognostic (2.77e-3)" "unprognostic (8.21e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.83e-2)" "unprognostic (8.76e-3)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "unprognostic (9.12e-3)" "unprognostic (9.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.00e-1)" "unprognostic (8.12e-3)" "unprognostic (1.75e-1)" "unprognostic (4.42e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" 10.9 3.1 1.7 12.3 3.1 28.0 2.0 0.9 1.9 2.2 1.8 4.0 0.7 1.5 1.4 4.2 2.0 3.3 2.8 4.8 1.8 2.2 2.5 9.9 12.1 35.2 2.4 0.6 1.5 1.7 0.4 1.3 4.4 2.7 2.5 1.4 2.4 2.0 1.8 1.1 1.6 3.3 3.0 4.8 27.7 1.7 1.4 2.5 2.8 1.5 1.2 3.7 3.1 1.5 0.0 6.1 34.0 17.5 0.0 0.1 7.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 4.6 0.0 0.0 0.1 0.0 0.3 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.1 17.5 0.9 0.0 12.2 0.1 0.0 0.0 0.0 6.1 0.0 0.0 0.0 34.0 0.0 10.6 0.1 0.0 7.3 1.7 3.1 0.9 1.9 1.8 2.2 2.4 0.6 2.7 2.5 0.0 5.9 0.5 0.6 0.8 0.1 0.6 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.6 0.2 0.0 0.0 0.2 0.1 0.8 0.2 11.5 0.2 15.6 0.0 1.2 0.6 46.1 3.6 0.3 14.9 0.0 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.2 0.6 0.9 0.2 0.0 0.0 0.4 NFASC "FLJ46866, KIAA0756, NF, NRCAML" ENSG00000163531 Neurofascin O94856 1 204828651-205022822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.6" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 165.2;Horizontal cells: 208.2;Rod photoreceptor cells: 212.3" "Cancer enhanced" "Detected in many" "glioma: 8.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "gdT-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "BJ: 13.3;fHDF/TERT166: 24.1;hTERT-RPE1: 11.8;SCLC-21H: 11.2;U-138 MG: 31.3;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008832 Enhanced NA NA 2100000 "HPA008832: AB_1854411" "unprognostic (1.71e-1)" "unprognostic (1.07e-1)" "unprognostic (2.62e-1)" "unprognostic (3.39e-2)" "unprognostic (6.65e-2)" "unprognostic (1.18e-2)" "unprognostic (3.71e-3)" "unprognostic (3.37e-1)" "unprognostic (6.34e-3)" "unprognostic (2.79e-1)" "prognostic favorable (3.21e-5)" "unprognostic (3.76e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (1.56e-3)" "unprognostic (1.91e-1)" "unprognostic (6.90e-2)" "unprognostic (5.26e-3)" 4.9 8.7 21.1 3.9 25.9 0.6 3.8 22.3 37.3 4.6 7.8 49.6 1.1 5.1 9.1 10.4 11.3 12.0 6.6 17.4 19.5 10.8 10.7 2.4 5.7 2.6 27.9 25.2 11.9 6.4 1.6 11.7 11.2 28.7 8.7 6.8 8.1 2.6 18.4 3.3 4.2 5.6 15.3 17.5 6.8 5.3 2.0 34.0 0.0 3.0 0.2 3.4 8.9 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.2 0.4 0.0 13.3 0.0 9.7 2.9 0.0 0.0 0.0 0.0 24.1 9.1 6.3 0.2 0.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 6.1 0.3 11.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.1 0.0 1.1 0.0 0.0 0.0 11.2 0.6 0.0 0.7 0.0 1.0 0.1 0.0 0.0 31.3 6.7 0.0 0.0 0.0 0.0 0.0 15.5 0.0 7.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 25.9 22.3 35.0 19.5 10.8 27.9 25.2 28.7 34.0 0.0 1.1 0.0 1.5 1.9 165.2 19.5 0.0 0.0 1.2 0.0 11.8 0.3 0.0 0.2 5.3 4.9 0.0 0.0 0.0 0.2 10.1 1.0 0.0 2.0 0.4 208.2 36.4 2.5 0.6 9.7 6.1 0.0 1.7 0.0 4.8 12.0 0.8 0.0 5.3 1.4 212.3 51.8 51.4 1.9 3.2 4.1 0.6 0.0 0.9 0.7 NFATC2 "NF-ATP, NFAT1, NFATp" ENSG00000101096 "Nuclear factor of activated T cells 2" Q13469 20 51386957-51562831 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.6" "Cell type enhanced" "Detected in many" 8 "Melanocytes: 59.1;T-cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 14.4;HMC-1: 16.6;WM-115: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA008789, CAB018567, HPA024369" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB018567: AB_628012, HPA008789: AB_1079474, HPA024369: AB_1854413" "unprognostic (2.69e-3)" "unprognostic (2.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.15e-1)" "unprognostic (1.26e-2)" "unprognostic (3.94e-2)" "unprognostic (4.05e-2)" "unprognostic (9.26e-2)" "unprognostic (3.74e-3)" "unprognostic (2.17e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.57e-4)" "unprognostic (9.25e-2)" "unprognostic (1.02e-1)" "unprognostic (1.05e-2)" "unprognostic (6.59e-2)" 8.6 2.4 4.1 44.6 8.2 4.4 9.8 1.1 5.1 8.4 7.8 6.8 3.9 8.4 7.0 7.6 4.0 5.6 19.4 8.5 4.1 3.3 3.4 6.7 6.1 25.2 8.4 0.7 5.0 8.7 3.9 3.7 8.1 10.4 5.4 4.1 6.2 7.9 7.2 5.4 7.0 11.7 5.9 6.5 16.0 11.0 4.5 6.5 8.6 7.0 13.2 18.7 4.5 4.9 1.6 1.7 3.8 0.7 7.6 7.7 1.6 1.6 1.7 0.0 2.2 0.0 0.0 4.6 0.2 1.1 0.7 0.3 8.3 1.5 11.1 1.3 0.5 1.6 0.0 0.5 0.0 0.6 14.4 0.2 4.7 1.2 2.1 0.0 1.3 16.6 0.0 0.0 0.6 0.0 0.1 5.1 3.9 4.6 7.4 0.0 1.8 1.9 7.8 0.1 1.0 4.0 0.8 0.0 4.9 0.3 0.0 0.1 0.0 5.2 1.3 12.1 1.1 2.0 3.1 0.5 1.0 1.9 2.5 0.1 6.3 4.1 11.5 1.1 5.2 25.0 0.3 0.0 3.8 7.7 0.7 3.2 1.6 4.3 6.1 1.7 1.6 2.4 4.4 0.2 7.6 0.2 0.6 2.3 1.6 4.1 8.2 1.1 5.1 4.1 3.3 8.4 0.7 10.4 6.5 6.0 4.8 3.9 10.4 12.8 0.0 2.8 5.1 10.7 9.1 0.0 0.0 2.4 1.7 3.6 1.5 16.9 1.1 0.0 4.9 0.5 28.2 7.4 15.0 6.0 28.1 0.0 7.5 9.2 21.2 0.4 2.0 16.7 59.1 3.6 6.2 0.0 8.0 0.0 0.4 0.2 0.0 0.0 12.2 0.5 0.9 11.3 0.8 40.6 7.1 5.6 NFATC3 "NFAT4, NFATX" ENSG00000072736 "Nuclear factor of activated T cells 3" Q12968 16 68084751-68229259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 129.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050665 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA050665: AB_2681210" "unprognostic (1.19e-1)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.28e-2)" "unprognostic (7.28e-3)" "unprognostic (2.97e-1)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.93e-2)" "unprognostic (9.07e-3)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-1)" 9.6 6.8 4.3 16.0 6.6 12.0 7.8 7.5 5.8 9.8 11.0 9.7 7.6 7.1 12.2 6.5 7.7 8.3 7.6 7.0 4.7 4.0 8.2 12.1 11.3 14.2 8.7 3.5 10.0 7.0 18.7 6.8 6.6 5.1 10.5 6.1 11.1 7.9 7.6 27.1 14.0 12.0 9.0 6.7 12.3 6.2 25.9 5.8 129.5 11.0 8.1 16.0 10.2 14.1 6.7 3.1 12.0 7.1 13.4 15.6 9.0 4.9 5.9 9.5 10.5 8.6 5.5 8.8 3.3 4.1 9.2 8.1 8.6 4.4 16.8 5.0 5.4 3.0 7.5 11.9 5.6 9.1 3.4 7.7 16.5 6.2 19.2 5.7 14.7 43.4 4.1 7.2 9.3 5.1 4.8 7.8 13.8 21.2 4.8 6.8 10.1 22.7 20.1 6.2 7.7 3.2 12.9 9.2 17.3 4.0 5.8 7.2 7.8 24.5 6.2 3.1 6.1 8.5 11.2 4.9 4.7 5.1 5.5 4.8 6.6 11.4 30.5 3.7 13.7 6.6 12.0 2.4 5.3 15.6 3.7 14.8 5.2 8.9 15.2 2.9 6.7 9.1 14.0 3.3 13.4 7.1 3.1 6.0 9.0 4.3 6.6 7.5 5.8 4.7 4.0 8.7 3.5 5.1 5.8 32.8 43.8 26.5 36.2 69.6 25.5 1.2 58.6 28.1 20.5 55.8 31.4 42.2 19.9 24.1 115.7 21.0 23.8 23.3 19.3 12.6 19.4 42.3 47.4 89.3 20.8 35.0 25.0 35.6 50.9 81.4 20.1 25.0 21.9 16.2 39.9 8.2 24.8 38.6 25.1 33.5 23.7 19.4 17.8 57.1 69.8 125.2 71.1 59.3 49.1 48.0 NFE2 NF-E2 ENSG00000123405 "Nuclear factor, erythroid 2" Q16621 12 54292111-54301121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2" "Group enriched" "Detected in some" 6 "Erythroid cells: 93.5;Kupffer cells: 38.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 119.7;neutrophil: 80.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 119.7" "Group enriched" "Detected in some" 4 "HEL: 85.6;K-562: 37.0;NB-4: 26.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 1.4" HPA001914 Enhanced Approved "Nucleoplasm,Actin filaments" NA NA "Nucleoplasm, Actin filaments" "HPA001914: AB_1079475" "unprognostic (2.68e-4)" "unprognostic (2.93e-2)" "unprognostic (2.20e-2)" "unprognostic (2.31e-2)" "unprognostic (2.33e-2)" "unprognostic (1.85e-1)" "unprognostic (1.20e-2)" "unprognostic (4.55e-2)" "unprognostic (4.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-3)" "unprognostic (9.90e-6)" "unprognostic (1.81e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-2)" "unprognostic (3.46e-2)" 2.3 0.3 0.9 3.5 1.5 54.3 0.5 0.4 1.7 0.9 0.4 0.2 0.0 0.5 0.4 0.4 0.7 2.0 0.9 7.8 1.5 0.4 0.9 2.6 9.6 20.9 5.2 0.2 1.2 0.6 1.2 0.8 15.9 1.2 1.0 0.3 1.2 0.5 0.2 1.0 2.9 0.5 1.1 1.0 32.2 0.7 0.9 0.7 1.8 1.7 0.2 0.5 1.2 8.1 0.0 15.2 119.7 23.1 0.0 0.1 12.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 1.5 0.1 0.2 1.2 2.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 85.6 0.2 1.9 0.0 1.2 11.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 37.0 0.0 0.0 0.0 3.3 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.2 4.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 5.1 0.0 119.7 23.1 21.7 0.0 6.4 0.1 0.0 0.0 0.0 15.2 0.0 0.1 0.0 80.0 0.0 3.8 0.2 0.0 12.9 0.9 1.5 0.4 1.7 1.5 0.4 5.2 0.2 1.2 0.7 0.0 4.8 0.0 0.0 0.1 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.0 93.5 0.0 0.4 0.0 0.0 3.5 0.0 0.9 0.0 0.0 0.0 38.4 11.0 0.0 1.6 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.3 1.0 0.0 0.0 0.0 NFE2L1 "FLJ00380, LCR-F1, NRF1, TCF11" ENSG00000082641 "Nuclear factor, erythroid 2 like 1" Q14494 17 48048329-48061487 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 194.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 262.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063384, HPA065424" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA063384: AB_2684998, HPA065424: AB_2685488" "unprognostic (3.19e-1)" "unprognostic (2.41e-1)" "unprognostic (5.44e-2)" "prognostic favorable (8.20e-5)" "unprognostic (5.25e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (5.20e-2)" "unprognostic (5.58e-2)" "unprognostic (9.30e-2)" "unprognostic (2.61e-1)" "unprognostic (1.63e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.79e-6)" "unprognostic (2.20e-1)" "unprognostic (4.09e-2)" "unprognostic (6.19e-3)" "unprognostic (2.01e-2)" 24.2 25.7 15.5 13.1 15.5 4.6 50.3 9.1 19.8 18.8 17.5 17.4 32.3 17.4 31.4 30.5 21.4 22.7 16.3 85.5 18.2 19.2 27.9 18.4 13.9 12.6 21.7 21.2 26.2 11.1 16.6 16.3 16.6 25.0 16.5 13.6 22.6 17.7 26.1 194.7 19.9 18.3 24.3 27.5 17.7 13.9 18.8 16.5 5.8 22.4 58.9 10.7 17.3 24.2 4.1 9.4 19.7 9.4 2.1 2.6 0.9 19.2 43.0 28.2 23.8 59.2 28.9 21.2 31.5 43.8 22.4 25.0 52.4 22.3 22.2 64.0 39.7 29.1 40.1 19.9 25.1 24.1 38.0 16.6 12.5 29.1 17.5 70.3 27.8 20.2 39.4 62.8 40.7 45.8 37.5 34.9 15.0 22.1 61.6 27.5 16.5 17.6 8.7 18.2 17.4 16.4 12.5 39.9 21.1 24.7 28.9 17.4 26.3 21.5 14.5 44.4 38.3 28.6 19.1 46.7 54.9 23.8 18.5 31.5 103.1 69.0 20.8 52.1 11.8 31.1 7.9 9.4 2.7 2.6 4.8 1.5 3.8 2.5 2.6 1.9 4.1 1.9 2.1 19.7 2.1 5.6 9.4 0.9 0.9 15.5 15.5 9.1 19.8 18.2 19.2 21.7 21.2 25.0 16.5 53.6 49.6 9.7 17.8 49.5 67.0 262.2 61.1 40.2 31.8 73.3 33.4 18.6 21.6 36.9 6.0 55.4 91.6 0.0 31.5 17.7 25.0 31.4 26.7 111.7 30.3 68.3 28.9 55.9 33.7 7.9 94.6 19.5 20.3 41.5 46.8 24.4 46.3 54.1 78.8 38.4 33.8 58.2 41.2 22.3 20.4 42.3 18.7 14.4 38.2 19.7 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Group enriched" "Detected in many" 14 "Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.0;NTERA-2: 36.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA055889: AB_2682958" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavorable (7.58e-12)" "prognostic favorable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.7 1.1 0.5 1.3 0.0 0.0 44.0 2.5 5.0 4.9 9.1 8.4 22.3 0.9 16.8 0.2 18.6 2.7 1.9 4.3 11.3 8.7 2.7 1.7 1.8 6.1 3.4 1.5 17.0 0.4 0.5 2.0 0.7 7.3 11.4 3.6 2.6 22.6 1.0 1.7 1.0 2.7 36.9 3.5 4.5 1.5 0.1 6.3 6.7 12.6 4.0 4.7 0.0 1.0 0.4 12.8 0.6 0.9 23.9 0.4 0.7 0.2 10.2 13.8 21.9 1.0 0.0 5.5 17.0 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 6.0 3.2 0.8 2.8 1.5 1.2 1.4 17.8 1.4 5.7 10.4 0.0 226.3 0.0 9.8 0.7 3.8 3.3 0.0 4.7 28.3 2.3 3.6 27.6 0.0 21.3 0.0 1.2 3.1 12.9 0.0 0.0 11.1 1.7 5.4 6.5 0.9 11.2 4.3 0.0 0.3 1.3 0.0 1.0 0.3 5.7 1.4 584.2 4.9 8.3 5.4 NFE4 NF-E4 ENSG00000230257 "Nuclear factor, erythroid 4" 7 102973437-102988856 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "blood: 20.8;placenta: 15.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.1;Cone photoreceptor cells: 2.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 48 "eosinophil: 9.1;neutrophil: 20.8" "Lineage enriched" "Detected in single" 66 "granulocytes: 20.8" "Group enriched" "Detected in some" 4 "BEWO: 23.5;HUVEC TERT2: 28.9" NA NA "unprognostic (6.56e-2)" "unprognostic (1.36e-1)" "unprognostic (2.34e-1)" "unprognostic (3.40e-2)" "unprognostic (9.31e-3)" "unprognostic (7.47e-2)" "unprognostic (4.97e-2)" "unprognostic (2.19e-2)" "unprognostic (7.68e-2)" "unprognostic (5.51e-2)" "unprognostic (3.36e-9)" "unprognostic (1.31e-2)" "unprognostic (1.46e-1)" "unprognostic (5.84e-2)" "unprognostic (8.71e-3)" 0.2 1.9 0.2 0.4 0.2 2.6 0.2 0.2 2.2 0.2 0.2 0.2 0.2 0.3 0.2 2.2 0.5 0.0 0.4 0.6 0.2 0.2 0.2 1.2 0.6 0.2 0.2 1.1 0.6 0.0 0.2 15.7 0.2 0.2 0.0 0.2 0.2 0.2 0.2 1.7 0.2 0.2 0.2 2.5 0.1 1.5 0.2 0.2 1.5 2.9 0.2 0.2 0.2 0.1 0.1 20.8 0.1 0.0 0.3 0.0 0.2 0.2 0.8 0.2 0.0 0.0 23.5 0.2 0.0 0.0 0.0 1.1 0.6 0.6 0.3 0.0 0.2 0.3 0.0 0.0 0.1 0.1 1.5 5.7 4.2 0.1 0.3 2.1 0.3 0.2 0.0 0.8 0.0 0.6 28.9 0.7 2.6 0.4 0.6 0.3 1.0 1.8 0.3 0.2 0.3 0.9 0.5 0.2 0.0 0.5 0.9 0.3 0.3 0.4 0.0 3.4 0.5 0.6 0.3 1.0 2.9 1.5 0.2 0.8 5.9 0.3 1.8 6.1 0.6 0.0 0.1 9.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.2 20.8 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 NFIC "CTF, CTF5, NF-I, NFI" ENSG00000141905 "Nuclear factor I C" P08651 19 3314403-3469217 "Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 50.8;U-2197: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004300, CAB004674, HPA052625" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "CAB004300: , CAB004674: AB_425564, HPA052625: AB_2681889" "unprognostic (2.59e-1)" "unprognostic (5.07e-3)" "unprognostic (2.11e-1)" "prognostic favorable (1.52e-6)" "unprognostic (8.38e-2)" "unprognostic (1.71e-3)" "unprognostic (1.14e-1)" "unprognostic (3.04e-1)" "unprognostic (9.66e-2)" "unprognostic (1.73e-1)" "unprognostic (6.81e-2)" "unprognostic (3.16e-2)" "unprognostic (2.03e-2)" "unprognostic (2.54e-1)" "unprognostic (9.65e-2)" "unprognostic (2.85e-2)" "unprognostic (1.80e-3)" 25.1 19.8 8.5 11.1 11.1 5.7 14.9 15.3 19.9 23.3 19.7 16.8 27.1 6.4 20.8 14.2 19.6 18.5 21.5 25.7 9.5 6.3 14.4 29.0 12.9 9.1 11.8 8.1 31.8 46.9 22.7 14.6 5.1 11.7 18.8 5.3 20.4 33.9 22.2 101.7 16.8 8.5 26.5 10.9 11.6 16.4 8.6 11.3 2.7 15.6 23.2 10.2 22.4 17.4 2.3 4.0 11.3 5.3 8.4 3.3 3.2 18.0 26.6 0.3 16.1 14.7 12.7 1.7 16.5 9.3 11.2 8.0 0.6 6.3 0.1 6.0 15.0 7.9 8.8 4.5 11.1 4.6 12.8 3.8 3.4 21.5 5.3 11.6 5.3 6.8 11.1 7.9 15.4 6.0 7.2 10.3 1.0 9.1 17.0 8.1 13.0 3.0 1.1 0.8 0.7 11.0 7.9 10.2 7.1 4.2 3.7 3.7 9.8 50.8 5.1 4.9 0.2 14.9 4.1 15.4 19.2 17.3 50.2 22.5 0.5 0.7 0.1 26.5 11.6 27.8 1.8 5.2 2.4 3.3 5.3 2.8 2.1 3.0 3.0 4.0 2.3 2.1 2.1 11.3 8.4 1.1 1.6 1.1 3.2 8.5 11.1 15.3 19.9 9.5 6.3 11.8 8.1 11.7 11.3 74.5 75.4 25.9 115.4 89.0 183.3 100.5 295.5 62.9 37.5 87.2 55.0 7.9 44.7 127.5 28.8 99.2 19.6 23.3 164.2 5.6 86.6 147.1 25.4 318.2 50.4 76.3 46.0 115.4 123.7 14.1 233.8 34.0 43.9 52.3 35.0 141.1 110.1 39.6 237.9 45.2 62.2 71.1 110.3 9.0 44.9 85.4 7.1 18.8 48.6 91.9 NFIX NF1A ENSG00000008441 "Nuclear factor I X" Q14938 19 12995608-13098796 "Disease related genes, Predicted intracellular proteins, Transcription factors" "DNA replication, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 139.7" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 103.9;Peritubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 37.3;fHDF/TERT166: 50.2;U-138 MG: 47.9;U-2197: 45.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007533 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA007533: AB_2667855" "unprognostic (3.32e-1)" "unprognostic (1.37e-2)" "unprognostic (2.84e-1)" "unprognostic (2.20e-1)" "unprognostic (2.29e-1)" "unprognostic (8.12e-2)" "prognostic favorable (4.66e-4)" "prognostic favorable (2.35e-4)" "unprognostic (1.26e-1)" "unprognostic (2.01e-2)" "unprognostic (3.25e-1)" "unprognostic (2.63e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.92e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-2)" 28.6 6.6 21.3 8.0 23.8 5.8 15.5 57.0 60.8 25.1 17.9 41.0 8.9 9.2 29.9 12.4 29.2 29.2 21.8 24.1 27.3 15.0 4.6 8.9 20.3 3.1 21.6 29.8 31.8 10.2 6.8 7.0 5.3 22.1 35.4 8.7 19.5 56.6 26.1 139.7 39.7 10.1 27.6 28.3 5.0 14.6 7.2 23.4 1.2 12.8 29.1 8.1 15.6 17.7 1.1 0.6 0.6 0.8 0.1 2.6 0.5 9.2 3.8 0.2 29.4 27.9 37.3 0.3 11.6 16.5 11.1 7.9 0.3 0.8 0.1 3.4 50.2 7.6 4.2 3.1 9.0 4.9 6.1 4.9 4.7 1.9 4.0 13.4 1.9 2.6 24.9 2.6 10.8 6.0 19.8 2.9 2.0 1.5 1.4 7.0 2.9 3.4 1.5 0.1 2.0 32.3 10.0 5.5 5.3 0.1 2.0 4.4 11.8 8.6 0.0 10.7 0.0 5.5 4.1 3.0 47.9 6.1 45.6 16.2 1.1 0.4 0.0 12.3 2.9 14.9 0.6 0.4 0.0 2.4 0.8 2.6 0.1 0.1 0.0 0.1 1.1 0.9 0.2 0.5 0.1 0.2 0.6 0.0 0.5 21.3 23.8 57.0 60.8 27.3 15.0 21.6 29.8 22.1 23.4 11.9 53.6 3.7 37.7 52.2 7.5 30.5 28.1 20.1 20.5 14.0 3.9 0.2 1.7 21.7 42.2 15.7 8.9 93.5 10.9 0.2 43.1 67.6 3.5 26.3 0.9 0.0 11.6 14.7 2.9 29.0 103.9 3.6 25.3 1.0 24.1 87.7 12.8 14.0 118.5 8.8 2.0 6.5 26.2 12.9 13.2 44.9 0.2 0.7 26.2 27.1 NFKBIA "IkappaBalpha, IKBA, MAD-3, NFKBI" ENSG00000100906 "NFKB inhibitor alpha" P25963 14 35401511-35404749 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 209.1" "Cell type enhanced" "Detected in all" 8 "Basal keratinocytes: 3603.5;Suprabasal keratinocytes: 2990.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 84.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003815, HPA029207" Approved Enhanced Cytosol NA NA Cytosol "CAB003815: AB_344886, HPA029207: AB_10603122" "prognostic favorable (1.33e-5)" "unprognostic (3.39e-1)" "unprognostic (7.29e-2)" "unprognostic (7.24e-2)" "unprognostic (8.88e-2)" "unprognostic (1.62e-1)" "unprognostic (3.51e-1)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (2.46e-1)" "unprognostic (2.46e-1)" "unprognostic (7.19e-2)" "unprognostic (2.32e-2)" "unprognostic (3.69e-1)" "unprognostic (4.44e-2)" "unprognostic (9.74e-2)" "unprognostic (3.80e-2)" 49.0 38.5 14.9 63.7 25.7 209.1 60.8 16.1 27.8 33.8 32.8 10.3 36.7 13.5 21.3 15.6 50.4 30.5 34.3 30.9 18.8 10.5 30.6 45.1 73.0 47.7 29.7 7.8 57.4 22.1 6.5 25.3 25.5 21.8 28.7 18.6 19.5 44.2 64.6 33.1 48.2 42.3 24.9 23.0 47.4 26.1 19.6 23.9 35.0 27.8 46.2 38.1 41.8 45.2 45.3 55.0 118.2 58.3 33.2 37.3 51.7 13.1 11.7 4.4 4.0 26.1 17.4 15.8 5.5 52.8 11.9 10.6 3.6 8.0 8.0 14.7 8.7 28.0 17.4 8.4 22.8 17.1 48.5 3.2 3.9 8.4 21.5 15.6 6.2 3.3 18.9 23.0 8.1 20.7 7.9 10.7 4.0 3.3 12.9 8.4 15.5 8.2 15.0 4.1 12.8 7.2 18.6 5.1 6.6 20.4 84.8 4.0 6.9 14.6 25.7 6.1 9.6 14.6 13.3 19.9 16.4 5.9 4.7 8.8 15.8 16.0 13.6 13.7 4.7 3.3 35.8 58.3 36.6 24.2 33.4 37.3 34.0 29.3 25.4 55.0 45.3 25.6 21.7 118.2 33.2 22.1 29.7 19.5 51.7 14.9 25.7 16.1 27.8 18.8 10.5 29.7 7.8 21.8 23.9 497.3 711.4 171.6 1047.5 3603.5 25.1 132.1 298.1 131.2 346.9 59.3 11.8 146.4 165.8 692.3 3.4 543.9 448.5 23.3 344.2 134.5 404.0 1015.6 876.2 131.0 760.7 46.1 195.3 279.9 370.8 7.2 141.8 871.3 1029.1 602.3 143.8 87.6 391.8 259.6 109.3 89.7 34.8 200.5 1642.1 2.8 10.7 2990.0 552.0 370.7 198.2 907.4 NFKBIB "IKBB, TRIP9" ENSG00000104825 "NFKB inhibitor beta" Q15653 19 38899700-38908893 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.2" "Group enriched" "Detected in all" 13 "Early spermatids: 932.5;Late spermatids: 859.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063734 Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA063734: AB_2685107" "unprognostic (2.73e-1)" "unprognostic (3.24e-1)" "unprognostic (2.14e-1)" "unprognostic (9.16e-2)" "unprognostic (1.42e-1)" "unprognostic (4.35e-2)" "unprognostic (1.72e-1)" "unprognostic (2.79e-1)" "unprognostic (2.82e-1)" "unprognostic (8.84e-2)" "unprognostic (1.90e-1)" "unprognostic (4.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.19e-2)" "unprognostic (4.35e-1)" "unprognostic (2.08e-1)" "unprognostic (3.50e-3)" 7.9 7.1 7.0 12.5 9.8 22.0 6.8 2.9 7.3 3.9 7.6 8.1 7.6 10.8 5.8 5.7 8.6 5.1 7.6 7.1 7.3 5.8 7.9 14.6 6.7 8.7 11.2 5.2 4.3 9.7 4.0 3.9 7.2 7.2 5.0 3.6 5.1 8.6 6.6 13.9 8.0 11.7 5.1 9.9 9.2 12.4 80.2 9.3 6.0 6.6 8.7 8.7 6.6 5.1 3.8 5.4 12.4 5.8 8.7 7.2 2.9 8.1 10.2 1.5 3.6 1.5 0.9 4.8 5.5 2.2 3.0 3.4 7.2 4.4 9.0 6.2 1.2 2.8 4.5 3.8 2.7 0.9 27.5 4.9 6.0 1.9 4.1 5.3 6.9 12.8 1.2 3.0 3.3 4.2 0.8 1.6 6.7 7.0 8.3 1.1 5.3 8.5 6.8 5.1 6.9 4.2 12.0 6.3 8.2 1.4 3.2 8.9 5.3 3.5 5.1 3.9 0.9 3.0 5.9 3.9 5.1 6.5 8.7 8.4 17.3 15.3 19.2 3.3 7.2 6.2 1.5 4.3 12.4 5.3 5.8 4.1 3.6 3.1 4.5 3.8 3.8 2.3 3.4 9.0 8.7 4.7 5.4 7.2 2.9 7.0 9.8 2.9 7.3 7.3 5.8 11.2 5.2 7.2 9.3 8.9 22.4 22.8 35.7 28.0 10.9 6.5 10.2 4.0 11.4 12.2 3.9 24.4 6.6 26.6 932.5 20.4 53.1 23.3 27.0 21.6 13.5 31.8 66.8 18.7 21.9 23.8 21.2 8.0 14.6 859.8 12.7 18.6 16.9 37.9 17.0 13.0 38.2 17.5 14.2 19.2 11.5 19.4 18.9 20.1 14.9 21.1 49.4 29.9 18.2 31.5 NFKBID "IkappaBNS, TA-NFKBH" ENSG00000167604 "NFKB inhibitor delta" Q8NI38 19 35887653-35902303 "Predicted intracellular proteins, Transcription factors" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0" "Cell type enhanced" "Detected in many" 9 "granulocytes: 91.9;Macrophages: 54.1;monocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054778 Uncertain "Nuclear bodies,Plasma membrane,Cytosol" NA NA Cytosol "Nuclear bodies, Plasma membrane" "HPA054778: " "prognostic favorable (6.01e-4)" "unprognostic (9.60e-2)" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-2)" "prognostic favorable (5.43e-4)" "unprognostic (4.21e-2)" "unprognostic (7.68e-2)" "unprognostic (3.83e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (5.64e-2)" "unprognostic (6.83e-2)" "unprognostic (1.04e-1)" "unprognostic (5.21e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.34e-6)" 4.1 2.8 0.9 13.5 2.5 21.0 7.0 4.5 2.4 1.9 2.1 4.4 0.9 1.9 2.3 2.7 3.0 3.7 6.9 2.1 0.7 1.1 3.4 1.8 11.4 9.1 2.3 0.4 4.3 3.5 1.9 5.5 1.6 2.0 2.6 1.5 2.7 2.3 3.4 0.9 3.6 4.8 5.1 2.4 6.8 2.8 1.5 1.1 14.4 5.1 1.0 14.7 2.8 7.4 9.4 1.9 4.8 1.6 2.0 2.3 0.6 4.7 4.4 0.9 3.0 0.6 0.7 2.1 3.0 3.5 3.2 2.3 1.0 3.9 5.8 2.3 3.1 2.8 2.5 3.1 2.3 1.3 3.3 0.6 3.5 6.2 1.1 0.8 3.0 10.5 1.0 1.6 5.9 1.5 0.8 1.1 2.7 0.7 3.6 0.7 3.7 2.5 3.6 1.3 0.9 0.9 1.3 0.7 1.2 2.8 2.0 1.6 1.2 4.0 3.1 0.3 0.8 1.4 3.0 1.2 5.0 4.5 2.2 2.0 2.5 0.9 6.8 2.7 7.1 0.7 0.0 1.4 2.5 2.3 0.9 1.7 5.4 1.0 1.8 1.4 9.4 1.7 1.0 4.8 2.0 1.6 1.9 2.2 0.6 0.9 2.5 4.5 2.4 0.7 1.1 2.3 0.4 2.0 1.1 0.0 13.7 34.0 7.1 26.4 8.1 0.8 5.1 4.0 2.3 1.8 19.6 1.1 0.0 2.3 0.0 8.7 2.9 0.0 0.9 2.2 15.4 12.3 91.9 0.0 32.9 0.0 2.9 2.5 30.8 0.0 1.1 54.1 18.6 51.3 2.6 1.1 2.7 2.5 1.8 0.9 9.7 0.0 9.5 0.5 0.5 29.2 0.8 15.2 4.8 7.9 NFKBIZ "FLJ34463, INAP, MAIL" ENSG00000144802 "NFKB inhibitor zeta" Q9BYH8 3 101827991-101861022 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 116.9" "Cell type enhanced" "Detected in many" 5 "granulocytes: 368.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 20.0" "Group enriched" "Detected in many" 4 "granulocytes: 15.8;monocytes: 20.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 31.5;RPTEC TERT1: 31.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010547, HPA075363" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Nuclear speckles" "Cytoplasmic bodies" "HPA010547: AB_1854442, HPA075363: AB_2686745" "unprognostic (2.20e-2)" "unprognostic (1.11e-2)" "unprognostic (6.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-2)" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (5.96e-2)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" "prognostic unfavorable (4.30e-8)" "unprognostic (2.69e-1)" "unprognostic (8.90e-2)" "unprognostic (3.30e-1)" "unprognostic (8.52e-3)" 26.4 4.4 2.2 35.5 3.4 116.9 46.9 2.4 2.0 17.4 23.7 3.6 5.5 16.8 21.3 13.0 22.1 39.5 31.5 17.3 2.8 1.9 13.8 26.8 29.6 21.3 4.4 0.3 18.2 15.7 2.4 7.2 18.8 5.0 16.3 10.4 10.9 37.4 8.1 9.8 21.0 18.5 17.9 5.2 21.5 16.8 7.1 3.3 3.3 26.5 30.8 23.8 18.7 20.0 3.2 3.8 15.8 20.0 0.5 4.1 1.1 2.8 2.2 1.5 1.9 4.4 7.7 2.4 11.4 31.5 5.1 4.8 2.7 3.4 5.2 14.6 3.1 15.7 9.0 1.1 4.9 13.1 15.3 1.0 5.0 3.9 1.4 6.9 0.3 0.3 5.3 7.7 13.5 6.2 12.5 3.7 0.2 0.8 10.9 7.2 3.5 0.1 2.9 2.6 0.9 6.7 0.6 6.9 0.7 31.5 18.4 0.7 0.9 1.9 2.3 12.2 3.4 2.8 2.1 4.7 8.2 8.2 3.0 3.7 9.2 3.2 3.6 14.9 1.0 1.1 4.9 3.6 1.0 1.0 8.3 1.1 1.9 1.4 1.0 2.4 3.2 4.1 2.7 15.8 0.5 20.0 3.8 0.7 1.1 2.2 3.4 2.4 2.0 2.8 1.9 4.4 0.3 5.0 3.3 80.4 236.3 41.4 30.7 250.1 8.8 17.3 45.9 72.3 110.3 62.8 2.0 14.6 0.0 152.4 3.7 112.8 123.3 0.0 113.5 33.8 98.5 56.9 368.8 58.2 52.3 9.5 70.7 47.9 91.7 1.1 18.7 186.1 67.4 68.5 64.5 19.2 152.1 109.7 0.7 1.9 7.4 19.4 108.2 0.0 0.6 220.1 21.4 55.3 73.5 38.8 NFYB "CBF-A, HAP3, NF-YB" ENSG00000120837 "Nuclear transcription factor Y subunit beta" P25208 12 104117077-104138289 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 107.1" "Cell type enriched" "Detected in all" 4 "Syncytiotrophoblasts: 362.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 60.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004211, HPA065646" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB004211: AB_628018, HPA065646: " "unprognostic (5.82e-2)" "unprognostic (2.44e-3)" "unprognostic (4.90e-2)" "unprognostic (7.10e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "unprognostic (2.10e-2)" "unprognostic (2.44e-1)" "unprognostic (7.36e-2)" "unprognostic (2.63e-1)" "unprognostic (9.39e-2)" "unprognostic (8.51e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.62e-3)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.81e-3)" 16.1 23.4 22.2 13.9 21.3 10.8 17.5 18.5 17.5 16.1 28.2 13.6 107.1 9.9 16.8 25.8 13.7 16.0 13.7 20.0 22.6 16.9 15.4 21.8 16.0 17.4 21.9 12.4 15.9 11.3 17.3 19.0 16.3 15.6 23.5 14.4 10.1 10.3 53.7 18.5 11.2 10.6 20.0 24.9 10.1 13.8 13.7 20.4 21.4 19.2 13.5 18.5 20.2 27.9 15.6 7.4 22.8 10.2 15.1 21.1 10.7 13.7 11.9 22.7 13.8 15.3 16.7 21.4 13.8 11.4 15.3 10.5 8.8 6.5 18.5 6.7 12.3 10.0 9.1 18.2 8.8 16.6 12.6 5.7 11.2 13.3 8.1 16.1 15.9 7.8 24.1 12.0 6.2 12.0 27.8 9.9 16.8 10.8 7.5 12.7 15.6 20.0 16.0 21.4 10.0 12.9 18.8 13.1 8.1 10.8 14.0 13.6 11.2 24.2 60.4 7.8 17.6 22.6 16.4 7.4 9.0 6.1 8.1 9.9 14.4 12.3 20.6 5.7 9.8 9.2 17.3 7.5 22.8 16.3 9.5 21.1 15.6 15.7 17.1 7.4 11.3 17.5 17.4 10.5 15.1 10.2 6.8 20.5 10.7 22.2 21.3 18.5 17.5 22.6 16.9 21.9 12.4 15.6 20.4 50.6 26.1 11.9 86.4 33.2 21.7 32.7 10.2 25.4 27.3 17.4 3.9 51.6 31.5 20.9 2.8 30.3 11.3 23.3 15.8 71.2 32.7 42.2 20.8 28.0 20.2 14.3 11.5 52.2 13.0 4.5 31.7 23.0 27.0 18.0 15.1 27.5 22.7 14.4 28.7 28.6 23.3 19.4 31.9 67.7 31.1 32.4 362.3 27.7 13.4 49.2 NGB ENSG00000165553 Neuroglobin Q9NPG2 14 77265483-77271312 "Predicted intracellular proteins, Transporters" "Apoptosis, Oxygen transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.6;brain: 34.5;pancreas: 9.9" "Cell type enhanced" "Detected in single" 23 "Spermatogonia: 1.5" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Region enhanced" "Detected in many" "hypothalamus: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "RPMI-8226: 7.7;SCLC-21H: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042615, HPA058596" Enhanced NA NA "HPA042615: AB_2678079, HPA058596: AB_2683769" "unprognostic (1.02e-1)" "unprognostic (3.55e-2)" "unprognostic (8.86e-2)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (3.14e-1)" "unprognostic (4.08e-2)" "unprognostic (6.65e-2)" "unprognostic (6.58e-2)" "unprognostic (3.37e-4)" "unprognostic (1.80e-1)" "unprognostic (3.12e-1)" 0.4 15.6 4.2 0.7 4.8 0.3 0.3 1.2 14.2 0.3 2.1 0.5 0.9 0.7 0.3 0.5 0.6 2.9 0.3 0.3 1.7 34.5 0.3 0.3 0.3 0.3 2.0 6.4 0.3 9.9 0.3 7.0 0.3 8.0 0.3 1.3 0.0 0.3 0.3 0.3 0.3 0.9 0.5 1.4 0.3 0.3 0.7 0.9 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.7 0.0 0.0 16.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.8 1.2 14.2 1.7 34.5 2.0 6.4 8.0 0.9 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.5 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878686-233013272 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.1;brain: 55.6;intestine: 23.2" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 44.3;Hepatocytes: 17.7;Paneth cells: 20.1;Undifferentiated cells: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 25.6;HDLM-2: 21.6;HeLa: 10.4;PC-3: 28.1;T-47d: 15.9" "Group enriched" "Detected in many" 4 "amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2" "Low region specificity" "Detected in many" HPA008160 Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 0.8 29.1 15.8 1.4 55.6 0.3 1.4 0.8 53.8 1.4 7.9 1.6 0.0 23.2 2.8 2.6 5.3 3.1 2.0 0.9 7.0 5.1 4.2 9.7 0.6 0.3 3.2 26.7 1.5 1.8 7.9 0.9 0.4 5.4 1.3 6.1 0.0 0.8 0.7 0.7 16.5 16.6 4.0 1.4 0.5 6.2 2.3 12.0 0.0 0.8 1.0 0.4 0.9 1.6 0.0 0.5 0.5 0.3 0.0 0.0 0.0 25.6 7.5 0.3 0.1 0.1 4.2 0.4 0.4 0.0 0.2 0.0 0.3 2.5 0.0 7.6 5.3 2.7 3.3 5.7 1.4 0.2 21.6 1.8 0.0 10.4 8.0 0.1 0.0 0.1 0.0 0.1 1.7 0.3 0.1 0.9 0.1 0.1 0.1 0.2 1.9 0.0 0.0 0.6 0.1 28.1 0.0 0.0 0.0 0.5 0.7 0.9 0.2 3.2 1.6 0.0 1.0 15.9 0.2 0.0 0.2 2.3 0.1 0.5 0.2 0.1 0.0 1.9 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 15.8 55.6 0.8 53.8 7.0 5.1 3.2 26.7 5.4 12.0 0.0 0.0 0.0 1.0 8.9 0.2 2.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.6 0.4 44.3 0.0 9.2 0.2 0.3 0.6 0.0 17.7 0.1 1.6 4.7 0.0 0.3 1.3 0.0 0.2 1.7 0.0 13.6 5.2 7.7 20.1 1.1 6.3 0.0 0.0 0.7 1.1 0.4 6.6 0.0 0.0 17.8 0.3 NHLH1 "bHLHa35, HEN1, NSCL, NSCL1" ENSG00000171786 "Nescient helix-loop-helix 1" Q02575 1 160367067-160372848 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 10.8;skin 1: 4.2" "Cell type enhanced" "Detected in some" 11 "Cone photoreceptor cells: 2.0;Horizontal cells: 3.2;Intestinal endocrine cells: 1.7;Kupffer cells: 1.5;Rod photoreceptor cells: 1.3" "Group enriched" "Detected in some" 6 "glioma: 2.4;testis cancer: 0.8;urothelial cancer: 0.5" "Region enhanced" "Detected in many" "cerebellum: 10.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 24.8" "Region enhanced" "Detected in single" "hippocampal formation: 1.1" "Region enriched" "Detected in some" 12 "cerebellum: 37.9" HPA017943 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA017943: AB_2732421" "unprognostic (6.95e-2)" "unprognostic (3.02e-1)" "unprognostic (3.81e-1)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-2)" "unprognostic (2.24e-1)" "unprognostic (1.75e-2)" "unprognostic (7.06e-2)" "unprognostic (1.96e-2)" "unprognostic (4.21e-8)" "unprognostic (4.09e-2)" "unprognostic (2.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.36e-1)" 1.0 0.5 0.9 1.1 4.1 0.4 0.3 10.8 2.0 0.3 0.8 0.3 0.3 0.4 0.3 0.5 0.3 0.2 0.4 0.3 3.2 2.2 0.3 0.3 0.3 0.5 0.8 0.3 0.3 0.5 0.2 0.4 0.3 2.3 0.3 0.3 0.6 1.3 0.3 0.6 4.2 0.6 0.5 2.5 1.0 0.4 0.8 0.3 0.3 0.3 0.3 0.4 0.4 0.3 0.1 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.1 2.5 0.0 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.2 1.1 0.5 0.2 0.5 0.0 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.4 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.0 24.8 0.2 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.7 0.6 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 4.1 10.8 1.6 3.2 2.2 0.8 0.3 2.3 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 3.2 1.7 0.6 1.5 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 1.3 0.0 0.2 0.7 0.5 0.0 0.2 0.0 0.0 0.0 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 16.6;skin 1: 10.5" "Group enriched" "Detected in some" 7 "Basal glandular cells: 2.1;Basal keratinocytes: 2.5;Cardiomyocytes: 2.6;Intestinal endocrine cells: 1.7;Spermatocytes: 4.9;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 36.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nuclear bodies" Nucleoplasm "HPA055238: AB_2682752" "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.2 0.2 3.4 0.2 0.9 0.2 0.6 16.6 2.4 0.3 0.3 0.4 0.5 0.3 0.2 1.4 2.5 0.2 0.3 0.2 7.1 9.1 0.2 0.2 0.9 0.2 4.1 1.5 0.2 0.2 0.2 0.1 0.5 16.3 0.7 0.4 1.0 0.4 0.7 0.6 10.5 0.3 0.2 3.1 0.2 1.0 1.6 0.6 0.0 0.2 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 16.6 2.4 7.1 9.1 4.1 1.5 16.3 0.6 0.0 0.0 0.0 2.1 2.5 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 4.9 1.5 1.9 0.0 0.0 0.0 0.3 NHLRC4 ENSG00000257108 "NHL repeat containing 4" P0CG21 16 566996-569495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 21.1;fallopian tube: 17.3" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 9.4;Collecting duct cells: 22.7;Erythroid cells: 23.3;Leydig cells: 7.5;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 5.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 4.6;HMC-1: 13.8;REH: 3.6;RPMI-8226: 5.8" "Low region specificity" "Detected in single" HPA077301 Approved Mitochondria NA NA Mitochondria "HPA077301: " "unprognostic (7.95e-2)" "unprognostic (5.87e-2)" "unprognostic (4.28e-3)" "unprognostic (2.53e-2)" "unprognostic (1.08e-1)" "unprognostic (5.95e-3)" "unprognostic (2.21e-1)" "unprognostic (2.48e-1)" "unprognostic (2.28e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-3)" "unprognostic (1.19e-2)" "unprognostic (1.16e-2)" "unprognostic (5.16e-3)" "unprognostic (1.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.60e-1)" 1.3 6.9 1.6 1.4 2.3 3.4 1.4 1.4 1.8 2.4 0.9 1.7 9.5 1.4 2.5 21.1 0.7 17.3 1.5 1.8 2.4 2.4 7.0 0.3 4.8 3.8 0.5 0.9 5.1 0.2 5.9 1.4 1.5 2.0 2.2 0.3 2.1 3.1 10.9 2.3 0.3 1.7 0.5 0.8 4.8 0.8 2.8 0.7 7.8 0.4 0.4 1.2 1.3 0.7 1.1 4.4 5.0 0.5 0.7 1.5 0.7 0.0 0.0 0.6 0.1 0.1 0.3 0.1 0.0 0.8 0.2 0.2 0.1 0.2 0.8 0.6 0.1 0.0 0.1 0.0 0.1 0.0 2.4 0.2 4.6 0.0 1.0 1.0 0.3 13.8 2.9 0.0 0.1 0.3 0.0 0.3 0.8 1.4 1.6 0.0 0.0 0.5 3.4 0.3 0.0 0.0 3.6 0.0 5.8 0.3 0.2 0.0 1.3 0.0 0.0 0.5 0.1 0.6 0.7 0.7 0.0 0.1 0.0 0.0 2.1 1.9 0.9 0.0 0.2 0.4 0.0 0.5 5.0 0.4 0.2 0.7 1.1 1.3 0.6 0.6 0.7 1.5 0.8 0.0 0.7 0.2 4.4 1.4 0.7 1.6 2.3 1.4 1.8 2.4 2.4 0.5 0.9 2.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 9.4 2.3 22.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.3 0.2 0.0 0.4 0.2 0.0 0.0 1.3 0.0 0.0 1.3 0.0 0.0 7.5 0.5 0.0 0.0 0.0 0.8 0.0 0.0 4.2 0.0 0.0 6.5 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 NHSL1 "bA43P8.1, C6orf63, KIAA1357" ENSG00000135540 "NHS like 1" Q5SYE7 6 138422043-138692571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 93.0" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8;non-classical monocyte: 3.8" "Group enriched" "Detected in many" 14 "dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8" "Cell line enhanced" "Detected in many" "Hep G2: 22.4;TIME: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029966, HPA029967" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA029966: AB_10601972, HPA029967: AB_2673271" "unprognostic (1.85e-1)" "unprognostic (9.71e-2)" "unprognostic (6.19e-2)" "unprognostic (1.81e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.27e-1)" "unprognostic (8.34e-2)" "unprognostic (5.21e-2)" "unprognostic (9.99e-2)" "unprognostic (1.10e-1)" "unprognostic (8.00e-2)" "unprognostic (4.19e-2)" "unprognostic (3.73e-2)" "unprognostic (1.52e-1)" "unprognostic (6.55e-2)" "unprognostic (4.06e-2)" 7.4 1.1 6.0 5.4 5.7 0.2 2.4 3.7 8.6 2.2 46.3 4.3 3.4 13.4 3.0 11.2 10.0 0.9 7.2 18.4 4.8 3.4 17.4 19.5 15.0 2.0 4.2 1.3 1.2 4.6 2.8 1.7 3.5 6.3 1.7 10.0 7.9 3.4 0.4 2.3 10.5 93.0 3.0 2.8 2.0 6.8 1.6 1.6 0.2 1.2 3.6 1.7 2.4 3.9 0.1 1.2 1.0 3.8 0.1 0.1 0.7 2.6 2.3 16.6 6.9 4.8 6.0 6.2 2.4 1.1 0.9 0.8 3.0 1.5 0.0 3.1 2.0 1.6 6.1 10.0 6.2 0.4 0.2 6.7 1.6 1.1 22.4 7.2 5.9 1.2 8.6 3.5 0.4 7.2 0.9 11.7 0.9 0.0 0.9 3.6 5.2 0.6 0.4 6.6 1.5 4.4 6.8 1.7 0.5 5.7 6.8 6.3 0.0 2.5 5.2 16.7 11.5 1.6 1.9 31.9 2.3 2.3 2.3 6.5 0.6 1.2 0.0 0.2 2.4 12.8 1.0 3.4 0.5 0.1 3.8 0.1 0.1 0.0 0.1 1.2 0.0 0.1 0.1 0.1 0.1 3.8 0.7 0.0 0.7 6.0 5.7 3.7 3.5 4.8 3.4 4.2 1.3 6.3 1.6 56.6 50.9 0.8 2.4 38.0 0.7 20.3 5.1 25.4 12.5 27.9 27.5 12.0 8.3 3.0 0.8 8.3 65.2 0.0 3.1 3.0 11.6 3.5 8.1 32.7 3.9 35.0 19.4 29.4 6.7 0.0 0.6 3.8 20.3 0.0 29.8 14.7 3.5 45.6 0.0 12.9 0.9 6.5 4.6 0.0 0.7 43.0 36.3 0.9 40.2 7.4 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 52.1;Glandular cells: 82.4;Ito cells: 55.3;Kupffer cells: 52.6;Urothelial cells: 89.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7" "Cell line enhanced" "Detected in some" "AF22: 16.8;EFO-21: 19.9;HUVEC TERT2: 18.3;TIME: 10.6;U-937: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049771 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Cell Junctions" "Plasma membrane" "HPA049771: AB_2680872" "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 7.8 2.3 11.0 4.8 22.5 3.4 5.2 27.1 9.4 6.6 5.5 1.5 0.9 1.3 8.7 2.7 5.5 3.8 7.4 3.6 4.9 3.2 2.0 1.6 5.5 1.3 2.2 4.9 3.1 1.6 3.1 6.1 3.7 4.3 6.4 3.3 6.2 2.6 8.7 2.8 2.3 2.6 11.7 2.4 4.5 3.4 9.6 2.7 0.3 5.3 4.6 1.6 6.3 4.4 0.0 3.5 13.5 5.7 0.9 1.8 1.7 0.2 0.4 16.8 0.1 0.2 0.7 0.1 0.5 3.1 0.1 0.2 0.1 0.0 0.1 19.9 1.7 0.0 0.0 1.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.6 0.0 0.0 18.3 0.0 0.0 2.7 0.1 0.1 0.1 1.3 3.2 0.0 0.0 0.0 1.0 0.0 0.1 1.9 0.4 3.8 0.0 0.0 0.0 4.9 0.0 1.1 10.6 0.0 1.1 1.3 0.0 0.0 0.0 0.1 0.8 13.3 0.0 4.1 5.7 11.8 1.8 3.9 1.7 0.0 1.0 1.6 3.5 0.0 0.1 0.2 13.5 0.9 3.0 0.0 0.1 1.7 11.0 22.5 27.1 9.4 4.9 3.2 2.2 4.9 4.3 2.7 0.0 3.4 0.0 52.1 0.5 0.6 16.3 10.2 0.0 0.0 1.8 0.0 15.3 0.0 0.2 3.0 21.8 2.4 23.3 0.6 18.6 11.2 82.4 7.0 14.3 16.2 0.0 1.2 55.3 52.6 4.9 29.4 3.4 1.7 0.0 4.5 1.2 0.3 0.0 20.1 1.4 0.3 25.8 2.2 2.5 1.7 0.3 20.8 27.7 4.9 89.4 NIM1K "MGC42105, NIM1" ENSG00000177453 "NIM1 serine/threonine protein kinase" Q8IY84 5 43192071-43280850 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 23.7;pituitary gland: 9.7" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 7.1;Cone photoreceptor cells: 5.9;Horizontal cells: 17.5;Muller glia cells: 8.2;Rod photoreceptor cells: 6.1" "Cancer enriched" "Detected in some" 11 "glioma: 6.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 10 "dendritic cells: 1.2;T-cells: 3.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 4.5;HDLM-2: 4.9;PC-3: 5.6;U-87 MG: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007695 Uncertain Approved Cytosol NA NA Cytosol "HPA007695: AB_2667897" "unprognostic (7.97e-2)" "unprognostic (9.79e-2)" "unprognostic (8.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.17e-1)" "unprognostic (2.40e-1)" "unprognostic (4.35e-2)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (8.84e-4)" "unprognostic (1.25e-1)" "unprognostic (1.55e-5)" "unprognostic (2.18e-1)" "unprognostic (2.66e-1)" "unprognostic (6.46e-3)" "unprognostic (4.98e-3)" 1.4 3.5 9.4 1.6 10.9 0.9 1.3 4.9 23.7 1.6 1.4 6.3 0.0 1.1 1.2 1.6 1.6 1.4 1.5 1.8 8.7 7.7 1.4 1.2 3.6 1.2 5.6 5.8 1.2 1.5 1.2 9.7 1.8 6.4 1.4 1.7 1.7 2.3 2.4 2.0 1.8 1.2 1.3 4.9 1.0 3.0 1.4 8.1 0.0 2.7 0.0 1.0 1.1 0.8 0.1 1.2 0.0 0.0 0.2 3.2 0.0 0.2 0.6 0.1 0.1 0.9 0.6 0.0 1.0 3.2 1.2 4.5 0.1 0.0 0.5 0.6 0.8 1.6 0.3 0.6 0.0 2.8 4.9 0.3 0.1 0.6 0.2 1.6 0.2 0.7 1.9 0.1 0.5 0.0 1.7 0.0 0.1 0.2 0.3 0.9 0.2 0.3 0.2 0.0 0.0 5.6 0.2 0.3 0.5 0.1 0.7 0.9 0.1 1.8 0.5 0.3 0.2 0.4 1.5 0.0 0.9 0.8 0.8 0.7 1.6 0.4 0.3 6.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 1.2 3.2 0.0 9.4 10.9 4.9 11.6 8.7 7.7 5.6 5.8 6.4 8.1 0.0 4.1 0.0 0.1 0.5 7.1 0.3 0.0 0.0 0.0 0.0 5.9 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.1 17.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 8.2 0.2 0.0 0.7 0.0 6.1 0.0 0.4 0.4 0.5 0.4 0.0 0.0 0.0 0.0 NINJ1 NIN1 ENSG00000131669 "Ninjurin 1" Q92982 9 93121489-93134288 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 149.2" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 430.2;monocytes: 299.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 149.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 149.2" "Cell line enhanced" "Detected in many" "Hep G2: 48.1;HHSteC: 43.8;MCF7: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045063 Uncertain NA NA "HPA045063: AB_10964133" "unprognostic (1.23e-2)" "unprognostic (8.25e-3)" "unprognostic (3.64e-3)" "unprognostic (1.40e-2)" "unprognostic (8.18e-2)" "unprognostic (1.28e-2)" "unprognostic (4.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.82e-2)" "unprognostic (9.06e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-2)" "unprognostic (9.45e-3)" "unprognostic (2.51e-1)" "unprognostic (2.69e-2)" "unprognostic (1.40e-3)" "unprognostic (7.46e-3)" 20.7 42.5 14.8 15.2 15.5 92.9 30.5 7.5 14.7 14.9 19.9 20.4 9.6 10.6 12.9 27.0 14.7 14.9 16.5 27.1 14.3 14.6 39.0 51.7 24.3 28.1 17.1 7.2 16.9 17.9 39.3 20.2 37.3 15.6 18.9 7.3 24.6 31.9 25.7 16.9 30.7 15.4 17.2 20.7 34.7 13.5 21.7 12.9 11.4 43.8 13.7 13.4 25.4 14.3 0.6 6.7 149.2 29.5 3.9 9.0 15.3 10.5 16.5 3.4 7.2 12.6 5.0 13.3 7.7 21.9 11.2 6.9 7.2 3.6 0.1 3.7 7.4 12.4 11.0 3.8 21.3 2.4 24.4 7.3 1.6 4.2 48.1 43.8 1.1 3.4 16.7 20.9 10.7 5.8 34.8 10.6 4.1 1.1 12.0 2.5 46.8 3.3 3.4 4.6 13.0 13.6 5.9 2.5 18.9 9.0 4.5 1.0 4.7 16.2 25.6 9.9 6.0 19.8 7.4 7.5 3.9 11.5 8.1 5.3 6.8 2.6 0.2 11.9 3.5 3.0 9.8 27.1 69.4 6.6 27.3 9.0 0.6 6.1 5.6 6.7 0.2 7.5 5.2 149.2 3.9 29.5 0.9 6.3 15.3 14.8 15.5 7.5 14.7 14.3 14.6 17.1 7.2 15.6 12.9 26.8 38.2 13.7 83.7 101.8 2.3 26.6 58.6 2.7 31.8 38.4 0.0 109.8 109.5 86.6 2.1 46.7 23.4 0.0 90.1 67.0 78.7 64.1 47.2 36.4 430.2 1.6 17.3 22.7 131.8 10.5 38.9 172.3 140.0 299.4 18.9 48.7 57.0 24.6 68.2 194.8 2.7 12.9 88.6 0.5 7.2 118.6 61.3 41.5 18.0 50.4 NINJ2 ENSG00000171840 "Ninjurin 2" Q9NZG7 12 564296-663779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.7;brain: 43.6" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 32.8;Hofbauer cells: 25.9;Kupffer cells: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 41.4;MOLT-4: 70.0;THP-1: 14.8;U-698: 13.3" "Low region specificity" "Detected in many" "HPA058980, HPA067226" Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol" NA NA "Endoplasmic reticulum" "Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol" "HPA058980: AB_2683869, HPA067226: " "unprognostic (1.16e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.37e-1)" "prognostic favorable (5.31e-4)" "unprognostic (5.72e-3)" "unprognostic (1.90e-3)" "unprognostic (4.60e-2)" "unprognostic (4.98e-3)" "unprognostic (5.88e-2)" "unprognostic (5.12e-2)" "unprognostic (2.68e-2)" "unprognostic (9.05e-2)" "unprognostic (1.03e-2)" "unprognostic (3.51e-3)" "unprognostic (1.23e-1)" 11.8 1.4 9.8 9.2 14.1 27.8 9.2 2.4 18.5 7.3 5.0 43.6 1.6 4.6 2.9 3.3 8.4 3.8 4.7 7.9 16.4 8.7 1.4 13.8 31.3 10.8 21.8 10.2 0.8 1.8 0.9 1.1 3.9 17.2 2.7 4.5 2.9 4.5 2.8 20.1 6.7 3.9 4.8 26.4 8.8 3.6 3.9 21.1 3.6 2.6 2.2 9.2 9.0 3.9 5.6 14.9 34.2 17.7 5.7 44.7 9.1 0.4 0.1 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.1 1.6 0.4 0.0 0.0 0.0 0.0 2.3 0.0 41.4 9.9 0.5 0.0 1.1 1.7 0.6 0.0 0.0 0.0 0.0 0.8 0.8 2.4 7.1 0.0 0.0 70.0 2.2 0.7 0.0 0.0 1.8 0.0 0.2 0.7 0.0 0.0 0.0 7.8 0.0 0.0 0.1 0.0 14.8 0.2 0.0 0.4 2.7 0.0 0.0 1.1 13.3 0.1 7.7 0.0 2.0 17.7 14.1 10.5 13.7 3.1 5.6 11.8 11.1 14.9 4.5 2.6 5.5 34.2 5.7 11.2 7.8 44.7 9.1 9.8 14.1 2.4 18.5 16.4 8.7 21.8 10.2 17.2 21.1 20.8 32.8 6.5 0.2 5.0 0.0 1.2 0.0 6.7 14.8 0.0 0.0 2.3 1.7 0.0 2.1 5.4 1.6 0.0 0.0 3.2 5.6 0.2 2.3 10.6 25.9 0.0 4.1 5.5 33.3 1.9 7.5 17.3 6.8 6.4 3.2 0.3 0.5 3.5 3.9 0.0 0.0 0.0 1.0 3.2 2.5 4.8 0.7 14.4 3.3 0.0 NIPA1 "MGC35570, SLC57A1, SPG6" ENSG00000170113 "Non imprinted in Prader-Willi/Angelman syndrome 1" Q7RTP0 15 22773063-22829791 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 9.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 9.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023269 Uncertain NA NA "HPA023269: AB_1854485" "unprognostic (1.64e-2)" "unprognostic (7.60e-2)" "unprognostic (2.61e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (1.79e-1)" "unprognostic (3.31e-2)" "unprognostic (2.13e-2)" "unprognostic (2.77e-1)" "unprognostic (2.42e-2)" "unprognostic (6.25e-2)" "unprognostic (6.32e-2)" "unprognostic (6.95e-2)" "unprognostic (8.80e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.66e-2)" 3.4 4.9 15.2 4.1 18.1 1.3 3.4 8.3 27.0 4.6 4.6 20.7 1.3 7.3 2.7 2.6 4.5 3.1 5.5 2.9 18.7 15.7 7.3 4.7 5.3 5.4 26.9 11.8 1.6 7.6 12.3 2.9 4.0 24.8 7.9 5.0 2.2 3.9 4.2 2.4 5.6 7.2 2.9 36.7 4.5 7.4 4.9 15.1 2.6 8.5 0.4 6.0 3.6 2.6 2.0 9.1 0.6 0.2 0.6 1.7 0.8 9.8 11.6 3.6 8.3 4.7 3.8 2.9 11.5 8.4 5.8 4.7 8.8 4.9 4.5 9.7 4.8 12.3 6.7 10.8 3.2 6.8 26.5 7.0 6.9 7.1 7.4 5.6 0.1 14.0 1.4 10.4 3.7 6.5 9.2 5.5 10.2 5.5 7.8 3.2 3.7 3.8 6.2 4.1 10.4 13.2 8.4 5.1 3.6 9.0 9.8 10.2 10.5 9.2 1.0 10.9 5.0 7.9 9.0 9.9 16.3 9.5 6.7 18.1 8.8 8.8 8.5 8.5 0.0 10.8 0.6 0.2 0.3 1.1 0.1 1.2 1.8 1.7 1.2 1.4 2.0 0.8 0.6 0.5 0.6 0.1 9.1 1.3 0.8 15.2 18.1 8.3 19.7 18.7 15.7 26.9 11.8 24.8 15.1 11.9 5.1 1.5 3.5 7.8 4.1 3.5 10.2 2.7 4.5 5.2 5.9 2.0 3.3 5.1 2.8 6.0 8.0 0.0 10.3 1.9 4.7 6.9 0.0 5.8 3.4 4.8 2.9 4.9 4.5 3.2 2.0 2.6 5.0 5.4 6.0 5.2 12.8 5.9 2.8 4.8 5.8 19.4 4.4 3.7 9.8 13.0 1.3 5.0 6.0 4.6 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.8" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 40.1;Paneth cells: 31.6;Urothelial cells: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.0;CAPAN-2: 9.9;HaCaT: 13.1;HBEC3-KT: 9.4;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036765 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.5 0.4 0.4 5.4 1.4 0.0 2.2 0.8 0.7 3.6 9.1 0.1 0.0 3.3 0.4 6.3 18.5 1.1 1.8 0.6 0.7 0.7 4.6 10.7 0.5 0.0 0.4 0.2 0.8 6.6 2.9 5.5 30.8 0.7 3.0 8.9 1.2 5.3 0.6 0.7 17.1 12.6 1.0 0.6 0.4 4.3 0.8 0.3 0.2 2.0 9.8 11.2 4.2 5.3 1.0 1.4 1.4 0.8 0.6 0.9 0.0 11.0 0.2 0.0 0.0 0.0 0.0 1.8 2.1 2.0 1.6 2.8 6.6 9.9 0.0 1.5 0.0 2.9 13.1 1.9 9.4 4.1 0.1 2.4 0.0 0.1 0.4 0.0 0.1 0.1 0.1 3.5 0.1 2.3 2.7 0.5 0.7 0.1 0.0 2.3 4.2 0.1 0.1 1.7 7.6 2.9 0.0 0.0 0.0 5.6 15.1 1.0 0.3 1.0 3.7 1.6 0.9 2.4 0.0 4.2 0.1 3.9 0.0 0.2 0.1 0.1 0.0 0.2 0.0 4.2 0.9 0.8 0.5 0.8 0.4 0.6 0.4 0.5 0.3 0.1 1.0 0.7 0.9 1.4 0.6 0.5 1.4 0.3 0.0 0.4 1.4 0.8 0.7 0.7 0.7 0.4 0.2 0.7 0.3 8.9 6.7 0.0 22.7 12.8 0.1 2.6 0.0 2.7 14.8 40.1 0.0 1.6 0.0 8.8 0.5 0.3 27.6 0.0 5.8 1.0 1.3 24.9 0.0 10.4 0.3 0.0 11.1 0.6 0.0 0.0 0.0 0.2 1.7 1.0 27.4 0.5 10.3 31.6 0.0 1.0 3.8 0.0 2.1 1.0 1.5 28.9 3.0 0.7 29.9 36.3 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415794-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.4" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favorable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (3.95e-4)" "unprognostic (2.85e-1)" 5.3 5.1 21.4 5.2 21.8 4.9 8.3 41.2 29.4 6.9 8.9 42.4 5.6 7.1 4.2 7.4 10.3 10.4 6.3 9.2 25.5 21.3 9.4 2.3 9.2 7.1 32.9 14.7 5.5 11.3 14.0 6.5 2.8 31.5 38.4 9.3 7.1 9.9 5.7 3.5 7.7 8.5 8.1 34.8 4.8 9.6 3.1 22.5 5.8 20.7 2.3 7.9 7.8 5.4 12.9 8.4 8.9 3.6 9.2 26.0 9.7 12.8 5.2 0.5 1.7 7.9 8.8 1.9 41.7 29.9 15.3 11.3 1.8 14.7 6.0 13.4 23.0 3.1 12.6 5.1 15.5 15.0 12.2 15.9 6.6 8.7 2.1 7.3 5.8 6.0 8.8 14.4 10.1 30.9 13.9 5.2 11.8 3.8 3.8 9.2 2.8 4.7 2.4 3.2 6.2 14.7 2.2 0.0 6.8 16.2 4.1 19.4 1.8 5.6 7.9 11.2 3.6 10.8 4.4 7.5 13.7 2.9 4.5 9.1 11.9 9.7 2.1 9.2 10.6 12.2 8.9 3.6 4.7 10.8 3.4 10.7 12.9 18.2 14.0 6.5 10.9 26.0 16.1 1.6 9.2 2.3 8.4 17.6 9.7 21.4 21.8 41.2 24.6 25.5 21.3 32.9 14.7 31.5 22.5 44.7 28.0 14.5 11.0 8.1 52.0 21.5 17.8 9.4 19.4 38.4 104.1 3.0 3.3 11.5 2.8 8.5 24.1 46.7 13.4 4.0 8.5 26.1 12.7 3.2 4.2 12.7 18.0 7.4 3.8 5.6 3.7 7.1 13.5 6.4 14.9 15.3 17.2 14.4 4.9 3.6 53.0 0.0 6.2 2.4 5.5 14.3 3.5 20.8 16.3 16.1 NIPAL4 ICHYN ENSG00000172548 "NIPA like domain containing 4" Q0D2K0 5 157460019-157474717 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" Receptor "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;skin 1: 38.1" "Group enriched" "Detected in some" 6 "Basal glandular cells: 9.4;Basal keratinocytes: 26.4;Suprabasal keratinocytes: 36.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 33 "memory B-cell: 2.6;naive B-cell: 8.7" "Lineage enriched" "Detected in single" 51 "B-cells: 8.7" "Group enriched" "Detected in some" 8 "hTCEpi: 14.1;RT4: 46.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038259 Approved NA NA "HPA038259: AB_10672510" "unprognostic (6.74e-4)" "unprognostic (9.54e-2)" "unprognostic (2.63e-2)" "unprognostic (1.49e-1)" "unprognostic (2.61e-1)" "unprognostic (6.56e-2)" "unprognostic (3.55e-2)" "unprognostic (5.20e-2)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.92e-1)" "unprognostic (1.76e-2)" "unprognostic (5.28e-9)" "unprognostic (3.12e-2)" "unprognostic (8.66e-3)" "unprognostic (1.18e-2)" "prognostic favorable (6.82e-4)" 0.6 0.5 1.5 2.5 7.1 3.3 3.0 0.4 7.7 3.6 2.1 25.9 0.0 0.8 1.7 0.6 10.6 0.5 1.0 1.0 3.1 1.7 0.5 0.5 0.5 0.9 8.0 2.5 0.5 0.5 0.5 0.4 1.1 10.9 2.6 1.1 0.0 1.2 1.9 0.6 38.1 0.7 5.8 11.9 0.7 1.9 0.6 6.9 0.0 0.8 15.8 6.0 10.7 7.7 8.7 0.0 0.1 0.0 0.0 0.1 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.3 0.2 0.0 2.7 0.1 1.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 14.1 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 46.8 0.0 0.1 0.0 0.0 0.0 4.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.1 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 7.1 0.4 7.7 3.1 1.7 8.0 2.5 10.9 6.9 0.0 0.3 0.8 9.4 26.4 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 36.8 0.0 0.0 0.0 3.9 NIPSNAP1 ENSG00000184117 "Nipsnap homolog 1" Q9BPW8 22 29554808-29581337 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.5" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 105.4;Proximal tubular cells: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059227 Uncertain NA NA "HPA059227: AB_2683951" "unprognostic (7.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (2.15e-2)" "unprognostic (7.25e-2)" "unprognostic (6.91e-2)" "unprognostic (3.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "unprognostic (1.43e-2)" "unprognostic (1.23e-2)" "unprognostic (1.78e-1)" "prognostic favorable (8.82e-6)" "unprognostic (2.81e-2)" "unprognostic (8.69e-2)" "unprognostic (9.03e-2)" "unprognostic (1.72e-1)" 3.5 17.1 14.3 7.8 21.3 4.6 10.7 16.3 22.2 7.7 12.2 7.4 12.8 21.9 6.7 8.8 9.1 9.2 8.9 8.6 14.0 16.4 38.0 94.5 6.0 12.7 13.6 13.8 11.3 9.8 20.1 13.5 5.9 16.7 8.4 13.0 10.5 8.5 16.4 1.5 6.8 15.7 6.2 8.1 6.4 9.5 5.4 5.6 9.7 11.2 6.1 9.0 8.5 6.3 14.9 10.3 7.2 8.4 17.6 21.1 10.0 15.7 19.0 39.6 49.2 7.1 14.6 7.4 9.2 16.7 12.8 16.7 12.8 21.4 11.2 18.6 13.3 13.5 16.0 20.7 23.6 15.6 22.7 21.8 3.8 9.2 39.7 10.8 8.3 5.6 14.6 12.2 10.5 13.2 31.1 17.3 25.1 7.1 18.8 11.6 35.7 13.4 11.4 33.5 24.5 16.1 26.9 12.4 32.5 30.6 13.9 49.1 43.3 10.8 19.9 21.3 20.0 32.7 13.4 8.1 5.6 19.7 6.9 7.3 25.8 12.6 10.5 15.0 13.3 9.3 5.2 4.6 7.2 17.8 8.4 21.1 14.9 17.7 18.4 10.3 14.1 17.2 20.6 6.7 17.6 5.0 5.3 20.8 10.0 14.3 21.3 16.3 22.2 14.0 16.4 13.6 13.8 16.7 5.6 23.8 11.2 12.0 12.7 4.2 18.1 18.5 22.9 13.4 21.6 40.1 9.8 34.7 58.0 39.6 1.7 7.1 20.2 23.3 16.4 12.2 8.4 9.5 25.4 105.4 12.4 9.5 40.2 8.0 8.5 3.9 10.3 6.4 5.0 30.7 27.7 30.1 20.8 17.5 13.4 94.7 22.6 12.9 4.1 1.4 7.1 7.0 12.4 15.8 36.2 7.2 NIPSNAP2 GBAS ENSG00000146729 "Nipsnap homolog 2" O75323 7 55951793-56000181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 97.3;skeletal muscle: 144.4" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 161.9;Distal tubular cells: 192.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 80.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063084 Enhanced Supported Mitochondria NA NA Mitochondria "HPA063084: AB_2684938" "unprognostic (6.88e-2)" "unprognostic (6.53e-3)" "unprognostic (8.20e-3)" "unprognostic (4.95e-2)" "unprognostic (5.79e-2)" "unprognostic (1.53e-3)" "unprognostic (5.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" "unprognostic (6.38e-3)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.02e-8)" "unprognostic (1.79e-2)" "unprognostic (1.88e-1)" "unprognostic (6.65e-3)" "unprognostic (3.59e-1)" 14.5 19.3 18.4 8.4 22.9 8.6 16.6 11.8 24.5 12.6 14.6 8.9 11.8 8.1 11.0 11.1 12.9 13.4 8.0 97.3 18.7 15.9 16.6 5.2 13.2 16.6 17.0 16.7 9.5 13.5 11.8 8.6 8.0 17.2 14.3 14.2 6.8 18.9 15.5 144.4 6.3 8.3 21.6 19.3 6.5 11.6 5.8 12.1 7.4 22.6 39.8 7.2 12.4 7.8 14.3 34.1 14.1 33.1 15.2 14.1 24.7 80.6 14.3 18.9 31.4 10.9 19.1 9.3 6.8 16.1 19.7 15.2 9.9 17.9 11.8 11.4 12.7 19.1 10.8 14.2 14.4 19.6 7.5 20.9 8.4 8.5 12.6 15.7 18.1 8.5 17.3 22.1 6.7 18.3 22.4 20.7 17.2 14.9 11.7 15.2 3.5 18.0 18.8 18.5 18.0 14.5 18.3 8.8 24.3 26.5 12.7 20.2 22.8 15.5 18.7 21.0 15.6 36.2 19.6 12.0 9.0 13.6 3.1 14.0 9.6 8.1 21.9 9.9 11.4 26.5 13.4 33.1 14.1 8.7 31.8 10.6 14.3 11.7 9.3 34.1 12.3 14.1 10.1 5.8 15.2 23.9 14.1 13.6 24.7 18.4 22.9 11.8 24.5 18.7 15.9 17.0 16.7 17.2 12.1 47.6 42.3 0.0 0.0 0.0 0.0 0.0 0.0 161.9 79.6 59.3 0.0 65.3 192.3 62.3 0.0 0.0 0.0 0.0 50.1 44.3 0.0 0.0 15.1 0.0 79.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 69.5 0.0 0.0 39.8 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.0 NIPSNAP3B FLJ11275 ENSG00000165028 "Nipsnap homolog 3B" Q9BS92 9 104764157-104777457 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 28.6;skeletal muscle: 34.6" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 19.0;Ito cells: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 1.7;granulocytes: 6.5" "Cell line enhanced" "Detected in some" "REH: 7.6;THP-1: 5.3;U-266/70: 5.9" "Low region specificity" "Detected in all" HPA042491 Uncertain NA NA "HPA042491: AB_2678023" "unprognostic (1.72e-2)" "unprognostic (1.47e-2)" "unprognostic (9.76e-2)" "unprognostic (1.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.08e-1)" "unprognostic (8.36e-2)" "unprognostic (1.41e-3)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (4.25e-5)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (5.61e-3)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (4.81e-2)" 14.4 8.4 6.1 2.1 11.3 1.2 10.1 3.7 7.8 4.0 1.7 1.5 4.2 1.5 5.0 4.5 3.1 3.5 3.0 28.6 4.4 6.8 2.3 1.3 2.1 2.2 4.4 7.7 5.4 4.7 2.5 8.0 5.1 5.0 5.1 1.7 3.8 2.2 5.9 34.6 1.7 1.9 3.2 3.4 2.5 1.9 2.0 2.8 0.4 3.1 14.1 2.8 2.2 2.5 3.5 1.7 6.5 0.5 0.8 0.6 0.5 0.0 0.3 0.5 0.2 2.0 1.8 1.4 0.4 0.9 1.3 0.6 0.3 0.8 0.9 0.3 0.8 0.0 0.0 0.6 0.5 0.5 0.0 0.6 3.5 1.9 0.2 1.6 0.6 0.8 1.4 0.7 0.5 0.1 1.6 0.5 1.4 3.1 0.2 0.2 0.4 1.5 3.2 0.7 0.0 0.5 7.6 0.0 0.2 0.5 0.4 1.3 4.0 4.7 0.0 0.4 0.4 3.7 5.3 0.3 0.6 1.6 0.7 0.1 5.9 2.3 0.1 0.0 0.3 0.1 6.5 0.1 2.4 0.2 0.1 0.0 3.5 0.4 0.0 1.7 2.0 0.6 0.3 0.0 0.8 0.5 1.2 0.0 0.5 6.1 11.3 3.7 7.8 4.4 6.8 4.4 7.7 5.0 2.8 0.0 1.4 2.7 1.5 0.3 4.4 19.0 0.0 4.0 0.0 3.5 0.0 0.6 5.0 0.5 0.0 2.2 0.0 0.0 0.2 0.2 1.3 0.3 1.1 0.0 4.8 0.0 1.2 7.4 1.6 0.0 2.3 2.3 0.0 6.4 0.0 0.9 0.1 0.0 6.3 0.0 0.3 0.0 3.3 0.1 1.1 0.6 0.7 0.0 0.0 0.1 NIT2 ENSG00000114021 "Nitrilase family member 2" Q9NQR4 3 100334701-100361635 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 41.1" "Cell type enhanced" "Detected in many" 10 "Proximal tubular cells: 436.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036999, HPA041289" Approved Supported Centrosome,Cytosol NA NA 960000 Cytosol Centrosome "HPA036999: AB_10672105, HPA041289: " "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.06e-3)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.28e-2)" "unprognostic (2.10e-1)" "unprognostic (4.56e-1)" "unprognostic (1.12e-1)" "unprognostic (6.60e-3)" "unprognostic (2.21e-1)" "unprognostic (6.68e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (8.26e-2)" "unprognostic (1.47e-3)" 9.9 7.4 6.7 5.4 9.9 5.9 12.4 3.7 10.5 6.4 7.2 6.1 10.6 5.5 6.6 13.3 9.2 7.9 7.1 7.4 5.8 6.3 29.8 41.1 5.6 8.9 5.9 8.0 7.2 8.5 4.7 7.6 4.9 7.7 7.2 6.8 11.3 8.2 10.2 14.7 7.7 5.3 7.0 5.4 5.7 6.8 3.3 3.3 4.4 10.8 14.5 10.5 8.2 5.6 4.2 5.9 1.5 2.4 3.0 4.3 1.3 9.9 9.9 1.2 5.2 8.9 12.1 6.2 4.1 6.1 9.7 9.3 8.4 11.2 10.0 6.2 5.9 4.2 7.5 4.5 11.0 11.6 3.1 2.3 7.2 3.2 4.3 10.9 4.7 4.9 7.6 16.8 5.2 8.5 5.1 6.2 5.7 3.3 8.1 11.8 9.5 3.1 4.3 4.4 12.5 15.1 3.5 4.2 9.8 16.0 6.3 6.9 3.2 5.6 9.6 6.1 3.3 7.1 4.5 4.5 6.1 2.5 2.9 3.5 5.0 5.5 8.5 9.6 8.0 7.7 0.4 2.4 1.1 3.3 2.1 4.3 4.2 3.1 2.5 5.9 3.7 3.6 3.5 1.5 3.0 1.6 1.8 3.1 1.3 6.7 9.9 3.7 10.5 5.8 6.3 5.9 8.0 7.7 3.3 11.9 12.1 26.5 41.3 29.0 11.3 49.4 30.6 38.8 26.1 55.8 15.7 80.0 159.2 63.8 2.3 15.5 14.9 0.0 46.2 64.1 34.7 40.0 20.7 147.3 56.1 12.7 23.1 16.0 18.8 2.4 40.9 33.3 47.2 136.1 20.8 11.7 55.0 25.7 35.3 436.2 23.6 38.8 46.4 1.5 14.5 36.4 49.5 26.2 34.7 40.6 NKAIN1 "FAM77C, FLJ12650" ENSG00000084628 "Sodium/potassium transporting ATPase interacting 1" Q4KMZ8 1 31179745-31239554 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 1.7;Suprabasal keratinocytes: 1.3" "Group enriched" "Detected in many" 5 "breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.4;AN3-CA: 17.2;NTERA-2: 44.3;SCLC-21H: 13.2;SH-SY5Y: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006873 Uncertain NA NA "HPA006873: AB_1848410" "unprognostic (1.58e-2)" "unprognostic (7.99e-2)" "unprognostic (8.54e-2)" "unprognostic (6.11e-5)" "unprognostic (6.59e-2)" "unprognostic (1.24e-1)" "unprognostic (4.30e-4)" "unprognostic (1.04e-2)" "unprognostic (2.36e-1)" "unprognostic (2.78e-2)" "unprognostic (2.01e-2)" "unprognostic (8.07e-2)" "unprognostic (6.31e-9)" "unprognostic (1.00e-2)" "unprognostic (8.83e-3)" "unprognostic (1.62e-4)" "unprognostic (5.50e-2)" 0.7 15.5 4.2 0.8 13.3 0.5 1.2 23.2 11.8 0.6 0.7 10.7 0.0 0.7 1.5 5.8 1.4 0.8 0.6 0.6 6.3 4.3 0.6 0.5 0.5 0.5 4.7 7.2 0.6 0.7 0.7 0.3 0.9 18.2 2.2 0.7 0.0 0.7 1.1 26.2 1.9 0.7 0.8 3.3 0.5 0.6 0.9 9.0 0.0 0.5 0.1 0.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.4 17.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 44.3 0.0 0.4 0.0 0.1 0.0 0.0 1.5 13.2 21.0 0.4 0.1 1.1 1.2 4.6 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.3 23.2 9.5 6.3 4.3 4.7 7.2 18.2 9.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 1.3 0.3 0.0 0.0 0.1 NKAIN2 "FAM77B, TCBA1" ENSG00000188580 "Sodium/potassium transporting ATPase interacting 2" Q5VXU1 6 123804141-124825657 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 9 "brain: 43.2" "Group enriched" "Detected in some" 16 "Horizontal cells: 44.5;Muller glia cells: 20.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 4.3" "Lineage enriched" "Detected in single" 44 "granulocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045860 Approved Cytosol NA NA Cytosol "HPA045860: AB_10983192" "unprognostic (3.09e-2)" "unprognostic (1.06e-2)" "unprognostic (2.33e-2)" "unprognostic (4.53e-3)" "unprognostic (5.67e-2)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-1)" "unprognostic (5.41e-3)" "unprognostic (2.02e-3)" "unprognostic (2.61e-1)" "unprognostic (5.95e-3)" "unprognostic (3.63e-3)" "unprognostic (1.77e-1)" "unprognostic (1.66e-1)" "unprognostic (1.63e-1)" 2.2 1.6 12.9 1.1 12.1 1.9 1.3 17.3 43.2 1.4 1.7 24.9 0.0 1.1 1.2 1.6 1.4 1.4 1.3 2.6 17.5 8.8 1.3 1.2 1.3 1.3 18.1 10.9 1.2 1.0 1.0 1.1 1.2 18.0 1.4 1.3 0.5 1.1 1.3 4.8 1.1 1.5 1.5 42.9 1.1 1.0 1.6 16.1 0.0 1.2 0.5 1.3 1.5 0.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.2 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 13.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.1 17.3 15.3 17.5 8.8 18.1 10.9 18.0 16.1 0.0 0.0 0.0 0.0 0.1 2.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 44.5 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NKAIN3 "FAM77D, FLJ39630" ENSG00000185942 "Sodium/potassium transporting ATPase interacting 3" Q8N8D7 8 62248591-62999652 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.4;Early spermatids: 1.9;Late spermatids: 2.9;Melanocytes: 1.7;Proximal tubular cells: 1.0" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.5;HeLa: 2.0;OE19: 1.0;PC-3: 2.5;REH: 2.6;RT4: 1.6;SCLC-21H: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018833 Enhanced NA NA "HPA018833: AB_2669943" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (1.12e-2)" "unprognostic (1.83e-1)" "unprognostic (3.56e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-3)" "unprognostic (4.88e-2)" "unprognostic (1.26e-1)" "unprognostic (3.22e-2)" "unprognostic (3.15e-2)" "unprognostic (1.58e-1)" 0.8 3.4 13.7 1.2 15.5 0.8 1.0 0.6 9.7 1.3 1.4 6.9 0.0 0.7 1.7 0.7 0.8 1.1 0.8 1.1 15.1 1.6 0.8 0.9 0.7 0.8 2.3 7.5 0.9 0.7 0.7 0.8 1.0 7.3 1.0 0.8 0.3 5.9 1.4 2.2 0.7 2.3 0.7 7.3 0.9 0.9 1.9 7.1 0.0 0.8 0.0 0.7 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 2.6 0.0 0.0 0.0 1.6 5.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 15.5 0.6 9.7 15.1 1.6 2.3 7.5 7.3 7.1 0.0 0.0 0.0 0.1 0.3 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.1 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.3 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 NKAIN4 "bA261N11.2, C20orf58, FAM77A" ENSG00000101198 "Sodium/potassium transporting ATPase interacting 4" Q8IVV8 20 63240784-63272694 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 51.7" "Group enriched" "Detected in some" 11 "Muller glia cells: 68.6;Proximal tubular cells: 169.4" "Cancer enriched" "Detected in many" 6 "glioma: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.6;MOLT-4: 25.4;SK-MEL-30: 5.6;SuSa: 20.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "amygdala: 3.2;cerebral cortex: 3.9;hippocampal formation: 2.5" HPA029876 Approved NA NA "HPA029876: AB_10602038" "unprognostic (1.26e-1)" "unprognostic (4.27e-1)" "unprognostic (6.07e-5)" "prognostic unfavorable (3.14e-4)" "unprognostic (6.65e-2)" "unprognostic (2.59e-1)" "unprognostic (7.07e-3)" "unprognostic (1.94e-1)" "unprognostic (3.62e-2)" "unprognostic (2.69e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (2.12e-2)" "unprognostic (1.44e-4)" "unprognostic (5.66e-2)" "unprognostic (6.74e-2)" "unprognostic (4.01e-1)" 1.1 1.9 21.7 1.2 23.0 1.0 1.0 5.7 51.7 1.3 1.1 9.9 0.0 1.2 1.4 1.3 0.9 1.3 1.0 0.9 15.5 15.5 10.9 0.9 0.9 0.9 18.5 11.8 0.9 1.0 0.9 0.4 3.9 6.2 1.0 1.0 1.0 0.9 1.1 0.9 1.4 1.1 1.0 9.1 1.0 1.1 2.7 7.1 0.0 1.2 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.7 0.5 0.0 2.4 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 25.4 0.0 3.2 0.0 0.0 4.6 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.1 5.6 20.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 23.0 5.7 13.2 15.5 15.5 18.5 11.8 6.2 7.1 0.0 0.0 0.0 0.0 0.2 1.3 0.3 0.0 0.0 0.0 10.4 0.0 0.6 5.0 0.2 0.1 0.1 0.0 0.0 0.5 3.6 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 4.9 0.0 0.0 0.0 0.0 68.6 2.6 0.0 0.0 169.4 1.7 0.0 0.2 0.2 1.9 0.0 1.9 0.0 0.0 0.0 NKAPL "bA424I5.1, C6orf194" ENSG00000189134 "NFKB activating protein like" Q5M9Q1 6 28259320-28260958 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 35.4" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 224.7;Rod photoreceptor cells: 72.8;Spermatocytes: 169.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 6.1;BJ: 2.6;fHDF/TERT166: 4.0;HHSteC: 8.7;HSkMC: 5.7;HUVEC TERT2: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (3.93e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (9.73e-2)" "unprognostic (2.47e-1)" "unprognostic (7.86e-2)" "unprognostic (2.34e-2)" "unprognostic (1.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.88e-2)" "unprognostic (3.84e-3)" "unprognostic (5.78e-2)" "unprognostic (5.83e-5)" "unprognostic (6.65e-3)" "unprognostic (2.38e-1)" "unprognostic (2.08e-2)" "unprognostic (2.47e-2)" 2.8 2.3 3.2 1.4 5.1 0.8 2.6 6.7 5.1 1.4 2.4 1.7 2.7 0.9 1.6 2.8 1.8 1.2 2.2 6.9 2.7 2.6 1.8 1.6 1.5 1.4 3.8 1.2 3.2 2.5 0.7 10.3 1.6 9.9 2.4 1.1 2.0 2.4 4.1 7.0 1.4 1.1 5.1 3.9 2.2 1.6 35.4 4.0 0.0 1.9 2.0 1.2 2.3 3.9 2.2 5.2 4.8 2.6 0.5 0.8 0.4 0.0 0.0 0.0 0.0 6.1 1.8 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 5.7 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 2.1 3.1 0.3 2.6 0.8 2.2 0.1 0.5 1.9 0.4 0.5 0.4 4.8 0.5 2.1 5.2 0.0 0.4 3.2 5.1 6.7 5.1 2.7 2.6 3.8 1.2 9.9 4.0 0.0 0.0 0.5 1.6 0.9 25.4 12.0 2.5 0.0 2.3 1.8 41.2 0.1 8.3 1.5 224.7 3.6 0.0 0.0 0.6 0.0 2.8 1.1 0.0 2.9 2.7 31.8 0.0 3.1 3.8 15.8 5.2 2.6 5.0 3.6 0.0 15.8 1.6 0.0 6.0 3.6 72.8 0.0 4.6 169.4 25.8 0.6 0.2 0.0 0.0 0.5 NKD2 Naked2 ENSG00000145506 "Naked cuticle homolog 2" Q969F2 5 1008829-1038943 "Predicted intracellular proteins" "Exocytosis, Transport, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 25.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 5.5;Fibroblasts: 6.6;Melanocytes: 6.8;Muller glia cells: 5.6;Spermatogonia: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.5;HEK 293: 5.5;NB-4: 11.6;RPMI-8226: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049463 Uncertain NA NA "HPA049463: AB_2680777" "unprognostic (6.23e-3)" "unprognostic (2.82e-1)" "unprognostic (4.38e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (6.24e-3)" "unprognostic (5.87e-3)" "unprognostic (4.43e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (3.35e-2)" "unprognostic (6.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.36e-1)" "unprognostic (1.48e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-1)" 2.6 3.0 1.6 1.7 2.3 0.8 2.6 0.3 5.2 1.5 2.2 0.8 1.9 1.5 0.9 1.2 5.1 2.3 4.4 5.7 2.7 1.0 3.7 1.9 25.1 9.8 0.9 2.0 2.2 3.6 0.7 1.2 3.1 3.4 3.9 0.9 1.6 4.4 1.6 0.9 10.4 2.4 2.8 1.2 9.8 1.3 4.7 0.6 13.3 1.3 0.9 3.7 1.9 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.5 0.0 0.0 12.5 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 1.0 3.7 11.6 0.5 2.9 0.0 4.2 0.0 28.2 0.0 2.3 0.4 0.2 0.1 0.0 0.7 0.2 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.3 0.3 5.2 2.7 1.0 0.9 2.0 3.4 0.6 0.0 0.0 0.0 2.3 5.5 0.0 2.2 5.1 0.0 0.0 0.0 2.0 0.1 0.0 2.7 0.4 2.1 0.0 0.0 0.0 0.0 6.6 1.3 0.0 0.0 0.2 1.6 0.0 0.6 0.0 0.8 0.3 0.4 6.8 0.0 0.0 5.6 0.1 0.0 0.4 1.0 0.0 0.0 1.9 0.4 10.7 5.0 0.0 0.0 0.0 0.9 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372715 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 270.6;bone marrow: 108.2" "Cell type enriched" "Detected in many" 16 "T-cells: 1698.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7" "Group enriched" "Detected in all" 46 "NK-cells: 166.7;T-cells: 270.6" "Group enriched" "Detected in some" 5 "NB-4: 60.2;THP-1: 17.9;U-937: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles NA NA Vesicles "HPA071454: AB_2686399" "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favorable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 7.4 1.8 1.3 11.2 1.7 108.2 3.3 0.7 1.0 2.9 2.2 0.8 0.4 2.2 5.4 6.3 3.8 1.8 10.6 6.0 1.2 1.2 3.2 9.4 26.1 31.0 2.3 0.7 4.1 2.6 0.0 1.8 9.3 1.3 6.8 1.6 6.2 3.5 0.9 5.6 1.0 7.6 2.5 2.8 63.3 2.5 1.9 0.2 7.3 3.1 2.0 16.0 5.1 2.3 1.1 3.2 4.5 4.7 166.7 270.6 141.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.6 0.2 0.0 0.0 6.4 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.2 0.0 0.0 0.7 60.2 0.0 0.0 0.1 1.4 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 17.9 0.1 0.0 0.0 0.2 0.0 0.9 0.2 0.3 0.0 15.6 0.0 2.2 1.3 0.5 270.6 4.7 113.5 1.1 34.1 168.7 3.2 0.5 11.5 130.3 4.5 166.7 3.6 2.5 0.6 141.5 1.3 1.7 0.7 1.0 1.2 1.2 2.3 0.7 1.3 0.2 3.0 10.1 16.0 0.0 4.4 0.0 0.4 10.2 1.4 2.3 5.2 0.0 0.4 3.3 0.0 0.0 2.8 0.3 0.0 0.0 0.4 2.3 0.0 24.2 3.4 12.4 0.0 0.0 45.4 103.5 0.0 0.0 26.0 16.9 1.8 0.0 0.0 0.0 0.3 0.0 6.9 0.0 0.0 0.5 0.0 0.2 5.6 0.9 1698.3 0.0 0.1 NKPD1 FLJ33600 ENSG00000179846 "NTPase KAP family P-loop domain containing 1" Q17RQ9 19 45149750-45158737 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skin 1: 17.5" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 4.8" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043339 Uncertain NA NA "HPA043339: AB_10962493" "unprognostic (3.98e-2)" "unprognostic (5.94e-2)" "unprognostic (2.14e-1)" "unprognostic (8.30e-4)" "unprognostic (2.23e-1)" "unprognostic (4.60e-2)" "unprognostic (2.41e-3)" "unprognostic (2.01e-2)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (7.73e-4)" "unprognostic (1.30e-1)" "unprognostic (2.77e-5)" "unprognostic (1.00e-1)" "unprognostic (1.26e-1)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" 0.0 0.1 0.0 0.0 0.1 0.2 0.8 0.5 0.2 0.9 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.8 0.1 17.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.4 0.2 0.2 0.5 0.1 0.2 1.8 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.4 0.3 0.7 0.0 0.1 0.4 0.0 0.0 0.0 0.5 0.6 1.5 0.1 0.1 0.1 0.0 0.0 0.2 4.0 0.0 0.1 0.1 0.1 0.2 0.4 0.7 0.0 1.1 0.7 0.5 0.3 1.8 0.4 0.1 0.0 0.3 0.0 0.1 0.6 0.3 3.5 1.8 0.1 0.5 1.3 0.3 0.0 0.0 0.0 0.0 0.0 7.3 1.7 0.3 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.5 0.6 0.0 0.2 1.8 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 1.1 0.1 0.0 0.0 0.0 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119605895 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 3.8 7.9 14.5 6.2 24.3 7.6 6.5 11.4 34.9 4.9 4.0 4.4 1.1 4.7 4.8 5.6 5.6 5.2 4.1 3.8 15.4 14.0 6.9 6.9 4.1 9.7 8.1 24.6 7.4 3.9 8.3 6.5 7.5 25.7 4.9 4.5 2.9 4.6 4.3 4.8 6.4 4.4 4.7 6.0 6.4 4.0 1.9 3.5 7.4 5.4 1.4 9.7 5.2 4.8 3.8 2.7 2.8 2.2 1.3 5.5 1.7 11.0 11.2 6.6 7.7 5.8 5.9 10.1 6.7 5.5 9.1 9.9 11.9 9.5 19.6 11.8 5.8 7.8 13.0 27.7 10.3 11.2 9.8 18.9 10.3 13.4 7.9 5.4 20.0 8.0 6.2 8.5 10.5 12.3 6.2 9.2 9.7 11.1 8.3 8.1 17.0 12.7 16.0 14.8 16.1 12.6 10.0 9.5 20.1 12.0 8.2 10.9 9.1 9.4 14.7 9.9 7.2 6.2 12.2 7.5 5.8 6.2 12.4 16.8 6.8 8.2 20.7 6.0 22.4 6.5 2.8 1.3 1.5 3.3 2.2 3.1 3.7 3.6 3.7 1.3 3.8 5.5 4.8 0.2 1.3 1.1 2.7 4.3 1.7 14.5 24.3 11.4 34.9 15.4 14.0 8.1 24.6 25.7 3.5 6.0 6.2 9.0 9.2 17.2 13.3 4.0 10.2 2.7 2.3 5.2 25.5 11.6 1.7 3.8 0.1 4.5 2.6 0.0 3.1 13.2 6.2 8.4 14.9 3.4 5.6 7.9 10.3 4.3 6.0 0.0 7.2 7.8 5.0 6.4 3.8 4.0 3.1 0.0 6.3 3.7 8.3 0.0 8.2 0.5 1.1 22.5 12.5 7.0 5.7 8.7 NKX1-1 "HSPX153, SAX2" ENSG00000235608 "NK1 homeobox 1" Q15270 4 1402932-1406331 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 19 "pituitary gland: 1.0;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "pons and medulla: 0.2" HPA029367 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX1-2 "bB238F13.2, C10orf121" ENSG00000229544 "NK1 homeobox 2" Q9UD57 10 124445239-124450184 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;intestine: 2.9;skin 1: 2.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 3.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.0;hTCEpi: 5.9;NTERA-2: 11.6;SCLC-21H: 5.1;SuSa: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029367 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA029367: AB_2673011" "unprognostic (2.43e-1)" "unprognostic (7.85e-3)" "unprognostic (6.81e-5)" "unprognostic (1.55e-2)" "unprognostic (3.61e-2)" "unprognostic (5.40e-2)" "unprognostic (7.28e-2)" "unprognostic (2.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (8.68e-2)" 0.0 0.0 0.7 0.0 2.0 0.0 0.9 0.2 2.9 0.4 0.0 1.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.4 0.0 0.7 3.7 0.3 0.0 0.0 0.0 0.4 2.2 0.0 0.0 0.0 1.2 0.0 0.0 2.2 2.9 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 6.0 0.5 0.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.1 14.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.0 0.2 2.9 0.6 0.3 0.7 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-1 "BCH, NKX2A, TITF1, TTF-1, TTF1" ENSG00000136352 "NK2 homeobox 1" P43699 14 36516392-36521149 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "lung: 51.5;thyroid gland: 122.8" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 128.1;Alveolar cells type 2: 108.1;Club cells: 46.6" "Group enriched" "Detected in some" 39 "lung cancer: 30.9;thyroid cancer: 103.2" "Group enriched" "Detected in some" 6 "basal ganglia: 2.4;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 48.7" "Group enriched" "Detected in some" 5 "basal ganglia: 3.4;hypothalamus: 12.0" "Group enriched" "Detected in some" 13 "basal ganglia: 6.4;hypothalamus: 16.1" "CAB000078, CAB053633, HPA074316" Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "CAB000078: , CAB053633: AB_442138, HPA074316: " "unprognostic (3.79e-1)" "unprognostic (4.25e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" "unprognostic (1.26e-2)" "unprognostic (2.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.29e-1)" "unprognostic (1.83e-2)" "unprognostic (4.18e-1)" 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.5 0.0 0.0 51.5 0.1 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.4 0.0 122.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 48.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.1 0.2 2.5 0.0 0.1 0.1 0.4 128.1 108.1 0.0 0.0 0.0 0.0 0.6 0.0 14.7 46.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NKX2-2 "NKX2.2, NKX2B" ENSG00000125820 "NK2 homeobox 2" O95096 20 21511010-21514026 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 30.6;pancreas: 12.1" "Cell type enriched" "Detected in some" 68 "Intestinal endocrine cells: 159.5" "Group enriched" "Detected in many" 5 "glioma: 9.5;pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.5;T-47d: 5.3;U-138 MG: 18.9;U-2 OS: 3.9;WM-115: 7.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003468 Approved NA NA "HPA003468: AB_1079490" "unprognostic (5.13e-3)" "unprognostic (5.54e-2)" "unprognostic (3.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.75e-2)" "unprognostic (2.93e-3)" "unprognostic (1.10e-1)" "unprognostic (3.24e-2)" "unprognostic (3.29e-1)" 0.6 0.6 6.5 0.7 8.1 0.7 0.6 3.4 15.5 0.6 1.4 19.1 0.0 6.2 0.6 0.6 0.6 0.6 0.6 0.6 7.8 6.9 0.6 0.6 0.6 0.7 14.2 6.4 0.6 12.1 1.0 4.6 0.6 10.9 0.7 1.4 0.0 0.6 0.6 0.6 0.8 2.5 0.6 30.6 0.6 7.0 0.6 9.4 0.0 0.6 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.3 0.0 18.9 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.1 3.4 7.6 7.8 6.9 14.2 6.4 10.9 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532933-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HAP1: 2.1;NB-4: 4.8;REH: 6.2;THP-1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 0.8 0.0 0.1 17.2 0.1 0.0 0.1 0.1 0.1 0.3 21.6 0.1 0.1 10.4 0.2 0.1 0.5 0.0 12.5 0.1 0.1 0.0 0.1 0.2 0.1 1.1 0.1 0.1 0.1 6.4 0.0 0.1 0.1 0.1 0.1 4.6 0.1 9.0 0.5 0.1 0.0 19.1 3.1 0.1 36.8 1.8 0.1 0.1 0.2 1.0 0.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 6.2 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.4 0.0 1.6 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NKX2-4 "NKX2.4, NKX2D" ENSG00000125816 "NK2 homeobox 4" Q9H2Z4 20 21395367-21398028 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;pituitary gland: 1.2;testis: 5.2" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 1.2;Early spermatids: 2.4;Late spermatids: 1.9;Spermatocytes: 3.8;Spermatogonia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HEK 293: 7.8;SCLC-21H: 5.1;SK-MEL-30: 5.9;WM-115: 1.8" "Region enriched" "Detected in single" 22 "hypothalamus: 3.1" "Region enriched" "Detected in single" 32 "hypothalamus: 1.4" HPA074996 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA074996: AB_2686725" "unprognostic (3.77e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.2 0.0 0.0 0.0 0.0 0.0 NKX2-5 "CSX, CSX1, NKX2.5, NKX2E, NKX4-1" ENSG00000183072 "NK2 homeobox 5" P52952 5 173232109-173235357 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Atrial septal defect, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 95.6" "Cell type enriched" "Detected in some" 32 "Cardiomyocytes: 56.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 21.0;NTERA-2: 7.6;SK-MEL-30: 9.3;U-2 OS: 17.3;U-251 MG: 12.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065034 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA065034: AB_2685409" "unprognostic (3.81e-1)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (9.57e-3)" "unprognostic (3.22e-3)" "unprognostic (6.63e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-1)" "unprognostic (2.31e-1)" "unprognostic (5.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.77e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.1 0.0 0.0 0.2 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.0 1.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 4.9 21.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.1 0.3 4.2 0.0 9.3 2.9 0.0 0.0 0.0 4.0 17.3 5.3 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.1 0.1 0.0 0.0 0.0 NKX2-6 "CSX2, NKX4-2" ENSG00000180053 "NK2 homeobox 6" A6NCS4 8 23702451-23706598 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 3.4;heart muscle: 2.7;lymphoid tissue: 3.0;salivary gland: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTEC/SVTERT24-B: 8.7;JURKAT: 4.0;LHCN-M2: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.7 0.0 0.1 0.0 4.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell type enhanced" "Detected in single" 18 "Basal glandular cells: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.5 10.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 0.0 0.0 0.0 2.3 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.3 NKX3-1 "BAPX2, NKX3.1, NKX3A" ENSG00000167034 "NK3 homeobox 1" Q99801 8 23678693-23682927 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "prostate: 95.3" "Group enriched" "Detected in many" 6 "Basal glandular cells: 52.8;Glandular cells: 96.8" "Cancer enriched" "Detected in many" 65 "prostate cancer: 392.7" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 7 "eosinophil: 23.5;neutrophil: 23.4" "Lineage enriched" "Detected in many" 19 "granulocytes: 23.5" "Cell line enhanced" "Detected in many" "GAMG: 16.9;SiHa: 16.7;U-138 MG: 17.0;U-251 MG: 14.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA025693, HPA078571" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA025693: AB_1854522, HPA078571: AB_2732384" "unprognostic (1.47e-2)" "unprognostic (4.03e-2)" "unprognostic (2.67e-1)" "unprognostic (5.87e-2)" "unprognostic (2.56e-6)" "unprognostic (6.90e-3)" "unprognostic (1.13e-1)" "unprognostic (4.11e-3)" "unprognostic (9.42e-2)" "unprognostic (1.41e-1)" "unprognostic (3.00e-2)" "unprognostic (1.87e-1)" "unprognostic (4.37e-2)" "unprognostic (4.60e-2)" "unprognostic (3.88e-2)" "unprognostic (3.09e-2)" "unprognostic (1.69e-1)" 0.6 1.3 0.3 0.6 0.9 0.6 1.5 0.1 0.8 1.1 0.6 0.2 0.5 0.5 0.7 0.5 1.2 0.7 0.8 2.4 0.8 0.3 0.4 1.6 0.8 0.7 0.6 0.2 1.6 0.6 0.5 0.4 0.3 1.2 95.3 0.2 0.5 17.9 0.7 2.0 0.2 0.4 0.7 0.6 0.3 0.5 12.3 0.7 0.0 0.6 3.2 20.5 0.7 2.5 1.0 0.0 23.5 0.0 0.2 1.2 0.1 3.0 2.3 0.0 5.6 2.1 0.5 4.6 4.2 2.7 9.0 10.7 1.3 3.5 0.0 0.6 3.1 16.9 0.8 2.2 4.8 7.1 0.0 1.1 2.1 1.7 3.4 4.0 0.0 0.8 0.8 1.3 9.1 0.5 5.6 0.5 12.9 0.1 0.0 3.5 1.0 7.3 0.6 1.3 0.0 1.6 0.0 3.6 0.3 0.5 3.6 1.1 0.3 16.7 3.1 0.3 6.8 2.2 0.3 0.6 17.0 6.0 1.3 14.5 0.0 0.0 0.0 8.3 1.6 2.0 3.4 0.0 23.5 0.5 0.0 0.1 1.0 0.2 0.5 0.0 0.9 0.7 1.2 23.4 0.2 0.0 0.0 0.0 0.1 0.3 0.9 0.1 0.8 0.8 0.3 0.6 0.2 1.2 0.7 3.0 4.0 0.5 52.8 4.9 1.7 7.0 0.0 1.4 5.7 0.0 7.9 0.3 0.0 2.4 2.0 6.8 0.4 0.0 6.1 1.2 4.1 96.8 0.0 3.8 0.2 3.2 6.3 4.9 0.3 4.5 2.0 2.9 1.7 1.0 0.4 4.3 4.7 0.0 6.0 0.5 4.5 0.0 13.3 0.7 1.4 1.8 0.2 0.5 0.5 9.3 NKX3-2 "BAPX1, NKX3.2, NKX3B" ENSG00000109705 "NK3 homeobox 2" P78367 4 13540830-13545050 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 18.3;lymphoid tissue: 6.5" "Cell type enriched" "Detected in single" 31 "Cardiomyocytes: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA027564 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027564: AB_10601973" "unprognostic (3.26e-2)" "unprognostic (1.26e-1)" "unprognostic (7.42e-3)" "unprognostic (5.97e-2)" "unprognostic (9.15e-3)" "unprognostic (5.72e-2)" "unprognostic (2.24e-5)" "unprognostic (3.49e-2)" "unprognostic (1.12e-1)" "unprognostic (4.06e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.93e-8)" "unprognostic (5.81e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.15e-1)" 1.7 0.0 0.1 6.5 0.1 0.0 0.1 0.1 0.1 1.1 18.3 0.1 0.1 1.6 0.9 0.1 2.3 0.2 0.4 1.8 0.1 0.0 0.4 0.1 0.1 2.0 0.1 0.1 2.9 0.2 0.0 0.9 0.1 0.1 0.6 2.4 0.1 1.5 0.6 0.1 0.1 2.0 3.2 0.1 5.3 2.8 0.9 0.1 0.1 0.3 0.9 0.1 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 1.9 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 1.0 0.0 4.6 0.0 0.0 0.0 2.6 0.6 1.7 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 1.9 0.0 0.7 1.7 0.0 0.7 0.0 0.4 12.7 7.2 0.0 0.5 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.3 1.0 7.6 0.0 0.5 3.0 0.1 0.5 2.2 0.0 0.0 0.4 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NKX6-1 "Nkx6.1, NKX6A" ENSG00000163623 "NK6 homeobox 1" P78426 4 84491987-84498450 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 6.0;esophagus: 11.0;pancreas: 10.8" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 7.1;Early spermatids: 2.5;Spermatocytes: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;HAP1: 8.1;HEK 293: 7.1;HMC-1: 5.5;PC-3: 4.8;U-2197: 9.0" "Region enhanced" "Detected in single" "pons and medulla: 1.7" "Low region specificity" "Detected in many" "HPA036774, CAB070169" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB070169: AB_10011794, HPA036774: AB_10673664" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (9.13e-2)" "unprognostic (3.19e-1)" "unprognostic (1.38e-2)" "unprognostic (1.30e-1)" "unprognostic (2.71e-2)" "unprognostic (2.46e-1)" "unprognostic (2.75e-2)" "unprognostic (3.82e-2)" "unprognostic (1.82e-3)" "unprognostic (1.85e-1)" "unprognostic (5.41e-2)" "unprognostic (7.13e-3)" "unprognostic (3.68e-1)" 0.2 0.0 0.3 0.2 2.2 0.0 6.0 1.0 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 11.0 0.0 0.2 0.2 0.4 1.3 0.2 0.2 0.2 0.2 2.5 0.2 0.2 10.8 0.0 0.2 0.2 0.9 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 1.3 0.2 1.5 2.1 0.2 0.2 3.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.6 0.9 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.2 2.3 0.0 8.1 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.3 1.5 0.0 0.7 0.0 0.0 1.5 0.0 0.8 0.1 0.0 2.5 9.0 2.3 0.0 0.0 0.0 1.5 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 1.0 1.1 0.4 1.3 2.5 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 2.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.0 0.0 0.0 0.0 0.0 0.0 NKX6-2 "GTX, NKX6.1, NKX6B" ENSG00000148826 "NK6 homeobox 2" Q9C056 10 132783179-132786052 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 25 "brain: 50.0;stomach 1: 31.7" "Cell type enhanced" "Detected in some" 30 "Cardiomyocytes: 1.1;Pancreatic endocrine cells: 5.3;Spermatogonia: 1.5" "Cancer enriched" "Detected in some" 5 "glioma: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.92e-1)" "unprognostic (4.39e-2)" "unprognostic (2.26e-1)" "unprognostic (2.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.57e-1)" "unprognostic (1.62e-1)" 1.0 1.0 14.8 1.0 21.7 1.0 1.0 2.2 18.7 1.0 1.0 25.9 0.0 1.0 1.0 1.0 1.1 1.0 1.0 1.0 25.6 13.2 1.0 1.0 1.0 1.0 34.7 6.3 1.0 1.1 1.0 0.0 1.0 18.1 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 50.0 1.0 31.7 1.6 26.8 0.0 1.0 0.0 1.0 1.0 0.1 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.8 21.7 2.2 12.7 25.6 13.2 34.7 6.3 18.1 26.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 NKX6-3 FLJ25169 ENSG00000165066 "NK6 homeobox 3" A6NJ46 8 41645178-41650669 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.8;intestine: 10.8;stomach 1: 33.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "endometrial cancer: 0.9;pancreatic cancer: 3.1;stomach cancer: 3.9;testis cancer: 1.6" "Region enriched" "Detected in some" 10 "cerebellum: 13.8" "Cell type enriched" "Detected in single" 17 "naive B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Group enriched" "Detected in some" 7 "Daudi: 11.0;THP-1: 5.1" NA NA "unprognostic (1.87e-1)" "unprognostic (9.91e-3)" "unprognostic (4.04e-1)" "unprognostic (5.73e-2)" "unprognostic (1.98e-1)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (1.13e-1)" "unprognostic (2.17e-2)" "unprognostic (1.92e-1)" "unprognostic (1.78e-1)" 0.2 0.0 0.4 0.2 0.5 0.0 0.2 13.8 1.3 0.2 4.6 0.2 0.2 10.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.8 2.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.7 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 13.8 1.3 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128753-35142315 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 40.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 6.3 6.9 7.0 8.2 7.6 6.4 11.4 7.6 9.1 5.6 5.8 5.4 3.3 5.1 10.0 5.5 7.9 10.0 8.3 4.8 6.0 6.4 4.8 6.9 4.5 9.1 5.6 7.7 16.3 40.3 5.1 4.2 6.1 5.4 9.2 5.3 6.2 9.1 7.5 8.8 7.6 5.1 10.2 5.1 8.3 6.8 7.2 6.4 10.0 10.0 6.6 8.3 6.3 5.4 6.4 4.5 0.4 3.2 2.4 9.1 3.0 8.2 20.0 6.7 12.0 4.2 6.3 10.8 7.4 7.0 13.3 11.0 13.8 8.0 18.2 10.2 6.2 9.7 11.0 15.3 19.0 9.1 2.9 23.8 8.2 9.6 17.2 5.7 15.7 6.6 7.1 10.2 13.7 21.0 5.9 8.5 17.9 22.0 6.7 7.8 11.3 24.1 12.8 12.7 6.9 8.9 19.5 11.8 20.1 7.8 8.0 13.9 8.4 7.0 7.2 8.8 6.5 17.6 11.4 7.6 7.2 10.1 6.9 24.8 5.2 4.0 15.3 5.0 13.0 13.7 0.1 3.0 0.0 5.7 3.2 9.1 4.8 5.4 6.0 4.5 6.4 7.4 5.1 0.4 2.4 1.6 1.0 3.0 3.0 7.0 7.6 7.6 9.1 6.0 6.4 5.6 7.7 5.4 6.4 3.0 0.6 12.4 6.2 7.7 4.1 2.0 12.7 4.0 3.4 3.5 2.0 9.0 0.0 8.7 0.6 4.2 1.6 0.0 12.9 16.0 8.2 4.0 3.5 5.5 6.7 1.6 4.7 4.3 2.8 4.7 3.7 2.2 1.7 3.6 7.8 1.4 9.4 2.9 4.6 5.6 2.9 0.0 4.1 3.6 5.3 8.8 4.1 4.4 12.0 5.1 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 50.9;Leydig cells: 23.9;Muller glia cells: 30.8" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 16.2;HUVEC TERT2: 15.8;RH-30: 16.9;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680, CAB033261" Enhanced Uncertain "Nuclear bodies,Plasma membrane" NA NA 40000 "Plasma membrane" "Nuclear bodies" "CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 3.9 2.4 13.4 1.4 9.4 0.6 1.6 20.2 26.9 6.3 3.2 5.6 0.0 1.0 4.3 5.0 4.8 5.9 3.3 5.7 8.8 9.1 5.6 0.6 1.2 1.0 6.3 7.8 2.8 2.0 0.6 6.9 1.4 6.8 4.4 2.2 4.3 0.9 5.9 0.7 1.0 1.6 8.2 4.6 0.7 2.0 11.1 8.9 0.0 2.2 0.4 0.8 5.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 7.7 8.3 0.0 3.2 8.1 0.4 0.5 0.0 0.3 0.0 0.1 16.2 3.0 0.0 2.3 0.0 0.8 0.0 3.8 1.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 6.5 15.8 0.0 0.0 1.0 0.1 0.0 0.0 0.0 4.6 0.0 1.1 0.0 16.9 3.9 3.0 0.0 1.6 1.1 0.0 0.0 7.9 0.7 0.4 0.0 1.9 8.8 0.9 6.3 7.2 7.6 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.4 20.2 10.9 8.8 9.1 6.3 7.8 6.8 8.9 0.0 0.3 0.0 0.6 0.7 11.4 2.0 0.0 0.0 0.0 3.5 3.9 0.2 0.0 0.3 50.9 0.3 0.0 0.0 0.0 0.1 2.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 23.9 0.0 13.5 0.0 0.0 30.8 0.1 0.0 13.4 7.1 9.7 6.5 1.0 0.4 0.7 0.6 0.1 0.0 0.0 0.1 NLGN2 KIAA1366 ENSG00000169992 "Neuroligin 2" Q8NFZ4 17 7404874-7419860 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 31.6;Horizontal cells: 54.0;Muller glia cells: 23.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "AF22: 26.1" "Low region specificity" "Detected in all" "HPA055321, HPA069278" Enhanced Approved Mitochondria NA NA Mitochondria "HPA055321: AB_2682783, HPA069278: AB_2686105" "unprognostic (1.31e-1)" "unprognostic (1.87e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-3)" "unprognostic (2.92e-1)" "unprognostic (1.56e-1)" "unprognostic (6.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.58e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (5.50e-3)" "unprognostic (1.81e-2)" 13.0 10.9 31.3 9.9 45.3 2.4 7.4 32.7 47.0 16.9 11.3 18.3 9.5 4.4 25.3 16.4 9.0 13.8 15.5 6.6 28.8 16.0 5.7 3.3 6.2 6.1 13.9 27.5 24.3 7.4 20.7 8.3 8.5 21.3 11.6 5.9 11.2 6.5 19.2 6.3 8.7 5.4 24.3 19.4 7.5 5.9 4.8 15.9 0.0 4.8 1.7 5.0 9.8 11.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 4.2 5.9 26.1 15.1 8.0 11.2 0.6 7.0 11.1 11.9 11.0 1.3 1.4 0.0 3.4 9.7 7.0 2.4 4.8 2.9 6.4 6.3 4.9 1.8 5.3 1.0 4.1 1.8 6.4 9.0 2.4 9.8 1.6 18.0 4.0 2.3 1.7 3.4 5.0 4.0 0.8 1.8 4.4 0.2 2.8 7.5 3.1 0.8 3.5 0.9 0.4 10.5 3.2 1.5 1.8 5.4 4.2 0.2 5.5 10.3 13.1 6.5 3.4 3.9 1.3 0.7 10.7 1.7 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.3 45.3 32.7 37.2 28.8 16.0 13.9 27.5 21.3 15.9 0.0 1.6 0.0 2.5 4.1 31.6 10.9 0.0 0.0 0.0 0.0 7.9 0.3 0.0 2.7 1.3 5.2 0.0 0.0 0.3 5.7 11.2 2.1 0.0 2.1 0.8 54.0 0.0 4.9 0.3 2.5 15.8 0.0 1.7 1.0 0.0 23.0 2.1 0.0 20.8 1.0 15.3 32.3 10.3 0.3 1.3 3.3 0.7 1.0 0.0 1.0 NLGN3 "ASPGX1, AUTSX1, HNL3, KIAA1480" ENSG00000196338 "Neuroligin 3" Q9NZ94 X 71144831-71171201 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.9" "Cell type enriched" "Detected in some" 6 "Peritubular cells: 16.3" "Cancer enriched" "Detected in many" 19 "glioma: 37.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.3" "Cell line enhanced" "Detected in some" "AF22: 11.1;NTERA-2: 8.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003183, HPA004066" Enhanced Supported "Golgi apparatus,Cell Junctions" "Intracellular and membrane" NA NA "Golgi apparatus, Cell Junctions" "HPA003183: AB_1079469, HPA004066: AB_2732397" "unprognostic (4.06e-2)" "unprognostic (1.77e-1)" "unprognostic (1.59e-2)" "unprognostic (2.38e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-1)" "unprognostic (6.52e-2)" "unprognostic (1.63e-1)" "unprognostic (7.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (6.18e-2)" "unprognostic (4.27e-9)" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (2.22e-5)" "unprognostic (9.01e-2)" 1.4 8.9 16.3 1.6 19.4 2.2 1.3 11.5 45.9 3.2 1.6 30.0 0.1 1.1 4.2 8.1 1.5 6.0 2.4 2.1 15.7 9.7 1.2 0.9 1.3 1.2 12.7 13.1 6.1 1.2 1.4 1.1 1.5 15.2 7.9 1.4 1.6 1.6 16.0 0.8 1.6 1.6 2.9 12.9 1.4 1.5 3.8 12.3 0.0 1.0 0.0 1.1 1.5 1.3 0.2 0.1 3.3 0.3 0.3 0.5 0.0 0.1 0.8 11.1 0.3 2.6 1.1 1.9 0.3 0.1 0.0 0.2 0.1 0.5 0.8 0.8 0.1 0.0 0.2 0.4 0.0 0.2 0.7 1.3 0.5 0.5 0.1 0.0 0.2 0.9 0.6 0.1 0.3 0.0 0.5 0.1 3.1 0.7 2.1 0.1 0.6 0.7 1.7 8.1 0.1 0.0 0.9 0.4 0.5 0.0 1.2 2.7 4.4 0.3 0.0 1.0 1.4 0.0 0.5 0.3 0.2 1.3 0.5 0.1 1.7 1.5 0.6 0.3 0.5 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.5 0.1 3.3 0.3 0.0 0.1 0.1 0.0 16.3 19.4 11.5 23.1 15.7 9.7 12.7 13.1 15.2 12.3 0.0 0.0 0.0 0.4 0.6 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.5 2.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 16.3 0.0 0.5 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.3 NLGN4X "HLNX, KIAA1260, NLGN, NLGN4" ENSG00000146938 "Neuroligin 4, X-linked" Q8N0W4 X 5840637-6228863 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Asperger syndrome, Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 19.4;Cone photoreceptor cells: 23.6;Leydig cells: 16.7;Melanocytes: 13.5;Peritubular cells: 28.0;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "glioma: 8.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 6 "B-cells: 1.5" "Group enriched" "Detected in some" 4 "AF22: 29.3;NTERA-2: 23.2;SuSa: 23.7" HPA001651 Approved NA NA "HPA001651: AB_1079470" "unprognostic (2.21e-1)" "unprognostic (4.01e-2)" "unprognostic (1.11e-1)" "unprognostic (8.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.36e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-1)" "unprognostic (9.49e-2)" "unprognostic (1.48e-2)" "unprognostic (9.32e-2)" "unprognostic (5.10e-3)" "unprognostic (7.16e-4)" "unprognostic (6.70e-2)" "unprognostic (2.98e-2)" "unprognostic (1.10e-2)" 4.9 2.3 8.3 2.8 10.7 0.3 3.4 12.2 19.2 8.2 3.6 3.7 0.4 2.1 3.7 1.0 1.3 3.4 4.0 5.4 7.9 9.9 0.8 2.2 1.9 1.7 5.6 6.4 16.8 0.9 12.3 2.6 5.4 5.7 2.0 3.2 2.1 1.5 3.3 0.7 1.2 2.9 5.6 4.3 3.2 1.9 3.9 3.9 56.3 1.0 0.0 1.1 3.6 1.8 1.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 3.7 0.0 23.2 0.0 0.0 0.0 0.0 0.0 2.1 5.9 1.4 1.8 0.0 0.0 0.0 23.7 3.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 8.3 10.7 12.2 14.7 7.9 9.9 5.6 6.4 5.7 3.9 0.0 0.3 0.0 0.1 0.2 19.4 2.7 0.0 1.4 0.0 0.0 23.6 3.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.0 4.3 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.3 0.2 16.7 0.0 13.5 0.0 0.0 10.3 0.0 0.0 28.0 0.0 3.0 12.9 0.7 1.6 4.9 0.5 3.0 0.0 0.0 0.3 NLGN4Y KIAA0951 ENSG00000165246 "Neuroligin 4, Y-linked" Q8NFZ3 Y 14522573-14845650 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.8;seminal vesicle: 15.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 9.5;Bipolar cells: 8.5;Urothelial cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 3.0;memory CD4 T-cell: 1.7" "Group enriched" "Detected in many" 12 "B-cells: 3.0;T-cells: 1.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 19.6;fHDF/TERT166: 15.0;HDLM-2: 17.5;hTCEpi: 13.1;SuSa: 12.8;U-138 MG: 14.3" HPA001651 Approved "Intracellular and membrane" NA NA "HPA001651: AB_1079470" "unprognostic (2.31e-1)" "unprognostic (9.19e-2)" "unprognostic (2.84e-5)" "unprognostic (7.85e-2)" "unprognostic (6.46e-2)" "unprognostic (8.80e-3)" "unprognostic (7.71e-2)" "unprognostic (6.26e-2)" "unprognostic (5.89e-2)" "unprognostic (7.20e-3)" "unprognostic (1.88e-1)" "unprognostic (5.65e-2)" 1.4 1.9 4.7 1.4 18.7 0.4 1.3 11.2 23.8 0.4 2.5 11.2 2.4 1.2 0.4 4.0 4.3 0.4 4.8 0.8 4.9 5.7 2.0 4.4 1.3 2.7 3.7 0.0 0.5 3.3 0.4 2.9 0.9 12.6 12.6 3.1 7.2 2.2 15.3 0.6 1.3 2.0 3.7 3.5 1.1 1.5 1.3 0.0 2.5 2.6 4.0 2.5 6.0 0.0 3.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 4.3 19.6 1.2 1.6 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 3.1 17.5 0.0 0.0 0.0 2.8 2.1 0.0 0.0 6.8 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.2 0.0 3.9 0.0 0.0 0.0 1.2 0.0 4.7 7.5 2.6 0.0 0.0 0.0 0.0 12.8 0.0 0.4 5.6 14.3 0.0 0.0 3.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.0 1.7 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.6 0.0 4.7 18.7 11.2 23.8 4.9 5.7 3.7 0.0 12.6 0.0 0.0 2.2 0.0 9.5 3.1 8.5 0.7 2.5 2.7 6.8 7.0 0.0 0.3 0.0 1.6 0.0 0.7 0.0 0.0 0.0 0.1 7.1 4.5 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 2.6 0.0 1.7 4.6 0.0 4.0 0.0 0.0 7.8 0.6 0.7 0.0 1.0 0.1 0.4 2.8 0.2 0.0 0.0 10.1 NLRC3 "CLR16.2, FLJ00348, NOD3" ENSG00000167984 "NLR family CARD domain containing 3" Q7RTR2 16 3539033-3577400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.0" "Cell type enhanced" "Detected in some" 14 "Ito cells: 6.2;T-cells: 15.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 6.3;HL-60: 13.1;HMC-1: 6.6;JURKAT: 6.5;NB-4: 14.0;U-698: 20.2;U-937: 9.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA048062 Supported "Vesicles,Centriolar satellite,Cytosol" NA NA Cytosol "Vesicles, Centriolar satellite" "HPA048062: AB_2680242" "unprognostic (4.93e-3)" "unprognostic (3.84e-4)" "unprognostic (7.61e-4)" "unprognostic (4.94e-7)" "unprognostic (9.56e-2)" "unprognostic (3.76e-5)" "unprognostic (1.86e-3)" "unprognostic (6.70e-3)" "unprognostic (2.66e-2)" "unprognostic (7.02e-2)" "unprognostic (3.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.40e-2)" "unprognostic (5.13e-2)" "unprognostic (7.15e-3)" "unprognostic (4.54e-2)" "unprognostic (2.08e-2)" 0.2 0.4 0.0 20.1 0.1 2.8 0.0 0.0 0.2 0.4 1.3 0.0 0.2 1.2 1.0 0.1 1.0 0.0 1.8 0.8 0.0 0.6 0.5 6.0 11.2 0.2 0.0 0.1 1.5 0.0 0.0 0.6 0.2 0.9 0.7 0.9 2.7 0.2 0.5 0.0 2.4 0.1 0.0 10.5 1.4 0.0 0.0 27.0 0.4 1.1 18.1 1.6 1.0 1.0 0.0 2.6 0.0 4.7 4.1 3.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 6.3 0.1 0.0 0.0 13.1 6.6 0.0 0.0 0.0 0.0 0.3 0.2 6.5 0.1 0.0 0.0 0.3 5.4 14.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 3.3 0.4 0.2 0.0 0.2 0.1 0.3 0.0 20.2 0.1 9.8 0.0 2.6 0.0 0.0 3.7 0.0 4.1 1.0 2.7 3.8 0.0 0.8 2.1 2.0 0.0 4.7 0.0 0.0 3.1 3.3 3.0 0.0 4.2 0.2 0.0 1.6 3.7 0.0 1.4 1.2 1.8 3.9 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 6.2 0.6 0.7 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.5 0.2 0.0 0.0 15.2 0.0 0.1 NLRC4 "CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf" ENSG00000091106 "NLR family CARD domain containing 4" Q9NPP4 2 32224453-32265854 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.8;lymphoid tissue: 22.4" "Group enriched" "Detected in some" 4 "Hofbauer cells: 10.7;Kupffer cells: 20.0;Macrophages: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 19.8;intermediate monocyte: 23.8;myeloid DC: 13.3;neutrophil: 9.7;non-classical monocyte: 17.6" "Group enriched" "Detected in many" 35 "dendritic cells: 13.3;granulocytes: 9.7;monocytes: 23.8" "Cell line enhanced" "Detected in many" "HL-60: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA006592 Uncertain NA NA "HPA006592: AB_2667620" "unprognostic (7.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.25e-2)" "unprognostic (1.97e-1)" "unprognostic (8.88e-2)" "unprognostic (2.45e-2)" "unprognostic (1.17e-2)" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (6.33e-2)" "unprognostic (6.33e-2)" "unprognostic (6.03e-6)" "unprognostic (7.42e-2)" "unprognostic (2.06e-3)" "unprognostic (2.02e-2)" "unprognostic (1.63e-1)" 8.4 2.4 2.2 11.7 5.2 11.2 1.3 1.3 3.7 0.8 1.1 2.0 0.3 1.1 0.9 1.4 0.8 1.7 2.0 2.7 2.1 1.4 1.7 2.2 8.3 16.2 5.4 0.8 1.0 1.5 0.0 1.2 2.8 3.0 0.9 1.1 1.2 1.1 0.2 1.5 0.6 1.7 2.9 5.5 22.4 1.2 1.0 3.6 1.7 0.9 0.0 1.5 2.7 2.3 0.4 13.3 9.7 23.8 0.1 0.1 6.5 0.6 0.6 0.9 1.8 0.2 0.0 1.1 0.9 0.0 0.0 0.0 0.7 0.9 0.9 0.7 0.0 0.5 0.8 0.0 0.0 0.0 2.0 0.7 1.3 0.3 1.0 0.0 7.0 1.3 0.0 1.0 0.0 3.6 1.1 0.0 0.4 0.7 1.1 0.0 0.1 0.5 3.3 0.5 0.5 0.5 0.3 1.1 1.1 0.0 0.9 0.8 1.7 0.5 0.6 2.9 1.3 0.3 3.4 0.2 0.8 0.8 0.7 1.0 1.4 1.9 3.1 1.4 3.1 1.0 0.1 19.8 2.3 0.0 23.8 0.1 0.2 0.0 0.0 13.3 0.4 0.0 0.0 9.7 0.1 17.6 0.1 0.0 6.5 2.2 5.2 1.3 3.7 2.1 1.4 5.4 0.8 3.0 3.6 0.0 2.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 10.7 0.0 0.0 0.6 20.0 0.0 0.0 11.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7959424-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 13.2;skin 1: 10.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.0;BJ: 5.5;HBF TERT88: 7.8;LHCN-M2: 3.4" "Region enhanced" "Detected in some" "olfactory region: 2.6" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 2.7 1.3 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP11 "CLR19.6, NALP11, NOD17, PAN10, PYPAF6" ENSG00000179873 "NLR family pyrin domain containing 11" P59045 19 55785397-55836800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6" "Cell type enhanced" "Detected in some" 26 "Collecting duct cells: 1.8;Early spermatids: 10.0;Late spermatids: 2.7;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 39.1;RPMI-8226: 22.0;U-266/70: 38.9;U-266/84: 16.8;U-698: 28.3" "Not detected" "Not detected" "HPA046402, HPA078027" Uncertain Supported Cytosol NA NA Cytosol "HPA046402: AB_10962951, HPA078027: AB_2732369" "unprognostic (2.36e-2)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (4.36e-3)" "unprognostic (3.31e-2)" "unprognostic (7.88e-2)" "unprognostic (9.95e-3)" "unprognostic (8.04e-2)" "unprognostic (1.94e-1)" "unprognostic (2.52e-1)" "unprognostic (3.75e-2)" "unprognostic (3.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.06e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-2)" "unprognostic (7.61e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 4.0 0.1 0.3 0.2 0.1 0.1 0.0 0.7 3.3 0.1 0.6 0.1 0.1 0.9 0.4 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 1.2 0.1 0.1 0.3 0.5 3.6 0.1 0.1 0.1 0.1 4.5 0.1 0.1 1.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 39.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.7 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.7 0.0 0.0 38.9 16.8 28.3 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 2.7 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 NLRP12 "CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2" ENSG00000142405 "NLR family pyrin domain containing 12" P59046 19 53793603-53824394 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 22.8;neutrophil: 15.0" "Group enriched" "Detected in many" 4 "granulocytes: 22.8;monocytes: 8.7" "Group enriched" "Detected in some" 4 "HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042099, HPA042981" Approved Uncertain "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA042099: , HPA042981: AB_10795712" "unprognostic (6.92e-2)" "unprognostic (3.11e-1)" "unprognostic (6.66e-3)" "unprognostic (9.82e-2)" "unprognostic (1.81e-4)" "unprognostic (3.90e-2)" "unprognostic (5.79e-2)" "unprognostic (6.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-5)" "unprognostic (1.63e-1)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (1.46e-2)" "unprognostic (4.48e-1)" 1.9 0.3 0.2 4.2 0.6 11.0 0.4 0.2 0.2 0.9 0.3 0.1 0.9 0.3 0.7 0.7 0.6 1.0 0.5 3.3 0.2 0.2 0.5 0.5 6.5 13.5 0.6 0.3 1.0 0.3 0.1 0.2 1.1 0.8 0.3 0.1 0.5 1.7 0.0 0.2 0.2 0.3 1.4 0.5 10.2 0.4 1.0 0.6 0.3 0.3 0.4 0.2 1.1 1.4 0.0 3.6 22.8 8.7 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.6 7.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 6.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 7.3 6.1 0.0 22.8 8.7 11.0 0.0 2.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 15.0 0.0 1.5 0.0 0.0 2.1 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.3 0.8 0.6 6.0 9.0 0.0 0.7 0.3 0.8 0.4 0.0 4.0 6.8 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.4 0.7 7.0 0.0 2.4 0.0 0.0 0.0 12.3 0.0 0.3 6.1 1.7 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.6 NLRP13 "CLR19.7, NALP13, NOD14, PAN13" ENSG00000173572 "NLR family pyrin domain containing 13" Q86W25 19 55891699-55932336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "breast: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060459 Uncertain NA NA "HPA060459: AB_2684284" "unprognostic (2.16e-1)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP14 "CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8" ENSG00000158077 "NLR family pyrin domain containing 14" Q86W24 11 7020446-7071308 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 2.5;testis: 3.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 1.7;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7;Early spermatids: 1.5;Rod photoreceptor cells: 2.9;Spermatocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HEK 293: 1.7;HL-60: 1.2;HUVEC TERT2: 4.1;U-698: 2.2" "Not detected" "Not detected" HPA039477 Approved Uncertain Cytosol NA NA Cytosol "HPA039477: AB_10794748" "unprognostic (6.46e-3)" "unprognostic (5.76e-3)" "unprognostic (1.44e-4)" "unprognostic (7.20e-4)" "unprognostic (5.57e-2)" "unprognostic (8.02e-3)" "unprognostic (6.57e-2)" "unprognostic (2.65e-1)" "unprognostic (2.68e-1)" "unprognostic (1.44e-1)" "unprognostic (2.68e-1)" "unprognostic (2.65e-2)" "unprognostic (3.17e-3)" "unprognostic (6.69e-2)" "unprognostic (3.22e-1)" "unprognostic (3.85e-2)" "unprognostic (1.25e-1)" 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.8 0.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.3 0.3 1.6 2.5 0.4 0.2 0.4 1.3 0.0 1.7 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 1.2 0.3 0.0 3.4 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.2 0.9 0.5 0.7 0.0 0.4 1.6 0.0 0.1 0.4 0.0 0.0 0.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 4.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 2.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.3 2.9 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.0 0.0 NLRP2 "CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2" ENSG00000022556 "NLR family pyrin domain containing 2" Q9NX02 19 54953130-55001142 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.3" "Group enriched" "Detected in many" 5 "Extravillous trophoblasts: 180.1;Syncytiotrophoblasts: 81.4" "Cancer enriched" "Detected in many" 7 "testis cancer: 78.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 25.0;K-562: 10.4;SuSa: 11.1;U-266/84: 11.3" HPA021183 Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles, Cytosol" "HPA021183: AB_2670615" "unprognostic (1.66e-2)" "unprognostic (9.28e-2)" "unprognostic (6.60e-2)" "unprognostic (6.50e-3)" "unprognostic (1.09e-2)" "unprognostic (4.57e-3)" "unprognostic (4.27e-1)" "unprognostic (1.79e-2)" "unprognostic (2.39e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.63e-1)" "unprognostic (2.34e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.86e-2)" "unprognostic (7.57e-2)" 0.6 0.9 1.1 5.0 3.8 1.7 1.4 0.6 2.7 2.6 2.6 0.9 0.2 2.5 2.1 3.7 10.8 1.0 3.7 0.7 2.0 1.8 4.7 0.9 2.2 5.0 0.8 0.8 1.0 6.1 0.3 1.7 8.1 2.9 2.1 1.2 2.4 4.1 1.6 1.4 3.5 2.9 1.1 1.0 3.0 3.1 14.3 0.9 4.2 3.1 0.2 3.5 4.7 5.6 3.8 1.8 0.6 0.9 3.4 2.6 0.8 2.3 3.9 1.9 0.4 0.1 0.1 25.0 0.1 0.0 0.2 0.1 5.0 0.5 2.6 0.2 0.1 0.1 4.1 0.0 4.2 0.2 2.5 0.2 2.5 0.3 0.0 0.3 0.1 0.3 0.1 0.2 0.0 0.1 0.1 0.0 0.0 10.4 0.3 0.0 0.3 0.2 1.0 3.0 4.4 0.0 2.8 0.0 1.4 2.3 0.9 2.4 0.6 0.1 1.1 0.0 11.1 3.4 0.8 0.0 0.2 0.5 0.3 0.3 2.7 11.3 0.9 0.3 0.7 0.1 0.6 0.7 0.3 2.6 0.9 1.5 3.8 1.1 1.0 0.6 2.6 0.8 1.5 0.5 3.4 0.5 1.8 1.2 0.8 1.1 3.8 0.6 2.7 2.0 1.8 0.8 0.8 2.9 0.9 8.9 5.3 0.5 1.3 0.5 2.1 0.6 2.5 6.7 7.9 1.8 3.9 28.7 0.0 4.2 18.8 0.2 1.3 0.0 1.8 180.1 0.4 2.2 4.6 0.0 10.4 0.0 2.4 0.0 0.0 4.9 0.9 0.5 0.0 4.6 2.8 1.1 4.4 0.0 0.0 0.3 2.2 0.0 0.3 13.5 11.4 1.1 81.4 0.5 2.3 3.1 NLRP2B "CLRX.1, NALP2P, NLRP2P, NOD24, POP4" ENSG00000215174 "NLR family pyrin domain containing 2B" P0DMW2 X 57677067-57680260 "Predicted intracellular proteins" "Immunity, Innate immunity" "Signal transduction inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.9" NA NA "unprognostic (3.37e-2)" "unprognostic (1.07e-1)" "unprognostic (6.67e-2)" "unprognostic (3.84e-2)" "unprognostic (1.80e-1)" "unprognostic (5.78e-3)" "unprognostic (3.49e-2)" "unprognostic (1.44e-3)" "unprognostic (1.39e-2)" "unprognostic (7.56e-4)" "unprognostic (7.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.75e-3)" "unprognostic (9.00e-2)" 0.3 0.2 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP3 "AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, FCAS, FCU, MWS, NALP3, PYPAF1" ENSG00000162711 "NLR family pyrin domain containing 3" Q96P20 1 247416156-247449108 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" Activator "Amyloidosis, Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 40.3;bone marrow: 38.2" "Group enriched" "Detected in some" 11 "Hofbauer cells: 15.0;Kupffer cells: 26.7;Macrophages: 42.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 40.3" "Group enriched" "Detected in many" 20 "dendritic cells: 13.4;granulocytes: 40.3;monocytes: 12.5" "Cell line enhanced" "Detected in some" "NB-4: 7.2;THP-1: 41.6;U-937: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012878 Uncertain "Intracellular and membrane" NA NA "HPA012878: AB_1846752" "unprognostic (3.56e-2)" "unprognostic (1.33e-1)" "unprognostic (6.23e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (7.86e-2)" "unprognostic (4.46e-2)" "unprognostic (3.84e-1)" "unprognostic (7.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-2)" "unprognostic (4.88e-3)" "unprognostic (2.17e-4)" "unprognostic (1.10e-1)" "unprognostic (6.10e-2)" 7.4 1.4 2.8 8.3 3.3 38.2 3.2 0.7 3.7 1.8 1.5 6.9 1.5 0.8 4.5 0.9 2.4 3.0 8.9 2.0 3.0 3.1 1.3 1.8 8.2 8.9 3.3 0.8 1.3 1.4 1.1 1.2 3.0 5.2 1.0 1.7 2.4 1.5 0.7 0.9 0.8 2.5 4.1 4.9 8.5 1.6 0.6 3.3 1.0 1.0 3.2 2.8 3.3 0.9 0.0 13.4 40.3 12.5 0.0 1.1 3.9 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 1.3 1.6 0.2 0.0 0.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 0.2 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 41.6 0.0 1.7 1.3 0.0 0.1 0.0 0.0 0.0 4.0 10.4 1.2 40.3 12.5 0.1 0.2 7.7 0.6 0.0 1.1 0.4 13.4 0.0 0.4 0.2 3.0 0.0 3.6 0.6 0.0 3.9 2.8 3.3 0.7 3.7 3.0 3.1 3.3 0.8 5.2 3.3 0.0 0.3 0.5 0.0 0.9 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.8 0.0 2.3 0.0 15.0 0.0 0.0 0.6 26.7 0.0 0.0 42.3 0.0 1.0 0.0 0.5 0.1 0.0 0.4 0.0 0.2 0.0 0.5 0.5 0.2 0.5 1.1 2.5 0.0 0.0 NLRP4 "CLR19.5, CT58, FLJ32126, NALP4, PAN2, PYPAF4, RNH2" ENSG00000160505 "NLR family pyrin domain containing 4" Q96MN2 19 55836578-55881854 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.4;lymphoid tissue: 9.0;testis: 12.1" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 10.4;Late spermatids: 5.5;Spermatogonia: 2.3" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 5 "B-cells: 2.4" "Cell line enriched" "Detected in some" 8 "Daudi: 42.9" HPA062128 Approved Mitochondria NA NA Mitochondria "HPA062128: " "unprognostic (2.48e-1)" "unprognostic (7.01e-2)" "unprognostic (4.21e-2)" "unprognostic (1.34e-2)" "unprognostic (3.11e-1)" "unprognostic (1.81e-1)" "unprognostic (2.36e-3)" "unprognostic (3.72e-2)" "unprognostic (2.36e-1)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-2)" 0.2 0.2 1.9 1.0 1.8 0.0 0.2 0.2 2.9 0.2 0.2 2.7 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 1.0 0.3 0.2 0.2 0.2 2.8 5.1 0.6 0.4 0.2 0.1 0.3 0.0 2.9 0.2 0.1 0.0 0.8 0.0 0.2 0.2 0.3 0.1 9.4 0.3 0.2 12.1 2.2 0.0 0.2 0.4 9.0 0.2 0.2 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 1.8 0.2 2.9 1.0 0.3 5.1 0.6 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.0 0.0 0.0 0.0 NLRP5 "CLR19.8, MATER, NALP5, PAN11, PYPAF8" ENSG00000171487 "NLR family pyrin domain containing 5" P59047 19 55999726-56061813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "parathyroid gland: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "Karpas-707: 3.1;U-2 OS: 9.2" HPA056271 Uncertain "Intracellular and membrane" NA NA "HPA056271: AB_2683083" "unprognostic (9.67e-2)" "unprognostic (2.22e-2)" "unprognostic (5.03e-1)" "unprognostic (7.78e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 19.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP6 "CLR11.4, NALP6, PAN3, PYPAF5" ENSG00000174885 "NLR family pyrin domain containing 6" P59044 11 278365-285359 "Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 63.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 14.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "REH: 4.4;U-266/70: 8.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA043681, HPA048500" Supported NA NA "HPA043681: AB_2678614, HPA048500: AB_2680422" "unprognostic (6.37e-3)" "unprognostic (4.69e-2)" "unprognostic (4.26e-2)" "unprognostic (3.42e-2)" "unprognostic (6.40e-2)" "unprognostic (1.18e-2)" "prognostic favorable (4.23e-5)" "unprognostic (8.82e-2)" "unprognostic (2.40e-1)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (2.19e-1)" "unprognostic (3.11e-3)" "unprognostic (4.96e-2)" "unprognostic (2.14e-2)" "unprognostic (6.90e-3)" "unprognostic (3.69e-2)" 0.4 0.0 0.1 1.3 0.1 0.2 0.1 0.1 0.1 0.1 29.1 0.1 0.1 25.9 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.9 1.6 0.6 0.6 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 63.8 0.1 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.1 14.6 4.0 0.9 2.4 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 1.5 0.0 0.4 0.5 1.0 0.3 0.0 0.0 4.4 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 8.8 0.5 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.3 1.4 0.3 1.7 1.2 0.1 0.1 2.0 2.4 14.6 0.9 4.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLRP7 "CLR19.4, NALP7, NOD12, PAN7, PYPAF3" ENSG00000167634 "NLR family pyrin domain containing 7" Q8WX94 19 54923509-54966312 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 7.4;testis: 7.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 6.5;Extravillous trophoblasts: 4.7;Late spermatids: 11.4;Spermatocytes: 4.7" "Cancer enriched" "Detected in many" 30 "testis cancer: 146.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 7.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 7.4" "Cell line enhanced" "Detected in some" "BEWO: 4.0;RT4: 2.0;SuSa: 3.3;U-266/84: 9.7" HPA051382 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA051382: AB_2681461" "unprognostic (2.15e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-3)" "unprognostic (1.24e-2)" "unprognostic (5.29e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-1)" "unprognostic (5.01e-1)" "unprognostic (5.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.34e-1)" "unprognostic (3.25e-8)" "unprognostic (1.84e-1)" "unprognostic (1.18e-1)" "unprognostic (7.31e-3)" "unprognostic (4.45e-1)" 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 1.5 0.0 7.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 7.4 0.4 0.0 1.2 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.7 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 7.4 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.7 2.3 0.0 1.6 0.0 0.0 0.3 NLRP8 "CLR19.2, NALP8, NOD16, PAN4" ENSG00000179709 "NLR family pyrin domain containing 8" Q86W28 19 55947832-55988629 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.7;breast: 1.9;heart muscle: 1.5" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 10.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA056989 Uncertain NA NA "HPA056989: AB_2683301" "unprognostic (2.43e-2)" "unprognostic (3.35e-1)" "unprognostic (3.13e-1)" "unprognostic (6.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.7 0.3 1.7 0.2 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.4 0.0 0.2 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.3 0.7 0.5 0.0 0.7 0.7 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.3 1.7 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.0 0.7 0.3 0.3 0.8 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 NLRP9 "CLR19.1, NALP9, NOD6, PAN12" ENSG00000185792 "NLR family pyrin domain containing 9" Q7RTR0 19 55708432-55738402 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 5.3" "Cell type enriched" "Detected in some" 17 "Extravillous trophoblasts: 21.1" "Cancer enriched" "Detected in single" 59 "testis cancer: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HEK 293: 1.0;Karpas-707: 1.2;U-266/84: 1.3" "Not detected" "Not detected" HPA042623 Uncertain NA NA "HPA042623: AB_10965692" "unprognostic (2.50e-1)" "unprognostic (3.03e-1)" "unprognostic (1.74e-1)" "unprognostic (2.85e-1)" "unprognostic (8.82e-2)" "unprognostic (6.53e-2)" "unprognostic (9.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.55e-2)" "unprognostic (3.68e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.56e-3)" "unprognostic (2.73e-1)" "unprognostic (3.46e-1)" "unprognostic (9.56e-2)" "unprognostic (8.09e-3)" 0.1 0.2 0.0 0.2 0.5 0.7 0.1 0.5 0.1 0.1 0.3 0.2 0.4 0.7 0.1 0.4 0.2 0.1 0.0 0.0 1.0 0.9 0.4 0.2 0.0 0.7 0.8 0.1 0.6 0.1 5.3 0.1 0.1 0.2 0.1 0.4 1.2 0.1 0.0 0.9 2.0 1.9 0.2 0.1 0.1 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 1.2 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.9 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 1.3 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: AB_2684548" "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favorable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.1 12.2 1.3 9.7 4.2 4.8 1.9 5.5 6.4 2.8 4.8 0.7 10.2 7.4 16.9 7.0 4.1 10.3 3.7 3.1 0.9 9.5 4.0 9.7 4.2 6.6 6.4 3.4 5.7 5.4 13.2 3.6 7.0 5.6 5.6 9.9 0.1 4.9 2.8 10.9 5.7 8.2 6.0 5.3 6.8 11.2 1.7 2.4 6.6 5.3 1.8 6.4 8.1 4.3 3.5 2.0 14.0 10.1 6.5 5.5 4.9 4.9 2.8 1.8 1.9 2.5 0.8 10.4 3.9 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 0.0 6.4 1.7 1.6 2.3 1.2 10.8 5.1 6.7 2.3 7.0 2.0 3.0 1.7 6.0 1.5 3.0 4.2 0.0 3.4 1.7 2.5 1.8 0.0 9.6 5.7 0.0 2.4 4.3 5.3 2.7 1.1 1.9 1.7 5.4 4.1 5.6 5.1 7.0 1.1 4.3 3.2 0.0 2.1 1.9 1.9 4.1 0.5 0.5 4.5 0.9 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 91.4" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 28.0" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 28.0 10.7 2.0 0.4 5.5 2.5 0.2 1.7 3.3 3.8 5.2 3.7 7.7 1.2 4.5 4.4 0.0 5.0 10.7 2.2 2.2 10.5 13.5 4.3 4.2 17.4 1.4 2.9 4.7 2.5 0.9 5.9 2.3 2.5 5.5 7.7 0.0 0.4 2.1 16.4 2.7 9.5 7.9 5.9 3.1 8.4 0.0 12.4 3.6 2.2 1.1 12.2 2.8 1.6 12.7 2.1 1.9 11.2 1.4 0.7 3.7 3.5 2.7 0.2 3.0 2.6 8.7 16.2 4.5 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 3.0 2.4 14.3 22.9 13.9 1.6 2.2 7.6 10.7 7.9 29.6 0.0 1.7 11.6 91.4 24.0 11.3 1.7 0.0 50.2 7.5 17.3 30.7 5.7 2.9 30.9 4.8 17.9 4.9 4.8 7.5 4.0 28.4 32.1 29.7 4.9 7.0 39.2 7.0 3.5 22.5 2.3 12.9 29.9 11.1 21.2 11.2 2.6 11.4 8.0 39.6 NMBR "BB1, BB1R" ENSG00000135577 "Neuromedin B receptor" P28336 6 142058330-142088799 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.5;fallopian tube: 3.3;testis: 5.1" "Cell type enhanced" "Detected in some" 35 "Early spermatids: 5.9;Late spermatids: 1.6;Spermatocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;RPTEC TERT1: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026665 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026665: AB_1854527" "unprognostic (6.24e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (7.88e-2)" "unprognostic (3.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (3.95e-1)" "unprognostic (7.94e-3)" "unprognostic (3.44e-1)" "unprognostic (2.11e-1)" "unprognostic (8.45e-2)" 0.1 0.0 0.6 0.0 2.5 0.0 0.4 0.0 0.8 0.5 0.0 0.0 0.2 0.3 0.6 3.3 0.0 0.0 0.5 1.6 0.2 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.8 0.1 0.2 5.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 0.9 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.9 0.0 0.6 0.1 0.0 0.3 0.5 0.0 0.0 0.5 0.2 0.0 0.4 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115172-138139443 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.1;testis: 36.2" "Group enriched" "Detected in many" 4 "Ciliated cells: 327.9;Early spermatids: 516.0;Late spermatids: 184.0;Spermatocytes: 142.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555, HPA058103" Enhanced Approved "Nucleoplasm,Nuclear bodies" Yes NA "Nucleoplasm, Nuclear bodies" "HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: " "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favorable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.3 5.2 12.3 0.6 18.4 0.3 3.7 3.5 13.9 7.1 1.2 3.9 4.7 0.5 4.1 18.2 1.0 28.1 6.8 2.9 12.0 10.7 15.4 0.6 3.6 0.6 9.4 9.9 4.5 3.5 12.1 8.9 0.4 13.1 4.2 1.1 4.8 3.1 3.9 0.4 0.4 0.5 2.6 4.2 0.4 2.2 36.2 4.8 0.0 9.6 0.3 0.4 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.7 0.0 0.0 0.0 0.6 0.4 0.6 0.2 0.1 1.5 0.0 0.9 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 1.9 0.0 0.8 0.0 3.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 25.6 0.0 5.9 2.2 0.0 0.7 3.8 1.5 0.5 1.3 0.0 0.6 0.0 0.0 0.8 0.4 0.6 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 18.4 3.5 13.9 12.0 10.7 9.4 9.9 13.1 4.8 6.0 6.9 0.0 9.1 0.6 11.4 2.8 2.5 327.9 26.1 31.4 13.7 0.4 72.9 18.8 516.0 3.4 0.0 0.0 3.6 0.0 3.2 7.9 0.0 0.5 0.1 6.4 5.2 1.3 0.0 184.0 8.3 0.7 10.1 1.0 2.5 15.8 5.2 0.0 13.1 66.5 21.6 0.0 1.0 142.0 20.4 0.3 0.0 0.0 1.1 5.6 NME8 "CILD6, NM23-H8, SPTRX2, TXNDC3" ENSG00000086288 "NME/NM23 family member 8" Q8N427 7 37848597-37900401 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 7.9;bone marrow: 13.4;testis: 11.3" "Group enriched" "Detected in some" 5 "Early spermatids: 33.4;Late spermatids: 14.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.7;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.5;THP-1: 3.2;U-937: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016416, HPA019259, HPA029572" Enhanced Supported "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "CAB016416: , HPA019259: AB_1858475, HPA029572: " "unprognostic (7.44e-3)" "unprognostic (2.32e-2)" "unprognostic (9.11e-2)" "unprognostic (2.97e-2)" "unprognostic (6.05e-2)" "unprognostic (1.20e-2)" "unprognostic (6.56e-2)" "unprognostic (4.22e-2)" "unprognostic (7.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.24e-1)" "unprognostic (2.34e-2)" "unprognostic (8.13e-8)" "unprognostic (5.90e-2)" "unprognostic (3.36e-1)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 0.5 0.1 13.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.8 1.9 0.1 11.3 0.0 0.2 0.0 0.0 0.0 7.9 3.8 1.9 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 1.9 1.5 0.7 0.4 0.0 0.0 0.1 1.3 1.5 0.0 0.0 0.7 3.8 0.2 0.0 7.9 0.0 0.8 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.8 0.0 0.0 0.0 3.0 14.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 3.8 0.0 0.0 NME9 "NM23-H9, TXL-2, TXNDC6" ENSG00000181322 "NME/NM23 family member 9" Q86XW9 3 138261437-138329886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 30.4" "Cell type enriched" "Detected in some" 12 "Ciliated cells: 64.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.2" "Lineage enriched" "Detected in single" 4 "T-cells: 4.2" "Cell line enhanced" "Detected in many" "HMC-1: 4.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020943, HPA040000, HPA043881" Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712" "unprognostic (2.71e-5)" "unprognostic (1.68e-1)" "unprognostic (5.09e-2)" "unprognostic (3.01e-3)" "unprognostic (3.67e-1)" "unprognostic (1.69e-3)" "unprognostic (4.58e-2)" "unprognostic (5.19e-2)" "unprognostic (1.66e-1)" "unprognostic (1.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.72e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (9.14e-2)" "unprognostic (4.89e-2)" "unprognostic (7.17e-3)" 1.0 1.7 5.3 1.3 11.3 4.4 1.0 6.2 8.3 1.5 0.8 4.1 3.5 1.1 1.6 3.6 0.8 30.4 1.3 0.9 5.6 8.2 1.7 0.8 4.0 1.1 3.6 3.1 2.5 3.3 1.8 7.5 1.1 10.3 1.7 0.8 0.9 3.4 1.9 4.3 1.8 1.1 1.0 3.6 1.2 1.5 6.0 3.9 0.9 2.3 0.0 1.0 0.8 0.5 0.6 0.6 0.3 0.9 0.3 4.2 0.5 1.1 1.6 1.1 0.5 0.0 0.0 1.7 0.7 0.0 0.2 0.1 0.9 1.9 2.5 1.2 0.0 1.3 1.3 0.2 0.0 0.0 0.5 1.8 2.1 1.6 0.6 0.0 2.7 4.9 0.9 0.0 0.1 0.0 2.9 0.1 3.2 0.6 1.4 0.2 0.4 0.6 2.5 0.7 0.5 1.2 1.0 0.0 0.7 1.7 2.6 3.7 1.0 1.6 0.6 0.4 0.9 0.9 0.1 3.0 0.5 0.8 0.8 0.6 0.9 1.2 1.1 1.0 1.1 0.5 0.1 0.9 0.0 0.5 0.0 4.2 0.2 1.7 0.4 0.3 0.6 2.8 1.2 0.3 0.3 0.2 0.6 0.7 0.5 5.3 11.3 6.2 8.3 5.6 8.2 3.6 3.1 10.3 3.9 0.0 0.3 0.0 0.2 0.0 1.3 1.1 2.5 64.3 3.4 1.8 0.0 0.1 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 2.3 0.0 0.0 5.5 0.5 0.0 0.2 0.0 0.0 0.0 NMI ENSG00000123609 "N-myc and STAT interactor" Q13287 2 151270465-151290057 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 75.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008588 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008588: AB_1079493" "unprognostic (5.28e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (2.41e-2)" "unprognostic (9.25e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.42e-2)" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.57e-7)" "unprognostic (1.91e-1)" "unprognostic (4.69e-2)" "unprognostic (1.52e-2)" "unprognostic (4.57e-2)" 12.0 14.2 5.0 18.6 7.1 26.4 14.0 1.3 5.8 8.9 15.0 3.4 11.1 13.2 8.6 10.4 16.1 9.8 14.7 8.7 5.9 3.8 13.0 20.4 18.5 26.9 5.1 2.7 14.8 8.4 2.9 6.5 24.6 6.9 13.6 10.5 5.0 9.8 7.9 5.1 7.3 26.0 13.1 7.7 30.2 10.2 5.3 6.4 36.7 14.9 10.2 14.2 10.4 10.3 10.8 17.0 75.1 26.9 14.3 12.5 14.9 10.9 5.4 0.3 0.0 3.1 8.5 10.7 3.2 7.5 15.4 23.5 1.1 25.0 10.7 11.9 4.8 5.1 6.3 1.1 2.8 3.9 22.7 0.6 30.1 5.6 0.6 13.2 28.5 8.7 5.5 3.8 9.2 2.1 6.8 19.0 11.9 14.9 2.6 2.9 8.4 23.9 42.6 6.3 2.2 8.1 25.8 0.6 9.2 12.7 9.5 1.5 0.0 6.7 7.3 4.1 1.1 1.2 32.5 10.3 2.2 5.0 7.2 4.6 0.4 0.4 0.6 5.3 34.3 2.4 31.6 19.7 21.6 10.8 26.9 12.5 10.8 11.3 10.7 17.0 9.1 9.2 9.4 75.1 14.3 24.4 6.9 9.7 14.9 5.0 7.1 1.3 5.8 5.9 3.8 5.1 2.7 6.9 6.4 23.8 19.8 16.0 18.1 14.8 0.2 3.1 15.3 38.8 27.3 12.2 0.0 62.5 13.3 54.5 2.6 35.8 24.2 0.0 36.0 53.3 19.2 13.1 34.7 16.0 71.3 0.0 17.3 17.2 39.1 0.0 18.1 53.0 1.7 45.9 20.9 5.8 34.1 23.0 13.1 20.9 0.0 6.5 14.7 3.3 1.7 15.6 45.5 40.7 19.5 19.2 NMNAT2 "C1orf15, KIAA0479, PNAT2" ENSG00000157064 "Nicotinamide nucleotide adenylyltransferase 2" Q9BZQ4 1 183248237-183418602 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.9" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 30.1;Early spermatids: 50.3;Horizontal cells: 19.1;Late spermatids: 19.5;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 12.9;SCLC-21H: 37.5;SuSa: 12.3;U-2197: 21.9;U-87 MG: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015708, HPA061714" Enhanced Approved Cytosol NA NA Cytosol "HPA015708: , HPA061714: AB_2732669" "unprognostic (3.70e-1)" "unprognostic (7.98e-3)" "unprognostic (8.83e-2)" "unprognostic (4.16e-2)" "unprognostic (8.95e-2)" "unprognostic (9.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.35e-1)" "unprognostic (7.92e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.73e-3)" "unprognostic (2.90e-3)" "unprognostic (1.87e-1)" "unprognostic (7.51e-2)" "unprognostic (1.02e-1)" 9.6 7.7 26.2 1.9 34.5 1.0 2.9 53.9 53.5 3.6 2.2 2.0 0.0 1.5 2.5 2.7 1.9 3.8 4.1 19.6 20.6 15.1 1.5 1.1 1.8 1.7 8.6 28.3 1.5 2.9 1.3 17.4 2.0 15.6 1.3 2.1 0.5 1.5 4.1 1.3 1.7 2.0 2.7 4.1 1.2 2.1 8.7 6.3 0.0 7.2 0.0 1.7 1.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.2 2.5 0.0 1.5 6.2 2.2 1.6 4.1 0.8 0.2 1.2 2.4 0.0 6.8 0.4 0.7 1.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 12.9 0.5 1.0 0.2 5.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 4.4 0.0 2.4 0.0 0.1 0.0 2.8 2.0 37.5 2.9 0.3 0.1 0.0 12.3 0.3 0.6 1.4 1.2 0.4 21.9 1.5 0.3 0.0 0.0 17.1 0.1 0.1 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 26.2 34.5 53.9 34.7 20.6 15.1 8.6 28.3 15.6 6.3 0.0 1.0 0.0 0.2 0.7 10.7 30.1 0.0 2.7 3.4 0.0 0.0 0.6 0.0 0.1 50.3 2.9 0.0 0.0 0.0 9.6 0.4 0.1 0.0 0.0 0.5 19.1 0.0 0.0 0.6 19.5 0.0 0.5 1.7 0.0 0.0 0.3 0.5 0.0 0.0 0.0 1.6 19.4 5.0 0.5 0.2 0.3 1.1 0.0 0.0 0.0 NMRK2 "ITGB1BP3, MIBP, NRK2" ENSG00000077009 "Nicotinamide riboside kinase 2" Q9NPI5 19 3933103-3942416 "Enzymes, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "heart muscle: 271.6;skeletal muscle: 103.2" "Cell type enriched" "Detected in single" 1346 "Cardiomyocytes: 751.9" "Cancer enhanced" "Detected in some" "renal cancer: 32.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 22.8;NTERA-2: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049909, HPA054792, HPA072450" Approved Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522" "unprognostic (3.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.18e-2)" "unprognostic (2.54e-1)" "unprognostic (1.03e-1)" "unprognostic (7.61e-2)" "unprognostic (3.30e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.72e-1)" "unprognostic (3.29e-2)" "unprognostic (5.38e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.0 0.0 0.0 271.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 1.0 1.9 0.1 103.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 18.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 751.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 NMS ENSG00000204640 "Neuromedin S" Q5H8A3 2 100470482-100483280 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 3.2;testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "HL-60: 12.6;HMC-1: 7.7" "Group enriched" "Detected in some" 4 "basal ganglia: 2.6;hypothalamus: 6.3;pons and medulla: 1.4" "Secreted in brain" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NMU ENSG00000109255 "Neuromedin U" P48645 4 55595229-55636698 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.9;skin 1: 28.3;tongue: 28.4" "Cell type enhanced" "Detected in some" 24 "Basal keratinocytes: 14.4;Erythroid cells: 23.3;Suprabasal keratinocytes: 64.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Group enriched" "Detected in some" 10 "MAIT T-cell: 7.2;memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 51 "T-cells: 7.2" "Cell line enhanced" "Detected in many" "HaCaT: 81.3;K-562: 63.9;Karpas-707: 29.3" "Region enhanced" "Detected in single" "pons and medulla: 4.7" "Low region specificity" "Detected in many" HPA025926 Uncertain "Secreted in other tissues" NA NA "HPA025926: AB_1854539" "unprognostic (4.42e-2)" "unprognostic (1.00e-1)" "unprognostic (5.83e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.19e-2)" "unprognostic (7.12e-2)" "unprognostic (7.29e-3)" "unprognostic (9.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.07e-10)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (2.54e-2)" "unprognostic (5.55e-2)" 0.1 0.3 0.2 2.0 1.1 5.9 1.3 0.1 3.4 5.4 1.1 0.2 2.5 0.6 0.5 0.0 42.9 0.2 0.3 0.3 0.2 0.9 0.1 0.0 1.0 0.4 0.4 0.5 0.0 0.0 0.0 2.8 2.1 0.3 0.1 0.6 0.0 6.6 1.5 0.1 28.3 1.7 0.2 1.2 0.1 3.1 1.3 0.0 0.7 17.2 28.4 8.5 0.1 12.2 0.1 0.0 0.0 0.0 0.0 7.2 0.1 8.5 0.0 4.7 1.2 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 13.1 18.9 1.8 0.0 1.8 81.3 9.8 0.7 0.5 1.1 5.3 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 2.2 0.0 1.3 63.9 29.3 0.0 2.0 0.2 0.0 2.5 1.5 2.4 0.0 0.0 0.1 0.4 0.0 4.2 10.7 6.5 0.1 0.0 0.9 4.5 0.0 0.5 0.0 6.1 0.0 11.4 8.5 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 2.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.1 3.4 0.2 0.9 0.4 0.5 0.3 0.0 0.0 2.9 1.5 0.6 14.4 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.2 0.2 0.0 23.3 0.2 0.1 1.1 0.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.5 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 1.5 7.6 64.4 0.1 0.0 1.7 8.0 NMUR2 NMU2R ENSG00000132911 "Neuromedin U receptor 2" Q9GZQ4 5 152391532-152433368 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.9;stomach 1: 5.0;testis: 8.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.5;endometrial cancer: 0.6;pancreatic cancer: 1.8;stomach cancer: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 14.8" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" "HPA027800, HPA045836" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA027800: , HPA045836: AB_10968856" "unprognostic (1.82e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-1)" "unprognostic (9.29e-2)" "unprognostic (5.87e-2)" "unprognostic (6.44e-3)" "unprognostic (3.13e-1)" "unprognostic (6.47e-2)" "unprognostic (5.63e-2)" "unprognostic (8.20e-3)" "unprognostic (8.90e-5)" "unprognostic (1.48e-2)" "unprognostic (9.24e-2)" "unprognostic (9.56e-2)" "unprognostic (2.29e-1)" 0.1 0.5 0.6 0.7 1.0 0.0 0.1 0.2 1.2 0.4 0.2 0.7 1.1 0.6 0.9 0.2 0.4 0.1 0.6 1.4 0.9 2.8 2.0 0.1 2.9 0.1 4.3 0.4 0.1 0.0 0.0 0.7 0.5 1.6 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.3 0.2 8.9 0.0 5.0 8.0 1.4 0.9 2.5 0.0 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 14.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 1.2 0.9 2.8 4.3 0.4 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NNAT Peg5 ENSG00000053438 Neuronatin Q16517 20 37521215-37523693 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 117.2;pituitary gland: 165.1;placenta: 69.1" "Group enriched" "Detected in many" 9 "Early spermatids: 30.8;Late spermatids: 51.7;Muller glia cells: 77.7" "Group enriched" "Detected in many" 16 "glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4" "Region enhanced" "Detected in all" "basal ganglia: 117.2" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 22 "SH-SY5Y: 127.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-2)" "unprognostic (7.41e-3)" "unprognostic (1.85e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (7.08e-2)" "unprognostic (1.42e-1)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (7.52e-2)" "unprognostic (4.94e-2)" "unprognostic (1.64e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-3)" "unprognostic (5.90e-2)" 17.0 11.6 35.4 2.6 117.2 2.3 3.5 4.9 68.4 2.3 7.0 11.1 0.0 3.4 4.6 2.5 2.6 2.8 4.2 1.7 35.0 21.4 1.4 1.1 1.7 1.9 4.9 14.0 1.3 1.6 1.0 165.1 69.1 7.9 2.4 3.9 1.5 3.4 1.5 8.0 3.8 3.2 4.4 2.1 1.8 2.1 2.9 3.8 0.2 1.5 0.0 1.1 3.3 0.6 0.7 0.7 0.3 0.3 0.0 1.0 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.6 0.0 0.0 3.2 0.3 127.5 0.1 0.7 0.0 0.1 0.2 0.0 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 1.0 0.3 0.0 0.0 0.7 0.0 0.0 35.4 117.2 4.9 41.0 35.0 21.4 4.9 14.0 7.9 3.8 0.0 0.0 0.0 0.7 3.5 3.7 0.0 0.0 1.4 1.2 0.0 0.0 0.5 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.4 1.0 2.2 1.1 0.0 1.4 0.0 0.0 0.0 0.0 51.7 0.6 0.0 1.7 0.0 0.0 77.7 0.0 0.0 1.1 0.0 6.0 0.0 0.4 1.1 3.8 0.9 0.2 0.0 0.0 2.3 NNMT ENSG00000166741 "Nicotinamide N-methyltransferase" P40261 11 114257787-114313285 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 97.7" "Cell type enriched" "Detected in many" 9 "Hepatocytes: 3284.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 68.8;LHCN-M2: 40.9;RPTEC TERT1: 105.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059180 Approved Approved "Golgi apparatus,Cytosol" NA NA 15000 "Golgi apparatus" Cytosol "HPA059180: AB_2683940" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" "unprognostic (1.61e-2)" "unprognostic (6.14e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (2.07e-4)" "unprognostic (1.76e-1)" "unprognostic (5.84e-2)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.20e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.02e-6)" "prognostic unfavorable (1.75e-4)" "unprognostic (1.11e-1)" "unprognostic (3.37e-3)" "unprognostic (2.77e-2)" 23.7 1.4 0.6 8.8 0.9 0.1 14.6 0.6 1.7 13.1 8.5 0.7 4.9 0.5 15.8 8.7 12.0 8.3 15.3 8.2 1.6 0.0 4.7 97.7 10.0 3.4 1.1 0.6 11.2 2.0 0.6 2.6 8.6 3.3 9.6 3.3 1.6 3.6 6.7 18.3 8.2 4.3 12.4 1.5 5.8 5.1 7.3 0.6 1.3 5.3 2.2 3.1 10.9 35.3 0.6 0.1 0.7 0.2 0.0 0.9 0.0 0.0 4.8 0.0 4.3 24.8 32.2 0.0 6.1 16.3 9.8 19.5 0.0 6.6 0.0 21.8 12.5 1.3 0.0 0.0 2.2 9.9 0.0 0.0 0.0 7.6 0.0 33.8 0.0 0.0 68.8 23.8 6.9 10.3 8.2 13.5 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 27.4 0.0 105.9 0.0 0.0 0.0 30.7 0.0 0.0 1.5 0.0 0.0 9.5 5.6 22.6 8.7 1.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.9 0.2 0.0 0.2 0.1 0.6 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.6 1.7 1.6 0.0 1.1 0.6 3.3 0.6 41.7 380.8 30.2 10.6 92.0 0.5 4.0 76.5 18.7 20.5 76.8 0.0 0.9 8.3 207.6 0.2 191.1 0.0 163.5 133.3 1.9 375.3 11.6 12.8 3284.1 21.8 0.0 5.1 176.1 103.2 1.0 68.7 12.7 91.1 10.0 0.0 0.0 366.0 0.0 12.4 27.9 0.1 0.0 113.1 0.3 0.4 80.5 1.8 46.0 0.0 2.4 NNT ENSG00000112992 "Nicotinamide nucleotide transhydrogenase" Q13423 5 43602692-43707405 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.0" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 303.5;Hepatocytes: 274.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004829, CAB004975" Enhanced Approved Mitochondria,Cytosol NA NA 1100000 Mitochondria Cytosol "CAB004975: AB_425908, HPA004829: AB_1079495" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (4.81e-2)" "unprognostic (5.02e-2)" "unprognostic (1.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.98e-2)" "unprognostic (1.65e-1)" "unprognostic (8.33e-2)" "prognostic favorable (1.22e-15)" "unprognostic (8.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (2.58e-1)" 10.8 10.5 11.7 8.3 14.0 7.3 9.1 8.3 19.0 7.6 11.2 7.3 8.8 9.2 7.1 8.8 7.9 5.4 7.1 62.1 10.8 8.2 26.0 48.5 7.2 9.6 9.2 10.3 5.8 12.2 15.6 6.2 5.8 10.0 8.5 12.1 6.7 14.4 7.8 100.0 6.0 8.9 14.7 6.1 6.5 13.6 4.2 6.1 14.0 14.0 32.6 8.7 10.9 6.2 11.4 25.5 13.1 18.5 18.2 19.1 13.5 8.3 6.2 14.3 26.6 16.7 18.6 4.5 8.4 14.4 10.4 9.4 7.1 13.9 8.6 10.5 16.0 11.0 8.0 56.7 2.0 11.0 13.6 15.3 12.4 33.3 8.7 9.6 20.7 18.5 16.0 6.3 5.9 8.5 18.2 20.5 12.5 8.9 34.4 24.7 5.7 22.3 11.2 2.8 0.0 5.6 25.1 33.8 30.8 19.7 7.4 21.1 17.6 30.9 0.4 19.1 3.1 21.6 20.9 11.2 15.2 14.8 6.3 4.1 18.5 19.0 13.2 3.1 27.7 9.8 9.3 14.2 13.1 14.4 18.4 14.8 11.4 15.6 14.5 25.5 10.3 14.6 13.3 2.4 18.2 18.5 9.2 19.1 13.5 11.7 14.0 8.3 19.0 10.8 8.2 9.2 10.3 10.0 6.1 50.6 27.8 20.7 7.7 10.2 17.5 303.5 28.1 24.1 31.8 26.2 33.4 7.2 23.2 10.7 12.2 12.6 17.2 23.3 9.3 2.1 17.9 10.5 23.3 274.2 21.7 6.4 19.1 20.3 31.4 3.4 13.8 18.2 13.5 10.8 24.6 13.2 9.5 11.5 18.0 21.1 11.9 0.0 15.1 2.1 1.2 7.0 1.7 27.7 25.8 7.6 NOA1 "C4orf14, hAtNOS1, hNOA1, MGC3232, MTG3" ENSG00000084092 "Nitric oxide associated 1" Q8NC60 4 56963370-56978823 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 22.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035838, HPA035839" Approved Supported Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035838: AB_10669531, HPA035839: AB_10669658" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (1.65e-3)" "unprognostic (5.19e-2)" "unprognostic (9.06e-2)" "unprognostic (1.49e-2)" "unprognostic (2.04e-2)" "unprognostic (1.29e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "unprognostic (1.33e-1)" "prognostic favorable (2.38e-4)" "unprognostic (8.97e-2)" "unprognostic (6.87e-2)" "unprognostic (1.79e-2)" "unprognostic (4.27e-2)" 4.5 4.7 2.6 3.0 3.2 5.4 5.3 4.3 2.8 4.3 5.3 7.0 5.9 3.8 6.1 6.0 2.9 3.5 2.5 2.1 3.6 2.8 3.3 5.1 2.1 5.6 13.9 3.6 2.1 2.3 3.8 4.9 5.9 3.7 10.5 6.8 4.9 3.2 2.6 3.8 6.0 1.7 4.0 5.8 6.7 4.5 20.2 16.5 7.0 14.1 20.3 22.3 14.3 7.5 7.0 5.2 9.2 9.6 17.2 14.3 6.0 10.8 6.9 7.0 12.0 14.2 27.1 10.4 5.0 5.7 8.1 9.8 10.6 6.6 5.0 12.7 6.8 6.2 13.0 7.5 12.3 7.4 15.9 12.9 6.4 11.2 14.7 11.5 11.9 11.4 9.8 9.3 10.9 17.6 16.5 6.8 14.5 10.8 12.3 5.6 10.2 9.9 11.3 12.0 10.2 6.1 25.0 8.9 6.9 11.2 8.8 7.5 5.6 13.4 6.7 11.1 12.6 5.2 14.1 5.7 7.9 7.1 6.2 14.1 7.0 12.2 13.0 18.3 20.2 18.2 15.2 16.5 17.0 22.3 18.4 4.8 20.3 11.2 13.3 21.1 14.3 3.0 4.3 15.3 14.0 22.6 6.3 12.0 12.7 18.7 10.3 7.0 3.9 27.0 16.6 15.6 19.3 11.3 11.0 0.0 19.7 29.3 15.0 12.7 8.1 4.3 16.0 1.6 16.8 6.7 17.8 9.1 15.0 14.6 11.8 19.0 19.9 8.0 18.7 21.0 21.9 11.2 8.0 12.9 16.5 7.5 10.5 21.7 23.3 19.1 38.8 19.5 NOBOX "OG2, Og2x" ENSG00000106410 "NOBOX oogenesis homeobox" O60393 7 144397240-144410227 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "testis: 2.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AN3-CA: 1.0" NA NA "unprognostic (7.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015789-139045939 "Enzymes, Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Cone photoreceptor cells: 13.7;Extravillous trophoblasts: 7.7;Syncytiotrophoblasts: 10.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 17.5 3.9 3.3 4.9 8.0 38.7 7.4 3.2 7.3 2.7 3.1 2.7 0.0 2.2 2.8 1.5 4.0 2.5 7.9 5.4 4.9 3.7 6.9 25.8 5.1 3.1 3.0 3.1 1.7 4.4 4.0 4.7 9.3 3.7 2.0 2.8 1.8 10.8 1.4 12.0 3.9 10.5 4.5 2.3 3.2 3.0 4.9 2.6 3.7 2.9 11.8 3.9 3.7 4.6 1.9 1.5 6.3 3.1 1.4 2.4 0.2 4.7 5.5 2.2 4.1 5.0 2.1 13.5 7.1 5.1 10.1 7.3 7.3 2.0 15.8 5.7 5.3 14.3 3.4 11.4 6.2 9.6 7.0 4.6 7.3 3.3 6.4 4.5 10.7 4.3 2.4 3.1 11.2 7.6 2.0 4.4 3.2 13.1 5.2 4.5 5.4 7.3 5.6 7.0 2.1 5.9 6.0 6.4 5.6 6.8 3.1 8.2 5.5 4.5 5.1 4.0 8.9 3.7 8.3 6.6 5.5 7.1 5.2 8.4 4.3 4.0 10.0 5.1 21.2 6.9 1.5 1.4 0.8 2.4 1.5 1.4 1.1 1.1 1.3 0.6 1.9 0.8 1.6 6.3 1.4 3.1 1.5 0.7 0.2 3.3 8.0 3.2 7.3 4.9 3.7 3.0 3.1 3.7 2.6 8.9 0.6 0.0 2.6 0.0 4.7 0.0 2.5 1.4 1.2 0.0 13.7 4.3 1.7 1.9 0.6 0.0 0.3 0.0 0.2 7.7 0.5 2.0 2.3 1.5 1.4 1.6 0.0 0.6 2.2 0.0 0.9 0.7 0.0 0.0 0.1 0.3 1.8 0.0 0.0 3.1 4.6 0.0 0.0 0.9 3.2 0.0 10.1 0.0 0.0 1.7 NODAL ENSG00000156574 "Nodal growth differentiation factor" Q96S42 10 70432315-70447951 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Developmental protein, Growth factor" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.0;skeletal muscle: 5.1;testis: 5.2" "Group enriched" "Detected in some" 23 "Early spermatids: 14.4;Late spermatids: 24.3" "Cancer enriched" "Detected in some" 10 "testis cancer: 20.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 4.3;SH-SY5Y: 3.2;SuSa: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045201 Uncertain "Secreted to blood" NA NA "HPA045201: AB_2679252" "unprognostic (3.07e-2)" "unprognostic (2.10e-1)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.70e-1)" "unprognostic (4.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (5.66e-3)" "unprognostic (3.12e-2)" "unprognostic (8.77e-2)" "unprognostic (1.61e-1)" "unprognostic (1.63e-5)" "unprognostic (4.37e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (2.02e-1)" 1.2 0.1 1.1 0.3 2.4 2.0 0.9 2.4 5.0 0.9 0.5 3.8 0.3 0.8 0.7 0.3 1.4 0.4 1.0 0.7 1.2 1.0 0.3 0.3 1.0 0.7 1.5 0.3 0.9 0.3 0.0 0.3 0.9 2.9 0.8 0.0 0.3 0.5 0.3 5.1 3.5 0.6 0.3 0.4 0.9 0.9 5.2 0.3 0.8 0.3 0.3 0.3 0.7 0.7 1.2 0.4 1.1 0.6 0.0 2.2 0.3 0.8 0.5 1.8 2.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 4.3 0.5 1.4 0.1 0.0 0.0 0.1 0.0 1.6 0.0 1.2 0.1 0.0 0.1 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.6 0.6 0.0 0.5 0.2 0.5 1.2 0.5 0.1 0.5 0.5 1.2 0.0 0.2 0.3 3.2 0.9 0.4 0.0 8.5 0.9 0.4 0.0 0.0 0.5 0.3 0.2 1.0 2.3 2.7 0.0 0.4 0.2 0.0 0.6 0.0 0.2 0.5 0.7 0.2 1.2 2.2 0.4 1.2 0.8 0.6 1.1 0.0 0.4 0.0 0.2 0.3 1.1 2.4 2.4 5.0 1.2 1.0 1.5 0.3 2.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 NOG "SYM1, SYNS1" ENSG00000183691 Noggin Q13253 17 56593699-56595590 "Disease related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;placenta: 37.1;retina: 18.6" "Cell type enriched" "Detected in single" 11 "Extravillous trophoblasts: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1" "Lineage enriched" "Detected in single" 81 "T-cells: 32.8" "Cell line enhanced" "Detected in some" "EFO-21: 51.0;LHCN-M2: 15.5;NB-4: 11.3;PC-3: 15.4;U-2 OS: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061318 Approved "Secreted to blood" NA NA "HPA061318: AB_2684478" "unprognostic (1.49e-1)" "unprognostic (1.17e-2)" "unprognostic (1.49e-5)" "prognostic favorable (6.66e-4)" "unprognostic (4.69e-2)" "unprognostic (5.23e-3)" "unprognostic (1.26e-2)" "unprognostic (3.06e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (6.86e-5)" "unprognostic (2.88e-1)" "unprognostic (1.14e-6)" "unprognostic (8.39e-2)" "unprognostic (1.40e-1)" "unprognostic (5.00e-1)" "unprognostic (1.65e-1)" 0.9 0.3 4.9 2.0 7.2 0.7 0.5 0.9 8.3 5.5 0.6 1.8 0.4 0.5 0.8 6.3 0.4 0.4 0.3 0.4 3.8 3.1 0.8 0.4 1.0 3.3 1.9 2.7 0.3 0.5 0.3 0.8 37.1 1.1 1.4 0.4 18.6 0.4 2.9 3.6 0.4 0.7 0.5 0.8 1.5 0.8 1.6 1.8 1.7 0.3 0.0 1.1 0.9 3.1 0.0 0.1 0.4 0.1 0.2 32.8 1.7 2.4 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.4 0.5 0.5 0.1 0.4 0.0 51.0 0.6 2.0 0.2 0.8 0.1 1.4 0.0 0.9 0.0 1.9 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 15.5 0.0 0.4 11.3 1.0 0.0 15.4 6.7 4.7 0.0 1.2 0.0 0.1 0.0 2.6 0.0 0.0 4.3 0.0 0.2 0.3 0.9 15.8 0.1 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.3 0.0 0.1 0.2 0.1 0.1 0.0 1.9 0.2 0.0 0.0 32.8 15.1 0.4 0.2 0.1 0.1 1.3 1.7 4.9 7.2 0.9 2.5 3.8 3.1 1.9 2.7 1.1 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 8.9 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 0.0 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003547 Uncertain Approved "Nucleoplasm,Nucleoli,Mitotic chromosome,Vesicles" Yes No "Nucleoli, Mitotic chromosome" "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favorable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favorable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavorable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favorable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 16.9 15.7 11.7 13.4 3.8 4.0 14.8 8.5 3.9 3.8 4.1 8.8 7.1 14.5 5.1 3.8 4.0 18.5 6.7 22.4 1.3 15.2 24.5 12.3 12.6 20.1 10.3 29.1 18.1 5.9 7.3 15.2 5.9 5.3 7.3 8.6 9.1 13.1 3.3 14.8 15.9 21.7 13.4 7.6 21.2 21.8 7.6 10.9 8.5 6.0 9.5 18.7 9.9 9.1 13.5 1.8 13.0 13.8 10.2 16.2 16.4 11.8 15.6 11.0 13.4 18.7 15.4 21.6 18.9 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 3.0 11.7 16.1 10.3 34.7 11.5 3.1 7.6 9.4 7.9 14.0 5.9 16.5 3.3 23.3 77.4 12.6 26.9 0.0 25.4 13.3 12.5 7.3 15.0 4.9 12.1 27.0 12.1 9.8 8.7 31.6 9.2 16.0 20.3 19.0 18.9 9.1 18.7 31.6 10.6 6.4 8.1 12.9 8.2 14.4 24.4 34.8 16.6 16.7 18.4 13.2 NOL3 "ARC, CARD2, MYP, NOP30" ENSG00000140939 "Nucleolar protein 3" O60936 16 67170154-67175735 "Disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 6.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 32.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009208 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB009208: AB_634091" "unprognostic (2.83e-2)" "unprognostic (1.63e-2)" "unprognostic (3.34e-3)" "unprognostic (1.07e-1)" "unprognostic (2.70e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (6.43e-5)" "unprognostic (5.74e-2)" "unprognostic (4.07e-2)" "unprognostic (1.83e-1)" "unprognostic (2.15e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (2.41e-4)" "unprognostic (1.39e-2)" "unprognostic (3.65e-2)" "unprognostic (3.90e-2)" "unprognostic (1.48e-2)" 16.3 22.6 13.0 3.2 19.6 1.3 9.4 7.3 14.1 8.4 7.1 10.8 19.7 5.3 7.5 10.5 15.4 7.8 15.7 29.1 11.1 8.3 10.1 12.8 10.1 2.6 15.9 12.3 6.8 12.3 22.8 14.8 8.6 12.7 19.8 6.1 13.8 18.0 13.3 76.1 39.7 5.2 10.6 11.6 3.7 11.1 2.7 15.8 0.6 9.6 27.7 6.3 9.4 9.2 0.0 2.1 1.5 6.8 0.7 3.4 2.5 6.2 10.2 1.7 9.6 8.6 6.5 9.6 5.0 5.4 5.5 3.3 2.2 16.5 0.1 16.8 5.9 1.4 10.5 2.3 7.8 1.3 5.6 3.6 0.2 8.1 3.2 5.4 0.5 1.3 4.0 14.5 4.3 3.1 15.8 2.3 2.2 2.2 6.6 10.3 16.2 0.1 0.8 1.6 5.7 25.2 5.6 3.6 12.4 9.3 1.9 13.6 7.3 21.2 15.4 2.2 2.3 32.8 1.7 5.3 7.3 6.2 7.1 4.3 9.7 3.0 1.7 20.6 1.6 2.4 0.0 6.8 0.0 0.3 0.6 0.1 0.0 3.4 0.3 2.1 0.0 0.0 0.5 1.5 0.7 0.2 2.1 0.0 2.5 13.0 19.6 7.3 14.1 11.1 8.3 15.9 12.3 12.7 15.8 26.8 25.2 2.2 26.4 12.2 16.6 45.2 33.1 8.1 13.6 3.5 15.7 7.0 13.3 54.2 0.9 10.5 15.3 0.0 30.2 9.9 15.1 25.5 2.3 27.7 9.5 52.4 21.5 8.0 5.1 0.4 23.3 3.1 20.3 20.8 17.6 28.3 36.8 10.5 28.3 17.3 46.0 12.9 36.2 0.2 1.1 17.2 9.3 2.2 13.7 21.4 NOL4 "CT125, HRIHFB2255, NOLP" ENSG00000101746 "Nucleolar protein 4" O94818 18 33851100-34224952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 12.5;testis: 14.5" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 203.4;Intestinal endocrine cells: 70.9;Late spermatids: 68.6" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 28.9;SH-SY5Y: 7.7;U-698: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046740 Supported Nucleoplasm No NA Nucleoplasm "HPA046740: AB_10960527" "unprognostic (7.86e-2)" "unprognostic (1.58e-1)" "unprognostic (3.61e-1)" "unprognostic (5.43e-7)" "unprognostic (5.76e-2)" "unprognostic (1.56e-2)" "unprognostic (7.19e-2)" "unprognostic (3.45e-1)" "unprognostic (1.12e-2)" "unprognostic (4.78e-2)" "unprognostic (3.52e-2)" "unprognostic (1.23e-1)" "unprognostic (1.39e-1)" "unprognostic (7.77e-2)" "unprognostic (7.71e-2)" 0.0 2.4 3.3 0.0 6.2 0.0 0.0 8.9 12.5 0.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 5.3 1.0 2.8 0.2 0.2 1.2 0.0 2.0 0.0 3.2 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 14.5 2.1 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.1 0.0 0.0 0.0 28.9 7.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.4 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.0 203.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 30.2 70.9 0.0 0.0 68.6 2.3 0.0 0.0 0.0 0.0 12.9 0.2 0.0 2.1 2.2 2.0 0.0 0.0 1.0 1.5 0.0 0.0 0.0 0.2 0.0 NOMO1 PM5 ENSG00000103512 "NODAL modulator 1" Q15155 16 14833681-14896160 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.0" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 40.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 21.0;Hep G2: 37.3;RPMI-8226: 23.8;SiHa: 43.2" "CAB025192, HPA046697, HPA061174" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB025192: , HPA046697: AB_2679758, HPA061174: AB_2684444" "unprognostic (5.33e-3)" "unprognostic (1.60e-1)" "unprognostic (5.27e-1)" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.51e-1)" "unprognostic (4.18e-3)" "unprognostic (2.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.76e-1)" "unprognostic (2.08e-2)" "unprognostic (8.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.09e-1)" "unprognostic (1.50e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (3.15e-4)" 4.2 3.3 4.4 10.1 11.1 0.8 4.6 7.9 10.2 2.4 3.7 5.4 1.5 1.4 6.1 3.6 3.4 8.3 2.8 12.9 5.2 6.4 11.3 8.9 4.1 3.4 4.6 10.6 11.7 40.0 1.2 3.3 9.1 6.6 5.9 10.3 2.7 4.1 5.9 12.2 6.9 7.0 9.0 3.5 1.8 5.9 15.0 2.8 1.5 9.9 1.5 2.4 2.6 1.9 1.2 3.8 5.2 4.0 1.4 1.0 1.0 0.3 12.7 16.0 21.0 0.0 1.5 10.4 1.3 3.2 3.9 4.0 0.2 0.9 1.3 1.0 2.9 0.3 0.2 2.9 0.1 4.0 1.9 0.0 1.2 17.0 37.3 13.9 1.8 1.0 0.2 0.2 2.0 2.2 0.4 2.9 0.0 7.2 0.8 18.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 1.5 23.8 0.0 0.7 0.3 11.8 43.2 0.0 0.2 0.8 17.6 0.1 0.4 0.5 0.0 1.8 14.8 0.0 0.6 1.5 0.9 0.7 0.5 5.2 0.6 0.6 0.3 1.2 0.7 0.2 0.3 0.9 0.5 1.2 0.5 0.8 1.6 1.4 4.0 3.8 1.0 1.0 4.4 11.1 7.9 10.2 5.2 6.4 4.6 10.6 6.6 2.8 3.0 8.0 5.2 1.2 5.7 8.3 40.4 2.5 4.0 5.7 10.4 5.9 5.1 0.0 13.8 22.9 7.4 13.6 0.0 25.8 11.0 5.7 1.6 24.1 6.8 5.7 33.4 7.5 8.6 10.4 6.4 2.6 2.6 5.0 6.4 10.8 5.1 26.8 8.6 6.0 8.2 7.1 6.5 7.2 9.8 13.8 5.1 8.0 4.4 11.1 1.3 NOP10 "MGC70651, NOLA3, NOP10P" ENSG00000182117 "NOP10 ribonucleoprotein" Q9NPE3 15 34341713-34343177 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 210.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059198 Supported Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA059198: AB_2683945" "unprognostic (2.65e-1)" "unprognostic (1.72e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.48e-5)" "unprognostic (3.12e-1)" "unprognostic (2.39e-3)" "unprognostic (8.11e-3)" "unprognostic (9.99e-2)" "unprognostic (2.28e-1)" "unprognostic (8.31e-3)" "unprognostic (1.77e-3)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" "unprognostic (2.61e-1)" "unprognostic (2.59e-1)" "unprognostic (1.05e-1)" "unprognostic (6.77e-3)" 39.1 45.3 29.8 33.1 34.7 45.7 73.3 17.3 41.2 31.8 40.5 14.8 34.3 28.2 28.7 74.7 51.4 30.8 31.1 73.6 29.9 26.9 46.1 59.6 78.1 77.3 31.1 27.2 19.6 64.7 21.2 28.2 31.5 30.7 27.4 52.3 17.0 34.7 33.1 49.4 30.7 34.2 41.0 29.5 51.2 34.1 22.3 27.5 39.5 33.2 58.7 51.9 30.3 34.8 52.4 61.9 210.0 66.4 36.8 50.3 66.7 25.4 56.6 40.6 25.4 65.2 55.3 21.5 34.6 56.5 67.7 86.4 42.5 24.6 17.5 41.6 54.5 79.1 36.1 72.5 60.4 64.0 26.0 41.5 55.6 51.6 60.8 91.1 36.2 28.9 64.2 56.7 62.4 72.8 38.3 94.6 49.1 48.6 25.7 82.6 34.6 27.7 58.0 39.9 75.7 54.9 30.4 28.1 28.8 91.1 56.3 26.3 35.2 24.9 26.4 25.7 57.9 29.3 75.5 40.6 37.2 27.8 52.3 29.3 25.3 47.2 47.2 47.7 58.6 26.4 64.6 66.4 64.3 29.5 62.3 31.2 52.4 38.6 35.0 47.8 46.9 41.3 36.2 210.0 36.8 48.2 61.9 50.3 66.7 29.8 34.7 17.3 41.2 29.9 26.9 31.1 27.2 30.7 27.5 101.3 155.8 223.3 137.7 212.8 30.3 273.4 158.0 135.1 101.2 141.3 11.8 188.6 378.0 338.0 9.2 278.7 249.3 23.3 304.9 331.5 173.6 191.2 159.4 293.3 773.8 12.7 187.9 235.7 558.9 10.8 96.1 363.6 180.5 240.7 228.5 38.4 457.1 277.0 94.0 485.0 22.3 103.5 116.2 12.6 93.8 264.7 179.0 191.9 189.8 424.9 NOS1 "nNOS, NOS" ENSG00000089250 "Nitric oxide synthase 1" P29475 12 117208142-117452170 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 13.4;skeletal muscle: 36.3" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 7.9;Basal keratinocytes: 3.4;Glandular cells: 2.8;Ito cells: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 6.3;RH-30: 13.1;RPTEC TERT1: 8.2;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002167, HPA058312, HPA069509" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: " "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (6.64e-3)" "unprognostic (4.91e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-1)" "unprognostic (9.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (7.56e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-4)" "unprognostic (1.87e-1)" 0.5 0.6 3.8 3.5 13.4 0.7 0.6 4.4 4.8 0.7 2.0 1.1 0.0 0.5 0.6 0.7 1.3 0.8 0.5 0.5 2.8 4.4 1.9 0.5 1.4 0.6 2.4 1.6 0.5 1.9 0.4 0.8 0.4 5.9 1.6 0.9 0.6 3.8 0.6 36.3 2.2 0.6 0.8 1.2 0.5 0.5 0.9 3.0 0.0 0.6 0.0 0.5 0.9 0.6 0.9 0.6 2.1 0.5 0.8 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 13.1 0.1 8.2 0.1 0.3 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 2.1 0.5 0.5 0.5 0.4 0.4 0.7 0.4 0.3 0.2 0.9 0.5 0.5 1.9 0.8 0.5 0.6 0.3 0.0 3.8 13.4 4.4 4.8 2.8 4.4 2.4 1.6 5.9 3.0 0.0 0.0 0.0 7.9 3.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.2 0.3 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.5 0.0 0.0 0.0 1.0 NOS1AP "CAPON, KIAA0464" ENSG00000198929 "Nitric oxide synthase 1 adaptor protein" O75052 1 162069774-162370475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 192.4;Horizontal cells: 63.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 6.9;HaCaT: 5.2;HEL: 8.3" "Low region specificity" "Detected in all" "CAB018582, HPA030066, HPA055561" Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851" "unprognostic (7.04e-3)" "unprognostic (2.20e-1)" "unprognostic (1.79e-2)" "unprognostic (3.93e-2)" "unprognostic (1.58e-2)" "unprognostic (4.75e-2)" "unprognostic (2.07e-1)" "unprognostic (1.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (1.71e-1)" "unprognostic (2.15e-5)" "unprognostic (1.82e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (5.08e-3)" 2.1 7.9 10.2 1.6 7.0 4.8 6.2 23.1 34.1 2.4 3.7 3.1 7.1 2.7 2.4 1.7 2.2 2.6 7.4 2.3 19.0 10.1 2.9 7.6 2.3 1.4 6.5 13.0 1.6 3.5 2.0 2.7 2.2 5.5 2.5 3.9 2.7 4.6 9.7 1.7 2.4 3.1 2.1 4.4 1.3 3.8 4.0 3.1 0.0 1.6 0.2 1.8 1.8 2.2 0.0 0.1 1.1 0.5 0.0 0.3 0.1 6.9 0.0 3.2 1.9 0.1 0.0 0.5 0.6 0.8 0.9 0.8 1.5 1.7 0.0 4.4 0.2 1.1 5.2 1.1 0.2 0.3 0.1 3.2 8.3 1.2 1.7 0.0 0.0 0.1 0.3 0.2 0.0 0.3 0.9 1.7 1.0 0.6 0.1 0.1 3.6 0.6 0.0 2.4 1.1 3.1 0.1 1.3 0.2 1.5 2.3 2.6 1.8 1.6 0.3 1.2 0.9 1.9 0.4 0.8 0.1 0.8 0.0 1.2 4.7 0.0 0.0 1.1 0.1 0.9 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.1 10.2 7.0 23.1 21.1 19.0 10.1 6.5 13.0 5.5 3.1 0.0 0.3 0.0 5.3 2.6 8.5 1.9 2.5 1.4 1.2 21.0 192.4 0.0 8.3 0.9 24.7 1.6 3.8 0.0 1.0 0.2 1.2 9.9 0.0 19.5 0.1 63.5 6.4 2.5 0.6 8.0 4.0 0.0 0.0 0.0 7.3 20.7 0.6 5.5 6.7 0.2 2.2 6.5 0.3 1.9 1.3 1.8 0.5 0.0 4.4 6.4 NOS2 "HEP-NOS, iNOS, NOS, NOS2A" ENSG00000007171 "Nitric oxide synthase 2" P35228 17 27756766-27800499 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.8;lymphoid tissue: 15.6" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 22.7;Undifferentiated cells: 6.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 16.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "CACO-2: 17.0;SCLC-21H: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB002014 Enhanced NA NA "CAB002014: " "unprognostic (1.95e-3)" "unprognostic (3.08e-3)" "unprognostic (4.75e-3)" "unprognostic (4.42e-3)" "unprognostic (3.49e-1)" "unprognostic (2.13e-2)" "unprognostic (5.61e-2)" "unprognostic (5.09e-2)" "unprognostic (9.91e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "unprognostic (1.34e-1)" "unprognostic (6.04e-2)" "unprognostic (8.02e-2)" "unprognostic (3.68e-1)" "unprognostic (8.69e-2)" "unprognostic (4.03e-2)" 1.0 0.7 1.6 15.6 1.6 0.0 0.5 1.5 7.3 0.4 6.8 0.0 0.0 11.8 0.4 0.0 1.0 0.5 0.4 0.7 1.3 1.1 1.7 0.2 3.8 1.8 1.0 2.2 1.0 0.3 0.1 2.1 3.4 0.4 0.9 9.0 1.2 0.2 0.2 0.7 0.4 20.8 1.7 0.8 0.2 0.3 0.4 0.2 0.2 0.5 5.3 1.7 5.4 0.3 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.9 1.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.6 1.5 7.3 1.3 1.1 1.0 2.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.0 22.7 0.0 0.6 0.0 0.0 0.5 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 6.6 0.3 NOS3 "ECNOS, eNOS" ENSG00000164867 "Nitric oxide synthase 3" P29474 7 150990995-151014588 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 62.0;Endothelial cells: 23.5;Ito cells: 30.1;Late spermatids: 21.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 32.4;cerebral cortex: 12.4;hippocampal formation: 18.8;pons and medulla: 35.3" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 5 "T-cells: 5.3" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HUVEC TERT2: 22.1;K-562: 7.8;TIME: 40.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002168 Enhanced NA NA "CAB002168: AB_564072" "unprognostic (6.53e-2)" "unprognostic (3.36e-1)" "unprognostic (1.63e-2)" "unprognostic (8.46e-2)" "unprognostic (2.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (6.97e-2)" "unprognostic (2.56e-1)" "unprognostic (9.40e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (3.63e-4)" "unprognostic (1.25e-2)" "unprognostic (6.63e-2)" "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" 11.4 4.5 3.1 7.5 32.4 1.9 25.6 1.8 12.4 4.6 3.2 1.7 1.0 4.0 8.3 2.5 4.7 5.0 6.6 35.2 18.8 3.4 5.5 5.4 14.0 10.3 4.7 1.7 4.5 4.1 2.7 4.8 11.5 35.3 5.2 2.5 5.2 3.0 3.2 6.0 4.9 4.0 5.4 25.9 70.6 3.6 4.5 1.6 0.0 5.9 2.1 2.4 5.1 7.3 1.1 0.5 0.7 0.4 0.5 5.3 1.2 0.2 0.0 0.6 2.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.1 1.0 0.2 1.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 1.0 0.1 3.0 0.3 0.2 5.1 0.0 0.1 0.0 0.0 0.0 22.1 2.5 7.8 1.8 0.0 0.0 0.1 0.2 0.8 0.3 0.0 1.4 0.0 0.8 0.0 0.1 0.2 0.2 0.1 0.7 0.0 0.2 0.1 0.7 40.2 0.1 0.4 0.2 0.0 1.2 4.1 1.0 0.0 3.6 0.0 0.3 0.3 0.2 2.5 0.4 1.5 0.8 3.9 2.2 0.5 1.1 5.3 2.1 0.7 0.5 0.4 0.5 4.4 1.2 3.1 32.4 1.8 12.4 18.8 3.4 4.7 1.7 35.3 1.6 8.9 2.1 0.0 0.0 0.8 0.0 2.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.5 62.0 23.5 0.0 0.0 0.0 0.1 3.1 0.2 5.7 0.0 0.3 0.0 0.0 30.1 0.6 21.4 0.9 0.4 0.0 0.0 0.0 0.0 1.0 0.0 1.1 0.1 0.3 0.0 1.0 3.7 2.5 0.5 3.0 0.0 0.0 0.2 NOSIP CGI-25 ENSG00000142546 "Nitric oxide synthase interacting protein" Q9Y314 19 49555711-49590262 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 119.4" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 645.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043464, HPA062132" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA043464: AB_10794284, HPA062132: AB_2684693" "unprognostic (2.27e-1)" "unprognostic (4.69e-2)" "unprognostic (1.39e-1)" "unprognostic (4.17e-2)" "unprognostic (1.59e-2)" "unprognostic (9.46e-2)" "unprognostic (1.47e-2)" "unprognostic (9.42e-2)" "unprognostic (3.79e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (9.73e-2)" "unprognostic (3.97e-2)" "unprognostic (2.15e-1)" "unprognostic (9.76e-2)" "unprognostic (1.02e-1)" "unprognostic (2.95e-3)" 13.4 13.9 14.2 14.0 14.0 14.3 11.5 12.1 14.2 11.3 15.9 12.3 13.1 17.3 12.5 8.1 12.7 11.1 11.7 14.9 12.3 11.4 13.2 14.5 12.6 24.6 18.3 10.8 12.9 39.7 7.1 13.6 15.6 14.3 11.6 7.9 11.3 19.2 11.4 66.9 11.9 16.5 11.0 13.1 18.0 13.9 40.2 16.3 20.6 15.5 17.6 16.3 11.7 15.0 20.4 21.5 31.8 16.8 29.7 119.4 69.2 66.5 36.1 14.1 31.0 12.6 9.2 13.5 15.7 13.9 26.5 24.4 25.2 11.8 17.9 27.6 13.2 11.1 14.9 13.8 27.6 11.6 20.4 39.9 22.6 20.8 28.0 19.9 18.3 19.1 12.0 19.2 20.1 10.9 10.8 15.9 28.8 25.0 14.3 13.8 17.8 18.6 39.4 19.1 25.0 31.4 24.4 23.4 15.9 12.3 20.1 17.6 22.9 21.2 18.1 15.8 6.7 14.7 19.4 23.5 23.0 19.5 8.0 30.0 26.9 50.8 24.2 8.7 25.2 17.7 28.0 16.8 23.5 35.1 15.7 45.4 20.4 71.4 40.2 16.6 19.8 119.4 65.8 31.8 29.7 14.3 21.5 37.5 69.2 14.2 14.0 12.1 14.2 12.3 11.4 18.3 10.8 14.3 16.3 17.9 37.0 70.7 51.2 64.7 22.7 33.5 58.6 30.8 14.8 48.8 21.6 81.7 72.9 76.5 286.4 75.9 124.9 46.7 245.7 72.4 65.6 38.9 66.9 45.0 63.5 11.1 56.3 82.3 64.5 645.6 66.4 58.6 59.1 85.6 76.3 39.5 185.4 94.7 67.8 92.9 31.4 58.2 62.7 203.6 46.2 66.7 114.0 101.0 98.9 47.7 NOSTRIN MGC20702 ENSG00000163072 "Nitric oxide synthase trafficking" Q8IVI9 2 168786539-168865514 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 51.2" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 61.2;Ito cells: 157.8;Sertoli cells: 71.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.8;HEL: 25.9;K-562: 19.5;OE19: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044384, HPA076885" Approved Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA044384: AB_2678922, HPA076885: " "unprognostic (4.74e-2)" "unprognostic (2.42e-1)" "unprognostic (8.73e-2)" "unprognostic (2.27e-1)" "unprognostic (3.15e-3)" "unprognostic (3.02e-6)" "unprognostic (4.89e-3)" "unprognostic (3.15e-1)" "unprognostic (3.14e-4)" "unprognostic (5.47e-3)" "unprognostic (1.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.63e-1)" "unprognostic (1.75e-1)" "unprognostic (2.33e-1)" "unprognostic (6.47e-2)" "unprognostic (4.98e-2)" 27.1 11.6 4.4 7.6 5.6 0.2 17.4 2.7 6.0 20.5 11.0 2.3 10.3 10.4 11.9 12.1 7.8 9.0 20.5 9.8 4.8 4.1 27.9 7.8 19.6 3.5 5.8 3.7 11.2 14.8 2.3 4.2 18.5 7.9 9.4 12.5 2.8 51.2 13.6 7.6 4.2 22.3 9.7 5.1 5.6 16.5 11.2 3.9 0.7 8.5 8.6 2.6 7.6 12.8 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.5 0.0 0.0 0.0 6.8 0.2 0.0 0.0 0.0 4.0 4.3 0.0 2.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 25.9 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.1 0.1 0.7 0.0 2.2 0.9 0.0 0.1 0.1 1.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 4.4 5.6 2.7 6.0 4.8 4.1 5.8 3.7 7.9 3.9 8.9 10.1 6.5 0.6 0.9 0.0 3.9 15.3 2.7 5.7 3.5 0.0 14.5 11.6 7.5 21.4 61.2 43.4 0.0 18.9 6.3 2.1 3.0 0.0 0.6 1.3 0.0 10.9 157.8 7.0 42.2 8.1 0.9 23.6 1.0 34.1 2.0 16.3 18.2 5.3 37.6 0.2 71.1 2.2 11.4 1.6 0.4 22.0 0.5 13.9 1.1 NOTCH2NL N2N ENSG00000264343 "Notch 2 N-terminal like" Q7Z3S9 1 146146203-146229026 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.8" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 42.9;Melanocytes: 45.5;Suprabasal keratinocytes: 51.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 43.8" CAB004669 Uncertain "Secreted to blood" NA NA "CAB004669: AB_426149" "unprognostic (1.54e-1)" "unprognostic (8.28e-3)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (2.75e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (4.28e-4)" "unprognostic (1.26e-2)" "unprognostic (1.81e-1)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.91e-1)" "unprognostic (7.59e-2)" "unprognostic (1.83e-2)" 1.9 0.3 0.8 1.3 2.5 0.7 5.8 1.0 0.3 1.7 3.5 2.3 2.3 1.2 1.4 1.0 3.9 1.6 0.7 2.7 1.6 1.7 1.9 2.7 1.0 1.3 2.0 0.0 4.2 0.8 1.6 2.0 0.3 4.7 2.0 1.2 0.7 18.8 14.4 22.8 13.8 3.7 5.0 3.8 10.7 4.1 5.4 2.4 5.9 14.9 2.1 5.7 16.1 9.0 11.2 2.3 6.2 2.3 2.7 6.1 4.4 4.8 3.4 9.8 11.0 6.3 2.7 8.9 12.7 1.0 13.3 3.6 3.1 18.6 3.3 11.1 27.3 9.0 6.7 4.1 2.5 19.3 11.1 11.2 2.2 2.6 1.5 2.0 8.3 2.0 5.9 10.3 6.2 7.3 0.8 0.5 10.6 6.7 2.2 4.0 9.9 4.0 19.1 4.7 4.6 10.0 7.8 43.8 11.1 6.1 8.4 3.3 4.6 11.1 13.8 22.8 3.3 11.0 3.6 18.8 3.6 3.6 14.4 12.3 5.0 3.4 14.1 3.7 12.9 14.3 4.0 3.8 20.8 11.5 0.0 9.1 42.9 0.2 0.0 10.2 6.7 7.9 1.8 9.8 0.6 0.0 5.4 0.4 1.0 0.4 0.0 2.2 1.9 5.8 4.4 9.3 3.0 2.0 0.0 0.0 1.3 11.8 1.1 4.9 10.2 45.5 2.8 0.4 7.8 4.2 22.0 3.9 0.9 5.4 0.0 3.5 3.2 1.1 51.2 0.8 4.3 2.2 9.4 NOTCH4 INT3 ENSG00000204301 "Notch 4" Q99466 6 32194843-32224067 "Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 31.3;lung: 26.2" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 65.0;Ito cells: 155.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "EFO-21: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 820000 "unprognostic (2.27e-1)" "unprognostic (2.27e-1)" "unprognostic (6.80e-3)" "unprognostic (9.50e-2)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.88e-2)" "unprognostic (3.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.31e-2)" "unprognostic (1.66e-1)" "unprognostic (1.56e-1)" "unprognostic (3.13e-1)" 31.3 3.5 3.6 2.9 6.3 1.5 16.7 2.5 8.2 3.4 5.9 1.3 3.3 3.2 5.8 12.1 3.7 4.0 2.7 10.5 4.2 2.1 6.1 5.0 26.2 2.6 4.9 1.1 2.5 3.4 1.5 2.9 6.0 5.5 4.6 2.0 3.7 1.9 4.3 8.5 4.1 2.7 1.5 4.8 3.4 3.6 2.0 5.1 0.0 9.3 4.3 2.0 3.3 12.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.6 6.3 2.5 8.2 4.2 2.1 4.9 1.1 5.5 5.1 0.0 9.6 11.8 23.5 4.6 2.8 6.4 0.0 4.0 6.8 5.2 3.9 0.3 0.0 1.8 31.8 65.0 0.0 0.0 1.0 0.2 3.1 3.1 0.0 0.8 1.6 6.4 5.8 155.3 11.0 26.3 6.6 4.9 3.3 1.0 0.6 19.5 0.3 0.0 4.9 0.8 3.5 0.0 5.9 4.2 1.6 1.4 0.2 2.5 1.0 4.7 NOTO ENSG00000214513 "Notochord homeobox" A8MTQ0 2 73202258-73212513 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034660, HPA063906" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA034660: AB_10601974, HPA063906: " "unprognostic (6.09e-2)" "unprognostic (9.77e-2)" "unprognostic (4.84e-2)" "unprognostic (1.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.68e-2)" 0.2 0.8 0.3 0.6 0.4 2.3 0.3 1.4 0.2 0.1 0.5 0.1 0.1 0.8 0.1 0.6 0.1 0.1 0.4 0.2 0.2 0.6 0.1 0.2 0.3 0.5 0.3 0.1 0.2 0.1 0.0 0.4 0.1 2.4 1.3 0.3 0.6 0.2 0.1 0.5 2.2 2.7 0.1 0.5 0.5 0.5 5.7 0.1 0.7 0.1 0.1 0.1 0.4 0.1 0.8 0.8 2.6 0.8 1.4 1.0 0.3 0.2 0.2 0.4 0.5 0.2 0.3 0.7 0.3 0.0 0.1 0.2 1.1 0.8 0.3 0.2 0.3 0.3 1.1 0.1 0.4 0.5 0.8 0.4 0.5 1.8 0.7 0.0 0.6 1.4 0.2 0.4 0.1 0.0 0.3 0.0 0.5 0.1 1.0 0.0 0.6 0.1 0.4 0.7 0.0 0.5 0.7 0.2 0.3 0.1 0.8 0.9 0.6 1.1 0.8 0.0 0.6 0.7 0.6 1.3 0.8 0.4 0.2 0.7 0.7 0.2 0.8 0.3 1.0 0.2 1.9 0.8 0.3 0.6 0.3 0.9 0.6 0.8 0.5 0.3 0.8 0.8 1.0 2.6 1.4 0.5 0.8 0.5 0.3 0.3 0.4 1.4 0.2 0.2 0.6 0.3 0.1 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 NOTUM ENSG00000185269 "Notum, palmitoleoyl-protein carboxylesterase" Q6P988 17 81952507-81961840 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "placenta: 127.4" "Cell type enriched" "Detected in some" 47 "Extravillous trophoblasts: 865.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 96.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022851 Approved "Endoplasmic reticulum" "Secreted in female reproductive system" NA NA 59000 "Endoplasmic reticulum" "HPA022851: " "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-2)" "unprognostic (4.80e-3)" "unprognostic (1.97e-1)" "unprognostic (9.02e-3)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (6.49e-2)" "unprognostic (8.72e-2)" "unprognostic (1.40e-1)" "unprognostic (2.01e-2)" "unprognostic (4.48e-6)" "unprognostic (1.76e-1)" "unprognostic (9.88e-2)" "unprognostic (1.22e-3)" "unprognostic (1.00e-1)" 0.2 0.1 1.1 0.2 1.2 0.1 0.2 0.3 1.0 0.2 0.2 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.3 0.3 0.5 0.9 0.8 10.4 1.8 0.2 0.7 0.4 0.2 0.2 0.0 0.2 127.4 0.6 0.4 0.0 0.2 0.3 0.2 4.9 2.4 0.2 0.2 0.3 0.3 0.9 3.0 0.5 0.2 0.2 0.3 0.2 1.3 1.3 0.7 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.5 0.6 96.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 15.6 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.9 0.4 1.4 0.5 0.0 1.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 1.2 0.3 1.0 0.5 0.9 0.7 0.4 0.6 0.5 0.0 3.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 865.2 2.3 0.0 0.0 0.9 17.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.8 0.0 18.4 0.0 0.0 0.0 NOV "CCN3, IGFBP9" ENSG00000136999 "Nephroblastoma overexpressed" P48745 8 119416306-119424353 "Plasma proteins, Predicted secreted proteins, Transporters" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 236.7" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 36.6;granulocytes: 23.1;Melanocytes: 74.2" "Cancer enhanced" "Detected in all" "melanoma: 62.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 113 "eosinophil: 28.1;neutrophil: 14.0" "Lineage enriched" "Detected in single" 151 "granulocytes: 28.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 43.7;hTERT-RPE1: 13.6;U-2197: 45.2" "Group enriched" "Detected in many" 7 "amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1" "Low region specificity" "Detected in many" "HPA018449, HPA019684, CAB034423" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 269000000 2900000 Vesicles "CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190" "unprognostic (5.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.36e-3)" "unprognostic (1.30e-3)" "unprognostic (9.35e-3)" "unprognostic (4.92e-1)" "unprognostic (8.10e-2)" "unprognostic (6.04e-2)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.67e-1)" "unprognostic (3.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.74e-3)" "unprognostic (1.51e-1)" "unprognostic (1.98e-1)" "unprognostic (2.72e-2)" 6.3 236.7 2.2 1.4 7.9 1.0 5.6 3.1 12.3 5.0 2.0 3.6 3.6 1.5 5.8 2.9 1.9 3.0 2.0 5.7 3.5 1.9 4.9 0.9 2.9 1.1 2.1 15.1 1.8 2.7 2.1 13.4 0.8 7.4 5.6 2.2 1.2 1.2 5.0 1.6 3.6 1.5 2.5 2.5 1.0 1.6 2.6 0.0 0.0 6.9 4.8 1.1 3.3 2.5 0.0 0.1 28.1 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 4.0 1.0 0.0 5.8 43.7 5.3 3.0 0.0 0.1 0.0 4.6 7.3 4.1 3.6 0.2 0.0 1.8 0.0 0.1 0.0 3.4 0.0 0.1 0.0 0.0 0.2 0.0 2.0 0.2 13.6 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 8.7 0.0 0.0 0.0 5.6 0.0 1.3 0.0 2.1 0.0 8.1 0.0 0.0 0.0 0.0 3.8 5.8 45.2 1.2 0.0 0.0 0.0 6.0 1.8 4.3 0.0 0.1 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.2 7.9 3.1 12.3 3.5 1.9 2.1 15.1 7.4 0.0 0.0 1.1 0.0 0.6 16.7 0.0 1.2 0.0 2.7 2.3 36.6 0.0 0.0 0.0 7.2 0.0 12.6 0.3 0.0 1.0 0.0 15.4 14.0 23.1 0.0 1.4 3.2 9.2 0.6 1.2 0.0 2.8 0.4 74.2 0.0 1.3 0.0 0.6 2.9 0.7 0.0 0.2 0.0 20.8 0.0 0.0 14.8 0.1 0.0 9.8 0.9 NOVA1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443093-26597754 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 198.3;Horizontal cells: 128.7;Leydig cells: 139.2;Spermatocytes: 170.1" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 25.9;ASC diff: 14.1;HAP1: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 17.8 6.7 17.5 3.4 17.4 1.3 32.9 54.7 49.2 12.2 6.3 13.3 5.0 2.5 9.4 6.9 4.0 6.2 6.2 3.0 17.1 25.1 7.0 2.2 2.7 4.4 19.2 17.8 6.3 2.7 4.4 14.1 1.3 26.4 5.4 6.5 4.0 2.8 17.5 6.9 3.1 3.4 9.9 22.5 2.1 3.3 10.3 14.9 0.0 4.1 2.7 5.2 5.6 9.4 0.3 0.3 0.6 0.4 2.2 0.5 0.0 0.0 6.1 25.9 0.0 14.1 7.6 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.4 4.2 0.1 12.7 0.1 0.0 0.0 1.0 0.0 0.0 0.2 5.3 0.0 1.2 9.4 0.0 1.9 1.9 9.4 5.4 5.4 0.0 0.0 4.1 0.0 5.3 0.1 7.6 0.0 6.1 0.7 8.6 0.1 3.6 4.9 8.3 4.8 0.0 0.0 0.0 2.6 0.7 0.0 0.0 3.6 4.2 3.1 0.7 0.0 0.0 0.0 5.1 0.0 3.8 0.6 0.0 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.5 0.6 2.2 0.4 0.3 0.4 0.0 17.5 17.4 54.7 26.9 17.1 25.1 19.2 17.8 26.4 14.9 0.0 1.0 0.0 6.8 4.6 198.3 0.8 2.5 8.1 0.0 14.0 3.9 0.0 8.3 0.0 14.7 6.2 0.5 0.0 0.3 0.0 12.1 2.1 0.0 0.2 0.2 128.7 63.4 35.0 1.2 11.2 139.2 1.9 3.3 0.0 2.3 26.6 3.1 10.5 61.9 20.4 13.0 6.5 19.8 170.1 57.9 2.8 0.0 0.0 3.7 0.6 NOVA2 "ANOVA, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45973546 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.5" "Group enriched" "Detected in some" 11 "Bipolar cells: 50.9;Endothelial cells: 25.9;Horizontal cells: 20.6;Ito cells: 35.6" "Cancer enhanced" "Detected in many" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.3;HDLM-2: 8.8;HUVEC TERT2: 14.2;SH-SY5Y: 4.8;TIME: 21.2;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 11.8 4.5 23.9 2.7 22.7 1.3 5.7 13.0 33.5 3.9 2.5 7.2 0.0 2.5 5.6 2.7 2.4 3.6 4.2 5.8 17.1 10.9 3.2 2.7 9.4 2.2 7.1 17.3 2.0 2.5 3.3 5.7 9.7 11.1 2.6 2.4 2.5 2.4 3.1 5.5 2.7 2.0 5.7 5.5 2.4 2.5 4.3 8.7 0.0 4.5 0.4 1.8 3.9 3.5 0.0 0.0 0.4 0.1 0.4 0.1 0.0 0.0 0.1 8.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 1.1 0.0 0.0 8.8 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 4.8 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 5.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 23.9 22.7 13.0 29.3 17.1 10.9 7.1 17.3 11.1 8.7 0.0 0.0 0.0 0.1 0.6 50.9 3.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.3 25.9 0.0 0.0 0.2 0.0 0.4 0.2 0.0 0.4 0.1 20.6 0.0 35.6 2.6 2.4 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.4 0.0 3.1 0.0 0.0 2.3 1.9 0.1 0.0 0.0 0.0 0.3 NOX1 "GP91-2, MOX1, NOH-1, NOH1" ENSG00000007952 "NADPH oxidase 1" Q9Y5S8 X 100843324-100874345 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0" "Cell type enriched" "Detected in some" 5 "Undifferentiated cells: 70.7" "Cancer enriched" "Detected in many" 18 "colorectal cancer: 82.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 14 "CACO-2: 25.8;OE19: 9.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (8.31e-2)" "unprognostic (2.07e-3)" "prognostic favorable (9.71e-4)" "unprognostic (1.67e-2)" "unprognostic (3.37e-1)" "unprognostic (6.55e-3)" "unprognostic (5.48e-3)" "unprognostic (8.68e-3)" "unprognostic (1.32e-1)" "unprognostic (5.23e-2)" "unprognostic (1.18e-1)" "unprognostic (3.86e-3)" "unprognostic (2.56e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-3)" 0.1 0.1 0.2 8.8 0.2 0.0 0.1 0.2 0.2 0.2 28.3 0.0 15.0 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.3 36.3 0.0 0.1 18.0 0.1 0.8 1.7 0.7 0.1 0.1 0.1 0.4 0.0 0.4 0.1 0.0 0.1 0.6 0.1 0.2 0.7 0.9 0.6 0.8 1.5 0.2 0.3 0.9 0.4 0.3 0.2 0.0 0.3 0.3 0.0 0.0 0.0 25.8 0.3 0.3 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.3 1.2 0.4 0.6 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.2 0.0 0.2 1.1 1.0 0.7 9.7 0.9 0.6 0.6 0.4 0.0 0.9 0.4 0.5 0.6 0.3 0.6 0.2 0.2 0.8 0.2 0.3 0.2 0.5 0.6 0.3 0.6 0.3 0.7 1.1 0.2 0.9 0.3 0.3 0.5 0.3 0.3 0.2 1.1 0.2 0.1 0.1 1.5 0.6 0.1 0.8 0.6 0.7 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 70.7 0.5 NOX3 GP91-3 ENSG00000074771 "NADPH oxidase 3" Q9HBY0 6 155395370-155455903 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "adrenal gland: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "MCF7: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073837 Uncertain Vesicles NA NA Vesicles "HPA073837: " "unprognostic (3.42e-1)" 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 119.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm NA NA Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 8.5 15.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 4.3 0.3 0.0 34.8 0.1 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 4.1 1.1 0.0 0.0 0.0 10.4 5.9 1.2 13.3 0.0 0.8 1.1 0.0 0.0 0.0 0.6 1.1 0.1 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.4 0.3 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 119.8 19.3 0.0 0.3 0.5 0.1 0.3 2.1 0.0 0.0 0.0 NOX5 "NOX5A, NOX5B" ENSG00000255346 "NADPH oxidase 5" Q96PH1 15 68930525-69062743 "Predicted membrane proteins, Transporters" "Angiogenesis, Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 19.1;placenta: 11.1;testis: 43.7" "Group enriched" "Detected in some" 4 "Early spermatids: 14.7;Late spermatids: 9.0;Spermatocytes: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.5;EFO-21: 3.2" "Low region specificity" "Detected in many" NA NA "unprognostic (2.33e-1)" "unprognostic (1.63e-2)" "unprognostic (6.11e-2)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (4.91e-3)" "unprognostic (6.80e-2)" "unprognostic (5.50e-3)" "unprognostic (3.48e-2)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (8.21e-2)" "unprognostic (4.58e-3)" "unprognostic (2.71e-3)" "unprognostic (4.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" 1.5 1.0 0.8 0.4 2.3 0.4 1.5 0.8 1.2 3.0 0.9 0.9 5.3 0.4 1.5 2.5 1.1 1.1 1.1 1.6 0.8 0.9 1.4 0.5 0.6 1.1 1.3 0.1 1.2 0.6 0.5 1.9 11.1 2.7 2.1 0.9 1.1 0.6 2.3 0.9 0.8 1.0 2.3 1.3 19.1 0.9 43.7 0.5 0.2 1.4 0.2 0.6 1.5 1.0 0.4 0.1 0.4 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.6 2.0 2.5 1.3 1.5 0.0 3.2 0.4 0.1 0.0 0.0 0.1 1.6 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.5 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.7 1.1 0.0 0.0 0.7 0.6 1.5 0.0 0.1 0.3 1.3 0.0 1.7 0.0 0.1 0.6 2.0 0.2 0.9 0.3 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 2.3 0.8 1.2 0.8 0.9 1.3 0.1 2.7 0.5 0.0 0.0 0.0 0.1 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 4.3 1.3 0.0 1.5 0.0 0.0 0.0 NOXO1 "P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28" ENSG00000196408 "NADPH oxidase organizer 1" Q8NFA2 16 1978917-1984192 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0;intestine: 10.5;lymphoid tissue: 10.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 20.0;Mucus-secreting cells: 25.4;Paneth cells: 19.0;Undifferentiated cells: 31.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.6;HaCaT: 3.2;OE19: 8.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA071540 Enhanced NA NA "HPA071540: AB_2686415" "unprognostic (3.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.73e-2)" 0.5 0.0 1.1 10.6 3.1 0.3 0.5 7.0 2.0 0.9 10.5 0.5 0.5 4.6 0.5 1.5 2.2 0.2 2.8 0.5 1.0 0.9 0.5 2.2 1.0 0.5 0.6 0.5 0.5 0.5 0.3 0.8 0.5 0.5 0.5 8.6 0.5 4.9 0.5 0.5 0.6 4.2 0.6 0.5 0.5 0.3 4.8 0.5 1.4 0.5 0.5 4.1 1.1 0.5 0.7 0.2 1.3 0.0 0.0 0.3 0.0 0.3 0.9 0.9 0.2 0.5 0.0 0.0 0.1 0.2 0.8 0.5 0.7 5.6 0.5 0.4 0.0 0.0 3.2 0.0 0.2 0.0 1.0 0.0 0.0 1.6 0.0 0.1 0.0 0.5 0.9 0.2 0.9 0.3 0.9 0.0 1.4 0.2 0.0 0.0 0.2 2.8 0.0 0.0 8.7 0.0 0.4 0.8 0.1 0.6 0.0 2.9 0.0 1.2 1.1 0.1 0.2 2.2 0.9 0.0 0.6 0.1 0.0 1.4 0.1 0.5 1.3 0.5 0.1 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 1.1 3.1 7.0 2.0 1.0 0.9 0.6 0.5 0.5 0.5 0.0 0.0 0.0 1.3 0.2 0.0 0.0 2.5 0.0 0.0 5.2 0.0 0.6 0.0 0.8 5.8 0.0 20.0 0.0 1.7 2.6 0.0 3.2 0.0 0.2 0.2 0.0 6.3 0.0 0.3 1.0 0.6 0.0 0.0 1.0 25.4 0.3 1.1 19.0 0.4 0.8 0.0 0.0 0.0 2.7 2.8 0.4 1.3 0.0 31.2 4.3 NOXRED1 "C14orf148, FLJ32809" ENSG00000165555 "NADP dependent oxidoreductase domain containing 1" Q6NXP6 14 77394021-77423517 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.9" "Group enriched" "Detected in some" 27 "Early spermatids: 112.2;Late spermatids: 97.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.9" "Lineage enhanced" "Detected in single" "granulocytes: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055658 Approved NA NA "HPA055658: AB_2682878" "unprognostic (1.92e-2)" "unprognostic (4.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-1)" "unprognostic (2.49e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-2)" "unprognostic (1.36e-1)" "unprognostic (2.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.08e-3)" "unprognostic (1.24e-2)" "unprognostic (1.29e-2)" "unprognostic (2.60e-1)" "unprognostic (5.70e-2)" "unprognostic (1.70e-3)" "unprognostic (1.07e-3)" 0.4 0.8 0.5 0.4 0.9 0.1 0.7 0.4 0.4 0.4 0.7 0.4 0.4 0.7 0.6 0.8 0.4 1.2 0.9 0.4 0.5 0.7 0.6 0.5 0.4 0.8 0.4 0.4 0.4 0.7 0.8 1.4 0.4 0.4 0.4 0.6 0.4 0.4 0.5 0.4 1.8 0.4 0.6 0.4 0.6 0.2 13.9 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.2 0.0 2.9 0.0 0.0 0.8 0.0 1.2 2.5 1.0 1.4 0.5 2.5 1.8 1.1 1.8 1.3 0.8 1.4 1.2 2.5 0.6 2.1 0.5 0.7 0.4 0.5 1.4 1.2 0.9 1.4 0.1 2.4 0.9 0.5 2.3 1.4 3.4 1.1 1.8 1.5 0.7 2.9 0.5 1.8 0.6 2.7 0.6 0.8 0.0 0.7 2.2 0.7 0.6 0.1 1.2 0.6 2.5 1.8 1.6 0.6 0.4 2.7 2.4 1.5 3.0 0.8 0.8 1.6 0.4 2.5 2.3 1.4 1.2 0.3 1.0 0.0 0.0 2.9 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.8 0.0 0.5 0.9 0.4 0.4 0.5 0.7 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.8 97.5 0.9 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.0 1.7 0.0 0.0 3.2 1.9 0.0 0.0 0.0 0.0 0.1 NPAP1 C15orf2 ENSG00000185823 "Nuclear pore associated protein 1" Q9NZP6 15 24675868-24683393 "Predicted intracellular proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 17.7" "Group enriched" "Detected in some" 5 "Spermatocytes: 16.7;Spermatogonia: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-266/70: 3.4" "HPA018828, HPA019562" Uncertain NA NA "HPA018828: AB_2669941, HPA019562: AB_2670190" "unprognostic (4.40e-2)" "unprognostic (1.85e-2)" "unprognostic (6.98e-3)" "unprognostic (7.45e-2)" "unprognostic (9.90e-2)" "unprognostic (1.08e-2)" "unprognostic (5.11e-3)" 0.2 0.2 0.2 0.2 1.2 1.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.8 0.6 0.2 0.2 0.2 0.2 0.2 1.4 0.9 0.0 1.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.4 0.3 0.2 17.7 0.2 0.2 1.2 0.2 0.2 0.6 0.2 0.4 0.3 1.6 0.1 0.9 1.2 0.0 0.4 0.2 0.6 0.7 0.1 0.0 0.8 0.4 0.0 0.1 0.0 0.5 0.5 0.5 0.2 0.1 0.3 0.4 0.2 0.4 0.1 0.2 0.5 0.4 1.0 0.5 0.0 0.5 0.2 0.2 0.4 0.3 0.2 0.4 0.0 0.5 0.6 0.5 0.0 0.5 0.2 0.6 0.9 0.2 0.6 0.1 0.1 0.1 0.1 1.4 0.5 0.2 0.3 0.8 0.2 0.4 0.9 0.2 0.9 0.5 1.6 0.2 0.2 3.4 0.2 0.7 0.5 0.3 0.2 1.6 0.1 0.2 1.1 0.1 0.5 0.2 0.2 1.0 0.1 0.4 0.2 1.2 0.9 0.9 0.1 0.3 0.2 0.0 0.2 1.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 10.4 0.0 0.0 0.0 0.0 0.1 NPAS1 "bHLHe11, MOP5, PASD5" ENSG00000130751 "Neuronal PAS domain protein 1" Q99742 19 47019820-47045775 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 14.2;skin 1: 10.5;stomach 1: 8.0" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 15.7;Muller glia cells: 5.6;Rod photoreceptor cells: 5.1" "Cancer enhanced" "Detected in many" "testis cancer: 5.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 2.2" "Lineage enhanced" "Detected in single" "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ: 8.9;Daudi: 9.1;HEK 293: 10.0;HMC-1: 8.3;NB-4: 15.9;U-266/84: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043364, HPA072259" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA043364: , HPA072259: AB_2686500" "unprognostic (2.34e-3)" "unprognostic (6.25e-2)" "unprognostic (7.32e-4)" "unprognostic (1.38e-1)" "unprognostic (6.24e-2)" "unprognostic (2.46e-2)" "unprognostic (2.76e-3)" "unprognostic (2.21e-2)" "unprognostic (1.09e-1)" "unprognostic (3.75e-1)" "unprognostic (5.91e-2)" "unprognostic (2.64e-1)" "unprognostic (2.14e-8)" "unprognostic (8.82e-2)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (4.20e-2)" 0.6 0.6 9.5 1.3 4.1 0.9 1.3 0.4 14.2 0.4 0.9 0.4 0.0 0.5 0.6 0.4 0.8 1.2 0.5 0.9 9.0 5.2 1.2 0.8 0.9 1.7 3.0 4.1 0.4 1.5 0.7 1.1 0.8 5.1 0.6 0.5 3.4 0.7 0.5 0.5 10.5 0.4 0.7 0.8 3.9 8.0 0.8 0.2 0.0 0.6 0.0 1.3 0.5 0.4 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.2 0.2 0.4 0.2 0.2 0.0 8.9 0.2 0.1 0.4 0.7 0.5 9.1 2.0 7.2 0.4 0.2 1.9 0.2 0.1 0.6 10.0 0.7 0.8 2.2 0.0 4.8 8.3 0.8 0.4 0.0 0.1 0.5 0.2 1.2 3.1 0.8 1.2 0.7 0.3 15.9 2.2 0.4 1.5 0.8 0.3 0.7 0.5 0.5 0.7 0.6 0.8 0.3 2.1 0.7 1.9 1.5 0.1 0.1 0.9 0.1 0.2 5.0 9.7 1.9 1.1 1.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 9.5 4.1 0.4 14.2 9.0 5.2 3.0 4.1 5.1 0.2 0.0 1.1 0.0 1.2 0.7 0.7 0.8 0.0 2.7 0.0 0.0 15.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 1.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.6 0.8 0.0 0.0 0.5 5.1 0.0 0.3 0.0 2.0 1.9 0.0 0.0 0.5 0.9 NPAS3 "bHLHe12, MOP6, PASD6" ENSG00000151322 "Neuronal PAS domain protein 3" Q8IXF0 14 32934933-33804176 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 7.8;Early spermatids: 16.1;Horizontal cells: 9.5;Late spermatids: 12.4" "Cancer enhanced" "Detected in some" "endometrial cancer: 6.4;glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.0;U-266/70: 22.3;U-266/84: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075337 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA075337: " "unprognostic (6.02e-3)" "unprognostic (2.37e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-2)" "unprognostic (3.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.14e-2)" "unprognostic (5.65e-2)" "unprognostic (2.74e-1)" "unprognostic (3.12e-3)" "unprognostic (5.29e-3)" "unprognostic (1.38e-1)" "unprognostic (3.18e-3)" "unprognostic (2.65e-3)" "unprognostic (1.50e-1)" "unprognostic (2.69e-3)" "unprognostic (3.27e-1)" 1.8 2.4 17.4 1.4 14.4 1.0 2.7 8.5 29.8 14.0 1.8 15.8 0.7 1.5 9.1 2.6 1.6 8.5 2.2 1.6 18.7 10.3 2.4 1.3 1.3 1.3 11.7 13.0 6.4 2.2 2.5 1.6 2.0 16.2 2.5 1.7 0.8 2.7 3.6 2.0 1.4 1.6 2.2 13.8 3.1 2.8 3.5 16.3 0.0 4.4 0.0 1.5 1.1 1.4 0.0 0.6 0.1 0.2 0.0 0.2 0.0 0.0 0.0 9.0 0.0 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 22.3 6.4 0.0 0.3 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.6 0.0 0.0 17.4 14.4 8.5 15.3 18.7 10.3 11.7 13.0 16.2 16.3 0.0 0.0 0.0 0.7 0.9 7.8 2.0 0.0 2.7 0.0 1.8 0.0 1.2 1.7 0.1 16.1 1.9 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.4 9.5 1.2 6.2 0.0 12.4 6.6 0.0 0.0 0.0 0.0 5.8 0.3 0.0 4.9 0.6 0.3 0.0 3.1 0.2 0.1 0.4 0.2 0.0 0.0 0.4 NPAS4 "bHLHe79, Le-PAS, NXF, PASD10" ENSG00000174576 "Neuronal PAS domain protein 4" Q8IUM7 11 66421004-66426707 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 18.7;pituitary gland: 19.5" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 5.1;Horizontal cells: 11.1;Rod photoreceptor cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;BJ: 1.4;HMC-1: 1.2;Karpas-707: 4.6;SCLC-21H: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 4.3;basal ganglia: 3.2;cerebral cortex: 8.0;hippocampal formation: 7.1;olfactory region: 5.3" "Low region specificity" "Detected in all" HPA039255 Uncertain NA NA "HPA039255: AB_10674282" "unprognostic (7.81e-2)" "unprognostic (9.93e-2)" "unprognostic (1.55e-2)" "unprognostic (1.24e-1)" "unprognostic (2.51e-1)" "unprognostic (1.78e-3)" "unprognostic (4.97e-1)" "unprognostic (7.84e-2)" "unprognostic (1.85e-2)" "unprognostic (3.29e-2)" "unprognostic (3.96e-2)" "unprognostic (1.12e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-1)" "unprognostic (4.24e-1)" "unprognostic (3.21e-2)" 1.1 1.1 1.4 1.7 12.7 0.2 0.5 18.7 12.6 1.1 1.6 1.0 2.4 0.7 4.4 2.0 1.3 0.9 0.8 0.4 4.3 3.1 0.3 0.3 0.4 0.2 0.2 1.5 0.6 1.3 0.7 19.5 0.3 2.9 2.1 0.6 1.5 0.5 2.9 0.3 0.2 0.8 4.0 0.4 0.5 0.9 0.7 0.0 0.0 0.2 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.4 0.2 0.6 0.6 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.5 0.0 0.5 0.0 4.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.4 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 12.7 18.7 12.6 4.3 3.1 0.2 1.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 4.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPB "PPL7, PPNPB" ENSG00000183979 "Neuropeptide B" Q8NG41 17 81900745-81902905 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.2" "Group enriched" "Detected in many" 8 "Spermatogonia: 28.8;Syncytiotrophoblasts: 81.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 2.1;MAIT T-cell: 2.2" "Group enriched" "Detected in many" 14 "granulocytes: 2.1;T-cells: 2.2" "Cell line enhanced" "Detected in some" "HDLM-2: 4.2;PC-3: 5.6;RH-30: 4.3;SH-SY5Y: 4.7;U-2 OS: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (2.44e-2)" "unprognostic (6.21e-2)" "unprognostic (2.90e-1)" "unprognostic (3.47e-3)" "unprognostic (9.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.31e-1)" "unprognostic (1.92e-1)" "unprognostic (3.55e-2)" "unprognostic (5.40e-2)" "unprognostic (5.86e-2)" "unprognostic (1.96e-1)" "unprognostic (6.06e-2)" "unprognostic (3.71e-1)" "unprognostic (4.32e-1)" 1.5 0.6 4.7 5.2 5.1 1.1 2.2 3.4 6.9 2.3 1.3 3.8 0.1 0.4 2.8 2.4 0.6 2.1 0.8 1.0 2.7 10.3 1.3 1.2 1.1 4.4 6.1 2.7 2.4 0.9 1.1 0.7 8.0 4.5 1.4 1.2 1.9 0.8 1.8 1.6 2.5 1.3 1.9 13.2 2.8 1.0 2.0 1.4 1.9 0.7 0.0 3.7 0.8 2.5 0.1 0.0 2.1 0.0 0.0 2.2 0.0 0.7 2.1 1.5 0.4 0.3 0.4 1.3 0.6 0.4 0.4 0.0 1.0 0.2 0.4 0.2 0.3 1.3 0.0 0.9 0.3 0.6 4.2 0.2 0.9 0.1 0.0 0.3 0.1 0.6 0.0 1.7 0.6 0.5 1.2 0.1 1.0 1.3 0.2 0.2 0.4 0.1 1.1 0.5 0.6 5.6 0.4 4.3 0.0 0.3 1.1 0.9 4.7 0.4 0.6 0.9 3.0 0.1 0.1 0.5 0.8 5.3 0.2 0.6 0.6 0.5 0.0 0.1 1.3 0.4 0.2 0.0 2.1 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 4.7 5.1 3.4 6.9 2.7 10.3 6.1 2.7 4.5 1.4 0.0 0.0 0.0 0.4 2.3 0.9 0.0 2.5 0.0 0.0 0.0 0.0 1.8 1.7 0.8 1.3 0.0 0.6 0.0 0.2 2.2 3.3 0.9 0.0 0.0 1.1 0.0 0.0 1.8 1.9 2.8 4.6 0.0 5.0 0.0 0.2 0.3 1.3 3.2 2.5 1.8 1.3 0.0 1.5 6.9 28.8 1.0 81.1 0.0 0.3 0.4 NPBWR1 GPR7 ENSG00000183729 "Neuropeptides B and W receptor 1" P48145 8 52938431-52941117 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.1;brain: 2.8;liver: 2.6" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 9 "classical monocyte: 1.6;eosinophil: 3.1" "Group enriched" "Detected in many" 9 "granulocytes: 3.1;monocytes: 1.6" "Group enriched" "Detected in some" 5 "A549: 2.3;HaCaT: 2.9;SiHa: 4.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 10.5" NA NA "unprognostic (2.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.86e-2)" "unprognostic (2.67e-2)" "unprognostic (2.05e-1)" "unprognostic (1.02e-2)" "unprognostic (2.21e-1)" "unprognostic (3.89e-3)" "unprognostic (2.18e-1)" "unprognostic (8.55e-2)" "unprognostic (2.84e-1)" "unprognostic (6.76e-2)" "unprognostic (4.71e-2)" "unprognostic (2.26e-1)" "unprognostic (4.90e-2)" "unprognostic (2.68e-1)" "unprognostic (1.23e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.3 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 0.1 0.0 0.0 3.1 1.6 0.0 0.2 0.8 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.3 0.0 4.6 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 3.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPBWR2 GPR8 ENSG00000125522 "Neuropeptides B and W receptor 2" P48146 20 64105820-64107171 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 0.6;hypothalamus: 0.4;olfactory region: 1.5" NA NA "unprognostic (1.44e-1)" 0.2 2.4 0.3 0.3 1.8 0.3 0.2 0.4 14.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 2.3 0.2 0.2 0.2 1.6 0.2 0.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.4 14.8 0.2 0.5 0.2 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles NA NA 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.7 4.6 7.4 15.0 11.6 10.5 9.3 20.2 9.9 21.5 7.1 7.8 4.5 7.2 13.4 33.8 15.0 5.8 16.0 8.8 3.5 4.6 1.6 9.7 16.0 21.4 6.1 7.4 11.1 15.9 20.9 70.4 19.6 9.7 5.2 4.8 12.1 11.1 8.1 2.5 3.6 3.2 6.1 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.2 13.7 7.4 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.3 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 23.8 44.3 6.2 23.3 8.2 5.0 4.4 10.2 0.0 15.9 8.7 17.7 11.6 0.0 9.3 1.1 11.4 11.3 0.0 12.8 6.2 6.5 30.4 10.4 7.9 25.1 3.2 3.5 7.4 9.2 1.4 8.3 17.9 11.8 2.8 4.8 16.2 23.5 14.0 9.9 4.7 12.4 0.0 9.0 12.6 20.4 12.7 19.9 20.3 4.5 51.4 NPC1L1 SLC65A2 ENSG00000015520 "NPC1 like intracellular cholesterol transporter 1" Q9UHC9 7 44512535-44541315 "FDA approved drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 77.0;liver: 29.8" "Group enriched" "Detected in some" 9 "Cholangiocytes: 10.2;Early spermatids: 13.1;Hepatocytes: 27.0" "Group enriched" "Detected in many" 5 "liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 6.9;Hep G2: 17.2;SCLC-21H: 14.8" "Region enhanced" "Detected in single" "cerebral cortex: 0.7" "Low region specificity" "Detected in all" "CAB070127, CAB070128" Enhanced NA NA "CAB070127: AB_10002744, CAB070128: AB_10000815" "unprognostic (2.96e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-3)" "unprognostic (8.43e-2)" "unprognostic (1.62e-1)" "unprognostic (2.07e-1)" "unprognostic (9.40e-2)" "unprognostic (6.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.96e-2)" "unprognostic (4.51e-2)" "unprognostic (7.59e-2)" "unprognostic (8.08e-10)" "unprognostic (1.64e-2)" "unprognostic (2.83e-1)" "unprognostic (3.62e-2)" "unprognostic (5.83e-2)" 0.5 0.1 0.1 0.0 0.2 0.0 0.4 0.5 0.2 0.3 42.0 0.0 0.0 30.5 0.4 0.3 0.3 0.3 11.4 0.1 0.1 0.1 0.7 29.8 0.2 0.0 0.1 0.0 0.5 1.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 77.0 0.0 0.1 0.1 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 14.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 10.2 0.0 0.0 1.8 0.0 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.0 27.0 0.0 0.0 1.7 1.8 1.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 NPC2 "EDDM1, HE1, NP-C2" ENSG00000119655 "NPC intracellular cholesterol transporter 2" P61916 14 74476192-74494177 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "epididymis: 982.9" "Cell type enhanced" "Detected in all" 7 "Alveolar cells type 2: 1546.9;Hofbauer cells: 2619.0;Kupffer cells: 1574.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 769.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 139.0;granulocytes: 44.2;monocytes: 112.5" "Cell line enhanced" "Detected in many" "ASC diff: 145.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000835, CAB032888" Enhanced "Secreted to blood" NA NA 63000000 "CAB032888: AB_2157036, HPA000835: AB_1079499" "unprognostic (1.27e-3)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.83e-5)" "unprognostic (1.17e-1)" "unprognostic (1.82e-2)" "unprognostic (3.72e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (6.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-3)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.97e-1)" "prognostic favorable (6.55e-4)" "unprognostic (1.42e-1)" 34.8 23.7 9.0 14.7 12.2 13.9 27.2 2.4 7.6 21.1 16.0 12.5 92.3 11.9 16.8 982.9 17.1 14.9 17.5 34.1 9.1 9.9 29.2 13.6 65.0 48.8 15.1 6.7 25.3 14.6 4.5 21.3 22.1 25.5 17.8 14.4 39.8 21.8 54.0 9.4 16.6 19.1 12.1 26.5 30.0 13.6 26.6 10.6 7.6 49.8 15.9 15.4 16.4 18.1 18.7 139.0 44.2 112.5 6.3 12.2 67.2 29.9 18.9 12.6 16.0 145.7 42.9 39.8 21.7 73.0 19.2 42.8 32.4 37.9 7.3 15.9 16.9 34.9 59.6 16.3 40.2 16.8 11.7 12.7 2.9 9.8 24.8 32.5 4.7 56.1 43.5 34.1 17.3 33.3 86.9 24.7 8.1 3.0 56.6 18.4 12.6 7.3 7.3 6.5 43.5 30.5 3.5 22.6 24.8 43.6 65.7 0.5 8.8 31.1 11.5 27.1 33.9 19.7 20.5 26.7 27.1 37.1 39.3 19.0 26.3 45.0 2.6 28.9 15.1 15.2 34.1 83.8 17.9 6.6 112.5 6.2 18.7 9.2 6.6 39.1 17.0 9.0 7.5 44.2 6.3 76.2 139.0 12.2 67.2 9.0 12.2 2.4 7.6 9.1 9.9 15.1 6.7 25.5 10.6 354.4 1546.9 199.4 441.4 332.9 6.2 41.4 180.9 202.1 410.6 314.0 21.6 204.0 258.6 495.5 43.7 268.3 275.4 46.7 246.5 603.6 321.0 334.4 324.3 159.5 2619.0 7.9 115.0 406.4 1574.1 41.8 524.7 1241.8 571.9 500.5 250.2 141.9 373.8 381.4 274.4 754.1 22.6 129.4 139.6 230.6 151.8 280.3 176.0 111.8 255.9 447.4 NPFF FMRFAL ENSG00000139574 "Neuropeptide FF-amide peptide precursor" O15130 12 53506690-53507638 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 28 "epididymis: 154.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "cerebellum: 2.0;hypothalamus: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HHSteC: 17.7" "Region enriched" "Detected in single" 7 "pons and medulla: 11.9" "Region enriched" "Detected in all" 7 "cerebellum: 143.2" "Secreted in male reproductive system" NA NA 0.3 0.1 0.1 0.1 0.3 0.0 0.1 2.0 0.1 0.5 0.2 0.1 1.1 0.2 0.1 154.7 0.1 0.2 0.1 0.1 0.1 1.4 0.1 0.1 0.5 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 5.5 0.2 0.1 1.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.7 0.2 0.8 0.2 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.3 0.1 2.0 0.4 0.0 0.8 0.3 0.0 0.3 0.2 0.5 2.0 0.1 0.0 0.2 0.0 0.7 0.2 2.4 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.0 0.1 0.1 1.4 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPFFR1 "GPR147, NPFF1R1, OT7T022" ENSG00000148734 "Neuropeptide FF receptor 1" Q9GZQ6 10 70247329-70283676 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 34.9" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 15.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in all" 5 "basal ganglia: 10.2;cerebellum: 34.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 4.8" "Group enriched" "Detected in some" 6 "basal ganglia: 16.1;hypothalamus: 7.3" "Low region specificity" "Detected in many" HPA037521 Uncertain NA NA "HPA037521: AB_2675520" "unprognostic (1.73e-3)" "unprognostic (7.29e-4)" "unprognostic (2.12e-1)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (8.66e-3)" "unprognostic (1.37e-1)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (3.51e-1)" "unprognostic (9.62e-2)" "unprognostic (6.78e-2)" "unprognostic (5.84e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" 0.6 0.5 1.9 1.8 10.2 1.3 0.9 34.9 2.6 0.9 0.6 2.6 0.0 0.8 1.0 1.2 0.4 1.6 0.6 0.4 2.7 4.1 0.5 0.5 1.3 2.5 2.2 4.1 0.8 0.3 0.9 0.4 0.4 4.7 0.6 0.8 5.4 0.4 1.1 1.0 1.0 0.8 0.4 4.0 1.0 1.4 4.7 2.0 0.0 0.6 0.0 1.4 0.6 0.7 1.0 1.2 2.4 2.2 1.3 0.6 2.6 1.1 0.8 0.9 0.7 0.8 1.3 0.7 0.3 0.4 0.3 0.3 1.3 2.3 0.8 0.7 1.0 0.4 1.0 2.2 1.2 0.7 0.7 0.9 1.1 1.0 1.0 0.8 0.8 1.3 0.7 1.1 0.5 0.8 0.9 0.9 1.0 0.9 0.9 0.5 0.9 0.7 0.9 0.8 1.9 0.3 0.9 0.8 0.5 0.8 0.8 0.8 0.8 0.8 1.2 0.4 0.8 0.5 0.6 1.0 0.9 4.8 0.8 1.0 0.7 0.8 0.5 0.6 0.9 0.7 2.4 2.2 0.4 0.5 0.7 0.5 0.5 0.5 0.4 1.2 1.0 0.6 0.6 1.9 1.3 0.4 0.9 0.4 2.6 1.9 10.2 34.9 2.6 2.7 4.1 2.2 4.1 4.7 2.0 0.0 1.3 0.0 1.2 1.4 0.7 0.8 2.5 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.1 1.0 1.0 2.3 0.0 0.1 0.0 0.0 0.0 0.3 1.1 0.6 1.1 0.0 0.0 0.0 15.1 0.1 0.0 0.4 0.0 1.5 0.0 1.4 0.2 0.4 1.8 0.9 0.0 0.0 0.8 NPFFR2 "GPR74, NPFF2, NPGPR" ENSG00000056291 "Neuropeptide FF receptor 2" Q9Y5X5 4 72031804-72148067 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.4;seminal vesicle: 10.1" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 7.3;Horizontal cells: 3.2;Muller glia cells: 4.8;Syncytiotrophoblasts: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "GAMG: 22.5;NTERA-2: 7.3;RPTEC TERT1: 9.5;SH-SY5Y: 11.2;U-2 OS: 11.2" "Region enriched" "Detected in single" 4 "olfactory region: 5.3" "Low region specificity" "Detected in many" HPA026825 Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "HPA026825: AB_10603123" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (6.07e-2)" "unprognostic (4.68e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.51e-1)" "unprognostic (2.40e-5)" "unprognostic (5.75e-2)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-1)" 0.9 0.2 5.5 0.7 2.6 0.2 1.4 0.2 3.5 0.5 0.5 0.0 0.0 0.5 0.1 2.8 0.3 0.8 0.4 0.4 0.9 2.9 0.6 0.2 0.2 0.6 0.5 4.0 0.3 1.2 0.1 1.0 4.6 1.5 3.2 0.9 1.4 0.3 10.1 0.3 0.7 0.5 0.2 0.6 0.5 0.4 1.6 0.0 15.4 1.2 0.0 0.6 2.5 0.7 0.6 0.3 2.3 0.3 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 11.2 0.0 0.0 0.0 1.6 0.0 0.0 1.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.2 1.1 0.8 0.3 0.3 0.2 0.1 5.5 2.6 0.2 3.5 0.9 2.9 0.5 4.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.4 0.1 0.0 0.0 0.2 7.3 1.0 0.0 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 8.1 0.0 0.0 0.0 NPHP1 "JBTS4, NPH1, SLSN1" ENSG00000144061 "Nephrocystin 1" O15259 2 110122311-110205066 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.7" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 172.6;Early spermatids: 98.9;Rod photoreceptor cells: 72.4;Spermatocytes: 129.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046093, HPA074071" Approved Uncertain Vesicles NA NA Vesicles "HPA046093: AB_2679535, HPA074071: " "unprognostic (2.10e-2)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (5.58e-2)" "unprognostic (4.63e-2)" "unprognostic (1.56e-3)" "unprognostic (4.66e-2)" "unprognostic (1.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.66e-2)" "unprognostic (1.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-3)" "unprognostic (3.35e-2)" "unprognostic (1.82e-1)" "unprognostic (8.64e-2)" 3.1 4.3 8.5 1.8 13.7 0.8 5.1 2.1 7.2 5.6 4.7 4.9 8.8 1.7 7.2 11.3 2.1 19.3 4.3 4.4 9.0 7.5 8.7 1.5 5.7 1.5 3.8 6.2 5.4 3.5 17.7 28.1 2.1 20.3 4.4 2.6 4.6 2.8 8.9 36.7 1.7 1.8 7.2 5.4 1.9 3.7 25.0 7.2 0.0 8.9 3.2 1.3 4.1 3.7 3.5 1.0 1.0 0.3 3.2 1.8 0.7 8.5 2.7 5.7 4.2 3.2 6.8 1.2 2.2 7.1 7.7 7.6 2.8 6.4 0.5 5.7 5.1 7.3 4.2 2.7 6.9 9.2 1.6 3.4 0.2 1.6 1.9 4.5 1.3 0.0 4.6 4.2 12.0 3.8 11.6 4.8 1.8 0.1 0.8 4.6 1.7 0.8 2.1 2.5 0.2 4.5 0.0 5.9 0.2 13.0 0.7 3.0 3.1 3.2 3.9 7.8 2.9 4.6 1.0 3.1 4.5 3.8 4.9 7.0 2.4 2.5 0.6 13.1 0.2 3.2 0.7 0.1 0.1 1.2 0.3 1.8 2.7 0.9 0.6 1.0 3.5 1.8 1.4 1.0 3.2 0.1 0.1 0.1 0.7 8.5 13.7 2.1 7.2 9.0 7.5 3.8 6.2 20.3 7.2 6.0 6.2 0.9 7.4 4.6 11.8 11.8 7.6 172.6 30.7 8.7 45.2 1.5 16.6 12.1 98.9 6.7 0.0 0.0 4.4 0.4 4.6 3.5 0.0 2.4 1.3 20.6 0.0 7.4 1.0 44.3 6.9 2.3 6.8 0.0 0.5 10.9 6.3 0.2 9.2 21.1 72.4 12.9 3.9 129.6 24.9 3.4 0.2 1.0 1.8 4.7 NPHP3-ACAD11 ENSG00000274810 "NPHP3-ACAD11 readthrough (NMD candidate)" 3 132558142-132722459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 6.0" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;granulocytes: 1.1;Rod photoreceptor cells: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.4" NA NA "unprognostic (1.50e-1)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.91e-1)" "unprognostic (2.45e-1)" "unprognostic (5.84e-2)" "unprognostic (2.07e-2)" "unprognostic (3.07e-1)" "unprognostic (2.38e-1)" "unprognostic (3.48e-1)" "unprognostic (3.63e-5)" "unprognostic (4.17e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-1)" "unprognostic (2.59e-2)" 2.1 0.4 0.0 0.6 1.7 1.2 0.5 1.2 0.0 2.5 0.0 0.2 0.8 0.3 0.0 0.0 0.2 1.7 0.4 6.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 3.5 0.0 0.0 0.0 0.6 0.1 0.8 0.0 0.3 0.0 0.6 0.7 1.0 1.1 0.1 2.0 0.0 1.5 0.0 2.6 0.4 1.8 10.4 1.6 2.9 2.6 0.5 1.2 0.0 0.9 0.5 1.3 2.8 3.6 0.4 0.3 0.8 1.5 0.0 0.6 0.0 0.0 1.8 1.0 0.0 3.5 4.8 1.7 0.6 1.5 5.9 0.0 0.8 0.4 0.9 0.7 0.0 0.0 1.1 0.5 1.9 0.0 0.0 2.0 0.5 0.2 0.0 0.3 2.4 2.0 0.3 3.0 2.3 0.5 1.6 5.4 3.2 2.4 1.4 0.0 1.6 0.0 0.5 3.3 0.0 2.0 0.3 0.0 1.0 0.1 1.1 0.1 0.6 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.1 0.0 0.7 2.0 0.0 3.0 0.6 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.1 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.5 NPHS1 "CNF, NPHN" ENSG00000161270 "NPHS1, nephrin" O60500 19 35825964-35869287 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Myogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 20.2;pancreas: 21.8" "Cell type enhanced" "Detected in some" 17 "Collecting duct cells: 3.5;Early spermatids: 9.6;Late spermatids: 4.7" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "A549: 1.1;HMC-1: 4.8;JURKAT: 3.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB035555 Enhanced NA NA "CAB035555: " "unprognostic (3.42e-2)" "unprognostic (1.53e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-2)" "unprognostic (1.65e-1)" "unprognostic (2.39e-2)" "unprognostic (6.47e-3)" "unprognostic (2.25e-2)" "unprognostic (1.58e-1)" "unprognostic (1.69e-1)" "unprognostic (3.32e-2)" "unprognostic (3.17e-1)" "unprognostic (3.83e-5)" "unprognostic (4.30e-2)" "unprognostic (4.38e-2)" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 3.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.9 0.0 0.0 0.1 0.1 2.4 0.0 0.1 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.7 1.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 9.6 0.0 0.0 0.0 2.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.0 0.8 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.5 0.0 0.0 0.7 0.5 0.4 0.4 0.0 0.0 0.0 0.3 NPHS2 "PDCN, SRN1" ENSG00000116218 "NPHS2, podocin" Q9NP85 1 179550539-179575952 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 143 "kidney: 66.5" "Group enriched" "Detected in some" 12 "Collecting duct cells: 19.2;Early spermatids: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "NTERA-2: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "CAB037267, HPA049486" Enhanced NA NA "CAB037267: AB_261982, HPA049486: AB_2680788" "unprognostic (6.77e-2)" "unprognostic (9.71e-2)" "unprognostic (1.86e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 NPIPA1 "morpheus, NPIP" ENSG00000183426 "Nuclear pore complex interacting protein family member A1" Q9UND3 16 14922802-14952060 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.1" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 54.9;Early spermatids: 43.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 16 "B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3" "Cell line enhanced" "Detected in many" "HHSteC: 34.1" HPA053611 Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (2.77e-2)" "unprognostic (1.25e-1)" "unprognostic (4.48e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-2)" "unprognostic (2.29e-2)" "unprognostic (9.21e-2)" "unprognostic (1.65e-2)" "unprognostic (5.12e-2)" "unprognostic (1.08e-1)" "unprognostic (8.82e-3)" "unprognostic (3.65e-2)" "unprognostic (1.74e-7)" "unprognostic (2.28e-1)" "unprognostic (8.76e-2)" "unprognostic (1.73e-2)" "unprognostic (2.66e-5)" 5.1 6.0 5.9 3.8 4.9 4.2 4.8 33.1 8.3 5.0 5.8 1.8 15.6 0.0 3.0 16.3 2.7 4.6 7.0 6.2 6.6 3.0 4.3 5.4 3.7 25.2 4.7 1.1 13.6 3.0 7.8 3.3 2.5 11.7 7.9 16.3 3.0 12.4 3.8 5.0 3.2 6.5 6.1 4.1 5.0 4.0 2.3 0.0 1.7 0.1 0.1 1.3 0.7 0.1 5.3 24.6 9.5 0.0 0.4 4.2 9.3 6.5 8.6 7.7 3.7 5.8 1.5 13.4 12.9 10.3 4.3 11.3 1.3 8.9 4.8 4.3 0.0 8.3 19.6 34.1 11.7 2.8 18.9 18.5 7.2 13.1 5.1 4.1 8.1 1.3 6.5 9.7 11.3 0.0 6.3 0.2 0.0 0.2 4.6 0.1 2.1 13.8 11.3 1.0 9.3 5.0 0.6 10.6 3.1 1.9 10.3 0.8 11.5 0.5 0.2 2.9 3.9 2.8 3.1 0.4 0.7 5.8 1.7 0.0 0.0 0.8 0.0 1.3 2.3 0.3 1.2 0.0 1.3 0.6 0.4 0.0 0.1 0.1 0.0 0.7 0.7 6.0 18.3 0.0 1.1 8.2 7.4 2.0 0.0 54.9 29.6 8.7 5.9 1.8 0.0 5.2 43.7 3.6 2.6 0.0 1.7 1.2 6.2 1.3 20.9 2.9 2.0 6.4 4.7 6.7 5.2 17.6 19.8 4.0 0.0 6.4 4.5 3.0 4.9 3.5 18.0 1.0 4.8 19.4 3.9 12.2 10.4 3.4 1.0 5.0 7.5 0.9 NPIPA2 ENSG00000254852 "Nuclear pore complex interacting protein family member A2" E9PIF3 16 14748066-14765413 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.8" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.5;Club cells: 3.4;granulocytes: 9.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 12.2;NB-4: 4.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" 1.6 1.2 1.3 1.1 1.5 0.9 1.8 11.8 3.8 0.6 3.2 0.6 1.7 2.7 1.1 2.4 0.8 1.3 1.8 1.5 0.6 0.5 1.6 0.9 1.0 2.6 1.2 2.3 4.1 1.1 2.2 2.6 3.1 1.0 4.2 4.1 1.0 0.8 1.3 0.9 1.6 5.9 1.2 0.8 3.3 1.5 1.6 0.0 0.1 0.1 0.0 0.5 0.0 0.4 0.4 0.3 0.0 0.4 0.3 12.2 1.0 0.5 0.1 0.3 0.4 1.7 0.0 1.1 0.9 0.2 1.4 0.3 0.0 0.1 1.0 0.7 0.8 1.0 0.2 0.4 0.2 2.9 0.1 1.6 1.6 1.2 0.1 0.3 1.6 0.8 0.8 0.2 2.4 1.3 4.1 0.8 0.0 0.5 1.3 0.8 0.2 0.7 0.6 1.1 0.6 0.4 0.7 1.7 1.8 0.0 1.0 0.9 0.4 0.3 0.0 0.5 0.4 0.3 0.3 1.5 0.7 1.0 0.1 0.1 0.0 0.5 0.0 0.3 0.7 0.5 0.1 0.0 1.6 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.5 0.0 0.0 2.1 0.0 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 NPIPA3 ENSG00000224712 "Nuclear pore complex interacting protein family member A3" F8WFD2 16 14708944-14726338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 13.2" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 3.0;Cardiomyocytes: 4.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 5.0;hTERT-RPE1: 7.1;NB-4: 11.2;SK-MEL-30: 16.1" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.44e-1)" "unprognostic (7.83e-3)" "unprognostic (8.12e-3)" "unprognostic (1.87e-1)" "unprognostic (1.60e-1)" "unprognostic (5.69e-3)" "unprognostic (3.11e-2)" "unprognostic (4.58e-3)" "unprognostic (4.87e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (2.04e-1)" "unprognostic (1.67e-3)" "unprognostic (1.20e-3)" "unprognostic (1.35e-1)" "unprognostic (1.79e-2)" "unprognostic (1.71e-2)" 1.3 1.4 1.8 2.3 1.3 1.9 1.2 13.2 5.0 0.8 2.9 0.5 2.4 2.2 1.1 2.8 6.4 1.0 2.2 1.8 1.1 0.8 1.2 1.0 1.1 2.8 1.5 7.2 4.1 1.3 2.3 2.6 1.9 2.9 5.3 3.2 3.4 1.2 1.0 1.0 1.3 1.8 1.4 1.0 1.9 1.6 0.1 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.3 0.0 0.1 1.5 0.5 0.0 0.4 0.4 0.0 2.1 3.5 0.2 1.3 0.8 0.1 0.1 2.3 0.3 0.1 0.0 0.4 0.7 0.4 0.2 0.1 0.5 5.0 0.7 1.3 0.2 7.1 0.1 0.7 0.1 0.3 0.3 1.3 0.0 11.2 0.9 0.0 0.0 0.1 0.0 0.0 3.1 1.0 0.5 0.5 0.0 0.2 16.1 0.7 0.2 0.0 0.5 0.6 0.1 0.0 0.1 0.0 0.2 0.1 1.9 0.1 2.0 1.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.5 0.0 4.1 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 1.2 0.0 0.3 0.2 0.6 0.0 0.0 0.0 0.6 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.5 0.0 NPIPA5 ENSG00000183793 "Nuclear pore complex interacting protein family member A5" E9PKD4 16 15363624-15381047 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 25.3" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Early spermatids: 15.7;granulocytes: 10.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "THP-1: 15.7" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (1.94e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (4.19e-4)" "unprognostic (5.85e-2)" "unprognostic (5.92e-2)" "unprognostic (7.85e-2)" "unprognostic (6.58e-2)" "unprognostic (9.02e-3)" "unprognostic (1.57e-2)" "unprognostic (4.34e-3)" "unprognostic (1.85e-1)" "unprognostic (2.85e-1)" "unprognostic (9.18e-2)" "unprognostic (4.02e-2)" 2.0 2.7 4.9 0.8 4.0 3.2 3.3 25.3 6.6 3.2 4.5 2.4 8.0 8.4 4.0 5.8 4.8 4.2 5.5 5.7 1.9 2.5 4.5 2.4 3.6 5.5 4.0 7.6 8.9 1.0 3.3 2.4 1.6 2.5 4.6 13.9 2.1 2.6 2.5 2.7 2.3 8.8 2.9 1.0 2.8 2.5 0.8 0.3 0.1 0.1 1.1 0.7 0.1 0.9 1.4 4.9 0.7 9.3 9.9 0.7 1.9 4.6 6.4 6.6 2.0 0.8 2.1 0.5 4.9 2.0 2.1 1.7 4.9 3.3 3.9 1.9 2.6 5.9 9.8 1.4 0.7 3.7 1.9 8.5 2.5 3.4 2.9 3.4 7.7 2.8 1.5 6.2 1.0 2.1 3.2 6.9 4.0 0.9 0.7 0.7 0.6 5.5 1.9 0.0 0.7 5.5 2.4 6.1 0.6 2.4 15.7 7.8 0.0 2.5 7.6 0.4 4.3 6.0 7.3 0.9 3.8 1.4 0.1 0.1 0.0 0.1 0.0 0.7 0.8 0.4 0.2 0.3 0.4 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 0.0 3.0 0.0 0.2 4.2 1.7 2.8 0.0 13.4 3.4 1.8 0.0 0.5 0.0 0.1 15.7 2.1 0.3 0.0 0.2 0.2 7.3 0.3 10.5 1.0 0.3 1.6 0.0 1.3 1.5 2.2 1.4 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 2.7 0.0 5.7 3.9 0.9 4.0 0.2 0.0 0.0 0.1 NPIPA8 LCR16a9 ENSG00000214940 "Nuclear pore complex interacting protein family member A8" P0DM63 16 18317942-18336736 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell type enhanced" "Detected in single" 28 "granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 18.2;EFO-21: 18.3;HMC-1: 67.5;SCLC-21H: 16.5;THP-1: 18.2" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (1.68e-1)" "unprognostic (3.60e-2)" "unprognostic (2.81e-1)" 2.6 7.9 2.0 1.3 2.8 3.9 2.3 14.1 10.8 1.4 5.5 0.0 0.6 0.0 0.9 5.1 0.0 2.6 3.4 1.9 1.1 1.0 2.4 1.5 0.5 6.0 1.1 7.6 6.6 4.8 2.3 1.3 1.5 6.5 1.5 4.6 1.7 0.0 0.2 4.4 1.4 2.1 1.6 0.0 3.8 0.5 1.8 0.5 1.7 0.6 0.1 1.1 0.3 0.0 0.7 0.1 0.1 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.1 3.2 18.2 18.3 0.1 0.0 0.0 7.2 2.1 0.0 0.0 0.0 0.0 0.5 0.5 3.0 0.0 67.5 0.1 0.0 0.0 0.0 0.0 1.3 4.4 7.1 0.0 0.0 0.0 0.0 0.0 5.0 7.4 0.0 0.7 11.2 0.5 0.1 0.0 16.5 5.2 0.0 0.1 0.1 3.6 0.0 18.2 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 5.8 5.0 0.4 0.0 0.6 0.0 0.6 0.0 1.1 1.8 0.5 0.2 0.3 0.2 0.7 0.4 1.7 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 NPIPB15 "LOC440348, NPIPL2" ENSG00000196436 "Nuclear pore complex interacting protein family member B15" A6NHN6 16 74377878-74392080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 18.6" "Group enriched" "Detected in many" 8 "Early spermatids: 335.7;Late spermatids: 195.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "memory B-cell: 4.0" "Lineage enriched" "Detected in single" 5 "B-cells: 4.0" "Cell line enhanced" "Detected in many" "T-47d: 13.5" "HPA011188, HPA053611" Supported Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (2.23e-2)" "unprognostic (3.48e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-1)" "unprognostic (9.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.56e-2)" "unprognostic (5.53e-2)" "unprognostic (2.41e-2)" "unprognostic (7.73e-2)" "unprognostic (4.58e-3)" "unprognostic (1.53e-1)" "unprognostic (2.81e-2)" "unprognostic (1.97e-1)" "unprognostic (7.34e-3)" "unprognostic (2.53e-1)" "unprognostic (1.14e-3)" 1.8 1.2 0.8 0.5 1.3 2.9 3.8 4.5 1.5 2.1 6.2 4.1 1.1 0.0 3.0 2.1 2.1 1.1 1.1 0.8 3.1 8.4 2.4 2.6 0.8 1.8 6.1 4.4 5.2 2.7 7.1 11.2 6.1 1.1 3.0 4.1 5.3 1.5 0.9 3.1 4.3 18.6 4.4 2.2 1.4 1.8 4.0 0.2 0.8 0.3 0.6 0.6 0.5 2.8 0.1 2.7 1.6 3.3 2.3 0.6 1.9 2.6 2.1 5.9 1.6 0.1 4.7 0.0 3.7 0.0 5.3 0.0 2.2 1.7 0.0 3.0 0.1 6.2 2.7 1.5 1.9 9.5 3.2 4.8 4.3 3.3 3.2 0.0 0.1 0.4 1.9 1.8 4.3 1.0 0.0 0.6 1.4 0.0 1.0 2.7 3.1 0.0 1.8 3.8 0.0 7.0 0.0 4.5 0.0 13.5 2.2 0.2 2.0 5.6 0.0 1.0 6.5 1.8 1.1 2.7 1.3 1.4 0.0 0.3 0.2 0.6 0.0 0.0 4.0 0.2 0.6 0.2 0.7 0.2 0.0 0.8 0.6 0.1 0.1 0.0 0.5 3.0 5.1 3.7 1.6 1.8 2.8 1.1 7.6 4.0 7.9 7.0 7.9 1.0 0.0 1.2 335.7 2.9 12.4 0.0 3.3 0.9 3.4 5.9 0.0 2.1 1.0 0.0 16.8 3.1 4.0 195.5 10.6 1.2 3.3 1.0 35.4 1.1 2.1 28.1 7.1 0.5 1.7 0.0 2.8 7.2 5.3 2.4 2.1 4.5 15.8 5.5 NPIPB4 ENSG00000185864 "Nuclear pore complex interacting protein family member B4" C9JG80 16 21834569-21880827 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skin 1: 31.2" "Cell type enriched" "Detected in many" 7 "Early spermatids: 92.2" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA053611 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA053611: AB_2682206" "unprognostic (3.09e-3)" "unprognostic (3.51e-3)" "unprognostic (4.01e-2)" "unprognostic (1.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-3)" "unprognostic (2.03e-1)" "unprognostic (1.35e-1)" "unprognostic (6.82e-2)" "unprognostic (3.66e-1)" "unprognostic (1.76e-1)" "unprognostic (4.05e-3)" "unprognostic (6.04e-8)" "unprognostic (3.37e-1)" "unprognostic (7.78e-2)" "unprognostic (2.32e-1)" "unprognostic (5.46e-3)" 5.5 3.7 4.4 7.0 4.6 23.5 6.1 10.4 5.4 5.1 6.5 4.5 5.4 22.4 4.5 5.7 4.9 4.2 5.0 4.0 5.4 6.6 6.0 10.7 3.8 5.9 5.3 3.3 5.4 3.8 6.6 8.2 5.5 3.2 7.1 31.2 8.6 3.5 4.4 10.1 7.3 4.3 7.9 7.5 4.1 5.4 6.3 3.7 4.7 2.5 5.2 2.3 0.3 7.1 9.7 9.3 7.3 6.7 9.7 15.7 8.8 2.7 3.0 4.9 20.6 10.2 13.8 6.8 7.6 2.8 8.2 5.2 7.4 6.0 5.6 4.7 5.5 24.8 27.2 4.5 22.6 14.6 7.2 9.2 8.0 13.3 6.1 6.5 11.3 11.8 12.2 4.5 20.9 8.5 14.2 11.3 2.3 5.4 13.0 5.6 8.0 3.4 7.1 9.4 5.7 5.9 6.8 4.8 9.3 9.0 6.8 14.2 16.0 8.0 7.6 7.6 6.3 5.8 14.7 5.0 10.8 7.4 4.7 2.5 0.7 1.8 1.0 1.3 2.2 2.3 1.1 0.4 6.3 1.8 1.9 3.0 5.2 1.2 3.7 0.6 0.3 3.0 12.6 2.0 1.0 6.8 4.7 1.5 0.0 6.7 10.3 0.0 3.9 0.4 0.0 0.9 92.2 4.2 1.1 0.0 0.5 0.2 5.9 0.4 10.4 1.0 0.6 1.6 1.2 1.8 0.8 13.6 0.3 3.0 0.0 2.8 1.1 1.9 1.2 2.3 0.4 0.0 7.1 0.0 2.9 1.6 0.5 7.3 0.7 2.2 1.7 0.5 NPIPB6 ENSG00000198156 "Nuclear pore complex interacting protein family member B6" E9PJ23 16 28342555-28363508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 26.8" "Group enriched" "Detected in some" 15 "Early spermatids: 188.9;Late spermatids: 89.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 3.1;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "Cell line enhanced" "Detected in many" "A549: 6.0;BEWO: 5.6;hTCEpi: 5.8;NB-4: 5.8;RPMI-8226: 6.0" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (7.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.86e-2)" "unprognostic (2.43e-1)" "unprognostic (3.21e-1)" "unprognostic (1.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.31e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" "unprognostic (6.79e-4)" "unprognostic (3.20e-1)" "unprognostic (8.36e-2)" "unprognostic (4.78e-1)" "unprognostic (1.04e-3)" 0.2 0.0 0.9 0.3 1.4 0.5 0.6 1.8 0.9 0.4 0.5 0.3 0.7 1.0 0.1 0.9 0.1 0.1 1.1 0.7 0.1 0.1 0.2 0.4 0.7 1.2 0.2 0.4 0.9 0.2 0.7 0.6 0.2 0.5 0.6 1.8 0.3 0.4 0.9 0.6 0.6 26.8 0.6 0.2 0.2 0.3 3.1 0.1 0.1 0.0 0.1 0.6 0.5 0.2 6.0 2.9 0.6 1.4 0.3 5.6 0.3 0.5 0.1 0.5 0.2 2.4 1.9 0.5 0.2 0.6 0.7 0.3 0.5 0.3 1.3 0.5 1.4 1.1 0.0 0.0 1.7 0.4 1.0 5.8 0.4 1.3 1.0 0.1 3.2 0.2 4.8 0.0 1.4 0.5 5.8 1.6 0.5 0.3 3.1 2.5 6.0 0.1 0.1 0.7 1.3 0.2 0.3 0.6 3.4 1.2 0.4 0.6 0.7 2.3 0.5 0.4 2.2 2.3 0.7 0.2 0.9 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.1 0.6 0.5 0.0 1.8 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.6 0.0 0.2 0.5 0.3 0.4 0.0 9.4 1.2 0.0 0.0 0.5 0.0 0.0 188.9 0.1 0.2 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 89.0 1.1 0.1 0.0 0.0 0.1 1.0 0.1 0.3 1.8 0.0 0.1 0.0 0.0 4.4 1.1 1.1 1.1 0.0 0.5 0.4 NPIPB7 "LOC440350, NPIPL1" ENSG00000233232 "Nuclear pore complex interacting protein family member B7" O75200 16 28456372-28471175 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 14.9" "Cell type enriched" "Detected in some" 6 "Early spermatids: 117.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 6.2;hTCEpi: 2.5;U-266/70: 1.6" "HPA011188, HPA053611" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (1.94e-1)" "unprognostic (7.43e-2)" "unprognostic (3.07e-3)" "unprognostic (3.35e-2)" "unprognostic (3.44e-1)" "unprognostic (2.78e-2)" "unprognostic (3.62e-2)" "unprognostic (3.04e-2)" "unprognostic (4.40e-1)" "unprognostic (2.22e-1)" "unprognostic (7.73e-2)" "unprognostic (2.03e-2)" 0.0 0.0 0.5 0.2 0.9 0.1 0.1 2.3 0.5 0.1 0.3 0.3 0.3 0.3 0.0 0.2 0.1 0.1 0.5 0.8 0.0 0.0 0.2 0.4 0.3 0.5 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.8 0.2 0.1 0.2 0.1 0.1 14.9 0.4 0.1 0.1 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 6.2 0.0 0.2 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.5 0.4 0.2 0.1 0.0 1.2 0.0 0.1 0.0 0.9 0.1 1.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.4 0.1 0.0 1.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 117.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 NPIPB8 ENSG00000255524 "Nuclear pore complex interacting protein family member B8" E9PQR5 16 28637654-28658682 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 14.4" "Group enriched" "Detected in some" 12 "Early spermatids: 12.1;Late spermatids: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "hTCEpi: 22.2" "HPA011188, HPA053611" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (8.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.10e-1)" "unprognostic (5.78e-2)" "unprognostic (1.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" 0.4 0.7 0.0 0.6 0.3 0.5 0.5 1.6 0.4 0.3 0.9 2.2 0.6 0.7 0.5 0.3 0.1 0.1 0.1 0.0 0.3 1.1 0.6 0.3 0.1 1.1 1.1 0.1 1.3 0.2 1.1 0.4 1.3 0.4 0.9 0.7 2.2 0.2 0.1 0.6 0.7 14.4 1.0 0.4 0.5 0.6 0.6 0.3 0.1 0.1 0.5 0.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.6 0.3 22.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPIPB9 ENSG00000196993 "Nuclear pore complex interacting protein family member B9" F8W1W9 16 28751787-28772807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "testis: 13.6" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 8.0;U-266/70: 6.7" "HPA011188, HPA053611" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA011188: AB_2668455, HPA053611: AB_2682206" "unprognostic (7.38e-2)" "unprognostic (6.63e-4)" "unprognostic (6.63e-2)" "unprognostic (5.05e-2)" "unprognostic (5.53e-2)" "unprognostic (4.44e-2)" "unprognostic (1.53e-1)" "unprognostic (9.36e-2)" "unprognostic (7.52e-2)" "unprognostic (2.84e-1)" "unprognostic (2.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.71e-2)" 0.6 0.3 1.7 0.9 1.8 1.6 0.4 2.7 1.4 0.4 1.0 0.0 1.1 2.4 0.4 1.5 0.6 0.2 2.2 1.3 0.4 0.4 0.4 1.5 1.7 1.4 0.2 0.5 1.4 0.4 1.2 0.8 0.9 0.9 1.1 2.8 0.8 0.8 2.2 1.1 0.5 13.6 1.7 1.0 0.3 0.7 3.1 0.1 0.5 0.2 1.8 0.7 0.3 0.4 4.0 1.1 0.6 0.5 1.3 3.3 0.0 0.1 0.0 0.0 0.4 2.1 1.6 1.1 0.0 0.5 0.4 0.7 0.2 0.1 0.4 1.9 0.7 0.0 0.8 0.1 2.5 2.7 0.2 8.0 0.6 1.5 0.8 0.0 2.9 0.4 2.5 0.2 3.0 0.9 3.3 1.6 0.2 0.9 3.3 0.0 1.6 0.0 0.4 0.1 0.0 0.2 0.4 0.2 2.2 2.2 1.1 0.0 0.0 2.8 1.9 0.6 6.7 2.9 2.0 0.1 0.9 0.5 0.0 0.2 0.0 0.7 0.0 0.2 3.1 0.4 0.1 0.1 1.2 0.3 0.1 0.5 1.8 0.2 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.0 NPL "C1orf13, DHDPS1, NPL1" ENSG00000135838 "N-acetylneuraminate pyruvate lyase" Q9BXD5 1 182789293-182830384 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.0" "Cell type enhanced" "Detected in many" 18 "Cytotrophoblasts: 103.5;Hofbauer cells: 387.9;Ito cells: 109.2;Kupffer cells: 121.2;Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.0" "Group enriched" "Detected in many" 36 "granulocytes: 76.0;monocytes: 23.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028345, HPA075808" Enhanced Approved "Vesicles,Plasma membrane" NA NA 190000 Vesicles "Plasma membrane" "HPA028345: AB_10610145, HPA075808: " "unprognostic (2.43e-2)" "unprognostic (5.71e-3)" "unprognostic (1.72e-2)" "unprognostic (1.06e-1)" "unprognostic (1.57e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (4.41e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.49e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.93e-2)" "unprognostic (2.35e-2)" "unprognostic (7.44e-2)" 14.9 6.8 10.9 14.2 12.3 12.4 5.3 3.5 10.2 3.9 5.3 15.0 11.4 2.4 2.5 23.7 8.0 4.1 10.1 4.7 9.2 8.7 37.4 15.4 14.3 20.4 16.0 8.6 2.8 3.2 2.5 2.5 32.9 15.4 4.4 7.4 3.9 5.7 5.8 2.4 6.5 4.8 5.8 15.3 32.1 4.0 4.0 14.4 3.1 3.4 1.3 10.9 11.8 5.5 0.7 1.3 76.0 23.6 0.0 1.3 10.3 2.7 0.5 0.8 0.0 2.4 2.4 0.7 0.9 1.8 1.0 0.5 0.0 1.2 7.3 1.3 0.0 0.0 1.1 1.6 2.0 0.2 0.0 1.2 11.6 0.3 0.1 1.3 4.4 7.0 1.9 7.8 0.2 0.0 0.1 0.1 8.5 8.7 11.7 1.8 0.9 0.2 2.9 9.3 5.7 0.9 1.1 0.6 8.9 0.2 6.1 2.6 3.9 4.2 0.2 3.7 0.9 2.4 7.1 0.2 1.0 2.0 0.6 0.1 8.4 10.1 7.4 2.1 7.8 3.0 3.6 23.6 18.0 1.0 20.8 0.9 0.3 0.8 0.9 1.3 0.7 0.7 0.9 76.0 0.0 16.0 0.2 1.3 10.3 10.9 12.3 3.5 10.2 9.2 8.7 16.0 8.6 15.4 14.4 0.0 5.6 9.1 4.0 5.5 5.1 2.5 2.5 0.0 1.2 7.0 2.0 103.5 16.6 1.0 14.0 2.1 1.3 23.3 2.1 6.6 3.3 1.2 5.7 2.4 387.9 6.4 1.7 109.2 121.2 20.9 0.9 25.3 10.1 21.6 1.1 2.4 1.4 0.0 0.4 55.2 2.4 0.0 2.9 8.6 8.3 6.1 89.7 3.5 0.8 3.9 NPLOC4 "FLJ20657, KIAA1499, NPL4" ENSG00000182446 "NPL4 homolog, ubiquitin recognition factor" Q8TAT6 17 81556887-81648465 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021560, HPA023295" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA021560: AB_1854586, HPA023295: AB_1854587" "unprognostic (3.17e-1)" "unprognostic (2.98e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-3)" "unprognostic (8.72e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.16e-5)" "unprognostic (1.06e-2)" "unprognostic (4.42e-1)" "unprognostic (2.97e-1)" "unprognostic (4.15e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.95e-7)" "unprognostic (1.01e-1)" "unprognostic (6.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.72e-1)" 21.7 23.0 15.3 18.7 16.1 22.0 15.4 14.7 24.1 13.2 15.9 18.6 14.2 14.7 18.9 16.3 25.1 14.7 14.4 35.4 16.2 13.5 20.2 28.2 18.4 18.3 16.4 15.5 13.9 18.2 17.8 17.1 25.6 17.2 16.7 13.3 21.0 16.4 14.9 89.8 24.2 16.4 19.4 14.9 22.0 17.6 31.0 13.4 19.7 14.7 17.1 20.6 15.7 16.6 4.6 5.9 5.7 18.1 2.5 4.6 7.8 29.0 38.3 15.3 23.8 18.9 15.7 19.0 24.1 26.9 40.1 37.2 29.0 26.3 21.6 19.4 28.1 29.4 23.6 15.0 20.2 34.9 13.5 19.8 25.0 31.0 25.7 18.1 26.3 31.9 15.5 19.6 37.4 13.4 19.4 40.9 20.2 26.3 32.9 24.2 18.8 35.4 14.3 17.9 14.5 24.2 23.4 24.6 17.6 14.4 28.1 20.5 23.7 30.3 42.3 27.3 30.5 33.1 19.4 29.2 52.7 36.6 28.6 38.6 25.1 17.7 26.6 42.0 17.7 33.8 3.0 18.1 3.9 4.6 4.6 2.8 4.6 3.2 3.6 5.9 3.7 2.9 3.8 5.7 2.5 2.8 4.6 3.0 7.8 15.3 16.1 14.7 24.1 16.2 13.5 16.4 15.5 17.2 13.4 11.9 17.8 16.0 14.4 15.7 22.7 39.6 12.7 8.1 18.2 19.2 27.5 16.5 1.7 17.6 91.1 20.1 26.2 46.7 32.2 17.3 15.5 19.7 3.5 46.4 16.9 19.1 29.2 29.4 24.0 71.7 16.4 19.3 11.8 19.8 15.0 18.4 36.6 20.1 12.0 20.4 35.3 19.4 16.4 22.3 23.3 21.1 31.0 15.0 15.3 23.7 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 28.1;Cone photoreceptor cells: 19.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 4.1;T-cells: 2.2" "Cell line enhanced" "Detected in many" "HaCaT: 13.3;HEL: 10.7;Hep G2: 23.7;JURKAT: 7.2;THP-1: 8.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041070: AB_2677285" "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favorable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favorable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.8 15.6 14.4 0.5 11.4 1.3 2.3 20.4 27.6 1.9 1.4 0.8 0.3 2.4 4.9 1.3 1.4 2.8 2.2 1.5 13.0 13.8 2.9 1.3 2.0 1.0 14.9 15.7 0.8 7.4 40.2 7.8 0.9 7.2 4.7 1.4 3.7 3.1 1.8 0.8 2.0 1.4 4.0 3.0 7.5 2.0 3.1 2.4 0.1 23.2 0.0 0.8 1.4 0.8 0.4 0.0 4.1 0.0 0.0 2.2 0.1 2.9 0.4 0.1 0.2 0.7 0.0 1.2 0.3 0.4 1.9 3.8 1.2 2.8 0.0 0.9 0.0 0.2 13.3 0.3 0.0 1.1 0.1 0.3 10.7 0.7 23.7 2.4 1.4 1.0 0.4 1.8 0.0 0.2 2.9 0.0 7.2 0.3 0.0 0.1 0.0 0.1 2.8 0.6 4.7 0.3 0.2 1.0 0.6 4.4 0.0 2.9 0.2 0.0 0.0 3.5 0.0 0.5 8.4 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.9 0.0 2.2 0.0 0.9 2.1 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.1 14.4 11.4 20.4 27.6 13.0 13.8 14.9 15.7 7.2 2.4 0.0 1.4 0.5 8.2 0.1 28.1 2.0 2.5 9.4 11.4 0.0 19.6 0.1 3.3 6.3 15.2 0.3 0.4 0.0 7.0 0.2 0.4 3.3 0.0 0.4 3.5 6.4 10.9 2.5 0.0 10.4 0.6 1.2 10.1 1.8 1.5 0.9 5.4 0.0 0.4 9.8 3.9 0.0 1.4 0.5 0.3 1.0 0.2 4.3 0.6 5.8 NPNT "EGFL6L, POEM" ENSG00000168743 Nephronectin Q6UXI9 4 105894775-106004027 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 125.3" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 104.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003711, HPA050203" Supported Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cell Junctions, Cytosol" "HPA003711: AB_1854591, HPA050203: AB_2681050" "unprognostic (1.24e-1)" "unprognostic (7.93e-2)" "unprognostic (1.59e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-1)" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (7.85e-3)" "unprognostic (4.78e-4)" "unprognostic (1.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "prognostic favorable (8.28e-8)" "unprognostic (4.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (2.31e-2)" 5.4 1.6 3.4 2.4 4.4 0.0 8.3 0.7 2.5 13.3 11.0 1.9 4.2 16.4 8.7 11.4 5.7 5.9 19.0 2.5 2.5 2.7 22.7 1.3 34.9 0.9 7.5 2.4 4.1 11.6 0.0 14.6 3.0 2.2 26.3 7.6 16.9 2.8 5.7 2.6 2.1 37.7 4.0 0.9 4.4 4.0 3.0 2.8 3.4 125.3 3.7 2.3 3.7 6.2 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 15.2 0.1 0.0 0.0 0.0 7.6 9.9 0.1 0.4 0.1 0.0 0.9 3.8 0.0 0.0 0.0 3.9 0.4 17.2 13.7 0.0 0.0 0.1 1.7 1.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 12.2 0.2 0.7 0.1 0.0 6.2 0.0 0.0 0.1 20.0 0.8 0.9 0.3 0.9 7.4 0.0 2.3 26.8 0.6 0.0 0.3 0.2 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.4 0.7 2.5 2.5 2.7 7.5 2.4 2.2 2.8 172.7 69.4 0.0 4.6 1.6 0.2 2.0 33.1 10.7 97.8 31.4 0.0 2.2 1.7 19.0 11.6 8.0 8.0 0.0 2.1 0.1 0.9 29.6 0.0 0.0 0.3 0.0 15.0 3.1 0.0 11.8 2.3 1.3 5.0 0.0 9.2 0.0 6.3 3.1 0.0 3.0 0.1 0.0 33.5 0.5 1.5 1.0 1.3 0.0 6.9 2.8 NPPA "ANP, PND" ENSG00000175206 "Natriuretic peptide A" P01160 1 11845709-11848345 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hormone, Vasoactive, Vasodilator" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 418 "heart muscle: 1267.7" "Cell type enriched" "Detected in some" 14450 "Cardiomyocytes: 19644.9" "Cancer enriched" "Detected in some" 9 "glioma: 7.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.5;SH-SY5Y: 12.0" "Region enriched" "Detected in some" 8 "olfactory region: 28.1" "Not detected" "Not detected" "HPA058269, HPA064007" Enhanced "Secreted to blood" NA NA 190000 "HPA058269: AB_2683660, HPA064007: " "unprognostic (1.27e-3)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-1)" "unprognostic (2.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.48e-1)" "unprognostic (3.25e-2)" "unprognostic (9.72e-3)" "unprognostic (2.21e-1)" "unprognostic (5.93e-4)" "unprognostic (2.31e-1)" "unprognostic (1.59e-1)" "unprognostic (1.20e-1)" "unprognostic (6.70e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 1267.7 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.0 0.3 0.8 0.0 0.5 3.0 1.1 1.7 2.6 2.1 0.0 0.0 1.6 0.9 0.0 0.0 0.0 6.7 2.7 4.3 0.3 0.0 1.5 4.0 0.0 0.0 0.0 1.0 2.6 2.7 1.5 6.6 0.0 1.4 4.6 0.0 0.0 0.0 0.0 0.6 0.0 1.2 5.9 5.1 0.0 0.9 0.5 7.7 1.9 0.1 0.7 0.6 0.8 0.8 0.0 1.8 12.5 12.0 0.7 0.0 2.2 1.2 1.6 0.2 0.4 2.1 4.3 3.4 0.3 1.3 3.2 4.9 0.3 3.5 1.1 0.0 0.4 0.0 0.1 0.8 0.4 1.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.5 0.0 0.0 3.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19644.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPPB ENSG00000120937 "Natriuretic peptide B" P16860 1 11857464-11858931 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Hormone, Vasoactive" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 296 "heart muscle: 348.6" "Group enriched" "Detected in some" 14 "Cardiomyocytes: 146.6;Ductal cells: 75.3;Pancreatic endocrine cells: 62.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 34.0;CACO-2: 88.4;SuSa: 17.8" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 9680 "unprognostic (3.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.49e-1)" "unprognostic (4.23e-1)" "unprognostic (3.28e-2)" 0.1 0.0 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 348.6 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.9 0.5 0.4 0.7 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 34.0 0.0 0.0 0.5 0.2 88.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.3 0.8 0.4 1.0 1.0 0.6 1.0 0.5 0.5 1.1 1.1 0.0 0.7 0.3 0.9 0.7 0.9 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 146.6 0.0 1.4 0.0 0.0 0.0 3.3 0.0 75.3 0.0 0.0 0.0 0.0 6.9 1.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 62.5 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 NPPC CNP ENSG00000163273 "Natriuretic peptide C" P23582 2 231921820-231926403 "Predicted secreted proteins, Transporters" Osteogenesis "Hormone, Vasoactive" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 34.2;retina: 24.7" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 28.5;Collecting duct cells: 10.4;Cone photoreceptor cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "HEK 293: 7.9;NTERA-2: 3.7;SCLC-21H: 5.2;SK-MEL-30: 22.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 33.4" HPA035362 Uncertain "Secreted to blood" NA NA 6140 "HPA035362: AB_10671103" "unprognostic (9.70e-2)" "unprognostic (4.45e-2)" "unprognostic (1.99e-1)" "unprognostic (1.06e-2)" "unprognostic (5.67e-3)" "unprognostic (1.52e-1)" "unprognostic (2.83e-1)" "unprognostic (3.22e-3)" "unprognostic (9.81e-3)" "unprognostic (9.16e-2)" "unprognostic (2.10e-2)" "unprognostic (4.06e-2)" "unprognostic (1.17e-1)" "unprognostic (6.58e-2)" "unprognostic (1.18e-1)" "unprognostic (3.72e-1)" "unprognostic (1.91e-1)" 1.4 0.9 4.1 6.3 4.4 4.5 1.4 5.4 12.0 3.0 5.0 2.9 0.7 0.9 1.6 34.2 7.3 1.8 0.6 3.9 6.9 6.3 0.9 0.5 0.8 4.5 2.8 2.2 1.8 0.5 0.5 3.8 1.1 12.4 13.1 1.3 24.7 4.4 2.0 2.4 0.8 1.6 2.2 13.3 1.7 4.3 1.0 0.9 13.7 2.1 9.3 6.0 0.5 0.6 0.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.9 0.0 3.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 5.2 0.3 0.2 0.2 22.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.1 4.4 5.4 12.0 6.9 6.3 2.8 2.2 12.4 0.9 0.0 0.0 0.0 28.5 3.1 1.1 1.6 0.0 0.0 0.0 10.4 9.8 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.3 0.3 1.7 0.0 1.3 5.8 0.6 2.5 0.0 0.0 3.7 0.0 0.9 0.3 3.4 1.0 0.2 0.0 0.6 2.6 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell type enriched" "Detected in many" 10 "Ito cells: 136.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "ASC diff: 60.5" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in single" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favorable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 60.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 10.0 0.0 7.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 0.0 5.8 0.0 0.4 1.3 0.0 4.8 5.1 0.0 0.0 14.0 0.0 0.1 0.0 0.6 8.0 14.2 0.0 0.0 0.0 0.9 3.9 0.4 0.0 1.5 0.2 0.0 0.0 136.2 6.0 7.9 9.5 0.0 0.0 9.0 0.0 0.0 0.7 0.0 3.9 2.8 0.0 0.0 0.9 0.2 0.1 0.9 0.6 0.0 0.0 0.0 NPR2 "AMDM, ANPb, ANPRB, GUCY2B, NPRB" ENSG00000159899 "Natriuretic peptide receptor 2" P20594 9 35792154-35809732 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "cGMP biosynthesis, Osteogenesis" "Lyase, Receptor" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.7" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 8.6;Muller glia cells: 8.2;Peritubular cells: 7.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 6 "dendritic cells: 3.1;T-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC diff: 27.6;ASC TERT1: 20.6;BJ hTERT+: 16.8;HSkMC: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.93e-2)" "unprognostic (8.22e-3)" "unprognostic (9.25e-3)" "unprognostic (3.59e-2)" "unprognostic (6.13e-2)" "unprognostic (2.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.56e-1)" "unprognostic (1.56e-1)" "unprognostic (2.40e-1)" "unprognostic (3.06e-1)" "unprognostic (1.49e-1)" "unprognostic (3.99e-2)" "unprognostic (6.99e-3)" "unprognostic (7.10e-2)" "unprognostic (3.24e-1)" "unprognostic (7.86e-2)" 9.0 4.8 3.8 1.9 6.4 0.0 7.2 32.7 11.2 29.2 7.8 1.8 4.4 1.8 22.6 9.8 5.3 7.6 5.7 7.6 3.7 4.2 3.7 8.4 4.7 2.3 2.5 5.1 8.0 1.3 2.7 7.9 7.1 11.8 8.3 4.0 8.3 3.3 9.5 7.7 6.2 3.7 17.1 3.9 2.6 4.5 5.5 4.0 0.9 3.2 2.4 2.0 6.2 8.9 0.4 3.1 0.0 0.0 0.1 2.1 0.1 0.0 1.6 1.9 0.0 27.6 20.6 1.2 7.7 16.8 6.2 6.7 4.0 2.7 1.1 2.0 15.0 11.6 0.7 2.3 0.2 5.6 1.3 0.7 1.0 1.8 2.0 15.0 0.1 0.0 20.4 1.1 6.9 0.5 6.1 10.1 1.7 0.5 0.1 11.6 0.5 0.3 0.4 2.6 0.8 2.8 1.3 0.1 0.5 1.0 0.8 0.5 0.6 0.2 0.0 0.3 3.1 0.1 0.0 6.5 6.6 5.1 2.1 0.7 0.2 0.3 3.0 8.4 0.3 3.7 0.0 0.0 0.0 1.1 0.0 0.0 0.4 1.2 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.0 3.1 2.1 0.1 3.8 6.4 32.7 11.2 3.7 4.2 2.5 5.1 11.8 4.0 3.0 4.3 0.0 0.6 1.0 4.0 0.6 0.0 1.4 0.0 0.0 2.0 0.3 0.0 0.4 0.1 2.3 0.1 0.0 0.7 0.1 5.7 1.7 1.1 5.7 0.3 3.2 0.0 2.5 0.3 0.0 8.6 0.0 0.0 0.0 0.9 8.2 0.5 3.1 7.4 0.6 2.1 0.0 1.9 2.8 2.0 1.4 0.2 0.0 1.0 0.3 NPR3 "ANPRC, C5orf23, FLJ14054, GUCY2B, NPRC" ENSG00000113389 "Natriuretic peptide receptor 3" P17342 5 32689070-32791724 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.2" "Group enriched" "Detected in many" 4 "Distal tubular cells: 44.7;Proximal tubular cells: 133.6" "Cancer enhanced" "Detected in many" "renal cancer: 19.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.3" "Cell line enhanced" "Detected in some" "ASC TERT1: 17.3;fHDF/TERT166: 10.5;HeLa: 37.5;HSkMC: 24.4;U-138 MG: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052702 Supported Approved Cytosol NA NA Cytosol "HPA052702: AB_2681922" "unprognostic (8.56e-3)" "unprognostic (1.54e-2)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (7.64e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-2)" "unprognostic (9.28e-2)" "unprognostic (6.78e-3)" "unprognostic (1.76e-1)" "unprognostic (6.07e-2)" "unprognostic (3.46e-3)" "prognostic favorable (5.43e-6)" "unprognostic (6.00e-4)" "unprognostic (5.74e-2)" "unprognostic (2.80e-2)" "unprognostic (3.38e-2)" 26.9 3.5 0.4 0.4 1.5 1.9 2.7 0.2 0.8 4.5 5.3 0.3 1.4 0.3 4.2 3.3 6.8 2.5 3.9 16.4 0.4 0.5 54.2 7.6 24.2 0.5 0.2 0.8 1.9 0.7 0.3 0.7 5.3 3.1 8.8 0.5 7.3 1.2 18.1 9.5 3.7 1.4 1.8 0.3 4.5 1.0 1.5 0.0 1.1 11.0 13.4 1.4 5.5 4.5 1.4 0.9 7.3 0.6 1.1 1.1 0.2 0.1 1.9 0.1 0.2 1.1 17.3 0.0 4.6 0.9 0.2 0.2 0.0 0.1 0.0 0.1 10.5 0.3 0.0 2.3 0.0 0.5 0.0 0.0 0.2 37.5 0.0 3.4 0.0 0.1 24.4 0.3 1.2 3.3 1.1 0.1 0.0 0.0 0.3 1.5 0.3 0.0 0.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 6.3 0.0 0.1 0.1 0.0 0.1 10.3 0.1 0.8 0.1 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.6 0.4 0.8 0.3 0.5 0.9 0.7 0.5 0.0 1.4 0.9 1.1 7.3 1.1 0.1 0.9 0.4 0.2 0.4 1.5 0.2 0.8 0.4 0.5 0.2 0.8 3.1 0.0 14.9 8.2 0.9 0.0 4.7 3.3 20.6 0.0 6.7 2.3 8.7 0.0 0.0 44.7 0.0 1.1 3.3 0.0 0.0 0.0 0.1 1.5 2.5 3.5 1.5 0.1 3.2 0.0 4.9 0.0 2.2 10.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 12.0 133.6 1.2 6.5 2.7 0.1 0.9 1.1 0.1 0.0 0.0 0.1 NPS ENSG00000214285 "Neuropeptide S" P0C0P6 10 127549369-127552639 "Predicted secreted proteins" Neuropeptide "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 1.9" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "head and neck cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "midbrain: 6.5;pons and medulla: 5.3" "Region enriched" "Detected in some" 8 "cerebral cortex: 5.8" CAB020139 Uncertain "Secreted - unknown location" NA NA "CAB020139: AB_776718" "unprognostic (2.83e-1)" 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPSR1 "GPR154, GPRA, PGR14" ENSG00000187258 "Neuropeptide S receptor 1" Q6W5P4 7 34658239-34878332 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.5;retina: 9.1;stomach 1: 3.7" "Cell type enriched" "Detected in single" 6 "Early spermatids: 3.7" "Cancer enhanced" "Detected in some" "stomach cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 4.7;SCLC-21H: 2.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 9.6" NA NA "unprognostic (3.56e-1)" "unprognostic (9.34e-2)" "unprognostic (7.55e-2)" "unprognostic (1.80e-1)" "unprognostic (2.00e-2)" "unprognostic (9.35e-2)" "unprognostic (6.34e-3)" "unprognostic (2.85e-1)" "unprognostic (1.36e-2)" "unprognostic (2.08e-2)" 0.0 0.2 0.5 1.0 0.1 0.0 0.0 3.5 1.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 3.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.6 9.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 3.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 3.5 1.0 0.6 3.2 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 NPTX1 ENSG00000171246 "Neuronal pentraxin 1" Q15818 17 80467148-80477843 "Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.9" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 164.9" "Cancer enhanced" "Detected in many" "glioma: 4.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.5" "Cell line enhanced" "Detected in some" "HAP1: 12.4;HeLa: 9.7;SiHa: 15.8;U-138 MG: 33.8;WM-115: 46.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6" HPA077062 Enhanced Approved "Secreted in brain" NA NA 1000000 "HPA077062: AB_2732329" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-2)" "unprognostic (6.95e-2)" "unprognostic (4.16e-3)" "unprognostic (2.43e-2)" "unprognostic (1.48e-2)" "unprognostic (3.63e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-1)" "unprognostic (1.81e-2)" "unprognostic (9.63e-3)" "unprognostic (1.05e-6)" "unprognostic (1.41e-4)" "unprognostic (1.35e-1)" "unprognostic (8.86e-6)" "unprognostic (2.71e-3)" 1.0 3.4 28.8 1.4 14.7 0.8 1.1 68.9 62.5 0.8 9.1 0.2 0.0 1.3 1.3 2.5 1.4 1.4 1.7 0.7 15.5 3.0 0.8 0.7 1.0 1.4 1.0 18.2 0.7 0.7 0.7 0.8 1.6 4.6 1.3 2.5 0.6 0.7 2.9 1.0 3.2 1.5 1.4 1.9 2.3 1.5 1.3 0.0 0.9 0.7 0.0 0.7 0.9 0.2 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.0 0.7 0.2 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 1.3 0.0 12.4 0.0 0.0 0.0 7.7 0.0 9.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.2 0.0 0.0 8.4 0.0 15.8 0.0 0.0 0.1 0.0 0.2 0.1 33.8 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 28.8 14.7 68.9 29.9 15.5 3.0 1.0 18.2 4.6 0.0 0.0 0.0 0.0 0.1 1.3 8.7 2.8 0.0 0.0 1.2 0.0 164.9 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.9 0.0 0.0 0.0 0.0 0.8 0.3 0.0 2.1 0.0 2.6 0.0 0.9 1.1 0.5 2.6 0.1 0.0 0.0 0.0 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617297-98629868 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7" "Group enriched" "Detected in many" 6 "Peritubular cells: 306.6;Sertoli cells: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 128.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" NA NA 2490000 320000 "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 4.3 24.0 7.1 2.3 8.4 1.0 1.4 0.2 45.6 8.2 3.8 3.2 0.1 1.1 1.8 3.9 2.2 1.5 1.6 3.2 9.2 11.0 0.9 0.9 0.8 0.7 9.4 2.2 1.5 19.5 0.8 71.6 0.8 7.0 2.1 1.4 1.3 1.5 2.2 2.9 4.0 1.3 2.9 2.9 6.1 1.9 20.7 5.0 0.0 1.6 0.1 0.9 1.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 7.1 8.4 0.2 24.6 9.2 11.0 9.4 2.2 7.0 5.0 0.0 1.1 0.0 0.4 3.4 17.7 2.8 5.1 0.0 2.3 0.0 3.9 0.0 0.0 5.8 9.7 2.9 2.4 0.0 11.0 0.2 6.2 3.2 0.0 0.2 0.4 0.0 15.3 6.2 0.0 19.9 13.0 0.0 11.8 0.0 0.0 0.8 4.7 0.0 306.6 0.0 2.4 148.8 3.8 14.0 40.1 2.6 0.1 0.0 0.4 0.5 NPTXR ENSG00000221890 "Neuronal pentraxin receptor" O95502 22 38818452-38843982 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 73.6" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 11.4;SCLC-21H: 15.0;SiHa: 11.2;U-87 MG: 43.1" "Low region specificity" "Detected in all" HPA001079 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 280000 "Plasma membrane, Cytosol" Nucleoplasm "HPA001079: AB_1078414" "unprognostic (6.29e-2)" "prognostic favorable (3.93e-4)" "unprognostic (6.82e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.55e-2)" "unprognostic (6.93e-2)" "unprognostic (1.05e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.71e-1)" "unprognostic (1.52e-3)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.49e-2)" "unprognostic (9.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.77e-2)" 2.3 3.8 39.1 1.8 17.5 0.8 1.9 16.2 73.6 5.8 2.6 4.3 0.5 1.5 5.6 3.3 2.7 6.1 2.0 10.5 57.4 15.2 1.3 0.8 1.7 1.6 5.6 20.7 6.2 3.6 5.9 2.0 0.9 4.5 6.2 1.7 1.0 3.2 5.6 0.9 1.2 1.4 5.7 3.3 2.1 2.0 1.6 4.0 0.0 2.5 0.0 1.6 2.5 1.9 0.3 0.2 0.6 0.2 0.6 2.3 0.4 0.4 2.9 0.1 0.8 6.0 0.6 0.0 1.9 0.4 3.8 1.3 2.9 0.6 0.0 3.5 0.5 11.4 0.4 0.8 0.1 1.3 0.2 1.0 0.0 0.1 4.5 0.6 0.0 0.1 1.9 0.1 3.5 0.0 5.6 0.1 0.0 3.6 0.1 0.1 4.5 0.0 0.2 3.5 1.4 1.0 0.7 0.0 7.0 1.0 8.1 15.0 0.9 11.2 0.0 0.3 0.8 4.8 1.1 0.2 6.9 4.2 0.0 0.3 1.0 0.0 0.0 43.1 8.7 3.5 0.5 0.2 0.1 1.8 0.0 1.3 0.1 1.0 2.3 0.0 0.3 1.5 1.2 0.6 0.6 0.1 0.2 0.0 0.4 39.1 17.5 16.2 49.0 57.4 15.2 5.6 20.7 4.5 4.0 0.0 0.0 0.0 1.9 1.0 5.4 14.2 5.1 2.7 3.4 3.5 2.0 0.0 0.0 5.7 1.6 4.2 0.0 0.0 3.3 0.0 0.8 4.6 0.0 0.2 0.2 0.0 1.7 5.5 0.3 0.4 1.7 0.3 1.7 0.0 0.0 6.5 3.1 0.0 2.1 0.5 3.1 0.0 2.6 0.0 0.8 0.9 0.0 0.0 0.0 3.3 NPVF "C7orf9, RFRP" ENSG00000105954 "Neuropeptide VF precursor" Q9HCQ7 7 25224570-25228486 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "brain: 9.5;lymphoid tissue: 2.9;retina: 7.0" "Cell type enriched" "Detected in some" 44 "Muller glia cells: 336.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 95 "hypothalamus: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "hypothalamus: 7.2" "Region enriched" "Detected in some" 4 "hypothalamus: 3.8" HPA041733 Enhanced "Secreted in other tissues" NA NA "HPA041733: AB_10794524" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 336.5 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPW PPL8 ENSG00000183971 "Neuropeptide W" Q8N729 16 2009926-2020755 "Predicted intracellular proteins, Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 49.0;placenta: 17.7" "Cell type enriched" "Detected in many" 5 "Intestinal endocrine cells: 152.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 17.1;PC-3: 9.5;RPMI-8226: 29.9;SCLC-21H: 52.0" "Low region specificity" "Detected in single" HPA064874 Approved "Secreted to blood" NA NA "HPA064874: AB_2685378" "unprognostic (7.54e-2)" "unprognostic (4.45e-3)" "unprognostic (3.20e-1)" "unprognostic (4.31e-3)" "unprognostic (8.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.20e-2)" "unprognostic (6.26e-3)" "unprognostic (2.37e-1)" "unprognostic (1.81e-5)" "unprognostic (6.53e-3)" "unprognostic (1.26e-1)" "unprognostic (4.41e-1)" "unprognostic (3.43e-2)" 0.9 0.6 0.6 1.3 0.8 2.3 0.4 0.6 1.6 1.6 1.3 0.0 3.1 1.4 5.9 3.0 0.9 1.1 0.7 0.3 0.5 0.9 1.0 49.0 0.4 1.3 0.4 0.7 1.0 2.0 0.3 5.9 17.7 1.2 1.5 0.7 1.1 0.5 3.4 0.3 2.3 0.7 0.6 0.5 2.8 6.0 4.3 0.4 3.7 0.8 0.9 1.0 0.6 1.3 1.6 2.0 4.7 2.1 1.6 1.8 0.6 0.1 0.8 0.1 1.1 0.1 0.0 0.2 0.3 0.1 0.2 0.4 1.9 0.6 0.2 0.0 0.3 0.2 0.3 0.5 0.2 0.2 0.7 1.0 0.0 1.2 0.6 0.8 0.1 0.0 0.5 0.5 0.3 0.8 0.0 0.0 0.9 2.9 0.6 0.0 0.5 0.1 17.1 0.7 0.6 9.5 3.3 0.0 29.9 0.1 0.0 52.0 4.2 0.4 0.9 0.1 0.2 2.2 1.4 0.6 0.1 0.2 0.1 0.0 1.4 0.4 0.4 0.2 0.4 0.1 3.6 2.1 1.9 0.6 1.3 1.8 1.4 0.3 0.2 2.0 1.6 0.9 0.3 4.7 1.6 0.6 1.1 1.1 0.6 0.6 0.8 0.6 1.6 0.5 0.9 0.4 0.7 1.2 0.4 0.0 0.0 1.9 2.8 1.8 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.6 0.1 2.6 0.0 0.2 0.6 0.8 6.4 9.2 30.0 2.1 0.0 152.5 0.6 0.3 1.7 2.0 0.1 3.3 0.0 23.4 0.0 2.2 3.6 2.1 0.5 0.3 0.0 1.0 3.8 26.6 1.9 1.4 0.8 3.0 3.2 NPY PYY4 ENSG00000122585 "Neuropeptide Y" P01303 7 24284163-24291865 "Plasma proteins, Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 50.5;brain: 63.6;prostate: 131.2" "Cell type enriched" "Detected in some" 5 "Glandular cells: 55.9" "Cancer enriched" "Detected in many" 187 "prostate cancer: 1214.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 36 "SH-SY5Y: 124.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016733, CAB034368, HPA036636, HPA044572, HPA056798" Supported Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 30700000 "Golgi apparatus" "CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371" "unprognostic (2.00e-1)" "prognostic unfavorable (5.78e-4)" "unprognostic (4.15e-1)" "unprognostic (3.76e-2)" "unprognostic (1.59e-2)" "unprognostic (1.87e-1)" "unprognostic (6.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.78e-1)" "unprognostic (2.52e-1)" 1.6 50.5 27.2 5.5 63.6 2.8 1.0 0.1 55.9 1.0 1.8 2.8 1.4 4.7 1.1 1.1 2.5 1.0 1.4 1.0 11.9 20.6 1.1 1.0 1.1 1.0 2.6 18.3 1.0 4.0 1.0 0.5 1.0 1.9 131.2 1.7 0.0 1.0 14.7 1.0 1.0 5.0 1.4 1.4 1.0 1.7 1.3 13.9 0.0 1.1 0.0 1.0 3.9 4.5 0.5 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.1 124.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 27.2 63.6 0.1 31.2 11.9 20.6 2.6 18.3 1.9 13.9 0.0 0.0 0.0 1.3 0.1 1.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.2 0.2 55.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.5 0.3 0.0 1.7 0.0 0.0 0.4 0.5 0.0 0.4 0.0 0.5 0.0 0.0 2.3 2.1 0.0 4.2 0.0 0.0 0.7 NPY1R NPYR ENSG00000164128 "Neuropeptide Y receptor Y1" P25929 4 163323961-163344832 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.2" "Cell type enhanced" "Detected in many" 25 "Intestinal endocrine cells: 31.4;Ito cells: 157.8;Sertoli cells: 45.3" "Cancer enriched" "Detected in many" 13 "breast cancer: 65.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 18 "HEL: 51.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "prognostic favorable (7.68e-5)" "unprognostic (9.14e-3)" "unprognostic (1.55e-1)" "unprognostic (5.09e-2)" "unprognostic (2.60e-1)" "unprognostic (9.29e-2)" "unprognostic (5.28e-3)" "unprognostic (2.26e-1)" "unprognostic (4.14e-2)" "unprognostic (2.50e-1)" "unprognostic (1.89e-2)" "unprognostic (5.92e-2)" "unprognostic (7.39e-2)" "unprognostic (1.92e-3)" "unprognostic (5.48e-2)" "unprognostic (1.74e-1)" "unprognostic (2.21e-1)" 18.0 15.9 5.2 1.5 17.1 0.2 17.5 0.9 11.4 6.2 3.1 0.7 3.9 0.7 5.0 5.4 2.3 4.3 2.4 2.6 7.1 4.2 16.6 8.3 1.2 7.2 1.5 5.8 1.8 14.5 1.1 3.9 2.7 3.5 1.9 2.4 2.0 11.0 4.5 1.5 5.0 0.9 3.1 3.7 55.2 1.2 2.7 6.0 0.0 4.4 1.4 0.6 3.4 3.3 0.5 0.3 1.2 0.4 0.3 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.6 0.0 2.0 0.7 0.4 1.2 0.5 0.1 0.6 0.4 0.7 0.9 0.0 0.5 0.7 1.2 1.1 0.3 0.2 0.3 0.3 0.0 5.2 17.1 0.9 11.4 7.1 4.2 1.5 5.8 3.5 6.0 0.0 0.3 0.0 0.7 2.5 4.4 0.8 0.0 0.0 0.0 0.0 2.0 0.0 11.6 7.6 3.7 2.4 2.0 0.0 0.0 0.0 1.2 0.4 0.0 0.8 0.1 0.0 31.4 157.8 11.8 2.0 10.6 0.0 5.0 0.0 0.9 0.5 0.2 10.4 0.4 0.0 1.8 45.3 5.1 0.5 0.2 1.5 0.0 0.0 1.3 0.3 NPY2R ENSG00000185149 "Neuropeptide Y receptor Y2" P49146 4 155208629-155217078 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.2;breast: 4.1" "Cell type enriched" "Detected in some" 11 "Leydig cells: 19.5" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.6;ASC diff: 3.6;HSkMC: 1.7;SH-SY5Y: 12.9" "Group enriched" "Detected in many" 5 "amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7" "Region enriched" "Detected in all" 5 "hippocampal formation: 19.7" NA NA "unprognostic (7.14e-2)" "unprognostic (4.36e-3)" "unprognostic (7.08e-2)" "unprognostic (5.50e-2)" "unprognostic (9.35e-2)" 0.8 1.1 3.4 1.3 6.9 0.1 4.1 0.1 8.6 0.4 2.7 1.8 0.0 1.1 0.2 0.4 0.2 0.5 0.2 0.7 7.3 5.5 0.3 0.1 0.2 0.2 0.8 0.0 0.4 0.1 0.1 0.2 0.2 7.8 0.5 2.8 0.2 2.0 0.2 0.1 0.5 1.5 0.6 10.2 0.6 0.3 2.5 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 6.9 0.1 8.6 7.3 5.5 0.8 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 NPY4R "PP1, PPYR1, Y4" ENSG00000204174 "Neuropeptide Y receptor Y4" P50391 10 46461099-46465881 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 9.4;skin 1: 4.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Group enriched" "Detected in some" 5 "cerebellum: 1.6;cerebral cortex: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "A549: 25.5" HPA027863 Approved NA NA "HPA027863: AB_10602819" "unprognostic (2.26e-6)" "unprognostic (2.94e-1)" "unprognostic (8.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (1.77e-3)" "unprognostic (1.98e-1)" "unprognostic (2.64e-3)" "unprognostic (6.58e-2)" "unprognostic (9.79e-2)" 0.2 0.0 0.2 0.7 0.2 0.0 0.2 1.6 1.2 0.3 7.4 0.2 0.2 2.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.9 9.4 0.2 0.2 0.2 0.2 4.3 2.6 1.4 0.2 0.2 2.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 25.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.7 0.0 0.0 5.2 0.0 0.4 0.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.6 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY4R2 CH17-360D5.1 ENSG00000264717 "Neuropeptide Y receptor Y4-2" 10 47918739-47923524 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.2;intestine: 6.3;skin 1: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "A549: 21.2" HPA027863 Uncertain NA NA "HPA027863: AB_10602819" "unprognostic (1.74e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-1)" "unprognostic (7.78e-2)" "unprognostic (6.72e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" 0.2 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.4 0.0 6.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.7 0.0 0.0 0.0 0.0 3.3 3.4 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 21.2 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY5R NPYR5 ENSG00000164129 "Neuropeptide Y receptor Y5" Q15761 4 163343939-163351934 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.2;lymphoid tissue: 13.6" "Cell type enhanced" "Detected in single" 21 "Spermatocytes: 1.6" "Cancer enhanced" "Detected in single" "breast cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;RPTEC TERT1: 3.5;T-47d: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (4.63e-6)" "unprognostic (3.00e-1)" "unprognostic (2.79e-1)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "unprognostic (3.74e-2)" "unprognostic (3.94e-2)" "unprognostic (5.40e-2)" "unprognostic (4.30e-2)" "unprognostic (3.99e-2)" "unprognostic (1.76e-1)" "unprognostic (3.94e-1)" 10.6 5.7 3.6 1.6 12.2 0.1 3.2 0.3 6.2 1.5 0.7 0.1 0.3 0.2 2.2 1.9 0.6 1.4 1.0 1.3 4.5 3.1 7.8 1.8 0.7 6.6 1.3 4.6 0.5 1.8 0.8 0.6 4.9 2.3 0.5 0.6 1.1 6.1 1.7 0.4 1.4 0.3 1.5 4.2 13.6 0.5 9.1 2.2 0.0 1.3 0.4 0.3 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 12.2 0.3 6.2 4.5 3.1 1.3 4.6 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 NQO1 "DHQU, DIA4, DTD, NMOR1, QR1" ENSG00000181019 "NAD(P)H quinone dehydrogenase 1" P15559 16 69706996-69726951 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 142.1" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 203.8;Ciliated cells: 259.6;monocytes: 222.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 149.4;OE19: 264.4;SiHa: 169.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007308, CAB012421" Enhanced Supported Cytosol NA NA 310000 Cytosol "CAB012421: , HPA007308: AB_1079501" "unprognostic (1.04e-2)" "unprognostic (1.95e-3)" "unprognostic (3.14e-1)" "unprognostic (3.76e-3)" "unprognostic (9.03e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.05e-3)" "unprognostic (1.97e-1)" "unprognostic (5.07e-2)" "unprognostic (1.24e-2)" "unprognostic (1.49e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-2)" "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.98e-1)" "unprognostic (3.27e-1)" 31.3 24.2 12.8 6.4 20.7 0.6 77.1 2.7 9.1 7.6 23.2 7.8 5.7 29.5 3.9 8.6 36.3 8.2 77.2 9.3 9.9 7.5 44.7 1.2 17.2 6.9 11.3 6.0 3.7 2.5 7.0 3.7 3.5 25.5 9.8 20.8 20.2 10.5 7.6 7.6 2.3 17.7 22.7 10.4 6.0 142.1 3.8 4.9 0.1 25.7 69.7 16.2 21.2 18.9 5.2 3.2 0.9 3.2 15.1 12.3 4.4 13.1 149.4 12.5 55.9 31.2 45.3 4.7 22.3 40.0 23.0 35.6 18.1 85.3 0.4 26.5 115.2 40.2 13.8 4.8 25.1 11.8 5.3 0.2 0.6 37.0 131.8 41.5 3.1 10.7 10.6 15.9 39.9 4.6 34.6 57.0 1.0 5.4 0.9 122.9 42.6 0.6 5.7 6.6 264.4 14.5 1.0 2.6 6.1 45.9 47.9 4.5 1.0 169.7 24.1 99.3 14.9 39.0 10.5 38.6 23.2 9.6 8.7 17.5 0.7 2.9 0.6 29.7 1.7 114.7 0.6 3.2 0.2 5.7 0.3 2.9 5.2 6.6 7.2 3.2 2.1 2.1 4.7 0.9 15.1 0.3 1.2 12.3 4.4 12.8 20.7 2.7 9.1 9.9 7.5 11.3 6.0 25.5 4.9 23.8 13.4 1.4 19.5 4.6 4.0 4.5 203.8 259.6 28.4 40.1 3.9 2.1 124.3 22.1 0.3 55.5 72.0 0.0 134.0 3.1 13.1 25.1 19.6 3.2 12.5 3.2 19.5 31.9 3.3 0.9 23.3 8.2 16.9 222.8 60.8 7.6 63.7 49.1 11.3 24.5 10.7 6.5 17.6 0.2 1.5 4.0 1.6 4.4 33.4 25.4 NR0B1 "AHC, AHCH, DAX1, DSS" ENSG00000169297 "Nuclear receptor subfamily 0 group B member 1" P51843 X 30304206-30309598 "Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Receptor, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 23.9;testis: 36.0" "Cell type enhanced" "Detected in some" 15 "Intestinal endocrine cells: 5.2;Melanocytes: 1.7;monocytes: 4.6;Pancreatic endocrine cells: 2.0" "Cancer enhanced" "Detected in many" "lung cancer: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 35.1;RT4: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA061948, HPA067207" Supported "Nuclear speckles,Vesicles,Centriolar satellite" NA NA "Nuclear speckles" "Vesicles, Centriolar satellite" "HPA061948: AB_2732673, HPA067207: AB_2732761" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" "unprognostic (9.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (7.45e-3)" "unprognostic (4.83e-2)" "unprognostic (9.00e-2)" "unprognostic (1.33e-3)" 0.4 23.9 1.0 0.0 0.8 0.0 0.2 0.4 1.1 1.3 0.1 1.7 0.0 0.0 0.4 0.9 0.1 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.1 0.0 0.5 0.6 3.5 2.1 0.0 1.6 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.6 0.1 0.7 36.0 0.7 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.4 1.1 0.9 0.9 0.5 0.6 0.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.7 1.1 0.0 1.7 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 NR0B2 SHP ENSG00000131910 "Nuclear receptor subfamily 0 group B member 2" Q15466 1 26911489-26913966 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Receptor, Repressor" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 47.2;liver: 49.4;pancreas: 52.8" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 56.0;Distal tubular cells: 44.7;Exocrine glandular cells: 37.2;Hepatocytes: 149.9" "Group enriched" "Detected in many" 5 "liver cancer: 52.3;stomach cancer: 11.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 32 "Hep G2: 41.9" "Region enriched" "Detected in single" 6 "cerebellum: 1.9" "Low region specificity" "Detected in many" NA NA "unprognostic (2.99e-2)" "unprognostic (1.86e-1)" "unprognostic (1.95e-3)" "unprognostic (4.68e-3)" "unprognostic (9.21e-2)" "unprognostic (8.22e-2)" "unprognostic (3.97e-2)" "unprognostic (2.44e-2)" "unprognostic (1.83e-1)" "unprognostic (3.09e-1)" "unprognostic (2.11e-2)" "unprognostic (6.74e-3)" "unprognostic (1.04e-1)" "unprognostic (2.03e-1)" "unprognostic (4.12e-3)" "unprognostic (1.10e-2)" 0.1 7.5 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.1 11.8 0.3 0.1 32.6 0.1 0.8 0.1 0.0 18.5 16.6 0.1 0.0 9.3 49.4 2.4 0.1 0.1 0.1 0.1 52.8 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.3 0.1 3.5 0.0 47.2 0.1 0.1 5.3 8.5 0.4 0.1 0.1 0.1 0.2 0.1 0.1 0.1 1.0 0.6 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 41.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 1.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 3.0 12.0 1.5 0.0 0.0 0.0 7.4 56.0 0.0 1.2 12.2 0.0 0.0 44.7 17.4 0.4 0.0 1.7 23.3 37.2 0.0 0.0 0.0 0.0 149.9 0.1 27.0 23.4 1.8 2.2 0.0 0.0 0.0 0.0 0.0 5.8 0.2 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 5.7 0.0 NR1H3 "LXR-a, RLD-1" ENSG00000025434 "Nuclear receptor subfamily 1 group H member 3" Q13133 11 47248300-47269032 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 74.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 54.2;Hofbauer cells: 54.7;Kupffer cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 14.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.9;HSkMC: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036443, CAB037109" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB037109: AB_1840991, HPA036443: AB_10966142" "unprognostic (2.95e-3)" "unprognostic (5.31e-3)" "unprognostic (5.19e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.19e-1)" "unprognostic (2.65e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.51e-1)" "unprognostic (1.76e-1)" "unprognostic (7.73e-2)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.40e-5)" "unprognostic (3.56e-1)" "unprognostic (4.42e-2)" "unprognostic (2.84e-1)" "prognostic favorable (3.40e-4)" 74.2 9.4 4.8 12.7 6.9 1.2 22.8 7.0 5.5 10.2 17.9 4.4 7.2 23.1 6.7 10.0 6.6 8.1 9.2 8.5 4.0 2.9 10.3 35.7 13.7 29.4 6.8 5.6 7.5 7.8 4.3 3.5 16.1 4.3 10.1 5.9 6.4 7.1 9.0 6.1 5.1 19.0 7.1 3.4 40.2 7.6 13.7 4.1 6.3 9.7 2.6 10.7 10.8 12.9 1.1 4.5 6.5 14.6 6.1 3.8 2.1 1.6 6.8 3.1 3.0 20.9 22.9 14.7 1.7 8.6 2.8 4.4 8.3 21.5 2.9 3.3 1.4 1.0 4.5 3.7 2.9 1.9 2.7 3.0 3.9 9.0 12.4 8.6 1.4 0.5 29.9 1.8 4.4 2.6 4.9 2.4 4.6 4.8 1.2 1.9 7.1 2.7 7.9 3.4 9.1 2.3 4.0 4.2 1.9 2.5 15.3 3.0 1.0 6.1 4.0 5.1 3.2 9.7 3.7 0.6 2.3 3.1 4.5 1.0 6.0 8.7 3.5 4.2 1.8 1.1 6.5 2.9 2.4 1.5 14.6 2.1 1.1 1.7 1.4 4.5 0.9 1.8 1.5 1.5 6.1 4.5 0.8 3.8 2.1 4.8 6.9 7.0 5.5 4.0 2.9 6.8 5.6 4.3 4.1 0.0 9.9 6.1 6.3 3.0 2.1 4.5 22.9 1.4 5.7 5.2 2.0 9.7 10.0 4.4 23.5 12.0 39.9 0.0 7.5 11.4 9.9 3.2 12.7 54.2 54.7 1.6 1.7 21.5 70.5 33.3 8.3 7.9 3.3 6.4 9.7 4.8 4.0 10.5 5.6 19.2 0.9 19.4 6.4 27.2 16.3 2.0 5.5 2.9 12.1 4.1 NR1H4 "FXR, HRR-1, HRR1, RIP14" ENSG00000012504 "Nuclear receptor subfamily 1 group H member 4" Q96RI1 12 100473708-100564413 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Disease mutation, FDA approved drug targets, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 109.4" "Cell type enhanced" "Detected in some" 15 "Cholangiocytes: 79.0;Distal tubular cells: 36.5;Hepatocytes: 90.4;Proximal tubular cells: 116.5" "Group enriched" "Detected in some" 11 "liver cancer: 18.7;renal cancer: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "Hep G2: 18.4;HHSteC: 11.1;RPTEC TERT1: 29.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA047699 Approved Nucleoplasm NA NA Nucleoplasm "HPA047699: AB_10965320" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (6.68e-2)" "unprognostic (2.49e-1)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (2.01e-1)" "unprognostic (1.88e-2)" "unprognostic (1.16e-1)" "unprognostic (2.43e-1)" "unprognostic (3.77e-3)" 0.1 11.3 0.1 1.4 0.4 0.0 0.2 0.1 0.2 0.2 5.8 0.4 0.1 11.3 0.1 0.4 0.1 0.1 7.0 0.1 0.1 0.0 25.0 109.4 0.6 2.4 0.1 0.1 7.7 2.7 0.0 2.9 0.2 0.3 0.5 0.4 0.6 0.1 0.1 0.1 0.0 19.5 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.3 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 79.0 0.0 0.0 21.0 0.0 0.0 36.5 6.3 0.2 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 90.4 0.0 0.0 0.0 14.7 1.9 1.3 0.9 0.0 0.0 0.0 0.1 0.0 0.6 2.9 0.0 116.5 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.3 0.9 NR1I2 "BXR, ONR1, PAR2, PXR, SXR" ENSG00000144852 "Nuclear receptor subfamily 1 group I member 2" O75469 3 119780484-119818485 "FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 7.1;intestine: 15.4;liver: 22.2" "Group enriched" "Detected in some" 4 "Enterocytes: 29.0;Hepatocytes: 28.7" "Group enriched" "Detected in some" 24 "colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7" "Cell type enriched" "Detected in single" 18 "NK-cell: 7.1" "Lineage enriched" "Detected in single" 18 "NK-cells: 7.1" "Cell line enriched" "Detected in some" 4 "Hep G2: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029309, HPA055121, HPA073926" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643" "unprognostic (6.76e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (1.24e-4)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" "unprognostic (4.03e-3)" "unprognostic (3.97e-2)" "unprognostic (5.78e-2)" "unprognostic (5.05e-2)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.51e-6)" "unprognostic (4.86e-1)" "unprognostic (6.95e-2)" "unprognostic (3.13e-1)" "unprognostic (6.12e-3)" 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 0.0 22.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.8 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.0 0.0 0.0 29.0 0.0 0.2 0.0 0.0 0.0 0.0 28.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 NR1I3 "CAR, CAR1, MB67" ENSG00000143257 "Nuclear receptor subfamily 1 group I member 3" Q14994 1 161229666-161238302 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "liver: 63.1" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 124.3" "Cancer enriched" "Detected in single" 67 "liver cancer: 17.6" "Region enriched" "Detected in single" 6 "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA051365 Approved Nucleoplasm NA NA Nucleoplasm "HPA051365: AB_2616454" "unprognostic (2.59e-3)" "unprognostic (1.06e-2)" "unprognostic (9.33e-2)" "unprognostic (6.92e-4)" "unprognostic (2.55e-1)" "unprognostic (1.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.51e-2)" "unprognostic (8.69e-2)" "unprognostic (1.85e-1)" "unprognostic (6.23e-2)" "unprognostic (5.63e-3)" "unprognostic (2.71e-1)" "unprognostic (5.79e-2)" "unprognostic (6.44e-2)" "unprognostic (5.48e-3)" "unprognostic (2.62e-2)" 0.1 0.0 0.2 0.1 1.9 0.1 0.1 0.1 0.2 0.1 0.7 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 3.5 63.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.3 2.3 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.7 0.3 0.0 0.6 0.3 0.3 0.9 1.1 0.6 0.0 0.0 0.9 0.4 0.0 0.0 0.0 9.4 0.3 1.0 0.6 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.9 0.0 0.2 2.2 0.0 1.7 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.9 1.2 0.4 0.0 0.8 0.3 0.6 1.7 1.8 1.3 0.9 0.8 0.6 0.0 1.8 2.3 1.4 0.3 2.9 0.4 1.4 2.1 1.2 2.2 0.7 0.7 1.5 0.2 1.5 2.2 1.3 0.5 2.9 0.5 0.7 0.2 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.9 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.3 20.8 16.0 2.2 1.1 0.6 0.7 0.3 2.5 8.1 9.1 3.5 0.0 0.1 3.3 0.1 1.7 0.3 0.0 0.0 0.0 0.1 0.4 0.4 12.7 124.3 0.3 0.0 0.0 3.1 5.3 1.2 0.3 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.4 28.7 1.7 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.8 NR2E1 "TLL, TLX, XTLL" ENSG00000112333 "Nuclear receptor subfamily 2 group E member 1" Q9Y466 6 108166058-108188809 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 19.0" "Cell type enriched" "Detected in single" 50 "Muller glia cells: 39.7" "Cancer enriched" "Detected in single" 14 "glioma: 6.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 6.4;GAMG: 3.0;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036954, HPA055642" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA036954: AB_10670958, HPA055642: AB_2682871" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.00e-1)" "unprognostic (1.78e-2)" "unprognostic (7.31e-2)" "unprognostic (8.64e-2)" "unprognostic (9.59e-8)" "unprognostic (2.87e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" 0.6 1.1 14.5 0.6 16.0 0.8 0.8 0.0 19.0 0.6 0.6 2.8 0.0 0.7 0.6 0.6 0.6 0.6 0.6 0.7 10.8 4.3 0.9 0.6 0.6 0.7 3.5 7.5 0.7 0.7 0.8 0.1 0.7 0.0 0.6 0.6 3.3 1.0 0.6 0.7 0.9 0.6 0.6 0.0 0.7 0.7 0.8 4.1 0.0 0.7 0.0 0.6 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 3.0 0.1 0.0 0.0 0.0 0.0 2.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 14.5 16.0 0.0 10.0 10.8 4.3 3.5 7.5 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 NR2E3 "PNR, rd7, RP37" ENSG00000278570 "Nuclear receptor subfamily 2 group E member 3" Q9Y5X4 15 71792638-71818259 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "DNA-binding, Receptor, Repressor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "retina: 50.2" "Cell type enriched" "Detected in some" 35 "Rod photoreceptor cells: 1391.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.0;GAMG: 2.5;MCF7: 3.2;T-47d: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.63e-3)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (9.85e-3)" "unprognostic (3.60e-2)" "unprognostic (2.59e-1)" "unprognostic (2.89e-1)" "unprognostic (3.51e-1)" "unprognostic (3.65e-1)" "unprognostic (4.75e-2)" "unprognostic (2.11e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" 0.1 0.4 0.1 0.1 0.1 0.2 1.5 0.1 0.1 1.9 0.2 0.1 0.1 0.0 0.2 1.3 0.1 0.7 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 1.8 0.2 50.2 0.9 0.1 0.1 0.7 0.5 0.1 0.1 0.1 0.9 1.3 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.7 0.0 0.3 1.8 0.0 3.0 0.1 0.9 0.0 0.7 0.4 0.1 0.1 0.3 0.3 1.3 1.2 0.0 2.5 2.2 1.0 0.7 0.2 0.0 0.9 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.2 0.2 0.5 1.5 0.3 0.0 0.0 0.0 0.1 3.2 0.0 0.8 0.2 0.3 1.4 0.1 1.0 0.0 1.6 0.2 0.3 0.2 0.3 0.4 0.5 0.6 2.9 0.3 1.6 0.4 0.2 1.1 0.2 0.3 0.5 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 1.7 0.0 29.1 0.6 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.0 3.6 0.0 0.0 0.1 28.6 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 38.7 0.3 0.0 1.8 0.0 1391.6 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.5 0.6 NR4A2 "HZF-3, NOT, NURR1, RNR1, TINUR" ENSG00000153234 "Nuclear receptor subfamily 4 group A member 2" P43354 2 156324432-156342348 "Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 102.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 342.7;Melanocytes: 229.5;Smooth muscle cells: 233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 14.4;HMC-1: 10.7;U-266/70: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000543, CAB010481" Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "CAB010481: AB_2298676, HPA000543: AB_1854631" "unprognostic (4.26e-2)" "unprognostic (2.14e-1)" "unprognostic (3.42e-2)" "unprognostic (4.10e-2)" "unprognostic (3.04e-2)" "unprognostic (5.26e-2)" "unprognostic (2.30e-1)" "unprognostic (6.14e-2)" "unprognostic (8.63e-2)" "unprognostic (3.88e-2)" "unprognostic (1.60e-2)" "unprognostic (2.89e-1)" "unprognostic (2.39e-2)" "unprognostic (3.58e-2)" "unprognostic (3.43e-1)" "unprognostic (9.29e-3)" "unprognostic (1.11e-1)" 15.0 58.5 3.1 10.2 5.7 49.1 7.5 15.2 14.4 9.1 4.2 7.3 11.0 1.4 6.4 7.5 5.7 13.6 21.3 15.8 5.2 2.6 5.9 7.6 12.5 2.8 4.8 4.2 60.0 4.2 8.7 23.7 2.3 5.1 11.7 8.5 5.3 18.0 102.1 6.1 5.3 6.0 8.4 5.9 2.1 8.3 3.8 3.7 2.1 6.8 8.0 5.3 17.8 7.5 0.7 2.8 10.1 2.3 0.0 1.6 0.6 0.8 1.2 0.5 1.8 3.2 0.7 0.9 1.0 5.3 0.4 1.3 0.0 3.7 0.0 1.2 0.4 0.4 1.5 2.5 0.7 0.4 1.2 1.3 1.0 14.4 0.0 0.6 0.8 10.7 0.6 1.1 0.4 0.4 2.1 0.3 0.0 1.4 1.0 1.1 1.8 0.0 0.9 2.2 1.4 1.0 0.2 0.7 3.0 0.6 0.8 2.6 0.1 2.5 4.0 7.1 0.3 0.2 0.9 0.7 2.8 0.8 0.7 0.4 14.5 1.5 0.0 5.3 0.9 6.7 3.0 2.3 3.4 1.6 0.5 0.9 0.7 0.5 0.8 2.8 0.5 0.9 0.4 10.1 0.0 0.9 0.0 0.5 0.6 3.1 5.7 15.2 14.4 5.2 2.6 4.8 4.2 5.1 3.7 23.8 129.3 22.9 17.5 194.2 9.3 10.4 7.6 40.2 34.2 68.0 47.1 4.2 0.0 11.1 31.2 31.6 24.7 0.0 8.2 5.0 68.9 34.7 342.7 4.0 110.1 0.0 198.2 24.5 106.2 25.4 3.7 192.8 229.5 8.2 78.3 0.6 8.9 45.3 0.7 0.2 26.4 12.9 233.9 1.7 2.8 186.8 8.2 117.1 49.4 27.5 NR4A3 "CHN, CSMF, MINOR, NOR1" ENSG00000119508 "Nuclear receptor subfamily 4 group A member 3" Q92570 9 99821855-99866891 "Cancer-related genes, Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 80.6" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 218.8;granulocytes: 120.9;Melanocytes: 84.4;Smooth muscle cells: 116.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;NK-cell: 1.3" "Group enriched" "Detected in many" 6 "granulocytes: 1.3;NK-cells: 1.3" "Group enriched" "Detected in some" 5 "BJ hTERT+: 21.5;HeLa: 7.4;SK-MEL-30: 14.8;U-266/70: 8.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043360 Uncertain NA NA "HPA043360: AB_10961186" "prognostic favorable (5.97e-4)" "unprognostic (6.92e-3)" "unprognostic (5.34e-2)" "unprognostic (2.78e-3)" "unprognostic (1.40e-1)" "unprognostic (9.46e-2)" "unprognostic (2.89e-2)" "unprognostic (3.30e-2)" "unprognostic (2.65e-3)" "unprognostic (1.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.30e-1)" "unprognostic (2.25e-1)" "unprognostic (1.29e-3)" "unprognostic (6.11e-2)" "unprognostic (2.80e-2)" "unprognostic (1.69e-1)" 19.9 46.5 3.5 10.2 4.5 22.1 5.9 1.6 5.0 9.7 4.8 9.5 6.3 0.8 10.7 6.1 3.1 15.7 16.6 37.3 4.1 2.5 3.8 7.1 12.4 1.2 1.6 3.1 37.2 4.0 4.0 12.2 4.7 5.0 12.0 3.2 7.0 1.6 80.6 28.5 1.5 4.2 23.0 5.1 2.6 9.0 1.3 3.4 7.6 4.2 15.5 1.9 23.5 7.5 0.0 0.2 1.3 0.0 1.3 0.0 0.0 0.1 0.1 0.6 0.1 1.2 0.4 1.0 1.3 21.5 0.2 0.3 0.2 0.1 0.1 0.3 0.5 0.4 0.1 0.4 0.0 0.1 1.8 0.3 0.1 7.4 0.0 0.1 0.1 2.1 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.2 0.0 0.1 0.6 0.0 1.0 0.0 0.0 0.1 0.4 0.4 2.4 1.7 14.8 0.2 0.0 0.0 0.1 1.4 0.4 1.7 0.1 8.8 0.1 0.0 0.9 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 3.5 4.5 1.6 5.0 4.1 2.5 1.6 3.1 5.0 3.4 11.9 22.4 0.9 7.4 70.6 0.7 218.8 2.5 18.7 14.8 15.7 9.8 1.8 0.0 0.1 1.3 7.3 0.6 0.0 1.4 1.2 43.7 5.1 120.9 0.5 10.3 0.0 26.1 8.6 16.8 1.2 1.4 35.2 84.4 74.9 2.2 1.0 0.2 0.3 1.1 0.0 0.8 0.0 116.4 0.3 1.4 51.9 4.7 5.0 0.9 2.3 NR5A1 "AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1" ENSG00000136931 "Nuclear receptor subfamily 5 group A member 1" Q13285 9 124481236-124507430 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 47.7;lymphoid tissue: 50.8" "Group enriched" "Detected in some" 10 "Leydig cells: 10.9;Peritubular cells: 7.1;Sertoli cells: 12.9" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.3" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.3" "Cell line enhanced" "Detected in some" "HEL: 39.1;Hep G2: 25.3;K-562: 9.3" "Region enriched" "Detected in single" 20 "hypothalamus: 6.1" "Not detected" "Not detected" HPA079181 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA079181: " "unprognostic (1.66e-1)" "unprognostic (3.08e-1)" "unprognostic (6.13e-5)" "unprognostic (2.32e-7)" "unprognostic (3.95e-1)" "unprognostic (1.16e-1)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (1.60e-2)" "unprognostic (9.74e-2)" "unprognostic (4.14e-2)" "unprognostic (4.75e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-2)" 0.2 47.7 0.2 0.2 0.5 0.0 0.2 0.2 0.4 0.2 0.2 1.3 0.2 0.0 0.2 0.4 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 13.1 0.2 0.0 5.8 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.8 0.0 9.4 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 25.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.5 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NR5A2 "B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1" ENSG00000116833 "Nuclear receptor subfamily 5 group A member 2" O00482 1 200027602-200177424 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "intestine: 38.7;liver: 36.1;pancreas: 100.4" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 35.9;Exocrine glandular cells: 46.6;Hepatocytes: 34.2;Ito cells: 46.1;Pancreatic endocrine cells: 31.2;Undifferentiated cells: 29.8" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "A549: 19.7;HAP1: 12.0;HMC-1: 5.2;HUVEC TERT2: 16.5" "Region enhanced" "Detected in single" "hypothalamus: 1.5" "HPA005455, HPA017067" Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA005455: AB_1078140, HPA017067: AB_1844767" "unprognostic (7.47e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (1.19e-2)" "unprognostic (6.63e-3)" "unprognostic (4.46e-2)" "unprognostic (3.78e-2)" "unprognostic (3.34e-1)" "unprognostic (8.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.44e-1)" "unprognostic (1.00e-7)" "unprognostic (5.48e-2)" "unprognostic (5.07e-2)" "unprognostic (9.23e-2)" "unprognostic (1.37e-1)" 2.9 0.2 0.2 4.5 0.3 0.0 2.6 0.2 0.2 2.3 23.8 0.2 0.6 8.1 3.5 1.3 0.7 1.3 5.7 0.5 0.2 0.4 0.4 36.1 1.6 0.7 0.3 0.3 1.0 100.4 0.0 0.3 0.3 0.3 1.1 6.3 0.3 0.5 1.3 1.0 0.7 38.7 1.8 0.4 0.3 0.6 0.6 0.2 0.2 0.8 0.3 0.4 0.8 1.1 1.3 1.4 5.5 1.2 1.5 1.1 0.3 0.0 19.7 0.0 0.1 0.0 0.2 0.5 0.0 0.3 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.6 0.5 12.0 0.0 0.0 2.5 0.8 0.0 0.2 2.0 0.4 0.0 5.2 0.1 0.0 0.0 0.1 0.0 16.5 0.1 0.0 0.3 0.0 0.5 0.0 0.3 0.8 0.0 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.6 3.8 0.3 0.1 0.8 0.2 0.1 0.1 2.8 1.8 2.0 0.3 0.1 0.1 5.5 1.2 1.1 0.6 0.7 0.7 0.7 1.0 0.8 0.4 1.3 1.1 1.0 4.2 1.5 0.5 1.4 0.9 0.3 0.2 0.3 0.2 0.2 0.2 0.4 0.3 0.3 0.3 0.2 0.0 1.7 0.0 0.1 1.6 0.1 6.2 22.9 1.4 0.0 0.0 0.0 0.0 0.0 25.4 0.2 16.3 35.9 0.0 46.6 0.0 0.6 0.2 12.7 34.2 0.1 0.0 4.7 46.1 6.5 0.0 0.6 0.0 0.0 5.4 9.8 0.0 31.2 24.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.3 0.0 0.0 29.8 0.2 NR6A1 "CT150, GCNF, GCNF1, RTR" ENSG00000148200 "Nuclear receptor subfamily 6 group A member 1" Q15406 9 124517275-124771310 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8" "Cancer enriched" "Detected in many" 16 "testis cancer: 27.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.6" "Lineage enriched" "Detected in many" 7 "granulocytes: 8.6" "Cell line enhanced" "Detected in many" "BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031461, HPA045145" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA031461: AB_2673894, HPA045145: AB_2679233" "unprognostic (1.73e-1)" "unprognostic (6.66e-2)" "unprognostic (4.53e-1)" "unprognostic (1.34e-6)" "unprognostic (4.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.52e-5)" "unprognostic (6.31e-2)" "unprognostic (8.01e-3)" "unprognostic (2.71e-2)" "unprognostic (1.58e-2)" "unprognostic (1.63e-1)" "unprognostic (7.26e-2)" "unprognostic (7.20e-3)" "unprognostic (1.71e-1)" "unprognostic (6.77e-3)" "unprognostic (1.09e-1)" 0.6 1.0 2.9 1.4 3.4 5.5 1.8 5.8 3.5 0.8 7.9 1.2 1.3 2.5 0.9 1.4 2.2 1.0 0.9 1.0 3.3 1.3 1.9 2.8 1.8 0.7 2.1 2.4 0.6 3.3 1.5 2.2 4.2 2.2 1.7 2.3 1.7 1.5 1.4 1.9 2.6 5.3 0.8 2.3 1.1 0.7 28.2 2.8 0.0 7.3 0.8 1.1 1.3 1.4 0.3 1.0 8.6 1.2 0.1 0.0 0.1 0.5 1.2 6.3 0.8 0.1 0.1 47.8 0.1 0.4 0.3 0.5 11.0 1.2 2.1 0.4 0.0 1.6 1.1 0.6 0.5 0.7 0.5 2.0 1.7 1.8 10.7 0.0 1.0 3.1 0.0 0.6 0.5 0.7 0.1 0.1 0.5 14.1 0.3 0.2 0.2 0.0 1.3 17.0 0.5 0.5 0.5 0.6 0.9 0.2 0.8 0.9 0.3 0.0 0.3 0.4 9.8 1.1 0.5 0.0 0.6 1.3 0.4 0.3 1.4 10.3 1.9 0.3 1.0 0.3 0.1 1.2 2.0 0.0 0.9 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 8.6 0.1 0.6 0.2 0.0 0.1 2.9 3.4 5.8 3.5 3.3 1.3 2.1 2.4 2.2 2.8 0.0 7.7 0.0 15.1 33.2 2.8 1.4 10.2 4.0 4.5 5.2 27.5 30.8 1.7 7.9 43.0 2.7 13.2 0.0 3.1 112.0 3.0 14.2 1.1 5.5 7.1 1.6 4.6 1.3 1.8 22.4 1.1 4.6 8.5 5.4 6.7 8.0 2.3 7.0 1.8 1.9 10.5 0.0 2.1 68.9 111.8 34.8 25.6 0.0 13.0 11.9 NRAP ENSG00000197893 "Nebulin related anchoring protein" Q86VF7 10 113588716-113664127 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 74.1;skeletal muscle: 268.1;tongue: 82.3" "Cell type enriched" "Detected in some" 147 "Cardiomyocytes: 530.6" "Group enriched" "Detected in some" 7 "head and neck cancer: 8.2;prostate cancer: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "OE19: 3.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA037953, HPA037954" Enhanced NA NA "HPA037953: AB_2675755, HPA037954: AB_10672394" "unprognostic (1.13e-1)" "unprognostic (2.95e-1)" "unprognostic (3.61e-2)" "unprognostic (2.05e-2)" "unprognostic (5.75e-2)" "unprognostic (1.97e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-3)" "unprognostic (3.72e-2)" "unprognostic (4.20e-2)" "unprognostic (6.40e-2)" "unprognostic (2.88e-1)" "unprognostic (5.39e-4)" "unprognostic (8.21e-2)" "unprognostic (1.16e-1)" "unprognostic (3.16e-1)" 5.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 9.4 5.8 0.0 0.0 74.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.3 0.1 0.0 4.2 0.0 268.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.8 82.3 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 530.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.1 0.0 0.0 0.2 0.0 NRARP MGC61598 ENSG00000198435 "NOTCH regulated ankyrin repeat protein" Q7Z6K4 9 137300482-137302251 "Predicted intracellular proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 41.7" "Group enriched" "Detected in many" 7 "Basal keratinocytes: 86.2;Suprabasal keratinocytes: 333.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 23.4;HEK 293: 11.8;NTERA-2: 17.2;OE19: 11.5;T-47d: 11.9;TIME: 17.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025729 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA025729: AB_1854633" "unprognostic (9.92e-2)" "unprognostic (1.75e-2)" "unprognostic (1.56e-1)" "unprognostic (7.17e-3)" "unprognostic (1.78e-1)" "unprognostic (1.15e-1)" "unprognostic (3.42e-2)" "unprognostic (1.89e-2)" "unprognostic (1.00e-2)" "unprognostic (6.42e-2)" "unprognostic (4.73e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.73e-6)" "unprognostic (2.85e-3)" "unprognostic (1.34e-1)" "unprognostic (4.90e-2)" "unprognostic (3.28e-3)" 7.9 1.6 6.5 8.4 7.8 1.7 13.8 3.9 11.7 5.6 41.7 6.1 1.1 17.1 5.2 1.9 17.4 3.2 26.0 7.1 5.0 6.5 3.2 2.9 7.0 1.8 6.0 3.0 5.6 14.2 3.1 7.1 8.9 7.4 11.8 22.8 5.6 1.9 2.8 4.4 19.7 15.7 4.5 3.2 7.7 8.7 6.0 3.4 2.3 4.2 14.0 14.4 7.6 10.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.5 3.5 4.2 0.0 0.0 1.6 0.1 0.1 0.0 0.0 2.8 1.4 0.0 6.4 0.0 0.1 23.4 6.4 0.2 0.1 0.2 11.8 0.7 1.0 2.6 0.4 0.9 2.3 0.0 1.1 0.0 0.2 0.0 5.3 0.1 6.9 0.1 0.0 7.7 0.1 2.7 17.2 11.5 3.5 4.6 0.7 8.4 0.6 0.2 2.4 4.4 0.7 1.2 0.0 0.7 11.9 1.9 17.1 0.0 0.0 0.1 1.0 0.1 0.1 1.4 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 6.5 7.8 3.9 6.8 5.0 6.5 6.0 3.0 7.4 3.4 0.0 0.0 0.5 2.8 86.2 0.3 2.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 11.7 6.0 10.7 0.0 1.0 0.0 0.6 6.0 0.0 0.0 0.4 0.0 9.8 5.5 0.8 2.9 0.0 0.0 16.9 0.0 15.3 9.4 0.6 31.1 0.4 0.0 2.5 6.5 23.4 0.0 0.8 333.1 0.0 0.0 19.6 5.5 NRBF2 "COPR1, COPR2, DKFZp564C1664, FLJ30395" ENSG00000148572 "Nuclear receptor binding factor 2" Q96F24 10 63133247-63155031 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.9" "Cell type enhanced" "Detected in many" 8 "Syncytiotrophoblasts: 238.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 100.9" "Lineage enriched" "Detected in all" 8 "granulocytes: 100.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021670, HPA059477" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA021670: AB_2670803, HPA059477: AB_2684032" "unprognostic (7.71e-2)" "unprognostic (2.74e-1)" "unprognostic (1.71e-1)" "unprognostic (2.05e-2)" "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-2)" "unprognostic (2.42e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (2.36e-4)" "unprognostic (2.38e-1)" "unprognostic (3.21e-2)" "unprognostic (2.44e-2)" "unprognostic (1.59e-2)" 15.1 10.0 10.7 16.1 10.2 22.1 21.6 10.9 13.9 12.3 12.3 7.0 9.0 12.4 13.9 9.9 13.9 10.0 13.2 13.6 10.9 9.5 10.6 50.2 19.1 29.4 13.1 8.9 9.2 10.3 6.9 11.5 21.3 11.7 8.7 12.8 6.0 14.8 11.0 46.2 14.6 15.0 10.8 11.7 22.9 10.5 10.0 8.9 16.4 14.2 13.9 14.6 14.6 13.5 7.0 10.0 100.9 13.3 4.3 5.7 7.2 8.9 8.1 8.1 7.4 19.5 30.1 8.1 12.8 21.9 10.3 14.6 17.2 9.6 11.6 6.3 14.3 10.3 7.0 7.9 10.8 14.1 10.4 7.9 8.6 4.2 13.7 25.0 11.3 10.0 27.9 23.2 16.7 41.0 19.3 10.5 7.6 8.7 13.5 13.0 6.6 9.5 20.1 9.4 7.3 33.9 9.3 7.3 6.8 11.8 5.1 4.6 8.0 7.6 14.9 22.2 13.9 9.2 11.3 10.7 7.1 10.5 11.1 13.6 17.0 13.0 14.1 19.9 18.2 5.7 13.8 11.8 22.8 4.5 13.3 4.7 7.0 4.6 4.9 10.0 5.9 5.7 5.3 100.9 4.3 12.5 4.9 5.1 7.2 10.7 10.2 10.9 13.9 10.9 9.5 13.1 8.9 11.7 8.9 3.0 27.1 28.8 40.1 25.5 11.4 6.2 10.2 25.4 19.4 12.2 3.9 45.0 19.9 27.6 5.4 22.2 25.7 0.0 30.6 61.0 36.0 34.9 13.9 47.4 43.7 19.1 15.0 14.7 52.1 5.3 21.6 53.4 43.9 52.3 26.6 14.8 33.1 28.5 20.1 23.0 7.6 19.4 24.5 21.3 67.9 27.9 238.6 37.4 22.2 49.9 NRBP2 DKFZp434P086 ENSG00000185189 "Nuclear receptor binding protein 2" Q9NSY0 8 143833594-143840974 "Enzymes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020944, HPA029051, HPA029052" Approved Approved Cytosol NA NA Cytosol "CAB020944: , HPA029051: AB_2672886, HPA029052: AB_10602714" "unprognostic (1.84e-1)" "unprognostic (4.66e-2)" "unprognostic (2.54e-2)" "unprognostic (1.53e-3)" "unprognostic (1.01e-1)" "unprognostic (2.00e-2)" "unprognostic (4.03e-1)" "unprognostic (2.86e-1)" "unprognostic (3.97e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (2.01e-5)" "unprognostic (3.86e-2)" "unprognostic (3.98e-1)" "unprognostic (4.56e-2)" "unprognostic (2.04e-1)" 18.5 10.7 21.6 6.8 21.1 1.9 10.0 17.5 32.6 7.6 13.3 47.5 8.7 8.8 11.2 10.0 9.9 14.6 11.3 15.2 23.5 14.9 14.0 18.9 14.9 4.9 30.9 23.6 10.7 10.4 8.4 8.8 6.1 30.2 17.8 6.9 10.1 22.1 15.5 7.6 23.0 9.3 12.3 54.1 7.5 10.1 6.1 27.5 1.0 9.0 3.6 3.8 8.2 7.8 0.5 0.0 0.0 0.4 0.0 1.5 0.3 5.9 7.4 6.7 8.3 10.5 16.2 1.5 12.1 5.3 4.4 6.4 1.7 5.5 0.6 3.2 14.4 3.3 9.5 3.9 4.2 1.7 7.1 2.9 1.1 19.6 3.0 10.8 0.0 2.8 20.7 10.0 2.3 2.2 14.9 6.1 2.1 3.7 7.8 9.3 2.5 0.5 0.3 2.5 6.0 4.1 2.0 6.2 2.7 6.0 2.0 2.4 4.9 15.5 7.9 6.0 4.5 11.3 0.4 14.0 2.6 8.0 12.5 3.9 4.3 0.2 0.1 13.9 2.4 3.5 0.0 0.4 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 21.6 21.1 17.5 21.4 23.5 14.9 30.9 23.6 30.2 27.5 41.7 10.7 0.8 6.0 8.1 14.2 8.1 28.1 5.3 13.6 10.4 13.7 0.7 0.0 4.0 0.3 7.1 5.1 0.0 3.6 0.9 5.8 9.0 0.0 32.1 2.4 15.9 8.6 7.4 4.1 0.0 26.7 3.2 10.1 4.6 8.4 23.2 4.7 3.5 20.1 2.8 10.6 12.9 10.3 1.1 2.3 8.0 0.7 2.9 4.5 3.7 NRCAM "Bravo, KIAA0343" ENSG00000091129 "Neuronal cell adhesion molecule" Q92823 7 108147623-108456717 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 82.0" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 66.8;Cone photoreceptor cells: 96.2;Muller glia cells: 46.7" "Cancer enriched" "Detected in all" 7 "glioma: 57.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 5.5" "Lineage enriched" "Detected in single" 15 "T-cells: 5.5" "Cell line enhanced" "Detected in some" "A549: 26.4;AF22: 25.7;EFO-21: 47.9;HMC-1: 51.2;SH-SY5Y: 31.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012606 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 70000000 Nucleoplasm "Vesicles, Plasma membrane" "HPA012606: AB_1854636" "unprognostic (2.66e-1)" "unprognostic (2.65e-1)" "unprognostic (2.52e-3)" "unprognostic (2.18e-2)" "unprognostic (4.08e-3)" "unprognostic (1.01e-2)" "unprognostic (4.47e-3)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "unprognostic (4.81e-2)" "unprognostic (9.10e-3)" "unprognostic (4.33e-2)" "unprognostic (2.22e-2)" "unprognostic (9.70e-3)" "unprognostic (6.42e-2)" "unprognostic (6.51e-3)" "unprognostic (3.28e-2)" 2.5 28.7 24.5 2.3 23.7 1.2 1.6 16.6 82.0 5.0 1.6 10.5 9.5 1.5 2.6 26.6 1.5 3.7 6.3 1.1 19.1 15.9 5.8 1.3 2.7 1.6 11.8 21.2 2.1 21.5 1.2 14.6 6.4 21.7 1.6 1.6 0.7 2.4 12.1 1.0 1.6 1.5 1.6 10.8 4.2 2.3 2.2 9.9 0.0 4.0 0.0 2.9 1.5 0.8 0.1 0.0 0.3 0.0 0.0 5.5 0.6 0.0 26.4 25.7 0.0 3.1 0.6 0.5 0.1 0.1 0.2 0.4 10.6 0.0 0.0 47.9 0.2 0.4 0.1 0.6 0.4 0.2 0.0 3.4 0.0 0.2 0.2 0.0 0.2 51.2 4.3 0.0 0.0 0.1 0.0 16.5 0.0 0.0 0.2 0.4 9.9 0.1 0.0 3.5 15.7 0.0 0.0 7.5 8.6 5.9 0.0 5.0 31.5 0.3 0.0 0.5 0.9 0.0 0.0 17.5 1.1 0.2 0.0 4.3 0.0 0.1 0.2 0.2 0.0 14.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.6 24.5 23.7 16.6 34.7 19.1 15.9 11.8 21.2 21.7 9.9 0.0 0.0 0.0 0.0 0.3 66.8 0.5 2.5 0.0 0.0 5.2 96.2 2.1 3.3 1.3 25.4 0.9 0.0 0.0 10.2 0.2 0.9 0.7 22.0 0.0 0.7 12.7 0.0 2.5 1.5 4.7 0.9 0.0 3.3 1.0 0.0 46.7 5.7 0.0 0.4 2.1 7.9 0.0 0.9 1.0 1.1 0.1 3.7 0.0 0.0 0.0 NRDC "hNRD1, hNRD2, NRD1" ENSG00000078618 "Nardilysin convertase" O43847 1 51789191-51878937 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4" "Group enriched" "Detected in many" 8 "Early spermatids: 492.5;Late spermatids: 1318.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053661 Approved Nucleoplasm NA NA Nucleoplasm "HPA053661: AB_2682221" "unprognostic (1.22e-1)" "unprognostic (6.52e-2)" "unprognostic (2.14e-2)" "unprognostic (5.62e-2)" "unprognostic (2.61e-1)" "unprognostic (3.25e-2)" "prognostic unfavorable (5.49e-6)" "unprognostic (1.42e-1)" "unprognostic (4.17e-2)" "unprognostic (1.67e-1)" "unprognostic (5.86e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.12e-9)" "unprognostic (2.75e-1)" "unprognostic (2.35e-2)" "unprognostic (9.54e-2)" "unprognostic (5.53e-3)" 16.4 15.9 13.4 15.8 17.5 14.5 11.7 14.7 16.9 12.2 13.7 11.0 9.9 11.2 11.8 12.1 14.4 10.9 10.9 25.7 13.1 13.3 12.4 28.5 12.0 13.6 16.2 10.6 11.7 15.9 19.3 21.4 14.2 15.7 13.8 12.1 9.8 11.9 11.3 96.4 19.1 10.3 13.3 14.0 13.6 11.9 32.3 14.5 19.4 11.7 21.5 15.1 13.0 16.0 13.8 18.5 36.3 19.1 15.8 15.1 16.2 46.9 26.5 26.6 38.1 28.0 43.3 30.9 47.5 41.1 34.6 36.7 18.5 18.6 31.0 25.4 35.7 46.4 27.4 39.0 36.8 43.8 36.7 19.2 37.0 36.0 16.1 28.7 32.3 28.2 34.4 28.2 50.4 46.8 29.8 35.9 33.0 48.7 20.8 43.2 17.2 29.2 11.2 47.2 19.4 28.5 28.6 31.8 34.2 25.5 27.3 25.5 19.2 43.3 34.9 25.7 53.9 23.3 39.3 29.8 30.4 28.2 33.1 40.3 31.1 46.9 29.0 35.9 40.7 34.8 19.3 18.1 26.0 13.7 19.1 13.7 13.8 12.7 15.1 18.5 9.3 12.5 13.4 36.3 15.8 14.5 15.0 14.4 16.2 13.4 17.5 14.7 16.9 13.1 13.3 16.2 10.6 15.7 14.5 32.8 55.9 17.8 35.3 0.0 67.0 0.0 17.8 108.4 63.7 26.2 76.6 47.3 26.6 38.1 492.5 33.3 18.8 70.0 55.1 37.0 33.6 42.0 32.5 52.9 39.9 58.8 17.5 28.3 38.2 1318.0 61.2 53.3 0.0 60.5 26.4 53.0 45.7 14.0 55.5 15.1 68.3 58.2 0.0 37.6 20.9 0.0 69.0 40.6 27.9 33.4 NREP "C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17" ENSG00000134986 "Neuronal regeneration related protein" Q16612 5 111662621-111997464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 82.5;Cytotrophoblasts: 84.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 149.5" "Group enriched" "Detected in many" 5 "myeloid DC: 16.0;NK-cell: 4.1;plasmacytoid DC: 16.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 70.3;SH-SY5Y: 76.1" HPA000545 Approved Approved Vesicles NA NA Vesicles "HPA000545: AB_1845721" "unprognostic (2.85e-2)" "unprognostic (1.00e-2)" "unprognostic (2.30e-1)" "unprognostic (1.48e-3)" "unprognostic (4.37e-1)" "unprognostic (2.26e-1)" "unprognostic (8.16e-3)" "unprognostic (1.58e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (3.76e-2)" "unprognostic (2.02e-1)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (5.76e-3)" 4.2 14.4 14.1 5.0 21.9 7.1 6.4 149.5 45.5 8.2 8.5 6.7 4.3 3.5 21.7 4.1 5.2 4.6 16.0 17.2 15.7 10.5 11.7 11.7 6.3 3.3 11.0 21.5 10.4 2.9 1.7 5.0 28.2 27.8 13.1 5.9 16.1 8.3 18.2 39.6 4.7 3.9 13.1 8.0 8.3 5.6 3.0 4.3 34.1 4.7 8.6 3.8 7.4 6.4 0.9 16.2 0.0 2.6 4.1 1.1 1.4 0.1 1.1 70.3 14.9 3.3 7.9 3.3 23.4 13.9 22.2 36.9 0.1 0.4 11.5 7.3 11.3 3.1 0.0 14.6 0.8 11.5 4.6 2.1 9.0 5.9 12.4 4.7 11.9 0.1 7.6 3.7 21.5 7.4 52.5 25.1 13.1 0.1 1.2 23.1 0.2 47.4 8.4 39.8 0.0 5.4 51.0 28.4 3.1 8.5 0.2 16.0 76.1 5.1 0.3 0.5 38.6 2.9 33.1 4.9 27.1 9.1 13.2 2.5 5.6 4.5 14.6 6.0 25.3 5.3 0.0 2.6 0.0 0.0 1.3 0.0 0.9 0.1 0.1 16.0 0.8 0.8 1.1 0.0 4.1 0.6 16.2 0.0 1.4 14.1 21.9 149.5 45.5 15.7 10.5 11.0 21.5 27.8 4.3 6.0 25.0 2.7 1.4 16.1 66.2 29.9 10.2 0.0 9.1 12.2 82.5 84.9 28.2 13.3 2.0 15.7 1.1 0.0 4.9 16.2 34.0 0.8 4.7 8.5 30.5 19.1 20.7 33.7 14.5 0.8 7.8 6.9 13.5 1.8 7.6 12.1 7.6 0.0 21.9 42.5 28.6 12.9 22.3 0.9 11.3 11.0 26.3 4.9 10.7 0.1 NRG1 "GGF, HGL, HRG, NDF, NRG1-IT2" ENSG00000157168 "Neuregulin 1" Q02297 8 31639386-32767959 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7;Basal glandular cells: 36.6;Early spermatids: 31.2;Horizontal cells: 27.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "classical monocyte: 22.8" "Lineage enriched" "Detected in many" 5 "monocytes: 22.8" "Cell line enhanced" "Detected in many" "A549: 38.0;BJ: 26.0;fHDF/TERT166: 29.1;GAMG: 40.0;HBF TERT88: 25.6;hTEC/SVTERT24-B: 27.3;hTERT-HME1: 28.6" "Low region specificity" "Detected in all" HPA010964 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA010964: AB_1854641" "unprognostic (5.76e-3)" "unprognostic (8.60e-2)" "unprognostic (1.96e-4)" "unprognostic (2.67e-1)" "unprognostic (1.94e-4)" "unprognostic (4.99e-2)" "unprognostic (6.69e-2)" "unprognostic (7.72e-2)" "unprognostic (2.98e-1)" "unprognostic (5.65e-2)" "unprognostic (7.99e-2)" "unprognostic (8.49e-2)" "unprognostic (4.47e-2)" "unprognostic (1.31e-1)" "unprognostic (2.88e-1)" "unprognostic (5.40e-2)" "unprognostic (7.83e-2)" 0.7 2.1 4.6 5.0 3.3 1.2 8.8 14.8 8.1 10.6 4.2 0.3 2.1 3.5 2.5 1.1 3.7 2.0 4.8 2.2 4.7 15.4 11.5 23.6 5.7 0.6 6.2 3.5 2.9 0.9 0.8 23.9 0.2 28.3 3.2 5.4 3.6 2.5 1.6 0.2 4.3 5.7 1.1 2.5 1.7 3.1 6.4 0.8 0.2 13.8 7.2 2.2 7.2 3.5 0.0 4.9 0.8 22.8 0.0 0.0 4.6 0.1 38.0 0.6 0.0 0.3 0.7 0.0 26.0 18.4 21.6 16.6 0.0 0.8 0.0 4.8 29.1 40.0 20.5 0.1 10.4 25.6 0.0 0.2 0.5 0.5 0.5 0.1 0.0 0.0 0.3 1.1 27.3 28.6 1.9 12.4 0.0 0.0 0.1 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 16.0 1.1 1.1 1.3 1.9 0.0 0.0 2.1 0.0 0.0 9.0 15.0 4.6 23.9 14.5 0.0 0.0 0.2 7.7 0.0 1.8 0.0 22.8 0.2 0.0 2.1 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.6 4.6 3.3 14.8 8.1 4.7 15.4 6.2 3.5 28.3 0.8 35.7 2.4 0.5 36.6 23.1 11.2 1.7 10.2 4.0 13.6 3.5 7.9 0.0 8.3 1.8 31.2 1.4 0.0 0.0 0.2 0.0 0.7 14.3 1.1 6.6 0.5 27.0 0.0 6.7 16.0 14.6 0.3 1.8 1.7 0.0 0.0 4.8 0.8 0.0 0.4 14.6 3.0 0.0 0.9 1.4 1.0 5.4 0.0 0.0 0.0 5.6 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.3" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 9.0;Bipolar cells: 15.1;Leydig cells: 8.9;Muller glia cells: 9.7;Peritubular cells: 9.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 4 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "AN3-CA: 8.4;Karpas-707: 5.6;PC-3: 14.8;RPTEC TERT1: 7.5;SCLC-21H: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted to blood" No NA Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: AB_2680226" "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 4.5 4.5 4.0 1.4 7.0 0.6 4.4 27.3 5.1 13.1 2.3 3.8 2.6 1.0 3.0 2.9 3.7 7.6 7.6 1.5 4.2 3.5 1.3 0.6 1.2 2.1 5.2 3.4 15.9 3.2 15.8 7.7 1.1 4.1 4.5 0.9 2.9 13.6 4.7 6.0 5.0 1.0 5.1 3.6 3.3 1.1 2.7 4.9 0.0 0.8 1.0 1.5 4.8 3.7 0.4 0.1 0.0 0.1 0.0 2.1 0.1 0.0 2.0 0.2 8.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.1 0.0 0.4 0.0 4.0 2.4 0.4 0.2 0.1 4.8 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.5 0.9 0.2 0.2 0.0 5.6 0.0 0.4 0.0 0.0 0.1 0.0 14.8 0.1 0.0 0.0 7.5 1.8 5.6 3.4 0.0 3.2 3.3 0.0 0.0 0.0 0.2 2.6 0.4 0.0 1.6 1.1 0.0 0.0 3.7 0.0 0.7 0.0 0.0 0.0 2.1 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.4 1.2 0.0 0.0 0.0 0.1 0.0 0.1 4.0 7.0 27.3 5.1 4.2 3.5 5.2 3.4 4.1 4.9 0.0 0.0 0.0 9.0 2.5 15.1 1.4 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.3 0.5 0.9 0.0 0.0 1.9 0.0 1.8 1.3 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.6 8.9 0.0 3.3 0.0 0.0 9.7 0.8 0.0 9.6 1.5 0.7 6.5 1.1 3.0 4.3 0.3 0.0 0.8 0.0 5.9 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875314-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.7;Cholangiocytes: 5.1;Early spermatids: 17.6;Ito cells: 7.4;Late spermatids: 7.9;Muller glia cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;HEK 293: 3.4;HUVEC TERT2: 1.7;SK-MEL-30: 7.3;U-2 OS: 6.4" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.9 1.5 15.6 1.2 8.2 0.6 2.8 1.9 30.6 0.8 0.9 4.8 0.0 0.8 0.7 0.7 0.9 8.0 5.3 0.9 14.5 6.2 1.2 1.5 1.6 0.8 4.9 8.0 0.7 0.9 0.7 1.6 1.2 6.5 0.9 0.9 3.1 5.0 1.1 0.7 0.8 0.9 0.9 5.6 0.8 0.8 3.3 6.0 0.0 0.9 0.0 0.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 7.3 0.5 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.2 1.9 12.8 14.5 6.2 4.9 8.0 6.5 6.0 0.0 0.0 0.0 0.0 0.0 13.7 0.8 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.9 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 7.9 0.6 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.7 0.0 1.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 36.6" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 14.7;Cone photoreceptor cells: 13.7;Exocrine glandular cells: 20.5;Pancreatic endocrine cells: 14.0;Rod photoreceptor cells: 22.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.7;HL-60: 3.2;THP-1: 2.9;U-698: 2.9;U-937: 5.3" "Not detected" "Not detected" "Region enriched" "Detected in all" 4 "cerebellum: 282.0" HPA010957 Uncertain "Secreted to digestive system" NA NA "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.4 0.5 3.5 0.2 1.3 0.8 0.3 6.9 2.7 0.3 0.4 0.5 0.0 0.2 0.3 2.1 0.8 2.2 0.2 0.4 1.4 1.0 0.5 1.1 0.7 0.2 0.5 1.8 0.3 36.6 0.2 2.5 0.8 2.1 1.2 0.3 0.0 1.5 0.3 4.8 0.6 0.3 0.2 0.5 0.4 3.0 6.3 0.3 0.0 0.4 0.5 0.2 0.5 0.3 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.8 0.0 0.0 1.3 0.4 0.1 0.0 0.1 1.5 0.1 8.7 0.4 0.0 3.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 2.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 5.3 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.3 6.9 2.7 1.4 1.0 0.5 1.8 2.1 0.3 0.0 0.0 2.2 0.9 6.6 2.2 0.2 0.0 14.7 3.4 1.8 13.7 2.0 1.7 0.2 12.2 0.3 0.3 0.0 20.5 1.9 0.4 1.7 2.3 2.9 0.3 6.4 1.2 1.3 0.0 7.0 0.6 0.3 1.7 0.0 0.0 1.5 14.0 2.9 0.0 0.0 22.2 0.0 0.1 6.1 0.7 1.1 0.7 0.0 0.3 3.8 NRGN RC3 ENSG00000154146 Neurogranin Q92686 11 124739846-124747210 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 223.3" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 53.1;Kupffer cells: 51.5;Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 7 "amygdala: 79.5;basal ganglia: 172.6;cerebral cortex: 220.7;hippocampal formation: 63.6;olfactory region: 71.9" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "dendritic cells: 2.5;granulocytes: 3.8;monocytes: 5.0" "Cell line enhanced" "Detected in many" "HEL: 49.3;PC-3: 40.0" "Group enriched" "Detected in many" 9 "amygdala: 797.3;basal ganglia: 614.3;cerebral cortex: 1197.5;hippocampal formation: 705.6" "Group enriched" "Detected in all" 5 "basal ganglia: 2514.3;cerebral cortex: 5912.4;hippocampal formation: 3143.5" "CAB006908, HPA038171" Enhanced NA NA 10000000 "CAB006908: , HPA038171: AB_2675878" "unprognostic (1.37e-1)" "unprognostic (8.24e-3)" "unprognostic (3.95e-2)" "unprognostic (1.45e-2)" "unprognostic (3.49e-2)" "unprognostic (5.33e-3)" "unprognostic (1.02e-2)" "unprognostic (9.16e-2)" "unprognostic (2.87e-2)" "unprognostic (3.72e-3)" "unprognostic (4.14e-3)" "unprognostic (5.20e-2)" "prognostic unfavorable (1.52e-5)" "unprognostic (8.29e-2)" "unprognostic (2.12e-1)" "unprognostic (4.06e-2)" "unprognostic (4.03e-2)" 4.3 2.8 79.5 4.0 172.6 11.8 1.7 0.3 223.3 2.8 2.7 3.2 0.0 2.1 3.5 2.5 2.5 4.6 3.3 3.8 63.6 13.3 3.7 1.8 14.9 2.6 9.5 71.9 2.8 1.9 1.5 0.5 3.5 4.6 2.0 2.0 0.0 1.9 2.4 2.5 1.9 2.6 3.2 1.8 8.5 2.6 2.3 17.5 0.0 2.5 0.0 2.0 2.9 0.7 0.6 2.5 3.8 5.0 0.2 0.3 9.4 4.2 3.6 15.2 17.0 0.2 0.0 0.5 2.0 1.2 1.9 1.2 2.4 6.7 12.1 7.4 0.4 4.9 1.3 3.0 5.1 0.8 2.0 8.1 49.3 1.7 1.4 0.0 1.2 15.7 0.1 0.0 1.6 0.4 1.5 9.7 4.3 2.6 5.0 1.5 16.3 0.0 0.6 5.2 2.5 40.0 6.8 7.1 1.2 1.0 2.9 2.7 5.4 2.8 9.2 0.5 3.1 8.4 13.2 10.0 7.3 5.3 3.0 5.3 1.1 0.2 0.1 5.1 12.8 8.9 1.6 5.0 1.1 0.2 2.8 0.3 0.4 0.3 0.1 2.5 0.6 0.3 0.2 3.8 0.2 1.7 0.7 0.1 9.4 79.5 172.6 0.3 220.7 63.6 13.3 9.5 71.9 4.6 17.5 0.0 53.1 0.0 0.9 3.2 0.6 1.4 2.5 0.0 0.0 0.0 0.0 0.6 3.3 0.9 2.8 7.7 0.3 0.0 0.2 2.9 1.5 0.5 1.1 0.0 11.9 0.0 5.8 3.7 51.5 4.2 0.6 13.8 5.0 0.0 1.1 0.2 0.2 0.0 0.7 0.0 1.2 19.4 16.3 4.2 4.1 1.3 0.1 1.3 1.3 1.4 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Rod photoreceptor cells: 9.2;Sertoli cells: 25.8;Smooth muscle cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favorable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 5.1 5.8 3.9 20.1 4.3 3.9 48.5 20.9 6.0 4.2 13.5 1.1 2.9 9.8 9.9 3.0 5.9 7.4 6.2 9.7 7.3 9.2 1.6 2.0 4.6 27.6 5.6 11.7 2.5 0.5 2.6 3.3 11.9 3.2 3.8 4.6 4.3 6.6 5.4 3.2 4.1 6.4 7.2 8.0 3.3 2.6 27.7 0.7 5.9 3.0 3.0 3.8 6.3 2.1 0.8 5.9 1.1 1.1 2.3 0.3 0.8 1.7 2.9 1.7 0.0 0.0 3.6 2.1 0.0 0.0 0.0 4.3 2.1 2.3 0.6 0.0 0.7 1.6 0.0 0.0 0.0 1.6 2.5 3.6 4.5 0.5 0.0 4.4 2.7 0.1 0.0 0.0 0.0 4.4 0.0 2.5 2.0 5.3 0.0 1.8 2.7 2.3 2.9 1.7 0.8 1.7 3.1 1.4 0.0 2.9 2.3 3.3 1.6 2.4 0.5 5.4 1.6 0.8 2.3 1.2 1.5 1.7 3.0 0.9 0.2 3.4 2.9 2.1 1.5 5.9 1.1 0.4 1.7 0.7 0.9 2.1 1.3 1.5 0.7 2.0 2.3 1.0 0.5 1.1 0.4 0.8 0.5 0.3 5.8 20.1 48.5 20.9 9.7 7.3 27.6 5.6 11.9 27.7 0.0 0.6 0.0 0.5 0.1 4.0 1.4 0.0 0.0 0.0 1.8 5.9 0.2 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 4.9 0.0 9.2 25.8 17.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 NRIP3 C11orf14 ENSG00000175352 "Nuclear receptor interacting protein 3" Q9NQ35 11 8980576-9004049 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.5;blood: 13.8;bone marrow: 12.7;brain: 28.4;testis: 30.3" "Group enriched" "Detected in many" 7 "Early spermatids: 432.1;Horizontal cells: 228.8;Late spermatids: 344.8;Spermatocytes: 110.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "basophil: 13.8" "Lineage enriched" "Detected in many" 13 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 14.4;HMC-1: 26.2;SiHa: 17.0;U-87 MG: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058827, HPA072961" Approved Approved Cytosol NA NA Cytosol "HPA058827: AB_2683829, HPA072961: " "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (8.84e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-1)" "unprognostic (2.68e-1)" "unprognostic (2.03e-4)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (3.63e-2)" "unprognostic (1.04e-2)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.41e-1)" "unprognostic (5.88e-3)" "unprognostic (1.30e-1)" 2.9 11.5 10.0 2.0 19.7 12.7 4.8 27.6 24.7 1.9 1.0 3.1 0.0 1.0 3.9 3.8 1.4 2.1 2.2 1.4 28.4 9.6 1.2 0.7 1.3 1.3 10.5 6.8 0.8 0.8 2.4 0.7 1.3 11.0 1.2 1.2 3.3 1.1 1.4 0.6 0.9 1.0 2.8 4.5 1.0 1.6 30.3 0.8 0.0 1.4 0.0 1.1 1.0 0.3 0.1 0.2 13.8 0.3 0.1 1.0 0.2 0.0 0.4 0.9 0.1 0.4 1.4 0.0 10.2 4.0 8.2 8.7 1.5 0.9 0.0 1.5 2.9 4.9 0.1 2.7 0.2 14.4 0.7 4.0 1.1 0.5 0.1 0.6 12.7 26.2 1.9 0.1 8.5 0.1 8.7 6.6 2.2 2.0 0.1 7.5 0.0 0.6 4.1 3.3 0.0 0.0 0.0 1.4 0.0 0.1 0.6 2.7 0.8 17.0 0.5 2.6 0.7 1.7 1.2 8.3 12.7 6.0 0.7 0.0 0.0 0.0 0.0 24.5 1.5 6.1 13.8 0.1 2.0 0.1 0.3 0.2 0.1 0.5 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.0 0.2 10.0 19.7 27.6 19.6 28.4 9.6 10.5 6.8 11.0 0.8 0.0 2.2 0.0 4.8 1.9 6.7 1.2 0.0 0.0 0.0 0.0 9.8 0.4 5.0 0.4 432.1 1.4 0.0 0.0 1.0 0.4 1.2 2.6 15.1 0.0 12.7 228.8 5.1 0.0 1.5 344.8 6.4 5.2 3.3 1.0 0.0 4.1 4.8 0.0 5.3 0.0 9.8 0.0 2.1 110.3 37.3 0.9 0.8 0.0 0.0 3.4 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.0 0.0 1.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 18.9 0.3 0.0 0.1 0.0 1.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 56.0 16.6 0.2 0.9 0.3 0.0 0.0 0.0 7.2 0.5 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 105.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.6 1.4 0.0 56.8 0.0 0.0 0.1 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24080107-24115014 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 124.5" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2618.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 1.5 2.7 4.4 2.3 4.1 1.0 1.8 2.1 2.8 1.9 1.3 1.7 1.7 3.2 1.4 7.9 1.3 1.4 1.2 2.7 3.8 3.1 3.5 3.9 1.7 1.9 3.9 1.4 1.8 3.4 5.4 2.8 1.8 2.1 1.8 1.0 124.5 1.6 2.4 4.1 0.9 1.9 1.0 4.4 2.6 1.3 4.3 1.2 3.3 4.3 1.8 1.6 1.5 2.2 3.8 1.4 4.1 1.3 2.0 2.7 1.2 0.8 1.7 0.5 1.8 0.5 0.5 1.6 0.4 0.4 2.2 1.0 1.1 0.8 2.5 0.8 1.0 1.6 1.0 1.0 1.2 0.3 1.8 1.5 0.7 0.5 3.7 1.2 1.9 3.3 0.7 1.0 0.6 1.2 0.4 1.1 3.1 1.6 3.0 0.8 2.6 2.2 1.8 0.6 3.4 1.8 2.2 2.1 0.7 1.2 1.7 2.0 2.0 1.3 1.5 1.6 0.7 1.1 2.6 0.4 1.4 0.8 0.6 1.2 7.6 3.2 2.7 0.2 1.6 1.5 0.0 1.1 4.1 1.1 1.2 0.7 3.8 1.1 1.6 1.3 2.4 2.7 2.3 0.2 2.0 1.3 1.4 1.0 1.2 4.4 4.1 2.1 2.8 3.8 3.1 3.9 1.4 2.1 1.2 0.0 0.3 4.4 1.7 0.7 340.0 1.6 0.0 0.0 1.2 7.0 406.4 1.0 11.6 0.5 1.7 0.6 2.1 23.3 1.0 0.8 0.5 2.4 0.0 2.6 1.7 236.8 1.7 0.0 0.6 2.8 1.1 0.2 1.7 1.0 1.8 381.3 0.4 0.9 1.8 6.8 2618.0 0.0 0.5 8.2 3.4 0.4 2.1 1.5 0.9 1.6 NRN1 NRN ENSG00000124785 "Neuritin 1" Q9NPD7 6 5997999-6007605 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 32.1;brain: 59.3" "Group enriched" "Detected in many" 4 "Endothelial cells: 56.9;Extravillous trophoblasts: 52.2;Ito cells: 80.4" "Cancer enhanced" "Detected in all" "glioma: 38.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "MAIT T-cell: 5.7;neutrophil: 5.6" "Group enriched" "Detected in many" 8 "granulocytes: 5.6;T-cells: 5.7" "Cell line enhanced" "Detected in many" "ASC diff: 37.3;ASC TERT1: 29.0;fHDF/TERT166: 37.6;JURKAT: 34.8;REH: 49.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.24e-2)" "unprognostic (2.47e-2)" "unprognostic (1.35e-2)" "unprognostic (1.22e-1)" "unprognostic (1.26e-2)" "unprognostic (5.57e-2)" "unprognostic (4.70e-3)" "unprognostic (2.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (1.67e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.79e-5)" "unprognostic (1.26e-1)" "unprognostic (2.04e-1)" "unprognostic (2.90e-1)" "unprognostic (4.37e-3)" 32.1 3.7 38.8 4.0 21.5 0.7 16.8 53.3 59.3 6.1 5.8 3.5 1.1 2.6 5.9 2.9 5.4 6.2 6.9 9.9 40.2 9.8 3.2 3.1 9.3 5.3 10.0 22.1 2.5 1.9 1.9 3.5 25.5 23.4 3.2 3.4 4.1 3.7 5.2 10.0 7.8 3.4 6.8 5.6 9.3 3.2 0.8 1.8 0.0 3.0 2.8 2.5 7.8 5.7 0.7 0.5 5.6 0.4 0.0 5.7 0.2 4.2 0.2 0.4 0.1 37.3 29.0 5.7 0.7 0.0 3.1 4.3 0.0 0.0 0.0 0.6 37.6 6.6 0.1 11.1 0.0 3.0 6.9 5.7 3.5 0.2 0.0 0.0 14.6 11.6 4.6 0.0 2.8 0.0 0.0 14.9 34.8 0.1 0.2 11.0 1.0 22.2 0.7 0.1 0.0 0.0 49.3 12.6 0.1 0.0 0.1 6.6 2.4 0.0 0.2 3.5 0.1 0.1 4.4 3.1 15.1 0.4 5.7 9.3 0.0 0.5 0.3 22.8 0.3 2.3 1.0 0.3 0.0 0.3 0.4 5.7 0.7 0.4 0.7 0.0 0.0 0.0 0.1 5.6 0.0 0.3 0.5 0.2 0.2 38.8 21.5 53.3 58.3 40.2 9.8 10.0 22.1 23.4 1.8 0.0 2.2 3.7 0.0 9.3 6.2 2.2 2.5 0.0 0.0 0.0 2.0 1.3 0.0 0.0 0.0 56.9 0.0 0.0 0.4 52.2 3.2 0.4 0.0 0.0 1.5 3.2 0.0 80.4 3.4 0.0 0.9 1.4 15.1 0.0 0.0 4.7 0.3 0.0 0.0 0.0 12.7 0.0 5.0 0.3 0.1 9.8 1.1 0.0 0.0 0.6 NRN1L "MRCC2446, UNQ2446" ENSG00000188038 "Neuritin 1 like" Q496H8 16 67884805-67888855 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 20.9" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 8.1;Bipolar cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "BEWO: 27.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041761 Uncertain "Secreted - unknown location" NA NA "HPA041761: AB_10961155" "unprognostic (2.79e-2)" "unprognostic (3.32e-1)" "unprognostic (1.19e-1)" "unprognostic (3.99e-2)" "unprognostic (4.85e-1)" 1.9 2.1 3.4 1.9 11.6 7.2 1.8 8.5 5.1 2.0 1.7 6.3 0.4 3.1 2.2 0.9 1.5 2.5 1.7 4.8 5.9 5.3 1.6 1.8 4.4 4.4 5.7 3.1 4.9 2.6 3.6 6.5 1.6 6.4 2.6 1.4 20.9 4.4 2.0 4.5 6.8 2.6 1.6 3.5 4.3 2.2 2.6 6.1 0.4 2.4 1.5 1.5 3.9 1.9 1.6 0.5 2.1 1.9 0.8 3.8 0.9 0.1 0.4 0.6 0.7 0.3 0.8 27.1 0.4 0.0 0.3 0.2 0.0 0.4 0.3 0.5 0.1 0.1 0.3 0.0 0.2 0.2 0.3 0.6 0.2 1.1 1.5 0.6 0.1 1.1 0.5 0.9 0.0 0.0 0.4 0.0 1.1 0.7 0.6 0.2 1.4 0.5 3.3 5.1 0.0 0.3 1.3 0.0 0.5 0.2 0.4 0.8 0.3 0.4 0.4 0.4 5.3 0.9 1.1 0.5 0.3 0.2 0.0 0.0 0.2 0.3 0.7 0.1 0.4 0.1 0.0 1.9 0.0 3.8 1.1 2.0 1.6 2.3 1.2 0.5 1.3 2.0 1.1 2.1 0.8 1.3 0.4 1.3 0.9 3.4 11.6 8.5 5.1 5.9 5.3 5.7 3.1 6.4 6.1 3.0 8.1 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 NRROS "ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030" ENSG00000174004 "Negative regulator of reactive oxygen species" Q86YC3 3 196639686-196662004 "Predicted membrane proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.4" "Cell type enhanced" "Detected in some" 14 "Hofbauer cells: 61.8;Ito cells: 18.4;Kupffer cells: 33.8;Macrophages: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 7.4;classical monocyte: 1.9;eosinophil: 3.3;intermediate monocyte: 2.0;myeloid DC: 2.5;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.5;granulocytes: 7.4;monocytes: 2.0" "Cell line enhanced" "Detected in some" "HEL: 16.4;HMC-1: 34.6;Karpas-707: 21.4;MOLT-4: 18.2;NB-4: 42.6;RPMI-8226: 21.2;THP-1: 18.8;U-937: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031586 Uncertain NA NA "HPA031586: AB_10601543" "unprognostic (5.28e-2)" "unprognostic (8.92e-3)" "unprognostic (1.02e-1)" "unprognostic (3.05e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-3)" "unprognostic (1.05e-1)" "unprognostic (9.67e-2)" "unprognostic (3.20e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (6.73e-3)" "unprognostic (1.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" 17.0 3.6 3.8 9.3 4.4 30.4 12.4 1.6 3.1 4.7 3.3 4.0 1.0 3.0 7.6 7.1 2.7 4.2 5.8 8.5 3.1 2.7 4.3 3.4 13.4 23.0 4.3 1.3 2.6 2.6 1.2 2.3 12.4 3.4 4.5 2.2 5.7 3.8 2.2 3.1 3.1 6.9 4.9 5.2 22.5 3.4 2.8 4.8 15.6 3.5 2.4 8.8 6.3 3.5 0.6 2.5 7.4 2.0 0.6 0.7 1.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.3 0.0 0.0 1.2 0.0 16.4 0.0 0.0 0.1 13.4 34.6 0.1 0.0 0.5 0.2 0.6 1.3 15.5 1.6 21.4 0.4 0.0 18.2 42.6 1.4 0.0 0.0 4.9 0.0 21.2 0.0 0.1 0.1 0.0 0.0 0.0 8.6 0.3 0.0 18.8 0.1 0.1 0.0 0.6 0.0 8.6 12.9 3.8 1.1 23.7 0.2 7.4 1.9 3.3 0.7 2.0 0.2 0.6 0.5 0.4 2.5 0.5 0.2 0.4 0.0 0.6 1.9 0.3 0.5 1.2 3.8 4.4 1.6 3.1 3.1 2.7 4.3 1.3 3.4 4.8 0.0 0.3 15.9 0.0 1.3 0.0 0.1 0.0 0.0 1.2 0.0 3.9 0.3 0.0 0.0 0.9 3.8 0.0 0.0 0.0 0.5 0.8 0.0 13.9 0.0 61.8 0.0 0.0 18.4 33.8 0.0 0.6 36.2 8.5 3.6 0.0 0.0 0.0 0.0 0.7 0.0 0.4 6.5 0.5 0.5 0.2 0.6 0.5 13.1 0.0 0.0 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 114.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019681: , HPA061006: AB_2684413" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.7 0.1 1.7 0.0 0.0 0.3 0.1 0.0 0.1 1.7 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 2.0 1.3 0.1 0.2 0.3 0.9 0.7 0.2 2.5 0.5 0.2 0.5 0.0 0.0 14.6 11.7 0.0 0.1 0.9 0.2 1.7 3.5 0.2 0.5 0.6 0.1 0.4 0.8 2.3 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 0.0 0.0 0.0 0.0 0.0 24.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NRSN2 "C20orf98, dJ1103G7.6" ENSG00000125841 "Neurensin 2" Q9GZP1 20 346782-359660 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.9" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015967 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA015967: AB_1854647" "unprognostic (5.67e-2)" "unprognostic (3.47e-1)" "unprognostic (7.50e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (4.05e-2)" "unprognostic (4.48e-2)" "unprognostic (1.48e-1)" "unprognostic (4.96e-2)" "unprognostic (5.92e-2)" "prognostic favorable (1.61e-4)" "unprognostic (6.96e-2)" "unprognostic (1.96e-3)" "unprognostic (2.94e-2)" "unprognostic (1.96e-1)" "unprognostic (7.85e-3)" "unprognostic (1.73e-3)" 8.4 18.6 34.3 6.0 39.3 0.9 7.2 22.7 70.9 12.8 6.6 11.0 4.9 3.5 12.5 16.0 6.1 13.4 9.3 13.5 31.1 24.9 10.1 1.8 8.7 4.1 17.1 28.5 18.3 10.5 26.5 16.3 10.1 27.8 12.2 6.1 12.8 13.3 16.5 1.4 5.0 3.8 16.3 8.7 5.7 5.3 12.8 6.8 1.3 14.9 2.5 4.2 9.4 4.8 9.4 4.8 1.5 1.1 3.4 3.9 1.5 18.9 23.0 13.9 13.1 18.4 20.6 5.4 12.6 24.3 22.9 23.0 12.6 0.4 0.0 4.4 23.3 16.8 8.3 11.2 1.9 14.6 0.1 11.3 6.8 11.0 24.0 18.6 0.2 1.1 23.3 1.5 16.3 2.7 18.7 15.7 0.1 13.5 12.3 20.0 3.3 0.3 5.8 10.7 0.2 11.9 10.8 7.8 0.9 22.8 0.1 28.4 20.4 15.0 4.4 21.5 9.5 18.4 7.1 10.4 24.5 13.0 0.9 15.3 2.3 0.4 5.1 3.2 0.2 12.9 0.0 1.1 1.5 3.8 0.3 1.1 7.2 1.1 3.9 2.1 9.4 1.6 2.7 0.0 3.4 0.4 4.8 0.9 1.5 34.3 39.3 22.7 70.9 31.1 24.9 17.1 28.5 27.8 6.8 0.0 1.9 0.0 3.1 2.9 24.5 4.0 0.0 2.7 7.9 12.2 2.0 6.1 1.7 11.0 5.5 4.5 1.3 0.0 1.4 5.3 10.8 2.5 4.7 0.4 2.7 15.9 28.3 4.3 1.2 10.0 12.0 1.2 3.3 3.6 2.7 12.3 3.8 1.9 9.9 5.7 12.7 19.4 9.2 21.3 6.6 1.9 3.7 1.0 2.0 2.7 NRTN NTN ENSG00000171119 Neurturin Q99748 19 5823802-5828324 "Disease related genes, Predicted secreted proteins" "Growth factor" "Disease mutation, Hirschsprung disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 15.3;pancreas: 12.3" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 10.8;Cone photoreceptor cells: 11.8;Hepatocytes: 10.6;Rod photoreceptor cells: 43.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9;T-reg: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 7.2;K-562: 7.1;REH: 18.6;SH-SY5Y: 10.0;U-266/70: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA065260 Approved "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA065260: AB_2685448" "unprognostic (4.85e-2)" "unprognostic (1.66e-2)" "unprognostic (2.96e-2)" "prognostic favorable (3.86e-4)" "unprognostic (1.60e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.21e-3)" "unprognostic (5.60e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.38e-1)" "unprognostic (2.08e-2)" "unprognostic (1.28e-2)" "unprognostic (6.78e-3)" "unprognostic (3.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.32e-2)" 0.0 3.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 4.9 1.5 0.3 0.6 2.1 0.4 0.5 15.3 0.0 0.0 1.8 7.6 0.0 0.0 0.0 0.0 12.3 0.6 0.3 0.0 1.3 0.0 6.8 1.2 0.0 3.0 1.5 0.9 0.0 0.0 5.0 0.3 0.0 0.0 1.8 1.3 0.7 1.9 0.0 0.1 0.0 1.7 0.3 0.5 0.7 0.8 2.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.9 0.0 0.5 0.1 2.9 0.0 0.0 7.2 5.2 0.0 0.0 2.3 0.9 0.1 1.9 0.1 0.8 0.0 0.0 0.0 0.0 2.5 7.1 0.0 0.0 1.5 0.6 0.7 2.4 1.1 1.8 18.6 2.4 4.3 0.3 0.0 0.5 10.0 0.1 0.9 1.0 0.3 0.3 0.6 0.0 0.0 1.6 0.0 0.0 10.7 2.2 0.5 0.0 1.2 0.7 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.7 0.1 0.4 0.7 0.3 0.3 0.0 0.0 0.0 1.9 1.7 0.3 0.0 2.6 0.0 1.5 1.6 4.7 10.8 2.5 0.0 0.0 3.5 11.8 0.1 3.3 0.2 0.0 0.3 0.0 0.0 0.6 0.0 0.6 1.1 0.0 10.6 0.2 0.0 1.2 4.3 0.0 0.2 0.9 0.0 5.0 0.0 0.0 5.1 1.0 0.0 0.0 0.3 43.6 0.0 0.9 0.3 2.3 4.0 0.1 0.0 0.6 0.9 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 70.6;Early spermatids: 130.0;Horizontal cells: 73.1;Late spermatids: 79.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" NA NA 620000 "Plasma membrane" "HPA071400: AB_2732180" "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 29.0 1.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 0.0 0.0 0.0 0.4 0.0 70.6 15.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.0 130.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 73.1 1.7 5.5 0.0 79.3 2.3 0.2 1.7 0.0 0.0 20.9 0.3 0.0 0.7 0.0 8.0 0.0 0.3 9.9 3.8 0.1 0.2 0.0 0.0 0.0 NRXN2 ENSG00000110076 "Neurexin 2" "P58401, Q9P2S2" 11 64606174-64723188 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.5" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 43.6;Horizontal cells: 141.4;Muller glia cells: 51.8;Peritubular cells: 55.5" "Cancer enhanced" "Detected in many" "glioma: 12.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.0;non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 6 "monocytes: 2.0" "Cell line enhanced" "Detected in some" "REH: 28.4;SCLC-21H: 14.3;SH-SY5Y: 6.5;U-2 OS: 16.6;U-87 MG: 11.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.87e-2)" "unprognostic (1.54e-4)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "unprognostic (8.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (5.08e-2)" "unprognostic (3.23e-1)" "unprognostic (5.93e-3)" "unprognostic (3.40e-1)" "unprognostic (9.97e-3)" "unprognostic (2.39e-2)" "unprognostic (6.99e-2)" "unprognostic (4.27e-4)" "unprognostic (5.46e-3)" 3.4 7.5 33.3 4.1 26.3 2.5 2.3 68.8 101.5 7.3 4.6 6.5 1.0 3.1 11.7 3.3 2.5 6.4 4.4 2.9 28.8 23.5 3.8 2.4 2.5 3.0 15.2 32.8 6.3 2.5 2.2 1.3 2.8 14.0 4.5 2.7 3.5 3.2 5.6 2.5 2.2 3.0 4.7 12.4 3.5 2.4 11.6 8.7 0.0 2.9 0.0 2.5 2.4 2.5 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.2 0.2 1.5 1.3 0.0 2.0 0.0 0.0 0.2 0.2 3.9 0.0 0.0 0.0 0.0 0.3 0.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 5.5 1.9 0.0 0.4 0.2 4.7 0.0 0.0 28.4 0.9 1.1 0.0 0.0 14.3 6.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.7 16.6 0.3 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 33.3 26.3 68.8 41.2 28.8 23.5 15.2 32.8 14.0 8.7 0.0 0.0 0.0 0.0 0.5 43.6 2.4 0.0 0.0 0.0 1.8 5.9 0.1 3.3 0.0 19.4 0.9 2.0 0.0 2.3 0.2 2.5 0.0 0.0 6.4 0.2 141.4 6.4 3.1 0.0 37.1 39.4 0.0 0.0 1.0 1.1 51.8 0.7 3.4 55.5 34.9 18.9 0.0 3.1 19.5 7.0 0.1 0.2 0.0 0.6 0.0 NRXN3 "C14orf60, KIAA0743" ENSG00000021645 "Neurexin 3" "Q9HDB5, Q9Y4C0" 14 78170373-79868290 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 134.6;Horizontal cells: 109.7;Muller glia cells: 64.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 8.4;RT4: 20.7;SK-BR-3: 8.0" "Low region specificity" "Detected in all" HPA002727 Approved NA NA 520000 "HPA002727: AB_1079468" "unprognostic (7.96e-2)" "unprognostic (5.70e-4)" "unprognostic (8.18e-3)" "unprognostic (2.19e-2)" "unprognostic (2.31e-4)" "unprognostic (9.56e-2)" "unprognostic (2.80e-1)" "unprognostic (2.99e-3)" "unprognostic (1.12e-2)" "unprognostic (7.91e-2)" "unprognostic (2.40e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.83e-7)" "unprognostic (4.81e-2)" "unprognostic (2.61e-1)" "unprognostic (3.61e-2)" "unprognostic (2.91e-1)" 1.8 7.5 15.1 4.1 24.7 1.1 2.8 75.3 36.9 6.3 12.3 2.6 7.3 3.6 4.7 2.8 6.7 3.9 3.9 2.3 12.7 9.4 2.3 1.3 4.0 1.3 11.9 20.2 1.4 4.5 1.7 9.2 2.3 14.7 9.5 6.0 7.8 4.1 15.7 1.1 2.9 5.6 25.5 8.6 7.4 6.9 7.5 4.3 0.0 1.2 0.0 1.2 8.1 2.1 0.5 0.3 2.2 0.4 0.4 0.2 0.1 0.0 0.0 6.4 0.0 0.1 0.3 0.0 2.5 1.9 8.4 6.3 2.2 0.0 0.1 0.0 0.2 0.0 2.4 0.0 0.2 5.8 2.4 5.2 0.0 0.2 0.0 0.7 0.0 0.0 1.5 0.2 3.6 1.2 4.0 2.1 0.0 0.0 0.1 0.1 0.0 0.2 0.2 1.4 0.0 0.0 0.2 0.0 0.0 4.5 20.7 1.1 0.0 0.0 8.0 0.4 2.8 0.0 0.0 0.0 0.1 5.5 0.0 2.7 0.0 0.0 0.0 1.5 0.3 4.6 2.2 0.4 0.5 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.5 0.2 0.2 1.6 0.4 0.2 0.3 0.1 0.1 15.1 24.7 75.3 36.9 12.7 9.4 11.9 20.2 14.7 4.3 11.9 5.6 0.0 7.9 4.0 134.6 3.9 2.5 10.7 4.5 3.5 11.8 5.3 0.0 2.2 11.3 1.4 0.0 0.0 2.8 0.3 1.0 6.1 0.0 0.0 0.6 109.7 5.8 2.5 0.0 14.4 6.9 0.0 16.9 0.0 0.2 64.1 1.0 0.0 6.0 0.0 9.9 0.0 0.7 0.7 0.7 0.6 31.7 0.0 0.2 1.4 NSF "SEC18, SKD2" ENSG00000073969 "N-ethylmaleimide sensitive factor, vesicle fusing ATPase" P46459 17 46590669-46757464 "Enzymes, Predicted intracellular proteins, Transporters" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 95.1;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 82.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003154, CAB009324, HPA071089" Enhanced Supported "Golgi apparatus,Cytosol" NA NA 6900 Cytosol "Golgi apparatus" "CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343" "unprognostic (5.70e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.95e-2)" "unprognostic (5.48e-2)" "unprognostic (2.37e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (3.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.74e-1)" 1.9 3.6 11.2 2.7 19.1 1.6 2.6 14.1 35.4 2.5 4.0 1.4 1.9 2.7 3.9 2.2 2.8 1.5 13.9 14.4 3.4 2.5 2.2 3.1 12.6 1.3 3.5 6.5 5.5 2.6 2.8 5.5 2.4 2.1 4.3 2.4 3.2 2.2 3.1 1.6 3.0 3.1 3.6 3.4 3.3 1.0 7.2 15.5 10.4 13.3 6.7 11.1 8.8 6.1 13.6 9.1 0.6 5.4 7.6 7.4 8.4 9.9 8.1 7.9 9.3 0.0 15.0 15.1 18.6 8.4 1.1 10.2 3.1 13.3 5.3 13.4 0.5 9.8 12.8 8.0 0.4 3.3 6.9 4.3 16.4 6.9 4.3 12.7 3.8 10.0 8.2 17.9 12.0 10.0 3.9 5.1 19.1 16.2 7.2 8.8 14.0 9.3 12.8 8.4 9.5 12.4 0.0 5.9 10.1 15.6 18.7 10.3 22.9 8.1 12.1 12.6 17.7 10.1 8.9 6.4 8.1 16.1 10.4 13.3 7.8 8.2 12.1 8.9 6.8 8.2 10.5 15.5 7.2 6.9 8.1 6.0 6.7 12.1 6.2 11.1 8.8 8.9 9.9 12.6 3.2 3.5 95.1 6.2 10.2 4.0 7.9 21.0 82.5 10.9 10.0 10.3 26.6 10.6 25.1 0.0 14.0 12.0 9.3 10.6 9.2 18.7 16.9 41.3 29.3 11.6 27.2 34.0 5.5 15.5 10.1 28.9 27.8 21.3 11.7 14.4 8.1 12.2 82.9 0.0 11.7 28.9 31.3 5.0 15.4 10.9 16.1 7.8 NSG1 "D4S234E, NEEP21, P21" ENSG00000168824 "Neuronal vesicle trafficking associated 1" P42857 4 4348140-4419058 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.8;pituitary gland: 49.1;skin 1: 70.0" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 151.1;Cytotrophoblasts: 92.7;Melanocytes: 276.7;Suprabasal keratinocytes: 155.8" "Cancer enhanced" "Detected in many" "melanoma: 61.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 25.5" "Lineage enriched" "Detected in single" 58 "T-cells: 25.5" "Cell line enhanced" "Detected in some" "HAP1: 23.4;SCLC-21H: 47.7;SH-SY5Y: 23.2;SK-MEL-30: 22.3;TIME: 56.4;U-698: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.21e-3)" "unprognostic (2.33e-1)" "unprognostic (5.29e-3)" "unprognostic (7.60e-2)" "unprognostic (8.06e-2)" "unprognostic (1.49e-1)" "unprognostic (1.32e-3)" "unprognostic (3.47e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-3)" "prognostic favorable (9.49e-4)" "unprognostic (2.50e-1)" "unprognostic (6.85e-2)" "unprognostic (4.21e-2)" "unprognostic (7.33e-2)" "unprognostic (2.85e-1)" "unprognostic (7.41e-2)" 1.4 16.1 8.9 2.8 44.8 1.0 4.2 32.2 32.0 4.7 5.1 3.1 0.4 4.4 5.3 2.6 17.2 12.7 1.3 3.8 6.0 31.9 1.3 0.7 1.4 2.3 15.8 19.2 29.5 1.6 0.5 49.1 20.9 38.8 14.4 4.8 7.6 4.5 12.5 1.0 70.0 3.8 4.7 6.2 1.8 5.3 9.8 4.4 3.7 0.8 4.3 2.6 10.2 8.3 0.0 0.0 0.4 0.0 0.3 25.5 6.9 0.0 0.0 0.2 0.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.9 0.1 0.9 0.6 23.4 1.5 0.1 0.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.3 0.0 0.6 0.0 4.0 6.2 0.0 0.0 0.3 0.0 1.8 0.1 2.8 0.0 0.1 0.0 0.0 0.1 0.0 1.3 47.7 23.2 0.1 0.0 22.3 2.0 0.2 0.0 56.4 0.0 3.7 0.0 0.0 0.0 0.1 20.3 0.0 0.0 0.1 0.0 0.0 0.0 19.2 0.0 25.5 0.0 18.0 15.6 0.0 0.0 4.7 12.0 0.4 0.3 0.0 0.0 1.7 6.9 8.9 44.8 32.2 32.0 6.0 31.9 15.8 19.2 38.8 4.4 8.9 0.0 0.0 71.8 77.0 151.1 0.0 0.0 1.4 5.7 0.0 3.9 92.7 0.0 0.0 30.8 0.5 0.0 0.0 0.0 13.3 7.6 12.1 1.1 0.0 7.4 7.9 2.4 1.8 0.0 35.3 2.8 1.7 276.7 0.0 0.0 6.4 0.2 0.0 5.3 3.7 17.4 0.0 2.1 2.3 12.8 155.8 64.2 11.5 0.0 80.5 NSG2 "CALY3, HMP19, Nsg2" ENSG00000170091 "Neuronal vesicle trafficking associated 2" Q9Y328 5 174045604-174243501 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 120.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 8 "glioma: 12.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 58 "SCLC-21H: 21.9;SH-SY5Y: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046531, HPA056191" Enhanced Enhanced "Golgi apparatus" NA NA "Golgi apparatus" "HPA046531: AB_2732528, HPA056191: AB_2683062" "unprognostic (1.25e-2)" "unprognostic (1.36e-1)" "unprognostic (3.27e-1)" "unprognostic (3.36e-5)" "unprognostic (1.93e-1)" "unprognostic (2.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.07e-1)" "unprognostic (3.29e-1)" "unprognostic (1.76e-1)" "unprognostic (3.86e-3)" "unprognostic (8.06e-2)" "unprognostic (2.29e-2)" "unprognostic (3.02e-2)" "unprognostic (5.20e-2)" "unprognostic (9.31e-4)" "unprognostic (1.55e-1)" 1.7 23.1 31.6 3.0 92.4 1.4 1.4 19.7 120.8 1.4 3.6 5.0 0.0 2.8 1.4 1.7 1.5 1.4 1.6 1.6 27.3 40.2 1.6 1.4 1.6 1.4 20.2 27.6 1.4 2.0 1.4 0.9 1.4 22.5 1.4 4.1 0.8 1.4 1.5 1.4 1.4 3.8 2.5 4.6 1.4 3.3 5.0 11.7 0.0 1.8 0.0 1.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 92.4 19.7 49.8 27.3 40.2 20.2 27.6 22.5 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NSMF NELF ENSG00000165802 "NMDA receptor synaptonuclear signaling and neuronal migration factor" Q6X4W1 9 137447573-137459334 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 96.4" "Cell type enhanced" "Detected in many" 6 "Peritubular cells: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.1;non-classical monocyte: 10.5" "Group enriched" "Detected in many" 5 "dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044316 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA044316: AB_10964877" "unprognostic (1.48e-1)" "unprognostic (4.03e-2)" "unprognostic (5.40e-2)" "unprognostic (3.92e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.35e-1)" "unprognostic (7.96e-2)" "unprognostic (3.26e-2)" "unprognostic (2.38e-3)" "unprognostic (2.34e-3)" "prognostic favorable (1.85e-6)" "unprognostic (1.97e-2)" "unprognostic (4.14e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-2)" 8.8 8.8 61.7 6.9 34.4 6.1 5.3 6.4 67.3 6.0 8.1 18.2 2.1 16.9 8.6 6.6 6.6 7.2 5.7 5.0 96.4 21.8 15.3 6.2 5.2 6.9 20.4 30.2 5.0 14.7 10.8 13.7 4.2 12.1 9.0 6.3 5.4 11.5 8.7 4.0 9.7 13.7 8.2 9.6 6.8 9.6 7.8 15.0 2.4 5.1 1.3 5.8 6.4 3.8 0.2 6.0 3.1 12.1 0.0 1.5 1.4 7.7 6.3 11.1 16.6 26.2 12.4 9.6 7.5 9.9 7.1 5.5 16.7 4.6 9.6 10.1 11.0 16.0 23.6 16.4 10.0 4.3 12.6 17.6 7.5 14.8 22.1 14.2 5.1 17.2 14.1 19.2 8.3 19.5 16.2 7.5 0.2 17.2 1.6 9.6 17.9 0.2 22.1 14.2 31.2 16.9 4.6 17.7 21.5 4.9 3.9 46.9 38.2 17.9 10.0 11.2 4.8 7.1 10.6 19.0 12.7 10.4 30.7 12.6 3.4 5.2 14.7 7.2 6.8 11.6 1.5 2.0 3.1 1.5 12.1 0.2 0.2 0.5 0.9 6.0 0.1 0.6 0.7 0.3 0.0 10.5 0.2 0.7 1.4 61.7 34.4 6.4 62.9 96.4 21.8 20.4 30.2 12.1 15.0 0.0 4.6 5.1 6.4 12.0 7.2 4.4 15.3 1.4 0.0 10.4 7.9 0.3 5.0 7.8 6.1 9.9 41.2 0.0 18.2 1.0 8.2 16.2 2.3 18.3 5.6 27.0 18.4 11.6 8.9 11.4 22.2 5.9 15.1 4.6 15.7 10.4 18.9 17.5 67.1 26.7 13.1 12.9 13.0 2.5 5.3 12.8 1.3 5.7 11.5 13.9 NSUN4 "MGC22960, SHTAP" ENSG00000117481 "NOP2/Sun RNA methyltransferase family member 4" Q96CB9 1 46340177-46365152 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, rRNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 18.4;testis: 55.1" "Group enriched" "Detected in many" 9 "Early spermatids: 122.0;Late spermatids: 421.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028489 Approved NA NA "HPA028489: AB_10601444" "unprognostic (3.28e-2)" "unprognostic (1.86e-1)" "unprognostic (1.33e-2)" "unprognostic (5.53e-2)" "prognostic favorable (8.99e-4)" "unprognostic (2.02e-2)" "prognostic unfavorable (1.97e-5)" "unprognostic (5.50e-2)" "unprognostic (1.34e-2)" "unprognostic (6.79e-2)" "unprognostic (1.22e-1)" "unprognostic (2.19e-1)" "unprognostic (1.22e-3)" "unprognostic (2.65e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-3)" "unprognostic (2.28e-1)" 5.0 8.2 3.3 4.5 4.6 6.2 5.3 4.4 6.0 3.2 3.4 5.5 5.4 3.5 4.8 4.1 5.5 4.2 4.5 5.0 2.8 2.8 5.0 5.1 4.6 3.5 5.3 3.3 5.7 4.8 5.2 5.2 4.2 5.1 4.9 3.9 4.7 5.3 6.2 4.7 5.0 4.2 3.8 4.0 4.9 4.0 55.1 4.1 4.3 5.0 3.9 4.7 5.0 4.9 7.2 7.7 18.4 6.8 4.0 4.5 3.3 3.9 8.2 6.4 7.6 7.7 5.7 9.1 4.0 5.2 8.4 9.2 9.7 3.7 9.9 11.7 6.1 11.8 5.8 5.5 8.9 6.4 11.8 9.5 10.0 9.1 13.2 9.0 7.7 7.6 7.5 9.2 11.6 13.1 3.6 9.2 7.9 14.8 10.4 8.6 12.1 6.5 4.1 7.5 5.7 3.8 8.9 4.3 13.2 14.4 12.8 9.7 3.6 6.6 8.0 8.5 6.7 5.4 9.6 7.3 5.7 6.3 4.5 5.0 6.1 5.1 8.6 3.2 9.5 6.4 1.3 6.8 7.0 3.1 4.6 4.5 7.2 3.5 4.2 6.3 5.7 4.2 3.0 18.4 4.0 3.2 7.7 1.8 3.3 3.3 4.6 4.4 6.0 2.8 2.8 5.3 3.3 5.1 4.1 17.9 13.7 5.2 11.9 4.9 8.8 13.2 15.3 5.3 13.6 8.7 7.9 9.4 1.7 8.0 122.0 13.7 5.4 0.0 6.1 9.3 5.4 12.3 28.9 10.6 8.0 4.8 7.5 9.8 10.4 421.7 11.5 9.2 3.3 5.4 8.8 5.2 7.7 3.5 10.3 9.3 10.8 0.0 9.2 6.6 10.0 5.1 12.7 5.3 9.2 12.0 NSUN6 "ARL5B-AS1, FLJ23743, NOPD1" ENSG00000241058 "NOP2/Sun RNA methyltransferase family member 6" Q8TEA1 10 18545561-18659285 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 48.7" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 72.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045902 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA045902: AB_10962354" "unprognostic (7.34e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-3)" "unprognostic (9.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.33e-3)" "unprognostic (1.63e-2)" "prognostic favorable (8.42e-4)" "unprognostic (1.60e-1)" "unprognostic (2.45e-1)" "unprognostic (9.96e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (2.23e-1)" "unprognostic (7.53e-3)" "unprognostic (3.18e-2)" "unprognostic (2.00e-3)" 5.2 9.8 9.4 8.0 10.3 9.1 8.1 17.8 12.1 8.7 8.2 5.9 13.4 7.2 8.2 10.7 5.7 6.5 5.3 6.3 9.2 8.9 6.0 48.7 4.7 8.7 9.5 6.6 10.2 8.9 8.5 17.7 5.5 7.2 9.3 7.3 3.8 7.0 8.3 3.3 7.6 11.1 9.1 10.8 7.5 7.1 12.3 8.7 10.7 9.3 3.7 8.9 8.0 12.5 9.3 4.5 3.1 8.4 5.5 11.6 2.8 5.7 4.9 13.3 9.8 6.6 9.1 5.8 8.0 2.0 6.7 9.1 9.2 8.8 13.1 3.5 3.1 4.7 8.6 13.4 8.4 8.7 12.7 11.0 13.6 6.4 11.1 6.8 6.1 9.3 7.0 8.2 6.4 4.5 6.7 3.1 15.6 18.8 12.7 6.4 3.2 14.0 7.1 6.8 11.4 3.8 10.0 6.8 13.4 5.0 7.1 7.1 8.8 6.8 7.2 5.4 9.4 4.6 4.9 5.2 5.7 6.6 10.2 5.8 7.9 8.1 14.6 4.0 11.1 3.3 1.4 4.2 3.1 5.4 5.3 8.5 9.3 7.8 6.7 3.3 7.9 9.6 8.1 1.9 5.5 8.4 4.5 11.6 2.8 9.4 10.3 17.8 12.1 9.2 8.9 9.5 6.6 7.2 8.7 8.9 13.7 12.3 15.4 25.4 33.6 6.1 22.9 18.7 17.0 8.7 21.6 8.5 5.0 8.6 13.3 25.1 25.9 0.0 10.9 6.7 13.2 8.6 17.3 72.5 6.4 23.8 13.9 25.8 22.1 11.9 23.9 17.1 11.8 7.2 17.6 18.6 10.1 17.3 15.9 7.9 30.8 12.9 11.1 50.9 20.0 23.3 5.6 20.4 14.5 15.3 NSUN7 FLJ14001 ENSG00000179299 "NOP2/Sun RNA methyltransferase family member 7" Q8NE18 4 40749897-40809985 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.5" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 48.2;Early spermatids: 34.5;Late spermatids: 53.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.1" "Cell line enhanced" "Detected in some" "A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;SuSa: 5.1;T-47d: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020653 Uncertain Approved Vesicles NA NA Vesicles "HPA020653: AB_1848710" "unprognostic (2.32e-1)" "unprognostic (4.22e-1)" "unprognostic (4.77e-2)" "unprognostic (1.50e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (4.01e-3)" "unprognostic (4.37e-2)" "unprognostic (3.06e-1)" "unprognostic (2.24e-1)" "unprognostic (8.42e-2)" "prognostic favorable (2.76e-8)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-2)" 0.7 1.2 0.9 2.8 2.0 0.7 5.1 0.2 1.0 3.2 7.0 2.4 7.3 2.3 5.9 9.7 4.5 9.1 5.4 5.5 1.0 1.9 6.6 0.7 8.1 4.2 1.0 0.5 4.6 14.1 7.7 7.5 2.8 2.6 5.7 3.2 4.3 15.2 10.3 0.1 1.9 6.7 2.6 1.8 3.6 3.8 39.5 0.2 2.4 11.9 1.5 5.3 3.7 1.5 1.1 0.0 6.1 0.1 0.0 0.0 0.0 3.9 0.4 1.9 0.0 0.0 0.0 2.9 0.0 0.3 0.2 0.2 1.5 8.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 4.1 0.1 0.0 2.3 0.0 0.5 0.1 0.1 0.0 4.2 1.1 1.0 2.3 0.6 2.7 0.0 5.1 6.3 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.2 1.0 1.0 1.9 1.0 0.5 2.6 0.2 8.9 5.6 0.0 3.3 1.0 0.0 3.7 0.0 48.2 15.9 8.7 0.0 7.5 8.3 4.4 34.5 0.3 2.1 0.0 4.7 2.8 0.5 4.2 0.0 0.0 3.0 0.0 7.9 0.6 0.3 53.6 1.4 0.7 0.0 1.8 5.8 2.0 5.3 0.0 0.0 5.2 0.0 0.0 0.3 22.8 12.4 0.9 3.8 0.5 7.5 4.3 NT5C1A "CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201" ENSG00000116981 "5'-nucleotidase, cytosolic IA" Q9BXI3 1 39659121-39672038 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 51.9;tongue: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "SH-SY5Y: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA050283, HPA054158" Supported NA NA "HPA050283: AB_2681072, HPA054158: AB_2682402" "unprognostic (7.85e-2)" "unprognostic (1.60e-1)" "unprognostic (6.19e-1)" "unprognostic (1.51e-3)" "unprognostic (7.19e-2)" "unprognostic (2.87e-1)" "unprognostic (3.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.29e-2)" "unprognostic (1.81e-2)" 0.7 2.8 1.2 0.8 3.0 0.5 0.5 5.6 7.6 0.7 0.5 1.0 0.0 0.5 0.6 2.9 3.0 0.7 0.5 9.8 1.7 1.7 0.9 0.5 0.5 0.5 1.8 4.9 0.7 6.0 0.5 0.5 0.5 6.9 0.9 0.5 0.0 0.7 0.7 51.9 0.5 0.6 0.6 5.2 0.5 0.6 0.7 1.0 0.0 0.5 13.9 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 20.4 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.0 5.6 7.6 1.7 1.7 1.8 4.9 6.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NT5C1B "AIRP, CN-IB" ENSG00000185013 "5'-nucleotidase, cytosolic IB" Q96P26 2 18562872-18589572 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 52.6" "Group enriched" "Detected in some" 90 "Early spermatids: 137.7;Late spermatids: 218.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA056683 Uncertain NA NA "HPA056683: AB_2683207" "unprognostic (4.18e-2)" "unprognostic (1.20e-2)" "unprognostic (7.67e-2)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "unprognostic (4.97e-2)" "unprognostic (4.96e-2)" "unprognostic (4.84e-1)" "unprognostic (8.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.91e-2)" "unprognostic (2.35e-1)" "unprognostic (1.61e-1)" "unprognostic (6.96e-2)" "unprognostic (2.50e-1)" "unprognostic (1.15e-1)" "unprognostic (3.77e-1)" 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.3 0.7 0.0 0.4 0.3 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.5 52.6 0.1 0.1 0.5 0.1 0.1 0.5 0.1 1.2 3.7 0.0 0.1 0.7 2.6 0.4 3.2 0.7 0.3 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 3.5 1.6 0.5 0.0 2.2 1.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.9 0.0 0.6 0.1 0.0 0.0 0.2 0.0 3.3 0.0 0.5 1.1 0.2 0.0 2.9 0.1 0.2 0.6 0.6 1.6 0.3 0.7 0.8 0.1 2.9 2.4 1.2 2.6 0.4 1.5 0.4 0.7 0.7 1.6 1.5 1.0 2.9 0.5 1.0 0.7 2.0 2.5 0.0 1.2 0.0 0.1 0.0 1.3 0.0 2.3 0.1 1.3 1.3 0.3 1.2 2.6 2.2 0.0 0.7 0.1 3.7 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 NT5C1B-RDH14 ENSG00000250741 "NT5C1B-RDH14 readthrough" 2 18555545-18589564 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 74 "testis: 49.4" "Group enriched" "Detected in some" 76 "Early spermatids: 43.1;Late spermatids: 43.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "TIME: 1.1" HPA056683 Uncertain NA NA "HPA056683: AB_2683207" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 NT5DC3 "FLJ11266, TU12B1-TY" ENSG00000111696 "5'-nucleotidase domain containing 3" Q86UY8 12 103770453-103841197 "Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.0" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 22.0" "Low region specificity" "Detected in all" HPA041634 Approved Mitochondria,Cytosol "Secreted - unknown location" NA NA Mitochondria Cytosol "HPA041634: AB_10795597" "unprognostic (2.61e-2)" "unprognostic (1.16e-1)" "unprognostic (7.30e-2)" "unprognostic (2.72e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.31e-4)" "unprognostic (1.57e-1)" "unprognostic (2.19e-1)" "unprognostic (2.45e-2)" "unprognostic (5.43e-2)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.72e-6)" "unprognostic (8.60e-3)" "unprognostic (7.42e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (8.11e-4)" 4.2 5.4 14.8 3.2 10.5 23.9 5.4 2.7 16.2 12.2 52.0 2.9 9.4 2.0 17.9 8.4 8.9 3.5 2.6 2.2 13.3 5.7 2.2 4.0 2.8 2.3 2.8 11.7 3.8 3.5 1.8 4.2 4.5 10.4 9.8 12.5 3.7 3.9 9.1 7.0 2.8 4.2 32.9 2.1 1.9 6.6 3.5 2.7 0.0 2.9 0.9 2.4 22.4 5.2 4.1 4.9 2.4 1.6 1.5 3.3 0.8 3.3 6.0 3.5 4.0 4.9 3.9 6.5 5.5 3.3 3.9 2.5 4.1 0.9 5.6 1.1 6.5 4.3 3.8 4.9 10.9 5.7 4.1 4.0 7.0 2.2 4.7 2.8 3.7 1.9 3.4 2.4 5.0 22.0 8.0 2.3 2.9 11.0 2.9 8.7 3.0 3.2 6.0 4.3 4.8 6.5 4.5 6.1 2.1 6.2 2.3 4.7 1.9 4.6 5.2 6.5 3.3 2.9 3.5 3.0 3.9 4.7 5.3 11.0 2.6 3.1 4.2 3.7 5.7 5.6 0.8 1.5 0.1 1.7 1.6 3.3 3.5 2.4 1.4 3.8 4.1 2.1 1.8 2.4 1.5 1.0 4.9 0.6 0.8 14.8 10.5 2.7 16.2 13.3 5.7 2.8 11.7 10.4 2.7 0.0 2.9 0.8 17.0 3.9 1.5 2.8 2.5 9.4 2.3 1.8 0.0 4.2 0.0 1.8 8.8 1.6 1.6 0.0 1.8 4.4 3.9 10.0 0.0 4.3 1.7 9.5 39.5 1.3 3.5 7.4 4.6 2.5 0.0 2.8 9.1 0.8 2.3 0.0 7.8 1.5 4.9 0.0 8.0 0.5 3.1 3.9 3.4 0.9 9.0 8.6 NT5DC4 ENSG00000144130 "5'-nucleotidase domain containing 4" Q86YG4 2 112721486-112742879 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.0;testis: 6.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 20.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Cell type enhanced" "Detected in single" "eosinophil: 3.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.0" "Cell line enriched" "Detected in some" 7 "K-562: 18.7" "Low region specificity" "Detected in all" HPA046856 Uncertain NA NA "HPA046856: AB_2679841" "unprognostic (2.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-2)" "unprognostic (1.34e-2)" "unprognostic (2.20e-4)" "unprognostic (2.26e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-1)" "unprognostic (1.19e-1)" "unprognostic (5.38e-4)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (1.60e-4)" "unprognostic (9.02e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-4)" 0.1 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 6.0 0.0 1.0 0.0 0.0 0.0 0.0 3.0 0.4 0.0 0.0 0.1 1.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.2 0.2 0.1 0.0 1.3 0.4 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.7 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.7 1.5 0.0 0.0 0.2 2.6 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.2 0.6 0.0 0.2 0.1 0.1 0.0 0.2 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 NT5M "dNT-2, dNT2, mdN" ENSG00000205309 "5',3'-nucleotidase, mitochondrial" Q9NPB1 17 17303335-17347663 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 27.1" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 14.9;Erythroid cells: 23.3;Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 10.1;U-266/70: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043777 Uncertain NA NA "HPA043777: AB_10962842" "unprognostic (5.70e-2)" "unprognostic (3.20e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (8.61e-3)" "unprognostic (1.24e-1)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.48e-1)" "prognostic favorable (8.42e-5)" "unprognostic (4.28e-5)" "unprognostic (2.27e-1)" "unprognostic (4.93e-2)" "unprognostic (3.89e-2)" "unprognostic (1.05e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" 2.6 1.8 7.2 2.0 7.4 9.4 2.1 8.8 11.8 3.3 2.8 3.7 3.1 2.1 2.8 1.9 2.7 3.0 1.9 6.6 5.8 5.3 3.3 5.5 1.7 1.7 5.5 3.9 3.8 1.9 2.9 5.0 1.5 5.7 3.3 1.4 3.5 2.7 2.7 27.1 2.1 2.2 2.0 4.1 1.7 1.3 7.0 2.0 4.2 1.7 2.4 1.6 2.6 1.7 0.2 0.6 3.6 0.0 0.0 1.5 3.1 0.4 0.9 0.4 3.5 2.2 2.4 1.6 0.7 0.2 0.3 0.5 0.0 0.2 4.0 2.1 0.0 0.7 0.0 0.2 0.1 0.0 3.4 2.2 2.6 0.0 0.3 2.1 0.7 5.2 1.7 1.8 0.3 1.4 0.7 0.1 10.1 2.2 0.0 0.0 1.0 3.3 2.9 2.2 1.1 3.1 2.5 0.3 7.1 1.2 0.0 4.4 6.8 1.2 0.2 3.1 2.7 1.2 1.0 0.0 1.1 1.3 0.3 0.9 11.1 1.4 0.6 0.6 0.5 2.8 0.0 0.0 3.6 0.1 0.0 1.4 0.0 0.1 1.5 0.6 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 3.1 7.2 7.4 8.8 11.8 5.8 5.3 5.5 3.9 5.7 2.0 0.0 0.3 0.0 1.7 1.4 5.8 7.2 0.0 0.0 1.2 8.7 2.0 0.5 14.9 0.2 0.8 0.8 0.0 23.3 0.5 0.9 1.0 1.2 0.0 1.0 1.2 15.9 1.2 0.6 0.3 3.6 0.6 0.5 0.0 0.0 0.6 3.5 0.0 0.0 1.1 1.7 1.5 0.0 0.9 0.9 4.1 0.4 0.5 0.9 0.2 0.4 NTF3 NGF2 ENSG00000185652 "Neurotrophin 3" P20783 12 5432112-5521536 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.2" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 26.7;Basal keratinocytes: 16.5;Sertoli cells: 32.3;Smooth muscle cells: 32.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;HBF TERT88: 15.0;RT4: 6.8" "Group enriched" "Detected in many" 5 "amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3" "Low region specificity" "Detected in all" HPA032001 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA032001: AB_2674106" "unprognostic (3.04e-2)" "unprognostic (7.46e-2)" "unprognostic (7.33e-3)" "unprognostic (4.66e-3)" "unprognostic (8.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.36e-3)" "unprognostic (7.68e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.86e-1)" "unprognostic (2.20e-1)" "unprognostic (7.77e-4)" "unprognostic (4.02e-3)" "unprognostic (1.92e-1)" "unprognostic (8.06e-3)" "unprognostic (4.51e-3)" 4.9 2.7 0.5 2.4 0.5 0.0 5.4 29.2 0.6 12.9 4.7 0.3 5.6 2.7 9.2 6.8 5.0 2.2 5.3 4.1 1.7 0.2 4.3 10.4 2.5 1.0 0.7 0.2 16.8 0.4 0.1 1.3 2.7 1.2 8.9 1.5 8.9 4.6 3.7 3.6 3.7 6.6 11.5 0.4 8.5 3.0 3.5 0.0 0.2 1.2 3.9 2.0 10.4 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.5 0.0 0.0 0.0 0.0 3.4 9.2 12.1 16.2 0.1 0.2 0.0 5.5 5.7 0.0 2.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.6 3.8 6.8 0.2 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 29.2 0.6 1.7 0.2 0.7 0.2 1.2 0.0 0.0 0.0 0.0 26.7 16.5 0.0 0.6 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 5.2 4.7 0.0 2.4 0.0 0.0 0.0 8.0 0.0 0.0 7.8 0.9 6.8 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 32.3 32.7 0.6 0.7 2.9 0.1 0.0 0.0 3.9 NTF4 "GLC1O, NT-4/5, NTF5" ENSG00000225950 "Neurotrophin 4" P34130 19 49061066-49065054 "Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 24.3" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 28.5;Club cells: 9.1;Cytotrophoblasts: 12.3;Urothelial cells: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.3;HaCaT: 18.8;HBEC3-KT: 7.0;hTCEpi: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049376 Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA049376: AB_2680735" "unprognostic (4.15e-2)" "unprognostic (1.07e-1)" "unprognostic (9.27e-4)" "unprognostic (1.76e-4)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.73e-2)" "unprognostic (4.87e-3)" "unprognostic (3.90e-4)" "unprognostic (2.97e-1)" "unprognostic (1.40e-3)" "unprognostic (3.71e-2)" "unprognostic (2.49e-1)" "unprognostic (1.89e-2)" "unprognostic (2.46e-3)" 0.3 0.0 0.3 0.3 0.3 0.0 3.6 0.3 1.0 2.8 0.3 0.3 5.7 0.0 0.3 8.0 7.1 1.7 0.3 0.3 0.3 0.0 0.3 0.3 3.3 0.3 0.3 0.3 0.3 0.3 0.0 2.3 3.0 0.3 11.9 0.0 0.3 5.7 6.1 11.9 24.3 0.3 1.4 0.3 0.3 0.0 1.3 0.3 1.4 0.9 2.3 2.2 6.2 5.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.2 1.3 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.0 8.3 0.0 2.1 0.0 0.3 18.8 0.0 7.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 31.0 0.0 1.0 1.9 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.4 0.1 0.0 2.8 4.9 0.1 0.1 1.1 2.2 0.1 5.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 1.0 0.3 0.0 0.3 0.3 0.3 0.3 3.0 0.0 0.0 28.5 6.3 0.0 0.4 0.0 1.4 9.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.4 3.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 2.8 2.3 0.0 0.0 9.9 NTM "CEPU-1, HNT, IGLON2, NTRI" ENSG00000182667 Neurotrimin Q9P121 11 131370478-132336822 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.2" "Cell type enhanced" "Detected in many" 21 "Alveolar cells type 1: 565.8;Cone photoreceptor cells: 895.3;Rod photoreceptor cells: 1396.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 157 "plasmacytoid DC: 15.6" "Lineage enriched" "Detected in single" 157 "dendritic cells: 15.6" "Cell line enhanced" "Detected in many" "LHCN-M2: 38.4;U-138 MG: 15.3;U-2 OS: 26.6;WM-115: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB024875 Enhanced "Intracellular and membrane" NA NA 58000000 "CAB024875: " "unprognostic (1.52e-2)" "unprognostic (4.38e-3)" "unprognostic (1.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.25e-1)" "unprognostic (1.07e-1)" "unprognostic (9.99e-3)" "unprognostic (9.61e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-2)" "unprognostic (4.29e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.10e-8)" "unprognostic (4.60e-3)" "unprognostic (1.37e-1)" "unprognostic (2.94e-1)" "unprognostic (9.31e-3)" 14.0 5.0 22.5 2.7 22.5 0.9 3.5 39.0 63.0 2.4 4.7 31.2 0.0 3.0 2.0 1.4 9.0 1.7 9.1 15.9 23.4 13.7 1.6 1.1 22.6 1.2 29.3 20.8 0.9 1.7 7.5 0.6 1.4 29.6 1.6 4.2 8.7 3.3 3.4 1.5 5.9 4.1 4.6 66.2 1.3 1.8 1.4 29.1 0.0 1.5 0.3 1.2 3.8 1.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 7.3 0.0 11.4 6.1 3.7 2.2 0.0 0.0 0.0 0.0 6.2 0.0 0.1 0.0 13.6 4.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 12.0 14.4 9.2 2.3 0.0 0.0 0.1 38.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 6.6 0.0 0.7 1.2 0.0 0.0 0.0 0.4 0.0 0.0 2.5 15.3 26.6 0.7 9.6 0.0 0.0 0.0 0.0 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 22.5 22.5 39.0 25.8 23.4 13.7 29.3 20.8 29.6 29.1 565.8 25.9 0.0 0.0 1.5 253.4 5.5 0.0 2.7 54.6 19.2 895.3 0.0 0.0 0.1 8.4 0.6 0.0 0.0 0.0 0.0 5.1 0.2 48.8 0.0 0.1 38.1 0.0 0.6 0.0 1.1 0.3 0.7 3.3 0.0 0.0 31.8 0.2 0.0 0.4 0.0 1396.8 0.0 2.8 0.3 0.0 4.3 0.0 0.0 0.0 0.0 NTN3 NTN2L ENSG00000162068 "Netrin 3" O00634 16 2471499-2474145 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 8.2;SCLC-21H: 10.5;SH-SY5Y: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050817 Uncertain "Secreted in brain" NA NA "HPA050817: AB_2681247" "unprognostic (2.60e-2)" "unprognostic (1.95e-2)" "unprognostic (1.79e-1)" "unprognostic (9.17e-2)" "unprognostic (6.44e-2)" "unprognostic (2.23e-2)" "unprognostic (9.62e-3)" "unprognostic (2.11e-1)" "unprognostic (4.55e-2)" "unprognostic (6.95e-2)" "unprognostic (5.58e-2)" "unprognostic (2.34e-1)" "unprognostic (1.35e-2)" "unprognostic (3.26e-2)" "unprognostic (6.68e-2)" "unprognostic (2.39e-2)" "unprognostic (6.61e-2)" 1.2 0.7 5.8 0.5 6.0 0.8 0.5 1.4 3.8 1.8 0.6 1.6 0.0 0.3 1.9 0.5 0.4 0.8 0.6 0.8 6.3 2.4 0.6 1.5 0.5 0.7 1.8 3.0 0.3 2.1 0.3 1.3 0.5 4.7 0.6 0.3 1.3 1.0 0.9 1.0 0.3 0.9 0.3 2.3 1.1 0.5 3.1 3.3 2.5 0.8 0.0 0.4 0.4 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.2 0.6 0.1 0.0 0.0 0.3 0.1 0.0 0.0 1.3 1.2 0.1 2.4 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 1.2 0.3 0.0 0.1 8.2 0.1 0.2 0.0 0.0 10.5 5.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.5 0.1 0.1 0.6 0.4 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 6.0 1.4 3.8 6.3 2.4 1.8 3.0 4.7 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NTN4 ENSG00000074527 "Netrin 4" Q9HB63 12 95657807-95791152 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 76.9" "Cell type enhanced" "Detected in many" 15 "Collecting duct cells: 188.5;Ito cells: 457.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 4.9" "Lineage enriched" "Detected in single" 49 "T-cells: 4.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 94.4;hTERT-HME1: 39.1;PC-3: 35.7;TIME: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049832 Approved "Secreted to extracellular matrix" NA NA "HPA049832: AB_2680905" "unprognostic (3.08e-1)" "unprognostic (2.17e-1)" "unprognostic (2.33e-1)" "unprognostic (4.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.67e-1)" "unprognostic (3.03e-2)" "unprognostic (8.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (2.85e-1)" "prognostic favorable (8.12e-9)" "unprognostic (3.52e-2)" "unprognostic (7.08e-2)" "unprognostic (1.93e-1)" "prognostic favorable (6.67e-5)" 11.1 8.5 4.0 4.4 6.3 0.0 22.8 1.2 9.0 9.9 8.9 2.5 7.3 3.4 8.2 11.9 10.7 10.7 13.0 27.2 3.9 2.4 35.8 13.6 21.7 0.7 4.1 6.1 28.5 18.2 6.6 4.5 7.7 2.8 24.1 5.4 8.4 14.7 19.6 7.2 3.8 8.7 7.2 2.2 76.9 14.5 6.5 2.2 1.5 6.7 9.7 4.2 14.1 11.9 0.0 0.0 0.0 0.0 0.0 4.9 0.0 4.8 13.3 0.3 0.0 5.4 8.7 0.5 9.2 94.4 12.6 15.1 10.4 9.2 0.0 0.6 19.5 17.2 7.7 0.1 2.7 6.4 0.0 0.8 0.4 2.4 2.0 0.3 0.0 0.0 0.2 8.1 14.5 39.1 13.9 24.7 0.0 0.0 0.0 4.7 3.6 0.0 0.0 0.2 1.4 35.7 0.0 0.1 0.0 12.2 24.8 0.0 0.1 11.2 14.4 0.2 0.4 4.2 0.0 53.7 4.9 1.8 19.1 0.9 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.0 6.3 1.2 9.0 3.9 2.4 4.1 6.1 2.8 2.2 38.7 99.7 15.7 94.2 4.1 1.9 36.7 40.8 14.7 17.0 188.5 0.0 3.8 5.0 34.9 7.2 20.0 1.7 0.0 24.2 2.0 15.0 61.0 1.1 6.8 0.3 0.0 0.0 457.9 41.5 3.1 2.0 2.5 6.8 1.0 41.2 0.2 37.2 2.9 3.2 38.3 0.0 25.8 33.3 1.9 0.5 1.9 1.4 4.9 5.3 78.5 NTN5 ENSG00000142233 "Netrin 5" Q8WTR8 19 48661407-48673081 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 7.0" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 4.3;Early spermatids: 3.9;Horizontal cells: 7.9;Late spermatids: 8.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 3.1;Karpas-707: 4.1;U-266/70: 3.1;U-266/84: 2.6" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Region enriched" "Detected in single" 5 "cerebellum: 7.5" "Secreted in brain" NA NA "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "unprognostic (5.26e-6)" "unprognostic (4.48e-2)" "unprognostic (2.23e-1)" "unprognostic (4.33e-2)" "unprognostic (3.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.89e-3)" "unprognostic (9.40e-3)" "unprognostic (1.74e-3)" "unprognostic (4.60e-1)" "unprognostic (5.11e-2)" "unprognostic (1.60e-3)" "unprognostic (3.51e-1)" "unprognostic (1.44e-1)" "unprognostic (2.71e-3)" 0.3 0.8 1.1 0.3 1.6 0.6 1.5 1.6 0.9 1.1 0.3 0.3 2.6 1.6 0.8 3.9 1.8 0.1 0.9 0.6 0.6 0.1 0.3 1.9 0.7 3.7 0.0 2.1 7.0 0.0 3.1 0.0 3.2 2.4 0.6 3.5 0.4 0.1 0.7 1.3 0.6 0.3 2.3 0.7 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.7 0.1 0.1 0.1 0.4 0.0 1.0 0.0 0.0 0.5 0.9 1.8 0.7 0.0 0.0 2.0 0.0 0.8 3.1 0.3 0.0 0.0 1.1 0.7 1.3 0.0 4.1 0.0 1.2 0.9 0.8 0.0 0.3 2.2 0.6 0.0 0.0 1.1 0.7 0.3 0.4 0.0 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.0 3.1 2.6 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 7.9 0.0 0.0 0.0 8.1 0.6 0.0 1.7 0.0 0.0 1.9 0.0 0.0 0.4 0.0 2.1 0.0 0.0 2.5 0.2 0.1 0.1 0.0 0.0 0.1 NTNG1 "KIAA0976, Lmnt1" ENSG00000162631 "Netrin G1" Q9Y2I2 1 107140007-107483458 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 6.0;Bipolar cells: 23.3;Collecting duct cells: 7.0;Early spermatids: 7.6;Leydig cells: 7.5;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 28.6;fHDF/TERT166: 13.9;RPTEC TERT1: 15.6;U-138 MG: 13.1;U-251 MG: 9.4;U-87 MG: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065954 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA065954: AB_2685585" "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.67e-2)" "unprognostic (9.38e-5)" "unprognostic (1.93e-3)" "unprognostic (9.87e-3)" "unprognostic (3.34e-1)" "unprognostic (8.38e-3)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "unprognostic (2.05e-2)" "unprognostic (3.10e-4)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (1.93e-5)" 4.2 11.0 6.8 1.3 6.4 0.9 1.1 7.3 12.8 7.0 2.9 9.6 0.3 0.8 2.2 0.9 1.2 1.3 2.1 0.9 9.8 16.4 13.0 0.8 9.2 1.7 5.0 5.3 1.9 1.1 0.7 7.4 3.2 10.0 9.0 1.7 6.4 2.8 12.1 1.1 1.9 1.7 7.5 7.4 1.3 1.4 1.7 6.1 0.0 0.8 0.0 2.0 5.3 3.0 4.4 0.8 1.4 0.7 0.8 0.6 0.3 0.0 0.0 1.7 0.0 2.9 28.6 0.0 7.8 1.1 0.7 0.6 0.0 0.0 0.0 0.3 13.9 0.0 0.0 0.0 0.8 1.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.2 0.2 2.0 1.1 8.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 3.6 0.0 1.9 0.0 15.6 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 13.1 2.5 4.8 9.4 0.0 0.0 0.0 14.6 0.0 1.4 1.4 0.3 0.4 0.3 0.4 0.5 4.4 0.4 0.3 0.4 1.0 0.6 0.5 0.9 0.8 0.7 0.8 0.4 0.3 6.8 6.4 7.3 12.3 9.8 16.4 5.0 5.3 10.0 6.1 0.0 0.0 0.5 6.0 0.5 23.3 0.8 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 7.6 0.3 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 7.5 0.0 1.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 2.1 6.5 1.4 0.2 0.4 0.5 0.0 0.0 0.0 4.3 NTNG2 "KIAA1857, Lmnt2, NTNG1" ENSG00000196358 "Netrin G2" Q96CW9 9 132161676-132244534 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.9;brain: 32.0" "Group enriched" "Detected in many" 7 "Bipolar cells: 56.2;Cone photoreceptor cells: 161.0;Rod photoreceptor cells: 109.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "HL-60: 4.8;HMC-1: 12.2;NB-4: 27.6;U-937: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065089, HPA071290" Approved Approved "Plasma membrane,Cytokinetic bridge,Midbody ring" "Intracellular and membrane" NA NA "Plasma membrane" "Cytokinetic bridge, Midbody ring" "HPA065089: AB_2732730, HPA071290: AB_2686381" "unprognostic (5.01e-2)" "unprognostic (2.95e-2)" "unprognostic (4.12e-2)" "unprognostic (1.01e-1)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.73e-2)" "unprognostic (2.87e-1)" "unprognostic (4.86e-2)" "unprognostic (1.47e-1)" "unprognostic (2.62e-2)" "prognostic favorable (6.06e-4)" "unprognostic (9.30e-12)" "unprognostic (1.66e-1)" "unprognostic (3.23e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" 1.2 1.4 11.9 1.6 10.9 38.9 0.6 4.4 32.0 1.0 0.8 11.5 0.2 1.8 0.7 0.9 0.8 0.7 1.4 4.6 11.4 3.1 0.8 0.8 2.0 1.9 4.4 7.4 0.6 1.8 11.9 1.0 1.1 11.7 7.4 0.7 10.7 1.3 1.8 0.9 0.8 1.1 0.8 5.3 2.8 1.2 1.8 2.8 0.0 0.7 0.0 1.0 1.1 0.9 0.1 0.1 4.0 0.2 0.0 0.4 0.0 0.0 0.3 0.2 0.4 0.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.7 4.8 12.2 0.0 0.0 0.2 0.0 1.0 0.0 1.0 0.0 0.0 0.3 0.1 0.2 27.6 1.0 0.0 0.1 0.3 0.3 0.1 0.0 0.0 3.4 3.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.6 2.2 2.6 0.1 0.1 0.0 0.0 1.0 7.2 0.8 0.6 0.2 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.0 0.0 0.1 0.1 0.1 0.0 11.9 10.9 4.4 32.0 11.4 3.1 4.4 7.4 11.7 2.8 0.0 1.1 0.0 0.5 0.2 56.2 2.8 0.0 0.0 1.2 0.0 161.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.0 0.0 1.5 1.4 1.1 0.0 0.6 1.6 0.0 1.3 0.3 1.0 0.6 0.1 1.7 0.0 0.0 15.3 0.2 0.0 1.1 0.0 109.1 6.5 0.6 0.2 0.0 0.3 0.1 0.0 0.0 0.3 NTRK1 "MTC, TRK, TRKA" ENSG00000198400 "Neurotrophic receptor tyrosine kinase 1" P04629 1 156815640-156881850 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adrenal gland: 15.8;blood: 32.3;brain: 28.3" "Group enriched" "Detected in some" 8 "granulocytes: 56.4;Horizontal cells: 54.0" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enriched" "Detected in many" 5 "pons and medulla: 28.3" "Cell type enriched" "Detected in single" 127 "basophil: 32.3" "Lineage enriched" "Detected in single" 323 "granulocytes: 32.3" "Cell line enriched" "Detected in some" 4 "HMC-1: 42.1" "Region enhanced" "Detected in some" "basal ganglia: 8.2" "Low region specificity" "Detected in all" "CAB004606, HPA035799, HPA076570" Approved Approved Vesicles,Cytosol NA NA 140000 "Vesicles, Cytosol" "CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: " "unprognostic (5.89e-3)" "unprognostic (7.56e-2)" "unprognostic (2.74e-2)" "unprognostic (5.99e-3)" "unprognostic (7.26e-2)" "unprognostic (1.43e-3)" "unprognostic (1.56e-1)" "unprognostic (7.42e-3)" "unprognostic (7.63e-2)" "unprognostic (1.35e-1)" "unprognostic (6.73e-2)" "unprognostic (2.29e-2)" "unprognostic (3.18e-11)" "unprognostic (2.18e-3)" "unprognostic (3.79e-2)" "unprognostic (1.07e-1)" "unprognostic (4.89e-1)" 1.0 15.8 0.5 0.8 6.0 0.9 0.4 0.0 0.7 0.9 1.1 0.1 0.0 0.8 1.6 2.0 0.7 0.6 2.1 1.5 0.0 1.2 2.9 0.2 1.9 0.3 2.1 0.6 0.3 0.3 0.3 1.1 0.5 28.3 2.2 0.2 3.1 1.2 0.5 0.7 0.2 0.4 1.1 1.2 0.2 1.0 2.4 1.5 0.4 0.3 0.0 0.4 0.7 0.8 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 6.8 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.6 1.2 0.0 0.1 0.0 0.0 0.8 9.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 32.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.0 0.0 0.6 0.0 1.2 2.1 0.6 28.3 1.5 0.0 2.2 0.0 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 56.4 0.0 0.1 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 2.5 0.1 0.0 0.0 0.0 0.0 NTRK2 TRKB ENSG00000148053 "Neurotrophic receptor tyrosine kinase 2" Q16620 9 84668551-85027070 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Epilepsy, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 133.8;thyroid gland: 63.4" "Cell type enhanced" "Detected in many" 12 "Horizontal cells: 228.8;Leydig cells: 96.4;Muller glia cells: 248.1;Sertoli cells: 122.9;Smooth muscle cells: 96.9" "Group enriched" "Detected in many" 5 "glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.7;SH-SY5Y: 13.4;SuSa: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007637, CAB010346, HPA074873" Enhanced Approved Cytosol NA NA 13000000 Cytosol "CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: " "unprognostic (2.75e-3)" "unprognostic (3.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.26e-2)" "unprognostic (2.56e-2)" "unprognostic (1.29e-2)" "unprognostic (9.16e-2)" "unprognostic (6.13e-2)" "unprognostic (1.05e-1)" "unprognostic (4.25e-2)" "unprognostic (2.18e-2)" "unprognostic (2.66e-2)" "unprognostic (1.20e-2)" "unprognostic (1.21e-2)" "unprognostic (1.31e-1)" "unprognostic (1.39e-3)" 19.8 2.7 66.1 2.0 56.7 1.2 33.2 15.1 133.8 6.4 4.4 27.4 0.0 1.4 3.0 3.3 5.6 3.7 18.7 5.8 61.0 30.7 12.5 2.1 6.3 2.7 32.4 41.4 6.6 18.9 1.6 3.0 2.1 34.1 3.8 3.1 2.0 8.6 11.9 2.0 7.2 1.6 3.0 22.1 6.5 1.4 2.4 34.1 0.0 63.4 2.6 3.4 3.5 3.8 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 11.7 0.8 0.9 13.4 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.1 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 66.1 56.7 15.1 45.6 61.0 30.7 32.4 41.4 34.1 34.1 0.0 0.3 0.0 1.0 50.4 24.4 8.7 0.0 2.7 0.0 8.7 5.9 0.0 23.2 26.5 1.5 4.5 0.0 0.0 0.6 0.1 10.6 0.9 0.0 0.0 0.2 228.8 0.0 5.5 0.0 1.7 96.4 1.2 16.9 1.0 0.0 248.1 0.5 7.2 45.3 7.9 9.1 122.9 96.9 0.7 1.1 21.5 0.0 0.0 5.4 0.8 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 58.9;Early spermatids: 85.5;Late spermatids: 103.3;Sertoli cells: 51.8;Smooth muscle cells: 37.7" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "U-138 MG: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 11000000 "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 20.8 7.4 22.0 2.5 28.1 1.5 6.2 30.4 41.8 7.0 4.0 8.4 1.3 2.0 12.4 6.7 3.4 9.5 3.9 5.5 22.0 11.1 5.1 2.0 5.7 3.1 11.2 18.7 5.1 2.9 1.6 7.9 2.8 14.7 6.8 4.7 8.0 11.5 8.7 1.9 2.9 2.5 7.7 13.7 4.1 3.0 13.8 13.7 0.0 2.5 0.7 4.3 7.1 4.8 0.7 0.4 1.3 0.5 0.5 0.8 0.0 0.0 6.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 48.6 0.9 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.1 1.2 0.5 0.4 0.3 0.1 0.2 0.4 0.3 0.3 0.1 0.7 0.4 0.4 1.3 0.5 0.1 0.4 0.8 0.0 22.0 28.1 30.4 28.9 22.0 11.1 11.2 18.7 14.7 13.7 0.0 0.0 0.0 5.9 0.5 58.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 85.5 0.7 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.9 1.6 0.0 1.8 0.0 103.3 3.1 0.2 0.0 0.0 0.0 8.9 0.0 0.0 25.8 0.0 2.7 51.8 37.7 8.8 1.9 0.1 0.1 0.0 0.0 0.1 NTS ENSG00000133636 Neurotensin P30990 12 85874295-85882992 "Predicted secreted proteins" Vasoactive "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 115.3" "Cell type enhanced" "Detected in some" 19 "Club cells: 27.3;Collecting duct cells: 8.7;Ito cells: 11.1" "Cancer enhanced" "Detected in many" "lung cancer: 155.1" "Group enriched" "Detected in many" 4 "hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 70.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 81.8" "HPA026664, HPA071012" Enhanced Supported Vesicles "Secreted to digestive system" NA NA 120000 Vesicles "HPA026664: AB_2671936, HPA071012: " "unprognostic (3.63e-1)" "prognostic favorable (9.94e-5)" "unprognostic (8.18e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-3)" "unprognostic (8.83e-2)" "unprognostic (1.74e-2)" "unprognostic (3.76e-2)" "unprognostic (1.30e-6)" "unprognostic (2.94e-2)" "unprognostic (2.25e-1)" "unprognostic (2.17e-1)" "unprognostic (7.48e-2)" 2.9 0.6 3.9 1.4 3.2 0.1 2.5 0.3 0.4 0.5 5.2 2.5 0.0 2.8 0.2 1.6 2.5 0.5 0.8 0.8 10.3 22.1 0.9 0.7 2.0 15.1 6.3 0.1 0.7 0.4 0.1 15.0 0.3 25.0 0.4 0.7 0.0 1.6 0.5 0.1 0.1 115.3 0.5 2.7 0.2 18.8 0.3 0.4 0.1 0.9 0.8 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.3 0.0 0.5 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 70.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.3 0.4 10.3 22.1 6.3 0.1 25.0 0.4 0.0 0.3 0.0 0.4 1.1 0.0 0.3 0.0 5.3 27.3 8.7 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.2 0.2 2.8 0.0 0.0 0.2 0.0 2.4 11.1 0.8 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 1.9 0.1 0.0 0.0 1.1 NTSR1 NTR ENSG00000101188 "Neurotensin receptor 1" P30989 20 62708837-62762771 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0;intestine: 15.1" "Cell type enhanced" "Detected in single" 29 "Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "PC-3: 35.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050299 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA050299: " "unprognostic (4.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.75e-2)" "unprognostic (8.87e-4)" "unprognostic (9.27e-3)" "unprognostic (1.45e-1)" "unprognostic (4.17e-2)" "unprognostic (2.80e-3)" "unprognostic (7.16e-2)" "unprognostic (3.10e-3)" "unprognostic (3.55e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" 0.3 0.1 3.7 2.5 3.6 3.8 0.1 0.1 7.0 0.1 15.1 0.0 0.0 0.4 0.2 0.1 0.1 0.1 1.4 0.1 2.0 1.1 0.6 0.2 0.3 0.3 3.3 1.0 0.4 0.1 0.2 0.3 0.2 1.4 0.2 0.5 1.2 0.3 0.1 0.2 0.2 1.5 0.8 0.8 0.6 0.5 0.5 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 6.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 1.7 0.1 1.6 0.2 0.7 35.8 1.1 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.7 3.6 0.1 7.0 2.0 1.1 3.3 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NTSR2 NTR2 ENSG00000169006 "Neurotensin receptor 2" O95665 2 11658178-11670164 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 33.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;NTERA-2: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.40e-2)" "unprognostic (2.30e-2)" "unprognostic (2.36e-2)" "unprognostic (5.32e-2)" "unprognostic (2.23e-1)" "unprognostic (1.80e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-1)" "unprognostic (1.64e-1)" 1.3 1.8 22.3 1.1 30.7 1.1 1.1 2.1 33.4 1.1 1.1 11.9 0.0 1.1 1.1 1.2 1.1 1.1 1.1 1.1 13.4 15.6 1.1 1.1 1.1 1.1 26.8 13.8 2.8 1.7 1.1 0.0 1.1 10.6 1.1 1.1 0.0 1.1 1.1 1.2 1.1 1.1 1.1 4.3 1.1 1.1 1.5 8.7 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 30.7 2.1 14.5 13.4 15.6 26.8 13.8 10.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 NUAK1 "ARK5, KIAA0537, NuaK1" ENSG00000074590 "NUAK family kinase 1" O60285 12 106063340-106140033 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, DNA damage" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3;parathyroid gland: 18.6" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 46.0;Endothelial cells: 46.6;Ito cells: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "AF22: 23.1;EFO-21: 23.1;RH-30: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057143 Approved "Nucleoplasm,Nucleoli fibrillar center,Microtubules" Yes No "Nucleoli fibrillar center" "Nucleoplasm, Microtubules" "HPA057143: AB_2683349" "unprognostic (4.20e-2)" "unprognostic (8.42e-2)" "unprognostic (3.71e-2)" "prognostic unfavorable (9.83e-4)" "unprognostic (4.13e-2)" "unprognostic (2.34e-1)" "unprognostic (1.43e-1)" "unprognostic (4.80e-2)" "unprognostic (9.91e-2)" "unprognostic (4.06e-3)" "unprognostic (3.29e-1)" "unprognostic (1.31e-1)" "unprognostic (1.93e-3)" "prognostic unfavorable (4.27e-4)" "unprognostic (2.31e-1)" "unprognostic (8.70e-2)" "unprognostic (4.47e-2)" 8.2 1.8 4.2 2.0 13.0 0.0 5.5 9.9 20.1 4.6 1.7 24.3 1.1 1.0 5.8 1.6 1.9 3.6 2.7 11.3 5.1 3.3 2.5 2.4 4.9 1.5 8.7 8.4 3.2 1.2 18.6 1.9 2.5 7.6 3.6 2.2 2.3 1.8 3.7 9.4 11.6 1.5 6.3 5.5 1.1 1.5 1.3 9.3 1.1 1.8 1.1 1.4 3.4 3.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 5.0 3.4 23.1 0.2 9.3 1.0 10.7 5.7 3.9 4.4 3.3 1.7 0.8 0.0 23.1 10.4 1.9 4.8 4.8 4.6 2.1 0.0 1.3 0.0 3.7 1.8 1.9 0.0 0.0 4.8 3.1 2.5 0.8 7.6 8.4 0.0 0.0 16.8 3.1 0.5 0.1 0.2 4.5 0.0 1.4 0.0 33.2 4.0 2.5 5.9 2.7 0.1 2.6 0.8 0.2 15.9 1.2 0.1 6.2 3.8 12.9 1.4 6.8 0.0 0.0 0.3 1.1 0.0 3.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.2 13.0 9.9 17.5 5.1 3.3 8.7 8.4 7.6 9.3 0.0 3.7 0.0 32.0 11.9 30.8 46.0 2.5 0.0 5.7 7.0 0.0 0.4 3.3 5.0 0.3 46.6 0.0 23.3 8.3 4.1 9.2 4.4 0.0 10.5 6.1 38.1 0.0 119.1 9.7 1.7 3.7 1.3 10.1 1.0 2.0 1.7 11.7 0.0 2.8 1.4 2.6 0.0 14.4 0.7 5.5 13.9 0.2 0.9 0.9 3.7 NUAK2 "FLJ90349, SNARK" ENSG00000163545 "NUAK family kinase 2" Q9H093 1 205302059-205321791 "Enzymes, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.4" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 31.4;Ductal cells: 40.9;monocytes: 48.7;Mucus-secreting cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 42.4" "Group enriched" "Detected in all" 4 "B-cells: 15.3;granulocytes: 42.4;T-cells: 10.7" "Cell line enhanced" "Detected in many" "BEWO: 22.8;RPMI-8226: 17.6;RPTEC TERT1: 20.9;SuSa: 24.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA008958 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA008958: AB_1080040" "unprognostic (2.24e-2)" "unprognostic (6.33e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.01e-7)" "unprognostic (8.24e-3)" "unprognostic (1.58e-2)" "unprognostic (3.00e-2)" "unprognostic (1.08e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "prognostic favorable (7.94e-6)" "unprognostic (3.71e-2)" "unprognostic (3.17e-2)" "unprognostic (4.90e-2)" "unprognostic (5.80e-2)" "unprognostic (4.54e-2)" "unprognostic (1.61e-1)" 1.4 2.8 0.8 12.5 2.4 8.3 0.9 9.2 1.5 18.9 10.4 3.9 2.4 13.6 2.7 3.8 31.3 3.4 1.3 1.1 1.7 1.0 14.5 3.6 16.2 20.3 5.5 1.5 3.3 13.2 0.1 2.3 7.2 2.0 1.5 7.5 9.8 9.7 2.0 0.7 12.9 15.4 0.9 2.7 10.4 2.0 5.6 2.4 5.5 14.5 20.1 31.7 2.8 24.6 15.3 3.6 42.4 5.6 5.7 10.7 5.4 2.1 11.6 7.1 0.3 0.1 0.3 22.8 2.8 2.9 7.6 3.1 12.2 0.4 3.4 1.7 0.7 12.5 4.2 1.6 4.2 3.3 0.0 0.2 0.0 0.7 2.1 4.9 0.0 0.0 1.3 3.1 4.4 2.6 1.7 0.3 0.0 0.4 0.9 1.4 0.5 0.0 0.0 4.5 1.5 0.3 0.0 0.5 17.6 20.9 0.0 1.1 0.1 0.8 3.3 0.3 24.7 3.3 0.0 0.8 2.7 1.3 0.3 4.3 6.2 0.9 2.1 0.4 0.0 1.0 3.4 5.6 13.2 3.9 4.2 2.8 14.2 4.8 4.6 3.6 15.3 10.7 8.1 42.4 5.7 4.1 1.4 2.8 5.4 0.8 2.4 9.2 1.5 1.7 1.0 5.5 1.5 2.0 2.4 6.0 5.0 9.1 0.8 1.0 0.8 1.4 20.4 2.7 0.0 31.4 0.0 6.5 5.0 40.9 1.7 2.2 20.3 0.0 1.5 27.7 4.0 1.8 0.0 2.9 4.6 0.0 10.4 1.3 11.7 1.2 0.0 6.5 6.8 48.7 40.0 1.7 7.2 2.9 0.0 15.0 0.5 6.5 2.5 0.5 0.9 4.6 3.4 4.5 18.7 0.2 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" 11 17208153-17349980 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 160.3" "Cell type enhanced" "Detected in all" 8 "Ciliated cells: 702.6;Early spermatids: 595.9;Syncytiotrophoblasts: 968.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 188.9" "Low region specificity" "Detected in many" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 10.2 13.9 9.5 7.5 13.1 66.4 17.9 13.5 7.5 18.3 7.8 3.8 79.5 6.6 11.4 59.6 29.7 13.7 7.3 25.0 7.5 10.9 10.8 51.1 12.5 13.5 8.5 7.6 15.4 92.8 58.9 69.7 35.8 10.3 13.4 8.3 5.8 160.3 104.9 7.2 4.2 6.8 11.3 9.4 9.8 11.4 18.7 6.1 86.1 22.7 17.7 10.4 12.1 11.0 3.7 71.7 28.8 7.6 45.2 49.5 20.1 12.2 5.1 5.7 17.2 12.9 17.8 6.9 27.4 40.0 12.3 21.8 5.0 2.8 18.9 6.9 26.0 11.5 5.3 3.6 6.9 19.3 13.0 8.0 13.9 6.4 8.7 37.3 188.9 25.6 7.7 9.2 8.8 21.6 30.7 15.0 71.0 12.0 38.3 12.1 10.8 66.5 68.3 1.3 20.0 5.4 24.6 13.9 1.5 5.5 3.9 6.8 3.8 12.0 12.1 6.1 8.7 9.9 51.4 13.4 13.1 12.1 39.5 11.5 7.5 4.1 10.4 15.1 66.8 11.1 28.8 7.6 27.6 17.1 5.0 22.3 3.7 16.3 31.5 6.9 2.4 46.0 49.5 7.0 45.2 4.0 71.7 7.0 20.1 9.5 13.1 13.5 7.5 7.5 10.9 8.5 7.6 10.3 6.1 41.7 59.0 14.1 53.1 24.5 64.5 145.2 50.9 702.6 152.4 40.1 51.1 105.9 23.2 65.4 595.9 97.2 5.4 23.3 116.0 281.9 179.4 156.8 63.8 119.0 65.3 33.4 40.7 105.0 27.2 377.7 138.7 39.7 65.8 11.8 82.2 101.2 103.6 8.6 107.5 16.5 80.2 45.3 51.5 125.6 53.1 26.3 968.6 104.6 35.5 54.9 NUDT1 MTH1 ENSG00000106268 "Nudix hydrolase 1" P36639 7 2242222-2251146 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.5" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012636 Approved Supported Cytosol No No Cytosol "HPA012636: AB_1854696" "unprognostic (1.31e-1)" "unprognostic (1.19e-2)" "unprognostic (2.13e-2)" "unprognostic (2.37e-1)" "unprognostic (3.01e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (2.15e-2)" "unprognostic (4.77e-1)" "unprognostic (3.81e-2)" "unprognostic (3.81e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (3.49e-2)" "unprognostic (1.70e-1)" 8.8 3.9 7.4 12.6 13.4 37.1 10.8 5.0 10.8 5.9 9.0 8.7 2.2 9.1 8.2 9.2 13.1 6.0 8.1 11.3 8.7 4.7 4.1 2.9 7.2 18.9 8.2 7.0 4.8 4.0 0.7 1.8 5.8 7.2 7.2 6.3 4.0 5.5 4.2 12.0 18.8 9.3 10.5 11.9 11.1 5.5 26.7 5.3 30.7 4.1 14.4 17.2 6.8 8.1 18.3 59.5 11.9 21.3 10.1 20.4 13.0 21.7 35.1 19.3 25.5 7.1 9.8 14.2 9.6 8.4 13.2 15.4 18.9 16.5 23.0 7.8 10.5 26.9 26.6 14.6 14.6 7.7 10.2 25.0 17.9 29.6 16.0 1.7 13.9 18.1 6.4 3.8 19.0 6.8 4.3 7.1 33.5 14.2 25.7 14.7 55.5 25.9 54.2 41.4 10.8 21.7 36.3 28.6 19.2 7.2 12.3 19.4 26.9 9.9 29.2 4.4 14.6 19.2 37.0 6.5 12.7 48.5 29.3 22.8 19.9 15.0 23.8 12.8 34.7 45.6 9.0 17.5 11.9 12.9 21.3 10.2 18.3 15.1 13.6 26.6 18.0 15.1 13.1 4.6 10.1 17.4 59.5 20.4 13.0 7.4 13.4 5.0 10.8 8.7 4.7 8.2 7.0 7.2 5.3 6.0 6.9 41.2 21.9 35.6 10.2 15.1 12.7 8.1 7.9 10.4 3.9 30.9 16.6 20.1 42.6 10.8 14.4 233.6 32.2 67.3 28.8 13.6 61.0 5.3 76.9 0.0 7.5 4.3 37.3 78.4 20.4 69.4 43.9 36.9 26.8 18.6 17.6 17.3 17.7 11.7 6.1 32.3 28.5 80.4 63.8 32.4 19.8 39.2 33.8 16.0 NUDT10 "DIPP3a, hDIPP3alpha" ENSG00000122824 "Nudix hydrolase 10" Q8NFP7 X 51332231-51337525 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 28.8;seminal vesicle: 36.3;testis: 27.2" "Group enriched" "Detected in some" 5 "Ito cells: 54.6;Peritubular cells: 27.3" "Group enriched" "Detected in many" 6 "glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 6.2;HAP1: 11.6;HEK 293: 8.6;NTERA-2: 21.3;SH-SY5Y: 4.6;SuSa: 4.4;U-2 OS: 10.7" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.61e-2)" "unprognostic (1.12e-2)" "unprognostic (7.40e-3)" "unprognostic (7.84e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.54e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (1.27e-1)" "unprognostic (1.51e-3)" "unprognostic (1.80e-3)" "unprognostic (1.04e-2)" "unprognostic (1.12e-2)" "unprognostic (5.04e-5)" 1.0 2.3 9.3 1.4 10.7 1.8 1.4 6.0 13.1 4.4 2.0 0.9 28.8 1.1 5.5 18.3 1.7 3.4 2.0 0.9 4.9 13.6 3.1 1.9 0.7 0.9 5.3 8.0 19.2 0.6 0.5 4.5 0.5 6.2 17.9 1.3 0.8 1.0 36.3 0.5 1.0 1.2 4.9 1.9 3.1 1.1 27.2 1.2 0.0 0.8 0.0 0.9 2.8 2.9 0.8 0.1 0.0 0.7 2.1 1.0 0.3 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.0 0.0 11.6 0.5 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.1 0.0 0.8 1.0 0.0 0.1 0.3 0.0 0.6 0.0 2.1 0.5 0.0 0.0 0.3 9.3 10.7 6.0 11.7 4.9 13.6 5.3 8.0 6.2 1.2 0.0 2.2 0.0 4.6 0.9 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.4 0.4 2.1 0.0 0.0 0.2 0.0 0.0 54.6 3.4 4.0 5.5 0.0 1.7 0.0 0.0 1.8 0.0 0.0 27.3 0.0 0.4 0.0 1.9 2.4 7.9 0.1 0.3 0.0 0.0 0.0 NUDT11 "DIPP3b, FLJ10628, hDIPP3beta" ENSG00000196368 "Nudix hydrolase 11" Q96G61 X 51490011-51496596 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;testis: 35.5" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 13.6;Peritubular cells: 19.4;Smooth muscle cells: 12.7;Spermatocytes: 13.4;Spermatogonia: 11.9" "Cancer enhanced" "Detected in many" "testis cancer: 17.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.7;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 1.9;naive CD8 T-cell: 3.1;NK-cell: 1.9" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 3.7" "Cell line enhanced" "Detected in many" "HAP1: 33.6;NTERA-2: 21.0" "HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (2.01e-1)" "unprognostic (2.57e-1)" "unprognostic (8.21e-2)" "unprognostic (1.93e-3)" "unprognostic (6.61e-2)" "unprognostic (1.13e-3)" "unprognostic (5.52e-3)" "unprognostic (1.25e-1)" "unprognostic (2.25e-2)" "unprognostic (2.18e-1)" "unprognostic (8.41e-2)" "unprognostic (1.33e-1)" "unprognostic (7.80e-12)" "unprognostic (4.34e-4)" "unprognostic (1.17e-2)" "unprognostic (2.78e-1)" "unprognostic (3.94e-4)" 1.2 5.4 11.2 1.4 21.9 1.6 2.8 7.4 26.1 3.8 2.6 0.8 4.4 1.7 5.9 4.3 1.9 1.6 2.2 0.8 7.0 17.9 0.9 0.6 0.8 1.1 5.3 12.7 10.0 3.8 0.5 2.8 0.6 5.3 10.1 1.4 0.5 1.3 11.9 0.6 1.7 1.5 5.0 1.8 0.9 0.9 35.5 1.1 3.6 1.0 0.2 1.1 1.7 1.6 0.5 0.4 0.0 0.2 1.9 3.7 1.0 0.0 0.5 10.1 0.0 8.8 11.2 0.0 4.7 1.3 0.2 0.2 0.0 0.0 0.0 0.2 5.7 5.6 0.7 33.6 11.5 0.1 0.0 2.2 0.0 0.0 0.0 4.1 0.0 2.2 6.8 4.6 3.0 11.1 1.9 7.9 10.4 0.0 0.0 9.5 0.2 12.7 0.0 21.0 0.0 8.5 0.0 7.1 0.0 2.1 0.0 0.0 6.6 2.0 0.0 1.8 5.2 0.0 0.0 4.6 2.4 11.1 0.7 0.0 4.4 2.0 7.2 1.5 0.0 0.9 0.0 0.0 0.0 3.7 0.0 1.4 0.5 1.2 1.9 0.4 0.3 0.2 3.1 0.0 1.9 0.2 0.2 0.0 1.0 11.2 21.9 7.4 14.9 7.0 17.9 5.3 12.7 5.3 1.1 0.0 0.0 0.0 4.8 13.6 1.5 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 9.4 0.0 0.0 0.0 1.3 0.9 4.1 9.3 0.0 0.0 0.1 0.0 0.0 0.0 0.8 10.2 8.1 0.6 5.0 0.0 0.0 0.9 2.2 0.0 19.4 0.0 0.1 0.0 12.7 13.4 11.9 8.0 0.2 0.0 0.0 1.1 NUDT4 "DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487" ENSG00000173598 "Nudix hydrolase 4" Q9NZJ9 12 93377883-93408146 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 140.7" "Cell type enhanced" "Detected in all" 5 "Muller glia cells: 411.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA017593, HPA047027, HPA057684" Approved Approved Cytosol NA NA Cytosol "HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501" "unprognostic (1.44e-2)" "unprognostic (2.15e-1)" "unprognostic (4.40e-3)" "unprognostic (4.25e-1)" "unprognostic (3.08e-3)" "unprognostic (1.42e-1)" "unprognostic (8.12e-2)" "unprognostic (9.09e-3)" "unprognostic (1.88e-1)" "unprognostic (1.51e-1)" "unprognostic (2.60e-2)" "unprognostic (1.96e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.75e-1)" "unprognostic (2.87e-1)" "unprognostic (5.01e-1)" "unprognostic (8.32e-3)" 17.2 29.7 14.1 14.7 9.5 37.4 20.4 7.0 29.0 15.2 14.7 6.7 17.5 6.5 13.6 24.8 13.7 12.8 40.0 140.7 12.4 12.4 47.9 11.2 11.3 10.9 9.4 13.7 41.9 21.1 16.1 11.9 19.2 13.9 27.1 16.9 25.1 65.2 14.8 40.3 8.1 12.7 13.8 12.6 9.2 13.1 10.6 6.3 14.6 25.5 22.4 8.9 19.6 32.9 6.0 4.1 13.6 3.6 7.6 6.6 2.5 5.8 5.0 9.1 10.2 34.0 14.1 11.5 16.3 13.0 9.4 6.9 46.9 14.6 8.2 3.6 13.0 6.1 7.4 25.5 8.2 14.4 12.5 5.4 30.7 4.4 23.9 32.7 15.9 7.4 30.5 27.5 9.6 21.6 47.1 53.1 14.8 31.1 11.5 10.7 6.0 14.8 15.2 14.4 14.4 12.0 12.4 8.2 8.8 11.2 42.3 7.4 9.5 13.2 25.9 36.5 15.3 18.8 20.8 20.1 8.0 4.7 12.0 10.3 6.5 8.1 12.1 4.2 12.6 24.4 8.2 2.8 13.6 3.9 3.6 6.6 6.0 5.8 3.9 2.6 4.7 6.2 5.8 2.4 7.6 2.9 4.1 5.2 2.5 14.1 9.5 7.0 29.0 12.4 12.4 9.4 13.7 13.9 6.3 17.9 42.6 40.8 110.6 103.7 39.3 226.3 94.3 91.0 31.8 59.3 58.9 156.3 306.7 20.9 78.9 50.0 102.5 327.1 14.7 23.0 86.0 142.6 25.3 48.9 37.7 39.7 146.0 28.8 34.5 17.0 36.2 31.8 101.3 12.6 83.5 411.5 37.2 85.6 43.9 43.1 40.3 71.1 166.9 28.7 7.7 84.6 137.0 29.9 64.3 133.5 NUDT7 ENSG00000140876 "Nudix hydrolase 7" P0C024 16 77722492-77742260 "Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 45.1" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 16.9;THP-1: 27.9;U-698: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042042 Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA042042: AB_10806232" "unprognostic (1.92e-1)" "unprognostic (1.17e-2)" "unprognostic (6.64e-2)" "unprognostic (5.95e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.84e-4)" "unprognostic (2.48e-1)" "unprognostic (4.05e-2)" "unprognostic (2.11e-1)" "unprognostic (2.46e-2)" "unprognostic (4.74e-2)" "unprognostic (4.52e-1)" "prognostic favorable (5.36e-11)" "unprognostic (1.19e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (3.42e-2)" 8.7 19.0 5.4 4.8 8.3 1.4 6.2 4.2 8.6 4.6 8.4 5.7 5.9 7.1 6.2 12.4 8.6 7.1 5.7 24.8 4.8 7.3 14.8 45.1 5.0 6.8 6.3 6.2 5.2 8.5 9.1 4.7 4.2 7.8 6.4 8.3 11.6 5.9 5.3 5.0 6.0 9.4 7.1 7.2 5.5 5.4 6.7 3.5 6.1 19.7 6.5 5.9 6.3 6.0 13.6 7.9 2.5 11.0 2.3 20.6 6.0 1.1 4.0 3.6 2.0 16.9 4.3 3.4 1.0 5.2 1.6 2.1 1.1 5.0 5.8 3.9 3.9 3.8 4.0 2.7 4.3 0.9 1.8 3.7 0.0 0.2 5.3 1.8 3.9 0.8 7.3 5.5 0.9 3.1 0.7 2.7 8.4 4.1 2.5 0.6 10.6 2.0 9.3 3.8 6.9 1.0 4.3 0.4 1.7 8.1 0.0 3.0 2.9 3.7 1.5 3.0 6.5 10.7 27.9 2.1 1.8 0.2 0.8 0.2 0.0 0.0 22.5 7.1 5.0 0.0 2.5 8.5 1.0 9.1 11.0 10.1 8.8 10.8 10.8 6.8 13.6 14.3 9.9 1.4 2.3 10.6 7.9 20.6 6.0 5.4 8.3 4.2 8.6 4.8 7.3 6.3 6.2 7.8 3.5 14.9 5.4 2.2 7.3 8.7 2.6 16.1 28.1 22.7 4.5 14.0 0.0 15.8 49.7 4.9 8.7 6.7 13.4 0.0 8.3 7.4 8.5 3.2 1.1 37.1 5.5 6.4 6.4 4.9 8.3 3.4 5.2 3.0 8.5 0.0 8.1 22.7 4.2 10.5 4.6 35.0 6.1 6.5 9.2 4.8 11.3 12.2 5.6 6.7 14.6 3.3 NUF2 "CDCA1, CT106, NUF2R" ENSG00000143228 "NUF2, NDC80 kinetochore complex component" Q9BZD4 1 163266576-163355764 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 38.6;testis: 29.0" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 232.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059692, HPA076604" Supported Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA059692: AB_2684103, HPA076604: " "unprognostic (9.41e-2)" "unprognostic (2.61e-1)" "unprognostic (2.56e-1)" "unprognostic (5.32e-3)" "unprognostic (6.20e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.04e-5)" "prognostic unfavorable (9.16e-4)" "prognostic unfavorable (4.83e-4)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.75e-4)" "unprognostic (3.70e-2)" "unprognostic (0.00e+0)" "unprognostic (9.79e-2)" "unprognostic (7.88e-2)" "unprognostic (2.69e-1)" "unprognostic (5.96e-2)" 1.3 0.9 0.8 9.8 0.9 14.1 0.6 0.5 0.9 1.4 2.5 0.6 0.9 2.3 0.6 2.1 6.1 0.5 0.7 1.5 0.8 0.6 0.7 0.6 1.9 9.9 0.8 0.6 0.7 0.4 0.3 0.4 3.6 0.7 0.6 2.9 0.8 1.3 0.0 0.5 2.2 3.2 1.0 1.4 4.4 1.6 29.0 0.3 38.6 0.5 5.1 9.2 1.5 1.8 1.4 0.6 2.6 0.2 3.0 7.7 1.0 26.3 9.2 24.5 10.2 0.7 2.5 13.3 16.7 11.8 27.2 23.9 7.0 23.3 22.7 14.0 6.7 11.3 15.5 14.9 6.3 34.5 23.7 10.7 8.9 10.6 10.0 0.0 15.3 18.4 0.3 0.6 13.7 9.7 5.1 12.3 22.3 16.7 31.5 25.7 5.1 27.9 20.6 13.3 19.4 14.2 19.0 21.4 20.1 7.7 3.6 18.3 21.1 8.9 9.7 9.2 15.9 14.9 32.1 8.7 20.3 22.8 15.2 33.6 22.6 31.8 43.3 6.7 12.6 22.4 2.6 0.2 2.5 2.4 0.1 1.0 1.2 3.6 2.4 0.5 1.4 2.5 2.1 0.9 3.0 0.2 0.6 7.7 1.0 0.8 0.9 0.5 0.9 0.8 0.6 0.8 0.6 0.7 0.3 0.0 0.3 3.7 1.8 5.3 1.0 0.8 0.0 0.0 4.5 0.0 0.0 2.7 0.0 0.7 15.8 0.1 0.8 46.7 0.2 23.9 1.8 0.4 4.6 0.2 11.3 0.0 0.0 1.8 3.7 10.7 2.3 2.5 0.0 1.0 0.9 2.5 0.2 0.0 2.1 0.0 2.0 6.5 0.5 232.2 40.5 2.0 3.3 3.8 2.2 1.4 NUGGC "C8orf80, HMFN0672, SLIP-GC" ENSG00000189233 "Nuclear GTPase, germinal center associated" Q68CJ6 8 28021964-28083871 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 21.1;lymphoid tissue: 32.2" "Cell type enhanced" "Detected in some" 14 "Club cells: 6.8;Hepatocytes: 12.3;Proximal tubular cells: 4.6;T-cells: 6.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Daudi: 45.7;Karpas-707: 15.7;U-698: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.23e-2)" "unprognostic (2.17e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (2.15e-2)" "unprognostic (1.83e-4)" "unprognostic (2.08e-3)" "unprognostic (6.19e-2)" "unprognostic (4.70e-2)" "unprognostic (1.59e-3)" "unprognostic (2.45e-1)" "unprognostic (1.95e-1)" "unprognostic (3.39e-3)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (6.14e-2)" 0.8 0.3 0.3 32.2 0.4 0.5 0.4 0.3 0.3 0.3 4.9 0.1 0.4 1.1 0.3 0.4 1.6 0.5 0.4 0.5 0.3 0.3 4.1 21.1 1.1 12.9 0.3 0.0 0.9 0.3 0.0 0.3 0.0 0.0 0.5 0.8 0.3 3.6 2.7 0.3 0.3 4.6 0.0 0.3 5.2 1.6 0.5 0.0 0.1 2.3 1.4 23.2 1.8 0.4 3.3 1.2 2.5 1.1 1.2 7.8 0.9 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 45.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.7 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 6.1 0.5 33.6 0.1 0.1 0.0 1.8 1.1 0.5 7.8 0.7 1.0 3.3 3.4 4.9 0.3 1.9 0.7 2.1 2.5 1.2 0.4 1.2 0.2 0.9 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 2.1 0.8 0.2 0.2 0.0 0.5 0.0 0.0 6.8 1.8 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 12.3 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.5 0.0 0.0 0.9 0.0 6.9 0.0 0.2 NUP155 "KIAA0791, N155" ENSG00000113569 "Nucleoporin 155" O75694 5 37288137-37371181 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Atrial fibrillation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "lymphoid tissue: 20.4;testis: 70.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 50.6;Late spermatids: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037775 Enhanced Enhanced "Nuclear membrane" "Intracellular and membrane" NA NA "Nuclear membrane" "HPA037775: AB_10671885" "unprognostic (1.10e-2)" "unprognostic (7.94e-2)" "unprognostic (1.28e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (2.18e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "unprognostic (9.49e-2)" "unprognostic (1.49e-2)" "unprognostic (6.80e-2)" "unprognostic (2.27e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" 6.8 5.3 3.9 6.5 5.9 11.2 7.3 6.9 7.5 6.4 5.1 5.9 3.4 4.4 9.7 3.7 6.9 5.0 3.7 4.7 3.9 4.1 4.4 5.3 5.1 8.1 3.8 4.2 7.9 5.5 8.1 7.0 8.4 5.2 5.5 6.3 5.9 6.0 5.9 6.1 8.1 5.0 5.9 3.9 7.2 4.9 70.1 2.5 20.4 5.4 4.8 9.8 5.8 6.0 7.3 4.9 7.1 7.1 7.7 10.0 4.4 13.8 11.0 12.0 17.7 3.7 5.5 43.1 11.2 5.9 15.4 11.3 16.2 11.4 15.7 5.2 7.2 16.7 11.3 20.2 11.0 24.2 10.3 11.4 12.2 40.1 7.5 4.7 20.3 8.6 4.0 4.6 23.7 12.0 4.2 8.1 7.1 22.1 8.4 10.2 6.8 10.8 5.5 11.3 8.5 10.0 13.1 37.8 12.5 3.5 13.3 14.5 10.0 25.8 11.1 6.5 8.9 13.7 8.1 7.0 18.6 15.6 14.0 17.0 9.6 16.0 21.1 8.7 18.4 14.0 7.1 3.4 5.8 6.1 7.1 10.0 7.3 5.7 5.3 4.9 5.8 5.8 6.5 1.3 7.7 5.0 3.4 4.1 4.4 3.9 5.9 6.9 7.5 3.9 4.1 3.8 4.2 5.2 2.5 3.0 5.0 11.5 5.6 9.3 6.5 7.3 2.5 12.0 11.4 3.5 5.9 11.9 0.0 5.9 50.6 7.4 3.8 0.0 5.2 17.5 5.8 6.6 4.7 7.9 6.8 4.8 1.2 13.5 8.8 71.9 10.3 7.4 0.0 4.6 9.7 3.5 5.5 3.5 9.6 3.1 13.1 0.0 6.1 27.7 19.6 10.2 6.3 8.7 10.3 4.4 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol No No Nucleoplasm "Nucleoli, Cytosol" "HPA061750: AB_2684602, HPA063942: AB_2685156" "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favorable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.9 21.0 17.4 23.7 13.2 13.1 15.6 15.4 12.2 28.3 18.9 25.3 8.8 19.2 5.8 16.9 18.3 32.6 39.0 19.1 21.2 15.4 18.8 17.1 39.2 19.9 8.4 29.2 17.3 9.1 9.0 29.7 15.2 8.3 16.2 25.0 37.5 13.7 19.9 27.8 24.9 11.9 23.3 21.1 20.2 22.9 37.7 19.6 8.7 12.4 24.5 11.8 39.9 15.2 5.9 13.4 16.7 10.8 13.1 23.5 16.7 23.6 27.5 11.7 21.6 26.0 13.7 18.7 17.3 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 0.0 13.0 7.5 5.2 5.8 14.9 2.7 7.6 4.0 2.3 5.2 43.2 6.4 1.7 5.5 10.1 6.8 3.2 0.0 5.6 5.9 6.9 7.5 5.8 3.8 7.4 19.1 8.7 12.9 4.9 3.1 8.9 7.2 1.7 4.6 6.7 7.5 7.5 0.0 11.0 1.9 25.0 25.8 4.2 41.6 37.7 9.8 7.2 7.0 6.0 7.2 NUP210 "FLJ22389, GP210, KIAA0906, POM210" ENSG00000132182 "Nucleoporin 210" Q8TEM1 3 13316235-13420309 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.0;lymphoid tissue: 44.2" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 33.4;T-cells: 37.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 47.0;U-266/84: 52.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066888 Approved NA NA 28000 "HPA066888: AB_2685741" "unprognostic (3.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (2.33e-1)" "unprognostic (9.72e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (1.96e-3)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-2)" "unprognostic (1.63e-2)" 1.6 4.1 4.0 25.6 5.2 31.0 3.7 12.6 6.7 1.7 4.2 8.0 3.3 4.9 1.8 7.0 5.6 2.9 4.0 2.0 4.1 5.3 6.8 13.8 5.3 25.6 4.9 3.5 1.4 11.4 7.2 10.9 4.3 4.5 4.2 3.9 6.3 6.8 4.4 7.2 3.8 16.4 1.6 3.6 25.3 5.6 6.6 6.1 44.2 6.5 3.1 23.1 5.6 1.8 6.7 6.8 1.0 3.9 6.2 9.3 3.6 8.4 14.9 7.4 19.1 0.0 0.0 29.4 0.1 0.0 1.8 0.0 7.6 13.8 34.4 11.9 0.0 0.8 4.9 16.3 0.0 0.7 27.6 12.1 13.3 16.9 8.0 0.0 42.5 4.8 0.0 0.0 0.0 0.0 1.3 0.0 26.0 20.5 37.0 0.0 21.1 22.5 16.9 8.5 2.6 3.1 0.0 0.0 47.0 3.6 7.9 8.5 8.5 10.7 14.3 4.5 3.4 13.6 35.4 0.1 0.0 2.5 0.0 6.5 37.6 52.0 30.0 0.0 23.8 0.0 0.0 2.9 1.0 9.3 3.9 7.4 6.7 6.7 9.0 6.4 4.5 5.6 7.3 0.1 6.2 2.4 6.8 5.6 3.6 4.0 5.2 12.6 6.7 4.1 5.3 4.9 3.5 4.5 6.1 14.9 4.8 32.0 1.2 1.4 16.7 9.6 10.2 2.7 6.8 5.2 13.7 13.4 3.3 5.0 18.8 0.7 1.1 23.3 3.8 3.8 0.5 3.1 4.7 11.6 14.7 33.4 7.9 4.3 12.8 16.6 0.6 8.0 1.7 2.8 4.6 3.2 3.5 0.0 0.4 3.4 20.9 0.0 0.3 3.8 10.0 2.0 4.1 37.3 3.8 1.6 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 42.7" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 15.2;Late spermatids: 6.7;Sertoli cells: 6.5;Spermatocytes: 26.5;Spermatogonia: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 43 "MCF7: 18.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" No No "Nuclear bodies" "HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.1 1.5 0.0 0.0 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.0 0.4 0.4 0.6 0.1 0.0 0.8 0.9 0.4 0.1 0.1 0.1 3.4 0.2 0.1 0.1 42.7 0.0 0.3 0.3 0.0 0.1 1.2 0.1 0.6 0.6 1.8 0.2 0.9 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.8 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.3 0.1 0.2 0.6 0.4 0.5 0.0 0.5 0.8 0.3 1.8 0.9 0.0 0.6 0.7 0.0 0.1 0.3 0.1 0.9 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.3 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 6.5 0.1 26.5 5.1 0.5 0.0 0.0 0.0 0.2 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Cell line enhanced" "Detected in all" "K-562: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: AB_2680521" "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.8 9.8 8.4 5.0 6.8 6.6 8.8 6.1 6.3 8.0 6.5 8.0 5.0 11.1 4.9 8.4 8.3 15.7 11.3 8.0 7.8 8.0 5.5 6.9 14.0 15.6 6.0 10.8 7.5 7.1 7.4 10.2 8.3 5.1 8.1 7.4 73.0 6.4 8.2 12.8 14.2 16.4 9.1 9.9 8.6 5.0 10.6 11.1 9.2 6.3 7.1 7.4 10.2 9.4 5.3 6.3 12.4 27.0 7.0 14.1 7.9 9.2 9.9 5.6 10.9 10.8 6.9 6.5 8.5 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 17.9 19.9 15.2 9.5 7.7 29.6 24.0 15.3 16.0 15.9 22.7 43.2 10.9 8.3 9.1 225.7 14.6 13.6 0.0 13.1 9.3 11.4 11.4 8.1 11.9 75.5 15.9 19.5 18.4 255.0 282.5 21.6 77.0 10.1 15.4 14.3 14.8 12.0 5.8 19.1 6.7 31.6 6.5 8.1 90.1 44.5 9.5 9.2 11.8 16.3 9.3 NUP62CL FLJ20130 ENSG00000198088 "Nucleoporin 62 C-terminal like" Q9H1M0 X 107123427-107206433 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 40.6" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 12.0;Distal tubular cells: 18.3;Spermatogonia: 9.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "pons and medulla: 18.3" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.3;NK-cells: 1.7;T-cells: 2.6" "Cell line enhanced" "Detected in many" "A549: 13.8;CAPAN-2: 14.9;HeLa: 19.9;K-562: 14.0" HPA001884 Approved NA NA "HPA001884: AB_1079512" "unprognostic (1.62e-2)" "prognostic favorable (5.66e-5)" "unprognostic (8.80e-2)" "unprognostic (4.23e-2)" "unprognostic (1.44e-1)" "unprognostic (8.19e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-2)" "unprognostic (6.47e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-1)" "unprognostic (2.82e-3)" "unprognostic (4.52e-3)" 0.5 12.4 1.2 2.9 2.6 1.4 2.6 0.3 0.6 1.7 3.1 3.2 8.7 2.4 2.0 40.6 2.3 15.0 2.3 1.6 1.7 2.2 5.5 2.0 2.4 1.4 1.1 1.2 4.4 12.6 2.5 9.0 0.7 18.3 1.0 2.7 1.1 2.5 10.9 0.5 1.5 3.3 0.2 1.3 0.6 1.3 11.0 1.7 3.3 8.6 1.0 3.4 1.4 1.4 4.3 0.2 0.6 0.5 1.7 2.6 0.6 8.3 13.8 1.2 0.0 0.0 0.0 6.0 0.0 0.5 0.3 0.3 1.3 14.9 4.8 1.6 0.0 7.7 7.5 8.8 3.0 0.0 0.0 11.3 0.5 19.9 2.4 0.0 0.0 0.0 0.1 4.1 0.0 2.1 0.0 0.0 7.5 14.0 1.2 0.0 4.1 1.8 0.0 1.8 11.9 5.0 0.0 0.0 0.4 4.5 2.2 3.6 4.1 4.9 1.5 0.0 5.3 0.0 0.2 0.0 0.0 4.6 0.1 0.0 1.6 5.5 2.6 0.0 0.0 0.0 0.0 0.1 0.6 0.6 0.4 0.7 4.3 2.6 0.2 0.1 3.3 1.3 1.5 0.0 1.7 0.5 0.2 1.1 0.6 1.2 2.6 0.3 0.6 1.7 2.2 1.1 1.2 18.3 1.7 3.0 0.0 3.2 3.2 1.6 0.2 0.8 2.5 12.0 1.2 8.7 0.0 1.3 18.3 1.6 6.4 0.0 1.1 0.0 3.0 0.7 0.2 0.8 0.0 1.8 0.7 1.6 0.0 0.0 0.0 1.5 0.3 0.0 5.0 0.0 2.5 1.2 0.9 0.0 0.7 4.5 0.0 6.5 0.0 4.2 9.7 2.5 0.8 0.0 2.5 2.3 NUPR1 "COM1, p8" ENSG00000176046 "Nuclear protein 1, transcriptional regulator" O60356 16 28532708-28539174 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 297.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 11.5;eosinophil: 4.2;neutrophil: 3.1" "Lineage enriched" "Detected in many" 10 "granulocytes: 11.5" "Cell line enhanced" "Detected in many" "HHSteC: 51.1;hTCEpi: 84.2;SK-MEL-30: 60.2;T-47d: 35.8;U-87 MG: 32.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA006349 Supported "Nucleoplasm,Cytokinetic bridge" NA NA Nucleoplasm "Cytokinetic bridge" "HPA006349: " "unprognostic (2.64e-2)" "unprognostic (2.77e-2)" "unprognostic (3.76e-2)" "unprognostic (1.86e-1)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (7.72e-3)" "unprognostic (5.77e-3)" "unprognostic (3.61e-2)" "unprognostic (2.77e-1)" "unprognostic (1.04e-2)" "unprognostic (2.32e-2)" "unprognostic (3.27e-2)" "unprognostic (1.51e-1)" "unprognostic (6.14e-2)" "unprognostic (6.36e-3)" "unprognostic (2.80e-2)" 26.9 38.6 13.1 8.9 20.0 1.7 24.4 13.4 10.1 30.0 28.6 10.4 114.1 4.5 19.9 36.6 31.2 16.5 19.3 16.2 14.8 12.2 19.3 47.1 33.7 7.5 20.5 8.2 41.0 297.9 2.2 5.8 16.1 23.1 46.5 16.5 23.5 89.5 128.3 22.2 27.5 8.9 35.3 23.9 7.6 17.4 18.6 17.6 4.2 146.4 14.4 11.5 47.9 79.1 0.8 0.8 11.5 0.6 1.1 0.5 0.1 0.2 1.6 0.0 13.2 19.7 17.3 10.3 11.5 10.0 0.4 9.3 0.0 0.0 0.0 6.4 17.7 1.1 0.3 0.0 0.3 0.3 0.0 0.5 0.0 0.7 8.3 51.1 0.0 0.0 16.4 84.2 5.4 24.0 12.7 0.0 0.0 0.0 0.5 5.8 2.3 0.0 0.2 0.0 0.0 6.4 0.0 0.0 0.4 0.0 1.1 0.1 0.0 3.3 13.8 60.2 0.2 35.8 1.9 0.0 3.7 9.2 9.8 1.6 0.0 0.0 0.1 32.1 0.0 0.4 11.5 0.6 4.2 0.4 0.4 0.5 0.4 0.4 0.3 0.2 0.8 0.5 0.5 3.1 1.1 0.5 0.8 0.3 0.1 13.1 20.0 13.4 10.1 14.8 12.2 20.5 8.2 23.1 17.6 268.0 266.9 12.9 284.3 281.4 2.7 143.0 84.1 203.4 100.1 307.1 2.0 116.3 18.3 217.4 9.2 223.9 44.6 0.0 489.4 49.3 360.2 373.9 19.7 654.2 297.7 1.6 58.7 232.7 44.1 22.4 489.5 65.6 146.8 10.8 319.6 165.4 272.9 60.4 662.3 199.5 3.2 200.5 420.6 5.8 4.3 464.9 591.9 17.5 358.7 334.3 NUPR2 NUPR1L ENSG00000185290 "Nuclear protein 2, transcriptional regulator" A6NF83 7 56114681-56116400 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 93.5" "Group enriched" "Detected in many" 21 "Early spermatids: 3268.4;Late spermatids: 11633.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.3" "Lineage enriched" "Detected in many" 4 "T-cells: 9.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (5.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (9.52e-2)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.17e-2)" "unprognostic (1.50e-2)" "prognostic favorable (9.53e-5)" "unprognostic (1.66e-1)" "unprognostic (8.44e-2)" "unprognostic (2.74e-1)" "unprognostic (5.44e-2)" 1.1 2.1 2.0 0.4 2.7 0.3 1.6 2.0 1.5 1.0 0.3 0.1 7.8 0.5 0.2 6.5 0.3 0.9 1.1 0.6 0.8 1.5 4.1 1.3 0.8 0.2 0.8 0.7 0.7 3.2 1.1 3.7 0.3 1.2 1.8 0.3 0.2 5.2 11.8 0.7 0.4 0.2 0.2 0.4 0.2 1.9 93.5 0.1 0.0 4.8 0.0 0.4 0.3 0.3 0.9 1.4 2.1 0.7 0.6 9.3 1.6 1.2 3.9 1.8 5.0 4.7 2.0 0.6 0.2 1.8 0.9 0.6 0.5 2.7 0.4 6.0 0.2 1.9 0.4 2.4 0.6 1.1 0.9 7.6 2.9 1.7 3.4 2.5 0.9 0.5 3.6 2.6 1.3 5.6 2.2 1.7 3.9 3.6 3.2 1.8 4.1 1.6 3.7 1.6 1.5 4.2 1.4 2.0 14.4 2.8 0.7 5.0 4.6 2.4 0.6 6.7 6.2 1.5 0.9 1.3 0.8 2.1 1.2 0.9 4.8 5.6 5.5 3.1 3.7 1.4 2.1 0.6 1.0 0.6 0.1 0.9 0.8 3.2 1.0 0.7 0.9 9.3 2.6 0.1 0.6 0.7 1.4 0.8 1.6 2.0 2.7 2.0 1.5 0.8 1.5 0.8 0.7 1.2 0.1 0.0 1.0 0.0 18.3 0.0 0.8 0.0 0.0 5.3 3.4 85.5 0.0 9.2 358.1 3.1 3268.4 0.0 0.0 0.0 1.7 0.9 0.0 39.9 1.1 0.0 0.5 15.9 14.0 0.0 0.0 11633.4 87.2 0.4 0.0 0.0 2.5 0.2 0.9 0.0 64.3 1.9 0.4 84.1 0.0 86.6 50.7 0.0 2.4 0.0 1.0 16.6 NUSAP1 "ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41332694-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 38.3;lymphoid tissue: 123.4" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 350.4;Extravillous trophoblasts: 100.9;Spermatocytes: 103.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "T-reg: 16.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042904, HPA074847" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" Yes Yes Nucleoplasm "Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavorable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavorable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 3.2 12.9 0.7 20.3 1.3 38.3 3.8 0.7 0.9 2.9 5.4 1.1 4.4 5.8 1.5 2.8 16.1 0.9 2.5 2.7 0.7 0.7 2.5 4.2 5.7 16.5 0.9 0.5 4.2 3.0 0.0 0.6 9.2 0.9 1.8 6.5 0.8 3.6 5.6 4.4 6.0 6.3 2.2 1.2 7.4 4.1 8.6 0.6 123.4 0.8 9.7 19.4 2.9 5.3 2.7 3.1 6.4 1.4 1.7 16.3 3.1 37.4 12.6 41.8 19.9 2.2 3.6 13.9 30.0 17.7 33.1 32.1 17.0 19.6 19.4 16.7 11.3 26.6 36.2 32.2 14.7 31.8 34.9 15.8 49.4 31.3 16.0 0.6 31.4 22.2 1.1 1.7 17.6 13.6 6.5 19.8 30.1 27.0 66.3 25.6 10.0 38.8 21.1 21.5 38.5 15.6 41.9 44.6 21.0 11.8 11.7 30.3 20.8 41.3 24.3 8.6 15.9 36.6 23.3 12.0 25.7 32.3 29.0 52.7 24.7 47.7 62.1 13.5 47.2 44.1 6.4 1.4 4.4 0.7 0.9 0.4 2.7 3.5 2.6 3.1 2.1 0.2 1.9 0.8 1.7 1.2 2.9 16.3 3.1 0.7 1.3 0.7 0.9 0.7 0.7 0.9 0.5 0.9 0.6 0.0 1.0 6.7 5.9 34.2 0.8 0.8 22.9 0.0 4.5 0.0 0.0 10.7 3.3 2.1 20.6 0.7 1.8 350.4 0.4 100.9 8.5 4.1 6.9 3.8 30.5 0.0 2.9 9.2 13.2 8.5 0.3 16.4 3.3 6.4 3.4 1.5 1.6 0.0 1.8 3.9 0.9 0.0 4.1 103.5 65.4 21.8 16.1 13.4 10.2 4.7 NUTM1 "C15orf55, DKFZp434O192, FAM22H, NUT" ENSG00000184507 "NUT midline carcinoma family member 1" Q86Y26 15 34343315-34357737 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 48.9" "Group enriched" "Detected in some" 5 "Early spermatids: 35.9;Spermatogonia: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NTERA-2: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040421 Enhanced NA NA "HPA040421: AB_10793965" "unprognostic (4.14e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-1)" "unprognostic (7.38e-2)" "unprognostic (1.99e-1)" "unprognostic (8.37e-2)" "unprognostic (8.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-2)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (2.77e-1)" "unprognostic (4.27e-2)" "unprognostic (4.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.3 0.5 0.3 0.0 0.0 0.4 0.5 0.1 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.3 0.1 2.2 0.6 0.3 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.2 0.6 0.2 0.0 0.7 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.2 0.0 0.0 0.0 0.0 0.0 NUTM2F "DKFZp434I1117, FAM22F" ENSG00000130950 "NUT family member 2F" A1L443 9 94318196-94328644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "NTERA-2: 5.5" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (1.40e-1)" "unprognostic (4.93e-3)" "unprognostic (4.16e-2)" "unprognostic (1.47e-1)" "unprognostic (9.26e-3)" "unprognostic (1.03e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (6.72e-3)" "unprognostic (8.48e-2)" "unprognostic (1.11e-2)" "unprognostic (5.14e-1)" "unprognostic (1.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUTM2G FAM22G ENSG00000188152 "NUT family member 2G" Q5VZR2 9 96928310-96940253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "testis: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 4.6;SiHa: 4.4" HPA064635 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA064635: " "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.78e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.50e-2)" "unprognostic (1.92e-2)" "unprognostic (3.50e-3)" "unprognostic (2.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.13e-1)" "unprognostic (4.52e-2)" 0.1 0.4 0.1 0.4 0.2 1.9 0.2 0.5 0.2 0.2 0.2 0.2 0.5 0.0 0.7 0.3 0.8 0.2 0.2 0.2 0.4 0.2 0.5 1.1 0.2 0.8 0.6 0.0 0.3 0.4 0.5 0.0 1.4 0.0 2.6 3.1 0.4 0.0 0.4 1.2 0.6 6.2 0.7 0.0 0.4 0.6 1.6 1.2 1.5 0.6 0.0 0.7 0.0 1.6 1.5 1.3 2.2 0.0 0.0 1.6 0.7 0.0 0.0 0.0 4.6 0.6 1.6 0.3 0.0 1.4 2.1 0.0 0.0 0.0 1.1 1.9 1.5 3.7 2.1 0.0 2.3 2.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 2.4 1.2 0.0 2.6 0.9 1.8 2.4 1.6 1.1 1.2 1.6 0.2 0.0 1.7 2.0 0.5 4.4 0.5 0.2 0.7 0.4 0.0 1.0 2.5 1.0 0.8 0.9 0.6 0.1 0.9 0.3 0.7 1.1 0.0 0.6 1.5 0.7 0.6 0.0 0.3 0.3 0.5 0.3 1.6 0.3 0.5 0.6 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719976-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.8;fallopian tube: 14.1" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 101.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 12 "MCF7: 3.4;U-937: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075476 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA075476: " "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favorable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.6 0.7 6.9 0.6 8.1 0.8 1.0 0.9 5.9 1.7 0.9 11.3 0.5 0.7 1.1 6.5 0.6 14.1 0.8 0.7 10.9 4.2 1.0 0.7 1.8 0.7 3.9 7.8 0.7 4.3 0.6 1.3 0.7 27.8 10.6 0.9 10.3 2.7 3.9 0.8 0.6 0.7 0.8 2.2 0.6 1.0 1.4 4.6 0.0 1.6 0.0 0.6 0.8 0.5 0.5 0.1 1.3 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 1.3 0.5 0.0 0.1 0.0 0.1 6.9 8.1 0.9 5.9 10.9 4.2 3.9 7.8 27.8 4.6 0.0 1.0 0.0 1.6 0.2 0.1 0.6 0.0 101.7 5.7 0.0 0.0 0.1 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 6.7 0.0 0.0 0.1 0.0 1.2 0.0 0.0 2.7 0.6 0.2 0.0 0.0 0.6 9.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.4 1.4 NWD2 KIAA1239 ENSG00000174145 "NACHT and WD repeat domain containing 2" Q9ULI1 4 37244220-37449465 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.8;breast: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046911 Uncertain NA NA "HPA046911: AB_2679861" "unprognostic (1.14e-2)" "unprognostic (3.12e-2)" "unprognostic (2.53e-1)" "unprognostic (5.47e-2)" "unprognostic (9.42e-2)" "unprognostic (2.55e-1)" "unprognostic (5.15e-2)" "unprognostic (1.63e-2)" "unprognostic (7.47e-2)" "unprognostic (1.00e-1)" "unprognostic (7.00e-2)" "unprognostic (1.98e-1)" "unprognostic (1.86e-2)" "unprognostic (7.65e-2)" "unprognostic (4.36e-2)" "unprognostic (1.26e-2)" 4.9 0.3 2.1 0.3 2.9 0.2 20.0 1.0 11.8 0.3 1.6 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 2.3 3.2 0.2 0.5 0.2 0.3 0.7 2.0 0.2 0.7 0.3 0.3 0.3 2.0 0.2 0.8 0.0 0.4 0.2 0.2 0.7 0.4 0.4 0.3 0.2 0.3 0.6 0.0 0.4 2.7 0.0 0.3 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.9 1.0 8.9 2.3 3.2 0.7 2.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXF2 "CT39, TAPL-2" ENSG00000269405 "Nuclear RNA export factor 2" Q9GZY0 X 102247161-102326719 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "epididymis: 16.7;testis: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "U-266/84: 27.8" HPA002079 Uncertain NA NA "HPA002079: AB_1079515" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 NXF2B bA353J17.1 ENSG00000269437 "Nuclear RNA export factor 2B" Q9GZY0 X 102360396-102439932 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "epididymis: 18.9" "Group enriched" "Detected in some" 5 "Late spermatids: 1.4;Spermatocytes: 1.0;Spermatogonia: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "U-266/84: 27.8" HPA002079 Uncertain NA NA "HPA002079: AB_1079515" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.0 NXF3 ENSG00000147206 "Nuclear RNA export factor 3" Q9H4D5 X 103075810-103093125 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 18.0;gallbladder: 16.4;testis: 50.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 5.1;Ito cells: 2.5;Kupffer cells: 3.7;Late spermatids: 3.4;Paneth cells: 2.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 16.8;HL-60: 15.9;NB-4: 14.8;THP-1: 11.5;U-2197: 48.8;U-937: 35.6" "HPA003132, HPA046757" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA003132: AB_1079514, HPA046757: AB_2679789" "unprognostic (1.20e-3)" "unprognostic (6.72e-2)" "unprognostic (2.74e-1)" "unprognostic (3.05e-2)" "unprognostic (6.75e-4)" "unprognostic (1.72e-1)" "unprognostic (1.21e-1)" "unprognostic (8.86e-2)" "unprognostic (6.19e-2)" "unprognostic (3.13e-2)" "unprognostic (3.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.21e-10)" "unprognostic (1.90e-2)" "unprognostic (4.51e-2)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 1.3 0.5 0.1 0.0 0.3 2.4 0.2 0.1 0.2 0.9 0.3 0.0 1.0 0.2 0.2 8.2 0.6 18.0 16.4 1.1 0.2 0.1 0.7 2.1 5.7 1.3 0.3 0.0 4.4 0.7 0.0 0.1 0.2 0.1 0.3 0.6 0.4 4.2 0.3 0.1 0.1 1.9 0.2 0.3 0.4 0.2 50.0 0.0 0.0 0.2 0.9 0.2 0.2 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 16.8 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.7 0.0 3.0 0.3 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 48.8 0.0 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.9 0.1 0.3 0.1 0.2 0.2 0.1 0.3 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 3.7 3.4 0.3 0.0 0.0 0.0 0.3 0.0 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.8 0.0 NXF5 ENSG00000126952 "Nuclear RNA export factor 5" Q9H1B4 X 101832112-101857577 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" HPA002079 Uncertain NA NA "HPA002079: AB_1079515" "unprognostic (1.23e-1)" "unprognostic (2.85e-1)" "unprognostic (2.73e-1)" "unprognostic (1.44e-3)" "unprognostic (9.58e-2)" "unprognostic (5.65e-2)" "unprognostic (2.24e-1)" "unprognostic (2.91e-2)" 0.7 0.2 0.3 0.0 0.4 0.7 0.2 0.8 0.7 0.0 0.0 0.0 0.0 1.5 0.1 0.3 0.4 0.1 0.6 0.5 0.8 0.5 0.2 0.4 0.7 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.2 0.9 0.8 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXNL1 "RDCVF, TXNL6" ENSG00000171773 "Nucleoredoxin like 1" Q96CM4 19 17455425-17460954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 48.8" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 90.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.62e-1)" "unprognostic (5.49e-1)" "unprognostic (1.81e-1)" "unprognostic (3.63e-1)" "unprognostic (1.13e-1)" 5.6 4.3 1.2 0.3 1.8 0.5 2.2 0.4 1.0 0.3 0.3 0.5 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.9 1.2 0.6 0.3 0.3 0.4 0.4 1.6 0.3 0.8 0.3 0.0 0.3 0.3 1.8 0.5 0.1 48.8 1.2 0.3 1.9 1.9 0.3 0.3 0.8 0.3 0.2 0.7 0.3 0.3 0.9 0.3 0.3 0.3 0.3 1.8 1.8 1.8 1.0 0.7 1.3 0.2 0.9 2.2 1.2 1.7 2.4 1.6 0.9 0.7 0.2 2.1 0.4 1.0 0.4 0.2 0.9 1.9 0.8 1.0 1.0 1.1 0.2 0.8 1.5 1.1 0.5 1.8 1.8 0.8 1.6 0.4 0.5 0.9 1.1 0.6 0.0 1.9 0.8 2.2 0.0 2.5 0.3 1.1 0.7 0.6 1.4 1.1 2.3 0.5 0.6 0.3 1.8 0.6 0.3 0.0 1.8 1.4 0.7 0.4 0.1 0.3 0.9 1.4 0.3 1.4 1.4 2.0 0.1 1.2 0.0 0.2 1.0 1.2 0.8 0.9 0.2 0.7 0.7 0.4 0.2 1.8 1.1 0.7 1.8 0.7 0.6 1.8 1.3 0.2 1.2 1.8 0.4 1.0 1.2 0.6 1.6 0.3 1.8 0.3 0.0 0.0 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 90.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXNL2 "C9orf121, RdCVF2" ENSG00000130045 "Nucleoredoxin like 2" Q5VZ03 9 88535101-88584274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 11.7" "Group enriched" "Detected in some" 5 "Early spermatids: 8.6;Proximal tubular cells: 12.2" "Group enriched" "Detected in some" 7 "breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA045526 Uncertain Approved Cytosol NA NA Cytosol "HPA045526: AB_10961044" "prognostic favorable (6.53e-4)" "unprognostic (9.70e-2)" "unprognostic (4.78e-3)" "prognostic favorable (3.83e-8)" "unprognostic (2.70e-2)" "unprognostic (3.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-4)" "unprognostic (1.92e-2)" "unprognostic (1.69e-1)" "unprognostic (2.62e-3)" "unprognostic (5.58e-2)" "prognostic favorable (9.60e-4)" "unprognostic (1.37e-1)" "unprognostic (2.52e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-2)" 7.2 0.4 1.6 1.0 1.6 4.4 3.2 0.6 1.1 6.7 0.5 2.0 0.4 0.6 6.2 9.7 0.8 6.6 0.7 0.5 1.8 2.9 4.4 5.1 0.4 0.4 1.3 1.0 11.7 0.5 0.0 0.7 3.9 1.2 0.8 0.0 2.0 1.4 3.7 1.0 1.3 0.5 0.4 1.8 0.8 0.5 2.2 0.4 0.4 1.2 0.4 0.4 1.2 1.5 1.2 1.1 4.8 1.0 1.7 2.4 0.7 2.0 4.2 1.7 1.5 0.2 1.1 1.2 3.9 1.0 0.5 0.7 0.9 1.3 1.0 1.6 0.4 1.0 2.0 0.6 0.2 1.4 0.6 1.3 1.9 4.0 1.3 0.8 1.2 1.4 0.8 0.3 0.4 0.4 0.6 0.0 1.4 1.3 4.2 1.0 1.0 1.1 1.9 2.1 0.7 0.9 0.8 0.8 1.4 15.3 1.4 1.1 0.7 2.3 1.3 0.7 1.1 1.7 1.0 1.5 1.5 2.9 2.1 0.9 1.4 1.2 1.1 1.3 1.6 1.0 4.8 1.0 2.3 2.1 0.5 2.1 0.8 1.2 2.4 0.3 1.2 2.1 2.4 2.8 1.7 0.5 1.1 2.0 0.7 1.6 1.6 0.6 1.1 1.8 2.9 1.3 1.0 1.2 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.5 8.6 0.0 0.0 0.0 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 2.1 12.2 0.7 0.0 0.8 0.3 0.4 0.1 0.9 0.0 0.0 1.8 NXPE1 "FAM55A, MGC34290" ENSG00000095110 "Neurexophilin and PC-esterase domain family member 1" Q8N323 11 114521645-114559895 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 44.0;lymphoid tissue: 20.4" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 50.2;Late spermatids: 47.7;Mucus-secreting cells: 34.2;Undifferentiated cells: 40.5" "Cancer enriched" "Detected in single" 23 "colorectal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;U-138 MG: 1.1;WM-115: 1.0" HPA049133 Enhanced "Intracellular and membrane" NA NA "HPA049133: AB_2680647" "unprognostic (2.81e-1)" "unprognostic (2.19e-3)" "unprognostic (3.40e-3)" "unprognostic (4.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (1.76e-1)" 0.1 0.0 0.1 20.4 0.1 0.0 0.1 0.1 0.1 0.1 44.0 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 36.9 0.1 0.3 0.1 0.1 0.0 4.4 1.0 0.1 0.1 0.0 2.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 12.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.0 0.0 47.7 0.3 0.0 0.0 0.0 34.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 40.5 0.0 NXPE2 "FAM55B, FLJ25224" ENSG00000204361 "Neurexophilin and PC-esterase domain family member 2" Q96DL1 11 114678386-114706933 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 22.9;salivary gland: 44.1" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.1;Enterocytes: 1.3;Intestinal endocrine cells: 1.7;Mucus-secreting cells: 2.5;Undifferentiated cells: 1.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.0;U-87 MG: 2.7" "Low region specificity" "Detected in some" "HPA039744, HPA039876" Enhanced NA NA "HPA039744: AB_2676660, HPA039876: AB_2676721" "unprognostic (2.85e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.46e-2)" "unprognostic (9.35e-2)" "unprognostic (1.27e-1)" "unprognostic (6.40e-2)" "unprognostic (1.61e-1)" "unprognostic (3.96e-4)" "unprognostic (9.00e-2)" "unprognostic (9.22e-2)" 0.2 0.1 0.2 3.0 0.2 0.0 0.2 0.1 0.2 0.3 7.4 0.0 0.8 0.3 0.5 22.9 0.4 0.2 0.0 0.3 0.2 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.5 7.1 0.0 44.1 0.0 0.2 0.2 1.8 0.5 0.2 0.1 0.2 0.5 0.0 0.0 0.2 0.7 4.8 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 3.0 0.1 0.8 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.2 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101827392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 37.8;Horizontal cells: 46.1;Ito cells: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted - unknown location" NA NA 7600 Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 6.1 4.7 7.2 7.6 16.6 7.8 5.3 6.1 16.2 6.3 5.2 29.5 6.0 2.4 7.9 2.6 4.5 8.2 4.8 12.6 9.8 5.9 3.0 2.5 6.9 10.7 24.0 8.6 5.5 2.6 15.8 6.9 4.7 22.0 6.2 3.4 3.4 4.2 7.5 44.6 2.5 4.9 7.6 9.4 8.7 4.6 5.1 17.2 6.6 5.3 4.1 9.8 7.3 5.0 8.9 11.6 15.9 13.6 6.7 19.5 11.1 7.8 12.0 10.4 3.7 11.2 11.7 2.3 8.7 11.1 10.5 15.3 2.8 0.8 11.5 25.8 9.8 12.7 1.7 11.5 9.4 13.0 14.3 3.6 8.9 7.6 7.4 14.8 7.5 8.3 6.7 1.6 8.7 3.2 13.7 11.3 11.2 1.8 37.8 17.3 4.1 10.0 1.8 5.9 0.4 7.4 4.6 12.6 4.9 7.7 2.0 8.2 9.8 3.7 0.9 6.5 6.5 1.7 10.8 9.8 11.7 13.9 1.3 9.0 18.0 17.8 13.6 10.0 33.3 2.2 6.3 13.6 15.9 12.7 10.4 8.8 8.9 14.2 13.2 11.6 5.8 19.5 15.5 6.9 6.7 9.9 7.4 16.3 11.1 7.2 16.6 6.1 16.2 9.8 5.9 24.0 8.6 22.0 17.2 23.8 6.1 9.7 1.9 3.3 23.7 37.8 5.1 2.7 3.4 0.0 7.9 0.7 0.0 2.6 1.0 11.7 0.0 0.0 2.2 1.2 7.8 0.8 12.7 1.6 6.3 46.1 6.9 40.5 18.4 1.3 8.6 9.5 6.8 10.8 0.5 22.7 2.0 0.0 7.1 0.5 15.7 19.4 7.6 9.3 15.2 2.6 0.6 10.9 0.4 1.0 NXPE4 "C11orf33, FAM55D, FLJ20127" ENSG00000137634 "Neurexophilin and PC-esterase domain family member 4" Q6UWF7 11 114570591-114595762 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 29.3;Mucus-secreting cells: 101.9;Paneth cells: 37.4;Undifferentiated cells: 91.1" "Cancer enriched" "Detected in some" 15 "colorectal cancer: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA042801 Approved "Secreted to digestive system" NA NA "HPA042801: AB_10793986" "unprognostic (1.35e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-3)" "unprognostic (1.27e-1)" "unprognostic (3.51e-3)" "unprognostic (1.06e-1)" "unprognostic (1.32e-1)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (7.47e-3)" "unprognostic (4.36e-2)" "unprognostic (2.05e-1)" 0.2 0.2 0.2 21.7 0.2 0.0 0.2 0.2 0.2 0.2 41.5 0.1 0.1 0.0 0.2 2.4 0.3 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.2 0.1 0.2 0.2 0.0 0.2 0.1 0.1 2.1 44.3 0.1 71.7 0.1 0.2 0.2 0.5 1.9 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.3 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 29.3 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 37.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.1 0.1 NXPH1 ENSG00000122584 "Neurexophilin 1" P58417 7 8433955-8752963 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "adrenal gland: 41.1;brain: 30.1" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.1;Early spermatids: 4.3;Late spermatids: 1.3;Rod photoreceptor cells: 3.4" "Group enriched" "Detected in some" 62 "breast cancer: 2.3;glioma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 15.4;WM-115: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in brain" NA NA "unprognostic (2.84e-2)" "unprognostic (1.30e-1)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-2)" "unprognostic (1.46e-4)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (5.32e-1)" "unprognostic (9.46e-2)" 0.8 41.1 9.6 0.7 9.8 0.7 1.1 3.6 30.1 0.7 0.7 3.0 0.0 0.7 0.7 0.7 0.7 0.7 0.8 0.7 6.5 13.9 0.7 0.7 0.7 0.7 6.2 7.1 0.7 0.7 0.7 1.9 0.7 6.8 0.7 0.7 0.0 1.0 0.7 0.7 0.7 0.7 0.7 3.3 0.7 0.7 0.9 1.9 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.4 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 9.8 3.6 11.5 6.5 13.9 6.2 7.1 6.8 1.9 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 NXPH2 NPH2 ENSG00000144227 "Neurexophilin 2" O95156 2 138670772-138780348 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 15 "brain: 23.0;kidney: 8.0;ovary: 19.3" "Cell type enriched" "Detected in single" 7 "Distal tubular cells: 1.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 4 "pons and medulla: 23.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034759 Approved "Secreted in brain" NA Yes "HPA034759: AB_10669732" "unprognostic (5.83e-2)" "unprognostic (8.83e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.80e-1)" 0.4 0.5 3.1 0.6 3.7 0.2 0.4 0.8 6.0 0.6 0.3 0.0 0.0 0.2 1.1 0.5 0.2 0.6 0.2 0.2 1.9 1.5 8.0 0.3 0.3 0.2 2.4 2.0 19.3 0.2 0.4 0.4 0.4 23.0 0.3 0.3 0.5 0.2 1.1 0.2 0.2 0.4 0.3 0.7 0.2 0.2 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 2.4 1.6 6.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 10.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 3.7 0.8 5.6 1.9 1.5 2.4 2.0 23.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NXPH4 NPH4 ENSG00000182379 "Neurexophilin 4" O95158 12 57216795-57226449 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.1;skin 1: 17.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 12.9;Cytotrophoblasts: 24.5;Muller glia cells: 15.7;Syncytiotrophoblasts: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Cell line enhanced" "Detected in many" "AN3-CA: 35.1;RH-30: 28.7;RPMI-8226: 18.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "unprognostic (1.08e-2)" "unprognostic (4.84e-2)" "unprognostic (2.70e-3)" "prognostic unfavorable (6.21e-4)" "prognostic unfavorable (5.42e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (2.57e-4)" "unprognostic (3.07e-1)" "unprognostic (1.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (7.83e-2)" "unprognostic (2.73e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-3)" 2.8 1.4 2.6 0.8 3.8 0.9 1.9 18.1 9.4 1.9 0.4 0.0 0.0 0.3 0.3 0.7 2.5 0.4 0.4 4.6 1.6 3.7 0.7 1.1 0.4 1.1 2.6 6.2 0.3 1.6 0.7 0.7 4.8 10.9 8.2 0.3 2.7 3.2 0.4 0.6 17.7 0.4 0.5 3.4 0.8 0.4 1.3 0.0 0.0 1.0 0.7 1.7 0.5 2.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.6 0.1 35.1 4.0 1.0 3.2 2.2 5.2 1.0 1.2 2.2 0.4 8.6 3.5 2.3 1.5 7.3 4.7 1.0 0.3 1.5 9.4 0.0 0.3 0.1 3.5 0.3 1.1 0.9 1.8 0.9 1.5 1.1 0.0 0.5 0.3 9.1 0.7 8.2 0.0 0.0 0.3 0.1 6.1 0.4 28.7 18.8 0.0 1.4 5.7 0.3 5.0 10.3 10.0 0.1 10.2 0.2 0.0 2.5 8.4 1.0 2.5 5.0 1.0 3.0 1.6 4.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.8 18.1 5.7 1.6 3.7 2.6 6.2 10.9 0.0 0.0 0.0 1.3 0.2 12.9 2.7 0.6 0.0 0.0 0.0 0.0 7.9 24.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 1.6 0.2 2.9 0.0 0.0 1.7 1.6 6.9 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 15.7 0.9 0.0 0.4 0.0 0.3 0.0 2.0 0.0 4.9 9.2 24.5 0.0 0.0 0.3 NXT2 P15-2 ENSG00000101888 "Nuclear transport factor 2 like export factor 2" Q9NPJ8 X 109535781-109544690 "Predicted intracellular proteins" "mRNA transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.7" "Cell type enhanced" "Detected in many" 5 "monocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 48.9;U-937: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024199, HPA072010" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA024199: AB_1854738, HPA072010: AB_2686483" "unprognostic (1.72e-1)" "unprognostic (1.39e-2)" "unprognostic (7.99e-2)" "unprognostic (5.31e-2)" "unprognostic (6.58e-2)" "unprognostic (3.69e-2)" "unprognostic (5.39e-2)" "unprognostic (3.14e-1)" "unprognostic (8.77e-2)" "unprognostic (3.36e-3)" "unprognostic (2.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-3)" "unprognostic (2.59e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (4.90e-2)" 10.1 6.5 10.4 6.0 9.7 12.3 12.9 3.7 8.4 8.1 6.2 9.0 1.3 7.4 4.7 6.1 10.1 5.8 5.0 3.3 9.9 6.9 7.7 9.6 6.4 9.2 10.1 6.3 5.5 7.9 5.5 2.6 17.4 10.6 6.9 7.0 3.8 8.8 3.6 2.6 10.0 9.1 5.9 11.4 7.6 6.7 38.7 9.1 14.0 7.3 6.3 11.1 7.4 7.2 7.4 11.4 4.2 11.6 12.3 11.6 9.3 4.4 3.9 3.8 6.6 5.7 4.6 8.4 2.8 4.8 3.7 4.8 3.0 6.3 5.7 9.0 3.5 10.0 3.4 5.0 4.4 5.6 7.4 3.1 4.8 3.8 5.0 2.3 48.9 20.1 3.3 3.9 3.5 2.2 2.7 3.2 6.0 5.0 23.6 3.6 4.6 7.4 5.2 6.1 6.3 5.9 2.9 5.4 6.8 3.4 4.4 1.5 4.8 12.2 6.9 3.8 3.5 2.9 16.6 2.4 5.3 3.0 7.0 2.9 4.9 6.0 8.7 4.6 53.7 5.4 3.9 8.5 4.2 11.6 11.6 7.5 7.4 8.7 9.5 11.4 6.8 8.6 8.4 1.8 12.3 9.2 7.0 9.9 9.3 10.4 9.7 3.7 8.4 9.9 6.9 10.1 6.3 10.6 9.1 3.0 6.2 5.6 17.9 17.1 1.3 25.0 0.0 8.1 12.5 3.5 0.0 13.0 18.3 10.9 10.7 4.7 5.5 0.0 12.3 20.9 7.8 17.5 5.7 4.4 10.2 0.0 1.2 3.7 7.5 4.0 4.4 9.0 1.7 45.9 5.0 7.1 7.8 8.4 4.2 12.5 0.9 12.9 6.8 17.7 31.4 20.5 24.4 9.5 5.9 19.2 NYAP1 "C7orf51, FLJ37538, KIAA1486L" ENSG00000166924 "Neuronal tyrosine phosphorylated phosphoinositide-3-kinase adaptor 1" Q6ZVC0 7 100483927-100494799 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.8" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 4.3;Horizontal cells: 12.7;Muller glia cells: 3.8;Peritubular cells: 4.2" "Cancer enhanced" "Detected in some" "glioma: 4.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 10.5;HUVEC TERT2: 5.2;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022251 Uncertain Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA022251: AB_1848915" "unprognostic (6.59e-4)" "unprognostic (2.67e-2)" "unprognostic (1.82e-2)" "unprognostic (2.51e-4)" "unprognostic (2.89e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (4.86e-2)" "unprognostic (2.54e-2)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.20e-1)" "unprognostic (3.06e-2)" "unprognostic (4.31e-1)" "unprognostic (8.65e-2)" 3.1 6.3 11.8 1.6 15.2 1.3 1.4 15.4 32.8 1.8 1.6 3.8 0.0 1.6 2.8 1.3 1.5 1.9 1.6 1.2 13.2 12.8 1.9 1.1 1.3 1.4 7.4 13.4 5.7 2.1 1.1 10.2 1.7 11.4 2.9 1.4 1.0 2.3 3.2 1.2 1.9 1.8 2.1 3.9 1.6 2.3 9.0 4.4 0.0 1.2 0.0 1.2 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 4.1 1.8 2.7 1.7 0.3 0.1 1.3 0.2 0.6 0.5 0.2 0.0 1.4 0.4 10.5 0.1 0.8 0.2 0.0 1.8 0.2 0.2 0.4 0.2 2.0 0.0 1.1 1.8 0.0 0.6 0.7 0.4 5.2 0.3 0.7 0.1 0.0 0.4 0.0 0.0 0.8 0.4 0.1 0.1 0.0 0.0 0.1 0.0 1.2 12.7 0.4 0.3 1.2 1.6 0.2 0.0 1.9 0.0 2.6 0.7 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 15.2 15.4 20.6 13.2 12.8 7.4 13.4 11.4 4.4 0.0 0.0 0.0 0.1 0.1 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 4.2 0.0 0.7 0.0 0.0 0.9 2.4 0.1 0.0 0.0 0.0 0.0 NYAP2 KIAA1486 ENSG00000144460 "Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2" Q9P242 2 225399710-225654018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 17.9;pituitary gland: 13.5" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 17.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.2;U-2 OS: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045531, HPA056945" Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045531: AB_10960749, HPA056945: " "unprognostic (2.49e-1)" "unprognostic (3.34e-1)" "unprognostic (1.24e-1)" "unprognostic (2.63e-1)" "unprognostic (2.35e-1)" "unprognostic (6.13e-3)" "unprognostic (3.33e-1)" "unprognostic (2.08e-1)" "unprognostic (1.32e-8)" "unprognostic (9.83e-2)" "unprognostic (2.92e-1)" "unprognostic (6.46e-2)" "unprognostic (1.27e-1)" 0.8 1.1 10.8 1.0 16.4 1.4 0.7 17.9 11.9 0.6 0.7 0.8 0.0 1.0 0.7 0.7 1.2 0.6 0.8 0.7 8.5 2.5 0.7 0.7 1.9 1.1 2.6 8.5 0.6 0.8 0.6 13.5 0.7 2.5 0.7 0.8 0.0 0.7 0.6 2.6 1.2 0.9 0.6 2.7 0.9 0.8 1.0 2.9 0.0 0.6 0.0 0.8 1.2 0.6 0.5 0.5 2.1 0.3 0.2 0.4 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.7 1.0 2.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.1 0.3 0.2 0.3 0.2 0.4 0.3 0.2 0.1 0.0 0.5 0.3 0.4 1.2 0.2 0.2 0.5 0.1 0.1 10.8 16.4 17.9 11.9 8.5 2.5 2.6 8.5 2.5 2.9 0.0 2.9 0.0 1.1 1.1 17.8 0.3 0.0 0.0 1.2 0.0 2.0 0.2 0.0 0.4 0.4 0.0 0.0 0.0 1.0 0.1 0.4 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.2 0.9 0.1 0.0 0.0 0.8 NYNRIN "CGIN1, FLJ11811, KIAA1305" ENSG00000205978 "NYN domain and retroviral integrase containing" Q9P2P1 14 24398786-24419288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 45.9" "Cell type enhanced" "Detected in many" 5 "Club cells: 12.5;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 26.6" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 9.1;HEL: 9.1;HUVEC TERT2: 22.7;RT4: 18.7;TIME: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018945 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA018945: AB_1859538" "unprognostic (9.41e-3)" "unprognostic (3.96e-2)" "unprognostic (2.02e-1)" "unprognostic (4.49e-3)" "unprognostic (5.08e-2)" "unprognostic (1.14e-2)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.44e-3)" "unprognostic (4.21e-1)" "unprognostic (1.01e-1)" "unprognostic (4.51e-2)" "unprognostic (3.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (3.39e-1)" "unprognostic (2.43e-1)" 8.1 2.8 2.1 4.3 2.2 0.2 6.8 26.6 2.6 16.7 7.6 2.5 29.6 2.9 14.6 45.9 11.6 13.4 14.5 5.1 2.2 4.2 6.1 3.6 7.5 2.0 1.8 1.8 28.0 2.9 4.5 4.9 10.5 2.4 9.8 4.1 9.1 5.5 20.2 2.5 9.1 4.5 8.0 1.5 5.2 4.5 7.3 1.4 3.5 7.5 8.5 6.5 8.6 10.2 0.0 1.7 0.0 0.1 0.5 0.1 0.0 0.1 0.0 3.0 0.0 4.1 8.7 0.2 1.4 1.4 0.9 1.1 2.1 9.1 0.2 0.4 5.4 0.1 0.0 4.8 0.1 1.0 0.0 0.5 9.1 1.2 0.2 3.1 0.0 0.0 8.8 0.4 0.6 0.0 1.6 22.7 0.1 1.4 0.0 0.1 0.4 0.0 0.4 1.7 0.6 0.0 1.2 0.0 0.0 0.0 18.7 0.4 6.5 0.0 0.8 0.1 7.6 1.6 1.3 10.9 0.1 5.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 2.1 2.2 26.6 2.6 2.2 4.2 1.8 1.8 2.4 1.4 3.0 1.7 0.0 3.9 4.0 0.4 1.7 7.6 1.4 12.5 8.7 0.0 0.9 0.0 3.3 0.7 7.1 1.3 0.0 2.7 0.9 6.6 0.8 0.0 1.8 8.5 0.0 5.2 16.0 5.1 0.0 2.3 0.8 3.3 1.0 8.5 5.3 3.7 3.5 0.4 0.1 0.3 0.0 4.7 0.0 1.1 3.3 0.9 0.0 8.3 3.1 NYX "CLRP, CSNB1, CSNB1A, CSNB4" ENSG00000188937 Nyctalopin Q9GZU5 X 41447434-41475710 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 13.9" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HDLM-2: 7.4;NTERA-2: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (3.27e-2)" "unprognostic (6.72e-2)" "unprognostic (4.21e-2)" "unprognostic (4.10e-4)" "unprognostic (1.83e-1)" "unprognostic (3.96e-2)" "unprognostic (1.80e-1)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 13.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.4 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.5 1.1 0.0 0.2 0.0 0.0 0.0 OAF MGC52117 ENSG00000184232 "Out at first homolog" Q86UD1 11 120210767-120230332 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 93.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 187.7;Muller glia cells: 261.4;Urothelial cells: 195.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6" "Group enriched" "Detected in many" 12 "dendritic cells: 4.6;monocytes: 6.2" "Cell line enhanced" "Detected in many" "EFO-21: 35.0;Hep G2: 54.7;NB-4: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047412 Uncertain Approved Nucleoplasm "Secreted - unknown location" NA NA 65000000 Nucleoplasm "HPA047412: AB_10960631" "unprognostic (1.59e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" "unprognostic (2.80e-1)" "unprognostic (5.69e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.11e-1)" "unprognostic (3.98e-3)" "unprognostic (5.09e-2)" "unprognostic (3.90e-2)" "unprognostic (3.28e-2)" "unprognostic (1.52e-2)" "unprognostic (1.07e-2)" "unprognostic (1.12e-2)" "unprognostic (7.15e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-1)" 16.2 22.5 8.6 6.9 15.4 3.5 24.9 1.2 10.3 18.7 16.8 4.0 8.0 19.4 14.3 17.2 10.7 13.4 20.6 13.7 8.7 1.4 21.5 93.4 5.6 8.1 5.4 6.4 26.2 43.7 2.4 7.4 4.6 3.2 10.3 13.5 18.2 26.5 5.8 3.7 3.0 22.1 11.7 3.3 15.3 9.9 5.5 5.5 1.2 6.8 8.6 3.6 11.2 10.9 0.1 4.6 0.3 6.2 0.0 0.4 1.3 7.0 2.2 8.4 4.2 13.1 14.8 0.5 13.8 14.3 5.6 8.2 2.2 11.0 0.0 35.0 9.3 9.2 7.4 2.3 3.5 2.2 5.1 5.7 5.8 1.4 54.7 11.7 12.8 2.3 18.4 2.1 5.3 14.9 10.8 16.0 3.5 3.7 6.7 1.3 2.6 0.0 36.7 3.4 1.9 11.2 3.3 0.2 6.8 8.4 3.9 0.4 3.0 4.0 4.5 11.4 2.4 1.4 21.3 9.7 12.0 4.4 12.2 1.3 0.2 0.1 0.1 9.2 21.4 4.1 0.0 6.2 0.0 0.2 2.9 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.4 0.3 0.0 0.6 0.9 0.3 1.3 8.6 15.4 1.2 10.3 8.7 1.4 5.4 6.4 3.2 5.5 0.0 1.1 1.5 19.1 8.4 3.2 3.6 33.1 0.0 2.3 68.0 2.0 1.8 23.2 14.3 0.1 24.8 97.4 23.3 24.3 4.7 46.2 12.2 1.1 187.7 5.5 0.0 21.9 11.1 10.6 0.0 15.5 9.7 15.1 1.8 55.8 261.4 23.5 41.9 4.2 64.1 8.0 51.8 45.3 0.5 6.7 8.9 5.1 3.2 42.0 195.3 OAS1 "IFI-4, OIAS, OIASI" ENSG00000089127 "2'-5'-oligoadenylate synthetase 1" P00973 12 112906777-112933222 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 83.9" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 91.2;Urothelial cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 83.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 50.8;BJ hTERT+ SV40 Large T+ RasG12V: 73.0;OE19: 48.0;U-266/70: 71.6;U-266/84: 54.4" "HPA003657, CAB021104" Uncertain Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "CAB021104: AB_10057722, HPA003657: AB_1854747" "unprognostic (1.03e-1)" "unprognostic (6.59e-2)" "unprognostic (8.56e-3)" "unprognostic (2.20e-3)" "unprognostic (2.78e-1)" "unprognostic (1.30e-1)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.20e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (6.91e-2)" "unprognostic (3.68e-2)" "unprognostic (5.67e-2)" "prognostic favorable (6.12e-6)" 31.2 7.3 6.1 16.6 7.1 5.7 8.4 2.1 6.0 16.4 25.4 11.0 2.6 23.6 5.8 21.0 39.1 5.1 10.7 5.1 4.2 5.7 18.3 23.3 20.7 17.3 5.9 5.3 7.4 3.2 4.3 6.1 18.8 8.6 11.5 20.5 11.7 31.8 4.2 2.9 6.3 27.2 7.6 9.4 30.1 22.7 4.2 6.2 21.6 9.4 13.5 27.3 20.9 13.0 18.2 24.4 4.1 83.9 4.5 16.8 29.0 1.0 5.8 0.0 0.0 2.0 1.5 0.4 0.0 7.5 50.8 73.0 3.3 6.2 7.9 2.2 0.0 27.5 2.6 0.0 0.7 0.7 5.8 0.0 0.2 10.4 1.2 0.6 0.1 0.4 0.1 2.2 1.9 0.0 0.8 2.7 0.2 0.0 3.5 0.0 0.1 0.2 3.6 0.3 48.0 5.0 1.6 0.0 3.3 2.5 16.4 0.1 0.3 0.8 1.0 19.4 0.0 0.2 1.3 10.0 0.0 0.1 0.7 0.1 71.6 54.4 5.5 0.6 2.3 0.4 1.0 40.9 0.5 4.9 63.6 4.6 18.2 6.5 6.1 24.4 13.6 2.5 3.3 4.1 4.5 83.9 22.1 16.8 29.0 6.1 7.1 2.1 6.0 4.2 5.7 5.9 5.3 8.6 6.2 3.0 2.1 16.4 10.9 3.1 0.2 1.2 15.3 12.0 7.9 5.2 0.0 11.1 5.0 15.7 0.2 16.3 40.3 23.3 10.7 32.3 5.9 6.4 4.7 9.4 91.2 0.0 4.1 12.3 28.2 0.9 6.6 27.7 5.0 10.0 56.5 14.1 14.1 45.6 9.9 19.4 0.4 6.5 1.4 0.0 0.2 1.9 4.8 7.5 10.4 142.9 OASL "OASL1, p59OASL, TRIP14" ENSG00000135114 "2'-5'-oligoadenylate synthetase like" Q15646 12 121019111-121039242 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;bone marrow: 33.1" "Cell type enriched" "Detected in many" 4 "Urothelial cells: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 52.2;BJ hTERT+ SV40 Large T+ RasG12V: 26.9;GAMG: 14.8;hTEC/SVTERT24-B: 20.9" "Not detected" "Not detected" HPA001474 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001474: AB_1079518" "unprognostic (2.39e-2)" "unprognostic (7.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "unprognostic (2.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.03e-1)" "unprognostic (1.62e-2)" "unprognostic (6.22e-2)" "unprognostic (5.93e-3)" "prognostic unfavorable (9.20e-4)" "unprognostic (4.61e-1)" "prognostic unfavorable (3.70e-9)" "unprognostic (2.52e-1)" "unprognostic (2.72e-2)" "unprognostic (1.18e-1)" "unprognostic (3.17e-2)" 20.5 0.5 1.0 8.3 1.4 33.1 2.7 0.4 1.9 3.6 5.9 1.7 0.1 1.6 1.7 1.3 4.7 0.6 3.1 2.2 0.7 0.9 4.0 22.6 16.5 1.9 1.3 1.2 1.4 0.4 0.2 0.8 3.6 2.3 2.5 3.0 2.3 3.4 0.3 1.1 0.8 2.0 1.1 1.9 5.2 15.7 2.1 0.6 6.0 3.2 3.7 7.6 2.9 1.5 0.8 3.2 44.5 10.8 6.9 23.6 10.8 1.0 0.2 0.0 0.3 0.4 0.9 0.0 0.1 0.5 52.2 26.9 0.0 5.0 0.3 1.5 0.0 14.8 2.7 0.0 0.3 3.8 9.2 0.0 0.0 5.2 0.0 0.3 0.0 0.7 0.3 0.2 20.9 0.0 0.1 0.1 0.3 0.0 1.8 0.2 0.5 0.0 2.7 0.0 1.8 1.1 0.0 0.1 0.6 0.2 4.9 0.0 0.0 0.4 0.2 8.2 0.0 0.1 0.8 0.0 0.2 0.4 0.6 0.1 2.0 3.7 0.0 7.8 0.4 0.1 4.2 10.3 22.4 20.4 10.8 5.3 0.8 14.1 23.6 3.2 0.3 4.0 15.7 44.5 6.9 7.4 0.1 9.9 10.8 1.0 1.4 0.4 1.9 0.7 0.9 1.3 1.2 2.3 0.6 0.0 6.2 0.0 3.8 1.9 0.0 0.3 0.0 4.0 3.4 0.0 0.0 0.2 0.0 2.7 3.1 2.1 4.2 0.0 3.4 0.6 0.5 1.1 11.5 3.9 12.3 0.0 1.7 0.0 4.0 2.5 0.3 6.8 0.0 4.6 15.9 0.0 7.4 3.5 0.0 0.3 0.0 0.0 2.2 1.9 0.1 0.9 0.1 17.3 1.2 72.1 OAT HOGA ENSG00000065154 "Ornithine aminotransferase" P04181 10 124397303-124418976 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 208.5" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB033576, HPA040098, HPA064742" Enhanced Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343" "unprognostic (1.61e-2)" "unprognostic (1.70e-2)" "unprognostic (9.96e-2)" "unprognostic (1.02e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.03e-1)" "unprognostic (4.43e-3)" "unprognostic (1.65e-1)" "unprognostic (2.37e-2)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.21e-1)" "unprognostic (2.19e-1)" "unprognostic (2.72e-2)" "unprognostic (2.00e-2)" 13.5 37.1 25.9 9.1 26.7 20.3 33.8 17.2 39.8 24.7 71.9 22.8 33.9 164.0 21.6 15.5 26.1 14.9 16.0 12.7 25.6 29.8 25.6 36.8 11.6 9.3 27.9 30.1 21.8 12.3 12.1 18.0 14.8 37.8 17.9 15.8 13.3 55.2 29.1 13.7 16.3 208.5 22.5 25.5 8.4 17.3 14.6 19.4 4.9 15.9 23.1 15.2 15.5 18.2 10.2 26.5 23.0 23.6 9.6 20.1 16.3 42.0 7.6 5.0 17.9 51.0 49.3 17.1 25.5 52.1 22.8 25.0 19.5 5.5 0.0 18.6 43.0 21.7 44.8 22.8 47.7 24.8 7.4 31.6 47.1 5.3 14.5 26.3 0.0 31.1 32.2 24.6 20.5 24.0 37.8 26.5 8.7 81.0 9.1 31.8 10.9 12.4 2.6 10.0 12.9 10.8 11.6 19.1 11.4 21.8 0.7 10.5 11.2 16.0 42.8 35.9 30.1 14.2 11.6 20.4 13.0 12.2 21.5 15.8 7.8 8.1 11.4 18.0 12.7 6.2 18.6 23.6 20.7 18.5 20.7 20.1 9.6 15.6 19.4 26.5 10.2 19.6 19.1 23.0 9.6 20.8 5.7 14.4 16.3 25.9 26.7 17.2 39.8 25.6 29.8 27.9 30.1 37.8 19.4 17.9 38.8 36.2 123.3 134.4 27.8 14.0 22.9 44.2 75.1 33.2 25.5 97.9 76.3 32.5 16.9 35.8 49.1 303.7 12.0 67.3 125.7 58.3 43.8 69.3 56.5 41.3 41.3 35.6 32.6 9.0 96.4 49.4 81.0 20.8 48.6 32.0 11.7 36.8 112.8 114.0 21.3 77.6 123.8 32.5 27.0 110.2 40.3 40.6 67.9 76.5 OAZ3 ENSG00000143450 "Ornithine decarboxylase antizyme 3" Q9UMX2 1 151762899-151771334 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 102.2" "Cell type enriched" "Detected in many" 4 "Late spermatids: 9340.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030136, HPA045808" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030136: AB_2673331, HPA045808: " "unprognostic (2.12e-1)" "unprognostic (3.86e-1)" "unprognostic (1.53e-1)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.01e-2)" "unprognostic (1.48e-3)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (1.01e-4)" "unprognostic (1.57e-2)" "unprognostic (2.89e-1)" "unprognostic (8.05e-6)" "unprognostic (3.94e-2)" "unprognostic (1.32e-1)" "unprognostic (2.50e-2)" "unprognostic (8.36e-2)" 0.4 0.3 0.5 0.7 0.5 0.0 0.6 0.6 0.6 0.3 0.4 0.4 0.7 0.1 0.3 2.0 0.4 0.2 0.3 0.6 0.5 0.5 0.5 0.8 0.6 0.8 0.5 0.5 0.3 0.6 1.4 0.6 0.3 0.4 4.0 0.5 0.3 3.1 0.7 1.0 0.3 0.3 0.5 0.6 0.6 0.2 102.2 0.2 0.3 0.8 0.7 0.4 0.4 0.6 1.4 3.2 2.2 5.0 2.6 2.4 1.6 1.2 2.3 1.4 3.3 1.1 3.3 2.9 2.3 0.6 2.2 1.0 1.3 3.1 1.0 2.0 0.7 1.6 1.2 1.3 2.3 0.7 7.3 6.9 1.1 4.4 1.8 1.3 0.6 1.3 5.1 1.4 2.6 3.5 1.4 3.4 3.0 1.4 3.7 2.3 9.7 0.9 1.6 3.3 4.6 2.5 0.4 1.1 1.7 0.4 2.9 1.5 3.6 1.0 5.2 4.6 3.2 10.4 2.7 3.0 1.3 0.7 2.6 1.3 5.1 9.5 2.6 1.7 1.6 3.5 2.2 3.0 0.6 1.4 1.5 1.3 1.4 1.3 2.4 3.2 1.2 1.5 2.2 2.1 2.6 5.0 1.3 2.2 1.6 0.5 0.5 0.6 0.4 0.5 0.5 0.5 0.5 0.4 0.2 0.0 1.7 0.0 2.1 0.7 0.6 1.2 0.0 2.7 1.2 0.0 2.0 1.4 1.7 1.8 2210.4 2.7 3.0 0.0 2.7 2.3 1.1 27.3 1.1 2.6 4.0 0.0 3.5 1.8 4.0 9340.9 42.6 1.1 1.7 2.8 7.2 1.6 2.5 4.2 40.0 2.8 1.6 0.0 0.8 57.9 27.9 0.5 1.3 0.0 1.8 3.1 OBP2A "hOBPIIa, LCN13, OBP" ENSG00000122136 "Odorant binding protein 2A" Q9NY56 9 135546139-135549969 "Predicted secreted proteins" "Olfaction, Sensory transduction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 23.7;testis: 13.3" "Group enriched" "Detected in some" 6 "Late spermatids: 1.0;Leydig cells: 1.4;Melanocytes: 1.7" "Cancer enriched" "Detected in some" 6 "ovarian cancer: 18.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "U-266/70: 2.8;U-266/84: 10.6" HPA055955 Uncertain "Secreted in other tissues" NA NA "HPA055955: AB_2682985" "unprognostic (2.30e-1)" "unprognostic (3.68e-1)" "unprognostic (4.63e-1)" "unprognostic (1.66e-2)" "unprognostic (2.17e-1)" "unprognostic (3.20e-1)" "unprognostic (2.75e-1)" "unprognostic (7.65e-2)" "unprognostic (2.23e-2)" "unprognostic (8.27e-2)" "unprognostic (1.91e-1)" "unprognostic (6.83e-11)" "unprognostic (5.17e-2)" "unprognostic (3.61e-1)" "unprognostic (1.26e-1)" "unprognostic (3.84e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 23.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.0 1.2 0.4 0.1 0.4 0.0 0.1 0.1 0.1 0.1 2.9 0.1 0.1 0.1 0.2 0.0 13.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OBP2B "hOBPIIb, LCN14" ENSG00000171102 "Odorant binding protein 2B" Q9NPH6 9 133205277-133209250 "Predicted secreted proteins" "Olfaction, Sensory transduction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 3.6;skin 1: 3.0;testis: 12.1" "Cell type enhanced" "Detected in some" 13 "Late spermatids: 1.4;Leydig cells: 1.1;Melanocytes: 1.7" "Group enriched" "Detected in many" 8 "breast cancer: 7.8;endometrial cancer: 16.2;ovarian cancer: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 2.4" "Secreted in other tissues" NA NA "unprognostic (1.40e-1)" "unprognostic (5.70e-2)" "unprognostic (9.45e-3)" "unprognostic (6.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.30e-1)" "unprognostic (7.03e-2)" "unprognostic (6.82e-6)" "unprognostic (2.00e-2)" "unprognostic (1.12e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OBSCN "ARHGEF30, KIAA1556, KIAA1639, UNC89" ENSG00000154358 "Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF" Q5VST9 1 228208130-228378874 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 180.2;tongue: 48.4" "Cell type enriched" "Detected in many" 14 "Cardiomyocytes: 136.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.0" "Low region specificity" "Detected in single" "HPA021186, HPA065801" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021186: AB_1854761, HPA065801: " "unprognostic (8.47e-3)" "unprognostic (1.56e-1)" "unprognostic (9.99e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (5.30e-3)" "unprognostic (6.36e-2)" "unprognostic (4.54e-3)" "unprognostic (1.82e-1)" "unprognostic (8.81e-2)" "unprognostic (1.93e-2)" "unprognostic (3.38e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-2)" 2.5 0.9 0.5 0.9 4.4 0.6 0.7 3.1 0.6 0.6 0.8 0.5 0.5 0.6 0.8 4.4 2.4 1.0 0.6 21.2 0.5 0.7 1.6 0.5 1.0 1.0 0.5 0.5 1.7 1.4 0.4 2.4 0.5 0.9 1.7 0.3 5.2 2.6 1.1 180.2 1.1 0.8 0.5 0.6 1.4 0.5 0.7 0.6 0.5 2.2 48.4 3.5 0.6 0.7 1.0 1.1 0.1 0.4 0.6 3.2 0.7 2.9 2.8 8.0 4.5 0.2 0.1 5.6 1.5 0.5 1.0 0.9 2.0 2.1 5.7 8.1 0.5 0.6 1.0 0.4 1.1 0.2 2.2 5.1 1.9 16.0 0.0 2.0 1.3 6.1 3.0 1.0 0.4 0.2 5.4 0.4 9.4 5.3 1.3 0.3 5.0 2.1 1.6 8.8 0.8 1.8 8.1 0.1 1.3 4.6 1.5 3.0 9.0 0.2 2.9 1.1 2.4 8.0 3.7 0.7 0.0 9.3 0.2 0.1 4.7 0.9 1.4 0.0 0.8 2.1 0.1 0.4 0.0 0.9 0.1 0.9 0.5 0.9 0.7 0.9 1.0 3.2 0.5 0.1 0.6 0.1 1.1 0.8 0.7 0.5 4.4 3.1 0.6 0.5 0.7 0.5 0.5 0.9 0.6 0.0 5.6 0.0 5.9 1.9 3.2 136.5 2.5 1.4 4.5 5.2 9.8 0.1 10.0 2.9 3.8 1.6 0.4 0.0 0.4 0.4 1.5 1.9 6.9 0.5 0.1 0.0 0.0 1.3 0.0 4.0 2.8 0.3 1.7 0.0 1.7 9.7 1.0 0.0 4.2 4.2 2.8 0.0 1.2 0.1 2.5 1.5 1.0 1.8 1.1 3.4 OBSL1 KIAA0657 ENSG00000124006 "Obscurin like 1" O75147 2 219550729-219571859 "Disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 82.2" "Group enriched" "Detected in many" 4 "Early spermatids: 829.2;Late spermatids: 1255.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.8;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 10 "dendritic cells: 2.7;granulocytes: 6.8" "Cell line enhanced" "Detected in many" "BEWO: 45.0;SK-BR-3: 43.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036404, HPA036405" Approved Approved Centrosome NA NA Centrosome "HPA036404: AB_10670437, HPA036405: AB_2675104" "unprognostic (2.36e-1)" "unprognostic (6.79e-2)" "unprognostic (3.86e-2)" "unprognostic (6.57e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.27e-3)" "unprognostic (2.89e-2)" "unprognostic (9.89e-2)" "unprognostic (4.22e-3)" "unprognostic (1.25e-1)" "unprognostic (4.21e-3)" "unprognostic (7.00e-2)" "unprognostic (3.95e-2)" "unprognostic (3.62e-2)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (2.16e-1)" 10.7 26.9 13.4 7.0 11.5 1.2 11.7 18.0 16.2 17.6 8.7 10.3 10.5 3.8 18.2 23.3 7.3 19.9 14.5 30.7 12.8 8.2 19.6 14.5 9.3 3.4 5.5 10.9 82.2 35.6 23.5 16.6 19.3 11.5 15.1 2.3 19.1 25.5 19.1 21.0 14.8 4.8 10.5 8.8 8.2 10.3 15.5 11.5 0.8 34.1 12.4 2.6 10.1 12.1 0.1 2.7 6.8 0.4 0.1 0.2 0.0 9.5 6.4 11.9 24.7 8.2 6.1 45.0 7.2 10.6 9.2 8.5 5.6 14.9 0.0 15.3 9.8 8.9 9.8 9.2 5.4 1.9 0.0 16.1 20.7 6.2 28.3 6.2 0.5 0.1 16.5 4.5 2.1 3.5 16.4 1.0 0.0 8.5 0.2 6.5 23.6 0.0 5.9 28.2 2.7 6.6 10.6 10.4 0.0 16.6 9.0 5.2 17.8 8.2 43.7 16.4 31.4 4.0 17.9 2.4 9.8 10.6 3.0 2.8 0.0 0.0 0.0 5.7 0.0 9.7 6.8 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.8 0.1 0.4 2.7 0.0 0.0 13.4 11.5 18.0 16.2 12.8 8.2 5.5 10.9 11.5 11.5 8.9 14.8 0.0 19.2 7.4 33.3 45.9 25.5 8.1 10.3 50.6 2.0 55.5 44.7 13.5 829.2 12.0 2.0 0.0 10.7 57.4 14.5 10.9 4.6 13.9 6.6 39.7 19.7 10.4 1.0 1255.6 71.4 3.2 13.5 1.0 3.1 79.6 9.7 2.5 69.6 15.4 9.5 12.9 17.5 239.3 51.1 5.8 72.3 0.0 2.3 7.8 OC90 PLA2L ENSG00000253117 "Otoconin 90" Q02509 8 132024220-132059380 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "SK-MEL-30: 4.7" "Secreted in other tissues" NA NA "unprognostic (1.92e-1)" "unprognostic (2.93e-1)" 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.2 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099358 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.9;skin 1: 12.3" "Cell type enhanced" "Detected in some" 24 "Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SH-SY5Y: 5.9;SK-MEL-30: 22.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036402 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.4 0.1 0.9 1.3 4.8 0.0 0.3 0.2 2.9 2.4 0.3 3.6 0.2 0.0 0.4 1.7 2.9 1.6 0.5 0.2 1.3 3.6 0.4 0.4 1.2 3.1 0.3 0.4 0.4 0.2 0.0 1.0 2.9 9.5 0.9 0.2 37.9 1.9 2.7 0.4 12.3 0.2 0.2 0.2 2.0 0.1 2.6 0.2 0.3 7.0 0.5 1.5 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 5.9 0.0 0.0 22.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 4.8 0.2 2.9 1.3 3.6 0.3 0.4 9.5 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 8.6 0.0 40.5 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 1.7 2.9 3.9 0.6 0.1 0.0 0.0 0.1 OCLN PPP1R115 ENSG00000197822 Occludin Q16625 5 69492292-69558104 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 58.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 101.3;Urothelial cells: 183.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;CAPAN-2: 28.4;HaCaT: 22.9;MCF7: 22.6;RPTEC TERT1: 17.7;RT4: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005933, CAB013075, CAB068212, CAB068213, CAB068214" Enhanced Supported "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA "Plasma membrane, Cell Junctions" "CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520" "unprognostic (2.28e-1)" "unprognostic (1.88e-1)" "unprognostic (2.50e-2)" "unprognostic (9.94e-2)" "unprognostic (3.65e-1)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.08e-2)" "unprognostic (8.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.58e-2)" "unprognostic (3.48e-1)" "prognostic favorable (6.59e-11)" "unprognostic (2.83e-1)" "unprognostic (4.01e-1)" "unprognostic (1.33e-1)" "unprognostic (3.35e-1)" 1.2 0.8 3.4 3.8 3.7 0.5 7.6 3.9 2.9 4.3 15.5 3.2 21.9 10.2 1.7 7.4 10.6 7.9 17.1 1.1 4.0 2.9 15.3 31.7 29.2 0.4 4.0 1.7 2.3 33.2 12.0 3.2 9.0 6.7 5.7 10.9 7.7 7.1 25.0 0.5 8.7 24.5 1.2 3.8 2.1 15.1 2.0 1.5 0.4 58.1 9.8 8.6 5.0 6.5 1.2 1.2 1.8 0.3 2.0 0.9 0.1 15.4 6.2 0.1 0.5 0.2 0.4 12.5 0.0 1.5 2.1 3.1 21.3 28.4 0.1 5.4 0.3 7.8 22.9 6.3 3.0 5.8 0.1 11.1 1.2 0.2 6.5 0.1 0.5 1.6 0.0 3.2 4.8 0.2 1.1 1.2 2.1 0.0 0.1 0.0 22.6 0.6 0.4 2.4 6.8 2.6 0.0 4.7 0.5 17.7 19.3 2.1 1.0 0.1 16.9 0.2 4.4 9.5 1.9 0.2 0.1 6.4 1.3 1.5 0.3 0.1 0.1 0.1 0.1 0.1 0.8 0.3 0.7 0.8 0.2 0.2 0.8 0.9 0.3 0.1 1.2 0.7 0.9 1.8 2.0 0.2 1.2 0.4 0.1 3.4 3.7 3.9 2.9 4.0 2.9 4.0 1.7 6.7 1.5 101.3 47.6 3.2 51.5 3.3 6.0 1.3 56.0 48.2 55.7 24.4 13.7 26.5 8.3 49.2 2.0 5.3 55.1 0.0 52.8 1.2 3.2 76.5 2.3 42.9 2.6 6.4 25.2 16.0 25.3 1.1 2.8 2.6 1.7 5.4 35.4 3.5 63.1 47.2 1.4 11.3 6.2 12.9 2.7 4.2 7.8 13.6 13.7 4.9 33.9 183.7 OCM OCM1 ENSG00000122543 Oncomodulin P0CE72 7 5879827-5886362 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;brain: 9.5;lymphoid tissue: 5.5" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.7;Late spermatids: 1.8;Spermatogonia: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 2.1;PC-3: 1.9;THP-1: 1.5;U-937: 2.2" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " "unprognostic (1.79e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (1.50e-1)" "unprognostic (5.39e-2)" "unprognostic (1.31e-2)" "unprognostic (2.30e-2)" "unprognostic (7.62e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-3)" "unprognostic (6.13e-2)" "unprognostic (2.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.02e-1)" "unprognostic (3.23e-1)" "unprognostic (3.90e-4)" 0.1 0.5 9.5 0.7 1.7 1.8 1.6 3.1 1.4 0.2 0.5 0.0 0.2 2.7 0.3 0.3 0.5 0.0 2.0 1.8 0.3 0.1 0.1 5.5 0.9 0.5 0.3 0.0 0.2 0.0 0.2 0.6 0.9 0.8 0.0 2.0 0.7 0.2 0.8 1.4 0.1 2.3 0.6 2.3 0.3 0.1 2.1 0.1 2.0 0.8 0.0 5.7 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.8 0.4 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 1.5 0.0 0.0 0.2 0.5 0.4 0.3 0.3 0.1 0.0 2.2 0.0 0.0 0.8 2.0 1.1 0.5 0.4 0.9 2.8 0.8 0.1 2.1 3.7 1.0 1.6 0.0 0.4 0.0 5.7 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 OCM2 ENSG00000135175 "Oncomodulin 2" P0CE71 7 97984684-97991169 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "WM-115: 1.7" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OCSTAMP "C20orf123, dJ257E24.3" ENSG00000149635 "Osteoclast stimulatory transmembrane protein" Q9BR26 20 46540946-46550574 "Predicted membrane proteins, Transporters" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.9;blood: 2.6" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 26 "dendritic cells: 2.6" "Cell line enhanced" "Detected in some" "AF22: 2.7;HMC-1: 5.2;Karpas-707: 3.0;NB-4: 5.7;RPMI-8226: 2.4;U-266/70: 1.9;U-266/84: 5.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA031116 Uncertain NA NA "HPA031116: AB_10600758" "unprognostic (2.77e-1)" "unprognostic (3.04e-1)" "unprognostic (8.80e-2)" "unprognostic (5.02e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "unprognostic (9.59e-2)" "unprognostic (2.08e-1)" 6.9 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.6 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.4 0.0 0.1 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODAM "APin, FLJ20513" ENSG00000109205 "Odontogenic, ameloblast associated" A1E959 4 70196496-70204576 "Cancer-related genes, Predicted intracellular proteins" Biomineralization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "salivary gland: 157.7" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.4;Ductal cells: 6.3;Exocrine glandular cells: 7.3;Pancreatic endocrine cells: 3.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Hep G2: 24.2;OE19: 16.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036279, HPA036543, HPA070297" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA036279: , HPA036543: AB_10669797, HPA070297: " "unprognostic (2.34e-2)" "unprognostic (2.43e-1)" "unprognostic (1.26e-1)" "unprognostic (1.75e-1)" "unprognostic (3.34e-3)" "unprognostic (1.06e-1)" "unprognostic (1.88e-2)" "unprognostic (3.47e-1)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (2.72e-1)" "unprognostic (1.86e-2)" "unprognostic (2.50e-2)" 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.0 2.5 0.2 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.2 0.0 0.4 0.1 0.0 157.7 2.6 0.0 0.0 0.3 1.9 0.1 0.0 2.5 0.0 0.0 0.0 5.1 10.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 3.4 0.0 1.1 0.0 0.0 0.0 2.5 0.0 2.3 1.8 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 ODAPH "AI2A4, C4orf26, FLJ23657" ENSG00000174792 "Odontogenesis associated phosphoprotein" Q17RF5 4 75556048-75565885 "Disease related genes, Predicted secreted proteins" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 10.4;placenta: 34.3" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 6.2;Syncytiotrophoblasts: 22.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "basophil: 10.4" "Lineage enriched" "Detected in single" 24 "granulocytes: 10.4" "Cell line enriched" "Detected in some" 5 "HDLM-2: 31.1" "Secreted in other tissues" NA NA "unprognostic (1.13e-1)" "unprognostic (4.45e-3)" "unprognostic (3.78e-1)" "unprognostic (1.66e-1)" "unprognostic (6.12e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (2.44e-1)" "unprognostic (3.87e-2)" "unprognostic (5.30e-2)" "unprognostic (3.43e-1)" "unprognostic (1.17e-7)" "unprognostic (8.31e-2)" "unprognostic (2.70e-2)" "unprognostic (8.40e-4)" "unprognostic (6.53e-3)" 0.3 0.1 1.5 0.4 1.9 0.6 0.2 1.2 0.9 0.3 0.2 0.2 0.2 0.1 0.3 0.4 0.4 0.1 0.3 0.2 1.9 1.5 0.3 0.4 0.3 0.5 2.4 0.2 0.4 0.2 0.0 1.3 34.3 0.7 0.2 0.5 0.2 0.2 0.3 1.6 0.9 0.3 0.2 2.7 0.4 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.1 10.4 0.2 0.2 0.3 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 31.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 1.4 0.0 1.3 0.1 0.1 0.0 0.0 1.4 0.1 0.4 5.6 0.0 0.1 0.3 0.2 0.0 10.4 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 1.5 1.9 1.2 0.9 1.9 1.5 2.4 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 6.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 ODF1 "CT133, HSPB10, ODF27, ODFPG, RT7" ENSG00000155087 "Outer dense fiber of sperm tails 1" Q14990 8 102551572-102561017 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "testis: 80.3" "Group enriched" "Detected in some" 29 "Early spermatids: 151.2;Late spermatids: 223.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA064295 Approved NA NA "HPA064295: AB_2685235" "unprognostic (3.79e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 223.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.5 0.0 6.5 1.4 0.0 0.0 0.0 0.0 0.0 ODF2 "CT134, ODF84" ENSG00000136811 "Outer dense fiber of sperm tails 2" Q5BJF6 9 128455186-128501292 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 101.1" "Group enriched" "Detected in all" 22 "Early spermatids: 1694.9;Late spermatids: 5811.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001874, HPA048841" Enhanced Supported Centrosome NA NA Centrosome "HPA001874: AB_1079522, HPA048841: AB_2680536" "unprognostic (4.54e-3)" "unprognostic (9.91e-2)" "unprognostic (4.02e-2)" "unprognostic (1.57e-3)" "unprognostic (6.11e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.88e-1)" "unprognostic (1.79e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (1.93e-2)" "unprognostic (9.23e-3)" "unprognostic (1.47e-1)" "unprognostic (1.62e-1)" "unprognostic (7.65e-2)" 6.2 4.8 5.6 9.9 6.7 10.2 7.0 14.3 7.7 7.1 5.7 6.7 5.4 4.0 9.7 6.4 5.2 8.8 5.7 5.7 6.3 5.1 4.7 6.7 5.8 8.9 6.2 4.1 6.4 5.1 7.6 18.2 6.0 7.5 6.6 6.0 5.4 5.3 8.3 3.7 7.2 5.3 8.0 5.2 7.3 5.7 101.1 7.1 18.4 5.5 3.7 9.6 6.4 6.4 8.3 8.8 16.0 16.3 11.0 14.6 9.1 14.7 17.9 29.9 34.0 11.9 14.3 24.1 24.9 11.7 20.7 10.9 17.6 10.9 26.5 9.4 20.2 16.1 38.8 21.8 14.8 21.1 17.5 10.1 23.5 27.2 14.7 6.9 25.4 29.8 11.8 9.4 22.0 15.6 12.9 18.0 20.3 27.7 14.9 19.5 45.2 26.9 31.1 11.6 30.3 12.9 24.7 28.8 20.5 10.8 11.5 18.0 15.4 23.3 22.3 8.1 14.1 20.8 18.5 17.1 25.9 16.0 29.7 24.1 28.0 40.3 19.1 11.8 23.2 22.4 16.0 8.9 9.8 12.4 13.4 14.6 8.3 10.9 12.9 8.8 8.2 7.9 10.0 3.1 11.0 16.3 8.4 8.0 9.1 5.6 6.7 14.3 7.7 6.3 5.1 6.2 4.1 7.5 7.1 6.0 5.0 9.0 13.5 14.8 8.2 8.9 10.2 46.8 9.1 7.0 9.8 10.4 10.0 9.2 1694.9 15.1 3.2 46.7 7.8 14.2 11.0 11.6 18.5 9.6 10.8 7.9 3.5 8.0 10.2 5811.6 39.4 10.0 10.1 9.0 8.2 6.5 7.1 2.9 31.8 5.9 8.2 12.9 13.9 171.1 48.6 11.5 27.8 12.5 6.6 11.8 ODF3 "CT135, hSHIPPO, SHIPPO1" ENSG00000177947 "Outer dense fiber of sperm tails 3" Q96PU9 11 196738-200261 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 12.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 76.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038919, HPA039241" Enhanced NA NA "HPA038919: AB_2676270, HPA039241: AB_10673417" "unprognostic (4.17e-1)" "unprognostic (2.41e-1)" "unprognostic (1.24e-2)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 ODF3L1 MGC48986 ENSG00000182950 "Outer dense fiber of sperm tails 3 like 1" Q8IXM7 15 75723977-75727688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "testis: 53.2" "Cell type enriched" "Detected in some" 10 "Early spermatids: 64.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "myeloid DC: 2.4" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.4" "Cell line enhanced" "Detected in some" "A549: 3.0;CAPAN-2: 2.7;HaCaT: 2.7;HeLa: 3.6;U-87 MG: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.24e-2)" "unprognostic (1.97e-2)" "unprognostic (4.58e-2)" "unprognostic (8.42e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (7.55e-4)" "unprognostic (9.65e-2)" "unprognostic (9.96e-3)" "unprognostic (6.40e-2)" "unprognostic (4.14e-2)" "unprognostic (8.94e-3)" "unprognostic (1.45e-2)" 1.5 0.1 0.5 0.8 0.7 0.1 1.3 0.3 0.5 0.6 1.2 0.3 0.5 0.4 1.3 1.5 1.8 1.1 3.1 1.2 0.6 0.6 0.3 1.2 1.8 0.1 0.3 0.4 0.8 0.3 0.0 1.2 1.3 0.8 0.8 0.3 0.8 0.5 0.5 0.1 1.7 1.5 3.0 0.2 0.4 2.0 53.2 0.2 0.5 1.6 1.2 0.6 0.6 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.8 0.0 0.2 0.6 0.2 0.4 1.5 0.1 0.2 0.6 2.7 0.0 0.1 0.4 0.0 2.7 0.1 1.7 0.0 2.1 1.2 0.0 3.6 0.5 0.8 0.0 0.0 2.0 0.1 0.6 1.1 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.3 0.3 0.0 0.0 0.2 1.4 0.1 1.6 0.0 0.7 0.1 0.0 0.1 0.6 0.2 0.0 3.8 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.5 0.6 0.6 0.3 0.4 0.8 0.2 0.0 0.6 0.0 3.6 5.5 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.6 0.0 0.2 64.7 0.2 0.7 0.0 0.0 0.6 2.0 1.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 4.2 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.7 0.6 0.0 6.5 0.2 0.9 0.2 5.6 1.6 0.0 0.0 2.2 ODF3L2 "C19orf19, FLJ40059" ENSG00000181781 "Outer dense fiber of sperm tails 3 like 2" Q3SX64 19 463346-474983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "skeletal muscle: 12.5;testis: 16.7" "Cell type enriched" "Detected in some" 5 "Late spermatids: 894.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067065, HPA067973" Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA067065: , HPA067973: AB_2685937" "unprognostic (3.75e-4)" "unprognostic (1.79e-2)" "unprognostic (1.83e-3)" "unprognostic (9.69e-3)" "unprognostic (5.88e-2)" "unprognostic (5.65e-2)" "unprognostic (9.32e-2)" "unprognostic (1.35e-1)" "unprognostic (2.34e-2)" "unprognostic (1.77e-2)" "unprognostic (2.13e-2)" "unprognostic (4.06e-2)" "unprognostic (2.02e-5)" "unprognostic (3.13e-3)" "unprognostic (8.99e-2)" "unprognostic (3.05e-1)" "unprognostic (1.99e-1)" 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.3 0.5 0.0 16.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.5 0.0 0.0 2.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 3.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 2.3 0.0 0.3 0.0 0.2 1.1 0.0 0.0 0.6 0.1 0.6 1.0 0.1 0.0 0.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 187.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 894.9 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.6 0.0 0.7 0.0 0.1 6.4 5.2 0.0 0.0 0.0 0.0 0.0 ODF4 "CT136, OPPO1" ENSG00000184650 "Outer dense fiber of sperm tails 4" Q2M2E3 17 8339864-8346048 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 15.6" "Group enriched" "Detected in some" 84 "Early spermatids: 23.8;Late spermatids: 23.4;Spermatocytes: 24.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072129 Enhanced NA NA "HPA072129: " "unprognostic (5.16e-2)" "unprognostic (5.13e-1)" "unprognostic (3.54e-4)" "unprognostic (3.64e-1)" "unprognostic (5.40e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.1 0.0 0.0 0.0 0.0 0.0 OGDH E1k ENSG00000105953 "Oxoglutarate dehydrogenase" Q02218 7 44606572-44709066 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 99.3" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019514, HPA020347" Supported Enhanced Mitochondria No No 53000 Mitochondria "HPA019514: AB_1854772, HPA020347: AB_1854773" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (4.39e-1)" "unprognostic (5.64e-3)" "unprognostic (3.02e-3)" "unprognostic (1.20e-1)" "unprognostic (3.45e-1)" "unprognostic (7.58e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-2)" "unprognostic (3.38e-1)" "unprognostic (3.30e-2)" "prognostic favorable (2.22e-14)" "unprognostic (1.53e-1)" "unprognostic (1.62e-1)" "unprognostic (2.23e-2)" "unprognostic (5.88e-3)" 18.9 20.8 12.3 14.5 18.5 8.7 11.0 14.3 23.7 10.1 19.4 15.9 13.5 29.0 16.2 11.1 19.5 11.1 11.8 73.9 11.3 12.8 28.8 14.8 13.0 11.1 14.2 11.7 9.8 13.0 25.5 11.0 14.5 22.2 12.3 13.3 22.3 23.7 15.9 99.3 15.6 35.5 16.4 10.1 12.1 14.9 11.3 11.0 11.3 17.8 39.8 15.8 13.0 10.8 7.2 13.4 7.5 20.4 11.2 25.7 11.6 10.8 22.8 13.7 20.8 21.2 23.3 13.3 17.0 16.6 19.3 16.9 20.7 22.5 47.8 20.2 24.7 39.0 33.8 27.0 25.4 18.9 27.9 7.1 14.5 46.1 10.2 10.8 17.9 16.3 21.6 19.3 27.4 19.7 14.2 26.2 16.0 16.7 14.3 20.4 15.3 17.7 10.3 12.6 30.2 25.7 17.0 9.6 53.6 22.2 32.4 23.4 11.2 24.5 34.1 10.6 25.9 20.2 18.0 20.6 13.9 12.6 24.2 19.6 13.0 24.9 26.4 25.3 20.3 25.3 4.8 12.1 7.3 11.7 17.7 12.8 7.2 13.5 11.7 13.4 5.9 5.8 7.0 7.5 11.2 20.4 6.6 25.7 11.6 12.3 18.5 14.3 23.7 11.3 12.8 14.2 11.7 22.2 11.0 6.0 22.7 20.4 11.1 17.3 20.1 100.7 15.3 12.0 9.1 45.4 17.7 19.4 26.6 13.2 43.1 14.2 61.4 0.0 14.8 14.3 16.4 14.4 20.8 17.5 29.3 58.8 22.4 14.1 22.4 20.0 10.9 21.9 20.3 21.6 29.2 15.4 16.7 21.0 16.3 38.9 22.2 19.4 18.2 9.1 20.0 23.1 30.7 13.8 27.6 14.2 OGDHL FLJ10851 ENSG00000197444 "Oxoglutarate dehydrogenase like" Q9ULD0 10 49734643-49762379 "Citric acid cycle related proteins, Predicted intracellular proteins" Glycolysis Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.9;liver: 48.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 28.8;Collecting duct cells: 27.9;Cone photoreceptor cells: 29.5;Distal tubular cells: 77.9;Hepatocytes: 45.6;Horizontal cells: 28.6;Proximal tubular cells: 55.6" "Cancer enhanced" "Detected in many" "renal cancer: 44.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "AN3-CA: 13.7;RPTEC TERT1: 28.2;SH-SY5Y: 10.6;SK-BR-3: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043716, HPA052497" Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA043716: , HPA052497: AB_2681853" "unprognostic (9.05e-2)" "unprognostic (3.93e-3)" "unprognostic (5.30e-2)" "unprognostic (2.50e-1)" "unprognostic (3.70e-3)" "unprognostic (2.03e-1)" "unprognostic (1.46e-3)" "unprognostic (4.19e-1)" "unprognostic (2.07e-1)" "unprognostic (1.46e-2)" "unprognostic (1.52e-3)" "unprognostic (4.60e-1)" "prognostic favorable (1.21e-14)" "unprognostic (3.25e-2)" "unprognostic (1.85e-1)" "unprognostic (1.59e-3)" "unprognostic (8.38e-2)" 0.9 8.1 8.3 1.0 15.3 0.8 0.8 16.2 23.6 1.3 1.3 4.9 2.7 1.4 2.2 1.7 0.9 1.5 1.1 4.1 8.7 13.7 74.9 48.8 0.8 0.9 12.1 11.0 1.9 3.4 23.1 11.7 0.9 23.6 1.8 1.0 8.2 10.3 5.0 0.9 0.8 1.4 1.2 2.9 1.0 1.4 1.9 3.2 0.0 13.0 0.0 1.1 1.4 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.0 13.7 0.0 0.0 1.7 0.0 0.0 0.7 0.1 6.6 1.5 0.0 7.4 0.0 2.2 0.2 4.7 0.1 0.2 0.0 0.3 0.0 0.1 3.3 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.0 3.4 0.3 0.0 0.0 2.0 5.0 4.5 1.3 0.5 0.6 0.0 0.0 0.0 28.2 0.4 7.8 10.6 0.1 10.4 0.7 4.2 2.9 1.8 0.0 0.0 7.1 0.0 0.4 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 15.3 16.2 23.6 8.7 13.7 12.1 11.0 23.6 3.2 0.0 0.0 1.9 0.5 0.0 28.8 3.2 2.5 0.0 0.0 27.9 29.5 0.0 77.9 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 45.6 0.1 28.6 4.6 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.1 0.0 0.0 55.6 16.3 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.1 OGFOD1 "FLJ10826, KIAA1612, TPA1" ENSG00000087263 "2-oxoglutarate and iron dependent oxygenase domain containing 1" Q8N543 16 56451490-56479100 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003215, HPA003722" Approved Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003215: AB_1078881, HPA003722: " "unprognostic (1.13e-1)" "unprognostic (4.52e-2)" "unprognostic (3.80e-3)" "unprognostic (2.86e-2)" "unprognostic (2.48e-3)" "prognostic unfavorable (6.65e-4)" "prognostic unfavorable (7.02e-4)" "unprognostic (5.51e-2)" "unprognostic (6.87e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-2)" "unprognostic (4.59e-2)" "unprognostic (7.49e-2)" "unprognostic (7.20e-2)" "unprognostic (6.11e-2)" "unprognostic (1.25e-1)" "unprognostic (1.84e-2)" 8.8 13.4 10.0 8.0 11.6 3.3 9.4 10.3 14.3 10.8 7.0 12.4 6.0 7.4 9.5 8.4 18.1 10.1 7.8 12.9 7.7 11.1 12.9 13.9 7.5 7.5 9.1 10.4 10.2 6.5 13.7 13.1 8.3 15.6 8.0 8.9 8.5 8.4 10.0 56.1 8.8 5.8 15.1 11.1 8.6 7.4 8.2 6.2 10.6 9.3 12.6 13.0 9.6 8.3 7.8 7.5 11.8 8.9 8.7 12.1 6.5 11.3 13.4 13.2 16.4 15.0 18.1 12.4 18.5 14.9 26.3 19.1 16.3 8.3 20.8 9.5 14.7 11.2 16.3 27.9 12.6 29.8 6.4 15.0 15.1 11.7 16.8 11.5 16.3 17.8 12.0 14.4 19.5 16.3 11.4 21.3 14.0 21.0 4.0 22.2 7.3 12.9 9.3 22.4 10.1 23.2 24.2 20.2 24.2 11.8 8.2 10.6 11.8 22.9 14.8 12.4 14.7 13.5 13.5 13.9 14.7 11.7 11.2 16.3 8.2 15.8 30.5 11.7 11.8 11.6 11.8 4.7 4.8 8.8 6.3 11.9 7.8 11.2 10.4 7.1 6.1 12.1 10.0 1.7 8.7 8.9 7.5 9.3 6.5 10.0 11.6 10.3 14.3 7.7 11.1 9.1 10.4 15.6 6.2 3.0 13.6 19.9 10.7 15.8 10.3 17.9 17.8 8.1 18.2 8.7 9.8 14.3 21.6 13.0 17.1 11.2 3.9 23.3 12.0 16.6 20.5 7.5 45.0 15.3 10.6 12.7 2.4 9.8 8.1 14.5 11.2 11.3 10.1 19.8 6.3 12.1 13.7 5.8 14.9 11.0 14.1 12.9 17.8 14.6 28.1 16.6 9.7 15.0 9.5 7.1 OGFRL1 dJ331H24.1 ENSG00000119900 "Opioid growth factor receptor like 1" Q5TC84 6 71288803-71308950 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 79.5;Macrophages: 93.2;Muller glia cells: 83.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 12.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 12.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027122 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA027122: AB_2156775" "unprognostic (8.44e-3)" "unprognostic (1.41e-2)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (4.24e-3)" "prognostic unfavorable (3.62e-4)" "unprognostic (9.62e-3)" "unprognostic (2.30e-2)" "unprognostic (2.49e-1)" "unprognostic (4.22e-2)" "unprognostic (2.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (3.25e-2)" "unprognostic (5.58e-3)" 16.9 8.7 20.2 11.3 26.8 16.9 36.0 22.3 33.3 6.7 7.2 29.1 2.8 2.9 8.3 10.7 24.5 5.2 8.3 5.8 30.2 17.6 5.7 4.8 8.5 9.6 27.7 18.3 5.4 6.0 5.8 10.0 9.9 37.8 6.7 4.3 3.3 31.8 10.3 4.1 14.6 5.7 24.1 52.2 11.7 5.4 2.4 29.1 3.2 4.8 4.3 17.8 5.4 9.4 0.7 2.4 12.8 3.0 0.5 0.5 0.6 3.8 1.1 4.1 0.0 11.2 10.3 1.5 17.4 10.8 7.0 7.2 1.4 0.7 23.7 24.0 7.5 6.5 1.9 3.1 12.0 25.0 5.0 2.5 5.2 4.2 0.6 9.1 2.4 1.8 10.3 10.3 5.2 16.4 5.9 5.6 0.0 0.3 1.9 24.1 3.2 0.0 3.8 1.7 1.5 1.0 1.6 12.6 5.4 16.3 0.3 14.1 6.4 5.1 3.2 1.1 6.2 5.5 19.2 8.6 17.3 8.7 1.8 5.7 2.5 0.1 3.1 5.8 16.5 3.0 3.1 3.0 0.1 0.5 2.0 0.5 0.4 0.4 0.5 2.4 0.7 0.1 0.3 12.8 0.5 1.4 0.9 0.2 0.6 20.2 26.8 22.3 27.4 30.2 17.6 27.7 18.3 37.8 29.1 6.0 21.8 14.3 18.0 34.6 15.3 7.8 5.1 1.4 11.4 10.4 23.6 19.2 1.7 12.9 0.4 21.0 0.0 0.0 27.8 10.1 31.4 13.9 5.8 4.0 53.5 36.5 13.8 8.6 79.5 1.1 15.3 93.2 30.4 27.9 2.4 83.6 18.3 0.0 31.1 3.1 5.0 25.8 18.6 0.4 1.1 40.7 15.9 12.1 4.3 14.9 OGN "mimecan, OIF, SLRR3A" ENSG00000106809 Osteoglycin P20774 9 92383967-92404696 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 68.7" "Group enriched" "Detected in many" 5 "Fibroblasts: 137.8;Leydig cells: 153.9;Peritubular cells: 199.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "T-reg: 5.1" "Lineage enriched" "Detected in single" 8 "T-cells: 5.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 18.1;HSkMC: 8.1;JURKAT: 11.6;MOLT-4: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013132 Approved Supported "Endoplasmic reticulum" "Secreted in other tissues" NA NA 190000000 "Endoplasmic reticulum" "HPA013132: AB_1854825" "unprognostic (2.31e-1)" "unprognostic (3.94e-3)" "unprognostic (1.74e-1)" "unprognostic (2.08e-2)" "unprognostic (2.60e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-4)" "unprognostic (4.42e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.47e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.37e-3)" "unprognostic (3.86e-2)" "unprognostic (2.20e-3)" "prognostic unfavorable (2.03e-4)" 35.6 3.9 0.7 7.1 1.3 0.0 14.7 2.0 2.2 47.8 15.2 0.7 11.7 1.5 25.2 19.8 11.7 12.9 47.5 27.6 0.9 0.7 1.9 1.0 7.8 1.3 2.8 1.6 26.1 1.9 68.7 7.1 9.7 2.9 27.7 5.7 10.7 2.9 4.9 2.4 1.6 5.9 31.1 6.0 0.8 9.4 10.7 0.8 1.3 5.9 7.0 1.5 32.0 10.0 0.6 0.3 0.0 0.0 0.4 5.1 0.2 0.0 0.0 0.0 0.0 3.9 18.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 8.1 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 23.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.5 0.3 0.6 0.1 0.1 0.0 0.4 0.0 0.1 5.1 0.2 0.7 1.3 2.0 2.2 0.9 0.7 2.8 1.6 2.9 0.8 6.0 1.0 0.0 0.0 3.8 0.6 2.4 0.0 5.3 13.6 3.5 0.0 1.6 0.0 0.0 1.2 3.5 0.0 0.0 0.0 1.5 137.8 0.2 1.1 0.0 4.2 0.0 0.0 30.7 0.3 1.3 153.9 1.2 1.7 0.0 0.0 0.0 0.0 0.0 199.4 0.0 0.2 6.5 11.8 0.6 0.3 4.0 4.8 0.0 0.0 0.1 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309268-41332621 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.7;testis: 41.7" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 19.9;Spermatocytes: 82.8;Spermatogonia: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" NA Yes "Nuclear speckles" Vesicles "HPA052271: AB_2681780, HPA059602: AB_2684079" "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 1.3 2.1 0.5 3.8 0.8 7.5 0.7 1.5 1.1 1.1 3.4 0.7 2.3 3.0 0.6 0.6 4.6 0.6 1.3 1.9 0.9 0.4 1.1 1.1 1.0 4.3 0.6 0.4 1.2 0.6 0.0 0.3 1.6 0.5 0.5 3.1 0.2 1.2 1.3 8.3 2.5 3.1 0.6 0.8 2.7 1.4 41.7 0.7 16.7 0.5 6.3 4.0 0.7 1.5 2.5 7.7 1.1 1.3 1.9 5.9 1.7 13.3 7.1 14.1 10.3 0.7 0.9 13.4 8.3 3.8 9.9 10.7 12.7 6.6 8.0 7.3 3.0 15.6 20.9 14.3 6.4 7.9 17.2 16.5 16.9 20.8 13.1 0.1 18.4 9.5 0.3 1.3 5.6 5.9 2.1 8.4 16.8 23.1 15.4 6.6 6.4 10.8 13.7 12.8 19.9 15.5 13.3 11.8 12.0 4.4 6.2 22.4 7.5 13.7 14.0 3.8 5.9 13.9 10.5 4.1 10.2 15.8 10.2 14.7 7.4 32.4 28.3 3.0 22.5 14.7 0.0 0.8 1.1 0.6 1.3 1.5 2.1 1.8 1.6 1.4 2.5 2.6 1.7 0.0 1.9 0.8 7.7 5.9 1.7 0.5 0.8 1.5 1.1 0.9 0.4 0.6 0.4 0.5 0.7 0.0 0.3 0.0 0.6 3.7 0.0 0.2 0.0 0.0 2.3 0.0 0.0 7.1 0.0 0.5 5.5 0.1 0.9 0.0 0.3 19.9 1.5 0.3 1.1 0.8 6.5 0.0 0.0 0.0 0.6 9.2 0.9 1.6 0.0 1.0 1.7 0.6 0.1 0.0 1.1 0.2 0.2 6.5 0.9 82.8 66.8 2.0 3.2 0.7 3.0 0.1 OIT3 "FLJ39116, LZP" ENSG00000138315 "Oncoprotein induced transcript 3" Q8WWZ8 10 72893581-72933033 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 49.1" "Cell type enriched" "Detected in some" 10 "Ito cells: 487.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 5.8;Hep G2: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 150000000 "unprognostic (2.42e-2)" "unprognostic (6.76e-2)" "unprognostic (7.98e-4)" "unprognostic (9.26e-2)" "unprognostic (9.47e-4)" "unprognostic (3.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.50e-3)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" "unprognostic (1.35e-1)" "unprognostic (2.44e-1)" "unprognostic (3.68e-3)" "unprognostic (1.19e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.1 0.3 0.0 0.1 2.0 0.1 0.0 0.6 49.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.5 0.1 0.1 6.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.0 5.8 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.3 6.1 0.2 0.2 0.1 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 487.3 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OLAH "FLJ11106, SAST, THEDC1" ENSG00000152463 "Oleoyl-ACP hydrolase" Q9NV23 10 15032227-15073852 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 61.3;testis: 24.0" "Cell type enriched" "Detected in some" 10 "Early spermatids: 347.4" "Group enriched" "Detected in some" 7 "testis cancer: 3.6;thyroid cancer: 0.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 6.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.6" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;hTCEpi: 7.4;LHCN-M2: 5.6;SK-BR-3: 8.8;SuSa: 4.8;U-266/70: 4.9" "HPA037947, HPA037948" Enhanced NA NA "HPA037947: AB_10795028, HPA037948: AB_10805352" "unprognostic (2.01e-1)" "unprognostic (6.12e-2)" "unprognostic (8.20e-3)" "unprognostic (4.04e-3)" "unprognostic (1.92e-1)" "unprognostic (8.09e-2)" "unprognostic (7.12e-2)" "unprognostic (5.12e-2)" "unprognostic (4.55e-1)" "unprognostic (3.74e-2)" "unprognostic (4.70e-1)" "unprognostic (1.69e-1)" "unprognostic (5.22e-10)" "unprognostic (4.55e-2)" "unprognostic (2.09e-1)" "unprognostic (5.11e-2)" "unprognostic (9.78e-2)" 1.0 1.1 0.2 0.2 0.7 1.2 5.2 0.3 0.7 0.8 0.5 0.3 0.1 0.0 0.2 0.4 2.7 1.4 1.1 0.8 0.2 0.2 0.8 0.4 1.9 4.3 0.9 0.1 0.2 0.1 0.1 1.5 61.3 0.4 0.1 0.0 0.3 3.0 0.1 0.5 0.4 0.3 0.1 0.5 8.0 0.2 24.0 0.3 0.2 1.2 0.1 0.3 0.3 1.1 0.5 1.1 6.6 0.4 1.0 0.6 0.1 0.2 0.6 0.7 0.5 0.3 1.1 2.2 0.4 0.4 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.2 0.7 0.4 0.2 0.3 0.4 0.0 0.9 0.0 0.6 5.8 7.4 0.9 0.1 0.1 0.7 0.2 0.5 0.3 5.6 0.0 0.5 0.7 0.7 0.2 0.4 0.7 1.3 1.8 0.0 0.0 0.0 0.4 0.3 8.8 0.1 4.8 0.2 0.5 1.0 0.1 2.9 1.3 0.1 4.9 1.6 0.4 2.7 0.5 0.0 1.4 0.4 0.4 0.4 0.2 0.3 0.2 0.6 0.2 0.2 0.5 0.3 0.3 6.6 1.0 0.2 1.1 0.4 0.1 0.2 0.7 0.3 0.3 0.2 0.2 0.9 0.1 0.4 0.3 3.0 1.1 0.0 0.2 0.2 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.9 347.4 0.0 0.0 0.0 0.0 1.4 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.2 35.4 4.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 7.8 0.0 0.7 6.5 0.4 1.7 1.7 0.3 9.5 0.5 0.0 0.1 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 36.5;Ito cells: 74.3;Leydig cells: 41.1" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Cell line enhanced" "Detected in some" "HeLa: 25.5;MCF7: 21.5;NTERA-2: 28.6;OE19: 20.3;SCLC-21H: 41.3;SiHa: 34.2;T-47d: 53.0;U-2197: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" NA NA 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: AB_2683443" "unprognostic (6.77e-2)" "prognostic favorable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.6 3.2 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 13.1 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.5 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 21.5 0.1 0.0 28.6 20.3 0.0 0.0 0.0 12.0 0.0 0.0 41.3 5.5 34.2 0.1 2.1 2.2 53.0 0.0 0.0 2.0 4.6 23.1 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 0.0 9.3 0.0 2.8 8.7 20.7 5.8 7.6 0.0 3.4 0.0 41.2 0.0 0.0 7.4 5.8 26.1 0.0 0.0 2.3 0.0 8.2 6.1 2.3 0.5 0.3 36.5 2.4 74.3 4.5 8.9 41.1 2.8 20.3 0.0 1.7 32.6 3.6 2.9 27.6 0.0 12.0 0.0 11.7 0.6 3.4 5.5 0.0 0.0 5.5 0.9 OLFM2 "NOE2, OlfC" ENSG00000105088 "Olfactomedin 2" O95897 19 9853718-9936552 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.4;skin 1: 60.2" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 111.0;Late spermatids: 38.1;Muller glia cells: 72.1;Suprabasal keratinocytes: 103.3" "Cancer enhanced" "Detected in all" "glioma: 96.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.9" "Group enriched" "Detected in many" 27 "granulocytes: 24.9;T-cells: 8.9" "Cell line enhanced" "Detected in many" "AN3-CA: 15.7;ASC diff: 14.9;BJ hTERT+: 11.3;SH-SY5Y: 15.2;U-2 OS: 18.2;WM-115: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049961, HPA057771" Uncertain Approved Nucleoplasm "Secreted in other tissues" NA NA 2300000 Nucleoplasm "HPA049961: AB_2680972, HPA057771: AB_2683524" "unprognostic (1.42e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.99e-2)" "unprognostic (5.91e-2)" "unprognostic (3.39e-2)" "unprognostic (8.78e-2)" "unprognostic (4.47e-2)" "unprognostic (8.04e-2)" "unprognostic (4.03e-2)" "unprognostic (1.41e-3)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.23e-2)" "unprognostic (5.67e-2)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" 20.9 12.2 37.2 2.7 39.7 0.8 5.8 9.1 51.4 4.5 1.9 11.6 0.3 2.1 7.9 3.8 3.9 6.6 4.9 3.9 26.2 21.6 1.8 23.5 3.2 5.0 19.6 17.9 3.5 7.9 1.1 4.4 5.2 15.4 5.2 1.4 3.2 7.1 10.3 1.7 60.2 2.0 5.1 9.0 2.2 1.4 5.2 4.6 16.0 8.4 1.1 3.7 2.6 3.2 0.0 0.0 24.9 0.0 0.6 8.9 1.7 0.0 2.2 1.8 15.7 14.9 9.2 1.0 3.4 11.3 0.8 0.9 0.1 1.5 0.0 1.4 2.5 1.3 0.9 6.0 1.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.0 2.7 4.8 0.9 0.1 0.1 0.4 0.0 2.9 0.1 0.2 0.0 4.9 0.1 0.1 9.7 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.1 15.2 0.6 0.0 3.1 6.3 0.6 0.0 0.1 6.6 18.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 15.7 9.6 0.0 24.9 3.5 0.0 3.8 0.0 4.1 3.1 0.0 0.0 8.0 5.1 0.3 0.6 0.0 0.0 8.9 1.7 37.2 39.7 9.1 38.0 26.2 21.6 19.6 17.9 15.4 4.6 0.0 0.0 0.0 4.6 111.0 2.9 0.6 5.1 0.0 0.0 7.0 0.0 0.1 1.7 0.6 6.8 0.5 0.0 0.0 2.0 0.0 9.6 5.0 4.6 16.1 0.2 1.6 1.2 0.6 0.3 38.1 12.7 0.3 16.9 0.0 0.0 72.1 6.6 0.0 9.2 0.0 2.5 0.0 18.7 2.1 9.3 103.3 0.1 7.5 0.0 2.3 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802574-101997030 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 25.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.7 3.2 5.0 1.4 13.7 0.7 0.8 24.2 30.0 0.9 1.8 0.4 0.0 1.0 0.9 1.2 0.7 0.8 0.8 0.7 4.8 7.4 1.5 0.8 0.7 0.7 6.0 11.9 0.8 0.7 0.7 2.4 0.8 16.6 0.7 1.7 0.3 0.8 0.7 0.7 0.7 2.1 1.3 1.5 0.9 1.0 0.9 0.7 0.0 1.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.7 24.2 26.7 4.8 7.4 6.0 11.9 16.6 0.7 0.0 0.0 0.0 0.0 0.0 25.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OLFM4 "GC1, GW112, OlfD" ENSG00000102837 "Olfactomedin 4" Q6UX06 13 53028759-53052057 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 280.2;pancreas: 105.8" "Group enriched" "Detected in many" 6 "Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0" "Group enriched" "Detected in many" 14 "colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA077718 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol" "Secreted in other tissues" Yes NA "Nucleoplasm, Plasma membrane" "Cytokinetic bridge, Cytosol" "HPA077718: AB_2732358" "prognostic favorable (8.77e-4)" "unprognostic (4.84e-2)" "unprognostic (1.65e-3)" "unprognostic (2.33e-1)" "unprognostic (7.24e-2)" "unprognostic (1.34e-1)" "unprognostic (3.74e-2)" "unprognostic (5.16e-2)" "unprognostic (1.40e-1)" "unprognostic (1.22e-1)" "unprognostic (4.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-2)" "unprognostic (4.84e-3)" 0.3 0.0 0.3 18.1 0.3 11.4 2.5 0.3 0.5 50.3 132.5 0.4 0.2 121.4 0.8 3.3 0.5 0.9 6.0 1.1 0.3 0.1 7.5 0.3 1.6 0.4 0.3 0.2 0.7 105.8 0.0 0.2 0.9 0.3 16.2 58.9 0.2 2.9 0.2 0.3 0.1 280.2 5.6 0.2 2.2 2.4 1.4 0.3 1.8 0.3 0.4 0.3 18.4 40.9 0.0 0.0 1.4 0.6 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 4.4 1.9 15.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 21.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 8.3 0.0 0.0 0.7 4.7 0.1 0.0 0.9 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.9 0.3 0.3 0.3 0.5 0.3 0.1 0.3 0.2 0.3 0.3 0.0 0.0 0.0 149.7 0.1 0.0 0.4 0.0 0.0 0.0 132.6 0.0 0.0 1.7 216.4 0.2 0.0 104.8 0.0 804.6 0.0 0.0 16.5 0.0 0.0 0.1 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 18.0 135.9 3.2 1519.9 238.2 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 937.7 2045.0 OLIG1 "BHLHB6, bHLHe21" ENSG00000184221 "Oligodendrocyte transcription factor 1" Q8TAK6 21 33070144-33072420 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.6" "Cell type enriched" "Detected in some" 11 "Distal tubular cells: 54.7" "Cancer enriched" "Detected in some" 18 "glioma: 116.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 6.3;eosinophil: 22.0" "Lineage enriched" "Detected in many" 14 "granulocytes: 22.0" "Group enriched" "Detected in some" 6 "NB-4: 24.3;RPMI-8226: 12.7;THP-1: 16.0;U-937: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.13e-2)" "unprognostic (6.46e-2)" "unprognostic (4.06e-1)" "unprognostic (3.58e-1)" "unprognostic (9.01e-3)" "unprognostic (2.40e-1)" "unprognostic (7.93e-2)" "unprognostic (1.50e-1)" "unprognostic (3.82e-3)" "unprognostic (5.19e-2)" "unprognostic (8.17e-2)" "unprognostic (2.51e-1)" "unprognostic (4.05e-2)" "unprognostic (5.96e-3)" "unprognostic (3.20e-2)" "unprognostic (1.17e-1)" 1.8 1.8 44.6 1.9 51.6 2.5 1.9 7.3 95.6 1.8 1.8 58.3 0.0 1.9 1.8 1.8 1.8 1.8 1.8 1.8 42.7 30.4 3.1 1.8 1.9 1.8 40.7 22.7 1.8 1.9 1.8 0.1 1.8 35.5 1.8 1.8 0.0 1.9 1.8 3.0 1.8 2.0 1.8 41.4 2.3 2.0 2.2 35.7 0.0 1.8 0.0 1.8 1.9 0.0 0.0 0.2 22.0 1.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 1.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.3 0.1 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.9 0.0 0.0 0.0 2.9 0.0 0.1 16.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 18.3 1.0 6.3 1.6 22.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.4 0.1 0.0 0.3 44.6 51.6 7.3 35.2 42.7 30.4 40.7 22.7 35.5 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 54.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 3.5 0.0 0.0 0.5 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Cell line enhanced" "Detected in some" "HMC-1: 30.0;NB-4: 21.7;THP-1: 18.8;WM-115: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.8 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.7 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.1 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OLIG3 "Bhlhb7, bHLHe20" ENSG00000177468 "Oligodendrocyte transcription factor 3" Q7RTU3 6 137492202-137494250 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;esophagus: 1.4;placenta: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "pons and medulla: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;NTERA-2: 4.8;SuSa: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA018303, CAB024865" Uncertain NA NA "CAB024865: , HPA018303: AB_1854796" "unprognostic (1.07e-3)" "unprognostic (1.44e-1)" "unprognostic (2.77e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.8 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.5 3.1 0.5 2.0 0.7 32.7 0.0 0.4 0.0 4.2 0.1 17.2 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 34.6 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 65.9 26.2 0.0 4.9 7.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 26.8 30.9 0.0 0.2 1.3 0.4 0.0 2.5 12.0 7.9 0.0 0.0 386.0 0.0 0.0 9.4 1.2 0.0 0.0 0.0 8.5 1.3 0.0 14.0 0.8 209.3 0.0 0.0 0.0 21.9 7.6 0.3 102.1 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 387.3 0.0 0.0 0.0 OMG OMGP ENSG00000126861 "Oligodendrocyte myelin glycoprotein" P23515 17 31272013-31297539 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 40 "brain: 89.6" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 335.9" "Group enriched" "Detected in some" 7 "endometrial cancer: 3.5;glioma: 9.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "HAP1: 3.6;U-87 MG: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008206, HPA012693" Enhanced "Intracellular and membrane" NA NA "HPA008206: AB_1854240, HPA012693: AB_1854239" "unprognostic (8.05e-4)" "unprognostic (2.11e-2)" "unprognostic (1.27e-1)" "unprognostic (3.03e-3)" "unprognostic (1.85e-1)" "unprognostic (4.16e-2)" "unprognostic (1.63e-1)" "unprognostic (3.81e-2)" "unprognostic (9.54e-2)" "unprognostic (8.60e-2)" "unprognostic (7.03e-2)" "unprognostic (1.52e-1)" "unprognostic (3.96e-13)" "unprognostic (7.80e-3)" "unprognostic (6.00e-2)" "unprognostic (3.24e-1)" "unprognostic (2.42e-2)" 1.6 1.8 25.2 1.6 25.4 2.2 1.6 10.2 89.6 1.6 1.7 20.3 0.0 1.7 1.6 1.6 1.6 1.6 1.6 1.6 26.8 20.6 1.6 1.6 1.6 1.6 30.8 23.2 1.6 1.6 1.6 0.1 1.6 36.8 1.6 1.7 1.4 1.6 1.6 1.7 1.6 1.7 1.6 23.0 1.7 1.6 1.6 39.6 0.0 1.6 0.0 1.6 1.6 0.0 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.6 1.4 0.0 0.7 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 25.2 25.4 10.2 34.1 26.8 20.6 30.8 23.2 36.8 39.6 0.0 3.0 0.0 0.0 0.3 3.7 0.7 0.0 335.9 6.8 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 11.2 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 9.8 0.7 0.0 0.0 OMP ENSG00000254550 "Olfactory marker protein" P47874 11 77102840-77103331 "Predicted intracellular proteins" "Olfaction, Sensory transduction" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 5.4;liver: 3.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.7;CACO-2: 3.3;OE19: 4.5" "Region enriched" "Detected in single" 63 "olfactory region: 119.4" NA NA "unprognostic (2.22e-1)" "unprognostic (2.44e-1)" "unprognostic (8.53e-2)" "unprognostic (3.54e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.52e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-2)" "unprognostic (4.23e-1)" "unprognostic (5.33e-3)" "unprognostic (3.94e-3)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (8.17e-2)" 0.0 0.8 0.1 0.2 0.2 1.9 0.0 0.1 0.1 0.4 3.0 5.4 0.0 0.0 1.3 0.2 2.3 0.2 0.0 0.1 0.6 3.9 0.2 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.5 3.8 0.3 0.1 0.0 0.0 5.0 0.1 0.1 0.1 1.9 0.7 0.2 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 1.1 0.0 2.7 0.4 3.3 0.0 0.0 0.6 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.3 0.3 0.2 0.0 0.7 0.0 0.3 0.0 0.0 4.5 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.7 0.7 0.0 0.0 1.5 0.3 1.1 1.1 0.0 1.3 0.5 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ONECUT1 "HNF-6, HNF6, HNF6A" ENSG00000169856 "One cut homeobox 1" Q9UBC0 15 52756989-52791078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "gallbladder: 40.1;liver: 59.9;pancreas: 46.3" "Cell type enriched" "Detected in some" 17 "Horizontal cells: 611.8" "Group enriched" "Detected in some" 7 "liver cancer: 2.9;pancreatic cancer: 0.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.3;Hep G2: 4.0;MCF7: 5.1;RT4: 4.1;WM-115: 3.7" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Low region specificity" "Detected in all" HPA003457 Enhanced NA NA "HPA003457: AB_1079525" "unprognostic (5.12e-2)" "unprognostic (2.45e-2)" "unprognostic (2.64e-2)" "unprognostic (4.82e-2)" "unprognostic (9.19e-2)" "unprognostic (7.05e-2)" "unprognostic (5.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.70e-7)" "unprognostic (9.76e-3)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.5 0.0 0.1 1.2 0.1 0.9 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 40.1 0.1 0.2 0.2 0.1 59.9 0.1 0.0 0.1 0.0 0.1 46.3 0.0 0.1 0.0 1.4 0.1 0.0 3.5 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.3 1.2 3.3 1.5 0.0 0.0 1.5 0.0 0.0 0.0 0.1 1.4 0.2 2.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.2 1.4 4.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.3 0.4 0.0 5.1 0.0 0.0 2.5 0.4 0.3 0.9 0.3 0.0 0.0 4.1 1.7 0.0 0.6 0.1 0.4 2.9 1.0 0.2 0.0 2.1 2.7 0.0 0.4 0.3 0.1 0.3 0.4 0.4 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.9 0.3 0.2 0.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 35.7 0.0 0.0 0.0 0.0 0.0 1.7 10.3 0.9 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 8.2 0.0 611.8 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 1.0 5.3 0.0 0.0 0.0 3.6 0.0 0.3 2.3 0.5 0.0 0.0 0.0 0.0 0.0 ONECUT2 OC-2 ENSG00000119547 "One cut homeobox 2" O95948 18 57435685-57491297 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.6;gallbladder: 60.7;intestine: 18.0" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 910.5" "Group enriched" "Detected in many" 7 "liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4" "Region enhanced" "Detected in many" "basal ganglia: 18.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3" HPA057058 Enhanced Supported "Nucleoplasm,Actin filaments" NA NA Nucleoplasm "Actin filaments" "HPA057058: AB_2683323" "unprognostic (3.02e-2)" "unprognostic (5.36e-2)" "unprognostic (9.06e-3)" "unprognostic (3.79e-5)" "unprognostic (1.13e-2)" "unprognostic (4.48e-4)" "unprognostic (2.10e-2)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (4.56e-3)" "unprognostic (8.66e-3)" "unprognostic (1.16e-2)" "unprognostic (5.34e-4)" "unprognostic (3.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.13e-1)" "unprognostic (3.21e-1)" 0.3 0.4 0.3 0.3 18.6 0.2 0.3 3.0 3.7 0.2 16.5 0.0 0.0 15.0 0.3 0.3 0.3 0.2 60.7 0.2 0.5 0.9 0.3 12.8 0.3 0.3 0.5 0.9 0.3 4.3 3.2 5.1 0.2 1.1 0.3 0.3 0.7 0.3 0.3 0.3 0.3 18.0 0.3 0.3 0.3 0.5 0.6 6.6 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.1 3.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 1.4 0.0 3.3 0.0 0.1 18.7 3.0 0.7 11.9 2.7 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 2.2 3.6 0.6 0.0 0.4 1.7 0.0 0.1 1.5 0.7 0.0 1.1 0.0 1.6 6.3 9.8 1.6 0.1 0.0 0.2 0.1 0.4 0.7 0.0 1.0 1.3 0.2 0.2 0.3 2.7 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 3.0 3.7 0.5 0.9 0.5 0.9 1.1 6.6 0.0 0.0 0.0 0.2 0.1 3.0 2.6 155.4 0.0 0.0 7.0 13.7 0.0 0.0 69.5 2.0 0.6 0.3 0.0 7.6 0.1 0.0 0.3 0.0 44.2 0.8 910.5 8.5 9.2 0.6 2.8 0.3 0.0 0.0 0.0 0.7 2.9 24.1 3.1 0.0 0.0 4.9 0.0 0.7 1.4 1.7 0.1 0.0 0.0 0.4 0.0 ONECUT3 ENSG00000205922 "One cut homeobox 3" O60422 19 1752373-1780988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "stomach 1: 9.4;testis: 3.8" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 295.6" "Group enriched" "Detected in some" 7 "pancreatic cancer: 3.5;stomach cancer: 3.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 8 "HaCaT: 7.6;OE19: 10.1;PC-3: 17.1" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "hypothalamus: 1.3" HPA059936 Supported Nucleoplasm NA NA Nucleoplasm "HPA059936: AB_2684172" "unprognostic (9.43e-2)" "unprognostic (1.36e-1)" "unprognostic (6.28e-2)" "unprognostic (1.36e-3)" "unprognostic (2.27e-1)" "unprognostic (1.09e-2)" "unprognostic (2.21e-1)" "unprognostic (3.61e-3)" "unprognostic (2.02e-1)" "unprognostic (1.84e-1)" "unprognostic (3.87e-2)" "unprognostic (3.64e-1)" "unprognostic (3.08e-10)" "unprognostic (1.18e-1)" "unprognostic (9.86e-2)" "unprognostic (4.62e-1)" "unprognostic (1.21e-2)" 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 1.3 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 9.4 3.8 0.1 0.0 0.0 0.0 0.6 0.4 1.6 0.4 0.4 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 10.1 17.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.5 0.3 0.2 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.3 1.6 0.4 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.7 73.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 295.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.4 0.0 2.3 0.0 0.0 1.8 0.6 0.3 0.0 0.0 0.0 0.4 OOEP "C6orf156, Em:AC019205.2, KHDC2" ENSG00000203907 "Oocyte expressed protein" A6NGQ2 6 73368555-73395133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 8.7;testis: 18.5" "Group enriched" "Detected in some" 6 "Spermatocytes: 55.7;Spermatogonia: 46.4" "Cancer enriched" "Detected in single" 26 "testis cancer: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.0;granulocytes: 1.6;T-cells: 2.7" "Cell line enhanced" "Detected in some" "BEWO: 4.2;CAPAN-2: 13.0;MCF7: 4.2;U-2 OS: 2.9" HPA055165 Approved NA NA "HPA055165: AB_2682722" "unprognostic (7.95e-2)" "unprognostic (1.13e-1)" "unprognostic (2.63e-1)" "unprognostic (4.50e-1)" "unprognostic (4.68e-1)" "unprognostic (2.20e-3)" "unprognostic (6.86e-2)" "unprognostic (3.99e-2)" "unprognostic (7.22e-2)" "unprognostic (2.52e-1)" "unprognostic (6.04e-2)" "unprognostic (1.17e-2)" "unprognostic (1.86e-2)" "unprognostic (8.66e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" "unprognostic (4.98e-2)" 0.4 0.3 0.1 0.2 0.6 0.1 0.5 0.2 0.2 0.2 0.4 0.2 0.0 0.3 0.3 0.0 0.4 0.2 2.6 0.8 0.1 0.2 0.3 0.5 1.1 0.8 0.4 0.0 0.9 1.6 0.0 0.3 5.2 0.6 0.5 0.1 0.6 8.7 1.5 0.1 1.7 0.6 1.3 0.3 0.4 0.8 18.5 0.0 0.2 2.0 0.3 1.6 0.8 0.2 2.0 0.2 1.6 0.3 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.3 0.0 0.2 0.3 0.0 13.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.9 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.6 2.7 0.0 1.4 2.0 1.1 0.8 0.0 0.7 0.0 1.6 0.3 0.0 0.3 0.2 0.8 0.1 0.1 0.6 0.2 0.2 0.1 0.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 8.5 0.5 0.0 0.0 0.5 2.4 0.8 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.9 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.8 0.1 0.0 0.1 55.7 46.4 0.9 3.8 0.0 0.0 0.3 OOSP2 "FLJ36198, PLAC1L, TMEM122" ENSG00000149507 "Oocyte secreted protein 2" Q86WS3 11 60040275-60048044 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 48.6" "Cell type enriched" "Detected in single" 4 "Late spermatids: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 32 "basophil: 3.2" "Lineage enriched" "Detected in single" 32 "granulocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA050914 Enhanced "Secreted in male reproductive system" NA NA "HPA050914: AB_2681271" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 OPALIN "HTMP10, TMEM10, TMP10" ENSG00000197430 "Oligodendrocytic myelin paranodal and inner loop protein" Q96PE5 10 96343216-96359365 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 69.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 36 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "JURKAT: 1.2;MOLT-4: 2.2;REH: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014372 Supported NA NA "HPA014372: AB_2158172" "unprognostic (1.18e-1)" 1.5 1.5 35.0 1.5 42.1 1.6 1.5 2.8 69.7 1.5 1.5 52.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 1.5 40.1 15.1 1.5 1.5 1.5 1.5 19.9 17.8 1.5 1.5 1.5 0.0 1.5 13.8 1.5 1.5 0.0 1.5 1.5 1.5 1.5 1.5 1.5 17.8 1.5 1.5 1.5 29.5 0.0 1.5 0.0 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 42.1 2.8 33.4 40.1 15.1 19.9 17.8 13.8 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPCML "IGLON1, OBCAM, OPCM" ENSG00000183715 "Opioid binding protein/cell adhesion molecule like" Q14982 11 132414977-133532519 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 49.9" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 32.6;Early spermatids: 6.7;Late spermatids: 9.8;Sertoli cells: 6.5" "Group enriched" "Detected in some" 10 "glioma: 3.7;renal cancer: 0.7;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BJ: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 6300000 "unprognostic (1.59e-1)" "unprognostic (2.26e-2)" "unprognostic (3.70e-2)" "unprognostic (3.31e-4)" "unprognostic (8.23e-2)" "unprognostic (3.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (8.46e-3)" "unprognostic (2.59e-2)" "unprognostic (2.80e-1)" "unprognostic (4.73e-2)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" "unprognostic (1.76e-1)" "unprognostic (9.71e-2)" "unprognostic (2.19e-1)" 1.2 1.5 10.5 1.1 22.3 0.9 1.0 31.4 49.9 1.6 1.1 3.9 0.0 1.1 1.7 1.1 1.5 1.6 1.3 1.4 14.7 8.9 2.9 1.0 1.0 1.0 4.2 21.2 1.3 1.0 7.0 1.1 0.9 4.0 1.1 1.2 4.8 1.2 1.8 1.0 1.1 1.1 1.7 2.6 1.8 1.2 1.5 6.6 0.0 1.2 0.0 1.0 1.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 14.4 0.1 2.2 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.1 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.9 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.5 22.3 31.4 35.6 14.7 8.9 4.2 21.2 4.0 6.6 0.0 0.0 0.0 0.0 0.1 32.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 6.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.1 0.3 3.4 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPLAH "5-Opase, OPLA" ENSG00000178814 "5-oxoprolinase, ATP-hydrolysing" O14841 8 144051266-144063965 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.3" "Group enriched" "Detected in many" 4 "Early spermatids: 97.1;Late spermatids: 174.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.0;intermediate monocyte: 1.0;neutrophil: 3.8" "Group enriched" "Detected in many" 9 "granulocytes: 3.8;monocytes: 3.0" "Cell line enhanced" "Detected in many" "AN3-CA: 22.7;BEWO: 14.2;Hep G2: 12.2;PC-3: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026562, HPA028260, HPA052429" Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830" "unprognostic (7.89e-2)" "unprognostic (3.08e-2)" "unprognostic (1.69e-1)" "unprognostic (9.09e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-3)" "unprognostic (2.04e-2)" "unprognostic (9.37e-2)" "unprognostic (2.90e-1)" "unprognostic (1.26e-1)" "unprognostic (6.82e-2)" "unprognostic (3.62e-1)" "prognostic favorable (1.53e-6)" "unprognostic (4.03e-3)" "unprognostic (4.33e-1)" "unprognostic (3.54e-2)" "unprognostic (8.24e-2)" 5.6 5.6 3.3 1.7 3.9 2.3 3.1 4.9 5.3 1.9 7.0 7.0 4.5 11.8 1.6 1.9 5.9 1.3 5.2 16.2 2.5 1.7 10.8 17.2 2.9 2.0 4.5 4.2 2.0 6.0 5.8 1.2 1.3 5.5 3.5 2.0 4.8 9.4 5.6 25.6 5.5 10.4 1.2 4.4 3.7 7.2 49.3 4.9 0.3 1.9 5.4 1.8 2.1 3.3 0.0 0.3 3.8 3.0 0.0 0.1 0.8 2.7 2.7 0.3 22.7 1.0 2.2 14.2 1.3 0.9 0.8 0.5 5.2 5.1 0.0 4.6 2.5 0.0 3.6 0.7 2.0 0.0 0.7 0.0 0.9 4.1 12.2 7.3 0.1 0.0 3.0 9.4 0.9 0.0 0.0 0.1 3.9 3.2 0.0 0.0 3.1 0.2 2.1 1.9 4.2 17.5 0.3 0.0 3.5 2.4 3.3 0.8 0.1 0.0 0.9 0.0 0.3 5.9 3.0 0.1 0.0 3.8 0.0 0.9 0.8 0.9 0.7 0.3 0.7 0.0 0.0 3.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 3.8 0.0 0.4 0.0 0.0 0.8 3.3 3.9 4.9 5.3 2.5 1.7 4.5 4.2 5.5 4.9 3.0 2.7 0.8 1.7 1.8 1.0 2.6 5.1 1.4 3.4 8.7 0.0 1.4 10.0 3.5 97.1 0.7 32.0 0.0 2.4 2.2 1.1 1.6 0.0 20.2 2.1 0.0 1.2 3.1 6.0 174.0 2.3 1.7 0.0 1.0 6.3 5.2 3.8 11.2 3.5 11.0 0.0 0.0 1.0 3.5 2.3 1.6 2.1 1.3 10.9 2.0 OPN1LW "CBBM, CBP, COD5, RCP" ENSG00000102076 "Opsin 1, long wave sensitive" P04000 X 154144224-154159032 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 14.0" "Cell type enriched" "Detected in some" 29 "Cone photoreceptor cells: 683.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.05e-2)" 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 683.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OPN1MW "CBBM, CBD, COD5, GCP, OPN1MW1" ENSG00000268221 "Opsin 1, medium wave sensitive" P04001 X 154182596-154196135 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.5" "Cell type enriched" "Detected in single" 97 "Cone photoreceptor cells: 31.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.9" NA NA 0.0 0.6 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1MW2 ENSG00000166160 "Opsin 1, medium wave sensitive 2" P0DN77 X 154219756-154233286 "Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1MW3 ENSG00000269433 "Opsin 1, medium wave sensitive 3" P0DN78 X 154257538-154271805 "Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 4 "blood: 2.2;skin 1: 1.8" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 17.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772491-128775790 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 11.4;retina: 23.9" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (9.33e-4)" 0.9 1.8 0.7 3.7 0.9 1.7 0.7 1.0 2.3 0.7 2.2 0.7 0.7 0.5 2.6 0.7 2.4 0.8 4.2 11.4 0.7 0.8 0.7 0.7 0.9 1.0 0.7 1.3 0.7 0.7 0.0 0.7 0.7 0.7 1.4 0.0 23.9 1.1 0.7 1.9 0.9 0.9 0.7 0.7 1.1 1.4 1.1 0.7 0.7 2.3 0.7 0.7 4.3 0.7 0.5 1.2 0.6 1.4 0.0 1.4 0.3 1.7 2.2 5.2 1.7 0.0 0.0 1.5 9.8 0.0 0.0 0.0 5.0 2.1 2.6 1.5 0.0 1.6 1.4 0.0 0.0 0.0 0.3 3.6 1.6 3.0 2.5 0.0 2.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 1.7 2.2 0.6 1.1 0.7 2.0 3.6 4.7 1.7 3.0 1.0 5.4 3.0 0.0 0.6 0.7 6.9 2.3 5.2 4.4 7.3 0.5 2.0 4.0 10.0 1.0 7.7 8.7 2.1 2.2 1.6 37.6 4.6 9.3 0.0 0.3 0.6 1.4 1.4 0.9 0.2 0.8 1.0 1.2 0.5 0.3 0.9 0.0 0.0 1.0 0.7 0.4 0.3 0.7 0.9 1.0 0.9 0.7 0.8 0.7 1.3 0.7 0.7 0.0 0.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OPN4 "melanopsin, MOP" ENSG00000122375 "Opsin 4" Q9UHM6 10 86654557-86666848 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Biological rhythms, Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;skeletal muscle: 14.6" "Cell type enriched" "Detected in single" 34 "Cardiomyocytes: 3.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039147 Approved NA NA "HPA039147: AB_10673304" "unprognostic (3.67e-3)" "unprognostic (1.40e-2)" "unprognostic (3.02e-2)" "unprognostic (1.62e-1)" "unprognostic (7.03e-3)" "unprognostic (2.89e-2)" "unprognostic (3.26e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (8.88e-3)" "unprognostic (1.93e-6)" "unprognostic (4.10e-2)" "unprognostic (5.58e-2)" "unprognostic (6.76e-2)" 3.5 0.3 5.4 0.4 21.2 0.2 1.1 0.0 5.1 0.6 0.9 0.0 0.0 0.5 0.4 0.4 0.6 0.4 0.5 3.1 3.0 0.1 0.3 0.2 0.3 0.2 0.2 3.3 0.3 0.4 3.6 0.6 0.5 0.0 0.2 0.7 1.2 1.6 0.2 14.6 1.2 1.1 0.5 0.0 0.3 0.5 0.5 2.0 0.0 1.4 2.7 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 21.2 0.0 3.5 3.0 0.1 0.2 3.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN5 "dJ402H5.1, neuropsin, TMEM13" ENSG00000124818 "Opsin 5" Q6U736 6 47781982-47832780 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 7.3" "Group enriched" "Detected in some" 42 "Early spermatids: 22.0;Late spermatids: 19.1;Spermatocytes: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 1.0;SK-BR-3: 1.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 4 "hypothalamus: 1.3" HPA026084 Supported NA NA "HPA026084: AB_2671807" "unprognostic (1.95e-1)" "unprognostic (6.18e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 OPRD1 ENSG00000116329 "Opioid receptor delta 1" P41143 1 28812142-28871267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 3.4;Urothelial cells: 1.1" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "RH-30: 14.9;SCLC-21H: 5.9;SH-SY5Y: 5.9;WM-115: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070831 Approved NA NA "HPA070831: AB_2732167" "unprognostic (1.44e-1)" "unprognostic (4.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.89e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-3)" "unprognostic (6.28e-3)" "unprognostic (5.92e-2)" "unprognostic (1.82e-2)" "unprognostic (5.95e-3)" "unprognostic (4.28e-3)" "unprognostic (2.98e-1)" "unprognostic (1.52e-7)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-3)" 0.4 2.4 5.5 0.6 3.9 1.9 0.4 0.4 8.7 0.4 0.6 0.0 0.0 0.5 0.4 0.4 0.4 0.4 0.6 0.4 3.0 1.3 0.4 0.4 0.5 0.7 0.6 5.9 0.5 1.3 0.2 0.5 0.5 4.7 0.4 0.5 0.1 1.0 0.2 3.2 1.0 0.6 0.4 0.4 0.7 0.8 0.8 0.2 0.0 0.6 0.0 0.2 0.4 0.4 1.2 1.1 3.1 0.5 1.1 0.7 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.9 0.0 0.0 0.0 14.9 0.1 0.0 0.0 5.9 5.9 0.0 0.1 1.0 0.3 0.1 0.1 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.3 19.8 3.1 0.5 0.6 0.6 0.3 0.4 0.6 0.6 0.5 0.1 1.2 0.6 0.7 2.5 1.1 0.3 1.1 0.3 0.1 5.5 3.9 0.4 8.7 3.0 1.3 0.6 5.9 4.7 0.2 0.0 0.0 0.0 0.8 0.0 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.1 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 7.3;Leydig cells: 4.4" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: AB_2732770" "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 22.1 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 OPRL1 "KOR-3, NOCIR, NOPr, OOR, ORL1" ENSG00000125510 "Opioid related nociceptin receptor 1" P41146 20 64080173-64100643 "G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.9;brain: 17.5" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 10.8;Kupffer cells: 5.7;Late spermatids: 23.7;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 3.7;eosinophil: 5.6;intermediate monocyte: 5.6;myeloid DC: 4.9;neutrophil: 4.9;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 8 "dendritic cells: 4.9;granulocytes: 5.6;monocytes: 11.9" "Cell line enhanced" "Detected in many" "REH: 6.1;SCLC-21H: 10.4;U-937: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.03e-3)" "unprognostic (4.78e-2)" "unprognostic (4.35e-3)" "unprognostic (3.74e-1)" "unprognostic (4.13e-2)" "unprognostic (9.63e-2)" "unprognostic (2.13e-4)" "unprognostic (1.53e-1)" "unprognostic (1.67e-1)" "unprognostic (2.91e-1)" "unprognostic (2.66e-4)" "unprognostic (1.47e-1)" "unprognostic (1.12e-4)" "unprognostic (1.99e-2)" "unprognostic (4.17e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-3)" 2.1 2.6 4.7 2.9 9.4 3.6 1.5 6.0 17.5 1.7 0.8 3.6 0.7 1.1 1.7 1.4 0.9 1.4 1.8 0.9 4.5 8.9 1.6 1.1 2.5 6.3 3.9 0.9 1.1 4.2 0.8 1.5 2.4 4.0 1.3 0.8 0.2 5.0 1.2 0.7 0.7 1.4 1.1 2.7 8.2 0.9 9.2 1.5 1.9 0.8 0.3 5.2 1.6 1.3 0.9 4.9 5.6 11.9 0.0 0.4 1.8 0.0 0.8 1.1 4.5 3.3 1.0 0.6 0.2 0.3 0.1 0.4 0.2 1.0 1.7 0.6 0.8 3.6 0.0 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.3 0.1 4.4 0.8 1.1 0.2 0.0 0.1 0.3 1.8 2.2 0.3 1.5 0.0 0.1 0.4 2.4 0.3 0.5 1.9 6.1 0.0 0.2 0.0 0.0 10.4 3.5 0.0 0.0 0.0 1.7 0.4 4.2 0.4 0.4 0.3 0.0 0.0 0.2 0.8 3.0 0.6 11.6 0.4 0.0 3.7 5.6 0.2 5.6 0.4 0.7 0.3 0.1 4.9 0.9 0.2 0.0 4.9 0.0 11.9 0.5 0.4 1.8 4.7 9.4 6.0 11.9 4.5 8.9 3.9 0.9 4.0 1.5 0.0 1.4 3.5 0.1 0.7 0.2 1.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 10.8 0.3 0.0 0.0 0.0 0.1 0.5 0.3 1.1 0.0 2.6 3.2 0.0 1.3 5.7 23.7 0.0 1.3 0.0 3.6 0.0 0.2 0.3 0.0 0.0 0.0 0.1 6.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.9" "Group enriched" "Detected in some" 33 "Early spermatids: 24.0;Late spermatids: 23.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 37.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 24 "SH-SY5Y: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported NA NA "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.5 3.4 7.0 0.6 17.5 1.8 0.9 37.9 7.6 0.5 0.6 0.8 0.0 0.6 0.7 1.4 3.7 0.5 1.0 0.5 2.6 2.3 0.5 0.5 0.5 0.9 0.6 9.3 0.8 0.7 0.4 0.6 0.5 5.2 0.7 0.4 0.0 0.6 0.2 0.9 1.8 0.5 0.3 1.9 0.6 1.0 8.0 0.5 0.0 1.0 0.0 0.3 0.5 0.5 0.5 0.2 2.1 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.5 0.3 0.3 0.2 0.1 0.3 0.1 0.1 0.4 0.1 0.0 0.3 0.5 0.1 0.5 0.0 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.3 13.1 0.0 0.1 0.3 0.4 0.3 0.1 0.3 0.4 0.1 0.3 0.1 0.4 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.6 0.6 0.0 0.7 0.2 0.3 0.5 0.1 0.5 0.4 0.1 2.1 0.1 0.0 0.2 0.3 0.0 7.0 17.5 37.9 7.6 2.6 2.3 0.6 9.3 5.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.5 0.0 0.1 OPRPN "BPLP, PRL1, PROL1" ENSG00000171199 "Opiorphin prepropeptide" Q99935 4 70397882-70410194 "Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "breast: 19.1;salivary gland: 59.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 7.4;liver cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "GAMG: 1.0" HPA065711 Approved "Secreted in other tissues" NA NA 36000 "HPA065711: AB_2685541" "unprognostic (3.11e-3)" "unprognostic (2.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPTC ENSG00000188770 Opticin Q9UBM4 1 203494143-203508864 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 92 "retina: 245.8" "Cell type enriched" "Detected in single" 6 "Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.0;HeLa: 1.4;hTERT-RPE1: 1.3;NTERA-2: 2.4;RT4: 1.5;SCLC-21H: 1.2;SuSa: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034951, HPA034952" Enhanced "Secreted in other tissues" NA NA "HPA034951: AB_10669852, HPA034952: AB_2674379" "unprognostic (3.29e-1)" "unprognostic (1.56e-1)" "unprognostic (7.69e-2)" "unprognostic (3.19e-2)" "unprognostic (1.70e-3)" "unprognostic (8.24e-2)" "unprognostic (3.65e-2)" 0.3 0.0 0.2 0.1 0.2 0.0 0.2 0.4 1.0 0.4 1.3 0.1 0.1 0.4 1.3 2.2 0.8 0.8 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 1.1 0.3 0.0 0.1 0.4 0.1 0.7 0.3 245.8 0.1 0.6 0.1 1.1 0.2 1.1 0.1 0.1 0.1 2.6 0.1 0.1 0.2 0.1 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 1.0 0.3 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.7 0.0 0.1 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.9 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 OPTN "FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP" ENSG00000123240 Optineurin Q96CV9 10 13099449-13138308 "Disease related genes, Predicted intracellular proteins" "Autophagy, Host-virus interaction, Immunity, Innate immunity" "Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 170.7" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 620.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003279, HPA003360, CAB019303" Approved Enhanced Cytosol NA NA Cytosol "CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528" "unprognostic (2.84e-2)" "unprognostic (3.37e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-3)" "unprognostic (5.58e-2)" "unprognostic (3.74e-2)" "unprognostic (5.15e-3)" "unprognostic (3.14e-2)" "unprognostic (2.68e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-2)" "unprognostic (6.14e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (7.62e-2)" "unprognostic (5.67e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" 19.3 21.4 16.1 8.4 15.4 9.6 17.9 17.1 20.4 9.5 11.8 9.4 5.8 14.3 9.4 6.9 14.5 7.3 10.1 32.5 11.9 13.6 16.6 16.7 12.0 9.5 16.2 18.0 22.1 8.2 8.9 9.9 13.0 21.0 9.9 13.4 5.8 10.2 10.2 170.7 17.6 16.0 10.3 16.9 12.4 12.7 16.0 12.5 4.9 6.4 24.5 8.4 11.0 19.8 6.0 1.8 11.9 1.1 16.0 34.5 9.2 18.4 5.3 3.0 4.1 40.9 42.2 3.5 22.2 25.4 16.9 28.0 9.2 24.8 0.1 8.8 30.4 26.5 17.3 3.9 21.3 12.9 42.9 2.1 3.8 7.4 4.9 41.9 0.1 14.0 22.6 16.9 16.1 16.9 41.8 14.3 5.4 4.7 28.7 22.7 3.9 1.8 0.5 1.2 5.0 2.3 0.3 5.9 1.9 20.6 13.2 0.8 3.1 19.3 5.9 14.4 12.2 12.6 2.6 39.0 13.9 6.9 18.8 6.2 14.8 5.1 0.1 20.9 3.2 2.6 11.9 0.8 0.1 19.7 0.5 15.0 6.0 24.9 22.6 0.1 3.4 10.1 12.3 0.7 16.0 1.1 1.8 34.5 9.2 16.1 15.4 17.1 20.4 11.9 13.6 16.2 18.0 21.0 12.5 62.5 31.4 21.6 40.4 66.1 34.5 210.2 58.6 71.0 84.2 29.6 17.7 73.8 28.2 124.6 229.9 71.6 159.4 93.5 100.1 33.9 80.3 54.6 67.2 28.0 27.2 85.8 40.9 41.7 11.3 620.2 88.6 13.1 86.0 59.5 91.3 27.5 138.2 161.4 97.2 125.5 92.1 109.9 116.4 72.2 7.5 68.1 63.0 86.3 38.1 54.0 OR10A2 "OR10A2P, OST363" ENSG00000170790 "Olfactory receptor family 10 subfamily A member 2" Q9H208 11 6863057-6874717 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.04e-2)" 0.0 0.3 0.2 0.4 0.6 1.0 0.0 0.0 0.3 0.2 0.0 0.5 0.2 0.0 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.8 0.0 0.0 0.2 0.4 0.0 0.6 0.1 0.1 0.3 0.0 0.6 0.8 2.9 0.4 0.5 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.3 0.1 0.8 0.1 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.6 0.3 0.5 0.3 0.0 0.8 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.2 0.2 0.1 0.1 0.8 0.3 0.0 0.4 0.6 0.0 0.4 0.5 0.0 0.3 0.1 0.4 0.2 0.0 0.4 0.2 0.2 0.4 0.1 0.3 1.2 0.4 0.3 0.3 0.2 0.2 0.4 0.2 0.1 0.0 0.6 0.3 0.3 2.9 0.5 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A3 "HSHTPCRX12, HTPCRX12" ENSG00000170683 "Olfactory receptor family 10 subfamily A member 3" P58181 11 7937171-7941708 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;bone marrow: 1.4;skin 1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "A-431: 2.2;HMC-1: 2.8" NA NA "unprognostic (2.53e-2)" "unprognostic (3.24e-3)" 0.1 0.1 0.0 0.2 0.0 1.4 0.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 1.8 0.2 0.0 0.0 0.4 0.3 0.2 0.1 0.0 0.9 0.1 0.5 0.4 2.2 0.3 0.2 0.3 0.1 2.2 0.2 0.0 0.4 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.8 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.2 0.8 0.3 0.4 0.2 0.5 0.2 0.1 0.2 0.3 0.2 0.1 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.2 0.1 0.0 0.3 0.1 0.2 0.3 0.3 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.5 0.2 0.3 1.7 0.2 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A4 OR10A4P ENSG00000170782 "Olfactory receptor family 10 subfamily A member 4" Q9H209 11 6876625-6877619 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 4 "NTERA-2: 1.6" "Not detected" "Not detected" NA NA "unprognostic (1.16e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A6 ENSG00000279000 "Olfactory receptor family 10 subfamily A member 6 (gene/pseudogene)" Q8NH74 11 7924592-7931268 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;Karpas-707: 1.2;LHCN-M2: 2.4;RPMI-8226: 2.3" NA NA 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 1.2 2.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 2.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10A7 ENSG00000179919 "Olfactory receptor family 10 subfamily A member 7" Q8NGE5 12 55221025-55221975 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055111 Uncertain NA NA "HPA055111: AB_2682698" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10D3 "HTPCRX09, OR10D3P" ENSG00000197309 "Olfactory receptor family 10 subfamily D member 3 (putative)" Q8NH80 11 124183345-124188780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 38 "testis: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G2 ENSG00000255582 "Olfactory receptor family 10 subfamily G member 2" Q8NGC3 14 21633836-21634940 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "GAMG: 1.4" "Not detected" "Not detected" NA NA "unprognostic (7.80e-3)" 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G3 ENSG00000169208 "Olfactory receptor family 10 subfamily G member 3" Q8NGC4 14 21568520-21580076 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 3.4;bone marrow: 2.0;pituitary gland: 4.3;skin 1: 1.2" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 18.9;Club cells: 4.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1" "Not detected" "Not detected" HPA019766 Uncertain NA NA "HPA019766: AB_1854780" 0.3 0.4 0.0 0.2 0.0 2.0 0.2 0.0 0.2 0.1 0.1 0.0 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 4.3 0.0 0.0 0.1 0.0 0.0 0.2 1.2 0.6 0.0 0.0 0.1 0.2 0.6 0.1 0.0 0.0 0.0 1.0 0.9 3.4 1.0 0.7 0.7 0.0 0.1 0.0 0.7 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.0 2.1 0.6 0.8 0.1 0.0 0.3 0.4 0.7 0.0 0.3 0.6 0.0 0.0 0.8 0.0 0.0 0.7 0.3 0.0 0.0 0.0 1.0 0.7 0.4 0.9 0.1 0.4 0.4 0.0 0.6 0.4 0.6 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.0 1.0 0.5 1.2 0.0 0.0 0.9 0.6 0.9 0.1 0.2 0.2 0.2 0.6 0.5 0.3 0.9 1.0 0.5 0.6 0.2 0.3 0.4 0.5 0.4 0.2 1.0 0.7 0.5 3.4 0.7 0.3 0.9 0.3 0.0 6.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G4 ENSG00000254737 "Olfactory receptor family 10 subfamily G member 4" Q8NGN3 11 124012997-124018732 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 2.7;pancreas: 3.7" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.4;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 3.0" NA NA 0.1 0.2 0.1 0.1 0.1 2.7 0.1 0.1 0.1 0.1 0.3 0.3 0.1 0.5 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.2 3.7 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.5 0.7 0.4 0.0 0.1 0.4 0.1 0.6 0.2 0.0 0.2 0.1 1.2 0.5 1.6 0.6 0.5 0.5 0.1 0.3 0.1 0.4 0.3 0.5 0.1 0.5 0.4 0.0 0.1 0.0 0.4 0.3 0.0 0.4 0.2 0.4 0.2 0.1 0.0 0.1 0.6 1.0 1.5 1.6 0.9 0.1 0.6 3.0 0.0 0.5 0.0 0.1 0.3 0.3 0.1 0.3 1.4 0.0 1.1 0.2 1.6 1.2 0.4 1.0 0.1 0.4 0.4 0.0 1.2 0.5 0.2 0.2 0.3 0.2 0.5 0.2 0.5 0.5 0.6 0.3 0.8 0.1 0.7 0.5 0.2 0.2 1.4 0.2 0.7 0.5 0.8 0.5 0.2 0.3 0.5 0.5 0.5 0.3 1.2 0.5 0.5 1.6 0.5 0.6 0.5 0.3 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G6 "OR10G6P, OR10G6Q" ENSG00000198674 "Olfactory receptor family 10 subfamily G member 6" Q8NH81 11 123994163-123995161 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "pancreas: 1.7" "Cell type enriched" "Detected in single" 17 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10G7 ENSG00000182634 "Olfactory receptor family 10 subfamily G member 7" Q8NGN6 11 124036013-124041325 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "pancreas: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10H1 ENSG00000186723 "Olfactory receptor family 10 subfamily H member 1" Q9Y4A9 19 15804549-15815664 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.7;urinary bladder: 6.1" "Group enriched" "Detected in some" 60 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 43.2;Ciliated cells: 37.5;Club cells: 54.6;granulocytes: 36.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 8.0" NA NA "unprognostic (3.29e-1)" "unprognostic (1.97e-3)" "unprognostic (4.18e-1)" "unprognostic (1.63e-2)" "unprognostic (2.38e-1)" "unprognostic (9.30e-2)" 0.4 0.3 0.3 0.4 0.3 2.3 0.5 0.3 0.8 0.3 0.3 1.1 0.3 1.3 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.6 0.3 0.2 0.4 0.0 0.9 0.2 0.4 0.0 2.1 1.8 0.6 0.2 0.3 0.3 0.3 1.8 0.3 0.1 6.1 0.4 1.1 1.0 3.7 0.7 1.2 0.7 0.1 1.1 0.5 1.2 0.9 0.1 0.5 1.2 1.6 0.0 0.2 0.2 0.5 2.0 1.2 1.3 0.4 1.9 1.0 0.4 0.6 0.3 0.9 0.6 1.7 1.5 0.6 0.2 1.0 2.1 0.4 0.2 0.4 0.4 1.6 0.0 1.1 0.7 2.7 0.3 0.3 0.7 1.1 1.2 1.0 0.6 0.9 0.9 0.7 0.6 8.0 0.7 0.7 3.0 0.9 0.9 1.4 0.5 0.5 1.6 2.4 2.1 1.1 1.6 1.4 0.9 1.1 1.0 0.7 0.7 3.7 0.7 0.6 0.5 0.4 0.6 0.6 0.5 0.4 0.2 1.1 0.6 0.7 3.7 1.2 0.4 1.0 0.4 0.1 53.6 43.2 0.0 0.0 0.0 0.0 0.0 0.0 37.5 54.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 OR10H5 ENSG00000172519 "Olfactory receptor family 10 subfamily H member 5" Q8NGA6 19 15787661-15801025 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.3" "Group enriched" "Detected in some" 19 "Alveolar cells type 2: 1.7;Ciliated cells: 2.7;Club cells: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.2 0.3 0.4 0.4 0.3 2.5 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.5 0.3 0.3 0.3 0.2 0.4 0.6 0.2 0.2 0.2 0.5 0.4 0.4 0.3 0.0 0.5 0.1 0.2 0.4 0.2 0.0 2.2 1.7 0.4 0.0 0.3 0.4 0.3 1.1 0.4 0.1 1.0 0.2 1.5 1.2 4.3 0.9 1.2 0.7 0.1 0.9 0.8 1.0 1.3 0.9 0.4 1.7 0.7 0.1 0.3 0.4 0.7 1.5 1.3 0.5 0.4 0.7 0.9 1.1 0.8 0.2 0.7 1.4 1.2 2.8 0.9 0.2 1.6 1.3 0.5 0.3 0.5 0.4 0.5 0.3 1.2 0.8 1.9 0.1 1.6 0.7 1.8 0.7 0.3 0.5 1.0 0.3 0.7 0.4 1.4 1.0 0.8 1.0 1.0 0.6 1.0 1.0 0.9 0.9 1.3 1.2 1.3 0.9 1.3 0.5 1.0 1.1 1.6 1.0 4.3 0.9 0.7 0.6 0.5 0.4 0.6 0.5 0.4 0.2 1.5 0.6 0.7 3.3 1.2 0.5 1.2 0.4 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10J1 "HGMP07J, HSHGMP07J" ENSG00000196184 "Olfactory receptor family 10 subfamily J member 1" P30954 1 159437845-159443078 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 10.9" "Group enriched" "Detected in some" 47 "Early spermatids: 31.7;Late spermatids: 34.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;RT4: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.8 0.4 2.4 0.5 0.5 0.5 0.2 0.2 0.5 0.3 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.6 0.7 0.3 0.0 0.4 0.2 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.8 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.2 1.1 0.0 0.5 0.3 0.2 0.2 0.0 0.0 0.2 0.2 1.0 0.1 1.1 0.1 0.0 0.1 0.3 0.0 0.1 0.4 0.3 0.0 0.6 0.6 0.2 0.4 0.3 0.2 0.3 0.4 0.2 0.3 2.4 0.5 0.4 0.3 0.2 0.2 0.3 0.3 0.3 0.1 0.8 0.3 0.5 2.1 0.5 0.5 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 OR10J3 OR10J3P ENSG00000196266 "Olfactory receptor family 10 subfamily J member 3" Q5JRS4 1 159313670-159314659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "placenta: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "LHCN-M2: 5.6" HPA042963 Uncertain NA NA "HPA042963: AB_10961176" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10J5 ENSG00000184155 "Olfactory receptor family 10 subfamily J member 5" Q8NHC4 1 159535078-159536007 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "liver: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10K1 ENSG00000173285 "Olfactory receptor family 10 subfamily K member 1" Q8NGX5 1 158461574-158470857 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;esophagus: 2.9" "Group enriched" "Detected in some" 149 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 13.9;Ciliated cells: 22.7;Club cells: 9.1;granulocytes: 8.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA059125 Uncertain NA NA "HPA059125: AB_2683913" 0.2 0.4 0.2 0.8 0.3 2.0 0.2 0.2 0.4 0.7 0.3 0.2 0.3 0.8 2.9 0.2 0.2 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.3 0.0 0.2 0.0 0.2 0.0 1.6 0.4 0.3 0.0 0.3 0.5 0.3 0.9 0.2 1.0 0.8 0.3 1.4 0.5 2.4 0.6 0.9 1.2 0.1 1.2 1.0 1.0 1.0 0.7 0.6 1.3 0.7 0.5 0.1 0.4 0.6 0.9 1.2 1.8 0.3 2.8 1.0 0.4 0.4 1.5 1.6 0.4 1.3 1.1 0.8 0.3 0.9 1.6 0.1 0.1 0.9 0.4 0.7 0.1 0.6 0.9 3.8 0.1 0.4 1.2 1.6 2.1 0.2 0.2 1.0 0.5 0.8 0.0 0.9 0.8 1.2 0.8 0.4 2.0 0.9 0.9 1.1 0.4 1.2 2.2 2.1 0.9 2.1 1.6 1.0 0.7 1.0 1.9 1.6 0.6 0.2 1.2 0.5 1.2 0.7 0.9 1.0 0.3 1.4 0.9 1.0 2.4 0.9 0.4 0.5 0.8 0.1 20.8 13.9 0.0 0.0 0.0 0.0 0.0 0.0 22.7 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10K2 ENSG00000180708 "Olfactory receptor family 10 subfamily K member 2" Q6IF99 1 158418210-158426237 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "MCF7: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA059125 Uncertain NA NA "HPA059125: AB_2683913" 0.1 0.1 0.1 0.3 0.0 0.4 0.1 0.1 0.3 0.1 0.1 0.4 0.1 0.7 0.1 0.4 0.2 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.6 0.7 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.5 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.7 0.2 1.2 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.5 0.5 2.2 0.2 0.2 0.2 0.5 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.2 0.1 0.4 0.8 0.1 0.3 0.0 0.0 0.9 0.1 0.1 0.2 0.1 0.2 0.6 0.1 0.2 0.0 0.7 0.3 0.4 1.2 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10P1 "OR10P1P, OR10P2P, OR10P3P, OST701" ENSG00000175398 "Olfactory receptor family 10 subfamily P member 1" Q8NGE3 12 55636860-55637854 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 2.0;heart muscle: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.0;T-reg: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.0" "Cell line enhanced" "Detected in single" "THP-1: 2.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA074114 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA074114: " 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Q1 ENSG00000180475 "Olfactory receptor family 10 subfamily Q member 1" Q8NGQ4 11 58227882-58228918 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 1.3;placenta: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HHSteC: 1.2" "Not detected" "Not detected" HPA046968 Uncertain NA NA "HPA046968: AB_2679881" "unprognostic (4.82e-1)" "unprognostic (6.34e-2)" "unprognostic (4.37e-1)" 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.3 0.6 0.0 0.7 0.2 0.5 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10R2 OR10R2Q ENSG00000198965 "Olfactory receptor family 10 subfamily R member 2" Q8NGX6 1 158472220-158480936 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "thyroid gland: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "MOLT-4: 26.4" "HPA059775, HPA060399" Uncertain NA NA "HPA059775: AB_2684124, HPA060399: AB_2684276" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10S1 ENSG00000196248 "Olfactory receptor family 10 subfamily S member 1" Q8NGN2 11 123976661-123977781 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "thyroid gland: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.4;hTCEpi: 3.1" "Not detected" "Not detected" HPA019038 Uncertain NA NA "HPA019038: AB_1854785" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10X1 OR10X1P ENSG00000279111 "Olfactory receptor family 10 subfamily X member 1 (gene/pseudogene)" Q8NGY0 1 158578919-158579899 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Z1 ENSG00000198967 "Olfactory receptor family 10 subfamily Z member 1" Q8NGY1 1 158605268-158612514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "bone marrow: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "K-562: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.9 0.1 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.2 0.3 4.8 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.8 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11A1 "hs6M1-18, OR11A2" ENSG00000204694 "Olfactory receptor family 11 subfamily A member 1" Q9GZK7 6 29425504-29457071 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Group enriched" "Detected in some" 73 "Early spermatids: 29.0;Late spermatids: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.3;U-2197: 1.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 1.1 0.1 0.4 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 1.3 0.1 0.2 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR11G2 ENSG00000196832 "Olfactory receptor family 11 subfamily G member 2" Q8NGC1 14 20190894-20201075 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "blood: 5.9" "Group enriched" "Detected in some" 57 "Alveolar cells type 2: 7.4;Ciliated cells: 4.0;Club cells: 5.7;granulocytes: 5.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "neutrophil: 5.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.9" "Cell line enriched" "Detected in single" 14 "HEL: 7.2" NA NA 0.4 0.2 0.1 0.4 0.1 1.0 0.1 0.1 0.2 0.3 0.1 0.4 0.3 0.6 0.1 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.4 0.0 0.1 0.2 0.2 0.0 0.5 0.0 0.5 0.8 0.2 0.0 0.1 0.7 0.2 1.2 0.4 0.0 0.2 0.1 0.3 0.2 5.9 0.3 0.4 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.2 7.2 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.8 0.3 1.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.2 0.2 5.9 0.4 0.2 0.2 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H4 ENSG00000176198 "Olfactory receptor family 11 subfamily H member 4" Q8NGC9 14 20239286-20244349 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.1;U-266/70: 1.5" "Not detected" "Not detected" HPA052790 Uncertain NA NA "HPA052790: AB_2681950" 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11H6 ENSG00000176219 "Olfactory receptor family 11 subfamily H member 6" Q8NGC7 14 20223710-20224702 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR11L1 ENSG00000197591 "Olfactory receptor family 11 subfamily L member 1" Q8NGX0 1 247840928-247841896 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "thyroid gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13A1 ENSG00000256574 "Olfactory receptor family 13 subfamily A member 1" Q8NGR1 10 45302298-45315608 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.3;urinary bladder: 4.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.8" "Cell type enhanced" "Detected in single" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "Daudi: 13.5;U-698: 12.5" "Not detected" "Not detected" HPA057237 Uncertain NA NA "HPA057237: AB_2683378" "unprognostic (7.88e-2)" "unprognostic (1.90e-1)" "unprognostic (5.52e-2)" "unprognostic (2.33e-5)" "unprognostic (6.43e-3)" "unprognostic (6.04e-2)" "unprognostic (8.65e-2)" "unprognostic (3.59e-1)" "unprognostic (2.45e-1)" "unprognostic (2.54e-2)" "unprognostic (1.31e-1)" "unprognostic (1.67e-15)" "unprognostic (6.54e-2)" "unprognostic (2.87e-1)" "unprognostic (8.55e-2)" "unprognostic (4.09e-3)" 0.0 0.0 0.1 0.4 0.2 0.5 0.1 1.9 0.1 0.0 0.2 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.4 2.2 0.2 0.1 0.2 0.0 0.0 0.0 0.9 0.3 0.5 0.0 0.3 0.0 1.6 0.0 0.4 2.3 0.2 0.3 0.0 2.0 4.2 0.3 2.0 0.0 0.0 0.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.2 0.0 0.0 0.1 0.3 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 OR13C3 ENSG00000204246 "Olfactory receptor family 13 subfamily C member 3" Q8NGS6 9 104535749-104536856 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.4" "Not detected" "Not detected" HPA053978 Uncertain NA NA "HPA053978: AB_2682330" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C5 ENSG00000277556 "Olfactory receptor family 13 subfamily C member 5" Q8NGS8 9 104598457-104599413 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.1;CACO-2: 1.0;HEL: 1.6" NA NA "unprognostic (4.88e-2)" 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.4 0.0 0.3 0.6 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR13C8 ENSG00000186943 "Olfactory receptor family 13 subfamily C member 8" Q8NGS7 9 104569168-104570130 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "T-reg: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13C9 ENSG00000136839 "Olfactory receptor family 13 subfamily C member 9" Q8NGT0 9 104617248-104618204 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "pituitary gland: 1.2;skeletal muscle: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13D1 ENSG00000179055 "Olfactory receptor family 13 subfamily D member 1" Q8NGV5 9 104694379-104695485 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.0" "Not detected" "Not detected" HPA055921 Uncertain NA NA "HPA055921: AB_2682970" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13G1 ENSG00000197437 "Olfactory receptor family 13 subfamily G member 1" Q8NGZ3 1 247670812-247679739 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;NB-4: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "olfactory region: 0.1" NA NA 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR13J1 ENSG00000168828 "Olfactory receptor family 13 subfamily J member 1" Q8NGT2 9 35869263-35870601 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.2;skeletal muscle: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "AN3-CA: 2.4" "Not detected" "Not detected" NA NA "unprognostic (6.58e-2)" "unprognostic (2.89e-2)" "unprognostic (1.82e-1)" "unprognostic (2.49e-1)" "unprognostic (9.58e-2)" "unprognostic (7.73e-2)" "unprognostic (1.45e-1)" "unprognostic (2.09e-3)" "unprognostic (1.68e-1)" "unprognostic (4.07e-1)" 0.1 0.2 1.2 0.2 1.6 0.0 0.0 0.9 2.2 0.0 0.1 0.4 0.1 0.0 0.4 0.1 0.2 0.6 1.7 0.8 0.1 0.1 0.0 0.2 0.6 0.4 0.0 0.0 0.4 0.1 0.3 0.1 1.1 0.0 1.4 0.5 0.0 0.0 0.8 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14A16 OR5AT1 ENSG00000196772 "Olfactory receptor family 14 subfamily A member 16" Q8NHC5 1 247814660-247824119 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.9" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14A2 "OR5AX1, OR5AX1P" ENSG00000241128 "Olfactory receptor family 14 subfamily A member 2" Q96R54 1 247722957-247724043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 12 "testis: 7.4" "Cell type enriched" "Detected in some" 7 "Early spermatids: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 109 "GAMG: 10.9" HPA052685 Uncertain NA NA "HPA052685: AB_2681914" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR14C36 OR5BF1 ENSG00000177174 "Olfactory receptor family 14 subfamily C member 36" Q8NHC7 1 248348775-248349713 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "prostate: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "HeLa: 2.3" NA NA 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14I1 "OR5BU1, OR5BU1P" ENSG00000189181 "Olfactory receptor family 14 subfamily I member 1" A6ND48 1 248681369-248682304 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 7.4" "Cell type enriched" "Detected in single" 7 "Early spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.1" NA NA "unprognostic (3.68e-1)" "unprognostic (1.63e-1)" 0.0 0.0 1.2 0.0 1.9 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14J1 "hs6M1-28, OR5U1" ENSG00000204695 "Olfactory receptor family 14 subfamily J member 1" Q9UGF5 6 29301701-29313017 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.5;testis: 4.4" "Group enriched" "Detected in some" 9 "Ciliated cells: 1.4;Club cells: 2.3;granulocytes: 4.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.4 0.4 0.4 1.0 0.4 3.0 0.4 0.4 0.7 0.4 0.4 0.8 0.4 1.5 0.4 0.4 0.5 0.4 0.4 0.5 0.4 1.4 0.4 0.8 0.4 0.6 0.4 0.0 0.4 0.4 0.4 0.1 0.7 0.0 0.9 2.0 0.7 0.0 0.4 0.9 0.6 4.4 0.4 0.0 0.4 0.4 1.7 1.0 3.5 0.8 1.0 1.2 0.0 2.3 0.9 1.9 2.1 0.7 0.6 1.3 1.6 0.2 0.2 0.1 1.4 1.8 1.9 2.3 0.4 1.0 1.0 0.3 0.3 0.2 2.2 0.5 1.8 3.6 1.8 0.1 1.9 1.8 0.2 0.2 0.4 0.5 0.8 0.1 1.3 1.5 5.4 0.5 1.1 1.1 1.9 2.4 0.7 0.7 1.1 1.3 1.5 0.4 2.3 1.6 2.2 1.9 1.2 0.7 1.9 1.7 1.5 3.9 2.2 2.0 3.7 1.8 3.4 2.0 1.4 1.7 1.6 1.8 3.5 0.8 0.7 1.2 0.5 0.8 0.9 0.7 0.8 0.3 1.7 0.8 0.8 3.2 1.0 0.8 1.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR14K1 OR5AY1 ENSG00000153230 "Olfactory receptor family 14 subfamily K member 1" Q8NGZ2 1 247738615-247739559 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "GAMG: 11.0" "Not detected" "Not detected" HPA016643 Uncertain NA NA "HPA016643: AB_1854788" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" 0.1 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.2 0.2 0.0 0.3 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1A1 OR17-7 ENSG00000172146 "Olfactory receptor family 1 subfamily A member 1" Q9P1Q5 17 3207539-3218896 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.1;bone marrow: 3.2;salivary gland: 4.2" "Group enriched" "Detected in some" 169 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 15.6;Ciliated cells: 13.4;Club cells: 27.3;granulocytes: 10.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 7.9" NA NA 0.3 0.3 0.4 0.6 0.5 3.2 0.3 0.4 0.6 1.2 0.4 0.8 0.3 0.9 0.4 0.3 0.1 0.5 0.4 0.3 0.4 0.4 0.3 0.5 0.3 0.4 0.5 0.0 0.3 0.0 0.3 0.0 4.2 0.0 0.5 1.5 0.3 0.0 0.4 0.5 0.4 1.2 0.3 0.1 0.6 0.4 2.2 1.4 4.1 1.3 1.5 1.6 0.3 1.6 0.9 0.8 1.4 0.4 0.3 1.6 0.8 0.3 0.2 0.3 0.6 1.1 1.9 1.5 0.4 1.6 0.9 0.1 0.2 0.3 2.1 0.6 1.3 2.9 0.8 0.1 1.4 4.3 0.4 0.3 0.3 0.4 0.4 0.3 1.2 0.9 7.9 0.0 0.9 1.6 1.5 1.9 0.6 1.0 2.0 1.3 2.4 0.2 1.8 1.5 1.2 0.6 1.0 1.0 1.4 1.6 1.5 0.8 1.4 2.6 1.4 1.5 3.3 2.0 1.5 1.1 1.5 1.2 4.1 1.2 1.0 1.4 1.2 1.2 1.3 1.2 1.0 0.8 2.2 1.6 1.5 2.0 1.5 1.3 1.4 0.9 0.3 17.9 15.6 0.0 0.0 0.0 0.0 0.0 0.0 13.4 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1B1 OR9-B ENSG00000280094 "Olfactory receptor family 1 subfamily B member 1 (gene/pseudogene)" Q8NGR6 9 122628579-122629573 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "RT4: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.2 0.0 0.0 1.2 0.7 0.6 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 4.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1C1 "HSTPCR27, TPCR27" ENSG00000221888 "Olfactory receptor family 1 subfamily C member 1" Q15619 1 247754846-247760556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "blood: 1.4;testis: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA "unprognostic (3.40e-1)" "unprognostic (3.58e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 5.7 0.1 0.0 0.1 0.0 0.7 0.5 1.4 0.6 0.4 0.6 0.3 0.7 1.4 0.6 0.7 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.1 0.6 0.8 0.4 0.1 1.0 0.6 0.2 0.0 0.0 0.1 0.1 0.5 0.3 0.4 0.0 0.8 0.7 0.0 0.4 0.5 0.0 0.3 0.0 0.1 0.4 0.7 0.0 0.8 0.2 0.2 0.3 0.6 0.7 0.1 0.4 0.0 0.1 0.3 0.4 0.1 0.1 0.2 0.1 1.4 0.5 0.5 0.9 1.0 1.1 0.4 0.7 0.0 0.1 0.3 0.6 0.3 1.5 1.3 0.2 0.4 0.3 0.6 0.3 0.4 0.5 0.2 0.4 0.7 0.4 0.6 1.4 0.4 0.6 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1E1 "HGM071, OR13-66, OR17-2, OR17-32, OR1E5, OR1E6, OR1E9P" ENSG00000180016 "Olfactory receptor family 1 subfamily E member 1" P30953 17 3397104-3398410 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.7;placenta: 1.5;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Not detected" "Not detected" NA NA "unprognostic (1.12e-1)" "unprognostic (1.33e-1)" 0.4 0.1 0.2 0.0 0.4 0.0 0.6 0.0 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.9 0.0 1.4 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1E2 "OR17-135, OR17-93, OR1E4" ENSG00000127780 "Olfactory receptor family 1 subfamily E member 2" P47887 17 3432870-3433841 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "HL-60: 1.6" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.3 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1F1 "Olfmf, OR16-36, OR16-37, OR16-88, OR16-89, OR16-90, OR1F10, OR1F13P, OR1F4, OR1F5, OR1F6, OR1F7, OR1F8, OR1F9, OR3-145" ENSG00000168124 "Olfactory receptor family 1 subfamily F member 1" O43749 16 3204247-3205188 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.2;brain: 7.4;testis: 2.8" "Group enriched" "Detected in some" 33 "Early spermatids: 2.7;Late spermatids: 4.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "eosinophil: 2.2;memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 18 "granulocytes: 2.2;T-cells: 1.2" "Cell line enhanced" "Detected in some" "THP-1: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.72e-1)" "unprognostic (2.99e-2)" "unprognostic (1.22e-1)" "unprognostic (4.94e-2)" "unprognostic (4.88e-1)" "unprognostic (4.16e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.5 0.2 1.8 0.4 0.0 7.4 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.7 2.2 1.4 0.2 0.0 0.0 0.3 1.2 0.2 1.1 0.8 2.3 0.0 0.0 0.0 0.6 0.3 0.7 0.0 1.8 0.7 1.0 0.0 1.3 1.2 0.6 0.3 0.3 0.0 1.5 0.0 0.0 0.7 1.7 0.8 1.0 0.0 0.3 0.0 0.5 0.4 0.0 0.0 1.5 0.6 0.0 0.0 1.1 0.7 2.4 0.0 0.0 1.6 0.0 0.0 1.2 0.3 0.0 3.5 2.1 0.0 1.1 0.3 0.3 0.4 0.0 0.0 1.4 1.4 0.3 0.0 0.0 2.2 0.3 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1G1 "OR17-209, OR1G2" ENSG00000183024 "Olfactory receptor family 1 subfamily G member 1" P47890 17 3126584-3127581 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 1.6;urinary bladder: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.2" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.5 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1I1 "OR19-20, OR1I1P, OR1I1Q" ENSG00000094661 "Olfactory receptor family 1 subfamily I member 1" O60431 19 15082211-15092970 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.5;bone marrow: 3.1" "Group enriched" "Detected in some" 23 "Alveolar cells type 2: 3.4;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.3 0.6 0.4 0.7 0.4 3.1 0.3 0.4 0.4 0.3 0.3 0.4 0.4 0.9 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.3 0.7 0.4 0.4 0.8 0.0 0.3 0.8 0.4 0.1 0.3 0.0 0.7 2.2 0.3 0.0 0.3 0.5 0.4 0.7 0.7 0.0 0.3 0.4 2.0 1.7 4.5 1.3 3.2 1.5 0.9 0.9 1.3 1.0 1.1 0.6 0.7 1.5 0.7 0.4 0.3 0.3 0.9 1.5 1.7 0.6 0.9 0.5 1.9 0.6 0.2 0.5 1.5 0.9 1.6 3.7 1.3 0.4 0.9 3.2 0.6 0.8 0.3 0.4 1.0 0.3 1.2 1.4 2.2 0.6 1.3 1.0 1.7 1.4 0.7 1.3 0.7 0.8 0.9 0.3 2.2 1.2 1.1 0.7 0.8 0.4 2.0 1.2 0.7 0.7 1.7 1.1 1.6 0.7 1.4 0.7 1.2 0.7 0.9 0.9 3.1 1.2 1.0 1.2 0.9 1.4 1.3 1.0 1.2 0.5 2.0 1.3 1.5 4.5 3.2 1.3 1.7 1.1 0.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J2 "OR1J3, OR1J5, OST044" ENSG00000197233 "Olfactory receptor family 1 subfamily J member 2" Q8NGS2 9 122510802-122511743 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.3;testis: 1.2;urinary bladder: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;HSkMC: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.4 1.3 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 1.2 0.0 0.0 1.7 0.0 0.5 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1J4 "HSHTPCRX01, HTPCRX01" ENSG00000239590 "Olfactory receptor family 1 subfamily J member 4" Q8NGS1 9 122519141-122520082 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 1.4;BJ hTERT+: 3.1;fHDF/TERT166: 2.6;HMC-1: 1.3;JURKAT: 1.6;U-266/70: 1.2" "Not detected" "Not detected" NA NA "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (4.13e-2)" "unprognostic (1.82e-1)" "unprognostic (4.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.3 2.0 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.6 0.2 0.8 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 1.4 3.1 0.0 0.0 0.0 0.4 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1K1 "hg99, MNAB" ENSG00000165204 "Olfactory receptor family 1 subfamily K member 1" Q8NGR3 9 122800123-122801073 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.77e-1)" 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.6 0.8 0.0 0.1 0.2 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L1 "OR1L2, OR9-C" ENSG00000173679 "Olfactory receptor family 1 subfamily L member 1" Q8NH94 9 122661566-122662648 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "urinary bladder: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "RT4: 2.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L3 OR9-D ENSG00000171481 "Olfactory receptor family 1 subfamily L member 3" Q8NH93 9 122675036-122676153 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" HPA058878 Uncertain NA NA "HPA058878: AB_2683843" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.1 1.3 0.7 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L4 "OR1L5, OR9-E" ENSG00000136939 "Olfactory receptor family 1 subfamily L member 4" Q8NGR5 9 122723990-122724925 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "breast: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1L8 ENSG00000171496 "Olfactory receptor family 1 subfamily L member 8" Q8NGR8 9 122567117-122583384 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "RT4: 10.4" "Not detected" "Not detected" NA NA "unprognostic (9.76e-2)" "unprognostic (1.11e-1)" "unprognostic (4.32e-2)" "unprognostic (3.86e-2)" "unprognostic (1.68e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-2)" "unprognostic (9.11e-3)" "unprognostic (8.51e-3)" "unprognostic (1.81e-4)" "unprognostic (9.82e-3)" "unprognostic (3.33e-1)" "unprognostic (7.99e-2)" "unprognostic (1.06e-1)" 0.9 0.1 0.3 0.0 0.6 0.1 1.0 0.3 0.7 0.8 0.4 0.1 1.4 0.7 0.2 0.9 0.8 0.9 0.7 0.9 0.7 0.6 0.8 0.5 0.5 0.4 0.1 0.0 0.6 0.5 0.6 0.2 0.8 0.4 0.7 0.6 0.3 0.4 0.9 3.7 0.3 2.0 0.7 0.2 1.1 0.5 0.6 0.2 1.6 0.2 1.1 1.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.4 0.2 0.0 0.1 0.1 0.2 0.2 0.0 0.6 1.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1M1 OR19-6 ENSG00000170929 "Olfactory receptor family 1 subfamily M member 1" Q8NGA1 19 9087061-9095669 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (3.29e-2)" 0.2 0.3 0.3 0.4 0.3 2.7 0.3 0.3 0.7 0.7 0.3 0.4 0.2 0.4 0.3 1.2 0.7 0.3 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.7 0.4 0.1 0.3 0.1 0.3 0.1 0.9 0.0 0.4 2.2 0.5 0.0 0.2 0.2 0.3 0.5 1.7 0.0 0.8 0.3 1.7 1.1 4.2 1.0 1.0 0.9 0.2 0.8 0.6 0.6 1.2 0.9 1.0 2.5 0.4 0.1 0.3 0.7 1.5 2.0 1.1 0.5 0.4 0.7 1.7 0.0 0.3 0.8 0.6 1.0 0.7 1.3 0.9 0.5 0.8 1.2 0.6 0.2 0.8 0.7 0.6 0.2 1.2 0.5 2.8 0.3 1.1 1.1 0.9 0.8 0.7 0.1 0.5 1.0 0.7 0.6 1.8 1.0 1.3 0.2 1.2 0.4 1.0 1.6 0.2 0.7 2.1 1.1 1.7 0.9 1.3 0.7 0.7 0.7 1.5 0.9 2.8 0.9 1.0 0.8 0.6 0.7 0.9 0.7 0.6 0.3 1.7 0.9 0.9 4.2 1.0 1.0 1.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1N1 "OR1-26, OR1N3" ENSG00000171505 "Olfactory receptor family 1 subfamily N member 1" Q8NGS0 9 122526358-122527296 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "cervix, uterine: 1.2;testis: 1.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "endometrial cancer: 0.8;ovarian cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.2;U-266/70: 1.3" NA NA "unprognostic (3.63e-2)" 0.2 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1Q1 "HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106" ENSG00000165202 "Olfactory receptor family 1 subfamily Q member 1" Q15612 9 122614738-122615682 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "epididymis: 4.4;urinary bladder: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.2;CAPAN-2: 1.4;fHDF/TERT166: 2.3;HSkMC: 1.4;JURKAT: 1.7;Karpas-707: 1.6" "Not detected" "Not detected" HPA044828 Uncertain NA NA "HPA044828: AB_10960565" "unprognostic (5.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.98e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.2 0.0 0.7 4.4 0.2 0.5 0.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.3 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.4 0.3 0.0 0.1 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 1.2 0.2 1.0 3.2 0.0 0.0 0.0 1.4 0.0 0.2 2.3 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.3 0.0 0.0 0.0 0.0 1.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A1 ENSG00000221970 "Olfactory receptor family 2 subfamily A member 1" Q8NGT9 7 144312464-144322668 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "thyroid gland: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.1;T-reg: 1.0" "Group enriched" "Detected in many" 4 "granulocytes: 1.1;T-cells: 1.0" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.4;SK-MEL-30: 2.4;WM-115: 1.9" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (3.98e-1)" "unprognostic (6.53e-2)" "unprognostic (1.13e-2)" "unprognostic (9.14e-2)" "unprognostic (2.22e-1)" 1.1 1.1 0.0 0.8 0.0 1.8 1.4 0.0 0.3 1.0 0.6 0.4 0.8 0.7 0.2 0.8 1.0 0.8 0.0 0.0 0.8 0.5 1.4 0.8 0.0 2.4 0.4 0.0 0.5 0.2 0.7 0.0 0.5 0.3 0.5 1.0 1.0 0.5 0.0 1.4 0.4 0.2 5.2 0.4 0.7 1.0 0.2 0.0 1.1 0.1 0.0 1.0 0.1 0.3 0.0 0.0 0.2 0.1 0.2 0.9 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.2 0.2 0.3 0.3 0.1 0.0 0.4 0.3 0.0 0.4 0.3 0.0 0.3 0.2 0.0 0.5 0.0 0.2 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.6 0.0 0.7 0.2 0.0 0.2 0.5 0.3 0.0 0.1 0.5 0.2 2.4 0.2 0.1 0.2 0.0 0.1 0.3 0.1 0.9 0.3 0.1 0.3 0.0 0.1 1.9 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A12 OR2A12P ENSG00000221858 "Olfactory receptor family 2 subfamily A member 12" Q8NGT7 7 144086278-144098953 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "parathyroid gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.3 1.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.6 0.5 0.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A25 "OR2A25P, OR2A27" ENSG00000221933 "Olfactory receptor family 2 subfamily A member 25" A4D2G3 7 144069811-144075870 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.4" "Group enriched" "Detected in some" 55 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 6.9;Club cells: 3.4;granulocytes: 5.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;THP-1: 1.5" "Not detected" "Not detected" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" 0.1 0.7 0.0 1.1 0.0 0.5 0.3 0.0 0.1 0.3 0.1 0.5 0.3 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.5 0.4 0.0 0.2 0.1 0.2 0.3 0.3 0.0 0.2 1.0 0.3 0.0 0.0 0.2 0.1 0.4 1.0 0.1 0.1 0.2 1.4 0.8 3.4 0.5 0.7 0.5 0.5 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.3 0.4 0.6 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.2 1.5 0.0 0.0 0.3 0.4 0.1 0.4 0.0 0.0 0.2 0.2 0.2 3.4 0.5 0.2 0.3 0.3 0.3 0.6 0.5 0.4 0.2 1.4 0.4 0.5 1.8 0.7 0.2 0.8 0.4 0.5 6.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A4 OR2A10 ENSG00000180658 "Olfactory receptor family 2 subfamily A member 4" O95047 6 131699644-131701401 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 10.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 17 "renal cancer: 0.8" "Group enriched" "Detected in some" 48 "basophil: 10.6;NK-cell: 3.8" "Group enriched" "Detected in many" 48 "granulocytes: 10.6;NK-cells: 3.8" "Cell line enhanced" "Detected in some" "HEL: 1.3;HMC-1: 1.1;MCF7: 1.7" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (1.22e-5)" "unprognostic (3.60e-2)" 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.2 1.4 2.1 0.0 0.0 0.4 0.4 0.8 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 1.0 0.0 1.0 0.3 0.5 0.0 0.6 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.9 0.2 0.0 0.0 10.6 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.5 0.5 0.0 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.3 1.3 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.9 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A42 ENSG00000212807 "Olfactory receptor family 2 subfamily A member 42" Q8NGT9 7 144228244-144239605 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "thyroid gland: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.3;THP-1: 1.1;WM-115: 3.8" HPA058272 Uncertain NA NA "HPA058272: AB_2683662" "unprognostic (1.41e-1)" "unprognostic (3.14e-1)" 0.6 0.8 0.1 0.0 0.1 1.7 0.9 0.0 0.0 0.7 0.2 0.1 0.4 0.5 0.2 0.3 0.5 0.5 0.0 0.0 0.7 0.2 0.7 1.2 0.1 1.2 0.3 0.0 0.4 0.0 0.4 0.2 0.7 0.1 0.3 1.9 0.9 0.0 0.0 1.4 0.3 0.2 3.8 0.0 1.0 0.4 1.4 0.5 1.5 0.5 1.0 1.0 0.0 0.9 0.2 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.5 0.3 0.0 0.0 0.0 1.3 0.8 0.1 0.2 0.6 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.8 0.1 1.1 0.8 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 3.8 1.1 0.5 0.4 0.4 0.3 0.3 0.6 0.4 0.3 0.2 1.4 0.5 0.4 1.5 1.0 0.3 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2A5 "OR2A26, OR2A8, OR7-138, OR7-141" ENSG00000221836 "Olfactory receptor family 2 subfamily A member 5" Q96R48 7 144048948-144058845 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7" "Not detected" "Not detected" NA NA 0.3 0.2 0.0 0.6 0.1 1.0 0.7 0.0 0.1 0.0 0.2 0.1 0.4 0.5 0.1 0.3 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.3 0.1 0.3 0.4 0.2 0.2 0.3 0.3 0.2 0.6 0.1 0.1 0.8 0.1 0.0 0.0 0.3 0.2 0.6 0.9 0.1 0.6 0.2 0.4 0.3 1.8 0.2 0.5 0.2 0.0 0.1 0.2 0.4 0.2 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.4 0.4 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.5 0.2 0.2 0.2 0.1 0.1 0.0 0.3 0.2 0.5 0.1 0.5 0.4 1.7 0.2 0.1 0.9 0.4 0.2 0.0 0.0 1.1 1.2 0.2 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.5 0.0 0.0 0.7 0.4 0.4 0.5 0.3 0.6 0.8 0.3 0.2 0.2 0.1 0.6 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.2 1.8 0.5 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AG1 OR2AG3 ENSG00000279486 "Olfactory receptor family 2 subfamily AG member 1 (gene/pseudogene)" Q9H205 11 6783020-6791558 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "blood: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "TIME: 2.0" NA NA 0.0 0.0 0.2 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.4 0.2 0.0 0.0 0.6 0.5 1.5 0.2 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.3 2.0 0.1 0.1 0.5 0.2 0.0 0.2 0.1 0.0 0.3 0.2 1.2 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.6 0.1 0.2 1.5 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AG2 OR2AG2P ENSG00000188124 "Olfactory receptor family 2 subfamily AG member 2" A6NM03 11 6765626-6771976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 2.6;U-698: 2.5" NA NA "unprognostic (6.24e-3)" "unprognostic (7.69e-2)" "unprognostic (1.21e-2)" "unprognostic (1.56e-1)" "unprognostic (7.30e-2)" 0.0 0.1 0.3 0.4 1.1 1.7 0.0 0.1 0.8 0.4 0.3 0.6 0.1 0.3 0.1 0.4 0.0 0.1 0.2 0.5 0.1 0.2 0.1 0.5 0.2 0.5 0.3 0.0 0.1 0.0 0.3 0.5 0.1 0.0 0.3 0.2 0.3 0.2 0.0 0.1 0.0 1.0 0.2 0.3 0.5 0.1 0.6 0.4 1.0 0.4 0.5 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.8 1.0 1.3 0.4 1.5 0.1 0.0 0.6 0.2 1.0 0.9 0.3 0.3 1.1 1.3 0.0 0.8 0.0 0.2 0.0 0.6 1.9 0.0 0.4 0.2 0.0 1.6 0.1 1.5 0.1 2.6 0.9 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.0 0.2 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.3 1.0 0.9 0.2 0.0 0.3 0.0 2.5 1.2 0.2 0.7 0.9 0.4 0.1 0.2 0.2 0.1 0.6 0.5 0.2 0.0 0.6 0.6 0.3 1.0 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AJ1 "OR2AJ1P, OR2AJ1Q" ENSG00000177275 "Olfactory receptor family 2 subfamily AJ member 1" Q8NGZ0 1 247924889-247935339 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.5;thyroid gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.5" NA NA 0.0 0.0 0.3 0.0 0.3 0.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AK2 OR2AK1P ENSG00000187080 "Olfactory receptor family 2 subfamily AK member 2" Q8NG84 1 247965233-247966386 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "bone marrow: 2.5;testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.5" HPA052544 Uncertain NA NA "HPA052544: AB_2681865" 0.0 0.2 0.0 0.0 0.3 2.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2AT4 ENSG00000171561 "Olfactory receptor family 2 subfamily AT member 4" A6NND4 11 75081753-75096876 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.6;bone marrow: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 6.8" "Not detected" "Not detected" NA NA 0.4 0.5 0.4 0.4 0.6 3.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.2 0.4 1.7 0.4 0.3 0.5 0.4 0.4 0.4 0.4 1.7 0.5 0.7 0.4 0.4 0.8 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.5 1.9 0.6 0.4 0.4 0.6 0.4 1.5 0.4 0.4 0.6 0.4 0.4 0.4 0.4 1.2 0.8 3.6 0.8 0.7 0.7 0.1 1.1 0.8 1.5 1.3 0.7 0.8 1.2 0.7 0.4 0.4 0.4 1.3 1.3 2.1 0.7 0.7 0.9 1.1 0.7 0.5 0.8 1.0 0.9 2.3 2.2 1.2 0.4 1.6 1.7 0.6 0.6 0.7 0.7 1.2 0.6 1.6 6.8 3.1 0.4 1.3 0.8 1.7 2.0 0.5 0.8 1.1 1.6 1.9 0.5 1.9 1.7 1.2 0.7 1.1 1.0 1.7 1.0 0.9 1.6 1.2 1.3 1.2 0.7 1.7 1.5 1.3 1.1 1.1 1.3 1.7 0.8 0.5 0.7 0.5 0.6 0.6 0.6 0.5 0.3 1.2 0.7 0.7 3.6 0.7 0.7 0.8 0.5 0.1 0.4 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B11 ENSG00000177535 "Olfactory receptor family 2 subfamily B member 11" Q5JQS5 1 247449118-247458105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.1" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 14.7;Club cells: 9.1;granulocytes: 3.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 5 "THP-1: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047459 Uncertain NA NA "HPA047459: AB_10963692" "unprognostic (1.83e-1)" 1.5 0.1 0.1 1.2 0.1 3.1 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.1 0.7 1.0 0.2 0.1 0.1 0.0 0.1 0.4 0.3 0.1 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.7 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.5 1.5 0.0 0.3 0.0 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.1 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.0 5.2 0.6 0.1 0.4 0.1 0.1 0.1 0.1 0.4 0.9 0.6 0.1 0.5 0.8 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 14.7 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2B2 "hs6M1-10, OR2B2Q, OR2B9, OR6-1" ENSG00000168131 "Olfactory receptor family 2 subfamily B member 2" Q9GZK3 6 27911185-27912396 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "liver: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;U-266/84: 2.4" "Low region specificity" "Detected in some" NA NA "unprognostic (2.28e-1)" "unprognostic (1.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2C1 "OLFmf3, OR2C2P" ENSG00000168158 "Olfactory receptor family 2 subfamily C member 1" O95371 16 3355889-3357294 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Daudi: 3.9;RPMI-8226: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (1.40e-1)" "unprognostic (1.46e-1)" "unprognostic (7.58e-2)" "unprognostic (1.01e-2)" "unprognostic (2.76e-1)" "unprognostic (7.11e-3)" "unprognostic (5.26e-2)" "unprognostic (8.44e-2)" "unprognostic (2.83e-2)" "unprognostic (4.10e-3)" "unprognostic (2.41e-2)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" 0.2 0.3 0.7 0.0 1.0 0.0 0.5 0.9 1.0 0.3 0.1 0.1 0.7 0.0 0.0 3.8 0.1 0.1 0.9 0.7 0.5 0.3 0.0 0.8 0.7 0.6 0.2 1.3 0.1 0.2 0.5 0.3 0.1 0.7 0.1 0.3 0.2 0.3 1.3 0.6 0.1 0.7 0.3 0.8 0.3 0.1 1.3 0.1 0.0 0.0 0.4 1.9 0.4 0.1 0.0 0.3 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.6 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.6 0.1 1.3 1.9 0.8 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2C3 "OR2C4, OR2C5P, OST742" ENSG00000196242 "Olfactory receptor family 2 subfamily C member 3" Q8N628 1 247524677-247536440 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 1.6;granulocytes: 1.1;Late spermatids: 2.1;Spermatocytes: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 4.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 18 "dendritic cells: 1.3;granulocytes: 4.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8" HPA058578 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA058578: AB_2683761" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.03e-1)" 0.2 0.4 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.9 0.1 0.0 0.2 0.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 1.3 0.1 0.4 0.7 0.0 0.1 0.0 0.5 0.1 0.1 0.4 0.1 0.1 0.1 4.6 0.1 0.0 0.2 0.1 0.0 1.3 4.2 0.0 0.1 0.1 0.0 0.5 0.3 0.6 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.3 1.8 0.6 0.2 0.0 1.1 0.3 0.0 0.1 0.0 0.7 0.5 0.1 0.2 0.1 0.1 0.2 0.5 0.5 0.0 0.1 0.0 0.4 0.1 0.5 1.2 0.7 0.1 0.0 0.4 0.2 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.5 0.6 0.6 0.3 0.7 0.4 1.2 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.5 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 OR2F1 "OLF3, OR14-60, OR2F3, OR2F3P, OR2F4, OR2F5, OR7-139, OR7-140" ENSG00000213215 "Olfactory receptor family 2 subfamily F member 1 (gene/pseudogene)" Q13607 7 143954844-143997312 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Hep G2: 1.2" NA NA 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2F2 OR7-1 ENSG00000221910 "Olfactory receptor family 2 subfamily F member 2" O95006 7 143935166-143936279 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2G6 ENSG00000188558 "Olfactory receptor family 2 subfamily G member 6" Q5TZ20 1 248508073-248527337 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.2" "Group enriched" "Detected in some" 19 "Alveolar cells type 2: 2.6;Ciliated cells: 2.7;Club cells: 1.2;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 3.2" NA NA 0.2 0.2 0.2 0.2 0.2 3.2 0.2 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 1.1 0.0 0.2 0.1 0.8 0.0 0.6 0.0 0.3 0.9 0.3 0.0 0.2 0.5 1.1 1.9 0.2 0.3 0.4 0.2 1.4 0.7 1.8 0.8 0.6 0.6 0.1 0.7 0.5 0.6 0.7 0.1 0.4 1.0 1.0 0.1 0.1 0.2 0.7 0.9 0.8 1.1 0.0 0.6 0.8 0.3 0.1 0.4 0.9 0.7 0.8 1.3 0.4 0.0 1.0 0.9 0.1 0.4 0.1 0.4 0.5 0.3 0.9 0.7 3.2 0.1 0.6 0.7 0.8 1.2 0.3 0.7 0.9 0.6 0.4 0.2 1.4 0.6 0.8 0.8 0.7 0.7 0.6 2.0 0.9 2.4 0.9 1.2 1.2 0.8 1.3 0.9 1.0 0.5 0.9 0.7 1.7 0.5 0.5 0.5 0.3 0.4 0.4 0.4 0.4 0.2 1.4 0.5 0.6 1.8 0.6 0.8 0.7 0.3 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2H1 "OR2H6, OR2H8, OR6-2" ENSG00000204688 "Olfactory receptor family 2 subfamily H member 1" Q9GZK4 6 29457181-29464328 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 124 "testis: 12.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 52.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 OR2H2 hs6M1-12 ENSG00000204657 "Olfactory receptor family 2 subfamily H member 2" O95918 6 29585121-29590500 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "brain: 3.3;epididymis: 11.7;testis: 4.8" "Cell type enriched" "Detected in some" 7 "Early spermatids: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.3;NTERA-2: 3.5;TIME: 1.9" NA NA "unprognostic (2.95e-1)" "unprognostic (3.76e-1)" "unprognostic (2.33e-2)" "unprognostic (2.42e-1)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" 0.2 0.1 1.5 0.3 3.3 1.5 0.1 2.2 0.9 0.1 0.1 0.0 0.2 11.7 0.1 0.1 0.1 0.3 1.2 0.9 0.1 0.1 0.2 0.4 0.6 0.2 0.0 0.0 0.7 0.1 0.2 0.1 0.1 0.9 0.1 0.4 0.1 0.1 0.2 0.4 0.2 4.8 0.2 0.2 0.1 0.1 0.4 0.2 0.8 0.1 0.1 0.3 0.0 0.4 0.0 2.3 0.3 0.0 0.0 0.5 0.2 0.1 0.0 0.2 0.0 0.2 0.5 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.2 0.7 0.9 0.7 0.6 0.1 0.6 1.0 0.1 0.1 0.0 0.2 0.3 0.3 0.7 0.4 0.7 0.2 0.1 0.0 0.2 3.5 0.1 0.2 0.4 0.3 0.0 0.0 0.2 0.7 0.2 0.3 0.2 0.0 1.1 0.2 0.2 1.9 0.4 0.9 0.3 0.2 1.0 0.2 0.5 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2J2 "dJ80I19.4, hs6M1-6, OR6-8" ENSG00000204700 "Olfactory receptor family 2 subfamily J member 2" O76002 6 29170907-29175811 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.6;bone marrow: 1.5;testis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 2.2" NA NA 0.0 0.0 0.3 0.4 0.7 1.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.6 0.2 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.3 3.0 0.5 0.0 0.1 0.0 1.0 0.7 1.6 0.4 0.3 0.5 0.0 0.1 0.3 0.1 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.2 0.3 1.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.7 0.0 0.4 0.3 0.0 0.0 0.4 0.1 0.6 0.4 0.7 0.5 0.2 0.3 0.4 0.3 0.3 0.1 1.0 0.4 0.3 1.6 0.3 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 OR2J3 OR6-6 ENSG00000204701 "Olfactory receptor family 2 subfamily J member 3" O76001 6 29108059-29114770 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "CAPAN-2: 1.5" NA NA 0.2 0.0 0.1 0.1 0.0 0.6 0.3 0.0 0.2 0.4 0.1 0.4 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.3 0.5 0.4 0.1 0.3 0.2 0.0 0.1 0.0 0.5 0.3 0.1 0.0 0.1 0.1 0.2 2.5 0.2 0.0 0.1 0.2 0.2 0.3 1.2 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.2 0.0 0.3 0.0 0.1 0.2 0.2 0.4 1.5 0.3 0.2 0.0 0.5 0.5 0.4 0.2 0.7 0.2 0.4 0.6 0.7 0.1 0.8 0.0 0.8 0.2 0.0 0.4 0.6 0.7 0.0 0.0 0.3 0.1 0.4 0.5 0.2 0.0 0.5 0.4 0.5 0.0 0.8 0.0 0.1 0.2 0.7 0.0 0.3 0.4 0.1 0.0 0.5 0.0 0.4 0.5 0.5 0.9 0.6 0.0 0.3 0.2 0.1 0.2 0.7 0.6 0.3 0.2 0.1 0.3 0.2 0.0 0.0 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2K2 "HSHTPCRH06, HTPCRH06, OR2AR1P" ENSG00000171133 "Olfactory receptor family 2 subfamily K member 2" Q8NGT1 9 111327483-111330183 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.2;skeletal muscle: 1.6;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;Karpas-707: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA024261 Uncertain NA NA "HPA024261: AB_1854786" "unprognostic (1.03e-1)" 0.0 0.2 0.3 0.0 0.4 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.9 0.8 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.7 0.0 0.2 3.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L13 OR2L14 ENSG00000196071 "Olfactory receptor family 2 subfamily L member 13" Q8N349 1 248095184-248101103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.2;brain: 7.3" "Cell type enhanced" "Detected in single" 20 "Early spermatids: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 13 "B-cells: 1.0;granulocytes: 3.2;T-cells: 1.5" "Group enriched" "Detected in some" 9 "ASC diff: 1.1;GAMG: 2.5;WM-115: 2.9" NA NA "unprognostic (1.39e-2)" "unprognostic (1.53e-1)" "unprognostic (9.89e-2)" "unprognostic (3.66e-1)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.14e-1)" 0.0 2.0 2.1 0.0 2.4 0.2 0.6 0.7 7.3 0.1 0.1 0.0 0.0 1.2 0.0 1.0 0.0 0.0 2.5 3.2 0.0 0.0 0.0 0.2 3.5 0.2 0.0 0.0 0.2 0.1 1.8 0.1 0.0 0.6 0.0 0.0 0.0 0.1 4.5 1.1 0.0 1.2 0.9 0.1 0.1 0.0 1.0 0.1 3.2 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 3.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.6 0.1 1.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 OR2L2 "HSHTPCRH07, HTPCRH07, OR2L12, OR2L4P" ENSG00000203663 "Olfactory receptor family 2 subfamily L member 2" Q8NH16 1 248030070-248042305 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.1;testis: 3.3" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 10.8;Ciliated cells: 18.7;Club cells: 13.6;granulocytes: 10.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "unprognostic (3.37e-2)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (2.96e-2)" 0.3 0.4 1.1 0.4 1.1 2.7 0.0 0.4 0.9 0.1 0.1 0.9 0.2 0.1 0.3 0.1 0.4 0.0 1.6 1.2 0.2 1.7 0.2 0.3 1.7 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.0 2.2 0.6 1.0 0.0 4.1 0.7 0.9 3.3 0.2 0.0 0.0 0.0 1.7 0.8 2.7 0.8 1.2 1.0 0.2 1.0 0.7 0.9 1.0 0.2 0.1 2.3 0.6 0.0 0.0 0.0 0.6 1.2 1.2 1.2 0.1 0.9 0.8 0.0 0.0 0.3 1.2 0.3 1.0 1.8 0.7 0.0 0.7 1.2 0.0 0.1 0.1 0.0 1.0 0.1 1.0 0.5 2.9 0.1 0.6 0.4 1.4 1.2 1.0 1.4 1.2 1.4 0.8 0.2 1.6 1.3 2.2 1.3 0.7 0.5 1.4 0.9 0.7 1.4 0.9 1.9 1.9 1.4 2.2 1.3 1.1 1.3 1.0 1.3 2.5 0.8 0.6 1.0 0.4 0.8 0.7 0.6 0.5 0.2 1.7 0.8 0.9 2.7 1.2 0.6 0.8 0.4 0.2 17.9 10.8 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OR2L3 ENSG00000198128 "Olfactory receptor family 2 subfamily L member 3" Q8NG85 1 248046836-248063407 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.0;prostate: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.8;Karpas-707: 1.9" NA NA 0.3 0.2 0.4 1.0 0.4 3.0 0.6 1.3 0.5 0.4 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.0 0.6 0.8 0.0 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.9 0.2 4.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 1.5 0.8 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.0 0.5 0.2 0.1 0.3 0.0 0.5 0.4 0.8 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.0 0.9 0.3 0.0 0.0 0.1 0.3 0.3 0.0 1.8 0.1 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.2 1.9 0.0 0.8 0.4 0.5 0.5 0.2 0.7 0.1 0.8 0.2 0.1 0.5 0.2 0.1 0.4 0.0 0.0 0.5 0.1 1.0 0.0 0.8 0.5 0.3 0.4 1.0 0.5 0.7 1.1 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2L5 "OR2L11, OR2L5P" ENSG00000197454 "Olfactory receptor family 2 subfamily L member 5" Q8NG80 1 248013660-248024276 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.2" NA NA 0.1 0.1 0.3 0.2 0.6 1.7 0.0 0.7 0.6 0.5 0.1 0.0 0.1 0.5 0.0 0.2 0.2 0.0 0.5 0.5 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.2 0.6 0.5 0.0 0.1 0.5 0.6 0.0 0.5 0.3 0.5 0.2 0.0 0.6 0.2 0.7 0.3 0.1 0.4 0.0 0.1 0.4 0.0 0.1 0.4 0.3 0.6 0.5 0.1 0.0 0.1 0.4 0.5 0.1 0.1 0.6 0.4 0.4 0.0 0.6 0.0 0.0 0.0 0.3 0.9 0.6 0.0 0.2 0.5 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.5 0.0 0.3 0.1 0.1 0.1 0.0 1.2 0.4 0.2 0.2 0.0 0.2 0.1 0.0 0.3 0.2 0.0 0.7 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.4 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2M4 "HSHTPCRX18, HTPCRX18, OST710, TPCR100" ENSG00000171180 "Olfactory receptor family 2 subfamily M member 4" Q96R27 1 248231417-248244679 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" HPA051308 Uncertain NA NA "HPA051308: AB_2681435" 0.4 0.1 0.5 0.0 0.6 2.6 0.5 0.4 1.3 0.3 0.2 0.2 0.3 1.1 0.1 0.5 0.5 0.1 0.7 1.3 0.1 1.5 0.1 0.2 1.1 0.8 1.4 0.6 0.3 0.0 0.2 0.0 0.7 0.0 0.1 1.0 0.2 0.0 1.0 0.2 0.2 0.4 0.4 0.0 0.2 0.2 1.0 0.6 2.1 0.6 1.3 0.7 0.3 0.7 0.2 0.5 0.7 1.2 2.3 0.4 0.4 0.2 0.1 0.0 0.8 0.4 0.7 0.3 0.3 0.9 0.4 0.5 0.7 0.1 0.1 0.3 1.0 1.6 0.7 0.1 1.2 0.7 1.6 0.1 0.3 0.2 0.4 0.8 0.5 0.9 1.8 0.2 0.9 0.3 1.0 0.9 0.2 0.8 1.9 0.4 0.8 0.2 1.4 1.3 1.0 0.4 0.5 0.8 0.5 0.6 0.1 1.7 0.8 0.8 0.9 0.3 1.3 0.7 0.4 0.6 1.0 1.0 1.9 0.6 0.4 0.6 0.5 0.4 0.5 0.5 0.4 0.1 1.0 0.5 0.7 2.1 1.3 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2S2 ENSG00000278889 "Olfactory receptor family 2 subfamily S member 2 (gene/pseudogene)" Q9NQN1 9 35957108-35958154 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;BJ: 1.3;BJ hTERT+: 1.9;fHDF/TERT166: 1.3;HeLa: 1.3;HHSteC: 1.6;U-138 MG: 2.2" "Region enriched" "Detected in single" 8 "cerebellum: 0.6" NA NA 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T10 ENSG00000184022 "Olfactory receptor family 2 subfamily T member 10" Q8NGZ9 1 248590487-248597700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "kidney: 11.2" "Cell type enriched" "Detected in single" 59 "Proximal tubular cells: 5.9" "Cancer enhanced" "Detected in single" "renal cancer: 0.7" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 15 "B-cells: 1.4" "Group enriched" "Detected in some" 7 "BJ hTERT+: 3.1;Karpas-707: 2.4" HPA052019 Uncertain NA NA "HPA052019: AB_2681696" "unprognostic (8.58e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T11 OR2T11Q ENSG00000279301 "Olfactory receptor family 2 subfamily T member 11 (gene/pseudogene)" Q8NH01 1 248623557-248635091 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;bone marrow: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.2" NA NA 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.1 0.4 1.4 0.3 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.3 0.7 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.2 0.4 0.0 0.2 0.3 0.0 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.0 1.1 0.0 0.1 1.4 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T12 ENSG00000177201 "Olfactory receptor family 2 subfamily T member 12" Q8NG77 1 248290139-248303424 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.4;epididymis: 2.9;liver: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 4.7;U-2197: 3.6" NA NA 0.1 0.1 0.1 0.2 0.3 0.9 0.2 0.1 0.4 0.4 0.2 0.1 0.3 2.9 0.1 0.3 0.0 0.1 0.4 0.4 0.1 4.7 0.2 0.2 0.4 0.2 0.1 0.0 0.2 0.0 0.1 0.4 0.1 0.0 0.2 0.7 0.3 0.0 0.2 0.2 0.2 0.7 0.6 0.2 0.2 0.2 1.3 0.6 2.4 0.4 1.0 0.8 0.1 1.0 0.3 0.4 0.8 0.1 0.2 0.8 0.1 0.1 0.1 0.2 0.7 0.6 1.1 0.5 0.1 0.5 0.3 0.2 0.3 0.2 0.9 0.3 0.9 4.7 0.7 0.1 0.9 1.2 0.2 0.2 0.3 0.0 0.3 0.1 0.6 0.4 2.1 0.1 0.9 1.4 0.8 1.3 0.4 0.3 0.5 0.6 0.7 0.2 1.1 0.7 0.8 0.6 0.9 0.3 1.0 0.7 0.9 1.2 1.0 0.9 3.6 0.6 0.9 0.9 0.5 0.6 0.5 0.8 2.4 0.4 0.3 0.8 0.3 0.6 0.8 0.6 0.6 0.2 1.3 0.8 0.8 1.1 1.0 0.4 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T2 OR2T2P ENSG00000196240 "Olfactory receptor family 2 subfamily T member 2" Q6IF00 1 248445512-248455725 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 14.1" "Cell type enriched" "Detected in single" 14 "Proximal tubular cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enriched" "Detected in single" 22 "Karpas-707: 3.2" NA NA 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 1.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T27 ENSG00000187701 "Olfactory receptor family 2 subfamily T member 27" Q8NH04 1 248649838-248655528 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T29 ENSG00000182783 "Olfactory receptor family 2 subfamily T member 29" Q8NH02 1 248556912-248562772 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.5;kidney: 2.7;prostate: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "memory B-cell: 1.3;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 15 "B-cells: 1.5" "Cell line enriched" "Detected in single" 33 "Karpas-707: 3.2" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T3 ENSG00000196539 "Olfactory receptor family 2 subfamily T member 3" Q8NH03 1 248473351-248474307 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T33 ENSG00000177212 "Olfactory receptor family 2 subfamily T member 33" Q8NG76 1 248269917-248277976 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.2;thyroid gland: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 2.1" NA NA "unprognostic (5.79e-2)" "unprognostic (2.22e-1)" 0.1 0.2 0.4 0.2 1.0 2.2 0.1 0.0 0.8 0.5 0.1 0.5 0.0 0.5 0.1 0.2 0.3 0.0 0.2 1.1 0.1 0.2 0.0 0.2 0.8 0.5 0.0 0.0 0.1 0.1 0.5 0.0 1.5 0.0 0.7 0.3 0.6 0.0 0.1 0.3 0.7 1.7 2.4 0.1 0.6 0.0 0.6 0.9 1.3 0.3 0.4 0.7 0.0 0.6 0.0 0.3 0.4 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.4 2.1 0.5 0.0 1.2 0.6 0.0 0.0 0.0 0.6 0.1 1.6 0.7 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.4 0.3 0.9 0.0 0.6 0.5 0.7 0.4 0.5 1.8 0.3 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 0.3 0.8 0.1 0.4 0.6 0.7 0.9 1.8 0.1 0.8 0.3 0.8 0.2 1.2 0.5 1.3 0.2 0.3 0.5 0.3 0.3 0.6 0.4 0.4 0.2 0.6 0.7 0.7 0.7 0.4 0.3 0.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T34 ENSG00000183310 "Olfactory receptor family 2 subfamily T member 34" Q8NGX1 1 248573801-248574757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 15 "T-cells: 1.4" "Cell line enriched" "Detected in single" 15 "Karpas-707: 1.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T4 OR2T4Q ENSG00000196944 "Olfactory receptor family 2 subfamily T member 4" Q8NH00 1 248361581-248362627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 1.0;cervix, uterine: 1.1;prostate: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.4" NA NA 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T5 ENSG00000203661 "Olfactory receptor family 2 subfamily T member 5" Q6IEZ7 1 248488589-248491113 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2T8 OR2T8P ENSG00000177462 "Olfactory receptor family 2 subfamily T member 8" A6NH00 1 247920252-247921956 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 2.4;thyroid gland: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.0;HaCaT: 1.1;HEL: 2.6;PC-3: 1.9;U-2 OS: 1.2;U-937: 2.4" NA NA "unprognostic (7.26e-2)" "unprognostic (4.16e-1)" "unprognostic (2.88e-1)" "unprognostic (1.06e-1)" "unprognostic (2.83e-2)" 0.1 0.0 0.3 0.1 1.1 2.4 0.2 0.0 0.7 0.2 0.1 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 1.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 1.1 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OR2V1 "OR2V1P, OST265" ENSG00000185372 "Olfactory receptor family 2 subfamily V member 1" Q8NHB1 5 181123122-181131169 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "fallopian tube: 3.5;liver: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA049953 Uncertain NA NA "HPA049953: AB_2680971" 0.2 0.1 0.1 0.2 0.1 0.6 1.2 0.1 0.2 0.4 0.1 0.0 0.3 0.7 0.2 3.5 0.0 0.1 0.5 0.1 0.2 5.0 0.1 0.5 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.1 0.3 0.2 0.2 1.3 0.2 0.1 0.1 1.7 0.7 1.0 0.5 0.2 0.7 0.2 1.3 0.9 2.1 1.9 0.6 0.5 0.6 0.6 0.2 0.9 0.2 1.1 1.0 1.0 0.8 0.1 1.8 1.3 0.2 0.8 0.7 0.4 0.1 0.8 0.8 0.9 0.6 0.7 1.3 0.8 0.2 0.9 1.0 0.8 0.3 0.8 0.6 1.4 1.1 1.1 1.3 0.8 1.4 0.5 0.3 0.7 0.5 0.4 0.2 2.4 1.8 1.4 0.8 0.1 0.4 0.6 0.9 0.7 1.1 0.8 1.0 0.3 1.2 1.1 0.9 1.2 0.4 0.5 0.2 0.7 0.5 1.0 0.7 0.2 0.6 1.7 0.7 0.3 0.1 1.0 0.4 0.4 0.7 0.2 0.3 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2V2 "OR2V3, OST713" ENSG00000182613 "Olfactory receptor family 2 subfamily V member 2" Q96R30 5 181147586-181159285 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.8;bone marrow: 2.5;fallopian tube: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" HPA049953 Uncertain NA NA "HPA049953: AB_2680971" 0.3 0.2 0.2 0.3 0.2 2.5 0.1 0.3 0.3 0.3 0.1 0.1 0.2 0.0 0.2 2.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.2 0.7 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.9 0.3 0.0 0.1 0.3 0.4 0.7 0.4 0.0 0.2 0.1 0.7 0.4 2.8 0.3 0.5 0.3 0.1 0.4 0.8 0.5 0.8 0.2 0.0 0.4 0.2 0.1 0.0 0.3 0.4 1.0 0.2 0.2 0.0 0.1 0.6 0.2 0.1 0.1 0.1 0.7 0.8 1.9 0.7 0.0 0.7 1.0 0.1 0.1 0.0 0.0 0.7 0.0 0.7 0.5 1.1 0.0 1.6 0.6 0.4 0.4 0.1 0.6 0.4 0.2 0.5 0.0 0.8 0.6 0.5 0.5 1.7 0.4 0.6 0.8 1.4 0.4 0.4 0.7 0.7 0.2 0.8 0.3 0.3 0.5 0.7 0.1 2.8 0.3 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.7 0.3 0.3 1.6 0.5 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2W1 hs6M1-15 ENSG00000204704 "Olfactory receptor family 2 subfamily W member 1" Q9Y3N9 6 29044213-29045240 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2W3 "OR2W3P, OR2W8P, OST718" ENSG00000238243 "Olfactory receptor family 2 subfamily W member 3" Q7Z3T1 1 247895587-247896531 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "bone marrow: 13.8;thyroid gland: 8.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Cell type enhanced" "Detected in some" "myeloid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 13.1;PC-3: 13.2;U-2 OS: 8.6;U-937: 6.2;WM-115: 9.4" HPA045594 Uncertain NA NA "HPA045594: AB_10960280" "unprognostic (9.44e-2)" "unprognostic (3.03e-1)" "unprognostic (3.29e-2)" "unprognostic (1.57e-5)" "unprognostic (1.98e-1)" "unprognostic (5.11e-2)" "unprognostic (2.79e-6)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (2.71e-3)" "unprognostic (9.05e-3)" "unprognostic (9.34e-3)" "unprognostic (5.66e-2)" "unprognostic (1.48e-1)" 0.2 0.7 0.6 0.3 1.6 13.8 0.2 0.0 2.2 0.4 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.4 1.7 0.0 0.1 0.5 0.0 1.1 0.0 0.2 0.0 0.3 1.6 0.5 0.6 0.0 0.0 0.0 0.3 0.2 0.4 0.4 0.8 0.1 1.1 8.2 0.0 0.3 0.2 0.6 1.4 1.0 0.6 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 3.9 0.0 0.0 0.0 0.3 13.1 0.0 0.0 0.0 1.7 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.1 0.5 0.0 13.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 8.6 0.0 0.0 1.5 0.0 0.0 0.0 6.2 9.4 0.0 0.2 1.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.6 0.2 0.0 0.8 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR2Y1 ENSG00000174339 "Olfactory receptor family 2 subfamily Y member 1" Q8NGV0 5 180739042-180740099 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A1 "OLFRA03, OR17-40, OR40" ENSG00000180090 "Olfactory receptor family 3 subfamily A member 1" P47881 17 3291017-3298360 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 19 "B-cells: 1.4;dendritic cells: 1.8;T-cells: 2.4" "Cell line enriched" "Detected in some" 20 "HDLM-2: 20.9" "Low region specificity" "Detected in many" NA NA "unprognostic (3.69e-3)" "unprognostic (4.73e-2)" 0.0 0.4 0.1 0.0 0.4 0.0 0.4 0.0 0.3 0.6 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.4 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.2 4.1 0.0 0.2 0.0 0.0 1.4 1.8 0.0 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 1.9 1.4 1.4 1.6 0.6 0.4 0.0 2.4 0.0 0.0 0.0 1.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A2 "OLFRA04, OR17-228, OR228" ENSG00000221882 "Olfactory receptor family 3 subfamily A member 2" P47893 17 3276942-3386317 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 2: 4.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 13.1;JURKAT: 14.2" NA NA "unprognostic (7.58e-2)" "unprognostic (5.10e-2)" "unprognostic (6.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.32e-1)" 0.5 0.5 2.2 0.5 8.6 0.5 0.6 0.4 2.8 0.6 0.4 1.2 0.0 0.4 0.5 1.5 0.4 0.3 0.2 0.4 2.5 1.2 0.5 0.3 0.8 6.5 1.4 0.6 1.0 0.4 0.2 5.5 1.0 2.7 0.7 0.4 1.3 0.3 0.5 0.8 0.6 0.5 0.4 1.9 0.9 0.4 10.9 2.1 2.3 0.3 0.0 0.7 0.6 0.4 3.0 3.4 3.6 0.6 0.7 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.6 0.7 0.9 0.3 1.6 3.0 1.2 0.3 0.8 0.8 1.2 1.8 1.6 0.7 0.4 3.4 0.5 0.8 2.2 8.6 0.4 2.8 2.5 1.2 1.4 0.6 2.7 2.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR3A3 "OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P" ENSG00000159961 "Olfactory receptor family 3 subfamily A member 3" P47888 17 3411370-3424070 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 10.6;bone marrow: 2.6" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 10.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 10.6" "Cell line enriched" "Detected in single" 5 "HDLM-2: 4.4" NA NA "unprognostic (2.01e-1)" 0.1 0.0 0.6 0.2 0.9 2.6 0.1 1.2 0.4 0.2 0.2 0.5 0.4 0.1 0.0 0.2 0.5 0.2 0.6 0.5 0.2 0.2 0.1 0.8 1.1 0.1 0.0 0.0 0.3 0.4 0.1 0.0 0.1 0.1 0.5 1.0 0.0 0.0 0.5 0.4 0.4 1.1 0.2 0.4 0.3 0.2 0.3 10.6 0.6 0.2 0.2 0.2 0.0 0.2 0.1 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.5 0.1 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.0 4.4 0.5 0.4 0.6 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.4 0.4 0.0 0.3 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.3 0.1 0.2 0.9 0.3 0.2 0.1 0.0 0.3 0.2 0.3 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.6 0.2 0.1 10.6 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A16 OR4A16Q ENSG00000181961 "Olfactory receptor family 4 subfamily A member 16" Q8NH70 11 55343151-55344231 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4A47 ENSG00000237388 "Olfactory receptor family 4 subfamily A member 47" Q6IF82 11 48488717-48489780 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "memory CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA059763 Uncertain NA NA "HPA059763: AB_2684122" 0.0 0.0 0.2 0.6 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C3 ENSG00000176547 "Olfactory receptor family 4 subfamily C member 3" Q8NH37 11 48324920-48328471 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049116 Uncertain NA NA "HPA049116: AB_2680638" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4C6 ENSG00000181903 "Olfactory receptor family 4 subfamily C member 6" Q8NH72 11 55662201-55666195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 1.8;lymphoid tissue: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "memory B-cell: 1.8" "Lineage enriched" "Detected in single" 18 "B-cells: 1.8" "Group enriched" "Detected in some" 5 "CAPAN-2: 8.1;Karpas-707: 8.6" NA NA 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 1.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D1 "OR4D3, TPCR16" ENSG00000141194 "Olfactory receptor family 4 subfamily D member 1" Q15615 17 58148449-58159555 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 4.4;bone marrow: 2.2;lymphoid tissue: 1.8;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 2.0;NK-cells: 4.4;T-cells: 3.7" "Cell line enhanced" "Detected in some" "BEWO: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.5 0.1 2.2 0.1 0.1 0.6 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 1.8 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.1 1.3 0.1 1.5 0.1 0.9 0.5 0.1 0.2 0.4 2.0 0.1 4.4 3.7 0.9 0.2 0.3 0.1 0.7 0.0 0.3 3.7 0.2 0.0 0.1 0.3 0.4 0.6 0.2 0.2 0.1 0.4 0.2 0.3 0.1 0.2 0.4 1.1 0.2 0.4 0.3 0.3 0.5 0.3 0.0 0.4 0.4 0.4 0.1 0.1 0.5 0.6 1.0 0.0 0.4 0.3 0.7 1.9 0.1 0.4 0.2 0.1 0.5 0.1 0.5 0.7 0.6 0.3 0.8 0.0 0.7 0.4 0.8 0.0 0.4 1.1 0.6 0.3 0.4 0.4 0.5 0.5 1.0 0.6 2.0 0.1 0.8 2.3 0.1 2.4 0.2 2.2 2.1 0.1 0.2 3.4 3.7 0.8 4.4 0.1 0.4 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D5 ENSG00000171014 "Olfactory receptor family 4 subfamily D member 5" Q8NGN0 11 123939543-123940637 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "pancreas: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045005 Uncertain NA NA "HPA045005: AB_10959302" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D6 ENSG00000166884 "Olfactory receptor family 4 subfamily D member 6" Q8NGJ1 11 59456938-59457991 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.96e-3)" 0.2 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4D9 ENSG00000172742 "Olfactory receptor family 4 subfamily D member 9" Q8NGE8 11 59511368-59520703 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.6;bone marrow: 3.4" "Group enriched" "Detected in some" 15 "Alveolar cells type 2: 1.7;Ciliated cells: 1.4;Collecting duct cells: 1.8;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA 0.2 0.2 0.2 0.5 0.2 3.4 0.2 0.2 0.3 0.5 0.3 1.4 0.4 0.3 0.2 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.3 0.0 0.2 0.1 0.2 0.4 0.5 0.0 0.3 1.4 0.7 0.0 0.2 0.5 0.3 0.5 0.2 0.0 0.7 0.3 1.6 1.0 4.6 1.1 1.6 0.8 0.5 0.8 0.8 0.5 1.2 0.0 0.6 1.1 0.7 0.1 0.3 0.5 1.2 1.4 1.0 0.5 0.4 0.6 1.4 0.5 0.5 0.4 0.7 0.7 1.2 3.2 0.9 0.1 0.8 1.2 0.2 0.3 0.5 0.4 0.5 0.3 1.3 1.3 2.9 0.2 1.2 0.7 1.9 1.1 0.3 1.0 1.2 0.6 0.3 0.2 1.3 1.3 0.7 0.7 1.0 1.9 1.0 1.0 0.9 1.0 1.6 1.0 1.5 0.9 1.2 0.7 1.2 0.9 1.2 1.0 3.4 1.1 0.9 0.7 0.6 0.5 0.9 0.6 0.6 0.5 1.6 0.7 0.8 4.6 1.6 0.5 1.0 0.4 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4E1 OR4E1P ENSG00000276240 "Olfactory receptor family 4 subfamily E member 1 (gene/pseudogene)" 14 21667940-21673818 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9;bone marrow: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.0 0.0 0.8 1.4 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.8 0.1 0.4 0.2 0.1 0.0 1.3 0.4 2.9 0.5 0.9 1.1 0.0 0.3 0.2 0.3 0.5 0.2 0.0 0.2 0.7 0.0 0.3 0.0 0.4 0.6 0.2 0.4 0.0 0.5 0.5 0.0 0.0 0.6 0.3 0.0 0.8 1.2 0.5 0.0 0.0 0.3 0.8 0.7 0.4 0.1 0.4 0.1 0.4 0.1 0.3 0.5 0.5 0.1 0.5 0.3 0.1 0.5 0.1 0.0 0.2 0.3 0.2 0.8 0.0 0.6 0.7 0.3 0.3 0.5 0.0 0.7 1.1 0.4 0.7 0.4 0.6 0.3 0.0 0.0 0.8 0.2 2.0 0.5 0.3 0.5 0.3 0.8 0.7 0.5 0.4 0.1 1.3 1.1 1.1 2.9 0.9 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4E2 ENSG00000221977 "Olfactory receptor family 4 subfamily E member 2" Q8NGC2 14 21653835-21667642 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.5 0.5 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.1 0.1 0.8 0.1 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.6 0.0 0.5 0.2 1.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.8 0.0 0.0 0.2 0.1 0.3 0.0 0.8 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.6 0.1 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 1.0 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.3 0.0 0.5 0.3 0.5 0.8 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F15 ENSG00000182854 "Olfactory receptor family 4 subfamily F member 15" Q8NGB8 15 101812202-101820197 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 2.7;neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.7" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" NA NA 0.1 0.1 0.1 0.8 0.1 0.7 0.1 0.1 0.3 0.7 0.1 0.5 0.3 0.2 0.4 0.4 0.4 0.4 0.0 0.1 0.1 0.1 0.5 0.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.1 0.8 0.1 0.4 0.4 0.0 0.3 0.2 0.5 0.3 2.7 0.3 0.5 0.2 0.1 0.1 0.0 0.9 0.9 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.5 1.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.7 1.1 0.4 0.0 0.2 1.0 0.6 0.0 0.2 0.0 0.3 0.0 0.5 0.3 0.4 0.0 0.7 0.1 0.7 0.5 0.0 0.5 0.3 0.1 0.3 0.5 0.3 0.3 0.0 0.2 0.3 0.0 0.5 0.5 0.6 0.0 1.5 0.5 1.2 0.7 0.9 0.3 0.5 1.5 0.3 0.8 2.7 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.2 0.2 1.9 0.5 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F16 ENSG00000284662 "Olfactory receptor family 4 subfamily F member 16" Q6IEY1 1 685679-686673 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F17 "OR4F11P, OR4F18, OR4F19" ENSG00000176695 "Olfactory receptor family 4 subfamily F member 17" Q8NGA8 19 107104-117102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "urinary bladder: 1.0" "Group enriched" "Detected in some" 462 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 42.0;Ciliated cells: 44.2;Club cells: 47.8;granulocytes: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 1.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 71.5 42.0 0.0 0.0 0.0 0.0 0.0 0.0 44.2 47.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F21 OR4F21P ENSG00000176269 "Olfactory receptor family 4 subfamily F member 21" O95013 8 166049-167043 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "testis: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 5.6" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.1 0.0 0.0 0.3 0.2 0.0 0.4 0.6 0.2 0.3 0.2 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.7 0.6 0.0 0.5 1.0 0.3 0.1 0.1 0.0 0.0 0.8 0.2 0.2 0.1 0.5 0.2 1.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F29 ENSG00000284733 "Olfactory receptor family 4 subfamily F member 29" Q6IEY1 1 450703-451697 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F3 ENSG00000230178 "Olfactory receptor family 4 subfamily F member 3" Q6IEY1 5 181367268-181368262 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047705 Uncertain NA NA "HPA047705: AB_2680125" 0.0 0.1 0.1 0.0 0.4 0.0 0.4 0.2 0.2 0.3 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.2 0.2 0.4 0.1 0.1 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.6 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.3 0.0 0.0 0.3 0.7 0.2 0.2 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F4 OR4F18 ENSG00000177693 "Olfactory receptor family 4 subfamily F member 4" Q96R69 15 101922042-101923095 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "cervix, uterine: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K1 ENSG00000155249 "Olfactory receptor family 4 subfamily K member 1" Q8NGD4 14 19930917-19936757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HEL: 3.2" "Not detected" "Not detected" HPA028877 Uncertain NA NA "HPA028877: AB_10600923" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K13 ENSG00000176253 "Olfactory receptor family 4 subfamily K member 13" Q8NH42 14 20029399-20036038 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.7;skin 1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA 0.1 0.6 0.1 0.4 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 1.6 0.1 0.0 0.1 0.4 0.1 0.5 0.4 0.0 0.2 0.3 0.8 0.6 1.7 0.6 0.8 0.3 0.2 0.2 0.1 0.4 0.7 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.4 0.4 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.5 1.1 0.6 0.3 0.3 0.6 0.0 0.2 0.1 0.0 0.3 0.0 0.3 0.3 1.2 0.0 0.5 0.6 0.4 0.4 0.1 0.0 0.4 0.1 0.2 0.0 0.4 0.4 0.3 0.1 0.2 0.1 0.3 0.9 0.0 0.2 0.8 0.4 0.7 0.2 0.6 0.3 0.4 0.6 0.3 0.1 1.7 0.6 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.1 0.8 0.3 0.3 1.3 0.8 0.3 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4K17 ENSG00000176230 "Olfactory receptor family 4 subfamily K member 17" Q8NGC6 14 20110739-20122199 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "bone marrow: 3.5;liver: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA 0.2 0.2 0.2 0.4 0.2 3.5 0.2 0.2 0.3 1.0 0.3 0.7 0.4 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.4 7.7 0.2 0.5 0.3 0.2 0.3 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1.3 0.9 0.2 0.0 0.2 0.3 0.3 0.4 0.3 0.0 0.4 0.3 1.3 1.2 3.0 1.3 1.4 1.3 0.5 1.3 1.3 1.6 1.5 0.3 0.2 1.9 0.4 0.0 0.1 0.2 1.3 1.9 2.2 1.2 0.2 1.1 1.2 0.2 0.6 0.2 2.0 1.1 2.5 2.0 0.8 0.3 2.6 2.0 0.4 0.4 0.5 0.4 1.0 0.3 2.0 2.4 2.3 0.1 1.9 1.2 2.8 2.0 1.5 1.0 1.0 1.5 1.5 0.2 2.1 1.3 1.5 2.0 1.4 0.6 1.4 1.4 1.2 1.1 1.4 0.8 1.2 1.0 2.5 1.2 2.4 1.4 1.4 0.6 3.0 1.0 1.4 0.8 1.0 0.9 1.0 1.0 0.9 0.6 1.3 1.3 1.2 2.7 1.4 1.3 1.2 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4M1 ENSG00000176299 "Olfactory receptor family 4 subfamily M member 1" Q8NGD0 14 19773504-19783696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "testis: 3.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR4M2 ENSG00000274102 "Olfactory receptor family 4 subfamily M member 2" Q8NGB6 15 22070241-22083221 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Cell type enriched" "Detected in single" 9 "Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-2 OS: 1.0" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N2 ENSG00000176294 "Olfactory receptor family 4 subfamily N member 2" Q8NGD1 14 19719015-19830253 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 9.0" "Group enriched" "Detected in some" 43 "Early spermatids: 23.4;Late spermatids: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTERT-HME1: 2.7;U-2 OS: 6.7" NA NA "unprognostic (2.80e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 22 "testis: 13.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 20.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.7;THP-1: 2.9" HPA057442 Uncertain Uncertain Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 OR4P4 OR4P3P ENSG00000181927 "Olfactory receptor family 4 subfamily P member 4" Q8NGL7 11 55635113-55640309 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.6;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.7;MOLT-4: 1.6" HPA059458 Uncertain NA NA "HPA059458: AB_2684027" 0.1 0.3 0.1 0.0 0.1 2.2 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.7 1.3 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.3 0.1 0.7 0.4 1.6 0.2 1.3 0.4 0.2 0.1 0.7 0.2 0.7 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.7 0.8 0.2 1.7 0.5 0.0 0.5 0.7 0.0 0.0 0.2 0.8 0.1 0.1 0.7 0.0 0.4 0.0 0.0 1.6 1.1 0.7 0.0 0.0 0.2 0.3 1.1 0.0 0.8 0.3 0.6 0.2 0.3 0.7 0.1 0.7 0.1 0.0 0.8 0.0 0.0 0.2 0.4 0.3 0.3 0.4 0.4 0.4 0.9 0.1 0.4 0.4 0.2 0.3 0.4 0.2 0.3 0.1 0.7 0.3 0.3 1.6 1.3 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4Q3 "C14orf13, OR4Q4" ENSG00000182652 "Olfactory receptor family 4 subfamily Q member 3" Q8NH05 14 19743571-19749469 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.0;testis: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "A549: 2.2;Karpas-707: 1.2" "Not detected" "Not detected" HPA049924 Uncertain NA NA "HPA049924: AB_2680955" 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.2 0.2 1.0 0.2 0.3 0.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.2 0.0 0.2 0.1 0.3 1.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4X2 ENSG00000172208 "Olfactory receptor family 4 subfamily X member 2 (gene/pseudogene)" Q8NGF9 11 48245056-48246080 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51A7 ENSG00000176895 "Olfactory receptor family 51 subfamily A member 7" Q8NH64 11 4903783-4909462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA061356 Uncertain NA NA "HPA061356: AB_2684488" "unprognostic (4.57e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B4 ENSG00000183251 "Olfactory receptor family 51 subfamily B member 4" Q9Y5P0 11 5301014-5301946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 7.2;U-2197: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.16e-2)" "unprognostic (5.01e-1)" 0.3 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.7 0.1 0.0 0.6 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.6 0.2 0.0 0.3 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 9.2 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51B5 ENSG00000167355 "Olfactory receptor family 51 subfamily B member 5" Q9H339 11 5303444-5505652 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.0;epididymis: 1.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.1" "Cell type enriched" "Detected in single" 4 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 4 "T-cells: 1.0" "Group enriched" "Detected in some" 6 "K-562: 9.3;U-2197: 2.8" "Region enhanced" "Detected in single" "olfactory region: 0.3" HPA063124 Uncertain NA NA "HPA063124: AB_2684943" "unprognostic (9.22e-3)" "unprognostic (1.80e-1)" "unprognostic (2.01e-1)" "unprognostic (3.76e-2)" "unprognostic (4.75e-1)" "unprognostic (1.36e-1)" "unprognostic (7.37e-5)" "unprognostic (2.94e-1)" "unprognostic (2.43e-1)" "unprognostic (4.20e-2)" "unprognostic (2.71e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.7 0.0 0.3 0.0 0.1 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51D1 OR51D1Q ENSG00000197428 "Olfactory receptor family 51 subfamily D member 1" Q8NGF3 11 4637477-4643060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.0;SCLC-21H: 1.1" "Not detected" "Not detected" HPA061240 Uncertain NA NA "HPA061240: AB_2684457" "unprognostic (1.90e-1)" 1.1 0.1 0.0 0.2 0.0 0.8 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.1 0.4 0.0 0.0 0.7 0.1 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.5 0.0 1.0 0.6 1.3 0.7 0.1 0.6 0.0 0.3 0.3 0.0 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.1 0.3 0.0 0.1 1.3 0.7 0.4 0.6 0.3 0.5 0.4 0.5 0.3 0.1 1.0 0.5 0.6 1.3 0.1 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51E1 "GPR136, GPR164, OR51E1P, OR52A3P" ENSG00000180785 "Olfactory receptor family 51 subfamily E member 1" Q8TCB6 11 4643420-4655488 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 10.0;prostate: 12.1" "Group enriched" "Detected in some" 6 "Intestinal endocrine cells: 20.4;Sertoli cells: 25.8" "Cancer enriched" "Detected in many" 21 "prostate cancer: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 114 "SCLC-21H: 14.4" "Low region specificity" "Detected in many" "CAB019995, HPA051439" Approved NA NA "CAB019995: AB_10283600, HPA051439: AB_2681487" "unprognostic (6.67e-3)" "unprognostic (2.34e-3)" "unprognostic (9.71e-2)" "unprognostic (4.87e-5)" "unprognostic (3.55e-2)" "unprognostic (9.80e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.94e-3)" "unprognostic (7.36e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.72e-3)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" 7.6 0.0 0.6 1.9 0.8 0.0 5.1 0.1 0.6 0.9 2.6 0.1 0.1 0.4 2.5 0.3 0.8 0.8 0.7 4.8 0.1 0.2 1.6 0.1 0.1 1.9 0.6 0.1 1.0 0.1 0.2 1.0 10.0 0.6 12.1 1.1 0.8 4.4 0.8 2.4 0.3 2.1 1.3 1.8 0.1 0.9 0.3 0.1 0.1 0.9 0.9 0.4 1.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.1 0.6 0.1 0.2 0.6 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.1 0.0 20.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 25.8 3.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 OR51E2 PSGR ENSG00000167332 "Olfactory receptor family 51 subfamily E member 2" Q9H255 11 4680171-4697854 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "prostate: 42.1;retina: 14.6" "Cell type enriched" "Detected in some" 13 "Intestinal endocrine cells: 74.5" "Cancer enriched" "Detected in some" 274 "prostate cancer: 217.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.9;BJ hTERT+: 3.3;hTERT-RPE1: 4.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.98e-3)" "unprognostic (1.91e-1)" "unprognostic (6.09e-3)" "unprognostic (1.57e-2)" "unprognostic (8.00e-4)" "unprognostic (3.61e-2)" "unprognostic (6.27e-2)" "unprognostic (1.66e-1)" "unprognostic (3.05e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-1)" "unprognostic (3.61e-1)" "unprognostic (5.04e-5)" "unprognostic (3.34e-2)" "unprognostic (4.66e-2)" "unprognostic (5.76e-2)" "unprognostic (3.29e-1)" 0.7 0.2 0.2 5.0 0.2 0.1 1.7 0.1 0.5 0.6 8.2 0.0 0.5 0.2 1.6 1.3 0.6 0.6 0.3 1.1 0.2 0.2 0.4 0.1 0.1 0.0 0.2 0.0 1.1 0.2 0.1 0.2 5.1 0.4 42.1 2.2 14.6 0.2 2.4 0.5 0.3 0.9 2.0 0.2 0.1 0.5 0.7 0.0 0.0 0.2 0.4 0.0 1.6 0.3 1.6 0.9 2.2 0.6 0.8 1.2 0.4 0.0 0.0 0.1 0.1 0.7 5.9 0.2 0.0 3.3 0.0 0.2 0.2 0.3 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.1 1.1 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 4.3 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.3 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.4 0.7 0.3 0.0 0.4 0.0 0.1 0.4 0.0 0.0 1.5 0.6 0.5 1.2 0.5 0.8 0.8 0.8 0.6 0.3 1.6 0.8 1.1 2.2 0.8 0.5 0.9 0.4 0.4 0.2 0.2 0.1 0.5 0.2 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.6 0.0 0.0 0.1 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I1 ENSG00000167359 "Olfactory receptor family 51 subfamily I member 1" Q9H343 11 5440570-5441514 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.0;U-2197: 1.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 9 "olfactory region: 6.3" NA NA "unprognostic (2.36e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.2 1.8 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51I2 ENSG00000187918 "Olfactory receptor family 51 subfamily I member 2" Q9H344 11 5449323-5456518 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51Q1 ENSG00000167360 "Olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene)" Q8NH59 11 5422111-5423206 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "RT4: 8.0" "Region enriched" "Detected in single" 11 "olfactory region: 4.5" HPA044998 Uncertain NA NA "HPA044998: AB_10794780" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.2 0.0 0.0 0.0 2.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51S1 ENSG00000176922 "Olfactory receptor family 51 subfamily S member 1" Q8NGJ8 11 4847489-4849238 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51T1 ENSG00000176900 "Olfactory receptor family 51 subfamily T member 1" Q8NGJ9 11 4881819-4882883 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "prostate: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "pons and medulla: 0.5" "Low region specificity" "Detected in some" HPA046877 Uncertain NA NA "HPA046877: AB_2679853" "unprognostic (2.59e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51V1 OR51A12 ENSG00000176742 "Olfactory receptor family 51 subfamily V member 1" Q9H2C8 11 5199735-5200700 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HMC-1: 1.0" "Region enriched" "Detected in single" 9 "olfactory region: 0.3" NA NA 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52A1 HPFH1OR ENSG00000182070 "Olfactory receptor family 52 subfamily A member 1" Q9UKL2 11 5143219-5154757 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;testis: 1.9" "Group enriched" "Detected in some" 33 "Ciliated cells: 22.7;Club cells: 18.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 3.0;U-266/70: 3.5" NA NA 0.2 0.3 0.2 0.5 0.2 0.6 0.4 1.1 0.3 0.2 0.2 0.4 0.3 0.4 0.2 0.6 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.4 0.0 1.2 0.9 0.4 0.0 0.2 0.2 0.5 1.9 0.2 0.0 0.2 0.2 1.3 0.6 2.3 0.5 0.8 0.5 0.1 0.4 0.6 0.1 0.5 0.0 0.1 1.2 0.4 0.0 0.2 0.0 0.6 1.1 0.5 0.5 0.0 0.3 0.5 0.0 0.0 0.0 2.5 0.4 0.6 1.6 0.5 0.0 0.7 1.6 0.0 0.2 0.2 0.0 0.2 0.1 0.7 0.9 2.6 0.0 0.7 0.3 1.5 1.7 0.3 0.3 0.6 0.3 0.7 0.1 0.5 0.8 0.9 0.4 1.7 0.3 0.6 0.7 1.3 0.4 0.6 3.0 0.6 0.4 3.5 0.8 1.0 0.4 0.6 0.3 1.7 0.5 1.4 0.4 0.3 0.4 1.2 0.4 0.4 0.2 1.3 0.5 0.4 2.3 0.8 0.3 0.6 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 22.7 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52A5 ENSG00000171944 "Olfactory receptor family 52 subfamily A member 5" Q9H2C5 11 5128776-5138356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "bone marrow: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B2 ENSG00000255307 "Olfactory receptor family 52 subfamily B member 2" Q96RD2 11 6169330-6170408 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.53e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.3 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52B6 ENSG00000187747 "Olfactory receptor family 52 subfamily B member 6" Q8NGF0 11 5580877-5581884 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "ovary: 1.4;pancreas: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.57e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.0 1.4 1.8 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52D1 ENSG00000181609 "Olfactory receptor family 52 subfamily D member 1" Q9H346 11 5488685-5489749 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 19 "testis: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046965 Uncertain NA NA "HPA046965: AB_2679878" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E2 ENSG00000176787 "Olfactory receptor family 52 subfamily E member 2" Q8NGJ4 11 5058650-5059627 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045748 Uncertain NA NA "HPA045748: AB_10959665" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E5 ENSG00000277932 "Olfactory receptor family 52 subfamily E member 5" Q8NH55 11 5893208-5902730 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 5 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52E6 ENSG00000205409 "Olfactory receptor family 52 subfamily E member 6" Q96RD3 11 5840928-5841952 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 2.1" NA NA "unprognostic (2.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52I2 ENSG00000226288 "Olfactory receptor family 52 subfamily I member 2" Q8NH67 11 4581743-4593340 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA049343 Uncertain NA NA "HPA049343: AB_2680721" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 2.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K1 ENSG00000196778 "Olfactory receptor family 52 subfamily K member 1" Q8NGK4 11 4482646-4493497 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1;bone marrow: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 5.1;RT4: 7.5" NA NA 0.3 0.3 0.3 0.8 0.3 3.9 0.2 0.2 0.3 0.3 0.3 0.5 0.3 0.5 0.3 0.3 0.2 0.2 0.3 0.2 0.9 0.8 0.5 0.9 0.4 1.2 0.3 0.0 0.2 1.4 0.3 0.1 0.3 0.0 0.4 1.2 1.8 0.0 0.5 0.9 0.2 1.1 0.3 0.6 0.4 0.4 0.6 0.6 3.1 1.4 0.3 0.5 0.3 0.9 1.9 1.4 1.5 0.3 0.2 0.9 1.3 0.3 0.8 0.8 1.8 1.5 1.1 1.2 0.7 0.9 1.8 1.4 0.8 1.0 0.6 0.8 1.4 5.1 1.9 0.2 0.7 2.0 0.4 0.3 0.9 0.7 0.5 0.6 1.4 0.9 2.7 2.1 1.0 0.5 1.6 0.8 0.3 1.1 1.8 1.0 0.8 0.5 7.5 1.6 0.7 0.4 0.6 0.3 1.3 1.1 0.5 0.3 2.6 0.7 0.8 2.7 1.5 0.7 0.7 0.6 2.5 1.6 0.7 1.4 0.4 0.4 1.2 0.2 0.3 0.3 0.5 0.6 0.6 0.4 0.5 3.1 0.3 1.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52K2 ENSG00000181963 "Olfactory receptor family 52 subfamily K member 2" Q8NGK3 11 4449295-4450361 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 6.9;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 1.9;neutrophil: 6.9" "Group enriched" "Detected in many" 25 "granulocytes: 6.9;monocytes: 1.9" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 6.9 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.9 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52L1 ENSG00000183313 "Olfactory receptor family 52 subfamily L member 1" Q8NGH7 11 5985892-5986985 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.5 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52M1 OR52M1P ENSG00000197790 "Olfactory receptor family 52 subfamily M member 1" Q8NGK5 11 4545191-4546144 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N1 ENSG00000181001 "Olfactory receptor family 52 subfamily N member 1" Q8NH53 11 5786471-5791265 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 1.8;bone marrow: 1.4" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 1.4;granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "Karpas-707: 1.7" HPA054028 Uncertain NA NA "HPA054028: AB_2682348" 1.8 0.0 0.0 0.3 0.0 1.4 0.3 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.2 0.9 0.2 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.3 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.5 0.7 1.2 0.6 1.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.3 0.0 0.2 0.7 0.5 0.0 0.2 0.3 0.2 0.0 0.1 0.0 0.7 0.8 0.7 0.2 0.1 0.2 0.0 0.1 0.4 0.6 1.2 0.6 0.2 0.5 0.4 0.6 0.5 0.7 0.6 0.0 0.5 0.7 0.7 0.5 1.0 0.5 0.7 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N2 ENSG00000180988 "Olfactory receptor family 52 subfamily N member 2" Q8NGI0 11 5820314-5821348 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 7.0;testis: 2.9" "Group enriched" "Detected in some" 26 "Early spermatids: 2.2;Late spermatids: 3.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 29 "basophil: 7.0" "Lineage enriched" "Detected in single" 29 "granulocytes: 7.0" "Cell line enhanced" "Detected in some" "HDLM-2: 1.7;SK-BR-3: 1.4" NA NA "unprognostic (3.45e-1)" "unprognostic (2.81e-1)" "unprognostic (3.44e-1)" "unprognostic (7.82e-2)" 0.7 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.2 0.3 0.1 0.7 0.9 0.3 0.1 0.0 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.0 0.3 0.0 0.2 0.0 0.2 0.5 0.2 0.7 0.8 0.0 0.1 1.1 0.0 2.9 0.0 0.5 0.1 0.1 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N4 ENSG00000181074 "Olfactory receptor family 52 subfamily N member 4 (gene/pseudogene)" Q8NGI2 11 5754243-5755905 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3;T-reg: 3.1" "Group enriched" "Detected in many" 6 "B-cells: 2.3;T-cells: 3.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 1.5;hTERT-RPE1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (2.59e-3)" "unprognostic (4.06e-2)" "unprognostic (1.32e-1)" "unprognostic (2.86e-4)" "unprognostic (1.75e-1)" "unprognostic (1.95e-1)" "unprognostic (3.03e-1)" "unprognostic (5.08e-2)" "unprognostic (2.62e-1)" "unprognostic (5.62e-2)" "unprognostic (1.41e-3)" "unprognostic (1.41e-1)" "unprognostic (3.80e-2)" "unprognostic (3.18e-2)" "unprognostic (4.41e-2)" 1.3 0.4 0.1 1.1 0.1 0.8 1.4 0.0 0.4 0.8 0.6 0.0 1.4 3.4 0.7 1.6 0.5 0.7 0.2 0.1 1.1 0.3 1.3 2.9 0.2 3.5 0.0 0.0 0.9 0.0 1.2 0.6 0.6 1.8 0.2 0.6 3.6 0.1 0.5 5.7 0.4 0.6 0.6 2.9 0.5 1.4 2.3 0.4 0.0 0.1 0.0 3.1 0.3 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.0 0.2 0.2 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.7 0.0 0.0 2.3 0.4 0.6 0.0 0.0 0.1 0.4 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52N5 OR52N5Q ENSG00000181009 "Olfactory receptor family 52 subfamily N member 5" Q8NH56 11 5776165-5783355 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "adipose tissue: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 1.8 0.2 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.8 0.3 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.4 2.1 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR52W1 OR52W1P ENSG00000175485 "Olfactory receptor family 52 subfamily W member 1" Q6IF63 11 6199146-6200259 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "bone marrow: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "JURKAT: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 0.0 0.0 0.1 0.2 0.7 1.9 0.0 0.8 0.4 0.0 0.3 0.5 0.3 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.4 0.4 0.0 0.3 0.8 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A1 ENSG00000180934 "Olfactory receptor family 56 subfamily A member 1" Q8NGH5 11 6019336-6034338 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8;testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.2 0.1 1.8 0.1 0.1 0.2 0.1 0.4 0.0 0.2 0.8 0.1 0.2 0.5 0.1 0.1 0.2 0.3 0.8 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.1 0.4 0.0 0.1 0.3 0.1 0.0 0.1 0.3 0.1 2.7 0.3 0.0 0.2 0.1 0.8 0.4 0.8 0.1 0.6 1.2 0.1 0.4 0.1 0.8 0.6 0.1 0.5 0.3 0.7 0.6 0.5 0.2 0.2 1.0 0.9 1.2 0.2 0.6 0.6 0.1 0.0 0.9 0.3 0.3 0.6 0.7 0.8 0.2 0.9 0.8 0.3 1.2 0.6 0.2 0.7 0.2 0.5 0.8 0.8 0.2 1.0 0.2 0.6 1.2 0.4 0.4 0.6 0.8 0.1 0.5 0.8 0.6 0.8 0.1 0.5 0.5 2.1 0.6 0.6 0.5 0.9 0.9 0.5 0.3 1.0 0.7 0.4 0.5 0.5 0.6 0.7 0.1 0.4 0.6 0.0 1.0 0.5 1.0 0.8 0.1 0.8 1.2 0.9 0.8 0.6 0.1 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A3 "OR56A3P, OR56A6" ENSG00000184478 "Olfactory receptor family 56 subfamily A member 3" Q8NH54 11 5938751-5951347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.1;U-266/84: 2.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A4 ENSG00000183389 "Olfactory receptor family 56 subfamily A member 4" Q8NGH8 11 5999445-6006946 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;bone marrow: 1.5" "Cell type enriched" "Detected in single" 11 "granulocytes: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.1" NA NA 0.3 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.4 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.4 0.6 0.4 0.0 0.1 0.1 0.1 1.0 0.1 0.0 0.0 0.1 0.5 0.4 2.2 0.5 0.4 0.4 0.0 0.7 0.2 0.2 0.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.6 0.9 0.5 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.5 1.3 0.1 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.2 2.1 0.1 0.6 0.0 0.5 0.9 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.4 0.7 0.5 0.2 0.3 0.2 0.5 0.0 1.4 0.4 1.3 0.2 0.4 0.8 0.6 0.4 0.5 0.2 0.4 0.6 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.5 0.4 0.4 2.2 0.4 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56B1 OR56B1P ENSG00000181023 "Olfactory receptor family 56 subfamily B member 1" Q8NGI3 11 5736448-5738522 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045043 Uncertain NA NA "HPA045043: AB_10794296" 0.2 0.0 0.0 1.2 0.0 0.3 0.3 0.0 0.2 0.9 0.1 0.0 0.3 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.5 1.3 0.0 0.8 0.0 0.7 0.1 0.0 0.3 0.1 0.2 0.5 0.0 0.0 0.7 0.0 0.0 1.4 0.0 0.2 0.1 0.9 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5A1 "OR5A1P, OST181" ENSG00000172320 "Olfactory receptor family 5 subfamily A member 1" Q8NGJ0 11 59436469-59451380 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;bone marrow: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5" "Not detected" "Not detected" NA NA "unprognostic (1.73e-2)" 0.2 0.4 0.2 0.4 0.2 2.4 0.2 0.2 0.3 0.7 0.3 0.1 0.3 1.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.5 0.2 0.5 0.3 0.0 0.2 0.1 0.2 0.0 0.4 0.0 0.5 2.0 0.4 0.0 0.2 0.5 0.3 1.6 0.4 0.0 0.3 0.2 0.8 0.4 2.4 0.3 0.3 0.5 0.0 0.7 0.3 0.8 1.2 0.5 0.3 0.8 0.6 0.1 0.1 0.1 0.8 0.7 1.3 0.6 0.1 0.7 0.7 0.3 0.0 0.1 0.7 1.0 0.9 2.6 0.6 0.1 0.7 1.7 0.0 0.3 0.1 0.1 0.7 0.1 0.9 1.0 3.5 0.3 0.7 0.8 1.0 1.3 0.3 0.8 0.7 0.7 1.4 0.2 1.5 1.0 0.9 0.7 0.4 0.4 1.1 1.2 0.7 0.6 0.9 1.1 0.9 0.7 1.3 1.0 0.8 1.1 1.0 0.8 0.9 0.3 0.2 0.5 0.2 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.4 2.4 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AC2 HSA1 ENSG00000196578 "Olfactory receptor family 5 subfamily AC member 2" Q9NZP5 3 98087173-98088102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 2.3" "Cell type enriched" "Detected in single" 9 "Early spermatids: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AK2 ENSG00000181273 "Olfactory receptor family 5 subfamily AK member 2" Q8NH90 11 56988872-56989867 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 42 "lymphoid tissue: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AN1 ENSG00000176495 "Olfactory receptor family 5 subfamily AN member 1" Q8NGI8 11 59358895-59371714 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.5;bone marrow: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.5" NA NA 0.1 0.0 0.0 0.0 0.1 2.2 0.1 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.4 0.1 0.1 1.5 0.7 0.4 0.0 0.1 0.0 0.4 0.1 0.2 0.5 0.0 0.5 0.2 0.7 0.5 0.1 0.1 0.2 0.1 1.0 0.2 1.4 0.6 0.2 0.2 0.8 0.4 0.4 0.3 0.6 0.7 0.7 0.0 0.3 0.4 0.0 0.0 0.5 2.5 0.5 0.1 0.2 0.7 1.2 0.7 1.1 0.1 0.4 0.3 0.1 1.5 0.6 0.4 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.2 0.2 0.2 0.2 1.4 0.4 1.4 0.8 0.3 0.4 0.6 0.7 0.7 0.2 0.3 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AS1 ENSG00000181785 "Olfactory receptor family 5 subfamily AS member 1" Q8N127 11 56027654-56038191 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.6" "Group enriched" "Detected in some" 7 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 8.3;Ciliated cells: 8.1;Club cells: 10.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.5 0.6 0.5 0.5 0.5 3.2 0.7 0.6 1.3 1.5 0.6 0.2 0.6 1.4 0.5 0.7 0.3 0.9 0.6 0.5 0.5 1.6 0.5 0.7 0.6 1.1 0.6 0.0 0.5 1.0 0.8 0.2 0.9 0.5 0.7 2.8 0.5 0.0 0.5 0.7 0.5 1.6 0.5 0.0 0.7 0.6 2.7 1.3 4.6 1.6 1.6 1.6 0.2 2.1 1.0 3.0 2.3 0.9 1.4 2.3 1.5 0.3 0.4 0.8 1.9 2.1 3.7 2.0 1.0 2.1 2.3 0.7 0.9 1.2 3.0 1.2 2.2 4.4 1.5 0.4 2.6 2.8 1.1 1.3 1.9 1.0 1.5 1.0 2.1 2.8 5.7 0.6 1.4 3.1 2.3 3.6 1.2 1.2 2.0 2.7 1.2 0.9 2.6 2.0 2.2 1.5 1.4 1.1 2.8 2.7 1.4 3.9 3.3 2.7 2.6 1.8 3.8 2.9 1.2 2.0 2.4 4.1 4.6 1.6 1.0 1.6 1.1 1.4 1.1 1.3 1.2 0.9 2.7 1.4 1.4 3.8 1.6 1.5 1.3 0.7 0.2 6.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 8.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AU1 ENSG00000169327 "Olfactory receptor family 5 subfamily AU member 1" Q8NGC0 14 21148370-21159060 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.3;bone marrow: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2197: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.1 0.1 0.2 0.1 0.3 2.4 0.6 0.1 0.3 0.4 0.2 0.4 0.2 0.5 0.2 0.1 0.2 0.1 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.4 0.9 1.7 0.6 0.4 0.0 0.1 0.4 0.2 0.9 0.3 0.0 0.1 0.5 0.8 0.8 2.3 0.7 0.7 0.4 0.0 0.3 0.4 0.3 0.3 0.2 0.1 0.5 0.4 0.0 0.0 0.0 0.7 0.6 0.3 0.3 0.2 0.3 0.7 0.1 0.0 0.1 0.3 0.2 0.7 0.9 0.8 0.3 0.6 0.6 0.1 0.0 0.1 0.2 0.1 0.1 0.8 0.7 1.0 0.1 0.5 0.3 0.9 0.4 0.5 0.1 0.5 0.7 0.3 0.1 0.8 0.7 0.6 0.6 1.7 0.1 0.8 0.3 0.1 0.1 0.7 0.4 4.5 0.4 0.6 0.4 0.4 0.4 1.0 0.5 1.1 0.7 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.1 0.8 0.4 0.3 2.3 0.7 0.3 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B12 "OR5B12P, OR5B16, OST743" ENSG00000172362 "Olfactory receptor family 5 subfamily B member 12" Q96R08 11 58439077-58442758 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+: 1.0" NA NA 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.5 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.2 0.4 0.0 0.3 1.2 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.3 0.6 0.7 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B2 OST073 ENSG00000172365 "Olfactory receptor family 5 subfamily B member 2" Q96R09 11 58421264-58428121 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.2 0.6 0.0 0.0 0.1 1.8 0.5 0.4 0.3 0.5 0.1 0.0 0.2 0.2 0.3 0.4 0.4 0.1 0.1 0.1 0.4 0.3 0.3 0.6 0.0 0.6 0.1 0.3 0.2 0.3 0.4 0.3 0.2 0.3 0.3 0.5 0.5 0.0 0.1 0.5 0.2 1.0 0.2 0.1 0.7 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.6 0.3 0.5 0.2 0.0 0.6 0.0 0.8 0.4 0.2 0.0 0.2 0.3 1.4 0.3 0.8 0.2 0.3 0.1 0.2 0.6 0.9 0.2 1.3 0.9 0.0 0.0 0.4 1.2 1.0 0.5 0.4 0.4 0.6 0.0 1.7 0.3 1.2 0.7 0.5 1.6 0.6 0.3 0.5 0.2 1.0 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.6 0.7 0.3 1.0 0.5 0.0 0.3 0.1 0.2 0.8 0.4 0.1 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5B21 ENSG00000198283 "Olfactory receptor family 5 subfamily B member 21" A6NL26 11 58507175-58508105 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "testis: 1.9;urinary bladder: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 3.5;hTEC/SVTERT24-B: 1.6;U-2197: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.2 1.9 0.0 0.8 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5C1 "hRPK-465_F_21, OR5C2P, OR9-F" ENSG00000148215 "Olfactory receptor family 5 subfamily C member 1" Q8NGR4 9 122788933-122789895 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.0" "Not detected" "Not detected" NA NA "unprognostic (2.73e-1)" 1.0 0.2 0.3 0.2 1.3 0.2 2.8 0.4 0.8 0.5 0.2 0.3 0.0 0.2 0.2 0.4 0.2 0.5 0.6 6.1 1.2 0.2 0.8 0.5 0.3 0.5 0.1 0.4 0.4 0.3 0.2 0.4 1.0 0.1 1.0 0.2 0.0 1.5 0.2 2.4 0.8 0.3 0.2 0.9 0.6 0.2 1.0 0.1 0.0 1.2 0.7 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.7 1.2 0.2 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5D18 ENSG00000186119 "Olfactory receptor family 5 subfamily D member 18" Q8NGL1 11 55819607-55820597 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H1 "HSHTPCRX14, HTPCRX14" ENSG00000231192 "Olfactory receptor family 5 subfamily H member 1" A6NKK0 3 98130721-98138548 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.1" "Cell line enriched" "Detected in single" 6 "BEWO: 5.2" NA NA 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.6 0.0 0.1 0.5 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.5 0.1 1.5 0.2 0.0 0.6 0.1 0.2 1.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 0.0 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.4 0.0 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H14 ENSG00000236032 "Olfactory receptor family 5 subfamily H member 14" A6NHG9 3 98147479-98156614 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.1;placenta: 2.1" "Group enriched" "Detected in some" 17 "Collecting duct cells: 1.8;Early spermatids: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.4 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.2 0.1 0.0 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.2 0.1 0.4 0.4 2.1 0.4 0.4 0.4 0.0 0.6 0.6 0.6 0.6 0.3 0.1 0.5 0.8 0.5 0.1 0.0 0.9 0.5 0.3 0.4 0.0 0.6 0.9 0.1 0.3 0.0 0.5 0.6 0.6 1.0 0.7 0.2 0.4 0.5 0.1 0.7 0.2 0.0 0.5 0.0 1.1 0.3 1.4 0.0 1.0 0.3 0.7 0.7 0.3 1.1 0.7 0.2 0.4 0.1 1.0 0.3 0.5 0.4 0.4 0.5 1.1 0.6 0.3 0.1 0.6 1.1 0.9 0.4 0.8 0.8 0.7 0.5 0.3 0.5 2.1 0.4 0.4 0.4 0.2 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.3 1.4 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H2 ENSG00000197938 "Olfactory receptor family 5 subfamily H member 2" Q8NGV7 3 98282888-98283832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skeletal muscle: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H6 ENSG00000230301 "Olfactory receptor family 5 subfamily H member 6 (gene/pseudogene)" Q8NGV6 3 98263252-98265356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Group enriched" "Detected in some" 12 "Early spermatids: 1.2;Late spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NTERA-2: 1.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5J2 ENSG00000174957 "Olfactory receptor family 5 subfamily J member 2" Q8NH18 11 56176618-56177556 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Not detected" "Not detected" HPA059466 Uncertain NA NA "HPA059466: AB_2684029" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K2 ENSG00000231861 "Olfactory receptor family 5 subfamily K member 2" Q8NHB8 3 98497604-98498663 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.4;THP-1: 3.0;U-266/70: 1.5" NA NA "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (8.45e-3)" "unprognostic (1.69e-3)" "unprognostic (6.47e-3)" "unprognostic (7.17e-2)" "unprognostic (1.45e-1)" "unprognostic (3.61e-2)" "unprognostic (1.19e-2)" "unprognostic (6.57e-2)" "unprognostic (3.77e-2)" "unprognostic (5.93e-2)" 0.4 0.4 0.0 0.6 1.3 0.0 0.4 2.3 0.8 0.9 1.4 0.2 1.2 0.0 0.6 0.1 0.4 0.9 0.0 0.0 0.4 0.0 1.4 1.2 0.0 1.4 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.0 4.3 1.5 1.3 0.0 0.0 1.4 0.4 0.6 0.4 0.0 1.1 0.6 0.5 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.3 0.9 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M10 ENSG00000254834 "Olfactory receptor family 5 subfamily M member 10" Q6IEU7 11 56576736-56577787 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M11 OR11-199 ENSG00000255223 "Olfactory receptor family 5 subfamily M member 11" Q96RB7 11 56542262-56543281 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 1.3;urinary bladder: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 2.6" NA NA "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5M8 ENSG00000181371 "Olfactory receptor family 5 subfamily M member 8" Q8NGP6 11 56490349-56491395 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "U-2 OS: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5P2 JCG3 ENSG00000183303 "Olfactory receptor family 5 subfamily P member 2" Q8WZ92 11 7795905-7796973 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "skin 1: 1.7;urinary bladder: 1.3" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RT4: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5P3 JCG1 ENSG00000182334 "Olfactory receptor family 5 subfamily P member 3" Q8WZ94 11 7824818-7830840 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 1.7;skin 1: 2.1;urinary bladder: 1.0" "Group enriched" "Detected in some" 21 "Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060787 Uncertain NA NA "HPA060787: AB_2684364" "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 OR5T2 ENSG00000181718 "Olfactory receptor family 5 subfamily T member 2" Q8NGG2 11 56231282-56234255 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "skin 1: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.3 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 0.3 0.1 0.1 0.2 0.0 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.7 0.2 0.3 1.6 0.3 0.0 0.4 0.1 0.1 0.9 0.1 0.0 0.3 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.7 2.2 0.2 0.6 0.2 0.3 0.6 0.2 0.5 1.4 0.0 0.8 0.1 0.1 1.0 1.2 0.5 0.6 0.1 1.3 1.8 0.6 0.7 1.4 0.0 0.4 0.5 0.2 0.0 0.3 0.2 0.7 0.9 1.0 0.6 0.5 0.0 0.4 0.6 1.1 0.9 0.1 0.4 0.4 0.8 0.2 0.0 1.0 0.7 0.5 0.1 0.3 0.3 0.5 0.5 0.4 0.4 1.0 0.2 0.5 0.4 1.1 2.4 0.7 0.3 1.0 0.8 0.0 0.0 0.0 0.3 0.0 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5V1 hs6M1-21 ENSG00000243729 "Olfactory receptor family 5 subfamily V member 1" Q9UGF6 6 29353749-29431967 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.1" "Group enriched" "Detected in some" 23 "Early spermatids: 13.0;Late spermatids: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA046707 Uncertain NA NA "HPA046707: AB_2679763" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6A2 "OR11-55, OR6A1, OR6A2P" ENSG00000184933 "Olfactory receptor family 6 subfamily A member 2" O95222 11 6791736-6799689 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B1 OR7-3 ENSG00000221813 "Olfactory receptor family 6 subfamily B member 1" O95007 7 144000320-144008793 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 3.2;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 5.6;RPMI-8226: 2.1;U-266/84: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 20 "olfactory region: 0.1" HPA053164 Uncertain NA NA "HPA053164: AB_2682065" 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.5 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "brain: 1.6;epididymis: 6.5;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C2 OR6C67 ENSG00000179695 "Olfactory receptor family 6 subfamily C member 2" Q9NZP2 12 55444069-55453347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "epididymis: 1.5;testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "Karpas-707: 3.9" "Not detected" "Not detected" NA NA "unprognostic (2.37e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.1 1.5 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C4 ENSG00000179626 "Olfactory receptor family 6 subfamily C member 4" Q8NGE1 12 55549602-55555832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-266/84: 3.2" NA NA 0.3 0.2 0.1 0.9 0.2 1.3 0.2 0.2 0.8 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.3 0.8 0.1 0.1 0.3 0.2 0.2 1.0 0.2 0.6 0.8 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.5 1.6 0.4 0.0 0.1 0.4 0.3 0.4 0.6 0.0 0.5 0.2 0.9 1.6 2.9 0.6 1.2 1.1 0.2 0.8 0.0 1.1 1.3 0.1 0.0 0.9 0.8 0.1 0.0 0.0 0.6 0.7 1.5 0.2 0.2 0.6 0.6 0.0 0.0 0.0 1.5 0.6 0.6 1.2 0.6 0.1 1.6 1.0 0.0 0.1 0.0 0.0 0.5 0.2 0.9 0.6 2.1 0.1 0.4 0.7 1.0 0.8 0.1 0.6 0.4 0.9 1.6 0.1 0.9 1.4 1.1 0.4 0.8 1.7 0.7 0.1 1.3 1.1 1.8 0.8 0.7 0.5 1.1 3.2 1.2 0.9 1.2 1.5 2.9 0.6 0.7 0.7 0.4 0.7 0.6 0.7 0.6 0.2 0.9 1.1 0.9 1.5 1.2 0.4 1.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C6 ENSG00000188324 "Olfactory receptor family 6 subfamily C member 6" A6NF89 12 55293988-55296569 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.3;skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;MCF7: 1.6;THP-1: 1.0" HPA051090 Uncertain Approved "Lipid droplets,Plasma membrane" NA NA "Lipid droplets, Plasma membrane" "HPA051090: AB_2681341" 0.0 0.0 0.0 0.4 0.1 1.1 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.5 1.7 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.1 1.0 2.3 0.5 0.5 0.6 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.0 0.0 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.8 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.5 0.2 2.3 0.5 0.9 0.6 0.1 0.3 0.6 0.5 0.4 0.1 1.1 0.5 0.6 1.8 0.5 0.3 1.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C68 ENSG00000205327 "Olfactory receptor family 6 subfamily C member 68" A6NDL8 12 55492378-55493316 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "heart muscle: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-266/70: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C70 ENSG00000184954 "Olfactory receptor family 6 subfamily C member 70" A6NIJ9 12 55469200-55470138 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "heart muscle: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "Karpas-707: 7.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C76 ENSG00000185821 "Olfactory receptor family 6 subfamily C member 76" A6NM76 12 55426254-55427192 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "epididymis: 1.2;fallopian tube: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6F1 OST731 ENSG00000169214 "Olfactory receptor family 6 subfamily F member 1" Q8NGZ6 1 247711436-247716646 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "testis: 4.6" "Group enriched" "Detected in some" 63 "Early spermatids: 13.9;Late spermatids: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 57 "GAMG: 6.4" "Not detected" "Not detected" NA NA "unprognostic (5.75e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR6J1 "OR6J1P, OR6J2" ENSG00000255804 "Olfactory receptor family 6 subfamily J member 1 (gene/pseudogene)" Q8NGC5 14 22630929-22644352 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.3;bone marrow: 3.4" "Group enriched" "Detected in some" 18 "Ciliated cells: 1.4;granulocytes: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" NA NA 0.3 0.2 0.7 0.7 0.6 3.4 0.3 0.3 1.0 0.3 0.2 0.3 0.5 0.9 0.3 0.2 0.3 0.2 0.5 0.3 0.3 0.3 0.4 0.4 0.7 0.4 0.5 0.0 0.3 0.0 0.3 0.1 0.7 0.0 1.0 1.5 0.6 0.0 0.4 0.6 0.6 0.6 0.4 0.0 0.1 0.4 0.9 0.8 3.3 0.8 1.1 0.9 0.4 1.1 0.6 1.3 1.4 0.3 0.4 2.1 0.3 0.0 0.2 0.1 1.5 1.1 1.0 0.6 0.0 0.6 1.1 0.2 0.2 0.2 1.9 0.8 0.7 2.9 1.6 0.0 1.2 1.8 0.1 0.6 0.3 0.3 0.4 0.1 1.1 0.6 2.5 0.6 1.3 1.2 1.0 1.2 0.7 0.8 1.0 0.7 0.7 0.2 1.8 1.7 1.4 1.4 1.1 0.7 1.4 1.2 0.5 1.7 1.1 1.1 1.2 0.4 1.1 0.7 1.4 0.7 1.2 0.6 3.1 0.8 1.1 0.7 0.6 0.7 0.5 0.7 0.5 0.2 0.9 0.7 0.9 3.3 1.1 0.6 0.8 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6K3 ENSG00000203757 "Olfactory receptor family 6 subfamily K member 3" Q8NGY3 1 158716327-158720720 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 10.4;bone marrow: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 6 "basophil: 10.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.4" "Cell line enhanced" "Detected in some" "Karpas-707: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA055949 Uncertain NA NA "HPA055949: AB_2682982" 0.1 0.1 0.0 0.0 0.1 4.8 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 2.2 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.5 0.1 0.4 0.1 0.0 0.2 0.1 1.3 1.0 10.4 0.9 0.9 1.5 0.3 0.2 0.3 0.1 0.9 0.6 0.2 0.5 0.2 0.4 0.4 0.2 0.6 0.7 1.1 0.3 0.2 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.5 0.2 0.8 0.4 0.9 0.6 0.3 1.8 0.4 0.3 0.7 0.5 2.8 0.2 0.7 0.3 1.0 0.2 0.5 0.0 0.4 0.2 0.4 0.2 0.6 0.4 0.0 0.0 0.3 0.1 0.7 0.2 0.0 1.6 0.6 0.5 0.4 0.1 0.6 0.6 0.6 0.0 0.6 0.7 10.4 0.9 0.9 1.3 0.8 1.4 1.1 1.3 1.0 0.4 1.3 1.4 1.5 1.7 0.9 0.7 1.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6K6 ENSG00000180433 "Olfactory receptor family 6 subfamily K member 6" Q8NGW6 1 158754720-158755891 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "blood: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 57 "basophil: 5.7" "Lineage enriched" "Detected in single" 57 "granulocytes: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6M1 ENSG00000196099 "Olfactory receptor family 6 subfamily M member 1" Q8NGM8 11 123805335-123806387 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "pancreas: 3.1;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;SCLC-21H: 2.1" "Not detected" "Not detected" HPA048674 Uncertain NA NA "HPA048674: AB_2680489" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6N1 ENSG00000197403 "Olfactory receptor family 6 subfamily N member 1" Q8NGY5 1 158747814-158772195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 7.5;bone marrow: 4.4" "Cell type enriched" "Detected in single" 33 "Distal tubular cells: 3.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "basophil: 7.5" "Lineage enriched" "Detected in single" 75 "granulocytes: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6N2 ENSG00000188340 "Olfactory receptor family 6 subfamily N member 2" Q8NGY6 1 158774222-158781204 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "blood: 2.9;bone marrow: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "basophil: 2.9" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA056637 Uncertain NA NA "HPA056637: AB_2683198" 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6P1 ENSG00000186440 "Olfactory receptor family 6 subfamily P member 1" Q8NGX9 1 158560606-158570580 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047466 Uncertain NA NA "HPA047466: AB_10963091" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6S1 OR6S1Q ENSG00000181803 "Olfactory receptor family 6 subfamily S member 1" Q8NH40 14 20640696-20641691 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HDLM-2: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.62e-2)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.1 0.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6T1 ENSG00000181499 "Olfactory receptor family 6 subfamily T member 1" Q8NGN1 11 123942785-123943873 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "pancreas: 4.5;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "hTCEpi: 2.3" "Low region specificity" "Detected in some" HPA060893 Uncertain NA NA "HPA060893: AB_2684380" "unprognostic (9.30e-4)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6V1 GPR138 ENSG00000225781 "Olfactory receptor family 6 subfamily V member 1" Q8N148 7 143052320-143053347 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.24e-2)" 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6X1 ENSG00000221931 "Olfactory receptor family 6 subfamily X member 1" Q8NH79 11 123753488-123754545 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A17 HTPCRX19 ENSG00000185385 "Olfactory receptor family 7 subfamily A member 17" O14581 19 14878203-14886132 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1" "Group enriched" "Detected in some" 59 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 4.3;Club cells: 6.8;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" NA NA 0.2 0.3 0.2 0.9 0.2 1.5 0.2 0.2 0.6 1.0 0.2 0.0 0.2 1.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.5 0.2 0.0 0.2 0.0 0.2 0.3 0.2 0.0 0.4 1.6 0.2 0.0 0.2 0.4 0.2 0.2 0.9 0.0 0.4 0.2 1.4 1.0 3.1 0.7 1.0 0.7 0.2 1.4 0.6 0.7 1.6 0.5 0.4 0.5 0.6 0.8 0.6 0.7 0.5 2.4 0.1 0.5 0.5 0.2 1.0 1.2 0.2 0.7 0.4 1.0 0.5 1.9 0.5 0.0 1.0 0.5 0.5 0.6 0.7 0.2 1.0 0.3 0.3 1.1 1.9 1.4 0.3 0.7 1.1 0.6 0.0 0.3 0.3 0.6 0.4 0.3 1.1 0.7 0.7 0.2 0.1 0.4 0.5 0.7 0.1 0.9 1.8 0.4 1.1 0.3 0.5 0.4 0.4 0.6 0.6 0.1 2.3 0.7 0.7 0.7 0.5 0.4 0.8 0.5 0.3 0.2 1.4 0.5 0.7 3.1 1.0 0.5 1.0 0.4 0.2 8.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7A5 HTPCR2 ENSG00000188269 "Olfactory receptor family 7 subfamily A member 5" Q15622 19 14824251-14835285 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.4;pituitary gland: 33.6" "Cell type enhanced" "Detected in single" 25 "Spermatocytes: 1.2" "Cancer enriched" "Detected in single" 8 "melanoma: 2.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA053823 Uncertain NA NA "HPA053823: AB_2682274" "unprognostic (3.26e-4)" "unprognostic (1.44e-1)" "unprognostic (7.46e-2)" "unprognostic (6.19e-3)" "unprognostic (4.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (6.78e-2)" "unprognostic (2.01e-7)" "unprognostic (6.45e-2)" "unprognostic (9.64e-2)" "unprognostic (6.44e-2)" "unprognostic (2.47e-3)" 0.3 0.7 1.7 0.4 7.3 1.0 2.0 0.4 3.8 0.7 0.5 4.7 3.2 0.5 0.4 10.1 0.5 0.5 0.5 0.3 4.4 2.1 0.6 0.8 0.6 0.5 16.4 1.3 0.4 0.8 6.9 33.6 0.4 10.9 1.5 0.6 7.0 0.9 2.6 0.5 2.2 0.7 0.3 6.1 0.5 6.4 5.0 16.4 0.0 0.5 0.0 0.3 0.4 0.9 1.0 0.7 1.3 0.3 0.4 0.5 0.0 0.5 0.6 0.4 0.6 0.1 0.1 0.7 0.2 0.2 0.0 0.1 0.6 0.7 0.6 0.3 0.0 0.3 0.5 0.2 0.1 0.0 0.3 0.3 0.5 1.8 0.6 0.1 1.2 0.3 1.8 0.7 0.4 0.2 0.4 0.2 0.5 0.4 1.0 0.0 0.6 0.3 0.5 1.1 0.1 0.2 0.6 0.1 0.6 0.0 1.5 0.4 0.4 0.6 0.2 1.8 0.8 0.1 0.1 0.7 0.4 0.5 0.5 0.3 1.0 0.3 0.5 0.5 0.6 0.7 1.1 0.3 0.3 0.5 0.2 0.3 0.4 0.3 0.2 0.1 1.0 0.4 0.5 1.3 0.4 0.2 0.7 0.1 0.0 1.7 7.3 0.4 3.8 4.4 2.1 16.4 1.3 10.9 16.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 OR7C1 "OR19-5, OR7C4" ENSG00000127530 "Olfactory receptor family 7 subfamily C member 1" O76099 19 14789260-14835376 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.6;pituitary gland: 34.0" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 5.6;Ciliated cells: 2.7;Club cells: 4.5;Melanocytes: 1.7" "Cancer enriched" "Detected in single" 9 "melanoma: 1.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 4 "granulocytes: 4.8;monocytes: 1.5" "Low cell line specificity" "Detected in many" HPA047127 Uncertain NA NA "HPA047127: AB_2679944" "unprognostic (7.68e-4)" "unprognostic (1.31e-1)" "unprognostic (2.13e-1)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.39e-1)" "unprognostic (4.30e-2)" "unprognostic (6.11e-4)" "unprognostic (1.90e-1)" "unprognostic (6.80e-2)" "unprognostic (6.91e-2)" 0.5 3.3 1.4 0.7 7.4 1.9 1.5 0.5 3.9 0.7 0.5 4.7 3.2 0.7 0.5 5.9 0.5 0.5 0.6 0.5 3.2 0.9 0.6 0.6 0.5 0.8 16.6 1.4 0.5 0.5 7.3 34.0 0.5 11.0 3.0 0.4 7.1 1.1 2.9 3.6 3.1 0.7 0.3 3.8 0.7 0.6 6.3 16.6 0.0 1.0 0.0 0.4 0.5 1.0 0.7 0.5 4.8 1.5 0.5 0.4 0.2 0.8 1.1 0.8 2.2 0.7 0.5 1.1 0.5 0.3 0.6 0.8 1.2 1.8 1.4 1.5 0.6 0.8 1.0 0.3 0.6 0.8 0.7 0.6 1.0 2.2 0.7 0.6 0.9 1.4 0.8 0.3 0.5 0.5 1.0 0.3 1.1 0.7 3.1 0.3 0.5 0.7 1.5 1.1 0.5 1.0 0.8 0.4 0.6 0.7 1.3 1.7 1.0 0.6 0.7 1.0 1.0 0.6 1.6 0.9 1.0 2.2 1.1 0.7 1.3 0.8 1.0 1.0 0.8 0.7 2.9 0.9 1.7 0.3 0.8 0.3 0.4 0.3 0.2 0.4 0.7 0.3 0.4 4.8 0.5 1.5 0.5 0.2 0.2 1.4 7.4 0.5 3.9 3.2 0.9 16.6 1.4 11.0 16.6 0.0 5.6 0.0 0.6 0.0 0.0 0.0 0.0 2.7 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 OR7D2 "FLJ38149, HTPCRH03, OR19-4" ENSG00000188000 "Olfactory receptor family 7 subfamily D member 2" Q96RA2 19 9178979-9188817 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 4.4" "Cell type enriched" "Detected in single" 9 "Early spermatids: 4.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 6.0" NA NA "unprognostic (5.00e-4)" "unprognostic (2.03e-1)" "unprognostic (3.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.84e-1)" "unprognostic (2.86e-2)" "unprognostic (2.56e-2)" "unprognostic (3.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "unprognostic (5.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.63e-1)" "unprognostic (4.08e-2)" "unprognostic (4.92e-4)" 0.6 0.8 0.6 0.9 0.8 2.3 0.5 0.7 1.5 0.6 0.5 0.1 0.7 0.8 0.4 0.5 0.2 0.4 0.6 0.8 0.6 0.5 0.3 1.9 0.4 0.3 0.6 0.1 0.8 0.1 0.6 0.4 0.5 1.2 0.9 1.9 0.8 0.6 0.6 1.5 1.2 4.4 0.6 0.9 0.9 0.3 1.0 1.2 3.1 0.7 1.3 1.0 0.1 0.6 0.5 0.8 2.8 0.9 0.8 0.6 0.6 0.1 0.3 0.2 0.5 0.7 1.2 1.4 0.2 0.8 1.3 0.5 0.4 0.5 0.9 0.7 6.0 1.2 1.0 0.2 0.8 1.4 0.2 0.8 0.2 0.3 0.7 0.2 1.4 1.8 2.9 0.1 0.3 1.4 1.6 0.8 0.3 0.8 1.3 1.3 0.0 0.1 1.8 1.1 0.8 0.6 1.1 0.4 1.2 1.0 0.3 0.0 1.0 1.1 0.6 0.7 1.6 0.9 1.0 0.8 0.7 0.5 2.8 0.7 0.5 0.9 0.4 0.7 0.6 0.6 0.5 0.3 1.0 0.7 1.0 3.1 1.3 0.6 1.2 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 OR7D4 "hg105, OR19-B, OR7D4P" ENSG00000174667 "Olfactory receptor family 7 subfamily D member 4" Q8NG98 19 9210276-9219589 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.8;testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "HDLM-2: 2.6" NA NA "unprognostic (1.30e-1)" 0.1 0.2 0.1 0.3 0.1 2.0 0.2 0.2 0.7 0.4 0.2 0.2 0.2 0.6 0.4 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.2 0.2 0.3 0.2 0.0 0.5 1.1 0.5 0.0 0.1 0.6 0.2 2.1 0.3 0.4 0.2 0.2 0.7 0.7 3.8 0.4 0.9 0.4 0.0 0.3 0.2 0.7 1.2 0.4 0.1 0.8 0.2 0.0 0.4 0.0 0.5 0.3 1.0 0.3 0.1 0.5 1.1 0.6 0.1 0.3 2.6 1.1 0.8 1.4 0.9 0.1 0.8 1.3 0.4 0.1 0.5 0.2 0.6 0.0 0.6 0.5 1.4 0.0 0.9 1.0 0.6 0.9 0.1 0.1 0.7 0.6 0.2 0.2 0.6 0.6 0.4 0.7 0.4 0.5 0.6 0.9 0.3 1.2 0.9 0.5 1.0 0.4 1.1 0.3 0.6 0.5 0.6 0.9 3.8 0.4 0.3 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.4 0.3 2.3 0.9 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7E24 "HSHT2, OR19-8, OR7E24P, OR7E24Q" ENSG00000237521 "Olfactory receptor family 7 subfamily E member 24" Q6IFN5 19 9247344-9252625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 5.8" "Group enriched" "Detected in some" 32 "Early spermatids: 12.3;Late spermatids: 4.0" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR7G2 OST260 ENSG00000170923 "Olfactory receptor family 7 subfamily G member 2" Q8NG99 19 9100407-9107475 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" NA NA "unprognostic (2.04e-1)" 0.2 0.4 0.2 0.3 0.2 1.7 0.1 0.2 0.3 0.4 0.2 0.4 0.5 0.5 0.5 0.6 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.7 1.7 0.2 0.0 0.1 0.3 0.3 0.7 0.3 0.0 0.4 0.2 1.3 0.7 4.3 0.9 1.5 0.6 0.2 0.8 0.2 0.4 1.4 0.0 0.0 1.3 0.4 0.1 0.0 0.1 1.1 1.2 0.6 0.7 0.2 0.3 0.8 0.5 0.0 0.4 1.3 1.0 0.3 1.2 0.7 0.1 0.6 1.2 0.1 0.3 0.2 0.0 0.6 0.1 0.7 0.8 1.9 0.0 0.7 0.5 0.8 0.9 0.1 0.6 0.5 0.5 0.9 0.0 0.7 0.8 0.4 0.9 0.7 0.7 0.3 1.0 0.8 0.0 1.3 0.6 1.4 0.9 1.1 1.3 0.5 0.5 1.0 0.9 3.4 0.9 0.7 0.6 0.5 0.5 0.9 0.5 0.3 0.2 1.3 0.6 0.6 4.3 1.5 0.4 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR7G3 OST085 ENSG00000170920 "Olfactory receptor family 7 subfamily G member 3" Q8NG95 19 9126012-9126950 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "fallopian tube: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B12 ENSG00000170953 "Olfactory receptor family 8 subfamily B member 12" Q8NGG6 11 124539635-124545333 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.1" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8B2 ENSG00000284680 "Olfactory receptor family 8 subfamily B member 2" Q96RD0 11 124382394-124384462 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 52 "testis: 5.2" "Group enriched" "Detected in some" 48 "Early spermatids: 32.9;Late spermatids: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR8B3 ENSG00000284609 "Olfactory receptor family 8 subfamily B member 3" Q8NGG8 11 124395534-124399024 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 28 "testis: 2.7" "Group enriched" "Detected in some" 21 "Early spermatids: 9.7;Late spermatids: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BJ hTERT+ SV40 Large T+ RasG12V: 1.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 OR8B8 TPCR85 ENSG00000197125 "Olfactory receptor family 8 subfamily B member 8" Q15620 11 124437445-124445696 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.4" NA NA 0.2 0.3 0.2 0.7 0.2 1.3 0.2 0.4 0.7 0.4 0.2 1.2 0.4 0.0 0.3 0.4 0.4 0.9 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.7 0.7 0.0 0.2 0.3 0.2 0.0 0.7 0.0 0.2 2.0 0.6 0.0 0.2 0.8 1.1 0.4 0.6 0.0 0.5 0.2 1.2 1.1 2.6 1.6 0.8 0.9 0.5 0.7 0.5 0.7 1.7 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.1 1.4 0.4 0.8 0.0 0.8 1.3 0.0 0.0 0.0 0.5 0.6 0.9 0.7 0.3 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.9 2.2 1.8 0.0 1.3 0.7 0.8 0.4 0.8 0.6 0.9 0.5 1.1 0.0 0.4 0.9 1.6 0.8 1.5 0.7 0.9 2.9 0.9 1.9 1.3 0.9 0.8 0.5 3.0 0.7 1.2 0.9 1.7 1.4 2.6 1.6 1.2 0.8 1.0 0.6 1.0 0.8 0.7 1.1 1.2 0.9 0.8 2.2 0.8 0.6 0.8 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D1 "OR8D3, OST004" ENSG00000196341 "Olfactory receptor family 8 subfamily D member 1" Q8WZ84 11 124302831-124315099 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.2;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.3;K-562: 1.8;PC-3: 1.5" "Not detected" "Not detected" HPA059510 Uncertain NA NA "HPA059510: AB_2684045" 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.1 0.0 0.1 0.2 1.2 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.3 0.2 0.0 0.4 1.8 0.7 0.0 0.9 0.1 0.0 0.2 0.1 1.5 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.6 0.8 0.1 0.6 0.2 0.0 0.0 0.0 1.2 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D2 ENSG00000279116 "Olfactory receptor family 8 subfamily D member 2 (gene/pseudogene)" Q9GZM6 11 124319238-124320288 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "K-562: 1.3" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8D4 ENSG00000181518 "Olfactory receptor family 8 subfamily D member 4" Q8NGM9 11 123902167-123909229 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8;pancreas: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "U-138 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.1 1.0 0.3 0.0 0.3 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 2.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.3 0.0 0.6 0.6 1.8 0.5 0.9 0.5 0.3 0.0 0.0 0.4 0.6 0.0 0.7 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.6 0.2 0.3 0.0 0.6 0.0 0.2 0.3 0.2 0.0 0.4 0.1 0.3 0.0 0.9 0.1 0.0 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.1 0.0 0.3 0.0 0.8 0.1 0.0 0.0 1.2 0.1 0.2 0.4 0.2 0.0 0.0 0.2 0.6 0.2 1.6 0.5 0.6 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.6 0.4 0.5 1.8 0.9 0.4 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8G1 "HSTPCR25, OR8G1P, TPCR25" ENSG00000197849 "Olfactory receptor family 8 subfamily G member 1 (gene/pseudogene)" Q15617 11 124241095-124254364 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 23 "testis: 18.2" "Group enriched" "Detected in some" 21 "Early spermatids: 2.7;Late spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.3 18.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.5 0.3 0.7 0.4 0.1 0.3 0.0 0.3 0.1 0.7 0.2 0.0 0.6 1.2 0.4 0.4 0.7 0.1 0.0 0.7 0.7 0.2 0.0 0.1 0.6 0.3 0.4 0.2 0.2 0.4 0.5 0.6 0.5 0.1 1.3 0.5 0.1 0.2 0.4 0.4 0.3 0.1 0.8 1.0 0.7 0.1 1.2 0.5 0.5 0.6 0.3 0.4 0.2 0.3 0.1 0.1 0.3 0.9 0.4 0.1 0.3 0.0 0.5 0.4 0.5 0.8 0.3 0.2 0.7 0.2 0.4 0.6 0.3 0.2 0.3 0.4 0.3 0.4 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 OR8G5 "OR8G5P, OR8G6" ENSG00000255298 "Olfactory receptor family 8 subfamily G member 5" Q8NG78 11 124256376-124266218 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 5.2;lung: 4.0;testis: 7.8" "Group enriched" "Detected in some" 23 "Early spermatids: 12.8;Late spermatids: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 5.1;PC-3: 3.2;T-47d: 5.4" NA NA "unprognostic (1.48e-1)" 5.2 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.1 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 17.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 OR8H1 ENSG00000181693 "Olfactory receptor family 8 subfamily H member 1" Q8NGG4 11 56288462-56292254 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.2;NTERA-2: 1.0" NA NA 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.6 0.1 0.9 0.8 2.6 0.7 1.2 1.5 0.2 1.2 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.7 0.4 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.5 0.0 0.5 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.4 0.0 0.0 0.2 0.0 0.6 1.0 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.3 0.6 0.0 0.0 0.2 0.8 0.2 0.2 0.0 0.1 0.3 0.0 0.2 0.7 0.4 0.0 0.4 0.1 0.0 1.7 0.7 0.6 1.5 0.4 0.7 0.6 1.1 0.7 0.4 0.9 1.0 1.0 2.6 1.2 0.7 0.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8H2 ENSG00000181767 "Olfactory receptor family 8 subfamily H member 2" Q8N162 11 56103687-56107658 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.1;bone marrow: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 3.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 3.1" "Not detected" "Not detected" NA NA 0.3 0.1 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.5 0.1 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.7 0.1 0.2 0.1 3.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.4 0.5 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.1 3.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR8S1 ENSG00000284723 "Olfactory receptor family 8 subfamily S member 1" Q8NH09 12 48525632-48528103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "intestine: 1.2;ovary: 1.0" "Cell type enriched" "Detected in single" 7 "Spermatocytes: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CAPAN-2: 1.6" "Not detected" "Not detected" HPA045595 Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA045595: AB_10964447" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 OR9A2 ENSG00000179468 "Olfactory receptor family 9 subfamily A member 2" Q8NGT5 7 143026158-143027195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9A4 ENSG00000258083 "Olfactory receptor family 9 subfamily A member 4" Q8NGU2 7 141916399-141920625 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.9;epididymis: 1.0;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-937: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.77e-1)" 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 0.1 0.2 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.4 0.1 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9G4 ENSG00000172457 "Olfactory receptor family 9 subfamily G member 4" Q8NGQ1 11 56741223-56748697 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9Q1 ENSG00000186509 "Olfactory receptor family 9 subfamily Q member 1" Q8NGQ5 11 58023881-58181616 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "skeletal muscle: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.65e-3)" "unprognostic (2.27e-1)" 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.4 0.3 0.7 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.2 0.5 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.8 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9Q2 OR9Q2P ENSG00000186513 "Olfactory receptor family 9 subfamily Q member 2" Q8NGE9 11 58189070-58194053 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ORAI1 "CRACM1, FLJ14466, TMEM142A" ENSG00000276045 "ORAI calcium release-activated calcium modulator 1" Q96D31 12 121626550-121642677 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 26.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016583, HPA061823" Approved Enhanced Cytosol NA NA Cytosol "HPA016583: AB_1848720, HPA061823: AB_2684619" "unprognostic (2.22e-2)" "unprognostic (3.78e-3)" "unprognostic (7.82e-3)" "unprognostic (8.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.99e-3)" "unprognostic (4.25e-3)" "unprognostic (1.92e-1)" "unprognostic (2.00e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "unprognostic (6.84e-2)" "unprognostic (1.95e-1)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (1.57e-2)" 4.3 1.3 0.0 6.2 1.1 3.7 7.1 0.0 1.3 2.1 9.8 1.7 5.0 10.6 2.3 2.2 3.4 1.7 4.8 3.5 0.4 4.9 9.6 7.5 14.1 2.5 0.6 4.8 5.9 1.4 0.0 4.6 5.6 3.3 0.1 10.6 6.8 3.0 26.0 17.0 14.0 4.4 0.9 11.4 3.9 6.8 0.9 8.1 6.5 7.0 9.1 3.8 2.3 6.9 5.6 6.3 4.3 4.9 14.4 5.1 6.1 13.1 1.4 6.0 1.5 2.0 6.7 7.4 1.2 3.4 2.2 11.3 5.0 4.4 12.3 1.4 5.1 11.3 1.1 5.1 0.0 14.8 3.1 8.0 2.2 4.9 4.2 5.0 15.0 0.6 2.1 5.1 0.2 1.9 5.5 13.3 6.4 1.0 1.0 13.6 14.3 35.2 6.2 4.5 15.6 6.5 2.3 7.1 2.5 3.4 5.4 0.8 2.8 3.8 5.5 0.1 8.7 1.9 6.5 7.8 3.5 9.2 5.6 3.8 2.5 1.8 5.2 8.8 5.8 6.3 4.2 5.7 14.1 4.3 10.9 4.4 11.5 14.4 5.6 6.9 11.2 9.8 5.2 4.9 3.7 1.4 10.0 5.1 26.8 16.0 20.4 7.7 20.0 1.9 3.7 22.9 8.1 15.9 1.8 3.9 2.0 1.7 10.9 2.7 38.3 8.6 23.3 17.0 12.5 10.4 5.4 6.9 14.3 32.8 0.0 2.4 32.5 19.7 9.7 12.4 33.8 20.3 19.8 7.1 4.5 23.1 7.0 8.9 9.0 6.5 0.0 8.2 1.2 3.2 32.6 6.5 41.5 16.4 7.5 ORC1 "HSORC1, ORC1L, PARC1" ENSG00000085840 "Origin recognition complex subunit 1" Q13415 1 52372829-52404459 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.9;lymphoid tissue: 29.1" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.6;Extravillous trophoblasts: 8.3;Spermatogonia: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027439, HPA027450" Approved Supported Nucleoplasm NA Yes Nucleoplasm "HPA027439: , HPA027450: AB_10602041" "unprognostic (3.28e-1)" "unprognostic (4.42e-3)" "prognostic favorable (1.74e-5)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (3.22e-5)" "unprognostic (3.77e-3)" "prognostic unfavorable (3.69e-4)" "unprognostic (3.86e-2)" "unprognostic (2.70e-3)" "unprognostic (8.39e-2)" "unprognostic (1.25e-10)" "unprognostic (4.56e-3)" "unprognostic (1.05e-1)" "unprognostic (2.45e-1)" "unprognostic (1.57e-2)" 0.9 1.2 0.2 9.9 0.4 22.9 0.8 1.4 1.1 1.1 3.4 0.4 0.1 1.4 0.6 1.5 5.3 0.5 0.8 0.9 0.3 0.4 1.0 1.1 1.4 5.7 0.3 0.4 1.0 0.7 0.2 0.9 1.6 0.9 0.8 3.8 0.5 1.4 0.8 0.9 2.0 3.0 0.7 0.4 4.2 1.2 8.7 0.5 29.1 0.5 8.0 11.3 1.0 1.7 1.0 1.3 0.7 0.4 7.5 2.3 0.7 7.4 8.2 13.3 8.7 0.3 1.1 12.8 5.3 4.9 15.8 16.4 10.1 4.2 17.2 4.7 3.3 7.2 10.3 19.5 6.7 13.8 7.3 11.2 20.6 12.2 10.0 0.0 27.6 11.8 0.6 0.3 15.4 1.7 1.1 4.6 10.9 23.9 8.4 5.1 5.5 21.6 13.1 29.4 4.5 11.8 23.3 20.7 16.8 2.7 9.8 7.5 6.3 12.3 7.5 4.2 13.0 4.1 11.1 2.1 6.4 9.3 10.0 13.2 4.4 11.7 21.3 6.3 20.6 7.8 0.1 0.2 0.0 0.5 0.3 0.6 0.4 0.8 0.8 1.3 1.0 0.3 0.7 0.7 7.5 0.4 0.1 2.3 0.7 0.2 0.4 1.4 1.1 0.3 0.4 0.3 0.4 0.9 0.5 0.0 0.0 0.8 0.2 0.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.2 4.6 0.1 0.0 0.0 0.2 8.3 0.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.8 0.6 0.2 0.0 0.0 0.7 0.2 0.1 0.0 0.4 3.3 0.9 0.0 0.1 3.2 7.3 1.0 1.5 0.5 1.9 0.1 ORC6 ORC6L ENSG00000091651 "Origin recognition complex subunit 6" Q9Y5N6 16 46689643-46698394 "Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 84.9;Spermatogonia: 102.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016330, HPA072587" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No Nucleoplasm "Nucleoli fibrillar center" "CAB016330: AB_670295, HPA072587: AB_2686537" "unprognostic (3.47e-2)" "unprognostic (8.99e-3)" "unprognostic (2.92e-1)" "unprognostic (4.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-2)" "unprognostic (3.15e-6)" "unprognostic (1.36e-2)" "prognostic unfavorable (3.53e-4)" "prognostic favorable (1.48e-4)" "unprognostic (1.50e-4)" "unprognostic (3.97e-2)" "unprognostic (3.90e-14)" "unprognostic (2.08e-1)" "unprognostic (4.24e-1)" "unprognostic (2.79e-1)" "unprognostic (5.98e-2)" 0.8 1.4 4.1 8.9 7.0 14.2 1.1 3.8 6.1 1.3 2.8 1.2 1.4 2.7 1.5 1.9 6.7 0.9 1.2 2.3 4.4 3.5 0.8 1.6 1.5 10.6 3.1 4.5 0.9 0.6 0.3 1.2 5.2 2.4 0.8 3.1 0.5 1.4 0.6 0.4 1.9 2.7 1.7 2.9 4.1 1.5 23.1 1.4 12.8 0.9 4.2 10.7 2.6 2.0 4.1 3.4 1.0 2.6 2.8 4.1 2.5 10.9 10.1 16.2 12.6 2.0 2.5 12.0 19.6 7.3 21.7 11.4 14.2 6.7 12.7 10.3 3.7 11.0 11.2 20.8 5.4 18.4 6.5 16.8 10.5 5.4 14.3 2.5 17.2 11.1 0.7 1.0 11.8 6.2 3.5 7.1 11.1 12.7 6.5 13.1 9.6 23.1 21.6 17.9 7.6 27.9 27.9 29.8 12.9 5.3 3.8 19.4 11.5 10.0 11.1 6.8 13.5 5.9 13.7 4.3 20.0 13.6 12.6 18.4 5.0 6.7 44.4 8.5 11.3 15.4 0.0 1.1 1.0 3.5 2.6 1.4 2.7 2.0 2.0 2.2 4.1 2.9 1.4 0.5 2.8 2.5 3.4 4.1 2.5 4.1 7.0 3.8 6.1 4.4 3.5 3.1 4.5 2.4 1.4 3.0 16.4 15.2 2.4 6.0 6.1 3.3 2.5 17.4 9.1 5.2 3.9 22.0 1.7 2.6 9.4 3.0 2.1 0.0 0.6 30.9 9.9 1.7 1.1 8.3 13.2 11.1 1.7 0.0 3.3 6.2 2.6 6.1 32.1 0.0 5.6 2.5 1.6 0.0 3.2 0.7 8.4 0.0 2.2 84.9 102.2 5.3 9.2 4.4 10.3 1.7 ORM1 ENSG00000229314 "Orosomucoid 1" P02763 9 114323056-114326475 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 834.6" "Cell type enriched" "Detected in some" 35 "Hepatocytes: 50531.7" "Cancer enriched" "Detected in many" 16 "liver cancer: 2506.9" "Cell type enriched" "Detected in some" 45 "neutrophil: 53.4" "Lineage enriched" "Detected in many" 45 "granulocytes: 53.4" "Cell line enriched" "Detected in some" 11 "Hep G2: 161.7" "CAB006265, HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 945000000000 120000000000 Vesicles "Golgi apparatus" "CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (3.85e-1)" "unprognostic (2.12e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (3.22e-2)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (1.16e-1)" "unprognostic (4.85e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.35e-4)" "unprognostic (2.10e-1)" "unprognostic (4.38e-2)" "unprognostic (9.32e-3)" "unprognostic (4.51e-2)" 0.1 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 834.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 161.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 14.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 0.0 0.2 0.0 0.0 0.3 3.0 14.9 263.0 0.0 0.0 0.0 0.0 1452.2 0.0 1.2 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 794.3 4.5 0.1 0.0 31.6 0.0 50531.7 0.1 0.0 0.0 844.6 848.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.3 ORM2 "AGP-B, AGP-B', AGP2" ENSG00000228278 "Orosomucoid 2" P19652 9 114329869-114333252 "Plasma proteins, Predicted secreted proteins" "Acute phase, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 404.1" "Cell type enriched" "Detected in some" 43 "Hepatocytes: 9578.7" "Cancer enriched" "Detected in many" 34 "liver cancer: 873.1" "Cell type enriched" "Detected in single" 35 "neutrophil: 13.2" "Lineage enriched" "Detected in single" 35 "granulocytes: 13.2" "Cell line enriched" "Detected in single" 237 "Hep G2: 136.6" "HPA046438, HPA047725, HPA057726" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 422000000 61000000000 Vesicles "Golgi apparatus" "HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512" "unprognostic (6.77e-2)" "unprognostic (8.00e-2)" "unprognostic (1.19e-1)" "unprognostic (4.44e-3)" "unprognostic (1.18e-1)" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (9.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (1.23e-9)" "unprognostic (3.23e-1)" "unprognostic (6.80e-2)" "unprognostic (7.62e-2)" "unprognostic (9.15e-4)" 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 404.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 136.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.0 0.1 0.0 8.0 42.8 0.0 0.0 0.0 0.0 224.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.5 0.0 0.0 70.0 5.4 0.0 0.0 2.1 0.0 9578.7 0.0 0.0 0.0 141.2 136.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSBP2 "KIAA1664, ORP-4, ORP4, OSBPL1" ENSG00000184792 "Oxysterol binding protein 2" Q969R2 22 30693782-30907824 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.1;retina: 45.7" "Cell type enhanced" "Detected in many" 24 "Early spermatids: 112.6;Late spermatids: 239.9;Rod photoreceptor cells: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.6;HeLa: 55.9;hTERT-HME1: 15.0;SiHa: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021514 Uncertain Approved Cytosol NA NA Cytosol "HPA021514: AB_1854813" "unprognostic (2.89e-1)" "unprognostic (2.04e-1)" "unprognostic (2.83e-1)" "unprognostic (6.94e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (1.38e-5)" "unprognostic (3.01e-1)" "unprognostic (2.57e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (2.31e-1)" "prognostic favorable (3.79e-6)" "unprognostic (9.00e-2)" "unprognostic (2.68e-1)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" 1.0 8.5 5.7 2.3 11.6 36.1 1.2 17.0 14.4 1.4 1.6 8.5 1.3 6.3 1.9 13.0 3.3 2.0 2.7 10.0 7.7 5.6 2.1 0.7 1.8 1.9 7.1 6.2 1.7 4.9 8.8 14.1 4.0 7.3 2.2 1.7 45.7 2.5 2.4 2.3 4.6 4.6 1.2 6.4 3.4 3.2 19.6 5.5 0.0 2.9 0.3 1.3 4.3 2.2 1.9 1.6 2.5 3.1 2.7 3.2 6.2 2.6 5.8 0.5 2.5 0.4 2.3 0.6 0.5 1.2 1.8 1.9 5.2 1.4 4.6 2.2 0.7 0.6 1.5 2.3 0.2 1.3 2.5 0.7 15.6 55.9 1.0 0.3 0.1 0.9 0.1 6.5 4.6 15.0 0.6 4.6 1.8 9.7 0.2 4.2 2.9 0.4 1.6 1.4 1.2 5.4 1.3 0.2 0.2 0.2 1.0 6.5 2.7 14.9 1.6 0.1 1.2 1.8 0.8 3.3 1.3 7.0 1.2 2.6 1.2 1.7 0.8 5.2 0.0 1.0 0.6 1.8 1.1 1.5 3.1 3.1 1.7 2.9 1.4 1.6 1.9 3.0 3.2 2.5 2.7 2.3 0.7 1.9 6.2 5.7 11.6 17.0 14.4 7.7 5.6 7.1 6.2 7.3 5.5 0.0 1.9 0.0 1.0 4.6 89.3 8.5 0.0 1.4 1.2 1.8 76.6 0.2 1.7 1.4 112.6 1.8 0.4 23.3 1.3 0.2 2.5 1.0 0.0 0.0 0.2 17.5 6.9 0.0 0.0 239.9 2.3 0.2 1.7 0.0 2.3 23.7 0.7 5.8 1.8 0.4 571.4 0.0 1.2 16.2 3.4 8.3 0.2 0.0 1.3 1.6 OSBPL10 ENSG00000144645 "Oxysterol binding protein like 10" Q9BXB5 3 31657890-32077580 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 39.6" "Group enriched" "Detected in many" 13 "Early spermatids: 436.6;Late spermatids: 951.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "memory B-cell: 11.5;naive B-cell: 6.6" "Lineage enriched" "Detected in single" 22 "B-cells: 11.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 31.5;RPTEC TERT1: 33.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003636 Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Golgi apparatus, Plasma membrane, Cytosol" "HPA003636: AB_1079529" "unprognostic (5.28e-3)" "unprognostic (2.06e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.98e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (8.55e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.15e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.85e-4)" 11.7 3.5 3.8 8.7 4.3 1.0 6.7 1.4 7.6 8.6 5.6 0.4 5.9 2.5 11.8 6.7 10.0 5.5 16.7 2.9 2.6 2.6 14.5 1.6 4.6 8.2 3.1 3.6 4.1 2.5 1.3 12.0 16.5 2.5 12.8 6.0 8.5 7.3 16.6 2.0 5.5 7.3 39.6 1.2 9.5 4.4 24.0 1.2 0.4 4.3 4.3 15.1 25.2 11.8 11.5 0.1 0.5 0.0 0.0 0.0 0.2 6.2 3.5 0.6 12.5 1.1 2.3 20.9 1.7 1.9 1.6 2.3 8.7 4.5 14.7 16.8 0.4 5.7 3.7 2.7 14.7 1.9 0.1 2.7 0.0 8.7 5.5 0.9 0.0 0.1 2.4 12.4 2.5 31.5 6.1 7.2 0.0 0.0 0.0 6.8 5.1 0.0 0.0 7.9 20.0 9.0 0.1 0.2 0.2 33.2 2.5 0.9 0.1 3.1 5.4 1.7 12.3 3.6 0.0 5.1 2.0 21.5 0.2 8.2 1.4 1.0 14.0 2.9 0.0 12.7 0.2 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 6.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 3.8 4.3 1.4 7.6 2.6 2.6 3.1 3.6 2.5 1.2 8.9 3.8 36.5 6.8 9.6 4.8 2.0 5.1 6.7 4.5 7.0 0.0 12.6 8.3 1.9 436.6 17.1 5.7 0.0 4.4 21.8 5.4 16.4 0.0 0.0 2.2 0.0 14.5 20.9 1.2 951.1 10.3 0.9 8.5 1.8 3.5 52.0 10.6 4.5 3.9 20.7 1.7 19.4 9.4 6.5 4.1 10.8 25.3 2.9 7.4 8.6 OSBPL11 "FLJ13012, FLJ13164, ORP-11, ORP11" ENSG00000144909 "Oxysterol binding protein like 11" Q9BXB4 3 125528858-125595090 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.9" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039144 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA039144: AB_10794086" "unprognostic (1.14e-1)" "unprognostic (1.31e-3)" "unprognostic (2.57e-3)" "unprognostic (9.73e-3)" "unprognostic (6.38e-2)" "unprognostic (6.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.43e-1)" "unprognostic (6.68e-2)" "unprognostic (1.42e-1)" "unprognostic (9.25e-2)" "unprognostic (9.84e-2)" "unprognostic (6.43e-2)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (3.58e-2)" "unprognostic (1.13e-1)" 8.1 5.1 12.6 8.1 16.9 4.7 13.2 5.7 9.7 5.4 7.2 14.1 4.9 5.1 6.1 6.1 6.8 5.0 5.2 5.3 11.0 7.7 6.8 22.4 10.9 11.1 11.2 8.3 4.5 3.8 8.5 5.1 9.0 8.7 4.6 6.6 4.6 5.1 9.7 48.9 6.3 6.0 7.0 10.3 11.4 5.2 7.8 10.9 8.3 5.9 6.0 9.4 6.3 5.3 3.5 11.8 12.8 9.5 1.9 2.2 3.2 13.1 7.1 13.6 7.7 15.5 8.3 17.8 9.9 8.0 12.6 14.5 13.7 4.7 21.7 12.4 8.2 10.4 9.9 15.1 8.7 16.9 5.8 6.5 9.9 8.6 9.1 8.7 7.4 13.6 6.7 10.7 10.5 9.2 5.1 9.1 10.5 10.2 9.9 11.4 7.8 14.7 3.6 18.7 9.7 6.4 13.0 7.9 25.3 10.5 8.2 3.0 8.1 12.2 7.0 10.5 9.8 7.3 3.9 9.4 10.1 9.1 14.6 7.7 6.3 6.6 26.6 7.1 2.6 9.7 10.8 9.3 2.4 1.8 9.5 1.5 3.5 1.0 1.8 11.8 2.7 1.2 1.4 12.8 1.9 7.8 4.5 2.2 3.2 12.6 16.9 5.7 8.4 11.0 7.7 11.2 8.3 8.7 10.9 8.9 11.8 18.6 7.4 8.9 18.9 7.9 5.1 9.4 12.5 8.7 11.8 10.0 5.0 8.2 0.8 9.2 12.6 0.0 6.1 9.0 7.4 5.3 3.5 31.6 22.8 7.9 4.1 11.6 56.9 2.5 6.1 35.7 11.8 13.6 5.2 11.2 8.5 11.9 6.7 8.0 32.0 6.5 8.1 9.1 20.4 13.8 19.3 8.4 6.2 9.6 OSBPL1A "ORP-1, ORP1, OSBPL1B" ENSG00000141447 "Oxysterol binding protein like 1A" Q9BXW6 18 24162044-24397880 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 18 "basophil: 33.7" "Lineage enriched" "Detected in many" 18 "granulocytes: 33.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040959, HPA043401" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA040959: AB_10964295, HPA043401: AB_10960208" "unprognostic (1.75e-2)" "unprognostic (3.35e-2)" "unprognostic (9.84e-3)" "unprognostic (4.92e-3)" "unprognostic (2.34e-1)" "unprognostic (3.06e-2)" "unprognostic (5.82e-2)" "unprognostic (2.06e-1)" "unprognostic (5.88e-2)" "unprognostic (2.62e-2)" "unprognostic (2.41e-1)" "unprognostic (8.53e-2)" "prognostic favorable (4.98e-13)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.18e-2)" "unprognostic (5.42e-3)" "unprognostic (1.56e-1)" 32.3 14.3 33.3 5.9 28.9 7.0 23.8 6.2 43.1 27.7 13.8 33.9 6.2 10.2 24.4 9.0 15.5 15.2 10.6 24.7 37.6 22.6 21.7 6.6 11.9 5.0 40.6 27.7 14.3 8.3 21.0 8.8 4.2 29.9 12.0 11.5 16.6 23.3 13.9 73.2 8.7 9.8 20.4 49.0 4.8 9.7 6.9 29.0 1.0 14.6 9.9 4.1 12.0 29.7 0.2 1.8 33.7 1.8 0.1 0.4 0.6 15.3 4.6 11.0 20.5 25.8 21.1 10.3 5.7 16.7 5.2 4.3 2.9 16.1 0.0 6.8 10.2 8.3 15.7 4.3 10.0 4.8 0.0 8.1 4.8 3.3 0.0 12.9 12.1 2.5 27.3 14.5 3.9 16.3 22.9 6.5 4.3 0.0 0.1 6.4 6.5 2.7 3.6 9.0 7.9 15.3 0.0 8.8 1.3 1.4 11.3 7.2 7.0 13.4 15.7 18.3 10.8 5.7 8.7 1.4 19.5 4.1 6.2 5.5 0.1 2.1 0.4 9.4 3.5 11.1 33.7 1.8 0.4 0.1 0.9 0.0 0.0 0.4 0.2 1.7 0.2 0.2 0.2 0.7 0.1 0.3 1.8 0.3 0.6 33.3 28.9 6.2 43.1 37.6 22.6 40.6 27.7 29.9 29.0 14.9 16.3 3.2 36.9 17.9 60.0 66.8 28.1 24.1 23.9 19.2 21.6 9.0 54.7 10.3 58.6 58.9 23.8 0.0 6.7 7.0 27.8 29.4 17.3 10.4 24.0 23.8 4.6 33.7 16.4 59.6 39.7 21.9 55.6 1.8 32.2 86.9 8.0 14.8 51.6 55.2 92.0 32.3 45.3 6.7 10.6 8.9 5.4 4.3 8.6 23.1 OSBPL6 ORP6 ENSG00000079156 "Oxysterol binding protein like 6" Q9BZF3 2 178194481-178402891 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 33.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 59.0;Ciliated cells: 133.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Group enriched" "Detected in many" 8 "granulocytes: 2.2;T-cells: 1.4" "Cell line enhanced" "Detected in many" "HEL: 25.0;hTERT-HME1: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032131 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA032131: AB_10670963" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "unprognostic (2.47e-1)" "unprognostic (5.95e-3)" "unprognostic (5.26e-2)" "unprognostic (1.40e-2)" "unprognostic (7.55e-2)" "unprognostic (4.81e-2)" "unprognostic (3.32e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.49e-2)" "unprognostic (1.15e-5)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (3.73e-4)" "unprognostic (4.44e-6)" 2.4 2.8 9.2 1.9 10.5 0.8 3.2 10.2 18.4 1.9 1.7 3.2 0.2 1.6 1.8 1.7 4.1 2.1 2.2 5.9 7.5 6.3 4.5 8.7 6.3 2.0 4.9 8.0 2.8 2.3 1.2 15.1 1.4 11.3 5.3 2.1 2.5 2.9 2.9 33.4 11.6 5.6 2.6 4.3 2.0 1.7 2.4 4.3 0.0 4.1 6.3 1.7 1.5 2.3 0.2 0.1 2.2 0.0 0.2 1.4 0.6 0.0 0.5 4.4 8.9 3.7 4.1 3.4 7.2 3.8 6.4 7.9 0.7 0.1 0.0 0.3 6.6 3.5 0.1 10.3 5.9 10.9 0.1 5.3 25.0 1.6 0.0 2.4 4.0 0.1 2.7 9.4 14.1 27.4 2.3 3.0 3.2 0.4 3.1 8.4 3.5 0.0 0.0 5.3 0.0 5.3 0.0 9.0 1.6 0.4 0.0 3.4 2.0 3.2 0.9 7.1 5.1 1.2 0.0 5.9 7.4 4.6 4.9 8.4 17.0 6.6 0.0 8.8 0.0 3.4 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.8 0.0 0.2 1.4 0.1 2.2 0.2 0.0 0.1 0.0 0.6 9.2 10.5 10.2 18.4 7.5 6.3 4.9 8.0 11.3 4.3 0.0 4.5 0.0 2.3 11.7 59.0 12.9 7.6 133.8 11.4 0.0 23.6 0.2 1.7 0.6 0.7 1.8 0.3 0.0 0.7 2.5 1.1 1.8 6.9 4.3 2.9 1.6 1.7 0.0 2.2 0.9 0.0 0.9 5.0 0.0 3.8 11.5 0.3 0.0 1.4 5.3 6.6 0.0 5.3 0.0 0.1 18.2 0.1 0.0 0.1 0.5 OSBPL7 "MGC71150, ORP7" ENSG00000006025 "Oxysterol binding protein like 7" Q9BZF2 17 47807372-47821834 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 37.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 25.9;Mucus-secreting cells: 23.6;Paneth cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036076, HPA053083, HPA073967" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: " "unprognostic (3.88e-2)" "unprognostic (2.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (6.55e-3)" "unprognostic (2.05e-3)" "unprognostic (1.19e-1)" "unprognostic (3.95e-2)" "unprognostic (3.33e-1)" "unprognostic (1.97e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (8.30e-4)" "unprognostic (2.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.08e-1)" "prognostic favorable (1.19e-5)" 4.1 3.4 9.0 9.6 13.4 7.3 3.9 10.7 11.9 6.8 16.8 12.0 7.5 24.6 6.7 3.7 2.8 6.1 10.5 4.6 9.7 7.3 7.2 1.4 6.3 7.9 13.9 9.8 7.4 11.4 5.3 7.8 3.2 10.3 10.1 10.3 7.7 8.8 10.1 20.2 1.9 32.2 6.2 6.6 12.3 37.9 1.4 16.4 7.9 8.4 2.9 8.1 6.8 5.2 2.6 2.9 1.7 1.4 1.1 5.5 2.1 3.8 4.6 2.0 2.3 2.2 3.2 1.7 1.5 2.1 2.5 2.9 4.6 11.8 3.9 5.8 2.1 0.9 28.9 1.1 3.1 0.8 13.1 1.6 2.9 8.6 3.0 2.0 6.0 0.1 5.0 0.6 1.6 1.1 7.9 5.1 6.9 2.8 5.4 3.9 5.0 6.0 6.4 1.2 15.5 5.8 5.6 3.1 5.4 3.4 3.0 2.0 4.8 2.4 0.8 2.2 2.6 4.2 3.9 5.9 3.9 3.4 0.0 1.2 9.9 3.6 3.8 4.2 5.1 1.4 0.0 1.4 1.7 5.5 1.0 2.3 2.6 2.2 3.1 1.7 1.4 1.6 2.3 0.9 1.1 0.0 2.9 2.7 2.1 9.0 13.4 10.7 11.9 9.7 7.3 13.9 9.8 10.3 16.4 0.0 3.8 4.5 1.0 0.1 5.7 2.8 2.5 1.4 7.9 3.5 5.9 0.2 0.0 2.4 0.0 3.7 25.9 0.0 13.3 0.1 1.5 2.4 2.3 0.4 2.3 11.1 5.8 5.5 2.8 0.0 2.6 0.8 1.7 1.0 23.6 7.7 6.3 26.8 2.5 0.8 7.7 0.0 1.0 0.0 0.2 0.1 0.5 7.2 13.6 0.5 OSCAR ENSG00000170909 "Osteoclast associated, immunoglobulin-like receptor" Q8IYS5 19 54094668-54102692 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 34 "classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2" "Group enriched" "Detected in many" 75 "dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6" "Cell line enhanced" "Detected in some" "EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA073996 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 72000000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA073996: " "unprognostic (9.09e-2)" "unprognostic (6.79e-3)" "unprognostic (8.47e-3)" "unprognostic (2.14e-1)" "unprognostic (2.12e-2)" "unprognostic (9.04e-2)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.05e-2)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.71e-5)" "unprognostic (1.84e-1)" "unprognostic (2.88e-2)" "unprognostic (9.69e-2)" "unprognostic (4.28e-2)" 4.5 1.0 1.4 3.8 2.8 18.9 1.4 0.4 1.5 1.3 0.9 3.5 0.0 0.4 0.7 1.3 1.2 2.2 2.3 1.1 3.8 1.9 1.0 1.7 40.4 4.7 3.5 0.4 1.2 0.7 0.3 0.5 2.2 4.0 0.8 0.7 1.0 1.3 0.8 0.7 1.9 1.0 2.8 5.6 20.2 1.3 0.6 2.4 1.7 1.0 0.0 1.2 1.7 3.1 0.0 9.4 18.3 20.6 0.0 0.2 7.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.4 0.0 13.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 9.3 0.7 0.0 0.0 0.2 0.6 4.9 0.8 0.0 0.1 0.0 0.4 0.1 0.1 0.0 5.4 0.3 0.2 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.6 0.5 16.8 0.0 0.0 20.6 11.7 0.1 12.8 0.0 0.0 0.1 0.2 9.4 0.0 0.0 0.0 18.3 0.0 11.2 0.4 0.1 7.0 1.4 2.8 0.4 1.4 3.8 1.9 3.5 0.4 4.0 2.4 3.0 5.1 0.0 0.5 0.7 0.0 0.3 2.5 6.7 3.4 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.8 0.2 1.1 0.0 36.7 0.0 0.0 0.0 33.7 0.0 0.0 28.2 0.0 39.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.6 0.1 0.2 0.0 0.0 0.3 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favorable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.2 5.0 6.2 7.1 7.4 7.2 1.1 3.2 7.8 7.9 5.4 0.1 4.6 1.1 6.0 5.7 5.8 4.1 0.2 6.0 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.8 11.1 4.9 11.5 5.4 5.0 0.1 1.3 6.2 3.7 2.7 1.9 6.3 2.0 2.1 2.9 2.5 0.9 12.9 1.8 16.6 7.3 5.9 2.8 4.1 6.1 6.1 0.9 4.6 5.7 2.1 10.3 5.3 2.3 2.3 0.5 11.0 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 8.9 7.5 0.5 6.7 1.3 5.3 4.7 5.1 144.6 19.4 12.2 15.7 9.8 19.9 11.2 336.5 2.4 0.7 0.0 8.1 2.6 4.1 4.3 0.0 1.9 3.8 4.8 4.7 2.5 0.6 35.1 11.5 1.2 3.3 0.0 2.6 12.3 7.9 4.0 8.5 18.1 18.9 0.0 3.3 91.2 18.9 2.8 16.8 0.7 2.6 3.3 OSGIN1 "BDGI, OKL38" ENSG00000140961 "Oxidative stress induced growth inhibitor 1" Q9UJX0 16 83948282-83966332 "Predicted intracellular proteins" "Differentiation, Growth regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 63.5" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 47.5;Enterocytes: 69.2;Hepatocytes: 52.5;Late spermatids: 191.7" "Cancer enriched" "Detected in all" 5 "liver cancer: 65.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 12.3" "Group enriched" "Detected in many" 8 "granulocytes: 4.5;monocytes: 12.3" "Cell line enhanced" "Detected in many" "A549: 25.7;Hep G2: 38.6;T-47d: 28.7;WM-115: 24.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA019239 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA019239: AB_1854779" "unprognostic (8.36e-2)" "unprognostic (9.44e-2)" "unprognostic (4.28e-2)" "prognostic favorable (4.89e-5)" "unprognostic (3.31e-3)" "unprognostic (9.14e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" "unprognostic (2.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.20e-2)" "unprognostic (2.80e-2)" "unprognostic (2.45e-2)" "unprognostic (2.48e-2)" "unprognostic (8.28e-3)" "unprognostic (1.89e-1)" 4.0 9.8 1.7 3.0 6.5 0.8 28.2 0.6 3.7 1.7 17.4 2.1 0.7 18.1 1.3 1.7 5.6 1.8 5.1 6.9 1.3 1.4 13.8 63.5 8.2 1.6 13.4 0.0 3.2 5.2 2.5 1.4 1.2 6.6 2.1 1.8 5.1 2.0 1.7 7.8 1.6 21.3 5.5 13.7 5.4 5.0 5.6 1.9 0.0 5.2 13.5 2.9 6.0 10.6 0.0 1.0 4.5 12.3 0.0 0.0 0.8 1.7 25.7 0.2 1.1 1.6 2.4 2.0 2.9 2.8 2.6 1.0 6.3 9.3 0.0 6.9 2.4 11.9 4.7 1.1 1.9 1.0 0.3 0.3 0.4 5.7 38.6 5.6 0.9 10.1 1.4 1.5 7.0 1.6 1.5 2.6 1.8 2.3 2.5 3.4 11.9 0.3 0.3 0.2 6.2 5.9 0.8 2.6 1.2 1.8 2.2 0.1 0.6 6.2 2.0 12.5 0.7 28.7 1.0 8.9 4.2 6.3 6.1 2.0 1.1 0.4 0.1 14.0 1.3 24.0 0.1 2.1 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 4.5 0.0 12.3 0.0 0.0 0.8 1.7 6.5 0.6 3.7 1.3 1.4 13.4 0.0 6.6 1.9 14.9 3.8 0.5 8.2 1.3 0.5 6.9 10.2 1.4 1.2 1.8 0.0 1.2 5.0 10.5 47.5 2.7 69.2 0.0 5.7 0.3 2.1 9.5 1.1 52.5 8.5 0.0 4.1 6.7 8.6 191.7 3.7 3.2 6.8 2.8 7.3 7.5 11.6 10.5 11.3 8.7 0.2 12.9 8.0 1.9 1.0 1.5 1.1 0.0 7.1 5.8 OSM MGC20461 ENSG00000099985 "Oncostatin M" P13725 22 30262829-30266840 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth regulation" "Cytokine, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.9;bone marrow: 63.0" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 2: 18.3;granulocytes: 14.0;Hofbauer cells: 72.9;Macrophages: 23.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 24.9;neutrophil: 17.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 24.9" "Cell line enhanced" "Detected in some" "HDLM-2: 16.2;HL-60: 3.9;HMC-1: 12.0;Karpas-707: 3.7;NB-4: 6.9" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 39700 "unprognostic (5.15e-2)" "unprognostic (8.80e-3)" "unprognostic (1.01e-1)" "unprognostic (6.02e-2)" "unprognostic (7.37e-2)" "unprognostic (2.61e-2)" "unprognostic (6.78e-2)" "unprognostic (3.77e-2)" "unprognostic (2.81e-2)" "unprognostic (4.60e-2)" "unprognostic (1.58e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.00e-2)" "unprognostic (7.72e-2)" "unprognostic (1.52e-1)" "unprognostic (1.82e-1)" 5.3 2.6 0.9 8.5 2.5 63.0 3.7 0.7 1.7 1.6 1.0 5.3 0.4 0.6 1.2 1.9 0.8 3.8 4.1 2.2 3.8 1.7 1.9 1.8 11.4 9.4 2.0 0.0 3.0 1.0 1.0 2.5 6.4 5.9 1.2 0.7 1.8 1.4 0.5 1.7 0.4 1.0 2.1 7.8 6.9 1.4 2.3 1.2 0.6 1.1 0.5 2.2 6.8 0.9 0.1 0.4 24.9 0.2 1.9 3.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.2 0.0 0.3 0.0 0.0 0.0 3.9 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 3.7 0.0 0.0 0.5 6.9 0.0 0.0 0.0 0.6 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.4 0.0 24.9 0.2 0.9 1.0 0.1 3.4 0.0 2.5 1.3 0.4 0.1 0.5 1.2 17.5 1.9 0.0 0.1 0.7 0.8 0.9 2.5 0.7 1.7 3.8 1.7 2.0 0.0 5.9 1.2 8.9 18.3 0.0 0.1 0.7 0.0 0.4 0.0 1.4 6.8 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.6 0.1 14.0 0.0 72.9 0.0 0.0 0.0 6.2 0.0 0.0 23.5 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 7.0 0.0 0.0 OSR1 ODD ENSG00000143867 "Odd-skipped related transciption factor 1" Q8TAX0 2 19351485-19358653 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 68.3;urinary bladder: 62.1" "Cell type enhanced" "Detected in some" 29 "Fibroblasts: 21.5;Leydig cells: 123.7;Peritubular cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "U-2197: 48.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015525 Uncertain NA NA "HPA015525: AB_1854822" "unprognostic (1.71e-3)" "unprognostic (1.23e-1)" "unprognostic (6.85e-4)" "unprognostic (1.42e-1)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (8.47e-4)" "unprognostic (2.79e-1)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "unprognostic (3.56e-2)" "unprognostic (1.03e-1)" "unprognostic (2.21e-3)" "unprognostic (1.89e-1)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (1.62e-1)" 16.9 1.3 0.2 5.0 0.5 0.1 40.0 0.7 1.0 12.6 11.7 0.3 2.0 1.3 9.2 5.6 18.5 4.0 5.7 21.3 0.6 0.2 0.9 0.3 7.9 2.6 0.2 0.8 5.2 2.6 0.2 1.2 3.7 1.5 45.5 1.9 1.6 28.4 3.6 5.9 5.1 5.2 68.3 0.5 0.1 5.1 5.7 0.0 0.1 6.0 7.2 5.0 62.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.2 1.5 4.5 0.0 2.7 1.3 2.6 1.3 0.0 0.0 0.0 0.0 3.9 1.2 0.0 1.4 0.6 0.6 0.0 0.1 0.0 0.0 1.5 1.9 0.0 0.1 2.2 0.0 2.4 3.2 1.9 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.6 2.3 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.2 48.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.7 1.0 0.6 0.2 0.2 0.8 1.5 0.0 0.0 0.3 0.0 0.8 4.1 0.0 3.9 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 21.5 0.4 1.1 0.0 0.8 0.0 0.0 0.0 0.0 1.1 123.7 0.0 3.3 0.0 0.0 0.0 0.4 0.0 43.2 2.4 0.0 0.0 3.8 0.3 0.0 3.6 0.3 0.0 0.0 1.1 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.9" "Group enriched" "Detected in many" 7 "Leydig cells: 726.0;Peritubular cells: 712.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "ASC diff: 113.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052425: AB_2681826, HPA063486: AB_2685022" "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favorable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 10.6 2.4 0.5 4.2 0.7 0.0 10.9 0.6 0.5 41.7 3.1 0.5 10.2 0.0 47.9 18.9 4.6 37.6 7.3 1.9 0.5 0.0 1.3 0.5 1.3 2.0 0.8 0.5 36.3 1.4 0.6 1.0 7.7 0.7 20.9 0.8 0.5 1.4 23.7 3.5 6.7 7.4 15.3 0.8 0.5 1.3 27.0 0.6 0.8 1.8 1.8 3.0 6.7 24.1 0.0 0.0 1.0 0.0 0.0 0.6 0.6 6.3 0.9 0.0 0.8 113.9 3.6 0.9 3.5 6.7 2.8 2.8 0.6 0.8 0.0 0.6 5.3 0.1 2.5 0.5 0.9 1.4 0.3 2.6 0.1 0.6 0.3 1.8 0.1 0.1 3.5 2.0 0.4 0.3 0.1 0.0 0.9 0.7 0.0 0.1 2.8 0.5 1.1 0.0 0.5 0.5 2.7 0.3 0.2 0.2 0.5 0.2 0.0 0.3 1.5 0.0 0.0 0.8 1.4 0.0 0.4 0.0 2.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.8 0.5 0.7 0.6 0.0 0.0 0.0 4.2 12.6 0.0 0.6 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.0 5.0 0.6 1.3 0.0 0.0 96.9 87.0 2.9 0.0 0.0 8.4 0.0 0.0 0.0 0.8 6.4 726.0 1.5 15.1 0.0 1.7 0.0 0.0 0.0 712.8 0.0 0.0 32.3 19.6 3.4 4.7 8.0 20.3 0.0 1.2 0.9 OSTN ENSG00000188729 Osteocrin P61366 3 191199241-191265615 "Predicted secreted proteins" Differentiation "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.8;brain: 7.9;prostate: 8.0" "Cell type enhanced" "Detected in single" 31 "Early spermatids: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "memory B-cell: 7.8" "Lineage enriched" "Detected in single" 10 "B-cells: 7.8" "Cell line enriched" "Detected in some" 24 "U-2197: 30.2" "Region enriched" "Detected in single" 4 "cerebellum: 1.2" "Low region specificity" "Detected in all" "CAB024997, CAB025649, HPA030878" Uncertain "Secreted in other tissues" NA NA "CAB024997: , CAB025649: , HPA030878: AB_2673642" "unprognostic (2.35e-2)" "unprognostic (9.12e-2)" "unprognostic (6.30e-2)" "unprognostic (2.34e-1)" "unprognostic (2.51e-1)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (8.11e-3)" "unprognostic (2.90e-1)" "unprognostic (1.45e-1)" 0.9 0.4 1.9 1.6 2.1 0.0 0.6 0.2 7.9 7.1 0.4 0.0 0.0 0.0 0.2 4.4 0.1 1.9 1.9 1.5 1.8 1.9 0.5 1.6 1.0 1.3 1.5 2.4 0.5 0.1 0.0 0.3 1.1 0.4 8.0 0.1 0.0 0.4 0.2 2.3 3.4 0.3 2.3 1.1 0.5 0.6 1.1 0.0 0.0 0.6 0.7 0.0 3.7 1.0 7.8 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 1.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 1.9 2.1 0.2 7.9 1.8 1.9 1.5 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 OTC ENSG00000036473 "Ornithine carbamoyltransferase" P00480 X 38352545-38421450 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "intestine: 59.1;liver: 90.3" "Group enriched" "Detected in some" 7 "Hepatocytes: 74.1;Ito cells: 20.3" "Cancer enriched" "Detected in some" 20 "liver cancer: 59.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;NB-4: 1.7;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8" "Not detected" "Not detected" "HPA000243, HPA000570" Enhanced Supported Mitochondria NA NA 1800000 Mitochondria "HPA000243: AB_1079535, HPA000570: AB_1079534" "unprognostic (6.93e-2)" "unprognostic (2.48e-1)" "unprognostic (1.89e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.70e-3)" "unprognostic (5.61e-2)" 0.4 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.1 0.8 16.5 0.0 0.2 26.9 1.1 0.2 0.2 0.3 5.3 0.2 0.1 0.2 0.1 90.3 0.7 2.3 0.2 0.0 0.2 0.8 0.0 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.1 0.1 59.1 0.8 0.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.6 1.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 1.7 0.0 0.2 0.0 0.0 0.0 0.0 74.1 0.0 0.0 1.2 20.3 1.9 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.5 0.0 OTOA "CT108, DFNB22" ENSG00000155719 Otoancorin Q7RTW8 16 21663971-21761935 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 4.1;lymphoid tissue: 4.5;testis: 7.8" "Group enriched" "Detected in some" 4 "Hofbauer cells: 94.1;Kupffer cells: 35.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "myeloid DC: 1.7;plasmacytoid DC: 4.1" "Lineage enriched" "Detected in single" 14 "dendritic cells: 4.1" "Cell line enhanced" "Detected in some" "HDLM-2: 2.3;THP-1: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA041405 Approved "Secreted in other tissues" NA NA 44000 "HPA041405: AB_10796344" "unprognostic (7.96e-2)" "unprognostic (2.44e-4)" "unprognostic (1.66e-2)" "unprognostic (9.69e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (5.11e-1)" "unprognostic (4.71e-2)" "unprognostic (7.92e-2)" "unprognostic (3.58e-1)" "unprognostic (1.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.08e-4)" "unprognostic (1.83e-1)" "unprognostic (1.20e-1)" "unprognostic (2.24e-1)" "unprognostic (2.18e-2)" 0.2 0.3 0.2 0.0 0.1 0.4 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.3 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 4.5 0.0 7.8 0.0 0.1 0.0 0.0 0.0 4.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.3 3.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.2 8.7 0.3 0.0 0.0 0.3 0.6 0.2 0.2 5.7 0.2 94.1 0.0 1.2 1.3 35.6 15.7 0.3 5.1 1.7 0.0 0.0 0.0 0.1 0.8 0.0 0.6 0.0 6.5 1.1 9.1 5.3 0.1 0.5 0.0 0.0 0.1 OTOF "DFNB6, DFNB9, FER1L2" ENSG00000115155 Otoferlin Q9HC10 2 26457203-26558698 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "bone marrow: 13.8;brain: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "basal ganglia: 26.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.6" "Lineage enhanced" "Detected in single" "T-cells: 1.6" "Cell line enriched" "Detected in some" 17 "HDLM-2: 27.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012410 Approved NA NA "HPA012410: AB_1854836" "unprognostic (4.01e-3)" "unprognostic (7.85e-2)" "unprognostic (8.95e-2)" "unprognostic (7.20e-5)" "unprognostic (1.82e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.61e-2)" "unprognostic (1.78e-2)" "unprognostic (1.26e-1)" "unprognostic (2.97e-3)" "unprognostic (4.85e-14)" "unprognostic (1.33e-2)" "unprognostic (5.19e-1)" "unprognostic (9.65e-2)" "unprognostic (8.96e-5)" 0.5 0.7 5.5 0.8 26.8 13.8 0.2 0.4 2.2 0.3 0.4 0.3 0.0 1.1 0.2 0.1 0.4 0.3 0.9 0.2 1.6 2.0 0.1 0.2 0.6 0.5 0.6 0.7 0.2 0.1 0.1 0.0 0.2 1.1 0.3 0.3 0.0 0.3 0.2 0.7 0.2 0.7 0.4 0.7 1.2 0.5 1.4 2.6 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.6 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 5.5 26.8 0.4 2.2 1.6 2.0 0.6 0.7 1.1 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.1 0.0 0.0 0.0 OTOG "FLJ46346, mlemp, OTGN" ENSG00000188162 Otogelin Q6ZRI0 11 17547373-17647150 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "pituitary gland: 4.8;testis: 3.5" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 10.1;Late spermatids: 21.0;Muller glia cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "CACO-2: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.25e-2)" "unprognostic (1.19e-1)" "unprognostic (6.95e-3)" "unprognostic (1.85e-6)" "unprognostic (1.89e-1)" "unprognostic (3.60e-1)" "unprognostic (5.14e-5)" "unprognostic (1.78e-1)" "unprognostic (8.97e-2)" "unprognostic (1.57e-2)" "unprognostic (4.72e-5)" "unprognostic (5.55e-2)" "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.0 OTOGL "C12orf64, FLJ90579" ENSG00000165899 "Otogelin like" Q3ZCN5 12 80099537-80380879 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 4 "amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 5.2" "HPA040364, HPA053392" Uncertain Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA040364: AB_10795365, HPA053392: AB_2682135" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (2.55e-2)" "unprognostic (1.50e-1)" "unprognostic (5.99e-2)" "unprognostic (3.10e-1)" "unprognostic (3.34e-3)" "unprognostic (4.76e-2)" "unprognostic (2.72e-2)" "unprognostic (4.52e-2)" "unprognostic (2.79e-2)" "unprognostic (1.57e-1)" "unprognostic (1.95e-5)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" "unprognostic (2.79e-2)" "unprognostic (2.04e-2)" 0.4 0.2 3.5 0.2 4.3 0.1 0.4 0.2 5.8 0.4 2.7 0.0 0.0 0.2 0.5 3.1 0.5 0.5 0.4 9.8 1.0 0.4 13.3 0.1 0.3 0.5 0.5 3.6 0.2 0.7 0.2 21.0 1.4 0.3 0.5 0.3 1.4 0.3 0.5 1.0 0.3 0.6 0.6 0.3 0.4 0.4 0.8 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.5 3.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.4 0.5 2.5 0.0 0.2 0.9 0.0 0.1 7.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 0.2 5.8 1.0 0.4 0.5 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OTOL1 "C1QTNF15, C1QTNF16" ENSG00000182447 "Otolin 1" A6NHN0 3 161496808-161503942 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "brain: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041030 Uncertain "Secreted in other tissues" NA NA "HPA041030: AB_10795000" 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOP1 ENSG00000163982 "Otopetrin 1" Q7RTM1 4 4188803-4226889 "Predicted membrane proteins, Transporters" "Biomineralization, Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.1;skin 1: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA035599 Uncertain NA NA "HPA035599: AB_10600924" "unprognostic (1.83e-1)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOP2 ENSG00000183034 "Otopetrin 2" Q7RTS6 17 74924275-74933912 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 20.4;testis: 5.1" "Cell type enriched" "Detected in some" 48 "Paneth cells: 508.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enriched" "Detected in single" 47 "HDLM-2: 15.2" "Region enriched" "Detected in single" 13 "olfactory region: 15.6" "Low region specificity" "Detected in all" "HPA024524, HPA053090" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024524: AB_2671592, HPA053090: AB_2682041" "unprognostic (1.62e-2)" "unprognostic (1.45e-1)" "unprognostic (7.25e-2)" "unprognostic (3.21e-2)" "unprognostic (3.62e-1)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.81e-1)" "unprognostic (9.04e-2)" "unprognostic (2.04e-2)" 0.1 0.0 0.1 2.9 0.1 0.0 0.1 0.1 0.1 0.1 20.4 0.1 0.1 0.2 0.5 0.1 1.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 10.9 0.1 0.1 0.1 0.1 0.2 11.3 0.2 0.1 0.1 0.0 5.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.4 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 10.6 0.0 0.0 0.0 0.0 2.7 0.0 0.0 508.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.5 0.0 OTOP3 ENSG00000182938 "Otopetrin 3" Q7RTS5 17 74935719-74949992 "Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "esophagus: 17.5;intestine: 42.9" "Cell type enriched" "Detected in some" 11 "Paneth cells: 71.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.3;HDLM-2: 2.4;RPMI-8226: 2.3;SH-SY5Y: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.28e-3)" "prognostic favorable (3.86e-4)" "unprognostic (2.77e-1)" "unprognostic (8.60e-2)" "unprognostic (3.42e-1)" "unprognostic (1.03e-1)" "unprognostic (8.36e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 34.1 0.0 0.0 42.9 0.0 0.0 17.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 2.5 29.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 71.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 OTOR "FDP, MIAL, MIAL1" ENSG00000125879 Otoraplin Q9NRC9 20 16748358-16770062 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;stomach 1: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 17.0" "Not detected" "Not detected" HPA024335 Uncertain "Secreted in other tissues" NA NA "HPA024335: AB_1854838" "unprognostic (8.50e-3)" "unprognostic (9.56e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-1)" "unprognostic (1.72e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 17.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTOS OTOSP ENSG00000178602 Otospiralin Q8NHW6 2 240139026-240144562 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "pituitary gland: 39.1;thyroid gland: 41.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 6.5;thyroid cancer: 28.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;hTEC/SVTERT24-B: 1.8;U-138 MG: 2.2" "Region enriched" "Detected in single" 4 "hippocampal formation: 1.8" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (8.52e-2)" "unprognostic (1.73e-1)" "unprognostic (9.01e-3)" "unprognostic (1.35e-1)" "unprognostic (2.72e-1)" "unprognostic (3.27e-3)" 0.3 0.3 4.5 0.3 4.6 0.3 0.4 0.3 3.8 0.5 0.3 0.7 0.0 0.3 0.4 0.7 0.3 0.4 0.3 0.3 2.4 1.1 0.3 0.3 0.3 0.3 0.6 2.0 0.3 0.3 0.3 39.1 0.3 5.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.4 0.8 0.0 41.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.2 0.7 0.0 0.5 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 4.6 0.3 3.8 2.4 1.1 0.6 2.0 5.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTP ENSG00000171540 "Orthopedia homeobox" Q5XKR4 5 77628712-77639688 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 16.2" "Group enriched" "Detected in some" 8 "Sertoli cells: 6.5;Spermatocytes: 2.6" "Cancer enriched" "Detected in single" 6 "glioma: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 3.3;SCLC-21H: 1.6;THP-1: 1.5" "Region enriched" "Detected in some" 7 "hypothalamus: 23.4" "Region enhanced" "Detected in some" "hypothalamus: 24.0" HPA059342 Enhanced Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies" NA NA Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies" "HPA059342: AB_2732635" "unprognostic (1.00e-1)" "unprognostic (2.40e-2)" "unprognostic (6.25e-2)" "unprognostic (8.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (7.77e-2)" "unprognostic (2.39e-2)" "unprognostic (9.66e-2)" "unprognostic (4.64e-2)" "unprognostic (7.76e-14)" "unprognostic (3.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.49e-3)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 OTUB2 "C14orf137, FLJ21916, MGC3102" ENSG00000089723 "OTU deubiquitinase, ubiquitin aldehyde binding 2" Q96DC9 14 94026329-94048930 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.5" "Group enriched" "Detected in many" 9 "Early spermatids: 657.5;Late spermatids: 1026.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 2.1;intermediate monocyte: 2.5;myeloid DC: 3.3;non-classical monocyte: 1.9" "Group enriched" "Detected in many" 5 "dendritic cells: 3.3;monocytes: 2.5" "Cell line enhanced" "Detected in many" "GAMG: 14.5;Karpas-707: 15.7;OE19: 15.3;RPTEC TERT1: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002329, HPA075090" Enhanced NA NA "HPA002329: AB_1079537, HPA075090: AB_2686734" "unprognostic (6.80e-3)" "unprognostic (1.39e-3)" "unprognostic (3.68e-3)" "unprognostic (4.82e-3)" "unprognostic (1.66e-1)" "unprognostic (2.20e-1)" "unprognostic (2.30e-3)" "unprognostic (1.18e-2)" "unprognostic (2.55e-1)" "unprognostic (3.09e-3)" "unprognostic (2.80e-2)" "unprognostic (1.16e-2)" "unprognostic (6.25e-3)" "unprognostic (1.15e-1)" "unprognostic (2.06e-2)" "unprognostic (1.02e-4)" "unprognostic (3.16e-1)" 2.3 1.3 2.6 0.5 3.3 0.4 1.7 1.0 5.3 2.9 1.0 0.8 1.9 0.7 1.7 1.4 5.2 1.2 0.8 0.4 3.3 1.1 1.7 1.5 0.7 0.6 0.8 1.3 1.6 1.7 4.6 1.0 6.2 1.4 1.2 1.6 0.8 1.9 0.5 0.3 9.5 0.7 0.6 1.0 0.6 1.0 34.5 0.5 0.0 0.6 1.0 2.6 1.7 2.0 0.2 3.3 0.2 2.5 0.0 0.5 0.9 1.1 3.1 2.1 2.0 0.8 0.7 2.4 0.4 0.3 1.2 1.8 0.7 5.1 0.3 2.0 0.5 14.5 0.2 2.8 1.5 1.0 0.7 1.2 0.0 0.3 3.2 1.2 0.0 0.5 0.5 1.9 0.4 0.8 1.6 1.4 2.8 0.1 15.7 0.6 1.1 0.1 0.3 0.6 15.3 2.6 0.1 0.2 0.8 9.9 1.4 1.6 1.1 0.6 0.7 1.6 1.5 5.5 0.7 1.4 0.8 2.5 0.6 0.8 2.6 1.8 0.0 1.5 0.7 1.2 0.0 2.1 0.0 0.3 2.5 0.0 0.2 0.4 0.5 3.3 0.0 0.2 0.0 0.2 0.0 1.9 0.1 0.2 0.9 2.6 3.3 1.0 5.3 3.3 1.1 0.8 1.3 1.4 0.5 0.0 0.3 0.0 0.6 0.1 1.6 0.3 0.0 1.4 1.2 0.0 0.0 3.1 1.7 3.6 657.5 0.0 0.7 0.0 1.4 1.2 0.5 0.5 0.0 0.8 1.3 0.0 0.0 0.0 1.2 1026.7 6.4 2.8 0.0 0.0 0.6 0.8 3.5 0.6 3.2 1.1 1.2 6.5 0.1 6.6 4.0 1.9 98.3 0.0 0.6 2.0 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439458-23442390 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.8;tongue: 61.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.3;HaCaT: 23.8;SiHa: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: AB_2676049, HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 11.6 9.2 5.9 8.5 6.9 39.3 14.7 9.7 9.5 13.8 8.8 9.3 6.9 4.9 9.8 10.0 8.2 9.0 9.9 25.9 6.0 5.9 14.7 7.3 26.6 11.0 6.2 6.7 10.9 6.5 12.8 7.8 11.5 5.4 8.0 5.8 9.8 6.4 6.2 60.8 17.5 7.9 7.3 6.5 13.1 16.9 9.9 5.8 8.1 14.9 61.1 12.3 12.7 10.5 3.5 1.0 5.1 4.0 0.2 3.5 0.5 3.0 1.5 1.6 0.7 6.4 3.2 2.1 1.2 2.7 3.0 2.7 0.6 25.3 1.4 2.7 1.6 1.0 23.8 1.7 3.0 2.0 10.7 4.6 0.0 3.7 0.9 5.6 0.2 2.1 3.3 13.2 0.9 4.2 2.6 1.0 1.5 0.3 10.1 1.6 1.5 0.9 0.9 1.2 1.7 0.8 1.5 7.3 1.4 3.9 2.6 0.7 1.7 15.4 2.7 7.0 4.4 1.1 2.2 1.8 1.7 2.4 4.6 0.5 5.0 9.2 0.7 2.6 1.0 0.7 5.1 1.6 2.6 0.8 1.7 1.0 1.9 1.5 0.8 1.0 3.5 1.2 1.7 3.6 0.2 4.0 0.6 3.5 0.5 5.9 6.9 9.7 9.5 6.0 5.9 6.2 6.7 5.4 5.8 62.5 14.4 35.3 7.1 28.4 17.9 124.4 10.2 8.1 4.5 5.2 2.0 2.2 10.0 5.5 7.1 15.7 28.0 0.0 6.1 2.7 16.0 9.2 5.7 7.2 41.9 50.9 5.8 16.5 44.2 4.7 6.1 61.4 32.1 1.8 19.7 27.9 10.6 14.4 12.4 18.8 24.4 6.5 18.9 6.7 2.8 26.7 6.6 10.1 12.6 5.9 OTUD6A "DUBA2, FLJ25831, HSHIN6" ENSG00000189401 "OTU deubiquitinase 6A" Q7L8S5 X 70062491-70064179 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "blood: 3.8;testis: 13.6" "Group enriched" "Detected in some" 7 "Spermatocytes: 20.9;Spermatogonia: 6.6" "Cancer enriched" "Detected in single" 57 "testis cancer: 2.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.8" "Cell line enhanced" "Detected in some" "MCF7: 2.0;U-2 OS: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA053304 Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA053304: AB_2682107" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 13.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.4 3.8 0.4 0.7 0.6 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.4 1.0 0.5 0.0 0.7 0.8 0.4 0.3 0.2 0.0 0.0 0.5 0.8 0.8 0.0 0.3 0.7 0.3 0.4 0.2 0.3 0.2 0.0 1.1 0.2 0.6 0.0 2.0 0.3 0.9 0.6 0.0 0.2 0.0 0.0 0.0 0.8 0.7 0.6 0.3 0.5 0.2 0.0 0.5 0.1 0.1 0.0 0.2 1.9 0.3 0.5 1.6 0.3 1.5 0.1 0.2 0.2 3.8 0.4 0.3 0.4 0.2 0.4 0.3 0.3 0.2 0.0 0.9 0.3 0.6 2.6 0.7 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.4 0.3 1.1 0.0 0.1 0.0 0.0 0.0 1.2 0.7 0.3 0.5 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 1.9 0.0 0.0 20.9 6.6 0.5 0.2 0.0 0.0 0.3 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 20.5;Horizontal cells: 23.8;Spermatogonia: 6.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Uncertain Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 2.6 2.0 12.4 1.7 13.9 5.9 1.5 13.2 17.0 1.8 3.4 16.0 0.0 1.5 1.9 1.9 1.9 2.0 2.3 2.1 10.0 4.6 2.3 1.0 1.5 3.5 20.4 7.1 2.0 2.5 4.6 1.7 0.9 10.5 1.2 3.1 0.7 1.6 2.0 1.8 3.2 2.1 2.9 9.1 2.2 2.3 8.2 17.4 0.0 2.3 0.0 2.4 1.9 1.3 0.1 3.2 0.3 1.4 0.1 0.7 0.4 3.7 4.1 4.5 6.1 0.4 1.3 3.2 2.5 1.3 3.9 2.0 2.5 3.2 2.9 2.2 0.9 2.2 4.6 4.9 2.1 3.2 5.9 6.6 3.7 8.3 2.0 0.3 4.1 5.8 0.0 0.2 3.9 4.3 1.1 3.5 6.4 6.0 5.5 1.8 2.9 3.1 3.9 2.1 4.8 2.0 5.7 3.1 1.4 1.6 3.9 11.0 6.0 3.4 3.0 1.0 2.3 2.5 4.3 2.3 5.4 5.3 3.0 6.3 3.4 2.4 3.0 2.9 5.8 4.5 0.0 0.4 0.3 0.6 0.5 0.3 0.0 0.3 0.7 0.2 0.1 0.2 0.2 0.0 0.1 1.4 3.2 0.0 0.4 12.4 13.9 13.2 13.8 10.0 4.6 20.4 7.1 10.5 17.4 3.0 0.0 0.0 0.6 0.3 20.5 2.2 0.0 0.0 1.2 1.8 2.0 0.0 0.0 0.4 1.0 1.0 0.9 0.0 0.8 0.0 0.7 1.3 0.0 0.8 0.2 23.8 3.5 1.3 0.0 1.1 0.9 0.0 1.7 0.0 1.0 3.7 0.4 0.0 2.5 1.2 2.9 0.0 1.0 4.1 6.1 0.4 0.1 0.0 1.0 0.8 OTX1 ENSG00000115507 "Orthodenticle homeobox 1" P32242 2 63050057-63057836 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.3;retina: 18.9;salivary gland: 19.6;skin 1: 14.3" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 1.4;Ciliated cells: 6.7;Club cells: 2.3;Suprabasal keratinocytes: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 113 "neutrophil: 11.3" "Lineage enriched" "Detected in single" 113 "granulocytes: 11.3" "Cell line enriched" "Detected in many" 9 "THP-1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB012341, HPA052122" Uncertain Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "CAB012341: AB_2157155, HPA052122: AB_2681736" "unprognostic (2.25e-2)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-3)" "unprognostic (2.32e-1)" "unprognostic (1.67e-2)" "unprognostic (6.92e-3)" "unprognostic (3.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.43e-1)" "unprognostic (2.26e-3)" "unprognostic (1.71e-1)" "unprognostic (0.00e+0)" "unprognostic (4.64e-2)" "unprognostic (2.31e-1)" "unprognostic (3.80e-4)" "unprognostic (3.67e-3)" 0.5 0.4 8.2 0.4 4.3 0.4 1.1 0.2 7.2 0.4 0.4 5.8 0.0 0.6 0.4 0.4 1.4 0.5 0.5 0.4 9.0 1.4 0.4 0.5 0.8 0.4 2.0 3.4 0.6 0.6 0.4 0.1 0.4 0.1 2.3 0.4 18.9 19.6 0.4 0.4 14.3 0.4 0.4 0.1 0.6 1.0 0.9 4.4 0.0 0.4 4.4 5.6 0.6 0.2 0.0 0.0 11.3 0.0 0.0 0.0 0.0 1.5 0.8 2.8 1.7 0.0 0.1 3.9 0.0 0.2 0.2 0.2 2.8 1.5 0.1 0.5 0.0 0.7 2.0 1.8 1.2 0.3 0.7 1.6 1.8 1.4 3.2 0.0 1.2 1.3 0.0 0.5 0.0 0.5 0.5 0.0 1.7 1.5 0.0 0.1 1.3 1.6 2.9 0.0 1.4 1.0 1.5 2.4 0.4 0.7 0.5 0.3 0.4 1.1 0.1 0.9 0.0 0.6 34.7 0.1 0.6 1.1 0.0 0.6 1.0 0.7 2.6 0.2 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 8.2 4.3 0.2 7.2 9.0 1.4 2.0 3.4 0.1 4.4 0.0 0.0 0.0 0.0 1.4 0.0 0.8 0.0 6.7 2.3 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.3 0.1 0.0 0.0 0.0 OTX2 ENSG00000165588 "Orthodenticle homeobox 2" P32243 14 56799905-56810479 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "brain: 27.7;retina: 78.2" "Group enriched" "Detected in some" 16 "Bipolar cells: 181.3;Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 203.6" "Cancer enriched" "Detected in single" 27 "testis cancer: 11.6" "Group enriched" "Detected in many" 5 "cerebellum: 20.4;pons and medulla: 27.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HAP1: 63.9;NTERA-2: 53.5" "Low region specificity" "Detected in many" "HPA000633, HPA001123" Uncertain Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA000633: AB_1079538, HPA001123: " "unprognostic (3.82e-1)" "unprognostic (2.56e-2)" "unprognostic (9.28e-2)" 0.2 0.2 0.0 0.2 0.3 0.2 0.2 20.4 0.3 0.2 0.2 3.7 0.0 0.2 0.2 1.0 0.2 0.2 0.2 0.2 1.8 2.7 0.2 0.2 0.2 0.5 4.7 0.0 0.5 0.2 0.2 2.8 0.2 27.7 0.3 0.2 78.2 0.2 1.3 0.2 0.5 0.2 0.2 0.2 0.4 0.2 3.1 2.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.4 0.3 1.8 2.7 4.7 0.0 27.7 2.3 0.0 0.0 0.0 0.0 0.0 181.3 0.2 0.0 0.0 0.0 0.0 159.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 203.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 OVCH1 OVCH ENSG00000187950 "Ovochymase 1" Q7RTY7 12 29412474-29497686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 9.5;testis: 4.6" "Group enriched" "Detected in some" 6 "Early spermatids: 2.4;Late spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "Daudi: 11.0" "Low region specificity" "Detected in many" "Secreted in female reproductive system" NA NA "unprognostic (3.32e-1)" "unprognostic (2.20e-1)" "unprognostic (2.03e-1)" "unprognostic (1.56e-5)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (4.41e-2)" "unprognostic (1.83e-1)" "unprognostic (2.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.36e-1)" "unprognostic (5.48e-2)" "unprognostic (5.59e-3)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" 0.6 0.4 0.0 0.4 0.3 0.1 0.5 0.0 0.1 0.4 0.2 0.0 0.2 0.0 0.1 0.2 0.4 0.2 0.1 0.2 0.2 0.3 9.5 0.2 0.1 0.3 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.3 0.5 0.1 0.0 0.2 1.9 0.2 4.6 2.1 0.0 0.1 0.2 0.5 0.2 1.3 0.5 0.0 0.6 0.3 0.0 0.0 0.6 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.3 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.8 0.0 0.5 0.8 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.5 0.0 0.6 1.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OVCH2 OVTN ENSG00000183378 "Ovochymase 2 (gene/pseudogene)" 11 7689438-7706421 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "epididymis: 60.7" "Group enriched" "Detected in some" 8 "Collecting duct cells: 7.0;Rod photoreceptor cells: 17.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "REH: 22.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.59e-2)" "unprognostic (3.74e-1)" "unprognostic (8.03e-2)" "unprognostic (9.77e-2)" "unprognostic (1.85e-1)" "unprognostic (1.70e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.84e-2)" "unprognostic (3.06e-1)" "unprognostic (9.27e-2)" "unprognostic (7.65e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 60.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.6 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.6 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 22.3 0.0 0.1 0.2 2.3 0.0 0.2 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 7.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 17.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 OVGP1 "CHIT5, MUC9" ENSG00000085465 "Oviductal glycoprotein 1" Q12889 1 111414314-111427777 "Plasma proteins, Predicted intracellular proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 240.9" "Cell type enhanced" "Detected in many" 11 "Syncytiotrophoblasts: 14.5" "Group enriched" "Detected in many" 13 "endometrial cancer: 58.7;ovarian cancer: 27.9" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 7.2;OE19: 9.2;SK-BR-3: 7.4" "Region enhanced" "Detected in some" "cerebellum: 6.6" "Not detected" "Not detected" "HPA031666, HPA062205" Enhanced Approved Vesicles,Microtubules "Intracellular and membrane" NA NA "Vesicles, Microtubules" "HPA031666: , HPA062205: AB_2684710" "unprognostic (1.52e-1)" "unprognostic (2.06e-2)" "unprognostic (3.35e-2)" "prognostic favorable (1.36e-4)" "unprognostic (8.39e-2)" "unprognostic (3.58e-2)" "unprognostic (2.33e-2)" "unprognostic (3.34e-2)" "unprognostic (5.44e-2)" "unprognostic (3.82e-2)" "unprognostic (7.68e-3)" "unprognostic (2.58e-1)" "unprognostic (5.35e-3)" "unprognostic (2.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.86e-3)" "prognostic favorable (3.93e-5)" 0.4 0.1 0.4 0.4 0.9 0.2 0.4 1.9 1.0 0.7 0.4 0.4 0.4 0.2 9.7 7.1 0.4 240.9 0.4 0.4 0.5 0.5 0.5 1.0 0.4 0.4 0.4 0.4 32.5 0.4 1.5 0.4 0.4 0.4 0.7 0.3 0.4 0.4 0.4 0.4 1.1 0.6 0.4 0.4 0.5 0.2 1.3 0.4 0.6 0.4 0.4 0.4 0.5 0.4 0.8 0.9 0.0 0.5 0.0 1.6 0.2 0.7 0.5 1.4 0.7 2.8 3.1 2.5 0.3 2.0 0.5 1.1 0.8 0.0 1.2 2.6 0.9 0.0 0.8 0.4 0.4 0.8 2.9 7.2 0.4 1.0 3.4 1.0 1.2 3.3 2.8 4.4 0.1 1.6 2.1 0.6 4.9 0.4 2.3 0.2 0.8 0.9 1.7 0.3 9.2 2.6 0.9 0.3 1.0 2.1 5.3 0.9 0.9 0.2 7.4 1.0 3.8 0.5 1.2 1.2 0.3 0.3 3.7 1.0 2.8 0.8 0.6 0.3 2.3 0.3 0.0 0.5 0.0 0.7 0.0 0.0 0.3 0.5 0.0 0.9 0.8 1.6 1.2 0.0 0.0 0.5 0.0 0.1 0.2 0.4 0.9 1.9 1.0 0.5 0.5 0.4 0.4 0.4 0.4 0.0 1.4 0.0 1.0 2.7 1.7 0.4 0.0 0.0 0.0 0.0 0.0 5.0 1.7 0.3 2.4 1.5 0.7 0.0 0.0 2.1 0.6 1.2 0.0 3.0 0.5 0.0 0.0 1.3 0.3 4.9 1.4 0.3 0.0 0.0 0.9 0.3 0.1 0.0 1.8 1.7 0.7 0.0 0.9 4.1 0.7 2.8 14.5 0.0 1.7 1.4 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787022-65797219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;tongue: 37.4" "Cell type enhanced" "Detected in many" 16 "Syncytiotrophoblasts: 291.8;Urothelial cells: 75.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 10.1;BEWO: 29.1;CACO-2: 7.3;HaCaT: 17.2;RT4: 16.9;SK-BR-3: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA003984 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.2 0.1 0.2 3.3 0.3 0.0 2.2 0.4 0.2 7.2 11.5 0.0 3.0 9.6 0.4 0.7 42.6 0.3 4.2 0.1 0.2 0.2 4.7 0.2 1.7 0.0 0.2 0.0 0.1 5.6 5.0 0.2 14.4 0.0 2.3 5.1 1.1 13.9 6.1 0.5 24.1 14.2 0.8 0.2 0.2 0.8 17.3 0.0 0.6 1.8 37.4 25.3 8.3 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.8 16.9 0.1 0.0 0.0 13.4 0.1 3.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.5 0.0 33.3 23.7 0.0 0.4 10.2 8.1 2.3 3.5 0.0 20.8 0.0 2.2 61.4 0.4 47.4 0.0 3.4 12.0 1.1 21.2 2.3 0.0 1.8 0.0 30.3 0.0 0.0 65.1 1.1 1.3 0.0 0.0 49.6 0.0 3.6 38.6 1.8 4.2 0.0 0.0 0.4 13.7 5.4 50.2 291.8 0.0 42.1 75.8 OVOL3 HOVO3 ENSG00000105261 "Ovo like zinc finger 3" O00110 19 36111151-36113711 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.9;skin 1: 3.0;testis: 5.1" "Cell type enhanced" "Detected in some" 17 "Intestinal endocrine cells: 1.7;Rod photoreceptor cells: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/84: 7.5" "Not detected" "Not detected" NA NA "unprognostic (1.70e-1)" "unprognostic (6.14e-3)" "unprognostic (3.19e-2)" "unprognostic (1.99e-2)" "unprognostic (7.38e-2)" "unprognostic (1.61e-2)" "unprognostic (1.31e-1)" "unprognostic (4.91e-2)" "unprognostic (1.19e-2)" "unprognostic (2.55e-2)" "unprognostic (6.60e-2)" "unprognostic (3.75e-2)" "unprognostic (2.96e-5)" "unprognostic (1.85e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.2 0.7 3.0 0.1 0.0 0.2 0.1 0.0 5.1 0.0 0.8 0.2 0.1 0.2 0.0 1.9 0.3 0.0 0.9 0.0 1.6 2.7 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.4 0.5 1.3 0.3 0.0 0.4 1.5 0.0 0.0 0.3 0.8 1.1 0.3 2.6 0.4 0.0 1.2 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.6 1.1 0.0 0.0 1.2 0.6 0.4 0.0 1.3 1.7 0.5 1.4 0.0 0.2 0.6 0.8 0.3 0.2 0.4 0.1 1.1 0.2 0.0 0.0 2.0 0.6 0.6 2.3 7.5 1.3 0.1 0.9 0.2 0.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.2 0.5 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 OXCT1 "OXCT, SCOT" ENSG00000083720 "3-oxoacid CoA-transferase 1" P55809 5 41730065-41870519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 108.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 212.2;Distal tubular cells: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 56.9;SiHa: 74.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012047, HPA061425" Enhanced Enhanced Mitochondria "Intracellular and membrane" NA NA 1000000 Mitochondria "HPA012047: AB_1854857, HPA061425: AB_2684515" "unprognostic (4.26e-2)" "unprognostic (2.10e-2)" "unprognostic (2.89e-2)" "unprognostic (1.51e-1)" "unprognostic (5.51e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (7.42e-3)" "unprognostic (1.74e-3)" "unprognostic (1.67e-1)" "unprognostic (2.80e-2)" "unprognostic (3.62e-1)" "prognostic favorable (1.86e-8)" "unprognostic (2.66e-2)" "unprognostic (9.99e-2)" "unprognostic (5.86e-3)" "unprognostic (2.28e-3)" 21.9 8.0 17.3 7.5 30.3 5.8 9.5 26.6 36.8 6.7 9.2 8.3 10.7 4.4 8.6 8.7 13.1 6.9 7.5 108.8 19.3 15.2 25.3 1.2 4.2 9.5 13.1 25.7 7.2 3.0 20.9 8.4 2.8 21.2 12.5 10.4 6.6 8.5 14.7 13.4 10.7 6.5 17.0 8.9 5.2 14.6 6.2 5.3 22.8 13.0 10.7 11.8 8.0 7.5 8.0 4.6 3.3 1.6 7.5 15.6 5.1 7.9 0.3 6.6 7.9 20.5 11.0 0.0 14.3 9.1 11.9 7.2 1.2 5.4 20.7 3.5 10.9 6.1 4.7 18.0 12.9 14.0 17.7 2.1 14.5 56.9 2.7 8.9 28.2 4.9 10.3 3.5 11.6 19.6 5.8 10.8 18.9 2.9 26.7 13.6 1.0 23.5 1.3 1.4 0.0 5.7 18.7 18.5 15.6 9.7 0.6 6.6 6.8 74.0 0.0 8.7 0.6 0.1 6.1 6.5 9.5 12.4 16.2 11.5 4.4 3.6 0.8 14.3 20.7 7.2 1.0 1.0 3.3 9.1 1.1 10.9 8.0 9.2 9.8 4.6 6.1 10.8 8.9 0.3 7.5 1.6 1.8 15.6 5.1 17.3 30.3 26.6 36.8 19.3 15.2 13.1 25.7 21.2 5.3 6.0 8.6 7.5 12.0 13.2 13.1 212.2 7.6 5.3 18.2 10.4 2.0 5.2 159.2 4.7 14.3 5.6 2.3 0.0 0.6 9.8 8.4 11.2 9.2 0.0 29.1 12.7 12.7 4.9 1.0 5.6 5.8 4.4 15.1 3.6 13.4 11.3 3.9 3.5 7.1 11.3 19.5 12.9 15.6 36.7 14.9 18.9 5.7 17.3 15.5 5.2 OXCT2 "FKSG25, FLJ00030, SCOT-T" ENSG00000198754 "3-oxoacid CoA-transferase 2" Q9BYC2 1 39769523-39771348 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 31.8" "Group enriched" "Detected in some" 89 "Early spermatids: 428.2;Late spermatids: 642.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "memory B-cell: 3.3;naive B-cell: 1.9;NK-cell: 1.4" "Group enriched" "Detected in many" 9 "B-cells: 3.3;NK-cells: 1.4" "Cell line enhanced" "Detected in many" "Karpas-707: 9.9;THP-1: 10.6;U-266/70: 8.2" HPA075423 Enhanced NA NA "HPA075423: AB_2732292" "unprognostic (2.42e-3)" "unprognostic (2.11e-1)" "unprognostic (6.50e-2)" "unprognostic (7.16e-2)" "unprognostic (9.68e-2)" "unprognostic (1.13e-1)" "unprognostic (1.32e-1)" "unprognostic (1.93e-3)" "unprognostic (2.74e-1)" "unprognostic (3.16e-1)" "unprognostic (2.57e-3)" "unprognostic (4.18e-2)" "unprognostic (5.39e-5)" "unprognostic (3.24e-1)" "unprognostic (4.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.85e-1)" 0.0 0.6 0.2 0.2 0.2 0.1 0.0 0.8 0.5 0.3 0.3 0.4 0.5 0.7 0.4 0.2 0.5 3.9 0.4 0.1 0.0 0.1 0.0 0.3 0.3 1.5 0.4 0.2 0.3 0.0 0.8 0.2 0.0 1.2 0.0 1.4 0.5 0.4 0.4 0.3 0.2 31.8 1.6 0.0 0.1 0.0 3.3 0.0 0.0 0.2 1.4 0.0 0.1 0.5 0.3 0.0 1.2 0.4 1.5 0.0 1.5 0.0 1.4 0.7 5.0 0.6 0.0 1.0 2.0 0.2 0.5 1.5 0.1 0.7 0.0 3.3 0.9 3.3 0.2 2.4 0.0 0.5 0.7 0.4 0.2 0.1 0.0 1.1 0.4 0.3 9.9 0.2 1.4 0.0 1.5 0.1 0.0 1.3 1.3 1.6 1.5 0.4 1.0 1.7 0.9 4.3 0.3 1.5 0.1 0.5 10.6 1.2 0.0 0.3 4.8 0.0 8.2 4.3 0.6 0.1 0.6 2.4 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.1 0.8 0.2 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 428.2 0.5 0.5 0.0 0.6 0.1 0.3 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 642.7 3.7 0.8 1.7 1.0 0.6 0.3 0.6 0.0 6.0 0.0 0.0 0.0 5.6 2.7 2.2 0.4 0.0 0.0 0.3 0.1 OXER1 "GPCR, GPR170, TG1019" ENSG00000162881 "Oxoeicosanoid receptor 1" Q8TDS5 2 42762481-42764261 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.9;liver: 26.9" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 5.1;Hepatocytes: 8.1" "Cancer enhanced" "Detected in all" "liver cancer: 12.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 17.4;eosinophil: 42.9" "Lineage enriched" "Detected in single" 76 "granulocytes: 42.9" "Cell line enhanced" "Detected in some" "CACO-2: 9.0;Hep G2: 10.0;HMC-1: 8.6;REH: 4.3;THP-1: 3.9" HPA051433 Uncertain NA NA "HPA051433: AB_2681485" "unprognostic (6.77e-2)" "unprognostic (4.20e-2)" "unprognostic (3.13e-2)" "unprognostic (1.07e-1)" "unprognostic (4.09e-3)" "unprognostic (4.45e-3)" "unprognostic (7.80e-2)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-3)" "unprognostic (5.39e-2)" "unprognostic (1.82e-3)" "unprognostic (5.83e-2)" "unprognostic (1.66e-1)" "unprognostic (4.89e-2)" "unprognostic (5.46e-2)" 8.2 0.7 0.7 1.2 0.7 2.0 0.9 0.7 1.5 1.9 2.1 0.7 0.7 4.9 1.7 2.9 1.1 1.4 1.1 2.0 1.5 0.3 4.1 26.9 9.1 4.1 0.7 0.7 5.4 3.8 0.4 2.0 2.7 1.3 3.4 1.6 3.3 3.4 1.7 2.1 2.9 8.3 0.7 0.7 6.4 1.6 1.1 2.7 3.8 1.6 2.2 1.6 2.5 4.8 0.0 0.4 42.9 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 9.0 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.5 3.0 0.0 10.0 0.1 0.2 8.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 1.9 0.1 0.0 4.3 1.5 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.9 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 17.4 0.5 42.9 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.7 1.5 1.5 0.3 0.7 0.7 1.3 2.7 0.0 0.3 0.0 0.6 0.5 0.7 0.4 5.1 0.0 0.0 1.8 0.0 0.1 1.7 0.4 0.0 0.0 2.1 0.0 1.7 0.1 1.5 0.4 2.3 8.1 0.8 0.0 1.2 0.6 1.5 0.0 3.1 1.4 3.3 1.8 2.7 0.8 0.6 4.5 1.8 3.7 0.0 0.0 1.9 0.0 0.0 0.1 0.2 0.0 3.3 0.1 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 7.0" "Cell type enriched" "Detected in some" 11 "Extravillous trophoblasts: 35.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 2.9;plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Cell line enhanced" "Detected in some" "RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA067673: AB_2685883" "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 2.1 0.0 0.7 1.7 0.2 0.0 6.7 0.0 2.0 1.6 3.0 0.1 0.6 4.0 3.2 2.5 0.0 0.0 0.8 0.8 7.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.3 1.2 0.5 2.4 4.9 0.3 0.1 4.3 0.5 0.5 1.6 0.3 0.1 0.0 0.8 0.9 1.8 0.9 0.0 5.2 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.2 0.0 3.6 0.0 0.2 1.7 0.0 0.0 0.0 4.1 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.1 1.7 0.0 0.2 0.1 0.0 0.0 0.0 35.1 0.1 0.0 0.0 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.8 0.0 OXT "OT, OT-NPI, OXT-NPI" ENSG00000101405 "Oxytocin/neurophysin I prepropeptide" P01178 20 3071620-3072517 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 232.0" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 9.2;Hepatocytes: 37.5;Late spermatids: 23.3;Proximal tubular cells: 10.5" "Cancer enriched" "Detected in some" 5 "testis cancer: 12.1" "Region enriched" "Detected in some" 59 "hypothalamus: 232.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CACO-2: 5.2;HL-60: 1.3;HMC-1: 3.8;PC-3: 2.7" "Region enriched" "Detected in some" 5 "hypothalamus: 210.0" "Group enriched" "Detected in some" 1042 "basal ganglia: 840.1;hypothalamus: 2453.1" HPA071892 Supported Supported "Secreted to blood" NA NA 1500000 "HPA071892: AB_2732190" "unprognostic (7.45e-3)" "unprognostic (1.99e-2)" "unprognostic (2.66e-2)" "unprognostic (2.28e-1)" "unprognostic (2.62e-1)" "unprognostic (3.82e-2)" "unprognostic (8.22e-2)" "unprognostic (8.36e-2)" "unprognostic (6.02e-2)" "unprognostic (3.05e-2)" "unprognostic (6.65e-2)" "unprognostic (6.18e-1)" "unprognostic (3.81e-1)" "unprognostic (3.36e-2)" "unprognostic (1.95e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" 5.0 0.2 0.0 0.1 3.9 0.2 0.2 0.0 0.3 0.1 0.0 0.4 0.0 2.6 0.0 3.8 0.0 0.0 0.0 0.0 0.1 232.0 1.6 24.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 1.8 0.6 0.2 0.2 0.0 0.0 0.4 0.2 0.2 0.2 2.4 0.0 0.0 0.2 0.2 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 1.5 6.3 0.4 0.4 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 6.3 0.8 0.4 1.0 3.7 1.7 1.1 0.9 3.6 3.2 3.6 1.1 0.4 0.0 1.5 2.4 0.9 0.0 3.9 0.0 0.3 0.1 232.0 0.0 0.0 0.2 0.0 0.0 2.6 3.7 0.6 0.7 0.0 0.2 0.0 1.4 2.3 5.2 0.0 0.0 1.7 0.1 9.2 0.0 0.3 0.0 0.0 0.0 1.3 0.1 0.0 37.5 0.2 0.0 0.0 0.0 0.3 23.3 0.9 0.3 3.3 0.0 0.3 0.0 0.2 1.4 1.1 10.5 0.0 0.0 1.0 0.9 4.5 0.9 0.0 0.0 0.0 0.1 OXTR ENSG00000180914 "Oxytocin receptor" P30559 3 8750408-8769628 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "breast: 42.5" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 93.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ: 81.2;BJ hTERT+: 24.9;BJ hTERT+ SV40 Large T+: 23.6;fHDF/TERT166: 81.3;HBF TERT88: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-1)" "unprognostic (7.94e-2)" "unprognostic (4.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (2.02e-1)" "unprognostic (1.46e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (3.42e-1)" "unprognostic (2.76e-1)" "unprognostic (3.80e-2)" "unprognostic (4.24e-4)" "unprognostic (8.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-1)" 0.5 0.4 1.8 0.3 6.5 0.6 42.5 0.9 2.2 0.5 0.3 0.1 0.0 0.3 2.8 0.5 1.1 2.7 1.0 0.6 1.8 4.0 0.6 0.4 1.0 0.4 8.6 0.8 2.8 0.3 0.3 0.3 1.3 3.7 0.9 0.3 1.6 0.4 0.9 0.3 0.4 0.4 0.6 2.5 0.5 0.3 0.5 1.2 0.1 0.4 0.0 0.4 0.4 0.0 0.0 0.2 1.6 0.1 0.1 0.3 1.0 0.2 0.8 0.4 0.1 0.1 0.2 0.1 81.2 24.9 23.6 12.6 0.1 2.1 0.0 0.1 81.3 0.3 0.1 0.3 0.1 18.4 0.7 0.4 0.2 0.3 0.1 0.4 0.1 0.2 0.1 0.1 0.3 0.1 7.1 0.0 0.2 0.0 0.1 13.1 0.0 0.1 0.6 0.5 0.2 3.6 0.1 0.3 4.8 0.9 0.0 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.1 0.1 1.1 0.3 0.2 0.2 0.1 0.2 0.0 0.1 0.2 0.2 0.5 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.3 1.6 0.1 0.0 0.1 0.1 1.0 1.8 6.5 0.9 2.2 1.8 4.0 8.6 0.8 3.7 1.2 8.9 1.4 0.0 0.4 0.3 0.2 1.2 0.0 93.7 11.4 0.0 0.0 0.0 0.0 2.6 0.9 0.0 0.0 0.0 0.0 0.1 0.5 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 5.8 1.0 0.0 0.4 0.0 0.0 0.0 0.5 0.7 1.3 0.1 0.0 0.0 0.0 0.1 P2RX1 P2X1 ENSG00000108405 "Purinergic receptor P2X 1" P51575 17 3896592-3916500 "Predicted membrane proteins" "Apoptosis, Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 98.3;urinary bladder: 60.0" "Cell type enriched" "Detected in some" 17 "granulocytes: 178.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 22.4" "Group enriched" "Detected in many" 22 "dendritic cells: 8.2;granulocytes: 12.8;monocytes: 22.4" "Cell line enhanced" "Detected in some" "HEL: 12.4;HMC-1: 8.0;Karpas-707: 15.5;THP-1: 12.8;U-937: 6.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA 1300000 "unprognostic (1.27e-3)" "unprognostic (1.61e-2)" "unprognostic (2.65e-1)" "unprognostic (3.54e-2)" "unprognostic (7.34e-3)" "unprognostic (9.89e-5)" "unprognostic (1.77e-2)" "unprognostic (6.15e-3)" "unprognostic (2.98e-1)" "unprognostic (2.52e-3)" "unprognostic (1.90e-1)" "unprognostic (2.20e-2)" "unprognostic (4.47e-3)" "unprognostic (2.60e-1)" "unprognostic (5.58e-2)" "unprognostic (4.29e-1)" "unprognostic (1.09e-2)" 5.2 0.7 0.3 2.9 0.5 17.0 1.1 0.3 0.6 5.9 6.3 0.5 10.7 4.0 4.2 5.2 11.0 2.0 3.0 1.1 0.4 0.3 0.9 0.6 3.8 2.0 0.4 0.5 2.4 29.7 0.0 0.4 1.8 0.5 15.3 4.1 0.7 1.8 16.9 1.0 3.0 4.6 98.3 0.7 6.7 1.4 1.6 0.5 1.5 0.5 1.2 2.7 60.0 5.8 0.6 8.2 12.8 22.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.1 0.1 1.0 1.6 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.2 3.0 0.0 0.3 0.0 2.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 6.7 0.0 0.0 5.8 6.1 0.0 10.6 0.0 0.2 0.0 0.0 3.2 0.6 0.0 0.0 12.8 0.0 22.4 8.2 0.0 4.5 0.3 0.5 0.3 0.6 0.4 0.3 0.4 0.5 0.5 0.5 3.0 6.2 10.4 0.0 0.3 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.7 0.1 0.5 0.0 178.1 0.0 3.2 0.0 0.0 0.0 4.6 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.2 0.0 P2RX2 "DFNA41, P2X2" ENSG00000187848 "Purinergic receptor P2X 2" Q9UBL9 12 132618776-132622386 "Disease related genes, Predicted membrane proteins" "Hearing, Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 23.1;prostate: 11.1;seminal vesicle: 16.1" "Cell type enriched" "Detected in single" 5 "Peritubular cells: 2.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 4 "amygdala: 6.1;hippocampal formation: 8.6" "Cell type enriched" "Detected in single" 13 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.2" "Group enriched" "Detected in some" 4 "MCF7: 6.7;T-47d: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.12e-1)" "unprognostic (1.49e-2)" "unprognostic (5.92e-2)" "unprognostic (5.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (3.12e-1)" "unprognostic (5.79e-3)" "unprognostic (6.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.11e-2)" "unprognostic (3.66e-2)" "unprognostic (1.88e-2)" "unprognostic (6.21e-2)" "unprognostic (3.05e-1)" "unprognostic (9.12e-2)" 0.4 0.1 6.1 0.5 0.6 0.0 0.3 0.3 1.6 0.7 1.5 0.3 3.0 1.1 0.3 23.1 5.3 2.5 0.3 0.3 8.6 0.9 1.1 0.3 3.6 1.8 0.3 0.3 0.3 0.3 0.0 0.9 0.7 0.3 11.1 0.3 0.6 0.3 16.1 0.3 0.0 3.4 0.3 0.3 2.4 1.3 1.3 0.3 0.3 0.3 0.3 0.8 0.7 1.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 6.7 0.1 0.4 0.7 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.0 0.0 2.7 0.0 1.0 15.4 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.3 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.1 0.6 0.3 1.6 8.6 0.9 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 P2RX3 P2X3 ENSG00000109991 "Purinergic receptor P2X 3" P56373 11 57338374-57370600 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 7.9;testis: 16.3" "Group enriched" "Detected in some" 40 "Early spermatids: 34.4;Late spermatids: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;hTEC/SVTERT24-B: 1.4;NTERA-2: 1.2;U-87 MG: 1.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057776 Uncertain NA NA "HPA057776: AB_2683526" "unprognostic (5.44e-2)" "unprognostic (9.43e-2)" "unprognostic (2.84e-1)" "unprognostic (1.33e-3)" "unprognostic (2.24e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-7)" "unprognostic (1.58e-1)" "unprognostic (2.88e-1)" "unprognostic (3.00e-2)" "unprognostic (1.29e-1)" 0.1 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.6 7.9 0.1 0.0 0.0 3.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.4 0.4 0.0 2.3 0.0 0.0 1.8 0.0 0.7 0.0 0.4 0.0 1.2 16.3 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.8 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.2 1.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 P2RX5 "LRH-1, P2X5" ENSG00000083454 "Purinergic receptor P2X 5" Q93086 17 3672199-3696404 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4" "Cell type enriched" "Detected in some" 7 "B-cells: 69.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 18 "memory B-cell: 28.1;naive B-cell: 30.4" "Lineage enriched" "Detected in many" 19 "B-cells: 30.4" "Cell line enhanced" "Detected in many" "Daudi: 24.5;Karpas-707: 15.9;RPMI-8226: 27.6;U-698: 22.8" "HPA021948, HPA067827" Supported Supported Cytosol NA NA Cytosol "HPA021948: AB_1854878, HPA067827: AB_2685908" "unprognostic (1.08e-3)" "unprognostic (9.16e-2)" "unprognostic (1.40e-2)" "unprognostic (5.81e-2)" "unprognostic (1.79e-1)" "unprognostic (1.06e-1)" "unprognostic (8.33e-2)" "unprognostic (4.34e-1)" "unprognostic (1.24e-1)" "unprognostic (1.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-2)" "unprognostic (1.99e-8)" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (3.50e-2)" "unprognostic (3.63e-2)" 0.6 0.3 2.2 32.0 4.9 4.8 0.5 4.1 5.1 0.3 1.4 0.0 0.4 0.9 0.2 0.2 2.4 0.2 0.8 4.9 1.8 3.0 0.8 0.4 1.0 39.1 1.5 2.1 0.2 0.8 0.1 1.2 0.2 1.7 0.5 1.2 0.0 5.4 0.1 11.4 0.2 12.0 0.4 0.6 29.6 1.8 0.6 0.2 9.3 0.5 1.9 27.6 2.2 0.3 30.4 0.1 0.7 0.0 0.0 1.6 1.6 3.9 3.2 0.0 0.0 0.1 0.6 0.0 4.1 1.9 0.4 1.3 2.4 4.8 24.5 2.5 1.9 1.3 2.1 8.8 0.0 0.8 0.4 1.5 1.2 8.7 2.9 0.6 1.6 2.1 1.0 0.9 0.1 5.7 3.2 0.0 5.8 0.2 15.9 8.9 0.0 11.0 3.7 2.4 1.9 9.9 0.5 0.0 27.6 0.1 3.0 2.0 0.0 3.4 1.1 1.8 0.0 1.0 1.5 0.0 0.0 2.3 0.1 0.7 5.6 11.9 22.8 0.0 2.4 0.2 0.0 0.0 0.7 1.1 0.0 1.6 28.1 1.0 0.8 0.1 30.4 0.1 0.1 0.0 0.0 0.0 0.0 0.5 1.6 2.2 4.9 4.1 5.1 1.8 3.0 1.5 2.1 1.7 0.2 0.0 1.1 69.3 0.1 0.3 0.4 2.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 4.6 0.4 0.2 0.0 0.0 0.6 1.2 2.2 1.4 0.6 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.7 0.0 0.0 9.6 0.0 0.0 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 12.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 7.4;Ciliated cells: 4.0;Intestinal endocrine cells: 3.4" "Cancer enhanced" "Detected in some" "melanoma: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 11.4;LHCN-M2: 7.7;RH-30: 4.8;U-87 MG: 13.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA028776: AB_2672771, HPA028777: AB_2672772" "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.2 1.6 0.0 0.2 0.2 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.1 1.9 0.2 0.8 0.1 0.0 0.2 0.0 0.6 0.3 0.0 0.0 1.6 1.1 0.2 0.0 0.1 1.1 12.4 0.0 0.0 0.0 0.8 2.3 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.8 0.3 0.1 0.0 1.0 0.1 1.9 0.8 1.4 0.0 0.0 0.0 1.3 0.5 3.4 1.6 0.0 0.1 0.1 0.3 0.0 2.1 0.8 0.0 3.3 0.0 2.8 0.4 0.0 1.4 0.1 11.4 0.0 0.0 2.3 0.7 7.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.8 0.2 0.0 0.0 0.2 3.6 1.4 0.1 0.6 0.2 0.0 0.0 0.0 2.5 0.4 0.0 0.0 0.2 0.0 0.0 13.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.1 7.4 2.4 0.0 4.0 0.0 1.8 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.9 0.2 2.3 0.0 0.1 1.6 3.4 2.5 0.0 1.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.4 0.0 0.6 0.0 0.0 1.4 0.4 0.1 0.3 0.0 0.0 0.0 P2RX7 "MGC20089, P2X7" ENSG00000089041 "Purinergic receptor P2X 7" Q99572 12 121132819-121188032 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell type enhanced" "Detected in many" 8 "Hofbauer cells: 22.5;Kupffer cells: 18.7;Macrophages: 34.0" "Cancer enhanced" "Detected in all" "melanoma: 19.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 4.2;monocytes: 7.5;T-cells: 2.3" "Cell line enhanced" "Detected in some" "Karpas-707: 23.5;RPMI-8226: 13.8;SK-MEL-30: 23.3;U-266/70: 12.9;U-266/84: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034968, HPA042013, HPA044141" Approved NA NA "HPA034968: AB_10673105, HPA042013: AB_2677797, HPA044141: AB_2678830" "unprognostic (1.05e-1)" "unprognostic (4.90e-2)" "unprognostic (8.87e-2)" "unprognostic (6.54e-3)" "unprognostic (4.49e-2)" "unprognostic (1.55e-2)" "unprognostic (8.82e-2)" "unprognostic (9.11e-2)" "unprognostic (1.05e-2)" "unprognostic (1.08e-1)" "unprognostic (2.42e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.91e-1)" "unprognostic (3.59e-2)" "unprognostic (5.55e-2)" "unprognostic (1.65e-1)" 2.4 3.1 13.7 5.7 25.2 2.9 2.4 7.8 23.3 4.6 3.0 26.5 0.1 1.7 4.8 1.8 1.7 2.9 4.1 1.5 14.8 5.9 1.2 5.3 7.4 6.0 30.5 9.4 10.2 1.2 2.4 2.0 3.4 14.5 2.3 2.8 3.1 2.8 2.2 0.8 15.1 1.7 5.1 16.3 6.5 1.8 1.6 26.1 0.4 1.4 0.5 4.0 3.1 3.3 0.6 4.2 0.5 7.5 1.0 2.3 1.3 0.0 0.0 0.0 0.6 0.7 0.3 0.5 0.0 1.1 0.4 1.0 0.0 0.0 0.0 0.0 0.4 2.5 0.1 0.0 0.0 0.3 1.0 0.1 0.4 0.0 0.0 0.5 0.9 6.9 0.6 0.0 1.1 0.0 0.0 1.1 0.2 0.0 23.5 0.0 0.0 0.1 2.5 0.0 0.0 0.2 2.1 5.2 13.8 0.0 0.0 0.3 1.4 0.1 0.0 23.3 0.0 0.3 4.5 0.0 0.4 0.1 0.0 0.1 12.9 11.2 0.1 1.4 6.7 3.6 0.4 4.8 0.0 2.3 7.5 0.8 0.6 1.1 1.0 4.2 0.4 1.0 1.0 0.5 1.0 5.1 0.8 2.3 1.3 13.7 25.2 7.8 23.3 14.8 5.9 30.5 9.4 14.5 26.1 3.0 4.5 2.0 3.1 6.2 2.0 2.2 7.6 6.7 6.8 0.0 2.0 2.5 0.0 0.8 0.6 3.4 0.0 0.0 0.0 0.8 2.3 0.9 5.8 2.9 22.5 1.6 0.0 5.5 18.7 0.4 10.3 34.0 15.1 3.6 0.0 1.4 0.3 0.0 9.9 0.0 0.7 6.5 2.3 1.1 0.7 3.1 3.3 4.6 0.0 0.7 P2RY1 "P2Y1, SARCC" ENSG00000169860 "Purinergic receptor P2Y1" P47900 3 152834693-152841439 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;placenta: 24.7" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 22.9;Kupffer cells: 17.8;Muller glia cells: 16.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 29.1" "Group enriched" "Detected in some" 5 "basophil: 7.0;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 7.0;monocytes: 4.1" "Cell line enriched" "Detected in some" 5 "HEL: 30.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015577 Enhanced NA NA "HPA015577: AB_1854882" "unprognostic (3.30e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.76e-2)" "unprognostic (9.70e-2)" "unprognostic (1.40e-3)" "unprognostic (3.32e-2)" "unprognostic (2.53e-1)" "unprognostic (5.14e-1)" "unprognostic (2.58e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (2.04e-7)" "unprognostic (1.36e-1)" "unprognostic (8.98e-2)" "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" 2.9 1.7 4.7 5.9 29.1 4.8 2.0 3.1 6.3 6.7 8.7 4.9 0.6 3.3 8.5 0.8 19.4 2.3 2.2 2.9 8.4 2.3 1.1 1.6 10.4 2.1 1.8 6.1 9.6 3.6 0.5 2.3 24.7 2.4 8.0 6.9 2.6 5.6 2.6 7.1 8.8 6.1 4.8 3.8 2.4 1.7 1.3 3.3 3.0 1.5 9.9 3.5 3.0 9.5 0.0 0.9 7.0 4.1 0.0 0.0 0.2 0.0 0.5 4.8 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 6.0 0.0 0.0 0.5 0.0 0.7 1.0 2.6 0.8 0.2 0.0 2.3 30.3 0.0 0.0 0.0 3.5 2.8 0.4 6.0 0.0 0.3 2.4 0.0 1.0 0.9 0.0 0.0 0.0 0.5 0.1 4.4 0.0 3.7 0.0 0.1 0.8 0.0 2.0 0.8 0.0 0.0 0.0 0.6 1.1 0.0 1.6 0.0 0.5 1.2 0.0 2.5 0.0 0.0 0.0 3.1 0.0 3.5 7.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.2 4.7 29.1 3.1 6.3 8.4 2.3 1.8 6.1 2.4 3.3 0.0 0.3 0.8 6.8 1.6 8.2 6.3 22.9 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.6 10.5 0.0 0.0 0.2 2.7 6.6 9.3 0.2 6.2 0.0 0.0 12.9 17.8 0.0 13.8 6.3 0.0 0.0 8.4 16.6 1.1 10.5 5.6 0.0 1.0 0.0 0.5 0.5 0.4 1.8 0.1 0.0 6.6 4.2 P2RY10 P2Y10 ENSG00000078589 "P2Y receptor family member 10" O00398 X 78945332-78961954 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 51.6;lymphoid tissue: 47.0" "Group enriched" "Detected in some" 5 "B-cells: 33.8;granulocytes: 29.9;monocytes: 54.1;T-cells: 38.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 51.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 53.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036757, HPA065766" Enhanced NA NA "HPA036757: AB_10696786, HPA065766: AB_2685556" "unprognostic (3.02e-3)" "unprognostic (1.47e-3)" "unprognostic (1.50e-6)" "unprognostic (6.62e-3)" "unprognostic (1.19e-1)" "unprognostic (1.13e-4)" "unprognostic (3.33e-2)" "unprognostic (8.30e-2)" "unprognostic (1.13e-2)" "unprognostic (4.13e-3)" "unprognostic (1.01e-1)" "unprognostic (8.66e-2)" "prognostic unfavorable (3.63e-4)" "unprognostic (2.23e-1)" "unprognostic (6.54e-2)" "unprognostic (3.85e-2)" "unprognostic (3.99e-2)" 1.9 0.5 0.4 19.1 0.5 5.7 1.0 0.4 0.4 1.4 3.8 0.0 0.1 1.7 1.0 0.5 2.6 0.8 2.2 0.8 0.5 0.5 1.4 1.0 6.2 47.0 0.5 0.0 1.1 0.5 0.0 0.6 0.1 0.1 0.9 2.5 0.8 3.9 0.3 0.5 0.8 11.0 0.4 0.7 31.2 2.3 0.5 0.0 23.3 1.5 1.8 30.0 9.9 1.3 19.3 0.9 51.6 2.3 4.0 9.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 53.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.6 0.0 0.1 0.0 51.6 0.0 36.8 3.2 0.2 2.9 17.8 7.3 6.4 0.9 19.3 6.8 5.0 6.8 4.0 2.3 0.7 9.7 3.2 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.0 0.1 0.0 0.0 1.7 33.8 0.0 1.5 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 29.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 8.5 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.0 38.8 0.0 0.1 P2RY12 "HORK3, P2Y12, SP1999" ENSG00000169313 "Purinergic receptor P2Y12" Q9H244 3 151337380-151384812 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.0" "Cell type enhanced" "Detected in some" 27 "granulocytes: 1.1;Kupffer cells: 2.9" "Cancer enriched" "Detected in many" 14 "glioma: 17.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 12.4" "Group enriched" "Detected in many" 13 "dendritic cells: 5.0;monocytes: 12.4" "Cell line enhanced" "Detected in some" "HSkMC: 1.7;JURKAT: 1.1;Karpas-707: 1.1;REH: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013796, HPA014518" Enhanced NA NA "HPA013796: AB_1854884, HPA014518: AB_2669027" "unprognostic (2.39e-2)" "unprognostic (1.60e-3)" "unprognostic (5.93e-2)" "unprognostic (1.77e-1)" "unprognostic (2.41e-2)" "unprognostic (2.52e-2)" "unprognostic (8.09e-2)" "unprognostic (1.72e-3)" "unprognostic (6.46e-2)" "unprognostic (8.64e-4)" "unprognostic (4.84e-2)" "unprognostic (5.96e-2)" "unprognostic (2.03e-1)" "unprognostic (8.92e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-2)" "unprognostic (4.04e-1)" 7.4 4.3 15.3 2.2 14.2 0.8 4.3 2.3 46.0 2.0 2.0 13.4 0.0 1.6 1.1 1.1 1.7 3.2 2.7 1.8 14.3 11.6 1.1 2.7 2.9 9.2 21.1 10.0 2.2 0.9 2.0 0.9 2.7 16.8 1.4 1.8 0.2 3.1 2.9 0.6 0.8 3.1 2.1 24.9 5.3 1.5 0.6 18.8 0.0 0.9 0.0 8.6 1.9 0.9 0.6 5.0 0.3 12.4 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.3 0.3 0.0 2.9 0.0 0.0 12.4 0.0 0.6 0.0 0.0 5.0 0.6 0.0 0.0 0.3 0.0 3.3 0.5 0.0 2.0 15.3 14.2 2.3 14.6 14.3 11.6 21.1 10.0 16.8 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P2RY13 "FKSG77, GPR86, GPR94, P2Y13" ENSG00000181631 "Purinergic receptor P2Y13" Q9BPV8 3 151326312-151329548 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 88.4;lymphoid tissue: 44.1" "Group enriched" "Detected in some" 6 "Kupffer cells: 83.1;Macrophages: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 88.4" "Group enriched" "Detected in many" 6 "granulocytes: 88.4;monocytes: 26.1" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;U-937: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049047 Enhanced NA NA "HPA049047: AB_2680611" "unprognostic (1.09e-3)" "unprognostic (7.51e-4)" "unprognostic (1.68e-2)" "unprognostic (2.37e-3)" "unprognostic (3.95e-2)" "unprognostic (8.66e-3)" "unprognostic (7.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.84e-3)" "unprognostic (1.83e-1)" "unprognostic (4.97e-2)" "unprognostic (1.17e-1)" "unprognostic (4.05e-1)" "unprognostic (4.46e-1)" "unprognostic (5.95e-2)" "unprognostic (2.21e-3)" "unprognostic (3.78e-1)" 4.0 2.6 5.1 13.4 6.1 15.1 2.7 1.7 8.2 1.7 2.8 13.8 0.1 3.0 1.5 2.2 2.1 2.1 2.5 1.7 4.9 4.7 1.8 5.1 5.0 35.1 7.1 3.4 1.3 2.1 1.0 1.7 3.2 8.1 2.1 4.2 2.0 1.9 2.1 1.3 1.6 7.4 3.5 8.2 44.1 1.8 1.2 5.1 2.0 1.5 1.1 5.5 3.8 1.5 0.2 10.1 88.4 26.1 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.2 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 23.6 20.3 0.0 23.5 0.0 0.2 0.0 0.0 10.1 0.0 0.0 0.0 88.4 0.0 26.1 0.1 0.0 10.2 5.1 6.1 1.7 8.2 4.9 4.7 7.1 3.4 8.1 5.1 0.0 9.6 3.2 0.1 0.0 0.8 0.4 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 6.6 1.6 0.0 0.6 83.1 0.0 0.0 40.1 0.0 6.4 0.0 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 P2RY14 "GPR105, KIAA0001" ENSG00000174944 "Purinergic receptor P2Y14" Q15391 3 151212117-151278467 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 54.9" "Group enriched" "Detected in some" 4 "granulocytes: 45.0;Macrophages: 18.5;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "eosinophil: 54.9;plasmacytoid DC: 24.4" "Group enriched" "Detected in many" 8 "dendritic cells: 24.4;granulocytes: 54.9" "Cell line enriched" "Detected in single" 73 "HMC-1: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022646 Uncertain NA NA "CAB022646: " "unprognostic (9.78e-2)" "unprognostic (7.47e-4)" "unprognostic (3.89e-2)" "unprognostic (4.52e-4)" "unprognostic (1.69e-2)" "unprognostic (2.57e-5)" "unprognostic (2.68e-2)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (1.64e-3)" "unprognostic (6.30e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.72e-5)" "unprognostic (3.79e-2)" "unprognostic (6.89e-2)" "unprognostic (1.58e-1)" "unprognostic (2.58e-2)" 14.3 0.9 3.9 9.0 6.9 0.5 6.1 1.9 3.8 5.2 17.6 1.3 1.3 5.7 7.2 9.4 17.6 1.2 4.4 4.4 4.3 3.0 2.1 0.7 8.5 7.1 5.0 2.8 1.8 0.9 2.2 4.7 25.9 3.7 10.4 8.3 11.2 2.1 1.1 4.2 2.8 16.3 15.8 2.3 4.4 17.2 2.1 4.2 4.7 3.6 8.9 5.3 21.4 1.7 4.9 24.4 54.9 0.1 2.8 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 39.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.1 54.9 0.2 0.0 5.0 0.8 0.1 0.5 3.3 4.9 0.0 0.0 2.2 2.8 0.0 24.4 0.2 0.5 3.9 6.9 1.9 3.8 4.3 3.0 5.0 2.8 3.7 4.2 3.0 0.3 6.7 0.0 2.1 1.7 1.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.3 2.8 0.0 45.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 18.5 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 25.8 2.7 0.0 0.1 1.5 0.2 2.9 0.0 0.1 P2RY2 P2U ENSG00000175591 "Purinergic receptor P2Y2" P41231 11 73218298-73236352 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.1;skeletal muscle: 29.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 14.0;Enterocytes: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 28.1" "Group enriched" "Detected in many" 12 "granulocytes: 28.1;monocytes: 10.4" "Cell line enhanced" "Detected in many" "HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB022642 Uncertain Uncertain Cytosol NA NA Cytosol "CAB022642: " "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (6.50e-4)" "unprognostic (2.04e-2)" "unprognostic (4.66e-3)" "unprognostic (8.93e-2)" "unprognostic (2.87e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (9.69e-2)" "unprognostic (4.92e-4)" "unprognostic (1.34e-1)" "unprognostic (2.82e-1)" "unprognostic (1.05e-1)" "unprognostic (8.57e-3)" 0.4 2.3 0.9 1.4 1.2 10.8 1.3 0.3 1.1 5.5 3.1 1.1 0.3 2.2 1.3 2.3 20.0 1.2 2.8 11.7 0.6 0.3 0.9 2.6 2.9 1.5 1.2 0.6 1.7 1.7 6.1 1.1 10.3 1.0 1.7 2.4 3.3 4.0 1.6 29.5 3.4 10.8 0.4 0.4 6.6 0.6 0.7 0.6 0.6 20.2 20.6 12.8 2.1 10.9 0.0 1.6 28.1 10.4 0.0 0.0 1.2 3.6 3.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 8.4 2.8 0.0 5.6 0.2 0.0 16.4 0.4 7.7 0.0 0.0 0.3 1.2 0.2 1.5 0.0 15.5 0.0 0.0 3.6 1.2 0.2 0.0 0.7 0.0 0.7 0.0 0.0 12.4 0.0 12.6 0.2 3.3 12.9 0.0 0.0 0.5 1.2 8.8 0.0 0.0 0.2 14.3 0.0 0.1 6.6 36.3 5.3 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 2.8 0.0 0.2 3.4 28.1 0.0 10.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 1.2 0.9 1.2 0.3 1.1 0.6 0.3 1.2 0.6 1.0 0.6 3.0 0.3 0.0 6.8 3.3 0.5 5.3 7.6 0.0 4.5 0.0 0.0 14.0 1.7 5.0 5.3 0.5 12.9 0.0 5.6 0.5 0.4 1.1 0.0 4.5 2.3 0.0 0.0 0.0 2.7 6.7 0.0 0.9 0.0 0.0 2.9 5.2 11.6 10.5 0.0 0.3 0.2 0.0 0.2 0.0 0.0 6.4 9.2 0.0 2.3 11.1 P2RY4 "NRU, P2P, P2Y4, UNR" ENSG00000186912 "Pyrimidinergic receptor P2Y4" P51582 X 70258170-70259764 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" CAB022644 Uncertain NA NA "CAB022644: " "unprognostic (4.59e-2)" "unprognostic (4.23e-1)" "unprognostic (7.10e-2)" "unprognostic (1.69e-1)" "unprognostic (9.53e-4)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (6.77e-2)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.90e-2)" "unprognostic (3.72e-2)" "unprognostic (3.61e-2)" "unprognostic (1.50e-2)" "unprognostic (3.89e-1)" 0.3 0.1 0.2 0.2 0.2 0.1 0.4 0.2 0.2 2.1 2.9 0.2 0.2 0.7 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 1.6 0.2 0.6 0.2 0.2 2.1 14.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.8 0.3 0.5 0.0 0.2 0.4 0.1 0.3 0.1 0.6 0.1 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.5 1.8 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.6 0.0 1.1 0.3 0.8 0.2 0.6 0.1 0.0 0.3 0.7 0.3 0.0 0.0 0.4 0.1 0.7 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.8 1.2 0.1 1.2 0.3 0.6 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P2RY6 P2Y6 ENSG00000171631 "Pyrimidinergic receptor P2Y6" Q15077 11 73264505-73298617 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 36.4;lymphoid tissue: 31.1;placenta: 38.0" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 107.7;Syncytiotrophoblasts: 227.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "myeloid DC: 10.9;plasmacytoid DC: 36.4" "Lineage enriched" "Detected in many" 20 "dendritic cells: 36.4" "Cell line enhanced" "Detected in some" "AN3-CA: 33.7;EFO-21: 10.6;MCF7: 15.7;SK-BR-3: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074751 Enhanced NA NA "HPA074751: " "unprognostic (2.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.04e-2)" "unprognostic (5.54e-3)" "unprognostic (4.18e-3)" "unprognostic (1.94e-2)" "unprognostic (3.93e-3)" "unprognostic (4.00e-3)" "unprognostic (1.86e-4)" "unprognostic (3.08e-1)" "unprognostic (1.25e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (2.50e-7)" "unprognostic (1.48e-2)" "unprognostic (1.38e-3)" "unprognostic (7.67e-2)" "unprognostic (1.05e-1)" 2.5 1.8 2.7 8.3 3.5 0.8 1.5 0.5 3.2 2.5 2.1 3.1 0.0 3.0 1.2 2.6 2.9 1.6 2.4 2.7 1.8 1.0 6.2 3.7 3.0 4.8 2.3 1.7 2.1 1.7 0.5 2.7 38.0 2.8 2.1 2.2 5.9 2.0 0.9 2.9 0.9 4.9 3.4 3.8 31.1 1.9 0.8 3.5 3.3 5.0 1.8 3.1 4.1 1.6 0.0 36.4 0.1 1.8 1.5 0.1 1.0 0.7 8.0 0.0 33.7 0.0 0.0 6.9 0.1 0.0 0.1 0.1 7.2 0.1 0.0 10.6 0.3 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.8 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.1 15.7 0.1 1.3 0.1 0.1 0.0 0.0 0.0 1.0 5.5 0.0 0.1 0.5 1.4 27.2 0.0 0.6 6.4 1.5 0.1 1.3 0.1 1.1 0.1 0.3 0.0 0.0 1.3 2.2 0.0 0.0 1.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.1 1.5 0.6 36.4 0.0 1.0 2.7 3.5 0.5 3.2 1.8 1.0 2.3 1.7 2.8 3.5 0.0 1.1 1.5 0.3 0.1 0.0 0.8 0.0 1.4 0.0 8.7 0.0 107.7 3.3 2.4 0.4 2.2 0.0 0.0 13.1 7.5 0.2 0.2 0.0 0.0 17.0 0.0 0.0 1.8 3.9 1.7 0.0 9.7 0.0 21.6 0.0 0.6 9.6 0.0 0.0 7.0 0.0 0.0 0.8 0.0 0.0 0.4 227.8 0.0 0.0 0.1 P2RY8 P2Y8 ENSG00000182162 "P2Y receptor family member 8" Q86VZ1 X 1462572-1537107 "Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.7;lymphoid tissue: 19.0" "Group enriched" "Detected in some" 5 "B-cells: 29.8;Kupffer cells: 10.2;monocytes: 20.8;T-cells: 20.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 33.9;MOLT-4: 16.7;NB-4: 16.7;RPMI-8226: 20.8;THP-1: 20.8;U-266/70: 28.5;U-698: 55.5;U-937: 17.2" "Not detected" "Not detected" HPA003631 Enhanced NA NA "HPA003631: AB_1079543" "unprognostic (4.32e-2)" "unprognostic (3.22e-5)" "unprognostic (6.31e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.80e-5)" "prognostic favorable (1.73e-4)" "unprognostic (5.27e-3)" "unprognostic (5.76e-3)" "unprognostic (5.52e-3)" "prognostic favorable (6.54e-4)" "unprognostic (4.29e-2)" "unprognostic (8.45e-3)" "unprognostic (2.90e-1)" "unprognostic (4.00e-2)" "unprognostic (3.55e-1)" "unprognostic (2.80e-1)" 2.9 4.8 0.5 8.9 2.2 13.9 8.2 0.9 1.8 4.7 1.6 0.5 0.5 1.3 7.1 0.5 0.8 0.8 1.6 11.8 0.9 0.2 13.5 0.8 2.1 19.0 3.6 1.7 5.8 1.1 1.0 6.9 3.4 2.7 1.6 1.3 0.5 1.6 0.5 1.1 0.4 7.8 0.5 3.9 16.6 2.0 0.5 2.0 0.5 8.1 0.5 16.7 2.7 2.8 18.5 5.8 17.8 7.3 15.6 26.7 18.3 0.1 0.1 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 33.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.1 0.3 0.3 1.7 0.0 14.8 3.6 0.0 0.0 0.0 0.0 0.3 0.0 10.1 0.3 14.3 0.0 0.0 16.7 16.7 0.2 0.0 0.3 15.1 0.1 20.8 0.0 0.2 0.0 0.2 0.1 0.3 0.1 0.3 0.1 20.8 0.0 0.3 0.3 0.1 0.0 28.5 5.3 55.5 0.0 17.2 0.0 17.8 7.3 12.4 26.7 5.5 24.6 15.4 20.2 25.1 5.8 18.5 16.1 16.5 4.7 15.6 2.2 1.5 15.9 18.3 0.5 2.2 0.9 1.8 0.9 0.2 3.6 1.7 2.7 2.0 0.0 2.6 29.8 0.0 0.3 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.4 0.1 1.1 0.0 1.9 0.0 0.0 4.3 10.2 0.0 0.0 1.6 1.7 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 20.1 0.0 0.0 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 74.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 62.9;Collecting duct cells: 41.8;Ito cells: 44.8;Muller glia cells: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 20.3" "Lineage enriched" "Detected in single" 104 "dendritic cells: 20.3" "Cell line enhanced" "Detected in many" "GAMG: 38.1;HaCaT: 34.0;RPTEC TERT1: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 2.4 22.6 2.9 4.0 3.9 0.2 3.1 0.7 2.2 14.3 11.8 6.2 11.5 1.2 15.0 13.5 8.9 4.6 8.4 3.8 2.8 2.1 74.5 3.5 22.5 3.6 8.1 1.0 11.2 3.9 1.4 6.1 11.0 5.6 19.9 5.3 10.3 2.7 14.3 0.6 8.6 3.6 16.3 7.6 33.7 12.0 2.8 5.3 2.0 1.7 6.3 2.7 5.7 9.8 0.0 20.3 0.1 0.1 0.0 0.0 0.1 14.0 5.6 11.0 0.0 0.2 0.4 13.3 15.0 5.9 2.4 4.0 4.5 5.5 0.0 8.5 2.6 38.1 34.0 0.0 20.1 5.1 0.1 1.9 0.0 3.8 0.0 11.4 0.0 0.1 5.4 6.8 4.8 1.7 23.3 0.4 0.0 0.0 0.1 3.8 0.3 0.0 0.1 3.4 9.4 1.1 0.0 2.2 0.8 34.7 23.7 0.8 0.1 20.4 1.1 8.9 16.9 0.0 0.2 7.5 14.6 5.5 0.1 2.7 1.0 0.0 0.1 3.3 0.0 18.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.1 2.9 3.9 0.7 2.2 2.8 2.1 8.1 1.0 5.6 5.3 44.7 62.9 1.9 7.4 0.0 2.2 1.0 5.1 0.0 5.7 41.8 3.9 30.9 5.0 3.8 14.3 4.5 0.0 0.0 0.7 11.7 2.0 13.7 1.1 0.6 9.1 9.5 0.0 44.8 4.6 11.4 4.4 4.7 0.0 1.0 0.2 49.8 18.0 0.0 0.0 24.5 0.8 0.0 2.7 0.5 0.4 0.0 32.3 0.0 0.0 2.8 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 105.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 94.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" Yes No "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavorable (9.01e-4)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavorable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 16.8 14.4 16.5 10.4 20.2 7.0 47.6 9.9 18.2 18.5 10.9 11.3 7.4 5.6 14.8 12.2 11.6 22.4 14.1 23.9 17.0 10.9 19.0 39.9 18.1 7.5 33.5 4.9 22.3 13.1 11.1 8.6 33.5 25.4 17.9 9.4 8.6 8.5 10.4 63.5 10.3 7.8 15.1 45.8 9.7 11.1 9.7 30.9 4.1 19.4 7.5 7.3 34.4 105.7 6.9 14.8 10.2 17.3 3.4 7.3 6.1 15.2 3.9 11.4 22.1 35.2 27.1 9.5 44.7 40.5 17.3 41.6 6.5 11.9 5.2 17.1 44.2 10.5 17.3 7.1 16.3 37.9 6.6 2.7 4.4 3.7 7.7 14.7 8.1 3.1 16.4 9.5 14.7 19.5 94.8 8.1 4.4 6.8 2.7 14.9 4.0 3.2 7.8 4.1 7.1 17.3 2.9 7.6 9.3 9.7 6.6 1.0 6.4 9.1 27.0 10.6 26.9 4.1 7.6 7.7 21.2 8.7 5.9 10.4 15.6 5.6 2.5 38.0 11.8 10.3 0.8 13.5 10.2 5.2 16.4 6.7 6.0 6.2 6.0 14.8 6.9 4.6 4.7 7.4 3.4 17.3 11.8 7.3 6.1 16.5 20.2 9.9 18.2 17.0 10.9 33.5 4.9 25.4 30.9 6.0 27.9 18.6 25.1 32.3 12.9 37.9 2.5 56.2 31.8 22.7 25.5 25.0 0.0 26.6 10.0 23.3 10.7 0.0 17.0 76.6 76.1 22.0 39.3 25.1 39.6 11.1 9.9 19.0 44.8 4.7 48.1 41.1 42.2 36.1 7.6 33.4 37.2 18.2 44.2 22.8 17.6 38.8 31.1 35.7 35.8 20.8 27.8 13.8 6.5 17.3 P4HA3 C-P4Halpha(III) ENSG00000149380 "Prolyl 4-hydroxylase subunit alpha 3" Q7Z4N8 11 74235801-74311657 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 22.6" "Cell type enhanced" "Detected in some" 10 "Cone photoreceptor cells: 13.7;Early spermatids: 16.6;Erythroid cells: 23.3;Horizontal cells: 17.5;Rod photoreceptor cells: 14.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.8;fHDF/TERT166: 6.2;HSkMC: 6.2;HUVEC TERT2: 25.4;TIME: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007897 Approved "Intracellular and membrane" NA NA "HPA007897: AB_2156427" "unprognostic (2.74e-2)" "unprognostic (1.37e-4)" "unprognostic (1.31e-3)" "unprognostic (3.19e-2)" "unprognostic (2.54e-4)" "unprognostic (9.65e-3)" "unprognostic (4.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.02e-1)" "unprognostic (4.21e-3)" "unprognostic (1.38e-2)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.34e-9)" "unprognostic (1.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (7.83e-4)" 3.0 1.2 0.1 4.7 0.5 0.0 1.3 2.1 0.4 2.5 2.3 0.4 2.8 0.3 7.1 22.6 0.7 1.9 7.5 1.1 0.4 0.2 0.9 1.7 2.2 0.9 0.1 0.0 3.8 0.3 0.0 5.7 7.4 1.1 9.8 0.9 6.4 2.0 6.1 1.1 0.5 1.0 13.7 0.4 0.2 0.7 2.3 0.0 0.0 4.1 1.6 0.4 9.7 2.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 4.3 0.4 0.0 12.8 0.9 0.6 1.4 0.0 0.0 0.0 1.2 6.2 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.7 0.0 5.5 0.0 0.0 6.2 0.0 4.4 0.5 0.7 25.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 18.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.1 0.4 0.4 0.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.3 8.6 0.3 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.2 16.6 0.7 0.0 23.3 0.0 0.4 1.0 0.7 0.0 0.0 0.3 17.5 0.0 4.3 0.0 1.1 0.0 0.0 0.0 1.8 0.1 3.1 0.4 0.0 0.4 0.0 14.5 0.0 0.5 2.6 3.4 0.3 0.1 0.0 0.1 0.6 P4HB "DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB" ENSG00000185624 "Prolyl 4-hydroxylase subunit beta" P07237 17 81843159-81860694 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Chaperone, Isomerase" "Craniosynostosis, Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 383.4;pancreas: 677.5" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 1160.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012463, HPA018884" Enhanced Supported "Endoplasmic reticulum" "Secreted - unknown location" No No 140000000 "Endoplasmic reticulum" "CAB012463: , HPA018884: AB_1854896" "unprognostic (9.47e-3)" "unprognostic (1.09e-2)" "unprognostic (2.99e-2)" "unprognostic (7.14e-3)" "unprognostic (7.75e-3)" "unprognostic (1.05e-2)" "unprognostic (1.30e-1)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (4.73e-3)" "unprognostic (1.43e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (2.30e-11)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (4.99e-3)" "unprognostic (3.19e-3)" 18.0 34.7 6.3 15.4 8.4 35.0 16.1 6.1 6.5 22.1 40.5 9.0 45.0 42.6 14.7 29.1 40.3 12.8 42.3 20.7 6.3 5.9 27.2 383.4 20.9 29.1 7.9 4.5 14.3 677.5 6.4 23.4 58.5 7.2 22.5 8.5 12.3 251.9 42.5 31.0 24.3 112.8 11.0 5.2 36.7 31.6 9.1 7.2 10.5 29.7 50.7 46.4 16.5 20.5 21.6 71.3 45.8 60.8 38.8 55.9 70.8 58.4 50.9 18.9 60.8 51.0 60.1 44.7 114.3 73.7 49.8 67.5 37.4 51.3 23.6 50.3 73.4 30.1 41.5 20.7 44.7 28.9 15.2 35.1 35.3 53.6 152.0 67.1 111.5 58.5 45.3 30.4 39.9 42.3 64.5 82.1 16.9 25.0 102.0 35.5 53.4 31.9 88.6 14.8 62.0 46.4 26.1 33.8 46.8 38.7 70.7 22.7 25.1 57.0 164.5 59.3 32.6 74.4 131.4 63.7 93.6 46.9 53.1 55.7 73.4 53.1 22.3 123.0 43.0 71.3 45.8 60.8 38.3 53.5 38.7 55.9 21.6 36.4 42.8 43.4 18.7 21.2 31.5 20.0 38.8 27.6 71.3 25.7 70.8 6.3 8.4 6.1 6.5 6.3 5.9 7.9 4.5 7.2 7.2 95.3 135.6 82.0 139.4 106.7 53.8 19.6 234.4 58.9 83.0 106.4 31.4 682.3 34.9 562.2 31.8 104.1 635.2 0.0 930.3 1160.9 218.5 265.2 99.1 768.8 403.4 58.8 191.7 211.1 166.1 51.9 130.9 120.0 129.9 349.9 361.7 113.5 636.3 443.3 105.4 92.7 40.7 155.2 103.8 85.8 107.3 126.5 837.3 139.5 385.8 170.2 PABPC1L2A RBM32A ENSG00000186288 "Poly(A) binding protein cytoplasmic 1 like 2A" Q5JQF8 X 73077276-73079512 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.6;prostate: 5.2" "Group enriched" "Detected in some" 12 "Early spermatids: 10.8;Late spermatids: 36.2" "Cancer enriched" "Detected in single" 15 "prostate cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 9.1;NTERA-2: 3.3;SK-MEL-30: 1.8" HPA041573 Approved NA NA "HPA041573: AB_2677556" "unprognostic (4.30e-2)" "unprognostic (2.19e-1)" "unprognostic (3.22e-1)" 0.1 3.5 3.3 0.2 5.0 0.0 0.1 7.1 9.6 0.1 0.2 0.4 0.1 1.4 0.0 0.2 0.2 0.0 3.5 9.2 0.2 0.1 0.1 0.0 2.9 0.4 0.1 0.0 1.2 0.0 5.2 0.1 0.8 0.6 0.1 0.1 0.2 0.0 2.4 0.7 0.1 3.2 0.3 0.1 0.2 0.0 0.2 0.1 0.7 0.2 0.8 0.1 0.3 0.0 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.1 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 9.1 0.4 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.5 0.1 1.8 0.3 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.7 0.3 0.1 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.8 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 PABPC1L2B RBM32B ENSG00000184388 "Poly(A) binding protein cytoplasmic 1 like 2B" Q5JQF8 X 73003517-73005713 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 12.2;prostate: 6.6" "Cell type enhanced" "Detected in single" 34 "Early spermatids: 1.2" "Cancer enriched" "Detected in single" 23 "prostate cancer: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "HAP1: 2.7;NTERA-2: 5.8;U-2 OS: 1.9" HPA041573 Approved NA NA "HPA041573: AB_2677556" "unprognostic (1.73e-1)" "unprognostic (2.26e-1)" "unprognostic (3.31e-1)" 0.1 1.6 3.3 0.1 4.9 0.1 0.1 6.4 12.2 0.1 0.1 0.4 0.1 0.5 0.1 0.1 0.1 0.1 3.5 10.2 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.1 1.0 0.1 6.6 0.1 0.8 0.5 0.1 0.1 0.1 0.1 2.1 0.2 0.1 1.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 PABPC3 "PABP3, PABPL3, tPABP" ENSG00000151846 "Poly(A) binding protein cytoplasmic 3" Q9H361 13 25095868-25099254 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 50.9" "Group enriched" "Detected in many" 9 "Early spermatids: 131.2;Late spermatids: 106.4;Spermatocytes: 81.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 14 "U-266/84: 11.7" "HPA045423, HPA067156" Approved Approved Cytosol NA NA Cytosol "HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (2.17e-2)" "unprognostic (6.50e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.78e-1)" "unprognostic (2.98e-1)" "unprognostic (8.76e-3)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.00e-4)" "unprognostic (5.26e-4)" "unprognostic (1.04e-1)" "unprognostic (1.17e-2)" "unprognostic (5.18e-2)" "unprognostic (5.32e-2)" "unprognostic (1.39e-1)" "unprognostic (7.61e-3)" 0.5 0.2 0.2 0.5 0.8 0.2 1.0 0.1 1.1 0.7 0.5 0.1 0.0 0.2 0.2 0.3 0.7 0.2 0.2 0.2 0.3 0.1 0.2 0.2 1.2 2.0 0.2 0.4 0.4 0.3 0.1 0.4 0.2 0.3 0.4 0.2 0.0 0.6 0.9 0.2 0.4 0.5 0.2 0.1 0.4 0.2 50.9 0.0 0.8 0.3 0.0 0.2 0.3 0.4 1.6 1.9 0.5 2.2 1.8 2.5 1.9 0.4 0.0 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.2 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.8 0.7 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.8 0.2 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.2 0.4 11.7 0.2 0.1 0.3 0.1 0.4 1.4 0.5 0.7 2.1 1.6 1.6 1.7 1.3 1.9 1.3 2.5 2.2 0.5 1.8 2.2 1.1 1.5 1.9 0.2 0.8 0.1 1.1 0.3 0.1 0.2 0.4 0.3 0.0 0.0 0.0 0.5 4.6 10.4 0.0 4.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 131.2 3.6 0.6 0.0 0.3 1.4 3.5 3.4 4.6 0.6 1.4 1.6 4.1 3.1 5.6 106.4 2.8 3.9 5.0 0.0 1.3 1.0 0.1 3.5 4.6 0.8 0.0 6.5 4.1 81.1 4.6 11.3 2.4 2.2 3.3 3.1 PABPC4 "APP-1, iPABP" ENSG00000090621 "Poly(A) binding protein cytoplasmic 4" Q13310 1 39560816-39576790 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 137.3;skeletal muscle: 117.8" "Cell type enhanced" "Detected in all" 6 "Kupffer cells: 414.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027301, HPA056496" Supported Enhanced Cytosol NA NA Cytosol "HPA027301: AB_2672208, HPA056496: AB_2683153" "unprognostic (6.81e-2)" "unprognostic (7.01e-3)" "unprognostic (2.93e-2)" "unprognostic (5.45e-2)" "unprognostic (3.63e-1)" "unprognostic (1.29e-2)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.22e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.76e-2)" "unprognostic (5.71e-2)" "prognostic unfavorable (3.00e-10)" "unprognostic (1.87e-1)" "unprognostic (3.18e-1)" "unprognostic (2.91e-1)" "unprognostic (5.08e-1)" 30.0 19.2 9.0 23.0 7.9 20.8 19.6 7.2 9.6 19.1 26.0 14.0 22.0 12.4 22.2 21.1 20.3 13.7 20.2 32.0 8.6 7.2 12.3 28.8 24.9 38.2 8.3 7.3 28.6 137.3 9.1 8.2 16.2 8.6 20.7 11.5 15.4 16.4 22.9 117.8 12.9 21.1 22.4 16.4 27.5 28.0 29.2 6.4 21.5 18.1 51.1 21.0 25.3 20.3 13.9 13.7 6.7 21.2 8.2 21.4 5.5 57.5 15.7 16.7 27.7 41.8 83.0 54.9 34.1 23.9 26.5 19.7 31.4 30.2 49.8 33.9 42.8 12.6 30.8 31.8 38.1 34.3 25.4 26.2 41.9 17.9 31.2 41.9 27.7 28.2 71.9 45.1 32.2 49.1 37.4 33.2 39.6 44.4 27.6 42.5 22.5 28.7 35.8 51.6 19.4 18.0 22.1 53.5 37.7 25.5 56.9 15.8 24.0 23.8 22.7 51.5 31.7 24.2 82.2 29.9 25.8 35.8 62.4 43.0 71.2 78.1 38.7 38.3 28.1 14.7 6.7 13.9 3.5 9.9 18.0 10.6 13.8 16.1 10.3 13.7 13.9 21.4 15.1 1.4 8.2 21.2 13.5 11.2 5.5 9.0 7.9 7.2 9.6 8.6 7.2 8.3 7.3 8.6 6.4 17.9 49.3 108.2 65.3 49.6 24.0 117.4 112.1 8.1 54.6 45.4 76.6 73.5 34.9 38.4 37.3 38.0 79.4 70.0 78.6 128.3 61.8 38.6 51.9 117.5 95.8 31.8 56.9 82.3 414.4 19.0 63.9 76.1 54.0 32.5 56.2 26.4 58.7 46.3 43.5 34.2 89.3 6.5 60.6 30.6 120.1 36.5 89.6 43.3 61.7 91.4 PABPC5 PABP5 ENSG00000174740 "Poly(A) binding protein cytoplasmic 5" Q96DU9 X 91434595-91438584 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 20.9" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 10.6;Horizontal cells: 7.9;Leydig cells: 5.5;Peritubular cells: 11.0;Sertoli cells: 12.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.9;HSkMC: 4.1;LHCN-M2: 2.7;RH-30: 11.9;U-2 OS: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000164, HPA000165" Approved NA NA "HPA000164: AB_1079551, HPA000165: AB_1079552" "unprognostic (1.05e-1)" "unprognostic (2.98e-1)" "unprognostic (3.68e-2)" "unprognostic (2.92e-1)" "unprognostic (1.37e-1)" "unprognostic (1.56e-2)" "unprognostic (1.23e-1)" "unprognostic (3.52e-1)" "unprognostic (2.89e-2)" "unprognostic (1.01e-1)" "unprognostic (2.93e-2)" "unprognostic (2.46e-1)" "unprognostic (1.26e-1)" "unprognostic (6.87e-3)" "unprognostic (1.27e-1)" "unprognostic (4.55e-2)" "unprognostic (8.07e-2)" 4.3 14.1 5.3 1.9 4.3 0.4 7.3 2.2 6.2 8.1 4.0 5.7 1.3 1.2 10.3 5.2 2.8 3.9 2.9 3.6 3.7 3.7 2.0 1.0 2.4 1.8 5.1 2.4 20.9 1.3 1.5 11.7 1.8 4.9 5.5 1.9 3.8 1.9 4.3 1.3 1.3 1.9 5.8 5.2 3.4 2.3 3.3 4.9 0.0 4.5 2.1 1.4 4.9 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.3 0.0 0.1 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.3 2.2 5.9 3.7 3.7 5.1 2.4 4.9 4.9 0.0 0.0 0.0 0.3 0.1 10.6 0.6 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.1 7.9 0.0 1.3 0.0 0.4 5.5 0.0 3.3 0.0 0.0 3.2 0.0 0.0 11.0 0.0 2.8 12.9 2.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 PABPN1L ePABP2 ENSG00000205022 "Poly(A) binding protein nuclear 1 like, cytoplasmic" A6NDY0 16 88863333-88866660 "Predicted intracellular proteins" RNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.6;bone marrow: 3.0;brain: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 5.0;NB-4: 3.5;SCLC-21H: 9.6;T-47d: 2.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "cerebellum: 3.6" HPA043415 Uncertain NA NA "HPA043415: AB_10981610" "unprognostic (2.19e-1)" "unprognostic (1.50e-2)" "unprognostic (1.40e-3)" "unprognostic (8.96e-3)" "unprognostic (1.57e-1)" "unprognostic (3.19e-1)" 0.5 3.6 0.0 0.2 1.1 3.0 0.1 5.3 0.5 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 0.0 0.3 0.2 1.1 0.0 0.1 1.8 0.0 0.3 0.0 0.8 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 1.1 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 5.0 0.6 3.5 0.0 0.0 0.0 0.2 0.4 0.3 0.0 0.0 9.6 0.2 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PACRG "FLJ32724, Glup, HAK005771, PARK2CRG" ENSG00000112530 "Parkin coregulated" Q96M98 6 162727132-163315492 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 30.3;pituitary gland: 55.9;testis: 44.6" "Group enriched" "Detected in many" 4 "Ciliated cells: 96.4;Early spermatids: 253.8;Late spermatids: 263.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066293 Enhanced NA NA "HPA066293: AB_2685652" "unprognostic (3.06e-2)" "unprognostic (1.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.56e-2)" "unprognostic (2.48e-1)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (3.34e-1)" "unprognostic (8.31e-3)" "unprognostic (1.48e-1)" "prognostic favorable (2.55e-6)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (8.35e-2)" "unprognostic (2.93e-3)" 0.7 2.3 8.6 1.0 15.5 4.7 1.8 2.3 10.6 2.3 1.1 6.5 4.4 1.2 4.7 8.6 2.7 30.3 4.3 10.7 10.3 12.1 6.8 4.1 5.5 1.4 4.7 9.4 3.8 3.4 2.0 55.9 0.4 17.7 3.2 2.3 2.0 2.5 3.4 1.8 4.3 0.7 1.9 3.7 1.5 1.7 44.6 5.9 0.0 3.7 0.0 0.9 4.5 0.9 1.7 1.1 6.0 2.0 0.1 3.3 0.5 0.8 2.5 1.1 1.6 0.0 1.0 1.8 0.6 2.3 0.0 0.5 5.1 0.6 4.6 0.6 0.0 0.5 2.7 1.2 0.0 2.6 0.0 1.7 0.0 2.6 0.0 0.0 0.6 0.8 2.1 0.0 0.9 0.0 1.0 0.0 1.6 0.8 0.9 0.5 0.1 0.3 1.7 0.0 4.1 4.4 0.8 0.0 0.0 5.5 5.4 10.6 4.8 0.0 0.0 0.0 0.4 0.0 1.6 1.8 1.1 0.6 0.0 0.4 2.1 0.7 1.7 0.5 1.3 2.0 4.3 2.0 1.4 1.9 0.6 1.4 0.9 2.6 1.2 0.3 1.7 3.3 1.6 6.0 0.1 0.2 1.1 1.1 0.5 8.6 15.5 2.3 10.6 10.3 12.1 4.7 9.4 17.7 5.9 0.0 1.7 0.0 3.4 0.2 1.7 43.4 0.0 96.4 6.8 5.2 7.9 0.1 46.4 2.6 253.8 0.9 0.0 0.0 6.4 0.1 1.0 3.0 0.0 3.6 0.1 0.0 6.3 0.0 0.6 263.8 3.4 0.1 0.0 0.0 0.3 6.3 2.3 0.3 2.5 5.1 7.7 0.0 0.9 13.4 3.6 0.3 0.2 0.0 0.4 2.2 PACS2 "KIAA0602, PACS1L" ENSG00000179364 "Phosphofurin acidic cluster sorting protein 2" Q86VP3 14 105300563-105398147 "Predicted intracellular proteins, Transporters" "Apoptosis, Host-virus interaction" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.7;skeletal muscle: 63.8" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 92.2;Late spermatids: 63.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077892 Approved Mitochondria NA NA Mitochondria "HPA077892: AB_2686865" "unprognostic (4.31e-2)" "unprognostic (2.61e-1)" "unprognostic (4.53e-2)" "unprognostic (1.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.08e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.18e-2)" "unprognostic (1.37e-1)" "unprognostic (1.90e-1)" "prognostic favorable (2.95e-4)" "unprognostic (1.49e-1)" "prognostic favorable (1.56e-4)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" "unprognostic (2.58e-1)" "unprognostic (1.30e-1)" 15.3 10.8 18.8 7.7 25.5 6.1 13.3 20.5 29.8 8.0 7.7 41.7 6.5 8.4 10.0 8.1 8.9 9.6 8.7 15.1 23.9 18.0 6.8 3.7 9.3 6.1 36.8 13.9 11.8 21.3 10.3 8.1 6.9 26.3 7.6 5.5 6.7 11.8 9.8 63.8 7.2 9.1 8.1 65.7 10.9 7.4 13.4 26.8 2.7 7.1 7.0 4.4 8.3 7.3 0.6 5.4 0.3 4.0 2.1 2.0 0.9 9.3 12.9 12.2 11.5 12.2 11.9 14.5 7.1 8.3 6.1 5.4 5.6 17.8 10.2 12.1 10.8 7.9 10.8 7.4 10.2 4.4 12.7 6.1 4.6 5.1 8.3 16.1 3.8 8.5 13.8 9.8 4.3 10.0 7.8 11.1 10.4 2.9 9.6 5.3 29.3 6.4 5.1 4.7 11.9 10.7 14.4 7.4 6.5 5.2 21.6 27.5 14.6 6.8 6.2 10.6 8.0 15.6 7.1 16.8 9.1 4.2 14.3 7.1 12.7 8.2 3.8 13.9 6.9 8.8 0.0 1.6 0.2 0.9 2.7 1.7 0.2 0.8 1.0 2.7 0.6 0.3 1.0 0.3 2.1 4.0 5.4 2.0 0.9 18.8 25.5 20.5 18.9 23.9 18.0 36.8 13.9 26.3 26.8 8.9 14.3 0.8 6.5 8.0 30.2 17.8 7.6 1.4 13.6 5.2 11.8 3.8 11.6 11.7 47.3 15.8 19.0 0.0 19.9 2.8 11.2 8.4 1.1 7.8 15.0 92.2 12.5 19.6 14.3 63.1 16.1 13.3 25.3 8.2 13.4 14.7 14.0 10.5 15.6 10.5 22.4 6.5 12.7 12.9 11.3 7.3 2.9 5.3 16.6 7.1 PACSIN1 SDPI ENSG00000124507 "Protein kinase C and casein kinase substrate in neurons 1" Q9BY11 6 34466061-34535231 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 81.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 70.2;Cone photoreceptor cells: 76.6;Horizontal cells: 65.2;Rod photoreceptor cells: 88.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 15.0" "Lineage enriched" "Detected in many" 5 "dendritic cells: 15.0" "Cell line enhanced" "Detected in some" "MCF7: 9.9;RPMI-8226: 11.5;T-47d: 18.3;U-266/84: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009929, HPA028852, HPA055491" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834" "unprognostic (3.33e-1)" "unprognostic (1.21e-1)" "unprognostic (6.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.72e-2)" "unprognostic (2.47e-3)" "unprognostic (2.14e-2)" "unprognostic (2.65e-1)" "unprognostic (1.74e-1)" "unprognostic (6.63e-2)" "unprognostic (3.95e-4)" "unprognostic (9.12e-2)" "unprognostic (3.02e-2)" "unprognostic (4.18e-2)" "unprognostic (9.90e-2)" "unprognostic (5.50e-2)" "unprognostic (9.33e-2)" 1.5 2.1 42.5 2.4 33.8 2.0 1.4 29.3 81.7 1.5 1.7 2.1 0.0 1.8 1.9 1.5 1.4 2.0 1.7 4.7 32.8 21.9 1.6 1.4 1.5 4.4 14.6 32.9 1.7 6.1 1.4 1.2 1.4 31.6 1.8 1.6 5.5 1.6 1.7 1.5 1.4 1.8 1.5 3.7 2.5 2.4 1.9 4.1 0.0 1.4 0.0 3.4 2.0 0.0 0.0 15.0 0.0 0.0 3.1 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 3.8 0.7 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.9 0.1 0.0 9.9 0.6 0.0 2.4 0.1 0.0 0.1 0.0 11.5 0.0 0.3 3.6 0.2 0.0 1.9 0.0 0.4 18.3 2.0 0.0 0.0 0.3 0.0 0.0 3.0 13.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 15.0 0.0 0.1 42.5 33.8 29.3 56.3 32.8 21.9 14.6 32.9 31.6 4.1 0.0 0.0 0.0 0.0 0.0 70.2 4.0 0.0 0.0 0.0 0.0 76.6 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 1.1 88.6 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 PACSIN3 SDPIII ENSG00000165912 "Protein kinase C and casein kinase substrate in neurons 3" Q9UKS6 11 47177525-47186443 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 102.9;Muller glia cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039480, HPA043904" Approved Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039480: AB_2676531, HPA043904: AB_2678725" "unprognostic (1.75e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (6.89e-2)" "unprognostic (4.66e-2)" "unprognostic (8.17e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.86e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-2)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" 4.1 17.0 3.9 2.2 5.7 0.4 4.3 3.5 4.7 6.5 8.5 8.6 7.1 1.6 6.7 7.6 12.6 4.8 5.8 40.6 4.0 2.4 2.9 10.0 3.9 0.8 7.6 3.6 6.3 14.6 4.8 1.0 8.0 4.4 8.6 1.1 4.6 11.3 6.7 121.6 11.9 1.9 7.4 8.3 1.5 6.0 1.6 6.5 0.3 8.5 44.6 7.1 6.4 5.7 0.0 0.1 0.0 0.9 0.0 0.2 0.9 16.7 8.4 3.9 16.9 3.4 3.4 19.0 5.3 7.6 11.1 6.2 12.5 2.4 0.1 1.6 2.9 7.3 27.7 7.7 12.7 4.4 2.6 13.2 2.6 32.0 28.9 6.7 0.5 2.6 9.5 17.2 5.8 9.3 8.9 4.9 4.5 5.6 0.2 4.5 33.3 0.3 12.4 4.8 13.6 16.9 10.3 14.7 2.7 4.6 16.0 0.1 13.3 8.3 5.9 7.7 8.6 41.9 2.2 2.3 19.3 19.4 2.4 14.4 2.9 1.3 1.5 6.3 5.9 9.9 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.9 5.7 3.5 4.7 4.0 2.4 7.6 3.6 4.4 6.5 0.0 7.2 0.0 23.5 31.9 0.2 102.9 25.5 1.4 7.9 5.2 0.0 27.6 8.3 35.7 0.0 5.9 0.0 0.0 13.1 53.0 16.3 28.4 0.0 29.9 5.0 0.0 0.0 9.2 1.8 0.0 15.0 1.9 16.9 0.0 0.0 62.8 30.4 0.0 11.7 18.2 2.3 32.3 27.0 0.2 10.2 26.1 15.3 0.0 0.2 20.9 PADI1 "HPAD10, PAD1, PDI, PDI1" ENSG00000142623 "Peptidyl arginine deiminase 1" Q9ULC6 1 17205126-17246005 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 48.7;lymphoid tissue: 60.2" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 12.6;Extravillous trophoblasts: 10.0;Urothelial cells: 3.8" "Cancer enhanced" "Detected in many" "pancreatic cancer: 13.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.5;EFO-21: 4.6;HaCaT: 2.9;LHCN-M2: 3.6;RPTEC TERT1: 4.9" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Not detected" "Not detected" HPA062294 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA062294: AB_2684741" "unprognostic (9.30e-2)" "unprognostic (2.44e-1)" "unprognostic (6.15e-2)" "unprognostic (1.40e-1)" "unprognostic (5.22e-2)" "unprognostic (7.27e-2)" "unprognostic (3.84e-1)" "unprognostic (3.37e-2)" "unprognostic (1.41e-1)" "unprognostic (7.75e-2)" "unprognostic (1.01e-3)" "unprognostic (3.64e-2)" "prognostic unfavorable (8.34e-11)" "unprognostic (2.00e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.3 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.1 0.0 4.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.1 60.2 1.3 6.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.2 0.0 0.1 9.5 0.0 4.6 0.4 0.4 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 4.9 0.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 12.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.2 3.8 PADI2 "KIAA0994, PDI2" ENSG00000117115 "Peptidyl arginine deiminase 2" Q9Y2J8 1 17066761-17119435 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.7;skeletal muscle: 126.4" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 90.3;monocytes: 42.3;Mucus-secreting cells: 71.1;Paneth cells: 95.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 15.1;neutrophil: 37.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 37.2" "Cell line enhanced" "Detected in some" "A549: 6.9;RPTEC TERT1: 20.3;SK-BR-3: 31.1;T-47d: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047735 Enhanced NA NA "HPA047735: AB_2680139" "unprognostic (2.61e-2)" "unprognostic (3.60e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (2.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (3.74e-3)" "unprognostic (2.78e-3)" "unprognostic (3.28e-3)" "unprognostic (1.29e-1)" "unprognostic (3.07e-1)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-1)" "unprognostic (2.27e-1)" "unprognostic (5.91e-3)" 2.1 1.4 16.2 5.0 25.1 10.9 19.2 3.3 25.6 2.7 41.4 76.7 1.3 1.6 1.4 1.3 3.8 2.3 1.8 1.1 21.9 15.6 5.5 1.3 2.2 1.4 36.8 13.6 1.1 1.7 1.3 1.5 1.6 45.6 2.3 43.4 4.6 21.1 1.8 126.4 2.8 3.6 3.9 69.6 4.2 2.1 1.3 26.0 0.0 1.2 14.8 1.6 2.1 0.7 0.0 4.2 37.2 5.1 0.0 0.0 1.7 0.0 6.9 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.1 2.9 0.1 0.9 0.3 0.1 0.9 0.2 0.0 0.2 0.0 0.5 0.3 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 2.2 0.3 0.8 1.0 2.3 0.0 0.0 0.0 0.2 20.3 0.0 1.2 0.1 0.0 31.1 0.0 1.8 8.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.4 5.1 15.1 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 37.2 0.0 0.1 0.1 0.0 1.7 16.2 25.1 3.3 22.0 21.9 15.6 36.8 13.6 45.6 26.0 0.0 2.2 0.0 0.2 0.2 2.2 0.3 0.0 0.0 2.3 1.8 90.3 0.1 10.0 0.5 5.7 0.0 25.6 0.0 0.0 0.4 0.4 0.3 16.2 0.0 7.6 0.0 3.5 1.3 6.8 8.5 0.3 4.8 27.0 42.3 71.1 30.6 0.0 95.1 0.7 0.2 29.3 0.0 1.0 0.2 0.3 0.4 0.1 0.0 21.7 0.1 PADI3 PDI3 ENSG00000142619 "Peptidyl arginine deiminase 3" Q9ULW8 1 17249098-17284233 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Urothelial cells: 6.4" "Cancer enhanced" "Detected in many" "urothelial cancer: 48.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 13.5;RT4: 16.2;T-47d: 12.2;U-87 MG: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA043739 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA043739: AB_10959466" "unprognostic (4.47e-2)" "unprognostic (9.32e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.05e-3)" "unprognostic (6.66e-2)" "unprognostic (3.10e-3)" "unprognostic (5.88e-2)" "unprognostic (2.06e-4)" "unprognostic (1.03e-1)" "unprognostic (3.47e-4)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.55e-11)" "unprognostic (2.40e-2)" "unprognostic (4.73e-3)" "unprognostic (2.64e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 3.2 10.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.6 6.4 0.0 2.3 0.0 9.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 28.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 13.5 0.0 1.3 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 16.2 0.0 0.0 0.0 2.4 0.1 0.1 12.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 PADI4 "PAD, PADI5, PDI4, PDI5" ENSG00000159339 "Peptidyl arginine deiminase 4" Q9UM07 1 17308195-17364004 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 5.9;granulocytes: 11.6;Kupffer cells: 4.7;Spermatogonia: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2" "Group enriched" "Detected in many" 9 "granulocytes: 48.2;monocytes: 18.6" "Cell line enhanced" "Detected in some" "BEWO: 1.8;HEL: 4.2;NB-4: 1.7;RPMI-8226: 4.9" "Not detected" "Not detected" "HPA017007, HPA042825" Enhanced NA NA 12000 "HPA017007: AB_1854921, HPA042825: AB_2678189" "unprognostic (1.70e-1)" "unprognostic (2.25e-1)" "unprognostic (2.23e-1)" "unprognostic (2.98e-1)" "unprognostic (1.27e-1)" "unprognostic (1.13e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (8.49e-2)" "unprognostic (5.22e-2)" "unprognostic (8.55e-2)" "unprognostic (1.81e-1)" "unprognostic (1.66e-3)" "unprognostic (1.50e-1)" "unprognostic (1.28e-1)" "unprognostic (1.56e-2)" "unprognostic (1.80e-1)" 1.2 0.2 0.3 0.5 0.2 54.8 0.2 0.1 0.8 0.2 0.2 0.5 0.0 0.2 0.2 0.1 0.4 0.9 0.4 9.8 0.6 0.1 0.3 1.2 9.7 5.2 1.8 0.0 0.9 0.3 0.1 0.6 4.1 0.6 0.1 0.2 0.9 0.5 0.1 0.2 0.2 0.2 0.4 0.2 24.2 0.3 1.0 0.3 2.6 0.6 0.2 0.2 0.4 7.5 0.4 3.6 48.2 18.6 1.1 1.2 8.1 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.4 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.2 0.0 4.2 0.1 0.4 0.0 0.4 0.6 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 1.7 0.2 0.0 0.2 0.2 0.0 4.9 0.0 0.3 0.2 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.1 0.0 0.2 0.5 0.1 17.0 18.6 24.6 0.1 1.4 0.0 0.2 0.1 0.2 3.6 0.4 0.7 1.2 48.2 1.1 0.4 1.6 0.1 8.1 0.3 0.2 0.1 0.8 0.6 0.1 1.8 0.0 0.6 0.3 0.0 5.9 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 11.6 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.5 0.0 0.0 PADI6 ENSG00000276747 "Peptidyl arginine deiminase 6" Q6TGC4 1 17372196-17401699 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 4 "blood: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 3.5" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Not detected" "Not detected" NA NA "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (3.02e-2)" "unprognostic (6.56e-2)" "unprognostic (1.23e-1)" 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 3.5 0.0 0.8 0.0 1.9 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.9 0.1 0.0 0.0 0.2 1.1 3.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAEP "GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14" ENSG00000122133 "Progestagen associated endometrial protein" P09466 9 135561756-135566955 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "ductus deferens: 176.9;endometrium 1: 79.9;placenta: 105.3" "Group enriched" "Detected in some" 20 "Club cells: 7.9;Ductal cells: 4.2" "Cancer enriched" "Detected in many" 8 "melanoma: 275.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 22.0" "CAB016762, HPA020108, HPA029473" Enhanced "Secreted in female reproductive system" NA NA "CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147" "unprognostic (3.39e-2)" "unprognostic (8.47e-3)" "unprognostic (6.84e-2)" "unprognostic (3.46e-2)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.61e-6)" "unprognostic (1.27e-2)" "unprognostic (1.72e-1)" "unprognostic (3.95e-3)" "unprognostic (1.93e-3)" "prognostic unfavorable (0.00e+0)" "prognostic unfavorable (5.46e-4)" "unprognostic (4.24e-1)" "unprognostic (4.98e-2)" 0.3 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 1.3 0.1 0.0 176.9 0.2 79.9 0.1 0.1 5.0 0.0 0.1 0.1 0.3 0.1 0.3 0.4 0.0 0.1 0.0 0.8 0.1 0.0 0.2 105.3 0.0 1.1 0.0 0.0 0.2 13.9 0.1 1.1 0.1 0.0 0.1 0.2 2.0 0.5 0.0 0.0 0.1 0.0 0.0 0.8 0.1 1.3 1.3 5.8 0.9 0.8 0.8 0.3 0.1 0.5 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.7 0.5 0.4 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.6 2.3 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.2 3.1 0.5 0.0 0.3 0.0 0.7 0.5 0.0 0.0 0.2 0.2 0.4 0.0 0.2 0.5 0.2 0.1 0.2 22.0 0.7 0.4 0.2 0.0 0.1 1.1 0.3 0.1 1.0 2.1 0.2 0.3 0.4 0.5 5.8 0.9 0.6 0.6 0.5 0.5 0.6 0.8 0.6 0.3 1.3 0.7 0.8 4.0 0.8 0.8 1.3 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687450-49695993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 18.2" "Cell type enhanced" "Detected in some" 30 "Sertoli cells: 32.3;Spermatocytes: 65.7;Spermatogonia: 164.4" "Cancer enhanced" "Detected in many" "liver cancer: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 49.0;Karpas-707: 37.8;U-266/84: 58.3" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 37.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.7 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 5.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 32.3 0.0 65.7 164.4 0.0 0.0 0.0 0.0 0.0 PAGE2 "CT16.4, GAGEC2, MGC62094, PAGE-2" ENSG00000234068 "PAGE family member 2" Q7Z2X7 X 55089008-55092842 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 23.6" "Group enriched" "Detected in some" 4 "Spermatocytes: 63.7;Spermatogonia: 207.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "naive CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Group enriched" "Detected in some" 5 "U-266/70: 121.2;U-266/84: 156.1" HPA052619 Supported NA NA "HPA052619: AB_2681887" "unprognostic (3.49e-2)" "unprognostic (7.73e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.7 0.1 0.2 121.2 156.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 8.2 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.8 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 32.3 0.0 63.7 207.0 0.0 3.3 0.0 0.0 0.0 PAGE2B CT16.5 ENSG00000238269 "PAGE family member 2B" Q5JRK9 X 55075063-55078909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 33.2" "Group enriched" "Detected in some" 8 "Spermatocytes: 162.2;Spermatogonia: 278.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "U-266/70: 140.3;U-266/84: 214.4" HPA052619 Supported NA NA "HPA052619: AB_2681887" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.40e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (3.52e-1)" "unprognostic (3.22e-1)" "unprognostic (3.81e-2)" "unprognostic (2.05e-8)" "unprognostic (1.41e-1)" "unprognostic (8.84e-2)" 0.1 0.0 0.1 0.1 0.1 2.8 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.0 33.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.2 140.3 214.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 28.1 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 4.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.5 0.0 0.0 19.4 0.0 162.2 278.1 0.0 0.2 0.0 0.0 0.0 PAGE3 "CT16.6, GAGED1, PAGE-3" ENSG00000204279 "PAGE family member 3" Q5JUK9 X 55258412-55264846 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 111 "testis: 11.1" "Group enriched" "Detected in some" 54 "Early spermatids: 91.5;Late spermatids: 208.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;PC-3: 1.9" "HPA045032, HPA062248" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nuclear speckles" Nucleoplasm "HPA045032: , HPA062248: AB_2684725" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 208.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.8 1.6 0.0 0.0 0.0 0.0 0.0 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49833973 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "epididymis: 129.2;placenta: 199.4;prostate: 58.4" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 11201.2;Syncytiotrophoblasts: 7128.6" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.0;U-266/70: 8.6;U-266/84: 31.4" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.2 0.7 0.5 0.1 0.1 0.0 0.1 0.2 0.2 0.6 0.1 0.2 5.7 0.0 6.6 129.2 0.1 6.8 0.1 0.1 0.4 0.5 0.8 0.1 0.2 0.1 0.1 0.2 0.9 0.1 0.0 0.6 199.4 0.2 58.4 0.0 0.1 0.1 9.8 0.8 0.1 0.1 2.4 0.2 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.6 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.2 0.2 0.4 0.5 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11201.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 341.9 0.2 0.3 0.0 0.0 908.5 0.0 0.0 0.0 0.0 6.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 2.3 0.0 7128.6 0.0 0.0 0.0 PAGE5 "CT16.1, CT16.2, PAGE-5" ENSG00000158639 "PAGE family member 5" Q96GU1 X 55220355-55224108 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 32.0" "Group enriched" "Detected in some" 7 "Spermatocytes: 84.1;Spermatogonia: 158.4" "Group enriched" "Detected in many" 6 "liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.5" "Lineage enriched" "Detected in single" 14 "T-cells: 4.5" "Group enriched" "Detected in some" 164 "Karpas-707: 67.1;U-266/84: 141.6" "HPA052619, HPA055869" Supported Approved Mitochondria NA NA Mitochondria "HPA052619: AB_2681887, HPA055869: " "unprognostic (4.03e-1)" "unprognostic (4.51e-2)" "unprognostic (7.86e-4)" "unprognostic (1.39e-2)" "unprognostic (7.21e-2)" "unprognostic (1.06e-4)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (3.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 32.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.0 4.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.6 141.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 4.5 0.3 3.8 1.6 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.3 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 9.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 6.5 0.0 84.1 158.4 0.1 0.0 0.0 0.0 0.0 PAGR1 "C16orf53, GAS, MGC4606, PA1" ENSG00000280789 "PAXIP1 associated glutamate rich protein 1" Q9BTK6 16 29815952-29820117 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 49.1" "Cell type enhanced" "Detected in many" 7 "monocytes: 35.1" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041440, HPA043608" Uncertain NA NA "HPA041440: AB_10795541, HPA043608: AB_10797144" "unprognostic (2.35e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" "unprognostic (1.44e-2)" "unprognostic (4.20e-1)" "unprognostic (1.14e-3)" "unprognostic (7.09e-3)" "unprognostic (5.12e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (1.84e-3)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (8.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (5.39e-2)" 3.9 7.2 4.0 4.7 7.9 3.8 5.5 8.7 6.0 8.3 6.8 8.2 11.3 8.0 11.5 8.5 5.1 7.6 6.2 6.9 5.1 6.8 11.4 4.3 7.1 9.8 4.9 20.2 9.8 7.4 5.7 6.5 5.6 9.4 3.1 7.0 13.2 10.9 8.9 4.1 8.7 4.7 5.0 7.4 5.7 10.2 7.2 15.5 11.6 5.6 7.6 3.6 4.7 37.1 30.0 49.1 21.5 15.9 31.1 20.1 17.1 20.5 19.3 9.6 5.1 4.7 15.8 11.8 9.3 13.4 10.5 17.0 15.8 23.7 16.6 6.1 7.3 12.0 9.7 15.6 5.6 17.2 28.7 13.2 17.0 23.2 5.4 18.1 21.7 4.4 9.5 11.7 8.5 10.4 8.8 21.9 15.3 10.1 8.3 42.1 19.0 20.0 21.9 8.6 18.6 41.5 17.2 24.6 7.8 6.4 33.0 12.3 8.4 25.4 8.3 9.0 19.0 10.9 6.2 16.6 11.5 13.7 16.9 16.1 10.7 9.6 14.1 21.2 16.1 23.9 21.5 49.1 25.0 20.3 29.0 37.1 23.1 25.9 26.0 34.8 31.1 26.5 12.6 15.9 21.3 30.0 16.4 20.1 0.0 9.8 0.0 0.4 0.0 2.6 0.3 12.7 5.3 12.5 1.8 0.0 4.7 0.0 18.8 0.2 0.7 10.0 0.0 18.9 6.9 0.1 0.5 7.0 1.8 6.5 4.8 14.0 5.5 6.6 0.2 0.9 1.9 0.0 35.1 9.2 1.4 13.5 19.2 3.2 1.2 2.2 0.0 0.0 1.9 1.7 0.4 5.6 4.5 13.5 0.1 PAH PH ENSG00000171759 "Phenylalanine hydroxylase" P00439 12 102836885-102958410 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Phenylalanine catabolism" "Allosteric enzyme, Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 65.1;liver: 220.0" "Group enriched" "Detected in some" 8 "Cholangiocytes: 226.7;Hepatocytes: 723.9;Proximal tubular cells: 215.9" "Cancer enriched" "Detected in some" 17 "liver cancer: 94.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "Hep G2: 72.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA028407, HPA031642" Enhanced Approved "Endoplasmic reticulum,Vesicles" No NA "Endoplasmic reticulum, Vesicles" "HPA028407: AB_10601241, HPA031642: AB_2673974" "unprognostic (1.16e-1)" "unprognostic (1.52e-1)" "unprognostic (4.47e-2)" "unprognostic (9.13e-3)" "unprognostic (5.19e-2)" "unprognostic (5.99e-2)" "prognostic favorable (4.30e-4)" "unprognostic (1.27e-1)" "unprognostic (6.60e-2)" "unprognostic (4.45e-3)" "unprognostic (1.94e-3)" "unprognostic (1.83e-1)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (1.64e-1)" "unprognostic (3.96e-2)" "unprognostic (1.68e-2)" 0.1 1.3 0.5 0.0 0.5 0.0 0.1 0.2 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.1 20.3 0.1 0.8 0.3 65.1 220.0 0.0 0.0 0.3 0.7 0.1 1.7 0.0 1.6 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 2.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 1.0 0.8 0.3 0.3 0.7 0.8 0.4 0.0 0.0 16.2 0.0 0.0 0.0 0.4 226.7 0.0 0.0 5.2 0.0 0.0 18.3 2.0 50.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 723.9 0.0 3.2 1.7 14.1 22.2 13.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 215.9 0.1 0.0 0.0 0.7 0.4 0.0 0.0 5.0 0.0 0.0 PAIP2B KIAA1155 ENSG00000124374 "Poly(A) binding protein interacting protein 2B" Q9ULR5 2 71182739-71227083 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 60.6;Hepatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 13.2;SCLC-21H: 20.5" "Low region specificity" "Detected in all" "HPA046784, HPA072371" Approved Approved Cytosol NA NA Cytosol "HPA046784: AB_2679804, HPA072371: AB_2686514" "unprognostic (8.70e-2)" "unprognostic (8.20e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (8.17e-5)" "unprognostic (4.56e-2)" "unprognostic (1.34e-1)" "unprognostic (9.67e-3)" "unprognostic (1.51e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (2.76e-1)" "prognostic favorable (6.96e-12)" "unprognostic (1.63e-2)" "unprognostic (3.87e-1)" "unprognostic (1.21e-2)" "unprognostic (4.61e-2)" 2.8 2.4 36.3 2.3 28.8 1.8 4.8 11.9 15.7 3.3 4.2 50.9 5.1 4.0 3.5 2.5 6.2 7.4 1.8 17.8 39.5 25.1 9.9 16.6 3.3 2.5 47.7 9.7 11.6 47.8 6.4 2.1 1.4 21.9 5.2 4.2 2.7 29.9 5.6 39.4 15.1 3.2 3.4 44.9 2.7 6.7 2.7 24.6 0.6 11.1 3.5 4.7 2.7 2.3 5.8 4.5 1.0 0.9 1.5 4.6 1.2 2.1 0.5 0.9 3.1 0.3 0.5 3.9 0.3 0.1 0.3 0.1 0.8 0.9 2.7 0.6 0.0 2.1 1.7 5.3 3.1 1.0 1.4 4.3 2.6 0.3 0.1 1.5 0.7 0.2 0.6 2.9 0.1 3.2 0.8 0.5 6.2 4.6 2.7 0.1 2.7 0.8 1.5 2.3 4.9 2.0 0.0 9.2 13.2 1.7 1.4 20.5 1.2 2.3 1.5 0.9 5.0 6.5 0.1 0.1 0.2 1.7 1.7 0.9 5.3 4.5 3.4 0.2 1.0 0.5 1.0 0.7 1.0 2.0 0.9 2.6 4.9 2.8 2.0 0.8 5.8 4.6 4.0 0.5 1.5 0.8 4.5 1.1 1.2 36.3 28.8 11.9 15.7 39.5 25.1 47.7 9.7 21.9 24.6 3.0 5.0 3.0 6.2 6.9 10.8 60.6 15.3 12.0 0.0 7.0 5.9 3.0 18.3 4.1 33.7 3.6 1.1 0.0 35.4 5.9 2.7 8.7 1.1 52.1 1.6 6.4 39.9 4.9 2.2 18.6 4.9 2.1 13.5 3.6 5.9 7.8 16.3 3.5 4.9 43.1 39.1 0.0 3.1 9.3 7.5 17.6 5.3 3.8 7.5 4.7 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77321707-77474635 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0;brain: 71.4" "Cell type enhanced" "Detected in many" 4 "granulocytes: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4" "Group enriched" "Detected in all" 11 "dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 200000 "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 5.4 6.0 30.5 13.8 39.5 22.9 7.8 49.1 71.4 9.8 18.2 8.4 2.3 18.2 9.1 13.3 9.9 9.8 13.2 5.3 19.0 16.9 11.3 6.0 6.9 7.5 12.8 40.6 10.4 9.2 11.8 10.8 11.9 39.2 12.2 20.2 5.4 10.4 8.8 34.0 6.7 18.9 11.6 7.8 11.7 17.1 11.1 6.6 7.6 17.7 3.9 9.4 10.5 10.4 2.7 42.3 70.0 30.4 4.3 2.4 12.2 11.4 7.7 16.8 7.6 6.8 11.5 13.4 13.1 9.4 12.4 14.7 11.0 15.3 10.2 4.8 11.3 16.2 5.9 11.7 13.8 19.7 11.8 9.4 10.8 5.2 0.7 4.5 18.2 16.0 8.5 8.4 14.6 21.7 11.0 2.9 12.0 7.1 18.0 22.6 0.8 11.6 8.4 24.7 47.4 6.6 17.8 21.7 0.4 3.1 9.5 7.2 7.1 7.0 3.0 5.5 17.3 13.4 8.3 0.2 8.3 14.4 44.3 10.9 49.6 25.5 6.8 6.9 12.2 8.9 0.3 29.3 45.0 1.9 28.7 1.5 2.7 1.4 1.8 42.3 1.9 1.3 2.4 70.0 4.3 30.4 3.6 1.1 12.2 30.5 39.5 49.1 71.4 19.0 16.9 12.8 40.6 39.2 6.6 3.0 21.5 16.1 27.9 10.5 48.2 3.1 33.1 41.5 33.0 24.4 7.9 23.0 38.1 26.3 31.5 3.0 46.3 0.0 49.4 46.4 13.1 25.6 126.2 10.9 45.2 1.6 36.2 3.1 43.9 20.0 13.3 71.3 28.7 94.6 47.0 14.0 41.8 55.2 12.4 28.6 6.7 12.9 18.2 25.6 42.1 9.2 79.4 12.2 47.1 27.2 PAK1IP1 "bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84" ENSG00000111845 "PAK1 interacting protein 1" Q9NWT1 6 10694695-10709782 "Predicted intracellular proteins" "Ribosome biogenesis" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 48.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030111, HPA030112" Supported Supported Nucleoli NA NA Nucleoli "HPA030111: AB_2732454, HPA030112: AB_10603125" "unprognostic (9.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.67e-2)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (7.23e-2)" "unprognostic (9.29e-3)" "unprognostic (1.06e-3)" "unprognostic (2.14e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.02e-8)" "unprognostic (8.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.11e-1)" "unprognostic (2.10e-1)" 12.8 9.9 12.0 12.2 9.7 11.5 15.9 9.1 15.7 12.7 8.7 5.8 7.7 5.9 10.5 9.9 15.7 8.7 7.2 8.6 9.2 9.8 12.3 17.5 7.2 16.3 10.9 9.2 13.8 10.6 6.8 9.1 9.1 11.3 48.8 9.8 4.2 10.3 10.4 20.6 7.8 6.8 10.5 10.1 10.9 7.4 6.3 9.9 8.4 9.3 18.5 11.7 8.2 9.1 8.4 11.5 2.4 10.3 8.1 12.3 5.8 14.3 5.6 7.3 12.7 9.2 8.4 10.6 9.4 7.8 14.3 14.1 12.4 6.4 14.5 23.6 8.0 17.9 7.7 15.0 12.1 20.6 8.5 10.1 8.0 5.3 14.2 13.5 22.1 10.5 7.7 10.6 13.9 23.6 4.8 9.5 8.0 24.1 4.2 11.8 8.5 11.0 20.3 16.0 13.4 10.1 11.5 9.6 22.5 10.3 8.6 11.1 9.6 7.0 18.1 20.1 13.0 8.0 8.0 8.2 11.6 8.3 12.4 23.2 10.0 27.3 15.9 4.7 14.9 21.7 1.1 7.1 2.4 8.4 10.3 8.6 8.4 7.6 8.4 10.0 6.4 10.2 12.3 0.3 8.1 8.0 11.5 4.8 5.8 12.0 9.7 9.1 15.7 9.2 9.8 10.9 9.2 11.3 9.9 17.9 10.5 28.3 38.3 59.0 12.9 16.6 17.8 22.7 36.4 10.4 3.9 22.4 16.6 36.8 10.2 17.7 5.4 0.0 23.3 24.5 23.5 36.7 34.6 18.1 32.0 12.7 5.2 16.0 9.9 8.3 19.8 14.9 11.8 19.0 10.5 11.8 25.6 3.5 19.4 17.9 10.1 6.5 25.9 23.4 49.7 43.5 14.6 12.5 19.9 26.0 PAK3 "bPAK, hPAK3, MRX30, MRX47" ENSG00000077264 "P21 (RAC1) activated kinase 3" O75914 X 110944285-111227361 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.2;pancreas: 46.5;pituitary gland: 37.2" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 81.5;Leydig cells: 31.7;Peritubular cells: 76.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "MAIT T-cell: 4.3" "Lineage enriched" "Detected in single" 7 "T-cells: 4.3" "Cell line enhanced" "Detected in some" "EFO-21: 9.8;HAP1: 8.8;HDLM-2: 11.0;NTERA-2: 8.6;SCLC-21H: 11.2;SH-SY5Y: 7.0;U-2197: 6.8;U-251 MG: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044791, HPA060219" Approved Approved Vesicles NA NA Vesicles "HPA044791: , HPA060219: AB_2684223" "unprognostic (1.80e-2)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "unprognostic (3.27e-4)" "unprognostic (2.46e-1)" "unprognostic (5.63e-3)" "unprognostic (7.29e-2)" "unprognostic (3.23e-2)" "unprognostic (1.27e-2)" "unprognostic (3.01e-1)" "unprognostic (6.80e-3)" "unprognostic (1.66e-1)" "unprognostic (1.89e-4)" "unprognostic (5.71e-3)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" 2.0 6.8 17.6 2.5 17.5 1.0 6.4 1.8 24.6 3.7 1.6 0.9 9.1 1.0 6.8 7.6 1.7 3.7 2.6 1.2 26.2 20.8 1.6 1.1 1.8 2.5 7.9 21.9 7.9 46.5 0.9 37.2 1.6 12.9 4.8 1.7 1.4 3.0 7.1 2.4 2.0 1.4 6.1 5.8 2.9 3.0 3.6 1.9 0.0 7.7 0.0 1.7 2.0 1.5 0.1 0.1 0.6 0.1 0.2 4.3 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 9.8 1.0 1.4 0.0 8.8 0.5 1.2 11.0 0.3 0.0 1.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 2.0 5.2 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 8.6 0.0 1.9 0.1 4.0 0.0 0.8 0.0 11.2 7.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.6 4.3 6.8 11.7 0.0 0.1 0.1 1.2 0.0 0.1 0.6 0.1 0.1 0.1 0.0 4.3 0.0 0.7 0.4 0.0 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.0 17.6 17.5 1.8 18.5 26.2 20.8 7.9 21.9 12.9 1.9 3.0 1.4 0.0 14.1 0.2 81.5 0.8 12.7 0.0 1.2 0.0 0.0 0.3 0.0 3.0 3.4 2.4 0.0 0.0 11.6 0.3 5.8 1.3 1.1 0.0 0.2 6.4 3.5 0.6 0.3 4.7 31.7 2.0 0.0 1.0 0.0 19.0 7.3 0.0 76.4 0.5 5.5 0.0 0.4 1.1 0.6 1.0 5.6 2.2 0.0 0.9 PAK5 "KIAA1264, PAK7" ENSG00000101349 "P21 (RAC1) activated kinase 5" Q9P286 20 9537389-9839041 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 30.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 10.2;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020444 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA020444: AB_1854947" "unprognostic (5.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.05e-1)" "unprognostic (8.63e-2)" "unprognostic (3.21e-1)" "unprognostic (3.04e-1)" "unprognostic (2.25e-4)" "unprognostic (3.76e-1)" "unprognostic (2.56e-2)" "unprognostic (3.83e-1)" "unprognostic (3.35e-2)" "unprognostic (6.04e-2)" "unprognostic (4.58e-1)" 0.5 5.2 5.7 0.6 11.7 0.5 1.6 30.3 19.6 0.8 0.6 0.8 0.0 0.7 1.0 2.2 1.0 0.7 3.4 0.6 4.0 3.3 1.0 2.3 0.7 0.6 1.6 8.8 0.6 3.5 0.5 2.0 0.6 5.3 1.6 0.6 0.6 1.2 1.6 0.6 1.6 0.6 0.6 1.2 0.6 1.2 1.0 1.7 0.0 0.6 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 3.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 5.7 11.7 30.3 13.6 4.0 3.3 1.6 8.8 5.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40238759-40277487 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 22.2" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.3 5.3 14.7 0.8 18.4 0.8 2.3 11.3 20.1 3.0 1.3 1.6 2.5 1.4 1.0 1.1 15.8 4.3 1.4 7.9 11.6 5.2 3.4 0.4 2.6 1.0 3.0 10.9 0.6 7.4 12.9 6.4 8.1 2.1 3.6 1.2 0.3 3.4 7.5 3.5 22.2 1.4 0.8 1.2 1.0 3.6 12.8 2.2 0.0 7.4 8.5 5.1 3.0 5.1 1.4 0.7 2.9 0.7 2.0 5.5 1.2 2.7 0.0 0.2 0.1 0.0 0.0 4.4 0.0 0.1 0.6 0.4 14.8 2.0 0.1 2.4 0.0 0.9 23.0 3.3 4.9 0.2 0.1 0.7 0.0 1.9 0.1 0.0 0.1 0.3 0.0 14.1 0.2 3.3 0.2 0.0 3.9 1.1 0.2 0.0 3.2 0.0 0.3 0.4 2.7 2.0 0.2 0.1 1.8 1.1 6.0 5.4 1.3 1.9 7.8 0.2 1.3 0.9 7.2 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.0 0.5 0.4 0.1 2.1 0.7 2.9 5.5 0.3 2.1 1.4 0.5 4.2 0.7 0.5 0.3 1.2 1.3 2.0 0.2 0.5 0.1 1.2 14.7 18.4 11.3 20.1 11.6 5.2 3.0 10.9 2.1 2.2 0.0 3.4 0.0 6.8 8.8 3.9 0.0 7.6 4.0 4.5 5.2 0.0 38.8 11.6 4.0 5.9 0.0 0.0 0.0 3.7 1.2 0.6 4.0 0.0 0.0 3.5 0.0 4.7 0.0 0.3 4.5 1.7 0.3 1.7 0.0 0.8 1.4 2.7 0.0 1.8 0.0 0.0 0.0 0.1 1.6 1.5 16.7 7.6 1.3 1.9 6.8 PALLD "CGI-151, KIAA0992, SIH002" ENSG00000129116 "Palladin, cytoskeletal associated protein" Q8WX93 4 168497066-168928457 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 203.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 352.0;Cardiomyocytes: 495.5;Peritubular cells: 375.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035905, CAB070159" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" No No "Plasma membrane, Actin filaments" Cytosol "CAB070159: AB_1726016, HPA035905: AB_2674854" "unprognostic (3.59e-2)" "unprognostic (3.99e-1)" "unprognostic (2.55e-2)" "unprognostic (5.03e-3)" "unprognostic (2.51e-1)" "unprognostic (7.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.40e-2)" "unprognostic (3.57e-2)" "unprognostic (4.21e-2)" "unprognostic (2.38e-1)" "unprognostic (3.86e-1)" "unprognostic (8.54e-2)" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.28e-4)" 17.3 8.9 8.5 19.6 7.5 0.1 28.1 2.1 6.7 58.4 71.9 5.7 46.4 6.7 82.2 25.6 84.3 31.3 30.8 95.0 9.2 3.2 12.7 3.6 24.9 17.0 4.6 4.7 28.0 3.0 25.6 3.9 14.0 6.0 71.4 17.9 9.2 11.4 50.9 30.5 8.9 16.8 203.3 6.7 25.8 31.4 14.1 6.9 2.2 12.7 17.2 5.8 140.3 82.7 0.2 2.2 13.6 3.2 0.6 5.1 1.5 17.7 8.7 19.5 12.0 17.9 19.6 27.3 12.1 30.5 10.7 15.2 0.2 1.0 7.7 3.1 5.2 6.5 3.7 11.8 30.8 13.7 16.0 3.6 0.1 25.2 2.2 31.4 0.0 0.2 29.7 19.3 19.1 28.7 25.8 4.5 4.4 0.0 0.1 64.5 0.8 5.1 0.3 5.6 4.5 5.2 1.7 18.0 0.1 1.2 3.5 2.0 10.5 22.8 1.7 1.6 35.4 10.8 0.1 14.5 11.2 42.5 4.7 19.7 10.9 0.1 0.3 9.4 0.2 3.1 13.6 3.2 0.0 5.1 1.9 0.2 0.1 0.6 2.7 2.2 0.2 0.6 2.0 0.8 0.6 1.2 0.2 0.5 1.5 8.5 7.5 2.1 6.7 9.2 3.2 4.6 4.7 6.0 6.9 29.8 10.3 2.4 352.0 83.1 5.7 495.5 28.1 104.4 76.2 41.8 17.7 42.5 1.7 24.0 99.1 28.5 10.3 0.0 44.7 98.6 137.0 124.3 50.8 12.3 21.9 25.4 42.9 68.7 21.6 111.6 120.6 22.6 21.9 88.4 27.7 54.5 57.6 17.3 375.5 14.4 3.4 174.6 188.1 18.6 3.9 43.2 18.7 4.5 24.8 88.9 PALM KIAA0270 ENSG00000099864 Paralemmin O75781 19 708939-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.6;brain: 56.5" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 44.7;Ito cells: 46.6;Leydig cells: 44.8;Muller glia cells: 69.4;Peritubular cells: 42.5;Proximal tubular cells: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 35 "monocytes: 4.7" "Cell line enhanced" "Detected in many" "AN3-CA: 16.5;EFO-21: 15.3;REH: 27.2;SH-SY5Y: 17.5;U-2197: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favorable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 47.6 11.8 49.1 5.1 39.9 2.2 11.3 13.3 56.5 22.7 8.2 12.4 4.2 9.2 10.7 6.7 5.8 17.7 7.2 9.6 37.7 18.9 21.9 3.5 9.0 2.2 19.2 28.1 21.2 2.1 1.2 10.2 17.6 11.9 12.2 2.7 6.1 5.9 18.6 7.0 6.9 7.5 9.0 14.7 10.5 3.6 8.2 12.5 0.0 3.3 3.3 1.9 5.0 8.4 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 4.4 8.6 16.5 1.3 0.1 1.2 1.1 0.0 1.1 0.3 1.0 0.0 0.0 15.3 0.1 0.1 1.5 4.3 0.0 0.2 0.0 8.5 0.0 3.5 5.4 6.0 0.0 0.1 3.9 0.0 0.7 0.0 2.4 0.6 1.9 3.0 0.1 1.1 8.7 0.6 5.1 3.5 0.8 2.4 27.2 0.0 0.1 0.4 0.0 0.9 17.5 4.4 0.0 0.1 2.8 1.5 4.1 0.0 0.0 9.0 14.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 49.1 39.9 13.3 44.4 37.7 18.9 19.2 28.1 11.9 12.5 0.0 1.7 1.4 5.5 6.4 7.6 3.6 0.0 0.0 3.4 5.2 11.8 0.8 44.7 1.6 1.1 26.3 2.1 0.0 0.2 2.5 21.8 8.7 0.0 0.2 0.8 23.8 0.0 46.6 2.2 5.3 44.8 1.6 16.9 0.0 0.0 69.4 0.3 0.3 42.5 43.5 4.2 0.0 13.3 0.9 1.3 6.0 1.6 0.0 0.0 5.0 PALM2 ENSG00000243444 "Paralemmin 2" Q8IXS6 9 109640788-109946703 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;liver: 19.7" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 5.9;Fibroblasts: 5.4;Hepatocytes: 14.7;Intestinal endocrine cells: 7.9;Smooth muscle cells: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 5.9;RH-30: 20.8" "Low region specificity" "Detected in many" "HPA074153, HPA076866" Approved "Plasma membrane" NA NA "Plasma membrane" "HPA074153: AB_2686669, HPA076866: " "unprognostic (7.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.51e-2)" "unprognostic (2.77e-2)" "unprognostic (2.36e-2)" "unprognostic (3.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.09e-1)" "unprognostic (5.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.74e-6)" "unprognostic (8.39e-2)" 14.8 6.1 8.1 2.0 11.1 1.2 6.7 1.7 17.9 4.3 2.4 9.1 0.0 1.8 4.9 1.7 2.4 3.8 3.0 7.6 6.3 1.8 2.7 19.7 4.8 1.5 5.0 9.7 2.3 2.2 1.4 1.6 3.1 8.4 2.4 2.4 0.0 3.2 1.4 2.5 3.1 2.0 2.2 4.9 1.5 2.2 2.7 8.7 0.0 4.3 0.0 1.4 2.8 2.6 0.5 0.1 1.1 0.2 0.3 0.1 0.0 0.1 0.6 0.5 0.0 0.4 0.9 0.2 0.4 1.2 0.7 1.7 0.3 0.7 0.1 0.1 1.9 4.2 1.8 0.0 0.6 1.3 0.1 1.0 0.0 2.5 0.2 0.0 0.0 0.1 2.0 0.8 5.9 0.9 0.6 0.0 0.0 0.0 0.0 2.5 0.5 0.0 0.0 3.4 0.2 1.3 0.0 20.8 0.4 2.9 0.4 3.9 0.0 5.1 0.2 1.6 0.9 2.0 0.4 0.2 2.1 3.0 0.1 1.7 0.1 0.7 0.1 1.6 0.0 2.4 0.3 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.0 1.1 0.3 0.1 0.1 0.0 0.0 8.1 11.1 1.7 12.7 6.3 1.8 5.0 9.7 8.4 8.7 0.0 0.3 0.0 0.5 1.1 0.0 5.9 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.3 0.4 0.3 0.0 0.0 0.2 1.5 5.4 0.4 0.0 14.7 0.1 0.0 7.9 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 6.6 0.2 1.0 2.0 0.2 0.0 0.4 0.1 PALM2-AKAP2 ENSG00000157654 "PALM2-AKAP2 readthrough" 9 109780309-110172512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.0;heart muscle: 26.8" "Group enriched" "Detected in some" 14 "Alveolar cells type 1: 125.0;granulocytes: 32.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.7;hTEC/SVTERT24-B: 15.1;RH-30: 29.7;U-251 MG: 13.2;WM-115: 17.3" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 41.0 2.8 1.6 3.3 1.6 0.1 19.6 0.7 4.7 4.8 2.3 1.5 2.1 1.1 15.2 4.7 2.1 2.5 5.0 26.8 1.8 2.4 2.4 24.8 9.7 1.2 1.9 0.5 5.9 1.1 1.6 1.1 9.2 3.0 3.2 0.6 1.1 2.0 3.6 4.5 1.8 1.0 7.8 1.4 0.5 1.1 1.4 0.9 0.0 3.8 2.5 0.3 5.2 8.9 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 3.3 0.0 15.7 5.6 1.3 5.5 5.4 1.6 3.7 0.0 0.1 0.0 0.5 5.7 6.5 2.0 0.0 1.3 4.6 0.2 1.6 0.0 5.1 0.1 0.1 0.0 0.0 7.1 0.1 15.1 2.4 4.8 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 4.4 0.0 1.4 0.0 29.7 0.0 4.1 0.0 1.8 0.0 2.1 0.2 7.5 4.6 0.6 0.0 0.1 3.4 8.6 0.3 13.2 0.0 0.2 0.0 4.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 1.6 1.6 0.7 3.0 1.8 2.4 1.9 0.5 3.0 0.9 125.0 5.8 0.0 0.0 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053365-14059159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.5;testis: 19.7" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 53.6;Alveolar cells type 2: 36.3;Cholangiocytes: 17.8;Club cells: 18.2;Collecting duct cells: 36.6;Exocrine glandular cells: 24.3;Hepatocytes: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 22.1;CACO-2: 23.7;HAP1: 19.8;NTERA-2: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: AB_2681952, HPA056119: AB_2683042" "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.2 0.2 4.3 0.9 1.9 0.0 2.1 3.7 3.6 2.9 0.5 3.2 0.2 2.7 0.4 11.1 0.2 1.5 1.6 0.2 4.2 2.8 12.9 26.5 2.4 0.2 1.7 4.3 0.4 11.7 1.8 0.2 0.7 10.1 1.8 0.2 1.1 6.9 8.0 0.2 0.2 0.8 0.9 2.7 0.2 13.0 19.7 4.9 0.2 6.8 0.2 1.0 3.9 1.9 0.9 0.2 0.0 0.3 0.0 1.8 0.0 1.6 1.5 3.7 22.1 0.3 0.1 4.5 0.4 0.1 1.3 0.6 23.7 0.5 0.0 0.2 0.4 7.0 0.1 19.8 0.0 0.3 0.0 1.3 0.1 0.5 2.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.1 0.0 4.6 0.0 0.0 3.7 0.2 0.1 14.2 1.8 1.3 0.0 0.0 0.0 0.0 1.9 2.7 3.6 0.1 0.0 0.0 4.0 1.4 0.0 0.2 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.9 0.8 0.3 0.0 0.1 0.9 1.8 1.8 0.0 0.0 0.1 0.2 0.5 0.0 4.3 1.9 3.7 3.6 4.2 2.8 1.7 4.3 10.1 4.9 53.6 36.3 0.0 0.6 0.0 0.8 0.3 17.8 2.7 18.2 36.6 0.0 0.2 1.7 6.7 0.0 0.0 0.9 0.0 24.3 2.0 1.0 1.4 1.1 31.8 0.1 0.0 1.2 1.3 1.3 0.0 0.9 0.1 1.7 1.8 1.9 0.4 3.8 0.6 2.5 6.8 0.5 0.0 0.0 0.0 6.8 0.0 1.8 0.0 0.6 0.2 PALMD "C1orf11, FLJ20271, PALML" ENSG00000099260 Palmdelphin Q9NP74 1 99645943-99694541 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 84.9;skeletal muscle: 106.9" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 153.8;Ciliated cells: 174.0;Endothelial cells: 169.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 43.5;LHCN-M2: 14.0;TIME: 60.9;U-87 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017959, HPA030549" Supported Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Actin filaments" "Plasma membrane, Focal adhesion sites" "HPA017959: AB_1854949, HPA030549: AB_2673518" "unprognostic (1.48e-2)" "unprognostic (1.15e-2)" "unprognostic (2.05e-2)" "prognostic favorable (9.42e-4)" "unprognostic (7.67e-2)" "prognostic favorable (5.90e-5)" "unprognostic (1.54e-2)" "unprognostic (2.10e-1)" "unprognostic (3.93e-2)" "unprognostic (1.64e-1)" "unprognostic (8.32e-2)" "unprognostic (6.18e-2)" "unprognostic (5.19e-2)" "unprognostic (1.63e-2)" "unprognostic (1.88e-1)" "unprognostic (2.70e-1)" "unprognostic (8.08e-2)" 84.9 18.6 8.3 6.2 4.3 0.0 46.4 1.1 3.7 17.1 6.5 3.9 4.0 1.3 18.6 10.1 16.2 8.7 5.3 59.0 5.6 3.4 5.1 20.9 10.6 3.4 3.9 3.8 17.4 2.2 4.4 4.7 16.8 19.0 8.1 2.6 7.9 34.0 4.4 106.9 18.0 3.5 12.2 4.1 2.3 2.8 7.5 2.2 2.1 3.4 48.2 6.2 6.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.7 0.1 3.0 0.0 0.1 0.0 0.0 0.0 0.0 5.7 7.3 0.0 0.0 0.0 1.1 0.5 0.0 0.0 1.2 43.5 0.0 6.1 0.0 14.0 0.1 0.0 0.0 0.0 0.4 1.9 0.0 10.9 0.0 0.0 2.2 0.2 0.1 0.0 2.8 0.0 0.3 0.6 0.0 60.9 0.0 0.1 4.7 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 4.3 1.1 3.7 5.6 3.4 3.9 3.8 19.0 2.2 6.0 9.3 0.0 9.8 34.2 0.2 153.8 35.7 174.0 45.5 3.5 0.0 0.2 5.0 7.1 73.5 169.5 0.0 0.0 0.2 0.4 4.8 4.7 1.1 55.2 0.5 3.2 1.7 58.9 1.3 7.9 8.6 1.7 23.6 0.0 0.0 54.8 2.5 0.0 22.6 0.0 2.1 0.0 6.1 0.5 0.2 40.7 0.2 0.0 0.0 0.7 PAM "PAL, PHM" ENSG00000145730 "Peptidylglycine alpha-amidating monooxygenase" P19021 5 102753981-103031105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 304.2" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026119, HPA042260" Enhanced Approved "Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA 59000000 "Golgi apparatus, Cytosol" "CAB026119: , HPA042260: AB_2677919" "unprognostic (4.30e-3)" "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "prognostic favorable (1.63e-4)" "unprognostic (4.23e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (6.20e-4)" "unprognostic (7.58e-2)" "unprognostic (6.62e-2)" "unprognostic (2.71e-1)" "unprognostic (9.91e-2)" "unprognostic (3.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.08e-1)" "unprognostic (9.79e-2)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" 16.5 24.5 8.2 6.5 16.4 0.8 17.3 6.6 16.5 74.9 14.0 5.4 9.5 5.8 21.3 83.8 11.7 10.6 11.5 304.2 8.8 23.5 13.7 2.1 13.2 5.8 10.0 7.6 17.0 16.4 49.5 18.3 26.3 15.5 13.4 9.5 8.7 53.8 29.4 22.0 8.5 8.5 18.5 4.8 8.9 17.2 7.2 4.6 1.8 21.7 13.2 7.3 15.8 15.3 0.5 2.0 10.1 5.3 16.2 14.1 6.3 14.7 2.2 27.1 12.0 75.3 45.1 10.8 41.8 62.6 12.4 37.8 7.1 19.5 0.0 9.0 96.5 17.5 5.0 1.5 18.4 34.3 1.8 6.1 3.0 8.8 2.3 11.4 0.9 3.3 24.6 7.9 9.1 6.9 78.8 25.5 1.2 0.1 2.0 35.1 3.0 0.0 0.4 4.8 2.6 8.1 1.1 15.1 8.1 47.8 1.7 12.8 8.9 17.8 1.1 10.9 16.6 4.6 0.9 19.6 39.4 10.2 18.4 12.4 4.6 1.1 0.0 45.2 4.1 33.9 1.9 5.3 0.1 14.1 0.9 10.0 0.5 8.5 10.4 2.0 0.3 2.9 4.8 10.1 16.2 1.9 1.1 12.1 6.3 8.2 16.4 6.6 16.5 8.8 23.5 10.0 7.6 15.5 4.6 50.6 28.7 3.7 10.4 25.0 10.9 852.6 0.0 10.7 27.3 57.6 2.0 0.7 6.6 11.6 5.0 54.1 6.8 0.0 18.6 37.1 102.7 20.4 9.2 2.4 5.5 7.9 308.8 70.0 12.0 4.7 55.8 6.7 35.4 5.4 12.6 13.0 34.7 2.9 55.2 41.6 2.8 19.4 47.4 1.6 2.1 20.7 5.6 15.3 6.6 13.1 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 36.3" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.9 7.7 4.2 10.3 2.8 3.9 10.9 9.5 2.3 3.6 2.9 5.4 5.8 11.5 10.6 2.8 3.7 8.1 3.9 4.2 1.7 11.2 25.4 12.0 7.2 3.8 4.6 8.4 9.0 5.8 5.4 4.3 4.7 3.2 2.8 8.1 14.1 5.5 3.0 10.6 7.6 14.7 6.8 2.5 17.2 14.5 3.5 11.1 3.7 3.8 16.0 12.4 8.2 7.0 9.7 3.3 9.2 10.2 3.5 7.2 9.3 36.3 10.4 8.2 8.8 14.3 2.6 8.2 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 3.0 4.5 2.2 0.9 3.5 0.5 0.4 10.2 6.7 5.7 0.0 0.0 1.9 6.6 3.1 2.6 0.7 2.1 0.0 2.6 2.3 2.7 1.0 1.1 10.9 1.5 1.6 0.0 4.3 7.8 0.8 4.6 1.1 1.7 7.2 2.1 0.3 5.2 3.4 3.5 3.0 0.6 6.5 1.4 8.9 12.9 5.1 1.0 1.7 3.4 1.0 PANK1 "MGC24596, PANK, PANK1a, PANK1b" ENSG00000152782 "Pantothenate kinase 1" Q8TE04 10 89579497-89645572 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 20.1;liver: 63.8" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 59.7;Hepatocytes: 103.1;Proximal tubular cells: 48.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.00e-1)" "unprognostic (2.19e-1)" "unprognostic (2.02e-2)" "unprognostic (1.09e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "prognostic favorable (1.50e-4)" "unprognostic (1.59e-1)" "unprognostic (1.38e-2)" "unprognostic (1.61e-1)" "unprognostic (4.55e-4)" "unprognostic (4.61e-2)" "prognostic favorable (1.55e-10)" "unprognostic (3.49e-2)" "unprognostic (4.69e-2)" "unprognostic (5.34e-2)" "unprognostic (6.64e-2)" 1.1 2.5 2.3 1.2 1.9 0.0 1.0 13.4 4.1 2.4 6.1 1.3 0.5 9.0 0.9 1.9 2.9 1.2 1.5 3.9 1.9 2.6 20.1 63.8 2.1 0.6 2.1 2.7 1.1 1.2 2.6 2.2 1.0 3.1 1.5 7.8 1.8 1.4 1.0 5.7 5.5 9.2 1.0 1.7 0.9 2.0 1.5 1.0 2.6 4.7 2.4 1.0 1.1 5.5 1.0 2.3 0.9 0.6 0.1 1.6 0.7 5.6 3.7 20.4 14.0 11.1 8.1 10.3 3.3 3.6 3.2 4.2 5.7 5.8 4.1 2.2 2.5 2.3 5.6 9.2 2.1 3.4 1.4 4.1 2.7 4.0 11.3 3.3 8.4 1.5 4.9 9.3 4.8 3.8 6.7 3.6 3.5 4.7 0.5 4.5 4.3 9.3 8.7 16.0 14.7 2.2 8.3 4.0 2.7 9.7 2.7 6.4 7.6 4.1 5.0 3.2 12.7 5.4 6.2 1.5 1.9 1.8 3.8 3.9 4.7 8.7 5.0 2.5 6.8 1.3 0.9 0.3 0.1 0.7 0.1 1.4 1.0 0.8 1.6 1.0 0.1 1.0 0.2 0.7 0.1 0.6 2.3 1.1 0.7 2.3 1.9 13.4 4.1 1.9 2.6 2.1 2.7 3.1 1.0 6.0 3.0 5.6 0.7 2.1 4.1 10.2 10.2 1.4 2.3 10.4 2.0 3.9 59.7 0.8 0.4 1.0 20.9 0.0 0.6 3.8 1.8 0.5 0.0 103.1 2.0 12.7 10.9 4.3 3.7 0.2 1.1 1.6 0.0 0.0 16.2 0.8 0.1 8.6 2.1 48.4 1.0 0.0 2.7 0.5 0.9 2.5 1.5 1.5 22.8 0.4 PANK3 FLJ12899 ENSG00000120137 "Pantothenate kinase 3" Q9H999 5 168548495-168579600 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 101.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078669 Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA078669: " "unprognostic (1.24e-2)" "unprognostic (5.71e-2)" "prognostic favorable (3.94e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-2)" "unprognostic (2.42e-2)" "unprognostic (1.20e-2)" "unprognostic (8.43e-2)" "unprognostic (1.29e-1)" "unprognostic (2.22e-1)" "unprognostic (9.48e-2)" "unprognostic (2.30e-1)" "unprognostic (3.71e-2)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (1.97e-3)" "unprognostic (2.01e-1)" 9.1 16.6 11.6 17.5 10.4 10.5 17.6 22.8 11.9 8.9 23.9 9.0 8.5 28.0 10.2 8.8 12.8 7.8 6.9 7.4 11.7 9.1 13.2 39.2 12.5 8.2 8.4 7.5 10.7 8.8 14.6 11.2 9.4 10.8 9.1 17.9 6.7 11.0 9.6 8.2 11.9 63.0 8.0 10.3 9.6 10.9 10.2 11.0 10.2 10.5 13.4 8.2 9.9 11.6 4.1 2.7 3.5 4.7 0.9 2.5 1.1 13.9 7.9 32.7 17.4 12.3 14.2 13.9 8.4 9.0 11.3 16.7 13.1 13.0 21.6 13.9 11.9 18.3 10.1 22.0 17.0 20.4 20.0 10.6 11.0 7.5 9.7 14.2 14.9 15.0 11.4 23.0 14.2 16.0 8.0 13.3 16.4 10.2 21.9 15.5 7.8 14.8 6.7 14.0 10.9 5.8 10.8 22.4 8.8 14.2 20.8 15.3 32.7 9.7 16.0 23.9 17.2 20.8 18.8 13.6 15.3 21.5 9.0 17.9 15.3 21.0 16.1 9.1 15.2 11.8 3.5 3.2 1.6 1.9 3.8 2.5 4.1 1.9 1.9 2.0 1.6 1.3 2.3 1.3 0.9 4.7 2.7 2.4 1.1 11.6 10.4 22.8 11.8 11.7 9.1 8.4 7.5 10.8 11.0 23.8 17.1 17.4 18.7 30.5 27.4 13.5 22.9 18.7 17.0 24.4 25.5 14.0 8.3 15.1 9.7 23.2 101.4 0.0 17.5 11.9 20.0 29.7 15.0 79.1 19.5 27.0 32.8 17.8 27.0 13.1 15.5 18.7 21.9 10.8 33.0 12.0 18.9 31.7 16.6 19.6 26.0 25.8 31.6 26.0 27.4 49.1 35.0 10.1 35.0 45.2 PANK4 FLJ10782 ENSG00000157881 "Pantothenate kinase 4" Q9NVE7 1 2508533-2526628 "Enzymes, Predicted intracellular proteins" "Coenzyme A biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.1" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 22.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 9.0;HDLM-2: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011723, HPA012036, HPA027961" Uncertain Approved Cytosol NA NA Cytosol "HPA011723: AB_2668522, HPA012036: AB_1854952, HPA027961: AB_10602042" "unprognostic (1.23e-1)" "unprognostic (2.31e-1)" "unprognostic (3.36e-1)" "unprognostic (1.13e-1)" "unprognostic (4.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.34e-1)" "unprognostic (2.55e-1)" "unprognostic (6.51e-2)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (3.29e-2)" "prognostic favorable (1.57e-5)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (2.25e-1)" "unprognostic (8.15e-2)" 5.3 14.4 10.7 17.8 12.6 4.2 5.4 14.9 12.4 5.5 7.1 6.8 4.9 4.2 7.0 4.2 9.8 5.6 9.2 11.8 8.0 5.2 7.2 7.0 6.7 12.5 9.0 6.8 5.7 5.8 4.2 8.3 6.7 7.4 5.8 6.1 8.9 5.6 5.3 43.1 19.0 7.6 9.1 4.4 8.1 6.3 11.0 9.7 9.4 6.8 6.8 7.2 7.2 5.7 4.5 4.8 11.7 6.9 11.4 8.9 5.3 2.5 6.7 2.3 0.0 0.0 2.7 1.6 9.0 0.0 8.2 7.7 0.0 0.0 1.1 3.1 2.5 0.0 3.9 1.9 0.0 1.8 9.4 5.7 0.0 3.9 5.6 2.6 0.0 4.7 0.0 0.0 0.0 0.0 1.2 1.9 1.3 2.5 0.0 2.2 0.0 1.3 0.3 0.0 0.8 2.8 0.0 0.0 1.8 0.0 0.0 2.0 0.0 5.1 1.9 0.0 0.9 0.0 3.4 0.0 0.0 1.9 4.7 2.2 1.3 4.6 6.1 3.0 0.9 0.0 11.7 4.9 4.5 6.2 6.6 5.1 4.5 3.9 6.4 4.8 3.0 7.4 8.0 6.4 11.4 6.9 0.9 8.9 5.3 10.7 12.6 14.9 12.4 8.0 5.2 9.0 6.8 7.4 9.7 6.0 3.2 5.6 4.9 3.7 7.2 22.5 2.5 0.0 2.3 3.5 9.8 6.5 6.6 5.2 1.1 5.2 4.9 0.0 6.0 4.2 7.0 3.2 1.1 7.6 4.6 3.2 2.9 3.7 5.9 0.4 5.5 5.9 5.0 8.2 4.0 4.5 4.7 7.0 8.5 3.6 13.0 19.4 5.9 4.8 5.2 3.9 8.1 8.5 5.0 3.1 PANO1 PANO ENSG00000274897 "Proapoptotic nucleolar protein 1" I0J062 11 797511-799190 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.7;pancreas: 5.0" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 5.7;Cone photoreceptor cells: 11.8;Early spermatids: 9.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.7;SCLC-21H: 7.5" NA NA "unprognostic (3.25e-2)" "unprognostic (2.24e-1)" "unprognostic (9.77e-3)" "unprognostic (2.56e-4)" "unprognostic (1.41e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.34e-1)" "unprognostic (7.81e-2)" "unprognostic (1.84e-2)" "unprognostic (2.32e-5)" "unprognostic (5.96e-2)" "unprognostic (2.02e-5)" "unprognostic (1.70e-1)" "unprognostic (3.54e-1)" "unprognostic (4.64e-1)" "unprognostic (1.33e-1)" 0.2 1.2 0.5 1.9 0.0 1.4 0.0 0.0 0.3 0.2 1.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.3 5.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.1 0.1 0.0 1.0 0.5 0.9 0.0 0.0 0.0 0.8 0.8 3.7 0.6 2.2 1.3 0.2 1.7 1.6 2.6 4.5 0.6 1.1 9.7 3.0 0.4 0.6 0.3 1.0 2.0 2.2 1.2 1.0 1.1 4.3 0.6 0.2 0.2 4.4 3.5 1.6 1.3 1.0 0.6 1.5 4.7 1.6 0.6 0.3 0.4 0.9 0.2 2.4 0.8 2.3 0.8 1.9 2.2 2.7 3.2 2.0 1.0 2.7 0.8 0.2 1.2 0.5 7.5 3.4 1.1 2.1 1.2 0.7 1.5 0.8 1.2 2.0 1.4 1.0 1.4 2.3 1.3 1.9 1.8 1.7 2.0 2.4 0.5 0.3 0.7 0.5 0.6 0.4 0.6 0.8 0.3 0.8 0.7 1.3 3.7 2.2 0.6 0.8 0.2 0.2 0.0 0.0 0.9 1.5 0.0 5.7 0.2 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.3 9.9 0.1 0.0 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.3 7.9 0.0 1.3 0.0 0.5 0.3 0.0 0.0 0.0 0.2 2.9 0.2 0.0 0.4 0.4 1.4 0.0 0.1 0.2 0.7 0.0 0.2 0.0 0.0 0.8 PANX2 "hPANX2, PX2" ENSG00000073150 "Pannexin 2" Q96RD6 22 50170731-50180294 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 10.2;Hepatocytes: 6.8;Muller glia cells: 21.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Group enriched" "Detected in many" 36 "dendritic cells: 1.8;granulocytes: 5.2" "Cell line enhanced" "Detected in many" "EFO-21: 9.1;HDLM-2: 13.9;Hep G2: 16.3;MCF7: 9.0;SCLC-21H: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004624, HPA039117" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004624: , HPA039117: AB_10805354" "unprognostic (1.00e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-2)" "unprognostic (1.05e-1)" "unprognostic (3.01e-3)" "unprognostic (2.11e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (3.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-9)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.00e-1)" "unprognostic (4.08e-1)" 1.6 2.6 10.3 2.6 9.2 5.3 1.4 22.4 31.4 1.8 1.1 1.2 10.5 1.1 2.4 2.7 3.8 4.9 2.3 1.1 14.2 8.8 3.4 7.8 2.4 1.2 15.9 7.9 3.5 3.0 1.0 4.1 1.6 23.9 3.8 1.0 1.5 5.5 6.2 1.5 2.6 1.2 1.2 4.5 2.7 1.4 2.6 2.4 0.0 3.8 0.2 1.5 1.8 0.9 0.0 1.8 5.2 0.0 0.0 0.0 0.0 0.8 1.8 0.3 2.0 0.0 0.2 4.3 2.2 2.2 0.5 0.4 0.4 6.9 0.0 9.1 0.2 1.3 0.4 1.1 0.9 0.1 13.9 1.2 0.3 2.9 16.3 0.7 0.1 1.1 0.2 0.9 0.6 0.0 1.0 0.5 0.0 1.1 0.0 0.2 9.0 0.0 0.8 3.4 0.0 3.7 0.8 0.0 3.3 0.0 1.4 8.6 0.8 1.4 0.1 5.2 0.4 0.6 0.6 3.8 0.4 3.7 5.9 4.1 1.6 0.1 0.5 0.2 0.0 6.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.8 0.0 0.0 10.3 9.2 22.4 31.4 14.2 8.8 15.9 7.9 23.9 2.4 0.0 1.4 0.0 2.3 0.5 10.2 0.6 2.5 4.0 4.5 0.0 0.0 0.0 5.0 1.7 0.2 0.0 0.0 0.0 2.4 0.1 0.5 4.0 0.0 6.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.8 0.0 21.1 2.2 0.0 1.1 1.2 3.6 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 2.8 PANX3 Px3 ENSG00000154143 "Pannexin 3" Q96QZ0 11 124611490-124620356 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;MCF7: 2.6;U-266/70: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.80e-2)" "unprognostic (3.10e-1)" 0.1 0.4 0.1 0.1 1.8 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.2 0.0 0.1 1.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 2.6 0.2 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 2.8 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.5 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PAOX PAO ENSG00000148832 "Polyamine oxidase" Q6QHF9 10 133379234-133391694 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.7" "Group enriched" "Detected in many" 11 "Early spermatids: 115.5;Late spermatids: 346.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 6.4;K-562: 5.0;U-266/70: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047782 Uncertain Nucleoplasm,Centrosome NA NA Centrosome Nucleoplasm "HPA047782: " "unprognostic (3.67e-3)" "prognostic favorable (6.07e-5)" "unprognostic (2.49e-2)" "unprognostic (1.28e-3)" "unprognostic (1.96e-2)" "prognostic favorable (1.38e-5)" "unprognostic (7.39e-2)" "unprognostic (1.99e-3)" "unprognostic (2.20e-1)" "unprognostic (4.48e-2)" "unprognostic (1.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (9.49e-4)" "unprognostic (3.56e-2)" "unprognostic (2.86e-1)" "unprognostic (7.61e-2)" "unprognostic (8.29e-3)" 6.7 4.1 4.3 5.8 6.7 1.5 4.7 6.8 8.7 3.7 6.0 10.8 5.6 5.6 3.7 1.8 7.4 3.4 2.4 2.5 5.7 2.7 8.9 9.2 2.8 5.2 10.0 3.4 3.6 3.2 1.9 2.5 2.1 4.2 4.8 1.5 2.8 9.9 5.1 3.5 4.4 8.5 2.8 4.7 8.2 7.5 36.7 7.6 0.7 2.4 2.1 5.4 4.6 4.2 4.3 1.1 1.0 1.0 1.7 0.3 0.4 6.4 0.0 0.2 1.2 0.0 0.7 1.6 2.9 1.2 1.4 0.2 1.1 0.1 0.0 0.9 0.6 0.8 3.5 0.4 0.8 0.6 4.2 0.5 0.6 0.0 0.2 1.7 0.0 1.0 0.1 0.3 0.9 0.4 0.0 0.1 0.0 5.0 0.3 0.0 0.1 0.0 0.1 1.2 0.0 3.0 4.6 0.0 0.0 0.2 0.0 0.3 2.2 0.9 0.1 0.0 0.0 1.4 0.0 2.8 0.3 1.4 1.2 0.0 18.5 3.4 1.7 0.0 0.0 0.1 1.0 0.3 0.0 0.2 1.0 0.0 1.6 0.3 0.2 1.1 4.3 0.0 0.0 0.0 1.7 0.9 0.8 0.0 0.4 4.3 6.7 6.8 6.5 5.7 2.7 10.0 3.4 4.2 7.6 0.0 5.8 20.9 6.2 3.3 1.5 1.5 5.1 1.4 0.0 1.8 0.0 0.7 5.0 4.5 115.5 2.3 6.8 0.0 3.0 1.7 2.3 4.8 5.7 11.3 4.1 4.8 0.0 3.7 10.4 346.0 8.9 3.9 0.0 17.2 3.4 7.7 2.9 2.9 7.4 13.2 2.7 19.4 2.5 9.9 3.0 3.1 0.2 4.6 3.2 8.6 PAPOLB PAPT ENSG00000218823 "Poly(A) polymerase beta" Q9NRJ5 7 4857733-4861994 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 33.0" "Group enriched" "Detected in some" 4 "Early spermatids: 67.3;Late spermatids: 69.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Not detected" "Not detected" HPA047285 Approved Nucleoplasm NA NA Nucleoplasm "HPA047285: " "unprognostic (7.58e-2)" "unprognostic (1.25e-1)" "unprognostic (1.68e-2)" "unprognostic (1.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.3 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.3 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.7 0.0 0.5 16.1 2.3 0.6 0.2 0.0 0.0 0.3 PAPPA "ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1" ENSG00000182752 "Pappalysin 1" Q13219 9 116153804-116402322 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 86 "placenta: 484.6" "Group enriched" "Detected in many" 6 "Collecting duct cells: 157.1;Proximal tubular cells: 39.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 19.3;ASC TERT1: 14.8;HSkMC: 53.2;U-138 MG: 13.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8" "HPA001667, CAB016724" Enhanced "Secreted in female reproductive system" NA NA 41000 "CAB016724: , HPA001667: AB_1854960" "unprognostic (3.25e-1)" "unprognostic (6.18e-6)" "unprognostic (2.47e-1)" "unprognostic (6.49e-2)" "unprognostic (2.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (5.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.87e-2)" "unprognostic (6.87e-3)" "unprognostic (8.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.37e-3)" "unprognostic (2.48e-1)" "unprognostic (4.01e-1)" "unprognostic (1.02e-3)" 4.8 2.3 0.5 1.0 0.5 0.0 0.8 0.4 0.6 3.6 2.4 0.6 1.0 0.1 3.5 1.0 3.6 2.0 1.1 3.7 0.4 0.0 4.3 0.5 2.4 0.7 0.4 0.4 1.4 0.7 5.6 0.7 484.6 0.7 1.4 0.9 0.9 0.5 1.2 0.5 1.1 0.9 2.4 0.6 0.6 1.0 0.8 0.5 0.4 1.3 1.0 1.0 2.3 3.4 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 5.5 8.4 0.0 19.3 14.8 0.0 4.5 8.0 1.2 2.1 0.0 0.0 0.0 0.0 3.1 0.4 0.6 0.0 0.0 6.0 0.0 0.0 0.9 4.6 0.0 9.4 0.0 0.0 53.2 0.0 6.2 0.7 10.3 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 2.7 0.0 0.0 10.7 13.9 0.7 0.4 0.5 0.0 0.0 0.0 9.9 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.6 0.4 0.0 0.4 0.4 0.7 0.5 0.0 1.0 0.0 0.2 2.6 5.0 2.2 0.0 0.0 2.3 157.1 11.8 0.3 8.3 5.8 14.3 0.7 0.0 0.0 0.8 7.4 16.4 0.6 1.1 0.0 0.4 0.0 0.0 5.5 0.0 12.7 13.3 0.3 1.7 0.0 0.0 2.3 0.5 0.0 8.1 39.6 2.7 0.0 8.2 1.7 0.4 1.0 11.7 0.0 0.0 0.1 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845605 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 406.4" "Group enriched" "Detected in many" 7 "Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-87 MG: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" NA NA "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.2 0.2 0.0 3.0 0.8 0.3 5.0 0.6 0.2 0.2 0.0 0.3 0.2 0.2 0.2 1.1 0.2 0.2 0.1 11.6 0.7 0.2 0.2 0.2 0.2 0.2 1.5 0.0 1.2 406.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.3 0.5 0.2 1.0 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.3 4.6 2.2 3.8 0.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.3 1.7 1.4 0.1 0.6 0.3 0.4 0.0 21.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.8 0.3 0.2 0.1 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 5.2 0.0 0.8 10.0 0.0 1.9 0.0 0.0 0.0 0.2 11.6 0.6 0.0 0.0 0.2 1.2 0.0 135.4 0.0 0.0 1.3 10.6 0.0 0.0 0.0 0.2 47.6 1.2 0.0 10.3 0.3 1.1 6.5 0.5 1.2 1.9 0.0 61.9 0.0 0.0 0.0 PAPSS2 ATPSK2 ENSG00000198682 "3'-phosphoadenosine 5'-phosphosulfate synthase 2" O95340 10 87659613-87747705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 59.2;liver: 49.0" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 223.4;Enterocytes: 147.6;Hepatocytes: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 5.3;myeloid DC: 2.7;non-classical monocyte: 9.7" "Group enriched" "Detected in many" 7 "dendritic cells: 2.7;monocytes: 9.7" "Cell line enhanced" "Detected in many" "BJ: 35.4;fHDF/TERT166: 89.6;HHSteC: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071224, HPA075267" Enhanced Approved Mitochondria No No Mitochondria "HPA071224: AB_2686366, HPA075267: " "unprognostic (3.98e-3)" "unprognostic (7.06e-2)" "unprognostic (4.95e-3)" "unprognostic (1.02e-1)" "unprognostic (2.67e-1)" "unprognostic (1.61e-2)" "unprognostic (4.96e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (3.50e-2)" "prognostic favorable (6.58e-4)" "unprognostic (1.14e-1)" "unprognostic (4.90e-2)" "unprognostic (6.72e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.21e-5)" "unprognostic (3.46e-3)" 16.0 59.2 3.5 18.1 6.0 0.3 18.1 1.9 4.3 8.6 25.5 2.2 1.9 9.2 4.0 7.0 3.7 5.3 10.7 9.1 3.9 2.1 9.9 49.0 31.3 15.6 4.4 1.6 10.8 21.2 0.4 1.7 19.0 5.2 3.8 21.2 6.2 6.2 2.0 4.8 1.7 19.4 5.5 3.4 2.9 2.9 3.6 4.3 0.8 7.3 6.2 11.0 5.7 5.3 0.0 2.7 0.8 9.7 0.0 0.1 0.8 3.5 3.7 1.2 0.0 25.7 32.8 0.0 35.4 30.3 21.6 15.6 0.1 0.7 0.0 1.8 89.6 0.6 1.5 2.6 2.5 24.7 0.0 1.9 1.6 2.6 0.0 38.9 0.0 0.7 11.6 0.0 12.4 1.0 26.0 17.9 0.2 0.0 16.7 15.1 13.5 0.0 0.1 1.4 0.8 4.6 0.0 0.0 0.0 22.5 1.6 0.1 0.3 17.2 0.6 0.2 2.5 2.5 0.9 22.4 7.3 4.3 24.7 2.5 0.0 0.1 0.0 3.5 0.0 0.0 0.0 1.4 0.0 0.0 5.3 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.8 0.0 9.7 0.0 0.0 0.8 3.5 6.0 1.9 4.3 3.9 2.1 4.4 1.6 5.2 4.3 223.4 31.0 5.2 0.8 2.1 0.0 3.5 5.1 2.7 14.8 8.7 0.0 0.4 11.6 4.4 0.9 11.3 147.6 0.0 25.2 0.6 18.5 2.7 0.0 93.7 11.5 0.0 12.1 28.8 29.3 0.2 16.1 25.7 1.7 1.8 25.6 1.0 24.6 48.9 4.9 8.4 0.0 12.9 11.3 0.4 0.6 1.1 1.1 1.3 42.4 0.9 PAQR3 ENSG00000163291 "Progestin and adipoQ receptor family member 3" Q6TCH7 4 78887127-78939438 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 70.2;Late spermatids: 101.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.5;HMC-1: 3.6;MOLT-4: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.41e-2)" "unprognostic (2.43e-1)" "unprognostic (2.27e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (2.33e-1)" "unprognostic (7.12e-3)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.74e-1)" "unprognostic (4.39e-2)" "unprognostic (7.65e-2)" "unprognostic (6.45e-2)" "unprognostic (5.93e-2)" "unprognostic (2.75e-1)" "unprognostic (1.34e-3)" "unprognostic (1.27e-1)" 2.7 2.1 4.6 3.4 7.7 2.8 2.2 5.2 6.7 2.1 2.9 4.3 0.0 5.1 2.2 1.7 2.1 1.9 2.9 2.4 3.6 1.9 2.7 2.3 2.1 4.0 3.7 4.2 2.2 2.1 1.4 2.1 2.2 5.6 2.3 1.7 1.6 2.4 1.3 2.4 3.5 4.4 1.6 7.6 2.6 2.4 12.9 3.3 1.5 2.6 1.7 1.9 2.3 2.2 0.6 0.3 0.1 0.1 0.9 0.3 0.0 0.5 0.0 0.6 1.0 0.1 0.1 0.9 1.4 0.1 0.2 0.1 0.0 0.3 1.8 1.5 0.2 0.0 0.4 0.6 0.2 0.2 0.7 3.5 1.1 0.9 0.4 0.2 1.8 3.6 0.1 0.0 0.2 0.1 0.3 0.1 0.7 1.9 0.6 0.2 0.0 3.9 0.7 0.4 0.8 0.8 1.5 0.6 0.3 0.0 0.5 1.3 1.0 2.1 0.2 1.3 0.6 0.3 0.7 1.6 0.8 2.0 0.6 1.7 1.4 0.9 1.1 1.2 0.8 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.6 0.1 0.2 0.0 0.9 0.1 0.3 0.1 0.0 4.6 7.7 5.2 6.7 3.6 1.9 3.7 4.2 5.6 3.3 3.0 8.8 2.7 4.7 15.7 19.7 8.6 2.5 2.7 5.7 10.4 3.9 7.8 0.0 2.4 70.2 5.8 8.5 0.0 3.2 10.7 10.6 4.8 23.1 9.0 3.8 4.8 8.1 2.5 6.0 101.4 6.9 6.9 6.8 1.8 6.7 11.1 2.4 7.0 9.9 2.4 11.0 12.9 5.9 9.1 13.6 20.5 10.9 6.9 5.0 2.8 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles NA Yes Vesicles "HPA068394: AB_2685980" "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.01e-6)" "prognostic favorable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.9 11.0 12.5 18.0 2.0 3.7 4.2 4.9 5.9 9.1 8.6 6.6 13.8 12.9 6.7 5.6 6.4 18.2 12.9 7.7 3.8 13.7 5.6 3.9 21.6 8.9 0.2 8.4 14.4 0.9 4.1 4.9 1.3 4.6 5.9 11.0 7.7 35.1 7.7 25.9 12.1 9.0 10.5 19.4 7.5 24.1 16.4 41.6 6.2 4.5 28.6 13.3 18.2 17.6 13.2 1.7 18.9 13.1 3.6 16.0 9.8 7.3 6.9 15.3 10.6 17.2 7.0 11.4 17.5 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 0.0 0.0 2.9 1.4 2.7 14.6 0.8 12.7 10.7 6.8 0.0 55.0 0.7 0.0 4.4 0.5 1.0 2.0 0.0 9.9 7.2 0.8 7.5 2.3 0.0 11.5 6.4 4.1 3.7 9.5 3.0 0.6 4.5 5.0 1.0 5.3 15.7 6.5 2.9 0.0 0.3 145.7 0.0 1.2 1.6 5.2 4.4 0.5 0.0 9.3 0.8 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298947-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.4" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 39.7;Early spermatids: 33.3;granulocytes: 65.8;Late spermatids: 86.2;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 17.5;CAPAN-2: 21.1;fHDF/TERT166: 14.9;HMC-1: 37.0;U-87 MG: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA076729 Approved Vesicles NA NA Vesicles "HPA076729: AB_2686813" "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 1.8 15.4 1.9 4.1 2.6 0.7 1.2 1.5 3.1 1.6 12.3 3.0 1.7 1.5 1.1 1.6 9.0 1.0 1.7 1.9 1.8 1.5 41.4 1.0 10.4 0.3 2.0 1.0 0.5 4.8 5.8 0.9 1.0 3.5 1.1 10.8 3.6 1.8 4.2 0.4 3.2 5.2 3.2 3.8 0.2 4.5 1.5 2.2 0.0 0.6 5.7 4.9 2.3 2.6 0.2 0.2 3.5 0.3 0.4 0.7 0.0 5.1 17.5 0.3 0.3 0.7 2.0 0.1 1.6 10.1 2.0 4.3 1.0 21.1 0.0 2.7 14.9 1.7 0.3 5.0 0.2 3.5 0.0 0.7 3.0 2.7 0.3 1.3 0.1 37.0 1.0 0.8 9.0 9.7 2.6 0.0 0.1 0.0 0.3 8.4 0.7 0.0 0.1 1.2 2.7 1.5 0.0 0.3 0.9 7.7 0.4 1.5 0.3 2.7 1.0 1.4 1.0 0.4 1.2 0.2 6.1 2.0 0.5 0.2 0.1 0.1 0.0 15.4 0.0 1.7 3.5 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.7 1.3 0.4 0.2 0.2 0.1 0.0 1.9 2.6 1.5 3.1 1.8 1.5 2.0 1.0 3.5 2.2 11.9 21.8 0.0 1.1 0.8 0.5 0.8 22.9 1.4 1.2 19.2 0.0 0.0 39.7 16.0 33.3 0.4 18.4 0.0 0.4 0.0 0.2 0.5 65.8 0.0 3.5 0.0 0.0 0.0 0.3 86.2 0.9 0.9 0.0 0.0 4.8 5.7 1.8 3.5 1.1 33.2 0.0 6.5 0.4 0.3 0.5 1.6 0.1 0.5 11.5 0.7 PAQR6 "FLJ22672, PRdelta" ENSG00000160781 "Progestin and adipoQ receptor family member 6" Q6TCH4 1 156243321-156248117 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 138.1" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 71.8" "Cancer enriched" "Detected in all" 6 "glioma: 34.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "NK-cell: 10.5" "Lineage enriched" "Detected in many" 6 "NK-cells: 10.5" "Cell line enhanced" "Detected in many" "U-266/70: 20.9" NA No "unprognostic (1.64e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.60e-5)" "unprognostic (7.42e-2)" "unprognostic (5.52e-2)" "unprognostic (4.50e-3)" "unprognostic (4.75e-1)" "unprognostic (2.25e-1)" "unprognostic (2.57e-1)" "unprognostic (3.13e-1)" "unprognostic (4.25e-3)" "prognostic unfavorable (1.99e-4)" "prognostic unfavorable (1.58e-8)" "unprognostic (1.26e-2)" "unprognostic (1.34e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.86e-4)" 2.1 3.6 42.5 2.2 38.0 7.6 2.2 8.7 71.6 2.0 2.7 102.9 0.0 2.8 2.3 2.9 2.5 2.2 2.9 2.0 48.1 37.6 2.0 2.1 2.1 2.1 82.7 16.1 1.6 1.6 2.4 1.2 2.2 72.5 3.5 2.3 0.0 3.2 3.0 2.1 11.5 3.0 2.0 138.1 2.3 3.1 2.5 46.0 0.0 2.0 0.0 2.0 2.5 0.3 0.8 1.6 0.0 0.0 10.5 1.2 0.1 1.8 2.0 3.3 3.4 0.6 0.5 8.2 0.2 0.5 0.0 0.2 1.0 6.4 3.3 1.5 0.5 0.2 5.8 0.0 0.7 0.4 1.9 2.7 2.0 1.7 0.9 0.3 0.6 5.3 1.6 2.6 2.4 2.4 3.3 0.3 6.7 1.5 9.5 0.6 6.7 0.2 1.0 3.8 1.1 0.9 1.4 0.7 1.5 2.3 10.7 2.9 5.8 0.7 0.7 3.8 6.9 10.8 1.1 0.5 1.0 5.3 1.7 0.5 20.9 4.6 2.0 0.2 7.5 0.9 0.0 0.0 0.0 0.4 0.0 1.2 0.8 0.6 0.2 0.0 0.1 0.0 0.0 0.0 10.5 0.0 1.6 0.1 0.1 42.5 38.0 8.7 34.4 48.1 37.6 82.7 16.1 72.5 46.0 0.0 0.3 0.0 0.2 1.1 3.2 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.7 0.7 0.0 3.0 0.1 0.6 0.7 1.1 0.9 0.5 6.4 4.1 0.6 0.6 0.6 0.3 0.7 0.0 0.0 0.4 71.8 1.3 0.0 2.1 0.0 10.3 0.0 0.2 0.7 0.4 1.3 0.2 4.6 0.9 0.4 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 94.7;Mucus-secreting cells: 40.0;Paneth cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 19.4;OE19: 41.1;SuSa: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA064625: AB_2685304" "prognostic favorable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favorable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.4 0.4 5.2 2.2 3.1 5.1 3.5 1.5 5.8 1.0 2.1 1.9 1.8 0.5 0.5 1.0 2.3 0.2 0.6 2.5 1.6 6.9 0.8 3.1 0.4 19.4 0.8 0.8 0.4 1.4 0.3 0.6 3.7 3.6 5.5 6.1 0.7 3.1 4.0 0.7 2.0 2.8 2.6 41.1 0.2 5.3 0.8 1.2 6.0 1.4 1.9 4.2 0.4 0.1 5.8 17.5 0.1 6.9 2.3 2.0 0.8 0.5 0.9 0.9 1.2 0.7 1.8 8.0 10.3 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 3.0 8.8 0.0 3.2 1.8 1.6 4.6 15.3 0.0 1.2 3.5 7.9 1.4 0.0 3.2 0.4 3.8 94.7 0.0 1.0 2.6 4.7 6.0 4.6 0.0 7.9 0.0 22.1 3.7 16.7 1.0 5.2 3.9 13.5 5.4 40.0 4.5 3.0 55.1 9.6 0.0 3.0 0.0 1.9 11.4 2.9 0.9 0.7 5.9 24.1 7.8 PAQR9 FLJ41938 ENSG00000188582 "Progestin and adipoQ receptor family member 9" Q6ZVX9 3 142949164-142963682 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.1;heart muscle: 12.1;liver: 18.6;testis: 20.8" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 33.7;Erythroid cells: 23.3;Hepatocytes: 17.3;Late spermatids: 72.6;Syncytiotrophoblasts: 30.6" "Cancer enriched" "Detected in single" 15 "liver cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.4;AF22: 3.4;HEL: 3.7;NTERA-2: 4.1;U-266/70: 10.2;U-266/84: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052798 Uncertain NA NA "HPA052798: AB_2681955" "unprognostic (4.13e-2)" "unprognostic (2.54e-1)" "unprognostic (2.81e-1)" "unprognostic (3.09e-2)" "unprognostic (1.21e-2)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.56e-2)" "unprognostic (1.23e-2)" "unprognostic (1.09e-1)" "unprognostic (6.91e-2)" 0.4 0.6 2.5 0.3 7.0 7.0 0.3 0.5 10.1 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.4 12.1 3.3 1.7 0.3 18.6 0.3 0.3 0.7 3.1 0.3 0.5 0.3 1.4 0.8 6.0 0.4 0.3 2.7 0.3 0.3 5.9 0.3 0.3 0.3 1.0 0.3 0.3 20.8 0.3 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 1.0 0.0 0.1 0.0 0.3 3.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 4.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.0 0.7 0.4 10.2 5.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 7.0 0.5 10.1 3.3 1.7 0.7 3.1 6.0 0.3 0.0 0.0 0.0 0.0 0.2 4.5 5.3 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 17.3 0.1 0.0 0.0 0.0 0.0 72.6 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 1.8 0.0 6.4 0.0 0.0 1.1 4.9 0.1 30.6 0.0 0.0 0.0 PARD6A "PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40" ENSG00000102981 "Par-6 family cell polarity regulator alpha" Q9NPB6 16 67660946-67662778 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.8;pancreas: 31.0" "Cell type enriched" "Detected in many" 5 "Late spermatids: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009733, HPA041551" Approved Supported "Cell Junctions,Actin filaments,Cytosol" No No "Cell Junctions, Actin filaments" Cytosol "CAB009733: AB_2159676, HPA041551: AB_2677545" "prognostic favorable (5.40e-4)" "unprognostic (6.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (4.08e-3)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (6.59e-2)" "unprognostic (2.09e-1)" "unprognostic (1.98e-3)" "unprognostic (9.13e-2)" "prognostic favorable (3.08e-7)" "unprognostic (9.22e-3)" "unprognostic (6.69e-2)" "unprognostic (1.25e-1)" "unprognostic (1.39e-2)" 2.7 6.1 11.7 3.5 12.4 2.1 2.8 26.8 16.1 2.0 3.0 2.2 3.7 2.0 2.4 3.6 2.7 2.5 3.1 2.3 13.8 7.2 5.5 3.1 3.5 4.0 7.9 5.7 3.3 31.0 5.3 13.9 1.5 7.4 2.7 2.0 1.4 3.8 4.6 7.0 1.5 2.5 2.7 3.7 3.7 3.2 16.9 3.4 2.5 2.3 1.4 3.4 2.9 3.1 11.4 5.3 3.7 1.0 1.2 8.5 2.1 5.5 6.0 1.7 14.8 1.2 0.2 3.1 0.1 0.7 2.2 2.1 3.0 2.3 9.4 2.8 0.1 0.8 4.4 3.4 0.7 0.5 4.4 3.2 3.8 2.8 3.4 1.6 1.5 8.9 0.1 0.3 2.1 0.8 1.4 1.1 14.1 0.3 2.2 0.4 5.5 9.6 2.0 2.0 7.7 3.9 17.4 1.1 15.2 5.9 3.2 14.3 7.7 0.9 2.1 2.3 0.5 12.9 0.6 0.9 0.2 0.5 1.4 2.9 2.3 7.3 8.4 1.7 3.4 0.6 2.1 1.0 0.4 4.5 0.5 8.5 11.4 6.4 5.9 1.2 7.4 3.2 2.4 3.7 1.2 0.1 5.3 6.1 2.1 11.7 12.4 26.8 16.1 13.8 7.2 7.9 5.7 7.4 3.4 3.0 4.3 8.1 1.4 0.8 9.7 1.0 12.7 4.0 2.3 19.2 3.9 4.6 28.2 6.6 42.8 2.7 2.1 0.0 13.1 0.2 2.4 2.1 5.7 3.8 4.0 30.2 32.6 1.3 3.2 203.1 3.4 3.1 5.0 1.0 2.4 15.2 5.2 2.6 1.4 12.9 7.6 0.0 2.1 4.6 2.6 1.4 2.4 9.6 2.9 1.4 PARD6B PAR-6B ENSG00000124171 "Par-6 family cell polarity regulator beta" Q9BYG5 20 50731544-50756795 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 40.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 15.8;MCF7: 27.8;T-47d: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013376 Uncertain Supported Cytosol NA NA Cytosol "HPA013376: AB_1854972" "unprognostic (1.13e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.39e-3)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.02e-5)" "unprognostic (2.12e-1)" "unprognostic (1.37e-1)" "unprognostic (9.33e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.27e-1)" "prognostic favorable (6.38e-5)" "unprognostic (1.84e-2)" "unprognostic (1.97e-1)" "unprognostic (4.18e-2)" "unprognostic (1.07e-2)" 3.7 2.3 1.6 3.1 2.3 2.6 7.9 3.5 2.0 2.7 13.9 1.4 11.3 4.5 2.2 12.1 5.8 5.7 6.6 2.1 2.0 1.9 40.0 8.0 15.4 1.9 1.5 1.3 3.4 9.9 7.3 3.7 24.1 2.7 4.0 3.0 12.2 3.6 17.2 4.3 3.8 17.5 1.0 1.6 2.4 8.3 6.4 0.5 2.9 14.4 1.0 5.8 3.5 5.5 3.6 3.1 3.4 1.5 3.8 6.1 1.1 2.9 3.4 1.0 2.1 0.6 0.2 4.5 0.2 0.3 0.5 0.4 15.8 7.0 1.3 3.0 0.0 2.2 2.4 1.4 2.1 0.8 0.6 0.8 0.7 1.1 6.2 0.6 0.5 0.7 0.0 1.0 0.3 0.9 1.0 0.0 1.2 1.6 0.9 0.0 27.8 1.3 1.2 1.7 4.9 1.3 0.7 0.9 1.1 7.1 3.2 0.6 0.9 2.2 5.3 1.5 4.2 27.2 0.7 0.1 0.3 1.8 0.3 0.5 1.1 0.7 1.1 0.7 0.5 0.6 2.9 0.7 3.4 3.6 0.9 4.0 2.9 3.7 3.6 0.8 3.6 6.1 3.8 2.8 3.8 1.5 3.1 2.3 1.1 1.6 2.3 3.5 2.0 2.0 1.9 1.5 1.3 2.7 0.5 175.7 50.3 4.5 51.0 55.9 12.3 3.3 28.1 25.4 33.0 85.5 51.1 28.8 34.9 22.0 3.2 1.1 39.4 0.0 21.2 12.5 2.6 39.6 1.1 17.8 3.1 4.8 14.3 2.5 0.3 2.2 1.7 2.5 15.1 1.0 18.0 10.0 40.3 18.2 0.7 63.2 52.4 6.5 2.3 11.2 9.8 59.7 40.5 4.6 12.1 85.3 PARD6G "PAR-6G, PAR6gamma" ENSG00000178184 "Par-6 family cell polarity regulator gamma" Q9BYG4 18 80157232-80247546 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 35.1;Sertoli cells: 19.4;Suprabasal keratinocytes: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 21.6;hTCEpi: 20.1;RT4: 16.1;U-2 OS: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047017 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA047017: AB_2679904" "unprognostic (1.11e-1)" "unprognostic (4.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.40e-2)" "unprognostic (2.97e-1)" "unprognostic (5.48e-3)" "prognostic unfavorable (3.19e-4)" "unprognostic (1.80e-1)" "unprognostic (9.96e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.09e-2)" "unprognostic (6.86e-3)" "unprognostic (9.65e-2)" "unprognostic (1.01e-1)" "unprognostic (4.85e-1)" "unprognostic (2.72e-1)" 2.9 2.2 3.1 4.0 3.1 0.8 8.8 2.0 4.3 15.1 5.0 3.1 8.2 2.1 9.5 6.1 17.3 6.7 4.5 3.0 4.3 4.1 5.5 3.5 2.6 10.4 2.8 2.4 8.9 3.1 2.1 3.7 5.7 3.7 8.8 2.5 4.0 7.0 6.6 2.0 37.0 2.9 8.2 2.6 2.4 2.5 2.4 1.8 6.9 20.7 14.1 11.2 8.4 10.7 0.5 0.5 2.5 0.4 0.6 1.0 0.1 1.7 2.5 10.5 7.8 0.3 0.4 7.6 1.9 0.4 1.7 0.2 0.7 0.7 0.0 0.8 0.8 3.0 7.7 3.7 11.1 1.7 0.3 3.3 0.1 2.0 5.9 0.5 2.2 21.6 3.4 20.1 0.2 1.1 1.3 0.8 2.4 0.7 0.5 2.5 2.8 2.0 0.2 3.1 0.8 3.0 0.0 6.9 0.8 0.3 16.1 4.4 4.5 2.3 1.3 11.0 5.4 1.5 2.0 0.6 3.5 17.4 1.3 0.9 0.5 0.7 0.1 1.1 0.5 6.4 2.5 0.2 0.4 0.3 0.2 0.2 0.3 0.3 1.0 0.2 0.5 0.4 0.5 1.2 0.6 0.4 0.5 0.1 0.1 3.1 3.1 2.0 4.3 4.3 4.1 2.8 2.4 3.7 1.8 3.0 1.1 0.0 12.6 35.1 1.6 2.2 2.5 1.4 1.2 3.5 0.0 0.5 0.0 0.3 0.4 3.1 0.0 0.0 0.2 4.2 5.6 5.4 0.0 1.6 0.7 0.0 0.0 8.0 1.9 0.4 1.7 1.1 11.8 0.0 0.0 2.0 0.9 0.0 1.8 6.3 2.2 19.4 5.8 0.9 4.1 55.8 0.3 2.2 0.5 10.1 PARP15 "FLJ40597, pART7" ENSG00000173200 "Poly(ADP-ribose) polymerase family member 15" Q460N3 3 122577602-122639047 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.9;lymphoid tissue: 40.4" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 12.8;B-cells: 22.9;Ciliated cells: 18.7;granulocytes: 18.5;Hofbauer cells: 6.6;monocytes: 6.4;T-cells: 12.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5" "Group enriched" "Detected in many" 6 "B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3" "Cell line enhanced" "Detected in some" "HEL: 10.6;JURKAT: 6.6;REH: 4.9;THP-1: 5.1;TIME: 12.6" "Not detected" "Not detected" HPA035757 Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "HPA035757: AB_10669656" "unprognostic (8.19e-3)" "unprognostic (2.88e-3)" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (9.01e-5)" "unprognostic (4.79e-2)" "unprognostic (1.83e-2)" "unprognostic (3.91e-2)" "unprognostic (5.40e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "unprognostic (9.24e-7)" "unprognostic (9.03e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (1.22e-2)" 2.4 0.9 0.5 24.5 0.4 9.8 1.3 0.3 0.8 1.2 2.8 1.2 0.5 1.0 1.5 2.3 1.9 1.4 2.8 1.5 0.6 0.5 1.5 1.9 5.6 20.3 0.6 0.6 1.1 2.7 0.0 1.0 1.0 0.6 1.3 2.1 1.8 5.5 0.2 2.6 0.7 22.9 0.9 0.9 40.4 1.7 1.7 0.4 9.4 1.9 1.7 34.8 3.6 1.2 11.9 1.2 1.3 0.6 5.2 9.3 2.7 0.6 0.2 0.5 0.5 0.2 0.3 0.6 0.3 0.2 0.1 0.1 0.3 1.0 0.8 0.6 0.2 0.3 0.6 0.1 0.0 0.0 1.9 0.2 10.6 0.8 0.5 0.2 0.7 0.5 2.2 0.1 0.4 0.2 0.4 2.4 6.6 0.3 2.1 0.0 0.5 3.2 0.7 0.7 0.2 0.3 4.9 0.4 0.6 0.0 1.0 0.8 0.5 0.3 0.2 0.3 0.6 0.8 5.1 12.6 0.4 1.1 0.5 0.4 1.0 0.7 2.4 0.7 0.3 0.2 1.3 0.2 0.1 9.3 0.5 6.5 11.2 5.0 6.4 0.9 11.9 4.3 5.9 0.7 5.2 0.6 1.2 4.5 2.7 0.5 0.4 0.3 0.8 0.6 0.5 0.6 0.6 0.6 0.4 17.9 12.8 22.9 0.0 0.5 0.0 0.4 0.0 18.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 18.5 0.5 6.6 0.0 0.0 2.5 3.5 0.0 0.0 3.2 1.7 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 12.9 0.0 0.0 PARPBP "C12orf48, FLJ20641, PARI" ENSG00000185480 "PARP1 binding protein" Q9NWS1 12 102120185-102197520 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 23.3;Spermatocytes: 14.6;Spermatogonia: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA039677 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA039677: AB_10673426" "unprognostic (7.84e-3)" "unprognostic (1.34e-2)" "unprognostic (4.54e-3)" "unprognostic (3.03e-2)" "unprognostic (1.84e-1)" "unprognostic (3.03e-1)" "unprognostic (1.30e-5)" "unprognostic (2.52e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.38e-1)" "unprognostic (3.95e-3)" "unprognostic (2.83e-1)" "unprognostic (5.61e-8)" "unprognostic (3.50e-3)" "unprognostic (2.34e-1)" "unprognostic (9.16e-3)" "unprognostic (6.14e-2)" 1.8 1.5 1.7 6.3 1.9 11.0 2.4 2.0 2.8 1.8 4.0 1.0 1.4 3.3 2.4 1.9 6.7 0.9 1.4 2.4 1.6 4.8 3.1 1.0 1.8 5.4 1.8 2.2 1.8 1.1 0.3 1.0 4.1 4.4 2.9 5.5 0.4 2.2 1.1 1.2 2.6 3.7 2.2 1.7 5.6 2.4 14.5 0.4 26.6 1.4 5.9 6.7 3.3 2.7 3.0 1.9 6.2 1.5 1.2 4.5 1.9 7.4 15.9 13.4 7.6 2.2 2.0 9.4 11.5 6.3 18.4 16.4 8.2 5.6 13.8 6.6 4.1 9.3 8.1 21.8 6.5 19.5 14.1 13.0 17.5 9.5 7.4 0.6 18.5 5.3 1.8 1.4 12.8 7.8 4.6 12.0 10.5 16.2 8.5 11.8 5.8 16.4 17.0 17.8 9.8 14.7 11.1 21.9 8.9 5.7 11.6 9.1 8.7 7.6 9.3 6.6 14.7 15.1 6.6 4.6 9.4 9.2 11.7 14.0 6.6 13.1 12.3 6.5 18.8 12.3 6.2 1.2 2.4 1.6 1.5 0.4 3.0 2.5 2.2 1.9 1.5 1.4 1.6 0.0 1.2 1.2 1.7 4.5 1.9 1.7 1.9 2.0 2.8 1.6 4.8 1.8 2.2 4.4 0.4 0.0 0.0 5.2 1.6 3.3 1.7 0.4 0.0 1.4 2.3 1.8 0.0 6.2 5.0 1.0 1.5 1.9 0.9 23.3 1.1 11.1 3.6 0.5 5.7 0.0 5.5 3.2 1.7 2.5 4.5 1.6 1.1 3.2 0.0 2.8 1.6 0.2 0.8 0.0 0.4 1.1 0.7 0.0 0.5 14.6 13.9 1.4 3.0 3.2 5.0 1.0 PARVB CGI-56 ENSG00000188677 "Parvin beta" Q9HBI1 22 43999211-44172949 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 64.5;Hofbauer cells: 82.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 44.5;RPMI-8226: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062601, HPA072217" Enhanced Approved Cytosol NA NA 90000000 Cytosol "HPA062601: AB_2684803, HPA072217: " "unprognostic (2.41e-1)" "unprognostic (5.52e-3)" "unprognostic (1.66e-1)" "unprognostic (3.83e-2)" "unprognostic (2.10e-3)" "unprognostic (7.65e-3)" "unprognostic (1.28e-1)" "unprognostic (1.73e-2)" "unprognostic (2.28e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-2)" "unprognostic (6.45e-2)" "unprognostic (1.28e-2)" "unprognostic (4.87e-3)" "unprognostic (3.19e-2)" "unprognostic (4.19e-2)" "unprognostic (7.05e-3)" 15.9 10.7 6.4 9.7 7.3 16.8 17.4 3.1 8.3 8.0 7.2 3.5 6.3 3.7 8.6 8.7 7.3 6.8 5.3 28.5 5.6 8.8 7.3 7.3 12.6 19.7 8.0 6.3 13.4 4.8 8.6 9.3 10.2 5.8 7.8 4.4 9.3 5.3 7.2 82.1 5.1 6.3 11.9 8.3 15.2 5.4 5.7 4.5 2.3 4.9 22.4 7.9 11.7 26.0 6.3 14.1 4.8 6.4 0.7 2.2 8.3 6.4 7.7 0.1 5.4 8.2 10.4 0.0 9.1 5.6 5.9 4.5 7.9 3.8 0.0 5.0 24.2 4.7 0.2 12.9 0.6 3.3 9.0 8.0 27.6 13.4 0.0 13.6 20.7 24.8 16.1 6.8 4.3 0.0 4.3 44.5 0.1 9.8 18.9 6.4 4.3 0.1 13.7 2.7 5.6 5.3 0.0 0.2 43.4 0.1 0.1 7.0 4.9 2.4 0.4 22.8 0.9 4.5 8.4 27.6 5.4 5.8 8.3 0.9 4.7 4.1 0.2 23.8 6.1 29.8 4.5 6.1 1.4 1.0 6.4 1.6 6.0 1.7 1.4 6.8 6.3 0.4 0.9 4.8 0.7 2.6 14.1 2.2 8.3 6.4 7.3 3.1 8.3 5.6 8.8 8.0 6.3 5.8 4.5 0.0 11.7 29.8 2.6 4.6 9.2 34.8 5.1 6.7 1.2 1.8 15.7 0.9 23.2 1.0 5.5 46.8 0.0 46.7 2.7 8.6 19.0 3.2 64.5 9.8 82.8 6.4 1.2 46.1 44.1 13.6 18.4 40.4 18.6 44.1 0.1 6.7 5.5 0.0 10.3 11.6 13.3 6.5 6.9 1.4 3.2 3.9 1.5 12.8 0.6 1.1 PARVG ENSG00000138964 "Parvin gamma" Q9HBI0 22 44172956-44219533 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.4;bone marrow: 31.2;lymphoid tissue: 27.7" "Group enriched" "Detected in many" 9 "Alveolar cells type 2: 21.8;B-cells: 64.9;granulocytes: 57.8;Hofbauer cells: 62.1;Kupffer cells: 83.7;Macrophages: 73.9;monocytes: 28.9;T-cells: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HL-60: 44.8;NB-4: 17.3;THP-1: 25.4;U-937: 21.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031833, HPA031834" Uncertain NA NA "HPA031833: AB_2674063, HPA031834: AB_10601242" "unprognostic (9.83e-3)" "unprognostic (2.30e-2)" "unprognostic (2.06e-1)" "prognostic favorable (4.44e-6)" "unprognostic (2.79e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (3.19e-2)" "unprognostic (7.02e-2)" "unprognostic (2.17e-1)" "unprognostic (3.87e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.43e-6)" "unprognostic (3.73e-1)" "unprognostic (1.35e-2)" "unprognostic (1.09e-1)" "unprognostic (9.89e-2)" 8.0 2.9 3.5 22.2 6.9 31.2 2.7 1.2 3.1 3.5 3.5 4.9 0.8 2.7 1.9 2.7 1.9 3.1 4.5 3.5 4.2 3.3 3.1 3.1 13.1 20.3 8.9 1.5 1.6 2.0 0.5 2.1 2.3 5.4 2.6 2.7 2.5 5.2 1.0 1.0 1.7 10.1 2.2 10.8 27.7 3.1 1.7 5.6 19.7 2.4 0.0 18.8 4.5 5.9 8.4 18.5 27.4 23.6 4.8 6.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 44.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 6.4 17.3 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.4 0.0 0.0 4.8 0.1 0.0 0.1 0.0 0.1 0.0 21.1 0.7 3.6 23.6 25.3 5.5 21.3 5.5 8.3 3.3 6.0 18.5 8.4 3.7 4.2 27.4 4.8 22.6 12.6 4.4 14.2 3.5 6.9 1.2 3.1 4.2 3.3 8.9 1.5 5.4 5.6 6.0 21.8 64.9 0.0 2.2 0.0 0.9 0.0 2.7 5.7 0.0 0.0 0.5 0.0 0.0 3.6 1.4 0.0 0.0 0.2 0.6 0.7 0.0 57.8 0.8 62.1 0.0 0.0 4.9 83.7 1.8 0.0 73.9 5.0 28.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.9 1.6 0.8 38.9 0.0 0.0 PASD1 CT63 ENSG00000166049 "PAS domain containing repressor 1" Q8IV76 X 151563622-151676739 "Predicted intracellular proteins" "Biological rhythms" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 301 "testis: 30.0" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 63.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 20.0;HMC-1: 31.8;U-266/84: 14.8" "HPA011122, HPA011152" Enhanced Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA011122: AB_1854990, HPA011152: AB_1854991" "unprognostic (3.34e-1)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 8.0 63.0 0.0 0.0 0.0 0.0 0.0 PASK "KIAA0135, PASKIN, STK37" ENSG00000115687 "PAS domain containing serine/threonine kinase" Q96RG2 2 241106099-241150264 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 24.1;testis: 22.0" "Cell type enhanced" "Detected in many" 6 "Ito cells: 27.0;Peritubular cells: 23.0;Rod photoreceptor cells: 17.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 24.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA016450, HPA021079" Uncertain Supported Cytosol NA NA Cytosol "HPA016450: AB_1854992, HPA021079: AB_1854993" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.84e-1)" "unprognostic (1.41e-2)" "unprognostic (1.14e-1)" "unprognostic (8.99e-6)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.60e-3)" "unprognostic (1.58e-2)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.52e-3)" "unprognostic (1.68e-1)" "unprognostic (6.44e-2)" "unprognostic (4.38e-3)" 1.5 1.1 2.4 10.3 24.1 8.9 3.1 6.3 5.2 2.2 2.1 2.2 2.1 3.8 2.9 6.7 3.1 7.2 3.3 1.1 2.9 2.7 3.7 1.3 3.0 14.5 1.3 1.6 1.9 3.3 4.4 4.9 1.1 3.6 12.1 2.8 4.7 2.7 1.8 2.0 4.9 3.9 1.4 1.6 4.4 3.4 22.0 7.2 9.0 4.8 1.9 9.9 2.7 1.9 7.1 1.1 4.8 1.0 2.7 6.0 3.0 5.0 6.8 9.2 11.6 0.8 1.4 12.3 4.8 1.5 4.5 6.3 5.5 5.1 2.6 1.0 1.1 10.0 12.6 10.4 4.2 3.3 10.6 9.9 7.2 12.6 9.7 0.5 9.8 11.3 0.7 3.3 4.6 1.3 1.9 3.2 11.2 9.3 3.6 3.1 5.7 11.6 10.3 10.2 5.9 4.1 18.5 9.3 3.2 1.7 11.4 16.3 4.9 2.9 5.6 2.1 5.1 4.7 7.1 4.2 6.1 5.6 7.8 6.4 4.8 4.9 12.4 3.8 7.4 5.6 4.8 1.0 0.7 1.7 0.6 1.5 7.1 5.9 5.3 1.1 6.6 3.7 3.9 1.3 2.7 1.0 0.7 6.0 3.0 2.4 24.1 6.3 5.2 2.9 2.7 1.3 1.6 3.6 7.2 3.0 9.3 10.6 1.0 2.4 2.3 2.8 2.5 6.7 1.2 3.5 3.9 0.8 0.0 1.2 7.7 2.4 1.8 0.0 1.8 1.5 0.9 2.5 3.5 1.0 1.6 1.6 0.0 27.0 5.3 2.2 5.5 1.9 11.8 1.0 2.9 1.6 0.6 0.0 23.0 1.0 17.7 0.0 0.3 14.7 12.7 1.3 0.2 13.1 2.7 0.7 PATE1 PATE ENSG00000171053 "Prostate and testis expressed 1" Q8WXA2 11 125746293-125749867 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "ductus deferens: 426.3;epididymis: 222.7;seminal vesicle: 185.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.9;NB-4: 6.6;RPMI-8226: 1.6;SH-SY5Y: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA076587 Approved "Secreted in male reproductive system" NA NA "HPA076587: AB_2732316" 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.3 0.2 0.3 0.2 0.0 426.3 0.0 0.2 222.7 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.0 10.0 0.0 0.0 0.2 185.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 1.4 0.0 0.0 0.2 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PATE2 "C11orf38, LVLF3112, PATE-M, UNQ3112" ENSG00000196844 "Prostate and testis expressed 2" Q6UY27 11 125776113-125778819 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "ductus deferens: 56.1;epididymis: 112.4;seminal vesicle: 44.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Early spermatids: 3.8;Late spermatids: 8.2;Spermatocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 4.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (3.28e-1)" "unprognostic (7.26e-2)" "unprognostic (2.95e-1)" "unprognostic (1.18e-2)" "unprognostic (2.63e-1)" "unprognostic (6.84e-3)" "unprognostic (1.55e-2)" "unprognostic (5.08e-1)" "unprognostic (2.55e-1)" 0.1 0.1 0.4 0.0 1.0 0.1 0.1 0.7 0.6 0.1 0.2 0.0 56.1 0.0 0.1 112.4 0.0 0.1 0.0 0.2 0.5 0.9 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 44.9 0.1 0.0 0.0 0.0 0.4 0.0 0.1 4.2 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.5 0.2 1.6 0.6 0.2 1.0 0.0 0.9 0.0 0.2 0.7 0.4 0.0 1.7 0.5 0.2 0.6 0.3 0.4 0.8 0.2 0.7 0.5 0.8 0.4 0.1 0.3 0.8 0.7 0.3 0.8 1.1 0.0 0.0 0.7 1.4 0.0 0.1 0.7 0.5 0.6 0.0 0.3 0.6 1.8 0.1 1.7 0.5 4.5 1.6 0.6 1.6 1.2 0.1 1.9 0.8 0.7 0.5 0.5 2.6 1.6 0.3 0.7 1.4 2.0 2.7 0.9 0.6 0.9 0.6 0.9 0.5 0.8 1.6 0.8 1.5 0.7 0.6 0.6 0.3 0.6 0.2 0.3 0.2 0.1 0.2 0.5 1.0 0.3 1.6 0.2 0.3 0.2 0.3 0.0 0.4 1.0 0.7 0.6 0.5 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.7 0.0 0.0 0.0 0.0 0.0 PATE3 "HEL-127, PATE-DJ" ENSG00000236027 "Prostate and testis expressed 3" B3GLJ2 11 125788111-125791600 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "epididymis: 86.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RPMI-8226: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.3 0.2 0.1 0.1 0.0 8.7 0.0 0.1 86.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 3.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PATE4 "FLJ41047, PATE-B" ENSG00000237353 "Prostate and testis expressed 4" P0C8F1 11 125833316-125840069 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "ductus deferens: 194.5;seminal vesicle: 232.9" "Group enriched" "Detected in some" 108 "Early spermatids: 16.9;Late spermatids: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA045632 Approved "Secreted in male reproductive system" NA NA "HPA045632: AB_10960489" "unprognostic (4.90e-1)" "unprognostic (2.93e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.4 0.2 0.2 0.1 0.0 194.5 0.0 0.1 7.3 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 8.4 0.0 0.0 0.1 232.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.1 0.0 0.0 2.1 0.2 1.6 1.5 1.2 0.6 0.6 0.9 0.1 0.5 0.5 0.8 1.5 0.4 0.5 0.4 0.3 0.2 0.0 0.3 0.6 1.0 1.7 0.5 0.0 1.0 0.9 0.1 0.1 0.4 0.3 0.3 0.6 1.6 0.8 0.1 0.5 3.2 0.7 0.3 0.2 0.6 0.7 0.1 0.5 0.9 2.6 0.2 0.7 0.2 0.9 1.6 0.4 0.8 0.6 0.6 0.6 0.6 1.9 0.4 0.3 0.5 0.1 0.3 0.9 0.9 0.1 1.8 1.3 1.6 2.6 0.8 1.4 0.7 0.8 1.1 0.2 1.3 0.6 0.6 0.3 0.9 0.5 0.6 1.4 0.7 0.4 0.3 1.6 0.9 0.8 1.2 0.6 0.4 1.5 0.2 0.1 0.2 0.2 0.4 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 PATJ "Cipp, INADL" ENSG00000132849 "PATJ, crumbs cell polarity complex component" Q8NI35 1 61742406-62178675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.4" "Group enriched" "Detected in some" 9 "Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 66.4" "Cell type enhanced" "Detected in many" "eosinophil: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1" "Low region specificity" "Detected in many" "HPA066352, HPA066960, HPA069079" Approved Supported "Cell Junctions,Centriolar satellite,Cytosol" NA NA "Cell Junctions" "Centriolar satellite, Cytosol" "HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079" "unprognostic (1.81e-1)" "unprognostic (5.70e-3)" "unprognostic (1.75e-2)" "unprognostic (2.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-1)" "unprognostic (7.96e-2)" "unprognostic (7.60e-2)" "unprognostic (1.88e-1)" "unprognostic (9.90e-2)" "unprognostic (3.39e-3)" "unprognostic (2.99e-2)" "prognostic favorable (1.47e-5)" "unprognostic (3.05e-3)" "unprognostic (6.72e-3)" "unprognostic (2.21e-2)" "unprognostic (2.43e-1)" 2.6 4.6 3.4 6.3 4.4 1.9 11.6 66.4 3.2 5.7 9.6 2.0 17.9 5.5 4.4 17.7 11.6 5.3 10.3 27.8 2.3 5.1 19.8 7.7 12.5 6.1 4.6 2.0 4.7 17.9 15.2 21.4 2.8 14.2 8.4 7.0 4.4 24.8 24.3 25.4 13.9 15.7 5.2 15.8 2.2 6.3 2.7 3.0 1.3 17.0 11.1 9.6 7.4 7.5 1.8 0.3 9.9 0.2 3.2 4.1 0.8 19.2 3.9 1.3 1.7 0.7 1.9 16.3 1.1 1.5 1.2 1.6 6.7 7.3 0.1 5.2 2.4 10.5 11.6 2.8 10.2 2.1 1.9 4.8 0.1 5.6 5.9 1.6 0.0 0.1 0.7 10.9 2.0 4.6 3.0 0.6 0.0 0.0 0.0 1.0 6.7 0.0 0.0 6.7 8.7 1.0 0.0 1.4 2.7 16.9 18.1 3.3 1.1 4.9 16.0 4.2 13.8 12.7 0.2 0.1 1.0 2.4 0.1 2.2 0.8 1.4 2.5 0.9 0.0 0.2 0.4 0.1 9.9 1.9 0.1 3.5 1.8 3.1 2.6 0.1 1.5 4.1 2.6 0.9 3.2 0.2 0.3 2.7 0.8 3.4 4.4 66.4 3.2 2.3 5.1 4.6 2.0 14.2 3.0 80.4 49.2 0.0 0.0 0.0 0.0 0.0 0.0 49.5 71.7 54.1 0.0 2.5 5.0 30.3 0.0 0.0 0.0 0.0 23.0 0.6 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.0 0.0 0.0 PATL2 Pat1a ENSG00000229474 "PAT1 homolog 2" C9JE40 15 44665732-44711316 "Disease related genes, Predicted intracellular proteins" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.7;lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" 12 "B-cells: 19.0;Cardiomyocytes: 9.8;Ciliated cells: 8.1;T-cells: 12.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 16.7" "Lineage enriched" "Detected in many" 7 "T-cells: 16.7" "Cell line enriched" "Detected in some" 28 "U-266/70: 54.3" "Low region specificity" "Detected in some" NA NA "unprognostic (1.28e-2)" "unprognostic (8.59e-3)" "unprognostic (3.30e-3)" "unprognostic (5.55e-2)" "unprognostic (7.28e-2)" "unprognostic (1.11e-2)" "unprognostic (3.00e-3)" "unprognostic (7.82e-2)" "unprognostic (3.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.44e-2)" "unprognostic (9.48e-2)" "unprognostic (1.35e-3)" "unprognostic (2.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (9.69e-4)" 1.4 2.3 0.6 5.6 1.3 5.2 1.1 0.4 1.2 0.9 1.3 0.4 0.4 1.5 1.1 1.4 2.1 1.3 5.1 1.6 1.1 0.5 1.4 1.5 4.7 12.7 2.0 1.3 1.3 0.7 0.0 1.7 1.0 1.0 1.7 1.7 1.2 4.8 0.4 1.0 1.8 6.5 0.4 1.8 13.1 2.0 1.0 1.5 0.9 1.4 0.4 8.4 2.2 0.9 2.5 0.5 1.7 0.4 1.7 16.7 2.2 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.2 0.3 0.4 0.2 0.5 0.3 0.0 0.1 0.7 0.5 0.0 0.1 0.2 0.9 0.0 0.5 0.0 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.1 0.1 0.0 0.5 0.0 1.9 0.1 0.1 0.0 0.6 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.3 0.0 54.3 1.7 0.1 0.5 1.3 0.1 1.0 0.2 1.7 16.7 0.4 2.4 2.5 4.7 13.0 0.5 2.4 2.8 10.1 1.1 1.7 0.3 0.4 0.6 2.2 0.6 1.3 0.4 1.2 1.1 0.5 2.0 1.3 1.0 1.5 3.0 1.7 19.0 0.5 0.8 0.0 9.8 0.0 8.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.5 1.7 0.0 0.5 0.4 0.5 0.7 0.0 0.8 1.8 0.0 0.0 1.3 2.5 0.0 0.3 3.5 0.0 4.6 1.3 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.6 0.2 12.9 0.6 0.8 PAX1 ENSG00000125813 "Paired box 1" P15863 20 21705659-21718486 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "lymphoid tissue: 70.7;parathyroid gland: 56.0" "Cell type enhanced" "Detected in single" 30 "Melanocytes: 1.7" "Cancer enriched" "Detected in single" 7 "head and neck cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.74e-2)" "unprognostic (3.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.64e-2)" "unprognostic (1.04e-2)" "unprognostic (2.33e-2)" "unprognostic (4.04e-2)" "unprognostic (2.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (8.08e-2)" 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 56.0 4.2 0.9 70.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735603-100829941 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 137.9;Distal tubular cells: 41.4" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Group enriched" "Detected in some" 6 "cerebellum: 1.0;pons and medulla: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AN3-CA: 14.6;EFO-21: 20.2;RPTEC TERT1: 14.5" "Group enriched" "Detected in some" 9 "cerebellum: 1.5;pons and medulla: 3.5" "Region enhanced" "Detected in single" "pons and medulla: 8.1" "CAB013024, HPA047704, HPA070751" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305" "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.1 0.1 0.2 0.0 0.1 0.0 0.1 1.0 0.1 3.1 0.1 0.0 30.5 0.0 1.5 93.7 0.1 9.1 0.0 0.1 0.1 0.1 43.1 0.1 0.1 0.0 0.2 0.0 1.5 0.3 0.6 0.7 0.0 1.8 0.8 0.0 0.5 0.1 19.4 0.1 0.1 0.1 0.0 1.7 0.1 0.1 2.4 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 14.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.1 0.1 0.1 0.2 0.0 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 137.9 0.0 0.0 41.4 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 18.8 0.4 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 PAX3 "HUP2, WS1" ENSG00000135903 "Paired box 3" P23760 2 222199888-222298996 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 19.1;retina: 39.6" "Group enriched" "Detected in some" 8 "Early spermatids: 10.9;Late spermatids: 19.5;Melanocytes: 32.1" "Cancer enriched" "Detected in some" 24 "melanoma: 20.3" "Group enriched" "Detected in some" 6 "cerebellum: 19.1;pons and medulla: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 9.1;HBF TERT88: 6.7;RH-30: 13.1;SK-MEL-30: 23.1" "Group enriched" "Detected in some" 7 "cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4" "Group enriched" "Detected in many" 5 "cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5" "HPA063659, HPA069000" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063659: AB_2685080, HPA069000: AB_2686067" "unprognostic (2.57e-2)" "unprognostic (1.48e-2)" "unprognostic (1.27e-2)" "unprognostic (1.65e-1)" "unprognostic (2.61e-2)" "unprognostic (3.70e-1)" "unprognostic (6.18e-2)" "unprognostic (1.41e-1)" "unprognostic (2.26e-1)" "unprognostic (9.70e-2)" 0.8 0.1 0.0 0.1 0.8 0.1 2.9 19.1 0.2 0.3 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.2 2.2 0.0 0.1 0.2 0.1 0.0 0.1 7.8 0.4 0.1 39.6 7.9 0.2 8.6 7.9 0.1 0.1 4.2 0.1 0.2 2.9 0.8 0.0 0.1 3.9 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 5.2 5.1 7.6 9.1 0.0 0.5 0.0 0.0 3.5 0.1 0.0 0.0 0.0 6.7 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.4 0.1 0.0 0.0 0.0 13.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 23.1 5.9 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.8 19.1 0.1 0.0 0.2 2.2 0.0 7.8 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.9 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.3 0.4 0.0 0.0 0.0 0.0 PAX4 MODY9 ENSG00000106331 "Paired box 4" O43316 7 127610292-127618114 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 3.9;testis: 3.6" "Cell type enriched" "Detected in some" 9 "Intestinal endocrine cells: 81.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 62 "SCLC-21H: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.52e-1)" "unprognostic (9.71e-2)" "unprognostic (4.86e-3)" "unprognostic (1.21e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.4 0.1 0.1 3.8 0.1 0.8 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 3.9 0.1 0.1 0.1 0.1 0.0 2.1 0.1 0.1 0.1 0.0 3.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 81.6 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PAX5 BSAP ENSG00000196092 "Paired box 5" Q02548 9 36833275-37034185 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 21.6;lymphoid tissue: 33.4" "Cell type enriched" "Detected in some" 27 "B-cells: 57.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "midbrain: 1.6" "Group enriched" "Detected in some" 209 "memory B-cell: 20.1;naive B-cell: 21.6" "Lineage enriched" "Detected in single" 216 "B-cells: 21.6" "Group enriched" "Detected in some" 8 "Daudi: 21.5;REH: 62.5;U-698: 28.2" "Region enriched" "Detected in single" 11 "midbrain: 4.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2" "CAB026269, CAB026869, HPA056394, HPA068498" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997" "unprognostic (4.69e-4)" "unprognostic (3.83e-1)" "unprognostic (9.13e-2)" "unprognostic (1.42e-1)" "unprognostic (2.65e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.46e-2)" "unprognostic (1.11e-3)" "unprognostic (3.15e-1)" "unprognostic (8.96e-2)" "unprognostic (6.03e-2)" "unprognostic (1.01e-1)" 0.4 0.2 0.2 33.4 0.2 5.5 0.2 0.2 0.2 0.2 0.7 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.5 0.3 0.3 23.2 1.6 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.3 0.3 0.4 2.5 0.0 0.6 0.2 8.7 0.0 0.3 16.5 0.7 0.9 0.0 2.3 0.4 0.2 30.1 1.3 0.2 21.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.1 62.5 0.1 0.1 0.0 0.0 4.4 1.0 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 0.0 0.2 0.0 0.0 0.0 57.6 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Group enriched" "Detected in some" 5 "Horizontal cells: 249.5;Muller glia cells: 410.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.1 9.4 12.1 2.9 4.0 3.6 0.0 0.0 0.1 0.0 0.7 2.2 0.0 3.8 1.2 5.5 0.2 1.0 0.0 0.2 0.0 11.3 5.3 8.8 5.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 32.3 0.0 3.3 4.2 0.0 0.1 0.0 2.2 0.3 0.2 0.0 6.1 0.0 4.4 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 3.2 0.2 0.0 9.9 0.0 0.1 0.0 5.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 0.0 0.0 0.0 0.0 0.5 15.4 4.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 249.5 71.5 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.1 410.0 4.1 0.6 0.0 0.0 27.5 0.0 0.3 3.7 2.9 0.0 0.0 0.0 0.0 0.0 PAX7 Hup1 ENSG00000009709 "Paired box 7" P23759 1 18631006-18748866 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Myogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 12.9;tongue: 12.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 3.4;CAPAN-2: 3.8;U-2 OS: 8.2" "Region enriched" "Detected in single" 17 "midbrain: 5.5" "Low region specificity" "Detected in many" NA NA "unprognostic (8.41e-4)" "unprognostic (2.07e-1)" "unprognostic (5.35e-2)" "unprognostic (3.96e-2)" "unprognostic (4.21e-1)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" 0.4 0.1 0.6 0.0 0.6 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.5 0.1 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.4 0.0 3.4 0.3 0.0 0.0 0.1 0.1 12.9 0.0 0.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 3.4 0.8 0.8 2.4 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAX8 ENSG00000125618 "Paired box 8" Q06710 2 113215997-113278950 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 69.3;thyroid gland: 120.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 233.8;Proximal tubular cells: 100.4" "Group enriched" "Detected in many" 12 "endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "EFO-21: 27.1;GAMG: 16.8;RPTEC TERT1: 63.8" "Region enriched" "Detected in some" 4 "pons and medulla: 5.8" "HPA030062, CAB055097, CAB061888, HPA064554" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283" "unprognostic (2.63e-3)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (7.24e-2)" "unprognostic (5.16e-5)" "unprognostic (1.56e-2)" "unprognostic (3.29e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (4.13e-2)" "unprognostic (4.00e-2)" "unprognostic (3.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.37e-1)" "unprognostic (8.93e-3)" "unprognostic (1.02e-1)" 0.9 1.4 1.1 0.5 0.4 0.0 0.6 0.2 0.8 3.8 0.4 0.2 11.7 0.1 2.2 15.2 0.6 9.6 0.8 0.6 0.5 0.5 69.3 0.4 0.5 0.7 0.4 0.3 3.8 0.6 0.1 0.7 0.8 1.5 1.1 0.1 0.5 0.5 10.0 0.3 0.5 0.6 0.4 0.8 0.3 0.4 1.9 0.2 0.4 120.5 0.0 0.2 0.8 1.9 4.4 2.8 1.5 3.4 1.9 2.5 1.1 2.9 0.2 0.1 0.0 0.1 0.0 1.0 0.8 2.7 0.2 0.4 1.8 0.5 0.5 27.1 0.2 16.8 0.0 0.5 0.8 0.2 1.2 0.0 0.4 0.2 1.0 0.3 0.0 0.0 0.7 0.1 0.2 0.6 3.3 0.0 0.0 0.4 2.0 0.8 0.6 0.3 1.2 0.1 0.7 1.8 0.0 0.2 0.6 63.8 4.7 0.5 0.0 3.4 0.0 1.8 0.0 0.0 1.1 0.9 4.6 0.1 0.8 2.3 0.4 1.4 0.1 4.0 0.6 0.0 1.5 3.4 0.0 0.6 1.8 1.5 4.4 1.5 1.1 2.8 1.9 2.5 1.5 0.5 1.9 1.3 1.1 0.8 1.1 1.1 0.4 0.2 0.8 0.5 0.5 0.4 0.3 1.5 0.2 3.0 1.3 0.8 1.7 0.6 0.6 0.8 2.5 0.0 4.5 233.8 0.0 2.1 39.7 9.6 1.5 0.5 5.8 0.0 2.6 2.0 1.9 1.0 0.0 0.0 4.5 0.0 4.6 1.3 1.3 3.1 4.6 2.6 0.0 2.8 2.3 3.3 17.3 7.0 0.4 100.4 0.7 6.5 0.1 4.2 5.8 0.6 0.7 1.0 3.7 1.7 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679715 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1" "Group enriched" "Detected in some" 19 "Basal glandular cells: 7.6;Ciliated cells: 29.4;Club cells: 14.8;Glandular cells: 15.1;Urothelial cells: 10.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 2.7" "Lineage enriched" "Detected in single" 19 "T-cells: 2.7" "Cell line enhanced" "Detected in many" "HaCaT: 8.1;HBEC3-KT: 8.1;HDLM-2: 30.7;PC-3: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016239, HPA038462" Enhanced Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB016239: AB_2159984, HPA038462: AB_10672594" "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.1 0.0 0.1 0.3 0.5 0.0 0.1 3.7 0.4 0.0 0.0 0.0 0.2 0.1 58.6 0.2 0.0 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.0 0.1 0.1 34.6 1.4 0.0 0.1 2.7 0.0 0.1 86.1 0.0 0.1 0.3 0.1 0.4 0.1 0.1 0.2 0.2 0.0 11.8 0.5 27.1 33.2 0.4 3.4 0.1 0.0 0.0 0.0 0.0 2.7 0.1 3.5 1.0 0.0 1.7 1.4 2.4 1.3 0.0 0.1 0.0 0.0 0.7 1.1 0.7 0.4 0.0 0.3 8.1 1.2 8.1 0.0 30.7 5.4 0.5 0.5 0.0 0.0 0.0 2.7 0.5 3.8 0.0 1.2 0.0 0.0 3.5 2.0 0.8 0.1 4.6 0.5 0.0 0.1 1.2 13.2 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.8 4.1 0.9 0.7 3.5 0.0 0.0 0.0 0.5 1.3 0.6 0.0 0.0 3.1 0.4 0.3 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.8 0.0 0.3 0.0 29.4 14.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.6 15.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.3 0.1 0.0 0.2 10.8 PBK "CT84, FLJ14385, Nori-3, SPK, TOPK" ENSG00000168078 "PDZ binding kinase" Q96KB5 8 27809620-27838095 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "lymphoid tissue: 19.4;testis: 67.9" "Group enriched" "Detected in many" 4 "Early spermatids: 218.2;Spermatocytes: 187.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.1;T-reg: 1.6" "Group enriched" "Detected in many" 10 "NK-cells: 2.1;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 61.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005753, HPA050656" Enhanced Supported Approved Cytosol NA Yes Cytosol "HPA005753: AB_1855018, HPA050656: AB_2681205" "unprognostic (7.17e-2)" "unprognostic (7.21e-3)" "unprognostic (1.04e-3)" "unprognostic (2.77e-2)" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.29e-5)" "unprognostic (3.65e-3)" "unprognostic (7.38e-2)" "unprognostic (2.88e-3)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.20e-1)" "prognostic unfavorable (1.18e-12)" "unprognostic (9.61e-2)" "unprognostic (1.86e-1)" "unprognostic (8.30e-2)" "unprognostic (8.68e-2)" 0.6 0.8 0.2 7.7 0.3 3.3 1.3 0.3 0.4 1.1 3.8 0.3 0.2 3.7 0.4 0.6 6.2 0.3 0.8 3.3 0.3 0.2 0.7 0.9 1.2 5.4 0.3 0.2 0.4 0.4 0.0 0.2 2.2 0.3 0.4 4.6 0.2 1.1 0.2 0.4 1.9 3.6 0.9 0.6 1.7 1.7 67.9 0.2 19.4 0.3 4.7 5.3 0.7 1.9 0.1 0.0 0.0 0.0 2.1 1.6 0.5 61.3 20.0 19.7 12.5 1.9 3.5 8.3 28.2 13.4 29.0 24.5 6.9 11.4 32.7 10.0 10.8 32.3 16.3 18.9 9.5 31.9 8.0 10.2 7.8 14.2 10.1 0.1 5.1 11.7 0.9 7.8 13.4 7.2 5.2 14.6 16.2 11.5 22.0 34.2 6.9 19.3 6.0 3.5 16.6 17.4 12.1 27.4 8.8 10.9 9.5 7.8 12.2 10.5 12.4 15.8 5.7 13.0 7.8 8.5 19.1 46.0 24.2 29.9 3.1 8.7 15.1 11.6 9.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 1.6 0.5 0.2 0.3 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.9 7.9 0.0 0.3 5.1 0.0 2.3 0.0 0.0 3.1 0.0 0.5 218.2 0.0 1.3 46.7 0.0 40.6 2.9 0.7 0.0 1.0 4.2 0.0 0.0 7.4 1.9 37.5 7.8 0.6 0.0 0.0 4.3 0.0 0.2 0.0 2.8 0.0 0.0 6.5 0.5 187.0 31.0 2.0 5.6 0.0 5.3 0.7 PBLD "FLJ14767, MAWBP, MAWDBP" ENSG00000108187 "Phenazine biosynthesis like protein domain containing" P30039 10 68282660-68333049 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 47.3;kidney: 74.5;liver: 91.4" "Cell type enhanced" "Detected in many" 16 "Distal tubular cells: 92.9;Enterocytes: 114.6;Hepatocytes: 159.6;Proximal tubular cells: 362.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038035, HPA038036" Enhanced Approved Vesicles NA NA 420000 Vesicles "HPA038035: AB_10672470, HPA038036: AB_10675625" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (6.14e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "prognostic favorable (1.44e-4)" "unprognostic (8.25e-2)" "unprognostic (3.62e-2)" "unprognostic (3.36e-3)" "unprognostic (1.19e-1)" "unprognostic (6.26e-3)" "unprognostic (3.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.07e-2)" "unprognostic (8.28e-2)" "unprognostic (6.68e-2)" 5.0 5.9 3.6 2.4 6.4 2.5 2.9 2.3 8.0 4.1 9.4 11.8 6.8 47.3 4.5 5.1 1.5 2.3 2.9 3.3 3.9 3.1 74.5 91.4 2.3 2.8 6.7 5.6 2.3 17.9 2.4 2.4 7.0 8.4 2.6 8.0 9.4 2.2 6.2 2.3 1.8 39.3 6.5 4.9 1.6 15.0 2.1 6.2 2.5 1.9 4.3 1.6 4.1 1.6 1.7 5.6 6.4 5.8 3.3 2.3 2.5 3.4 6.9 6.7 4.6 6.1 3.5 3.1 13.9 8.8 5.3 5.6 6.3 8.8 3.9 5.4 9.7 2.2 5.3 3.1 3.6 4.6 1.8 5.1 3.1 7.5 5.7 3.0 4.5 3.1 6.2 4.3 3.2 4.0 9.6 3.2 3.7 2.7 8.6 8.3 5.3 4.1 7.9 1.9 2.7 3.0 7.2 8.8 6.4 10.6 5.0 3.9 5.2 9.3 5.4 6.4 1.9 18.7 5.4 10.0 5.3 3.8 2.5 2.2 5.2 3.7 5.7 6.3 2.5 1.3 4.2 5.8 2.9 0.9 2.9 1.8 1.7 1.4 0.9 5.6 1.6 2.3 1.6 6.4 3.3 1.7 2.4 2.3 2.5 3.6 6.4 2.3 8.0 3.9 3.1 6.7 5.6 8.4 6.2 3.0 3.4 6.1 1.7 1.6 4.7 2.8 25.5 17.4 5.7 52.4 9.8 3.1 92.9 5.7 0.8 2.9 114.6 0.0 28.7 2.1 3.3 2.4 1.1 159.6 2.6 9.5 6.9 7.4 7.8 0.0 3.7 4.2 1.7 4.6 34.2 5.0 16.3 35.1 2.8 362.3 16.5 0.0 5.6 1.2 1.4 0.5 2.6 2.2 34.0 3.1 PBOV1 "UC28, UROC28" ENSG00000254440 "Prostate and breast cancer overexpressed 1" Q9GZY1 6 138215986-138218491 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.5;bone marrow: 1.9;brain: 1.9" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 1.0;Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "MCF7: 1.1" HPA063021 Uncertain NA NA "HPA063021: AB_2684923" "unprognostic (3.32e-3)" "unprognostic (8.23e-2)" "unprognostic (9.35e-2)" "unprognostic (1.22e-1)" "unprognostic (4.77e-2)" "unprognostic (2.51e-1)" "unprognostic (1.35e-4)" 0.0 0.0 0.2 0.0 0.3 1.9 0.2 1.9 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.2 1.1 0.1 0.1 0.0 0.1 0.0 0.8 0.7 0.3 0.0 0.5 0.0 0.5 0.0 0.2 0.5 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.8 0.4 2.5 0.4 1.1 0.4 0.1 0.0 0.5 0.1 0.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.8 0.2 1.1 0.4 0.8 0.4 0.1 0.0 0.3 0.1 0.3 0.0 0.4 0.3 0.5 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.9 0.1 0.0 0.5 0.1 0.0 2.5 0.4 0.3 0.2 0.2 0.1 0.4 0.2 0.3 0.1 0.8 0.4 0.4 2.0 1.1 0.2 0.4 0.1 0.1 0.0 0.3 0.0 0.3 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 86.7" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 52.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 16.1" "Lineage enriched" "Detected in all" 4 "dendritic cells: 16.1" "Cell line enhanced" "Detected in many" "THP-1: 36.5" "Region enhanced" "Detected in all" "olfactory region: 205.0" "Region enriched" "Detected in all" 4 "olfactory region: 287.4" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 8.0 25.0 4.4 16.2 11.6 3.0 10.4 6.6 3.4 16.6 18.9 3.7 6.5 3.1 10.7 10.9 9.1 5.9 22.8 16.1 2.9 6.3 3.4 7.6 9.4 6.1 9.5 3.4 35.0 12.9 86.7 6.8 3.1 13.0 18.8 6.1 7.1 10.5 12.3 3.6 8.2 6.0 21.2 17.6 5.5 10.0 5.1 6.2 6.8 14.7 5.5 3.8 13.3 12.0 1.8 16.1 2.9 1.8 3.8 2.1 1.0 4.7 4.6 20.8 19.2 5.8 9.5 3.7 12.4 7.1 8.7 6.2 5.9 9.4 4.7 1.5 9.9 8.9 3.6 11.7 5.0 17.2 5.0 8.3 4.0 3.5 2.3 7.4 4.4 7.3 4.8 5.7 6.8 4.4 19.2 9.7 3.2 0.2 4.5 17.9 2.5 4.1 2.1 15.3 5.7 3.1 7.7 31.0 0.6 6.6 2.8 11.2 19.4 8.6 1.6 3.8 8.2 7.1 36.5 11.7 17.6 4.8 10.3 23.2 3.2 5.0 4.9 8.4 6.2 9.0 2.9 1.8 2.3 0.9 1.6 1.2 1.4 1.2 1.0 2.1 1.8 2.1 1.0 1.7 3.8 1.3 16.1 1.8 1.0 4.4 11.6 6.6 3.4 2.9 6.3 9.5 3.4 13.0 6.2 8.9 14.7 3.2 9.5 20.1 6.8 52.9 2.5 9.4 13.6 12.2 35.3 0.3 6.6 9.5 11.1 10.8 0.9 0.0 2.2 0.8 11.1 16.7 16.1 9.6 14.6 39.7 11.1 11.1 29.5 8.8 18.4 15.9 6.8 9.0 6.2 8.0 2.8 15.9 10.6 1.5 38.9 0.0 12.0 12.2 7.9 23.1 0.3 7.2 2.3 7.6 PBX4 ENSG00000105717 "PBX homeobox 4" Q9BYU1 19 19561707-19618916 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.9;thyroid gland: 14.4" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 23.3;Spermatogonia: 8.7;T-cells: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 2.8;MAIT T-cell: 3.3;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7;T-reg: 5.4" "Lineage enriched" "Detected in single" 14 "T-cells: 5.4" "Cell line enhanced" "Detected in many" "A-431: 4.0;PC-3: 4.3;RT4: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049859, HPA056469" Enhanced Approved Vesicles NA NA Vesicles "HPA049859: AB_2680918, HPA056469: AB_2797256" "unprognostic (5.36e-3)" "prognostic favorable (8.69e-6)" "unprognostic (9.39e-3)" "unprognostic (1.03e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-4)" "unprognostic (2.87e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.86e-2)" "unprognostic (3.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.44e-6)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "unprognostic (5.89e-2)" "prognostic favorable (5.94e-7)" 1.0 0.5 2.2 4.5 3.4 1.7 1.0 1.2 1.9 0.9 1.6 0.0 4.6 1.1 0.6 1.3 0.8 1.0 7.1 0.6 2.3 2.5 1.0 0.5 1.8 3.6 0.8 1.2 1.2 0.5 0.7 1.7 1.2 1.5 1.1 1.1 0.7 1.4 2.7 0.5 2.0 1.7 0.5 0.7 1.8 1.7 16.9 0.6 6.1 14.4 0.5 9.6 1.4 0.8 0.3 0.0 0.0 0.1 0.0 5.4 0.8 4.0 0.2 1.9 0.0 0.0 0.0 2.1 0.0 1.6 1.7 1.7 0.0 1.4 0.4 0.9 1.0 1.6 1.6 2.7 0.0 0.7 0.3 0.8 0.0 0.9 0.1 0.3 0.0 1.3 0.5 0.0 0.3 0.0 0.0 0.0 1.8 0.1 0.0 0.3 0.8 1.4 0.1 0.3 2.2 4.3 0.8 0.0 0.0 1.1 5.3 1.2 2.3 1.5 0.2 0.9 0.2 0.8 0.0 0.0 0.0 1.0 2.1 0.8 0.0 1.8 0.3 0.1 0.2 0.0 0.0 0.0 0.0 2.8 0.0 3.3 0.3 2.0 2.9 0.0 0.0 1.8 1.7 0.0 0.0 0.1 0.0 5.4 0.8 2.2 3.4 1.2 1.9 2.3 2.5 0.8 1.2 1.5 0.6 0.0 2.6 0.5 2.2 4.2 0.4 0.4 0.0 2.7 2.3 0.0 0.0 0.0 1.7 0.8 1.6 0.0 0.5 0.0 0.0 1.0 2.6 2.1 0.0 0.0 0.4 0.0 0.0 0.6 0.8 1.1 0.3 0.3 1.7 1.8 2.1 1.1 1.5 0.0 0.7 0.0 0.0 6.5 1.2 23.3 8.7 2.3 0.0 15.0 0.6 2.6 PC PCB ENSG00000173599 "Pyruvate carboxylase" P11498 11 66848233-66958376 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Lipid biosynthesis, Lipid metabolism" "Ligase, Multifunctional enzyme" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 41.1;liver: 76.0" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 192.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9" "Cell line enhanced" "Detected in many" "HeLa: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033742, HPA043922, HPA058765" Enhanced Enhanced Mitochondria Yes No 96000 Mitochondria "CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812" "unprognostic (2.10e-1)" "unprognostic (1.51e-1)" "unprognostic (1.36e-2)" "unprognostic (8.24e-3)" "unprognostic (3.67e-1)" "unprognostic (3.18e-2)" "unprognostic (2.97e-1)" "unprognostic (3.00e-1)" "unprognostic (3.63e-1)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "prognostic favorable (8.22e-5)" "unprognostic (8.58e-3)" "unprognostic (5.67e-2)" "unprognostic (9.15e-3)" "unprognostic (1.05e-1)" 41.1 10.7 11.1 2.8 14.6 3.1 12.9 13.1 14.9 2.4 3.8 10.7 21.4 5.6 2.1 2.4 5.0 2.7 2.9 4.0 11.3 8.9 18.7 76.0 2.1 1.6 15.5 11.5 4.4 4.3 19.4 4.0 4.1 10.9 5.4 3.1 3.4 24.2 24.4 5.7 2.8 6.7 1.8 9.4 1.5 3.3 6.1 13.1 0.6 4.2 2.5 2.5 2.2 2.1 0.6 2.6 0.0 3.8 0.3 2.9 2.0 2.9 9.1 3.4 8.3 13.9 5.5 3.5 1.9 7.9 3.6 3.5 4.5 3.3 0.0 3.8 2.9 4.8 3.9 3.8 21.0 1.1 1.8 5.3 4.5 28.3 17.3 10.9 0.0 5.9 21.0 5.4 2.9 6.6 2.3 2.9 7.9 8.5 0.0 1.2 19.4 5.1 2.4 6.4 7.7 7.6 3.8 7.0 1.8 3.3 0.9 7.4 10.5 17.6 9.4 7.2 2.6 7.7 1.2 3.2 4.0 3.7 4.7 2.1 2.0 2.3 0.0 4.1 2.9 3.4 0.0 3.8 0.0 1.2 0.9 1.4 0.2 0.5 1.9 2.6 0.6 2.9 1.6 0.0 0.3 0.5 1.0 1.5 2.0 11.1 14.6 13.1 13.6 11.3 8.9 15.5 11.5 10.9 13.1 0.0 4.8 2.2 1.1 1.1 4.7 3.7 10.2 0.0 1.2 3.5 2.0 15.6 1.7 3.1 15.2 1.4 18.6 0.0 1.6 3.5 1.9 2.4 9.2 192.6 11.2 0.0 8.6 4.3 6.9 39.9 0.6 1.6 5.0 32.5 4.2 9.2 2.3 7.0 3.9 37.8 4.7 0.0 1.4 6.0 4.2 0.5 21.3 1.3 6.0 1.1 PCBD1 "DCOH, PCBD, PCD" ENSG00000166228 "Pterin-4 alpha-carbinolamine dehydratase 1" P61457 10 70882280-70888784 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation" "Activator, Lyase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.0" "Cell type enhanced" "Detected in all" 7 "Hepatocytes: 577.2;Proximal tubular cells: 733.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 67.0;Hep G2: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037575, HPA061723" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 210000 Nucleoplasm Cytosol "HPA037575: AB_10671761, HPA061723: AB_2684594" "unprognostic (1.02e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (3.69e-1)" "unprognostic (5.39e-2)" "unprognostic (4.80e-3)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (2.40e-2)" "unprognostic (2.95e-1)" "unprognostic (5.63e-2)" "unprognostic (3.38e-2)" "unprognostic (9.26e-2)" "unprognostic (1.74e-1)" "unprognostic (5.76e-2)" "unprognostic (7.43e-3)" 18.3 25.5 18.1 9.6 15.6 4.3 19.7 13.2 14.8 13.9 18.4 7.8 24.3 12.6 13.9 21.4 26.5 25.6 22.9 32.5 10.8 23.7 38.7 99.0 14.0 7.8 16.7 12.3 18.5 73.0 15.8 15.5 11.7 16.4 26.9 20.3 16.3 16.2 20.7 23.1 5.8 17.2 18.1 14.5 10.2 19.2 7.0 8.7 4.3 36.8 16.2 12.3 22.4 31.8 11.8 20.9 3.5 19.4 8.0 16.9 7.5 20.2 48.2 2.9 29.9 10.9 10.2 3.9 6.6 10.9 10.2 8.2 67.0 36.0 4.1 19.1 7.2 7.9 13.5 18.2 10.5 7.0 10.9 32.8 3.6 7.7 65.8 11.5 3.6 13.5 10.0 11.5 10.1 4.8 15.5 27.4 2.6 7.1 0.3 7.1 33.9 0.4 12.1 4.0 54.9 45.1 1.9 4.0 13.3 42.9 21.0 12.6 21.4 5.4 37.3 14.2 8.4 10.8 7.0 11.3 1.7 14.3 2.5 16.0 0.1 0.8 0.1 9.3 11.8 2.6 0.0 10.7 3.5 8.8 19.4 6.9 11.8 11.6 12.6 20.9 4.1 3.8 7.9 0.6 8.0 13.3 15.3 16.9 7.5 18.1 15.6 13.2 14.8 10.8 23.7 16.7 12.3 16.4 8.7 38.7 59.6 41.0 140.4 44.3 32.7 140.4 142.7 72.3 73.9 177.9 5.9 105.7 384.7 161.2 1.3 33.8 116.6 23.3 147.5 63.7 71.1 169.6 31.1 577.2 160.3 33.4 169.3 32.5 54.4 5.8 62.5 71.4 74.2 90.2 228.3 70.5 157.8 147.3 89.8 733.2 28.5 84.1 57.7 4.9 7.9 40.0 64.9 33.8 199.7 158.3 PCBD2 "DCOH2, DCOHM" ENSG00000132570 "Pterin-4 alpha-carbinolamine dehydratase 2" Q9H0N5 5 134904906-135007959 "Enzymes, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036428 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036428: AB_10670103" "unprognostic (3.70e-2)" "unprognostic (3.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (4.22e-1)" "unprognostic (6.43e-2)" "unprognostic (4.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.57e-2)" "unprognostic (6.34e-2)" "unprognostic (9.32e-3)" "unprognostic (1.50e-1)" 4.9 8.1 5.4 7.0 6.6 6.6 5.3 3.0 4.4 3.9 8.7 6.5 9.4 8.0 6.5 8.4 9.3 4.9 6.9 13.8 5.0 5.3 9.2 9.8 6.5 5.0 5.6 5.2 5.1 12.9 9.6 6.1 4.8 6.8 4.7 6.4 9.6 14.2 7.9 47.0 6.7 12.7 7.6 7.0 5.5 7.1 5.5 5.8 5.3 8.3 13.5 8.1 5.6 5.5 8.2 11.5 7.2 10.1 6.3 6.6 4.3 7.8 7.6 8.1 6.1 5.6 4.8 6.0 6.3 4.9 3.6 3.6 14.2 20.1 9.4 10.6 4.2 7.1 5.3 5.5 6.0 3.3 13.1 3.7 5.3 8.1 8.5 5.4 6.1 3.8 2.6 5.9 3.7 8.7 4.2 4.2 7.3 7.7 14.1 6.3 16.1 6.4 10.4 4.5 10.8 7.4 10.2 7.6 8.3 6.6 6.7 6.1 8.0 9.4 4.9 7.8 7.1 13.7 8.1 4.6 6.9 5.2 6.1 8.0 11.0 15.0 6.4 6.2 7.5 4.5 2.7 10.1 7.2 5.1 6.3 5.0 8.2 6.3 5.3 8.6 8.2 5.4 5.3 3.3 6.3 6.1 11.5 6.6 4.3 5.4 6.6 3.0 4.1 5.0 5.3 5.6 5.2 6.8 5.8 8.9 6.4 4.5 5.6 3.2 12.0 29.7 17.8 10.7 3.4 15.7 11.8 10.5 18.3 14.5 5.4 8.4 17.2 46.7 15.8 21.0 4.9 6.2 5.8 21.7 21.4 22.3 4.1 6.7 5.9 2.5 6.6 9.5 5.0 31.5 8.4 13.5 15.4 3.5 2.1 21.4 46.7 0.0 5.3 5.6 10.4 5.3 8.5 7.5 15.8 7.2 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" "HPA030247, HPA073145" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244, HPA073145: " "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.9 14.9 0.0 0.8 0.2 1.6 0.7 0.0 0.0 0.0 0.3 4.0 1.9 0.0 0.8 0.0 0.2 27.2 0.1 0.0 0.0 0.0 7.0 0.0 0.0 20.9 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.1 0.9 0.3 7.7 1.6 0.4 0.0 1.3 0.0 0.0 1.1 0.0 0.0 2.6 23.6 0.5 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 6.1 0.0 0.3 1.5 0.0 12.6 15.1 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 0.0 0.0 1.4 0.1 0.2 151.7 2.8 0.0 0.0 1.2 1.8 47.1 0.0 0.0 0.1 29.4 0.5 0.0 0.0 0.2 0.1 1.3 0.9 0.0 0.0 0.4 109.7 2.9 2.5 0.0 60.8 7.8 0.2 3.3 0.0 0.0 29.6 1.4 0.0 12.0 0.0 75.1 0.0 5.3 25.0 12.0 0.0 0.0 0.0 0.0 0.3 PCBP4 "LIP4, MCG10" ENSG00000090097 "Poly(rC) binding protein 4" P57723 3 51957454-51974016 "Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 97.5" "Group enriched" "Detected in many" 7 "Bipolar cells: 389.4;Cone photoreceptor cells: 616.5;Rod photoreceptor cells: 516.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 20 "B-cells: 4.6;granulocytes: 4.6;T-cells: 10.2" "Cell line enhanced" "Detected in many" "SH-SY5Y: 49.4;SK-MEL-30: 41.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057754 Supported Cytosol NA NA Cytosol "HPA057754: AB_2683517" "unprognostic (7.17e-2)" "unprognostic (8.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.34e-2)" "unprognostic (4.94e-3)" "unprognostic (1.94e-2)" "unprognostic (4.97e-3)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (5.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.13e-2)" "unprognostic (6.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (4.72e-2)" 19.5 16.6 27.2 9.6 21.9 3.0 10.6 86.0 56.3 12.7 16.7 36.2 16.0 15.1 15.4 12.1 14.5 10.4 18.3 36.5 29.2 29.9 21.2 38.9 13.9 17.0 28.9 13.0 16.3 22.0 22.9 15.8 7.8 16.4 20.1 8.6 47.3 20.3 19.6 97.5 13.6 29.0 14.4 44.4 10.9 13.3 10.6 19.7 11.9 17.3 11.0 15.7 13.3 9.6 4.6 0.3 4.6 0.0 0.1 10.2 2.4 10.2 3.5 14.1 20.5 6.4 11.5 2.4 23.6 11.5 14.2 9.2 13.0 3.7 0.3 3.5 18.6 12.6 2.4 13.1 8.2 6.7 16.2 2.1 1.3 11.8 13.5 10.4 1.3 10.0 15.5 15.4 9.0 4.0 17.7 7.1 6.0 0.6 4.6 22.7 4.8 0.5 1.6 6.8 6.5 9.5 7.1 6.8 1.8 5.0 7.3 27.8 49.4 6.4 3.5 41.8 3.9 6.5 5.0 14.1 15.2 28.8 4.8 12.5 3.1 1.9 2.0 17.6 2.9 22.1 4.6 0.0 3.1 10.2 0.0 7.1 4.6 9.6 9.8 0.3 2.3 4.6 3.5 0.0 0.1 0.0 0.1 10.0 2.4 27.2 21.9 86.0 24.2 29.2 29.9 28.9 13.0 16.4 19.7 3.0 2.7 2.2 13.9 7.7 389.4 6.7 2.5 1.4 4.5 8.7 616.5 1.2 14.9 28.1 52.1 11.2 7.3 0.0 20.1 1.1 16.4 16.8 1.1 3.9 1.0 39.7 59.5 12.3 0.3 76.2 20.8 1.1 21.9 1.0 8.6 56.4 34.6 14.0 15.2 7.9 516.1 6.5 15.3 0.9 2.3 10.3 0.5 6.9 4.8 9.7 PCCA ENSG00000175198 "Propionyl-CoA carboxylase alpha subunit" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 106.7" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 84.6;Proximal tubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 54.3;SCLC-21H: 30.1;U-937: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria NA NA 120000 Mitochondria "HPA041716: AB_2677635, HPA047792: AB_2680156" "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favorable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 15.6 26.2 9.7 11.3 11.1 3.2 12.0 24.0 10.7 12.0 17.5 12.0 14.3 6.7 16.4 106.7 8.8 8.4 7.6 12.4 9.5 7.5 51.3 44.3 8.1 4.0 11.2 8.2 9.7 12.7 5.5 12.4 10.5 12.6 13.1 13.7 11.7 12.2 10.4 10.7 7.7 7.8 17.0 12.0 8.2 16.1 4.7 10.9 4.2 11.9 5.0 6.9 10.8 8.8 3.7 13.0 1.6 10.8 7.3 6.1 4.7 3.3 5.9 9.8 3.2 9.4 8.2 5.5 3.3 5.0 3.1 2.9 7.3 4.5 0.2 5.1 3.2 4.0 3.8 2.9 4.6 5.1 5.5 3.2 7.7 4.2 15.8 5.2 0.3 3.7 7.5 5.0 2.9 4.8 7.6 6.4 4.2 3.0 4.4 5.6 3.6 0.8 17.3 6.1 11.8 2.6 6.7 4.2 5.4 54.3 6.6 30.1 3.6 2.2 12.6 5.5 11.1 9.1 13.7 4.6 3.2 2.7 2.2 2.3 4.3 3.9 0.1 6.1 41.9 2.2 1.5 8.5 1.6 4.6 10.3 6.1 3.7 3.0 4.3 13.0 2.6 4.1 5.1 1.3 7.3 10.8 1.1 6.0 4.7 9.7 11.1 24.0 10.7 9.5 7.5 11.2 8.2 12.6 10.9 3.0 8.3 7.3 25.7 1.6 15.4 8.7 38.2 10.7 10.3 19.2 27.5 21.2 84.6 13.8 14.8 9.9 14.0 0.0 7.3 5.4 7.1 14.3 13.9 41.9 10.3 27.0 3.5 11.6 10.2 7.9 8.1 7.2 5.0 2.8 10.1 10.4 6.2 14.0 12.7 63.9 32.3 12.9 8.9 4.8 4.3 3.3 25.3 4.9 26.5 19.5 PCCB ENSG00000114054 "Propionyl-CoA carboxylase beta subunit" P05166 3 136250306-136337896 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.2" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 317.0;Late spermatids: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036939, HPA036940" Enhanced "Intracellular and membrane" NA NA 79000 "HPA036939: AB_10671366, HPA036940: AB_10669779" "unprognostic (2.74e-1)" "unprognostic (7.88e-3)" "unprognostic (3.99e-2)" "unprognostic (2.89e-2)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.05e-2)" "unprognostic (1.50e-1)" "unprognostic (2.31e-2)" "unprognostic (2.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.47e-7)" "unprognostic (2.43e-2)" "unprognostic (2.64e-1)" "unprognostic (3.50e-1)" "unprognostic (4.13e-1)" 13.0 46.0 14.3 7.7 16.3 12.7 11.8 7.8 19.2 8.1 17.5 21.0 11.6 15.3 7.1 6.4 11.8 8.1 12.5 36.7 14.1 12.6 36.0 80.2 7.7 8.7 18.9 16.4 6.8 20.8 16.2 9.6 10.0 22.3 10.2 17.6 10.0 10.9 10.6 30.5 8.0 11.1 14.1 18.6 7.9 11.5 17.6 15.5 6.3 15.7 12.4 8.1 9.6 6.6 12.4 24.6 3.9 16.6 12.8 14.9 11.5 19.8 14.2 13.7 20.5 10.4 11.5 24.2 10.5 11.4 16.0 22.6 21.1 14.1 24.8 29.3 14.8 14.3 11.1 16.0 14.1 24.3 14.8 13.6 43.5 16.8 31.8 22.2 33.4 19.4 13.6 13.5 10.1 23.1 10.3 17.9 41.8 31.6 13.3 12.2 37.9 33.0 19.6 11.5 30.5 12.9 9.2 11.3 35.5 29.3 21.8 27.3 20.3 26.5 15.8 24.1 12.9 31.3 19.9 13.4 8.0 8.6 22.4 9.2 25.4 21.0 20.7 11.4 13.0 9.3 2.8 16.2 3.9 13.2 16.6 14.9 12.4 8.8 13.6 24.6 10.2 9.0 11.1 1.4 12.8 14.6 21.2 7.9 11.5 14.3 16.3 7.8 19.2 14.1 12.6 18.9 16.4 22.3 15.5 8.9 9.4 10.0 7.3 3.7 15.1 45.4 12.7 18.7 11.4 19.2 9.8 51.9 33.2 19.9 317.0 6.0 14.4 23.3 12.5 19.8 10.3 9.0 28.8 63.8 31.1 11.1 8.7 8.6 13.1 128.9 12.7 15.4 18.6 24.4 12.7 10.3 14.9 14.8 10.3 71.0 13.1 12.9 8.3 10.9 28.8 2.9 42.6 9.6 21.7 8.9 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 5.0 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 16.1 0.0 0.2 0.0 2.4 0.0 13.4 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 32.0 8.6 0.0 0.0 7.3 0.0 0.0 0.0 0.6 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 0.0 1.1 0.0 0.2 0.1 16.2 2.0 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.0 3.3 1.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 2.3 0.0 4.7 1.8 0.7 0.3 2.4 0.0 0.0 0.4 PCDH11X "PCDH-X, PCDH11, PCDHX, PPP1R119" ENSG00000102290 "Protocadherin 11 X-linked" Q9BZA7 X 91779261-92623230 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.0;ovary: 12.6;parathyroid gland: 5.2" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 16.9;Horizontal cells: 31.8;Syncytiotrophoblasts: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.3;AN3-CA: 6.5;NTERA-2: 1.1;SuSa: 1.9;THP-1: 1.1" HPA077495 Approved NA NA "HPA077495: " "unprognostic (4.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.39e-4)" "unprognostic (1.18e-1)" "unprognostic (8.20e-3)" "unprognostic (6.32e-2)" "unprognostic (9.10e-2)" "unprognostic (6.19e-2)" "unprognostic (4.58e-1)" "unprognostic (1.58e-1)" "unprognostic (2.45e-2)" "unprognostic (3.86e-1)" 0.0 0.3 2.6 0.1 7.0 0.0 0.2 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 4.2 0.0 0.0 0.0 0.2 1.3 12.6 0.0 5.2 0.3 1.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 9.0 0.0 0.3 1.3 3.5 0.6 0.0 1.4 5.7 0.0 0.0 16.9 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.8 0.2 1.1 0.4 0.9 31.8 0.0 1.3 0.0 0.0 8.9 1.4 10.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 6.5 1.0 0.0 0.9 0.6 13.2 0.0 0.0 0.4 PCDH11Y "PCDH22, PCDHY" ENSG00000099715 "Protocadherin 11 Y-linked" Q9BZA8 Y 5000226-5742224 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.9;seminal vesicle: 9.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 42.2;Ciliated cells: 17.4;Club cells: 25.0;Collecting duct cells: 14.0;granulocytes: 17.4;Horizontal cells: 44.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 21.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;RPMI-8226: 2.3;SuSa: 2.1;U-266/70: 2.2" NA NA "unprognostic (9.26e-2)" "unprognostic (1.84e-1)" "unprognostic (7.64e-3)" "unprognostic (2.36e-2)" "unprognostic (3.55e-2)" 0.2 0.3 4.5 5.4 3.1 0.3 0.1 0.0 21.9 0.2 0.4 1.1 2.7 0.2 0.2 0.3 0.5 0.1 0.3 0.5 4.2 5.6 0.2 0.2 0.3 0.4 1.8 0.0 0.5 0.2 0.2 0.2 1.8 0.7 0.5 0.9 0.9 0.3 9.1 0.2 0.4 0.6 0.2 0.4 0.6 0.4 0.4 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.5 0.4 2.0 0.3 0.8 0.3 0.6 0.0 0.2 0.3 0.4 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.1 0.7 1.4 0.0 0.2 0.1 0.0 2.3 0.3 0.1 0.3 0.1 0.2 0.0 0.0 2.1 0.0 0.8 0.2 0.1 0.2 0.0 0.1 2.2 0.0 0.2 0.2 0.2 0.1 0.8 0.3 0.2 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.3 2.0 0.8 0.1 0.4 0.1 0.6 4.5 3.1 0.0 21.9 4.2 5.6 1.8 0.0 0.7 0.0 6.0 42.2 0.0 0.9 1.5 1.9 0.5 0.0 17.4 25.0 14.0 0.0 3.7 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 1.2 0.7 17.4 0.0 0.2 44.5 0.0 0.6 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 3.8 0.0 0.0 0.2 2.1 1.4 1.8 0.0 0.0 1.6 PCDH12 VE-cadherin-2 ENSG00000113555 "Protocadherin 12" Q9NPG4 5 141943585-141969741 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.9" "Group enriched" "Detected in some" 5 "Endothelial cells: 24.8;Hofbauer cells: 25.9;Ito cells: 56.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.0" "Lineage enriched" "Detected in single" 35 "monocytes: 7.0" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 14.2;Karpas-707: 35.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051242 Uncertain "Secreted to blood" NA NA 720000 "HPA051242: AB_2681402" "unprognostic (6.62e-2)" "unprognostic (6.94e-2)" "unprognostic (4.74e-3)" "unprognostic (4.12e-2)" "unprognostic (3.99e-1)" "unprognostic (3.25e-1)" "unprognostic (4.35e-1)" "unprognostic (1.88e-2)" "unprognostic (4.29e-2)" "unprognostic (2.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.11e-2)" "unprognostic (5.21e-2)" "unprognostic (9.37e-2)" "unprognostic (9.33e-2)" 7.9 2.9 0.5 0.7 0.6 0.0 3.1 2.2 0.6 1.3 0.8 0.7 1.3 0.0 0.7 1.2 1.8 4.6 0.5 0.4 3.7 2.1 9.0 0.7 0.4 0.9 0.6 1.4 2.5 17.9 1.1 0.4 0.6 1.0 1.6 0.5 1.0 2.6 0.3 11.3 1.0 0.1 4.8 0.1 2.1 1.1 0.1 0.2 0.0 7.0 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.2 14.2 0.1 0.0 35.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.1 1.5 0.0 0.1 0.2 0.3 0.0 0.0 0.2 0.1 0.0 0.9 0.9 0.2 0.0 0.5 0.0 0.2 0.1 0.0 0.2 5.7 1.2 0.0 0.4 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.6 1.0 4.4 0.0 0.0 0.0 0.0 2.0 0.2 3.3 0.0 1.4 24.8 0.0 0.0 0.0 0.2 0.2 0.0 1.1 0.0 25.9 0.0 0.0 56.4 7.5 0.8 0.0 0.1 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 PCDH15 "CDHR15, DFNB23, USH1F" ENSG00000150275 "Protocadherin related 15" Q96QU1 10 53802771-55627942 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Hearing" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 27.4;retina: 25.1" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 92.2" "Cancer enriched" "Detected in single" 9 "glioma: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;HUVEC TERT2: 1.7;SH-SY5Y: 1.6;U-138 MG: 1.6;U-2 OS: 2.8;U-266/70: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074437 Supported "Intracellular and membrane" NA NA "HPA074437: " "unprognostic (1.38e-1)" "unprognostic (3.39e-1)" "unprognostic (8.15e-5)" "unprognostic (3.07e-3)" "unprognostic (2.79e-1)" "unprognostic (9.15e-4)" "unprognostic (2.02e-1)" "unprognostic (3.89e-2)" "unprognostic (1.12e-3)" "unprognostic (1.31e-3)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" "unprognostic (3.27e-1)" "unprognostic (7.66e-3)" 0.7 27.4 9.7 0.9 7.4 0.6 0.5 4.3 10.9 0.7 0.7 5.6 0.0 0.8 0.6 1.1 0.6 0.6 0.6 0.9 10.5 5.8 11.0 0.5 3.7 1.8 6.0 3.2 0.5 0.5 0.4 6.9 0.7 8.7 0.7 0.5 25.1 0.6 0.5 0.4 0.5 0.8 0.5 5.7 1.3 0.9 4.4 7.9 0.0 0.6 0.0 1.2 1.5 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.6 2.8 0.0 0.0 8.3 0.8 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.7 7.4 4.3 7.1 10.5 5.8 6.0 3.2 8.7 7.9 0.0 0.0 0.0 0.0 0.2 4.2 3.2 0.0 0.0 0.0 0.0 82.5 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.7 92.2 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 PCDH17 "PCDH68, PCH68" ENSG00000118946 "Protocadherin 17" O14917 13 57631810-57729311 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 31.0;Endothelial cells: 49.1;Ito cells: 86.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "eosinophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "AF22: 16.2;HEK 293: 10.1;U-87 MG: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026817 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA 31000 Cytosol "Vesicles, Plasma membrane" "HPA026817: AB_1855044" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-1)" "unprognostic (6.52e-2)" "unprognostic (6.98e-3)" "unprognostic (1.95e-2)" "unprognostic (8.26e-4)" "unprognostic (3.56e-1)" "unprognostic (2.38e-2)" "unprognostic (2.82e-1)" "unprognostic (5.40e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.40e-2)" 2.0 2.4 8.0 2.1 11.2 0.3 0.9 4.6 18.2 2.9 1.2 6.2 0.3 1.1 2.6 1.3 1.7 2.5 3.6 2.3 6.5 12.1 1.6 1.4 13.5 0.9 7.4 4.8 0.8 6.2 2.0 1.0 4.7 4.4 1.2 1.2 1.1 1.0 1.1 1.8 0.6 0.7 2.6 4.4 32.7 1.8 8.9 7.7 0.0 3.4 0.4 0.8 3.4 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.1 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 2.5 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 1.4 0.0 1.0 0.0 0.0 0.0 6.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 11.2 4.6 7.8 6.5 12.1 7.4 4.8 4.4 7.7 0.0 7.0 0.0 0.0 2.4 3.5 4.2 0.0 9.4 15.9 1.8 0.0 0.2 0.0 6.9 31.0 49.1 0.0 0.0 7.0 0.1 1.8 0.3 0.0 0.0 0.5 0.0 0.0 86.5 2.8 11.9 1.7 0.8 10.1 2.8 0.0 2.1 2.1 0.0 1.1 0.0 0.0 6.5 7.6 15.8 10.1 0.9 0.0 0.0 0.0 0.1 PCDH19 "EFMR, EIEE9, KIAA1313" ENSG00000165194 "Protocadherin 19" Q8TAB3 X 100291644-100410273 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 27.1" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 7.1;Cholangiocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "AF22: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027533 Approved Approved Cytosol NA NA Cytosol "HPA027533: AB_10602043" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-1)" "unprognostic (5.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (4.77e-2)" "unprognostic (3.64e-2)" "unprognostic (1.36e-2)" "unprognostic (2.53e-1)" "unprognostic (2.79e-1)" "unprognostic (9.77e-3)" "unprognostic (2.82e-3)" "unprognostic (1.53e-1)" "unprognostic (1.80e-4)" "unprognostic (1.37e-1)" 4.9 1.1 19.8 1.3 10.5 0.7 3.7 1.0 22.5 5.5 4.0 1.9 0.0 1.2 3.8 1.3 2.9 2.2 2.0 1.6 27.1 12.8 1.4 0.9 1.0 1.3 3.7 14.2 3.6 1.1 1.2 2.1 1.0 7.3 1.4 5.5 6.4 2.1 1.6 2.4 3.3 1.8 3.1 3.7 0.8 2.0 2.3 1.0 0.0 1.1 0.7 0.9 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 3.5 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 10.5 1.0 22.5 27.1 12.8 3.7 14.2 7.3 1.0 0.0 0.3 0.0 0.0 2.7 7.1 1.4 7.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.7 2.8 0.0 0.0 0.0 0.1 1.8 0.4 0.0 0.0 0.1 0.0 1.7 1.3 0.0 1.9 3.1 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.4 0.0 1.6 0.0 0.5 0.0 0.7 1.4 0.0 0.0 0.0 0.0 PCDH20 "FLJ22218, PCDH13" ENSG00000280165 "Protocadherin 20" Q8N6Y1 13 61409685-61415522 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;smooth muscle: 12.7" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Melanocytes: 1.7;Mucus-secreting cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "RPTEC TERT1: 34.6" HPA062669 Approved "Vesicles,Cytokinetic bridge" NA NA Vesicles "Cytokinetic bridge" "HPA062669: AB_2732687" "unprognostic (2.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.45e-1)" "unprognostic (7.83e-2)" "unprognostic (6.79e-4)" "unprognostic (2.32e-2)" "unprognostic (1.56e-1)" "unprognostic (5.34e-4)" "unprognostic (6.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.12e-1)" 0.3 1.6 6.7 0.4 5.8 0.0 1.3 0.0 13.1 3.5 4.5 0.0 0.2 1.2 4.3 4.3 1.8 0.2 0.9 4.8 13.4 1.2 1.8 4.7 0.0 8.8 3.8 0.3 0.1 0.0 0.7 1.3 6.9 1.5 2.5 0.0 0.7 1.5 0.1 0.5 1.4 12.7 8.4 1.6 1.5 0.4 6.3 0.0 0.3 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 34.6 0.0 0.5 1.3 0.0 2.4 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.1 PCDH8 "ARCADLIN, PAPC" ENSG00000136099 "Protocadherin 8" O95206 13 52842889-52848641 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.6" "Cell type enriched" "Detected in some" 7 "Muller glia cells: 31.8" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AF22: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010509 Uncertain Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA010509: AB_10601384" "unprognostic (3.50e-3)" "unprognostic (6.48e-2)" "unprognostic (1.40e-1)" "unprognostic (9.11e-4)" "unprognostic (2.12e-2)" "unprognostic (1.97e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-1)" "unprognostic (1.17e-1)" "unprognostic (3.59e-1)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" 0.8 0.9 11.5 1.1 18.6 0.8 0.8 0.4 20.6 0.9 1.0 1.1 0.0 0.9 1.0 0.8 0.8 0.8 0.8 0.8 18.2 4.8 0.8 0.8 0.9 0.8 3.6 8.4 0.8 0.8 0.8 1.4 0.8 0.8 1.7 0.9 0.8 0.8 0.8 1.4 0.8 1.1 0.9 0.9 0.8 1.2 2.3 2.5 0.0 1.4 0.0 0.8 0.9 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.6 0.4 20.6 18.2 4.8 3.6 8.4 0.8 2.5 0.0 0.0 0.0 2.5 0.1 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 1.3 PCDH9 ENSG00000184226 "Protocadherin 9" Q9HC56 13 66302834-67230445 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 16.5;brain: 47.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 324.5;Cardiomyocytes: 94.6;Horizontal cells: 187.5;Muller glia cells: 87.9" "Cancer enriched" "Detected in single" 8 "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive B-cell: 16.5" "Lineage enriched" "Detected in many" 7 "B-cells: 16.5" "Cell line enhanced" "Detected in many" "AF22: 12.6;LHCN-M2: 20.8;TIME: 24.1;U-698: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015581 Approved Nucleoplasm,Centrosome NA NA 1300000 "Nucleoplasm, Centrosome" "HPA015581: AB_1855048" "unprognostic (1.77e-1)" "unprognostic (8.36e-2)" "unprognostic (9.12e-3)" "unprognostic (4.42e-5)" "unprognostic (7.54e-2)" "unprognostic (1.18e-1)" "unprognostic (3.04e-1)" "unprognostic (1.38e-1)" "unprognostic (2.35e-1)" "unprognostic (8.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.14e-1)" "unprognostic (8.47e-4)" "unprognostic (6.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.27e-1)" "unprognostic (4.35e-4)" 4.5 3.2 18.4 1.1 24.7 4.1 1.5 6.7 47.0 1.8 1.3 7.8 0.0 0.9 1.0 2.1 1.0 1.1 2.4 5.7 15.0 10.0 3.5 2.3 2.3 1.4 21.4 11.0 1.4 2.0 0.7 1.3 0.7 16.6 2.5 1.3 0.0 1.0 5.6 2.0 0.9 1.0 1.2 11.0 1.6 1.7 1.6 18.9 0.7 1.8 0.0 1.4 1.1 0.6 16.5 1.0 2.5 0.0 0.7 0.1 0.2 0.0 9.5 12.6 0.0 3.4 2.6 0.0 1.9 0.1 1.3 0.5 0.0 0.0 2.7 0.0 1.4 0.4 0.0 1.0 0.3 0.6 0.0 5.0 0.1 0.1 0.0 3.3 0.3 0.1 6.3 0.3 1.5 2.5 0.3 1.0 1.1 0.3 0.1 20.8 0.7 5.7 0.0 0.1 0.2 1.2 8.7 0.4 0.0 0.2 0.0 1.6 0.6 0.0 0.1 0.1 0.3 0.0 0.0 24.1 0.7 0.6 2.9 1.0 3.7 0.0 31.7 5.4 0.0 2.5 2.5 0.0 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 16.5 0.1 0.1 0.1 0.7 0.0 1.0 0.0 0.2 18.4 24.7 6.7 24.6 15.0 10.0 21.4 11.0 16.6 18.9 17.9 45.8 7.2 2.3 1.6 324.5 94.6 0.0 0.0 7.9 5.2 19.6 0.1 8.3 1.7 3.0 2.9 0.0 0.0 0.0 0.2 8.7 2.6 1.1 3.4 0.2 187.5 60.1 19.0 2.2 2.2 27.3 1.0 10.1 0.0 0.2 87.9 0.2 0.3 13.8 0.6 25.3 6.5 25.0 4.7 5.8 0.3 0.0 1.7 0.4 0.7 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ito cells: 1.3;Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "T-47d: 14.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" NA NA "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 0.3 14.4 0.5 0.0 1.6 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA10 "CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10" ENSG00000250120 "Protocadherin alpha 10" Q9Y5I2 5 140855883-141012344 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.3" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 7.0;Cone photoreceptor cells: 7.9;Horizontal cells: 7.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "EFO-21: 20.2" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (4.24e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (4.70e-2)" "unprognostic (4.19e-1)" "unprognostic (2.36e-1)" "unprognostic (6.46e-2)" "unprognostic (8.24e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-2)" "unprognostic (2.65e-1)" "unprognostic (6.14e-3)" "unprognostic (1.93e-2)" "unprognostic (3.57e-3)" "unprognostic (5.21e-2)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" 2.1 1.7 6.1 1.1 6.6 0.6 2.4 8.0 20.3 3.0 0.9 4.9 0.9 1.1 4.5 6.3 0.5 2.7 3.1 0.8 7.1 2.7 4.3 0.6 2.1 0.7 7.2 3.6 2.8 7.8 0.8 11.2 0.5 6.1 1.6 0.9 1.9 3.2 1.0 0.5 0.7 1.8 4.0 6.9 0.7 1.1 1.9 8.2 0.0 5.0 0.0 0.5 0.7 0.7 0.6 0.4 1.5 0.3 0.6 0.3 0.0 0.0 0.2 0.4 2.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.3 1.6 0.8 0.0 0.1 0.0 4.1 0.3 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.1 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.2 0.1 0.6 0.2 0.3 1.5 0.6 0.2 0.4 0.1 0.0 6.1 6.6 8.0 6.9 7.1 2.7 7.2 3.6 6.1 8.2 0.0 1.0 0.0 0.3 0.0 7.0 0.5 2.5 0.0 0.0 0.0 7.9 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 7.9 1.7 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 1.7 0.0 0.0 0.4 2.6 0.0 0.3 1.0 0.2 0.0 0.0 0.0 0.0 0.2 PCDHA11 "CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11" ENSG00000249158 "Protocadherin alpha 11" Q9Y5I1 5 140868183-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.3;parathyroid gland: 4.7" "Cell type enhanced" "Detected in single" 20 "Bipolar cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 16.8;EFO-21: 8.8;MCF7: 4.5;T-47d: 6.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077160 Approved "Vesicles,Cell Junctions,Cytoplasmic bodies" NA NA "Vesicles, Cell Junctions" "Cytoplasmic bodies" "HPA077160: AB_2686827" "unprognostic (1.54e-2)" "unprognostic (1.83e-3)" "unprognostic (2.75e-1)" "unprognostic (2.59e-1)" "unprognostic (6.98e-3)" "unprognostic (1.36e-1)" "unprognostic (9.28e-3)" "unprognostic (2.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (3.13e-4)" "unprognostic (9.91e-5)" "unprognostic (1.05e-1)" "unprognostic (3.85e-3)" "unprognostic (3.26e-2)" 0.1 0.6 1.0 0.1 1.6 0.0 0.2 7.0 9.3 1.3 0.0 0.0 0.6 0.1 0.0 0.2 1.0 0.0 0.8 1.0 1.2 0.0 0.8 0.0 0.3 0.0 3.3 4.7 1.6 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 4.0 16.8 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 8.8 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.5 0.4 0.0 1.0 0.0 0.1 0.0 4.5 0.0 0.0 3.7 0.8 3.2 0.0 0.0 0.0 0.4 1.9 0.8 2.2 0.0 1.8 0.4 2.4 6.0 0.0 0.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4" HPA035812 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA035812: AB_2674796" "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 2.4 2.6 7.8 0.0 0.0 0.0 0.3 7.7 0.3 4.4 0.0 0.9 0.1 0.5 1.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 26.8 3.2 0.0 0.0 0.0 11.2 0.4 5.1 0.0 0.0 1.8 5.9 0.0 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.4 0.2 2.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 PCDHA13 "CNR5, CNRN5, CNRS5, CRNR5, PCDH-ALPHA13" ENSG00000239389 "Protocadherin alpha 13" Q9Y5I0 5 140882208-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 5.6;parathyroid gland: 12.2" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Bipolar cells: 2.5;Club cells: 1.2;Horizontal cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AN3-CA: 2.7;PC-3: 9.0;WM-115: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.07e-1)" "unprognostic (5.25e-2)" "unprognostic (5.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (1.01e-2)" "unprognostic (1.14e-1)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.48e-2)" "unprognostic (2.64e-3)" "unprognostic (5.53e-2)" "unprognostic (1.36e-1)" 1.0 0.9 2.1 0.6 2.3 0.2 0.6 5.6 5.3 1.0 0.2 2.3 0.0 0.3 0.8 1.2 0.2 0.5 2.4 0.3 1.7 1.6 0.7 1.2 0.8 0.6 1.1 3.8 0.2 1.9 12.2 1.2 0.2 1.0 0.6 0.2 2.7 1.0 0.2 0.3 0.2 0.2 0.5 1.1 0.3 0.3 1.6 1.0 0.0 1.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 9.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.8 1.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.3 5.6 5.3 1.7 1.6 1.1 3.8 1.0 1.0 3.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 PCDHA2 ENSG00000204969 "Protocadherin alpha 2" Q9Y5H9 5 140794852-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;SH-SY5Y: 2.8;T-47d: 2.7;WM-115: 2.3" HPA035653 Uncertain NA NA "HPA035653: AB_10670969" "unprognostic (3.54e-2)" "unprognostic (5.87e-2)" "unprognostic (3.27e-2)" "unprognostic (8.39e-3)" "unprognostic (4.61e-2)" "unprognostic (4.16e-3)" "unprognostic (1.23e-1)" "unprognostic (4.30e-2)" "unprognostic (3.35e-3)" "unprognostic (5.64e-6)" "unprognostic (2.17e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-3)" "unprognostic (3.42e-1)" 1.1 1.4 3.7 0.3 4.4 0.2 1.7 7.3 4.5 1.1 0.5 1.2 0.0 0.8 3.5 0.2 0.2 1.1 1.6 0.8 3.8 1.6 1.5 0.2 0.9 0.5 2.8 4.9 1.9 1.7 0.5 4.1 0.2 3.1 1.2 0.3 0.1 0.8 0.2 0.6 0.7 0.9 1.0 1.3 0.6 1.0 2.5 3.8 0.0 0.6 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.7 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.5 2.8 0.0 0.6 0.4 0.8 2.7 0.0 0.2 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.4 7.3 4.5 3.8 1.6 2.8 4.9 3.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA3 PCDH-ALPHA3 ENSG00000255408 "Protocadherin alpha 3" Q9Y5H8 5 140801028-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.3;pituitary gland: 9.9" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.8;AF22: 2.4;SH-SY5Y: 2.4;T-47d: 14.4;WM-115: 3.6" NA NA "unprognostic (5.21e-2)" "unprognostic (2.77e-2)" "unprognostic (7.20e-3)" "unprognostic (2.69e-1)" "unprognostic (1.62e-1)" "unprognostic (7.83e-2)" "unprognostic (2.72e-3)" "unprognostic (1.19e-1)" "unprognostic (1.12e-2)" "unprognostic (7.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.09e-3)" "unprognostic (1.72e-2)" "unprognostic (7.25e-3)" "unprognostic (8.41e-2)" "unprognostic (5.66e-3)" "unprognostic (2.67e-2)" 2.0 3.8 3.1 0.7 5.0 0.2 2.2 10.3 5.8 2.6 1.4 2.6 0.3 1.0 5.9 1.4 0.9 2.3 2.6 0.9 2.8 3.1 3.4 0.6 2.6 0.9 3.7 2.5 4.9 4.8 0.6 9.9 0.4 3.7 2.2 1.0 1.3 1.0 1.8 0.6 0.6 1.4 2.1 6.4 0.9 1.1 2.9 4.8 0.0 2.6 0.4 0.4 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.6 0.0 0.0 0.0 0.0 0.0 1.1 2.4 0.0 0.3 1.0 0.6 14.4 0.0 0.5 0.1 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 10.3 5.6 2.8 3.1 3.7 2.5 3.7 4.8 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 3.0;Ciliated cells: 5.3;granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 9.1;AF22: 8.9;EFO-21: 7.7;T-47d: 7.7" "Low region specificity" "Detected in all" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: AB_2686608" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.9 0.8 5.1 0.9 6.5 3.2 1.7 12.1 8.7 2.1 1.1 1.6 0.4 0.9 2.3 2.0 0.6 1.6 5.1 1.2 4.5 3.2 2.0 0.6 1.7 1.5 1.9 2.1 1.1 4.1 1.0 1.4 0.7 3.9 1.8 1.1 0.4 1.1 1.3 1.1 2.0 0.9 1.1 3.0 1.1 1.0 1.4 2.4 0.0 1.3 0.1 0.7 1.3 0.8 1.5 1.3 2.0 0.7 0.8 1.1 0.0 0.2 9.1 8.9 0.4 0.1 0.3 0.3 0.2 0.1 0.1 0.1 0.2 1.8 0.3 7.7 0.2 0.4 0.3 0.0 0.1 0.2 0.2 0.2 0.4 0.6 0.3 0.1 0.3 0.5 0.4 2.4 0.2 0.4 0.6 0.5 0.4 0.2 1.2 0.3 0.2 0.2 0.3 2.5 1.9 1.3 0.2 0.2 0.3 0.3 0.4 0.4 3.8 0.1 2.0 0.8 1.6 7.7 0.3 0.9 2.0 1.3 0.7 0.2 0.5 0.2 0.2 0.3 0.4 0.8 1.8 0.7 0.7 1.1 0.4 0.8 0.8 0.8 0.7 0.3 1.5 0.8 1.1 2.0 0.8 0.7 1.3 0.6 0.0 5.1 6.5 12.1 6.6 4.5 3.2 1.9 2.1 3.9 2.4 3.0 1.3 0.0 0.5 0.0 0.9 0.8 0.0 5.3 1.2 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.7 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.3 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 2.2;Horizontal cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.5;T-47d: 7.7;WM-115: 2.8" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" NA NA "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.1 7.7 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 0.0 2.2 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;pituitary gland: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.0;EFO-21: 12.6;hTERT-RPE1: 3.3;U-2 OS: 5.2;WM-115: 7.5" "HPA059326, HPA078110" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059326: AB_2683980, HPA078110: AB_2732371" "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 1.1 1.8 2.9 0.8 7.1 0.4 1.6 10.2 10.7 1.9 0.7 2.3 0.0 1.2 2.9 2.3 0.4 1.6 1.6 0.5 3.8 3.8 2.3 0.4 1.1 0.7 4.6 4.1 2.1 3.7 4.7 11.2 0.4 3.6 1.3 0.7 1.6 0.7 0.5 0.4 0.6 1.3 1.4 3.4 0.8 0.7 1.4 3.2 0.0 0.9 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.1 1.3 0.2 0.6 0.0 2.0 0.0 5.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.1 10.2 9.6 3.8 3.8 4.6 4.1 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA7 "CNR4, CNRS4, CRNR4" ENSG00000204963 "Protocadherin alpha 7" Q9UN72 5 140834248-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 10.1;testis: 2.9" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 1.4;Horizontal cells: 1.6;Spermatocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 2.0;NTERA-2: 3.2;SCLC-21H: 2.0;SK-BR-3: 2.8;SK-MEL-30: 3.6;U-2 OS: 2.4;WM-115: 3.5" NA NA "unprognostic (1.99e-1)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (5.28e-2)" "unprognostic (3.05e-1)" "unprognostic (7.08e-2)" "unprognostic (9.29e-3)" "unprognostic (4.11e-3)" "unprognostic (7.20e-2)" "unprognostic (3.18e-3)" "unprognostic (3.12e-4)" "unprognostic (9.54e-4)" "unprognostic (6.86e-5)" "unprognostic (5.34e-4)" "unprognostic (2.88e-1)" "unprognostic (3.72e-1)" "unprognostic (1.14e-1)" 0.9 1.1 0.9 0.6 2.3 0.2 1.0 10.1 6.8 0.6 0.8 3.2 0.0 1.2 1.3 0.9 0.2 0.6 1.5 0.6 1.8 1.1 0.8 0.3 1.0 0.5 2.2 1.8 1.4 1.1 0.7 1.4 0.4 4.3 0.6 0.6 0.3 1.1 0.4 0.2 0.5 1.0 1.3 3.7 0.3 0.9 2.9 0.4 0.0 0.7 0.0 0.3 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.9 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.6 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 2.8 3.6 1.4 0.9 0.0 0.5 0.5 2.4 0.6 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 10.1 6.8 1.8 1.1 2.2 1.8 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 PCDHA8 ENSG00000204962 "Protocadherin alpha 8" Q9Y5H6 5 140841187-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AN3-CA: 18.3;SCLC-21H: 5.1" HPA044585 Uncertain NA NA "HPA044585: AB_10793953" "unprognostic (1.11e-2)" "unprognostic (1.15e-2)" "unprognostic (1.35e-1)" "unprognostic (1.95e-1)" "unprognostic (4.20e-2)" "unprognostic (9.67e-2)" "unprognostic (8.58e-3)" "unprognostic (7.87e-4)" "unprognostic (5.62e-3)" "unprognostic (2.22e-2)" "unprognostic (5.48e-1)" "unprognostic (1.20e-2)" 0.2 1.6 1.0 0.2 2.3 0.2 0.2 6.2 4.7 0.4 0.4 1.4 0.0 0.3 0.8 0.2 0.3 0.3 0.4 0.2 1.2 1.2 0.5 0.3 0.4 0.3 1.0 3.6 0.7 0.9 0.2 1.8 0.3 2.8 0.3 0.5 0.7 0.5 0.2 0.2 0.2 0.4 0.7 1.1 0.2 0.2 1.7 1.3 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 18.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.1 2.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 6.2 4.7 1.2 1.2 1.0 3.6 2.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHA9 "KIAA0345, PCDH-ALPHA9" ENSG00000204961 "Protocadherin alpha 9" Q9Y5H5 5 140847463-141012344 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 1.8;brain: 3.1;pancreas: 3.4;testis: 3.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.7;Early spermatids: 1.3;Horizontal cells: 1.6;Spermatocytes: 1.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 11.6" NA NA "unprognostic (1.53e-3)" "unprognostic (1.13e-1)" "unprognostic (7.54e-4)" "unprognostic (1.28e-2)" "unprognostic (4.65e-2)" "unprognostic (1.48e-1)" "unprognostic (5.20e-3)" "unprognostic (6.49e-3)" "unprognostic (1.31e-4)" "unprognostic (1.82e-1)" "unprognostic (8.79e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-1)" 0.2 0.4 0.4 0.1 0.5 0.6 0.0 3.1 1.8 0.4 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.3 0.2 3.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.9 0.1 0.0 3.5 0.2 0.0 0.0 0.0 0.9 0.5 1.8 0.4 0.7 0.5 0.2 0.0 0.1 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 11.6 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.3 0.4 0.4 0.5 0.3 0.4 0.4 0.3 0.4 0.2 0.9 0.4 0.5 1.8 0.7 0.4 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 1: 6.0;Bipolar cells: 1.7;Ciliated cells: 1.4;Rod photoreceptor cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.7;EFO-21: 3.7;hTCEpi: 11.3;PC-3: 6.4;SCLC-21H: 5.0" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles No No "Nucleoplasm, Nucleoli" Vesicles "HPA052775: AB_2681942" "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.7 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 6.4 0.0 0.0 0.0 0.5 0.4 5.0 2.4 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 6.0 0.3 0.0 0.0 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PCDHAC2 PCDH-ALPHA-C2 ENSG00000243232 "Protocadherin alpha subfamily C, 2" Q9Y5I4 5 140966235-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 14.1;parathyroid gland: 52.5" "Cell type enhanced" "Detected in some" 17 "Ciliated cells: 2.7;Ito cells: 2.5;Rod photoreceptor cells: 1.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 36.9" HPA076190 Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA076190: AB_2686785" "unprognostic (1.47e-1)" "unprognostic (3.58e-3)" "unprognostic (2.59e-1)" "unprognostic (5.31e-4)" "unprognostic (3.89e-1)" "unprognostic (1.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-1)" "unprognostic (2.13e-2)" "unprognostic (2.45e-1)" "unprognostic (1.41e-1)" "unprognostic (2.30e-1)" "unprognostic (4.46e-4)" "unprognostic (9.90e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-3)" 1.1 1.7 5.7 1.0 9.2 0.5 0.7 13.6 14.1 1.5 0.9 2.3 0.0 0.7 1.2 0.6 0.6 0.8 3.2 1.2 4.5 5.2 0.9 1.3 2.5 2.2 2.9 6.4 0.7 0.9 52.5 3.1 2.2 3.8 0.9 0.9 2.7 1.1 0.7 0.6 0.6 0.7 1.4 2.0 2.1 1.0 2.4 1.7 0.0 1.6 0.0 1.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.7 36.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.0 1.5 0.0 0.7 4.0 0.0 0.0 0.1 0.0 8.4 0.0 0.5 0.0 0.0 0.1 5.5 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 1.3 0.0 0.0 0.0 1.3 0.0 1.6 6.6 0.0 0.0 0.1 0.8 1.4 0.2 0.0 0.7 0.7 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.2 13.6 14.1 4.5 5.2 2.9 6.4 3.8 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.8 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.1 1.5 0.0 0.1 0.2 0.9 1.2 1.2 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 1.7 0.2 1.0 0.8 2.6 0.2 1.4 0.7 0.9 1.2 1.2 0.4 1.2 1.0 0.9 0.1 1.0 2.2 0.8 0.1 1.8 1.3 1.2 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.1 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 0.0 1.4 0.0 1.1 0.0 0.2 2.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141181399-141186399 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.4;Horizontal cells: 7.9;Muller glia cells: 6.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.2;LHCN-M2: 6.5;T-47d: 6.8;U-138 MG: 26.9;U-2197: 7.2;U-87 MG: 6.4" HPA014668 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.7 2.6 2.1 1.4 2.7 0.2 2.5 9.7 3.1 8.4 1.1 5.3 0.0 0.4 6.4 6.2 3.3 2.8 2.5 4.5 1.8 2.5 1.0 3.2 0.5 1.7 0.4 9.8 2.6 10.9 17.5 1.5 3.4 6.2 1.1 7.1 2.2 1.1 3.6 1.5 1.1 3.5 2.5 1.1 0.5 2.3 5.0 0.0 3.1 0.0 0.3 6.5 3.3 0.9 1.0 1.4 0.6 0.9 0.8 0.1 0.0 0.0 0.6 12.2 5.5 3.9 0.3 0.5 2.8 0.0 0.2 0.1 0.2 0.0 4.5 0.6 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.1 0.1 0.0 1.1 6.5 0.3 0.0 0.0 0.9 0.0 0.1 0.0 2.3 0.0 0.3 0.1 0.4 1.7 0.2 0.4 2.1 0.3 6.8 0.0 0.3 26.9 1.3 7.2 1.3 0.0 0.0 0.0 6.4 0.0 3.4 0.7 0.5 0.4 0.6 0.5 0.3 0.6 0.5 0.6 0.3 0.9 0.8 0.6 1.4 0.9 0.6 1.0 0.5 0.1 3.0 1.0 0.0 0.0 0.7 13.4 1.2 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.7 1.0 2.7 0.0 0.0 4.1 0.0 3.8 0.1 0.0 0.0 0.1 7.9 1.7 1.3 0.3 1.1 4.4 0.0 0.0 0.0 0.0 6.3 1.7 0.0 5.3 0.6 1.1 0.0 3.5 4.1 0.0 1.3 0.0 0.0 0.0 0.0 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.3" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 12.4;HAP1: 3.8;SH-SY5Y: 16.5;U-138 MG: 5.8" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles NA NA Vesicles "HPA050296: AB_2681078" "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 5.7 4.6 3.1 2.6 9.3 0.4 5.9 3.8 6.2 4.8 2.5 2.2 1.3 1.4 8.0 3.0 1.3 3.1 3.1 3.6 3.8 3.0 4.9 0.8 3.3 1.0 3.0 3.8 5.6 3.9 4.4 17.3 1.8 4.0 5.4 2.1 3.4 2.4 2.4 1.9 2.0 2.1 3.8 3.0 1.5 1.8 11.6 2.0 0.0 2.1 2.3 0.7 2.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.4 2.1 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.2 1.8 0.0 3.8 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 16.5 0.0 0.2 0.0 0.6 2.1 0.1 0.0 5.8 0.8 0.6 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.3 3.8 6.2 3.8 3.0 3.0 3.8 4.0 2.0 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.3 0.7 0.6 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 7.9 0.0 0.6 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.8 0.5 0.0 0.7 0.0 0.2 0.0 0.5 1.4 0.9 0.3 0.0 0.0 0.0 0.3 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150022-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 13.4" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.9;SH-SY5Y: 7.2;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 2.5 2.4 3.9 1.0 5.1 0.4 2.5 4.2 8.4 2.3 1.5 2.6 0.0 0.6 4.5 3.7 0.7 2.1 1.4 1.6 3.5 1.9 1.6 1.4 1.7 0.7 2.6 3.6 3.7 1.5 13.4 6.4 1.5 2.9 1.5 0.9 0.7 2.5 1.5 1.4 2.4 1.0 3.0 3.3 1.5 0.9 5.4 3.1 0.0 1.1 1.0 0.7 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.9 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.2 0.0 0.1 3.6 0.4 5.4 2.2 0.0 0.6 1.3 7.6 0.0 0.0 0.0 0.0 3.9 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.1 4.2 8.4 3.5 1.9 2.6 3.6 2.9 3.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.0 0.2 0.0 1.2 9.9 0.1 0.4 0.0 0.0 0.0 0.0 PCDHB9 "PCDH-BETA9, PCDH3H" ENSG00000177839 "Protocadherin beta 9" Q9Y5E1 5 141187127-141191541 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 19.7;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 10.8;ASC TERT1: 10.0;SH-SY5Y: 14.8" HPA013445 Uncertain NA NA "HPA013445: AB_1855054" "unprognostic (1.85e-2)" "unprognostic (3.27e-2)" "unprognostic (2.73e-1)" "unprognostic (8.97e-3)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.12e-1)" "unprognostic (6.78e-3)" "unprognostic (1.34e-2)" "unprognostic (4.46e-2)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (1.86e-4)" "unprognostic (1.71e-1)" "unprognostic (9.80e-2)" "unprognostic (1.17e-1)" "unprognostic (8.01e-2)" 1.9 1.9 5.3 0.3 4.1 0.3 1.6 1.8 10.9 3.6 1.0 3.2 0.0 0.2 2.8 4.7 0.9 2.3 1.6 2.0 5.9 0.9 0.2 1.4 0.2 1.2 3.1 4.7 1.7 2.1 6.6 1.1 4.1 1.1 0.6 1.2 1.4 0.8 0.7 0.9 1.0 2.6 4.6 0.6 0.5 1.2 2.5 0.0 0.8 0.3 0.2 0.7 1.0 0.5 0.2 1.9 0.2 0.9 1.3 0.0 0.0 0.0 0.9 6.2 10.8 10.0 0.3 0.1 3.6 0.4 0.6 0.0 1.1 0.4 4.1 0.1 2.9 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.9 0.0 0.0 2.0 0.0 0.1 0.0 2.7 3.0 0.9 0.5 0.7 0.4 0.0 0.4 2.8 5.6 0.0 0.6 0.1 2.1 14.8 0.6 0.1 1.0 0.4 2.9 0.2 0.9 6.0 0.5 5.0 1.2 0.1 0.0 0.0 3.3 0.2 2.2 1.1 0.2 0.5 0.2 0.1 0.1 0.2 0.4 1.3 0.0 0.5 0.3 0.3 1.9 0.9 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.2 0.0 19.7 0.2 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 9.5 0.0 1.3 0.3 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.8 0.2 0.7 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 "Protocadherin gamma subfamily A, 1" Q9Y5H4 5 141330571-141512981 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Bipolar cells: 1.6;Cardiomyocytes: 1.7;Horizontal cells: 3.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 7.0;T-47d: 11.5;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA008755, HPA010580, HPA036547" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA036547: AB_10669798" "unprognostic (9.50e-4)" "unprognostic (2.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.42e-3)" "unprognostic (3.39e-1)" "unprognostic (3.97e-2)" "unprognostic (2.42e-1)" "unprognostic (5.61e-3)" "unprognostic (1.70e-2)" "unprognostic (6.89e-2)" "unprognostic (2.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-3)" "unprognostic (4.76e-2)" "unprognostic (1.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-3)" 1.4 1.3 2.7 0.9 11.7 1.0 1.1 6.8 7.9 1.4 1.2 2.7 0.5 1.0 2.8 3.9 1.3 1.1 0.8 3.9 3.5 2.8 1.2 0.5 1.2 1.0 2.5 2.5 2.9 2.5 2.8 6.1 2.3 5.4 1.5 0.9 2.4 1.1 1.0 1.7 1.5 0.6 1.8 2.4 1.1 0.8 2.7 1.1 0.0 1.3 0.6 0.7 1.2 0.9 1.2 0.9 2.7 0.5 0.8 1.0 0.2 0.1 0.4 0.5 1.9 1.2 2.1 0.3 1.7 1.1 0.5 1.0 0.5 0.2 0.5 2.8 1.1 0.9 0.2 0.2 0.3 1.1 0.3 0.3 0.2 0.4 0.3 0.3 0.1 0.2 1.8 0.5 0.0 0.7 3.4 0.1 0.3 0.2 0.8 7.0 0.1 0.2 0.8 0.3 0.1 0.3 3.1 2.7 0.3 0.3 0.3 1.8 2.1 0.3 0.9 1.7 0.5 11.5 0.4 0.8 3.3 0.7 1.6 0.4 0.3 1.0 0.2 3.9 0.2 5.2 2.7 0.5 0.5 0.7 0.4 0.4 0.7 0.7 0.5 0.2 1.2 1.0 0.8 1.1 0.8 0.5 0.9 0.6 0.2 2.7 11.7 6.8 6.1 3.5 2.8 2.5 2.5 5.4 1.1 3.0 0.0 0.0 0.0 0.0 1.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 "Protocadherin gamma subfamily A, 10" Q9Y5H3 5 141412987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 33.7" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 27.0;Cone photoreceptor cells: 15.7;Horizontal cells: 22.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 12.2;HSkMC: 13.8;T-47d: 16.3;U-2197: 9.6" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA077276" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077276: " "unprognostic (2.92e-1)" "unprognostic (2.17e-4)" "unprognostic (1.63e-1)" "unprognostic (3.33e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-2)" "unprognostic (9.99e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" "unprognostic (4.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.64e-3)" "unprognostic (2.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.06e-1)" "unprognostic (8.83e-3)" 5.2 4.2 7.9 1.6 11.4 1.2 2.7 2.4 33.7 3.6 2.9 9.8 1.2 2.4 3.0 2.4 4.3 3.6 3.7 2.3 9.1 4.4 2.0 6.5 3.5 1.7 5.1 7.2 3.6 1.9 1.4 2.4 7.4 5.3 3.6 2.6 4.9 4.1 4.6 2.0 4.7 2.9 3.1 6.7 2.5 4.7 2.0 6.5 0.0 4.9 1.5 3.3 2.5 3.5 0.9 1.1 1.5 0.7 0.8 1.0 0.2 0.0 0.0 12.2 6.2 5.4 2.3 5.8 2.1 0.1 3.0 4.8 0.3 0.7 0.7 8.1 3.0 0.2 0.3 2.9 1.9 2.4 0.8 0.0 0.0 0.3 0.0 2.2 1.2 0.2 13.8 0.3 2.0 0.8 0.3 1.1 0.3 0.0 0.1 7.4 0.0 0.1 0.3 1.2 0.0 0.1 0.1 1.0 0.0 2.1 0.1 1.6 0.6 0.3 0.0 0.3 3.0 16.3 1.5 2.7 5.6 0.3 9.6 0.1 0.2 0.9 0.1 2.9 0.0 0.3 1.5 0.3 0.3 1.0 0.4 1.0 0.6 0.4 0.6 0.1 0.9 0.4 0.9 0.9 0.8 0.7 1.1 0.3 0.2 7.9 11.4 2.4 8.5 9.1 4.4 5.1 7.2 5.3 6.5 0.0 1.3 0.0 1.8 0.1 27.0 2.3 2.5 0.0 2.3 1.8 15.7 1.7 0.0 0.9 0.0 2.1 0.4 0.0 1.2 1.1 1.2 3.2 1.1 1.1 0.8 22.3 1.2 3.1 0.0 0.0 3.1 0.3 1.7 0.0 1.1 8.7 2.1 0.0 2.1 0.0 5.2 6.5 1.1 0.3 0.7 0.4 0.3 0.0 0.8 0.9 PCDHGA11 PCDH-GAMMA-A11 ENSG00000253873 "Protocadherin gamma subfamily A, 11" Q9Y5H2 5 141421047-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.6" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Horizontal cells: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.13e-2)" "unprognostic (1.78e-3)" "unprognostic (9.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.68e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.16e-3)" "unprognostic (1.09e-1)" "unprognostic (1.95e-2)" "unprognostic (2.97e-1)" "unprognostic (2.22e-1)" "unprognostic (3.03e-2)" "unprognostic (3.74e-2)" "unprognostic (3.54e-1)" "unprognostic (4.34e-3)" "unprognostic (1.89e-1)" 3.4 2.5 7.4 2.8 9.4 0.5 2.1 4.1 8.5 2.4 2.5 8.5 0.0 1.2 2.6 1.7 3.1 2.1 2.1 3.4 11.6 1.9 1.9 1.2 2.3 1.8 4.5 5.2 3.8 2.3 1.3 1.9 8.3 5.0 2.5 1.5 3.3 2.8 3.4 2.8 6.6 1.2 3.3 4.9 1.6 1.8 2.2 7.1 0.1 3.4 0.6 1.7 1.7 2.2 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 12.0 13.0 0.4 2.6 5.0 2.0 3.2 0.0 0.1 0.3 4.3 2.6 22.7 1.7 0.0 0.3 3.2 0.0 1.1 0.0 0.0 0.0 2.0 0.2 0.0 9.3 0.1 3.5 0.0 33.8 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 5.0 0.2 1.5 3.6 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.4 9.4 4.1 8.5 11.6 1.9 4.5 5.2 5.0 7.1 0.0 0.6 0.0 0.1 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PCDHGA12 "CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12" ENSG00000253159 "Protocadherin gamma subfamily A, 12" O60330 5 141430589-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.9" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 3.5;Cardiomyocytes: 1.8;Ito cells: 1.3" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 7.7;BJ hTERT+: 12.9;fHDF/TERT166: 19.1;HHSteC: 6.3;HSkMC: 14.3;TIME: 6.1" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.17e-3)" "unprognostic (2.71e-2)" "unprognostic (1.04e-2)" "unprognostic (2.67e-1)" "unprognostic (2.74e-1)" "unprognostic (5.06e-2)" "unprognostic (1.99e-1)" "unprognostic (9.01e-3)" "unprognostic (1.19e-1)" "unprognostic (4.65e-4)" "unprognostic (2.98e-1)" "unprognostic (3.02e-1)" "unprognostic (1.28e-4)" "unprognostic (8.30e-3)" "unprognostic (1.57e-1)" "unprognostic (2.42e-1)" "unprognostic (6.85e-3)" 5.1 12.7 14.8 2.8 18.9 0.7 2.4 4.7 13.8 4.9 1.8 8.6 0.6 1.4 5.4 2.3 3.5 2.7 11.3 6.5 15.7 5.6 3.1 2.8 6.5 1.6 4.7 7.3 6.2 3.6 2.0 2.7 6.5 8.4 3.5 1.7 3.4 1.7 4.9 1.9 5.1 1.5 5.3 8.4 3.7 2.2 1.6 12.4 0.4 3.0 0.6 1.7 4.5 3.6 3.7 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.6 1.2 0.1 7.7 12.9 0.0 0.0 0.0 0.0 0.4 0.0 19.1 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 14.3 0.0 3.8 0.0 0.0 4.5 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 6.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 14.8 18.9 4.7 10.4 15.7 5.6 4.7 7.3 8.4 12.4 0.0 0.0 0.0 0.2 0.0 3.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGA5 "CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5" ENSG00000253485 "Protocadherin gamma subfamily A, 5" Q9Y5G8 5 141364232-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 19.1" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 10.6;Horizontal cells: 9.5;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC diff: 18.9;ASC TERT1: 7.5" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.61e-2)" "unprognostic (1.04e-2)" "unprognostic (5.28e-2)" "unprognostic (4.83e-1)" "unprognostic (6.60e-3)" "unprognostic (5.71e-2)" "unprognostic (8.46e-2)" "unprognostic (6.53e-3)" "unprognostic (4.07e-1)" "unprognostic (9.40e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.12e-1)" "unprognostic (5.90e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (8.38e-4)" 4.0 2.7 6.1 1.8 9.1 0.9 3.9 19.1 9.6 9.0 2.7 7.7 4.1 1.0 7.6 3.2 3.3 4.7 4.5 4.9 6.9 4.0 1.5 1.2 3.3 1.3 3.2 3.8 6.6 1.7 3.3 3.7 2.7 4.6 5.6 1.6 4.1 2.5 4.0 1.5 3.0 1.5 4.3 6.3 1.4 1.7 1.7 3.7 0.0 1.8 0.9 1.0 2.5 4.2 0.9 0.8 1.6 0.6 1.9 0.7 0.2 0.0 0.5 0.3 0.1 18.9 7.5 0.0 0.8 0.2 0.1 0.4 0.0 0.0 0.9 0.4 0.3 1.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.2 0.1 0.1 1.8 0.2 0.0 0.0 0.4 0.6 0.0 0.1 0.6 0.8 0.3 0.5 0.7 0.1 0.0 0.3 0.9 0.7 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.3 0.3 1.6 0.0 1.0 0.7 0.2 1.0 0.7 0.1 1.0 0.1 0.3 0.2 0.8 1.5 0.6 0.6 0.7 0.3 0.3 0.6 0.6 0.4 0.1 0.9 0.7 0.7 1.6 1.9 0.2 0.8 0.4 0.2 6.1 9.1 19.1 9.6 6.9 4.0 3.2 3.8 4.6 3.7 0.0 0.6 0.0 0.6 0.1 10.6 1.6 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.3 1.1 0.0 0.1 9.5 0.0 1.8 0.3 0.0 3.4 0.0 0.0 0.0 0.0 3.3 0.2 0.0 1.8 0.0 1.1 6.5 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 PCDHGA6 PCDH-GAMMA-A6 ENSG00000253731 "Protocadherin gamma subfamily A, 6" Q9Y5G7 5 141373914-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 9.7;Cardiomyocytes: 4.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;SCLC-21H: 11.2;T-47d: 6.5;WM-115: 14.0" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (4.49e-2)" "unprognostic (8.91e-3)" "unprognostic (5.45e-2)" "unprognostic (1.43e-1)" "unprognostic (1.15e-1)" "unprognostic (1.49e-2)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (3.86e-3)" "unprognostic (2.02e-2)" "unprognostic (5.26e-2)" "unprognostic (7.44e-2)" "unprognostic (5.21e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-3)" 4.1 3.8 6.1 2.3 8.4 0.8 2.9 19.6 10.8 7.9 3.4 8.3 2.9 1.0 6.9 4.7 2.6 4.3 3.6 3.7 5.0 4.3 2.8 1.7 3.3 1.4 2.9 4.7 9.7 2.5 2.5 4.5 6.9 3.3 4.0 1.6 5.8 4.1 5.3 2.1 4.7 1.5 6.1 2.8 2.8 1.7 2.2 2.9 0.2 3.8 1.2 1.5 4.6 3.6 1.3 0.7 2.8 0.6 0.5 0.8 0.2 0.1 0.4 3.2 0.5 1.6 5.4 0.1 2.3 0.8 1.2 1.2 0.0 0.2 2.2 3.1 3.7 1.2 0.5 0.1 0.5 0.8 0.0 0.3 0.0 0.3 0.3 0.9 0.1 0.1 5.8 0.4 0.3 0.1 1.1 1.8 0.1 0.3 1.3 0.4 0.5 0.7 1.8 0.3 0.1 0.1 1.5 0.4 0.0 0.4 0.1 11.2 0.9 0.1 0.3 0.7 0.7 6.5 0.1 5.5 0.9 0.4 0.9 0.8 0.4 1.8 0.4 0.9 0.8 14.0 1.8 0.6 0.3 0.8 0.3 0.3 0.8 0.6 0.2 0.1 1.3 0.3 0.5 2.8 0.5 0.3 0.7 0.5 0.2 6.1 8.4 19.6 10.8 5.0 4.3 2.9 4.7 3.3 2.9 0.0 2.1 0.5 0.5 0.0 9.7 4.5 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 1.3 0.1 0.3 0.4 0.0 0.5 0.1 1.6 0.0 1.8 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 2.1 0.0 1.0 0.0 0.5 0.1 0.2 0.0 0.2 0.0 0.0 0.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 "Protocadherin gamma subfamily A, 7" Q9Y5G6 5 141382739-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.9" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 3.5;Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.00e-2)" "unprognostic (4.73e-3)" "unprognostic (1.42e-1)" "unprognostic (7.49e-2)" "unprognostic (2.10e-1)" "unprognostic (6.85e-2)" "unprognostic (2.61e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (5.78e-2)" "unprognostic (3.72e-2)" "unprognostic (1.66e-1)" "unprognostic (3.56e-1)" "unprognostic (4.21e-3)" "unprognostic (6.30e-2)" "unprognostic (4.99e-2)" "unprognostic (1.42e-3)" 1.7 2.0 3.1 1.3 9.0 0.6 2.1 5.3 14.9 3.5 3.0 7.1 2.1 1.0 4.2 4.1 2.2 3.3 1.9 3.0 5.1 3.3 3.2 1.9 2.2 1.0 5.1 6.6 4.7 2.5 4.6 3.4 4.8 5.4 3.7 1.5 5.8 2.6 3.3 1.6 3.8 1.2 3.0 6.3 1.3 1.4 2.1 5.1 0.0 6.6 1.5 1.0 2.4 2.5 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 1.9 0.0 5.8 9.9 0.0 2.6 17.3 3.5 5.2 0.0 0.0 0.4 4.3 0.5 0.1 0.1 0.0 0.1 2.9 0.0 0.3 0.0 0.4 0.1 1.0 0.0 0.0 4.3 0.1 0.0 0.6 9.3 1.4 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 15.5 0.0 0.1 0.1 3.3 6.8 0.0 5.2 0.1 0.1 2.5 0.0 0.1 1.5 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.0 5.3 7.7 5.1 3.3 5.1 6.6 5.4 5.1 0.0 0.0 0.0 0.4 0.0 3.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 PCDHGA8 "KIAA0327, PCDH-GAMMA-A8" ENSG00000253767 "Protocadherin gamma subfamily A, 8" Q9Y5G5 5 141390157-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 7.1" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 10.4;Cardiomyocytes: 2.5;Horizontal cells: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 2.9;neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.9" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (3.28e-2)" "unprognostic (2.27e-2)" "unprognostic (4.86e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (4.10e-2)" "unprognostic (7.68e-2)" "unprognostic (2.30e-2)" "unprognostic (1.83e-2)" "unprognostic (2.23e-1)" "unprognostic (1.24e-1)" "unprognostic (1.35e-2)" "unprognostic (1.49e-3)" "unprognostic (7.59e-2)" "unprognostic (3.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.99e-3)" 0.6 0.7 0.8 0.7 0.6 2.5 0.7 2.3 2.2 1.2 1.2 1.0 7.1 0.4 2.3 1.5 2.1 0.7 0.9 2.0 1.4 0.5 0.5 0.9 1.1 0.7 0.5 0.4 2.6 0.6 0.2 1.9 1.4 3.5 0.9 0.8 0.4 0.8 0.5 2.2 2.5 1.1 0.7 1.6 0.7 0.7 1.0 1.3 1.1 2.4 0.4 0.6 0.6 1.2 0.7 0.4 2.9 0.4 0.5 0.3 0.1 0.3 0.2 1.1 0.6 1.1 2.6 0.6 2.4 1.5 1.7 0.7 0.2 0.4 1.1 1.0 1.8 0.3 0.4 0.0 0.0 1.3 0.3 0.2 0.3 0.5 0.3 0.1 0.4 0.8 1.4 0.1 0.5 0.1 0.5 0.4 0.2 0.2 0.9 0.2 0.2 0.5 0.7 2.6 0.0 0.1 1.0 0.2 0.1 0.1 0.3 0.7 0.6 0.3 0.9 0.4 2.4 1.2 1.7 2.5 2.6 0.9 0.6 0.2 0.3 0.3 0.4 1.3 0.4 1.3 2.9 0.4 0.5 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.2 0.3 2.8 0.5 0.3 0.4 0.2 0.1 0.8 0.6 2.3 2.2 1.4 0.5 0.5 0.4 3.5 1.3 0.0 1.1 0.0 0.8 0.0 10.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 3.2 0.0 0.6 0.8 0.0 2.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.4 0.0 1.7 0.0 0.2 0.6 0.9 0.0 0.0 0.0 0.0 0.4 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 "Protocadherin gamma subfamily B, 1" Q9Y5G3 5 141350102-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 32.2;pituitary gland: 13.7" "Group enriched" "Detected in some" 17 "Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD8 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA076182" Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody" Yes No "Vesicles, Plasma membrane" "Nucleoplasm, Focal adhesion sites, Midbody" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783" "unprognostic (1.53e-2)" "unprognostic (1.94e-3)" "unprognostic (3.21e-1)" "unprognostic (4.38e-3)" "unprognostic (2.98e-1)" "unprognostic (8.36e-3)" "unprognostic (2.37e-1)" "unprognostic (9.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.06e-1)" "unprognostic (3.44e-2)" "unprognostic (4.78e-2)" "unprognostic (6.33e-2)" "unprognostic (3.15e-2)" "unprognostic (8.75e-2)" "unprognostic (1.93e-1)" "unprognostic (7.63e-3)" 2.3 2.7 8.2 1.4 7.5 1.0 2.1 4.3 32.2 2.5 1.4 9.4 0.1 1.2 3.7 2.0 1.7 1.9 2.1 2.2 7.6 5.7 2.1 1.3 2.4 1.2 5.5 5.0 4.1 2.8 1.4 13.7 1.6 7.0 2.5 1.4 2.6 1.7 3.1 1.1 1.4 1.3 3.0 6.9 1.4 1.2 1.5 5.6 0.0 2.5 0.0 1.2 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 2.0 1.8 0.0 14.7 7.7 0.1 1.4 3.6 0.5 0.8 0.2 0.5 0.5 4.7 0.5 3.5 0.6 0.4 0.2 0.5 0.0 0.9 0.0 0.2 1.3 0.2 0.0 0.1 1.2 0.0 0.0 0.0 8.0 0.1 0.0 0.2 0.2 3.3 1.8 0.4 0.3 0.2 0.0 0.0 0.0 2.7 0.1 0.0 0.0 1.1 0.8 0.0 0.9 0.1 1.5 9.6 0.0 1.1 0.2 1.6 1.2 0.0 0.0 2.6 0.3 2.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.5 4.3 9.6 7.6 5.7 5.5 5.0 7.0 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGB5 PCDH-GAMMA-B5 ENSG00000276547 "Protocadherin gamma subfamily B, 5" Q9Y5G0 5 141397987-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 11.2" "Group enriched" "Detected in some" 4 "Bipolar cells: 1.7;Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;ASC TERT1: 24.8;BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (2.71e-3)" "unprognostic (1.95e-2)" "unprognostic (1.09e-1)" "unprognostic (4.14e-2)" "unprognostic (2.35e-1)" "unprognostic (1.20e-1)" "unprognostic (3.64e-2)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.29e-1)" "unprognostic (1.69e-4)" "unprognostic (9.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.25e-4)" 2.1 1.9 0.8 0.3 3.2 0.0 3.6 2.0 4.3 1.4 0.4 2.5 1.9 0.0 2.1 2.5 1.1 2.1 0.8 1.9 0.0 1.6 3.1 6.8 2.6 0.9 1.5 4.9 2.8 11.2 2.1 9.5 1.5 2.2 0.2 3.7 3.2 3.2 1.4 2.6 0.0 1.9 3.0 0.5 0.7 1.0 2.2 0.8 3.5 0.0 0.7 1.9 1.4 0.5 0.2 0.0 0.3 0.0 1.9 0.1 0.0 1.2 0.1 0.0 32.8 24.8 0.6 8.7 0.0 14.2 16.0 1.4 4.7 4.9 11.4 9.6 0.0 6.6 0.0 3.6 8.0 0.0 1.4 0.0 0.0 0.0 3.4 0.0 3.1 8.7 0.7 0.8 4.6 6.1 4.3 0.0 0.1 0.0 0.4 3.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.0 1.0 9.2 0.0 4.4 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.3 0.0 0.2 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 "Protocadherin gamma subfamily B, 6" Q9Y5F9 5 141408021-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 6.4;Cone photoreceptor cells: 5.9;Horizontal cells: 9.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 18.6;EFO-21: 6.3;HSkMC: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (2.63e-1)" "unprognostic (7.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.90e-1)" "unprognostic (1.18e-1)" "unprognostic (1.85e-2)" "unprognostic (3.51e-1)" "unprognostic (1.11e-1)" "unprognostic (4.77e-2)" "unprognostic (9.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.27e-1)" "unprognostic (1.21e-2)" "unprognostic (7.71e-4)" 6.7 7.2 8.8 2.6 9.9 1.6 4.4 6.1 26.6 5.8 4.1 10.1 0.3 1.8 7.2 5.7 3.0 5.1 4.4 4.6 8.9 5.7 3.2 9.4 4.4 2.2 6.9 4.4 13.3 5.2 16.1 4.7 6.8 5.9 4.0 2.3 9.0 5.3 5.9 5.7 4.7 2.2 4.8 4.1 4.0 2.5 2.1 6.7 0.3 6.1 1.9 2.1 4.2 5.1 0.8 0.5 3.2 0.4 0.5 0.9 0.2 0.0 0.1 18.6 0.2 0.6 0.7 0.9 1.7 0.0 0.4 1.0 0.2 0.3 1.5 6.3 1.0 0.3 0.3 0.0 0.4 1.2 0.0 0.3 0.0 0.2 0.1 1.5 0.1 0.1 4.3 2.1 0.9 0.1 0.2 0.6 0.4 0.1 0.3 0.1 0.3 0.1 1.2 0.8 0.0 0.0 0.2 0.1 0.1 3.0 0.2 0.2 0.3 0.0 0.1 0.1 0.4 1.5 0.4 3.0 0.1 0.3 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.9 1.1 0.4 0.2 0.9 0.3 0.2 0.6 0.4 0.2 0.1 0.8 0.4 0.3 3.2 0.5 0.3 0.5 0.2 0.2 8.8 9.9 6.1 7.9 8.9 5.7 6.9 4.4 5.9 6.7 3.0 0.3 0.0 1.3 0.0 6.4 2.5 0.0 1.4 2.3 0.0 5.9 0.1 0.0 0.4 0.0 0.9 0.0 0.0 1.1 0.1 0.4 0.6 0.0 0.8 0.2 9.5 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.3 1.6 0.0 1.1 0.0 2.4 0.0 1.0 0.2 0.3 0.1 0.1 0.0 0.0 0.6 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 6.9;Horizontal cells: 11.1;Muller glia cells: 4.9" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 15.2" "Lineage enriched" "Detected in single" 22 "dendritic cells: 15.2" "Cell line enhanced" "Detected in many" "ASC diff: 43.5;ASC TERT1: 41.7;HSkMC: 40.8;U-138 MG: 52.4;WM-115: 78.0" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" NA NA 74000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077289: AB_2686832" "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (6.00e-4)" 14.9 15.0 52.8 7.0 49.0 0.5 11.2 30.1 99.3 28.0 8.7 38.9 2.4 3.8 20.6 27.6 12.8 15.7 14.6 11.0 40.2 25.2 7.1 8.0 20.9 4.2 32.0 24.9 16.6 4.4 18.8 7.9 17.7 25.8 17.1 10.2 17.3 8.4 20.1 5.8 18.3 5.6 19.8 28.1 5.3 6.6 4.8 24.1 0.9 5.4 6.4 7.1 8.6 11.1 0.6 15.2 0.0 0.0 0.0 0.1 0.0 2.8 1.6 10.8 2.9 43.5 41.7 0.1 14.2 37.9 7.0 7.6 0.0 2.7 9.4 9.2 24.7 26.5 10.3 1.4 4.4 6.7 0.0 4.3 0.0 0.2 0.2 13.4 0.1 0.3 40.8 6.8 10.6 8.7 25.8 4.7 0.0 0.0 0.3 17.7 5.2 0.2 1.0 0.4 0.1 0.0 6.3 21.9 0.0 3.7 3.0 3.5 15.4 3.8 0.1 23.3 4.0 8.8 13.1 5.7 52.4 2.7 10.2 15.3 0.0 0.1 0.1 12.5 0.0 78.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 52.8 49.0 30.1 38.9 40.2 25.2 32.0 24.9 25.8 24.1 0.0 0.0 0.0 0.4 0.2 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.9 0.6 0.0 0.0 0.2 0.1 0.7 0.3 0.0 0.0 0.2 11.1 0.0 0.6 0.3 0.4 1.1 0.0 0.0 0.0 0.0 4.9 0.5 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.5 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 "Protocadherin gamma subfamily C, 4" Q9Y5F7 5 141484997-141512979 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 23.6" "Cell type enhanced" "Detected in single" 32 "Horizontal cells: 3.2" "Cancer enriched" "Detected in single" 10 "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "REH: 9.3;SCLC-21H: 7.9;SH-SY5Y: 15.2;SuSa: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008755, HPA010580" Uncertain Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401" "unprognostic (6.05e-2)" "unprognostic (1.26e-3)" "unprognostic (4.78e-2)" "unprognostic (1.41e-1)" "unprognostic (3.44e-1)" "unprognostic (7.84e-2)" "unprognostic (9.48e-2)" "unprognostic (3.27e-1)" "unprognostic (4.55e-1)" "unprognostic (1.17e-1)" "unprognostic (8.72e-3)" "unprognostic (4.73e-3)" "unprognostic (2.20e-4)" "unprognostic (8.78e-2)" "unprognostic (3.06e-2)" "unprognostic (1.47e-1)" "unprognostic (2.75e-2)" 0.7 2.9 5.7 0.7 9.5 0.5 0.8 23.6 21.9 1.0 1.1 2.3 0.0 0.6 0.9 1.2 0.8 1.0 1.0 1.3 4.1 10.1 0.6 0.6 1.0 0.9 3.3 4.5 0.8 1.2 0.8 1.3 0.8 8.6 0.8 0.8 1.9 1.0 0.7 1.2 1.5 0.7 0.9 2.3 0.8 0.7 1.5 0.8 0.0 0.7 0.0 1.0 0.6 0.2 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.2 0.9 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 1.5 0.0 0.0 9.3 0.5 0.0 0.0 0.1 7.9 15.2 0.1 0.0 0.2 11.2 0.1 0.3 0.1 0.8 0.1 0.2 0.7 0.2 0.0 0.2 0.6 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 9.5 23.6 15.6 4.1 10.1 3.3 4.5 8.6 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 "Protocadherin gamma subfamily C, 5" Q9Y5F6 5 141489121-141512979 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 43.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "glioma: 3.1;head and neck cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8" "Group enriched" "Detected in many" 5 "amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4" "HPA008755, HPA010580, HPA076140" Supported Uncertain "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: " "unprognostic (2.86e-3)" "unprognostic (7.63e-4)" "unprognostic (2.00e-1)" "unprognostic (3.52e-3)" "unprognostic (5.42e-2)" "unprognostic (1.14e-1)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-2)" "unprognostic (3.90e-1)" "unprognostic (1.66e-2)" "unprognostic (1.01e-9)" "unprognostic (6.87e-3)" "unprognostic (3.89e-2)" "unprognostic (3.13e-1)" "unprognostic (3.77e-3)" 1.0 1.1 7.4 1.1 34.5 0.9 1.1 3.0 43.7 1.1 1.0 2.8 0.0 0.9 1.4 1.3 1.0 1.2 1.2 2.8 11.8 2.8 0.9 0.9 1.1 0.9 2.2 10.0 1.1 1.0 1.0 1.1 1.0 2.3 1.3 1.0 0.0 0.9 1.6 1.6 1.5 0.9 2.0 0.8 1.0 1.0 1.3 1.1 0.0 1.0 0.0 1.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.7 0.2 0.8 0.6 0.5 0.6 0.0 0.0 0.5 1.6 2.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.5 0.0 5.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 8.4 0.1 0.2 0.1 16.0 0.2 0.2 6.8 0.0 0.0 0.0 9.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 34.5 3.0 39.2 11.8 2.8 2.2 10.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCED1B "FAM113B, MGC16044" ENSG00000179715 "PC-esterase domain containing 1B" Q96HM7 12 47079603-47236662 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 40.2" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 29.9;T-cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 32.7;K-562: 24.4;SK-BR-3: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043901 Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA043901: AB_10959888" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (3.29e-3)" "unprognostic (1.47e-3)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.32e-2)" "unprognostic (5.13e-2)" "unprognostic (2.36e-3)" "unprognostic (7.74e-2)" "unprognostic (3.39e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (4.55e-6)" "unprognostic (4.79e-2)" "unprognostic (3.74e-1)" "unprognostic (3.74e-2)" "prognostic favorable (5.36e-5)" 5.7 28.4 4.1 25.9 3.9 7.1 4.4 0.6 3.6 5.1 6.4 5.7 1.2 1.8 7.6 4.6 4.5 6.9 5.8 2.4 2.8 2.3 4.1 2.7 7.8 25.6 3.8 2.9 19.6 2.1 0.6 2.0 3.2 3.7 6.0 2.3 3.3 6.5 2.8 1.0 2.0 8.5 11.7 7.7 20.8 2.9 9.1 3.3 5.7 2.6 1.3 40.2 10.0 4.2 16.5 12.5 1.5 0.8 9.1 32.1 10.9 1.7 32.7 0.8 0.0 0.2 0.0 1.6 1.0 1.8 0.4 0.1 1.6 6.4 5.8 1.8 3.3 0.6 4.7 0.0 4.8 0.0 6.8 0.0 0.2 0.3 0.6 0.7 1.3 0.2 0.1 2.1 0.5 3.7 4.6 1.4 0.4 24.4 5.5 2.3 0.7 0.3 1.1 5.6 4.0 0.4 0.1 0.8 4.0 5.0 2.7 0.2 0.0 2.9 16.3 0.0 1.8 3.0 2.0 0.4 0.1 0.5 0.0 1.1 6.0 4.2 10.6 1.6 4.5 0.2 0.4 0.3 0.8 14.9 0.7 16.9 16.5 17.9 18.8 2.1 10.1 32.1 29.1 1.5 9.1 0.8 12.5 18.9 10.9 4.1 3.9 0.6 3.6 2.8 2.3 3.8 2.9 3.7 3.3 3.0 6.4 11.2 1.0 1.0 2.5 0.4 0.0 1.4 2.3 1.8 0.0 0.5 0.0 3.3 0.7 1.9 0.0 0.0 11.4 7.7 1.6 1.0 1.1 0.0 29.9 0.0 9.8 12.9 3.2 1.1 3.4 2.7 1.7 5.4 1.1 0.8 9.7 0.0 0.7 0.3 0.0 0.0 3.4 0.7 0.2 0.5 1.7 23.3 0.2 2.1 PCK1 PEPCK-C ENSG00000124253 "Phosphoenolpyruvate carboxykinase 1" P35558 20 57561080-57568112 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Kinase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 419.5" "Cell type enhanced" "Detected in many" 24 "Distal tubular cells: 499.0;Enterocytes: 868.1;Hepatocytes: 756.2;Proximal tubular cells: 2559.6" "Cancer enriched" "Detected in many" 5 "liver cancer: 99.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "ASC diff: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006277, HPA006507, CAB017027" Approved NA NA 380000 "CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578" "unprognostic (3.50e-2)" "unprognostic (5.60e-2)" "unprognostic (4.60e-2)" "unprognostic (8.62e-3)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-2)" "unprognostic (4.43e-2)" "unprognostic (1.84e-1)" "unprognostic (2.37e-1)" "unprognostic (1.64e-1)" "prognostic favorable (1.47e-5)" "unprognostic (1.03e-1)" "unprognostic (6.40e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-1)" 10.0 0.1 0.4 2.2 0.4 0.0 11.1 0.2 0.6 0.1 52.0 0.2 0.1 19.2 0.1 0.7 0.2 0.1 5.6 0.4 0.3 0.2 72.0 419.5 0.2 0.3 0.2 0.2 0.4 0.2 0.0 5.0 0.1 0.5 0.2 14.0 0.2 0.2 0.1 0.3 0.1 58.5 0.4 0.1 0.1 0.1 0.2 0.2 0.1 0.4 0.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.6 0.3 0.2 0.2 0.2 0.5 0.2 0.0 0.0 9.5 0.0 0.1 0.2 0.3 30.6 0.0 1.2 85.5 0.0 0.0 499.0 0.3 0.0 0.1 868.1 0.0 0.0 0.0 0.2 0.0 9.2 756.2 0.0 3.2 51.8 23.4 17.7 0.0 0.0 0.0 0.0 0.0 182.0 8.0 0.1 241.9 0.0 2559.6 0.2 0.0 2.1 0.0 0.0 0.3 0.2 8.5 181.4 0.0 PCK2 "PEPCK, PEPCK2" ENSG00000100889 "Phosphoenolpyruvate carboxykinase 2, mitochondrial" Q16822 14 24094053-24110598 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Gluconeogenesis "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 156.3;liver: 115.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 152.4;Hepatocytes: 291.7;Proximal tubular cells: 166.4" "Cancer enhanced" "Detected in all" "liver cancer: 91.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 35.3;hTCEpi: 34.3;SK-MEL-30: 32.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB018734, HPA051162, HPA053502" Enhanced Enhanced Mitochondria NA NA 3300000 Mitochondria "CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171" "unprognostic (3.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.50e-2)" "unprognostic (4.07e-1)" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (2.81e-4)" "unprognostic (3.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.26e-1)" "unprognostic (3.67e-2)" "unprognostic (1.33e-2)" "unprognostic (2.81e-1)" "unprognostic (3.71e-1)" "unprognostic (2.82e-2)" "unprognostic (1.17e-1)" 8.2 2.5 1.0 4.9 1.9 1.0 4.3 1.3 1.3 1.3 69.7 1.4 6.9 51.8 1.3 8.5 4.5 1.2 4.2 2.6 1.5 1.0 26.4 115.1 6.0 4.4 1.7 1.2 1.8 8.5 3.4 1.7 1.2 1.8 2.0 5.4 1.9 11.5 4.9 1.0 2.7 156.3 1.1 1.7 6.7 3.3 3.9 1.3 1.3 5.8 1.9 4.6 2.8 1.9 8.8 10.8 2.4 15.1 1.5 6.5 3.9 5.5 3.1 0.9 5.9 3.7 3.7 15.0 6.9 8.3 5.8 9.4 5.1 6.4 14.1 0.8 10.6 1.9 8.1 6.0 8.9 4.8 7.2 0.2 2.5 1.7 27.5 35.3 4.9 11.1 4.3 34.3 3.6 8.9 1.6 4.6 16.4 7.2 26.1 2.2 23.9 1.2 2.5 1.0 12.5 4.2 2.8 3.4 8.0 1.7 8.6 3.7 5.9 5.3 6.8 32.5 0.9 9.2 7.6 0.8 1.2 6.7 1.8 1.9 17.9 5.6 3.5 3.5 7.7 3.1 0.1 8.2 2.4 3.1 15.1 3.4 8.8 3.5 3.5 10.8 6.1 2.2 2.0 1.0 1.5 14.4 1.9 6.5 3.9 1.0 1.9 1.3 1.3 1.5 1.0 1.7 1.2 1.8 1.3 11.9 22.0 24.4 8.8 3.0 4.1 1.2 20.4 2.7 3.4 17.4 0.0 3.4 29.9 17.2 49.9 3.5 152.4 0.0 67.0 11.6 5.3 6.8 1.1 291.7 56.2 0.0 8.7 10.4 15.0 15.5 3.1 14.5 6.8 29.7 43.0 5.6 27.0 63.4 2.8 166.4 5.4 0.0 5.1 8.6 0.9 4.3 2.5 9.6 63.5 11.9 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364311-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 42.1;lymphoid tissue: 78.3" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 32.4;Extravillous trophoblasts: 120.0;Hofbauer cells: 92.8;Syncytiotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "T-reg: 24.2" "Lineage enriched" "Detected in many" 5 "T-cells: 24.2" "Low cell line specificity" "Detected in many" HPA047929 Supported Centrosome NA Yes Centrosome "HPA047929: AB_2680215" "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavorable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.1 1.8 0.7 24.5 0.8 42.1 2.6 0.4 0.8 1.8 7.7 0.6 1.0 4.6 1.6 2.8 18.8 0.6 4.0 2.2 0.8 1.0 2.5 3.0 4.0 21.8 1.4 0.4 0.9 1.4 0.1 0.6 5.1 0.7 1.6 10.1 0.5 3.1 0.4 0.9 2.8 8.1 1.6 1.9 10.9 4.9 3.0 0.5 78.3 1.2 18.0 20.7 4.3 5.7 2.2 3.2 2.0 0.4 5.2 24.2 2.7 30.8 35.7 30.4 19.4 3.2 11.5 22.2 23.9 21.2 46.0 66.7 40.1 29.4 59.3 8.5 12.1 12.5 23.2 75.7 18.4 52.0 37.6 27.2 58.1 37.6 34.5 0.3 38.2 21.5 3.9 1.9 36.3 7.4 9.9 34.9 36.3 35.7 21.8 52.8 35.6 46.3 85.8 11.3 38.9 15.5 60.5 57.6 38.9 21.8 31.9 3.0 15.7 18.9 15.0 11.0 15.8 21.2 53.2 4.9 22.8 47.9 27.6 63.6 11.9 41.1 37.1 9.5 84.4 15.3 2.0 0.2 1.2 1.6 0.1 0.2 2.2 4.8 4.5 3.2 0.5 0.4 0.8 1.6 5.2 0.4 0.2 24.2 2.7 0.7 0.8 0.4 0.8 0.8 1.0 1.4 0.4 0.7 0.5 8.9 14.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 9.1 1.8 0.0 32.4 1.7 5.8 0.0 0.0 0.0 0.0 2.7 120.0 0.0 0.0 3.5 0.0 92.8 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.8 0.0 0.0 3.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 95.6;Cone photoreceptor cells: 123.7;Horizontal cells: 81.0;Intestinal endocrine cells: 57.6;Rod photoreceptor cells: 84.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "REH: 62.4;U-2 OS: 71.7" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 1.9 0.1 1.4 0.5 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.2 1.1 62.4 1.0 0.0 0.4 0.2 1.2 0.8 0.0 0.6 0.1 0.3 0.8 0.1 0.0 0.0 71.7 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 8.9 14.1 0.0 8.3 2.3 95.6 24.6 20.4 9.4 18.2 1.8 123.7 0.9 6.6 4.6 9.0 4.1 14.6 0.0 4.4 0.3 0.4 5.3 0.0 0.0 1.3 81.0 57.6 0.0 0.0 5.6 2.6 0.0 0.0 0.0 12.3 17.5 2.5 14.4 6.0 16.7 84.6 0.0 0.3 3.9 13.8 3.0 0.6 0.0 7.7 4.8 PCNA ENSG00000132646 "Proliferating cell nuclear antigen" P12004 20 5114953-5126626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction" DNA-binding "Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 115.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB000148, HPA030521, HPA030522, HPA030523" Enhanced Enhanced Nucleoplasm No Yes Nucleoplasm "CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199" "unprognostic (5.21e-2)" "prognostic favorable (1.86e-5)" "unprognostic (2.96e-2)" "unprognostic (2.43e-1)" "unprognostic (3.17e-1)" "unprognostic (5.60e-3)" "prognostic unfavorable (2.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.89e-2)" "unprognostic (1.01e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.03e-6)" "unprognostic (2.12e-2)" "unprognostic (2.29e-1)" "unprognostic (7.11e-3)" "unprognostic (7.46e-2)" 13.9 21.4 11.1 31.8 15.8 87.2 13.7 17.2 14.6 13.7 23.1 15.6 13.7 18.9 15.7 13.7 36.0 12.7 17.5 13.6 11.6 9.8 21.7 14.9 17.8 41.6 18.8 10.8 14.4 14.3 14.0 13.9 24.0 14.3 10.8 26.1 18.7 17.7 15.6 11.0 16.5 20.5 12.8 16.1 24.5 15.7 40.5 17.4 115.8 18.1 40.7 38.7 17.3 17.2 16.9 16.0 8.7 11.6 19.6 24.4 16.9 74.2 58.5 59.3 25.5 14.1 13.2 41.6 48.9 28.8 46.1 65.6 45.6 59.4 75.5 15.9 17.4 40.4 55.8 35.0 58.9 42.3 22.4 38.7 53.0 22.5 106.2 6.0 72.5 23.8 9.6 14.0 39.2 9.3 9.7 26.3 50.4 47.2 63.8 44.9 26.8 138.7 80.3 44.4 58.0 32.4 76.6 52.2 60.9 20.8 43.4 51.0 34.6 34.3 53.0 33.6 22.8 37.4 37.0 17.5 33.3 38.3 46.8 55.8 32.4 92.5 127.9 15.0 69.1 42.6 2.4 11.6 8.7 19.2 10.9 23.8 16.9 24.4 19.3 16.0 13.6 22.4 20.1 3.8 19.6 11.4 14.7 23.3 16.9 11.1 15.8 17.2 14.6 11.6 9.8 18.8 10.8 14.3 17.4 41.7 27.0 42.4 43.7 60.1 36.0 11.2 17.8 34.8 43.3 55.8 25.5 92.8 51.4 37.7 137.5 25.2 25.5 46.7 34.8 161.2 34.6 21.0 20.9 24.7 83.0 30.2 19.1 35.6 27.3 83.6 33.4 41.7 35.4 67.7 35.2 57.6 24.8 21.0 37.8 36.6 74.2 51.8 33.9 133.4 89.3 43.4 55.5 43.6 63.4 25.0 PCNT "KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4" ENSG00000160299 Pericentrin O95613 21 46324122-46445769 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 82.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 10.7" "Group enriched" "Detected in many" 6 "dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016820, HPA019887, HPA032101" Enhanced Enhanced Centrosome NA NA Centrosome "HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151" "unprognostic (9.07e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (1.30e-2)" "unprognostic (5.35e-2)" "unprognostic (3.40e-3)" "unprognostic (1.27e-2)" "unprognostic (2.59e-1)" "unprognostic (9.29e-2)" "unprognostic (1.35e-2)" "unprognostic (1.59e-3)" "unprognostic (3.86e-2)" "unprognostic (1.95e-2)" "unprognostic (5.83e-2)" "unprognostic (2.90e-1)" "unprognostic (3.36e-1)" "unprognostic (5.86e-2)" 4.7 4.7 16.6 6.9 20.4 12.6 3.6 8.3 16.5 3.2 4.0 4.4 3.8 3.7 3.7 4.1 5.1 3.4 5.0 8.2 12.0 4.2 3.2 4.4 4.3 6.4 7.0 9.7 4.9 3.3 5.9 8.0 3.4 5.6 4.0 4.1 2.0 4.1 4.1 82.3 10.4 4.0 4.2 4.3 5.5 4.6 14.5 9.7 9.1 4.4 2.2 4.8 4.7 5.1 0.4 5.3 4.9 1.2 0.5 10.7 2.3 9.3 7.4 11.4 7.0 5.7 5.8 7.2 7.2 5.0 7.2 6.5 8.9 6.1 9.3 4.7 8.2 9.9 6.7 9.2 6.3 5.0 27.3 12.9 24.8 13.8 6.8 2.0 12.5 10.3 3.1 4.8 9.7 4.8 3.5 5.5 10.1 12.5 14.2 9.9 15.5 12.3 12.9 11.3 8.5 5.1 15.3 4.7 8.2 5.6 10.1 14.0 6.2 15.7 9.8 4.7 2.9 9.3 9.8 7.5 13.0 6.6 7.4 11.5 12.2 10.2 10.1 8.1 12.3 7.0 4.9 0.8 1.3 2.0 0.6 5.9 0.4 0.9 5.9 2.3 0.2 0.7 10.7 0.5 0.5 1.2 5.3 0.9 2.3 16.6 20.4 8.3 16.5 12.0 4.2 7.0 9.7 5.6 9.7 26.8 33.0 4.5 5.0 7.3 11.2 30.0 12.7 17.4 22.7 0.0 5.9 4.4 0.0 5.7 17.8 6.0 6.4 0.0 6.6 6.7 5.4 3.8 15.1 8.2 18.3 22.3 15.0 7.4 7.5 19.3 11.8 11.4 0.0 15.4 6.6 3.9 5.0 6.5 11.3 3.7 10.2 25.8 7.1 43.2 42.2 6.1 5.4 10.0 8.1 4.9 PCNX2 "FLJ11383, KIAA0435, PCNXL2" ENSG00000135749 "Pecanex homolog 2" A6NKB5 1 232983435-233295713 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 29.6" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 8.9;Ciliated cells: 8.1;Club cells: 12.5;Collecting duct cells: 12.2;Distal tubular cells: 6.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013815, HPA014427" Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA013815: AB_2236561, HPA014427: AB_1855081" "unprognostic (3.15e-1)" "unprognostic (5.61e-3)" "unprognostic (1.92e-2)" "unprognostic (1.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.25e-2)" "unprognostic (3.79e-1)" "unprognostic (2.40e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.27e-5)" "unprognostic (1.12e-1)" "unprognostic (2.92e-2)" "unprognostic (1.49e-2)" "unprognostic (1.29e-1)" 4.7 4.7 11.4 7.5 16.8 4.2 7.7 29.6 23.1 4.9 3.9 6.3 4.2 3.4 6.6 14.0 5.2 9.0 8.1 2.3 11.9 8.2 5.4 1.2 4.7 9.4 8.0 13.1 11.4 5.2 8.6 18.6 2.4 14.3 6.2 4.8 6.0 6.0 8.1 5.6 6.3 5.6 5.2 5.8 5.3 5.8 5.5 5.5 4.0 7.9 3.4 8.8 6.0 5.7 1.5 1.8 0.9 0.9 0.8 3.1 1.1 3.8 9.4 5.1 0.1 8.4 9.2 1.5 2.3 6.8 2.4 4.3 3.0 4.7 8.1 5.5 6.3 9.0 6.4 2.3 6.7 5.7 6.8 6.9 0.1 4.8 0.0 3.8 2.6 1.6 7.0 5.9 4.8 19.1 8.3 4.5 6.1 0.0 4.3 2.4 2.3 7.4 0.2 16.5 3.3 5.7 0.1 1.4 1.1 4.4 6.0 8.8 7.3 3.4 1.5 1.4 3.0 3.4 0.7 1.7 6.8 4.4 7.7 7.6 5.2 5.4 0.1 6.2 3.0 7.8 0.9 0.9 0.4 3.1 0.5 2.4 1.5 2.5 2.9 1.8 1.3 1.1 2.1 0.7 0.8 0.7 0.6 2.7 1.1 11.4 16.8 29.6 23.1 11.9 8.2 8.0 13.1 14.3 5.5 8.9 5.1 0.0 0.0 0.0 0.0 0.0 0.0 8.1 12.5 12.2 0.0 0.3 6.6 5.1 0.0 0.0 0.0 0.0 2.9 1.1 0.0 0.0 1.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.0 0.0 4.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PCOLCE2 PCPE2 ENSG00000163710 "Procollagen C-endopeptidase enhancer 2" Q9UKZ9 3 142815922-142889203 "Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 55.6" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 99.1;Extravillous trophoblasts: 55.3;Fibroblasts: 87.7;Syncytiotrophoblasts: 202.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;RPMI-8226: 13.5;U-2197: 29.0;U-266/70: 28.7;U-266/84: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA013203 Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA "Nucleoplasm, Cytosol" "HPA013203: AB_1855084" "unprognostic (1.31e-1)" "unprognostic (3.75e-2)" "unprognostic (5.71e-6)" "unprognostic (8.36e-6)" "unprognostic (3.03e-2)" "unprognostic (1.06e-3)" "unprognostic (2.78e-2)" "unprognostic (9.39e-2)" "unprognostic (1.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.85e-4)" "unprognostic (1.43e-1)" "unprognostic (1.74e-4)" "prognostic unfavorable (1.08e-4)" 35.2 1.2 1.0 2.0 0.5 5.5 29.0 0.3 0.7 12.4 3.6 0.5 9.1 0.0 3.9 6.0 16.8 2.1 3.8 55.6 1.4 1.2 7.3 7.9 6.9 1.6 0.6 0.7 2.5 0.6 0.1 13.8 20.1 0.4 14.2 2.1 2.5 2.7 3.9 6.3 2.7 1.5 41.6 0.8 1.2 2.0 1.9 0.3 0.0 3.5 6.2 0.9 28.2 30.6 0.0 0.0 1.4 0.2 0.0 0.0 0.3 0.5 4.3 1.4 0.0 25.9 7.2 0.0 0.3 0.1 1.2 1.5 0.2 0.5 0.0 1.2 1.9 6.4 0.0 5.1 0.0 1.4 0.0 8.5 0.9 2.8 0.0 0.0 0.5 0.0 2.9 0.0 2.6 0.7 5.9 0.0 0.7 0.2 0.0 0.5 0.7 1.5 0.4 2.1 0.1 9.0 0.0 3.2 13.5 1.3 0.0 2.7 1.7 6.7 0.0 2.5 1.9 0.0 1.8 0.0 2.3 5.2 29.0 2.1 28.7 13.2 0.0 6.4 0.7 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 1.0 0.5 0.3 0.7 1.4 1.2 0.6 0.7 0.4 0.3 0.0 2.7 0.0 0.5 6.5 13.2 33.1 0.0 0.0 1.2 12.2 23.6 99.1 0.0 0.0 0.5 2.7 0.0 0.0 0.0 55.3 87.7 0.6 1.1 12.1 13.7 6.4 0.0 0.6 0.6 0.6 0.6 2.6 3.3 0.0 0.0 13.7 0.5 0.0 0.0 0.0 11.1 0.0 6.3 8.7 49.4 6.5 202.1 0.0 0.0 0.1 PCP2 "GPSM4, MGC41903" ENSG00000174788 "Purkinje cell protein 2" Q8IVA1 19 7631611-7633748 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 45.5;retina: 20.2;testis: 80.7" "Cell type enriched" "Detected in many" 5 "Late spermatids: 3770.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 14 "cerebellum: 45.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4" "Region enriched" "Detected in some" 43 "cerebellum: 2422.3" "Region enriched" "Detected in some" 18 "cerebellum: 135.0" HPA057428 Approved "Nuclear speckles,Vesicles" Yes NA "Nuclear speckles" Vesicles "HPA057428: AB_2683436" "prognostic favorable (7.93e-4)" "unprognostic (6.06e-2)" "unprognostic (1.19e-2)" "unprognostic (4.43e-2)" "unprognostic (1.49e-1)" "unprognostic (1.79e-4)" "unprognostic (1.19e-1)" "unprognostic (4.88e-5)" "unprognostic (1.11e-1)" "unprognostic (6.23e-2)" "unprognostic (9.15e-3)" "unprognostic (6.01e-2)" "unprognostic (1.36e-2)" "unprognostic (8.17e-2)" "unprognostic (1.18e-1)" "unprognostic (8.70e-2)" "prognostic favorable (2.76e-5)" 0.5 0.4 0.5 0.5 0.5 1.9 3.3 45.5 0.6 1.0 0.5 0.5 0.5 0.6 0.5 2.0 0.5 1.3 1.2 0.5 0.5 0.0 2.5 1.0 1.2 1.4 0.5 0.5 0.5 1.6 0.3 0.5 0.5 3.2 2.0 0.0 20.2 10.6 1.0 0.5 4.2 0.5 0.5 1.9 1.1 0.9 80.7 0.5 0.5 1.9 0.5 0.6 0.5 0.5 1.0 1.7 2.6 0.3 0.7 1.2 5.2 1.8 0.4 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 1.7 0.8 1.2 0.0 0.0 1.4 0.0 0.2 0.0 0.8 0.6 2.8 2.5 0.1 0.0 0.3 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.2 4.6 0.0 0.3 0.4 18.4 0.4 0.3 0.0 0.8 0.2 0.7 0.9 0.1 0.1 0.0 1.5 1.6 0.0 0.4 4.0 3.4 0.2 0.0 0.6 0.4 0.1 1.6 0.6 0.2 0.0 2.1 0.0 0.0 0.3 0.0 0.9 0.1 1.2 0.4 0.5 0.5 0.5 1.0 0.8 1.0 2.6 0.7 0.0 1.7 0.2 5.2 0.5 0.5 45.5 0.6 0.5 0.0 0.5 0.5 3.2 0.5 0.0 2.9 0.0 0.8 0.7 166.8 0.0 0.0 0.0 2.3 5.2 21.6 0.2 8.3 0.6 765.5 0.0 0.6 0.0 0.2 0.0 0.0 1.2 1.1 0.0 0.4 22.3 0.0 0.0 1.2 3770.2 9.8 1.0 1.7 1.8 0.2 24.5 0.5 0.0 12.4 0.3 79.8 19.4 0.0 11.1 6.4 1.0 0.0 1.5 0.5 0.6 PCP4 PEP-19 ENSG00000183036 "Purkinje cell protein 4" P48539 21 39867317-39929397 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 177.9;seminal vesicle: 234.5" "Cell type enhanced" "Detected in many" 23 "Bipolar cells: 431.9;Distal tubular cells: 547.2;Horizontal cells: 1320.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "basal ganglia: 177.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 57.7;SK-BR-3: 9.7;T-47d: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005792 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA005792: AB_1855086" "unprognostic (6.82e-2)" "prognostic favorable (9.76e-4)" "unprognostic (5.26e-2)" "unprognostic (1.56e-1)" "unprognostic (4.03e-2)" "unprognostic (2.94e-1)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (3.95e-3)" "unprognostic (2.63e-1)" "prognostic favorable (1.85e-7)" "unprognostic (9.00e-2)" "unprognostic (2.99e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" 2.1 11.0 5.6 1.4 177.9 1.0 2.6 15.8 15.8 39.3 10.6 11.4 50.8 1.9 11.4 65.7 38.4 2.9 1.7 1.7 8.3 14.0 9.7 1.0 1.1 1.0 11.6 3.7 1.2 2.1 3.4 1.0 1.3 20.0 60.9 6.9 49.0 1.7 234.5 1.0 1.4 1.5 93.5 3.7 1.5 1.1 1.2 37.5 0.0 39.2 0.0 1.2 65.6 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.5 0.0 0.0 0.0 0.0 57.7 0.0 0.0 0.1 0.1 0.0 9.7 0.0 0.0 18.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 177.9 15.8 15.8 8.3 14.0 11.6 3.7 20.0 37.5 0.0 1.0 0.0 0.5 2.7 431.9 8.1 5.1 0.0 0.0 73.3 58.9 0.2 547.2 0.3 1.1 0.3 0.0 0.0 0.2 0.2 1.5 4.0 0.0 0.0 0.2 1320.5 1.2 0.0 0.0 0.0 8.9 1.9 20.3 0.0 0.0 53.7 1.2 0.0 0.4 219.7 168.9 0.0 3.1 0.5 3.8 5.3 2.4 0.0 0.2 0.9 PCP4L1 IQM1 ENSG00000248485 "Purkinje cell protein 4 like 1" A6NKN8 1 161258727-161285450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.7;urinary bladder: 33.2" "Cell type enhanced" "Detected in many" 13 "Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7" "Group enriched" "Detected in many" 6 "cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8" "Group enriched" "Detected in all" 5 "basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8" "Cell type enhanced" "Detected in single" "T-reg: 3.1" "Lineage enhanced" "Detected in single" "T-cells: 3.1" "Group enriched" "Detected in some" 6 "RT4: 16.1;T-47d: 10.5" "Low region specificity" "Detected in all" HPA052833 Enhanced Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA052833: AB_2681968" "unprognostic (1.81e-2)" "unprognostic (9.39e-2)" "unprognostic (5.25e-2)" "unprognostic (2.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.87e-2)" "unprognostic (2.51e-1)" "prognostic favorable (8.10e-5)" "unprognostic (2.39e-1)" "unprognostic (1.92e-1)" "unprognostic (4.93e-2)" "unprognostic (7.37e-2)" "unprognostic (3.63e-5)" "unprognostic (4.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (6.15e-2)" 3.2 1.0 5.7 1.3 67.7 0.6 2.2 4.4 28.9 4.3 4.3 1.4 1.5 2.2 2.2 3.3 16.5 2.1 3.9 1.3 3.9 6.3 1.0 4.3 5.0 0.7 7.8 4.6 2.6 0.5 0.6 21.9 0.9 30.8 5.5 3.2 5.9 1.2 17.8 1.0 2.8 3.3 6.8 7.5 0.8 1.2 2.3 5.3 0.0 1.0 0.0 3.0 33.2 4.1 0.0 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 16.1 2.2 0.0 0.0 0.3 0.0 0.2 10.5 0.4 0.2 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 5.7 67.7 4.4 17.9 3.9 6.3 7.8 4.6 30.8 5.3 3.0 5.4 0.0 23.9 0.0 34.5 0.2 0.0 0.0 7.9 0.0 5.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.2 1.8 1.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 1.8 0.0 4.1 19.4 9.5 0.2 0.2 0.3 1.5 0.0 0.0 42.7 PCSK1 "NEC1, PC1, PC3, SPC3" ENSG00000175426 "Proprotein convertase subtilisin/kexin type 1" P29120 5 96390415-96434143 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.6" "Cell type enriched" "Detected in some" 39 "Intestinal endocrine cells: 215.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Group enriched" "Detected in some" 5 "SCLC-21H: 19.0;U-138 MG: 16.1;U-87 MG: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048564, HPA079656" Approved "Secreted in other tissues" NA NA "HPA048564: AB_2680444, HPA079656: " "unprognostic (1.86e-2)" "unprognostic (2.13e-2)" "unprognostic (4.66e-3)" "unprognostic (8.20e-5)" "prognostic unfavorable (9.13e-5)" "unprognostic (8.47e-4)" "unprognostic (1.46e-1)" "unprognostic (5.84e-3)" "unprognostic (4.71e-1)" "unprognostic (3.07e-3)" "unprognostic (1.89e-3)" "unprognostic (1.01e-1)" "unprognostic (7.90e-6)" "unprognostic (5.25e-2)" "unprognostic (9.96e-2)" "unprognostic (1.33e-3)" "unprognostic (9.37e-3)" 2.3 8.5 1.3 6.0 10.1 0.5 1.3 0.5 36.6 1.2 3.3 0.5 0.0 6.7 0.5 8.8 0.4 0.4 0.6 1.0 2.8 27.1 0.5 0.4 0.8 0.4 3.1 14.0 0.6 9.8 0.3 10.9 0.4 7.5 0.5 3.3 0.1 2.8 0.5 0.5 1.7 4.6 1.0 1.3 0.5 8.4 0.5 0.4 0.0 1.9 0.0 0.3 0.9 0.6 0.0 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.1 0.0 0.0 0.0 0.0 1.7 0.9 0.3 0.1 0.1 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 2.7 0.0 0.0 0.4 0.0 0.0 1.0 16.1 0.5 0.2 0.1 0.0 0.0 0.1 13.4 0.0 0.3 1.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 10.1 0.5 36.6 2.8 27.1 3.1 14.0 7.5 0.4 0.0 0.0 0.0 0.1 0.0 5.5 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 215.9 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.1 2.4 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 PCSK1N "BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII" ENSG00000102109 "Proprotein convertase subtilisin/kexin type 1 inhibitor" Q9UHG2 X 48831094-48835633 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.9;kidney: 72.9;pituitary gland: 127.7" "Group enriched" "Detected in many" 5 "Intestinal endocrine cells: 2932.5;Proximal tubular cells: 1024.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1" "Lineage enriched" "Detected in single" 77 "T-cells: 8.2" "Cell line enhanced" "Detected in some" "HEK 293: 20.0;PC-3: 50.7;SCLC-21H: 20.1;SH-SY5Y: 18.6;SiHa: 17.6;U-266/84: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003925, HPA064734" Enhanced Supported Approved Vesicles "Secreted to blood" NA NA 5300000 Vesicles "HPA003925: AB_1079582, HPA064734: AB_2685339" "unprognostic (2.44e-3)" "unprognostic (5.86e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (3.36e-1)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.79e-3)" "prognostic favorable (1.36e-4)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" 4.1 27.5 49.1 2.6 72.7 2.1 2.2 15.6 70.3 3.2 9.8 10.8 1.5 12.4 4.4 10.9 2.1 2.3 2.8 2.7 38.5 74.9 72.9 2.1 2.6 2.2 33.5 29.0 2.2 20.0 12.4 127.7 2.3 32.9 4.6 2.7 6.6 2.8 3.1 2.2 2.8 8.5 2.7 18.3 2.4 26.0 3.8 9.8 0.0 2.2 0.0 2.1 2.1 0.5 0.1 0.0 0.0 0.0 0.0 8.2 0.8 0.0 1.8 0.0 5.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.6 0.0 1.4 0.2 0.0 0.3 0.0 0.0 20.0 0.0 0.0 3.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 2.7 0.0 50.7 0.0 0.0 0.1 0.4 0.0 20.1 18.6 17.6 0.0 1.4 0.2 0.0 0.0 0.0 0.0 7.8 0.0 1.6 4.6 23.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 3.0 0.0 6.5 6.3 0.0 0.1 2.7 8.2 0.0 0.0 0.0 0.0 2.1 0.8 49.1 72.7 15.6 70.3 38.5 74.9 33.5 29.0 32.9 9.8 0.0 0.0 2.2 1.5 14.1 134.7 1.0 5.1 1.4 0.0 369.9 49.1 0.5 235.4 7.5 11.6 0.5 12.9 0.0 0.6 43.5 6.2 36.6 0.0 0.0 1.5 413.2 2932.5 0.0 0.0 41.9 3.1 2.7 54.0 0.0 16.6 54.9 36.6 411.7 6.7 1024.2 101.7 0.0 16.5 18.2 20.6 10.0 1.6 3.2 10.1 2.6 PCSK2 "NEC2, PC2, SPC2" ENSG00000125851 "Proprotein convertase subtilisin/kexin type 2" P16519 20 17226107-17484578 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 35.0;thyroid gland: 79.5" "Cell type enhanced" "Detected in many" 26 "Horizontal cells: 125.5;Melanocytes: 199.1;Muller glia cells: 518.9" "Group enriched" "Detected in many" 6 "pancreatic cancer: 14.6;thyroid cancer: 65.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 5 "AF22: 36.7;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049627 Approved Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA049627: AB_2680835" "unprognostic (2.03e-3)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.07e-3)" "unprognostic (4.31e-1)" "unprognostic (5.88e-2)" "unprognostic (2.50e-3)" "unprognostic (2.14e-1)" "unprognostic (7.26e-5)" "unprognostic (2.29e-1)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-1)" 1.6 35.0 16.3 1.7 20.5 1.3 1.3 7.7 27.8 2.9 4.2 1.6 0.0 6.2 0.9 1.2 2.1 2.0 1.4 3.1 18.0 11.1 1.1 1.0 2.2 0.8 4.1 16.2 11.6 23.7 0.9 1.7 1.5 9.0 1.3 2.8 16.6 2.7 2.3 1.0 16.6 3.3 1.3 5.4 0.9 11.9 4.7 3.8 0.0 79.5 0.0 0.9 1.9 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 20.5 7.7 27.8 18.0 11.1 4.1 16.2 9.0 3.8 0.0 5.3 0.0 0.0 7.2 27.6 0.9 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 76.9 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 125.5 0.0 8.0 0.0 2.7 2.6 0.2 199.1 0.0 0.0 518.9 4.6 0.0 0.0 0.0 11.5 0.0 1.0 0.5 0.2 1.3 0.0 0.0 0.0 0.1 PCSK4 "DKFZp434B217, MGC34749, PC4, SPC5" ENSG00000115257 "Proprotein convertase subtilisin/kexin type 4" Q6UW60 19 1481428-1490752 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "testis: 50.7" "Group enriched" "Detected in many" 5 "Early spermatids: 214.2;Late spermatids: 528.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.2;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.7;T-cells: 1.2" "Cell line enhanced" "Detected in some" "AN3-CA: 9.7;HMC-1: 5.2;JURKAT: 7.4;U-266/70: 10.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA005572 Uncertain NA NA "HPA005572: AB_1855087" "unprognostic (1.00e-2)" "unprognostic (9.12e-2)" "unprognostic (2.36e-3)" "prognostic favorable (9.45e-5)" "unprognostic (5.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.78e-1)" "unprognostic (6.34e-3)" "unprognostic (2.94e-1)" "unprognostic (8.29e-3)" "unprognostic (1.93e-2)" "unprognostic (7.44e-2)" "unprognostic (6.56e-2)" "unprognostic (3.82e-2)" "unprognostic (1.71e-2)" "unprognostic (3.57e-2)" "unprognostic (7.03e-2)" 0.5 1.2 2.5 0.6 3.4 0.9 0.7 0.6 1.8 1.2 0.9 1.8 2.5 2.5 0.8 2.2 0.7 4.2 1.0 0.4 2.5 2.1 1.7 2.0 0.8 0.6 1.0 2.0 0.8 3.8 1.4 4.2 0.5 2.3 1.2 0.4 2.4 1.3 2.4 0.5 0.8 1.1 0.6 1.2 0.7 1.2 50.7 1.8 1.2 2.0 0.0 0.4 0.7 0.6 0.0 1.7 0.0 0.3 0.0 1.2 0.1 0.8 0.5 1.7 9.7 0.2 0.3 2.6 0.7 0.2 0.1 0.3 0.9 1.4 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.2 0.4 1.4 1.3 0.6 0.0 5.2 0.8 0.0 0.0 0.1 0.4 0.2 7.4 1.6 2.5 0.0 0.0 0.2 0.4 0.1 0.4 0.5 1.7 0.1 0.2 0.6 0.0 0.0 2.0 0.2 0.4 0.1 0.6 3.5 0.5 0.0 0.8 0.1 0.2 0.0 10.7 1.9 0.3 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 1.7 0.0 0.1 2.5 3.4 0.6 1.8 2.5 2.1 1.0 2.0 2.3 1.8 0.0 0.6 0.0 1.0 0.6 1.3 1.1 0.0 4.0 4.5 0.0 7.9 0.4 5.0 1.3 214.2 0.4 2.1 0.0 0.9 0.3 0.2 0.5 0.0 3.2 0.6 3.2 0.0 0.0 0.0 528.7 5.8 0.0 3.3 0.0 1.2 2.3 0.9 0.0 4.9 1.4 9.8 0.0 0.0 80.2 9.6 0.0 0.2 0.0 2.0 0.7 PCSK5 "PC5, PC6, SPC6" ENSG00000099139 "Proprotein convertase subtilisin/kexin type 5" Q92824 9 75890644-76362339 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Pregnancy "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 157.6;intestine: 71.5" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 67.7;Horizontal cells: 52.4;Muller glia cells: 43.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "basophil: 157.6;neutrophil: 57.4" "Lineage enriched" "Detected in all" 12 "granulocytes: 157.6" "Cell line enhanced" "Detected in many" "BEWO: 15.9;HaCaT: 22.2;RH-30: 14.7;RPTEC TERT1: 20.6;U-2 OS: 32.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031072 Approved Supported "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA031072: AB_10602190" "unprognostic (3.28e-2)" "unprognostic (1.44e-1)" "unprognostic (4.13e-4)" "unprognostic (4.08e-2)" "unprognostic (7.43e-3)" "unprognostic (3.17e-1)" "unprognostic (2.07e-3)" "unprognostic (9.39e-2)" "unprognostic (1.15e-1)" "unprognostic (5.92e-2)" "unprognostic (2.81e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (2.99e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-2)" "unprognostic (1.77e-5)" 15.8 3.8 2.9 13.7 2.8 1.5 9.5 2.4 3.2 8.5 51.8 2.9 4.5 19.7 6.5 13.9 9.6 7.8 22.9 6.7 3.8 2.4 3.7 1.9 7.7 5.6 2.3 3.1 17.2 3.4 9.5 3.2 7.7 3.5 4.5 6.7 3.3 5.0 5.8 4.0 4.8 71.5 6.9 3.5 2.5 3.3 5.1 2.4 18.0 6.4 14.2 4.5 7.1 11.4 11.7 12.2 157.6 4.4 12.6 12.7 0.8 1.1 0.8 2.4 1.6 1.5 0.5 15.9 2.2 0.2 0.1 0.0 8.4 0.9 0.3 0.6 0.3 0.0 22.2 1.1 0.6 0.1 0.2 1.9 2.9 1.6 0.7 0.4 0.8 1.3 3.0 0.2 0.5 0.2 0.1 4.6 1.5 3.3 1.0 1.6 5.3 3.3 5.0 10.8 1.9 0.9 0.6 14.7 0.9 20.6 1.2 0.2 0.2 3.3 0.7 0.2 4.8 1.2 3.6 3.6 0.7 32.2 1.8 0.9 0.2 0.1 0.4 2.5 1.2 12.2 157.6 4.2 16.2 9.7 2.3 8.3 8.8 9.8 8.9 1.9 11.7 9.9 12.7 57.4 12.6 4.4 12.2 8.4 0.8 2.9 2.8 2.4 3.2 3.8 2.4 2.3 3.1 3.5 2.4 6.0 4.5 0.0 4.1 5.8 4.4 3.7 10.2 17.4 20.5 5.2 0.0 1.4 0.0 5.2 19.6 8.9 67.7 0.0 5.4 25.1 17.5 1.4 0.0 0.9 2.8 52.4 1.2 14.1 4.0 31.4 19.0 3.4 1.7 3.6 8.8 43.7 7.8 17.5 23.7 3.3 1.2 19.4 8.2 1.1 1.5 2.6 2.1 6.4 16.1 0.7 PCSK6 "PACE4, SPC4" ENSG00000140479 "Proprotein convertase subtilisin/kexin type 6" P29122 15 101297142-101525202 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.3;liver: 76.0;lymphoid tissue: 37.4" "Group enriched" "Detected in many" 9 "Hepatocytes: 210.8;Horizontal cells: 185.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 24.9;CACO-2: 17.4;HEK 293: 26.1;Hep G2: 23.3;OE19: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004774 Uncertain "Secreted to extracellular matrix" NA NA 38000 "HPA004774: AB_1079583" "prognostic favorable (9.99e-4)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (2.46e-2)" "unprognostic (9.83e-2)" "unprognostic (8.14e-2)" "unprognostic (2.20e-3)" "unprognostic (8.56e-2)" "unprognostic (2.16e-1)" "unprognostic (2.39e-2)" "unprognostic (3.85e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.06e-7)" "unprognostic (2.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 3.0 1.5 5.1 1.5 25.1 0.9 6.1 4.5 11.5 1.5 8.4 41.9 0.0 3.6 1.4 2.5 4.8 1.9 1.9 10.1 8.9 5.7 1.7 76.0 2.3 4.6 38.8 8.4 4.0 1.7 0.5 3.1 16.5 29.0 1.9 8.2 0.7 1.5 0.7 3.5 4.0 4.8 1.9 69.3 37.4 5.3 6.6 24.5 3.7 1.4 3.5 1.3 1.6 1.6 2.6 0.7 1.9 2.4 7.5 1.4 2.5 8.1 6.7 1.2 0.8 0.0 0.1 24.9 0.5 1.3 0.0 0.1 17.4 3.8 0.1 1.1 0.2 0.5 5.6 6.7 0.7 0.1 1.2 26.1 14.3 3.4 23.3 0.8 2.0 0.3 0.4 4.6 0.1 0.2 0.1 0.0 1.8 11.0 0.2 0.0 3.9 0.1 1.8 3.5 31.6 2.9 0.1 0.2 1.8 2.2 11.6 3.4 3.6 11.5 0.8 3.7 3.8 0.9 9.1 0.1 0.1 0.7 0.2 0.0 0.3 0.3 0.3 0.1 0.3 3.3 1.3 0.6 1.9 0.6 0.8 0.7 1.1 1.0 0.5 0.2 2.6 1.4 1.3 1.1 7.5 2.4 0.7 0.2 2.5 5.1 25.1 4.5 10.4 8.9 5.7 38.8 8.4 29.0 24.5 3.0 1.1 0.8 0.2 0.3 1.9 1.5 7.6 1.4 1.2 1.8 19.6 5.6 0.0 0.4 1.3 4.3 5.1 0.0 0.7 21.0 2.8 0.8 0.0 210.8 1.3 185.9 0.0 19.6 6.3 2.2 9.8 0.3 0.0 0.0 4.1 1.5 5.2 7.0 0.0 0.0 1.5 0.0 0.9 4.2 2.1 0.1 2.7 1.5 4.5 0.1 PCSK9 "FH3, HCHOLA3, NARC-1" ENSG00000169174 "Proprotein convertase subtilisin/kexin type 9" Q8NBP7 1 55039548-55064852 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 47.1;lung: 14.6" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 15.3;Hepatocytes: 17.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 9 "cerebellum: 6.9;pons and medulla: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 29.1;CACO-2: 13.5;HaCaT: 38.9;HeLa: 33.9;RPTEC TERT1: 19.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 143000000 300000000 "unprognostic (1.28e-3)" "unprognostic (6.93e-2)" "unprognostic (4.02e-1)" "unprognostic (2.19e-2)" "unprognostic (7.30e-2)" "unprognostic (1.82e-1)" "unprognostic (1.20e-3)" "unprognostic (1.14e-2)" "unprognostic (5.44e-3)" "unprognostic (1.22e-2)" "unprognostic (2.09e-3)" "unprognostic (3.70e-2)" "unprognostic (2.45e-4)" "unprognostic (1.49e-1)" "unprognostic (1.86e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (2.40e-4)" 0.2 0.1 0.0 6.1 0.5 0.4 0.0 6.9 0.2 0.6 4.4 0.0 0.0 3.9 0.2 0.7 5.2 0.4 2.6 0.0 0.0 0.0 0.1 47.1 14.6 0.0 0.1 0.0 0.1 11.0 0.0 0.0 0.0 2.6 0.0 1.9 0.1 0.3 0.3 0.0 0.8 5.1 0.8 0.1 0.2 1.0 0.4 0.0 0.0 0.0 6.1 0.9 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 6.5 0.9 0.0 2.1 1.5 0.1 0.0 0.0 0.0 0.0 13.5 4.6 0.0 5.3 2.5 0.1 38.9 1.1 11.8 0.0 0.0 0.0 0.0 33.9 9.4 0.7 0.0 0.0 2.3 8.8 8.5 6.2 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 5.5 0.5 0.7 0.0 0.0 0.3 19.2 0.0 0.5 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.9 0.2 0.0 0.0 0.1 0.0 2.6 0.0 14.9 15.3 0.0 0.0 0.5 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.5 0.0 1.3 0.0 0.4 0.1 0.0 17.0 0.1 0.0 4.1 1.8 1.6 0.2 0.0 0.0 1.7 0.0 2.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 2.9 0.2 PCTP STARD2 ENSG00000141179 "Phosphatidylcholine transfer protein" Q9UKL6 17 55750979-55842830 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.4;liver: 53.2" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.2;Hepatocytes: 64.8;Syncytiotrophoblasts: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 56.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 38.8" "Low region specificity" "Detected in all" HPA022979 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA022979: AB_2671018" "unprognostic (1.14e-1)" "unprognostic (5.20e-2)" "unprognostic (4.27e-2)" "unprognostic (7.35e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.43e-6)" "unprognostic (9.35e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" "unprognostic (8.65e-2)" "unprognostic (6.63e-3)" "unprognostic (1.16e-1)" "unprognostic (5.36e-3)" "unprognostic (1.26e-1)" "unprognostic (4.93e-1)" "unprognostic (6.89e-3)" "unprognostic (3.04e-1)" 8.2 5.6 4.9 8.2 8.2 5.1 8.4 3.1 5.3 6.2 11.9 3.0 29.8 9.3 5.2 15.8 6.6 4.9 10.1 12.1 5.1 4.7 17.0 53.2 11.6 7.8 6.2 4.9 5.2 7.5 4.2 5.3 19.4 5.5 7.5 12.7 5.3 7.1 32.1 10.8 4.1 9.8 8.3 5.0 10.0 12.5 8.0 3.9 3.0 5.7 5.8 5.2 8.1 9.9 2.0 12.1 56.4 15.3 6.2 2.7 6.5 8.7 8.1 6.1 2.2 8.2 8.0 15.7 3.4 4.6 5.5 5.4 9.1 11.4 2.4 26.8 5.4 5.1 4.9 3.5 5.8 5.0 38.8 8.2 21.7 2.4 16.9 7.3 8.2 17.2 6.6 7.7 3.2 6.0 6.8 10.6 7.4 15.6 8.8 6.0 7.6 6.5 6.7 6.6 0.0 7.2 3.3 8.8 2.0 5.8 6.5 3.0 6.9 1.7 3.8 14.5 14.0 10.1 14.3 7.7 6.3 4.5 7.0 4.5 24.9 7.8 1.5 5.8 13.6 10.8 15.1 15.3 56.4 2.5 12.6 1.5 2.0 1.6 2.5 12.1 1.4 0.9 2.2 15.9 6.2 13.2 0.9 2.7 6.5 4.9 8.2 3.1 5.3 5.1 4.7 6.2 4.9 5.5 3.9 3.0 7.2 5.1 2.5 0.9 3.8 15.3 17.8 2.7 0.0 8.7 2.0 42.8 10.0 11.2 13.2 7.3 11.8 0.0 12.0 61.2 6.7 1.4 15.0 64.8 19.2 1.6 12.6 9.2 22.6 15.4 15.3 12.6 11.8 10.8 16.2 3.5 8.3 7.0 24.4 30.7 2.2 12.9 10.3 9.8 8.1 1.3 56.2 8.5 14.3 1.7 PCYT1B "CCT-beta, CTB" ENSG00000102230 "Phosphate cytidylyltransferase 1, choline, beta" Q9Y5K3 X 24558087-24672677 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;testis: 15.6" "Group enriched" "Detected in some" 6 "Early spermatids: 21.7;Late spermatids: 58.8;Muller glia cells: 30.2" "Cancer enhanced" "Detected in some" "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.7;neutrophil: 2.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "AF22: 8.3;CACO-2: 17.8;HEL: 21.9;Hep G2: 9.1;NTERA-2: 9.4;SCLC-21H: 6.5;SuSa: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006367 Uncertain NA NA "HPA006367: AB_1079585" "unprognostic (4.49e-1)" "unprognostic (2.20e-1)" "unprognostic (1.16e-1)" "unprognostic (7.39e-2)" "unprognostic (9.88e-2)" "unprognostic (6.83e-2)" "unprognostic (5.05e-2)" "unprognostic (2.92e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-1)" "unprognostic (1.65e-2)" "unprognostic (5.64e-2)" "unprognostic (2.63e-6)" "unprognostic (2.62e-4)" "unprognostic (4.56e-2)" "unprognostic (1.75e-2)" "unprognostic (1.96e-4)" 0.8 1.1 12.0 1.1 11.4 2.0 1.0 3.1 23.9 1.6 1.1 13.7 2.3 1.3 3.2 1.7 2.8 5.7 1.7 4.2 10.0 6.0 1.0 0.6 2.1 0.6 7.8 10.5 4.0 3.1 0.7 1.4 3.6 10.7 2.3 1.3 2.1 1.0 6.4 0.7 0.7 1.1 6.1 10.3 1.0 0.9 15.6 8.7 0.0 0.6 0.0 0.7 0.9 0.4 0.4 0.5 2.7 0.5 0.6 0.2 1.4 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 17.8 0.0 0.0 4.7 0.0 0.0 0.9 3.9 0.0 0.0 0.0 0.1 21.9 0.0 9.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.2 0.5 9.4 0.0 0.0 0.0 1.1 0.0 0.0 0.0 6.5 5.2 0.0 0.0 0.4 7.1 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.0 4.3 0.6 0.2 2.7 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.4 0.2 0.2 2.2 0.6 0.5 0.5 0.2 1.4 12.0 11.4 3.1 11.3 10.0 6.0 7.8 10.5 10.7 8.7 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 6.7 1.2 0.0 0.0 0.1 0.0 0.7 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 1.7 0.0 0.0 58.8 0.3 0.0 0.0 0.0 0.0 30.2 0.3 0.0 2.5 0.0 1.2 0.0 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.0 PCYT2 ET ENSG00000185813 "Phosphate cytidylyltransferase 2, ethanolamine" Q99447 17 81900965-81911464 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.8" "Group enriched" "Detected in many" 11 "Early spermatids: 615.4;Late spermatids: 2143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023033, HPA023034" Enhanced Approved Nucleoplasm,Cytosol NA NA 7000 Cytosol Nucleoplasm "HPA023033: AB_1855094, HPA023034: AB_1855095" "unprognostic (4.05e-3)" "unprognostic (4.39e-3)" "unprognostic (3.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (9.86e-2)" "unprognostic (1.24e-2)" "unprognostic (1.06e-1)" "unprognostic (4.24e-1)" "unprognostic (8.97e-3)" "unprognostic (1.84e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.29e-6)" "unprognostic (1.19e-1)" "unprognostic (8.59e-2)" "unprognostic (1.63e-1)" "unprognostic (4.47e-2)" 13.6 5.5 13.3 5.7 12.7 5.3 10.4 12.2 17.0 6.5 16.2 13.4 6.4 30.7 5.8 8.6 7.6 12.2 8.0 17.7 14.0 11.8 21.7 46.5 7.2 6.3 13.4 16.0 7.8 11.5 8.2 4.6 6.0 15.9 10.1 8.5 5.8 10.8 6.6 13.5 4.5 26.5 5.0 14.3 4.1 11.5 70.8 11.0 5.6 6.7 6.8 5.8 7.5 4.4 7.3 6.6 2.1 3.5 4.7 8.4 4.0 11.8 6.8 5.5 15.5 27.6 14.5 8.1 8.5 18.4 12.0 14.3 26.7 12.4 4.1 4.7 8.9 22.3 9.8 8.3 15.9 7.0 1.2 6.8 9.0 9.4 61.2 29.5 9.0 7.6 11.9 9.2 10.8 8.4 4.3 11.1 12.7 16.7 8.6 8.9 10.0 10.7 11.1 4.4 41.7 7.3 7.1 5.9 14.7 14.4 22.5 7.0 6.4 6.4 35.5 8.3 11.3 9.8 21.4 7.4 8.9 5.8 6.6 7.0 5.6 2.3 4.0 9.2 12.1 8.7 2.1 3.5 1.2 7.1 3.4 4.6 6.0 8.4 7.2 6.6 7.3 7.0 7.2 1.0 4.7 3.0 6.5 5.0 4.0 13.3 12.7 12.2 17.0 14.0 11.8 13.4 16.0 15.9 11.0 0.0 15.9 13.0 6.8 4.7 11.8 14.9 56.0 10.7 4.5 24.4 0.0 67.4 101.2 15.9 615.4 7.1 65.6 23.3 16.0 30.7 6.8 9.0 9.2 125.6 20.2 15.9 13.4 20.3 10.0 2143.8 25.6 9.3 32.1 21.6 22.6 19.8 17.5 17.3 24.4 119.0 7.1 25.8 11.4 131.3 17.2 5.0 42.4 12.5 30.7 4.5 PDC MEKA ENSG00000116703 Phosducin P20941 1 186443566-186461122 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "retina: 56.6" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 341.6;Rod photoreceptor cells: 807.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;BJ: 1.9;BJ hTERT+: 3.6;hTERT-HME1: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA062235 Enhanced NA NA "HPA062235: AB_2684720" "unprognostic (2.06e-2)" "unprognostic (3.31e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-4)" "unprognostic (2.18e-1)" "unprognostic (7.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (2.39e-2)" "unprognostic (8.28e-3)" "unprognostic (4.07e-7)" "unprognostic (3.48e-2)" "unprognostic (2.11e-2)" "unprognostic (1.61e-1)" "unprognostic (1.67e-2)" 0.5 0.0 0.3 0.2 0.5 0.2 0.2 2.0 1.5 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.4 0.1 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.6 0.4 0.2 0.5 0.5 0.0 0.2 0.2 0.2 0.7 0.0 56.6 0.6 1.2 2.3 0.7 0.2 0.2 0.4 0.2 0.2 1.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.0 1.9 0.0 1.9 3.6 0.0 0.0 0.0 0.3 0.4 0.3 0.3 0.0 0.2 0.0 0.3 0.7 0.1 0.0 0.0 0.7 0.3 0.0 0.7 0.1 0.0 0.0 0.2 1.9 0.4 0.0 0.6 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.4 0.0 1.2 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 2.0 0.5 0.5 0.3 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.0 0.0 341.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.4 0.0 0.0 0.0 0.0 807.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDCD1 "CD279, hSLE1, PD-1, PD1, SLEB2" ENSG00000188389 "Programmed cell death 1" Q15116 2 241849881-241858908 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" "FDA approved drug targets, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;lymphoid tissue: 21.5" "Cell type enriched" "Detected in some" 9 "T-cells: 15.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "gdT-cell: 4.1;MAIT T-cell: 3.9;memory CD4 T-cell: 6.8;memory CD8 T-cell: 11.6;T-reg: 3.5" "Lineage enriched" "Detected in single" 93 "T-cells: 11.6" "Group enriched" "Detected in some" 7 "MOLT-4: 9.5;RPMI-8226: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035981, CAB038418, CAB076386" Enhanced NA NA "CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664" "unprognostic (2.90e-3)" "unprognostic (4.50e-3)" "unprognostic (7.78e-2)" "prognostic favorable (9.44e-5)" "unprognostic (7.18e-3)" "unprognostic (1.31e-3)" "unprognostic (3.83e-2)" "unprognostic (7.33e-2)" "unprognostic (5.82e-3)" "unprognostic (3.75e-2)" "unprognostic (6.57e-2)" "unprognostic (3.94e-1)" "prognostic unfavorable (3.48e-7)" "unprognostic (1.20e-2)" "unprognostic (3.10e-1)" "unprognostic (5.35e-2)" "unprognostic (5.06e-3)" 1.4 0.4 0.0 21.5 0.7 3.0 0.5 0.1 0.3 1.2 1.9 0.0 0.0 0.4 0.5 1.6 2.0 0.8 1.7 9.2 0.2 0.5 1.3 0.5 5.6 16.6 0.1 0.3 0.7 1.0 0.2 1.9 0.3 0.4 1.3 0.2 1.2 3.0 0.5 0.2 0.2 4.9 0.4 0.3 9.5 1.9 0.4 0.2 16.6 1.9 3.0 20.1 1.3 0.8 0.1 0.0 0.0 0.0 0.0 11.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.5 9.5 0.0 0.0 0.0 0.0 0.0 0.1 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.9 0.1 6.8 11.6 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 3.5 1.5 0.0 0.7 0.1 0.1 0.2 0.5 0.1 0.3 0.4 0.2 0.0 1.1 0.0 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 15.9 0.0 0.0 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 153.1" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 657.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 59.4;U-266/70: 65.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 14.9 9.1 9.4 20.6 9.8 11.8 28.1 15.6 8.1 20.0 46.7 9.1 64.0 18.0 19.1 18.1 40.6 12.3 11.9 8.1 8.4 8.1 6.5 30.6 9.9 13.8 7.8 6.4 27.8 153.1 61.2 30.3 51.4 8.5 18.7 26.1 16.2 81.7 61.7 5.8 37.3 47.1 13.2 8.6 24.0 27.6 10.1 9.5 22.6 55.4 18.8 27.8 15.1 22.7 18.5 12.6 50.9 9.0 26.9 33.1 11.2 5.2 5.1 8.3 8.7 12.4 23.0 4.9 6.1 18.0 3.0 5.2 3.2 13.0 50.2 17.2 8.4 2.3 24.2 5.0 15.5 6.5 43.4 10.0 25.3 29.8 5.3 5.6 12.6 27.6 18.3 49.8 3.1 16.9 13.6 5.6 8.0 6.7 23.8 7.4 13.3 4.6 14.5 2.1 3.7 9.0 2.0 14.8 26.6 4.9 7.3 3.6 15.2 11.7 6.3 21.3 9.2 59.4 23.9 14.3 4.7 3.5 3.4 2.3 65.3 31.6 28.9 4.4 17.6 4.9 50.9 6.1 15.9 18.5 8.3 33.1 18.5 17.1 20.2 7.3 14.3 14.9 18.1 12.0 26.9 9.0 12.6 9.2 11.2 9.4 9.8 15.6 8.1 8.4 8.1 7.8 6.4 8.5 9.5 17.9 50.8 79.3 72.6 118.1 53.9 14.6 22.9 45.5 69.4 24.4 29.5 205.4 29.9 41.5 11.1 69.1 177.9 0.0 89.4 54.3 62.3 50.5 127.3 20.3 49.3 20.6 32.3 79.2 72.9 9.0 134.3 49.5 276.7 41.5 157.6 33.5 61.9 230.3 209.3 20.9 191.1 38.8 44.8 44.6 64.0 144.5 657.3 161.3 172.4 52.3 PDCL2 GCPHLP ENSG00000163440 "Phosducin like 2" Q8N4E4 4 55556525-55592212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 43.0" "Group enriched" "Detected in some" 19 "Early spermatids: 1101.1;Late spermatids: 498.3" "Group enriched" "Detected in some" 5 "endometrial cancer: 0.8;ovarian cancer: 2.0;testis cancer: 3.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 11 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "AF22: 1.1;Daudi: 3.6;HaCaT: 6.2;HAP1: 1.1;PC-3: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA048260 Enhanced NA NA "HPA048260: AB_2680333" "unprognostic (5.93e-3)" "unprognostic (1.19e-7)" "unprognostic (1.04e-1)" "unprognostic (3.01e-3)" "unprognostic (1.16e-1)" "unprognostic (1.54e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.2 0.0 0.0 6.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1101.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 498.3 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 12.9 0.0 42.2 43.2 0.3 0.1 0.0 0.0 0.0 PDE10A ENSG00000112541 "Phosphodiesterase 10A" Q9Y233 6 165327287-165986603 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.8" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 15.9;Muller glia cells: 21.0" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 7.7;LHCN-M2: 14.0;RH-30: 8.2;RT4: 8.5;SH-SY5Y: 8.6;TIME: 14.5;U-2 OS: 7.9" "Region enriched" "Detected in many" 11 "basal ganglia: 307.0" "Group enriched" "Detected in all" 4 "basal ganglia: 155.2;cerebellum: 80.7" "CAB045998, HPA047200" Supported NA NA "CAB045998: AB_2162589, HPA047200: AB_2679981" "unprognostic (1.02e-1)" "unprognostic (3.63e-2)" "unprognostic (3.58e-2)" "unprognostic (2.91e-1)" "unprognostic (1.20e-1)" "unprognostic (1.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.36e-2)" "unprognostic (6.03e-2)" "unprognostic (3.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (4.44e-7)" "unprognostic (3.59e-3)" "unprognostic (2.37e-2)" "unprognostic (3.44e-2)" "unprognostic (5.90e-3)" 3.1 1.9 1.7 1.0 36.8 0.0 3.4 4.5 6.9 2.2 1.0 1.1 4.3 0.8 2.9 7.5 0.7 3.1 3.2 3.6 2.6 2.1 8.8 0.9 4.3 1.4 2.7 1.1 3.4 0.8 1.2 2.5 5.3 1.7 2.6 0.5 0.6 0.7 4.9 0.9 0.6 0.8 4.3 1.1 2.5 1.2 8.7 16.0 0.0 12.2 1.0 0.8 7.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.8 0.0 0.0 0.0 5.0 0.0 2.8 0.0 0.0 0.0 3.4 0.0 7.7 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 7.5 0.0 0.0 0.0 14.0 0.1 1.1 0.0 1.5 0.0 5.6 1.7 8.2 0.0 7.4 8.5 2.2 8.6 0.0 0.0 0.4 0.6 0.0 0.0 14.5 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 36.8 4.5 6.9 2.6 2.1 2.7 1.1 1.7 16.0 0.0 0.0 0.0 2.8 0.3 8.8 6.9 0.0 1.4 1.2 5.2 2.0 6.0 3.3 1.7 8.9 10.3 0.0 0.0 0.0 5.2 2.0 11.7 1.1 0.0 0.7 15.9 0.0 9.8 0.0 11.8 0.0 0.0 1.7 0.0 0.0 21.0 0.2 0.0 0.4 6.5 0.6 0.0 2.1 6.6 0.5 0.3 2.4 0.0 0.0 2.2 PDE11A ENSG00000128655 "Phosphodiesterase 11A" Q9HCR9 2 177623252-178072755 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Allosteric enzyme, Hydrolase" "Cushing syndrome, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 20.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "prostate cancer: 1.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;fHDF/TERT166: 5.6;HAP1: 3.2;Hep G2: 6.4" HPA034560 Approved "Intracellular and membrane" NA NA "HPA034560: AB_10602140" "unprognostic (1.02e-1)" "unprognostic (4.73e-2)" "unprognostic (1.02e-1)" "unprognostic (9.61e-3)" "unprognostic (2.34e-2)" "unprognostic (1.43e-2)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "unprognostic (3.91e-1)" "unprognostic (9.95e-2)" "unprognostic (2.80e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.75e-1)" "unprognostic (4.11e-4)" "unprognostic (1.64e-3)" 2.9 0.5 1.3 0.7 1.0 0.2 2.5 0.2 0.8 4.2 3.1 0.1 0.0 1.2 1.9 1.5 0.3 0.4 5.4 2.6 1.6 2.0 4.0 11.8 0.5 0.0 3.3 0.0 0.5 7.8 9.8 13.6 0.0 1.2 20.8 0.5 5.6 8.5 1.2 7.5 0.3 7.6 1.7 5.6 0.1 0.4 3.8 0.0 0.1 13.2 0.7 0.1 0.6 0.3 1.0 0.8 2.2 0.9 0.9 0.7 0.2 0.1 1.0 0.5 0.2 0.2 0.0 0.2 2.5 0.4 0.1 0.9 0.5 3.8 0.1 1.6 5.6 0.6 0.2 3.2 0.1 0.1 0.0 2.0 2.4 0.2 6.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.1 0.4 0.6 0.9 0.3 1.3 0.1 0.7 0.5 0.1 0.5 0.0 1.1 0.1 0.7 1.7 0.0 0.2 0.4 0.5 0.3 0.0 0.0 0.3 0.6 0.2 0.3 0.5 0.0 0.0 1.0 0.1 0.2 1.6 0.7 1.1 0.7 0.6 0.5 0.7 0.6 0.7 0.4 1.0 0.6 0.7 2.2 0.9 0.9 0.8 0.7 0.2 1.3 1.0 0.2 0.7 1.6 2.0 3.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PDE11A ENSG00000284741 "Phosphodiesterase 11A" 2 177628069-178108339 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 1.2;parathyroid gland: 1.5;testis: 3.6;thyroid gland: 1.6" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 28.4;Late spermatids: 33.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "fHDF/TERT166: 3.0" HPA034560 Uncertain NA NA "HPA034560: AB_10602140" 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.8 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 28.4 0.6 0.6 0.0 5.8 0.0 0.7 3.3 0.0 9.5 0.0 0.0 6.4 1.3 0.8 33.9 1.4 0.6 0.0 0.0 0.7 4.6 2.1 0.0 0.7 1.1 1.0 0.0 1.1 5.4 6.6 1.1 0.0 0.0 0.8 0.7 PDE1A ENSG00000115252 "Phosphodiesterase 1A" P54750 2 182140036-182523192 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.0;kidney: 37.1" "Group enriched" "Detected in many" 6 "Distal tubular cells: 157.5;Early spermatids: 314.8;Late spermatids: 455.7" "Cancer enhanced" "Detected in many" "thyroid cancer: 13.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "ASC diff: 22.8;HHSteC: 13.5;HSkMC: 28.9" "Group enriched" "Detected in many" 6 "amygdala: 118.0;basal ganglia: 76.2;cerebral cortex: 161.5;hippocampal formation: 155.8;hypothalamus: 47.8" "Low region specificity" "Detected in all" HPA022151 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA022151: AB_1855118" "unprognostic (3.63e-1)" "unprognostic (7.21e-2)" "unprognostic (1.32e-1)" "unprognostic (8.61e-2)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (3.84e-1)" "unprognostic (3.82e-1)" "unprognostic (1.02e-1)" "unprognostic (5.38e-2)" "unprognostic (2.78e-1)" "unprognostic (2.86e-1)" "unprognostic (5.55e-3)" "unprognostic (2.50e-3)" "unprognostic (5.96e-2)" "unprognostic (1.37e-1)" "unprognostic (1.40e-3)" 7.6 3.9 13.8 3.6 11.5 0.5 4.1 66.0 25.3 11.5 8.8 6.2 1.7 2.6 7.3 6.7 4.7 7.4 18.2 11.8 12.6 4.1 37.1 3.2 3.1 1.8 7.1 15.7 9.2 2.0 1.3 2.3 1.3 6.9 3.8 5.6 3.0 1.8 4.8 2.4 2.1 4.6 11.8 10.1 2.6 4.6 24.6 9.0 0.0 35.1 2.6 1.1 8.3 9.0 0.0 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.0 22.8 1.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.2 0.0 13.5 0.0 0.0 28.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 3.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 13.8 11.5 66.0 25.3 12.6 4.1 7.1 15.7 6.9 9.0 0.0 1.6 0.0 2.2 1.1 12.6 3.6 0.0 0.0 2.3 26.2 0.0 0.1 157.5 0.3 314.8 5.8 0.0 0.0 0.3 0.0 1.9 2.0 0.0 0.0 0.1 0.0 0.0 8.0 0.0 455.7 13.8 0.2 0.0 0.0 0.6 0.2 0.2 0.0 7.8 1.4 1.1 51.8 47.4 4.4 3.9 1.1 0.0 0.0 0.0 0.7 PDE1B PDES1B ENSG00000123360 "Phosphodiesterase 1B" Q01064 12 54549350-54579239 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Kupffer cells: 11.5;Sertoli cells: 12.9;Smooth muscle cells: 9.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 52.6" "Cell type enriched" "Detected in single" 4 "naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 11.5;HL-60: 6.4;HMC-1: 12.3;NB-4: 8.1;THP-1: 7.8;U-937: 6.5" "Region enriched" "Detected in all" 6 "basal ganglia: 895.2" "Region enriched" "Detected in all" 7 "basal ganglia: 253.8" HPA018492 Enhanced NA NA "HPA018492: AB_1855119" "unprognostic (2.90e-1)" "unprognostic (1.51e-1)" "unprognostic (7.67e-4)" "unprognostic (5.63e-3)" "unprognostic (7.02e-2)" "unprognostic (7.51e-2)" "unprognostic (1.97e-1)" "unprognostic (9.39e-2)" "unprognostic (1.14e-1)" "unprognostic (5.11e-2)" "unprognostic (3.84e-3)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.77e-6)" "unprognostic (6.64e-4)" "unprognostic (2.14e-1)" "unprognostic (3.09e-1)" "unprognostic (2.83e-2)" 12.3 1.4 9.9 4.6 52.6 5.6 2.7 3.1 19.4 2.6 3.7 1.4 0.0 1.2 3.9 2.5 1.7 2.4 2.9 1.9 3.7 3.8 1.3 1.6 2.9 1.6 3.0 9.3 12.5 0.6 11.0 0.5 0.5 5.8 1.0 1.7 0.5 1.3 2.1 0.7 1.0 2.6 4.9 1.2 4.8 2.5 1.1 7.7 0.0 2.7 0.0 1.1 2.8 1.1 0.2 0.3 0.1 0.3 0.1 1.6 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 11.5 0.3 4.7 0.0 0.0 0.0 6.4 12.3 0.7 0.0 0.0 0.0 0.0 0.0 4.6 0.0 1.9 0.0 0.0 0.7 8.1 3.4 0.0 0.0 2.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.8 0.0 0.0 0.2 0.0 0.0 0.0 0.1 2.4 0.0 6.5 1.3 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 1.6 0.0 0.1 0.1 0.0 0.0 0.0 0.4 9.9 52.6 3.1 19.4 3.7 3.8 3.0 9.3 5.8 7.7 0.0 0.6 0.0 0.2 0.9 0.1 3.1 0.0 0.0 1.2 3.5 0.0 0.0 0.0 0.0 4.8 0.3 0.0 23.3 0.0 0.0 0.4 0.3 0.0 0.0 7.3 4.8 1.7 0.0 11.5 3.4 2.0 5.2 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.1 12.9 9.5 0.9 0.5 0.4 0.2 1.5 0.0 0.1 PDE1C Hcam3 ENSG00000154678 "Phosphodiesterase 1C" Q14123 7 31751179-32299329 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.6;heart muscle: 56.2" "Group enriched" "Detected in some" 7 "Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052375 Approved Nucleoplasm NA NA Nucleoplasm "HPA052375: AB_2681802" "unprognostic (1.29e-2)" "unprognostic (2.20e-5)" "unprognostic (1.68e-2)" "unprognostic (1.20e-3)" "unprognostic (2.29e-1)" "unprognostic (5.65e-2)" "unprognostic (4.06e-3)" "unprognostic (2.75e-1)" "unprognostic (6.79e-3)" "unprognostic (6.49e-2)" "unprognostic (3.88e-5)" "unprognostic (7.03e-2)" "unprognostic (3.09e-3)" "unprognostic (5.76e-2)" "unprognostic (5.80e-2)" "unprognostic (1.49e-1)" "unprognostic (1.06e-3)" 2.9 2.7 10.6 3.2 27.7 0.9 5.1 2.4 17.1 1.2 2.7 30.1 0.0 2.3 3.1 6.8 7.4 8.4 2.4 56.2 14.8 7.5 4.0 1.0 5.0 1.4 31.1 12.0 4.9 2.7 1.3 1.3 4.0 16.3 2.9 2.7 7.9 2.6 4.2 1.4 0.9 2.8 10.4 17.1 1.4 3.8 4.2 33.6 0.0 3.9 0.2 1.0 7.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.2 0.0 0.2 0.1 0.0 15.2 6.2 7.2 5.9 0.0 0.0 0.0 0.0 49.0 0.0 0.4 0.0 0.0 9.3 0.0 0.0 0.4 0.4 0.0 0.0 0.0 10.9 0.6 0.0 1.5 0.1 15.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 8.1 3.0 0.1 26.5 0.0 0.0 0.0 0.7 0.1 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 27.7 2.4 17.1 14.8 7.5 31.1 12.0 16.3 33.6 0.0 0.0 0.0 0.8 0.0 55.0 112.6 0.0 4.0 1.2 1.8 49.1 0.0 0.0 5.6 40.4 2.9 0.0 0.0 0.4 0.0 0.0 0.2 8.1 0.0 0.1 3.2 0.0 0.0 0.0 38.3 0.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.4 0.0 4.4 0.0 2.1 1.1 0.7 0.0 0.0 0.0 0.0 0.0 PDE2A ENSG00000186642 "Phosphodiesterase 2A" O00408 11 72576141-72674591 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0;lymphoid tissue: 65.4" "Group enriched" "Detected in some" 6 "Endothelial cells: 33.1;Intestinal endocrine cells: 33.1;Ito cells: 118.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.7;T-cells: 9.6" "Cell line enriched" "Detected in some" 8 "HeLa: 107.5" "Group enriched" "Detected in all" 5 "amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9" "CAB009752, HPA031192" Enhanced Supported Cytosol NA NA Cytosol "CAB009752: AB_2268159, HPA031192: AB_2673781" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (4.58e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-1)" "unprognostic (2.50e-1)" "prognostic favorable (1.76e-6)" "unprognostic (3.06e-2)" "unprognostic (1.35e-1)" "unprognostic (3.01e-3)" "unprognostic (3.13e-3)" "unprognostic (1.50e-2)" "unprognostic (1.77e-2)" "unprognostic (2.85e-3)" "unprognostic (6.31e-2)" "unprognostic (7.72e-2)" "unprognostic (7.96e-4)" 27.8 18.4 30.4 3.0 34.2 2.5 25.4 1.0 48.0 8.9 7.7 3.8 1.9 3.5 9.4 4.9 10.2 11.6 12.0 11.3 18.0 6.1 7.0 10.4 5.1 3.8 3.8 27.0 3.4 2.4 4.4 3.4 6.6 6.7 4.8 5.2 3.0 2.3 6.3 6.6 4.8 4.2 10.3 2.1 65.4 4.2 2.9 7.4 0.1 7.0 3.9 2.2 8.3 11.2 3.7 1.2 0.2 1.0 0.1 9.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 107.5 0.1 0.2 0.0 1.6 0.0 0.2 0.5 4.4 0.2 2.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 2.9 0.0 0.0 0.2 0.0 0.0 9.6 0.5 0.0 0.0 0.4 0.1 0.0 0.0 13.7 0.0 2.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 9.6 1.0 5.6 3.7 5.7 5.6 1.2 2.5 3.7 3.0 0.2 0.1 0.5 0.0 2.3 1.9 30.4 34.2 1.0 48.0 18.0 6.1 3.8 27.0 6.7 7.4 0.0 0.3 0.0 0.0 2.3 2.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 33.1 0.0 0.0 0.0 0.2 0.9 0.1 1.1 0.9 0.5 1.6 33.1 118.4 10.0 1.5 0.3 1.0 1.7 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.4 0.0 4.3 1.4 0.8 2.5 0.0 0.0 0.0 0.3 PDE3A CGI-PDE ENSG00000172572 "Phosphodiesterase 3A" Q14432 12 20369245-20684381 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.2" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 41.0;Cardiomyocytes: 107.8;Horizontal cells: 49.3;Smooth muscle cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;HEL: 14.6;HeLa: 39.5;HUVEC TERT2: 7.1;SH-SY5Y: 14.8;U-138 MG: 11.4" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 35.4" "HPA014492, HPA074258" Approved Approved "Plasma membrane" NA NA 23000 "Plasma membrane" "HPA014492: AB_1855120, HPA074258: " "unprognostic (2.59e-2)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (8.14e-2)" "unprognostic (1.49e-1)" "unprognostic (4.25e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (1.72e-6)" "unprognostic (5.58e-2)" "unprognostic (5.94e-2)" "unprognostic (4.28e-2)" "unprognostic (2.76e-4)" 7.1 1.0 1.7 4.7 2.0 0.0 3.8 3.5 1.4 7.8 15.9 1.0 2.0 2.1 7.8 3.5 9.1 4.9 5.5 62.2 1.6 1.4 3.7 1.8 3.9 3.3 1.9 1.1 7.1 6.5 1.0 2.8 13.8 2.7 6.3 9.0 12.0 7.8 4.2 2.0 1.4 21.4 6.0 1.8 2.1 5.5 2.3 0.7 0.0 2.8 1.9 0.9 4.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.9 0.0 1.8 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.6 39.5 0.2 0.6 0.0 0.0 1.8 0.0 0.4 0.1 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.0 0.0 0.0 2.2 0.0 0.1 14.8 0.0 0.0 0.0 3.5 0.0 0.0 0.2 11.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.0 3.5 1.4 1.6 1.4 1.9 1.1 2.7 0.7 0.0 0.0 0.0 0.1 0.2 41.0 107.8 5.1 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.2 2.2 24.6 0.0 0.4 0.0 3.5 0.5 16.2 0.0 0.5 49.3 4.1 0.6 0.0 0.0 1.4 0.0 1.7 0.0 7.4 2.5 0.5 24.6 0.7 2.6 2.2 6.5 51.8 0.2 0.4 0.3 0.0 0.0 13.9 0.2 PDE3B HcGIP1 ENSG00000152270 "Phosphodiesterase 3B" Q13370 11 14643723-14872044 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Angiogenesis Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 42.6" "Cell type enhanced" "Detected in many" 7 "granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 5.0;T-cells: 8.7" "Cell line enhanced" "Detected in many" "HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056111 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA056111: AB_2683041" "unprognostic (1.05e-1)" "unprognostic (2.86e-2)" "unprognostic (4.12e-2)" "unprognostic (2.76e-3)" "unprognostic (4.25e-1)" "unprognostic (1.84e-3)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "prognostic favorable (7.91e-4)" "unprognostic (1.77e-1)" "unprognostic (2.33e-2)" "unprognostic (1.39e-2)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (9.03e-3)" 42.6 1.0 2.3 12.6 2.2 6.7 17.0 19.2 3.0 2.9 21.8 0.9 0.8 2.2 0.9 1.4 2.6 1.0 6.9 4.7 2.2 2.1 2.4 18.2 10.2 14.1 1.6 1.6 0.9 7.3 0.3 5.1 5.5 1.5 10.7 8.1 1.9 16.5 1.3 0.8 0.9 6.3 9.7 2.1 8.7 3.0 12.5 0.8 7.8 1.2 2.3 7.1 10.5 4.5 0.3 0.4 5.0 1.2 0.1 8.7 1.8 0.0 1.5 3.4 5.5 6.8 0.0 1.3 0.4 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 1.6 0.0 5.1 0.0 0.0 0.1 11.3 0.1 8.3 10.2 2.4 13.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 4.0 11.9 15.7 0.0 0.1 2.7 6.6 4.6 1.8 2.5 6.5 1.5 10.3 0.0 1.1 5.2 9.7 1.3 8.8 3.0 1.6 0.0 16.7 0.0 0.0 0.8 0.0 0.0 17.7 5.4 0.4 0.1 2.3 1.0 0.0 0.7 2.9 1.4 0.7 2.9 0.3 4.2 3.2 0.4 0.2 8.7 7.5 5.0 0.1 1.2 0.1 4.2 1.8 2.3 2.2 19.2 3.0 2.2 2.1 1.6 1.6 1.5 0.8 14.9 9.9 1.9 0.8 0.2 0.4 8.2 0.0 6.7 11.4 1.8 0.0 1.0 1.7 0.0 12.4 2.2 2.6 23.3 4.3 1.9 8.5 3.4 34.7 50.5 6.3 0.0 1.2 7.4 14.0 10.1 1.4 12.3 0.0 1.0 13.1 4.5 2.9 17.5 8.5 1.9 0.3 0.0 0.1 45.1 11.1 0.1 2.1 11.7 9.7 0.9 PDE4A DPDE2 ENSG00000065989 "Phosphodiesterase 4A" P27815 19 10416773-10469631 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5;testis: 31.8" "Cell type enhanced" "Detected in many" 13 "Late spermatids: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 22.0;NB-4: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017632, HPA043310, HPA076091" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775" "unprognostic (1.29e-2)" "unprognostic (3.98e-2)" "unprognostic (8.91e-2)" "unprognostic (1.82e-1)" "unprognostic (7.00e-2)" "unprognostic (6.84e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-2)" "unprognostic (6.90e-2)" "unprognostic (2.41e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-2)" "unprognostic (2.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.15e-1)" 6.4 2.5 9.0 4.2 13.9 3.4 6.3 15.0 38.5 8.4 4.3 3.2 0.4 2.0 4.4 1.1 3.1 4.8 5.0 4.1 12.4 6.9 2.8 1.9 7.7 2.0 5.3 19.4 1.7 9.8 17.3 2.3 4.9 34.7 3.7 3.0 3.1 7.1 4.0 26.1 2.2 2.7 4.7 3.6 4.1 6.1 31.8 4.5 0.0 5.4 1.0 1.9 4.6 3.5 0.2 3.3 5.9 4.4 5.3 2.0 1.3 0.0 1.4 0.3 3.9 11.6 6.9 2.2 3.3 6.6 0.4 1.1 3.5 3.2 1.5 9.7 8.5 0.2 0.3 2.3 0.4 0.2 3.8 3.3 13.6 4.7 3.8 7.5 2.2 22.0 5.1 0.4 3.7 0.0 0.4 3.1 1.2 10.7 3.3 2.3 1.0 1.3 25.3 1.8 3.9 2.8 8.9 2.2 11.7 0.6 0.8 2.5 0.9 0.2 0.1 3.6 0.6 0.5 4.5 6.6 5.0 6.5 3.4 2.1 6.5 0.5 7.2 2.1 0.1 4.0 5.9 2.6 5.1 1.5 4.4 0.8 0.2 0.5 2.0 3.3 0.1 0.1 0.7 0.2 5.3 4.4 0.2 1.2 1.3 9.0 13.9 15.0 38.5 12.4 6.9 5.3 19.4 34.7 4.5 3.0 15.2 8.0 2.7 9.0 23.9 5.8 12.7 10.7 7.9 8.7 0.0 0.3 0.0 2.8 44.2 10.9 1.3 0.0 11.1 4.3 13.4 3.1 32.2 0.8 9.8 52.4 0.0 11.6 18.3 164.4 16.1 37.2 13.5 14.4 6.2 1.3 10.6 0.0 17.0 0.0 2.6 6.5 8.1 7.7 7.8 7.0 0.3 16.0 6.8 1.4 PDE4B DPDE4 ENSG00000184588 "Phosphodiesterase 4B" Q07343 1 65792514-66374579 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 48.2" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 81.5;Horizontal cells: 108.1;monocytes: 104.6" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 36.6" "Group enriched" "Detected in all" 5 "B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3" "Cell line enhanced" "Detected in many" "AN3-CA: 24.4;HUVEC TERT2: 36.6;NTERA-2: 22.2;SK-MEL-30: 22.0;TIME: 20.4;U-266/84: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003005 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA003005: AB_1079587" "unprognostic (7.86e-2)" "unprognostic (3.13e-1)" "unprognostic (4.62e-2)" "unprognostic (2.90e-1)" "unprognostic (3.21e-1)" "unprognostic (3.33e-3)" "unprognostic (1.35e-1)" "unprognostic (1.15e-3)" "unprognostic (1.04e-2)" "unprognostic (6.10e-2)" "unprognostic (8.78e-2)" "unprognostic (4.24e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (2.89e-2)" "unprognostic (3.54e-1)" "unprognostic (9.04e-3)" "unprognostic (8.33e-3)" 14.9 2.9 21.5 28.4 29.0 48.2 15.0 12.7 31.9 6.4 6.6 39.2 0.7 3.9 6.7 2.1 3.9 3.5 8.1 16.1 20.7 18.8 3.7 8.7 10.0 15.9 36.3 14.2 2.0 1.7 1.7 3.4 13.1 32.2 18.3 8.6 6.6 15.9 10.3 28.2 6.2 8.5 9.5 37.4 18.5 4.2 3.2 36.9 2.3 5.5 5.5 14.7 16.1 3.9 16.1 2.6 36.6 2.8 4.4 13.3 3.7 0.1 7.0 13.8 24.4 0.7 0.7 0.0 4.5 5.3 4.2 5.6 0.0 0.0 2.0 0.1 8.4 0.1 0.0 0.1 0.0 4.2 5.9 0.0 0.1 2.0 0.0 0.5 4.9 0.0 1.4 0.2 2.1 0.1 0.6 36.6 0.0 0.0 1.3 1.8 0.1 0.0 2.8 22.2 0.0 0.3 1.0 2.4 1.3 3.4 0.0 0.1 10.6 0.0 1.2 22.0 1.2 0.1 1.7 20.4 3.3 0.8 1.8 0.7 0.6 19.1 7.5 3.4 5.1 1.4 2.7 2.8 8.4 4.4 2.4 8.4 15.4 8.3 6.2 2.4 16.1 9.4 6.5 36.6 4.4 2.1 2.6 13.3 3.7 21.5 29.0 12.7 24.6 20.7 18.8 36.3 14.2 32.2 36.9 8.9 16.4 50.2 24.5 18.0 35.4 29.1 0.0 2.7 12.5 5.2 0.0 5.2 0.0 0.5 7.9 23.2 0.0 0.0 0.8 1.6 9.3 81.5 14.0 1.6 12.6 108.1 4.1 12.3 25.8 5.6 0.3 42.5 49.0 104.6 1.2 12.2 0.1 0.0 2.5 1.6 3.3 0.0 10.3 0.1 0.7 7.0 4.7 36.2 1.1 5.7 PDE4C DPDE1 ENSG00000105650 "Phosphodiesterase 4C" Q08493 19 18208652-18248200 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 28.6" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 141.8;Paneth cells: 179.9;Undifferentiated cells: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.0;Hep G2: 4.0;U-87 MG: 9.0" "HPA048975, HPA054218" Approved Approved "Midbody ring,Centrosome,Cytosol" NA NA "Centrosome, Cytosol" "Midbody ring" "HPA048975: AB_2680581, HPA054218: " "unprognostic (4.20e-2)" "unprognostic (4.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (5.22e-4)" "unprognostic (1.44e-2)" "unprognostic (7.70e-2)" "unprognostic (1.15e-1)" "unprognostic (4.01e-2)" "unprognostic (5.69e-2)" "unprognostic (2.50e-3)" "unprognostic (2.21e-1)" "unprognostic (7.25e-10)" "unprognostic (2.73e-2)" "unprognostic (2.65e-1)" "unprognostic (9.21e-2)" "unprognostic (2.45e-2)" 2.0 1.3 1.8 1.5 2.8 1.0 2.0 0.8 6.1 4.1 4.4 1.5 3.1 1.5 6.4 6.8 1.3 4.2 5.6 4.2 1.6 1.9 4.1 2.0 4.1 0.5 1.7 5.1 2.0 0.8 0.3 3.5 7.0 2.8 5.8 1.3 2.5 1.3 5.4 13.4 0.6 4.1 3.4 0.7 2.3 5.2 2.6 1.1 0.4 1.2 28.6 0.7 1.8 3.3 1.3 0.6 3.5 0.7 1.0 0.7 0.2 0.1 0.3 0.2 0.3 0.1 0.3 6.0 0.1 0.0 0.2 0.3 1.2 0.2 0.2 0.6 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.4 4.0 0.2 0.2 0.6 0.7 0.1 2.6 0.0 0.5 0.0 0.3 0.9 2.1 0.1 0.4 0.2 0.3 0.2 0.4 0.2 0.2 0.3 0.4 0.1 0.2 0.2 0.8 0.3 0.5 0.0 1.6 0.5 0.3 0.0 0.4 0.2 0.7 0.1 1.3 0.6 0.2 9.0 0.2 0.3 3.4 0.7 1.0 0.6 0.4 0.5 0.5 0.5 0.4 0.2 1.3 0.5 0.7 3.5 1.0 0.4 0.6 0.3 0.2 1.8 2.8 0.8 6.1 1.6 1.9 1.7 5.1 2.8 1.1 3.0 8.8 0.0 2.2 4.8 3.0 28.1 5.1 0.0 1.2 0.0 5.9 1.9 0.0 0.0 29.1 3.6 141.8 0.0 0.0 3.5 4.2 1.8 4.6 0.0 0.4 0.0 6.9 1.3 2.2 26.0 0.6 1.1 1.7 0.0 34.4 2.7 0.0 179.9 3.9 0.0 3.3 45.3 13.4 1.9 1.9 3.3 0.9 0.0 66.4 18.4 PDE4D DPDE3 ENSG00000113448 "Phosphodiesterase 4D" Q08499 5 58969038-60522120 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 76.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 28.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.1" "Cell line enhanced" "Detected in many" "A549: 25.3;AN3-CA: 29.1;HeLa: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045895 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA045895: AB_10960275" "unprognostic (1.14e-1)" "unprognostic (8.73e-3)" "unprognostic (4.35e-2)" "unprognostic (7.87e-2)" "unprognostic (5.97e-2)" "unprognostic (2.03e-1)" "unprognostic (8.10e-4)" "unprognostic (1.17e-1)" "unprognostic (6.59e-2)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "prognostic favorable (4.00e-5)" "unprognostic (1.51e-1)" "unprognostic (8.20e-2)" "unprognostic (1.77e-2)" "unprognostic (2.56e-2)" 8.2 1.9 4.4 6.8 8.6 46.2 5.3 4.2 13.0 13.5 18.6 1.4 14.7 4.1 17.1 14.0 10.3 6.6 12.7 15.5 4.5 5.8 12.8 3.4 11.1 3.7 5.2 6.6 5.3 2.9 7.0 9.0 11.8 2.7 18.2 11.2 8.6 24.4 16.5 60.0 5.1 7.5 35.8 5.0 3.8 10.2 2.6 2.8 4.4 6.2 11.3 9.5 20.0 11.2 6.1 0.7 28.1 1.1 0.1 0.8 0.5 0.0 25.3 5.3 29.1 1.0 1.9 4.2 0.6 0.7 1.4 2.1 9.9 0.8 1.9 0.1 0.2 4.3 4.3 0.0 1.1 2.5 1.1 2.9 3.7 41.9 2.1 3.9 1.7 0.2 3.9 0.9 4.0 0.7 0.4 3.0 0.1 0.0 0.6 2.4 1.8 1.4 4.1 1.0 0.7 1.3 0.4 6.7 4.2 6.6 9.5 0.9 3.3 6.7 11.3 5.7 5.0 0.8 3.7 3.4 0.3 0.1 5.0 1.3 1.4 0.0 0.2 4.3 7.0 1.1 2.0 1.1 28.1 0.8 0.0 0.8 6.1 0.7 0.3 0.7 6.1 0.5 0.4 1.5 0.1 0.1 0.0 0.4 0.5 4.4 8.6 4.2 13.0 4.5 5.8 5.2 6.6 2.7 2.8 29.8 76.9 9.1 30.5 9.4 13.6 32.7 10.2 22.7 48.9 40.1 68.7 9.2 10.0 0.5 16.6 12.4 16.7 0.0 1.6 14.8 13.1 46.1 21.9 0.8 4.3 1.6 32.0 14.1 6.0 29.3 1.4 9.4 10.1 4.6 18.4 16.1 5.4 10.5 4.6 17.7 52.1 0.0 5.3 0.5 7.1 7.8 2.6 37.3 10.1 21.1 PDE4DIP "CMYA2, KIAA0454, KIAA0477, MMGL" ENSG00000178104 "Phosphodiesterase 4D interacting protein" Q5VU43 1 148808181-149048286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "heart muscle: 106.0;skeletal muscle: 276.2" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 631.5;Rod photoreceptor cells: 241.6;Syncytiotrophoblasts: 258.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 63.3;ASC TERT1: 51.5;K-562: 51.7" "Low region specificity" "Detected in all" HPA012678 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA012678: AB_1855123" "unprognostic (2.14e-1)" "unprognostic (3.27e-1)" "unprognostic (5.31e-2)" "unprognostic (6.73e-2)" "unprognostic (7.82e-2)" "unprognostic (1.16e-2)" "unprognostic (2.17e-1)" "unprognostic (9.72e-2)" "unprognostic (7.65e-2)" "unprognostic (1.67e-1)" "unprognostic (2.23e-2)" "unprognostic (5.08e-2)" "unprognostic (1.70e-3)" "unprognostic (1.82e-1)" "unprognostic (4.14e-2)" "unprognostic (9.13e-2)" "unprognostic (2.28e-1)" 4.8 2.9 9.2 4.3 8.3 2.3 9.0 12.1 15.1 4.8 6.2 8.3 5.6 3.8 3.1 11.8 6.1 3.3 5.0 106.0 9.7 7.8 6.6 9.3 5.5 3.8 15.6 8.1 2.3 3.4 13.6 7.7 10.2 9.3 4.6 4.1 7.2 5.4 4.5 276.2 4.1 7.7 3.1 18.5 2.9 4.4 1.7 11.2 1.5 3.1 18.1 3.8 3.6 6.1 12.0 6.7 7.4 5.9 4.7 13.2 4.3 7.9 1.5 2.2 2.4 63.3 51.5 13.2 9.3 8.9 9.1 12.0 7.3 5.0 4.0 2.9 13.4 26.1 4.1 5.4 6.6 15.5 3.0 7.7 2.0 3.3 2.9 16.7 1.8 2.2 36.6 13.2 38.8 21.1 20.9 3.5 3.4 51.7 9.5 16.2 13.5 1.3 1.1 7.9 6.6 3.3 2.9 5.7 1.5 5.4 8.2 10.9 1.0 9.1 26.7 7.3 10.0 7.9 2.3 4.7 10.6 2.4 26.5 20.7 4.2 5.9 6.0 43.3 1.6 6.5 7.4 5.3 4.1 5.4 5.9 5.5 12.0 10.9 7.2 6.7 11.7 8.4 4.6 1.2 4.7 1.9 2.9 13.2 4.3 9.2 8.3 12.1 10.2 9.7 7.8 15.6 8.1 9.3 11.2 47.6 46.3 21.7 9.6 25.5 78.0 631.5 35.7 121.8 61.4 66.3 108.0 166.9 53.0 10.9 30.1 5.7 27.3 0.0 6.1 103.0 37.0 5.3 12.8 70.6 41.3 31.8 41.5 6.2 35.7 38.7 9.8 70.6 52.3 22.6 33.0 44.3 4.9 20.7 9.2 14.7 241.6 32.3 42.4 6.7 16.8 14.3 258.6 12.8 17.8 3.8 PDE6A "PDEA, RP43" ENSG00000132915 "Phosphodiesterase 6A" P16499 5 149857955-149944793 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 153.4" "Cell type enriched" "Detected in many" 12 "Rod photoreceptor cells: 2864.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "CACO-2: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016970, HPA074677" Enhanced NA NA "HPA016970: AB_1855125, HPA074677: AB_2732264" "unprognostic (6.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (4.39e-3)" "unprognostic (8.83e-2)" "unprognostic (6.54e-2)" "unprognostic (5.91e-3)" "unprognostic (1.77e-2)" "unprognostic (9.21e-2)" "unprognostic (7.57e-5)" "unprognostic (9.93e-2)" "unprognostic (3.08e-1)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" 0.2 2.3 0.2 0.2 0.2 0.9 0.2 0.3 0.2 0.2 1.8 0.2 0.3 0.2 0.2 20.1 2.4 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 4.6 0.2 0.2 0.2 1.0 153.4 1.4 0.2 0.2 1.6 0.2 0.2 0.2 0.2 0.1 3.1 0.2 0.2 0.4 0.3 0.5 0.2 0.2 1.5 0.8 3.3 0.8 1.2 0.8 0.1 0.4 0.8 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.4 0.1 7.6 0.8 0.9 1.4 0.2 1.4 0.7 0.2 0.4 0.5 0.6 0.3 1.0 1.1 0.6 0.2 0.8 0.6 0.3 1.1 0.9 0.6 0.6 0.2 0.4 0.3 1.4 1.5 0.4 0.5 0.9 0.5 0.2 0.5 0.3 0.8 0.7 0.5 1.0 0.8 1.1 0.0 0.7 0.2 0.6 1.0 0.5 1.4 0.8 1.7 0.8 0.5 0.6 0.4 0.5 0.8 0.8 0.6 3.3 0.8 0.5 0.6 0.4 0.5 0.7 0.6 0.5 0.2 1.5 0.7 0.8 2.8 1.2 0.5 0.8 0.4 0.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 7.2 0.0 0.5 1.0 117.9 3.6 0.0 5.3 4.5 0.0 229.7 0.9 0.0 0.0 7.0 0.6 3.9 0.0 0.2 1.9 0.6 0.3 3.5 0.8 0.3 71.5 0.0 2.5 0.3 4.0 1.1 0.5 0.0 1.0 0.2 162.2 0.1 2.9 0.4 0.0 2864.0 0.0 1.0 1.1 0.9 0.5 2.4 0.5 0.9 0.1 PDE6B "CSNB3, CSNBAD2, PDEB, rd1, RP40" ENSG00000133256 "Phosphodiesterase 6B" P35913 4 625584-670782 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2;retina: 64.2" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 453.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054148, HPA059929" Enhanced Approved Cytosol NA NA Cytosol "HPA054148: AB_2682401, HPA059929: AB_2684166" "unprognostic (2.43e-2)" "unprognostic (1.33e-4)" "unprognostic (2.45e-4)" "unprognostic (7.18e-3)" "unprognostic (1.88e-2)" "unprognostic (5.04e-3)" "unprognostic (7.32e-3)" "prognostic favorable (5.34e-4)" "unprognostic (9.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.37e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" 1.6 1.9 12.1 4.6 19.1 6.7 3.8 2.3 13.2 2.3 1.3 30.2 1.5 0.8 2.5 3.9 1.4 9.6 3.2 5.2 18.1 10.2 4.6 0.7 4.2 12.0 29.6 9.8 2.6 1.4 9.1 3.2 2.6 14.5 2.5 1.0 64.2 3.5 2.9 0.7 1.8 2.2 2.1 20.2 8.7 2.5 3.6 22.4 4.3 11.4 0.2 8.3 4.1 1.1 16.5 14.1 11.2 5.8 10.2 13.1 7.1 0.0 0.2 0.8 0.4 0.2 0.3 0.2 0.0 0.0 0.5 1.4 0.0 0.1 0.2 8.0 0.2 0.7 0.1 1.7 0.4 0.0 0.1 0.0 0.6 0.2 0.0 4.1 0.1 0.3 0.5 0.1 2.4 0.0 0.5 0.7 11.8 0.1 0.6 0.0 0.2 20.5 0.2 6.5 0.4 0.2 11.1 0.2 0.4 1.4 0.9 14.0 8.2 0.0 0.3 0.1 3.3 0.4 0.0 0.2 0.1 0.8 0.1 0.3 5.4 15.2 0.2 0.2 0.2 0.1 11.2 4.2 0.6 11.5 5.8 10.5 10.0 7.7 7.9 6.6 16.5 12.2 13.1 1.1 10.2 5.6 14.1 11.4 7.1 12.1 19.1 2.3 10.0 18.1 10.2 29.6 9.8 14.5 22.4 3.0 5.3 4.5 1.2 0.3 18.2 3.7 0.0 16.0 5.7 0.0 78.5 0.1 1.7 5.1 0.4 1.8 0.0 0.0 0.6 0.2 0.8 0.9 3.5 0.0 9.2 11.1 1.7 2.5 3.9 0.0 1.4 3.4 3.3 7.2 0.2 20.9 0.7 0.0 1.4 6.7 453.5 0.0 0.2 3.9 2.7 0.3 0.2 7.0 0.1 0.6 PDE6C "ACHM5, COD4, PDEA2" ENSG00000095464 "Phosphodiesterase 6C" P51160 10 93612588-93666010 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 12.8" "Cell type enriched" "Detected in some" 18 "Cone photoreceptor cells: 53.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.39e-3)" "unprognostic (7.41e-3)" "unprognostic (2.61e-2)" "unprognostic (2.24e-1)" "unprognostic (3.17e-2)" "unprognostic (5.23e-3)" "unprognostic (2.46e-3)" "unprognostic (2.81e-3)" "unprognostic (9.68e-2)" "unprognostic (2.64e-1)" "unprognostic (1.51e-2)" "unprognostic (2.96e-3)" "unprognostic (2.19e-7)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (1.81e-1)" "unprognostic (1.80e-3)" 0.4 0.6 0.3 0.4 0.4 1.3 0.4 3.0 0.7 0.8 0.3 0.3 0.3 0.4 0.5 0.3 0.3 0.5 0.3 0.3 0.3 0.2 0.3 0.5 0.5 1.0 0.3 0.3 1.0 0.3 0.0 0.8 0.3 0.3 0.7 0.0 12.8 0.8 0.3 3.1 3.1 0.7 0.3 0.3 0.9 0.6 0.7 0.3 0.3 0.6 0.3 0.3 0.4 0.7 0.2 0.1 0.2 0.2 0.3 0.6 0.0 0.2 0.7 0.4 1.4 0.0 0.1 1.0 0.8 0.0 0.0 0.0 0.8 1.0 0.6 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.6 0.5 1.4 2.4 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.3 0.8 0.0 0.2 1.0 1.6 0.8 0.1 0.4 0.6 0.0 0.1 0.0 0.2 1.2 0.1 0.2 0.0 0.1 0.5 0.5 0.3 0.2 0.0 0.4 0.0 0.2 0.7 0.6 0.6 0.6 0.4 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.6 0.5 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.4 3.0 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 260.3" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2889.5" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 29.7;NK-cell: 57.8" "Group enriched" "Detected in all" 5 "granulocytes: 29.7;NK-cells: 57.8" "Cell line enhanced" "Detected in some" "Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 0.9 1.3 0.4 2.9 0.5 4.7 0.7 0.5 0.6 0.4 0.8 0.5 0.4 0.0 0.4 0.5 0.6 0.3 1.6 0.5 0.5 0.7 3.8 2.6 2.0 13.8 0.6 0.5 0.5 0.4 0.0 0.5 8.6 0.5 0.5 0.5 260.3 0.5 0.4 0.6 0.8 2.8 0.4 0.8 17.9 0.7 2.2 0.5 2.5 0.6 0.4 4.6 2.1 0.4 1.3 8.6 29.7 7.7 57.8 2.4 3.7 0.2 0.3 0.5 0.0 0.3 0.0 0.0 0.3 1.1 1.2 1.3 0.1 0.8 0.6 0.2 0.7 0.6 0.1 0.2 0.2 2.8 0.2 0.0 0.9 0.1 6.3 0.9 0.1 0.2 0.0 0.2 1.2 0.0 2.4 3.3 0.4 0.1 0.3 1.3 0.8 0.1 6.7 11.6 0.0 0.4 13.5 0.1 2.0 0.0 0.0 0.1 0.3 0.0 0.3 0.5 8.6 0.1 0.8 1.3 0.4 0.1 0.2 0.3 0.1 0.6 1.0 1.6 2.7 0.2 29.7 5.1 8.6 1.2 7.7 0.4 0.8 0.3 0.6 8.6 1.3 0.7 2.4 0.7 57.8 4.2 0.8 0.0 3.7 0.4 0.5 0.5 0.6 0.5 0.7 0.6 0.5 0.5 0.5 0.0 1.1 1.4 0.0 0.8 338.0 0.0 0.0 0.0 0.0 5.2 486.9 0.2 1.7 0.4 0.6 0.0 0.0 0.0 0.2 0.3 0.2 0.1 24.1 0.0 18.8 247.9 0.0 3.1 3.8 1.6 0.0 3.2 3.3 19.8 0.0 402.2 0.3 0.0 0.0 0.3 2889.5 0.0 0.0 0.7 0.2 1.3 0.2 2.1 0.0 0.0 PDE6H ENSG00000139053 "Phosphodiesterase 6H" Q13956 12 14973022-14981865 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 67.4" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 783.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.2;JURKAT: 1.0;MOLT-4: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (1.47e-3)" "unprognostic (1.07e-2)" 0.1 1.3 1.2 0.2 1.5 9.4 0.1 0.1 4.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 1.0 2.1 0.1 0.1 0.2 0.2 2.2 0.1 0.1 0.1 0.0 0.1 2.5 0.7 0.1 0.1 67.4 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.8 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.6 0.7 0.0 0.0 1.4 0.2 0.0 0.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 1.2 1.5 0.1 4.2 1.0 2.1 2.2 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 47.5 0.0 0.0 0.0 0.0 0.0 783.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 1.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 141.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PDE7A HCP1 ENSG00000205268 "Phosphodiesterase 7A" Q13946 8 65717510-65842322 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 87.5;skeletal muscle: 48.3" "Cell type enhanced" "Detected in many" 5 "B-cells: 80.1;Rod photoreceptor cells: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 32.0;MOLT-4: 53.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018770, HPA027340" Approved NA NA "CAB018770: AB_677329, HPA027340: AB_1855127" "unprognostic (2.76e-1)" "unprognostic (2.94e-2)" "unprognostic (1.36e-1)" "unprognostic (1.17e-2)" "unprognostic (2.15e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (5.64e-4)" "unprognostic (1.44e-2)" "unprognostic (6.94e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.35e-4)" "unprognostic (3.08e-2)" "unprognostic (1.26e-1)" "unprognostic (5.06e-2)" "unprognostic (2.03e-2)" 6.9 1.4 4.4 22.7 4.6 12.3 10.0 7.3 4.3 7.1 4.1 5.8 5.9 5.6 3.6 8.2 3.6 3.8 6.1 21.0 4.3 3.6 13.4 2.7 10.1 27.7 4.3 2.7 3.4 9.2 1.4 7.5 4.0 4.6 7.3 5.0 3.3 11.7 12.6 48.3 4.3 13.6 4.0 3.4 16.3 6.2 4.8 5.5 87.5 13.0 25.4 22.4 5.4 4.7 7.7 2.2 5.3 0.7 2.1 12.6 1.8 4.0 3.6 15.8 7.4 2.3 2.0 6.7 3.0 2.6 3.8 3.7 4.4 2.7 11.4 0.7 1.9 3.4 4.5 5.8 6.4 4.1 13.3 3.0 8.2 5.7 3.1 1.1 6.5 3.3 2.9 10.8 2.5 7.6 3.3 3.8 27.9 6.1 32.0 2.6 2.3 53.3 8.2 16.8 3.2 1.6 19.9 2.4 2.9 2.6 8.1 7.9 9.0 3.2 1.6 1.6 11.4 8.7 17.1 2.4 5.4 6.7 3.8 2.4 15.6 6.7 19.8 5.5 13.9 2.9 0.2 0.7 5.3 3.7 0.6 6.0 6.7 5.7 3.7 1.5 7.7 12.6 9.6 2.6 2.1 0.1 2.2 4.5 1.8 4.4 4.6 7.3 4.3 4.3 3.6 4.3 2.7 4.6 5.5 17.9 17.7 80.1 11.5 16.1 26.4 35.0 17.8 26.8 25.0 3.5 53.0 11.4 0.0 6.7 20.3 9.0 4.2 0.0 4.6 7.2 18.3 16.5 9.2 3.9 9.2 17.5 9.2 8.0 14.5 10.3 6.9 15.6 15.1 10.0 6.4 11.4 5.1 5.8 7.1 15.4 69.6 0.0 10.3 10.0 11.5 16.4 7.2 50.7 6.0 8.1 PDE8B ENSG00000113231 "Phosphodiesterase 8B" O95263 5 77210449-77429807 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Cushing syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 67.7" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 26.4;Cone photoreceptor cells: 51.1;Glandular cells: 41.8;Horizontal cells: 65.2;Muller glia cells: 77.6" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "BJ hTERT+: 12.4;HeLa: 28.4;SK-BR-3: 7.6" "HPA036911, HPA036912" Supported Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036911: AB_2675378, HPA036912: AB_10670377" "unprognostic (1.30e-1)" "unprognostic (7.95e-2)" "unprognostic (3.35e-2)" "unprognostic (7.61e-4)" "unprognostic (1.59e-2)" "unprognostic (1.41e-1)" "unprognostic (2.66e-2)" "unprognostic (4.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.98e-2)" "unprognostic (2.44e-1)" "unprognostic (9.04e-3)" "unprognostic (3.40e-2)" "unprognostic (3.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.19e-2)" 6.8 2.5 9.9 0.7 14.2 0.4 3.8 1.1 16.3 6.3 1.2 2.3 0.3 1.2 11.3 3.2 1.1 10.1 2.1 7.9 8.2 9.2 3.1 1.2 2.2 0.7 5.4 8.3 1.9 4.2 0.3 3.8 13.1 8.6 10.5 0.8 2.0 5.3 7.1 0.4 0.7 1.3 10.3 2.3 0.4 1.5 1.5 5.7 0.3 67.7 0.3 0.7 0.8 1.4 0.2 0.8 1.4 2.3 0.4 0.4 0.1 0.3 3.4 1.4 0.4 1.2 0.0 0.5 1.1 12.4 0.2 0.1 1.4 0.2 0.5 0.2 0.1 0.3 0.9 0.1 0.0 0.2 0.2 1.1 0.7 28.4 0.3 0.0 0.5 0.6 0.5 0.0 0.0 0.0 0.6 0.0 0.6 0.2 0.3 0.0 0.2 0.6 0.7 0.8 0.3 0.1 0.8 1.4 0.7 0.0 0.3 3.8 1.1 1.7 7.6 0.8 1.1 1.6 1.1 0.6 0.4 0.2 0.2 0.6 0.9 0.5 0.6 1.6 0.7 0.4 0.0 0.3 1.4 0.3 2.2 0.1 0.2 0.2 0.3 0.8 0.2 0.4 0.0 0.3 0.4 2.3 0.5 0.1 0.1 9.9 14.2 1.1 16.3 8.2 9.2 5.4 8.3 8.6 5.7 3.0 3.2 0.0 1.6 0.3 11.8 26.4 0.0 0.0 2.3 1.8 51.1 0.0 0.0 1.8 3.6 0.7 0.0 0.0 0.0 0.0 2.3 41.8 1.1 0.0 0.3 65.2 4.7 4.3 0.6 3.0 5.5 0.0 1.7 0.0 0.6 77.6 0.2 0.0 0.0 0.8 4.6 6.5 8.2 0.6 2.1 1.0 0.0 0.0 0.5 2.4 PDF ENSG00000258429 "Peptide deformylase, mitochondrial" Q9HBH1 16 69328621-69330595 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 30.2" "Cell type enhanced" "Detected in single" 21 "Alveolar cells type 1: 3.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063409 Approved Approved Nucleoplasm,Mitochondria "Intracellular and membrane" No No Mitochondria Nucleoplasm "HPA063409: AB_2685007" "unprognostic (4.28e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.73e-4)" "unprognostic (2.98e-3)" "prognostic unfavorable (7.35e-4)" "unprognostic (5.84e-2)" "unprognostic (4.35e-1)" "unprognostic (1.02e-1)" "unprognostic (1.00e-1)" "prognostic favorable (6.11e-4)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (5.98e-2)" "unprognostic (1.22e-2)" 6.6 7.9 4.8 7.8 4.5 5.3 4.8 3.1 6.9 3.6 7.6 3.8 3.3 7.1 5.3 5.6 8.4 4.4 6.5 3.8 4.6 3.3 14.9 30.2 3.7 7.0 3.0 5.2 5.0 14.2 8.2 3.9 4.9 4.4 5.3 4.1 4.3 12.8 4.6 10.4 6.0 5.2 3.4 2.3 5.0 8.3 3.7 2.0 10.2 7.3 9.2 6.2 3.7 4.0 10.3 3.2 2.5 2.8 1.7 6.9 1.5 9.0 6.1 1.2 2.9 1.8 1.4 10.7 7.6 2.0 5.4 4.7 15.0 6.4 16.7 10.1 2.6 2.5 13.0 3.7 4.0 2.2 4.0 31.0 8.5 5.8 21.4 3.7 11.8 6.8 2.8 7.1 4.8 2.3 0.9 3.1 8.6 20.3 1.9 2.9 11.6 9.2 12.4 7.8 3.3 11.2 21.7 1.9 15.5 4.3 5.7 10.4 8.3 13.1 2.3 6.4 0.5 12.9 3.8 4.7 4.7 8.8 5.4 8.7 15.8 10.5 19.7 3.1 8.8 6.0 0.0 2.8 2.5 1.2 1.6 3.1 4.3 3.9 3.9 3.0 10.3 6.9 2.5 0.0 1.7 1.5 3.2 3.0 1.5 4.8 4.5 3.1 6.9 4.6 3.3 3.0 5.2 4.4 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 PDGFA "PDGF-A, PDGF1" ENSG00000197461 "Platelet derived growth factor subunit A" P04085 7 497258-520296 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.1" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 83.4;Paneth cells: 77.2;Smooth muscle cells: 97.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "WM-115: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005579, HPA065024" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 300000 "Golgi apparatus" "CAB005579: AB_2161916, HPA065024: " "unprognostic (2.22e-1)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.75e-4)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.63e-3)" "unprognostic (4.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.96e-1)" "unprognostic (1.85e-1)" "unprognostic (8.26e-2)" "unprognostic (1.07e-2)" "unprognostic (5.87e-2)" "unprognostic (8.35e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (8.67e-4)" 9.5 6.1 13.1 6.6 20.4 2.1 16.5 9.0 16.6 11.1 14.8 33.4 5.8 16.3 15.5 11.2 8.5 12.1 10.0 14.0 14.9 14.2 10.4 5.4 16.5 8.1 29.8 12.5 6.6 54.7 5.7 6.1 21.5 21.1 14.4 12.7 7.4 16.6 10.2 63.1 10.6 20.3 10.7 26.4 11.8 20.9 4.5 22.7 1.6 6.0 8.6 2.7 11.0 12.7 3.0 3.3 11.6 4.6 5.3 3.6 2.9 5.8 4.0 0.4 5.7 1.1 0.2 13.6 1.3 0.7 1.7 1.2 6.2 6.7 0.1 2.3 1.1 0.7 14.9 0.4 18.1 0.9 3.3 0.6 0.1 3.3 2.2 7.4 0.6 0.7 0.8 7.2 0.8 5.7 2.3 3.3 0.3 0.5 0.8 4.1 7.3 0.8 1.3 10.7 2.3 0.8 2.9 0.4 0.6 2.3 1.4 0.6 0.5 20.1 1.1 3.4 13.4 2.8 0.7 9.7 3.7 10.3 2.1 7.9 0.2 0.3 0.2 3.3 1.8 82.4 11.6 2.6 3.5 2.7 2.9 3.6 3.0 2.7 2.5 2.3 3.0 3.3 3.3 7.6 5.3 4.6 3.3 2.8 2.9 13.1 20.4 9.0 14.5 14.9 14.2 29.8 12.5 21.1 22.7 83.4 11.0 0.0 18.2 24.8 15.7 25.0 5.1 6.7 17.0 14.0 7.9 7.8 5.0 14.2 0.3 19.6 51.1 0.0 46.6 3.8 15.1 23.5 10.4 0.6 1.9 30.2 12.5 22.1 1.5 0.0 2.0 1.6 13.5 1.8 28.3 0.5 52.4 77.2 6.0 8.0 1.9 38.8 97.6 0.2 1.1 8.5 2.4 0.0 20.3 14.5 PDGFD "IEGF, MSTP036, SCDGF-B" ENSG00000170962 "Platelet derived growth factor D" Q9GZP0 11 103907186-104164379 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 48.2" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 30.6;Ductal cells: 17.7;Horizontal cells: 25.4;T-cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 7.1;gdT-cell: 13.6;memory CD8 T-cell: 5.8;naive CD8 T-cell: 5.1;NK-cell: 12.6" "Group enriched" "Detected in many" 27 "granulocytes: 7.1;NK-cells: 12.6;T-cells: 13.6" "Group enriched" "Detected in some" 6 "ASC diff: 56.8;HHSteC: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046183, HPA066271" Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 24000 "Golgi apparatus, Vesicles" "HPA046183: AB_2679573, HPA066271: AB_2685645" "unprognostic (2.21e-1)" "unprognostic (9.35e-2)" "unprognostic (5.60e-2)" "unprognostic (1.72e-1)" "unprognostic (5.81e-2)" "unprognostic (8.83e-2)" "unprognostic (2.14e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (2.26e-1)" "unprognostic (7.01e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.19e-1)" "unprognostic (6.72e-2)" "unprognostic (3.57e-3)" 26.1 48.2 1.1 10.1 1.5 0.1 21.2 0.6 1.8 13.8 5.6 1.1 15.0 1.5 9.8 10.2 2.7 5.3 20.6 13.9 0.9 1.9 4.3 1.8 2.3 3.5 0.8 1.6 33.4 32.8 5.0 14.4 8.5 6.4 8.5 4.0 16.7 6.0 16.2 9.8 5.1 2.2 4.0 2.1 2.3 8.6 5.4 0.0 1.1 11.5 4.4 4.6 13.5 10.0 0.4 0.0 7.1 0.0 12.6 13.6 2.9 0.0 3.0 1.6 0.0 56.8 1.7 0.0 0.3 0.3 0.2 0.3 0.0 0.5 2.8 0.5 2.8 2.0 0.1 0.0 0.1 0.1 0.0 1.2 0.0 0.6 0.1 17.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.8 0.0 2.6 0.0 0.0 3.8 0.0 5.4 1.2 0.7 0.0 0.7 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 7.1 13.6 0.0 1.1 0.4 1.5 5.8 0.0 0.0 0.1 5.1 0.2 12.6 0.0 0.0 0.1 2.9 1.1 1.5 0.6 1.8 0.9 1.9 0.8 1.6 6.4 0.0 0.0 0.0 1.7 5.5 2.7 1.0 3.1 30.6 0.0 1.2 5.2 0.0 0.1 0.0 17.7 7.6 7.1 0.0 0.0 3.8 0.1 7.6 1.2 0.0 0.0 0.3 25.4 1.7 3.7 0.3 9.4 0.3 0.0 0.0 1.0 0.7 1.1 3.7 0.0 2.1 0.1 0.3 6.5 2.1 0.3 1.7 1.8 0.0 18.5 0.6 3.1 PDGFRA "CD140a, GAS9, PDGFR2" ENSG00000134853 "Platelet derived growth factor receptor alpha" P16234 4 54229097-54298247 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Chemotaxis, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 81.5" "Group enriched" "Detected in many" 9 "Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4" "Cancer enhanced" "Detected in all" "glioma: 30.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004947, CAB018143" Supported Approved "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 150000 "Nucleoplasm, Plasma membrane, Cell Junctions" "CAB018143: AB_2162351, HPA004947: AB_2732399" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "unprognostic (4.59e-3)" "unprognostic (1.60e-1)" "unprognostic (8.92e-2)" "prognostic favorable (9.33e-4)" "unprognostic (1.24e-1)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (2.18e-2)" "unprognostic (2.18e-1)" "unprognostic (7.01e-2)" "prognostic unfavorable (9.79e-6)" "unprognostic (9.58e-3)" "unprognostic (9.87e-2)" "unprognostic (2.16e-2)" "unprognostic (1.72e-3)" 35.0 12.4 12.6 16.1 7.6 0.9 17.2 2.4 20.1 33.2 19.1 9.2 6.4 9.6 27.6 14.6 21.9 22.5 16.2 15.3 8.9 7.4 22.8 8.4 24.1 26.9 9.2 4.0 81.5 6.8 1.6 2.1 25.1 7.2 18.6 15.2 19.2 8.5 8.3 11.9 7.0 17.4 19.7 8.8 51.6 13.6 19.0 9.3 0.5 11.3 12.8 4.3 35.9 24.6 0.9 0.4 2.5 0.4 0.3 0.8 0.3 0.0 0.0 0.2 0.1 82.8 38.8 0.1 4.3 48.0 0.0 0.1 11.5 0.0 0.1 0.1 33.4 0.1 0.1 3.3 0.0 0.0 0.4 0.1 0.1 0.1 0.2 28.0 0.0 0.0 70.4 0.0 5.5 0.0 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.6 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 6.7 0.0 0.1 0.0 0.3 0.1 0.0 0.1 15.2 0.5 16.6 0.0 0.0 0.0 0.1 0.4 0.0 0.3 2.5 0.4 0.2 0.5 0.2 0.2 0.6 0.8 0.4 0.0 0.9 0.7 0.4 2.3 0.3 0.3 0.4 0.2 0.3 12.6 7.6 2.4 7.3 8.9 7.4 9.2 4.0 7.2 9.3 0.0 0.3 0.9 0.3 15.1 0.7 4.0 0.0 0.0 0.0 0.0 0.0 1.3 1.7 2.9 1.6 3.3 0.0 0.0 5.8 1.2 171.4 0.4 0.0 0.8 2.8 0.0 0.0 38.1 0.6 3.7 416.6 1.6 21.9 8.2 0.0 18.3 12.2 0.0 384.4 0.0 0.4 0.0 13.2 1.1 3.5 13.8 1.1 0.0 0.0 0.8 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Cell type enhanced" "Detected in many" 11 "Fibroblasts: 36.0;Leydig cells: 69.0;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "AN3-CA: 49.5;BJ hTERT+: 40.1;HSkMC: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" NA NA "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA052801: AB_2681956" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.5 0.2 49.5 1.5 0.6 3.2 0.9 40.1 1.8 8.0 0.2 0.0 0.0 0.2 0.6 6.0 0.0 2.7 0.2 1.0 0.0 3.0 0.0 1.4 1.0 3.8 0.0 0.0 21.9 0.0 2.2 0.0 0.0 3.3 0.4 0.0 0.6 0.2 3.2 0.0 0.1 2.4 0.2 0.7 0.0 0.0 0.1 0.2 2.9 0.1 0.3 0.3 0.3 0.8 3.0 0.1 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.4 11.7 0.4 2.2 0.0 0.0 3.4 0.0 0.0 14.1 0.0 2.5 19.2 2.7 0.1 0.0 6.4 17.2 36.0 1.7 0.0 0.0 2.7 0.0 1.2 2.5 0.0 3.1 69.0 0.3 10.1 2.8 1.0 1.3 4.9 0.0 66.4 0.0 0.4 0.0 6.1 0.5 1.0 8.7 8.1 0.0 0.2 0.3 PDHA1 PDHA ENSG00000131828 "Pyruvate dehydrogenase E1 alpha 1 subunit" P08559 X 19343893-19361705 "Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.3" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 422.4;Distal tubular cells: 300.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria "Intracellular and membrane" NA NA 15000 Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" "unprognostic (5.71e-3)" "unprognostic (2.46e-3)" "unprognostic (5.71e-2)" "unprognostic (3.36e-3)" "unprognostic (3.12e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-2)" "unprognostic (4.28e-1)" "unprognostic (1.01e-1)" "unprognostic (7.01e-3)" "unprognostic (6.90e-2)" "unprognostic (8.68e-2)" "prognostic favorable (1.13e-7)" "unprognostic (3.72e-2)" "unprognostic (3.03e-1)" "unprognostic (1.92e-2)" "unprognostic (9.06e-2)" 22.5 16.1 14.7 11.7 24.3 20.4 14.7 18.6 25.0 12.3 28.6 13.0 27.7 22.7 13.0 21.6 17.2 12.4 11.8 89.3 15.5 12.2 36.6 26.6 10.5 8.9 14.8 19.9 12.2 28.7 25.0 11.6 14.9 19.0 10.8 28.2 12.7 41.8 18.3 107.3 12.7 21.1 21.2 12.7 11.5 24.9 6.3 12.0 11.3 15.0 44.9 14.9 13.1 12.4 39.4 45.1 34.8 46.1 35.5 36.6 31.9 25.6 31.9 23.1 24.3 22.4 17.2 28.4 17.7 15.8 36.7 28.4 45.4 16.5 43.8 13.2 21.3 49.1 33.5 70.9 30.7 38.7 14.5 39.5 21.7 54.9 39.9 23.8 34.7 17.8 22.1 28.6 33.8 33.6 18.6 22.3 27.4 19.1 18.6 25.6 33.9 28.9 35.6 23.5 47.1 55.8 29.9 38.8 53.6 63.2 26.2 12.8 13.6 28.2 35.8 32.0 52.0 37.7 24.4 13.8 19.0 17.1 51.6 22.4 15.8 16.2 29.0 17.9 24.3 16.4 34.8 35.0 24.2 30.3 46.1 36.6 39.4 29.4 32.8 45.1 29.3 29.0 30.6 6.1 35.5 39.1 29.8 31.1 31.9 14.7 24.3 18.6 25.0 15.5 12.2 14.8 19.9 19.0 12.0 41.7 37.7 36.5 48.9 26.6 58.2 422.4 79.0 26.8 50.0 144.8 31.4 91.3 300.1 74.7 2.0 28.6 76.1 23.3 52.1 102.6 45.2 31.9 42.6 65.5 65.3 23.8 40.3 16.0 21.0 2.9 32.8 35.5 54.0 51.3 52.9 37.8 43.3 57.5 38.2 164.1 60.9 32.3 48.4 17.4 13.0 29.2 111.6 30.9 97.8 51.0 PDHA2 PDHAL ENSG00000163114 "Pyruvate dehydrogenase E1 alpha 2 subunit" P29803 4 95840019-95841474 "Citric acid cycle related proteins, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 60.5" "Group enriched" "Detected in some" 6 "Early spermatids: 311.1;Late spermatids: 202.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047487, HPA047864, HPA063053" Approved Supported Mitochondria NA NA Mitochondria "HPA047487: AB_2680066, HPA047864: AB_2680190, HPA063053: AB_2684931" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 311.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.7 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 45.9 1.6 0.0 0.0 0.0 0.0 0.0 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 13.5 14.9 13.4 8.6 17.2 4.2 10.4 13.9 23.3 9.2 13.3 10.6 9.3 12.2 8.9 8.6 10.9 6.7 7.7 46.1 14.4 12.8 15.0 25.7 7.8 6.8 14.7 14.1 7.7 13.1 14.6 14.7 15.8 22.1 12.0 12.7 8.9 12.4 14.1 70.5 8.8 12.3 11.5 12.0 6.6 13.7 15.7 9.0 5.9 9.1 19.0 8.7 13.0 10.7 12.8 19.5 12.1 21.7 15.0 14.9 9.8 9.1 24.0 13.9 5.5 10.2 12.1 13.6 17.1 14.0 19.4 18.9 31.0 8.5 12.6 11.2 14.4 22.7 17.8 26.9 14.4 19.3 11.3 22.5 11.8 25.3 35.6 22.2 22.3 14.0 12.3 17.9 10.6 14.5 11.2 14.0 10.8 25.3 11.6 15.2 15.6 13.8 13.8 11.3 25.2 14.4 12.1 24.9 10.9 29.0 24.1 14.7 10.7 15.1 22.9 23.4 14.5 25.7 13.8 9.7 14.4 16.2 14.8 18.9 11.1 22.0 15.6 11.3 11.0 14.5 8.6 13.6 12.1 11.5 15.0 10.8 12.8 10.9 9.4 19.5 11.7 13.3 9.6 2.8 15.0 21.7 5.2 14.9 9.8 13.4 17.2 13.9 23.3 14.4 12.8 14.7 14.1 22.1 9.0 32.8 21.1 9.0 18.1 23.1 25.5 117.0 20.4 18.7 19.4 5.2 27.5 53.6 54.7 18.3 35.0 10.9 12.8 23.3 12.6 28.3 19.4 19.1 5.7 22.1 23.1 19.1 8.6 9.8 15.0 31.1 10.0 15.5 20.3 28.9 16.0 18.1 13.9 14.4 12.7 22.7 23.2 0.0 20.9 40.9 33.4 22.2 69.5 10.4 19.0 16.9 PDIA2 "PDA2, PDI, PDIP, PDIR" ENSG00000185615 "Protein disulfide isomerase family A member 2" Q13087 16 283152-287215 "Enzymes, Predicted intracellular proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "pancreas: 286.5" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 253.2" "Cancer enriched" "Detected in many" 5 "pancreatic cancer: 28.6" "Region enhanced" "Detected in many" "cerebellum: 15.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.2;HEK 293: 11.6;Hep G2: 8.6;Karpas-707: 4.0;MCF7: 6.1;SH-SY5Y: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051692, HPA053492" Enhanced "Intracellular and membrane" NA NA "HPA051692: AB_2681575, HPA053492: AB_2682169" "unprognostic (3.46e-2)" "unprognostic (7.98e-3)" "unprognostic (3.01e-2)" "unprognostic (1.30e-1)" "unprognostic (2.21e-1)" "unprognostic (2.17e-2)" "unprognostic (6.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.98e-1)" "unprognostic (1.76e-1)" "unprognostic (4.42e-2)" "unprognostic (2.90e-2)" "unprognostic (1.58e-14)" "unprognostic (3.06e-2)" "unprognostic (1.66e-1)" "unprognostic (8.75e-2)" "unprognostic (2.87e-2)" 0.3 0.3 2.1 0.2 1.5 0.3 0.2 15.3 3.0 0.2 0.7 4.3 0.2 2.9 0.2 0.3 0.2 0.2 0.8 0.4 2.8 3.0 0.2 0.2 0.2 0.2 4.0 0.5 0.4 286.5 0.2 0.2 0.5 2.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 1.0 0.2 5.4 0.2 10.2 0.3 2.8 0.1 0.2 0.2 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.1 0.1 0.1 5.2 0.2 0.7 0.1 11.6 0.0 0.3 8.6 1.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.2 0.0 0.4 4.0 0.2 6.1 0.2 0.6 0.4 2.1 0.0 0.1 0.0 1.1 0.0 0.0 2.2 5.0 0.0 0.1 0.0 0.7 1.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 1.5 15.3 3.0 2.8 3.0 4.0 0.5 2.2 2.8 0.0 0.3 0.0 0.0 0.5 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 253.2 0.6 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.0 0.2 39.2 0.3 0.4 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.9 0.0 PDIA4 "ERP70, ERP72" ENSG00000155660 "Protein disulfide isomerase family A member 4" P13667 7 149003062-149028641 "Enzymes, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 164.3" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 542.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006139, HPA006140, CAB017368" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 12000000 "Endoplasmic reticulum" "CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257" "unprognostic (1.98e-1)" "unprognostic (1.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.11e-2)" "unprognostic (5.11e-2)" "unprognostic (3.24e-3)" "unprognostic (6.08e-3)" "unprognostic (3.20e-2)" "prognostic unfavorable (5.20e-9)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" 17.6 13.0 7.7 25.6 11.9 7.4 27.4 5.1 7.9 25.5 20.9 12.1 28.8 18.2 19.4 46.3 15.2 20.8 28.1 16.9 7.3 8.0 27.7 164.3 19.1 29.1 11.6 6.2 19.4 76.3 7.0 19.1 24.7 12.0 18.0 21.9 7.8 36.4 26.5 5.8 10.1 21.3 17.8 13.9 27.9 23.7 11.5 11.3 19.2 89.8 11.9 24.3 17.4 22.6 26.6 63.3 16.2 21.2 21.5 35.9 34.5 32.4 30.9 33.6 93.9 30.7 21.9 48.7 45.7 30.6 26.2 42.8 25.6 87.8 23.4 102.6 37.5 72.2 21.3 22.6 43.3 23.1 16.6 13.3 11.2 8.9 56.1 41.2 25.5 31.7 21.5 19.4 28.7 23.1 34.2 53.2 12.0 18.3 63.8 23.0 35.5 24.3 29.1 50.1 66.4 18.0 16.0 26.1 56.6 30.6 25.5 10.7 28.2 41.5 29.9 15.9 41.9 17.0 19.7 29.0 20.7 11.7 50.1 32.1 48.6 21.8 16.4 48.3 30.2 70.3 16.2 20.1 12.1 34.3 21.2 35.9 26.6 22.6 26.7 19.4 15.1 21.5 22.7 2.7 21.5 21.0 63.3 16.6 34.5 7.7 11.9 5.1 7.9 7.3 8.0 11.6 6.2 12.0 11.3 26.8 33.4 29.0 71.4 30.8 3.3 20.4 96.8 65.6 44.3 40.1 3.9 152.3 13.3 102.2 2.7 35.1 89.5 46.7 79.9 277.0 90.5 103.6 57.6 542.5 131.4 0.0 59.1 95.8 80.7 3.2 54.7 53.4 82.7 48.7 104.5 19.3 96.2 87.1 40.3 54.4 6.1 32.3 34.2 53.4 71.9 25.0 192.7 54.6 97.0 59.2 PDIA5 "FLJ30401, PDIR" ENSG00000065485 "Protein disulfide isomerase family A member 5" Q14554 3 123067062-123225227 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.0" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 12.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030353, HPA030355" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA 2900000 "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA030353: AB_10599734, HPA030355: AB_10602200" "unprognostic (8.81e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-2)" "prognostic favorable (4.55e-4)" "unprognostic (4.34e-2)" "unprognostic (2.10e-2)" "unprognostic (7.38e-2)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (4.02e-2)" "unprognostic (1.55e-1)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.09e-11)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-2)" "unprognostic (4.06e-3)" 11.6 17.1 2.6 11.2 3.1 6.3 9.3 1.0 4.0 10.0 11.0 2.4 10.9 5.6 12.2 17.1 6.7 9.1 22.2 7.2 2.5 1.2 11.0 66.0 14.4 7.1 2.2 1.8 11.4 18.3 5.2 12.1 29.1 1.9 14.3 10.8 12.7 10.8 7.6 8.1 6.1 8.2 9.5 2.3 8.6 17.6 18.0 2.5 3.2 18.2 5.5 7.9 7.8 6.9 3.2 12.8 0.3 9.0 0.5 2.4 2.3 8.2 5.1 6.4 7.7 29.4 26.7 34.1 15.8 26.5 8.8 24.4 16.3 7.6 0.0 20.6 24.4 5.7 4.4 2.8 9.6 9.4 0.2 3.1 3.6 1.5 19.4 12.2 9.1 0.6 22.8 14.5 6.0 12.6 9.5 29.8 3.5 4.6 21.6 6.0 10.1 2.4 10.6 4.7 18.9 5.3 2.3 4.6 22.8 7.4 4.8 6.9 4.2 7.7 8.6 13.5 10.9 7.5 11.1 16.6 2.3 7.3 10.6 4.2 6.4 1.7 3.7 7.3 7.2 7.7 0.0 9.0 0.3 1.4 2.2 2.4 3.2 1.0 0.9 5.4 0.8 0.6 0.6 0.2 0.5 0.4 12.8 0.0 2.3 2.6 3.1 1.0 4.0 2.5 1.2 2.2 1.8 1.9 2.5 17.9 27.8 1.5 3.6 4.4 9.3 2.0 25.5 8.1 13.6 5.2 37.3 39.8 0.0 28.0 1.1 21.8 3.3 0.0 25.3 119.9 23.6 13.9 3.5 42.3 10.8 0.0 8.1 37.4 8.4 1.5 22.5 4.5 8.5 1.8 26.1 2.0 13.8 3.5 20.8 4.9 29.6 12.9 7.3 1.2 1.5 3.6 42.0 2.2 16.3 4.3 PDILT PDIA7 ENSG00000169340 "Protein disulfide isomerase like, testis expressed" Q8N807 16 20359170-20404737 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Chaperone, Developmental protein, Isomerase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "stomach 1: 42.3;testis: 26.5" "Cell type enriched" "Detected in some" 7 "Early spermatids: 103.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 6.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "HBEC3-KT: 15.0;hTCEpi: 12.4;hTERT-HME1: 3.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041913 Approved "Intracellular and membrane" NA NA "HPA041913: AB_10795644" "unprognostic (1.99e-1)" "unprognostic (6.09e-2)" "unprognostic (2.05e-3)" "unprognostic (2.63e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.6 0.1 0.0 0.6 0.1 0.1 0.1 42.3 26.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.2 6.4 3.0 0.9 2.2 0.8 0.4 0.1 0.3 1.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.4 0.1 0.0 0.2 0.2 0.3 0.0 15.0 0.1 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.2 12.4 0.0 3.8 0.0 0.0 0.0 0.6 0.4 0.0 0.2 0.3 0.2 0.2 0.1 0.5 0.1 0.0 0.2 0.1 0.1 0.3 0.4 0.0 0.2 0.2 0.0 0.2 0.1 0.0 0.1 0.2 0.4 0.2 0.2 0.3 0.1 0.1 0.0 1.1 1.8 0.5 0.3 0.3 0.4 0.4 1.2 0.7 0.5 0.4 0.9 0.4 0.8 3.0 2.2 0.9 6.4 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 103.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 101.0" "Cell type enhanced" "Detected in many" 6 "Proximal tubular cells: 118.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favorable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 20.6 26.1 17.2 5.2 27.5 3.2 10.8 53.7 34.4 10.1 16.1 16.1 10.1 15.5 13.1 69.8 12.5 14.4 11.5 51.7 18.2 13.0 33.7 27.8 9.0 5.7 14.6 20.9 27.7 24.1 16.9 7.5 8.6 14.2 12.7 12.4 19.5 14.0 16.5 101.0 10.6 16.5 15.1 9.9 7.8 13.6 7.2 11.4 6.2 15.6 31.4 7.4 13.8 9.4 11.3 20.1 8.9 12.9 16.5 17.4 12.2 6.4 9.2 11.1 10.0 11.8 8.9 1.2 7.0 10.4 10.5 10.2 0.8 7.0 8.1 11.7 19.5 7.1 3.1 7.4 2.8 10.3 16.3 10.3 7.2 9.1 6.8 6.3 0.0 7.8 18.7 10.8 6.8 0.5 18.5 9.1 10.4 2.9 8.1 5.9 8.2 6.0 0.0 2.4 19.5 9.0 9.1 24.9 10.9 5.7 5.5 7.4 11.2 9.9 3.1 4.7 14.2 18.3 7.2 4.7 12.3 10.1 8.4 5.1 16.0 15.1 4.4 18.0 2.6 7.9 8.9 12.9 6.8 14.0 9.8 11.1 11.1 12.5 14.8 14.2 11.3 14.6 15.0 2.2 16.5 10.5 20.1 17.4 12.2 17.2 27.5 53.7 34.4 18.2 13.0 14.6 20.9 14.2 11.4 8.9 9.3 13.6 13.9 13.5 20.8 5.0 10.2 1.4 11.4 19.2 5.9 15.1 49.7 8.0 7.3 8.3 46.6 0.0 7.9 3.4 19.5 7.6 1.1 39.8 16.7 41.3 13.3 13.5 13.7 15.0 22.5 7.9 23.6 15.4 45.3 33.6 7.9 43.6 49.5 118.5 9.2 19.4 12.1 3.3 4.4 16.4 6.6 15.8 37.1 8.4 PDK4 ENSG00000004799 "Pyruvate dehydrogenase kinase 4" Q16654 7 95583499-95596491 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 351.0;skeletal muscle: 497.0" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 766.1;Collecting duct cells: 359.4;Kupffer cells: 351.0" "Cancer enhanced" "Detected in all" "renal cancer: 107.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 11 "classical monocyte: 14.2;eosinophil: 15.6;intermediate monocyte: 26.1;myeloid DC: 7.1;non-classical monocyte: 15.6" "Group enriched" "Detected in many" 11 "dendritic cells: 7.1;granulocytes: 15.6;monocytes: 26.1" "Cell line enriched" "Detected in some" 7 "ASC diff: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056731 Approved NA NA "HPA056731: AB_2683218" "unprognostic (3.18e-3)" "unprognostic (1.98e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (5.15e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-3)" "unprognostic (3.47e-1)" "unprognostic (6.38e-2)" "unprognostic (2.24e-3)" "unprognostic (1.87e-2)" "unprognostic (8.75e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.80e-4)" "unprognostic (9.15e-2)" "unprognostic (4.20e-2)" "unprognostic (1.12e-1)" 90.7 41.9 6.9 5.9 14.6 0.4 49.1 2.5 9.1 12.3 30.9 9.0 150.6 13.6 10.7 13.7 29.0 14.7 15.6 351.0 9.2 3.7 27.7 39.5 14.1 6.1 18.2 2.4 46.6 102.9 0.8 8.1 19.4 26.1 29.3 8.4 4.4 8.4 150.6 497.0 10.2 46.2 20.7 13.9 19.0 21.2 10.8 17.4 1.0 13.4 12.3 2.5 23.8 46.4 0.7 7.1 15.6 26.1 1.4 0.0 4.7 0.0 8.0 0.3 2.0 107.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.7 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.5 0.1 0.6 0.0 0.6 1.6 0.5 0.2 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 14.2 15.6 0.0 26.1 0.0 0.1 0.0 0.0 7.1 0.7 0.0 0.0 1.0 1.4 15.6 0.2 0.0 4.7 6.9 14.6 2.5 9.1 9.2 3.7 18.2 2.4 26.1 17.4 29.8 13.6 12.6 245.0 9.3 0.0 766.1 28.1 96.4 52.4 359.4 0.0 2.7 11.6 4.3 10.2 89.9 112.9 0.0 4.7 0.7 44.7 113.9 4.7 93.7 42.3 0.0 53.1 160.8 351.0 2.5 124.3 29.1 86.0 1.8 47.0 11.6 8.2 42.1 42.1 35.5 0.3 161.7 181.3 0.2 0.5 8.2 9.2 5.7 27.3 131.1 PDLIM2 ENSG00000120913 "PDZ and LIM domain 2" Q96JY6 8 22578279-22598025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 81.6" "Cell type enhanced" "Detected in many" 12 "Syncytiotrophoblasts: 663.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003880 Approved Supported "Actin filaments,Focal adhesion sites" NA NA "Actin filaments, Focal adhesion sites" "HPA003880: AB_1855149" "unprognostic (1.04e-1)" "unprognostic (3.53e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-3)" "unprognostic (9.33e-2)" "unprognostic (3.69e-2)" "unprognostic (4.55e-2)" "unprognostic (1.79e-2)" "unprognostic (1.22e-3)" "unprognostic (1.52e-1)" "unprognostic (3.37e-1)" "prognostic unfavorable (1.37e-7)" "unprognostic (6.14e-2)" "unprognostic (8.17e-2)" "unprognostic (3.47e-2)" "unprognostic (3.08e-3)" 10.4 7.0 5.4 10.9 5.9 6.0 10.4 16.2 7.9 19.8 27.6 8.4 7.7 17.8 11.1 11.0 41.1 9.0 19.9 10.1 6.3 5.0 20.9 16.4 26.5 17.2 6.9 7.1 13.1 15.6 2.2 5.7 42.3 10.8 11.2 3.2 11.3 12.4 10.0 53.5 48.8 32.2 16.2 10.1 81.6 5.6 8.5 5.0 7.5 5.5 23.4 21.0 12.7 23.2 9.6 12.4 49.3 20.2 8.7 16.4 10.2 22.9 14.2 9.6 16.9 19.0 32.6 10.9 36.4 27.3 26.2 26.6 16.2 3.8 9.5 10.3 32.8 4.8 11.7 5.4 24.8 5.1 0.0 3.7 2.9 9.3 11.7 24.1 3.3 23.1 34.7 3.1 12.8 3.5 20.7 14.3 5.3 0.8 6.2 17.7 12.1 4.2 3.9 7.9 9.7 1.4 3.4 1.8 1.0 4.6 4.7 3.0 7.2 7.6 20.8 32.9 6.0 7.3 6.7 17.7 28.5 29.4 34.1 16.6 0.1 0.2 3.0 29.4 13.2 20.9 22.7 15.5 49.3 16.4 20.2 14.6 8.4 12.4 16.1 12.4 9.6 8.6 12.2 32.9 8.7 19.4 8.0 12.8 10.2 5.4 5.9 16.2 7.9 6.3 5.0 6.9 7.1 10.8 5.0 71.5 9.6 36.7 11.1 84.4 2.3 7.6 22.9 0.0 18.2 17.4 0.0 44.5 13.3 24.7 0.8 39.4 132.3 23.3 23.2 92.2 139.6 25.2 27.6 40.4 50.0 3.2 1.2 92.7 45.1 1.5 122.3 51.2 45.5 1.8 8.4 19.8 61.5 119.3 205.1 104.7 3.1 58.2 92.0 0.7 4.5 88.1 663.2 89.7 11.3 15.2 PDLIM3 ALP ENSG00000154553 "PDZ and LIM domain 3" Q53GG5 4 185500660-185535612 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 447.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 159.2;Ductal cells: 168.1;Melanocytes: 118.1;Peritubular cells: 184.2;Smooth muscle cells: 182.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 51.1;RH-30: 12.6;U-266/70: 41.1;U-266/84: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004749 Enhanced Supported Cytosol NA NA 270000 Cytosol "HPA004749: AB_1855150" "unprognostic (2.75e-1)" "unprognostic (3.85e-2)" "unprognostic (3.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.08e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (9.46e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.97e-7)" "unprognostic (1.64e-3)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.78e-3)" 7.8 1.2 1.6 5.2 1.9 0.1 3.7 2.2 1.0 6.6 16.5 1.4 7.9 2.3 22.2 17.0 27.2 9.3 9.9 29.5 1.5 1.6 0.8 0.8 5.6 1.4 1.6 1.0 11.1 2.1 0.1 1.9 2.2 1.6 15.2 3.6 4.8 5.3 18.7 447.7 1.0 6.1 49.5 1.4 3.4 10.2 3.9 0.7 0.1 6.2 87.3 9.1 28.4 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.4 1.9 5.6 0.0 0.0 4.0 0.0 1.2 0.0 5.1 4.2 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.9 0.0 0.4 0.0 12.6 0.1 0.0 0.0 7.6 5.7 0.0 0.0 3.0 1.5 0.3 0.0 2.8 0.0 3.0 0.0 2.6 41.1 11.6 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 2.2 1.0 1.5 1.6 1.6 1.0 1.6 0.7 8.9 5.9 0.0 9.4 7.9 7.2 159.2 7.6 5.3 3.4 0.0 11.8 1.4 0.0 168.1 0.3 50.8 0.0 0.0 14.6 2.1 51.6 14.4 0.0 0.6 1.3 4.8 3.4 65.1 2.7 1.5 18.1 4.4 118.1 5.4 0.0 30.9 51.1 0.0 184.2 0.0 39.4 103.5 182.4 2.8 12.4 6.1 10.2 0.0 0.0 4.1 PDLIM5 "Enh, LIM" ENSG00000163110 "PDZ and LIM domain 5" Q96HC4 4 94451857-94668227 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 129.6;skeletal muscle: 173.0" "Cell type enriched" "Detected in all" 8 "Cardiomyocytes: 1784.7" "Cancer enriched" "Detected in all" 8 "prostate cancer: 132.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 51.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.1" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013511, HPA016740, HPA020026" Enhanced Supported "Nucleoplasm,Plasma membrane,Focal adhesion sites" NA NA 2200000 "Nucleoplasm, Plasma membrane, Focal adhesion sites" "CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154" "unprognostic (6.20e-2)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.08e-2)" "unprognostic (6.61e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (2.46e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-2)" "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.11e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" "unprognostic (1.04e-1)" 11.6 4.8 6.2 4.2 6.1 8.7 9.8 3.4 5.8 12.7 11.0 3.7 7.1 5.6 37.5 12.9 14.0 10.2 11.0 129.6 5.3 5.2 12.9 13.9 5.6 5.3 5.4 4.5 10.3 8.1 3.4 6.8 18.9 10.2 15.3 5.4 12.6 15.3 12.5 173.0 5.6 15.8 22.1 4.9 7.0 5.6 5.5 3.7 1.0 5.3 52.9 9.5 17.7 7.1 3.2 5.6 51.1 12.2 2.7 3.9 3.8 8.2 24.4 9.5 3.7 21.0 14.4 3.7 20.1 16.7 11.5 9.3 22.5 18.3 3.3 20.6 20.1 5.9 8.5 12.9 18.8 19.3 5.8 5.4 12.0 15.9 8.5 30.3 3.9 10.8 19.3 16.6 27.6 21.5 51.4 25.9 3.4 5.1 3.6 24.5 8.1 4.0 1.3 3.2 18.1 10.2 1.9 7.0 2.9 12.9 26.4 4.7 6.3 11.0 25.1 5.6 8.0 2.9 1.2 32.4 30.1 4.8 13.0 12.2 2.5 3.2 3.3 16.4 2.8 7.0 51.1 6.8 5.9 3.8 11.8 3.1 3.2 3.7 3.9 5.6 2.5 2.5 3.2 6.8 2.7 12.2 1.9 3.4 3.8 6.2 6.1 3.4 3.9 5.3 5.2 5.4 4.5 10.2 3.7 41.7 23.4 12.7 232.1 172.6 4.3 1784.7 58.6 30.8 37.5 47.1 29.5 9.2 11.6 82.1 14.6 128.1 146.3 23.3 81.9 91.7 90.4 234.4 50.8 159.4 34.4 1.6 105.0 135.1 57.1 6.8 38.3 60.2 59.1 29.7 89.1 79.1 115.5 83.5 62.6 63.8 35.6 77.6 141.3 13.2 30.2 137.1 19.9 15.0 51.0 185.7 PDLIM7 ENIGMA ENSG00000196923 "PDZ and LIM domain 7" Q9NR12 5 177483394-177497606 "Predicted intracellular proteins" "Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 159.6" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 173.8;Exocrine glandular cells: 213.2;Pancreatic endocrine cells: 210.7;Peritubular cells: 209.7;Sertoli cells: 161.7;Smooth muscle cells: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 27.2;eosinophil: 20.5;neutrophil: 80.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 80.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018794, HPA048815" Approved Enhanced "Actin filaments,Focal adhesion sites" NA NA 7600000 "Actin filaments, Focal adhesion sites" "HPA018794: AB_1855155, HPA048815: AB_2680530" "unprognostic (7.70e-3)" "unprognostic (3.75e-2)" "unprognostic (9.27e-3)" "prognostic unfavorable (5.45e-4)" "unprognostic (1.40e-1)" "unprognostic (3.48e-2)" "unprognostic (9.18e-3)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.01e-2)" "unprognostic (3.10e-1)" "unprognostic (7.24e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (6.19e-10)" "unprognostic (6.72e-3)" "unprognostic (3.02e-1)" "unprognostic (1.93e-1)" "unprognostic (3.68e-2)" 12.4 5.6 3.7 21.1 9.3 12.5 8.3 0.5 5.9 54.6 76.0 3.2 42.6 9.0 85.0 35.8 33.9 35.5 52.3 11.1 3.8 5.0 8.3 2.4 11.6 8.9 3.5 5.8 28.2 3.1 2.1 10.3 11.5 5.6 42.0 7.6 17.6 9.1 61.7 159.6 5.3 16.5 129.5 3.1 12.7 27.0 11.7 2.4 3.7 5.4 24.9 6.5 67.8 19.6 1.8 4.8 80.6 8.4 0.4 1.4 3.9 24.9 5.0 23.9 18.8 6.5 11.9 24.2 47.9 26.1 27.3 19.6 9.6 22.6 4.5 49.5 29.3 15.0 12.1 3.9 32.4 6.3 6.2 5.8 14.7 16.3 9.0 17.7 7.8 49.6 25.8 5.5 21.8 10.5 38.7 16.3 4.1 10.9 3.2 19.7 19.3 1.4 17.3 16.5 4.8 21.5 29.1 21.3 2.8 18.2 5.1 3.7 7.8 18.7 3.6 9.1 8.4 5.1 7.0 58.6 32.9 35.7 12.5 43.7 0.8 0.9 5.3 15.6 8.4 7.4 27.2 8.4 20.5 0.9 3.9 1.1 1.8 0.6 1.4 4.8 1.0 0.6 0.7 80.6 0.4 4.9 0.3 1.2 3.9 3.7 9.3 0.5 5.9 3.8 5.0 3.5 5.8 5.6 2.4 0.0 1.1 5.9 34.1 12.9 5.2 16.1 5.1 4.0 2.3 24.4 13.7 10.1 21.6 173.8 19.2 30.0 1.3 0.0 213.2 44.5 47.3 13.0 17.3 0.9 64.5 7.9 3.4 50.3 15.5 30.6 41.4 23.5 10.1 34.3 1.9 12.4 210.7 35.1 209.7 6.7 20.4 161.7 171.6 10.9 35.2 13.8 11.8 14.9 1.7 21.1 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 71.4;Early spermatids: 99.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 39.5;hTERT-RPE1: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 7.9 3.9 8.6 3.6 7.1 13.1 2.8 6.3 7.0 7.4 8.7 4.1 29.6 4.4 21.2 10.0 39.5 17.7 3.6 5.3 11.0 0.4 1.8 2.1 4.9 1.4 8.2 1.0 3.0 8.4 10.5 12.6 20.2 39.3 16.7 4.0 0.7 7.3 9.0 1.9 6.2 3.2 3.9 8.6 5.1 1.5 5.1 0.8 5.1 5.5 0.8 3.7 4.1 0.4 19.3 7.3 1.3 1.2 29.6 9.0 5.8 21.0 7.4 4.1 1.7 3.7 11.5 3.7 7.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 11.9 5.6 13.4 11.2 11.6 34.7 71.4 22.9 22.7 17.0 15.7 7.9 3.5 5.0 24.3 99.2 14.7 6.0 0.0 11.9 3.2 11.6 13.3 5.8 2.5 5.7 9.5 9.8 14.1 20.8 22.0 10.6 16.2 10.1 2.8 5.2 19.0 22.2 7.0 12.7 8.6 10.6 6.5 12.7 7.2 9.7 9.5 3.7 10.1 8.9 17.0 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 30.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 72.6 1.7 0.0 0.1 50.4 9.0 0.0 0.1 9.2 0.0 0.0 0.0 44.7 0.0 0.0 6.1 16.8 3.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.1 48.3 8.5 7.3 0.1 0.0 0.0 0.0 0.1 18.1 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 98.3 9.1 0.0 29.7 12.9 1.2 6.9 0.0 6.7 29.6 0.0 3.9 1.8 0.0 0.4 0.5 7.4 0.0 0.0 0.0 1.6 108.5 3.5 1.1 0.0 6.5 0.0 0.0 7.4 0.0 0.4 18.7 4.1 6.8 202.8 0.0 85.7 0.5 0.0 59.1 0.0 2.8 0.0 6.2 0.9 8.6 6.0 2.4 0.0 0.0 3.4 PDSS1 "COQ1, TPRT, TPT" ENSG00000148459 "Decaprenyl diphosphate synthase subunit 1" Q5T2R2 10 26697659-26746798 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Isoprene biosynthesis, Ubiquinone biosynthesis" Transferase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 22.4;lymphoid tissue: 31.8" "Cell type enhanced" "Detected in many" 5 "Undifferentiated cells: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038032, HPA042741" Uncertain Approved Cytosol NA NA Cytosol "HPA038032: AB_10670650, HPA042741: AB_2678139" "unprognostic (1.41e-2)" "unprognostic (3.92e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (1.66e-4)" "unprognostic (6.79e-3)" "unprognostic (5.43e-2)" "prognostic unfavorable (1.25e-5)" "unprognostic (2.47e-2)" "unprognostic (9.43e-2)" "unprognostic (2.33e-2)" "unprognostic (2.20e-1)" "unprognostic (4.11e-2)" "unprognostic (2.99e-3)" "unprognostic (2.93e-3)" "unprognostic (8.85e-2)" "unprognostic (9.83e-2)" "unprognostic (6.36e-2)" 3.1 2.6 2.4 7.0 3.1 5.6 3.5 5.6 5.1 3.1 18.2 1.5 1.2 20.6 3.8 2.1 8.3 3.4 3.7 4.2 2.2 2.2 8.6 7.2 4.0 7.8 2.1 2.3 2.8 3.8 1.7 2.5 2.8 2.9 2.3 17.0 3.2 3.5 1.8 10.4 2.7 22.4 3.6 3.1 5.7 3.8 3.0 1.6 31.8 2.1 4.7 5.0 2.9 4.0 3.2 5.2 0.9 5.3 0.8 3.4 1.3 7.6 5.9 4.5 8.3 1.5 2.8 6.3 7.1 1.9 10.3 7.0 9.1 4.3 17.4 3.7 3.5 3.9 9.7 14.5 10.8 8.8 7.3 12.1 15.1 5.2 6.6 2.2 10.0 6.0 3.5 4.7 9.6 2.6 1.8 5.4 11.5 13.8 4.6 7.2 12.0 31.5 7.0 9.1 12.3 5.8 14.7 13.0 12.6 6.0 3.6 13.3 8.2 6.8 14.2 7.7 4.9 5.0 11.7 3.4 5.8 9.2 11.8 11.2 1.8 6.7 12.7 5.7 25.5 4.4 0.0 5.3 0.9 0.9 4.1 2.1 0.5 1.8 1.3 5.2 3.2 3.4 1.5 0.3 0.8 2.1 1.4 0.1 1.3 2.4 3.1 5.6 5.1 2.2 2.2 2.1 2.3 2.9 1.6 0.0 0.0 3.7 3.2 6.2 2.8 1.8 7.6 1.4 3.4 3.5 3.9 5.3 6.6 6.6 9.3 2.2 14.7 0.0 3.3 10.1 2.9 2.7 0.0 3.4 7.9 1.6 10.4 3.1 6.8 2.5 2.0 5.1 1.7 2.8 9.8 1.2 4.2 7.0 2.5 17.7 4.7 0.0 3.8 7.0 9.8 2.8 5.3 3.3 23.4 2.5 PDX1 "IDX-1, IPF1, MODY4, PDX-1, STF-1" ENSG00000139515 "Pancreatic and duodenal homeobox 1" P52945 13 27920020-27926231 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 10.4;intestine: 33.0;pancreas: 24.2" "Group enriched" "Detected in some" 10 "Cholangiocytes: 5.1;Ductal cells: 7.6;Exocrine glandular cells: 8.8;Intestinal endocrine cells: 13.3;Pancreatic endocrine cells: 3.3" "Group enriched" "Detected in many" 11 "colorectal cancer: 8.4;liver cancer: 1.9;pancreatic cancer: 8.6;stomach cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 6.2;HEK 293: 3.7;HeLa: 9.4;OE19: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025873, HPA059146" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB025873: , HPA059146: AB_2683927" "unprognostic (2.79e-2)" "unprognostic (2.22e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (6.84e-2)" "unprognostic (3.89e-2)" "unprognostic (6.75e-3)" "unprognostic (7.10e-3)" "unprognostic (3.83e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 33.0 0.0 0.0 31.1 0.1 0.0 0.1 0.1 10.4 0.1 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.0 0.1 24.2 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 17.6 0.0 0.2 0.1 4.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 6.2 3.7 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PDXDC1 KIAA0251 ENSG00000179889 "Pyridoxal dependent decarboxylase domain containing 1" Q6P996 16 14974591-15139339 "Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 91.1" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 401.3;Late spermatids: 547.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 47.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047369, HPA049121, HPA051484" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502" "unprognostic (3.67e-2)" "unprognostic (4.99e-1)" "unprognostic (1.97e-3)" "unprognostic (1.84e-1)" "unprognostic (9.08e-2)" "unprognostic (2.18e-1)" "unprognostic (6.47e-3)" "unprognostic (4.97e-2)" "unprognostic (2.43e-1)" "unprognostic (2.74e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.13e-4)" "unprognostic (4.58e-2)" "unprognostic (8.11e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 10.5 13.2 11.0 11.7 10.7 6.0 27.8 15.4 16.9 13.8 21.6 9.0 11.8 27.7 10.9 16.5 14.2 11.0 16.6 15.5 11.5 8.1 21.9 33.8 11.2 12.7 10.2 10.0 11.2 37.4 17.2 26.0 19.6 12.8 19.6 25.3 13.7 25.2 14.7 22.1 8.8 30.9 13.1 14.9 10.6 24.6 91.1 8.7 6.9 16.3 8.2 9.5 13.4 11.1 11.0 12.8 12.0 8.3 7.7 12.6 7.8 8.0 11.8 12.2 10.2 6.8 8.3 20.3 7.6 6.7 5.6 7.8 14.5 17.6 15.4 16.7 10.1 8.1 13.2 8.6 7.7 8.2 9.4 11.8 9.3 19.9 38.0 17.9 7.3 22.3 8.6 8.1 9.8 8.3 11.1 5.9 8.4 6.8 10.1 13.3 19.7 4.8 3.9 6.0 7.9 4.5 7.5 5.0 18.3 9.0 13.1 12.6 9.0 20.4 11.7 19.5 8.1 47.4 11.5 9.1 4.4 4.0 4.8 9.8 9.5 9.2 14.9 9.0 6.2 13.9 3.2 8.0 12.0 11.0 8.3 12.6 9.2 8.0 8.9 12.8 11.0 10.0 9.4 1.1 7.7 6.6 5.9 7.0 7.8 11.0 10.7 15.4 16.9 11.5 8.1 10.2 10.0 12.8 8.7 35.7 64.2 44.4 35.2 34.0 30.0 37.5 76.5 53.5 60.3 27.9 29.5 42.4 23.2 33.3 401.3 30.8 115.5 46.7 50.6 46.8 36.2 61.2 38.1 114.3 27.4 38.1 154.8 28.3 33.9 547.7 45.5 27.9 25.3 22.6 185.7 19.3 38.0 111.2 42.8 35.6 48.6 45.3 23.4 134.2 70.5 37.3 67.5 33.0 94.5 51.0 PDXK "C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79" ENSG00000160209 "Pyridoxal kinase" O00764 21 43719094-43762307 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.9" "Group enriched" "Detected in all" 7 "Early spermatids: 1421.5;Late spermatids: 3146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030196, HPA030197, HPA030198, CAB033918" Enhanced Enhanced Nucleoplasm NA NA 870000 Nucleoplasm "CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570" "unprognostic (1.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.88e-2)" "unprognostic (1.87e-1)" "unprognostic (8.29e-2)" "unprognostic (4.31e-3)" "unprognostic (3.64e-3)" "unprognostic (1.32e-1)" "unprognostic (8.66e-2)" "unprognostic (9.34e-2)" "unprognostic (2.10e-1)" "unprognostic (3.54e-1)" "unprognostic (3.70e-2)" "unprognostic (1.31e-3)" "unprognostic (1.10e-1)" "unprognostic (4.78e-2)" "unprognostic (1.51e-3)" 28.1 13.2 37.4 8.7 36.6 13.3 13.3 21.9 38.5 9.7 13.8 11.0 15.7 16.7 9.0 13.2 11.0 12.9 8.8 11.4 26.1 30.4 22.8 17.4 20.4 9.5 24.1 22.7 16.4 17.6 25.7 20.7 12.6 20.3 10.6 11.8 7.8 18.3 13.9 5.8 14.3 22.1 8.8 10.1 7.8 15.2 68.9 10.7 3.9 13.6 7.0 11.0 9.7 8.6 2.7 2.5 1.3 7.7 1.9 3.3 2.4 17.4 21.4 3.4 6.5 8.4 11.9 4.2 6.3 9.9 6.1 5.2 17.4 27.3 5.9 6.7 9.0 8.5 13.2 6.6 17.9 4.1 6.6 5.7 6.0 23.4 12.8 16.5 5.6 8.7 16.8 17.2 6.4 7.2 10.0 2.9 2.6 10.4 13.6 5.8 11.8 0.8 10.1 9.3 17.0 8.2 6.7 2.0 16.3 26.6 21.4 3.3 3.9 26.1 24.2 9.3 1.5 8.0 7.9 5.1 4.5 8.8 6.0 5.8 8.3 3.9 3.4 18.4 16.2 4.3 1.3 4.8 0.2 1.7 4.4 3.3 1.4 1.7 1.9 2.5 2.7 2.0 1.4 1.3 1.9 7.7 1.2 1.5 2.4 37.4 36.6 21.9 38.5 26.1 30.4 24.1 22.7 20.3 10.7 74.5 71.3 17.5 132.2 25.2 41.8 39.3 25.5 21.4 31.8 96.0 21.6 37.3 152.5 146.7 1421.5 25.3 96.0 46.7 174.9 62.9 26.6 143.6 32.2 46.0 193.8 49.3 28.9 18.4 44.0 3146.3 46.3 89.3 40.5 27.1 42.8 10.9 164.5 30.9 50.9 69.5 40.4 6.5 25.8 332.6 27.9 24.8 103.8 22.4 42.8 203.8 PDXP "CIN, dJ37E16.5, FLJ32703" ENSG00000241360 "Pyridoxal phosphatase" Q96GD0 22 37658727-37666934 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.4;liver: 34.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 1.1;Enterocytes: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "plasmacytoid DC: 12.9" "Lineage enriched" "Detected in many" 8 "dendritic cells: 12.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000531 Approved NA NA 17000 "HPA000531: AB_2666018" "unprognostic (6.29e-2)" "unprognostic (7.89e-3)" "unprognostic (1.00e-1)" "unprognostic (2.89e-1)" "unprognostic (2.15e-2)" "unprognostic (3.25e-2)" "unprognostic (2.81e-1)" "unprognostic (4.44e-2)" "unprognostic (2.54e-1)" "unprognostic (1.46e-1)" "unprognostic (1.57e-3)" "unprognostic (2.76e-2)" "unprognostic (1.77e-1)" "unprognostic (3.03e-3)" "unprognostic (2.04e-1)" "unprognostic (4.66e-2)" "unprognostic (2.38e-1)" 2.4 14.8 43.5 1.7 32.0 3.0 2.5 24.9 55.4 1.7 8.3 5.3 0.8 15.4 3.7 4.1 1.0 3.4 2.7 12.9 38.1 27.7 10.2 34.7 1.3 3.9 16.4 15.8 3.5 8.4 6.1 7.9 1.0 13.6 3.3 7.6 3.8 7.1 4.2 5.7 0.9 15.8 4.8 9.1 2.6 3.3 10.4 4.6 4.2 3.4 1.0 5.4 2.2 0.7 1.5 12.9 0.5 0.4 0.8 0.9 0.1 2.8 6.8 14.1 12.4 4.5 1.1 1.7 6.6 3.1 12.1 9.5 2.6 0.3 18.4 6.8 3.3 10.4 1.4 19.1 0.1 10.4 5.6 37.9 3.1 9.7 13.8 2.9 12.6 15.5 0.4 1.2 5.9 8.7 4.7 5.6 21.8 11.2 11.1 10.8 2.4 25.7 21.0 7.2 4.2 16.7 20.0 10.2 13.5 5.3 0.3 33.0 20.8 6.4 5.4 11.7 6.4 1.3 10.0 3.3 10.5 13.1 11.1 13.3 11.5 14.6 19.6 9.9 4.0 13.2 0.0 0.3 0.5 0.9 0.4 0.1 1.5 0.3 0.6 0.6 1.4 0.3 0.1 0.4 0.8 0.2 12.9 0.3 0.1 43.5 32.0 24.9 50.6 38.1 27.7 16.4 15.8 13.6 4.6 0.0 1.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 PDYN "ADCA, PENKB, SCA23" ENSG00000101327 Prodynorphin P01213 20 1978757-1994285 "Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 55.9" "Group enriched" "Detected in some" 102 "Early spermatids: 39.7;Late spermatids: 87.7" "Group enriched" "Detected in some" 29 "glioma: 2.6;ovarian cancer: 1.6" "Region enriched" "Detected in many" 4 "basal ganglia: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;NTERA-2: 2.8;THP-1: 2.7" "Group enriched" "Detected in many" 4 "basal ganglia: 150.7;hypothalamus: 70.9" "Region enhanced" "Detected in many" "basal ganglia: 131.1" "HPA053342, CAB079777" Enhanced Supported "Secreted in brain" NA NA "CAB079777: , HPA053342: AB_2682121" "unprognostic (7.00e-2)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" "unprognostic (3.73e-2)" 0.4 0.4 13.2 0.4 55.9 0.4 0.4 0.0 40.3 0.4 0.4 1.2 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 5.0 3.9 0.4 0.4 0.4 0.4 0.7 3.7 0.4 0.4 0.4 0.0 0.4 0.2 0.4 0.4 0.0 0.4 0.4 0.4 0.6 0.4 0.4 2.2 0.4 0.4 3.2 1.1 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 55.9 0.0 3.8 5.0 3.9 0.7 3.7 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 PDZD2 "KIAA0300, PDZK3" ENSG00000133401 "PDZ domain containing 2" O15018 5 31639410-32110931 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.8" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 92.3;Early spermatids: 193.7;Rod photoreceptor cells: 66.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 9.1;EFO-21: 5.1;SiHa: 12.7;SK-BR-3: 11.8;T-47d: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020784, HPA036503, HPA036504, HPA064387, HPA076072" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: " "unprognostic (3.65e-2)" "unprognostic (4.06e-2)" "unprognostic (6.63e-2)" "unprognostic (5.42e-5)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (3.38e-2)" "unprognostic (2.45e-2)" "unprognostic (1.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-3)" "unprognostic (4.13e-2)" "unprognostic (6.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.79e-1)" 16.3 1.3 7.8 1.0 28.8 0.3 5.6 3.6 18.1 2.9 1.9 5.1 2.4 0.8 3.0 7.4 6.1 2.8 1.2 19.6 6.6 4.8 9.5 0.4 10.0 0.5 5.4 8.8 16.7 1.5 0.8 2.6 11.9 11.5 2.0 1.1 4.3 2.3 2.5 2.6 11.1 1.1 2.9 3.2 0.5 2.0 6.2 6.1 0.3 1.3 0.7 2.0 1.1 2.9 0.4 0.7 0.7 0.6 0.2 1.0 0.0 0.1 0.0 3.5 0.1 0.0 0.0 9.1 0.0 0.0 0.6 0.6 0.0 0.0 0.0 5.1 0.0 1.3 4.7 1.8 1.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 2.7 0.3 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.8 0.0 0.0 0.0 4.0 0.1 0.1 0.8 12.7 11.8 0.0 3.1 6.1 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 3.0 0.0 0.0 1.2 0.4 0.5 0.4 0.5 0.1 1.0 0.1 0.3 0.1 0.1 0.4 0.1 0.1 0.7 0.2 0.6 0.7 0.0 0.0 7.8 28.8 3.6 18.1 6.6 4.8 5.4 8.8 11.5 6.1 41.7 30.5 0.0 3.4 14.9 5.2 41.8 0.0 1.4 5.7 5.2 92.3 19.5 0.0 0.1 193.7 6.8 0.0 0.0 0.2 2.5 5.6 1.0 1.1 0.0 1.9 14.3 0.0 6.2 0.3 37.2 6.9 1.7 6.8 0.0 0.0 5.2 2.1 0.0 9.9 8.7 66.0 45.3 2.0 10.1 2.7 16.2 17.6 0.0 0.0 1.3 PDZD3 "FLJ22756, IKEPP, PDZK2" ENSG00000172367 "PDZ domain containing 3" Q86UT5 11 119185457-119190223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 12.8;intestine: 44.2;kidney: 12.5" "Group enriched" "Detected in some" 4 "Enterocytes: 67.0;Paneth cells: 26.4;Proximal tubular cells: 25.2;Undifferentiated cells: 17.9" "Cancer enhanced" "Detected in some" "renal cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 3.3;OE19: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077887 Enhanced NA NA "HPA077887: " "unprognostic (2.42e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.39e-2)" "unprognostic (6.07e-2)" "unprognostic (3.22e-1)" "unprognostic (1.86e-2)" "unprognostic (6.58e-3)" "unprognostic (9.00e-2)" "unprognostic (6.08e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (3.37e-1)" "unprognostic (1.38e-1)" "unprognostic (3.41e-3)" 0.9 0.0 0.1 5.8 0.1 0.0 0.1 0.1 0.1 0.1 24.9 0.0 0.0 15.1 0.0 2.6 0.1 0.8 12.8 0.3 0.0 0.0 12.5 0.5 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 5.5 0.0 0.1 0.0 0.1 0.1 44.2 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 7.6 1.4 0.0 0.0 5.9 0.0 3.3 0.0 0.0 0.0 67.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 26.4 0.0 25.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.9 0.0 PDZD4 "FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L" ENSG00000067840 "PDZ domain containing 4" Q76G19 X 153802166-153830565 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 71.6" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 14.4;Ciliated cells: 8.1;Ito cells: 6.2;Rod photoreceptor cells: 12.9" "Cancer enhanced" "Detected in many" "glioma: 20.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5" "Group enriched" "Detected in many" 25 "NK-cells: 1.5;T-cells: 3.5" "Cell line enhanced" "Detected in some" "AF22: 16.1;NTERA-2: 8.2;RH-30: 11.4;SCLC-21H: 19.6;SH-SY5Y: 19.0;U-2 OS: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003878 Enhanced NA NA "HPA003878: AB_2162807" "unprognostic (9.18e-3)" "unprognostic (1.25e-1)" "unprognostic (1.11e-4)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (1.85e-2)" "unprognostic (1.92e-3)" "unprognostic (2.17e-1)" "unprognostic (2.32e-3)" "unprognostic (5.90e-2)" "prognostic favorable (2.96e-5)" "unprognostic (2.27e-1)" "unprognostic (2.54e-4)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.83e-2)" "unprognostic (2.87e-2)" 3.3 5.8 42.8 2.6 36.7 2.5 2.0 40.1 71.6 2.3 3.5 5.1 0.4 2.5 4.4 2.2 3.3 7.9 2.8 3.3 40.8 14.8 1.6 1.7 3.0 2.6 9.9 24.9 1.7 2.6 1.5 7.4 1.2 9.0 4.5 2.3 1.8 4.3 10.5 3.6 4.8 3.3 5.0 7.0 7.0 2.3 3.4 6.4 0.0 1.6 0.0 1.6 2.4 1.4 0.0 0.0 0.0 0.0 1.5 3.5 0.6 0.0 1.0 16.1 4.1 0.0 0.1 0.0 0.4 0.0 0.5 0.5 0.4 0.0 0.0 0.2 0.0 5.2 0.1 2.9 0.0 0.1 0.0 0.5 0.0 1.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 3.1 0.1 0.5 8.2 0.0 0.2 0.0 11.4 0.0 0.0 0.0 19.6 19.0 0.8 0.0 5.7 5.7 1.8 0.1 0.0 0.0 9.5 0.2 1.1 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 0.0 3.5 0.0 0.8 0.0 1.5 2.0 0.0 0.0 0.1 0.9 0.0 1.5 0.0 0.0 0.0 0.6 42.8 36.7 40.1 49.2 40.8 14.8 9.9 24.9 9.0 6.4 0.0 0.0 0.0 0.0 0.2 14.4 1.4 0.0 8.1 2.3 0.0 5.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.3 1.1 0.0 0.0 1.6 1.7 6.2 1.0 0.0 0.6 0.0 3.3 0.0 0.0 2.5 0.5 0.0 3.5 0.0 12.9 0.0 1.7 0.2 3.4 0.6 0.0 3.2 0.0 0.1 PDZD7 "bA108L7.8, DFNB57, FLJ23209, PDZK7" ENSG00000186862 "PDZ domain containing 7" Q9H5P4 10 101007683-101032295 "Disease related genes, Predicted intracellular proteins" "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;intestine: 25.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 13.1;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1;THP-1: 17.7" "Low region specificity" "Detected in many" HPA074542 Supported Nucleoplasm NA NA Nucleoplasm "HPA074542: " "unprognostic (1.46e-1)" "unprognostic (2.85e-3)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "unprognostic (2.15e-2)" "unprognostic (2.83e-2)" "unprognostic (1.38e-2)" "unprognostic (5.31e-2)" "unprognostic (2.52e-2)" "unprognostic (2.95e-2)" "unprognostic (2.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-3)" "unprognostic (3.89e-1)" "unprognostic (1.79e-1)" "unprognostic (3.51e-2)" "unprognostic (2.80e-1)" 2.4 2.3 7.0 1.7 10.7 2.4 0.9 15.9 11.6 0.8 3.4 2.4 0.0 17.4 2.5 1.9 1.0 1.1 3.0 1.2 6.3 7.8 2.2 0.7 1.9 1.6 12.5 8.3 1.4 1.7 3.8 6.2 1.8 17.7 1.5 0.7 1.1 2.1 1.2 1.4 3.8 25.3 2.0 9.1 2.6 1.9 2.1 4.8 0.0 2.2 0.0 0.6 1.3 1.0 1.3 0.7 6.9 2.1 2.3 1.5 0.6 7.4 1.1 0.6 0.9 1.0 0.2 2.5 1.3 0.7 0.0 0.4 1.7 1.9 3.7 3.6 0.3 1.0 2.3 0.2 0.7 0.0 1.0 2.5 0.2 3.6 2.4 0.6 0.6 3.3 0.4 0.3 0.2 0.2 4.3 0.3 3.4 0.6 0.9 0.1 1.9 0.5 1.4 0.6 1.5 2.7 1.7 1.0 0.5 1.8 0.8 12.1 5.6 0.8 0.4 1.2 1.2 2.5 17.7 0.5 1.2 2.6 1.5 1.1 1.6 0.1 0.3 6.6 1.3 0.7 2.9 2.1 1.5 1.0 1.3 1.0 1.1 0.9 1.3 0.4 1.3 1.5 0.8 6.9 2.3 0.8 0.7 0.6 0.6 7.0 10.7 15.9 11.6 6.3 7.8 12.5 8.3 17.7 4.8 0.0 0.0 0.0 0.6 0.5 13.1 1.4 5.1 0.0 0.0 1.8 21.6 0.1 1.7 0.7 1.4 0.3 0.3 0.0 0.3 4.7 0.7 0.5 0.0 0.0 1.8 1.6 0.0 0.6 1.2 1.0 0.3 0.8 0.0 0.0 0.0 0.8 0.9 0.0 1.1 1.3 7.6 0.0 0.8 2.8 2.3 0.4 1.6 0.0 0.0 0.1 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375467 "Predicted intracellular proteins" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.7" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 174.2;Late spermatids: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 52.1" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: AB_2681549" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 8.1 7.8 12.2 5.1 13.3 61.7 8.2 8.7 12.9 9.1 14.8 11.4 32.8 14.0 10.7 15.1 11.4 7.7 10.3 7.0 12.0 10.4 13.5 21.1 7.4 3.7 14.7 7.4 10.1 20.1 18.9 8.6 6.0 12.9 7.3 12.0 6.3 12.4 21.3 6.7 6.6 13.7 7.6 14.8 5.0 10.6 23.2 12.4 8.9 7.5 5.4 4.2 8.0 15.3 1.0 1.7 5.7 2.0 2.5 2.5 0.5 5.2 9.0 3.3 6.3 5.7 5.1 1.8 5.0 4.4 2.3 1.8 4.5 7.0 6.2 4.6 7.6 2.6 7.9 5.7 5.4 4.5 3.9 5.1 52.1 3.7 4.4 4.2 21.7 4.9 5.0 6.4 4.1 12.3 8.5 4.0 5.1 4.7 6.5 5.6 2.1 4.2 2.8 2.6 2.7 8.1 3.4 12.7 2.6 6.7 3.8 2.6 4.2 5.4 2.3 3.9 3.1 1.6 3.2 6.4 3.8 4.2 6.8 8.6 3.5 2.9 4.5 4.7 10.0 3.3 2.7 1.4 5.7 2.2 1.1 2.5 0.9 1.8 1.8 1.7 1.0 1.5 2.0 5.6 2.5 2.0 1.3 0.8 0.5 12.2 13.3 8.7 12.9 12.0 10.4 14.7 7.4 12.9 12.4 11.9 27.8 8.8 17.7 26.4 29.3 16.7 43.3 38.8 25.0 17.4 21.6 8.3 8.3 27.0 174.2 17.8 23.8 23.3 70.7 5.7 19.5 25.1 41.7 45.8 6.8 30.2 32.4 16.5 12.3 366.0 21.9 15.2 21.9 9.0 31.7 24.9 56.7 21.0 26.9 23.1 40.1 25.8 18.9 16.9 29.3 28.2 5.6 18.7 39.0 34.2 PDZD9 "C16orf65, MGC50721" ENSG00000155714 "PDZ domain containing 9" Q8IXQ8 16 21983865-22001110 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 13 "testis: 34.1" "Group enriched" "Detected in some" 19 "Early spermatids: 69.0;Late spermatids: 148.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 1.3;MOLT-4: 1.0;U-87 MG: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.66e-2)" "unprognostic (6.23e-4)" "unprognostic (2.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.09e-2)" "unprognostic (2.52e-3)" "unprognostic (8.29e-3)" "unprognostic (2.05e-3)" "unprognostic (3.93e-2)" "unprognostic (1.11e-2)" "unprognostic (3.85e-3)" "unprognostic (1.42e-2)" "unprognostic (1.97e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (1.63e-1)" "unprognostic (4.69e-2)" 0.2 0.2 0.5 0.1 1.2 0.1 0.1 2.6 1.0 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 34.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.8 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 1.0 0.1 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 1.0 0.1 0.5 1.2 2.6 1.0 0.5 0.6 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.7 1.1 0.0 0.0 0.0 0.0 0.0 PDZK1 "NHERF3, PDZD1" ENSG00000174827 "PDZ domain containing 1" Q5T2W1 1 145670852-145708148 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 49.2;kidney: 124.3" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 758.4" "Group enriched" "Detected in many" 12 "breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3" "Region enriched" "Detected in single" 17 "cerebellum: 10.0" "Cell type enriched" "Detected in many" 4 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 4 "NK-cells: 7.6" "Group enriched" "Detected in some" 4 "RPTEC TERT1: 43.1;T-47d: 112.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA005755, HPA006155, CAB008971" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163" "unprognostic (4.56e-3)" "unprognostic (3.07e-1)" "unprognostic (8.79e-2)" "unprognostic (4.41e-2)" "unprognostic (9.15e-2)" "unprognostic (2.09e-1)" "unprognostic (2.18e-1)" "unprognostic (3.42e-1)" "unprognostic (2.08e-1)" "unprognostic (3.27e-1)" "unprognostic (2.34e-2)" "unprognostic (9.87e-3)" "prognostic favorable (2.54e-7)" "unprognostic (9.90e-2)" "unprognostic (3.02e-1)" "unprognostic (1.00e-3)" "unprognostic (8.87e-2)" 0.1 0.6 0.2 0.2 0.3 0.0 5.8 10.0 0.2 0.3 16.5 0.2 0.8 13.2 0.3 6.7 0.1 0.1 10.6 0.1 0.2 0.2 124.3 25.7 0.4 0.1 0.3 0.2 0.2 4.2 0.0 0.1 0.9 0.5 0.1 1.3 1.2 0.1 0.1 0.1 0.7 49.2 0.1 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.1 0.1 0.1 1.0 1.1 0.5 0.2 7.6 1.8 0.5 1.3 0.2 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 18.9 0.1 0.1 0.2 1.1 0.0 0.6 0.0 0.1 0.1 1.8 0.3 0.1 0.4 7.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 1.1 0.1 0.2 0.2 0.2 0.5 0.0 1.3 0.2 43.1 0.0 0.1 1.2 0.3 0.3 0.0 1.2 112.0 0.1 0.1 0.2 0.2 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 1.5 0.2 0.6 1.0 0.4 1.8 0.2 1.0 0.4 0.7 0.4 7.6 0.1 1.1 0.1 0.5 0.2 0.3 10.0 0.2 0.2 0.2 0.3 0.2 0.5 0.1 0.0 0.0 0.9 0.0 0.1 0.4 0.4 61.1 0.0 0.0 54.1 0.0 0.0 117.7 1.7 8.9 0.0 18.0 0.0 1.6 0.1 0.2 0.1 0.0 45.6 0.2 0.0 6.3 1.8 1.2 5.2 0.0 0.0 0.0 0.0 0.5 0.0 1.8 2.9 0.0 758.4 0.3 0.0 0.3 0.2 0.2 0.0 0.1 0.0 1.0 0.0 PDZK1IP1 "DD96, MAP17, SPAP" ENSG00000162366 "PDZK1 interacting protein 1" Q13113 1 47183593-47191044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 281.3" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 4006.8" "Cancer enhanced" "Detected in all" "renal cancer: 340.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 31.5;RPTEC TERT1: 104.5" "Not detected" "Not detected" HPA014907 Enhanced Approved "Nuclear speckles,Cytosol" NA NA Cytosol "Nuclear speckles" "HPA014907: AB_1855166" "unprognostic (2.97e-1)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" "unprognostic (9.16e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (8.14e-3)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.65e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (2.64e-2)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (1.75e-3)" "unprognostic (1.89e-1)" 2.7 1.2 0.6 2.4 0.6 3.9 4.1 0.6 0.6 9.2 9.1 0.6 0.6 2.2 1.3 4.8 30.4 2.9 23.9 0.7 0.5 0.0 281.3 1.6 7.2 0.5 0.6 0.5 2.3 16.8 0.0 0.6 3.2 0.6 2.1 3.4 0.8 33.9 12.4 0.7 19.9 9.5 0.5 0.5 0.7 9.0 1.4 0.6 1.1 1.0 18.3 18.5 4.1 8.3 0.1 0.5 2.1 1.1 0.2 0.3 42.4 11.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 31.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 104.5 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.1 0.2 0.0 0.5 0.3 42.4 0.6 0.6 0.6 0.6 0.5 0.0 0.6 0.5 0.6 0.6 71.5 39.6 6.7 11.1 12.6 0.0 0.0 359.2 6.7 34.2 221.6 0.0 0.0 351.5 818.0 0.0 1.6 60.9 140.2 656.9 0.0 0.9 37.3 10.4 1.0 0.2 0.0 38.1 2.5 0.3 0.0 3.1 1.5 8.5 21.6 123.8 0.5 959.8 81.8 0.0 4006.8 0.0 0.0 2.3 0.0 0.1 47.2 0.7 1.5 119.5 16.8 PDZRN4 "DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4" ENSG00000165966 "PDZ domain containing ring finger 4" Q6ZMN7 12 41188448-41574590 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 18.3;seminal vesicle: 20.8" "Cell type enhanced" "Detected in some" 25 "Fibroblasts: 10.4;Leydig cells: 25.9;Peritubular cells: 53.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/70: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042101 Enhanced NA NA "HPA042101: AB_2732496" "unprognostic (6.74e-2)" "unprognostic (6.86e-2)" "unprognostic (3.82e-2)" "unprognostic (2.88e-2)" "unprognostic (1.49e-1)" "unprognostic (5.34e-2)" "unprognostic (2.48e-2)" "unprognostic (1.38e-2)" "unprognostic (8.19e-2)" "unprognostic (7.85e-3)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" "unprognostic (7.44e-2)" "unprognostic (1.90e-3)" "unprognostic (1.80e-1)" "unprognostic (7.33e-2)" "unprognostic (1.41e-3)" 1.6 1.3 2.4 5.0 1.8 0.1 2.6 2.7 3.7 3.1 13.9 1.0 13.8 1.3 1.1 18.3 4.1 3.4 3.0 0.5 2.1 2.1 0.8 0.9 0.5 0.1 1.8 2.4 3.3 0.8 0.3 0.7 4.5 2.5 8.3 4.0 4.8 0.6 20.8 0.6 0.8 4.2 17.2 5.0 0.4 5.9 4.1 2.0 0.0 0.5 0.5 0.5 7.3 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.8 2.7 3.3 2.1 2.1 1.8 2.4 2.5 2.0 0.0 0.0 0.0 0.0 0.7 4.7 0.3 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 10.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 1.2 25.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 53.0 0.0 0.9 0.0 7.3 0.0 0.1 0.5 0.3 0.0 0.0 0.0 PEA15 "HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15" ENSG00000162734 "Proliferation and apoptosis adaptor protein 15" Q15121 1 160205337-160215376 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 199.4" "Cell type enhanced" "Detected in many" 7 "monocytes: 420.2;Muller glia cells: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 30.6" "Group enriched" "Detected in all" 6 "B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028356, HPA070820" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA028356: AB_10602814, HPA070820: AB_2732166" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.05e-1)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (1.64e-2)" "unprognostic (1.99e-3)" "unprognostic (6.10e-2)" "unprognostic (4.57e-1)" "unprognostic (1.25e-1)" "unprognostic (6.31e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (6.53e-7)" "unprognostic (2.60e-2)" "unprognostic (1.39e-1)" "unprognostic (2.82e-3)" "unprognostic (1.24e-1)" 45.3 20.4 105.3 28.7 83.6 3.8 25.3 30.5 173.1 25.1 15.5 68.1 5.0 8.0 21.5 21.8 22.6 19.2 22.1 53.9 70.5 81.3 14.8 10.4 23.8 16.6 106.5 67.0 19.7 9.7 14.9 10.2 25.1 74.1 24.4 15.3 18.2 12.3 31.1 10.2 16.9 8.8 47.4 199.4 23.8 10.0 17.5 53.7 1.6 12.6 6.0 22.9 22.4 17.5 7.6 22.1 1.8 30.6 3.1 3.5 5.4 16.9 5.9 24.6 10.6 45.6 25.6 8.2 73.6 64.4 61.3 43.1 13.0 9.2 7.9 26.7 91.9 29.5 18.6 9.1 23.0 48.0 4.2 5.1 6.5 4.1 3.3 56.4 2.1 8.0 21.4 13.0 33.7 43.1 33.9 46.0 5.8 6.7 14.4 81.9 8.4 2.5 5.1 16.3 20.1 17.0 4.2 25.9 5.4 22.2 8.9 4.9 13.0 39.0 26.7 22.4 55.7 16.4 15.3 61.3 40.8 32.0 30.3 31.6 11.4 7.0 15.0 37.6 4.1 57.7 0.3 15.3 1.8 3.5 30.6 2.7 7.6 2.6 2.8 22.1 5.0 1.6 1.8 0.7 3.1 13.9 9.7 2.9 5.4 105.3 83.6 30.5 78.2 70.5 81.3 106.5 67.0 74.1 53.7 14.9 34.6 27.0 105.8 71.2 125.0 203.8 12.7 14.7 27.3 5.2 68.7 17.0 24.9 58.7 49.2 107.8 6.4 0.0 40.4 47.2 66.7 105.1 31.1 4.9 63.6 87.4 11.5 95.2 34.2 51.6 61.9 76.5 70.9 420.2 11.3 271.7 77.0 3.5 103.3 8.1 109.8 45.3 97.6 12.7 2.7 64.1 37.9 14.9 9.7 151.1 PEAK3 "C19orf35, FLJ45778" ENSG00000188305 "PEAK family member 3" Q6ZS72 19 2274622-2282176 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 24.5;lymphoid tissue: 19.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 1.4;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 24.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 24.5" "Cell line enriched" "Detected in some" 10 "HMC-1: 16.9" "Group enriched" "Detected in many" 5 "basal ganglia: 6.4;cerebellum: 6.0" HPA057806 Uncertain Uncertain Cytosol NA NA Cytosol "HPA057806: AB_2683534" "unprognostic (9.42e-2)" "unprognostic (3.26e-2)" "unprognostic (7.27e-2)" "unprognostic (6.23e-2)" "unprognostic (2.65e-2)" "unprognostic (8.40e-3)" "unprognostic (3.67e-1)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (2.08e-1)" "unprognostic (6.89e-2)" "unprognostic (1.43e-1)" "unprognostic (2.19e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-2)" "unprognostic (3.20e-2)" "unprognostic (1.90e-1)" 1.9 1.3 1.4 4.7 3.3 8.2 0.9 0.8 2.0 1.3 1.7 2.1 0.1 1.1 0.7 1.0 0.8 1.6 0.9 2.1 2.0 0.9 3.8 2.0 4.4 14.3 3.3 0.9 1.0 0.8 0.6 1.2 0.8 2.3 1.0 1.1 0.7 0.8 0.6 1.5 1.0 2.5 0.9 4.0 19.1 1.1 0.6 1.7 0.6 0.8 0.0 2.7 0.9 1.9 0.2 1.1 24.5 3.4 2.8 1.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.2 0.6 0.1 16.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 5.3 2.7 6.6 1.0 3.4 0.1 0.1 0.1 0.1 1.1 0.2 0.0 0.2 24.5 2.8 1.1 0.1 0.0 0.5 1.4 3.3 0.8 2.0 2.0 0.9 3.3 0.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PEBP1 "HCNP, PBP, PEBP, RKIP" ENSG00000089220 "Phosphatidylethanolamine binding protein 1" P30086 12 118135858-118145584 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 260.7" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 3140.1;Proximal tubular cells: 3872.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA008819, CAB009906, CAB013493, HPA063904" Enhanced Approved "Plasma membrane,Cytosol" NA NA 62000000 "Plasma membrane, Cytosol" "CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708" "unprognostic (4.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.28e-2)" "unprognostic (3.39e-3)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-2)" "unprognostic (7.35e-3)" "unprognostic (5.67e-2)" "unprognostic (3.55e-2)" "prognostic favorable (1.52e-4)" "unprognostic (1.63e-1)" "prognostic favorable (2.15e-13)" "unprognostic (2.17e-1)" "unprognostic (7.72e-2)" "unprognostic (7.96e-2)" "unprognostic (8.80e-2)" 26.8 207.3 83.0 15.2 82.3 13.5 32.3 63.3 102.7 35.5 50.4 58.0 18.9 75.3 22.9 52.8 24.3 28.5 22.6 57.6 77.6 69.7 132.7 260.7 22.1 16.0 77.8 71.5 43.5 46.2 139.2 30.8 16.5 59.1 35.4 25.4 41.2 43.6 33.1 65.1 20.9 75.4 23.4 79.1 15.3 20.6 22.7 43.5 8.7 94.9 26.1 19.7 20.2 17.8 45.2 37.3 3.0 12.1 20.9 45.3 36.4 32.2 27.6 39.1 40.6 61.7 30.2 60.8 25.7 30.0 40.6 20.9 16.4 11.1 52.0 25.9 38.4 16.2 23.2 57.8 23.9 31.7 13.0 55.3 26.1 31.1 114.3 35.7 47.2 11.4 29.9 39.7 24.0 16.7 46.7 18.8 27.8 43.3 19.4 40.6 38.2 25.7 95.7 37.9 27.1 33.4 50.8 29.1 94.8 49.8 31.5 46.9 36.4 53.4 37.1 50.3 25.0 53.4 32.2 20.4 31.2 17.8 30.5 25.8 19.0 33.7 26.8 36.7 35.4 33.8 0.7 11.0 3.0 26.9 12.1 42.4 45.2 45.3 33.3 33.3 32.5 43.9 35.3 1.2 20.9 10.3 37.3 41.2 36.4 83.0 82.3 63.3 102.7 77.6 69.7 77.8 71.5 59.1 43.5 375.2 339.6 254.0 392.9 282.7 501.7 637.3 598.7 327.9 273.0 743.2 90.3 819.2 3140.1 396.3 35.6 178.6 306.2 116.8 213.3 686.7 314.8 422.6 353.3 1736.5 486.8 681.7 307.9 178.0 167.5 50.5 502.8 218.5 705.2 448.2 324.1 1385.1 201.0 263.6 687.7 3872.6 306.7 362.2 321.6 273.2 133.6 284.3 514.8 194.5 466.9 324.1 PEBP4 "CORK1, hPEBP4, MGC22776" ENSG00000134020 "Phosphatidylethanolamine binding protein 4" Q96S96 8 22713251-23000000 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 85.8;skeletal muscle: 124.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 101.3;Alveolar cells type 2: 146.5;Cardiomyocytes: 105.2;Muller glia cells: 177.5" "Group enriched" "Detected in many" 13 "lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;neutrophil: 2.7;NK-cell: 2.6" "Group enriched" "Detected in many" 19 "B-cells: 2.7;granulocytes: 2.7;NK-cells: 2.6" "Cell line enriched" "Detected in some" 6 "U-266/70: 9.5" HPA025064 Uncertain "Secreted in other tissues" NA NA 200000000 "HPA025064: AB_1855174" "unprognostic (1.34e-2)" "unprognostic (2.97e-2)" "unprognostic (4.11e-2)" "unprognostic (3.66e-1)" "unprognostic (3.35e-1)" "unprognostic (4.78e-2)" "unprognostic (1.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.60e-1)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "unprognostic (8.76e-3)" "unprognostic (9.70e-8)" "unprognostic (1.13e-2)" "unprognostic (2.56e-1)" "unprognostic (3.48e-1)" "unprognostic (4.59e-1)" 2.7 0.9 2.2 0.2 4.9 0.2 0.9 1.0 1.9 0.3 0.2 2.4 0.8 0.1 0.3 85.8 1.6 0.5 0.6 43.8 2.2 5.1 0.6 0.7 31.8 0.3 10.8 0.8 0.4 7.4 0.4 4.7 0.2 7.8 10.4 0.2 18.9 12.3 0.8 124.6 0.3 0.2 0.2 1.0 0.2 1.7 1.4 2.5 0.0 22.3 16.6 2.3 0.2 0.0 2.7 0.1 2.7 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.7 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.1 0.0 0.2 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.5 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.4 0.0 0.0 2.7 2.6 0.0 0.1 0.0 0.0 2.2 4.9 1.0 1.9 2.2 5.1 10.8 0.8 7.8 2.5 101.3 146.5 0.0 0.9 1.6 10.4 105.2 0.0 5.3 13.6 1.8 2.0 0.6 3.3 0.0 27.5 2.1 0.0 0.0 8.3 0.1 1.0 11.1 7.0 0.6 1.1 9.5 0.0 3.1 0.0 19.3 3.1 1.1 1.7 0.0 0.0 177.5 0.3 0.0 10.3 1.8 7.3 0.0 3.1 2.2 0.7 0.6 0.0 0.7 0.0 0.9 PECAM1 CD31 ENSG00000261371 "Platelet and endothelial cell adhesion molecule 1" 17 64319415-64413776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 77.7;blood: 88.4;placenta: 65.7" "Cell type enhanced" "Detected in many" 23 "Endothelial cells: 481.1;Ito cells: 205.6;Kupffer cells: 91.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 88.4" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 121.0;TIME: 83.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004690 Enhanced NA NA "HPA004690: AB_1078462" "unprognostic (2.79e-1)" "unprognostic (2.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (4.42e-3)" "unprognostic (2.84e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.25e-2)" "unprognostic (4.53e-2)" "unprognostic (9.68e-2)" "prognostic unfavorable (8.98e-5)" "unprognostic (9.72e-3)" "unprognostic (9.57e-2)" "unprognostic (1.56e-1)" "unprognostic (4.16e-2)" 77.7 2.5 2.2 10.2 3.3 3.8 26.5 1.2 3.6 14.2 9.2 1.6 3.7 3.5 15.2 7.6 12.3 4.7 12.2 13.8 2.2 13.4 3.5 50.2 10.7 3.0 0.3 7.4 2.3 2.7 1.2 65.7 3.7 10.2 4.9 4.6 2.9 3.0 21.2 2.0 4.8 11.6 2.8 13.9 3.4 6.4 2.0 7.8 15.7 10.0 7.8 15.2 16.2 5.0 21.0 53.3 88.4 5.2 10.0 24.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 121.0 5.3 0.3 9.1 0.0 0.0 4.9 1.2 0.0 0.0 1.3 0.2 2.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.4 83.3 0.1 0.0 0.1 0.0 0.5 0.9 1.0 0.2 1.0 0.0 6.2 34.8 28.9 2.8 57.2 2.7 3.6 0.3 6.7 21.0 5.0 5.4 10.0 53.3 5.2 88.4 12.0 0.2 24.2 14.9 44.7 12.6 0.5 0.0 0.0 17.1 0.0 13.4 5.7 8.7 0.0 0.4 0.0 0.2 0.6 481.1 0.0 0.0 0.2 3.5 1.1 1.0 8.1 0.9 47.0 0.0 0.0 205.6 91.8 0.5 2.3 71.5 0.0 12.6 0.0 0.1 0.1 0.0 1.8 0.5 0.9 0.0 0.3 0.1 0.2 0.0 0.7 20.3 0.0 0.9 PECR "HSA250303, SDR29C1, TERP" ENSG00000115425 "Peroxisomal trans-2-enoyl-CoA reductase" Q9BY49 2 215996329-216082955 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 78.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 72.5;monocytes: 42.3;Proximal tubular cells: 49.9" "Cancer enhanced" "Detected in all" "liver cancer: 30.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 24.6;RPTEC TERT1: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021593, HPA022539" Enhanced Supported Peroxisomes NA NA Peroxisomes "HPA021593: AB_1855177, HPA022539: AB_1855178" "unprognostic (7.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (2.90e-1)" "unprognostic (6.40e-2)" "unprognostic (1.16e-3)" "unprognostic (3.56e-2)" "unprognostic (4.03e-2)" "unprognostic (1.11e-1)" "unprognostic (5.01e-3)" "unprognostic (5.61e-2)" "prognostic favorable (1.36e-5)" "unprognostic (6.63e-2)" "unprognostic (1.84e-2)" "unprognostic (7.75e-2)" "unprognostic (6.64e-2)" 14.2 4.4 3.2 6.5 3.3 3.5 7.0 6.7 3.7 2.8 11.5 4.4 2.7 13.2 2.0 6.6 2.4 4.5 7.2 2.7 3.3 3.1 17.4 78.4 3.6 3.8 4.4 2.9 3.2 3.1 3.8 5.4 0.9 3.5 3.1 4.2 6.2 3.5 3.5 3.4 3.3 20.9 3.2 5.1 2.8 2.6 0.9 3.6 2.4 8.5 2.0 3.5 2.2 4.1 5.1 1.4 4.1 3.9 8.8 14.7 4.1 3.8 4.3 1.7 0.1 10.6 3.9 2.1 0.9 2.1 2.5 4.2 4.9 11.2 0.1 8.0 2.3 6.2 0.9 4.7 5.7 4.4 6.1 5.1 5.0 2.5 24.6 10.7 1.3 3.5 3.3 4.0 2.6 3.7 3.8 2.4 3.0 2.1 5.7 5.4 2.8 1.5 1.4 3.2 0.0 3.2 3.4 3.3 0.5 23.8 0.6 2.4 3.5 2.3 4.9 9.7 4.4 5.8 4.2 0.0 1.6 1.7 4.0 2.8 6.7 5.6 2.0 3.6 1.8 3.7 0.8 3.9 1.3 6.4 1.5 7.3 4.2 8.6 7.3 1.4 5.1 9.2 6.0 4.1 8.8 2.0 0.2 14.7 4.1 3.2 3.3 6.7 3.7 3.3 3.1 4.4 2.9 3.5 3.6 6.0 9.9 3.7 3.8 3.3 10.0 3.1 35.7 9.4 2.3 27.9 13.7 3.5 11.6 10.3 0.1 3.3 12.7 0.0 3.4 6.4 3.5 1.9 1.1 72.5 8.0 3.2 6.9 7.4 2.8 0.0 5.2 5.9 10.1 42.3 6.5 7.8 4.3 17.5 7.8 49.9 6.4 0.0 4.2 0.0 1.8 2.5 1.4 8.7 13.3 1.4 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4" "Group enriched" "Detected in many" 13 "Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 143.8" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4" "Region enhanced" "Detected in many" "hypothalamus: 130.3" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372" "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 2.3 67.5 32.0 2.1 143.8 1.4 10.6 25.6 16.8 4.2 2.1 7.4 0.0 1.5 3.3 1.9 2.0 5.1 2.4 1.8 21.0 47.0 4.0 2.0 7.3 2.9 13.1 21.3 27.0 5.4 2.3 102.6 171.4 27.4 2.2 1.9 1.8 4.3 2.2 1.9 1.4 1.6 2.6 14.4 1.8 2.1 19.8 11.1 1.5 5.4 0.0 2.3 1.8 1.0 2.6 0.0 0.0 0.0 2.7 0.7 0.2 2.6 13.4 95.0 40.1 2.0 3.6 5.5 7.3 4.3 5.2 7.1 22.3 4.4 0.2 0.2 8.4 10.8 0.8 123.3 5.2 7.3 0.3 13.0 0.0 15.3 95.0 1.5 15.1 0.0 8.0 1.7 13.0 9.0 4.6 3.1 0.0 0.0 29.8 10.2 0.6 0.0 0.0 43.5 2.2 8.5 5.7 30.4 7.9 23.9 9.9 60.4 3.4 0.0 2.0 7.2 24.9 12.9 0.0 0.0 4.2 0.2 0.5 5.5 8.0 5.3 11.8 9.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.7 0.0 2.6 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.2 32.0 143.8 25.6 14.4 21.0 47.0 13.1 21.3 27.4 11.1 142.9 64.2 2.4 7.4 0.7 70.4 25.2 7.6 16.0 126.3 15.7 7.9 1669.7 54.7 10.7 2.8 2.4 0.0 0.0 4.3 85.1 27.1 7.0 2.3 2.9 150.9 35.0 58.0 2.5 0.0 11.4 8.3 1.4 13.5 0.0 0.7 118.3 4.2 0.0 3.9 10.0 25.7 6.5 12.5 16.4 5.1 0.6 2388.4 0.5 0.1 0.6 PEG3 "KIAA0287, ZKSCAN22, ZNF904, ZSCAN24" ENSG00000198300 "Paternally expressed 3" Q9GZU2 19 56810083-56840728 "Predicted intracellular proteins, Transcription factors" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.0;ovary: 106.4;placenta: 49.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 267.6;Horizontal cells: 139.8;Peritubular cells: 103.3;Syncytiotrophoblasts: 399.0" "Cancer enhanced" "Detected in many" "testis cancer: 9.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.3;plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.3" "Group enriched" "Detected in some" 5 "BEWO: 32.2;Hep G2: 65.4;RH-30: 22.4" "Low region specificity" "Detected in all" HPA026070 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026070: AB_10603328" "unprognostic (1.38e-2)" "unprognostic (1.90e-2)" "unprognostic (1.20e-1)" "unprognostic (7.12e-2)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (4.84e-2)" "unprognostic (4.44e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (9.92e-2)" "unprognostic (2.48e-5)" "unprognostic (6.92e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.68e-3)" 2.0 29.8 10.1 1.0 51.0 0.5 4.5 9.8 22.4 4.1 2.4 5.9 0.0 0.7 9.1 2.6 1.7 5.8 1.2 2.3 9.7 9.6 1.8 2.1 1.7 0.7 3.5 16.0 106.4 1.9 7.3 24.6 49.8 21.3 1.8 1.2 0.4 2.3 2.5 1.7 1.8 1.7 4.1 4.8 1.6 2.0 12.3 7.3 0.0 2.7 0.0 2.7 2.6 2.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 22.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 10.1 51.0 9.8 22.4 9.7 9.6 3.5 16.0 21.3 7.3 0.0 5.8 0.0 1.7 4.2 19.4 12.3 2.5 4.0 3.4 1.8 7.9 267.6 1.7 0.7 24.4 2.6 0.0 0.0 0.0 33.5 7.8 1.7 0.0 2.9 29.8 139.8 0.0 4.9 0.6 15.2 54.4 1.0 13.5 0.0 0.0 18.1 0.5 0.0 103.3 0.8 11.8 12.9 7.3 26.9 17.4 2.3 399.0 0.0 0.0 0.7 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 199.1;Suprabasal keratinocytes: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Cell line enhanced" "Detected in many" "CACO-2: 21.8;U-698: 54.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" NA NA "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: AB_2682072" "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.3 1.0 14.0 9.3 1.6 1.2 3.2 1.8 2.0 1.6 2.6 21.8 1.5 17.9 4.4 0.6 0.6 2.1 4.2 3.9 3.3 4.4 3.3 1.6 0.7 3.5 4.9 1.7 3.2 1.6 3.1 2.4 8.4 1.7 9.2 6.9 1.0 4.5 1.4 0.1 3.8 2.5 9.1 4.1 0.6 4.8 4.8 10.2 6.7 4.0 6.4 9.0 1.3 2.1 4.8 4.5 1.1 1.2 6.5 1.5 2.2 1.5 2.6 10.4 1.0 54.2 0.8 1.6 4.1 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 26.8 45.1 22.4 65.1 199.1 0.9 5.1 10.2 30.8 55.7 5.2 0.0 1.4 1.7 4.5 8.5 42.7 37.0 0.0 23.1 6.5 25.9 43.3 14.0 6.8 19.1 3.2 24.6 36.2 52.6 7.8 1.4 57.1 106.3 13.6 22.2 4.5 18.2 28.1 1.8 7.7 1.8 0.0 48.4 6.1 7.8 190.1 3.3 11.5 27.3 104.0 PEMT "PEMPT, PEMT2" ENSG00000133027 "Phosphatidylethanolamine N-methyltransferase" Q9UBM1 17 17505563-17591708 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 95.7;liver: 103.5" "Cell type enhanced" "Detected in many" 12 "Hepatocytes: 168.4;Peritubular cells: 326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042375, HPA073930" Approved Supported "Endoplasmic reticulum,Vesicles,Mitochondria,Cytosol" NA NA "Endoplasmic reticulum, Mitochondria" "Vesicles, Cytosol" "HPA042375: AB_10796905, HPA073930: " "unprognostic (1.39e-2)" "unprognostic (3.43e-1)" "unprognostic (2.43e-2)" "prognostic favorable (6.77e-6)" "unprognostic (2.85e-1)" "unprognostic (7.14e-2)" "unprognostic (1.31e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-1)" "unprognostic (3.41e-2)" "unprognostic (5.47e-3)" "unprognostic (2.67e-1)" "unprognostic (8.63e-3)" "unprognostic (2.08e-1)" "unprognostic (2.10e-1)" "unprognostic (6.66e-2)" "unprognostic (7.60e-2)" 21.8 7.5 5.6 2.8 6.2 4.2 26.5 2.9 8.1 16.1 6.1 6.4 13.2 7.4 8.7 95.7 5.6 10.5 4.7 5.3 5.3 6.1 8.5 103.5 5.5 6.7 6.3 4.8 7.7 11.4 4.4 5.7 7.1 6.2 7.3 2.2 7.3 12.7 12.9 7.4 7.3 5.8 4.0 6.4 2.8 4.6 19.1 3.2 3.8 9.9 6.3 5.4 3.9 5.2 12.8 17.0 1.6 23.4 15.1 14.4 11.6 14.2 27.3 7.2 18.8 15.4 10.8 10.8 9.1 8.2 12.5 9.9 15.9 9.7 12.5 16.6 9.3 9.4 17.0 10.6 5.5 3.2 9.2 37.0 6.2 14.9 22.8 17.0 5.5 9.3 11.0 11.5 8.3 12.7 4.2 6.7 17.6 5.9 5.3 5.5 27.2 9.8 9.9 10.1 27.3 22.4 9.2 11.6 11.4 10.3 5.3 7.2 17.2 6.5 4.4 16.3 14.5 6.7 2.1 5.8 12.3 12.4 20.5 7.9 7.3 4.9 2.2 11.4 7.7 10.1 1.0 23.4 1.1 10.1 20.8 14.4 12.6 13.2 12.7 17.0 12.8 10.6 11.9 1.6 15.1 14.2 15.5 12.0 11.6 5.6 6.2 2.9 8.1 5.3 6.1 6.3 4.8 6.2 3.2 14.9 13.7 17.0 16.7 16.3 4.4 12.5 12.7 16.0 26.1 26.2 0.0 16.2 14.9 26.3 2.2 18.3 14.6 0.0 33.6 18.8 27.5 23.7 12.7 168.4 21.4 4.8 66.0 9.2 11.1 6.8 87.8 10.8 20.3 1.0 24.8 26.7 26.0 10.5 326.0 21.4 4.8 6.5 30.9 11.1 18.5 15.8 12.2 7.0 22.8 16.6 PENK ENSG00000181195 Proenkephalin P01210 8 56436674-56446734 "Plasma proteins, Predicted secreted proteins, Transporters" "Endorphin, Neuropeptide, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 124.3;brain: 171.5" "Cell type enhanced" "Detected in some" 32 "Leydig cells: 1053.7;Peritubular cells: 212.2;Spermatocytes: 309.0" "Cancer enhanced" "Detected in many" "lung cancer: 4.5" "Region enriched" "Detected in many" 12 "basal ganglia: 171.5" "Cell type enhanced" "Detected in some" "naive B-cell: 3.1" "Group enriched" "Detected in many" 19 "B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 16.6;ASC TERT1: 9.9;BJ: 9.2;THP-1: 8.6" "Region enriched" "Detected in all" 7 "basal ganglia: 3244.3" "Region enriched" "Detected in all" 7 "basal ganglia: 1049.6" "HPA013138, CAB016390" Enhanced "Secreted in other tissues" NA NA 35000 "CAB016390: AB_2161515, HPA013138: AB_1855191" "unprognostic (6.89e-2)" "unprognostic (1.21e-1)" "unprognostic (2.71e-2)" "unprognostic (1.17e-3)" "unprognostic (1.56e-2)" "unprognostic (3.58e-3)" "unprognostic (1.31e-2)" "unprognostic (3.60e-1)" "unprognostic (6.34e-2)" "unprognostic (5.73e-2)" "unprognostic (3.47e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-3)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.98e-3)" 2.5 124.3 2.8 1.7 171.5 0.3 0.9 3.9 7.8 14.3 2.2 0.9 0.1 0.6 3.0 0.9 0.9 2.6 4.0 9.1 1.2 9.1 0.3 0.2 1.0 0.3 2.5 0.4 8.2 0.6 0.2 1.5 1.1 8.4 11.7 0.9 2.2 0.9 8.1 1.1 0.5 0.9 1.7 7.0 0.3 1.1 29.9 14.7 0.0 0.6 0.3 0.3 0.5 0.6 3.1 1.2 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 16.6 9.9 0.0 9.2 2.9 1.7 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 3.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 2.8 171.5 3.9 7.8 1.2 9.1 2.5 0.4 8.4 14.7 0.0 1.0 0.0 0.0 0.1 0.0 0.6 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 56.7 0.5 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 37.9 1053.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 212.2 0.0 0.0 6.5 0.4 309.0 17.5 0.4 0.0 0.0 0.0 0.0 PEPD ENSG00000124299 "Peptidase D" P12955 19 33386950-33521794 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Collagen degradation" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 92.9;kidney: 106.0" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1020.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015599, HPA072045" Enhanced Approved Nucleoplasm NA NA 1000000000 Nucleoplasm "HPA015599: AB_1855192, HPA072045: AB_2732194" "unprognostic (1.39e-1)" "unprognostic (2.62e-2)" "unprognostic (2.27e-1)" "unprognostic (4.01e-2)" "unprognostic (2.98e-1)" "unprognostic (6.77e-2)" "unprognostic (2.82e-1)" "unprognostic (3.64e-2)" "unprognostic (3.96e-1)" "unprognostic (5.10e-2)" "unprognostic (1.11e-2)" "unprognostic (1.99e-1)" "prognostic favorable (6.50e-9)" "unprognostic (4.38e-2)" "unprognostic (1.99e-1)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" 23.5 17.2 9.8 8.9 10.4 4.1 21.8 7.6 14.9 9.8 60.1 18.7 6.9 58.1 14.3 11.5 14.9 9.6 13.6 8.0 10.8 9.1 106.0 48.6 11.1 10.6 16.0 7.7 12.6 9.0 9.6 12.5 10.4 13.0 9.2 6.6 13.3 9.6 9.0 9.7 11.4 92.9 10.4 17.4 13.4 9.3 8.4 11.5 8.4 15.0 9.7 10.6 11.9 11.9 17.1 32.3 27.5 39.1 16.8 25.8 32.6 13.3 36.3 10.7 17.3 45.7 17.6 24.8 11.9 24.4 15.2 17.3 31.6 11.8 5.4 17.8 29.8 11.7 3.5 15.4 9.7 12.5 15.4 15.2 34.7 7.4 32.1 31.3 10.1 42.1 21.7 9.2 13.8 8.6 11.2 20.3 10.7 6.6 15.8 16.5 16.3 7.7 3.4 14.7 26.6 14.8 15.2 14.6 15.0 13.1 35.3 13.2 33.8 22.2 11.0 17.9 9.4 7.6 11.0 16.9 14.7 15.9 19.0 13.7 14.5 21.5 4.8 15.7 14.6 20.9 27.5 36.1 2.5 25.8 39.1 22.6 17.1 25.7 23.8 32.3 16.3 16.9 19.6 1.9 16.8 27.2 9.9 23.6 32.6 9.8 10.4 7.6 14.9 10.8 9.1 16.0 7.7 13.0 11.5 20.8 24.3 20.2 26.1 17.2 33.9 11.7 43.3 26.8 11.4 69.8 3.9 19.3 167.5 63.4 7.6 44.9 37.6 0.0 38.3 59.7 34.6 21.4 55.5 161.7 189.6 58.8 16.6 35.0 46.9 8.9 45.8 63.2 64.1 131.7 14.5 69.3 37.3 28.5 57.0 1020.8 23.8 38.8 38.8 11.4 48.3 17.8 25.4 31.0 16.7 18.0 PERM1 "C1orf170, MGC13275, Perm1, RP11-54O7.8" ENSG00000187642 "PPARGC1 and ESRR induced regulator, muscle 1" Q5SV97 1 975204-982093 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "heart muscle: 23.8;skeletal muscle: 68.1;tongue: 24.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 18.8;Early spermatids: 5.1;Late spermatids: 5.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.5;HaCaT: 4.4;MCF7: 3.1;SK-BR-3: 4.7" "Not detected" "Not detected" "HPA031711, HPA031712" Enhanced NA NA "HPA031711: AB_10669636, HPA031712: AB_2674005" "unprognostic (3.67e-2)" "unprognostic (5.72e-2)" "unprognostic (6.05e-2)" "unprognostic (1.89e-1)" "unprognostic (2.86e-2)" "unprognostic (4.25e-2)" "unprognostic (7.58e-4)" "unprognostic (2.34e-1)" "unprognostic (1.70e-1)" "unprognostic (2.64e-1)" "unprognostic (1.69e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.70e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (1.96e-2)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.0 1.1 0.0 0.0 23.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.9 0.0 68.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 24.7 0.9 0.1 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.5 0.1 0.0 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.0 1.5 1.6 0.0 0.5 0.0 1.1 4.4 0.0 0.0 0.0 1.4 0.5 0.0 1.4 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.0 3.1 0.0 0.0 0.0 0.7 1.1 0.0 0.0 1.8 0.0 0.9 0.0 0.1 1.3 4.7 1.0 0.3 0.4 0.0 0.9 0.7 0.9 0.0 0.7 0.5 0.0 0.0 1.8 0.4 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.5 18.8 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 1.4 PERP "dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW" ENSG00000112378 "PERP, TP53 apoptosis effector" Q96FX8 6 138088505-138107511 "Predicted membrane proteins" "Apoptosis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 250.2;skin 1: 157.9;tongue: 230.6" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 2942.7;Suprabasal keratinocytes: 5094.7;Urothelial cells: 1450.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.3" "Group enriched" "Detected in many" 9 "granulocytes: 21.3;T-cells: 5.6" "Cell line enhanced" "Detected in many" "HaCaT: 37.9;hTCEpi: 142.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022269 Enhanced NA NA "HPA022269: AB_1855219" "prognostic unfavorable (5.46e-4)" "unprognostic (2.90e-1)" "unprognostic (1.94e-1)" "unprognostic (5.18e-2)" "unprognostic (2.82e-2)" "unprognostic (1.27e-1)" "unprognostic (6.28e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.92e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (4.02e-2)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.51e-2)" 4.2 1.6 1.0 2.7 1.2 0.0 25.5 1.3 0.9 51.9 12.5 0.5 7.1 6.3 6.4 11.7 250.2 7.7 15.6 14.7 1.2 1.5 4.4 28.0 8.4 1.7 1.3 0.3 3.3 11.5 5.0 3.3 31.5 1.6 17.5 5.0 2.4 46.6 7.9 1.4 157.9 23.4 7.1 1.3 0.6 8.4 1.9 0.6 6.7 8.7 230.6 113.6 14.0 57.8 1.4 0.0 21.3 0.0 0.0 5.6 0.8 10.2 11.5 0.0 1.1 8.1 8.6 24.0 16.7 18.9 2.4 1.7 9.4 21.2 0.0 6.0 4.2 19.9 37.9 2.0 30.2 0.5 16.1 9.4 0.0 11.5 8.8 5.8 0.0 0.0 6.4 142.2 0.2 15.5 13.8 9.4 0.6 0.1 4.5 0.2 7.1 0.0 0.5 4.9 24.5 6.2 0.0 3.8 0.0 16.1 12.0 4.0 0.0 17.7 9.5 8.1 11.6 5.3 2.1 11.2 4.2 1.6 4.5 0.0 1.4 1.8 0.0 3.3 0.0 8.8 21.3 0.0 0.0 3.0 0.0 5.2 1.4 3.8 2.6 0.0 0.4 0.4 1.7 0.2 0.0 0.0 0.0 5.6 0.8 1.0 1.2 1.3 0.9 1.2 1.5 1.3 0.3 1.6 0.6 196.5 66.8 11.7 1261.9 2942.7 3.4 114.6 234.4 397.5 227.5 146.5 15.7 849.6 53.0 494.4 1.4 53.7 255.2 0.0 273.4 823.5 67.6 524.2 10.4 153.4 71.8 3.2 141.3 9.8 2.2 2.0 9.8 5.1 332.3 18.0 159.9 23.8 453.2 273.5 2.5 10.1 25.6 6.5 122.7 1.8 0.9 5094.7 689.2 31.2 162.2 1450.6 PET100 C19orf79 ENSG00000229833 "PET100 homolog" P0DJ07 19 7629737-7631956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 106.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067288 Approved Mitochondria NA NA Mitochondria "HPA067288: AB_2732762" "unprognostic (7.02e-2)" "prognostic favorable (6.81e-4)" "unprognostic (1.57e-1)" "unprognostic (9.87e-3)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (1.70e-1)" "prognostic favorable (7.97e-4)" "unprognostic (4.89e-1)" "unprognostic (2.88e-3)" "unprognostic (2.49e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (2.66e-2)" "prognostic favorable (2.44e-4)" 18.7 27.8 24.9 21.3 23.3 42.3 22.9 16.1 27.8 13.2 21.9 9.7 29.3 22.2 13.4 27.4 18.0 11.0 24.0 47.3 31.6 18.3 24.7 36.8 14.9 20.5 19.8 25.3 11.9 24.7 11.0 20.7 18.0 21.0 16.4 16.4 14.7 29.9 30.1 41.1 14.8 18.8 12.9 21.3 18.2 25.6 14.4 12.4 16.4 17.5 29.9 17.5 10.2 13.6 52.6 86.9 106.6 82.2 33.8 60.1 72.1 18.4 16.6 30.5 18.2 14.8 10.7 11.2 15.8 9.1 10.9 10.7 14.8 12.5 12.3 27.9 11.9 13.5 16.4 13.7 14.4 9.0 28.1 27.8 17.6 35.1 23.6 7.4 30.0 16.9 12.1 9.3 7.3 7.7 17.4 15.4 30.3 12.7 47.7 11.4 20.1 32.2 47.2 19.7 21.4 36.3 20.3 17.3 28.6 21.9 22.5 17.0 20.3 21.0 18.9 17.0 19.5 13.8 39.8 16.7 8.6 10.6 17.2 23.5 42.9 33.5 22.4 15.8 23.2 10.2 106.6 82.2 89.2 41.9 63.7 39.0 52.6 48.6 43.8 49.8 51.0 45.4 47.7 77.2 33.8 56.1 86.9 60.1 72.1 24.9 23.3 16.1 27.8 31.6 18.3 19.8 25.3 21.0 12.4 140.0 188.2 119.3 34.8 44.6 49.0 48.4 231.8 145.9 121.7 246.0 21.6 109.5 182.4 187.3 33.6 64.6 254.8 210.2 275.3 108.9 79.7 58.6 101.9 470.9 149.2 17.5 184.1 168.8 266.1 38.0 94.0 169.6 108.0 232.6 239.3 60.6 286.3 280.5 78.1 209.8 67.5 84.1 54.7 111.8 89.1 51.7 149.5 147.2 189.2 40.8 PEX5L "PEX5R, PXR2, TRIP8b" ENSG00000114757 "Peroxisomal biogenesis factor 5 like" Q8IYB4 3 179794958-180037053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 41.9;parathyroid gland: 60.1" "Cell type enriched" "Detected in some" 10 "Cone photoreceptor cells: 237.6" "Cancer enhanced" "Detected in some" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 5.8;MOLT-4: 20.2;RPMI-8226: 16.1;SCLC-21H: 9.9;U-266/70: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058026 Enhanced NA NA "HPA058026: AB_2683582" "unprognostic (5.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.93e-1)" "unprognostic (1.82e-3)" "unprognostic (2.68e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-4)" "unprognostic (9.67e-5)" "unprognostic (3.84e-1)" "unprognostic (2.66e-10)" "unprognostic (2.27e-3)" "unprognostic (1.45e-2)" "unprognostic (1.69e-2)" "unprognostic (4.03e-3)" 1.3 1.4 17.0 1.3 26.6 1.2 1.2 1.8 41.9 1.3 1.2 24.5 0.0 1.3 1.2 1.5 1.3 1.4 1.2 1.3 16.9 8.1 1.3 1.2 1.3 1.2 38.4 18.9 2.9 10.6 60.1 5.3 1.1 24.1 1.4 1.2 0.0 1.3 1.2 1.4 1.2 1.3 1.1 32.3 1.2 1.3 5.4 36.5 0.0 1.3 0.0 1.2 1.2 0.4 0.8 0.4 0.8 0.1 0.4 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 5.8 0.0 0.0 0.1 0.0 0.0 1.1 0.1 0.1 0.0 0.0 1.0 0.5 0.0 0.5 0.0 2.9 0.0 0.0 20.2 0.0 1.2 0.0 0.2 0.1 0.0 16.1 0.0 0.0 9.9 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.1 0.1 0.0 0.5 13.0 0.4 0.0 0.3 0.1 0.5 0.6 0.1 0.2 0.6 0.1 0.5 0.0 0.1 0.0 0.0 0.8 0.2 0.3 0.8 0.4 0.1 0.4 0.0 0.0 17.0 26.6 1.8 26.0 16.9 8.1 38.4 18.9 24.1 36.5 0.0 0.0 0.0 0.2 0.0 6.9 2.8 0.0 0.0 0.0 0.0 237.6 0.0 0.0 0.0 23.1 0.4 0.0 0.0 0.5 0.0 0.2 0.3 0.0 0.0 0.1 9.5 0.0 0.0 0.0 15.4 0.3 0.0 0.0 1.0 0.0 2.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.7 0.9 0.3 0.0 0.0 0.0 0.0 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963870-42979220 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 73.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 13.0 14.9 12.1 11.5 18.9 9.0 11.5 21.7 19.0 14.7 16.9 14.6 15.3 9.8 11.9 8.8 18.2 23.4 13.0 10.4 12.9 12.1 11.3 18.8 7.4 17.6 17.3 9.1 20.0 73.2 21.3 18.2 10.6 16.0 17.8 8.5 10.8 15.0 12.8 15.2 14.2 24.6 10.5 9.9 12.8 10.6 10.6 17.2 22.3 21.5 6.9 10.9 11.2 12.4 4.3 4.3 4.8 3.2 4.0 6.1 2.5 15.9 7.7 3.9 14.5 14.5 14.0 4.0 2.8 4.4 2.3 4.8 4.8 4.7 6.5 3.9 6.7 9.8 15.1 13.5 14.6 2.4 12.6 7.2 2.1 10.9 2.8 9.8 2.2 4.5 17.4 16.9 9.5 2.6 18.8 11.7 8.9 11.3 6.7 5.0 1.8 5.7 7.2 4.8 36.3 6.7 12.3 6.8 2.6 5.9 4.6 12.2 5.3 2.6 10.4 14.7 6.6 20.5 9.8 6.5 7.4 1.4 3.6 6.4 10.1 8.8 8.9 2.5 11.3 5.9 2.1 3.2 4.8 3.0 2.4 5.4 2.6 4.4 6.1 4.3 4.3 5.5 5.1 2.0 4.0 1.5 2.5 2.1 2.5 12.1 18.9 21.7 19.0 12.9 12.1 17.3 9.1 16.0 17.2 6.0 1.6 2.7 8.8 4.4 14.5 4.5 5.1 5.3 3.4 7.0 2.0 7.7 11.6 2.4 2.2 4.0 12.4 0.0 1.3 5.7 6.4 6.2 0.0 10.5 4.9 20.6 5.2 9.8 6.7 2.2 13.6 2.8 8.5 1.0 7.4 10.6 1.7 7.0 8.9 9.8 6.4 0.0 5.2 7.7 2.8 4.8 6.2 4.4 8.0 5.5 PF4 "CXCL4, SCYB4" ENSG00000163737 "Platelet factor 4" P02776 4 73981077-73982124 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Chemotaxis "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6" "Cell type enhanced" "Detected in some" 18 "Intestinal endocrine cells: 12.9;Pancreatic endocrine cells: 6.2;Undifferentiated cells: 5.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 18.3;neutrophil: 16.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Cell line enriched" "Detected in some" 10 "HEL: 30.4" "CAB026008, HPA052485" Enhanced "Secreted to blood" NA NA 7700000 "CAB026008: , HPA052485: AB_2681847" "unprognostic (4.14e-4)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.96e-4)" "unprognostic (7.58e-2)" "unprognostic (1.42e-1)" "unprognostic (7.55e-2)" "unprognostic (2.04e-1)" "unprognostic (9.02e-3)" "unprognostic (1.84e-2)" "unprognostic (3.03e-2)" "unprognostic (9.54e-5)" "unprognostic (2.55e-1)" "unprognostic (8.77e-2)" "unprognostic (9.69e-2)" "unprognostic (4.81e-2)" 0.7 0.4 0.2 0.7 0.9 46.8 0.8 0.2 0.3 0.3 1.1 0.0 0.0 0.1 0.2 0.4 0.2 0.5 0.8 46.0 0.8 0.3 0.5 1.7 9.1 3.3 2.6 0.3 3.0 0.4 0.1 0.4 4.8 1.9 0.2 0.9 1.0 0.4 0.2 1.0 0.2 0.3 0.2 0.9 42.6 0.9 0.6 0.0 0.0 1.8 0.9 0.1 1.0 3.0 0.3 1.9 18.3 1.4 0.0 0.3 50.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 30.4 0.0 0.0 1.5 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 1.4 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.5 0.3 0.2 0.1 16.5 0.0 1.1 1.9 0.2 50.5 0.2 0.9 0.2 0.3 0.8 0.3 2.6 0.3 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.3 0.0 12.9 1.8 2.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.1 0.1 PF4V1 "CXCL4L1, CXCL4V1, SCYB4V1" ENSG00000109272 "Platelet factor 4 variant 1" P10720 4 73853189-73854155 "Plasma proteins, Predicted secreted proteins" "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.6;lymphoid tissue: 27.8" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 10.2;Club cells: 2.3;Intestinal endocrine cells: 5.1" "Cancer enhanced" "Detected in some" "renal cancer: 3.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 28 "basophil: 9.1;neutrophil: 11.2" "Lineage enriched" "Detected in single" 30 "granulocytes: 11.2" "Cell line enhanced" "Detected in some" "BJ: 2.8;CAPAN-2: 3.6;EFO-21: 5.7;HHSteC: 2.2;HSkMC: 3.5;HUVEC TERT2: 1.8;RPTEC TERT1: 3.3;U-2197: 1.9" HPA052485 Supported "Secreted to blood" NA NA 1400000000 "HPA052485: AB_2681847" "unprognostic (4.95e-1)" "unprognostic (5.68e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-3)" "unprognostic (9.88e-2)" "unprognostic (1.72e-2)" "unprognostic (1.68e-3)" "unprognostic (2.66e-1)" "unprognostic (6.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.95e-3)" "unprognostic (1.39e-2)" "unprognostic (2.11e-1)" 0.3 0.2 0.1 0.9 0.4 2.8 0.6 0.2 0.5 0.8 0.7 0.0 0.7 4.8 0.1 1.1 0.6 0.5 0.5 8.7 0.4 0.6 2.0 1.9 2.6 0.9 0.4 0.3 7.4 0.4 0.1 0.4 2.0 1.2 1.0 0.7 0.2 1.5 4.0 0.1 0.2 3.2 0.0 0.6 27.8 0.2 0.3 0.0 0.1 0.2 1.1 0.2 5.0 1.0 0.1 0.3 11.2 0.2 0.0 0.2 12.6 0.0 0.0 0.0 0.0 0.7 0.6 0.3 2.8 0.4 0.0 0.0 0.0 3.6 0.0 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.2 0.0 0.0 3.5 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 11.2 0.0 0.1 0.3 0.0 12.6 0.1 0.4 0.2 0.5 0.4 0.6 0.4 0.3 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 10.2 0.0 2.3 1.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 PFKFB1 PFRX ENSG00000158571 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1" P16118 X 54932961-54998534 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 15.5" "Cancer enriched" "Detected in some" 11 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 13.9;Hep G2: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.51e-1)" "unprognostic (2.39e-2)" "unprognostic (1.17e-2)" "unprognostic (4.38e-3)" "unprognostic (1.64e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "unprognostic (3.33e-1)" "unprognostic (3.26e-3)" "unprognostic (2.88e-1)" "unprognostic (5.36e-3)" "unprognostic (5.06e-1)" "unprognostic (4.87e-2)" "unprognostic (1.16e-4)" "unprognostic (1.96e-3)" 24.2 0.2 0.1 1.6 0.1 0.1 13.1 0.1 0.2 0.1 1.7 0.1 0.1 0.0 0.1 0.2 0.5 0.0 0.1 0.1 0.1 0.1 0.4 24.4 0.1 1.6 0.1 0.1 0.1 0.6 0.2 0.2 0.1 0.1 0.3 0.2 0.1 1.3 0.1 48.3 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 8.3 0.6 0.2 2.0 1.5 0.1 0.0 0.7 1.3 2.1 0.3 0.3 0.2 0.4 0.6 13.9 0.3 1.0 0.0 0.1 0.2 0.0 0.9 0.2 0.6 0.3 0.1 0.6 0.5 0.1 0.3 0.5 0.4 1.1 0.4 0.1 5.5 0.0 0.1 0.6 0.2 0.6 0.1 0.4 0.0 0.0 1.3 0.1 2.2 0.2 0.7 0.6 0.3 0.4 0.4 0.3 0.5 0.2 0.2 0.0 0.4 0.4 0.3 0.5 1.6 0.2 1.2 0.4 0.0 0.2 0.1 0.5 0.4 0.2 1.1 1.7 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.2 0.7 2.1 1.5 0.2 0.0 0.0 0.8 0.0 0.8 0.0 1.3 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.5 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 PFKFB3 ENSG00000170525 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3" Q16875 10 6144934-6254644 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.6;skeletal muscle: 135.7" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 20.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 72.7;RPTEC TERT1: 45.9;T-47d: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008266, CAB020795, HPA043889" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717" "unprognostic (1.61e-1)" "unprognostic (5.08e-3)" "unprognostic (2.89e-2)" "unprognostic (6.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.79e-1)" "unprognostic (3.11e-3)" "unprognostic (1.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.04e-1)" "unprognostic (3.30e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.89e-2)" "unprognostic (1.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.74e-1)" 105.6 9.0 16.4 25.7 17.9 77.0 43.4 8.5 29.4 6.6 8.8 29.1 10.6 7.4 9.4 6.3 13.0 14.4 22.4 5.7 16.6 13.2 22.1 11.2 15.1 12.1 19.2 12.9 8.0 8.1 4.0 10.2 7.5 20.7 5.4 3.8 19.3 9.1 20.0 135.7 11.8 6.9 6.5 36.0 12.4 6.7 4.6 16.8 3.3 2.9 4.7 10.3 10.3 10.1 1.5 3.6 20.5 7.1 0.8 4.7 2.9 5.2 72.7 5.8 4.7 21.9 2.7 3.0 7.7 5.5 5.8 9.0 3.4 19.3 9.0 5.1 3.3 4.5 17.0 6.2 12.3 6.7 10.7 4.3 5.3 3.7 1.2 1.8 5.1 8.1 1.9 4.1 9.9 2.4 14.8 11.1 6.3 3.9 3.4 4.6 8.6 3.6 4.8 5.6 7.5 5.1 8.2 2.8 3.5 45.9 2.7 5.5 2.2 5.6 6.2 11.0 10.4 47.8 6.1 14.0 6.1 5.6 0.7 9.3 7.0 2.4 8.1 16.7 6.0 9.2 2.2 5.6 5.5 1.8 7.1 4.7 1.5 3.4 2.3 3.6 1.4 2.5 2.4 20.5 0.8 4.1 2.2 3.2 2.9 16.4 17.9 8.5 16.9 16.6 13.2 19.2 12.9 20.7 16.8 71.5 75.9 13.7 14.3 91.1 7.8 17.3 15.3 13.4 42.1 184.9 49.1 0.2 0.0 42.7 5.1 29.2 7.4 0.0 22.5 4.6 29.8 4.3 41.7 11.6 19.4 6.4 8.2 9.2 79.2 6.1 2.6 37.7 43.9 23.4 5.2 0.4 46.2 5.8 6.7 2.4 1.6 0.0 21.1 0.7 1.6 55.8 0.8 21.3 5.4 9.9 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.0" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2" "Group enriched" "Detected in many" 6 "granulocytes: 21.6;monocytes: 12.2" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli NA NA Nucleoli "HPA047719: AB_2680129, HPA066058: AB_2685606" "unprognostic (7.60e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 2.0 2.2 4.0 3.9 4.9 12.7 2.1 6.3 6.3 2.6 17.1 8.6 3.0 17.8 2.1 18.5 6.4 1.5 1.8 1.4 4.2 5.2 3.6 1.7 3.8 6.3 7.4 2.7 3.5 18.9 4.1 5.1 9.5 6.9 3.3 3.5 3.3 2.5 2.0 4.8 3.3 24.0 2.5 5.3 10.0 1.2 26.0 5.2 0.4 1.6 3.6 2.6 4.9 4.2 0.2 2.7 21.6 12.2 0.2 0.5 2.1 5.0 1.5 3.6 3.3 1.2 1.8 7.1 2.5 4.3 5.2 12.6 2.5 1.8 2.2 2.4 1.9 12.4 1.4 1.5 4.4 4.6 1.5 1.2 5.1 3.3 2.7 1.0 0.9 2.3 1.8 6.6 8.3 0.8 22.9 1.2 2.9 1.7 1.9 4.1 1.1 0.3 7.1 2.2 1.0 3.4 0.4 1.7 2.3 2.0 4.7 1.0 2.2 2.7 1.2 9.9 3.7 2.8 2.2 0.3 5.3 2.1 0.6 15.3 8.8 1.9 1.3 36.5 1.8 31.7 0.0 6.5 11.4 0.2 7.3 0.1 0.2 0.3 0.0 2.7 0.1 0.5 0.1 21.6 0.2 12.2 0.3 0.0 2.1 4.0 4.9 6.3 6.3 4.2 5.2 7.4 2.7 6.9 5.2 0.0 2.2 0.0 0.3 2.9 5.0 0.6 0.0 1.4 1.2 0.0 2.0 11.1 0.0 2.0 2.6 0.4 1.7 0.0 1.3 36.2 1.5 0.4 1.1 0.0 5.3 6.4 4.1 1.8 11.0 2.0 0.9 4.4 1.7 0.0 11.8 3.6 2.9 0.3 0.7 0.0 4.3 0.0 0.8 0.5 0.5 1.5 4.6 0.0 1.5 0.0 PFKM "PFK-1, PFKX, PPP1R122" ENSG00000152556 "Phosphofructokinase, muscle" P08237 12 48105139-48146404 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 284.3" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 326.0;Horizontal cells: 114.4;Muller glia cells: 114.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002117 Approved Approved "Endoplasmic reticulum" NA NA 1100000 "Endoplasmic reticulum" "HPA002117: AB_1855245" "unprognostic (4.60e-2)" "unprognostic (2.56e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (5.85e-6)" "unprognostic (4.97e-1)" "prognostic unfavorable (7.91e-5)" "unprognostic (5.93e-3)" "unprognostic (1.63e-1)" "unprognostic (2.80e-1)" "unprognostic (1.86e-1)" "unprognostic (2.29e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (1.53e-1)" "unprognostic (5.72e-2)" "unprognostic (1.30e-2)" 4.4 11.6 10.0 3.0 16.2 2.3 3.9 13.0 23.6 5.8 5.3 6.1 5.4 3.0 6.4 5.8 9.1 5.4 4.8 55.5 8.2 10.1 10.9 2.7 3.6 2.4 9.4 10.8 10.8 3.0 14.2 11.4 3.3 17.9 7.1 4.2 10.8 5.2 9.4 284.3 2.6 2.8 8.3 4.6 2.7 4.1 10.3 3.8 0.0 5.5 54.9 4.6 5.3 3.7 10.7 6.7 8.7 3.2 2.2 5.4 3.5 8.7 8.5 27.0 24.5 27.5 20.0 5.5 23.7 21.8 20.5 14.5 21.0 11.0 52.1 19.6 11.4 12.0 9.7 23.3 23.9 19.3 1.2 12.2 14.8 19.3 0.6 14.7 0.7 8.6 28.3 14.1 18.0 29.7 34.3 23.2 0.8 17.8 26.3 18.8 6.6 18.3 1.2 19.2 9.6 26.5 30.8 15.7 40.0 14.0 9.7 31.9 23.5 14.0 22.2 23.7 22.4 22.5 3.2 20.9 9.5 13.1 13.9 19.7 14.4 38.3 28.5 18.4 1.5 7.9 0.4 3.2 8.7 2.5 2.8 1.0 10.7 4.3 2.4 6.7 7.0 5.4 3.0 0.8 2.2 2.3 1.0 3.8 3.5 10.0 16.2 13.0 23.6 8.2 10.1 9.4 10.8 17.9 3.8 14.9 5.9 6.8 17.7 6.5 38.0 326.0 17.8 9.4 7.9 21.0 41.2 2.2 56.3 9.4 29.7 15.8 2.2 0.0 2.2 3.5 16.7 6.1 1.1 2.5 3.5 114.4 8.7 9.8 2.7 19.6 28.4 3.2 52.3 18.0 6.2 114.5 3.3 0.0 44.9 25.8 41.0 25.8 26.2 46.8 11.5 4.5 2.1 4.4 12.1 7.6 PFN1 ENSG00000108518 "Profilin 1" P07737 17 4945652-4949061 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 509.4" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 4080.6;monocytes: 7018.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037134, CAB037140" Enhanced Approved Cytosol NA NA 1100000000 Cytosol "CAB037134: AB_1079599, CAB037140: AB_1079598" "unprognostic (1.07e-1)" "unprognostic (3.57e-1)" "unprognostic (1.60e-1)" "unprognostic (5.45e-3)" "unprognostic (1.65e-1)" "unprognostic (7.54e-2)" "unprognostic (4.01e-3)" "unprognostic (7.83e-3)" "unprognostic (3.38e-1)" "unprognostic (1.09e-3)" "unprognostic (2.17e-1)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (3.62e-1)" "unprognostic (8.17e-2)" "unprognostic (1.02e-2)" "unprognostic (1.28e-1)" 65.2 48.2 24.0 125.4 36.7 118.0 61.3 15.6 25.9 63.8 102.3 33.1 46.7 66.4 97.4 52.9 96.6 67.5 87.8 40.7 22.0 19.6 80.5 137.3 70.5 159.4 37.4 17.3 53.7 37.2 18.3 27.5 82.8 28.5 62.0 68.2 39.3 46.0 52.6 51.6 51.2 96.4 119.4 33.3 138.7 70.4 27.2 30.5 199.3 46.6 65.3 116.3 97.9 54.4 154.4 263.4 356.5 322.9 223.0 288.9 509.4 140.1 169.1 63.5 50.9 32.8 40.9 95.3 119.9 78.8 104.2 79.0 65.4 49.5 101.9 104.3 101.3 63.0 88.6 56.6 122.1 83.9 177.2 111.3 104.3 86.6 84.9 90.0 65.7 248.2 48.5 53.7 80.7 80.5 63.7 93.4 69.8 57.5 74.4 124.7 69.7 125.2 141.8 98.8 60.2 103.9 125.5 85.3 65.6 100.8 75.0 26.0 77.5 80.5 50.5 73.4 55.5 47.3 55.8 114.2 91.1 84.5 68.3 174.1 53.1 53.8 82.1 78.5 79.0 138.3 168.7 216.8 356.5 286.3 278.7 190.1 154.4 236.8 270.9 263.4 135.2 154.8 221.1 255.4 223.0 322.9 212.4 288.9 509.4 24.0 36.7 15.6 25.9 22.0 19.6 37.4 17.3 28.5 30.5 104.2 205.8 866.8 636.2 1604.2 21.1 131.7 501.9 111.1 149.0 703.1 0.0 1882.1 840.6 1770.0 14.2 550.7 1316.6 93.5 1422.2 4080.6 968.1 512.4 473.6 682.9 3613.7 36.5 580.1 689.9 1477.5 18.5 244.2 2021.5 828.4 7018.1 1219.5 67.9 2136.3 1369.2 352.5 1192.8 11.6 498.0 1013.7 95.6 348.1 1322.9 1407.4 2210.4 1246.9 991.4 PFN2 ENSG00000070087 "Profilin 2" P35080 3 149964904-150050788 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 89.7" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 391.3;Muller glia cells: 211.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035611, CAB037073" Enhanced NA NA "CAB037073: AB_1079600, HPA035611: AB_10672870" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.42e-4)" "prognostic unfavorable (2.19e-7)" "unprognostic (4.11e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-2)" "unprognostic (2.96e-3)" "unprognostic (4.86e-3)" "unprognostic (6.82e-2)" "unprognostic (1.25e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.99e-1)" 9.2 13.9 59.1 6.7 49.6 1.3 12.8 35.1 89.7 14.5 10.3 22.8 11.6 8.8 21.4 54.1 9.0 33.8 12.5 15.4 64.8 39.9 39.8 8.7 6.6 2.6 36.1 44.6 21.8 11.7 15.7 12.9 7.4 33.6 23.4 10.0 11.7 15.8 23.9 75.0 2.9 11.7 20.5 30.5 5.5 8.5 9.4 15.9 2.3 34.4 9.1 3.7 15.2 6.8 2.7 0.3 1.5 0.3 1.6 9.7 3.1 76.1 26.6 64.0 26.2 14.3 48.9 17.1 24.5 37.2 38.7 45.1 9.9 61.6 0.0 51.8 53.5 67.1 0.8 26.5 34.8 56.3 2.4 15.7 0.8 14.5 28.3 19.1 4.2 1.2 30.7 29.5 38.0 49.6 41.4 22.5 12.4 0.2 3.1 40.1 28.2 3.6 0.2 27.9 0.5 35.2 4.2 47.6 0.3 28.5 38.9 34.8 35.9 12.1 5.8 32.9 46.4 9.3 0.6 16.2 18.5 26.0 30.7 31.5 4.1 0.3 2.0 40.0 0.2 22.5 1.2 0.3 0.5 2.9 0.1 6.0 2.7 6.3 5.3 0.1 1.5 9.7 5.7 1.5 1.6 0.1 0.3 1.6 3.1 59.1 49.6 35.1 87.5 64.8 39.9 36.1 44.6 33.6 15.9 6.0 5.8 3.7 35.9 8.8 49.5 43.7 17.8 87.0 28.4 129.1 17.7 12.7 391.3 40.2 41.5 12.8 18.6 0.0 24.2 9.3 48.3 55.3 8.1 10.6 2.8 25.4 116.4 20.9 1.5 20.9 68.4 4.9 33.7 8.2 29.0 211.2 14.6 22.1 90.9 120.7 30.8 12.9 44.3 20.5 17.4 6.6 8.6 2.2 31.2 22.7 PFN3 ENSG00000196570 "Profilin 3" P60673 5 177400107-177400636 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 24.8" "Group enriched" "Detected in some" 135 "Early spermatids: 653.6;Late spermatids: 972.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;HDLM-2: 2.5" "Region enhanced" "Detected in single" "cerebral cortex: 0.3" NA NA "unprognostic (1.03e-2)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 653.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 972.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 5.2 4.6 0.0 0.0 0.0 0.0 0.0 PFN4 ENSG00000176732 "Profilin family member 4" Q8NHR9 2 24115371-24123477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 82.3" "Group enriched" "Detected in some" 10 "Early spermatids: 326.9;Spermatocytes: 142.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 5 "B-cells: 1.5;T-cells: 3.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" NA NA "unprognostic (4.20e-3)" "unprognostic (2.41e-1)" "unprognostic (1.77e-1)" "unprognostic (1.24e-1)" "unprognostic (3.52e-2)" "unprognostic (1.37e-1)" "unprognostic (4.56e-4)" "unprognostic (1.25e-1)" "unprognostic (3.82e-2)" "unprognostic (2.21e-2)" "unprognostic (2.74e-2)" "unprognostic (8.97e-3)" "unprognostic (1.77e-5)" "unprognostic (2.55e-2)" "unprognostic (1.52e-1)" "unprognostic (1.16e-1)" "unprognostic (9.10e-2)" 0.3 0.4 0.4 0.2 0.6 0.0 0.7 0.4 0.9 0.4 0.3 0.6 1.6 0.0 0.4 1.3 0.5 0.9 0.3 0.5 0.5 0.4 0.5 0.2 0.3 0.1 0.3 0.8 0.9 1.0 0.5 0.7 0.2 0.4 0.4 0.2 0.6 0.7 0.5 0.4 0.2 0.2 0.4 0.3 0.2 0.2 82.3 0.4 0.1 1.1 0.1 0.4 0.2 0.4 1.5 0.4 0.0 0.4 0.4 3.3 0.1 3.9 1.9 0.7 3.6 4.4 5.1 1.5 1.5 0.6 1.5 1.1 1.2 4.4 1.8 0.8 0.0 4.3 0.7 0.0 0.7 0.8 2.0 0.0 0.8 0.6 0.2 3.0 0.8 0.2 5.0 2.9 0.7 1.8 1.1 1.2 2.8 0.5 2.5 2.8 3.1 0.9 0.9 0.7 0.0 3.0 0.8 1.8 0.0 2.3 0.7 1.5 2.8 1.6 0.5 1.4 1.5 4.8 0.6 1.1 1.9 1.5 0.4 1.2 3.4 2.7 1.7 3.2 0.0 2.8 0.0 0.4 0.0 0.4 0.2 0.6 0.4 0.0 0.4 0.4 1.5 0.0 3.3 0.0 0.4 0.0 0.3 0.0 0.1 0.4 0.6 0.4 0.9 0.5 0.4 0.3 0.8 0.4 0.4 0.0 1.4 0.0 0.5 0.2 0.5 2.4 0.0 5.3 0.0 0.0 0.0 0.4 3.3 0.4 326.9 0.3 0.0 0.0 1.2 0.7 0.8 0.2 0.0 0.8 0.9 1.6 0.0 0.0 0.0 23.6 6.1 0.0 0.0 0.0 0.2 1.0 0.8 0.0 1.8 1.3 1.0 0.0 0.4 142.7 2.2 0.5 0.2 0.0 0.0 0.4 PGA3 ENSG00000229859 "Pepsinogen 3, group I (pepsinogen A)" P0DJD8 11 61203307-61213098 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "stomach 1: 1048.8" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Exocrine glandular cells: 5.8;Rod photoreceptor cells: 3.2" "Cancer enriched" "Detected in single" 498 "stomach cancer: 24.8" "Region enriched" "Detected in single" 15 "cerebral cortex: 4.8" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.7" "Lineage enriched" "Detected in many" 4 "monocytes: 6.7" "Group enriched" "Detected in some" 5 "HMC-1: 13.7;THP-1: 4.5" "CAB026358, HPA046875" Enhanced "Secreted to digestive system" NA NA "CAB026358: , HPA046875: AB_2679851" "unprognostic (6.39e-2)" "unprognostic (1.11e-1)" 0.3 0.1 0.0 0.2 0.3 0.0 0.3 0.0 4.8 0.2 0.4 19.9 0.0 0.1 0.1 0.5 36.8 0.2 0.0 0.4 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.4 17.7 0.0 0.0 0.2 0.0 0.2 0.0 0.1 2.0 0.1 0.1 0.0 0.0 0.7 0.0 1.4 1048.8 0.1 0.0 0.0 0.1 3.8 0.0 0.1 0.0 0.3 0.3 1.1 6.7 0.5 1.5 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.3 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.5 4.3 0.2 1.5 6.7 0.9 0.2 0.5 1.4 0.3 0.3 0.2 1.4 1.1 0.5 1.7 0.2 0.1 3.0 0.0 0.3 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PGA4 ENSG00000229183 "Pepsinogen 4, group I (pepsinogen A)" P0DJD7 11 61222216-61231927 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 120 "stomach 1: 924.0" "Cell type enriched" "Detected in single" 128 "Exocrine glandular cells: 100.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "classical monocyte: 7.6;intermediate monocyte: 5.9;non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 23 "monocytes: 7.6" "Group enriched" "Detected in some" 8 "BJ hTERT+: 17.6;THP-1: 8.9" HPA046875 Supported "Secreted to digestive system" NA NA "HPA046875: AB_2679851" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 924.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 7.6 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 2.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 100.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGA5 ENSG00000256713 "Pepsinogen 5, group I (pepsinogen A)" P0DJD9 11 61241042-61251448 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "stomach 1: 296.9" "Cell type enriched" "Detected in some" 278 "Exocrine glandular cells: 4020.2" "Cancer enriched" "Detected in some" 12 "stomach cancer: 15.0" "Group enriched" "Detected in some" 50 "classical monocyte: 3.4;intermediate monocyte: 7.7;non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 77 "monocytes: 7.7" "Cell line enriched" "Detected in some" 14 "BJ hTERT+: 25.7" HPA046875 Supported "Secreted to digestive system" NA NA "HPA046875: AB_2679851" "unprognostic (1.36e-3)" "unprognostic (2.98e-2)" "unprognostic (5.83e-3)" "unprognostic (2.11e-1)" "unprognostic (4.22e-1)" "unprognostic (4.36e-2)" "unprognostic (2.16e-2)" "unprognostic (1.05e-1)" "unprognostic (7.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 296.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4020.2 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 6.3 1.3 0.9 0.3 0.0 1.0 0.0 14.5 5.9 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Group enriched" "Detected in many" 13 "Early spermatids: 421.0;Late spermatids: 1332.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215" 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 4.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 0.0 0.0 0.5 0.2 1.0 4.3 0.0 0.0 0.0 0.0 0.0 9.8 0.0 68.0 0.0 421.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 22.0 0.0 0.3 1332.7 7.2 0.4 1.7 0.0 0.0 3.8 0.2 0.2 5.6 1.9 4.2 25.8 3.1 30.5 5.6 0.5 0.0 0.0 0.2 0.4 PGAP2 "CWH43-N, FRAG1, MRT21" ENSG00000148985 "Post-GPI attachment to proteins 2" Q9UHJ9 11 3797724-3826371 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 117.3" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 62.9;Early spermatids: 124.4;Late spermatids: 246.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063099 Approved Approved Microtubules NA NA Microtubules "HPA063099: AB_2684940" "unprognostic (1.94e-1)" "unprognostic (1.14e-1)" "unprognostic (2.19e-1)" "unprognostic (3.18e-2)" "unprognostic (5.13e-2)" "unprognostic (6.06e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (3.07e-1)" "unprognostic (1.11e-1)" "unprognostic (6.44e-2)" "unprognostic (3.85e-2)" "unprognostic (4.66e-3)" "unprognostic (4.13e-2)" "unprognostic (2.17e-2)" "unprognostic (2.67e-2)" 4.9 9.5 7.6 7.3 8.2 5.2 6.9 5.0 10.6 7.3 12.3 12.4 18.3 10.2 7.4 117.3 20.0 11.1 8.1 9.3 8.0 6.3 8.6 17.1 9.5 8.6 6.9 8.8 7.1 30.8 12.6 9.1 10.7 5.6 10.1 7.9 12.5 14.5 19.6 6.4 25.0 16.7 4.9 8.9 6.6 7.5 17.7 8.4 15.0 14.1 14.6 15.3 7.7 10.4 11.2 8.7 15.9 8.0 8.7 17.0 7.5 12.5 17.2 8.4 7.6 7.5 14.5 13.3 5.2 4.5 7.8 7.0 14.6 22.2 13.6 6.0 3.8 4.6 21.2 13.3 14.5 7.6 16.5 14.5 8.3 7.5 17.9 5.3 10.5 10.9 11.5 20.4 5.6 19.3 5.0 8.7 18.4 17.5 20.3 8.0 18.8 12.9 9.0 15.7 26.7 10.4 20.2 1.0 13.1 14.6 15.2 11.1 11.0 9.4 25.2 5.6 10.3 20.9 4.6 8.2 4.8 4.6 11.4 3.2 12.7 13.9 10.1 6.3 7.2 9.2 1.9 5.8 5.0 8.8 8.0 10.8 11.0 12.6 10.7 8.7 11.2 17.0 11.3 15.9 8.7 8.0 5.9 11.5 7.5 7.6 8.2 5.0 10.6 8.0 6.3 6.9 8.8 5.6 8.4 11.9 8.8 5.1 11.3 28.2 13.3 11.1 10.2 17.4 6.8 12.2 21.6 62.9 1.7 10.5 124.4 10.0 13.1 0.0 18.5 14.0 7.4 10.2 8.1 11.6 13.9 3.2 2.9 3.7 7.0 246.9 8.1 6.1 5.0 11.8 8.5 7.8 12.8 5.8 6.3 7.8 9.1 6.5 7.6 17.7 19.2 25.0 24.5 6.4 20.8 12.4 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102073-34108684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: AB_2684134" "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 2.5 3.6 3.9 4.1 8.5 6.7 3.4 5.3 11.1 2.6 2.8 4.8 4.7 3.2 2.6 3.9 3.8 4.6 2.4 4.0 5.4 3.6 3.4 5.3 2.4 5.2 6.0 6.1 3.0 4.6 4.9 6.7 2.5 12.7 3.0 3.4 3.2 3.3 2.6 18.6 4.4 5.1 2.2 4.0 6.0 4.5 7.9 5.8 4.5 3.3 2.0 4.2 3.2 2.7 2.8 1.7 6.4 1.4 1.6 2.6 0.6 2.0 3.6 2.5 4.1 7.4 4.9 1.5 3.1 3.0 2.0 2.5 2.5 2.7 4.1 2.6 2.4 4.0 5.6 1.4 3.6 2.5 4.3 3.8 6.7 6.9 1.8 3.1 2.3 6.1 3.8 4.1 2.6 4.7 3.4 2.2 7.6 4.6 5.0 4.1 1.4 3.7 5.4 1.0 4.1 2.7 5.6 3.4 2.1 2.6 4.2 3.7 3.4 1.6 3.5 1.1 3.1 3.5 3.6 2.5 6.1 3.5 3.2 2.0 5.9 3.8 2.3 5.4 5.2 3.6 6.4 1.4 1.5 1.3 1.2 1.1 1.5 1.7 1.3 0.8 2.8 2.6 2.4 3.2 1.6 0.9 1.7 1.3 0.6 3.9 8.5 5.3 11.1 5.4 3.6 6.0 6.1 12.7 5.8 0.0 2.7 4.9 1.9 0.7 5.3 3.7 2.5 5.3 3.4 0.0 5.9 1.5 8.3 1.1 8.8 1.4 3.2 0.0 0.6 0.6 0.6 1.8 1.1 1.7 1.1 9.5 0.0 4.3 3.5 10.2 1.1 2.1 0.0 1.8 1.8 3.8 1.7 0.9 0.4 0.7 6.1 12.9 0.9 6.0 0.7 0.3 2.7 4.5 1.7 1.4 PGBD5 "DKFZp761A0620, FLJ11413" ENSG00000177614 "PiggyBac transposable element derived 5" Q8N414 1 230314482-230426371 "Disease related genes, Predicted intracellular proteins" Transposition "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 23.0;Cone photoreceptor cells: 19.6;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 18.0;GAMG: 9.2;NTERA-2: 18.3;RH-30: 10.0;SCLC-21H: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065010 Supported Nucleoplasm NA NA Nucleoplasm "HPA065010: AB_2685402" "unprognostic (2.00e-2)" "unprognostic (4.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.61e-2)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.44e-2)" "unprognostic (4.66e-2)" "unprognostic (4.91e-2)" "unprognostic (3.97e-1)" "unprognostic (1.15e-1)" "unprognostic (7.48e-3)" "unprognostic (2.57e-1)" "unprognostic (3.29e-2)" "unprognostic (6.69e-2)" "unprognostic (2.12e-1)" "unprognostic (3.13e-3)" "unprognostic (2.51e-1)" 0.8 10.8 16.0 0.8 14.1 0.6 0.7 17.9 27.0 21.9 1.5 6.0 0.1 1.0 5.8 0.5 1.8 5.6 2.2 13.3 20.0 8.0 1.5 2.8 1.8 0.9 7.1 8.9 0.9 21.6 0.9 4.0 2.6 8.0 1.4 1.3 1.0 3.2 1.2 2.8 0.9 1.0 3.0 5.0 2.6 1.6 5.8 4.6 0.5 6.0 0.6 5.1 1.6 1.5 0.8 0.6 1.5 0.6 0.6 0.6 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 4.0 0.0 18.0 1.7 0.1 9.2 3.4 1.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.1 0.9 0.1 3.6 18.3 0.0 0.1 0.0 10.0 2.8 2.1 0.0 25.3 4.7 0.6 0.0 0.2 0.4 0.2 6.1 0.0 0.0 1.5 0.0 1.4 7.7 5.8 0.0 0.0 1.5 0.3 1.5 0.6 1.2 0.6 0.6 0.5 0.4 0.5 0.4 0.4 0.8 0.6 0.6 1.2 0.6 0.6 0.6 0.4 0.2 16.0 14.1 17.9 23.8 20.0 8.0 7.1 8.9 8.0 4.6 0.0 3.4 0.0 0.6 0.1 23.0 5.5 0.0 1.4 0.0 0.0 19.6 0.0 0.0 6.1 0.6 0.1 0.0 0.0 5.1 0.1 0.4 1.3 10.4 4.0 8.7 20.6 8.7 0.0 3.7 0.4 0.0 0.6 1.7 0.0 0.0 2.4 4.9 0.0 0.0 0.6 9.3 0.0 0.7 0.7 1.5 0.0 0.2 0.0 0.0 0.9 PGC ENSG00000096088 Progastricsin P20142 6 41736711-41754109 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Digestion "Aspartyl protease, Hydrolase, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7" "Cell type enhanced" "Detected in some" 28 "Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0" "Cancer enhanced" "Detected in many" "stomach cancer: 1050.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 7 "monocytes: 1.9" "Group enriched" "Detected in some" 11 "Hep G2: 69.6;OE19: 42.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031717, HPA031718" Enhanced Approved Nucleoplasm "Secreted to digestive system" NA NA Nucleoplasm "HPA031717: AB_10670130, HPA031718: AB_10610148" "unprognostic (9.18e-2)" "unprognostic (1.87e-1)" "unprognostic (9.83e-2)" "unprognostic (2.27e-1)" "unprognostic (7.18e-2)" "unprognostic (2.74e-1)" "unprognostic (1.47e-1)" "unprognostic (8.50e-2)" "unprognostic (1.86e-1)" "unprognostic (9.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (1.65e-1)" "unprognostic (8.74e-2)" 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.1 3.0 249.6 41.7 0.1 0.0 3.3 0.3 16.8 0.1 0.1 0.1 0.1 0.3 139.4 0.0 0.1 0.0 0.1 798.6 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.1 35.9 0.1 0.1 0.1 0.0 0.1 0.1 963.7 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.6 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.6 42.3 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 23.8 270.0 0.0 3.1 0.3 0.0 0.2 150.3 5.3 9.1 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 117.5 1.0 0.1 95.4 9.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 843.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.4 0.0 0.0 2.6 PGD ENSG00000142657 "Phosphogluconate dehydrogenase" P52209 1 10398592-10420144 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Gluconate utilization, Pentose shunt" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 115.1;esophagus: 123.8" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 204.0;monocytes: 212.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4" "Group enriched" "Detected in all" 5 "granulocytes: 115.1;monocytes: 32.0" "Cell line enhanced" "Detected in all" "A549: 181.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031314, HPA031315" Enhanced Supported Approved "Intermediate filaments,Cytosol" No No 59000000 "Intermediate filaments, Cytosol" "HPA031314: AB_10610278, HPA031315: AB_2673825" "unprognostic (4.65e-2)" "unprognostic (2.58e-1)" "unprognostic (8.65e-2)" "unprognostic (9.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.90e-2)" "unprognostic (2.83e-1)" "unprognostic (1.40e-2)" "unprognostic (4.92e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" 29.8 12.7 10.9 14.2 11.8 85.5 23.7 8.0 19.1 16.0 14.1 13.8 8.1 22.9 6.3 12.5 123.8 8.4 24.9 14.3 10.3 12.1 15.4 23.2 25.6 34.9 12.4 11.4 14.3 8.3 16.2 10.8 17.0 19.3 7.9 12.9 19.7 31.8 6.8 8.5 10.6 25.3 9.5 12.6 27.6 13.4 27.0 7.4 16.8 21.2 68.8 49.9 14.8 26.1 3.9 15.9 115.1 32.0 2.0 3.0 19.0 23.1 181.8 45.3 48.7 69.0 42.7 9.8 15.7 27.8 21.8 29.8 26.6 26.7 22.8 19.4 16.1 29.9 19.7 33.1 28.1 14.7 15.7 28.9 30.8 32.7 55.9 21.0 50.8 34.2 30.4 14.1 34.4 8.5 27.8 51.4 32.0 41.0 20.2 27.8 26.3 41.9 25.5 27.2 31.8 16.0 32.5 41.6 41.9 30.4 12.5 24.4 21.3 13.4 21.3 18.5 31.2 23.5 43.6 48.1 11.5 20.4 13.7 17.3 15.3 27.9 40.8 25.1 55.2 10.3 98.6 32.0 115.1 2.6 15.3 3.0 3.9 2.5 2.4 15.9 2.3 2.4 2.6 38.4 2.0 10.9 11.4 2.4 19.0 10.9 11.8 8.0 19.1 10.3 12.1 12.4 11.4 19.3 7.4 17.9 31.2 16.0 28.9 11.6 7.9 9.5 50.9 17.4 23.9 19.2 17.7 114.8 44.7 45.3 7.1 17.5 32.9 0.0 35.1 31.4 28.8 33.1 24.4 48.2 117.8 1.6 22.4 16.0 204.0 9.8 15.8 88.3 16.9 212.8 23.7 12.9 39.9 25.9 9.9 40.3 16.4 19.4 9.8 33.4 37.9 14.4 68.0 16.0 44.1 66.7 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in many" 16 "Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "BEWO: 93.4;HUVEC TERT2: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.3 0.4 0.0 93.4 0.8 0.8 0.4 0.5 2.2 0.1 0.0 2.0 0.6 0.0 0.1 0.4 4.2 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.1 1.0 1.7 0.4 0.1 44.0 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.4 0.0 0.7 0.0 11.6 0.0 0.1 0.2 7.0 3.8 0.0 0.1 1.6 5.9 0.0 0.1 8.9 0.0 2.3 0.0 3.7 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 8.9 5.8 0.8 13.0 21.9 0.8 2.8 0.0 1.4 7.9 0.0 13.7 75.1 0.0 0.9 0.1 15.8 0.5 0.0 0.4 1478.5 42.9 3.3 5.8 0.0 33.1 0.0 6.8 7.4 0.3 0.6 12.0 4.5 20.3 0.0 1.1 1.9 0.6 0.2 18.4 0.4 7.5 103.5 62.6 0.2 3.4 17.1 1775.1 0.9 1.7 4.7 PGGHG "ATHL1, FLJ22635" ENSG00000142102 "Protein-glucosylgalactosylhydroxylysine glucosidase" Q32M88 11 289135-296107 "Enzymes, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "pancreas: 148.7" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 54.5;U-266/70: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039383, HPA058829" Uncertain Enhanced Cytosol NA Yes Cytosol "HPA039383: AB_10796225, HPA058829: AB_2683830" "unprognostic (1.40e-3)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (2.37e-1)" "unprognostic (1.36e-2)" "unprognostic (5.83e-2)" "unprognostic (7.95e-3)" "unprognostic (2.77e-2)" "unprognostic (2.16e-2)" "unprognostic (2.14e-2)" "unprognostic (2.71e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (2.85e-3)" "unprognostic (1.09e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.12e-4)" 5.6 1.8 6.0 16.7 9.3 6.3 10.5 2.9 7.7 12.7 5.6 3.3 10.4 21.1 6.9 14.9 5.6 8.4 8.3 4.4 6.3 1.7 14.8 17.0 15.7 24.6 7.6 2.5 3.5 148.7 2.6 3.6 3.4 8.0 8.5 3.0 7.1 8.9 21.8 5.6 2.4 23.2 5.2 10.1 24.2 4.7 2.3 7.5 6.3 18.0 6.4 15.4 7.3 8.7 2.3 2.5 4.9 4.2 6.9 8.5 2.7 2.1 2.3 4.4 4.8 1.8 1.6 3.3 1.7 1.4 1.0 0.8 2.0 6.1 0.0 2.2 2.0 2.1 1.3 0.3 0.7 0.1 5.2 1.6 1.0 1.5 2.6 2.2 0.1 9.4 5.9 0.6 0.3 0.3 3.7 3.3 54.5 4.0 6.5 0.5 3.1 8.9 4.7 3.4 0.7 0.3 8.5 0.8 3.0 2.3 0.7 0.0 1.0 0.6 3.2 2.9 2.0 2.3 1.1 3.0 2.1 2.9 0.6 0.2 14.3 0.4 2.3 0.3 1.7 2.4 1.5 0.9 1.2 8.5 4.2 7.2 2.1 1.3 4.7 0.6 2.3 3.1 6.1 4.9 6.9 3.2 2.5 0.2 2.7 6.0 9.3 2.9 7.7 6.3 1.7 7.6 2.5 8.0 7.5 148.9 104.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 58.0 31.4 0.0 0.3 0.0 4.9 0.0 0.0 0.0 0.0 7.1 2.9 0.0 0.0 5.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.0 14.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PGK2 "PGK-2, PGKPS" ENSG00000170950 "Phosphoglycerate kinase 2" P07205 6 49785651-49787307 "Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 55 "testis: 70.2" "Group enriched" "Detected in some" 48 "Early spermatids: 906.2;Late spermatids: 2050.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.0;U-2197: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045385, HPA073644, HPA073656" Supported NA NA "HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235" "unprognostic (8.87e-3)" "unprognostic (5.02e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 906.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2050.3 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 6.5 0.0 30.9 8.6 0.0 0.0 0.0 0.0 0.0 PGLYRP1 "PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L" ENSG00000008438 "Peptidoglycan recognition protein 1" O75594 19 46019153-46023065 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 73.7;bone marrow: 130.1" "Cell type enhanced" "Detected in single" 35 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 190 "eosinophil: 63.0;neutrophil: 73.7" "Lineage enriched" "Detected in single" 205 "granulocytes: 73.7" "Cell line enhanced" "Detected in some" "A549: 7.3;HEK 293: 4.1;HeLa: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045702, HPA070227" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 47000000 Vesicles "Nucleoplasm, Cytosol" "HPA045702: AB_10960204, HPA070227: " "unprognostic (2.87e-2)" "unprognostic (4.26e-1)" "unprognostic (1.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.58e-1)" "unprognostic (4.93e-3)" "unprognostic (2.20e-1)" "unprognostic (6.46e-2)" "unprognostic (7.77e-2)" "unprognostic (2.61e-2)" "unprognostic (8.51e-3)" "unprognostic (7.18e-2)" "unprognostic (2.04e-2)" "unprognostic (2.96e-1)" "unprognostic (1.03e-1)" "unprognostic (1.73e-1)" "unprognostic (4.37e-3)" 0.7 0.1 0.2 0.5 0.4 130.1 0.2 0.4 0.2 0.1 0.3 0.3 0.0 0.2 0.1 0.1 0.2 0.4 0.1 10.9 0.2 0.2 0.2 1.5 10.9 1.0 0.2 0.0 0.7 0.2 0.1 1.4 4.1 0.1 0.1 0.1 0.5 0.7 0.1 1.3 0.3 0.2 0.1 0.1 26.9 0.2 0.9 0.0 7.5 1.3 0.0 0.5 0.1 5.5 0.0 0.0 73.7 0.3 0.0 0.0 0.4 0.6 7.3 1.2 0.8 0.0 0.0 2.0 0.6 0.0 0.0 0.0 1.2 0.6 2.0 0.2 0.0 0.6 2.7 0.0 0.0 0.0 1.9 4.1 0.8 3.5 0.3 0.0 0.4 2.1 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.7 0.6 0.0 0.5 0.4 2.2 0.4 0.0 2.7 1.6 0.2 0.2 0.0 2.6 0.8 0.2 0.5 0.1 0.0 0.6 0.3 0.1 0.0 0.1 0.3 0.7 1.1 1.6 1.3 0.8 1.1 1.7 0.1 0.0 0.0 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.0 0.3 0.0 0.0 0.4 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PGLYRP2 "PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like" ENSG00000161031 "Peptidoglycan recognition protein 2" Q96PD5 19 15468645-15498956 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 95.8" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 136.1" "Cancer enriched" "Detected in some" 16 "liver cancer: 42.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7" "Group enriched" "Detected in some" 6 "MCF7: 10.9;T-47d: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033468, HPA046311, HPA075237" Supported Approved "Cell Junctions" "Secreted to blood" NA NA 160000000000 "Cell Junctions" "CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739" "unprognostic (7.39e-3)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (8.79e-2)" "unprognostic (3.97e-1)" "unprognostic (4.88e-4)" "unprognostic (5.93e-3)" "unprognostic (6.48e-2)" "unprognostic (1.99e-1)" "unprognostic (1.18e-2)" "unprognostic (3.15e-2)" "unprognostic (2.40e-1)" "unprognostic (6.66e-16)" "unprognostic (6.35e-3)" "unprognostic (2.80e-1)" "unprognostic (2.45e-2)" "unprognostic (2.81e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 3.6 7.1 0.6 3.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 3.6 0.7 0.3 2.6 2.4 2.5 0.3 1.6 1.3 0.2 0.0 3.6 3.7 2.5 0.6 7.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 136.1 0.3 0.0 0.0 3.1 1.3 2.5 0.3 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 2.9 0.0 0.0 PGLYRP3 "PGLYRPIalpha, PGRP-Ialpha, PGRPIA" ENSG00000159527 "Peptidoglycan recognition protein 3" Q96LB9 1 153297862-153310718 "Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 21.3;skin 1: 39.1;vagina: 10.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.5" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Group enriched" "Detected in some" 15 "HaCaT: 8.8;HDLM-2: 3.5;hTCEpi: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA030369 Uncertain "Secreted in other tissues" NA NA "HPA030369: AB_10603984" "unprognostic (6.34e-2)" "unprognostic (1.60e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-2)" "unprognostic (2.46e-1)" "unprognostic (5.42e-2)" "unprognostic (3.88e-3)" "unprognostic (1.28e-1)" "unprognostic (1.82e-1)" "unprognostic (2.25e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.8 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 10.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 PGLYRP4 "PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67" ENSG00000163218 "Peptidoglycan recognition protein 4" Q96LB8 1 153330120-153348840 "Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 1.8;Early spermatids: 1.6;Melanocytes: 1.7;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in some" 9 "cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "HaCaT: 8.2;HDLM-2: 5.3;hTCEpi: 1.7;Karpas-707: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB025879 Approved "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB025879: " "unprognostic (2.76e-2)" "unprognostic (1.19e-1)" "unprognostic (6.10e-2)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.46e-1)" "unprognostic (3.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.15e-1)" "unprognostic (1.81e-1)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.0 0.1 2.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.2 0.2 0.0 1.5 0.0 0.1 19.5 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 13.7 6.5 0.0 8.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 5.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.1 PGM1 ENSG00000079739 "Phosphoglucomutase 1" P36871 1 63593276-63660245 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Isomerase "Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 233.5" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 209.3;Hepatocytes: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004666, HPA024190, HPA024637, HPA046329" Enhanced Approved Cytosol NA NA 20000000 Cytosol "CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625" "unprognostic (2.50e-1)" "unprognostic (2.26e-3)" "unprognostic (1.74e-2)" "unprognostic (5.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.28e-2)" "unprognostic (1.86e-3)" "unprognostic (2.42e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.74e-5)" "unprognostic (7.07e-2)" "unprognostic (1.55e-2)" "unprognostic (6.58e-3)" "unprognostic (1.37e-1)" "unprognostic (2.46e-1)" "unprognostic (9.74e-3)" 17.8 14.1 7.0 4.4 8.3 3.5 9.8 4.4 8.3 6.7 12.9 5.2 4.6 10.6 4.6 7.7 8.8 3.3 8.9 36.9 6.4 5.4 10.0 56.4 7.6 2.7 6.2 6.3 9.7 21.6 12.9 6.2 11.5 8.5 8.7 9.1 5.4 7.9 9.4 233.5 5.3 12.4 8.4 5.6 3.0 5.7 3.0 5.5 3.0 6.0 42.8 6.3 9.4 4.7 12.2 25.9 25.6 17.9 21.1 23.3 16.6 29.8 12.5 4.7 15.5 31.2 23.1 38.3 12.3 16.7 13.4 22.0 10.3 13.9 9.4 25.8 19.0 29.7 7.1 6.5 25.9 15.8 11.5 8.7 19.9 21.2 10.6 25.8 17.4 1.1 29.1 16.7 15.6 24.8 36.0 8.0 9.8 0.0 12.6 21.5 1.8 5.0 9.6 21.4 0.9 20.1 7.1 22.0 3.0 19.5 9.4 2.8 18.4 26.9 28.2 41.0 22.9 8.8 6.6 0.7 19.9 10.2 17.6 10.4 8.0 11.7 15.4 32.5 15.3 8.5 20.5 17.9 25.6 23.3 12.0 18.6 12.2 13.7 17.5 25.9 6.9 12.5 14.5 21.2 21.1 10.2 7.5 10.6 16.6 7.0 8.3 4.4 8.3 6.4 5.4 6.2 6.3 8.5 5.5 86.4 31.4 19.9 24.0 15.9 8.1 140.8 50.9 14.7 10.3 15.7 9.8 71.5 74.6 42.0 24.0 10.7 74.3 0.0 209.3 136.9 28.0 18.3 4.7 186.6 22.2 0.0 12.6 16.0 18.3 5.2 20.4 10.7 25.3 32.5 40.1 54.2 92.3 23.0 35.7 59.8 10.7 12.9 17.9 4.7 7.5 15.8 49.2 21.8 71.1 13.6 PGM2L1 "BM32A, FLJ32029" ENSG00000165434 "Phosphoglucomutase 2 like 1" Q6PCE3 11 74330318-74398473 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 48.6" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 76.3;Exocrine glandular cells: 109.6;Pancreatic endocrine cells: 102.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 13.4;LHCN-M2: 16.0;RH-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056995, HPA060948" Enhanced Approved Mitochondria No No 64000 Mitochondria "HPA056995: AB_2683305, HPA060948: AB_2684394" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" "unprognostic (7.28e-3)" "unprognostic (8.91e-2)" "unprognostic (6.16e-2)" "unprognostic (1.55e-1)" "unprognostic (7.16e-6)" "unprognostic (1.43e-1)" "unprognostic (1.95e-1)" "unprognostic (5.97e-3)" "unprognostic (1.70e-2)" "unprognostic (2.98e-1)" "unprognostic (9.33e-3)" "unprognostic (3.71e-1)" "unprognostic (1.97e-1)" "unprognostic (3.04e-1)" "unprognostic (1.03e-2)" 3.0 4.0 30.6 4.9 19.8 4.0 3.2 6.3 48.6 6.1 4.5 1.3 1.0 2.3 6.1 1.9 2.1 4.7 4.8 1.6 30.1 15.1 2.5 2.1 2.7 4.0 9.7 20.4 1.7 4.4 1.4 4.5 2.1 11.7 3.8 5.1 2.9 3.2 2.5 7.1 1.7 2.6 5.6 2.6 2.5 3.4 2.3 0.3 10.0 4.1 1.3 4.0 5.2 2.6 2.4 1.7 2.5 0.6 3.0 7.5 1.1 2.1 3.0 11.8 2.1 3.6 1.6 0.3 2.8 2.1 2.4 2.7 1.1 5.5 0.2 7.0 1.8 4.3 1.0 2.3 0.5 2.3 0.8 1.2 1.6 1.6 0.9 0.4 1.9 2.6 0.8 0.5 5.5 1.0 2.7 13.4 4.0 2.1 1.5 16.0 0.3 7.6 1.7 2.3 1.6 2.7 2.4 15.4 0.1 6.4 0.4 0.5 2.3 4.5 1.0 2.0 3.4 0.2 0.3 11.1 5.5 5.1 2.2 2.9 2.0 2.9 0.2 0.5 2.7 1.3 2.5 0.6 1.1 2.1 0.6 2.8 2.4 3.5 2.3 0.5 1.8 3.3 1.9 0.7 3.0 0.3 1.7 7.5 1.1 30.6 19.8 6.3 24.4 30.1 15.1 9.7 20.4 11.7 0.3 6.0 5.4 13.7 35.5 6.8 10.1 6.1 12.7 76.3 30.7 8.7 15.7 0.6 5.0 31.7 9.2 20.2 5.3 70.0 109.6 4.7 15.4 55.2 8.1 0.9 4.8 7.9 11.3 20.3 20.4 2.3 2.3 14.4 15.1 3.6 15.9 5.0 102.3 7.0 3.5 3.3 9.9 25.8 11.3 17.6 14.5 4.5 0.1 17.0 18.7 42.9 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 123.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 88.7;Endothelial cells: 35.0;Ito cells: 31.9;Sertoli cells: 51.8;Smooth muscle cells: 36.4" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 89 "neutrophil: 8.9" "Lineage enriched" "Detected in single" 89 "granulocytes: 8.9" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 15.9;PC-3: 29.8;RH-30: 20.7;SK-BR-3: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 380000 Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 5.9 13.6 0.8 7.5 1.3 0.0 4.1 2.1 1.5 25.9 52.2 1.8 26.1 2.9 36.9 10.3 22.6 20.9 11.1 31.6 1.0 0.4 2.0 1.5 2.7 5.9 0.9 1.3 9.3 1.9 0.5 1.2 1.7 1.3 37.1 7.6 4.3 2.9 51.1 8.5 2.2 15.4 123.0 1.5 1.7 16.6 4.3 0.9 0.9 2.8 4.5 1.5 57.4 24.5 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 4.2 3.4 2.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.0 0.0 29.8 0.0 20.7 0.9 0.9 0.0 0.0 0.1 0.0 25.9 1.4 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.8 1.3 2.1 1.5 1.0 0.4 0.9 1.3 1.3 0.9 0.0 1.7 0.0 5.1 2.1 22.3 88.7 0.0 1.4 3.4 12.2 3.9 0.0 1.7 0.1 1.2 35.0 0.0 0.0 0.0 0.1 3.3 2.7 0.0 0.0 0.1 0.0 0.0 31.9 3.2 0.0 7.5 1.9 3.3 1.8 0.0 8.4 0.1 0.0 4.6 0.6 1.1 51.8 36.4 0.1 0.2 2.0 0.0 0.0 0.0 1.3 PGP ENSG00000184207 "Phosphoglycolate phosphatase" A6NDG6 16 2211997-2214807 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 40.7" "Cell type enhanced" "Detected in all" 13 "Cone photoreceptor cells: 380.9;Early spermatids: 399.7;Late spermatids: 977.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043096, HPA046739" Approved Approved "Nuclear bodies" NA NA 46000 "Nuclear bodies" "HPA043096: AB_2678311, HPA046739: AB_2679779" "unprognostic (8.33e-2)" "unprognostic (4.77e-3)" "unprognostic (2.36e-2)" "unprognostic (7.23e-2)" "unprognostic (2.12e-3)" "unprognostic (1.76e-1)" "unprognostic (5.75e-3)" "unprognostic (5.87e-2)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (6.50e-2)" "unprognostic (9.04e-2)" "prognostic favorable (7.05e-4)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "prognostic favorable (6.42e-4)" 5.7 7.2 10.9 7.3 12.5 9.2 3.6 31.4 21.4 3.9 6.7 4.8 7.3 7.9 4.7 6.5 3.6 3.7 4.4 15.6 11.4 9.8 6.1 5.5 6.2 7.5 9.6 12.8 2.5 6.6 8.7 6.1 6.9 17.8 5.3 5.3 4.7 6.2 6.8 40.7 5.6 7.5 4.9 6.0 8.0 6.7 23.0 7.4 5.9 8.8 7.9 5.0 4.2 2.6 1.8 1.9 6.1 3.4 0.3 2.2 0.4 9.2 15.2 10.8 10.3 4.5 3.5 20.8 10.9 5.2 10.1 10.4 23.6 11.8 7.1 10.8 5.0 8.2 15.6 7.6 9.3 4.5 9.6 21.1 7.0 23.1 10.6 3.0 12.5 11.7 4.2 4.2 9.4 3.5 3.6 6.5 11.7 12.8 7.5 5.5 25.3 14.1 20.5 14.3 5.7 14.4 23.1 9.4 15.9 8.3 5.9 14.5 8.8 9.7 18.3 7.5 8.1 13.6 14.6 6.4 10.4 13.7 9.3 10.8 17.8 7.7 10.0 3.5 11.1 8.0 0.0 2.3 6.1 2.2 3.4 0.3 0.7 1.3 1.6 1.6 1.8 0.8 1.4 1.4 0.3 3.1 1.9 1.3 0.4 10.9 12.5 31.4 21.4 11.4 9.8 9.6 12.8 17.8 7.4 6.0 8.5 13.4 7.0 20.7 194.2 37.5 12.7 1.4 5.7 38.4 380.9 102.8 49.7 8.0 399.7 21.1 46.4 23.3 12.2 86.7 22.8 21.1 10.3 30.7 50.8 136.7 28.6 19.0 30.8 977.0 23.9 41.2 33.7 8.2 22.2 54.1 10.8 24.6 26.5 28.7 225.9 38.8 21.2 167.9 61.0 27.9 45.5 23.5 34.6 14.4 PGPEP1L ENSG00000183571 "Pyroglutamyl-peptidase I-like" A6NFU8 15 98968230-99007795 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 34.7" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7;Early spermatids: 2.7;Spermatocytes: 2.8;Spermatogonia: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "basophil: 2.0;neutrophil: 1.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "HeLa: 1.9;U-2 OS: 4.5" "Not detected" "Not detected" HPA041781 Uncertain NA NA "HPA041781: AB_10795642" "unprognostic (2.48e-1)" "unprognostic (2.82e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-3)" "unprognostic (7.18e-2)" "unprognostic (3.99e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (9.78e-2)" "unprognostic (1.58e-1)" "unprognostic (4.53e-3)" "unprognostic (1.86e-1)" "unprognostic (2.62e-1)" "unprognostic (2.00e-2)" "unprognostic (1.65e-1)" 0.7 0.1 0.5 0.2 1.4 0.1 0.6 0.2 0.5 0.4 0.4 0.4 0.0 0.2 0.2 0.4 0.8 0.2 0.5 3.6 0.6 0.4 0.4 0.0 0.2 0.3 0.4 0.2 0.2 0.5 0.0 0.1 0.3 0.4 0.6 0.0 1.6 0.9 0.5 34.7 0.1 0.2 0.3 0.3 0.1 0.2 5.0 0.2 0.1 0.1 8.6 0.5 0.2 0.3 0.0 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.2 0.7 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.2 0.0 1.9 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.9 1.4 0.1 0.0 0.2 0.4 1.3 0.2 0.4 0.4 0.1 1.2 0.0 1.0 0.3 0.4 0.5 1.4 0.2 0.4 0.8 0.0 0.7 0.0 4.5 0.2 0.1 0.8 0.2 0.7 0.0 0.6 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 1.4 0.2 0.5 0.6 0.4 0.4 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 2.8 2.0 0.0 0.1 0.0 0.0 0.0 PGR "NR3C3, PR" ENSG00000082175 "Progesterone receptor" P06401 11 101029624-101130524 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 50.7;endometrium 1: 116.4;smooth muscle: 31.2" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 14.5;Early spermatids: 47.8;Late spermatids: 35.6;Leydig cells: 13.6" "Group enriched" "Detected in some" 13 "breast cancer: 10.1;endometrial cancer: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 349 "T-47d: 62.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB000068, HPA004751, HPA008428, HPA017176, CAB055100" Enhanced NA NA "CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728" "unprognostic (2.59e-2)" "unprognostic (9.80e-3)" "unprognostic (5.23e-3)" "prognostic favorable (5.76e-8)" "unprognostic (2.81e-2)" "unprognostic (1.56e-1)" "unprognostic (4.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.08e-1)" "unprognostic (2.50e-1)" "unprognostic (3.29e-2)" "unprognostic (1.77e-1)" "unprognostic (7.71e-3)" "unprognostic (1.90e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (5.44e-3)" 0.8 0.7 0.2 0.3 0.6 0.0 5.0 0.2 0.7 50.7 1.3 0.2 0.4 0.0 116.4 6.1 0.5 13.2 0.4 2.0 0.5 0.6 0.4 0.1 1.2 0.3 0.4 0.1 10.6 0.8 0.0 2.8 1.8 0.8 3.8 0.1 0.7 3.5 5.5 0.3 0.3 1.2 31.2 0.9 0.5 0.4 1.5 0.3 0.1 0.3 0.8 0.2 1.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 62.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.7 0.5 0.6 0.4 0.1 0.8 0.3 3.0 0.0 0.0 0.7 0.1 1.6 14.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 47.8 2.1 0.0 0.0 0.0 0.1 6.7 0.3 0.0 0.0 0.1 0.0 0.0 4.3 0.0 35.6 13.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.0 0.0 6.5 7.6 0.7 1.5 0.5 0.0 0.0 0.0 0.8 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 163.9" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 412.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Supported "Nucleoli,Endoplasmic reticulum" NA NA 6000000 "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 25.0 46.0 37.7 11.9 36.9 5.6 60.2 21.8 37.8 36.2 30.5 30.9 42.9 27.0 39.9 71.4 15.0 38.9 20.1 10.0 38.6 50.4 58.7 163.9 15.6 8.8 38.1 29.6 24.7 10.9 23.8 15.5 12.3 35.3 33.5 22.5 22.1 17.5 53.7 5.7 12.5 42.9 22.0 46.9 10.0 18.9 14.2 27.1 6.9 24.7 12.2 7.7 21.3 17.3 3.6 9.9 11.4 11.8 4.8 8.0 28.7 27.3 17.3 34.0 39.1 73.6 35.3 22.1 41.3 48.2 22.0 27.4 20.9 33.6 7.9 45.3 42.8 25.7 21.9 37.1 17.3 29.7 8.4 42.6 8.9 16.6 23.4 12.3 14.5 4.8 36.3 9.8 26.7 13.9 16.3 14.1 9.5 9.3 4.9 25.7 29.2 10.9 10.7 89.1 30.0 29.2 13.0 21.3 11.4 29.0 20.9 31.8 14.2 30.2 50.3 16.2 34.3 11.6 9.3 10.9 15.3 22.6 54.1 38.9 5.2 9.5 8.5 41.9 23.2 29.2 9.2 11.8 11.4 5.5 11.3 7.3 3.6 7.5 8.0 9.9 3.1 7.7 6.3 5.7 4.8 10.0 7.1 7.6 28.7 37.7 36.9 21.8 37.2 38.6 50.4 38.1 29.6 35.3 27.1 116.1 75.0 12.3 114.6 83.6 185.1 15.3 109.5 124.5 78.5 69.8 64.8 71.9 58.0 77.8 2.7 78.8 222.6 23.3 64.6 112.3 104.2 108.1 39.3 412.3 46.0 62.0 55.4 54.6 35.5 4.9 159.3 45.1 97.8 14.4 77.2 101.7 56.7 112.1 170.8 277.5 72.5 103.5 130.8 27.1 70.9 76.7 51.9 21.5 125.9 110.4 PHACTR1 "dJ257A7.2, KIAA1733, RPEL1" ENSG00000112137 "Phosphatase and actin regulator 1" Q9C0D0 6 12716805-13290484 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;brain: 80.3" "Cell type enhanced" "Detected in many" 7 "B-cells: 134.6;Horizontal cells: 170.0;Kupffer cells: 97.1;Macrophages: 102.6" "Cancer enhanced" "Detected in many" "melanoma: 10.2" "Region enhanced" "Detected in all" "basal ganglia: 80.3" "Group enriched" "Detected in many" 13 "memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9" "Group enriched" "Detected in many" 17 "B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1" "Cell line enhanced" "Detected in many" "HMC-1: 16.7;SK-MEL-30: 15.7;U-266/70: 41.2;U-266/84: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029755, HPA029756, HPA029757" Enhanced Uncertain "Plasma membrane" NA NA "Plasma membrane" "HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870" "unprognostic (7.86e-2)" "unprognostic (7.49e-2)" "unprognostic (2.74e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (7.72e-2)" "unprognostic (4.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-4)" "unprognostic (1.53e-1)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.31e-1)" "unprognostic (1.43e-1)" "unprognostic (5.00e-2)" "unprognostic (1.16e-1)" 3.5 1.6 11.6 7.2 80.3 22.6 1.6 4.9 31.4 1.4 1.4 1.3 0.3 2.0 1.3 2.6 1.5 1.9 4.2 9.2 10.9 4.4 3.9 1.9 9.0 8.7 2.7 16.6 1.8 4.2 0.5 6.0 1.7 2.2 1.4 1.5 0.6 1.4 0.7 1.2 2.6 2.9 1.7 2.6 6.5 2.0 2.2 7.2 0.4 1.3 0.0 13.4 3.4 1.4 20.9 25.9 10.1 1.1 0.4 0.2 1.1 0.0 0.1 1.1 0.2 0.0 0.0 3.2 0.3 1.2 1.2 2.1 0.1 0.0 0.2 0.4 0.1 1.6 0.1 0.0 0.0 1.5 4.2 0.3 8.4 0.1 0.1 0.1 7.9 16.7 0.4 0.0 0.0 0.1 0.1 1.5 0.5 3.9 7.1 1.2 0.0 0.1 6.1 1.1 0.0 0.0 4.0 2.2 0.7 1.0 0.1 5.0 1.5 0.0 3.2 15.7 1.6 9.6 1.9 1.7 0.1 0.3 0.0 0.0 41.2 26.8 7.0 0.6 2.3 6.4 0.1 1.1 0.6 0.1 0.9 0.0 7.2 0.1 0.0 7.7 20.9 0.1 0.2 10.1 0.4 0.3 25.9 0.0 1.1 11.6 80.3 4.9 31.4 10.9 4.4 2.7 16.6 2.2 7.2 62.5 37.4 134.6 1.5 3.3 35.3 9.1 2.5 9.4 14.8 59.3 3.9 1.2 26.6 0.6 54.5 8.3 0.4 0.0 2.5 2.0 6.2 0.8 80.7 0.8 76.1 170.0 1.7 15.4 97.1 44.3 4.4 102.6 45.5 18.0 0.1 21.8 1.0 0.0 6.0 0.6 13.0 0.0 4.0 1.2 2.7 2.8 1.6 2.5 0.4 0.7 PHACTR2 "C6orf56, KIAA0680" ENSG00000112419 "Phosphatase and actin regulator 2" O75167 6 143536845-143831185 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 60.1" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 199.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031719, HPA031720, HPA031725" Approved NA NA "HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279" "unprognostic (3.25e-3)" "unprognostic (1.07e-1)" "unprognostic (4.39e-2)" "unprognostic (5.25e-2)" "unprognostic (1.90e-2)" "unprognostic (8.38e-2)" "unprognostic (3.19e-2)" "unprognostic (9.92e-2)" "unprognostic (7.46e-2)" "unprognostic (3.61e-2)" "unprognostic (2.49e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.99e-4)" "unprognostic (3.60e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" 14.6 28.1 6.6 10.8 4.1 5.4 13.3 2.8 5.2 10.9 10.2 4.6 12.0 5.8 12.3 7.9 16.7 6.6 11.0 17.6 6.3 3.8 6.2 13.0 16.1 10.0 4.4 5.3 8.6 4.2 11.0 8.0 60.1 13.0 10.6 6.8 18.7 9.7 8.9 9.8 4.4 10.7 8.4 3.8 11.9 9.1 7.2 2.7 2.6 12.0 8.9 8.8 8.6 10.5 0.5 3.6 6.9 3.9 3.6 14.3 1.8 9.3 5.9 1.6 11.8 1.7 3.7 6.8 7.9 12.0 3.4 4.3 10.3 4.2 0.5 21.5 22.6 2.4 2.8 0.9 7.8 4.1 7.7 3.7 15.3 6.6 6.0 2.8 3.9 4.7 5.1 4.4 3.4 11.3 5.3 20.8 2.9 4.3 0.0 5.5 10.3 0.5 0.9 12.0 3.3 1.7 1.4 11.8 0.1 4.2 8.4 2.3 2.3 8.8 11.7 0.1 6.3 4.4 5.7 36.1 15.8 8.3 6.8 5.1 0.1 0.0 0.1 3.9 4.1 1.4 4.5 3.9 6.9 3.9 2.8 14.3 0.5 4.7 5.1 3.6 0.2 2.9 2.0 2.0 3.6 2.8 3.6 5.7 1.8 6.6 4.1 2.8 5.2 6.3 3.8 4.4 5.3 13.0 2.7 199.5 74.0 12.8 13.8 21.5 17.3 67.7 30.6 62.9 89.9 21.0 2.0 63.3 11.6 24.0 10.1 116.8 34.9 0.0 19.6 43.1 109.6 43.7 38.1 25.2 32.0 95.3 20.7 163.2 98.4 15.9 95.5 36.8 23.6 80.2 16.0 7.3 34.1 19.5 112.8 21.3 2.8 97.0 46.7 3.0 1.2 15.1 43.9 34.1 24.4 10.6 PHACTR3 "C20orf101, PPP1R123" ENSG00000087495 "Phosphatase and actin regulator 3" Q96KR7 20 59577509-59847711 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 56.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 11.9;Bipolar cells: 9.8;Cardiomyocytes: 7.3;Cholangiocytes: 10.2;Club cells: 6.8" "Group enriched" "Detected in some" 5 "glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "THP-1: 53.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051834, HPA054847" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA051834: AB_2681629, HPA054847: " "unprognostic (7.14e-2)" "unprognostic (1.22e-1)" "unprognostic (3.72e-2)" "unprognostic (1.43e-7)" "unprognostic (1.99e-1)" "unprognostic (2.87e-2)" "unprognostic (5.83e-3)" "unprognostic (8.92e-2)" "unprognostic (5.02e-2)" "unprognostic (2.30e-2)" "unprognostic (7.71e-2)" "unprognostic (7.22e-2)" "unprognostic (1.74e-2)" "unprognostic (1.66e-1)" "unprognostic (5.43e-2)" "unprognostic (2.53e-3)" "unprognostic (1.32e-1)" 1.6 2.7 31.3 1.8 29.2 2.0 1.4 15.9 56.1 1.5 1.9 20.0 0.0 2.1 1.3 2.0 2.8 1.4 3.3 3.0 27.3 14.6 2.0 2.1 5.3 1.4 28.3 19.4 6.9 1.5 1.4 0.5 1.9 21.3 1.4 1.8 0.0 1.3 1.3 1.4 2.6 2.1 1.5 25.4 8.0 1.8 1.8 29.8 0.0 1.4 0.0 1.4 1.6 0.0 0.0 2.5 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.8 0.0 0.0 0.0 10.4 0.0 0.7 2.7 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 31.3 29.2 15.9 34.1 27.3 14.6 28.3 19.4 21.3 29.8 11.9 0.3 0.0 1.0 0.6 9.8 7.3 10.2 1.4 6.8 3.5 0.0 0.0 1.7 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.1 1.9 0.0 0.0 0.2 4.8 1.2 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.8 0.0 0.0 0.0 1.6 0.0 0.7 0.0 0.7 0.4 0.0 0.0 0.8 3.0 PHEX "HPDR, HPDR1, HYP, HYP1, PEX, XLH" ENSG00000102174 "Phosphate regulating endopeptidase homolog X-linked" P78562 X 22032441-22251310 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" Biomineralization "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 8.3;lung: 6.7" "Cell type enhanced" "Detected in some" 21 "Basal glandular cells: 5.2;Horizontal cells: 15.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 37 "plasmacytoid DC: 8.3" "Lineage enriched" "Detected in single" 37 "dendritic cells: 8.3" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.8;HUVEC TERT2: 4.4;PC-3: 4.8;TIME: 4.9;U-87 MG: 10.6;WM-115: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (2.01e-2)" "unprognostic (2.69e-1)" "unprognostic (2.43e-1)" "unprognostic (1.05e-3)" "unprognostic (1.22e-1)" "unprognostic (3.04e-2)" "unprognostic (2.25e-3)" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-2)" "unprognostic (7.53e-2)" "unprognostic (7.45e-2)" "unprognostic (9.84e-8)" "unprognostic (1.18e-1)" "unprognostic (1.58e-1)" "prognostic favorable (2.51e-4)" "unprognostic (7.68e-2)" 0.3 0.0 1.8 1.9 1.1 0.0 1.7 0.9 1.1 0.8 0.9 0.8 0.3 1.2 5.0 0.3 0.4 0.1 2.0 0.3 1.5 1.8 0.3 0.3 6.7 3.4 2.0 0.3 3.9 0.3 0.0 0.3 0.3 5.0 1.3 0.0 0.3 2.8 0.9 0.3 0.1 1.4 3.9 3.8 3.4 0.0 0.3 0.3 1.3 4.8 0.3 4.3 0.5 0.6 0.1 8.3 0.0 0.0 0.0 0.2 0.0 0.3 0.8 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.1 0.3 1.3 0.1 0.1 1.3 0.1 0.2 0.1 0.0 5.8 0.3 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.2 2.2 1.1 1.1 3.4 0.2 4.4 0.4 0.0 0.5 0.5 0.0 0.0 0.2 0.0 0.0 4.8 0.0 1.0 0.0 0.6 0.2 0.1 0.2 0.4 2.5 0.8 0.6 2.9 0.0 4.9 1.0 0.2 0.6 0.8 0.0 0.1 0.0 10.6 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 8.3 0.0 0.0 1.8 1.1 0.9 1.1 1.5 1.8 2.0 0.3 5.0 0.3 0.0 0.0 0.0 5.2 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.4 0.2 1.7 0.0 1.0 0.1 0.5 1.6 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.8 0.7 0.0 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 2.7 PHF21B "BHC80L, FLJ34161, PHF4" ENSG00000056487 "PHD finger protein 21B" Q96EK2 22 44881162-45009999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 12.5;Cone photoreceptor cells: 21.6;Early spermatids: 12.7;Horizontal cells: 27.0;Late spermatids: 30.5;Rod photoreceptor cells: 25.4" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.2;AN3-CA: 7.3;JURKAT: 6.4;NTERA-2: 5.2;SCLC-21H: 6.4;SH-SY5Y: 28.4;U-2 OS: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053834, HPA074665" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA053834: AB_2682276, HPA074665: " "unprognostic (1.04e-1)" "unprognostic (7.76e-2)" "unprognostic (2.00e-1)" "unprognostic (7.44e-2)" "unprognostic (1.37e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.55e-1)" "unprognostic (3.83e-3)" "unprognostic (1.86e-3)" "unprognostic (2.02e-1)" "unprognostic (9.35e-2)" "unprognostic (2.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.22e-1)" 0.7 3.5 8.4 0.8 7.4 0.5 0.8 3.7 10.9 10.1 0.7 3.6 0.9 0.7 8.6 1.7 1.6 2.3 0.8 1.3 7.8 3.4 2.2 0.5 0.6 0.6 4.7 3.2 5.6 1.8 2.0 17.9 0.6 4.2 4.8 0.6 6.5 0.8 2.1 0.7 0.5 0.7 2.3 4.4 0.6 1.0 8.5 7.3 0.0 3.0 0.0 0.6 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 7.3 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 1.5 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.2 0.4 0.0 0.0 6.4 0.0 0.0 0.1 0.6 0.9 0.0 5.2 0.0 0.3 0.0 1.9 0.1 0.0 0.1 6.4 28.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 6.4 0.0 0.2 0.3 0.0 3.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 7.4 3.7 7.3 7.8 3.4 4.7 3.2 4.2 7.3 0.0 0.0 0.0 0.8 0.1 12.5 1.3 0.0 1.4 0.0 0.0 21.6 0.0 1.7 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 27.0 0.0 0.0 0.0 30.5 0.6 0.0 0.0 0.0 0.0 4.6 0.1 0.0 1.8 0.0 25.4 0.0 0.0 0.7 3.4 0.0 0.0 0.0 0.0 0.1 PHF24 KIAA1045 ENSG00000122733 "PHD finger protein 24" Q9UPV7 9 34957608-34982544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 43.0;testis: 15.9" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 7.9;Late spermatids: 4.9;Muller glia cells: 12.9;Spermatocytes: 3.9;Spermatogonia: 3.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 45 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 45 "granulocytes: 5.4" "Group enriched" "Detected in some" 6 "NTERA-2: 3.8;WM-115: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020974 Approved NA NA "HPA020974: AB_1852364" "unprognostic (5.54e-3)" "unprognostic (1.21e-1)" "unprognostic (9.00e-2)" "unprognostic (2.44e-1)" "unprognostic (1.00e-2)" "unprognostic (6.30e-2)" "unprognostic (3.66e-2)" "unprognostic (1.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.97e-1)" "unprognostic (4.80e-4)" "unprognostic (1.24e-1)" "unprognostic (4.58e-6)" "unprognostic (1.87e-2)" "unprognostic (1.41e-1)" "unprognostic (9.23e-2)" "unprognostic (2.30e-1)" 1.2 1.0 14.9 1.2 13.3 0.7 1.1 6.1 43.0 1.1 0.9 1.5 0.0 0.9 1.1 1.0 1.1 1.3 1.0 0.8 12.3 7.5 0.8 0.8 0.9 1.7 6.5 15.6 0.8 0.7 1.0 0.0 0.7 9.0 0.8 1.0 0.6 0.8 0.8 0.8 1.8 0.9 1.2 1.9 0.9 0.8 15.9 0.0 0.0 0.8 0.0 1.6 0.9 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 14.9 13.3 6.1 26.8 12.3 7.5 6.5 15.6 9.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 1.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.1 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.1 1.8 0.0 0.0 3.9 3.9 0.0 0.0 0.0 0.0 0.0 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410657-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "testis: 260.7" "Group enriched" "Detected in many" 45 "Early spermatids: 2196.1;Late spermatids: 5962.4;Spermatocytes: 1575.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.1;U-266/70: 16.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: AB_2686248" "prognostic favorable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favorable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 0.9 0.6 0.3 0.6 1.5 0.8 0.9 1.0 1.4 0.5 1.0 1.2 0.4 0.7 0.5 2.0 0.6 0.6 0.4 1.9 0.6 0.4 0.6 0.9 0.6 0.5 1.1 0.7 0.4 0.9 0.6 0.5 0.5 0.7 0.7 1.0 1.2 1.0 0.7 1.5 1.0 1.0 0.5 0.9 0.7 0.6 260.7 0.4 1.7 0.5 0.6 0.6 0.9 0.5 6.7 2.6 3.9 2.5 2.2 4.9 1.7 2.0 0.6 1.5 6.4 1.1 1.6 2.7 2.0 2.1 1.6 2.0 1.0 0.8 3.4 0.2 1.5 1.0 1.1 1.1 3.2 2.8 4.1 1.5 3.8 0.4 2.3 1.1 4.2 7.2 0.9 3.6 1.5 3.4 0.5 2.3 7.8 2.3 14.1 1.2 0.9 4.9 1.6 0.7 0.6 4.3 2.2 1.4 4.1 1.7 0.9 1.1 1.2 1.8 0.1 1.6 2.0 0.9 2.1 1.7 2.7 1.9 2.9 4.1 16.7 8.0 2.0 1.1 9.7 1.6 0.7 2.2 3.9 2.1 2.5 2.5 6.7 2.5 3.7 1.1 3.8 1.7 3.5 0.5 2.2 1.4 2.6 4.9 1.7 0.3 1.5 1.0 1.4 0.6 0.4 1.1 0.7 0.7 0.4 3.0 2.9 5.6 4.6 4.0 10.6 7.0 2.5 6.7 0.0 7.0 7.9 3.0 11.6 2.4 2196.1 2.9 8.4 0.0 2.5 1.7 2.9 1.7 6.9 4.0 3.7 12.7 11.1 1.8 4.3 5962.4 71.4 2.6 8.5 2.8 3.3 6.5 3.1 0.0 59.4 5.5 15.7 51.8 3.9 1575.4 63.9 2.6 0.5 4.4 11.8 2.2 PHGR1 ENSG00000233041 "Proline, histidine and glycine rich 1" C9JFL3 15 40351033-40356434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 308.0;lymphoid tissue: 83.6" "Cell type enhanced" "Detected in some" 30 "Enterocytes: 27312.8;Mucus-secreting cells: 5830.8;Paneth cells: 7178.6;Undifferentiated cells: 3711.5" "Group enriched" "Detected in many" 16 "colorectal cancer: 248.3;stomach cancer: 94.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "OE19: 136.7" HPA068787 Enhanced Approved Vesicles NA NA Vesicles "HPA068787: AB_2686035" "prognostic favorable (2.05e-4)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (1.18e-1)" "unprognostic (2.80e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" 0.3 0.1 0.3 83.6 0.3 0.0 0.6 0.3 0.3 0.3 245.3 0.3 0.3 77.9 0.3 0.3 0.4 0.5 4.1 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.4 32.9 0.3 0.4 0.3 0.3 0.3 308.0 1.3 0.3 0.3 15.1 0.3 0.3 0.3 0.3 0.3 0.3 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 136.7 0.0 0.0 0.0 1.7 0.0 0.2 10.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 193.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27312.8 0.0 0.2 0.0 0.0 1.8 220.4 0.0 0.0 0.0 1865.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5830.8 0.0 2.9 7178.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3711.5 0.9 PHKA1 PHKA ENSG00000067177 "Phosphorylase kinase regulatory subunit alpha 1" P46020 X 72578814-72714319 "Disease related genes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Muscle protein" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 57.4" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 10.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "HDLM-2: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001081, HPA075355" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001081: AB_1079607, HPA075355: " "unprognostic (3.68e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.84e-4)" "unprognostic (3.52e-1)" "unprognostic (5.48e-2)" "unprognostic (1.23e-2)" "unprognostic (9.64e-2)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (2.18e-1)" "unprognostic (4.76e-1)" "unprognostic (9.45e-3)" "unprognostic (9.94e-2)" "unprognostic (2.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" 2.7 10.3 3.8 1.9 7.2 0.7 3.4 3.2 3.5 2.2 2.1 2.0 7.8 1.0 2.7 4.7 4.8 2.8 2.6 5.5 3.0 3.0 2.1 1.8 1.6 1.0 4.2 1.6 5.8 4.2 16.9 14.2 1.8 4.7 4.3 2.5 6.5 6.8 5.1 57.4 2.5 1.3 3.4 3.1 2.3 3.7 3.5 2.7 0.8 6.5 12.6 2.8 3.1 3.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 8.6 12.2 0.7 7.3 4.3 4.1 7.6 1.6 1.5 0.3 0.1 3.5 7.7 0.0 4.9 0.2 8.9 3.4 14.4 5.9 0.4 22.1 14.7 4.0 9.9 3.2 4.5 0.0 0.0 5.5 6.0 1.4 9.9 7.4 8.4 7.3 6.1 0.0 7.9 6.2 6.2 0.4 9.6 14.3 16.3 0.0 0.0 0.0 2.2 4.1 7.6 9.0 7.7 10.1 0.1 9.5 3.6 0.3 4.3 0.0 3.7 1.5 4.2 10.1 9.4 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 7.2 3.2 2.9 3.0 3.0 4.2 1.6 4.7 2.7 0.0 3.0 0.0 4.0 2.2 1.8 5.6 2.5 6.7 2.3 10.4 7.9 0.8 0.0 1.5 0.3 3.5 0.5 0.0 2.2 0.9 0.5 8.7 5.8 1.5 1.3 3.2 2.4 6.2 6.0 0.0 2.8 0.2 1.7 0.0 2.0 1.3 4.4 0.0 8.1 1.1 2.9 0.0 1.3 0.0 0.7 3.0 0.5 0.0 2.4 7.0 PHKG1 PHKG ENSG00000164776 "Phosphorylase kinase catalytic subunit gamma 1" Q16816 7 56080283-56092996 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 105.6;tongue: 32.9" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 50.9" "Cancer enriched" "Detected in many" 18 "glioma: 23.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012057 Enhanced NA NA "HPA012057: AB_1855305" "unprognostic (2.00e-3)" "unprognostic (1.09e-1)" "unprognostic (7.09e-3)" "unprognostic (5.87e-3)" "unprognostic (2.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.31e-1)" "unprognostic (6.69e-3)" "unprognostic (2.10e-1)" "unprognostic (1.99e-1)" "unprognostic (9.14e-4)" "unprognostic (1.92e-1)" "unprognostic (7.97e-9)" "unprognostic (6.61e-3)" "unprognostic (2.34e-1)" "unprognostic (1.12e-2)" "unprognostic (3.85e-2)" 2.0 1.5 4.9 0.8 6.1 1.1 1.5 6.0 5.8 0.7 2.6 6.5 0.0 1.0 0.9 1.5 3.2 0.9 1.1 11.8 4.1 2.9 0.6 0.7 0.9 0.8 3.5 3.9 1.0 0.8 1.2 0.6 0.6 6.8 1.4 0.8 0.0 1.6 0.8 105.6 1.6 0.9 1.1 3.6 0.8 0.8 0.7 4.8 0.0 0.6 32.9 1.2 1.8 0.3 1.3 0.6 3.3 0.7 0.3 1.9 0.2 2.9 2.1 0.5 1.8 3.2 5.4 1.4 0.4 0.6 1.0 0.8 0.7 1.3 0.8 0.5 1.0 1.2 1.6 1.2 0.2 0.8 0.8 2.1 0.8 3.0 0.7 0.8 1.5 3.3 3.4 2.3 1.6 0.7 0.8 0.3 2.1 2.2 4.0 0.1 1.3 2.2 5.6 1.0 0.9 1.3 1.2 0.3 1.0 0.6 1.9 1.5 1.6 0.3 2.2 0.1 0.5 1.2 1.9 0.8 0.5 1.7 4.5 1.1 1.8 0.7 2.2 1.2 1.4 1.0 0.4 0.5 0.0 0.8 0.2 1.9 0.3 1.2 0.3 0.2 1.3 0.6 0.6 3.3 0.3 0.7 0.6 0.5 0.2 4.9 6.1 6.0 5.8 4.1 2.9 3.5 3.9 6.8 4.8 11.9 3.4 25.1 6.4 1.1 4.0 1.4 50.9 4.0 6.8 26.2 0.0 6.6 1.7 13.2 2.2 1.4 11.4 23.3 10.9 11.6 6.1 9.6 8.1 41.4 11.0 11.1 16.0 20.9 30.5 5.6 16.7 6.0 1.7 8.2 10.9 4.8 12.7 10.5 15.2 9.0 4.3 12.9 1.0 7.6 9.4 0.9 6.1 8.7 14.4 7.0 PHKG2 ENSG00000156873 "Phosphorylase kinase catalytic subunit gamma 2" P15735 16 30748270-30761176 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 44.5;testis: 95.4" "Group enriched" "Detected in many" 6 "Early spermatids: 304.4;Late spermatids: 1171.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065618, HPA068751" Supported Cytosol NA NA Cytosol "HPA065618: AB_2685520, HPA068751: AB_2686025" "unprognostic (7.63e-3)" "prognostic favorable (7.90e-4)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "prognostic favorable (1.90e-4)" "unprognostic (6.45e-2)" "unprognostic (1.25e-2)" "prognostic favorable (8.02e-4)" "unprognostic (6.15e-2)" "unprognostic (5.27e-2)" "unprognostic (1.36e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" 4.3 8.3 8.7 6.9 8.0 15.9 5.8 9.1 12.0 4.7 7.9 7.3 9.0 6.8 5.6 7.8 5.3 6.8 7.2 6.4 9.0 9.3 8.2 11.0 5.8 6.8 8.6 9.2 4.7 5.1 17.3 8.5 6.3 11.8 7.7 7.6 6.4 7.0 9.9 6.4 8.4 7.3 6.3 5.8 6.9 7.2 95.4 7.3 5.5 8.6 5.5 7.7 5.2 4.7 8.8 21.2 44.5 22.7 23.5 16.8 17.6 13.7 9.0 7.6 9.3 7.1 5.8 17.1 9.6 14.4 13.2 15.1 7.8 6.9 11.9 11.4 9.9 6.7 13.2 7.9 12.2 10.6 6.4 21.9 6.5 15.0 21.8 11.0 10.0 9.3 7.8 6.6 12.6 5.9 6.3 13.4 8.5 8.8 6.9 9.5 31.5 11.8 14.8 10.5 9.9 10.5 16.0 11.9 15.8 15.1 15.5 10.2 7.0 7.8 21.8 9.2 7.2 17.1 8.7 7.9 8.1 9.0 10.1 8.8 13.9 7.5 8.1 16.1 19.6 6.5 14.0 22.7 44.5 16.2 22.4 13.3 8.8 11.6 16.4 21.2 8.5 10.4 12.1 18.2 23.5 15.9 18.2 16.8 17.6 8.7 8.0 9.1 12.0 9.0 9.3 8.6 9.2 11.8 7.3 11.9 23.7 12.6 12.5 18.7 8.9 10.6 2.5 25.4 29.6 17.4 9.8 26.7 23.2 11.4 304.4 9.9 23.2 0.0 21.4 32.3 12.9 24.0 12.7 19.5 25.4 19.1 15.6 9.2 22.4 1171.9 16.1 24.0 11.8 42.3 15.6 9.8 16.8 15.0 21.9 32.7 8.4 0.0 12.5 127.4 23.3 20.1 63.2 26.2 19.6 12.4 PHLDA1 "DT1P1B11, PHRIP, TDAG51" ENSG00000139289 "Pleckstrin homology like domain family A member 1" Q8WV24 12 76025447-76033932 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 142.4" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1" "Group enriched" "Detected in many" 7 "monocytes: 2.5;T-cells: 4.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 65.6;RPTEC TERT1: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016160, HPA019000, HPA063520" Enhanced Supported "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028" "unprognostic (9.09e-2)" "unprognostic (2.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.51e-3)" "unprognostic (2.33e-1)" "unprognostic (2.60e-3)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-1)" "unprognostic (1.16e-1)" "unprognostic (5.21e-3)" "unprognostic (5.03e-2)" "unprognostic (1.21e-1)" "unprognostic (3.34e-2)" "unprognostic (2.32e-1)" "unprognostic (1.29e-1)" "unprognostic (4.55e-3)" 13.2 15.9 9.4 8.4 12.1 9.0 13.5 6.4 15.7 11.5 4.5 11.1 4.8 3.4 7.1 3.1 33.3 5.1 20.0 9.6 8.2 7.9 13.8 33.2 14.2 3.0 8.4 5.6 10.8 8.8 2.6 6.0 7.1 10.0 4.8 5.5 24.9 142.4 6.5 3.3 6.3 7.0 7.6 9.7 14.6 10.8 2.3 10.1 2.5 18.0 13.2 19.9 17.0 17.8 0.3 0.1 0.4 2.5 0.3 4.1 0.6 12.7 15.3 12.0 6.6 5.6 11.7 0.8 10.8 29.2 4.9 6.8 8.4 15.6 0.0 3.2 4.5 16.3 6.5 0.3 18.1 10.6 1.9 0.2 0.3 0.7 14.3 8.2 0.3 3.3 3.6 13.3 20.4 40.6 65.6 11.8 0.0 1.0 0.3 25.1 1.6 0.0 1.6 4.4 7.7 23.6 0.0 3.1 0.3 51.5 28.9 0.8 2.3 1.8 0.1 35.1 15.6 7.7 0.1 10.9 16.8 1.6 19.5 10.6 0.1 0.0 0.0 28.4 0.1 20.9 0.3 0.1 0.2 2.4 0.2 3.9 0.3 2.5 2.5 0.0 0.2 0.5 0.6 0.4 0.3 2.5 0.1 4.1 0.6 9.4 12.1 6.4 7.7 8.2 7.9 8.4 5.6 10.0 10.1 11.9 17.2 2.7 1037.1 173.4 1.5 29.5 10.2 6.7 22.7 29.6 2.0 4.8 71.3 68.6 1.0 95.1 0.7 0.0 35.8 6.3 85.4 57.9 80.5 117.3 97.6 1.6 112.7 23.9 10.8 1.3 8.6 53.3 271.7 41.5 10.3 90.9 162.8 3.5 14.5 32.7 4.0 265.1 353.3 0.5 0.4 66.0 6.2 23.0 8.0 680.5 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 163.9" "Cell type enhanced" "Detected in many" 18 "Cytotrophoblasts: 3794.0;Syncytiotrophoblasts: 8329.2;Urothelial cells: 2915.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 83.8;PC-3: 68.1;SK-MEL-30: 53.5;WM-115: 73.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli NA NA Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavorable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 3.8 1.1 0.5 3.6 0.7 1.4 7.7 0.3 1.4 5.6 7.9 0.5 1.7 5.9 2.3 5.5 20.3 2.4 15.6 1.5 0.5 1.9 4.8 3.7 3.9 0.8 1.3 0.5 1.8 4.6 1.2 1.2 163.9 1.9 8.0 1.4 0.8 5.3 2.0 0.8 9.6 7.4 1.9 1.0 1.8 11.1 1.0 0.5 0.2 3.5 24.7 15.1 6.1 8.7 1.5 8.2 0.0 4.9 0.0 3.9 1.5 9.4 8.4 0.3 0.1 0.1 1.7 9.1 21.0 5.3 3.0 2.2 3.4 18.7 0.0 10.3 2.3 6.9 11.7 0.0 8.3 0.3 83.8 2.8 0.0 4.5 2.1 6.9 0.0 5.0 2.8 3.8 2.5 2.0 1.7 2.5 0.0 1.8 0.1 1.2 29.8 0.0 1.4 3.4 4.7 68.1 0.0 0.0 5.7 6.1 2.9 0.9 0.0 6.7 4.6 53.5 0.4 1.4 0.8 13.9 6.7 3.6 9.4 7.1 0.1 0.1 0.0 5.5 1.4 73.4 0.0 4.9 0.0 0.7 3.0 0.8 1.5 3.9 0.9 8.2 0.0 1.0 0.2 0.0 0.0 0.6 0.0 1.4 1.5 0.5 0.7 0.3 1.4 0.5 1.9 1.3 0.5 1.9 0.5 17.9 37.7 0.5 1363.4 350.5 0.0 4.8 48.4 16.0 48.9 41.8 0.0 3794.0 8.3 172.2 2.1 8.7 316.4 0.0 128.2 1743.3 110.0 1372.9 82.9 3.4 356.1 0.0 189.0 11.6 9.2 0.4 3.4 47.2 97.8 17.2 122.2 0.0 313.5 273.8 2.8 0.3 0.1 51.8 311.1 0.5 4.5 599.1 8329.2 3.8 109.0 2915.8 PHLDB1 "FLJ00141, KIAA0638, LL5a" ENSG00000019144 "Pleckstrin homology like domain family B member 1" Q86UU1 11 118606440-118658038 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 68.1;Late spermatids: 60.6;Leydig cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 39.2;ASC TERT1: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037959, HPA038448, HPA061506" Approved Approved "Nucleoplasm,Mitotic spindle" Yes No Nucleoplasm "Mitotic spindle" "HPA037959: AB_10673651, HPA038448: AB_10697390, HPA061506: AB_2684545" "unprognostic (7.81e-2)" "unprognostic (8.32e-3)" "unprognostic (1.13e-1)" "unprognostic (9.36e-3)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" "unprognostic (4.37e-3)" "unprognostic (1.22e-1)" "unprognostic (3.21e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.36e-6)" "unprognostic (7.09e-2)" "unprognostic (2.42e-2)" "unprognostic (3.69e-2)" "unprognostic (1.44e-1)" 40.5 7.4 19.6 9.5 52.2 0.9 19.0 4.6 30.8 25.0 10.7 87.0 3.6 8.1 22.0 9.6 8.2 18.7 18.5 20.8 22.4 11.8 9.6 2.8 13.7 4.0 47.0 19.9 21.4 18.9 4.9 4.5 20.8 26.9 9.4 5.9 8.0 7.1 14.6 10.0 9.2 8.8 16.0 27.6 10.2 7.9 7.0 51.0 0.0 10.7 5.4 2.3 10.8 11.6 0.5 0.4 2.1 0.3 1.9 0.7 0.1 1.6 2.6 10.5 5.1 39.2 39.8 3.7 7.8 9.6 4.6 2.7 3.9 11.4 0.0 14.7 15.6 6.2 6.6 2.3 16.0 0.7 0.2 1.5 3.0 1.9 1.9 10.1 0.0 5.7 20.7 3.5 6.4 4.4 10.4 13.1 0.2 2.6 0.1 5.9 1.2 0.0 0.1 3.7 0.1 1.3 0.4 2.7 0.2 4.6 2.4 2.4 5.2 19.9 1.7 5.5 4.2 7.3 0.9 16.0 9.5 8.6 4.8 6.2 0.0 0.0 0.0 2.7 0.5 10.7 0.5 0.3 0.4 0.2 0.0 0.3 0.2 0.3 0.7 0.0 0.5 0.7 0.5 2.1 1.9 0.2 0.4 0.2 0.1 19.6 52.2 4.6 30.8 22.4 11.8 47.0 19.9 26.9 51.0 6.0 13.6 0.9 8.3 16.4 3.5 3.9 0.0 0.0 10.3 29.6 0.0 0.9 0.0 9.1 68.1 25.1 16.5 0.0 3.9 1.3 32.9 5.0 1.1 0.6 5.0 3.2 8.1 31.3 3.5 60.6 62.2 7.0 11.8 3.6 21.4 6.7 15.4 28.1 41.8 5.7 1.8 38.8 45.5 7.4 5.8 8.0 1.3 2.2 13.5 2.1 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 104.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 138.6;Basal keratinocytes: 222.0;Smooth muscle cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.4;HaCaT: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: AB_2674492" "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favorable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 15.5 3.8 1.3 13.2 1.9 0.4 9.9 1.6 2.9 13.9 22.8 1.4 8.4 2.8 17.4 10.1 10.7 10.7 9.1 21.7 1.3 1.2 36.6 24.6 14.4 2.2 2.1 1.9 8.5 6.4 0.9 5.3 104.0 7.1 16.7 4.4 6.9 7.0 14.3 6.0 5.8 6.5 49.3 2.4 7.9 11.4 4.3 0.4 1.7 5.9 6.8 2.3 33.8 17.8 1.0 1.0 0.4 0.1 1.7 5.6 1.3 32.4 3.6 20.4 0.0 6.6 10.9 8.4 18.8 9.2 12.5 14.8 10.2 2.4 0.0 19.8 7.2 12.6 33.8 0.3 12.1 22.8 0.5 0.4 0.0 8.7 3.3 7.2 0.0 0.1 12.8 7.2 8.6 16.0 14.1 20.0 0.3 0.0 0.1 3.7 0.0 1.3 0.0 8.2 0.3 6.3 2.8 26.3 0.0 7.4 7.8 0.5 1.5 18.5 0.3 1.9 11.7 0.6 0.1 17.4 3.4 28.6 9.0 4.5 1.7 0.0 0.0 3.4 0.0 6.4 0.2 0.0 0.0 5.2 0.0 3.7 0.4 3.6 5.6 0.1 1.0 0.0 2.3 0.4 1.7 0.1 1.0 0.8 1.3 1.3 1.9 1.6 2.9 1.3 1.2 2.1 1.9 7.1 0.4 74.5 9.8 2.4 138.6 222.0 0.1 94.0 25.5 5.3 12.5 31.4 2.0 21.1 19.9 56.7 10.2 32.4 0.0 0.0 17.6 42.7 33.9 48.7 6.9 28.4 3.0 0.0 10.4 43.6 3.2 3.9 13.3 3.2 21.9 1.8 3.4 0.0 37.0 0.0 21.2 28.0 0.3 12.9 129.6 0.3 2.1 100.2 55.8 7.0 1.4 85.9 PHLPP1 "KIAA0606, PHLPP, PLEKHE1, PPM3A, SCOP" ENSG00000081913 "PH domain and leucine rich repeat protein phosphatase 1" O60346 18 62715450-62980433 "Enzymes, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0" "Cell type enhanced" "Detected in many" 8 "Muller glia cells: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "neutrophil: 7.7;T-reg: 2.4" "Group enriched" "Detected in many" 7 "granulocytes: 7.7;T-cells: 2.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020200 Uncertain "Intracellular and membrane" NA NA "HPA020200: AB_2670383" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" "unprognostic (2.26e-1)" "unprognostic (1.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.07e-2)" "unprognostic (5.57e-2)" "unprognostic (5.24e-1)" "unprognostic (1.63e-1)" "unprognostic (3.10e-1)" "unprognostic (2.95e-1)" "unprognostic (6.03e-2)" "prognostic favorable (5.35e-8)" "unprognostic (1.52e-1)" "unprognostic (3.49e-2)" "unprognostic (8.13e-2)" "unprognostic (8.25e-2)" 5.8 10.6 22.1 2.3 34.1 7.4 7.4 8.3 29.6 4.3 6.0 48.0 0.9 6.2 4.4 2.5 6.1 4.0 4.9 3.0 22.4 12.3 4.0 18.5 3.4 3.0 44.4 13.8 5.5 8.0 9.6 5.6 6.3 20.6 5.0 6.7 4.4 11.2 4.5 3.9 9.1 5.5 4.0 18.6 2.0 5.6 11.5 44.8 2.3 5.6 1.6 4.1 5.6 3.2 0.6 0.7 7.7 0.2 0.6 2.4 0.1 9.0 3.4 14.0 4.6 2.4 2.0 10.9 2.7 2.5 5.4 5.6 7.4 5.5 6.1 1.7 4.1 2.1 11.1 7.2 4.3 7.0 18.8 6.0 2.0 3.7 13.7 3.4 3.1 1.0 2.1 2.9 5.8 5.3 4.4 3.8 3.3 5.2 12.3 5.2 2.0 2.3 2.7 5.6 1.8 3.3 21.7 7.9 7.3 3.1 11.8 6.5 2.6 3.0 6.8 5.6 8.5 3.0 8.9 4.8 4.5 2.1 2.6 6.3 1.4 0.7 7.2 2.6 3.6 3.4 0.0 0.2 0.1 0.7 0.0 0.0 0.6 0.1 0.0 0.7 0.2 0.4 0.1 7.7 0.6 0.2 0.3 2.4 0.1 22.1 34.1 8.3 21.1 22.4 12.3 44.4 13.8 20.6 44.8 3.0 1.0 0.0 3.7 14.9 14.8 3.3 15.3 8.1 5.7 0.0 27.5 10.8 1.7 2.5 26.9 5.8 5.6 0.0 3.6 4.7 6.0 6.4 2.3 16.3 2.1 25.4 11.6 6.2 2.8 24.6 5.5 4.6 23.6 3.6 7.9 82.5 3.7 5.8 3.5 1.8 16.7 0.0 4.4 5.0 16.9 16.3 21.9 0.0 11.5 7.4 PHLPP2 "KIAA0931, PHLPPL, PPM3B" ENSG00000040199 "PH domain and leucine rich repeat protein phosphatase 2" Q6ZVD8 16 71637835-71724701 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 29.9" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 98.2;Enterocytes: 51.9;Rod photoreceptor cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040761, HPA041837, HPA048598" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" NA No Cytosol "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA040761: , HPA041837: , HPA048598: AB_2680459" "unprognostic (5.67e-2)" "unprognostic (2.00e-1)" "unprognostic (2.29e-2)" "unprognostic (2.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.27e-1)" "unprognostic (1.22e-1)" "unprognostic (3.43e-1)" "unprognostic (1.97e-4)" "unprognostic (3.08e-2)" "unprognostic (8.85e-3)" "unprognostic (6.41e-2)" "unprognostic (4.92e-2)" "unprognostic (8.46e-3)" "unprognostic (8.27e-2)" 6.4 4.7 12.5 7.0 10.9 8.1 8.4 17.4 14.9 4.4 16.6 4.6 4.3 15.8 5.8 4.9 2.7 4.7 4.1 4.6 11.7 9.0 5.4 4.9 4.8 5.0 6.2 14.9 7.2 4.9 10.2 7.3 4.3 12.6 4.7 17.8 13.2 2.9 5.7 5.3 3.0 29.9 7.0 7.6 3.9 4.2 10.8 4.7 1.0 9.9 1.1 4.9 4.7 9.8 2.4 2.2 1.2 0.7 3.5 1.5 0.4 4.9 6.5 7.1 7.9 5.7 6.9 4.1 7.4 6.7 10.7 8.8 5.9 1.6 9.8 2.9 12.2 7.7 10.5 10.2 3.8 13.9 3.4 5.5 2.7 5.6 3.9 4.5 2.3 4.3 5.1 2.2 15.2 5.0 4.5 4.0 3.4 2.4 2.7 7.4 10.4 3.2 1.8 5.5 1.5 1.7 5.1 6.2 3.2 5.1 3.8 6.2 3.3 15.9 4.4 2.6 5.7 5.4 1.4 5.5 10.8 7.8 4.5 6.1 6.1 4.3 10.1 6.7 1.9 2.4 0.8 0.5 0.2 1.0 0.7 0.9 2.4 0.8 1.5 0.6 1.6 1.1 0.9 1.2 3.5 0.7 2.2 1.3 0.4 12.5 10.9 17.4 14.9 11.7 9.0 6.2 14.9 12.6 4.7 8.9 2.1 5.2 4.7 8.2 18.7 2.3 0.0 2.7 4.5 3.5 98.2 3.8 0.0 2.4 9.7 3.7 51.9 0.0 2.0 0.3 7.2 5.0 10.3 3.9 1.3 22.3 5.8 3.1 5.4 3.6 4.9 2.2 13.5 2.8 6.7 6.3 2.8 31.6 4.9 4.3 60.3 6.5 5.6 29.1 18.3 8.0 1.1 3.5 7.2 2.1 PHOSPHO1 ENSG00000173868 "Phosphoethanolamine/phosphocholine phosphatase" Q8TCT1 17 49223362-49230766 "Enzymes, Predicted intracellular proteins" "Mineral balance" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 80.0;testis: 52.3" "Cell type enriched" "Detected in some" 6 "Late spermatids: 1098.7" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebral cortex: 10.2;pons and medulla: 8.2" "Group enriched" "Detected in some" 171 "eosinophil: 30.6;neutrophil: 80.0" "Lineage enriched" "Detected in single" 248 "granulocytes: 80.0" "Cell line enhanced" "Detected in some" "Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9" "Low region specificity" "Detected in all" HPA065025 Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA065025: AB_2732727" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (7.53e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-1)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-2)" "unprognostic (2.04e-1)" "unprognostic (6.88e-2)" "unprognostic (1.02e-2)" "unprognostic (2.88e-1)" "unprognostic (2.03e-1)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" 2.5 1.3 1.1 2.9 1.9 15.3 0.7 1.0 10.2 0.6 0.6 0.2 0.2 2.5 0.9 2.7 0.9 1.3 2.1 1.0 1.7 1.3 1.0 0.9 2.5 2.0 2.1 1.5 1.1 1.0 0.1 0.8 7.6 8.2 0.9 0.0 1.6 0.9 0.5 2.2 1.1 2.6 0.3 1.5 12.6 0.7 52.3 0.1 0.0 0.8 0.1 0.1 1.4 1.3 0.0 0.0 80.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 2.0 0.1 0.2 0.0 0.3 0.4 0.0 0.1 2.7 0.0 8.6 5.8 0.0 3.3 0.0 1.6 0.5 0.1 6.1 0.2 1.2 1.1 0.4 0.0 0.0 1.1 0.4 0.0 0.6 0.0 0.6 0.0 1.1 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.3 1.6 1.7 3.2 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 8.9 0.2 0.1 3.5 0.4 2.8 1.9 0.0 0.2 0.3 0.6 2.5 3.3 0.3 0.0 0.1 30.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.0 0.0 0.3 0.0 0.0 0.1 1.1 1.9 1.0 10.2 1.7 1.3 2.1 1.5 8.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 185.3 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.6 0.0 1098.7 7.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.6 0.0 0.4 0.0 0.0 8.2 3.8 0.0 198.7 0.0 0.0 0.0 PHOX2A "ARIX, CFEOM2, FEOM2, PMX2A" ENSG00000165462 "Paired like homeobox 2a" O14813 11 72239077-72245664 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7" "Cell type enriched" "Detected in single" 9 "Spermatogonia: 3.6" "Cancer enriched" "Detected in some" 9 "ovarian cancer: 9.3" "Region enriched" "Detected in single" 96 "pons and medulla: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 228 "SH-SY5Y: 115.5" "Region enriched" "Detected in single" 9 "pons and medulla: 0.8" "Not detected" "Not detected" "HPA053810, HPA065621, HPA078004" Enhanced Supported Nucleoplasm No NA Nucleoplasm "HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367" "unprognostic (5.84e-2)" "unprognostic (8.51e-2)" "unprognostic (5.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (9.92e-4)" "unprognostic (3.03e-2)" 0.4 24.6 0.0 9.7 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.5 0.0 0.4 0.1 0.0 1.4 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.8 0.0 12.1 0.9 0.7 1.7 0.7 3.7 0.0 0.0 3.2 0.3 2.1 0.1 1.6 5.2 0.0 0.0 0.0 0.0 0.0 2.6 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 115.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 PHOX2B "NBPhox, Phox2b, PMX2B" ENSG00000109132 "Paired like homeobox 2b" Q99453 4 41744082-41748970 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 14.5;brain: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 99 "pons and medulla: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "SH-SY5Y: 53.6" "Region enriched" "Detected in single" 17 "pons and medulla: 5.9" "Region enriched" "Detected in single" 27 "pons and medulla: 2.0" "HPA074325, HPA074941" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA074325: AB_2686678, HPA074941: AB_2732272" "unprognostic (1.01e-1)" "unprognostic (2.47e-1)" "unprognostic (5.27e-2)" 0.0 14.5 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 24.8 0.2 1.4 0.8 0.0 0.0 0.0 0.0 3.2 0.5 0.4 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 53.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PHTF2 DKFZp434D166 ENSG00000006576 "Putative homeodomain transcription factor 2" Q8N3S3 7 77798792-77957503 "Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "non-classical monocyte: 18.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012312 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA012312: AB_2668649" "unprognostic (1.96e-1)" "unprognostic (2.60e-3)" "unprognostic (4.04e-1)" "unprognostic (1.44e-1)" "unprognostic (5.70e-2)" "unprognostic (1.99e-3)" "unprognostic (5.36e-3)" "unprognostic (2.81e-2)" "unprognostic (1.63e-2)" "unprognostic (1.41e-2)" "unprognostic (3.86e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.09e-7)" "unprognostic (8.28e-3)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (5.53e-2)" 7.5 4.5 5.6 15.1 8.6 7.7 5.9 8.7 10.3 7.0 5.9 8.9 5.3 3.2 7.3 4.6 6.4 5.7 7.8 9.1 7.0 5.2 5.4 4.7 6.8 13.7 7.0 6.3 7.4 4.7 27.7 8.2 11.4 9.3 5.9 5.1 4.7 5.7 6.9 67.0 5.5 7.8 8.5 8.2 12.1 4.7 9.1 5.8 9.2 5.7 18.2 15.5 7.9 6.3 6.7 2.1 9.2 18.2 3.8 6.2 2.0 15.2 7.0 9.6 19.5 8.4 9.3 8.0 27.0 24.7 16.2 18.4 11.9 12.4 13.7 2.2 20.9 17.6 12.7 13.7 7.0 23.1 9.2 10.9 5.6 7.7 3.5 9.2 7.4 15.5 5.5 6.7 9.4 14.2 10.4 5.7 7.7 9.1 24.4 17.2 9.6 6.0 4.8 8.7 4.3 8.3 6.1 19.5 11.2 4.4 20.6 9.3 13.0 15.1 17.2 9.8 14.8 18.2 5.8 5.7 27.9 15.0 15.6 15.8 11.5 13.4 17.1 8.8 12.0 24.0 9.2 2.1 3.4 1.5 9.2 3.0 6.7 4.7 1.4 2.1 4.2 1.4 1.5 1.2 3.8 18.2 1.0 6.2 2.0 5.6 8.6 8.7 10.3 7.0 5.2 7.0 6.3 9.3 5.8 6.0 17.5 23.8 17.3 14.2 7.8 21.5 15.3 9.4 9.1 7.0 11.8 11.2 0.0 4.0 10.8 9.0 5.3 0.0 5.8 7.0 14.7 6.5 37.1 4.3 10.4 3.2 5.2 23.4 33.1 4.4 11.2 29.4 10.1 1.8 6.0 4.0 6.0 5.8 12.7 1.8 9.3 12.9 12.8 22.9 32.2 15.6 12.4 35.5 4.5 20.4 PHYH "PAHX, PHYH1, RD" ENSG00000107537 "Phytanoyl-CoA 2-hydroxylase" O14832 10 13277796-13302412 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 128.3;skeletal muscle: 83.8" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 202.2;Proximal tubular cells: 218.2" "Cancer enhanced" "Detected in all" "liver cancer: 78.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007598, HPA011796" Enhanced NA NA "HPA007598: AB_1855334, HPA011796: AB_1855335" "unprognostic (5.78e-2)" "unprognostic (3.83e-1)" "unprognostic (6.98e-2)" "unprognostic (3.62e-2)" "unprognostic (5.52e-2)" "unprognostic (1.61e-3)" "unprognostic (1.16e-1)" "unprognostic (1.95e-2)" "unprognostic (7.09e-2)" "unprognostic (6.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.24e-1)" "prognostic favorable (7.28e-12)" "unprognostic (2.07e-1)" "unprognostic (1.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.19e-1)" 10.5 16.8 5.3 5.3 6.2 1.4 7.7 5.1 8.7 6.0 10.7 5.4 5.7 11.4 5.4 5.6 6.8 3.6 8.5 38.0 4.0 4.9 36.4 128.3 6.4 3.2 6.5 3.7 7.6 9.9 6.8 6.7 4.5 5.3 6.2 7.4 7.1 6.3 5.4 83.8 3.8 15.5 10.2 4.4 3.0 8.5 4.1 4.1 1.9 13.0 29.5 3.6 7.6 9.4 9.2 13.3 10.7 16.0 3.3 15.4 10.2 6.2 13.0 5.9 8.4 42.6 27.2 4.7 6.4 8.9 7.3 7.3 3.3 11.3 0.3 4.9 10.6 17.9 2.9 7.6 7.5 4.5 14.9 4.0 5.4 3.6 13.1 21.2 0.9 10.2 19.3 10.8 7.9 3.1 8.6 7.0 6.3 3.0 12.0 16.9 5.8 3.2 4.3 5.4 18.0 4.7 5.7 9.1 2.1 15.2 7.9 2.0 6.4 23.9 0.5 11.7 4.9 24.3 16.1 2.3 11.2 4.1 13.7 4.2 13.9 9.3 1.2 14.6 6.9 4.4 10.7 16.0 6.5 7.2 11.7 15.4 9.2 9.1 9.2 13.3 4.9 11.5 11.7 0.6 3.3 9.0 12.2 8.6 10.2 5.3 6.2 5.1 8.7 4.0 4.9 6.5 3.7 5.3 4.1 11.9 16.3 21.7 25.5 10.5 48.0 202.2 61.1 21.4 13.6 33.2 21.6 99.5 122.7 32.7 25.3 26.0 87.2 0.0 17.2 26.8 24.7 15.1 29.0 133.8 47.0 20.6 30.6 24.5 18.1 31.5 23.6 24.7 16.9 10.0 49.9 65.0 20.4 35.1 35.3 218.2 34.7 19.4 22.4 1.4 0.7 11.7 70.1 16.2 37.9 15.9 PHYHIP "DYRK1AP3, KIAA0273, PAHX-AP" ENSG00000168490 "Phytanoyl-CoA 2-hydroxylase interacting protein" Q92561 8 22219704-22232341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.4;skin 1: 37.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 16.8;Smooth muscle cells: 7.8;Suprabasal keratinocytes: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.9;SH-SY5Y: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "amygdala: 111.3;basal ganglia: 281.7;cerebellum: 369.4;cerebral cortex: 248.5;hippocampal formation: 314.4" "HPA068030, HPA069318" Approved Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068030: AB_2685944, HPA069318: AB_2686117" "unprognostic (1.19e-2)" "unprognostic (2.33e-2)" "unprognostic (3.06e-2)" "unprognostic (9.22e-3)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (2.80e-1)" "unprognostic (3.01e-2)" "unprognostic (7.44e-3)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (4.44e-5)" "unprognostic (8.62e-4)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (4.09e-3)" 5.4 18.6 25.0 2.3 71.8 1.3 3.5 58.9 89.4 3.2 2.1 3.0 0.0 2.2 6.0 3.4 7.1 9.8 6.2 2.9 31.2 12.3 2.2 1.4 1.8 1.4 7.3 40.3 2.3 2.2 1.3 5.5 3.0 21.1 3.6 1.7 0.0 1.4 5.9 1.7 37.9 2.4 7.2 3.5 3.6 1.6 5.8 10.4 0.0 2.0 0.0 1.4 7.8 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.3 0.5 0.0 0.3 0.8 1.1 0.3 1.3 0.4 0.4 0.1 2.0 0.0 2.2 0.6 1.4 3.8 0.0 0.7 0.1 0.0 0.2 0.0 4.0 1.5 1.7 0.0 0.0 0.9 0.0 0.8 0.0 3.6 2.5 0.1 0.2 1.3 0.0 0.0 0.0 0.0 0.9 0.7 0.3 0.0 0.2 12.9 0.0 0.0 4.3 5.0 2.9 0.0 3.4 0.3 0.0 0.3 1.1 0.0 2.1 1.6 0.7 1.0 0.2 0.0 2.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 71.8 58.9 82.9 31.2 12.3 7.3 40.3 21.1 10.4 0.0 0.0 0.0 5.1 16.8 0.7 1.2 0.0 0.0 2.3 3.5 0.0 0.1 0.0 0.2 0.6 1.3 0.5 0.0 1.8 0.2 2.3 0.5 0.0 0.9 0.2 0.0 0.0 1.3 0.0 1.3 2.8 0.0 1.7 0.0 0.3 0.4 0.4 0.0 3.5 2.2 0.9 0.0 7.8 0.2 0.0 9.5 1.8 0.0 0.0 3.9 PHYHIPL "Em:AC025038.1, KIAA1796" ENSG00000165443 "Phytanoyl-CoA 2-hydroxylase interacting protein like" Q96FC7 10 59176590-59247774 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 70.3" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 131.3;Early spermatids: 143.9;Horizontal cells: 136.7;Late spermatids: 172.3;Muller glia cells: 208.8;Spermatocytes: 91.0" "Group enriched" "Detected in many" 5 "glioma: 21.1;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.8;Hep G2: 24.9;SCLC-21H: 4.5;SH-SY5Y: 14.9;SK-BR-3: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038746 Uncertain Approved Cytosol NA NA Cytosol "HPA038746: AB_10673293" "unprognostic (6.34e-3)" "unprognostic (2.40e-1)" "unprognostic (1.04e-1)" "unprognostic (3.76e-3)" "unprognostic (7.06e-2)" "unprognostic (3.37e-1)" "unprognostic (5.63e-2)" "unprognostic (3.78e-2)" "unprognostic (1.06e-1)" "unprognostic (4.00e-3)" "unprognostic (2.67e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.60e-7)" "unprognostic (1.29e-3)" "unprognostic (1.30e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 1.9 23.1 22.2 2.0 22.4 1.6 1.8 17.6 70.3 2.1 2.1 25.4 0.4 11.2 2.5 3.8 2.0 2.5 1.8 1.7 20.8 21.4 14.8 2.7 1.7 1.6 28.0 25.0 2.5 5.6 1.6 4.4 10.6 24.8 4.4 2.0 7.6 2.2 4.9 1.6 1.6 11.5 1.7 27.4 1.6 2.2 8.9 31.0 0.0 1.6 0.0 1.6 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 14.9 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 22.4 17.6 32.6 20.8 21.4 28.0 25.0 24.8 31.0 0.0 0.0 0.0 11.5 0.0 131.3 0.4 0.0 0.0 0.0 3.5 11.8 0.9 11.6 0.3 143.9 0.3 0.0 0.0 5.7 0.2 0.2 3.3 0.0 2.1 0.5 136.7 0.0 1.3 0.0 172.3 12.0 0.0 1.7 0.0 0.0 208.8 2.8 0.0 0.4 46.1 49.8 0.0 0.1 91.0 13.2 0.0 41.0 0.0 0.0 3.2 PI16 "CD364, dJ90K10.5, MGC45378, MSMBBP" ENSG00000164530 "Peptidase inhibitor 16" Q6UXB8 6 36948263-36964837 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 87.2" "Cell type enhanced" "Detected in many" 20 "Fibroblasts: 45.7;Leydig cells: 190.7;Peritubular cells: 140.7" "Cancer enhanced" "Detected in many" "glioma: 15.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 29.9" "Lineage enriched" "Detected in many" 5 "T-cells: 29.9" "Cell line enriched" "Detected in some" 6 "JURKAT: 26.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076574 Approved "Secreted to blood" NA NA 3600000000 "HPA076574: AB_2732314" "unprognostic (6.24e-3)" "unprognostic (6.00e-3)" "unprognostic (7.34e-2)" "unprognostic (9.53e-2)" "unprognostic (3.38e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-2)" "unprognostic (5.06e-2)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (3.25e-2)" "unprognostic (4.46e-2)" "unprognostic (1.59e-3)" "unprognostic (5.82e-2)" "unprognostic (2.31e-1)" "unprognostic (1.28e-1)" "unprognostic (8.76e-2)" 22.2 1.7 2.9 1.4 8.8 0.3 27.9 0.7 4.5 62.7 4.5 21.4 22.5 0.8 11.1 27.0 10.5 5.3 17.4 43.1 4.6 3.5 0.8 0.5 3.7 1.1 9.0 3.9 2.8 2.5 0.6 3.3 1.2 9.3 15.0 3.4 87.2 4.0 14.2 5.5 19.8 2.0 55.5 13.7 0.8 8.5 8.3 9.3 0.1 8.3 8.7 4.8 32.7 49.8 0.7 0.2 0.2 0.0 5.7 29.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 26.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.3 9.8 2.9 0.0 0.7 3.4 1.0 0.2 5.7 0.0 0.2 29.9 1.7 2.9 8.8 0.7 4.5 4.6 3.5 9.0 3.9 9.3 9.3 0.0 1.0 0.0 0.1 19.2 0.0 3.2 0.0 0.0 1.2 1.8 0.0 0.0 1.7 0.0 10.5 2.7 0.0 0.0 0.0 0.0 45.7 0.1 0.0 0.0 0.1 0.0 0.0 17.2 0.0 14.4 190.7 1.0 10.1 0.0 0.0 0.0 0.1 0.0 140.7 0.2 0.0 0.0 2.2 1.9 1.1 16.2 0.1 0.0 0.0 0.1 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174876-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6" "Cell type enhanced" "Detected in many" 21 "Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1121 "neutrophil: 157.1" "Lineage enriched" "Detected in single" 1571 "granulocytes: 157.1" "Group enriched" "Detected in some" 5 "EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 2100000 "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favorable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.84e-6)" "prognostic unfavorable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavorable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 0.4 0.0 0.2 8.8 0.2 0.0 0.7 0.2 0.2 85.3 9.3 0.2 0.4 0.1 7.7 0.2 200.8 0.3 4.8 0.6 0.2 0.0 0.3 0.6 3.1 0.8 0.2 0.2 0.3 0.4 0.0 0.2 0.6 0.3 1.0 3.7 0.3 35.6 0.4 0.2 6.4 3.2 0.6 0.2 1.4 0.7 5.1 0.2 23.4 0.2 468.6 173.5 1.6 118.7 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.9 0.6 0.4 26.6 0.0 0.3 32.3 0.0 6.6 0.0 0.3 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 6.3 5.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 29.6 55.0 0.0 0.2 0.0 6.3 0.1 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.2 0.3 3.2 0.0 0.2 0.1 0.4 0.1 4.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 11.3 0.5 5.2 0.1 0.0 0.0 7.6 0.0 13.6 17.4 0.0 0.0 0.0 14.9 0.1 0.1 69.5 0.0 290.8 0.0 0.3 25.8 4.6 0.0 0.1 0.0 16.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.4 0.0 135.9 29.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 33.5 18.7 PI4K2B "FLJ11105, PI4KIIB, PIK42B" ENSG00000038210 "Phosphatidylinositol 4-kinase type 2 beta" Q8TCG2 4 25233975-25279092 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 49.3" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA004099 Approved Supported Cytosol NA NA Cytosol "HPA004099: AB_1855353" "unprognostic (1.02e-1)" "unprognostic (6.34e-3)" "prognostic favorable (9.64e-5)" "unprognostic (2.75e-2)" "unprognostic (1.98e-2)" "unprognostic (2.68e-2)" "unprognostic (7.54e-2)" "unprognostic (7.75e-2)" "unprognostic (5.06e-1)" "unprognostic (6.39e-3)" "unprognostic (1.71e-1)" "unprognostic (1.32e-1)" "unprognostic (9.07e-2)" "unprognostic (9.61e-2)" "unprognostic (2.39e-2)" "unprognostic (2.02e-2)" "unprognostic (4.47e-2)" 9.2 7.1 3.4 13.6 2.9 3.9 8.0 3.2 2.3 8.7 48.4 4.1 11.3 19.4 7.4 8.0 13.5 4.9 9.5 4.2 3.1 2.7 12.9 38.6 14.3 9.4 3.5 2.3 6.9 10.5 4.2 5.7 7.7 2.9 6.4 9.8 3.3 22.6 12.0 4.4 8.6 49.3 6.9 4.5 13.8 11.3 8.0 2.7 18.6 16.2 12.9 14.1 7.8 10.3 1.4 1.8 1.5 1.0 0.4 4.1 0.4 11.5 2.1 4.9 5.2 6.6 12.3 11.9 17.4 16.4 15.2 19.5 3.7 12.4 29.9 4.0 13.1 10.6 4.8 11.1 8.7 15.1 9.1 3.9 9.5 5.2 9.2 6.3 19.2 7.5 8.2 7.9 5.7 6.0 4.6 10.3 8.5 6.3 25.1 14.8 4.4 18.5 17.2 8.5 13.8 4.7 11.2 19.2 17.4 13.4 8.2 10.2 2.2 8.8 7.0 3.6 5.5 9.9 11.1 10.5 10.8 2.8 6.6 11.2 28.8 13.8 22.8 12.7 16.3 11.0 1.5 0.4 0.0 1.3 1.0 0.9 1.4 1.5 1.2 0.3 1.0 1.4 1.3 0.2 0.4 0.9 1.8 4.1 0.4 3.4 2.9 3.2 2.3 3.1 2.7 3.5 2.3 2.9 2.7 6.0 14.4 14.1 11.2 13.4 1.9 0.0 7.6 2.7 12.5 8.7 0.0 18.1 5.0 5.1 0.6 6.4 14.2 23.3 6.2 10.1 8.3 11.3 0.0 36.0 9.1 1.6 8.1 6.7 12.4 0.9 4.0 7.0 5.0 12.6 12.8 1.1 5.0 8.6 4.2 15.6 3.0 0.0 7.2 8.0 12.7 13.7 11.3 5.0 12.7 11.9 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 18000 Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: AB_2686753" "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favorable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favorable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 7.7 9.2 28.8 10.5 34.2 12.5 6.5 14.1 48.0 9.7 8.8 10.1 4.9 9.1 9.7 6.1 8.3 8.4 8.0 8.5 30.4 19.2 9.0 12.6 9.0 11.2 19.0 25.9 10.2 8.6 25.6 12.5 10.4 19.3 9.8 8.9 10.8 6.8 10.6 7.1 6.6 10.0 13.2 6.8 10.2 9.9 13.1 8.2 17.9 9.9 2.9 10.2 8.4 4.8 5.0 12.5 7.6 5.5 9.1 7.7 2.9 9.9 8.4 7.4 11.1 21.2 12.8 10.6 9.0 13.7 13.3 13.1 6.5 4.2 18.7 5.4 18.1 13.1 8.8 14.0 8.7 8.2 15.9 21.5 19.2 11.3 7.4 10.6 19.0 15.4 11.4 5.5 11.3 6.3 8.7 10.8 5.7 52.4 15.9 10.3 13.7 16.6 6.5 5.8 17.8 8.7 16.7 16.2 3.4 7.4 15.9 18.2 13.3 11.8 13.8 9.4 10.8 11.6 8.7 10.9 24.3 12.6 8.9 7.6 12.2 12.4 14.9 16.0 13.7 10.1 3.1 5.5 7.3 5.1 5.4 4.9 4.6 5.6 6.1 3.6 5.0 5.7 7.7 7.6 9.1 4.6 12.5 5.8 2.9 28.8 34.2 14.1 48.0 30.4 19.2 19.0 25.9 19.3 8.2 11.9 25.4 14.0 5.7 9.0 32.8 25.7 25.5 6.7 9.1 7.0 45.2 15.6 1.7 8.5 30.2 12.8 18.2 0.0 5.5 16.0 10.8 10.3 11.5 15.5 17.4 35.0 18.4 14.7 15.5 19.2 18.4 16.5 10.1 6.4 16.8 22.8 7.1 10.5 22.6 9.1 23.8 25.8 10.5 32.1 28.9 8.5 16.7 13.3 12.7 7.0 PIANP "C12orf53, DKFZp547D2210, PANP" ENSG00000139200 "PILR alpha associated neural protein" Q8IYJ0 12 6693792-6700800 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.7" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1" "Cancer enhanced" "Detected in many" "glioma: 14.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 7 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010631 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA010631: AB_10603680" "unprognostic (1.82e-1)" "unprognostic (9.21e-3)" "unprognostic (1.62e-2)" "unprognostic (7.65e-2)" "unprognostic (1.34e-1)" "unprognostic (3.03e-2)" "unprognostic (6.58e-2)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (6.41e-3)" "unprognostic (1.92e-2)" "unprognostic (3.89e-1)" "unprognostic (3.30e-3)" "unprognostic (3.26e-3)" "unprognostic (1.16e-1)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" 1.5 8.3 28.0 2.2 55.7 1.2 1.5 27.4 52.8 7.2 2.7 2.6 0.5 1.9 11.6 4.1 1.8 2.2 3.3 1.5 19.5 26.2 1.5 1.1 1.5 2.4 11.0 20.9 1.8 1.7 1.2 4.0 1.5 9.0 3.4 2.0 1.7 2.2 8.7 1.3 1.7 2.2 8.1 4.6 1.6 2.1 4.4 8.3 0.0 1.4 0.0 1.7 1.8 2.5 0.3 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.4 5.9 1.1 0.2 0.3 0.2 1.5 7.9 4.1 3.7 0.1 0.2 0.1 0.0 2.8 0.6 0.2 7.8 0.2 2.0 0.2 1.0 0.3 0.2 0.0 0.2 0.3 0.2 1.0 0.0 1.6 0.0 13.1 0.0 2.4 0.0 0.2 0.3 0.2 0.2 0.2 16.5 0.0 0.0 1.1 0.0 0.1 0.1 0.1 2.1 15.6 0.0 0.1 0.0 1.1 0.0 0.0 0.0 4.3 8.7 4.4 1.1 0.2 0.0 0.3 5.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.7 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 55.7 27.4 27.8 19.5 26.2 11.0 20.9 9.0 8.3 0.0 0.0 0.0 0.0 0.2 13.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 13.1 0.0 3.0 0.0 1.4 0.1 4.5 0.1 0.1 0.0 0.0 0.0 PIAS2 "ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4" ENSG00000078043 "Protein inhibitor of activated STAT 2" O75928 18 46803224-46920160 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.6" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 405.0;Late spermatids: 431.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068792 Enhanced Supported Nucleoplasm Yes No Nucleoplasm "HPA068792: AB_2686037" "unprognostic (9.59e-3)" "unprognostic (2.14e-1)" "unprognostic (1.63e-1)" "unprognostic (2.75e-2)" "unprognostic (1.25e-1)" "unprognostic (6.39e-2)" "unprognostic (1.05e-3)" "unprognostic (3.67e-2)" "unprognostic (1.05e-1)" "unprognostic (3.71e-3)" "unprognostic (1.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.58e-1)" "unprognostic (6.92e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.71e-1)" 5.6 6.7 9.8 4.7 12.7 7.0 6.1 16.7 13.5 4.7 5.6 8.1 8.0 3.7 6.0 8.8 4.7 5.3 5.5 7.5 8.4 8.1 7.4 6.6 4.9 6.5 7.9 8.5 5.8 5.0 19.3 10.4 4.8 12.1 7.7 8.1 8.2 5.9 7.9 15.6 8.5 4.8 5.7 7.6 6.5 5.3 61.6 9.1 7.5 9.2 4.1 5.8 5.3 4.6 6.8 5.1 2.9 4.4 4.8 6.7 2.1 11.9 4.9 5.6 7.9 5.6 7.1 2.6 6.3 5.1 5.5 5.1 5.8 4.5 12.1 3.5 4.7 5.6 4.1 11.1 6.7 7.9 5.9 4.2 7.4 4.7 6.7 5.5 12.3 5.4 7.3 4.1 4.8 5.2 9.0 4.9 10.6 5.5 3.2 10.8 6.4 7.2 7.3 6.1 2.2 3.2 13.2 12.0 0.1 5.1 9.2 10.7 8.3 5.7 3.7 4.1 6.6 5.5 5.6 6.2 11.9 5.1 4.1 4.7 9.4 4.6 15.4 8.8 13.4 11.6 1.5 4.4 2.8 5.4 3.4 3.8 4.1 4.8 6.1 5.0 6.8 6.7 5.7 2.9 4.8 3.0 5.1 4.2 2.1 9.8 12.7 16.7 13.5 8.4 8.1 7.9 8.5 12.1 9.1 17.9 18.7 15.8 17.1 18.3 46.7 26.5 12.7 10.7 6.8 24.4 84.4 1.9 16.6 11.8 405.0 21.0 11.6 23.3 7.7 1.9 16.5 28.6 13.9 17.9 22.7 30.2 27.3 35.6 40.4 431.0 31.1 16.5 11.8 31.5 14.1 27.0 7.6 17.5 32.9 18.9 39.4 6.5 16.4 130.6 70.9 13.4 1.1 15.0 21.8 15.3 PIDD1 "DKFZp434D229, LRDD, MGC16925, PIDD" ENSG00000177595 "P53-induced death domain protein 1" Q9HB75 11 799179-809753 "Predicted intracellular proteins" Apoptosis Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.9" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 23.0;Spermatogonia: 24.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 21.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB012647, HPA055473, HPA066948" Supported Approved "Golgi apparatus,Cytosol" NA Yes "Golgi apparatus, Cytosol" "CAB012647: , HPA055473: AB_2682827, HPA066948: " "unprognostic (1.38e-1)" "prognostic favorable (8.19e-5)" "unprognostic (5.07e-3)" "prognostic favorable (3.32e-5)" "unprognostic (7.25e-2)" "prognostic favorable (3.91e-4)" "unprognostic (8.17e-3)" "unprognostic (5.97e-2)" "unprognostic (3.10e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (2.17e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.84e-3)" "unprognostic (8.46e-2)" "unprognostic (2.24e-1)" "unprognostic (2.22e-2)" 3.4 3.0 3.3 6.7 3.7 15.0 3.9 7.7 10.0 4.4 4.3 2.2 0.4 7.1 3.2 4.1 6.8 3.3 3.0 2.2 4.7 2.9 2.9 5.6 3.1 7.0 4.4 10.9 2.9 5.6 3.0 2.8 10.1 3.2 5.2 2.0 2.7 6.1 3.5 7.1 7.9 6.5 2.0 5.9 5.3 5.9 5.0 1.9 21.9 3.9 4.3 9.2 3.3 2.8 1.9 3.1 0.1 1.8 0.4 3.3 1.2 4.2 4.9 2.3 4.9 0.5 1.9 21.5 5.9 1.6 2.2 2.9 4.4 8.1 3.5 1.9 0.8 2.0 6.2 1.7 2.4 0.4 6.9 9.9 2.9 3.4 9.1 5.7 3.3 7.5 7.0 4.3 1.1 0.3 0.4 4.0 8.2 3.4 2.6 0.9 1.9 9.2 5.5 3.2 4.5 3.5 15.0 3.4 6.7 0.8 1.5 4.1 5.5 2.5 6.6 1.6 1.4 4.8 5.6 2.2 2.8 6.2 2.0 3.8 8.5 4.8 6.6 3.6 2.7 4.4 0.0 1.7 0.1 1.9 1.8 1.8 1.5 1.4 1.5 3.1 1.9 1.7 1.7 0.0 0.4 1.6 0.8 3.3 1.2 3.3 3.7 7.7 10.0 4.7 2.9 4.4 10.9 3.2 1.9 3.0 9.1 8.1 3.4 0.0 13.1 2.8 7.6 0.0 10.3 3.5 9.8 23.0 1.7 2.5 1.1 2.2 8.6 0.0 4.0 5.2 1.3 3.4 1.1 8.9 4.7 1.6 8.6 1.8 1.9 0.7 6.6 2.8 0.0 1.8 7.9 5.7 3.4 8.0 3.9 3.1 16.2 0.0 1.7 9.2 24.7 0.0 8.1 5.3 8.6 2.6 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 10.2;Ciliated cells: 13.4;Early spermatids: 23.3;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.6;BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 14.9;HeLa: 23.8;U-266/70: 15.2;U-698: 9.9" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA040616" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043" "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.2 9.6 0.0 0.0 0.0 0.0 0.5 2.8 10.7 14.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.9 0.0 0.3 0.0 23.8 5.6 3.4 0.0 0.0 0.0 0.2 2.7 0.7 0.1 3.3 0.3 0.0 0.2 1.7 0.0 0.1 0.0 3.0 4.1 0.0 0.0 0.0 4.2 0.0 3.3 8.3 0.0 0.1 0.0 0.5 4.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 15.2 0.1 9.9 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.4 0.7 0.0 1.4 10.2 13.4 1.2 0.0 0.0 0.0 0.0 0.1 23.3 0.9 0.0 0.0 0.2 0.0 3.1 0.1 4.7 4.5 0.7 0.0 0.0 22.1 4.0 8.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.4 0.6 0.3 0.0 0.0 0.0 PIF1 "C15orf20, FLJ22692" ENSG00000140451 "PIF1 5'-to-3' DNA helicase" Q9H611 15 64815632-64825668 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.3" "Group enriched" "Detected in many" 5 "Early spermatids: 22.3;Erythroid cells: 70.0" "Cancer enhanced" "Detected in many" "testis cancer: 10.2" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB018701 Supported Supported Nucleoplasm NA Yes Nucleoplasm "CAB018701: AB_2164654" "unprognostic (1.99e-1)" "unprognostic (6.11e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.62e-1)" "unprognostic (8.33e-3)" "unprognostic (8.66e-4)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (6.68e-2)" "unprognostic (2.38e-2)" "unprognostic (3.27e-2)" "unprognostic (0.00e+0)" "unprognostic (2.96e-3)" "unprognostic (1.78e-1)" "unprognostic (9.61e-2)" "unprognostic (5.95e-2)" 1.8 1.1 0.6 12.9 0.6 6.0 0.6 0.6 1.2 1.2 5.2 0.6 0.6 3.3 2.0 1.3 4.6 0.8 1.4 0.9 0.6 1.8 0.7 0.6 1.9 7.5 0.9 0.6 0.6 0.6 0.0 0.6 1.4 1.0 2.5 1.8 0.9 0.8 1.2 0.6 1.6 3.7 2.1 0.6 7.0 2.7 3.3 0.6 14.3 0.6 5.1 6.0 1.8 1.9 0.7 0.3 0.0 0.0 0.0 3.2 0.4 5.2 6.1 15.0 6.0 2.7 3.2 5.5 5.1 2.8 5.2 4.0 9.6 8.8 6.3 2.1 2.5 4.8 14.5 15.3 4.3 1.9 10.0 5.6 7.3 17.1 6.9 1.4 2.9 6.0 1.8 0.0 2.3 1.9 1.3 5.3 9.5 4.8 12.7 4.9 4.6 3.1 12.2 12.2 6.6 4.2 6.5 5.0 8.9 2.9 2.9 6.2 4.0 3.9 4.4 2.3 6.9 4.9 3.2 3.6 3.1 16.4 5.0 9.4 10.2 9.4 6.0 3.0 12.9 4.4 0.0 0.0 0.0 1.5 0.0 0.5 0.7 0.1 1.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.3 3.2 0.4 0.6 0.6 0.6 1.2 0.6 1.8 0.9 0.6 1.0 0.6 0.0 1.4 0.8 0.6 1.6 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 22.3 1.5 0.3 70.0 0.0 5.6 2.6 0.9 0.0 0.0 4.8 0.0 0.0 7.4 2.2 1.3 1.4 3.1 0.0 0.0 0.8 0.6 0.2 0.0 2.1 0.0 0.8 6.5 2.7 0.1 1.9 0.9 0.9 8.9 0.9 1.1 PIFO "C1orf88, FLJ23853, pitchfork" ENSG00000173947 "Primary cilia formation" Q8TCI5 1 111346288-111353013 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.9;fallopian tube: 96.8" "Group enriched" "Detected in many" 5 "Ciliated cells: 720.1;Early spermatids: 388.2;Late spermatids: 350.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 55.9" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.3" "Group enriched" "Detected in many" 25 "B-cells: 1.6;T-cells: 3.3" "Cell line enhanced" "Detected in some" "hTCEpi: 4.5;hTERT-RPE1: 4.5;RPTEC TERT1: 6.2;RT4: 7.3;SuSa: 11.6;T-47d: 5.1;U-87 MG: 4.9" "Low region specificity" "Detected in many" NA NA "unprognostic (3.18e-3)" "unprognostic (3.23e-2)" "unprognostic (7.33e-2)" "unprognostic (3.03e-3)" "unprognostic (6.00e-2)" "unprognostic (7.43e-4)" "unprognostic (8.78e-7)" "unprognostic (6.43e-3)" "unprognostic (7.28e-2)" "unprognostic (9.07e-3)" "prognostic favorable (2.48e-4)" "unprognostic (3.32e-2)" "prognostic favorable (1.44e-4)" "unprognostic (6.03e-3)" "unprognostic (4.73e-2)" "unprognostic (6.37e-2)" "unprognostic (6.83e-2)" 1.1 2.0 6.6 1.2 10.1 0.8 3.8 0.7 3.9 4.4 3.0 15.9 3.5 1.1 4.9 15.5 2.8 96.8 2.7 6.4 8.6 8.6 5.4 0.8 10.8 0.9 5.0 6.5 9.2 4.2 5.1 13.8 4.3 55.9 7.5 1.4 4.2 2.2 4.3 0.9 1.6 1.1 3.4 4.2 1.0 2.6 26.5 5.4 0.4 8.8 0.1 1.1 5.4 0.6 1.6 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.1 0.7 0.8 0.8 0.9 1.4 0.0 1.7 0.4 0.0 1.3 1.4 0.0 0.3 0.0 1.5 0.0 1.2 0.2 0.0 1.8 0.2 0.0 0.2 1.1 0.7 0.0 0.0 0.9 4.5 0.0 0.0 4.5 0.0 0.4 0.2 0.1 2.6 0.1 0.7 0.0 2.6 0.1 0.0 0.0 0.0 0.0 6.2 7.3 3.1 0.3 0.0 0.2 0.2 11.6 5.1 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.4 0.5 4.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 3.3 1.6 0.9 1.0 0.0 0.9 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 6.6 10.1 0.7 3.9 8.6 8.6 5.0 6.5 55.9 5.4 3.0 14.4 0.0 7.4 3.8 0.8 12.3 0.0 720.1 70.5 5.2 3.9 7.2 18.3 11.6 388.2 0.9 0.0 0.0 1.9 3.6 3.9 10.1 0.0 0.0 1.1 0.0 2.9 0.0 0.0 350.3 5.5 2.0 8.5 0.0 0.0 10.4 1.5 0.0 3.2 19.3 5.4 6.5 2.0 97.0 7.2 2.5 5.8 0.0 0.0 2.6 PIGBOS1 ENSG00000225973 "PIGB opposite strand 1" A0A0B4J2F0 15 55317184-55319161 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Intracellular and membrane" NA NA "prognostic favorable (4.19e-4)" "unprognostic (1.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (2.31e-1)" "unprognostic (3.27e-2)" "unprognostic (2.58e-3)" "unprognostic (4.62e-3)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (4.96e-1)" 6.7 5.8 3.9 7.3 6.4 11.0 7.1 4.1 10.6 4.4 6.2 7.4 6.4 6.9 7.3 7.4 5.1 6.6 8.2 6.6 4.0 9.7 9.2 7.4 11.5 7.9 4.9 6.8 13.4 4.5 9.1 8.3 6.4 5.8 5.6 7.3 6.2 4.3 5.5 4.6 8.0 6.0 5.5 7.8 7.1 5.2 7.1 9.1 12.6 4.4 5.8 7.1 7.3 20.3 26.7 35.9 27.1 19.5 27.7 16.6 7.6 7.6 6.7 4.6 9.1 10.6 8.7 8.7 7.8 6.3 4.5 4.1 5.3 9.9 10.0 5.2 11.2 6.8 2.4 4.3 4.2 12.8 3.7 16.8 7.0 8.0 7.5 11.4 14.4 8.6 7.8 4.4 4.5 9.1 7.3 9.3 20.1 9.4 5.8 6.4 5.8 23.3 3.8 8.5 4.3 8.2 6.2 18.1 5.7 5.0 5.0 8.4 5.2 7.8 25.0 9.1 8.0 27.4 7.4 10.3 12.4 6.0 11.9 10.1 26.6 8.4 9.2 25.8 10.9 28.1 27.0 35.9 16.7 19.9 15.4 18.8 20.3 17.7 20.8 20.3 27.7 20.2 27.5 19.5 27.1 26.7 24.9 16.6 26.8 16.3 25.8 12.8 0.0 13.5 6.0 10.2 34.8 18.2 17.4 5.9 29.2 33.2 21.7 15.6 15.8 17.3 46.7 34.1 29.3 12.4 16.7 6.9 29.7 33.5 17.5 28.9 25.8 24.3 3.4 27.6 29.1 0.0 32.5 16.3 17.9 24.2 17.6 18.4 37.3 19.5 32.3 13.0 14.6 16.4 0.0 19.9 23.0 15.5 7.8 PIGR ENSG00000162896 "Polymeric immunoglobulin receptor" P01833 1 206928518-206946466 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 2375.7;Mucus-secreting cells: 2056.5;Paneth cells: 2331.9;Undifferentiated cells: 3429.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 731.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "EFO-21: 28.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006154, CAB009454, HPA012012" Enhanced "Intracellular and membrane" NA NA 1900000000 "CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371" "prognostic favorable (1.22e-5)" "unprognostic (7.42e-2)" "unprognostic (4.78e-3)" "prognostic favorable (2.57e-4)" "unprognostic (2.31e-2)" "unprognostic (6.71e-2)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (2.13e-1)" "prognostic favorable (5.08e-5)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (6.92e-3)" "unprognostic (3.39e-2)" 0.3 0.3 0.3 74.2 0.3 0.0 6.9 0.3 0.3 35.1 232.8 0.6 0.4 158.9 2.6 0.5 2.6 0.7 139.0 0.3 0.3 0.3 52.5 5.0 25.1 0.3 0.3 0.3 0.6 4.2 0.0 0.9 0.4 0.3 3.0 75.6 0.4 398.1 0.6 0.4 0.4 320.1 2.0 0.3 0.4 25.3 0.6 0.3 0.4 0.4 23.9 22.5 4.9 0.6 3.4 1.1 1.4 0.5 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 28.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 1.4 0.2 0.0 0.0 0.2 0.0 5.0 0.1 1.3 0.6 2.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.4 0.2 0.3 1.0 0.0 0.1 0.0 1.4 0.5 0.3 0.4 0.2 0.5 3.4 0.3 0.3 1.1 3.4 0.5 0.5 1.4 0.5 0.3 0.9 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 86.4 488.0 21.0 2.7 0.2 0.0 0.8 662.5 127.2 379.9 102.9 0.0 0.0 14.9 60.9 0.0 0.5 2375.7 0.0 58.6 0.0 0.0 57.7 51.8 26.7 0.3 0.0 410.4 1.8 1.5 0.0 0.0 3.2 1.7 1.0 2056.5 0.0 144.1 2331.9 0.0 262.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3429.8 34.0 PIGY MGC14156 ENSG00000255072 "Phosphatidylinositol glycan anchor biosynthesis class Y" Q3MUY2 4 88521573-88521789 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "blood: 38.4;intestine: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 6.5;GAMG: 12.0;hTEC/SVTERT24-B: 8.0;hTERT-RPE1: 6.5;JURKAT: 6.0;MOLT-4: 13.6;OE19: 23.5;SuSa: 6.6" HPA059018 Uncertain NA NA "HPA059018: AB_2683884" 1.4 2.9 0.5 1.1 1.2 1.1 1.2 1.8 1.4 2.0 10.6 1.1 2.1 1.1 1.7 1.1 1.1 1.6 0.1 0.3 1.1 1.7 1.1 1.1 1.1 1.3 1.4 1.1 1.2 1.1 1.1 1.1 1.1 1.1 3.1 1.1 1.1 1.1 2.3 1.2 1.3 1.1 1.5 1.1 1.4 1.3 24.8 38.4 21.0 26.6 24.3 33.1 35.9 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 8.0 0.0 6.5 0.0 6.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 16.3 26.0 21.0 27.3 26.6 28.5 24.8 27.9 27.5 38.4 19.8 30.1 29.1 4.5 24.3 21.6 14.2 33.1 35.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PIGZ "FLJ12768, MGC52163, SMP3" ENSG00000119227 "Phosphatidylinositol glycan anchor biosynthesis class Z" Q86VD9 3 196946343-196969060 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 26.5" "Group enriched" "Detected in many" 4 "Enterocytes: 66.9;Mucus-secreting cells: 56.2;Paneth cells: 75.0;Undifferentiated cells: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.3" "Group enriched" "Detected in many" 8 "dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058599, HPA059920" Approved NA NA "HPA058599: AB_2683771, HPA059920: AB_2684162" "unprognostic (1.46e-1)" "unprognostic (3.18e-3)" "unprognostic (1.06e-2)" "unprognostic (3.31e-2)" "unprognostic (3.90e-2)" "unprognostic (8.16e-2)" "unprognostic (4.25e-3)" "unprognostic (4.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (1.02e-1)" "unprognostic (3.93e-2)" "unprognostic (8.38e-5)" "unprognostic (5.02e-3)" 6.6 3.1 5.7 5.3 8.6 1.9 3.4 18.5 16.3 3.3 26.5 3.2 2.0 2.9 2.3 1.7 3.2 2.8 4.5 6.4 5.3 7.5 1.6 1.6 3.1 2.0 4.4 6.4 0.8 5.9 2.7 2.9 2.1 10.8 4.6 24.5 4.3 4.7 4.6 10.0 4.5 7.4 5.3 2.8 1.8 3.1 1.4 3.0 3.2 1.7 2.8 2.1 9.9 2.9 0.1 1.6 1.4 3.3 0.0 0.2 0.3 2.0 1.4 0.8 3.3 9.3 4.5 0.9 3.0 8.6 2.3 1.9 1.9 1.7 0.3 6.1 6.8 1.6 3.5 0.2 0.4 0.6 0.6 0.4 0.9 0.7 7.4 4.4 0.0 3.4 4.5 6.6 0.3 1.1 2.6 2.9 5.5 0.2 2.6 2.3 3.6 0.3 1.7 0.1 2.5 1.1 0.5 0.1 0.6 3.6 3.8 1.3 1.5 4.3 0.4 1.6 0.4 8.5 3.0 7.0 1.9 0.5 5.5 1.0 1.2 0.2 0.1 0.4 1.2 0.7 0.0 1.1 0.8 0.2 3.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 1.4 0.0 1.4 0.3 0.0 0.3 5.7 8.6 18.5 16.3 5.3 7.5 4.4 6.4 10.8 3.0 0.0 0.6 3.7 8.0 6.9 6.1 6.5 2.5 1.4 1.2 8.7 2.0 0.0 5.0 1.9 1.7 4.4 66.9 0.0 3.2 0.0 2.3 9.3 5.7 7.3 1.7 14.3 13.3 12.3 4.9 3.1 3.7 1.1 8.5 2.8 56.2 1.5 2.8 75.0 6.0 2.1 6.9 0.0 8.5 0.5 0.1 4.4 0.1 1.9 35.8 10.1 PIH1D2 ENSG00000150773 "PIH1 domain containing 2" Q8WWB5 11 112064010-112074274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 41.9" "Group enriched" "Detected in many" 10 "Ciliated cells: 123.1;Early spermatids: 307.7;Late spermatids: 93.6;Spermatocytes: 103.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039496 Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039496: AB_10959385" "unprognostic (8.74e-2)" "unprognostic (6.64e-3)" "unprognostic (1.29e-1)" "unprognostic (3.01e-3)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (3.74e-2)" "unprognostic (1.17e-1)" "unprognostic (2.43e-3)" "unprognostic (5.82e-2)" "unprognostic (9.05e-3)" "unprognostic (1.03e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.08e-2)" "unprognostic (3.38e-2)" "unprognostic (1.12e-1)" 0.7 1.0 1.5 0.3 3.3 0.2 1.6 0.9 2.0 1.6 0.8 3.2 2.3 0.4 1.5 8.1 1.0 14.4 1.2 0.9 2.6 2.0 4.9 0.5 2.8 0.3 1.1 1.8 2.5 1.2 4.4 10.5 0.5 9.7 1.4 0.7 2.7 1.1 1.5 0.9 0.9 0.5 0.9 0.8 0.4 0.8 41.9 1.2 0.1 5.8 0.6 0.3 0.9 0.8 1.2 1.0 0.7 1.2 0.3 0.3 0.2 2.9 1.5 4.6 2.0 2.3 2.6 3.2 1.1 3.8 3.8 3.7 5.7 9.4 1.3 4.0 2.2 4.5 3.7 1.0 2.4 3.7 1.4 3.8 2.1 2.5 2.5 2.1 2.2 1.4 1.6 2.8 7.0 4.0 3.4 2.0 2.7 2.7 0.8 2.3 1.1 0.9 2.8 1.3 1.6 2.5 1.8 3.0 3.2 9.8 1.5 5.9 1.5 3.7 1.4 1.9 1.9 12.6 0.6 1.1 2.1 2.4 1.3 1.0 1.1 0.4 1.6 3.1 0.3 1.7 0.0 0.3 0.7 0.0 1.2 0.3 1.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.2 1.5 3.3 0.9 2.0 2.6 2.0 1.1 1.8 9.7 1.2 6.0 0.3 0.0 1.6 0.6 2.0 2.0 7.6 123.1 10.3 3.5 2.0 0.8 13.3 3.1 307.7 0.9 0.2 0.0 2.0 0.6 0.9 0.7 1.1 0.0 0.6 1.6 2.9 0.6 0.3 93.6 2.6 0.8 3.3 1.0 0.3 3.4 1.5 0.0 1.4 6.8 15.4 0.0 1.0 103.7 7.7 0.9 0.2 0.0 0.4 0.8 PIH1D3 "CXorf41, MGC35261, NYSAR97" ENSG00000080572 "PIH1 domain containing 3" Q9NQM4 X 107206632-107244243 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.0;fallopian tube: 16.2;lung: 7.0;testis: 13.9" "Group enriched" "Detected in some" 11 "Ciliated cells: 148.5;Early spermatids: 139.2" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Region enhanced" "Detected in many" "pons and medulla: 8.0" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "WM-115: 1.7" "Region enhanced" "Detected in many" "midbrain: 4.6" HPA072496 Enhanced NA NA "HPA072496: AB_2732202" "unprognostic (8.66e-2)" "unprognostic (2.75e-3)" "unprognostic (7.73e-4)" "unprognostic (3.37e-1)" "unprognostic (8.61e-2)" "unprognostic (4.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.77e-2)" 0.0 0.1 0.9 0.0 4.0 0.2 0.0 0.0 0.1 1.3 0.0 1.9 1.0 0.1 0.5 4.5 0.1 16.2 0.1 0.1 1.6 1.5 0.2 0.0 7.0 0.1 0.0 0.0 4.8 0.0 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 13.9 1.3 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.3 2.1 0.3 0.6 0.2 0.2 0.3 0.9 0.1 0.0 0.5 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.8 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.7 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.5 0.5 0.6 0.3 0.3 0.2 1.0 0.0 0.2 0.0 0.8 0.4 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.3 1.7 2.1 0.3 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.5 0.1 0.2 1.2 0.6 0.2 0.3 0.1 0.2 0.9 4.0 0.0 0.0 1.6 1.5 0.0 0.0 8.0 1.3 3.0 1.0 0.0 0.2 0.1 0.0 0.0 0.0 148.5 12.5 0.0 0.0 0.0 1.7 0.0 139.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.5 8.8 0.0 0.0 0.0 0.0 0.0 PIK3AP1 "BCAP, FLJ35564" ENSG00000155629 "Phosphoinositide-3-kinase adaptor protein 1" Q6ZUJ8 10 96593312-96720514 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9" "Group enriched" "Detected in all" 6 "B-cells: 17.5;monocytes: 38.9" "Cell line enhanced" "Detected in some" "Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB026136, HPA038452" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" "Intracellular and membrane" No No Cytosol "Nucleoplasm, Plasma membrane" "CAB026136: , HPA038452: AB_2676019" "unprognostic (2.83e-2)" "unprognostic (4.61e-3)" "unprognostic (7.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.79e-1)" "unprognostic (1.49e-1)" "unprognostic (4.60e-2)" "unprognostic (1.10e-1)" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.96e-1)" "unprognostic (2.10e-1)" "unprognostic (5.11e-2)" "unprognostic (1.28e-1)" "unprognostic (4.69e-2)" "unprognostic (5.45e-1)" "unprognostic (1.13e-1)" 5.8 2.2 2.9 16.8 7.1 14.7 4.8 1.0 3.0 1.4 2.2 3.2 0.0 1.9 1.3 2.3 1.3 2.0 8.5 3.3 3.1 2.4 6.2 38.4 6.0 19.5 5.3 0.5 3.3 16.1 0.3 3.0 10.9 5.1 1.8 2.7 1.6 29.7 0.8 1.1 1.5 6.6 2.4 7.3 32.0 1.9 1.7 4.3 2.0 2.4 0.6 19.2 4.1 2.2 17.5 4.4 4.7 38.9 4.5 4.8 4.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.4 24.7 2.5 0.0 0.4 0.0 5.2 0.0 0.2 13.7 0.9 3.7 0.0 0.4 0.0 10.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.3 17.8 0.2 7.0 0.3 52.8 1.2 5.8 0.0 0.0 1.1 0.6 0.0 0.0 0.3 0.1 0.0 26.9 0.0 0.0 0.8 0.0 0.2 0.2 0.0 33.7 0.0 27.7 0.0 1.7 5.4 3.3 4.8 15.5 1.7 17.5 0.1 1.5 4.4 16.2 0.0 1.2 4.7 4.5 38.9 3.9 0.1 4.2 2.9 7.1 1.0 3.0 3.1 2.4 5.3 0.5 5.1 4.3 3.0 3.8 29.6 0.0 1.3 0.2 2.2 28.1 1.4 3.4 1.8 2.0 0.4 1.7 26.1 3.3 1.4 2.6 0.0 25.2 0.7 1.0 0.5 13.9 66.5 41.2 0.0 1.7 8.0 114.3 0.4 1.1 53.7 5.0 2.8 2.5 0.2 22.8 18.4 2.1 12.8 3.3 0.0 1.7 0.2 0.2 1.0 1.9 27.7 2.9 0.1 PIK3C2G ENSG00000139144 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma" O75747 12 18247614-18648416 "Enzymes, Plasma proteins, Predicted intracellular proteins" Chemotaxis "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 15.5;Cholangiocytes: 33.1;Collecting duct cells: 38.4;Hepatocytes: 21.5;Suprabasal keratinocytes: 18.7" "Cancer enhanced" "Detected in some" "stomach cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 2.9;HaCaT: 4.7;hTERT-HME1: 8.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (1.29e-1)" "unprognostic (1.61e-1)" "unprognostic (6.21e-2)" "unprognostic (1.47e-2)" "unprognostic (9.46e-2)" "unprognostic (8.27e-2)" "unprognostic (2.85e-1)" "unprognostic (6.52e-2)" "unprognostic (1.81e-3)" "prognostic unfavorable (3.50e-4)" "unprognostic (6.05e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-1)" "unprognostic (1.98e-1)" "unprognostic (2.37e-2)" 0.3 0.6 0.2 0.1 0.2 0.0 6.7 0.2 0.3 0.6 0.3 0.1 54.2 0.0 0.3 30.7 4.2 0.6 6.0 0.2 0.3 0.2 9.6 8.8 0.3 0.1 0.3 0.1 0.3 1.2 8.1 0.4 1.2 0.1 2.4 0.0 0.1 13.1 46.0 0.2 7.0 2.2 0.2 0.3 0.2 15.1 2.1 0.1 0.1 0.5 1.6 0.5 0.9 0.9 0.1 0.1 0.4 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.3 4.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 8.7 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.3 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 6.7 15.5 0.0 0.3 33.1 0.0 1.2 38.4 0.0 1.0 1.7 1.3 3.5 0.1 0.7 0.0 0.0 4.1 0.2 0.5 0.0 21.5 0.2 0.0 0.0 0.0 1.0 1.8 0.0 0.0 1.7 0.0 0.1 0.0 0.6 0.3 0.0 1.1 0.0 0.0 0.0 2.4 2.1 18.7 0.7 0.0 0.2 0.7 PIK3CD p110D ENSG00000171608 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta" O00329 1 9651732-9729114 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 20.7;granulocytes: 24.3;Kupffer cells: 28.8;T-cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 51.7;NB-4: 22.4;REH: 23.3;THP-1: 22.5;U-937: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015420, HPA044953" Enhanced Approved "Vesicles,Cytokinetic bridge" Yes No Vesicles "Cytokinetic bridge" "CAB015420: AB_831654, HPA044953: AB_2679153" "unprognostic (5.73e-3)" "unprognostic (2.75e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-2)" "unprognostic (4.71e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (2.78e-2)" "unprognostic (1.54e-2)" "unprognostic (3.46e-2)" "unprognostic (6.75e-2)" "unprognostic (8.65e-3)" "unprognostic (2.09e-1)" "unprognostic (1.34e-1)" "unprognostic (2.04e-1)" "unprognostic (6.78e-2)" 4.5 2.1 3.4 34.8 7.1 32.8 2.9 3.3 4.3 3.2 3.3 5.5 0.7 3.1 3.7 3.4 3.5 4.0 6.5 2.9 4.2 3.1 4.6 3.3 8.2 40.3 7.4 1.8 5.3 2.2 2.3 2.2 3.3 4.6 3.2 2.1 3.1 11.2 1.8 0.9 2.0 11.4 2.9 5.3 35.5 3.3 3.0 5.7 23.5 4.1 2.3 36.0 5.8 3.6 8.4 14.5 35.0 15.0 14.5 13.7 16.6 2.7 1.8 0.1 0.5 0.4 0.4 0.2 4.2 8.6 9.2 7.6 0.1 1.1 7.3 1.7 3.3 4.4 0.8 0.7 3.8 5.8 51.7 0.1 0.8 0.4 3.0 1.8 18.8 6.6 1.5 1.6 10.3 3.5 4.0 1.3 5.2 2.6 0.0 5.2 0.2 1.8 22.4 0.8 0.1 0.5 23.3 4.6 0.2 3.9 0.0 0.6 0.5 0.9 1.7 4.1 2.5 0.3 22.5 3.4 2.7 2.8 0.0 3.9 1.7 1.6 10.2 5.9 26.9 1.5 9.6 11.8 21.1 12.9 13.1 13.7 7.8 9.8 11.8 12.5 8.4 12.9 13.4 35.0 14.5 15.0 14.5 7.4 16.6 3.4 7.1 3.3 4.3 4.2 3.1 7.4 1.8 4.6 5.7 8.9 20.7 7.8 1.8 1.3 0.4 2.7 0.0 1.4 1.2 0.0 2.0 0.1 1.7 3.1 2.0 1.6 0.0 0.0 1.8 0.3 1.4 2.5 24.3 0.0 12.5 0.0 0.0 3.7 28.8 1.7 1.1 13.4 3.3 1.0 0.0 2.5 7.7 0.0 1.4 2.9 1.6 6.5 3.8 1.1 2.1 1.0 0.2 30.5 0.1 2.0 PIK3CG ENSG00000105851 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma" P48736 7 106865278-106907145 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in some" 8 "B-cells: 17.3;Early spermatids: 26.6;granulocytes: 19.7;monocytes: 24.4;T-cells: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HL-60: 12.1;HMC-1: 15.5;Karpas-707: 12.9;MOLT-4: 23.5;U-266/70: 31.5;U-937: 22.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069976 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA069976: AB_2686224" "unprognostic (8.34e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.71e-2)" "unprognostic (3.20e-2)" "unprognostic (3.82e-3)" "unprognostic (3.02e-1)" "unprognostic (6.77e-2)" "unprognostic (1.16e-1)" "unprognostic (7.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (9.08e-2)" "unprognostic (1.23e-1)" "unprognostic (5.38e-1)" "unprognostic (5.24e-2)" 5.0 1.8 2.2 16.0 3.1 27.8 2.3 0.8 1.7 1.7 4.1 2.7 0.0 2.8 1.7 2.0 2.0 1.8 3.5 1.7 1.7 1.5 1.9 1.5 4.3 13.1 3.0 1.0 1.7 1.5 0.6 1.4 2.0 2.5 2.2 2.6 1.9 3.1 0.5 1.1 1.3 6.1 1.9 6.4 17.4 2.5 7.6 3.0 40.8 2.3 0.9 21.2 4.1 1.5 6.2 5.6 14.2 24.5 5.3 5.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.6 0.0 0.0 0.0 12.1 15.5 0.0 0.0 0.0 0.0 0.0 4.8 7.4 8.6 12.9 0.0 0.0 23.5 4.6 0.0 0.0 0.0 6.2 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.2 0.0 0.1 0.0 0.0 31.5 0.0 11.7 0.0 22.2 2.9 4.6 3.4 14.2 5.6 10.6 5.1 4.7 2.6 4.2 5.6 6.2 2.8 3.8 13.9 5.3 24.5 4.9 2.6 3.6 2.2 3.1 0.8 1.7 1.7 1.5 3.0 1.0 2.5 3.0 0.0 2.6 17.3 0.0 0.7 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 26.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 19.7 0.5 5.9 0.0 0.0 1.8 11.0 12.8 0.6 13.3 6.8 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.1 0.3 0.1 17.5 0.0 0.0 PIK3IP1 "HGFL, MGC17330" ENSG00000100100 "Phosphoinositide-3-kinase interacting protein 1" Q96FE7 22 31281593-31292534 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.0" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 107.7;T-cells: 127.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 82.0" "Lineage enriched" "Detected in many" 6 "T-cells: 82.0" "Cell line enhanced" "Detected in many" "RT4: 14.2;SK-BR-3: 15.7;U-698: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 8600000 "unprognostic (1.02e-1)" "unprognostic (1.97e-3)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-3)" "unprognostic (5.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-1)" "unprognostic (1.99e-1)" "unprognostic (9.95e-3)" "unprognostic (1.28e-2)" "unprognostic (2.65e-3)" "unprognostic (4.42e-2)" "unprognostic (8.68e-2)" "prognostic favorable (3.80e-4)" 24.0 22.9 17.3 31.8 22.8 21.4 19.5 33.2 22.7 11.8 15.3 22.3 13.2 10.5 18.7 10.7 12.4 12.9 15.8 19.5 19.1 12.4 13.9 5.7 26.2 64.1 19.9 15.0 12.4 5.8 11.3 8.0 14.6 18.0 13.8 9.7 13.3 27.3 20.2 14.2 27.1 29.7 14.9 20.7 36.8 14.3 13.7 22.5 38.8 29.5 7.7 45.1 21.9 12.6 13.5 0.9 5.6 4.8 8.3 82.0 29.1 0.3 0.2 0.5 0.1 7.2 12.8 0.6 1.8 5.7 0.1 0.7 0.2 12.2 9.3 6.9 2.8 0.7 7.9 0.0 3.4 0.1 1.5 1.1 0.2 1.4 1.4 2.4 0.7 0.5 12.4 5.0 0.1 0.1 11.4 3.8 1.4 0.5 11.7 0.9 0.8 0.1 1.4 0.5 1.4 0.3 0.7 0.5 6.8 3.1 14.2 0.7 1.5 0.6 15.7 0.8 6.8 1.3 1.3 11.7 0.0 2.7 0.2 0.0 5.6 2.4 20.0 0.3 1.6 0.2 5.6 2.7 2.4 12.9 3.4 15.2 5.9 33.3 18.2 0.9 13.5 82.0 51.1 1.1 8.3 4.8 0.3 37.5 29.1 17.3 22.8 33.2 22.7 19.1 12.4 19.9 15.0 18.0 22.5 41.7 10.5 49.9 17.1 9.2 27.4 10.3 10.2 16.0 18.2 29.6 9.8 25.6 1.7 36.6 1.1 17.5 7.4 0.0 9.3 3.4 15.3 18.4 29.0 0.8 36.9 6.4 8.1 31.9 29.9 2.1 22.7 13.8 11.8 12.6 12.2 107.7 34.1 7.4 29.0 5.6 7.8 6.5 7.6 7.4 22.0 10.0 10.3 127.6 9.0 33.3 PIK3R5 "p101, P101-PI3K" ENSG00000141506 "Phosphoinositide-3-kinase regulatory subunit 5" Q8WYR1 17 8878911-8965712 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 51.0" "Cell type enhanced" "Detected in some" 9 "B-cells: 14.4;Hofbauer cells: 16.8;Kupffer cells: 22.6;Macrophages: 26.2;monocytes: 12.6;T-cells: 17.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 28.0;HMC-1: 4.2;JURKAT: 10.1;U-937: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044505, HPA052247, HPA052412" Uncertain Supported "Centriolar satellite,Cytosol" No NA Cytosol "Centriolar satellite" "HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823" "unprognostic (2.81e-1)" "unprognostic (1.31e-2)" "unprognostic (3.10e-2)" "unprognostic (2.37e-2)" "unprognostic (3.44e-2)" "unprognostic (9.89e-3)" "unprognostic (1.42e-1)" "unprognostic (5.70e-2)" "unprognostic (1.38e-1)" "unprognostic (7.95e-2)" "unprognostic (1.33e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" "unprognostic (6.89e-2)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (1.24e-1)" 13.8 4.1 2.0 13.0 3.4 51.0 7.2 0.6 1.8 2.1 5.6 3.6 0.0 2.5 1.9 3.1 3.1 3.8 5.7 3.1 3.4 1.6 2.7 2.4 16.4 22.9 5.0 0.6 2.5 1.8 0.7 1.3 2.3 3.0 2.7 2.1 2.4 3.1 1.0 1.0 1.8 10.4 2.9 5.3 23.8 2.6 4.0 2.5 17.6 2.2 1.9 12.4 4.5 2.8 3.6 8.0 23.8 12.1 5.7 13.6 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.3 1.0 0.0 0.0 0.0 0.4 4.2 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.2 1.0 1.8 0.4 0.0 0.0 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 4.9 10.6 3.7 13.6 10.0 8.8 3.2 7.5 11.4 8.0 3.6 5.8 8.9 23.8 5.7 12.1 6.4 9.2 9.5 2.0 3.4 0.6 1.8 3.4 1.6 5.0 0.6 3.0 2.5 0.0 9.6 14.4 0.0 0.9 0.0 2.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.2 1.1 0.1 4.7 0.2 16.8 0.0 0.0 1.8 22.6 6.3 0.3 26.2 1.7 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.6 0.3 17.9 0.0 0.0 PIK3R6 "C17orf38, FLJ34500, HsT41028, p87PIKAP" ENSG00000276231 "Phosphoinositide-3-kinase regulatory subunit 6" Q5UE93 17 8802723-8867677 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.1;lymphoid tissue: 12.2" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 8.7;granulocytes: 45.2;Late spermatids: 13.8" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "eosinophil: 32.1" "Lineage enriched" "Detected in many" 7 "granulocytes: 32.1" "Cell line enriched" "Detected in some" 8 "HMC-1: 58.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023077 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane, Cytosol" "HPA023077: AB_1854909" "unprognostic (4.29e-2)" "unprognostic (8.56e-3)" "unprognostic (9.39e-2)" "unprognostic (5.96e-3)" "unprognostic (2.46e-1)" "unprognostic (5.25e-3)" "unprognostic (4.50e-3)" "unprognostic (2.29e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (2.20e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (3.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-1)" "unprognostic (8.98e-2)" 2.2 0.0 2.1 12.2 5.4 5.3 1.0 0.0 3.7 1.5 1.9 2.5 1.4 3.5 2.6 2.3 1.2 0.4 6.6 2.6 3.1 0.0 0.6 3.4 4.4 2.5 0.0 0.3 0.8 0.3 0.0 1.4 3.2 2.4 1.5 1.4 0.9 0.7 1.0 1.8 5.2 2.2 3.1 6.3 2.3 1.1 2.7 6.9 0.0 0.8 6.4 3.0 3.3 1.3 4.9 32.1 4.3 0.5 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 7.5 0.0 0.0 0.0 0.0 58.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 7.7 3.4 32.1 0.2 4.3 0.2 1.3 0.0 0.1 4.9 0.1 0.0 0.1 0.5 0.5 3.3 0.0 0.0 1.4 0.0 2.2 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 45.2 0.0 6.3 0.0 0.0 0.0 2.6 13.8 0.0 3.2 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.5 0.0 0.0 PILRA FDF03 ENSG00000085514 "Paired immunoglobin like type 2 receptor alpha" Q9UKJ1 7 100367530-100400099 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 138.4" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 82.8;Kupffer cells: 85.3;Leydig cells: 48.6;Macrophages: 111.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 138.4" "Group enriched" "Detected in many" 5 "granulocytes: 138.4;monocytes: 87.3" "Cell line enhanced" "Detected in some" "ASC diff: 21.0;HMC-1: 18.8;NB-4: 14.2" HPA056132 Approved "Secreted to blood" NA NA "HPA056132: AB_2683048" "unprognostic (5.53e-2)" "prognostic favorable (2.99e-4)" "unprognostic (7.61e-2)" "unprognostic (2.88e-1)" "unprognostic (2.20e-1)" "unprognostic (5.88e-2)" "unprognostic (1.44e-1)" "unprognostic (2.85e-1)" "unprognostic (3.01e-3)" "unprognostic (9.95e-2)" "unprognostic (8.57e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.47e-2)" "unprognostic (3.17e-2)" "unprognostic (1.99e-1)" "unprognostic (4.80e-2)" 18.6 5.4 7.2 32.3 7.2 19.4 8.2 15.6 6.2 6.1 4.5 10.6 2.3 3.8 4.8 10.0 2.6 7.5 8.4 6.5 7.7 4.4 8.5 8.0 31.9 30.1 11.0 2.6 5.7 5.1 4.3 9.2 13.2 11.9 6.6 4.9 7.1 3.1 4.1 2.5 2.6 3.9 8.6 18.4 29.5 3.1 6.4 10.7 3.3 5.3 1.1 3.3 9.8 5.4 0.1 24.0 138.4 87.3 0.5 0.2 22.9 0.2 0.3 0.4 0.5 21.0 1.4 0.1 0.1 1.0 0.1 0.3 0.0 0.3 0.4 1.2 0.3 0.2 0.6 0.1 0.1 0.0 1.0 0.7 0.4 0.8 0.1 0.2 0.8 18.8 1.5 0.3 0.1 0.4 0.0 0.2 1.7 0.2 1.2 0.1 0.6 1.4 14.2 0.4 0.3 0.2 0.4 0.0 0.3 0.8 0.4 0.5 0.2 0.0 5.2 0.4 0.1 0.1 4.3 0.4 0.9 0.9 0.6 0.2 1.8 1.4 0.4 0.2 1.6 0.3 21.3 48.4 1.4 0.2 70.2 0.1 0.1 0.0 0.0 24.0 0.0 0.0 0.1 138.4 0.5 87.3 0.4 0.1 22.9 7.2 7.2 15.6 6.2 7.7 4.4 11.0 2.6 11.9 10.7 3.0 14.3 5.9 0.2 1.5 3.3 0.4 5.1 4.0 5.7 1.8 3.9 0.4 23.2 0.1 0.4 1.4 0.0 0.0 0.3 0.6 1.3 0.5 9.3 1.5 82.8 1.6 0.0 3.1 85.3 1.5 48.6 111.8 1.7 19.8 1.1 1.9 0.3 0.0 20.1 0.6 2.4 0.0 0.3 0.5 1.3 0.6 0.7 0.8 0.9 0.2 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin-like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 80.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 51.1;neutrophil: 34.8" "Group enriched" "Detected in many" 8 "granulocytes: 51.1;monocytes: 16.8" "Cell line enhanced" "Detected in all" "SK-BR-3: 81.3" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" NA Yes Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 10.6 11.3 8.2 11.2 8.2 11.2 10.2 25.2 10.3 9.9 8.2 8.2 8.2 11.4 10.3 12.6 8.2 10.0 8.8 8.2 8.2 5.0 18.6 17.6 8.2 13.2 8.2 8.2 12.1 12.9 19.0 27.6 9.8 8.2 13.6 10.2 8.2 12.0 10.7 12.3 15.8 10.1 8.2 10.5 16.7 9.2 80.1 8.2 8.2 18.3 8.2 11.0 9.9 8.2 0.3 4.3 51.1 16.8 4.0 2.9 4.7 14.0 11.9 13.7 23.7 15.2 3.5 13.3 8.5 3.8 6.1 6.0 8.4 16.4 11.5 16.3 4.4 10.9 15.1 7.5 9.0 4.2 9.4 11.1 10.6 39.9 7.2 3.4 10.6 27.6 4.4 10.6 8.2 16.8 7.6 5.1 17.2 11.3 28.0 4.2 19.0 16.7 55.3 5.9 11.8 6.3 9.8 4.0 11.7 27.5 23.1 12.8 9.2 7.2 81.3 10.1 15.3 14.2 16.5 12.2 21.8 13.9 13.9 11.0 16.9 21.5 13.9 6.1 15.9 12.8 4.1 8.5 51.1 2.9 14.0 1.7 0.1 0.3 1.8 4.3 0.3 0.3 0.7 34.8 4.0 16.8 0.1 0.1 4.7 8.2 8.2 25.2 10.3 8.2 5.0 8.2 8.2 8.2 8.2 35.7 41.6 25.1 19.4 14.0 37.1 1.1 63.7 37.5 42.1 14.0 64.8 10.8 1.7 5.8 13.5 16.4 15.8 0.0 4.9 9.6 8.9 14.5 23.3 62.2 8.5 71.5 28.3 17.8 14.3 9.1 68.4 12.3 18.6 10.0 23.8 26.5 6.4 17.3 48.1 3.4 60.9 25.8 12.0 43.6 9.8 11.8 13.2 66.0 24.8 10.8 PIM2 ENSG00000102096 "Pim-2 proto-oncogene, serine/threonine kinase" Q9P1W9 X 48913182-48919024 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 63.4;lymphoid tissue: 71.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 48.0;B-cells: 109.2;Melanocytes: 89.4;monocytes: 163.3;T-cells: 70.8" "Cancer enriched" "Detected in all" 6 "testis cancer: 171.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 60.3;Karpas-707: 74.7;RPMI-8226: 73.6;U-266/70: 136.0;U-266/84: 120.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000285 Approved Cytosol NA NA Cytosol "HPA000285: AB_1079619" "unprognostic (2.34e-3)" "prognostic favorable (4.05e-5)" "unprognostic (8.04e-2)" "unprognostic (7.30e-2)" "unprognostic (6.41e-3)" "unprognostic (2.74e-3)" "unprognostic (2.84e-1)" "unprognostic (5.23e-2)" "unprognostic (2.47e-2)" "unprognostic (4.01e-2)" "unprognostic (1.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.17e-11)" "unprognostic (3.36e-2)" "unprognostic (1.96e-2)" "unprognostic (1.27e-1)" "unprognostic (4.38e-2)" 3.6 3.4 4.3 37.2 7.2 30.4 3.4 7.1 7.9 4.5 13.4 2.1 2.2 29.5 2.8 4.3 10.0 5.6 8.3 3.1 5.6 6.7 5.2 5.4 10.6 59.7 3.8 4.6 5.4 3.0 1.0 4.9 2.4 6.7 3.6 17.7 6.1 16.9 4.9 1.5 3.0 19.2 2.2 3.1 71.2 14.7 5.7 1.3 39.4 4.8 3.6 47.9 24.6 3.3 26.0 2.9 46.9 3.0 17.0 63.4 13.2 1.8 1.6 0.8 1.7 0.3 0.2 1.3 1.1 1.4 1.6 1.4 1.4 1.4 8.0 0.5 0.5 0.6 1.1 2.7 1.0 1.5 60.3 2.1 9.7 1.6 1.4 0.7 2.3 6.5 0.6 0.9 1.7 1.0 1.3 0.6 1.0 10.2 74.7 0.9 1.3 0.8 4.8 18.2 0.6 2.5 1.0 0.6 73.6 1.6 0.2 0.6 0.8 1.2 0.8 0.8 4.3 2.1 3.1 0.3 0.4 0.2 0.3 1.1 136.0 120.2 15.3 1.5 2.0 0.4 46.9 1.5 14.3 12.5 1.9 21.2 26.0 34.4 17.6 2.5 15.9 36.9 23.0 38.3 17.0 3.0 2.9 63.4 13.2 4.3 7.2 7.1 7.9 5.6 6.7 3.8 4.6 6.7 1.3 11.9 48.0 109.2 9.5 18.0 2.3 2.0 0.0 14.7 12.5 3.5 2.0 5.3 3.3 2.8 1.4 4.3 4.0 0.0 3.1 5.0 7.5 4.0 22.0 5.4 6.3 11.1 12.6 3.1 9.1 1.4 1.7 18.6 89.4 163.3 6.6 2.3 1.6 3.5 3.9 5.4 2.2 0.0 8.1 2.1 1.5 12.0 2.1 70.8 8.1 3.9 PIMREG "CATS, FAM64A, FLJ10156, FLJ10491, RCS1" ENSG00000129195 "PICALM interacting mitotic regulator" Q9BSJ6 17 6444415-6451469 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 27.3" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 50.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA043783, HPA049934" Uncertain Enhanced Nucleoplasm Yes Yes Nucleoplasm "HPA043783: AB_2678669, HPA049934: AB_2680959" "unprognostic (5.32e-3)" "unprognostic (1.14e-2)" "unprognostic (2.33e-1)" "unprognostic (4.37e-3)" "unprognostic (1.46e-1)" "unprognostic (1.24e-2)" "unprognostic (6.55e-3)" "unprognostic (1.23e-3)" "unprognostic (1.80e-1)" "unprognostic (5.88e-2)" "unprognostic (1.47e-3)" "unprognostic (1.50e-2)" "unprognostic (0.00e+0)" "unprognostic (8.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 1.9 4.5 1.2 1.6 1.1 3.1 2.2 1.0 0.8 1.3 4.7 0.6 0.4 4.3 1.6 1.7 6.0 0.3 2.5 1.6 0.5 0.5 0.8 0.9 2.1 1.7 0.6 0.4 1.6 0.4 0.0 1.0 0.9 1.2 0.8 6.2 0.4 1.3 0.4 0.4 3.7 4.5 2.7 1.0 9.5 1.8 1.0 0.4 27.3 0.4 3.9 3.6 2.3 2.0 0.4 0.0 0.8 0.4 3.3 1.5 1.2 12.6 17.1 50.8 22.8 0.4 1.5 3.9 14.9 9.2 24.5 16.6 10.1 5.5 0.0 6.0 12.1 12.1 9.3 25.6 6.6 13.2 19.5 10.2 0.0 10.2 12.2 0.0 0.5 15.5 0.8 0.4 10.1 3.9 2.3 7.7 11.3 3.0 7.2 15.3 9.1 2.7 0.1 22.2 10.2 11.2 22.7 20.4 8.9 4.0 1.9 11.6 16.3 12.9 13.4 12.6 6.4 6.2 1.2 3.6 19.2 15.6 11.3 24.3 2.6 9.2 0.0 7.5 6.2 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.3 0.0 0.4 0.2 0.7 0.8 3.3 0.4 0.0 1.3 1.2 1.2 1.1 1.0 0.7 0.5 0.5 0.6 0.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PIN1 dod ENSG00000127445 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 1" Q13526 19 9835257-9849682 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.2" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 571.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB004528, CAB009326, HPA068650, HPA070887" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 30000 Nucleoplasm Cytosol "CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: " "unprognostic (2.54e-1)" "unprognostic (6.14e-3)" "unprognostic (6.50e-2)" "unprognostic (4.36e-2)" "unprognostic (1.71e-2)" "unprognostic (6.50e-3)" "unprognostic (1.90e-1)" "unprognostic (2.86e-2)" "unprognostic (2.67e-1)" "unprognostic (7.23e-3)" "prognostic favorable (3.25e-4)" "unprognostic (9.43e-2)" "prognostic favorable (7.80e-5)" "unprognostic (2.20e-2)" "unprognostic (2.56e-1)" "unprognostic (3.13e-2)" "unprognostic (1.21e-2)" 24.5 36.3 40.0 18.7 38.8 25.6 9.3 27.4 66.0 9.2 15.8 18.1 8.5 22.9 14.0 8.3 11.3 16.4 10.1 25.9 38.0 35.2 17.4 14.5 13.2 14.8 38.7 37.2 13.9 21.1 9.5 13.6 13.3 57.3 23.2 6.5 14.1 21.3 15.7 50.2 10.2 21.7 11.1 19.6 15.4 19.6 24.8 15.0 19.7 9.9 8.1 9.3 11.1 9.7 36.4 72.8 88.2 44.9 40.7 53.8 46.2 26.2 24.1 18.0 16.7 6.3 5.6 10.6 19.7 8.5 14.7 14.2 22.3 8.4 16.3 31.4 7.3 15.3 13.5 12.4 11.9 4.7 34.7 52.6 42.4 29.6 19.2 10.3 19.7 24.9 7.7 8.0 9.5 4.5 11.0 11.9 29.3 19.1 24.8 8.8 18.4 29.9 77.2 17.2 11.0 37.1 27.4 18.7 27.3 10.5 12.9 22.7 26.7 19.0 9.5 22.0 7.7 12.2 23.7 20.1 20.4 16.3 31.5 31.5 32.1 30.1 21.9 21.7 25.3 25.0 52.2 43.4 88.2 42.0 44.9 39.2 35.6 41.5 42.1 39.7 36.4 33.1 37.2 26.8 40.7 41.7 72.8 53.8 46.2 40.0 38.8 27.4 66.0 38.0 35.2 38.7 37.2 57.3 15.0 26.8 21.5 49.1 53.7 42.8 68.5 65.3 43.3 56.2 14.8 59.3 11.8 107.3 139.3 95.7 197.0 54.9 69.5 46.7 95.4 80.4 81.4 55.2 63.4 41.4 123.0 57.2 95.8 47.3 50.0 571.0 83.4 67.4 118.1 174.1 57.9 60.8 85.6 73.7 122.0 109.4 50.6 64.7 97.1 136.8 72.0 57.6 46.0 94.4 62.6 47.8 PIN4 "EPVH, PAR14, PAR17" ENSG00000102309 "Peptidylprolyl cis/trans isomerase, NIMA-interacting 4" Q9Y237 X 72181353-72302926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 68.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054483, HPA064504" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA054483: AB_2682503, HPA064504: AB_2685274" "unprognostic (2.47e-1)" "unprognostic (6.97e-3)" "unprognostic (1.65e-1)" "unprognostic (3.77e-2)" "unprognostic (8.42e-2)" "unprognostic (1.30e-2)" "unprognostic (1.14e-2)" "prognostic favorable (6.37e-4)" "unprognostic (1.56e-1)" "unprognostic (2.13e-2)" "unprognostic (2.49e-1)" "unprognostic (9.54e-2)" "unprognostic (2.09e-3)" "unprognostic (1.92e-1)" "prognostic favorable (2.58e-4)" "unprognostic (3.34e-3)" "prognostic favorable (2.66e-4)" 14.4 11.3 15.0 8.0 14.7 6.1 18.8 10.7 16.2 9.7 9.7 8.4 6.7 9.5 11.6 19.3 8.9 8.7 30.7 11.2 15.2 12.2 15.6 23.2 7.9 7.9 12.9 11.0 12.7 8.1 8.0 9.2 9.8 10.0 10.4 11.1 6.6 30.7 37.1 68.7 7.3 9.6 9.2 12.4 16.7 9.3 4.7 6.9 9.7 12.9 40.1 9.1 7.8 9.2 28.9 26.8 23.4 23.6 22.4 33.4 22.7 15.4 18.1 19.0 12.9 13.0 10.9 10.1 10.6 12.2 13.0 13.4 9.1 11.5 4.6 31.0 10.9 17.6 11.0 16.8 18.6 16.1 11.7 37.8 7.9 21.6 23.9 7.2 12.5 6.7 7.3 10.3 14.2 4.9 14.7 13.2 14.2 13.3 20.6 9.7 18.7 10.9 21.1 13.5 17.6 16.4 10.9 15.1 13.7 16.5 10.8 12.2 21.7 12.4 5.8 10.9 14.6 9.0 11.5 13.2 5.9 9.1 16.2 7.7 7.1 7.6 7.7 17.0 12.6 6.4 21.9 23.3 23.4 26.8 23.6 26.4 28.9 28.3 25.5 22.8 26.4 29.3 29.4 9.7 22.4 21.8 26.8 33.4 22.7 15.0 14.7 10.7 16.2 15.2 12.2 12.9 11.0 10.0 6.9 62.5 35.0 52.8 54.1 38.4 26.9 74.7 81.5 84.3 51.2 113.4 7.9 137.4 154.2 102.6 10.6 70.5 117.6 23.3 102.2 92.0 70.9 50.1 55.5 238.7 95.4 27.0 88.9 80.4 73.2 6.2 69.0 61.7 57.3 68.5 76.9 55.6 124.5 101.7 76.4 218.0 33.7 84.1 78.3 14.4 39.1 40.9 100.9 62.3 82.1 54.0 PINK1 PARK6 ENSG00000158828 "PTEN induced putative kinase 1" Q9BXM7 1 20633455-20651511 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 142.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.7" "Group enriched" "Detected in many" 4 "granulocytes: 10.7;monocytes: 4.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001931, CAB026191" Enhanced NA NA "CAB026191: , HPA001931: AB_1079620" "unprognostic (3.73e-3)" "unprognostic (2.29e-2)" "unprognostic (3.22e-1)" "unprognostic (4.33e-2)" "unprognostic (4.91e-2)" "unprognostic (2.93e-2)" "unprognostic (1.56e-2)" "unprognostic (3.36e-2)" "unprognostic (3.51e-2)" "unprognostic (4.06e-3)" "unprognostic (3.34e-2)" "unprognostic (2.54e-1)" "prognostic favorable (1.11e-16)" "unprognostic (2.68e-1)" "unprognostic (1.62e-1)" "unprognostic (6.57e-2)" "unprognostic (1.08e-1)" 17.9 35.9 38.9 6.7 38.0 6.0 10.1 16.8 45.0 9.8 13.0 17.8 10.0 15.2 9.3 9.8 20.7 10.7 11.4 51.4 31.0 28.7 20.2 26.1 10.0 5.1 39.5 27.1 11.6 24.3 16.3 7.1 13.9 31.0 12.4 7.7 10.6 23.9 15.4 142.0 10.8 12.7 10.8 30.2 8.3 10.5 27.2 16.8 3.3 16.0 21.5 4.6 12.7 9.5 1.2 1.4 10.7 4.4 0.7 1.7 0.8 17.7 8.1 3.8 11.0 13.3 12.6 4.0 25.1 25.2 12.2 21.3 2.8 14.5 4.2 19.9 25.5 28.4 8.2 5.5 13.3 6.1 5.0 21.0 2.1 22.7 4.3 10.3 2.2 6.7 11.8 14.4 15.2 5.3 13.7 7.9 3.9 5.1 5.4 8.7 7.5 3.2 5.0 1.7 4.6 26.8 2.8 6.7 3.3 7.6 4.2 14.2 5.5 27.3 9.0 7.6 4.8 3.0 7.8 11.9 11.0 5.7 18.4 3.5 6.3 1.2 1.9 23.9 6.4 5.1 4.8 2.2 4.7 1.1 1.4 1.4 0.3 1.0 1.5 0.7 1.2 0.8 1.1 10.7 0.7 4.4 1.4 1.7 0.8 38.9 38.0 16.8 45.0 31.0 28.7 39.5 27.1 31.0 16.8 20.8 16.3 7.5 31.9 14.0 40.7 0.8 28.1 1.4 6.8 41.8 35.3 21.6 68.0 22.2 58.2 29.5 63.2 23.3 24.0 29.3 21.6 60.4 0.0 92.6 20.3 27.0 19.3 46.6 19.9 102.1 32.8 20.6 20.3 4.6 26.4 52.6 41.8 45.6 53.4 91.3 57.1 84.1 37.3 110.5 24.5 21.0 28.6 13.1 18.0 30.8 PIP "GCDFP-15, GCDFP15, GPIP4" ENSG00000159763 "Prolactin induced protein" P12273 7 143132077-143139746 "Plasma proteins, Predicted secreted proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "salivary gland: 1246.7;seminal vesicle: 651.3" "Group enriched" "Detected in some" 11 "Ciliated cells: 105.7;Melanocytes: 383.0" "Cancer enriched" "Detected in many" 70 "breast cancer: 672.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "memory B-cell: 1.5;naive B-cell: 2.6" "Lineage enriched" "Detected in single" 17 "B-cells: 2.6" "Cell line enriched" "Detected in single" 330 "T-47d: 126.4" "CAB002661, HPA009177" Enhanced "Secreted in other tissues" NA NA 89000000 "CAB002661: , HPA009177: AB_1845459" "unprognostic (2.80e-1)" "unprognostic (2.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.01e-2)" "unprognostic (5.93e-2)" "unprognostic (2.25e-2)" "unprognostic (1.54e-1)" "unprognostic (1.05e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.14e-1)" "unprognostic (3.49e-2)" "unprognostic (5.55e-1)" 0.4 0.1 0.1 0.0 0.2 0.0 144.4 0.2 0.1 0.2 0.1 0.0 219.3 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.6 0.0 0.2 0.0 0.1 0.7 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1246.7 651.3 0.2 7.7 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 49.3 1.1 1.8 0.1 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 126.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.3 0.0 1.1 9.6 0.0 0.0 0.0 105.7 6.8 1.8 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 2.1 0.0 0.6 21.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 383.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.0 0.0 0.0 1.8 PIP4K2A "PIP5K2A, PIP5KIIA, PIP5KIIalpha" ENSG00000150867 "Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha" P48426 10 22534849-22714555 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.0" "Cell type enhanced" "Detected in all" 7 "Erythroid cells: 93.5;Melanocytes: 99.5;T-cells: 152.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065440, HPA068771" Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 8800000 "Golgi apparatus" "Plasma membrane, Cytosol" "HPA065440: AB_2685490, HPA068771: AB_2686030" "unprognostic (1.11e-1)" "unprognostic (2.71e-3)" "unprognostic (1.57e-3)" "unprognostic (4.20e-3)" "unprognostic (1.55e-1)" "unprognostic (8.80e-3)" "unprognostic (1.56e-3)" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (7.08e-2)" "unprognostic (1.29e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.52e-3)" "unprognostic (2.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.92e-3)" 13.0 7.3 43.8 20.3 63.8 17.3 6.9 6.6 41.4 13.2 7.8 75.5 1.0 5.9 9.9 5.6 9.2 7.2 15.1 5.9 56.0 31.7 7.6 8.3 11.5 33.4 65.7 22.9 4.3 4.9 29.5 4.2 10.5 36.5 4.4 9.0 5.7 3.9 6.3 2.6 4.0 8.1 14.4 92.0 26.6 8.4 5.4 59.8 10.1 5.9 1.0 38.5 11.5 5.8 14.7 12.0 26.3 16.6 38.4 46.7 39.3 8.9 8.8 10.3 3.3 16.5 22.5 7.8 16.6 17.7 9.0 11.1 8.2 14.3 18.7 6.0 33.3 19.8 3.1 8.9 4.6 9.1 41.4 9.3 35.2 6.4 18.1 29.3 6.7 27.6 11.2 4.2 12.2 11.9 13.9 13.3 25.3 19.5 36.6 16.6 3.7 26.9 6.0 4.2 4.3 6.3 10.9 14.7 25.4 13.3 1.7 1.8 4.3 5.3 2.7 26.4 12.2 2.3 11.7 16.0 7.0 10.2 12.8 10.1 23.3 13.1 13.6 18.9 20.5 5.3 16.1 8.8 26.3 34.5 15.6 46.7 14.7 27.5 40.0 11.6 8.6 18.6 34.9 10.9 38.4 16.6 12.0 19.6 39.3 43.8 63.8 6.6 30.3 56.0 31.7 65.7 22.9 36.5 59.8 3.0 7.9 43.2 3.6 15.7 4.1 6.8 15.3 1.4 7.9 17.4 2.0 6.7 10.0 8.7 15.7 24.8 2.6 93.5 9.3 4.0 17.1 5.4 22.0 6.4 27.8 12.7 4.7 68.2 77.2 23.8 15.5 49.0 99.5 85.6 2.8 4.0 16.5 3.5 9.6 9.8 8.1 19.4 21.1 4.1 2.3 14.8 10.4 152.2 2.3 5.5 PIP4K2B "PIP5K2B, PIP5KIIB, PIP5KIIbeta" ENSG00000276293 "Phosphatidylinositol-5-phosphate 4-kinase type 2 beta" P78356 17 38765689-38800126 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 23.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062220 Supported Nucleoplasm NA NA Nucleoplasm "HPA062220: AB_2684715" "unprognostic (7.77e-2)" "unprognostic (8.37e-2)" "unprognostic (3.74e-2)" "unprognostic (1.13e-1)" "unprognostic (2.67e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (2.64e-1)" "unprognostic (2.33e-1)" "unprognostic (1.50e-2)" "unprognostic (6.10e-3)" "unprognostic (3.79e-1)" "unprognostic (4.82e-3)" "unprognostic (3.38e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.36e-4)" "unprognostic (2.48e-1)" 5.1 6.5 12.4 3.3 12.9 1.1 5.0 8.8 17.4 6.8 2.7 7.0 4.2 2.2 7.2 5.9 3.5 7.4 3.6 7.1 9.6 4.1 2.2 5.0 4.2 5.4 13.3 13.3 3.0 5.1 2.7 5.4 7.5 5.1 3.2 4.1 3.8 6.5 23.6 5.8 2.3 7.3 4.7 5.1 2.5 2.8 6.5 2.0 4.7 2.2 4.5 3.7 5.9 3.3 3.1 2.4 2.4 3.4 5.0 3.7 5.7 12.7 21.2 22.0 18.5 14.7 4.3 10.8 12.0 13.6 11.2 8.6 5.7 14.8 6.8 18.4 11.9 12.4 14.0 8.9 13.1 10.2 9.0 12.8 8.2 12.6 8.4 14.6 7.9 12.9 10.9 10.6 7.9 19.2 11.3 15.4 11.2 7.0 14.6 4.3 13.4 10.7 11.8 6.4 5.9 14.6 20.9 8.1 10.0 7.2 11.8 17.1 10.9 4.4 11.0 23.1 14.0 13.8 11.9 11.5 7.6 9.9 9.3 9.2 11.5 6.7 13.7 11.6 10.4 1.6 2.4 0.8 4.8 2.2 5.0 3.1 4.1 4.6 3.1 3.3 4.7 4.2 2.4 3.4 1.8 3.0 3.9 3.7 17.9 10.7 3.7 3.7 5.5 33.8 18.9 7.6 4.0 9.1 5.2 9.8 6.3 1.7 4.7 8.7 14.6 3.9 0.0 4.2 4.1 8.5 4.5 1.1 9.8 7.5 41.3 11.1 20.3 8.3 13.7 14.1 5.7 1.7 1.8 6.9 12.9 5.4 3.5 15.6 6.7 13.4 6.5 7.2 4.6 8.1 3.9 2.1 7.2 7.3 1.8 PIPOX LPIPOX ENSG00000179761 "Pipecolic acid and sarcosine oxidase" Q9P0Z9 17 28950513-29057220 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "kidney: 33.5;liver: 114.3" "Group enriched" "Detected in many" 6 "Hepatocytes: 183.0;Proximal tubular cells: 123.0" "Group enriched" "Detected in many" 13 "glioma: 15.5;liver cancer: 73.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AF22: 12.5;Hep G2: 37.6;NTERA-2: 24.8;RH-30: 35.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 390000 "unprognostic (8.02e-2)" "unprognostic (3.50e-4)" "unprognostic (3.03e-1)" "unprognostic (6.25e-3)" "unprognostic (1.52e-1)" "unprognostic (5.01e-2)" "unprognostic (1.95e-3)" "unprognostic (1.15e-2)" "unprognostic (2.17e-1)" "unprognostic (3.45e-1)" "prognostic favorable (1.49e-4)" "unprognostic (2.39e-1)" "unprognostic (3.13e-3)" "unprognostic (2.58e-3)" "unprognostic (2.01e-1)" "unprognostic (2.79e-2)" "unprognostic (1.22e-1)" 0.2 0.2 2.4 0.2 3.1 0.1 0.2 2.2 2.9 0.2 1.4 3.8 0.0 3.1 0.4 5.8 0.5 2.1 0.8 0.2 3.5 2.5 33.5 114.3 0.3 0.3 3.6 3.1 0.3 0.2 0.3 0.2 1.0 4.0 0.5 0.3 0.2 0.2 0.9 0.1 0.2 2.6 0.6 1.7 0.3 0.2 0.2 0.7 0.0 0.1 0.0 0.2 0.3 0.1 0.7 4.7 3.7 0.7 0.9 1.9 0.7 0.0 0.0 12.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.2 0.1 37.6 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.2 24.8 0.7 0.0 0.1 35.8 0.7 0.0 0.0 4.0 1.2 0.1 0.0 0.2 2.1 0.0 1.5 0.0 0.0 0.0 0.0 1.6 0.3 4.2 0.1 0.0 0.2 1.2 1.8 0.7 0.7 0.8 0.5 0.9 0.3 0.5 1.2 4.7 0.7 0.3 1.9 3.7 0.9 0.3 0.4 0.8 0.7 2.4 3.1 2.2 2.9 3.5 2.5 3.6 3.1 4.0 0.7 0.0 1.1 2.2 0.2 0.2 1.7 0.4 5.1 0.0 0.0 0.0 3.9 0.1 8.3 0.0 1.3 0.6 0.7 0.0 0.2 4.4 0.4 0.3 5.7 183.0 1.2 0.0 1.2 2.5 3.5 1.5 0.3 1.7 0.0 3.6 0.0 24.0 0.0 0.0 1.1 123.0 1.3 0.0 0.4 0.0 1.0 0.1 0.3 0.5 0.0 0.1 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PITPNM2 "NIR3, RDGB2, RDGBA2" ENSG00000090975 "Phosphatidylinositol transfer protein membrane associated 2" Q9BZ72 12 122983480-123150015 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "lymphoid tissue: 169.5" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Horizontal cells: 38.1;Late spermatids: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Group enriched" "Detected in many" 4 "NK-cells: 4.7;T-cells: 2.3" "Cell line enhanced" "Detected in many" "HEL: 16.1;JURKAT: 20.1;MOLT-4: 29.7;WM-115: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003414, HPA003978" Approved Supported Vesicles NA NA Vesicles "HPA003414: AB_1855410, HPA003978: AB_1855411" "unprognostic (2.43e-1)" "unprognostic (9.29e-2)" "unprognostic (2.00e-1)" "unprognostic (5.39e-2)" "unprognostic (2.14e-1)" "unprognostic (6.76e-2)" "unprognostic (2.26e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (9.28e-2)" "unprognostic (1.50e-3)" "unprognostic (7.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.19e-2)" "unprognostic (9.99e-2)" 3.4 5.9 3.3 3.2 7.9 3.5 3.1 9.3 8.0 3.9 3.5 2.4 3.2 3.5 3.6 5.2 3.7 2.5 2.2 4.6 2.8 2.2 3.7 4.3 5.1 6.1 2.4 2.6 14.0 2.5 5.3 4.2 3.0 2.3 2.7 1.6 3.7 2.7 3.1 3.3 3.0 3.6 4.5 2.5 3.3 2.7 14.8 2.2 169.5 2.3 2.2 4.3 4.7 2.7 0.8 0.0 0.1 0.1 4.7 2.3 1.6 2.4 4.9 1.6 2.3 1.1 2.2 9.6 0.4 0.6 1.3 0.7 2.1 2.1 0.0 2.1 0.8 2.7 7.1 1.3 1.2 0.4 0.1 1.5 16.1 2.8 5.7 0.8 0.6 3.4 1.0 2.1 1.7 1.3 6.2 2.5 20.1 3.6 0.2 1.6 1.6 29.7 3.3 1.8 0.7 2.2 8.6 0.1 6.1 2.3 2.6 1.4 0.5 3.5 2.9 2.3 0.9 0.6 1.7 7.4 1.9 2.1 3.1 2.8 0.5 0.5 11.4 4.7 1.2 14.3 0.0 0.0 0.1 2.3 0.0 0.2 0.4 0.6 1.7 0.0 0.8 1.5 1.4 0.0 4.7 0.1 0.0 1.1 1.6 3.3 7.9 9.3 8.0 2.8 2.2 2.4 2.6 2.3 2.2 0.0 5.3 0.8 0.5 3.2 15.9 6.1 2.5 0.0 2.3 8.7 51.1 1.0 1.7 2.8 25.0 6.7 4.3 0.0 3.9 5.0 1.9 0.6 1.1 12.9 0.4 38.1 0.0 6.2 0.8 77.8 1.7 0.6 1.7 1.0 3.7 3.7 3.7 0.0 4.6 2.2 15.5 0.0 2.8 3.6 2.3 1.4 3.1 1.0 2.3 0.4 PITPNM3 "ACKR6, CORD5, NIR1, RDGBA3" ENSG00000091622 "PITPNM family member 3" Q9BZ71 17 6451264-6556494 "Disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 16.8;Ito cells: 35.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "neutrophil: 5.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.3;HeLa: 8.8;hTCEpi: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022432, HPA059005" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA022432: AB_2670936, HPA059005: AB_2683876" "unprognostic (2.97e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "prognostic favorable (3.67e-6)" "unprognostic (1.25e-2)" "unprognostic (6.86e-2)" "unprognostic (3.66e-2)" "unprognostic (3.01e-2)" "unprognostic (2.99e-3)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-2)" "unprognostic (1.61e-1)" "unprognostic (3.55e-1)" "unprognostic (2.63e-1)" 1.1 2.4 17.9 1.2 18.8 0.5 1.7 18.7 23.0 2.4 4.5 0.7 3.4 1.5 1.9 3.4 9.4 4.3 3.8 0.8 7.2 5.2 1.5 1.6 3.1 0.6 2.9 11.9 24.2 0.9 1.9 0.7 0.6 2.5 2.7 3.6 2.3 1.9 8.3 1.1 14.3 1.4 3.8 0.9 43.3 3.2 2.4 1.5 0.0 2.4 0.7 2.1 1.3 2.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 5.6 0.6 0.4 0.2 0.0 0.1 0.4 0.4 0.1 0.5 0.4 0.3 4.0 0.1 2.1 0.1 1.5 11.3 0.2 2.3 0.2 0.2 0.4 0.1 8.8 0.1 0.6 0.2 0.4 0.1 33.0 0.6 1.9 2.7 0.3 0.4 0.1 0.0 0.3 0.5 0.1 0.1 0.6 2.8 1.6 0.2 1.2 0.0 0.8 0.1 0.3 0.3 5.2 2.4 0.1 0.2 0.8 0.0 0.2 0.3 2.1 0.4 1.3 0.3 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 17.9 18.8 18.7 23.0 7.2 5.2 2.9 11.9 2.5 1.5 3.0 16.8 0.0 1.7 4.5 6.9 2.2 7.6 8.1 9.1 1.8 3.9 0.0 0.0 2.2 3.8 2.7 5.4 0.0 0.5 0.0 0.6 1.5 5.7 0.9 0.1 4.8 1.2 35.0 4.9 1.3 0.6 0.0 0.0 0.0 3.6 0.5 5.9 5.8 0.0 0.0 10.2 0.0 0.5 2.1 1.6 5.1 0.1 0.8 6.0 3.6 PITX1 "BFT, POTX, PTX1" ENSG00000069011 "Paired like homeodomain 1" P78337 5 135027735-135034813 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8" "Cell type enhanced" "Detected in some" 27 "Basal glandular cells: 84.7;Glandular cells: 52.7;Urothelial cells: 214.7" "Cancer enhanced" "Detected in many" "cervical cancer: 73.6" "Region enriched" "Detected in single" 11 "pons and medulla: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 40.4;HeLa: 33.0;K-562: 32.2;T-47d: 48.1" "Not detected" "Not detected" HPA008743 Approved Approved Nucleoli Yes No Nucleoli "HPA008743: AB_1855413" "unprognostic (1.84e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (4.62e-2)" "unprognostic (5.08e-2)" "unprognostic (5.26e-3)" "unprognostic (1.03e-2)" "unprognostic (1.66e-2)" "unprognostic (5.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.60e-2)" "unprognostic (2.27e-1)" "unprognostic (5.80e-14)" "unprognostic (6.22e-2)" "unprognostic (1.33e-1)" "unprognostic (5.98e-3)" "unprognostic (4.97e-3)" 0.3 0.3 0.0 4.7 0.0 0.3 0.2 0.0 0.2 14.8 2.8 0.0 0.0 5.6 0.5 1.2 119.4 0.3 1.9 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 32.9 1.3 1.0 8.8 1.1 10.8 33.0 0.2 8.6 0.5 3.2 18.6 0.0 0.2 7.4 0.4 0.0 0.0 0.4 58.8 60.8 18.2 28.9 0.3 0.3 1.4 0.4 0.4 1.1 0.2 17.2 10.6 0.0 14.2 0.6 0.2 4.4 3.4 5.0 1.7 0.6 40.4 10.2 19.4 5.5 0.2 4.2 5.9 2.3 8.3 0.1 0.2 15.0 4.8 33.0 11.1 5.2 1.7 0.0 0.4 6.0 0.0 1.9 0.1 0.0 3.0 32.2 0.0 0.5 5.3 0.1 3.8 0.0 1.5 9.5 5.7 0.3 0.3 0.2 5.4 6.6 0.0 15.1 8.2 0.0 0.1 48.1 1.1 0.6 1.9 4.8 1.0 5.3 0.0 0.0 12.7 2.5 0.1 0.0 1.4 0.3 0.1 0.9 0.3 0.5 0.3 0.6 1.1 0.2 0.3 0.3 1.0 0.7 0.4 0.4 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 84.7 1.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.4 0.0 0.3 0.0 0.4 2.0 0.9 52.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.0 0.3 0.0 9.9 0.3 0.0 0.0 2.0 0.0 1.4 1.4 4.1 5.9 6.4 0.0 0.6 214.7 PITX2 "ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS" ENSG00000164093 "Paired like homeodomain 2" Q99697 4 110617423-110642123 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.4;retina: 53.5;skeletal muscle: 28.8" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 16 "hypothalamus: 2.1;midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7" "Region enhanced" "Detected in single" "hypothalamus: 9.8" "Region enhanced" "Detected in single" "hypothalamus: 5.1" "HPA050074, HPA062728" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050074: AB_2681005, HPA062728: AB_2684851" "unprognostic (1.08e-1)" "unprognostic (1.23e-2)" "unprognostic (9.29e-2)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-2)" "unprognostic (9.61e-4)" "unprognostic (3.22e-2)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.11e-15)" "unprognostic (6.97e-3)" "unprognostic (1.43e-1)" "unprognostic (5.98e-2)" "unprognostic (9.91e-2)" 0.6 0.1 0.0 18.6 0.0 0.1 0.3 0.0 0.1 1.1 3.0 0.0 0.3 0.1 0.1 1.3 2.7 0.2 1.1 3.5 0.0 2.1 0.3 0.1 0.1 0.1 1.1 0.0 0.1 0.5 0.1 12.5 30.4 0.0 8.3 0.3 53.5 9.3 0.2 28.8 0.9 3.4 15.9 0.0 0.1 0.5 0.3 0.0 0.0 0.1 16.8 0.4 19.4 5.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 1.9 0.0 0.7 1.9 1.6 3.0 0.6 0.3 2.0 1.5 18.1 0.0 0.0 3.9 3.7 2.4 0.3 0.1 0.0 1.1 0.0 8.0 0.0 1.4 0.0 6.7 0.0 3.8 2.1 0.1 0.3 0.0 0.6 0.0 2.0 0.5 0.0 18.6 0.5 2.0 0.0 0.3 0.0 0.3 0.0 15.7 0.0 0.3 2.5 0.0 0.0 1.4 2.5 0.2 0.3 0.1 0.0 0.0 2.5 5.9 0.0 2.9 0.0 0.1 0.8 1.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 12.7 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 6.5 0.0 0.3 5.4 4.5 0.2 0.0 0.0 6.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 1.7 1.2 5.6 0.1 8.8 0.0 1.2 0.0 PITX3 ASMD ENSG00000107859 "Paired like homeodomain 3" O75364 10 102230186-102241474 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 19.9;tongue: 13.7" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 5.4;Late spermatids: 2.4;Spermatocytes: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "midbrain: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "RH-30: 26.3" "Region enhanced" "Detected in single" "midbrain: 0.3" "Region enriched" "Detected in single" 5 "midbrain: 13.2" NA NA "unprognostic (8.13e-2)" "unprognostic (4.07e-1)" "unprognostic (5.15e-3)" "unprognostic (6.30e-2)" "unprognostic (1.06e-1)" "unprognostic (6.04e-5)" "unprognostic (6.30e-3)" "unprognostic (2.02e-1)" "unprognostic (6.36e-2)" "unprognostic (2.67e-2)" "unprognostic (3.73e-2)" "unprognostic (1.76e-2)" "unprognostic (6.76e-3)" "unprognostic (4.13e-2)" 1.5 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.1 0.0 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.4 13.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 1.4 1.0 0.1 0.0 0.0 0.0 0.0 PIWIL1 "CT80.1, HIWI, PIWI" ENSG00000125207 "Piwi like RNA-mediated gene silencing 1" Q96J94 12 130337887-130372637 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 77 "testis: 85.5" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 135.3;Spermatocytes: 150.2" "Cancer enhanced" "Detected in some" "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;OE19: 9.3;PC-3: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA066880 Enhanced NA NA "HPA066880: " "unprognostic (1.00e-2)" "unprognostic (1.46e-2)" "unprognostic (8.28e-2)" "unprognostic (2.22e-1)" "unprognostic (1.48e-1)" "unprognostic (3.01e-2)" "unprognostic (2.14e-1)" "unprognostic (8.81e-2)" "unprognostic (3.95e-1)" "unprognostic (1.86e-1)" "unprognostic (9.36e-2)" "unprognostic (9.85e-6)" "unprognostic (3.83e-2)" "unprognostic (2.70e-1)" "unprognostic (2.43e-2)" "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 85.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.1 7.4 1.0 0.0 0.0 0.0 1.8 115.8 0.4 0.0 0.3 37.4 0.3 0.3 0.0 0.0 0.2 0.8 0.3 0.0 0.0 0.3 1.6 1.2 1.8 2.2 22.0 2.6 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.1 0.8 135.3 0.0 0.2 150.2 4.1 1.1 0.8 0.0 0.4 0.1 PIWIL2 "CT80, FLJ10351, HILI, Mili" ENSG00000197181 "Piwi like RNA-mediated gene silencing 2" Q8TC59 8 22275297-22357563 "Predicted intracellular proteins" "Biological rhythms, Differentiation, Meiosis, Oogenesis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 37.3" "Group enriched" "Detected in many" 4 "Spermatocytes: 40.9;Spermatogonia: 22.6" "Cancer enriched" "Detected in some" 6 "testis cancer: 6.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 25 "NTERA-2: 29.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.91e-2)" "unprognostic (1.77e-2)" "unprognostic (6.51e-2)" "unprognostic (2.18e-1)" "unprognostic (8.29e-2)" "unprognostic (3.58e-3)" "unprognostic (2.60e-1)" "unprognostic (2.37e-1)" "unprognostic (7.59e-2)" "unprognostic (6.68e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.16e-7)" "unprognostic (1.27e-1)" "unprognostic (7.83e-2)" "unprognostic (1.05e-3)" "unprognostic (2.61e-2)" 0.9 0.2 0.3 0.6 1.3 0.1 5.7 1.5 1.0 1.1 0.7 0.5 0.2 5.7 0.8 0.5 0.3 0.9 0.2 0.9 0.5 1.0 0.2 1.0 0.2 1.0 0.6 0.7 1.9 2.2 0.0 1.4 0.5 0.9 1.6 0.9 1.2 0.8 0.5 2.2 0.5 1.7 0.6 0.8 0.2 1.4 37.3 0.2 0.4 1.3 1.6 0.8 1.0 0.7 0.3 0.0 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.3 1.3 1.5 1.0 0.5 1.0 0.6 0.7 0.9 0.2 6.0 4.0 0.0 0.7 0.9 6.1 1.1 0.0 4.0 0.0 1.8 7.9 0.1 0.0 0.0 3.2 0.0 6.2 0.0 1.4 0.2 1.7 0.8 1.1 3.0 0.1 0.0 0.0 0.6 0.0 4.8 2.6 0.9 1.7 1.0 4.4 0.9 1.1 1.9 2.1 0.3 3.0 0.0 2.0 40.9 22.6 1.4 0.2 0.0 4.9 0.9 PIWIL3 HIWI3 ENSG00000184571 "Piwi like RNA-mediated gene silencing 3" Q7Z3Z3 22 24719034-24774720 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 4.7" "Cell type enriched" "Detected in some" 13 "Early spermatids: 21.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.8;HeLa: 1.6;RPMI-8226: 1.1" HPA061955 Uncertain NA NA "HPA061955: AB_2684647" "unprognostic (9.05e-2)" "unprognostic (2.20e-1)" "unprognostic (3.12e-4)" "unprognostic (2.73e-1)" "unprognostic (7.33e-2)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.4 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;testis: 30.9" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 10.2;Mucus-secreting cells: 7.8;Paneth cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NB-4: 44.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036587, HPA036588, HPA057508" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 1.9 0.6 1.9 1.9 3.1 17.8 2.7 4.1 1.7 2.2 3.8 1.7 1.7 4.5 2.5 1.7 1.7 2.0 3.6 1.7 1.9 1.7 1.7 1.7 1.7 2.5 1.7 1.7 2.2 8.2 0.2 1.7 2.3 1.7 1.7 5.0 1.7 7.6 2.0 1.7 0.8 4.3 1.7 2.5 2.3 3.6 30.9 1.7 1.7 1.7 1.7 1.8 1.7 1.7 0.0 0.8 0.5 2.4 0.3 1.3 1.0 0.1 0.0 0.2 0.0 3.3 2.2 0.2 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 1.3 0.1 0.0 0.4 0.0 0.1 1.2 0.1 0.1 0.3 0.0 1.3 3.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.2 0.1 44.9 0.0 4.4 0.3 0.1 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.4 0.2 0.1 0.0 9.9 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 2.4 0.5 1.0 1.0 0.0 0.0 0.1 0.6 0.8 0.0 1.3 0.4 0.0 0.3 1.0 0.0 0.4 1.0 1.9 3.1 4.1 1.7 1.9 1.7 1.7 1.7 1.7 1.7 0.0 0.3 0.0 0.2 1.1 0.6 1.4 10.2 2.7 2.3 0.0 0.0 3.3 1.7 3.6 2.8 0.5 2.9 0.0 1.8 0.3 0.9 0.4 0.0 0.0 1.5 0.0 0.0 1.3 3.1 1.0 0.3 1.5 0.0 1.0 7.8 0.3 2.7 6.5 1.1 0.6 2.8 0.0 0.8 0.7 1.5 0.1 0.8 0.0 4.7 0.0 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165793 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 98.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 12.6 9.9 21.6 5.5 35.7 2.6 7.9 13.4 23.7 12.2 5.8 8.9 19.3 4.7 9.2 98.7 5.7 10.2 7.1 7.5 18.4 23.4 7.5 4.4 7.4 5.9 14.9 16.7 16.2 6.0 27.1 12.5 10.7 11.7 9.9 5.3 7.2 6.4 20.3 4.7 7.1 4.4 9.8 12.0 5.9 6.5 13.7 9.5 3.0 13.8 2.9 7.4 7.8 7.9 11.2 4.3 2.7 4.5 14.8 17.8 9.0 10.4 8.0 25.1 17.6 8.8 9.3 7.6 7.0 8.4 6.6 8.9 6.5 9.9 1.6 10.9 11.1 15.6 9.1 38.6 13.7 8.3 7.8 13.7 3.1 6.6 4.3 11.0 1.8 6.0 9.7 9.1 11.3 6.7 6.4 7.4 5.3 2.9 1.1 6.7 5.6 0.8 3.6 17.1 8.9 13.2 7.5 11.2 2.5 10.6 8.8 18.7 12.1 11.2 1.9 8.5 20.9 3.1 2.6 6.7 5.7 9.2 16.9 3.2 0.0 0.1 3.8 6.2 5.1 7.6 2.7 3.3 1.0 15.5 4.5 17.8 8.7 13.7 14.2 3.6 11.2 14.4 16.6 1.1 14.8 2.9 4.3 8.3 9.0 21.6 35.7 13.4 23.7 18.4 23.4 14.9 16.7 11.7 9.5 14.9 4.5 5.1 14.7 36.5 16.4 6.3 5.1 2.7 11.4 3.5 7.9 30.0 13.3 20.5 77.4 5.1 0.7 0.0 10.2 12.8 18.9 7.8 4.6 1.7 6.7 4.8 5.2 5.5 3.8 22.6 25.0 4.1 5.0 1.8 2.8 28.6 13.9 1.4 18.4 4.4 5.9 6.5 17.0 0.9 1.0 25.7 17.4 7.9 2.3 17.6 PJVK DFNB59 ENSG00000204311 Pejvakin Q0ZLH3 2 178451346-178461409 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 10.8;Club cells: 3.4;Distal tubular cells: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.5" "Cell line enhanced" "Detected in many" "SuSa: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042621 Approved Mitochondria No No Mitochondria "HPA042621: AB_10797503" "unprognostic (4.01e-2)" "unprognostic (4.28e-2)" "unprognostic (1.58e-2)" "unprognostic (2.64e-1)" "unprognostic (7.21e-3)" "unprognostic (9.36e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-1)" "unprognostic (8.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.90e-3)" "unprognostic (9.13e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (1.22e-1)" "unprognostic (1.47e-1)" "unprognostic (2.41e-2)" "unprognostic (8.06e-3)" 2.2 1.4 2.5 1.0 3.5 0.7 4.4 1.3 3.7 2.1 1.5 1.2 3.5 0.7 3.5 7.2 2.2 2.6 2.6 1.0 2.7 2.2 2.1 2.2 1.0 1.3 2.8 4.4 7.0 1.0 1.4 3.9 1.0 2.0 2.3 0.9 2.4 2.1 2.7 2.7 3.5 1.3 1.7 2.7 1.0 0.9 35.2 1.3 1.0 2.3 1.7 1.2 1.6 1.2 1.5 6.5 0.6 0.3 0.4 1.3 0.1 0.4 2.7 3.5 2.8 4.7 5.2 1.8 2.2 2.2 2.0 3.1 1.0 4.5 3.1 2.3 1.3 1.6 1.4 2.5 1.4 1.3 1.0 0.9 1.0 3.7 0.6 4.5 0.8 0.2 4.9 3.4 2.2 4.9 5.8 2.3 6.1 0.5 2.0 2.3 0.4 2.9 1.9 4.2 0.3 1.1 3.9 2.6 1.9 3.1 1.4 2.5 2.1 1.0 0.5 0.8 11.0 1.0 0.9 1.5 2.3 0.9 0.7 0.2 6.4 4.0 1.0 1.1 1.7 0.9 0.0 0.3 0.0 0.3 0.2 0.4 0.8 0.4 0.2 0.1 1.5 1.3 0.7 0.6 0.4 0.0 6.5 0.0 0.1 2.5 3.5 1.3 3.7 2.7 2.2 2.8 4.4 2.0 1.3 6.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.8 0.0 0.9 3.3 1.1 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKD1 "PBP, Pc-1, TRPP1" ENSG00000008710 "Polycystin 1, transient receptor potential channel interacting" P98161 16 2088710-2135898 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 45.3" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 112.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046448 Approved NA NA 120000 "CAB046448: AB_2163360" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (1.35e-1)" "unprognostic (1.79e-1)" "prognostic favorable (3.35e-4)" "unprognostic (1.98e-2)" "unprognostic (1.02e-2)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "prognostic favorable (3.38e-5)" "unprognostic (7.86e-2)" "unprognostic (4.07e-1)" "unprognostic (3.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.78e-2)" "unprognostic (2.81e-1)" 4.5 4.6 2.6 2.3 3.6 1.5 1.4 45.3 7.9 2.8 5.1 1.8 5.4 0.7 2.6 3.4 1.8 7.1 3.5 4.2 0.7 0.6 2.2 1.3 1.9 6.8 3.3 1.2 11.3 1.7 3.7 0.4 4.3 5.4 18.0 7.8 2.8 3.3 1.5 2.7 2.6 2.2 1.0 0.3 3.1 1.8 0.1 0.1 0.0 0.1 0.0 0.4 0.7 3.0 6.5 3.6 8.2 6.3 6.9 7.1 10.6 4.4 3.1 3.1 5.9 2.3 4.6 6.8 5.4 3.3 7.7 1.0 1.6 1.2 5.4 5.3 2.8 16.7 2.3 12.6 3.9 5.9 6.4 5.3 5.7 3.5 4.3 2.4 4.9 4.1 4.7 2.0 5.0 5.5 11.9 3.3 1.2 5.0 15.7 5.9 6.8 1.6 2.1 15.2 17.0 9.6 6.4 6.6 1.4 5.2 13.4 5.4 9.8 8.0 7.3 7.7 6.9 3.1 5.1 5.5 3.7 6.1 0.0 0.1 0.0 0.4 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.7 11.9 13.5 4.6 8.8 21.6 62.9 21.4 5.1 18.7 7.9 8.7 39.3 5.1 8.3 4.7 53.2 15.2 8.6 0.0 2.7 2.9 19.8 8.0 8.1 21.3 4.5 112.8 29.3 14.1 7.3 8.2 25.6 7.4 21.9 3.6 11.8 30.3 3.7 2.9 43.2 7.3 34.4 32.3 21.7 11.4 15.3 17.6 2.6 6.9 13.4 5.4 PKD1L1 PRO19563 ENSG00000158683 "Polycystin 1 like 1, transient receptor potential channel interacting" Q8TDX9 7 47774652-47948491 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" Heterotaxy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 13.4;tongue: 16.7" "Cell type enhanced" "Detected in some" 21 "Bipolar cells: 3.1;Early spermatids: 11.4;Ito cells: 2.5;Late spermatids: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "T-47d: 6.5;U-266/70: 17.1;U-266/84: 6.1" "Not detected" "Not detected" "HPA020422, HPA022424" Uncertain NA NA "HPA020422: AB_1855434, HPA022424: AB_1855435" "unprognostic (5.47e-2)" "unprognostic (5.33e-3)" "unprognostic (1.49e-2)" "unprognostic (9.74e-2)" "unprognostic (4.03e-2)" "unprognostic (6.31e-2)" "unprognostic (2.52e-2)" "unprognostic (1.11e-1)" "unprognostic (9.63e-3)" "unprognostic (7.96e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" "unprognostic (1.88e-4)" "unprognostic (1.88e-3)" "unprognostic (2.56e-1)" "unprognostic (2.50e-1)" "unprognostic (1.90e-1)" 5.4 0.2 1.0 2.3 1.8 0.2 1.6 1.3 1.1 1.2 0.8 0.7 0.1 2.0 2.5 1.6 0.9 0.6 1.0 7.4 0.8 1.5 0.5 1.1 13.4 1.2 0.9 0.1 0.6 0.3 0.1 1.2 2.0 1.0 0.3 0.9 10.0 2.6 0.1 6.4 0.7 0.7 1.7 1.0 0.8 0.4 3.8 0.1 0.9 1.2 16.7 1.4 2.2 1.4 0.0 0.2 0.0 0.8 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.2 0.0 0.1 0.3 0.1 6.5 0.0 0.0 0.0 0.9 0.0 0.0 17.1 6.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.8 1.3 1.1 0.8 1.5 0.9 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.1 3.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.0 1.6 0.0 2.5 0.0 2.5 0.3 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 PKD1L3 ENSG00000277481 "Polycystin 1 like 3, transient receptor potential channel interacting" Q7Z443 16 71929538-71999978 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.9;smooth muscle: 2.9;testis: 2.1" "Cell type enhanced" "Detected in single" 18 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.75e-1)" "unprognostic (1.55e-1)" "unprognostic (1.12e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (7.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.74e-1)" "unprognostic (9.90e-4)" "unprognostic (2.22e-1)" "unprognostic (1.35e-6)" "unprognostic (6.71e-2)" "unprognostic (1.73e-1)" "unprognostic (1.25e-1)" "unprognostic (1.93e-3)" 0.6 0.5 0.1 2.9 0.1 0.3 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.7 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 1.2 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 1.9 2.9 0.1 0.4 0.2 2.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.7 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.6 0.2 0.1 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.4 0.0 0.5 0.0 0.8 0.0 0.3 0.4 0.0 0.0 0.9 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 PKD2L1 "PCL, PKD2L, PKDL, TRPP3" ENSG00000107593 "Polycystin 2 like 1, transient receptor potential cation channel" Q9P0L9 10 100288154-100330486 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2;lymphoid tissue: 12.0" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 15.0;Hofbauer cells: 12.4;Horizontal cells: 57.2;Late spermatids: 15.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 3.0" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;NB-4: 1.8;PC-3: 2.0;RT4: 1.1;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.8;U-937: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB022621 Uncertain NA NA "CAB022621: " "unprognostic (2.67e-1)" "unprognostic (3.66e-7)" "unprognostic (8.07e-3)" "unprognostic (4.38e-2)" "unprognostic (4.70e-2)" "unprognostic (5.31e-2)" "unprognostic (2.19e-1)" "unprognostic (2.85e-2)" "unprognostic (2.01e-1)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (9.37e-2)" "unprognostic (1.49e-4)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" 0.3 0.3 0.4 0.6 3.7 1.3 1.4 0.1 6.2 0.1 1.5 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 2.0 0.3 0.5 2.7 4.0 2.3 0.5 4.0 0.2 0.2 0.0 0.2 0.7 1.3 0.4 2.2 1.0 0.3 0.0 0.1 0.1 0.8 0.0 1.5 12.0 0.1 2.3 0.0 0.3 0.1 0.0 2.9 0.4 0.1 0.2 0.3 0.6 3.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 1.6 0.0 0.0 0.0 1.8 0.0 1.0 2.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.8 0.0 0.0 1.4 0.0 0.0 2.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.6 0.0 2.3 0.0 0.0 0.4 0.4 3.7 0.1 6.2 2.0 0.3 0.5 4.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 12.4 57.2 0.0 0.6 6.6 15.9 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Group enriched" "Detected in many" 5 "Early spermatids: 25.9;Spermatocytes: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.9;U-266/70: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA041903: AB_2677734, HPA043634: AB_2678591" "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.8 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.5 0.0 0.1 0.7 0.1 0.0 0.1 1.5 1.1 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.7 0.6 3.3 1.5 5.9 0.8 0.5 1.1 2.4 0.6 0.1 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.5 0.2 0.9 0.7 0.4 0.5 0.5 1.0 1.8 0.7 1.0 4.6 3.4 0.4 2.3 0.7 1.8 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 3.0 2.1 0.5 1.6 1.9 2.3 1.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 25.9 0.8 0.0 0.0 0.0 0.1 1.3 1.3 1.1 0.2 0.2 3.2 0.0 1.3 0.6 4.7 0.6 0.2 3.3 0.0 0.0 0.9 0.1 0.0 0.4 0.2 3.9 0.0 1.2 19.5 2.2 1.0 0.1 0.7 0.0 0.5 PKDREJ ENSG00000130943 "Polycystin family receptor for egg jelly" Q9NTG1 22 46255663-46263355 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 13.8" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 1.8;Cone photoreceptor cells: 3.9;Early spermatids: 1.8;Late spermatids: 1.9;Spermatocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.1;U-2 OS: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA034587 Enhanced NA NA "HPA034587: AB_10670570" "unprognostic (9.48e-3)" "unprognostic (1.09e-1)" "unprognostic (3.51e-2)" "unprognostic (1.25e-1)" "unprognostic (6.11e-2)" "unprognostic (5.06e-4)" "unprognostic (1.13e-1)" "unprognostic (2.99e-1)" "unprognostic (8.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-1)" "unprognostic (3.36e-2)" "unprognostic (1.18e-1)" "unprognostic (1.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.37e-1)" 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.2 0.5 0.3 0.2 0.3 0.3 0.4 2.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.4 0.0 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.3 1.5 0.5 0.2 0.2 0.2 0.2 13.8 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.8 0.1 0.5 1.6 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.1 0.8 0.1 0.0 0.1 0.2 0.0 0.0 0.0 2.1 0.9 0.2 0.0 0.4 0.1 0.4 0.8 0.1 0.0 0.0 0.0 0.3 0.0 0.5 1.5 0.4 0.0 1.2 0.4 0.6 0.3 0.1 0.0 0.3 1.5 0.0 0.0 0.3 0.9 1.9 0.6 0.4 1.0 0.5 0.0 0.4 0.2 0.2 1.9 0.1 0.3 0.9 0.1 0.1 0.1 1.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 1.8 3.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 5.8 0.4 0.5 0.0 0.0 0.2 0.0 PKHD1 "ARPKD, FCYT, FPC, TIGM1" ENSG00000170927 "PKHD1, fibrocystin/polyductin" P08F94 6 51615300-52087625 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 19.8;kidney: 49.4;pancreas: 32.9" "Group enriched" "Detected in some" 5 "Cholangiocytes: 56.0;Collecting duct cells: 43.6;Early spermatids: 167.1;Late spermatids: 63.8" "Group enriched" "Detected in some" 5 "pancreatic cancer: 1.4;renal cancer: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA031227 Enhanced NA NA "HPA031227: AB_10602068" "unprognostic (6.34e-3)" "unprognostic (5.51e-2)" "unprognostic (8.80e-3)" "unprognostic (1.35e-1)" "unprognostic (3.80e-2)" "unprognostic (1.29e-2)" "unprognostic (4.03e-2)" "unprognostic (6.42e-2)" "unprognostic (7.08e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-2)" "unprognostic (2.62e-2)" "prognostic favorable (9.74e-8)" "unprognostic (2.33e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 5.6 0.0 0.1 19.8 0.1 0.1 6.3 0.1 0.1 0.1 49.4 2.5 0.1 0.0 0.1 0.0 0.1 32.9 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 1.2 0.1 0.4 0.1 0.1 0.1 0.1 0.5 1.4 0.0 0.0 0.1 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.5 15.8 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 2.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 56.0 0.0 0.0 43.6 0.0 0.1 1.7 11.7 167.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 2.6 0.1 0.0 0.0 0.0 0.0 63.8 2.0 0.0 5.0 0.0 0.0 1.9 2.9 0.0 0.4 17.7 0.0 0.0 0.0 1.4 1.8 0.0 0.0 0.0 0.0 0.1 PKHD1L1 ENSG00000205038 "PKHD1 like 1" Q86WI1 8 109362477-109530330 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "thyroid gland: 91.7" "Group enriched" "Detected in some" 7 "B-cells: 36.0;Ito cells: 10.4" "Group enriched" "Detected in some" 18 "endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Group enriched" "Detected in some" 9 "memory B-cell: 1.8;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 10 "B-cells: 1.8" "Cell line enhanced" "Detected in some" "HHSteC: 4.2;HUVEC TERT2: 2.3;TIME: 4.7;U-266/70: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA044458 Uncertain NA NA 5100000 "HPA044458: AB_2678949" "unprognostic (9.07e-3)" "unprognostic (3.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (7.61e-4)" "unprognostic (5.57e-2)" "unprognostic (1.30e-2)" "unprognostic (2.91e-2)" "unprognostic (3.45e-2)" "unprognostic (3.31e-2)" "unprognostic (1.98e-1)" "unprognostic (9.65e-3)" "unprognostic (1.92e-1)" "unprognostic (7.76e-6)" "unprognostic (4.56e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-3)" "unprognostic (2.73e-2)" 12.4 1.5 0.1 4.2 0.1 0.4 2.6 0.0 0.2 13.8 5.7 0.1 2.1 1.1 3.5 8.9 2.5 11.5 3.5 5.2 0.1 0.1 0.8 0.8 16.9 22.5 0.4 0.0 3.5 0.7 0.2 0.4 0.2 1.1 1.4 1.6 4.2 1.7 1.5 2.0 0.9 2.0 3.2 0.2 0.3 0.8 1.6 0.0 0.0 91.7 2.9 1.1 2.1 3.2 1.8 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 4.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 1.1 0.0 0.0 3.2 36.0 0.0 0.2 0.0 2.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.8 1.8 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.5 0.0 0.0 1.7 10.4 1.2 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 PKIA PRKACN1 ENSG00000171033 "CAMP-dependent protein kinase inhibitor alpha" P61925 8 78516139-78605267 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 258.0" "Cell type enhanced" "Detected in many" 25 "Cardiomyocytes: 268.3;Horizontal cells: 55.6;Muller glia cells: 80.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 16.5" "Lineage enriched" "Detected in many" 9 "T-cells: 16.5" "Cell line enhanced" "Detected in many" "HDLM-2: 22.6;HUVEC TERT2: 37.9;RT4: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042791 Uncertain NA NA "HPA042791: AB_10795761" "unprognostic (3.83e-3)" "unprognostic (1.89e-1)" "unprognostic (1.55e-2)" "unprognostic (5.59e-6)" "unprognostic (8.75e-2)" "unprognostic (1.56e-1)" "unprognostic (5.10e-3)" "unprognostic (1.65e-3)" "unprognostic (3.25e-2)" "unprognostic (2.58e-1)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" "unprognostic (2.93e-1)" "prognostic unfavorable (5.41e-4)" "unprognostic (3.14e-1)" "unprognostic (1.38e-1)" "unprognostic (7.52e-3)" 1.6 3.5 17.8 2.4 28.9 1.7 2.1 17.2 18.2 1.6 1.7 4.6 0.0 1.4 1.8 3.1 6.4 2.5 3.1 46.4 13.7 14.9 2.3 1.1 3.2 2.8 8.9 15.8 2.6 1.4 21.2 3.7 1.5 6.7 6.1 1.8 0.7 2.2 2.5 258.0 3.3 1.5 1.7 6.0 2.0 1.5 1.3 6.7 6.2 9.7 46.1 3.7 3.5 1.2 1.9 0.1 0.3 0.1 1.3 16.5 2.1 0.2 0.1 12.6 0.0 7.0 1.8 0.0 11.6 2.3 1.2 2.7 0.0 1.9 5.2 0.0 1.7 1.2 0.1 4.1 3.7 8.3 22.6 9.0 6.5 1.4 0.0 0.4 0.0 3.8 2.9 0.5 0.0 3.6 17.0 37.9 7.2 0.0 5.8 18.8 1.9 9.8 0.0 2.9 0.0 12.9 0.0 10.8 0.0 6.9 36.1 6.2 12.1 1.5 9.7 0.0 3.4 0.0 0.0 14.9 2.9 2.4 0.6 6.8 2.4 2.4 1.7 13.8 0.0 3.6 0.0 0.0 0.0 0.4 0.0 0.3 1.9 7.7 1.5 0.0 1.8 6.8 3.9 0.3 1.3 0.1 0.1 16.5 2.1 17.8 28.9 17.2 15.5 13.7 14.9 8.9 15.8 6.7 6.7 3.0 3.2 3.2 7.4 5.3 34.9 268.3 0.0 1.4 1.2 1.8 2.0 2.7 1.7 0.0 10.7 3.7 0.0 0.0 0.2 2.4 1.5 8.1 5.7 0.0 0.6 55.6 9.8 2.5 0.0 3.5 0.0 1.1 3.3 0.0 0.7 80.2 0.9 0.0 0.4 0.0 6.6 0.0 1.9 0.1 0.7 12.0 2.9 4.4 0.0 1.7 PKIB PRKACN2 ENSG00000135549 "CAMP-dependent protein kinase inhibitor beta" Q9C010 6 122471917-122726373 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 91.6;placenta: 140.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 457.3;Enterocytes: 299.8;Extravillous trophoblasts: 381.2;Syncytiotrophoblasts: 802.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 91.6" "Cell type enriched" "Detected in some" 11 "myeloid DC: 22.3" "Lineage enriched" "Detected in many" 11 "dendritic cells: 22.3" "Cell line enhanced" "Detected in many" "AF22: 20.0;MCF7: 22.6;OE19: 24.5;PC-3: 31.8;RPTEC TERT1: 52.0;SCLC-21H: 44.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 92.0;olfactory region: 58.4" HPA030156 Approved NA NA "HPA030156: AB_10602816" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (9.45e-2)" "prognostic unfavorable (4.72e-7)" "unprognostic (1.94e-2)" "unprognostic (5.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (2.47e-7)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" 0.8 2.0 3.3 7.3 3.7 0.0 8.8 91.6 2.3 1.8 33.0 1.0 1.0 5.4 0.9 1.2 1.6 1.8 2.3 0.5 2.8 4.5 0.9 2.6 2.0 0.9 6.1 2.2 0.5 2.3 18.9 22.3 140.9 17.7 2.0 23.6 5.6 2.8 1.2 0.5 3.1 12.0 1.2 2.8 0.8 12.2 1.2 0.7 1.6 1.0 1.3 2.5 1.8 0.7 0.1 22.3 0.0 1.9 1.4 0.5 0.5 0.0 0.7 20.0 0.1 0.1 0.0 17.5 0.0 0.2 0.0 0.3 0.1 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.4 0.2 0.1 1.0 0.3 1.1 0.4 0.0 0.0 3.4 0.1 0.3 0.3 4.3 9.6 0.1 0.1 5.8 0.1 0.0 22.6 0.0 0.1 8.2 24.5 31.8 0.1 3.0 0.1 52.0 2.8 44.3 0.0 0.0 4.7 0.5 11.5 3.3 0.4 1.7 0.0 13.5 0.0 1.6 0.0 0.0 0.0 13.2 0.4 0.1 0.0 0.4 0.0 0.0 1.9 0.5 0.0 0.0 0.0 22.3 0.1 0.3 0.1 0.0 1.4 0.1 0.3 0.2 0.5 3.3 3.7 91.6 2.3 2.8 4.5 6.1 2.2 17.7 0.7 3.0 3.8 2.7 2.1 17.5 14.0 0.3 5.1 97.7 13.6 1.8 3.9 457.3 16.6 18.6 103.5 1.5 299.8 0.0 30.1 381.2 7.1 14.7 38.1 3.8 46.4 6.4 94.2 1.8 40.2 208.8 1.1 124.0 42.2 40.5 65.2 9.4 67.0 45.5 0.4 3.3 47.6 6.5 4.0 2.7 5.4 14.9 802.7 3.2 47.0 4.7 PKLR ENSG00000143627 "Pyruvate kinase L/R" P30613 1 155289293-155301434 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 17.2;kidney: 12.4;liver: 47.8" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2" "Cancer enriched" "Detected in some" 9 "liver cancer: 56.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "K-562: 48.5" "Region enhanced" "Detected in single" "basal ganglia: 1.7" "Not detected" "Not detected" "HPA006653, CAB034376, CAB034378" Enhanced Approved "Golgi apparatus,Cytosol" No NA 2900000 "Golgi apparatus, Cytosol" "CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632" "unprognostic (9.16e-2)" "unprognostic (1.22e-1)" "unprognostic (2.22e-1)" "unprognostic (5.98e-2)" "unprognostic (2.62e-1)" "unprognostic (7.86e-4)" "unprognostic (1.53e-2)" "unprognostic (1.08e-1)" "unprognostic (8.79e-2)" "unprognostic (1.89e-1)" "unprognostic (4.07e-1)" "unprognostic (4.53e-2)" "unprognostic (1.96e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" "unprognostic (6.21e-3)" 0.1 0.0 0.1 0.3 0.1 7.2 0.1 0.9 0.2 0.1 4.9 0.1 0.1 5.8 0.1 1.3 0.1 0.0 0.7 0.1 0.1 0.4 12.4 47.8 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 17.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 8.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 PKM "OIP3, PK3, PKM2, THBP1" ENSG00000067225 "Pyruvate kinase M1/2" P14618 15 72199029-72231822 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Translation regulation" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 541.2" "Cell type enhanced" "Detected in all" 5 "monocytes: 1878.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019421, HPA029501" Uncertain Enhanced Cytosol No No 540000000 Cytosol "CAB019421: AB_2252325, HPA029501: AB_10602118" "unprognostic (8.73e-3)" "unprognostic (4.63e-3)" "unprognostic (1.68e-2)" "unprognostic (3.09e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (1.30e-4)" "prognostic unfavorable (2.74e-6)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.51e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (5.17e-5)" "unprognostic (3.16e-1)" "unprognostic (3.22e-1)" "unprognostic (7.85e-2)" "unprognostic (3.17e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-2)" 23.2 76.8 53.8 49.8 70.4 57.5 41.6 56.6 85.9 65.7 31.2 32.1 31.5 26.4 24.7 41.8 76.4 37.9 32.9 94.8 50.1 57.1 60.9 6.1 33.3 39.4 62.5 63.6 26.2 15.6 33.3 28.3 27.1 80.5 34.8 31.9 54.4 47.1 47.5 541.2 51.8 25.1 44.7 34.9 30.7 26.7 29.0 29.4 23.5 23.8 114.4 60.6 53.1 40.9 25.1 79.6 14.9 90.6 11.6 37.4 114.9 81.9 210.9 42.5 50.3 51.2 57.5 35.1 88.9 207.7 142.9 144.6 59.3 101.0 62.4 90.0 166.4 106.4 119.5 134.4 181.0 112.0 109.5 63.5 38.2 106.1 49.1 35.6 49.5 82.5 52.2 84.3 110.0 45.2 185.5 84.1 32.1 9.5 50.1 225.2 50.9 18.5 21.3 52.6 125.8 80.5 55.0 136.1 118.9 189.6 105.5 44.2 48.3 116.0 71.6 90.9 74.7 50.2 36.1 65.4 162.8 89.0 159.0 161.3 64.4 90.9 55.0 200.4 82.0 159.4 12.6 90.6 14.9 23.5 52.6 22.8 25.1 31.3 23.2 79.6 16.1 27.3 20.2 11.8 11.6 40.2 16.2 37.4 114.9 53.8 70.4 56.6 85.9 50.1 57.1 62.5 63.6 80.5 29.4 110.2 78.1 134.8 464.1 502.3 450.3 279.7 94.3 129.8 157.0 786.9 347.5 523.8 679.8 1147.1 307.8 224.6 361.4 70.0 528.2 1096.0 273.6 329.6 203.1 2.0 698.2 1005.9 270.8 71.2 307.3 1333.1 145.6 439.7 337.4 1878.3 130.3 624.4 887.7 231.5 252.1 165.5 510.0 122.9 245.6 32.6 84.3 340.0 481.5 163.0 247.6 730.1 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Group enriched" "Detected in many" 6 "Extravillous trophoblasts: 39.8;Spermatocytes: 108.0;Spermatogonia: 40.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.9 17.5 6.8 9.8 0.1 0.3 18.6 19.4 4.6 12.3 11.8 13.6 14.8 15.6 8.7 2.1 7.3 32.1 4.8 6.2 2.2 20.0 15.7 7.9 15.8 11.9 0.0 8.8 22.5 0.2 0.5 7.3 2.0 1.5 2.5 17.3 22.7 27.7 4.0 37.4 24.6 24.5 11.2 11.7 9.3 26.9 15.3 30.2 2.3 5.5 13.0 13.8 9.4 24.5 7.3 3.9 14.0 17.6 2.3 16.6 21.0 24.2 20.3 21.0 15.6 26.8 6.3 11.8 19.2 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 0.0 1.4 0.0 0.8 2.3 0.1 0.4 2.5 0.0 2.3 1.8 5.9 3.0 0.0 1.1 11.2 0.3 0.2 0.0 0.5 39.8 0.4 0.5 0.0 0.2 10.2 0.0 1.7 0.0 1.3 7.5 0.3 1.3 0.0 1.0 1.2 0.3 0.3 0.0 0.4 0.0 6.7 0.0 0.0 108.0 40.5 0.5 6.2 0.7 3.5 0.4 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;skin 1: 137.6;tongue: 129.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 295.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 2700000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 10.1 0.1 0.0 0.1 0.0 0.1 7.0 0.0 0.4 19.7 0.5 0.0 2.5 0.1 1.5 1.9 80.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.6 0.0 6.8 0.1 4.9 10.1 3.9 2.1 137.6 0.2 0.1 0.0 0.1 0.1 0.1 0.0 9.2 0.1 129.6 37.2 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 45.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.2 1.1 26.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 46.2 124.1 6.7 1.3 0.0 0.0 4.5 0.0 2.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 1.0 0.0 7.1 21.9 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 1.2 3.2 9.4 0.0 0.0 0.0 37.2 0.0 3.9 0.0 0.0 357.5 0.1 0.0 0.0 44.2 PKP2 ENSG00000057294 "Plakophilin 2" Q99959 12 32790745-32896840 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 134.7" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 399.9;Extravillous trophoblasts: 148.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 10.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 56.3;OE19: 20.4;SuSa: 45.7" "Region enriched" "Detected in many" 4 "hippocampal formation: 22.1" "Low region specificity" "Detected in all" "HPA014314, CAB037336, HPA056908" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272" "unprognostic (1.89e-1)" "unprognostic (1.70e-2)" "prognostic favorable (8.55e-4)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.79e-4)" "unprognostic (2.90e-1)" "unprognostic (1.83e-2)" "unprognostic (5.94e-3)" "unprognostic (2.22e-1)" "unprognostic (4.94e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (2.41e-2)" "unprognostic (3.76e-2)" 3.1 0.7 1.4 7.9 5.2 1.1 3.3 2.2 1.8 6.1 14.2 1.4 6.9 6.5 1.2 2.0 3.3 21.6 4.4 134.7 3.9 0.9 3.6 13.6 1.1 3.4 0.7 2.0 9.5 5.4 9.6 14.7 24.1 3.8 3.5 13.3 12.6 24.6 5.0 3.4 1.9 13.3 1.3 1.3 2.4 4.8 3.4 0.4 2.7 0.6 2.3 4.3 2.0 2.1 0.6 3.9 10.4 2.1 1.5 1.0 0.6 15.7 3.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 56.3 14.2 0.0 9.7 0.0 2.1 14.0 1.9 12.4 0.0 0.0 4.5 0.1 0.6 14.7 8.8 0.8 0.2 0.0 11.7 0.0 13.6 6.3 0.5 0.0 2.8 4.4 1.3 4.1 0.0 0.1 8.6 20.4 2.7 0.0 6.8 4.7 4.1 7.5 1.7 1.5 0.6 3.3 0.0 45.7 7.1 0.2 0.1 0.0 6.3 0.0 3.8 3.7 0.0 0.1 0.0 0.0 0.7 5.1 1.4 10.4 0.4 1.6 1.0 0.2 0.6 0.4 3.9 0.6 0.9 0.5 1.2 1.5 2.1 0.8 0.6 0.6 1.4 5.2 2.2 1.8 3.9 0.9 0.7 2.0 3.8 0.4 0.0 0.0 2.4 42.2 6.3 1.0 399.9 15.3 12.0 19.4 1.8 3.9 39.7 3.3 12.2 3.0 3.5 74.7 0.0 8.6 148.3 17.6 16.8 4.6 39.3 7.7 1.6 26.0 3.7 13.1 1.3 10.9 7.4 10.1 0.0 60.1 13.0 16.5 52.6 2.1 8.4 1.1 0.0 1.4 5.4 7.2 2.9 34.7 0.7 87.1 25.7 PKP3 ENSG00000184363 "Plakophilin 3" Q9Y446 11 392614-404908 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.0;skin 1: 48.4;tongue: 59.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 206.5;Extravillous trophoblasts: 144.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.6;NK-cell: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 2.3;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5" "Region enriched" "Detected in single" 37 "cerebellum: 10.0" "Low region specificity" "Detected in many" "CAB012993, HPA062937" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB012993: AB_2533221, HPA062937: AB_2684908" "unprognostic (4.74e-2)" "unprognostic (5.28e-2)" "unprognostic (4.45e-2)" "unprognostic (2.25e-2)" "unprognostic (1.58e-2)" "unprognostic (1.57e-1)" "unprognostic (8.88e-3)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.25e-1)" "unprognostic (6.73e-3)" "prognostic unfavorable (3.93e-4)" "unprognostic (3.55e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.16e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-1)" "unprognostic (3.15e-2)" 0.6 0.0 0.2 3.7 0.3 0.0 3.3 0.2 0.3 14.5 14.6 0.3 5.0 11.2 1.9 6.2 69.0 2.6 8.9 0.5 0.3 0.1 0.6 0.2 4.3 0.2 0.2 0.2 1.1 10.2 3.9 3.8 23.2 0.2 4.5 3.6 0.2 12.5 2.5 0.6 48.4 25.4 1.0 0.2 0.3 10.4 0.5 0.2 2.2 5.8 59.0 29.9 2.8 21.5 0.3 0.0 0.0 0.0 2.3 1.6 0.1 37.6 7.3 0.0 0.1 0.0 0.0 15.8 0.3 0.2 0.8 0.4 15.0 26.4 0.0 1.5 0.3 1.7 50.7 0.0 19.2 0.1 0.0 9.5 0.0 4.3 10.4 0.1 0.0 0.0 0.1 33.2 0.1 8.1 0.1 0.1 0.0 11.2 0.2 0.1 23.7 0.1 0.0 0.0 19.0 12.7 0.2 0.0 0.1 0.4 7.6 10.8 0.1 10.9 38.5 0.0 0.5 13.9 0.1 1.3 0.2 1.4 0.7 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.8 0.0 0.3 0.0 0.7 0.0 2.3 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.2 14.9 15.4 0.0 43.7 64.1 0.0 1.1 7.6 9.4 12.5 12.2 0.0 112.3 0.0 83.2 0.0 0.4 206.5 0.0 54.5 144.7 3.5 34.6 13.8 0.0 11.6 0.0 20.8 0.0 0.0 0.0 0.9 1.8 1.7 3.6 76.4 0.5 96.8 93.0 0.0 0.7 0.1 0.0 1.6 0.0 0.4 77.5 91.8 0.0 83.6 52.6 PKP4 p0071 ENSG00000144283 "Plakophilin 4" Q99569 2 158456964-158682879 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 111.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037334, HPA066647, HPA070648" Approved Enhanced "Plasma membrane,Cell Junctions" NA NA "Cell Junctions" "Plasma membrane" "CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291" "unprognostic (2.76e-1)" "unprognostic (5.26e-2)" "unprognostic (1.48e-2)" "prognostic favorable (5.80e-4)" "unprognostic (2.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (9.53e-2)" "unprognostic (1.82e-2)" "unprognostic (9.69e-2)" "prognostic favorable (3.29e-7)" "unprognostic (2.23e-1)" "unprognostic (9.80e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-3)" 7.3 3.9 42.7 3.7 42.1 4.2 15.5 14.5 26.6 19.8 7.1 49.9 6.9 7.1 8.3 8.9 10.7 11.8 8.9 12.1 47.7 31.2 34.2 9.7 7.3 3.0 66.9 14.7 8.3 8.7 12.2 6.6 3.4 28.4 7.8 8.1 10.4 19.3 13.1 4.0 9.4 6.4 8.5 111.7 3.2 7.7 5.6 31.6 3.3 18.2 2.4 5.5 9.1 6.9 0.1 0.7 1.0 5.3 0.0 2.1 0.5 16.7 9.3 12.9 14.6 5.9 6.5 12.3 14.0 7.5 21.1 18.3 31.3 15.9 10.7 10.4 16.2 7.7 13.6 16.6 13.9 35.3 16.1 8.5 10.1 10.5 25.5 10.0 16.0 2.2 2.8 13.5 14.5 22.1 12.8 10.6 13.8 13.7 17.1 16.0 18.5 7.0 6.8 13.7 23.4 7.1 9.3 19.2 9.2 31.1 12.1 22.4 4.0 9.7 14.6 11.4 12.4 17.3 14.7 4.9 12.6 14.2 9.3 17.5 9.8 8.2 7.9 7.4 8.8 12.2 0.0 1.0 0.0 0.4 0.3 0.7 0.0 1.5 0.6 0.4 0.1 1.2 0.4 1.0 0.0 5.3 0.7 2.1 0.5 42.7 42.1 14.5 26.6 47.7 31.2 66.9 14.7 28.4 31.6 38.7 17.6 4.9 19.0 24.0 32.4 44.7 50.9 33.5 34.2 45.4 27.5 0.3 19.9 20.4 10.2 56.2 10.3 23.3 15.9 0.3 10.4 28.3 9.3 23.7 2.6 4.8 8.6 20.3 8.1 7.0 10.0 6.7 6.8 1.8 17.6 8.1 14.4 10.5 15.9 25.9 18.6 12.9 13.4 10.7 5.9 26.6 0.2 3.5 19.5 18.6 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597842-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 14.0;Hepatocytes: 21.7;Peritubular cells: 13.4" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 5 "T-cells: 1.9" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" NA NA "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: AB_2684118" "unprognostic (1.35e-1)" "prognostic favorable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 2.5 0.4 3.8 1.5 4.7 0.2 1.8 1.4 2.5 2.5 1.3 1.7 47.8 0.6 3.2 63.1 0.8 2.7 1.3 5.0 3.6 4.3 9.3 17.2 13.7 6.1 6.0 1.0 0.5 1.8 11.4 1.0 4.4 7.0 6.0 1.2 10.7 1.5 123.8 10.3 0.3 1.9 4.2 7.4 0.5 2.2 2.0 2.5 0.4 5.0 0.4 3.7 2.1 1.3 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.7 0.3 0.5 0.1 0.0 0.2 0.0 0.0 23.9 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 3.8 4.7 1.4 2.5 3.6 4.3 6.0 1.0 7.0 2.5 0.0 1.7 0.0 0.3 0.6 0.0 1.2 2.5 2.7 1.2 14.0 0.0 0.1 1.7 2.7 5.2 8.7 0.0 0.0 1.9 0.0 0.6 0.3 1.1 21.7 1.6 0.0 1.7 4.9 0.3 2.2 0.3 5.3 1.7 7.2 0.0 0.0 2.2 0.0 13.4 4.9 0.0 0.0 0.3 0.0 0.2 0.5 1.6 0.0 0.0 0.3 PLA2G10 GXPLA2 ENSG00000069764 "Phospholipase A2 group X" O15496 16 14672545-14694669 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.4;stomach 1: 13.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 54.8;Exocrine glandular cells: 106.2;Extravillous trophoblasts: 45.9;Mucus-secreting cells: 110.3;Paneth cells: 80.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.6;CAPAN-2: 4.2;OE19: 4.6;SK-BR-3: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041893 Uncertain "Secreted in other tissues" NA NA "HPA041893: AB_10794495" "unprognostic (8.44e-3)" "unprognostic (2.37e-1)" "unprognostic (6.72e-2)" "prognostic favorable (5.74e-5)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (5.48e-2)" "unprognostic (6.76e-2)" "unprognostic (1.77e-2)" "unprognostic (2.72e-1)" "unprognostic (4.81e-2)" "unprognostic (2.39e-1)" "unprognostic (2.12e-1)" "unprognostic (4.08e-2)" "unprognostic (1.03e-1)" "unprognostic (2.30e-2)" "unprognostic (9.97e-3)" 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 9.4 2.4 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 13.0 2.1 0.0 0.0 2.8 0.0 0.9 0.5 2.0 0.5 0.1 0.4 0.1 0.1 0.9 0.1 0.1 0.0 0.1 2.6 0.1 0.0 0.0 0.0 0.6 4.2 0.3 0.4 0.0 0.1 2.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.0 0.1 0.8 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.7 0.0 1.9 0.3 0.2 0.4 4.6 0.1 0.8 0.3 0.2 0.0 0.3 0.6 0.5 1.0 2.6 0.3 0.3 0.4 0.4 0.8 0.0 0.3 0.1 0.0 0.7 2.1 0.7 0.6 0.1 0.1 0.1 0.5 0.5 0.3 0.4 0.3 0.1 0.2 0.4 0.5 0.9 0.3 0.3 2.0 0.1 0.3 0.3 0.1 0.1 32.8 17.2 0.0 0.7 0.0 0.0 0.0 10.2 32.1 9.1 1.8 0.0 0.4 0.0 0.3 0.3 0.0 54.8 0.0 106.2 45.9 0.0 1.9 0.0 0.0 0.8 0.0 12.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 110.3 0.0 15.5 80.4 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.5 0.0 23.8 12.6 PLA2G12B PLA2G13 ENSG00000138308 "Phospholipase A2 group XIIB" Q9BX93 10 72935170-72954778 "Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 47.8;liver: 42.8" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 47.8" "Cancer enriched" "Detected in many" 8 "liver cancer: 35.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "CACO-2: 12.1;Hep G2: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA057745, HPA059562" Approved "Secreted to blood" NA NA "HPA057745: AB_2683514, HPA059562: AB_2684064" "unprognostic (1.11e-2)" "unprognostic (2.66e-2)" "unprognostic (2.02e-3)" "unprognostic (3.41e-1)" "unprognostic (1.68e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 25.6 0.0 0.0 15.4 0.1 0.3 0.1 0.1 0.0 3.5 0.1 0.1 8.0 42.8 0.9 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.7 0.1 0.1 0.0 0.1 0.1 47.8 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 20.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 2.6 0.9 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.0 0.0 0.0 1.8 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.9 0.0 9.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PLA2G16 "AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754." ENSG00000176485 "Phospholipase A2 group XVI" P53816 11 63573195-63616883 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 113.6" "Cell type enhanced" "Detected in many" 9 "monocytes: 759.2;Proximal tubular cells: 471.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 52.4" "Group enriched" "Detected in many" 5 "dendritic cells: 52.4;T-cells: 16.0" "Cell line enhanced" "Detected in many" "A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011749, HPA058997" Uncertain Supported Mitochondria NA NA Mitochondria "HPA011749: , HPA058997: AB_2683874" "unprognostic (5.18e-2)" "unprognostic (3.67e-2)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-1)" "unprognostic (1.13e-1)" "unprognostic (3.06e-2)" "unprognostic (6.97e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (6.38e-2)" "unprognostic (1.93e-3)" "unprognostic (1.62e-1)" "unprognostic (1.75e-1)" "prognostic favorable (2.54e-5)" "unprognostic (2.35e-1)" 113.6 15.2 32.0 4.4 39.4 1.6 33.9 4.8 30.2 6.1 7.2 46.6 6.1 4.0 5.0 11.5 5.9 13.9 12.9 39.0 37.6 25.2 24.7 28.9 13.5 4.5 58.4 22.2 30.9 13.2 15.1 8.1 16.2 30.5 5.9 3.7 8.8 10.1 13.2 37.8 2.4 7.5 8.0 70.4 6.4 10.2 17.8 48.9 0.1 17.1 11.1 2.3 8.0 4.7 2.1 52.4 0.4 6.2 5.3 16.0 6.4 20.6 32.7 0.9 0.0 37.1 6.4 6.0 0.7 6.6 5.5 2.7 7.4 59.7 0.0 13.8 1.6 18.0 1.0 30.9 1.6 4.2 25.5 1.2 0.3 7.8 1.2 22.1 0.0 0.3 3.8 0.1 13.6 0.5 22.0 8.6 0.0 0.3 2.3 5.8 3.6 0.0 0.1 2.6 13.0 10.6 0.0 0.0 2.0 17.3 2.9 0.4 2.4 4.4 12.5 6.8 14.0 27.1 1.0 12.6 2.4 0.1 8.3 1.8 9.8 6.4 0.0 9.9 0.0 0.2 0.0 6.2 0.0 16.0 2.4 8.8 2.1 3.7 11.6 1.7 0.3 1.2 9.4 0.4 5.3 0.1 52.4 2.4 6.4 32.0 39.4 4.8 21.9 37.6 25.2 58.4 22.2 30.5 48.9 95.3 77.4 17.6 17.3 10.3 10.6 128.7 96.8 113.8 45.5 109.9 3.9 112.1 96.2 54.1 56.9 116.5 22.2 0.0 99.5 300.4 35.3 29.0 56.6 210.7 56.9 38.1 3.4 165.7 48.0 16.0 28.7 51.4 25.3 759.2 4.5 120.3 123.3 14.4 20.5 471.4 17.2 12.9 42.8 135.2 4.9 8.2 243.0 69.8 1.7 59.6 PLA2G1B "PLA2, PLA2A, PPLA2" ENSG00000170890 "Phospholipase A2 group IB" P04054 12 120322111-120327789 "Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 933 "pancreas: 2360.6" "Cell type enriched" "Detected in many" 10 "Exocrine glandular cells: 17927.2" "Cancer enriched" "Detected in many" 185 "pancreatic cancer: 763.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.5" "Group enriched" "Detected in many" 19 "NK-cells: 1.3;T-cells: 2.5" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;Hep G2: 6.4;U-2 OS: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047822, HPA060803" Enhanced "Secreted to digestive system" NA NA 3900000 "HPA047822: AB_2680169, HPA060803: AB_2684369" "unprognostic (1.28e-4)" "unprognostic (6.02e-2)" "unprognostic (1.84e-2)" "unprognostic (2.86e-2)" "unprognostic (2.74e-2)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (2.63e-2)" "unprognostic (3.61e-2)" "unprognostic (1.27e-1)" "unprognostic (1.03e-1)" "unprognostic (2.80e-4)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (3.60e-1)" "unprognostic (8.61e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 1.1 2360.6 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.3 2.5 0.9 0.2 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.5 0.0 0.3 1.3 0.3 1.6 0.0 0.0 0.3 0.0 0.1 0.6 0.0 1.0 0.2 4.7 0.6 0.6 0.0 1.2 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.3 0.0 0.0 2.5 0.9 0.0 1.3 0.0 0.0 0.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 11.9 65.5 0.0 0.1 0.0 0.0 0.3 0.0 1.4 1.2 0.0 0.0 0.0 1.7 16.1 7.5 0.0 0.7 0.0 17927.2 0.0 0.0 0.2 0.0 1.6 0.0 0.0 1.2 0.0 0.0 27.8 2.8 0.3 0.0 76.7 1.0 0.0 1839.8 1.1 3.2 2.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 1.2 0.0 PLA2G2A "PLA2B, PLA2L" ENSG00000188257 "Phospholipase A2 group IIA" P14555 1 19975431-19980416 "Enzymes, FDA approved drug targets, Predicted secreted proteins, RAS pathway related proteins" "Inflammatory response, Lipid metabolism, Phospholipid metabolism" "Antimicrobial, Bacteriolytic enzyme, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 377.9" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 366.3;Exocrine glandular cells: 945.9;Glandular cells: 937.5;Paneth cells: 354.3;Undifferentiated cells: 591.0" "Cancer enhanced" "Detected in all" "prostate cancer: 875.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "Hep G2: 23.4;OE19: 64.1;RT4: 21.5" "Not detected" "Not detected" HPA015236 Enhanced "Secreted to blood" NA NA 1000000 290000 "HPA015236: AB_10601047" "unprognostic (2.33e-2)" "unprognostic (1.28e-1)" "unprognostic (2.79e-2)" "unprognostic (7.85e-3)" "unprognostic (8.71e-2)" "unprognostic (9.27e-2)" "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "prognostic favorable (1.49e-4)" "unprognostic (1.68e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.77e-15)" "unprognostic (2.72e-2)" "unprognostic (9.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.51e-1)" 25.2 1.0 0.0 13.1 0.0 0.6 14.0 0.0 0.6 1.4 63.9 0.0 0.1 35.0 0.7 22.7 31.5 11.7 2.4 105.4 0.0 0.0 1.6 377.9 3.0 6.5 0.0 0.0 35.6 2.4 0.6 0.5 15.5 0.0 27.1 68.2 6.1 9.5 1.0 30.6 5.0 99.0 39.7 0.0 0.6 4.0 9.8 0.0 0.0 16.0 8.9 19.3 39.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.1 0.0 0.0 0.0 0.6 0.0 21.5 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 4.1 6.7 10.0 12.4 0.0 7.2 5.1 2.7 6.8 0.0 0.0 2.8 1.7 0.0 3.0 8.4 366.3 0.0 945.9 3.3 308.9 937.5 4.6 51.6 8.2 0.0 59.8 35.0 6.0 7.5 158.5 4.9 13.5 0.0 270.5 0.0 3.6 354.3 1.1 0.0 0.0 0.0 11.3 0.5 0.1 14.6 5.7 8.4 591.0 9.1 PLA2G2C ENSG00000187980 "Phospholipase A2 group IIC" Q5R387 1 20161253-20177424 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "esophagus: 4.2;intestine: 4.7" "Group enriched" "Detected in some" 4 "Early spermatids: 2.6;Late spermatids: 7.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HL-60: 4.5;NB-4: 1.4;SK-BR-3: 1.3;U-698: 5.0;U-937: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted - unknown location" NA NA "unprognostic (3.02e-3)" "unprognostic (2.75e-2)" "unprognostic (5.76e-2)" "unprognostic (3.00e-4)" "unprognostic (9.44e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "unprognostic (3.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.46e-1)" "unprognostic (1.22e-2)" "unprognostic (4.84e-2)" "unprognostic (1.67e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (8.16e-2)" 0.1 0.1 0.3 0.0 0.3 1.0 0.1 0.2 0.2 0.1 4.7 0.4 0.9 0.3 4.2 0.2 0.0 0.1 0.3 0.4 0.2 0.2 0.1 0.3 0.4 0.3 0.0 0.4 0.1 0.0 1.0 0.7 0.2 0.7 0.5 1.2 0.8 0.0 0.2 0.1 1.1 0.9 0.1 0.0 0.9 0.1 0.7 2.4 2.3 1.4 1.3 1.4 0.5 0.2 0.0 0.4 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.3 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.5 0.0 0.1 0.7 1.4 0.4 0.0 0.1 0.2 0.2 0.4 0.1 0.3 0.2 0.1 0.4 1.3 0.1 0.3 0.3 0.1 0.2 0.6 0.2 0.2 0.2 0.2 0.1 5.0 0.4 4.8 0.1 2.3 1.4 0.5 0.7 0.5 1.4 0.6 0.7 0.9 2.4 0.7 0.6 0.5 2.3 1.3 0.4 0.8 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 7.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PLA2G2D sPLA2S ENSG00000117215 "Phospholipase A2 group IID" Q9UNK4 1 20111939-20119566 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 39.9" "Group enriched" "Detected in some" 10 "Kupffer cells: 2.2;Melanocytes: 5.0" "Cancer enriched" "Detected in many" 6 "testis cancer: 25.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.6;naive B-cell: 5.6;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 5 "B-cells: 6.6;dendritic cells: 3.4" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 13.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Secreted - unknown location" NA NA "prognostic favorable (4.35e-4)" "prognostic favorable (8.15e-5)" "unprognostic (3.88e-3)" "prognostic favorable (9.74e-4)" "unprognostic (1.78e-1)" "unprognostic (2.56e-3)" "unprognostic (1.98e-1)" "unprognostic (1.60e-2)" "unprognostic (1.82e-5)" "unprognostic (7.51e-4)" "unprognostic (2.50e-2)" "unprognostic (1.22e-1)" "unprognostic (4.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (2.60e-1)" 0.4 0.3 0.3 38.8 0.3 0.0 0.4 0.3 0.3 0.3 0.9 0.0 0.0 0.3 0.3 0.2 0.4 0.5 0.4 0.3 0.3 0.3 0.4 0.4 1.0 39.9 0.3 0.0 0.3 0.3 0.0 0.3 0.2 0.0 0.4 1.2 0.1 5.0 0.3 0.3 0.3 7.7 0.0 0.3 18.1 0.6 0.3 0.0 6.6 0.7 0.5 33.0 2.5 0.3 6.6 3.4 1.0 0.2 0.3 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 13.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.3 0.2 2.1 0.1 0.2 0.1 0.1 0.0 1.0 0.2 0.2 0.1 0.1 0.1 6.6 0.1 0.1 0.1 5.6 0.1 0.1 0.4 0.3 0.1 3.4 0.0 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 PLA2G2E ENSG00000188784 "Phospholipase A2 group IIE" Q9NZK7 1 19920009-19923617 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Inflammatory response, Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "lymphoid tissue: 7.7;skin 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.9;CAPAN-2: 1.2;OE19: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA064085 Uncertain "Secreted - unknown location" NA NA "HPA064085: AB_2685188" "unprognostic (9.56e-2)" "unprognostic (3.71e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLA2G2F ENSG00000158786 "Phospholipase A2 group IIF" Q9BZM2 1 20139326-20150386 "Enzymes, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Innate immunity, Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.5" "Cancer enriched" "Detected in some" 18 "urothelial cancer: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 67 "RT4: 56.2" "Region enriched" "Detected in single" 4 "hippocampal formation: 3.3" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.79e-2)" "unprognostic (5.11e-2)" "unprognostic (4.63e-2)" "unprognostic (4.83e-2)" "unprognostic (1.51e-1)" "unprognostic (1.61e-2)" "unprognostic (3.36e-5)" "unprognostic (7.06e-2)" "unprognostic (1.84e-1)" "unprognostic (4.69e-1)" "prognostic favorable (3.86e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 7.7 0.0 0.0 0.0 0.0 0.0 13.7 0.1 6.5 0.0 0.0 0.3 0.1 0.0 2.8 0.0 6.3 11.1 19.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.7 PLA2G3 GIII-SPLA2 ENSG00000100078 "Phospholipase A2 group III" Q9NZ20 22 31134809-31140607 "Enzymes, Predicted secreted proteins, RAS pathway related proteins" "Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 13.1;skin 1: 14.1;tongue: 17.4" "Cell type enriched" "Detected in some" 7 "Suprabasal keratinocytes: 15.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 14.2;AN3-CA: 14.3;NTERA-2: 7.3;SCLC-21H: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021016 Uncertain "Secreted to blood" NA NA "HPA021016: AB_1855443" "unprognostic (1.80e-1)" "unprognostic (4.63e-3)" "unprognostic (1.07e-1)" "unprognostic (1.49e-2)" "unprognostic (9.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (1.74e-2)" "unprognostic (2.30e-1)" "unprognostic (4.25e-2)" "unprognostic (9.55e-3)" "unprognostic (4.41e-1)" "unprognostic (3.67e-1)" "unprognostic (3.29e-1)" "unprognostic (9.49e-3)" "unprognostic (3.72e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 2.0 0.4 0.9 5.3 0.1 0.1 1.9 0.5 0.3 0.1 13.1 0.0 0.1 0.1 0.6 0.0 0.3 0.1 4.2 0.1 0.1 0.4 0.1 0.1 1.7 0.1 0.1 3.1 0.4 0.0 0.8 1.8 0.5 0.3 14.1 0.1 0.1 0.1 0.1 0.9 0.3 0.1 0.4 0.8 17.4 3.5 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 14.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.9 0.6 0.0 0.1 0.4 3.1 0.1 0.0 2.2 0.0 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 15.6 0.0 0.0 0.0 0.4 PLA2G4A "cPLA2-alpha, PLA2G4" ENSG00000116711 "Phospholipase A2 group IVA" P47712 1 186828953-186988981 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 19.1;Peritubular cells: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2" "Group enriched" "Detected in many" 7 "dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4" "Cell line enhanced" "Detected in many" "HeLa: 23.0;OE19: 33.2;RPMI-8226: 28.5;U-2197: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010050, HPA050062, HPA054206" Approved Supported Vesicles,Cytosol NA NA 78000 Cytosol Vesicles "CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417" "prognostic favorable (9.07e-4)" "unprognostic (1.18e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.85e-4)" "unprognostic (5.55e-2)" "unprognostic (1.51e-3)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (2.63e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-1)" "unprognostic (1.68e-1)" "unprognostic (2.96e-2)" "unprognostic (8.07e-2)" "unprognostic (1.58e-1)" "unprognostic (1.90e-2)" "unprognostic (4.26e-2)" 6.0 8.6 3.4 3.5 5.3 2.2 3.8 1.5 4.7 8.5 10.9 2.9 52.6 5.4 7.7 7.4 7.0 12.3 4.2 6.6 3.3 2.5 6.7 1.1 4.9 5.2 6.5 1.4 5.1 3.8 63.5 2.7 2.9 5.6 10.9 4.2 2.9 5.8 56.1 0.6 6.1 10.3 14.6 7.5 4.2 5.1 2.7 5.3 0.4 2.7 5.9 2.3 19.4 9.4 0.0 7.8 7.7 8.4 1.1 0.2 1.5 0.0 15.8 0.0 0.0 9.9 4.0 0.0 0.6 6.1 0.7 1.3 0.1 6.2 0.0 0.0 0.0 2.8 1.1 9.9 2.9 0.3 4.8 0.2 2.9 23.0 0.0 6.1 4.3 1.5 2.2 2.0 7.9 1.6 1.0 6.6 1.3 6.4 2.3 0.0 0.0 0.0 0.0 0.8 33.2 2.1 0.0 0.0 28.5 0.0 2.1 0.0 0.0 2.3 0.8 2.8 0.3 0.3 5.8 1.3 5.9 0.8 27.0 1.2 0.9 0.0 0.0 2.1 12.8 8.3 0.1 7.1 7.7 0.0 8.4 0.2 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.6 1.1 3.9 3.2 0.0 1.5 3.4 5.3 1.5 4.7 3.3 2.5 6.5 1.4 5.6 5.3 0.0 0.6 0.0 2.8 19.1 0.0 0.8 0.0 1.4 1.2 0.0 0.0 0.1 1.7 1.6 0.7 6.0 1.3 0.0 0.0 0.0 4.3 1.7 10.4 0.0 5.5 0.0 1.2 1.3 8.8 0.6 9.8 6.0 5.0 1.0 1.7 0.0 1.1 2.8 13.8 0.1 0.2 0.0 3.4 0.5 0.1 7.9 0.0 0.0 2.9 10.5 PLA2G4B "cPLA2-beta, HsT16992" ENSG00000243708 "Phospholipase A2 group IVB" P0C869 15 41837775-41848147 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 36.0;skin 1: 32.8;tongue: 56.0" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.9;Club cells: 2.3;Rod photoreceptor cells: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in all" 4 "cerebellum: 10.8" "Cell type enhanced" "Detected in some" "NK-cell: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 11.0;T-47d: 5.9" NA NA "unprognostic (6.16e-2)" "unprognostic (6.48e-3)" "unprognostic (5.06e-3)" "unprognostic (1.27e-4)" "unprognostic (1.06e-1)" "unprognostic (2.56e-3)" "unprognostic (1.53e-1)" "unprognostic (2.27e-2)" "unprognostic (3.60e-2)" "unprognostic (1.90e-2)" "unprognostic (1.23e-2)" "unprognostic (5.14e-3)" "unprognostic (3.26e-5)" "unprognostic (4.36e-1)" "unprognostic (5.91e-2)" "unprognostic (1.22e-1)" "unprognostic (2.97e-2)" 1.8 1.2 1.8 1.8 2.2 3.4 3.6 10.8 2.1 6.1 1.8 1.8 1.8 1.9 2.7 2.3 19.3 2.0 1.9 1.8 1.8 2.5 2.5 2.6 2.2 3.3 1.8 1.8 4.2 3.5 1.4 3.2 1.8 1.8 4.8 1.1 1.8 7.0 2.7 1.8 32.8 2.4 1.8 1.8 3.0 1.8 1.8 1.8 2.2 4.8 56.0 36.0 2.0 5.9 3.0 0.5 0.2 0.8 3.9 1.5 0.1 1.3 0.7 0.0 0.0 0.1 0.0 3.7 0.4 1.2 1.3 0.1 0.3 0.7 0.3 0.1 0.7 0.1 4.4 1.5 0.5 0.3 0.0 2.5 1.1 1.4 3.4 1.7 0.2 1.4 0.9 4.9 0.2 1.3 0.1 0.6 1.9 1.7 0.2 0.4 2.1 1.0 4.1 1.0 5.5 1.2 0.0 1.2 0.9 1.0 11.0 0.2 1.1 0.0 2.0 1.0 0.9 5.9 1.8 0.0 0.0 1.0 1.0 0.1 3.4 0.0 0.9 0.3 5.0 0.0 0.0 0.8 0.0 1.5 0.5 0.9 0.1 0.4 0.8 0.5 3.0 0.9 0.8 0.2 3.9 0.2 0.5 1.2 0.1 1.8 2.2 10.8 2.1 1.8 2.5 1.8 1.8 1.8 1.8 0.0 1.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PLA2G4C cPLA2-gamma ENSG00000105499 "Phospholipase A2 group IVC" Q9UP65 19 48047843-48110817 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid metabolism, Phospholipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;skeletal muscle: 45.0" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 54.2;Cone photoreceptor cells: 62.8;Muller glia cells: 53.7;Rod photoreceptor cells: 133.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 8.2;HHSteC: 13.4;TIME: 18.6" "Not detected" "Not detected" HPA043083 Approved Approved Cytosol NA NA Cytosol "HPA043083: AB_10795714" "unprognostic (1.27e-1)" "unprognostic (3.88e-2)" "unprognostic (4.18e-2)" "unprognostic (2.82e-2)" "unprognostic (7.37e-2)" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (6.53e-2)" "unprognostic (8.30e-2)" "unprognostic (1.94e-1)" "unprognostic (5.11e-3)" "unprognostic (1.90e-1)" "unprognostic (4.66e-2)" "unprognostic (9.45e-2)" "unprognostic (2.28e-3)" "unprognostic (1.87e-1)" "unprognostic (9.01e-2)" 4.0 11.7 8.9 4.2 23.2 0.4 3.0 12.9 14.5 3.4 3.5 23.4 2.0 5.1 6.8 5.2 3.6 4.3 4.6 18.5 10.0 10.0 4.4 3.8 5.9 7.2 31.8 8.5 2.0 4.1 14.8 4.6 4.1 16.9 5.7 2.9 5.4 3.1 6.7 45.0 4.9 6.7 8.1 18.6 8.1 2.4 2.4 17.1 0.7 3.3 7.5 4.3 4.9 2.1 5.4 2.0 0.0 7.9 1.5 0.8 2.0 0.7 1.1 0.0 0.3 5.2 3.0 0.1 1.3 8.2 1.2 3.5 0.0 2.1 0.0 1.8 3.2 2.6 0.2 0.0 0.2 2.0 0.8 0.1 0.0 0.3 1.2 13.4 0.0 1.8 0.6 0.3 0.5 5.4 2.5 5.1 0.0 0.0 7.4 2.0 2.0 0.0 0.1 0.1 0.9 0.1 0.1 1.8 0.7 2.5 0.4 0.8 0.1 1.5 2.6 6.3 4.2 0.7 1.8 18.6 2.3 0.7 2.5 0.9 0.5 1.4 0.2 1.6 0.0 4.4 0.0 3.2 0.0 0.2 7.9 0.6 5.4 0.8 0.0 2.0 1.6 0.0 0.0 0.0 1.5 2.0 1.4 0.2 2.0 8.9 23.2 12.9 14.5 10.0 10.0 31.8 8.5 16.9 17.1 3.0 1.7 0.5 0.8 2.5 54.2 30.9 10.2 0.0 0.0 0.0 62.8 0.1 1.7 7.7 0.2 16.9 1.6 0.0 2.5 0.2 3.8 1.7 0.0 1.0 5.0 31.8 0.0 3.1 0.3 0.0 0.6 2.8 6.8 4.6 1.5 53.7 4.1 0.3 7.4 3.4 133.4 12.9 11.8 0.3 0.5 2.6 0.1 0.0 0.0 0.1 PLA2G4D cPLA2delta ENSG00000159337 "Phospholipase A2 group IVD" Q86XP0 15 42067009-42094554 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 2.0;Glandular cells: 2.2;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "RPMI-8226: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.16e-1)" "unprognostic (1.10e-2)" "unprognostic (2.91e-2)" "unprognostic (9.16e-3)" "unprognostic (9.33e-3)" "unprognostic (4.35e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-1)" "unprognostic (1.84e-1)" "unprognostic (1.28e-2)" "unprognostic (2.75e-1)" "unprognostic (2.64e-7)" "unprognostic (2.54e-2)" "unprognostic (2.34e-1)" "unprognostic (3.47e-2)" "unprognostic (4.32e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 35.6 0.1 0.1 0.1 0.0 1.4 0.3 1.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.1 22.4 0.0 0.1 0.6 0.1 0.1 13.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 11.6 1.2 0.6 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 19.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.8 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 3.0 0.0 0.0 0.0 0.3 PLA2G4E FLJ45651 ENSG00000188089 "Phospholipase A2 group IVE" Q3MJ16 15 41981582-42051190 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 19.9" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 2: 8.0;Basal keratinocytes: 16.1;Suprabasal keratinocytes: 39.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;HaCaT: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041105 Enhanced NA NA "HPA041105: AB_2677300" "unprognostic (2.98e-1)" "unprognostic (5.52e-1)" "unprognostic (2.60e-1)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.77e-1)" "unprognostic (4.22e-2)" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-7)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (4.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.2 16.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 39.3 0.0 0.0 0.0 0.5 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 30.4;skin 1: 48.1" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 14.1;RT4: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: AB_2683226" "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.1 0.1 0.0 2.5 0.3 0.3 1.8 0.0 0.1 4.5 11.0 0.0 4.7 4.2 0.4 9.7 10.4 0.2 3.1 1.0 0.0 0.0 10.8 0.2 30.4 0.1 0.0 0.0 0.1 0.1 0.7 4.1 0.3 0.0 3.3 2.5 0.0 5.3 2.8 8.6 48.1 12.3 1.1 0.1 0.2 1.6 0.1 0.0 6.2 1.6 14.9 3.4 2.2 6.3 0.6 0.3 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.1 0.0 14.1 0.1 0.0 0.0 0.1 0.0 10.6 0.6 0.1 0.0 1.1 0.0 0.1 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 54.9 0.0 3.3 4.8 0.0 3.2 0.0 0.0 0.0 5.2 0.0 1.5 3.3 0.2 0.0 0.0 12.0 0.0 1.2 0.7 0.2 2.7 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 4.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 1.0 0.0 4.3 1.6 PLA2G5 ENSG00000127472 "Phospholipase A2 group V" P39877 1 20028179-20091190 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.3;retina: 58.3" "Cell type enhanced" "Detected in some" 21 "Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7" "Group enriched" "Detected in many" 5 "glioma: 13.0;prostate cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 23 "dendritic cells: 2.3" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053361 Approved "Secreted - unknown location" NA NA "HPA053361: AB_2682127" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (5.68e-3)" "unprognostic (6.16e-2)" "unprognostic (2.01e-2)" "unprognostic (5.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.02e-1)" "unprognostic (2.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-3)" "unprognostic (6.00e-5)" "unprognostic (2.87e-2)" "unprognostic (3.00e-1)" "unprognostic (1.54e-1)" "unprognostic (4.97e-3)" 2.6 0.5 2.8 2.0 6.7 0.2 1.9 1.9 5.2 0.3 10.5 2.1 2.5 1.2 0.5 2.1 5.7 1.9 3.0 48.3 2.6 2.4 0.2 1.8 3.2 1.0 6.1 2.0 17.3 1.2 0.2 0.1 8.3 6.8 6.9 3.2 58.3 1.0 10.3 0.4 0.4 1.0 19.3 1.0 0.8 2.3 3.3 1.3 0.0 0.7 0.0 1.7 7.3 2.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 3.1 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 2.8 6.7 1.9 5.2 2.6 2.4 6.1 2.0 6.8 1.3 0.0 0.3 0.0 0.0 0.3 9.3 79.9 0.0 0.0 0.0 0.0 66.8 0.1 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 2.1 1.5 0.0 0.0 0.2 0.0 0.0 8.6 0.8 3.6 75.4 0.0 0.0 0.0 0.0 25.1 0.0 0.0 68.9 0.0 27.8 258.7 2.4 0.5 0.6 0.4 0.2 0.0 0.0 0.0 PLA2G7 "LDL-PLA2, PAFAH" ENSG00000146070 "Phospholipase A2 group VII" Q13093 6 46704201-46735693 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Asthma, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 57.0;lymphoid tissue: 32.9" "Cell type enriched" "Detected in some" 13 "Hofbauer cells: 332.5" "Cancer enhanced" "Detected in all" "prostate cancer: 37.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 24.2" "Group enriched" "Detected in many" 56 "dendritic cells: 7.9;monocytes: 24.2" "Cell line enhanced" "Detected in some" "GAMG: 2.2;NTERA-2: 3.9;PC-3: 7.9;RT4: 3.6;U-2 OS: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 7380000 170000000 "unprognostic (3.63e-3)" "unprognostic (2.82e-3)" "unprognostic (8.69e-2)" "unprognostic (3.00e-1)" "unprognostic (1.47e-1)" "unprognostic (6.26e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (1.43e-1)" "unprognostic (2.06e-2)" "unprognostic (5.33e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "unprognostic (9.20e-2)" "unprognostic (1.93e-1)" "unprognostic (7.08e-2)" 57.0 2.1 2.8 14.0 5.8 1.1 2.9 2.0 2.7 1.5 4.4 2.0 0.4 2.3 2.9 1.6 0.8 1.4 3.6 2.0 2.1 1.7 1.0 4.3 19.0 22.2 3.2 1.8 4.0 0.9 0.1 3.1 15.8 2.3 8.5 6.6 2.8 2.5 1.6 0.9 2.3 3.7 1.5 7.1 32.9 1.4 0.7 2.0 6.4 13.1 0.6 6.0 7.2 0.8 0.1 7.9 0.2 24.2 0.0 0.2 6.1 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 2.2 1.6 0.0 0.1 0.0 0.2 2.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 3.9 0.0 7.9 0.0 0.0 0.1 0.0 3.6 0.1 0.5 0.0 0.0 0.0 1.1 1.0 1.0 0.0 0.0 3.7 0.1 0.9 0.1 0.0 0.0 0.0 0.2 1.3 0.0 24.2 0.1 0.0 5.0 0.2 0.1 0.0 0.0 7.9 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 6.1 2.8 5.8 2.0 2.7 2.1 1.7 3.2 1.8 2.3 2.0 0.0 2.2 0.0 3.6 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.8 0.9 8.7 0.0 0.0 332.5 1.6 3.4 0.0 19.0 0.0 0.0 25.7 10.1 22.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 3.3 PLA2R1 "CLEC13C, PLA2-R, PLA2G1R, PLA2IR" ENSG00000153246 "Phospholipase A2 receptor 1" Q13018 2 159932006-160062610 "Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 46.1" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 31.4;Muller glia cells: 30.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB068217, CAB068218" Approved Approved Cytosol "Secreted to blood" NA NA 99000 Cytosol "CAB068217: AB_2665660, CAB068218: AB_2665661" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.39e-2)" "unprognostic (4.91e-3)" "unprognostic (6.01e-2)" "unprognostic (9.71e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.38e-3)" "unprognostic (4.30e-3)" "unprognostic (2.82e-1)" "unprognostic (2.14e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.62e-1)" "unprognostic (6.58e-2)" "unprognostic (2.02e-1)" 4.6 2.1 0.6 2.3 1.1 0.0 9.4 19.5 1.9 11.3 7.0 1.0 2.4 2.4 17.8 4.7 4.7 4.8 6.9 2.7 0.7 1.0 15.0 0.9 2.3 1.8 0.8 0.7 8.7 0.8 14.5 2.6 6.6 3.3 3.3 2.0 7.8 46.1 2.0 0.8 9.6 9.4 5.7 2.5 3.0 1.6 1.3 0.2 0.3 27.6 6.6 5.1 4.5 9.4 0.6 0.6 2.3 0.8 1.0 0.6 0.2 0.1 1.0 0.3 0.0 9.2 12.5 0.0 4.1 9.9 0.8 1.1 0.0 2.1 0.0 0.2 4.3 0.9 2.0 0.0 3.0 0.8 0.0 0.0 0.0 6.9 0.0 0.7 0.0 0.0 5.0 3.3 1.2 1.3 16.5 5.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 7.2 1.3 0.0 1.1 1.6 0.1 28.7 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.5 0.5 0.5 0.6 0.5 0.4 0.3 0.3 0.6 0.6 0.6 2.3 1.0 0.8 0.6 0.4 0.2 0.6 1.1 19.5 1.9 0.7 1.0 0.8 0.7 3.3 0.2 6.0 3.2 0.0 2.2 8.4 0.8 3.6 5.1 6.7 2.3 31.4 0.0 4.3 0.0 0.7 0.0 3.6 2.6 0.0 1.8 1.1 6.7 2.3 1.1 0.0 0.5 15.9 1.2 8.0 0.0 0.9 15.0 0.0 6.8 0.0 6.1 30.3 3.2 5.8 15.6 1.1 1.1 6.5 2.2 0.0 0.6 4.6 1.3 0.0 6.5 2.2 PLAC1 "CT92, OOSP2L" ENSG00000170965 "Placenta specific 1" Q9HBJ0 X 134565838-134764322 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 90.4" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 5.2;Peritubular cells: 7.4;Spermatogonia: 2.7;Syncytiotrophoblasts: 8.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 18.7;hTCEpi: 14.7;hTERT-HME1: 6.0" "Not detected" "Not detected" HPA063425 Enhanced "Secreted in female reproductive system" NA NA "HPA063425: AB_2685012" "unprognostic (2.93e-1)" "unprognostic (2.50e-3)" "unprognostic (2.89e-4)" "unprognostic (1.35e-7)" "unprognostic (3.83e-3)" "unprognostic (2.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.26e-1)" "unprognostic (2.01e-1)" "unprognostic (4.28e-2)" "unprognostic (1.48e-2)" "unprognostic (2.87e-2)" "unprognostic (3.33e-16)" "unprognostic (7.64e-3)" "unprognostic (4.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.1 90.4 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.1 0.0 0.2 1.1 0.3 0.3 1.0 0.0 1.7 0.2 0.1 1.7 0.3 0.4 18.7 0.0 0.1 0.2 2.3 0.0 0.0 0.8 14.7 0.1 6.0 0.1 2.2 0.1 0.1 1.6 0.1 0.9 0.0 0.2 0.0 1.2 2.4 0.0 0.3 3.2 0.0 0.0 2.9 0.0 0.0 3.5 0.6 2.2 0.1 0.0 0.0 0.4 0.7 0.2 0.0 0.4 0.0 0.3 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.0 0.0 0.9 2.7 0.0 8.9 0.0 0.0 0.0 PLAC8 "C15, onzin" ENSG00000145287 "Placenta specific 8" Q9NZF1 4 83090048-83137075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8" "Cell type enhanced" "Detected in many" 8 "B-cells: 305.1;Ciliated cells: 487.2;Enterocytes: 398.3;Extravillous trophoblasts: 527.8;Kupffer cells: 319.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 181.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 32.2;CAPAN-2: 93.1;HL-60: 57.7;NB-4: 28.4;RPMI-8226: 41.6;THP-1: 33.5;U-937: 26.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040465, HPA077912" Enhanced Approved Cytosol NA NA Cytosol "HPA040465: AB_10794875, HPA077912: AB_2686870" "unprognostic (6.82e-5)" "prognostic favorable (3.03e-4)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.05e-1)" "unprognostic (4.86e-2)" "unprognostic (1.14e-1)" "unprognostic (1.94e-3)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (7.44e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-7)" "unprognostic (3.89e-2)" "unprognostic (2.85e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" 2.3 1.3 1.7 47.9 5.9 62.0 1.6 0.7 4.1 6.1 44.1 0.6 0.2 14.6 1.0 0.9 34.5 3.1 7.5 2.4 1.4 1.9 1.6 12.4 23.4 51.6 2.5 0.2 1.9 1.2 0.0 1.3 32.3 3.0 2.0 31.4 1.3 9.7 1.0 0.8 0.7 66.5 3.1 5.2 74.8 21.8 0.7 2.7 18.2 1.5 1.4 53.1 3.4 2.5 41.5 181.6 7.0 47.8 77.6 32.9 36.0 32.2 0.2 0.1 0.2 0.0 0.0 5.3 0.8 0.2 2.0 2.5 0.6 93.1 5.4 0.2 9.4 3.2 3.4 0.5 0.2 7.7 0.0 0.1 0.1 6.4 2.7 0.3 57.7 0.3 0.1 0.6 0.3 0.4 0.0 0.1 2.8 0.0 0.4 5.3 0.1 10.9 28.4 0.2 2.5 0.1 1.4 1.9 41.6 0.1 0.9 4.7 0.0 0.2 5.4 0.1 1.7 0.3 33.5 0.2 0.2 6.0 0.1 0.1 0.3 0.0 14.4 0.4 26.6 0.0 2.7 11.0 7.0 32.9 47.8 24.9 41.5 15.7 18.7 10.0 38.4 19.4 22.0 2.4 77.6 25.8 181.6 1.0 36.0 1.7 5.9 0.7 4.1 1.4 1.9 2.5 0.2 3.0 2.7 181.7 50.7 305.1 1.9 0.3 0.0 0.4 2.5 487.2 61.4 0.0 0.0 7.9 0.0 0.0 0.2 1.4 398.3 0.0 3.3 527.8 0.9 0.9 25.5 1.5 20.9 1.6 83.1 171.9 319.5 0.4 0.0 79.4 6.8 1.0 179.6 1.3 57.7 270.0 0.0 0.8 0.1 6.5 0.3 0.2 0.1 0.1 11.9 261.7 36.3 8.4 PLAC8L1 ENSG00000173261 "PLAC8 like 1" A1L4L8 5 146084386-146104369 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 20.4" "Group enriched" "Detected in some" 78 "Early spermatids: 401.3;Late spermatids: 218.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074266 Approved Nucleoplasm NA NA Nucleoplasm "HPA074266: AB_2686676" "unprognostic (6.38e-3)" "unprognostic (1.90e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (4.13e-2)" "unprognostic (3.79e-1)" "unprognostic (6.45e-2)" "unprognostic (5.05e-2)" "unprognostic (1.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.21e-6)" "unprognostic (9.72e-2)" "unprognostic (1.79e-1)" "unprognostic (1.89e-1)" "unprognostic (4.18e-2)" 0.4 0.1 0.9 0.4 1.0 0.1 1.0 1.6 0.8 0.4 0.4 0.4 0.4 0.0 0.5 0.5 0.4 0.6 0.4 0.4 1.0 1.0 0.4 0.5 0.4 0.4 1.1 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.4 0.9 3.1 0.6 0.5 1.9 0.4 0.1 20.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.2 1.3 0.0 0.0 0.0 0.5 0.0 0.9 2.7 2.6 9.8 0.7 1.1 0.6 1.0 0.4 4.2 2.7 0.4 1.2 1.5 2.2 1.1 0.9 0.7 4.0 0.0 3.5 3.2 5.6 2.2 0.9 1.1 0.5 0.9 1.8 0.0 6.3 3.2 2.5 0.5 1.5 3.3 0.2 2.0 1.1 0.0 0.9 2.9 0.5 0.3 3.8 0.9 0.5 0.0 0.3 0.0 2.4 1.2 1.1 0.4 2.3 0.8 0.2 0.9 1.1 0.0 3.7 1.1 1.9 1.2 3.2 1.3 0.8 1.6 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.9 1.0 1.6 0.8 1.0 1.0 1.1 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 401.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 0.6 0.0 218.3 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.4 0.0 0.2 3.2 1.5 0.0 0.1 0.0 0.1 0.0 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 95.0" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 117.4;Leydig cells: 128.3;Peritubular cells: 91.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 35.7;ASC TERT1: 29.1;RH-30: 36.3" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" No No "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: AB_2682893" "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.94e-6)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 14.6 28.5 2.3 14.8 4.3 7.7 12.3 2.0 7.6 12.9 8.9 4.6 10.0 3.9 19.5 16.3 12.4 7.7 13.0 9.0 5.1 1.5 6.8 1.5 12.1 8.2 2.6 2.2 16.0 11.2 5.2 45.6 95.0 3.6 12.6 8.6 19.3 11.7 7.3 4.5 23.1 7.9 16.8 3.8 6.8 10.9 6.8 2.0 3.9 5.6 24.2 12.0 14.2 18.4 4.1 10.3 16.4 8.1 1.7 1.4 2.3 0.0 1.6 35.7 0.0 14.1 29.1 0.1 12.2 7.9 6.1 12.7 0.1 1.9 0.8 6.1 10.6 1.6 0.0 0.2 4.3 12.0 0.9 1.6 15.1 17.8 0.2 4.7 13.5 3.0 21.9 1.6 5.3 4.7 7.9 12.0 5.6 1.5 0.2 7.2 2.1 5.6 6.3 5.9 0.0 1.1 6.8 36.3 0.0 11.4 0.3 3.2 3.5 17.6 0.0 0.0 11.3 0.0 16.8 6.9 0.0 13.0 28.2 13.2 3.1 3.0 0.1 9.4 5.6 0.7 3.4 8.1 16.4 1.0 6.2 1.0 2.7 0.9 1.4 10.3 4.1 0.7 1.2 14.8 1.7 1.9 4.6 1.3 2.3 2.3 4.3 2.0 7.6 5.1 1.5 2.6 2.2 3.6 2.0 47.6 38.2 8.2 12.9 19.3 2.0 6.5 2.5 6.7 18.2 5.2 0.0 4.5 6.6 10.3 1.6 12.8 9.3 0.0 9.8 10.9 117.4 33.9 18.4 0.0 18.0 7.9 16.0 9.2 25.4 1.7 128.3 19.1 8.5 37.9 27.2 1.0 10.6 22.4 91.2 11.6 0.4 12.9 27.6 0.7 0.6 37.9 8.2 5.7 24.3 13.2 PLAT ENSG00000104368 "Plasminogen activator, tissue type" P00750 8 42175233-42207724 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 132.2" "Cell type enhanced" "Detected in many" 22 "Basal glandular cells: 379.6;Glandular cells: 176.4;granulocytes: 158.4;Urothelial cells: 792.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.1;T-reg: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 1.6;T-cells: 2.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 85.9;HMC-1: 55.1;hTERT-RPE1: 61.0;LHCN-M2: 55.7;U-2197: 58.1;WM-115: 115.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003412, CAB009335" Supported Approved "Actin filaments" "Secreted to blood" NA NA 9900000 12000 "Actin filaments" "CAB009335: AB_2237146, HPA003412: AB_1858205" "prognostic favorable (7.57e-4)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (3.39e-1)" "unprognostic (4.88e-3)" "unprognostic (9.39e-2)" "unprognostic (4.65e-3)" "unprognostic (5.78e-2)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.98e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (8.72e-3)" "unprognostic (1.37e-2)" "unprognostic (2.63e-2)" "unprognostic (6.09e-2)" 19.3 14.9 5.2 12.9 6.8 0.4 13.3 2.2 6.2 24.5 17.1 9.1 19.0 11.2 35.5 28.1 18.1 19.1 18.5 7.3 6.0 5.9 67.6 2.8 15.9 1.9 8.2 3.6 18.4 5.8 132.2 5.1 15.5 9.4 27.4 12.2 39.4 6.1 12.7 5.8 2.0 31.7 23.0 7.0 1.0 14.6 12.2 3.8 0.6 11.2 14.7 7.4 47.9 13.7 0.3 0.1 1.6 0.0 0.0 2.3 0.3 0.5 0.2 4.2 1.0 7.7 10.5 0.1 18.1 32.0 7.7 6.6 0.2 85.9 0.0 0.6 2.3 3.7 1.4 0.0 4.0 15.9 7.9 1.4 0.1 0.1 0.1 37.9 0.0 55.1 10.5 0.0 18.8 0.7 61.0 14.4 0.0 0.5 0.1 55.7 0.0 0.0 0.0 5.6 0.0 7.6 0.0 15.6 0.0 2.5 0.0 0.0 0.9 0.0 0.1 24.6 8.2 0.1 0.0 27.5 1.5 5.7 58.1 1.8 0.0 0.1 0.0 1.2 0.0 115.5 1.6 0.0 0.0 0.3 0.0 1.0 0.3 2.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 2.3 0.3 5.2 6.8 2.2 6.2 6.0 5.9 8.2 3.6 9.4 3.8 0.0 20.2 2.4 379.6 9.6 4.1 7.6 0.0 5.3 11.4 0.0 3.9 0.5 0.0 0.6 0.8 82.6 0.0 0.0 0.6 1.1 19.9 176.4 158.4 1.0 1.5 1.6 0.0 36.8 0.6 0.8 3.4 7.8 21.9 2.8 0.0 2.0 30.5 0.0 2.5 0.1 3.7 12.9 17.6 0.7 0.4 11.8 0.6 3.8 0.4 792.4 PLAU "UPA, URK" ENSG00000122861 "Plasminogen activator, urokinase" P00749 10 73909177-73917497 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 48.4" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 550.8;Pancreatic endocrine cells: 366.2;Urothelial cells: 779.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 2.4;neutrophil: 4.5;plasmacytoid DC: 4.5" "Group enriched" "Detected in many" 11 "dendritic cells: 4.5;granulocytes: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 70.3;LHCN-M2: 67.8;RPTEC TERT1: 257.8;U-251 MG: 69.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070796 Supported "Secreted to blood" NA NA 647000 58000 "HPA070796: " "unprognostic (1.96e-2)" "unprognostic (2.99e-2)" "unprognostic (7.40e-2)" "prognostic favorable (3.38e-4)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.39e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.26e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.83e-1)" "unprognostic (3.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.77e-2)" 26.7 2.4 1.0 15.5 2.1 11.3 9.7 1.6 1.5 6.9 5.8 2.9 4.9 3.8 10.7 21.2 9.1 6.5 10.7 14.3 1.3 1.0 23.3 2.3 23.4 5.5 1.6 1.5 6.8 3.7 3.6 1.8 48.4 3.1 7.5 6.7 4.5 10.6 5.0 12.2 9.0 8.1 8.4 2.5 23.8 7.8 5.8 1.3 4.8 10.9 11.6 8.2 16.3 9.3 0.1 4.5 4.5 0.4 0.0 0.0 0.3 13.3 7.1 3.0 0.1 0.2 5.1 0.1 8.1 37.9 3.3 5.2 0.1 70.3 0.0 15.0 1.1 35.0 9.2 0.0 13.5 3.8 0.7 0.0 0.0 0.3 0.1 6.2 1.2 2.6 13.5 1.6 22.6 8.7 37.6 9.4 0.0 0.0 0.0 67.8 0.0 0.0 1.7 0.8 0.0 18.7 0.0 9.2 0.0 257.8 10.5 0.0 0.0 0.0 0.3 0.2 2.2 0.0 1.8 23.8 0.2 1.7 1.7 69.2 0.0 0.1 0.1 18.2 2.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 4.5 0.0 0.0 4.5 0.0 0.3 1.0 2.1 1.6 1.5 1.3 1.0 1.6 1.5 3.1 1.3 3.0 5.8 0.5 550.8 33.2 0.0 2.4 0.0 1.4 10.3 27.9 0.0 17.1 58.0 65.4 0.5 11.7 0.0 0.0 18.1 16.5 18.1 169.7 31.1 0.0 38.5 0.0 3.4 6.2 3.9 0.0 2.3 31.5 6.8 41.5 0.0 0.0 366.2 0.0 0.0 0.7 0.0 6.5 25.9 0.0 0.1 25.7 14.6 0.5 0.9 779.6 PLAUR "CD87, UPAR, URKR" ENSG00000011422 "Plasminogen activator, urokinase receptor" Q03405 19 43646095-43670547 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 118.0;bone marrow: 165.0" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 664.4;Macrophages: 801.6;Urothelial cells: 2343.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 118.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 50.2;U-251 MG: 71.3;U-87 MG: 62.2;WM-115: 60.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050843, CAB073533" Uncertain Supported "Plasma membrane" "Intracellular and membrane" NA NA 760000 "Plasma membrane" "CAB073533: , HPA050843: AB_2681255" "unprognostic (9.28e-2)" "unprognostic (9.65e-3)" "unprognostic (1.39e-1)" "unprognostic (1.29e-3)" "unprognostic (3.59e-3)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "prognostic unfavorable (2.33e-5)" "unprognostic (8.08e-3)" "unprognostic (4.30e-2)" "unprognostic (2.29e-3)" "unprognostic (5.30e-2)" "prognostic unfavorable (7.83e-9)" "unprognostic (4.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.45e-2)" "unprognostic (9.33e-2)" 25.2 3.6 3.0 23.6 4.8 165.0 6.3 2.2 6.1 10.7 7.5 4.4 1.8 3.3 9.5 6.0 8.6 10.6 23.0 11.5 4.5 3.2 5.1 6.1 39.4 8.1 6.0 1.1 11.9 4.3 2.5 4.4 12.2 6.9 6.1 6.0 4.6 11.0 3.7 7.9 3.5 7.3 7.2 7.1 12.6 12.0 6.3 6.3 2.5 4.4 7.7 7.0 22.7 14.9 0.2 21.3 118.0 50.5 0.6 0.9 21.0 14.3 5.0 4.5 0.3 4.1 14.6 2.8 30.0 30.5 19.0 23.8 0.4 16.9 0.5 7.6 18.5 11.0 6.1 1.2 7.4 21.2 0.9 0.9 2.7 7.5 0.6 5.2 3.2 34.9 15.0 1.5 50.2 7.5 27.8 20.9 3.3 2.7 0.6 18.2 1.0 3.4 8.6 1.5 25.7 10.8 4.0 3.0 1.0 5.9 0.7 0.2 3.9 13.4 3.1 3.9 2.3 0.6 10.0 21.4 41.9 21.5 19.1 71.3 0.6 1.4 0.1 62.2 5.8 60.6 7.2 48.9 72.4 0.7 41.5 0.8 0.2 0.9 0.6 21.3 0.1 0.3 0.4 118.0 0.6 50.5 6.8 0.3 21.0 3.0 4.8 2.2 6.1 4.5 3.2 6.0 1.1 6.9 6.3 68.5 114.1 4.7 664.4 93.4 0.4 3.5 15.3 20.1 44.3 19.2 0.0 4.1 1.7 219.5 0.8 49.2 68.8 0.0 94.2 28.2 110.9 445.0 294.8 1.3 440.8 9.5 14.3 18.4 142.0 0.9 6.4 801.6 69.2 13.6 15.1 1.2 350.1 4.9 3.9 2.4 0.6 6.5 151.4 0.9 3.2 55.2 11.0 9.6 5.0 2343.3 PLB1 "FLJ30866, PLB" ENSG00000163803 "Phospholipase B1" Q6P1J6 2 28457145-28643788 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 66.7" "Group enriched" "Detected in many" 7 "Early spermatids: 22.5;Extravillous trophoblasts: 20.1;granulocytes: 5.7;Hofbauer cells: 10.2;Kupffer cells: 12.3;Late spermatids: 11.8;Macrophages: 8.7;Syncytiotrophoblasts: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 14 "classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2" "Group enriched" "Detected in many" 40 "dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2" "Cell line enhanced" "Detected in some" "BEWO: 5.8;OE19: 12.0;RT4: 4.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" NA NA "unprognostic (2.18e-2)" "unprognostic (2.49e-1)" "unprognostic (6.58e-2)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (4.91e-3)" "unprognostic (4.74e-2)" "unprognostic (4.48e-2)" "unprognostic (2.03e-2)" "unprognostic (1.53e-1)" "unprognostic (2.17e-1)" "unprognostic (2.61e-9)" "unprognostic (2.48e-2)" "unprognostic (2.19e-2)" "unprognostic (4.99e-2)" "unprognostic (8.03e-2)" 0.9 3.3 0.7 1.0 2.1 2.9 1.0 0.6 0.7 0.9 0.8 0.6 0.6 0.2 0.8 1.7 1.3 0.7 0.9 1.4 0.6 0.9 0.8 0.6 0.7 0.6 0.8 0.6 0.6 0.6 0.0 0.7 1.3 0.7 1.0 1.1 0.7 0.6 0.9 0.9 5.2 66.7 1.7 0.8 2.8 0.5 1.2 0.6 0.6 1.2 0.9 0.6 0.9 0.6 0.0 6.4 9.9 5.2 0.0 0.1 1.1 0.6 0.1 3.8 0.1 0.8 0.6 5.8 0.1 1.5 0.4 0.3 3.8 0.4 0.4 0.4 0.6 1.7 0.8 0.0 3.1 0.3 0.2 0.0 0.3 0.6 0.7 1.3 0.7 0.3 0.6 1.8 0.6 1.0 0.7 1.0 0.0 0.0 0.1 1.1 0.0 0.0 0.5 0.1 12.0 0.8 0.0 0.6 0.0 1.7 4.3 1.7 0.3 0.1 0.2 0.3 0.3 0.0 2.0 0.4 0.4 1.1 0.2 0.2 0.8 0.2 0.0 1.3 2.9 0.1 0.0 3.1 3.3 0.0 4.9 0.0 0.0 0.1 0.0 6.4 0.0 0.0 0.0 9.9 0.0 5.2 0.3 0.1 1.1 0.7 2.1 0.6 0.7 0.6 0.9 0.8 0.6 0.7 0.6 0.0 1.1 0.0 0.8 0.3 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.4 1.7 0.9 22.5 0.3 1.7 0.0 0.8 20.1 0.5 0.3 5.7 0.0 10.2 0.0 1.2 0.6 12.3 11.8 1.1 8.7 0.0 0.0 1.1 0.6 0.9 0.2 0.7 0.0 0.0 0.0 0.0 0.9 0.2 0.4 6.9 0.5 0.3 1.4 PLBD1 FLJ22662 ENSG00000121316 "Phospholipase B domain containing 1" Q6P4A8 12 14503661-14568349 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 76.8;bone marrow: 54.7;pancreas: 51.9" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 142.5;Hofbauer cells: 102.1;Kupffer cells: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 76.8;intermediate monocyte: 24.0;myeloid DC: 43.0;neutrophil: 53.2" "Group enriched" "Detected in many" 148 "dendritic cells: 43.0;granulocytes: 53.2;monocytes: 76.8" "Cell line enhanced" "Detected in some" "AN3-CA: 11.8;BEWO: 25.8;CAPAN-2: 66.8;MCF7: 11.1" "Not detected" "Not detected" HPA040303 Enhanced "Intracellular and membrane" NA NA "HPA040303: AB_2676922" "unprognostic (9.13e-3)" "unprognostic (5.77e-2)" "unprognostic (2.29e-1)" "unprognostic (7.87e-2)" "unprognostic (1.71e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (4.80e-2)" "unprognostic (1.85e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.12e-1)" "unprognostic (3.03e-3)" "unprognostic (3.47e-1)" "unprognostic (1.97e-1)" "unprognostic (4.99e-2)" "unprognostic (5.44e-2)" 9.6 1.2 2.0 6.3 2.5 54.7 12.4 1.2 1.8 8.4 10.7 2.2 5.7 5.4 5.5 3.4 22.0 5.0 7.6 11.8 1.0 0.5 8.8 6.0 11.9 7.2 2.4 1.6 4.7 51.9 0.4 1.7 10.9 4.7 4.8 14.5 4.8 6.1 3.5 6.6 10.8 9.1 4.7 2.4 13.5 6.7 11.3 2.0 1.9 3.2 5.0 5.1 15.5 14.2 0.3 43.0 53.2 76.8 0.2 0.1 38.5 1.7 1.1 0.1 11.8 0.0 0.0 25.8 0.0 0.0 0.7 0.6 3.4 66.8 0.0 0.4 0.3 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 1.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.3 11.1 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.1 0.1 7.0 0.0 0.1 8.8 3.7 0.6 6.8 2.4 2.3 0.0 0.1 0.1 0.0 0.1 2.2 6.6 0.0 0.0 0.0 0.1 0.0 76.8 0.6 0.1 24.0 0.0 0.3 0.0 0.0 43.0 0.1 0.0 0.0 53.2 0.2 8.0 0.5 0.1 38.5 2.0 2.5 1.2 1.8 1.0 0.5 2.4 1.6 4.7 2.0 8.9 11.3 3.7 6.3 6.1 0.0 14.2 22.9 13.4 7.9 31.4 0.0 80.6 10.0 11.6 23.8 7.1 36.4 0.0 41.7 142.5 27.8 2.6 4.7 1.7 102.1 0.0 8.7 4.9 116.3 3.1 24.2 96.9 5.0 28.9 29.4 1.3 26.8 70.2 26.2 13.5 0.1 0.0 4.1 3.8 10.0 17.3 58.8 0.7 65.0 23.0 PLBD2 p76 ENSG00000151176 "Phospholipase B domain containing 2" Q8NHP8 12 113358566-113391625 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 71.7" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 110.2;Late spermatids: 268.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017163 Approved "Intracellular and membrane" NA NA 890000 "HPA017163: AB_1853029" "unprognostic (8.28e-2)" "unprognostic (1.97e-1)" "unprognostic (1.50e-2)" "unprognostic (4.13e-1)" "unprognostic (2.36e-3)" "unprognostic (7.59e-3)" "unprognostic (5.92e-3)" "unprognostic (2.39e-2)" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.58e-11)" "unprognostic (7.55e-3)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" 20.5 71.7 9.8 10.3 15.6 5.1 15.3 10.3 23.0 14.6 7.6 17.1 5.3 5.3 11.5 17.6 7.7 9.6 13.2 20.1 8.7 14.5 8.8 19.8 11.0 10.3 13.6 11.0 33.1 16.1 12.6 28.4 8.2 28.8 12.2 8.7 11.7 9.9 11.1 14.9 12.2 6.1 17.5 12.7 8.8 7.7 33.2 10.7 2.0 10.1 7.1 6.9 13.0 8.3 0.9 6.6 0.7 6.2 1.6 3.1 2.9 5.1 9.5 4.1 15.7 68.0 38.1 5.6 10.9 21.8 7.7 9.7 8.1 3.1 2.4 9.1 29.7 12.7 5.6 3.9 6.5 8.7 4.8 2.8 4.2 5.9 9.6 21.3 5.0 13.1 32.0 8.6 9.3 5.6 23.8 12.0 2.2 12.6 5.9 11.9 8.8 0.9 5.4 4.5 4.2 4.2 4.0 4.3 6.4 9.1 7.2 4.2 4.1 15.1 11.9 6.6 7.5 7.8 4.9 19.2 18.4 7.1 18.4 6.3 3.0 5.4 3.0 30.6 4.3 10.7 0.1 6.2 0.4 2.5 4.0 2.2 0.9 2.9 3.1 6.6 0.9 2.2 2.8 0.7 1.6 2.9 2.5 1.5 2.9 9.8 15.6 10.3 23.0 8.7 14.5 13.6 11.0 28.8 10.7 8.9 8.3 5.6 3.8 4.7 9.4 8.9 5.1 4.0 1.2 1.8 5.9 3.9 0.0 16.9 110.2 5.6 4.7 0.0 12.1 9.5 10.6 6.9 10.3 13.4 29.6 19.1 5.1 6.2 21.6 268.4 37.4 14.3 20.3 56.9 3.5 4.3 11.6 2.9 45.3 4.3 4.8 6.5 8.2 8.3 7.2 1.6 3.7 3.3 4.0 2.8 PLCB1 "KIAA0581, PLC-I, PLC154" ENSG00000182621 "Phospholipase C beta 1" Q9NQ66 20 8077251-8968360 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 56.7" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 29.3;Distal tubular cells: 28.2;Endothelial cells: 30.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 22.0;Hep G2: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004275, CAB005334, HPA034743, HPA057910" Enhanced Approved "Plasma membrane" NA NA 5400 "Plasma membrane" "CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552" "unprognostic (2.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.63e-2)" "unprognostic (9.77e-2)" "unprognostic (9.87e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-4)" "unprognostic (1.13e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" "unprognostic (7.12e-3)" "unprognostic (6.57e-2)" "unprognostic (2.87e-3)" "unprognostic (3.20e-2)" "unprognostic (4.41e-2)" "unprognostic (1.71e-2)" "unprognostic (2.12e-1)" 5.6 7.0 13.8 4.4 27.7 3.4 5.9 7.5 31.1 6.5 9.9 2.1 20.6 5.5 8.0 10.3 4.5 7.4 6.6 8.6 15.7 9.1 10.0 3.1 4.0 1.6 9.3 14.5 3.2 10.8 56.7 4.6 14.2 5.5 10.4 3.6 1.3 19.7 22.2 9.8 2.3 4.5 12.3 4.0 2.9 5.5 2.6 8.0 4.1 3.1 1.9 1.1 8.6 6.3 0.5 0.8 2.8 3.3 2.4 5.2 0.4 0.0 0.6 2.3 0.1 4.3 8.3 3.2 9.8 6.5 2.6 1.6 22.0 2.4 1.0 4.1 1.9 0.1 0.0 1.8 0.0 1.9 0.0 2.1 0.4 1.6 33.1 1.1 0.5 0.3 0.5 0.4 3.5 0.0 3.3 5.2 6.3 3.3 12.9 0.0 2.9 0.5 1.6 7.4 5.1 3.6 7.0 0.0 5.8 2.0 8.1 8.5 3.6 0.0 2.0 0.4 8.9 9.8 3.2 0.9 8.5 3.8 0.6 6.1 9.7 11.2 16.6 4.3 6.1 14.5 0.8 3.3 2.8 3.6 0.7 5.2 0.2 1.0 1.3 0.4 0.5 0.5 1.1 2.1 2.4 0.4 0.8 0.2 0.4 13.8 27.7 7.5 30.8 15.7 9.1 9.3 14.5 5.5 8.0 0.0 4.3 0.8 17.4 1.6 0.8 29.3 5.1 16.0 3.4 15.7 0.0 1.9 28.2 0.9 7.6 30.5 0.3 0.0 11.3 1.9 7.9 21.8 1.1 2.1 0.7 1.6 0.0 21.5 4.6 3.1 3.1 2.5 6.8 1.0 1.9 16.3 2.4 0.0 3.5 7.9 3.7 0.0 13.0 3.1 4.3 1.5 1.5 5.1 1.2 16.2 PLCB2 FLJ38135 ENSG00000137841 "Phospholipase C beta 2" Q00722 15 40278176-40307935 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.5;lymphoid tissue: 36.3" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009443, HPA041298, HPA068595, HPA069308" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: " "unprognostic (5.52e-2)" "unprognostic (4.96e-3)" "unprognostic (6.09e-3)" "unprognostic (1.88e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.00e-4)" "unprognostic (1.66e-1)" "unprognostic (3.08e-2)" "unprognostic (1.28e-1)" "unprognostic (2.34e-1)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (9.89e-2)" "unprognostic (2.06e-3)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" 6.3 3.6 8.1 17.6 11.6 30.5 2.9 1.1 7.5 2.9 3.3 16.2 1.7 4.0 2.8 3.2 2.4 4.6 6.5 3.3 6.9 5.1 3.3 4.2 12.5 17.2 12.7 2.4 1.6 2.0 1.3 2.9 4.6 9.3 3.2 5.5 4.1 5.2 2.9 1.3 1.5 10.2 4.8 17.9 36.3 3.6 1.4 10.9 12.2 2.8 1.8 17.6 6.9 2.5 1.0 4.5 8.5 4.3 1.8 3.1 2.0 0.1 0.0 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.8 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 6.7 39.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.3 1.7 0.0 0.0 1.8 3.6 0.4 0.0 0.1 5.5 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.0 11.4 4.1 0.0 3.8 0.0 0.0 0.0 0.0 1.5 0.0 21.6 0.0 2.7 4.2 8.5 3.1 4.3 2.0 0.7 1.6 1.6 4.5 1.0 1.6 1.8 6.9 1.8 4.2 1.6 2.9 2.0 8.1 11.6 1.1 7.5 6.9 5.1 12.7 2.4 9.3 10.9 6.0 25.1 3.4 0.1 0.8 0.0 2.8 2.5 6.7 5.7 1.8 0.0 0.4 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.4 1.0 0.0 25.5 0.2 26.0 0.0 0.0 1.8 49.0 0.4 0.3 28.1 3.3 0.0 0.8 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.3 0.2 2.1 0.5 0.3 15.9 1.2 0.0 PLCB3 ENSG00000149782 "Phospholipase C beta 3" Q01970 11 64251523-64269150 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "intestine: 77.5" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 54.0;Mucus-secreting cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009257, HPA039279, HPA043907" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 94000 "Nucleoplasm, Golgi apparatus" "CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "unprognostic (2.86e-1)" "unprognostic (2.35e-1)" "unprognostic (9.35e-2)" "unprognostic (6.23e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (2.44e-2)" "unprognostic (6.61e-2)" "unprognostic (1.26e-1)" "unprognostic (8.07e-3)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.31e-5)" "unprognostic (5.04e-3)" "unprognostic (1.52e-1)" "unprognostic (1.20e-1)" "unprognostic (3.88e-2)" 5.8 9.7 6.1 7.0 5.4 3.7 10.9 6.3 5.8 8.6 40.6 3.1 8.8 59.3 9.1 5.9 16.8 7.7 11.8 4.8 5.4 2.6 5.5 3.2 9.1 4.8 3.5 2.2 11.0 4.0 7.6 2.9 11.1 4.8 6.4 7.0 5.0 6.5 6.3 3.8 10.7 77.5 7.0 4.5 7.2 8.0 4.6 5.4 4.2 5.0 8.2 9.3 6.3 8.8 0.3 4.4 0.9 1.4 0.3 0.8 0.4 17.8 10.0 9.9 14.7 10.4 8.0 9.9 14.2 10.8 12.2 7.4 8.8 13.6 1.2 8.6 17.8 10.5 30.8 11.1 13.3 4.2 8.5 6.1 13.9 20.6 6.6 7.2 3.3 9.2 6.7 8.9 13.2 9.8 13.4 17.7 5.4 6.8 1.5 15.4 21.5 4.2 7.0 16.0 22.7 11.0 9.3 22.3 5.2 7.5 18.9 2.6 10.9 21.0 26.5 10.1 6.4 13.9 6.5 30.7 11.3 13.5 25.8 9.1 1.9 0.9 1.4 18.7 8.0 10.4 0.0 1.4 0.2 0.7 1.4 0.8 0.1 0.8 0.7 1.3 0.3 0.4 0.4 0.9 0.3 1.4 4.4 0.2 0.4 6.1 5.4 6.3 5.8 5.4 2.6 3.5 2.2 4.8 5.4 3.0 9.3 0.0 5.1 11.6 1.0 2.6 10.2 0.0 3.4 15.7 0.0 7.8 1.7 6.2 0.9 7.3 54.0 0.0 6.7 14.6 9.3 5.1 5.7 2.6 9.0 3.2 2.4 19.6 12.7 1.1 9.2 11.0 8.5 29.7 41.8 4.3 12.8 23.0 11.7 3.3 0.7 25.8 7.2 2.6 8.7 10.3 12.2 1.3 31.0 7.2 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;retina: 40.2;salivary gland: 39.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Group enriched" "Detected in all" 4 "cerebellum: 44.9;pons and medulla: 11.9" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA007951: AB_2667944" "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 5.5 5.0 2.1 4.5 4.6 0.2 5.6 44.9 5.2 6.0 13.1 2.7 2.4 1.6 12.3 16.2 6.9 10.9 6.2 12.4 2.3 6.6 2.3 0.9 4.4 1.0 4.0 3.3 2.9 1.3 0.5 15.1 4.4 11.9 6.9 12.6 40.2 39.8 7.1 2.5 4.3 3.1 12.3 3.1 1.1 9.7 2.1 2.4 4.3 21.9 4.4 2.0 7.1 8.8 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 6.1 3.1 0.0 0.0 0.1 0.0 13.4 3.8 4.0 2.5 1.2 0.9 0.0 0.2 38.2 14.5 0.0 0.9 2.9 6.0 0.0 1.8 1.6 2.2 0.0 0.6 0.0 0.0 0.9 1.2 5.2 18.7 7.3 0.0 0.0 1.5 0.1 30.8 2.0 0.0 0.0 3.3 17.8 3.9 0.0 0.0 0.2 39.4 2.8 10.2 7.1 0.0 9.2 5.6 4.3 7.8 0.0 0.1 4.3 0.3 0.4 5.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.0 2.1 4.6 44.9 5.2 2.3 6.6 4.0 3.3 11.9 2.4 6.0 0.3 0.0 3.6 2.2 79.8 57.6 0.0 56.2 11.4 5.2 0.0 0.0 0.0 0.5 1.0 35.4 2.3 0.0 0.2 0.0 4.8 10.1 0.0 0.0 0.1 155.7 40.4 1.3 0.0 0.4 1.4 0.3 6.8 1.0 35.3 1.9 5.0 7.0 19.4 0.6 5.4 12.9 23.6 1.4 1.3 0.9 0.1 0.0 34.0 1.8 PLCD3 ENSG00000161714 "Phospholipase C delta 3" Q8N3E9 17 45108967-45133354 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 138.0;Paneth cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025711, HPA053665" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025711: AB_1855320, HPA053665: AB_2732580" "unprognostic (3.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.77e-2)" "unprognostic (1.27e-2)" "unprognostic (2.66e-1)" "unprognostic (4.14e-3)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.96e-1)" "unprognostic (9.53e-2)" "unprognostic (1.34e-3)" "unprognostic (6.21e-2)" "unprognostic (3.18e-2)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "prognostic favorable (4.28e-4)" "unprognostic (3.34e-3)" 5.7 12.0 10.1 4.8 16.5 2.4 6.6 12.2 12.9 5.0 24.9 14.0 2.8 2.9 6.3 6.4 8.9 5.8 9.4 13.1 11.6 6.6 3.6 1.2 4.5 1.7 13.9 11.4 9.9 2.7 1.5 3.0 5.7 19.5 5.8 13.7 10.3 4.7 5.7 63.6 9.9 2.8 12.9 15.0 2.0 17.9 5.4 14.6 0.0 2.3 20.1 2.8 17.5 10.5 1.3 0.9 2.9 1.5 1.3 0.9 0.5 8.4 21.1 1.5 3.1 2.3 5.0 10.7 4.6 10.4 4.3 4.1 5.1 15.5 0.3 16.7 10.8 3.5 19.3 2.4 19.9 1.7 4.2 7.9 0.3 22.2 6.6 11.9 0.4 1.2 5.4 8.0 3.9 5.3 11.0 2.6 0.9 1.8 0.6 4.6 13.2 1.3 1.9 1.8 40.6 20.8 3.0 3.5 0.5 13.6 16.9 0.4 2.7 5.0 8.4 4.5 3.4 17.9 0.9 5.3 2.7 14.8 3.5 5.4 0.8 0.9 0.6 4.4 0.5 2.1 2.3 1.5 2.4 0.9 1.5 0.6 1.0 0.7 0.6 0.5 1.3 0.9 0.8 2.9 1.3 0.3 0.9 0.6 0.5 10.1 16.5 12.2 11.5 11.6 6.6 13.9 11.4 19.5 14.6 11.9 2.2 0.0 10.9 6.8 27.2 23.8 12.7 1.4 2.3 7.0 23.6 2.5 1.7 7.0 12.5 9.2 138.0 0.0 2.9 7.2 8.2 9.8 1.1 0.4 1.5 6.4 4.7 8.6 0.3 3.6 18.4 0.3 3.3 1.0 13.0 6.8 18.3 62.6 31.1 1.7 37.9 6.5 4.2 1.9 6.6 5.0 6.1 0.0 26.3 40.1 PLCD4 ENSG00000115556 "Phospholipase C delta 4" Q9BRC7 2 218607765-218637184 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 81.4;Cone photoreceptor cells: 231.7;Rod photoreceptor cells: 181.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009914, HPA038139, HPA038140" Enhanced Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA Cytosol "Endoplasmic reticulum, Plasma membrane" "CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.76e-2)" "unprognostic (5.65e-5)" "unprognostic (7.77e-2)" "unprognostic (1.45e-2)" "unprognostic (7.06e-3)" "unprognostic (2.86e-2)" "unprognostic (3.15e-1)" "unprognostic (8.87e-3)" "unprognostic (7.54e-5)" "unprognostic (3.28e-2)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (8.46e-3)" "unprognostic (3.09e-1)" 1.1 2.5 1.5 1.0 1.6 0.5 1.0 0.9 2.4 0.6 6.4 0.3 3.8 0.9 0.8 1.1 3.7 0.6 0.9 0.9 1.0 1.5 3.9 0.5 0.7 0.7 1.6 1.0 0.7 0.4 1.4 4.7 0.6 2.6 6.4 1.5 23.0 1.4 0.6 62.5 0.8 1.4 33.1 1.1 0.5 3.5 3.9 0.5 0.0 1.4 6.8 0.5 9.6 5.3 0.9 1.2 0.3 0.4 0.9 0.9 1.0 0.6 1.6 2.2 0.4 0.2 1.4 1.2 1.2 2.6 0.4 1.4 2.4 0.3 1.4 1.8 0.4 1.0 1.0 0.0 1.5 0.3 0.5 1.8 1.2 3.6 1.9 0.2 1.2 0.6 3.0 0.1 2.0 0.5 4.8 2.8 0.8 1.0 1.1 2.3 1.8 0.4 1.2 0.7 0.2 3.4 0.9 0.8 0.5 4.4 3.0 2.3 21.5 1.0 0.8 0.3 1.3 2.6 0.5 6.1 1.6 1.2 0.7 0.7 0.5 0.8 0.9 4.7 0.3 1.6 0.0 0.4 0.0 0.5 0.0 0.1 0.0 0.3 0.9 0.3 0.9 0.7 0.8 0.3 0.9 0.0 1.2 0.7 1.0 1.5 1.6 0.9 2.4 1.0 1.5 1.6 1.0 2.6 0.5 0.0 1.4 0.0 0.2 0.5 81.4 0.8 0.0 0.0 0.0 0.0 231.7 0.1 0.0 0.2 14.2 1.1 0.0 0.0 0.0 12.6 0.6 0.0 0.0 0.0 0.5 7.9 0.0 0.0 0.0 22.0 0.3 0.0 0.0 0.0 0.0 8.8 0.4 0.0 0.0 1.4 181.4 0.0 1.4 2.2 0.8 0.1 0.7 0.0 0.0 0.1 PLCE1 "KIAA1516, NPHS3, PLCE" ENSG00000138193 "Phospholipase C epsilon 1" Q9P212 10 94030812-94332823 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Guanine-nucleotide releasing factor, Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 44.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 65.5;Enterocytes: 45.9;Muller glia cells: 98.6;Paneth cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 18.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015597, HPA015598" Enhanced Supported Cytosol NA NA Cytosol "HPA015597: AB_1855321, HPA015598: AB_1855322" "unprognostic (4.73e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.59e-3)" "unprognostic (3.01e-1)" "unprognostic (2.96e-1)" "unprognostic (1.73e-2)" "unprognostic (4.76e-3)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-3)" "unprognostic (3.56e-1)" "unprognostic (3.92e-2)" "unprognostic (3.54e-2)" "unprognostic (4.30e-2)" 3.2 2.4 4.1 9.1 5.5 0.0 2.2 1.8 7.9 9.2 13.8 3.1 1.6 5.0 11.4 4.6 4.5 4.2 3.8 12.8 4.1 2.6 6.3 0.7 7.2 0.4 2.4 6.8 3.2 12.8 0.1 5.2 3.1 6.4 3.3 12.6 44.6 2.1 7.7 4.3 0.7 4.6 5.8 2.4 5.8 8.7 1.7 2.3 0.0 15.1 7.3 1.1 7.9 5.4 3.2 1.2 0.8 0.9 1.1 2.3 0.5 5.8 8.1 1.7 0.9 0.9 5.7 2.3 3.6 1.0 0.8 1.1 5.2 1.4 0.6 1.8 2.9 2.9 2.5 4.1 1.0 1.3 0.3 2.0 0.4 4.4 0.4 0.1 0.7 0.3 2.3 0.0 2.2 0.0 9.7 0.0 0.3 0.4 0.3 7.0 0.2 0.6 0.8 0.6 11.0 8.4 0.1 5.5 0.2 0.2 18.2 0.8 1.4 4.2 5.8 0.5 7.9 4.9 0.5 0.5 3.7 10.9 2.3 4.7 0.5 0.2 0.3 3.0 1.0 3.3 0.4 0.5 0.1 1.5 0.9 1.3 2.6 1.6 1.1 0.6 3.2 2.3 1.8 0.8 1.1 0.8 1.2 0.6 0.5 4.1 5.5 1.8 7.9 4.1 2.6 2.4 6.8 6.4 2.3 65.5 4.8 9.3 7.4 7.2 11.5 32.3 0.0 10.7 13.6 0.0 0.0 3.2 1.7 1.3 15.0 7.4 45.9 0.0 5.7 2.0 7.3 2.9 0.0 1.1 0.6 6.4 1.7 6.2 0.6 3.4 11.2 1.4 6.8 1.0 6.4 98.6 3.2 46.7 21.9 2.1 19.4 6.5 19.4 3.5 7.8 6.5 1.6 4.3 28.0 6.0 PLCG2 ENSG00000197943 "Phospholipase C gamma 2" P16885 16 81739097-81962693 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 211.5;Muller glia cells: 142.4;Rod photoreceptor cells: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 40.5;HMC-1: 19.4;REH: 16.5;U-698: 90.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004280, HPA020099, HPA020100" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 21000 "Vesicles, Cytosol" Nucleoplasm "CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325" "unprognostic (2.86e-2)" "unprognostic (1.34e-1)" "unprognostic (1.09e-3)" "unprognostic (1.10e-1)" "unprognostic (1.58e-1)" "prognostic favorable (6.71e-4)" "unprognostic (6.23e-2)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" "unprognostic (4.58e-2)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" "prognostic favorable (4.88e-4)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-1)" "unprognostic (3.40e-3)" 8.4 3.8 3.3 55.8 4.9 14.1 10.7 1.0 2.4 5.6 10.3 5.3 3.1 8.7 11.2 12.2 6.0 4.7 10.1 4.4 3.3 2.8 20.6 8.8 10.7 35.5 5.2 1.8 2.0 3.6 1.0 1.8 4.1 4.5 4.3 3.6 4.6 8.8 2.8 2.0 4.1 17.6 4.6 8.6 33.6 4.2 2.3 4.2 6.3 5.3 2.6 44.6 7.5 7.7 18.8 3.9 26.8 12.2 14.0 1.1 2.3 0.3 0.7 0.1 0.6 0.0 0.0 0.9 0.0 0.1 0.5 0.2 0.2 1.8 40.5 6.9 0.0 1.7 0.9 0.9 0.1 0.3 0.3 0.4 4.8 0.0 0.0 0.3 4.8 19.4 0.0 0.4 0.3 0.2 0.0 0.9 1.8 0.5 3.4 0.1 1.2 0.5 12.1 0.7 0.5 0.2 16.5 0.0 5.2 0.1 0.8 0.3 0.1 1.1 0.3 0.3 0.9 0.7 15.0 0.2 0.0 0.7 0.1 0.1 8.1 13.2 90.0 0.0 6.7 0.3 2.8 4.4 26.8 0.7 5.7 0.3 18.8 0.2 1.1 3.9 17.3 0.3 0.8 24.8 14.0 12.2 2.6 0.1 2.3 3.3 4.9 1.0 2.4 3.3 2.8 5.2 1.8 4.5 4.2 11.9 81.1 49.9 1.4 2.6 211.5 5.2 40.8 10.7 21.6 15.7 98.2 11.2 11.6 2.3 17.0 11.7 1.0 70.0 0.0 1.8 5.8 2.7 38.3 37.2 23.7 95.3 20.6 36.2 45.8 26.9 10.3 15.6 8.5 7.2 0.4 142.4 0.1 5.8 4.6 4.5 205.4 6.5 2.3 4.4 2.9 1.9 9.3 26.2 1.2 4.8 PLCH1 "DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3" ENSG00000114805 "Phospholipase C eta 1" Q4KWH8 3 155375580-155745067 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7;testis: 15.8" "Cell type enriched" "Detected in many" 6 "Early spermatids: 148.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 8.4;AF22: 27.2;NTERA-2: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036176, HPA057978" Uncertain Enhanced Vesicles NA NA Vesicles "HPA036176: AB_10671837, HPA057978: AB_2683569" "unprognostic (1.08e-2)" "unprognostic (3.68e-1)" "unprognostic (2.17e-2)" "unprognostic (1.55e-2)" "unprognostic (3.50e-4)" "unprognostic (6.41e-2)" "unprognostic (2.94e-5)" "unprognostic (5.04e-2)" "unprognostic (2.41e-1)" "unprognostic (2.24e-3)" "unprognostic (4.84e-2)" "unprognostic (1.76e-2)" "prognostic favorable (3.03e-5)" "unprognostic (3.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-2)" 0.3 0.3 3.9 0.7 14.1 0.5 3.9 7.4 14.7 2.1 3.9 5.7 4.1 3.9 1.4 12.9 0.5 12.4 2.4 2.5 4.5 3.6 2.1 0.4 6.1 0.3 3.4 7.3 0.5 2.5 0.8 3.2 0.8 6.5 0.8 3.9 5.6 2.3 3.4 0.6 0.5 3.9 0.5 1.9 0.3 5.8 15.8 2.9 0.0 8.9 0.0 0.4 1.3 0.4 0.1 0.3 0.7 0.0 0.0 1.2 0.9 0.0 8.4 27.2 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 6.7 0.0 0.6 0.0 0.1 0.0 4.8 0.0 0.0 0.0 2.5 6.8 0.0 0.9 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.2 0.0 0.0 2.9 1.6 6.2 14.5 0.9 1.1 0.6 0.0 0.0 1.7 0.1 2.5 0.6 0.0 6.5 0.0 4.2 2.9 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.9 3.9 14.1 7.4 14.7 4.5 3.6 3.4 7.3 6.5 2.9 3.0 12.8 0.0 0.3 0.0 10.0 0.5 7.6 25.4 3.4 1.8 3.9 0.0 0.0 1.9 148.2 0.1 2.4 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.2 23.8 2.9 0.0 0.3 10.0 1.1 0.0 0.0 0.0 4.3 19.3 1.5 2.9 0.4 1.9 3.0 0.0 0.0 2.1 1.1 0.1 0.0 0.0 4.7 0.1 PLCH2 "KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1" ENSG00000149527 "Phospholipase C eta 2" O75038 1 2425980-2505530 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;retina: 28.6;skin 1: 36.6" "Cell type enhanced" "Detected in many" 18 "Bipolar cells: 76.1;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 155.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "NK-cells: 2.9;T-cells: 2.4" "Group enriched" "Detected in some" 4 "HBEC3-KT: 50.7;hTCEpi: 23.9;hTERT-HME1: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072705 Enhanced NA NA "HPA072705: AB_2732211" "unprognostic (2.06e-3)" "unprognostic (1.30e-2)" "unprognostic (1.09e-3)" "unprognostic (3.84e-3)" "unprognostic (1.99e-1)" "unprognostic (1.59e-2)" "unprognostic (7.39e-2)" "unprognostic (7.70e-2)" "unprognostic (7.58e-2)" "unprognostic (9.28e-2)" "unprognostic (2.26e-1)" "unprognostic (5.95e-2)" "unprognostic (6.61e-3)" "unprognostic (8.43e-2)" "unprognostic (1.07e-1)" "unprognostic (8.64e-2)" "unprognostic (5.80e-2)" 0.5 1.2 6.4 2.9 9.1 1.4 3.1 32.0 25.1 3.2 0.9 1.6 0.5 1.6 0.3 1.7 9.7 2.5 2.4 0.3 20.2 2.7 0.8 0.8 1.2 4.0 2.6 8.4 0.2 1.7 0.1 3.0 0.4 2.6 6.7 0.7 28.6 8.6 4.9 0.2 36.6 2.0 0.2 6.4 4.0 1.7 0.8 2.0 0.2 1.2 0.2 4.9 8.3 6.4 0.3 0.1 0.0 0.0 2.9 2.4 0.9 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 7.0 0.0 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 14.3 0.0 0.0 0.0 0.0 1.2 0.1 0.4 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.1 2.8 5.7 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.9 0.3 1.5 1.4 0.0 0.3 1.1 0.7 0.0 2.9 0.0 0.1 2.1 0.9 6.4 9.1 32.0 25.1 20.2 2.7 2.6 8.4 2.6 2.0 0.0 1.7 2.0 13.5 13.7 76.1 3.2 5.1 1.4 4.5 0.0 70.7 0.0 1.7 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.5 4.9 0.0 0.0 0.1 25.4 1.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 1.4 12.3 0.2 0.0 0.0 16.6 155.3 0.0 0.9 0.1 0.2 12.8 0.0 6.9 0.4 6.7 PLCL1 "PLC-L, PLCE, PLCL, PPP1R127, PRIP" ENSG00000115896 "Phospholipase C like 1 (inactive)" Q15111 2 197804702-198572581 "FDA approved drug targets, Predicted intracellular proteins" Transducer "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 128.1;Distal tubular cells: 49.7;Proximal tubular cells: 34.2;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 6 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 8.8;K-562: 14.7;Karpas-707: 11.1;MOLT-4: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031849 Enhanced NA NA "HPA031849: AB_10602192" "unprognostic (7.77e-3)" "unprognostic (2.57e-1)" "unprognostic (2.09e-1)" "unprognostic (5.18e-3)" "unprognostic (4.40e-2)" "unprognostic (7.14e-2)" "unprognostic (2.05e-1)" "unprognostic (4.42e-3)" "unprognostic (1.07e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-2)" "unprognostic (7.42e-2)" "prognostic favorable (3.91e-7)" "unprognostic (1.07e-4)" "unprognostic (6.74e-2)" "unprognostic (1.68e-1)" "unprognostic (3.20e-2)" 4.4 5.2 11.1 3.3 26.0 2.2 4.4 3.4 16.3 5.3 4.5 21.2 3.4 1.3 15.4 3.9 4.3 4.1 3.7 32.8 14.9 10.9 32.8 1.3 3.9 4.4 34.9 8.8 8.1 2.2 20.7 3.0 8.4 19.9 11.8 2.1 4.8 2.9 8.2 28.4 1.8 2.5 6.7 23.0 2.5 3.1 2.3 26.9 22.1 4.0 3.2 3.2 5.3 2.9 0.0 0.1 0.6 0.1 0.0 4.1 0.2 0.0 0.0 0.1 0.0 1.7 0.4 0.0 0.4 0.2 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 1.5 0.0 0.2 0.2 1.9 4.3 0.0 0.0 0.0 0.0 8.8 2.9 14.7 11.1 0.1 0.4 10.3 0.0 0.1 0.0 0.0 0.0 0.0 4.5 0.3 0.0 1.7 1.0 1.8 0.0 2.6 0.8 0.3 0.0 0.7 0.2 0.0 0.0 0.1 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 2.5 0.0 1.8 0.0 0.1 0.0 1.3 0.4 0.6 0.0 0.1 0.0 4.1 0.2 11.1 26.0 3.4 16.3 14.9 10.9 34.9 8.8 19.9 26.9 17.9 4.1 0.0 0.7 1.1 18.7 128.1 0.0 4.0 3.4 14.0 0.0 0.0 49.7 0.5 10.5 1.4 0.3 0.0 0.3 0.0 3.1 1.0 5.8 0.0 2.5 14.3 1.7 0.0 4.1 3.0 1.7 2.6 0.0 2.8 0.0 2.3 0.3 0.0 7.4 34.2 1.1 32.3 13.7 0.7 1.8 1.1 0.1 3.8 0.0 0.3 PLCL2 "KIAA1092, PLCE2" ENSG00000154822 "Phospholipase C like 2" Q9UPR0 3 16802651-17090594 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 32.7;Extravillous trophoblasts: 52.0;Syncytiotrophoblasts: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 15.7;Daudi: 17.1;HAP1: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047616, HPA061728" Enhanced NA NA "HPA047616: AB_2680105, HPA061728: " "unprognostic (2.95e-2)" "unprognostic (8.09e-2)" "unprognostic (3.96e-2)" "unprognostic (6.35e-2)" "unprognostic (1.59e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (9.31e-2)" "unprognostic (3.22e-2)" "unprognostic (8.72e-2)" "unprognostic (5.93e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.98e-10)" "unprognostic (2.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.70e-1)" "unprognostic (9.97e-2)" 6.7 9.2 5.6 9.0 7.9 9.6 5.3 32.0 9.2 5.1 5.1 2.0 1.7 7.0 7.3 6.9 1.5 4.8 5.2 11.3 4.9 3.4 8.1 5.8 4.3 12.3 3.0 7.4 14.1 4.7 0.5 7.8 5.5 8.0 2.7 6.2 3.1 3.6 1.5 22.7 2.1 7.6 4.5 3.8 13.0 5.6 3.2 3.4 7.3 4.0 1.0 8.0 3.4 3.1 2.4 1.6 3.0 1.8 10.0 4.9 1.7 0.0 1.3 1.8 0.0 6.8 15.7 1.4 1.3 3.6 0.6 1.5 0.0 1.3 17.1 0.0 1.1 0.7 0.0 17.6 0.7 1.3 8.1 3.7 0.0 1.9 0.0 0.2 2.6 2.0 2.5 0.1 5.0 0.0 1.1 3.1 5.7 3.9 6.7 0.0 0.0 2.9 0.3 3.6 0.0 1.8 6.5 0.0 9.2 0.0 0.2 5.8 2.6 0.7 2.2 0.5 1.3 0.0 2.8 3.1 0.9 1.2 0.8 2.9 6.4 0.0 11.1 0.9 3.6 0.6 1.2 1.4 2.8 3.6 1.5 4.5 2.2 3.4 4.9 1.6 2.4 3.3 3.7 3.0 10.0 1.8 0.9 2.4 1.7 5.6 7.9 32.0 9.2 4.9 3.4 3.0 7.4 8.0 3.4 0.0 2.1 7.1 1.0 0.9 11.0 32.7 17.8 1.4 1.2 3.5 3.9 1.6 6.6 1.7 0.6 3.3 9.0 23.3 8.3 52.0 4.5 0.4 2.3 4.2 6.5 15.9 3.5 4.9 8.8 1.1 18.1 7.8 0.0 0.0 7.6 0.8 2.1 25.9 18.0 5.0 1.8 6.5 3.8 1.4 5.8 0.5 41.6 16.6 4.7 0.4 PLCXD1 FLJ11323 ENSG00000182378 "Phosphatidylinositol specific phospholipase C X domain containing 1" Q9NUJ7 X 276322-303356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 25.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 53.8" "Low region specificity" "Detected in many" HPA007721 Approved Approved Cytosol NA Yes Cytosol "HPA007721: AB_1079630" "unprognostic (2.73e-2)" "unprognostic (5.67e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (3.80e-2)" "prognostic favorable (2.50e-4)" "unprognostic (1.47e-3)" "unprognostic (7.92e-2)" "unprognostic (1.72e-2)" "unprognostic (4.80e-2)" "unprognostic (7.25e-2)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.82e-14)" "unprognostic (6.01e-2)" "unprognostic (1.95e-1)" "unprognostic (3.59e-2)" "unprognostic (1.78e-1)" 7.4 1.5 6.5 5.3 42.3 18.8 8.7 24.6 19.1 8.9 3.7 2.1 2.1 5.3 9.1 2.1 11.4 3.5 5.3 2.8 7.1 4.2 3.1 5.4 3.5 10.0 4.8 3.6 19.3 4.3 2.3 5.5 12.5 29.2 3.5 3.5 2.1 7.0 2.4 4.5 11.6 5.9 2.1 22.2 10.5 17.3 3.6 6.7 2.1 5.1 2.1 5.4 4.7 7.9 5.8 2.9 6.3 11.9 1.8 4.1 2.7 8.8 33.9 8.2 12.3 1.7 1.3 6.5 8.0 0.9 4.3 4.2 13.7 9.6 11.4 5.6 3.5 6.4 2.8 2.0 5.3 2.3 6.8 15.1 53.8 11.0 18.2 5.3 5.5 21.2 7.0 0.7 15.8 1.6 2.9 3.3 18.6 14.0 6.2 3.1 2.8 16.6 8.1 17.4 2.3 6.6 9.4 4.4 16.6 1.3 4.1 8.8 4.7 8.1 4.8 7.4 5.9 9.2 7.7 2.3 5.7 9.1 6.2 8.8 2.1 5.6 26.3 3.7 14.6 6.1 4.3 3.8 6.3 2.8 8.1 3.9 2.3 2.2 3.4 2.9 5.8 2.8 2.7 4.9 1.8 11.9 2.7 4.1 2.7 6.5 42.3 24.6 19.1 7.1 4.2 4.8 3.6 29.2 6.7 8.9 25.9 6.1 8.4 6.2 8.1 2.2 7.6 0.0 2.3 0.0 2.0 8.4 0.0 5.1 0.6 3.9 11.5 0.0 1.6 9.0 3.4 4.9 3.5 6.4 4.8 7.9 2.9 6.2 6.5 0.6 2.3 6.4 0.0 1.0 7.5 2.8 12.0 8.7 3.5 1.4 6.1 12.9 4.1 7.9 18.3 7.5 22.5 4.4 7.4 7.1 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.0" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.2" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6" "Cell line enhanced" "Detected in many" "HBF TERT88: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 1.5 1.0 1.9 3.4 5.8 9.6 1.2 5.8 10.9 1.6 2.8 0.4 0.0 6.1 1.0 0.6 1.8 1.2 1.9 1.5 3.6 2.5 2.5 4.1 2.0 5.9 2.9 6.8 1.1 2.3 0.4 4.1 16.0 10.3 1.5 3.6 4.1 2.0 0.7 1.2 1.5 5.9 0.9 2.9 3.5 2.1 4.2 1.1 3.1 3.2 0.5 4.8 1.9 1.6 0.9 7.2 0.6 0.0 2.1 3.6 0.6 3.0 2.7 2.6 1.2 0.1 0.1 0.8 5.3 2.5 5.0 4.4 1.9 1.5 2.2 2.7 0.2 1.6 7.5 1.1 5.1 9.7 0.6 1.3 0.5 5.0 1.7 0.4 0.7 2.6 0.0 1.0 1.6 3.0 4.7 2.8 2.9 0.1 5.4 0.6 0.3 1.5 0.5 0.9 2.0 6.8 1.4 3.8 2.0 2.4 3.1 0.6 4.6 1.1 0.7 1.1 3.1 0.4 0.2 2.6 1.1 6.8 0.5 1.0 6.5 0.9 0.4 0.5 0.4 0.3 0.6 0.0 0.0 3.6 0.0 3.5 0.5 1.9 3.5 0.3 0.9 0.9 2.0 0.2 2.1 0.0 7.2 1.7 0.6 1.9 5.8 5.8 10.9 3.6 2.5 2.9 6.8 10.3 1.1 17.9 2.1 0.5 6.9 0.1 0.7 1.9 28.1 0.0 1.2 57.6 3.9 0.0 135.9 36.1 11.5 0.0 1.3 0.0 43.6 0.0 0.1 3.8 0.0 132.8 0.0 6.4 24.1 0.0 1.6 8.9 0.3 0.0 0.0 0.0 4.9 0.0 45.8 0.0 0.4 94.0 3.7 0.0 0.0 0.5 0.4 0.1 0.0 2.2 1.1 12.2 PLCXD3 ENSG00000182836 "Phosphatidylinositol specific phospholipase C X domain containing 3" Q63HM9 5 41306954-41510628 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.4;heart muscle: 36.6;ovary: 27.6" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 124.0;Intestinal endocrine cells: 40.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 33.4" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 15 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.4;PC-3: 5.6;SH-SY5Y: 26.3;TIME: 13.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046849 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA046849: AB_2679838" "unprognostic (1.71e-1)" "unprognostic (3.84e-2)" "unprognostic (2.00e-1)" "unprognostic (7.04e-3)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (4.90e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-2)" "unprognostic (3.12e-1)" "unprognostic (6.38e-3)" "unprognostic (2.57e-1)" "unprognostic (2.73e-2)" "unprognostic (2.15e-3)" "unprognostic (5.91e-5)" "unprognostic (5.11e-2)" "unprognostic (6.75e-2)" 7.0 15.3 6.9 1.2 4.5 0.8 4.5 33.4 6.5 4.5 1.4 2.0 1.4 1.3 1.6 1.7 1.4 2.5 3.4 36.6 4.8 8.1 7.3 2.2 2.0 7.9 4.2 4.2 27.6 4.8 1.3 13.7 0.8 9.0 1.9 1.5 0.5 1.2 2.0 0.9 0.9 1.7 2.1 5.8 0.9 5.9 1.1 2.1 0.0 1.4 0.0 1.0 1.4 6.1 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 1.3 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 26.3 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 6.9 4.5 33.4 5.5 4.8 8.1 4.2 4.2 9.0 2.1 0.0 0.0 0.0 0.0 0.1 0.4 124.0 7.6 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.7 3.6 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.2 0.1 1.6 40.9 19.6 0.3 2.5 7.2 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.4 9.7 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PLCZ1 "NYD-SP27, PLCzeta" ENSG00000139151 "Phospholipase C zeta 1" Q86YW0 12 18683169-18738057 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fertilization, Lipid degradation, Lipid metabolism" "Developmental protein, Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 29.5" "Group enriched" "Detected in some" 91 "Early spermatids: 451.0;Late spermatids: 242.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 3.8;hTERT-HME1: 1.4;NTERA-2: 2.1;U-2 OS: 1.2;U-251 MG: 1.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.10e-1)" "unprognostic (1.87e-2)" "unprognostic (1.39e-2)" "unprognostic (1.25e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 451.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 242.6 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 3.8 1.3 0.0 0.0 0.0 0.0 0.0 PLD1 ENSG00000075651 "Phospholipase D1" Q13393 3 171600405-171810950 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 52.1" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 50.9;Proximal tubular cells: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 30.3;SK-MEL-30: 16.9;TIME: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004527, HPA042396" Enhanced NA NA "CAB004527: AB_677324, HPA042396: AB_2677977" "unprognostic (3.23e-1)" "unprognostic (3.27e-1)" "unprognostic (5.82e-2)" "unprognostic (5.13e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.46e-1)" "unprognostic (6.23e-2)" "unprognostic (8.02e-2)" "unprognostic (2.06e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.76e-6)" 7.0 26.6 5.3 6.1 20.4 4.5 6.3 1.4 10.8 8.6 19.7 31.4 1.8 27.7 6.9 4.9 25.0 4.9 52.1 14.7 7.7 4.7 7.5 20.2 4.4 5.2 25.3 7.2 17.1 13.9 0.9 2.7 6.6 18.8 3.5 9.4 8.5 13.2 4.2 2.0 17.6 29.5 3.4 16.8 9.9 5.3 3.5 21.8 0.9 4.1 10.7 8.5 4.3 11.5 0.1 0.9 10.2 2.6 3.0 4.1 0.8 2.3 3.7 1.9 0.7 6.0 6.8 4.1 1.2 5.3 1.9 2.3 0.5 3.4 0.0 9.5 0.5 13.1 7.9 0.3 1.0 3.0 1.9 1.6 2.2 5.9 13.2 2.7 3.8 10.5 2.6 5.8 2.2 1.1 5.4 30.3 0.6 1.4 0.0 0.4 0.6 0.0 3.2 0.4 6.0 2.7 0.1 0.8 0.0 4.7 0.9 0.0 0.0 4.1 2.5 16.9 2.8 4.7 5.0 26.3 0.8 3.2 2.1 1.3 5.1 4.1 0.0 3.7 4.6 1.0 10.2 2.6 3.2 0.5 1.6 4.1 0.0 0.4 1.0 0.9 0.1 0.0 0.1 1.5 3.0 0.5 0.0 1.2 0.8 5.3 20.4 1.4 10.8 7.7 4.7 25.3 7.2 18.8 21.8 0.0 6.6 1.3 2.8 6.4 0.2 30.1 50.9 5.3 7.9 1.8 0.0 2.4 3.3 5.9 7.9 5.4 31.5 0.0 3.0 3.0 6.6 0.7 27.6 13.1 16.2 0.0 4.1 3.7 11.7 6.1 9.8 3.8 11.8 1.8 21.0 0.0 2.0 14.4 4.2 44.6 0.0 19.4 2.0 5.4 3.6 30.6 1.9 4.5 12.7 4.3 PLD4 C14orf175 ENSG00000166428 "Phospholipase D family member 4" Q96BZ4 14 104924816-104937790 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "blood: 229.9" "Group enriched" "Detected in some" 4 "B-cells: 25.7;Hofbauer cells: 28.1;Macrophages: 25.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 229.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 229.9" "Group enriched" "Detected in some" 5 "HMC-1: 34.9;RPMI-8226: 25.0;THP-1: 63.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051512 Uncertain NA NA 2000000 "HPA051512: AB_2681515" "unprognostic (4.50e-3)" "unprognostic (1.78e-4)" "unprognostic (7.12e-2)" "unprognostic (5.30e-3)" "unprognostic (5.54e-2)" "unprognostic (2.91e-3)" "unprognostic (2.56e-1)" "unprognostic (4.76e-3)" "unprognostic (1.45e-3)" "unprognostic (1.19e-3)" "unprognostic (3.45e-3)" "unprognostic (3.89e-1)" "unprognostic (6.90e-3)" "unprognostic (8.94e-2)" "unprognostic (2.83e-1)" "unprognostic (1.28e-2)" "unprognostic (2.41e-1)" 0.7 1.6 8.9 6.7 8.8 15.0 1.9 5.7 10.0 1.5 1.3 23.1 0.1 5.6 1.5 0.5 1.1 2.8 3.5 0.8 8.7 8.4 1.2 0.9 2.6 14.4 14.5 3.4 0.9 1.6 1.0 2.8 1.2 9.0 2.1 0.8 1.5 4.6 2.3 0.5 0.9 5.5 0.9 19.0 11.6 3.5 0.8 9.2 2.7 1.0 0.0 11.2 3.9 0.9 14.7 229.9 43.4 17.7 1.7 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 3.0 0.0 0.0 0.0 8.8 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 2.8 43.4 0.0 11.9 0.1 14.7 0.0 0.0 35.1 12.3 0.1 0.0 0.6 1.7 17.7 229.9 0.0 4.4 8.9 8.8 5.7 9.6 8.7 8.4 14.5 3.4 9.0 9.2 0.0 0.0 25.7 0.1 0.3 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.3 0.4 0.1 3.5 0.0 28.1 1.6 0.0 0.0 1.3 2.5 0.0 25.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 6.5 0.4 0.7 0.1 0.4 0.2 0.0 0.0 0.0 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol No No Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: AB_2681105" "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 4.0 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 9.5 4.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.5 0.0 0.7 0.5 0.2 0.1 0.2 0.0 0.0 0.0 PLD6 ENSG00000179598 "Phospholipase D family member 6" Q8N2A8 17 17200995-17206315 "Predicted membrane proteins" "Differentiation, Lipid degradation, Lipid metabolism, Meiosis, Spermatogenesis" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 15.6;Spermatogonia: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 5.0;T-cells: 11.4" "Cell line enhanced" "Detected in many" "HAP1: 25.9;REH: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA049345 Approved NA NA "HPA049345: AB_2680722" "unprognostic (1.71e-1)" "unprognostic (6.80e-3)" "unprognostic (3.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-2)" "unprognostic (8.21e-2)" "unprognostic (1.31e-1)" "unprognostic (7.83e-2)" "unprognostic (9.01e-2)" "unprognostic (1.48e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.32e-1)" "unprognostic (1.04e-1)" "unprognostic (6.08e-2)" "unprognostic (1.56e-1)" "unprognostic (3.51e-1)" "unprognostic (2.24e-1)" 5.0 5.9 4.8 2.3 12.5 2.4 5.1 18.2 9.6 6.7 5.8 4.5 2.9 2.3 4.4 7.2 2.6 6.5 3.6 5.5 4.9 8.1 3.4 4.6 2.5 5.2 5.0 4.1 10.4 16.2 6.8 6.3 3.7 5.6 7.5 2.5 5.1 4.5 6.5 3.7 3.2 2.2 3.4 4.0 3.0 3.7 37.1 1.7 2.0 3.3 1.7 4.1 5.9 3.3 5.6 1.3 0.5 0.4 5.0 11.4 4.0 4.2 3.3 0.1 3.8 1.5 0.6 0.2 1.3 2.2 2.5 1.5 3.9 1.3 9.5 2.1 1.4 1.5 1.2 25.9 0.7 2.4 5.9 7.5 9.1 2.5 6.9 6.7 6.8 3.8 1.3 2.8 1.5 6.2 2.9 0.6 4.5 8.1 0.2 2.9 5.5 5.0 9.6 0.0 4.9 4.6 19.2 1.9 6.9 2.3 0.3 15.0 6.1 1.7 2.5 4.5 2.9 2.4 11.0 0.7 0.1 0.2 5.6 2.7 1.2 4.4 0.0 3.1 7.0 5.3 0.3 0.4 0.2 2.8 0.3 9.2 5.6 10.7 5.6 0.1 4.3 11.4 5.1 0.5 5.0 0.2 1.3 7.6 4.0 4.8 12.5 18.2 9.6 4.9 8.1 5.0 4.1 5.6 1.7 3.0 3.5 2.9 4.1 4.8 4.6 5.6 2.5 5.3 2.3 1.8 0.0 3.4 1.7 0.9 6.0 0.5 0.5 0.0 0.6 0.9 2.4 3.6 1.1 1.7 2.4 6.4 1.2 0.6 0.3 1.6 4.0 0.0 3.3 1.0 1.7 5.8 0.9 0.0 4.6 1.1 1.2 0.0 1.4 15.6 25.4 1.4 0.7 3.8 1.2 0.9 PLEC "EBS1, PCN, PLEC1, PLTN" ENSG00000178209 Plectin Q15149 8 143915147-143976734 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 144.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 73.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003847, HPA025967, HPA029906" Enhanced Supported "Intermediate filaments,Focal adhesion sites,Cytosol" NA NA 7100000 "Intermediate filaments, Cytosol" "Focal adhesion sites" "CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279" "unprognostic (1.02e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.72e-3)" "unprognostic (1.13e-2)" "unprognostic (2.85e-3)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.98e-6)" "unprognostic (2.30e-1)" "unprognostic (4.04e-2)" "unprognostic (6.58e-2)" "unprognostic (5.58e-3)" 20.9 11.0 15.9 16.5 13.3 27.9 13.1 15.0 20.7 20.7 17.7 14.6 16.7 13.1 20.2 16.8 25.1 18.2 29.0 23.4 18.9 10.7 11.2 10.9 16.6 15.0 9.9 13.0 18.0 14.0 8.8 12.0 24.2 13.2 17.5 9.8 13.0 17.8 14.8 144.9 36.4 24.1 24.7 11.0 16.9 21.4 6.7 12.7 16.3 9.2 44.2 24.5 20.2 19.2 1.5 3.4 0.8 4.1 0.7 2.9 3.2 16.5 52.1 3.3 4.1 6.1 13.6 11.9 24.4 10.8 6.5 3.6 7.2 17.4 1.7 19.0 35.8 11.6 19.8 2.2 34.1 2.6 12.4 1.8 6.3 52.9 5.9 9.7 2.0 5.3 15.7 6.7 17.5 34.2 5.8 7.6 1.5 3.0 5.4 7.5 29.2 1.2 3.4 2.2 5.2 73.4 0.3 9.6 4.5 10.9 30.8 3.5 3.5 41.6 8.9 4.0 4.5 10.8 2.4 24.3 25.2 45.7 22.2 28.9 0.8 0.6 1.2 24.1 2.7 35.8 0.0 4.1 0.2 1.4 3.8 2.8 1.4 2.7 2.0 3.4 1.5 2.0 1.1 0.8 0.7 2.7 2.8 2.9 3.2 15.9 13.3 15.0 17.3 18.9 10.7 9.9 13.0 13.2 12.7 26.8 17.0 14.3 46.9 95.9 11.5 31.5 35.7 18.7 31.8 38.4 23.6 26.8 0.0 34.1 0.9 56.3 142.5 0.0 17.6 23.1 42.0 88.8 8.1 52.0 34.6 28.6 30.9 54.0 64.5 2.4 41.1 45.0 32.1 26.2 69.7 11.4 96.9 52.6 70.4 3.3 9.5 6.5 55.6 0.5 5.7 67.0 57.7 11.5 29.8 96.8 PLEK P47 ENSG00000115956 Pleckstrin P08567 2 68365173-68397453 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0" "Group enriched" "Detected in many" 5 "B-cells: 62.6;granulocytes: 59.1;Hofbauer cells: 195.0;Kupffer cells: 185.4;Macrophages: 211.6;monocytes: 179.5;T-cells: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 93.6;HL-60: 21.1;HMC-1: 35.8;NB-4: 31.4;THP-1: 36.6;U-266/84: 24.3;U-698: 24.9;U-937: 58.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031838, HPA057341" Enhanced Approved Nucleoli NA NA 970000000 Nucleoli "HPA031838: AB_10602146, HPA057341: AB_2732609" "unprognostic (2.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.52e-3)" "unprognostic (3.52e-1)" "unprognostic (3.08e-2)" "unprognostic (4.67e-2)" "unprognostic (3.40e-2)" "unprognostic (4.00e-2)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (3.57e-1)" "unprognostic (4.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" 27.8 3.6 3.0 21.7 7.7 120.1 4.6 1.0 3.0 1.8 4.2 7.0 0.4 2.4 2.4 7.5 3.5 5.5 4.9 4.9 2.6 2.4 3.8 6.5 17.0 36.6 6.4 0.8 4.3 2.8 0.7 2.0 8.5 5.0 4.0 4.5 2.7 3.5 0.8 2.3 1.7 8.0 5.0 8.6 51.0 3.2 5.7 3.7 8.2 3.8 2.7 25.7 7.3 2.0 22.9 66.9 80.4 50.8 33.2 44.7 65.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.6 0.0 0.0 0.0 21.1 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.3 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 1.4 24.3 24.9 0.0 58.0 0.0 24.8 39.7 57.2 44.7 49.2 23.5 22.9 8.2 32.2 32.1 13.5 2.3 25.3 80.4 33.2 50.8 66.9 0.8 65.9 3.0 7.7 1.0 3.0 2.6 2.4 6.4 0.8 5.0 3.7 17.9 30.6 62.6 0.1 5.8 0.0 1.7 0.0 24.1 28.4 1.8 0.0 1.0 0.0 0.1 1.4 3.1 0.0 0.0 0.5 1.3 6.1 0.1 59.1 0.9 195.0 0.0 0.0 4.9 185.4 4.5 0.6 211.6 16.9 179.5 0.0 0.0 0.1 0.0 0.4 0.6 0.0 12.9 2.6 0.9 0.7 5.8 2.2 116.7 0.0 0.1 PLEKHA6 "KIAA0969, PEPP3" ENSG00000143850 "Pleckstrin homology domain containing A6" Q9Y2H5 1 204218851-204377665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.1" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 37.9;Cholangiocytes: 35.7;Enterocytes: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 20.3;BEWO: 33.0;CAPAN-2: 27.6;OE19: 27.6;RT4: 22.9;SK-BR-3: 20.4;T-47d: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028152, HPA028157" Enhanced Approved "Vesicles,Cell Junctions" NA NA "Cell Junctions" Vesicles "HPA028152: AB_10601048, HPA028157: " "unprognostic (9.81e-3)" "unprognostic (3.05e-1)" "unprognostic (1.59e-2)" "unprognostic (3.14e-2)" "unprognostic (1.63e-1)" "unprognostic (1.30e-1)" "unprognostic (2.37e-2)" "unprognostic (1.38e-2)" "unprognostic (9.01e-2)" "unprognostic (3.32e-1)" "unprognostic (9.60e-3)" "unprognostic (1.53e-1)" "unprognostic (5.02e-3)" "unprognostic (1.23e-1)" "unprognostic (8.22e-2)" "unprognostic (5.17e-2)" "prognostic favorable (3.57e-4)" 2.4 4.6 18.2 4.1 27.8 0.4 10.6 60.1 34.5 3.4 23.2 13.4 1.4 18.2 2.6 10.0 13.0 7.4 9.8 11.8 14.2 11.4 20.9 13.9 2.4 0.6 11.5 23.3 2.8 7.6 3.7 17.6 6.3 18.9 9.4 21.9 21.7 5.2 11.2 2.6 2.0 20.8 4.8 19.0 1.9 29.1 2.7 14.2 0.0 2.2 1.3 1.9 7.3 6.1 0.9 1.4 0.1 0.2 0.0 0.4 0.0 20.3 12.8 8.1 0.0 0.1 0.1 33.0 0.7 2.3 0.0 0.1 6.1 27.6 0.1 6.2 0.4 0.1 2.3 0.1 2.2 0.1 0.0 1.3 0.0 5.0 8.7 1.2 0.0 0.0 0.3 6.9 0.0 1.8 2.5 3.6 0.3 0.0 0.0 8.3 9.1 0.0 0.0 2.5 27.6 15.7 0.0 0.0 0.0 8.2 22.9 1.7 16.9 9.2 20.4 0.1 1.8 19.5 0.1 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 18.2 27.8 60.1 34.5 14.2 11.4 11.5 23.3 18.9 14.2 0.0 10.4 0.0 4.3 0.1 37.9 13.9 35.7 2.7 1.2 8.7 19.6 5.7 3.3 6.8 6.8 1.1 45.2 0.0 4.5 1.4 2.6 7.3 0.0 18.7 0.7 17.5 16.1 0.6 0.0 2.9 4.9 0.2 0.0 0.0 27.5 0.9 9.4 28.8 3.5 9.1 6.7 0.0 0.2 0.1 0.1 0.5 18.1 0.9 24.0 6.9 PLEKHB1 "KPL1, PHR1, PHRET1" ENSG00000021300 "Pleckstrin homology domain containing B1" Q9UF11 11 73646178-73662819 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 220.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 324.0;Early spermatids: 111.8;Late spermatids: 139.9;Muller glia cells: 327.3;Rod photoreceptor cells: 320.5" "Cancer enhanced" "Detected in all" "glioma: 59.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 33.1" "Lineage enriched" "Detected in many" 5 "T-cells: 33.1" "Cell line enhanced" "Detected in many" "Hep G2: 36.2;OE19: 25.2;U-266/84: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.20e-1)" "unprognostic (5.07e-1)" "unprognostic (2.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.16e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-2)" "unprognostic (1.41e-3)" "unprognostic (3.01e-1)" "unprognostic (3.94e-2)" "prognostic favorable (6.02e-4)" "unprognostic (3.59e-1)" "prognostic favorable (1.99e-6)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (4.47e-1)" "unprognostic (7.44e-2)" 2.0 4.3 87.5 4.3 85.7 1.6 5.8 18.4 144.2 4.2 5.9 120.2 0.4 6.3 2.5 8.3 3.3 12.5 5.8 7.0 89.2 72.8 6.5 1.7 8.0 4.8 143.1 48.7 1.9 11.4 45.4 12.9 1.5 70.1 5.1 5.3 27.8 25.9 5.4 4.8 1.3 7.0 2.5 220.2 2.9 10.1 5.6 69.5 0.0 14.5 0.0 4.4 2.3 0.7 6.9 0.3 0.4 0.1 1.5 33.1 9.9 0.3 0.9 2.3 1.8 1.0 0.3 0.1 0.1 0.0 0.1 0.1 4.0 7.7 0.0 9.9 0.2 0.3 0.2 1.2 0.2 0.2 5.1 6.1 0.0 0.4 36.2 0.6 0.0 0.1 0.3 0.0 0.1 0.0 2.0 0.0 9.4 0.1 5.1 0.1 2.9 2.4 0.1 1.5 25.2 0.5 1.8 0.0 1.2 0.3 0.7 5.8 1.4 0.0 0.1 0.6 1.7 2.7 0.4 0.0 0.0 1.1 0.0 0.7 8.6 13.8 5.1 1.4 0.0 0.3 0.0 0.1 0.4 6.5 0.0 15.9 6.9 16.1 11.8 0.2 2.9 33.1 18.4 0.3 1.5 0.0 0.3 9.3 9.9 87.5 85.7 18.4 47.9 89.2 72.8 143.1 48.7 70.1 69.5 6.0 9.1 0.5 1.0 0.3 41.4 7.7 20.4 44.2 4.5 7.0 324.0 0.4 10.0 27.2 111.8 0.5 0.7 0.0 0.7 0.1 0.9 6.2 11.5 0.0 2.2 19.1 60.3 1.8 0.0 139.9 2.3 1.0 10.1 1.0 9.0 327.3 4.7 3.7 0.7 9.9 320.5 0.0 1.0 2.8 1.1 0.1 0.1 4.4 4.1 1.4 PLEKHD1 UPF0639 ENSG00000175985 "Pleckstrin homology and coiled-coil domain containing D1" A6NEE1 14 69484692-69531551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.4;brain: 16.0" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 217.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "cerebellum: 16.0" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.4" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.4" "Cell line enhanced" "Detected in some" "OE19: 2.8;SK-BR-3: 6.2;T-47d: 6.0;U-266/70: 2.8" "Region enhanced" "Detected in many" "cerebellum: 33.7" "Low region specificity" "Detected in all" HPA051875 Uncertain NA NA "HPA051875: AB_2681648" "unprognostic (8.73e-2)" "unprognostic (4.64e-3)" "unprognostic (3.73e-2)" "unprognostic (4.03e-2)" "unprognostic (7.58e-2)" "unprognostic (3.15e-3)" "unprognostic (1.44e-1)" "unprognostic (1.64e-3)" "unprognostic (3.28e-1)" "unprognostic (1.83e-1)" "unprognostic (4.56e-3)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.42e-2)" 0.3 0.3 0.4 0.1 1.5 1.1 1.4 16.0 2.2 0.5 0.2 0.5 2.5 0.3 0.2 4.2 0.2 0.2 0.2 0.3 0.6 0.5 1.8 0.1 0.4 2.0 0.8 0.1 0.2 0.5 4.5 0.6 0.1 1.4 0.2 0.0 4.1 3.9 4.0 0.2 2.0 0.2 0.1 0.6 0.4 0.3 1.8 0.4 0.8 4.0 0.1 0.5 0.2 0.2 0.2 7.4 0.6 0.1 0.1 0.1 0.0 0.3 0.3 0.5 0.9 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.7 0.5 0.5 0.1 0.2 0.5 0.8 0.1 0.1 0.5 0.4 0.1 0.4 0.1 0.1 0.5 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.3 0.2 1.2 0.1 0.9 0.4 0.4 0.7 2.8 0.1 0.3 0.1 0.2 0.5 0.5 0.8 1.9 0.2 6.2 0.1 0.2 6.0 0.2 0.2 0.3 0.8 0.4 0.3 2.8 0.6 0.3 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.6 0.1 0.1 7.4 0.1 0.0 0.4 1.5 16.0 2.2 0.6 0.5 0.8 0.1 1.4 0.4 0.0 8.2 0.0 1.7 0.3 46.2 0.8 0.0 1.4 3.4 0.0 3.9 0.0 3.3 0.1 0.3 0.7 0.0 0.0 0.2 0.1 0.4 1.4 1.1 0.0 0.1 217.7 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.0 0.0 1.7 0.2 0.0 0.0 0.1 5.3 0.0 0.4 0.5 0.2 0.3 0.1 0.5 0.0 0.6 PLEKHF1 "APPD, MGC4090, PHAFIN1, ZFYVE15" ENSG00000166289 "Pleckstrin homology and FYVE domain containing 1" Q96S99 19 29665056-29675457 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.3;skeletal muscle: 48.0" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 49.0;Cytotrophoblasts: 49.5;Leydig cells: 72.5;Peritubular cells: 68.2;T-cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 15 "NK-cells: 16.7;T-cells: 42.3" "Cell line enhanced" "Detected in many" "BEWO: 22.6;SK-BR-3: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA025925 Uncertain NA NA "HPA025925: AB_1844958" "unprognostic (5.01e-2)" "unprognostic (6.39e-2)" "unprognostic (1.31e-2)" "unprognostic (3.04e-2)" "unprognostic (9.43e-3)" "unprognostic (2.57e-1)" "unprognostic (4.73e-2)" "unprognostic (1.93e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.54e-5)" "unprognostic (1.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-2)" "prognostic favorable (4.54e-4)" 11.4 2.4 2.6 4.3 4.2 5.2 12.4 1.5 4.9 8.0 5.7 6.6 9.6 4.0 10.0 4.3 7.7 7.7 9.7 13.2 2.9 2.5 2.3 8.3 5.0 7.0 11.3 1.3 4.9 3.8 3.9 1.2 12.4 4.1 10.5 1.6 1.4 20.0 9.7 48.0 4.1 4.6 8.0 3.8 7.2 3.8 5.2 4.9 7.0 3.7 19.3 6.5 9.1 7.4 2.0 0.3 1.4 0.1 16.7 42.3 13.3 7.9 2.9 0.0 1.8 5.8 5.1 22.6 2.0 2.6 2.5 3.9 1.8 3.5 0.0 7.4 2.6 4.6 7.0 0.5 1.7 0.3 5.2 3.8 4.0 1.4 3.3 10.0 0.2 11.0 8.9 0.6 2.7 4.9 1.6 2.0 3.9 4.4 0.0 1.3 1.1 0.5 3.0 0.3 1.2 1.4 0.0 2.7 2.1 1.6 12.5 0.0 1.2 1.0 18.2 9.3 1.8 6.8 1.2 1.9 3.2 3.4 4.0 3.8 1.4 14.6 0.7 3.5 4.0 1.1 1.4 0.1 0.0 42.3 0.1 29.4 1.2 17.1 33.5 0.3 2.0 10.4 19.5 0.4 16.7 0.1 0.1 15.2 13.3 2.6 4.2 1.5 4.9 2.9 2.5 11.3 1.3 4.1 4.9 0.0 0.3 4.4 24.7 49.0 0.8 7.3 22.9 1.4 2.3 8.7 0.0 49.5 5.0 18.6 0.4 7.1 0.4 0.0 7.5 3.6 16.9 17.4 0.0 8.7 8.9 0.0 0.0 9.8 2.4 0.2 72.5 3.0 16.9 0.0 0.9 5.1 3.5 2.9 68.2 4.2 0.4 0.0 11.4 0.3 1.5 31.2 32.2 61.8 1.2 21.1 PLEKHG1 "ARHGEF41, KIAA1209" ENSG00000120278 "Pleckstrin homology and RhoGEF domain containing G1" Q9ULL1 6 150599883-150843665 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.7" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 43.2;Ito cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 28 "memory B-cell: 14.7;naive B-cell: 15.9" "Lineage enriched" "Detected in single" 29 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4" "Region enriched" "Detected in many" 5 "thalamus: 56.1" "Low region specificity" "Detected in all" "HPA027128, HPA027319, HPA028270" Approved Enhanced Nucleoplasm Yes No Nucleoplasm "HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388" "unprognostic (2.93e-1)" "unprognostic (3.44e-1)" "unprognostic (3.04e-3)" "unprognostic (2.34e-1)" "unprognostic (1.05e-1)" "unprognostic (2.80e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (4.62e-3)" "unprognostic (3.63e-1)" "unprognostic (4.30e-2)" "unprognostic (3.83e-1)" "unprognostic (2.15e-2)" 27.5 2.2 7.3 10.6 7.3 2.3 10.0 2.4 7.1 8.3 5.8 10.1 4.8 4.8 7.8 14.1 9.6 8.9 8.1 5.9 7.7 6.7 4.5 5.1 12.1 13.5 10.5 3.0 4.7 2.8 8.2 5.1 13.9 11.1 4.1 6.2 3.4 3.5 5.4 6.4 8.9 6.0 5.7 19.6 28.9 4.5 7.3 7.7 39.7 6.0 5.8 13.3 7.4 8.5 15.9 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 12.5 0.1 0.0 0.0 8.9 0.0 0.0 0.0 0.0 6.9 3.0 4.9 4.8 0.0 1.2 1.8 18.4 1.6 0.0 7.7 2.0 0.3 0.9 0.0 0.0 0.0 1.4 0.8 4.7 0.0 0.1 0.0 7.7 4.1 0.0 16.4 0.0 0.2 1.5 0.0 0.9 4.8 0.5 0.8 0.0 0.0 3.6 8.2 0.4 0.1 0.0 2.2 1.5 1.4 0.0 0.0 7.7 0.0 1.7 0.0 3.3 0.0 0.0 11.4 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.5 14.7 0.3 0.4 0.0 15.9 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.4 7.3 7.3 2.4 7.1 7.7 6.7 10.5 3.0 11.1 7.7 0.0 3.8 8.1 0.6 3.8 0.2 1.6 2.5 5.3 3.4 7.0 0.0 4.2 3.3 2.3 2.7 43.2 4.3 0.0 1.0 1.3 9.9 0.7 0.0 3.0 0.5 0.0 5.2 39.9 6.1 1.3 0.3 0.8 5.0 8.2 9.0 8.3 6.3 10.5 0.4 2.8 0.5 0.0 2.3 1.0 0.9 3.1 2.4 3.2 4.2 2.4 PLEKHG4 "ARHGEF44, DKFZP434I216, SCA4" ENSG00000196155 "Pleckstrin homology and RhoGEF domain containing G4" Q58EX7 16 67277510-67289499 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 28.2" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 28.6;Spermatogonia: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 3.7" "Not detected" "Not detected" HPA055696 Approved "Cell Junctions" NA NA "Cell Junctions" "HPA055696: AB_2682889" "unprognostic (2.63e-1)" "unprognostic (1.98e-3)" "unprognostic (1.16e-1)" "unprognostic (9.90e-2)" "unprognostic (3.40e-1)" "unprognostic (6.34e-2)" "unprognostic (1.50e-1)" "unprognostic (7.88e-2)" "unprognostic (6.88e-2)" "unprognostic (4.06e-3)" "unprognostic (4.48e-2)" "unprognostic (7.92e-2)" "prognostic unfavorable (6.72e-9)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (9.35e-3)" "unprognostic (5.01e-2)" 5.6 3.5 1.1 3.8 3.9 1.1 7.4 1.0 3.2 4.8 4.5 8.0 3.3 3.6 4.7 5.0 6.1 3.3 6.1 2.2 1.2 1.5 2.2 0.3 4.8 6.8 5.4 2.4 15.2 7.3 0.5 2.6 4.7 3.9 2.2 2.7 9.5 5.7 2.1 1.3 8.2 3.7 2.7 4.7 6.5 2.0 28.2 1.3 5.9 3.4 3.4 5.5 1.6 4.3 0.6 4.0 0.2 0.7 0.4 2.0 1.0 2.5 4.8 0.3 2.8 2.5 23.9 3.7 5.9 7.9 6.0 9.9 13.7 2.3 7.1 17.2 5.4 2.0 0.1 3.6 0.3 4.3 1.2 1.9 14.0 11.3 3.3 7.7 8.3 11.3 17.9 2.8 20.0 0.2 5.0 11.7 23.2 11.2 0.1 0.1 1.9 10.5 2.8 2.2 2.0 5.1 0.0 0.0 7.3 2.8 0.5 1.5 8.8 19.9 1.5 8.1 0.9 1.1 5.9 17.7 2.9 10.5 21.0 0.1 17.0 16.8 6.6 12.1 0.2 3.5 0.0 0.2 0.2 0.8 0.7 1.5 0.6 1.0 1.1 0.3 0.1 2.0 1.2 0.0 0.4 0.3 4.0 1.4 1.0 1.1 3.9 1.0 3.2 1.2 1.5 5.4 2.4 3.9 1.3 3.0 1.6 0.0 0.5 2.5 0.7 2.8 2.5 1.4 5.7 1.8 0.0 0.3 0.0 0.8 1.1 1.5 1.0 0.0 0.3 0.3 3.1 0.5 3.5 0.0 0.7 0.0 1.2 2.5 1.3 2.0 5.8 1.0 0.0 0.0 2.2 2.2 1.0 2.9 1.4 0.0 5.5 6.5 0.9 28.6 22.2 1.1 0.2 3.2 3.2 0.4 PLEKHG5 "GEF720, KIAA0720, Syx, Tech" ENSG00000171680 "Pleckstrin homology and RhoGEF domain containing G5" O94827 1 6466092-6520061 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.8;skin 1: 60.0" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 12.9;Suprabasal keratinocytes: 12.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 59.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 17.5" "Group enriched" "Detected in many" 4 "amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2" "Low region specificity" "Detected in all" HPA049570 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA049570: AB_2680818" "unprognostic (5.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.47e-1)" "unprognostic (2.81e-1)" "unprognostic (1.50e-3)" "unprognostic (5.10e-2)" "unprognostic (1.02e-1)" "unprognostic (5.46e-2)" "unprognostic (4.40e-2)" "unprognostic (1.02e-2)" "unprognostic (4.85e-1)" "unprognostic (2.70e-2)" "unprognostic (1.28e-3)" "unprognostic (4.85e-1)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (4.85e-2)" 10.6 9.7 8.7 2.9 6.3 0.7 4.1 59.8 11.6 3.9 3.0 1.2 2.5 3.3 3.8 4.5 7.1 3.9 6.5 5.4 7.7 2.9 2.3 0.8 3.6 2.7 1.8 6.7 2.6 3.1 4.0 15.2 7.6 4.4 3.4 2.8 4.9 4.2 5.3 3.4 60.0 4.3 2.7 1.8 16.9 2.6 2.6 1.4 0.0 2.4 6.5 4.8 2.3 4.4 0.5 0.6 2.1 0.5 0.3 1.0 0.4 4.0 1.1 8.1 4.7 0.8 2.8 1.4 5.5 3.1 1.7 1.0 2.3 8.0 0.1 12.6 1.8 3.1 13.7 0.9 12.0 0.9 7.9 1.6 0.0 5.6 1.4 1.2 0.0 0.7 2.9 6.4 5.9 6.9 10.5 12.3 0.9 0.0 1.0 0.4 3.4 0.1 15.6 2.5 1.2 12.2 0.1 1.0 1.1 4.3 1.3 5.2 14.9 0.6 4.1 0.3 4.1 5.4 0.1 17.5 4.2 3.0 0.0 3.3 0.1 0.0 0.9 4.6 0.0 0.3 1.8 0.5 0.3 0.4 0.4 1.0 0.2 0.8 0.7 0.1 0.5 0.5 0.6 2.1 0.3 0.2 0.6 0.2 0.4 8.7 6.3 59.8 11.6 7.7 2.9 1.8 6.7 4.4 1.4 0.0 1.0 0.0 2.1 6.5 0.6 3.2 2.5 1.4 2.3 3.5 2.0 2.2 0.0 1.1 8.6 4.5 3.3 0.0 1.2 3.3 1.8 1.4 0.0 0.0 4.0 1.6 3.4 5.5 1.2 2.6 1.7 0.0 0.0 0.0 5.2 9.2 3.3 5.8 8.1 0.6 1.5 12.9 1.0 1.9 3.2 12.7 1.6 0.0 2.7 5.5 PLEKHG6 "FLJ10665, MYOGEF" ENSG00000008323 "Pleckstrin homology and RhoGEF domain containing G6" Q3KR16 12 6310436-6328506 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.4;placenta: 39.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 64.9;Extravillous trophoblasts: 43.1;Paneth cells: 35.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 2.5;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.9;granulocytes: 2.5" "Cell line enhanced" "Detected in some" "BEWO: 56.1;CACO-2: 17.8;CAPAN-2: 9.8;OE19: 16.9;RT4: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041459, HPA058230" Uncertain Supported "Cell Junctions,Centrosome" NA NA "Cell Junctions" Centrosome "HPA041459: AB_10794518, HPA058230: AB_2683645" "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" "unprognostic (1.44e-1)" "unprognostic (8.03e-3)" "unprognostic (5.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.20e-2)" "unprognostic (1.22e-1)" "unprognostic (3.13e-1)" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (6.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (4.18e-2)" "unprognostic (5.73e-2)" 7.5 0.2 0.3 8.9 0.7 1.0 15.8 0.3 0.4 4.4 30.3 0.4 1.1 19.4 0.6 1.6 19.9 0.5 6.7 1.2 0.3 0.0 1.1 2.5 1.8 0.3 0.3 0.3 0.6 4.5 1.9 3.3 39.6 0.5 2.6 9.6 0.7 8.8 2.3 0.3 6.7 43.4 0.5 0.3 0.4 5.7 0.5 0.3 0.5 3.4 11.3 8.6 6.8 8.6 0.3 3.9 2.5 0.2 0.1 0.4 0.1 0.2 2.1 0.2 0.0 1.1 0.1 56.1 0.1 0.0 0.1 0.1 17.8 9.8 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 3.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.2 4.6 16.9 0.3 0.0 0.0 0.1 0.0 18.9 0.1 0.0 0.4 8.4 0.1 4.2 2.7 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.4 2.5 0.1 0.1 3.9 0.1 0.1 0.3 0.7 0.3 0.4 0.3 0.0 0.3 0.3 0.5 0.3 0.0 0.0 0.0 5.7 4.4 0.0 0.3 5.1 0.0 0.0 1.8 0.0 13.8 0.0 8.3 1.1 0.3 64.9 0.0 1.6 43.1 1.1 6.7 0.0 2.1 2.4 0.0 8.1 0.0 0.0 1.5 2.3 0.0 0.0 0.0 18.6 0.9 2.5 35.4 0.7 0.7 0.0 0.0 3.1 0.2 0.5 6.0 20.0 0.0 20.6 16.8 PLEKHG7 FLJ46688 ENSG00000187510 "Pleckstrin homology and RhoGEF domain containing G7" Q6ZR37 12 92721462-92772455 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 5.6;fallopian tube: 7.9" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 31 "memory B-cell: 4.5;naive B-cell: 1.6" "Lineage enriched" "Detected in single" 45 "B-cells: 4.5" "Cell line enhanced" "Detected in some" "Daudi: 1.8;HBF TERT88: 1.3;RPMI-8226: 5.1;RT4: 1.2;SK-BR-3: 4.2" HPA060632 Uncertain NA NA "HPA060632: AB_2684333" "unprognostic (4.47e-3)" "unprognostic (3.95e-2)" "unprognostic (1.16e-1)" "unprognostic (1.05e-3)" "unprognostic (1.80e-2)" "unprognostic (9.91e-5)" "unprognostic (1.38e-1)" "unprognostic (9.44e-2)" "unprognostic (1.61e-1)" "unprognostic (6.20e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (2.56e-1)" "unprognostic (2.13e-1)" "unprognostic (2.75e-1)" "unprognostic (3.27e-5)" 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 3.3 0.6 0.1 0.4 5.6 0.1 7.9 0.3 0.0 0.0 0.0 0.7 0.5 2.2 2.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.4 0.1 0.6 0.0 0.0 2.6 0.0 0.0 1.6 2.7 0.1 0.0 2.9 2.9 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.2 1.8 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 5.1 0.1 1.2 0.0 0.0 0.0 4.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.9 0.1 0.1 0.3 0.6 0.0 56.2 11.4 1.8 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 1.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 PLEKHH1 KIAA1200 ENSG00000054690 "Pleckstrin homology, MyTH4 and FERM domain containing H1" Q9ULM0 14 67533301-67589612 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0;thyroid gland: 30.2" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 37.3;Mucus-secreting cells: 17.4;Rod photoreceptor cells: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 10.0;BEWO: 9.7;RT4: 9.8;SK-MEL-30: 12.1;T-47d: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047707, HPA051964" Uncertain Approved Centrosome NA NA Centrosome "HPA047707: AB_2680126, HPA051964: AB_2681675" "unprognostic (2.47e-2)" "unprognostic (9.57e-2)" "unprognostic (3.94e-2)" "prognostic favorable (8.03e-5)" "unprognostic (4.74e-1)" "unprognostic (9.15e-3)" "unprognostic (8.43e-5)" "unprognostic (1.54e-2)" "unprognostic (2.28e-1)" "unprognostic (4.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.85e-1)" "prognostic favorable (4.03e-7)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" 1.3 4.5 9.7 1.6 33.7 0.5 2.9 8.6 26.8 3.5 6.8 61.0 2.5 11.6 1.9 8.9 1.6 3.8 2.5 1.1 16.2 8.7 2.7 0.8 1.2 0.6 35.8 16.6 0.6 7.7 10.3 3.3 2.0 26.9 10.7 7.0 5.1 20.3 2.9 1.1 4.1 9.0 1.3 38.1 1.3 6.6 2.3 34.4 0.0 30.2 0.0 0.7 2.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 2.0 10.0 0.2 0.0 9.7 0.0 0.0 0.1 0.1 3.1 1.6 0.0 1.6 0.0 0.9 2.2 3.5 0.8 0.1 0.3 3.5 0.0 1.6 2.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 1.2 3.7 0.0 0.0 7.2 0.0 0.2 3.0 5.7 0.6 0.1 0.3 1.4 1.1 9.8 2.7 2.5 0.8 1.9 12.1 4.9 9.6 2.0 0.0 0.8 3.7 1.0 0.6 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 33.7 8.6 18.1 16.2 8.7 35.8 16.6 26.9 34.4 3.0 8.3 0.0 0.7 0.1 6.9 3.1 2.5 1.4 0.0 8.7 37.3 2.2 3.3 1.8 0.4 0.0 11.9 0.0 3.5 0.3 0.4 3.5 0.0 0.0 0.7 3.2 7.0 0.0 0.8 0.0 0.3 0.8 3.3 0.0 17.4 5.5 2.5 8.6 0.4 1.3 37.9 0.0 0.4 0.4 1.4 1.9 8.9 0.0 16.1 1.0 PLEKHH3 FLJ21019 ENSG00000068137 "Pleckstrin homology, MyTH4 and FERM domain containing H3" Q7Z736 17 42667914-42676994 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 44.9" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 54.5;Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 22.6;T-47d: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046234 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA046234: AB_2679597" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.75e-2)" "unprognostic (5.72e-3)" "unprognostic (1.25e-1)" "unprognostic (3.42e-3)" "unprognostic (5.05e-3)" "unprognostic (5.95e-2)" "unprognostic (6.45e-2)" "unprognostic (1.63e-2)" "unprognostic (1.51e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (9.62e-5)" "unprognostic (1.87e-1)" "unprognostic (1.72e-1)" "unprognostic (9.30e-3)" "unprognostic (1.44e-3)" 8.1 7.7 4.0 2.6 4.1 5.1 20.4 9.0 6.1 16.9 6.0 3.3 6.2 4.6 10.0 7.6 13.6 11.0 10.7 6.5 4.4 1.6 4.4 6.6 8.1 1.8 3.9 3.8 14.7 44.9 8.2 6.6 4.4 4.3 10.9 1.8 8.1 9.2 11.3 23.7 10.6 3.4 9.9 6.7 4.0 11.5 8.1 4.1 1.9 5.6 7.3 5.1 10.3 9.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 6.9 6.3 3.0 4.9 3.8 1.6 5.4 2.6 2.5 2.1 2.0 3.1 3.7 1.0 3.1 3.1 3.5 13.0 2.2 3.5 0.6 5.9 5.0 0.3 12.9 2.6 4.2 0.1 4.4 2.7 5.9 2.7 0.4 2.1 1.4 0.4 7.7 16.3 0.9 12.7 0.3 5.5 1.1 3.6 5.6 1.0 2.9 22.6 0.7 7.9 10.8 11.6 4.0 5.9 5.9 0.7 25.9 5.8 2.1 6.8 6.0 7.5 4.8 18.4 20.5 5.3 4.9 1.5 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.0 4.1 9.0 6.1 4.4 1.6 3.9 3.8 4.3 4.1 11.9 13.3 0.0 17.2 13.9 54.5 9.7 10.2 1.4 5.7 8.7 21.6 9.1 0.0 2.2 7.8 8.1 3.5 70.0 6.6 3.7 10.0 17.2 2.3 10.5 1.8 31.8 7.5 14.1 3.5 1.5 16.4 2.3 15.1 1.0 5.8 16.2 5.3 0.0 21.2 2.0 21.9 25.8 18.9 0.7 12.5 16.3 5.1 0.9 6.8 12.2 PLEKHN1 DKFZP434H2010 ENSG00000187583 "Pleckstrin homology domain containing N1" Q494U1 1 966497-975865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 17.5;Glandular cells: 28.7;Pancreatic endocrine cells: 24.5;Suprabasal keratinocytes: 15.2;Urothelial cells: 37.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.3;HaCaT: 19.9;SK-BR-3: 13.6" "Not detected" "Not detected" HPA031742 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA031742: AB_10670704" "unprognostic (2.72e-3)" "unprognostic (8.05e-3)" "unprognostic (9.03e-2)" "unprognostic (4.47e-2)" "unprognostic (7.50e-4)" "unprognostic (2.93e-2)" "unprognostic (1.38e-2)" "unprognostic (1.78e-1)" "unprognostic (3.24e-1)" "unprognostic (1.01e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (9.98e-2)" "unprognostic (1.96e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" 0.4 0.6 0.0 1.8 0.2 0.4 1.4 0.0 0.1 7.7 0.9 0.0 0.0 0.8 1.1 2.7 31.5 0.3 5.0 0.5 0.3 0.0 2.3 0.8 1.1 0.3 0.0 0.0 0.1 0.5 0.3 0.0 1.5 0.0 3.7 0.2 0.3 5.3 1.2 1.5 31.3 0.7 0.6 0.6 0.5 1.7 0.8 0.0 0.2 0.7 20.2 21.2 6.0 10.6 0.0 0.3 2.0 0.9 2.3 1.1 0.2 11.3 1.2 0.0 0.8 0.0 0.6 1.9 5.3 1.3 3.4 0.8 1.5 8.8 0.0 2.5 2.1 4.5 19.9 0.2 3.3 0.5 3.9 0.8 0.0 3.5 2.3 0.5 0.2 0.1 0.1 2.8 2.2 1.2 2.9 0.3 0.0 0.2 3.2 0.2 6.6 0.0 0.2 0.4 1.6 9.1 0.0 0.0 4.2 3.7 3.4 0.1 0.1 5.9 13.6 0.8 0.3 2.6 0.0 2.4 4.3 1.9 0.4 3.5 2.6 0.1 0.1 5.2 1.9 2.4 0.0 0.9 2.0 0.3 0.3 0.0 0.0 0.5 1.1 0.3 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.9 17.5 4.0 0.1 0.8 0.0 1.4 1.2 0.0 0.0 5.9 0.0 11.4 0.0 0.6 0.0 0.0 12.2 1.5 0.6 28.7 0.0 0.0 1.0 3.2 0.0 0.0 0.8 0.0 0.0 1.4 1.7 1.8 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 15.2 8.2 2.5 0.0 37.9 PLEKHO1 "CKIP-1, OC120" ENSG00000023902 "Pleckstrin homology domain containing O1" Q53GL0 1 150149183-150164720 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 60.7" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 188.6;Late spermatids: 315.7;monocytes: 146.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061018 Supported Mitochondria NA NA Mitochondria "HPA061018: AB_2684416" "unprognostic (1.41e-2)" "unprognostic (7.04e-3)" "unprognostic (2.01e-2)" "unprognostic (1.78e-2)" "unprognostic (3.23e-2)" "unprognostic (4.77e-2)" "unprognostic (1.62e-2)" "unprognostic (8.33e-2)" "unprognostic (3.84e-2)" "unprognostic (3.18e-2)" "unprognostic (8.71e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (6.47e-11)" "unprognostic (9.30e-2)" "unprognostic (1.72e-1)" "unprognostic (1.87e-1)" "unprognostic (6.52e-2)" 10.9 17.0 14.2 34.4 22.1 10.2 10.5 17.0 14.4 9.6 44.5 5.4 6.4 11.8 16.9 7.7 16.8 11.9 14.1 17.8 10.2 6.9 5.8 5.8 12.9 29.0 8.2 13.1 13.5 2.5 1.4 3.5 10.1 8.0 18.2 8.3 7.9 4.7 12.1 15.8 3.6 17.4 60.7 6.5 29.4 22.3 24.8 7.3 15.0 3.8 3.1 17.4 29.3 17.7 11.0 16.0 18.7 15.8 2.1 5.1 5.4 5.1 1.2 17.5 13.6 5.6 5.0 1.4 9.0 12.5 12.3 10.9 0.3 0.1 0.1 1.8 10.6 9.1 0.4 8.7 0.4 4.0 31.1 4.4 1.0 0.7 3.2 10.7 7.1 29.6 7.4 0.4 15.3 2.3 11.7 11.6 14.5 1.9 13.7 16.7 2.4 27.1 14.2 16.4 0.0 2.4 24.7 9.5 5.9 2.0 1.5 11.0 17.9 0.7 0.0 6.8 8.8 0.9 7.1 16.2 8.1 9.2 8.4 10.8 5.2 0.1 3.2 32.3 0.0 3.1 1.5 15.8 0.3 3.5 14.1 3.8 11.0 5.1 3.7 11.7 10.5 3.5 3.0 18.7 2.1 12.8 16.0 3.7 5.4 14.2 22.1 17.0 14.4 10.2 6.9 8.2 13.1 8.0 7.3 32.8 12.8 62.7 62.8 19.2 5.4 33.9 5.1 0.0 2.3 0.0 0.0 1.4 1.7 6.5 188.6 39.6 0.0 0.0 6.7 2.5 27.6 51.8 5.7 0.9 96.3 7.9 17.0 51.5 68.8 315.7 16.1 106.5 23.6 146.1 0.1 32.6 10.1 0.0 23.0 0.0 6.1 71.1 83.4 126.2 12.1 12.4 1.3 24.5 0.3 24.4 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.9" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 56.4;Ito cells: 42.4;Kupffer cells: 40.1;Muller glia cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 10.4;granulocytes: 30.2;monocytes: 26.6" "Cell line enhanced" "Detected in many" "ASC diff: 31.3" HPA040055 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 22.1 17.4 12.9 19.9 16.6 29.4 12.4 6.2 9.9 10.3 12.2 11.5 5.2 6.8 11.9 13.3 10.7 13.0 17.4 9.3 13.3 8.0 8.1 8.2 22.4 19.6 10.1 8.7 10.4 5.7 5.1 6.4 22.6 17.2 10.5 5.6 17.0 6.1 10.2 5.9 6.0 9.4 16.9 14.5 57.9 10.2 7.0 11.3 5.1 18.6 6.6 13.8 17.1 14.1 4.0 10.4 30.2 26.6 2.7 5.4 10.3 2.7 1.8 3.5 3.4 31.3 18.0 8.3 8.1 12.2 8.7 8.9 2.2 1.7 7.4 4.3 16.5 8.8 1.0 4.0 3.3 5.1 11.4 1.2 7.4 0.8 2.5 24.1 8.3 11.1 13.0 2.9 10.8 3.5 7.5 12.0 1.5 2.2 26.5 11.5 0.8 1.7 9.0 6.7 1.4 1.7 6.4 8.5 5.3 1.4 1.9 0.3 3.0 3.4 1.2 11.1 6.0 1.2 11.3 15.5 6.7 6.2 6.3 3.3 9.9 15.5 2.5 7.2 10.8 3.9 7.0 14.3 9.2 5.4 20.4 5.0 4.0 3.1 5.0 10.4 2.6 1.3 2.7 30.2 2.7 26.6 1.2 4.1 10.3 12.9 16.6 6.2 9.9 13.3 8.0 10.1 8.7 17.2 11.3 0.0 9.3 8.6 2.1 4.9 0.7 2.6 2.5 1.4 2.3 8.7 0.0 3.3 3.3 2.2 3.2 18.3 0.0 0.0 1.3 4.0 9.3 2.4 18.4 0.8 56.4 0.0 0.0 42.4 40.1 1.8 17.0 30.6 13.5 6.4 0.1 62.2 2.1 0.0 24.1 2.1 3.2 12.9 8.0 0.9 1.9 3.9 5.0 11.5 0.2 3.1 PLEKHS1 "bA211N11.2, C10orf81, FLJ23537" ENSG00000148735 "Pleckstrin homology domain containing S1" Q5SXH7 10 113751454-113783429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 152.6;Club cells: 46.6;Exocrine glandular cells: 28.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.7;OE19: 31.9;RT4: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037583 Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA037583: AB_10671762" "unprognostic (2.64e-1)" "unprognostic (1.64e-2)" "unprognostic (2.74e-2)" "unprognostic (3.60e-2)" "unprognostic (1.07e-1)" "unprognostic (2.63e-2)" "unprognostic (1.74e-2)" "unprognostic (2.36e-2)" "unprognostic (8.43e-2)" "unprognostic (6.82e-2)" "unprognostic (2.57e-1)" "unprognostic (1.21e-2)" "unprognostic (0.00e+0)" "unprognostic (4.00e-3)" "unprognostic (2.19e-1)" "unprognostic (2.27e-1)" "prognostic favorable (1.03e-4)" 0.2 0.1 0.2 1.6 0.2 0.0 11.7 0.2 0.2 26.8 18.5 0.2 10.2 17.0 1.0 2.2 0.8 3.4 6.4 0.2 0.2 0.1 0.6 0.2 4.8 0.2 0.2 0.2 1.3 26.6 0.0 1.9 0.3 0.3 3.5 1.8 0.4 53.1 4.9 0.2 0.7 38.8 0.2 0.2 0.2 2.9 1.1 0.2 0.2 0.2 1.3 2.0 0.8 0.2 0.8 0.5 1.3 0.3 0.7 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 31.9 0.0 0.0 2.7 0.0 0.9 10.5 0.0 0.1 0.0 0.9 0.0 0.0 3.6 0.0 0.0 0.1 0.0 0.0 0.2 2.1 0.1 0.0 0.0 0.0 1.3 0.8 0.1 0.2 0.3 0.1 0.1 0.8 0.2 0.2 0.0 0.5 0.2 0.3 1.3 0.7 0.3 0.5 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.3 0.2 3.0 2.7 0.0 0.3 0.1 0.0 0.4 0.0 152.6 46.6 0.0 0.0 0.0 0.0 2.8 7.1 0.0 13.8 0.0 28.3 0.0 0.1 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 1.0 1.1 0.0 1.4 0.8 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 0.3 PLET1 C11orf34 ENSG00000188771 "Placenta expressed transcript 1" Q6UQ28 11 112248479-112260860 "Predicted membrane proteins" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 3.5" HPA040237 Uncertain NA NA "HPA040237: AB_10793960" "unprognostic (8.70e-2)" "unprognostic (1.75e-1)" "unprognostic (8.51e-3)" "unprognostic (5.19e-2)" 0.2 0.7 0.0 0.2 0.0 1.1 0.2 0.3 0.1 0.5 0.2 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.5 0.0 1.2 0.1 0.1 0.0 0.2 0.0 0.5 2.8 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.5 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 3.5 0.2 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.7 0.0 0.7 0.0 0.1 0.0 0.0 0.7 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLG ENSG00000122194 Plasminogen P00747 6 160702238-160753315 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 269.9" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 1391.0" "Cancer enriched" "Detected in some" 84 "liver cancer: 180.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.2;HL-60: 3.6;RH-30: 4.0;U-698: 2.0;U-937: 1.6" "CAB000668, CAB016678, HPA021602, HPA048823" Supported "Secreted to blood" NA NA 140000000000 41000000000 "CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.44e-1)" "unprognostic (8.54e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (6.28e-2)" "unprognostic (7.25e-2)" "prognostic favorable (4.22e-4)" "unprognostic (3.97e-3)" "unprognostic (5.21e-2)" "unprognostic (2.33e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 269.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.2 0.9 0.0 0.0 0.4 4.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 1.0 0.0 2.0 0.0 1.6 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.6 28.1 2.7 0.0 1.8 0.0 0.0 16.6 0.0 0.1 0.0 0.0 23.3 0.0 0.0 0.0 0.0 1.1 1391.0 0.1 0.0 0.0 26.4 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 203.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.9 0.0 0.0 PLGLB1 "PLGL, PRP-B" ENSG00000183281 "Plasminogen-like B1" Q02325 2 87002559-87021852 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 5 "liver: 66.8" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 67.6" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (7.25e-2)" "unprognostic (7.25e-2)" "unprognostic (2.35e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-5)" "unprognostic (7.04e-3)" "unprognostic (1.15e-1)" "unprognostic (8.53e-4)" "unprognostic (1.60e-1)" "unprognostic (4.56e-4)" "unprognostic (9.90e-3)" "unprognostic (2.96e-5)" "unprognostic (1.02e-1)" "unprognostic (1.16e-1)" "unprognostic (4.32e-2)" "unprognostic (3.98e-5)" 0.3 1.3 2.0 0.7 3.4 1.7 0.7 14.3 2.1 0.4 0.5 0.7 1.3 2.1 0.3 0.8 1.0 0.6 1.9 2.1 1.0 66.8 0.6 1.5 1.4 1.5 0.4 0.7 1.6 0.3 1.0 0.3 1.1 0.5 1.9 3.4 0.8 0.2 1.1 1.3 0.7 0.8 1.1 0.5 0.7 0.5 2.7 1.6 5.1 0.8 0.9 2.7 0.4 2.9 4.2 4.8 2.6 4.5 5.4 5.1 3.4 2.5 2.1 2.8 3.3 7.6 7.6 3.4 1.2 1.5 2.5 1.3 0.6 2.1 9.1 3.5 6.6 6.4 3.5 3.1 4.1 1.6 5.6 4.6 5.6 5.7 8.3 0.9 8.7 3.1 6.6 2.6 4.4 13.3 11.3 6.9 2.4 2.7 2.2 2.1 4.5 4.6 3.0 3.8 4.2 2.9 2.6 3.0 5.1 1.2 7.0 5.5 3.8 2.5 2.2 2.1 6.9 5.3 3.4 2.1 5.5 2.6 5.1 0.4 0.9 1.9 0.2 1.2 2.7 2.0 1.4 0.2 2.2 2.7 1.6 1.9 0.9 0.8 1.6 2.6 0.4 0.0 4.3 0.8 0.2 1.0 10.8 1.8 2.5 2.7 2.3 0.0 5.9 0.2 0.0 0.7 0.5 1.5 0.1 0.0 0.2 0.2 0.9 0.4 0.0 67.6 0.2 4.8 1.2 1.8 1.8 0.0 1.1 0.9 3.3 1.0 2.3 2.4 0.2 0.0 1.8 0.6 14.1 0.0 0.9 0.3 0.2 1.1 0.0 0.8 0.7 0.3 PLGLB2 PLGP1 ENSG00000125551 "Plasminogen-like B2" Q02325 2 87748087-87758793 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 28 "liver: 105.2" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 67.4" "Cancer enriched" "Detected in single" 25 "liver cancer: 1.2" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7;T-reg: 3.7" "Lineage enriched" "Detected in single" 16 "T-cells: 3.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 6.1;U-266/84: 4.9" "Secreted to blood" NA NA "unprognostic (1.10e-2)" "unprognostic (8.78e-2)" "unprognostic (3.42e-2)" "unprognostic (7.03e-4)" "unprognostic (1.68e-2)" "unprognostic (3.77e-1)" "unprognostic (1.82e-2)" "unprognostic (5.74e-2)" "unprognostic (2.94e-1)" "unprognostic (5.04e-4)" "unprognostic (6.39e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 105.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.7 0.2 0.0 1.3 4.3 1.4 0.0 1.3 0.0 3.7 2.2 0.6 2.5 0.0 1.4 2.7 2.6 0.5 0.1 1.0 0.5 0.0 0.8 0.0 1.1 0.9 3.2 0.0 0.3 0.6 0.5 0.0 0.0 0.3 0.4 6.1 0.5 2.6 0.3 0.0 0.9 0.0 2.5 0.0 0.0 0.4 0.0 2.4 0.0 0.0 4.3 0.3 0.0 3.2 0.8 1.0 0.1 0.6 0.2 1.7 0.0 0.0 1.9 0.9 1.3 2.8 4.9 0.4 1.5 0.0 1.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.7 0.8 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.4 0.1 0.0 0.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664365-89679427 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adipose tissue: 187.5;breast: 62.6" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 49.1" "Cancer enhanced" "Detected in many" "breast cancer: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 176 "ASC diff: 70.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes NA NA 8900 Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 187.5 2.6 1.8 7.1 1.3 0.3 62.6 0.8 0.8 0.3 10.6 1.6 0.4 0.4 0.3 1.9 0.5 0.4 7.4 8.3 2.7 0.6 0.6 5.8 0.3 2.8 0.8 1.5 0.4 1.4 0.3 0.1 0.3 1.0 0.4 1.1 0.0 7.6 1.5 7.2 2.2 2.2 0.6 0.4 0.3 0.5 1.6 1.8 0.0 0.7 8.0 0.3 1.5 1.5 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 70.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.8 1.3 0.8 0.7 2.7 0.6 0.8 1.5 1.0 1.8 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 49.1 0.0 0.0 0.0 1.8 1.3 4.9 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.4 0.0 0.0 0.0 0.7 PLIN2 "ADFP, ADRP" ENSG00000147872 "Perilipin 2" Q99541 9 19108375-19149290 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 233.1;liver: 139.9" "Cell type enhanced" "Detected in many" 12 "Syncytiotrophoblasts: 1518.0" "Group enriched" "Detected in all" 5 "liver cancer: 63.0;renal cancer: 136.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 83.5;eosinophil: 76.1" "Group enriched" "Detected in all" 5 "granulocytes: 83.5;monocytes: 21.1" "Group enriched" "Detected in many" 5 "ASC diff: 201.9;HHSteC: 174.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016607, CAB037331" Supported Supported "Lipid droplets" NA NA "Lipid droplets" "CAB037331: , HPA016607: AB_2669403" "unprognostic (2.02e-1)" "unprognostic (4.30e-2)" "unprognostic (3.47e-1)" "unprognostic (2.55e-2)" "unprognostic (2.41e-2)" "unprognostic (3.08e-2)" "unprognostic (3.02e-2)" "unprognostic (3.28e-3)" "unprognostic (4.92e-2)" "unprognostic (4.66e-2)" "unprognostic (1.40e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (3.32e-4)" "unprognostic (3.14e-3)" "unprognostic (7.89e-2)" "prognostic favorable (2.16e-4)" "unprognostic (1.77e-1)" 233.1 17.4 1.8 6.5 2.8 14.9 98.9 1.1 3.2 11.2 47.4 2.0 5.4 28.4 7.7 7.8 6.2 6.1 10.9 37.0 1.7 1.6 36.0 139.9 18.3 9.6 2.2 1.2 37.5 4.5 2.0 4.7 46.4 3.0 17.1 3.5 5.9 8.5 4.5 75.7 13.5 61.6 6.8 3.1 9.8 5.5 16.5 2.4 4.4 8.8 4.0 4.6 63.2 102.9 3.2 8.6 83.5 21.1 2.0 11.5 11.8 0.0 2.8 3.3 2.4 201.9 27.5 36.6 9.3 7.2 5.7 6.5 4.4 0.6 0.0 0.1 19.0 36.6 0.3 3.2 0.0 9.8 11.8 0.0 15.5 0.4 16.5 174.9 1.8 28.4 29.1 3.3 13.9 0.0 4.6 7.0 0.0 2.8 3.4 22.0 0.8 4.2 6.3 4.4 0.0 5.7 10.2 1.5 0.1 0.0 10.8 0.2 5.4 4.3 1.1 9.1 4.4 2.2 4.1 11.0 0.0 1.7 8.8 0.0 2.0 2.0 6.2 0.0 3.1 0.9 83.5 14.9 76.1 11.5 19.7 10.0 3.2 10.1 8.2 8.6 2.9 9.9 8.4 0.9 2.0 21.1 1.0 9.6 11.8 1.8 2.8 1.1 3.2 1.7 1.6 2.2 1.2 3.0 2.4 17.9 63.4 41.2 370.9 183.2 2.2 58.6 89.2 24.1 69.4 12.2 0.0 148.6 23.2 64.2 3.3 59.0 94.5 116.8 13.9 494.8 114.6 78.6 397.7 505.9 405.3 11.1 14.3 96.3 188.8 7.8 36.8 170.1 82.7 39.7 15.4 42.6 57.0 23.0 65.0 211.8 4.8 12.9 104.0 7.7 23.3 94.9 1518.0 59.8 29.9 214.1 PLIN4 "KIAA1881, S3-12" ENSG00000167676 "Perilipin 4" Q96Q06 19 4502180-4518465 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2" "Cell type enhanced" "Detected in some" 14 "Cardiomyocytes: 31.3;Cholangiocytes: 10.2;Hepatocytes: 25.9;Ito cells: 10.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Cell line enriched" "Detected in some" 9 "ASC diff: 77.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044682, HPA054657" Enhanced Enhanced "Lipid droplets,Plasma membrane,Cytosol" NA NA 11000 "Plasma membrane, Cytosol" "Lipid droplets" "HPA044682: AB_2679044, HPA054657: AB_2682559" "unprognostic (2.97e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (8.31e-4)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.65e-2)" "unprognostic (6.77e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-2)" "unprognostic (9.89e-3)" "unprognostic (1.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.81e-1)" "unprognostic (1.90e-1)" "unprognostic (6.09e-3)" "unprognostic (3.10e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" 155.0 1.2 0.9 7.4 0.8 0.8 80.6 0.5 0.9 2.4 8.5 0.6 2.4 0.8 3.7 2.2 3.8 2.5 8.3 15.5 0.6 0.1 0.6 11.1 0.4 2.0 0.8 0.8 2.9 3.3 0.3 0.2 0.3 0.9 2.8 1.2 0.7 6.8 3.9 45.2 1.8 2.4 10.3 1.3 0.4 3.5 0.7 0.8 0.1 0.7 8.2 0.7 5.9 3.9 0.0 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 77.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.4 1.1 0.0 0.0 2.5 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.1 0.0 0.9 0.8 0.5 0.9 0.6 0.1 0.8 0.8 0.9 0.8 0.0 4.5 0.0 1.0 0.2 0.1 31.3 10.2 0.0 3.4 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 1.3 0.3 0.0 0.4 0.0 25.9 0.1 0.0 0.0 10.4 2.7 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.9 0.0 3.9 0.8 0.0 6.5 0.5 0.5 0.5 0.3 0.3 0.0 0.0 1.3 PLIN5 "LSDA5, LSDP5, MLDP, OXPAT" ENSG00000214456 "Perilipin 5" Q00G26 19 4522531-4535224 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 2: 37.2;Hepatocytes: 133.7;Ito cells: 46.1" "Cancer enhanced" "Detected in many" "liver cancer: 9.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "neutrophil: 14.7" "Lineage enriched" "Detected in single" 18 "granulocytes: 14.7" "Cell line enhanced" "Detected in some" "BEWO: 5.6;RT4: 5.1;SH-SY5Y: 4.8;T-47d: 10.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA077050 Supported "Vesicles,Lipid droplets" NA NA "Vesicles, Lipid droplets" "HPA077050: " "prognostic favorable (7.68e-4)" "unprognostic (1.01e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (8.56e-4)" "unprognostic (1.24e-2)" "unprognostic (6.06e-3)" "prognostic favorable (2.81e-4)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (1.97e-4)" "unprognostic (3.18e-1)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "prognostic favorable (2.16e-4)" 20.9 1.7 8.0 2.9 5.2 3.9 6.5 4.2 5.8 1.8 3.3 2.0 10.5 1.6 1.6 5.5 1.9 3.1 1.9 12.0 7.8 1.4 5.8 44.6 2.8 1.5 3.4 2.6 25.8 30.1 0.5 6.2 0.6 3.7 4.5 0.9 3.4 40.3 4.6 40.8 1.7 1.3 1.5 1.7 1.8 11.5 1.4 4.2 0.0 2.2 6.0 1.1 3.7 5.7 0.6 0.4 14.7 0.5 0.8 0.4 0.1 0.5 0.3 1.1 3.9 2.9 0.1 5.6 0.2 0.2 0.2 0.1 0.4 1.0 0.3 1.2 0.2 0.3 0.4 0.0 0.0 0.0 0.6 0.4 0.3 1.4 1.7 0.7 0.4 0.9 0.7 0.0 0.0 0.1 0.5 0.3 0.3 1.2 0.5 0.4 0.9 0.3 0.9 0.7 0.5 0.5 0.3 0.2 3.5 0.3 5.1 0.7 4.8 0.5 0.8 0.0 0.4 10.6 0.7 1.0 0.6 0.5 0.5 0.3 0.6 0.2 0.2 0.6 1.1 0.2 1.5 0.5 0.8 0.3 0.4 0.2 0.3 0.2 0.2 0.1 0.6 0.3 0.4 14.7 0.8 0.3 0.4 0.2 0.1 8.0 5.2 4.2 5.8 7.8 1.4 3.4 2.6 3.7 4.2 8.9 37.2 0.8 13.9 0.5 1.4 30.7 22.9 9.4 18.2 1.8 0.0 0.3 8.3 3.8 1.1 2.7 0.2 0.0 10.5 0.4 0.4 6.9 3.5 133.7 0.4 0.0 0.0 46.1 7.3 0.0 0.3 1.2 0.0 0.0 1.2 6.0 7.6 0.2 2.5 7.8 0.9 12.9 1.0 5.5 5.7 0.9 1.1 1.3 1.2 9.2 PLK1 PLK ENSG00000166851 "Polo like kinase 1" P53350 16 23677656-23690367 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 83.9;testis: 32.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 86.9;Erythroid cells: 23.3;Extravillous trophoblasts: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "T-reg: 9.0" "Lineage enriched" "Detected in many" 5 "T-cells: 9.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA051638, HPA053229" Approved NA Yes "HPA051638: AB_2681561, HPA053229: AB_2682084" "unprognostic (7.21e-3)" "unprognostic (1.77e-1)" "unprognostic (1.98e-3)" "unprognostic (4.97e-3)" "unprognostic (9.56e-2)" "unprognostic (5.12e-2)" "prognostic unfavorable (2.70e-7)" "prognostic unfavorable (2.28e-5)" "unprognostic (2.55e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.33e-1)" "unprognostic (8.10e-2)" "unprognostic (1.19e-1)" "unprognostic (1.26e-2)" 2.9 1.1 1.1 14.2 1.5 15.9 1.7 2.1 1.1 1.5 7.1 0.7 0.5 6.0 1.1 0.9 10.4 0.7 1.5 1.0 1.0 0.8 1.3 1.2 2.6 15.2 0.8 0.6 1.2 0.7 0.0 0.8 6.8 0.7 0.9 5.9 0.5 1.7 0.8 0.8 2.9 5.9 2.0 0.7 8.3 3.6 32.4 0.5 83.9 0.6 6.6 20.4 2.1 2.6 1.9 0.5 0.7 0.1 1.3 9.0 2.3 43.5 45.5 37.6 20.4 1.1 2.6 21.1 24.9 16.5 39.1 29.1 39.7 28.8 21.8 13.0 16.8 20.6 25.1 51.2 20.5 47.1 31.0 28.9 27.7 35.9 54.2 0.3 31.9 30.4 1.0 1.1 27.7 28.6 4.9 28.5 28.6 43.0 30.1 30.1 39.8 30.1 31.9 42.9 17.9 23.2 46.9 25.5 34.6 11.1 9.5 21.2 14.7 28.5 20.0 12.9 22.4 25.4 19.7 14.4 18.6 23.8 18.2 42.5 21.5 33.3 37.8 15.8 27.8 30.4 0.0 0.1 0.0 0.0 0.0 0.0 1.9 1.4 0.5 0.5 0.0 0.0 0.0 0.7 1.3 0.0 0.0 9.0 2.3 1.1 1.5 2.1 1.1 1.0 0.8 0.8 0.6 0.7 0.5 3.0 0.0 0.8 1.0 1.1 1.3 0.6 0.0 0.0 0.0 0.0 3.9 4.5 0.0 0.6 86.9 0.5 1.5 23.3 0.7 48.0 0.7 1.0 1.1 0.9 17.0 0.0 0.0 3.1 3.7 4.8 1.1 2.6 0.0 0.0 2.9 1.1 0.8 0.0 0.7 0.0 1.1 0.0 0.3 3.2 5.0 1.6 3.2 1.3 3.9 1.8 PLK4 "Sak, STK18" ENSG00000142731 "Polo like kinase 4" O00444 4 127880861-127899195 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017327, HPA035026, HPA043198" Approved Supported Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504" "unprognostic (2.44e-1)" "unprognostic (4.24e-2)" "prognostic favorable (7.46e-5)" "unprognostic (2.18e-1)" "unprognostic (3.79e-1)" "unprognostic (9.20e-2)" "unprognostic (1.06e-5)" "prognostic unfavorable (5.13e-4)" "unprognostic (1.44e-3)" "unprognostic (5.66e-2)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.27e-1)" "unprognostic (2.22e-11)" "unprognostic (2.29e-2)" "unprognostic (3.58e-1)" "unprognostic (4.75e-2)" "unprognostic (7.93e-2)" 1.4 1.3 1.5 4.7 2.4 16.5 2.2 0.5 2.2 2.0 3.2 0.3 0.6 2.3 1.3 1.3 5.4 1.1 1.2 2.0 1.2 1.3 1.5 0.9 1.5 5.9 1.2 1.4 1.5 0.9 0.3 0.6 5.0 2.6 1.4 3.7 0.8 1.7 0.7 0.4 2.7 3.2 1.9 1.8 2.7 1.6 21.7 1.0 21.7 1.0 2.1 6.0 1.5 2.2 0.7 0.7 1.5 0.8 1.4 4.0 0.8 11.8 5.6 21.1 10.8 0.7 2.1 9.6 11.6 8.2 15.5 16.0 7.8 12.2 16.0 4.3 6.4 12.6 7.8 14.8 9.3 23.9 12.4 6.1 14.5 9.0 7.3 0.2 20.4 17.1 0.6 0.9 14.1 6.5 2.8 11.9 12.3 16.8 21.4 13.0 8.2 31.4 9.1 9.8 12.1 6.4 16.4 14.7 5.5 5.1 7.6 11.6 9.6 7.3 6.7 3.5 9.3 5.4 8.8 5.1 12.2 11.8 8.3 14.4 11.0 12.1 22.8 6.2 15.5 13.5 0.0 0.4 1.5 1.6 0.8 1.1 0.3 1.8 1.7 0.7 0.7 0.6 2.3 0.0 1.4 0.3 0.4 4.0 0.8 1.5 2.4 0.5 2.2 1.2 1.3 1.2 1.4 2.6 1.0 0.0 1.1 0.8 0.6 1.4 2.1 0.5 0.0 2.7 0.0 1.8 0.0 3.6 0.0 0.6 48.9 0.4 0.0 23.3 0.3 10.4 0.7 0.4 1.1 0.2 3.1 0.0 2.4 0.6 1.0 60.1 2.6 1.6 0.0 1.8 1.9 1.1 0.1 0.0 0.4 0.3 0.7 0.0 0.3 27.0 12.1 0.6 3.2 1.8 2.1 0.9 PLK5 "PLK5P, SgK384ps" ENSG00000185988 "Polo like kinase 5" Q496M5 19 1524074-1536046 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 50.1" "Group enriched" "Detected in some" 5 "Leydig cells: 33.6;Peritubular cells: 63.6" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 6 "cerebellum: 50.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 5.0" HPA035024 Enhanced NA NA "HPA035024: AB_2674418" "unprognostic (4.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (7.69e-2)" "unprognostic (1.11e-2)" "unprognostic (1.33e-1)" "unprognostic (2.69e-1)" "unprognostic (8.38e-2)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" "unprognostic (3.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.18e-3)" "unprognostic (3.21e-1)" "unprognostic (7.49e-2)" "unprognostic (3.54e-2)" "unprognostic (4.01e-4)" 0.4 0.7 8.3 0.4 4.8 1.7 0.8 50.1 7.9 5.9 0.4 1.6 0.3 0.5 6.4 6.2 1.6 2.7 0.4 0.3 3.2 1.7 0.3 0.3 0.3 0.4 1.1 1.9 0.8 0.6 0.5 0.5 0.3 2.9 0.9 0.4 8.4 0.6 3.2 0.5 1.0 0.7 2.8 0.8 0.4 0.2 7.4 1.8 0.0 0.4 0.0 0.3 0.2 2.9 1.2 1.2 4.4 0.9 1.0 1.1 0.1 0.2 0.9 0.8 1.2 0.4 0.9 1.0 0.2 0.5 0.5 0.4 0.5 1.0 5.0 0.3 0.5 0.3 1.2 0.8 0.5 0.2 0.5 0.7 1.0 1.3 0.8 0.1 0.2 1.1 1.0 0.3 0.8 0.2 2.0 0.3 0.7 0.8 1.7 0.8 1.0 0.4 1.0 1.4 0.3 0.9 1.0 0.3 0.4 0.6 0.1 0.5 0.7 0.7 0.4 0.3 0.6 1.5 0.7 0.0 0.9 1.0 1.3 0.2 1.5 0.4 0.6 0.4 0.7 0.5 1.6 0.9 2.2 0.8 0.5 0.5 0.7 0.8 0.5 0.2 1.2 1.1 0.6 4.4 1.0 0.6 1.2 1.0 0.1 8.3 4.8 50.1 7.9 3.2 1.7 1.1 1.9 2.9 1.8 0.0 0.0 0.0 0.1 0.1 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 33.6 0.0 1.7 0.0 0.0 10.1 0.0 0.0 63.6 0.0 0.6 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.1 PLLP "PMLP, TM4SF11" ENSG00000102934 Plasmolipin Q9Y342 16 57248547-57284687 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 92.3" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 150.3;Collecting duct cells: 85.5;Pancreatic endocrine cells: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "naive CD4 T-cell: 15.1;naive CD8 T-cell: 5.7" "Lineage enriched" "Detected in many" 8 "T-cells: 15.1" "Cell line enhanced" "Detected in many" "EFO-21: 12.6;Hep G2: 34.8;OE19: 34.6;RPTEC TERT1: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041862 Enhanced NA NA "HPA041862: AB_2677712" "unprognostic (7.96e-2)" "unprognostic (2.07e-3)" "unprognostic (3.86e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-1)" "unprognostic (9.56e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (5.64e-2)" "unprognostic (6.99e-3)" "unprognostic (2.83e-2)" "prognostic favorable (6.21e-9)" "unprognostic (2.06e-2)" "unprognostic (9.06e-3)" "unprognostic (3.86e-1)" "unprognostic (3.32e-2)" 3.5 2.3 35.9 1.8 46.1 1.8 7.8 5.6 45.6 15.6 12.0 92.3 13.1 20.2 4.3 2.0 10.1 14.3 16.8 2.8 52.5 26.8 19.2 3.6 22.1 1.8 42.3 25.0 1.4 28.4 4.7 1.1 2.1 32.3 3.2 8.1 3.5 25.3 18.7 2.6 25.5 19.5 2.0 46.2 6.1 42.8 3.0 40.3 0.0 7.0 1.4 3.3 6.9 5.8 1.2 0.5 1.9 1.1 0.6 15.1 2.2 0.7 2.5 3.2 0.6 0.0 0.0 1.6 0.5 0.1 0.1 0.1 7.0 3.0 0.2 12.6 0.0 0.8 2.3 1.5 2.2 0.0 0.7 1.2 3.2 1.4 34.8 0.4 0.3 0.9 0.1 0.5 0.0 0.2 1.7 3.6 0.8 0.6 0.9 0.0 0.9 0.4 0.8 2.7 34.6 1.0 0.4 0.6 0.6 14.9 7.5 0.7 1.3 0.8 1.0 1.4 1.0 5.2 1.1 2.6 0.6 0.7 0.4 0.6 0.7 0.7 0.4 0.7 0.2 2.1 1.3 1.1 0.6 0.8 0.5 0.6 0.7 2.1 0.6 0.2 1.2 15.1 5.7 1.9 0.6 0.4 0.5 0.6 2.2 35.9 46.1 5.6 41.1 52.5 26.8 42.3 25.0 32.3 40.3 59.6 24.5 1.3 16.9 12.4 2.2 2.5 150.3 1.4 14.8 85.5 2.0 1.6 13.3 52.2 0.7 13.8 36.4 0.0 62.6 1.1 1.9 5.8 3.5 3.4 0.7 4.8 1.2 7.4 0.6 0.8 4.4 2.2 3.3 1.8 19.1 0.5 76.9 48.4 20.8 24.4 6.4 0.0 3.8 1.9 1.5 37.4 0.9 2.1 21.5 6.7 PLN "CMD1P, PLB" ENSG00000198523 Phospholamban P26678 6 118548298-118560730 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "heart muscle: 337.5" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 2230.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.3;Karpas-707: 1.6;NB-4: 1.8;SuSa: 1.7;U-2197: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005597, HPA026900" Enhanced NA NA "CAB005597: AB_2252716, HPA026900: AB_1855314" "unprognostic (2.49e-1)" "unprognostic (5.67e-2)" "unprognostic (1.96e-3)" "unprognostic (4.81e-2)" "unprognostic (1.20e-1)" "unprognostic (5.54e-2)" "unprognostic (2.35e-3)" "unprognostic (4.66e-2)" "unprognostic (3.97e-1)" "unprognostic (8.98e-2)" "unprognostic (8.98e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.11e-4)" "unprognostic (2.98e-3)" "unprognostic (1.80e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (5.59e-4)" 9.0 1.8 0.4 2.7 0.5 0.0 5.4 0.4 0.6 22.3 22.2 0.0 9.8 2.0 21.1 22.3 27.3 11.6 29.8 337.5 0.4 0.5 6.4 0.4 5.3 0.8 0.7 1.4 18.6 0.5 0.1 0.4 0.1 1.4 14.4 3.9 0.0 1.6 6.0 68.4 1.5 14.0 30.8 1.2 0.6 6.5 12.3 0.0 0.0 2.8 23.7 0.8 32.2 6.6 0.3 0.0 1.3 0.4 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.3 0.5 0.2 0.1 0.0 0.2 0.2 1.6 0.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.7 0.2 0.8 0.4 0.1 0.0 1.7 0.4 0.0 0.5 0.3 0.2 1.3 0.3 0.2 0.3 0.4 0.0 1.0 0.1 0.0 0.4 1.3 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.3 1.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.4 0.6 0.4 0.5 0.7 1.4 1.4 0.0 0.0 0.0 0.0 0.0 3.8 1.6 2230.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 71.2 0.4 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.7 0.9 0.3 3.3 0.0 0.0 0.0 0.1 0.0 11.0 0.0 0.2 271.7 280.1 1.1 0.4 1.4 0.0 0.0 0.0 0.4 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 36.7 14.1 11.2 18.0 12.1 0.7 28.5 7.9 13.5 8.8 25.2 5.1 8.3 21.6 14.8 7.5 12.0 8.0 22.3 16.6 12.5 8.2 16.4 73.1 9.3 3.0 10.7 4.8 17.7 14.4 13.9 7.8 41.0 13.0 11.1 16.1 7.2 7.7 11.3 4.8 3.2 24.7 24.2 19.4 3.2 13.6 6.3 10.9 6.1 47.6 3.5 3.0 21.8 28.7 0.0 0.0 1.5 0.3 0.0 0.0 1.9 16.4 11.8 3.7 1.2 13.5 14.5 9.4 58.5 17.9 31.9 60.2 0.9 1.7 0.0 11.4 9.9 14.6 3.5 4.3 50.3 82.6 0.0 6.8 4.1 11.5 8.2 34.7 0.0 0.0 25.4 7.2 27.6 13.5 93.9 44.0 0.0 5.4 0.2 56.3 6.0 0.0 0.0 2.3 0.0 5.1 0.0 2.4 0.0 13.4 0.8 1.8 0.0 46.6 5.0 4.9 18.1 13.6 0.5 55.2 39.5 12.0 12.5 34.9 17.9 2.5 0.0 73.6 0.0 7.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 11.2 12.1 7.9 13.5 12.5 8.2 10.7 4.8 13.0 10.9 14.9 10.7 0.5 5.9 6.3 14.5 10.6 61.1 12.0 13.6 26.2 33.4 6.8 8.3 62.8 0.4 21.2 46.1 0.0 45.9 109.4 34.5 8.1 0.0 50.8 4.7 0.0 19.0 18.4 1.5 1.3 12.0 2.7 13.5 1.0 18.3 65.1 83.0 31.5 4.6 6.9 22.4 19.4 38.1 8.0 16.3 4.8 15.7 0.7 21.3 5.4 PLP1 "GPM6C, PLP, SPG2" ENSG00000123560 "Proteolipid protein 1" P60201 X 103773718-103792619 "Cancer-related genes, Disease related genes, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 463.6" "Cell type enriched" "Detected in some" 16 "Melanocytes: 376.2" "Group enriched" "Detected in many" 22 "glioma: 160.5;melanoma: 75.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 9 "dendritic cells: 2.3" "Group enriched" "Detected in some" 5 "SK-MEL-30: 67.9;WM-115: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004128 Enhanced NA NA "HPA004128: AB_1079635" "unprognostic (5.72e-2)" "unprognostic (1.77e-2)" "unprognostic (2.27e-2)" "unprognostic (4.09e-3)" "unprognostic (1.32e-1)" "unprognostic (3.95e-2)" "unprognostic (2.57e-2)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-5)" "unprognostic (4.91e-2)" "unprognostic (1.86e-1)" "unprognostic (3.46e-2)" "unprognostic (1.16e-2)" 3.6 5.6 90.6 2.8 109.9 1.9 3.1 8.9 463.6 3.9 5.7 208.1 0.0 3.3 3.6 3.5 4.2 2.5 4.0 5.0 143.8 73.8 2.1 2.1 2.1 2.0 174.8 42.2 3.0 2.2 17.9 0.3 1.9 124.4 3.6 5.4 0.0 3.4 9.3 2.2 7.3 5.1 7.0 453.8 2.0 2.8 9.2 145.2 0.0 2.0 0.0 2.0 2.7 0.8 0.0 2.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.9 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 40.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 90.6 109.9 8.9 68.1 143.8 73.8 174.8 42.2 124.4 145.2 0.0 0.0 0.0 0.4 14.2 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 3.8 0.9 0.0 0.0 0.1 0.0 0.0 5.5 0.0 2.0 6.9 0.0 376.2 0.0 0.0 23.1 0.0 0.0 2.8 0.0 1.2 0.0 1.0 0.5 0.2 2.3 0.0 0.0 0.0 0.0 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 12.7;Distal tubular cells: 6.6;Early spermatids: 7.1;Late spermatids: 7.9;Leydig cells: 17.8;Peritubular cells: 7.4;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 62.8;U-251 MG: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA045188: AB_2679246" "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.8 1.7 1.0 0.0 1.0 0.0 0.0 8.0 6.3 0.1 0.7 0.1 0.9 1.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.8 0.0 62.8 6.5 0.0 0.7 1.6 0.7 0.0 0.0 0.0 0.7 0.0 2.0 0.0 0.0 0.0 3.3 0.0 0.6 0.1 0.5 0.0 0.5 3.5 1.4 0.0 9.0 7.2 4.0 0.3 34.8 0.0 0.0 0.0 6.6 0.0 1.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 12.7 0.0 0.0 3.5 0.0 0.0 6.6 0.0 7.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.9 0.0 0.0 2.5 0.0 7.9 17.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 7.4 7.6 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.3 PLPP5 "DPPL1, HTPAP, PPAPDC1B" ENSG00000147535 "Phospholipid phosphatase 5" Q8NEB5 8 38263130-38269243 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.8" "Cell type enhanced" "Detected in many" 4 "Glandular cells: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "memory B-cell: 37.2;naive B-cell: 65.4" "Lineage enriched" "Detected in all" 5 "B-cells: 65.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055777 Approved Vesicles NA NA Vesicles "HPA055777: AB_2682915" "unprognostic (4.54e-2)" "unprognostic (2.51e-3)" "unprognostic (3.66e-2)" "prognostic favorable (1.48e-5)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (5.58e-2)" "prognostic favorable (8.72e-5)" "unprognostic (9.79e-2)" "prognostic favorable (2.42e-5)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (8.33e-10)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (1.57e-2)" 5.5 9.3 6.9 11.9 7.9 4.8 8.8 7.5 6.7 11.2 11.5 3.9 33.9 14.4 5.7 30.9 6.6 10.2 21.0 4.6 6.1 6.1 9.6 20.3 7.5 12.0 4.5 5.1 8.4 77.8 4.2 29.9 8.3 6.7 27.9 12.8 16.2 52.0 36.5 2.3 4.7 18.4 5.2 3.5 12.8 16.1 4.6 4.4 3.8 11.9 5.0 14.8 8.0 6.7 65.4 5.3 13.3 3.6 4.3 5.0 3.7 5.5 11.1 6.6 13.5 13.0 12.7 9.1 15.8 19.9 8.1 10.6 5.1 8.5 0.4 13.5 16.3 11.7 6.2 5.4 11.5 6.9 3.5 3.5 9.8 4.7 14.8 22.1 2.8 11.8 9.9 12.0 11.2 14.8 14.3 13.1 13.1 0.4 25.5 9.8 11.4 6.3 4.7 10.0 22.5 3.8 6.9 4.9 51.3 20.2 7.2 5.2 8.0 6.5 10.1 9.2 6.1 21.6 5.5 7.8 5.7 5.0 9.6 4.1 15.8 10.4 1.6 15.8 7.5 9.8 13.3 2.7 4.5 3.0 2.7 5.0 37.2 3.9 3.8 2.5 65.4 2.0 1.9 1.6 4.3 3.6 5.3 3.4 3.7 6.9 7.9 7.5 6.7 6.1 6.1 4.5 5.1 6.7 4.4 8.9 44.0 74.7 61.1 0.0 5.3 0.0 38.2 101.7 39.8 71.5 15.7 39.2 36.5 59.1 22.7 13.5 17.2 0.0 78.1 37.8 35.3 138.3 29.1 20.7 32.8 58.8 43.3 16.5 9.1 6.2 16.4 24.8 0.0 10.0 73.6 37.6 56.5 36.8 8.9 20.3 3.5 12.9 0.0 24.7 4.3 0.0 73.7 17.0 51.4 46.1 PLPP7 "C9orf67, FLJ14662, MGC12921, NET39, PPAPDC3" ENSG00000160539 "Phospholipid phosphatase 7 (inactive)" Q8NBV4 9 131289459-131359022 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.0;skeletal muscle: 107.3" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 16.8;Horizontal cells: 7.9;Leydig cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 11.0;ASC diff: 11.6;ASC TERT1: 8.8;SCLC-21H: 11.3;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070252 Uncertain Approved Nucleoplasm,Vesicles No No Vesicles Nucleoplasm "HPA070252: AB_2686242" "unprognostic (2.19e-1)" "unprognostic (3.07e-1)" "unprognostic (3.07e-2)" "unprognostic (2.71e-1)" "unprognostic (8.78e-2)" "unprognostic (7.03e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.43e-1)" "unprognostic (1.65e-1)" "unprognostic (3.96e-3)" "unprognostic (1.47e-1)" "unprognostic (1.71e-3)" "unprognostic (3.69e-2)" "unprognostic (1.10e-2)" "unprognostic (7.85e-2)" "unprognostic (9.72e-3)" 3.6 3.7 3.3 1.7 4.6 1.2 2.8 7.7 8.2 2.3 3.2 4.6 0.0 1.5 2.5 3.1 2.5 2.0 2.3 29.0 3.6 3.9 1.9 1.1 1.5 1.3 3.7 4.2 3.9 1.8 1.1 1.7 1.4 3.7 2.6 1.3 2.0 1.6 2.6 107.3 1.3 1.6 2.9 3.2 1.7 1.4 2.2 3.2 0.0 1.2 22.6 1.2 2.1 1.6 1.3 4.6 0.0 5.2 2.3 0.5 1.9 0.0 0.0 2.2 11.0 11.6 8.8 2.3 1.7 1.2 0.3 0.0 0.0 0.0 0.0 0.3 4.4 2.5 0.0 0.2 0.0 0.1 0.0 1.9 0.0 0.1 3.5 2.9 0.0 0.0 3.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 2.5 0.0 11.3 8.7 0.0 0.1 0.0 0.3 0.3 2.7 0.1 0.1 0.8 0.5 0.0 0.0 0.4 0.0 1.9 0.0 1.7 0.0 5.2 0.0 0.0 3.3 0.0 1.0 0.0 0.0 4.6 1.3 0.4 0.5 0.0 2.3 2.8 2.0 0.0 1.9 3.3 4.6 7.7 8.2 3.6 3.9 3.7 4.2 3.7 3.2 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.5 7.9 0.0 1.8 0.8 1.3 4.6 0.4 0.0 0.0 0.0 2.3 0.4 0.0 3.5 1.9 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Distal tubular cells: 31.5;Proximal tubular cells: 27.8" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Hep G2: 5.8;SCLC-21H: 10.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130" "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favorable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.9 10.5 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 0.0 4.6 0.0 0.0 0.0 2.2 0.0 2.5 0.0 1.2 0.0 0.0 0.0 31.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.4 0.1 0.0 1.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 27.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Cell type enhanced" "Detected in single" 21 "Horizontal cells: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Group enriched" "Detected in some" 6 "NB-4: 24.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: AB_2681787, HPA057034: AB_2683316" "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 5.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.1 0.0 0.6 0.0 0.2 1.7 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.4 0.0 24.1 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 2.7 2.2 51.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.9 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 PLPPR4 "KIAA0455, LPPR4, PHP1, PRG-1" ENSG00000117600 "Phospholipid phosphatase related 4" Q7Z2D5 1 99263953-99309590 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 55.3" "Group enriched" "Detected in some" 5 "Horizontal cells: 28.6;Muller glia cells: 25.5" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 22 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 20.3;BJ hTERT+ SV40 Large T+ RasG12V: 7.9;fHDF/TERT166: 6.8;SH-SY5Y: 15.3;U-138 MG: 7.6;U-87 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.32e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-2)" "unprognostic (1.67e-2)" "unprognostic (2.95e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-2)" "unprognostic (9.09e-2)" "unprognostic (9.70e-3)" "unprognostic (3.36e-2)" "unprognostic (2.21e-1)" "unprognostic (7.25e-12)" "unprognostic (1.67e-5)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "unprognostic (1.16e-3)" 3.0 1.7 25.1 1.2 25.8 0.8 1.8 2.0 55.3 4.6 1.5 2.6 0.0 1.2 1.7 1.7 3.2 1.3 6.0 1.4 39.2 10.8 1.4 0.8 3.5 1.5 5.2 16.7 0.8 1.5 1.7 9.0 1.9 6.1 1.1 1.9 0.6 1.4 1.3 1.2 4.6 1.5 2.1 2.2 1.3 1.1 5.2 2.7 0.0 1.5 0.4 1.7 7.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.3 0.0 0.0 3.9 20.3 4.5 7.9 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.1 0.0 0.0 0.0 12.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 25.1 25.8 2.0 33.8 39.2 10.8 5.2 16.7 6.1 2.7 0.0 1.1 0.0 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.6 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 25.5 0.0 0.0 1.4 0.6 4.3 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.2;Horizontal cells: 3.2" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 12.3;SH-SY5Y: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 12.3 0.0 0.0 0.0 0.5 0.1 0.4 22.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PLS1 "I-plastin, Plastin-1" ENSG00000120756 "Plastin 1" Q14651 3 142596387-142713664 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "intestine: 193.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 327.0;Mucus-secreting cells: 111.2;Paneth cells: 126.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 4.9;NK-cells: 5.9;T-cells: 5.0" "Cell line enhanced" "Detected in many" "BEWO: 33.7;OE19: 48.1;RPTEC TERT1: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA055744, HPA061936" Enhanced NA NA 50000000 "HPA055744: AB_2682903, HPA061936: " "unprognostic (1.29e-1)" "unprognostic (2.61e-1)" "unprognostic (3.15e-3)" "unprognostic (2.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (4.84e-4)" "unprognostic (3.14e-2)" "prognostic favorable (8.76e-6)" "unprognostic (1.99e-2)" "unprognostic (8.64e-2)" "unprognostic (7.22e-2)" "unprognostic (3.82e-2)" 0.5 2.3 1.0 8.2 1.0 1.0 1.7 1.5 2.0 2.0 42.3 0.6 0.2 40.0 0.5 1.1 5.7 1.3 6.3 0.9 1.2 1.1 12.5 10.6 4.4 0.3 0.9 1.0 0.6 5.0 3.8 13.6 0.8 4.5 1.8 30.0 2.9 5.3 0.9 0.5 1.2 193.0 0.6 1.2 0.5 9.6 2.6 0.5 2.5 3.7 1.3 1.6 5.1 2.3 0.7 0.9 4.9 0.4 5.9 5.0 1.8 25.7 20.3 1.4 3.1 0.2 0.0 33.7 0.5 0.7 2.8 6.1 9.2 20.3 4.4 10.8 0.1 9.6 5.5 5.5 8.4 6.0 1.5 8.0 7.8 3.2 3.3 0.2 3.7 0.5 0.0 1.4 5.3 3.4 4.5 1.3 4.8 3.3 0.5 0.3 6.0 6.0 2.0 5.6 48.1 7.6 2.5 6.1 3.6 43.1 23.9 7.2 2.9 2.9 2.1 2.3 4.1 16.6 0.6 0.3 0.3 3.4 1.0 6.2 3.8 3.5 5.1 0.9 3.7 1.0 3.4 0.4 4.9 2.9 0.3 3.8 0.7 3.5 3.8 0.7 0.6 4.3 5.0 3.3 5.9 0.4 0.9 2.1 1.8 1.0 1.0 1.5 2.0 1.2 1.1 0.9 1.0 4.5 0.5 50.6 29.4 4.7 3.1 2.6 2.4 2.4 43.3 40.2 51.2 41.8 15.7 4.9 18.3 15.2 52.6 0.4 327.0 0.0 29.7 1.6 0.5 7.8 9.2 28.7 0.6 4.8 51.8 1.3 0.6 12.6 1.1 1.3 1.7 1.0 111.2 2.8 50.2 126.2 0.0 34.0 12.5 0.0 0.8 5.1 3.6 2.9 1.1 0.0 65.5 9.7 PLSCR2 ENSG00000163746 "Phospholipid scramblase 2" Q9NRY7 3 146391421-146495991 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 8.1;testis: 16.8" "Group enriched" "Detected in some" 25 "Early spermatids: 161.5;Late spermatids: 194.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.9;EFO-21: 2.3;GAMG: 3.7;Karpas-707: 2.5;U-266/70: 2.1" HPA051352 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA051352: " "unprognostic (1.11e-1)" "unprognostic (9.83e-2)" "unprognostic (8.94e-3)" "unprognostic (7.53e-3)" "unprognostic (3.81e-2)" "unprognostic (1.51e-2)" "unprognostic (3.67e-2)" "unprognostic (1.84e-2)" "unprognostic (4.11e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.16e-1)" "unprognostic (1.88e-4)" "unprognostic (4.06e-1)" "unprognostic (9.71e-2)" "unprognostic (3.02e-1)" "unprognostic (1.23e-2)" 0.3 0.3 0.3 1.7 0.3 1.3 0.4 1.0 0.4 0.4 1.5 0.0 1.3 0.2 0.3 8.1 0.6 0.9 1.4 0.3 1.1 0.3 1.4 0.3 1.0 1.8 0.3 0.4 1.0 1.2 0.3 3.2 0.5 1.6 0.4 0.5 0.6 1.4 3.0 0.3 0.3 0.4 0.2 0.8 0.3 0.5 16.8 0.0 0.1 2.5 0.7 0.1 0.3 2.2 0.6 0.5 1.7 1.1 1.3 1.6 0.6 0.0 0.3 0.0 0.0 0.0 1.4 0.2 0.0 0.4 0.6 0.8 0.2 1.9 0.0 2.3 0.0 3.7 0.2 0.3 0.0 0.4 0.1 0.4 0.6 0.8 0.2 0.8 0.0 0.7 0.5 0.5 0.2 0.9 0.6 0.0 0.2 0.3 2.5 0.1 0.0 0.0 0.0 0.5 0.0 1.5 0.2 0.0 0.0 1.5 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.6 0.6 1.3 0.6 0.9 1.4 0.5 0.3 1.4 1.6 1.7 1.3 0.0 0.4 0.0 0.6 0.3 0.3 1.0 0.4 1.1 0.3 0.3 0.4 1.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.5 1.4 0.0 7.0 0.0 0.1 1.7 0.8 161.5 0.0 0.0 0.0 0.5 0.1 0.3 0.3 0.0 0.0 0.1 0.0 1.7 0.6 0.0 194.1 1.7 0.3 0.0 0.0 0.0 1.0 0.7 0.0 1.4 1.1 0.3 0.0 0.1 4.8 2.3 0.1 0.0 0.0 0.6 0.1 PLSCR5 ENSG00000231213 "Phospholipid scramblase family member 5" A0PG75 3 146576555-146606216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.8;intestine: 1.8;parathyroid gland: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "SuSa: 5.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047249 Uncertain NA NA "HPA047249: AB_2679997" 0.1 0.0 0.5 0.1 1.8 0.0 0.1 0.1 0.3 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.4 0.1 0.1 0.1 5.6 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 1.8 0.1 0.1 0.1 0.0 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.1 0.3 0.1 0.5 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351448-17377350 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.3" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 20.4;Endothelial cells: 32.1;Ito cells: 41.7;Melanocytes: 21.9;Suprabasal keratinocytes: 14.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 22.1" "Cell line enriched" "Detected in some" 28 "EFO-21: 112.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 128.3 9.8 0.8 16.4 0.9 0.0 56.3 0.4 1.5 28.7 29.8 3.2 12.8 20.2 32.0 19.8 27.4 16.6 43.1 18.9 1.1 0.4 33.7 4.6 13.1 34.6 0.9 0.5 14.3 22.9 13.8 16.1 12.6 2.7 26.1 5.2 26.3 16.0 10.4 20.7 11.5 23.7 13.5 1.2 77.8 22.1 9.5 0.7 3.8 88.3 13.9 15.2 30.1 87.7 0.0 22.1 0.0 3.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 22.1 0.0 0.3 0.8 0.9 0.4 1.5 1.1 0.4 0.9 0.5 2.7 0.7 6.0 0.0 0.0 0.7 20.4 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.7 32.1 0.0 0.0 2.3 0.1 5.6 1.4 0.0 0.0 1.4 0.0 0.0 41.7 2.7 0.6 0.0 3.8 21.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 10.8 0.4 0.4 14.6 0.1 0.0 0.0 1.7 PLXNA2 "FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2" ENSG00000076356 "Plexin A2" O75051 1 208022242-208244320 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 39.9" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 235.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 18.8;HaCaT: 19.3;HUVEC TERT2: 24.6;TIME: 56.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009763 Approved NA NA 580000 "CAB009763: AB_2166388" "unprognostic (8.25e-2)" "unprognostic (3.91e-2)" "unprognostic (8.85e-2)" "unprognostic (2.77e-2)" "unprognostic (8.66e-2)" "unprognostic (2.07e-1)" "unprognostic (1.97e-2)" "unprognostic (4.84e-2)" "unprognostic (6.88e-3)" "unprognostic (7.06e-2)" "unprognostic (2.61e-1)" "unprognostic (8.41e-2)" "unprognostic (4.49e-3)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (1.27e-2)" "unprognostic (2.40e-1)" 7.2 2.4 8.3 2.9 11.8 1.0 3.9 27.5 14.7 4.7 10.5 2.5 2.0 8.2 5.4 3.0 13.2 4.6 7.0 6.0 9.7 4.0 4.3 2.7 12.0 1.6 3.7 10.9 16.9 39.9 2.0 2.8 10.2 6.7 4.2 8.8 5.7 3.7 4.5 7.6 10.8 9.0 12.0 2.9 1.7 11.0 1.2 3.9 0.4 7.2 4.7 4.4 8.3 9.1 0.2 0.7 1.1 0.7 0.0 0.4 0.2 2.1 1.3 2.4 0.3 2.7 5.4 18.8 1.7 1.1 1.0 0.1 0.0 0.0 0.0 3.5 1.3 0.4 19.3 0.0 10.9 0.3 0.6 0.3 0.0 2.3 1.2 1.1 0.0 0.0 1.4 3.5 0.8 5.1 0.7 24.6 0.0 0.0 0.0 10.7 0.2 0.0 0.0 0.3 3.8 3.3 0.0 2.5 1.6 2.0 1.3 0.7 4.4 2.0 1.6 2.0 4.9 0.1 0.0 56.5 0.4 0.6 2.0 3.5 0.1 0.0 0.0 2.3 0.0 0.9 0.0 0.7 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.7 0.2 0.0 0.4 1.0 0.0 0.3 0.0 0.0 0.2 8.3 11.8 27.5 14.7 9.7 4.0 3.7 10.9 6.7 3.9 26.8 25.8 2.0 10.2 4.2 1.0 3.9 10.2 12.0 39.8 0.0 2.0 5.0 1.7 3.6 0.6 31.8 40.9 0.0 13.3 2.1 9.8 4.5 5.8 4.9 2.5 235.2 8.7 29.4 3.5 0.0 9.2 2.2 5.0 1.0 27.3 0.3 17.0 37.7 6.3 1.1 2.5 6.5 5.9 0.6 0.6 9.3 1.6 1.0 24.2 22.6 PLXNA4 "DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B" ENSG00000221866 "Plexin A4" Q9HCM2 7 132123332-132648688 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;breast: 34.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 9.9;Cardiomyocytes: 9.5;Collecting duct cells: 12.2;Cone photoreceptor cells: 15.7;Early spermatids: 9.9;Leydig cells: 13.0;Muller glia cells: 10.0" "Cancer enhanced" "Detected in many" "glioma: 3.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.1" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;HMC-1: 10.0;hTERT-RPE1: 12.9;RH-30: 10.7;TIME: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029919, HPA052141, HPA075592" Approved Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297" "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.61e-6)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-2)" "unprognostic (2.19e-1)" "unprognostic (7.99e-2)" "unprognostic (7.64e-2)" "unprognostic (1.14e-1)" "unprognostic (1.69e-5)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (5.90e-2)" "unprognostic (1.42e-3)" 23.2 5.1 8.7 3.5 9.0 1.1 34.7 3.9 15.1 16.2 2.0 1.0 0.8 1.5 2.3 1.0 7.7 3.0 4.2 6.9 9.7 7.2 2.0 1.3 1.8 2.5 4.0 6.6 6.2 1.0 1.0 1.6 6.7 6.6 1.4 2.1 0.7 1.2 2.4 1.7 4.1 1.4 5.1 1.5 2.4 2.8 2.4 1.8 0.0 3.3 0.0 1.3 2.1 9.4 0.0 6.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 10.0 0.1 0.0 0.0 0.0 12.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 10.7 1.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.1 0.0 0.0 32.6 3.3 0.1 0.7 0.2 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 6.1 0.0 0.0 8.7 9.0 3.9 15.1 9.7 7.2 4.0 6.6 6.6 1.8 0.0 0.0 0.0 0.1 0.6 9.9 9.5 0.0 0.0 0.0 12.2 15.7 0.0 0.0 0.0 9.9 0.7 0.0 0.0 0.0 0.1 5.4 0.2 1.1 0.0 0.1 0.0 1.2 1.8 0.0 5.9 13.0 0.0 6.8 0.0 0.0 10.0 0.4 0.0 6.7 0.3 1.4 0.0 1.4 0.2 0.1 1.1 0.0 0.0 0.0 0.5 PLXNB1 "KIAA0407, PLXN5, SEP" ENSG00000164050 "Plexin B1" O43157 3 48403854-48430051 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 51.3;Intestinal endocrine cells: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040586 Enhanced "Intracellular and membrane" NA NA 55000000 "HPA040586: AB_10794034" "unprognostic (1.31e-3)" "unprognostic (7.09e-2)" "unprognostic (9.63e-2)" "unprognostic (8.13e-2)" "unprognostic (3.65e-1)" "prognostic favorable (5.03e-4)" "unprognostic (1.06e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.01e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-2)" "prognostic favorable (2.77e-5)" "unprognostic (4.01e-2)" "unprognostic (1.61e-1)" "unprognostic (6.98e-2)" "prognostic favorable (7.60e-4)" 5.8 3.6 23.1 3.7 34.0 1.4 7.5 11.5 25.6 8.4 9.0 47.4 7.2 10.6 10.8 6.7 14.3 25.0 11.3 7.8 26.3 7.4 17.1 14.8 10.8 2.0 48.7 19.3 11.1 24.9 9.1 9.9 7.6 28.9 12.5 6.2 8.8 11.5 18.7 1.0 21.0 9.9 8.5 22.6 6.3 10.1 3.2 34.7 1.4 19.9 3.6 3.0 11.3 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 5.0 9.3 5.5 3.4 2.8 19.1 2.5 1.4 1.5 0.9 6.1 11.4 0.0 9.3 1.7 0.9 9.0 2.0 20.2 0.3 5.1 0.4 0.0 9.7 11.5 5.1 3.9 1.7 5.0 17.7 0.3 4.2 5.7 2.4 2.0 0.7 0.4 1.4 5.1 0.7 3.5 16.5 6.4 1.1 4.5 2.0 0.6 8.8 13.4 4.8 10.3 3.2 19.3 2.9 2.6 10.3 3.3 4.6 1.5 4.5 2.1 2.8 0.1 0.0 0.1 0.3 1.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 34.0 11.5 25.6 26.3 7.4 48.7 19.3 28.9 34.7 32.8 22.4 0.0 14.1 10.2 1.9 16.5 33.1 28.1 23.9 43.6 2.0 17.8 5.0 17.9 4.3 3.1 27.1 0.0 13.6 2.1 4.8 11.8 0.0 51.3 2.5 3.2 50.6 6.7 2.4 2.9 14.1 1.1 1.7 1.0 18.0 19.3 17.6 22.0 14.5 10.9 4.9 0.0 5.9 0.5 2.6 8.4 8.2 1.5 21.5 9.5 PLXNB3 "PLEXB3, PLEXR, PLXN6" ENSG00000198753 "Plexin B3" Q9ULL4 X 153764196-153779346 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.3;salivary gland: 28.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.7" "Lineage enhanced" "Detected in single" "dendritic cells: 2.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 11.0;WM-115: 38.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048046 Enhanced NA NA 17000 "HPA048046: AB_2680239" "prognostic unfavorable (6.13e-4)" "unprognostic (2.60e-1)" "unprognostic (9.10e-4)" "unprognostic (2.30e-2)" "unprognostic (1.45e-1)" "unprognostic (8.53e-2)" "unprognostic (1.15e-3)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-1)" "unprognostic (2.66e-1)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.68e-2)" "unprognostic (1.14e-1)" "unprognostic (9.73e-3)" "unprognostic (1.98e-2)" 3.7 17.4 15.5 2.9 34.9 1.5 4.5 16.1 46.3 3.5 14.8 45.8 1.8 3.3 8.1 5.3 6.4 3.8 6.1 3.1 19.9 9.4 1.3 1.3 2.1 1.4 39.7 17.3 1.3 5.6 1.1 0.6 1.4 18.4 9.0 3.2 2.8 28.9 10.7 1.4 11.3 3.4 8.9 25.6 1.3 4.4 7.2 40.2 0.0 1.3 0.2 1.2 6.8 3.8 0.1 2.7 0.0 0.0 0.7 0.0 0.7 4.8 0.6 0.6 0.4 0.6 0.4 0.3 4.6 0.9 0.6 1.6 0.0 0.1 0.0 3.0 1.2 0.9 0.5 0.0 3.9 0.5 0.1 0.0 3.0 5.5 3.4 1.3 0.0 0.3 1.0 2.8 2.9 1.8 11.0 1.9 0.1 0.2 1.7 1.2 4.0 0.0 0.7 0.1 3.3 7.6 1.4 0.5 0.0 0.7 2.3 1.3 4.1 0.2 4.2 10.2 0.1 5.7 0.0 8.0 4.8 2.4 3.7 5.7 1.6 0.4 0.1 10.3 0.2 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.7 15.5 34.9 16.1 20.8 19.9 9.4 39.7 17.3 18.4 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 PLXNC1 "CD232, VESPR" ENSG00000136040 "Plexin C1" O60486 12 94148723-94307675 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 43.5;retina: 40.6" "Cell type enhanced" "Detected in many" 14 "Kupffer cells: 41.4;Macrophages: 32.1;Melanocytes: 91.1" "Cancer enhanced" "Detected in all" "melanoma: 24.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.2" "Group enriched" "Detected in many" 4 "granulocytes: 14.2;monocytes: 6.7" "Cell line enhanced" "Detected in many" "HAP1: 15.3;Karpas-707: 11.9;SK-MEL-30: 19.0;U-266/70: 30.1;U-266/84: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066899 Approved Mitochondria NA NA 82000 Mitochondria "HPA066899: AB_2685743" "unprognostic (1.49e-1)" "unprognostic (4.01e-2)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (2.33e-1)" "unprognostic (3.24e-2)" "unprognostic (4.67e-3)" "unprognostic (2.80e-2)" "unprognostic (3.49e-1)" "unprognostic (4.64e-2)" "unprognostic (1.78e-2)" "unprognostic (2.38e-1)" "unprognostic (4.02e-2)" "unprognostic (5.33e-3)" "unprognostic (3.19e-2)" "unprognostic (6.85e-3)" "unprognostic (5.48e-2)" 6.6 7.5 7.1 16.1 6.9 12.6 3.9 16.8 8.6 8.0 5.1 3.1 0.8 3.1 7.3 2.2 4.9 4.3 8.3 4.1 6.3 15.2 3.2 2.0 15.2 43.5 4.5 7.7 13.0 2.3 0.5 6.3 7.5 5.2 4.3 5.4 40.6 3.7 3.7 2.9 6.6 5.0 5.7 4.9 28.6 3.4 12.1 3.3 8.6 3.3 2.7 10.2 9.6 6.5 2.4 2.5 14.2 6.7 0.9 1.7 1.5 0.4 0.2 1.2 0.2 0.7 0.5 0.1 0.6 0.8 0.8 2.4 4.1 0.0 9.8 0.0 0.9 0.7 0.0 15.3 0.6 0.5 6.8 0.3 0.5 0.2 2.7 8.5 2.0 3.4 8.4 0.0 0.9 0.4 1.0 0.0 0.9 0.2 11.9 0.2 0.1 0.4 1.0 2.5 0.1 0.5 1.6 0.4 5.3 0.0 0.7 1.0 0.7 0.1 0.1 19.0 3.1 0.0 1.6 0.3 0.2 1.1 0.1 0.3 30.1 31.3 0.6 0.1 5.3 0.6 0.0 3.0 12.2 1.4 5.2 1.6 2.4 1.6 1.7 2.5 1.4 1.4 1.5 14.2 0.9 6.7 0.9 1.0 1.5 7.1 6.9 16.8 8.6 6.3 15.2 4.5 7.7 5.2 3.3 3.0 3.7 11.2 0.2 5.5 2.1 3.7 2.5 4.0 0.0 0.0 0.0 0.1 1.7 0.2 6.7 1.8 0.2 0.0 0.5 0.1 2.6 0.2 16.1 0.8 19.6 0.0 19.0 9.8 41.4 5.9 1.4 32.1 91.1 19.8 1.6 0.0 0.4 0.0 3.2 3.1 0.6 6.5 1.4 1.5 1.2 1.4 0.1 3.2 1.0 0.1 PM20D1 "Cps1, FLJ32569" ENSG00000162877 "Peptidase M20 domain containing 1" Q6GTS8 1 205828022-205850132 "Enzymes, Predicted secreted proteins" "Hydrolase, Lyase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "pancreas: 103.5" "Group enriched" "Detected in some" 6 "Exocrine glandular cells: 18.7;Proximal tubular cells: 5.8" "Cancer enriched" "Detected in some" 32 "urothelial cancer: 30.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.5" "Lineage enriched" "Detected in single" 5 "T-cells: 4.5" "Cell line enriched" "Detected in single" 9 "Karpas-707: 6.6" "Low region specificity" "Detected in all" "Secreted to digestive system" NA NA 3000000 "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (4.83e-1)" "unprognostic (4.08e-3)" "unprognostic (1.17e-3)" "unprognostic (3.11e-1)" "unprognostic (1.20e-1)" "unprognostic (5.50e-2)" "unprognostic (5.81e-2)" "unprognostic (4.57e-2)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (1.45e-1)" "unprognostic (2.48e-1)" "unprognostic (1.68e-2)" 0.5 0.0 0.0 0.5 0.2 0.0 0.6 0.1 0.4 0.0 0.2 0.6 0.4 0.0 0.2 0.3 0.0 0.1 0.0 0.3 0.3 0.0 3.2 0.1 0.2 0.5 0.2 0.0 0.3 103.5 0.0 0.0 0.1 0.4 0.8 0.0 0.3 0.2 0.4 0.0 14.3 0.1 0.1 0.1 0.4 1.2 0.2 0.1 0.1 0.1 0.1 0.4 1.5 0.3 0.3 0.0 0.8 0.2 0.0 4.5 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.3 0.3 0.9 2.4 0.0 0.2 0.3 0.9 0.0 0.0 0.2 0.0 4.5 1.0 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.7 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 5.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PMAIP1 "APR, NOXA" ENSG00000141682 "Phorbol-12-myristate-13-acetate-induced protein 1" Q13794 18 59899948-59904306 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.3;bone marrow: 45.5" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 713.3;Suprabasal keratinocytes: 604.1;Urothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 42.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 51.8;U-138 MG: 50.1" HPA051063 Uncertain Uncertain Vesicles NA NA Vesicles "HPA051063: AB_2681330" "unprognostic (1.35e-3)" "unprognostic (5.02e-2)" "unprognostic (5.57e-2)" "unprognostic (4.88e-2)" "unprognostic (6.65e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.41e-2)" "unprognostic (6.12e-2)" "unprognostic (8.47e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.53e-1)" "unprognostic (7.68e-2)" "unprognostic (8.74e-2)" "unprognostic (1.09e-1)" 1.9 0.4 2.2 9.4 2.4 45.5 3.1 0.9 2.5 6.0 2.8 1.6 0.1 2.2 3.3 1.7 12.4 1.7 4.8 1.3 3.3 2.3 1.3 1.3 10.9 7.8 2.6 0.8 1.6 1.3 5.6 27.3 14.7 3.3 3.0 2.0 0.6 3.9 0.8 1.8 20.2 6.4 1.1 2.3 7.6 1.7 1.7 0.8 12.7 1.3 11.7 18.7 7.3 6.8 10.6 3.7 42.3 9.2 1.9 7.4 4.1 6.2 4.2 1.3 0.4 2.2 17.3 4.8 30.1 20.5 17.6 17.6 0.4 7.8 24.7 4.2 5.6 51.8 9.3 5.0 2.8 17.4 7.9 37.4 4.5 6.3 1.0 22.0 15.5 7.0 7.1 7.6 23.1 12.0 6.4 5.8 11.3 6.1 4.3 5.8 0.6 12.4 4.7 37.0 0.6 7.9 12.7 7.0 9.0 10.2 5.8 9.8 8.0 1.5 0.8 16.7 14.5 1.2 12.9 21.7 50.1 13.3 2.5 33.4 0.7 0.0 21.6 4.1 8.9 11.7 42.3 5.1 30.5 3.5 7.8 3.1 10.6 1.6 2.2 3.7 7.8 1.4 1.9 16.3 1.9 9.2 3.0 7.4 4.1 2.2 2.4 0.9 2.5 3.3 2.3 2.6 0.8 3.3 0.8 29.8 22.6 94.8 231.2 713.3 0.2 2.8 10.2 25.4 37.5 3.5 2.0 82.2 0.0 47.6 0.3 21.1 112.8 0.0 57.4 7.9 58.2 192.2 32.2 0.0 75.3 0.0 127.9 6.7 15.8 1.0 0.9 67.5 70.9 235.4 45.1 0.2 105.0 80.7 1.1 0.2 0.7 0.0 36.8 0.2 3.6 604.1 263.6 50.7 55.5 478.7 PMCH MCH ENSG00000183395 "Pro-melanin concentrating hormone" P20382 12 102196459-102197845 "Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein, Hormone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 124.8" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 1.6;monocytes: 1.8" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.8" "Region enriched" "Detected in some" 27 "hypothalamus: 124.8" "Cell type enriched" "Detected in some" 8 "T-reg: 11.3" "Lineage enriched" "Detected in single" 81 "T-cells: 11.3" "Cell line enriched" "Detected in some" 8 "HDLM-2: 31.3" "Group enriched" "Detected in some" 131 "hypothalamus: 737.6;thalamus: 373.6" "Region enriched" "Detected in some" 30 "hypothalamus: 98.6" "HPA046055, HPA061884" Enhanced Supported "Secreted to blood" NA NA 274000 "HPA046055: AB_2679517, HPA061884: AB_2684632" "unprognostic (3.23e-3)" "unprognostic (8.04e-2)" "unprognostic (3.96e-4)" "unprognostic (2.09e-2)" "unprognostic (1.75e-1)" "unprognostic (7.73e-2)" "unprognostic (4.31e-3)" "unprognostic (1.43e-2)" "unprognostic (3.18e-3)" "unprognostic (4.51e-2)" "unprognostic (1.21e-1)" "unprognostic (2.16e-6)" "unprognostic (1.17e-2)" "unprognostic (1.93e-1)" "unprognostic (5.10e-2)" "unprognostic (3.53e-2)" 0.1 0.0 0.3 2.1 2.0 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 1.1 1.0 0.0 0.2 0.6 0.8 124.8 0.1 0.1 0.2 6.4 0.4 0.1 0.1 0.1 0.0 1.4 0.2 4.5 0.2 0.0 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.9 1.1 2.0 0.2 0.7 1.0 0.1 0.1 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.1 11.3 0.0 0.3 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.2 0.2 0.0 0.0 0.0 31.3 0.1 0.5 0.6 0.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.2 3.8 0.4 0.7 0.1 0.0 0.0 0.6 1.0 0.5 0.5 1.2 0.3 0.6 1.2 0.0 0.2 0.3 0.4 0.4 0.6 0.1 0.3 0.2 0.1 0.4 0.4 0.4 0.1 0.5 0.1 0.6 0.4 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 0.3 2.0 0.1 0.1 0.8 124.8 0.4 0.1 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 PMEL "D12S53E, gp100, Pmel17, SI, SIL, SILV" ENSG00000185664 "Premelanosome protein" P40967 12 55954105-55973317 "Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 230.1" "Cell type enriched" "Detected in many" 34 "Melanocytes: 1396.9" "Cancer enriched" "Detected in many" 500 "melanoma: 2481.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 66 "SK-MEL-30: 442.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031649 Enhanced Supported "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA 14000000 "Endoplasmic reticulum" "Golgi apparatus" "HPA031649: AB_2673976" "unprognostic (4.63e-1)" "unprognostic (8.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.60e-1)" "unprognostic (5.90e-2)" "unprognostic (6.46e-2)" "unprognostic (1.94e-1)" "unprognostic (1.46e-3)" "unprognostic (6.44e-2)" "unprognostic (1.21e-1)" "unprognostic (5.12e-2)" "unprognostic (3.98e-1)" "prognostic favorable (3.70e-4)" "unprognostic (2.86e-2)" "unprognostic (1.54e-1)" "unprognostic (7.60e-2)" "unprognostic (1.04e-1)" 0.9 0.1 0.4 0.4 0.5 0.4 3.4 0.4 0.5 38.2 1.0 0.4 0.5 0.4 11.8 0.4 0.4 0.2 0.6 0.5 0.4 0.0 0.6 1.8 0.7 1.9 0.4 0.4 1.6 0.6 0.9 0.4 0.9 0.4 0.5 0.2 230.1 1.1 0.4 0.6 46.8 0.6 1.3 0.8 0.4 0.2 1.5 0.4 0.4 0.4 0.6 0.6 0.5 0.8 1.3 2.3 2.1 1.4 0.2 1.9 0.6 0.7 0.0 0.2 0.0 4.5 0.0 6.6 0.0 0.0 0.1 0.1 0.6 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 442.3 0.2 0.2 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.5 0.1 0.0 0.1 0.0 0.0 1.4 0.7 0.3 0.0 1.9 1.3 0.5 0.4 0.0 0.9 1.1 0.1 2.1 0.2 0.4 2.3 0.4 0.6 0.4 0.5 0.4 0.5 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.3 0.0 0.6 40.8 0.0 0.2 2.5 0.0 2.3 0.0 0.0 8.0 0.0 1.3 6.7 0.6 1.3 0.0 2.0 12.0 2.4 0.7 0.0 2.4 1.5 0.0 0.0 0.0 0.3 4.1 11.2 0.3 1396.9 1.0 1.5 0.3 0.9 0.0 0.7 2.1 0.0 0.0 0.5 3.0 2.7 8.9 20.8 0.0 1.5 0.3 PMEPA1 "STAG1, TMEPAI" ENSG00000124225 "Prostate transmembrane protein, androgen induced 1" Q969W9 20 57648392-57711536 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 60.4;prostate: 67.3" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 306.3;Glandular cells: 287.7;Muller glia cells: 308.1;Pancreatic endocrine cells: 506.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 5.2;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 7 "B-cells: 5.2;dendritic cells: 18.4" "Cell line enhanced" "Detected in many" "SiHa: 40.4;U-2 OS: 26.3;U-251 MG: 92.9;WM-115: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072291 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA072291: AB_2686509" "unprognostic (2.72e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (5.77e-2)" "unprognostic (1.73e-1)" "unprognostic (6.61e-2)" "unprognostic (2.11e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.73e-5)" "unprognostic (5.53e-1)" "unprognostic (1.32e-3)" "unprognostic (7.83e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (9.87e-3)" "prognostic unfavorable (7.60e-4)" 27.0 7.8 7.5 10.6 34.8 1.3 9.5 2.6 12.6 60.4 10.8 11.0 4.2 4.4 22.1 6.7 7.1 7.7 21.8 10.7 7.5 8.6 5.3 1.7 8.5 4.5 10.2 5.9 6.2 18.6 2.6 5.6 3.0 12.1 67.3 5.7 21.3 11.6 13.3 17.4 6.8 7.6 17.6 8.1 4.0 5.3 3.2 9.1 1.3 5.4 6.0 6.2 8.4 13.0 5.2 18.4 0.1 0.3 0.0 1.6 0.4 6.0 14.8 0.4 0.7 0.4 0.0 0.1 0.9 0.0 0.3 0.1 0.2 19.2 0.0 3.5 1.4 10.4 23.5 0.3 19.8 0.2 0.1 0.8 0.0 4.1 0.0 0.3 0.0 0.1 0.2 11.1 0.8 2.4 3.3 2.5 13.3 0.1 0.2 1.2 12.5 0.7 0.1 1.8 2.9 1.9 0.0 7.2 2.1 4.8 0.0 3.5 2.7 40.4 24.0 2.8 1.1 3.7 0.7 6.4 3.6 26.3 0.3 92.9 1.1 0.1 0.0 1.6 0.2 46.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.6 0.2 0.0 5.2 1.6 0.9 0.1 0.0 0.0 18.4 0.4 0.4 7.5 34.8 2.6 12.6 7.5 8.6 10.2 5.9 12.1 9.1 53.6 35.4 14.7 85.0 148.4 56.2 22.6 114.7 0.0 14.8 10.4 2.0 0.0 3.3 306.3 1.1 39.7 9.5 0.0 53.6 2.0 27.8 287.7 60.9 0.0 5.6 1.6 9.7 16.0 3.4 1.4 2.8 6.7 30.4 10.0 11.5 308.1 506.6 17.5 20.5 1.3 6.6 71.1 116.0 0.0 6.8 156.0 0.1 1.9 9.2 71.5 PMFBP1 ENSG00000118557 "Polyamine modulated factor 1 binding protein 1" Q8TBY8 16 72112157-72176878 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 13.6;testis: 30.8" "Group enriched" "Detected in some" 5 "Early spermatids: 98.0;Late spermatids: 189.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 21.0;SH-SY5Y: 10.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA056716, HPA075825" Approved Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA056716: AB_2683215, HPA075825: " "unprognostic (1.46e-1)" "unprognostic (3.62e-1)" "unprognostic (5.95e-2)" "unprognostic (1.04e-1)" "unprognostic (2.44e-2)" "unprognostic (7.03e-2)" "unprognostic (1.06e-4)" "unprognostic (1.60e-1)" "unprognostic (3.81e-1)" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (2.68e-5)" "unprognostic (9.85e-2)" "unprognostic (2.66e-1)" "unprognostic (9.85e-2)" "unprognostic (8.67e-2)" 1.1 0.9 1.1 1.1 1.1 3.9 1.1 2.1 1.1 1.1 2.1 1.1 1.1 2.6 1.1 13.6 1.6 0.9 1.1 1.1 1.1 0.7 1.3 1.6 1.1 1.5 1.1 1.1 1.5 4.2 2.9 1.5 1.1 1.1 2.1 3.3 1.1 1.1 1.1 1.1 4.1 2.9 1.1 1.1 2.9 1.1 30.8 1.1 1.1 1.1 1.1 1.1 1.1 1.1 0.5 1.9 0.9 2.0 0.0 0.3 0.2 0.2 0.4 2.8 2.5 0.0 0.6 1.8 0.5 0.2 0.5 2.1 1.0 2.6 1.8 0.4 0.1 0.1 1.8 1.0 0.1 1.3 0.2 4.2 1.8 3.0 2.9 0.0 4.1 3.2 0.0 0.8 0.1 2.1 0.6 0.8 2.1 0.3 1.6 0.1 2.3 1.0 6.0 0.8 0.1 1.2 2.7 0.2 1.4 0.3 0.7 21.0 10.5 0.0 0.0 0.2 2.0 0.5 2.6 1.7 1.3 2.1 0.6 1.3 3.9 1.4 1.2 0.6 2.7 0.7 0.0 1.6 0.9 0.1 0.5 0.0 0.0 0.1 0.2 1.6 0.5 0.1 0.1 0.2 0.0 2.0 1.9 0.3 0.2 1.1 1.1 2.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 0.0 1.1 0.0 0.1 0.3 0.0 0.7 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 98.0 0.2 0.0 0.0 0.2 0.1 0.2 0.1 3.5 0.0 4.6 28.6 5.2 0.0 1.0 189.3 1.1 2.8 0.0 0.0 0.3 1.3 0.1 0.0 1.4 0.3 0.1 0.0 0.1 1.6 0.8 0.0 0.1 0.0 0.5 0.0 PMIS2 IFITMD9 ENSG00000283758 "PMIS2, transmembrane protein" 19 35586161-35587296 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 43 "testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "NTERA-2: 1.2;U-138 MG: 2.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PMP2 "FABP8, M-FABP, MP2" ENSG00000147588 "Peripheral myelin protein 2" P02689 8 81440326-81447523 "Predicted intracellular proteins" Transport "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 30 "brain: 124.8" "Cell type enriched" "Detected in some" 18 "Muller glia cells: 30.0" "Cancer enriched" "Detected in some" 59 "glioma: 239.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.0;Karpas-707: 1.4;U-87 MG: 1.6;WM-115: 5.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "midbrain: 78.0;pons and medulla: 111.5" NA NA "unprognostic (5.87e-2)" "unprognostic (5.81e-2)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (8.03e-3)" "unprognostic (1.10e-2)" "unprognostic (8.45e-2)" "unprognostic (4.43e-2)" "unprognostic (7.21e-2)" "unprognostic (4.41e-1)" "unprognostic (3.27e-3)" 2.7 2.5 39.2 2.4 36.9 1.5 1.6 13.4 124.8 2.5 2.2 14.5 0.0 1.8 1.6 2.8 2.0 1.7 2.2 2.4 30.4 31.2 1.6 1.6 1.5 1.5 48.3 18.3 1.7 1.8 1.5 0.0 1.5 66.6 2.0 2.0 0.0 2.2 4.2 1.7 1.7 1.9 1.7 106.3 1.5 1.6 1.6 45.8 0.0 1.5 0.0 1.5 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 36.9 13.4 27.8 30.4 31.2 48.3 18.3 66.6 45.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 30.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PNCK "CaMK1b, MGC45419" ENSG00000130822 "Pregnancy up-regulated nonubiquitous CaM kinase" Q6P2M8 X 153669730-153689010 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.4;seminal vesicle: 38.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 16.5;Cone photoreceptor cells: 21.6;Extravillous trophoblasts: 44.0;Rod photoreceptor cells: 19.4;Syncytiotrophoblasts: 41.4" "Cancer enhanced" "Detected in many" "renal cancer: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "AN3-CA: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007458 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA007458: AB_1079644" "unprognostic (1.56e-1)" "unprognostic (2.56e-1)" "unprognostic (1.16e-2)" "unprognostic (5.95e-3)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-2)" "unprognostic (3.60e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.04e-6)" "unprognostic (2.86e-3)" "unprognostic (1.43e-1)" "unprognostic (2.66e-1)" "unprognostic (6.26e-3)" 1.6 1.8 21.4 2.2 35.4 0.6 0.9 3.7 24.9 0.9 21.9 0.9 6.9 3.8 4.2 3.1 14.5 2.9 2.9 3.8 19.5 17.0 1.0 0.5 0.7 0.6 6.1 15.5 0.7 0.5 1.4 0.3 2.4 3.8 12.6 4.2 0.4 0.7 38.5 2.2 1.4 5.2 15.3 2.6 0.7 5.5 4.7 1.7 0.0 0.5 0.0 0.7 10.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 27.1 0.0 0.0 2.9 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.2 0.3 0.4 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.2 3.2 0.0 0.1 2.2 0.8 0.3 0.3 0.0 0.2 1.1 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 35.4 3.7 23.2 19.5 17.0 6.1 15.5 3.8 1.7 0.0 0.0 0.0 0.4 0.6 16.5 2.8 0.0 0.0 0.0 0.0 21.6 8.3 0.0 0.2 0.2 0.3 2.0 0.0 0.3 44.0 0.2 0.2 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.4 2.7 4.8 0.0 0.4 0.1 19.4 0.0 0.4 0.5 0.6 0.5 41.4 0.0 0.0 0.9 PNLDC1 "dJ195P10.2, FLJ40240" ENSG00000146453 "PARN like, ribonuclease domain containing 1" Q8NA58 6 159800249-159820704 "Enzymes, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 26.7" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 7.6;Early spermatids: 13.6;Late spermatids: 10.3;Spermatocytes: 11.1;Spermatogonia: 9.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basal ganglia: 5.7;cerebral cortex: 3.9" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.8;plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;HAP1: 2.3;hTCEpi: 3.8;RPMI-8226: 2.1;SuSa: 1.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA052026 Uncertain NA NA "HPA052026: AB_2681699" "unprognostic (1.58e-1)" "unprognostic (3.88e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-3)" "unprognostic (8.47e-3)" "unprognostic (3.55e-2)" "unprognostic (2.04e-1)" "unprognostic (4.24e-1)" "unprognostic (1.01e-1)" "unprognostic (5.37e-2)" "unprognostic (4.19e-1)" "unprognostic (9.98e-2)" "unprognostic (2.69e-9)" "unprognostic (1.14e-2)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-1)" 0.6 0.5 0.6 0.5 5.7 0.4 1.4 0.2 3.9 0.3 0.3 0.3 0.0 0.2 0.3 1.3 0.2 3.6 0.3 0.2 0.7 0.2 0.8 0.8 0.5 0.4 0.4 0.7 0.8 2.3 0.3 0.3 0.3 0.3 0.4 0.3 0.0 1.2 0.4 0.5 1.4 0.3 0.3 0.4 0.5 0.3 26.7 0.3 0.5 0.4 0.3 0.7 0.2 0.0 0.1 1.7 0.0 1.8 0.4 1.0 0.4 0.0 0.4 0.2 1.8 1.0 0.0 1.1 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.2 0.3 0.1 0.1 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 3.8 0.0 0.1 0.2 0.0 1.0 0.1 0.8 0.2 0.1 0.8 0.1 0.9 0.3 0.8 0.1 0.0 2.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.9 0.0 0.1 0.2 0.3 0.0 0.3 0.7 0.1 0.0 0.6 0.1 0.0 0.2 0.0 0.1 1.8 0.0 0.0 0.2 0.0 0.7 0.1 1.0 0.1 0.0 0.4 0.0 1.7 0.5 0.4 0.6 5.7 0.2 3.9 0.7 0.2 0.4 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 13.6 0.0 0.0 0.0 0.8 0.0 0.2 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 10.3 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 11.1 9.0 0.0 0.0 0.0 0.0 0.1 PNLIP PL ENSG00000175535 "Pancreatic lipase" P16233 10 116545931-116567855 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1895 "pancreas: 3207.8" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 3478.1" "Cancer enriched" "Detected in some" 4854 "pancreatic cancer: 2731.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 3.1;HDLM-2: 2.8;U-2 OS: 4.6;U-251 MG: 1.1;U-266/84: 1.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA062430, HPA062494" Enhanced "Secreted to digestive system" NA NA 13000000 "HPA062430: AB_2684761, HPA062494: AB_2684782" "unprognostic (2.05e-2)" "unprognostic (4.46e-2)" 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 3207.8 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 1.1 0.0 1.5 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.5 0.0 0.0 0.0 3478.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 25.2 0.0 0.0 826.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNLIPRP1 PLRP1 ENSG00000187021 "Pancreatic lipase related protein 1" P54315 10 116590385-116609175 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 2629 "pancreas: 516.5" "Cell type enriched" "Detected in some" 5 "Exocrine glandular cells: 576.9" "Cancer enriched" "Detected in single" 475 "pancreatic cancer: 32.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "EFO-21: 1.1;U-2 OS: 1.8;U-266/84: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to digestive system" NA NA 210000 "unprognostic (1.21e-1)" "unprognostic (4.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.80e-1)" "unprognostic (2.76e-2)" "unprognostic (1.41e-1)" "unprognostic (1.46e-1)" "unprognostic (1.49e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 516.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 576.9 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 3.6 0.1 0.0 108.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 PNLIPRP3 ENSG00000203837 "Pancreatic lipase related protein 3" Q17RR3 10 116427867-116477957 "Enzymes, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 1.0;Late spermatids: 1.6;Melanocytes: 1.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "hTCEpi: 86.9" "Not detected" "Not detected" "HPA046202, HPA052009" Uncertain "Secreted - unknown location" NA NA "HPA046202: AB_10959739, HPA052009: AB_2681692" "unprognostic (2.62e-4)" "unprognostic (1.60e-1)" "unprognostic (6.97e-2)" 8.5 0.1 0.0 0.0 0.2 0.0 15.9 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.0 0.4 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 15.5 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 8.1 1.9 0.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 PNMA2 "MA2, RGAG2" ENSG00000240694 "PNMA family member 2" Q9UL42 8 26504686-26514092 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 82.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 28.6;Muller glia cells: 27.1" "Cancer enhanced" "Detected in many" "glioma: 28.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 25.6;hTERT-RPE1: 32.1;JURKAT: 17.4;SH-SY5Y: 18.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001936 Enhanced NA NA "HPA001936: AB_1079647" "unprognostic (1.25e-2)" "unprognostic (1.27e-2)" "unprognostic (6.39e-2)" "unprognostic (1.43e-6)" "unprognostic (1.18e-1)" "unprognostic (1.37e-1)" "unprognostic (8.76e-2)" "prognostic favorable (1.81e-4)" "unprognostic (4.66e-2)" "unprognostic (1.34e-2)" "unprognostic (1.46e-2)" "unprognostic (1.52e-1)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (5.12e-2)" "unprognostic (4.58e-5)" "unprognostic (9.00e-3)" 2.6 9.5 24.4 1.9 33.2 1.3 2.5 5.9 82.6 4.1 1.9 4.3 0.0 1.7 1.8 1.9 1.5 3.0 4.0 2.9 21.6 36.7 3.0 1.7 6.1 1.4 14.5 26.8 1.4 4.0 2.1 5.1 1.5 16.6 1.7 1.8 1.7 1.2 1.8 1.4 1.6 1.9 2.5 7.0 1.4 3.4 2.3 4.6 0.0 3.1 0.0 1.3 2.6 0.4 0.9 0.4 3.0 0.3 0.4 0.5 0.1 0.0 4.7 25.6 0.2 5.1 1.0 0.0 1.3 6.9 3.2 1.0 0.2 3.4 0.0 0.9 0.4 7.9 0.1 15.8 0.0 2.4 0.0 2.8 0.0 3.5 0.0 0.3 0.0 0.2 1.8 0.0 13.6 0.1 32.1 15.1 17.4 0.0 0.0 1.9 0.1 7.4 0.0 14.1 0.2 0.0 0.0 5.2 0.0 7.6 1.7 12.6 18.4 0.0 0.0 0.8 1.9 0.0 0.5 7.4 0.3 5.3 6.5 1.0 2.4 1.8 0.0 14.8 0.0 0.4 3.0 0.3 0.2 0.4 0.1 0.2 0.3 0.2 0.2 0.1 0.9 0.3 0.5 0.9 0.4 0.2 0.4 0.2 0.1 24.4 33.2 5.9 42.3 21.6 36.7 14.5 26.8 16.6 4.6 3.0 8.8 2.2 0.2 0.0 3.8 0.4 0.0 5.3 6.8 0.0 2.0 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.1 1.1 0.0 1.1 0.0 0.1 28.6 10.4 0.6 0.6 1.5 10.3 0.0 1.7 0.0 0.0 27.1 2.1 0.0 11.3 5.4 4.4 0.0 4.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 PNMA3 "MA3, MA5, MGC132756, MGC132758" ENSG00000183837 "PNMA family member 3" Q9UL41 X 153056409-153060467 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 17.4;epididymis: 35.5" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 4.3;Cardiomyocytes: 2.6;Horizontal cells: 6.4;Muller glia cells: 4.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.9;NTERA-2: 8.2;SCLC-21H: 2.7;SH-SY5Y: 2.0;THP-1: 2.1" "Low region specificity" "Detected in all" HPA047920 Approved NA NA "HPA047920: AB_2680210" "unprognostic (1.66e-2)" "unprognostic (8.97e-3)" "unprognostic (8.70e-2)" "prognostic unfavorable (4.14e-5)" "unprognostic (9.43e-2)" "unprognostic (3.10e-3)" "unprognostic (1.16e-1)" "unprognostic (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (6.20e-2)" "unprognostic (7.62e-4)" "unprognostic (1.93e-1)" "unprognostic (5.92e-3)" "unprognostic (2.93e-3)" "unprognostic (7.25e-2)" "unprognostic (7.84e-2)" "unprognostic (2.07e-2)" 0.4 1.4 4.8 0.8 6.8 0.4 0.3 3.0 17.4 0.5 0.3 0.2 0.0 0.4 0.5 35.5 0.3 1.2 0.4 1.4 4.9 1.0 0.3 0.3 1.4 0.0 13.7 0.6 0.5 0.4 0.7 0.3 11.2 0.5 0.3 0.7 0.4 0.6 0.3 0.6 0.5 0.3 1.3 0.8 0.3 5.9 0.0 0.0 0.9 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.1 0.1 0.0 0.0 8.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.7 2.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 6.4 0.0 0.6 1.9 1.1 1.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 1.9 1.6 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.0 0.1 PNMA5 KIAA1934 ENSG00000198883 "PNMA family member 5" Q96PV4 X 152988824-152994127 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 21.6;testis: 16.8" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 94.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 573 "HMC-1: 63.5;U-266/70: 100.0;U-266/84: 59.3" "HPA044690, HPA073946" Enhanced NA NA "HPA044690: AB_2679049, HPA073946: " "unprognostic (5.25e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (2.25e-4)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (3.55e-2)" "prognostic favorable (3.16e-4)" "unprognostic (1.15e-1)" "unprognostic (1.16e-3)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (4.76e-9)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (1.41e-2)" 0.4 0.3 8.2 0.5 21.6 0.4 0.3 0.0 11.6 0.3 0.4 0.3 0.0 0.5 0.4 0.5 0.4 0.4 0.4 0.4 3.9 19.1 0.4 0.4 0.4 0.6 1.0 6.6 0.3 0.3 0.3 0.6 0.7 2.4 0.3 0.4 0.0 0.4 0.4 0.3 1.2 0.4 0.4 0.5 1.1 0.7 16.8 0.0 0.0 0.4 0.0 0.5 0.5 0.0 0.8 0.7 0.1 1.2 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 100.0 59.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.8 0.0 0.8 0.6 0.0 0.7 0.0 0.2 0.0 0.1 0.0 1.2 0.4 0.6 0.2 8.2 21.6 0.0 11.6 3.9 19.1 1.0 6.6 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 94.9 0.0 0.2 0.0 0.0 0.0 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072482-153075018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 21.6;Distal tubular cells: 10.0;Horizontal cells: 22.3;Muller glia cells: 18.8;Proximal tubular cells: 20.3;Rod photoreceptor cells: 7.1" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 28 "granulocytes: 5.3" "Cell line enhanced" "Detected in some" "HHSteC: 8.0;HMC-1: 6.9;SK-MEL-30: 6.6;U-2 OS: 15.2;U-698: 8.3" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA045007: AB_2679181, HPA052115: AB_2681734" "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favorable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.3 2.0 7.2 0.1 6.2 0.2 0.3 7.0 16.3 3.7 0.2 0.5 1.8 7.0 0.1 1.5 0.9 2.1 6.5 11.0 6.2 7.9 0.1 0.2 5.5 3.1 0.7 0.4 3.9 0.1 0.1 0.1 0.9 0.7 0.0 0.3 0.3 0.6 1.6 0.5 0.5 0.8 1.8 0.2 0.1 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 5.3 0.1 1.6 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.9 0.4 0.9 0.0 2.9 0.0 0.0 0.0 0.6 0.0 0.3 0.2 8.0 3.2 6.9 1.2 0.0 0.1 0.0 0.2 0.2 5.7 1.3 0.0 0.1 0.4 1.1 0.0 3.4 5.8 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.9 0.4 0.0 6.6 0.3 0.0 4.1 0.0 0.0 15.2 0.0 0.0 5.8 4.3 8.3 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 21.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 2.5 3.2 22.3 0.0 0.6 0.0 0.4 2.6 0.0 0.0 0.0 0.0 18.8 0.4 0.0 2.8 20.3 7.1 0.0 0.2 1.0 2.2 0.0 0.0 0.0 0.0 0.1 PNMA6E ENSG00000214897 "PNMA family member 6E" A0A0J9YXQ4 X 153395640-153401420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 8.0;ovary: 6.5;testis: 26.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;SCLC-21H: 2.7;THP-1: 1.0;U-937: 2.0" NA NA "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (2.99e-2)" "unprognostic (1.77e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNMA6F PNMA6BL ENSG00000225110 "PNMA family member 6F" A0A0J9YX94 X 153317681-153321822 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adrenal gland: 2.5;brain: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "AN3-CA: 2.2" NA NA "unprognostic (6.52e-2)" "unprognostic (7.19e-2)" 0.0 2.5 1.7 0.1 6.5 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.1 0.9 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 61.0" "Group enriched" "Detected in some" 4 "Ciliated cells: 20.1;Collecting duct cells: 10.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 17.9;K-562: 18.9;LHCN-M2: 19.6;SH-SY5Y: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012956, HPA077702" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328, HPA077702: " "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.2 17.4 18.6 1.2 26.4 1.1 3.9 24.8 61.0 2.9 1.6 5.1 1.2 1.2 9.7 12.7 1.5 16.7 4.3 10.7 16.6 29.9 7.2 0.9 1.8 0.8 14.1 25.7 13.5 5.0 3.8 14.5 2.4 19.5 7.1 1.1 5.4 4.4 8.1 1.2 1.5 1.3 5.9 8.9 0.9 1.4 16.1 4.4 4.3 11.7 0.0 1.0 1.9 0.7 1.1 1.1 3.0 0.5 0.8 2.6 0.3 0.0 7.4 10.8 10.7 3.2 7.2 2.0 0.7 0.1 1.3 0.7 0.1 0.8 0.0 10.1 0.5 3.8 0.1 17.9 2.9 0.9 0.0 6.7 0.0 0.2 0.2 5.3 0.1 0.1 1.8 3.6 4.5 0.0 1.0 1.0 6.4 18.9 0.1 19.6 0.0 0.1 0.1 9.1 0.0 0.0 0.0 11.9 0.0 4.5 0.0 8.8 17.4 0.0 0.2 0.0 10.4 0.1 0.2 0.6 0.0 0.1 0.1 3.6 0.0 0.0 0.1 0.1 0.0 1.2 3.0 0.5 0.3 0.3 0.3 0.2 1.1 0.3 0.9 0.1 0.7 0.4 2.6 1.3 0.8 0.1 1.1 0.2 0.3 18.6 26.4 24.8 37.2 16.6 29.9 14.1 25.7 19.5 4.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 20.1 3.4 10.4 0.0 0.7 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PNMA8B "KIAA1183, PNMAL2" ENSG00000204851 "PNMA family member 8B" Q9ULN7 19 46486906-46496498 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 10.3;brain: 22.5" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 2.2;Distal tubular cells: 1.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "AF22: 3.7;AN3-CA: 4.7;fHDF/TERT166: 1.6;JURKAT: 2.7;NTERA-2: 1.9;SH-SY5Y: 3.9" "Low region specificity" "Detected in all" HPA054810 Enhanced NA NA "HPA054810: AB_2682609" "unprognostic (1.31e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-2)" "unprognostic (3.38e-3)" "unprognostic (2.90e-1)" "unprognostic (1.35e-1)" "unprognostic (4.15e-1)" "unprognostic (4.19e-3)" "unprognostic (4.26e-4)" "unprognostic (7.30e-2)" "unprognostic (5.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.07e-1)" "unprognostic (3.38e-1)" "unprognostic (1.32e-2)" 2.3 10.3 9.1 0.3 6.7 0.0 0.5 2.5 22.5 0.8 0.3 0.3 0.6 0.5 0.4 0.7 0.9 1.2 9.0 15.6 0.4 0.2 0.6 0.3 6.4 3.9 0.8 0.1 1.8 0.3 1.0 0.1 1.4 1.0 0.4 1.6 0.5 0.5 2.8 1.6 0.4 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.3 1.8 0.3 0.0 0.0 3.7 4.7 1.1 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.0 0.0 1.8 0.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PNMA8C ENSG00000277531 "PNMA family member 8C" A0A1B0GUJ8 19 46424697-46428951 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 23.5" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 11 "glioma: 7.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "AF22: 2.6;HMC-1: 5.6;SH-SY5Y: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.25e-2)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (4.91e-3)" "unprognostic (2.58e-1)" "unprognostic (4.61e-3)" "unprognostic (1.16e-2)" "unprognostic (1.69e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-2)" "unprognostic (2.92e-2)" 0.4 2.1 5.3 0.5 8.1 0.6 0.6 2.1 23.5 0.4 0.5 3.3 0.0 0.4 0.4 3.7 0.4 2.3 0.7 0.6 4.8 0.4 0.3 0.6 0.3 1.9 11.5 0.6 0.4 0.7 4.6 0.3 7.0 0.9 0.4 0.0 0.4 1.0 1.3 0.5 0.5 0.5 1.8 0.4 0.4 1.2 1.6 0.0 0.4 0.0 0.3 0.4 0.0 1.1 1.4 2.7 0.5 1.7 0.6 0.1 0.0 0.0 2.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 1.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 8.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 2.7 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.3 0.2 1.1 0.5 0.6 2.3 1.7 0.5 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PNMT PENT ENSG00000141744 "Phenylethanolamine N-methyltransferase" P11086 17 39667981-39670475 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 94.6;ductus deferens: 53.7;seminal vesicle: 40.7" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 12.2;Collecting duct cells: 5.2;Ito cells: 11.6" "Cancer enhanced" "Detected in many" "cervical cancer: 27.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.5" "Group enriched" "Detected in many" 5 "B-cells: 1.0;T-cells: 2.5" "Cell line enhanced" "Detected in some" "HEL: 4.9;K-562: 10.4;NB-4: 20.7;NTERA-2: 4.0;SCLC-21H: 5.6;SH-SY5Y: 5.2" "Region enhanced" "Detected in some" "basal ganglia: 1.3" "Not detected" "Not detected" "CAB017029, HPA043412, HPA051005" Enhanced NA NA "CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306" "unprognostic (1.50e-1)" "unprognostic (3.74e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (3.95e-5)" "unprognostic (4.27e-2)" "unprognostic (3.02e-1)" "unprognostic (2.98e-2)" "unprognostic (5.75e-2)" "unprognostic (5.29e-2)" "unprognostic (1.30e-1)" "unprognostic (1.51e-1)" "unprognostic (1.33e-1)" "unprognostic (1.52e-4)" "unprognostic (1.58e-1)" "unprognostic (1.97e-1)" "unprognostic (4.72e-2)" "unprognostic (1.87e-2)" 2.3 94.6 3.9 0.8 13.8 1.6 5.4 0.9 3.0 1.3 1.9 1.5 53.7 0.9 1.0 2.7 0.9 1.9 0.8 4.9 1.7 5.4 1.0 0.7 1.6 0.8 9.1 1.5 0.9 0.7 2.4 12.9 2.4 3.6 4.3 0.7 0.9 0.7 40.7 10.5 0.8 1.0 0.8 0.7 0.9 0.9 1.3 2.7 0.0 0.7 0.8 0.7 1.3 1.7 1.0 0.0 0.3 0.3 0.0 2.5 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 4.9 0.1 0.4 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 20.7 4.0 0.4 0.0 0.1 0.0 0.3 0.0 0.0 5.6 5.2 0.0 2.2 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.4 1.0 0.4 1.5 0.0 0.4 0.0 0.7 0.3 0.0 0.3 0.0 0.0 0.3 3.9 13.8 0.9 3.0 1.7 5.4 9.1 1.5 3.6 2.7 0.0 0.0 0.0 0.6 0.5 0.4 12.2 2.5 0.0 0.0 5.2 0.0 0.0 1.7 0.0 0.6 2.8 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 0.0 2.9 11.6 0.0 0.9 2.0 0.0 0.0 0.0 0.1 2.8 0.1 0.0 0.4 0.0 0.4 0.0 0.3 0.3 2.1 0.4 0.0 0.0 0.2 1.6 PNOC "N/OFQ, NOP, PPNOC" ENSG00000168081 Prepronociceptin Q13519 8 28316986-28343355 "Predicted intracellular proteins, Predicted secreted proteins" "Neuropeptide, Neurotransmitter, Opioid peptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 47.9;brain: 22.6;lymphoid tissue: 18.1" "Cell type enriched" "Detected in some" 5 "B-cells: 64.0" "Cancer enriched" "Detected in many" 8 "ovarian cancer: 32.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "memory B-cell: 46.6;naive B-cell: 47.9;plasmacytoid DC: 33.7" "Group enriched" "Detected in many" 17 "B-cells: 47.9;dendritic cells: 33.7" "Group enriched" "Detected in some" 6 "Daudi: 24.6;Karpas-707: 19.4;RPMI-8226: 7.1;U-698: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044507, HPA056724" Enhanced "Secreted to blood" NA NA 12300 "HPA044507: AB_10795043, HPA056724: AB_2683216" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (3.53e-2)" "prognostic unfavorable (2.94e-6)" "unprognostic (3.71e-2)" "unprognostic (5.16e-5)" "unprognostic (1.03e-1)" "unprognostic (1.50e-1)" "unprognostic (7.81e-4)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (9.99e-3)" "unprognostic (7.57e-9)" "unprognostic (2.19e-2)" "unprognostic (5.45e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-1)" 0.4 0.6 4.0 7.2 7.4 2.0 0.5 0.9 22.6 0.3 2.3 1.0 0.0 3.3 0.2 0.0 1.2 13.5 0.9 0.3 3.1 8.4 1.2 0.4 0.9 18.1 5.9 3.2 2.2 0.2 0.1 0.2 0.0 7.5 0.3 1.3 0.0 2.5 0.1 0.2 0.2 6.5 0.4 4.3 16.9 2.4 0.7 0.0 0.6 0.6 0.0 18.1 5.2 0.4 47.9 33.7 0.4 2.4 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.7 2.7 14.8 0.1 0.1 0.0 0.0 2.4 0.4 0.0 1.5 0.0 46.6 0.0 0.0 0.2 47.9 0.0 0.0 0.2 0.2 0.6 33.7 0.1 2.4 4.0 7.4 0.9 15.7 3.1 8.4 5.9 3.2 7.5 0.0 0.0 3.4 64.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.8 0.0 1.8 0.3 0.0 13.5 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.1 PNP "NP, PUNP" ENSG00000198805 "Purine nucleoside phosphorylase" P00491 14 20468954-20477094 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 153.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 276.6;Syncytiotrophoblasts: 540.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.7;U-937: 94.3" "Low region specificity" "Detected in all" HPA001625 Enhanced Supported Cytosol NA NA 100000000 Cytosol "HPA001625: AB_1854577" "unprognostic (1.20e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" "unprognostic (1.70e-1)" "unprognostic (3.10e-1)" "unprognostic (7.06e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (4.94e-3)" "unprognostic (3.87e-2)" "unprognostic (7.45e-2)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "prognostic favorable (2.24e-4)" "unprognostic (1.69e-1)" "unprognostic (7.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.64e-3)" 24.7 7.6 9.5 15.0 14.0 69.4 15.7 13.9 11.8 9.5 19.1 6.2 25.2 29.4 5.9 153.1 34.0 7.8 15.7 12.1 11.5 8.4 49.7 24.2 18.3 13.2 13.5 3.4 3.6 11.0 8.7 8.4 45.3 17.7 6.0 16.1 3.8 9.2 7.9 3.3 10.6 32.0 9.8 16.3 18.0 17.0 4.5 12.5 7.0 7.1 21.7 19.1 7.5 14.7 13.1 20.7 4.1 12.4 15.7 33.7 12.1 13.4 18.2 3.8 8.7 4.4 3.5 11.9 13.8 6.5 11.3 11.1 10.5 12.3 36.0 16.0 7.3 13.3 14.6 20.4 26.0 15.0 11.6 17.9 30.1 15.5 17.3 4.1 82.7 15.7 2.4 9.4 34.0 15.1 6.2 48.1 22.3 14.8 22.5 14.1 12.5 24.3 48.8 11.0 34.4 30.4 20.6 5.8 14.0 40.1 12.8 16.9 3.7 26.5 33.7 2.1 5.6 12.4 14.7 38.5 7.7 10.3 17.3 23.4 10.3 17.2 40.7 6.6 94.3 0.7 4.0 12.4 4.1 18.1 11.5 33.7 11.2 20.3 20.0 20.7 13.1 12.9 16.3 1.6 15.7 10.6 11.7 6.9 12.1 9.5 14.0 13.9 11.8 11.5 8.4 13.5 3.4 17.7 12.5 0.0 26.3 18.6 51.4 75.2 4.8 3.1 28.1 8.1 17.0 78.5 13.7 276.6 33.2 38.4 1.0 60.2 56.3 93.5 44.5 26.6 19.4 21.8 56.6 23.1 63.4 15.9 44.5 19.6 22.4 0.0 0.3 46.2 28.7 1.0 31.7 70.2 85.7 56.1 0.7 91.5 17.0 0.0 33.8 0.2 0.6 55.8 540.4 19.3 34.8 70.5 PNPLA1 "dJ50J22.1, FLJ38755" ENSG00000180316 "Patatin like phospholipase domain containing 1" Q8N8W4 6 36243203-36312229 "Disease related genes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 28.5;skin 1: 25.1" "Cell type enhanced" "Detected in some" 18 "granulocytes: 4.6;Late spermatids: 1.3;Proximal tubular cells: 1.4;Suprabasal keratinocytes: 3.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basophil: 28.5;eosinophil: 9.5" "Lineage enriched" "Detected in many" 14 "granulocytes: 28.5" "Cell line enriched" "Detected in some" 5 "U-937: 21.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (3.57e-2)" "unprognostic (2.04e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-4)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (7.37e-2)" "unprognostic (2.49e-1)" "unprognostic (8.89e-2)" "unprognostic (1.13e-2)" "unprognostic (2.95e-1)" "unprognostic (2.76e-2)" "unprognostic (2.70e-2)" "unprognostic (9.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.04e-2)" "unprognostic (1.65e-2)" 0.8 0.2 0.1 0.5 0.1 3.6 0.5 0.1 0.5 0.3 1.5 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 4.5 1.0 1.0 5.5 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.2 25.1 7.4 0.1 0.8 3.7 1.4 0.8 0.1 0.9 0.1 0.1 0.1 0.1 0.5 0.0 0.9 28.5 1.9 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.7 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.1 4.5 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 21.0 0.0 28.5 1.9 9.5 0.0 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 3.1 0.0 0.5 0.0 0.0 0.4 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.6 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 3.1 0.1 0.0 0.0 0.1 PNPLA2 "ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2" ENSG00000177666 "Patatin like phospholipase domain containing 2" Q96AD5 11 818902-825573 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 158.1;breast: 155.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055173, HPA062602, HPA075175" Approved Enhanced "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: " "unprognostic (2.11e-2)" "unprognostic (3.37e-2)" "unprognostic (5.87e-3)" "unprognostic (2.51e-2)" "unprognostic (8.97e-3)" "unprognostic (1.68e-2)" "unprognostic (6.39e-2)" "unprognostic (3.28e-2)" "unprognostic (3.00e-1)" "unprognostic (5.61e-2)" "unprognostic (7.93e-2)" "unprognostic (2.09e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.46e-1)" "unprognostic (4.09e-1)" "unprognostic (2.07e-2)" 158.1 7.2 1.6 9.4 1.8 11.2 155.2 2.7 2.3 4.1 35.9 1.5 3.8 5.6 4.5 7.8 8.6 4.3 7.2 12.6 1.7 1.1 15.6 7.4 11.3 4.5 1.6 1.6 4.9 11.8 2.5 4.2 11.6 1.8 5.2 1.5 1.9 8.1 8.1 25.0 6.1 23.1 3.0 2.1 4.9 8.2 4.0 1.5 1.5 11.3 4.8 5.1 13.0 18.6 4.2 6.5 18.7 8.5 3.6 5.3 3.6 10.5 8.3 1.7 4.5 65.2 5.8 11.2 11.3 9.1 7.1 6.3 7.1 10.7 6.3 6.7 8.5 4.4 9.5 2.6 4.7 2.2 8.1 23.1 8.7 3.7 11.3 21.4 6.0 11.0 11.4 6.1 4.7 5.5 7.3 5.8 4.7 7.4 6.4 6.3 6.2 8.0 13.1 5.0 10.8 17.9 7.7 3.8 14.1 7.0 2.4 6.4 8.5 21.0 17.9 6.5 1.1 7.7 6.9 10.4 6.4 5.0 4.1 5.1 24.7 15.2 5.3 16.1 8.5 4.4 9.3 8.5 18.7 3.6 5.5 3.5 4.2 4.6 5.2 5.7 3.6 5.3 4.3 7.7 3.6 6.0 6.5 3.9 3.6 1.6 1.8 2.7 1.9 1.7 1.1 1.6 1.6 1.8 1.5 6.0 16.9 27.0 63.2 39.3 8.8 42.3 63.7 5.3 13.6 48.8 7.9 56.2 28.2 55.9 14.2 38.0 114.0 23.3 57.3 27.0 25.2 72.1 11.5 41.9 27.6 11.1 49.4 84.1 28.5 4.2 44.8 24.9 40.5 27.9 80.0 34.7 98.9 112.2 36.7 37.9 7.5 64.7 32.2 42.2 28.2 36.0 141.7 36.2 41.4 167.2 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923739-43964488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 31.1;retina: 39.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.5;LHCN-M2: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA Nucleoli "Mitochondria, Cytosol" "HPA058058: AB_2683590" "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.8 0.4 0.5 0.7 1.0 0.3 4.0 0.3 2.4 0.8 1.3 0.4 0.0 1.0 0.5 1.9 0.4 1.1 0.5 0.9 0.8 0.6 4.6 31.1 1.4 0.4 0.3 1.8 0.5 0.2 0.6 0.2 0.4 2.2 0.2 0.2 39.3 0.9 0.2 2.2 5.3 0.6 0.2 0.5 0.6 0.3 0.5 0.3 0.0 0.2 0.0 0.3 0.2 0.4 1.2 0.7 1.8 0.6 0.9 0.8 0.0 3.9 1.3 13.5 5.5 3.8 4.3 0.4 2.4 1.4 3.3 7.2 3.9 7.1 0.0 2.1 4.0 1.9 3.4 8.4 3.9 2.8 0.0 0.7 0.2 3.2 7.2 6.2 0.0 0.2 4.9 3.1 10.6 0.5 5.7 0.4 0.1 0.0 0.0 15.3 0.6 0.2 0.0 9.2 0.4 0.0 0.0 7.3 0.1 1.5 0.2 1.2 0.1 2.7 1.1 3.8 2.4 4.2 4.6 0.4 1.3 4.1 0.1 0.1 0.0 0.0 0.0 11.6 0.0 4.8 1.5 0.6 0.4 0.5 0.4 0.3 0.7 0.4 0.3 0.2 1.2 0.6 0.8 1.8 0.9 0.3 0.7 0.2 0.0 0.5 1.0 0.3 2.4 0.8 0.6 0.3 1.8 2.2 0.3 0.0 0.0 0.0 0.5 0.3 37.1 1.1 15.3 0.0 0.0 0.0 17.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.0 42.7 0.6 0.0 1.7 0.6 2.6 0.0 0.3 0.0 1.7 0.0 0.5 1.3 1.5 0.0 0.7 5.0 34.3 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.4 PNPLA5 "dJ388M5.4, GS2L" ENSG00000100341 "Patatin like phospholipase domain containing 5" Q7Z6Z6 22 43879678-43892013 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.6;epididymis: 6.2;skin 1: 4.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NTERA-2: 4.0;RPMI-8226: 7.3;SCLC-21H: 2.5" "Not detected" "Not detected" "HPA050409, HPA054211" Uncertain NA NA "HPA050409: AB_2681118, HPA054211: AB_2682418" "unprognostic (6.69e-5)" "unprognostic (3.53e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (3.33e-3)" "unprognostic (1.05e-1)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" 0.0 0.1 0.5 0.2 5.6 1.0 0.9 0.1 2.4 0.1 0.0 0.1 0.3 6.2 0.0 0.6 0.5 0.0 0.8 0.9 0.0 1.7 0.1 0.1 0.4 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.1 0.1 0.0 4.6 0.0 0.1 0.1 0.2 0.1 0.4 0.5 0.0 0.0 0.0 0.7 1.0 2.2 0.5 0.2 0.7 0.0 0.2 0.0 0.2 0.4 0.1 0.4 0.2 0.1 0.3 0.1 0.9 0.4 0.4 0.1 0.4 0.2 0.3 0.4 0.2 0.5 0.1 0.8 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.3 0.1 0.4 0.2 0.3 0.4 0.3 0.1 0.3 4.0 0.0 0.1 0.2 0.2 7.3 0.1 0.0 2.5 0.2 0.5 0.1 0.1 0.5 0.3 0.1 0.2 0.6 0.2 0.3 0.1 0.3 0.1 0.3 0.4 0.2 0.1 2.2 0.5 0.1 0.7 0.3 0.5 0.4 0.6 0.6 0.1 0.7 0.4 0.6 1.6 0.2 0.5 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PNPO PDXPO ENSG00000108439 "Pyridoxamine 5'-phosphate oxidase" Q9NVS9 17 47941506-47949308 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Pyridoxine biosynthesis" Oxidoreductase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 53.0;Hepatocytes: 47.2;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023204, HPA027776" Enhanced Approved Nucleoplasm,Cytosol NA NA 150000 "Nucleoplasm, Cytosol" "HPA023204: AB_1855506, HPA027776: AB_10601246" "unprognostic (1.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (1.07e-1)" "unprognostic (9.25e-2)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (1.41e-1)" "unprognostic (2.62e-1)" "unprognostic (1.97e-2)" "unprognostic (6.65e-2)" "unprognostic (8.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.47e-3)" "unprognostic (8.75e-2)" "unprognostic (3.34e-2)" "unprognostic (2.74e-1)" 6.0 13.1 9.9 5.1 13.0 2.9 8.6 8.3 16.5 6.2 7.0 8.6 6.9 8.5 4.2 9.6 8.1 8.4 10.1 10.2 8.7 12.0 26.0 64.7 5.3 7.7 11.2 9.9 8.0 13.7 17.3 7.4 5.8 11.1 6.9 7.4 8.4 8.3 7.1 14.7 5.5 9.6 5.2 7.1 6.8 6.7 6.4 6.0 5.2 14.4 8.2 6.1 5.4 5.2 6.8 12.2 2.4 16.4 7.7 8.2 8.7 17.6 14.6 1.1 2.7 7.5 5.8 0.0 6.0 3.9 6.7 5.8 23.9 13.0 16.8 28.6 5.9 2.7 10.6 9.1 16.3 9.7 20.4 7.8 11.8 6.8 24.8 8.0 10.5 8.2 7.6 12.7 12.4 15.5 6.2 8.7 12.6 11.1 5.8 7.8 13.1 10.6 3.4 2.1 17.5 18.1 9.0 5.1 12.2 18.6 9.1 5.9 4.9 5.5 8.9 5.0 4.3 15.7 3.8 9.1 10.8 6.4 10.8 12.4 13.9 15.3 8.9 8.8 9.1 5.5 2.1 11.0 2.4 6.8 16.4 8.0 6.8 6.2 7.4 12.2 5.7 8.2 7.9 1.1 7.7 10.4 8.9 6.4 8.7 9.9 13.0 8.3 16.5 8.7 12.0 11.2 9.9 11.1 6.0 11.9 15.2 1.5 5.9 1.3 0.7 1.7 22.9 5.3 7.9 12.2 3.9 7.5 53.0 15.3 0.4 3.6 11.0 0.0 13.5 2.0 3.1 7.8 12.7 47.2 15.2 3.2 3.5 4.9 7.0 0.4 9.2 8.5 1.7 8.2 9.9 6.7 13.1 10.5 5.6 75.4 1.7 0.0 1.7 0.7 1.3 1.9 5.3 1.0 13.6 4.8 POC1A "DKFZP434C245, WDR51A" ENSG00000164087 "POC1 centriolar protein A" Q8NBT0 3 52075253-52154690 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Dwarfism, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 19.7;testis: 34.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 39.9;Extravillous trophoblasts: 27.7;Late spermatids: 45.8;Spermatocytes: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040600 Approved NA NA "HPA040600: AB_10672837" "unprognostic (2.68e-1)" "unprognostic (7.17e-2)" "prognostic favorable (1.78e-4)" "unprognostic (5.08e-2)" "unprognostic (3.61e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-3)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (9.43e-7)" "unprognostic (9.90e-3)" "unprognostic (1.96e-1)" "unprognostic (3.62e-2)" "unprognostic (2.32e-2)" 2.2 4.6 1.3 5.5 1.6 9.2 1.8 1.0 2.2 1.3 5.5 1.5 1.5 4.4 1.0 2.8 5.0 1.4 2.8 1.7 1.8 1.4 1.8 5.2 2.2 4.6 1.5 0.6 1.1 0.9 0.5 0.7 5.9 1.3 1.4 5.9 0.9 1.5 1.5 1.5 2.2 3.5 2.5 1.4 3.1 2.7 34.3 1.1 19.7 1.1 5.5 6.9 1.8 1.8 2.2 3.9 1.1 4.5 2.8 5.5 2.2 13.4 11.5 11.7 15.6 2.4 3.1 15.9 13.8 13.3 29.7 23.2 10.1 14.4 14.2 4.1 10.9 22.9 8.5 17.6 15.6 21.7 11.6 7.4 9.6 12.3 10.8 0.6 10.9 6.1 1.7 3.4 23.4 12.3 4.1 13.5 21.4 8.3 15.4 17.5 10.7 20.2 19.9 8.9 15.3 19.1 8.8 9.3 13.5 6.6 9.6 5.4 7.9 11.0 11.0 8.4 12.8 13.6 20.7 4.4 13.5 13.3 21.7 22.2 13.1 21.4 11.9 9.1 19.2 13.5 0.0 3.4 0.0 2.8 4.5 0.3 2.2 2.0 0.9 3.9 1.1 1.6 1.1 1.1 2.8 3.2 3.9 5.5 2.2 1.3 1.6 1.0 2.2 1.8 1.4 1.5 0.6 1.3 1.1 0.0 2.2 7.8 1.0 1.4 0.7 0.6 0.0 2.7 0.0 1.8 0.0 9.2 0.0 1.8 39.9 1.1 1.7 0.0 2.7 27.7 1.0 0.8 0.0 3.9 11.1 1.6 1.7 1.3 1.6 45.8 1.1 2.9 1.7 4.6 2.1 0.8 1.5 0.0 0.4 2.2 0.0 0.0 1.4 27.7 18.5 1.6 6.3 1.3 4.1 1.1 PODNL1 "FLJ23447, SLRR5B" ENSG00000132000 "Podocan like 1" Q6PEZ8 19 13931187-13953392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.5" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 34.2;Leydig cells: 17.0;Peritubular cells: 35.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8.8;HSkMC: 16.2;hTERT-RPE1: 25.7;SiHa: 13.0;U-2 OS: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA042807 Approved "Secreted - unknown location" NA NA "HPA042807: AB_10795514" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (8.08e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.61e-8)" "unprognostic (1.78e-1)" "unprognostic (1.86e-2)" "unprognostic (3.68e-1)" "unprognostic (2.02e-1)" "unprognostic (3.08e-3)" "unprognostic (4.37e-2)" "unprognostic (1.01e-1)" "unprognostic (0.00e+0)" "unprognostic (3.94e-3)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.49e-4)" 2.4 1.6 2.2 3.5 4.1 2.2 4.5 7.9 3.2 6.7 2.3 3.0 2.2 1.9 1.7 2.5 8.7 1.7 5.9 4.4 2.0 7.5 1.4 1.0 3.8 1.3 4.2 2.3 3.1 2.5 0.7 4.7 24.5 5.0 6.1 1.5 11.1 4.2 4.1 3.7 12.7 2.7 2.6 3.8 1.3 3.0 7.6 2.1 0.8 2.4 14.9 3.9 4.8 9.9 0.9 3.4 1.3 1.7 1.0 0.8 0.6 0.4 0.5 0.5 0.3 0.8 2.1 0.1 5.5 3.3 1.1 2.2 0.4 0.6 0.3 0.4 8.8 0.2 2.1 0.2 0.2 0.6 2.0 0.9 1.1 0.4 0.1 6.8 0.3 0.7 16.2 1.0 1.5 0.2 25.7 0.0 0.1 0.5 0.4 2.2 3.5 0.3 0.3 0.2 0.4 0.5 0.2 0.1 0.0 0.4 0.1 1.0 0.6 13.0 0.1 0.4 0.6 0.1 0.6 1.0 2.7 9.4 0.7 0.3 0.4 0.0 0.1 1.1 1.2 0.2 0.7 1.7 0.7 0.8 1.4 0.3 0.9 0.6 0.3 3.4 0.5 0.4 0.3 1.3 1.0 0.2 0.5 0.2 0.6 2.2 4.1 7.9 3.2 2.0 7.5 4.2 2.3 5.0 2.1 0.0 0.3 0.0 0.8 1.1 34.2 1.2 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.1 1.2 1.0 1.1 0.0 0.0 0.1 7.7 0.4 0.0 0.0 7.5 1.6 0.0 0.6 1.5 1.6 17.0 1.1 1.7 0.0 1.3 1.6 0.4 6.2 35.7 0.0 4.0 0.0 0.5 0.7 0.5 3.8 0.7 0.0 1.1 1.2 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629181-127672809 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 84.6;Horizontal cells: 77.9;Intestinal endocrine cells: 61.0;Late spermatids: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 32.6;SCLC-21H: 48.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "CAB024934: , HPA042265: AB_2677920" "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.0 16.1 19.1 2.6 19.7 1.8 8.1 31.4 42.8 3.0 8.3 9.0 1.6 6.6 4.5 2.5 2.8 4.3 4.4 2.5 22.2 37.3 4.5 1.6 2.1 2.2 21.3 17.5 10.8 12.0 1.2 20.9 1.3 31.5 12.0 7.6 8.7 21.4 2.4 2.8 4.6 6.1 2.0 17.0 2.1 12.2 16.4 7.7 0.6 4.1 1.6 2.7 2.1 0.9 1.6 2.6 0.1 0.8 0.2 2.7 0.7 0.1 3.9 10.8 25.6 0.0 0.0 16.0 1.2 0.0 2.3 0.4 8.0 0.4 9.5 9.7 0.1 3.5 0.0 8.8 0.0 0.2 0.0 18.1 0.2 9.0 8.1 0.3 21.5 22.0 0.4 1.9 0.0 0.0 6.1 0.6 0.0 12.4 0.0 0.8 4.8 0.1 0.0 16.2 2.2 19.1 0.0 0.3 32.6 3.2 1.1 48.6 27.3 11.6 24.8 21.1 1.1 6.3 10.9 0.1 0.0 5.0 0.4 7.5 0.0 0.0 7.4 0.2 14.0 7.1 0.0 0.2 0.0 0.8 0.8 1.1 1.6 2.7 0.7 0.0 1.3 1.3 0.6 0.1 0.2 0.0 2.6 1.7 0.7 19.1 19.7 31.4 33.8 22.2 37.3 21.3 17.5 31.5 7.7 0.0 0.6 0.0 3.7 4.8 84.6 0.4 0.0 1.4 0.0 8.7 29.5 1.9 1.7 5.5 45.3 0.6 8.0 0.0 17.9 3.1 4.6 10.6 1.1 0.5 1.1 77.9 61.0 0.6 0.6 110.3 8.1 0.7 20.3 12.6 18.4 17.7 13.0 18.2 5.3 3.3 35.4 6.5 5.3 18.6 51.7 4.8 1.3 0.0 19.5 2.2 POF1B "FLJ22792, POF" ENSG00000124429 "POF1B, actin binding protein" Q8WVV4 X 85277396-85379743 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.8;skin 1: 55.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 90.6;Mucus-secreting cells: 54.0;Paneth cells: 51.8;Undifferentiated cells: 38.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 44.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 6.0;naive B-cell: 3.2" "Lineage enriched" "Detected in single" 7 "B-cells: 6.0" "Group enriched" "Detected in some" 5 "OE19: 59.5;RT4: 26.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002033, HPA050027" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA 430000 "Golgi apparatus" Nucleoplasm "HPA002033: AB_1079650, HPA050027: " "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.54e-3)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.97e-1)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (1.86e-1)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (1.17e-2)" "unprognostic (2.50e-1)" "unprognostic (4.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.81e-1)" "unprognostic (5.57e-4)" "unprognostic (1.01e-2)" 0.5 0.4 0.3 9.9 0.3 0.0 3.7 0.4 0.4 7.0 41.8 0.0 0.5 10.9 0.8 1.6 21.4 1.6 10.0 6.3 0.3 0.3 2.5 0.5 1.4 0.4 0.3 0.2 1.0 2.9 0.0 2.5 3.4 0.1 3.9 16.9 0.1 5.6 0.9 0.4 55.6 55.8 0.7 0.4 5.5 7.6 0.4 0.0 0.3 0.7 20.3 9.2 4.9 6.9 6.0 0.0 0.0 0.0 0.0 0.8 0.1 1.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 7.8 3.9 1.1 0.0 0.0 7.9 1.7 0.1 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.2 1.3 0.0 3.0 0.0 0.0 0.0 59.5 0.0 0.0 0.3 0.0 0.0 26.5 0.0 0.0 0.0 2.0 0.0 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 3.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.3 0.4 0.4 0.3 0.3 0.3 0.2 0.1 0.0 0.0 0.3 0.9 4.2 8.0 0.0 13.2 10.2 8.1 11.4 5.2 0.0 2.1 0.0 10.5 0.0 2.2 90.6 0.0 13.4 0.7 0.2 3.2 0.0 0.0 0.2 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 54.0 0.0 17.7 51.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 25.0 4.5 0.0 38.3 17.2 POLB ENSG00000070501 "DNA polymerase beta" P06746 8 42338454-42371808 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.6" "Group enriched" "Detected in many" 5 "Early spermatids: 173.0;Late spermatids: 102.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 73.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 81.2" "Low region specificity" "Detected in all" "CAB011616, HPA049104" Enhanced Uncertain Vesicles NA NA Vesicles "CAB011616: AB_731977, HPA049104: AB_2680632" "unprognostic (1.67e-1)" "unprognostic (2.68e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (8.49e-2)" "unprognostic (2.64e-2)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.31e-2)" "unprognostic (1.99e-1)" "unprognostic (4.57e-2)" "unprognostic (4.77e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.65e-4)" 5.5 8.6 10.1 9.5 10.7 21.9 13.5 73.6 16.6 7.0 5.5 5.8 6.0 4.9 6.2 11.2 12.4 6.3 11.3 16.3 9.8 9.6 7.2 15.8 9.1 11.8 8.4 10.3 10.3 7.7 10.3 11.6 5.0 10.9 11.4 6.3 6.8 22.1 6.9 36.6 10.8 4.9 6.6 10.0 8.1 6.4 29.5 5.4 9.7 7.7 17.2 10.1 11.5 9.2 4.9 33.8 25.1 9.4 7.9 7.2 4.2 11.0 6.6 11.5 23.0 6.4 6.1 9.7 7.1 8.2 11.7 10.8 9.3 13.0 10.0 9.0 4.5 12.4 5.7 9.6 8.2 14.5 6.5 10.4 7.3 5.5 12.5 9.9 5.1 81.2 5.4 9.8 8.6 10.2 14.9 8.9 21.6 15.8 6.4 11.3 6.6 21.2 14.5 15.5 13.2 7.6 12.1 11.6 8.6 22.0 8.9 6.6 11.9 8.4 5.6 21.3 12.4 14.9 8.8 4.9 5.6 7.8 14.0 6.8 9.3 15.6 14.1 5.6 10.9 14.6 12.5 5.9 17.3 4.9 7.2 5.5 4.9 5.2 5.3 6.1 4.5 5.8 5.4 25.1 7.9 9.4 33.8 7.2 4.2 10.1 10.7 73.6 16.6 9.8 9.6 8.4 10.3 10.9 5.4 3.0 12.8 13.8 19.3 14.9 3.3 19.1 7.6 22.7 28.4 7.0 7.9 6.3 5.0 11.3 173.0 10.3 3.6 0.0 8.4 5.6 5.6 27.3 22.0 11.9 6.5 6.4 5.8 6.2 5.6 102.4 6.6 8.9 6.8 4.6 4.7 6.0 22.7 5.9 3.5 5.6 4.3 0.0 5.8 19.1 12.9 17.6 9.3 10.5 6.1 25.5 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.6;lymphoid tissue: 17.6" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 23.3;Spermatogonia: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" No No "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 3.3 2.2 1.5 11.6 2.8 17.6 3.4 1.7 1.6 4.4 4.2 1.1 1.5 2.6 2.8 3.5 9.0 2.4 2.3 1.6 1.0 1.2 2.5 5.1 2.2 5.3 1.1 0.3 2.7 5.0 1.4 2.5 4.1 1.4 2.1 5.2 2.6 2.6 0.7 1.1 3.7 7.7 2.9 2.7 5.4 3.0 5.3 2.4 17.6 1.6 10.3 8.4 2.1 4.2 1.2 0.9 0.7 0.0 3.2 2.7 0.5 17.3 8.9 16.9 7.8 0.8 5.0 8.6 9.9 5.0 15.8 18.3 8.9 13.6 10.8 5.6 5.5 8.5 10.7 16.9 6.1 18.7 12.6 9.3 16.1 9.8 11.0 0.4 19.2 7.0 1.4 0.4 8.6 1.4 2.0 9.1 14.5 14.1 6.9 15.8 15.2 19.5 12.5 9.9 14.2 20.8 16.6 15.5 9.8 5.7 9.8 12.2 7.0 10.0 5.9 3.1 8.5 11.8 6.8 3.2 2.5 18.8 10.5 7.8 5.1 10.3 25.0 4.8 14.2 10.2 0.0 0.0 0.7 0.9 0.0 0.7 1.2 0.9 1.7 0.6 1.2 0.1 0.8 0.0 3.2 0.0 0.9 2.7 0.5 1.5 2.8 1.7 1.6 1.0 1.2 1.1 0.3 1.4 2.4 3.0 0.3 0.8 1.6 4.2 0.8 0.8 0.0 1.4 1.2 0.0 0.0 5.3 0.0 1.2 0.9 0.8 0.8 23.3 1.3 8.5 2.6 1.2 0.0 3.2 4.7 0.0 1.2 6.7 3.7 0.2 1.4 1.2 1.7 1.0 2.0 2.1 0.6 0.0 2.8 0.8 3.3 0.0 1.9 3.0 22.2 3.1 2.9 0.9 2.9 0.8 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 9.5;lymphoid tissue: 21.4" "Cell type enhanced" "Detected in some" 10 "Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 5.2" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.5 0.8 0.2 8.2 0.7 9.5 0.6 0.6 0.4 0.9 3.5 0.2 0.8 2.0 0.9 0.6 6.0 0.3 0.4 0.8 0.3 0.2 0.4 0.6 0.9 4.7 0.3 0.0 0.4 0.4 0.0 0.2 2.8 0.3 0.4 3.7 0.1 1.1 0.8 1.2 2.4 3.9 0.5 0.4 2.6 1.1 5.8 0.6 21.4 0.3 5.6 7.5 0.6 1.7 0.5 1.1 1.6 0.4 0.0 0.4 0.0 13.5 9.2 7.9 5.6 0.7 0.9 7.2 6.4 2.5 7.6 10.2 7.3 5.0 16.1 2.9 3.5 9.2 10.7 9.3 4.1 12.9 4.7 5.1 10.3 5.7 4.5 0.0 11.1 9.5 0.1 0.3 6.9 4.3 1.3 3.7 6.0 6.8 12.3 7.9 5.2 10.0 6.5 7.5 4.1 4.5 8.5 9.5 5.7 2.4 7.8 4.3 3.9 7.4 4.0 2.6 7.2 3.7 11.1 2.9 6.7 8.8 2.6 8.3 6.2 5.0 16.7 3.2 8.3 4.9 1.6 0.2 0.0 0.3 0.2 0.0 0.3 0.4 0.3 0.4 0.5 0.0 0.2 0.0 0.0 0.4 1.1 0.1 0.0 0.2 0.7 0.6 0.4 0.3 0.2 0.3 0.0 0.3 0.6 0.0 0.3 0.0 0.4 0.8 0.3 1.4 0.0 1.4 3.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.4 0.0 0.0 2.8 0.7 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.2 0.3 1.5 0.0 1.0 0.4 0.5 0.3 0.3 0.0 0.1 0.1 0.0 0.5 7.0 3.3 0.1 0.2 0.9 0.9 0.9 POLR2D RBP4 ENSG00000144231 "RNA polymerase II subunit D" O15514 2 127843551-127858157 "Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034694, HPA046092" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA034694: AB_2674284, HPA046092: AB_10963049" "unprognostic (3.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.59e-1)" "unprognostic (2.54e-2)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.91e-4)" "unprognostic (2.51e-1)" "unprognostic (7.95e-3)" "unprognostic (2.64e-3)" "unprognostic (1.97e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.66e-2)" "unprognostic (6.57e-2)" "unprognostic (1.17e-1)" "unprognostic (2.38e-1)" 8.2 9.4 8.1 8.9 9.1 17.9 7.9 9.3 12.6 6.9 7.7 12.3 6.9 6.3 7.5 6.2 9.8 7.7 7.6 7.3 7.8 6.3 6.3 13.5 7.2 11.8 9.9 7.5 10.3 17.4 7.4 9.4 10.2 8.7 7.2 9.9 7.3 7.6 6.5 21.9 8.9 7.8 9.8 8.8 11.1 7.8 46.4 9.9 16.7 6.3 9.1 16.8 8.0 7.2 16.7 20.6 11.4 22.1 16.7 21.0 14.3 18.4 12.1 22.5 15.7 8.4 9.2 18.1 17.7 8.4 21.4 19.2 27.3 15.3 28.7 15.3 11.9 12.2 9.8 32.3 15.3 33.2 16.8 17.6 28.4 12.1 25.0 9.8 30.4 15.8 6.5 11.5 28.5 16.4 5.9 13.9 21.1 39.5 25.8 12.2 14.7 30.2 13.8 31.5 19.4 14.0 29.1 23.8 25.9 7.1 12.7 14.0 18.7 11.9 14.8 14.9 17.6 16.6 21.1 14.0 18.6 26.2 10.5 20.4 30.5 49.4 51.7 16.2 15.2 18.2 5.7 15.8 11.4 19.4 21.5 18.1 16.7 15.6 16.9 20.6 15.1 21.0 17.8 5.0 16.7 22.1 13.5 13.9 14.3 8.1 9.1 9.3 12.6 7.8 6.3 9.9 7.5 8.7 9.9 3.0 9.4 14.9 17.2 9.6 14.8 9.0 10.2 8.1 12.5 12.2 7.9 26.9 10.0 17.6 54.9 9.5 7.0 23.3 15.2 23.1 10.3 13.9 18.4 14.9 19.4 31.8 8.1 9.2 9.1 142.9 16.4 11.5 8.5 25.2 10.6 11.8 13.4 10.5 17.3 8.7 12.9 12.9 14.1 61.1 55.3 8.8 22.3 13.8 13.4 14.0 POLR2J2 RPB11b1 ENSG00000228049 "RNA polymerase II subunit J2" Q9GZM3 7 102665368-102671629 "Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.6" "Cell type enhanced" "Detected in many" 6 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 18.1;RT4: 13.0;U-2 OS: 12.8" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 3.8 3.9 12.0 9.5 10.0 5.4 6.6 10.6 32.6 7.2 4.6 6.5 3.4 7.9 6.9 6.5 4.8 4.6 7.4 4.3 12.5 5.5 5.8 6.1 6.1 7.8 10.1 7.7 9.0 3.7 3.2 6.1 5.7 7.8 4.6 5.2 4.5 11.2 3.4 11.9 9.9 10.3 9.8 9.3 7.5 6.6 3.5 6.2 4.2 5.8 1.3 11.0 4.7 5.1 7.9 6.0 11.3 4.0 2.9 6.5 1.3 2.5 2.2 1.5 1.9 3.4 4.8 3.0 2.8 0.6 1.7 1.8 1.6 5.1 2.6 0.5 1.9 1.0 2.4 1.1 0.7 4.3 1.8 3.0 1.4 3.1 1.0 1.5 6.1 2.8 0.9 0.5 1.3 2.4 0.8 0.6 1.6 2.6 6.6 1.3 1.0 18.1 1.8 1.1 0.9 0.6 2.3 0.4 2.4 1.0 13.0 1.4 1.7 2.4 1.3 1.1 2.4 0.8 1.0 1.0 3.9 12.8 0.6 2.1 2.9 2.1 2.3 1.6 2.7 1.3 11.3 4.0 2.9 5.9 2.3 3.9 5.5 6.0 4.2 1.9 7.9 6.5 5.0 3.2 2.9 3.6 6.0 3.5 1.3 12.0 10.0 10.6 32.6 12.5 5.5 10.1 7.7 7.8 6.2 6.0 1.6 10.0 3.2 1.4 6.1 0.0 2.5 4.0 1.2 8.7 9.8 6.1 5.0 2.9 0.0 3.1 2.9 23.3 0.7 3.5 2.4 2.0 1.1 1.7 3.2 4.8 3.5 5.5 3.2 0.0 8.3 3.8 0.0 8.2 1.9 1.3 1.5 0.0 3.2 2.9 4.1 0.0 2.2 8.6 10.7 1.1 6.5 4.3 2.3 2.7 POLR2J3 ENSG00000168255 "RNA polymerase II subunit J3" 7 102537918-102572653 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 12.3" "Group enriched" "Detected in some" 635 "Cytotrophoblasts: 71.6;Extravillous trophoblasts: 52.6;Hofbauer cells: 37.9;Syncytiotrophoblasts: 92.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 21.5" "HPA011403, HPA046970" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA011403: AB_2668503, HPA046970: AB_2679882" "unprognostic (3.55e-2)" "unprognostic (2.04e-4)" "unprognostic (4.55e-3)" "unprognostic (5.85e-2)" "unprognostic (1.71e-1)" "unprognostic (9.26e-2)" "unprognostic (2.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.12e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (1.00e-1)" "unprognostic (5.90e-4)" "unprognostic (3.04e-1)" "unprognostic (7.43e-2)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" 2.8 3.0 0.9 1.7 1.4 2.3 1.9 4.0 4.7 3.1 2.4 3.6 4.5 0.1 2.3 4.9 0.3 1.3 1.1 1.1 2.2 2.8 2.2 1.0 1.5 4.5 1.7 2.9 2.3 1.7 2.5 2.1 4.1 0.2 1.0 5.0 3.5 1.8 1.6 3.9 2.2 0.8 4.0 3.5 4.1 2.2 4.9 5.9 12.3 5.6 4.4 4.4 3.4 8.5 4.1 1.7 0.1 0.2 0.7 0.7 5.1 1.5 3.3 3.8 3.2 2.4 1.2 0.3 0.0 4.8 4.1 2.7 2.1 3.6 21.5 4.7 2.4 3.2 1.0 0.9 3.0 2.2 0.3 1.8 1.7 1.7 6.5 5.2 2.1 2.7 1.5 0.5 6.9 7.5 0.4 0.0 3.0 5.2 0.3 2.9 2.0 0.8 1.1 1.7 0.3 9.4 0.9 5.0 2.1 0.0 1.4 4.2 3.1 8.3 0.0 1.3 0.2 0.6 3.6 5.2 2.4 3.4 9.0 5.6 7.8 3.3 2.0 1.7 4.7 3.1 4.4 5.9 4.9 3.8 3.6 12.3 4.4 3.5 4.3 4.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.0 0.0 0.0 0.0 POLR2J3 ENSG00000285437 "RNA polymerase II subunit J3" 7 102562133-102572583 "Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.2;skeletal muscle: 14.6" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 246.4;Cone photoreceptor cells: 333.8;Rod photoreceptor cells: 291.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA046970 Approved Nucleoplasm NA NA Nucleoplasm "HPA046970: AB_2679882" 0.5 2.3 1.9 5.5 1.3 5.7 0.0 3.9 2.0 2.7 3.7 1.7 0.0 0.5 0.0 2.9 2.7 0.5 1.9 1.3 0.3 0.0 0.5 0.5 2.0 0.0 0.6 14.6 2.0 1.6 0.0 2.1 1.6 1.2 0.5 1.1 0.5 22.4 26.8 29.2 25.2 16.5 23.5 14.4 14.4 1.8 20.7 18.4 1.1 4.3 7.8 20.3 0.7 4.4 1.3 6.8 11.5 6.7 10.1 3.5 10.7 8.9 2.7 4.8 13.4 0.9 3.1 15.4 26.1 20.2 2.9 25.7 15.2 4.7 6.0 2.4 1.8 12.0 5.9 12.3 13.3 39.1 1.9 7.3 36.5 11.4 6.2 18.4 0.5 17.1 18.6 19.3 5.8 18.4 9.9 14.8 16.1 16.2 14.2 24.5 6.2 14.8 6.5 27.6 12.5 24.2 16.3 17.6 25.9 40.6 15.4 18.1 16.6 26.8 19.9 29.2 17.7 18.0 16.1 22.4 23.5 20.0 17.9 20.2 20.4 19.5 21.1 16.5 25.2 26.8 21.8 14.4 6.0 1.6 68.9 89.5 10.9 246.4 14.3 89.2 9.4 5.7 7.0 333.8 0.0 1.7 0.3 6.1 20.5 47.8 23.3 0.3 0.0 14.6 61.1 13.8 37.1 0.0 168.5 56.1 102.5 57.8 5.0 84.0 10.8 23.6 1.8 38.2 55.9 0.9 59.6 48.4 2.2 291.4 25.8 24.7 93.1 107.3 12.9 0.0 90.0 43.8 82.1 POLR3G "RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514553 "Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.2" "Cell type enhanced" "Detected in many" 10 "Spermatogonia: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010109, HPA052658, HPA074330" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 2.7 1.6 7.1 3.6 10.2 4.4 3.8 7.2 7.2 3.7 2.6 6.7 1.4 2.8 2.7 8.4 7.3 2.7 2.4 2.7 7.7 7.7 1.7 4.0 2.9 8.1 10.3 6.1 4.1 4.1 11.1 3.9 3.1 20.2 2.9 3.1 2.6 4.2 1.5 4.4 7.4 2.3 4.2 16.0 3.3 2.1 8.0 8.1 1.0 5.9 8.5 3.2 4.4 4.7 3.9 2.1 6.8 2.8 5.4 3.2 0.8 10.7 6.2 7.4 1.9 2.3 4.1 3.4 5.4 1.7 8.6 7.0 3.6 8.0 29.4 1.8 2.2 8.5 4.5 9.2 8.6 30.8 13.5 8.2 10.8 2.9 5.5 3.9 7.5 2.7 2.7 4.0 14.3 10.9 1.7 10.6 11.7 15.3 2.7 3.1 5.2 7.9 4.7 34.9 1.5 27.7 7.0 3.2 16.6 2.5 1.0 9.4 2.5 2.2 4.1 14.9 3.4 2.2 2.1 12.7 4.7 9.0 6.6 20.3 6.8 17.4 21.7 10.4 10.0 37.3 6.8 0.6 0.3 3.2 0.8 1.6 3.9 1.1 2.0 0.9 2.4 2.4 2.6 1.6 5.4 2.8 2.1 0.5 0.8 7.1 10.2 7.2 7.2 7.7 7.7 10.3 6.1 20.2 8.1 6.0 2.1 0.8 1.2 3.2 2.7 3.4 0.0 2.7 0.0 1.8 7.9 0.7 3.3 2.6 3.0 1.4 0.5 0.0 3.9 5.2 1.5 3.0 6.9 2.4 1.5 3.2 6.4 3.7 0.3 1.0 0.3 0.6 1.7 0.0 1.3 0.6 2.9 2.0 1.1 1.3 0.8 0.0 1.4 7.7 27.4 7.4 0.7 0.0 1.6 0.6 POM121L12 DKFZp564N2472 ENSG00000221900 "POM121 transmembrane nucleoporin like 12" Q8N7R1 7 53035642-53036924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 175 "testis: 36.1" "Cell type enriched" "Detected in single" 7 "Spermatocytes: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA027836 Enhanced NA NA "HPA027836: AB_10669592" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 POM121L2 POM121-L ENSG00000158553 "POM121 transmembrane nucleoporin like 2" Q96KW2 6 27285903-27312170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 88 "testis: 35.6" "Cell type enhanced" "Detected in single" 33 "Spermatocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.0;HEL: 3.4;HMC-1: 1.9;K-562: 1.5;LHCN-M2: 2.5" HPA046150 Uncertain NA NA "HPA046150: AB_10960993" "unprognostic (2.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-2)" "unprognostic (5.88e-3)" "unprognostic (3.48e-2)" "unprognostic (1.93e-1)" "unprognostic (3.51e-2)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 2.5 0.6 0.4 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 POMC "ACTH, CLIP, LPH, MSH, NPP, POC" ENSG00000115138 Proopiomelanocortin P01189 2 25160853-25168903 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Endorphin, Hormone" "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "pituitary gland: 811.1" "Group enriched" "Detected in many" 5 "Early spermatids: 92.7;Late spermatids: 265.2;Spermatocytes: 70.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 18.5" "Region enriched" "Detected in single" 5 "hypothalamus: 1.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CACO-2: 2.7;HMC-1: 4.2;HSkMC: 1.2;NTERA-2: 1.2;THP-1: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "hypothalamus: 77.9" "CAB002762, HPA046135, HPA063644, CAB079881" Enhanced "Secreted to blood" NA NA 380000 "CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071" "unprognostic (8.02e-2)" "unprognostic (1.47e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-3)" "unprognostic (3.15e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (4.30e-2)" "unprognostic (8.74e-3)" "unprognostic (1.38e-1)" "prognostic favorable (5.70e-4)" "unprognostic (8.02e-2)" "unprognostic (4.29e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (3.84e-2)" 1.0 3.2 0.3 0.8 0.3 0.5 0.3 0.3 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 0.3 0.0 0.3 0.3 0.3 1.8 0.5 0.3 0.3 0.6 0.3 0.3 0.3 22.2 0.0 811.1 0.9 0.3 0.3 0.0 0.3 0.4 0.3 3.6 0.9 0.3 0.3 0.3 1.3 0.4 2.9 0.3 0.3 0.3 0.4 0.3 0.3 0.3 13.7 22.2 6.6 10.1 12.6 10.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 4.2 1.2 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 9.9 6.6 9.8 10.1 7.7 12.8 7.5 9.3 12.5 13.7 9.9 10.5 3.1 12.6 5.9 22.2 7.9 7.6 0.3 0.3 0.3 0.3 0.3 1.8 0.3 0.3 0.3 0.3 0.0 2.1 11.0 1.4 3.9 1.8 2.6 0.0 0.0 1.2 0.0 0.0 0.3 13.3 7.0 92.7 6.9 0.0 0.0 14.7 5.6 3.3 3.9 6.9 1.3 29.5 6.4 0.0 9.8 6.3 265.2 4.4 7.2 16.9 8.2 0.0 4.1 9.1 0.0 12.4 2.1 7.1 12.9 3.1 70.4 22.9 4.8 0.3 8.7 0.0 3.0 PON1 "ESA, PON" ENSG00000005421 "Paraoxonase 1" P27169 7 95297676-95324707 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "liver: 144.1" "Cell type enriched" "Detected in some" 47 "Hepatocytes: 399.2" "Cancer enriched" "Detected in some" 78 "liver cancer: 97.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA001610 Approved "Secreted to blood" NA NA 96000000000 24000000000 "HPA001610: AB_1079656" "unprognostic (2.02e-2)" "unprognostic (2.41e-2)" "unprognostic (3.04e-1)" "unprognostic (3.54e-2)" "unprognostic (2.70e-1)" "prognostic favorable (7.24e-7)" "unprognostic (2.24e-1)" "unprognostic (1.95e-1)" "unprognostic (9.02e-3)" "unprognostic (1.76e-3)" "unprognostic (3.97e-2)" "unprognostic (6.74e-9)" "unprognostic (1.09e-3)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (5.54e-3)" 0.0 1.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 144.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 0.0 1.0 0.1 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.2 0.0 1.0 0.0 0.0 0.3 0.6 0.1 0.0 0.3 0.0 0.2 0.4 0.0 0.5 0.0 0.1 0.0 0.2 1.0 0.3 0.0 0.0 0.2 0.3 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 399.2 0.0 0.0 2.9 8.0 8.6 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 PON2 ENSG00000105854 "Paraoxonase 2" Q15165 7 95404863-95435329 "Candidate cardiovascular disease genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 81.0" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 257.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "myeloid DC: 22.1" "Lineage enriched" "Detected in many" 4 "dendritic cells: 22.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025430, HPA029193" Enhanced "Secreted to blood" NA NA 350000000 "CAB025430: , HPA029193: AB_10602148" "unprognostic (1.43e-1)" "prognostic unfavorable (1.43e-5)" "unprognostic (3.80e-1)" "unprognostic (4.14e-1)" "unprognostic (3.89e-2)" "unprognostic (3.77e-3)" "unprognostic (1.19e-3)" "unprognostic (9.87e-3)" "unprognostic (9.54e-2)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "unprognostic (2.80e-1)" "prognostic unfavorable (4.30e-8)" "unprognostic (1.40e-1)" "unprognostic (6.43e-2)" "unprognostic (7.99e-3)" "unprognostic (2.56e-1)" 17.0 42.2 54.1 7.5 59.1 3.3 23.1 25.4 52.2 16.5 24.0 29.7 7.4 28.2 16.6 22.7 10.2 15.0 18.9 13.1 57.2 31.4 23.9 81.0 33.1 4.5 41.4 31.0 10.6 7.2 10.9 15.0 34.3 34.8 14.7 31.1 9.9 8.5 17.2 4.3 19.4 19.1 18.4 44.2 7.3 8.8 9.6 40.1 1.8 13.6 5.1 11.2 13.7 8.1 0.9 22.1 0.5 5.2 5.0 3.5 3.0 9.6 60.7 49.4 26.7 6.9 15.3 13.9 19.8 23.2 15.4 16.8 13.7 22.2 0.0 27.8 19.5 29.6 6.5 9.0 15.2 17.6 0.1 11.8 4.9 36.5 45.2 11.0 0.0 6.8 22.1 17.6 8.3 11.3 31.6 31.9 0.0 3.2 0.2 45.4 8.8 0.0 5.4 9.7 25.9 14.1 0.0 23.3 2.3 47.7 7.6 3.4 10.6 28.2 31.5 19.0 29.8 9.3 3.2 34.7 23.2 16.9 7.8 19.0 5.2 6.0 0.0 21.7 4.5 30.2 0.0 5.2 0.5 3.5 2.6 3.1 0.9 1.3 3.2 22.1 0.4 1.9 2.4 0.0 5.0 1.2 5.3 0.6 3.0 54.1 59.1 25.4 34.3 57.2 31.4 41.4 31.0 34.8 40.1 119.1 85.8 10.2 37.2 14.9 3.9 25.4 71.4 37.5 67.1 80.3 0.0 66.3 8.3 132.9 1.4 51.7 71.3 70.0 44.3 257.9 23.1 23.4 13.9 127.1 35.6 36.5 12.1 36.8 21.8 2.0 15.0 30.4 106.3 20.8 37.6 174.2 71.8 87.7 20.5 39.6 7.9 19.4 40.1 1.9 5.5 14.1 42.1 9.2 65.6 18.4 PON3 ENSG00000105852 "Paraoxonase 3" Q15166 7 95359944-95396368 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 148.0" "Cell type enriched" "Detected in many" 14 "Hepatocytes: 460.4" "Group enriched" "Detected in many" 9 "liver cancer: 30.8;lung cancer: 7.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 12 "NK-cells: 1.1" "Cell line enhanced" "Detected in some" "A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA014848, CAB025250" Enhanced "Secreted to blood" NA NA 1760000000 350000000 "CAB025250: , HPA014848: AB_1855540" "unprognostic (2.67e-1)" "unprognostic (1.03e-1)" "unprognostic (6.28e-3)" "unprognostic (5.52e-3)" "unprognostic (1.36e-1)" "unprognostic (4.87e-1)" "unprognostic (1.44e-3)" "unprognostic (6.32e-2)" "unprognostic (1.11e-1)" "unprognostic (6.44e-3)" "unprognostic (9.14e-2)" "unprognostic (7.18e-3)" "unprognostic (8.30e-9)" "unprognostic (1.66e-1)" "unprognostic (1.04e-2)" "unprognostic (8.29e-2)" "unprognostic (5.12e-2)" 0.4 0.7 0.3 0.1 0.6 0.0 6.9 0.2 0.5 0.9 1.0 0.3 2.3 1.5 0.2 1.2 0.2 0.4 0.7 0.4 0.7 0.3 0.7 148.0 4.0 0.0 0.4 0.2 2.4 7.1 0.0 15.5 0.2 0.5 0.2 0.4 0.8 21.4 5.5 0.1 1.8 1.7 0.1 0.3 0.2 0.5 3.6 0.4 0.4 1.5 0.0 1.1 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.2 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 12.6 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.5 0.7 0.3 0.4 0.2 0.5 0.4 6.0 32.1 1.4 0.7 0.8 0.0 0.3 25.5 8.1 14.8 3.5 0.0 1.5 1.7 0.2 9.0 0.5 4.0 0.0 1.8 1.9 2.6 2.2 0.0 460.4 0.2 0.0 0.0 8.6 7.0 3.6 7.5 0.0 13.5 0.0 2.3 3.0 1.5 0.0 2.8 5.2 0.0 0.0 0.1 17.7 13.6 1.1 1.1 0.5 2.3 0.3 POPDC2 POP2 ENSG00000121577 "Popeye domain containing 2" Q9HBU9 3 119636457-119665324 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 90.5" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 250.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 26.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA024255 Enhanced NA NA "HPA024255: AB_1855545" "unprognostic (1.13e-1)" "unprognostic (1.17e-3)" "unprognostic (8.91e-3)" "unprognostic (9.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.64e-2)" "unprognostic (2.73e-2)" "unprognostic (2.43e-1)" "unprognostic (3.18e-2)" "unprognostic (1.72e-2)" "unprognostic (5.86e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-2)" "unprognostic (6.26e-3)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-2)" 1.3 0.3 0.2 1.0 0.2 0.0 0.6 0.3 0.2 1.8 16.0 0.2 7.6 0.6 2.0 1.3 3.3 1.8 6.1 90.5 0.2 0.0 0.5 0.3 0.3 1.4 0.2 0.3 0.8 0.7 0.1 0.2 0.3 0.3 5.0 1.5 0.3 0.6 13.4 12.1 0.4 2.2 12.6 0.2 0.5 2.4 0.5 0.2 0.3 0.5 3.8 0.8 10.2 1.1 0.9 0.7 2.1 3.0 0.3 2.2 0.4 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 26.1 0.0 0.0 0.4 2.5 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.7 0.0 0.1 0.1 0.2 0.5 2.1 0.1 1.3 0.9 0.1 1.1 0.3 1.1 1.0 0.1 0.9 2.2 0.7 0.1 0.3 3.0 0.7 1.6 0.4 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.3 0.3 0.2 0.0 0.3 0.0 0.2 0.3 2.4 250.7 0.0 2.7 1.2 0.0 0.0 0.4 0.0 0.4 0.2 3.6 0.3 0.0 0.2 0.1 1.4 0.7 1.1 0.0 1.3 1.6 2.9 1.3 1.2 0.4 1.1 2.2 0.0 2.8 0.6 1.2 0.7 0.0 1.8 0.3 2.8 58.2 8.5 0.5 0.4 0.5 1.0 1.0 0.4 0.2 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105158280-105179995 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "heart muscle: 23.9;skeletal muscle: 68.9" "Cell type enhanced" "Detected in some" 27 "Cardiomyocytes: 40.0;Early spermatids: 75.0;Late spermatids: 14.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 25.2;LHCN-M2: 11.9;RH-30: 13.4;U-87 MG: 12.0;WM-115: 11.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012514 Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.9 0.8 2.2 1.4 4.5 0.6 2.5 0.4 6.8 0.8 1.4 2.1 0.8 0.7 1.3 2.2 2.1 0.7 1.1 23.9 3.7 2.3 0.6 0.6 0.7 0.7 6.1 3.5 0.7 0.6 0.6 3.2 1.2 4.0 1.2 0.6 1.9 1.0 0.8 68.9 0.6 0.6 0.6 3.6 0.6 1.6 3.6 4.0 0.0 0.8 8.8 0.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.4 0.1 2.4 6.3 0.5 2.4 2.6 4.3 5.2 0.0 1.4 0.0 1.0 4.9 25.2 0.0 1.2 1.1 3.6 0.0 2.6 0.0 0.9 0.0 0.1 0.0 0.0 2.5 0.2 6.9 0.9 1.2 0.3 0.0 2.6 7.3 11.9 0.0 0.0 0.9 2.8 0.0 4.1 0.4 13.4 0.0 0.0 0.0 6.1 11.0 0.0 0.0 8.6 1.5 0.0 4.7 5.4 2.6 0.0 1.7 9.0 0.0 0.0 0.0 12.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.5 0.4 6.8 3.7 2.3 6.1 3.5 4.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 75.0 0.0 0.0 0.0 0.0 1.1 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.6 0.6 0.0 0.0 3.6 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 1.6 1.4 0.0 0.1 0.0 0.0 0.0 POR "CYPOR, FLJ26468" ENSG00000127948 "Cytochrome p450 oxidoreductase" P16435 7 75899200-75986855 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 443.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004372, HPA010136" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB004372: AB_627391, HPA010136: AB_1079657" "unprognostic (1.89e-1)" "unprognostic (1.53e-1)" "unprognostic (2.81e-3)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.65e-1)" "unprognostic (1.17e-2)" "unprognostic (4.32e-2)" "unprognostic (1.69e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (2.58e-1)" "unprognostic (1.11e-1)" "unprognostic (9.31e-2)" "unprognostic (1.71e-1)" "unprognostic (3.94e-2)" "unprognostic (9.89e-2)" 12.8 48.2 7.4 7.5 10.8 3.6 15.0 5.3 16.4 11.0 20.8 9.6 32.1 24.9 9.0 8.2 13.4 12.8 9.9 8.4 7.1 7.2 12.0 78.4 13.7 9.9 5.2 10.1 14.4 12.8 12.1 18.5 18.6 7.1 9.3 5.3 10.8 7.8 58.7 13.1 10.0 24.3 7.0 5.2 11.7 9.8 22.4 5.0 8.2 33.3 9.9 8.6 9.8 10.2 5.7 20.6 26.7 18.4 11.2 9.9 13.9 12.8 28.2 12.9 24.0 48.9 18.6 21.6 5.4 17.7 10.2 14.3 21.1 57.3 12.3 5.0 11.7 34.8 6.3 16.9 8.5 4.4 10.5 12.5 5.7 8.3 39.0 34.0 5.7 10.2 38.1 10.7 13.4 9.8 8.2 9.4 6.1 17.0 5.3 9.1 18.9 6.1 10.2 16.1 20.2 16.0 8.8 8.5 13.2 11.5 15.6 13.5 12.9 14.5 74.1 19.5 7.6 21.2 9.6 8.5 9.6 10.6 14.4 10.6 5.2 8.0 8.4 13.6 8.7 12.3 26.7 18.4 25.3 9.9 17.7 8.3 5.4 8.4 9.2 20.6 5.7 8.4 7.1 24.3 11.2 13.0 5.8 8.7 13.9 7.4 10.8 5.3 16.4 7.1 7.2 5.2 10.1 7.1 5.0 35.7 31.2 12.6 24.7 15.1 30.1 9.3 56.0 78.9 37.5 69.8 11.8 88.1 1.7 55.5 13.2 25.3 144.8 0.0 25.7 71.6 24.8 20.8 24.3 443.8 58.9 14.3 19.0 27.6 38.6 6.1 70.2 40.5 11.8 16.2 29.0 33.2 24.3 119.3 105.7 27.5 21.8 64.7 30.9 14.7 32.6 12.8 161.6 20.0 36.8 40.7 POTEB "A26B1, CT104.5, POTE-15, POTE15" ENSG00000233917 "POTE ankyrin domain family member B" 15 21846329-21877703 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 77 "testis: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB2 ENSG00000230031 "POTE ankyrin domain family member B2" H3BUK9 15 20835372-20866314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 72 "testis: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 2.6" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB3 ENSG00000278522 "POTE ankyrin domain family member B3" "A0JP26, Q6S5H4" 15 21408243-21440451 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 53 "testis: 5.2" "Cell type enriched" "Detected in single" 10 "Spermatocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 POTEC "A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18" ENSG00000183206 "POTE ankyrin domain family member C" B2RU33 18 14507339-14543585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "testis: 5.9" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-266/70: 1.4" NA NA "unprognostic (1.63e-1)" "unprognostic (9.88e-2)" "unprognostic (8.05e-2)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.5 3.8 0.0 0.2 0.0 0.0 0.0 POTED "A26B3, ANKRD21, CT104.1, POTE, POTE-21, POTE21" ENSG00000166351 "POTE ankyrin domain family member D" Q86YR6 21 13609858-13641585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 63 "testis: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 POTEE "A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma" ENSG00000188219 "POTE ankyrin domain family member E" Q6S8J3 2 131218067-131265278 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 2.4;prostate: 2.0;testis: 4.9" "Cell type enhanced" "Detected in some" 19 "Basal glandular cells: 2.6;Glandular cells: 1.9;Spermatocytes: 6.6;Spermatogonia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.8;BEWO: 3.6;K-562: 3.6;U-2 OS: 7.0;U-266/84: 2.1" "HPA041264, HPA041271, HPA043260" Uncertain NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (3.13e-2)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (5.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.84e-2)" "unprognostic (1.05e-1)" "unprognostic (6.61e-3)" "unprognostic (5.77e-2)" "unprognostic (7.60e-2)" "unprognostic (7.46e-3)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (1.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 2.4 0.1 0.0 0.2 2.8 0.0 0.0 3.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.7 2.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 2.6 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 6.6 1.9 0.1 0.3 0.0 0.0 1.1 POTEF "A26C1B, POTE2alpha, POTEACTIN" ENSG00000196604 "POTE ankyrin domain family member F" A5A3E0 2 130074030-130129222 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 5.7" "Group enriched" "Detected in some" 5 "Melanocytes: 1.7;Spermatocytes: 2.3;Spermatogonia: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.4;BEWO: 3.5;CACO-2: 4.1;MCF7: 3.0;U-2 OS: 9.9;U-266/70: 4.7" "HPA041264, HPA041271, HPA043260" Uncertain NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (1.04e-1)" "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.18e-2)" "unprognostic (8.13e-3)" "unprognostic (1.44e-2)" "unprognostic (2.90e-2)" "unprognostic (1.16e-1)" "unprognostic (3.38e-1)" "unprognostic (2.23e-1)" "unprognostic (3.50e-1)" "unprognostic (1.02e-1)" "unprognostic (4.48e-1)" "unprognostic (1.05e-2)" "unprognostic (9.35e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.1 0.7 0.7 0.7 0.2 0.5 1.1 0.2 0.2 0.0 4.4 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 9.9 0.1 0.2 4.7 1.3 0.0 0.0 0.0 0.0 0.5 0.6 0.7 0.4 0.7 0.1 0.1 0.2 0.3 0.7 0.1 0.1 0.3 0.6 0.2 0.7 0.1 0.5 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.5 0.0 0.1 0.0 0.0 0.0 POTEG "A26C2, CT104.4, POTE-14, POTE14, POTE14alpha" ENSG00000187537 "POTE ankyrin domain family member G" Q6S5H5 14 19402486-19434341 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 14.0;prostate: 7.4" "Cell type enhanced" "Detected in single" 31 "Spermatocytes: 1.4" "Cancer enhanced" "Detected in single" "prostate cancer: 0.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 2.2;U-2 OS: 2.9" NA NA "unprognostic (4.01e-1)" "unprognostic (1.51e-1)" "unprognostic (6.00e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (2.69e-2)" "unprognostic (1.05e-1)" "unprognostic (2.05e-3)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (2.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.1 2.9 10.2 14.0 10.7 3.7 6.8 12.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.8 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.2 6.4 14.0 4.8 10.7 3.7 2.9 4.3 4.5 10.2 2.9 3.4 5.2 7.6 3.7 10.3 2.8 6.8 12.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 POTEH "A26C3, ACTBL1, CT104.7, POTE22" ENSG00000198062 "POTE ankyrin domain family member H" Q6S545 22 15690026-15721631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "prostate: 9.5;testis: 2.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 28 "prostate cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;U-2 OS: 4.8;U-266/84: 1.3" NA NA "unprognostic (4.66e-2)" "unprognostic (1.02e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 POTEI POTE2beta ENSG00000196834 "POTE ankyrin domain family member I" P0CG38 2 130459455-130509666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 6.5;prostate: 14.8;testis: 7.0" "Cell type enhanced" "Detected in some" 22 "Cardiomyocytes: 1.7;Ciliated cells: 1.4;Glandular cells: 2.3;Spermatocytes: 6.2;Spermatogonia: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AN3-CA: 4.3;BEWO: 5.3;K-562: 5.1;U-2 OS: 11.6" "HPA041264, HPA041271, HPA043260" Uncertain NA NA "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (2.52e-3)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.37e-1)" "unprognostic (2.99e-1)" "unprognostic (8.59e-2)" "unprognostic (2.67e-1)" "unprognostic (2.22e-3)" "unprognostic (5.52e-2)" "unprognostic (1.47e-1)" "unprognostic (3.38e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 14.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 7.0 0.1 0.0 0.0 0.0 1.6 4.6 6.0 4.9 1.8 3.2 6.5 0.7 0.7 0.3 4.3 0.0 0.0 5.3 0.2 0.0 0.0 0.0 2.3 0.0 0.1 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.7 2.3 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 5.1 0.9 0.0 2.7 0.2 0.3 0.5 0.4 0.3 0.0 0.2 2.2 0.0 0.2 0.2 0.8 0.1 2.4 0.1 0.9 1.7 0.0 0.2 0.1 11.6 0.4 0.0 2.6 1.5 0.1 0.2 0.1 0.1 3.0 3.0 6.0 2.4 4.8 1.9 1.6 2.0 2.3 4.6 1.3 1.6 2.4 4.0 1.8 4.9 1.6 3.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 1.7 0.0 0.0 0.0 0.0 0.1 POTEJ POTE2beta ENSG00000222038 "POTE ankyrin domain family member J" P0CG39 2 130611481-130658091 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 2.6;testis: 3.4" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 1.4;Spermatocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "RPMI-8226: 3.3" "HPA041264, HPA041271, HPA043260" Uncertain NA NA 1700000000 "HPA041264: AB_2677383, HPA041271: AB_2677386, HPA043260: AB_2678396" "unprognostic (8.11e-2)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "unprognostic (3.55e-1)" "unprognostic (3.35e-1)" "unprognostic (2.07e-2)" "unprognostic (5.44e-2)" "unprognostic (1.90e-1)" "unprognostic (2.18e-1)" "unprognostic (1.16e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" "unprognostic (1.18e-2)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (3.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 POTEM "ACT, P704P, POTE14beta" ENSG00000222036 "POTE ankyrin domain family member M" A6NI47 14 18967434-18999012 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 31 "prostate: 4.0;testis: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.16e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 POU1F1 "GHF-1, PIT1, POU1F1a" ENSG00000064835 "POU class 1 homeobox 1" P28069 3 87259404-87276587 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 49 "pituitary gland: 138.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;SiHa: 1.1;U-87 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041646, HPA050624" Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA041646: AB_10794672, HPA050624: AB_2681192" "unprognostic (1.88e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.93e-1)" "unprognostic (1.87e-2)" "unprognostic (7.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.50e-1)" "unprognostic (4.69e-3)" "unprognostic (1.55e-1)" "unprognostic (1.52e-2)" "unprognostic (1.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.05e-4)" 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 138.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.8 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 POU2AF1 "BOB1, OBF1" ENSG00000110777 "POU class 2 associating factor 1" Q16633 11 111352252-111455630 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 21.2;lymphoid tissue: 84.0" "Cell type enhanced" "Detected in many" 13 "B-cells: 67.0;Ciliated cells: 73.6;Erythroid cells: 46.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 11 "memory B-cell: 19.9;naive B-cell: 14.2" "Lineage enriched" "Detected in many" 13 "B-cells: 19.9" "Cell line enhanced" "Detected in some" "Daudi: 46.5;Karpas-707: 53.2;U-266/70: 51.9;U-266/84: 23.4;U-698: 95.5" "Not detected" "Not detected" "Not detected" "Not detected" CAB011193 Enhanced NA NA "CAB011193: AB_532299" "prognostic favorable (1.68e-4)" "prognostic favorable (1.63e-4)" "unprognostic (1.04e-2)" "unprognostic (5.50e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.59e-4)" "unprognostic (2.09e-1)" "unprognostic (3.63e-3)" "unprognostic (7.15e-2)" "unprognostic (2.52e-2)" "unprognostic (1.34e-1)" "unprognostic (4.81e-2)" "unprognostic (8.51e-8)" "unprognostic (2.35e-1)" "unprognostic (3.90e-1)" "unprognostic (7.14e-3)" "unprognostic (1.23e-1)" 0.9 0.5 0.6 62.7 0.7 2.0 1.4 0.4 0.6 1.9 7.8 1.8 0.0 6.7 0.7 0.3 8.7 1.1 1.4 0.5 0.8 0.7 2.1 1.0 2.6 42.6 1.0 0.5 1.2 0.5 0.0 0.4 0.5 1.2 1.3 4.1 1.2 8.4 0.9 0.4 0.4 21.2 0.0 1.4 74.2 12.2 1.0 0.9 5.0 1.7 1.4 84.0 5.0 1.4 19.9 0.1 1.5 0.2 0.3 0.7 0.6 0.1 0.1 0.0 0.0 0.8 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 46.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.7 53.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 9.9 0.1 12.5 0.0 0.1 0.1 0.9 0.1 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.4 0.0 0.0 51.9 23.4 95.5 0.0 0.1 0.0 1.5 0.1 0.3 0.1 0.1 0.1 19.9 0.2 0.1 0.0 14.2 0.2 0.1 0.9 0.3 0.2 0.1 0.7 0.6 0.6 0.7 0.4 0.6 0.8 0.7 1.0 0.5 1.2 0.9 0.0 5.1 67.0 6.0 0.2 0.0 1.6 12.7 73.6 18.2 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 46.7 5.0 0.0 0.6 1.1 0.0 0.0 0.1 0.0 2.9 1.3 0.3 7.9 0.3 0.2 8.5 0.0 0.1 0.0 0.4 0.2 0.4 0.3 0.0 0.0 0.0 5.9 0.7 0.0 0.0 0.5 0.0 7.3 POU2F1 "OCT1, OTF1" ENSG00000143190 "POU class 2 homeobox 1" P14859 1 167220829-167427345 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 106.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002608, HPA058559, HPA064323" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" No No "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245" "unprognostic (1.74e-1)" "unprognostic (9.33e-2)" "unprognostic (1.28e-2)" "unprognostic (1.40e-3)" "unprognostic (5.78e-3)" "unprognostic (4.26e-2)" "unprognostic (5.67e-6)" "unprognostic (4.47e-2)" "unprognostic (5.14e-1)" "unprognostic (7.94e-3)" "unprognostic (1.95e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.98e-5)" "unprognostic (1.89e-1)" "unprognostic (4.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.17e-2)" 6.9 5.7 15.5 7.3 11.9 12.6 7.2 36.4 13.8 7.7 6.6 9.5 5.2 4.1 7.5 8.4 5.3 6.5 4.3 5.1 14.5 6.7 7.0 5.8 6.6 8.2 7.7 10.8 8.1 6.1 15.5 8.3 9.6 7.1 6.7 6.8 12.0 5.5 6.5 10.5 8.8 6.6 5.5 6.3 9.3 6.1 10.1 10.9 7.4 6.9 4.9 9.7 7.6 6.2 7.5 5.9 8.6 5.9 1.4 4.4 2.2 6.4 5.2 13.5 4.1 1.6 1.6 5.5 0.8 1.4 1.6 1.6 7.5 3.7 7.3 3.5 1.3 1.5 5.0 8.2 2.5 2.4 2.9 3.1 5.1 3.6 6.1 1.0 5.6 3.4 1.1 1.4 1.8 3.3 2.0 2.1 5.1 5.4 4.2 2.1 3.4 5.1 3.6 15.7 3.5 2.1 7.5 4.9 3.2 2.8 3.6 8.2 6.2 5.0 3.7 3.3 7.1 4.1 6.9 3.4 3.1 4.9 1.9 3.1 4.0 1.8 16.9 1.4 3.4 3.9 8.6 2.3 2.8 4.4 2.7 3.3 7.5 2.3 2.0 2.5 6.8 3.2 2.4 3.3 1.4 5.9 5.9 2.1 2.2 15.5 11.9 36.4 13.8 14.5 6.7 7.7 10.8 7.1 10.9 11.9 12.1 21.9 10.4 11.8 54.9 13.2 12.7 6.7 10.3 19.2 96.2 15.4 5.0 8.8 23.3 16.6 8.5 0.0 10.1 15.3 13.4 14.9 19.6 11.6 11.2 44.5 23.2 11.1 35.6 28.6 23.9 14.6 6.8 23.4 14.3 47.2 12.6 7.0 19.4 6.9 106.3 25.8 11.9 18.5 40.0 9.7 43.3 13.8 13.0 9.7 POU2F2 "OCT2, OTF2" ENSG00000028277 "POU class 2 homeobox 2" P09086 19 42086110-42196585 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 158.6;Bipolar cells: 50.4;Kupffer cells: 98.2;Macrophages: 80.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 33.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.5;Daudi: 39.0;hTEC/SVTERT24-B: 15.3;U-266/70: 27.1;U-266/84: 26.2;U-698: 30.9;U-87 MG: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002513, HPA049056, HPA062096, HPA064404, HPA073998" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: " "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-2)" "unprognostic (8.89e-2)" "unprognostic (6.77e-2)" "unprognostic (1.44e-2)" "unprognostic (1.62e-2)" "unprognostic (3.34e-1)" "unprognostic (8.39e-2)" "unprognostic (2.09e-1)" "unprognostic (1.52e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (7.57e-11)" "unprognostic (2.31e-1)" "unprognostic (1.76e-1)" "unprognostic (2.61e-2)" "unprognostic (1.54e-1)" 1.9 2.0 5.6 43.1 7.4 4.8 1.2 12.0 5.7 0.9 3.2 2.5 0.0 2.1 0.9 1.7 1.4 1.5 2.3 4.8 5.7 5.9 1.6 1.4 3.1 31.4 6.8 1.5 0.7 1.6 0.4 2.1 2.5 6.6 2.5 2.1 1.4 2.1 2.3 0.7 1.2 10.8 1.9 6.5 22.7 3.1 6.0 6.2 1.9 1.3 0.6 30.0 4.3 1.0 13.9 8.0 1.7 33.1 0.6 2.7 4.5 0.3 0.5 0.6 0.0 0.0 1.0 0.2 2.8 18.5 1.8 3.6 0.1 0.5 39.0 1.0 1.0 0.3 0.3 0.2 3.0 8.3 0.1 0.1 0.9 0.1 0.0 0.2 0.3 0.8 0.8 0.6 15.3 1.0 0.1 1.1 0.8 0.4 9.0 0.4 0.3 0.1 2.0 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.2 0.6 0.3 0.1 0.2 0.3 0.2 0.0 4.9 1.5 7.9 0.8 0.0 0.3 27.1 26.2 30.9 15.0 1.0 1.0 1.0 10.7 0.1 1.2 19.3 1.1 11.0 1.8 1.6 8.0 13.9 0.9 1.3 1.7 0.6 33.1 1.3 2.7 4.5 5.6 7.4 12.0 5.7 5.7 5.9 6.8 1.5 6.6 6.2 0.0 9.5 158.6 6.7 6.9 50.4 2.2 5.1 1.4 3.4 0.0 5.9 0.7 0.0 0.9 12.2 1.4 2.7 0.0 2.5 0.8 2.0 2.9 5.8 0.8 41.8 1.6 9.1 4.9 98.2 7.7 0.9 80.0 8.5 1.8 1.1 1.7 2.5 0.0 0.4 0.5 6.9 0.0 2.4 31.0 7.0 7.8 3.1 17.5 0.7 4.7 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319944 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.2 0.2 0.1 0.2 0.1 0.0 1.6 0.1 0.1 1.2 0.9 0.0 36.5 0.7 0.4 1.2 2.5 0.3 0.4 0.2 0.1 0.1 0.3 0.2 1.6 0.4 0.1 0.0 0.2 0.3 6.4 1.3 4.4 0.1 1.1 0.1 0.0 1.1 13.2 0.1 38.2 1.0 0.2 0.1 0.2 0.4 0.6 0.0 0.4 4.5 4.8 2.2 0.7 2.6 1.0 0.7 2.1 0.5 0.9 0.6 0.2 2.5 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.6 0.0 0.0 0.1 7.2 0.3 2.7 0.0 0.1 1.3 0.0 0.4 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.7 0.4 0.2 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.2 0.3 0.1 0.6 0.0 0.0 0.1 0.0 1.9 0.5 0.1 0.1 5.3 0.0 0.9 9.7 0.4 0.8 0.0 0.2 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.1 1.4 0.4 0.5 0.5 0.3 0.5 0.5 0.6 0.4 0.1 1.0 0.6 0.6 2.1 0.9 0.5 0.7 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 5.1 0.0 9.0 18.5 0.0 0.8 0.0 1.4 2.3 10.4 0.0 1.2 0.0 3.6 1.7 0.0 0.3 0.0 1.2 0.2 0.2 5.0 0.0 0.4 0.1 0.0 2.9 0.0 0.0 3.8 0.0 0.0 5.0 0.0 0.0 0.2 12.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 33.0 6.6 0.0 0.5 10.1 POU3F1 "OCT6, OTF6, SCIP" ENSG00000185668 "POU class 3 homeobox 1" Q03052 1 38044611-38046794 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 10.5;skin 1: 31.0" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 24.3;Cone photoreceptor cells: 21.6;Muller glia cells: 14.6;Rod photoreceptor cells: 19.3;Suprabasal keratinocytes: 48.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.1;HDLM-2: 19.2;NTERA-2: 5.3;SCLC-21H: 3.8;SK-MEL-30: 15.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7" "HPA055980, HPA073824" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055980: AB_2682995, HPA073824: AB_2686635" "unprognostic (9.99e-2)" "unprognostic (1.63e-1)" "unprognostic (1.69e-1)" "unprognostic (1.43e-2)" "unprognostic (7.46e-3)" "unprognostic (1.96e-2)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.40e-1)" "unprognostic (4.61e-4)" "unprognostic (2.79e-2)" "unprognostic (1.97e-1)" "unprognostic (3.61e-2)" "unprognostic (2.67e-3)" 0.8 2.1 4.0 0.9 10.5 0.7 0.8 1.2 6.8 0.6 0.7 1.1 0.0 0.6 0.7 0.8 3.4 0.7 0.7 0.7 7.7 0.9 0.7 0.6 0.6 1.7 3.9 2.9 0.7 0.8 0.6 0.0 0.6 1.4 3.6 0.6 1.6 0.6 0.7 1.3 31.0 0.7 2.5 0.6 0.7 0.7 1.5 2.6 0.0 0.7 1.3 1.7 1.5 0.4 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 11.1 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 19.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 3.8 0.0 0.0 0.0 15.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 10.5 1.2 6.8 7.7 0.9 3.9 2.9 1.4 2.6 0.0 0.0 0.0 1.7 24.3 7.4 4.3 0.0 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.1 0.9 0.8 0.0 0.0 0.2 1.6 1.7 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.6 14.6 0.0 0.0 0.0 0.0 19.3 0.0 2.0 0.2 1.7 48.8 0.1 0.0 0.4 2.1 POU3F2 "BRN2, OCT7, OTF7, POUF3" ENSG00000184486 "POU class 3 homeobox 2" P20265 6 98834592-98839470 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "brain: 28.0" "Cell type enriched" "Detected in some" 8 "Muller glia cells: 12.3" "Cancer enriched" "Detected in some" 11 "glioma: 16.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 52.2;SK-MEL-30: 7.1;U-251 MG: 15.9;WM-115: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047081, HPA056261" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA047081: , HPA056261: AB_2683081" "unprognostic (5.94e-4)" "unprognostic (7.80e-2)" "unprognostic (3.07e-3)" "unprognostic (1.83e-1)" "unprognostic (3.57e-1)" "unprognostic (1.38e-1)" "unprognostic (1.17e-3)" "unprognostic (1.84e-1)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (4.77e-1)" "unprognostic (9.38e-11)" "unprognostic (4.77e-2)" "unprognostic (2.84e-2)" "unprognostic (8.47e-3)" "unprognostic (4.04e-1)" 0.9 1.0 9.0 0.9 10.8 0.9 0.9 3.4 28.0 0.9 0.9 10.3 0.0 0.9 0.9 0.9 0.9 0.9 0.9 0.9 9.8 7.1 0.9 0.9 0.9 0.9 10.7 6.8 0.9 0.9 0.9 0.0 0.9 9.7 0.9 0.9 0.0 0.9 0.9 0.9 1.0 0.9 0.9 8.4 0.9 0.9 1.2 9.0 0.0 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 52.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 2.2 1.7 0.4 0.0 0.0 0.0 2.9 1.5 0.0 0.0 7.1 0.0 0.4 0.0 0.0 0.3 0.0 0.1 15.9 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.0 10.8 3.4 12.5 9.8 7.1 10.7 6.8 9.7 9.0 0.0 0.0 0.0 0.2 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.1 0.0 0.0 0.0 0.2 POU3F3 "BRN1, OTF8" ENSG00000198914 "POU class 3 homeobox 3" P20264 2 104855511-104858574 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 55.8;Distal tubular cells: 23.2" "Group enriched" "Detected in some" 6 "glioma: 21.5;renal cancer: 24.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 27.6;AN3-CA: 26.4;HEK 293: 10.2;RPTEC TERT1: 31.4;SH-SY5Y: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052792, HPA056039, HPA067151" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790" "unprognostic (3.05e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (4.26e-5)" "unprognostic (9.66e-2)" "unprognostic (1.97e-1)" "unprognostic (4.69e-1)" "unprognostic (1.16e-1)" "unprognostic (7.28e-2)" "unprognostic (1.15e-3)" "unprognostic (7.15e-2)" 0.2 0.2 9.0 0.1 8.6 0.0 0.1 4.3 18.9 0.0 0.3 0.0 0.0 27.2 0.0 0.0 0.0 0.0 9.9 6.0 23.7 0.0 0.0 0.1 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.0 0.5 0.0 0.0 10.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.9 0.2 0.3 0.2 0.0 0.0 0.0 27.6 26.4 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.9 0.6 0.0 31.4 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 1.0 0.0 0.0 0.0 55.8 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 POU3F4 "BRN4, DFN3, DFNX2, OTF9" ENSG00000196767 "POU class 3 homeobox 4" P49335 X 83508261-83512127 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "brain: 39.0" "Cell type enriched" "Detected in some" 6 "Collecting duct cells: 10.4" "Cancer enriched" "Detected in single" 21 "glioma: 5.6" "Region enriched" "Detected in all" 6 "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 145 "AF22: 15.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062295 Supported Nucleoplasm NA NA Nucleoplasm "HPA062295: AB_2732681" "unprognostic (5.73e-2)" "unprognostic (2.00e-1)" 0.5 0.5 3.3 0.5 39.0 0.6 0.5 5.0 15.2 0.5 0.7 2.4 0.0 0.5 0.5 0.5 0.5 0.5 1.3 0.5 2.8 1.6 2.5 0.5 0.5 0.5 2.4 3.7 1.1 0.5 0.5 0.1 0.5 2.4 0.5 0.6 0.0 0.5 0.5 0.5 0.5 0.5 0.6 1.7 0.5 0.5 0.5 6.6 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 39.0 5.0 4.2 2.8 1.6 2.4 3.7 2.4 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU4F1 "BRN3A, RDC-1" ENSG00000152192 "POU class 4 homeobox 1" Q01851 13 78598362-78603560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.3" "Cell type enhanced" "Detected in some" 14 "Rod photoreceptor cells: 1.1;Spermatocytes: 1.6;Spermatogonia: 2.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 23 "pons and medulla: 25.3" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "HEK 293: 10.9;HEL: 11.6;JURKAT: 9.3;REH: 8.2;RH-30: 14.0;SCLC-21H: 13.4;U-266/70: 12.6" "Group enriched" "Detected in some" 14 "midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4" "Group enriched" "Detected in some" 26 "midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5" HPA068024 Enhanced Approved NA NA "HPA068024: AB_2685943" "unprognostic (6.70e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (6.30e-2)" "unprognostic (6.00e-2)" "unprognostic (1.70e-2)" "unprognostic (9.17e-2)" "unprognostic (8.98e-2)" "unprognostic (9.95e-2)" "unprognostic (1.53e-1)" "unprognostic (4.75e-3)" 0.1 0.0 1.1 2.3 1.0 1.2 1.0 0.2 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.2 1.0 1.0 0.0 0.5 0.1 2.3 0.7 0.0 0.0 0.1 0.1 0.0 0.9 25.3 0.0 0.3 6.3 0.2 0.0 1.8 0.4 0.3 0.0 2.5 0.3 0.3 4.4 0.4 2.7 0.0 0.2 3.5 0.3 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.0 0.0 0.0 10.9 11.6 0.0 1.4 0.0 5.7 3.4 0.0 0.1 0.0 0.0 0.0 0.0 9.3 2.3 0.0 0.5 0.0 0.8 1.0 0.0 1.5 0.0 8.2 14.0 0.0 0.0 0.0 13.4 0.2 0.0 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.2 0.0 12.6 3.8 0.0 0.0 6.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 1.0 0.2 0.4 1.0 1.0 0.7 0.0 25.3 0.4 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 1.1 0.0 0.0 1.6 2.5 0.4 0.0 0.0 0.0 0.0 POU4F2 "Brn-3b, BRN3B" ENSG00000151615 "POU class 4 homeobox 2" Q12837 4 146638893-146642474 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "brain: 5.7;testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "midbrain: 1.8;pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;SCLC-21H: 6.4;THP-1: 1.0" "Region enriched" "Detected in single" 6 "midbrain: 5.2" "Group enriched" "Detected in some" 15 "midbrain: 4.7;pons and medulla: 1.3;thalamus: 1.8" NA NA "unprognostic (4.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU4F3 "BRN3C, DFNA15, DFNA42, DFNA52" ENSG00000091010 "POU class 4 homeobox 3" Q15319 5 146338839-146341722 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Region enhanced" "Detected in single" "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;SCLC-21H: 1.9;U-2 OS: 1.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 0.5" HPA038215 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA038215: AB_10697245" "unprognostic (8.41e-3)" "unprognostic (9.46e-2)" "unprognostic (1.84e-1)" "unprognostic (6.26e-4)" "unprognostic (1.86e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (9.54e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-3)" "unprognostic (1.20e-3)" "unprognostic (1.24e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (8.84e-2)" "unprognostic (7.82e-2)" 0.6 0.1 0.4 0.4 0.6 1.0 0.4 2.8 0.9 0.3 0.2 0.2 0.2 0.1 0.6 0.7 0.2 0.4 0.3 0.2 0.7 0.4 0.3 0.2 0.3 0.2 0.7 0.2 0.6 0.2 0.0 0.2 1.8 0.2 0.2 0.2 0.2 1.1 0.4 0.2 0.8 0.2 0.8 2.4 0.6 0.2 0.4 0.2 1.5 0.5 0.2 0.2 0.6 0.2 0.7 0.4 0.0 0.0 0.0 0.4 0.0 0.2 1.0 0.2 0.4 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.9 0.2 0.3 0.2 0.3 0.1 0.5 0.3 0.0 0.9 0.4 0.5 0.0 0.1 0.0 0.1 0.1 0.8 0.4 1.6 0.4 0.1 0.0 0.3 0.2 0.2 0.5 0.1 0.1 0.4 2.0 0.1 0.0 0.3 0.8 0.0 0.1 0.4 0.5 1.9 1.6 0.6 0.5 0.1 0.3 0.4 0.1 0.0 0.0 1.9 0.0 0.6 0.6 0.9 0.7 0.0 0.6 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.8 0.2 0.7 0.4 0.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POU5F2 "FLJ25680, SPRM-1" ENSG00000248483 "POU domain class 5, transcription factor 2" Q8N7G0 5 93733220-93741637 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 26.8" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 15.9;Rod photoreceptor cells: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "U-2 OS: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077615 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA077615: " "unprognostic (1.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.53e-1)" "unprognostic (1.17e-1)" "unprognostic (3.03e-1)" "unprognostic (9.17e-3)" "unprognostic (3.72e-2)" "unprognostic (5.87e-3)" "unprognostic (4.58e-1)" "unprognostic (1.49e-1)" "unprognostic (3.53e-2)" "unprognostic (3.84e-1)" "unprognostic (6.16e-9)" "unprognostic (1.87e-1)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-3)" 0.2 0.2 0.2 0.2 0.2 1.2 0.8 0.2 0.9 0.2 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.2 1.4 0.6 0.2 0.2 0.3 0.5 26.8 0.2 0.2 0.5 0.2 0.2 0.2 0.2 2.0 0.5 2.7 0.6 1.1 1.3 0.3 0.4 0.6 1.1 0.5 0.2 0.4 0.5 0.2 0.0 0.3 0.1 0.3 0.5 0.9 0.4 0.2 0.7 0.6 0.9 0.3 0.5 0.6 0.7 0.8 0.7 0.7 0.2 0.8 0.8 0.5 0.7 0.5 0.4 0.5 0.2 0.8 0.6 1.1 0.4 0.4 0.7 1.0 0.7 0.3 0.3 0.5 1.2 0.9 0.2 0.3 1.0 0.9 0.6 0.7 0.2 0.5 0.5 0.7 0.7 0.6 8.5 0.7 0.7 0.8 0.5 0.8 0.5 0.9 0.4 1.4 0.6 0.3 1.0 0.4 1.0 0.8 0.7 0.6 0.1 2.0 0.7 1.1 2.7 1.1 0.4 0.5 1.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 3.0 2.1 3.0 2.1 1.9 10.5 0.4 2.5 1.4 0.0 1.8 5.9 0.7 0.0 1.5 1.7 1.4 1.4 0.0 0.8 0.9 1.4 2.0 8.1 0.8 1.0 15.9 2.9 2.5 1.3 4.5 4.4 2.9 1.7 2.8 0.5 5.4 1.7 0.0 1.4 0.1 15.8 0.0 0.9 6.9 2.3 2.4 0.5 5.4 1.0 2.0 POU6F2 RPF-1 ENSG00000106536 "POU class 6 homeobox 2" P78424 7 38977998-39493095 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;pancreas: 12.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 4.3;Cholangiocytes: 12.7;Cone photoreceptor cells: 7.9;Early spermatids: 3.5;Smooth muscle cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.5;Karpas-707: 3.3;NTERA-2: 4.3;SK-BR-3: 3.5;SuSa: 3.7;T-47d: 7.7;U-266/70: 8.5;U-266/84: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "unprognostic (2.48e-1)" "unprognostic (1.80e-4)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (1.96e-1)" "unprognostic (7.22e-3)" "unprognostic (2.32e-1)" "unprognostic (1.60e-2)" "unprognostic (5.00e-3)" "unprognostic (4.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.99e-1)" 0.9 0.3 2.9 0.4 6.2 0.8 1.0 0.4 13.2 1.2 0.4 0.6 0.0 0.6 0.3 0.3 0.7 0.3 2.4 1.9 3.1 2.1 0.5 2.9 0.5 0.3 2.0 11.2 1.0 12.3 0.3 0.9 3.6 2.3 0.4 0.4 1.5 0.5 0.5 0.3 0.5 0.4 0.3 0.8 0.4 0.4 2.0 1.0 0.0 0.4 0.0 0.4 3.0 0.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.3 0.0 0.0 0.0 0.0 4.3 0.9 0.0 0.0 0.0 0.1 0.0 0.3 2.7 0.0 0.0 3.5 0.0 3.7 7.7 0.0 0.0 0.0 0.8 0.0 0.0 8.5 10.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 6.2 0.4 13.2 3.1 2.1 2.0 11.2 2.3 1.0 0.0 1.7 0.0 0.1 0.0 4.3 1.6 12.7 0.0 0.0 0.0 7.9 0.2 0.0 0.9 3.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 3.9 0.3 1.0 0.0 0.1 0.0 0.0 0.0 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.8" "Group enriched" "Detected in some" 83 "Early spermatids: 319.7;Late spermatids: 185.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/84: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" NA NA Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: AB_2685611" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.1 0.2 0.1 3.0 0.1 0.7 0.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.3 0.3 0.2 0.1 0.1 0.3 0.2 28.8 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.7 0.5 1.2 0.6 0.0 0.9 0.0 0.3 0.6 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.5 0.8 1.5 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.2 0.6 0.6 0.9 0.2 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.5 0.7 0.0 0.2 1.0 0.8 1.0 0.4 0.3 0.9 0.9 1.6 0.0 0.3 0.4 1.9 0.1 2.3 1.4 1.1 0.7 0.8 0.3 0.0 0.3 0.3 0.5 0.6 4.1 1.6 1.8 0.8 0.3 0.0 0.5 0.9 0.8 0.6 0.3 0.2 0.5 0.4 0.1 0.7 0.9 0.8 1.2 0.0 0.4 0.5 0.0 0.0 0.1 0.1 0.7 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 319.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 97.6;breast: 102.1" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 90.9;Extravillous trophoblasts: 187.1;Urothelial cells: 210.8" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.8;intermediate monocyte: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 47.9;ASC TERT1: 27.3;BEWO: 56.5;CAPAN-2: 25.2;HSkMC: 28.1;RT4: 34.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081" "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favorable (5.52e-5)" 97.6 1.6 1.9 17.1 1.2 0.7 102.1 1.5 1.3 3.1 24.9 0.8 2.1 7.5 3.5 2.2 2.8 2.4 8.7 12.5 1.4 0.9 6.7 5.9 24.8 11.4 1.1 0.9 6.7 1.2 2.8 0.3 26.8 0.9 10.4 13.9 1.1 5.8 1.5 5.0 2.7 9.6 7.4 1.2 7.0 11.9 3.5 0.6 0.9 6.2 4.3 2.1 30.2 14.1 0.0 0.4 0.0 2.3 0.0 0.7 0.3 9.7 8.7 0.0 0.0 47.9 27.3 56.5 0.9 10.5 1.3 0.5 1.8 25.2 0.0 0.0 0.9 17.1 4.0 3.5 0.1 0.2 23.5 4.9 0.0 1.9 2.3 12.8 0.0 0.0 28.1 2.3 2.4 9.1 5.0 0.1 0.2 0.0 0.0 2.0 2.5 0.0 0.1 0.1 22.7 25.2 0.0 0.0 0.0 7.2 34.5 0.0 0.2 4.1 1.5 0.5 1.7 0.0 7.8 7.9 1.8 2.6 1.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.0 1.8 0.0 0.0 2.3 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.3 1.9 1.2 1.5 1.3 1.4 0.9 1.1 0.9 0.9 0.6 3.0 7.4 0.0 33.7 0.9 0.5 5.2 2.5 2.7 3.4 5.2 0.0 90.9 1.7 0.1 2.6 17.7 47.1 0.0 0.6 187.1 4.3 35.2 9.2 3.8 46.3 0.0 8.1 19.6 14.5 0.8 3.7 8.6 3.3 2.8 20.5 0.5 10.2 42.1 0.0 11.3 0.0 12.9 5.7 7.9 21.8 1.0 74.4 1.3 16.6 210.8 PPARGC1A "PGC-1alpha, PGC1, PGC1A, PPARGC1" ENSG00000109819 "PPARG coactivator 1 alpha" Q9UBK2 4 23755041-23904089 "Cancer-related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Activator, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 49.5;liver: 49.7;skeletal muscle: 55.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 81.8;Cholangiocytes: 66.2;Early spermatids: 52.7;Hepatocytes: 48.9;Late spermatids: 51.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "A-431: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063136 Supported Nucleoplasm NA NA Nucleoplasm "HPA063136: AB_2684948" "unprognostic (1.08e-1)" "unprognostic (7.47e-2)" "unprognostic (6.85e-3)" "unprognostic (2.28e-6)" "unprognostic (5.00e-2)" "unprognostic (1.15e-1)" "prognostic favorable (3.35e-6)" "unprognostic (3.04e-1)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (6.77e-2)" "unprognostic (4.58e-2)" "prognostic favorable (1.49e-14)" "unprognostic (3.62e-2)" "unprognostic (2.31e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (3.07e-3)" 5.7 2.4 3.1 2.4 4.2 0.3 1.3 4.7 5.5 2.6 9.4 4.2 1.8 5.7 0.9 4.8 3.0 1.2 2.2 24.6 3.3 3.1 49.5 49.7 2.5 0.4 3.1 1.8 1.3 2.8 14.6 7.6 0.3 7.8 2.6 6.6 14.0 30.4 3.0 55.6 5.5 14.2 1.6 3.2 0.8 3.1 3.4 3.4 0.3 17.4 18.2 1.5 1.7 1.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 43.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 2.1 5.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 3.5 0.0 0.0 0.3 0.0 6.3 0.0 2.1 0.1 1.4 0.0 1.8 2.2 0.2 0.7 0.0 0.4 0.4 0.0 0.8 3.9 0.0 0.0 0.8 0.7 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 4.2 4.7 5.5 3.3 3.1 3.1 1.8 7.8 3.4 17.9 1.6 1.7 5.5 0.8 3.8 81.8 66.2 8.1 6.8 34.9 37.3 0.0 44.7 6.6 52.7 0.3 26.8 0.0 0.0 0.0 0.2 1.4 1.1 48.9 0.0 0.0 25.6 1.8 2.4 51.4 0.9 0.0 6.8 0.0 13.0 5.8 0.9 7.0 2.1 22.6 0.7 0.0 5.1 0.7 0.2 1.0 0.0 1.0 10.8 0.4 PPBP "b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1" ENSG00000163736 "Pro-platelet basic protein" P02775 4 73987038-73988197 "Plasma proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Ductal cells: 3.4;Kupffer cells: 8.8;Pancreatic endocrine cells: 4.1" "Cancer enriched" "Detected in many" 7 "colorectal cancer: 86.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 9 "basophil: 30.0;neutrophil: 18.4" "Lineage enriched" "Detected in many" 11 "granulocytes: 30.0" "Cell line enhanced" "Detected in some" "HBEC3-KT: 4.1;HEL: 12.0;RPTEC TERT1: 2.8" "Low region specificity" "Detected in all" "HPA008354, CAB017624" Supported "Secreted to blood" NA NA 24500000 3500000000 "CAB017624: AB_1127132, HPA008354: AB_1847353" "unprognostic (2.13e-1)" "prognostic unfavorable (6.17e-4)" "unprognostic (7.69e-2)" "unprognostic (1.67e-1)" "unprognostic (4.37e-2)" "unprognostic (3.13e-1)" "unprognostic (2.79e-1)" "unprognostic (6.98e-3)" "unprognostic (2.58e-1)" "unprognostic (4.21e-2)" "unprognostic (1.81e-1)" "unprognostic (2.88e-1)" "unprognostic (2.38e-3)" "unprognostic (1.49e-1)" "unprognostic (2.90e-1)" "unprognostic (2.15e-3)" "unprognostic (2.59e-2)" 1.4 0.6 0.4 0.6 1.7 67.0 0.6 0.2 0.4 0.5 0.2 0.1 0.0 0.1 0.3 0.5 0.5 0.8 0.9 35.7 0.3 0.3 0.5 1.9 13.3 0.1 1.6 0.0 6.0 0.4 0.1 0.5 8.7 1.3 0.6 0.2 0.4 0.5 0.1 1.0 0.3 0.2 0.2 1.3 60.0 0.3 0.5 0.0 0.0 2.2 0.9 0.1 1.7 11.0 0.3 2.6 30.0 1.8 0.2 0.5 206.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 30.0 1.8 1.1 0.2 0.6 0.3 0.1 0.1 0.0 1.0 0.3 0.5 0.1 18.4 0.2 0.5 2.6 0.2 206.7 0.4 1.7 0.2 0.4 0.3 0.3 1.6 0.0 1.3 0.0 3.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.3 8.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PPDPFL C8orf22 ENSG00000168333 "Pancreatic progenitor cell differentiation and proliferation factor like" Q8WWR9 8 49054311-49076090 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 311.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "glioma: 0.7;renal cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "HEL: 5.7" HPA060329 Uncertain NA NA "HPA060329: AB_2684255" "unprognostic (6.33e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.06e-10)" 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.7 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.1 311.2 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 57.2 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPEF1 "PPEF, PPP7CA" ENSG00000086717 "Protein phosphatase with EF-hand domain 1" O14829 X 18675909-18827921 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;testis: 20.2" "Group enriched" "Detected in some" 11 "Early spermatids: 51.1;Late spermatids: 94.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 3.6;HAP1: 1.3;HeLa: 5.3;SH-SY5Y: 2.9;SK-MEL-30: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034577 Uncertain "Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane" "Cytokinetic bridge" "HPA034577: AB_10602817" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-2)" "unprognostic (9.85e-2)" "unprognostic (3.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.38e-1)" "unprognostic (3.43e-2)" "unprognostic (4.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.89e-1)" "unprognostic (1.10e-11)" "unprognostic (5.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "unprognostic (1.19e-2)" 0.1 0.5 3.1 0.2 6.4 1.4 3.9 0.2 10.6 0.2 0.2 0.1 0.0 0.1 0.3 0.9 0.2 0.2 0.3 0.3 1.9 1.0 0.3 0.1 0.4 0.3 1.7 6.9 0.2 0.2 0.1 0.7 1.0 0.2 0.5 0.1 0.0 0.3 0.6 0.1 0.7 0.1 0.2 10.5 0.3 0.1 20.2 0.0 0.1 0.4 0.0 0.3 0.4 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.2 0.0 3.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 1.2 0.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 6.4 0.2 10.6 1.9 1.0 1.7 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 6.4 0.0 0.0 0.0 94.3 0.6 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 PPEF2 PPP7CB ENSG00000156194 "Protein phosphatase with EF-hand domain 2" O14830 4 75859864-75902571 "Enzymes, Predicted intracellular proteins" "Sensory transduction, Vision" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "retina: 75.7" "Group enriched" "Detected in some" 22 "Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 518.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "cerebellum: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.19e-2)" "unprognostic (2.92e-1)" "unprognostic (2.50e-1)" "unprognostic (4.73e-2)" "unprognostic (1.53e-1)" "unprognostic (9.02e-2)" "unprognostic (3.32e-4)" "unprognostic (2.74e-2)" "unprognostic (4.54e-8)" "unprognostic (2.89e-1)" "unprognostic (5.98e-2)" "unprognostic (5.16e-1)" "unprognostic (3.66e-3)" 0.1 0.0 0.0 0.2 0.4 0.2 0.3 3.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 75.7 0.0 0.0 0.3 0.4 0.1 0.1 0.1 0.3 0.1 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.3 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.2 518.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 PPFIA2 ENSG00000139220 "PTPRF interacting protein alpha 2" O75334 12 81257975-81759553 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 48.8" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 98.7;Cone photoreceptor cells: 84.4;Early spermatids: 111.1;Rod photoreceptor cells: 206.9" "Cancer enhanced" "Detected in some" "prostate cancer: 1.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "basophil: 2.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "HAP1: 25.2;hTERT-RPE1: 4.5;SCLC-21H: 8.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.31e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-2)" "unprognostic (6.78e-5)" "unprognostic (4.69e-3)" "unprognostic (2.13e-1)" "unprognostic (6.67e-2)" "unprognostic (7.10e-2)" "unprognostic (8.92e-2)" "unprognostic (3.97e-2)" "unprognostic (3.76e-1)" "unprognostic (9.84e-2)" "unprognostic (3.27e-3)" "unprognostic (2.45e-2)" "unprognostic (4.88e-2)" "unprognostic (4.49e-3)" "unprognostic (1.06e-3)" 2.6 8.3 23.0 1.4 17.7 0.9 1.8 7.2 48.8 6.0 2.3 10.5 0.0 1.4 3.2 1.8 1.8 2.4 3.2 1.2 19.2 10.6 2.0 1.3 1.9 1.1 10.1 20.9 2.2 1.7 1.0 4.5 1.0 8.6 2.7 2.7 2.5 1.2 5.5 1.0 1.9 1.7 3.7 7.7 1.2 2.0 8.2 9.7 0.0 1.3 0.0 1.1 2.4 2.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 25.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.1 0.0 1.2 0.0 8.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 17.7 7.2 38.3 19.2 10.6 10.1 20.9 8.6 9.7 0.0 1.4 0.0 0.0 0.3 98.7 0.4 0.0 0.0 0.0 0.0 84.4 0.0 1.7 0.0 111.1 0.1 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.1 46.1 15.6 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 15.6 0.0 206.9 0.0 6.2 2.8 1.7 0.5 0.1 0.0 0.0 0.0 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119389-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.1;pituitary gland: 14.9;skin 1: 25.3" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 35.8;Horizontal cells: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 6 "T-cells: 1.1" "Cell line enhanced" "Detected in many" "OE19: 14.1;PC-3: 22.8;SK-BR-3: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" NA NA "Nucleoli fibrillar center, Vesicles" "HPA043567: AB_2678558, HPA050340: AB_2681096" "prognostic unfavorable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favorable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favorable (6.46e-7)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 1.6 3.9 13.9 1.6 9.3 0.9 2.2 22.1 20.8 1.2 4.3 1.6 1.7 5.1 1.6 1.1 4.4 1.3 1.4 1.4 12.8 12.2 1.1 1.6 1.8 1.6 7.4 13.7 1.0 4.9 4.1 14.9 1.1 7.3 3.4 2.0 1.6 2.7 1.6 1.7 25.3 4.6 1.2 2.4 1.3 2.3 2.1 1.8 0.0 1.8 1.2 2.2 1.1 1.9 0.0 0.0 0.0 0.0 0.2 1.1 0.3 1.9 2.0 2.0 5.0 0.0 0.0 3.9 0.2 0.2 1.0 1.4 1.4 0.8 4.5 2.7 0.2 1.5 1.0 3.1 0.4 0.2 4.8 6.8 2.8 1.8 1.0 0.2 1.1 7.2 0.2 1.1 0.6 0.3 0.4 0.0 7.5 5.4 7.1 0.1 8.7 1.4 1.9 0.9 14.1 22.8 4.5 4.0 2.1 0.3 1.0 4.2 5.7 0.8 18.7 1.9 0.0 10.3 2.7 0.4 1.1 3.9 0.7 0.1 13.2 10.8 3.3 1.1 4.4 2.5 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.4 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.0 0.0 0.3 13.9 9.3 22.1 19.8 12.8 12.2 7.4 13.7 7.3 1.8 0.0 1.1 0.0 6.2 6.4 35.8 3.7 7.6 0.0 1.2 5.2 13.7 0.4 16.6 1.6 0.9 13.5 15.1 23.3 3.7 1.9 3.4 21.2 0.0 7.6 2.1 41.3 25.4 26.4 2.4 1.1 5.2 0.8 15.1 0.0 23.8 14.6 1.9 11.0 3.5 3.6 15.4 0.0 3.3 2.3 5.2 10.3 0.5 0.0 19.0 5.0 PPFIA4 ENSG00000143847 "PTPRF interacting protein alpha 4" O75335 1 203026498-203078740 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 32.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebellum: 72.6;cerebral cortex: 21.1" "Cell type enhanced" "Detected in some" "myeloid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 7.4;hTERT-RPE1: 12.8;RH-30: 13.2;U-266/70: 8.3;U-87 MG: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053419, HPA054132" Enhanced NA NA "HPA053419: AB_2682143, HPA054132: AB_2682393" "unprognostic (2.83e-1)" "unprognostic (2.34e-3)" "unprognostic (3.38e-5)" "unprognostic (3.19e-1)" "unprognostic (6.58e-2)" "unprognostic (5.36e-2)" "unprognostic (7.49e-8)" "unprognostic (4.65e-1)" "unprognostic (6.01e-4)" "unprognostic (1.29e-1)" "unprognostic (7.70e-2)" "unprognostic (2.60e-2)" "prognostic unfavorable (1.73e-8)" "unprognostic (6.82e-3)" "unprognostic (9.96e-2)" "unprognostic (1.11e-1)" "unprognostic (4.28e-2)" 0.6 1.3 9.2 1.0 10.9 1.6 0.9 72.6 21.1 1.8 1.0 1.4 0.0 1.1 1.7 3.5 1.3 1.2 2.6 26.2 6.6 5.0 1.9 0.6 1.2 0.8 3.0 10.8 0.9 0.6 1.3 0.7 3.9 11.4 1.5 0.8 0.6 1.4 1.3 20.4 2.9 1.3 2.0 2.0 2.2 0.8 3.3 2.3 0.0 0.9 0.4 0.8 0.9 0.9 0.0 1.4 1.3 0.9 0.0 0.6 0.0 7.4 0.0 0.1 1.9 0.0 0.3 0.3 0.4 0.9 0.7 3.1 0.3 0.3 0.3 1.6 1.7 0.2 0.8 0.6 1.4 1.5 0.0 0.6 0.1 0.0 0.0 0.1 0.0 1.0 2.4 0.1 0.4 0.0 12.8 0.0 1.5 0.1 0.3 6.2 1.0 0.5 0.9 0.9 0.0 0.3 1.3 13.2 2.1 0.0 0.0 2.5 3.2 0.8 0.1 1.0 1.2 0.2 0.6 0.0 4.7 2.8 0.1 0.0 8.3 0.2 0.1 12.1 0.6 0.5 0.0 0.9 1.3 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.6 0.0 9.2 10.9 72.6 21.1 6.6 5.0 3.0 10.8 11.4 2.3 0.0 0.0 0.0 0.1 0.0 2.4 32.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 1.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.3 6.4 0.0 1.3 0.0 1.9 0.3 0.0 0.0 0.0 0.0 2.6 0.5 0.0 1.8 0.0 0.8 0.0 0.9 0.5 1.2 0.0 0.2 0.0 0.0 0.0 PPIAL4A "COAS2, PPIAL4, PPIAL4B" ENSG00000263353 "Peptidylprolyl isomerase A like 4A" Q9Y536 1 120889746-120890405 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.5;intestine: 1.6" "Cell type enriched" "Detected in single" 10 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 3.8;NB-4: 4.6;SK-BR-3: 4.7" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (3.49e-3)" "unprognostic (2.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-1)" "unprognostic (1.77e-1)" "unprognostic (2.09e-1)" "unprognostic (1.42e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.83e-2)" "unprognostic (1.74e-1)" 0.3 0.8 1.0 1.4 0.2 1.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 3.0 3.2 0.6 1.6 2.2 2.4 3.5 0.9 0.0 0.1 1.4 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 1.0 0.7 0.2 0.0 0.3 1.8 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.2 3.8 0.3 0.6 1.7 4.6 2.5 0.0 0.0 0.8 1.5 1.9 0.0 0.0 1.0 0.3 0.3 4.7 0.4 0.1 3.1 2.5 0.7 3.0 1.2 2.9 1.7 1.4 0.9 2.5 2.6 1.6 3.2 0.2 1.6 0.6 1.4 1.2 1.4 3.0 2.3 2.4 3.1 2.2 1.5 2.4 0.0 2.2 1.2 3.2 2.4 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPIAL4C ENSG00000263464 "Peptidylprolyl isomerase A like 4C" A0A0B4J2A2 1 149583865-149584464 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 10.9;intestine: 5.5" "Cell type enriched" "Detected in single" 16 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 14.4;THP-1: 16.9" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (3.16e-1)" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (7.93e-2)" "unprognostic (5.98e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-1)" "unprognostic (6.61e-2)" "unprognostic (2.25e-1)" 0.0 3.3 2.7 0.1 0.0 1.5 0.0 0.8 5.5 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 2.9 0.2 0.0 0.9 0.7 0.3 0.0 0.0 0.0 0.2 0.5 2.9 0.0 1.4 0.9 0.0 0.0 0.3 0.0 9.1 9.7 1.9 6.0 4.6 7.8 10.9 3.6 0.3 0.4 3.1 0.1 0.3 2.0 0.6 0.4 1.0 0.7 0.0 4.8 1.3 2.1 0.0 2.5 3.9 0.0 0.2 0.6 3.5 0.0 0.5 0.0 0.0 0.1 2.0 1.9 0.1 0.5 0.6 0.3 0.0 0.0 0.5 0.9 5.4 0.7 0.4 5.3 14.4 6.2 1.0 0.1 5.3 0.0 9.0 0.2 0.0 4.0 5.5 1.1 11.3 6.2 0.3 5.3 16.9 1.3 3.6 5.6 3.3 8.2 4.2 5.6 9.2 3.9 4.6 7.8 0.9 4.3 1.9 5.4 6.0 6.0 9.1 6.1 5.7 9.4 7.2 5.0 5.9 0.0 4.6 5.3 9.7 7.8 10.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPIAL4D ENSG00000256374 "Peptidylprolyl isomerase A like 4D" F5H284 1 145241630-145242124 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 4 "blood: 5.4;brain: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.1;NB-4: 1.9;RPMI-8226: 1.0;SK-MEL-30: 1.8;THP-1: 1.5" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (9.32e-2)" "unprognostic (1.33e-1)" "unprognostic (3.05e-2)" 0.0 0.0 0.5 0.0 0.7 0.0 0.0 3.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.0 4.5 3.8 0.7 3.7 1.8 4.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.9 0.4 0.0 0.0 0.0 1.8 0.0 0.6 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.7 1.4 0.3 1.2 3.7 1.4 4.5 2.7 1.7 3.6 3.1 2.8 3.5 0.0 1.8 1.8 3.8 4.1 5.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 PPIAL4E ENSG00000271567 "Peptidylprolyl isomerase A like 4E" A0A075B759 1 144372875-144373659 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.2;hTERT-RPE1: 1.9;NB-4: 1.4;SK-BR-3: 2.0;TIME: 1.9" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (6.97e-2)" "unprognostic (5.22e-2)" "unprognostic (2.28e-1)" 0.0 0.4 0.0 2.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 1.9 2.0 3.4 2.9 0.6 0.6 0.5 0.4 0.1 0.0 0.0 0.4 0.2 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.3 1.0 0.0 0.0 1.9 0.1 0.5 0.3 0.0 0.6 0.4 0.2 0.0 0.2 0.0 0.0 2.0 1.0 2.9 0.5 1.9 1.3 1.6 1.3 0.5 1.7 0.5 0.5 1.9 3.4 1.5 0.6 0.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPIAL4G ENSG00000236334 "Peptidylprolyl isomerase A like 4G" P0DN37 1 148479824-148483679 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 6.9;skeletal muscle: 6.8" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 6.1;Suprabasal keratinocytes: 10.9;T-cells: 6.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058345 Uncertain NA NA "HPA058345: AB_2683685" "unprognostic (2.17e-3)" "unprognostic (3.63e-1)" "unprognostic (4.83e-1)" "unprognostic (2.26e-1)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (3.95e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" 0.2 0.1 1.3 0.7 1.8 1.3 0.3 6.9 1.2 0.1 0.2 0.5 0.4 1.0 0.3 0.1 0.3 0.2 0.9 1.1 0.1 0.2 0.2 1.1 0.5 0.4 0.0 0.1 0.3 0.1 0.2 0.3 0.4 0.0 6.8 0.8 0.7 0.0 0.4 2.7 0.5 0.5 0.4 0.3 0.0 0.0 2.2 0.6 2.4 0.8 2.4 3.2 0.2 0.8 1.1 0.5 1.7 0.2 0.3 1.3 0.3 0.3 0.1 0.1 1.3 0.9 1.2 0.8 0.3 0.2 1.0 0.1 0.2 0.2 0.5 0.7 1.2 2.4 1.0 0.1 1.5 1.2 0.2 1.8 0.1 0.3 0.3 0.2 1.0 0.7 1.8 0.0 0.9 0.8 2.5 1.1 0.1 0.3 0.6 0.3 0.8 0.3 1.3 0.7 1.0 1.0 0.7 0.4 0.9 1.2 1.4 0.8 0.9 0.9 1.4 0.7 1.4 1.2 1.0 0.7 1.0 0.9 2.2 0.4 1.0 3.2 0.4 2.4 0.9 1.5 1.7 0.3 2.2 1.6 2.8 2.4 2.4 0.8 0.6 0.5 0.2 0.0 1.1 0.0 0.4 6.1 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.1 0.4 0.2 1.6 0.0 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 10.9 0.1 6.7 0.0 0.1 PPIL6 "bA425D10.6, dJ919F19.1, MGC41939, RSPH12" ENSG00000185250 "Peptidylprolyl isomerase like 6" Q8IXY8 6 109390215-109441171 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 36.5" "Group enriched" "Detected in many" 4 "Ciliated cells: 187.4;Early spermatids: 262.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036717, HPA058165" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA036717: AB_10671969, HPA058165: " "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (5.68e-2)" "unprognostic (2.68e-2)" "unprognostic (3.12e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (5.53e-2)" "unprognostic (3.14e-1)" "unprognostic (8.03e-2)" "unprognostic (1.42e-3)" "unprognostic (2.51e-2)" "unprognostic (4.71e-2)" "unprognostic (1.95e-1)" "unprognostic (3.29e-2)" "unprognostic (5.86e-2)" "unprognostic (2.32e-1)" 1.5 1.4 5.5 1.1 8.6 0.7 3.6 5.0 4.8 4.6 1.7 7.2 7.4 1.9 3.8 12.7 2.0 36.5 1.7 2.6 6.0 5.4 4.9 1.2 8.9 1.1 3.4 3.2 6.3 4.3 6.6 7.6 1.6 18.3 1.8 1.6 2.6 2.8 5.0 3.9 1.7 1.1 5.4 3.2 1.3 2.3 20.4 5.3 0.0 17.2 1.4 1.1 2.9 2.0 5.1 1.7 2.0 1.3 1.7 1.3 1.1 1.8 1.0 1.2 6.5 10.4 12.9 1.1 0.0 2.3 0.5 0.2 0.1 1.8 0.0 0.5 0.6 0.9 1.2 1.0 0.0 0.3 0.5 0.9 0.5 0.1 0.0 5.2 0.6 0.3 2.7 6.2 0.2 3.9 9.3 0.8 1.4 0.9 0.3 0.4 0.6 0.1 0.6 0.2 4.2 1.3 0.8 0.0 0.6 5.0 0.1 1.5 2.5 0.2 0.3 4.3 0.3 0.5 1.0 0.4 0.1 0.2 1.1 0.2 0.3 0.1 0.1 2.1 0.1 0.4 2.0 1.2 1.2 0.9 1.3 0.9 5.1 1.2 1.1 1.7 3.2 1.1 1.0 1.6 1.7 1.1 1.7 1.3 1.1 5.5 8.6 5.0 4.8 6.0 5.4 3.4 3.2 18.3 5.3 6.0 5.8 0.0 3.5 1.9 2.1 3.3 5.1 187.4 22.7 3.5 2.0 0.5 21.6 1.6 262.5 1.5 0.7 0.0 1.0 0.7 1.7 2.9 0.0 0.0 0.3 1.6 2.9 0.6 0.0 40.8 4.9 0.5 3.3 1.0 1.8 4.9 0.7 0.0 4.9 8.0 11.5 0.0 1.2 52.6 22.0 2.6 0.6 0.5 1.7 1.1 PPIP5K1 "HISPPD2A, IPS1, KIAA0377, VIP1" ENSG00000168781 "Diphosphoinositol pentakisphosphate kinase 1" Q6PFW1 15 43533462-43590253 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 42.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039380 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039380: AB_10673528" "unprognostic (8.72e-2)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-1)" "unprognostic (2.38e-1)" "unprognostic (2.78e-1)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (2.59e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (6.67e-2)" "unprognostic (2.85e-3)" "prognostic favorable (7.14e-8)" "unprognostic (2.67e-2)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (7.95e-3)" 1.7 5.2 3.4 1.8 6.4 1.1 3.4 28.4 7.0 2.8 6.1 9.1 2.2 5.6 3.7 3.1 2.5 2.1 3.6 5.0 2.5 1.4 1.4 2.0 3.3 3.0 2.9 13.4 7.6 0.9 3.4 6.5 4.7 2.7 6.3 7.2 8.8 2.3 2.8 2.3 5.3 4.5 5.0 3.0 3.3 2.7 5.3 3.2 4.3 2.8 3.5 3.8 3.0 8.4 5.6 4.9 9.1 3.0 1.9 8.4 4.2 5.4 6.1 9.0 6.4 8.1 7.9 6.4 5.8 9.1 23.1 9.5 18.4 6.2 7.8 7.5 11.9 16.9 3.4 6.8 13.6 12.4 3.4 16.2 7.4 11.4 8.3 6.4 18.6 8.6 11.8 4.5 6.6 4.5 7.7 2.4 15.9 6.0 9.7 5.0 4.0 6.6 15.3 14.8 4.6 10.9 10.4 4.1 7.3 19.2 11.4 2.8 5.3 6.4 6.7 10.2 2.6 3.2 9.8 10.0 15.6 5.1 4.3 1.4 0.0 2.7 2.8 3.8 5.3 3.3 3.6 3.2 3.6 2.7 2.5 1.0 3.5 2.1 2.4 0.8 3.0 0.0 2.1 0.0 1.5 3.5 15.3 4.0 5.1 0.0 2.3 7.0 39.3 2.7 0.0 2.1 1.7 2.4 8.8 0.0 1.3 0.8 0.8 1.3 0.0 1.1 1.6 9.5 2.4 4.3 2.7 1.6 1.7 1.6 0.0 1.0 5.0 4.3 1.8 3.5 6.7 1.4 42.3 6.5 1.0 6.6 1.3 2.9 1.8 2.1 7.6 3.2 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5;Collecting duct cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: AB_2678048, HPA059859: AB_2684145" "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.9 2.5 0.0 0.0 18.7 27.2 9.0 0.0 0.4 0.0 0.1 11.6 17.8 0.1 4.1 0.3 1.0 57.0 0.3 6.8 0.0 0.0 0.4 0.0 13.8 2.0 1.2 0.0 0.0 1.3 6.3 0.0 2.2 1.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 1.8 9.2 5.4 0.0 0.0 8.7 13.6 11.1 9.4 0.1 30.5 10.2 0.1 2.8 5.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 68.5 23.2 0.5 33.9 31.1 7.7 3.5 30.6 12.0 30.7 54.1 5.9 1.6 1.7 15.3 0.6 6.4 4.5 0.0 4.0 1.2 11.0 30.6 0.0 10.9 0.6 1.6 37.8 4.3 0.8 0.2 51.2 1.8 16.9 1.8 3.9 5.3 16.8 5.8 3.9 0.8 11.2 0.0 5.6 3.9 2.9 44.8 1.1 0.7 5.0 47.5 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755869-58985176 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 10.7;brain: 36.5;testis: 13.1" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 16.0;Cone photoreceptor cells: 29.5;Early spermatids: 22.1;Horizontal cells: 73.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 2.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "AF22: 10.2;HAP1: 16.5;MOLT-4: 7.8;SCLC-21H: 7.6;SH-SY5Y: 15.8;THP-1: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.7 10.7 15.0 0.8 7.5 0.7 0.7 11.9 23.3 1.0 0.7 3.6 0.0 0.8 1.1 2.2 0.7 3.3 0.8 2.3 36.5 5.4 1.9 2.4 1.0 0.9 3.2 9.2 1.0 1.7 0.8 3.4 0.6 10.5 3.2 0.7 3.5 0.8 0.7 0.6 0.7 1.0 1.3 2.7 0.8 1.4 13.1 2.0 0.0 0.8 0.0 1.0 0.6 0.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.5 0.0 0.0 0.8 0.0 0.0 0.8 1.2 0.0 0.0 6.5 0.1 0.1 2.3 0.0 16.5 0.0 0.4 0.1 4.9 0.0 0.1 0.0 1.2 0.5 2.1 0.3 1.3 0.1 0.0 0.5 0.0 4.1 1.6 0.0 0.0 2.9 7.8 0.0 2.9 0.0 0.8 0.0 1.3 0.0 0.0 0.0 7.6 15.8 0.2 0.0 1.0 0.1 0.0 7.0 0.0 0.0 1.9 0.0 2.4 0.0 0.1 4.4 0.3 0.0 2.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 7.5 11.9 14.0 36.5 5.4 3.2 9.2 10.5 2.0 0.0 0.0 0.0 0.0 0.0 16.0 1.6 0.0 0.0 3.4 0.0 29.5 0.0 0.0 0.0 22.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.8 0.1 73.1 2.9 0.0 0.3 14.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.4 0.0 11.7 0.0 0.0 9.3 2.5 0.0 0.0 0.0 0.0 0.0 PPM1G "PP2CG, PP2Cgamma" ENSG00000115241 "Protein phosphatase, Mg2+/Mn2+ dependent 1G" O15355 2 27381194-27409687 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 93.3" "Cell type enhanced" "Detected in all" 17 "Early spermatids: 1236.5;Late spermatids: 2467.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035530, HPA035531" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA035530: AB_10670021, HPA035531: AB_10610283" "unprognostic (7.50e-2)" "unprognostic (8.89e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-1)" "unprognostic (2.27e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (3.14e-7)" "unprognostic (9.36e-3)" "unprognostic (7.73e-2)" "prognostic favorable (6.08e-5)" "unprognostic (3.74e-2)" "unprognostic (1.23e-1)" "unprognostic (7.46e-3)" "unprognostic (1.06e-2)" "unprognostic (5.33e-2)" "unprognostic (1.78e-1)" "unprognostic (7.83e-2)" 12.7 17.0 9.9 19.9 9.2 19.4 30.2 10.9 19.3 17.9 14.6 9.1 16.9 12.1 26.8 12.5 19.4 19.2 17.7 13.6 8.8 7.6 12.6 18.6 14.7 20.2 9.4 8.0 13.4 18.6 13.8 13.2 11.4 8.7 10.2 16.4 9.1 16.4 18.7 24.1 10.9 12.2 14.9 6.7 14.7 14.1 93.3 8.4 25.8 14.1 19.1 22.5 25.2 17.3 20.2 40.3 24.5 29.1 22.7 38.3 19.0 50.9 42.1 30.9 23.7 19.7 16.1 28.5 31.8 20.9 38.2 30.7 64.8 27.0 60.2 23.4 22.5 32.5 27.9 51.9 35.7 34.4 25.1 42.2 58.6 30.7 68.4 17.8 57.8 24.8 17.4 20.7 38.9 31.4 18.2 36.5 29.9 49.0 18.7 28.9 45.6 42.9 62.8 44.9 35.4 30.4 44.4 64.8 31.6 25.8 35.6 41.6 47.1 28.5 31.6 22.8 25.6 17.5 19.0 29.3 28.6 34.6 25.0 48.2 40.8 45.7 95.2 22.4 47.4 21.4 22.1 17.8 24.5 26.9 22.3 26.5 20.2 28.7 27.9 28.5 18.0 21.7 22.4 9.1 22.7 29.1 40.3 38.3 19.0 9.9 9.2 10.9 19.3 8.8 7.6 9.4 8.0 8.7 8.4 59.6 43.5 61.1 65.0 72.0 42.0 33.6 50.9 61.6 66.0 66.3 27.5 71.4 28.2 97.8 1236.5 66.3 54.6 23.3 120.2 139.9 42.7 66.0 58.8 37.8 76.1 46.1 77.4 35.6 49.4 2467.5 65.0 65.1 23.6 147.9 59.6 64.9 122.3 42.1 66.8 48.3 34.6 45.3 45.8 594.3 323.3 70.4 44.4 79.7 83.2 121.2 PPM1H "ARHCL1, FLJ13253, KIAA1157, NERPP-2C" ENSG00000111110 "Protein phosphatase, Mg2+/Mn2+ dependent 1H" Q9ULR3 12 62643982-62935037 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.1;parathyroid gland: 36.6" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Group enriched" "Detected in many" 11 "dendritic cells: 2.3;granulocytes: 5.3;monocytes: 1.7" "Cell line enhanced" "Detected in many" "CACO-2: 35.9;HMC-1: 29.0;SK-BR-3: 16.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020694, HPA044244, HPA058777" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816" "unprognostic (3.41e-2)" "unprognostic (1.94e-1)" "unprognostic (9.51e-2)" "unprognostic (8.61e-3)" "unprognostic (1.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (5.85e-2)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" "unprognostic (5.53e-3)" "unprognostic (2.19e-1)" "prognostic favorable (2.72e-5)" "unprognostic (3.90e-2)" "unprognostic (1.73e-1)" "unprognostic (8.04e-3)" "unprognostic (1.14e-1)" 2.6 2.1 10.6 1.6 12.4 3.1 5.7 37.1 16.3 8.5 2.8 14.0 12.4 3.6 6.9 7.7 1.1 7.5 9.1 2.2 13.0 12.2 11.7 3.9 3.2 1.5 14.3 9.0 9.4 4.9 36.6 13.3 7.1 8.5 15.0 3.6 7.7 10.2 11.6 1.5 1.2 2.1 2.2 8.9 1.3 6.2 1.4 15.0 0.5 3.8 0.1 2.1 3.4 1.2 0.0 2.3 5.3 1.7 0.2 0.0 0.3 0.5 5.6 1.0 0.0 0.2 0.0 12.2 1.3 1.3 0.8 0.2 35.9 2.6 0.0 1.2 0.6 0.8 0.7 3.9 0.1 0.5 0.1 1.9 6.7 1.0 8.1 0.0 2.0 29.0 0.0 0.1 0.0 0.3 0.8 0.1 1.2 1.7 0.0 0.6 4.1 0.6 0.9 7.3 1.8 2.7 0.9 2.5 10.0 8.3 12.7 3.2 0.0 2.2 16.4 5.3 4.1 8.9 1.2 0.1 0.2 0.7 0.1 0.4 1.5 9.2 1.8 0.1 0.0 0.5 5.3 1.7 3.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.2 1.4 0.0 0.0 0.3 10.6 12.4 37.1 16.3 13.0 12.2 14.3 9.0 8.5 15.0 6.0 6.6 0.0 0.1 0.1 7.9 1.4 15.3 5.3 1.2 15.7 25.5 18.6 3.3 4.1 8.8 1.4 0.1 0.0 5.5 1.3 1.1 4.6 13.9 4.9 5.4 11.1 8.6 12.3 3.0 8.0 0.9 0.7 3.3 1.8 2.2 6.0 4.6 2.5 1.4 5.7 10.6 0.0 0.0 0.0 0.1 0.1 5.7 0.0 2.4 0.4 PPM1J "DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ" ENSG00000155367 "Protein phosphatase, Mg2+/Mn2+ dependent 1J" Q5JR12 1 112709994-112715477 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.9;skeletal muscle: 45.1;testis: 31.9" "Group enriched" "Detected in many" 8 "Early spermatids: 105.4;Late spermatids: 189.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 30.9" "Lineage enriched" "Detected in many" 17 "dendritic cells: 30.9" "Cell line enhanced" "Detected in many" "T-47d: 20.4" "Region enriched" "Detected in some" 8 "olfactory region: 33.6" "Low region specificity" "Detected in all" HPA046045 Uncertain Approved Vesicles NA NA Vesicles "HPA046045: AB_2679516" "unprognostic (8.68e-2)" "unprognostic (5.65e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.93e-3)" "unprognostic (2.34e-2)" "unprognostic (3.55e-2)" "unprognostic (3.74e-2)" "unprognostic (2.55e-1)" "unprognostic (9.30e-3)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (1.46e-1)" "unprognostic (2.28e-2)" "unprognostic (9.96e-4)" 0.8 2.3 6.4 0.9 4.8 0.8 1.9 7.8 6.8 0.9 0.7 2.1 1.6 0.7 1.4 14.8 3.0 2.4 1.3 5.4 4.3 4.8 1.2 0.7 0.7 2.4 3.7 4.4 1.3 3.8 2.4 1.1 0.8 3.9 1.4 0.7 1.5 2.3 2.3 45.1 13.3 0.6 1.3 1.6 1.3 0.7 31.9 0.7 1.4 1.6 5.3 1.9 1.6 1.5 0.4 30.9 0.0 1.7 0.0 0.0 0.3 2.7 0.1 1.6 1.7 0.8 1.6 1.2 0.3 0.8 0.3 1.0 1.2 0.8 0.4 0.5 0.8 0.9 5.1 1.1 4.8 0.4 0.0 2.8 0.8 0.2 0.2 1.0 0.0 0.2 1.8 3.2 0.9 4.9 1.1 2.2 0.2 1.0 0.0 1.2 2.9 0.0 0.0 1.7 1.5 2.4 0.1 0.2 0.0 2.9 0.1 0.8 0.2 0.6 4.6 1.4 2.4 20.4 0.0 1.2 0.3 3.0 0.0 0.2 0.1 0.0 0.0 2.5 0.6 2.7 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 1.7 30.9 0.0 0.3 6.4 4.8 7.8 6.8 4.3 4.8 3.7 4.4 3.9 0.7 0.0 0.3 0.0 3.5 1.9 3.1 4.8 0.0 0.0 1.2 1.8 9.8 0.9 8.3 2.0 105.4 2.2 0.5 0.0 3.7 1.1 1.3 3.3 0.0 0.0 0.6 0.0 0.0 0.6 0.8 189.5 2.8 1.8 0.0 1.0 0.7 19.0 1.6 3.2 2.5 0.6 8.4 6.5 2.7 2.3 11.5 2.5 0.5 0.0 0.6 2.3 PPM1K "BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm" ENSG00000163644 "Protein phosphatase, Mg2+/Mn2+ dependent 1K" Q8N3J5 4 88257620-88284769 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 59.1" "Cell type enhanced" "Detected in all" 12 "Cardiomyocytes: 417.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 27.5;Karpas-707: 24.0;U-698: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020066, HPA020862, HPA023891" Approved Supported Mitochondria No No Mitochondria "HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630" "unprognostic (2.38e-2)" "unprognostic (5.86e-2)" "unprognostic (7.42e-3)" "unprognostic (6.70e-3)" "unprognostic (1.18e-1)" "unprognostic (1.17e-3)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (5.50e-2)" "unprognostic (1.41e-2)" "unprognostic (9.25e-3)" "unprognostic (6.56e-2)" "unprognostic (9.82e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.11e-1)" "unprognostic (2.28e-1)" 3.6 6.1 19.2 8.8 17.2 5.9 9.3 21.1 26.8 12.9 3.8 12.5 2.5 3.0 21.8 5.5 7.6 14.1 6.0 59.1 23.1 14.6 11.8 5.1 6.5 14.5 21.6 15.9 22.0 7.3 10.4 8.4 6.4 17.0 11.1 4.3 4.7 7.1 5.3 8.3 1.9 6.7 18.2 15.0 10.9 5.4 12.3 19.4 7.3 5.4 1.9 15.8 6.5 8.1 31.8 38.8 5.5 3.4 7.9 16.1 7.1 2.2 0.7 2.8 5.0 4.3 5.6 1.1 3.5 6.4 11.8 14.0 5.7 0.5 27.5 3.9 2.2 5.7 0.2 8.4 2.7 4.7 21.2 3.5 4.9 2.2 5.1 3.3 6.7 2.6 3.7 1.3 7.2 6.3 2.4 1.9 11.9 7.3 24.0 3.4 3.1 8.8 3.7 1.7 1.6 1.1 5.0 4.7 10.5 4.1 0.9 2.2 1.9 2.2 0.2 2.6 4.9 11.4 1.9 0.4 4.1 2.1 1.3 2.0 7.6 6.9 23.0 4.5 5.5 6.8 5.5 2.9 2.3 12.4 3.4 16.1 30.4 11.8 12.4 5.5 31.8 11.7 14.1 0.9 7.9 0.9 38.8 13.3 7.1 19.2 17.2 21.1 26.8 23.1 14.6 21.6 15.9 17.0 19.4 44.7 11.3 104.3 16.5 8.8 97.4 417.4 7.6 24.1 17.0 47.1 17.7 9.4 132.6 5.9 6.1 17.6 2.0 46.7 5.4 2.6 28.3 31.2 18.5 22.1 23.1 81.0 9.2 20.3 11.1 6.2 22.2 13.9 20.3 111.0 15.6 19.2 6.3 4.9 29.7 39.1 14.1 25.8 38.7 35.6 21.3 4.6 2.4 54.8 2.9 5.7 PPM1N FLJ40125 ENSG00000213889 "Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)" Q8N819 19 45488777-45502510 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 43.7;skeletal muscle: 81.9" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 29.5;Extravillous trophoblasts: 60.2;Rod photoreceptor cells: 73.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "non-classical monocyte: 43.7" "Lineage enriched" "Detected in all" 10 "monocytes: 43.7" "Cell line enhanced" "Detected in many" "OE19: 16.9;RT4: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043577 Supported Vesicles NA NA Vesicles "HPA043577: " "unprognostic (2.38e-2)" "unprognostic (1.11e-2)" "unprognostic (8.53e-2)" "unprognostic (6.59e-2)" "unprognostic (4.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-3)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-16)" "unprognostic (3.42e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (1.86e-3)" 1.7 0.9 5.4 1.2 4.5 1.3 1.9 0.7 4.1 1.3 1.7 0.1 0.7 0.6 1.5 1.0 2.2 0.8 1.0 0.9 3.3 2.3 1.2 1.5 1.5 1.6 2.6 2.2 0.8 0.5 1.3 1.4 2.4 2.7 2.3 1.0 10.6 1.5 1.4 81.9 2.4 1.4 2.6 3.4 15.7 1.7 2.9 3.5 2.5 0.9 0.0 2.4 4.0 1.9 1.9 4.3 2.3 43.7 1.1 2.9 1.9 1.9 5.0 0.9 3.8 4.4 5.9 11.0 1.4 2.2 0.4 1.7 1.2 11.7 7.9 2.4 1.3 3.0 5.5 2.2 1.6 0.7 7.7 3.2 6.3 2.0 1.4 1.1 0.5 13.4 2.5 2.5 2.2 1.3 2.9 0.7 3.1 7.1 7.2 0.8 1.3 2.2 3.4 3.0 16.9 1.1 1.4 1.1 2.2 2.4 21.3 4.3 5.1 0.7 8.1 6.2 6.8 2.8 1.9 1.0 6.2 3.8 3.0 1.0 1.2 3.1 1.6 4.5 1.6 5.4 1.7 1.6 1.0 2.2 7.2 2.0 1.9 1.4 2.2 4.3 1.3 1.6 2.9 2.3 1.1 43.7 0.8 1.5 1.9 5.4 4.5 0.7 4.1 3.3 2.3 2.6 2.2 2.7 3.5 0.0 2.4 10.4 8.5 3.1 9.5 1.6 2.5 0.0 1.2 3.5 29.5 2.7 0.0 2.5 12.0 1.8 5.2 0.0 1.6 60.2 3.8 5.0 6.9 0.8 16.7 1.6 2.9 4.9 10.1 4.5 0.9 14.1 1.7 1.8 3.1 8.1 3.2 2.5 0.7 0.3 73.0 0.0 0.9 1.0 9.8 3.6 7.1 6.9 2.5 7.6 PPME1 PME-1 ENSG00000214517 "Protein phosphatase methylesterase 1" Q9Y570 11 74171099-74254703 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 69.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 92.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004541, HPA043900, HPA064396" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 16000 Nucleoplasm "Nuclear bodies" "CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254" "unprognostic (2.99e-2)" "unprognostic (1.27e-2)" "unprognostic (2.28e-1)" "unprognostic (1.98e-1)" "unprognostic (9.26e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (4.45e-6)" "unprognostic (2.31e-2)" "unprognostic (7.92e-2)" "unprognostic (9.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.84e-1)" "unprognostic (1.54e-1)" "unprognostic (4.14e-3)" "unprognostic (1.33e-3)" 9.4 16.1 13.3 6.2 27.6 8.4 9.3 27.4 38.5 11.4 9.2 13.5 9.4 7.1 13.1 16.5 13.5 15.2 8.9 12.8 14.6 18.3 12.3 6.5 8.2 5.5 13.6 18.6 12.4 10.4 69.0 13.6 15.5 22.4 15.1 9.8 9.6 11.9 15.9 21.0 16.2 7.4 13.4 12.7 5.0 8.3 22.9 9.3 8.6 14.9 7.9 8.5 11.4 10.2 7.5 11.3 10.9 9.6 12.2 14.0 8.4 10.1 13.3 9.1 9.6 9.6 7.9 9.0 15.0 9.9 28.4 22.5 29.3 6.8 5.4 10.5 11.1 15.8 17.0 13.5 10.2 26.7 7.6 5.2 8.1 14.5 12.5 19.0 5.9 7.2 7.6 8.4 15.0 6.6 11.1 8.2 7.8 18.8 4.6 49.5 6.7 6.9 6.3 7.2 12.5 10.6 8.2 92.7 8.2 10.7 7.1 12.4 10.7 17.9 8.2 21.0 9.9 15.0 6.1 5.0 11.4 13.6 10.9 11.4 8.7 11.0 9.6 8.4 5.3 9.2 1.3 8.6 10.9 10.8 9.6 13.3 6.9 13.8 12.7 10.8 7.5 14.0 11.2 5.0 12.2 8.5 11.3 9.7 8.4 13.3 27.6 27.4 38.5 14.6 18.3 13.6 18.6 22.4 9.3 26.8 10.9 9.0 17.3 18.0 29.2 15.3 7.6 36.1 30.7 33.2 35.3 10.9 14.9 14.1 36.8 11.4 10.9 70.0 11.8 27.4 13.1 16.6 8.1 7.4 11.8 31.8 24.6 8.0 5.7 10.9 12.7 13.2 3.3 13.6 11.9 15.0 12.8 10.8 23.7 10.1 18.2 6.5 17.0 60.5 41.0 21.8 12.9 10.4 10.7 15.4 PPP1CA "PP-1A, PP1A, PP1alpha, PPP1A" ENSG00000172531 "Protein phosphatase 1 catalytic subunit alpha" P62136 11 67398183-67421183 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 177.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004545, HPA046833" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 8100000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB004545: AB_628177, HPA046833: AB_2679829" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.51e-2)" "unprognostic (3.15e-3)" "unprognostic (3.93e-2)" "unprognostic (2.07e-1)" "unprognostic (3.89e-2)" "unprognostic (5.05e-3)" "unprognostic (8.00e-2)" "unprognostic (1.66e-1)" "unprognostic (9.96e-2)" "unprognostic (7.69e-2)" "prognostic favorable (1.17e-4)" "unprognostic (7.60e-2)" 28.4 35.4 24.2 42.0 32.3 42.1 25.1 19.6 33.4 23.9 39.6 22.1 29.9 33.9 19.6 25.8 59.7 22.8 28.6 33.0 21.8 17.1 43.7 55.0 27.6 49.3 19.9 19.9 20.1 53.3 23.1 21.6 44.0 19.3 27.2 33.2 23.2 49.7 31.1 39.0 34.4 47.3 20.5 21.3 53.7 35.1 15.7 19.4 77.7 38.5 40.5 63.9 25.5 25.7 78.8 76.6 126.2 118.0 68.2 113.9 177.2 45.3 52.4 31.1 45.8 15.5 19.0 31.7 22.5 26.4 45.4 34.5 74.9 54.8 39.1 38.4 34.1 33.8 39.8 35.9 46.8 27.9 41.1 24.4 37.5 24.7 39.2 33.9 47.6 48.5 21.4 31.0 38.6 22.8 21.6 45.5 38.3 34.8 32.4 36.7 103.5 60.3 93.6 51.6 86.5 41.5 42.9 43.0 33.8 44.6 37.6 24.3 40.4 26.1 46.9 69.4 24.3 56.1 33.0 32.4 35.1 35.9 41.3 29.1 32.5 30.1 44.4 42.0 32.7 36.9 81.4 80.1 126.2 88.6 100.5 69.3 78.8 79.8 90.5 76.6 77.0 49.1 69.2 93.3 68.2 118.0 54.4 113.9 177.2 24.2 32.3 19.6 33.4 21.8 17.1 19.9 19.9 19.3 19.4 71.5 93.0 166.0 108.0 88.8 35.0 7.9 117.2 41.5 46.6 82.0 9.8 320.7 180.8 238.7 1.8 77.3 292.4 23.3 272.4 398.0 69.2 127.9 107.3 102.4 338.5 41.3 93.0 87.2 194.1 5.3 45.5 157.2 129.9 390.5 160.1 42.9 250.4 210.5 26.9 236.5 23.6 97.0 60.9 13.0 106.5 106.3 357.3 222.6 164.6 168.4 PPP1R11 "CFAP255, HCG-V, HCGV, TCTE5, Tctex5" ENSG00000204619 "Protein phosphatase 1 regulatory inhibitor subunit 11" O60927 6 30066709-30070333 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 93.3" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 578.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 18.8;AN3-CA: 25.1;HBEC3-KT: 15.7;HEL: 15.1;JURKAT: 29.4;RPTEC TERT1: 17.5;U-266/84: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043266, HPA060174" Approved Approved Vesicles NA NA Vesicles "HPA043266: AB_2678400, HPA060174: AB_2684216" "unprognostic (2.00e-2)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (4.24e-2)" "unprognostic (3.45e-1)" "unprognostic (1.05e-1)" "unprognostic (1.77e-2)" "unprognostic (1.18e-1)" "unprognostic (2.81e-1)" "unprognostic (1.74e-3)" "unprognostic (3.33e-2)" "unprognostic (2.68e-1)" "unprognostic (8.36e-3)" "unprognostic (1.74e-1)" "unprognostic (3.31e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-3)" 36.0 18.2 18.5 8.3 21.6 4.4 12.9 9.8 31.7 11.0 27.0 17.3 7.9 33.2 16.0 93.3 26.8 33.7 23.9 16.8 16.6 17.6 18.2 22.6 12.9 13.2 15.5 14.5 26.2 33.1 5.9 8.8 21.1 14.6 13.6 4.6 14.0 20.4 8.8 39.0 37.0 28.6 9.4 13.4 16.0 27.2 18.1 11.4 16.9 20.6 10.9 29.6 15.8 12.4 2.6 2.7 4.4 3.5 0.8 3.2 1.8 18.8 0.0 0.0 25.1 11.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 12.1 0.0 0.0 15.7 0.0 0.0 12.9 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.5 8.2 0.0 0.0 0.0 8.5 0.2 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 16.7 7.3 0.0 0.0 0.0 2.9 2.6 4.4 1.7 3.5 2.0 2.1 1.9 3.1 1.3 2.6 2.7 2.1 2.9 0.8 2.9 2.7 3.2 1.8 18.5 21.6 9.8 31.7 16.6 17.6 15.5 14.5 14.6 11.4 17.9 19.8 58.2 65.2 46.9 29.4 15.0 43.3 24.1 19.4 38.4 5.9 51.3 81.2 116.6 185.3 36.0 115.4 0.0 120.0 106.5 33.8 60.5 77.3 26.0 59.8 12.7 51.5 36.8 38.6 578.9 30.0 49.9 59.1 73.1 76.9 44.8 105.0 77.2 37.8 70.2 30.1 38.8 48.4 51.5 22.6 58.2 62.9 66.0 52.1 78.8 PPP1R12B "MGC131980, MGC87886, MYPT2, PP1bp55" ENSG00000077157 "Protein phosphatase 1 regulatory subunit 12B" O60237 1 202348699-202592706 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 105.2" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 719.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 15.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024171, HPA024640" Enhanced Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA024171: AB_1854266, HPA024640: AB_1854265" "unprognostic (5.24e-2)" "unprognostic (8.59e-2)" "unprognostic (1.38e-1)" "unprognostic (2.75e-2)" "unprognostic (3.04e-1)" "unprognostic (5.45e-3)" "unprognostic (3.12e-2)" "unprognostic (9.13e-3)" "unprognostic (4.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (3.60e-3)" "unprognostic (6.98e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" 10.6 2.8 6.9 8.1 9.0 1.8 7.7 13.9 10.5 55.3 62.0 15.0 31.0 5.8 105.2 9.4 37.4 21.9 17.4 83.1 5.8 4.5 5.0 2.9 8.1 4.2 10.1 9.2 18.7 2.3 2.0 4.5 8.4 9.5 36.4 16.3 13.7 5.7 50.3 17.6 5.3 14.1 59.5 7.3 6.9 20.8 3.4 11.1 1.3 5.0 11.2 3.5 35.1 11.4 2.3 1.7 15.9 1.8 0.7 1.7 0.5 2.6 5.3 4.1 3.9 5.8 4.2 6.7 2.1 2.1 2.2 2.1 2.2 4.7 3.0 1.0 3.9 5.3 8.4 6.0 3.2 2.4 3.8 3.7 3.0 7.7 1.4 1.4 6.3 3.4 3.3 3.7 3.1 3.3 11.3 1.8 3.4 4.4 3.5 3.8 2.0 4.7 4.0 2.8 2.9 1.1 3.1 10.5 4.3 1.8 9.6 5.0 3.8 4.0 4.8 2.4 5.6 4.2 2.9 2.3 3.1 1.9 2.3 1.8 5.2 4.8 3.2 2.9 5.2 12.3 1.8 1.8 1.3 1.7 0.9 1.4 1.7 1.1 1.0 1.4 2.3 1.4 1.0 15.9 0.7 1.4 1.7 1.6 0.5 6.9 9.0 13.9 10.5 5.8 4.5 10.1 9.2 9.5 11.1 11.9 17.5 3.7 31.2 15.3 56.6 719.4 12.7 16.0 18.2 12.2 70.7 12.7 10.0 7.2 30.9 9.2 21.3 0.0 11.3 7.2 19.0 16.4 17.4 6.8 7.8 25.4 23.1 20.9 18.5 10.9 11.2 6.0 8.5 1.8 14.0 11.8 6.3 11.5 48.1 4.5 32.3 32.3 105.4 11.9 13.7 9.5 21.3 11.5 30.2 28.9 PPP1R13L "IASPP, RAI" ENSG00000104881 "Protein phosphatase 1 regulatory subunit 13 like" Q8WUF5 19 45379634-45406349 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 78.3" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 77.1;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.6;hTCEpi: 52.2;hTERT-HME1: 36.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB005016, HPA041231, HPA059883" Approved Enhanced Cytosol NA Yes Cytosol "CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151" "unprognostic (1.87e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (2.92e-1)" "unprognostic (3.74e-1)" "unprognostic (2.06e-2)" "unprognostic (1.31e-3)" "prognostic unfavorable (3.39e-5)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.40e-4)" "unprognostic (2.52e-3)" "unprognostic (1.92e-2)" "unprognostic (1.55e-3)" "unprognostic (1.34e-1)" "unprognostic (7.69e-2)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" 6.7 6.6 2.5 3.6 4.1 0.6 14.5 3.5 3.4 13.2 6.2 2.4 8.5 2.9 5.8 8.2 51.6 3.6 4.7 37.2 4.0 1.2 8.0 5.7 8.5 1.6 3.9 2.5 4.4 12.4 6.6 6.6 38.7 3.9 11.5 3.8 5.1 17.8 15.7 3.8 78.3 7.1 3.8 3.3 2.5 4.4 1.6 6.1 2.7 10.6 24.4 25.6 13.2 22.9 0.6 0.7 0.0 1.5 0.0 2.3 0.2 21.2 3.0 1.2 1.0 1.3 0.8 18.5 3.8 0.6 4.8 6.7 6.0 19.8 2.5 1.7 3.0 9.9 28.4 1.0 35.6 4.4 6.5 1.5 0.3 9.8 2.2 2.8 0.2 0.9 1.1 52.2 7.6 36.2 21.7 8.9 2.1 2.1 0.9 0.3 17.4 0.4 0.4 1.4 9.7 5.0 1.9 1.5 0.4 6.2 25.5 0.6 2.2 19.7 18.9 0.4 8.5 16.5 0.5 13.6 6.1 18.7 0.4 18.7 10.6 10.9 1.6 0.9 0.7 1.5 0.0 0.0 0.0 1.5 0.4 0.7 0.6 2.3 0.4 0.2 0.2 0.1 0.7 0.0 0.0 1.5 0.7 1.3 0.2 2.5 4.1 3.5 3.4 4.0 1.2 3.9 2.5 3.9 6.1 32.8 8.8 0.5 77.1 61.0 2.0 34.3 20.4 8.1 22.7 19.2 9.8 69.5 5.0 28.4 0.5 11.2 15.4 0.0 13.4 33.0 6.1 31.1 4.6 2.1 6.7 0.0 6.9 8.0 2.6 0.2 5.5 2.7 11.8 1.8 6.2 2.2 35.6 14.0 11.7 2.7 25.6 6.5 10.4 2.9 1.9 62.0 107.4 0.7 7.1 62.2 PPP1R14C "CPI17-like, KEPI, NY-BR-81" ENSG00000198729 "Protein phosphatase 1 regulatory inhibitor subunit 14C" Q8TAE6 6 150143076-150250357 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 50.0;skeletal muscle: 32.0;skin 1: 37.1;thyroid gland: 32.4" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 248.9;Suprabasal keratinocytes: 294.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 6 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HaCaT: 15.7;HBEC3-KT: 33.3;HEK 293: 14.1;hTCEpi: 40.7;hTERT-HME1: 16.4;RPTEC TERT1: 14.0;SK-BR-3: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.81e-3)" "unprognostic (7.65e-2)" "unprognostic (4.25e-3)" "unprognostic (6.92e-2)" "unprognostic (3.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.81e-3)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (5.13e-2)" "unprognostic (4.50e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.98e-1)" "unprognostic (7.49e-3)" "unprognostic (6.77e-2)" 0.3 0.4 4.2 1.9 7.7 0.3 3.7 1.3 12.8 4.5 6.8 0.8 0.0 5.7 1.0 0.7 8.0 9.0 0.3 50.0 4.7 3.7 5.3 0.3 6.7 0.4 2.7 7.6 0.2 0.5 4.7 0.8 13.9 7.7 0.9 5.0 0.1 1.5 0.3 32.0 37.1 1.2 0.7 1.3 0.3 0.7 3.5 1.0 0.0 32.4 8.8 3.2 0.4 8.3 0.0 0.0 0.0 0.2 0.0 1.2 0.1 10.4 0.0 4.6 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.5 1.4 0.2 3.1 2.0 0.7 15.7 2.3 33.3 0.0 0.0 14.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 40.7 0.0 16.4 0.0 0.0 0.2 8.7 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 14.0 0.5 2.4 0.0 0.2 14.8 0.8 0.3 0.0 0.7 0.0 0.0 8.0 12.7 3.6 0.0 0.0 0.0 5.6 6.1 0.7 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 4.2 7.7 1.3 12.8 4.7 3.7 2.7 7.6 7.7 1.0 17.9 37.9 0.0 8.9 248.9 0.6 64.6 0.0 44.2 17.0 14.0 0.0 0.1 1.7 2.4 0.2 2.8 13.5 0.0 0.2 0.1 5.7 1.2 1.1 0.0 2.9 1.6 27.1 0.0 0.0 1.1 0.0 1.7 28.7 1.8 2.5 0.0 7.5 37.9 0.4 18.3 0.0 0.0 4.1 0.5 0.4 294.2 1.6 0.0 8.4 1.4 PPP1R14D "CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016" ENSG00000166143 "Protein phosphatase 1 regulatory inhibitor subunit 14D" Q9NXH3 15 40815445-40828709 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 71.3" "Cell type enhanced" "Detected in some" 20 "Enterocytes: 300.2;Intestinal endocrine cells: 58.9;Mucus-secreting cells: 61.7;Paneth cells: 192.9;Undifferentiated cells: 90.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 45.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.6;RPMI-8226: 6.7;RT4: 4.3;SK-BR-3: 2.8;T-47d: 2.6;U-266/84: 4.5" "Not detected" "Not detected" HPA041846 Uncertain NA NA "HPA041846: AB_10794307" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (5.91e-3)" "unprognostic (1.17e-2)" "unprognostic (4.68e-2)" "unprognostic (1.89e-1)" "unprognostic (7.74e-2)" "unprognostic (2.86e-1)" "unprognostic (5.26e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.55e-1)" "unprognostic (1.43e-2)" "unprognostic (3.74e-3)" "unprognostic (3.11e-2)" 0.2 0.1 0.2 13.6 0.2 0.0 0.3 0.3 0.2 0.2 33.6 0.2 0.2 33.9 0.2 0.3 0.3 0.4 10.0 0.2 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.5 28.9 0.2 0.5 0.2 0.2 0.3 71.3 0.8 0.2 0.2 0.4 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 1.2 1.1 0.4 1.9 0.3 1.0 0.2 0.1 0.8 0.1 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 2.1 0.3 0.3 0.0 0.4 0.3 0.0 0.2 0.0 0.3 0.2 0.2 0.5 3.6 0.0 0.5 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.2 1.2 0.0 0.5 0.1 0.4 0.1 2.3 0.0 0.1 0.4 6.7 0.0 4.3 1.2 0.8 0.0 2.8 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.1 0.0 0.2 4.5 0.8 0.1 0.1 0.0 0.4 1.2 0.1 0.6 0.9 0.3 0.1 1.0 0.3 0.1 1.2 0.6 0.8 0.4 0.3 1.9 1.1 0.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.0 1.8 0.0 0.2 0.0 0.8 0.0 0.0 300.2 0.0 4.9 0.0 0.0 0.2 4.6 0.0 0.1 0.0 58.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.7 0.0 2.0 192.9 0.0 24.5 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 90.6 0.1 PPP1R15A GADD34 ENSG00000087074 "Protein phosphatase 1 regulatory subunit 15A" O75807 19 48872392-48876057 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 156.9" "Cell type enhanced" "Detected in all" 4 "Smooth muscle cells: 862.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.8" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 69.8" "Cell line enhanced" "Detected in all" "HHSteC: 55.5;hTERT-HME1: 95.7" "Low region specificity" "Detected in all" "CAB018395, HPA020240" Approved Uncertain Vesicles NA NA Vesicles "CAB018395: AB_2237473, HPA020240: AB_1849404" "unprognostic (2.43e-3)" "unprognostic (3.21e-1)" "unprognostic (7.75e-2)" "unprognostic (1.17e-3)" "unprognostic (2.22e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.22e-1)" "unprognostic (6.43e-3)" "unprognostic (1.49e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" 39.8 29.1 16.2 33.6 12.9 156.9 56.3 12.1 12.8 26.3 19.7 13.6 12.0 12.0 37.8 19.5 28.2 34.0 32.3 42.0 14.6 13.9 18.6 18.6 56.5 10.6 29.5 6.3 24.5 10.9 9.8 16.2 44.7 31.5 28.2 15.6 12.4 9.2 23.6 35.2 40.0 16.0 36.2 17.7 13.3 19.8 14.5 17.8 3.4 18.6 46.7 19.0 41.1 114.7 8.1 23.8 69.8 10.3 2.5 6.1 6.6 10.1 4.4 4.7 3.9 13.9 7.9 7.5 17.8 28.0 20.4 18.6 6.7 5.2 3.5 4.8 12.8 28.1 7.3 1.7 9.3 15.5 1.9 2.7 15.9 2.5 3.3 55.5 3.6 22.9 10.8 25.9 28.1 95.7 9.2 10.6 4.0 21.3 29.6 13.1 1.1 2.0 5.1 1.1 18.5 8.0 2.3 4.4 1.1 4.2 11.9 2.7 4.6 9.2 6.3 40.3 5.2 2.2 6.6 11.3 24.4 6.1 17.0 10.9 15.9 12.6 3.3 8.9 2.5 29.2 27.4 10.3 17.7 4.9 6.3 4.3 8.1 4.8 4.0 7.3 5.5 2.7 2.4 69.8 2.5 7.1 23.8 6.1 6.6 16.2 12.9 12.1 12.8 14.6 13.9 29.5 6.3 31.5 17.8 268.0 205.4 97.6 586.8 428.3 24.0 122.8 56.0 235.5 175.1 12.2 33.4 76.9 3.3 199.0 3.9 212.9 352.3 46.7 84.3 175.7 303.2 750.2 686.4 11.0 180.2 33.4 163.8 100.7 105.3 3.6 54.4 379.2 376.2 163.3 114.7 30.7 160.5 315.6 21.5 6.2 26.9 84.1 862.1 4.9 11.1 376.8 241.2 156.6 127.8 653.4 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 23.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 167.9;Proximal tubular cells: 269.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 26.1" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 3.0 3.8 6.5 3.1 6.8 2.2 3.0 3.3 4.8 3.0 11.1 3.0 3.0 20.5 3.0 3.0 3.0 6.7 3.0 3.0 6.5 4.6 6.5 5.3 3.0 3.0 3.1 3.0 3.0 5.7 4.0 10.2 3.0 3.0 3.4 1.6 3.0 5.4 4.5 3.4 3.7 23.3 3.0 3.0 3.0 7.8 7.4 3.0 3.0 6.8 3.0 3.0 3.0 3.0 2.5 3.2 0.7 4.1 0.7 3.2 2.1 15.8 12.9 2.1 8.2 0.9 1.5 10.6 4.4 2.8 3.4 2.8 3.4 11.4 2.6 11.6 1.6 3.1 10.5 1.1 3.6 0.5 5.3 6.4 3.1 12.5 3.5 2.6 2.2 4.3 1.5 4.9 4.0 1.1 2.2 2.4 4.4 12.3 3.3 1.2 26.1 7.9 10.4 4.0 8.2 16.4 8.3 1.0 5.2 3.1 5.3 6.8 13.1 8.0 7.4 6.6 0.5 17.5 4.8 4.1 3.9 18.4 10.8 8.3 2.2 2.1 0.9 12.6 4.3 3.5 0.0 2.3 0.0 3.2 3.4 2.8 2.5 2.3 2.9 3.2 0.5 1.7 3.1 0.7 0.7 4.1 1.8 1.7 2.1 6.5 6.8 3.3 4.8 6.5 4.6 3.1 3.0 3.0 3.0 3.0 12.5 7.3 31.2 38.4 23.1 75.5 101.9 32.1 17.0 38.4 13.7 6.0 102.8 26.8 8.2 10.5 167.9 0.0 36.4 19.6 9.1 37.1 3.5 156.2 5.4 28.6 49.5 10.4 7.6 9.5 21.0 12.3 8.5 2.8 69.6 87.7 27.8 95.1 14.5 269.6 48.8 6.5 13.3 58.4 27.0 54.1 5.6 6.2 83.9 21.8 PPP1R16B "ANKRD4, KIAA0823, TIMAP" ENSG00000101445 "Protein phosphatase 1 regulatory subunit 16B" Q96T49 20 38805705-38923024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 35.0;Ito cells: 32.5;monocytes: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 22.7;HMC-1: 24.5;HUVEC TERT2: 14.5;U-266/70: 39.9;U-266/84: 16.0;U-698: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049571, HPA079512" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA049571: , HPA079512: " "unprognostic (2.62e-2)" "prognostic favorable (2.11e-4)" "unprognostic (2.67e-3)" "unprognostic (3.35e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.87e-5)" "unprognostic (1.13e-1)" "unprognostic (4.17e-2)" "unprognostic (4.31e-2)" "unprognostic (6.28e-2)" "unprognostic (4.09e-3)" "unprognostic (4.77e-2)" "unprognostic (3.45e-2)" "unprognostic (8.53e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.90e-2)" 11.2 3.2 26.3 15.9 44.4 13.0 4.4 19.7 35.1 3.6 4.5 25.6 0.0 3.6 3.5 1.9 3.3 5.8 5.3 4.9 25.5 9.1 24.4 2.6 7.3 30.1 15.0 18.8 1.6 1.5 1.2 1.8 3.7 10.9 2.1 5.1 1.6 2.3 2.3 3.4 1.8 9.2 6.8 18.6 14.4 4.9 1.2 15.1 5.1 3.2 0.5 35.0 7.5 3.7 8.4 4.9 3.5 1.3 3.9 5.2 1.6 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.5 0.1 1.7 0.0 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.0 0.0 14.5 3.1 0.3 4.8 0.0 0.0 2.8 3.8 3.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 8.1 0.0 0.0 0.0 0.3 0.0 1.2 2.2 0.0 0.3 0.0 0.0 39.9 16.0 15.6 0.0 0.0 0.0 0.0 0.3 3.5 5.2 0.7 2.8 8.4 3.7 5.1 1.1 5.4 2.2 3.0 0.0 3.9 1.3 4.9 3.7 1.6 26.3 44.4 19.7 35.1 25.5 9.1 15.0 18.8 10.9 15.1 3.0 4.8 8.3 0.0 0.9 1.2 15.2 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 14.6 0.0 0.0 0.0 0.0 0.5 0.0 3.5 0.0 0.1 35.0 0.0 32.5 3.0 0.6 0.0 2.4 8.5 35.1 0.0 0.2 0.0 0.0 0.0 10.8 0.2 0.0 0.3 0.0 0.2 1.1 0.0 15.0 0.0 0.1 PPP1R17 "C7orf16, GSBS" ENSG00000106341 "Protein phosphatase 1 regulatory subunit 17" O96001 7 31686715-31708455 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 10.5;blood: 24.5;brain: 29.7" "Group enriched" "Detected in some" 126 "Early spermatids: 30.6;Late spermatids: 68.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in many" 6 "cerebellum: 29.7;hypothalamus: 8.5" "Cell type enriched" "Detected in some" 4 "non-classical monocyte: 24.5" "Lineage enriched" "Detected in many" 19 "monocytes: 24.5" "Group enriched" "Detected in some" 197 "NTERA-2: 15.7;SCLC-21H: 47.7" "Region enriched" "Detected in some" 32 "cerebellum: 483.2" "Region enriched" "Detected in many" 4 "cerebellum: 339.5" "HPA047819, HPA073123" Enhanced NA NA "HPA047819: AB_2680166, HPA073123: AB_2732219" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "unprognostic (6.56e-2)" "unprognostic (5.55e-2)" "unprognostic (2.33e-1)" 0.6 10.5 0.9 0.6 1.3 0.8 0.1 29.7 4.6 0.1 0.1 1.7 0.0 0.1 0.8 0.3 0.1 0.1 0.1 0.4 0.6 8.5 0.1 0.2 1.1 0.1 1.1 0.9 0.1 0.1 0.1 2.9 0.1 2.6 0.3 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.4 1.0 0.3 0.3 1.7 3.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 1.2 0.0 24.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.4 0.9 1.3 29.7 3.3 0.6 8.5 1.1 0.9 2.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 68.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 PPP1R18 "KIAA1949, phostensin" ENSG00000146112 "Protein phosphatase 1 regulatory subunit 18" Q6NYC8 6 30676389-30687895 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.5" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 175.4;monocytes: 233.6;T-cells: 186.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "eosinophil: 54.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.5" "Cell line enhanced" "Detected in many" "HMC-1: 35.0;U-937: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044745, HPA051000" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA044745: AB_2679070, HPA051000: AB_2681304" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.01e-1)" "unprognostic (2.11e-2)" "unprognostic (1.59e-2)" "unprognostic (2.90e-2)" "unprognostic (3.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (3.61e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (9.33e-2)" "unprognostic (4.76e-2)" 17.2 7.1 5.6 24.7 7.9 34.0 16.1 1.7 4.7 12.6 15.9 6.2 4.6 5.3 17.5 7.3 11.5 10.9 13.9 10.1 6.5 3.4 6.1 8.3 20.2 44.9 7.2 1.8 14.9 4.0 2.3 2.9 13.3 6.0 11.2 3.7 7.3 7.9 6.1 6.6 9.5 11.3 13.9 9.8 37.4 9.1 4.9 6.2 48.2 7.8 7.8 23.6 18.2 18.0 4.2 3.4 54.5 4.1 10.2 11.9 5.2 10.0 1.6 6.0 7.2 4.3 11.6 0.2 6.0 7.0 5.3 3.6 1.2 2.0 9.8 5.5 10.5 12.0 6.7 3.0 6.6 2.8 8.2 0.6 23.6 2.9 1.2 3.4 6.1 35.0 7.1 7.7 13.1 11.8 6.3 4.3 16.6 4.3 4.9 6.2 1.1 8.7 12.1 0.0 0.3 0.4 27.8 5.3 8.0 3.1 0.6 0.4 2.0 5.6 2.2 11.1 0.3 1.6 8.4 14.2 21.0 5.3 0.0 14.9 1.8 9.6 12.1 6.0 36.4 24.5 8.1 2.8 54.5 11.7 4.1 8.5 3.1 5.7 11.9 1.8 4.2 4.7 9.0 13.2 10.2 3.0 3.4 9.4 5.2 5.6 7.9 1.7 4.7 6.5 3.4 7.2 1.8 6.0 6.2 3.0 20.7 66.3 25.5 96.9 1.3 2.8 10.2 6.7 4.5 8.7 0.0 2.5 0.0 20.1 23.9 64.4 0.4 0.0 7.1 17.8 32.0 15.2 51.9 7.8 175.4 3.2 1.7 30.7 131.5 14.6 25.6 119.9 37.1 233.6 0.5 0.9 18.0 0.0 21.9 1.3 2.9 25.8 79.5 0.5 1.4 52.1 3.3 186.8 0.4 22.5 PPP1R1A ENSG00000135447 "Protein phosphatase 1 regulatory inhibitor subunit 1A" Q13522 12 54575387-54588659 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 67.0;skeletal muscle: 227.2" "Cell type enriched" "Detected in many" 5 "Distal tubular cells: 1142.3" "Cancer enhanced" "Detected in many" "liver cancer: 17.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Group enriched" "Detected in some" 4 "ASC diff: 6.5;NTERA-2: 21.2;RPTEC TERT1: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB007811, HPA041542" Approved NA NA "CAB007811: AB_598171, HPA041542: AB_2677542" "unprognostic (6.39e-3)" "unprognostic (2.61e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.19e-3)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (7.04e-2)" "unprognostic (2.71e-3)" "unprognostic (1.76e-3)" "unprognostic (2.88e-3)" "unprognostic (7.68e-3)" "unprognostic (2.17e-1)" "unprognostic (8.49e-3)" "unprognostic (7.49e-2)" 67.0 2.1 9.9 1.6 33.2 1.3 51.8 2.2 8.2 1.6 4.0 2.9 0.5 2.2 1.7 1.8 4.3 1.6 1.9 34.6 6.6 3.7 35.4 27.5 1.3 1.4 6.4 4.8 3.3 5.6 3.9 0.1 1.2 4.8 2.9 1.8 0.1 3.1 2.3 227.2 1.3 2.4 2.3 2.7 1.3 4.7 1.7 7.8 0.0 1.4 16.6 1.4 1.4 4.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.9 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 21.2 0.0 0.0 0.0 0.0 0.1 23.4 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 33.2 2.2 8.2 6.6 3.7 6.4 4.8 4.8 7.8 0.0 0.0 1.9 0.0 0.1 0.7 215.5 2.5 0.0 0.0 17.4 0.0 0.0 1142.3 2.9 1.5 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 215.6 0.7 106.5 2.4 6.2 3.8 1.3 1.1 0.0 0.0 0.0 0.3 1.4 4.1 0.0 1.1 55.9 2.9 0.0 9.8 0.0 1.7 0.3 0.0 0.0 0.5 0.1 PPP1R1B "DARPP-32, FLJ20940" ENSG00000131771 "Protein phosphatase 1 regulatory inhibitor subunit 1B" Q9UD71 17 39626740-39636626 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 173.9;salivary gland: 105.3" "Cell type enhanced" "Detected in many" 12 "Melanocytes: 128.2;Mucus-secreting cells: 299.8;Undifferentiated cells: 342.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "basal ganglia: 173.9" "Cell type enriched" "Detected in single" 37 "eosinophil: 3.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "ASC diff: 5.5;CAPAN-2: 8.7;HSkMC: 23.1;OE19: 10.7;SCLC-21H: 19.3" "Region enriched" "Detected in many" 8 "basal ganglia: 1113.7" "Region enriched" "Detected in all" 20 "basal ganglia: 1698.9" "CAB004026, HPA048630, HPA061142" Approved Approved NA NA "CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438" "unprognostic (2.71e-1)" "unprognostic (4.09e-2)" "unprognostic (6.91e-3)" "unprognostic (2.42e-1)" "unprognostic (3.01e-1)" "unprognostic (7.69e-2)" "unprognostic (6.00e-3)" "unprognostic (2.76e-2)" "unprognostic (1.75e-2)" "unprognostic (6.13e-2)" "unprognostic (6.07e-2)" "unprognostic (2.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.52e-3)" "unprognostic (1.55e-1)" 26.2 10.0 25.6 5.8 173.9 0.6 23.3 14.6 24.1 7.4 64.1 16.2 39.4 25.7 1.8 2.2 1.9 9.4 4.6 0.7 17.3 11.2 2.0 0.5 5.1 0.5 21.9 22.2 2.6 19.1 0.6 1.7 0.5 17.9 19.9 63.3 6.9 105.3 49.6 0.5 5.7 20.9 4.1 12.4 0.5 13.6 4.6 40.0 0.0 0.5 0.3 0.8 3.6 1.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 3.3 0.1 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 10.7 0.6 0.0 0.0 0.4 0.0 0.0 19.3 0.4 0.0 1.0 0.0 1.8 0.4 0.7 0.0 0.0 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 173.9 14.6 24.1 17.3 11.2 21.9 22.2 17.9 40.0 0.0 26.7 0.0 99.4 1.1 0.3 1.1 0.0 0.0 0.0 1.8 0.0 0.0 102.8 13.3 0.7 0.1 36.6 0.0 3.1 0.0 1.3 59.5 4.6 0.0 0.2 0.0 92.9 3.1 0.0 2.2 31.9 1.0 128.2 0.0 299.8 28.7 1.0 94.7 5.3 0.4 0.9 0.0 0.6 0.5 3.2 0.4 0.0 0.0 342.5 101.6 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 106.6;Late spermatids: 139.1;Spermatocytes: 41.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;JURKAT: 1.1;MOLT-4: 2.1;SiHa: 1.3;SuSa: 1.2;U-266/70: 1.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: AB_2797251" "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 1.2 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.9 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 11.9 5.4 0.0 0.5 0.2 0.8 34.2 10.2 1.4 11.4 3.5 0.0 2.7 1.7 2.3 106.6 0.0 0.0 0.0 9.8 5.6 0.7 0.1 0.0 17.9 0.5 0.0 5.8 0.0 0.3 139.1 5.5 0.0 3.3 6.4 0.3 6.0 14.6 0.0 0.7 0.5 1.9 0.0 0.5 41.8 2.0 0.3 2.1 0.0 0.7 0.9 PPP1R27 "DYSFIP1, toonin" ENSG00000182676 "Protein phosphatase 1 regulatory subunit 27" Q86WC6 17 81833492-81835050 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 211.0" "Cell type enriched" "Detected in some" 10 "Early spermatids: 22.1" "Cancer enriched" "Detected in single" 10 "head and neck cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 23 "HL-60: 63.9;THP-1: 123.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042227, HPA048632" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042227: , HPA048632: AB_2680469" "unprognostic (3.35e-2)" "unprognostic (1.12e-4)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-1)" "unprognostic (1.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.21e-2)" "unprognostic (7.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.98e-6)" "unprognostic (7.97e-2)" "unprognostic (1.21e-1)" "unprognostic (2.19e-3)" "unprognostic (1.30e-1)" 1.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.0 1.7 0.0 211.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 9.6 1.2 0.0 0.0 0.8 0.4 3.2 0.4 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 123.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.2 0.3 0.8 0.3 0.4 3.2 0.7 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 22.1 0.0 2.0 0.0 0.4 2.1 0.2 0.1 0.0 1.0 0.5 0.0 1.2 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.1 1.1 0.0 0.9 0.1 PPP1R2B "MGC87149, PPP1R2P3" ENSG00000231989 "PPP1R2 family member B" 5 156850538-156852528 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 13 "U-266/84: 5.3" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (9.36e-2)" "unprognostic (1.46e-2)" "unprognostic (1.89e-1)" "unprognostic (4.47e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-2)" "unprognostic (1.77e-1)" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-2)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.2 0.3 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.0 36.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 0.5 0.4 0.9 0.5 0.5 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 0.0 0.1 0.0 0.1 0.5 0.1 0.9 0.2 0.5 0.5 0.5 0.6 0.5 0.4 0.2 1.1 0.5 0.6 0.5 0.2 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R2C "I-4, PPP1R2P9" ENSG00000102055 "PPP1R2C family member C" O14990 X 42777368-42778247 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 37.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 38 "testis cancer: 1.8" "Group enriched" "Detected in some" 7 "memory B-cell: 1.2;T-reg: 2.4" "Group enriched" "Detected in many" 18 "B-cells: 1.2;T-cells: 2.4" "Not detected" "Not detected" NA NA "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R32 "C11orf66, FLJ32771, IIIG9" ENSG00000162148 "Protein phosphatase 1 regulatory subunit 32" Q7Z5V6 11 61481120-61490931 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 141.3" "Group enriched" "Detected in many" 7 "Ciliated cells: 95.0;Early spermatids: 216.0;Late spermatids: 279.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039068 Enhanced NA NA "HPA039068: AB_10672840" "unprognostic (1.70e-1)" "unprognostic (3.18e-3)" "unprognostic (4.48e-4)" "prognostic favorable (4.13e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (1.50e-3)" "unprognostic (4.52e-2)" "unprognostic (2.81e-1)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (3.03e-2)" "unprognostic (9.44e-9)" "unprognostic (2.64e-1)" "unprognostic (2.71e-1)" "unprognostic (2.32e-1)" "unprognostic (1.75e-2)" 2.1 1.5 4.7 1.5 11.5 2.2 1.9 2.4 3.2 2.8 1.7 13.6 1.1 1.6 3.1 13.8 1.2 22.3 1.6 1.3 5.9 5.6 1.8 3.2 7.0 3.2 1.7 2.2 5.5 1.4 1.1 5.5 1.8 21.2 1.6 1.1 1.1 1.9 2.3 1.8 5.8 1.5 2.3 1.6 2.9 1.4 141.3 3.1 1.1 1.3 1.1 1.9 1.3 1.7 1.4 1.4 5.6 3.5 2.0 3.8 2.7 0.7 1.5 9.7 4.0 4.4 6.6 1.2 1.9 1.5 1.3 1.0 0.5 8.4 1.8 2.7 0.9 0.5 1.0 1.3 0.7 2.4 2.9 2.0 2.4 0.5 0.3 4.3 1.5 1.9 6.8 2.4 0.5 7.2 7.8 1.0 6.8 0.8 5.7 0.5 2.1 2.3 3.4 0.7 1.6 0.9 4.5 0.2 0.6 1.2 0.4 1.1 2.4 0.3 4.2 0.7 0.8 4.9 5.2 3.5 0.5 2.0 1.5 0.4 9.3 2.4 1.2 1.1 6.7 0.8 3.8 3.0 2.0 3.0 3.5 2.8 1.3 2.0 0.7 1.4 1.4 1.3 3.8 5.6 2.0 1.1 1.1 2.3 2.7 4.7 11.5 2.4 3.2 5.9 5.6 1.7 2.2 21.2 3.1 3.0 0.6 0.5 0.7 0.1 0.5 1.0 0.0 95.0 7.9 5.2 0.0 0.6 26.6 0.3 216.0 1.6 1.0 0.0 1.4 0.3 0.8 1.1 0.0 8.3 0.7 0.0 3.4 0.6 1.5 279.3 3.4 0.8 0.0 1.0 0.6 2.6 0.7 0.0 3.9 13.6 0.1 0.0 1.4 4.3 1.2 0.3 0.3 0.0 0.6 0.5 PPP1R36 C14orf50 ENSG00000165807 "Protein phosphatase 1 regulatory subunit 36" Q96LQ0 14 64549902-64589380 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 37.3" "Group enriched" "Detected in many" 9 "Early spermatids: 280.9;Late spermatids: 602.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 18.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077492 Enhanced NA NA "HPA077492: AB_2732348" "unprognostic (3.43e-4)" "unprognostic (5.75e-2)" "unprognostic (4.48e-2)" "unprognostic (6.04e-4)" "unprognostic (1.12e-2)" "unprognostic (9.37e-2)" "unprognostic (1.52e-3)" "unprognostic (9.21e-2)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" "unprognostic (2.42e-1)" "unprognostic (1.17e-1)" "unprognostic (4.80e-3)" "unprognostic (9.77e-3)" "unprognostic (3.53e-1)" "unprognostic (7.12e-2)" "unprognostic (5.46e-2)" 1.5 0.3 0.7 1.3 1.6 0.0 1.0 0.2 1.1 1.1 6.0 1.4 0.5 5.1 0.6 2.4 0.4 8.9 2.7 0.7 1.1 1.1 2.5 0.5 1.4 0.0 1.5 0.0 2.2 8.3 0.6 2.9 1.1 2.9 0.5 4.0 0.8 6.5 0.6 0.7 0.8 6.7 0.0 2.8 0.5 5.3 37.3 0.7 0.0 0.3 1.2 0.5 1.2 0.8 0.0 0.6 0.4 0.4 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.1 0.3 0.0 0.3 0.8 0.0 18.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 3.7 0.2 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 1.0 0.0 1.6 1.1 0.6 0.0 0.1 1.4 0.4 0.5 0.2 0.5 1.8 0.0 0.7 1.6 0.2 1.1 1.1 1.1 1.5 0.0 2.9 0.7 0.0 1.1 0.0 0.5 0.5 0.0 0.6 2.5 49.5 10.3 3.5 0.0 0.4 1.7 0.6 280.9 3.6 6.3 0.0 7.3 2.0 1.1 0.2 0.0 0.0 0.3 0.0 4.1 2.5 0.3 602.3 3.1 0.3 0.0 0.0 7.7 0.8 5.5 0.0 3.5 0.0 0.3 0.0 0.3 23.2 4.1 0.4 0.5 0.0 7.8 0.6 PPP1R3A "GM, PPP1R3" ENSG00000154415 "Protein phosphatase 1 regulatory subunit 3A" Q16821 7 113876777-114075920 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4" "Cell type enriched" "Detected in some" 13 "Cardiomyocytes: 136.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 64 "THP-1: 18.1" "Region enriched" "Detected in single" 19 "thalamus: 1.2" "Not detected" "Not detected" "HPA070440, HPA073138" Enhanced NA NA "HPA070440: , HPA073138: " "unprognostic (8.96e-3)" 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.7 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.4 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 75.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 PPP1R3C "PPP1R5, PTG" ENSG00000119938 "Protein phosphatase 1 regulatory subunit 3C" Q9UQK1 10 91628442-91633054 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 259.9" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 213.5;Hepatocytes: 61.4;Muller glia cells: 120.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 16.4;HHSteC: 20.8;hTERT-RPE1: 33.7;LHCN-M2: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027041 Uncertain NA NA "HPA027041: AB_1855649" "unprognostic (2.11e-1)" "unprognostic (1.86e-3)" "unprognostic (1.01e-1)" "unprognostic (2.44e-1)" "unprognostic (7.15e-3)" "unprognostic (1.57e-2)" "unprognostic (3.33e-2)" "unprognostic (6.38e-2)" "unprognostic (1.85e-2)" "unprognostic (1.75e-3)" "unprognostic (5.63e-3)" "unprognostic (1.59e-2)" "unprognostic (5.48e-3)" "unprognostic (8.44e-3)" "unprognostic (4.86e-2)" "unprognostic (2.49e-1)" "unprognostic (4.61e-3)" 4.0 5.4 10.4 2.8 18.9 1.5 3.5 1.1 15.8 24.9 4.1 8.0 8.3 2.7 7.1 6.5 26.5 4.5 6.0 53.3 13.1 5.7 5.4 39.5 5.4 1.8 6.1 8.1 6.6 5.6 2.8 1.7 6.3 12.2 11.0 2.8 4.5 10.0 13.4 259.9 4.4 2.2 14.8 9.1 2.2 5.2 2.2 6.1 0.0 2.4 28.2 7.7 11.4 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.7 10.4 4.7 2.2 0.0 11.4 8.9 4.7 5.1 0.0 0.8 0.0 0.4 10.7 1.9 0.6 0.2 1.2 8.7 0.0 0.0 0.1 16.4 1.8 20.8 0.0 0.0 7.6 2.0 3.0 0.1 33.7 1.1 0.0 5.3 0.0 39.7 0.3 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.4 10.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.7 7.8 2.1 2.1 2.7 1.6 0.0 0.2 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 18.9 1.1 15.8 13.1 5.7 6.1 8.1 12.2 6.1 0.0 0.0 0.0 10.2 4.0 8.9 213.5 0.0 0.0 0.0 3.5 0.0 0.1 6.6 1.7 0.0 3.5 0.0 0.0 10.2 0.2 6.6 3.2 0.0 61.4 1.1 17.5 9.7 1.8 2.4 0.0 2.6 0.0 11.8 0.0 0.0 120.0 6.4 0.0 7.1 1.6 12.5 0.0 21.7 0.2 1.4 3.4 0.2 0.0 0.0 0.9 PPP1R3G ENSG00000219607 "Protein phosphatase 1 regulatory subunit 3G" B7ZBB8 6 5084581-5089487 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 8.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 16.7" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Group enriched" "Detected in some" 4 "classical monocyte: 1.7;intermediate monocyte: 1.2;myeloid DC: 2.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 2.9" "Cell line enhanced" "Detected in some" "EFO-21: 4.9;PC-3: 4.7;THP-1: 16.4;U-266/70: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA056393 Uncertain NA NA "HPA056393: AB_2683115" "unprognostic (1.99e-2)" "unprognostic (5.50e-3)" "unprognostic (2.10e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (6.56e-3)" "unprognostic (8.64e-3)" "unprognostic (1.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.04e-2)" "unprognostic (3.71e-1)" "unprognostic (7.60e-2)" "unprognostic (1.33e-2)" "unprognostic (5.56e-2)" "unprognostic (3.17e-3)" "unprognostic (1.27e-1)" 1.9 3.5 3.3 0.6 4.0 0.1 1.0 0.1 2.3 2.1 1.7 0.4 1.2 1.9 2.0 1.1 0.6 8.3 1.8 1.4 0.8 6.4 0.4 0.7 2.4 1.7 0.0 0.0 0.0 1.3 2.0 0.8 0.4 3.0 0.9 0.9 0.5 0.9 0.1 5.3 0.5 0.3 0.1 0.5 3.2 2.2 0.3 2.4 0.4 2.9 0.3 0.2 0.5 0.0 0.3 0.1 0.0 1.9 1.2 0.1 0.3 0.5 0.3 0.4 0.1 0.3 0.0 4.9 0.7 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.1 0.5 0.5 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.9 0.1 0.0 4.7 0.1 0.0 0.0 0.4 0.5 0.0 0.1 0.6 0.0 0.0 0.4 0.1 16.4 0.0 0.0 0.0 1.0 0.6 2.9 2.3 0.1 0.9 0.0 0.1 0.4 1.7 0.0 0.0 1.2 0.0 0.3 0.2 0.0 2.4 0.2 0.0 0.1 0.3 0.3 2.9 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.5 0.7 16.7 0.0 0.0 0.0 3.5 0.0 0.7 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.3 3.7 0.3 0.0 0.0 3.5 0.0 1.2 0.6 1.9 0.0 0.9 1.9 0.0 1.8 0.3 0.0 0.4 1.9 2.8 1.2 0.1 0.0 1.4 0.0 0.2 0.3 0.7 0.0 0.0 0.8 PPP1R42 "dtr, LRRC67, TLLR" ENSG00000178125 "Protein phosphatase 1 regulatory subunit 42" Q7Z4L9 8 66964099-67056604 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.2;fallopian tube: 10.2;testis: 20.2" "Group enriched" "Detected in some" 5 "Ciliated cells: 158.0;Spermatocytes: 89.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.3;RPTEC TERT1: 1.8;SCLC-21H: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024313, HPA027983, HPA028628" Uncertain NA NA "HPA024313: AB_1853053, HPA027983: AB_10599300, HPA028628: AB_2250064" "unprognostic (8.03e-3)" "unprognostic (5.45e-2)" "unprognostic (4.18e-2)" "unprognostic (2.32e-1)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.99e-2)" "unprognostic (1.03e-1)" "unprognostic (3.61e-3)" "unprognostic (6.86e-2)" "unprognostic (8.58e-3)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-1)" 0.3 0.5 2.3 0.3 5.7 0.3 0.3 0.3 2.3 0.9 0.3 3.5 0.0 0.3 0.6 8.0 0.3 10.2 0.4 0.4 3.1 1.4 1.1 0.3 4.1 0.3 0.6 0.8 2.6 0.5 1.0 6.7 0.3 11.2 0.3 0.3 0.8 0.3 1.5 0.3 0.3 0.3 0.4 2.0 0.3 0.3 20.2 1.8 0.0 1.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 5.7 0.3 2.3 3.1 1.4 0.6 0.8 11.2 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 158.0 13.6 5.2 0.0 0.0 3.3 0.3 25.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 8.5 0.6 0.0 0.0 0.0 0.0 2.8 0.2 0.0 1.8 1.3 2.6 6.5 0.2 89.9 3.3 0.0 0.0 0.0 0.0 0.0 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.9" "Group enriched" "Detected in all" 5 "Early spermatids: 249.6;Hepatocytes: 68.4;Late spermatids: 93.2;Spermatocytes: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favorable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 31.6 7.2 7.1 7.6 9.8 7.7 13.5 14.8 7.1 7.9 8.2 13.6 5.7 7.7 6.3 5.6 7.9 5.0 7.8 4.6 7.4 5.0 10.3 94.9 5.4 6.2 12.6 3.4 8.7 18.5 5.4 19.4 6.7 9.8 4.6 8.5 6.6 8.8 4.0 6.2 6.7 9.4 5.9 8.7 4.2 11.9 28.6 13.9 10.1 6.1 7.2 9.4 6.0 5.1 11.5 14.7 9.9 11.9 14.1 14.3 12.0 13.0 8.8 12.7 8.6 12.8 6.9 12.8 13.0 9.1 9.7 8.9 29.7 13.8 16.6 9.8 8.4 9.2 12.4 18.8 10.7 12.4 11.5 5.8 16.2 5.2 12.9 6.3 18.9 12.9 7.8 6.5 10.9 8.0 6.8 11.9 17.4 19.6 22.1 10.6 4.2 20.4 7.7 15.6 14.2 9.6 15.7 8.4 20.3 14.4 14.5 4.1 11.3 11.6 10.7 2.1 14.3 12.4 7.1 12.8 11.3 13.7 5.6 8.2 2.3 5.8 60.8 4.0 22.1 14.3 5.4 10.0 9.9 13.7 11.9 13.4 10.4 13.9 12.7 14.7 11.5 12.3 13.1 2.5 14.1 10.7 6.3 14.3 12.0 7.1 9.8 14.8 7.1 7.4 5.0 12.6 3.4 9.8 13.9 17.9 8.0 12.6 9.8 12.7 4.9 3.0 10.2 16.0 6.8 12.2 7.9 11.5 11.6 16.5 249.6 12.3 16.1 23.3 20.0 14.9 9.4 9.7 8.1 68.4 8.4 1.6 15.0 8.6 7.8 93.2 6.1 5.6 8.5 11.8 11.5 9.1 21.0 7.0 7.1 15.9 10.5 12.9 9.5 71.5 18.5 12.8 14.8 7.5 11.5 13.6 PPP2R2B "B55beta, PR52B, PR55-BETA, SCA12" ENSG00000156475 "Protein phosphatase 2 regulatory subunit Bbeta" Q00005 5 146581146-147084784 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 73.2" "Cell type enhanced" "Detected in many" 20 "Cone photoreceptor cells: 141.4;Early spermatids: 312.5;Late spermatids: 670.1;Rod photoreceptor cells: 261.9" "Cancer enriched" "Detected in some" 8 "glioma: 7.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0" "Group enriched" "Detected in many" 33 "NK-cells: 9.5;T-cells: 16.1" "Cell line enriched" "Detected in some" 4 "HDLM-2: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038118, HPA042122, HPA042770" Approved Uncertain Cytosol NA NA Cytosol "HPA038118: AB_10697238, HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (4.54e-5)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.80e-4)" "unprognostic (2.48e-1)" "unprognostic (1.44e-1)" "unprognostic (2.76e-1)" "unprognostic (1.84e-2)" "unprognostic (2.68e-1)" "unprognostic (3.20e-2)" "unprognostic (9.73e-4)" "unprognostic (4.51e-2)" "unprognostic (1.49e-8)" "unprognostic (2.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.48e-5)" "unprognostic (1.14e-4)" 2.0 9.7 30.8 2.5 35.2 2.9 1.8 10.2 73.2 1.6 2.7 26.0 0.0 3.0 1.7 1.8 2.9 14.5 2.9 2.9 26.4 20.9 4.7 2.4 2.5 4.3 25.5 22.4 1.6 2.9 16.0 6.4 2.6 27.5 2.7 2.8 4.6 2.0 2.9 1.5 4.9 2.3 3.5 18.6 2.9 2.2 15.7 29.3 0.0 4.2 0.0 2.4 6.8 1.1 0.0 0.0 0.3 0.0 9.5 16.1 4.1 0.4 0.4 2.4 1.0 0.1 0.1 0.2 0.5 0.2 1.1 1.6 1.3 4.8 0.2 0.1 0.0 0.0 10.2 0.8 1.0 1.1 47.5 0.2 0.6 2.8 0.5 0.2 0.0 0.2 0.1 0.7 0.0 0.2 0.7 0.1 0.4 0.6 0.5 0.7 0.3 0.0 0.0 6.3 0.0 1.1 0.7 0.1 0.1 4.2 10.9 1.9 0.2 0.3 0.0 0.2 1.7 0.4 0.1 0.3 0.2 0.7 2.5 0.4 0.4 0.2 0.0 1.7 4.3 1.4 0.2 0.0 0.0 15.1 0.0 13.8 0.0 7.1 16.1 0.0 0.0 1.3 12.0 0.3 9.5 0.0 0.0 8.0 4.1 30.8 35.2 10.2 34.1 26.4 20.9 25.5 22.4 27.5 29.3 3.0 2.6 0.0 1.1 1.8 83.2 1.2 12.7 0.0 1.2 8.7 141.4 14.1 18.3 1.3 312.5 2.1 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.8 44.5 12.5 0.0 1.2 670.1 3.1 1.7 5.0 0.0 0.0 31.8 0.8 0.0 2.1 4.0 261.9 0.0 8.6 3.7 1.6 1.3 4.5 16.7 0.0 0.7 PPP2R2C "B55gamma, IMYPNO, MGC33570, PR52, PR55G" ENSG00000074211 "Protein phosphatase 2 regulatory subunit Bgamma" Q9Y2T4 4 6320578-6563600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.4" "Group enriched" "Detected in some" 5 "Early spermatids: 52.2;Late spermatids: 144.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 14.2;A549: 21.0;CAPAN-2: 14.0;GAMG: 34.1;MCF7: 17.3;PC-3: 19.9;SCLC-21H: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042122, HPA042770, HPA060473" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291" "unprognostic (9.39e-2)" "unprognostic (7.10e-2)" "unprognostic (9.12e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (5.91e-2)" "unprognostic (2.70e-4)" "prognostic unfavorable (4.94e-4)" "unprognostic (1.77e-1)" "unprognostic (3.90e-1)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (1.36e-13)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.66e-3)" "unprognostic (9.90e-3)" 1.5 6.6 28.2 1.6 33.9 1.1 2.4 17.0 78.4 11.8 1.5 13.8 0.5 1.7 25.3 7.0 25.2 10.5 1.4 1.9 25.8 19.5 1.2 1.1 1.1 1.3 25.6 19.3 1.3 1.7 1.1 5.9 1.1 19.1 5.5 1.4 0.4 1.4 14.4 1.7 28.8 2.0 11.8 32.0 1.3 1.9 4.7 13.5 0.0 1.1 3.9 3.6 1.5 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.2 21.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 9.2 0.0 34.1 6.6 10.3 0.3 0.0 0.0 1.2 0.0 1.4 1.6 0.3 0.0 0.0 3.0 5.5 0.0 0.0 0.0 0.0 2.2 0.0 0.0 2.8 17.3 0.0 0.0 1.0 0.3 19.9 0.0 0.0 0.6 0.0 0.0 19.3 3.6 0.6 0.0 0.0 0.6 8.9 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.2 33.9 17.0 40.2 25.8 19.5 25.6 19.3 19.1 13.5 0.0 0.0 0.0 0.5 13.1 10.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.2 0.1 0.0 0.0 0.2 0.0 0.2 1.2 0.0 0.0 0.1 3.2 0.0 0.0 0.0 144.3 6.4 0.0 0.0 0.0 0.0 4.1 1.3 0.0 4.2 0.0 2.4 0.0 1.4 1.0 0.9 19.3 0.0 0.0 0.0 0.1 PPP2R2D "B55D, B55delta, MDS026" ENSG00000175470 "Protein phosphatase 2 regulatory subunit Bdelta" Q66LE6 10 131900644-131959834 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 34.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042122, HPA042770" Approved Approved Cytosol NA NA Cytosol "HPA042122: AB_2677859, HPA042770: AB_2678155" "unprognostic (7.75e-3)" "unprognostic (7.11e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (1.40e-1)" "unprognostic (3.57e-1)" "unprognostic (9.64e-3)" "unprognostic (1.83e-1)" "unprognostic (3.13e-2)" "unprognostic (1.76e-2)" "unprognostic (8.74e-2)" "unprognostic (8.46e-2)" "unprognostic (8.04e-2)" "unprognostic (4.41e-3)" "unprognostic (1.10e-1)" "unprognostic (6.57e-2)" "unprognostic (6.66e-2)" "unprognostic (1.90e-2)" 4.5 8.1 5.4 4.0 6.6 1.6 11.4 13.5 12.5 3.7 5.2 5.4 2.4 5.3 3.9 5.2 4.2 4.6 4.7 7.9 5.5 4.7 4.9 4.3 5.5 6.0 4.9 5.2 8.5 34.3 9.9 6.3 5.3 4.7 4.8 5.4 4.9 7.8 5.7 11.4 6.8 5.8 6.0 4.4 5.1 4.4 4.4 5.1 6.3 6.1 3.0 4.4 5.6 6.4 0.4 0.0 0.3 0.6 0.1 0.3 0.0 5.2 4.6 2.5 1.5 3.5 2.6 4.1 1.8 3.7 3.5 3.7 3.2 3.6 2.1 1.3 1.9 2.0 9.2 3.7 0.6 3.5 5.4 5.2 3.6 3.9 1.5 0.8 3.2 3.4 0.9 8.4 3.9 5.6 5.7 2.1 2.9 4.7 0.7 3.7 2.1 1.6 8.9 1.8 1.6 4.5 2.1 1.9 0.4 2.8 0.4 2.2 2.9 2.4 1.9 2.0 2.8 1.2 2.9 3.1 1.9 0.7 2.7 9.5 3.2 1.8 2.5 1.7 2.2 0.6 0.0 0.2 0.0 0.2 0.4 0.1 0.4 0.1 0.3 0.0 0.0 0.1 0.3 0.3 0.1 0.6 0.0 0.1 0.0 5.4 6.6 13.5 9.2 5.5 4.7 4.9 5.2 4.7 5.1 17.9 11.0 20.7 31.2 33.2 46.6 33.4 15.3 4.0 11.4 8.7 9.8 9.2 16.6 7.9 7.9 16.9 20.4 0.0 15.3 11.1 13.4 31.3 5.8 18.7 12.5 49.3 10.3 14.1 7.9 5.8 16.1 16.7 11.8 3.6 15.1 24.9 15.7 18.2 19.4 18.8 30.8 25.8 14.4 12.3 14.9 29.6 9.8 10.0 15.6 30.1 PPP2R3A "PPP2R3, PR130, PR72" ENSG00000073711 "Protein phosphatase 2 regulatory subunit B''alpha" Q06190 3 135965673-136147891 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 85.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 102.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 19.2;BJ hTERT+: 18.8;RPTEC TERT1: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035829, HPA035830, HPA065338" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475" "unprognostic (3.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.71e-1)" "unprognostic (4.04e-1)" "unprognostic (1.44e-4)" "unprognostic (9.43e-2)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (8.92e-2)" "prognostic favorable (1.15e-5)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.91e-4)" 6.3 3.3 3.4 1.9 6.4 0.7 4.3 1.5 4.9 5.5 6.7 5.2 5.8 1.7 6.8 5.1 5.0 3.0 3.3 27.4 3.9 2.8 31.7 1.2 2.6 0.9 7.0 4.4 3.7 3.8 7.5 3.7 9.0 5.3 3.8 3.5 1.6 7.7 7.8 85.6 10.4 2.5 11.4 6.1 1.2 5.2 4.2 6.5 0.0 2.3 31.6 1.2 6.5 3.9 1.5 1.8 1.7 1.4 1.8 1.5 0.6 19.2 1.1 5.5 2.6 4.5 5.7 6.4 15.1 18.8 7.1 8.9 1.2 1.2 0.0 5.8 15.4 5.1 2.5 2.3 5.3 15.5 0.0 0.7 0.8 0.6 0.0 3.2 0.0 0.8 5.1 4.6 9.1 4.3 7.2 6.8 0.5 0.5 0.0 10.2 3.2 0.1 0.1 3.8 0.2 3.7 0.0 8.1 0.0 25.0 0.7 0.4 3.1 2.4 3.0 5.8 5.2 4.8 0.2 4.4 7.5 4.1 10.1 6.6 0.2 0.5 0.0 5.5 0.4 2.6 1.1 1.2 1.5 0.9 1.4 0.5 0.7 1.0 0.8 1.1 1.5 1.5 1.2 1.7 1.8 1.2 1.8 0.7 0.6 3.4 6.4 1.5 4.9 3.9 2.8 7.0 4.4 5.3 6.5 26.8 22.2 2.7 15.3 23.5 4.1 102.3 0.0 9.4 11.4 52.4 0.0 7.6 18.3 18.1 6.1 8.7 15.8 0.0 8.5 13.2 12.8 12.5 3.5 2.4 2.2 3.2 12.5 5.5 2.1 9.5 22.7 4.6 27.0 14.4 7.9 9.5 12.6 9.9 17.3 37.2 2.2 6.5 11.9 6.6 19.6 29.1 8.7 3.8 7.3 15.3 PPP2R3B "PPP2R3L, PPP2R3LY, PR48, PR70" ENSG00000167393 "Protein phosphatase 2 regulatory subunit B''beta" Q9Y5P8 X 333963-386955 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 43.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 62.0;Cone photoreceptor cells: 25.5;Spermatogonia: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 15.5;U-698: 24.3" "Low region specificity" "Detected in all" HPA026606 Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026606: " "unprognostic (1.25e-1)" "unprognostic (4.35e-3)" "unprognostic (5.10e-2)" "unprognostic (1.16e-1)" "unprognostic (6.03e-2)" "unprognostic (2.46e-3)" "unprognostic (1.56e-2)" "unprognostic (2.73e-2)" "unprognostic (1.75e-1)" "unprognostic (1.79e-2)" "prognostic favorable (2.92e-5)" "unprognostic (4.65e-2)" "unprognostic (2.29e-8)" "unprognostic (1.15e-1)" "unprognostic (4.97e-2)" "unprognostic (3.17e-1)" "prognostic favorable (1.90e-5)" 1.8 1.3 8.8 1.1 11.7 3.8 4.8 9.1 8.7 7.6 1.2 0.0 0.0 1.4 6.6 0.7 2.4 2.3 1.4 17.7 12.2 2.9 4.1 1.1 1.5 1.7 15.4 6.2 6.9 2.9 1.5 11.0 8.9 13.0 2.4 0.7 0.0 1.6 1.2 43.5 3.9 1.3 1.6 8.3 1.8 1.8 4.1 15.0 0.0 1.0 0.0 0.9 2.9 2.6 0.1 0.6 2.3 0.1 0.0 1.3 0.1 0.5 5.3 0.7 2.2 0.1 0.2 7.1 5.9 1.5 5.3 6.3 5.3 0.0 0.0 3.2 4.5 0.6 0.0 0.2 0.0 1.4 3.7 4.3 1.2 1.8 0.2 0.0 1.9 2.2 0.1 0.1 0.0 3.2 0.2 0.1 3.2 1.0 0.3 1.2 2.6 9.0 7.8 2.3 0.1 15.5 4.1 3.4 0.3 1.4 1.5 0.0 9.2 0.0 0.9 4.2 4.2 0.0 2.3 0.3 3.1 2.9 0.0 2.0 0.0 0.0 24.3 0.1 2.7 3.9 0.0 0.0 2.3 0.1 0.1 1.3 0.1 0.1 0.0 0.6 0.1 0.3 0.3 0.1 0.0 0.1 0.5 0.0 0.1 8.8 11.7 9.1 8.7 12.2 2.9 15.4 6.2 13.0 15.0 0.0 1.7 0.9 7.8 6.1 11.5 62.0 2.5 2.7 1.2 0.0 25.5 5.6 0.0 2.8 0.5 3.5 1.4 0.0 3.5 5.6 3.0 2.2 0.0 1.0 3.2 6.4 4.6 4.3 2.1 1.5 3.7 5.3 5.0 3.6 3.8 11.2 2.6 0.0 2.8 1.3 19.8 0.0 3.8 12.9 25.5 6.6 3.3 1.9 3.1 3.9 PPP2R5B "B56B, B56beta, FLJ35411, PR61B" ENSG00000068971 "Protein phosphatase 2 regulatory subunit B'beta" Q15173 11 64917553-64934473 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "eosinophil: 11.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036607 Approved NA NA "HPA036607: AB_10670235" "unprognostic (2.20e-2)" "unprognostic (7.31e-2)" "unprognostic (7.11e-2)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (3.24e-5)" "unprognostic (1.98e-1)" "unprognostic (1.68e-1)" "unprognostic (3.33e-2)" "unprognostic (9.37e-3)" "unprognostic (8.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.40e-1)" "unprognostic (2.12e-2)" 11.0 11.7 18.9 8.5 36.7 12.1 6.6 51.9 41.3 7.5 10.0 16.3 8.3 7.5 8.9 11.7 7.8 6.2 16.1 13.7 19.0 24.5 9.1 5.6 11.4 8.4 20.2 23.1 6.3 15.1 17.8 11.6 9.8 27.5 8.7 8.6 10.5 8.7 15.7 13.7 12.3 8.7 14.2 15.2 14.0 7.2 3.4 13.3 2.9 9.0 4.4 8.0 8.9 6.0 1.1 0.6 11.0 1.7 0.9 1.0 0.3 7.4 3.7 4.9 11.4 10.3 7.7 0.7 8.4 7.7 12.0 9.7 2.7 5.7 1.8 6.0 9.9 13.3 5.0 4.6 7.2 6.8 10.9 3.3 2.1 6.6 1.8 9.9 0.9 9.8 4.8 12.5 13.0 14.8 13.7 9.5 6.5 4.1 4.7 8.9 3.0 1.2 3.3 1.5 2.3 10.7 2.2 1.4 4.2 9.0 3.4 12.9 12.0 5.1 3.8 7.6 4.4 4.3 1.8 9.5 15.4 5.1 16.5 3.1 5.8 4.6 1.5 19.3 1.3 7.0 1.2 0.9 11.0 1.0 1.4 0.7 0.9 0.5 0.9 0.6 1.1 0.5 0.6 0.4 0.9 1.7 0.5 1.0 0.3 18.9 36.7 51.9 41.3 19.0 24.5 20.2 23.1 27.5 13.3 0.0 4.0 6.0 5.2 7.6 33.5 2.4 0.0 0.0 0.0 1.8 25.5 1.6 11.6 8.9 0.5 11.7 7.8 0.0 5.8 3.6 6.4 8.6 4.6 2.6 5.7 27.0 15.0 11.6 3.8 0.9 5.5 4.0 6.8 1.8 6.0 14.7 12.7 5.7 7.8 9.7 14.1 12.9 6.2 0.5 2.3 8.4 2.4 5.0 2.3 14.2 PPP3CA "CALN, CALNA, CNA1, PPP2B" ENSG00000138814 "Protein phosphatase 3 catalytic subunit alpha" Q08209 4 101023409-101348278 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.8" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 7 "prostate cancer: 98.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012778, CAB018581" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 35000 Nucleoplasm Cytosol "CAB018581: AB_2168324, HPA012778: AB_1855660" "unprognostic (6.66e-2)" "unprognostic (1.96e-1)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.56e-1)" "unprognostic (7.81e-2)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "unprognostic (7.87e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.82e-4)" "unprognostic (3.38e-2)" "unprognostic (2.51e-2)" "unprognostic (5.12e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-2)" "unprognostic (5.74e-2)" 12.2 9.2 22.7 7.4 71.8 7.7 10.6 42.1 52.4 9.4 9.5 4.8 9.8 5.8 6.2 6.9 7.4 7.2 6.8 4.3 36.0 13.5 5.8 8.4 10.0 6.7 10.1 22.1 9.6 4.7 7.0 4.2 6.6 11.9 34.6 8.4 2.6 10.4 21.1 23.7 11.4 6.4 7.9 7.5 6.9 11.0 5.3 13.0 3.8 6.8 6.8 8.9 8.4 6.8 27.7 18.3 44.3 14.9 22.3 15.5 6.6 19.4 13.8 3.8 7.5 21.6 16.4 7.4 21.5 19.8 8.7 9.2 8.0 24.4 9.3 9.0 19.4 10.8 9.8 13.9 28.6 14.8 22.7 6.4 14.7 19.8 10.2 15.9 23.6 7.5 17.0 15.0 19.0 21.8 16.6 16.3 6.0 5.7 25.6 13.9 23.4 4.9 17.7 6.4 22.5 9.0 9.0 35.0 10.7 8.4 15.4 30.4 11.5 17.7 15.2 10.3 5.5 13.6 13.5 19.0 20.6 23.5 18.8 14.2 12.0 12.2 16.4 11.4 13.4 5.5 24.6 11.8 24.8 13.6 11.4 15.5 27.7 12.9 13.1 9.9 23.4 6.2 12.3 44.3 22.3 14.9 18.3 8.6 6.6 22.7 71.8 42.1 51.5 36.0 13.5 10.1 22.1 11.9 13.0 71.5 48.8 59.1 33.3 149.9 74.7 24.1 33.1 32.1 20.5 29.6 37.3 28.9 28.2 18.2 1.8 105.6 33.9 0.0 27.3 76.5 53.9 157.6 33.6 37.0 32.1 17.5 122.2 43.6 52.2 4.7 60.1 49.5 87.7 44.1 39.6 19.3 41.1 107.8 57.3 31.7 81.9 12.9 39.4 7.2 22.1 150.4 23.0 55.4 39.9 32.0 PPP3CB "CALNA2, CALNB, CNA2, PP2Bbeta" ENSG00000107758 "Protein phosphatase 3 catalytic subunit beta" P16298 10 73436428-73496024 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 133.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008233, HPA008823" Uncertain Approved Mitochondria NA NA Mitochondria "HPA008233: AB_1855661, HPA008823: AB_2668148" "unprognostic (3.05e-1)" "unprognostic (2.54e-1)" "unprognostic (1.50e-1)" "unprognostic (4.93e-2)" "unprognostic (8.93e-2)" "unprognostic (4.28e-2)" "prognostic unfavorable (9.59e-4)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (2.12e-2)" "prognostic favorable (6.96e-5)" "unprognostic (4.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.01e-1)" "unprognostic (1.45e-1)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" 17.3 16.1 40.0 11.7 36.3 7.6 22.5 44.5 42.7 13.4 16.1 7.9 9.5 10.1 17.0 15.0 14.0 12.3 12.0 16.7 39.7 20.5 11.9 9.1 9.8 13.1 18.2 40.7 17.2 10.5 19.3 16.8 10.6 21.1 16.8 12.8 9.5 10.4 17.6 133.0 10.9 9.4 23.0 18.1 10.0 10.7 11.6 11.9 8.4 10.1 10.0 14.3 14.1 14.4 4.2 5.7 4.8 3.8 4.5 10.6 2.7 19.1 10.6 19.0 19.6 27.3 37.9 9.1 17.6 24.2 17.3 17.2 6.7 9.8 17.0 5.7 25.4 8.2 10.3 15.3 13.5 24.4 23.8 12.5 7.2 9.6 12.7 16.3 16.0 15.1 26.8 16.3 16.3 21.9 31.9 11.9 14.9 9.0 20.0 34.8 6.0 14.3 14.8 7.7 8.4 31.0 9.6 10.3 8.0 16.8 9.3 10.2 11.8 10.3 25.8 12.9 16.5 19.4 15.5 13.0 13.8 12.7 11.0 23.8 13.4 36.5 11.9 17.1 23.1 7.8 3.2 2.9 4.8 6.2 3.8 7.3 4.2 6.7 6.6 3.0 3.0 5.3 7.9 1.7 4.5 2.3 5.7 10.6 2.7 40.0 36.3 44.5 42.7 39.7 20.5 18.2 40.7 21.1 11.9 3.0 11.0 18.2 26.7 22.8 52.0 42.6 10.2 13.4 11.4 17.4 19.6 17.9 53.0 15.6 5.9 18.3 10.2 0.0 16.6 13.6 21.4 23.8 20.7 12.3 17.9 36.5 40.9 17.2 30.2 7.6 31.1 18.8 25.3 27.1 12.3 32.9 15.6 14.4 27.3 25.6 28.0 6.5 37.1 38.5 44.0 27.6 18.5 15.7 14.4 19.3 PPP3R1 "CALNB1, CNB, CNB1" ENSG00000221823 "Protein phosphatase 3 regulatory subunit B, alpha" P63098 2 68178857-68256237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.2" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005610, HPA047157" Approved Approved "Plasma membrane,Cytosol" NA NA 43000 "Plasma membrane, Cytosol" "CAB005610: AB_325975, HPA047157: AB_2679960" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.08e-6)" "unprognostic (5.90e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.59e-1)" "unprognostic (3.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (5.24e-3)" "unprognostic (5.35e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-1)" 25.8 20.1 43.3 15.9 66.2 32.3 25.7 47.9 78.2 14.8 14.0 7.7 6.9 13.1 16.6 14.2 15.7 10.5 14.7 10.2 56.2 28.7 11.3 29.6 15.5 18.8 23.7 45.1 13.6 9.8 9.4 8.9 18.5 25.4 14.3 14.8 6.8 12.1 16.6 41.7 17.1 12.0 18.5 21.6 16.5 12.6 10.4 16.5 12.7 12.6 7.7 20.1 14.4 13.3 1.0 1.8 6.4 1.4 0.9 1.4 0.9 17.8 15.2 20.6 14.1 14.2 16.5 21.0 25.9 22.1 29.3 25.9 21.9 16.2 24.9 8.9 17.5 20.9 12.1 21.7 18.7 35.8 17.5 15.5 80.8 12.4 20.1 28.1 31.7 27.3 16.6 17.0 22.7 23.3 16.6 19.6 21.1 19.5 28.5 21.3 15.4 26.8 27.9 24.2 15.0 13.0 19.6 27.2 39.6 18.1 19.0 27.2 19.2 14.9 21.2 18.6 14.0 10.0 14.8 20.5 25.3 23.2 19.1 22.3 16.1 17.7 36.9 18.4 33.4 15.8 3.2 1.2 2.9 0.7 0.8 1.4 0.5 0.8 0.5 1.3 1.0 0.9 1.4 6.4 0.9 1.4 1.8 0.9 0.9 43.3 66.2 47.9 78.2 56.2 28.7 23.7 45.1 25.4 16.5 8.9 16.7 16.6 10.6 66.4 21.5 16.1 10.2 2.7 6.8 15.7 49.1 9.8 10.0 5.9 11.6 21.5 14.4 23.3 7.5 14.8 14.0 14.4 19.6 18.5 21.1 11.1 14.6 15.4 42.9 6.5 9.2 22.7 33.7 4.6 14.0 20.4 10.5 10.1 8.1 12.9 86.2 12.9 17.3 2.6 5.3 61.6 10.1 20.3 12.0 16.8 PPP3R2 PPP3RL ENSG00000188386 "Protein phosphatase 3 regulatory subunit B, beta" Q96LZ3 9 101591615-101595021 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 81.9" "Group enriched" "Detected in some" 25 "Early spermatids: 271.7;Late spermatids: 141.7;Spermatocytes: 319.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Low region specificity" "Detected in single" HPA047157 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA047157: AB_2679960" "unprognostic (8.81e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 271.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 319.9 3.0 0.0 0.0 0.0 0.0 0.0 PPP4R3C "FLFL3P, FLJ32867, PPP4R3CP, SMEK3P, smk1" ENSG00000224960 "Protein phosphatase 4 regulatory subunit 3C" Q6ZMV5 X 27460211-27463341 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 6.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "liver cancer: 0.6;testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 148 "U-2197: 21.8" "Not detected" "Not detected" NA NA "unprognostic (8.74e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP4R4 "CFAP14, KIAA1622, PP4R4" ENSG00000119698 "Protein phosphatase 4 regulatory subunit 4" Q6NUP7 14 94146128-94279735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3;testis: 14.0" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 20.1;Cone photoreceptor cells: 70.7;Spermatocytes: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RH-30: 16.6;T-47d: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041866, HPA050321" Approved Supported Cytosol NA NA Cytosol "HPA041866: AB_10804120, HPA050321: AB_2681086" "unprognostic (2.65e-3)" "unprognostic (3.06e-1)" "unprognostic (9.07e-2)" "unprognostic (9.49e-3)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (3.88e-2)" "unprognostic (2.45e-1)" "unprognostic (1.25e-1)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (1.72e-2)" "unprognostic (8.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.35e-2)" "unprognostic (1.77e-1)" "unprognostic (6.24e-2)" 1.0 1.7 15.2 1.3 15.5 1.1 3.5 4.9 21.3 6.9 1.0 1.9 0.1 1.0 2.1 4.0 1.4 4.0 1.5 1.1 11.1 6.9 1.3 3.0 3.1 1.2 4.7 9.8 11.5 1.6 1.1 7.1 1.7 8.0 1.4 1.1 2.3 1.2 1.8 1.0 2.0 1.0 1.3 5.2 1.0 2.1 14.0 4.1 0.0 1.3 0.0 1.8 1.2 1.3 0.3 0.0 1.1 0.0 0.0 0.3 0.0 0.7 0.0 1.8 0.9 0.4 0.0 0.5 0.2 1.6 1.0 0.4 0.1 0.5 0.9 0.0 0.0 3.6 0.0 4.1 4.2 0.4 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.3 0.0 0.4 0.0 3.9 0.0 0.0 1.2 0.0 0.1 0.4 0.5 0.0 0.1 1.1 0.0 0.9 0.1 16.6 0.0 0.2 0.9 0.2 0.1 0.0 0.0 0.1 0.8 17.6 0.0 0.0 3.2 1.7 0.1 0.1 0.8 0.1 0.3 1.9 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 15.2 15.5 4.9 13.2 11.1 6.9 4.7 9.8 8.0 4.1 3.0 7.4 0.0 4.2 4.2 0.6 0.4 0.0 20.1 3.4 0.0 70.7 0.0 0.0 2.1 12.4 0.1 0.0 0.0 0.3 0.1 0.0 3.0 0.0 1.0 0.1 1.6 0.0 8.6 2.6 13.6 5.5 0.0 0.0 0.0 0.0 5.7 0.3 0.0 5.3 0.0 0.6 0.0 0.1 26.5 4.9 2.3 0.0 0.0 0.0 7.3 PPTC7 TA-PP2C ENSG00000196850 "PTC7 protein phosphatase homolog" Q8NI37 12 110533245-110583320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.8" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039335, HPA040614" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039335: AB_10805474, HPA040614: AB_10795526" "unprognostic (2.44e-1)" "unprognostic (2.38e-2)" "unprognostic (1.11e-1)" "unprognostic (9.44e-2)" "unprognostic (2.38e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.43e-5)" "prognostic unfavorable (6.76e-4)" "unprognostic (1.09e-1)" "prognostic favorable (4.48e-5)" "unprognostic (5.34e-2)" "unprognostic (2.83e-1)" "unprognostic (5.01e-3)" "unprognostic (1.83e-1)" 10.4 15.3 6.5 10.3 9.6 26.2 10.3 8.3 12.9 9.7 11.8 5.7 4.9 7.5 9.3 4.6 12.6 7.8 8.8 35.3 9.0 9.0 12.6 11.9 13.1 10.9 10.4 6.8 8.9 7.5 13.0 12.7 6.9 15.3 7.7 9.8 8.0 12.9 8.2 53.8 13.4 11.7 13.1 7.4 9.4 8.4 8.2 6.5 16.1 8.0 15.5 13.1 12.4 12.4 2.1 1.4 6.1 1.7 1.7 2.4 0.6 12.2 7.0 6.0 6.3 15.0 13.2 8.6 5.6 7.5 6.2 6.2 7.9 4.8 21.5 5.9 5.5 8.9 11.9 12.0 13.1 12.6 15.6 10.0 19.0 7.5 8.5 14.3 21.0 15.7 11.4 21.6 8.8 25.9 9.3 11.7 15.0 14.1 6.1 10.0 3.1 18.5 18.0 8.5 6.6 13.1 15.5 8.1 13.1 25.7 13.7 9.7 7.6 10.7 14.8 12.4 6.1 7.0 11.3 13.4 5.7 6.1 17.3 9.5 17.8 19.7 24.0 9.6 11.6 11.2 0.1 1.7 1.3 2.3 1.5 2.4 1.3 1.9 1.8 1.3 2.1 2.2 1.9 6.1 1.7 1.1 1.4 1.3 0.6 6.5 9.6 8.3 12.9 9.0 9.0 10.4 6.8 15.3 6.5 20.8 21.2 21.7 47.9 81.6 8.5 96.6 15.3 25.4 22.7 8.7 13.7 6.3 14.9 6.8 29.6 22.2 18.4 23.3 7.1 7.0 37.6 42.4 23.1 24.9 15.0 12.7 16.1 14.7 25.1 17.5 10.6 19.9 32.1 10.0 14.2 3.9 11.1 14.4 9.2 10.5 24.1 12.9 39.1 12.5 22.5 91.1 5.6 20.8 13.8 64.3 PPY PNP ENSG00000108849 "Pancreatic polypeptide" P01298 17 43940804-43942468 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "pancreas: 275.8" "Group enriched" "Detected in some" 23 "Intestinal endocrine cells: 38.8;Pancreatic endocrine cells: 40.9" "Cancer enriched" "Detected in some" 132 "pancreatic cancer: 630.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "myeloid DC: 4.1" "Lineage enriched" "Detected in single" 42 "dendritic cells: 4.1" "Group enriched" "Detected in some" 4 "BEWO: 7.1;EFO-21: 6.6;U-2 OS: 7.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB016735, HPA032122" Enhanced "Secreted to blood" NA NA 70300 "CAB016735: , HPA032122: AB_2674164" "unprognostic (5.12e-3)" "unprognostic (1.10e-1)" "unprognostic (3.27e-2)" "unprognostic (1.65e-2)" "unprognostic (7.56e-3)" "unprognostic (8.13e-2)" "unprognostic (1.33e-1)" "unprognostic (7.78e-3)" "unprognostic (1.42e-1)" 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 275.8 7.5 0.1 0.1 0.1 0.1 2.5 0.1 0.1 0.1 0.1 2.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 6.6 0.0 0.4 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.6 1.0 0.0 7.4 0.8 0.9 0.0 0.5 1.4 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 38.8 0.0 0.0 1.7 0.0 0.0 1.7 0.0 0.2 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.5 0.0 0.1 0.0 PQLC2L C3orf55 ENSG00000174899 "PQ loop repeat containing 2 like" A1A4F0 3 157543246-157677749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.8;breast: 36.0" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 21.0;Ductal cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 33.9;ASC TERT1: 18.8;EFO-21: 12.8;HSkMC: 12.1;hTERT-RPE1: 13.4;LHCN-M2: 17.0" HPA054395 Uncertain Approved "Nucleoplasm,Nuclear bodies" No NA "Nucleoplasm, Nuclear bodies" "HPA054395: AB_2682473" "unprognostic (1.25e-1)" "unprognostic (1.19e-1)" "unprognostic (6.80e-2)" "unprognostic (1.41e-2)" "unprognostic (3.80e-3)" "unprognostic (1.65e-3)" "unprognostic (1.83e-5)" "unprognostic (2.29e-2)" "unprognostic (2.67e-1)" "unprognostic (3.56e-2)" "unprognostic (3.34e-2)" "unprognostic (4.59e-3)" "unprognostic (7.47e-7)" "unprognostic (1.17e-3)" "unprognostic (2.75e-1)" "unprognostic (4.81e-2)" "unprognostic (7.56e-3)" 29.8 1.6 0.2 1.8 1.3 0.1 36.0 0.0 0.8 5.3 4.1 0.0 0.0 0.1 1.3 2.0 3.1 1.8 4.3 5.6 0.3 1.2 4.5 0.1 8.4 1.6 0.5 0.1 0.4 1.4 0.1 5.9 2.6 1.3 3.9 1.4 4.6 4.5 1.0 4.8 2.2 1.6 3.4 0.3 0.1 3.8 2.7 0.0 0.0 11.8 3.0 0.5 4.2 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.0 0.0 33.9 18.8 0.0 1.7 3.5 0.7 1.0 0.0 2.4 0.0 12.8 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 2.7 0.0 0.0 12.1 0.6 5.2 0.3 13.4 5.3 0.0 0.3 0.0 17.0 0.1 0.0 0.0 0.1 0.6 3.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 0.1 1.1 0.0 0.0 4.8 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.0 0.8 0.3 1.2 0.5 0.1 1.3 0.0 0.0 0.3 0.0 0.6 0.0 0.3 0.3 2.5 1.4 1.2 21.0 0.0 0.0 0.0 5.8 4.2 0.0 0.0 0.0 1.8 0.6 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.7 0.8 1.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.6 PRAC1 "C17orf92, PRAC" ENSG00000159182 "PRAC1 small nuclear protein" Q96KF2 17 48721719-48722522 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 62.1;prostate: 40.3" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 873.8;Mucus-secreting cells: 545.9;Undifferentiated cells: 434.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 291.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 33 "PC-3: 92.5" HPA047871 Uncertain Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047871: AB_2680195" "unprognostic (7.59e-2)" "unprognostic (2.43e-2)" "unprognostic (2.04e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.6 2.0 30.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 40.3 62.1 0.1 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 9.9 5.1 0.8 0.0 2.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 92.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.5 0.0 0.2 0.5 0.0 0.4 0.0 0.8 0.1 0.1 2.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 97.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 67.9 0.0 0.0 0.0 0.1 118.0 0.0 0.0 0.0 0.0 873.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 545.9 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 434.0 46.7 PRAC2 "C17orf93, HOXB-AS5, HOXB13-AS1, NCRNA00253" ENSG00000229637 "Prostate cancer susceptibility candidate 2" D3DTV9 17 48723168-48724758 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "intestine: 11.2;prostate: 12.8;urinary bladder: 3.4" "Cell type enhanced" "Detected in some" 8 "Basal glandular cells: 28.5;Early spermatids: 35.3;Glandular cells: 28.1;Intestinal endocrine cells: 30.7;Late spermatids: 33.5;Undifferentiated cells: 22.4;Urothelial cells: 19.2" "Cancer enriched" "Detected in many" 8 "prostate cancer: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "PC-3: 32.0;REH: 12.5" "Intracellular and membrane" NA NA "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (4.26e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (9.98e-2)" "unprognostic (3.27e-2)" "unprognostic (9.77e-2)" "unprognostic (8.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 5.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 12.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.8 32.0 12.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 0.0 5.9 0.0 0.0 0.0 0.4 28.1 0.0 0.0 0.1 0.0 30.7 0.0 0.0 33.5 0.3 0.0 0.0 0.0 17.4 0.0 0.0 8.6 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 22.4 19.2 PRADC1 "C2orf7, hPAP21, MGC13004, PAP21" ENSG00000135617 "Protease associated domain containing 1" Q9BSG0 2 73228006-73233238 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.4" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051066 Approved "Secreted to blood" NA NA "HPA051066: AB_2681333" "unprognostic (2.94e-1)" "unprognostic (1.93e-2)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (9.23e-2)" "unprognostic (3.93e-2)" "unprognostic (8.54e-2)" "unprognostic (9.08e-3)" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (1.09e-3)" "unprognostic (9.99e-3)" "unprognostic (3.56e-2)" "unprognostic (2.96e-1)" "unprognostic (4.89e-1)" "unprognostic (1.93e-1)" "unprognostic (9.23e-2)" 10.3 12.0 11.6 5.6 13.9 4.2 22.5 9.3 13.3 6.2 12.3 6.7 6.6 13.6 4.5 9.5 9.1 4.1 6.4 37.3 10.6 7.7 11.8 23.3 6.4 14.4 10.6 7.3 3.9 39.7 4.8 8.3 4.7 10.9 6.6 12.0 6.9 25.6 8.7 59.4 6.7 16.2 13.1 9.6 8.5 8.7 9.6 7.0 4.1 7.8 22.2 5.8 7.5 5.7 6.2 25.6 11.6 33.8 13.3 10.5 15.0 8.2 7.0 7.0 13.4 22.0 8.6 9.3 13.8 6.5 14.2 8.2 19.5 8.8 9.1 8.0 16.1 12.8 7.8 11.1 9.6 10.1 13.7 10.0 13.7 10.0 14.6 6.8 7.2 13.7 11.1 5.9 12.7 6.8 4.1 13.1 16.6 11.9 20.0 16.2 17.5 20.0 13.7 2.1 39.3 28.2 11.6 27.3 28.6 7.9 8.1 14.6 4.8 6.6 18.3 6.4 7.9 9.7 6.5 6.8 16.5 6.5 14.1 12.4 21.0 15.8 8.2 10.6 15.9 6.7 4.1 12.3 11.6 9.1 28.9 7.4 6.1 8.9 8.5 12.7 6.2 8.4 7.4 1.6 13.3 33.8 25.6 10.5 15.0 11.6 13.9 9.3 13.3 10.6 7.7 10.6 7.3 10.9 7.0 8.9 5.8 9.3 10.2 13.9 13.7 52.0 15.3 6.7 5.7 14.0 7.9 22.4 61.3 20.8 39.5 14.7 47.7 0.0 40.8 39.3 23.7 7.9 28.8 55.1 42.8 11.1 31.0 30.7 18.1 109.7 15.5 14.2 15.1 1.0 41.5 20.9 19.4 28.1 15.2 56.4 20.4 32.3 14.7 23.2 19.6 21.0 11.3 11.3 48.1 8.2 PRAF2 "JM4, Yip6a" ENSG00000243279 "PRA1 domain family member 2" O60831 X 49071156-49074071 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 125.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002859, HPA005504, CAB011655" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340" "unprognostic (1.50e-1)" "prognostic favorable (7.42e-4)" "unprognostic (1.17e-2)" "unprognostic (1.32e-2)" "unprognostic (4.29e-1)" "unprognostic (3.67e-1)" "prognostic unfavorable (1.66e-6)" "prognostic favorable (2.81e-4)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "prognostic favorable (4.88e-6)" "unprognostic (8.39e-3)" "prognostic unfavorable (5.83e-6)" "unprognostic (4.96e-2)" "unprognostic (1.69e-1)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" 13.5 17.5 25.0 12.3 26.9 6.7 9.0 18.0 39.7 28.1 11.8 26.3 12.6 6.0 22.1 125.1 7.3 15.6 12.3 12.9 25.3 29.9 12.4 6.9 11.5 11.3 26.1 18.9 20.1 6.2 19.7 31.0 9.8 25.5 12.2 10.0 13.0 7.5 29.4 6.8 7.6 6.6 33.2 23.1 10.9 9.2 17.7 17.0 14.4 13.3 3.8 11.9 12.6 10.7 14.6 6.7 16.4 6.4 16.8 29.4 11.1 4.5 9.6 11.3 14.4 40.6 24.7 1.5 16.4 17.1 11.1 12.3 0.5 1.5 0.4 3.9 35.4 9.2 4.3 0.4 8.9 12.4 8.4 12.8 3.6 12.5 0.4 41.6 2.3 7.1 31.3 7.6 21.1 15.4 23.0 17.0 11.5 0.5 1.3 19.4 8.4 15.1 2.9 6.3 2.2 0.6 8.3 6.2 1.0 16.5 1.3 7.5 18.8 13.7 7.1 9.3 10.3 6.9 1.6 10.3 8.6 11.4 18.4 4.7 20.4 5.1 3.7 20.7 4.2 13.3 16.4 5.9 7.9 18.3 6.4 20.7 14.6 20.1 16.1 6.7 13.6 18.1 19.4 15.4 16.8 4.8 2.6 29.4 11.1 25.0 26.9 18.0 39.7 25.3 29.9 26.1 18.9 25.5 17.0 11.9 7.7 10.0 12.1 6.8 21.7 5.1 12.7 10.7 9.1 10.4 11.8 2.9 10.0 14.9 2.9 30.3 1.3 0.0 5.0 10.4 36.2 8.7 16.1 2.5 5.8 15.9 9.8 23.9 4.6 3.5 35.4 7.7 13.5 3.6 3.4 26.4 4.6 0.0 38.9 15.8 6.7 19.4 40.1 10.7 3.9 6.5 8.1 25.3 1.3 8.1 PRAG1 "DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223" ENSG00000275342 "PEAK1 related, kinase-activating pseudokinase 1" Q86YV5 8 8317736-8386498 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.4" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Cytotrophoblasts: 6.4;Ductal cells: 6.6;Extravillous trophoblasts: 5.5;Hofbauer cells: 14.8;Pancreatic endocrine cells: 5.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 27.5;NTERA-2: 17.8;SuSa: 19.0" "Low region specificity" "Detected in all" "HPA011776, HPA012066" Uncertain Uncertain "Nucleoli,Focal adhesion sites" NA NA Nucleoli "Focal adhesion sites" "HPA011776: , HPA012066: AB_1847706" "unprognostic (7.04e-3)" "unprognostic (7.90e-2)" "unprognostic (2.32e-1)" "unprognostic (2.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.92e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-3)" "unprognostic (2.64e-3)" "unprognostic (5.19e-2)" "unprognostic (4.95e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (5.27e-2)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (5.22e-3)" 7.6 0.2 6.4 8.8 4.9 0.1 5.4 30.4 7.0 2.4 5.7 1.8 3.2 9.8 0.8 1.7 2.6 5.0 4.0 1.8 2.1 1.3 0.9 4.3 9.1 0.0 1.4 1.7 1.0 2.2 0.0 5.4 1.2 1.5 3.4 0.0 1.7 5.7 5.6 2.8 9.4 0.9 1.4 5.7 3.9 0.7 1.2 1.8 15.4 4.7 6.2 1.5 0.2 3.1 4.6 2.2 1.6 1.3 3.9 0.4 3.3 27.5 3.1 0.4 0.0 0.2 7.8 7.0 1.5 2.8 1.1 13.6 8.0 5.5 4.8 3.3 7.6 12.0 0.5 8.4 0.6 0.2 0.8 0.0 3.3 7.6 3.0 0.8 8.7 0.7 5.5 0.4 1.2 1.6 5.7 0.8 0.0 0.0 2.1 4.6 0.7 2.6 17.8 10.5 7.1 3.5 3.3 1.3 4.1 9.5 1.5 1.0 2.7 7.7 2.7 19.0 6.0 3.4 7.5 0.2 7.4 0.0 1.7 0.4 0.6 7.5 1.7 1.8 4.1 0.0 0.5 2.2 1.2 0.1 0.9 3.1 1.5 0.4 0.7 2.6 3.9 3.2 0.0 1.3 1.6 4.6 0.2 0.4 8.9 6.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 6.4 0.0 6.6 0.0 0.0 0.0 0.0 2.7 5.5 0.0 0.0 2.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.8 0.0 0.0 5.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 PRAM1 PML-RAR ENSG00000133246 "PML-RARA regulated adaptor molecule 1" Q96QH2 19 8490056-8503112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.8;bone marrow: 70.7;brain: 25.1" "Group enriched" "Detected in some" 8 "Hofbauer cells: 29.1;Kupffer cells: 73.2;Macrophages: 49.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 23.6;intermediate monocyte: 28.1;myeloid DC: 16.1;neutrophil: 14.9;non-classical monocyte: 30.8" "Group enriched" "Detected in many" 7 "dendritic cells: 16.1;granulocytes: 14.9;monocytes: 30.8" "Cell line enhanced" "Detected in some" "HL-60: 9.3;NB-4: 7.3;THP-1: 16.2;U-937: 51.8" "Low region specificity" "Detected in all" "HPA045236, HPA050161" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA045236: AB_2679267, HPA050161: AB_2681036" "unprognostic (1.68e-2)" "unprognostic (3.79e-3)" "unprognostic (1.15e-2)" "unprognostic (3.91e-3)" "unprognostic (1.25e-1)" "unprognostic (6.54e-3)" "unprognostic (3.36e-1)" "unprognostic (1.74e-3)" "unprognostic (1.48e-2)" "unprognostic (1.26e-1)" "unprognostic (1.28e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.73e-1)" "unprognostic (2.15e-3)" "unprognostic (2.72e-1)" "unprognostic (6.12e-3)" 4.0 1.5 7.1 9.2 15.5 70.7 1.3 2.7 8.3 2.7 1.2 14.4 0.0 3.0 1.7 1.2 1.4 2.3 2.4 1.5 6.8 3.7 1.3 2.4 12.3 10.2 10.9 3.5 1.7 1.5 1.2 2.1 1.6 10.1 3.7 1.3 1.5 1.5 1.2 1.2 1.9 3.1 2.5 25.1 12.8 1.7 1.3 12.0 1.8 2.0 0.0 1.2 2.3 1.4 0.0 16.1 14.9 30.8 3.1 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 7.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 51.8 0.0 0.8 23.6 0.8 0.0 28.1 0.1 0.0 0.0 0.0 16.1 0.0 0.0 0.1 14.9 3.1 30.8 0.9 0.0 8.9 7.1 15.5 2.7 8.3 6.8 3.7 10.9 3.5 10.1 12.0 6.0 5.3 0.9 0.9 0.3 2.7 0.6 2.5 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 2.3 0.0 29.1 1.6 0.0 3.1 73.2 0.0 0.6 49.9 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.1 1.4 0.0 0.0 0.2 1.3 0.1 0.2 0.0 0.0 0.7 PRAME "CT130, MAPE" ENSG00000185686 "Preferentially expressed antigen in melanoma" P78395 22 22547701-22559361 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 54.3" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 241.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "K-562: 143.2" "Not detected" "Not detected" "HPA045153, HPA068562" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA045153: AB_10797259, HPA068562: " "unprognostic (9.36e-3)" "unprognostic (9.74e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.41e-4)" "unprognostic (3.43e-2)" "unprognostic (4.00e-2)" "unprognostic (1.33e-1)" "unprognostic (6.52e-3)" "unprognostic (9.68e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.48e-9)" "unprognostic (1.95e-1)" "unprognostic (2.21e-1)" "unprognostic (8.87e-2)" "unprognostic (1.26e-1)" 0.1 1.7 0.1 0.3 0.3 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.5 0.0 2.8 10.9 0.1 0.2 0.1 0.3 0.2 0.0 0.7 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.0 54.3 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 9.4 0.0 19.8 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 14.2 0.0 0.0 0.0 0.6 0.0 0.0 8.6 2.1 5.0 3.7 0.1 0.0 0.4 27.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 143.2 2.3 0.0 1.2 0.0 0.0 0.0 4.2 0.6 0.8 0.0 0.0 0.0 0.0 0.1 29.4 0.0 0.0 0.0 0.0 4.3 3.5 0.7 0.0 25.8 0.0 0.0 0.4 2.0 0.1 0.0 0.1 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 30.6 5.2 0.0 0.0 5.4 0.0 0.2 0.1 0.0 3.2 0.8 0.3 6.5 0.0 29.8 241.6 0.0 0.0 0.0 0.0 0.0 PRAMEF1 ENSG00000116721 "PRAME family member 1" O95521 1 12791397-12796628 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.2" "Group enriched" "Detected in some" 48 "Early spermatids: 6.8;Late spermatids: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" NA NA "unprognostic (2.78e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PRAMEF10 ENSG00000187545 "PRAME family member 10" O60809 1 12892896-12898270 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 67 "liver: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 29 "liver cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "SCLC-21H: 2.7" NA NA "unprognostic (1.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF11 ENSG00000239810 "PRAME family member 11" 1 12824605-12831410 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 18 "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF12 ENSG00000116726 "PRAME family member 12" O95522 1 12774841-12777906 "Plasma proteins, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.8" "HPA045286, HPA051704" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045286: AB_10794782, HPA051704: AB_2681581" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF13 ENSG00000279169 "PRAME family member 13" Q5VWM6 1 13196330-13201409 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.7" NA NA 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF15 ENSG00000204501 "PRAME family member 15" Q5VWM5 1 13315581-13322598 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "liver: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF18 ENSG00000279804 "PRAME family member 18" Q5VWM3 1 13222705-13226106 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "bone marrow: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057423 Uncertain NA NA "HPA057423: AB_2683435" 0.0 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.3 0.1 0.4 0.0 0.4 0.5 0.8 0.0 0.0 0.2 0.0 0.1 0.1 0.5 0.0 0.2 0.2 0.4 0.2 0.0 0.1 0.1 0.1 0.0 0.7 0.1 0.3 0.1 0.1 0.2 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF2 FLJ43580 ENSG00000120952 "PRAME family member 2" O60811 1 12857086-12861909 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "HDLM-2: 1.8" NA NA "unprognostic (1.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF20 "OTTHUMT00000008157, PRAMEF21" ENSG00000204478 "PRAME family member 20" Q5VT98 1 13410450-13421328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SCLC-21H: 3.4" NA NA "unprognostic (1.02e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAMEF4 RP5-845O24.6 ENSG00000243073 "PRAME family member 4" O60810 1 12879224-12886201 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "liver: 1.3" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 12 "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRAP1 UPA ENSG00000165828 "Proline rich acidic protein 1" Q96NZ9 10 133347146-133352683 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 196.7;liver: 112.7" "Group enriched" "Detected in many" 7 "Enterocytes: 2498.9;Hepatocytes: 739.9;Paneth cells: 1500.0" "Group enriched" "Detected in many" 6 "colorectal cancer: 72.9;liver cancer: 348.8" "Region enriched" "Detected in single" 4 "pons and medulla: 1.1" "Cell type enhanced" "Detected in some" "basophil: 2.9;NK-cell: 3.6" "Group enriched" "Detected in many" 4 "granulocytes: 2.9;NK-cells: 3.6" "Cell line enriched" "Detected in some" 4 "Hep G2: 45.4" "HPA038713, HPA052451" Supported "Secreted to digestive system" NA NA 330000000 "HPA038713: AB_10673117, HPA052451: AB_2681839" "unprognostic (1.63e-3)" "unprognostic (1.79e-2)" "unprognostic (1.09e-1)" "unprognostic (1.89e-3)" "unprognostic (1.18e-1)" "unprognostic (1.11e-1)" "unprognostic (8.90e-2)" "unprognostic (3.60e-2)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (4.35e-3)" "unprognostic (4.91e-2)" "unprognostic (8.23e-3)" "unprognostic (2.25e-1)" "unprognostic (3.15e-1)" "unprognostic (2.92e-2)" "unprognostic (2.22e-3)" 0.1 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.2 0.1 145.3 0.2 0.4 111.1 0.1 2.4 0.1 0.2 3.4 0.1 0.1 0.1 24.4 112.7 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.2 0.1 1.1 0.1 3.1 3.6 0.2 0.1 0.1 0.1 196.7 0.1 0.1 0.2 0.1 2.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.7 2.9 0.2 3.6 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 10.7 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 45.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.6 0.0 0.6 0.1 1.4 0.0 0.2 0.3 0.5 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.3 0.0 0.0 0.0 2.9 0.2 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.2 0.8 0.4 0.4 1.8 3.6 0.1 0.7 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.0 11.0 0.1 0.0 0.0 0.0 10.2 0.0 0.0 8.7 0.0 0.2 28.2 0.0 1.2 0.0 2498.9 0.0 0.2 0.2 0.0 0.1 9.2 739.9 0.2 0.0 17.6 11.6 15.9 6.1 1.1 0.0 0.0 0.0 55.9 0.0 0.2 1500.0 1.4 220.6 0.0 0.0 0.0 37.1 2.0 0.0 0.2 6.9 48.3 0.1 PRB1 "PM, PMF, PMS, PRB1L, PRB1M" ENSG00000251655 "Proline rich protein BstNI subfamily 1" 12 11351823-11395566 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 80 "salivary gland: 605.6" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.7" "Secreted to digestive system" NA NA 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 605.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PRB2 "cP7, PRPPRB1, Ps" ENSG00000121335 "Proline rich protein BstNI subfamily 2" P02812 12 11391540-11501041 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 94 "salivary gland: 544.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.8" "Cell type enriched" "Detected in single" 23 "myeloid DC: 2.2" "Lineage enriched" "Detected in single" 23 "dendritic cells: 2.2" "Cell line enriched" "Detected in single" 5 "U-2 OS: 2.3" "Secreted to digestive system" NA NA "unprognostic (1.36e-1)" "unprognostic (1.01e-2)" "unprognostic (2.61e-1)" "unprognostic (2.07e-2)" "unprognostic (9.21e-2)" "unprognostic (5.51e-3)" "unprognostic (1.97e-4)" "unprognostic (1.51e-1)" 0.1 0.0 1.3 0.1 5.8 0.0 0.1 0.1 2.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 2.3 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 544.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 5.8 0.1 2.9 2.3 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRB3 PRG ENSG00000197870 "Proline rich protein BstNI subfamily 3" Q04118 12 11265924-11269805 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 208 "salivary gland: 2125.3" "Group enriched" "Detected in some" 15 "Early spermatids: 8.3;Late spermatids: 3.1" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enhanced" "Detected in some" "NTERA-2: 6.9;RT4: 1.3;SuSa: 2.5;U-2 OS: 1.2" "Secreted to digestive system" NA NA "unprognostic (4.12e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.51e-1)" "unprognostic (7.46e-3)" "unprognostic (4.12e-2)" "unprognostic (9.65e-2)" "unprognostic (1.94e-2)" "unprognostic (8.27e-2)" "unprognostic (9.98e-2)" "unprognostic (2.35e-1)" "unprognostic (2.11e-2)" "unprognostic (1.04e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 2125.3 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.9 0.1 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.5 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 PRB4 ENSG00000230657 "Proline rich protein BstNI subfamily 4" 12 11307083-11310435 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 273 "salivary gland: 3472.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "lung cancer: 2.0;melanoma: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 31 "CACO-2: 7.8" "Secreted to digestive system" NA NA "unprognostic (1.05e-1)" "unprognostic (8.25e-2)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 12.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3472.8 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966038-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3" "Group enriched" "Detected in many" 4 "Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 18.9;T-reg: 5.8" "Group enriched" "Detected in many" 6 "granulocytes: 18.9;T-cells: 5.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 3.2 2.8 3.5 13.0 3.8 43.3 3.6 12.5 5.8 3.4 9.3 1.6 0.2 6.1 3.5 4.7 15.0 2.6 2.8 3.5 5.1 4.9 2.3 1.9 5.8 9.2 3.4 4.7 3.6 3.8 1.6 1.5 10.4 5.2 2.4 9.9 2.7 3.9 1.0 2.5 9.9 6.6 5.4 3.5 5.8 5.0 44.3 0.8 44.5 1.8 15.3 16.5 3.5 4.9 0.9 2.0 18.9 0.4 2.0 5.8 0.7 32.9 40.2 33.7 22.8 3.5 6.0 18.1 47.4 28.0 52.5 40.3 26.8 32.1 12.5 18.9 30.2 32.5 44.9 38.3 20.3 49.8 23.2 42.5 26.0 52.6 24.6 0.9 12.8 22.5 1.5 2.6 29.8 30.6 11.7 29.4 20.3 21.6 26.9 48.8 28.6 13.1 19.5 13.2 43.1 17.3 13.8 42.0 16.8 23.4 25.0 30.7 24.3 45.1 25.1 16.3 24.3 30.1 25.3 17.6 34.7 30.7 28.6 68.2 8.7 23.1 15.5 15.2 31.8 53.0 18.9 0.4 2.0 0.5 0.0 0.3 0.9 1.0 1.0 1.8 0.4 0.9 0.4 0.2 2.0 0.2 2.0 5.8 0.7 3.5 3.8 12.5 5.8 5.1 4.9 3.4 4.7 5.2 0.8 0.0 1.9 12.3 5.2 14.7 6.8 2.4 0.0 4.0 10.3 3.5 0.0 9.5 0.0 2.9 17.7 3.2 2.0 70.0 2.5 59.0 7.4 5.1 9.2 1.6 17.6 3.2 5.2 9.8 8.6 12.3 3.4 7.0 3.3 9.0 4.5 4.5 1.7 2.6 1.8 0.0 3.5 6.5 10.3 129.3 60.0 12.4 12.2 6.9 7.4 5.4 PRCD RP36 ENSG00000214140 "Photoreceptor disc component" Q00LT1 17 76527586-76553578 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "retina: 61.1" "Cell type enhanced" "Detected in many" 25 "Bipolar cells: 108.6;Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 413.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 12 "cerebellum: 14.8" "Group enriched" "Detected in some" 6 "memory B-cell: 1.0;naive B-cell: 1.8;NK-cell: 1.6" "Group enriched" "Detected in many" 7 "B-cells: 1.8;NK-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;ASC TERT1: 3.3;BEWO: 3.6;Hep G2: 5.0;HHSteC: 3.3;HSkMC: 4.1;PC-3: 2.1;SH-SY5Y: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-3)" "unprognostic (3.74e-1)" "unprognostic (1.31e-4)" "unprognostic (6.56e-2)" "unprognostic (4.07e-3)" "unprognostic (1.76e-1)" "unprognostic (2.07e-1)" "unprognostic (4.04e-2)" "unprognostic (2.45e-1)" "unprognostic (1.19e-6)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (8.94e-3)" "unprognostic (1.39e-2)" 1.6 2.2 0.7 0.7 0.7 0.0 1.5 14.8 1.1 1.2 0.7 0.7 0.7 0.7 1.5 3.5 0.7 1.1 1.5 2.0 0.7 0.5 0.7 0.7 1.1 1.4 0.7 0.7 1.3 0.8 4.1 0.7 1.4 1.2 1.1 0.0 61.1 2.3 1.2 1.2 1.5 0.7 0.7 1.0 2.3 0.4 0.7 0.7 0.7 1.0 1.0 0.7 1.7 1.9 1.8 0.0 0.2 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 3.4 3.3 3.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 5.0 3.3 0.0 0.0 4.1 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 1.8 0.0 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.7 0.7 14.8 1.1 0.7 0.5 0.7 0.7 1.2 0.7 0.0 0.0 13.0 0.1 0.5 108.6 3.5 0.0 0.0 1.2 0.0 143.3 0.0 0.0 0.2 2.4 4.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.1 35.0 0.0 1.3 0.0 6.8 5.8 0.0 6.8 0.0 0.0 64.0 0.1 0.0 1.8 0.0 413.5 6.5 1.0 0.5 1.1 0.3 0.2 4.3 0.0 0.0 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 106086320-106109939 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 49.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 49.1;T-cells: 100.2;Urothelial cells: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4" "Group enriched" "Detected in many" 5 "granulocytes: 6.8;T-cells: 19.3" "Cell line enhanced" "Detected in some" "Karpas-707: 68.5;RPMI-8226: 12.8;U-266/70: 25.7;U-266/84: 16.6" "Region enriched" "Detected in single" 6 "olfactory region: 4.4" "Low region specificity" "Detected in all" "HPA030033, HPA075427" Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA030033: AB_10601050, HPA075427: " "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavorable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 11.6 1.5 1.6 26.3 3.2 10.4 7.0 5.3 1.6 14.0 16.5 1.9 1.4 5.4 11.6 2.2 33.4 3.8 8.1 2.3 1.9 2.0 3.1 2.4 18.8 33.3 2.1 0.5 4.2 1.8 1.2 2.1 9.0 4.9 3.6 11.0 4.3 10.6 3.0 2.0 8.9 18.2 3.4 7.4 24.2 8.6 3.0 1.5 3.1 7.7 35.7 49.9 12.8 18.0 1.5 0.2 6.8 0.6 2.5 19.3 1.3 0.4 0.1 0.3 0.0 0.5 0.7 0.0 2.3 7.2 0.7 1.3 0.4 2.8 0.6 0.1 4.6 0.1 0.1 0.0 1.1 0.8 6.4 0.0 0.1 1.4 0.0 1.1 0.2 0.5 0.7 3.6 1.0 3.0 0.2 0.9 0.3 0.4 68.5 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 0.0 12.8 0.6 0.1 0.0 0.0 0.3 0.3 0.0 0.5 0.3 0.7 0.4 1.1 0.6 0.6 2.1 25.7 16.6 1.5 1.6 0.4 0.6 1.2 0.4 5.6 12.6 0.6 19.3 1.5 12.0 11.6 0.2 0.5 1.1 6.8 6.8 2.5 0.1 0.2 15.4 1.3 1.6 3.2 5.3 1.6 1.9 2.0 2.1 0.5 4.9 1.5 0.0 9.0 19.7 8.0 17.3 0.8 1.4 0.0 2.7 7.9 3.5 49.1 0.4 0.0 0.3 0.8 20.4 7.3 23.3 0.2 0.5 5.1 3.1 3.5 1.5 19.3 0.0 1.7 8.0 24.7 0.0 0.0 38.5 35.4 47.7 3.1 0.5 4.8 4.3 1.1 0.1 0.4 0.0 16.4 0.3 1.3 36.3 0.6 100.2 2.5 77.0 PRDM12 ENSG00000130711 "PR/SET domain 12" Q9H4Q4 9 130664594-130682981 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "RH-30: 19.4" "Region enriched" "Detected in single" 7 "basal ganglia: 11.2" "Group enriched" "Detected in some" 33 "basal ganglia: 6.1;hypothalamus: 2.0" HPA043143 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA043143: AB_10806379" "unprognostic (3.25e-2)" "unprognostic (2.32e-1)" "unprognostic (3.40e-1)" "unprognostic (1.81e-4)" "unprognostic (7.90e-2)" "unprognostic (4.75e-3)" "unprognostic (2.48e-3)" "unprognostic (4.18e-2)" "unprognostic (4.61e-1)" "unprognostic (2.70e-1)" "unprognostic (6.43e-2)" "unprognostic (7.58e-2)" "unprognostic (4.03e-3)" "unprognostic (3.01e-2)" "unprognostic (4.79e-2)" "unprognostic (6.30e-4)" "unprognostic (1.40e-1)" 0.1 0.7 1.0 0.3 1.5 0.0 0.1 1.1 2.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.0 0.0 1.0 3.7 0.0 0.2 0.0 0.0 0.5 0.0 0.8 0.1 0.2 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.1 0.0 0.4 0.0 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.9 0.0 0.8 0.0 0.1 0.1 0.0 19.4 0.5 0.0 0.0 0.9 0.3 0.4 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 PRDM13 ENSG00000112238 "PR/SET domain 13" Q9H4Q3 6 99606730-99615578 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.1" "Cell type enhanced" "Detected in single" 19 "Horizontal cells: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA070592 Uncertain NA NA "HPA070592: AB_2686283" "unprognostic (4.09e-1)" "unprognostic (1.68e-2)" "unprognostic (4.30e-1)" "unprognostic (3.65e-1)" "unprognostic (1.55e-1)" "unprognostic (3.16e-2)" "unprognostic (1.24e-2)" "unprognostic (2.93e-1)" "unprognostic (1.86e-2)" "unprognostic (7.54e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 PRDM14 ENSG00000147596 "PR/SET domain 14" Q9GZV8 8 70051651-70071693 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 658 "testis cancer: 34.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 57 "NTERA-2: 33.7;SuSa: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019094, HPA057070" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA019094: AB_1855686, HPA057070: AB_2683327" "unprognostic (5.86e-2)" "unprognostic (9.32e-2)" "unprognostic (6.14e-3)" "unprognostic (1.37e-2)" "unprognostic (8.62e-2)" 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 0.4 1.1 0.2 0.3 0.2 1.1 0.2 0.2 0.5 0.2 0.5 0.2 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 0.2 0.1 1.7 0.3 0.2 0.4 1.2 0.2 0.2 0.2 0.6 0.3 5.4 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.6 1.0 1.4 1.6 1.0 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 9.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.5 0.6 1.0 0.4 0.8 1.4 1.1 0.7 0.3 1.6 2.5 1.9 1.4 1.0 1.6 1.0 0.4 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 PRDM6 "KMT8C, PRISM" ENSG00000061455 "PR/SET domain 6" Q9NQX0 5 123089121-123194266 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 2.9;Fibroblasts: 6.0;Late spermatids: 4.1;Melanocytes: 3.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "pons and medulla: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.0;HEK 293: 9.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA030324 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030324: AB_10670032" "unprognostic (2.33e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (3.12e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" "unprognostic (1.54e-2)" "unprognostic (4.66e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-7)" "unprognostic (9.30e-4)" "unprognostic (1.10e-1)" "unprognostic (3.43e-4)" "unprognostic (1.27e-1)" 1.3 0.3 0.3 0.6 0.3 0.0 1.4 0.4 0.5 1.6 6.7 0.4 0.3 0.4 1.8 0.6 1.2 0.6 19.7 0.9 0.4 0.3 0.6 0.3 10.6 0.0 0.5 0.4 3.8 0.5 0.3 0.5 8.1 3.6 14.1 1.9 0.0 0.3 0.8 0.2 0.4 1.0 29.7 0.8 0.1 1.1 0.5 0.0 0.0 1.4 0.2 0.6 18.4 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.6 0.9 7.0 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.5 0.2 0.0 1.4 0.0 0.0 0.3 9.8 2.1 0.9 0.0 2.0 0.0 0.3 0.1 0.1 0.2 0.1 0.3 0.0 0.1 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 1.1 0.4 0.1 1.5 0.0 0.0 0.5 0.6 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.5 0.4 0.3 0.5 0.4 3.6 0.0 0.0 0.0 0.0 0.1 1.6 0.8 1.1 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.1 2.9 0.5 0.0 0.0 0.2 0.2 6.0 0.1 0.0 0.5 0.7 0.0 0.0 0.0 0.3 4.1 2.0 0.7 3.3 0.0 0.0 0.2 0.1 0.0 1.1 0.3 0.8 0.0 1.4 1.9 1.9 1.1 0.3 0.0 0.0 0.0 PRDM7 ZNF910 ENSG00000126856 "PR/SET domain 7" Q9NQW5 16 90056566-90092072 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 4.8" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.4;Cardiomyocytes: 5.0;Ciliated cells: 2.7" "Cancer enriched" "Detected in single" 30 "melanoma: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "REH: 9.1;SK-MEL-30: 6.7" HPA059944 Approved Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA059944: AB_2684174" "unprognostic (3.98e-1)" "unprognostic (8.89e-2)" "unprognostic (8.02e-3)" "unprognostic (8.26e-2)" "unprognostic (9.01e-2)" "unprognostic (5.61e-3)" "unprognostic (1.05e-2)" "unprognostic (1.46e-1)" "unprognostic (5.73e-1)" "unprognostic (5.52e-4)" "unprognostic (1.36e-1)" "unprognostic (1.61e-1)" "unprognostic (4.03e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 PRDM8 KMT8D ENSG00000152784 "PR/SET domain 8" Q9NQV8 4 80183879-80204329 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;prostate: 30.9;seminal vesicle: 34.0" "Cell type enriched" "Detected in many" 31 "Bipolar cells: 289.0" "Cancer enhanced" "Detected in many" "prostate cancer: 4.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.2;LHCN-M2: 18.2;NB-4: 20.4;SCLC-21H: 44.1" "Region enhanced" "Detected in many" "hippocampal formation: 31.4" "Group enriched" "Detected in all" 4 "amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7" HPA057253 Approved "Nuclear bodies" No NA "Nuclear bodies" "HPA057253: AB_2683382" "unprognostic (2.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (1.65e-1)" "unprognostic (7.95e-2)" "unprognostic (1.19e-1)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (2.80e-2)" "unprognostic (1.89e-11)" "unprognostic (4.64e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-1)" 3.6 3.5 17.6 6.3 10.1 4.4 3.3 3.6 31.0 9.3 8.2 10.9 1.8 2.1 8.2 3.0 2.8 3.7 2.7 1.9 30.9 6.0 1.4 0.9 2.0 6.1 12.3 18.1 5.5 1.1 0.8 4.5 5.6 7.5 30.9 2.6 4.3 1.5 34.0 3.0 2.1 4.4 8.6 15.2 2.5 4.4 1.9 9.0 0.0 1.1 0.0 3.5 9.0 8.2 2.2 0.5 2.1 0.0 0.7 2.4 0.4 0.9 0.0 0.3 0.0 0.9 3.3 0.0 2.5 9.0 1.2 1.4 0.0 0.9 0.0 0.0 3.1 0.8 0.3 0.0 1.0 5.4 3.7 0.8 0.3 0.0 0.0 1.9 3.7 1.1 2.0 0.0 4.9 1.4 12.2 0.1 1.0 0.0 1.6 18.2 0.0 1.7 20.4 0.0 0.0 7.4 0.6 0.0 0.0 0.5 0.1 44.1 6.1 0.1 0.0 0.0 0.0 0.0 1.9 3.8 3.2 0.4 2.3 0.1 0.7 0.0 0.0 7.9 1.8 0.4 0.0 0.0 0.0 1.6 0.0 2.4 0.3 2.1 2.0 0.3 2.2 1.3 0.7 2.1 0.7 0.0 0.5 0.9 0.4 17.6 10.1 3.6 31.0 30.9 6.0 12.3 18.1 7.5 9.0 0.0 0.3 3.5 3.2 0.6 289.0 1.8 0.0 6.7 9.1 1.8 2.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.2 0.1 3.0 2.3 0.0 0.0 0.5 3.2 0.0 0.0 0.0 3.3 2.8 0.7 1.7 1.0 0.0 4.1 0.4 0.0 3.2 0.0 9.2 0.0 1.7 0.4 0.5 0.1 0.1 1.0 0.0 0.6 PRDM9 "KMT8B, MSBP3, PFM6, ZNF899" ENSG00000164256 "PR/SET domain 9" Q9NQV7 5 23443586-23528597 "Enzymes, Predicted intracellular proteins, Transcription factors" "Meiosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.1;epididymis: 3.3;testis: 8.3" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 2.1;Late spermatids: 1.8;Spermatocytes: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "U-266/70: 12.4" "Low region specificity" "Detected in some" HPA059555 Uncertain NA NA "HPA059555: AB_2684061" "unprognostic (1.23e-4)" "unprognostic (8.64e-2)" "unprognostic (2.18e-2)" "unprognostic (8.34e-2)" "unprognostic (4.11e-1)" 0.1 0.0 0.1 0.1 0.1 1.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 3.3 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.2 0.0 8.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.5 0.5 4.1 0.7 2.3 1.0 0.1 0.0 0.5 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.2 0.9 0.0 0.0 12.4 0.2 0.1 0.1 0.2 0.1 2.9 0.7 0.3 0.7 0.3 0.8 0.9 0.8 0.6 0.3 1.5 0.8 1.0 4.1 2.3 0.5 0.5 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.4 1.0 0.0 0.0 0.0 0.0 0.0 PRDX4 AOE37-2 ENSG00000123131 "Peroxiredoxin 4" Q13162 X 23664262-23686399 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "liver: 127.6;pancreas: 320.8" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 604.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008659, CAB027389, CAB047362, HPA067039" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 11000000 "Endoplasmic reticulum, Cytosol" "CAB008659: AB_1620984, CAB027389: , CAB047362: , HPA067039: " "unprognostic (3.82e-2)" "unprognostic (6.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.06e-3)" "unprognostic (1.64e-1)" "unprognostic (1.65e-2)" "unprognostic (1.29e-3)" "unprognostic (1.08e-1)" "unprognostic (8.32e-2)" "unprognostic (3.75e-2)" "unprognostic (2.97e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (7.44e-2)" "unprognostic (1.29e-1)" "unprognostic (3.56e-1)" "unprognostic (4.10e-2)" 11.6 14.8 3.8 7.0 6.4 3.9 11.2 3.3 5.4 13.2 10.7 6.5 17.4 8.9 11.5 10.5 13.1 9.6 12.9 17.6 3.8 4.0 11.8 127.6 8.9 16.9 7.2 4.0 14.6 320.8 6.1 15.8 21.9 7.4 9.3 11.4 8.0 25.4 14.1 7.8 7.2 10.6 8.8 8.1 12.6 12.8 25.2 6.1 4.7 12.0 10.0 15.0 10.8 8.7 27.9 31.4 2.0 39.3 24.1 22.7 21.3 23.9 33.1 14.0 27.1 76.5 39.1 19.7 32.3 35.2 29.4 42.8 34.6 30.2 20.6 15.2 41.8 34.1 29.1 40.3 20.0 28.1 12.6 77.5 14.6 29.2 43.8 31.9 18.8 13.9 41.4 26.0 28.5 28.7 32.0 36.7 6.9 28.2 76.2 27.1 35.7 9.6 29.5 48.4 47.1 48.6 13.3 35.1 116.3 26.2 8.4 20.6 17.5 29.8 35.3 23.8 80.2 37.3 24.0 24.2 21.0 13.8 54.0 24.2 25.0 30.2 22.1 37.5 24.4 29.8 1.7 20.6 2.0 17.8 32.2 21.8 27.9 22.7 18.6 31.4 16.2 16.4 16.7 1.5 24.1 39.3 22.0 22.1 21.3 3.8 6.4 3.3 5.4 3.8 4.0 7.2 4.0 7.4 6.1 53.6 69.3 34.3 72.4 53.0 14.1 33.1 117.2 62.9 56.9 47.1 7.9 283.9 8.3 219.7 305.3 87.4 33.6 23.3 310.3 449.8 156.0 130.0 41.6 497.8 155.7 11.1 56.3 100.1 55.2 604.6 233.8 49.6 189.0 103.6 79.9 51.0 268.1 31.6 135.4 36.5 17.9 142.3 69.0 183.9 270.0 45.7 216.3 25.4 110.8 64.0 PRELID2 "FLJ38376, MGC21644" ENSG00000186314 "PRELI domain containing 2" Q8N945 5 145471799-145835369 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.2" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 377.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 15.8;myeloid DC: 5.2" "Group enriched" "Detected in all" 5 "dendritic cells: 5.2;granulocytes: 15.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042486 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA042486: AB_10797498" "unprognostic (9.45e-3)" "unprognostic (1.95e-1)" "unprognostic (7.58e-3)" "unprognostic (2.71e-5)" "unprognostic (1.96e-3)" "unprognostic (6.53e-4)" "unprognostic (6.62e-5)" "unprognostic (2.27e-1)" "unprognostic (4.21e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (9.65e-6)" "unprognostic (2.65e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-4)" "unprognostic (6.42e-3)" 6.6 2.4 1.6 5.3 2.0 3.9 4.4 0.7 2.9 4.9 16.4 2.3 2.8 10.6 5.2 2.9 2.4 3.0 14.5 6.4 1.4 1.4 2.6 2.7 2.4 2.7 2.3 1.1 5.2 15.9 1.3 2.8 0.9 2.0 4.2 16.2 9.2 4.3 2.7 1.3 3.0 31.2 6.2 2.5 2.1 7.8 2.5 1.5 0.8 4.1 2.4 1.9 4.3 11.6 1.8 5.2 15.8 1.9 1.8 2.0 0.9 10.8 3.6 3.4 5.4 0.8 1.9 0.0 3.6 6.3 6.8 9.6 11.6 17.9 0.0 6.2 4.3 15.6 3.3 2.6 8.2 10.1 3.1 4.2 12.5 4.0 6.0 2.1 1.6 13.3 1.1 3.5 7.8 6.9 9.5 7.6 0.0 6.8 5.0 3.3 1.8 0.0 1.9 1.7 12.6 2.4 0.0 0.0 1.7 3.2 1.7 1.5 3.0 4.6 0.6 7.2 1.6 5.5 2.4 7.0 5.9 3.2 10.4 8.1 0.2 0.0 0.0 10.6 0.0 2.4 15.8 1.3 0.4 0.8 1.9 0.4 1.7 1.6 1.2 5.2 1.8 0.2 1.2 0.5 1.8 1.3 0.6 2.0 0.9 1.6 2.0 0.7 2.9 1.4 1.4 2.3 1.1 2.0 1.5 0.0 2.4 1.9 11.1 3.7 19.4 7.7 5.1 2.7 6.8 0.0 377.0 0.1 0.0 11.6 3.4 5.8 91.5 0.0 11.4 2.4 5.3 2.7 17.3 2.1 2.4 4.8 9.2 3.1 2.1 1.0 3.1 4.3 0.0 3.6 27.5 7.5 15.0 48.0 4.2 2.4 47.8 0.0 4.7 0.9 1.0 2.9 0.2 3.2 32.3 8.0 PRELID3B "C20orf45, dJ543J19.5, SLMO2" ENSG00000101166 "PRELI domain containing 3B" Q9Y3B1 20 59033145-59042909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 91.2" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 165.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047721 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047721: AB_2680131" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (3.82e-2)" "prognostic unfavorable (5.04e-4)" "unprognostic (1.37e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (6.96e-5)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-2)" "unprognostic (1.71e-2)" "unprognostic (2.47e-2)" "unprognostic (1.20e-3)" "unprognostic (5.84e-2)" "unprognostic (2.64e-1)" "unprognostic (2.61e-2)" "unprognostic (8.96e-2)" 18.6 17.0 14.1 17.0 13.9 13.7 20.4 10.3 14.1 10.0 45.2 8.7 11.2 41.3 9.6 9.6 26.7 8.8 10.3 13.3 12.9 13.4 20.5 30.1 13.5 19.1 15.4 10.0 11.1 24.2 12.7 34.3 28.8 12.3 10.5 30.0 6.1 15.3 12.6 17.2 14.0 91.2 11.6 16.7 19.9 19.3 11.5 12.1 21.4 18.9 25.5 21.2 13.9 14.4 25.8 17.5 26.6 21.0 27.1 27.6 20.2 25.9 12.8 12.5 16.3 9.3 13.2 17.6 19.2 17.1 36.1 19.3 35.7 22.0 41.3 34.0 14.7 27.9 28.4 25.4 30.6 38.0 24.4 15.9 28.6 21.8 7.6 19.8 37.3 26.6 11.7 40.4 20.7 48.3 11.9 11.7 34.3 11.2 18.1 15.4 33.3 42.0 16.6 6.2 42.2 35.6 21.9 28.4 23.4 17.9 22.2 22.6 21.7 30.8 52.4 44.3 9.6 26.5 29.2 13.7 13.1 12.7 23.9 10.1 12.3 17.5 33.4 14.3 18.4 14.6 26.6 13.6 13.5 21.4 17.9 25.9 25.8 26.1 24.0 17.5 18.6 23.6 24.8 11.7 27.1 21.0 14.7 27.6 20.2 14.1 13.9 10.3 14.1 12.9 13.4 15.4 10.0 12.3 12.1 20.8 31.8 13.4 46.7 0.0 8.1 0.0 25.5 41.5 28.4 21.0 5.9 58.5 58.0 57.9 52.0 18.0 96.3 0.0 49.8 92.9 28.8 59.3 15.1 23.2 49.1 11.1 26.9 12.3 34.8 17.4 13.8 30.9 0.0 55.9 65.9 14.3 59.9 56.1 14.9 41.1 6.5 25.8 0.0 62.2 36.7 0.0 103.8 36.2 68.2 165.6 PRELP "prolargin, SLRR2A" ENSG00000188783 "Proline and arginine rich end leucine rich repeat protein" P51888 1 203475828-203491352 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 183.7" "Group enriched" "Detected in many" 4 "Fibroblasts: 65.7;Leydig cells: 93.2;Melanocytes: 182.2;Muller glia cells: 156.5;Peritubular cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "ASC diff: 18.7;BJ: 7.6;fHDF/TERT166: 11.5;SuSa: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA 280000 "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.83e-2)" "unprognostic (6.56e-2)" "unprognostic (2.75e-2)" "unprognostic (1.61e-1)" "unprognostic (2.84e-2)" "unprognostic (3.98e-2)" "unprognostic (2.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (5.62e-6)" "unprognostic (2.81e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (1.02e-4)" 46.7 16.0 6.3 7.7 5.8 1.1 52.3 3.6 5.0 57.4 35.7 3.7 16.8 5.0 45.3 17.8 46.2 29.5 27.4 58.6 7.0 1.8 8.1 7.3 49.9 5.2 6.4 9.5 62.3 6.6 1.8 7.3 8.3 8.6 48.3 6.6 64.6 10.4 52.5 24.5 16.4 17.0 61.8 7.7 22.6 13.5 23.4 3.3 0.0 25.1 16.1 11.5 98.7 183.7 1.0 1.0 4.0 1.2 1.1 0.8 0.6 0.2 0.2 0.5 0.2 18.7 0.5 0.5 7.6 1.0 0.2 0.2 0.0 0.2 1.2 0.7 11.5 0.2 0.7 0.2 0.3 0.3 0.1 0.2 0.4 0.4 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 2.1 0.1 0.4 0.3 0.5 1.4 0.1 0.2 0.5 0.5 0.3 0.1 0.4 0.2 0.5 0.0 0.3 1.1 0.3 0.2 0.2 0.8 5.6 0.3 0.2 0.6 0.5 0.3 0.3 0.1 0.3 0.4 1.2 0.1 0.2 0.5 4.0 1.2 1.7 0.7 1.0 0.8 0.6 0.7 0.5 0.4 1.0 0.7 0.6 2.7 1.1 1.1 1.0 0.6 0.6 6.3 5.8 3.6 5.0 7.0 1.8 6.4 9.5 8.6 3.3 0.0 8.0 0.5 0.9 16.3 2.9 4.3 0.0 2.7 1.2 0.0 2.0 0.0 0.0 0.0 0.6 10.9 0.0 0.0 0.0 0.1 65.7 0.5 4.7 0.0 0.3 1.6 0.0 30.7 0.0 2.3 93.2 1.9 182.2 0.0 0.0 156.5 0.0 0.0 187.7 0.0 4.7 25.8 26.8 2.7 0.8 8.7 0.2 0.0 0.0 0.7 PREPL KIAA0436 ENSG00000138078 "Prolyl endopeptidase like" Q4J6C6 2 44316281-44361862 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.4" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 136.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063238 Approved NA NA "HPA063238: AB_2684967" "unprognostic (5.60e-3)" "unprognostic (9.81e-2)" "unprognostic (4.51e-2)" "unprognostic (4.65e-3)" "unprognostic (2.22e-1)" "unprognostic (8.53e-2)" "unprognostic (5.98e-3)" "unprognostic (4.38e-3)" "unprognostic (2.27e-1)" "unprognostic (2.72e-2)" "unprognostic (1.52e-2)" "unprognostic (4.67e-2)" "unprognostic (2.33e-2)" "unprognostic (3.79e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (1.75e-1)" 11.5 24.5 32.6 8.2 78.4 2.5 15.0 57.3 75.8 18.1 11.3 18.7 6.0 12.0 22.1 34.2 10.9 16.4 13.4 28.2 51.8 50.2 30.4 9.9 11.4 7.6 28.5 44.0 24.3 11.6 34.9 33.2 9.9 69.4 18.1 14.1 13.0 11.7 16.5 13.7 10.2 12.6 16.3 31.3 10.5 12.1 12.6 21.5 5.2 28.9 7.1 8.2 10.7 10.3 8.8 6.3 4.7 4.8 11.1 12.5 5.8 18.4 14.2 16.4 20.8 26.5 27.9 12.6 20.7 15.8 14.9 12.9 15.3 13.0 23.7 28.8 21.5 17.1 15.9 23.5 15.0 28.8 21.6 16.6 16.5 11.3 11.6 19.3 15.6 15.3 17.9 30.1 28.8 23.4 29.4 14.3 11.1 20.2 34.5 20.0 9.8 17.2 7.6 15.7 23.7 16.2 13.6 20.0 16.9 28.6 10.8 28.2 21.8 13.5 14.3 30.0 16.6 19.1 12.4 15.1 26.6 15.1 20.7 14.0 19.0 12.5 15.5 31.1 18.6 19.5 4.7 4.5 3.4 8.5 4.8 12.2 8.8 8.1 9.2 6.3 7.4 12.5 9.7 1.3 11.1 4.1 3.1 8.7 5.8 32.6 78.4 57.3 75.8 51.8 50.2 28.5 44.0 69.4 21.5 29.8 32.0 11.7 12.7 11.6 79.2 75.5 43.3 26.8 18.2 61.1 45.2 7.0 33.2 13.9 7.2 19.7 12.3 0.0 20.5 4.1 18.2 21.3 12.7 29.7 10.1 136.7 31.7 16.5 15.7 7.2 32.8 7.8 16.9 1.8 24.5 38.9 14.6 17.6 31.1 30.6 56.8 19.4 17.0 23.0 23.0 12.9 7.3 15.2 15.7 8.3 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827883 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7;brain: 35.5" "Cell type enhanced" "Detected in many" 11 "Kupffer cells: 81.5;Macrophages: 39.6;T-cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 44.2;SK-BR-3: 46.4;T-47d: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favorable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 10.8 8.1 20.5 25.1 24.9 32.7 12.4 11.4 25.0 9.6 5.1 35.5 0.2 4.6 3.2 2.7 4.8 3.7 9.5 4.9 21.8 15.5 4.1 4.0 17.7 28.3 26.2 12.1 2.2 3.9 5.2 5.8 8.4 17.4 3.9 4.6 7.7 4.0 2.8 4.6 2.7 8.6 5.6 27.6 28.7 6.1 4.5 23.9 2.8 6.7 1.0 15.1 10.3 2.5 2.0 2.1 11.7 2.7 2.1 9.3 2.2 0.6 1.7 22.5 0.0 0.3 1.7 7.8 0.7 1.0 3.2 0.8 0.1 0.0 4.5 14.3 2.0 6.1 0.2 1.1 0.0 2.1 1.0 0.5 0.6 2.5 0.0 1.3 2.4 14.7 1.8 0.0 7.4 0.0 2.2 19.4 2.0 0.0 0.1 4.2 44.2 0.0 6.9 0.9 2.2 1.8 6.6 6.5 2.7 0.1 0.0 4.7 0.7 4.1 46.4 5.1 1.3 41.4 18.9 21.6 1.3 4.6 0.0 1.2 0.2 0.9 5.5 21.0 4.9 6.9 5.2 2.3 2.5 5.0 2.7 3.0 2.0 2.7 4.2 2.1 1.7 0.4 1.5 11.7 2.1 2.3 1.7 9.3 2.2 20.5 24.9 11.4 17.7 21.8 15.5 26.2 12.1 17.4 23.9 3.0 10.0 24.1 0.2 2.3 0.2 2.5 2.5 8.1 4.5 1.8 7.9 0.6 0.0 0.1 2.8 13.4 0.2 0.0 1.1 2.7 6.0 0.8 1.1 1.5 28.2 0.0 1.2 20.3 81.5 2.3 0.9 39.6 8.5 16.2 1.0 17.2 0.2 0.0 0.4 0.0 0.6 0.0 4.7 1.9 10.2 2.0 7.8 41.5 2.9 0.4 PRF1 "HPLH2, P1, PFP" ENSG00000180644 "Perforin 1" P14222 10 70597348-70602775 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Cytolysis "Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 100.3;lymphoid tissue: 38.7" "Cell type enriched" "Detected in some" 9 "T-cells: 203.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 4 "gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1" "Group enriched" "Detected in many" 48 "NK-cells: 65.1;T-cells: 100.3" "Cell line enriched" "Detected in some" 11 "HDLM-2: 72.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002436, HPA037940" Approved Approved Cytosol "Intracellular and membrane" NA NA 960000 Cytosol "CAB002436: AB_563955, HPA037940: AB_2675747" "unprognostic (6.11e-3)" "unprognostic (1.26e-2)" "unprognostic (1.71e-1)" "prognostic favorable (2.09e-4)" "unprognostic (1.87e-2)" "prognostic favorable (3.54e-4)" "unprognostic (6.98e-3)" "unprognostic (2.62e-1)" "unprognostic (1.44e-3)" "unprognostic (1.69e-2)" "unprognostic (5.22e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (7.38e-2)" "unprognostic (2.70e-1)" "unprognostic (7.97e-3)" "unprognostic (5.22e-3)" 8.8 1.3 0.9 5.5 1.1 15.3 2.4 0.5 0.7 1.7 3.8 0.4 0.2 1.4 4.4 2.9 2.7 1.7 5.3 4.1 0.8 0.9 1.8 6.5 19.6 11.3 2.5 0.3 2.1 1.6 0.0 1.1 3.1 1.2 3.3 0.8 3.9 2.5 3.3 2.6 0.9 5.1 1.2 1.4 38.7 3.1 1.6 0.2 12.7 2.8 1.0 10.3 3.2 1.7 0.4 0.3 1.7 0.2 65.1 100.3 46.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 0.4 0.0 2.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.2 0.0 100.3 0.1 70.9 0.4 14.6 54.9 0.2 0.2 6.2 36.1 1.7 65.1 0.2 0.3 11.1 46.7 0.9 1.1 0.5 0.7 0.8 0.9 2.5 0.3 1.2 0.2 3.0 22.3 6.5 0.0 0.3 0.0 0.8 0.0 2.7 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.1 8.1 2.1 0.1 0.0 0.0 8.6 5.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.6 0.6 203.1 0.0 0.0 PRG2 "BMPG, MBP, proMBP" ENSG00000186652 "Proteoglycan 2, pro eosinophil major basic protein" P13727 11 57386794-57390657 "Plasma proteins, Predicted intracellular proteins" Immunity "Antibiotic, Antimicrobial, Heparin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 322.3" "Cell type enhanced" "Detected in some" 19 "Erythroid cells: 23.3;Extravillous trophoblasts: 16.4;granulocytes: 5.8;Hofbauer cells: 6.6;Syncytiotrophoblasts: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "basophil: 9.1" "Lineage enriched" "Detected in single" 92 "granulocytes: 9.1" "Group enriched" "Detected in some" 63 "HL-60: 143.5;HMC-1: 228.2;NB-4: 453.7" "Not detected" "Not detected" HPA038515 Supported "Intracellular and membrane" NA NA 130000000 "HPA038515: AB_10675800" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (3.39e-2)" "unprognostic (3.49e-1)" "unprognostic (8.62e-4)" "unprognostic (4.77e-3)" "unprognostic (3.20e-2)" "unprognostic (4.17e-2)" "unprognostic (2.26e-2)" "unprognostic (5.19e-3)" "unprognostic (2.17e-1)" "unprognostic (1.40e-11)" "unprognostic (4.26e-2)" "unprognostic (4.52e-3)" "unprognostic (6.47e-2)" "unprognostic (2.32e-1)" 1.5 0.0 0.1 0.1 0.1 16.9 0.9 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.2 0.3 0.1 0.0 0.1 2.8 2.2 0.1 0.1 0.1 0.1 0.3 0.0 0.4 322.3 0.1 0.1 0.0 0.1 0.5 0.1 0.3 1.8 0.1 0.1 0.1 6.8 0.1 0.1 0.1 1.6 0.4 0.1 0.2 0.1 0.2 0.0 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 143.5 228.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 453.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.0 0.0 23.3 0.0 16.4 0.0 0.0 5.8 0.0 6.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 PRG3 "MBP2, MBPH" ENSG00000156575 "Proteoglycan 3, pro eosinophil major basic protein 2" Q9Y2Y8 11 57376769-57381150 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "bone marrow: 31.6;lymphoid tissue: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 48 "HMC-1: 68.2" "Not detected" "Not detected" HPA064183 Enhanced "Secreted in other tissues" NA NA 240000 "HPA064183: AB_2685205" 0.1 0.0 0.0 0.0 0.0 31.6 0.1 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 68.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRG4 "bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP" ENSG00000116690 "Proteoglycan 4" Q92954 1 186296279-186314562 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 20.9;liver: 76.0" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 298.2" "Cancer enriched" "Detected in many" 10 "liver cancer: 28.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "T-reg: 4.0" "Lineage enriched" "Detected in single" 33 "T-cells: 4.0" "Cell line enriched" "Detected in some" 7 "ASC diff: 81.7" "Low region specificity" "Detected in many" HPA028523 Uncertain "Secreted to extracellular matrix" NA NA 4300000000 "HPA028523: AB_10669642" "unprognostic (8.67e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-3)" "unprognostic (1.98e-1)" "unprognostic (1.77e-1)" "unprognostic (7.87e-2)" "unprognostic (7.33e-2)" "unprognostic (1.78e-1)" "unprognostic (1.28e-1)" "unprognostic (1.53e-1)" "unprognostic (5.03e-2)" "unprognostic (4.11e-1)" "unprognostic (1.91e-13)" "unprognostic (1.40e-2)" "unprognostic (2.60e-1)" "unprognostic (1.60e-3)" "unprognostic (7.05e-3)" 20.9 0.7 0.1 1.0 0.1 0.2 5.1 0.2 0.3 0.2 2.8 0.4 0.1 0.1 0.2 1.7 0.9 6.8 0.3 11.0 0.1 0.3 0.2 76.0 7.2 0.3 0.3 0.1 0.7 1.1 0.1 0.3 0.1 0.3 0.3 0.2 2.6 1.0 0.2 13.8 1.6 0.2 0.7 0.1 0.3 0.2 1.1 0.1 0.2 0.7 1.9 0.3 0.7 0.1 0.1 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 81.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 4.0 0.1 0.1 0.1 0.2 0.3 0.1 0.3 0.3 0.1 0.3 0.1 20.8 14.4 8.2 0.0 0.6 0.0 0.8 7.6 20.1 38.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.0 2.2 0.1 15.1 298.2 0.1 0.0 0.0 7.4 8.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.5 0.0 0.1 PRH1 Pa ENSG00000231887 "Proline rich protein HaeIII subfamily 1" 12 10824960-11171608 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 916 "salivary gland: 2360.8" "Group enriched" "Detected in many" 47 "Early spermatids: 597.0;Late spermatids: 1603.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 2.0;BJ hTERT+ SV40 Large T+: 2.4;CAPAN-2: 5.3;GAMG: 2.1;HSkMC: 1.9;OE19: 3.8" NA NA "unprognostic (1.39e-1)" "unprognostic (1.38e-1)" "unprognostic (3.83e-3)" "unprognostic (3.61e-1)" "unprognostic (1.66e-1)" "unprognostic (3.70e-1)" "unprognostic (6.81e-2)" "unprognostic (6.85e-2)" "unprognostic (7.35e-3)" "unprognostic (2.14e-1)" "unprognostic (5.00e-3)" "unprognostic (1.16e-1)" "unprognostic (1.61e-2)" "unprognostic (1.50e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-2)" "unprognostic (2.68e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2360.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.2 0.0 0.0 0.2 1.7 1.2 0.3 1.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.9 2.4 0.0 0.5 5.3 0.7 0.0 0.0 2.1 0.2 0.0 0.5 1.6 0.2 0.0 0.0 0.0 1.3 1.1 0.0 0.0 1.9 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.9 0.7 0.0 3.8 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 1.2 0.5 0.0 0.3 0.2 0.7 0.1 0.0 0.2 0.4 0.8 0.0 1.1 0.2 1.7 1.6 0.0 8.9 1.3 0.8 0.5 0.0 1.9 0.7 0.0 1.4 7.9 22.7 3.9 0.9 1.7 11.1 597.0 1.0 0.7 23.3 6.1 0.3 0.6 0.4 0.0 0.2 0.8 3.2 1.7 3.7 0.6 1603.2 7.2 2.4 0.0 18.0 0.1 1.2 12.4 0.0 6.0 1.6 0.9 0.0 0.0 7.1 3.4 0.0 0.7 2.2 0.8 0.1 PRH2 Pr ENSG00000134551 "Proline rich protein HaeIII subfamily 2" P02810 12 10929236-10932341 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 128 "salivary gland: 2507.3" "Group enriched" "Detected in some" 207 "Early spermatids: 34.1;Late spermatids: 83.4" "Cancer enriched" "Detected in some" 11 "head and neck cancer: 11.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;hTERT-HME1: 1.2;PC-3: 1.1" "Secreted to digestive system" NA NA "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" "unprognostic (3.59e-1)" "unprognostic (1.25e-1)" "unprognostic (5.52e-2)" "unprognostic (3.83e-2)" "unprognostic (9.49e-2)" "unprognostic (1.01e-2)" "unprognostic (7.37e-2)" "unprognostic (1.63e-5)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (4.26e-1)" "unprognostic (3.43e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.1 0.1 0.1 0.0 0.2 3.8 0.0 0.1 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2507.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 4.6 2.9 0.0 0.0 0.4 0.3 0.1 0.2 0.5 0.9 0.2 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.7 0.4 0.1 0.0 0.0 0.4 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.3 0.3 0.9 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.8 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.7 0.2 0.9 0.4 0.3 0.7 0.1 0.2 0.3 0.5 0.1 0.5 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 PRIM2 PRIM2A ENSG00000146143 "DNA primase subunit 2" P49643 6 57314805-57646849 "Plasma proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 21.7;prostate: 22.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046566 Supported Nucleoplasm NA NA Nucleoplasm "HPA046566: AB_2679701" "unprognostic (1.24e-1)" "unprognostic (1.55e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (3.08e-1)" "unprognostic (6.24e-2)" "prognostic unfavorable (3.44e-5)" "unprognostic (2.31e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.00e-5)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.89e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" 5.4 1.6 1.7 9.0 2.3 7.8 4.1 6.5 3.3 5.3 3.9 2.5 2.4 3.0 9.7 3.7 5.6 3.7 2.7 3.1 2.8 3.5 2.7 2.7 7.1 3.6 1.5 4.3 2.2 2.4 5.4 5.9 1.7 22.6 5.0 3.5 7.3 3.4 1.1 3.4 3.7 5.8 3.6 6.7 2.4 5.3 3.1 21.7 4.6 4.5 8.7 4.7 2.7 5.0 7.3 2.5 5.4 5.6 7.9 2.7 15.4 6.3 12.6 14.6 7.2 12.8 10.5 19.1 18.7 21.3 28.6 10.0 7.4 14.1 10.6 23.8 14.5 10.5 11.3 10.9 26.4 15.4 9.2 16.7 8.6 16.7 2.9 16.1 10.6 4.8 4.1 23.5 8.2 5.2 9.6 15.2 15.8 37.6 17.7 9.7 16.9 12.8 8.0 13.2 6.3 12.9 17.5 11.3 7.7 8.0 9.3 7.1 12.4 5.9 7.7 14.6 12.6 13.9 6.6 21.7 21.4 39.7 16.1 5.1 9.8 16.4 9.9 17.0 11.6 0.3 2.4 2.5 5.5 5.1 6.2 5.0 5.0 7.5 4.1 4.9 3.6 7.9 1.0 5.6 5.4 7.3 5.9 2.7 0.0 2.4 5.1 5.5 3.5 5.0 0.9 2.5 2.7 3.4 3.5 11.8 13.3 3.3 3.7 7.2 2.9 3.5 23.3 4.5 19.3 5.2 5.5 11.5 3.8 7.9 6.4 1.2 4.9 4.8 2.8 6.1 5.1 0.0 5.4 6.1 4.9 3.9 5.3 6.3 1.4 4.5 19.4 5.2 10.6 12.1 2.6 4.8 12.8 7.5 5.0 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell type enriched" "Detected in some" 11 "Muller glia cells: 33.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: AB_2679744, HPA060047: AB_2684194" "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavorable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 7.5 0.0 0.0 0.2 0.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 13.2 7.5 0.4 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 0.0 0.0 0.0 1.0 0.5 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.4 2.6 0.0 0.0 0.0 0.0 33.7 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.1 PRKAA2 "AMPK, AMPKa2, PRKAA" ENSG00000162409 "Protein kinase AMP-activated catalytic subunit alpha 2" P54646 1 56645322-56715335 "Enzymes, Predicted membrane proteins, Transporters" "Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 39.1;skeletal muscle: 40.2" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 309.5;Rod photoreceptor cells: 106.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044540 Approved Supported "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA044540: AB_2678977" "unprognostic (4.17e-3)" "unprognostic (1.62e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (4.80e-4)" "unprognostic (9.35e-2)" "unprognostic (1.92e-3)" "prognostic unfavorable (5.30e-4)" "unprognostic (7.30e-2)" "unprognostic (3.94e-1)" "unprognostic (1.82e-1)" "unprognostic (1.97e-1)" "unprognostic (8.64e-2)" "prognostic favorable (4.95e-5)" "unprognostic (1.30e-2)" "unprognostic (4.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.85e-1)" 2.4 2.1 3.7 1.2 6.3 0.7 4.1 7.2 8.1 2.2 5.5 1.2 2.4 1.2 3.0 3.2 6.3 3.5 2.6 39.1 4.2 2.9 14.5 1.4 2.0 0.8 2.4 6.2 2.5 2.6 10.4 2.6 1.2 5.0 4.6 2.2 6.0 4.5 3.5 40.2 1.4 2.1 7.2 1.9 1.9 3.2 1.7 0.8 0.0 4.0 12.3 0.8 4.4 2.1 0.2 0.0 1.0 0.1 0.1 0.1 0.0 0.0 3.7 2.0 0.0 0.7 0.5 2.3 1.8 1.4 2.4 4.2 3.7 4.7 0.0 0.6 0.6 7.4 0.0 7.7 0.0 7.1 0.0 8.5 0.0 6.9 5.2 0.0 0.0 0.1 0.6 0.0 3.5 0.3 5.7 0.8 1.9 0.0 0.0 1.0 0.1 0.0 0.0 5.5 0.0 5.4 0.0 0.0 0.0 13.9 1.2 2.0 5.4 5.7 0.1 0.0 6.2 3.2 0.0 0.0 1.5 2.3 2.7 6.2 0.0 0.0 0.0 4.5 0.0 1.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 3.7 6.3 7.2 8.1 4.2 2.9 2.4 6.2 5.0 0.8 8.9 3.7 0.0 5.9 0.8 39.3 309.5 22.9 10.7 15.9 47.1 47.1 0.8 46.4 9.1 2.3 11.7 1.0 0.0 4.1 0.3 3.5 15.6 2.3 6.4 0.1 25.4 13.8 3.7 0.0 1.9 6.4 0.9 5.0 0.0 7.7 16.8 6.7 0.0 27.6 74.2 106.6 6.5 21.2 7.2 2.8 0.4 0.3 0.0 5.2 11.2 PRKAB2 ENSG00000131791 "Protein kinase AMP-activated non-catalytic subunit beta 2" O43741 1 147155106-147172550 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 52.1" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044342 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044342: AB_10966508" "prognostic unfavorable (4.55e-4)" "unprognostic (2.03e-2)" "unprognostic (1.84e-1)" "unprognostic (4.03e-2)" "unprognostic (9.59e-3)" "prognostic unfavorable (7.32e-4)" "unprognostic (6.30e-2)" "unprognostic (1.23e-1)" "unprognostic (3.06e-2)" "unprognostic (6.78e-2)" "unprognostic (4.65e-2)" "unprognostic (1.98e-1)" "unprognostic (5.34e-2)" "unprognostic (1.31e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (6.78e-7)" "unprognostic (4.78e-2)" 7.7 7.6 5.6 4.6 7.1 4.7 7.6 13.3 10.9 9.3 24.6 8.9 8.9 19.1 13.0 8.1 10.0 7.4 6.5 15.2 5.6 5.2 6.2 32.6 6.3 3.8 5.9 9.3 8.1 21.0 18.4 6.2 7.5 7.8 10.9 6.9 6.3 5.7 12.6 52.1 9.4 19.1 20.5 8.4 5.7 11.1 6.9 5.5 2.6 5.8 19.9 4.7 19.0 10.3 1.2 1.7 2.9 1.6 5.1 2.5 0.8 3.9 2.2 5.9 4.5 14.0 12.1 21.3 7.5 4.1 5.0 5.5 8.8 7.9 7.2 3.8 5.9 2.9 10.6 6.8 8.4 4.9 2.8 4.7 3.2 7.0 14.2 9.6 3.7 1.4 9.5 16.9 5.2 24.7 7.5 4.9 5.6 4.4 2.9 4.3 4.0 2.7 2.1 12.3 6.8 9.8 4.3 7.9 3.5 3.6 3.2 3.8 7.1 5.6 6.4 26.7 22.0 6.0 4.6 5.6 5.7 12.6 5.2 12.1 4.7 5.1 3.7 5.9 3.3 7.4 2.9 1.2 1.9 1.5 1.2 2.5 1.2 1.6 0.9 1.7 1.1 1.7 1.1 0.3 5.1 1.6 0.8 0.7 0.8 5.6 7.1 13.3 10.9 5.6 5.2 5.9 9.3 7.8 5.5 3.0 1.3 5.0 9.8 14.7 13.2 57.1 25.5 4.0 2.3 17.4 13.7 15.9 1.7 5.0 0.4 6.7 25.7 0.0 6.0 30.8 10.6 4.3 1.1 35.0 5.1 11.1 10.9 6.7 7.3 1.1 8.9 4.1 15.1 9.0 10.7 6.6 7.4 10.1 15.2 4.7 18.6 19.4 21.1 12.4 9.4 12.3 17.2 7.5 8.8 3.9 PRKACB PKACb ENSG00000142875 "Protein kinase cAMP-activated catalytic subunit beta" P22694 1 84078062-84238498 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 85.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010363, HPA029754, HPA071185" Approved Approved "Cytokinetic bridge,Cytosol" NA NA 1500000 Cytosol "Cytokinetic bridge" "CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356" "unprognostic (9.38e-2)" "unprognostic (1.18e-1)" "unprognostic (6.37e-2)" "unprognostic (1.39e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.31e-1)" "unprognostic (4.62e-2)" "prognostic favorable (1.89e-6)" "unprognostic (1.22e-1)" "unprognostic (3.28e-1)" "unprognostic (1.12e-2)" "unprognostic (2.48e-1)" 7.0 21.5 40.0 10.5 57.0 6.2 8.0 54.7 85.5 9.4 23.6 16.9 3.9 4.8 8.7 17.6 8.1 5.2 11.5 10.1 43.1 52.1 10.6 9.0 6.9 16.2 38.3 33.5 8.3 11.9 12.2 18.3 5.1 35.5 13.8 22.6 4.9 32.9 12.7 3.2 2.6 6.3 12.6 47.7 14.6 14.2 3.6 25.9 25.5 11.1 1.8 15.3 13.5 4.6 13.5 7.1 17.1 5.4 25.9 27.6 22.0 3.1 6.3 10.1 12.1 11.7 10.3 4.7 15.6 11.9 8.0 7.5 0.1 2.8 16.6 10.8 12.2 14.6 2.2 4.7 5.1 8.5 16.1 2.6 36.5 8.6 1.2 11.5 14.4 0.8 6.1 2.3 7.7 4.3 11.6 36.6 6.2 1.1 9.6 12.9 0.6 18.7 7.6 9.9 0.0 4.4 14.5 15.7 10.0 19.4 11.2 3.3 12.9 8.6 3.3 9.5 7.9 3.0 3.0 32.4 11.1 8.6 11.2 11.8 7.1 8.5 16.7 5.3 15.4 13.8 17.1 2.7 5.8 23.3 3.6 18.7 13.5 17.3 20.6 7.1 10.2 26.4 27.6 1.5 25.9 5.4 4.1 15.9 22.0 40.0 57.0 54.7 58.2 43.1 52.1 38.3 33.5 35.5 25.9 0.0 1.0 20.3 6.7 4.5 44.0 38.9 15.3 4.0 5.7 14.0 33.4 1.4 28.2 6.9 2.4 8.4 61.7 0.0 10.3 1.0 11.0 15.2 57.7 14.8 23.2 44.5 20.8 26.4 52.7 2.6 13.8 32.7 15.1 1.0 61.1 36.9 13.3 28.8 20.5 15.6 30.0 12.9 13.7 5.9 6.9 2.5 0.6 69.2 52.4 6.5 PRKACG PKACg ENSG00000165059 "Protein kinase cAMP-activated catalytic subunit gamma" P22612 9 69012529-69014113 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 27.4" "Group enriched" "Detected in some" 8 "Early spermatids: 55.1;Late spermatids: 73.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.3" "CAB004530, HPA071185" Supported Uncertain "Cytokinetic bridge,Cytosol" NA NA Cytosol "Cytokinetic bridge" "CAB004530: AB_628137, HPA071185: AB_2686356" "unprognostic (2.74e-1)" "unprognostic (3.61e-2)" "unprognostic (7.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.5 0.0 0.0 0.0 0.0 0.0 PRKAG2 "AAKG, AAKG2, CMH6, H91620p, WPWS" ENSG00000106617 "Protein kinase AMP-activated non-catalytic subunit gamma 2" Q9UGJ0 7 151556111-151877125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Cardiomyopathy, Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 77.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 58.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004246, CAB018641" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB018641: AB_2170355, HPA004246: AB_1078151" "unprognostic (4.11e-2)" "unprognostic (2.82e-1)" "unprognostic (1.46e-2)" "unprognostic (9.29e-2)" "unprognostic (1.76e-1)" "unprognostic (4.33e-3)" "unprognostic (7.13e-2)" "unprognostic (8.09e-2)" "unprognostic (1.77e-1)" "unprognostic (1.18e-1)" "unprognostic (2.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.80e-1)" "unprognostic (3.61e-2)" "unprognostic (4.52e-1)" 12.8 5.5 15.3 8.7 28.8 6.3 9.7 31.1 19.2 8.8 11.5 7.5 9.4 16.7 10.4 10.9 10.8 8.6 12.0 77.2 15.1 13.5 15.4 18.5 8.6 7.7 12.3 14.3 6.8 6.2 6.7 5.1 20.0 18.3 17.5 13.5 7.8 11.9 14.8 21.5 6.9 17.8 32.8 8.5 12.8 13.8 9.7 9.5 2.3 12.6 5.2 7.1 22.4 12.4 7.9 7.8 18.4 6.0 3.1 6.1 3.5 15.5 4.5 3.0 3.6 13.9 11.8 5.4 7.1 6.4 7.7 7.6 2.9 19.9 0.0 11.8 9.5 58.6 5.0 1.9 8.3 12.5 3.7 2.1 4.1 0.5 0.3 20.7 3.1 4.0 5.7 17.8 7.7 8.2 12.8 13.2 4.7 1.4 1.9 23.3 5.8 1.6 2.2 3.1 6.8 13.2 1.5 2.2 3.2 14.7 3.7 13.7 2.1 4.2 7.8 3.1 8.3 2.5 4.1 17.6 1.8 1.5 0.9 4.5 1.4 1.6 0.0 21.9 9.6 17.3 18.4 6.0 10.5 5.1 5.4 3.7 7.9 4.5 4.5 4.3 3.8 4.2 6.1 13.6 3.1 5.4 7.8 2.4 3.5 15.3 28.8 31.1 19.2 15.1 13.5 12.3 14.3 18.3 9.5 6.0 17.5 17.5 32.5 9.4 15.4 84.3 7.6 14.7 13.6 43.6 7.9 2.9 54.7 13.4 39.3 19.4 29.8 0.0 19.9 19.0 16.6 41.6 21.9 55.7 17.5 3.2 12.6 19.6 50.9 26.6 6.9 39.9 15.1 42.3 27.6 18.6 19.6 17.5 7.4 14.7 4.4 12.9 29.1 3.5 19.8 9.5 42.3 26.1 25.4 38.3 PRKAG3 ENSG00000115592 "Protein kinase AMP-activated non-catalytic subunit gamma 3" Q9UGI9 2 218822383-218832086 "Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 40.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CAPAN-2: 2.4;HSkMC: 4.7;LHCN-M2: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.51e-1)" "unprognostic (4.41e-3)" "unprognostic (2.05e-1)" "unprognostic (1.53e-1)" "unprognostic (2.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.86e-3)" "unprognostic (7.74e-2)" "unprognostic (3.44e-2)" "unprognostic (5.85e-2)" "unprognostic (3.27e-1)" "unprognostic (9.04e-2)" "unprognostic (9.95e-2)" "unprognostic (1.49e-1)" "unprognostic (2.97e-1)" "unprognostic (7.69e-2)" 2.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 40.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 8.2 0.7 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRKAR1B ENSG00000188191 "Protein kinase cAMP-dependent type I regulatory subunit beta" P31321 7 549197-727650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 83.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 48.9;Horizontal cells: 50.9;Late spermatids: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026719 Approved NA NA "HPA026719: AB_1855419" "unprognostic (4.90e-2)" "unprognostic (4.92e-2)" "unprognostic (2.69e-1)" "unprognostic (4.34e-2)" "unprognostic (1.74e-3)" "unprognostic (1.02e-3)" "unprognostic (3.28e-2)" "unprognostic (4.24e-2)" "unprognostic (1.73e-1)" "unprognostic (1.41e-2)" "unprognostic (2.01e-3)" "unprognostic (1.95e-1)" "unprognostic (3.38e-3)" "unprognostic (5.18e-2)" "unprognostic (2.64e-1)" "unprognostic (9.23e-2)" "unprognostic (2.00e-1)" 5.0 6.8 33.6 4.3 30.4 4.5 4.0 24.0 83.6 4.8 5.7 3.4 1.6 7.2 7.2 2.7 4.2 6.2 4.6 7.7 35.5 42.8 5.4 3.8 5.5 5.2 22.5 29.2 12.9 4.1 5.6 7.0 3.5 29.7 6.0 4.2 2.5 3.9 5.5 3.8 3.0 7.6 5.3 9.1 8.2 3.8 4.8 3.7 2.5 2.9 1.4 3.3 3.5 2.6 7.0 5.5 1.5 2.6 3.5 12.8 10.3 25.3 17.5 2.6 6.4 1.7 1.5 7.4 5.1 2.4 3.3 1.9 31.3 5.6 19.2 3.5 2.3 10.9 18.7 8.7 9.7 1.4 4.0 6.3 1.3 11.3 20.6 3.2 12.1 3.1 4.3 3.0 2.1 6.2 3.6 3.5 5.1 18.4 3.9 2.9 24.3 14.7 8.0 41.0 7.0 6.9 9.5 0.5 8.5 8.2 6.7 34.4 25.9 13.0 12.8 10.0 1.1 6.6 4.6 4.2 1.5 3.2 1.9 10.3 2.4 6.9 12.5 2.7 9.4 19.1 1.5 2.0 0.0 4.6 2.6 6.9 6.2 7.9 7.1 2.4 7.0 12.8 11.7 0.8 3.5 0.9 5.5 5.2 10.3 33.6 30.4 24.0 68.6 35.5 42.8 22.5 29.2 29.7 3.7 3.0 4.1 8.2 6.8 3.4 9.4 11.5 0.0 0.0 5.7 5.2 3.9 3.1 21.6 4.0 48.9 11.3 13.8 0.0 3.0 5.1 4.7 4.5 6.9 7.4 9.0 50.9 4.1 16.0 3.3 101.7 10.9 2.3 6.8 1.0 10.6 5.1 6.7 12.9 14.5 15.3 4.4 0.0 5.0 9.5 8.5 4.1 2.9 8.7 13.8 4.1 PRKAR2A PRKAR2 ENSG00000114302 "Protein kinase cAMP-dependent type II regulatory subunit alpha" P13861 3 48744597-48847846 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.4" "Group enriched" "Detected in many" 8 "Early spermatids: 709.6;Late spermatids: 1080.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005023, HPA038268" Uncertain NA NA 350000 "CAB005023: AB_562330, HPA038268: AB_2675921" "unprognostic (2.81e-2)" "unprognostic (3.59e-1)" "prognostic favorable (4.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.01e-2)" "unprognostic (6.17e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (4.77e-2)" "unprognostic (2.65e-1)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (9.18e-2)" "prognostic favorable (2.07e-4)" "unprognostic (3.59e-2)" "unprognostic (3.54e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-2)" 14.4 14.0 7.7 8.2 7.9 10.0 8.7 8.3 9.1 11.0 13.9 9.7 12.7 7.9 10.5 9.6 13.7 11.2 10.6 16.8 6.5 8.4 13.2 20.1 8.1 7.2 7.7 7.9 13.2 9.2 11.6 6.9 7.0 7.9 10.6 12.4 11.3 14.3 13.5 47.7 9.5 12.6 10.6 6.9 8.3 9.7 58.4 6.1 3.2 11.0 14.2 10.6 13.3 13.9 8.1 8.7 13.3 14.6 9.7 10.1 6.7 17.2 11.6 9.7 7.5 14.7 14.9 11.0 19.8 9.9 17.4 11.1 15.3 7.8 15.2 13.9 20.5 11.3 7.9 27.7 17.4 23.6 12.4 10.3 20.2 21.2 11.3 10.8 21.1 13.1 12.4 13.7 22.4 16.5 6.5 18.3 5.2 22.7 9.8 16.4 6.7 0.1 6.9 6.9 12.7 13.0 6.4 12.4 19.2 11.2 19.0 9.7 10.0 19.5 23.4 13.1 11.0 15.7 16.5 23.1 15.4 12.3 24.9 27.2 16.7 32.0 14.7 20.7 23.5 11.6 10.9 9.1 10.5 10.1 8.1 9.7 8.1 8.5 8.6 8.7 7.6 6.1 6.0 13.3 9.7 14.6 5.4 7.4 6.7 7.7 7.9 8.3 9.1 6.5 8.4 7.7 7.9 7.9 6.1 17.9 57.6 32.6 21.1 37.3 43.0 58.5 48.4 37.5 29.6 43.6 64.8 20.5 18.3 35.9 709.6 35.8 55.1 0.0 52.6 28.9 32.5 32.7 12.7 106.1 42.1 58.8 40.4 56.4 50.0 1080.4 50.9 37.1 28.7 25.2 39.0 26.1 51.6 31.6 52.3 35.6 43.2 51.8 53.8 64.4 59.7 54.8 19.7 27.4 66.4 22.6 PRKAR2B PRKAR2 ENSG00000005249 "Protein kinase cAMP-dependent type II regulatory subunit beta" P31323 7 107044649-107161811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "adipose tissue: 80.2;breast: 114.1" "Cell type enhanced" "Detected in many" 7 "Peritubular cells: 49.8;Smooth muscle cells: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 20.1;Daudi: 27.6;K-562: 16.6;U-698: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008421, HPA063879" Enhanced Uncertain Mitochondria NA NA 1600000 Mitochondria "HPA008421: AB_1855421, HPA063879: " "unprognostic (3.18e-1)" "unprognostic (2.48e-2)" "prognostic favorable (6.38e-4)" "unprognostic (1.63e-2)" "unprognostic (3.33e-3)" "unprognostic (2.43e-3)" "unprognostic (2.76e-1)" "unprognostic (8.14e-3)" "unprognostic (1.70e-1)" "unprognostic (5.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.50e-1)" "unprognostic (5.12e-3)" "unprognostic (2.39e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (7.15e-2)" 80.2 21.5 9.4 6.0 17.2 8.4 114.1 4.5 17.0 3.9 9.1 1.9 2.4 3.1 5.1 3.9 8.4 3.4 4.7 9.0 8.8 8.6 4.5 2.4 3.2 3.0 8.4 12.1 19.5 6.5 5.6 8.1 10.7 3.0 6.4 5.5 2.6 6.8 3.9 2.2 1.6 4.7 7.4 3.4 11.1 4.1 14.5 4.6 0.8 1.6 2.8 3.3 8.4 11.8 0.2 3.1 1.3 1.5 0.5 0.1 2.5 0.0 0.4 2.6 20.1 10.8 0.0 0.0 1.0 3.2 0.8 0.8 0.0 0.0 27.6 0.2 0.6 2.5 0.0 2.0 0.0 1.6 0.7 2.2 9.2 0.0 0.0 3.0 0.1 1.3 0.1 0.0 0.0 0.0 0.9 12.1 1.5 16.6 0.8 0.0 2.0 3.7 0.1 4.9 0.0 0.8 1.1 0.0 0.0 0.0 0.0 3.3 4.8 1.5 0.3 1.0 6.9 0.6 1.9 6.8 1.0 2.6 0.0 1.9 0.6 0.0 71.0 0.7 4.8 9.6 1.3 1.5 0.0 0.0 1.4 0.1 0.2 0.0 0.0 3.1 0.0 0.1 0.1 0.7 0.5 0.7 1.1 0.0 2.5 9.4 17.2 4.5 17.0 8.8 8.6 8.4 12.1 3.0 4.6 3.0 1.0 0.8 1.4 2.2 29.0 26.0 10.2 6.7 1.2 7.0 9.8 0.0 0.0 1.7 6.2 15.5 0.0 0.0 0.0 0.4 5.1 5.9 4.6 0.0 1.5 4.8 0.0 14.1 14.0 4.7 27.6 10.4 16.9 13.6 0.5 5.5 0.2 2.6 49.8 0.6 9.1 19.4 35.8 1.6 4.5 2.0 0.0 2.9 1.9 3.9 PRKCB "PKCB, PRKCB1, PRKCB2" ENSG00000166501 "Protein kinase C beta" P05771 16 23835946-24220611 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 57.2;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in many" 11 "B-cells: 149.8;Bipolar cells: 172.0;Horizontal cells: 74.7;Kupffer cells: 192.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 41.7;HMC-1: 41.8;K-562: 59.4;THP-1: 18.8;U-937: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003843, HPA048321, HPA054203" Approved Supported Nucleoplasm,Cytosol NA NA 3400000 Nucleoplasm Cytosol "CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416" "unprognostic (1.53e-3)" "unprognostic (4.53e-4)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (1.72e-1)" "unprognostic (7.13e-3)" "unprognostic (2.06e-1)" "unprognostic (1.67e-3)" "unprognostic (3.19e-2)" "unprognostic (1.79e-1)" "unprognostic (7.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.17e-3)" "unprognostic (2.08e-1)" "unprognostic (2.12e-2)" "unprognostic (3.28e-1)" "unprognostic (4.95e-2)" 4.0 1.9 13.9 20.8 55.6 20.4 1.8 14.1 57.2 4.1 4.7 4.4 0.6 4.9 3.5 1.2 3.2 2.6 3.9 1.5 23.4 7.8 1.8 3.7 5.4 31.0 11.0 20.4 1.2 1.4 0.9 1.4 2.5 8.3 6.2 4.4 3.5 1.9 8.4 1.2 4.6 9.1 5.8 7.3 31.2 3.8 6.4 6.4 24.1 3.9 0.0 27.7 7.6 1.7 23.6 18.5 21.8 14.6 20.1 19.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.8 41.7 2.0 0.0 0.0 6.0 41.8 0.0 0.2 0.0 0.0 0.0 0.0 7.2 59.4 0.1 0.0 0.0 13.1 13.2 0.4 0.0 0.0 12.5 0.1 2.4 0.1 3.6 7.3 0.0 0.0 0.0 0.6 0.2 0.0 18.8 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.0 16.8 0.0 17.5 7.6 14.4 14.5 10.7 6.7 23.6 9.5 17.2 6.2 22.1 7.8 19.0 21.8 20.1 14.6 18.5 6.7 7.5 13.9 55.6 14.1 57.2 23.4 7.8 11.0 20.4 8.3 6.4 3.0 8.2 149.8 3.5 5.4 172.0 1.7 5.1 2.7 1.2 1.8 2.0 0.1 0.0 0.0 16.3 1.4 1.7 0.0 0.2 0.2 1.3 0.7 69.4 1.6 41.0 74.7 0.0 16.5 192.8 10.0 0.0 22.7 3.3 6.4 0.7 9.9 0.0 9.5 0.4 0.1 7.3 0.0 2.2 3.6 3.7 12.5 0.7 57.5 1.2 4.3 PRKCE ENSG00000171132 "Protein kinase C epsilon" Q02156 2 45651345-46187990 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 36.5" "Group enriched" "Detected in many" 5 "Early spermatids: 209.3;Late spermatids: 297.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 19.4;TIME: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001948, HPA008236, HPA044496" Enhanced Supported Supported "Vesicles,Plasma membrane,Intermediate filaments,Cytosol" NA NA "Intermediate filaments, Cytosol" "Vesicles, Plasma membrane" "CAB001948: , HPA008236: , HPA044496: AB_2678959" "unprognostic (1.10e-1)" "unprognostic (1.78e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (9.61e-2)" "unprognostic (5.70e-2)" "unprognostic (1.51e-1)" "prognostic favorable (9.62e-4)" "unprognostic (3.05e-1)" "unprognostic (6.72e-2)" "unprognostic (7.49e-3)" "unprognostic (9.99e-2)" "prognostic favorable (2.63e-7)" "unprognostic (1.21e-1)" "unprognostic (7.11e-2)" "unprognostic (6.43e-3)" "unprognostic (2.23e-2)" 5.5 7.4 15.3 7.2 14.2 9.3 8.1 28.8 36.5 6.6 5.5 3.8 5.9 3.6 5.6 4.6 4.7 7.6 4.7 7.7 22.5 10.0 12.8 15.5 17.5 6.9 6.0 15.0 4.1 4.2 16.3 6.0 10.4 9.1 3.6 4.7 3.7 3.6 8.6 7.2 3.0 3.7 6.2 4.4 4.9 4.4 7.2 3.7 1.5 6.5 1.2 5.4 5.0 6.5 5.5 2.2 1.7 1.4 0.9 1.3 0.6 5.4 2.0 2.9 2.9 4.4 5.2 2.3 3.8 7.0 3.2 3.5 0.5 5.4 8.2 3.6 4.0 4.6 1.3 1.8 2.0 4.6 4.9 3.5 0.0 1.4 1.1 5.0 0.6 2.9 4.6 2.3 4.8 3.5 2.7 11.8 1.8 1.1 2.0 3.7 2.8 2.6 0.3 1.0 3.0 1.0 19.4 13.8 8.8 2.9 3.7 2.0 4.4 1.7 5.8 12.5 1.1 4.7 1.9 19.5 6.3 6.6 4.6 3.8 0.0 0.0 6.9 5.2 4.6 6.3 0.0 1.2 1.7 1.0 0.4 1.1 3.6 0.7 0.7 2.2 5.5 1.3 0.4 0.4 0.9 1.4 0.9 0.0 0.6 15.3 14.2 28.8 33.2 22.5 10.0 6.0 15.0 9.1 3.7 6.0 8.6 20.1 6.3 4.4 47.5 9.3 12.7 22.7 27.3 10.4 13.7 0.3 3.3 3.0 209.3 9.9 4.5 0.0 3.3 6.9 8.0 5.7 6.9 7.3 2.6 11.1 7.5 12.3 17.0 297.3 4.9 11.1 13.5 7.2 5.3 7.0 3.0 3.5 5.6 21.3 6.7 12.9 6.6 2.7 2.2 4.3 2.4 4.3 6.2 7.1 PRKCG "MGC57564, PKCC, PKCG, SCA14" ENSG00000126583 "Protein kinase C gamma" P05129 19 53879190-53907652 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Biological rhythms" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 49.9" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 3.7;Horizontal cells: 4.8;Spermatocytes: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.8;OE19: 8.5;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054560 Enhanced NA NA "HPA054560: AB_2682523" "unprognostic (7.14e-2)" "unprognostic (5.42e-2)" "unprognostic (1.85e-1)" "unprognostic (3.86e-2)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.96e-2)" "unprognostic (4.46e-2)" "unprognostic (2.09e-1)" "unprognostic (2.64e-2)" "unprognostic (7.48e-3)" "unprognostic (2.68e-1)" "unprognostic (2.22e-7)" "unprognostic (2.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" 1.0 0.9 28.0 1.1 49.9 2.2 0.9 12.1 39.2 0.9 1.3 1.6 0.0 1.5 1.0 0.9 1.0 1.4 1.0 0.9 49.7 4.4 0.9 0.9 1.0 0.9 2.9 20.8 0.9 3.5 2.1 0.2 0.9 0.7 0.9 1.2 0.0 0.9 1.0 1.0 0.9 1.3 1.1 1.4 0.9 1.8 4.4 2.1 1.3 0.9 0.0 0.9 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 4.8 1.0 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.0 1.2 1.3 0.2 1.4 0.0 0.5 0.4 2.3 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.5 0.0 0.9 0.0 1.2 0.0 0.1 0.0 0.5 0.4 0.1 0.8 8.5 0.4 0.8 0.5 0.0 0.9 0.0 0.0 3.3 1.3 0.1 0.0 1.7 1.6 0.0 0.8 0.0 1.6 0.0 0.0 1.4 0.3 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 49.9 12.1 28.5 49.7 4.4 2.9 20.8 0.7 2.1 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.0 0.0 0.0 0.0 0.2 0.1 PRKCQ ENSG00000065675 "Protein kinase C theta" Q04759 10 6427143-6580301 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 2: 6.5;Distal tubular cells: 6.6;T-cells: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 10 "gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7" "Group enriched" "Detected in many" 11 "NK-cells: 6.5;T-cells: 19.7" "Cell line enhanced" "Detected in some" "HEL: 29.8;JURKAT: 21.2;MOLT-4: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065279, HPA073098" Enhanced "Centriolar satellite" NA NA 200000 "Centriolar satellite" "HPA065279: AB_2685453, HPA073098: AB_2686571" "unprognostic (6.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.87e-1)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (2.69e-3)" "unprognostic (2.46e-1)" "unprognostic (8.40e-2)" "unprognostic (2.66e-1)" "unprognostic (1.17e-1)" "unprognostic (3.22e-1)" "unprognostic (5.26e-2)" "unprognostic (7.74e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (3.51e-2)" 0.9 0.7 3.6 9.4 4.3 3.1 0.8 0.9 5.2 1.3 1.1 7.4 0.1 1.2 1.8 5.4 1.6 2.6 1.3 0.5 4.4 4.0 4.6 0.9 3.3 6.6 4.0 2.2 1.1 7.7 0.3 1.0 0.4 2.7 1.4 1.3 5.4 2.8 1.0 63.4 0.6 2.5 0.8 3.6 3.4 1.4 0.9 4.5 32.1 9.1 7.5 6.8 1.9 0.8 0.0 0.1 1.1 0.2 6.5 19.7 5.2 0.0 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.2 1.8 0.2 0.0 0.0 0.0 0.0 1.8 3.1 0.0 0.0 2.0 29.8 0.0 0.2 0.3 1.4 0.3 0.1 1.9 0.1 0.1 0.0 0.2 21.2 6.5 0.0 0.0 0.0 22.3 4.2 3.1 0.2 0.0 4.3 0.7 0.0 6.3 1.5 0.2 1.1 0.0 0.0 0.0 1.9 0.0 3.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.1 0.1 0.1 12.7 0.2 9.8 0.0 13.5 13.2 0.1 0.0 10.7 10.0 0.8 6.5 0.0 0.0 19.7 5.2 3.6 4.3 0.9 5.2 4.4 4.0 4.0 2.2 2.7 4.5 3.0 6.5 0.0 0.1 0.0 1.6 0.3 0.0 1.4 1.2 1.8 0.0 0.0 6.6 0.2 1.8 0.0 0.0 0.0 0.7 0.1 0.3 0.0 1.1 0.0 0.4 0.0 1.7 1.3 1.5 4.5 0.0 0.5 0.0 0.0 0.3 1.5 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.9 2.0 0.0 0.0 25.4 0.3 0.1 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Group enriched" "Detected in many" 4 "Late spermatids: 539.8;Syncytiotrophoblasts: 926.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "BEWO: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favorable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.3 4.7 1.7 8.7 0.0 0.0 23.0 0.5 0.2 5.5 0.3 11.9 16.0 0.0 14.6 1.8 4.8 12.9 9.9 12.3 3.9 0.5 11.0 0.0 7.6 15.8 1.6 0.0 5.7 0.3 7.4 0.0 4.2 0.0 0.0 1.9 3.2 0.1 0.1 9.0 0.4 0.0 3.3 20.2 11.4 0.0 0.0 2.5 9.4 7.8 12.0 9.7 6.0 13.4 2.5 14.9 9.4 2.0 0.0 0.0 6.9 0.0 0.0 3.5 0.6 0.1 0.6 0.1 8.3 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 113.2 71.1 0.8 10.2 11.6 22.8 1.2 2.5 21.4 26.1 7.0 3.9 84.1 6.6 10.9 181.6 6.0 56.7 0.0 9.3 48.8 3.1 16.4 8.1 12.5 12.7 58.8 9.8 6.7 1.0 539.8 8.9 3.3 6.8 5.4 22.1 15.6 12.2 31.6 8.1 19.0 21.6 0.0 2.2 15.8 26.8 11.7 926.6 7.7 25.3 11.9 PRKG2 "cGKII, PRKGR2" ENSG00000138669 "Protein kinase, cGMP-dependent, type II" Q13237 4 81087370-81215117 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 34.3" "Cell type enhanced" "Detected in some" 22 "Alveolar cells type 1: 32.8;Enterocytes: 13.8;Paneth cells: 8.6" "Cancer enhanced" "Detected in some" "melanoma: 4.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.0;MAIT T-cell: 2.2" "Group enriched" "Detected in many" 4 "granulocytes: 2.0;T-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC diff: 5.2;ASC TERT1: 4.0;HEL: 20.8;hTCEpi: 4.1;SCLC-21H: 6.4" "Low region specificity" "Detected in many" "HPA007386, CAB018739" Approved NA NA "CAB018739: AB_2284387, HPA007386: AB_1079678" "unprognostic (6.14e-2)" "unprognostic (2.77e-1)" "unprognostic (2.14e-1)" "unprognostic (5.01e-4)" "unprognostic (4.33e-2)" "unprognostic (6.85e-2)" "unprognostic (1.13e-1)" "unprognostic (5.57e-2)" "unprognostic (2.05e-1)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (1.48e-1)" "unprognostic (8.27e-2)" "unprognostic (2.33e-1)" "unprognostic (1.58e-1)" "unprognostic (4.00e-3)" "unprognostic (1.06e-1)" 4.7 0.4 5.2 0.4 2.9 0.6 2.2 0.8 5.3 1.4 7.7 1.2 0.7 12.2 0.6 0.6 3.8 0.6 0.4 6.3 2.9 3.3 0.7 0.3 4.3 0.3 2.5 1.9 0.3 1.8 0.0 12.1 0.2 9.3 12.7 3.8 1.4 0.8 4.6 0.3 2.1 34.3 0.7 1.3 0.3 1.3 1.7 2.4 0.0 1.3 0.0 0.6 1.2 1.3 0.4 0.0 2.0 0.0 0.4 2.2 0.4 0.1 0.3 0.1 0.0 5.2 4.0 0.0 0.3 0.0 0.0 0.0 0.4 2.4 0.0 0.2 0.9 0.0 0.1 0.3 1.6 0.0 0.4 0.0 20.8 0.6 0.0 0.0 0.0 0.0 0.6 4.1 0.0 0.0 1.1 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.1 0.9 0.6 0.4 0.0 0.0 0.1 0.0 0.9 6.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 2.2 0.2 0.5 0.3 0.0 0.4 0.8 0.9 0.0 0.4 0.0 0.0 0.0 0.4 5.2 2.9 0.8 5.3 2.9 3.3 2.5 1.9 9.3 2.4 32.8 1.6 0.0 0.6 0.0 0.0 2.6 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.1 5.3 0.0 13.8 0.0 0.0 0.1 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.6 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.2 PRKN "AR-JP, PARK2, parkin, PDJ" ENSG00000185345 "Parkin RBR E3 ubiquitin protein ligase" O60260 6 161347420-162727771 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 41.8" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.4;Distal tubular cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;HEL: 9.2;Karpas-707: 5.9;RPMI-8226: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016257, HPA036012" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB016257: AB_628104, HPA036012: AB_2732471" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (6.48e-2)" "unprognostic (2.69e-3)" "unprognostic (9.85e-2)" "unprognostic (5.85e-2)" "unprognostic (7.07e-2)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" "unprognostic (1.03e-3)" "unprognostic (8.16e-2)" "prognostic favorable (6.75e-12)" "unprognostic (9.93e-2)" "unprognostic (1.51e-1)" "unprognostic (5.24e-2)" "unprognostic (2.50e-1)" 6.8 7.1 7.9 2.3 12.2 1.5 4.2 7.2 13.4 5.3 4.3 6.3 4.6 2.8 7.8 4.4 6.1 3.4 4.3 17.7 9.2 6.2 17.4 3.6 2.6 3.0 5.8 5.2 6.4 3.0 5.6 8.6 2.0 5.5 4.0 2.4 8.3 3.5 4.8 41.8 4.0 3.3 6.6 5.9 2.7 3.5 10.3 6.8 0.6 3.8 4.7 2.7 4.9 2.1 4.6 1.2 4.2 0.8 1.8 4.6 1.3 0.1 0.3 1.3 3.7 0.9 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.0 0.9 0.0 0.2 0.2 0.0 0.4 0.6 9.2 0.2 0.0 0.9 0.2 0.1 3.2 0.1 0.0 0.5 0.6 0.0 0.4 0.4 5.9 1.0 0.5 0.1 0.1 0.2 0.6 0.9 0.0 0.0 5.9 0.7 0.1 1.0 2.5 0.0 0.0 0.3 1.2 0.0 0.6 0.0 0.1 0.3 0.1 0.3 0.8 0.1 0.0 0.1 0.2 2.2 2.8 0.8 4.2 2.1 0.5 3.5 1.5 2.0 2.2 1.2 4.6 4.4 4.6 1.5 1.8 0.4 0.3 0.2 1.3 7.9 12.2 7.2 11.7 9.2 6.2 5.8 5.2 5.5 6.8 8.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.4 16.6 0.8 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PRL ENSG00000172179 Prolactin P01236 6 22287244-22297501 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Lactation Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "pituitary gland: 1739.5" "Group enriched" "Detected in some" 7 "Early spermatids: 11.3;Late spermatids: 17.4;Rod photoreceptor cells: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.2;non-classical monocyte: 1.0" "Group enriched" "Detected in many" 12 "monocytes: 1.0;T-cells: 1.2" "Cell line enhanced" "Detected in some" "Daudi: 18.0;SCLC-21H: 6.7;U-937: 3.2" "Not detected" "Not detected" "CAB023353, HPA042416, HPA062017" Enhanced "Secreted to blood" NA NA 53900000 3300000 "CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660" "unprognostic (1.66e-1)" "unprognostic (4.08e-3)" "unprognostic (5.89e-3)" "unprognostic (4.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.11e-4)" "unprognostic (4.54e-1)" "unprognostic (1.57e-1)" "unprognostic (3.79e-2)" "unprognostic (4.29e-5)" "unprognostic (2.20e-1)" 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1739.5 21.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 17.4 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PRLH PRH ENSG00000071677 "Prolactin releasing hormone" P81277 2 237566574-237567175 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;heart muscle: 4.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.0;MCF7: 4.4;RPMI-8226: 3.7;SK-BR-3: 1.8;T-47d: 2.1;U-87 MG: 2.4" "Group enriched" "Detected in some" 58 "hypothalamus: 13.4;pons and medulla: 22.5" "Region enriched" "Detected in single" 13 "pons and medulla: 5.1" HPA014976 Approved "Secreted - unknown location" NA NA "HPA014976: AB_2732413" "unprognostic (8.28e-4)" "unprognostic (3.22e-2)" "unprognostic (5.42e-2)" 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.5 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 1.8 0.4 0.0 2.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRLHR "GPR10, PrRPR" ENSG00000119973 "Prolactin releasing hormone receptor" P49683 10 118589989-118595699 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1" "Cell type enriched" "Detected in single" 15 "Horizontal cells: 12.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 4 "SH-SY5Y: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA039361 Enhanced NA NA "HPA039361: AB_10673527" "unprognostic (1.83e-1)" "unprognostic (2.62e-3)" "unprognostic (1.22e-1)" "unprognostic (2.15e-2)" "unprognostic (1.48e-1)" "unprognostic (9.09e-2)" 0.2 11.3 1.4 0.2 3.0 0.2 0.1 3.2 5.1 8.3 0.2 0.8 0.0 0.3 5.4 0.2 0.2 0.4 0.2 0.1 0.6 4.0 0.1 0.2 0.2 0.1 3.4 0.9 0.1 0.5 0.1 11.8 0.1 10.6 0.3 0.2 0.1 0.2 1.4 0.2 0.2 0.2 8.1 0.5 0.2 0.5 0.2 1.0 0.0 0.2 0.0 0.1 0.1 5.4 0.5 0.4 1.3 0.3 0.7 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.5 0.3 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.5 0.3 0.2 1.3 0.7 0.3 0.4 0.0 0.0 1.4 3.0 3.2 1.9 0.6 4.0 3.4 0.9 10.6 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PRLR ENSG00000113494 "Prolactin receptor" P16471 5 35048756-35230589 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.3;placenta: 45.7;seminal vesicle: 42.7" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 26.1;Proximal tubular cells: 41.8;Syncytiotrophoblasts: 40.4" "Cancer enriched" "Detected in many" 9 "breast cancer: 20.6" "Region enriched" "Detected in many" 7 "pons and medulla: 54.3" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 2.8" "Lineage enriched" "Detected in single" 11 "monocytes: 2.8" "Cell line enriched" "Detected in some" 18 "T-47d: 93.7" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (3.81e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-2)" "unprognostic (6.04e-2)" "unprognostic (5.05e-2)" "unprognostic (8.21e-2)" "unprognostic (3.99e-2)" "unprognostic (7.94e-2)" "unprognostic (4.89e-2)" "unprognostic (1.67e-3)" "unprognostic (4.84e-4)" "unprognostic (2.50e-3)" "unprognostic (4.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (9.84e-5)" "unprognostic (1.24e-1)" 0.5 13.3 1.8 0.2 5.6 0.3 13.3 0.4 1.4 23.5 5.3 10.7 36.6 3.5 25.1 10.0 1.1 2.1 2.0 0.6 7.6 2.4 17.8 5.9 0.6 0.0 0.6 0.2 3.2 4.3 11.5 15.7 45.7 54.3 3.2 3.0 0.5 1.8 42.7 0.4 2.6 10.1 6.4 0.7 0.4 3.3 2.0 0.4 0.1 0.5 0.5 0.0 1.4 6.2 0.0 0.2 0.1 2.8 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.7 0.1 0.4 0.3 0.8 0.3 0.1 0.0 0.0 0.0 0.5 0.3 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.2 93.7 0.7 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.1 2.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.8 5.6 0.4 1.4 7.6 2.4 0.6 0.2 54.3 0.4 0.0 1.3 0.0 0.3 2.6 0.0 0.8 2.5 0.0 0.0 3.5 0.0 26.1 6.6 0.8 0.0 0.2 12.7 0.0 4.4 2.6 3.5 2.2 0.0 9.7 7.5 0.0 8.2 0.6 1.3 0.0 8.1 0.6 0.0 9.0 16.5 0.0 2.4 20.9 12.0 41.8 0.0 0.0 3.8 0.0 0.1 4.4 40.4 0.0 19.8 0.1 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280836-11281350 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "testis: 747.3" "Group enriched" "Detected in some" 154 "Early spermatids: 123959.8;Late spermatids: 465852.4" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;Hep G2: 1.1;NB-4: 6.0;U-2197: 4.5;U-698: 2.0" "HPA055150, HPA059371" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA055150: AB_2682718, HPA059371: " "unprognostic (2.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 747.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123959.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 465852.4 1718.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1588.2 0.0 0.0 1138.3 0.0 1916.0 855.6 0.0 0.0 0.0 0.0 0.0 PRM2 CT94.2 ENSG00000122304 "Protamine 2" P04554 16 11275639-11276480 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 99 "testis: 699.5" "Cell type enriched" "Detected in some" 5 "Late spermatids: 355121.5" "Cancer enriched" "Detected in single" 187 "testis cancer: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 3.5;NB-4: 3.8;U-2197: 5.7" "CAB032738, HPA056386" Enhanced NA NA "CAB032738: AB_2171312, HPA056386: AB_2683111" "unprognostic (3.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 699.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67214.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 355121.5 1424.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1572.7 0.0 0.0 899.0 0.0 1873.0 751.0 0.0 0.0 0.0 0.0 0.0 PRM3 ENSG00000178257 "Protamine 3" Q9NNZ6 16 11273218-11273641 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 39.0" "Group enriched" "Detected in some" 127 "Early spermatids: 824.0;Late spermatids: 2009.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "naive CD8 T-cell: 2.8" "Lineage enriched" "Detected in single" 28 "T-cells: 2.8" "Cell line enriched" "Detected in some" 6 "TIME: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.6 0.4 0.6 0.0 0.0 0.0 0.3 0.0 9.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 824.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2009.9 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 6.5 0.0 9.0 6.0 0.0 0.0 0.0 0.0 0.0 PRMT8 "HRMT1L3, HRMT1L4" ENSG00000111218 "Protein arginine methyltransferase 8" Q9NR22 12 3381349-3593973 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 24.8" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 6.0;Bipolar cells: 18.4;Ciliated cells: 13.4;Club cells: 9.1;Cone photoreceptor cells: 15.7;Early spermatids: 11.0;Horizontal cells: 4.8;Late spermatids: 11.4" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "hTERT-HME1: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039747, HPA069769" Enhanced NA NA "HPA039747: AB_2732482, HPA069769: AB_2686193" "unprognostic (3.09e-1)" "unprognostic (9.47e-2)" "unprognostic (5.59e-1)" "unprognostic (3.34e-3)" "unprognostic (4.80e-3)" "unprognostic (9.41e-2)" "unprognostic (3.41e-5)" "unprognostic (5.99e-1)" "unprognostic (1.93e-1)" "unprognostic (1.50e-2)" "unprognostic (7.06e-2)" "unprognostic (2.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.64e-1)" "unprognostic (6.02e-2)" "unprognostic (5.49e-2)" 0.6 0.6 4.6 0.6 18.3 0.6 0.7 8.7 24.8 0.8 0.7 0.2 0.1 0.7 0.7 0.6 0.6 3.1 0.6 2.3 4.0 2.1 1.2 0.6 2.2 0.6 3.5 10.0 0.7 1.8 0.6 0.0 0.6 1.4 0.6 0.7 0.0 0.6 0.7 0.6 0.6 0.6 0.6 0.4 0.6 0.7 3.0 1.8 1.0 0.6 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 18.3 8.7 14.6 4.0 2.1 3.5 10.0 1.4 1.8 6.0 1.7 0.0 0.0 0.0 18.4 1.2 0.0 13.4 9.1 0.0 15.7 0.0 0.0 0.0 11.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 11.4 0.6 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.6 1.1 0.0 0.0 1.8 1.2 0.0 0.0 0.0 0.0 0.1 PRND "dJ1068H6.4, DOPPEL, DPL, PrPLP" ENSG00000171864 "Prion like protein doppel" Q9UKY0 20 4721910-4728460 "Predicted membrane proteins, Transporters" Fertilization Prion "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 80.2" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 1.7;Late spermatids: 7.4;Leydig cells: 2.0;Spermatogonia: 1.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Region enriched" "Detected in single" 28 "pons and medulla: 6.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 2.2;NTERA-2: 3.2;U-698: 1.3" "Not detected" "Not detected" HPA043373 Enhanced NA NA "HPA043373: AB_2678450" "unprognostic (1.69e-1)" "unprognostic (3.66e-2)" "unprognostic (2.24e-2)" "unprognostic (8.46e-2)" "unprognostic (3.40e-2)" "unprognostic (3.47e-3)" "unprognostic (3.01e-1)" "unprognostic (6.41e-2)" "unprognostic (2.00e-2)" "unprognostic (1.56e-1)" "unprognostic (3.10e-1)" "unprognostic (5.85e-2)" "unprognostic (2.02e-3)" "unprognostic (6.11e-2)" "unprognostic (2.86e-1)" "unprognostic (2.45e-2)" "unprognostic (1.63e-3)" 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 1.1 0.7 0.2 0.0 2.5 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 6.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.1 80.2 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.9 0.5 2.2 0.5 0.6 0.4 0.1 0.2 0.4 0.1 0.3 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.2 0.3 0.0 0.0 0.6 0.1 0.3 2.2 0.5 0.0 1.1 0.2 0.2 0.1 0.3 3.2 0.0 0.0 0.2 0.0 0.0 0.3 0.4 0.3 0.4 0.0 0.1 0.1 0.2 0.3 0.1 0.4 0.3 0.7 0.4 0.1 0.3 0.1 1.3 0.2 0.2 0.0 2.2 0.5 0.5 0.3 0.3 0.2 0.6 0.4 0.2 0.2 0.9 0.3 0.3 1.4 0.6 0.5 0.5 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 2.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.0 0.0 0.0 0.1 PROB1 C5orf65 ENSG00000228672 "Proline rich basic protein 1" E7EW31 5 139390592-139395713 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 37.7" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 25.4;Ito cells: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.1;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "HDLM-2: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053354, HPA060103" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA053354: , HPA060103: AB_2684205" "unprognostic (4.14e-2)" "prognostic favorable (9.26e-4)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.53e-2)" "unprognostic (9.27e-3)" "unprognostic (4.72e-2)" "unprognostic (1.40e-1)" "unprognostic (8.28e-3)" "unprognostic (3.21e-2)" "unprognostic (4.84e-4)" "unprognostic (7.10e-2)" "unprognostic (1.75e-2)" "unprognostic (9.05e-2)" "unprognostic (3.62e-2)" "unprognostic (5.89e-2)" "unprognostic (8.24e-2)" 0.6 1.6 0.7 0.3 0.8 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.5 0.1 0.3 0.7 0.1 6.6 0.7 0.6 0.7 0.0 0.0 0.4 0.5 0.0 0.0 1.8 0.8 0.2 1.3 0.0 0.7 0.6 37.7 0.0 0.8 0.1 0.2 0.3 0.6 0.0 0.1 0.1 0.3 0.1 0.5 1.1 0.0 0.1 0.0 1.1 0.0 0.6 0.4 0.1 0.1 0.0 0.2 0.2 0.5 0.1 0.5 0.5 2.0 1.3 3.0 0.5 1.6 0.0 0.3 0.2 0.0 0.1 48.1 0.6 0.7 1.2 0.2 1.3 0.0 1.6 0.4 0.4 1.2 0.3 0.4 0.1 2.0 0.2 3.0 1.7 0.5 2.5 1.2 0.6 0.3 1.2 7.7 0.2 5.8 0.1 0.0 0.6 0.3 2.8 3.0 0.1 0.7 1.1 1.6 0.2 0.1 0.1 0.1 0.2 0.4 0.8 4.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 1.1 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.2 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.0 1.1 1.4 0.0 6.5 1.7 0.1 0.3 0.0 2.2 0.0 0.2 0.3 PROC ENSG00000115718 "Protein C, inactivator of coagulation factors Va and VIIIa" P04070 2 127418427-127429246 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 137.5" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 348.7" "Cancer enriched" "Detected in many" 22 "liver cancer: 118.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 29.2" "Lineage enriched" "Detected in many" 9 "dendritic cells: 29.2" "Cell line enriched" "Detected in some" 16 "Hep G2: 58.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005550, CAB016721, CAB016792" Supported "Secreted to blood" NA NA 6400000000 "CAB016721: , CAB016792: , HPA005550: AB_1079687" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (6.64e-2)" "unprognostic (3.13e-2)" "unprognostic (4.90e-3)" "unprognostic (2.63e-1)" "unprognostic (1.67e-1)" "unprognostic (3.29e-1)" "unprognostic (3.74e-3)" "unprognostic (2.56e-2)" "unprognostic (8.12e-3)" "unprognostic (2.01e-2)" "unprognostic (1.71e-1)" "unprognostic (4.60e-3)" "unprognostic (8.06e-2)" 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.2 4.2 137.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.4 29.2 3.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 0.0 0.3 0.0 0.1 3.7 0.0 0.1 0.0 0.0 0.0 0.0 2.8 58.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.0 29.2 0.0 0.1 0.4 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.4 0.0 0.0 0.0 4.3 0.6 0.7 0.0 0.3 40.8 1.4 0.0 0.0 0.0 0.0 5.0 0.4 0.0 0.0 2.6 0.0 0.2 0.0 0.2 0.0 0.0 348.7 3.9 0.0 9.9 9.8 4.5 0.0 0.0 1.7 0.0 0.0 8.1 0.0 1.2 8.7 0.0 78.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.5 1.5 0.1 PROCA1 MGC39650 ENSG00000167525 "Protein interacting with cyclin A1" Q8NCQ7 17 28703197-28711854 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 58.8" "Group enriched" "Detected in many" 45 "Early spermatids: 1437.9;Late spermatids: 5492.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 12.3;REH: 12.6" "Not detected" "Not detected" "HPA023648, HPA030218" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA023648: AB_1855726, HPA030218: AB_10601152" "unprognostic (5.78e-2)" "unprognostic (1.17e-2)" "unprognostic (3.11e-3)" "unprognostic (3.07e-2)" "unprognostic (2.97e-2)" "unprognostic (7.26e-3)" "unprognostic (6.90e-2)" "unprognostic (7.11e-3)" "unprognostic (2.86e-3)" "unprognostic (1.10e-1)" "unprognostic (3.01e-3)" "unprognostic (6.88e-2)" "unprognostic (1.21e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-1)" "unprognostic (1.88e-1)" "unprognostic (5.00e-2)" 1.2 1.1 1.7 1.8 2.6 1.6 1.1 7.8 2.8 2.1 2.0 2.6 2.9 1.8 1.8 1.2 0.9 2.2 1.0 1.0 1.9 2.0 1.8 0.5 1.3 2.6 1.7 2.3 3.1 0.7 0.9 1.2 0.9 3.5 1.2 1.0 4.0 0.8 1.4 2.2 1.3 2.1 1.2 2.4 3.5 1.1 58.8 1.6 1.0 0.7 0.0 1.5 0.9 1.6 3.1 5.0 6.2 3.0 1.1 2.2 1.1 1.1 1.4 4.6 8.6 3.4 2.4 3.1 1.5 0.6 1.1 0.9 1.4 4.2 0.2 0.8 0.8 0.6 3.7 3.6 0.2 0.6 2.1 1.9 3.4 3.4 0.9 0.5 6.4 0.3 1.6 0.4 1.8 0.7 2.6 0.8 2.5 4.1 2.8 0.9 0.9 4.1 12.3 7.1 0.9 0.9 12.6 4.7 0.1 1.3 1.0 2.2 1.9 1.4 0.6 0.5 5.7 7.0 5.4 0.5 0.8 1.4 0.9 0.9 1.5 2.0 1.9 1.3 7.0 1.1 6.2 2.2 6.2 1.1 3.0 0.4 3.1 2.2 0.7 1.4 1.1 1.0 1.8 1.3 1.1 2.5 5.0 1.2 1.1 1.7 2.6 7.8 2.8 1.9 2.0 1.7 2.3 3.5 1.6 0.0 1.4 0.0 1.1 0.9 3.3 5.5 0.0 1.4 2.3 0.0 3.9 0.7 0.0 0.4 1437.9 0.6 1.0 0.0 0.2 1.6 1.8 0.7 15.0 0.0 2.4 3.2 2.4 3.7 4.3 5492.6 23.6 4.3 0.0 1.0 1.1 7.8 0.5 0.0 18.4 0.8 4.6 19.4 1.9 76.2 19.6 0.3 0.6 1.0 1.6 0.3 PROCR "CCD41, CD201, EPCR" ENSG00000101000 "Protein C receptor" Q9UNN8 20 35172073-35216240 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 77.8" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 89.9;Sertoli cells: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 66.3;HUVEC TERT2: 103.3;TIME: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039461 Enhanced NA NA 1600000000 "HPA039461: AB_10673359" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.69e-2)" "unprognostic (4.69e-2)" "unprognostic (1.84e-1)" "unprognostic (1.52e-1)" "unprognostic (4.76e-2)" "unprognostic (5.22e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.62e-6)" "unprognostic (3.37e-2)" "unprognostic (2.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.19e-2)" 51.0 11.9 2.3 10.1 3.2 4.4 24.6 2.9 2.3 16.8 25.0 3.1 14.1 8.7 27.7 44.5 19.4 17.3 13.4 27.4 2.7 2.4 11.7 3.8 10.6 30.3 3.1 2.1 19.3 11.5 2.7 4.7 77.8 7.4 15.5 12.3 16.4 4.2 14.0 17.7 10.4 14.0 20.0 5.8 22.1 10.4 9.1 2.0 0.6 12.1 13.0 3.9 25.8 14.9 1.6 7.3 4.1 1.7 3.4 14.6 2.0 2.5 14.9 0.0 1.6 16.4 13.4 3.4 3.5 15.2 5.8 11.3 19.1 12.9 0.4 10.9 3.5 16.1 8.1 3.4 22.1 4.8 0.1 4.6 5.4 3.6 0.7 4.0 0.2 66.3 11.4 8.3 27.2 22.7 8.5 103.3 0.1 1.9 0.7 5.9 0.8 0.1 0.2 2.1 3.1 15.3 0.1 2.8 0.0 9.8 0.9 0.4 0.2 1.9 4.0 3.1 1.9 1.3 0.8 61.1 14.9 7.5 5.6 5.8 0.0 0.1 0.1 17.1 5.5 3.1 4.1 1.5 0.9 8.3 1.7 14.6 1.0 2.6 5.2 7.3 1.6 0.7 6.3 4.1 3.4 1.4 1.2 2.0 2.0 2.3 3.2 2.9 2.3 2.7 2.4 3.1 2.1 7.4 2.0 0.0 15.9 0.5 14.5 12.4 0.4 1.6 0.0 2.7 7.9 5.2 0.0 9.5 1.7 26.8 0.3 47.6 1.4 0.0 14.7 89.9 27.3 3.7 59.2 1.5 20.7 1.6 5.8 47.9 1.2 1.0 14.4 7.7 3.3 2.8 0.0 0.2 13.9 0.0 2.5 4.2 0.4 168.1 43.8 3.7 7.2 7.3 57.7 6.7 1.6 9.0 PRODH "HSPOX2, PIG6, PRODH1, PRODH2, TP53I6" ENSG00000100033 "Proline dehydrogenase 1" O43272 22 18912777-18936553 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "OE19: 39.9;RPTEC TERT1: 19.8" HPA020361 Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" "unprognostic (2.46e-2)" "prognostic favorable (1.54e-4)" "unprognostic (1.40e-1)" "unprognostic (3.70e-2)" "unprognostic (3.80e-2)" "unprognostic (1.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-2)" "unprognostic (2.49e-2)" "unprognostic (6.56e-2)" "unprognostic (3.12e-2)" "unprognostic (1.61e-2)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.34e-2)" "unprognostic (3.94e-2)" 3.8 2.3 20.8 2.8 19.3 2.0 3.3 9.8 21.3 2.0 3.5 16.2 0.1 13.8 2.3 2.2 8.8 2.4 2.2 4.6 22.2 10.8 9.9 6.6 8.6 2.3 14.9 21.8 2.4 2.2 1.9 1.5 2.4 13.5 2.6 2.6 7.4 2.1 2.4 15.5 13.0 48.9 1.9 12.6 2.2 2.1 3.5 9.8 0.1 4.3 4.1 3.7 2.1 2.3 0.4 0.4 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.4 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.4 39.9 0.0 0.0 0.0 0.2 19.8 0.4 0.0 0.1 0.4 0.6 0.1 2.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 20.8 19.3 9.8 21.3 22.2 10.8 14.9 21.8 13.5 9.8 14.9 24.6 0.0 0.2 4.5 0.0 1.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.0 0.3 13.2 0.0 0.0 0.4 0.1 PRODH2 HSPOX1 ENSG00000250799 "Proline dehydrogenase 2" Q9UF12 19 35799988-35813299 "Enzymes, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 29 "kidney: 51.2;liver: 49.3" "Group enriched" "Detected in some" 8 "Hepatocytes: 140.6;Proximal tubular cells: 216.9" "Group enriched" "Detected in some" 50 "liver cancer: 28.1;renal cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "Hep G2: 26.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA051287 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051287: AB_2681420" "unprognostic (2.58e-1)" "unprognostic (3.41e-3)" "unprognostic (2.75e-2)" "unprognostic (7.03e-2)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.7 0.1 0.0 0.3 0.1 0.1 0.0 51.2 49.3 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 3.4 0.0 0.1 0.3 0.3 0.0 0.0 0.0 12.2 0.0 0.0 23.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.6 0.1 0.0 0.0 1.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 216.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PROK1 "EGVEGF, PK1, PRK1" ENSG00000143125 "Prokineticin 1" P58294 1 110451200-110457354 "Predicted secreted proteins" Angiogenesis "Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ovary: 107.6;testis: 52.8" "Group enriched" "Detected in some" 50 "Leydig cells: 160.2;Peritubular cells: 627.9" "Cancer enhanced" "Detected in many" "testis cancer: 4.7" "Region enriched" "Detected in single" 9 "basal ganglia: 4.9" "Group enriched" "Detected in some" 8 "MAIT T-cell: 1.5;NK-cell: 1.0" "Group enriched" "Detected in many" 8 "NK-cells: 1.0;T-cells: 1.5" "Cell line enriched" "Detected in some" 11 "ASC diff: 23.8" "Region enriched" "Detected in single" 11 "pons and medulla: 1.4" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (2.66e-1)" "unprognostic (2.71e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-3)" "unprognostic (2.26e-1)" "unprognostic (1.86e-1)" "unprognostic (3.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.24e-2)" "unprognostic (3.74e-2)" "unprognostic (7.39e-3)" "unprognostic (1.90e-1)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" 0.8 2.8 0.1 0.1 4.9 0.0 1.2 0.1 0.3 3.4 0.2 0.2 0.5 0.0 0.3 1.5 0.3 1.0 0.1 1.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 107.6 0.1 0.0 0.1 18.0 0.5 3.6 0.0 0.1 0.1 4.0 0.2 0.4 0.1 0.1 0.4 0.3 0.0 52.8 0.1 0.1 0.2 0.2 0.1 1.5 6.8 0.1 0.0 0.0 0.1 1.0 1.5 0.0 0.0 0.0 0.0 0.1 23.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 4.9 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.8 160.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 627.9 0.0 0.0 0.0 0.0 3.1 1.1 0.0 0.8 0.0 0.0 0.1 PROK2 "BV8, KAL4, MIT1, PK2" ENSG00000163421 "Prokineticin 2" Q9HC23 3 71771656-71785206 "Disease related genes, Predicted secreted proteins" "Biological rhythms" Neuropeptide "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 82.6;bone marrow: 42.8" "Group enriched" "Detected in some" 7 "Kupffer cells: 15.8;Spermatocytes: 25.5" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.1" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 49 "neutrophil: 82.6" "Lineage enriched" "Detected in many" 49 "granulocytes: 82.6" "Cell line enhanced" "Detected in some" "HL-60: 9.0;NB-4: 7.8;NTERA-2: 5.5;U-266/70: 12.4;U-266/84: 20.1;U-937: 8.3" "Group enriched" "Detected in some" 6 "basal ganglia: 2.7;hypothalamus: 1.3;olfactory region: 4.3" "Region enhanced" "Detected in many" "olfactory region: 11.4" HPA041408 Approved "Secreted to blood" NA NA "HPA041408: AB_10964057" "unprognostic (5.24e-2)" "unprognostic (3.13e-3)" "unprognostic (3.51e-3)" "unprognostic (3.59e-2)" "unprognostic (1.89e-1)" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (9.52e-2)" "unprognostic (4.29e-2)" "unprognostic (9.91e-3)" "unprognostic (6.89e-2)" "unprognostic (5.73e-1)" "unprognostic (1.59e-4)" "unprognostic (2.02e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" 5.7 0.2 0.8 12.6 0.9 42.8 0.3 0.5 2.1 0.3 0.4 0.6 0.0 0.2 0.2 0.1 0.5 2.7 0.9 9.0 0.8 0.8 0.5 2.0 10.7 21.9 3.7 0.0 0.7 0.7 0.0 0.5 2.2 0.8 0.8 0.1 0.9 0.2 0.0 0.6 0.2 0.7 1.0 1.3 20.8 0.6 22.1 1.1 0.4 1.4 0.1 0.3 2.0 4.3 0.0 0.1 82.6 1.6 0.0 1.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.5 0.0 0.0 0.0 0.2 7.8 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 20.1 0.0 0.0 8.3 0.0 0.0 1.6 0.6 0.7 0.1 0.0 0.0 0.6 0.6 0.1 0.0 0.2 1.1 82.6 0.0 0.0 0.0 0.3 0.5 0.8 0.9 0.5 2.1 0.8 0.8 3.7 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.5 0.0 0.0 0.0 15.8 1.9 0.3 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 0.1 0.0 0.0 3.1 0.0 0.0 PROKR1 "GPR73, GPR73a, PKR1, ZAQ" ENSG00000169618 "Prokineticin receptor 1" Q8TCW9 2 68643589-68658247 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 3.3;epididymis: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Cell line enhanced" "Detected in some" "HMC-1: 2.2;NTERA-2: 6.7;SCLC-21H: 1.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA029396 Uncertain NA NA "HPA029396: AB_10610285" "unprognostic (5.46e-2)" "unprognostic (1.60e-2)" "unprognostic (8.75e-2)" "unprognostic (4.99e-4)" "unprognostic (1.18e-1)" "unprognostic (2.55e-3)" "unprognostic (1.07e-1)" "unprognostic (2.91e-2)" "unprognostic (1.85e-1)" "unprognostic (4.52e-2)" "unprognostic (1.89e-1)" "unprognostic (9.72e-2)" "unprognostic (8.96e-7)" "unprognostic (4.07e-2)" "unprognostic (2.53e-1)" "unprognostic (4.19e-1)" "unprognostic (7.22e-2)" 3.3 2.6 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROKR2 "dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2" ENSG00000101292 "Prokineticin receptor 2" Q8NFJ6 20 5302040-5314369 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.7;brain: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD8 T-cell: 1.6;neutrophil: 1.1" "Group enriched" "Detected in many" 8 "granulocytes: 1.1;T-cells: 1.6" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;NTERA-2: 3.3;SCLC-21H: 1.2;SH-SY5Y: 6.5" "Region enhanced" "Detected in many" "olfactory region: 20.9" "Low region specificity" "Detected in all" HPA047281 Uncertain NA NA "HPA047281: AB_10960057" "unprognostic (1.36e-1)" "unprognostic (1.69e-1)" 0.0 0.0 0.4 0.0 0.5 3.7 0.1 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.4 0.0 0.0 0.0 1.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 1.4 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROM1 "AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4" ENSG00000007062 "Prominin 1" O43490 4 15963076-16084378 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 52.4;salivary gland: 71.0" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 547.8;Rod photoreceptor cells: 281.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 13.9;CACO-2: 25.6;CAPAN-2: 10.9;EFO-21: 25.1;NTERA-2: 37.2;RPTEC TERT1: 34.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA004922, CAB011525, HPA031053" Enhanced NA NA "CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713" "unprognostic (6.33e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-1)" "unprognostic (3.39e-1)" "unprognostic (2.81e-1)" "unprognostic (2.16e-1)" "unprognostic (2.39e-1)" "unprognostic (6.64e-2)" "unprognostic (2.18e-2)" "unprognostic (2.17e-1)" "unprognostic (1.21e-2)" "unprognostic (9.06e-2)" "prognostic favorable (2.56e-5)" "unprognostic (2.16e-2)" "unprognostic (1.02e-1)" "unprognostic (9.38e-2)" "unprognostic (1.17e-1)" 0.5 0.5 2.5 11.5 2.2 1.3 11.2 1.0 2.2 20.1 13.8 2.3 1.6 5.2 4.7 3.1 1.8 1.9 12.6 2.7 3.1 2.1 30.2 1.6 3.6 0.1 2.3 0.6 1.6 10.7 0.0 1.8 12.7 2.1 1.6 7.4 52.4 71.0 2.9 0.7 1.1 13.5 1.7 1.8 0.6 10.9 5.0 0.9 0.3 1.7 3.8 10.2 3.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 10.9 0.3 25.1 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 37.2 0.0 0.0 1.0 0.0 0.0 34.5 0.1 4.3 1.5 0.0 0.8 1.0 1.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.5 2.2 1.0 2.2 3.1 2.1 2.3 0.6 2.1 0.9 3.0 3.7 0.0 0.1 0.0 10.1 7.9 30.6 93.7 22.7 78.5 547.8 0.4 0.0 51.2 32.2 2.5 26.6 0.0 14.0 0.1 0.0 0.9 0.0 0.0 0.1 9.5 42.7 0.6 0.0 34.0 2.8 0.7 0.0 1.0 9.2 47.2 32.3 24.9 6.0 1.4 281.4 0.0 0.3 1.2 0.7 0.0 0.1 0.0 18.0 0.9 PROP1 ENSG00000175325 "PROP paired-like homeobox 1" O75360 5 177992235-177996242 "Disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "pituitary gland: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049839 Enhanced NA NA "HPA049839: AB_2732557" "unprognostic (2.90e-1)" "unprognostic (4.90e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRORY CYorf17 ENSG00000183146 "Proline rich, Y-linked" Q9H606 Y 21382954-21386360 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "intestine: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "U-266/84: 8.5" NA NA "unprognostic (1.59e-1)" 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.4 0.0 2.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.4 5.4 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.3 1.2 0.4 0.3 0.9 0.2 0.2 0.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.1 0.0 0.8 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.2 0.3 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.6 1.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.5 0.1 0.7 0.5 0.6 0.0 0.2 0.4 1.0 0.0 0.9 8.5 0.2 0.2 0.7 0.1 0.6 0.2 0.5 0.7 0.4 0.5 0.4 0.4 0.7 0.2 0.9 0.7 0.9 1.2 0.3 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROS1 PROS ENSG00000184500 "Protein S" P07225 3 93873033-93974066 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 114.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 266.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "pons and medulla: 24.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 42.8;ASC TERT1: 31.9;HSkMC: 28.9;hTERT-RPE1: 24.2;SK-MEL-30: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007724, HPA023974, CAB032610" Approved "Secreted to blood" NA NA 22500000000 3400000000 "CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738" "unprognostic (2.00e-2)" "unprognostic (2.81e-2)" "unprognostic (9.21e-2)" "unprognostic (8.03e-3)" "unprognostic (3.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (5.18e-2)" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.90e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.42e-5)" 16.0 3.9 2.5 3.8 3.8 0.1 15.5 0.8 2.8 7.4 8.0 4.1 2.8 3.9 7.6 9.5 10.9 8.5 11.3 30.2 4.0 3.1 17.6 114.6 17.3 13.7 4.3 1.8 23.9 2.7 10.1 6.2 10.2 24.2 6.8 8.5 9.3 5.6 4.3 5.6 8.5 6.5 8.3 4.8 8.8 4.9 5.5 2.2 0.1 10.6 6.9 3.3 8.0 9.5 0.0 0.8 1.9 0.8 0.1 0.4 6.8 0.3 2.4 2.5 10.3 42.8 31.9 0.8 1.5 3.5 0.8 3.1 6.1 0.9 0.2 9.3 2.3 7.8 0.1 0.8 0.6 1.1 0.1 2.7 16.6 1.1 17.0 3.6 0.6 0.8 28.9 0.6 1.8 0.6 24.2 3.5 2.1 11.5 0.2 16.6 0.2 0.1 0.0 2.0 1.5 2.4 0.3 2.0 0.0 9.0 0.0 3.8 7.0 1.8 0.0 46.2 0.8 0.1 8.1 3.0 6.8 1.5 3.7 0.8 0.0 0.1 0.0 21.2 10.6 9.9 0.0 0.8 0.7 0.1 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 1.9 0.1 0.2 0.0 0.2 6.8 2.5 3.8 0.8 2.8 4.0 3.1 4.3 1.8 24.2 2.2 59.6 29.8 3.7 2.9 13.2 0.6 40.3 12.7 76.3 12.5 1.8 9.8 0.6 3.3 5.6 2.3 47.0 2.6 0.0 4.0 0.6 62.0 4.7 29.0 266.4 9.9 1.6 15.1 69.3 24.7 4.0 26.4 7.7 18.6 1.0 14.6 22.0 3.9 7.0 34.6 36.2 7.8 12.9 26.2 0.2 0.5 29.1 1.4 4.5 13.3 2.0 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 40.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 26.1;Urothelial cells: 72.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.9;CAPAN-2: 39.5;HBEC3-KT: 25.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 32.0" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 2.7 1.1 0.7 1.8 1.4 9.5 9.8 1.0 1.3 3.7 2.5 0.4 2.4 1.2 2.5 1.7 6.2 3.0 2.2 1.4 1.5 0.7 8.6 40.8 10.2 0.2 1.4 0.3 1.7 21.7 0.0 1.5 9.2 1.2 7.3 2.0 9.9 4.5 2.7 1.7 3.2 1.1 1.3 1.0 8.2 7.1 7.5 0.5 4.3 12.0 3.6 5.6 6.5 9.9 0.0 1.9 0.0 1.0 0.0 0.7 0.9 32.9 4.7 0.3 0.1 1.0 1.3 1.9 1.5 0.7 1.2 0.6 10.9 39.5 0.0 6.1 0.1 0.5 8.7 3.3 25.2 0.6 0.0 8.1 3.8 2.0 7.0 5.9 0.0 2.4 1.4 5.5 7.1 8.1 0.1 3.6 0.6 5.6 0.0 1.7 4.5 0.0 1.2 2.1 4.4 2.7 5.3 4.3 0.0 2.6 1.6 0.0 0.4 2.4 10.0 4.2 1.7 5.2 2.0 2.5 0.0 8.0 13.2 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 1.0 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.9 0.7 1.4 1.0 1.3 1.5 0.7 1.4 0.3 1.2 0.5 8.9 5.1 0.0 22.8 5.0 0.0 0.9 20.4 6.7 5.7 5.2 0.0 4.7 5.0 9.6 2.5 2.8 0.8 0.0 3.3 16.0 3.1 21.4 0.0 26.1 0.7 0.0 1.7 1.8 0.8 2.3 1.7 0.3 3.3 0.0 1.3 0.0 13.3 0.0 4.2 0.3 0.0 0.0 1.0 1.7 2.8 4.1 0.6 0.0 3.3 72.6 PROX1 ENSG00000117707 "Prospero homeobox 1" Q92786 1 213983181-214041502 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 72.4" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 195.1;Hepatocytes: 270.2;Horizontal cells: 494.2" "Cancer enhanced" "Detected in many" "liver cancer: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enhanced" "Detected in some" "Hep G2: 16.0;RH-30: 8.5;SH-SY5Y: 41.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000842, HPA001030, HPA027298" Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: " "unprognostic (3.07e-1)" "unprognostic (5.98e-2)" "unprognostic (1.06e-3)" "unprognostic (3.42e-1)" "unprognostic (7.71e-2)" "unprognostic (1.39e-1)" "unprognostic (1.45e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-2)" "unprognostic (2.31e-1)" "unprognostic (3.29e-3)" "unprognostic (6.64e-2)" "unprognostic (4.56e-6)" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (6.71e-4)" "unprognostic (1.05e-1)" 2.3 9.6 3.7 2.1 8.1 1.0 2.9 14.0 5.8 1.8 3.0 13.1 0.3 2.7 1.9 2.0 1.5 3.0 2.6 13.1 6.2 4.1 5.4 72.4 2.0 13.5 8.4 4.3 7.3 13.9 1.0 11.4 1.3 5.5 1.4 3.2 2.4 1.1 1.3 4.1 1.5 3.1 1.7 9.6 14.9 2.8 5.9 9.2 0.0 7.5 0.6 1.5 1.6 2.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.5 0.3 0.0 16.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.8 1.2 2.8 0.0 0.2 0.0 0.2 0.0 0.8 1.0 0.7 0.0 8.5 1.2 0.1 0.2 1.2 41.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 8.1 14.0 5.8 6.2 4.1 8.4 4.3 5.5 9.2 0.0 2.9 0.0 1.0 5.3 195.1 97.2 84.1 1.4 2.3 8.7 2.0 0.0 13.3 17.3 37.5 17.8 2.6 0.0 2.4 0.1 6.7 2.3 0.0 270.2 0.7 494.2 64.2 4.9 4.5 5.9 1.1 1.1 10.1 0.0 15.2 38.7 5.2 79.3 1.1 0.3 8.6 0.0 2.7 0.2 0.1 4.0 0.0 0.0 8.0 0.6 PROX2 FLJ36749 ENSG00000119608 "Prospero homeobox 2" Q3B8N5 14 74852871-74871940 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 5.8" "Cell type enhanced" "Detected in some" 31 "Alveolar cells type 2: 3.4;granulocytes: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 5.2;CACO-2: 3.9;U-698: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045057 Uncertain NA NA "HPA045057: AB_10960259" "unprognostic (4.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.57e-1)" "unprognostic (1.36e-2)" "unprognostic (1.31e-2)" "unprognostic (3.95e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (5.98e-3)" "unprognostic (2.98e-1)" "unprognostic (1.22e-2)" "unprognostic (9.87e-2)" "unprognostic (1.26e-1)" "unprognostic (3.59e-2)" "unprognostic (1.73e-4)" 0.6 0.3 0.4 1.6 1.6 4.1 0.6 1.8 1.2 1.9 0.5 0.6 0.9 2.1 0.6 1.2 0.3 0.4 0.5 0.9 0.5 0.2 0.8 2.4 0.8 2.9 0.6 0.8 1.4 0.6 1.3 1.0 0.9 1.1 0.5 5.8 1.0 0.2 1.0 2.0 0.4 0.7 1.7 1.5 0.6 1.2 0.8 1.0 4.2 0.7 3.5 0.7 0.3 0.2 0.5 5.2 1.9 1.5 0.7 1.5 0.4 0.0 0.0 0.3 3.9 0.5 0.3 0.4 0.0 0.1 1.2 0.4 0.0 0.0 0.0 0.2 1.8 1.8 1.0 0.5 0.1 2.4 0.0 0.4 0.0 0.0 1.3 0.0 0.3 0.2 0.3 0.0 2.2 0.2 0.8 0.3 0.1 0.5 1.2 0.9 0.1 0.0 1.0 1.4 0.6 0.2 0.4 0.0 0.5 0.5 1.8 0.4 1.3 0.5 0.5 0.3 0.8 0.5 3.7 0.1 1.6 0.0 0.2 0.7 3.0 0.5 0.6 0.7 0.8 0.2 0.4 0.4 0.5 0.4 0.6 4.2 3.5 0.5 1.0 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PROZ PZ ENSG00000126231 "Protein Z, vitamin K dependent plasma glycoprotein" P22891 13 113158654-113172383 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 45.0" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 56.9" "Cancer enriched" "Detected in single" 27 "liver cancer: 12.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.7;T-reg: 1.5" "Group enriched" "Detected in many" 12 "monocytes: 2.7;T-cells: 1.5" "Cell line enhanced" "Detected in many" "HaCaT: 4.9;Hep G2: 7.7" "Not detected" "Not detected" HPA052006 Supported "Secreted to blood" NA NA 1720000000 510000000 "HPA052006: AB_2681691" "unprognostic (5.03e-2)" "unprognostic (4.05e-2)" "unprognostic (1.11e-1)" "unprognostic (2.36e-1)" "unprognostic (6.48e-2)" "unprognostic (1.39e-1)" "prognostic favorable (3.46e-4)" "unprognostic (4.10e-1)" "unprognostic (2.21e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (2.87e-1)" "unprognostic (9.83e-2)" "unprognostic (5.63e-2)" "unprognostic (1.41e-1)" "unprognostic (9.99e-2)" "unprognostic (2.51e-4)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 9.3 45.0 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 2.7 0.0 1.5 0.2 0.9 1.5 0.7 1.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 3.0 1.8 0.8 0.0 0.0 0.3 4.9 0.0 0.0 0.0 0.8 2.4 1.0 2.9 7.7 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 2.5 1.1 0.6 0.0 1.0 0.6 0.8 1.8 3.1 0.4 1.3 0.2 0.3 0.0 1.1 2.9 0.2 0.0 0.3 1.3 1.7 0.0 1.0 0.7 0.8 0.1 0.8 0.3 1.6 0.9 0.8 1.6 0.9 0.7 0.0 0.0 0.0 0.3 2.7 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.1 1.5 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 PRPH "NEF4, PRPH1" ENSG00000135406 Peripherin P41219 12 49293252-49298686 "Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;testis: 30.4" "Group enriched" "Detected in some" 5 "Early spermatids: 268.2;Late spermatids: 616.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 23 "pons and medulla: 44.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AN3-CA: 91.5" "Group enriched" "Detected in many" 4 "hypothalamus: 22.7;pons and medulla: 36.8" "Low region specificity" "Detected in all" "CAB002437, HPA039277, HPA063887" Enhanced NA NA "CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142" "unprognostic (1.73e-2)" "unprognostic (3.03e-1)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.04e-3)" "unprognostic (1.88e-2)" "unprognostic (6.29e-2)" "unprognostic (1.87e-1)" "unprognostic (2.10e-1)" "unprognostic (7.38e-2)" "unprognostic (1.24e-1)" "unprognostic (4.25e-3)" "unprognostic (3.63e-2)" "unprognostic (5.73e-2)" "unprognostic (4.86e-3)" "unprognostic (6.36e-5)" 2.2 20.0 0.7 13.4 1.6 0.1 1.2 0.5 2.3 3.9 16.0 0.6 1.0 5.6 0.9 1.4 3.1 2.5 2.7 3.2 1.9 0.9 0.3 0.1 0.7 0.4 0.9 0.0 0.5 1.1 0.3 2.5 0.5 44.9 5.0 2.7 12.1 1.0 4.9 0.6 0.7 11.4 2.5 5.9 0.9 4.8 30.4 0.4 0.1 0.3 0.9 0.2 5.8 7.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 91.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.3 19.7 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.6 0.5 0.5 1.9 0.9 0.9 0.0 44.9 0.4 0.0 0.0 0.0 0.0 0.0 8.5 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 268.2 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.1 23.8 88.5 0.0 0.0 616.9 5.5 0.0 0.0 0.0 0.2 10.2 0.1 0.0 1.8 0.4 19.9 0.0 7.2 11.2 7.7 0.4 0.0 0.0 0.1 0.1 PRPH2 "CACD2, rd2, RDS, RP7, TSPAN22" ENSG00000112619 "Peripherin 2" P23942 6 42696600-42722574 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Sensory transduction, Vision" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 117.8" "Group enriched" "Detected in some" 13 "Cone photoreceptor cells: 245.4;Rod photoreceptor cells: 471.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Cell line enhanced" "Detected in some" "ASC diff: 4.3;ASC TERT1: 4.9;fHDF/TERT166: 7.1;HHSteC: 11.0;HSkMC: 8.5;LHCN-M2: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA029458 Enhanced NA NA "HPA029458: AB_10602193" "unprognostic (2.37e-1)" "unprognostic (4.88e-2)" "unprognostic (6.67e-2)" "unprognostic (8.43e-2)" "unprognostic (1.15e-1)" "unprognostic (2.87e-3)" "unprognostic (4.73e-1)" "unprognostic (1.85e-1)" "unprognostic (6.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.18e-2)" "unprognostic (7.07e-4)" "unprognostic (1.13e-3)" "unprognostic (1.59e-1)" "unprognostic (8.42e-2)" "unprognostic (8.96e-3)" 1.0 0.8 1.5 1.0 1.0 0.0 1.0 1.0 4.8 1.7 2.0 1.0 1.0 0.3 2.3 2.3 1.0 0.9 1.2 1.4 1.1 3.0 1.0 1.0 1.2 1.0 1.1 1.0 3.4 2.0 6.9 2.7 1.0 1.0 1.4 0.8 117.8 1.0 1.3 14.4 0.0 1.1 2.3 1.0 1.0 1.0 3.5 1.0 1.0 5.2 1.0 1.0 1.0 1.0 0.6 0.3 3.4 0.6 0.2 0.8 0.0 0.0 0.0 0.0 0.0 4.3 4.9 1.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 11.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.4 0.2 0.8 0.2 0.3 0.0 0.3 0.6 0.4 0.2 2.5 0.2 0.6 0.0 0.3 0.0 1.5 1.0 1.0 3.0 1.1 3.0 1.1 1.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 23.7 0.6 0.0 0.0 0.0 0.0 245.4 0.0 3.3 0.1 0.0 0.2 0.0 0.0 0.2 0.0 1.4 0.2 0.0 0.0 0.0 11.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.7 0.0 1.8 0.0 471.5 0.0 1.5 2.5 0.1 0.3 0.1 0.0 0.0 0.0 PRPS1L1 "PRPS3, PRPSL" ENSG00000229937 "Phosphoribosyl pyrophosphate synthetase 1-like 1" P21108 7 18026774-18027863 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 38.4" "Group enriched" "Detected in some" 8 "Early spermatids: 39.0;Spermatocytes: 72.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.3;K-562: 2.1" HPA051269 Uncertain Vesicles NA NA Vesicles "HPA051269: " "unprognostic (2.39e-2)" "unprognostic (3.18e-2)" "unprognostic (1.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.7 0.3 0.6 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.3 0.6 0.8 0.9 0.5 0.1 0.4 1.1 0.7 0.1 0.6 0.1 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 72.2 1.3 0.0 0.0 0.0 0.0 0.0 PRPS2 ENSG00000101911 "Phosphoribosyl pyrophosphate synthetase 2" P11908 X 12791355-12824222 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 138.1;testis: 109.7" "Group enriched" "Detected in many" 21 "Leydig cells: 1325.5;Peritubular cells: 1875.4;Sertoli cells: 614.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051269, HPA067599, CAB070417" Enhanced Approved "Nuclear speckles,Vesicles" NA NA Vesicles "Nuclear speckles" "CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869" "unprognostic (7.50e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.09e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (4.75e-2)" "unprognostic (6.98e-2)" "unprognostic (2.64e-3)" "unprognostic (4.44e-3)" "unprognostic (1.81e-1)" "unprognostic (7.83e-2)" "unprognostic (2.20e-1)" "unprognostic (1.50e-1)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" 5.4 20.8 4.0 10.2 8.7 6.1 6.1 3.7 11.5 18.7 13.3 5.7 44.4 4.1 17.0 21.7 9.6 9.6 13.2 3.3 4.0 3.5 10.8 9.0 5.4 10.7 2.7 7.7 75.3 19.9 20.1 2.4 3.2 2.9 14.9 10.2 4.4 11.1 138.1 1.5 10.3 6.3 12.2 3.9 7.6 14.3 109.7 3.1 26.2 7.8 5.5 10.9 15.1 10.2 21.9 17.7 10.5 12.5 15.0 22.7 16.7 31.3 20.8 7.2 13.1 8.9 10.6 4.1 15.6 8.6 17.3 16.9 14.7 25.2 9.2 7.1 7.5 14.8 23.8 14.0 17.1 20.4 24.7 30.1 11.3 17.1 13.6 8.3 22.3 11.7 10.2 11.5 12.9 17.1 8.9 7.0 26.8 8.3 12.9 14.6 21.6 34.0 10.3 15.4 25.5 28.1 18.2 31.1 23.5 10.4 26.1 14.0 9.4 18.9 0.7 11.8 10.4 18.8 10.1 6.5 13.7 9.9 49.9 16.6 30.3 11.1 21.9 14.3 11.3 21.4 10.5 12.5 5.6 11.7 12.4 13.6 18.0 17.0 11.1 17.7 21.9 22.7 15.3 5.5 15.0 7.7 12.6 14.0 16.7 4.0 8.7 3.7 11.5 4.0 3.5 2.7 7.7 2.9 3.1 3.0 5.4 25.1 40.7 56.8 0.6 1.6 5.1 21.4 5.7 52.4 0.0 0.6 61.3 17.7 9.4 10.8 8.4 23.3 33.8 5.7 24.8 42.5 27.6 13.9 22.0 0.0 20.9 11.6 18.7 23.3 1325.5 24.5 38.8 20.8 26.7 0.3 28.8 5.8 1875.4 8.7 0.0 614.4 21.7 4.9 5.8 38.1 0.3 29.3 48.2 31.1 PRR11 FLJ11029 ENSG00000068489 "Proline rich 11" Q96HE9 17 59155499-59204705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.8" "Cell type enhanced" "Detected in many" 14 "Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 10.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023923, HPA052376" Uncertain Approved "Endoplasmic reticulum" Yes Yes "Endoplasmic reticulum" "HPA023923: AB_1855783, HPA052376: AB_2681803" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-2)" "prognostic unfavorable (1.90e-4)" "unprognostic (2.15e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.22e-3)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.18e-4)" "unprognostic (2.80e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.56e-2)" "unprognostic (5.21e-2)" "unprognostic (1.84e-1)" "unprognostic (1.55e-3)" 3.2 1.4 2.8 13.8 4.2 14.9 2.0 0.9 2.8 3.1 4.2 2.2 0.7 6.9 2.0 2.1 10.3 1.7 2.1 1.4 3.1 2.3 1.7 1.1 3.4 9.6 3.2 1.6 1.7 1.0 0.2 0.6 4.8 2.0 1.2 5.5 1.2 2.2 0.5 1.3 2.9 4.8 3.2 5.1 7.3 2.5 2.5 2.1 40.8 1.3 7.7 11.7 2.8 3.2 1.4 3.0 2.5 10.6 0.7 2.0 0.8 27.6 13.3 21.0 6.1 0.6 4.9 8.6 17.2 10.8 17.9 14.3 16.4 18.7 17.9 17.6 12.6 14.6 10.2 16.1 17.7 39.3 24.8 10.3 19.7 14.7 11.0 0.2 20.8 8.3 1.1 1.3 19.7 26.2 4.4 20.2 15.0 10.7 19.5 19.1 21.5 20.4 3.7 8.7 13.0 22.5 16.4 31.5 11.5 4.8 7.5 9.1 12.6 14.2 5.2 7.5 10.6 14.0 8.0 13.7 36.8 43.0 18.5 30.6 12.6 24.2 18.0 8.2 11.6 35.9 1.0 2.3 2.5 0.8 5.1 0.3 1.4 0.6 1.0 3.0 0.9 0.6 0.8 2.3 0.7 10.6 1.6 2.0 0.8 2.8 4.2 0.9 2.8 3.1 2.3 3.2 1.6 2.0 2.1 0.0 1.7 7.0 1.9 1.6 2.0 0.8 0.0 0.0 2.3 0.0 0.0 1.8 0.0 0.3 0.5 1.1 0.4 46.7 0.4 19.2 1.6 1.0 2.3 0.0 6.5 1.6 4.7 3.7 13.3 0.2 0.9 5.1 1.7 6.4 2.2 0.8 0.6 0.0 2.1 0.3 2.8 0.0 2.1 3.0 5.1 1.1 1.7 2.5 4.3 1.4 PRR13 "DKFZP564J157, FLJ23818" ENSG00000205352 "Proline rich 13" Q9NZ81 12 53441605-53446645 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 190.5" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 1157.2;Enterocytes: 1047.2;Proximal tubular cells: 808.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039396, HPA046219" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA039396: AB_2676484, HPA046219: AB_10963936" "unprognostic (1.09e-1)" "prognostic favorable (9.08e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-1)" "unprognostic (8.97e-3)" "unprognostic (4.88e-3)" "unprognostic (1.86e-3)" "unprognostic (7.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.41e-2)" "unprognostic (6.81e-3)" "unprognostic (1.81e-1)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "prognostic favorable (7.55e-4)" 31.9 48.0 29.7 38.3 36.4 64.0 29.3 19.5 38.3 23.8 81.1 27.0 26.6 117.5 24.2 34.4 31.2 35.0 40.1 31.1 30.9 30.1 88.2 51.4 35.5 49.3 34.3 39.2 30.2 29.3 16.1 26.5 32.5 31.3 30.0 70.6 27.1 26.1 44.9 33.3 22.9 110.7 24.5 32.5 53.6 51.9 15.7 28.7 41.6 34.3 21.6 45.6 35.8 25.3 79.6 60.1 190.5 86.5 50.8 72.9 117.1 25.3 51.2 12.7 14.1 21.8 27.9 27.8 21.2 31.0 27.3 26.7 92.6 59.7 39.9 72.5 30.7 33.6 22.9 25.8 33.5 33.5 38.5 19.2 58.1 28.2 43.4 53.8 86.6 80.1 36.9 34.0 51.0 35.1 29.5 29.1 24.1 49.9 40.1 42.8 68.7 48.5 85.1 20.9 32.4 34.7 43.0 10.8 42.4 60.7 44.0 11.4 8.4 31.5 45.1 38.0 27.4 63.6 67.2 29.9 18.5 18.2 33.0 20.8 29.8 36.2 58.5 24.8 52.5 34.8 63.6 75.8 142.7 50.7 84.6 49.4 79.6 56.9 53.8 60.1 70.8 53.5 57.5 190.5 50.8 86.5 49.7 72.9 117.1 29.7 36.4 19.5 38.3 30.9 30.1 34.3 39.2 31.3 28.7 77.4 108.7 131.7 128.0 42.2 6.7 20.7 178.3 136.5 72.8 177.9 27.5 204.3 1157.2 205.4 8.6 70.6 1047.2 0.0 224.1 275.8 70.2 205.1 179.3 136.2 316.3 17.5 163.2 59.5 331.1 4.2 53.8 241.9 102.9 348.1 279.4 63.8 250.2 733.0 43.2 808.7 20.6 77.6 60.4 33.7 20.1 48.9 243.4 192.8 262.9 167.7 PRR15 ENSG00000176532 "Proline rich 15" Q8IV56 7 29563811-29567295 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 66.1" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 66.9;Enterocytes: 108.9;Paneth cells: 46.5;Undifferentiated cells: 48.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Lineage enhanced" "Detected in single" "B-cells: 1.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.5;HaCaT: 17.9;OE19: 38.3;RT4: 13.7;SK-BR-3: 30.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040996, HPA048121" Enhanced Uncertain "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA040996: AB_2677241, HPA048121: AB_2680271" "unprognostic (5.46e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "prognostic favorable (6.37e-4)" "unprognostic (7.49e-2)" "unprognostic (1.96e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.23e-4)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (3.69e-3)" "unprognostic (1.25e-1)" "prognostic favorable (1.83e-6)" "unprognostic (1.30e-2)" "unprognostic (5.71e-2)" "unprognostic (2.33e-3)" "unprognostic (1.58e-2)" 3.8 0.5 0.7 14.4 0.4 0.0 3.1 0.4 0.8 22.8 58.9 0.8 2.6 24.8 6.8 13.3 0.7 2.9 12.1 1.0 0.6 0.5 12.7 0.5 3.7 0.6 0.4 0.4 4.0 2.0 0.0 2.7 19.0 0.5 2.7 18.5 0.3 4.6 0.9 0.5 0.3 66.1 1.1 1.1 0.4 16.6 1.4 0.4 0.3 1.0 1.0 1.9 7.0 1.9 1.6 0.0 0.0 0.5 0.0 0.0 0.6 6.5 9.3 0.0 0.0 3.6 4.5 11.9 0.3 0.4 0.1 0.1 8.1 15.5 0.0 1.7 2.2 0.2 17.9 1.9 0.0 0.0 0.0 1.3 0.5 1.7 8.8 1.2 0.0 0.0 0.0 3.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 1.5 0.2 1.2 1.4 38.3 7.4 0.0 0.0 8.2 10.7 13.7 0.2 0.1 0.9 30.2 0.0 5.5 2.2 0.0 7.9 0.2 0.0 0.0 0.3 0.7 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.4 0.4 0.8 0.6 0.5 0.4 0.4 0.5 0.4 0.0 0.3 0.0 1.1 0.1 0.0 0.3 10.2 66.9 6.8 36.6 0.0 12.5 24.9 6.1 0.6 0.3 108.9 0.0 19.6 8.7 0.3 2.1 0.0 0.0 2.5 0.0 8.1 0.0 0.0 0.0 1.4 2.7 0.0 1.0 37.6 0.0 10.9 46.5 2.1 9.2 0.0 0.0 0.4 0.0 0.4 0.0 5.3 0.0 48.1 19.0 PRR15L "ATAD4, MGC11242" ENSG00000167183 "Proline rich 15 like" Q9BU68 17 47951967-47957878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 144.2;Enterocytes: 169.7;Mucus-secreting cells: 103.4;Paneth cells: 199.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.2" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 67.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 19.0" HPA022918 Approved Approved Cytosol No NA Cytosol "HPA022918: AB_2060743" "unprognostic (9.91e-2)" "unprognostic (4.77e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-3)" "unprognostic (1.83e-1)" "unprognostic (2.31e-2)" "unprognostic (2.48e-1)" "unprognostic (5.22e-2)" "unprognostic (2.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.32e-2)" "prognostic favorable (6.29e-13)" "prognostic favorable (1.69e-5)" "unprognostic (1.36e-1)" "unprognostic (8.26e-2)" "unprognostic (3.34e-2)" 0.9 0.2 0.2 13.5 0.2 0.0 10.0 0.2 0.3 3.2 88.7 0.6 22.9 44.9 0.6 8.3 4.9 6.6 21.2 0.3 0.4 0.2 37.3 1.6 20.3 0.2 0.2 0.2 1.9 75.4 0.0 8.5 0.2 2.2 8.1 32.0 0.4 38.7 26.7 0.2 3.7 113.1 0.5 0.2 0.2 27.2 1.3 0.2 0.3 61.0 2.5 5.8 2.1 2.4 1.3 0.5 0.0 0.2 1.2 2.2 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.8 1.9 0.0 0.1 0.0 0.0 6.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.1 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.1 0.1 0.0 67.3 0.2 0.1 0.0 0.4 0.3 0.8 4.0 0.1 0.0 12.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 2.2 0.1 0.0 0.5 0.5 1.3 0.8 0.6 0.0 1.2 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 2.2 0.2 20.8 13.7 0.0 1.4 0.0 0.0 0.0 73.9 16.0 17.0 15.7 0.0 0.0 144.2 20.3 4.5 0.0 169.7 0.0 32.6 0.0 0.0 25.3 0.0 0.5 0.1 0.0 30.3 0.0 0.0 6.7 1.1 0.0 0.0 1.0 103.4 0.0 11.5 199.8 0.4 24.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 76.5 6.8 PRR18 MGC35308 ENSG00000176381 "Proline rich 18" Q8N4B5 6 166305300-166308448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 35.7" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 5.1;Collecting duct cells: 1.8;Hepatocytes: 2.1" "Cancer enhanced" "Detected in some" "glioma: 3.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 9.3;SH-SY5Y: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077250 Enhanced NA NA "HPA077250: AB_2732336" "unprognostic (2.91e-1)" "unprognostic (7.18e-2)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (1.44e-1)" "unprognostic (9.65e-2)" "unprognostic (5.60e-3)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (3.16e-2)" "unprognostic (2.44e-3)" "unprognostic (4.79e-3)" "unprognostic (2.43e-1)" "unprognostic (3.35e-3)" "unprognostic (9.49e-2)" "unprognostic (9.58e-2)" "unprognostic (1.07e-1)" 1.3 0.9 12.4 0.9 17.3 0.9 0.9 1.7 34.8 1.1 0.9 35.7 0.0 1.4 0.9 0.9 0.9 4.4 0.9 0.9 18.6 9.0 1.0 6.4 1.1 0.9 23.1 7.0 1.0 1.1 3.3 0.4 0.9 11.0 1.3 0.9 0.0 1.0 1.1 0.9 0.9 1.0 0.9 21.7 0.9 1.2 0.9 18.9 0.0 1.1 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.3 5.5 0.6 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 17.3 1.7 14.9 18.6 9.0 23.1 7.0 11.0 18.9 0.0 0.0 0.0 0.1 0.0 1.0 0.6 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 25.8" "Group enriched" "Detected in some" 8 "Early spermatids: 22.2;Late spermatids: 45.8;Spermatocytes: 32.9;Spermatogonia: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria" Yes No "Nucleoli, Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: AB_2686259" "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.5 1.0 2.2 1.3 5.8 3.5 0.8 2.6 2.9 1.0 0.5 0.7 0.6 0.7 0.8 0.8 1.0 0.9 1.1 0.3 1.8 1.6 0.7 0.9 0.6 0.9 0.9 0.8 0.9 0.5 1.0 0.8 1.2 1.7 0.9 0.5 0.6 1.0 0.8 0.6 1.3 0.8 0.7 1.6 0.7 0.6 25.8 1.0 1.3 0.8 0.3 0.9 0.8 0.5 3.1 2.3 2.8 2.2 2.6 2.9 1.3 3.9 6.1 3.3 4.5 0.2 0.3 3.5 2.3 1.8 5.4 5.1 2.5 3.8 0.7 7.0 1.9 4.0 1.3 1.6 1.7 1.2 2.6 1.5 4.2 3.6 1.5 1.2 1.1 2.6 1.8 2.4 3.5 0.7 1.1 0.9 4.4 2.2 2.0 2.4 9.3 3.9 2.0 3.5 3.7 0.0 1.6 0.6 0.4 1.8 3.4 7.6 3.0 3.2 2.3 0.9 1.1 3.0 1.5 1.2 3.6 5.3 0.9 3.1 0.4 1.4 1.2 3.8 2.9 3.6 2.8 2.2 0.6 2.4 1.8 0.8 3.1 1.7 2.3 2.3 2.2 2.3 1.3 2.4 2.6 0.7 1.5 2.9 1.3 2.2 5.8 2.6 2.9 1.8 1.6 0.9 0.8 1.7 1.0 0.0 0.3 0.0 0.7 0.6 0.4 0.4 0.0 4.0 0.0 0.0 0.0 0.7 1.7 0.9 22.2 0.5 0.4 0.0 1.0 0.6 0.4 0.4 0.0 0.2 0.7 1.6 0.0 0.0 0.0 45.8 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.1 0.5 0.1 0.0 0.6 32.9 25.6 0.6 0.5 0.0 0.5 0.4 PRR20A "FLJ40296, PRR20" ENSG00000204919 "Proline rich 20A" P86496 13 57140918-57143939 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20B ENSG00000204918 "Proline rich 20B" P86481 13 57147488-57150509 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20C ENSG00000229665 "Proline rich 20C" P86479 13 57140918-57157082 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20D ENSG00000227151 "Proline rich 20D" P86480 13 57160632-57163653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20E ENSG00000234278 "Proline rich 20E" P86478 13 57167197-57170218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059485 Uncertain NA NA "HPA059485: AB_2684035" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR22 MGC24975 ENSG00000212123 "Proline rich 22" Q8IZ63 19 5782960-5784765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 82.5" "Group enriched" "Detected in many" 13 "Early spermatids: 151.0;Late spermatids: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA044157 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA044157: AB_10960694" "unprognostic (8.09e-2)" "unprognostic (1.53e-3)" "unprognostic (5.19e-3)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (1.80e-1)" "unprognostic (3.20e-2)" "unprognostic (2.89e-2)" "unprognostic (1.20e-1)" "unprognostic (3.77e-2)" "unprognostic (3.42e-3)" "unprognostic (9.37e-3)" "unprognostic (4.18e-2)" "unprognostic (9.93e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-1)" "unprognostic (2.79e-3)" 1.1 1.0 1.1 1.7 1.5 2.0 1.1 1.1 1.7 1.1 1.3 1.2 1.1 3.1 1.1 1.1 1.6 2.5 1.1 1.1 1.1 0.7 2.4 4.4 1.1 1.5 1.1 1.1 1.1 2.7 1.0 1.2 1.1 1.1 2.7 0.3 1.1 3.2 1.1 1.1 5.4 3.3 1.1 1.1 2.7 2.4 82.5 1.1 1.1 2.3 1.1 1.1 1.1 1.1 0.2 0.0 0.0 0.2 0.0 0.9 0.1 1.8 3.2 1.4 6.6 0.0 0.2 6.6 1.3 0.6 1.0 1.6 3.2 1.8 2.9 3.7 0.2 0.7 2.4 1.0 1.3 0.2 4.5 10.3 1.4 1.4 1.1 0.6 3.1 16.1 0.8 1.1 1.4 0.4 0.1 0.2 3.6 7.2 0.0 0.8 6.9 3.6 3.8 8.3 0.3 3.3 3.5 1.2 4.6 0.3 2.1 1.8 3.3 0.3 2.4 3.7 0.3 2.8 2.5 1.0 2.5 6.8 8.7 1.6 9.4 7.3 5.6 0.2 6.2 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.9 0.4 0.0 0.0 0.2 0.0 0.0 0.1 1.1 1.5 1.1 1.1 1.1 0.7 1.1 1.1 1.1 1.1 3.0 0.3 0.8 0.4 0.2 5.3 0.3 2.5 0.0 2.3 3.5 0.0 1.9 0.0 0.7 151.0 0.4 2.6 0.0 0.6 0.7 0.8 1.1 0.0 2.1 0.9 4.8 2.4 0.6 1.0 60.2 2.0 0.0 0.0 0.0 2.6 2.2 0.7 1.5 0.4 1.0 5.3 6.5 0.0 8.3 6.6 1.0 1.5 0.0 2.7 0.5 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139005468-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 8 "testis: 6.1" "Cell type enriched" "Detected in single" 6 "Spermatocytes: 1.1" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.8" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 4.7" "Group enriched" "Detected in some" 13 "Spermatocytes: 6.6;Spermatogonia: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 4.1 0.0 0.0 0.0 0.0 0.1 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 3.4;testis: 4.3" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 3.0;Late spermatids: 1.5;Spermatocytes: 1.4;Spermatogonia: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.2" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" NA NA "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 4.3 0.0 0.0 0.0 0.0 1.0 0.4 3.4 0.4 0.8 0.4 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.9 1.2 0.0 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.3 0.2 0.0 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.1 3.4 0.4 0.6 0.2 0.2 0.2 0.3 0.3 0.1 0.0 1.0 0.3 0.4 2.2 0.8 0.1 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.1 0.0 0.0 0.0 0.0 PRR23D1 ENSG00000255251 "Proline rich 23 domain containing 1" E9PI22 8 7539628-7542450 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "epididymis: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;JURKAT: 2.0" NA NA 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.0 0.1 0.0 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23D2 ENSG00000255378 "Proline rich 23 domain containing 2" P0DMB1 8 7778591-7781413 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "epididymis: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;JURKAT: 2.0" NA NA 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 2.0 0.1 0.0 0.0 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 PRR25 gs64 ENSG00000167945 "Proline rich 25" Q96S07 16 805443-813861 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 1.5;blood: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 1.2;HEK 293: 4.5;JURKAT: 1.7;PC-3: 1.6" HPA042974 Uncertain NA NA "HPA042974: AB_2678247" "unprognostic (2.49e-1)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (4.31e-2)" "unprognostic (3.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.60e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-3)" "unprognostic (3.15e-2)" "unprognostic (2.28e-1)" "unprognostic (8.10e-4)" "unprognostic (4.04e-4)" 1.5 0.0 0.6 1.0 0.6 0.4 0.0 0.8 0.9 0.2 0.3 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 0.1 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.6 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.6 0.5 0.0 0.7 0.0 0.1 0.5 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.5 4.5 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.6 0.7 0.0 0.0 0.1 0.2 0.1 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.5 0.5 0.5 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR27 C4orf40 ENSG00000187533 "Proline rich 27" Q6MZM9 4 70133616-70176799 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 268 "salivary gland: 669.3" "Group enriched" "Detected in some" 32 "Early spermatids: 11.0;Late spermatids: 7.0" "Cancer enriched" "Detected in single" 10 "breast cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.4" "Cell line enhanced" "Detected in single" "HeLa: 1.3" "HPA036150, HPA036151" Enhanced "Secreted to digestive system" NA NA "HPA036150: AB_10673001, HPA036151: AB_2674971" "unprognostic (9.52e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 669.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.5 0.2 2.4 0.3 0.5 0.2 0.0 0.3 0.2 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.2 1.3 0.1 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.1 0.0 0.2 0.2 0.5 0.0 0.7 0.1 0.4 0.5 0.0 0.1 0.2 0.1 0.5 0.0 0.0 0.1 0.1 0.4 0.2 0.2 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.2 0.4 0.1 0.3 0.1 0.0 0.4 1.5 0.3 0.2 0.2 0.2 0.0 0.3 0.1 0.2 0.0 0.5 0.2 0.2 2.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 PRR29 "C17orf72, DKFZp761M2312, FLJ11724" ENSG00000224383 "Proline rich 29" P0C7W0 17 63998351-64004304 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 17.9;fallopian tube: 48.7;testis: 23.5" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 164.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.8;REH: 7.0;TIME: 5.6" HPA051264 Uncertain Nucleoli NA NA Nucleoli "HPA051264: " "unprognostic (2.05e-2)" "unprognostic (6.46e-2)" "unprognostic (2.87e-2)" "unprognostic (2.92e-3)" "unprognostic (4.71e-3)" "unprognostic (3.22e-2)" "unprognostic (3.84e-1)" "unprognostic (3.95e-2)" "unprognostic (1.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.30e-3)" "unprognostic (6.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.98e-3)" 0.9 0.5 3.3 0.8 7.6 0.6 0.9 0.1 2.1 4.0 0.5 8.3 0.4 0.6 1.0 17.9 0.6 48.7 1.0 0.7 5.6 5.5 0.6 0.6 7.3 0.7 1.6 0.8 8.1 0.5 0.9 5.8 0.7 15.2 0.6 0.4 0.2 0.9 0.9 0.6 0.5 0.5 0.6 1.1 2.5 0.5 23.5 1.0 0.0 2.5 0.0 0.7 1.0 0.0 1.0 0.7 3.1 1.8 1.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.0 0.0 0.4 0.0 6.8 0.0 0.7 0.0 1.5 0.0 0.1 0.5 0.2 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.8 0.2 1.9 1.0 0.0 0.0 0.0 2.4 0.0 0.2 1.4 0.2 7.0 0.1 2.9 0.5 0.0 0.4 2.1 0.0 0.3 0.4 1.1 1.1 0.0 5.6 0.2 2.4 0.7 0.2 0.7 0.2 0.5 0.9 0.3 0.0 3.1 0.9 0.0 2.0 1.8 0.4 0.7 1.7 1.0 0.7 1.0 3.0 1.7 0.8 1.0 1.7 0.1 1.1 1.6 3.3 7.6 0.1 2.1 5.6 5.5 1.6 0.8 15.2 1.0 0.0 3.2 0.5 0.0 0.0 0.0 0.1 0.0 164.6 18.2 3.5 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 21.8 1.4 0.0 0.2 0.0 0.0 0.0 PRR30 "C2orf53, MGC44505" ENSG00000186143 "Proline rich 30" Q53SZ7 2 27136848-27139410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 66.1" "Group enriched" "Detected in some" 79 "Early spermatids: 529.6;Late spermatids: 559.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 529.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 559.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 6.9 3.8 0.0 0.0 0.0 0.0 0.0 PRR32 CXorf64 ENSG00000183631 "Proline rich 32" B1ATL7 X 126819764-126821786 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "heart muscle: 8.9;tongue: 26.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 5 "glioma: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "THP-1: 1.3" "Group enriched" "Detected in many" 4 "basal ganglia: 3.5;hippocampal formation: 12.0;pons and medulla: 14.2;thalamus: 8.8" "Low region specificity" "Detected in many" HPA048386 Uncertain Approved "Nuclear speckles,Plasma membrane,Centrosome" NA NA "Plasma membrane" "Nuclear speckles, Centrosome" "HPA048386: AB_2680380" "unprognostic (7.10e-3)" "unprognostic (7.97e-2)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.4 0.0 1.1 3.4 0.0 8.9 0.2 0.1 0.0 0.3 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 1.7 0.0 3.1 0.1 0.0 0.3 0.5 0.3 0.0 0.0 0.1 0.0 0.0 26.7 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR34 "C22orf26, FLJ10945" ENSG00000182257 "Proline rich 34" Q9NV39 22 46049478-46054144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 13.2" "Cell type enhanced" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7;granulocytes: 2.3;Intestinal endocrine cells: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 9.2;Karpas-707: 7.8;PC-3: 6.3" NA NA "unprognostic (8.66e-2)" "unprognostic (5.21e-3)" "unprognostic (2.66e-2)" "unprognostic (2.79e-2)" "unprognostic (1.33e-1)" "unprognostic (1.77e-2)" "unprognostic (1.76e-2)" "unprognostic (1.96e-1)" "unprognostic (6.88e-2)" "unprognostic (1.30e-1)" "unprognostic (5.58e-4)" "unprognostic (1.66e-3)" "unprognostic (1.11e-1)" "unprognostic (5.37e-2)" "unprognostic (5.72e-4)" "unprognostic (1.16e-3)" "unprognostic (5.96e-2)" 2.7 2.0 2.2 1.8 1.8 2.0 13.2 4.4 3.1 2.2 1.7 1.7 0.0 1.9 3.0 2.2 1.0 1.4 0.7 4.1 1.9 1.5 1.9 1.3 4.2 7.1 2.6 1.1 1.8 1.4 1.9 1.9 0.8 2.2 1.6 0.6 1.4 1.8 1.2 11.7 1.4 1.4 3.2 2.3 4.0 1.7 0.9 2.0 0.2 1.3 1.8 1.0 2.6 9.7 5.0 2.4 7.4 4.0 6.2 3.5 2.1 4.0 3.7 0.0 1.0 0.6 0.2 0.0 1.2 0.3 0.4 0.1 0.0 1.3 2.2 1.9 0.8 1.5 2.1 0.6 0.6 0.0 0.0 3.3 1.3 9.2 0.0 0.1 0.0 1.3 1.1 0.1 0.5 0.6 0.9 0.4 0.7 0.0 7.8 0.4 1.8 0.4 0.0 0.0 0.6 6.3 0.2 0.5 2.4 0.3 0.0 1.7 1.2 2.2 2.2 1.7 0.0 1.1 0.7 2.4 1.3 2.7 1.1 1.9 5.0 2.4 0.4 2.4 0.0 0.9 3.5 4.0 7.4 2.4 3.6 1.4 5.0 3.5 1.9 2.2 4.8 3.3 2.6 5.1 6.2 3.1 2.4 2.6 2.1 2.2 1.8 4.4 3.1 1.9 1.5 2.6 1.1 2.2 2.0 0.0 0.3 0.0 0.5 0.0 0.7 0.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.2 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.6 2.3 0.0 0.6 0.0 1.7 1.3 0.6 0.0 0.6 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.0 0.6 0.3 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.5 PRR35 C16orf11 ENSG00000161992 "Proline rich 35" P0CG20 16 560422-565528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "brain: 51.1" "Cell type enriched" "Detected in some" 16 "Collecting duct cells: 34.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 27 "cerebellum: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.3;HMC-1: 1.0;K-562: 2.1;NTERA-2: 1.0;RT4: 1.3;U-2 OS: 1.4" "Region enriched" "Detected in single" 5 "cerebellum: 4.8" "Region enhanced" "Detected in single" "cerebellum: 0.9" HPA069297 Uncertain NA NA "HPA069297: AB_2686113" "unprognostic (6.96e-2)" "unprognostic (3.08e-2)" "unprognostic (5.25e-1)" "unprognostic (8.11e-2)" "unprognostic (2.56e-1)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 1.8 0.0 0.0 1.1 0.1 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 0.1 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 PRR36 ENSG00000183248 "Proline rich 36" Q9H6K5 19 7868719-7874379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.5;pituitary gland: 6.5" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 12.4;Cone photoreceptor cells: 11.8;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 22.3;SCLC-21H: 6.5;SH-SY5Y: 14.6;T-47d: 7.3" "Low region specificity" "Detected in all" HPA062741 Uncertain Approved "Nucleoplasm,Nuclear speckles,Golgi apparatus" Yes No "Golgi apparatus" "Nucleoplasm, Nuclear speckles" "HPA062741: AB_2684860" "unprognostic (3.15e-2)" "unprognostic (1.02e-1)" "unprognostic (6.23e-2)" "unprognostic (5.61e-2)" "unprognostic (1.72e-1)" "unprognostic (1.20e-2)" "unprognostic (9.62e-2)" "unprognostic (3.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.15e-3)" "unprognostic (1.75e-2)" "unprognostic (2.99e-1)" "unprognostic (5.69e-3)" "unprognostic (7.89e-2)" "prognostic favorable (7.74e-4)" "unprognostic (3.56e-1)" "unprognostic (8.52e-3)" 0.4 2.0 11.8 0.5 11.4 0.3 1.5 12.0 20.5 0.7 0.4 0.8 0.0 0.8 1.2 0.8 0.3 1.1 0.5 0.3 8.0 1.1 0.4 1.3 0.4 0.0 10.6 0.9 3.2 1.6 6.5 0.3 5.5 2.5 0.4 0.5 3.0 1.0 0.3 0.8 0.4 0.4 0.7 0.4 1.4 0.7 1.2 0.0 1.0 0.0 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.7 5.3 4.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 2.3 0.0 1.5 0.0 0.5 0.1 4.1 0.0 0.0 0.0 5.2 0.0 0.2 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.1 0.0 2.3 0.2 0.2 2.0 0.3 0.4 22.3 0.0 0.2 3.0 4.3 6.5 14.6 0.0 0.2 0.0 0.4 7.3 0.0 0.0 0.0 2.7 0.1 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 12.4 0.8 2.5 0.0 0.0 5.2 11.8 0.2 5.0 2.7 5.2 0.0 0.0 0.0 0.8 0.2 0.0 1.8 0.0 0.2 0.1 9.5 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 4.2 0.7 0.0 0.0 1.0 4.3 0.0 0.3 0.2 0.7 0.0 0.2 0.0 0.4 1.0 PRR4 "LPRP, PROL4" ENSG00000111215 "Proline rich 4 (lacrimal)" Q16378 12 10845849-10849475 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "salivary gland: 1184.0" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 85.6;Cone photoreceptor cells: 131.6;Horizontal cells: 81.0;Rod photoreceptor cells: 108.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 7.7" HPA042133 Supported "Secreted to digestive system" NA NA 25000000 "HPA042133: AB_10793979" "unprognostic (1.34e-1)" "unprognostic (2.13e-1)" "unprognostic (1.35e-2)" "unprognostic (1.74e-2)" "unprognostic (1.99e-1)" "unprognostic (5.03e-2)" "unprognostic (3.01e-3)" "unprognostic (3.91e-2)" "unprognostic (1.70e-1)" "unprognostic (1.23e-1)" "unprognostic (3.19e-2)" "unprognostic (1.09e-2)" "unprognostic (3.57e-6)" "unprognostic (2.81e-2)" "unprognostic (9.15e-2)" "unprognostic (1.21e-1)" "unprognostic (2.15e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1184.0 1.1 0.0 4.2 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 20.0 38.4 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 1.0 0.8 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.3 7.7 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 7.8 6.3 2.7 85.6 0.6 5.1 0.0 2.3 1.8 131.6 13.2 1.7 0.1 8.2 9.6 6.0 0.0 0.3 2.1 10.1 8.9 9.2 5.5 6.6 81.0 15.5 11.6 7.0 10.2 20.1 2.2 27.0 0.0 5.3 27.5 1.9 13.1 23.0 0.0 108.4 12.9 10.3 8.1 7.0 1.9 3.3 8.7 8.3 3.1 PRR5-ARHGAP8 ENSG00000248405 "PRR5-ARHGAP8 readthrough" 22 44702233-44862706 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.5;placenta: 17.9" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Collecting duct cells: 5.2;Pancreatic endocrine cells: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 15 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "BEWO: 5.1;CACO-2: 3.3;HEK 293: 5.5;MCF7: 3.6;U-266/70: 10.6" NA NA "unprognostic (1.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "unprognostic (5.52e-2)" "unprognostic (3.65e-2)" "unprognostic (6.61e-3)" "unprognostic (3.29e-2)" "unprognostic (1.77e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-2)" "unprognostic (2.53e-2)" "unprognostic (6.47e-3)" "unprognostic (9.28e-8)" "unprognostic (8.64e-2)" "unprognostic (9.91e-2)" "unprognostic (2.41e-2)" "unprognostic (3.45e-1)" 1.5 0.5 0.8 2.0 0.8 0.9 3.9 0.6 0.9 4.8 3.1 0.0 1.4 2.3 2.6 7.7 3.7 2.8 2.5 0.5 0.7 0.8 5.7 0.9 1.9 10.6 0.6 0.0 2.6 3.1 3.6 4.2 17.9 0.6 3.4 1.5 4.0 4.9 4.1 0.5 1.6 4.9 0.7 0.6 17.5 1.6 4.3 0.2 3.8 5.6 4.3 7.5 1.8 6.2 0.0 0.0 0.0 0.1 0.0 2.4 0.0 2.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 2.1 0.0 0.0 3.3 0.5 0.0 0.2 0.0 0.0 1.2 0.8 2.3 0.0 0.0 5.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.8 0.3 1.2 0.4 0.0 0.0 1.5 0.0 0.1 2.0 0.0 0.0 0.0 0.7 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.8 0.8 0.6 0.7 0.7 0.8 0.6 0.0 0.6 0.2 3.0 1.0 0.0 0.5 0.3 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.5 1.7 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.4 0.9 PRR5L "FLJ14213, PROTOR-2" ENSG00000135362 "Proline rich 5 like" Q6MZQ0 11 36296288-36465204 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 30.1;Paneth cells: 31.7;T-cells: 21.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 16.6;HMC-1: 27.5;hTERT-HME1: 28.6;SiHa: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070174 Approved "Cytokinetic bridge,Cytosol" Yes No "Cytokinetic bridge, Cytosol" "HPA070174: AB_2686231" "unprognostic (6.76e-2)" "unprognostic (1.61e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.30e-5)" "unprognostic (2.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.63e-1)" "unprognostic (7.45e-2)" "unprognostic (3.61e-1)" "unprognostic (1.46e-2)" "unprognostic (3.03e-3)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.71e-8)" "prognostic unfavorable (4.86e-4)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (2.98e-2)" 2.9 1.5 4.2 8.1 15.5 3.1 2.4 1.7 9.5 9.5 25.7 34.1 1.1 2.5 2.6 1.6 1.4 4.9 5.3 1.6 7.2 5.1 3.8 2.3 10.4 6.2 24.9 3.8 11.4 2.0 1.0 2.7 2.8 16.6 2.3 21.4 3.3 6.3 1.6 0.7 1.6 9.3 4.8 22.8 26.1 2.6 1.2 19.7 1.1 3.0 0.2 2.6 3.6 3.6 1.1 4.2 16.9 12.3 4.6 20.1 7.2 0.0 2.8 5.0 0.1 0.7 0.0 0.0 6.0 4.7 12.8 13.2 0.0 0.0 0.0 2.0 7.5 2.9 0.2 1.0 3.1 6.2 2.3 1.7 0.6 16.6 0.0 1.6 0.0 27.5 2.0 4.3 1.2 28.6 12.0 5.3 0.0 0.0 0.0 6.5 1.5 0.3 0.0 0.3 0.0 1.1 1.7 0.5 0.5 13.0 3.1 0.0 0.2 18.9 0.0 1.2 3.3 0.0 0.2 3.7 10.8 3.4 0.0 7.5 0.1 0.0 0.0 4.6 0.6 3.3 16.9 1.1 13.3 20.1 11.8 4.6 0.0 7.2 16.8 1.3 1.1 1.6 10.8 6.5 4.6 12.3 4.2 0.0 7.2 4.2 15.5 1.7 9.5 7.2 5.1 24.9 3.8 16.6 19.7 17.9 6.2 0.0 0.2 0.3 0.0 0.8 2.5 10.7 6.8 7.0 0.0 0.1 1.7 1.2 12.4 4.7 18.8 0.0 2.1 0.1 1.3 0.2 4.7 0.5 7.3 0.0 1.7 14.1 9.5 30.1 0.6 1.5 0.0 3.6 17.0 1.0 2.3 31.7 0.4 0.3 0.3 6.5 1.2 0.4 0.5 0.5 0.2 21.3 13.3 0.3 PRR7 MGC10772 ENSG00000131188 "Proline rich 7, synaptic" Q8TB68 5 177446445-177456286 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 41.2;Suprabasal keratinocytes: 58.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 17.4;SK-MEL-30: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046636 Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA046636: AB_2679730" "unprognostic (3.69e-1)" "unprognostic (9.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.48e-2)" "unprognostic (4.08e-2)" "unprognostic (7.94e-3)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (4.75e-2)" "unprognostic (5.86e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (8.84e-3)" "unprognostic (2.22e-1)" "unprognostic (3.76e-2)" "unprognostic (1.69e-1)" 1.9 2.4 12.5 3.2 22.0 15.1 1.7 4.1 28.5 1.1 2.9 9.8 0.0 2.9 1.7 1.3 1.9 3.2 1.9 1.1 14.1 7.6 1.5 2.2 2.0 3.6 4.8 8.4 1.2 4.0 2.6 6.2 1.3 6.2 2.0 1.4 4.7 5.2 1.5 1.7 8.8 2.6 1.2 4.4 4.9 4.6 3.2 4.6 1.2 1.2 0.8 2.3 1.5 0.9 3.2 3.0 10.8 0.6 2.0 7.3 1.5 7.2 2.8 0.8 5.7 0.0 0.4 2.5 3.4 0.6 1.0 1.3 0.6 3.9 7.0 9.0 0.5 2.9 6.1 0.4 3.1 0.4 6.1 9.0 2.1 2.7 2.1 0.6 4.2 5.1 0.6 1.3 0.4 0.2 0.9 0.4 2.7 1.1 5.0 0.9 9.7 3.5 10.7 1.4 1.1 17.4 9.9 2.6 7.0 1.2 0.6 14.1 10.1 1.3 3.4 16.1 0.0 3.0 0.6 2.6 5.7 9.7 5.1 8.2 2.7 1.5 3.4 5.6 6.8 4.1 2.4 0.1 10.8 3.0 0.5 7.3 2.1 3.4 5.1 0.1 3.2 3.2 4.1 4.8 2.0 0.6 3.0 2.5 1.5 12.5 22.0 4.1 28.5 14.1 7.6 4.8 8.4 6.2 4.6 3.0 0.0 13.7 25.0 38.5 12.6 1.2 10.2 0.0 1.2 7.0 0.0 0.9 8.3 10.1 10.8 4.5 7.1 0.0 9.4 0.7 3.9 23.6 27.5 2.8 1.4 6.4 41.2 1.8 2.2 9.7 0.9 2.9 27.0 1.0 9.4 15.2 9.0 7.8 2.1 9.8 13.1 0.0 9.8 3.3 11.7 58.5 1.1 25.5 9.1 15.4 PRR9 ENSG00000203783 "Proline rich 9" Q5T870 1 153217584-153219317 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "skin 1: 33.1;tongue: 13.0" "Group enriched" "Detected in some" 16 "Early spermatids: 3.6;Late spermatids: 8.1;Syncytiotrophoblasts: 7.4" "Group enriched" "Detected in many" 6 "cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SuSa: 20.7" "Not detected" "Not detected" HPA027714 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles" "HPA027714: AB_10602194" "unprognostic (1.45e-1)" "unprognostic (1.46e-1)" "unprognostic (4.17e-1)" "unprognostic (3.48e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-2)" 1.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.6 0.3 13.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 20.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 PRRG1 PRGP1 ENSG00000130962 "Proline rich and Gla domain 1" O14668 X 37349275-37457295 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078129 Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA078129: AB_2686878" "unprognostic (8.82e-2)" "prognostic unfavorable (4.65e-4)" "unprognostic (8.34e-2)" "unprognostic (2.08e-3)" "unprognostic (1.92e-1)" "unprognostic (5.11e-3)" "unprognostic (2.24e-2)" "unprognostic (7.23e-3)" "unprognostic (1.01e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (8.21e-2)" "prognostic favorable (2.05e-7)" "unprognostic (1.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.48e-1)" 11.6 5.5 12.0 3.1 22.0 0.7 5.8 2.6 18.7 6.7 5.7 35.9 4.6 4.1 6.2 2.5 5.9 4.0 12.4 8.5 17.9 10.7 14.9 10.7 6.3 2.5 31.0 9.9 6.2 2.6 1.2 2.3 10.6 21.3 5.1 6.0 3.0 3.9 11.6 19.3 3.1 4.3 7.5 43.4 4.0 3.4 2.4 23.7 0.0 11.6 2.9 1.6 5.9 4.5 0.6 0.2 2.6 1.7 0.2 0.4 0.1 15.0 3.4 2.8 2.8 9.4 7.6 1.2 6.4 8.6 2.3 4.0 8.2 9.7 0.0 11.1 5.0 4.3 4.9 7.6 4.8 4.0 0.0 2.4 2.7 3.6 2.8 11.5 0.0 3.5 11.8 4.0 4.5 3.8 4.6 11.9 0.0 1.2 0.0 8.0 1.1 0.0 0.0 3.3 2.4 7.2 0.0 6.2 0.0 39.4 0.7 0.0 0.0 4.7 7.5 2.8 7.7 0.0 1.6 8.5 3.6 2.2 7.0 1.9 0.0 0.0 0.0 3.6 0.0 3.3 2.6 1.7 0.1 0.2 0.5 0.2 0.6 0.1 0.3 0.1 0.4 0.2 0.4 0.8 0.2 0.2 0.2 0.2 0.1 12.0 22.0 2.6 13.9 17.9 10.7 31.0 9.9 21.3 23.7 6.0 3.4 0.0 4.2 10.1 1.8 7.6 12.7 0.0 0.0 31.4 0.0 5.5 6.6 5.9 0.6 16.5 5.6 0.0 2.7 11.7 8.7 5.9 1.1 15.3 3.8 17.5 2.9 14.7 5.1 0.0 4.4 1.4 3.3 1.0 4.8 1.9 12.9 8.0 2.5 7.3 0.2 6.5 5.6 0.9 3.6 5.5 8.7 0.0 4.1 7.4 PRRG3 TMG3 ENSG00000130032 "Proline rich and Gla domain 3" Q9BZD7 X 151695124-151705924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.4;epididymis: 10.3" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 16.4;Cardiomyocytes: 5.0;Melanocytes: 6.8;Suprabasal keratinocytes: 19.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HeLa: 2.0;NTERA-2: 3.0;SuSa: 7.5;U-2197: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060566 Uncertain NA NA "HPA060566: AB_2684321" "unprognostic (1.85e-1)" "unprognostic (1.21e-1)" "unprognostic (7.71e-2)" "unprognostic (1.77e-2)" "unprognostic (4.42e-4)" "unprognostic (7.24e-2)" "unprognostic (2.29e-2)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" "unprognostic (5.11e-2)" "unprognostic (3.01e-2)" "unprognostic (2.26e-1)" "unprognostic (1.98e-2)" "unprognostic (7.69e-2)" "unprognostic (4.64e-2)" "unprognostic (1.57e-1)" "unprognostic (1.84e-2)" 3.1 0.2 5.6 1.2 12.4 0.4 2.0 1.0 10.2 9.2 1.1 1.0 0.1 0.3 3.0 10.3 4.0 1.0 3.3 1.6 5.3 11.6 0.4 0.1 2.0 0.2 3.2 5.3 3.9 0.1 0.4 1.3 1.3 5.3 1.1 1.0 1.4 1.3 0.4 3.3 2.5 0.5 2.4 1.2 2.6 0.6 0.6 0.7 0.1 0.7 0.6 0.4 1.4 2.4 1.2 1.4 3.8 1.8 2.4 1.4 1.0 0.1 0.1 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.2 0.1 0.2 1.6 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.4 3.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.7 0.3 0.0 0.2 0.0 7.5 0.1 0.1 0.0 0.4 0.3 1.7 0.1 0.1 1.0 0.0 0.2 0.1 0.1 3.8 1.3 1.3 1.2 1.2 1.4 1.1 0.9 0.9 1.0 1.2 1.3 1.1 3.1 2.4 1.8 1.4 1.1 1.0 5.6 12.4 1.0 10.2 5.3 11.6 3.2 5.3 5.3 0.7 0.0 0.0 0.0 0.3 16.4 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 19.7 0.0 0.0 0.0 0.1 PRRT1 "C6orf31, IFITMD7, NG5" ENSG00000204314 "Proline rich transmembrane protein 1" Q99946 6 32148359-32153083 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 41.1" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 64.7;Cardiomyocytes: 82.2;Horizontal cells: 30.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 4 "HEK 293: 1.5;SK-MEL-30: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055149, HPA059099" Enhanced NA NA "HPA055149: AB_2682717, HPA059099: AB_2732632" "unprognostic (1.40e-2)" "unprognostic (1.35e-1)" "unprognostic (2.10e-3)" "unprognostic (3.87e-3)" "unprognostic (2.89e-1)" "unprognostic (4.74e-2)" "unprognostic (5.51e-3)" "unprognostic (5.93e-2)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (8.08e-5)" "unprognostic (2.99e-1)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (9.40e-2)" "unprognostic (1.94e-1)" "unprognostic (1.78e-2)" 2.6 4.8 23.9 2.4 25.3 2.2 2.2 35.8 41.1 2.5 2.5 4.9 0.0 2.6 2.6 2.1 2.1 2.4 2.3 2.3 24.4 10.5 2.4 2.2 2.2 2.2 4.9 27.1 6.1 2.4 2.3 3.2 2.5 11.7 2.8 2.3 1.8 2.3 2.7 2.4 2.4 2.4 2.3 3.0 2.4 2.9 2.6 7.7 0.0 2.2 0.0 2.1 2.2 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.8 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.5 0.8 0.1 0.0 5.6 0.0 0.2 0.0 0.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 23.9 25.3 35.8 41.1 24.4 10.5 4.9 27.1 11.7 7.7 0.0 0.0 0.0 8.0 3.5 64.7 82.2 7.6 0.0 0.0 1.8 9.8 5.0 1.7 0.0 0.9 4.5 3.3 0.0 0.0 0.8 3.8 4.6 0.0 2.4 0.9 30.2 8.6 3.1 0.3 1.0 5.8 0.3 3.3 0.0 3.7 15.1 0.3 2.5 6.0 0.0 8.0 0.0 12.7 0.5 1.6 2.4 3.0 0.9 4.5 4.8 PRRT1B IFITMD8 ENSG00000283526 "Proline rich transmembrane protein 1B" 9 131545514-131558620 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "fallopian tube: 9.0;lung: 16.0;pancreas: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 16.0;BEWO: 10.7;MCF7: 4.2;T-47d: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.5 4.7 0.0 0.0 0.3 0.6 1.0 0.0 9.0 3.9 0.0 0.0 1.3 6.1 16.0 0.0 0.0 0.0 1.7 7.6 1.7 0.0 0.1 0.1 3.4 2.0 0.0 0.0 1.7 0.0 0.0 2.9 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 79.8;Cone photoreceptor cells: 29.5;Leydig cells: 33.4;Peritubular cells: 37.8;Rod photoreceptor cells: 40.1" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 7.3" "Cell line enhanced" "Detected in many" "AF22: 19.8;hTERT-RPE1: 12.2;REH: 15.1;U-138 MG: 13.7" "HPA014447, HPA019203, HPA048045" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 3.7 7.2 27.2 2.8 40.5 0.8 2.1 86.7 53.6 10.1 6.0 6.0 3.1 6.2 20.7 8.3 4.4 10.2 10.3 5.3 18.9 13.0 2.1 0.9 5.7 3.5 5.5 33.2 35.7 2.4 8.6 17.6 7.1 18.0 16.2 2.6 5.2 4.6 14.4 4.3 3.1 6.8 10.3 7.4 1.8 7.3 9.9 10.2 0.0 2.8 0.3 1.6 5.1 10.7 0.2 0.0 0.5 0.2 7.3 0.6 0.3 0.3 1.2 19.8 7.4 1.0 3.7 0.5 2.4 4.0 0.8 0.9 1.1 2.3 0.2 0.4 3.2 0.6 2.0 2.7 0.4 0.3 5.2 1.6 1.3 8.8 0.8 0.2 0.0 0.3 3.4 0.1 1.4 0.1 12.2 1.0 0.6 0.2 1.6 0.6 3.3 0.5 0.6 5.7 0.0 1.0 15.1 1.1 0.4 0.1 0.7 4.3 4.5 0.2 2.9 0.4 3.2 7.3 0.1 1.1 13.7 4.8 0.8 1.3 3.4 0.4 0.1 5.4 0.1 0.5 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.6 0.4 0.0 0.2 0.4 0.2 0.2 7.3 0.2 0.0 0.1 0.3 27.2 40.5 86.7 53.6 18.9 13.0 5.5 33.2 18.0 10.2 3.0 0.0 0.0 1.3 1.0 79.8 0.8 0.0 6.7 1.2 0.0 29.5 1.5 1.7 1.1 1.7 2.0 9.6 0.0 1.4 0.6 9.3 1.4 0.0 0.0 0.3 19.1 5.8 2.5 0.0 6.3 33.4 0.0 0.0 1.0 2.0 6.5 2.3 10.5 37.8 0.2 40.1 6.5 13.2 2.4 3.2 0.4 2.2 0.0 1.7 1.0 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 23.6;Rod photoreceptor cells: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 18000 "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.6 3.4 12.7 1.7 0.8 1.2 2.4 1.5 3.3 0.2 2.4 1.3 0.3 3.0 1.5 0.2 0.9 3.2 0.6 6.8 1.4 0.5 1.3 0.0 1.3 0.3 1.2 3.2 0.2 1.2 0.5 7.1 0.6 4.3 0.7 3.4 1.8 16.1 3.0 0.2 6.2 0.1 1.5 1.8 0.3 1.3 0.7 0.2 4.9 3.2 1.2 24.2 0.4 1.0 6.5 0.3 0.6 0.3 3.5 0.6 0.9 4.4 4.5 0.4 8.0 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 0.0 1.3 3.0 3.6 2.4 23.6 2.5 7.6 8.1 1.2 10.4 13.7 0.6 3.3 2.6 3.1 2.8 4.2 0.0 4.4 0.4 4.8 3.6 1.1 2.4 3.1 14.3 10.9 1.8 1.3 2.7 5.2 2.1 1.7 17.2 4.7 9.8 3.2 0.0 2.5 6.2 22.5 0.0 4.7 9.7 5.7 1.9 0.3 4.6 3.6 2.0 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 72.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.3 0.7 14.1 0.3 0.0 0.0 3.9 0.2 0.3 0.0 0.0 0.1 72.0 0.1 0.0 0.1 0.5 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 0.0 0.0 0.0 0.0 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 PRSS1 TRY1 ENSG00000204983 "Serine protease 1" P07477 7 142749468-142753076 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1708 "pancreas: 3057.4" "Cell type enriched" "Detected in some" 17 "Exocrine glandular cells: 49265.4" "Cancer enriched" "Detected in many" 224 "pancreatic cancer: 1920.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9" "CAB025487, CAB025538, HPA062452, HPA063471" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 26000000000 Vesicles "Endoplasmic reticulum" "CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017" "unprognostic (6.55e-5)" "unprognostic (5.28e-1)" "unprognostic (7.58e-2)" "prognostic unfavorable (6.41e-6)" "unprognostic (8.26e-2)" "prognostic favorable (7.05e-4)" "unprognostic (1.35e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-1)" "prognostic favorable (4.91e-4)" "unprognostic (3.12e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 1.6 3057.4 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.4 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 1.7 0.0 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 10.1 0.0 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.1 0.0 1.9 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 49265.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 208.2 0.0 0.5 2827.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 PRSS12 "BSSP-3, MRT1" ENSG00000164099 "Serine protease 12" P56730 4 118280038-118353003 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.5;testis: 31.3" "Group enriched" "Detected in many" 4 "Ciliated cells: 84.3;Club cells: 46.6;Cytotrophoblasts: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.8;SH-SY5Y: 66.0;THP-1: 29.5" "Group enriched" "Detected in many" 5 "amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0" "Low region specificity" "Detected in all" HPA035054 Uncertain Approved "Nucleoplasm,Actin filaments" "Secreted - unknown location" NA NA "Actin filaments" Nucleoplasm "HPA035054: AB_10603990" "unprognostic (4.30e-2)" "unprognostic (1.04e-2)" "unprognostic (2.55e-1)" "unprognostic (4.41e-2)" "prognostic favorable (2.66e-4)" "prognostic favorable (1.03e-4)" "unprognostic (4.21e-1)" "unprognostic (3.48e-2)" "unprognostic (7.83e-2)" "unprognostic (6.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.29e-1)" "unprognostic (1.85e-1)" "unprognostic (9.55e-2)" "unprognostic (1.09e-1)" 0.9 0.5 2.1 4.1 1.4 0.0 1.9 0.5 2.8 16.5 6.0 2.0 1.3 2.2 3.0 2.7 3.6 9.8 27.5 0.3 2.2 0.9 1.1 0.8 8.0 0.0 0.7 2.4 1.9 9.8 0.0 0.9 20.4 4.1 2.0 5.8 20.0 3.1 3.2 0.3 5.9 8.6 1.0 0.5 0.3 8.1 31.3 0.2 0.3 0.6 7.7 7.7 3.1 16.2 0.3 0.4 0.0 0.1 0.0 0.7 0.0 1.5 0.0 0.5 0.0 0.0 4.2 0.0 13.7 12.5 2.9 4.9 0.0 5.6 0.0 0.0 20.8 1.5 0.2 9.3 2.8 3.9 0.0 2.1 0.0 1.1 0.0 0.4 0.0 0.0 1.3 5.3 1.0 3.0 9.6 0.0 0.1 0.0 0.0 2.4 0.0 0.1 2.8 0.6 10.7 0.9 0.0 11.8 0.0 0.0 2.0 1.5 66.0 0.0 0.0 0.8 9.9 0.0 29.5 0.0 5.9 0.8 3.7 2.7 0.3 0.0 0.0 0.3 0.9 3.4 0.0 0.1 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.1 1.4 0.5 2.8 2.2 0.9 0.7 2.4 4.1 0.2 6.0 2.9 0.0 0.8 7.4 0.4 1.2 12.7 84.3 46.6 1.8 0.0 36.7 0.0 0.4 7.1 0.7 9.7 0.0 8.8 2.7 5.6 0.3 6.9 0.0 3.2 0.0 5.1 0.0 0.0 11.8 0.0 1.1 5.0 0.0 2.2 0.0 6.5 8.0 0.0 0.3 0.2 0.0 2.1 8.0 13.8 3.8 10.0 0.0 4.2 4.2 PRSS16 TSSP ENSG00000112812 "Serine protease 16" Q9NQE7 6 27247701-27256624 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 14 "lymphoid tissue: 242.8" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 36.3;Syncytiotrophoblasts: 26.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4" "Group enriched" "Detected in many" 39 "B-cells: 5.4;T-cells: 2.3" "Cell line enhanced" "Detected in many" "hTCEpi: 19.9;RPMI-8226: 10.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "unprognostic (6.95e-2)" "unprognostic (1.91e-2)" "unprognostic (1.51e-1)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (9.21e-3)" "unprognostic (1.57e-1)" "unprognostic (7.89e-2)" "prognostic favorable (6.46e-5)" "unprognostic (1.57e-1)" "unprognostic (3.49e-2)" "unprognostic (5.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.49e-2)" "unprognostic (2.10e-1)" "unprognostic (1.62e-2)" 0.9 0.5 0.9 0.9 0.9 0.0 3.6 0.9 0.9 2.0 3.3 0.9 0.9 2.3 0.9 9.3 3.6 3.3 2.1 0.9 0.9 0.0 1.4 0.9 2.4 0.9 0.9 0.9 1.2 17.1 6.4 1.8 2.1 0.9 1.8 4.1 0.9 4.3 2.5 0.9 2.9 2.8 0.9 0.9 0.9 3.9 0.9 0.9 242.8 8.7 0.9 0.9 2.0 1.1 5.4 0.0 0.0 0.0 0.0 2.3 0.4 3.0 0.2 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.1 3.4 4.6 0.0 0.7 0.0 0.0 1.5 2.5 3.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 2.0 0.5 0.0 19.9 0.0 4.0 0.5 0.0 1.6 2.3 1.9 0.0 1.2 0.4 0.0 0.7 1.9 0.5 0.0 0.0 10.7 2.3 3.4 0.0 0.0 1.3 3.0 0.0 4.6 1.9 0.8 0.0 0.0 0.8 0.0 0.0 0.7 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 2.0 5.4 2.3 1.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 8.9 7.7 0.8 9.8 5.7 0.0 0.4 7.6 2.7 3.4 14.0 0.0 36.3 1.7 6.8 0.5 0.3 16.0 0.0 15.6 21.7 0.4 6.6 5.7 0.0 3.4 0.0 4.1 0.0 0.3 0.0 0.6 0.0 5.0 0.0 17.5 1.0 10.5 19.8 0.0 0.2 0.0 0.0 0.7 1.0 5.3 5.6 26.5 0.0 14.5 7.4 PRSS2 TRY2 ENSG00000275896 "Serine protease 2" P07478 7 142760398-142774564 "Enzymes, Plasma proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 708 "pancreas: 6267.9" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 92348.3" "Cancer enriched" "Detected in many" 72 "pancreatic cancer: 3463.4" "Group enriched" "Detected in some" 6 "basophil: 5.6;T-reg: 5.1" "Group enriched" "Detected in many" 6 "granulocytes: 5.6;T-cells: 5.1" "Cell line enhanced" "Detected in some" "OE19: 11.6;RPMI-8226: 37.4;U-2 OS: 8.1" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 27000000000 Vesicles "Endoplasmic reticulum" "HPA062452: AB_2684768, HPA063471: AB_2685017" "prognostic favorable (2.32e-4)" "unprognostic (3.80e-1)" "unprognostic (2.46e-1)" "unprognostic (3.30e-3)" "unprognostic (1.99e-2)" "unprognostic (3.06e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-3)" "unprognostic (1.48e-1)" "unprognostic (4.65e-2)" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (3.50e-1)" "unprognostic (5.36e-3)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6267.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 5.6 0.0 0.7 5.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 2.4 0.2 0.0 0.0 0.0 1.1 0.0 11.6 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.5 2.1 0.0 1.6 0.2 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 5.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 307.0 0.0 0.0 0.0 0.0 92348.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 608.7 0.0 0.0 14696.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS21 "ESP-1, TEST1" ENSG00000007038 "Serine protease 21" Q9Y6M0 16 2817180-2826304 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 21.0;salivary gland: 20.9;testis: 37.5" "Cell type enhanced" "Detected in many" 17 "Late spermatids: 257.7;Spermatocytes: 426.2;Spermatogonia: 234.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 23.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 10.5;eosinophil: 21.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.4;HEL: 11.6;HeLa: 29.8;K-562: 13.7;U-698: 42.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 27 "basal ganglia: 6.7" HPA008477 Enhanced Approved Cytosol "Intracellular and membrane" NA NA Cytosol "HPA008477: AB_1079697" "unprognostic (4.35e-2)" "unprognostic (3.46e-2)" "unprognostic (7.06e-2)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (7.02e-2)" "unprognostic (1.22e-1)" "unprognostic (2.61e-2)" "unprognostic (2.33e-1)" "unprognostic (5.21e-2)" "unprognostic (8.83e-3)" "unprognostic (1.52e-3)" "unprognostic (2.97e-2)" "unprognostic (1.14e-2)" "unprognostic (5.07e-2)" "unprognostic (7.79e-2)" "unprognostic (2.99e-1)" 0.8 0.0 0.2 0.2 0.2 5.5 1.0 0.4 0.4 1.4 0.4 0.2 1.4 0.2 0.3 0.2 0.8 2.2 2.1 0.2 0.2 0.0 0.2 0.2 2.1 3.3 0.2 0.2 0.3 0.9 1.7 0.2 0.3 0.4 1.8 0.2 0.2 20.9 0.2 0.5 0.4 0.4 0.2 0.2 0.9 0.4 37.5 0.2 0.9 0.2 1.2 1.1 0.3 0.6 0.8 1.4 21.0 2.3 1.0 3.3 1.3 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.6 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.2 0.0 0.0 0.0 10.5 2.3 21.0 2.2 1.6 3.3 0.8 1.1 1.8 0.6 0.6 1.5 2.2 0.2 1.0 0.3 1.4 0.5 1.3 0.2 0.2 0.4 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 10.2 29.2 1.0 0.0 81.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 1.1 94.4 0.0 0.2 0.0 0.3 6.3 0.2 21.6 0.0 0.0 11.5 0.0 0.0 0.0 0.0 257.7 6.1 1.8 0.0 0.0 0.9 0.0 0.8 0.0 3.5 0.0 0.0 45.3 1.1 426.2 234.2 0.5 0.1 2.5 1.6 11.1 PRSS22 "BSSP-4, hBSSP-4, SP001LA" ENSG00000005001 "Serine protease 22" Q9GZN4 16 2852727-2858170 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5" "Cell type enhanced" "Detected in many" 18 "Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 16 "cerebellum: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.6" "Low region specificity" "Detected in all" HPA049161 Approved Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA049161: AB_2680660" "unprognostic (1.45e-1)" "unprognostic (9.80e-2)" "unprognostic (3.50e-2)" "unprognostic (4.48e-1)" "unprognostic (2.29e-4)" "unprognostic (2.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (5.06e-1)" "unprognostic (7.52e-2)" "unprognostic (3.74e-3)" "unprognostic (4.12e-1)" "unprognostic (2.32e-4)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" 0.4 0.7 0.0 0.4 0.0 0.6 1.3 1.5 0.4 9.9 1.0 0.0 8.6 1.5 3.0 0.6 40.4 3.0 6.8 0.4 0.0 0.0 2.4 0.7 3.0 0.4 0.0 0.0 0.4 7.5 0.4 1.1 4.3 0.0 5.1 0.6 0.0 13.4 10.6 2.3 1.3 0.4 0.7 0.0 0.4 3.5 0.4 0.0 0.0 1.5 36.5 40.1 5.2 9.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 13.4 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 187.4 20.6 0.0 0.2 33.1 8.1 23.9 15.7 0.0 30.9 1.7 101.8 0.0 0.0 4.2 0.0 86.5 19.4 0.8 63.4 0.0 0.0 2.0 0.0 3.5 0.0 0.0 0.0 0.0 0.9 6.8 1.8 5.3 0.0 242.0 10.5 0.0 0.0 0.0 0.0 1.0 0.0 0.1 24.1 8.8 0.0 5.2 517.3 PRSS27 "CAPH2, MPN" ENSG00000172382 "Serine protease 27" Q9BQR3 16 2712418-2720551 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 8.9;Horizontal cells: 11.1;Urothelial cells: 9.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;myeloid DC: 1.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 5.6;SK-BR-3: 22.3;T-47d: 13.1;U-266/70: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB024920, HPA028848" Approved Approved Vesicles "Secreted to digestive system" NA NA Vesicles "CAB024920: , HPA028848: " "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (3.46e-3)" "unprognostic (5.35e-2)" "unprognostic (5.25e-2)" "unprognostic (2.48e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (4.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.79e-2)" "unprognostic (4.40e-3)" "unprognostic (4.03e-3)" "unprognostic (2.40e-1)" "unprognostic (2.26e-1)" "unprognostic (2.04e-2)" "unprognostic (1.28e-2)" 0.2 0.3 0.1 0.2 0.5 0.2 0.4 0.7 0.4 15.3 0.2 0.1 0.1 0.1 1.2 0.1 94.1 0.3 0.2 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.2 0.1 0.1 10.0 0.3 0.2 1.2 0.1 0.2 0.1 0.2 0.1 0.5 0.1 0.3 0.2 64.5 97.2 0.5 24.0 0.1 1.7 0.2 0.0 0.2 1.4 1.2 0.0 0.2 0.5 1.8 0.3 0.6 5.6 0.0 0.2 0.2 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.1 0.1 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.5 0.0 1.7 0.0 0.9 1.3 0.1 0.0 0.8 0.2 0.1 0.1 0.3 0.6 2.7 0.0 22.3 0.5 0.1 13.1 1.5 0.0 0.4 0.0 0.0 0.0 4.6 3.2 0.4 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 1.7 0.0 0.3 0.7 0.2 0.2 0.0 0.0 0.0 1.2 0.1 0.5 0.7 0.1 0.1 0.4 0.1 0.1 0.1 0.1 8.9 8.0 0.0 2.4 1.5 5.2 1.1 0.0 5.3 5.7 1.8 3.9 0.5 0.0 1.2 1.5 1.0 0.4 0.0 1.2 0.3 1.1 1.6 3.5 0.8 0.3 11.1 0.0 0.6 0.0 0.4 0.3 1.3 1.7 1.0 0.0 3.2 0.9 0.2 0.0 0.5 4.7 0.0 1.5 2.1 3.8 2.0 2.7 0.0 0.6 9.7 PRSS3 "PRSS4, TRY3, TRY4" ENSG00000010438 "Serine protease 3" P35030 9 33750466-33799231 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "pancreas: 984.9" "Cell type enhanced" "Detected in many" 19 "Enterocytes: 998.3;Exocrine glandular cells: 1691.4;Pancreatic endocrine cells: 545.2;Paneth cells: 388.3" "Group enriched" "Detected in many" 7 "colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 82 "basophil: 39.0" "Lineage enriched" "Detected in single" 82 "granulocytes: 39.0" "Group enriched" "Detected in some" 5 "OE19: 46.2;PC-3: 121.2" "HPA062452, HPA063471" Supported Approved "Endoplasmic reticulum,Vesicles" "Secreted to digestive system" NA NA 490000000 Vesicles "Endoplasmic reticulum" "HPA062452: AB_2684768, HPA063471: AB_2685017" "unprognostic (6.90e-2)" "unprognostic (2.26e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.18e-1)" "unprognostic (1.64e-1)" "unprognostic (3.29e-2)" "unprognostic (5.89e-3)" "unprognostic (1.38e-1)" "unprognostic (2.06e-3)" "unprognostic (1.10e-2)" "unprognostic (8.94e-2)" "unprognostic (7.75e-4)" "unprognostic (5.46e-3)" "unprognostic (2.13e-1)" "unprognostic (8.79e-2)" "unprognostic (4.96e-1)" 0.3 0.3 1.6 1.7 1.5 0.2 0.2 2.8 4.2 0.9 8.2 0.0 0.0 2.8 0.2 0.2 2.9 0.2 4.8 0.4 1.2 0.7 0.3 0.4 0.2 0.2 0.3 1.6 0.7 984.9 0.2 0.1 0.2 2.3 0.2 2.3 0.0 0.6 0.2 0.2 2.0 23.9 0.3 0.2 0.2 0.8 0.3 0.0 0.0 0.2 6.6 3.5 0.2 1.3 0.0 0.1 39.0 0.4 0.1 0.3 0.1 1.7 1.9 0.1 0.0 0.0 0.9 0.0 4.8 1.1 0.5 0.2 4.7 0.4 0.0 0.0 2.1 0.0 2.1 0.0 4.4 1.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.5 15.8 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 46.2 121.2 0.0 0.0 0.0 0.0 0.2 0.0 12.2 0.0 0.0 0.0 0.1 0.0 0.0 10.7 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 39.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 1.5 2.8 4.2 1.2 0.7 0.3 1.6 2.3 0.0 0.0 0.0 2.2 0.2 50.7 0.2 0.9 48.4 0.0 0.0 1.8 0.0 0.0 3.3 13.8 29.4 1.1 998.3 0.0 1691.4 0.0 0.4 7.0 9.2 1.0 0.0 0.0 184.8 1.3 0.3 56.5 1.4 1.2 6.8 10.0 156.0 0.0 545.2 388.3 0.7 6.7 0.0 0.0 3.1 0.5 0.4 117.2 0.1 0.0 282.9 19.5 PRSS33 EOS ENSG00000103355 "Serine protease 33" Q8NF86 16 2783953-2787948 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "blood: 132.7" "Group enriched" "Detected in some" 6 "Collecting duct cells: 1.8;Melanocytes: 1.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 8.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 78 "eosinophil: 132.7" "Lineage enriched" "Detected in single" 422 "granulocytes: 132.7" "Cell line enhanced" "Detected in some" "HMC-1: 4.7;hTERT-RPE1: 8.5;SK-MEL-30: 9.5;U-2 OS: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (4.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.99e-2)" "unprognostic (3.38e-2)" "unprognostic (3.10e-1)" "unprognostic (2.86e-2)" "unprognostic (1.16e-1)" "unprognostic (4.13e-2)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (2.28e-1)" "unprognostic (1.91e-1)" "unprognostic (2.70e-2)" 0.0 0.0 0.3 1.1 0.3 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.0 0.8 0.1 0.0 0.1 10.2 3.6 0.0 0.1 0.1 0.3 0.0 0.2 1.1 0.1 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.2 22.5 1.9 0.0 0.0 0.0 1.8 0.8 0.0 0.7 1.1 0.9 0.2 0.2 0.2 1.0 0.2 1.0 0.0 0.0 0.0 132.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 132.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.4 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 PRSS35 "C6orf158, dJ223E3.1, MGC46520" ENSG00000146250 "Serine protease 35" Q8N3Z0 6 83512538-83525704 "Enzymes, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.1;ovary: 16.3" "Cell type enriched" "Detected in some" 55 "Muller glia cells: 458.8" "Cancer enhanced" "Detected in some" "testis cancer: 4.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 9 "MAIT T-cell: 17.1" "Lineage enriched" "Detected in single" 172 "T-cells: 17.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.2;CACO-2: 42.7;HAP1: 6.4;RPTEC TERT1: 12.6;SuSa: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7" "HPA038787, HPA038788" Uncertain "Secreted in female reproductive system" NA NA "HPA038787: AB_10675951, HPA038788: AB_2676208" "unprognostic (6.17e-2)" "unprognostic (8.75e-2)" "unprognostic (1.19e-2)" "unprognostic (2.63e-2)" "unprognostic (1.16e-1)" "unprognostic (4.03e-2)" "unprognostic (3.70e-4)" "unprognostic (6.08e-2)" "unprognostic (1.18e-3)" "unprognostic (2.33e-2)" "unprognostic (7.01e-2)" "unprognostic (9.07e-2)" "unprognostic (3.88e-6)" "unprognostic (7.15e-3)" "unprognostic (5.81e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-4)" 2.0 3.8 7.7 1.3 11.3 0.0 0.6 0.2 9.3 4.8 0.4 2.5 0.3 0.5 2.2 2.1 0.6 2.2 6.2 5.6 4.8 1.1 4.9 0.7 2.0 3.0 1.1 5.4 16.3 0.6 0.9 1.5 5.2 2.7 2.7 0.6 11.1 0.4 0.7 0.4 0.5 0.4 2.2 1.4 1.1 0.6 4.6 1.3 0.0 0.7 0.4 0.2 2.0 0.9 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.2 5.2 0.5 1.0 42.7 0.0 0.0 0.0 0.2 0.0 0.0 6.4 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.2 4.1 0.0 0.0 0.0 12.6 0.0 0.0 0.5 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 17.1 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.7 11.3 0.2 7.1 4.8 1.1 1.1 5.4 2.7 1.3 3.0 0.3 0.0 0.0 0.0 2.3 1.2 0.0 0.0 0.0 1.8 0.0 0.1 8.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.3 6.4 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 458.8 0.0 0.0 8.1 0.0 7.1 6.5 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 PRSS37 ENSG00000165076 "Serine protease 37" A4D1T9 7 141836286-141841487 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 127 "testis: 39.1" "Group enriched" "Detected in some" 164 "Early spermatids: 641.3;Late spermatids: 239.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 2.3;U-937: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA020541 Enhanced "Secreted in male reproductive system" NA NA "HPA020541: AB_1853004" "unprognostic (4.70e-2)" "unprognostic (5.56e-2)" "unprognostic (2.69e-1)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (1.30e-1)" "unprognostic (2.74e-2)" "unprognostic (1.23e-2)" "unprognostic (8.30e-7)" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (2.72e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 39.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 641.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 239.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 PRSS38 MPN2 ENSG00000185888 "Serine protease 38" A1L453 1 227815693-227846470 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 19 "blood: 2.2;testis: 8.4" "Group enriched" "Detected in some" 10 "Spermatocytes: 9.6;Spermatogonia: 8.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "gdT-cell: 1.4;NK-cell: 2.2" "Group enriched" "Detected in many" 18 "NK-cells: 2.2;T-cells: 1.4" "Cell line enriched" "Detected in single" 20 "U-266/84: 5.2" "Not detected" "Not detected" "HPA028003, HPA055809" Enhanced "Secreted in male reproductive system" NA NA "HPA028003: AB_1853572, HPA055809: AB_2682931" "unprognostic (9.54e-3)" "unprognostic (3.61e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 8.5 0.0 0.0 0.0 0.0 0.0 PRSS40A TISP43 ENSG00000183292 "Serine protease 40A" 2 130570829-130584161 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 5.7;testis: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 3.7" HPA044732 Uncertain NA NA "HPA044732: AB_10794054" "unprognostic (1.55e-2)" 0.1 0.1 0.1 0.0 0.1 0.4 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.0 0.3 0.2 0.5 0.9 0.1 0.0 0.1 0.1 0.1 10.2 0.4 0.0 0.1 0.1 1.1 0.6 5.7 0.9 0.7 2.8 0.2 0.9 1.0 1.7 1.9 3.7 1.4 0.0 0.6 0.7 0.0 0.0 0.5 0.9 0.4 0.8 0.3 0.8 1.2 0.9 0.3 0.6 0.4 1.6 1.7 1.6 1.4 1.3 0.3 1.0 1.7 1.7 0.0 1.3 0.3 0.0 1.7 0.9 1.1 1.7 1.0 1.2 1.1 0.9 1.1 0.3 0.1 0.6 0.3 0.8 0.5 1.5 1.5 0.7 0.9 0.8 0.4 0.5 0.0 0.0 1.0 0.6 1.3 0.6 0.9 0.2 0.1 1.3 0.3 1.7 2.6 0.9 0.8 1.9 0.6 0.3 0.7 0.6 1.7 0.2 1.1 0.7 2.8 5.7 0.7 0.4 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS40B ENSG00000184761 "Serine protease 40B" 2 130539095-130549883 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "testis: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS41 TESSP1 ENSG00000215148 "Serine protease 41" Q7RTY9 16 2798485-2805302 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 11.6;testis: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Cell type enriched" "Detected in single" 116 "eosinophil: 11.6" "Lineage enriched" "Detected in single" 116 "granulocytes: 11.6" "Cell line enriched" "Detected in single" 11 "BEWO: 6.5" NA NA "unprognostic (1.58e-1)" "unprognostic (3.65e-1)" "unprognostic (3.04e-3)" "unprognostic (1.03e-1)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (1.98e-1)" "unprognostic (1.24e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS42 TESSP2 ENSG00000178055 "Serine protease 42" Q7Z5A4 3 46829542-46834095 "Enzymes, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "heart muscle: 12.9;skeletal muscle: 19.2" "Cell type enriched" "Detected in single" 4 "Cardiomyocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.3;Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.7" HPA046925 Uncertain "Secreted - unknown location" NA NA "HPA046925: AB_10961401" "unprognostic (6.53e-2)" "unprognostic (2.72e-2)" "unprognostic (3.57e-3)" "unprognostic (9.14e-2)" "unprognostic (3.26e-1)" "unprognostic (2.37e-2)" "unprognostic (1.85e-1)" "unprognostic (6.54e-2)" "unprognostic (4.26e-2)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.45e-1)" "unprognostic (1.09e-2)" "unprognostic (1.38e-1)" "unprognostic (1.62e-1)" "unprognostic (7.98e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.2 3.4 0.0 0.2 0.0 12.9 0.0 0.0 1.3 0.5 0.2 0.0 0.0 0.2 0.2 1.6 0.0 0.1 0.4 0.0 0.3 0.2 19.2 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.8 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.8 0.2 1.6 0.0 0.0 0.0 0.7 0.2 2.3 4.0 0.4 0.0 0.1 0.0 0.0 0.2 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.4 3.7 0.5 0.0 1.3 0.0 0.0 0.1 0.0 0.6 0.5 0.5 0.0 0.3 1.2 0.0 0.5 0.0 1.0 0.7 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 PRSS45 TESSP5 ENSG00000188086 "Serine protease 45" Q7RTY3 3 46742092-46744755 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 7.6;skeletal muscle: 6.7" "Cell type enhanced" "Detected in some" 14 "Late spermatids: 1.1;Melanocytes: 1.7;Spermatocytes: 1.9;Spermatogonia: 1.2" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 19 "naive B-cell: 1.9" "Lineage enriched" "Detected in single" 19 "B-cells: 1.9" "Cell line enhanced" "Detected in some" "Daudi: 1.1;HHSteC: 2.4;OE19: 1.7;SuSa: 1.1" HPA060284 Uncertain NA NA "HPA060284: AB_2684242" "unprognostic (4.55e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-2)" "unprognostic (2.50e-1)" "unprognostic (6.07e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (6.20e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-4)" "unprognostic (2.33e-2)" "unprognostic (6.60e-3)" "unprognostic (1.27e-2)" "unprognostic (1.57e-2)" "unprognostic (2.15e-1)" "unprognostic (5.97e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.5 0.2 0.1 0.2 7.6 0.1 0.8 0.0 0.2 0.0 0.0 0.9 0.7 0.2 0.1 0.0 0.3 1.3 2.0 0.5 0.1 0.5 0.0 0.5 0.3 6.7 0.3 0.0 0.0 0.0 0.0 0.2 1.6 3.2 0.0 0.4 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 PRSS48 ESSPL ENSG00000189099 "Serine protease 48" Q7RTY5 4 151277171-151291453 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 1.0;skin 1: 1.9;testis: 4.1" "Cell type enriched" "Detected in some" 6 "Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053801 Uncertain "Secreted in male reproductive system" NA NA "HPA053801: AB_2682267" "unprognostic (9.68e-2)" "unprognostic (1.35e-2)" "unprognostic (2.15e-1)" "unprognostic (2.18e-2)" "unprognostic (3.76e-2)" "unprognostic (4.10e-2)" 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.5 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 6.5 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 PRSS50 "CT20, TSP50" ENSG00000206549 "Serine protease 50" Q9UI38 3 46712115-46812574 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 22.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;SuSa: 1.8" HPA040768 Supported NA NA "HPA040768: AB_2677126" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.32e-1)" "unprognostic (7.45e-2)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (8.91e-4)" "unprognostic (1.08e-1)" "unprognostic (1.46e-3)" "unprognostic (2.68e-2)" "unprognostic (1.79e-2)" "unprognostic (9.36e-2)" "unprognostic (3.66e-3)" 0.1 0.7 0.0 0.0 0.0 0.0 0.6 0.4 0.3 1.3 0.2 0.1 0.7 6.2 0.1 0.5 0.0 0.9 0.0 0.6 1.8 0.7 0.2 0.0 0.0 0.7 1.7 4.7 8.2 0.0 1.6 0.0 1.7 1.7 7.7 0.0 0.0 0.2 0.0 0.0 0.2 22.3 7.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS50 "CT20, TSP50" ENSG00000283706 "Serine protease 50" Q9UI38 3 46712115-46717907 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 33.4" "Group enriched" "Detected in some" 5 "Spermatocytes: 155.2;Spermatogonia: 236.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.1;HMC-1: 5.4;NTERA-2: 2.1" HPA040768 Supported "Intracellular and membrane" NA NA "HPA040768: AB_2677126" 0.1 0.8 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.9 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.3 0.9 1.7 1.1 0.1 0.1 0.2 0.0 0.1 1.6 1.8 0.1 0.0 0.1 0.1 0.1 0.1 0.0 33.4 0.1 0.4 1.6 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.1 0.0 0.0 0.0 0.3 0.9 0.4 0.0 0.0 0.0 0.4 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.5 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 38.8 0.0 155.2 236.5 0.0 0.0 0.0 0.0 0.3 PRSS51 ENSG00000253649 "Serine protease 51" A0A1B0GVH4 8 10482878-10547585 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "brain: 1.4;breast: 3.4;liver: 1.5;testis: 2.3" "Group enriched" "Detected in some" 27 "Early spermatids: 3.2;Late spermatids: 2.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;CAPAN-2: 1.6;OE19: 1.7;T-47d: 1.9;U-2 OS: 5.1" "Secreted - unknown location" NA NA "unprognostic (2.52e-1)" "unprognostic (3.00e-1)" "unprognostic (3.10e-1)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.72e-1)" "unprognostic (7.48e-2)" "unprognostic (1.64e-1)" "unprognostic (7.94e-2)" "unprognostic (1.02e-1)" "unprognostic (6.33e-3)" "unprognostic (2.71e-3)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.0 0.4 3.4 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS53 POL3S ENSG00000151006 "Serine protease 53" Q2L4Q9 16 31083425-31089628 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 10.9" "Cell type enhanced" "Detected in some" 10 "Leydig cells: 1.7;Peritubular cells: 1.1;Suprabasal keratinocytes: 1.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034955, HPA034956" Uncertain "Secreted - unknown location" NA NA "HPA034955: AB_2674380, HPA034956: AB_10696365" "unprognostic (3.13e-1)" "unprognostic (4.15e-1)" "unprognostic (3.88e-3)" "unprognostic (1.62e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.63e-2)" "unprognostic (1.04e-2)" "unprognostic (2.87e-2)" "unprognostic (2.72e-2)" "unprognostic (1.63e-4)" "unprognostic (2.53e-12)" "unprognostic (1.02e-1)" "unprognostic (2.01e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" 0.3 0.0 0.0 0.5 0.3 0.0 0.1 2.9 0.4 0.2 0.3 1.4 1.0 0.0 0.1 0.3 0.6 0.2 0.1 0.3 0.6 10.9 0.5 0.9 0.1 0.3 2.2 0.0 0.8 0.2 1.2 0.0 0.0 0.8 0.0 3.9 0.5 0.4 0.2 1.0 1.3 0.0 0.3 0.0 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.0 0.0 0.0 1.0 0.5 1.2 1.0 0.0 0.2 0.0 0.3 0.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.1 1.3 0.3 1.6 0.8 0.0 2.0 1.6 0.0 0.0 0.0 0.0 10.0 0.8 0.9 0.0 1.0 0.0 0.8 0.1 0.7 1.0 0.7 2.5 0.2 1.4 0.1 0.3 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.0 0.3 0.0 0.3 0.0 0.0 1.3 0.0 0.7 0.1 0.3 PRSS54 "CT67, FLJ25339, KLKBL4" ENSG00000103023 "Serine protease 54" Q6PEW0 16 58279997-58295047 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 35.1" "Group enriched" "Detected in some" 63 "Early spermatids: 433.8;Late spermatids: 185.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA041549 Enhanced "Secreted in male reproductive system" NA NA "HPA041549: AB_10795640" "unprognostic (1.13e-1)" "unprognostic (3.24e-2)" "unprognostic (3.09e-2)" "unprognostic (3.08e-1)" "unprognostic (4.88e-2)" "unprognostic (1.23e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.6 2.2 0.0 0.0 0.0 0.0 0.0 PRSS55 "CT153, T-SP1, UNQ9391" ENSG00000184647 "Serine protease 55" Q6UWB4 8 10525546-10554166 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 67 "testis: 25.5" "Cell type enriched" "Detected in some" 5 "Early spermatids: 179.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.64e-1)" "unprognostic (8.44e-3)" "unprognostic (6.10e-2)" "unprognostic (7.40e-2)" "unprognostic (6.23e-5)" "unprognostic (6.62e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 179.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.0 PRSS56 ENSG00000237412 "Serine protease 56" P0CW18 2 232520463-232525716 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;retina: 8.6;skeletal muscle: 16.2" "Group enriched" "Detected in some" 22 "Early spermatids: 30.4;Muller glia cells: 49.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.7" "Region enhanced" "Detected in many" "hypothalamus: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "Daudi: 4.8" "Group enriched" "Detected in some" 10 "basal ganglia: 1.6;olfactory region: 5.2" "Region enhanced" "Detected in many" "olfactory region: 32.6" NA NA "unprognostic (3.26e-1)" "unprognostic (1.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.73e-3)" "unprognostic (2.28e-1)" "unprognostic (7.15e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" 0.1 0.1 0.3 0.1 1.8 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.2 4.4 0.1 0.1 0.1 0.1 2.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.1 8.6 0.1 0.1 16.2 0.1 0.1 0.1 0.8 0.2 0.1 2.6 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.1 1.0 0.2 4.4 2.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 49.6 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 PRSS57 "PRSSL1, UNQ782" ENSG00000185198 "Serine protease 57" Q6UWY2 19 685546-695498 "Enzymes, Predicted secreted proteins" "Heparin-binding, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 61.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 10 "pancreatic cancer: 2.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 8.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "NB-4: 87.1;THP-1: 43.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.89e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (3.99e-4)" "unprognostic (3.07e-1)" "unprognostic (1.33e-2)" "unprognostic (3.50e-2)" "unprognostic (4.04e-2)" "unprognostic (7.70e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (8.16e-2)" "unprognostic (2.56e-2)" 0.3 0.2 0.0 0.0 0.0 61.8 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.6 0.0 3.9 0.0 0.1 0.2 0.8 4.0 0.1 0.1 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 5.1 0.0 0.2 0.0 9.3 0.3 0.0 0.9 0.0 0.2 0.0 2.2 8.7 1.6 3.1 4.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 87.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 8.7 1.6 0.0 0.6 0.3 0.0 0.0 0.0 4.5 2.2 0.0 0.0 0.8 1.0 3.1 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS58 TRYX3 ENSG00000258223 "Serine protease 58" Q8IYP2 7 142252143-142258058 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 27.2" "Group enriched" "Detected in some" 128 "Early spermatids: 636.2;Late spermatids: 161.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 22 "RH-30: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 27.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 636.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.5 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 0.0 PRSS8 ENSG00000052344 "Serine protease 8" Q16651 16 31131433-31135762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 123.2;salivary gland: 143.7" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 330.0;Extravillous trophoblasts: 497.6;Syncytiotrophoblasts: 376.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "pons and medulla: 3.4" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 58.3;CACO-2: 38.3;CAPAN-2: 26.3;hTCEpi: 37.6;SK-BR-3: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA030436 Uncertain "Secreted - unknown location" NA NA 3500000 "HPA030436: AB_10602291" "unprognostic (1.88e-1)" "unprognostic (2.97e-1)" "unprognostic (9.34e-2)" "unprognostic (4.08e-1)" "unprognostic (6.83e-2)" "unprognostic (5.07e-3)" "unprognostic (5.78e-2)" "unprognostic (2.05e-1)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "unprognostic (8.74e-3)" "unprognostic (1.58e-1)" "prognostic favorable (2.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-1)" "unprognostic (3.63e-3)" 0.3 0.2 0.3 11.5 0.3 0.0 7.6 0.7 0.4 8.0 72.6 0.6 12.8 31.6 3.4 46.7 37.2 2.8 45.3 0.3 0.4 0.3 48.0 20.3 30.0 0.3 0.3 0.3 1.3 46.3 2.7 2.6 93.1 3.4 11.4 14.7 1.1 143.7 7.4 0.3 29.7 123.2 0.5 0.3 0.3 37.0 1.8 0.3 11.3 33.4 18.4 26.7 2.6 13.4 0.2 0.0 1.0 0.3 0.0 0.2 0.0 14.4 0.0 0.0 0.0 0.0 0.0 58.3 0.0 0.0 0.0 0.0 38.3 26.3 0.0 0.3 0.0 0.0 17.3 0.0 16.2 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 37.6 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 15.5 0.1 0.3 4.8 18.3 0.0 0.1 0.0 0.2 1.8 3.0 0.2 0.1 0.0 44.2 0.0 4.7 10.1 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.4 0.4 0.3 0.3 0.3 3.4 0.3 92.3 62.1 0.9 60.6 33.7 0.6 0.3 53.5 9.4 53.4 40.1 0.0 127.8 24.9 145.8 0.0 0.7 330.0 23.3 197.1 497.6 3.6 80.0 6.9 12.8 20.5 0.0 9.2 0.0 0.3 0.0 0.6 2.5 3.3 7.2 109.4 0.3 182.1 150.8 0.0 24.9 0.0 0.0 3.1 0.0 0.1 47.2 376.9 1.3 110.4 79.5 PRTFDC1 HHGP ENSG00000099256 "Phosphoribosyl transferase domain containing 1" Q9NRG1 10 24848607-24952604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.0" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "NK-cell: 7.9" "Lineage enriched" "Detected in many" 7 "NK-cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 30.1;CAPAN-2: 38.0;HEL: 22.1" HPA021458 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA021458: AB_1855793" "unprognostic (2.61e-1)" "unprognostic (3.47e-1)" "unprognostic (3.69e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (9.49e-3)" "unprognostic (2.03e-1)" "unprognostic (1.26e-2)" "unprognostic (1.64e-1)" "unprognostic (2.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (7.66e-3)" "unprognostic (1.94e-2)" 4.1 18.3 18.1 3.3 18.2 0.6 6.1 6.1 24.0 8.1 7.7 29.0 2.4 13.9 12.9 6.1 4.5 5.9 11.8 8.6 16.8 13.0 4.0 2.2 3.4 2.8 18.1 12.6 17.1 3.6 10.2 11.0 2.3 16.2 6.5 9.2 6.0 7.2 6.9 0.9 1.4 13.2 8.0 22.5 2.3 13.8 1.7 20.7 2.3 3.7 1.1 2.4 6.0 4.6 0.0 0.3 0.1 0.0 7.9 1.1 1.7 7.6 16.5 12.3 5.0 2.0 10.3 0.0 8.1 6.1 5.8 8.0 30.1 38.0 0.0 1.3 9.4 0.4 4.3 14.0 0.0 9.1 0.0 0.6 22.1 3.0 0.0 6.1 0.0 0.0 3.0 0.1 3.1 0.0 5.5 9.1 0.9 7.2 4.2 2.7 0.2 3.4 0.0 8.5 1.3 0.3 3.8 0.0 0.0 5.2 0.2 8.8 0.4 7.7 0.0 0.0 0.3 0.4 1.7 4.9 2.6 6.5 9.4 4.8 0.4 0.0 0.0 6.9 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.4 0.5 0.3 0.0 0.1 0.3 0.1 7.9 0.0 0.2 0.0 1.7 18.1 18.2 6.1 15.8 16.8 13.0 18.1 12.6 16.2 20.7 0.0 0.3 0.0 3.7 2.4 10.4 6.9 5.1 1.4 4.5 3.5 2.0 0.5 5.0 4.6 1.0 1.6 4.1 0.0 0.5 4.3 14.2 0.7 0.0 0.0 5.4 6.4 5.2 9.2 1.6 0.8 11.2 0.3 3.3 1.8 4.2 32.0 2.4 2.6 9.2 0.0 15.3 0.0 9.5 2.3 4.1 2.5 0.7 0.0 14.3 0.9 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611546-55743090 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.5;thyroid gland: 23.9" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 180.6;Rod photoreceptor cells: 63.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 18 "monocytes: 1.7" "Group enriched" "Detected in some" 7 "AF22: 47.4;SuSa: 57.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 1.3 2.2 1.5 1.1 1.8 0.6 2.4 1.2 2.2 4.7 1.4 3.6 1.1 0.7 11.0 4.6 0.7 2.4 1.0 1.3 1.6 1.6 2.6 0.6 5.0 0.6 3.0 2.0 4.5 0.6 6.4 2.7 6.5 4.3 1.4 0.9 16.5 0.9 1.4 3.9 0.6 0.9 2.9 3.5 0.5 1.5 6.5 2.3 0.0 23.9 0.8 0.9 1.2 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 1.0 47.4 1.0 0.0 0.0 4.8 0.4 1.4 1.2 1.7 7.9 0.2 0.0 2.0 0.0 1.8 0.0 0.1 0.1 1.7 0.0 2.5 0.3 0.3 3.0 0.3 0.3 0.0 0.1 0.0 0.5 0.8 0.9 0.8 0.0 0.8 0.0 0.7 0.6 0.0 0.0 1.9 0.0 1.1 0.0 7.5 0.0 0.9 0.1 0.6 2.7 0.4 0.6 2.6 57.9 0.2 0.1 0.0 0.6 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.5 1.8 1.2 2.2 1.6 1.6 3.0 2.0 4.3 2.3 8.9 13.2 0.0 0.0 0.2 9.5 4.6 0.0 0.0 4.5 15.7 180.6 18.0 0.0 0.0 13.5 5.3 0.0 0.0 0.2 4.2 1.9 0.1 0.0 0.0 1.5 0.0 0.0 2.5 0.0 18.8 4.9 0.0 0.0 0.0 0.0 2.8 0.4 0.0 2.5 1.1 63.9 0.0 1.0 7.2 13.4 0.0 5.0 0.0 0.0 0.1 PRTN3 "ACPA, AGP7, C-ANCA, MBT, P29, PR-3" ENSG00000196415 "Proteinase 3" P24158 19 840960-848175 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 167.3" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 2.5;Kupffer cells: 1.2" "Cancer enhanced" "Detected in single" "stomach cancer: 1.0" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.9" "Cell line enriched" "Detected in some" 5 "THP-1: 151.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA005938, CAB017558" Enhanced Approved Vesicles,Cytosol "Secreted to blood" NA NA 120000 Cytosol Vesicles "CAB017558: AB_2172317, HPA005938: AB_1855764" "unprognostic (2.81e-2)" "unprognostic (2.10e-1)" "unprognostic (3.83e-3)" "unprognostic (4.20e-1)" "unprognostic (3.31e-2)" "unprognostic (3.34e-1)" "unprognostic (9.98e-3)" "unprognostic (3.67e-2)" "unprognostic (8.62e-6)" "unprognostic (5.31e-2)" "unprognostic (2.00e-1)" "unprognostic (5.14e-2)" 0.3 0.2 0.9 0.2 1.0 167.3 0.2 0.0 2.3 0.2 0.2 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.2 31.0 0.3 0.6 0.2 1.7 8.1 3.5 0.1 0.1 0.4 0.2 0.2 0.8 4.2 0.8 0.2 0.2 0.3 0.3 0.2 0.5 0.3 0.2 0.2 0.0 25.5 0.2 0.2 0.1 35.0 0.9 0.0 0.2 0.2 0.0 0.0 0.0 1.9 0.1 0.0 0.2 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 151.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 6.8 0.9 1.0 0.0 2.3 0.3 0.6 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRUNE2 "A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367" ENSG00000106772 "Prune homolog 2" Q8WUY3 9 76611376-76906087 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 89.3" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 47.7;Intestinal endocrine cells: 52.1;Mucus-secreting cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 21.9;LHCN-M2: 34.3;RH-30: 29.7;RPTEC TERT1: 16.8" "Low region specificity" "Detected in all" "HPA022470, HPA031079" Uncertain NA NA "HPA022470: AB_1845832, HPA031079: AB_10603230" "unprognostic (1.21e-1)" "unprognostic (3.65e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (2.43e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-2)" "unprognostic (3.60e-1)" "unprognostic (8.69e-2)" "unprognostic (2.11e-2)" "unprognostic (9.79e-2)" "prognostic favorable (1.37e-6)" "unprognostic (7.75e-2)" "unprognostic (1.06e-1)" "unprognostic (3.25e-3)" "unprognostic (3.80e-4)" 6.1 18.3 14.1 10.2 28.9 2.6 3.1 47.9 34.5 7.8 45.6 16.4 18.5 5.8 23.9 14.9 26.4 19.0 12.8 5.6 14.6 13.8 12.1 2.2 4.5 2.6 30.4 14.8 3.6 4.0 4.2 22.3 3.7 18.9 37.2 14.9 11.3 10.2 50.8 7.8 2.3 12.5 89.3 19.5 3.8 21.3 4.2 29.5 0.0 1.4 4.6 2.6 38.1 13.8 0.7 1.9 1.8 2.8 1.2 0.6 0.7 0.0 0.0 0.6 0.0 21.9 10.6 0.0 0.7 1.5 2.5 6.1 0.1 0.0 0.1 1.6 1.8 5.6 0.0 0.0 0.0 7.6 0.1 1.2 2.5 1.5 0.0 3.6 0.0 0.1 12.3 0.0 11.1 0.3 6.4 5.9 0.1 0.0 8.7 34.3 0.0 1.8 0.7 1.6 0.0 0.0 0.2 29.7 0.1 16.8 0.0 7.3 0.0 0.0 0.1 2.0 1.2 0.0 0.3 4.9 6.0 0.3 14.3 0.4 9.3 1.2 0.0 4.8 0.1 0.0 1.2 2.2 0.3 0.1 2.8 0.6 0.0 0.2 0.0 1.9 0.7 0.0 0.0 1.8 1.2 1.2 0.4 0.0 0.7 14.1 28.9 47.9 20.7 14.6 13.8 30.4 14.8 18.9 29.5 0.0 0.6 0.0 0.4 2.1 47.7 4.9 0.0 17.4 1.2 10.4 0.0 0.0 1.7 0.0 12.1 3.6 2.1 0.0 0.4 0.1 2.1 6.3 0.0 0.0 2.9 14.3 52.1 20.3 3.0 24.7 0.9 3.1 5.0 0.0 27.0 10.0 0.5 5.8 1.4 16.1 5.4 0.0 8.4 2.3 1.5 1.3 0.0 0.0 2.8 0.4 PRX KIAA1620 ENSG00000105227 Periaxin Q9BXM0 19 40393768-40413366 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 42.1;lung: 31.7;retina: 20.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 10.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "midbrain: 42.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enriched" "Detected in single" 21 "midbrain: 24.7" HPA001868 Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA001868: AB_2172440" "unprognostic (1.29e-2)" "unprognostic (3.04e-1)" "unprognostic (2.72e-2)" "unprognostic (9.72e-3)" "unprognostic (2.92e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (3.54e-2)" "unprognostic (5.82e-2)" "unprognostic (3.23e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-2)" "unprognostic (2.03e-3)" "unprognostic (4.42e-2)" "unprognostic (2.29e-1)" "unprognostic (1.38e-1)" "unprognostic (9.97e-2)" 3.4 4.4 4.8 1.0 4.1 1.1 2.7 2.2 5.4 3.0 2.3 1.8 2.8 1.2 3.8 2.0 2.2 3.2 2.4 2.9 4.0 2.2 4.3 0.6 31.7 1.3 42.1 3.7 7.5 5.4 7.3 1.1 6.0 10.3 3.2 0.8 20.6 3.9 4.4 5.4 2.2 1.5 3.3 11.0 1.7 2.4 1.6 3.6 0.0 7.2 6.7 0.9 3.1 2.0 0.3 0.4 0.0 0.3 0.1 1.2 0.2 2.5 2.7 3.3 4.3 2.7 7.0 4.1 2.0 2.3 2.9 2.1 2.3 2.7 0.8 2.6 1.9 1.5 1.3 1.1 1.0 1.0 1.2 1.4 0.5 0.9 0.7 3.2 0.2 3.6 5.0 4.9 1.9 1.6 3.3 1.5 4.5 3.0 0.8 1.5 3.2 1.1 0.8 0.7 5.6 2.5 4.8 2.8 2.4 0.5 1.3 0.3 1.5 3.9 3.4 3.0 1.5 4.9 1.2 2.2 5.9 4.6 2.3 1.2 8.4 7.3 1.1 1.8 1.3 1.3 0.0 0.3 0.0 0.6 0.2 0.2 0.0 0.4 0.6 0.0 0.3 0.3 1.2 0.0 0.1 0.0 0.4 0.3 0.2 4.8 4.1 2.2 5.4 4.0 2.2 42.1 3.7 10.3 3.6 3.0 5.1 0.0 1.0 5.6 0.0 10.8 5.1 0.0 1.2 1.8 0.0 0.8 0.0 0.3 0.0 4.4 0.5 0.0 0.5 0.6 2.5 2.1 0.0 1.0 0.9 0.0 0.0 4.9 1.8 0.0 3.1 1.2 3.3 0.0 0.3 2.7 0.5 0.9 4.2 1.3 0.0 0.0 2.6 0.2 0.7 3.6 2.3 1.3 1.4 0.9 PRY "PRY1, PTPN13LY" ENSG00000169789 "PTPN13-like, Y-linked" O14603 Y 22490397-22514637 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 1.9;epididymis: 2.3;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "memory CD4 T-cell: 1.9" "Lineage enriched" "Detected in single" 20 "T-cells: 1.9" "Cell line enhanced" "Detected in some" "A549: 3.1;HDLM-2: 2.3;SK-MEL-30: 1.5" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRY2 PTPN13LY2 ENSG00000169807 "PTPN13-like, Y-linked 2" O14603 Y 22071756-22096007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.4;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 14 "T-cells: 1.4" "Cell line enhanced" "Detected in single" "SK-MEL-30: 3.6" "HPA046366, HPA059887" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA046366: AB_2679639, HPA059887: " 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSAPL1 ENSG00000178597 "Prosaposin like 1 (gene/pseudogene)" Q6NUJ1 4 7430294-7434973 "Predicted secreted proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skin 1: 42.2;stomach 1: 23.9;testis: 19.9" "Cell type enriched" "Detected in single" 14 "Suprabasal keratinocytes: 2.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038013, HPA038482" Approved Enhanced Cytosol "Secreted - unknown location" NA NA Cytosol "HPA038013: AB_10673652, HPA038482: AB_2676037" "unprognostic (2.64e-2)" "unprognostic (2.40e-1)" "unprognostic (9.33e-2)" "unprognostic (2.40e-1)" "unprognostic (2.61e-1)" "unprognostic (7.90e-3)" "unprognostic (2.52e-1)" "unprognostic (2.08e-2)" "unprognostic (2.75e-1)" "unprognostic (2.63e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 1.4 0.6 0.0 1.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 42.2 0.1 0.1 0.1 0.1 23.9 19.9 0.1 2.5 0.1 0.1 2.1 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 PSAT1 PSA ENSG00000135069 "Phosphoserine aminotransferase 1" Q9Y617 9 78297143-78330093 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Serine biosynthesis" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 56.0;liver: 112.2" "Cell type enhanced" "Detected in many" 15 "Hepatocytes: 129.9;Proximal tubular cells: 244.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.3" "Lineage enriched" "Detected in many" 4 "T-cells: 13.3" "Cell line enhanced" "Detected in many" "hTCEpi: 147.9;SK-MEL-30: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014882, CAB040567, HPA042924" Enhanced Enhanced Cytosol NA NA 1700000 Cytosol "CAB014882: , CAB040567: , HPA042924: AB_2678223" "unprognostic (8.26e-3)" "unprognostic (4.69e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (5.62e-5)" "unprognostic (4.05e-3)" "unprognostic (1.41e-1)" "unprognostic (2.21e-3)" "unprognostic (1.86e-1)" "unprognostic (9.85e-2)" "unprognostic (2.25e-2)" "unprognostic (4.53e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-7)" "unprognostic (3.87e-3)" "unprognostic (1.21e-1)" "unprognostic (8.07e-3)" "unprognostic (1.71e-1)" 3.1 25.0 44.6 3.8 33.4 1.7 3.0 8.5 50.5 2.4 3.3 44.8 0.9 3.2 2.7 28.4 9.3 16.0 1.6 1.4 33.9 22.3 56.0 112.2 1.6 4.5 42.2 24.6 3.7 54.6 4.8 2.1 2.2 21.9 5.3 3.3 8.1 26.2 2.8 1.1 24.7 2.8 2.3 29.8 2.4 7.0 5.1 35.0 2.2 13.7 4.9 5.9 4.2 2.6 3.0 0.2 0.2 0.1 0.0 13.3 3.1 26.7 18.0 15.2 26.9 4.5 5.3 35.9 22.7 16.2 11.6 21.7 4.6 5.2 17.4 10.1 51.1 10.5 26.6 25.9 25.1 17.4 17.0 9.2 5.9 8.3 35.4 41.6 33.1 10.7 16.9 147.9 15.3 41.1 2.8 10.5 68.0 6.3 44.8 9.6 10.0 11.3 5.3 34.8 50.3 19.7 5.6 9.8 20.4 15.8 6.2 6.9 16.0 6.3 10.9 90.5 10.0 5.2 41.8 2.4 2.9 9.5 10.8 18.4 30.5 28.1 0.1 34.2 26.2 13.9 0.0 0.0 0.0 4.9 0.0 5.7 3.0 4.8 6.5 0.2 1.0 7.9 7.3 0.2 0.0 0.1 0.0 13.3 3.1 44.6 33.4 8.5 24.9 33.9 22.3 42.2 24.6 21.9 35.0 0.0 0.0 16.4 6.8 37.3 0.8 0.5 0.0 2.7 0.0 10.4 0.0 25.8 53.0 14.1 1.3 2.1 0.7 46.7 41.7 10.5 2.4 14.9 0.0 129.9 4.4 4.8 3.5 3.7 3.2 1.7 4.6 1.8 18.6 6.4 2.0 22.2 28.4 0.0 1.8 244.0 1.3 0.0 1.0 1.4 2.8 44.4 7.8 4.4 3.0 11.2 PSCA ENSG00000167653 "Prostate stem cell antigen" O43653 8 142670308-142682724 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0" "Cell type enhanced" "Detected in many" 19 "Cholangiocytes: 124.9;Glandular cells: 317.3;Intestinal endocrine cells: 265.2;Urothelial cells: 540.7" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 785.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.6;HeLa: 22.6;OE19: 8.9;RT4: 32.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030783, HPA056418" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA030783: AB_2673611, HPA056418: AB_2683123" "unprognostic (1.21e-3)" "unprognostic (1.76e-3)" "unprognostic (3.20e-1)" "unprognostic (2.24e-1)" "unprognostic (1.77e-2)" "unprognostic (7.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.81e-3)" "unprognostic (8.25e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (6.82e-2)" "unprognostic (2.38e-3)" "unprognostic (4.93e-2)" "unprognostic (2.68e-1)" "unprognostic (3.07e-1)" "unprognostic (1.06e-3)" 0.4 0.2 0.0 0.2 0.0 0.2 0.3 0.0 0.2 7.0 2.4 0.7 0.1 0.6 0.3 0.2 72.6 1.1 21.2 0.1 0.0 0.0 2.6 0.1 3.0 0.2 0.0 0.0 0.1 0.3 0.1 0.5 17.2 0.0 30.1 0.7 0.1 11.7 0.6 0.1 0.8 1.5 18.9 0.0 0.2 230.2 0.2 0.0 0.0 0.1 9.3 35.1 112.0 54.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 5.4 0.3 0.0 0.0 1.1 3.7 5.6 2.5 0.6 1.1 0.9 0.0 11.6 0.0 0.2 0.2 4.2 1.1 0.0 0.2 0.7 0.3 0.0 0.0 22.6 0.0 0.0 0.0 0.8 3.2 4.1 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.8 3.0 0.8 0.3 0.6 8.9 0.6 0.3 0.0 0.4 0.5 32.2 0.1 0.2 2.7 8.3 1.7 0.2 0.1 0.1 0.5 0.8 0.9 1.5 0.0 1.0 0.0 0.0 1.5 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.0 0.0 16.8 0.8 0.0 1.0 124.9 115.1 19.4 1.8 0.0 2.1 6.6 0.3 0.2 0.0 0.0 0.0 1.0 1.8 0.3 317.3 0.0 0.0 0.6 0.0 265.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 33.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 1.1 23.8 0.0 0.6 540.7 PSD "EFA6, EFA6A, KIAA2011, PSD1, TYL" ENSG00000059915 "Pleckstrin and Sec7 domain containing" A5PKW4 10 102402617-102421539 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 66.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 51.6;Cone photoreceptor cells: 90.3;Rod photoreceptor cells: 65.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 10.3;MOLT-4: 5.5;SCLC-21H: 9.7;SH-SY5Y: 8.5;U-2 OS: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059237 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA059237: AB_2683954" "unprognostic (2.43e-1)" "unprognostic (1.74e-1)" "unprognostic (5.62e-3)" "unprognostic (1.53e-1)" "unprognostic (3.16e-2)" "unprognostic (2.90e-2)" "unprognostic (7.73e-3)" "unprognostic (1.75e-1)" "unprognostic (9.59e-2)" "unprognostic (7.59e-2)" "unprognostic (2.24e-3)" "unprognostic (4.71e-2)" "unprognostic (1.52e-1)" "unprognostic (2.61e-2)" "unprognostic (8.50e-2)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" 1.2 9.8 48.7 4.3 59.4 1.6 1.5 8.0 66.8 6.7 21.5 1.7 0.0 6.7 23.9 2.4 3.2 11.1 9.4 1.9 48.7 12.2 1.5 1.4 1.7 1.8 7.6 26.7 5.6 4.7 2.5 13.6 1.8 4.2 6.2 4.4 3.7 1.5 2.2 1.2 2.1 5.8 20.7 1.8 1.5 4.8 4.6 7.0 0.0 1.2 0.0 1.5 11.7 3.0 0.8 0.0 1.1 0.2 0.9 1.3 0.0 0.3 0.1 3.9 3.5 1.4 0.8 0.3 0.3 0.0 0.1 0.0 2.7 0.4 0.3 2.5 0.1 0.3 0.2 0.2 0.0 0.0 0.3 0.2 0.1 0.1 0.1 2.2 0.0 0.1 10.3 0.3 0.6 0.1 1.7 0.0 1.4 0.6 0.9 0.0 2.1 5.5 0.3 0.5 0.3 0.0 1.5 0.0 0.1 0.0 0.2 9.7 8.5 0.1 0.1 0.2 0.3 0.6 0.5 0.0 2.9 4.7 0.2 0.0 2.5 0.3 0.1 0.3 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.8 0.3 1.3 1.1 0.9 0.0 0.0 0.0 0.0 48.7 59.4 8.0 41.2 48.7 12.2 7.6 26.7 4.2 7.0 3.0 0.3 0.0 0.2 0.6 51.6 1.2 5.1 0.0 2.3 0.0 90.3 0.2 1.7 0.1 4.1 0.3 0.8 0.0 1.7 0.1 1.7 0.3 0.0 0.5 0.6 12.7 17.2 0.0 0.0 2.0 3.4 0.0 0.0 0.0 0.6 8.6 0.7 0.6 3.9 0.7 65.1 0.0 0.3 3.7 3.4 0.1 0.6 0.0 0.8 0.1 PSD2 "DKFZp761B0514, EFA6C" ENSG00000146005 "Pleckstrin and Sec7 domain containing 2" Q9BQI7 5 139795821-139844466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 52.4" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 1.5;Muller glia cells: 2.7;Spermatocytes: 1.4" "Cancer enriched" "Detected in single" 43 "glioma: 19.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 3.6;U-2 OS: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054625 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA054625: " "unprognostic (3.76e-2)" "unprognostic (1.90e-1)" "unprognostic (1.34e-3)" "unprognostic (2.48e-3)" "unprognostic (1.34e-2)" "unprognostic (5.01e-2)" "unprognostic (1.22e-2)" "unprognostic (6.55e-2)" "unprognostic (2.42e-1)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (4.02e-1)" "unprognostic (4.16e-3)" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (2.12e-3)" 1.3 1.7 21.1 1.3 28.9 1.3 1.7 12.6 52.4 1.9 1.3 15.2 0.0 1.4 1.4 3.6 1.3 1.6 1.3 1.4 16.1 15.2 1.3 1.3 1.3 1.3 18.9 14.4 1.3 1.6 1.3 0.2 1.3 24.7 1.4 1.3 0.0 3.5 1.7 1.4 1.3 1.3 1.4 12.8 1.4 1.3 2.2 17.0 0.0 1.3 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.2 0.9 0.1 0.2 0.0 0.0 0.2 0.3 0.9 1.4 0.0 0.2 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.1 2.2 3.6 0.0 0.7 0.1 0.3 0.0 0.2 0.0 0.2 1.7 0.0 0.0 1.0 0.0 1.5 1.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 28.9 12.6 17.5 16.1 15.2 18.9 14.4 24.7 17.0 0.0 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 PSD3 "DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942" ENSG00000156011 "Pleckstrin and Sec7 domain containing 3" Q9NYI0 8 18527301-19084730 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.6" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 598.4;Late spermatids: 164.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.2;hTERT-RPE1: 22.8;LHCN-M2: 22.0;U-87 MG: 23.6" "Low region specificity" "Detected in all" HPA002455 Enhanced Approved Nucleoplasm,Vesicles,Cytosol Yes No "Nucleoplasm, Vesicles" Cytosol "HPA002455: AB_2666597" "unprognostic (3.87e-2)" "unprognostic (2.52e-2)" "prognostic favorable (7.55e-4)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.56e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-2)" "unprognostic (8.84e-2)" "unprognostic (7.27e-2)" "unprognostic (3.39e-1)" "unprognostic (2.50e-3)" "unprognostic (2.13e-1)" "unprognostic (7.18e-3)" "unprognostic (3.71e-2)" "unprognostic (8.77e-2)" "unprognostic (3.83e-2)" "unprognostic (1.45e-1)" 2.3 15.5 18.3 2.7 40.5 1.3 5.2 51.6 50.7 11.3 5.7 13.4 2.5 4.2 7.8 3.6 4.8 2.6 6.5 21.8 23.2 9.3 2.1 15.6 4.1 2.2 10.0 27.6 16.0 8.3 9.5 9.6 5.6 10.7 3.7 6.5 5.4 3.2 5.5 1.3 3.9 4.3 5.2 7.4 8.4 8.0 12.7 11.4 0.0 5.4 1.4 3.1 6.1 3.3 3.1 0.6 2.3 1.3 1.9 2.0 0.7 4.9 2.6 11.7 0.0 4.2 26.2 0.6 2.6 4.1 2.4 5.0 1.5 2.0 2.9 1.7 10.7 10.6 0.4 3.4 4.7 4.6 0.0 3.0 0.2 2.0 0.2 7.7 0.0 0.1 6.8 2.9 13.3 2.3 22.8 3.1 0.7 0.3 2.3 22.0 1.7 0.0 0.5 2.3 4.3 6.8 2.3 10.2 1.3 6.1 6.4 5.0 5.6 1.1 0.5 1.8 2.6 0.0 1.1 12.9 7.5 5.2 17.6 2.3 0.2 0.3 6.7 23.6 1.2 2.5 2.3 1.3 1.3 1.0 0.8 1.3 1.6 1.0 0.6 0.5 3.1 0.5 0.6 1.5 1.9 1.1 0.6 2.0 0.7 18.3 40.5 51.6 50.7 23.2 9.3 10.0 27.6 10.7 11.4 3.0 2.4 0.5 11.9 19.5 56.4 111.0 5.1 32.1 13.6 8.7 111.9 2.6 1.7 13.2 598.4 4.9 21.3 0.0 7.4 1.2 30.9 8.6 0.0 36.1 11.0 17.5 5.8 6.2 9.7 164.8 30.8 10.6 1.7 103.6 15.1 80.8 19.5 14.4 50.5 0.2 50.2 12.9 11.5 10.0 15.8 8.7 0.9 0.0 13.0 24.0 PSD4 "EFA6B, TIC" ENSG00000125637 "Pleckstrin and Sec7 domain containing 4" Q8NDX1 2 113157325-113209396 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "lymphoid tissue: 98.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 36.6;Hepatocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 20.8;HMC-1: 26.1" "Low region specificity" "Detected in many" "HPA034722, HPA077847" Enhanced NA NA "HPA034722: AB_10669730, HPA077847: " "unprognostic (1.87e-3)" "unprognostic (1.32e-2)" "unprognostic (2.46e-2)" "unprognostic (1.88e-1)" "unprognostic (2.21e-2)" "unprognostic (1.13e-3)" "prognostic favorable (9.91e-5)" "unprognostic (6.56e-2)" "unprognostic (4.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (1.34e-2)" "prognostic favorable (4.00e-4)" "unprognostic (8.12e-2)" "unprognostic (2.41e-1)" "unprognostic (3.60e-3)" 5.2 11.7 2.6 53.9 3.7 6.2 5.5 0.8 2.1 2.3 5.6 2.9 2.3 5.9 2.6 4.7 8.5 1.9 8.1 3.6 2.6 1.6 3.9 16.2 14.1 25.9 3.1 1.9 2.2 9.5 11.1 3.0 2.9 2.8 6.9 4.4 3.0 11.6 2.5 1.6 6.7 13.6 2.1 2.4 29.3 8.4 1.5 3.4 98.7 8.4 2.5 40.4 4.7 3.1 4.8 7.0 14.2 3.7 7.1 6.4 5.2 7.8 0.5 0.5 0.0 0.0 0.0 14.8 1.0 3.2 0.5 0.4 0.7 9.9 20.8 1.5 0.5 1.4 7.0 0.0 2.4 0.1 14.3 0.0 13.5 0.3 4.6 0.3 17.1 26.1 0.0 2.4 0.3 0.4 1.4 0.0 11.4 10.1 8.8 0.0 6.0 16.9 16.9 0.3 4.2 1.3 0.2 0.0 11.3 0.2 3.4 0.6 0.0 0.6 10.4 0.0 0.3 3.5 15.5 0.0 0.1 0.2 0.1 2.5 9.3 5.5 8.3 0.4 11.9 0.0 1.7 3.3 3.6 6.3 2.6 6.2 4.8 3.4 6.4 3.9 4.6 3.8 4.3 14.2 7.1 3.7 7.0 3.3 5.2 2.6 3.7 0.8 2.1 2.6 1.6 3.1 1.9 2.8 3.4 17.9 11.8 16.6 8.4 11.3 0.2 1.7 7.6 4.0 3.4 31.4 0.0 17.2 0.0 17.1 0.1 2.1 36.6 0.0 20.4 9.2 2.1 15.7 3.5 42.3 10.8 3.2 6.9 3.1 11.6 0.8 0.9 12.2 1.7 2.8 10.8 6.7 17.0 14.0 0.0 5.8 0.4 0.0 2.2 0.2 0.5 13.8 6.3 26.6 15.6 9.5 PSG1 "CD66f, PBG1, PSBG1, PSGGA" ENSG00000231924 "Pregnancy specific beta-1-glycoprotein 1" P11464 19 42866464-42879822 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 362 "placenta: 497.6" "Cell type enriched" "Detected in some" 130 "Syncytiotrophoblasts: 173.1" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 18 "U-2197: 98.0" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (2.02e-1)" "unprognostic (3.54e-1)" "unprognostic (2.44e-7)" "unprognostic (2.28e-2)" 1.3 0.0 0.1 0.0 0.1 0.0 0.6 0.5 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 497.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 1.4 0.3 0.5 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.4 0.0 0.0 0.1 0.0 0.0 98.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 173.1 0.0 0.0 0.0 PSG11 "MGC22484, PSG13, PSG14" ENSG00000243130 "Pregnancy specific beta-1-glycoprotein 11" Q9UQ72 19 43007656-43026512 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 220 "placenta: 151.1" "Cell type enriched" "Detected in single" 172 "Syncytiotrophoblasts: 135.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-2197: 19.7" "HPA042240, HPA046327" Enhanced "Secreted in female reproductive system" NA NA "HPA042240: AB_10797384, HPA046327: AB_2679624" "unprognostic (2.58e-1)" 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 151.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.4 0.0 0.0 0.0 PSG2 "CEA, PSBG2, PSG1, PSGGB" ENSG00000242221 "Pregnancy specific beta-1-glycoprotein 2" P11465 19 43064211-43083045 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 102 "placenta: 75.3" "Cell type enriched" "Detected in some" 35 "Syncytiotrophoblasts: 671.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 6.5;fHDF/TERT166: 14.0;HBF TERT88: 21.8;SuSa: 6.1;U-2197: 28.0" "Secreted in female reproductive system" NA NA "unprognostic (1.02e-2)" 0.4 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 75.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.6 2.9 0.0 0.0 0.0 0.0 14.0 0.8 0.3 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.8 0.2 0.0 0.0 0.0 0.0 19.2 0.3 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 671.0 0.0 0.0 0.6 PSG3 ENSG00000221826 "Pregnancy specific beta-1-glycoprotein 3" Q16557 19 42721638-42740569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 146 "placenta: 495.8" "Cell type enriched" "Detected in some" 171 "Syncytiotrophoblasts: 1321.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 495.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.7 0.4 0.1 0.0 0.0 0.0 0.5 0.6 0.6 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.5 6.3 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1321.0 0.0 0.0 0.0 PSG4 ENSG00000243137 "Pregnancy specific beta-1-glycoprotein 4" Q00888 19 43192702-43207299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 348.5" "Cell type enriched" "Detected in some" 54 "Syncytiotrophoblasts: 463.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 107.6;U-2197: 29.2" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (4.29e-2)" "unprognostic (5.18e-2)" "unprognostic (9.49e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (7.75e-2)" "unprognostic (8.82e-3)" "unprognostic (1.03e-3)" "unprognostic (1.68e-2)" "unprognostic (2.85e-1)" "unprognostic (2.57e-1)" 0.6 0.4 0.2 0.5 0.2 0.0 1.4 0.2 0.2 0.2 8.2 0.2 0.2 0.0 0.2 0.2 1.2 0.0 0.2 0.2 0.2 0.0 2.0 0.2 0.2 0.2 0.2 0.2 0.2 2.0 49.1 0.6 348.5 0.2 0.6 5.8 0.2 4.4 0.2 0.2 6.3 0.2 0.2 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.3 107.6 0.8 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 11.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 3.0 0.0 0.0 0.8 0.4 1.1 29.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 4.9 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 463.1 0.0 0.0 0.3 PSG5 "FL-NCA-3, PSG" ENSG00000204941 "Pregnancy specific beta-1-glycoprotein 5" Q15238 19 43166256-43186536 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 73 "placenta: 171.3" "Cell type enriched" "Detected in some" 41 "Syncytiotrophoblasts: 605.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "BJ: 52.4;fHDF/TERT166: 180.6" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (1.59e-1)" "unprognostic (3.38e-2)" "unprognostic (4.69e-2)" "unprognostic (1.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.04e-1)" "unprognostic (1.75e-2)" "unprognostic (1.12e-2)" "unprognostic (2.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.92e-2)" 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.1 171.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 2.0 0.5 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 52.4 15.1 0.8 7.3 0.0 0.0 0.0 0.0 180.6 0.2 2.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.4 0.7 0.4 0.5 0.6 0.5 0.5 0.2 1.0 0.7 0.5 2.0 0.6 0.4 0.5 0.4 0.0 0.0 0.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 1.8 0.0 5.3 0.0 4.3 0.8 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 605.9 0.0 0.0 0.0 PSG6 ENSG00000170848 "Pregnancy specific beta-1-glycoprotein 6" Q00889 19 42902079-42919563 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 124 "placenta: 330.8" "Cell type enriched" "Detected in some" 204 "Syncytiotrophoblasts: 304.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 27 "neutrophil: 2.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 2.6" "Cell line enriched" "Detected in some" 17 "U-2197: 57.9" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (4.23e-1)" 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 330.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.2 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 57.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 304.0 0.0 0.0 0.0 PSG7 ENSG00000221878 "Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)" 19 42924132-42937178 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 23.1" "Cell type enriched" "Detected in some" 105 "Syncytiotrophoblasts: 135.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 4.0;fHDF/TERT166: 2.8;HBF TERT88: 5.9;U-2197: 4.8" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.9 0.2 1.3 0.0 0.0 0.0 0.0 2.8 0.9 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.5 0.0 0.0 0.0 PSG8 ENSG00000124467 "Pregnancy specific beta-1-glycoprotein 8" Q9UQ74 19 42752686-42855691 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 88 "placenta: 142.2" "Cell type enriched" "Detected in some" 12 "Syncytiotrophoblasts: 28.7" "Cancer enriched" "Detected in single" 17 "thyroid cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;SuSa: 1.7;U-2197: 2.5" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 142.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 1.1 0.0 0.1 0.1 0.7 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 PSG9 "PSG11, PSGII" ENSG00000183668 "Pregnancy specific beta-1-glycoprotein 9" Q00887 19 43211791-43269530 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 205 "placenta: 299.0" "Cell type enriched" "Detected in some" 109 "Syncytiotrophoblasts: 231.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BJ: 5.0;GAMG: 16.0;HBF TERT88: 9.2;SuSa: 11.0;U-2197: 9.5" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (9.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.15e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.2 299.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.0 2.8 4.4 2.3 0.1 0.1 0.0 0.2 1.3 16.0 0.3 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.5 11.0 4.2 0.0 0.2 0.1 2.1 9.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 231.8 0.0 0.0 0.0 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell type enhanced" "Detected in single" 35 "Rod photoreceptor cells: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HEL: 14.3" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMA8 "MGC26605, PSMA7L" ENSG00000154611 "Proteasome subunit alpha 8" Q8TAA3 18 26133852-26193355 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 36.5" "Cell type enriched" "Detected in some" 26 "Spermatocytes: 183.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 80 "Daudi: 23.7;JURKAT: 6.8;U-266/70: 14.7;U-266/84: 15.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (5.39e-3)" "unprognostic (7.45e-5)" "unprognostic (2.94e-1)" "unprognostic (3.04e-2)" "unprognostic (1.59e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (8.30e-2)" "unprognostic (7.54e-4)" "unprognostic (4.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.56e-1)" 0.1 0.1 0.1 1.2 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 1.1 0.0 36.5 0.2 0.7 0.1 0.0 2.2 0.1 0.0 4.0 1.9 0.2 0.1 1.2 5.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 15.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.1 2.2 4.0 2.1 3.9 0.3 3.1 2.4 5.8 0.2 1.2 0.1 1.9 4.3 1.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.2 0.0 0.0 1.5 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.6 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 183.4 7.0 0.0 0.8 0.0 0.0 0.0 PSMB10 "beta2i, LMP10, MECL1, MGC1665" ENSG00000205220 "Proteasome subunit beta 10" P40306 16 67934502-67937087 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 117.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 36.6;U-266/70: 41.0" "HPA030224, HPA030225, CAB034384" Enhanced Approved Vesicles,Cytosol NA NA 1400000 Cytosol Vesicles "CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231" "unprognostic (1.18e-2)" "unprognostic (1.90e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-3)" "unprognostic (2.00e-1)" "unprognostic (1.85e-2)" "unprognostic (7.22e-2)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (8.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.32e-2)" "unprognostic (2.97e-2)" "unprognostic (1.98e-1)" "unprognostic (1.32e-2)" "prognostic favorable (5.44e-4)" 11.5 13.0 9.1 24.9 11.8 23.9 11.4 4.0 7.8 8.0 21.6 5.6 8.5 42.4 9.3 9.5 10.6 12.4 16.6 12.0 6.9 4.9 16.9 17.2 19.5 38.3 9.5 5.6 8.7 61.5 0.9 6.9 11.2 8.5 13.5 6.3 5.8 27.9 11.6 6.9 7.0 35.6 7.7 6.5 49.7 23.8 2.5 7.8 39.2 13.1 10.4 20.5 13.2 8.4 50.8 75.2 100.0 98.1 69.1 68.8 117.3 6.0 5.3 0.4 0.8 0.4 3.5 21.3 2.0 8.7 7.0 9.9 2.8 29.5 22.0 3.8 2.7 2.1 8.9 0.1 2.0 0.5 9.7 0.5 7.8 1.8 3.1 12.2 14.5 24.0 5.4 1.2 3.1 0.0 2.2 4.0 5.3 0.7 8.4 2.0 7.5 28.5 14.9 0.3 0.2 2.0 36.6 2.2 30.0 4.8 10.5 0.3 0.4 6.8 12.0 2.6 0.4 2.4 31.5 6.8 4.5 1.2 1.9 2.3 41.0 7.4 14.6 11.1 19.0 9.6 57.1 89.4 67.1 68.8 98.1 50.2 50.8 54.0 57.3 74.6 49.1 45.3 50.1 100.0 69.1 71.4 75.2 60.8 117.3 9.1 11.8 4.0 7.8 6.9 4.9 9.5 5.6 8.5 7.8 20.8 23.2 54.7 11.4 15.2 0.6 1.4 38.2 73.6 15.9 17.4 0.0 24.0 19.9 48.2 11.5 22.9 90.1 23.3 91.6 28.8 24.3 10.7 49.8 10.0 80.6 0.0 15.6 31.3 88.4 25.3 27.9 74.2 45.5 124.4 58.4 1.3 49.6 106.6 19.8 53.7 1.0 19.4 23.4 16.6 6.8 8.7 18.9 122.2 72.8 19.2 PSMB11 beta5t ENSG00000222028 "Proteasome subunit beta 11" A5LHX3 14 23042167-23044276 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "lymphoid tissue: 32.7" "Group enriched" "Detected in some" 7 "Early spermatids: 1.3;Late spermatids: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 2.1" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Cell line enriched" "Detected in single" 4 "PC-3: 1.8" "Region enriched" "Detected in single" 7 "olfactory region: 2.3" "Not detected" "Not detected" "HPA028967, HPA056970" Enhanced NA NA "HPA028967: AB_2732444, HPA056970: AB_2683293" "unprognostic (7.96e-2)" "unprognostic (2.77e-1)" 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.4 0.0 32.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PSMB3 "HC10-II, MGC4147" ENSG00000277791 "Proteasome subunit beta 3" P49720 17 38752736-38764231 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 99.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042775, HPA048147" Approved NA NA 28000000 "HPA042775: AB_2678158, HPA048147: AB_2680285" "unprognostic (1.86e-1)" "unprognostic (4.84e-3)" "unprognostic (1.44e-1)" "unprognostic (4.80e-2)" "unprognostic (6.68e-2)" "unprognostic (1.14e-3)" "unprognostic (5.46e-2)" "unprognostic (2.46e-2)" "unprognostic (2.02e-1)" "unprognostic (1.75e-2)" "unprognostic (3.65e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.71e-6)" "unprognostic (4.44e-1)" "unprognostic (1.28e-1)" "unprognostic (2.42e-3)" "unprognostic (6.03e-2)" 13.3 9.6 5.2 9.9 8.6 13.3 10.3 3.0 13.9 8.5 11.8 7.5 6.4 9.2 5.6 15.3 14.7 10.3 9.8 15.6 4.4 21.6 36.8 11.6 13.0 8.4 7.1 9.6 11.3 7.3 5.7 17.2 8.5 10.8 12.0 9.1 8.5 10.0 22.2 10.0 14.1 11.0 4.7 17.5 7.2 8.5 7.0 23.3 16.7 12.2 15.6 10.2 5.6 32.7 55.0 99.0 56.5 29.1 43.1 63.7 28.1 52.9 22.0 33.9 24.4 19.2 28.1 18.5 31.5 65.2 57.5 63.2 36.6 32.3 33.5 27.7 46.2 48.5 36.3 35.9 40.4 42.2 63.6 20.8 30.7 65.6 12.1 33.2 32.0 20.1 22.1 49.0 16.6 16.8 35.2 38.2 33.4 36.8 31.4 36.8 51.7 51.8 29.7 33.8 39.5 29.2 44.5 50.6 38.0 28.7 27.1 17.9 23.8 18.1 23.0 32.1 41.5 38.7 18.5 17.1 31.6 36.3 47.3 24.1 40.8 41.9 33.9 32.9 30.0 41.1 56.5 47.4 30.3 49.7 27.9 32.7 28.5 27.6 55.0 28.1 23.0 24.8 99.0 29.1 39.9 53.2 43.1 63.7 71.5 124.7 150.3 148.2 177.2 62.4 281.8 122.3 170.0 120.6 167.5 23.6 383.7 344.8 286.9 26.5 168.4 172.3 93.5 430.9 364.8 178.3 175.3 150.1 236.3 368.1 28.6 128.1 114.8 177.4 35.0 138.4 256.1 190.6 331.0 131.4 145.3 327.0 210.5 137.2 493.2 50.1 122.9 183.6 147.5 74.1 176.0 421.6 159.6 160.1 208.1 PSMB9 "beta1i, LMP2, PSMB6i, RING12" ENSG00000240065 "Proteasome subunit beta 9" P28065 6 32844136-32859585 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity" "Hydrolase, Protease, Threonine protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 69.1;lymphoid tissue: 54.9" "Cell type enhanced" "Detected in many" 6 "monocytes: 319.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 29.5;REH: 21.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB015180, HPA042818, HPA053280" Enhanced Supported Cytosol NA NA 420000 Cytosol "CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098" "unprognostic (1.09e-2)" "unprognostic (1.68e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-3)" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (5.68e-2)" "unprognostic (6.67e-2)" "unprognostic (1.56e-2)" "unprognostic (6.50e-3)" "unprognostic (1.87e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.65e-1)" "unprognostic (1.09e-1)" "unprognostic (4.96e-3)" "unprognostic (5.99e-2)" 13.3 9.7 5.0 30.0 7.9 10.7 11.6 1.6 5.3 7.6 16.5 6.0 3.4 15.7 8.8 7.1 10.8 7.4 10.8 8.9 5.1 4.7 12.2 12.2 17.7 32.7 7.3 3.7 9.2 5.4 1.2 4.5 5.5 6.3 12.5 5.8 7.7 9.0 3.5 6.2 7.6 36.1 5.7 9.8 54.9 11.2 3.0 6.7 35.4 14.4 9.3 35.2 15.9 8.8 31.8 17.2 69.1 30.5 23.4 31.1 45.7 0.0 1.4 0.0 0.1 1.2 3.0 2.0 0.2 3.3 4.2 9.9 0.0 9.2 29.5 0.4 2.7 10.8 6.0 0.4 6.3 0.6 16.6 0.0 18.0 0.5 1.1 15.9 3.1 1.3 1.4 0.2 2.7 0.4 2.3 1.5 8.5 0.7 5.5 1.4 0.5 13.6 4.2 0.0 0.0 0.9 21.8 0.0 7.0 2.8 0.5 0.0 0.0 2.7 1.8 2.0 0.0 2.4 6.6 1.5 4.6 0.4 8.6 2.6 10.2 15.5 9.4 4.7 11.9 3.8 21.9 22.4 39.3 28.7 30.5 23.8 31.8 23.3 27.5 17.2 23.4 17.5 22.9 69.1 23.4 29.4 12.7 31.1 45.7 5.0 7.9 1.6 5.3 5.1 4.7 7.3 3.7 6.3 6.7 38.7 64.6 199.7 29.6 64.5 1.9 5.3 73.9 30.8 34.2 24.4 0.0 0.9 16.6 87.6 1.0 123.4 127.8 46.7 101.9 4.2 38.3 33.2 76.1 23.2 118.3 0.0 32.1 108.1 113.4 0.7 27.0 117.7 33.7 319.2 103.0 19.5 69.2 118.1 14.9 33.5 1.1 32.3 41.0 1.4 6.5 51.3 1.1 214.2 55.9 33.0 PSMC1 "p56, S4" ENSG00000100764 "Proteasome 26S subunit, ATPase 1" P62191 14 90256495-90275429 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 178.0" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 478.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000872, HPA016885" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 46000 "Nucleoplasm, Cytosol" "HPA000872: AB_1079705, HPA016885: " "unprognostic (4.10e-1)" "unprognostic (9.70e-2)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (1.23e-2)" "unprognostic (1.00e-2)" "unprognostic (1.58e-1)" "unprognostic (1.03e-3)" "unprognostic (1.12e-2)" "unprognostic (1.10e-2)" "unprognostic (1.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.03e-1)" "unprognostic (2.85e-1)" "unprognostic (1.11e-2)" 23.7 21.6 28.2 16.7 26.6 26.9 24.6 17.1 39.1 18.4 21.0 11.8 14.3 12.7 23.7 27.9 23.4 18.0 13.7 34.5 37.8 19.1 22.8 29.7 17.9 16.2 19.8 29.3 16.1 20.4 21.8 15.9 25.3 37.2 19.0 23.0 12.1 18.9 22.8 178.0 22.9 17.2 23.2 31.3 19.3 20.0 42.1 15.6 14.4 18.0 29.2 25.4 23.3 17.2 21.4 37.7 57.0 38.1 28.7 36.4 37.8 32.4 30.9 35.5 37.0 31.2 28.7 37.4 31.5 44.2 69.7 52.6 28.5 36.7 27.7 48.2 38.1 32.0 33.8 43.4 36.8 81.7 33.1 19.0 21.7 20.7 24.4 27.0 32.9 29.1 25.7 29.2 45.3 33.4 29.2 41.9 30.9 30.6 16.7 47.8 61.7 24.4 42.9 31.3 42.0 38.3 29.4 46.0 22.6 39.2 33.9 37.4 25.0 25.7 67.0 26.3 30.8 42.1 29.1 31.7 26.9 24.0 28.8 45.5 29.0 45.7 41.1 38.9 30.0 40.9 30.9 37.6 57.0 26.6 34.1 26.2 21.4 27.5 27.2 37.7 20.7 25.3 24.8 41.7 28.7 38.1 26.4 36.4 37.8 28.2 26.6 17.1 39.1 37.8 19.1 19.8 29.3 37.2 15.6 95.3 66.7 41.0 73.5 57.8 47.2 33.6 99.3 137.9 116.0 52.4 49.1 265.6 101.2 136.5 478.8 81.7 77.7 46.7 171.7 144.5 72.1 66.8 95.8 167.6 133.3 74.7 54.8 77.3 91.6 350.7 70.8 81.8 64.1 188.4 56.4 79.4 161.0 64.3 77.1 126.3 54.1 84.1 75.2 77.1 45.5 43.8 392.6 74.6 66.8 81.4 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 134.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 180000 "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 27.9 25.9 37.3 24.1 49.3 31.8 26.2 25.6 39.7 25.1 28.2 24.9 21.1 20.3 27.2 26.0 29.4 25.0 21.8 45.7 32.8 28.0 30.7 60.2 21.5 22.8 36.1 27.3 21.0 25.2 31.0 16.8 39.8 28.2 22.6 24.0 21.3 32.1 29.8 134.7 34.8 20.9 30.8 24.3 25.7 24.9 24.0 22.9 33.5 27.1 38.3 28.8 25.5 25.3 39.2 45.1 32.6 54.7 45.0 51.1 61.3 39.2 44.7 43.0 31.6 20.7 22.3 41.9 32.8 48.8 82.5 58.6 39.8 23.0 31.9 20.4 41.2 36.3 39.5 37.6 42.9 37.3 47.4 48.7 30.6 54.7 38.4 26.8 35.6 32.8 24.8 23.2 33.4 37.8 18.3 46.3 33.2 43.3 30.1 50.2 87.5 44.9 45.4 42.1 49.9 54.0 47.6 84.6 27.9 38.4 29.6 31.5 27.2 26.8 37.8 20.6 19.0 46.8 37.2 32.6 47.3 59.9 66.9 83.9 32.7 37.7 36.9 48.9 35.8 59.1 24.4 43.5 32.6 47.9 53.1 43.7 39.2 40.4 43.8 45.1 32.8 35.6 36.2 9.8 45.0 54.7 45.1 51.1 61.3 37.3 49.3 25.6 39.7 32.8 28.0 36.1 27.3 28.2 22.9 53.6 40.7 50.7 95.5 76.6 41.9 207.9 76.5 49.5 45.5 64.6 15.7 229.8 129.3 164.4 108.0 86.3 137.8 116.8 176.4 216.8 106.9 72.7 72.8 141.0 139.1 35.0 61.9 63.8 58.5 158.2 82.0 66.5 94.5 170.5 67.3 81.7 174.0 108.7 94.0 148.2 36.4 116.4 134.6 87.3 61.8 67.5 295.1 69.6 93.3 88.7 PSMC3IP "GT198, Hop2, HUMGT198A, TBPIP" ENSG00000131470 "PSMC3 interacting protein" Q9P2W1 17 42572315-42577831 "Disease related genes, Predicted intracellular proteins" "DNA recombination, Meiosis" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.8" "Cell type enhanced" "Detected in many" 14 "Spermatocytes: 109.9;Spermatogonia: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044439 Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "HPA044439: AB_10964210" "unprognostic (2.98e-1)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (2.87e-1)" "unprognostic (6.59e-2)" "unprognostic (2.39e-2)" "unprognostic (1.28e-7)" "unprognostic (6.22e-2)" "unprognostic (6.14e-2)" "unprognostic (2.47e-1)" "unprognostic (7.26e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (9.41e-4)" "unprognostic (6.03e-2)" "unprognostic (3.68e-1)" "unprognostic (1.39e-2)" "unprognostic (1.82e-1)" 4.0 2.0 6.6 4.2 12.1 9.2 5.2 5.0 7.7 3.4 4.3 7.0 4.1 1.7 5.2 5.5 3.9 8.6 2.4 2.1 7.4 6.3 2.8 1.2 3.1 4.7 9.7 4.1 4.8 2.7 8.5 2.1 5.4 8.7 5.5 4.3 2.4 2.5 5.7 1.9 4.1 1.9 6.9 12.7 2.3 2.8 29.8 9.9 3.1 2.5 1.5 7.1 4.2 3.3 2.4 6.2 2.2 0.5 0.2 1.9 0.3 6.4 9.7 16.2 11.8 3.8 5.4 3.6 25.2 8.0 22.1 27.4 9.6 4.2 6.9 5.6 7.4 8.8 9.8 12.5 9.6 25.5 9.5 10.5 4.1 21.8 11.4 0.5 14.6 4.7 1.8 2.2 34.9 11.7 3.0 6.4 9.1 14.0 12.6 19.2 7.5 9.8 9.1 9.9 7.2 9.2 10.4 16.5 6.2 5.0 5.3 21.6 13.7 10.1 3.7 10.2 8.4 9.0 6.4 3.0 24.0 13.7 17.9 41.6 9.9 16.8 9.9 11.2 6.9 25.9 0.0 0.2 1.8 1.9 0.3 1.9 2.4 0.9 1.7 0.2 0.8 0.3 0.9 2.2 0.2 0.5 6.2 1.2 0.3 6.6 12.1 5.0 7.7 7.4 6.3 9.7 4.1 8.7 9.9 3.0 3.0 3.0 2.5 4.7 5.8 0.8 2.5 22.7 3.4 3.5 9.8 7.6 0.0 3.4 9.2 3.2 0.0 23.3 2.8 16.4 4.3 1.3 1.1 0.9 6.3 0.0 0.0 2.5 3.8 9.4 4.9 2.4 5.0 9.0 0.7 4.6 1.6 0.0 8.1 1.9 13.3 19.4 9.2 109.9 37.9 3.6 4.3 1.9 2.6 0.7 PSMD2 "MGC14274, P97, Rpn1, S2, TRAP2" ENSG00000175166 "Proteasome 26S subunit, non-ATPase 2" Q13200 3 184298709-184309054 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 107.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045192, HPA062363" Enhanced NA NA 380000 "HPA045192: AB_10961324, HPA062363: " "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (6.82e-2)" "unprognostic (2.43e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (9.98e-4)" "prognostic unfavorable (6.63e-7)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.69e-1)" "unprognostic (4.68e-2)" "unprognostic (1.51e-2)" "unprognostic (1.32e-1)" "unprognostic (4.25e-3)" "unprognostic (1.53e-1)" "unprognostic (9.12e-2)" "unprognostic (1.13e-2)" "unprognostic (2.74e-3)" 21.6 33.7 31.7 20.8 28.7 23.2 16.3 22.2 31.5 19.4 20.4 17.9 20.6 16.5 22.6 16.8 25.3 18.8 15.7 39.2 27.1 21.2 22.9 28.5 18.3 18.6 23.8 29.7 16.5 16.4 28.2 18.9 25.2 25.0 18.8 22.2 15.7 19.0 22.2 107.0 22.9 16.4 26.2 15.1 19.0 19.2 34.1 17.7 20.1 19.2 28.4 25.2 18.1 24.8 28.3 53.2 37.0 40.4 34.7 35.3 42.7 111.8 29.5 23.7 40.3 28.8 16.3 29.0 63.6 43.5 70.3 40.8 41.0 19.9 29.5 94.0 46.8 58.2 32.2 35.3 62.0 89.4 51.4 27.1 31.8 28.0 25.5 16.0 21.6 28.4 18.6 19.4 67.2 42.3 27.7 42.3 23.0 22.4 27.5 57.9 36.9 22.6 13.2 37.0 35.1 49.1 26.5 33.6 31.1 30.2 29.8 20.4 17.6 45.3 39.1 22.7 27.3 55.7 19.3 52.8 43.9 55.3 35.0 133.0 30.9 67.4 55.2 56.5 27.3 31.2 20.3 40.4 37.0 31.1 36.1 30.7 28.3 30.6 35.3 53.2 23.4 30.5 30.3 12.3 34.7 37.2 22.7 29.8 42.7 31.7 28.7 22.2 31.5 27.1 21.2 23.8 29.7 25.0 17.7 62.5 63.9 41.2 59.2 63.2 62.9 103.0 30.6 49.5 51.2 54.1 19.6 136.0 76.3 201.7 125.6 43.6 54.6 93.5 113.2 103.2 54.6 49.2 39.3 59.2 74.8 68.3 76.4 35.0 43.2 62.8 45.1 52.9 50.6 121.8 34.9 107.1 229.6 31.7 61.9 72.1 48.3 32.3 72.3 181.8 143.7 58.6 186.4 41.5 44.8 52.5 PSME2 PA28beta ENSG00000100911 "Proteasome activator subunit 2" Q9UL46 14 24143362-24147570 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 120.2" "Cell type enhanced" "Detected in many" 6 "monocytes: 1118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062661 Approved Nucleoplasm NA NA 8000000 Nucleoplasm "HPA062661: AB_2684825" "prognostic favorable (1.27e-4)" "unprognostic (7.55e-3)" "unprognostic (2.84e-1)" "unprognostic (8.72e-2)" "unprognostic (2.69e-1)" "unprognostic (1.50e-1)" "unprognostic (3.71e-1)" "unprognostic (1.02e-1)" "unprognostic (2.30e-2)" "unprognostic (2.90e-3)" "unprognostic (2.07e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.47e-5)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (6.43e-3)" "unprognostic (3.07e-3)" 15.4 43.4 14.9 33.9 17.1 16.4 17.1 14.2 14.3 17.5 42.7 9.9 33.5 63.3 17.6 30.2 24.4 17.6 31.3 15.8 13.1 14.7 36.3 64.6 27.5 38.7 13.9 11.0 20.7 26.4 14.6 30.1 25.9 15.3 22.2 35.5 14.3 28.2 36.8 13.6 15.1 102.2 18.6 12.3 61.5 21.4 12.5 13.8 32.7 27.5 27.9 35.9 20.0 18.5 38.8 48.9 20.0 112.2 49.9 45.1 120.2 18.7 19.5 12.6 28.5 9.4 13.7 18.7 11.1 25.9 35.3 44.2 15.1 43.7 25.6 6.5 12.4 36.0 16.9 7.6 19.5 21.2 40.5 6.5 14.9 10.9 60.3 30.4 21.0 22.5 13.6 6.0 24.4 9.9 14.3 17.3 17.1 7.3 32.3 13.5 41.6 41.0 31.0 4.3 31.1 26.5 38.7 19.3 27.9 23.9 44.0 7.7 10.2 20.3 34.6 14.4 7.0 17.7 25.1 13.2 17.6 16.2 8.1 20.2 30.1 39.2 28.4 12.9 23.0 21.9 8.3 60.5 20.0 43.6 112.2 45.1 38.8 43.6 42.8 48.9 29.4 32.8 39.9 19.4 49.9 71.7 35.8 41.7 120.2 14.9 17.1 14.2 14.3 13.1 14.7 13.9 11.0 15.3 13.8 47.6 112.2 196.6 142.5 137.6 37.8 61.3 160.5 129.8 102.4 111.7 21.6 275.9 253.7 303.1 9.6 150.1 574.8 0.0 494.7 240.1 145.1 162.7 140.6 195.6 314.2 27.0 94.0 60.2 127.5 9.7 68.4 275.5 129.9 1118.1 171.6 43.0 283.1 252.6 73.2 281.2 17.2 45.3 111.2 53.1 17.4 122.2 190.9 197.9 289.3 191.8 PSME4 "KIAA0077, PA200" ENSG00000068878 "Proteasome activator subunit 4" Q14997 2 53864067-53970840 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 49.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060922 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA060922: AB_2684386" "unprognostic (2.77e-2)" "unprognostic (1.57e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.26e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (4.84e-4)" "unprognostic (4.76e-2)" "unprognostic (6.67e-2)" "unprognostic (5.65e-2)" "unprognostic (3.72e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-3)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" "unprognostic (1.60e-1)" "unprognostic (2.89e-1)" 11.3 8.4 5.2 10.1 7.8 9.9 8.5 4.2 8.3 12.2 8.0 9.1 7.0 3.9 11.2 5.9 8.8 7.5 10.6 30.9 6.2 3.4 4.9 12.2 11.3 7.9 8.7 5.1 6.6 7.0 7.4 8.4 6.1 6.7 6.8 6.2 6.1 14.2 8.6 49.8 7.1 6.8 11.6 4.1 6.4 9.5 23.8 9.4 8.6 9.0 11.7 8.6 11.5 10.1 4.3 2.0 2.4 1.3 2.3 3.3 0.8 15.6 11.0 17.2 4.9 5.8 12.4 10.5 16.5 15.7 18.2 14.9 17.2 6.5 22.6 14.9 17.9 8.8 10.8 19.5 14.5 31.8 15.8 9.9 33.8 11.2 23.0 7.5 17.7 10.0 9.3 8.9 20.7 16.8 7.6 18.7 6.1 27.3 14.7 16.3 6.5 10.7 7.3 15.6 8.2 9.3 12.8 23.9 14.8 9.9 16.5 12.1 13.8 10.6 14.8 8.9 11.3 11.1 7.5 21.6 16.0 12.9 11.6 15.2 9.1 9.0 14.1 12.5 15.2 9.7 2.2 0.8 2.4 3.3 1.3 1.8 3.2 2.2 2.0 1.2 4.3 2.4 3.0 2.2 2.3 1.1 2.0 1.6 0.8 5.2 7.8 4.2 8.3 6.2 3.4 8.7 5.1 6.7 9.4 14.9 34.9 28.3 54.9 67.3 19.7 59.7 22.9 26.8 46.6 21.0 43.2 13.9 3.3 18.5 73.6 25.2 13.7 23.3 31.7 10.5 30.0 89.0 27.7 30.6 17.2 23.8 38.9 19.6 21.4 71.5 19.5 25.3 27.0 19.0 15.2 14.6 36.2 11.6 9.9 8.4 28.4 12.9 26.9 21.4 18.5 57.7 24.8 27.7 11.9 88.5 PSMG1 "c21-LRP, DSCR2, LRPC21, PAC1" ENSG00000183527 "Proteasome assembly chaperone 1" O95456 21 39174769-39183851 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.3" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 408.1;Spermatocytes: 226.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057193, HPA070225" Approved Enhanced "Nucleoplasm,Golgi apparatus,Cytosol" No No "Nucleoplasm, Golgi apparatus, Cytosol" "HPA057193: AB_2683363, HPA070225: AB_2686236" "unprognostic (1.52e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (2.10e-1)" "unprognostic (9.38e-2)" "unprognostic (5.06e-3)" "unprognostic (2.02e-1)" "unprognostic (1.66e-2)" "unprognostic (5.09e-2)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.84e-1)" "unprognostic (8.98e-2)" "unprognostic (1.32e-2)" "unprognostic (4.17e-3)" 7.0 11.0 8.2 8.7 8.0 15.1 6.9 7.7 13.1 7.0 10.2 4.7 5.2 9.2 8.2 9.2 12.5 6.9 9.4 7.6 7.5 8.9 11.7 21.4 6.1 8.1 6.9 10.2 7.9 21.5 5.1 10.0 7.5 8.5 5.7 10.0 7.3 8.0 5.2 13.0 7.0 8.4 8.3 7.1 7.0 7.1 67.3 4.6 7.8 10.6 10.4 7.6 6.7 7.4 11.4 11.5 7.3 7.9 6.7 14.9 7.9 27.1 8.9 6.5 8.9 3.2 3.7 17.3 15.0 6.6 11.8 7.6 16.3 7.1 29.4 8.0 4.2 10.5 7.8 10.2 8.0 7.7 12.6 16.1 55.6 13.8 21.1 5.8 26.4 11.1 5.1 6.0 12.5 12.6 2.6 6.2 12.8 40.9 16.9 7.0 14.4 16.2 14.3 22.4 10.4 13.9 26.5 8.1 29.9 4.9 8.1 20.7 6.1 18.9 10.7 14.9 1.2 10.1 13.3 7.0 13.6 4.7 18.2 21.2 13.0 20.5 25.5 11.5 44.7 10.4 7.3 6.4 3.5 10.6 7.8 12.2 11.4 14.9 12.2 11.5 9.0 11.9 10.4 0.5 6.7 7.9 10.5 12.6 7.9 8.2 8.0 7.7 13.1 7.5 8.9 6.9 10.2 8.5 4.6 6.0 18.3 19.9 34.3 120.8 14.8 21.8 22.9 12.0 29.6 19.2 3.9 93.4 56.3 35.1 408.1 22.4 14.4 0.0 43.3 92.9 37.1 22.6 34.7 28.1 51.9 7.9 28.7 19.6 18.1 33.7 29.4 26.6 43.9 26.2 40.2 9.4 31.9 21.0 31.1 76.3 16.1 25.8 31.9 226.4 91.0 85.4 45.5 20.3 50.8 26.7 PSORS1C1 "C6orf16, SEEK1" ENSG00000204540 "Psoriasis susceptibility 1 candidate 1" Q9UIG5 6 31114750-31140092 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "testis: 52.2" "Group enriched" "Detected in many" 5 "Early spermatids: 289.3;Late spermatids: 996.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;hTCEpi: 5.5;JURKAT: 2.4;U-2 OS: 1.7" HPA045049 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045049: " "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.72e-1)" "unprognostic (9.23e-2)" "unprognostic (4.77e-3)" "unprognostic (8.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "unprognostic (9.56e-2)" "unprognostic (5.72e-3)" "unprognostic (4.80e-2)" "unprognostic (1.59e-1)" "unprognostic (6.33e-2)" "unprognostic (1.30e-1)" 0.9 0.7 1.1 0.7 2.8 0.7 0.8 0.5 1.5 3.4 6.9 2.2 2.6 0.7 7.7 6.4 2.1 1.1 7.5 0.7 0.7 0.6 1.0 0.7 3.7 0.7 4.4 0.0 1.9 1.5 0.7 0.4 1.7 3.0 1.7 1.1 0.2 0.9 1.8 0.7 2.0 6.0 6.5 3.4 0.7 1.1 52.2 0.9 0.0 1.8 1.1 0.7 3.6 3.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 5.5 0.6 1.0 0.0 0.0 2.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.8 0.5 1.5 0.7 0.6 4.4 0.0 3.0 0.9 17.9 2.7 0.0 3.6 7.8 0.0 2.0 17.8 0.0 3.4 8.7 0.0 0.1 0.0 13.8 289.3 3.6 20.7 0.0 1.9 0.4 8.0 2.6 0.0 0.0 0.3 0.0 2.9 3.7 0.0 996.1 8.6 0.0 3.3 1.0 4.6 0.5 9.4 8.0 6.3 0.7 0.0 6.5 1.4 117.0 17.9 9.3 0.1 0.0 4.7 2.3 PSORS1C2 "C6orf17, SPR1" ENSG00000204538 "Psoriasis susceptibility 1 candidate 2" Q9UIG4 6 31137536-31139350 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.8;skin 1: 58.0;tongue: 35.9" "Group enriched" "Detected in some" 15 "Melanocytes: 8.5;Suprabasal keratinocytes: 6.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.1;HaCaT: 1.6;SiHa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA061228 Enhanced "Secreted in other tissues" NA NA "HPA061228: AB_2684455" "unprognostic (8.86e-2)" "unprognostic (7.73e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (5.20e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-2)" "unprognostic (3.78e-1)" "unprognostic (1.64e-2)" "unprognostic (1.06e-1)" "unprognostic (9.40e-5)" "unprognostic (2.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (2.66e-1)" 0.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 58.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 13.8 0.0 35.9 0.7 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.5 PSRC1 DDA3 ENSG00000134222 "Proline and serine rich coiled-coil 1" Q6PGN9 1 109279556-109283186 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 23.6;Extravillous trophoblasts: 28.6;Peritubular cells: 42.1;Rod photoreceptor cells: 70.6" "Cancer enhanced" "Detected in all" "glioma: 50.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 12.3" "Group enriched" "Detected in many" 10 "dendritic cells: 5.4;granulocytes: 7.3;monocytes: 12.3" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in some" 6 "amygdala: 3.5;cerebral cortex: 7.5;hippocampal formation: 6.3" "Low region specificity" "Detected in all" HPA056561 Approved Nucleoplasm,Cytosol NA Yes Cytosol Nucleoplasm "HPA056561: AB_2683175" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (1.42e-3)" "unprognostic (6.78e-3)" "unprognostic (2.17e-1)" "unprognostic (4.76e-2)" "prognostic unfavorable (1.36e-9)" "unprognostic (3.51e-2)" "unprognostic (6.21e-2)" "unprognostic (4.88e-3)" "unprognostic (1.76e-2)" "unprognostic (1.92e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (9.43e-2)" "unprognostic (2.08e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" 1.7 2.4 17.1 4.3 21.6 8.3 3.0 3.8 27.3 2.0 4.0 31.2 0.3 5.1 3.0 3.4 6.3 3.2 3.7 2.0 25.9 11.2 1.7 2.6 2.2 4.0 29.8 12.9 3.6 1.4 0.8 1.7 4.8 16.8 4.0 3.3 4.5 2.9 5.9 1.0 6.1 5.3 4.7 30.6 2.3 2.4 8.6 20.7 5.5 2.0 0.4 5.0 2.6 2.3 0.0 5.4 7.3 12.3 0.2 0.7 3.2 18.8 9.8 40.0 19.3 1.6 3.2 11.0 15.0 12.2 20.5 19.7 15.0 7.9 9.6 5.5 7.4 9.6 13.6 21.5 12.3 17.2 3.7 10.4 6.0 13.1 12.2 1.8 6.4 6.9 3.6 1.1 8.1 5.8 7.7 10.0 11.5 13.6 4.4 16.4 17.1 9.7 4.3 16.5 8.7 11.2 15.1 38.5 3.2 6.9 5.0 16.8 9.7 8.4 12.9 15.4 15.2 7.8 6.1 5.1 12.7 21.0 8.9 24.6 3.4 2.2 3.3 10.2 15.3 35.3 0.0 12.3 1.8 0.7 4.8 0.5 0.0 0.7 0.2 5.4 0.0 0.4 0.4 7.3 0.2 2.6 0.0 0.7 3.2 17.1 21.6 3.8 16.4 25.9 11.2 29.8 12.9 16.8 20.7 0.0 3.8 0.0 2.3 1.8 6.5 0.9 2.5 1.4 0.0 1.8 23.6 3.4 0.0 0.9 0.5 0.4 0.5 0.0 0.7 28.6 2.3 0.6 1.1 0.9 9.2 3.2 0.0 1.3 4.0 1.9 5.5 1.6 1.7 0.0 3.2 7.7 0.4 0.0 42.1 2.3 70.6 0.0 2.3 2.7 1.2 1.0 2.4 0.0 2.0 0.7 PSTPIP1 "CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP" ENSG00000140368 "Proline-serine-threonine phosphatase interacting protein 1" O43586 15 76993359-77037332 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.2;bone marrow: 41.0;lymphoid tissue: 29.3" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 36.9;Intestinal endocrine cells: 57.6;Kupffer cells: 54.2;Macrophages: 31.2;T-cells: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 29.5;HL-60: 7.0;NB-4: 11.8;THP-1: 7.9;U-937: 31.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010600 Enhanced NA NA "HPA010600: AB_1855870" "unprognostic (4.42e-3)" "unprognostic (1.31e-3)" "unprognostic (3.56e-2)" "prognostic favorable (4.74e-5)" "unprognostic (3.79e-2)" "unprognostic (1.12e-3)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (1.16e-1)" "unprognostic (9.85e-2)" "unprognostic (2.96e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (7.36e-9)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.91e-1)" "unprognostic (5.42e-2)" 6.0 1.9 1.7 29.3 1.7 41.0 2.7 0.4 0.9 2.4 3.8 0.6 0.1 2.0 3.6 4.1 3.3 2.2 7.2 3.8 2.0 1.4 2.8 2.2 10.6 28.1 1.8 0.0 1.8 1.2 0.4 1.1 2.3 1.0 2.5 0.9 2.1 7.6 2.6 2.3 1.2 6.6 1.9 2.4 24.5 2.5 2.3 0.9 15.7 2.1 2.4 18.6 2.8 2.0 6.4 23.0 34.2 27.9 15.4 17.3 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 29.5 0.0 0.0 0.0 1.8 0.0 7.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.3 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.0 31.9 0.0 1.8 27.9 26.7 17.3 12.7 13.3 5.5 11.6 14.2 23.0 6.4 6.4 9.9 34.2 15.4 13.0 1.9 10.3 14.8 1.7 1.7 0.4 0.9 2.0 1.4 1.8 0.0 1.0 0.9 0.0 9.0 17.1 1.0 8.2 0.0 1.6 0.0 0.0 4.5 0.0 0.0 0.3 0.0 0.0 8.3 0.7 0.3 0.0 0.2 0.6 1.1 0.1 2.3 0.8 36.9 0.0 57.6 1.8 54.2 13.7 0.9 31.2 6.8 15.4 3.4 0.2 0.1 0.8 2.5 0.1 0.4 0.0 1.6 0.2 1.2 4.3 0.5 51.7 0.2 0.8 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell type enhanced" "Detected in many" 5 "granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 37.7;HMC-1: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" No No 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.9 5.6 2.8 2.0 1.7 4.3 1.5 0.0 0.3 1.8 0.0 13.7 7.7 10.6 2.5 0.0 1.2 37.7 1.9 0.0 2.3 2.2 41.9 1.9 13.2 1.9 6.3 1.8 4.0 0.0 9.0 0.0 8.8 1.3 0.3 0.0 0.9 0.0 0.0 0.0 2.9 1.8 4.2 13.8 0.1 0.8 0.9 3.9 0.1 11.4 12.4 4.4 2.9 0.2 3.2 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 11.9 15.2 6.9 15.7 12.2 0.6 2.8 2.5 2.7 13.6 0.0 0.0 21.1 3.3 8.8 1.9 2.2 0.4 0.0 3.3 2.5 3.8 21.9 41.7 16.3 12.6 0.0 1.2 10.4 40.3 5.0 2.6 35.6 6.8 6.4 2.6 9.5 20.5 0.0 2.1 2.9 0.2 6.5 6.2 0.5 1.1 8.9 7.3 12.5 2.2 17.0 PTAFR ENSG00000169403 "Platelet activating factor receptor" P25105 1 28147166-28193936 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 98.3" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7" "Group enriched" "Detected in many" 5 "granulocytes: 98.3;monocytes: 28.2" "Group enriched" "Detected in some" 4 "HBEC3-KT: 14.7;HMC-1: 53.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027543 Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "HPA027543: AB_10610287" "unprognostic (2.22e-2)" "unprognostic (2.59e-2)" "unprognostic (6.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.75e-1)" "unprognostic (3.74e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.23e-1)" "unprognostic (2.39e-1)" "unprognostic (1.60e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.59e-2)" "unprognostic (5.48e-2)" "unprognostic (1.38e-2)" 5.6 2.3 2.4 16.2 1.9 20.3 2.4 0.6 2.0 6.9 3.4 1.6 3.5 1.8 2.8 1.4 16.8 2.8 7.5 3.5 2.1 2.3 6.4 1.8 9.2 6.1 4.1 1.0 1.5 2.7 0.9 0.7 3.5 1.8 2.6 3.4 0.6 3.4 2.6 1.1 2.8 5.0 3.8 5.1 15.4 2.3 2.2 1.1 2.3 1.4 22.2 21.7 5.9 3.6 1.5 13.2 98.3 28.2 0.0 0.1 10.1 7.7 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.1 2.2 0.5 0.0 0.0 0.1 5.3 0.2 14.7 0.3 0.1 0.2 2.9 0.0 0.3 0.0 0.7 53.6 0.0 2.4 0.2 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 7.2 0.2 0.2 0.1 0.1 0.0 0.0 3.6 0.8 0.1 0.0 0.0 7.3 0.0 0.2 0.1 2.0 0.0 0.1 0.3 0.0 0.0 0.5 0.4 2.1 0.0 0.9 0.2 5.9 28.2 98.3 0.0 8.9 0.1 1.5 0.0 0.0 13.2 0.7 0.0 0.0 85.7 0.0 3.5 0.1 0.1 10.1 2.4 1.9 0.6 2.0 2.1 2.3 4.1 1.0 1.8 1.1 6.0 7.9 4.3 1.5 5.8 1.2 2.0 2.5 6.7 2.3 1.8 2.0 0.5 0.0 8.8 0.0 5.9 0.2 0.0 4.6 0.4 2.2 0.4 73.9 0.8 62.8 0.0 0.0 1.8 70.6 0.0 0.6 55.7 0.0 4.6 0.0 0.2 55.1 0.0 0.0 0.0 0.8 0.0 0.9 2.1 0.5 2.5 1.3 1.0 0.0 8.6 PTCH2 ENSG00000117425 "Patched 2" Q9Y6C5 1 44819844-44843063 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "parathyroid gland: 82.4;salivary gland: 44.3;testis: 32.0" "Cell type enhanced" "Detected in many" 15 "Leydig cells: 99.8;Peritubular cells: 64.0" "Cancer enhanced" "Detected in many" "testis cancer: 9.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/84: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.54e-5)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (3.65e-3)" "unprognostic (3.89e-1)" "unprognostic (7.42e-3)" "unprognostic (3.01e-1)" "unprognostic (2.94e-2)" "unprognostic (1.51e-1)" "unprognostic (8.67e-2)" "prognostic favorable (5.74e-5)" "unprognostic (2.92e-1)" "unprognostic (5.74e-6)" "unprognostic (1.55e-2)" "unprognostic (4.86e-2)" "unprognostic (6.31e-2)" "unprognostic (6.81e-2)" 2.5 1.9 8.0 2.4 5.2 6.0 2.2 9.7 7.2 2.5 2.0 1.2 1.3 1.5 6.7 1.9 1.3 2.7 2.4 3.3 6.2 6.1 1.0 1.2 1.2 2.2 2.5 5.8 19.1 1.1 82.4 6.8 1.0 6.0 1.8 1.4 4.6 44.3 1.7 2.0 2.3 1.3 6.6 5.5 1.8 1.2 32.0 5.2 0.0 3.1 2.4 1.3 2.2 2.3 3.4 7.6 3.3 3.8 2.0 2.4 0.5 0.3 0.4 1.6 3.7 1.3 1.4 1.4 1.2 2.4 0.8 0.7 0.4 0.5 1.5 0.7 0.6 0.8 0.1 1.6 0.1 0.3 3.2 2.8 0.9 1.2 1.1 0.4 0.9 1.8 0.5 0.6 1.5 0.1 2.5 0.2 1.5 1.0 1.6 0.1 0.8 1.8 3.0 0.5 0.1 0.6 1.4 0.3 0.7 0.3 0.1 2.2 0.9 0.4 0.6 1.0 0.9 0.3 1.8 0.2 0.3 0.9 1.9 0.7 2.7 15.3 4.5 0.9 4.4 0.5 3.3 3.8 0.3 1.1 2.0 2.4 2.2 1.4 1.4 2.5 3.4 1.7 1.3 1.3 2.0 1.8 7.6 0.7 0.5 8.0 5.2 9.7 7.2 6.2 6.1 2.5 5.8 6.0 5.2 0.0 1.4 20.6 0.4 0.5 0.6 0.9 7.6 1.4 1.2 1.8 2.0 1.9 0.0 3.2 1.4 1.6 8.4 0.0 1.6 1.4 3.4 0.5 0.0 5.9 6.3 7.9 11.1 1.3 23.6 4.3 99.8 3.4 0.0 2.8 4.9 1.9 2.6 0.0 64.0 0.0 1.0 12.9 3.3 3.4 2.7 1.4 1.9 3.8 5.6 0.1 PTCHD1 FLJ30296 ENSG00000165186 "Patched domain containing 1" Q96NR3 X 23334016-23404372 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Autism, Autism spectrum disorder" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 6.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 27.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 3.4;RT4: 3.2;SuSa: 1.6;WM-115: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046110 Uncertain NA NA "HPA046110: AB_2679541" "unprognostic (1.50e-2)" "unprognostic (1.36e-2)" "unprognostic (7.43e-3)" "unprognostic (1.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-4)" "unprognostic (2.13e-1)" "unprognostic (1.48e-1)" "unprognostic (2.78e-1)" "unprognostic (2.13e-1)" "unprognostic (3.50e-1)" "unprognostic (3.19e-2)" "unprognostic (3.68e-4)" "unprognostic (5.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" 1.6 2.3 6.6 0.9 5.5 0.7 6.0 27.8 8.9 6.2 8.4 1.0 3.5 1.4 5.1 2.1 4.5 0.9 0.8 0.8 5.3 2.7 0.8 0.6 1.2 0.6 3.1 5.8 0.8 0.8 0.5 1.7 0.5 6.5 4.4 2.9 0.0 1.8 11.7 1.1 0.8 1.8 10.2 2.6 1.4 3.4 1.1 3.8 0.0 1.0 0.0 0.6 5.4 2.9 0.7 0.4 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 3.4 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.2 0.1 0.4 0.0 1.5 0.0 0.0 3.2 0.5 0.0 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 10.6 1.2 0.3 0.4 0.3 0.2 0.2 0.3 0.3 0.2 0.1 0.7 0.3 0.3 1.0 0.3 0.2 0.4 0.1 0.0 6.6 5.5 27.8 6.5 5.3 2.7 3.1 5.8 6.5 3.8 0.0 1.3 0.0 2.0 0.2 1.3 1.7 0.0 2.7 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.2 0.0 2.0 2.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.4 12.9 2.3 0.5 1.5 0.0 1.8 0.0 0.0 0.7 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 1.4;Collecting duct cells: 1.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.1 0.0 1.7 5.0 13.5 1.5 3.2 0.1 0.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 22.5 0.5 0.0 0.0 7.4 7.2 0.0 0.1 5.4 1.5 2.3 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.5 0.0 0.0 0.0 22.9 0.0 0.0 11.4 2.5 1.6 0.0 0.2 0.0 0.0 0.0 3.4 0.0 9.9 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTCRA "PT-ALPHA, PTA" ENSG00000171611 "Pre T cell antigen receptor alpha" Q6ISU1 6 42915989-42925835 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 20 "blood: 74.1;lymphoid tissue: 129.5" "Group enriched" "Detected in some" 4 "Hofbauer cells: 18.2;Kupffer cells: 8.0;Melanocytes: 5.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 39 "plasmacytoid DC: 74.1" "Lineage enriched" "Detected in many" 39 "dendritic cells: 74.1" "Group enriched" "Detected in some" 9 "MOLT-4: 29.5;SK-MEL-30: 10.0" NA NA "unprognostic (5.50e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-1)" "unprognostic (1.64e-1)" "unprognostic (2.83e-2)" "unprognostic (6.57e-4)" "unprognostic (7.18e-2)" "unprognostic (4.24e-2)" "unprognostic (8.16e-2)" "unprognostic (1.11e-2)" "unprognostic (2.73e-1)" "unprognostic (2.84e-4)" "unprognostic (1.16e-1)" "unprognostic (4.89e-1)" "unprognostic (3.22e-2)" "unprognostic (3.09e-2)" "unprognostic (1.45e-1)" 0.5 0.2 0.1 0.5 0.1 2.9 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.4 5.0 5.2 0.5 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.3 0.1 0.1 0.5 0.1 0.1 0.0 0.3 0.1 0.8 9.7 0.0 0.1 0.1 129.5 0.1 0.1 4.4 0.1 0.1 0.0 74.1 1.8 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 1.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 74.1 0.0 6.6 0.1 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 18.2 0.0 0.0 0.6 8.0 0.0 0.0 1.4 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 PTF1A "bHLHa29, PTF1-p48" ENSG00000168267 "Pancreas specific transcription factor, 1a" Q7RTS3 10 23192327-23194252 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 154 "pancreas: 129.8" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 1.3;Exocrine glandular cells: 4.2;Pancreatic endocrine cells: 1.3;Spermatocytes: 3.3" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-2 OS: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB022612 Approved Nucleoplasm NA NA Nucleoplasm "CAB022612: " "unprognostic (2.02e-1)" "unprognostic (1.85e-1)" "unprognostic (4.49e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.7 0.0 0.0 0.0 0.0 0.0 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267713-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Mast cell degranulation" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.1" "Group enriched" "Detected in some" 5 "T-cells: 31.9;Undifferentiated cells: 11.2" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons and medulla: 13.9" "Group enriched" "Detected in many" 5 "gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1" "Group enriched" "Detected in many" 30 "NK-cells: 30.1;T-cells: 25.4" "Group enriched" "Detected in some" 4 "ASC diff: 1.4;HSkMC: 1.6;REH: 2.4;U-138 MG: 1.8" "Low region specificity" "Detected in many" HPA049668 Enhanced NA NA "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 3.9 0.9 0.7 9.6 2.5 1.8 9.3 1.4 1.4 5.5 10.0 0.7 0.9 1.1 4.1 2.2 2.1 2.5 4.9 2.3 0.8 0.8 1.5 1.8 3.4 8.9 1.0 3.5 2.3 0.8 0.8 4.5 0.4 13.9 2.1 12.8 11.2 2.6 3.5 0.9 1.3 2.4 2.0 3.6 10.9 2.0 0.9 0.8 1.8 2.5 0.1 3.1 3.3 3.2 0.0 0.0 0.9 0.1 30.1 25.4 4.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 25.4 0.0 12.7 0.0 3.5 15.2 0.0 0.0 0.6 8.9 0.9 30.1 0.1 0.0 0.0 4.1 0.7 2.5 1.4 1.4 0.8 0.8 1.0 3.5 13.9 0.8 3.0 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 1.2 3.1 2.1 0.0 0.0 0.2 1.7 0.0 4.5 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 31.9 11.2 0.0 PTGDR2 "CD294, CRTH2, DP2, GPR44" ENSG00000183134 "Prostaglandin D2 receptor 2" Q9Y5Y4 11 60850940-60855971 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.8;lymphoid tissue: 28.1" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 2.0;granulocytes: 4.6;Intestinal endocrine cells: 1.2;Mucus-secreting cells: 1.3;Smooth muscle cells: 1.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 35.1;eosinophil: 51.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 51.8" "Cell line enhanced" "Detected in some" "HEL: 10.5;Hep G2: 5.1;HMC-1: 6.7;K-562: 4.3;MOLT-4: 3.4;NB-4: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014259 Uncertain NA NA "HPA014259: AB_1849304" "unprognostic (9.77e-2)" "unprognostic (1.35e-3)" "unprognostic (5.45e-3)" "unprognostic (1.69e-1)" "unprognostic (1.90e-1)" "unprognostic (1.85e-3)" "unprognostic (1.70e-1)" "unprognostic (2.30e-4)" "unprognostic (2.61e-1)" "unprognostic (7.92e-2)" "unprognostic (8.68e-3)" "unprognostic (1.52e-1)" "unprognostic (1.32e-2)" "unprognostic (1.52e-1)" "unprognostic (3.31e-1)" "unprognostic (1.49e-1)" "unprognostic (4.99e-2)" 1.2 0.3 3.9 2.3 8.0 0.4 2.8 2.3 8.2 1.7 10.7 4.0 0.3 7.5 0.9 0.6 1.4 1.5 1.6 5.1 4.3 2.8 0.5 0.7 1.4 1.9 4.9 5.9 0.5 1.1 5.9 0.6 1.9 5.7 0.9 7.4 0.6 0.5 0.5 11.3 1.0 10.8 0.9 2.2 1.1 13.3 0.5 0.8 28.1 0.4 5.6 0.6 1.1 0.4 0.0 1.2 51.8 7.8 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.4 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 10.5 0.0 5.1 1.2 0.0 6.7 2.2 0.1 0.0 0.0 0.0 0.0 0.3 4.3 0.0 0.0 0.1 3.4 15.2 0.0 0.1 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 35.1 0.0 51.8 0.0 2.5 0.0 0.0 0.3 0.2 1.2 0.0 0.0 0.0 0.1 0.0 7.8 0.2 0.3 0.4 3.9 8.0 2.3 8.2 4.3 2.8 4.9 5.9 5.7 0.8 0.0 0.0 0.0 0.0 0.3 0.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 PTGDS "L-PGDS, PGDS" ENSG00000107317 "Prostaglandin D2 synthase" P41222 9 136975092-136981742 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 286.6;retina: 331.2" "Group enriched" "Detected in many" 11 "Leydig cells: 35232.9;Peritubular cells: 61248.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 27 "plasmacytoid DC: 140.9" "Lineage enriched" "Detected in many" 27 "dendritic cells: 140.9" "Group enriched" "Detected in some" 6 "HHSteC: 106.3;HSkMC: 51.8" "HPA004938, CAB009916" Approved "Secreted to blood" NA NA 4300000000 "CAB009916: AB_2174617, HPA004938: AB_1855745" "unprognostic (2.79e-2)" "unprognostic (3.96e-3)" "unprognostic (9.70e-2)" "unprognostic (5.71e-3)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (2.85e-1)" "unprognostic (2.01e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.19e-7)" "unprognostic (8.49e-3)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (3.21e-2)" 34.1 27.9 138.1 37.5 159.8 2.5 11.3 61.5 154.6 260.4 10.5 192.5 23.0 6.4 22.5 130.0 26.0 72.4 65.8 286.6 121.0 85.2 22.3 6.0 39.7 114.8 170.8 130.6 7.0 20.0 1.8 20.6 38.5 118.8 78.5 4.2 331.2 18.8 149.8 17.0 19.7 11.2 18.6 188.0 50.1 13.5 218.5 103.2 3.3 3.4 4.3 51.1 49.5 75.8 0.0 140.9 0.2 0.1 0.3 5.2 1.0 0.0 0.0 0.0 0.0 1.0 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 4.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 106.3 0.0 0.2 51.8 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.2 0.1 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.1 13.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 5.2 0.1 0.3 0.0 0.4 0.6 0.1 0.0 0.1 1.1 0.2 0.3 0.0 140.9 0.1 1.0 138.1 159.8 61.5 154.6 121.0 85.2 170.8 130.6 118.8 103.2 0.0 1.1 0.0 3.5 62.5 41.8 283.2 0.0 0.0 0.0 130.9 49.1 12.3 58.0 0.3 163.9 98.7 0.0 0.0 0.0 31.2 935.4 19.2 1.1 1.6 48.0 20.6 0.0 51.5 2.8 458.6 35232.9 41.1 199.1 1.8 0.0 4317.3 1.2 0.0 61248.9 0.6 110.6 161.7 44.3 116.5 105.1 70.0 29.6 37.4 0.0 14.4 PTGER1 EP1 ENSG00000160951 "Prostaglandin E receptor 1" P34995 19 14472466-14475362 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 13.6;lymphoid tissue: 14.2" "Cell type enriched" "Detected in some" 75 "Collecting duct cells: 188.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.5;NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 2.9;PC-3: 7.2;SH-SY5Y: 4.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (3.44e-2)" "unprognostic (3.31e-1)" "unprognostic (2.68e-1)" "unprognostic (3.50e-4)" "unprognostic (8.69e-2)" "unprognostic (5.58e-2)" "unprognostic (2.39e-2)" "unprognostic (3.19e-2)" "unprognostic (2.05e-1)" "unprognostic (3.53e-2)" "unprognostic (1.41e-1)" "unprognostic (1.42e-1)" "unprognostic (7.74e-8)" "unprognostic (1.19e-1)" "unprognostic (4.41e-2)" "unprognostic (4.27e-3)" "unprognostic (4.88e-2)" 0.7 1.4 1.1 2.7 1.3 0.2 1.5 0.6 1.2 1.3 1.5 0.1 0.0 1.2 0.4 0.3 1.7 1.0 0.4 3.1 0.4 0.4 13.6 0.5 4.9 6.7 1.8 0.0 1.6 1.8 0.2 1.4 0.3 1.0 0.5 0.3 0.3 0.3 0.4 0.7 0.2 1.9 1.4 0.1 14.2 3.2 0.4 0.6 0.0 0.7 0.0 0.3 0.6 1.3 0.0 0.4 0.0 1.5 2.6 1.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.3 0.6 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.9 0.3 0.0 7.2 0.8 0.0 0.2 0.0 0.1 0.5 4.2 0.1 0.1 0.2 0.0 0.2 0.4 1.3 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.5 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.2 1.1 1.3 0.6 1.2 0.4 0.4 1.8 0.0 1.0 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.8 2.5 0.0 0.0 188.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.5 0.3 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.0 0.2 PTGER2 EP2 ENSG00000125384 "Prostaglandin E receptor 2" P43116 14 52314305-52328606 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 40.3" "Cell type enhanced" "Detected in many" 18 "granulocytes: 19.7;Kupffer cells: 20.5;T-cells: 80.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 12.5;ASC TERT1: 33.6;HHSteC: 21.3;HL-60: 12.0;HSkMC: 26.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (2.48e-2)" "unprognostic (1.36e-2)" "unprognostic (4.04e-3)" "unprognostic (1.55e-2)" "unprognostic (3.24e-1)" "unprognostic (3.11e-3)" "unprognostic (1.79e-1)" "unprognostic (2.42e-1)" "unprognostic (1.20e-3)" "unprognostic (1.18e-1)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.16e-4)" "unprognostic (8.48e-3)" "unprognostic (5.26e-3)" "unprognostic (6.71e-2)" "unprognostic (5.74e-2)" 8.2 1.2 0.4 9.4 0.5 21.8 9.3 0.4 0.5 22.1 8.7 0.6 2.9 4.0 13.6 5.5 5.4 4.5 6.5 4.8 0.4 0.6 5.5 2.8 8.8 15.9 1.1 0.3 8.2 1.1 0.0 1.4 14.1 1.8 19.4 4.3 10.9 4.1 2.6 1.8 1.6 14.9 3.2 1.1 20.4 11.8 4.1 0.3 4.4 2.2 1.1 3.0 6.0 6.0 0.0 5.6 9.8 17.1 19.7 40.3 17.4 0.7 0.2 0.0 0.0 12.5 33.6 0.1 1.0 0.1 1.1 1.3 0.0 0.0 0.0 0.9 0.7 0.0 4.5 0.0 0.2 1.6 0.0 6.0 0.0 0.3 0.0 21.3 12.0 0.1 26.9 0.5 2.7 0.4 3.6 0.0 0.0 0.0 0.0 6.3 0.5 0.0 0.4 0.5 2.0 4.1 0.0 0.0 0.0 9.6 0.0 0.4 10.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.4 0.7 7.7 0.0 0.0 0.0 0.0 2.8 6.7 0.1 1.8 11.2 9.8 33.8 8.9 40.3 0.0 28.7 35.2 5.6 0.0 7.2 21.8 1.5 19.7 17.1 0.2 13.4 17.4 0.4 0.5 0.4 0.5 0.4 0.6 1.1 0.3 1.8 0.3 3.0 1.7 0.9 0.2 1.5 0.0 1.5 0.0 8.1 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 16.9 0.8 19.7 0.4 10.4 0.0 5.8 4.3 20.5 0.0 3.7 15.1 3.3 4.6 4.9 0.0 0.9 0.0 2.8 0.0 0.0 0.0 5.2 0.0 0.1 1.4 0.2 80.9 0.4 0.1 PTGER3 EP3 ENSG00000050628 "Prostaglandin E receptor 3" P43115 1 70852353-71047808 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.2;endometrium 1: 65.2" "Cell type enriched" "Detected in many" 10 "Distal tubular cells: 190.6" "Group enriched" "Detected in some" 7 "breast cancer: 4.1;renal cancer: 9.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 49 "basophil: 22.4" "Lineage enriched" "Detected in single" 49 "granulocytes: 22.4" "Cell line enhanced" "Detected in some" "ASC diff: 15.2;HAP1: 10.8;HDLM-2: 16.3;HEL: 7.8;T-47d: 37.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010689 Uncertain NA NA "HPA010689: AB_1855883" "unprognostic (1.53e-3)" "unprognostic (3.48e-1)" "unprognostic (1.11e-1)" "unprognostic (3.86e-3)" "unprognostic (1.47e-1)" "unprognostic (3.37e-2)" "unprognostic (4.80e-2)" "unprognostic (2.01e-2)" "unprognostic (1.24e-1)" "unprognostic (4.64e-3)" "unprognostic (1.54e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (8.83e-3)" "unprognostic (1.86e-1)" "unprognostic (1.92e-2)" "unprognostic (1.41e-4)" 32.5 3.0 3.9 6.8 0.7 0.0 71.2 0.2 1.7 7.8 6.3 0.1 3.0 0.5 65.2 16.6 1.7 4.8 11.3 2.6 0.6 2.0 41.5 0.3 0.6 2.2 0.4 1.4 2.4 10.7 0.0 0.4 0.5 1.6 3.3 1.0 0.1 15.5 3.7 0.5 6.2 1.8 31.9 0.5 0.3 9.1 4.0 0.0 0.0 0.7 3.2 0.7 4.4 5.7 0.0 0.4 22.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.2 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 10.8 0.0 0.0 16.3 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.1 0.0 0.1 37.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 22.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.2 1.7 0.6 2.0 0.4 1.4 1.6 0.0 0.0 0.3 0.0 0.2 4.4 1.1 0.8 0.0 0.0 0.0 19.2 0.0 0.0 190.6 2.3 0.8 0.9 0.0 0.0 0.0 2.2 2.0 1.5 9.2 0.0 0.1 3.2 2.4 1.3 0.0 0.4 1.1 2.8 8.5 1.0 0.0 0.2 0.0 0.0 0.0 3.3 0.0 6.5 5.1 0.1 0.0 6.6 0.1 0.0 0.0 0.1 PTGER4 EP4 ENSG00000171522 "Prostaglandin E receptor 4" P35408 5 40679498-40693735 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 57.2" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 54.4;Macrophages: 56.4;monocytes: 52.3;T-cells: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 19.1;HUVEC TERT2: 13.5;LHCN-M2: 13.2;RT4: 19.2;THP-1: 12.8;TIME: 24.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA011226, HPA012756" Approved NA NA "HPA011226: AB_1855885, HPA012756: AB_1855884" "unprognostic (1.79e-2)" "unprognostic (6.53e-3)" "unprognostic (9.43e-3)" "unprognostic (6.77e-3)" "unprognostic (1.44e-1)" "unprognostic (7.16e-2)" "unprognostic (7.28e-3)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.02e-1)" "unprognostic (2.76e-1)" "unprognostic (3.61e-2)" "unprognostic (2.17e-1)" "unprognostic (2.48e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.48e-4)" 10.3 5.1 1.4 12.8 1.2 34.7 6.9 0.4 0.8 8.5 24.8 1.7 1.1 9.4 4.8 2.8 6.0 6.1 14.5 9.0 1.1 1.3 8.4 3.7 16.5 16.6 2.2 0.1 4.3 57.2 0.3 1.6 2.3 2.1 7.0 7.9 4.1 3.6 1.0 7.4 4.0 28.7 6.6 4.5 18.2 8.9 2.1 1.2 23.3 3.3 5.7 9.5 11.6 6.2 1.3 5.4 9.3 15.6 2.5 11.4 4.1 1.6 0.3 0.0 0.0 8.2 9.8 0.0 0.1 0.6 0.5 0.3 0.0 0.5 0.2 0.1 0.0 8.6 1.2 0.1 3.0 0.8 19.1 0.4 0.0 0.6 0.0 7.5 7.0 1.4 1.0 0.5 4.9 2.0 1.1 13.5 6.8 0.0 4.6 13.2 0.0 7.0 3.2 0.0 0.3 2.9 4.8 1.3 0.6 1.8 19.2 0.0 0.0 0.3 0.6 0.0 0.3 3.0 12.8 24.3 2.6 0.0 0.0 0.6 0.0 0.1 0.9 1.1 5.3 0.6 3.5 4.5 9.3 11.4 12.8 6.6 1.3 6.9 7.1 5.4 1.3 4.2 6.1 8.7 2.5 15.6 0.8 5.5 4.1 1.4 1.2 0.4 0.8 1.1 1.3 2.2 0.1 2.1 1.2 11.9 13.6 11.5 5.6 54.4 0.0 3.6 0.0 8.1 7.9 7.0 0.0 0.2 0.0 0.9 2.4 8.6 18.8 0.0 6.7 0.6 8.2 9.2 9.3 0.2 30.8 0.0 12.5 3.7 32.1 1.1 0.9 56.4 18.6 52.3 35.0 0.0 2.8 23.2 0.4 0.0 0.2 0.0 10.6 3.6 1.3 26.6 0.2 69.2 16.6 0.8 PTGES "MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12" ENSG00000148344 "Prostaglandin E synthase" O14684 9 129738331-129753047 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 16.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA045064 Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045064: AB_10795889" "unprognostic (2.92e-3)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (2.54e-2)" "unprognostic (1.94e-3)" "unprognostic (1.25e-1)" "unprognostic (5.38e-3)" "unprognostic (1.24e-3)" "unprognostic (2.92e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.22e-1)" "unprognostic (4.66e-2)" "unprognostic (9.78e-3)" "unprognostic (3.19e-2)" "unprognostic (1.30e-1)" "unprognostic (5.20e-2)" 17.0 0.6 1.1 6.2 1.7 3.0 16.7 1.1 1.8 11.9 4.2 0.8 59.8 1.2 2.0 9.1 8.7 2.7 4.1 4.2 2.1 3.5 3.9 0.4 3.5 3.1 1.3 0.7 2.7 0.6 6.3 0.7 51.7 2.1 11.2 2.0 2.9 16.3 182.9 2.5 19.8 3.7 4.8 1.4 1.3 3.4 9.9 0.6 2.3 1.7 6.6 14.1 14.5 15.0 0.0 0.1 16.8 3.2 0.0 0.0 0.1 0.2 18.7 0.0 8.9 30.0 10.4 31.9 1.4 12.3 0.2 0.3 0.9 13.7 0.0 0.5 3.4 57.8 41.7 0.1 1.4 0.1 0.0 0.1 0.0 13.3 0.0 0.7 0.0 0.0 6.1 9.7 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 8.9 1.6 0.0 0.0 0.0 1.0 19.9 0.1 0.7 16.7 30.6 0.1 1.3 16.0 0.0 0.0 0.0 0.0 79.1 0.0 0.0 0.0 0.0 15.7 0.0 0.1 16.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 3.2 0.0 0.0 0.1 1.1 1.7 1.1 1.8 2.1 3.5 1.3 0.7 2.1 0.6 0.0 0.0 0.0 8.2 15.9 0.0 0.0 0.0 0.0 4.5 3.5 0.0 118.4 1.7 10.6 0.4 0.3 0.0 0.0 1.0 226.1 92.9 6.9 1.1 0.0 15.4 0.0 7.0 0.0 0.0 0.0 0.3 3.8 13.5 12.6 6.4 0.0 5.7 0.0 0.0 0.5 0.0 0.0 11.2 0.3 0.0 37.6 231.0 0.0 0.3 38.2 PTGES2 "C9orf15, FLJ14038" ENSG00000148334 "Prostaglandin E synthase 2" Q9H7Z7 9 128120693-128128462 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.5" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 606.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020631, HPA020733" Approved Approved Mitochondria No No Mitochondria "HPA020631: AB_1855887, HPA020733: AB_2670508" "unprognostic (1.23e-1)" "unprognostic (1.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (1.68e-2)" "unprognostic (5.13e-3)" "unprognostic (2.56e-1)" "unprognostic (1.57e-1)" "unprognostic (7.10e-2)" "unprognostic (2.81e-2)" "unprognostic (4.33e-2)" "prognostic favorable (5.83e-7)" "unprognostic (2.10e-2)" "unprognostic (1.46e-1)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" 9.3 17.0 16.5 9.2 17.8 4.4 7.4 15.3 24.1 7.1 14.8 9.9 7.6 17.7 8.1 9.0 12.6 8.4 10.0 36.4 17.4 14.0 13.2 13.0 5.8 10.2 14.2 11.6 9.2 18.3 11.7 14.3 10.7 10.5 8.0 7.0 13.2 16.2 12.0 73.5 9.3 13.2 5.9 7.0 9.5 14.3 5.8 9.8 9.3 10.5 16.2 13.3 8.5 7.3 5.2 8.2 1.2 6.3 3.7 6.5 2.9 12.7 35.8 4.0 14.8 3.6 3.7 12.2 9.8 5.5 12.4 6.6 26.7 20.0 11.3 15.7 3.9 9.7 33.2 5.8 12.1 1.7 8.1 15.6 5.8 27.1 24.9 11.1 11.7 11.6 5.0 8.8 10.0 6.9 3.8 8.5 12.0 12.8 7.0 4.1 39.5 14.0 22.4 12.8 15.4 29.0 10.6 7.9 28.8 8.4 9.6 20.0 12.0 14.2 22.6 9.5 2.0 20.2 6.3 11.1 12.8 15.8 17.2 17.8 16.2 7.9 11.0 9.7 9.1 11.8 1.2 6.0 1.0 5.6 6.3 6.5 5.2 3.7 5.9 6.7 4.5 4.3 5.1 1.1 3.7 2.8 8.2 4.2 2.9 16.5 17.8 15.3 24.1 17.4 14.0 14.2 11.6 10.5 9.8 14.9 5.4 25.3 29.8 20.4 34.7 606.9 35.7 0.0 6.8 22.7 19.6 69.1 124.3 64.1 1.9 21.1 88.3 0.0 44.8 49.4 20.3 34.0 14.9 33.3 50.6 35.0 43.4 15.4 22.9 3.2 28.4 33.8 54.0 154.1 52.3 18.2 52.2 51.8 20.5 79.0 38.1 19.4 28.3 2.3 56.6 21.5 55.7 21.7 83.1 40.8 PTGES3 "cPGES, p23, TEBP" ENSG00000110958 "Prostaglandin E synthase 3" Q15185 12 56663341-56688408 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 358.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034319, HPA038672, HPA038673" Enhanced Approved Nucleoplasm,Cytosol NA NA 580000 Cytosol Nucleoplasm "CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786" "prognostic unfavorable (2.15e-5)" "unprognostic (2.60e-1)" "unprognostic (8.67e-3)" "unprognostic (7.07e-2)" "unprognostic (2.24e-1)" "unprognostic (2.96e-3)" "prognostic unfavorable (4.44e-6)" "unprognostic (4.33e-3)" "unprognostic (3.64e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.73e-2)" "unprognostic (2.31e-2)" "unprognostic (3.05e-3)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (2.07e-1)" 44.7 41.4 56.0 41.2 55.7 39.6 175.0 44.2 51.7 49.0 51.9 38.1 49.5 46.4 57.7 52.0 52.6 69.8 36.0 46.0 54.6 57.2 52.1 67.1 46.4 62.0 67.0 41.4 82.3 55.1 43.2 49.2 50.3 57.0 60.7 55.3 24.0 36.6 49.4 64.2 37.0 46.7 64.7 72.5 42.7 36.6 39.7 65.1 53.5 72.5 36.7 55.1 72.7 358.9 40.6 36.9 27.3 74.8 29.2 42.5 60.5 81.4 71.0 57.7 34.3 42.5 38.6 87.9 53.4 40.8 68.8 51.4 60.1 85.9 90.3 81.1 45.5 46.3 52.5 108.0 69.7 87.2 66.3 71.9 70.5 44.9 69.5 31.1 83.7 51.2 27.9 51.0 51.9 63.1 65.5 70.7 58.1 113.0 86.5 67.1 50.8 83.1 79.6 98.5 71.9 83.0 72.7 54.4 121.2 60.5 63.8 74.8 43.7 54.5 78.6 46.2 79.6 90.5 70.3 42.3 41.3 48.1 49.5 73.7 36.5 100.4 72.6 45.0 69.1 74.3 27.3 37.5 23.2 32.0 59.0 42.0 40.6 42.5 38.1 36.9 28.5 42.3 36.4 14.8 29.2 74.8 31.3 42.5 60.5 56.0 55.7 44.2 51.7 54.6 57.2 67.0 41.4 57.0 65.1 166.7 121.6 178.4 623.1 343.3 128.5 151.7 150.3 313.2 146.7 179.7 72.6 370.5 316.7 252.0 38.5 189.7 176.9 116.8 186.9 545.4 268.2 456.4 232.8 165.2 311.0 106.5 250.8 168.1 180.7 81.6 221.2 245.7 268.2 312.0 185.6 201.5 190.6 194.6 200.5 268.7 99.7 142.3 307.9 546.1 341.1 330.1 473.4 233.5 241.8 443.4 PTGES3L ENSG00000267060 "Prostaglandin E synthase 3 like" 17 42968088-42980433 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 18.3;skeletal muscle: 61.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 41.4" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 4.2" "Cell type enriched" "Detected in some" 7 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in many" 7 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "HMC-1: 8.9;RH-30: 8.7;THP-1: 22.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.83e-1)" "unprognostic (1.64e-1)" "unprognostic (9.77e-2)" "unprognostic (6.61e-2)" "unprognostic (7.45e-2)" "unprognostic (4.66e-2)" "unprognostic (2.36e-2)" "unprognostic (1.31e-2)" "unprognostic (1.24e-1)" "unprognostic (6.23e-2)" "unprognostic (2.80e-4)" "unprognostic (9.24e-2)" "unprognostic (3.03e-2)" "unprognostic (1.40e-1)" "unprognostic (3.10e-1)" "unprognostic (6.25e-2)" "unprognostic (4.08e-2)" 0.5 0.2 0.7 0.8 4.2 1.1 0.5 0.3 1.2 1.3 5.1 0.2 0.0 0.6 3.5 2.2 2.2 1.1 3.3 18.3 0.5 0.7 0.2 0.1 0.4 0.5 0.6 0.7 0.6 0.2 0.2 0.4 0.2 0.3 1.8 1.5 1.5 1.0 2.2 61.3 0.5 1.2 10.0 0.2 0.3 1.7 0.6 0.1 0.4 0.4 13.6 0.6 4.7 1.3 0.7 8.9 1.3 0.3 0.6 0.3 0.8 0.7 0.6 1.9 3.6 0.1 0.3 1.6 1.3 0.8 1.1 0.6 1.5 0.7 0.6 0.5 0.5 1.1 1.4 1.5 1.4 1.7 0.5 0.6 5.2 3.0 3.1 0.1 0.8 8.9 0.7 1.0 2.4 1.7 0.7 0.3 3.3 1.8 1.6 3.4 1.0 3.2 2.0 2.1 2.8 0.5 1.3 8.7 0.7 2.1 1.4 1.7 5.9 1.6 3.2 2.6 2.1 1.7 22.7 0.7 1.9 1.8 0.6 1.2 3.9 2.5 0.9 0.3 0.9 0.7 1.3 0.3 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.3 0.7 0.3 0.3 1.2 0.6 0.2 8.9 0.2 0.8 0.7 4.2 0.3 1.2 0.5 0.7 0.6 0.7 0.3 0.1 0.0 0.0 0.5 0.6 0.0 0.9 41.4 0.0 1.4 0.0 0.0 7.9 0.1 0.0 1.4 8.6 0.1 0.9 0.0 0.2 0.5 0.2 0.6 0.0 0.0 1.0 0.0 1.7 1.3 0.0 3.3 0.6 0.2 0.0 2.8 0.6 0.7 0.7 2.9 0.4 0.3 2.5 0.0 4.2 5.2 4.1 0.0 0.1 0.0 1.0 0.3 PTGES3L-AARSD1 ENSG00000108825 "PTGES3L-AARSD1 readthrough" Q9BTE6 17 42950526-42980528 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 46.6" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 4.0;Club cells: 1.2;granulocytes: 3.5" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 4.5" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 5.3" "Lineage enriched" "Detected in single" 28 "dendritic cells: 5.3" "Cell line enhanced" "Detected in many" "RH-30: 6.7;THP-1: 13.2" "Low region specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Approved Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (6.47e-2)" "unprognostic (1.25e-1)" "unprognostic (2.87e-1)" "unprognostic (5.44e-2)" "unprognostic (9.34e-4)" "unprognostic (1.56e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-2)" "unprognostic (1.82e-1)" "unprognostic (5.13e-1)" "unprognostic (3.27e-2)" "unprognostic (1.91e-4)" "unprognostic (1.83e-1)" 0.7 0.1 0.7 1.2 4.5 1.2 0.5 0.6 1.6 1.5 5.5 0.3 0.1 1.7 4.7 2.4 2.2 1.6 3.6 13.8 0.5 0.7 0.3 0.2 0.6 0.7 0.6 0.8 0.7 0.3 0.4 1.5 0.4 0.4 2.0 3.2 1.6 0.7 3.1 46.6 0.2 1.6 10.6 0.2 0.4 2.4 3.8 0.2 0.5 0.5 14.4 0.8 5.1 1.4 0.1 5.3 0.0 0.0 0.0 0.0 0.4 1.0 0.0 2.7 2.7 0.3 0.0 0.8 2.2 2.0 1.2 1.1 1.7 0.3 0.3 1.7 0.2 0.8 0.0 0.4 1.1 1.9 1.0 0.4 5.6 2.2 4.1 0.0 0.5 4.0 0.1 0.7 1.9 0.1 0.8 0.6 1.8 2.0 0.4 2.2 0.0 1.8 1.4 0.7 3.5 0.5 1.5 6.7 0.7 0.3 0.5 1.3 3.5 1.4 0.5 1.5 3.5 0.9 13.2 0.0 0.9 1.7 0.0 0.7 3.7 1.1 0.4 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.7 4.5 0.6 1.6 0.5 0.7 0.6 0.8 0.4 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 PTGIR IP ENSG00000160013 "Prostaglandin I2 receptor" P43119 19 46620468-46625118 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.7;lung: 35.1" "Cell type enriched" "Detected in many" 4 "monocytes: 249.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 10 "classical monocyte: 12.6;intermediate monocyte: 27.7;myeloid DC: 9.1;non-classical monocyte: 15.5" "Group enriched" "Detected in many" 12 "dendritic cells: 9.1;monocytes: 27.7" "Cell line enhanced" "Detected in some" "BJ: 8.5;BJ hTERT+: 9.7;fHDF/TERT166: 12.0;HDLM-2: 5.9;HEL: 22.0;HHSteC: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (3.49e-3)" "unprognostic (4.22e-2)" "unprognostic (6.09e-2)" "unprognostic (2.12e-1)" "unprognostic (7.45e-2)" "unprognostic (4.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (2.09e-8)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (1.16e-1)" "unprognostic (5.66e-2)" 7.8 6.3 0.4 8.0 0.6 3.8 3.0 0.1 0.6 6.5 6.0 1.2 1.4 2.7 5.0 2.7 4.5 2.7 6.4 16.0 0.6 0.3 9.0 9.6 35.1 6.5 0.8 0.7 6.9 3.5 0.1 1.2 6.3 1.1 3.2 1.4 3.3 2.5 1.3 12.2 3.0 3.7 4.1 0.5 11.3 4.5 1.6 0.8 3.5 14.5 3.4 4.3 10.2 6.5 0.5 9.1 0.5 27.7 0.0 1.5 7.2 0.0 0.0 0.0 0.0 0.1 4.6 0.0 8.5 9.7 1.2 3.5 0.0 0.0 0.0 0.7 12.0 0.1 0.0 0.0 0.0 0.7 5.9 0.0 22.0 0.0 0.0 5.9 0.0 0.0 1.4 0.0 3.1 0.2 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.4 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.0 12.6 0.0 0.0 27.7 0.2 0.5 0.1 0.0 9.1 0.3 1.5 0.0 0.5 0.0 15.5 0.8 1.4 7.2 0.4 0.6 0.1 0.6 0.6 0.3 0.8 0.7 1.1 0.8 0.0 1.1 4.5 0.9 3.8 0.5 0.8 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.1 0.1 2.6 0.0 0.0 0.3 0.1 8.9 0.8 3.5 0.0 2.6 0.0 0.0 5.5 6.0 0.0 2.0 14.1 6.8 249.7 0.0 0.0 0.5 0.0 0.0 0.0 0.6 6.5 58.0 0.1 0.4 3.9 0.2 0.9 0.0 0.3 PTGIS "CYP8A1, PGIS" ENSG00000124212 "Prostaglandin I2 synthase" Q16647 20 49503874-49568146 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 88.2" "Group enriched" "Detected in many" 8 "Ito cells: 78.5;Leydig cells: 24.7;Peritubular cells: 98.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "ASC diff: 17.8;ASC TERT1: 17.9;U-2197: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009517, HPA014193, HPA052244" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (5.09e-3)" "unprognostic (1.38e-2)" "unprognostic (1.80e-2)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (1.29e-2)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (2.45e-2)" "unprognostic (5.22e-2)" "prognostic unfavorable (4.74e-8)" "unprognostic (2.29e-2)" "unprognostic (7.61e-2)" "unprognostic (4.89e-3)" "prognostic unfavorable (9.99e-5)" 18.2 2.5 0.6 8.0 1.3 0.1 28.3 0.2 1.6 23.3 14.6 0.5 6.5 1.7 36.5 21.7 13.2 32.0 36.3 23.8 0.3 0.5 3.0 3.8 7.5 1.6 0.5 0.9 51.2 1.3 0.2 0.5 1.0 1.0 27.2 3.7 3.2 3.7 4.6 7.0 3.2 4.4 88.2 1.4 0.3 8.7 16.2 0.3 0.0 6.7 5.6 1.7 64.2 36.1 1.0 0.8 2.7 0.6 0.8 0.5 0.1 0.0 0.0 0.7 0.0 17.8 17.9 0.2 0.3 2.1 0.0 0.0 0.0 0.0 0.0 7.1 5.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.3 0.0 0.2 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.9 55.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.1 1.0 0.4 0.5 2.7 0.8 0.3 0.8 0.2 0.1 0.6 1.3 0.2 1.6 0.3 0.5 0.5 0.9 1.0 0.3 3.0 2.4 0.0 0.6 3.3 0.8 3.4 0.0 4.0 3.4 3.5 0.0 0.3 0.0 0.4 1.7 3.8 0.0 0.0 0.0 0.1 8.3 0.3 0.0 0.6 0.3 0.0 0.0 78.5 1.5 2.2 24.7 0.7 1.7 0.0 0.0 0.3 0.7 0.0 98.6 0.0 4.6 0.0 2.5 0.7 1.1 4.3 0.2 0.5 0.0 0.6 PTGR1 "LTB4DH, ZADH3" ENSG00000106853 "Prostaglandin reductase 1" Q14914 9 111549722-111599855 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 117.6;liver: 113.8" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 377.0;Hepatocytes: 710.5;Proximal tubular cells: 445.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 9 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "OE19: 135.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036724 Enhanced NA NA 940000 "HPA036724: AB_10670239" "unprognostic (1.54e-1)" "unprognostic (2.23e-1)" "unprognostic (1.10e-2)" "unprognostic (3.02e-3)" "unprognostic (8.46e-2)" "unprognostic (1.02e-3)" "unprognostic (1.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (3.48e-1)" "prognostic favorable (5.53e-4)" "unprognostic (2.25e-1)" "unprognostic (2.24e-1)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" 9.9 23.7 6.7 3.4 8.1 0.4 8.0 9.7 10.0 8.0 116.3 2.2 3.0 45.2 8.0 7.8 27.4 14.3 15.2 7.7 7.0 4.2 47.3 113.8 5.2 2.6 3.3 6.6 5.9 4.3 6.2 9.0 3.2 6.4 12.3 6.7 6.8 11.4 6.4 3.3 6.7 117.6 8.7 2.5 2.2 21.2 3.3 3.4 1.1 9.0 36.4 12.5 21.9 23.6 0.3 8.9 0.2 0.9 0.0 0.2 0.5 7.7 32.9 9.6 0.1 35.3 35.7 7.5 12.6 19.2 12.0 12.6 8.9 10.6 0.0 3.6 12.0 23.8 9.5 7.7 13.3 14.9 0.0 2.3 1.9 20.4 43.3 8.1 1.1 4.0 25.4 20.1 16.5 8.4 14.2 30.4 0.0 1.3 0.0 23.3 2.3 0.0 0.2 3.9 135.6 8.1 0.0 2.7 0.2 14.1 25.3 10.8 0.5 15.5 4.7 4.6 10.1 14.5 5.2 24.5 2.3 4.9 26.9 2.2 0.0 0.0 0.0 11.5 0.0 2.9 0.0 0.9 0.0 0.0 0.1 0.2 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 8.9 0.0 0.5 6.7 8.1 9.7 10.0 7.0 4.2 3.3 6.6 6.4 3.4 17.9 24.1 7.4 46.4 34.3 15.0 31.9 377.0 41.5 26.1 134.3 23.6 41.2 127.6 59.9 2.6 22.5 52.9 0.0 153.0 26.9 30.9 61.7 1.1 710.5 45.6 0.0 25.5 47.3 25.0 2.2 30.8 19.7 33.7 37.9 29.6 37.3 177.9 43.2 37.1 445.1 42.8 12.9 54.5 8.7 4.5 26.7 17.2 5.1 43.5 89.4 PTGS1 "COX1, PGHS-1, PTGHS" ENSG00000095303 "Prostaglandin-endoperoxide synthase 1" P23219 9 122370530-122395703 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 211.4;urinary bladder: 163.9" "Cell type enriched" "Detected in many" 4 "granulocytes: 205.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 53.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5" "Cell line enhanced" "Detected in some" "ASC diff: 28.8;ASC TERT1: 22.8;BJ: 27.9;BJ hTERT+: 38.1;HEL: 17.5;HMC-1: 74.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002834, CAB020315" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 25000000 "Golgi apparatus" Vesicles "CAB020315: , HPA002834: AB_1079711" "unprognostic (4.20e-1)" "unprognostic (6.23e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (5.88e-2)" "unprognostic (2.00e-2)" "unprognostic (1.22e-3)" "unprognostic (3.32e-1)" "unprognostic (2.24e-1)" "unprognostic (3.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (4.03e-2)" "unprognostic (1.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (9.35e-4)" 4.5 1.1 1.8 9.1 3.1 2.6 2.5 0.5 2.7 2.6 35.3 4.6 3.0 3.9 2.5 1.6 25.7 16.7 9.4 4.9 1.9 1.6 3.9 1.8 4.0 1.4 3.5 0.7 3.6 1.0 0.7 2.4 0.8 2.5 60.9 9.3 1.5 1.9 2.3 0.7 55.9 6.5 211.4 4.9 3.6 7.8 1.0 3.1 0.4 1.5 5.3 4.2 163.9 19.5 2.5 13.0 14.4 8.5 1.9 0.1 13.7 0.0 0.1 0.1 0.0 28.8 22.8 0.0 27.9 38.1 0.2 0.2 0.0 0.0 1.0 1.3 4.7 0.0 1.7 0.1 2.5 0.2 0.0 0.0 17.5 0.1 0.0 8.3 1.2 74.3 11.6 0.3 1.4 0.0 0.0 10.3 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.4 0.0 0.1 0.0 0.3 2.0 3.6 0.0 0.1 0.1 0.1 2.3 0.0 0.1 0.0 2.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 7.6 0.0 12.0 7.6 14.4 0.0 8.5 0.0 1.7 0.0 0.0 13.0 2.5 0.0 0.0 3.5 1.9 6.1 0.9 0.1 13.7 1.8 3.1 0.5 2.7 1.9 1.6 3.5 0.7 2.5 3.1 0.0 10.0 0.9 2.4 8.9 0.0 1.1 0.0 1.4 2.3 40.1 0.0 0.1 0.0 0.5 0.0 6.0 0.0 0.0 0.4 0.2 4.7 1.9 205.3 0.0 25.3 0.0 1.7 36.8 10.7 0.0 1.4 22.9 3.3 4.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 51.3 0.3 0.7 0.5 0.6 PTGS2 COX2 ENSG00000073756 "Prostaglandin-endoperoxide synthase 2" P35354 1 186671791-186680427 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Dioxygenase, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "ductus deferens: 324.6;seminal vesicle: 377.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 318.6;Glandular cells: 122.9;granulocytes: 329.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "neutrophil: 12.8" "Lineage enriched" "Detected in single" 16 "granulocytes: 12.8" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 95.4" "Region enhanced" "Detected in many" "hippocampal formation: 16.5" "Low region specificity" "Detected in all" "CAB000113, HPA001335" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "CAB000113: , HPA001335: AB_1079712" "unprognostic (1.36e-3)" "unprognostic (9.97e-3)" "unprognostic (3.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (5.96e-2)" "unprognostic (9.50e-2)" "unprognostic (9.03e-3)" "unprognostic (2.81e-1)" "unprognostic (3.24e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (9.79e-4)" "unprognostic (8.04e-3)" "unprognostic (4.38e-2)" "unprognostic (8.89e-2)" "unprognostic (3.74e-2)" 5.7 2.1 1.2 3.7 1.1 32.6 1.5 0.8 1.9 21.1 11.4 1.1 324.6 0.4 2.3 1.8 1.7 4.0 9.5 9.1 1.1 1.0 3.3 2.7 22.1 2.3 1.3 0.8 1.6 0.4 3.1 2.2 2.5 1.9 9.2 2.7 3.9 0.9 377.9 1.0 1.1 2.4 7.7 4.7 0.9 11.4 1.0 0.9 0.6 1.5 3.4 1.3 17.3 1.9 0.0 0.5 12.8 0.8 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.6 0.5 0.0 21.8 95.4 0.1 0.8 3.4 4.0 0.0 0.0 0.1 0.6 2.9 0.0 1.7 0.3 0.0 0.0 0.2 0.5 0.0 3.2 0.0 0.1 0.2 0.6 2.7 6.9 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.2 0.0 0.2 0.6 0.0 0.1 0.3 4.6 0.1 3.2 0.1 0.0 0.0 0.0 6.7 0.1 0.5 0.0 0.4 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.8 0.0 0.4 0.0 0.0 0.0 1.2 1.1 0.8 1.9 1.1 1.0 1.3 0.8 1.9 0.9 318.6 102.3 0.5 47.5 105.6 0.0 1.9 0.0 8.1 53.4 0.0 0.0 0.1 0.0 0.8 0.2 14.3 0.0 0.0 0.2 0.2 36.1 122.9 329.1 0.0 11.5 0.0 1.2 6.7 16.5 0.0 0.0 112.3 33.7 0.0 0.5 0.0 3.2 0.0 0.0 0.0 0.2 0.0 21.7 0.1 0.4 24.8 0.5 0.0 1.3 107.5 PTH PTH1 ENSG00000152266 "Parathyroid hormone" P01270 11 13492055-13496181 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 963.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000072, CAB023409, CAB026363, HPA048540" Enhanced "Secreted to blood" NA NA 28000 "CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: AB_2680435" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 963.9 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 129.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTH1R "PTHR, PTHR1" ENSG00000160801 "Parathyroid hormone 1 receptor" Q03431 3 46877746-46903799 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 90.4" "Cell type enhanced" "Detected in many" 20 "Distal tubular cells: 81.2;Proximal tubular cells: 259.5;Sertoli cells: 135.8" "Cancer enhanced" "Detected in many" "renal cancer: 18.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075879 Enhanced NA NA "HPA075879: " "unprognostic (1.26e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-5)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (5.02e-2)" "unprognostic (3.84e-3)" "unprognostic (5.47e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (7.51e-2)" "unprognostic (8.44e-2)" "prognostic favorable (6.79e-6)" "unprognostic (4.22e-3)" "unprognostic (1.50e-1)" "unprognostic (1.35e-4)" "unprognostic (6.62e-3)" 8.5 17.9 4.2 1.4 5.9 0.8 5.0 3.7 5.0 6.2 2.3 5.2 1.1 1.5 4.5 2.5 2.3 3.8 2.8 4.3 5.5 3.9 90.4 13.4 4.1 6.9 6.0 5.0 5.4 1.6 1.0 0.9 10.1 4.7 3.2 1.2 3.4 1.5 3.0 4.0 2.6 1.8 4.6 4.1 9.6 1.5 2.2 5.7 0.0 1.2 0.6 1.0 2.8 5.5 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 7.2 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 2.3 0.0 51.7 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 5.9 3.7 5.0 5.5 3.9 6.0 5.0 4.7 5.7 0.0 0.0 0.5 0.0 1.1 0.7 2.2 0.0 0.0 0.0 31.4 0.0 0.5 81.2 0.0 8.7 1.5 0.0 0.0 0.5 48.7 10.8 0.0 0.0 0.4 1.8 1.6 0.0 22.1 1.5 22.5 5.5 0.0 0.0 0.0 0.0 3.0 0.2 0.0 2.1 259.5 0.6 135.8 3.1 0.7 1.3 0.6 0.7 0.0 0.0 0.1 PTH2 TIP39 ENSG00000142538 "Parathyroid hormone 2" Q96A98 19 49422414-49423441 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 28 "blood: 2.4;brain: 4.1;testis: 1.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 1.6;Late spermatids: 1.1;Muller glia cells: 2.6;Spermatocytes: 1.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 18 "B-cells: 2.4" "Cell line enhanced" "Detected in some" "Hep G2: 1.4;REH: 3.8;SCLC-21H: 3.3;U-266/84: 1.1;U-937: 1.0" "Region enriched" "Detected in single" 10 "olfactory region: 3.5" "Region enriched" "Detected in many" 4 "cerebellum: 36.9" "Secreted in brain" NA NA "unprognostic (3.41e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 1.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 PTH2R PTHR2 ENSG00000144407 "Parathyroid hormone 2 receptor" P49190 2 208359714-208854503 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.6;brain: 8.9;salivary gland: 8.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 11.8;Distal tubular cells: 6.6;Proximal tubular cells: 12.3;Rod photoreceptor cells: 23.9" "Cancer enhanced" "Detected in many" "renal cancer: 6.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 11.7;HEL: 16.6;HL-60: 4.1;SH-SY5Y: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010655 Approved NA NA "HPA010655: AB_2668333" "unprognostic (4.76e-3)" "unprognostic (1.39e-3)" "unprognostic (1.64e-1)" "unprognostic (5.78e-2)" "unprognostic (3.77e-1)" "unprognostic (8.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (3.45e-2)" "unprognostic (2.14e-2)" "unprognostic (1.70e-1)" "unprognostic (1.09e-3)" "unprognostic (2.54e-3)" "unprognostic (6.87e-2)" "unprognostic (1.30e-2)" "unprognostic (1.37e-2)" 2.5 0.9 6.0 0.6 3.5 8.6 2.1 0.2 8.6 0.2 0.2 0.0 0.0 0.0 1.6 4.9 0.2 0.2 0.2 0.2 8.9 4.3 0.5 1.4 0.3 0.3 0.5 4.3 0.1 1.4 0.0 1.0 2.7 0.1 1.2 0.1 0.0 8.2 1.4 0.1 0.3 0.2 1.2 0.4 0.4 0.1 1.7 0.0 0.0 0.2 0.1 0.2 0.2 0.2 1.4 0.6 0.9 1.3 0.0 0.8 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.7 1.3 0.8 1.4 0.0 0.0 0.0 1.0 0.4 0.0 0.9 0.0 0.9 0.6 0.0 0.4 6.0 3.5 0.2 8.6 8.9 4.3 0.5 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 5.2 11.8 0.5 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 12.3 23.9 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 PTHLH "HHM, PLP, PTHR, PTHRP" ENSG00000087494 "Parathyroid hormone like hormone" P12272 12 27958084-27972705 "Cancer-related genes, Disease related genes, Predicted secreted proteins" Hormone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 45.6" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 7.9;Melanocytes: 21.9;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 64.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "T-reg: 3.0" "Lineage enriched" "Detected in single" 30 "T-cells: 3.0" "Group enriched" "Detected in some" 4 "HaCaT: 64.7;HBEC3-KT: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035982 Approved Approved Supported "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA035982: AB_10794631" "unprognostic (1.67e-1)" "unprognostic (5.26e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (2.11e-1)" "unprognostic (1.13e-1)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.60e-2)" "unprognostic (1.18e-1)" "unprognostic (5.16e-2)" "unprognostic (4.09e-3)" "unprognostic (3.84e-1)" "prognostic unfavorable (1.82e-9)" "unprognostic (2.01e-2)" "unprognostic (1.34e-1)" "unprognostic (5.23e-3)" "unprognostic (7.87e-3)" 2.9 1.0 6.5 3.5 5.3 0.0 20.2 1.4 8.7 11.0 2.3 1.4 2.1 2.4 11.2 2.0 17.0 1.2 45.6 4.0 4.3 3.5 0.4 0.2 1.3 1.1 1.4 4.3 2.6 1.7 0.7 2.3 3.6 3.1 5.5 1.8 2.4 5.3 2.6 0.7 1.5 1.6 13.4 0.8 3.6 1.9 1.3 1.0 0.1 1.4 15.8 3.4 8.0 12.3 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.3 2.2 0.0 0.0 0.6 0.6 0.0 0.0 0.2 0.1 0.2 0.0 1.7 0.0 0.1 0.5 2.1 64.7 0.2 80.0 0.0 1.6 0.3 0.1 0.4 0.0 0.2 0.0 0.1 0.0 4.4 2.0 7.9 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.7 0.0 0.3 0.1 7.7 0.0 0.0 0.0 3.6 0.0 0.4 2.7 0.1 0.0 1.2 0.3 2.0 1.1 17.0 1.0 0.0 2.6 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 6.5 5.3 1.4 6.2 4.3 3.5 1.4 4.3 3.1 1.0 0.0 0.0 0.0 1.1 4.0 0.1 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.0 4.2 1.3 0.0 0.0 7.9 0.0 4.4 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.9 0.2 21.9 1.0 0.0 2.2 5.5 0.0 0.0 0.0 0.3 6.5 2.8 0.4 0.1 1.3 0.0 0.0 0.0 0.1 PTK2B "CADTK, CAKB, FAK2, PTK, PYK2, RAFTK" ENSG00000120899 "Protein tyrosine kinase 2 beta" Q14289 8 27311482-27459391 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.7;brain: 65.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 73.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.7;REH: 41.9" "Group enriched" "Detected in many" 4 "amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5" "Low region specificity" "Detected in all" "CAB003850, HPA026091, HPA026276" Approved Supported "Plasma membrane,Cytosol" NA NA 84000 "Plasma membrane, Cytosol" "CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234" "unprognostic (2.36e-2)" "prognostic favorable (3.32e-4)" "unprognostic (1.06e-1)" "unprognostic (7.36e-3)" "unprognostic (3.72e-2)" "unprognostic (3.11e-2)" "unprognostic (2.70e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-2)" "unprognostic (3.32e-1)" "unprognostic (2.40e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "prognostic favorable (5.11e-4)" "unprognostic (3.33e-3)" 7.2 4.7 20.4 24.3 30.0 46.7 4.9 65.2 48.3 5.4 14.5 7.8 5.0 16.6 4.3 4.7 7.9 6.8 6.4 4.7 30.5 7.0 6.8 5.0 11.5 35.6 4.3 25.4 2.4 5.4 5.2 5.3 4.1 3.9 10.1 11.9 8.3 12.6 6.7 2.2 15.1 18.4 5.5 4.8 32.0 10.8 4.3 3.7 37.8 5.6 2.9 35.4 13.0 6.0 26.9 18.7 24.0 25.8 14.7 19.0 21.5 11.1 3.1 0.8 0.9 24.0 1.7 6.5 0.9 0.6 0.6 0.8 2.9 6.5 37.7 1.2 1.7 0.9 10.3 0.3 9.4 0.3 2.5 0.2 7.8 3.0 0.6 4.9 8.3 14.0 13.0 14.0 0.8 5.4 4.0 0.3 10.9 9.1 26.3 0.6 1.1 14.3 16.8 0.6 9.7 0.8 41.9 0.2 25.8 2.6 8.8 6.0 1.1 4.0 2.8 1.5 2.1 3.3 21.6 5.3 0.4 0.8 0.7 0.3 21.1 9.1 20.4 1.6 18.1 0.7 22.3 23.7 18.0 19.0 22.4 12.5 25.5 9.6 13.3 18.7 26.9 12.1 14.2 24.0 14.7 25.8 6.2 9.5 21.5 20.4 30.0 65.2 48.3 30.5 7.0 4.3 25.4 3.9 3.7 3.0 30.9 54.0 32.1 33.5 4.1 3.1 12.7 13.4 13.6 14.0 0.0 2.4 0.0 6.4 1.1 7.5 48.3 0.0 7.0 23.9 3.8 16.5 27.7 21.8 20.9 7.9 7.5 3.1 73.4 0.8 1.4 42.5 8.5 34.3 18.6 3.4 9.4 35.1 0.7 14.7 4.0 0.0 1.6 4.2 5.5 26.3 1.6 39.9 14.9 14.8 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537370 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.0;intestine: 24.2;skin 1: 24.2" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane, Cytosol" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.7 0.0 0.4 5.3 0.4 0.0 1.7 0.4 0.4 7.6 18.1 0.5 0.8 13.6 0.6 0.5 44.0 0.0 11.7 0.4 0.4 0.0 0.8 1.7 1.1 0.4 0.4 0.4 0.4 1.4 0.0 0.4 0.6 0.4 2.2 7.4 0.4 7.6 0.4 0.4 24.2 24.2 0.9 0.4 0.4 12.5 0.4 0.4 0.4 0.4 18.9 17.2 6.5 15.0 1.3 4.5 1.2 2.4 0.3 1.9 0.9 10.6 1.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 20.4 0.0 3.6 0.0 0.0 16.6 0.0 0.0 0.0 2.6 0.2 0.0 4.3 0.0 0.0 0.0 3.4 0.0 22.5 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.1 5.9 0.0 0.1 0.1 27.4 7.7 0.0 0.6 0.2 0.0 13.0 0.1 1.1 1.2 4.0 0.0 0.0 12.5 0.8 0.1 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.2 0.2 0.5 1.2 2.4 0.4 0.5 1.7 1.9 1.2 0.4 0.1 4.5 1.3 0.4 0.6 1.2 0.3 1.3 0.3 0.5 0.9 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 34.1 0.0 2.8 5.3 2.0 0.4 12.7 9.4 17.0 0.0 2.0 0.2 0.0 1.4 0.0 0.3 90.1 0.0 1.4 0.1 0.4 1.3 9.2 1.5 0.7 0.0 5.2 0.6 4.1 0.0 0.3 2.8 0.0 0.0 39.1 2.4 10.3 65.1 0.0 0.1 3.9 0.0 0.4 0.2 0.2 13.6 0.1 0.0 18.8 13.8 PTN "HBGF8, HBNF, NEGF1" ENSG00000105894 Pleiotrophin P21246 7 137227341-137343865 "Cancer-related genes, Predicted secreted proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 160.7" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 182.0;Extravillous trophoblasts: 368.5;Fibroblasts: 184.0;Horizontal cells: 497.4;Leydig cells: 159.9;Muller glia cells: 523.9;Peritubular cells: 174.3;Syncytiotrophoblasts: 161.7" "Cancer enriched" "Detected in all" 11 "glioma: 514.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "AF22: 190.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017685, HPA073913" Enhanced Supported "Endoplasmic reticulum" "Secreted to blood" NA NA 167000 1800000 "Endoplasmic reticulum" "CAB017685: AB_1128556, HPA073913: " "unprognostic (1.51e-2)" "unprognostic (7.87e-2)" "unprognostic (5.44e-2)" "unprognostic (4.23e-2)" "unprognostic (1.92e-1)" "unprognostic (7.19e-2)" "unprognostic (2.81e-2)" "unprognostic (7.29e-2)" "unprognostic (1.30e-1)" "unprognostic (1.09e-2)" "unprognostic (3.86e-1)" "unprognostic (1.22e-2)" "prognostic favorable (1.35e-4)" "unprognostic (2.34e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" 7.8 6.6 55.5 2.0 43.3 0.9 27.7 38.6 58.5 30.7 7.2 26.9 9.9 2.5 25.2 18.7 25.0 7.2 18.2 29.4 42.3 29.7 12.7 3.4 6.5 2.6 31.6 27.0 7.2 3.4 160.7 52.5 11.8 31.4 38.5 7.7 19.0 12.0 18.1 1.5 3.6 4.0 17.7 23.4 12.4 5.4 16.8 23.3 1.3 5.1 8.7 5.3 7.7 18.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 190.8 2.3 0.0 0.1 15.6 4.9 14.6 2.7 3.8 0.0 0.0 0.0 0.0 6.4 1.7 0.1 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 1.8 0.0 2.7 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.9 13.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.2 3.7 0.2 10.6 0.0 0.0 0.0 13.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 43.3 38.6 42.0 42.3 29.7 31.6 27.0 31.4 23.3 0.0 0.0 0.0 1.3 20.6 19.5 14.2 0.0 2.7 4.5 1.8 5.9 182.0 8.3 1.2 11.9 8.4 0.0 0.0 0.0 368.5 184.0 17.1 0.0 0.0 18.1 497.4 0.0 8.6 0.3 8.3 159.9 1.4 42.2 0.0 0.0 523.9 0.2 0.0 174.3 5.1 27.0 58.2 33.4 1.8 1.5 12.2 161.7 0.0 0.0 2.0 PTP4A1 "PRL-1, PRL1, PTPCAAX1" ENSG00000112245 "Protein tyrosine phosphatase type IVA, member 1" Q93096 6 63521748-63583587 "Enzymes, Predicted intracellular proteins" "Cell cycle" "Developmental protein, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 135.1;skeletal muscle: 111.2" "Cell type enhanced" "Detected in many" 14 "Late spermatids: 2420.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003281 Approved NA NA "HPA003281: AB_1855903" "unprognostic (8.63e-2)" "prognostic unfavorable (5.53e-4)" "unprognostic (9.05e-2)" "unprognostic (7.96e-2)" "unprognostic (2.79e-2)" "unprognostic (2.71e-2)" "unprognostic (6.12e-2)" "unprognostic (1.96e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.23e-2)" "unprognostic (1.07e-2)" "unprognostic (6.64e-2)" "unprognostic (1.28e-1)" "unprognostic (2.10e-2)" "unprognostic (1.11e-2)" 13.9 42.3 11.3 10.5 14.0 54.3 10.8 7.1 17.0 17.5 30.2 18.9 8.0 17.9 13.1 13.5 16.1 12.3 16.7 10.0 12.0 14.8 14.2 135.1 25.0 9.0 16.1 13.8 24.1 87.4 5.0 12.8 19.8 16.3 17.7 31.2 13.6 20.1 10.0 111.2 17.2 18.3 35.7 24.2 7.1 15.5 19.8 13.3 6.4 11.4 19.9 9.3 31.0 12.6 14.6 18.2 46.9 20.6 15.8 20.1 14.4 19.3 24.0 30.3 29.2 20.7 19.2 60.6 34.1 22.8 12.4 17.4 20.2 11.4 16.5 14.8 20.1 25.8 9.6 20.6 42.8 20.0 17.8 13.9 10.3 67.2 91.7 41.0 31.6 16.9 23.4 83.1 26.9 71.9 15.2 19.2 15.7 23.5 32.1 34.5 26.2 15.1 14.2 12.5 21.7 13.1 20.2 12.6 13.1 27.7 23.0 11.4 21.1 74.4 16.3 33.6 36.3 15.7 28.1 19.1 31.3 34.4 24.7 33.5 26.9 23.0 30.5 16.7 16.9 36.7 34.6 19.8 15.2 13.7 20.6 20.1 14.6 15.0 14.6 18.2 12.4 14.8 14.2 46.9 15.8 14.2 9.1 18.1 14.4 11.3 14.0 7.1 17.0 12.0 14.8 16.1 13.8 16.3 13.3 20.8 83.0 74.7 257.9 605.1 22.1 73.9 163.1 38.8 51.2 71.5 15.7 216.2 68.0 128.0 616.2 31.2 259.4 0.0 168.0 175.7 85.2 143.0 64.4 416.3 88.4 11.1 124.3 41.1 65.9 2420.5 26.4 64.7 161.9 36.1 129.4 17.8 159.8 140.8 22.6 85.2 23.2 6.5 110.2 32.8 21.3 560.3 384.3 37.0 97.1 110.7 PTP4A3 "PRL-3, PRL-R, PRL3" ENSG00000184489 "Protein tyrosine phosphatase type IVA, member 3" O75365 8 141391993-141432454 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 166.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 234.6;Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 210.7;Smooth muscle cells: 93.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 30.3;non-classical monocyte: 27.8" "Group enriched" "Detected in many" 7 "granulocytes: 30.3;monocytes: 27.8" "Cell line enhanced" "Detected in some" "HDLM-2: 70.2;Karpas-707: 21.4;REH: 12.0;RPMI-8226: 22.0;U-266/84: 23.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA003281 Uncertain NA NA "HPA003281: AB_1855903" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.55e-2)" "unprognostic (1.10e-3)" "unprognostic (2.08e-1)" "unprognostic (6.18e-2)" "unprognostic (3.61e-2)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (2.50e-1)" "unprognostic (5.73e-3)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.81e-5)" "unprognostic (2.25e-1)" "unprognostic (1.12e-2)" "unprognostic (2.28e-2)" "unprognostic (1.77e-1)" 5.9 2.4 2.8 3.9 6.5 1.7 4.1 3.9 10.9 5.5 6.2 2.6 2.5 3.4 7.6 5.4 5.5 6.1 3.0 48.0 2.7 3.0 5.1 1.7 5.5 7.9 2.8 5.0 4.8 13.6 2.4 22.0 4.1 4.6 7.2 2.0 15.7 8.2 3.8 166.4 3.4 3.3 7.6 1.5 5.6 9.9 3.5 0.6 1.7 3.3 15.9 5.1 5.5 3.3 2.8 4.3 30.3 27.8 0.8 3.5 2.5 0.1 0.5 0.8 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 2.0 0.0 6.5 0.1 0.0 0.0 0.1 0.0 0.0 70.2 0.5 5.0 0.0 1.1 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.6 2.7 21.4 0.0 5.4 0.6 0.1 1.3 0.5 0.3 12.0 0.0 22.0 0.0 0.1 9.0 2.1 0.4 0.0 1.8 0.6 1.0 0.3 0.1 0.0 1.3 0.0 0.0 6.7 23.3 0.2 0.0 2.0 0.2 0.4 1.6 6.6 1.6 14.8 1.1 2.8 3.5 1.6 1.2 0.8 3.4 1.9 30.3 0.8 27.8 4.3 2.5 2.5 2.8 6.5 3.9 10.9 2.7 3.0 2.8 5.0 4.6 0.6 3.0 45.2 18.2 3.6 8.9 90.4 234.6 5.1 0.0 5.7 7.0 115.8 0.2 8.3 6.5 9.8 29.7 0.0 0.0 53.0 0.2 11.8 9.7 1.1 0.2 3.2 14.3 9.8 9.2 2.8 3.6 3.4 6.0 20.3 10.8 2.4 25.7 16.3 0.0 1.8 4.2 210.7 32.3 93.8 1.8 22.8 8.9 0.2 8.7 2.3 2.5 PTPDC1 "FLJ37312, PTP9Q22" ENSG00000158079 "Protein tyrosine phosphatase domain containing 1" A2A3K4 9 94030794-94109856 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.3" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 5 "B-cells: 1.1;T-cells: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016747, HPA026832" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA016747: AB_1855908, HPA026832: AB_10602917" "unprognostic (3.99e-2)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (4.91e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-2)" "unprognostic (1.90e-3)" "unprognostic (4.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.56e-1)" "unprognostic (3.49e-2)" "unprognostic (3.55e-2)" "unprognostic (2.48e-2)" "unprognostic (2.45e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (2.61e-2)" 7.0 12.0 7.6 4.4 32.3 1.5 6.4 4.7 16.4 4.7 4.9 25.3 1.4 3.1 6.2 4.9 4.4 4.4 4.7 10.0 12.1 6.9 5.1 2.4 6.8 3.7 13.9 8.9 6.3 12.2 6.8 8.9 3.7 19.9 5.6 5.9 4.1 4.3 4.4 7.0 6.2 3.6 8.3 20.5 3.0 7.1 15.0 13.0 1.6 5.1 1.3 3.9 4.9 3.6 1.1 0.3 0.0 0.2 0.0 2.0 0.1 6.1 2.7 4.9 6.3 6.1 8.5 6.5 4.5 3.2 4.6 3.9 2.6 5.2 5.2 3.1 3.4 10.6 4.9 5.0 2.9 4.5 7.0 1.4 1.2 7.2 2.8 8.0 1.4 4.0 8.4 10.5 7.0 9.8 2.8 4.9 8.6 3.0 0.0 8.6 3.3 5.2 2.2 3.4 5.0 5.1 5.6 9.7 0.0 2.6 1.5 4.3 5.5 6.2 5.8 9.7 6.8 3.1 2.5 6.9 6.2 3.8 9.5 5.4 7.6 8.4 0.7 4.6 2.5 8.6 0.0 0.2 0.0 0.1 0.0 0.1 0.4 1.1 0.0 0.3 1.1 2.0 0.7 0.0 0.0 0.2 0.2 0.0 0.1 7.6 32.3 4.7 16.4 12.1 6.9 13.9 8.9 19.9 13.0 0.0 7.7 1.9 2.6 4.2 10.5 8.4 2.5 1.4 1.2 5.2 9.8 0.3 3.3 2.9 8.0 5.7 0.9 0.0 2.5 1.6 5.0 1.9 5.7 0.8 2.7 4.8 3.4 6.2 0.3 3.8 3.4 2.7 3.3 0.0 2.4 2.3 5.0 1.1 13.4 1.0 9.8 19.4 4.8 12.0 15.9 3.8 0.2 2.5 2.3 1.7 PTPN20 "bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B" ENSG00000204179 "Protein tyrosine phosphatase, non-receptor type 20" Q4JDL3 10 46911396-47002488 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.2" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 18.3;Early spermatids: 42.1;Late spermatids: 22.4;Spermatocytes: 17.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "HDLM-2: 32.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA043337, HPA046896, HPA048310, HPA069148" Enhanced Supported "Centriolar satellite" NA NA "Centriolar satellite" "HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: " "unprognostic (1.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.04e-2)" "unprognostic (2.82e-3)" "unprognostic (6.78e-2)" "unprognostic (1.85e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (1.53e-1)" "unprognostic (2.22e-2)" "unprognostic (2.83e-1)" "unprognostic (1.24e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-2)" "unprognostic (1.75e-1)" "unprognostic (8.34e-2)" 1.2 9.7 1.0 1.9 3.1 0.0 3.4 3.4 5.4 0.8 1.3 1.0 5.0 1.1 1.4 0.4 3.4 1.0 0.5 8.8 1.4 3.4 4.3 0.6 0.6 0.2 2.4 0.8 1.6 3.9 0.0 2.3 0.3 11.7 1.1 1.5 1.2 7.8 3.2 11.0 5.6 1.0 0.6 1.2 1.0 1.0 13.2 0.0 0.2 1.9 1.7 0.5 1.0 1.0 2.8 2.2 0.0 0.0 2.3 3.1 0.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.9 0.0 2.5 0.0 0.0 0.0 32.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.5 0.9 6.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 2.8 1.7 0.4 1.1 0.6 2.2 3.1 0.0 2.3 0.0 2.2 1.3 0.7 1.0 3.1 3.4 5.4 1.4 3.4 2.4 0.8 11.7 0.0 0.0 1.0 0.0 1.7 0.0 5.8 12.1 0.0 6.7 4.5 8.7 5.9 0.0 18.3 1.3 42.1 0.0 0.0 0.0 0.8 0.1 1.0 0.6 0.0 0.5 0.4 11.1 1.2 1.8 0.0 22.4 0.0 0.0 0.0 1.0 0.1 5.4 2.4 0.0 6.7 12.9 2.7 0.0 0.3 17.9 10.9 0.0 0.1 0.0 0.6 0.9 PTPN22 "Lyp, Lyp1, Lyp2, PTPN8" ENSG00000134242 "Protein tyrosine phosphatase, non-receptor type 22" Q9Y2R2 1 113813811-113871759 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Autophagy, Immunity" "Hydrolase, Protein phosphatase" "Diabetes mellitus, Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.6;lymphoid tissue: 46.0" "Cell type enhanced" "Detected in many" 15 "B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6" "Region enriched" "Detected in single" 10 "cerebellum: 5.9" "Not detected" "Not detected" "HPA004912, CAB012209, HPA013350" Approved Uncertain "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570" "unprognostic (2.25e-2)" "unprognostic (5.31e-3)" "unprognostic (3.48e-1)" "unprognostic (3.33e-4)" "unprognostic (9.14e-2)" "unprognostic (2.47e-3)" "unprognostic (9.60e-2)" "unprognostic (8.14e-2)" "unprognostic (3.71e-1)" "unprognostic (1.82e-1)" "unprognostic (1.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.75e-6)" "unprognostic (3.19e-1)" "unprognostic (1.10e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-2)" 4.2 1.4 0.5 17.1 0.8 23.6 1.9 1.0 0.5 2.4 3.3 0.3 1.0 4.1 2.0 2.2 2.0 1.7 3.2 2.5 0.6 0.7 3.4 1.8 9.0 14.9 0.7 0.4 1.5 2.4 0.0 0.9 0.9 1.0 1.7 2.8 1.3 2.7 3.0 0.6 1.0 9.9 0.9 2.1 19.0 3.1 1.1 0.4 46.0 1.5 2.4 12.8 4.8 1.7 7.2 6.2 17.2 3.5 7.5 14.9 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.3 0.0 0.2 33.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 4.7 0.0 0.0 0.1 13.3 10.5 3.0 0.0 1.4 0.1 2.7 5.2 8.4 0.0 7.7 5.1 0.1 9.4 7.5 0.0 0.0 0.0 0.5 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 2.4 8.0 0.1 0.1 0.2 14.4 3.0 18.0 5.5 13.6 0.0 10.2 3.5 17.2 12.8 0.9 14.9 7.2 6.5 10.1 6.2 4.7 3.9 9.4 1.7 7.5 0.4 3.7 10.0 4.6 0.5 0.8 1.0 0.5 0.6 0.7 0.7 0.4 1.0 0.4 0.0 9.2 29.6 0.2 2.3 0.4 0.5 0.0 4.0 0.0 1.8 2.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.5 0.2 0.9 0.2 26.6 0.6 7.1 0.0 0.0 0.6 19.2 0.6 0.0 20.5 3.3 1.8 1.0 0.0 0.6 0.0 0.0 0.0 0.4 12.9 0.9 0.3 0.2 2.4 0.1 65.4 1.7 0.2 PTPN3 PTPH1 ENSG00000070159 "Protein tyrosine phosphatase, non-receptor type 3" P26045 9 109375466-109498313 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 38.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 2.8" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "OE19: 16.9;RPTEC TERT1: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038343, HPA046728" Approved NA NA "HPA038343: AB_10671741, HPA046728: AB_2679776" "prognostic unfavorable (6.71e-4)" "unprognostic (3.48e-1)" "unprognostic (3.64e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.32e-2)" "unprognostic (1.27e-1)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (3.71e-2)" "unprognostic (5.38e-2)" "unprognostic (6.37e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.22e-15)" "unprognostic (1.64e-2)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (8.21e-2)" 2.7 1.9 3.4 4.8 5.0 0.0 4.8 2.1 11.1 4.4 9.4 2.0 10.7 7.6 3.2 13.4 10.3 6.4 6.3 12.1 3.1 2.8 28.8 21.1 4.9 0.5 1.2 3.9 1.5 17.0 10.6 4.9 14.5 4.5 4.7 6.5 3.8 13.1 13.6 38.1 18.8 18.8 0.8 0.9 0.9 5.9 2.1 0.0 1.1 9.4 7.2 9.5 4.1 5.5 0.6 0.3 2.8 0.6 0.3 0.3 0.1 6.3 7.9 0.3 2.1 0.0 0.0 12.6 1.4 0.0 1.7 1.9 4.2 10.4 0.0 1.4 0.1 4.4 15.2 2.2 8.9 1.8 3.5 4.8 0.0 3.8 4.3 0.0 0.0 0.1 0.1 9.6 2.2 4.6 0.7 0.0 2.7 0.0 0.1 0.1 8.0 10.9 1.9 1.0 16.9 5.9 0.0 2.6 0.1 20.6 12.3 5.2 1.1 3.5 13.0 0.0 4.5 7.4 1.0 0.0 0.6 5.0 0.8 0.0 6.3 10.2 0.0 6.8 0.0 4.5 0.4 0.6 0.8 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.6 0.3 0.3 2.8 0.3 0.6 0.3 0.1 0.1 3.4 5.0 2.1 11.1 3.1 2.8 1.2 3.9 4.5 0.0 14.9 25.0 0.0 20.1 10.5 9.6 46.0 20.4 24.1 19.4 29.6 0.0 19.8 14.9 13.1 20.8 2.2 25.4 0.0 16.7 20.5 3.6 23.7 1.1 32.7 2.2 0.0 12.6 4.3 0.0 12.7 1.1 1.9 3.3 1.0 16.5 0.3 22.0 23.5 1.8 16.1 2.1 6.5 6.2 0.9 11.7 18.1 9.0 0.8 17.3 26.2 PTPN5 "PTPSTEP, STEP, STEP61" ENSG00000110786 "Protein tyrosine phosphatase, non-receptor type 5" P54829 11 18727928-18792721 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 70.0" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4" "Group enriched" "Detected in some" 6 "glioma: 1.6;testis cancer: 2.0" "Region enhanced" "Detected in many" "basal ganglia: 70.0" "Cell type enriched" "Detected in single" 9 "basophil: 1.5" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031014, HPA072091" Supported Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA031014: AB_10669550, HPA072091: AB_2686487" "unprognostic (1.23e-1)" "unprognostic (2.91e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-2)" "unprognostic (5.83e-3)" "unprognostic (3.59e-1)" "unprognostic (4.91e-2)" "unprognostic (2.59e-1)" "unprognostic (2.00e-1)" "unprognostic (3.58e-1)" "unprognostic (8.44e-4)" "unprognostic (4.21e-3)" "unprognostic (3.90e-2)" "unprognostic (9.39e-2)" "unprognostic (8.49e-2)" 2.5 1.6 16.3 1.1 70.0 1.1 1.2 0.9 47.5 1.5 1.1 0.4 0.0 1.1 1.2 1.0 1.3 1.7 1.4 4.3 9.1 8.6 1.1 0.9 2.7 1.1 3.5 16.0 2.5 1.2 1.5 0.5 0.9 6.1 1.6 1.4 0.0 1.3 1.7 1.8 1.0 1.4 1.4 2.1 1.3 1.3 3.4 9.3 0.0 1.2 0.0 1.0 1.5 0.3 0.1 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.0 3.7 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 5.8 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 70.0 0.9 25.1 9.1 8.6 3.5 16.0 6.1 9.3 0.0 0.0 0.0 0.0 0.1 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 PTPN6 "HCP, HCPH, PTP-1C, SHP-1, SHP1" ENSG00000111679 "Protein tyrosine phosphatase, non-receptor type 6" P29350 12 6946468-6961316 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 107.1;lymphoid tissue: 69.0" "Group enriched" "Detected in many" 5 "B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001466, CAB004572, CAB072845" Enhanced Supported Nucleoplasm,Nucleoli NA NA 7400000 Nucleoplasm Nucleoli "CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930" "unprognostic (4.28e-3)" "prognostic favorable (1.87e-4)" "prognostic unfavorable (5.42e-4)" "prognostic favorable (6.65e-4)" "unprognostic (6.54e-2)" "unprognostic (7.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.44e-2)" "unprognostic (6.93e-3)" "unprognostic (3.57e-1)" "unprognostic (1.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.60e-3)" "unprognostic (1.98e-3)" "unprognostic (2.60e-2)" "unprognostic (5.91e-2)" "prognostic favorable (2.64e-8)" 6.6 8.8 2.4 42.9 4.4 27.7 4.6 1.2 2.7 2.8 7.0 5.1 4.7 7.5 3.7 8.8 7.0 5.0 9.8 2.9 3.1 2.3 7.0 6.8 25.4 58.1 5.2 1.8 2.3 6.7 2.7 5.6 7.7 3.9 5.6 5.2 3.6 10.6 7.0 1.3 6.1 21.0 2.6 4.9 69.0 6.6 1.5 3.3 31.4 6.3 4.1 50.7 8.5 4.2 63.9 38.0 107.1 103.2 22.2 28.2 63.2 2.9 5.6 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 3.0 6.6 2.0 1.5 0.0 0.0 3.4 0.0 3.9 0.0 1.2 1.2 28.7 0.6 2.4 0.0 25.5 112.6 0.0 2.8 0.0 1.2 0.0 0.0 10.3 0.0 0.2 0.0 6.1 9.2 14.9 1.5 6.8 0.9 8.4 0.0 14.5 3.1 5.5 0.5 0.0 0.9 4.6 0.0 4.1 1.4 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 11.2 0.1 54.4 35.9 107.1 28.2 71.3 18.2 62.3 13.7 21.0 38.0 63.9 15.8 19.9 66.7 22.2 103.2 10.0 14.4 63.2 2.4 4.4 1.2 2.7 3.1 2.3 5.2 1.8 3.9 3.3 6.0 18.1 106.2 8.1 8.0 0.0 1.6 12.7 12.0 11.4 5.2 0.0 21.7 13.3 12.3 45.6 4.1 15.8 23.3 13.5 15.5 3.5 4.1 130.8 10.2 168.2 0.0 23.7 9.8 145.1 8.7 0.9 118.2 13.5 6.4 12.0 0.4 11.8 17.3 0.0 10.5 0.6 6.5 2.3 0.3 1.1 7.5 15.4 105.5 15.6 5.6 PTPN7 "HEPTP, LC-PTP" ENSG00000143851 "Protein tyrosine phosphatase, non-receptor type 7" P35236 1 202147013-202161588 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.5;lymphoid tissue: 63.7" "Group enriched" "Detected in many" 5 "B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basal ganglia: 9.4;thalamus: 2.9" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6" "Cell line enhanced" "Detected in some" "HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2" "Region enriched" "Detected in single" 10 "basal ganglia: 5.5" "Region enriched" "Detected in all" 4 "basal ganglia: 10.9" "CAB009530, HPA019118" Approved Supported "Microtubules,Mitotic spindle,Cytosol" NA NA Cytosol "Microtubules, Mitotic spindle" "CAB009530: AB_2173845, HPA019118: AB_1855755" "unprognostic (4.19e-3)" "unprognostic (1.08e-3)" "unprognostic (3.09e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.91e-2)" "prognostic favorable (1.84e-4)" "unprognostic (3.01e-2)" "unprognostic (3.16e-2)" "unprognostic (1.43e-2)" "unprognostic (4.84e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.42e-8)" "unprognostic (1.46e-1)" "unprognostic (4.51e-2)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" 2.6 3.1 0.5 27.1 9.4 24.5 0.6 0.4 0.5 0.6 2.3 0.6 0.0 3.0 0.7 0.6 1.7 0.8 2.9 0.5 0.6 0.8 1.1 0.9 3.2 16.5 1.2 0.2 0.6 0.6 0.0 0.7 0.4 0.8 1.3 1.9 0.7 5.3 0.3 0.4 0.6 3.7 0.9 1.6 15.4 1.4 12.7 2.9 63.7 0.9 0.6 24.8 2.9 0.8 2.6 2.6 17.0 1.1 9.9 10.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 16.7 0.0 0.0 0.0 36.3 48.9 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.7 1.5 0.0 0.0 4.9 15.8 0.0 0.0 0.0 0.7 0.0 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.1 0.0 0.0 7.4 1.8 10.5 0.0 26.2 0.0 11.5 1.1 17.0 10.6 1.1 9.5 1.9 7.1 10.5 2.0 2.6 5.3 6.4 7.1 9.9 0.4 2.6 9.0 2.8 0.5 9.4 0.4 0.5 0.6 0.8 1.2 0.2 0.8 2.9 3.0 9.0 40.6 1.0 2.1 2.4 0.7 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.2 0.4 2.9 0.0 0.0 0.0 0.1 1.7 0.5 137.4 0.5 15.6 0.0 0.0 4.9 6.2 1.3 4.9 23.4 8.5 9.0 0.0 5.6 0.1 0.0 2.1 0.6 4.4 0.0 0.9 0.9 0.4 2.0 0.7 156.8 0.0 0.5 PTPRC "CD45, GP180, LCA, T200" ENSG00000081237 "Protein tyrosine phosphatase, receptor type C" 1 198638457-198757476 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 116.9;lymphoid tissue: 172.5" "Cell type enhanced" "Detected in many" 12 "B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000052, HPA000440, CAB002800, CAB056154, CAB068221" Enhanced Uncertain Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377" "unprognostic (1.51e-2)" "unprognostic (1.24e-2)" "unprognostic (5.10e-3)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.40e-3)" "unprognostic (1.62e-1)" "unprognostic (3.17e-2)" "unprognostic (1.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.08e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (2.42e-4)" "unprognostic (2.31e-1)" "unprognostic (3.43e-2)" "unprognostic (6.41e-2)" "unprognostic (7.06e-2)" 9.8 2.9 3.4 48.0 6.2 36.1 4.3 1.3 3.5 3.1 5.6 2.8 0.5 4.9 2.9 3.9 4.8 5.6 8.8 4.9 3.9 4.5 4.4 5.2 27.5 93.2 7.9 1.3 2.9 2.1 0.3 2.5 4.5 5.3 4.2 5.8 3.3 10.7 1.0 1.7 2.5 22.2 4.5 13.2 89.3 6.5 2.3 5.3 172.5 4.6 3.9 53.2 13.1 3.7 28.5 42.8 94.7 103.8 53.7 76.1 116.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 26.6 0.0 0.0 0.0 24.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 61.5 0.5 0.7 0.0 0.0 35.5 14.5 0.1 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.1 0.0 0.0 19.7 0.3 0.0 0.2 0.1 0.1 22.0 20.0 28.2 0.0 21.5 0.1 20.8 52.0 56.3 76.1 99.7 64.5 28.5 52.9 72.7 42.8 26.8 60.2 60.3 94.7 53.7 103.8 6.4 54.6 116.9 3.4 6.2 1.3 3.5 3.9 4.5 7.9 1.3 5.3 5.3 41.7 86.9 266.4 0.7 14.1 0.0 4.1 7.6 21.4 26.1 1.8 0.0 0.4 0.0 0.0 2.0 11.9 0.1 23.3 0.0 0.5 8.9 0.9 232.9 3.0 90.3 0.0 1.2 14.1 338.8 1.5 1.1 290.3 20.3 120.0 0.2 0.0 0.1 0.0 0.0 1.7 0.2 6.5 4.3 0.2 0.2 13.2 0.7 539.1 0.5 0.9 PTPRCAP "CD45-AP, LPAP" ENSG00000213402 "Protein tyrosine phosphatase, receptor type C associated protein" Q14761 11 67435510-67438067 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 104.7;lymphoid tissue: 149.8" "Cell type enhanced" "Detected in some" 32 "Basal keratinocytes: 11.3;Melanocytes: 37.1;Suprabasal keratinocytes: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 40.0;HDLM-2: 28.0;HL-60: 16.4;MOLT-4: 23.7;NB-4: 113.3;U-698: 28.1" "Region enhanced" "Detected in single" "basal ganglia: 0.5" "Low region specificity" "Detected in some" HPA043734 Enhanced "Intracellular and membrane" NA NA "HPA043734: AB_10962214" 1.8 1.2 1.0 79.2 1.3 8.5 1.6 1.8 0.6 2.6 10.1 0.4 0.4 5.5 1.9 1.8 5.9 3.0 6.2 1.5 1.0 0.8 3.9 2.3 6.9 71.4 1.2 0.3 1.9 1.4 0.2 1.7 1.1 0.4 3.8 1.0 1.5 14.6 0.9 1.3 1.1 21.5 0.6 1.8 56.5 8.4 2.5 0.3 149.8 5.0 4.2 67.1 3.0 2.1 104.7 50.3 4.1 0.4 45.5 97.2 58.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 16.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.1 4.2 0.0 0.4 23.7 113.3 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 28.1 0.0 0.0 0.0 1.2 0.3 4.1 97.2 0.3 82.7 80.5 60.5 85.6 0.7 104.7 44.9 68.9 2.0 45.5 0.4 50.3 78.4 58.1 1.0 1.3 1.8 0.6 1.0 0.8 1.2 0.3 0.4 0.3 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 PTPRD "HPTP, PTPD" ENSG00000153707 "Protein tyrosine phosphatase, receptor type D" P23468 9 8314246-10612723 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 37.5" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 110.1;Intestinal endocrine cells: 34.0;Muller glia cells: 44.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 23.5;HAP1: 5.1;HSkMC: 8.0;NTERA-2: 5.7;RH-30: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054829 Uncertain Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 2500000 Vesicles Nucleoplasm "HPA054829: AB_2682618" "unprognostic (4.74e-1)" "unprognostic (4.79e-2)" "unprognostic (1.44e-2)" "unprognostic (7.86e-2)" "unprognostic (2.34e-1)" "unprognostic (9.90e-2)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (1.91e-2)" "unprognostic (2.13e-2)" "unprognostic (7.52e-3)" "unprognostic (2.62e-1)" "prognostic favorable (7.45e-6)" "unprognostic (3.56e-4)" "unprognostic (7.59e-2)" "unprognostic (4.84e-2)" "unprognostic (3.08e-3)" 2.6 1.7 19.7 1.5 19.2 1.1 1.1 27.9 32.1 5.6 5.4 21.7 0.2 4.0 3.6 1.8 1.5 3.6 2.6 3.0 18.0 13.5 11.4 4.2 3.4 0.9 17.9 22.3 12.7 1.7 37.5 4.4 9.4 15.1 3.3 5.3 1.9 1.1 2.0 1.0 1.2 4.6 2.8 29.7 1.4 1.7 2.5 18.5 0.0 3.2 0.0 1.0 2.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 23.5 0.0 0.3 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 2.6 4.8 0.6 0.0 0.0 0.0 0.2 8.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 5.7 0.0 1.5 2.9 8.7 0.0 2.1 0.0 4.0 0.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.7 19.2 27.9 32.1 18.0 13.5 17.9 22.3 15.1 18.5 0.0 2.7 0.0 0.2 0.5 110.1 4.6 25.5 0.0 2.3 5.2 15.7 0.3 0.0 2.5 13.0 0.4 10.1 0.0 0.0 0.1 7.6 1.7 0.0 12.8 1.0 4.8 34.0 1.3 0.6 3.7 14.7 0.0 0.0 0.0 14.3 44.7 0.3 3.5 0.0 22.3 7.4 0.0 3.7 1.1 1.1 0.6 0.2 0.0 5.2 0.0 PTPRE PTPE ENSG00000132334 "Protein tyrosine phosphatase, receptor type E" P23469 10 127907061-128085855 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 91.0" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 141.1;Macrophages: 249.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 91.0;plasmacytoid DC: 65.7" "Group enriched" "Detected in all" 11 "dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015870, HPA021872" Supported Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA015870: AB_1855759, HPA021872: AB_1855760" "unprognostic (5.23e-2)" "unprognostic (1.37e-1)" "unprognostic (1.99e-1)" "unprognostic (7.11e-2)" "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (6.50e-2)" "unprognostic (4.49e-2)" "unprognostic (2.11e-1)" "unprognostic (2.56e-2)" "unprognostic (8.71e-3)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (1.52e-1)" "unprognostic (6.71e-3)" "unprognostic (2.49e-2)" "unprognostic (5.59e-2)" 16.8 18.5 12.5 24.0 12.5 39.5 11.0 7.4 15.3 4.8 9.2 14.5 1.6 9.6 5.1 8.1 8.8 6.2 10.7 12.3 15.0 12.2 4.4 4.8 22.5 20.0 12.5 6.5 4.3 3.1 3.4 6.5 8.0 9.8 4.5 9.8 4.8 7.0 3.1 1.9 4.9 12.7 7.7 14.3 26.4 7.7 4.3 10.9 11.4 6.6 6.1 12.2 10.0 5.0 1.2 65.7 91.0 25.5 4.0 5.4 4.9 1.9 0.4 0.2 0.0 1.2 0.2 3.6 0.0 0.0 0.8 1.7 0.8 12.0 1.5 1.3 1.0 2.6 1.1 1.0 5.7 0.3 1.8 0.9 0.1 0.7 0.0 2.0 7.4 5.6 0.4 3.3 2.9 5.9 18.8 19.8 4.9 0.0 0.9 1.2 1.8 2.2 14.9 0.1 2.1 0.7 8.8 1.2 2.9 3.3 8.5 0.0 1.2 3.4 0.6 0.1 0.9 0.3 9.4 37.4 0.8 0.8 3.7 4.1 0.4 0.6 2.1 5.5 5.8 0.0 17.4 25.5 19.3 5.4 9.0 3.2 0.9 2.4 3.6 13.3 1.2 1.7 2.9 91.0 4.0 6.8 65.7 3.5 4.9 12.5 12.5 7.4 12.7 15.0 12.2 12.5 6.5 9.8 10.9 77.4 67.6 24.7 47.2 52.9 2.6 15.1 5.1 9.4 33.0 3.5 0.0 33.6 0.0 4.3 1.6 49.4 12.3 0.0 4.0 40.5 9.9 8.3 30.1 1.3 53.6 0.0 6.4 46.1 141.1 1.7 0.6 249.1 23.6 4.6 14.4 0.0 28.7 11.5 0.4 1.9 0.8 0.0 8.1 0.5 1.4 56.6 14.2 52.4 10.2 34.4 PTPRH SAP-1 ENSG00000080031 "Protein tyrosine phosphatase, receptor type H" Q9HD43 19 55181248-55209506 "Enzymes, Predicted membrane proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 106.7;Paneth cells: 38.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.5" "Lineage enhanced" "Detected in single" "monocytes: 1.5" "Cell line enhanced" "Detected in many" "HHSteC: 9.1;K-562: 10.6;OE19: 22.4;SK-MEL-30: 15.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA042300 Approved Mitochondria NA NA Mitochondria "HPA042300: AB_10796900" "unprognostic (1.87e-1)" "unprognostic (1.10e-1)" "unprognostic (2.59e-1)" "unprognostic (7.57e-3)" "unprognostic (5.01e-3)" "unprognostic (8.14e-2)" "unprognostic (1.15e-1)" "unprognostic (1.96e-3)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (6.16e-2)" "unprognostic (1.47e-11)" "unprognostic (4.08e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-2)" "unprognostic (1.57e-1)" 0.5 8.9 0.5 5.2 0.7 0.0 0.5 0.5 1.0 0.7 39.9 0.6 0.5 30.1 0.5 0.5 0.6 0.0 29.6 0.5 1.3 1.6 0.6 7.8 0.6 0.5 3.0 0.5 0.6 2.8 0.0 3.0 0.6 0.5 1.0 9.6 0.6 0.5 0.5 0.5 0.0 84.3 0.7 6.9 21.2 10.2 0.5 0.5 0.5 0.5 1.0 0.8 1.1 2.4 0.0 0.7 0.0 1.5 0.0 0.0 0.0 4.9 3.0 0.0 1.2 1.0 2.7 0.0 0.1 2.7 0.5 1.1 1.3 7.0 0.0 0.2 0.5 6.2 0.0 0.0 0.0 0.6 0.0 0.1 0.4 0.1 3.5 9.1 0.0 3.6 0.7 2.2 1.7 2.7 0.3 0.1 0.0 10.6 0.5 0.0 0.0 0.0 0.2 0.0 22.4 7.2 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 3.1 15.9 0.0 0.0 1.4 0.0 0.7 1.1 0.3 0.0 0.0 2.6 0.0 0.8 0.1 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.7 0.5 0.5 1.3 1.6 3.0 0.5 0.5 0.5 0.0 0.0 0.0 2.4 1.5 0.0 0.6 20.4 0.0 0.0 1.8 0.0 0.0 0.0 11.7 0.0 0.2 106.7 0.0 22.9 0.0 0.2 3.1 0.0 5.1 0.2 15.9 4.6 1.3 0.0 0.0 0.0 0.8 0.0 1.0 14.0 0.2 20.1 38.6 0.0 0.0 0.3 0.0 0.4 0.0 0.2 1.0 0.1 0.0 15.6 17.9 PTPRN "IA-2, ICA512" ENSG00000054356 "Protein tyrosine phosphatase, receptor type N" Q16849 2 219289623-219309648 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Receptor "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.6;pancreas: 28.9;pituitary gland: 43.4" "Group enriched" "Detected in some" 13 "Bipolar cells: 48.9;Cone photoreceptor cells: 56.9;Horizontal cells: 92.2;Intestinal endocrine cells: 45.2;Rod photoreceptor cells: 31.1" "Group enriched" "Detected in some" 12 "glioma: 5.3;pancreatic cancer: 18.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "U-2 OS: 20.3;U-87 MG: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007152, HPA007179" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA007152: AB_2667759, HPA007179: AB_1079714" "unprognostic (1.43e-1)" "unprognostic (1.33e-4)" "unprognostic (2.91e-3)" "unprognostic (5.83e-3)" "prognostic unfavorable (1.45e-7)" "unprognostic (3.64e-2)" "unprognostic (1.24e-4)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (6.20e-4)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-10)" "unprognostic (1.43e-2)" "unprognostic (2.49e-1)" "unprognostic (1.10e-2)" "unprognostic (8.61e-2)" 1.7 22.3 19.3 4.7 35.7 1.7 1.3 17.3 89.6 1.2 2.4 2.5 0.0 2.5 1.5 1.2 1.5 1.3 1.5 1.4 21.6 40.1 1.5 1.2 1.4 1.3 14.4 19.8 1.3 28.9 1.2 43.4 1.4 22.0 1.4 1.9 3.1 1.2 1.3 1.2 2.0 2.5 2.4 3.5 1.3 6.0 1.4 2.1 0.0 1.5 0.0 1.2 2.7 0.0 0.1 0.3 0.2 0.0 0.0 0.6 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.3 2.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.1 2.5 0.0 6.2 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 3.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.2 75.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.6 3.7 19.3 35.7 17.3 54.0 21.6 40.1 14.4 19.8 22.0 2.1 0.0 0.0 0.0 0.1 0.1 48.9 1.7 0.0 0.0 0.0 0.0 56.9 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 92.2 45.2 0.0 0.0 0.2 0.3 0.0 1.7 0.0 0.0 4.1 4.3 0.0 0.0 0.0 31.1 0.0 0.3 2.2 2.3 0.1 0.0 0.0 0.0 0.0 PTPRN2 "IA-2beta, ICAAR, KIAA0387, phogrin" ENSG00000155093 "Protein tyrosine phosphatase, receptor type N2" Q92932 7 157539056-158587788 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Protein phosphatase, Receptor" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;pancreas: 51.3" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 84.3;Intestinal endocrine cells: 126.1" "Cancer enhanced" "Detected in all" "prostate cancer: 40.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 14.8" "Cell line enhanced" "Detected in some" "AF22: 15.6;HDLM-2: 22.0;NB-4: 22.6;SCLC-21H: 12.5;SH-SY5Y: 12.7;THP-1: 11.1;U-87 MG: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006900, HPA007255, HPA026656" Enhanced Approved Vesicles NA NA Vesicles "HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912" "unprognostic (2.42e-1)" "unprognostic (4.17e-2)" "unprognostic (7.82e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (9.37e-5)" "unprognostic (7.12e-3)" "unprognostic (1.04e-1)" "unprognostic (4.55e-2)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.60e-2)" "unprognostic (1.48e-1)" "unprognostic (1.43e-3)" "unprognostic (6.16e-2)" 2.1 10.5 20.1 1.7 33.9 1.0 1.1 6.2 40.6 1.7 4.6 2.9 0.0 5.1 2.0 2.9 1.5 6.9 4.7 1.9 18.2 21.3 2.0 1.2 3.1 2.1 11.3 22.3 5.8 51.3 0.5 20.0 1.5 10.3 10.2 3.7 1.5 3.4 2.6 0.8 0.7 4.2 1.6 5.3 7.7 24.2 2.2 5.2 0.0 5.6 0.3 1.7 2.8 0.6 3.4 1.3 14.8 1.1 1.5 3.5 1.1 0.0 0.2 15.6 1.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.6 0.2 3.7 0.0 0.4 0.0 0.0 22.0 0.2 0.0 0.0 2.5 0.6 0.0 0.0 1.1 0.2 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.2 6.5 22.6 3.1 5.5 0.8 0.0 0.7 0.1 0.0 0.0 12.5 12.7 0.0 0.0 0.0 0.0 0.0 11.1 3.3 5.1 1.9 0.0 0.4 0.1 0.0 0.0 15.4 9.2 3.7 8.7 1.1 1.6 0.9 0.1 0.3 2.3 1.5 1.1 1.3 3.4 1.4 0.9 14.8 1.5 0.0 0.2 3.5 1.1 20.1 33.9 6.2 40.6 18.2 21.3 11.3 22.3 10.3 5.2 3.0 11.7 10.4 12.5 2.1 31.6 2.2 7.6 84.3 13.6 38.4 9.8 0.4 29.9 15.8 35.1 23.3 4.5 0.0 11.7 0.4 3.9 21.1 18.5 0.8 34.3 11.1 126.1 41.1 11.0 13.1 11.5 6.0 11.8 3.6 39.6 40.1 6.1 5.8 18.4 3.5 6.3 25.8 5.1 41.6 11.7 1.3 0.6 10.0 7.2 22.5 PTPRO "GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2" ENSG00000151490 "Protein tyrosine phosphatase, receptor type O" Q16827 12 15322397-15597399 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1;intestine: 28.5;kidney: 21.6" "Cell type enhanced" "Detected in some" 7 "Bipolar cells: 16.3;Collecting duct cells: 15.7;Hofbauer cells: 22.6;Horizontal cells: 23.8;Kupffer cells: 17.2;monocytes: 19.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 8.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "GAMG: 13.0;NTERA-2: 8.2;SCLC-21H: 5.0;SH-SY5Y: 9.9;THP-1: 4.1" "Region enhanced" "Detected in many" "olfactory region: 215.3" "Low region specificity" "Detected in all" HPA034525 Enhanced "Intracellular and membrane" NA NA "HPA034525: AB_10669785" "unprognostic (3.68e-2)" "unprognostic (3.49e-1)" "unprognostic (9.64e-2)" "unprognostic (1.25e-2)" "unprognostic (7.87e-2)" "unprognostic (2.08e-1)" "unprognostic (5.93e-3)" "unprognostic (5.37e-2)" "unprognostic (2.03e-1)" "unprognostic (3.72e-2)" "unprognostic (2.00e-1)" "unprognostic (5.43e-2)" "unprognostic (4.89e-2)" "unprognostic (2.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" 3.3 1.2 16.2 3.1 26.1 0.6 1.1 1.0 15.3 1.7 10.4 1.5 0.0 2.0 4.5 2.1 0.8 1.2 1.6 0.7 11.3 10.6 21.6 1.6 6.7 3.2 4.8 8.8 0.7 0.6 0.6 3.8 4.4 4.0 0.7 28.5 1.1 0.8 1.1 0.5 0.7 1.9 7.1 2.6 3.6 1.0 0.9 3.5 0.0 0.5 0.0 3.5 1.7 0.5 8.3 9.5 0.0 10.5 0.1 2.9 2.7 0.0 0.1 0.5 0.3 0.5 0.1 0.2 0.0 0.0 0.8 2.0 0.0 0.0 0.3 0.1 0.0 13.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.3 0.1 0.2 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 8.2 1.7 0.0 0.0 0.0 0.0 0.1 0.2 5.0 9.9 1.2 0.0 0.1 0.1 0.1 4.1 0.0 0.1 0.3 0.0 0.3 1.2 0.0 0.4 0.1 0.3 1.5 0.0 5.2 0.0 0.0 10.5 0.0 8.3 1.7 0.4 7.4 7.0 2.9 1.3 0.0 0.1 10.5 9.5 1.3 2.7 16.2 26.1 1.0 15.3 11.3 10.6 4.8 8.8 4.0 3.5 0.0 0.3 4.5 0.8 0.2 16.3 0.6 0.0 0.0 3.4 15.7 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 22.6 23.8 3.5 1.8 17.2 0.0 0.6 9.2 0.0 19.0 2.6 0.3 0.1 3.5 0.4 0.0 4.6 0.0 0.4 0.3 1.0 0.4 0.2 0.0 11.2 0.7 PTPRQ DFNB84 ENSG00000139304 "Protein tyrosine phosphatase, receptor type Q" 12 80402178-80680271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6;urinary bladder: 19.2" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 14.9;Club cells: 7.9;Early spermatids: 7.0;Late spermatids: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 24 "basal ganglia: 12.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.4;BJ: 6.2;HBF TERT88: 4.4;RH-30: 4.9;RT4: 5.4;SiHa: 3.1;U-2197: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA053245 Uncertain Approved Cytosol No NA Cytosol "HPA053245: AB_2682087" "unprognostic (9.10e-2)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "unprognostic (3.30e-2)" "unprognostic (1.37e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (4.47e-11)" "unprognostic (8.51e-3)" "unprognostic (1.47e-1)" "unprognostic (1.73e-2)" "unprognostic (2.66e-2)" 4.6 0.2 0.3 1.0 12.6 0.0 5.2 0.2 0.3 1.7 1.3 0.0 1.6 0.0 0.5 4.7 1.6 4.1 0.5 1.3 0.4 0.5 6.5 0.2 5.4 2.1 0.2 0.0 0.9 0.6 0.0 1.1 6.4 0.0 6.5 0.0 0.0 0.4 0.5 0.5 0.3 0.2 4.0 0.2 0.2 0.2 5.8 0.0 0.0 3.9 0.0 0.6 19.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 6.2 1.3 1.9 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.9 0.0 0.8 0.2 0.5 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 5.4 0.0 0.0 3.1 0.1 0.0 0.3 0.3 0.0 0.0 0.5 0.1 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 12.6 0.2 0.3 0.4 0.5 0.2 0.0 0.0 0.0 14.9 0.6 0.0 1.5 0.0 0.0 1.7 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 PTPRR "EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ" ENSG00000153233 "Protein tyrosine phosphatase, receptor type R" Q15256 12 70638073-70920843 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 56.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 14.3;RT4: 27.4" "Region enriched" "Detected in all" 5 "cerebellum: 100.5" "Low region specificity" "Detected in all" "CAB011461, HPA011851, HPA071067" Uncertain Supported "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340" "unprognostic (4.98e-2)" "unprognostic (1.91e-2)" "unprognostic (1.55e-1)" "unprognostic (2.04e-1)" "unprognostic (3.63e-3)" "unprognostic (3.48e-5)" "unprognostic (5.44e-3)" "unprognostic (1.77e-3)" "unprognostic (1.13e-1)" "unprognostic (9.01e-2)" "unprognostic (1.37e-3)" "unprognostic (8.06e-2)" "unprognostic (1.10e-2)" "unprognostic (1.92e-2)" "unprognostic (4.78e-2)" "unprognostic (2.72e-1)" "prognostic favorable (1.40e-5)" 0.4 3.8 18.8 1.6 11.3 0.3 0.4 56.1 20.9 0.5 11.2 0.1 0.0 5.1 8.4 0.3 0.4 0.5 1.9 0.4 8.6 4.9 0.4 0.4 0.4 0.4 1.3 13.2 0.4 0.6 0.3 0.9 0.7 3.3 0.5 7.8 0.8 0.4 2.1 0.4 0.4 11.3 4.9 3.1 0.4 4.4 0.4 1.4 0.0 0.4 0.0 0.3 4.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 27.4 0.1 4.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.8 11.3 56.1 20.9 8.6 4.9 1.3 13.2 3.3 1.4 0.0 0.0 0.0 0.1 0.5 11.2 2.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.1 1.7 1.5 7.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 1.9 11.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.4 0.3 PTPRT "KIAA0283, RPTPrho" ENSG00000196090 "Protein tyrosine phosphatase, receptor type T" O14522 20 42072752-43189970 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 23.5;fallopian tube: 17.0" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 40.8;Ciliated cells: 33.5;Early spermatids: 10.0;Late spermatids: 9.9" "Cancer enhanced" "Detected in many" "breast cancer: 5.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.6;RPMI-8226: 1.2;SCLC-21H: 2.9;U-266/70: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017336, CAB069423" Approved NA NA "CAB069423: AB_1622602, HPA017336: AB_1855943" "unprognostic (7.17e-3)" "unprognostic (1.02e-1)" "unprognostic (5.61e-3)" "unprognostic (1.08e-2)" "unprognostic (5.95e-2)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (6.93e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-6)" "unprognostic (3.16e-1)" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (3.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" 0.6 0.8 5.0 0.6 11.1 0.5 4.6 1.6 23.5 1.6 0.7 0.9 0.0 1.2 0.5 1.8 0.5 17.0 0.7 0.8 4.7 6.5 0.6 0.9 2.1 1.0 2.2 12.6 0.5 0.9 0.5 4.1 4.6 5.1 0.8 0.6 0.5 2.0 4.6 0.5 0.8 1.0 0.5 1.4 0.7 1.8 2.8 0.9 4.9 0.5 0.0 1.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 11.1 1.6 22.6 4.7 6.5 2.2 12.6 5.1 0.9 0.0 0.6 0.0 0.0 0.8 40.8 1.1 0.0 33.5 1.2 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 4.8 0.0 7.4 0.3 9.9 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 PTPRZ1 "phosphacan, PTP18, PTPRZ, PTPZ, RPTPB" ENSG00000106278 "Protein tyrosine phosphatase, receptor type Z1" P23471 7 121873089-122062036 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 118.1" "Cell type enhanced" "Detected in some" 17 "Club cells: 27.3;Horizontal cells: 62.0;Muller glia cells: 107.0" "Cancer enriched" "Detected in many" 14 "glioma: 175.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "AF22: 94.3;NTERA-2: 26.3;WM-115: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015103 Enhanced Approved Vesicles,Cytosol "Secreted in brain" NA NA 950000 Cytosol Vesicles "HPA015103: AB_1855946" "unprognostic (8.49e-4)" "unprognostic (3.96e-3)" "unprognostic (4.11e-2)" "unprognostic (1.37e-1)" "unprognostic (9.18e-2)" "unprognostic (2.41e-2)" "unprognostic (8.30e-3)" "unprognostic (3.78e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (9.17e-4)" "unprognostic (1.83e-1)" "unprognostic (8.72e-6)" "unprognostic (2.00e-1)" "unprognostic (2.16e-1)" "unprognostic (8.77e-2)" "prognostic unfavorable (9.36e-4)" 2.0 2.5 33.1 2.3 44.1 1.5 4.0 15.4 118.1 2.4 2.2 19.3 0.0 1.9 1.6 2.0 7.0 1.7 1.9 2.0 39.6 15.9 1.6 1.6 2.1 1.5 18.6 17.8 2.0 3.3 1.5 1.6 1.6 67.6 2.1 2.3 0.8 2.4 2.0 1.5 19.3 1.9 2.4 76.6 2.1 9.8 1.7 23.6 0.0 1.5 1.8 3.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.1 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 44.1 15.4 39.6 39.6 15.9 18.6 17.8 67.6 23.6 0.0 1.0 0.0 5.6 22.3 14.1 0.8 0.0 17.4 27.3 0.0 3.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.1 1.1 1.1 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.4 0.3 0.0 18.6 0.0 0.0 107.0 0.6 0.0 0.0 0.0 6.2 0.0 0.4 0.0 0.2 18.7 0.2 0.0 0.0 7.4 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "Pituitary tumor-transforming 1" O95997 5 160421822-160428744 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.5;testis: 100.1" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 470.4;Erythroid cells: 654.1;Spermatocytes: 278.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 54.5" "Lineage enriched" "Detected in all" 7 "T-cells: 54.5" "Low cell line specificity" "Detected in all" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol NA Yes Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 1.5 1.7 2.1 16.2 5.5 34.1 2.9 1.4 4.6 3.8 8.2 1.0 0.7 5.8 1.3 2.6 24.1 1.0 1.9 2.3 5.1 2.7 1.7 1.4 3.8 19.2 1.5 2.2 1.1 1.2 0.2 2.0 5.0 2.2 1.6 11.3 1.5 4.5 1.1 1.2 8.7 5.8 4.5 1.4 7.5 3.4 100.1 1.0 29.8 23.9 23.2 35.1 3.3 7.2 8.1 6.1 2.4 2.1 3.3 54.5 4.7 45.7 23.8 53.8 38.5 9.1 9.0 16.8 24.3 55.7 64.6 70.8 46.0 40.3 50.0 21.7 27.6 74.3 24.0 33.4 67.6 92.7 57.1 30.3 26.4 32.2 27.7 1.8 23.9 23.2 4.2 11.3 43.8 26.6 19.8 45.5 33.5 21.1 39.0 66.3 21.5 28.6 58.8 27.1 37.7 34.6 26.7 63.3 42.9 32.9 9.3 33.5 21.3 35.1 21.4 72.2 45.5 43.7 26.2 19.4 29.2 39.1 22.8 70.9 33.6 29.9 57.2 31.5 41.4 51.7 1.9 0.7 2.4 7.0 2.1 2.5 8.1 14.4 16.2 6.1 5.5 3.6 8.9 0.8 3.3 1.4 5.8 54.5 4.7 2.1 5.5 1.4 4.6 5.1 2.7 1.5 2.2 2.2 1.0 6.0 15.5 20.5 54.1 220.3 1.3 4.9 7.6 1.4 11.4 5.2 0.0 50.4 3.3 4.0 470.4 10.3 6.3 654.1 4.5 163.8 37.7 15.3 38.0 2.9 72.7 0.0 5.8 17.8 20.0 39.3 10.3 35.9 82.7 39.7 15.4 2.7 3.5 9.1 7.4 1.2 0.7 6.5 35.3 278.1 72.8 136.5 26.7 44.5 34.5 30.7 PTTG2 ENSG00000250254 "Pituitary tumor-transforming 2" Q9NZH5 4 37960435-37961125 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.8" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 4.1;Early spermatids: 3.1;Spermatocytes: 1.9;Suprabasal keratinocytes: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.4;T-reg: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 1.5;MOLT-4: 3.1;U-698: 2.1" "HPA008890, HPA045034" Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (3.29e-1)" "unprognostic (4.41e-4)" "unprognostic (1.11e-1)" "unprognostic (2.07e-2)" "unprognostic (1.74e-2)" "unprognostic (9.58e-2)" "unprognostic (2.27e-1)" "unprognostic (2.74e-1)" "unprognostic (7.07e-2)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (3.32e-1)" "unprognostic (8.60e-5)" 1.0 0.4 0.9 5.2 1.2 5.0 0.5 2.2 2.4 1.1 3.9 0.2 0.0 0.0 1.6 2.2 3.3 1.8 1.5 2.5 1.0 0.4 0.7 0.5 0.9 1.0 0.7 0.4 1.2 1.0 1.4 0.4 1.8 0.3 0.8 0.7 0.0 0.2 1.4 1.9 0.6 3.1 2.0 0.9 2.3 1.0 5.3 0.0 15.8 1.3 7.5 7.3 1.8 0.7 0.4 0.0 1.4 0.4 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.5 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 3.1 0.5 0.0 0.0 0.0 0.7 0.5 0.9 0.0 0.5 0.3 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 1.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.4 0.0 1.4 0.0 0.0 0.0 1.0 0.1 0.9 1.2 2.2 2.4 1.0 0.4 0.7 0.4 0.3 0.0 0.0 0.0 1.4 0.5 4.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.7 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.2 2.5 0.0 0.0 0.0 0.3 PTX3 "TNFAIP5, TSG-14" ENSG00000163661 "Pentraxin 3" P26022 3 157436789-157443628 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0" "Cell type enhanced" "Detected in some" 10 "Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5" "Cancer enhanced" "Detected in many" "glioma: 22.5" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.1;pons and medulla: 3.6" "Cell type enhanced" "Detected in some" "eosinophil: 3.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA069320 Approved Approved "Plasma membrane" "Secreted to blood" NA NA 1090000 310000 "Plasma membrane" "HPA069320: AB_2686118" "unprognostic (1.93e-2)" "unprognostic (4.96e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (8.35e-9)" "unprognostic (5.79e-3)" "prognostic unfavorable (6.36e-4)" "unprognostic (6.03e-3)" "prognostic unfavorable (8.75e-6)" "unprognostic (2.45e-1)" "unprognostic (6.69e-2)" "unprognostic (7.60e-2)" "unprognostic (2.63e-1)" "unprognostic (2.76e-9)" "unprognostic (6.03e-3)" "unprognostic (5.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.92e-3)" 61.7 3.4 0.3 16.7 0.2 31.6 35.3 0.2 0.7 0.8 13.2 0.3 0.6 0.5 0.5 0.8 2.0 6.5 3.5 14.7 1.1 0.0 3.0 0.6 22.5 7.0 0.3 0.1 6.8 18.0 0.3 1.0 4.9 3.6 2.5 1.2 5.2 1.8 0.4 67.7 6.0 1.9 6.4 0.9 9.6 4.9 0.9 0.2 0.3 2.7 0.4 0.4 77.0 2.5 0.0 1.3 3.2 1.2 0.0 0.0 0.1 0.0 0.0 52.1 0.0 86.4 125.2 0.0 9.0 82.2 3.9 4.2 0.0 0.5 0.0 32.1 10.6 6.1 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 160.8 0.1 0.0 167.5 0.0 88.5 30.1 7.7 18.2 0.0 0.0 0.0 26.0 0.0 0.0 0.1 0.7 0.0 0.3 0.0 0.0 0.0 0.3 3.5 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 119.2 17.7 0.8 111.1 1.5 0.0 0.0 0.0 3.7 0.4 5.0 0.0 1.2 3.2 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.2 0.2 1.1 0.0 0.3 0.1 3.6 0.2 0.0 1.7 0.0 1.1 1.4 0.8 0.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 6.0 1.9 2.0 0.0 0.0 0.0 0.0 10.1 0.4 0.0 0.0 2.6 0.0 0.0 3.1 4.6 0.8 0.3 5.9 13.5 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.4 0.0 4.2 0.0 0.4 0.9 0.2 0.0 0.0 0.1 PTX4 C16orf38 ENSG00000251692 "Pentraxin 4" Q96A99 16 1485886-1488981 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;bone marrow: 4.0;testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 21 "intermediate monocyte: 1.1;non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 31 "monocytes: 3.0" "Group enriched" "Detected in some" 6 "HL-60: 19.5;NB-4: 14.5" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Low region specificity" "Detected in all" HPA073694 Supported "Secreted - unknown location" NA NA "HPA073694: AB_2732237" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.54e-2)" "unprognostic (1.55e-2)" "unprognostic (1.12e-1)" "unprognostic (1.84e-4)" "unprognostic (3.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.10e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-2)" "unprognostic (3.54e-1)" "unprognostic (1.52e-4)" "unprognostic (2.23e-3)" "unprognostic (4.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.03e-1)" 0.2 1.0 0.6 0.2 0.8 4.0 0.2 0.8 0.5 0.4 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.4 0.3 0.2 0.8 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.4 0.0 0.4 0.4 0.2 0.9 0.1 3.9 0.2 1.5 0.2 0.2 0.2 0.4 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.5 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 14.5 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.6 0.8 0.8 0.3 0.8 1.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Group enriched" "Detected in some" 7 "Bipolar cells: 11.8;Early spermatids: 11.1;Horizontal cells: 19.1;Late spermatids: 16.8;Muller glia cells: 11.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.7;JURKAT: 6.1;NTERA-2: 6.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: AB_2680145" "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 3.0 0.0 2.9 0.0 1.0 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 1.0 4.3 6.1 0.4 0.5 0.2 0.0 0.9 0.0 6.8 0.0 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.2 0.0 0.0 0.0 3.3 0.0 0.0 2.6 2.9 3.7 0.0 0.4 0.3 0.0 0.2 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 0.0 0.0 0.0 0.0 0.0 11.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 11.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 11.3 0.0 0.0 1.4 0.0 1.8 0.0 0.3 1.7 1.1 0.0 0.0 0.0 0.0 0.0 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Group enriched" "Detected in some" 10 "Distal tubular cells: 543.8;Horizontal cells: 1442.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 134.1" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in all" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" No NA Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: AB_2680433" "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 134.1 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 0.0 0.0 0.0 0.0 0.0 39.1 0.2 0.0 0.0 0.0 36.6 9.8 0.2 543.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.5 0.0 40.7 1442.9 0.0 40.5 3.7 0.0 0.6 0.9 0.0 0.0 0.0 41.2 0.0 0.0 0.0 0.8 104.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 PVALEF AATK-AS1 ENSG00000225180 "Parvalbumin like EF-hand containing" 17 81165507-81183164 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "adipose tissue: 1.2;brain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.3;REH: 1.0" NA NA "unprognostic (1.35e-2)" "unprognostic (2.55e-1)" "unprognostic (4.40e-1)" "unprognostic (2.30e-1)" "unprognostic (3.26e-1)" "unprognostic (1.09e-1)" 1.2 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PVR "CD155, HVED, Necl-5, NECL5, PVS, Tage4" ENSG00000073008 "Poliovirus receptor" P15151 19 44643798-44663583 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 65.6" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1" "Group enriched" "Detected in many" 5 "dendritic cells: 5.6;monocytes: 8.1" "Cell line enhanced" "Detected in many" "TIME: 53.4" "HPA012568, HPA064739" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" "Secreted - unknown location" NA NA 940000000 "Nucleoplasm, Vesicles, Plasma membrane" "HPA012568: AB_1846248, HPA064739: " "unprognostic (2.90e-3)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.36e-1)" "unprognostic (2.34e-1)" "unprognostic (7.89e-2)" "unprognostic (2.45e-3)" "unprognostic (3.06e-2)" "prognostic unfavorable (9.30e-4)" "unprognostic (9.05e-3)" "unprognostic (1.69e-1)" "unprognostic (2.09e-3)" "unprognostic (2.64e-3)" "unprognostic (1.69e-1)" "unprognostic (4.97e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-3)" "prognostic unfavorable (2.75e-4)" 10.0 13.9 7.4 7.5 8.1 4.7 9.2 11.0 11.0 6.5 10.6 6.5 4.1 13.7 11.3 5.7 6.6 8.8 9.2 23.5 5.8 10.0 10.6 65.6 14.8 2.4 6.0 6.5 10.4 15.9 9.9 20.7 15.5 9.7 10.4 7.7 6.6 8.5 6.9 19.8 5.5 13.0 11.1 7.0 4.8 12.3 6.0 7.2 2.3 8.5 10.8 3.7 8.3 6.7 0.0 5.6 1.2 8.1 0.6 0.4 2.2 21.8 15.3 1.5 6.1 1.9 2.3 2.6 36.9 10.3 12.1 13.9 8.9 9.3 0.0 21.2 10.7 21.2 14.4 5.2 14.0 8.1 2.6 10.1 3.9 9.6 6.0 12.9 1.5 8.4 2.9 6.9 10.7 21.0 12.1 13.1 2.3 1.8 0.0 5.6 1.9 1.3 1.3 3.4 7.4 11.3 0.0 7.0 2.0 26.0 6.7 6.6 7.7 23.4 14.7 5.2 1.7 8.3 3.7 53.4 14.7 18.1 10.8 28.8 0.0 2.1 0.0 11.7 7.5 8.3 0.0 6.4 0.0 0.2 6.6 0.0 0.0 0.0 0.4 5.6 0.0 0.2 0.1 1.2 0.6 8.1 0.5 0.0 2.2 7.4 8.1 11.0 11.0 5.8 10.0 6.0 6.5 9.7 7.2 14.9 28.0 4.5 12.8 3.2 6.9 11.2 20.4 2.7 18.2 1.8 2.0 2.4 3.3 43.0 8.5 13.5 11.9 0.0 30.3 30.1 5.4 11.3 1.1 36.5 7.4 1.6 12.6 7.4 9.2 10.2 5.2 7.8 1.7 25.2 9.7 1.3 48.8 14.4 14.9 2.8 3.3 0.0 17.8 3.4 1.5 4.8 0.8 0.0 10.6 6.5 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 51.7;lymphoid tissue: 21.0" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 1.1;granulocytes: 2.3;Horizontal cells: 3.2;T-cells: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 32 "gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8" "Group enriched" "Detected in many" 37 "B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7" "Group enriched" "Detected in some" 26 "Daudi: 36.9;JURKAT: 21.8;MOLT-4: 40.2;U-698: 11.9" "Low region specificity" "Detected in all" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" NA NA "Nucleoli, Endoplasmic reticulum" "HPA047497: AB_2680069" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.5 0.1 0.4 5.6 0.7 1.2 0.4 0.4 1.1 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.5 0.9 0.9 15.9 0.4 0.4 0.6 0.5 0.0 0.4 0.4 0.8 0.4 0.0 0.4 0.7 0.4 2.0 0.0 8.9 0.4 0.4 21.0 1.4 0.6 0.4 18.0 0.5 0.4 4.2 1.0 0.4 24.8 0.2 1.0 0.1 42.9 51.7 17.5 0.1 0.8 0.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 21.8 0.0 0.1 0.0 0.1 40.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.1 0.1 0.0 43.5 0.1 51.7 24.8 28.9 42.9 0.1 19.3 32.6 32.2 1.0 42.9 0.1 0.2 22.8 17.5 0.4 0.7 0.4 0.4 0.4 0.0 0.4 0.4 0.8 0.4 0.0 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 PWWP2A KIAA1935 ENSG00000170234 "PWWP domain containing 2A" Q96N64 5 160061801-160119423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.7" "Cell type enhanced" "Detected in all" 5 "Bipolar cells: 94.1;Horizontal cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046733, HPA058233" Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA046733: AB_2679777, HPA058233: AB_2683647" "unprognostic (1.03e-1)" "unprognostic (2.67e-1)" "unprognostic (5.13e-2)" "unprognostic (1.85e-1)" "unprognostic (1.18e-2)" "unprognostic (7.86e-3)" "unprognostic (1.40e-3)" "unprognostic (6.24e-2)" "unprognostic (2.42e-2)" "unprognostic (7.08e-2)" "unprognostic (7.25e-2)" "unprognostic (8.24e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.23e-1)" "unprognostic (3.88e-2)" "unprognostic (1.08e-1)" "prognostic favorable (3.51e-4)" 8.4 9.3 9.5 12.7 22.3 11.9 9.1 52.7 16.0 14.4 13.6 19.9 5.3 9.6 10.8 7.2 8.7 9.5 8.1 7.4 15.9 8.8 10.3 8.6 9.8 12.0 25.2 8.9 10.5 10.5 10.6 15.1 11.2 17.0 11.9 14.7 10.3 8.8 8.4 7.0 14.7 10.6 9.3 13.8 12.5 11.8 6.3 21.3 18.6 9.8 5.8 11.4 10.7 10.1 6.0 2.9 6.0 4.4 1.1 4.9 0.9 10.7 5.2 13.5 11.5 15.1 11.8 19.1 8.6 7.0 7.7 7.9 16.8 21.0 17.4 13.2 6.6 12.6 7.8 11.7 13.5 12.7 18.0 13.0 12.5 9.6 8.6 11.5 12.5 9.5 8.4 6.7 15.5 11.8 17.3 12.3 9.9 9.5 11.3 13.0 9.0 10.7 12.2 15.9 9.2 6.7 16.9 12.0 11.1 9.4 7.7 15.9 11.1 14.5 14.7 15.6 11.5 11.3 13.9 16.4 13.5 9.3 10.0 16.7 13.0 11.6 15.5 8.8 12.7 13.2 6.0 4.4 2.4 2.8 2.0 2.2 6.0 3.0 3.3 2.9 3.7 4.9 2.7 5.0 1.1 2.6 2.7 2.5 0.9 9.5 22.3 52.7 16.0 15.9 8.8 25.2 8.9 17.0 21.3 8.9 14.8 18.5 12.5 28.3 94.1 10.6 10.2 14.7 17.0 19.2 68.7 11.2 14.9 11.6 1.5 15.3 18.4 23.3 9.6 10.5 16.2 15.6 23.1 7.6 7.8 89.0 31.6 12.9 11.0 2.1 51.8 14.6 10.1 12.6 19.4 22.7 13.1 14.4 36.0 5.8 50.6 25.8 22.6 9.7 17.2 22.6 7.8 17.3 20.4 11.2 PXDC1 C6orf145 ENSG00000168994 "PX domain containing 1" Q5TGL8 6 3722614-3752026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 79.6" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 93.5;Extravillous trophoblasts: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.2" "Lineage enriched" "Detected in single" 4 "B-cells: 4.2" "Cell line enhanced" "Detected in many" "HHSteC: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019246 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA019246: AB_2670113" "unprognostic (1.55e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (1.14e-4)" "unprognostic (2.82e-2)" "unprognostic (3.80e-2)" "unprognostic (2.95e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" "unprognostic (2.01e-2)" "unprognostic (6.17e-3)" "unprognostic (1.10e-1)" "unprognostic (2.97e-1)" "unprognostic (2.84e-1)" 26.3 5.5 5.9 5.9 6.5 0.4 30.6 3.2 6.6 11.1 10.3 6.4 5.3 10.7 10.1 14.4 13.9 8.3 18.5 10.8 6.5 4.4 13.4 79.6 14.2 5.8 7.5 3.1 6.2 10.0 3.4 4.3 32.9 6.2 9.1 3.1 7.5 12.3 8.1 11.9 11.7 16.9 20.6 7.0 6.1 8.9 3.9 6.9 1.0 16.8 11.5 5.8 14.9 21.0 4.2 0.3 0.5 0.0 0.0 0.9 0.3 11.7 5.0 8.2 5.5 26.0 19.7 26.4 21.4 16.5 18.3 14.2 8.3 2.3 0.0 13.9 35.0 13.5 8.8 1.6 5.9 8.7 11.9 1.6 0.0 3.6 7.4 43.5 0.0 0.0 17.8 19.4 11.3 24.4 15.1 20.0 0.8 0.0 1.5 14.3 0.7 0.0 0.1 0.3 2.3 6.0 0.6 4.4 0.4 6.9 9.9 0.9 0.4 14.2 14.6 28.7 11.4 1.2 0.7 20.8 15.5 6.6 6.0 14.5 0.0 0.0 0.0 3.5 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.3 4.2 0.1 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.3 5.9 6.5 3.2 6.6 6.5 4.4 7.5 3.1 6.2 6.9 44.7 10.4 4.2 93.5 42.8 0.4 6.9 15.3 5.3 12.5 7.0 0.0 26.6 10.0 30.2 0.4 37.0 1.3 0.0 44.5 114.0 36.1 45.1 3.5 57.1 21.2 0.0 0.0 36.2 9.1 0.2 21.0 17.8 23.6 37.9 0.8 14.3 55.0 0.0 17.0 16.8 0.7 0.0 31.6 0.5 3.8 29.0 65.6 2.9 0.0 38.2 PXDN "D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN" ENSG00000130508 Peroxidasin Q92626 2 1631887-1744852 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrogen peroxide" "Oxidoreductase, Peroxidase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 60.8" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 40.8;Ito cells: 86.5;Sertoli cells: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 57.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA012375 Approved "Secreted to extracellular matrix" NA NA 4000000 "HPA012375: AB_1855965" "unprognostic (4.37e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (8.16e-3)" "unprognostic (1.91e-1)" "unprognostic (1.92e-2)" "unprognostic (3.15e-3)" "unprognostic (6.50e-3)" "unprognostic (1.34e-2)" "unprognostic (6.78e-2)" "unprognostic (2.23e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.18e-1)" "unprognostic (7.33e-3)" "unprognostic (5.54e-3)" 36.4 3.2 2.6 13.1 2.0 0.5 60.8 0.3 3.7 15.5 17.7 2.7 5.1 4.3 20.4 8.9 7.4 9.7 12.9 16.2 2.0 2.6 5.8 6.9 14.3 8.5 1.8 1.4 19.2 2.1 1.5 6.5 18.3 3.6 15.2 5.0 7.6 7.3 6.8 8.4 3.7 8.4 41.0 2.6 13.7 7.8 5.8 1.2 4.3 5.9 4.8 3.4 26.3 20.1 0.5 2.0 0.0 0.0 0.0 1.1 0.1 6.6 2.3 12.6 0.0 35.7 32.8 9.6 39.9 31.7 17.5 19.2 0.0 0.1 0.0 57.3 39.4 0.8 1.4 0.0 24.5 22.3 0.1 0.4 0.0 24.9 0.0 35.4 0.1 0.0 36.1 7.2 19.7 14.9 53.1 42.9 6.2 0.0 0.0 24.7 3.9 1.1 1.3 10.2 0.0 9.1 2.2 44.1 0.1 20.5 0.0 0.0 23.3 0.0 12.9 0.0 26.4 4.7 0.1 41.6 28.9 14.3 1.0 30.7 0.0 33.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 2.0 0.0 0.1 2.6 2.0 0.3 2.7 2.0 2.6 1.8 1.4 3.6 1.2 6.0 2.9 0.0 2.3 2.6 1.4 5.3 7.6 2.7 0.0 1.8 0.0 0.6 0.0 7.9 33.3 40.8 0.0 0.0 0.0 7.7 15.2 12.9 1.1 0.8 1.6 0.0 1.7 86.5 9.7 24.5 24.7 1.1 6.8 1.0 0.8 11.2 0.8 0.0 14.2 0.0 0.7 45.3 26.2 1.8 10.1 2.5 1.1 0.0 0.0 1.0 PXDNL "FLJ25471, PMR1" ENSG00000147485 "Peroxidasin like" A1KZ92 8 51319578-51809445 "Enzymes, Predicted intracellular proteins" "Hydrogen peroxide" "Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 59.1" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 29.9;Early spermatids: 34.8;Muller glia cells: 18.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 4 "B-cells: 1.5" "Group enriched" "Detected in some" 7 "AF22: 11.1;Daudi: 8.3;SH-SY5Y: 8.9" HPA007919 Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA007919: AB_1855966" "prognostic unfavorable (3.27e-5)" "unprognostic (4.59e-4)" "unprognostic (5.57e-3)" "unprognostic (2.83e-3)" "unprognostic (2.71e-1)" "unprognostic (5.14e-2)" "unprognostic (1.18e-1)" "unprognostic (7.18e-3)" "unprognostic (1.85e-1)" "unprognostic (1.15e-1)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-4)" "unprognostic (2.28e-2)" "unprognostic (3.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.97e-4)" 1.1 0.1 0.3 0.1 0.2 0.0 0.2 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 7.9 0.4 0.1 0.7 59.1 0.2 0.3 1.0 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.8 1.1 0.3 0.9 0.2 0.2 0.1 0.2 0.3 0.1 5.2 0.0 0.1 0.2 2.5 0.3 0.2 0.1 1.5 0.3 0.3 0.0 0.0 0.1 0.0 0.7 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 8.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.3 0.2 0.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.7 29.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.6 0.1 0.0 0.0 0.0 0.0 PXK "FLJ20335, Slob" ENSG00000168297 "PX domain containing serine/threonine kinase like" Q7Z7A4 3 58332880-58426126 "Enzymes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 81.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024068 Approved Supported "Plasma membrane,Centriolar satellite,Cytosol" NA NA Cytosol "Plasma membrane, Centriolar satellite" "HPA024068: AB_1855967" "unprognostic (2.98e-2)" "unprognostic (3.29e-1)" "unprognostic (2.71e-3)" "unprognostic (1.61e-1)" "unprognostic (2.40e-1)" "unprognostic (6.62e-3)" "unprognostic (5.03e-3)" "prognostic favorable (5.68e-4)" "unprognostic (3.90e-1)" "unprognostic (8.09e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-3)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" 9.3 9.4 20.7 17.0 51.4 33.6 7.6 22.6 31.4 28.9 8.9 81.1 2.4 6.3 14.2 5.3 6.6 8.0 9.6 7.5 33.7 19.9 10.4 5.7 8.2 23.8 68.6 23.4 11.1 8.5 13.7 6.1 17.5 43.9 6.0 6.4 4.4 8.8 7.7 7.6 7.5 7.7 11.8 55.9 13.5 8.3 6.7 56.6 3.7 40.3 2.5 26.1 9.8 13.1 31.3 18.8 31.8 22.5 8.7 11.2 13.4 4.3 2.5 1.9 3.5 26.9 23.9 5.7 6.9 14.7 6.7 9.4 1.2 0.9 22.8 1.6 11.7 9.7 1.3 6.0 4.4 7.1 5.7 3.8 3.9 3.1 1.7 31.4 33.9 6.9 20.4 10.6 8.4 14.6 23.6 5.9 14.6 4.8 7.5 12.0 1.6 7.4 35.0 2.3 1.3 6.3 12.8 3.3 4.1 4.2 2.4 1.7 1.2 4.7 3.4 5.5 3.6 11.5 35.1 6.0 8.4 3.5 15.9 7.3 5.9 5.8 22.7 12.1 48.2 3.5 14.6 20.1 29.4 11.2 16.2 9.9 29.0 8.1 9.4 18.8 31.3 7.1 8.4 31.8 8.7 22.5 13.5 8.7 13.4 20.7 51.4 22.6 31.4 33.7 19.9 68.6 23.4 43.9 56.6 8.9 4.6 34.0 4.9 12.6 29.2 11.8 7.6 8.1 6.8 22.7 19.6 13.3 28.2 5.9 60.8 14.3 6.3 23.3 5.0 6.5 30.9 6.4 19.6 6.8 12.0 19.1 7.5 18.4 24.8 27.6 28.4 16.3 16.9 8.2 5.2 29.3 3.5 3.5 23.7 9.1 20.8 19.4 15.5 14.0 19.4 11.4 29.4 15.9 4.4 3.2 PXMP2 PMP22 ENSG00000176894 "Peroxisomal membrane protein 2" Q9NR77 12 132687606-132704991 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 78.9" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 191.4;Hepatocytes: 515.6;Proximal tubular cells: 287.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.12e-2)" "unprognostic (7.96e-2)" "unprognostic (4.70e-3)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.84e-4)" "unprognostic (7.39e-3)" "unprognostic (2.83e-1)" "unprognostic (2.44e-2)" "unprognostic (3.02e-1)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "prognostic favorable (2.75e-4)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.71e-3)" "unprognostic (3.04e-1)" 5.7 4.1 6.5 6.5 5.3 6.7 10.3 3.4 7.6 3.4 18.1 3.8 7.4 17.4 4.3 7.9 5.3 5.0 14.1 16.3 5.3 3.7 18.4 78.9 3.6 5.0 4.4 6.1 6.8 32.3 2.5 2.4 2.7 4.4 5.4 13.3 4.6 9.0 3.6 12.8 4.3 25.9 3.9 3.2 3.5 22.9 4.2 4.6 13.8 7.9 5.8 4.4 4.6 4.1 3.3 9.9 4.3 1.9 2.2 4.4 1.9 24.0 10.1 15.2 14.1 9.2 7.1 8.9 8.6 8.0 18.8 16.7 12.2 9.3 15.0 10.5 12.3 6.6 17.2 20.2 10.9 10.3 8.5 32.1 13.3 18.2 13.4 18.0 9.8 6.0 9.3 9.1 7.7 6.2 13.1 5.0 23.1 22.9 11.8 9.8 21.8 31.0 15.5 14.9 28.4 14.0 32.0 16.4 12.3 13.8 10.2 29.0 9.4 18.6 9.8 11.8 12.3 26.3 22.7 5.8 9.3 21.7 8.0 14.3 10.7 10.3 24.0 10.3 14.1 7.3 0.0 1.9 4.3 3.8 0.8 3.7 3.3 3.1 3.9 3.3 3.3 3.0 2.5 0.9 2.2 0.9 9.9 4.4 1.9 6.5 5.3 3.4 7.6 5.3 3.7 4.4 6.1 4.4 4.6 3.0 4.5 6.7 18.1 7.4 5.1 33.1 147.7 0.0 3.4 24.4 3.9 37.1 140.9 15.6 15.2 9.0 191.4 0.0 9.0 32.9 16.1 31.2 4.6 515.6 27.8 0.0 18.0 36.8 18.3 24.3 28.7 8.0 11.8 1.0 64.3 21.8 13.0 122.2 32.9 287.1 5.0 19.4 10.5 15.3 20.7 9.4 23.8 7.5 155.8 17.5 PXT1 STEPP ENSG00000179165 "Peroxisomal, testis specific 1" Q8NFP0 6 36390551-36442889 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 6.4" "Group enriched" "Detected in some" 8 "Kupffer cells: 1.9;Spermatocytes: 7.1;Spermatogonia: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 2.2;neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 6.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.85e-2)" "unprognostic (1.12e-3)" "unprognostic (9.92e-2)" "unprognostic (5.49e-2)" "unprognostic (4.43e-1)" "unprognostic (9.38e-2)" "unprognostic (2.28e-2)" "unprognostic (2.92e-3)" "unprognostic (4.64e-2)" "unprognostic (1.92e-1)" "unprognostic (5.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.94e-5)" "unprognostic (2.98e-1)" "unprognostic (2.16e-1)" "unprognostic (7.21e-3)" "unprognostic (2.61e-3)" 0.2 0.0 0.5 1.0 0.5 0.7 0.2 2.2 1.9 0.1 0.1 0.1 0.1 1.1 0.3 0.7 0.1 0.3 2.7 0.3 0.5 0.2 1.2 0.1 0.4 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.1 1.8 0.2 0.0 0.1 0.3 0.1 0.7 0.2 0.4 0.1 0.2 0.4 0.1 6.4 0.1 0.1 0.1 0.1 1.0 0.3 0.1 2.2 0.0 1.5 0.2 0.0 0.7 0.2 0.1 0.0 0.7 0.0 0.0 0.0 1.6 0.0 0.2 0.2 0.0 1.0 0.8 0.1 0.1 0.0 0.4 0.0 0.0 0.5 0.0 6.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.8 0.5 0.0 0.3 0.0 0.0 0.6 1.0 0.0 0.0 0.4 0.2 1.1 0.1 1.3 0.2 0.3 0.0 0.0 0.9 0.0 0.2 0.5 0.0 0.0 0.0 2.2 0.1 0.3 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.7 0.2 0.5 0.5 2.2 1.9 0.5 0.2 0.2 0.1 1.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.1 5.1 0.0 0.2 0.0 0.0 0.1 PXYLP1 "ACPL2, FLJ23751" ENSG00000155893 "2-phosphoxylose phosphatase 1" Q8TE99 3 141228726-141367753 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 89.2" "Cell type enhanced" "Detected in many" 16 "Collecting duct cells: 43.6;Early spermatids: 163.2;Late spermatids: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017243 Uncertain "Intracellular and membrane" NA NA "HPA017243: AB_1844509" "unprognostic (9.55e-2)" "unprognostic (3.48e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (8.45e-2)" "unprognostic (8.04e-3)" "unprognostic (4.05e-3)" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (6.95e-2)" "unprognostic (5.07e-3)" "unprognostic (4.67e-2)" "unprognostic (1.29e-2)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (8.56e-2)" "unprognostic (8.17e-3)" 4.1 4.4 9.1 3.8 11.8 3.2 5.5 3.8 13.2 6.5 3.7 5.9 23.7 3.8 8.6 89.2 2.2 5.8 5.4 8.9 6.6 6.6 5.1 3.5 4.9 9.0 4.5 7.4 6.5 8.6 8.6 6.5 10.8 5.2 6.7 4.0 5.2 5.1 20.7 3.3 4.2 4.7 4.8 5.4 3.8 5.5 13.7 4.6 28.0 4.3 1.9 6.1 6.0 4.5 0.5 3.8 7.2 4.1 13.0 16.8 6.3 3.4 3.6 15.6 12.3 6.2 5.4 3.7 2.3 5.9 6.1 8.5 6.0 1.2 0.2 3.3 5.4 1.3 0.8 16.4 1.5 5.9 11.1 10.8 1.2 4.9 4.7 13.2 3.0 0.6 5.0 7.0 1.8 0.6 7.7 0.4 11.8 0.5 1.4 2.8 2.9 16.3 3.9 6.5 8.5 2.0 2.3 9.1 2.1 4.3 14.9 6.8 12.1 6.1 1.9 5.0 3.0 6.5 1.8 0.7 7.9 4.7 5.3 2.2 3.3 0.2 0.5 7.3 4.2 6.9 7.2 4.1 6.2 9.9 2.8 6.4 0.5 5.7 6.6 3.8 0.4 16.8 13.5 2.8 13.0 1.3 1.3 3.0 6.3 9.1 11.8 3.8 13.2 6.6 6.6 4.5 7.4 5.2 4.6 8.9 8.3 0.8 3.8 0.0 2.2 6.7 2.5 5.3 3.4 43.6 5.9 1.6 0.0 3.0 163.2 1.5 2.6 0.0 3.3 5.9 3.1 6.0 2.3 3.0 0.6 6.4 4.1 0.6 1.9 68.3 18.7 1.4 0.0 2.8 2.2 6.0 3.3 8.6 14.2 9.5 5.4 12.9 1.7 31.9 9.4 0.0 0.9 2.5 3.7 5.5 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "Cell line enhanced" "Detected in many" "MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.7 13.5 0.1 0.0 1.3 3.0 0.1 2.8 4.0 1.8 1.2 0.0 7.2 2.4 0.0 2.7 0.0 16.0 0.7 10.7 0.0 17.3 0.0 2.2 1.6 4.4 4.6 20.1 16.0 4.0 5.6 0.8 0.1 0.0 3.9 0.0 9.9 3.7 0.5 34.5 0.0 54.4 3.7 2.3 0.0 17.5 0.0 7.6 0.1 5.6 0.1 0.0 2.4 0.0 2.7 0.0 3.3 40.1 2.6 0.1 0.2 2.4 0.0 0.1 0.0 0.0 1.4 24.9 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 20.8 28.2 73.7 67.5 65.8 0.1 2.8 28.1 36.1 29.6 24.4 0.0 46.3 5.0 83.5 0.3 38.6 312.0 23.3 50.3 8.9 26.7 26.8 108.5 3.0 375.8 0.0 56.6 41.7 516.6 1.5 43.7 364.0 92.8 16.2 110.6 0.0 56.2 271.9 21.2 1.4 0.6 25.8 23.3 0.3 1.1 143.2 14.9 75.0 247.3 42.2 PYCR1 P5C ENSG00000183010 "Pyrroline-5-carboxylate reductase 1" P32322 17 81932384-81942412 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis, Stress response" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "pancreas: 56.1;salivary gland: 53.3;stomach 1: 16.6" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 55.5;Extravillous trophoblasts: 46.4;Mucus-secreting cells: 41.0;Pancreatic endocrine cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 7.7" "Group enriched" "Detected in many" 7 "B-cells: 7.7;dendritic cells: 3.3;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047660 Approved NA NA "HPA047660: AB_2680115" "unprognostic (1.12e-2)" "unprognostic (2.13e-2)" "unprognostic (7.04e-2)" "unprognostic (7.27e-2)" "unprognostic (9.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (2.80e-1)" "unprognostic (9.36e-3)" "unprognostic (6.65e-2)" "unprognostic (3.02e-3)" "unprognostic (7.12e-2)" "prognostic unfavorable (7.33e-12)" "unprognostic (7.98e-2)" "unprognostic (1.56e-1)" "unprognostic (1.12e-2)" "unprognostic (5.92e-2)" 2.1 1.3 4.3 5.0 5.0 4.0 6.9 2.1 4.3 10.4 9.1 2.3 10.1 5.6 4.2 2.2 6.4 3.5 5.7 3.5 3.5 3.6 2.4 3.1 4.9 2.3 6.0 2.0 7.6 56.1 0.0 7.6 8.3 6.4 10.4 5.6 1.5 53.3 4.7 3.4 1.8 4.8 4.6 2.9 2.4 16.6 8.7 4.0 1.7 3.3 4.5 6.4 4.9 4.0 7.7 3.3 0.0 0.4 0.6 3.0 2.2 19.1 20.5 11.7 43.3 6.9 13.3 22.4 32.2 15.9 10.4 14.0 23.4 21.6 29.4 7.2 34.4 6.2 8.4 27.5 12.2 6.2 7.6 3.4 17.3 10.6 63.2 41.5 11.4 13.4 11.3 24.5 12.7 33.6 12.2 17.6 24.0 55.6 27.4 6.5 67.8 12.1 9.2 9.8 53.1 31.8 0.1 19.7 37.0 9.3 7.0 45.0 31.7 6.7 38.0 41.0 9.1 39.1 21.3 12.9 10.1 38.9 17.0 11.9 34.6 24.0 27.3 10.8 0.1 33.2 0.0 0.3 0.0 0.5 0.4 0.7 7.7 1.3 0.4 2.3 3.5 3.0 2.3 0.0 0.6 0.0 3.3 0.5 2.2 4.3 5.0 2.1 3.6 3.5 3.6 6.0 2.0 6.4 4.0 0.0 3.8 3.7 8.2 6.3 0.2 0.6 0.0 1.4 3.4 3.5 0.0 1.7 0.0 14.6 10.8 3.5 4.1 0.0 55.5 46.4 23.5 32.3 4.6 1.7 4.3 3.2 10.4 4.3 0.0 25.5 6.9 0.0 8.5 1.0 41.0 0.1 48.3 20.1 3.5 1.3 0.0 0.0 3.1 24.5 15.2 5.3 3.2 1.0 37.6 7.4 PYDC1 "ASC2, POP1" ENSG00000169900 "Pyrin domain containing 1" Q8WXC3 16 31215962-31217359 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;skin 1: 10.1" "Cell type enriched" "Detected in single" 14 "Suprabasal keratinocytes: 5.5" "Cancer enriched" "Detected in some" 8 "breast cancer: 8.0" "Cell type enhanced" "Detected in single" "memory B-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "SCLC-21H: 2.5;T-47d: 2.5;U-266/70: 1.3" NA NA "unprognostic (9.72e-3)" "unprognostic (1.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.61e-1)" "unprognostic (1.32e-2)" "unprognostic (1.49e-1)" "unprognostic (2.85e-1)" "unprognostic (2.62e-1)" "unprognostic (5.34e-2)" "unprognostic (3.15e-2)" "unprognostic (2.60e-10)" "unprognostic (3.62e-1)" "unprognostic (1.74e-1)" "unprognostic (1.70e-1)" "unprognostic (9.47e-2)" 0.1 0.1 7.7 0.2 9.0 0.2 1.0 12.4 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.5 2.4 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 3.0 10.1 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.0 0.1 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 PYDC2 POP2 ENSG00000253548 "Pyrin domain containing 2" Q56P42 3 191461163-191461456 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 1.0;testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 51 "A549: 5.0" HPA055895 Uncertain NA NA "HPA055895: AB_2682962" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PYGB ENSG00000100994 "Glycogen phosphorylase B" P11216 20 25248069-25298014 "Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 101.9" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 93.8;Enterocytes: 83.8;Peritubular cells: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 71.7;SK-MEL-30: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031067 Approved Approved Cytosol NA NA 16000000 Cytosol "HPA031067: AB_2673722" "unprognostic (6.13e-2)" "unprognostic (5.98e-2)" "unprognostic (1.21e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.37e-4)" "prognostic unfavorable (1.10e-4)" "unprognostic (1.23e-3)" "unprognostic (8.39e-3)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "unprognostic (3.41e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.43e-4)" 19.0 11.3 24.2 12.1 22.9 6.1 28.4 38.3 34.8 14.3 47.0 21.5 19.0 12.5 15.9 13.8 49.6 14.1 21.1 72.5 21.1 21.3 13.5 4.4 14.8 8.1 22.9 24.7 11.9 9.7 8.0 18.2 6.2 28.0 42.2 33.8 11.0 58.4 52.0 5.0 23.9 13.1 101.9 17.8 8.2 24.1 14.5 17.4 9.5 21.1 8.4 10.3 56.7 14.8 4.5 11.2 5.2 16.8 8.1 10.6 16.0 5.3 38.3 6.9 6.7 17.7 33.4 5.1 10.8 14.2 9.1 7.7 8.6 6.6 6.3 12.8 14.4 17.1 21.5 7.8 28.8 5.0 3.5 4.8 5.1 3.1 14.7 21.0 7.5 7.1 19.4 27.0 23.1 34.3 11.3 11.6 4.0 2.7 16.1 12.7 14.8 7.5 5.8 6.2 6.5 71.7 5.7 12.6 8.4 49.9 9.8 10.4 6.5 7.4 13.0 89.9 5.7 9.1 4.8 25.5 10.8 6.6 11.5 22.0 6.2 9.6 2.4 12.1 5.9 58.7 2.6 10.2 5.2 8.5 15.5 8.3 4.5 6.8 7.5 11.2 4.2 8.8 10.6 2.5 8.1 16.8 5.5 7.5 16.0 24.2 22.9 38.3 34.8 21.1 21.3 22.9 24.7 28.0 17.4 8.9 28.8 2.2 18.7 10.5 23.6 93.8 15.3 9.4 9.1 24.4 35.3 5.9 10.0 15.4 2.4 10.8 83.8 0.0 14.5 5.7 9.1 20.1 5.8 5.9 10.0 17.5 27.1 8.6 15.2 6.8 25.3 11.0 33.7 18.0 47.4 20.4 19.1 57.9 81.3 9.9 9.4 0.0 17.6 1.7 4.9 8.8 3.7 12.8 52.1 7.1 PYGM ENSG00000068976 "Glycogen phosphorylase, muscle associated" P11217 11 64746389-64760297 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 37 "skeletal muscle: 572.6;tongue: 172.6" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 46.7;Late spermatids: 32.1;Peritubular cells: 41.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 9.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.9" "Cell line enhanced" "Detected in some" "HSkMC: 8.3;NB-4: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056003 Enhanced NA NA 12000000 "HPA056003: AB_2683006" "unprognostic (3.33e-1)" "unprognostic (6.03e-3)" "unprognostic (3.87e-4)" "unprognostic (1.95e-3)" "unprognostic (8.71e-2)" "unprognostic (1.09e-2)" "unprognostic (1.25e-3)" "unprognostic (2.92e-1)" "unprognostic (3.88e-1)" "unprognostic (3.08e-2)" "unprognostic (1.12e-1)" "unprognostic (2.64e-1)" "unprognostic (6.33e-6)" "unprognostic (3.37e-3)" "unprognostic (1.81e-1)" "unprognostic (1.62e-2)" "unprognostic (5.68e-2)" 6.4 0.8 2.2 0.7 3.0 0.7 0.8 1.1 3.1 0.9 2.1 1.8 0.7 0.7 1.1 4.6 7.1 1.5 0.9 5.5 2.9 1.0 0.7 0.6 0.7 0.7 1.5 1.1 0.7 0.7 0.6 0.3 0.7 6.6 2.5 0.9 1.6 7.9 2.8 572.6 0.6 0.8 2.5 4.1 0.7 0.8 0.9 1.8 0.0 1.2 172.6 6.4 1.5 0.6 1.9 0.3 9.9 0.0 1.6 0.3 0.2 0.2 0.1 1.7 0.2 1.2 1.7 0.3 0.2 0.1 0.3 0.0 0.7 0.7 1.3 0.5 0.0 0.3 0.4 0.5 0.1 0.1 1.4 0.3 0.8 0.3 0.0 0.8 0.8 0.3 8.3 0.6 0.6 0.2 0.1 0.0 2.4 1.5 1.5 0.0 2.2 1.5 4.8 1.7 0.2 0.2 0.9 1.5 0.3 0.0 0.2 0.5 0.1 0.6 0.7 0.9 1.1 0.7 0.9 0.6 0.0 0.9 0.4 0.1 2.4 2.8 1.0 0.0 0.2 0.0 9.9 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 0.0 1.9 0.0 0.1 0.2 1.6 0.0 0.3 0.3 0.2 2.2 3.0 1.1 3.1 2.9 1.0 1.5 1.1 6.6 1.8 0.0 2.9 0.0 0.6 0.7 3.6 46.7 0.0 0.0 1.2 0.0 3.9 0.5 0.0 0.1 11.7 1.0 0.7 0.0 0.0 0.2 2.1 0.4 0.0 0.0 0.4 0.0 0.0 1.8 1.2 32.1 15.3 0.9 0.0 0.0 0.7 9.1 0.2 0.0 41.4 0.0 1.2 6.5 15.3 1.0 0.9 0.5 0.1 1.3 0.8 0.3 PYGO1 ENSG00000171016 "Pygopus family PHD finger 1" Q9Y3Y4 15 55538890-55588947 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 26.6" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 11.3;Spermatocytes: 10.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-698: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042248 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042248: AB_10794272" "unprognostic (5.55e-2)" "unprognostic (9.82e-2)" "unprognostic (2.61e-2)" "unprognostic (4.54e-2)" "unprognostic (7.20e-2)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "unprognostic (2.29e-1)" "unprognostic (6.72e-6)" "unprognostic (3.36e-4)" "unprognostic (4.84e-2)" "unprognostic (2.30e-2)" "unprognostic (1.80e-2)" 3.0 3.8 3.8 1.6 8.2 0.6 3.1 10.1 5.1 10.8 5.1 2.8 8.2 0.9 9.8 5.8 3.3 4.2 3.9 2.6 5.2 4.3 1.8 0.6 3.2 1.0 4.2 2.8 14.2 2.3 26.6 6.9 3.2 5.0 7.9 1.9 5.5 1.9 9.4 18.7 1.5 1.8 7.9 5.2 0.8 2.8 6.0 3.2 0.0 10.1 5.7 1.0 7.6 9.2 0.6 0.2 0.9 0.2 0.3 0.4 0.0 2.8 5.1 8.9 4.7 3.4 7.7 3.7 6.1 6.7 4.8 5.6 3.4 0.0 0.0 1.8 3.9 6.8 0.0 9.1 0.0 6.2 0.0 3.1 1.3 1.4 0.3 4.9 4.9 0.0 4.1 4.7 4.3 0.7 4.9 2.5 0.7 0.1 0.0 7.6 0.1 0.2 0.0 2.4 0.6 2.6 0.0 11.4 0.0 1.5 2.0 4.9 5.8 5.5 0.0 4.2 1.3 1.7 1.5 0.0 12.1 5.5 0.2 7.1 0.1 0.1 25.9 3.8 0.0 2.8 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.3 0.0 0.0 0.6 0.3 0.4 0.9 0.3 0.1 0.2 0.1 0.0 3.8 8.2 10.1 2.8 5.2 4.3 4.2 2.8 5.0 3.2 8.9 4.6 0.0 4.1 1.4 4.9 3.9 0.0 2.7 3.4 8.7 0.0 0.9 0.0 0.3 1.7 0.7 0.0 0.0 0.0 0.1 6.6 4.8 0.0 0.0 0.4 0.0 0.0 0.6 0.6 1.9 9.2 0.8 6.8 0.0 0.0 6.3 0.8 0.0 11.3 0.0 3.1 0.0 4.1 10.7 2.1 0.6 0.2 0.0 0.0 0.5 PYHIN1 "IFIX, MGC23885" ENSG00000163564 "Pyrin and HIN domain family member 1" Q6K0P9 1 158930796-158977054 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.4;lymphoid tissue: 23.3" "Cell type enriched" "Detected in some" 11 "T-cells: 126.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 33.4;MAIT T-cell: 19.1;memory CD4 T-cell: 14.2;memory CD8 T-cell: 25.2;naive CD8 T-cell: 16.0;NK-cell: 11.4;T-reg: 21.0" "Group enriched" "Detected in many" 5 "NK-cells: 11.4;T-cells: 33.4" "Cell line enriched" "Detected in some" 6 "U-698: 33.1" "HPA051224, HPA055373" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA051224: AB_2681394, HPA055373: " "unprognostic (1.64e-3)" "unprognostic (1.75e-3)" "unprognostic (2.93e-3)" "unprognostic (2.64e-3)" "unprognostic (3.99e-2)" "unprognostic (3.57e-3)" "unprognostic (2.44e-3)" "unprognostic (2.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.47e-3)" "unprognostic (3.94e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-6)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-2)" "unprognostic (4.45e-3)" 4.0 0.6 0.5 20.1 0.5 3.9 2.1 0.4 0.4 2.0 2.7 0.2 0.3 1.2 2.2 1.4 1.7 1.6 3.2 1.2 0.6 0.5 1.8 2.6 11.7 18.8 0.7 0.0 1.6 0.8 0.0 0.8 1.7 0.4 2.6 1.8 1.2 3.4 1.2 0.7 0.9 7.8 0.4 1.3 20.7 2.0 1.0 0.0 6.6 2.5 1.9 23.3 5.7 1.6 4.9 0.1 1.2 0.1 11.4 33.4 6.0 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 33.1 0.0 5.1 0.0 0.4 0.1 0.1 33.4 0.1 19.1 4.9 14.2 25.2 0.1 2.4 4.8 16.0 1.2 11.4 0.1 0.1 21.0 6.0 0.5 0.5 0.4 0.4 0.6 0.5 0.7 0.0 0.4 0.0 11.9 3.2 9.5 0.7 0.3 0.2 0.3 0.0 9.4 3.4 3.5 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.4 2.3 1.3 2.1 0.0 0.0 3.1 4.3 0.0 0.0 1.4 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.1 0.5 0.1 126.8 0.0 0.3 PYROXD2 "C10orf33, FLJ23849" ENSG00000119943 "Pyridine nucleotide-disulphide oxidoreductase domain 2" Q8N2H3 10 98383565-98415184 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.8" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 50.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 50.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 28.6;U-937: 18.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037566, HPA037567, HPA067394" Approved Approved Mitochondria NA NA Mitochondria "HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832" "unprognostic (2.35e-2)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (6.76e-2)" "unprognostic (1.27e-2)" "unprognostic (3.38e-2)" "unprognostic (2.69e-1)" "unprognostic (3.34e-1)" "unprognostic (2.20e-1)" "unprognostic (1.63e-1)" "unprognostic (9.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-2)" "prognostic favorable (3.37e-4)" 11.0 15.5 5.1 9.0 7.0 2.7 9.2 2.6 6.3 12.2 6.5 12.0 14.2 2.5 8.3 15.5 4.1 11.6 13.1 9.5 5.3 3.8 6.7 11.7 8.6 2.9 12.6 3.0 11.5 4.3 7.5 6.0 5.0 9.6 12.9 5.8 12.5 26.9 11.3 9.6 3.2 4.1 12.2 8.1 5.2 5.5 3.7 10.7 4.3 9.2 2.3 3.0 11.9 6.9 0.0 0.5 50.8 0.0 11.3 1.8 0.4 2.1 5.3 3.0 0.1 4.7 9.5 1.1 3.5 10.9 2.0 3.8 0.0 7.4 0.0 6.3 3.7 0.5 1.0 0.9 1.2 2.1 0.2 0.8 4.3 8.8 0.4 6.1 0.0 10.0 5.6 1.6 1.6 1.9 28.6 1.5 2.0 0.1 0.1 3.0 6.5 0.1 10.2 0.9 4.1 1.8 1.3 1.1 0.0 2.9 3.3 0.2 0.1 3.8 0.5 2.6 4.3 3.1 4.8 2.0 0.0 2.3 0.6 3.4 0.7 0.4 0.0 3.5 18.7 0.3 1.1 0.0 50.8 1.8 0.0 0.4 0.0 0.6 1.5 0.5 0.0 0.3 1.1 0.1 11.3 0.0 0.1 0.1 0.4 5.1 7.0 2.6 6.3 5.3 3.8 12.6 3.0 9.6 10.7 8.9 3.2 0.0 5.5 0.5 0.0 8.1 0.0 13.4 6.8 1.8 0.0 4.5 6.6 2.1 0.2 3.1 2.0 0.0 2.2 3.3 4.6 2.8 2.3 2.4 7.5 0.0 1.2 4.3 3.8 0.2 3.1 2.5 1.7 1.0 4.9 3.1 1.1 0.0 3.5 7.3 0.8 6.5 4.2 2.6 1.5 0.5 1.5 4.4 6.0 8.4 PYY PYY1 ENSG00000131096 "Peptide YY" P10082 17 43952738-44004469 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 40.0" "Cell type enriched" "Detected in some" 360 "Intestinal endocrine cells: 18684.3" "Group enriched" "Detected in many" 8 "endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 7.9" "Region enriched" "Detected in single" 22 "pons and medulla: 1.4" "Not detected" "Not detected" "HPA010973, CAB016734" Enhanced "Secreted to blood" NA NA 87100 "CAB016734: AB_876471, HPA010973: AB_1855194" "unprognostic (8.17e-3)" "unprognostic (5.41e-2)" "unprognostic (9.93e-2)" "unprognostic (1.81e-3)" "unprognostic (2.48e-4)" "unprognostic (5.26e-2)" "unprognostic (4.14e-2)" "unprognostic (1.80e-2)" "unprognostic (1.75e-2)" "unprognostic (1.54e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-1)" "unprognostic (5.69e-3)" "unprognostic (3.77e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-1)" "unprognostic (1.20e-1)" 0.1 0.8 0.1 2.0 0.2 0.0 0.2 0.1 0.1 0.1 40.0 0.1 0.1 1.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.5 0.1 20.6 0.1 0.1 0.3 0.1 0.0 24.8 0.1 0.1 0.1 0.1 1.0 0.1 4.2 0.2 0.1 0.1 0.1 0.1 0.9 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.6 0.7 1.3 1.0 1.7 0.2 1.2 0.3 1.4 0.8 1.3 0.9 0.7 1.6 1.4 1.1 0.7 1.1 0.4 0.9 3.2 0.6 1.8 0.5 0.2 1.2 0.5 7.9 2.3 0.4 1.3 0.6 1.7 0.3 0.7 0.4 1.3 1.2 1.7 0.5 1.0 1.6 1.2 0.7 0.4 0.3 0.2 2.1 0.1 1.3 0.3 0.7 0.0 2.1 1.1 1.2 0.1 1.3 1.6 1.4 0.3 1.1 0.1 1.2 0.2 1.8 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 27.6 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 18684.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 51.9 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 2.3 4.5 0.1 0.0 0.0 32.3 0.0 PZP CPAMD6 ENSG00000126838 "PZP, alpha-2-macroglobulin like" P20742 12 9148840-9208370 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "liver: 56.9" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 32.1;Early spermatids: 22.5;Hepatocytes: 23.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5;MAIT T-cell: 3.5" "Lineage enriched" "Detected in single" 12 "T-cells: 3.5" "Group enriched" "Detected in some" 8 "HeLa: 9.9;SiHa: 5.2" "HPA041403, HPA041471" Supported "Secreted to blood" NA NA 13000000000 "HPA041403: AB_10804003, HPA041471: AB_10795636" "unprognostic (8.48e-3)" "unprognostic (1.12e-2)" "unprognostic (2.28e-1)" "unprognostic (8.54e-4)" "unprognostic (4.79e-1)" "unprognostic (3.50e-2)" "unprognostic (2.04e-4)" "unprognostic (4.57e-2)" "unprognostic (2.18e-1)" "unprognostic (2.55e-2)" "unprognostic (9.71e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-5)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (9.81e-3)" 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.8 0.1 0.0 0.7 0.0 0.0 0.9 0.6 0.0 56.9 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 3.5 0.0 0.7 0.9 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.9 0.6 0.0 0.0 1.4 0.6 3.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 32.1 4.5 0.0 2.0 0.0 0.0 0.0 22.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 1.8 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.4 0.5 0.0 0.0 0.5 0.0 0.0 QDPR "DHPR, PKU2, SDR33C1" ENSG00000151552 "Quinoid dihydropteridine reductase" P09417 4 17460261-17512234 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Oxidoreductase "Disease mutation, Phenylketonuria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 114.1;liver: 64.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 298.8;Muller glia cells: 301.8;Proximal tubular cells: 369.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058951, HPA065649" Enhanced Approved Mitochondria NA NA 1800000 Mitochondria "HPA058951: AB_2683861, HPA065649: AB_2685526" "unprognostic (1.30e-2)" "unprognostic (4.29e-1)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" "unprognostic (3.29e-3)" "unprognostic (3.80e-3)" "unprognostic (1.19e-1)" "unprognostic (1.45e-1)" "unprognostic (6.82e-3)" "unprognostic (2.07e-1)" "prognostic favorable (7.84e-6)" "unprognostic (1.58e-1)" "unprognostic (2.60e-1)" "unprognostic (9.01e-2)" "unprognostic (3.19e-1)" 22.5 25.9 67.8 3.4 111.9 4.4 7.4 16.0 54.1 5.7 7.5 56.3 2.6 9.1 5.5 12.5 5.2 6.4 6.3 15.0 80.7 58.2 36.1 64.8 8.0 3.7 114.1 36.7 6.7 10.3 13.7 6.2 4.1 82.5 10.3 5.9 2.6 12.4 7.5 34.2 4.6 8.1 6.4 93.6 4.8 9.1 4.1 94.7 0.7 7.7 2.8 4.4 4.5 2.6 7.5 42.5 1.0 21.9 9.9 15.0 12.3 11.6 22.8 9.0 12.5 21.9 11.1 15.9 16.6 7.0 15.5 13.6 18.2 15.4 4.3 10.7 9.2 17.3 6.6 12.8 18.8 9.7 13.1 2.6 11.8 11.8 43.0 13.2 15.3 1.1 13.7 11.9 9.7 13.4 8.3 7.8 11.0 12.6 9.9 16.6 6.0 22.8 24.6 15.3 11.0 15.4 9.5 6.9 17.2 16.0 6.4 17.1 21.8 11.0 1.8 47.2 10.3 5.0 5.9 13.5 9.0 16.1 8.9 13.2 15.4 24.0 30.2 18.0 13.5 14.9 0.0 14.4 1.0 12.3 21.9 11.1 7.5 13.3 12.8 18.0 6.2 15.0 12.9 0.4 9.9 16.3 42.5 6.9 12.3 67.8 111.9 16.0 54.1 80.7 58.2 114.1 36.7 82.5 94.7 26.8 26.9 18.2 16.6 17.7 34.9 59.2 38.2 4.0 14.8 36.6 7.9 65.3 92.9 37.2 0.8 17.8 14.2 0.0 20.5 28.8 26.3 26.4 25.3 298.8 69.8 77.9 167.4 25.8 34.9 3.3 21.0 26.9 145.1 20.8 22.6 301.8 17.0 7.0 35.7 369.1 26.6 25.8 26.4 3.3 60.7 14.1 15.3 16.7 36.6 11.1 QKI QK3 ENSG00000112531 "QKI, KH domain containing RNA binding" Q96PU8 6 163414000-163578596 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport" "Developmental protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 100.3" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 308.9" "Cancer enriched" "Detected in all" 6 "glioma: 42.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "AF22: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019123, CAB022602" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB022602: , HPA019123: AB_1855980" "unprognostic (2.42e-1)" "unprognostic (5.81e-2)" "unprognostic (1.31e-1)" "unprognostic (1.06e-2)" "unprognostic (8.57e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.34e-1)" "unprognostic (7.06e-2)" "unprognostic (1.76e-3)" "unprognostic (1.08e-1)" "unprognostic (5.15e-2)" "prognostic unfavorable (2.31e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.16e-1)" "unprognostic (3.86e-1)" "unprognostic (4.09e-2)" 32.4 12.4 37.5 16.2 63.5 27.1 14.6 15.1 100.3 14.9 12.2 83.9 3.7 4.0 14.7 4.9 16.0 12.3 15.7 64.0 43.7 18.1 11.1 18.4 24.9 11.4 72.5 31.9 18.4 7.6 7.8 4.7 23.4 46.5 7.9 8.4 7.1 10.2 11.1 59.9 12.4 7.1 21.1 68.8 16.9 8.9 20.5 74.3 5.0 10.4 10.8 11.4 15.8 17.7 1.7 7.3 10.8 8.4 7.4 3.8 1.3 4.3 18.2 64.8 21.5 19.6 21.9 15.1 11.8 27.9 19.3 23.4 12.3 4.0 5.2 9.9 29.5 13.2 6.5 34.3 12.2 31.4 10.5 11.1 20.6 10.1 13.8 24.0 11.0 6.3 25.6 5.0 20.7 32.9 18.9 26.6 7.8 30.2 12.4 12.4 8.2 7.3 2.3 8.3 4.3 9.2 11.3 40.4 10.5 10.6 13.7 1.3 7.5 12.6 6.8 5.2 27.5 2.6 18.0 27.0 13.4 11.3 14.4 21.6 7.9 9.6 6.4 11.5 9.7 31.4 3.4 8.4 3.8 2.3 5.4 3.8 1.4 1.6 2.0 4.3 1.7 1.5 2.5 10.8 7.4 5.5 7.3 1.1 1.3 37.5 63.5 15.1 41.4 43.7 18.1 72.5 31.9 46.5 74.3 140.0 54.6 32.8 29.3 136.6 56.8 308.9 40.8 21.4 36.4 19.2 55.0 41.8 18.3 21.6 45.5 100.3 0.0 46.7 10.3 40.7 66.9 33.8 60.0 61.0 75.9 30.2 0.0 146.1 189.4 77.1 80.3 114.7 108.0 31.5 0.0 113.1 17.4 0.0 92.6 25.9 30.1 45.3 91.7 34.4 14.6 118.9 46.1 25.8 0.0 35.3 QPCT "GCT, QC" ENSG00000115828 "Glutaminyl-peptide cyclotransferase" Q16769 2 37344574-37373322 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6;blood: 137.6" "Group enriched" "Detected in many" 6 "Intestinal endocrine cells: 208.4;Melanocytes: 501.0" "Cancer enhanced" "Detected in all" "melanoma: 97.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 137.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 137.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 17.9;SCLC-21H: 24.3;SK-MEL-30: 81.6;U-266/84: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008406 Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA008406: AB_1855981" "unprognostic (6.25e-3)" "unprognostic (6.69e-2)" "unprognostic (4.95e-2)" "unprognostic (1.44e-1)" "unprognostic (1.44e-2)" "unprognostic (9.32e-2)" "unprognostic (1.13e-3)" "unprognostic (9.73e-2)" "unprognostic (2.71e-3)" "unprognostic (7.86e-2)" "unprognostic (3.67e-2)" "unprognostic (1.17e-1)" "unprognostic (6.78e-2)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (9.48e-3)" "unprognostic (3.62e-3)" 3.2 77.6 4.3 5.4 5.8 17.0 6.4 1.2 11.6 9.2 11.3 2.2 1.5 2.2 6.2 43.7 2.4 1.9 5.5 2.9 6.7 17.9 12.4 1.3 6.1 7.4 3.9 5.0 1.4 5.5 9.6 31.6 7.8 5.9 3.5 4.2 21.2 14.7 2.8 4.0 14.2 2.3 3.4 3.0 8.5 3.4 2.6 0.5 2.3 1.8 4.4 4.8 7.0 2.9 0.2 10.7 137.6 29.7 0.0 0.0 12.1 0.1 8.0 0.0 0.0 1.1 2.7 0.0 1.1 17.9 1.3 2.1 0.5 1.4 0.0 0.6 6.0 15.2 0.0 0.5 0.0 2.1 0.1 15.6 3.6 0.0 1.5 0.1 0.5 0.0 1.5 0.0 9.9 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 8.8 2.2 24.3 0.0 1.3 0.0 81.6 1.6 0.1 0.6 3.8 0.0 0.0 0.0 0.1 3.1 63.8 0.0 5.5 0.0 0.0 0.6 29.7 0.2 0.0 3.4 0.0 0.2 0.0 0.0 10.7 0.1 0.0 0.0 137.6 0.0 0.3 0.2 0.0 12.1 4.3 5.8 1.2 11.6 6.7 17.9 3.9 5.0 5.9 0.5 3.0 2.9 8.2 9.7 34.7 10.9 1.1 2.5 1.4 0.0 21.0 2.0 0.5 1.7 45.4 0.4 7.3 2.0 0.0 2.1 4.3 11.0 9.5 55.3 0.2 21.3 41.3 208.4 22.7 29.2 2.2 2.8 35.6 501.0 10.8 5.8 1.2 25.4 1.9 22.3 4.7 2.9 12.9 15.5 2.1 0.6 12.7 3.9 1.9 6.9 5.5 QPRT QPRTase ENSG00000103485 "Quinolinate phosphoribosyltransferase" Q15274 16 29679008-29698699 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 61.2" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 349.5;Extravillous trophoblasts: 260.2;Hepatocytes: 304.1;Proximal tubular cells: 417.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 4.6;monocytes: 7.7" "Cell line enhanced" "Detected in many" "EFO-21: 98.7;Hep G2: 41.2" "HPA011887, HPA076010" Enhanced Approved Vesicles "Intracellular and membrane" NA NA 230000 Vesicles "HPA011887: AB_2668555, HPA076010: " "prognostic unfavorable (5.10e-5)" "unprognostic (2.00e-1)" "unprognostic (9.48e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (9.31e-4)" "unprognostic (1.44e-2)" "unprognostic (8.75e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (6.81e-2)" "unprognostic (3.37e-2)" "unprognostic (1.33e-2)" "unprognostic (2.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.58e-2)" 3.2 36.4 6.1 3.0 5.2 1.1 2.4 1.6 5.8 17.9 10.8 4.4 43.3 20.0 12.7 44.3 1.3 14.9 4.9 11.3 4.9 7.5 40.1 61.2 4.7 2.9 7.9 7.5 15.3 22.9 6.1 2.6 24.3 10.0 4.4 5.2 12.6 15.0 19.4 1.5 1.6 24.1 4.7 6.4 5.3 2.7 3.1 2.6 3.7 2.2 0.3 2.1 5.9 5.1 0.1 4.6 1.2 7.7 0.5 1.4 2.2 0.1 0.2 9.4 10.3 1.6 3.9 23.1 0.9 0.9 1.5 1.9 23.6 16.8 0.4 98.7 1.8 1.5 0.1 3.2 0.1 0.8 0.1 2.1 4.8 0.3 41.2 9.0 0.7 2.0 12.3 0.2 0.8 0.0 2.3 0.0 4.6 12.1 0.5 0.0 22.9 3.0 16.8 28.7 0.5 0.0 13.3 2.8 9.3 8.6 0.7 7.6 15.4 0.0 26.8 19.8 16.1 20.0 21.5 0.1 0.4 3.9 0.1 0.0 0.3 0.7 3.1 0.7 1.7 1.5 0.0 3.7 0.4 1.3 4.7 1.4 0.1 0.9 1.0 4.6 0.1 0.1 0.7 1.2 0.5 7.7 2.6 0.8 2.2 6.1 5.2 1.6 5.8 4.9 7.5 7.9 7.5 10.0 2.6 8.9 22.7 18.6 9.6 3.2 1.5 34.8 7.6 0.0 0.0 61.1 0.0 349.5 43.1 0.9 0.0 2.8 125.5 0.0 48.0 260.2 17.5 2.9 4.7 304.1 118.1 6.4 27.2 11.1 13.0 0.0 27.0 12.3 40.5 5.4 45.2 20.3 17.4 77.2 25.5 417.3 3.5 6.5 11.3 0.5 2.5 1.8 180.3 6.4 95.6 6.4 QRFPR GPR103 ENSG00000186867 "Pyroglutamylated RFamide peptide receptor" Q96P65 4 121329312-121381059 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 6.9;heart muscle: 4.6" "Cell type enhanced" "Detected in some" 29 "Cardiomyocytes: 3.2;Early spermatids: 1.6" "Cancer enriched" "Detected in some" 6 "renal cancer: 5.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 5.3;hTERT-HME1: 7.2;JURKAT: 2.3;RPTEC TERT1: 4.6;SCLC-21H: 2.9;U-2 OS: 7.8;WM-115: 4.4" "Low region specificity" "Detected in many" HPA050236 Approved NA NA "HPA050236: " "unprognostic (1.24e-2)" "unprognostic (2.30e-1)" "unprognostic (1.93e-2)" "unprognostic (3.21e-1)" "unprognostic (2.77e-1)" "unprognostic (3.21e-4)" "unprognostic (2.71e-1)" "unprognostic (5.77e-3)" "unprognostic (5.37e-2)" "unprognostic (6.33e-2)" "unprognostic (2.12e-1)" "prognostic favorable (3.09e-4)" "unprognostic (3.09e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 1.6 1.2 0.7 0.3 1.9 0.0 0.5 0.1 2.0 0.3 0.2 0.3 0.0 0.0 0.2 1.1 0.8 0.1 1.1 4.6 1.3 6.9 3.2 0.2 0.1 0.0 0.8 0.8 0.4 0.0 1.0 0.8 0.2 4.9 0.6 0.1 3.3 0.0 2.3 0.1 0.0 0.4 0.2 2.6 0.0 1.3 0.7 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 4.6 0.0 2.9 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 7.8 0.0 0.0 0.1 1.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.1 2.0 1.3 6.9 0.8 0.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 QRICH2 DKFZP434P0316 ENSG00000129646 "Glutamine rich 2" Q9H0J4 17 76274049-76307998 "Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 27.4" "Cell type enhanced" "Detected in some" 21 "Cholangiocytes: 7.6;Early spermatids: 25.8;Late spermatids: 5.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA052219 Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles" NA NA "Nucleoplasm, Nuclear membrane, Vesicles" "HPA052219: AB_2681766" "unprognostic (3.11e-2)" "unprognostic (2.44e-3)" "unprognostic (9.11e-3)" "unprognostic (4.42e-3)" "unprognostic (1.35e-1)" "unprognostic (1.32e-2)" "unprognostic (2.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.83e-1)" "unprognostic (2.61e-1)" "unprognostic (8.82e-4)" "unprognostic (3.64e-1)" "unprognostic (1.39e-1)" "unprognostic (6.97e-2)" "unprognostic (7.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.71e-3)" 0.9 0.8 1.2 0.9 2.2 1.9 0.9 5.7 2.0 0.9 0.9 0.9 0.9 0.3 0.9 1.0 1.0 1.2 0.9 0.9 1.4 2.0 0.9 1.1 1.1 0.9 1.4 0.9 0.9 1.3 0.6 0.9 1.4 0.9 0.9 0.8 0.9 5.6 0.9 1.4 1.7 0.9 0.9 1.2 0.9 0.3 27.4 0.9 0.9 3.0 0.9 0.9 0.9 0.9 0.9 0.0 0.0 0.1 0.3 0.4 0.3 1.2 2.5 4.8 5.4 2.6 2.4 2.2 2.2 0.5 1.7 0.5 1.3 0.5 6.5 0.9 1.4 1.3 0.5 6.3 1.1 2.1 1.8 3.8 0.6 1.7 5.8 1.4 0.9 3.0 2.1 1.0 1.9 0.1 3.3 2.1 2.0 3.5 1.3 0.6 3.8 3.4 0.8 1.9 1.6 5.2 7.6 3.9 0.2 0.9 2.3 4.4 4.4 1.1 0.6 2.6 4.9 2.0 2.7 2.1 1.4 5.1 6.8 2.6 1.8 1.7 0.6 1.5 3.8 1.6 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.9 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 1.2 2.2 5.7 2.0 1.4 2.0 1.4 0.9 0.9 0.9 0.0 0.0 0.0 0.3 0.1 0.5 1.6 7.6 0.0 0.0 1.8 0.0 0.6 0.0 0.7 25.8 0.6 0.3 0.0 0.0 0.9 0.2 0.3 0.0 0.8 0.2 1.6 0.0 0.0 0.3 5.8 0.9 0.0 1.7 1.0 0.5 1.5 0.5 0.0 0.7 0.4 1.8 0.0 0.6 2.1 1.1 0.3 0.3 0.0 0.4 0.3 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154834-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 172.2" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 1528.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 197.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056243 Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 3200000000 "Golgi apparatus" Vesicles "HPA056243: AB_2683077" "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 15.9 18.7 8.0 14.5 9.5 30.1 12.6 7.3 13.6 23.5 25.3 13.8 24.9 19.8 17.8 44.9 36.8 18.9 91.9 54.4 10.1 9.0 15.4 23.1 42.3 19.5 8.5 9.1 46.5 59.8 6.2 13.5 172.2 13.4 28.0 24.5 12.1 20.6 19.4 18.4 12.3 19.0 33.9 15.5 13.4 52.8 50.3 9.1 6.7 7.8 18.2 18.3 35.8 26.1 2.9 19.2 20.4 25.5 8.0 7.1 11.4 42.1 6.0 1.4 18.0 18.4 38.1 71.7 44.9 45.4 38.4 27.1 0.7 13.6 0.6 27.9 35.9 5.3 9.2 1.7 12.1 18.8 2.5 2.7 1.3 3.5 1.8 197.7 4.6 13.0 20.3 5.5 40.9 49.1 50.6 56.5 3.1 1.9 6.6 25.2 7.3 0.9 8.6 4.9 29.2 17.3 1.8 3.3 1.1 6.3 12.0 5.2 5.3 13.1 17.9 8.7 3.4 3.2 21.9 66.5 48.1 18.9 32.2 37.9 4.8 7.9 1.1 18.3 14.8 14.4 5.8 25.5 9.5 7.1 14.7 5.3 2.9 4.8 5.0 19.2 1.8 4.4 4.3 20.4 8.0 13.1 3.9 5.5 11.4 8.0 9.5 7.3 13.6 10.1 9.0 8.5 9.1 13.4 9.1 53.6 87.2 7.8 26.2 12.2 9.8 43.7 68.8 14.7 43.3 68.0 23.6 13.2 0.0 189.3 48.3 38.6 47.7 0.0 114.6 1528.4 54.2 30.1 25.3 1.5 63.8 6.4 44.4 101.9 45.4 16.5 164.5 43.6 42.2 44.1 163.8 43.9 172.2 143.8 66.8 9.5 6.5 32.3 17.5 20.9 25.4 8.7 129.1 15.0 96.4 58.0 R3HDM1 "KIAA0029, R3HDM" ENSG00000048991 "R3H domain containing 1" Q15032 2 135531455-135725270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030936 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA030936: AB_10670835" "unprognostic (1.93e-1)" "unprognostic (4.32e-2)" "unprognostic (8.16e-3)" "unprognostic (1.10e-3)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (2.00e-3)" "prognostic unfavorable (8.02e-4)" "unprognostic (3.51e-2)" "unprognostic (9.52e-2)" "unprognostic (5.51e-2)" "unprognostic (5.76e-2)" "prognostic unfavorable (5.83e-7)" "unprognostic (1.16e-2)" "unprognostic (7.23e-2)" "unprognostic (4.32e-3)" "unprognostic (2.47e-1)" 6.5 6.4 23.2 8.3 27.8 13.4 5.3 22.2 57.6 6.7 7.5 4.5 2.4 4.5 6.9 6.6 6.2 5.5 6.3 5.3 17.9 15.5 6.0 6.2 5.0 11.0 11.5 32.7 5.3 8.4 20.1 13.2 4.2 7.7 5.4 10.3 4.3 4.3 6.1 13.5 5.3 5.6 8.6 7.9 6.6 5.4 14.3 7.6 14.2 8.7 3.6 13.2 8.4 4.3 6.5 12.7 3.5 8.4 9.6 9.6 5.0 20.2 12.5 17.7 20.4 9.5 13.0 10.4 12.7 13.4 12.9 14.1 22.3 14.1 32.2 10.2 18.1 9.4 9.2 23.0 23.7 22.6 20.2 11.6 26.0 15.9 22.2 11.4 22.1 16.8 12.2 10.6 22.6 29.1 11.7 20.6 35.2 26.8 27.7 14.7 20.9 38.3 15.2 13.6 15.2 14.7 22.8 12.2 19.3 12.8 17.9 18.1 14.1 20.5 8.4 9.2 16.1 11.3 11.9 15.0 11.9 11.9 15.0 16.0 22.2 30.4 30.3 13.5 18.2 15.2 3.5 7.8 3.0 6.1 8.4 5.8 6.5 6.6 9.1 11.2 4.4 6.4 7.2 1.0 9.6 7.1 12.7 9.6 5.0 23.2 27.8 22.2 57.6 17.9 15.5 11.5 32.7 7.7 7.6 6.0 1.9 14.1 5.9 7.0 44.7 14.0 12.7 4.0 18.2 7.0 19.6 6.4 16.6 7.5 37.1 12.0 3.8 23.3 6.5 8.3 7.5 7.5 17.4 10.2 10.6 25.4 22.0 13.5 20.0 33.7 12.7 14.2 6.8 10.8 9.7 8.7 7.2 3.5 10.6 9.0 38.8 0.0 8.6 22.3 25.1 8.4 2.6 13.8 10.3 5.2 R3HDM4 "C19orf22, MGC16353" ENSG00000198858 "R3H domain containing 4" Q96D70 19 896503-913245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 93.1" "Lineage enriched" "Detected in all" 12 "granulocytes: 93.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043025, HPA048638" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA043025: AB_2678275, HPA048638: AB_2680472" "unprognostic (9.22e-2)" "unprognostic (2.32e-2)" "unprognostic (1.28e-2)" "prognostic favorable (7.33e-6)" "unprognostic (4.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.28e-1)" "unprognostic (1.46e-3)" "unprognostic (7.44e-2)" "unprognostic (4.52e-1)" "unprognostic (2.08e-1)" "unprognostic (6.74e-2)" 15.4 11.7 23.3 33.2 19.5 57.7 15.4 12.7 26.6 15.9 16.5 16.3 10.0 17.1 15.3 13.2 33.0 15.7 20.1 12.5 20.2 11.9 18.8 24.1 22.7 43.3 14.8 11.9 19.2 34.9 10.0 16.2 18.5 12.8 17.7 12.6 15.5 24.2 14.5 21.6 22.4 18.0 13.4 10.3 41.1 24.1 8.1 12.5 31.9 14.6 19.6 43.0 20.6 19.0 6.4 2.2 93.1 2.0 1.2 7.7 3.8 17.8 10.5 11.2 15.2 7.1 12.7 18.5 12.2 9.7 12.3 10.9 11.1 15.4 13.0 10.1 13.7 2.6 16.4 6.5 14.4 5.6 19.8 13.7 17.8 9.2 19.4 21.5 9.7 31.6 16.8 27.9 7.9 16.8 11.3 14.1 15.5 32.9 26.5 11.4 32.0 13.9 18.7 14.5 21.8 17.3 13.7 5.4 24.6 20.3 18.8 19.8 19.2 10.7 23.7 19.9 9.0 20.9 23.6 14.2 22.5 12.5 26.1 12.0 29.5 15.4 18.9 14.3 14.1 19.5 14.6 2.0 16.2 2.5 1.5 3.9 6.4 5.0 3.4 2.2 3.8 4.8 3.3 93.1 1.2 2.0 0.9 7.7 3.8 23.3 19.5 12.7 26.6 20.2 11.9 14.8 11.9 12.8 12.5 17.9 28.7 41.0 33.3 31.1 15.9 6.0 20.4 12.0 13.6 17.4 7.9 34.5 6.6 39.6 0.9 18.0 18.6 23.3 47.7 40.0 23.1 40.7 23.1 10.5 23.7 27.0 31.4 12.9 21.9 1.7 10.3 25.3 23.6 54.1 28.0 6.0 48.9 26.9 11.0 13.6 10.4 25.8 23.1 0.7 3.9 27.7 57.7 29.8 20.7 65.5 R3HDML dJ881L22.3 ENSG00000101074 "R3H domain containing like" Q9H3Y0 20 44336986-44351235 "Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.4;intestine: 5.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;CACO-2: 3.6;OE19: 3.6;U-2 OS: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA070264 Enhanced "Secreted - unknown location" NA NA "HPA070264: AB_2686244" "unprognostic (1.89e-1)" "unprognostic (2.23e-1)" "unprognostic (9.86e-2)" "unprognostic (9.12e-2)" "unprognostic (6.06e-3)" "unprognostic (2.64e-1)" "unprognostic (6.32e-2)" "unprognostic (4.95e-3)" 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.0 1.5 5.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.4 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.8 1.4 0.1 0.0 0.0 0.0 0.3 0.5 0.9 0.0 0.2 0.2 0.0 0.0 0.3 1.7 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.6 0.8 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.6 0.4 0.2 1.2 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.1 0.0 0.2 3.6 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.4 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.4 2.7 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.5 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB11FIP1 "FLJ22524, FLJ22622, Rab11-FIP1, RCP" ENSG00000156675 "RAB11 family interacting protein 1" Q6WKZ4 8 37858618-37899467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 741.5;Urothelial cells: 458.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 39.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 39.0" "Cell line enhanced" "Detected in many" "K-562: 29.7" "Low region specificity" "Detected in single" "CAB017037, HPA023904, HPA024010, HPA025960" Enhanced Enhanced Vesicles No No Vesicles "CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992" "unprognostic (1.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.22e-3)" "unprognostic (2.87e-1)" "unprognostic (1.06e-1)" "prognostic favorable (6.61e-4)" "unprognostic (4.32e-1)" "unprognostic (4.50e-3)" "unprognostic (1.58e-1)" "unprognostic (4.72e-2)" "unprognostic (2.82e-3)" "unprognostic (2.73e-2)" "prognostic favorable (1.14e-6)" "unprognostic (4.94e-2)" "unprognostic (8.41e-2)" "unprognostic (9.99e-2)" "unprognostic (1.50e-1)" 6.9 3.2 1.3 16.8 1.0 17.8 7.4 1.8 1.3 8.9 37.1 1.9 17.8 13.8 2.9 8.8 30.9 5.6 31.5 5.9 1.1 1.3 8.4 4.1 64.5 8.4 1.1 0.6 4.7 31.5 3.9 12.9 26.0 6.9 7.0 16.4 9.9 20.9 21.3 3.4 13.8 90.6 5.3 1.3 10.9 15.2 5.4 0.9 16.4 8.5 14.9 34.1 9.6 9.6 2.3 6.9 39.0 7.7 4.1 4.0 3.3 17.2 7.6 0.8 3.4 0.2 0.0 23.5 1.8 2.8 3.3 4.2 17.0 9.9 7.0 5.5 2.1 0.2 13.4 6.2 3.9 4.9 18.2 5.8 1.3 4.0 4.9 9.3 3.0 15.7 2.2 5.3 1.2 3.4 4.8 0.0 9.4 29.7 3.5 1.7 4.1 5.0 4.4 5.1 17.0 2.3 1.6 4.2 5.4 17.0 17.8 3.2 3.7 4.5 22.5 5.5 16.8 15.2 5.8 0.2 0.1 10.2 0.2 0.3 7.1 8.3 1.9 0.1 4.1 2.4 6.9 7.7 13.7 1.8 3.7 4.0 2.3 1.3 1.2 6.9 1.7 0.8 0.9 39.0 4.1 6.9 4.2 2.9 3.3 1.3 1.0 1.8 1.3 1.1 1.3 1.1 0.6 6.9 0.9 741.5 109.5 15.9 71.9 14.2 4.8 11.6 68.8 238.3 205.9 61.1 15.7 29.6 13.3 135.4 0.8 10.5 359.4 0.0 214.5 4.9 15.3 195.3 29.0 12.1 29.4 6.4 233.5 17.8 43.0 0.7 1.7 62.6 15.1 32.5 172.7 18.1 301.2 259.6 1.4 12.9 19.9 6.5 12.8 2.6 5.9 26.7 80.3 74.0 158.8 458.6 RAB11FIP3 "eferin, KIAA0665, Rab11-FIP3" ENSG00000090565 "RAB11 family interacting protein 3" O75154 16 425619-523011 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 70.5" "Cell type enriched" "Detected in many" 14 "Proximal tubular cells: 333.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028088, HPA028631, HPA030086" Enhanced Enhanced "Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria" Yes No "Vesicles, Centriolar satellite" "Nucleoplasm, Cytokinetic bridge, Mitochondria" "HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596" "unprognostic (6.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.51e-1)" "prognostic favorable (1.22e-4)" "unprognostic (2.87e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.87e-5)" "unprognostic (6.71e-2)" "unprognostic (4.74e-1)" "unprognostic (9.66e-2)" "prognostic favorable (3.16e-5)" "unprognostic (1.12e-1)" "prognostic favorable (7.99e-4)" "unprognostic (1.39e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-1)" "unprognostic (1.44e-1)" 10.2 13.4 19.3 7.5 16.9 8.7 7.3 29.7 27.4 11.5 10.6 12.2 9.0 13.4 11.9 11.0 8.2 9.5 11.3 14.0 18.7 12.1 70.5 12.2 10.5 8.1 12.0 18.0 13.4 22.2 22.4 14.6 10.0 10.6 11.5 5.4 9.9 13.2 12.6 23.5 12.2 14.6 10.8 8.9 10.2 7.6 13.5 11.9 5.7 8.6 7.4 5.3 9.7 16.6 1.1 0.8 0.1 0.1 0.1 1.5 0.6 4.4 10.2 9.8 8.6 14.5 9.5 8.5 8.5 8.0 7.8 5.6 7.5 2.1 12.3 10.0 12.4 6.9 4.6 6.1 9.0 2.7 9.1 8.7 5.5 9.5 21.7 15.5 5.5 6.9 9.1 6.2 8.0 7.0 9.1 11.9 8.5 2.8 4.9 9.8 13.7 8.9 10.9 8.2 3.2 4.2 18.5 7.8 3.2 7.8 2.7 10.2 9.5 8.7 10.7 5.4 3.5 5.9 10.2 19.2 11.4 7.6 10.6 5.6 6.8 5.3 14.5 4.3 3.9 8.4 0.0 0.1 0.0 1.5 0.0 1.3 0.8 0.9 0.7 0.5 1.1 0.6 0.3 0.1 0.1 0.0 0.8 0.0 0.6 19.3 16.9 29.7 27.4 18.7 12.1 12.0 18.0 10.6 11.9 3.0 1.7 3.4 0.4 3.3 8.2 11.7 7.6 4.0 6.8 5.2 5.9 0.8 23.2 1.4 1.0 2.5 6.4 0.0 1.0 0.1 2.3 1.1 1.1 14.1 0.7 20.6 2.9 19.6 5.1 1.6 0.6 1.2 0.0 0.0 2.7 6.1 1.6 1.7 1.8 333.9 7.1 6.5 2.1 2.7 3.0 1.9 0.7 2.6 4.1 0.3 RAB11FIP4 "FLJ00131, KIAA1821, MGC11316, RAB11-FIP4" ENSG00000131242 "RAB11 family interacting protein 4" Q86YS3 17 31391624-31538217 "Predicted intracellular proteins" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.9;brain: 39.3" "Cell type enhanced" "Detected in many" 23 "Early spermatids: 303.9;Horizontal cells: 200.2;Late spermatids: 884.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 32.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.9" "Cell line enhanced" "Detected in many" "BEWO: 31.1;Daudi: 17.1;Hep G2: 18.8;HMC-1: 20.1;RT4: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021595 Approved NA NA "HPA021595: AB_2670769" "unprognostic (2.11e-1)" "unprognostic (1.48e-1)" "prognostic favorable (2.70e-4)" "unprognostic (6.03e-3)" "unprognostic (4.29e-2)" "unprognostic (4.15e-2)" "unprognostic (1.11e-1)" "unprognostic (1.35e-3)" "unprognostic (2.71e-1)" "unprognostic (3.20e-1)" "unprognostic (1.16e-1)" "unprognostic (1.49e-1)" "prognostic favorable (7.74e-8)" "prognostic favorable (1.22e-4)" "unprognostic (3.00e-1)" "unprognostic (2.00e-2)" "unprognostic (4.13e-3)" 1.2 1.5 25.7 7.1 30.2 12.4 4.3 16.6 39.3 2.9 8.7 22.0 4.8 11.9 1.5 11.0 4.4 7.4 3.3 2.7 28.8 19.7 6.9 3.1 5.5 10.1 29.7 16.9 2.7 16.2 5.6 2.7 9.5 14.9 2.7 7.1 1.6 6.8 4.4 0.8 7.5 13.2 1.2 26.6 6.6 12.2 25.4 16.3 2.0 4.6 0.4 9.7 4.3 1.8 4.4 2.4 32.9 6.5 2.5 6.4 3.3 5.7 0.6 0.6 1.5 0.2 0.0 31.1 0.1 0.0 0.4 0.4 9.6 0.9 17.1 2.2 0.1 6.4 4.9 5.8 2.7 0.2 3.4 5.2 0.0 0.2 18.8 0.1 1.2 20.1 0.1 2.8 0.4 1.3 0.1 0.0 5.2 1.2 0.4 0.0 4.5 1.2 0.3 5.0 10.6 0.1 0.4 0.0 3.3 1.1 17.7 9.2 6.5 1.3 8.3 7.1 4.4 12.3 0.6 0.0 0.3 3.2 0.0 0.2 3.2 2.5 1.6 0.1 1.7 1.2 1.9 3.6 32.9 6.4 5.1 4.1 2.6 3.4 4.7 2.4 4.4 3.6 4.2 17.7 2.5 6.5 0.5 4.0 3.3 25.7 30.2 16.6 32.1 28.8 19.7 29.7 16.9 14.9 16.3 6.0 8.8 0.5 10.0 2.7 4.3 7.7 17.8 5.3 10.3 10.4 9.8 52.8 11.6 14.8 303.9 0.7 26.2 0.0 24.4 9.2 2.2 10.0 11.5 3.9 5.4 200.2 14.3 0.0 0.6 884.4 4.9 6.7 10.1 5.4 16.9 56.5 21.3 18.7 4.6 8.9 7.3 0.0 1.9 6.6 11.1 2.6 42.1 11.3 18.0 13.9 RAB11FIP5 "GAF1, KIAA0857, pp75, RIP11" ENSG00000135631 "RAB11 family interacting protein 5" Q9BXF6 2 73073382-73156721 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 64.5;Late spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.6" "Lineage enriched" "Detected in single" 18 "T-cells: 2.6" "Cell line enhanced" "Detected in many" "TIME: 25.4" "Low region specificity" "Detected in all" "HPA036406, HPA036407" Enhanced Enhanced "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA036406: AB_2675105, HPA036407: AB_10669778" "unprognostic (1.49e-1)" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-3)" "unprognostic (3.26e-2)" "unprognostic (1.58e-3)" "unprognostic (4.08e-3)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (3.23e-3)" "unprognostic (1.45e-1)" "prognostic favorable (2.26e-5)" "unprognostic (1.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "unprognostic (9.66e-3)" 8.4 5.4 5.3 3.8 9.3 1.5 6.3 9.5 16.7 5.2 4.2 2.8 4.6 3.5 7.9 7.3 5.3 5.6 8.2 7.2 4.9 6.3 14.9 2.3 4.8 2.1 5.6 6.5 6.7 8.4 22.3 4.3 11.4 16.0 5.3 2.1 5.1 9.5 5.9 9.0 5.8 2.6 5.2 2.9 18.9 4.9 46.4 2.5 0.0 3.9 4.7 2.7 5.3 7.4 0.1 0.0 0.0 0.0 0.0 2.6 0.5 12.2 5.5 0.4 3.9 4.0 4.9 7.2 18.5 10.2 6.3 4.9 4.0 3.0 0.0 9.8 9.4 6.9 5.0 2.4 5.7 2.8 21.3 6.8 4.5 2.3 2.6 5.0 0.0 0.8 5.9 5.4 7.8 5.1 5.9 8.6 2.5 3.4 2.4 4.5 0.3 0.0 0.1 2.9 1.8 8.7 4.1 5.0 10.4 5.5 1.5 1.9 2.0 6.1 2.5 2.8 1.3 1.4 0.2 25.4 15.4 8.9 11.4 9.6 8.0 2.3 0.0 12.0 4.8 1.5 0.0 0.0 0.0 2.6 0.0 0.5 0.0 1.2 1.9 0.0 0.1 0.2 1.5 0.0 0.0 0.0 0.0 0.8 0.5 5.3 9.3 9.5 16.7 4.9 6.3 5.6 6.5 16.0 2.5 6.0 2.2 0.8 6.8 22.7 3.4 11.5 17.8 0.0 0.0 19.2 0.0 0.9 23.2 11.3 64.5 16.9 3.2 0.0 15.8 7.7 9.5 10.5 0.0 4.2 1.6 6.4 1.7 11.1 1.8 127.2 13.3 2.2 8.5 1.8 2.5 6.7 17.4 2.9 8.1 38.3 2.0 25.8 10.8 22.8 5.5 15.4 12.4 1.8 4.7 8.1 RAB12 ENSG00000206418 "RAB12, member RAS oncogene family" Q6IQ22 18 8609445-8639381 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040727 Approved Approved Vesicles NA NA Vesicles "HPA040727: AB_10794858" "unprognostic (7.92e-2)" "unprognostic (4.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (1.25e-2)" "unprognostic (2.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (2.02e-1)" "unprognostic (1.63e-1)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (9.11e-2)" 20.0 16.0 18.0 10.2 18.3 7.2 15.6 23.5 22.1 17.2 16.8 13.8 9.2 7.3 18.5 12.3 17.3 13.4 11.2 45.6 16.2 16.2 18.4 20.7 15.8 12.5 13.7 17.8 19.0 7.5 10.4 12.7 17.6 15.3 15.3 10.5 13.7 10.1 18.6 96.4 18.1 10.3 25.4 12.2 16.3 10.8 8.3 10.6 7.7 12.1 21.2 11.9 19.4 20.2 3.2 4.1 7.7 5.1 3.9 3.1 1.3 11.6 6.9 8.1 8.5 24.2 20.6 4.5 15.9 21.9 18.2 21.4 9.4 10.8 4.0 15.5 19.0 13.6 7.4 9.4 17.0 22.1 1.6 7.6 3.4 7.4 9.8 22.5 4.5 3.6 20.3 24.1 13.3 17.1 18.8 21.9 3.6 5.2 5.8 17.6 12.6 5.1 4.5 5.2 40.4 6.6 3.6 19.7 3.8 17.7 15.7 13.5 9.6 12.1 16.5 19.9 12.0 4.8 6.9 18.3 21.1 12.3 21.0 24.1 3.9 2.2 3.4 15.8 4.2 13.4 7.7 2.2 2.4 2.1 3.6 3.0 3.2 2.3 2.5 1.8 3.0 3.1 3.0 4.1 3.9 5.1 4.1 2.5 1.3 18.0 18.3 23.5 22.1 16.2 16.2 13.7 17.8 15.3 10.6 11.9 17.1 3.4 1.7 5.8 14.8 87.9 2.5 10.7 13.6 3.5 5.9 1.4 3.3 2.0 0.0 7.4 1.6 0.0 1.2 1.1 5.0 3.2 5.8 15.3 1.5 11.1 5.2 19.6 13.9 0.0 3.1 6.9 3.3 2.8 2.8 14.3 2.5 0.0 4.2 4.9 6.7 0.0 5.2 1.0 1.5 7.3 0.9 2.5 2.3 3.5 RAB15 ENSG00000139998 "RAB15, member RAS oncogene family" P59190 14 64945814-64973226 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.4" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 31.6" "Cancer enhanced" "Detected in all" "testis cancer: 83.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Cell line enhanced" "Detected in many" "HAP1: 38.0;RH-30: 45.4;RT4: 33.2;SK-BR-3: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041177 Uncertain Approved "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA041177: AB_10794547" "unprognostic (9.80e-2)" "unprognostic (1.42e-2)" "unprognostic (1.53e-1)" "unprognostic (4.94e-2)" "unprognostic (6.29e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (4.68e-4)" "unprognostic (7.14e-2)" "unprognostic (3.12e-1)" "unprognostic (4.25e-2)" "unprognostic (2.79e-2)" "unprognostic (2.02e-1)" "unprognostic (1.98e-2)" "unprognostic (1.29e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-2)" "unprognostic (2.82e-2)" 2.3 4.0 16.7 4.2 19.2 0.6 6.3 40.4 32.9 5.7 9.9 2.2 3.2 9.1 2.4 4.5 1.8 1.9 4.7 14.1 21.2 10.8 7.5 11.4 4.3 2.6 7.8 12.6 1.4 5.6 16.2 4.0 11.9 10.2 4.3 15.4 1.9 27.2 3.8 3.9 2.8 9.6 8.6 4.2 1.2 5.3 1.0 2.5 2.4 2.9 0.6 2.2 13.4 1.8 0.0 5.2 0.0 0.1 0.8 0.7 0.1 3.0 16.5 6.1 6.0 1.4 1.9 17.1 1.9 2.7 4.0 3.6 7.7 8.4 0.1 1.1 4.8 1.9 3.2 38.0 0.3 2.9 1.0 1.8 3.5 0.3 6.7 0.2 0.1 2.2 1.3 0.7 1.7 0.3 1.0 12.6 8.6 0.1 0.5 7.1 17.6 4.2 3.2 13.6 18.9 2.4 5.2 45.4 0.2 4.7 33.2 19.6 3.8 1.0 34.8 4.4 7.4 9.8 3.3 3.1 3.5 15.0 1.6 2.4 0.1 0.1 1.6 0.7 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 5.2 0.3 0.1 16.7 19.2 40.4 32.9 21.2 10.8 7.8 12.6 10.2 2.5 6.0 3.8 0.0 3.0 2.3 0.4 20.1 2.5 1.4 5.7 15.7 0.0 20.0 3.3 7.2 0.4 2.1 3.5 0.0 10.4 13.7 2.1 5.0 1.1 8.7 2.4 11.1 1.2 4.9 0.0 0.4 0.3 0.9 0.0 1.8 31.6 2.0 12.0 3.5 1.4 3.7 2.7 0.0 3.3 0.5 0.3 1.0 15.0 0.5 12.0 9.1 RAB17 ENSG00000124839 "RAB17, member RAS oncogene family" Q9H0T7 2 237574322-237601614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.8;liver: 37.0" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 100.1;Distal tubular cells: 116.0;Hepatocytes: 115.6;Proximal tubular cells: 151.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "pons and medulla: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.5;MCF7: 18.0;SK-BR-3: 19.6;SK-MEL-30: 47.0;T-47d: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA035176 Approved NA NA "HPA035176: AB_10696368" "unprognostic (8.66e-2)" "unprognostic (1.13e-1)" "unprognostic (1.44e-3)" "unprognostic (9.14e-2)" "unprognostic (2.48e-3)" "unprognostic (1.26e-3)" "unprognostic (1.33e-1)" "unprognostic (5.36e-2)" "unprognostic (3.49e-2)" "unprognostic (2.68e-2)" "prognostic favorable (4.14e-4)" "unprognostic (5.87e-2)" "prognostic favorable (3.33e-13)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (3.44e-1)" "prognostic favorable (2.51e-4)" 0.8 1.0 0.5 1.4 0.5 0.0 4.7 0.4 0.8 1.2 21.4 1.2 10.3 19.2 0.8 9.5 1.8 2.9 5.2 1.0 1.1 0.5 20.6 37.0 7.9 0.4 0.5 0.4 0.8 25.4 9.8 6.1 6.5 5.3 2.9 4.2 1.9 13.5 15.2 0.7 0.9 57.8 0.6 0.4 0.5 10.0 0.9 0.4 0.6 22.9 0.9 1.2 1.8 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 4.1 0.1 0.0 8.1 0.0 0.1 16.5 0.0 0.0 0.0 0.0 11.0 10.0 0.0 2.7 0.0 0.0 0.2 0.0 4.9 0.1 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 3.4 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.3 18.0 0.0 0.2 0.2 8.4 0.0 0.4 0.0 1.0 4.5 9.0 4.3 0.0 0.0 19.6 47.0 5.0 12.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 0.4 0.8 1.1 0.5 0.5 0.4 5.3 0.4 56.6 26.4 0.5 4.0 1.5 1.6 0.8 61.1 16.0 13.6 43.6 100.1 13.2 116.0 28.3 0.0 1.0 61.9 0.0 24.3 3.1 0.5 6.9 0.0 115.6 1.6 0.0 29.0 0.6 1.3 0.2 8.1 0.7 5.0 1.0 18.1 0.2 29.1 52.6 3.5 151.7 0.6 0.0 0.3 0.0 0.2 0.5 10.3 1.5 18.8 6.2 RAB19 RAB19B ENSG00000146955 "RAB19, member RAS oncogene family" A4D1S5 7 140404043-140426250 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 14.5" "Cell type enriched" "Detected in single" 12 "Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 4 "T-cells: 3.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.9;HDLM-2: 12.8;MCF7: 5.7;RPTEC TERT1: 4.2;RT4: 8.3;SK-BR-3: 6.5;T-47d: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051077 Uncertain NA NA "HPA051077: AB_2681336" "unprognostic (3.40e-1)" "unprognostic (2.07e-2)" "unprognostic (2.26e-1)" "unprognostic (3.10e-2)" "unprognostic (1.54e-1)" "unprognostic (6.48e-2)" "unprognostic (1.65e-1)" "unprognostic (2.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.72e-2)" "unprognostic (7.91e-2)" "unprognostic (2.53e-1)" "prognostic favorable (2.36e-8)" "unprognostic (1.73e-3)" "unprognostic (6.42e-2)" "unprognostic (3.44e-1)" "unprognostic (6.09e-3)" 0.4 0.3 0.3 2.8 0.3 6.7 0.8 0.3 0.3 0.6 5.2 0.0 0.8 4.0 0.4 2.8 0.7 1.2 8.7 0.3 0.3 0.3 8.9 0.5 2.4 4.7 0.3 0.0 0.3 14.5 5.6 10.5 1.5 0.0 2.6 5.0 0.0 5.7 0.2 0.3 0.7 12.1 0.0 0.3 1.1 2.4 0.5 0.0 3.6 11.3 1.7 3.6 1.7 0.4 0.8 0.0 0.3 0.0 0.6 3.5 0.4 0.8 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.1 5.9 0.0 0.6 0.0 0.0 0.9 0.0 1.6 0.0 12.8 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.7 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.2 8.3 1.1 0.0 0.0 6.5 0.0 0.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.1 0.8 0.9 3.2 0.0 0.0 1.4 1.4 0.3 0.6 0.0 0.0 3.5 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB23 ENSG00000112210 "RAB23, member RAS oncogene family" Q9ULC3 6 57186992-57222314 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Developmental protein" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 62.4;urinary bladder: 48.9" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 23.8;Leydig cells: 18.4;Peritubular cells: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.6;U-2197: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029135, HPA029136" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA029135: AB_10602070, HPA029136: AB_10601794" "unprognostic (8.78e-2)" "unprognostic (6.55e-2)" "unprognostic (7.17e-2)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (2.28e-2)" "unprognostic (2.55e-2)" "unprognostic (5.33e-3)" "unprognostic (6.41e-2)" "unprognostic (6.55e-2)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "unprognostic (9.12e-3)" "unprognostic (1.36e-2)" "unprognostic (2.38e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-3)" 6.0 3.0 6.7 5.7 5.1 0.2 4.0 7.3 4.8 23.1 32.9 5.1 9.6 3.0 34.1 8.0 9.7 8.1 12.4 7.0 7.4 4.5 3.3 1.8 4.9 1.7 6.4 5.4 8.2 1.6 2.9 3.5 12.3 6.7 24.9 7.5 3.6 2.8 26.9 4.7 3.1 7.0 62.4 6.6 1.1 8.7 4.3 7.2 1.4 15.1 3.9 1.7 48.9 11.2 0.3 1.5 1.3 0.6 0.9 2.0 0.3 4.8 1.9 7.0 4.9 10.7 32.6 6.4 14.3 24.8 12.6 13.1 4.2 2.3 0.9 4.4 22.9 6.3 1.7 7.2 5.2 15.0 3.6 3.4 3.5 3.2 3.3 6.6 1.8 0.5 12.1 6.0 15.6 14.7 6.1 6.5 2.1 5.4 3.0 13.9 4.0 1.6 1.9 2.6 3.2 2.6 1.7 10.3 1.4 8.7 3.4 3.6 2.5 7.1 3.4 3.6 9.1 3.1 2.1 8.7 19.6 6.1 57.6 8.3 2.6 2.8 2.4 11.0 3.9 9.6 0.3 0.4 1.3 0.3 0.4 0.0 0.3 1.1 0.5 0.3 0.3 2.0 0.8 0.0 0.9 0.6 1.5 0.0 0.3 6.7 5.1 7.3 4.8 7.4 4.5 6.4 5.4 6.7 7.2 11.9 5.3 0.0 1.6 3.7 2.9 3.1 2.5 6.7 1.2 0.0 2.0 10.0 0.0 2.8 2.1 1.4 1.3 0.0 2.5 8.4 23.8 3.6 0.0 3.0 3.7 1.6 1.2 4.9 0.6 1.3 18.4 1.3 5.0 12.6 1.2 3.2 2.8 0.0 28.7 4.4 0.7 0.0 9.0 6.7 7.1 4.4 11.4 0.0 1.2 1.4 RAB25 CATX-8 ENSG00000132698 "RAB25, member RAS oncogene family" P57735 1 156061160-156070514 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 98.3" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 238.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.3;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 24 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 24.3;CAPAN-2: 23.6;MCF7: 32.8;OE19: 75.9;RT4: 29.8;SK-BR-3: 48.5;T-47d: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010872, CAB033645" Enhanced Uncertain "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "CAB033645: AB_1128883, HPA010872: AB_1079729" "unprognostic (2.43e-1)" "unprognostic (4.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (4.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.82e-1)" "unprognostic (2.03e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.38e-6)" "unprognostic (2.31e-2)" "unprognostic (3.24e-2)" "unprognostic (3.14e-2)" "unprognostic (4.94e-2)" 0.4 0.3 0.3 10.9 0.3 0.0 10.8 0.5 0.4 23.6 28.4 0.3 28.1 14.8 4.0 15.9 98.3 9.7 33.3 0.3 0.3 0.3 18.2 1.0 19.1 0.6 0.3 0.2 2.3 27.4 8.6 9.5 19.1 0.3 13.3 16.2 0.4 44.1 26.8 0.4 48.0 43.0 2.1 0.4 0.3 16.2 1.1 0.2 3.7 36.1 74.6 60.9 13.0 31.8 0.1 0.0 0.0 0.0 0.0 3.4 0.8 17.8 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 17.5 23.6 0.0 0.0 0.0 0.0 21.5 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 0.9 75.9 0.0 0.0 0.0 0.0 0.0 29.8 2.6 0.0 0.0 48.5 0.0 4.4 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 2.8 0.8 0.0 0.0 3.4 2.9 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.3 0.5 0.4 0.3 0.3 0.3 0.2 0.3 0.2 26.8 27.6 0.0 90.6 48.9 0.0 0.1 79.0 53.5 27.3 82.0 0.0 84.0 140.9 146.8 0.0 0.1 182.7 0.0 132.5 23.0 3.7 95.3 5.7 0.0 6.1 0.0 82.1 0.0 0.0 0.0 0.3 2.5 20.3 6.4 160.3 0.0 154.4 238.4 0.0 16.8 0.0 0.0 2.1 0.2 0.7 135.3 67.2 1.5 195.0 192.0 RAB26 ENSG00000167964 "RAB26, member RAS oncogene family" Q9ULW5 16 2140803-2154165 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7" "Group enriched" "Detected in many" 7 "Bipolar cells: 34.1;Intestinal endocrine cells: 95.4;Mucus-secreting cells: 41.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 13.9;HeLa: 15.2;MCF7: 9.1;SCLC-21H: 19.3;SK-BR-3: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075624 Uncertain "Vesicles,Plasma membrane,Centrosome" "Intracellular and membrane" No No "Vesicles, Plasma membrane" Centrosome "HPA075624: " "unprognostic (1.01e-2)" "prognostic favorable (8.20e-5)" "unprognostic (7.25e-2)" "unprognostic (1.52e-1)" "unprognostic (7.34e-2)" "unprognostic (9.41e-3)" "unprognostic (2.81e-2)" "unprognostic (5.10e-2)" "unprognostic (1.82e-2)" "unprognostic (3.55e-2)" "unprognostic (3.75e-2)" "unprognostic (2.14e-1)" "unprognostic (6.48e-2)" "unprognostic (5.68e-2)" "unprognostic (1.23e-1)" "unprognostic (7.16e-2)" "unprognostic (2.92e-3)" 0.6 1.0 13.6 0.4 19.9 0.5 0.9 30.5 13.5 2.0 4.1 0.5 1.5 5.7 0.4 2.3 1.2 0.9 1.1 1.2 18.0 6.2 0.7 21.9 0.6 0.6 5.6 9.1 0.6 24.6 3.1 9.2 0.3 2.5 2.2 5.4 0.7 17.7 1.6 1.1 1.2 6.0 0.4 1.9 0.6 5.3 0.6 3.2 0.0 1.2 0.0 1.1 0.9 0.0 0.8 0.2 0.0 0.1 0.0 1.1 0.7 1.1 13.9 0.0 3.5 0.2 0.1 0.1 0.6 1.1 0.5 0.9 0.4 2.8 0.2 1.0 0.9 0.4 2.2 0.7 0.2 0.0 1.5 1.4 0.5 15.2 1.2 0.6 0.0 0.4 0.5 0.1 0.1 0.2 3.3 0.3 2.2 0.3 0.0 1.6 9.1 0.0 0.6 0.8 4.5 1.3 1.1 1.1 2.3 5.4 0.9 19.3 3.8 0.3 17.5 0.7 0.2 5.7 0.2 0.6 0.0 2.5 0.2 0.2 2.0 0.1 0.2 0.4 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 13.6 19.9 30.5 13.5 18.0 6.2 5.6 9.1 2.5 3.2 0.0 0.6 1.4 1.9 1.1 34.1 1.2 2.5 0.0 2.3 0.0 3.9 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.8 0.0 0.0 1.6 0.0 7.3 0.2 1.6 95.4 0.6 0.3 0.0 0.0 0.0 3.3 0.0 41.2 8.1 0.8 1.9 0.0 0.4 8.4 0.0 0.1 0.0 2.3 0.1 0.1 0.0 2.7 1.4 RAB27B ENSG00000041353 "RAB27B, member RAS oncogene family" O00194 18 54717860-54895516 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.0;stomach 1: 36.6" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 200.3;granulocytes: 234.0;Late spermatids: 149.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 4.6;NK-cell: 5.0" "Group enriched" "Detected in many" 4 "NK-cells: 5.0;T-cells: 4.6" "Cell line enhanced" "Detected in many" "HEL: 20.9;hTCEpi: 16.0;hTERT-HME1: 19.4;U-87 MG: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017712, HPA019849" Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 37000000 "Golgi apparatus, Plasma membrane" Cytosol "CAB017712: , HPA019849: AB_1856000" "unprognostic (1.59e-1)" "unprognostic (5.20e-2)" "unprognostic (9.89e-3)" "unprognostic (7.51e-2)" "unprognostic (8.89e-2)" "unprognostic (1.84e-2)" "unprognostic (1.52e-1)" "unprognostic (2.73e-3)" "unprognostic (6.82e-2)" "unprognostic (8.12e-2)" "prognostic unfavorable (2.13e-4)" "unprognostic (1.39e-2)" "unprognostic (1.20e-3)" "unprognostic (1.42e-1)" "unprognostic (1.84e-2)" "unprognostic (5.75e-1)" "unprognostic (1.29e-1)" 1.1 2.4 13.8 2.3 11.3 1.0 10.8 0.8 30.0 4.5 4.4 0.3 0.0 4.5 1.1 0.7 17.0 1.3 9.8 0.9 12.0 7.9 0.8 1.4 6.2 0.7 4.6 18.4 0.7 5.3 1.3 3.6 2.4 8.6 18.0 4.8 0.0 12.8 3.3 0.6 13.2 4.3 1.1 2.1 1.8 36.6 4.8 0.4 0.1 0.7 13.9 5.9 6.8 7.1 0.0 0.0 1.1 0.0 5.0 4.6 3.4 2.5 7.4 0.2 0.0 0.5 6.8 0.0 0.5 4.5 0.6 0.4 0.0 2.9 0.4 0.0 1.3 5.8 4.9 0.0 3.0 0.1 0.0 0.2 20.9 1.8 0.0 0.9 1.1 2.3 5.4 16.0 8.8 19.4 7.3 0.2 0.1 0.0 1.3 5.5 2.5 0.0 2.4 0.1 4.6 5.0 0.0 0.0 0.1 1.4 9.6 0.0 3.6 0.7 4.5 0.0 0.0 2.8 0.1 0.1 6.5 0.2 3.3 0.6 0.1 0.0 0.0 56.8 11.9 0.3 1.1 0.0 0.2 4.6 0.0 1.1 0.0 1.5 2.3 0.0 0.0 0.6 2.3 0.5 5.0 0.0 0.0 0.0 3.4 13.8 11.3 0.8 30.0 12.0 7.9 4.6 18.4 8.6 0.4 44.7 32.8 0.0 6.7 22.8 1.7 0.4 15.3 6.7 21.6 5.2 2.0 5.4 1.7 5.2 200.3 0.7 3.1 0.0 35.6 4.0 2.5 73.1 234.0 0.8 0.6 6.4 4.1 3.1 0.8 149.0 2.0 2.4 6.8 1.8 17.2 1.3 24.0 17.5 0.4 0.0 0.4 6.5 1.3 2.2 1.2 43.0 2.4 20.1 8.1 27.8 RAB32 ENSG00000118508 "RAB32, member RAS oncogene family" Q13637 6 146543693-146554965 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.8" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 26.5" "Group enriched" "Detected in many" 40 "dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA025731 Approved Approved Cytosol NA NA 330000 Cytosol "HPA025731: AB_1856001" "unprognostic (3.07e-1)" "unprognostic (5.32e-2)" "prognostic favorable (1.56e-4)" "prognostic unfavorable (6.51e-4)" "unprognostic (1.26e-1)" "unprognostic (2.34e-3)" "prognostic unfavorable (1.08e-7)" "unprognostic (2.64e-2)" "unprognostic (9.71e-2)" "unprognostic (3.38e-2)" "unprognostic (2.80e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.54e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" 18.4 9.0 5.2 11.0 4.9 57.8 29.9 1.1 4.4 8.4 14.6 6.6 6.3 6.7 14.8 12.8 10.2 10.2 11.2 15.3 5.2 3.0 10.7 23.0 16.5 26.4 6.2 3.5 11.0 7.4 1.5 2.8 5.9 7.4 12.5 14.9 11.3 10.1 6.9 6.3 10.2 9.0 28.2 7.5 29.4 10.6 20.8 5.5 10.4 5.8 7.0 5.6 15.6 15.2 0.0 16.0 26.5 17.3 0.5 0.0 4.9 12.0 6.4 7.5 12.5 11.4 19.4 0.0 23.5 26.1 32.2 53.6 3.9 6.0 0.0 8.6 24.7 35.8 16.0 0.4 15.1 43.5 0.0 5.8 15.3 16.1 14.1 49.6 21.1 22.7 17.1 25.4 18.4 26.2 16.9 20.8 0.0 2.9 0.0 17.5 2.8 9.6 11.5 0.9 0.0 12.4 0.0 8.0 0.1 12.6 8.4 0.0 9.9 27.5 3.3 40.5 6.9 6.4 17.2 16.6 9.8 13.4 25.7 28.5 0.0 1.7 0.0 22.5 15.9 13.2 26.5 17.3 2.9 0.0 7.7 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 6.3 0.5 5.3 0.8 0.0 4.9 5.2 4.9 1.1 4.4 5.2 3.0 6.2 3.5 7.4 5.5 44.7 6.5 5.3 93.5 47.6 1.4 1.4 48.4 2.7 9.1 10.4 3.9 1.7 21.6 146.0 64.9 29.2 39.3 0.0 90.9 5.3 38.7 32.5 57.6 67.1 193.4 0.0 57.7 31.9 182.0 123.7 22.7 98.6 160.3 72.1 30.8 9.1 140.5 43.2 24.1 61.7 1.3 19.4 20.6 31.1 12.3 16.7 2.6 5.7 62.4 55.7 RAB33A RabS10 ENSG00000134594 "RAB33A, member RAS oncogene family" Q14088 X 130171649-130184870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;brain: 32.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 23.0;Melanocytes: 11.8;T-cells: 20.3" "Group enriched" "Detected in many" 6 "glioma: 10.7;melanoma: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 32.2;Karpas-707: 36.5;U-266/70: 26.8;U-937: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059737 Uncertain Uncertain Vesicles NA NA Vesicles "HPA059737: AB_2684115" "unprognostic (5.40e-2)" "unprognostic (6.64e-3)" "unprognostic (3.48e-2)" "unprognostic (8.47e-3)" "unprognostic (4.88e-2)" "unprognostic (1.17e-2)" "unprognostic (2.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.12e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-2)" "unprognostic (8.28e-2)" "unprognostic (7.00e-6)" "unprognostic (2.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.61e-1)" 1.8 2.3 12.5 4.9 11.6 6.8 1.6 15.8 32.4 2.0 1.7 20.8 0.0 1.6 2.1 1.4 1.4 2.2 3.5 10.3 15.9 9.9 1.1 1.5 1.9 11.9 13.0 12.6 2.5 0.8 3.2 1.6 2.3 10.1 1.1 1.9 0.6 1.5 1.0 0.8 1.0 1.9 1.6 21.5 3.3 2.3 1.5 17.3 1.2 1.0 0.0 13.1 3.3 0.6 7.1 3.3 27.3 1.7 5.7 22.9 5.9 0.1 0.0 2.2 0.0 0.9 0.2 0.0 0.2 0.6 0.5 0.9 0.0 0.2 1.6 0.0 0.1 0.1 0.0 2.6 0.0 0.5 8.4 0.0 9.6 0.0 0.0 8.9 7.7 32.2 0.3 0.0 0.1 0.3 0.2 0.2 10.0 0.0 36.5 0.0 0.0 3.5 2.7 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 7.0 5.8 0.0 0.0 0.1 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.0 26.8 8.0 0.0 1.1 15.2 0.0 9.4 0.4 27.3 11.2 0.2 7.0 7.1 10.1 11.1 3.3 2.6 9.8 13.9 1.3 5.7 1.7 0.3 22.9 5.9 12.5 11.6 15.8 18.5 15.9 9.9 13.0 12.6 10.1 17.3 0.0 0.6 0.5 0.5 1.6 8.4 4.2 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.9 2.1 0.0 0.0 0.2 1.1 5.8 0.3 23.0 0.0 1.9 4.8 0.0 3.1 0.3 0.0 1.7 3.7 11.8 2.8 0.0 1.3 0.6 0.0 0.4 0.0 7.4 0.0 4.1 0.1 1.1 1.0 1.1 20.3 0.0 0.5 RAB36 ENSG00000100228 "RAB36, member RAS oncogene family" O95755 22 23145326-23164350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 38.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 53.5;Late spermatids: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 12.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 12.7" "Cell line enhanced" "Detected in many" "RPMI-8226: 17.8;U-266/84: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059631 Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059631: " "unprognostic (2.74e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-2)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (6.60e-2)" "unprognostic (1.22e-1)" "unprognostic (3.46e-1)" "unprognostic (2.49e-2)" "unprognostic (7.94e-2)" "unprognostic (2.02e-3)" "unprognostic (5.56e-3)" "prognostic favorable (4.55e-4)" "unprognostic (7.08e-2)" "unprognostic (7.18e-2)" "unprognostic (1.64e-1)" "unprognostic (3.08e-1)" 2.4 5.9 7.6 2.0 11.9 1.3 3.5 2.7 14.1 6.5 2.8 6.8 9.3 1.4 5.4 12.7 3.0 38.2 6.6 1.9 7.7 8.4 8.2 0.8 6.1 1.7 4.5 9.3 8.1 4.3 1.9 16.6 7.0 5.8 5.1 1.8 4.8 4.6 11.2 1.2 1.9 1.5 4.9 2.6 1.9 2.7 12.8 3.1 0.0 20.7 1.2 1.9 3.6 2.1 1.0 0.3 12.7 0.6 1.7 0.7 0.3 5.6 6.6 5.1 7.7 1.2 2.5 2.1 3.2 6.5 7.1 2.7 0.4 0.0 0.0 3.5 4.2 4.0 7.1 0.2 3.7 2.3 0.0 3.0 0.0 0.2 0.6 3.0 0.0 0.9 3.2 1.4 6.6 1.3 4.7 1.0 0.0 0.3 5.8 0.3 4.5 0.0 0.1 0.6 3.7 1.8 0.0 0.0 17.8 9.2 1.0 12.6 5.5 0.3 2.8 1.6 0.4 0.0 0.6 0.5 0.9 2.2 2.5 4.6 12.6 17.5 0.0 6.5 0.0 4.2 0.3 0.6 0.0 0.7 0.3 0.4 1.0 0.1 0.2 0.3 0.3 0.5 0.4 12.7 1.7 0.3 0.0 0.1 0.3 7.6 11.9 2.7 14.1 7.7 8.4 4.5 9.3 5.8 3.1 0.0 2.7 0.8 0.6 0.5 0.6 0.8 5.1 53.5 9.1 1.8 5.9 5.3 5.0 2.8 10.0 0.1 0.0 0.0 0.2 0.3 1.0 0.4 1.1 0.0 0.3 1.6 6.4 0.6 1.2 16.9 3.1 0.0 1.7 0.0 0.5 3.2 0.1 0.0 2.8 7.8 0.5 0.0 0.8 1.9 1.6 0.1 2.4 0.0 0.0 0.3 RAB37 ENSG00000172794 "RAB37, member RAS oncogene family" Q96AX2 17 74670578-74747335 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.0;brain: 52.1" "Cell type enhanced" "Detected in many" 16 "granulocytes: 49.7;T-cells: 27.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 52.1" "Cell type enhanced" "Detected in many" "basophil: 47.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 22.7;HMC-1: 24.8;OE19: 9.5;U-266/70: 36.2;U-937: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA 1100000 "unprognostic (2.10e-2)" "unprognostic (7.04e-4)" "unprognostic (5.95e-2)" "unprognostic (9.80e-4)" "unprognostic (3.49e-1)" "unprognostic (7.04e-5)" "unprognostic (1.74e-1)" "unprognostic (1.48e-2)" "unprognostic (7.62e-3)" "unprognostic (9.47e-3)" "unprognostic (3.05e-2)" "unprognostic (2.02e-2)" "prognostic unfavorable (8.80e-6)" "unprognostic (7.30e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (7.80e-2)" "unprognostic (4.01e-2)" 1.3 1.2 1.3 7.5 2.1 15.5 1.0 52.1 9.8 1.5 3.9 0.3 0.0 2.6 1.2 1.0 1.3 1.5 3.5 1.4 4.1 2.8 1.4 9.3 4.8 12.8 2.6 2.7 0.8 1.0 0.0 1.0 1.1 14.7 3.5 3.8 2.1 2.2 0.9 0.9 1.2 6.5 1.6 1.6 11.3 4.6 0.8 0.0 15.8 1.0 1.0 10.9 4.2 2.0 3.4 1.8 47.0 10.8 11.1 12.7 9.8 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.1 0.0 1.7 24.8 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.0 6.3 0.0 0.1 6.6 5.5 0.0 9.5 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 1.3 0.1 4.7 0.0 0.0 0.1 0.0 0.0 36.2 1.4 0.5 0.0 15.3 0.0 47.0 3.1 43.0 12.7 6.6 3.2 3.4 5.6 9.1 1.8 3.4 3.3 7.4 14.5 11.1 10.8 0.3 9.2 9.8 1.3 2.1 52.1 9.8 4.1 2.8 2.6 2.7 14.7 0.0 3.0 5.6 11.5 0.2 0.1 1.9 1.4 5.1 2.7 0.0 0.0 5.9 0.0 0.0 1.1 0.0 0.3 0.3 0.0 0.8 0.0 0.8 0.1 49.7 9.6 0.6 3.2 5.2 1.8 0.8 0.0 0.6 0.3 0.0 0.0 4.1 1.2 0.5 0.8 1.1 1.1 0.8 6.5 0.3 0.0 1.2 0.1 0.0 27.7 0.5 0.2 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113242-88175467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.5;tongue: 38.1" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 41.2;Cytotrophoblasts: 78.5;Melanocytes: 124.9;Suprabasal keratinocytes: 86.1;Syncytiotrophoblasts: 45.8" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Region enriched" "Detected in single" 5 "pons and medulla: 3.2" "Group enriched" "Detected in many" 5 "NK-cell: 15.3;plasmacytoid DC: 4.2" "Group enriched" "Detected in many" 5 "dendritic cells: 4.2;NK-cells: 15.3" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.4;hTCEpi: 69.6;hTERT-HME1: 62.0;SK-MEL-30: 37.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071701 Uncertain "Nuclear bodies,Mitochondria" NA NA "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favorable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 1.8 15.6 0.4 1.2 0.4 0.4 4.6 0.3 0.6 10.8 1.6 1.2 2.8 1.0 7.0 8.7 29.9 2.8 8.2 1.7 0.6 0.5 2.6 0.8 5.3 0.4 0.5 0.2 3.0 2.3 0.9 4.6 7.7 3.2 4.0 0.4 35.5 4.9 5.2 0.5 24.9 2.4 2.7 0.7 1.3 0.9 5.3 0.1 1.6 6.6 38.1 21.0 4.2 13.3 0.0 4.2 0.5 1.3 15.3 1.8 0.6 2.3 0.3 0.0 0.1 0.0 0.5 0.1 1.4 5.8 2.3 4.3 1.0 1.0 0.1 1.4 1.5 0.2 15.9 1.2 19.4 3.2 0.2 1.1 11.7 1.5 0.0 0.2 0.1 0.1 0.5 69.6 0.3 62.0 2.9 2.7 0.2 0.0 0.2 0.0 0.0 0.1 3.9 1.8 0.1 0.0 0.1 0.0 0.1 4.5 8.9 0.4 0.2 0.0 0.0 37.4 1.4 3.5 1.0 1.5 0.0 1.0 0.0 0.2 0.3 1.4 0.0 0.3 0.4 0.2 0.0 0.6 0.1 1.6 0.6 0.9 0.0 0.5 1.8 1.5 0.0 0.1 0.9 0.5 15.3 1.3 4.2 0.9 0.6 0.4 0.4 0.3 0.6 0.6 0.5 0.5 0.2 3.2 0.1 0.0 4.1 0.0 12.1 41.2 0.0 0.1 0.0 4.0 7.9 0.0 0.0 78.5 3.3 1.3 0.0 1.5 1.1 0.0 1.0 6.8 6.7 2.1 16.1 0.0 14.7 0.0 0.0 0.0 1.0 0.0 3.1 4.9 124.9 10.8 0.0 0.5 1.8 1.1 1.1 3.2 5.9 0.0 2.8 0.0 3.2 86.1 45.8 1.5 2.1 22.8 RAB39A RAB39 ENSG00000179331 "RAB39A, member RAS oncogene family" Q14964 11 107928503-107963482 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.3;pituitary gland: 10.0" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 3.9;Hofbauer cells: 3.2;Kupffer cells: 4.3;Macrophages: 2.6;Spermatocytes: 3.4;Spermatogonia: 3.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 3.3;intermediate monocyte: 5.0;memory B-cell: 1.4;myeloid DC: 2.4;naive B-cell: 1.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 7 "B-cells: 1.4;dendritic cells: 2.4;monocytes: 5.0" "Cell line enhanced" "Detected in some" "GAMG: 9.2;NTERA-2: 6.7;RPMI-8226: 11.9;SCLC-21H: 22.0;SH-SY5Y: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042505 Uncertain NA NA "HPA042505: AB_2678030" "unprognostic (1.45e-1)" "unprognostic (1.48e-2)" "unprognostic (1.83e-1)" "unprognostic (3.40e-2)" "unprognostic (4.99e-1)" "unprognostic (4.30e-2)" "unprognostic (4.26e-3)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (7.36e-2)" "unprognostic (4.22e-3)" "unprognostic (2.24e-2)" "unprognostic (1.41e-3)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (5.02e-2)" "unprognostic (2.43e-1)" 2.3 2.8 5.3 7.3 5.1 1.7 1.2 16.3 11.0 1.0 1.6 4.1 0.0 1.5 0.8 0.5 1.0 1.3 2.3 1.1 5.9 5.2 1.7 1.9 2.5 5.0 3.7 3.0 0.9 1.1 0.5 10.0 3.4 10.2 1.0 2.3 0.9 1.3 0.6 0.8 1.0 2.1 2.0 4.1 7.3 1.8 2.3 4.9 3.3 1.0 0.0 3.7 3.5 0.9 1.4 2.4 0.4 5.0 0.1 0.2 0.9 0.0 1.4 5.7 0.1 0.0 0.0 0.7 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.1 0.0 9.2 0.0 5.7 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.3 5.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.2 0.0 3.1 11.9 0.0 0.0 22.0 13.6 0.0 0.0 0.3 1.4 0.3 2.3 0.0 0.1 1.6 0.0 1.0 0.1 3.1 0.0 0.3 1.3 3.2 0.2 3.3 0.1 0.1 5.0 0.1 1.4 0.1 0.0 2.4 1.3 0.2 0.2 0.4 0.1 3.5 0.3 0.0 0.9 5.3 5.1 16.3 7.1 5.9 5.2 3.7 3.0 10.2 4.9 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 1.7 0.0 4.3 0.0 0.0 2.6 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.5 0.2 0.0 0.0 3.4 3.0 0.1 0.0 0.0 0.0 0.0 RAB39B "MRX72, WSN" ENSG00000155961 "RAB39B, member RAS oncogene family" Q96DA2 X 155258241-155264589 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Autism spectrum disorder, Disease mutation, Mental retardation, Parkinson disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell type enhanced" "Detected in many" 8 "B-cells: 14.4;Bipolar cells: 10.6;Cone photoreceptor cells: 7.9;Horizontal cells: 9.5;Muller glia cells: 11.5" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.9;GAMG: 8.9;Karpas-707: 21.0;U-266/70: 21.2;U-266/84: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001114, HPA042505" Approved NA NA "HPA001114: AB_1079732, HPA042505: AB_2678030" "prognostic favorable (8.95e-4)" "unprognostic (1.20e-3)" "unprognostic (3.52e-2)" "unprognostic (7.10e-5)" "unprognostic (1.77e-1)" "unprognostic (7.47e-4)" "unprognostic (2.19e-1)" "unprognostic (6.00e-4)" "unprognostic (1.78e-1)" "unprognostic (5.64e-2)" "unprognostic (3.87e-4)" "unprognostic (5.41e-2)" "unprognostic (1.72e-1)" "unprognostic (7.21e-2)" "unprognostic (4.94e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" 0.9 3.8 9.4 4.8 12.1 1.7 1.7 14.2 21.5 1.3 1.7 5.8 1.8 1.5 1.0 11.6 1.1 1.4 1.6 1.1 10.4 11.0 1.8 1.0 1.5 8.5 10.1 9.6 1.2 4.7 7.7 10.8 0.9 11.9 3.9 1.6 1.0 1.2 2.8 0.6 0.6 2.0 0.9 9.5 5.3 2.6 2.0 7.3 4.5 4.6 0.0 9.9 2.4 0.7 4.9 5.4 3.3 0.5 3.5 8.7 3.8 0.0 0.2 3.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.9 0.7 0.0 8.9 0.0 0.0 0.1 0.0 6.7 0.3 1.3 0.0 0.0 1.0 0.0 2.8 0.1 0.0 0.2 4.7 0.5 0.0 6.0 0.0 21.0 0.1 1.2 5.7 0.0 4.1 0.0 0.3 0.0 0.0 1.3 0.0 0.0 8.0 6.2 0.0 0.0 3.6 1.1 0.2 0.1 0.0 0.4 1.3 0.0 0.6 21.2 14.6 3.6 3.7 0.0 0.0 1.0 0.4 2.5 5.7 0.3 5.9 4.9 7.7 7.4 5.4 3.4 8.1 8.7 3.3 3.5 0.5 1.4 5.6 3.8 9.4 12.1 14.2 15.8 10.4 11.0 10.1 9.6 11.9 7.3 0.0 0.0 14.4 0.5 0.5 10.6 2.0 0.0 0.0 0.0 1.8 7.9 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.8 0.0 0.3 1.0 0.0 0.0 0.1 9.5 1.7 3.1 0.0 0.0 0.0 0.5 3.3 2.8 0.0 11.5 0.7 0.0 1.8 0.7 7.1 0.0 1.0 0.5 0.7 0.1 0.0 5.0 0.0 0.0 RAB3A ENSG00000105649 "RAB3A, member RAS oncogene family" P20336 19 18196784-18204074 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 114.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 94.1;Distal tubular cells: 33.2;Horizontal cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 13.8;SCLC-21H: 25.3;SH-SY5Y: 12.1;U-2197: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003160, CAB009949, CAB078998" Enhanced Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731" "unprognostic (1.82e-1)" "unprognostic (2.22e-1)" "unprognostic (6.80e-3)" "prognostic unfavorable (3.17e-4)" "unprognostic (1.21e-1)" "unprognostic (1.88e-1)" "unprognostic (1.36e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (1.13e-1)" "prognostic favorable (6.14e-7)" "unprognostic (1.23e-1)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (6.14e-2)" 2.3 13.0 32.3 2.6 50.5 2.0 2.0 39.1 114.7 2.8 3.1 6.3 0.0 3.6 2.7 2.6 2.4 3.2 2.8 17.0 40.8 32.7 4.1 2.2 2.5 2.4 31.5 35.6 8.0 2.3 5.0 7.5 2.4 38.2 3.8 2.8 5.8 4.2 4.4 7.5 2.5 3.0 2.9 7.0 2.5 2.5 2.2 4.8 0.0 2.9 0.1 2.1 2.9 0.7 4.6 6.0 5.1 3.0 0.7 4.2 2.6 0.9 1.0 2.4 3.2 3.8 1.0 1.4 2.1 1.2 1.4 1.9 0.9 0.6 3.4 2.3 1.7 1.3 2.7 11.0 1.3 0.7 0.7 3.5 1.3 4.0 3.8 1.0 2.3 4.2 3.2 1.3 0.8 0.4 2.8 0.4 4.2 0.7 1.2 1.3 3.2 5.1 0.6 1.9 2.8 13.8 3.6 0.2 2.8 1.5 0.5 25.3 12.1 1.0 4.4 2.4 1.0 0.9 0.4 0.4 1.3 0.9 17.5 1.2 2.1 4.6 0.8 3.3 1.7 1.1 0.0 3.0 3.8 3.0 2.2 4.0 4.6 3.2 3.0 6.0 2.2 4.1 4.2 5.1 0.7 2.7 5.5 1.8 2.6 32.3 50.5 39.1 95.0 40.8 32.7 31.5 35.6 38.2 4.8 0.0 0.0 0.9 2.1 2.9 94.1 1.1 2.5 0.0 0.0 15.7 7.9 1.4 33.2 2.1 2.4 1.4 1.4 0.0 0.8 3.6 3.9 1.4 0.0 1.5 4.3 87.4 9.2 3.1 1.6 0.0 4.0 4.3 10.1 2.8 2.3 11.3 0.8 2.0 5.3 6.3 28.8 0.0 8.6 0.3 2.8 4.3 1.5 2.2 3.7 1.4 RAB3B ENSG00000169213 "RAB3B, member RAS oncogene family" P20337 1 51907956-51990764 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;placenta: 37.6;prostate: 20.0" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 137.0;Alveolar cells type 2: 101.3;Intestinal endocrine cells: 282.2" "Group enriched" "Detected in many" 6 "prostate cancer: 19.4;testis cancer: 6.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 44.6;BJ hTERT+: 17.3;fHDF/TERT166: 16.1;HBF TERT88: 15.3;TIME: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003159, CAB023293" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB023293: , HPA003159: AB_1856005" "unprognostic (1.10e-1)" "unprognostic (2.20e-3)" "unprognostic (5.43e-3)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.20e-2)" "unprognostic (8.77e-3)" "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-2)" "unprognostic (2.02e-3)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 0.4 5.8 16.6 1.4 8.5 0.8 1.8 2.0 13.8 0.4 3.1 0.9 0.0 1.6 0.5 0.8 0.5 0.7 2.7 0.4 9.9 15.8 1.4 1.3 0.5 0.5 4.5 9.3 3.2 2.1 0.4 13.7 37.6 18.2 20.0 4.4 0.1 0.8 0.6 1.0 3.7 1.9 0.9 1.4 0.5 2.7 0.8 1.3 0.0 0.5 0.0 0.6 0.6 0.4 1.1 0.8 2.1 0.5 0.5 0.4 0.0 0.6 3.0 0.4 0.5 0.1 0.8 0.0 44.6 17.3 9.0 4.4 3.6 1.3 0.2 0.7 16.1 1.3 0.0 5.5 4.6 15.3 0.0 0.4 0.0 0.2 1.2 0.7 0.0 0.0 0.4 0.1 14.9 3.4 5.6 2.8 0.4 0.1 0.1 9.9 0.1 0.0 0.0 7.2 0.8 0.4 0.1 0.0 0.0 1.4 0.2 1.5 0.4 0.0 0.1 0.0 9.3 0.0 0.1 34.6 8.8 3.2 0.1 14.5 0.0 0.2 0.1 8.0 0.0 0.3 1.1 0.5 0.3 0.4 0.3 0.3 0.6 0.3 0.4 0.1 1.1 0.4 0.4 2.1 0.5 0.5 0.8 0.2 0.0 16.6 8.5 2.0 13.8 9.9 15.8 4.5 9.3 18.2 1.3 137.0 101.3 0.9 5.2 2.2 2.4 0.6 15.3 52.2 51.2 0.0 2.0 0.6 3.3 4.0 1.9 0.5 1.3 0.0 15.3 0.2 0.9 19.1 7.0 0.4 0.3 0.0 282.2 0.0 2.6 1.0 0.6 0.9 1.7 1.0 6.1 24.2 59.3 0.3 1.1 0.0 3.5 0.0 0.4 1.9 4.8 1.3 3.3 0.7 1.5 2.6 RAB3C ENSG00000152932 "RAB3C, member RAS oncogene family" Q96E17 5 58582221-58859394 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adrenal gland: 13.6;brain: 47.4;pituitary gland: 14.1" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 35.2;Early spermatids: 17.4;Intestinal endocrine cells: 55.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.4;HEL: 3.5;NB-4: 2.2;SCLC-21H: 14.6;SH-SY5Y: 5.3" "Low region specificity" "Detected in all" "HPA003160, HPA048156" Enhanced Approved Cytosol NA NA Cytosol "HPA003160: AB_1079731, HPA048156: AB_2680291" "unprognostic (1.30e-1)" "unprognostic (3.35e-2)" "unprognostic (9.94e-2)" "unprognostic (2.23e-2)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (8.73e-3)" "unprognostic (3.40e-2)" "unprognostic (6.90e-2)" "unprognostic (7.58e-2)" "unprognostic (9.52e-4)" "unprognostic (1.51e-3)" "unprognostic (3.70e-5)" "unprognostic (4.70e-2)" "unprognostic (1.05e-1)" "unprognostic (9.65e-2)" "unprognostic (3.61e-3)" 2.5 13.6 19.8 2.5 36.1 1.1 1.3 7.7 47.4 1.3 1.8 2.1 0.0 3.1 2.1 1.0 1.3 1.3 1.9 1.1 22.9 23.6 1.2 1.2 1.2 1.3 14.5 23.6 1.2 3.3 1.4 14.1 1.2 25.6 1.1 2.1 0.0 1.1 1.1 1.1 1.1 3.3 2.0 3.2 1.0 2.3 1.3 4.1 0.0 1.1 0.0 1.4 1.7 0.4 0.3 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 1.8 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.6 5.3 0.0 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.8 36.1 7.7 32.4 22.9 23.6 14.5 23.6 25.6 4.1 0.0 1.1 0.0 0.0 0.1 35.2 0.6 0.0 0.0 0.0 0.0 3.9 0.0 3.3 0.1 17.4 3.3 0.0 0.0 8.4 0.7 0.2 0.0 2.3 0.4 0.1 3.2 55.3 6.7 0.0 7.7 0.9 0.0 1.7 0.0 0.3 1.5 6.4 0.0 0.7 0.0 6.8 12.9 0.0 2.5 1.7 0.1 0.0 0.0 0.0 0.0 RAB40A "Rar-2, RAR2A" ENSG00000172476 "RAB40A, member RAS oncogene family" Q8WXH6 X 103499130-103519489 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 34.0" "Cell type enriched" "Detected in single" 7 "Peritubular cells: 5.6" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Cell line enhanced" "Detected in many" "AF22: 6.5;NTERA-2: 7.2" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (3.49e-1)" "unprognostic (6.01e-2)" "unprognostic (4.33e-2)" "unprognostic (4.49e-3)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (3.82e-2)" "unprognostic (4.43e-1)" "unprognostic (7.36e-4)" "unprognostic (7.85e-3)" "unprognostic (9.39e-5)" "unprognostic (1.43e-1)" "unprognostic (1.11e-3)" 2.0 1.4 0.6 0.6 4.2 0.0 0.8 0.6 1.1 2.8 0.8 0.6 11.9 0.5 5.5 34.0 10.6 2.6 2.9 0.6 0.6 0.9 1.3 0.6 2.0 1.7 0.6 0.6 5.4 0.6 0.6 2.4 0.8 0.8 5.5 0.4 0.6 0.6 6.2 0.6 0.7 0.9 1.3 0.6 0.8 0.5 7.8 0.6 0.6 0.6 0.6 0.6 1.5 2.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 1.7 6.5 0.2 1.5 1.9 3.2 1.9 0.4 0.3 0.5 1.3 0.9 1.6 2.5 0.3 2.0 0.1 0.4 0.1 0.3 0.0 3.8 0.5 3.0 0.3 0.6 0.1 0.3 1.5 0.3 0.6 0.4 2.5 0.3 0.5 2.3 1.0 0.6 0.4 0.4 0.2 7.2 0.0 1.0 0.0 0.5 0.1 0.1 0.6 2.7 3.4 0.6 0.1 1.4 2.0 0.0 0.2 3.2 2.7 1.5 4.1 1.8 1.2 0.7 1.2 3.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.6 4.2 0.6 0.6 0.6 0.9 0.6 0.6 0.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 RAB40AL "RAR2, RLGP" ENSG00000102128 "RAB40A like" P0C0E4 X 102937272-102938300 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.9" "Cell type enhanced" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Intestinal endocrine cells: 2.9;Ito cells: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HEK 293: 2.0" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (1.99e-1)" "unprognostic (3.05e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-1)" "unprognostic (3.49e-1)" "unprognostic (1.83e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" "unprognostic (5.90e-10)" "unprognostic (4.74e-1)" "unprognostic (1.32e-1)" "unprognostic (5.02e-3)" "unprognostic (2.64e-2)" 0.3 1.0 0.2 0.2 0.3 0.7 0.4 2.1 0.4 0.3 0.4 1.0 0.8 2.9 0.2 0.3 0.7 0.3 0.3 0.3 0.2 0.5 0.5 0.0 0.2 1.0 0.2 0.0 0.9 0.6 0.8 0.1 0.2 0.5 0.0 0.2 0.1 0.6 0.4 0.2 0.1 0.3 0.8 0.2 0.0 0.5 0.0 1.2 0.0 0.3 0.0 0.7 0.0 0.5 0.6 0.8 0.2 0.0 0.0 2.3 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.6 0.0 0.8 0.0 1.2 0.0 0.6 0.2 2.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.4 0.4 0.3 0.1 0.4 0.0 0.0 1.4 0.6 1.0 0.6 0.0 1.6 0.0 0.3 0.0 0.2 1.0 0.0 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.3 1.4 0.5 0.5 0.3 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.6 0.0 0.8 0.3 1.6 2.9 2.5 1.5 0.7 1.4 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.6 0.0 0.5 0.3 RAB40B "RAR, SEC4L" ENSG00000141542 "RAB40B, member RAS oncogene family" Q12829 17 82654973-82698728 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.3;OE19: 25.4" HPA076172 Approved Vesicles NA NA Vesicles "HPA076172: " "unprognostic (2.21e-2)" "unprognostic (7.50e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-1)" "unprognostic (6.03e-2)" "unprognostic (2.34e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.74e-1)" "unprognostic (3.28e-2)" "unprognostic (1.36e-1)" "unprognostic (3.14e-2)" "prognostic favorable (2.95e-6)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (9.83e-3)" 6.3 7.5 29.7 2.1 43.4 1.0 6.5 9.3 34.2 6.2 12.5 38.3 1.5 7.3 6.5 15.0 5.0 5.8 5.3 13.4 25.8 13.7 15.9 6.4 5.3 2.1 21.3 17.0 8.6 5.0 5.3 5.9 3.3 19.8 8.7 7.9 2.2 8.0 5.9 29.6 8.5 5.3 4.4 28.7 4.0 16.7 3.0 23.2 0.0 4.3 3.9 2.5 4.6 3.4 3.5 10.0 2.1 4.5 2.8 2.6 1.0 4.5 7.4 2.3 6.8 5.7 7.2 3.3 5.0 1.4 3.2 1.0 2.4 1.2 0.6 10.1 5.0 2.0 8.3 4.3 4.0 2.8 0.3 21.3 1.8 7.6 6.7 2.8 0.5 2.0 6.1 6.6 1.8 1.4 3.1 2.9 4.5 5.2 0.6 4.3 6.0 1.7 3.9 0.4 25.4 9.8 4.2 5.9 3.8 11.1 8.4 12.5 7.9 3.6 3.2 6.8 10.9 6.9 3.7 5.9 9.0 2.7 9.3 4.1 3.6 2.8 6.4 2.1 1.2 1.5 2.1 0.7 0.1 1.6 1.9 2.2 3.5 2.0 2.6 1.2 1.3 2.5 1.3 0.3 2.8 4.5 10.0 2.6 1.0 29.7 43.4 9.3 26.8 25.8 13.7 21.3 17.0 19.8 23.2 8.9 9.1 4.5 25.1 26.7 9.9 28.0 22.9 5.3 4.5 14.0 0.0 2.2 69.6 16.8 27.4 14.3 30.2 0.0 7.8 4.3 23.5 40.6 1.1 17.1 5.4 31.8 20.2 18.4 1.9 20.4 18.7 6.0 45.5 1.8 41.7 7.4 8.8 25.9 17.3 54.3 11.0 25.8 15.6 1.6 11.5 25.5 1.0 7.5 36.0 61.2 RAB40C "RARL, RASL8C" ENSG00000197562 "RAB40C, member RAS oncogene family" Q96S21 16 589357-629272 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 39.9" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076172 Approved Vesicles NA NA Vesicles "HPA076172: " "unprognostic (8.04e-2)" "unprognostic (3.63e-1)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (5.38e-3)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (5.78e-2)" "unprognostic (3.45e-2)" "unprognostic (2.90e-1)" "unprognostic (1.37e-3)" "unprognostic (3.89e-2)" "unprognostic (6.20e-2)" "unprognostic (7.48e-2)" "unprognostic (4.00e-3)" 6.8 4.3 9.1 4.8 15.2 5.8 5.3 18.1 29.9 5.2 9.1 5.9 5.3 14.1 6.2 6.5 11.0 7.6 5.1 7.6 9.7 6.5 6.3 5.3 7.7 4.2 6.6 13.2 8.5 39.9 5.7 12.2 7.2 7.5 7.9 5.0 3.3 14.5 7.2 10.5 25.7 14.1 8.0 4.6 4.7 12.6 6.1 6.1 8.7 5.3 4.3 6.0 8.8 7.6 1.3 1.7 14.0 3.0 0.9 2.2 1.2 5.9 12.9 7.6 10.6 4.4 5.5 10.2 8.0 3.8 6.5 5.3 11.5 10.9 6.9 8.7 4.7 5.7 13.6 4.6 6.6 1.3 7.2 7.9 3.8 8.6 8.1 7.8 7.9 7.2 4.6 14.5 5.2 5.4 4.6 5.3 8.2 8.6 7.1 2.8 17.5 7.3 13.9 8.9 10.5 7.7 11.9 5.5 10.8 3.7 8.6 10.4 8.4 8.8 19.4 7.4 3.7 14.2 15.3 6.5 6.9 9.8 9.1 4.7 6.9 6.6 8.4 4.5 10.5 7.1 1.1 3.0 14.0 0.4 1.8 2.2 1.3 1.5 1.7 1.7 0.9 1.1 0.8 5.3 0.9 0.9 0.7 0.6 1.2 9.1 15.2 18.1 29.9 9.7 6.5 6.6 13.2 7.5 6.1 8.9 14.9 0.9 9.0 15.5 10.4 4.1 2.5 4.0 6.8 10.4 7.9 21.2 6.6 5.9 3.3 4.4 25.8 0.0 10.8 12.8 4.7 8.7 6.9 13.2 8.2 15.9 10.4 8.6 6.5 4.1 4.6 3.8 6.8 3.6 16.3 7.5 9.0 19.9 6.0 6.8 2.7 0.0 5.2 14.2 10.0 27.1 47.5 4.4 15.8 7.4 RAB41 ENSG00000147127 "RAB41, member RAS oncogene family" Q5JT25 X 70282093-70285002 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.4;testis: 7.3" "Cell type enriched" "Detected in some" 22 "Cone photoreceptor cells: 502.6" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-2197: 7.0;U-87 MG: 8.8" HPA001510 Uncertain NA NA "HPA001510: AB_1079733" "unprognostic (1.32e-1)" "unprognostic (1.39e-1)" "unprognostic (3.36e-3)" "unprognostic (4.25e-3)" "unprognostic (1.18e-1)" "unprognostic (3.46e-2)" "unprognostic (6.33e-3)" "unprognostic (1.85e-3)" "unprognostic (1.38e-1)" "unprognostic (2.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.04e-3)" "unprognostic (7.63e-2)" "unprognostic (2.39e-1)" "unprognostic (9.78e-3)" "unprognostic (8.42e-2)" "unprognostic (9.89e-2)" 0.2 1.6 2.4 0.9 2.7 0.5 0.0 1.3 6.4 0.0 0.3 0.5 0.3 0.0 0.4 0.1 0.9 0.9 1.8 2.1 0.4 0.0 0.5 0.7 2.6 1.6 0.0 0.0 0.2 0.2 0.3 0.0 1.9 0.0 0.7 2.5 1.3 0.0 1.8 0.8 0.2 7.3 1.4 0.0 1.0 0.0 1.5 1.6 0.1 0.9 0.0 2.0 0.4 1.0 1.0 2.5 0.9 0.0 0.0 0.9 0.9 0.0 0.0 0.0 1.1 0.9 1.1 2.0 0.0 2.1 1.1 0.0 0.0 0.0 1.4 2.5 0.2 2.1 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.0 3.2 0.0 1.4 1.0 2.2 0.0 0.6 1.5 1.0 1.6 3.2 3.1 0.6 1.8 1.5 0.0 0.8 1.6 2.9 1.0 0.6 2.7 1.2 0.7 2.5 2.9 1.2 1.3 7.0 1.5 1.3 1.9 1.4 8.8 2.1 2.0 0.0 0.4 0.1 0.7 0.9 2.0 1.5 0.6 0.6 1.6 1.5 1.2 1.0 0.0 0.0 0.3 0.4 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 502.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 23.1 6.6 0.0 0.0 0.0 0.0 0.0 RAB42 MGC45806 ENSG00000188060 "RAB42, member RAS oncogene family" Q8N4Z0 1 28592200-28595443 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.3" "Cell type enriched" "Detected in some" 7 "Hofbauer cells: 74.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.6;Hep G2: 15.5;HSkMC: 11.0;REH: 8.5" HPA050290 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA050290: AB_2681075" "unprognostic (1.10e-1)" "unprognostic (2.56e-1)" "unprognostic (1.72e-1)" "unprognostic (1.00e-1)" "unprognostic (8.25e-2)" "unprognostic (7.59e-2)" "unprognostic (2.00e-4)" "unprognostic (8.81e-2)" "unprognostic (2.39e-1)" "unprognostic (4.09e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (1.52e-2)" "unprognostic (8.77e-2)" "unprognostic (3.02e-2)" "unprognostic (8.83e-2)" "unprognostic (2.07e-3)" 4.3 1.2 0.8 1.8 1.6 0.4 3.2 0.8 1.6 3.7 2.3 0.8 0.8 1.8 3.1 4.1 1.5 1.4 2.4 1.3 1.6 0.5 1.5 3.2 3.4 14.3 1.2 0.8 1.4 0.8 5.0 0.8 6.2 1.2 3.3 2.5 1.7 4.2 0.8 1.5 0.9 2.3 1.8 5.5 5.9 1.6 3.0 0.8 3.4 1.0 0.8 4.4 4.1 1.8 0.7 0.7 1.2 0.9 2.4 0.5 0.1 0.1 1.2 1.0 0.0 4.6 10.6 0.0 0.7 4.4 4.6 6.1 2.2 1.5 0.2 2.9 5.0 0.4 0.1 4.5 0.0 3.0 0.1 0.1 0.4 7.1 15.5 1.8 1.2 0.0 11.0 0.2 2.8 0.0 0.4 1.4 0.1 0.2 0.1 0.9 0.0 0.2 2.4 5.4 0.1 0.0 8.5 0.0 1.8 1.8 0.0 0.3 2.1 4.2 0.1 0.0 0.7 0.1 2.0 0.7 0.0 1.4 4.6 0.1 0.4 2.8 0.2 0.2 4.5 0.1 1.2 0.9 0.2 0.3 0.4 0.3 0.6 0.2 0.2 0.7 0.7 0.5 0.4 0.9 2.4 0.8 0.4 0.1 0.1 0.8 1.6 0.8 1.6 1.6 0.5 1.2 0.8 1.2 0.8 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.0 0.0 1.2 0.0 0.0 0.5 0.0 6.9 4.0 0.1 0.0 0.0 0.0 0.6 2.3 0.2 0.0 0.0 74.2 0.0 0.0 2.5 2.9 10.0 1.4 4.4 0.0 1.8 0.0 0.9 1.9 0.3 0.0 0.3 0.9 0.0 0.9 1.5 1.9 0.4 0.3 0.0 0.0 0.1 RAB43 "ISY1, RAB11B, RAB41" ENSG00000172780 "RAB43, member RAS oncogene family" Q86YS6 3 129087569-129122801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 73.9" "Cell type enhanced" "Detected in single" 13 "Club cells: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in all" 5 "granulocytes: 13.3;T-cells: 3.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046840, HPA060085" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA046840: , HPA060085: AB_2684199" "unprognostic (3.01e-1)" "unprognostic (1.14e-2)" "unprognostic (3.08e-1)" "unprognostic (1.01e-1)" "unprognostic (5.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.36e-2)" "unprognostic (3.17e-2)" "unprognostic (4.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.14e-1)" "unprognostic (3.08e-1)" "unprognostic (2.46e-2)" "unprognostic (9.32e-2)" "unprognostic (5.82e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" 5.4 6.2 3.9 8.0 3.3 14.6 5.3 6.0 3.6 6.4 7.0 3.2 7.2 5.8 5.4 6.8 4.1 5.3 12.0 3.8 2.8 2.0 9.1 73.9 11.4 12.1 2.7 1.6 7.8 7.4 2.5 8.0 4.7 3.7 7.3 1.7 7.7 7.4 4.7 1.9 3.0 5.9 4.9 2.7 9.9 5.7 5.2 2.1 17.3 17.1 2.6 13.6 6.6 6.0 1.3 1.1 13.3 1.6 1.5 3.5 1.3 15.6 4.3 1.0 4.1 2.0 0.9 6.2 5.4 3.6 3.1 2.6 6.7 6.7 0.4 12.6 4.0 4.2 6.6 0.4 6.2 0.7 7.9 4.2 1.0 0.7 8.7 19.4 3.6 9.3 5.3 3.8 1.6 0.4 1.3 6.2 9.4 1.7 7.9 4.3 6.6 3.5 6.9 5.0 3.6 7.0 7.5 2.3 4.5 10.1 13.3 0.3 1.9 2.4 5.0 10.0 1.7 2.1 3.8 8.9 6.9 4.9 5.6 2.0 12.4 6.5 2.4 6.2 0.7 7.4 0.5 1.5 2.6 1.9 1.6 0.9 0.6 1.8 1.5 0.7 1.3 3.5 3.0 13.3 1.5 0.7 1.1 2.7 1.3 3.9 3.3 6.0 3.6 2.8 2.0 2.7 1.6 3.7 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 RAB44 "dJ431A14.3, RASD3, RASL13" ENSG00000255587 "RAB44, member RAS oncogene family" 6 36697810-36733183 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.0;bone marrow: 36.0" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.9;granulocytes: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "basophil: 10.0;eosinophil: 7.8" "Lineage enriched" "Detected in single" 10 "granulocytes: 10.0" "Cell line enhanced" "Detected in some" "HEL: 8.7;HL-60: 12.2;HMC-1: 37.2;NB-4: 30.6;THP-1: 12.1;U-937: 24.4" "Region enriched" "Detected in single" 4 "basal ganglia: 0.3" NA NA "unprognostic (8.86e-2)" "unprognostic (5.58e-3)" "unprognostic (5.09e-2)" "unprognostic (4.66e-2)" "unprognostic (1.37e-1)" "unprognostic (1.28e-3)" "unprognostic (9.56e-2)" "unprognostic (6.35e-4)" "unprognostic (1.45e-1)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" "unprognostic (2.57e-1)" "unprognostic (3.02e-2)" "unprognostic (3.13e-3)" "unprognostic (3.03e-2)" "unprognostic (9.67e-3)" "unprognostic (5.79e-2)" 1.4 0.0 0.0 1.2 0.1 36.0 0.2 0.0 0.0 1.9 1.0 0.0 0.9 0.4 3.5 0.7 0.6 0.3 7.2 2.6 0.0 0.0 0.2 6.6 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 2.4 0.2 1.1 0.0 1.0 0.0 0.3 0.5 0.5 0.0 0.9 0.4 0.5 0.0 0.9 0.0 1.8 0.3 1.5 0.0 0.0 0.8 10.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 12.2 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 10.0 0.9 7.8 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 7.9 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 13.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB6B ENSG00000154917 "RAB6B, member RAS oncogene family" Q9NRW1 3 133824239-133895836 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 86.5;parathyroid gland: 33.1" "Cell type enhanced" "Detected in many" 17 "Cardiomyocytes: 26.9;Erythroid cells: 93.5;Horizontal cells: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 10.5" "Lineage enriched" "Detected in single" 54 "T-cells: 10.5" "Cell line enriched" "Detected in many" 4 "HEL: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017713, HPA059131" Uncertain Approved "Golgi apparatus" NA NA 11000000 "Golgi apparatus" "CAB017713: , HPA059131: AB_2683916" "unprognostic (2.87e-2)" "unprognostic (6.33e-3)" "unprognostic (4.53e-3)" "prognostic unfavorable (9.01e-4)" "unprognostic (3.61e-1)" "unprognostic (5.14e-2)" "unprognostic (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.97e-6)" "unprognostic (9.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (8.10e-2)" "unprognostic (9.53e-2)" "unprognostic (6.05e-3)" 5.3 8.4 38.2 2.6 26.1 7.0 2.3 18.4 86.5 2.8 3.1 4.1 2.7 2.5 2.6 2.3 3.6 11.5 2.9 14.4 29.2 29.1 3.6 1.1 2.1 2.8 25.6 43.6 2.2 3.8 33.1 4.4 2.0 26.9 2.7 2.3 3.4 6.8 5.0 2.4 1.5 1.9 6.1 12.1 4.6 4.3 3.5 7.0 0.0 4.3 0.0 2.2 1.6 1.0 0.1 0.1 0.0 0.0 0.1 10.5 1.1 0.0 0.9 1.8 4.7 3.3 3.4 0.1 1.0 1.9 2.3 0.2 0.5 0.4 0.0 2.1 0.7 6.7 0.1 4.3 0.1 1.1 0.0 3.3 70.8 1.0 0.1 0.4 0.4 2.8 1.0 0.9 0.3 0.0 0.0 0.9 2.6 16.5 0.2 0.3 1.6 0.2 6.5 5.8 3.3 0.8 0.0 0.1 0.7 1.2 0.4 15.3 3.3 1.4 1.3 8.3 7.5 5.2 3.0 1.1 2.1 5.1 1.0 1.7 1.8 0.4 0.1 0.2 0.1 1.7 0.0 0.0 0.0 1.0 0.0 10.5 0.1 0.2 2.5 0.1 0.1 0.2 0.6 0.0 0.1 0.0 0.1 0.1 1.1 38.2 26.1 18.4 54.0 29.2 29.1 25.6 43.6 26.9 7.0 0.0 0.0 0.0 1.7 1.1 6.9 26.9 2.5 10.7 3.4 1.8 2.0 0.2 3.3 2.4 0.1 2.4 0.0 93.5 1.2 0.5 4.0 2.1 0.0 0.0 0.2 63.5 0.0 3.1 0.3 0.0 1.7 0.0 1.7 0.0 0.0 6.6 3.6 0.0 6.3 0.8 17.4 0.0 9.2 0.5 3.8 1.3 0.2 1.0 0.0 0.6 RAB6C WTH3 ENSG00000222014 "RAB6C, member RAS oncogene family" Q9H0N0 2 129979664-129982738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 17.2" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 8.7" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.5;HMC-1: 4.0;REH: 9.3;T-47d: 5.8;U-266/70: 3.9" HPA059131 Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (3.84e-2)" "unprognostic (5.77e-2)" "unprognostic (1.02e-1)" "unprognostic (1.07e-1)" "unprognostic (2.54e-1)" "unprognostic (8.62e-2)" "unprognostic (1.83e-1)" "unprognostic (1.98e-1)" "unprognostic (1.38e-2)" "unprognostic (1.50e-2)" "unprognostic (1.28e-1)" "unprognostic (2.44e-1)" "unprognostic (1.33e-1)" "unprognostic (4.48e-2)" "unprognostic (6.04e-2)" "unprognostic (1.24e-1)" "unprognostic (4.78e-1)" 1.7 3.3 5.1 1.4 6.2 1.1 9.9 1.3 10.3 7.6 2.0 4.0 1.3 1.1 3.3 1.4 2.2 1.6 1.5 1.5 7.6 5.3 1.4 3.8 1.2 1.2 5.2 4.9 1.5 4.2 17.2 1.6 2.8 8.6 7.0 1.3 2.1 2.0 2.8 1.7 1.2 4.4 1.3 5.3 2.7 1.3 4.0 1.5 0.8 1.5 0.9 1.3 1.2 1.5 0.2 0.3 0.8 0.5 0.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.0 0.0 9.3 0.0 0.9 0.0 0.0 0.1 0.8 0.0 0.8 0.2 1.1 5.8 0.0 0.0 0.0 0.7 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.9 0.4 0.3 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.2 0.6 0.5 0.2 0.4 0.3 5.1 6.2 1.3 10.3 7.6 5.3 5.2 4.9 8.6 1.5 0.0 0.0 0.0 0.2 0.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.4 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.8 1.0 0.5 0.0 0.0 0.3 RAB6D "RAB6CL, WTH3DI" ENSG00000233087 "RAB6D, member RAS oncogene family" 2 131361111-131364142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "parathyroid gland: 13.4" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Cancer enhanced" "Detected in some" "prostate cancer: 1.3" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MOLT-4: 6.4;OE19: 2.6;REH: 2.5;U-2 OS: 2.5" HPA059131 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA059131: AB_2683916" "unprognostic (4.19e-2)" "unprognostic (8.54e-2)" "unprognostic (1.16e-1)" "unprognostic (3.03e-2)" "unprognostic (4.08e-1)" "unprognostic (4.79e-2)" "unprognostic (4.41e-2)" "unprognostic (1.01e-1)" "unprognostic (1.87e-2)" "unprognostic (2.42e-1)" "unprognostic (3.21e-1)" "unprognostic (2.55e-2)" "unprognostic (2.61e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.12e-1)" 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 1.9 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 1.4 0.4 0.5 0.5 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 6.4 0.1 0.9 2.6 0.0 2.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.0 2.5 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.1 1.4 0.3 0.5 0.4 0.4 0.4 0.1 0.5 0.3 0.3 0.2 0.5 0.4 0.2 0.5 0.4 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAB7B "MGC16212, MGC9726" ENSG00000276600 "RAB7B, member RAS oncogene family" Q96AH8 1 205976740-206003461 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 21.3;skin 1: 23.7" "Cell type enhanced" "Detected in many" 12 "Club cells: 11.4;Cytotrophoblasts: 23.0;Hofbauer cells: 33.5" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "myeloid DC: 8.4" "Lineage enriched" "Detected in many" 8 "dendritic cells: 8.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 11.7;HBEC3-KT: 15.3;HL-60: 9.6;HMC-1: 41.5;hTCEpi: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.18e-2)" "unprognostic (2.14e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (4.87e-4)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (9.14e-2)" "unprognostic (2.23e-3)" "unprognostic (5.97e-2)" "unprognostic (8.57e-2)" "unprognostic (3.89e-3)" "unprognostic (3.13e-2)" "unprognostic (8.19e-2)" "unprognostic (1.63e-2)" "unprognostic (8.82e-3)" 21.3 0.0 0.5 1.9 1.3 0.0 4.5 0.0 2.0 6.6 0.6 4.0 3.6 0.6 3.3 4.7 7.7 0.9 6.5 1.7 0.5 0.0 0.5 6.1 2.6 0.5 0.0 1.7 0.0 0.0 0.0 5.8 3.0 2.5 0.9 1.5 1.9 3.2 0.6 23.7 0.5 4.2 1.3 1.0 2.5 1.6 0.8 3.4 3.0 13.3 4.4 3.3 0.3 0.0 8.4 0.0 1.0 0.0 0.0 0.4 0.6 0.0 0.3 0.3 0.9 6.9 1.6 3.0 3.7 1.3 1.2 0.4 1.1 0.0 1.1 11.7 1.4 3.0 0.0 15.3 0.4 0.1 0.0 0.0 0.0 0.4 0.0 9.6 41.5 2.3 17.8 2.5 0.0 0.8 0.0 0.0 0.2 0.0 0.8 0.1 0.0 5.9 0.1 0.5 0.0 0.0 0.8 0.3 0.4 0.1 0.0 0.0 0.4 0.0 1.9 3.3 1.0 3.4 0.0 0.8 2.1 0.8 0.2 0.0 0.0 0.0 5.6 4.1 1.4 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.4 3.0 4.6 0.0 7.4 0.0 0.0 0.6 5.1 0.0 11.4 0.0 0.0 23.0 0.0 3.1 0.0 0.1 0.0 0.0 0.2 0.9 4.8 0.6 2.3 0.0 33.5 0.0 0.0 0.0 4.5 0.4 1.7 8.5 0.0 6.4 0.0 2.8 0.5 0.0 3.2 0.0 0.2 0.0 1.1 0.0 0.0 0.0 5.3 0.0 0.0 1.4 RAB9B RAB9L ENSG00000123570 "RAB9B, member RAS oncogene family" Q9NP90 X 103822322-103832228 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 27.6" "Group enriched" "Detected in many" 5 "Bipolar cells: 20.3;Cardiomyocytes: 74.2;Muller glia cells: 33.2;Peritubular cells: 28.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 7.4;MOLT-4: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061932 Approved "Intracellular and membrane" NA NA "HPA061932: AB_2684640" "unprognostic (1.69e-2)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (7.28e-5)" "unprognostic (5.81e-2)" "unprognostic (3.89e-2)" "unprognostic (8.40e-2)" "unprognostic (1.42e-2)" "unprognostic (8.34e-2)" "unprognostic (8.29e-2)" "unprognostic (3.52e-4)" "unprognostic (1.10e-1)" "unprognostic (9.21e-4)" "unprognostic (1.37e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (2.04e-1)" 2.7 4.3 7.8 1.6 19.1 0.6 2.2 20.0 12.6 2.8 5.9 1.3 5.4 1.8 7.2 3.7 11.4 6.7 3.5 27.6 7.2 11.0 1.0 0.7 1.3 1.2 5.0 9.3 9.9 1.7 6.6 7.2 0.8 10.8 10.0 3.5 1.8 1.8 13.2 11.0 1.0 1.9 14.8 7.6 1.2 2.6 2.7 4.3 0.0 2.4 1.4 1.0 7.6 1.8 2.2 0.4 0.6 0.2 2.9 0.8 0.4 0.0 0.0 4.9 2.5 1.4 0.3 0.2 1.2 3.1 3.0 2.9 0.3 0.0 0.2 2.9 2.4 1.9 0.0 0.8 0.1 2.8 0.2 3.2 0.2 0.0 0.0 0.3 0.3 0.2 0.8 0.0 1.3 0.0 3.0 0.2 7.4 0.0 1.8 0.2 2.1 5.8 0.0 0.9 0.1 0.8 5.1 5.5 0.2 1.7 0.5 5.0 3.6 0.3 0.1 1.0 0.9 0.5 0.3 0.2 0.1 0.9 1.6 0.9 0.3 0.0 0.4 2.7 0.3 1.5 0.0 0.1 0.6 0.2 0.2 0.0 1.9 0.2 0.0 0.4 2.2 0.8 0.2 0.0 2.9 0.0 0.3 0.4 0.4 7.8 19.1 20.0 12.6 7.2 11.0 5.0 9.3 10.8 4.3 0.0 3.7 0.0 0.7 0.3 20.3 74.2 0.0 1.4 1.2 0.0 0.0 0.3 0.0 0.4 0.0 1.6 0.0 0.0 0.9 0.2 1.1 0.4 4.6 0.0 0.2 0.0 7.5 1.3 0.0 0.0 6.1 0.2 0.0 0.0 0.4 33.2 1.1 2.9 28.3 0.0 2.7 6.5 2.5 0.7 0.9 0.3 0.0 0.0 0.5 0.1 RABGAP1L "FLJ38519, HHL, KIAA0471, TBC1D18" ENSG00000152061 "RAB GTPase activating protein 1 like" "B7ZAP0, Q5R372" 1 174159410-174995308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 89.4" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 201.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 46.9;Karpas-707: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054695 Uncertain NA NA "HPA054695: AB_2682577" "unprognostic (2.57e-2)" "unprognostic (7.77e-2)" "unprognostic (6.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.54e-2)" "unprognostic (6.96e-3)" "unprognostic (8.55e-2)" "prognostic favorable (1.16e-4)" "unprognostic (2.66e-2)" "unprognostic (3.51e-2)" "unprognostic (2.66e-2)" "unprognostic (1.98e-1)" "unprognostic (9.14e-3)" "unprognostic (6.69e-2)" "unprognostic (2.14e-1)" "unprognostic (5.03e-2)" "unprognostic (2.46e-1)" 9.9 5.4 27.2 19.9 22.7 16.2 9.5 31.4 34.1 9.6 11.8 9.5 8.9 12.8 9.0 10.4 11.2 11.5 13.1 89.4 21.2 14.5 10.2 9.6 15.3 22.2 13.7 26.1 18.0 13.4 10.8 25.1 22.2 19.0 7.5 12.8 15.0 13.3 6.8 6.0 10.0 16.3 8.2 28.0 15.8 13.3 16.9 10.7 9.6 7.4 5.4 27.9 15.1 8.8 10.7 16.0 31.0 48.9 22.6 12.1 9.3 5.3 2.8 2.2 2.4 6.0 8.8 4.8 6.4 5.6 2.8 3.8 2.6 19.6 46.9 4.5 4.9 3.3 6.9 1.8 4.3 4.0 13.0 3.0 11.7 4.0 4.2 3.7 5.2 4.8 6.9 2.9 2.1 3.0 4.8 6.2 4.5 6.9 31.1 4.5 1.9 4.0 5.0 13.2 7.2 1.7 14.1 4.3 15.6 5.5 24.6 6.3 3.8 6.0 10.2 4.1 7.0 5.0 6.2 8.6 3.8 3.4 4.0 3.7 27.1 8.8 29.4 4.0 3.5 2.7 4.4 15.0 31.0 8.1 24.3 7.1 10.7 10.0 9.8 11.8 7.9 5.0 7.5 26.5 22.6 48.9 16.0 12.1 9.3 27.2 22.7 31.4 34.1 21.2 14.5 13.7 26.1 19.0 10.7 68.5 88.4 30.5 10.8 11.0 34.9 201.7 40.8 68.3 33.0 31.4 29.5 32.3 11.6 21.9 81.5 11.7 30.6 0.0 31.8 8.0 14.7 11.5 23.2 13.0 33.4 20.6 47.2 21.5 41.5 91.0 14.4 28.4 15.1 93.8 38.8 15.8 24.3 36.0 17.7 11.7 21.3 6.5 14.7 37.9 17.7 11.4 23.6 48.4 25.8 19.6 RABL2A ENSG00000144134 "RAB, member of RAS oncogene family like 2A" Q9UBK7 2 113627229-113643396 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 29.3" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 119.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 12.2" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (7.76e-3)" "unprognostic (7.79e-3)" "unprognostic (7.00e-2)" "unprognostic (2.94e-2)" "unprognostic (1.99e-1)" "unprognostic (4.23e-2)" "unprognostic (4.89e-2)" "unprognostic (6.77e-3)" "unprognostic (6.61e-2)" "unprognostic (7.36e-2)" "unprognostic (5.78e-3)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (1.89e-2)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (3.19e-5)" 2.2 1.7 6.0 5.9 9.5 1.7 3.3 6.3 20.9 4.3 3.4 4.2 0.4 2.4 4.7 9.0 2.7 29.3 2.8 3.3 7.0 6.0 3.5 3.4 12.9 1.8 4.0 7.5 7.4 2.6 1.2 6.3 1.6 6.4 3.8 2.0 3.8 5.2 12.2 2.2 2.1 2.2 3.6 4.8 2.7 2.1 4.8 4.3 2.0 5.5 2.0 3.1 2.1 2.7 8.8 9.8 2.5 7.6 12.2 10.4 5.5 2.6 4.3 6.0 4.8 5.0 7.3 4.6 2.4 2.0 3.5 2.5 3.8 1.6 3.7 10.4 0.8 2.5 2.7 3.0 0.3 2.3 5.1 5.8 1.8 0.1 0.5 4.1 0.8 1.3 2.6 5.2 0.7 1.5 5.1 2.5 5.5 1.7 0.9 2.1 2.1 12.2 0.9 3.3 2.2 1.5 2.3 2.3 1.6 2.4 0.6 2.5 8.5 2.3 2.6 2.2 1.9 0.5 3.5 0.6 0.5 0.8 0.9 1.7 3.6 3.8 0.8 7.1 2.7 1.2 0.0 4.8 2.5 7.1 7.6 7.7 8.8 10.4 7.2 7.5 8.0 8.6 6.8 0.5 12.2 7.2 9.8 5.0 5.5 6.0 9.5 6.3 20.9 7.0 6.0 4.0 7.5 6.4 4.3 8.9 7.2 7.5 4.3 3.9 7.0 4.0 0.0 119.1 12.5 7.0 9.8 2.8 11.6 6.7 9.4 3.0 5.2 0.0 2.7 2.2 7.3 3.0 11.5 3.9 3.1 15.9 6.9 6.7 2.8 9.8 7.5 4.6 6.8 6.4 3.7 6.5 4.0 3.5 6.7 5.0 17.6 0.0 6.6 20.4 8.3 4.3 2.1 5.7 4.3 3.4 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783663 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 59.0" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 167.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favorable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 8.2 8.2 12.4 11.1 22.1 8.1 12.9 19.7 21.2 13.0 8.4 12.7 12.6 7.9 13.9 59.0 8.1 41.9 9.4 5.8 13.1 15.3 10.6 7.0 14.4 13.3 9.9 16.5 17.8 9.6 10.9 16.7 7.4 14.3 10.0 11.0 9.5 9.5 11.6 5.1 13.8 8.6 10.2 9.5 11.5 9.1 12.2 14.5 12.6 17.9 3.5 12.3 9.4 9.2 13.6 13.2 9.2 19.4 10.8 16.8 10.3 13.3 12.1 20.8 16.2 23.3 18.6 15.2 10.0 11.1 8.1 11.1 3.4 11.8 8.6 8.9 14.3 13.2 17.5 9.4 11.7 8.8 7.4 13.4 7.4 20.9 8.8 9.7 20.9 8.0 15.8 16.0 10.6 13.4 24.1 9.0 15.5 5.6 10.9 16.1 16.8 10.4 9.2 7.9 8.2 9.1 17.6 12.0 9.0 15.7 13.3 8.9 16.2 12.2 10.8 7.5 15.0 10.7 6.5 13.8 7.8 15.6 6.6 6.7 9.2 4.2 4.2 14.7 5.2 10.9 1.0 10.9 9.2 16.8 17.4 12.2 11.2 13.0 13.7 11.6 13.6 15.2 14.7 4.3 10.8 19.4 13.2 13.0 10.3 12.4 22.1 19.7 21.2 13.1 15.3 9.9 16.5 14.3 14.5 11.9 11.2 10.4 10.3 4.7 14.6 3.6 12.7 167.3 29.6 21.0 29.5 10.4 11.6 17.3 17.0 7.3 7.8 0.0 9.5 9.3 8.5 7.5 3.5 6.4 10.7 15.9 5.2 5.5 10.1 16.3 13.0 8.5 16.9 15.4 7.2 12.9 9.0 3.5 10.3 12.2 37.4 6.5 10.3 27.4 27.0 5.0 5.6 15.8 10.1 6.3 RABL6 "bA216L13.9, C9orf86, FLJ10101, FLJ13045, Parf, pp8875, RBEL1" ENSG00000196642 "RAB, member RAS oncogene family like 6" Q3YEC7 9 136807943-136841187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 98.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044037 Uncertain Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA044037: AB_10966437" "unprognostic (3.10e-3)" "unprognostic (8.52e-3)" "unprognostic (1.20e-1)" "prognostic favorable (4.00e-4)" "unprognostic (9.23e-2)" "unprognostic (2.44e-2)" "unprognostic (1.90e-3)" "unprognostic (7.55e-3)" "unprognostic (1.65e-1)" "unprognostic (4.92e-2)" "prognostic favorable (1.46e-4)" "unprognostic (5.23e-2)" "unprognostic (1.03e-3)" "prognostic favorable (9.14e-4)" "unprognostic (4.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.15e-1)" 20.8 17.7 31.0 21.6 42.8 32.9 17.9 43.6 41.4 12.5 25.1 18.0 14.8 29.4 13.7 14.6 17.9 12.8 22.2 29.4 28.2 22.2 17.1 7.3 17.2 18.5 22.7 21.6 13.9 39.6 17.4 23.3 16.0 16.7 24.3 16.6 13.1 24.8 16.9 98.6 21.5 29.4 15.6 20.6 20.0 24.5 16.5 17.2 20.9 13.9 22.6 13.9 13.8 19.9 4.7 4.1 2.9 5.7 6.1 5.2 1.4 19.2 25.6 18.4 21.5 7.5 8.5 48.4 17.5 11.3 17.0 12.5 28.5 20.5 27.3 11.0 13.6 17.9 42.3 20.4 15.5 5.8 28.4 26.3 16.7 32.0 33.3 13.6 30.9 21.5 9.4 16.0 10.5 11.7 10.4 17.7 23.6 36.3 13.4 11.6 38.5 33.0 21.4 34.4 23.7 22.1 43.3 22.0 26.6 11.2 17.2 60.6 25.1 30.9 36.3 21.6 10.2 31.2 31.2 21.3 22.1 19.2 23.2 28.3 11.5 13.1 22.2 18.5 15.1 20.6 1.2 4.8 2.9 3.7 5.7 3.8 4.5 3.9 3.6 3.3 4.7 3.2 4.1 2.3 6.1 2.0 4.1 5.2 1.4 31.0 42.8 43.6 41.4 28.2 22.2 22.7 21.6 16.7 17.2 26.8 48.3 8.9 15.4 16.0 37.2 29.1 0.0 8.1 7.9 24.4 19.6 20.7 26.6 28.0 10.1 16.9 100.2 0.0 49.7 27.9 22.0 31.8 15.0 0.0 27.4 36.5 49.8 0.0 0.0 10.9 18.1 26.0 38.8 26.2 55.1 18.1 55.1 51.0 25.1 38.5 38.3 0.0 17.3 15.4 26.4 16.9 23.7 12.9 57.2 21.6 RAC2 EN-7 ENSG00000128340 "Rac family small GTPase 2" P15153 22 37225261-37244448 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 166.3;bone marrow: 66.3;lymphoid tissue: 169.1" "Cell type enhanced" "Detected in many" 14 "B-cells: 269.8;granulocytes: 502.9;T-cells: 411.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 55.3;HL-60: 77.3;HMC-1: 158.6;Karpas-707: 75.3;U-87 MG: 69.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB022946, HPA047820" Enhanced NA Yes 34000000 "CAB022946: , HPA047820: AB_2680167" "prognostic favorable (1.03e-5)" "unprognostic (2.91e-1)" "unprognostic (3.21e-2)" "unprognostic (1.82e-3)" "unprognostic (6.74e-2)" "unprognostic (7.78e-2)" "unprognostic (3.47e-1)" "unprognostic (5.00e-2)" "unprognostic (8.52e-3)" "unprognostic (2.65e-1)" "unprognostic (7.65e-2)" "unprognostic (3.81e-1)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.45e-1)" "unprognostic (1.75e-1)" "unprognostic (6.21e-2)" "unprognostic (1.50e-2)" 17.4 2.6 2.0 79.2 4.1 66.3 8.3 0.9 2.0 3.3 7.5 1.5 1.2 6.0 3.2 3.5 7.8 4.7 11.2 5.6 1.7 1.9 4.8 5.3 29.6 89.3 3.0 0.2 4.9 2.3 0.0 1.8 3.5 2.2 6.2 5.9 3.3 16.9 2.2 1.4 2.9 29.4 3.2 4.1 102.8 7.0 2.5 2.0 169.1 3.6 3.6 74.2 11.2 4.0 85.3 79.1 166.3 88.3 98.4 121.7 130.9 14.3 0.0 0.0 0.0 1.6 14.8 0.0 1.9 4.5 1.5 3.2 0.0 4.8 17.8 2.2 5.6 0.0 3.6 0.1 25.0 1.7 55.3 0.0 22.2 0.4 0.0 4.0 77.3 158.6 10.8 3.5 2.7 9.4 0.1 26.2 17.3 5.2 75.3 0.2 0.0 22.8 30.7 0.3 1.4 9.5 7.6 0.0 20.3 2.4 0.0 0.2 0.0 0.0 2.5 0.3 0.1 1.0 41.7 28.1 0.0 2.6 0.1 0.2 34.1 17.5 18.8 69.1 33.7 3.8 115.0 53.8 166.3 111.5 73.2 84.4 85.3 89.3 97.9 53.4 70.9 69.5 88.6 146.6 98.4 88.3 79.1 121.7 130.9 2.0 4.1 0.9 2.0 1.7 1.9 3.0 0.2 2.2 2.0 14.9 73.5 269.8 1.9 4.7 0.0 0.8 2.5 6.7 15.9 1.8 0.0 0.6 0.0 10.2 0.1 6.8 1.3 0.0 1.8 1.5 4.6 0.3 502.9 1.3 136.6 0.0 4.1 13.5 121.0 0.4 0.3 135.5 28.7 2.8 3.2 0.0 13.1 11.5 0.0 1.0 0.0 12.9 3.8 0.0 0.9 3.4 2.4 411.2 10.7 2.8 RAC3 ENSG00000169750 "Rac family small GTPase 3" P60763 17 82031624-82034204 "Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.9" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 136.2;Spermatogonia: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.5;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 15 "dendritic cells: 1.5;T-cells: 1.5" "Cell line enhanced" "Detected in many" "CACO-2: 53.6;HEK 293: 64.6;NB-4: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047820 Uncertain NA NA "HPA047820: AB_2680167" "unprognostic (3.48e-2)" "unprognostic (2.26e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (6.21e-5)" "unprognostic (1.62e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (3.36e-2)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (1.22e-2)" "unprognostic (3.67e-1)" "unprognostic (4.39e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.69e-4)" "unprognostic (1.25e-3)" 10.2 5.8 13.2 2.2 7.7 8.0 14.5 33.9 27.8 3.5 2.9 3.3 12.8 4.3 1.8 14.7 5.0 3.5 3.8 2.4 11.6 20.7 6.3 9.1 3.0 2.1 13.7 12.7 2.3 5.6 10.7 11.2 6.9 16.8 9.0 2.0 4.2 18.4 7.8 0.5 9.2 3.6 1.8 6.7 0.8 7.1 23.0 3.4 0.3 5.5 3.5 2.0 2.5 3.2 0.0 1.5 0.0 0.0 0.0 1.5 0.0 2.5 3.5 11.0 15.0 2.4 4.5 12.1 1.8 1.7 6.3 5.3 53.6 5.0 1.3 2.7 1.1 0.4 3.6 10.4 4.2 1.0 0.8 64.6 14.9 4.4 3.8 11.5 6.4 2.9 6.8 3.1 0.8 2.9 4.7 14.3 8.0 23.6 7.2 2.5 8.1 1.6 35.6 14.8 9.1 6.5 10.9 1.0 6.3 4.7 1.2 26.7 26.6 0.9 13.6 12.4 4.1 13.8 9.5 5.0 2.6 2.3 1.3 2.7 3.5 2.2 0.9 1.6 4.0 4.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 1.1 0.0 13.2 7.7 33.9 27.8 11.6 20.7 13.7 12.7 16.8 3.4 0.0 0.0 0.0 9.4 7.7 5.3 0.1 2.5 0.0 0.0 5.2 0.0 27.5 18.3 8.0 19.6 0.7 3.3 0.0 2.9 136.2 2.3 14.9 4.6 10.2 8.1 6.4 2.9 2.5 0.0 11.5 5.2 0.5 13.5 3.6 4.5 5.6 4.8 2.9 1.8 13.0 6.8 0.0 1.9 1.1 34.7 6.6 11.8 0.0 5.2 3.5 RACGAP1 MgcRacGAP ENSG00000161800 "Rac GTPase activating protein 1" Q9H0H5 12 49976923-50033136 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025859, HPA039427, HPA043912" Enhanced Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728" "prognostic unfavorable (1.51e-4)" "unprognostic (1.91e-1)" "unprognostic (3.74e-3)" "unprognostic (1.53e-2)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.15e-3)" "unprognostic (3.07e-3)" "unprognostic (5.31e-2)" "prognostic unfavorable (4.12e-6)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (3.13e-2)" "unprognostic (4.94e-1)" "unprognostic (6.16e-2)" "unprognostic (2.15e-1)" 3.7 2.6 4.9 10.0 11.3 21.0 4.2 6.3 7.8 4.2 10.1 4.7 1.5 6.5 3.3 1.9 17.7 2.7 4.0 2.7 4.8 4.5 5.9 2.8 5.6 13.7 7.8 5.0 2.5 2.0 3.3 1.4 8.4 5.4 2.4 11.9 2.0 4.7 2.1 3.8 8.7 7.5 7.6 5.9 5.9 6.8 29.4 6.6 40.9 2.4 8.7 17.8 6.0 6.5 6.3 2.2 16.5 3.5 8.8 14.8 4.8 44.6 40.8 32.5 20.8 6.0 7.2 27.8 47.4 22.8 49.7 34.0 40.7 34.2 24.8 21.2 25.1 24.3 30.3 32.4 22.0 53.0 47.5 20.4 31.9 40.4 13.3 2.2 33.6 26.4 3.9 4.1 33.7 26.9 14.6 16.8 22.7 23.0 38.1 46.4 31.3 27.7 16.8 23.2 25.3 27.0 26.4 39.8 18.2 13.2 22.3 27.4 23.7 38.7 24.6 13.1 17.3 47.8 15.2 15.3 32.9 29.7 21.0 34.1 20.2 49.9 29.4 16.6 23.0 19.2 16.5 2.6 3.9 5.7 3.5 4.9 6.3 6.9 7.8 2.2 3.9 4.2 5.5 0.5 8.8 1.9 1.5 14.8 4.8 4.9 11.3 6.3 7.8 4.8 4.5 7.8 5.0 5.4 6.6 6.0 5.4 8.5 2.4 11.4 1.6 1.2 2.5 2.7 3.4 5.2 3.9 6.2 16.6 1.5 9.3 1.7 1.5 46.7 1.8 40.9 4.1 2.1 2.3 1.8 11.4 1.6 0.0 6.2 11.7 11.4 1.4 8.0 1.7 3.6 2.6 1.7 1.6 0.0 3.5 1.9 0.7 12.9 2.8 65.3 40.1 11.3 7.2 4.4 4.1 1.1 RAD21L1 "dJ545L17.2, RAD21L" ENSG00000244588 "RAD21 cohesin complex component like 1" Q9H4I0 20 1226056-1296421 "Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 17.4" "Group enriched" "Detected in some" 21 "Early spermatids: 95.6;Late spermatids: 76.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 3.1;cerebral cortex: 1.2;olfactory region: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;BJ hTERT+ SV40 Large T+: 2.5;TIME: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA053282 Approved NA NA "HPA053282: AB_2682099" "unprognostic (2.90e-1)" "unprognostic (3.35e-1)" "unprognostic (1.62e-4)" "unprognostic (2.04e-1)" "unprognostic (8.87e-4)" "unprognostic (1.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.84e-1)" 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.1 0.0 0.7 0.0 0.0 17.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.6 0.0 0.6 4.7 2.5 0.9 0.0 0.0 0.0 0.4 0.8 1.9 0.0 0.0 0.1 1.3 0.8 0.2 0.1 0.1 0.0 0.8 0.0 0.7 0.1 0.0 0.6 0.0 1.2 0.7 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.8 0.1 1.1 0.0 0.8 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.1 0.1 1.2 0.3 0.1 0.1 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.0 0.0 0.0 0.0 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "skeletal muscle: 225.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Enhanced Nucleoplasm,Cytosol NA NA 3100000 Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 19.6 15.2 19.1 13.4 17.7 19.9 16.0 15.1 25.3 12.9 18.0 14.6 10.7 13.6 15.3 14.3 19.9 17.7 13.6 34.3 16.6 16.0 13.2 24.5 14.2 14.1 15.4 15.6 17.1 21.1 14.0 12.3 17.3 15.5 15.1 10.7 12.6 18.6 15.8 225.3 19.8 11.9 16.5 15.4 15.7 14.9 19.1 12.5 14.6 17.2 37.7 13.8 20.7 17.0 29.5 30.0 22.7 35.6 26.5 32.1 22.5 31.6 11.7 13.6 14.0 22.6 26.0 22.8 15.5 31.2 36.9 33.6 13.1 22.9 27.0 35.8 23.3 24.9 24.6 18.6 32.2 14.0 38.1 23.6 10.9 15.2 12.6 44.1 23.5 32.0 26.5 48.4 26.6 51.0 22.0 25.3 42.9 27.9 24.9 33.2 31.0 29.2 29.1 18.6 28.7 29.1 15.5 14.1 43.9 28.7 12.7 25.2 19.8 17.2 31.3 34.3 10.4 24.4 40.8 19.8 53.1 14.2 63.0 47.3 36.0 30.2 19.7 43.7 44.5 43.6 10.4 27.9 22.7 29.7 35.6 32.1 29.2 25.3 25.1 23.4 29.5 24.6 27.8 3.9 26.5 34.9 30.0 27.0 22.5 19.1 17.7 15.1 25.3 16.6 16.0 15.4 15.6 15.5 12.5 80.4 45.1 117.4 151.7 107.0 47.8 58.9 99.3 85.6 69.4 52.4 19.6 181.0 140.9 124.8 141.7 106.7 99.7 397.1 165.8 204.0 114.4 158.2 108.6 79.1 154.6 49.3 83.8 66.9 72.2 22.4 109.6 119.4 135.0 233.6 105.8 52.4 156.1 119.3 107.1 115.4 44.7 109.9 155.2 223.5 168.2 128.1 204.7 114.9 143.0 156.7 RAD51 "BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA" ENSG00000051180 "RAD51 recombinase" Q06609 15 40694774-40732339 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.9;testis: 24.0" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Extravillous trophoblasts: 57.9;Spermatocytes: 52.6;Spermatogonia: 26.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB010381, HPA039310" Enhanced Supported "Nucleoli rim,Cytosol" NA Yes "Nucleoli rim" Cytosol "CAB010381: AB_2253533, HPA039310: AB_2676434" "prognostic unfavorable (7.94e-4)" "unprognostic (7.20e-3)" "unprognostic (1.22e-1)" "unprognostic (2.72e-2)" "unprognostic (8.23e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-3)" "unprognostic (2.53e-3)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (2.34e-1)" "unprognostic (9.59e-2)" "unprognostic (1.94e-2)" 1.0 0.9 0.4 6.6 0.9 5.3 1.0 0.7 0.9 1.1 5.7 0.4 0.3 1.7 0.8 2.0 4.9 0.5 1.7 1.8 0.5 0.5 1.0 1.0 1.9 7.4 0.5 0.3 0.9 0.7 0.0 0.4 6.2 0.7 0.8 7.6 0.4 1.4 0.3 1.3 2.1 2.6 1.2 1.1 5.0 1.5 24.0 0.5 27.9 0.6 3.7 9.7 1.0 1.9 3.1 1.7 2.7 2.2 2.2 8.8 1.7 12.4 5.5 13.2 5.0 1.3 3.6 12.0 22.0 6.1 19.5 19.7 13.0 8.5 7.0 10.9 7.8 7.5 26.4 24.9 10.3 19.1 14.6 8.5 17.6 10.8 9.9 0.1 14.2 12.1 0.5 1.7 13.1 5.8 3.0 10.6 19.9 23.1 19.7 16.9 10.9 20.3 13.1 15.1 29.3 6.9 23.2 18.7 11.8 7.1 16.8 5.9 11.1 9.7 17.1 3.5 16.7 10.3 11.8 4.4 14.1 9.0 19.8 11.3 5.0 24.6 23.4 6.1 29.7 12.4 2.0 0.9 2.7 4.1 2.0 0.8 3.1 4.3 5.5 1.7 1.6 1.2 2.1 1.3 2.2 2.2 1.2 8.8 1.7 0.4 0.9 0.7 0.9 0.5 0.5 0.5 0.3 0.7 0.5 0.0 0.0 0.8 1.2 3.2 0.4 0.8 0.0 0.0 1.2 0.0 0.0 16.0 0.0 0.0 2.6 0.1 0.9 46.7 0.0 57.9 0.6 0.7 0.0 0.0 10.9 0.0 0.0 1.8 2.4 4.0 0.6 0.5 0.0 0.0 3.2 0.2 0.1 3.7 0.7 0.0 0.0 0.0 0.2 52.6 26.0 1.4 21.2 1.5 5.2 1.3 RAD51AP1 PIR51 ENSG00000111247 "RAD51 associated protein 1" Q96B01 12 4538798-4560048 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 33.7;Erythroid cells: 46.7;Extravillous trophoblasts: 30.1;Hofbauer cells: 34.3;Late spermatids: 50.0;Spermatocytes: 35.8;Spermatogonia: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051499 Approved Nucleoplasm Yes Yes Nucleoplasm "HPA051499: AB_2681508" "unprognostic (1.03e-1)" "unprognostic (5.44e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (6.30e-2)" "unprognostic (5.25e-3)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.15e-2)" "unprognostic (2.26e-2)" "unprognostic (6.29e-3)" "prognostic unfavorable (1.22e-5)" "unprognostic (1.00e-1)" "prognostic unfavorable (4.44e-15)" "unprognostic (2.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.88e-2)" "unprognostic (3.75e-2)" 3.0 2.0 1.7 9.2 3.6 15.4 2.7 4.5 2.6 1.8 5.4 1.4 3.8 5.4 1.5 3.2 7.6 1.1 2.2 1.9 1.5 1.2 1.7 1.7 2.6 8.8 2.1 1.7 1.5 1.2 0.5 1.2 4.2 1.8 1.7 7.1 1.5 2.8 1.0 1.2 3.2 6.2 1.9 2.9 5.8 2.9 9.2 2.5 29.8 1.4 4.7 8.2 2.1 3.1 4.5 9.7 0.9 3.1 1.9 1.5 0.9 13.0 4.6 16.5 8.2 1.0 2.1 19.3 17.2 7.6 19.2 25.4 12.5 12.7 17.1 2.5 3.7 9.0 8.3 11.4 5.1 29.5 13.4 9.7 21.5 8.0 8.6 0.2 19.5 10.9 0.4 0.5 11.5 11.2 2.7 7.7 11.8 13.4 19.7 12.1 4.7 15.9 7.1 40.1 12.7 5.2 16.0 19.8 6.7 5.8 6.5 5.5 6.1 12.8 10.0 4.1 17.4 4.0 11.4 3.4 13.1 13.4 14.1 18.3 3.0 3.4 32.7 4.9 14.1 10.5 0.0 0.8 0.9 0.2 3.1 0.8 4.2 0.6 1.5 0.6 4.5 0.2 0.4 0.0 1.9 2.7 9.7 1.4 0.9 1.7 3.6 4.5 2.6 1.5 1.2 2.1 1.7 1.8 2.5 0.0 0.3 7.5 1.7 4.6 3.0 1.2 2.5 0.0 5.7 0.0 3.9 6.8 0.0 2.0 33.7 0.7 1.3 46.7 2.3 30.1 2.9 1.1 1.1 1.0 34.3 0.0 2.4 1.8 4.7 50.0 1.1 6.6 0.0 10.8 2.8 2.6 1.1 0.0 1.4 1.2 4.9 0.0 1.9 35.8 29.9 2.3 3.9 3.8 7.7 0.9 RAD51AP2 FLJ17540 ENSG00000214842 "RAD51 associated protein 2" Q09MP3 2 17510584-17518439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 19.1" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 222.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AN3-CA: 2.6;CAPAN-2: 3.8;HaCaT: 2.9" "Not detected" "Not detected" NA NA "unprognostic (3.87e-2)" "unprognostic (3.31e-2)" "unprognostic (9.98e-2)" "unprognostic (3.12e-2)" "unprognostic (4.61e-1)" "unprognostic (3.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.84e-3)" "unprognostic (2.64e-1)" "unprognostic (1.92e-1)" "unprognostic (1.71e-1)" "unprognostic (6.26e-3)" "unprognostic (3.82e-2)" "unprognostic (1.62e-3)" "unprognostic (1.15e-1)" 0.0 0.1 0.1 0.0 0.0 0.0 0.2 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.2 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.7 0.1 0.0 0.0 0.0 0.0 4.2 0.9 0.0 0.0 0.0 0.2 0.8 0.1 0.0 0.4 0.0 0.1 25.8 0.1 222.9 2.3 0.5 0.0 0.0 0.2 0.3 RAD54B RDH54 ENSG00000197275 "RAD54 homolog B (S. cerevisiae)" Q9Y620 8 94371960-94475109 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 21.2" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 17.7;Spermatogonia: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 1.4;MAIT T-cell: 4.4;memory B-cell: 1.7;memory CD4 T-cell: 2.4;memory CD8 T-cell: 1.3;naive B-cell: 2.6;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.6;T-reg: 1.4" "Group enriched" "Detected in many" 14 "B-cells: 2.6;T-cells: 4.4" "Low cell line specificity" "Detected in many" HPA007087 Enhanced NA NA "HPA007087: AB_1856040" "unprognostic (1.68e-3)" "unprognostic (2.51e-1)" "unprognostic (2.31e-2)" "unprognostic (8.84e-3)" "unprognostic (4.15e-2)" "unprognostic (1.44e-1)" "unprognostic (5.56e-8)" "unprognostic (1.96e-2)" "unprognostic (1.77e-2)" "unprognostic (5.39e-2)" "unprognostic (2.30e-2)" "unprognostic (2.64e-1)" "unprognostic (2.04e-12)" "unprognostic (5.86e-2)" "unprognostic (5.23e-1)" "unprognostic (9.08e-2)" "unprognostic (6.68e-5)" 2.7 3.9 3.9 7.7 8.6 4.6 4.7 11.8 9.1 6.1 4.7 3.8 4.4 3.8 4.0 4.7 5.4 7.7 2.3 3.5 7.7 3.5 3.5 4.3 2.6 6.3 5.4 4.2 5.2 4.1 5.0 6.6 3.7 7.2 5.2 4.8 3.1 3.7 5.7 1.9 4.2 3.4 3.1 9.4 3.2 4.2 10.5 6.7 21.2 3.6 5.0 6.7 6.7 3.8 2.6 0.2 0.0 0.2 0.2 4.4 0.9 14.2 9.9 14.0 7.5 1.1 1.5 7.6 10.7 5.8 15.1 14.5 5.0 9.7 10.3 16.3 3.0 7.8 7.7 12.3 5.4 16.6 11.8 7.3 15.6 5.7 4.0 1.3 5.8 5.5 1.3 0.7 7.6 9.4 2.9 5.5 12.3 11.5 6.7 15.4 6.7 19.8 3.8 9.7 14.0 8.7 4.8 15.2 5.9 6.3 6.9 8.9 6.3 7.6 1.9 5.7 12.6 9.7 3.3 4.3 10.3 5.5 11.5 11.8 3.5 7.6 5.3 5.5 10.4 10.3 0.0 0.0 0.0 1.4 0.0 4.4 1.7 2.4 1.3 0.2 2.6 1.8 2.6 0.0 0.2 0.2 0.1 1.4 0.9 3.9 8.6 11.8 9.1 7.7 3.5 5.4 4.2 7.2 6.7 0.0 0.3 0.5 0.8 0.3 9.2 1.4 2.5 2.7 0.0 3.5 25.5 0.9 1.7 0.8 0.2 0.2 0.2 0.0 0.7 3.1 0.7 0.5 0.0 1.5 1.2 0.0 1.2 4.9 0.6 0.0 3.1 0.2 0.0 1.0 1.0 4.0 0.5 0.0 2.1 1.1 17.7 0.0 0.4 5.2 14.5 0.5 0.2 1.0 1.5 0.6 RAD54L "hHR54, hRAD54, RAD54A" ENSG00000085999 "RAD54 like" Q92698 1 46247688-46278473 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 41.9;testis: 56.6" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 4 "T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028954, HPA051537" Approved Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA028954: AB_2672840, HPA051537: AB_2681525" "unprognostic (2.12e-2)" "prognostic favorable (6.67e-4)" "unprognostic (5.12e-2)" "unprognostic (5.36e-3)" "unprognostic (3.24e-1)" "unprognostic (1.08e-2)" "unprognostic (9.75e-6)" "unprognostic (3.91e-2)" "unprognostic (2.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.77e-4)" "unprognostic (5.58e-2)" "unprognostic (1.11e-16)" "unprognostic (6.76e-3)" "unprognostic (1.66e-1)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" 1.9 0.6 1.5 12.9 4.7 9.4 1.3 3.0 1.9 1.1 4.8 0.7 0.5 2.8 1.2 2.1 5.2 0.3 1.2 1.5 1.8 1.5 1.4 0.5 1.5 6.0 1.9 0.7 0.8 1.4 0.6 0.5 4.2 0.9 1.1 5.8 0.6 1.4 1.0 1.4 3.0 3.6 1.8 3.2 4.1 1.7 56.6 0.6 41.9 1.7 3.8 9.6 1.0 1.7 0.5 0.3 0.0 0.1 0.9 4.1 0.7 9.0 6.8 20.5 12.5 1.5 1.0 19.1 10.7 4.7 18.1 18.6 14.5 6.0 17.8 8.2 4.5 16.5 9.4 18.9 6.0 16.0 9.7 19.1 21.8 18.2 14.4 0.0 21.8 12.8 0.6 0.5 18.0 5.3 3.0 5.6 20.7 15.6 18.2 9.9 8.6 27.1 24.2 18.3 8.0 11.2 21.7 11.4 7.8 4.4 7.8 9.8 7.0 7.8 10.8 2.6 17.4 3.8 15.9 2.4 19.5 11.6 10.0 18.0 7.7 4.4 19.2 5.2 14.5 7.8 0.0 0.1 0.0 1.2 0.1 0.2 0.5 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.9 0.1 0.0 4.1 0.7 1.5 4.7 3.0 1.9 1.8 1.5 1.9 0.7 0.9 0.6 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 1.8 0.1 0.2 0.0 0.0 7.8 0.4 0.3 4.6 0.0 2.2 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.0 4.2 0.3 1.4 0.0 1.2 0.4 RAD9B FLJ40346 ENSG00000151164 "RAD9 checkpoint clamp component B" Q6WBX8 12 110501655-110532086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 31.8" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 63.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 6.1;SiHa: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040643 Approved NA NA "HPA040643: AB_10805716" "unprognostic (2.32e-1)" "unprognostic (2.55e-5)" "unprognostic (4.76e-2)" "unprognostic (1.30e-3)" "unprognostic (2.93e-1)" "unprognostic (6.27e-3)" "unprognostic (5.44e-2)" "unprognostic (2.00e-1)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (5.92e-2)" "unprognostic (2.26e-1)" "unprognostic (2.68e-3)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (2.15e-2)" "unprognostic (1.80e-2)" 0.3 0.1 0.5 0.1 0.7 0.2 0.4 0.6 0.5 0.3 0.2 0.5 0.1 0.0 0.6 0.9 0.5 0.4 0.1 0.9 0.4 0.3 0.1 0.4 0.3 1.7 0.5 0.1 0.8 0.1 0.3 0.4 0.1 0.6 0.3 0.1 0.4 0.1 0.6 1.0 0.1 0.2 0.5 0.8 0.3 0.1 31.8 0.4 0.6 0.2 0.4 0.5 0.3 0.2 0.9 2.0 6.7 2.0 0.5 0.6 0.8 3.6 0.2 0.0 0.6 0.2 0.1 0.1 1.1 0.2 1.7 1.4 3.3 0.1 2.0 0.8 0.4 0.7 0.2 0.4 0.1 0.4 0.3 0.5 2.5 0.1 0.0 0.5 3.8 0.7 0.3 0.4 1.4 1.3 0.3 0.1 6.1 0.7 1.9 2.1 0.5 0.8 0.8 0.1 1.1 1.2 0.3 0.8 0.5 0.1 0.3 0.6 0.1 5.6 0.8 0.6 0.0 1.3 2.3 0.6 0.7 0.0 0.6 0.4 0.8 0.5 1.5 0.2 1.6 2.3 6.7 1.2 0.5 0.6 0.8 0.3 0.9 0.5 0.3 2.0 0.8 0.6 0.2 1.1 0.5 2.0 1.1 0.3 0.8 0.5 0.7 0.6 0.5 0.4 0.3 0.5 0.1 0.6 0.4 0.0 0.0 0.0 0.2 0.5 0.2 1.2 0.0 4.0 0.0 0.0 0.0 0.0 1.7 0.3 2.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 1.2 1.9 1.4 0.1 0.0 2.8 0.0 0.5 0.3 0.0 0.0 0.0 0.9 0.0 0.3 63.2 11.3 0.4 0.1 0.0 0.0 0.1 RADIL "FLJ10324, KIAA1849, RASIP2" ENSG00000157927 "Rap associating with DIL domain" Q96JH8 7 4797055-4883719 "Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.9;testis: 18.5" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 12.7;Spermatocytes: 18.2;Spermatogonia: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 7.7;HEK 293: 6.0;NTERA-2: 6.8;SCLC-21H: 9.5;SH-SY5Y: 20.6;U-2197: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051776 Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA051776: AB_2681605" "unprognostic (6.77e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.80e-2)" "unprognostic (1.80e-2)" "unprognostic (1.21e-1)" "unprognostic (9.74e-4)" "unprognostic (4.63e-2)" "unprognostic (3.48e-1)" "unprognostic (2.83e-2)" "unprognostic (7.89e-4)" "unprognostic (5.32e-2)" "unprognostic (1.49e-4)" "unprognostic (5.10e-3)" "unprognostic (2.46e-1)" "unprognostic (3.33e-3)" "unprognostic (4.28e-3)" 7.5 2.4 4.3 0.8 4.6 0.5 3.7 29.9 9.9 5.9 3.3 3.3 0.7 0.8 6.1 1.4 1.7 6.4 2.1 7.8 4.1 4.0 1.1 0.7 7.5 0.6 3.4 4.4 1.6 2.5 1.5 3.3 7.2 7.5 2.1 1.1 2.7 1.1 4.3 4.5 1.2 1.8 3.1 4.3 1.0 1.4 18.5 4.0 0.0 2.8 0.6 0.7 2.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.8 7.7 0.2 1.9 0.0 0.9 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.8 1.1 0.0 3.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.7 4.1 0.0 0.4 2.1 0.0 0.0 6.8 0.0 1.3 5.0 0.2 0.0 0.0 0.0 9.5 20.6 0.1 0.0 0.0 1.6 3.0 0.6 0.0 0.0 0.0 5.5 1.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 4.6 29.9 9.9 4.1 4.0 3.4 4.4 7.5 4.0 3.0 1.0 0.0 0.0 0.7 0.5 1.7 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 1.6 0.0 2.4 0.4 0.0 0.0 0.1 12.7 0.0 0.0 0.0 4.1 3.1 0.0 6.8 0.0 0.1 3.3 0.3 0.0 3.5 0.0 0.5 6.5 3.6 18.2 9.7 0.5 0.1 0.0 0.0 0.0 RAE1 Mnrp41 ENSG00000101146 "Ribonucleic acid export 1" P78406 20 57351010-57379211 "Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048795 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA048795: AB_2680523" "unprognostic (1.20e-1)" "unprognostic (5.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (3.23e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (1.88e-1)" "unprognostic (8.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.50e-3)" "unprognostic (3.88e-2)" "unprognostic (7.48e-2)" "unprognostic (3.55e-1)" "unprognostic (9.49e-2)" "unprognostic (2.89e-1)" "unprognostic (2.01e-1)" 9.2 10.0 9.4 11.1 15.2 28.6 12.0 18.1 18.3 9.5 9.7 11.5 9.3 8.0 13.0 13.9 14.0 12.2 7.9 8.1 9.8 11.0 9.2 10.7 7.1 12.5 8.1 12.6 12.1 9.1 12.3 13.7 13.5 10.4 9.2 11.4 9.4 8.9 11.0 9.6 14.8 8.8 11.3 7.3 12.1 8.6 64.8 8.3 19.4 11.7 11.5 17.3 10.0 11.5 17.0 16.6 39.1 21.5 11.8 20.2 17.8 12.8 15.9 15.8 9.0 9.6 8.8 14.4 10.4 14.7 51.4 19.9 50.4 10.3 20.6 14.6 15.0 19.6 17.1 29.7 25.6 42.4 6.2 13.4 14.1 14.2 22.3 18.0 16.9 12.7 12.9 23.1 22.1 24.8 8.6 15.5 14.1 24.7 10.0 16.1 34.7 25.2 14.8 10.0 24.5 28.0 14.1 15.4 13.7 12.0 13.5 17.3 14.3 17.7 40.4 18.2 12.9 22.0 14.8 9.0 21.9 19.7 12.9 17.3 10.9 23.3 23.5 15.3 10.5 10.9 9.1 21.5 39.1 15.6 18.1 18.9 17.0 15.2 15.5 16.6 16.3 20.2 18.4 19.4 11.8 17.9 12.6 12.9 17.8 9.4 15.2 18.1 18.3 9.8 11.0 8.1 12.6 10.4 8.3 17.9 14.7 22.4 14.7 15.2 14.6 8.5 12.7 21.4 12.5 17.4 13.7 44.8 23.2 28.2 84.3 14.2 7.9 23.3 12.5 32.5 15.6 10.5 36.9 11.3 33.3 3.2 6.3 10.4 63.2 48.9 20.1 28.8 10.1 27.1 13.0 17.6 17.6 20.4 21.2 16.6 15.0 19.4 15.0 94.3 78.1 18.3 58.9 21.5 18.0 14.9 RAET1E "bA350J20.7, LETAL, ULBP4" ENSG00000164520 "Retinoic acid early transcript 1E" Q8TD07 6 149883375-149898102 "Predicted intracellular proteins, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 1.9;Early spermatids: 5.0;Late spermatids: 4.2;Suprabasal keratinocytes: 5.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.9;HeLa: 21.8;hTCEpi: 15.8;SiHa: 7.5;U-87 MG: 6.8" HPA054022 Supported "Focal adhesion sites,Cytosol" "Intracellular and membrane" NA NA "Focal adhesion sites" Cytosol "HPA054022: AB_2797250" "unprognostic (1.67e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "unprognostic (2.71e-2)" "unprognostic (1.36e-3)" "unprognostic (4.80e-4)" "unprognostic (1.11e-1)" "unprognostic (3.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (7.47e-5)" "unprognostic (2.41e-2)" "unprognostic (3.18e-2)" "unprognostic (3.17e-2)" "unprognostic (1.06e-1)" 1.6 0.5 0.2 0.5 0.2 0.0 1.4 0.2 0.2 10.4 0.3 0.2 0.2 0.2 0.8 0.6 39.7 0.6 0.2 0.2 0.2 0.0 2.8 0.2 0.6 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.5 0.2 0.4 0.3 0.2 7.0 0.2 0.7 14.6 0.3 0.3 0.2 0.6 0.2 0.5 0.3 0.3 0.2 19.8 22.5 1.3 12.6 0.6 0.4 2.3 0.6 0.5 0.7 0.1 1.5 0.9 0.0 0.0 0.2 1.3 0.1 0.1 0.9 0.1 0.3 0.0 3.7 0.0 2.1 3.1 2.0 1.7 0.0 15.9 0.2 0.4 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.3 15.8 0.9 3.3 0.5 0.1 0.0 0.0 1.3 0.9 0.1 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.2 0.3 0.7 0.2 0.0 7.5 2.0 0.0 0.0 1.1 0.0 3.0 1.1 0.4 0.1 0.9 0.0 0.0 0.0 6.8 0.3 0.0 2.0 0.6 0.4 0.4 0.3 0.2 0.2 0.6 0.3 0.1 0.6 0.7 0.4 2.3 0.5 0.2 0.4 0.3 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.0 0.9 1.9 0.6 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 1.8 RAET1G ULBP5 ENSG00000203722 "Retinoic acid early transcript 1G" Q6H3X3 6 149916878-149923121 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.2;tongue: 18.4" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6" HPA062673 Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA062673: " "unprognostic (4.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-3)" "unprognostic (1.49e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (5.35e-4)" "unprognostic (3.05e-1)" "unprognostic (1.57e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.33e-1)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" "unprognostic (8.85e-2)" "unprognostic (9.11e-2)" 2.5 10.0 0.3 0.6 0.3 0.0 2.5 0.2 1.0 5.6 0.6 0.5 1.4 0.2 0.8 4.3 21.2 0.5 1.2 0.9 0.4 0.2 2.3 0.2 1.3 0.1 0.3 0.1 1.9 0.1 0.1 1.2 0.1 0.5 2.9 0.1 0.8 3.9 2.2 0.4 4.3 0.5 1.8 0.9 0.2 0.6 0.5 0.2 0.2 0.7 18.4 10.7 2.8 5.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 1.0 0.0 1.3 1.9 1.8 0.0 0.6 2.4 1.1 1.5 0.0 1.2 0.0 0.5 1.3 1.1 2.0 0.7 4.1 0.8 0.2 1.3 0.4 23.4 0.0 0.5 0.0 0.0 2.7 18.7 2.8 1.3 1.3 0.4 0.6 0.2 0.2 0.4 1.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.8 2.5 0.3 0.2 9.2 0.4 0.0 0.1 0.3 0.3 1.3 0.5 0.4 1.1 0.6 0.0 0.0 0.0 7.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.0 0.4 0.2 0.3 0.1 0.5 0.2 0.0 0.0 0.0 4.2 2.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.0 0.0 9.5 RAET1L ENSG00000155918 "Retinoic acid early transcript 1L" Q5VY80 6 150018334-150025532 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 31.4;lymphoid tissue: 15.3;tongue: 25.1" "Group enriched" "Detected in some" 4 "Basal glandular cells: 5.9;Basal keratinocytes: 5.7;Glandular cells: 6.9;Suprabasal keratinocytes: 14.9;Urothelial cells: 6.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 10.1" "Region enriched" "Detected in single" 4 "amygdala: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 19.7" NA NA "unprognostic (1.80e-1)" "unprognostic (1.63e-1)" "unprognostic (2.15e-1)" "unprognostic (1.84e-1)" "unprognostic (4.24e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (8.34e-2)" "unprognostic (1.37e-1)" "unprognostic (2.26e-2)" "unprognostic (7.48e-2)" "unprognostic (1.46e-2)" "unprognostic (2.49e-1)" "unprognostic (1.29e-1)" "unprognostic (5.14e-2)" "unprognostic (7.43e-3)" 0.0 0.1 1.1 0.0 0.1 0.0 0.3 0.0 0.2 6.1 0.1 0.0 0.0 0.0 0.3 0.0 31.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.5 0.1 0.1 2.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 25.1 15.3 0.2 8.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 1.8 0.0 1.1 19.7 0.5 0.5 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.0 3.8 0.9 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.3 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.9 0.0 0.0 0.0 6.4 RAG1 "MGC43321, RNF74" ENSG00000166349 "Recombination activating 1" P15918 11 36510709-36593156 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA recombination, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 62 "lymphoid tissue: 462.4" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 3.3;Ito cells: 9.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MOLT-4: 67.2;REH: 64.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA043939 Supported Nucleoplasm NA NA Nucleoplasm "HPA043939: AB_2732512" "unprognostic (7.35e-2)" "unprognostic (1.57e-3)" "unprognostic (8.75e-2)" "unprognostic (3.44e-1)" "unprognostic (2.14e-1)" "unprognostic (1.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.43e-1)" "unprognostic (1.54e-2)" "unprognostic (5.98e-3)" "unprognostic (1.28e-1)" "unprognostic (1.16e-9)" "unprognostic (2.16e-2)" "unprognostic (1.04e-1)" "unprognostic (2.53e-4)" "unprognostic (1.53e-1)" 0.7 2.3 0.5 0.5 0.5 7.4 0.7 0.5 0.5 0.5 0.6 0.5 0.5 1.2 0.5 1.3 0.5 0.6 0.5 0.6 0.5 0.2 2.4 1.2 0.8 0.5 0.5 0.5 0.6 1.1 1.9 0.5 0.8 0.5 0.5 0.4 0.5 1.5 0.5 0.5 0.2 1.5 0.5 0.5 4.4 0.8 0.9 0.5 462.4 4.5 0.5 0.8 0.7 0.5 0.2 0.3 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.1 0.0 67.2 0.0 0.5 0.0 0.0 64.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.8 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.5 0.5 0.5 0.5 0.2 0.5 0.5 0.5 0.5 0.0 0.0 0.0 1.0 0.1 1.2 0.8 0.0 0.0 0.0 1.8 0.0 0.2 3.3 0.4 1.7 1.5 1.4 0.0 0.4 0.1 0.2 0.3 0.0 1.7 0.3 0.0 0.0 9.2 1.6 1.3 0.0 0.0 0.0 1.8 0.6 0.1 0.7 0.0 0.0 2.1 0.8 0.0 0.4 1.2 0.7 0.4 0.3 0.0 0.4 0.5 RAG2 ENSG00000175097 "Recombination activating 2" P55895 11 36575574-36598279 "Disease related genes, Predicted intracellular proteins" "DNA recombination" "Chromatin regulator" "Disease mutation, SCID" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "lymphoid tissue: 165.8" "Cell type enriched" "Detected in single" 6 "Early spermatids: 1.4" "Cancer enriched" "Detected in single" 21 "thyroid cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 14.0;MOLT-4: 15.6;REH: 62.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065704 Approved Nucleoplasm NA NA Nucleoplasm "HPA065704: AB_2732737" "unprognostic (4.30e-2)" "unprognostic (9.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.77e-1)" "unprognostic (4.58e-2)" "unprognostic (2.17e-1)" "unprognostic (8.11e-2)" "unprognostic (1.68e-3)" 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 165.8 24.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 62.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656237-34832627 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 5.6 4.5 3.9 8.3 5.9 0.5 5.1 4.4 3.2 23.3 9.1 5.5 14.1 2.5 29.2 8.2 8.8 6.8 8.8 3.6 4.4 3.5 7.7 11.2 10.4 5.1 6.9 1.5 9.5 4.8 6.4 2.7 64.4 5.6 10.4 4.0 8.2 8.4 10.8 2.0 7.6 3.6 34.7 17.0 21.2 6.0 26.6 5.7 2.1 6.7 2.7 3.8 22.5 14.9 0.8 0.6 2.5 0.8 2.5 3.3 0.3 2.7 10.8 12.5 8.3 6.7 23.5 16.0 32.7 26.4 18.9 19.0 8.2 3.5 0.6 13.1 16.0 20.7 1.8 14.2 24.1 41.1 0.0 6.8 4.5 10.2 5.0 20.8 0.1 0.4 21.9 7.6 33.9 27.1 31.2 59.9 1.0 6.3 0.2 24.6 2.2 0.4 0.1 9.7 1.6 10.5 3.9 19.1 0.1 22.0 15.6 3.3 1.8 19.3 2.9 8.8 19.1 3.3 0.5 38.5 30.8 16.5 7.5 14.2 0.7 0.0 0.0 26.0 0.0 11.9 2.5 0.8 0.3 3.3 0.3 0.4 0.5 1.0 0.2 0.2 0.8 0.3 0.6 1.6 2.5 0.1 0.6 0.1 0.3 3.9 5.9 4.4 3.2 4.4 3.5 6.9 1.5 5.6 5.7 98.3 166.4 1.7 20.2 10.6 1.9 3.3 5.1 24.1 95.5 33.2 64.8 23.9 6.6 30.0 198.0 51.8 3.2 0.0 24.7 59.3 26.2 11.8 3.5 21.9 6.5 14.3 1.7 16.5 2.4 250.8 66.7 4.2 5.0 1.8 0.8 18.5 39.1 1.9 29.7 18.0 4.7 0.0 17.3 8.1 12.4 13.8 130.6 2.5 2.3 63.1 RALB ENSG00000144118 "RAS like proto-oncogene B" P11234 2 120240064-120294713 "Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle, Cell division" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 155.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.6" "Group enriched" "Detected in all" 4 "granulocytes: 69.6;monocytes: 28.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026010, HPA065232" Enhanced NA NA 10000000 "CAB026010: , HPA065232: AB_2685440" "unprognostic (5.16e-2)" "unprognostic (9.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.38e-2)" "unprognostic (3.89e-2)" "unprognostic (5.92e-3)" "unprognostic (1.77e-2)" "unprognostic (4.15e-2)" "unprognostic (4.91e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (2.29e-2)" "unprognostic (8.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.38e-1)" "unprognostic (2.72e-2)" 21.1 16.1 21.5 19.6 18.9 16.9 17.6 9.1 32.7 17.1 20.0 11.2 7.0 18.0 16.5 9.4 28.0 16.4 16.3 19.6 20.3 16.4 23.2 11.7 18.3 19.7 23.7 18.9 14.8 11.0 155.9 9.8 21.0 15.0 18.1 16.7 9.8 16.7 11.9 12.3 11.1 20.0 15.6 16.1 23.7 13.6 13.4 11.6 7.5 15.3 12.6 12.6 17.2 24.5 9.8 12.2 69.6 28.6 4.3 4.2 9.1 38.7 11.1 10.5 6.7 16.7 25.8 15.2 27.9 24.0 21.4 16.2 22.4 26.5 1.6 14.9 29.4 20.1 14.3 5.1 20.5 17.6 64.8 5.8 18.5 8.6 15.7 10.8 9.6 33.0 14.2 22.1 22.2 16.6 17.9 60.3 1.3 14.4 5.9 22.8 20.4 1.2 19.0 6.8 15.2 23.3 0.2 13.3 8.1 20.0 10.4 2.9 7.1 11.4 30.9 17.6 9.3 9.7 13.9 38.5 21.1 16.0 21.6 10.6 3.7 2.0 2.8 16.6 12.3 21.3 15.7 14.7 41.4 3.7 20.6 3.7 8.5 3.5 3.6 12.2 9.8 2.3 2.7 69.6 4.3 28.6 1.2 4.2 9.1 21.5 18.9 9.1 32.7 20.3 16.4 23.7 18.9 15.0 11.6 8.9 24.8 18.2 25.1 17.2 3.6 48.4 12.7 58.9 23.9 10.4 11.8 4.4 56.3 65.6 12.1 80.8 40.7 0.0 48.5 94.9 28.7 36.1 99.7 9.3 46.6 12.7 17.9 69.3 46.2 17.7 18.4 56.0 33.7 42.3 19.6 12.4 88.9 42.5 29.4 84.1 6.1 19.4 33.0 8.6 17.7 16.6 30.7 21.9 27.4 29.1 RALGPS2 "FLJ10244, FLJ25604, KIAA0351" ENSG00000116191 "Ral GEF with PH domain and SH3 binding motif 2" Q86X27 1 178725147-178921841 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Alzheimer disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.7" "Cell type enhanced" "Detected in all" 10 "Cone photoreceptor cells: 194.4;Rod photoreceptor cells: 376.7;Spermatocytes: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 17.8;naive B-cell: 14.6" "Lineage enriched" "Detected in many" 12 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "U-266/84: 62.7;U-698: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027143, HPA028328" Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA027143: AB_10602071, HPA028328: AB_10601889" "unprognostic (8.13e-2)" "unprognostic (1.46e-2)" "unprognostic (4.06e-3)" "unprognostic (2.71e-1)" "unprognostic (1.23e-1)" "unprognostic (1.50e-1)" "unprognostic (5.72e-2)" "unprognostic (6.63e-3)" "unprognostic (4.07e-2)" "unprognostic (1.33e-1)" "unprognostic (2.82e-2)" "unprognostic (7.77e-2)" "unprognostic (1.55e-1)" "unprognostic (3.45e-1)" "unprognostic (6.35e-2)" "unprognostic (4.37e-2)" "unprognostic (8.97e-2)" 5.5 6.4 5.0 27.9 10.5 6.2 5.4 8.9 5.1 8.0 9.9 1.2 7.2 5.8 8.2 7.3 14.0 8.7 4.7 4.7 6.0 3.2 6.1 16.4 3.7 25.3 2.2 4.1 11.5 5.0 6.2 8.4 4.6 3.8 5.3 6.4 9.9 9.2 7.4 2.1 10.0 19.7 6.1 3.2 26.1 6.8 37.7 2.1 16.0 4.3 4.7 29.4 7.5 8.4 17.8 0.5 1.4 0.1 0.3 0.5 0.8 10.3 3.4 10.5 0.1 11.8 17.3 4.1 9.1 20.1 7.4 6.7 4.1 10.2 22.0 3.0 26.7 3.7 8.6 4.6 2.3 9.7 0.0 2.7 0.0 2.2 3.8 2.0 2.8 0.1 7.6 2.0 9.5 6.7 5.1 6.4 4.1 5.3 0.8 4.8 1.6 4.3 0.9 7.2 4.0 3.6 6.1 10.8 0.2 2.5 6.6 1.6 4.7 5.9 6.6 12.8 7.5 7.9 1.4 4.7 3.4 3.3 12.3 4.3 25.1 62.7 51.4 1.9 1.5 3.8 0.5 0.1 1.4 0.2 0.0 0.2 17.8 0.1 0.1 0.2 14.6 0.5 0.1 0.8 0.3 0.0 0.5 0.0 0.8 5.0 10.5 8.9 5.1 6.0 3.2 2.2 4.1 3.8 2.1 11.9 8.6 135.8 14.0 13.2 83.6 11.7 5.1 26.8 7.9 14.0 194.4 6.4 18.3 12.8 103.8 2.7 23.8 23.3 10.3 8.6 12.0 23.1 8.1 51.8 5.0 12.7 34.4 3.1 7.5 137.4 46.3 3.6 8.5 1.8 18.2 23.8 20.4 24.6 43.9 6.6 376.7 19.4 8.1 162.4 24.7 29.7 2.7 4.8 13.0 54.0 RALYL HNRPCL3 ENSG00000184672 "RALY RNA binding protein like" Q86SE5 8 84182787-84921844 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 25.6;brain: 54.9;kidney: 23.5" "Cell type enhanced" "Detected in some" 24 "Bipolar cells: 38.5;Distal tubular cells: 150.9;Horizontal cells: 31.8;Muller glia cells: 33.3" "Cancer enhanced" "Detected in single" "glioma: 1.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 26.8" "Low region specificity" "Detected in all" "HPA055868, HPA059112" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA055868: AB_2682950, HPA059112: AB_2683908" "unprognostic (1.13e-5)" "unprognostic (1.62e-1)" "unprognostic (7.48e-2)" "unprognostic (1.36e-1)" "unprognostic (5.04e-2)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (4.82e-5)" "unprognostic (2.74e-2)" "unprognostic (2.52e-1)" 1.1 25.6 14.0 1.1 23.0 1.2 1.1 54.9 38.2 0.9 1.3 1.1 0.0 1.4 1.1 1.8 0.9 1.7 7.1 3.7 14.9 22.6 23.5 1.3 1.1 1.0 14.7 20.0 1.0 3.7 1.0 7.6 2.4 9.8 1.2 1.5 0.4 1.1 3.4 1.1 1.2 1.8 1.1 4.6 3.8 1.6 1.4 3.5 0.0 1.1 0.0 1.0 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 26.8 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 14.0 23.0 54.9 23.0 14.9 22.6 14.7 20.0 9.8 3.5 0.0 0.0 0.0 0.0 0.0 38.5 4.4 22.9 0.0 0.0 7.0 2.0 0.0 150.9 0.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 31.8 1.7 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 33.3 0.1 0.0 0.0 14.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RAMP1 ENSG00000132329 "Receptor activity modifying protein 1" O60894 2 237858893-237912114 "FDA approved drug targets, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 91.6;pancreas: 94.7" "Cell type enhanced" "Detected in many" 18 "Exocrine glandular cells: 240.1;monocytes: 755.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 16 "NK-cell: 30.0" "Lineage enriched" "Detected in many" 16 "NK-cells: 30.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.1;HDLM-2: 37.9;PC-3: 44.2;SH-SY5Y: 55.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057814 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA057814: AB_2683536" "unprognostic (1.13e-2)" "unprognostic (5.96e-2)" "unprognostic (3.03e-3)" "unprognostic (3.69e-1)" "unprognostic (4.29e-1)" "unprognostic (1.75e-1)" "prognostic favorable (7.61e-4)" "unprognostic (2.54e-1)" "unprognostic (3.49e-1)" "unprognostic (5.45e-3)" "unprognostic (2.32e-1)" "unprognostic (1.43e-1)" "unprognostic (2.46e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.74e-1)" "unprognostic (3.98e-2)" "unprognostic (2.08e-3)" 3.5 13.8 22.4 9.4 23.9 1.2 1.6 7.8 22.5 34.1 38.8 9.9 8.9 24.9 91.6 21.7 8.9 29.1 19.0 61.7 19.6 15.4 3.1 13.4 3.1 3.3 18.0 12.7 8.4 94.7 1.0 1.6 4.5 14.6 25.5 3.5 1.5 1.5 25.1 62.4 2.4 14.4 51.8 19.5 2.4 14.2 4.3 17.1 0.0 1.1 5.4 2.0 18.3 14.0 0.1 0.4 0.2 0.0 30.0 1.8 1.4 7.9 0.0 0.1 0.0 3.4 5.3 0.3 0.5 0.9 0.5 0.4 0.0 13.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 37.9 1.0 0.0 0.0 0.2 10.7 0.0 0.0 4.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.7 0.0 0.3 0.1 0.0 44.2 0.0 0.4 0.2 0.0 0.0 0.4 55.7 0.8 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.2 0.1 0.2 30.0 0.0 0.0 0.0 1.4 22.4 23.9 7.8 15.3 19.6 15.4 18.0 12.7 14.6 17.1 0.0 1.0 0.5 11.4 10.3 2.1 136.4 91.7 14.7 9.1 10.4 0.0 2.1 0.0 55.5 0.2 4.2 4.9 0.0 240.1 7.5 28.8 73.7 1.1 137.8 18.7 1.6 110.7 51.5 4.0 0.4 7.8 6.3 60.8 755.6 26.2 3.3 79.4 4.0 10.6 0.0 2.3 6.5 86.3 0.0 4.9 5.1 1.9 3.2 6.6 3.8 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.3" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 76.6;Late spermatids: 31.1;Spermatocytes: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nuclear membrane,Nuclear bodies,Cytosol" Yes No "Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 1.6 4.9 1.3 1.8 2.1 0.8 1.8 10.4 3.6 1.8 2.0 2.9 1.1 1.5 5.3 2.8 1.0 2.2 2.7 1.5 1.4 2.2 2.4 1.8 4.1 2.4 1.5 1.7 1.8 7.2 3.6 9.4 5.0 5.3 2.4 2.3 5.4 5.1 2.7 1.0 1.1 2.6 2.4 3.1 1.0 2.5 16.3 0.4 0.1 4.7 0.1 1.4 1.5 1.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 1.1 5.5 4.5 1.5 0.5 3.4 4.0 1.8 2.9 1.7 2.3 0.0 0.1 3.3 3.8 0.0 0.0 0.0 1.7 5.8 0.0 4.3 1.1 2.2 0.0 1.6 0.0 0.0 4.5 0.3 0.3 0.0 0.3 2.6 0.0 0.4 0.0 1.6 2.8 0.0 0.0 0.4 0.8 0.5 0.0 3.6 0.0 0.9 1.4 0.3 2.0 0.0 5.5 2.8 2.5 0.9 1.5 3.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 2.1 10.4 3.6 1.4 2.2 1.5 1.7 5.3 0.4 8.9 1.3 0.0 5.2 0.2 20.8 1.4 5.1 0.0 2.3 0.0 13.7 8.7 0.0 6.3 76.6 2.8 2.8 0.0 1.2 2.7 2.6 5.1 0.0 1.3 1.6 0.0 5.2 3.1 1.2 31.1 2.6 0.0 1.7 1.8 3.3 5.6 3.6 3.5 2.8 0.7 24.1 0.0 2.2 27.1 24.0 0.0 2.1 0.0 4.5 6.1 RANBP3L FLJ25422 ENSG00000164188 "RAN binding protein 3 like" Q86VV4 5 36248434-36302114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;kidney: 33.8" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 8.7;Distal tubular cells: 39.7;Muller glia cells: 12.8;Sertoli cells: 12.9" "Cancer enhanced" "Detected in some" "prostate cancer: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037471, HPA037472, HPA061526" Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (1.27e-1)" "unprognostic (1.41e-3)" "unprognostic (5.52e-3)" "unprognostic (2.85e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-2)" "unprognostic (9.56e-2)" "unprognostic (2.66e-1)" "unprognostic (2.81e-1)" "unprognostic (1.28e-1)" "unprognostic (3.76e-4)" "unprognostic (1.68e-2)" "unprognostic (9.13e-2)" "unprognostic (8.87e-3)" "unprognostic (5.71e-2)" 4.6 2.8 25.7 1.0 27.5 0.8 10.7 8.5 24.5 2.4 1.1 5.6 0.6 1.0 1.4 3.1 1.4 2.3 3.0 2.5 30.3 5.6 33.8 12.2 3.2 1.1 8.2 16.5 3.4 1.2 1.1 5.3 7.0 12.2 18.6 1.3 1.0 1.5 4.7 0.9 0.9 1.0 6.6 21.4 1.0 2.7 6.4 18.4 0.0 3.6 0.0 1.5 8.2 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 16.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.1 0.0 3.5 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 27.5 8.5 21.2 30.3 5.6 8.2 16.5 12.2 18.4 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 8.7 0.0 0.0 39.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.2 0.0 1.3 1.4 0.0 0.0 0.6 0.0 0.0 2.0 0.0 1.7 0.0 0.0 12.8 0.0 0.0 2.1 0.1 0.5 12.9 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RAP1GAP "KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII" ENSG00000076864 "RAP1 GTPase activating protein" P47736 1 21596215-21669363 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 89.3;thyroid gland: 72.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 66.1;Distal tubular cells: 61.3;Horizontal cells: 87.4;Mucus-secreting cells: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 16.5;OE19: 57.5;SCLC-21H: 19.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 286.1" "HPA001922, CAB003851" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB003851: AB_562338, HPA001922: AB_1079743" "unprognostic (1.17e-2)" "unprognostic (4.33e-2)" "unprognostic (7.84e-2)" "unprognostic (2.45e-2)" "unprognostic (4.52e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (8.33e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (3.43e-2)" "unprognostic (1.35e-2)" "prognostic favorable (1.12e-6)" "unprognostic (1.11e-1)" "unprognostic (9.85e-3)" "unprognostic (4.86e-3)" "unprognostic (3.64e-2)" 0.9 38.2 30.2 1.9 89.3 1.1 3.1 27.1 40.1 4.7 10.5 5.7 0.0 6.9 1.7 1.8 2.9 3.0 13.4 2.7 17.8 12.9 33.2 10.3 7.8 1.2 8.6 20.6 1.6 49.3 7.1 8.2 5.8 14.6 7.4 9.4 2.4 43.9 1.2 0.7 2.1 11.6 1.1 3.2 0.9 28.4 2.1 14.2 0.0 72.5 0.9 1.6 2.5 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.3 2.1 16.5 0.1 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 2.3 0.0 1.7 0.0 11.1 2.8 1.6 0.1 0.0 0.3 0.8 0.7 1.5 7.7 0.2 0.0 2.4 0.1 1.1 0.0 0.0 0.0 0.0 8.0 10.2 0.4 0.0 5.5 2.6 0.2 1.0 57.5 2.5 1.5 0.4 0.3 3.8 1.2 19.2 3.4 2.7 10.0 3.2 0.7 1.0 1.8 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 30.2 89.3 27.1 30.4 17.8 12.9 8.6 20.6 14.6 14.2 8.9 21.1 0.5 0.9 1.1 66.1 3.3 25.5 0.0 6.8 14.0 0.0 0.1 61.3 10.9 0.6 0.0 4.2 23.3 24.6 1.1 0.6 8.3 0.0 5.6 0.2 87.4 6.4 0.0 0.8 0.0 0.0 0.7 15.1 1.0 97.4 10.0 20.3 10.2 0.0 10.2 6.2 0.0 0.4 1.0 3.4 1.0 1.3 0.0 6.9 1.1 RAP1GAP2 "GARNL4, KIAA1039" ENSG00000132359 "RAP1 GTPase activating protein 2" Q684P5 17 2755705-3037739 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.5;pancreas: 26.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 31.4;Horizontal cells: 35.0;Intestinal endocrine cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022148, HPA022896" Approved Supported "Nuclear membrane,Cytosol" NA NA 110000 "Nuclear membrane, Cytosol" "HPA022148: AB_1849474, HPA022896: AB_1849476" "unprognostic (1.85e-3)" "unprognostic (1.02e-2)" "unprognostic (8.92e-2)" "unprognostic (5.39e-1)" "unprognostic (4.04e-2)" "unprognostic (3.92e-1)" "unprognostic (6.52e-5)" "unprognostic (1.18e-2)" "unprognostic (2.91e-1)" "unprognostic (2.22e-1)" "unprognostic (1.66e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.36e-6)" "unprognostic (3.44e-2)" "unprognostic (6.38e-2)" "unprognostic (9.33e-2)" "unprognostic (7.50e-2)" 1.2 4.6 6.7 2.9 13.5 16.8 3.1 27.5 22.9 2.7 5.3 2.2 0.0 5.9 3.7 1.0 2.5 5.8 2.7 9.9 6.5 6.3 3.9 0.7 3.4 3.4 4.3 16.4 3.3 26.0 4.5 8.0 3.3 15.8 2.6 5.6 2.6 9.0 3.5 0.8 2.7 5.5 2.3 4.3 3.2 15.4 2.3 3.1 1.6 2.1 0.3 3.0 1.6 2.2 0.5 3.0 7.2 6.3 2.9 5.2 2.0 4.5 5.7 1.1 4.7 0.0 0.0 9.4 6.1 2.9 0.8 0.7 12.5 2.0 1.7 1.7 0.8 8.0 6.3 3.7 11.5 0.2 0.0 4.0 2.1 8.0 5.6 1.1 0.4 2.3 0.3 10.0 3.2 8.3 4.3 0.1 2.1 11.8 0.8 0.0 5.1 1.7 1.1 6.8 2.2 5.5 7.6 4.0 4.4 3.5 2.3 12.7 30.9 8.9 9.2 4.0 4.6 4.6 1.3 1.4 5.4 8.6 0.9 5.2 0.0 0.0 0.7 0.3 3.9 8.7 1.5 2.3 3.3 5.2 4.7 2.0 0.5 1.7 3.7 1.8 0.4 0.3 1.9 7.2 2.9 6.3 3.0 1.6 2.0 6.7 13.5 27.5 22.9 6.5 6.3 4.3 16.4 15.8 3.1 6.0 4.5 1.3 5.8 1.8 13.0 14.2 7.6 4.0 2.3 12.2 31.4 5.9 8.3 5.3 3.4 1.4 6.8 0.0 10.5 4.8 2.9 11.6 5.8 0.4 2.9 35.0 46.3 2.5 13.9 5.4 1.7 3.9 3.3 1.0 20.7 2.0 11.4 21.0 1.4 0.6 4.7 0.0 2.8 0.4 3.0 0.4 2.9 4.3 12.1 9.6 RAP2A "K-REV, RAP2" ENSG00000125249 "RAP2A, member of RAS oncogene family" P10114 13 97434222-97469128 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018552 Uncertain NA NA "CAB018552: AB_2177305" "unprognostic (2.40e-1)" "unprognostic (7.72e-2)" "unprognostic (1.94e-1)" "unprognostic (4.34e-2)" "unprognostic (2.04e-2)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" "unprognostic (2.10e-1)" "unprognostic (5.66e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (8.06e-4)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.53e-1)" 12.0 7.4 25.2 8.6 20.6 3.0 9.9 11.4 39.7 10.9 8.6 16.5 2.2 6.7 7.7 4.1 13.8 6.1 11.0 9.4 24.3 20.4 12.2 7.4 11.6 17.8 22.4 24.6 6.1 4.2 4.9 7.1 21.2 13.7 5.8 9.8 4.1 5.1 6.7 8.0 6.1 6.8 10.5 30.6 12.0 5.4 3.8 13.3 8.9 5.8 7.4 10.6 10.7 6.5 1.3 3.7 0.9 4.2 1.0 4.7 0.8 11.1 3.2 12.2 8.7 20.2 12.1 4.8 8.3 5.5 8.2 9.3 6.0 6.6 8.6 5.3 13.6 8.0 8.7 10.3 8.3 10.8 15.9 5.3 9.3 12.5 8.8 14.6 8.1 6.0 18.5 10.9 8.1 11.2 12.5 17.6 9.9 3.1 16.5 10.8 4.0 5.6 12.7 7.0 9.7 4.9 7.3 13.1 5.6 8.0 3.7 13.9 23.8 5.9 14.1 12.1 17.4 11.3 4.2 13.1 8.0 8.0 7.9 7.9 11.8 9.3 4.7 22.4 9.8 13.0 0.0 0.8 0.9 4.7 3.3 2.1 1.3 1.9 3.4 2.2 0.7 1.2 3.7 0.3 1.0 4.2 3.7 3.0 0.8 25.2 20.6 11.4 33.4 24.3 20.4 22.4 24.6 13.7 13.3 11.9 5.4 5.2 3.8 20.1 9.7 12.9 20.4 2.7 5.7 1.8 7.9 1.7 8.3 5.1 1.6 18.8 6.3 23.3 5.2 10.0 23.6 6.5 4.7 14.4 27.2 27.0 16.1 30.1 41.2 1.1 6.6 31.7 15.1 20.8 13.8 15.4 9.0 18.6 5.6 15.7 5.5 25.8 36.3 4.6 6.8 19.2 3.1 10.2 9.7 3.6 RAP2C DKFZp313B211 ENSG00000123728 "RAP2C, member of RAS oncogene family" Q9Y3L5 X 132203024-132219480 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 65.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.37e-2)" "unprognostic (8.80e-2)" "unprognostic (6.66e-2)" "unprognostic (1.54e-2)" "unprognostic (8.63e-2)" "unprognostic (4.14e-2)" "unprognostic (4.95e-2)" "unprognostic (3.44e-1)" "unprognostic (1.44e-1)" "unprognostic (1.21e-2)" "unprognostic (1.51e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.44e-2)" "unprognostic (1.00e-1)" 8.2 7.3 5.7 8.1 7.6 20.0 6.4 3.4 4.7 14.7 9.2 6.4 4.5 7.1 65.2 14.4 9.0 9.5 6.8 10.9 5.2 5.1 13.6 19.8 9.2 9.7 6.9 3.2 8.6 7.0 3.1 3.2 12.7 5.6 6.8 6.5 6.9 6.4 7.4 17.4 6.6 8.6 27.7 8.0 12.4 6.6 7.6 5.6 10.5 8.4 7.4 11.3 12.0 6.8 6.0 5.4 11.3 16.3 7.4 7.5 4.6 12.3 9.6 14.2 15.7 12.2 19.9 22.0 14.0 17.5 13.6 13.9 9.6 16.5 17.5 22.3 15.6 12.4 9.1 13.0 13.6 17.8 31.4 11.8 13.5 11.0 13.6 18.6 22.4 19.0 15.8 15.7 15.2 16.6 14.1 15.1 10.2 10.7 20.7 14.9 19.6 12.6 17.7 9.7 12.2 13.9 9.7 10.9 17.6 17.9 9.1 2.9 15.9 8.4 10.0 14.9 23.2 17.2 12.2 13.4 14.0 8.1 28.6 25.4 19.3 15.2 17.9 15.8 21.7 12.4 6.5 4.8 11.3 6.0 10.3 6.9 6.0 6.8 6.2 5.4 5.0 6.3 7.5 9.6 7.4 16.3 2.6 6.8 4.6 5.7 7.6 3.4 4.7 5.2 5.1 6.9 3.2 5.6 5.6 8.9 11.9 36.6 13.6 28.6 5.3 14.9 12.7 8.1 3.4 21.0 3.9 27.1 64.6 9.1 0.3 15.7 20.2 0.0 11.6 30.9 20.5 12.4 12.7 38.0 22.5 7.9 5.2 12.9 34.3 0.5 18.7 30.7 30.4 19.0 8.6 17.7 16.0 13.1 14.2 15.6 5.8 6.5 11.6 4.3 3.8 28.7 62.4 34.1 8.8 18.3 RAPGEF1 "C3G, GRF2" ENSG00000107263 "Rap guanine nucleotide exchange factor 1" Q13905 9 131576770-131740074 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.3" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 123.9;monocytes: 83.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006426, HPA075984" Enhanced Supported Vesicles NA NA Vesicles "HPA006426: AB_1856070, HPA075984: AB_2686771" "unprognostic (1.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.43e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-1)" "unprognostic (4.11e-2)" "unprognostic (1.74e-1)" "unprognostic (5.50e-2)" "unprognostic (6.04e-2)" "unprognostic (1.94e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.18e-5)" "unprognostic (5.66e-2)" "unprognostic (1.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.73e-2)" 16.2 10.8 18.4 21.5 28.0 19.7 18.5 21.8 19.5 9.6 11.5 13.7 6.0 10.1 11.1 6.9 10.3 11.4 10.2 21.5 17.4 16.0 9.4 9.7 16.9 21.7 13.1 10.2 7.4 24.1 9.0 7.3 28.5 13.5 9.0 10.3 16.8 8.5 10.0 83.3 9.2 13.7 13.2 13.0 16.7 12.0 6.8 11.6 12.4 9.9 8.8 25.9 11.3 12.0 9.2 2.9 5.3 3.9 2.0 6.5 2.3 10.6 12.4 12.6 12.7 12.9 14.0 48.4 9.2 18.9 10.7 7.7 15.4 7.0 19.3 11.6 18.5 23.0 19.5 14.4 12.8 5.4 44.7 5.9 5.6 20.8 8.1 10.9 23.3 26.1 10.6 23.6 14.0 16.7 10.8 19.3 22.5 15.1 38.3 13.8 11.1 16.4 8.3 12.7 10.6 11.3 16.4 29.4 26.8 4.9 12.9 10.7 10.7 13.4 12.8 13.4 13.2 12.2 19.7 20.3 28.8 12.1 18.2 14.0 12.9 11.2 38.1 13.7 10.0 6.9 5.3 2.0 2.6 6.5 3.8 3.7 9.2 4.2 4.2 2.4 5.3 1.1 2.9 2.3 2.0 3.9 2.9 3.0 2.3 18.4 28.0 21.8 18.5 17.4 16.0 13.1 10.2 13.5 11.6 6.0 17.3 13.3 8.3 16.7 18.8 12.5 22.9 20.1 14.8 5.2 13.7 16.3 5.0 6.8 2.1 30.2 16.8 0.0 15.9 28.3 7.6 9.5 19.7 11.3 25.1 123.9 11.6 22.1 24.1 1.5 8.1 48.3 30.4 83.8 12.0 19.1 15.1 14.4 11.3 7.0 13.2 6.5 7.2 4.4 10.7 9.9 43.3 23.5 10.2 10.2 RAPGEF4 "cAMP-GEFII, CGEF2" ENSG00000091428 "Rap guanine nucleotide exchange factor 4" Q8WZA2 2 172735274-173052893 "Predicted intracellular proteins" Exocytosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.6;brain: 70.9" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 43.2;Endothelial cells: 30.4;Ito cells: 23.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 68.3;basal ganglia: 31.5;cerebral cortex: 55.3;hippocampal formation: 70.9;olfactory region: 23.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 18.0;SCLC-21H: 7.0;U-266/70: 9.3;U-266/84: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004388, HPA028968" Approved Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "CAB004388: AB_670916, HPA028968: AB_2672846" "unprognostic (1.87e-1)" "unprognostic (4.22e-2)" "unprognostic (1.31e-1)" "unprognostic (2.98e-3)" "unprognostic (4.53e-2)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-1)" "unprognostic (3.23e-1)" "prognostic favorable (1.32e-4)" "unprognostic (6.32e-2)" "unprognostic (1.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.18e-2)" "unprognostic (5.70e-2)" "unprognostic (2.93e-1)" 3.3 29.6 68.3 1.6 31.5 0.6 5.2 10.9 55.3 4.9 1.5 5.4 1.0 2.1 6.6 2.7 2.3 2.9 3.7 5.7 70.9 10.2 3.8 24.6 5.4 1.7 10.0 23.8 9.7 2.0 3.2 2.4 2.3 8.6 3.5 1.7 11.3 1.7 2.9 1.4 10.6 1.8 4.3 2.9 0.9 5.4 3.7 11.5 0.0 4.3 0.9 1.8 4.2 1.2 0.4 0.6 1.4 0.6 0.6 0.7 0.1 0.1 0.1 2.7 0.4 0.0 0.2 0.1 0.9 0.5 0.1 0.2 0.0 3.1 0.0 0.2 0.0 0.2 0.5 2.3 0.6 0.3 0.1 4.8 0.4 2.3 0.0 0.0 3.0 0.8 0.0 0.7 0.0 0.0 2.7 2.9 1.3 0.0 18.0 0.1 0.0 0.2 0.2 0.3 1.5 0.3 0.0 0.6 0.0 0.0 5.4 7.0 2.6 0.1 0.1 0.9 1.4 0.1 0.1 0.8 0.1 0.3 0.0 0.2 9.3 18.0 0.0 0.3 0.1 0.2 1.4 0.4 0.4 0.3 0.4 0.6 0.4 0.4 0.3 0.3 0.4 0.6 0.7 1.0 0.6 0.6 0.6 0.3 0.1 68.3 31.5 10.9 55.3 70.9 10.2 10.0 23.8 8.6 11.5 3.0 3.2 0.9 1.0 5.5 2.5 6.7 0.0 0.0 0.0 0.0 43.2 0.1 0.0 0.6 2.1 30.4 0.0 0.0 2.3 0.0 0.9 0.5 0.0 9.9 0.1 1.6 7.5 23.9 1.9 1.1 4.0 0.0 3.3 0.0 0.2 1.2 2.4 0.0 1.4 0.0 8.9 0.0 1.4 0.5 2.0 3.3 0.1 0.0 0.0 0.6 RAPGEF5 "GFR, KIAA0277, MR-GEF" ENSG00000136237 "Rap guanine nucleotide exchange factor 5" Q92565 7 22118238-22357144 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 67.0;parathyroid gland: 258.2" "Cell type enhanced" "Detected in many" 8 "Ito cells: 81.0;Late spermatids: 45.4;Sertoli cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 11.8;HUVEC TERT2: 25.2;SCLC-21H: 19.5;TIME: 14.3;U-698: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057821, HPA076772" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA Nucleoplasm "Nuclear bodies" "HPA057821: AB_2683538, HPA076772: AB_2686814" "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (5.22e-2)" "prognostic favorable (3.52e-5)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-1)" "unprognostic (3.76e-2)" "unprognostic (6.36e-3)" "unprognostic (6.57e-2)" "unprognostic (2.55e-1)" "unprognostic (8.26e-3)" 10.8 5.8 12.6 3.6 22.6 1.8 6.2 5.2 25.1 4.5 4.6 47.6 0.6 3.9 4.4 3.1 6.1 4.2 7.0 6.7 21.3 10.1 7.3 8.5 14.1 5.7 41.8 13.3 3.7 7.9 258.2 3.3 23.2 31.5 2.8 5.2 0.9 3.4 3.4 2.7 4.4 4.1 5.6 67.0 17.1 3.7 3.5 29.5 3.9 5.4 1.8 4.9 3.9 4.9 0.7 0.0 0.0 0.0 0.0 0.2 0.4 1.5 0.0 2.6 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 3.0 0.8 11.8 0.6 0.1 0.4 7.4 1.5 1.1 0.0 0.0 2.3 0.1 0.0 2.9 0.0 0.0 0.0 0.3 1.3 0.7 0.4 0.4 25.2 3.3 2.6 0.1 0.0 0.6 1.6 0.0 2.0 2.9 2.3 2.9 0.0 4.0 2.4 1.0 19.5 5.2 0.3 3.4 0.0 0.4 1.7 0.0 14.3 0.0 0.6 0.2 0.6 6.6 1.3 21.2 0.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.6 22.6 5.2 25.1 21.3 10.1 41.8 13.3 31.5 29.5 8.9 13.9 2.2 4.3 9.7 14.8 7.3 10.2 0.0 5.7 0.0 0.0 0.1 1.7 4.3 41.5 38.5 14.3 0.0 5.9 0.1 2.1 2.2 8.1 5.8 0.2 22.3 6.9 81.0 5.1 45.4 1.7 1.5 6.8 0.0 16.0 0.5 6.0 17.5 4.6 0.2 1.1 84.1 10.3 0.9 1.1 9.8 0.2 2.1 8.8 3.7 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 87.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 40.4;Enterocytes: 66.1;Paneth cells: 46.5;Suprabasal keratinocytes: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 39.0;hTCEpi: 19.5;T-47d: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 1.5 1.3 15.9 2.7 17.2 1.8 4.1 8.2 22.7 8.9 19.5 1.8 0.9 18.8 1.6 4.3 37.7 2.9 5.9 1.1 11.2 6.2 0.6 1.7 1.6 1.1 2.8 20.2 0.8 1.6 0.8 2.7 1.2 5.5 3.4 17.7 1.3 5.7 3.2 4.6 87.1 15.5 2.0 1.9 1.4 12.6 2.4 2.9 0.2 0.9 13.3 10.7 6.5 19.4 0.1 0.9 2.9 0.4 0.0 0.6 0.0 2.1 1.1 5.8 4.3 0.6 1.4 2.8 0.8 0.6 1.1 1.3 2.4 3.1 1.7 0.8 1.1 1.0 39.0 1.1 1.3 1.6 3.1 2.9 1.0 1.3 2.4 0.7 2.1 3.6 1.6 19.5 1.2 0.5 1.7 1.7 5.8 0.7 1.2 0.8 6.0 1.9 2.5 1.8 10.7 1.1 3.6 0.7 1.0 0.7 11.4 11.2 2.3 1.3 13.2 0.5 5.1 34.1 1.6 3.3 1.4 2.9 1.5 1.3 1.9 1.8 1.4 3.3 1.3 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.4 0.9 0.0 0.1 0.2 2.9 0.0 0.4 0.2 0.0 0.0 15.9 17.2 8.2 22.7 11.2 6.2 2.8 20.2 5.5 2.9 0.0 0.6 0.8 9.6 40.4 2.1 1.6 20.4 0.0 1.2 1.8 5.9 0.1 0.0 0.5 2.4 1.6 66.1 0.0 0.7 0.2 1.0 5.0 5.7 3.8 0.5 1.6 4.7 4.9 0.8 1.4 3.1 1.6 5.0 1.8 32.6 2.8 1.2 46.5 3.5 0.0 4.6 0.0 1.4 11.5 10.4 84.8 0.6 0.0 32.3 31.9 RAPH1 "ALS2CR18, ALS2CR9, KIAA1681" ENSG00000173166 "Ras association (RalGDS/AF-6) and pleckstrin homology domains 1" Q70E73 2 203394345-203535410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 68.3;Ito cells: 89.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.8;non-classical monocyte: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA016744, HPA020027" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Nuclear bodies, Plasma membrane" Cytosol "HPA016744: AB_1844781, HPA020027: AB_1844782" "unprognostic (9.78e-2)" "unprognostic (9.05e-2)" "unprognostic (7.17e-4)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (8.32e-2)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.24e-4)" "unprognostic (1.92e-1)" "unprognostic (1.40e-2)" "unprognostic (5.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (2.79e-1)" 11.0 6.1 7.3 6.3 7.6 2.7 17.6 8.4 12.7 9.8 7.9 3.7 6.8 6.9 6.8 8.4 9.2 6.3 12.5 8.3 5.2 5.0 8.2 51.1 17.2 6.8 4.2 8.4 3.6 5.8 4.0 9.9 11.1 6.0 7.2 6.7 8.5 11.2 4.4 8.3 10.2 10.2 7.1 4.8 26.7 7.8 7.9 3.1 1.7 25.8 7.9 5.6 9.6 8.7 0.0 1.1 0.0 2.8 1.1 0.6 0.3 5.5 3.8 8.1 4.6 6.4 8.3 7.2 7.7 5.7 8.0 10.2 17.7 5.9 0.0 1.9 11.7 5.9 2.7 4.2 6.6 16.8 1.1 2.4 0.0 9.2 3.1 16.0 0.0 0.1 11.5 5.6 14.7 15.5 8.8 12.5 0.8 0.4 4.3 16.0 3.1 0.0 0.0 4.8 2.8 4.9 0.1 11.5 3.1 5.8 17.9 2.8 3.8 5.3 5.1 6.4 11.2 2.8 0.2 14.8 19.8 6.4 9.4 8.1 2.0 3.4 0.0 16.3 0.1 4.4 0.0 0.8 0.0 0.2 2.8 0.6 0.0 0.5 0.1 1.1 0.0 0.4 0.1 0.0 1.1 2.6 0.1 0.5 0.3 7.3 7.6 8.4 12.7 5.2 5.0 4.2 8.4 6.0 3.1 14.9 6.7 2.2 16.6 43.6 9.3 0.8 15.3 5.3 10.3 14.0 13.7 7.1 6.6 5.8 10.1 18.9 21.2 0.0 8.0 5.9 19.4 17.6 1.1 68.3 15.3 9.5 2.4 89.0 14.9 3.2 4.4 15.9 11.8 2.8 7.2 20.0 14.3 14.0 4.6 2.4 4.6 19.4 16.1 15.7 10.4 35.8 9.2 1.8 11.2 19.1 RAPSN "CMS1D, CMS1E, RNF205" ENSG00000165917 "Receptor associated protein of the synapse" Q13702 11 47437757-47449178 "Disease related genes, Predicted intracellular proteins" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "skeletal muscle: 45.3;tongue: 14.8" "Cell type enriched" "Detected in some" 4 "Late spermatids: 10.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "RH-30: 72.9" "Low region specificity" "Detected in single" HPA039475 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Centrosome, Cytosol" "HPA039475: AB_10794196" "unprognostic (5.37e-2)" "unprognostic (1.02e-1)" "unprognostic (7.34e-2)" "unprognostic (4.58e-2)" "unprognostic (2.95e-2)" "unprognostic (1.44e-1)" "unprognostic (2.62e-2)" "unprognostic (1.77e-3)" "unprognostic (1.35e-1)" "unprognostic (5.38e-2)" "unprognostic (4.81e-2)" "unprognostic (2.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.64e-4)" "unprognostic (3.83e-1)" "unprognostic (4.73e-3)" "unprognostic (4.48e-2)" 1.7 0.8 0.2 0.1 0.2 0.2 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 2.7 0.7 0.1 0.1 1.4 0.4 0.0 0.1 0.2 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.4 0.0 0.3 0.8 0.0 45.3 0.2 0.2 0.1 0.2 0.3 0.1 0.2 0.1 0.1 0.4 14.8 0.4 0.0 0.0 0.2 0.1 2.6 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.6 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.7 0.0 2.6 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 2.4 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.3 10.0 0.0 0.0 0.0 1.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 RARB "HAP, NR1B2, RRB2" ENSG00000077092 "Retinoic acid receptor beta" P10826 3 25174332-25597932 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 22.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1" "Region enriched" "Detected in many" 9 "basal ganglia: 97.9" "Low region specificity" "Detected in all" "CAB002617, HPA004174" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002617: , HPA004174: AB_1079744" "unprognostic (2.04e-2)" "unprognostic (3.53e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (2.70e-2)" "unprognostic (2.43e-1)" "unprognostic (4.71e-2)" "unprognostic (1.62e-1)" "unprognostic (2.86e-1)" "prognostic favorable (3.43e-5)" "unprognostic (9.24e-3)" "unprognostic (2.28e-1)" "unprognostic (9.99e-2)" "unprognostic (6.56e-3)" 3.9 7.1 2.4 2.3 22.6 0.0 6.8 1.5 9.1 13.4 6.0 2.2 6.8 1.7 14.4 7.5 8.1 6.2 5.3 13.6 2.6 2.2 17.5 6.2 5.6 5.6 2.0 3.7 12.2 1.5 12.8 18.9 13.9 3.2 13.0 2.3 39.1 13.7 11.8 2.5 1.4 2.4 14.7 4.6 7.7 4.8 1.7 4.8 0.0 10.0 2.9 4.6 12.1 10.2 1.0 0.4 0.1 0.6 0.1 0.8 0.0 0.0 0.9 0.6 3.1 7.0 1.8 0.0 0.8 0.4 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.5 0.1 0.1 0.0 3.7 0.0 0.0 0.0 41.7 6.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 4.2 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.5 0.0 1.1 3.4 0.1 0.0 0.0 2.8 0.1 18.1 0.0 0.6 0.0 0.8 0.1 0.3 0.3 0.5 0.5 0.4 1.0 0.6 0.8 0.1 0.1 0.1 0.4 0.0 0.0 2.4 22.6 1.5 9.1 2.6 2.2 2.0 3.7 3.2 4.8 0.0 0.3 0.0 17.9 0.1 4.2 9.3 7.6 6.7 12.5 10.4 23.6 0.1 0.0 1.4 1.3 3.8 0.0 0.0 0.8 0.1 3.1 5.5 0.0 2.0 0.3 4.8 0.0 20.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 27.5 1.1 0.0 0.0 0.5 6.1 0.0 9.2 0.2 1.1 0.1 0.2 0.0 0.0 7.1 RARG "NR1B3, RARC" ENSG00000172819 "Retinoic acid receptor gamma" P13631 12 53210567-53232980 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 49.4;skin 1: 52.1" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 30.3;Suprabasal keratinocytes: 48.8;Urothelial cells: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 17.0" "Group enriched" "Detected in all" 4 "dendritic cells: 5.6;T-cells: 17.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 33.3;MCF7: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053883 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA053883: AB_2682292" "unprognostic (7.29e-2)" "unprognostic (1.95e-2)" "unprognostic (6.11e-2)" "prognostic unfavorable (3.68e-6)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" "unprognostic (2.28e-1)" "unprognostic (1.08e-2)" "unprognostic (3.54e-3)" "unprognostic (7.21e-3)" "unprognostic (3.78e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (5.41e-3)" "unprognostic (1.98e-2)" "unprognostic (5.94e-3)" "unprognostic (7.41e-2)" 4.8 5.0 2.7 7.0 3.6 1.3 10.8 6.3 3.8 26.8 6.3 1.8 7.3 1.0 14.6 6.0 49.4 10.6 8.6 6.9 3.0 1.4 3.7 1.9 7.4 6.7 2.4 2.3 12.6 2.7 4.2 2.8 4.4 1.6 11.3 3.4 10.3 9.5 10.6 2.6 52.1 3.0 9.7 1.5 4.7 6.0 3.9 1.7 2.3 7.3 30.6 26.8 10.9 19.8 1.8 5.6 1.5 2.5 1.7 17.0 2.9 7.2 8.0 1.8 16.9 18.9 16.2 0.5 7.6 16.6 10.0 7.9 2.7 33.3 0.1 4.2 30.6 5.4 24.5 6.1 14.6 2.5 1.9 3.1 1.0 6.1 2.3 8.0 0.0 3.0 12.0 21.5 9.5 2.1 25.3 4.2 1.5 0.2 3.2 3.9 35.1 0.4 0.3 5.4 9.8 14.2 2.3 0.6 5.8 3.0 12.0 1.5 7.6 15.5 16.8 10.2 2.4 14.5 0.4 4.5 12.0 5.7 7.9 0.4 1.5 0.8 0.5 14.8 1.2 17.0 1.5 2.5 0.7 6.6 0.8 17.0 1.8 5.7 4.8 5.6 0.6 4.8 4.1 0.0 1.7 0.0 0.4 1.5 2.9 2.7 3.6 6.3 3.8 3.0 1.4 2.4 2.3 1.6 1.7 3.0 6.5 0.0 19.4 30.3 0.7 2.8 5.1 0.0 2.3 3.5 2.0 7.2 0.0 8.7 0.0 6.9 0.4 0.0 4.5 0.7 19.6 11.9 1.1 0.0 2.3 0.0 1.7 20.9 5.2 0.2 4.9 2.8 8.5 1.8 1.6 2.9 9.8 3.5 4.9 0.6 4.9 6.5 12.2 0.4 4.1 48.8 1.5 5.7 5.2 33.4 RARRES1 "LXNL, TIG1" ENSG00000118849 "Retinoic acid receptor responder 1" P49788 3 158696892-158732696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 105.0;vagina: 111.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 153.1;Glandular cells: 151.9;Paneth cells: 100.4;Urothelial cells: 237.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "CAPAN-2: 162.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003892 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "Endoplasmic reticulum" "HPA003892: AB_1856079" "unprognostic (5.76e-3)" "unprognostic (2.13e-1)" "unprognostic (8.85e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (9.29e-4)" "unprognostic (7.09e-2)" "unprognostic (8.93e-2)" "unprognostic (3.86e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.88e-6)" "unprognostic (3.49e-1)" "unprognostic (1.33e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" 49.4 6.1 0.4 26.5 0.5 0.0 54.5 0.3 0.4 18.5 29.9 0.6 10.0 2.1 6.8 24.2 11.5 40.6 8.3 105.0 0.6 0.3 26.8 2.7 13.4 13.3 0.5 0.5 75.5 3.9 0.0 19.7 1.6 2.0 46.2 15.7 19.4 49.0 17.9 10.5 3.3 9.3 20.7 2.4 3.2 6.6 19.0 0.2 1.0 31.5 1.7 5.9 39.6 111.3 1.0 1.2 0.0 0.9 0.2 0.7 0.1 2.5 0.8 0.0 0.1 0.5 1.6 0.0 0.2 0.7 0.1 0.2 0.1 162.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 17.8 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.2 2.2 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.4 0.0 0.4 1.0 0.7 0.3 0.0 0.2 0.9 1.2 0.3 0.1 0.4 0.5 0.3 0.4 0.6 0.3 0.5 0.5 2.0 0.2 0.0 1.1 0.0 153.1 0.5 0.4 0.8 7.6 28.1 30.7 14.0 0.0 2.4 0.0 8.0 19.5 1.6 68.0 0.0 4.2 0.6 13.4 151.9 29.9 3.8 10.7 0.0 35.9 16.5 1.5 25.5 10.0 2.9 5.0 0.0 75.6 3.4 1.6 100.4 1.1 18.7 0.4 0.0 1.0 2.3 0.5 0.4 9.5 0.0 69.1 237.5 RARRES2 "HP10433, TIG2" ENSG00000106538 "Retinoic acid receptor responder 2" Q99969 7 150338317-150341674 "Plasma proteins, Predicted secreted proteins" "Chemotaxis, Differentiation, Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 145.8;liver: 184.8;pancreas: 145.4" "Cell type enhanced" "Detected in all" 17 "Exocrine glandular cells: 588.4;Hepatocytes: 2447.4;Muller glia cells: 685.2" "Cancer enhanced" "Detected in all" "liver cancer: 420.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 8.2" "Lineage enriched" "Detected in single" 10 "dendritic cells: 8.2" "Group enriched" "Detected in some" 6 "AF22: 27.8;Hep G2: 40.2;HHSteC: 36.4;NTERA-2: 84.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 75000000 550000000 "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (2.31e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (2.72e-2)" "unprognostic (2.82e-3)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (5.29e-2)" "unprognostic (2.50e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.83e-4)" "unprognostic (2.94e-2)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.17e-2)" 46.5 145.8 4.6 20.5 5.0 0.0 28.0 2.6 4.4 51.2 31.0 10.7 10.9 5.0 23.8 21.0 18.3 21.9 30.5 12.9 5.3 3.6 21.9 184.8 33.2 10.7 7.6 3.0 40.2 145.4 66.7 6.3 5.6 12.0 35.5 8.0 23.5 6.1 12.2 7.4 3.2 10.3 27.5 7.7 11.0 10.9 11.1 5.4 1.0 7.8 5.2 10.5 26.3 39.7 0.1 8.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.3 2.2 5.2 0.8 3.6 0.2 1.6 0.2 3.2 0.6 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.1 4.5 40.2 36.4 0.4 0.0 7.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.2 0.4 0.5 84.7 0.2 0.0 0.0 3.7 0.0 0.6 0.2 0.1 0.3 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 8.2 0.0 0.0 4.6 5.0 2.6 4.4 5.3 3.6 7.6 3.0 12.0 5.4 62.5 30.1 23.0 74.0 31.1 4.9 79.7 318.5 28.1 67.1 78.5 2.0 9.5 87.9 15.0 2.3 24.8 16.7 23.3 588.4 5.3 340.2 52.4 11.5 2447.4 10.5 9.5 93.8 86.5 50.8 10.2 420.5 12.9 42.2 1.8 172.4 685.2 332.8 31.7 183.2 228.5 19.9 12.9 165.1 3.3 5.4 25.2 12.2 17.8 286.2 21.6 RARRES3 "HRASLS4, TIG3" ENSG00000133321 "Retinoic acid receptor responder 3" Q9UL19 11 63536809-63546462 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 86.6" "Cell type enhanced" "Detected in many" 9 "Proximal tubular cells: 687.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 60.2;HHSteC: 22.0;HSkMC: 22.0;RPTEC TERT1: 30.5;SK-BR-3: 46.1;U-266/70: 23.0" NA NA "prognostic favorable (1.35e-5)" "prognostic favorable (4.00e-4)" "unprognostic (4.12e-2)" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (2.45e-2)" "unprognostic (2.11e-1)" "unprognostic (6.91e-2)" "unprognostic (1.78e-1)" "unprognostic (2.92e-2)" "prognostic unfavorable (6.26e-6)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (3.42e-1)" "unprognostic (2.11e-1)" "unprognostic (9.36e-3)" "unprognostic (2.64e-1)" 13.3 5.9 15.0 16.4 14.6 4.6 30.9 3.1 10.6 13.7 32.7 12.9 12.5 25.1 16.0 18.6 12.1 29.7 21.0 7.3 11.7 10.2 86.6 31.8 36.5 23.5 12.1 10.8 23.1 8.2 0.2 7.9 5.8 8.7 25.0 16.8 9.8 25.4 23.5 7.1 2.6 50.0 12.6 15.0 21.6 18.0 5.4 11.4 24.0 66.4 8.5 17.0 14.3 7.5 10.9 6.6 30.8 15.4 33.3 66.1 63.1 5.8 3.6 0.0 0.1 5.5 19.1 1.3 0.5 10.1 7.7 7.0 0.1 60.2 0.9 5.1 1.0 6.1 1.6 1.3 1.0 1.6 9.9 0.0 0.3 0.4 0.0 22.0 0.1 0.2 22.0 0.1 2.9 0.0 16.2 0.9 2.0 0.0 7.7 1.1 0.0 14.1 1.1 0.0 0.9 0.5 6.4 0.0 0.4 30.5 1.2 0.0 0.0 1.2 46.1 2.4 0.3 5.4 0.4 1.7 0.5 0.0 1.1 0.2 23.0 0.3 0.2 2.3 3.6 0.4 30.8 11.3 7.1 63.6 15.4 47.3 10.9 47.6 66.1 6.6 7.2 41.5 53.7 8.4 33.3 12.5 0.8 35.7 63.1 15.0 14.6 3.1 10.6 11.7 10.2 12.1 10.8 8.7 11.4 291.8 62.1 57.5 128.0 17.3 0.2 5.0 76.5 232.9 87.6 82.0 0.0 11.3 252.0 40.6 0.1 30.9 264.6 0.0 98.0 19.1 35.1 48.0 63.4 78.1 25.0 0.0 20.1 56.4 44.3 1.1 68.7 43.5 13.5 14.4 46.4 43.6 91.5 259.6 19.1 687.8 1.1 6.5 15.5 0.4 0.0 11.2 25.2 276.7 11.5 252.0 RASA1 "CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA" ENSG00000145715 "RAS p21 protein activator 1" P20936 5 87267888-87391931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "placenta: 260.6" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 169.8;Syncytiotrophoblasts: 407.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007789, HPA036393, HPA064556" Enhanced NA NA 7900 "CAB007789: AB_598183, HPA036393: AB_2675097, HPA064556: AB_2685285" "unprognostic (1.57e-1)" "unprognostic (7.63e-2)" "unprognostic (1.88e-3)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.38e-2)" "unprognostic (6.88e-2)" "unprognostic (8.38e-3)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (4.12e-3)" "unprognostic (1.03e-1)" "unprognostic (3.98e-2)" "unprognostic (1.59e-2)" "unprognostic (5.39e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-3)" 12.4 8.8 12.3 8.9 12.8 6.4 11.4 17.3 16.3 11.3 8.1 8.6 9.3 6.9 12.4 11.4 10.2 9.5 9.3 7.2 12.0 10.9 8.7 6.5 8.4 9.2 10.1 13.8 15.9 8.2 20.3 12.2 260.6 9.3 8.0 9.8 9.6 10.6 9.6 6.9 9.7 10.0 9.0 9.4 13.7 7.4 14.4 10.0 10.7 14.4 5.7 9.6 11.3 9.8 2.0 1.3 3.1 2.6 8.1 3.5 1.1 11.7 6.5 11.5 7.3 9.8 14.4 8.9 18.7 12.1 11.6 19.1 4.4 31.0 7.6 4.5 20.4 13.2 5.5 5.3 15.2 35.1 7.4 4.2 5.6 5.6 4.8 9.9 4.1 6.8 8.1 9.7 32.5 18.4 19.4 16.1 4.3 3.1 16.4 39.8 7.1 5.0 6.1 5.9 2.5 12.3 6.3 26.0 11.2 10.0 10.2 7.0 7.6 6.9 8.9 9.9 11.1 8.0 6.4 23.8 14.8 6.5 7.6 23.3 5.7 5.9 7.7 21.6 8.6 10.5 3.1 1.3 1.4 2.0 2.6 3.5 1.4 2.4 1.9 1.1 2.0 2.1 1.9 1.7 8.1 2.4 1.3 3.0 1.1 12.3 12.8 17.3 16.3 12.0 10.9 10.1 13.8 9.3 10.0 11.9 12.0 2.9 5.9 13.3 23.6 5.6 5.1 14.7 12.5 15.7 27.5 169.8 5.0 9.8 4.8 14.0 10.7 0.0 6.8 47.6 15.3 9.3 8.1 10.5 40.5 30.2 15.5 19.0 22.7 3.6 13.0 12.2 13.5 10.8 13.7 12.2 17.6 15.9 12.7 8.8 17.6 0.0 10.3 33.3 14.9 15.3 407.7 13.1 12.1 7.9 RASA4 "CAPRI, GAPL, KIAA0538" ENSG00000105808 "RAS p21 protein activator 4" O43374 7 102573807-102616757 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 58.0" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 65.5;Intestinal endocrine cells: 69.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 27.6" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (6.44e-2)" "unprognostic (3.64e-2)" "unprognostic (8.93e-3)" "unprognostic (1.69e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (3.44e-1)" "unprognostic (7.45e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (4.62e-3)" "unprognostic (4.19e-2)" "unprognostic (4.81e-2)" "unprognostic (8.87e-3)" "unprognostic (2.47e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" 5.5 2.3 4.2 2.5 2.6 1.6 4.4 2.7 4.7 4.9 4.0 3.6 6.3 1.8 1.9 3.6 1.9 1.5 3.6 3.0 3.3 0.2 2.7 3.6 1.9 4.1 2.1 6.8 3.7 4.0 3.3 1.6 2.0 5.6 58.0 5.4 4.3 3.2 1.2 4.1 2.2 0.6 2.2 2.4 3.9 4.7 3.6 11.3 2.2 9.4 1.5 3.7 3.1 0.7 1.2 9.2 1.9 1.7 4.7 0.3 9.4 4.8 3.2 3.3 3.8 2.7 7.2 7.0 14.3 0.3 9.2 0.4 0.1 2.4 1.3 2.4 2.0 3.7 0.9 1.8 1.3 2.7 4.4 1.1 0.8 0.4 12.3 1.6 4.9 3.2 10.6 0.7 3.7 7.2 5.0 0.7 5.0 4.8 9.9 2.0 10.3 0.3 3.5 9.0 18.8 1.7 2.2 1.2 6.1 1.9 3.6 2.3 27.6 13.4 3.1 2.4 16.8 10.3 6.2 3.4 3.0 3.4 0.4 8.4 0.3 1.9 9.4 3.7 2.8 3.2 2.2 11.3 3.6 3.4 2.4 2.2 1.5 1.2 9.8 3.5 3.1 11.9 10.4 6.0 4.5 3.4 65.5 0.6 2.5 6.7 7.9 3.5 15.7 0.2 11.6 1.1 0.4 10.8 6.2 0.0 0.6 0.1 2.3 0.9 1.1 0.8 5.8 27.0 69.0 3.7 8.0 0.0 7.8 16.2 1.7 2.8 12.1 5.8 1.4 2.9 7.4 7.5 11.0 12.9 7.2 2.1 2.3 3.0 0.3 5.0 1.9 2.7 RASA4B ENSG00000170667 "RAS p21 protein activator 4B" C9J798 7 102482445-102517781 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 47.4" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 2.3;Cardiomyocytes: 4.0;Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 20 "dendritic cells: 6.2;monocytes: 3.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 9.1;SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.2" HPA043010 Uncertain Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA043010: AB_2678267" "unprognostic (1.05e-2)" "unprognostic (1.34e-2)" "unprognostic (1.03e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-2)" "unprognostic (1.40e-1)" "unprognostic (4.15e-2)" "unprognostic (1.55e-1)" "unprognostic (2.10e-1)" "unprognostic (6.79e-2)" "unprognostic (3.08e-3)" "unprognostic (2.31e-1)" "unprognostic (5.44e-4)" "unprognostic (1.18e-2)" "unprognostic (3.77e-2)" "unprognostic (4.37e-3)" "unprognostic (1.10e-1)" 2.9 1.1 2.3 1.4 1.2 0.0 2.1 0.5 4.4 3.2 2.4 2.5 4.1 0.0 0.6 1.5 1.3 0.5 1.8 2.0 0.9 0.1 0.8 1.3 1.1 2.2 0.9 0.0 1.1 1.7 1.5 0.0 0.7 3.7 47.4 1.8 3.0 0.5 0.5 1.9 0.8 0.2 0.3 0.2 1.4 2.3 0.1 6.2 0.0 3.7 0.0 0.2 1.8 0.2 0.9 3.2 0.2 0.5 1.9 0.1 5.7 3.1 1.2 2.9 0.2 0.4 2.2 6.4 6.6 0.5 7.7 0.0 0.0 0.0 0.2 0.7 0.3 1.7 0.5 0.0 0.0 0.2 2.1 0.3 0.0 0.0 9.1 0.8 0.1 0.6 8.1 0.7 2.2 0.0 1.1 0.0 0.3 0.9 2.3 1.1 3.6 0.0 0.8 2.2 11.8 0.9 0.2 0.2 2.2 0.2 1.6 1.0 16.5 14.2 1.3 0.5 2.7 1.9 0.2 1.9 0.4 2.6 0.0 3.7 0.0 0.2 3.7 0.1 0.1 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.6 3.9 0.0 1.8 0.0 1.1 0.5 0.2 0.3 2.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.4 0.0 0.3 0.0 0.3 0.7 0.0 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.4 0.0 0.9 0.2 0.0 1.0 0.1 0.5 0.0 0.1 RASAL1 RASAL ENSG00000111344 "RAS protein activator like 1" O95294 12 113098819-113136239 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 64.0" "Cell type enriched" "Detected in many" 9 "Collecting duct cells: 34.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 8.5;EFO-21: 11.1;REH: 12.3;RPMI-8226: 27.4;RPTEC TERT1: 10.9;U-698: 23.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7" HPA041650 Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cytosol" "Cell Junctions" "HPA041650: AB_2677598" "unprognostic (9.95e-2)" "unprognostic (1.11e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (3.26e-5)" "unprognostic (1.27e-2)" "unprognostic (7.73e-3)" "unprognostic (1.57e-2)" "unprognostic (1.43e-2)" "unprognostic (2.65e-1)" "unprognostic (3.02e-3)" "unprognostic (3.16e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-2)" "unprognostic (2.85e-3)" "unprognostic (1.15e-1)" "unprognostic (3.34e-2)" "unprognostic (2.64e-1)" 0.9 10.4 8.6 2.5 11.2 1.2 1.6 0.4 18.2 2.5 2.1 18.8 3.7 1.2 0.9 0.9 16.9 2.2 1.8 0.8 11.8 4.9 7.4 0.9 0.9 1.7 7.3 10.9 0.8 1.4 64.0 3.9 1.0 4.0 0.9 1.7 0.0 22.4 7.4 0.8 8.0 1.1 0.9 1.8 1.0 9.6 1.1 8.4 0.0 8.0 6.0 5.0 1.0 3.7 0.4 0.2 1.3 0.2 0.3 1.6 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.2 8.5 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 2.3 0.0 0.0 0.3 3.0 0.0 12.3 0.0 27.4 10.9 0.0 0.3 0.0 0.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 1.3 0.2 0.1 0.1 0.0 1.6 0.2 0.9 0.4 0.0 0.4 1.2 0.5 0.4 0.3 0.0 0.2 0.4 0.3 8.6 11.2 0.4 18.2 11.8 4.9 7.3 10.9 4.0 8.4 0.0 0.0 0.5 0.0 0.5 0.5 3.5 2.5 0.0 0.0 34.9 0.0 1.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 2.1 1.7 1.8 4.1 2.3 3.0 3.5 0.0 3.9 0.0 0.0 0.1 0.0 0.3 1.0 1.0 0.0 2.3 0.4 RASAL3 FLJ21438 ENSG00000105122 "RAS protein activator like 3" Q86YV0 19 15451624-15464571 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.9" "Group enriched" "Detected in many" 5 "B-cells: 38.9;granulocytes: 39.2;T-cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 14.4;HEL: 11.9;HMC-1: 23.1;Karpas-707: 25.7;NB-4: 13.1;RPMI-8226: 10.9;TIME: 17.1;U-937: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043417 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA043417: AB_2678473" "unprognostic (2.72e-2)" "prognostic favorable (8.75e-4)" "unprognostic (3.27e-2)" "prognostic favorable (3.58e-5)" "unprognostic (2.31e-1)" "prognostic favorable (3.07e-4)" "unprognostic (1.82e-2)" "unprognostic (6.21e-3)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (3.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (2.98e-1)" "unprognostic (1.90e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" 2.8 2.1 3.1 19.2 3.8 16.7 1.7 0.5 1.9 1.4 3.4 4.6 0.7 3.6 1.7 1.1 3.0 1.9 4.5 1.1 4.1 1.8 3.3 2.8 8.0 23.5 4.5 1.3 0.9 1.3 0.3 1.4 0.8 3.7 2.3 1.9 1.5 7.5 1.1 0.7 1.2 14.5 0.9 5.1 29.9 4.0 0.6 4.6 27.3 3.1 1.6 28.9 4.5 2.0 2.9 3.2 8.8 9.3 8.9 16.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 11.9 0.0 0.0 0.2 9.5 23.1 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 25.7 0.0 0.1 5.0 13.1 0.0 0.0 0.0 1.4 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 17.1 0.0 0.0 0.0 0.0 0.2 4.6 7.0 0.0 16.1 0.0 4.3 1.7 8.8 14.9 3.4 8.9 2.2 9.5 16.4 2.6 2.9 8.0 9.6 2.5 8.9 9.3 3.2 6.4 3.5 3.1 3.8 0.5 1.9 4.1 1.8 4.5 1.3 3.7 4.6 3.0 9.3 38.9 0.0 0.2 0.0 2.2 0.0 8.1 2.3 0.0 0.0 0.1 0.0 0.1 0.4 2.9 0.0 0.0 0.5 0.2 0.9 0.1 39.2 3.9 9.8 0.0 0.0 4.3 9.2 0.6 0.0 7.4 0.0 2.8 0.0 0.1 0.3 0.0 1.1 0.8 0.0 0.0 0.5 0.4 0.3 0.5 0.3 62.3 0.0 0.1 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540868-35554001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.0;seminal vesicle: 25.2" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5" "Region enriched" "Detected in many" 8 "basal ganglia: 527.8" "Region enriched" "Detected in all" 8 "basal ganglia: 265.8" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavorable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.6 7.9 8.6 2.5 71.0 3.4 1.3 1.8 23.5 1.1 8.3 2.2 3.2 2.5 3.5 16.4 5.2 6.2 2.5 2.8 4.1 5.0 0.8 0.5 1.5 0.6 3.4 8.0 0.8 1.0 0.9 1.0 0.4 2.1 9.6 4.4 3.5 4.0 25.2 13.6 0.8 3.4 7.5 2.2 0.4 1.8 0.6 15.3 0.0 1.4 0.1 1.4 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.8 0.0 0.5 0.0 0.0 0.1 0.7 0.2 1.1 0.9 0.1 0.5 0.0 0.2 2.4 4.3 0.1 0.2 0.0 1.0 0.0 0.7 0.0 0.1 0.0 1.4 0.0 0.0 0.2 3.3 2.2 0.3 13.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 1.3 0.0 0.9 0.0 0.0 2.0 0.3 2.2 7.6 0.0 0.2 0.6 0.2 0.1 1.8 4.4 0.2 0.8 1.9 0.6 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.6 71.0 1.8 23.5 4.1 5.0 3.4 8.0 2.1 15.3 0.0 0.0 0.0 0.2 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.2 0.7 0.0 0.1 45.3 4.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 RASGEF1A "CG4853, FLJ37817" ENSG00000198915 "RasGEF domain family member 1A" Q8N9B8 10 43194535-43266919 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.6;brain: 18.3" "Cell type enhanced" "Detected in some" 5 "Collecting duct cells: 3.5;Spermatogonia: 3.4;T-cells: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 13.2;SCLC-21H: 12.8;SK-BR-3: 11.6;T-47d: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035593 Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA035593: AB_10602083" "prognostic favorable (1.86e-5)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.28e-4)" "unprognostic (1.86e-1)" "unprognostic (3.92e-1)" "unprognostic (2.16e-2)" "unprognostic (5.73e-2)" "unprognostic (8.53e-2)" "unprognostic (9.00e-2)" "unprognostic (2.86e-1)" "unprognostic (3.52e-1)" "prognostic unfavorable (4.11e-7)" "unprognostic (2.88e-2)" "unprognostic (2.32e-1)" "unprognostic (1.89e-2)" "unprognostic (3.83e-2)" 1.1 2.3 13.1 1.6 16.2 16.6 4.4 11.0 18.3 2.1 0.9 4.0 0.0 1.2 1.6 0.7 1.5 3.4 3.0 1.5 12.3 10.6 1.4 0.4 1.8 6.0 7.2 8.7 1.8 4.8 10.7 3.3 1.1 7.2 1.7 0.7 2.3 4.6 2.6 1.1 0.9 0.8 1.7 3.5 3.5 1.0 3.1 4.1 0.0 1.2 0.2 4.6 2.2 1.9 2.1 5.8 10.4 0.6 7.1 3.6 1.1 7.5 6.5 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.2 4.2 6.6 7.1 0.6 0.0 0.1 1.0 6.2 0.0 0.0 5.1 0.0 0.1 0.3 3.1 0.0 2.5 1.6 7.2 0.6 0.0 0.0 0.0 0.3 13.2 0.0 0.0 1.5 0.0 0.1 0.6 3.3 0.0 0.0 0.0 0.2 0.5 3.6 12.8 0.0 0.0 11.6 0.1 6.1 12.7 0.1 0.0 0.0 2.9 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 6.6 3.6 0.6 1.3 0.2 0.9 2.6 3.3 2.1 0.3 1.8 10.4 7.1 0.4 5.8 0.0 1.1 13.1 16.2 11.0 17.8 12.3 10.6 7.2 8.7 7.2 4.1 0.0 0.0 2.2 0.2 0.5 0.7 2.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.3 1.1 0.4 0.0 0.0 1.2 0.9 0.4 0.6 0.0 0.0 1.0 1.6 0.0 1.8 0.3 0.4 0.0 1.5 0.0 1.0 0.0 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.5 0.6 3.4 0.3 0.2 2.9 0.8 0.0 RASGEF1C FLJ35841 ENSG00000146090 "RasGEF domain family member 1C" Q8N431 5 180100791-180209153 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 27.4;testis: 7.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 2.5;Late spermatids: 3.2;Spermatocytes: 5.5;Syncytiotrophoblasts: 1.6" "Cancer enhanced" "Detected in some" "glioma: 2.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 3.7;HEK 293: 2.8;MCF7: 3.9;SCLC-21H: 12.6;U-2 OS: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028242 Uncertain Approved Mitochondria NA NA Mitochondria "HPA028242: AB_10602294" "unprognostic (2.21e-1)" "unprognostic (2.18e-1)" "unprognostic (2.23e-1)" "unprognostic (4.75e-4)" "unprognostic (4.65e-2)" "unprognostic (4.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.02e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "unprognostic (2.35e-2)" "unprognostic (2.34e-1)" "unprognostic (1.65e-4)" "unprognostic (5.89e-2)" "unprognostic (8.25e-3)" "unprognostic (3.70e-1)" "unprognostic (1.77e-2)" 1.1 1.1 7.0 1.1 5.4 0.6 1.4 27.4 22.0 1.4 2.3 9.2 0.0 0.8 0.6 0.8 1.2 1.7 1.2 1.5 4.5 2.8 0.6 0.6 0.6 0.6 5.1 4.9 0.8 0.9 0.8 0.2 0.8 7.7 0.8 1.1 0.4 3.0 2.7 0.7 1.1 1.4 1.0 8.3 0.7 0.8 7.1 4.7 0.0 2.1 0.0 0.6 0.8 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.2 0.0 3.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.6 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.9 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 7.0 5.4 27.4 11.1 4.5 2.8 5.1 4.9 7.7 4.7 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 5.5 0.9 0.0 1.6 0.0 0.0 0.0 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959947-79090773 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 34.3;lung: 13.0" "Group enriched" "Detected in some" 11 "Alveolar cells type 2: 58.8;Horizontal cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Cell line enhanced" "Detected in some" "A-431: 7.9;BEWO: 7.7;Karpas-707: 10.2;RPMI-8226: 12.3;U-2 OS: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favorable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 1.0 1.1 7.6 2.3 12.2 0.8 1.1 34.3 33.0 1.9 1.1 11.5 0.0 1.1 1.6 1.1 1.0 1.5 1.0 0.9 12.8 8.6 1.3 0.9 13.0 2.8 8.9 12.0 2.3 4.5 0.9 0.8 1.2 19.2 1.7 1.2 0.4 0.9 1.2 0.8 0.9 1.2 1.0 16.9 1.8 1.1 1.2 5.8 0.0 0.8 0.0 3.1 1.7 0.3 1.9 0.2 0.0 0.0 0.0 0.6 0.1 7.9 0.1 0.1 0.0 0.0 0.0 7.7 0.0 0.4 0.4 1.1 0.0 1.5 0.4 0.2 0.0 0.6 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.4 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 10.2 1.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.8 12.3 0.0 0.3 0.8 0.0 0.0 0.1 1.6 0.7 0.0 1.6 0.0 0.0 15.0 0.0 0.2 0.0 3.5 2.8 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 7.6 12.2 34.3 33.0 12.8 8.6 8.9 12.0 19.2 5.8 3.0 58.8 2.7 0.5 0.6 3.7 0.9 0.0 2.7 3.4 0.0 0.0 0.7 0.0 0.1 0.1 0.6 0.0 0.0 0.0 1.7 0.2 0.1 0.0 0.0 1.6 23.8 0.0 0.0 0.0 0.0 0.0 2.4 3.3 1.0 0.0 1.0 0.4 0.0 0.4 3.9 1.8 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.2 RASGRF2 "GRF2, Ras-GRF2" ENSG00000113319 "Ras protein specific guanine nucleotide releasing factor 2" O14827 5 80960672-81230156 "Predicted intracellular proteins, RAS pathway related proteins" "Calmodulin-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 23.8;ovary: 24.6" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 55.0;Extravillous trophoblasts: 22.2;Rod photoreceptor cells: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 2.8;MAIT T-cell: 7.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 2.2;naive CD4 T-cell: 6.4;naive CD8 T-cell: 4.3" "Lineage enriched" "Detected in single" 78 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "BEWO: 23.7;CACO-2: 14.3;EFO-21: 7.5;Hep G2: 19.0;HHSteC: 13.2;hTERT-RPE1: 9.6;SuSa: 10.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 41.1;cerebral cortex: 118.3;hippocampal formation: 72.9;olfactory region: 58.3" HPA018679 Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA018679: AB_1856089" "unprognostic (1.32e-1)" "unprognostic (6.96e-2)" "unprognostic (7.27e-2)" "unprognostic (7.80e-2)" "unprognostic (3.62e-1)" "unprognostic (1.00e-1)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (4.02e-1)" "unprognostic (8.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.34e-1)" "unprognostic (1.47e-3)" "unprognostic (1.37e-3)" "unprognostic (2.13e-2)" "unprognostic (5.01e-2)" "unprognostic (1.12e-1)" 13.3 1.6 11.6 4.3 14.0 1.5 5.4 1.5 23.8 3.8 2.7 18.7 1.5 2.7 3.9 1.6 2.1 2.6 7.1 4.3 11.1 6.6 6.6 1.0 3.8 4.5 8.5 5.5 24.6 1.4 6.8 3.4 13.2 8.9 5.3 2.3 17.1 1.9 2.4 3.1 1.5 2.9 3.8 15.2 3.0 2.3 2.9 5.6 0.0 4.3 1.1 3.9 4.1 2.4 0.0 0.0 0.0 0.0 0.0 7.7 1.5 0.0 1.3 0.3 0.1 0.0 0.0 23.7 0.4 5.7 0.2 0.3 14.3 0.0 0.2 7.5 0.0 0.1 0.4 0.0 0.0 0.7 0.3 2.4 0.1 0.1 19.0 13.2 0.0 0.0 0.6 0.0 5.5 0.0 9.6 0.1 0.3 0.0 0.1 0.0 0.2 0.1 0.1 2.8 0.0 0.0 0.1 2.8 0.0 0.9 0.0 0.2 0.3 0.1 0.0 0.2 10.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 2.8 0.0 7.7 0.0 3.8 2.2 0.0 0.0 6.4 4.3 0.0 0.0 0.0 0.0 0.8 1.5 11.6 14.0 1.5 23.8 11.1 6.6 8.5 5.5 8.9 5.6 0.0 1.4 0.0 0.2 1.4 11.6 3.2 0.0 0.0 1.2 8.7 55.0 0.2 0.0 0.2 9.9 14.6 0.0 0.0 0.0 22.2 0.8 0.2 0.0 0.0 1.0 1.6 0.0 4.9 0.8 2.1 0.9 0.0 1.7 0.0 0.0 2.0 0.4 0.2 8.5 2.1 37.2 0.0 1.0 7.2 1.4 0.5 0.7 4.4 0.8 0.4 RASGRP1 "CalDAG-GEFII, RASGRP" ENSG00000172575 "RAS guanyl releasing protein 1" O95267 15 38488103-38565575 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.1;lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 31.4;Muller glia cells: 101.6;T-cells: 55.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 10.4" "Group enriched" "Detected in some" 4 "HDLM-2: 25.3;JURKAT: 33.6;MOLT-4: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039389 Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039389: AB_2732481" "unprognostic (3.44e-3)" "unprognostic (1.86e-2)" "unprognostic (1.17e-2)" "unprognostic (3.43e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-3)" "unprognostic (9.63e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (4.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (9.30e-2)" 1.7 1.0 5.7 9.9 17.0 7.8 1.9 33.1 18.5 1.4 1.6 0.8 0.0 2.5 1.6 1.6 6.7 4.7 2.7 1.6 6.1 3.2 5.9 1.2 4.2 20.0 3.0 6.2 0.8 2.0 0.3 1.2 4.9 22.3 1.0 2.3 1.4 2.5 1.0 0.8 7.3 3.7 0.7 1.6 8.6 4.8 2.2 1.1 55.8 1.2 1.6 16.3 4.3 2.4 1.2 0.0 0.8 0.0 2.4 10.4 1.4 0.0 0.1 0.5 0.1 0.0 0.0 0.0 1.9 0.6 1.0 0.8 2.1 0.0 5.4 0.4 0.0 0.1 0.1 1.1 0.0 0.9 25.3 1.0 0.4 0.2 0.0 0.3 0.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 33.6 0.2 1.7 0.0 0.8 23.9 0.0 0.3 0.0 0.0 6.7 0.1 0.0 1.0 0.0 2.3 0.8 1.2 0.0 0.1 0.7 0.6 0.0 0.1 0.2 0.8 2.7 0.3 4.2 2.0 6.4 0.1 0.0 0.2 0.0 0.0 0.8 5.7 0.0 4.2 1.2 6.4 5.7 0.0 0.7 6.0 6.0 0.3 2.4 0.0 0.0 10.4 1.4 5.7 17.0 33.1 11.7 6.1 3.2 3.0 6.2 22.3 1.1 6.0 15.4 11.3 0.4 2.2 9.4 2.6 10.2 0.0 0.0 31.4 9.8 0.2 3.3 16.1 1.2 0.0 0.0 0.0 8.9 0.1 1.0 0.4 3.5 0.0 0.6 6.4 0.0 0.6 0.3 0.2 0.0 0.0 6.8 0.0 0.5 101.6 22.6 0.0 0.0 5.9 18.1 0.0 1.5 0.9 2.8 7.2 0.0 55.4 0.4 0.3 RASGRP2 CALDAG-GEFI ENSG00000068831 "RAS guanyl releasing protein 2" Q7LDG7 11 64726911-64745456 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.6;bone marrow: 63.9;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" 9 "B-cells: 95.7;Kupffer cells: 67.8;Sertoli cells: 129.4;Smooth muscle cells: 71.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 23.1;HL-60: 41.7;NB-4: 79.1;REH: 23.6;THP-1: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015635, HPA015667" Approved Supported "Plasma membrane" NA NA 1900000 "Plasma membrane" "HPA015635: , HPA015667: AB_1856090" "unprognostic (5.96e-2)" "unprognostic (3.24e-3)" "unprognostic (5.55e-2)" "unprognostic (1.50e-2)" "unprognostic (3.52e-2)" "unprognostic (4.74e-5)" "unprognostic (1.11e-2)" "unprognostic (7.36e-3)" "unprognostic (2.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.91e-3)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.08e-1)" "unprognostic (5.40e-2)" "unprognostic (1.90e-1)" "unprognostic (1.23e-1)" 7.6 4.2 4.6 26.8 26.4 63.9 4.5 4.3 8.2 5.6 9.9 3.2 4.5 3.6 8.8 4.9 4.5 8.9 4.7 13.7 5.5 4.7 5.5 3.1 8.5 47.6 4.7 5.7 2.7 1.2 0.7 1.5 8.1 4.1 6.9 3.2 5.3 7.4 10.4 5.8 1.5 25.6 8.1 2.7 43.9 5.4 3.1 8.2 9.7 2.9 2.5 30.1 7.0 4.8 51.6 29.1 24.5 32.2 16.7 32.8 22.2 0.0 0.0 0.7 0.0 0.0 0.0 2.0 0.3 0.0 0.3 0.2 0.3 0.0 14.3 0.6 0.0 0.2 0.1 1.2 0.2 0.0 0.0 0.4 23.1 0.0 0.0 0.0 41.7 8.5 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.9 0.2 0.0 0.3 9.8 79.1 0.6 0.1 0.0 23.6 0.0 1.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.5 0.1 24.8 0.1 0.0 0.5 0.3 0.0 0.1 0.0 13.2 0.0 13.2 0.0 16.5 11.8 19.1 24.4 28.6 13.2 51.6 25.3 19.3 11.6 32.0 32.8 29.0 24.5 16.7 32.2 29.1 29.9 22.2 4.6 26.4 4.3 8.2 5.5 4.7 4.7 5.7 4.1 8.2 3.0 2.6 95.7 0.1 2.1 0.8 46.4 2.5 1.4 0.0 0.0 0.0 1.5 0.0 0.0 5.2 6.8 0.0 0.0 0.0 1.3 4.5 0.1 3.5 0.9 5.7 0.0 0.0 31.3 67.8 11.9 16.7 22.0 0.0 26.2 0.0 0.7 0.0 0.0 44.9 1.0 2.3 129.4 71.9 10.1 28.3 1.1 9.8 47.3 0.2 0.1 RASGRP3 "CalDAG-GEFIII, GRP3, KIAA0846" ENSG00000152689 "RAS guanyl releasing protein 3" Q8IV61 2 33436324-33564750 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.4;skeletal muscle: 28.7" "Cell type enhanced" "Detected in many" 5 "Endothelial cells: 50.6;Ito cells: 52.2;Urothelial cells: 57.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 15 "basophil: 11.4;memory B-cell: 10.4;naive B-cell: 13.4" "Group enriched" "Detected in many" 16 "B-cells: 13.4;granulocytes: 11.4" "Group enriched" "Detected in some" 6 "Daudi: 29.9;HEL: 31.6;U-266/70: 49.5;U-266/84: 18.9;U-698: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058937 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA058937: AB_2683858" "unprognostic (2.64e-1)" "unprognostic (9.50e-2)" "unprognostic (1.45e-1)" "unprognostic (5.76e-3)" "unprognostic (1.05e-1)" "unprognostic (1.09e-2)" "unprognostic (3.90e-1)" "unprognostic (7.57e-2)" "unprognostic (2.39e-2)" "unprognostic (4.35e-2)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (9.96e-3)" "unprognostic (1.83e-2)" "unprognostic (2.93e-2)" "unprognostic (2.87e-1)" "unprognostic (5.82e-2)" 7.8 2.6 9.4 13.6 13.3 3.2 4.9 2.0 9.6 3.1 3.5 35.0 0.0 5.7 2.6 1.3 2.0 2.1 5.0 24.3 13.4 8.8 5.1 4.1 5.8 19.8 25.2 5.5 1.6 3.7 9.3 3.1 8.2 19.9 2.1 5.3 6.7 5.4 1.7 28.7 2.3 4.5 3.7 42.4 10.1 5.4 1.3 26.3 1.9 6.7 5.0 25.0 5.4 2.1 13.4 0.2 11.4 0.1 0.2 0.7 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.2 1.5 4.5 0.8 0.2 29.9 0.1 0.2 0.3 0.0 0.0 0.0 0.4 3.1 0.3 31.6 0.2 0.0 0.4 0.1 4.3 0.0 0.0 0.0 0.0 0.6 1.8 0.3 0.1 1.6 0.6 0.0 0.2 2.3 0.1 0.2 0.0 0.0 1.4 0.0 0.3 1.9 0.2 0.0 0.0 0.1 1.4 0.0 0.0 0.2 0.5 0.1 0.1 0.1 0.2 49.5 18.9 13.2 0.0 0.1 0.1 11.4 0.0 0.0 0.3 0.0 0.4 10.4 0.5 0.5 0.2 13.4 0.7 0.2 0.0 0.2 0.1 0.0 0.7 0.9 9.4 13.3 2.0 9.6 13.4 8.8 25.2 5.5 19.9 26.3 0.0 8.0 43.4 28.1 4.7 1.2 45.2 0.0 4.0 5.7 5.2 0.0 0.4 10.0 14.6 1.0 50.6 0.0 0.0 47.5 1.1 3.9 22.2 18.4 4.4 38.6 0.0 0.0 52.2 7.2 0.6 0.9 10.2 38.8 22.6 0.0 0.3 44.4 0.0 1.8 9.8 1.1 0.0 3.8 0.9 2.3 3.1 0.5 4.4 0.0 57.1 RASGRP4 ENSG00000171777 "RAS guanyl releasing protein 4" Q8TDF6 19 38409051-38426305 "Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 10.9;granulocytes: 26.5;Hofbauer cells: 12.0;Kupffer cells: 34.4;Macrophages: 11.0" "Cancer enhanced" "Detected in many" "testis cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 19.4;HMC-1: 19.4;U-937: 5.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041929 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "HPA041929: AB_10961405" "unprognostic (1.22e-1)" "unprognostic (1.31e-1)" "unprognostic (1.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (1.39e-2)" "unprognostic (2.10e-1)" "unprognostic (2.00e-1)" "unprognostic (5.23e-4)" "unprognostic (6.54e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (2.19e-2)" "unprognostic (1.05e-1)" "unprognostic (4.56e-1)" "unprognostic (2.66e-2)" 4.5 1.8 2.4 8.0 3.3 23.3 5.4 0.7 1.8 1.8 1.7 2.8 0.1 1.4 1.6 2.9 1.6 2.6 3.4 6.2 2.0 1.3 1.5 1.8 11.8 23.1 3.4 0.2 1.1 1.6 0.5 0.9 3.0 1.8 1.7 1.2 1.7 1.6 0.8 1.5 1.4 2.4 2.7 4.2 19.2 1.9 0.8 2.4 0.5 1.0 0.2 1.0 2.6 3.1 0.1 5.2 22.4 9.5 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 19.4 0.0 0.0 0.0 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 6.0 7.1 10.6 0.0 8.5 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.0 22.4 0.0 9.5 0.4 0.7 2.1 2.4 3.3 0.7 1.8 2.0 1.3 3.4 0.2 1.8 2.4 0.0 1.1 0.0 0.0 0.7 0.0 10.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 26.5 0.0 12.0 0.0 0.0 1.8 34.4 0.0 0.0 11.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 RASL10A RRP22 ENSG00000100276 "RAS like family 10 member A" Q92737 22 29312933-29319679 "Predicted intracellular proteins" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 35.2" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 4.7;Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 19.9" "Cancer enhanced" "Detected in some" "testis cancer: 3.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.7;NB-4: 5.7;U-2 OS: 2.6;U-266/70: 6.4" "Group enriched" "Detected in many" 6 "amygdala: 34.5;basal ganglia: 16.7;cerebral cortex: 33.9;hippocampal formation: 29.1" "Region enhanced" "Detected in many" "cerebral cortex: 43.6" HPA056169 Approved NA NA "HPA056169: AB_2683053" "unprognostic (1.94e-1)" "unprognostic (2.51e-4)" "unprognostic (3.78e-2)" "unprognostic (1.75e-1)" "unprognostic (2.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.16e-1)" "unprognostic (7.99e-2)" "unprognostic (9.42e-2)" "unprognostic (1.61e-2)" "unprognostic (5.00e-4)" "unprognostic (2.44e-1)" "unprognostic (7.00e-4)" "unprognostic (3.12e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-2)" "unprognostic (3.61e-3)" 1.2 1.5 19.7 1.3 11.8 1.0 3.9 1.4 35.2 1.0 1.1 1.1 0.0 1.4 1.0 1.1 0.9 1.0 1.0 1.2 12.7 7.9 1.1 1.4 1.1 1.0 5.9 11.3 0.9 0.8 0.8 2.3 1.2 2.8 1.2 1.0 0.0 1.0 1.0 1.5 1.1 1.3 1.0 2.0 1.1 1.2 1.3 1.8 0.0 0.9 0.1 1.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.5 0.4 0.0 0.0 0.2 3.7 0.3 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.5 1.3 0.0 0.9 0.0 5.7 1.4 0.1 0.0 0.0 0.5 0.0 0.3 0.5 0.8 0.1 0.0 0.4 0.1 1.4 1.2 0.5 0.2 0.0 2.6 0.0 0.4 6.4 2.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 19.7 11.8 1.4 22.4 12.7 7.9 5.9 11.3 2.8 1.8 0.0 0.0 0.0 0.4 0.3 4.7 0.8 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.7 1.4 0.1 0.0 0.0 1.3 0.4 2.9 0.0 0.5 0.9 0.0 0.0 3.7 2.2 0.0 0.3 1.4 0.0 0.0 0.3 2.4 0.1 0.0 0.0 0.0 19.9 0.0 0.1 1.1 3.4 0.5 0.5 0.0 0.2 0.0 RASL10B "RRP17, VTS58635" ENSG00000270885 "RAS like family 10 member B" Q96S79 17 35731649-35743521 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 24.6;skeletal muscle: 26.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 12.2;Early spermatids: 9.3;Horizontal cells: 6.4;Late spermatids: 25.1;Muller glia cells: 17.6" "Cancer enhanced" "Detected in many" "testis cancer: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 14.1;HHSteC: 16.1;HSkMC: 11.7;NTERA-2: 24.1;REH: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046842, HPA057092" Enhanced Approved Vesicles NA NA Vesicles "HPA046842: AB_2679835, HPA057092: AB_2683332" "unprognostic (5.78e-2)" "unprognostic (2.15e-2)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.38e-6)" "unprognostic (8.60e-2)" "unprognostic (1.24e-1)" "unprognostic (2.69e-2)" "unprognostic (4.98e-2)" "unprognostic (1.97e-2)" "unprognostic (7.13e-2)" "unprognostic (2.61e-2)" "unprognostic (3.18e-2)" "unprognostic (1.71e-6)" "unprognostic (2.41e-3)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (9.60e-3)" 12.8 0.9 6.3 0.3 9.1 0.2 2.8 0.3 12.3 1.8 0.3 1.0 24.6 0.8 1.3 0.8 0.3 3.9 0.8 10.9 4.7 1.0 1.1 0.4 0.2 0.0 2.8 2.5 4.7 2.5 1.1 2.8 6.3 0.9 0.2 1.1 12.6 15.2 26.7 0.3 0.9 0.9 0.6 0.2 0.3 1.6 2.5 0.0 0.9 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 3.6 0.0 0.6 0.4 1.1 0.7 0.4 2.5 2.1 4.6 0.0 0.0 0.4 0.1 0.0 0.0 14.1 0.0 0.8 0.0 4.6 0.0 2.3 5.2 16.1 0.0 0.0 11.7 0.9 0.8 0.0 2.0 0.0 7.6 3.0 0.0 0.2 0.2 6.4 0.0 24.1 0.0 0.0 11.7 6.5 10.4 0.0 0.0 10.8 10.5 0.7 0.2 0.9 11.0 1.3 0.7 0.0 1.2 8.7 0.0 0.3 0.0 0.0 2.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 2.9 12.2 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.9 9.3 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 3.0 0.2 6.4 0.0 0.0 0.3 25.1 2.0 0.0 0.0 0.0 0.0 17.6 0.5 0.0 2.8 0.0 1.1 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 RASL11B ENSG00000128045 "RAS like family 11 member B" Q9BPW5 4 52862290-52866835 "Predicted intracellular proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 38.0" "Cell type enhanced" "Detected in many" 12 "Collecting duct cells: 31.4;Cytotrophoblasts: 80.5;Extravillous trophoblasts: 60.5;Peritubular cells: 64.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 9.9;CACO-2: 7.7;NTERA-2: 10.5;RPTEC TERT1: 6.6;SH-SY5Y: 26.8;SuSa: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057803 Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA057803: AB_2683533" "unprognostic (1.60e-1)" "unprognostic (1.95e-1)" "unprognostic (7.32e-3)" "unprognostic (1.19e-1)" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (1.22e-1)" "unprognostic (7.66e-2)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (9.71e-2)" "unprognostic (8.72e-2)" "unprognostic (7.20e-4)" "unprognostic (7.17e-2)" "unprognostic (1.35e-1)" "unprognostic (5.00e-6)" "unprognostic (1.10e-1)" 1.1 1.6 9.2 0.6 3.8 0.2 0.7 9.8 11.5 2.2 0.4 0.1 12.5 0.1 5.3 2.7 0.3 2.9 2.4 12.4 2.7 1.9 8.5 0.5 0.7 0.7 0.7 5.5 38.0 0.8 19.9 0.4 8.8 0.4 2.2 0.3 1.3 0.8 20.2 0.3 2.0 0.5 1.9 0.5 15.2 2.5 3.9 0.0 0.0 0.6 0.0 1.0 1.2 2.8 0.2 0.9 0.0 0.1 2.2 1.3 0.2 0.2 0.0 3.9 0.0 3.5 1.6 9.9 0.1 0.0 0.2 0.0 7.7 0.0 0.0 0.3 0.0 0.1 0.0 0.5 2.3 0.0 0.0 0.9 0.3 0.0 0.0 0.7 0.0 0.3 1.7 4.1 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.8 0.7 0.0 10.5 0.8 0.1 0.0 4.5 0.0 6.6 1.0 2.2 26.8 0.1 1.7 0.8 6.9 0.9 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.9 0.0 2.2 0.0 0.9 0.0 0.2 9.2 3.8 9.8 11.5 2.7 1.9 0.7 5.5 0.4 0.0 6.0 0.0 0.0 1.2 0.8 3.5 4.1 0.0 0.0 2.3 31.4 0.0 80.5 0.0 1.1 0.3 0.7 0.5 0.0 0.5 60.5 7.3 0.5 0.0 0.0 6.9 0.0 0.0 1.3 0.0 1.5 22.5 0.0 0.0 1.0 0.5 2.0 0.6 3.5 64.3 0.0 1.1 0.0 3.8 2.1 8.1 0.4 19.3 0.0 0.5 0.2 RASL12 RIS ENSG00000103710 "RAS like family 12" Q9NYN1 15 65053337-65076690 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 51.5" "Cell type enhanced" "Detected in some" 19 "Peritubular cells: 54.5;Sertoli cells: 97.0;Smooth muscle cells: 44.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;CACO-2: 11.5;EFO-21: 18.7;NTERA-2: 8.0;SuSa: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.13e-3)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (6.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.21e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-3)" "unprognostic (1.60e-1)" "unprognostic (4.45e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (1.76e-2)" "unprognostic (4.72e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.17e-4)" 13.6 3.0 9.4 3.5 11.9 0.4 6.2 4.2 8.2 22.1 13.0 17.7 8.6 2.7 26.7 18.7 19.4 21.9 12.7 22.4 12.0 13.3 2.2 0.8 15.2 3.1 19.2 7.1 13.0 2.0 1.3 3.2 11.0 27.2 27.5 4.8 13.0 4.9 51.5 21.3 4.6 3.4 24.6 19.0 4.4 3.2 13.2 14.0 0.0 3.4 3.3 1.6 18.6 14.9 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.5 4.2 0.1 0.0 0.4 0.0 0.0 11.5 0.0 0.0 18.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 14.8 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.4 11.9 4.2 5.4 12.0 13.3 19.2 7.1 27.2 14.0 0.0 0.0 0.0 3.9 1.3 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.1 9.3 0.3 0.0 0.0 0.3 0.0 0.0 2.5 0.0 3.1 12.0 0.0 0.0 0.0 0.0 17.6 0.1 0.0 54.5 0.0 0.8 97.0 44.3 0.5 0.9 0.1 0.2 0.0 0.0 0.0 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009577-13012106 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.3" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 13.4;Distal tubular cells: 21.6;Pancreatic endocrine cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 9.5;CAPAN-2: 8.5;HaCaT: 13.1;HMC-1: 6.5;RPTEC TERT1: 13.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040406: AB_2732485" "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favorable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.2 0.0 0.4 0.2 1.0 0.0 3.9 0.0 1.7 1.1 1.4 1.0 0.0 1.8 0.0 1.3 9.3 5.2 2.5 0.2 1.0 4.7 0.0 1.8 0.0 0.0 0.6 1.2 0.0 3.8 0.1 0.0 0.6 1.6 0.5 0.4 8.0 0.1 0.8 4.1 0.6 0.0 0.1 0.0 5.6 2.4 1.0 1.1 0.1 8.1 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.5 0.0 0.6 0.0 0.3 13.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.4 0.0 1.3 0.0 0.0 13.3 1.4 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 3.8 0.0 0.0 0.8 0.0 13.4 4.5 1.8 0.0 0.1 21.6 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 1.1 0.0 0.1 0.0 2.4 0.6 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.5 6.7 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 5.3 3.5 RASSF2 "CENP-34, KIAA0168" ENSG00000101265 "Ras association domain family member 2" P50749 20 4780023-4823645 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 106.1" "Cell type enhanced" "Detected in many" 9 "Kupffer cells: 93.0;monocytes: 117.2;Peritubular cells: 140.7;Rod photoreceptor cells: 154.5" "Cancer enhanced" "Detected in all" "glioma: 48.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 19.6;BEWO: 20.6;Daudi: 21.0;HL-60: 24.6;NB-4: 31.8;U-937: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051200 Uncertain Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane, Cytosol" "HPA051200: AB_2681386" "unprognostic (6.51e-2)" "unprognostic (3.67e-3)" "unprognostic (5.31e-2)" "unprognostic (1.47e-2)" "unprognostic (3.15e-1)" "unprognostic (1.46e-3)" "unprognostic (2.80e-1)" "unprognostic (7.01e-2)" "unprognostic (1.38e-2)" "unprognostic (2.41e-2)" "unprognostic (4.93e-2)" "unprognostic (3.90e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (3.51e-2)" "unprognostic (1.35e-1)" "unprognostic (3.49e-1)" "unprognostic (6.46e-2)" 8.3 5.1 26.5 21.5 26.9 38.6 3.6 10.2 45.8 14.9 4.1 59.5 0.1 2.7 13.0 11.6 5.2 9.8 7.8 2.4 33.2 22.4 2.0 3.0 10.1 26.2 54.7 8.7 3.5 1.7 0.7 2.6 4.5 39.7 3.9 5.0 19.8 2.0 4.8 1.2 2.2 5.7 18.6 106.1 14.9 3.3 9.9 27.3 4.7 2.5 0.6 34.2 10.7 2.7 7.9 14.1 42.1 17.9 2.4 4.7 10.6 0.0 4.9 12.1 19.6 0.1 0.0 20.6 1.2 3.4 0.2 0.0 1.1 0.0 21.0 1.9 1.0 0.4 0.0 1.7 0.0 0.3 7.5 0.7 13.7 0.0 0.2 0.0 24.6 14.0 0.0 0.0 0.4 0.0 0.4 8.0 2.4 0.0 8.3 0.0 0.0 3.6 31.8 2.7 0.0 0.4 5.6 1.3 8.0 0.0 9.7 0.1 0.9 0.0 0.3 0.6 2.7 0.0 15.7 0.2 0.5 2.6 0.2 1.5 0.1 1.9 12.9 0.1 39.2 0.1 21.1 17.9 29.5 2.4 15.4 4.7 7.9 3.9 3.3 14.1 5.3 2.6 2.1 42.1 2.4 16.8 9.4 3.4 10.6 26.5 26.9 10.2 19.3 33.2 22.4 54.7 8.7 39.7 27.3 0.0 14.9 27.7 0.0 4.1 37.9 1.6 2.5 0.0 3.4 0.0 25.5 2.4 1.7 1.0 5.0 12.7 0.0 0.0 0.8 4.8 8.2 0.8 51.0 0.8 24.8 6.4 0.0 16.0 93.0 15.3 30.8 38.0 8.5 117.2 0.0 12.7 0.4 0.0 140.7 0.2 154.5 0.0 3.3 0.7 0.6 2.3 1.1 10.2 0.0 0.9 RASSF5 "Maxp1, NORE1, RAPL" ENSG00000266094 "Ras association domain family member 5" Q8WWW0 1 206507530-206589448 "Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.0;lymphoid tissue: 34.1" "Cell type enhanced" "Detected in many" 10 "B-cells: 57.0;granulocytes: 136.3;T-cells: 81.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 24.9;JURKAT: 20.4;Karpas-707: 52.1;MOLT-4: 21.5;RPMI-8226: 56.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA070480 Approved NA NA "HPA070480: AB_2686271" "unprognostic (1.92e-3)" "prognostic favorable (1.46e-4)" "unprognostic (1.37e-2)" "unprognostic (4.44e-3)" "unprognostic (1.93e-1)" "unprognostic (5.17e-3)" "unprognostic (4.19e-2)" "unprognostic (3.95e-2)" "unprognostic (2.79e-1)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (9.39e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (3.29e-1)" "unprognostic (5.58e-2)" "unprognostic (4.28e-2)" "unprognostic (6.28e-3)" 1.7 3.5 1.5 14.1 1.7 29.2 1.6 0.0 6.2 1.9 2.1 2.0 7.8 2.2 1.0 1.7 13.7 2.8 8.5 1.6 1.6 0.5 4.9 8.8 17.8 0.2 1.8 1.7 7.2 2.6 3.1 1.0 2.8 2.7 2.4 1.8 12.3 12.6 1.6 5.2 2.7 2.0 1.3 23.9 4.9 0.5 0.6 34.1 1.1 8.7 24.6 7.4 4.4 7.0 10.3 61.0 18.2 29.2 29.1 30.1 2.6 1.1 0.0 0.4 0.9 0.5 0.0 0.1 1.3 0.5 0.6 0.1 5.4 8.5 0.7 0.5 0.1 4.1 0.9 0.6 0.4 5.8 3.4 9.2 0.2 0.0 0.3 15.3 24.9 0.6 2.6 0.6 0.7 0.9 0.1 20.4 3.7 52.1 0.2 0.2 21.5 9.8 0.5 0.0 1.0 10.2 1.2 56.7 0.0 4.0 1.2 0.0 4.6 0.4 0.1 0.0 1.0 9.8 0.0 0.1 1.8 2.4 0.5 18.5 13.3 7.9 0.8 9.0 0.2 41.0 9.1 61.0 27.7 12.5 25.1 7.0 20.9 29.1 10.3 6.4 29.0 26.8 37.1 29.2 18.2 8.1 17.9 30.1 35.7 37.1 57.0 15.5 29.1 1.3 5.3 5.1 8.1 12.5 0.0 0.0 0.1 3.3 5.9 0.1 3.4 0.0 0.0 7.9 0.0 6.7 8.7 136.3 5.1 11.5 7.9 2.4 5.5 41.0 0.0 6.9 49.4 13.5 20.8 0.4 0.0 6.6 0.0 8.5 0.6 0.1 0.0 15.3 0.0 0.2 23.8 0.1 81.6 1.7 39.8 RASSF6 ENSG00000169435 "Ras association domain family member 6" Q6ZTQ3 4 73571550-73620631 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.9" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 70.5;Intestinal endocrine cells: 115.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 8 "memory B-cell: 6.4" "Lineage enriched" "Detected in single" 13 "B-cells: 6.4" "Cell line enhanced" "Detected in some" "Daudi: 32.3;hTERT-HME1: 9.7;RPTEC TERT1: 10.4;RT4: 30.0;U-266/70: 8.9;U-698: 26.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA037712 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA037712: AB_2675625" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (3.09e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.05e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (6.76e-2)" "unprognostic (3.89e-2)" "unprognostic (5.86e-2)" "unprognostic (2.95e-1)" "unprognostic (8.97e-3)" "unprognostic (5.03e-2)" 0.5 0.3 0.3 12.9 0.3 0.0 4.8 0.3 0.3 1.8 12.1 0.4 3.7 5.8 0.4 3.7 3.7 1.3 7.7 0.3 0.3 0.5 13.4 1.2 4.2 3.0 0.3 0.1 1.8 11.3 0.0 2.2 11.2 1.1 6.4 7.8 0.4 5.1 6.3 0.4 3.1 23.2 2.1 0.5 0.6 21.5 0.9 0.1 77.9 3.3 2.0 8.2 11.0 2.5 6.4 0.0 0.4 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 5.2 32.3 0.5 0.0 0.1 1.6 0.0 2.6 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.7 0.1 0.0 0.0 0.2 10.4 30.0 1.2 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.9 0.0 26.4 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 6.4 0.4 0.0 0.0 0.7 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.3 0.3 0.3 0.5 0.3 0.1 1.1 0.1 11.9 3.2 3.2 34.4 8.8 0.0 1.1 25.5 37.5 40.9 7.0 0.0 42.9 14.9 16.0 0.2 0.1 49.3 0.0 70.5 17.2 0.7 17.9 1.1 3.9 3.9 0.0 115.4 0.0 0.8 0.0 0.0 0.7 1.7 1.0 48.1 14.3 57.4 59.6 0.0 32.3 0.4 0.0 1.0 0.0 0.0 1.3 39.5 0.0 16.8 36.0 RAX RX ENSG00000134438 "Retina and anterior neural fold homeobox" Q9Y2V3 18 59267035-59274086 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "pituitary gland: 12.9;retina: 45.2" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 461.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.4;HEK 293: 1.4;HMC-1: 6.1;SH-SY5Y: 3.2;THP-1: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.14e-2)" "unprognostic (1.79e-1)" "unprognostic (3.76e-3)" "unprognostic (2.28e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-1)" "unprognostic (3.46e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.1 2.1 0.0 45.2 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 3.0 1.0 0.0 0.0 0.0 0.0 78.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 461.5 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RAX2 "ARMD6, CORD11, MGC15631, RAXL1" ENSG00000173976 "Retina and anterior neural fold homeobox 2" Q96IS3 19 3769089-3772221 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" DNA-binding "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 51.7" "Group enriched" "Detected in some" 14 "Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 218.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 1.8" "Low region specificity" "Detected in some" HPA052533 Uncertain NA NA "HPA052533: AB_2681862" "unprognostic (5.53e-2)" "unprognostic (1.39e-2)" "unprognostic (4.48e-1)" 0.2 0.0 0.1 0.2 0.3 1.4 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.2 1.0 0.1 0.1 2.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 3.7 5.9 0.1 0.2 0.1 0.1 51.7 0.1 0.1 0.2 0.9 0.1 0.3 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.5 1.8 0.7 1.0 0.8 0.2 0.1 0.0 0.1 0.4 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.7 0.2 0.1 0.0 0.2 0.4 0.1 0.0 0.5 0.1 0.0 0.8 0.0 1.0 0.2 0.0 0.2 0.4 0.0 0.0 0.1 0.2 0.4 0.0 0.5 0.5 1.8 0.4 1.0 0.3 0.9 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.6 0.6 0.6 0.4 0.5 0.0 0.0 0.6 0.0 1.1 0.2 0.9 0.2 0.0 0.7 0.2 0.4 0.1 1.3 0.3 1.1 0.7 0.3 0.3 0.4 0.6 0.2 0.4 0.3 0.2 0.9 0.6 0.8 1.8 1.0 0.3 0.5 0.4 0.2 0.1 0.3 0.2 0.4 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 12.2 0.4 0.0 0.0 0.0 0.0 115.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 218.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBAK-RBAKDN ENSG00000272968 "RBAK-RBAKDN readthrough" 7 4983718-5073221 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "testis: 71.1" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 32.5;Spermatocytes: 34.9;Spermatogonia: 40.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 5.6;U-266/70: 6.1" NA NA "unprognostic (3.78e-2)" "unprognostic (3.57e-1)" "unprognostic (5.60e-2)" "unprognostic (1.55e-1)" "unprognostic (2.37e-1)" "unprognostic (1.50e-2)" "unprognostic (3.23e-1)" "unprognostic (5.44e-3)" "unprognostic (6.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.24e-1)" "unprognostic (2.62e-7)" "unprognostic (2.86e-1)" "unprognostic (4.96e-2)" "unprognostic (9.57e-2)" "unprognostic (3.10e-2)" 3.1 2.0 2.3 4.8 3.4 2.0 2.7 6.4 3.1 2.5 2.2 1.1 3.6 1.9 2.6 2.7 4.6 1.8 1.8 1.6 2.6 2.2 2.3 2.2 2.6 5.4 2.5 3.4 2.7 1.9 1.7 3.4 1.7 2.3 2.3 1.7 1.3 3.2 4.5 1.9 2.7 2.2 2.4 2.3 3.0 2.4 71.1 3.2 6.8 2.9 4.8 2.6 3.2 2.8 0.4 0.3 0.2 0.9 0.8 2.1 0.2 1.4 0.4 0.6 2.7 0.5 1.3 0.5 1.1 0.7 0.7 0.5 2.0 0.6 1.1 3.8 0.9 0.8 1.1 0.0 0.6 1.5 0.1 1.9 0.9 1.1 1.3 1.5 3.7 3.8 0.0 1.0 0.9 2.1 0.9 0.6 1.6 2.3 0.0 0.1 5.6 0.4 0.7 1.3 0.1 3.5 0.4 0.4 2.2 0.2 0.2 1.4 2.2 0.0 1.7 1.5 1.6 1.4 3.1 0.0 0.9 1.8 1.2 1.0 6.1 2.0 1.2 1.1 1.0 1.0 0.0 0.1 0.2 0.8 0.9 0.2 0.3 2.1 0.2 0.0 0.4 2.0 1.6 0.0 0.8 0.0 0.3 0.0 0.2 2.3 3.4 6.4 3.1 2.6 2.2 2.5 3.4 2.3 3.2 0.0 0.6 0.0 5.3 6.6 27.3 0.0 5.1 1.4 2.3 1.8 11.8 2.3 5.0 5.6 4.9 6.7 0.4 0.0 4.6 5.8 7.3 8.2 1.1 4.3 6.0 25.4 2.4 3.1 3.3 2.1 14.7 7.4 5.0 5.4 2.3 17.2 6.5 4.0 7.1 4.0 32.5 6.5 7.2 34.9 40.7 6.4 1.8 9.6 2.8 4.4 RBBP8NL "C20orf151, dJ908M14.3" ENSG00000130701 "RBBP8 N-terminal like" Q8NC74 20 62410237-62427533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 17.4" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 72.5;Mucus-secreting cells: 38.7;Paneth cells: 57.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.9;CACO-2: 21.4;MCF7: 8.7;SK-BR-3: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (8.99e-2)" "unprognostic (6.95e-3)" "unprognostic (2.71e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (1.27e-3)" "unprognostic (2.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.38e-1)" "unprognostic (2.76e-1)" "unprognostic (2.15e-1)" "unprognostic (1.44e-1)" "unprognostic (7.65e-3)" "prognostic favorable (6.91e-4)" 0.2 0.0 0.2 1.7 0.2 0.0 1.4 0.2 0.5 2.2 1.9 0.2 13.9 7.6 0.6 2.9 10.7 1.2 2.3 0.2 0.2 0.0 1.7 0.2 0.8 0.2 0.2 0.2 1.1 5.5 2.9 2.6 4.4 0.2 4.4 1.0 0.2 17.4 12.2 0.2 5.3 7.9 0.2 0.2 0.2 2.6 3.1 0.2 0.5 7.7 2.0 5.6 3.5 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 21.4 2.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 10.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.6 0.0 1.6 0.2 0.0 1.6 10.2 0.0 1.2 1.8 0.0 4.9 0.0 0.2 9.7 0.0 72.5 0.0 0.2 4.5 0.0 1.4 0.0 0.0 0.5 0.0 9.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 38.7 0.0 0.1 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 0.0 16.4 0.7 RBFOX1 "A2BP1, FOX-1, HRNBP1" ENSG00000078328 "RNA binding fox-1 homolog 1" Q9NWB1 16 5239802-7713338 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 81.4" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "RH-30: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040809, HPA066746, HPA075862" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" No No Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA040809: AB_10796228, HPA066746: , HPA075862: " "unprognostic (3.75e-3)" "unprognostic (2.11e-1)" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (5.19e-3)" "unprognostic (8.82e-5)" "unprognostic (5.02e-1)" "unprognostic (3.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.43e-2)" "unprognostic (3.24e-2)" "unprognostic (2.23e-1)" "unprognostic (5.00e-2)" "unprognostic (2.28e-1)" 1.2 2.4 19.9 1.5 33.0 1.6 1.3 31.5 57.2 1.4 1.9 1.9 0.0 1.3 1.3 5.0 2.0 2.2 1.3 17.6 16.4 6.7 1.5 1.3 1.2 1.2 3.7 21.7 1.4 1.3 1.2 0.5 1.3 13.5 2.6 1.7 0.0 1.7 4.9 67.6 1.5 1.4 1.2 3.5 1.2 1.4 1.7 5.6 0.0 1.3 9.7 1.2 1.5 0.3 1.7 0.7 3.1 0.7 1.2 1.4 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 25.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 2.4 0.6 2.0 1.1 0.3 0.7 1.0 0.9 0.8 0.3 1.7 1.4 1.0 3.1 1.2 0.7 0.7 1.0 0.0 19.9 33.0 31.5 34.3 16.4 6.7 3.7 21.7 13.5 5.6 0.0 0.3 0.0 0.0 0.0 2.3 81.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 1.1 0.0 1.7 1.0 0.4 7.1 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 RBFOX3 "FOX-3, HRNBP3, NeuN" ENSG00000167281 "RNA binding fox-1 homolog 3" A6NFN3 17 79089345-79516148 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.4;seminal vesicle: 21.5" "Cell type enhanced" "Detected in many" 12 "Glandular cells: 12.8;Peritubular cells: 9.9;Spermatogonia: 21.3" "Cancer enhanced" "Detected in some" "prostate cancer: 1.1" "Region enhanced" "Detected in all" "cerebellum: 60.4" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A549: 13.2;NTERA-2: 11.9;SCLC-21H: 19.2;U-2 OS: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030790, HPA075862, CAB078782" Enhanced Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB078782: , HPA030790: AB_10602305, HPA075862: " "unprognostic (2.84e-1)" "unprognostic (1.88e-1)" "unprognostic (4.10e-2)" "unprognostic (9.23e-3)" "unprognostic (8.85e-2)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (1.09e-1)" "unprognostic (7.72e-2)" "unprognostic (1.50e-1)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.22e-15)" "unprognostic (8.92e-3)" "unprognostic (1.92e-1)" "unprognostic (1.61e-1)" "unprognostic (1.88e-1)" 0.5 1.0 10.2 0.6 23.5 0.6 0.2 60.4 33.2 0.5 15.2 0.3 0.2 1.5 9.3 3.0 8.3 1.0 0.3 0.3 8.6 3.3 0.4 0.2 0.3 0.4 1.8 3.5 0.3 0.5 0.2 0.9 0.3 5.5 13.2 2.2 0.2 0.2 21.5 0.3 0.3 1.3 8.1 2.3 0.4 0.5 7.2 5.6 0.2 0.3 0.2 0.2 15.2 1.0 0.7 0.2 0.0 0.7 0.0 1.4 0.2 0.0 13.2 0.2 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 11.9 0.0 0.2 0.2 0.5 0.0 0.0 0.0 19.2 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.8 0.0 0.3 0.4 0.3 0.0 0.0 0.7 0.0 1.4 0.3 0.0 0.7 0.1 0.4 0.2 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.2 10.2 23.5 60.4 19.5 8.6 3.3 1.8 3.5 5.5 5.6 0.0 0.0 0.0 4.7 1.8 2.5 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 0.4 0.0 0.0 0.0 0.1 1.0 12.8 0.0 0.0 0.1 4.8 0.0 0.0 0.8 7.1 0.3 0.7 5.0 0.0 0.0 1.0 0.0 0.0 9.9 0.0 3.3 0.0 2.3 0.7 21.3 1.3 0.1 2.1 0.0 2.0 RBM11 ENSG00000185272 "RNA binding motif protein 11" P57052 21 14216130-14228372 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 20.6;epididymis: 55.3" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.1" "Lineage enriched" "Detected in single" 11 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "HEL: 3.6;NTERA-2: 2.8;REH: 2.8;SK-BR-3: 3.1;SuSa: 3.4;U-266/70: 2.8;WM-115: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045885 Supported Nucleoplasm NA NA Nucleoplasm "HPA045885: AB_10963937" "unprognostic (1.95e-2)" "unprognostic (1.35e-1)" "unprognostic (3.57e-1)" "unprognostic (5.44e-4)" "unprognostic (2.18e-1)" "unprognostic (7.97e-2)" "unprognostic (3.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (3.23e-2)" "unprognostic (9.92e-4)" "unprognostic (5.74e-2)" "unprognostic (1.16e-4)" "unprognostic (3.45e-2)" "unprognostic (4.81e-2)" "unprognostic (2.69e-1)" "unprognostic (9.24e-3)" 1.2 1.8 5.0 1.4 5.8 1.5 1.5 2.3 7.3 1.0 1.2 1.9 0.6 1.3 1.8 55.3 1.6 2.1 1.2 1.3 5.9 6.1 1.4 1.0 1.2 1.3 6.1 4.3 3.5 1.4 2.2 5.4 1.1 9.7 1.6 1.1 2.8 1.5 2.2 1.0 1.1 1.0 1.4 20.6 1.5 1.3 2.5 6.1 0.0 2.4 0.0 1.2 1.1 0.9 0.3 0.0 0.0 0.1 0.0 4.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.4 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.5 1.1 0.0 2.8 0.0 0.0 2.8 0.0 0.0 0.7 1.1 0.3 0.0 0.4 3.1 0.0 3.4 0.6 0.6 0.0 0.0 1.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.0 0.0 0.3 4.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 5.8 2.3 7.3 5.9 6.1 6.1 4.3 9.7 6.1 3.0 2.4 0.0 5.9 1.5 6.8 0.0 0.0 1.4 1.2 1.8 0.0 2.0 13.3 2.3 6.7 0.1 0.0 0.0 1.1 0.7 0.7 5.9 2.3 0.0 0.7 4.8 7.5 0.0 0.0 3.6 0.6 0.0 0.0 1.0 0.7 8.1 1.0 0.0 0.7 0.6 4.3 0.0 3.3 3.9 6.9 1.0 1.0 0.0 0.2 4.3 RBM15 "OTT, OTT1" ENSG00000162775 "RNA binding motif protein 15" Q96T37 1 110338506-110346681 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" RNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 48.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015201, HPA019824, HPA049642" Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (9.39e-2)" "unprognostic (7.57e-3)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.13e-1)" "unprognostic (1.84e-2)" "unprognostic (4.91e-2)" "unprognostic (9.67e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (1.37e-4)" "prognostic favorable (7.97e-4)" "unprognostic (2.88e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-1)" 8.5 7.6 6.3 12.2 7.6 48.7 7.9 18.6 8.3 6.6 8.8 7.6 8.3 7.3 8.5 7.2 8.0 7.3 6.6 8.8 5.2 4.3 6.3 11.0 10.5 13.7 8.3 6.0 8.6 7.5 7.1 8.1 7.1 5.9 5.7 5.7 8.1 7.4 6.4 17.2 7.2 11.3 5.5 5.0 12.5 8.3 14.0 7.9 21.8 7.0 5.3 13.4 6.5 8.6 10.5 4.8 9.8 6.9 5.0 9.9 5.5 7.1 7.8 7.0 7.2 4.5 4.7 11.1 3.8 5.0 6.0 7.9 9.5 6.5 13.5 6.1 4.3 4.9 10.1 11.0 9.5 8.9 14.0 10.1 10.9 11.8 6.9 6.2 11.8 11.6 4.3 6.6 8.3 7.8 3.1 6.3 10.3 15.4 23.7 6.0 7.3 10.6 9.3 15.0 6.3 4.4 12.6 10.6 9.2 4.9 7.2 8.5 4.3 8.3 10.5 8.0 7.9 7.2 14.3 4.4 5.7 10.4 6.2 6.9 18.3 9.2 29.3 8.6 12.0 7.1 8.2 6.9 9.4 7.0 6.0 9.9 10.5 7.7 6.0 4.8 10.0 6.8 8.2 9.8 5.0 6.4 4.7 7.5 5.5 6.3 7.6 18.6 8.3 5.2 4.3 8.3 6.0 5.9 7.9 6.0 3.0 15.3 8.2 29.5 5.4 10.8 7.6 9.4 2.3 3.5 13.7 7.6 0.0 3.4 6.2 9.8 7.5 0.0 3.1 6.2 8.9 8.6 28.8 13.5 5.6 0.0 9.2 10.4 5.7 4.1 3.7 5.5 8.5 1.8 8.4 5.6 4.2 2.9 4.9 3.3 7.1 0.0 13.3 24.4 14.5 29.5 3.9 12.5 7.6 6.7 RBM20 ENSG00000203867 "RNA binding motif protein 20" Q5T481 10 110644397-110839469 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.9;skeletal muscle: 20.9" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 137.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8" "Region enhanced" "Detected in some" "olfactory region: 4.6" "Not detected" "Not detected" "HPA035806, HPA070358" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Yes No "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA035806: AB_10672097, HPA070358: " "unprognostic (2.43e-1)" "unprognostic (8.24e-3)" "unprognostic (5.81e-2)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (2.03e-2)" "unprognostic (2.75e-2)" "unprognostic (5.47e-3)" "unprognostic (1.33e-1)" "unprognostic (2.78e-2)" "unprognostic (4.14e-3)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "unprognostic (3.34e-1)" "unprognostic (3.35e-2)" "unprognostic (1.20e-1)" "unprognostic (6.46e-2)" 1.7 0.1 0.4 0.6 1.9 0.1 2.2 0.5 1.5 0.9 2.6 1.3 0.0 0.2 2.5 7.5 3.6 1.9 2.3 45.9 0.6 0.2 1.1 0.1 0.5 0.1 0.3 1.3 2.4 13.7 0.9 1.2 1.4 1.4 1.0 0.5 4.3 6.3 0.7 20.9 0.7 1.0 2.1 0.6 0.1 0.6 0.9 1.4 0.0 0.7 3.4 0.5 1.8 3.2 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.5 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.0 0.0 2.3 5.7 4.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 1.4 0.0 15.7 0.0 0.0 0.0 0.1 14.6 0.1 0.0 0.6 5.0 8.8 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 1.9 0.5 1.5 0.6 0.2 0.3 1.3 1.4 1.4 0.0 0.0 0.0 0.2 0.1 1.3 137.1 0.0 17.4 0.0 0.0 2.0 1.0 1.7 0.0 0.7 0.6 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.4 4.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 12.7 1.4 2.3 6.5 1.9 0.0 0.5 0.0 2.6 0.0 0.0 0.1 RBM24 "dJ259A10.1, FLJ30829, RNPC6" ENSG00000112183 "RNA binding motif protein 24" Q9BX46 6 17281346-17293875 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 165.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA066927, HPA067231" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA066927: AB_2685750, HPA067231: AB_2685808" "unprognostic (9.05e-3)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-3)" "unprognostic (1.53e-1)" "unprognostic (4.54e-4)" "unprognostic (3.34e-2)" "unprognostic (1.33e-2)" "unprognostic (2.97e-3)" "unprognostic (3.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.16e-2)" "unprognostic (3.06e-2)" "unprognostic (1.08e-2)" "unprognostic (2.33e-4)" 3.4 0.2 1.4 0.9 2.2 0.1 1.1 0.3 1.9 7.0 2.7 0.1 3.0 0.5 9.7 7.3 3.4 7.8 1.7 41.0 1.5 1.7 0.3 0.4 0.4 0.2 0.5 1.1 2.1 0.2 0.1 1.8 0.2 0.3 3.6 2.4 1.6 2.5 2.2 153.8 0.4 1.2 9.3 0.5 0.4 0.8 1.3 0.1 0.1 1.4 37.3 1.9 5.1 2.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.7 4.5 6.0 0.0 0.0 0.0 0.0 9.1 3.3 6.2 6.6 0.0 0.5 0.0 2.9 6.5 9.8 0.0 5.6 0.2 11.3 0.0 0.2 0.0 0.5 3.1 0.2 0.0 0.5 3.3 0.0 1.2 0.2 8.0 0.7 0.0 0.0 0.0 29.0 1.3 0.0 0.0 2.0 0.0 0.7 0.0 29.8 0.0 0.0 0.0 3.9 0.4 0.0 0.0 0.1 4.9 13.9 0.2 0.0 2.1 5.0 0.0 7.8 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.2 0.3 1.9 1.5 1.7 0.5 1.1 0.3 0.1 0.0 0.0 0.0 0.2 1.0 1.6 165.8 0.0 20.1 2.3 0.0 0.0 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 9.2 0.8 0.2 1.1 0.0 0.2 1.6 4.6 0.0 0.0 1.0 0.0 0.0 1.7 0.0 3.9 0.6 0.2 0.0 0.7 0.1 0.0 6.5 16.2 0.3 7.7 0.9 0.7 0.0 1.5 0.1 RBM38 "dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D" ENSG00000132819 "RNA binding motif protein 38" Q9H0Z9 20 57391407-57409333 "Predicted intracellular proteins" "Cell cycle, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 64.3;skeletal muscle: 107.9" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;Intestinal endocrine cells: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 39.4;U-698: 41.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" CAB017036 Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB017036: " "unprognostic (1.03e-1)" "prognostic favorable (3.64e-7)" "unprognostic (3.71e-2)" "unprognostic (7.73e-3)" "unprognostic (4.16e-2)" "unprognostic (4.85e-2)" "unprognostic (1.53e-2)" "unprognostic (4.37e-3)" "unprognostic (3.04e-1)" "unprognostic (9.04e-3)" "unprognostic (3.90e-2)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.13e-2)" "unprognostic (2.29e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.83e-1)" 4.4 3.5 4.5 22.8 4.9 64.3 4.3 10.0 5.2 9.2 28.1 6.4 7.1 5.9 13.0 6.7 16.3 10.4 6.5 24.4 4.2 3.9 5.3 6.7 9.8 23.3 4.7 2.3 17.2 5.9 1.9 4.4 9.9 5.0 12.2 3.4 10.9 11.6 8.3 107.9 2.7 12.9 27.4 3.4 22.0 8.1 16.7 4.1 26.8 4.1 18.9 28.0 25.1 11.4 6.4 2.2 3.5 2.9 5.5 7.6 3.4 5.5 5.7 2.9 7.3 0.0 0.4 16.3 1.8 0.4 3.9 1.0 23.4 5.9 39.4 15.6 0.5 3.9 5.1 2.4 2.3 0.6 7.9 9.7 33.4 2.2 14.8 1.8 16.1 15.7 0.5 1.1 1.6 0.3 0.6 2.6 15.1 27.2 7.2 0.4 24.0 11.6 16.6 10.5 3.1 7.2 22.6 7.1 32.0 2.9 2.6 11.9 7.6 4.4 14.6 7.3 2.7 8.1 22.6 4.7 1.3 12.5 1.7 7.6 17.3 22.9 41.5 0.3 11.5 1.2 0.0 1.0 3.5 5.4 2.9 3.5 5.6 4.5 3.7 1.8 6.4 5.7 5.0 1.3 5.5 2.7 2.2 7.6 3.4 4.5 4.9 10.0 5.2 4.2 3.9 4.7 2.3 5.0 4.1 3.0 6.9 45.5 27.2 8.0 0.9 37.4 7.6 12.0 5.7 1.8 0.0 1.3 8.3 5.5 4.0 9.3 25.7 70.0 4.3 4.4 6.0 14.9 8.1 4.5 8.5 0.0 60.3 6.2 7.0 2.7 4.0 11.1 1.7 1.0 49.7 11.8 6.1 28.8 5.6 13.3 1.3 6.5 4.4 1.2 15.1 7.3 1.9 48.7 40.0 16.2 RBM44 FLJ40411 ENSG00000177483 "RNA binding motif protein 44" Q6ZP01 2 237798389-237842808 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 40.1" "Group enriched" "Detected in some" 7 "Spermatocytes: 107.6;Spermatogonia: 72.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 33 "basophil: 3.3" "Lineage enriched" "Detected in single" 33 "granulocytes: 3.3" "Cell line enhanced" "Detected in some" "NB-4: 3.5;RPTEC TERT1: 3.5" "Not detected" "Not detected" HPA003298 Enhanced NA NA "HPA003298: AB_2284846" "unprognostic (1.29e-1)" "unprognostic (2.66e-1)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "unprognostic (8.47e-3)" "unprognostic (3.15e-2)" "unprognostic (2.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.83e-2)" "unprognostic (8.12e-2)" "unprognostic (4.10e-2)" "unprognostic (4.57e-2)" "unprognostic (5.01e-5)" "unprognostic (1.90e-1)" "unprognostic (4.27e-2)" "unprognostic (6.85e-3)" "unprognostic (7.89e-3)" 0.5 0.0 0.1 0.1 0.1 0.8 0.4 0.1 0.3 0.4 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.0 0.3 0.1 0.5 0.8 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.6 0.1 0.2 0.2 0.2 0.3 0.1 0.4 0.2 40.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.1 0.4 0.9 0.3 1.0 0.7 0.5 0.7 0.5 0.4 0.4 0.0 0.0 0.0 0.0 0.3 0.3 1.3 0.4 0.2 0.9 0.7 0.1 1.5 1.3 0.8 0.6 1.4 1.3 0.1 1.0 0.2 1.2 1.9 0.4 1.3 0.1 1.2 0.0 0.2 0.9 3.5 0.7 0.2 1.1 0.4 0.2 0.9 3.5 1.1 0.6 0.9 0.0 0.4 0.3 0.7 0.5 2.1 0.0 0.0 0.3 0.0 0.8 0.7 0.2 0.2 0.7 1.5 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.3 0.1 0.0 0.6 0.0 0.6 0.7 0.0 0.6 2.5 2.7 2.3 1.8 0.0 0.1 0.0 0.1 13.1 0.9 0.0 0.0 0.2 0.2 0.5 1.5 0.0 0.4 0.3 0.0 0.0 0.0 0.8 10.9 2.6 1.8 1.7 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 6.5 0.4 107.6 72.4 0.5 0.0 0.0 0.0 1.0 RBM46 "CT68, MGC27016" ENSG00000151962 "RNA binding motif protein 46" Q8TBY0 4 154781213-154828813 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 34.5" "Group enriched" "Detected in some" 13 "Spermatocytes: 74.4;Spermatogonia: 75.5" "Cancer enriched" "Detected in single" 15 "testis cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 2.7;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079488 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA079488: " "unprognostic (4.79e-1)" "unprognostic (1.14e-2)" "unprognostic (3.23e-1)" "unprognostic (1.59e-2)" "unprognostic (3.33e-3)" "unprognostic (1.13e-1)" "unprognostic (8.11e-2)" "unprognostic (2.24e-2)" "unprognostic (2.99e-7)" "unprognostic (4.86e-2)" "unprognostic (7.31e-2)" "unprognostic (4.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 34.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 74.4 75.5 0.0 0.0 0.0 0.0 0.0 RBM8A "BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP" ENSG00000265241 "RNA binding motif protein 8A" Q9Y5S9 1 145917714-145927678 "Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018403 Supported Supported "Nuclear speckles" NA NA 120000 "Nuclear speckles" "HPA018403: AB_1858908" "unprognostic (3.81e-1)" "unprognostic (3.99e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-2)" "unprognostic (1.12e-1)" "unprognostic (3.16e-1)" "unprognostic (4.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (8.79e-3)" "unprognostic (7.27e-3)" "prognostic unfavorable (1.55e-4)" "unprognostic (3.30e-3)" "unprognostic (2.18e-1)" "unprognostic (3.77e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-3)" 6.2 6.5 9.1 9.5 9.8 18.7 6.1 6.3 9.8 8.3 6.2 9.6 9.8 6.2 7.4 5.0 15.1 5.7 5.0 6.4 7.3 6.4 6.5 5.5 11.2 7.0 7.1 7.6 5.1 6.9 5.5 7.9 13.5 5.7 5.0 5.7 6.2 6.3 24.6 7.2 6.0 6.8 13.2 6.5 5.8 8.5 9.5 6.8 6.3 4.8 11.7 7.1 3.5 101.9 120.1 118.0 85.5 85.3 89.3 115.9 51.9 42.6 38.9 31.0 14.0 13.8 47.9 31.8 21.6 45.9 33.8 56.2 39.6 47.8 50.4 21.9 24.2 35.8 41.4 34.8 37.7 42.3 39.4 36.8 32.3 41.5 19.8 61.4 32.3 15.1 26.3 41.0 44.0 20.1 34.0 41.6 55.3 45.3 35.2 143.7 61.7 48.7 66.9 45.3 74.3 54.7 34.0 47.5 29.3 50.2 40.0 49.0 47.5 24.4 43.2 35.2 45.7 74.8 35.0 37.0 47.2 36.3 87.0 51.2 80.8 70.1 33.2 37.0 31.9 89.7 77.6 118.0 86.5 85.5 82.1 101.9 82.5 87.8 76.5 90.1 77.7 86.3 89.3 85.3 79.9 120.1 89.3 115.9 65.5 127.4 197.4 354.6 295.8 63.8 60.9 81.5 131.2 154.7 83.7 51.1 325.5 159.2 190.8 135.1 157.7 103.0 116.8 192.9 427.5 170.0 170.0 239.0 101.1 184.0 33.4 152.5 103.2 99.7 35.5 94.6 186.8 197.4 240.7 91.6 97.7 203.4 129.8 80.2 155.5 75.0 97.0 213.9 194.7 163.6 277.9 615.1 199.5 104.0 335.7 RBMXL2 "HNRNPG-T, HNRPGT" ENSG00000170748 "RNA binding motif protein, X-linked like 2" O75526 11 7089027-7090900 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 199 "testis: 70.7" "Group enriched" "Detected in some" 9 "Early spermatids: 111.8;Late spermatids: 105.0;Spermatocytes: 228.1" "Cancer enriched" "Detected in single" 133 "testis cancer: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 1.5;HUVEC TERT2: 1.9;SuSa: 2.0" "HPA038912, HPA051842" Enhanced NA NA "HPA038912: AB_10670913, HPA051842: AB_2681634" "unprognostic (3.73e-1)" "unprognostic (2.24e-1)" "unprognostic (5.47e-2)" "unprognostic (1.51e-2)" "unprognostic (3.24e-1)" "unprognostic (8.28e-2)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.8 0.0 0.0 228.1 16.2 0.0 0.0 0.0 0.0 0.0 RBMXL3 "CXorf55, FLJ40249" ENSG00000175718 "RNA binding motif protein, X-linked like 3" Q8N7X1 X 115189427-115192868 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 6.8" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 15.8" "Cancer enriched" "Detected in single" 25 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051842 Supported NA NA "HPA051842: AB_2681634" "unprognostic (1.05e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 15.8 0.0 0.0 0.0 0.0 0.0 RBMY1A1 "RBM1, RBM2, YRRM1, YRRM2" ENSG00000234414 "RNA binding motif protein, Y-linked, family 1, member A1" P0DJD3 Y 21511372-21549326 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 132 "testis: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "U-266/84: 18.1" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1B ENSG00000242875 "RNA binding motif protein, Y-linked, family 1, member B" A6NDE4 Y 21511338-21549094 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 47 "testis: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HEL: 1.6" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1D ENSG00000244395 "RNA binding motif protein, Y-linked, family 1, member D" P0C7P1 Y 21880076-21894526 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1E ENSG00000242389 "RNA binding motif protein, Y-linked, family 1, member E" A6NEQ0 Y 21903618-21918067 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 71 "testis: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "U-266/84: 7.1" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 RBMY1F MGC33094 ENSG00000169800 "RNA binding motif protein, Y-linked, family 1, member F" Q15415 Y 22168542-22182982 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 65 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 232 "U-266/70: 22.4;U-266/84: 23.9" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1J ENSG00000226941 "RNA binding motif protein, Y-linked, family 1, member J" Q15415 Y 22403461-22417881 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 169 "U-266/70: 22.6;U-266/84: 11.1" "HPA001534, HPA053147" Supported NA NA "HPA001534: AB_2178972, HPA053147: AB_2682056" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 161.0;pancreas: 107.4;retina: 85.3" "Group enriched" "Detected in many" 7 "Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 136.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 56.8" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 1.9 43.1 6.5 3.3 11.3 0.1 7.5 5.1 7.8 7.8 3.2 11.5 8.4 4.5 26.8 11.3 3.3 58.4 42.7 7.5 7.7 8.1 3.7 20.1 4.9 6.5 10.4 4.9 161.0 107.4 4.3 26.2 20.6 31.5 9.8 2.1 85.3 4.7 6.4 1.8 2.9 4.8 17.5 8.7 4.7 2.8 12.9 4.3 0.9 3.3 2.6 2.0 7.7 7.2 0.5 0.5 2.1 0.9 0.7 0.4 0.2 1.2 0.3 1.1 26.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.2 0.0 8.7 0.0 0.4 0.0 6.1 0.1 0.0 0.0 0.7 0.0 0.4 11.2 25.8 0.0 0.0 0.4 0.0 0.0 0.0 26.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 5.2 0.0 0.0 0.0 3.2 136.6 5.6 0.0 0.0 2.3 0.5 0.1 0.0 0.0 20.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 1.2 0.9 0.8 0.4 0.8 0.1 0.4 0.2 0.1 0.0 0.5 0.3 0.2 2.1 0.7 0.5 0.5 0.1 0.2 6.5 11.3 5.1 7.8 7.7 8.1 10.4 4.9 31.5 4.3 29.8 5.1 10.5 43.6 15.7 12.3 15.5 63.7 5.3 12.5 22.7 2.0 2.6 11.6 920.8 3.9 54.2 0.0 0.0 932.2 6.9 95.1 21.2 0.0 6.6 16.2 3.2 41.3 319.8 11.5 8.3 25.0 2.8 8.5 23.4 0.5 79.7 450.0 0.0 4.2 2.7 7.0 25.8 22.5 2.3 4.1 30.6 3.2 2.5 0.8 27.7 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 198 "intestine: 333.2" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 8.9;Collecting duct cells: 12.2;Cone photoreceptor cells: 7.9;Enterocytes: 17.1;Pancreatic endocrine cells: 9.4;Paneth cells: 14.4" "Cancer enhanced" "Detected in many" "stomach cancer: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CACO-2: 41.9" "Region enriched" "Detected in single" 4 "basal ganglia: 4.6" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" NA NA 96000 "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 130.1 0.0 0.0 221.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.1 1.6 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 333.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 41.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.1 0.0 0.1 0.0 0.0 0.0 5.9 0.0 0.0 2.2 5.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 8.9 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 12.2 7.9 0.0 0.0 0.5 0.0 0.0 17.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 9.4 14.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 RBP3 "D10S64, D10S65, D10S66, RP66" ENSG00000265203 "Retinol binding protein 3" P10745 10 47348371-47357875 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Transport "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "retina: 135.2" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 1949.7;Rod photoreceptor cells: 1076.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 2.7;HDLM-2: 2.5;SH-SY5Y: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041301, HPA044239" Enhanced "Secreted in other tissues" NA NA "HPA041301: AB_2677398, HPA044239: AB_2678868" "unprognostic (3.48e-2)" "unprognostic (4.78e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.40e-1)" "unprognostic (1.58e-2)" "unprognostic (5.09e-2)" "unprognostic (5.14e-3)" "unprognostic (7.44e-2)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 135.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.3 0.3 0.0 0.0 0.0 0.0 1949.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.8 0.0 0.0 0.0 0.0 1076.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBP4 ENSG00000138207 "Retinol binding protein 4" P02753 10 93591687-93601744 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 23 "liver: 897.1" "Cell type enriched" "Detected in many" 13 "Hepatocytes: 11448.6" "Cancer enriched" "Detected in all" 27 "liver cancer: 3135.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 14 "classical monocyte: 1.2;myeloid DC: 1.5" "Group enriched" "Detected in many" 14 "dendritic cells: 1.5;monocytes: 1.2" "Cell line enriched" "Detected in some" 4 "Hep G2: 155.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001641, CAB004555" Supported "Secreted to blood" NA NA 46100000000 420000000000 "CAB004555: AB_670938, HPA001641: AB_1079795" "unprognostic (9.42e-3)" "unprognostic (3.40e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.60e-2)" "unprognostic (6.69e-4)" "prognostic favorable (1.74e-8)" "unprognostic (2.39e-1)" "unprognostic (5.76e-2)" "unprognostic (3.26e-2)" "unprognostic (3.26e-1)" "unprognostic (3.44e-1)" "unprognostic (7.14e-3)" "unprognostic (9.88e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (8.60e-2)" 39.0 2.0 1.4 2.4 3.1 0.3 27.0 0.0 2.1 0.3 1.8 0.0 0.1 0.5 0.4 0.4 0.3 0.4 2.1 1.2 1.4 2.2 7.9 897.1 1.5 1.0 0.2 1.1 0.5 4.7 0.3 28.3 1.8 0.4 0.9 0.6 5.6 1.8 0.5 0.4 0.4 0.6 0.3 0.1 0.3 0.7 0.4 0.0 0.0 0.3 0.5 0.2 0.6 1.6 0.0 1.5 0.0 1.2 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 37.5 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 155.4 0.0 1.2 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.2 0.3 17.6 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.5 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 3.1 0.0 2.1 1.4 2.2 0.2 1.1 0.4 0.0 0.0 3.4 60.7 0.2 0.7 0.0 0.4 853.5 1.4 1.2 22.7 5.9 0.2 82.9 7.1 2.2 0.7 2.1 46.7 0.2 11.9 6.8 1.7 0.0 11448.6 18.7 0.0 60.0 171.2 183.3 1.9 2.8 2.0 1.7 0.0 33.0 0.7 46.4 10.5 5.3 393.5 0.2 0.0 0.8 2.8 13.4 0.6 1.1 19.1 1.1 0.9 RBP5 CRBPIII ENSG00000139194 "Retinol binding protein 5" P82980 12 7123684-7128942 "Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 2221.9" "Group enriched" "Detected in all" 8 "liver cancer: 70.1;renal cancer: 126.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 12 "granulocytes: 1.3;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HEL: 7.0;Hep G2: 15.6;K-562: 32.0" "Low region specificity" "Detected in all" HPA038723 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA038723: AB_2676175" "unprognostic (5.70e-3)" "unprognostic (7.34e-2)" "unprognostic (2.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.87e-2)" "unprognostic (1.39e-3)" "unprognostic (2.49e-2)" "prognostic favorable (8.37e-4)" "unprognostic (1.04e-1)" "unprognostic (2.65e-1)" "unprognostic (1.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-2)" "unprognostic (3.33e-2)" "unprognostic (4.22e-1)" "prognostic favorable (3.68e-4)" 1.5 2.6 0.3 18.2 0.3 0.7 1.3 0.6 0.3 2.8 1.7 0.1 2.3 1.4 5.3 13.3 2.3 1.5 3.6 2.3 0.3 0.3 99.9 74.2 3.6 54.3 0.2 0.0 3.5 1.3 0.2 1.6 0.1 0.1 2.6 1.6 0.7 5.9 3.3 0.4 0.7 4.4 1.8 0.2 44.3 1.2 1.2 0.0 6.2 2.0 0.7 10.1 2.3 1.4 0.1 0.0 1.3 0.0 0.0 2.4 0.1 1.8 3.2 0.0 1.0 0.0 0.0 0.7 1.2 0.0 0.0 0.2 1.7 2.0 1.1 0.5 0.0 0.2 2.3 0.1 0.0 0.0 2.8 0.0 7.0 5.0 15.6 0.0 0.4 2.0 0.3 0.1 0.0 0.0 3.2 0.0 1.1 32.0 1.5 0.0 0.0 0.1 0.4 0.4 0.0 0.1 0.4 0.0 0.1 0.1 2.7 0.1 0.3 2.8 1.1 0.0 0.9 0.6 1.1 1.1 1.3 1.3 3.7 0.5 0.6 0.2 0.2 0.9 1.5 0.2 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 1.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.4 0.1 0.3 0.3 0.6 0.3 0.3 0.3 0.2 0.0 0.1 0.0 0.0 1.1 1.4 0.4 1.3 1.2 0.0 2.5 1.4 0.0 76.8 0.0 0.0 298.4 0.2 3.2 9.0 0.0 0.0 0.4 0.0 0.9 0.4 0.0 302.4 0.1 4.8 0.0 10.4 6.4 5.4 2.3 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.4 2221.9 1.6 0.0 1.0 0.2 0.4 1.9 0.0 2.1 0.0 0.3 RBP7 CRBPIV ENSG00000162444 "Retinol binding protein 7" Q96R05 1 9997206-10016020 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.1;breast: 210.2" "Group enriched" "Detected in many" 5 "Endothelial cells: 121.4;Kupffer cells: 402.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 54.1;intermediate monocyte: 23.4;neutrophil: 60.6" "Group enriched" "Detected in many" 30 "granulocytes: 60.6;monocytes: 54.1" "Cell line enhanced" "Detected in some" "EFO-21: 10.5;SK-MEL-30: 7.1;T-47d: 26.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA034749 Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA034749: AB_10602084" "unprognostic (1.93e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (9.59e-2)" "unprognostic (2.31e-1)" "unprognostic (6.28e-2)" "unprognostic (1.39e-2)" "unprognostic (1.85e-1)" "unprognostic (1.05e-3)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (7.90e-2)" "unprognostic (5.07e-2)" "unprognostic (2.38e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.61e-2)" 68.1 3.7 3.8 3.0 11.4 7.5 210.2 2.1 5.5 4.3 10.9 8.7 2.7 0.5 6.4 4.5 7.2 2.4 14.7 29.7 5.3 2.8 7.6 2.5 2.5 4.5 7.6 3.0 2.6 3.7 14.7 3.5 4.4 6.2 4.7 1.2 3.5 4.8 2.7 5.9 6.6 2.0 4.4 8.9 21.5 3.0 2.6 5.2 1.2 11.3 1.8 1.4 4.5 17.5 0.0 1.8 60.6 54.1 0.0 0.1 15.0 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.8 1.8 2.4 0.0 10.5 1.0 0.0 0.0 0.0 0.8 3.4 0.0 2.5 0.0 0.1 0.9 1.2 0.0 0.0 0.0 1.6 1.6 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 4.4 0.0 0.0 0.0 0.5 0.0 0.1 0.4 1.9 0.1 7.1 2.9 26.8 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 54.1 0.4 0.0 23.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 60.6 0.0 11.1 0.3 0.1 15.0 3.8 11.4 2.1 5.5 5.3 2.8 7.6 3.0 6.2 5.2 0.0 2.2 11.2 7.8 18.3 0.0 17.6 10.2 1.4 1.2 1.8 0.0 4.5 19.9 1.3 2.6 121.4 0.0 0.0 2.3 2.2 8.2 19.2 3.5 1.3 54.6 0.0 0.0 49.7 402.1 4.7 5.8 23.1 20.3 0.0 0.0 1.3 3.7 0.0 0.7 0.7 1.1 0.0 5.3 1.2 1.5 15.4 5.1 1.3 0.4 4.3 RBPJL "RBP-L, RBPSUHL, SUH, SUHL" ENSG00000124232 "Recombination signal binding protein for immunoglobulin kappa J region like" Q9UBG7 20 45306851-45317824 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 279 "pancreas: 188.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "liver cancer: 1.2;ovarian cancer: 1.2;pancreatic cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.2;NB-4: 4.8;SK-MEL-30: 1.3;U-937: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" CAB006846 Enhanced NA NA "CAB006846: " "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.34e-2)" "unprognostic (6.09e-1)" "unprognostic (3.07e-2)" "unprognostic (2.08e-1)" "unprognostic (9.60e-2)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (1.65e-1)" "unprognostic (3.92e-3)" "unprognostic (2.48e-7)" "unprognostic (5.08e-1)" "unprognostic (5.40e-2)" "unprognostic (2.26e-2)" "unprognostic (3.49e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 3.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.0 2.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 RBPMS2 ENSG00000166831 "RNA binding protein, mRNA processing factor 2" Q6ZRY4 15 64739892-64775587 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 75.1;smooth muscle: 69.6;urinary bladder: 51.6" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 203.2" "Cancer enhanced" "Detected in all" "testis cancer: 37.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 1.6;naive B-cell: 3.0" "Lineage enhanced" "Detected in single" "B-cells: 3.0" "Cell line enhanced" "Detected in many" "AF22: 15.1;AN3-CA: 21.3;HEL: 32.1;NTERA-2: 29.5;SuSa: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.68e-1)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.79e-2)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (4.51e-2)" "unprognostic (6.41e-2)" "unprognostic (5.86e-2)" "unprognostic (2.21e-2)" "unprognostic (4.47e-2)" "prognostic favorable (1.48e-4)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 6.9 1.1 0.7 5.8 0.9 0.5 8.3 0.6 1.2 7.0 32.2 1.2 11.5 2.2 13.5 5.7 17.4 7.2 20.5 75.1 1.5 0.6 9.5 3.8 1.7 0.3 1.1 1.1 6.0 1.1 5.5 1.0 2.8 2.1 19.8 3.1 5.9 1.8 17.9 2.4 1.2 7.3 69.6 1.0 1.1 14.7 3.2 0.5 0.2 3.5 2.2 0.3 51.6 12.8 3.0 0.0 0.0 0.0 0.7 0.4 1.8 0.0 2.4 15.1 21.3 0.0 0.0 2.2 0.4 0.0 2.7 0.6 1.8 0.2 0.0 2.0 0.4 2.5 0.0 11.0 0.0 1.0 0.0 3.5 32.1 3.6 3.6 1.5 0.0 0.3 0.0 0.0 1.7 0.0 0.5 0.2 0.7 0.1 0.0 0.2 1.0 0.0 0.1 29.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.2 3.2 0.0 0.6 35.3 3.0 0.1 0.0 0.0 11.3 1.5 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.4 0.0 3.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 1.8 0.7 0.9 0.6 1.2 1.5 0.6 1.1 1.1 2.1 0.5 0.0 0.0 0.0 0.2 0.7 0.2 203.2 0.0 0.0 0.0 3.5 0.0 0.4 8.3 0.3 4.1 3.6 0.0 0.0 1.4 1.0 3.6 1.6 0.0 7.3 0.3 0.0 0.0 3.1 1.2 0.4 3.4 0.5 1.7 0.0 0.0 3.2 2.0 0.0 6.0 22.3 0.9 45.3 49.2 0.7 12.0 1.0 2.6 0.0 0.0 0.1 RCAN1 DSCR1 ENSG00000159200 "Regulator of calcineurin 1" P53805 21 34513142-34615142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 220.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 195.4;Hepatocytes: 146.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "SK-MEL-30: 156.7;WM-115: 102.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037218, HPA068436" Enhanced Approved Cytosol NA NA Cytosol "CAB037218: AB_2179743, HPA068436: " "unprognostic (3.83e-2)" "unprognostic (4.40e-1)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (9.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.82e-3)" "unprognostic (5.27e-2)" "unprognostic (7.99e-2)" "unprognostic (4.83e-2)" "unprognostic (2.71e-1)" "unprognostic (2.04e-1)" "unprognostic (4.07e-3)" "unprognostic (1.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-2)" "unprognostic (2.60e-3)" 21.5 7.9 22.2 15.8 25.8 2.8 20.7 14.8 19.6 29.3 12.2 27.7 3.2 10.6 10.6 7.4 10.1 4.2 18.8 18.6 22.4 22.4 27.1 77.3 15.0 7.5 27.2 11.1 5.0 20.3 220.2 11.2 30.4 18.1 8.9 13.3 12.6 6.9 5.9 10.9 9.7 13.5 15.4 41.3 5.2 13.1 3.7 19.4 19.9 19.8 12.2 6.9 19.8 6.9 1.6 5.2 8.0 3.9 0.2 1.9 0.9 5.8 1.1 6.0 3.8 3.3 2.0 3.7 21.9 22.6 9.0 9.0 6.6 5.6 0.1 1.0 12.7 17.9 0.5 4.3 4.4 12.2 3.3 2.6 1.1 2.0 3.1 12.8 1.8 3.7 5.3 4.0 10.7 7.5 2.2 2.9 4.0 2.2 5.7 5.9 2.8 17.4 1.4 3.4 5.8 2.9 6.6 4.7 2.7 2.8 10.1 2.9 1.2 16.0 10.4 156.7 5.7 14.0 3.1 3.2 30.5 3.1 5.0 5.3 5.0 3.1 1.0 10.0 5.4 102.2 0.0 2.0 8.0 1.3 3.4 1.9 1.6 1.6 1.2 2.7 1.2 0.7 1.3 1.0 0.2 3.9 5.2 1.8 0.9 22.2 25.8 14.8 19.6 22.4 22.4 27.2 11.1 18.1 19.4 89.3 64.0 6.7 17.3 84.0 14.8 21.4 22.9 16.0 17.0 195.4 25.5 6.3 18.3 67.7 38.0 57.3 62.2 0.0 16.3 10.7 35.7 12.5 8.1 146.7 46.2 3.2 3.5 25.2 24.5 9.6 6.6 30.2 54.0 38.7 22.2 10.6 25.9 38.4 9.2 96.4 6.7 0.0 82.6 11.9 2.3 69.4 9.3 5.2 8.4 34.1 RCAN2 "DSCR1L1, ZAKI-4" ENSG00000172348 "Regulator of calcineurin 2" Q14206 6 46220736-46491972 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 98.8" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 229.0;Muller glia cells: 167.3;Sertoli cells: 97.0;Smooth muscle cells: 159.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 34 "gdT-cell: 3.9;memory CD4 T-cell: 2.6;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 43 "T-cells: 4.8" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 25.3;HDLM-2: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053880 Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA053880: AB_2682290" "unprognostic (2.82e-1)" "unprognostic (7.76e-2)" "unprognostic (4.13e-2)" "unprognostic (1.14e-1)" "unprognostic (5.55e-3)" "unprognostic (4.52e-2)" "unprognostic (1.29e-3)" "unprognostic (1.86e-3)" "unprognostic (2.26e-1)" "unprognostic (4.33e-1)" "prognostic favorable (2.48e-4)" "unprognostic (1.37e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" 13.7 7.2 13.2 4.3 33.4 0.8 5.9 19.5 51.8 10.9 10.6 13.4 2.3 5.5 7.3 27.6 13.9 7.8 18.0 98.8 14.7 24.2 17.5 4.0 8.3 2.6 38.3 27.1 13.5 6.2 47.7 6.7 1.1 60.3 13.8 12.2 27.9 5.5 14.9 29.3 5.9 7.7 14.2 17.0 4.1 14.0 3.5 11.0 0.0 10.8 14.4 4.1 15.9 8.8 0.0 0.0 0.1 0.1 0.0 4.8 0.8 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.4 6.1 0.4 0.0 0.0 0.0 0.0 0.3 25.3 0.0 0.0 0.0 0.0 0.1 50.9 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.1 0.2 0.1 5.6 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 2.6 4.8 0.0 0.0 0.0 3.7 0.1 0.0 0.1 0.0 0.0 0.8 13.2 33.4 19.5 51.8 14.7 24.2 38.3 27.1 60.3 11.0 6.0 4.3 0.8 3.8 5.6 19.4 229.0 2.5 0.0 0.0 3.5 3.9 0.0 59.7 5.8 22.0 10.8 0.0 0.0 2.1 0.0 5.6 1.7 0.0 0.2 0.1 28.6 24.1 0.0 0.3 11.0 27.0 1.8 30.4 0.0 0.3 167.3 4.3 0.0 47.4 1.4 8.0 97.0 159.7 0.7 0.9 6.5 0.0 0.0 0.1 1.1 RCAN3 DSCR1L2 ENSG00000117602 "RCAN family member 3" Q9UKA8 1 24502351-24541040 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 73.6;Intestinal endocrine cells: 78.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 37.0" "Group enriched" "Detected in many" 4 "MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2" "Lineage enriched" "Detected in many" 7 "T-cells: 19.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034533, HPA064289" Enhanced Approved "Nucleoli fibrillar center,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli fibrillar center" "HPA034533: AB_10601481, HPA064289: AB_2685232" "unprognostic (1.55e-3)" "unprognostic (1.58e-2)" "unprognostic (4.01e-2)" "unprognostic (1.51e-3)" "unprognostic (1.20e-1)" "unprognostic (4.20e-3)" "unprognostic (3.41e-3)" "unprognostic (3.66e-2)" "unprognostic (6.42e-2)" "unprognostic (2.47e-1)" "unprognostic (1.72e-3)" "unprognostic (7.44e-2)" "unprognostic (3.52e-3)" "unprognostic (9.83e-2)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "unprognostic (4.71e-2)" 3.2 1.5 2.7 15.8 4.0 4.7 7.6 37.0 3.7 3.9 5.0 7.6 3.2 5.2 3.2 7.7 12.6 11.2 6.5 3.1 3.3 7.8 5.3 2.1 8.1 27.2 5.5 1.9 2.0 15.0 5.5 15.0 7.0 7.6 27.7 5.2 6.1 17.4 4.8 1.6 10.0 6.7 2.6 7.9 7.9 13.2 2.6 2.9 17.2 11.7 8.6 23.2 6.0 6.3 2.8 1.5 1.4 0.9 1.9 19.2 4.2 10.5 8.3 0.1 2.6 2.3 5.3 9.6 7.2 3.9 5.7 5.4 2.4 14.1 7.9 6.6 12.1 4.2 10.0 7.5 9.1 6.2 7.6 4.5 0.8 2.2 7.2 1.4 2.6 7.0 1.9 6.8 1.9 3.0 5.0 1.2 9.9 1.1 0.3 2.6 3.5 6.9 4.0 11.1 8.2 6.1 2.8 0.1 0.2 4.3 9.1 22.6 5.6 5.7 7.5 22.2 5.2 7.7 5.4 8.2 6.8 8.2 0.4 4.9 10.7 12.8 10.1 2.8 10.8 7.9 1.4 0.9 1.1 0.7 0.5 5.6 2.6 14.0 5.0 1.5 2.8 19.2 9.9 0.3 1.9 0.2 1.1 19.2 4.2 2.7 4.0 37.0 3.7 3.3 7.8 5.5 1.9 7.6 2.9 17.9 14.1 12.6 24.9 12.6 37.2 5.9 15.3 73.6 18.2 19.2 60.9 2.9 11.6 18.2 0.9 7.5 6.5 0.0 24.5 9.2 6.2 52.5 16.1 1.1 8.7 23.8 78.8 7.4 7.9 0.0 1.7 18.6 28.7 34.3 13.5 9.4 32.0 11.2 1.1 0.7 32.8 0.0 8.1 0.5 12.8 19.1 4.5 35.7 11.0 21.8 RCC1L WBSCR16 ENSG00000274523 "RCC1 like" Q96I51 7 75027122-75074228 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor, RNA-binding, rRNA-binding" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 33.4" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 50.0;Distal tubular cells: 41.4;Extravillous trophoblasts: 33.6;monocytes: 29.7;Syncytiotrophoblasts: 45.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052184, HPA060643" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA052184: AB_2681752, HPA060643: AB_2684335" "unprognostic (9.73e-2)" "unprognostic (9.42e-2)" "unprognostic (1.69e-1)" "unprognostic (5.87e-2)" "prognostic unfavorable (4.88e-4)" "unprognostic (8.91e-2)" "unprognostic (3.34e-3)" "unprognostic (7.36e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (1.28e-3)" "unprognostic (6.35e-2)" "unprognostic (1.13e-3)" "unprognostic (2.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.43e-1)" 7.4 8.5 4.4 7.0 5.1 4.2 3.3 4.3 5.6 5.8 6.4 7.0 7.2 6.4 5.0 4.8 7.4 4.8 7.7 11.5 3.7 7.9 12.0 3.9 5.5 5.6 4.0 7.1 9.1 4.9 3.3 6.5 3.8 7.2 3.2 7.3 7.8 6.4 33.4 4.3 6.0 9.5 2.3 6.8 4.8 5.4 5.7 3.6 8.7 8.4 6.8 5.8 7.7 6.8 5.5 4.8 4.9 6.7 9.2 2.6 15.3 23.5 12.4 21.1 8.9 7.3 17.2 15.0 10.8 12.9 10.6 23.7 18.9 16.3 6.9 12.1 16.9 18.2 10.5 10.0 5.4 17.9 16.7 12.0 15.7 22.1 12.6 19.2 19.5 9.0 8.3 11.2 9.1 8.7 11.4 3.5 38.4 10.6 9.9 32.6 0.9 29.1 29.0 18.6 18.5 9.3 10.1 34.0 11.2 14.0 13.5 20.2 20.1 42.6 18.3 9.1 30.0 20.1 12.8 17.1 14.3 15.2 19.5 11.9 9.4 25.6 13.1 20.4 22.5 4.8 3.8 2.2 7.3 4.9 5.7 5.7 7.8 6.4 5.3 6.8 7.5 9.2 1.4 6.7 3.5 5.5 5.9 2.6 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.5 21.0 0.0 50.0 41.4 21.1 0.0 0.0 0.0 0.0 17.7 33.6 0.0 0.0 4.7 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 29.7 0.0 0.0 16.6 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 RCL1 "RNAC, RPCL1" ENSG00000120158 "RNA terminal phosphate cyclase like 1" Q9Y2P8 9 4792869-4885917 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "liver: 108.1;pancreas: 37.5" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "HDLM-2: 35.1;HEL: 90.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071308 Approved Nucleoplasm NA NA Nucleoplasm "HPA071308: AB_2686384" "prognostic favorable (5.48e-4)" "unprognostic (7.60e-3)" "unprognostic (7.55e-2)" "unprognostic (4.19e-2)" "unprognostic (1.07e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.02e-4)" "unprognostic (3.55e-1)" "unprognostic (1.47e-1)" "unprognostic (2.81e-2)" "unprognostic (1.19e-1)" "unprognostic (2.59e-2)" "prognostic favorable (2.40e-7)" "unprognostic (1.01e-1)" "unprognostic (1.06e-1)" "unprognostic (2.27e-1)" "unprognostic (3.66e-2)" 15.9 6.8 4.2 6.7 5.9 17.2 12.9 5.5 6.3 5.6 3.8 6.2 6.3 2.4 5.5 5.4 5.5 5.6 3.8 3.7 4.1 3.6 5.7 108.1 6.9 9.1 5.8 4.2 9.0 37.5 3.8 5.1 6.8 5.6 3.6 4.2 4.5 4.8 9.1 10.9 10.5 4.1 5.2 7.1 5.0 5.2 6.8 5.6 5.7 4.5 8.1 7.2 5.3 6.8 10.4 6.8 12.9 2.3 10.8 9.1 3.5 5.6 6.7 2.6 4.1 3.9 2.6 6.8 2.6 2.9 5.0 4.2 3.4 3.3 10.9 1.9 2.4 5.6 3.6 11.9 8.0 5.8 35.1 6.1 90.1 8.1 6.7 5.6 8.1 7.3 5.8 4.6 4.8 7.4 2.7 4.9 8.0 9.2 7.1 3.0 7.3 6.6 14.0 8.9 6.8 2.7 8.2 3.4 5.7 6.1 6.4 7.4 6.1 3.4 5.0 3.9 5.3 4.7 9.6 3.4 3.0 3.3 4.1 8.2 2.9 8.2 11.7 5.4 5.0 1.9 12.9 1.5 3.8 5.6 2.3 6.8 8.0 6.6 7.6 4.0 10.4 8.9 9.1 0.6 10.8 1.2 6.8 5.5 3.5 4.2 5.9 5.5 6.3 4.1 3.6 5.8 4.2 5.6 5.6 6.0 5.0 10.0 14.8 22.7 4.8 10.1 5.1 16.0 6.8 3.5 0.0 33.2 21.6 11.0 59.1 7.7 2.2 0.0 9.9 10.9 10.3 6.4 13.9 135.7 15.5 4.8 2.9 16.0 8.8 39.4 21.3 5.8 3.3 15.4 6.4 7.8 9.2 2.9 35.3 12.1 6.5 12.9 14.6 17.7 19.5 18.4 29.6 10.1 7.2 12.6 RCN1 "FLJ37041, PIG20, Rcal, RCN" ENSG00000049449 "Reticulocalbin 1" Q15293 11 32090904-32105755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 123.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 242.1;Muller glia cells: 309.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038474, HPA062104" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 2300000 "Endoplasmic reticulum" "HPA038474: AB_10672595, HPA062104: AB_2684683" "unprognostic (1.65e-1)" "unprognostic (7.69e-3)" "unprognostic (1.24e-1)" "unprognostic (2.03e-2)" "unprognostic (7.20e-3)" "unprognostic (1.70e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (7.13e-6)" "unprognostic (8.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.12e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (2.70e-13)" "unprognostic (1.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.14e-1)" "unprognostic (6.93e-3)" 25.0 19.8 9.6 14.3 38.8 1.6 38.2 7.6 11.4 22.3 13.6 5.8 17.0 10.8 23.3 123.1 12.2 18.2 15.3 19.4 9.2 9.8 12.4 33.7 17.9 20.2 7.0 5.9 35.2 16.4 17.9 34.9 32.6 9.7 22.6 12.6 11.4 37.0 24.2 12.8 9.1 10.5 19.2 10.9 11.5 11.8 11.4 6.9 5.4 16.8 10.0 6.9 25.3 32.3 4.3 11.0 0.5 11.8 7.5 12.4 6.5 13.4 14.5 33.6 22.4 82.6 63.0 38.7 46.2 56.4 32.6 58.9 12.7 17.2 0.0 32.0 75.3 40.8 16.6 12.1 13.7 49.1 6.5 26.4 2.9 10.5 4.6 61.1 2.1 4.4 87.7 17.1 20.6 23.3 36.9 71.4 6.2 1.7 2.4 37.3 11.1 6.1 4.1 14.4 0.1 16.4 4.7 42.1 3.9 27.8 31.3 9.0 4.7 12.3 2.9 35.4 24.6 17.7 8.5 37.2 42.3 24.1 36.6 39.1 0.1 0.1 0.1 58.7 2.7 23.9 0.2 10.0 0.3 12.4 11.8 9.7 4.3 5.7 9.9 11.0 3.5 4.2 8.0 0.5 7.5 7.2 6.4 2.0 6.5 9.6 38.8 7.6 11.4 9.2 9.8 7.0 5.9 9.7 6.9 50.6 33.3 14.5 59.0 37.0 39.4 8.5 35.7 38.8 54.6 45.4 11.8 140.9 6.6 116.4 132.8 75.8 7.0 0.0 39.7 242.1 157.4 112.2 12.7 53.4 41.2 14.3 51.0 85.3 14.3 130.4 74.5 21.1 30.4 70.3 54.8 309.5 40.2 24.6 68.6 12.6 14.1 25.8 71.0 10.7 6.4 24.7 181.5 9.2 62.9 78.0 RCN2 "E6BP, ERC-55, ERC55, TCBP49" ENSG00000117906 "Reticulocalbin 2" Q14257 15 76931619-76954392 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 147.5" "Cell type enhanced" "Detected in all" 4 "Spermatocytes: 314.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030694, HPA030695" Enhanced Supported Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 41000 "Endoplasmic reticulum" "HPA030694: AB_2673573, HPA030695: AB_2673574" "unprognostic (1.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (2.42e-1)" "unprognostic (8.71e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (1.74e-1)" "unprognostic (2.20e-2)" "unprognostic (4.61e-3)" "unprognostic (1.39e-1)" "unprognostic (1.98e-1)" "unprognostic (1.70e-2)" "unprognostic (2.11e-2)" "unprognostic (2.99e-1)" "unprognostic (1.15e-1)" "unprognostic (3.67e-2)" 13.8 14.7 29.9 12.1 32.6 9.9 16.8 25.1 37.5 16.8 15.0 17.3 28.1 10.4 20.6 147.5 14.9 25.0 15.3 17.3 29.5 41.5 22.6 9.3 13.5 12.5 27.2 29.5 18.8 11.0 28.4 17.8 27.7 24.6 19.6 17.2 15.5 12.0 21.9 22.7 10.6 11.0 18.2 18.5 12.4 13.8 48.2 14.8 14.8 22.1 17.0 14.3 17.8 13.3 15.9 12.0 9.8 7.2 14.1 19.0 11.5 20.2 14.4 64.4 30.3 27.9 31.8 40.3 24.2 33.1 31.6 26.5 17.8 17.5 12.7 35.2 26.3 34.1 31.2 48.6 20.9 40.5 9.7 38.0 6.3 21.1 29.4 33.3 22.6 9.7 28.7 28.9 15.5 20.0 33.5 33.3 21.9 15.8 12.7 32.9 13.0 22.4 15.6 49.0 21.4 16.1 23.7 42.4 8.1 20.8 27.4 36.8 36.8 39.6 22.2 46.1 59.9 21.6 25.2 17.8 37.4 30.2 23.7 49.7 18.3 56.3 15.1 21.3 19.1 33.8 4.5 4.8 9.8 14.8 4.4 17.2 14.8 15.7 19.0 10.2 15.9 17.8 17.2 2.6 14.1 7.2 12.0 10.9 11.5 29.9 32.6 25.1 37.5 29.5 41.5 27.2 29.5 24.6 14.8 23.8 40.4 56.2 99.4 72.9 83.3 92.8 50.9 25.4 19.4 94.2 35.3 163.6 41.4 99.8 42.5 52.4 14.8 23.3 39.4 255.8 92.7 76.9 28.8 26.7 49.5 120.8 70.6 55.9 24.2 59.2 57.2 29.6 87.7 34.3 51.1 85.4 53.2 35.1 88.1 44.0 51.5 58.2 72.1 314.9 144.1 61.9 136.8 66.0 76.6 95.7 RCOR2 ENSG00000167771 "REST corepressor 2" Q8IZ40 11 63911221-63916844 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.6" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021638 Uncertain Approved Nucleoplasm,Vesicles,Midbody Yes NA Nucleoplasm "Vesicles, Midbody" "HPA021638: AB_10960885" "unprognostic (1.96e-2)" "unprognostic (1.15e-1)" "unprognostic (4.10e-2)" "unprognostic (1.98e-3)" "unprognostic (3.10e-2)" "unprognostic (5.86e-2)" "unprognostic (2.33e-4)" "unprognostic (8.64e-2)" "unprognostic (1.46e-1)" "unprognostic (4.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-3)" "unprognostic (2.62e-1)" "unprognostic (1.75e-1)" "unprognostic (3.51e-1)" "unprognostic (9.93e-2)" "unprognostic (6.06e-3)" 0.8 1.4 3.3 0.7 8.0 0.3 0.7 9.3 16.6 3.0 1.4 3.4 0.0 2.0 3.5 2.6 1.2 3.7 1.6 5.9 4.0 2.6 0.7 0.4 1.0 0.3 2.4 3.8 5.2 1.4 3.2 5.0 1.8 1.8 1.7 1.7 3.3 2.3 1.7 3.1 0.6 1.6 2.5 2.2 0.5 1.2 7.0 2.5 4.1 0.6 0.6 0.3 2.5 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 18.1 1.2 0.3 1.5 5.4 0.1 0.3 0.2 0.6 0.7 0.1 0.1 0.2 0.4 0.3 0.2 7.9 0.0 0.2 0.2 1.0 0.2 0.1 5.8 3.0 0.0 0.1 1.8 0.0 0.3 0.0 0.0 0.1 2.4 0.9 0.0 0.0 1.6 1.6 6.4 23.4 2.3 0.0 5.8 1.0 0.5 0.0 0.0 36.7 24.4 0.1 1.6 0.9 4.6 1.3 2.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.0 9.3 11.0 4.0 2.6 2.4 3.8 1.8 2.5 0.0 0.0 0.0 0.0 0.0 15.7 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.7 0.5 0.0 0.0 0.0 0.2 3.2 1.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.9 0.3 0.0 0.4 0.0 2.1 0.0 0.2 0.7 2.6 0.3 0.7 0.0 1.1 0.0 RCSD1 "CapZIP, MGC21854, MK2S4" ENSG00000198771 "RCSD domain containing 1" Q6JBY9 1 167630093-167706249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3" "Cell type enhanced" "Detected in many" 9 "B-cells: 128.0;Kupffer cells: 116.2;monocytes: 64.1;Sertoli cells: 77.6;T-cells: 84.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 48.3;REH: 48.5;RPMI-8226: 33.1;THP-1: 25.5;U-266/70: 32.4;U-698: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016597, HPA073490" Enhanced Approved "Plasma membrane" NA NA 150000 "Plasma membrane" "HPA016597: AB_2669397, HPA073490: " "unprognostic (2.13e-2)" "unprognostic (7.38e-3)" "unprognostic (6.50e-3)" "unprognostic (1.37e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.97e-4)" "unprognostic (5.51e-2)" "unprognostic (8.90e-3)" "unprognostic (3.65e-1)" "unprognostic (8.48e-2)" "unprognostic (1.01e-1)" "unprognostic (6.33e-2)" "unprognostic (2.53e-3)" "unprognostic (3.19e-1)" "unprognostic (3.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.97e-2)" 8.5 2.9 3.5 33.3 4.8 19.2 7.3 1.2 3.1 3.0 8.4 3.6 1.3 3.6 2.7 5.4 4.1 3.1 8.8 18.4 3.9 3.6 4.2 3.7 9.0 45.6 5.1 2.2 2.5 1.5 0.8 2.0 7.0 3.1 3.7 5.0 3.1 6.5 2.5 52.3 2.3 20.1 7.4 6.9 40.6 4.9 3.7 3.4 70.8 4.8 12.7 29.2 7.4 4.5 51.0 22.1 56.4 38.2 26.6 27.8 26.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.3 0.0 0.0 0.0 8.3 0.9 0.1 0.0 0.1 0.0 0.0 0.0 19.7 15.5 14.2 6.5 0.0 15.3 11.9 0.4 0.0 0.0 48.5 0.2 33.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 25.5 0.1 0.0 0.1 0.0 0.0 32.4 9.6 31.8 0.0 15.8 0.0 48.4 38.2 56.4 15.2 25.1 18.3 45.6 19.8 18.9 22.1 51.0 17.2 15.9 38.5 26.6 24.1 12.8 27.8 26.3 3.5 4.8 1.2 3.1 3.9 3.6 5.1 2.2 3.1 3.4 3.0 10.7 128.0 1.2 1.0 0.6 40.7 0.0 0.0 5.7 1.8 0.0 0.4 0.0 0.1 0.4 17.9 0.0 0.0 0.0 0.2 3.1 0.7 12.8 1.7 37.5 0.0 0.0 27.0 116.2 1.5 0.9 47.2 5.0 64.1 0.0 0.0 0.1 0.0 0.4 0.3 0.7 77.6 21.5 0.0 0.1 1.5 1.0 84.1 0.0 0.3 RCVRN RCV1 ENSG00000109047 Recoverin P35243 17 9896320-9905621 "Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "retina: 208.6" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 447.7;Rod photoreceptor cells: 1089.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "WM-115: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015783, CAB022363" Enhanced NA NA "CAB022363: , HPA015783: AB_2669298" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-2)" "unprognostic (1.32e-1)" "unprognostic (7.95e-3)" "unprognostic (4.82e-2)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (1.94e-4)" "unprognostic (1.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.41e-2)" "unprognostic (9.23e-2)" 1.4 0.0 1.1 0.8 1.4 0.9 0.2 1.5 2.7 0.5 0.3 0.2 0.1 0.7 0.5 0.2 0.1 0.3 0.5 0.8 1.0 0.7 0.1 0.1 0.4 0.2 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.7 0.1 0.1 208.6 0.1 0.3 0.1 0.7 0.4 0.6 0.2 0.8 0.6 0.3 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 1.5 2.7 1.0 0.7 0.3 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 186.3 0.4 0.0 0.0 0.0 0.0 447.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 101.7 0.0 0.0 0.0 0.2 2.3 0.0 1.7 0.0 0.0 187.9 0.0 0.0 0.7 0.0 1089.5 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 RD3L "TDRD9-AS1, TDRD9AS1" ENSG00000227729 "Retinal degeneration 3-like" P0DJH9 14 103940426-103942308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "heart muscle: 32.6" "Group enriched" "Detected in some" 14 "Bipolar cells: 69.7;Cardiomyocytes: 39.9;Cone photoreceptor cells: 27.5;Horizontal cells: 25.4;Rod photoreceptor cells: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 1.1" "Region enhanced" "Detected in single" "olfactory region: 12.7" "Low region specificity" "Detected in all" HPA067971 Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA067971: AB_2685935" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.1 0.2 0.0 1.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.2 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.7 39.9 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RDH10 SDR16C4 ENSG00000121039 "Retinol dehydrogenase 10" Q8IZV5 8 73294612-73325281 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 134.3" "Group enriched" "Detected in many" 5 "Collecting duct cells: 193.7;Muller glia cells: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.4;T-cells: 2.3" "Cell line enhanced" "Detected in many" "ASC diff: 46.8;BJ: 33.5;CACO-2: 29.9;HDLM-2: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049199 Supported "Lipid droplets" NA NA "Lipid droplets" "HPA049199: AB_2680673" "unprognostic (1.78e-1)" "unprognostic (1.23e-1)" "unprognostic (8.86e-2)" "unprognostic (2.52e-1)" "unprognostic (2.45e-2)" "unprognostic (1.13e-2)" "unprognostic (1.14e-1)" "unprognostic (2.80e-2)" "unprognostic (7.87e-2)" "unprognostic (7.98e-2)" "unprognostic (1.18e-3)" "unprognostic (8.88e-3)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (1.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.23e-2)" 18.3 3.2 2.7 9.5 3.3 0.7 11.8 1.7 2.8 8.2 18.7 2.9 10.0 13.6 5.9 5.8 9.4 4.4 21.9 9.6 2.3 2.4 19.6 37.5 8.7 4.8 4.1 1.7 4.9 14.8 3.7 17.9 20.9 8.7 12.4 6.4 134.3 22.6 5.7 3.4 4.4 34.1 14.0 6.9 5.6 15.3 8.0 2.1 2.0 3.5 7.3 6.5 12.8 6.5 0.6 0.7 4.4 0.6 0.2 2.3 0.5 4.2 12.2 1.3 5.6 46.8 3.4 12.4 33.5 5.4 1.3 2.2 29.9 12.1 2.9 4.4 18.7 2.0 11.1 6.1 4.8 2.7 33.6 15.4 5.2 12.0 9.2 1.8 2.4 5.7 2.0 6.2 5.2 4.9 5.9 4.9 2.9 5.9 4.3 2.2 1.8 2.5 1.0 1.6 25.8 6.0 2.2 1.4 1.7 9.1 6.0 0.8 1.0 2.8 20.9 1.7 1.8 4.1 1.3 7.4 2.0 3.4 9.2 2.5 2.8 2.9 2.4 1.6 2.2 4.6 4.4 0.6 1.1 1.2 0.3 0.7 0.6 1.3 1.4 0.7 0.1 2.3 1.2 0.8 0.2 0.5 0.2 0.7 0.5 2.7 3.3 1.7 1.8 2.3 2.4 4.1 1.7 8.7 2.1 11.9 28.0 0.0 8.6 11.9 3.0 8.1 30.6 20.1 18.2 193.7 21.6 15.7 3.3 12.8 53.9 10.3 25.7 0.0 15.2 16.8 18.4 19.0 2.3 35.0 16.7 3.2 4.1 1.8 4.0 5.2 2.6 6.0 16.9 0.0 13.1 296.7 39.0 25.9 3.5 18.6 10.4 0.0 8.2 9.3 5.3 12.2 35.1 2.2 14.1 16.0 RDH11 "ARSDR1, MDT1, SDR7C1" ENSG00000072042 "Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)" Q8TC12 14 67676801-67695814 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Cataract, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 204.2" "Cell type enhanced" "Detected in all" 7 "Glandular cells: 335.2;Muller glia cells: 352.2" "Cancer enriched" "Detected in all" 13 "prostate cancer: 286.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046011 Enhanced "Intracellular and membrane" NA NA 9100000 "CAB046011: AB_11129613" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (1.77e-1)" "prognostic favorable (2.62e-4)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (9.29e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.58e-2)" "unprognostic (2.91e-2)" "unprognostic (1.27e-1)" "prognostic favorable (1.30e-7)" "unprognostic (1.65e-1)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (4.74e-2)" 8.8 24.9 18.3 8.9 19.0 5.1 10.8 15.7 25.3 13.0 10.8 24.3 16.1 12.3 13.0 31.4 13.6 9.3 15.6 7.2 18.5 19.9 40.7 51.6 12.6 7.2 21.8 16.6 11.4 15.3 28.7 13.1 8.3 31.1 204.2 12.0 40.4 16.2 13.5 3.6 11.2 10.2 15.8 32.5 10.8 11.6 10.3 15.8 12.5 24.2 8.1 9.5 14.8 11.4 11.5 17.0 62.4 19.7 14.4 20.8 28.2 47.8 21.8 19.4 22.0 31.0 28.2 16.2 18.2 36.1 22.9 41.6 18.1 58.3 8.3 14.1 17.1 28.6 38.4 27.9 40.2 31.3 16.7 11.3 17.2 11.6 17.9 29.9 6.3 12.6 26.3 26.7 29.8 25.3 17.5 26.1 23.1 13.4 27.5 20.8 25.4 18.5 9.9 10.9 13.0 25.1 14.1 24.0 11.9 52.4 24.7 20.2 16.9 19.2 24.3 25.4 16.5 27.2 10.0 20.1 24.7 28.2 10.5 13.0 13.0 10.3 10.8 32.1 17.7 20.0 62.4 19.7 28.2 18.7 16.1 20.4 11.3 20.5 18.5 14.5 11.5 20.8 20.1 3.3 14.4 16.9 17.0 17.6 28.2 18.3 19.0 15.7 25.3 18.5 19.9 21.8 16.6 31.1 15.8 23.8 57.7 45.5 30.5 10.2 50.0 15.5 73.9 22.7 28.4 45.4 47.1 23.0 6.6 75.7 1.9 38.4 22.6 46.7 73.5 33.5 32.0 335.2 28.8 124.8 32.2 74.7 41.6 54.0 39.8 5.1 40.0 33.9 33.7 38.7 21.8 352.2 48.1 34.5 52.6 56.8 94.6 45.3 30.9 19.1 14.3 16.8 53.1 30.8 15.7 29.3 RDH12 "FLJ30273, LCA13, RP53, SDR7C2" ENSG00000139988 "Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)" Q96NR8 14 67701886-67734452 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Oxidoreductase "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 29.3" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 371.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.7;K-562: 1.9;SK-MEL-30: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (4.25e-3)" "unprognostic (4.50e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (2.99e-1)" "unprognostic (1.99e-1)" "unprognostic (6.70e-2)" "unprognostic (2.13e-1)" "unprognostic (1.69e-2)" "unprognostic (2.72e-3)" "unprognostic (7.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.42e-2)" "unprognostic (6.47e-2)" "unprognostic (7.83e-2)" "unprognostic (3.58e-1)" "unprognostic (3.92e-1)" 0.0 1.9 0.0 0.0 0.5 0.0 1.2 0.3 0.5 4.9 0.0 0.0 0.0 5.3 9.9 0.1 10.6 0.0 0.1 0.3 7.7 1.9 0.0 0.0 1.3 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 29.3 0.0 0.0 0.0 0.0 6.9 0.0 0.4 0.6 0.0 9.7 0.2 0.6 0.0 0.9 0.5 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.3 1.5 0.0 2.7 0.7 0.2 0.6 0.0 0.0 0.6 0.4 0.0 0.9 0.1 0.0 0.2 0.0 1.0 0.1 0.2 0.0 0.7 0.2 1.9 0.7 0.1 0.7 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.0 0.3 1.2 0.0 0.0 1.0 2.3 0.1 0.7 0.1 0.0 0.3 1.3 0.4 0.0 1.6 0.7 0.0 0.4 0.1 0.0 0.0 0.6 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.0 0.0 0.0 0.2 4.1 37.5 0.0 20.4 0.0 0.0 1.8 137.4 0.0 0.0 0.7 0.1 0.1 0.0 0.0 1.6 0.0 0.9 0.4 0.0 4.2 0.2 19.1 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 29.8 1.0 0.2 0.0 6.5 371.5 0.0 0.1 0.0 0.0 33.8 0.0 0.0 0.0 0.3 RDH16 "RODH-4, SDR9C8" ENSG00000139547 "Retinol dehydrogenase 16 (all-trans)" O75452 12 56951431-56959374 "Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 59 "liver: 114.6" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 276.0" "Cancer enriched" "Detected in many" 20 "liver cancer: 44.0" "Cell type enhanced" "Detected in single" "gdT-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 3.4;hTCEpi: 7.7;OE19: 1.8" "Low region specificity" "Detected in single" HPA038518 Enhanced NA NA "HPA038518: AB_10672713" "unprognostic (5.42e-3)" "unprognostic (4.20e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" "prognostic favorable (2.16e-5)" "unprognostic (8.83e-3)" "unprognostic (1.04e-1)" "unprognostic (2.84e-1)" "unprognostic (6.85e-2)" "unprognostic (6.10e-1)" "unprognostic (7.99e-12)" "unprognostic (2.24e-1)" "unprognostic (1.29e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 114.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.8 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.1 0.0 7.7 0.0 0.8 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 0.2 0.0 1.8 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.3 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 4.5 1.0 0.0 2.2 2.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.3 0.1 0.0 23.3 0.3 0.0 0.1 4.2 0.0 276.0 0.2 1.6 0.0 3.1 5.1 4.1 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.4 0.3 0.0 0.0 0.0 0.4 RDH5 "HSD17B9, RDH1, SDR9C5" ENSG00000135437 "Retinol dehydrogenase 5" Q92781 12 55720367-55724705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sensory transduction, Steroid metabolism, Vision" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 39.4;retina: 127.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 68.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.0;ASC TERT1: 16.4;hTEC/SVTERT24-B: 9.9;hTERT-RPE1: 16.2;LHCN-M2: 9.9;U-87 MG: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063345 Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA063345: AB_2684992" "unprognostic (1.04e-2)" "unprognostic (6.45e-2)" "unprognostic (1.80e-1)" "unprognostic (2.67e-1)" "unprognostic (3.66e-2)" "unprognostic (1.48e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.35e-2)" "unprognostic (4.04e-2)" "unprognostic (4.05e-1)" "unprognostic (1.26e-3)" "unprognostic (7.63e-2)" "unprognostic (8.79e-2)" "unprognostic (3.46e-2)" "unprognostic (2.12e-3)" "unprognostic (3.27e-2)" 39.4 0.7 0.6 2.8 0.8 0.2 14.9 0.5 0.8 1.0 7.6 1.0 1.5 8.6 1.9 4.5 2.4 2.2 4.8 3.9 1.0 0.5 3.7 27.2 0.7 1.6 0.8 0.8 1.4 1.5 0.0 0.6 0.4 1.5 1.8 1.9 127.9 3.2 1.0 3.1 1.0 9.4 8.8 1.1 0.9 2.7 0.9 1.0 0.3 1.1 2.6 0.7 2.0 2.5 0.4 2.3 2.1 0.9 1.5 2.6 0.4 0.4 0.9 0.5 0.3 19.0 16.4 0.3 2.4 2.7 0.5 0.9 0.3 5.1 0.6 0.4 1.3 0.1 0.2 0.2 0.0 0.4 0.6 0.8 0.1 1.0 1.3 0.5 0.0 0.2 7.0 0.6 9.9 0.0 16.2 0.2 0.3 0.1 0.8 9.9 0.4 0.2 0.1 0.2 2.3 1.4 0.3 0.3 0.3 0.1 0.5 0.1 0.7 0.1 0.3 2.2 0.1 0.4 0.3 0.3 1.0 1.0 0.7 0.6 0.7 0.3 0.1 17.7 0.2 0.2 0.3 0.6 2.1 0.4 0.9 0.2 0.4 1.2 2.6 1.2 0.3 1.0 0.4 0.9 1.5 0.9 2.3 0.2 0.4 0.6 0.8 0.5 0.8 1.0 0.5 0.8 0.8 1.5 1.0 8.9 2.1 6.7 4.2 1.6 22.6 2.1 5.1 5.3 1.2 1.8 58.9 1.6 1.7 1.6 0.6 4.2 28.4 0.0 2.3 1.0 3.3 2.8 0.0 17.9 0.5 15.9 11.1 1.8 2.2 1.8 12.4 4.0 5.0 4.6 8.7 10.9 2.8 17.6 6.3 8.4 68.6 12.9 4.7 3.5 6.3 1.5 1.3 10.0 11.8 2.7 RDH8 "PRRDH, SDR28C2" ENSG00000080511 "Retinol dehydrogenase 8 (all-trans)" 19 10013249-10022279 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "retina: 29.4" "Cell type enhanced" "Detected in some" 28 "Bipolar cells: 33.9;Cone photoreceptor cells: 51.1;Early spermatids: 58.4;Rod photoreceptor cells: 203.6" "Group enriched" "Detected in some" 8 "melanoma: 2.2;stomach cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.9;SK-MEL-30: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA064473 Approved "Nucleoplasm,Midbody ring,Cytosol" NA NA Nucleoplasm "Midbody ring, Cytosol" "HPA064473: " "unprognostic (4.12e-1)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (9.98e-3)" "unprognostic (4.58e-3)" "unprognostic (2.66e-1)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (3.86e-1)" "unprognostic (2.63e-1)" 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.9 0.8 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.9 0.3 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.4 0.0 203.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;lymphoid tissue: 6.2;testis: 24.0" "Group enriched" "Detected in some" 16 "Early spermatids: 50.7;Late spermatids: 58.2;Spermatocytes: 19.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 5.7" "Group enriched" "Detected in many" 14 "NK-cells: 1.5;T-cells: 5.7" "Cell line enhanced" "Detected in many" "CACO-2: 10.2;JURKAT: 14.1;T-47d: 16.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: AB_2732769" "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.0 0.0 0.9 0.9 1.2 0.6 0.0 0.0 1.8 0.0 0.9 0.1 0.0 1.3 0.2 0.7 0.3 0.1 0.3 0.0 1.0 0.1 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.2 0.2 1.7 0.0 0.0 0.0 0.0 1.1 1.5 0.1 0.2 0.1 1.1 24.0 0.0 6.2 0.3 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 1.5 5.7 0.3 5.7 6.8 1.3 2.4 0.1 0.0 2.1 1.4 0.1 0.8 1.3 10.2 5.7 6.3 2.8 0.4 3.8 0.9 3.9 1.7 3.9 1.5 8.0 4.1 1.8 0.0 0.0 0.2 2.9 0.0 0.7 0.5 0.4 1.0 0.1 14.1 1.8 0.0 0.5 2.3 2.2 2.2 0.9 5.0 2.5 0.7 0.0 0.0 1.5 3.3 4.6 0.8 1.8 1.7 2.5 3.7 16.7 0.3 0.0 0.1 2.0 0.0 0.4 5.3 1.9 2.2 3.3 2.3 1.0 0.0 0.0 0.0 1.4 0.0 2.3 0.1 1.6 5.7 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.0 0.4 1.4 0.0 1.2 0.6 0.0 58.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.7 2.6 0.0 0.6 0.0 0.6 0.3 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296722 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 81.0" "Cell type enhanced" "Detected in all" 4 "Alveolar cells type 1: 449.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 77000000 "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 15.9 81.0 17.9 7.0 29.2 4.2 22.3 9.3 20.2 14.7 10.1 19.5 11.1 2.9 12.7 9.1 11.9 8.8 11.6 16.9 20.8 17.0 21.7 28.6 20.4 8.7 27.5 15.2 23.7 22.0 16.0 16.1 16.4 31.6 11.3 4.9 7.4 9.0 11.9 35.5 5.5 5.3 14.9 50.4 10.6 8.3 13.9 30.6 3.5 19.7 11.8 5.9 13.4 11.9 9.4 9.6 17.1 11.4 13.1 15.8 5.6 17.1 9.1 36.3 14.4 21.4 23.8 20.7 21.8 12.4 14.4 15.9 25.5 30.1 0.0 33.5 27.0 22.6 15.8 20.1 20.9 21.6 10.3 11.1 12.7 30.4 18.9 20.0 4.7 8.8 24.3 11.9 17.9 32.2 23.9 39.1 2.8 18.1 7.7 33.3 30.3 2.7 3.8 11.5 1.0 14.9 7.9 25.5 7.5 18.3 8.6 9.9 10.7 38.4 17.4 13.7 28.5 22.3 7.6 24.1 24.0 17.9 11.5 16.9 2.5 4.1 16.6 9.1 2.8 55.1 17.1 11.4 16.5 9.4 9.4 12.5 9.4 8.4 6.9 9.6 6.1 5.7 4.6 1.3 13.1 7.1 7.8 15.8 5.6 17.9 29.2 9.3 19.0 20.8 17.0 27.5 15.2 31.6 30.6 449.6 96.4 30.6 43.1 49.8 78.4 144.4 71.4 41.5 64.8 71.5 41.2 104.4 92.9 108.4 11.2 193.3 6.7 70.0 374.9 158.2 87.8 55.0 65.8 217.4 75.7 95.3 21.4 279.3 93.7 28.8 254.9 61.2 69.2 186.7 9.3 84.0 127.6 20.1 250.7 141.1 88.4 122.9 79.0 72.1 242.5 35.4 190.1 31.6 16.8 27.6 REC114 "C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677" ENSG00000183324 "REC114 meiotic recombination protein" Q7Z4M0 15 73443158-73560014 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 35.7" "Group enriched" "Detected in some" 6 "Early spermatids: 128.3;Spermatocytes: 118.3" "Cancer enriched" "Detected in single" 11 "testis cancer: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.6;U-266/84: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (4.58e-2)" "unprognostic (2.97e-1)" "unprognostic (8.06e-2)" "unprognostic (2.63e-2)" "unprognostic (2.48e-2)" "unprognostic (1.53e-7)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (1.98e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.2 1.7 0.2 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 4.4 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 1.1 1.7 0.3 0.1 0.1 0.3 0.2 0.2 0.3 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 118.3 20.8 0.0 0.0 0.0 0.0 0.0 REC8 "kleisin-alpha, REC8L1, Rec8p" ENSG00000100918 "REC8 meiotic recombination protein" O95072 14 24171853-24180257 "Plasma proteins, Predicted intracellular proteins" "Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 30.4" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 48.2;Early spermatids: 113.3;Late spermatids: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 6.7;HHSteC: 5.7;MOLT-4: 6.9;SH-SY5Y: 30.2;SuSa: 17.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031727, HPA031729" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA031727: AB_10602920, HPA031729: AB_10669915" "prognostic favorable (2.19e-4)" "unprognostic (2.57e-2)" "unprognostic (2.15e-2)" "unprognostic (1.77e-2)" "unprognostic (2.00e-1)" "unprognostic (5.10e-3)" "unprognostic (1.00e-1)" "unprognostic (1.21e-2)" "unprognostic (3.16e-1)" "unprognostic (1.31e-1)" "prognostic favorable (5.57e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.41e-7)" "unprognostic (8.98e-2)" "unprognostic (2.12e-1)" "unprognostic (1.88e-2)" "unprognostic (6.40e-3)" 2.8 4.6 3.1 2.9 4.6 8.2 1.5 20.3 6.1 3.0 2.7 5.2 9.9 2.0 3.3 3.0 1.5 17.4 30.4 1.6 3.8 3.8 6.3 1.7 3.6 4.0 3.8 5.4 2.2 1.7 0.9 21.4 1.0 10.8 3.2 0.9 8.0 2.1 10.3 1.3 1.4 2.2 3.7 5.1 4.2 8.5 13.3 3.4 22.3 2.0 0.0 4.4 1.7 1.7 2.1 6.2 10.7 6.3 3.3 6.9 1.3 0.0 0.1 6.7 0.0 0.2 0.3 0.3 0.3 0.3 0.6 0.5 0.0 0.7 0.1 0.0 0.0 0.4 0.3 0.2 0.0 0.4 0.6 0.1 0.2 0.3 0.0 5.7 0.1 0.9 3.1 0.3 0.2 0.0 2.6 1.2 0.2 0.0 0.9 0.0 0.1 6.9 1.1 2.1 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.1 30.2 0.0 0.0 0.2 17.5 0.1 0.2 0.2 0.0 0.1 0.2 0.0 1.1 0.3 0.1 0.0 0.1 0.1 2.6 0.1 10.7 6.1 1.2 6.9 2.1 2.2 3.3 3.8 1.6 1.0 3.1 0.1 3.3 6.3 6.2 3.5 1.3 3.1 4.6 20.3 6.1 3.8 3.8 3.8 5.4 10.8 3.4 11.9 13.3 7.0 4.4 1.6 15.5 1.7 22.9 48.2 13.6 26.2 0.0 1.1 5.0 2.2 113.3 4.1 3.5 0.0 2.4 2.8 2.4 1.0 3.5 2.5 2.0 6.4 4.6 4.3 5.9 57.2 4.4 5.6 1.7 1.0 2.3 23.8 3.6 0.0 2.8 23.3 1.6 0.0 1.4 1.9 37.5 1.8 0.3 8.7 1.7 1.8 RECQL4 RecQ4 ENSG00000160957 "RecQ like helicase 4" 8 144511288-144517845 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.0;lymphoid tissue: 18.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 7.1;Spermatocytes: 12.6;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 14 "B-cells: 1.9;monocytes: 1.0;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB017800, HPA025821" Supported Enhanced Nucleoplasm NA Yes Nucleoplasm "CAB017800: , HPA025821: AB_1856168" "unprognostic (5.92e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (9.17e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.12e-2)" "unprognostic (4.12e-2)" "unprognostic (7.53e-2)" "unprognostic (2.65e-2)" "unprognostic (4.26e-2)" "unprognostic (1.12e-3)" "unprognostic (8.82e-3)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" 2.0 1.6 2.6 12.3 5.6 21.0 2.8 11.5 3.7 1.8 4.3 1.5 1.6 5.6 2.5 4.9 9.4 1.5 1.9 1.9 2.3 1.7 1.6 1.9 1.6 5.9 1.5 2.2 1.9 3.5 0.3 2.4 2.7 2.2 7.7 1.5 1.4 5.4 0.9 2.1 9.4 4.8 1.1 1.7 4.7 3.0 18.1 1.8 18.9 2.5 5.3 8.0 1.6 1.8 1.9 0.1 0.0 1.0 0.0 1.6 0.2 10.4 18.7 8.7 18.4 0.5 0.9 15.3 10.6 1.9 7.9 6.6 18.4 15.5 7.1 7.1 1.7 4.6 12.7 5.8 4.5 2.2 12.5 22.0 25.7 32.0 13.7 0.1 6.5 21.5 1.1 0.6 8.8 1.8 1.1 2.2 14.6 25.5 9.3 2.7 32.4 23.7 17.7 6.1 8.7 22.4 24.9 6.9 11.9 2.1 11.3 17.3 10.4 14.4 12.1 3.7 2.5 14.7 14.4 2.9 12.8 38.7 15.3 19.5 5.2 5.4 12.1 7.3 20.2 12.8 0.0 0.1 0.0 1.1 1.0 0.0 1.9 0.5 1.1 0.1 0.0 0.9 1.6 0.0 0.0 0.0 0.1 0.0 0.2 2.6 5.6 11.5 3.7 2.3 1.7 1.5 2.2 2.2 1.8 0.0 0.0 2.2 0.4 1.3 2.5 1.6 2.5 0.0 0.0 0.0 3.9 1.2 0.0 0.4 3.1 0.0 0.4 0.0 0.4 7.1 0.8 0.5 0.0 0.6 3.0 0.0 0.0 0.0 0.3 6.2 1.1 0.6 0.0 0.0 1.4 0.2 0.3 0.0 1.4 0.3 1.6 0.0 0.4 12.6 21.1 0.9 1.3 0.0 3.1 0.4 REELD1 ENSG00000250673 "Reeler domain containing 1" 4 146214515-146230878 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 1.3;epididymis: 1.5;skin 1: 1.7" "Cell type enriched" "Detected in single" 17 "Ciliated cells: 2.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 87 "HDLM-2: 14.6" NA NA "unprognostic (6.26e-3)" "unprognostic (1.40e-1)" "unprognostic (3.81e-2)" "unprognostic (8.94e-2)" "unprognostic (3.77e-2)" "unprognostic (7.75e-2)" "unprognostic (7.88e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (1.04e-2)" "unprognostic (1.40e-1)" "unprognostic (3.55e-6)" "unprognostic (2.19e-2)" "unprognostic (3.14e-1)" "unprognostic (3.90e-1)" "unprognostic (3.13e-2)" 0.1 0.0 0.9 0.4 1.3 0.2 0.4 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.7 0.2 0.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.5 1.7 0.0 0.0 1.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 REEP1 "C2orf23, FLJ13110, SPG31, Yip2a" ENSG00000068615 "Receptor accessory protein 1" Q9H902 2 86213993-86338083 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 38.6" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 22.1;Ciliated cells: 21.4;Extravillous trophoblasts: 23.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 37.5;HAP1: 8.1;RPMI-8226: 8.4;SCLC-21H: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058061 Enhanced NA NA "HPA058061: AB_2683591" "unprognostic (1.94e-2)" "unprognostic (1.61e-3)" "unprognostic (2.03e-2)" "unprognostic (2.60e-1)" "unprognostic (2.29e-2)" "unprognostic (5.10e-2)" "unprognostic (6.63e-2)" "unprognostic (9.07e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (6.15e-2)" "unprognostic (2.35e-1)" "unprognostic (2.56e-2)" "unprognostic (6.77e-2)" "unprognostic (2.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.07e-3)" 3.4 6.3 10.1 2.0 16.1 0.5 5.1 6.8 29.4 2.4 19.2 2.5 2.2 4.4 9.8 3.9 6.1 8.3 3.8 9.9 9.0 20.4 2.3 1.5 2.8 0.9 13.9 10.2 1.1 9.1 10.0 7.7 2.5 21.1 6.3 5.1 4.9 1.0 12.6 16.0 1.5 4.5 19.5 4.1 1.9 4.8 38.6 3.0 0.0 1.2 1.8 1.0 10.2 3.4 0.4 0.5 0.2 0.0 0.0 0.6 0.7 0.0 0.0 1.2 1.6 0.0 0.0 37.5 0.0 0.0 2.5 0.3 1.3 0.0 0.0 1.7 0.0 1.9 2.7 8.1 0.0 2.2 0.0 4.4 0.0 2.9 0.2 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.0 0.0 3.6 8.4 0.2 0.1 17.7 1.7 1.8 0.9 0.1 0.8 2.8 0.5 0.0 0.0 1.3 0.7 3.3 4.0 2.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.0 0.5 0.0 0.7 10.1 16.1 6.8 19.7 9.0 20.4 13.9 10.2 21.1 3.0 8.9 0.3 0.5 0.2 1.8 10.8 22.1 2.5 21.4 4.5 0.0 2.0 1.1 1.7 3.7 12.3 3.2 0.0 0.0 5.2 23.2 0.8 1.8 0.0 0.0 0.7 3.2 4.6 17.8 1.5 10.4 2.3 0.9 1.7 1.0 0.0 13.0 4.6 0.0 3.2 4.2 15.1 19.4 12.2 5.0 2.2 1.0 5.5 0.0 0.4 0.3 REEP2 "C5orf19, SGC32445, SPG72, Yip2d" ENSG00000132563 "Receptor accessory protein 2" Q9BRK0 5 138439017-138446969 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 50.6;Cone photoreceptor cells: 66.8;Horizontal cells: 46.1;Rod photoreceptor cells: 59.8" "Cancer enriched" "Detected in many" 9 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Group enriched" "Detected in many" 21 "dendritic cells: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 41.9;SCLC-21H: 17.6;SH-SY5Y: 19.8;U-87 MG: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031813, HPA076571" Enhanced Approved Cytosol NA NA Cytosol "HPA031813: AB_2674054, HPA076571: " "prognostic favorable (7.83e-5)" "unprognostic (1.11e-2)" "unprognostic (3.97e-6)" "unprognostic (3.70e-3)" "prognostic unfavorable (6.65e-4)" "unprognostic (5.43e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-1)" "prognostic favorable (9.31e-4)" "unprognostic (5.93e-2)" "unprognostic (3.70e-3)" "unprognostic (9.78e-2)" "unprognostic (6.54e-3)" "unprognostic (7.54e-2)" "unprognostic (1.47e-3)" "unprognostic (6.19e-3)" "unprognostic (1.13e-3)" 5.2 10.9 27.2 3.4 27.2 1.2 2.0 37.0 58.9 3.0 4.4 5.9 0.4 2.8 3.7 2.6 5.6 2.8 3.6 10.5 29.3 32.1 1.6 1.0 1.5 1.4 27.9 19.6 3.5 2.9 2.8 13.9 1.6 25.8 6.1 3.3 7.9 2.1 9.9 15.6 2.0 3.1 13.6 9.7 1.2 2.2 4.5 6.3 0.0 1.4 0.5 1.5 4.1 1.1 0.0 1.0 0.0 0.0 0.0 3.2 0.3 0.2 3.1 12.0 41.9 1.8 4.7 0.0 3.6 1.7 4.9 5.7 2.2 0.4 0.0 0.6 4.4 0.1 0.2 11.4 2.3 3.8 1.2 10.1 0.0 0.8 5.4 4.4 0.0 0.0 1.5 0.1 2.8 0.2 8.9 1.0 11.7 0.0 3.0 1.6 1.8 1.0 0.7 7.4 0.0 0.1 4.0 1.1 0.0 0.9 0.0 17.6 19.8 1.2 0.0 3.0 3.2 1.1 0.4 0.1 2.8 2.9 2.7 6.7 7.8 4.9 0.3 15.8 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 3.2 0.3 27.2 27.2 37.0 35.6 29.3 32.1 27.9 19.6 25.8 6.3 0.0 0.0 0.0 0.8 0.6 50.6 8.7 0.0 0.0 0.0 1.8 66.8 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.1 46.1 4.6 0.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 16.1 0.1 0.0 2.5 0.2 59.8 0.0 3.4 0.4 3.0 0.4 0.0 0.0 0.0 0.1 REEP6 "C19orf32, DP1L1, FLJ25383, Yip2f" ENSG00000115255 "Receptor accessory protein 6" Q96HR9 19 1490747-1497927 "Disease related genes, Predicted membrane proteins" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 90.8;liver: 119.0;testis: 71.2" "Cell type enriched" "Detected in many" 5 "Late spermatids: 2546.7" "Cancer enhanced" "Detected in all" "liver cancer: 114.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 16.1;Hep G2: 15.4;K-562: 42.7;T-47d: 35.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA003895, HPA048015" Enhanced Supported "Endoplasmic reticulum" NA NA 26000 "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA048015: AB_2680233" "unprognostic (1.21e-1)" "unprognostic (1.56e-1)" "unprognostic (7.76e-2)" "unprognostic (1.63e-3)" "unprognostic (3.24e-1)" "unprognostic (2.43e-2)" "unprognostic (1.92e-1)" "unprognostic (6.85e-2)" "unprognostic (7.38e-2)" "unprognostic (4.56e-1)" "unprognostic (1.49e-1)" "unprognostic (1.93e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-1)" "unprognostic (8.08e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-2)" 2.4 20.1 4.1 0.7 5.9 0.6 3.9 3.1 6.0 1.4 41.7 2.8 4.4 60.2 1.0 5.7 2.7 1.4 7.6 0.9 4.5 1.9 6.1 119.0 0.6 0.7 2.6 2.1 1.7 10.1 0.5 2.2 0.7 2.1 4.9 0.7 27.4 5.6 11.8 0.7 1.7 90.8 1.1 1.6 0.6 1.3 71.2 1.1 0.3 1.6 1.1 2.1 3.2 1.2 1.0 4.2 0.1 4.8 5.8 7.1 2.3 2.0 2.5 0.8 10.5 1.6 0.5 11.7 0.5 0.1 0.5 0.5 16.1 6.6 1.1 3.7 0.3 0.7 2.1 2.7 0.1 0.2 0.5 1.1 6.1 0.3 15.4 1.2 0.4 2.0 1.3 1.1 0.0 0.3 0.9 0.3 1.4 42.7 1.5 0.1 8.1 0.5 1.3 3.9 5.9 5.7 1.6 0.3 2.7 3.0 0.9 0.2 5.8 2.8 4.1 1.7 0.4 35.7 1.6 0.9 0.8 1.7 2.5 0.4 5.1 1.4 0.1 3.6 2.6 2.3 0.0 1.5 0.0 7.1 1.7 3.8 0.1 2.1 1.5 2.5 1.0 2.8 3.2 0.1 5.8 4.8 4.2 2.0 2.3 4.1 5.9 3.1 6.0 4.5 1.9 2.6 2.1 2.1 1.1 3.0 2.7 3.4 6.8 6.1 23.2 1.6 86.6 5.3 6.8 5.2 31.4 55.0 6.6 28.9 512.6 2.8 17.0 0.0 61.1 7.5 2.5 15.7 10.3 229.1 8.2 22.3 5.8 4.3 5.7 2546.7 31.7 4.3 28.7 1.8 10.4 27.6 24.6 6.0 15.6 36.0 217.9 19.4 2.6 24.2 30.4 5.8 30.1 5.1 11.0 11.2 REG1A "PSP, PSPS, PSPS1, PTP, REG" ENSG00000115386 "Regenerating family member 1 alpha" P05451 2 79120362-79123419 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "pancreas: 1772.6" "Group enriched" "Detected in some" 77 "Exocrine glandular cells: 99849.5;Pancreatic endocrine cells: 36721.8" "Group enriched" "Detected in many" 10 "colorectal cancer: 313.8;pancreatic cancer: 1268.4;stomach cancer: 521.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.9;EFO-21: 11.9;HDLM-2: 9.4;NB-4: 6.8;OE19: 6.6;RPMI-8226: 19.2;SH-SY5Y: 8.3;U-2 OS: 19.2;U-251 MG: 6.4;U-266/84: 6.4" "CAB025138, HPA045549, HPA045579" Enhanced "Secreted to digestive system" NA NA 61000000 "CAB025138: , HPA045549: AB_2679365, HPA045579: AB_2679374" "unprognostic (1.89e-1)" "unprognostic (2.91e-2)" "unprognostic (3.39e-1)" "unprognostic (1.45e-1)" "unprognostic (2.10e-1)" "unprognostic (1.63e-1)" "unprognostic (5.52e-2)" "unprognostic (3.54e-3)" "unprognostic (5.53e-2)" "unprognostic (5.54e-2)" 0.3 0.1 0.3 2.8 0.4 0.0 0.3 0.3 0.3 0.3 37.9 0.3 0.3 129.0 0.3 0.3 0.3 0.1 1.3 0.3 0.3 0.0 14.6 0.3 0.3 0.3 0.3 0.3 0.3 1772.6 0.0 0.3 0.3 0.3 0.3 4.5 0.3 0.3 0.4 0.3 0.1 74.7 2.5 0.3 0.3 15.9 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.3 6.6 0.0 0.0 0.0 19.2 0.0 0.0 0.9 8.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.2 1.3 6.4 0.0 6.4 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.7 590.9 0.1 0.0 50.9 0.0 99849.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 885.5 47.9 0.0 36721.8 17.3 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 REG1B "PSPS2, REGH, REGI-BETA, REGL" ENSG00000172023 "Regenerating family member 1 beta" P48304 2 79085030-79088019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "pancreas: 969.2" "Group enriched" "Detected in some" 70 "Exocrine glandular cells: 30392.9;Pancreatic endocrine cells: 13036.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 201.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 7.4;HDLM-2: 4.6;RPMI-8226: 3.3;U-2 OS: 17.4;U-251 MG: 4.3;U-266/84: 3.9" "HPA045549, HPA045579" Supported "Secreted to digestive system" NA NA 37000000 "HPA045549: AB_2679365, HPA045579: AB_2679374" "unprognostic (4.08e-1)" "unprognostic (1.09e-1)" "unprognostic (3.51e-3)" "unprognostic (9.20e-2)" 0.5 0.1 0.3 3.7 0.4 0.7 0.3 0.3 0.3 0.3 14.3 0.3 0.3 88.2 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.1 0.5 0.3 0.3 0.3 0.3 0.3 0.3 969.2 0.0 0.3 0.3 0.3 0.3 13.2 0.3 0.3 0.3 0.3 1.6 56.3 13.0 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.1 4.3 0.0 3.9 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 7.4 0.0 30392.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 311.0 16.1 0.0 13036.6 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 REG3A "HIP, PAP, PAP1, PBCGF, REG-III, REG3" ENSG00000172016 "Regenerating family member 3 alpha" Q06141 2 79157003-79159753 "Plasma proteins, Predicted secreted proteins, Transporters" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "intestine: 354.2;pancreas: 502.4" "Cell type enriched" "Detected in some" 5 "Pancreatic endocrine cells: 8841.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 710.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2" "HPA047894, HPA048334, HPA060705" Supported Approved Cytosol "Secreted to digestive system" NA NA 22000000 Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (2.43e-2)" "unprognostic (2.12e-1)" "unprognostic (3.62e-2)" "unprognostic (1.42e-1)" 0.2 0.4 0.2 0.4 0.2 0.0 0.2 0.2 0.2 0.2 73.1 0.2 0.2 276.3 0.2 0.2 0.2 0.0 1.1 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 502.4 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 354.2 0.2 0.2 0.2 6.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.1 0.2 0.0 0.0 0.0 15.7 0.0 0.0 1.2 10.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.4 3.8 7.2 0.0 10.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.8 4.3 0.0 5.2 0.0 1666.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 97.4 19.1 0.0 8841.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 REG3G "LPPM429, PAP1B, UNQ429" ENSG00000143954 "Regenerating family member 3 gamma" Q6UW15 2 79025686-79028505 "Predicted secreted proteins" "Acute phase, Inflammatory response" Antimicrobial "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pancreas: 262.6" "Group enriched" "Detected in some" 25 "Exocrine glandular cells: 161.0;Pancreatic endocrine cells: 87.4" "Cancer enriched" "Detected in many" 13 "pancreatic cancer: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.0;RPMI-8226: 1.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3" "HPA047894, HPA048334, HPA060705" Uncertain Approved Cytosol "Secreted to digestive system" NA NA Cytosol "HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (1.29e-1)" "unprognostic (8.82e-2)" "unprognostic (7.20e-3)" "unprognostic (5.64e-2)" 0.1 3.9 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.8 0.6 0.1 61.1 0.1 0.0 0.1 0.1 0.1 0.0 7.1 0.1 0.1 0.1 0.1 0.1 0.1 262.6 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 2.8 0.3 0.1 0.1 0.0 19.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 1.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 161.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.6 0.0 0.0 1.0 0.0 0.0 87.4 0.0 0.7 2.4 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 REG4 "GISP, REG-IV, RELP" ENSG00000134193 "Regenerating family member 4" Q9BYZ8 1 119794018-119811660 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 55.1;intestine: 121.9" "Group enriched" "Detected in some" 14 "Intestinal endocrine cells: 425.3;Mucus-secreting cells: 633.6" "Group enriched" "Detected in many" 21 "colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 18.1" "Lineage enriched" "Detected in single" 115 "T-cells: 18.1" "Cell line enriched" "Detected in some" 58 "OE19: 350.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB025867, HPA046555" Enhanced "Secreted to digestive system" NA NA 400000 "CAB025867: , HPA046555: AB_2679696" "unprognostic (3.22e-2)" "unprognostic (2.57e-1)" "unprognostic (2.86e-3)" "unprognostic (2.57e-1)" "unprognostic (6.52e-2)" "unprognostic (6.20e-3)" "unprognostic (1.11e-1)" "unprognostic (1.64e-2)" "unprognostic (7.10e-2)" "unprognostic (7.85e-2)" "unprognostic (2.99e-1)" "unprognostic (5.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-3)" 0.2 0.1 0.2 4.2 0.2 0.0 0.2 0.2 0.2 0.2 55.5 0.3 0.2 36.3 0.2 0.2 1.2 0.1 55.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 23.8 0.0 0.2 0.2 0.2 0.6 43.1 0.2 0.6 0.2 0.2 0.1 121.9 0.8 0.2 0.2 2.2 0.7 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 18.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 350.7 6.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.8 18.1 0.1 0.0 0.0 0.0 0.0 2.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 38.0 0.0 0.9 0.0 0.0 4.9 0.0 0.0 0.0 0.0 425.3 0.0 0.0 18.8 0.6 0.0 0.0 0.0 633.6 0.0 2.0 28.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 21.8 0.1 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641077 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 27.6" "Cell type enhanced" "Detected in many" 16 "Horizontal cells: 62.0;Spermatocytes: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 18.3;JURKAT: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles NA NA Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 2.0 4.5 6.9 2.4 12.3 2.2 2.3 12.5 27.6 1.4 2.3 2.3 0.0 2.5 1.3 1.8 2.7 1.2 2.4 1.6 10.8 14.5 3.3 1.8 2.7 4.7 17.8 8.4 1.1 2.2 27.6 9.4 7.4 24.9 2.2 2.1 1.7 3.7 1.8 1.0 4.2 1.8 2.2 3.8 5.4 2.3 4.6 2.5 4.6 2.8 1.7 5.0 2.9 0.9 2.5 7.8 1.2 3.5 0.1 5.4 1.9 0.8 2.8 2.8 5.2 2.2 0.7 1.3 2.3 4.4 7.7 11.5 10.3 1.0 0.1 1.1 3.5 16.3 4.2 2.5 10.0 2.0 2.5 1.6 6.3 6.0 5.1 3.6 2.0 18.3 1.4 6.3 7.1 5.2 1.6 2.1 20.3 2.2 3.3 1.7 1.3 3.7 0.7 3.2 3.7 1.4 0.2 0.6 4.3 2.4 2.5 4.6 5.0 2.1 10.1 1.7 0.4 3.5 4.7 1.8 5.9 2.6 4.7 4.0 1.9 5.2 14.8 3.2 8.8 3.7 0.0 1.4 0.0 3.0 3.5 1.1 2.5 3.2 3.0 2.3 1.5 2.9 1.6 1.2 0.1 2.5 7.8 5.4 1.9 6.9 12.3 12.5 27.6 10.8 14.5 17.8 8.4 24.9 2.5 0.0 1.1 1.4 1.1 4.0 4.8 0.2 2.5 0.0 0.0 1.8 11.8 0.2 1.7 2.5 1.3 2.2 2.6 0.0 2.3 3.3 1.0 3.0 0.0 0.2 3.7 62.0 1.2 0.6 4.9 2.7 0.6 2.8 6.8 0.0 1.5 6.4 1.9 3.5 1.4 4.7 7.0 0.0 1.4 18.6 6.0 3.8 5.1 5.9 0.6 1.8 RELN "PRO1598, RL" ENSG00000189056 Reelin P78509 7 103471784-103989516 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Developmental protein, Hydrolase, Protease, Serine protease" "Disease mutation, Epilepsy, Lissencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 73.4;liver: 35.8" "Cell type enriched" "Detected in some" 15 "Ito cells: 182.3" "Cancer enhanced" "Detected in many" "liver cancer: 5.7" "Region enriched" "Detected in many" 11 "cerebellum: 73.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 34.4;PC-3: 7.0;SCLC-21H: 8.4;SH-SY5Y: 9.1;TIME: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077891 Approved "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 59000000 "Golgi apparatus" Vesicles "HPA077891: " "unprognostic (1.42e-1)" "unprognostic (2.93e-3)" "unprognostic (4.31e-2)" "unprognostic (1.29e-4)" "unprognostic (1.30e-1)" "unprognostic (6.95e-2)" "unprognostic (1.85e-1)" "unprognostic (8.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-2)" "unprognostic (3.31e-3)" "unprognostic (3.86e-1)" "unprognostic (2.02e-2)" "unprognostic (1.43e-2)" "unprognostic (3.03e-1)" "unprognostic (1.35e-1)" "unprognostic (3.06e-2)" 2.7 5.9 5.7 1.2 5.3 0.5 6.3 73.4 6.7 2.9 2.1 0.8 0.0 1.1 1.0 3.0 1.7 4.4 1.9 3.2 5.7 5.3 1.2 35.8 1.6 7.9 1.8 2.5 1.3 1.0 0.3 0.8 0.4 5.1 1.2 2.1 10.6 1.1 2.1 0.4 1.1 1.9 2.4 3.2 1.1 0.8 1.5 0.0 0.0 2.6 1.7 0.9 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.3 0.0 0.1 0.0 0.0 2.4 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 1.4 0.0 0.0 0.0 8.4 9.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 5.3 73.4 6.7 5.7 5.3 1.8 2.5 5.1 0.0 0.0 0.0 0.0 0.0 0.6 11.3 3.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.3 2.6 0.0 0.0 1.0 0.1 2.4 0.3 0.0 2.4 0.2 0.0 0.0 182.3 9.4 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.1 0.5 0.2 0.0 0.0 0.0 RELT "FLJ14993, TNFRSF19L" ENSG00000054967 "RELT, TNF receptor" Q969Z4 11 73376264-73397474 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Receptor "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 92.2" "Cell type enhanced" "Detected in many" 5 "Macrophages: 37.2;monocytes: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062824, HPA071518" Supported Nucleoplasm NA NA Nucleoplasm "HPA062824: AB_2684875, HPA071518: AB_2686408" "unprognostic (3.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.25e-1)" "unprognostic (1.67e-2)" "unprognostic (1.80e-3)" "unprognostic (9.92e-3)" "unprognostic (1.67e-3)" "unprognostic (1.17e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-1)" "unprognostic (8.42e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (4.07e-11)" "unprognostic (1.64e-1)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (1.69e-1)" 3.5 2.2 3.5 11.7 8.8 92.2 2.8 3.5 5.7 1.4 2.1 7.4 0.0 2.7 1.9 2.5 3.2 1.6 4.1 5.3 4.0 5.2 2.0 2.0 8.4 18.2 8.3 3.9 1.5 1.6 1.8 3.1 4.1 13.9 1.7 2.0 2.3 4.6 1.3 22.1 2.5 5.6 2.8 14.3 18.1 2.5 3.0 4.6 4.8 1.8 3.9 9.0 3.3 2.1 4.7 6.8 12.1 19.2 0.3 1.1 3.1 5.7 5.8 4.5 4.5 0.5 0.7 5.1 6.4 4.0 7.4 4.5 5.5 2.5 10.6 21.0 4.1 5.9 8.5 2.8 3.1 2.7 6.4 5.4 10.0 7.2 2.0 1.3 9.9 17.6 0.7 1.3 7.8 2.0 1.7 2.6 5.3 7.5 14.1 2.0 5.4 7.1 10.3 4.1 4.5 7.2 14.1 7.9 9.2 1.5 2.5 6.0 5.7 5.4 4.9 6.6 1.1 2.7 8.6 3.6 9.3 6.6 15.4 11.3 4.9 3.9 11.6 5.7 9.8 9.8 0.4 7.0 12.1 0.5 14.3 1.1 4.7 0.6 1.0 6.8 3.7 0.8 0.4 11.6 0.3 19.2 6.8 0.2 3.1 3.5 8.8 3.5 5.7 4.0 5.2 8.3 3.9 13.9 4.6 6.0 2.1 15.9 11.9 23.6 1.9 2.2 0.0 1.4 3.4 0.0 11.8 1.4 0.0 3.5 0.7 2.3 2.1 0.0 0.7 9.4 6.6 7.8 25.3 0.0 20.4 28.6 3.4 0.6 23.5 1.0 0.0 37.2 5.0 30.7 0.6 10.0 4.1 0.6 0.0 0.4 2.0 6.5 7.8 2.7 7.5 15.9 17.6 7.5 1.3 14.8 REM1 "GES, REM" ENSG00000088320 "RRAD and GEM like GTPase 1" O75628 20 31475293-31484905 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.7" "Cell type enhanced" "Detected in some" 27 "Peritubular cells: 11.0;Sertoli cells: 58.2;Smooth muscle cells: 21.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "WM-115: 22.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebellum: 4.4" HPA049821 Approved NA NA "HPA049821: AB_2680898" "unprognostic (6.16e-2)" "unprognostic (3.17e-3)" "unprognostic (2.62e-1)" "unprognostic (9.65e-2)" "unprognostic (6.03e-3)" "unprognostic (1.84e-2)" "unprognostic (4.39e-1)" "unprognostic (2.15e-1)" "unprognostic (2.48e-1)" "unprognostic (3.88e-2)" "unprognostic (4.77e-3)" "unprognostic (8.03e-2)" "prognostic unfavorable (1.84e-6)" "unprognostic (7.79e-2)" "unprognostic (4.88e-2)" "unprognostic (1.57e-1)" "unprognostic (3.06e-2)" 11.6 2.8 0.7 6.0 1.5 0.0 11.8 0.3 2.1 28.7 5.3 1.9 3.6 2.0 23.7 16.4 6.3 10.4 8.5 5.7 0.7 0.6 2.6 1.0 5.5 5.6 1.0 0.7 13.2 2.3 1.5 2.6 3.3 2.1 6.7 1.6 3.5 3.1 15.6 13.7 2.7 3.2 4.8 0.6 2.3 2.4 5.3 0.0 0.5 4.4 4.7 5.1 5.2 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.3 2.1 0.7 0.6 1.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 5.2 0.0 3.3 1.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 58.2 21.5 0.0 0.2 0.6 0.0 0.0 0.0 0.0 REM2 FLJ38964 ENSG00000139890 "RRAD and GEM like GTPase 2" Q8IYK8 14 22883165-22887686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.4;brain: 23.9" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 11.9;Early spermatids: 28.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 8 "basal ganglia: 23.9" "Cell type enriched" "Detected in some" 4 "neutrophil: 7.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 7.5" "Cell line enhanced" "Detected in some" "AF22: 7.4" "Region enhanced" "Detected in many" "basal ganglia: 40.1" "Low region specificity" "Detected in all" NA NA "unprognostic (4.56e-3)" "unprognostic (1.89e-2)" "unprognostic (1.47e-1)" "unprognostic (3.95e-1)" "unprognostic (1.49e-1)" "unprognostic (9.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.66e-3)" "unprognostic (1.49e-5)" "unprognostic (9.40e-2)" "unprognostic (4.63e-5)" "unprognostic (3.56e-1)" "unprognostic (2.72e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" 0.6 1.0 0.4 1.6 23.9 15.4 0.6 2.7 2.5 0.5 0.7 0.9 0.4 0.7 0.9 0.9 0.4 2.4 0.7 0.4 1.2 1.5 0.7 0.4 1.6 1.6 0.4 1.1 1.3 1.0 5.7 5.4 0.4 1.5 1.0 0.4 0.4 1.0 0.7 0.7 1.5 1.4 0.6 0.9 5.2 1.0 3.8 2.9 0.6 0.7 0.4 1.0 0.6 0.4 1.7 0.4 7.5 0.7 0.0 1.0 0.2 1.7 0.9 7.4 0.3 0.7 1.1 1.1 0.1 0.5 0.1 0.6 0.8 2.4 0.6 0.3 0.1 0.3 3.1 0.2 0.2 0.6 1.1 1.7 0.3 2.9 0.0 0.6 0.3 0.5 0.4 0.2 0.2 0.1 0.3 0.3 0.5 0.2 3.1 0.4 2.4 0.0 0.7 0.4 0.8 1.4 0.1 0.2 0.7 0.3 0.2 0.9 3.5 0.6 1.1 1.2 0.4 1.3 0.6 0.0 0.0 1.6 0.1 0.2 2.9 1.2 1.8 0.3 0.1 0.0 0.4 0.0 0.8 0.2 0.0 0.7 1.1 0.5 0.6 0.0 1.7 1.0 1.0 7.5 0.0 0.7 0.4 0.4 0.2 0.4 23.9 2.7 2.5 1.2 1.5 0.4 1.1 1.5 2.9 11.9 3.7 0.9 0.7 2.5 0.0 1.2 0.0 2.7 2.3 1.8 0.0 0.4 0.0 0.4 28.0 0.0 0.4 0.0 0.0 0.3 0.8 1.1 0.0 0.0 0.3 0.0 6.3 0.6 1.2 4.7 1.1 0.0 3.3 1.8 1.7 0.7 0.3 0.0 1.1 0.3 0.6 0.0 1.0 0.7 0.9 2.6 0.3 0.5 1.2 0.7 REN ENSG00000143839 Renin P00797 1 204154819-204190324 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Aspartyl protease, Hydrolase, Protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 63.6" "Group enriched" "Detected in some" 5 "Early spermatids: 6.1;Late spermatids: 19.3" "Cancer enriched" "Detected in many" 8 "renal cancer: 39.4" "Region enriched" "Detected in single" 12 "basal ganglia: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.4;BJ: 4.9;HMC-1: 6.5;RT4: 1.8;SK-BR-3: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA005131 Approved "Secreted to blood" NA NA 692000 "HPA005131: AB_1079174" "unprognostic (4.45e-2)" "unprognostic (3.35e-1)" "unprognostic (1.62e-1)" "unprognostic (8.58e-2)" "unprognostic (2.89e-1)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (1.13e-1)" "unprognostic (7.20e-3)" "unprognostic (1.37e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (6.45e-5)" "unprognostic (1.22e-1)" "unprognostic (1.70e-1)" "unprognostic (4.98e-2)" "unprognostic (6.49e-2)" 0.4 0.3 0.0 0.0 1.2 0.0 0.5 0.0 0.0 3.1 0.2 0.0 0.8 0.1 4.4 13.5 0.1 0.3 0.0 0.6 0.0 0.0 63.6 0.4 0.3 0.0 0.0 0.0 11.6 0.0 0.0 0.4 14.4 0.0 0.3 0.1 0.4 0.3 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 2.0 0.0 0.0 1.1 0.0 0.2 4.4 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 4.9 1.0 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 6.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 4.6 0.2 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 1.2 6.1 0.0 0.0 0.0 1.0 0.2 0.1 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.4 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.9 0.0 0.0 2.7 RENBP "RBP, RNBP" ENSG00000102032 "Renin binding protein" P51606 X 153935263-153944691 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 32.7;lymphoid tissue: 36.5" "Cell type enhanced" "Detected in many" 10 "granulocytes: 128.8;Hofbauer cells: 156.0;Ito cells: 72.4;Proximal tubular cells: 157.3" "Cancer enhanced" "Detected in all" "melanoma: 57.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 13.2;HMC-1: 44.8;SK-MEL-30: 29.7;U-266/84: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000428, HPA000522" Enhanced NA NA 42000 "HPA000428: AB_1079799, HPA000522: AB_1079798" "unprognostic (3.08e-1)" "prognostic favorable (3.95e-4)" "unprognostic (1.12e-2)" "unprognostic (3.29e-1)" "unprognostic (8.83e-3)" "unprognostic (1.85e-1)" "unprognostic (5.22e-2)" "unprognostic (1.02e-2)" "unprognostic (2.18e-2)" "unprognostic (1.15e-1)" "unprognostic (6.47e-3)" "unprognostic (1.99e-1)" "prognostic favorable (3.08e-5)" "unprognostic (2.39e-2)" "unprognostic (6.57e-2)" "unprognostic (4.25e-2)" "unprognostic (8.51e-2)" 12.7 11.1 7.8 11.2 16.8 8.6 8.4 2.3 11.5 4.2 6.2 11.3 1.1 7.4 2.1 6.0 3.0 2.5 5.7 8.7 9.4 9.1 32.7 4.6 12.8 12.1 16.9 7.4 1.2 1.6 1.8 3.4 8.1 11.6 3.6 3.0 9.6 3.4 2.0 1.4 5.2 7.5 4.5 12.7 36.5 4.4 1.4 13.5 3.0 2.9 1.1 4.4 5.7 2.9 1.1 0.6 5.3 3.1 0.3 0.9 0.7 0.0 0.0 1.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.5 10.0 0.0 0.9 7.7 0.0 44.8 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.8 3.5 0.0 0.2 2.0 0.1 0.1 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 29.7 1.1 0.0 3.5 0.4 0.0 0.3 0.0 0.0 4.5 25.7 1.8 0.9 4.7 3.5 2.9 2.0 5.3 0.3 1.4 0.3 1.1 0.1 0.1 0.2 0.6 0.9 0.4 4.5 0.3 3.1 0.6 0.0 0.7 7.8 16.8 2.3 11.5 9.4 9.1 16.9 7.4 11.6 13.5 0.0 2.1 9.7 1.1 4.1 1.6 0.8 5.1 0.0 0.0 8.7 0.0 1.0 31.5 1.0 0.0 4.3 1.3 0.0 0.3 4.4 2.3 1.3 128.8 0.8 156.0 14.3 1.7 72.4 62.0 0.0 0.3 37.4 27.0 35.1 0.5 12.6 0.5 0.9 0.4 157.3 0.7 12.9 3.9 0.0 1.2 1.8 2.4 7.9 0.5 0.4 REP15 RAB15EP ENSG00000174236 "RAB15 effector protein" Q6BDI9 12 27696519-27697596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 27.2;stomach 1: 35.4" "Cell type enriched" "Detected in many" 47 "Mucus-secreting cells: 406.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SuSa: 15.6" "Low region specificity" "Detected in many" "HPA040448, HPA059868" Approved NA NA "HPA040448: AB_10964206, HPA059868: AB_2684148" "unprognostic (4.13e-2)" "unprognostic (4.32e-3)" "prognostic favorable (9.43e-5)" "unprognostic (7.29e-2)" "unprognostic (7.42e-5)" "unprognostic (4.63e-2)" "unprognostic (2.31e-1)" "unprognostic (1.87e-3)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (5.13e-3)" "unprognostic (3.00e-1)" "unprognostic (5.30e-2)" "unprognostic (3.52e-1)" "unprognostic (2.76e-1)" "unprognostic (5.27e-5)" "unprognostic (1.77e-1)" 0.8 0.6 0.6 4.2 0.6 0.0 0.6 0.6 0.6 0.6 16.2 0.6 0.6 6.0 0.6 0.6 0.6 0.3 3.5 2.2 0.7 0.2 0.8 1.3 1.0 0.6 0.6 0.6 1.6 0.6 0.0 0.7 0.6 0.6 1.1 27.2 0.6 0.6 0.6 0.6 0.3 26.1 0.6 0.6 1.4 35.4 0.7 0.6 0.6 1.0 0.6 0.6 0.6 0.6 0.3 0.0 0.0 0.2 0.0 0.3 0.2 0.6 1.2 1.1 2.3 2.2 3.5 2.0 3.6 1.7 1.5 1.3 4.8 0.9 0.6 1.1 4.5 1.6 1.3 1.2 2.2 3.8 1.6 0.9 1.4 1.5 1.3 0.4 0.5 0.8 1.7 2.3 4.4 1.2 2.1 4.7 0.5 0.6 0.2 6.7 0.6 2.3 0.3 3.4 0.8 3.2 0.3 2.3 4.7 4.1 0.6 0.1 0.3 1.1 0.6 1.7 15.6 0.2 0.8 4.3 8.2 3.7 0.9 3.1 0.0 0.0 0.0 6.0 0.7 8.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.6 0.6 0.6 0.7 0.2 0.6 0.6 0.6 0.6 3.0 0.3 0.0 1.9 1.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 2.9 7.3 0.0 0.4 0.6 1.1 1.0 0.0 0.5 0.1 0.0 8.7 7.4 0.8 0.0 0.3 0.0 1.7 0.0 406.8 0.0 0.4 7.0 0.7 1.0 0.0 0.0 0.5 0.0 0.2 0.3 1.1 0.0 8.0 2.2 RERG MGC15754 ENSG00000134533 "RAS like estrogen regulated growth inhibitor" Q96A58 12 15107783-15348675 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 73.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 90.5;Smooth muscle cells: 84.3" "Cancer enhanced" "Detected in all" "breast cancer: 19.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "myeloid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AN3-CA: 8.2;BEWO: 18.8;T-47d: 36.0;U-2 OS: 12.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041387 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA041387: AB_10796669" "unprognostic (5.33e-2)" "unprognostic (1.05e-1)" "unprognostic (7.72e-2)" "prognostic unfavorable (7.56e-4)" "unprognostic (8.72e-2)" "unprognostic (9.42e-3)" "unprognostic (2.47e-1)" "unprognostic (2.38e-2)" "unprognostic (1.85e-3)" "unprognostic (2.76e-2)" "unprognostic (5.07e-2)" "unprognostic (2.69e-1)" "unprognostic (7.16e-3)" "unprognostic (2.61e-3)" "unprognostic (3.30e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" 12.6 21.9 3.5 8.2 23.9 0.2 22.8 0.8 9.3 31.9 14.5 0.8 24.6 2.0 73.6 43.2 7.3 29.0 6.7 6.0 4.2 4.8 19.5 1.3 7.8 2.0 4.3 4.1 23.6 5.1 0.9 0.9 15.4 17.6 12.6 4.6 2.9 6.0 38.9 3.5 4.2 7.4 40.3 2.3 15.2 9.8 11.7 3.5 0.0 2.6 2.8 1.8 15.7 10.6 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.1 8.2 3.4 0.2 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.3 0.0 3.3 0.0 2.6 0.0 1.1 0.4 0.5 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.7 0.3 0.1 0.1 0.9 0.0 0.5 0.0 0.0 0.1 3.2 0.1 0.0 1.2 1.3 1.4 0.0 0.6 36.0 0.0 0.0 0.5 12.1 0.2 0.1 0.1 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 23.9 0.8 9.3 4.2 4.8 4.3 4.1 17.6 3.5 0.0 2.1 0.0 7.7 3.4 1.0 0.7 5.1 0.0 5.7 7.0 0.0 10.8 13.3 6.3 15.0 2.2 0.0 0.0 9.0 11.7 23.8 2.4 0.0 0.0 1.8 3.2 1.7 1.8 0.0 13.1 20.4 2.3 6.8 0.0 0.0 6.0 1.6 0.0 30.1 20.9 0.6 90.5 84.3 7.9 14.5 4.8 11.7 0.0 0.0 4.2 RESP18 ENSG00000182698 "Regulated endocrine specific protein 18" Q5W5W9 2 219327409-219333177 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "brain: 28.7" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 6.6;Intestinal endocrine cells: 3.4;Late spermatids: 18.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "basal ganglia: 28.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" NA NA "unprognostic (2.57e-2)" "unprognostic (2.12e-1)" 0.4 0.4 2.6 0.4 28.7 0.4 0.5 0.1 7.5 0.4 0.4 0.3 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 3.1 4.0 0.4 0.4 0.4 0.4 3.6 1.0 0.4 0.4 0.4 0.0 0.4 2.3 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 2.4 2.5 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 28.7 0.1 1.8 3.1 4.0 3.6 1.0 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 18.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RET "CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51" ENSG00000165731 "Ret proto-oncogene" P07949 10 43077027-43130351 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 63.9" "Cell type enriched" "Detected in some" 44 "Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "breast cancer: 11.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;monocytes: 6.7" "Cell line enhanced" "Detected in some" "MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 6 "midbrain: 95.5" "CAB002581, HPA008356, HPA008495" Approved Supported Approved "Golgi apparatus,Plasma membrane,Cytosol" No NA 260000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: " "unprognostic (7.94e-2)" "unprognostic (3.68e-2)" "unprognostic (4.49e-1)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (9.13e-4)" "unprognostic (1.27e-2)" "unprognostic (3.62e-2)" "unprognostic (2.86e-1)" "unprognostic (2.01e-1)" "unprognostic (1.54e-3)" "unprognostic (4.43e-1)" "unprognostic (9.35e-5)" "unprognostic (1.64e-3)" "unprognostic (8.28e-2)" "unprognostic (3.67e-3)" "unprognostic (2.02e-2)" 1.8 15.2 1.1 1.8 1.3 0.7 1.2 4.1 9.0 1.9 3.1 0.9 1.1 1.5 0.9 0.6 1.2 0.7 1.0 1.2 1.5 5.8 1.0 11.7 0.7 0.8 17.5 1.2 0.8 1.3 63.9 6.3 0.8 16.8 2.2 1.5 2.8 13.6 2.0 4.5 1.1 2.6 1.1 2.8 0.6 2.1 2.0 0.0 0.1 0.8 5.1 0.6 1.9 1.4 0.2 2.1 0.0 6.7 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 11.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 91.8 0.0 0.0 0.0 0.1 1.3 27.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 6.7 2.1 0.3 0.4 1.1 1.3 4.1 9.0 1.5 5.8 17.5 1.2 16.8 0.0 0.0 0.3 0.0 0.5 0.2 0.1 1.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 1.7 1.0 1.2 1.1 0.8 0.1 74.7 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.4 1.1 0.5 0.0 0.0 0.0 0.1 RETN "ADSF, FIZZ3, RETN1" ENSG00000104918 Resistin Q9HD89 19 7669044-7670454 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Hormone "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.5;bone marrow: 79.5;lymphoid tissue: 27.6" "Group enriched" "Detected in some" 6 "Hofbauer cells: 97.8;Kupffer cells: 67.2;Macrophages: 72.2" "Cancer enhanced" "Detected in many" "pancreatic cancer: 4.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "classical monocyte: 45.5;myeloid DC: 30.3" "Group enriched" "Detected in many" 11 "dendritic cells: 30.3;monocytes: 45.5" "Group enriched" "Detected in some" 11 "NB-4: 102.5;U-937: 47.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 5120000 350000 "unprognostic (5.61e-2)" "unprognostic (6.20e-3)" "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (5.19e-4)" "unprognostic (1.53e-4)" "unprognostic (7.34e-2)" "unprognostic (3.35e-2)" "unprognostic (9.30e-2)" "unprognostic (1.35e-2)" "unprognostic (1.20e-1)" "unprognostic (4.02e-1)" "unprognostic (7.16e-5)" "unprognostic (4.23e-2)" "unprognostic (2.26e-1)" "unprognostic (8.91e-2)" "unprognostic (1.20e-1)" 1.3 0.4 0.0 1.9 0.6 79.5 0.6 0.4 0.9 0.1 0.2 0.1 0.7 2.3 0.3 0.1 0.2 1.3 0.2 21.9 0.0 0.0 0.9 1.6 17.3 7.5 1.3 0.0 0.8 1.6 0.1 0.4 1.1 0.2 0.2 0.1 0.7 0.7 0.1 0.6 0.2 0.3 1.5 0.4 27.6 0.4 0.4 0.5 2.7 0.8 0.0 0.4 0.2 2.3 0.0 30.3 3.4 45.5 0.0 2.4 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 102.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 47.9 0.0 0.0 45.5 0.0 0.1 21.7 0.3 0.0 0.5 0.4 30.3 0.0 1.1 2.4 3.4 0.0 11.1 1.2 0.0 14.0 0.0 0.6 0.4 0.9 0.0 0.0 1.3 0.0 0.2 0.5 11.9 13.5 2.7 0.0 0.2 0.0 0.0 0.0 2.7 7.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 3.5 0.0 97.8 0.0 0.0 0.6 67.2 0.0 0.0 72.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 RETNLB "FIZZ2, HXCP2, RELMb" ENSG00000163515 "Resistin like beta" Q9BQ08 3 108743424-108757384 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 71.9" "Group enriched" "Detected in some" 5 "Early spermatids: 1.9;Intestinal endocrine cells: 1.7;Late spermatids: 3.5;Mucus-secreting cells: 4.5" "Cancer enriched" "Detected in some" 10 "colorectal cancer: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 6.6" "Not detected" "Not detected" HPA049152 Enhanced "Secreted to blood" NA NA 123000 "HPA049152: AB_2680655" "prognostic favorable (6.86e-5)" "unprognostic (1.19e-3)" "unprognostic (3.37e-2)" "unprognostic (4.69e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-2)" "unprognostic (4.26e-1)" 0.1 0.0 0.1 7.0 0.1 0.0 0.1 0.1 0.1 0.1 20.6 0.1 0.1 4.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 71.9 0.1 0.1 0.1 0.1 0.0 24.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 RETREG1 "FAM134B, FLJ20152, JK1" ENSG00000154153 "Reticulophagy regulator 1" Q9H6L5 5 16473038-16617058 "Disease related genes, Predicted membrane proteins" Autophagy "Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 45.0;skeletal muscle: 78.5" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 68.5;Exocrine glandular cells: 51.0;Pancreatic endocrine cells: 69.1;Proximal tubular cells: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;T-cells: 4.4" "Cell line enhanced" "Detected in many" "ASC diff: 16.3;GAMG: 12.6;HSkMC: 18.1;RPTEC TERT1: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012077 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA012077: AB_2668621" "unprognostic (1.63e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-2)" "unprognostic (1.84e-2)" "unprognostic (4.96e-2)" "unprognostic (9.17e-3)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (4.35e-2)" "unprognostic (4.41e-2)" "unprognostic (1.37e-2)" "unprognostic (1.48e-1)" "prognostic favorable (5.25e-10)" "unprognostic (3.75e-1)" "unprognostic (9.96e-2)" "unprognostic (5.62e-2)" "unprognostic (2.58e-1)" 9.8 2.0 8.5 3.7 11.2 1.1 8.7 9.6 19.6 7.4 12.4 14.9 0.3 6.5 2.3 5.4 2.0 4.1 7.1 45.0 11.2 9.4 30.3 21.8 4.9 3.1 13.2 11.4 1.7 19.0 17.7 8.0 6.7 18.5 5.9 16.9 1.5 3.9 3.0 78.5 5.6 12.8 1.5 16.8 1.6 6.1 5.7 15.4 14.1 3.6 12.5 2.3 2.0 4.4 0.9 0.1 4.0 0.4 0.1 4.4 0.6 0.8 0.3 0.1 2.1 16.3 2.0 9.5 0.1 2.1 1.9 2.6 1.4 0.1 0.2 1.5 0.0 12.6 2.4 4.8 0.5 0.6 2.4 2.1 0.0 7.2 0.0 0.1 3.1 0.0 18.1 7.4 0.3 2.0 4.7 0.0 9.3 0.0 0.1 0.7 0.6 11.9 0.0 0.5 2.1 0.3 1.9 0.0 0.7 16.6 0.5 10.8 1.2 0.6 0.7 7.8 1.2 3.6 1.4 0.0 1.5 0.2 4.0 1.8 0.4 0.0 0.0 9.3 10.7 3.9 4.0 0.4 0.1 0.6 0.0 1.6 0.0 1.5 0.8 0.1 0.9 4.4 2.7 2.3 0.1 0.1 0.0 1.9 0.6 8.5 11.2 9.6 14.4 11.2 9.4 13.2 11.4 18.5 15.4 68.5 7.5 0.0 0.0 0.0 0.0 0.0 0.0 34.8 18.2 41.8 0.0 39.1 14.9 25.9 0.0 0.0 0.0 0.0 51.0 2.5 0.0 0.0 1.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.8 0.0 0.0 69.1 0.0 0.0 147.8 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85342088-85354620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 86.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 209.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 65.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli NA NA Nucleoli "HPA007961: AB_1079802, HPA046513: AB_2679680" "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 65.7 24.8 7.7 9.8 9.1 0.9 35.6 5.6 9.3 7.4 46.5 12.4 12.7 49.0 6.8 12.3 16.7 5.0 17.7 7.3 7.4 5.7 20.6 51.9 7.2 5.1 10.2 7.7 5.5 11.5 13.1 3.5 5.7 8.9 10.1 22.6 10.0 12.5 7.6 24.3 14.3 86.1 7.0 12.7 4.0 18.2 9.2 10.1 3.5 27.2 13.9 9.3 9.9 9.0 3.8 5.6 5.3 10.0 6.5 9.2 4.1 16.2 9.4 5.5 12.7 65.6 12.3 7.1 11.9 14.7 7.2 10.2 6.5 11.4 5.7 9.8 9.4 5.8 13.6 7.3 20.7 7.1 7.0 5.0 2.8 7.8 15.9 15.8 5.4 6.3 16.1 28.4 9.3 12.4 16.8 12.0 5.0 2.9 13.7 13.5 3.4 3.9 2.8 1.7 16.4 11.6 2.5 10.8 7.4 12.8 9.5 2.6 4.4 10.0 19.1 32.3 3.8 9.0 0.9 9.4 8.2 4.5 7.6 6.2 7.4 6.9 2.3 10.0 6.5 5.6 0.0 5.1 2.4 7.0 5.5 9.2 3.8 5.6 8.8 5.6 2.5 3.8 4.0 5.3 6.5 10.0 4.0 5.8 4.1 7.7 9.1 5.6 9.3 7.4 5.7 10.2 7.7 8.9 10.1 26.8 23.5 2.2 8.5 10.1 3.5 18.5 20.4 9.4 10.3 12.2 17.7 9.6 0.0 19.1 27.2 9.2 209.6 0.0 31.4 5.6 6.6 11.3 10.4 39.3 8.7 11.1 10.4 8.0 9.9 41.4 13.6 7.5 28.7 9.0 43.9 8.2 29.0 59.4 11.7 15.6 4.3 0.0 7.8 2.6 3.0 13.0 7.1 8.9 33.1 8.4 REX1BD "C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391" ENSG00000006015 "Required for excision 1-B domain containing" Q96EN9 19 18588685-18592336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 114.3;Distal tubular cells: 131.0;Hofbauer cells: 225.5;Proximal tubular cells: 163.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 25.6;EFO-21: 24.1;PC-3: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043414 Approved Approved Vesicles NA NA Vesicles "HPA043414: AB_10797141" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (6.78e-3)" "unprognostic (1.22e-1)" "unprognostic (4.87e-3)" "unprognostic (2.52e-2)" "unprognostic (1.45e-1)" "unprognostic (4.60e-1)" "unprognostic (3.10e-1)" "unprognostic (5.50e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-2)" "unprognostic (4.02e-2)" "unprognostic (9.27e-2)" "unprognostic (1.48e-1)" "prognostic favorable (8.47e-4)" 29.8 12.6 21.2 15.2 18.2 13.1 9.9 20.7 21.6 9.8 18.3 10.3 17.5 13.0 10.8 13.9 8.7 8.4 11.5 17.6 18.0 16.6 17.7 25.4 11.5 8.5 16.6 18.0 11.9 15.9 5.0 8.3 8.6 14.4 15.8 4.7 8.5 22.2 14.3 100.1 9.7 17.8 8.7 12.3 25.8 24.1 5.2 11.4 7.4 7.4 14.0 8.8 8.1 9.9 44.5 51.8 50.5 55.2 32.5 57.0 49.0 6.8 8.3 0.7 1.3 1.2 1.0 25.6 7.2 1.1 1.7 2.0 1.5 7.9 7.1 24.1 1.3 0.4 5.0 0.3 1.6 0.4 7.7 17.2 4.6 3.1 3.9 1.4 4.0 11.5 2.2 1.6 0.8 0.4 0.6 2.1 3.2 5.8 2.1 0.8 11.4 7.4 6.5 11.2 3.5 35.6 8.1 2.1 18.0 2.4 6.2 3.5 13.3 3.3 3.3 8.0 0.3 1.8 3.4 7.1 0.8 7.3 9.9 4.2 20.5 6.4 4.1 6.8 7.2 3.3 28.1 55.2 50.5 55.7 47.3 56.8 44.5 57.0 49.9 51.8 34.3 52.6 49.1 31.6 32.5 43.7 44.8 45.1 49.0 21.2 18.2 20.7 21.6 18.0 16.6 16.6 18.0 14.4 11.4 26.8 38.7 0.0 0.0 0.0 0.0 0.0 0.0 36.1 38.7 73.3 0.0 114.3 131.0 66.1 0.0 0.0 0.0 0.0 99.8 112.7 0.0 0.0 38.4 0.0 225.5 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 101.8 0.0 0.0 75.0 0.0 0.0 163.2 0.0 0.0 0.0 0.0 0.0 0.0 55.6 0.0 0.0 0.0 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849668 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "blood: 33.9;testis: 119.4" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 2.7;Club cells: 2.3;Cytotrophoblasts: 1.7;Extravillous trophoblasts: 2.0;Hofbauer cells: 1.9;monocytes: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "basophil: 33.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 33.9" "Cell line enhanced" "Detected in many" "K-562: 24.4;U-266/70: 25.2" "Low region specificity" "Detected in all" "HPA040755, HPA040868, HPA066145" Approved Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" NA NA "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549, HPA066145: " "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 0.8 0.7 0.7 1.4 1.9 2.6 1.0 1.0 1.0 0.4 0.6 0.6 0.2 0.7 0.9 0.8 0.6 1.1 0.7 1.1 0.6 0.5 0.5 0.5 0.6 0.7 0.4 1.2 0.8 0.6 3.3 0.4 0.4 0.6 1.4 0.8 0.7 0.8 0.7 0.4 0.6 0.6 0.7 0.3 0.3 1.6 119.4 0.4 4.1 0.3 0.5 0.9 0.8 0.6 0.0 0.3 33.9 0.2 0.8 0.7 0.1 6.4 3.6 5.7 2.5 2.3 4.8 1.9 4.3 4.8 4.8 5.3 2.7 5.6 3.9 6.9 3.6 3.3 3.2 4.3 1.9 5.0 4.1 3.1 6.5 5.4 3.7 0.5 9.6 9.5 2.2 0.8 5.6 7.3 2.1 1.6 0.0 24.4 17.5 11.7 8.3 1.5 7.2 3.1 2.5 3.7 7.8 10.8 7.0 1.4 2.2 5.1 5.7 4.0 5.5 1.4 1.7 9.3 8.2 0.8 3.5 3.2 4.7 5.1 25.2 17.0 1.5 7.4 12.4 3.4 33.9 0.2 2.2 0.1 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.7 0.1 0.7 1.9 1.0 1.0 0.6 0.5 0.4 1.2 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.0 1.3 2.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RFESD ENSG00000175449 "Rieske Fe-S domain containing" Q8TAC1 5 95646754-95684773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.3" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 163.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7" "Cell line enhanced" "Detected in many" "HEL: 21.2;K-562: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016546 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "CAB016546: AB_630417" "unprognostic (1.15e-1)" "unprognostic (5.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.37e-2)" "unprognostic (6.07e-3)" "unprognostic (2.72e-1)" "unprognostic (1.33e-3)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (9.91e-2)" "unprognostic (8.24e-3)" "unprognostic (4.89e-2)" "unprognostic (5.83e-3)" "unprognostic (6.78e-2)" "unprognostic (9.03e-2)" "unprognostic (9.35e-2)" "unprognostic (1.09e-1)" 2.4 3.8 2.8 2.8 5.5 28.3 8.6 4.9 5.1 3.5 2.6 3.1 3.3 1.8 3.1 6.2 3.4 2.8 1.9 5.4 3.8 3.1 3.4 4.4 3.7 3.8 4.5 4.1 4.2 10.7 6.9 9.7 2.9 5.5 4.5 2.2 2.8 8.1 4.9 6.8 9.7 2.3 2.1 8.6 3.7 3.4 16.0 3.9 8.6 4.5 1.4 4.1 3.3 2.9 3.7 1.6 0.3 0.9 5.0 12.7 2.8 1.8 2.9 0.5 1.8 1.9 3.4 0.0 1.0 1.5 1.6 1.7 2.3 2.0 3.0 2.1 0.8 3.9 2.7 2.0 1.5 1.8 4.4 1.7 21.2 2.9 0.8 2.3 1.9 2.2 1.5 2.9 2.1 1.9 1.5 1.6 8.9 39.4 2.3 2.6 1.2 6.2 8.4 2.3 0.8 2.7 3.0 0.3 1.3 0.6 1.1 2.8 2.0 2.8 1.3 0.0 0.2 1.4 1.0 0.8 2.1 1.6 1.5 1.7 2.1 5.0 2.3 1.8 2.3 1.1 0.0 0.7 0.3 3.5 0.9 9.4 3.7 8.5 6.0 1.5 2.9 12.7 7.2 0.0 5.0 0.8 1.6 4.9 2.8 2.8 5.5 4.9 5.1 3.8 3.1 4.5 4.1 5.5 3.9 11.9 3.5 4.5 3.7 2.9 2.2 8.3 0.0 6.7 5.7 1.8 0.0 2.9 1.7 2.0 11.8 1.1 0.1 163.5 1.5 10.4 1.9 1.5 3.5 1.6 3.3 1.6 0.0 2.5 1.0 6.3 1.7 0.8 0.0 3.6 1.0 2.7 2.1 0.0 1.1 2.1 1.2 6.5 1.1 39.4 10.8 5.9 1.7 2.2 1.3 2.5 RFFL "CARP-2, CARP2, fring, rififylin, RNF189, RNF34L" ENSG00000092871 "Ring finger and FYVE like domain containing E3 ubiquitin protein ligase" Q8WZ73 17 35005990-35089319 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 41.3;Karpas-707: 38.5" "CAB008096, HPA017910, HPA019492" Approved Approved Vesicles NA NA Vesicles "CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190" "unprognostic (2.59e-1)" "unprognostic (2.87e-1)" "prognostic favorable (4.92e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.79e-1)" "unprognostic (5.73e-3)" "unprognostic (4.34e-3)" "unprognostic (2.31e-1)" "unprognostic (9.26e-3)" "unprognostic (2.39e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.43e-5)" "unprognostic (1.44e-1)" "unprognostic (1.97e-1)" "unprognostic (8.68e-2)" "unprognostic (1.36e-1)" 5.8 6.1 11.1 9.9 22.9 22.1 6.7 4.4 15.7 6.7 14.6 56.8 5.9 14.8 6.9 5.3 21.6 5.4 11.5 5.8 14.4 10.5 15.4 25.0 6.8 8.9 32.1 7.3 5.2 10.1 8.3 4.9 6.5 30.7 10.7 12.6 4.5 9.6 7.0 12.2 5.2 11.9 7.3 32.1 9.9 13.4 15.7 27.5 13.1 23.0 5.4 15.0 10.2 9.2 4.2 5.2 26.8 7.6 6.7 14.5 7.1 7.9 15.0 4.0 5.6 6.6 9.4 2.1 5.2 8.5 5.4 6.5 5.1 15.8 2.3 6.6 6.6 11.5 11.2 6.2 10.1 7.5 41.3 4.3 12.4 4.0 12.5 5.6 8.0 7.4 6.3 6.0 8.1 14.3 7.2 5.2 7.2 5.8 38.5 4.8 2.5 1.8 7.1 4.7 15.6 9.0 5.5 6.4 13.9 8.0 15.9 4.4 5.5 3.3 3.5 3.2 8.9 5.3 8.8 10.3 3.2 5.6 3.1 8.4 14.4 12.1 3.7 12.3 5.6 2.8 11.3 7.6 16.3 8.8 4.6 10.6 4.2 9.9 8.3 5.2 4.1 8.5 7.5 26.8 6.7 4.1 0.6 14.5 7.1 11.1 22.9 4.4 15.7 14.4 10.5 32.1 7.3 30.7 27.5 38.7 30.1 16.1 9.1 5.4 10.1 1.0 17.8 10.7 23.9 0.0 13.7 7.5 1.7 6.4 36.4 5.8 22.2 0.0 13.0 1.3 8.0 22.0 24.3 26.6 6.5 6.4 14.5 11.6 15.7 81.0 2.8 14.9 1.7 16.2 20.7 19.9 13.9 17.3 4.2 16.8 31.7 6.5 5.1 11.8 9.1 5.4 4.2 20.1 16.1 33.9 RFLNA "Cfm2, FAM101A, FLJ44614, RefilinA" ENSG00000178882 "Refilin A" Q6ZTI6 12 123973241-124316024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "stomach 1: 118.3" "Cell type enriched" "Detected in some" 24 "Pancreatic endocrine cells: 66.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTEC/SVTERT24-B: 9.0;HUVEC TERT2: 12.8;LHCN-M2: 22.4;OE19: 23.3;RH-30: 7.3" "Low region specificity" "Detected in all" "HPA058911, HPA078021" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA058911: AB_2683853, HPA078021: AB_2732368" "unprognostic (1.71e-1)" "unprognostic (6.85e-2)" "unprognostic (1.63e-2)" "unprognostic (1.36e-1)" "unprognostic (3.15e-2)" "unprognostic (8.78e-4)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.16e-5)" "unprognostic (8.87e-2)" "unprognostic (1.59e-1)" "unprognostic (1.71e-3)" "unprognostic (1.15e-3)" "unprognostic (1.77e-8)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" 5.5 3.0 6.4 5.2 8.6 2.6 8.2 10.8 6.6 11.7 20.9 9.7 7.0 19.5 4.8 4.8 3.0 5.5 3.7 5.1 6.3 6.3 5.4 5.3 3.2 2.8 9.8 5.2 5.2 7.6 2.7 9.4 3.4 9.0 6.3 15.4 6.3 8.7 5.4 8.5 4.2 20.7 3.4 8.3 2.8 118.3 2.7 8.3 1.9 9.6 2.3 2.8 3.3 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.3 0.0 0.0 0.3 0.3 1.1 0.8 0.0 0.1 3.1 0.1 0.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.5 0.0 9.0 0.0 0.5 12.8 1.3 0.0 0.0 22.4 0.0 0.0 0.0 1.9 23.3 0.0 0.0 7.3 0.1 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.4 8.6 10.8 6.6 6.3 6.3 9.8 5.2 9.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFLNB "Cfm1, FAM101B, MGC45871, RefilinB" ENSG00000183688 "Refilin B" Q8N5W9 17 439978-445939 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 48.4;bone marrow: 40.9" "Cell type enhanced" "Detected in some" 25 "Alveolar cells type 2: 5.5;Hofbauer cells: 30.7;monocytes: 10.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 48.4" "Lineage enriched" "Detected in many" 16 "granulocytes: 48.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 28.0;HMC-1: 67.5;NB-4: 21.5;U-937: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030879, HPA060388" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Actin filaments" "Plasma membrane, Cytosol" "HPA030879: AB_2673643, HPA060388: AB_2732649" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (3.14e-1)" "unprognostic (3.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.31e-1)" "unprognostic (1.48e-1)" "unprognostic (1.94e-1)" "unprognostic (2.87e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (3.45e-2)" "unprognostic (9.22e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-3)" 6.8 1.6 1.9 4.1 2.3 40.9 5.6 1.1 1.5 2.6 4.9 1.8 4.2 2.2 1.1 2.1 2.7 3.7 2.1 1.5 2.7 1.7 5.2 2.9 1.8 1.8 1.0 0.8 1.3 6.3 3.6 1.1 1.2 1.7 2.8 1.9 3.2 3.6 2.3 4.1 3.2 0.9 3.0 2.7 4.5 1.4 0.0 2.5 48.4 2.1 0.5 3.0 1.0 8.8 2.3 1.2 5.6 4.0 2.9 6.3 14.5 6.3 4.8 2.3 0.1 0.3 0.0 0.3 28.0 2.1 0.8 3.3 0.3 4.4 0.0 1.9 0.4 0.4 0.6 5.9 3.2 67.5 1.6 0.1 1.5 0.6 1.8 4.8 1.4 1.3 0.1 5.4 0.1 0.1 21.5 2.6 0.2 0.0 0.9 2.6 0.0 0.8 0.0 0.1 13.2 5.8 0.0 5.1 4.7 0.1 10.1 0.9 3.7 3.4 2.2 0.0 2.1 2.2 0.0 0.0 18.7 5.8 48.4 2.1 21.6 1.8 1.4 1.8 0.0 1.8 1.5 0.6 0.0 3.0 2.7 10.2 0.5 1.8 2.5 1.1 1.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 1.1 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 10.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 6.5;Ito cells: 12.9;Kupffer cells: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 11.2;HMC-1: 4.3;Karpas-707: 4.7;SH-SY5Y: 5.8;SiHa: 2.8;THP-1: 5.3" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 11.2 0.7 0.0 1.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.8 2.8 0.0 0.0 0.3 0.0 5.3 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell type enriched" "Detected in single" 4 "Glandular cells: 3.1" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.5;OE19: 1.1;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.5 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.4 0.0 0.3 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.4" "Cell type enriched" "Detected in single" 7 "Early spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.8;NB-4: 4.8;U-266/70: 5.6;U-266/84: 5.5" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.0 0.0 0.3 0.0 0.3 1.0 0.0 0.7 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.6 0.5 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.3 1.1 0.2 0.0 0.1 0.5 0.0 23.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 0.1 0.8 2.4 0.7 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.3 2.4 1.1 0.1 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.1 1.8 0.0 0.9 1.4 4.8 0.2 0.3 0.1 2.4 0.5 0.6 0.0 0.4 1.8 0.5 0.1 0.4 1.3 0.6 0.0 0.4 0.0 0.0 0.9 0.4 0.0 5.6 5.5 0.1 0.1 1.7 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RFPL4A "RFPL4, RNF210" ENSG00000223638 "Ret finger protein like 4A" A6NLU0 19 55759014-55763175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.9" "Cell type enhanced" "Detected in some" "classical monocyte: 12.7" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 12.7" "Cell line enriched" "Detected in some" 17 "U-2 OS: 44.7" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (3.74e-1)" "unprognostic (2.96e-2)" "unprognostic (9.20e-2)" 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.2 0.0 0.1 0.2 0.0 0.0 0.0 0.4 7.1 0.0 0.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 1.6 0.4 3.8 0.0 0.1 0.0 0.0 0.0 3.8 1.7 12.7 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.7 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 12.7 0.0 0.0 2.7 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 1.7 0.0 0.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 RFPL4AL1 RNF210B ENSG00000229292 "Ret finger protein like 4A like 1" F8VTS6 19 55769141-55773179 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 5.4;myeloid DC: 2.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.5;monocytes: 5.4" "Cell line enriched" "Detected in some" 24 "U-2 OS: 24.8" HPA046368 Uncertain Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA046368: AB_2679640" "unprognostic (8.87e-2)" 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.0 0.0 0.3 3.0 0.0 0.4 0.0 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 2.3 0.2 1.5 0.3 0.0 0.3 0.0 0.0 2.5 0.4 5.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 RFPL4B RNF211 ENSG00000251258 "Ret finger protein like 4B" Q6ZWI9 6 112347330-112351296 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.0" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 13.9" "Group enriched" "Detected in some" 7 "liver cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.5;K-562: 3.1;RPTEC TERT1: 4.1;U-266/70: 1.7;U-266/84: 12.7" "HPA059324, HPA066464" Uncertain NA NA "HPA059324: , HPA066464: " "unprognostic (4.26e-1)" "unprognostic (1.45e-1)" "unprognostic (6.66e-2)" "unprognostic (3.78e-1)" "unprognostic (2.80e-3)" "unprognostic (3.73e-2)" 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 1.7 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 1.4 0.0 0.3 0.0 0.0 0.0 RFTN2 "C2orf11, FLJ30574, Raftlin-2" ENSG00000162944 "Raftlin family member 2" Q52LD8 2 197568224-197676045 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.5" "Group enriched" "Detected in many" 8 "Early spermatids: 98.7;Late spermatids: 274.3" "Group enriched" "Detected in many" 6 "glioma: 10.2;melanoma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 17.3;ASC diff: 12.0;ASC TERT1: 6.5;HSkMC: 6.5;WM-115: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035232, HPA043190" Approved NA NA "HPA035232: AB_10601495, HPA043190: " "unprognostic (1.15e-1)" "unprognostic (3.52e-1)" "unprognostic (2.07e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.05e-4)" "unprognostic (1.89e-2)" "unprognostic (1.81e-1)" "unprognostic (3.09e-2)" "unprognostic (2.16e-2)" "unprognostic (6.04e-2)" "unprognostic (1.39e-1)" "unprognostic (1.05e-1)" "unprognostic (8.44e-3)" "unprognostic (2.56e-2)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.77e-2)" 10.6 6.3 22.3 2.6 31.5 0.9 3.6 11.7 29.5 4.4 2.4 20.3 0.5 1.5 5.7 1.5 3.0 2.8 5.6 4.0 25.3 9.5 3.1 1.5 3.0 3.0 39.5 13.2 11.4 3.0 1.1 1.2 7.4 25.8 2.3 2.5 2.2 3.7 2.1 2.8 2.7 2.1 3.4 37.9 2.8 2.2 4.3 38.4 0.0 2.8 0.2 1.9 5.0 2.8 0.9 0.6 2.3 0.4 0.7 2.2 0.2 0.1 0.0 17.3 0.4 12.0 6.5 0.7 0.3 0.9 0.0 0.8 0.4 0.4 0.4 0.5 1.3 0.4 0.6 0.0 0.0 0.0 0.7 0.1 0.2 1.1 0.0 1.7 0.3 0.3 6.5 0.4 0.1 0.0 0.1 1.8 0.5 0.1 0.2 0.4 0.8 0.1 0.1 0.8 0.7 0.6 0.2 0.5 0.2 0.0 0.2 0.5 0.1 0.0 0.1 2.0 2.9 0.1 0.1 3.8 1.4 0.4 0.1 0.2 0.5 0.8 0.2 1.3 0.1 7.6 1.3 0.4 0.4 1.1 0.3 2.2 0.5 1.3 0.6 0.1 0.9 1.1 1.8 2.3 0.7 0.4 0.6 1.0 0.2 22.3 31.5 11.7 21.4 25.3 9.5 39.5 13.2 25.8 38.4 0.0 1.1 0.0 0.1 2.2 1.2 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.6 98.7 5.9 0.0 0.0 0.0 0.1 4.7 0.4 0.0 0.2 0.3 3.2 0.0 19.6 1.2 274.3 14.7 0.0 15.1 0.0 0.0 22.8 0.1 0.0 20.8 0.0 1.8 6.5 6.6 4.7 2.7 1.9 0.0 0.0 0.0 0.1 RFX2 FLJ14226 ENSG00000087903 "Regulatory factor X2" P48378 19 5993164-6199572 "Predicted intracellular proteins, Transcription factors" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 120.5;Early spermatids: 120.3;Late spermatids: 146.0;Spermatocytes: 95.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "neutrophil: 18.3" "Lineage enriched" "Detected in many" 9 "granulocytes: 18.3" "Cell line enhanced" "Detected in many" "HMC-1: 16.3;SCLC-21H: 20.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA048969 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "HPA048969: AB_2680577" "unprognostic (1.31e-1)" "prognostic favorable (2.80e-4)" "unprognostic (6.72e-2)" "prognostic favorable (2.67e-4)" "unprognostic (1.37e-1)" "unprognostic (4.15e-2)" "unprognostic (1.22e-2)" "unprognostic (1.12e-3)" "unprognostic (1.86e-2)" "unprognostic (3.84e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.73e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" 6.7 2.0 8.4 5.3 9.4 8.6 6.4 8.3 7.0 6.9 11.3 7.2 0.7 4.1 15.7 7.0 9.0 22.0 6.4 5.4 9.5 3.6 1.9 2.5 10.0 2.1 4.4 4.0 7.2 5.3 2.9 12.9 2.2 9.9 4.1 2.6 3.1 2.4 3.3 2.5 6.6 5.7 14.8 9.0 2.1 5.9 51.5 7.5 4.1 3.0 12.1 3.1 8.7 5.3 0.3 1.6 18.3 2.0 0.5 0.5 0.6 4.0 3.3 5.3 10.3 2.8 1.6 3.1 2.6 3.6 2.2 3.5 1.4 5.1 4.6 2.8 3.4 4.8 6.4 1.3 5.2 3.0 1.1 0.8 7.2 3.3 1.4 3.2 3.1 16.3 1.9 4.5 4.9 2.6 2.7 3.3 6.4 4.6 0.2 2.2 2.0 6.2 4.3 1.4 5.6 2.0 1.7 3.2 0.5 2.8 7.9 20.1 2.5 2.5 2.0 1.4 0.6 3.4 3.5 4.8 0.9 4.6 3.6 2.6 6.7 2.2 2.6 2.8 11.6 1.9 0.0 2.0 0.8 0.1 0.4 0.0 0.3 0.4 0.3 1.6 0.1 0.4 0.5 18.3 0.5 1.1 0.0 0.0 0.6 8.4 9.4 8.3 7.0 9.5 3.6 4.4 4.0 9.9 7.5 23.8 40.1 2.2 23.8 23.5 3.3 7.2 15.3 120.5 40.9 3.5 2.0 5.2 3.3 3.9 120.3 9.9 3.0 0.0 1.5 5.4 9.7 5.5 44.0 2.0 7.0 0.0 13.2 6.7 8.7 146.0 7.5 13.6 6.8 5.4 4.4 5.5 2.3 1.5 3.9 1.5 3.6 25.8 14.6 95.0 13.0 19.3 4.7 4.9 5.2 17.3 RFX3 ENSG00000080298 "Regulatory factor X3" P48380 9 3218297-3526004 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1;testis: 36.5" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 140.5;Early spermatids: 159.1;Intestinal endocrine cells: 135.5;Late spermatids: 86.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 22.4;HDLM-2: 13.2;SCLC-21H: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035689 Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035689: AB_10671224" "prognostic favorable (1.47e-4)" "unprognostic (8.78e-2)" "unprognostic (1.18e-1)" "unprognostic (5.52e-2)" "unprognostic (2.27e-2)" "unprognostic (1.50e-1)" "unprognostic (8.26e-3)" "unprognostic (3.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.49e-2)" "unprognostic (7.58e-3)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-1)" "unprognostic (2.52e-1)" "unprognostic (8.89e-3)" 5.2 4.6 17.9 7.6 14.9 11.4 6.7 35.1 19.5 6.9 4.7 6.9 5.0 5.0 6.8 6.3 3.8 22.0 5.2 4.0 12.8 7.5 5.0 4.1 7.2 6.7 6.0 11.9 7.0 5.4 9.0 21.7 5.8 9.9 6.1 5.6 4.2 4.7 4.6 5.7 4.4 5.0 4.0 12.5 5.7 6.6 36.5 11.0 12.7 5.7 2.9 7.5 4.5 7.8 8.3 4.6 8.9 4.8 5.3 9.3 3.2 2.0 2.7 22.4 5.4 0.9 1.0 2.2 0.8 2.4 1.9 1.4 0.8 2.6 3.2 0.9 1.1 1.6 1.1 5.5 2.3 3.4 13.2 1.5 6.0 3.0 1.8 1.1 1.2 0.8 1.4 1.1 2.3 3.8 3.8 3.3 4.2 1.1 3.3 2.0 1.6 3.8 4.4 5.9 1.7 1.2 4.0 1.5 0.8 3.1 1.6 12.0 5.3 1.3 0.6 2.0 4.6 1.1 3.2 2.0 1.4 3.3 0.7 1.3 1.1 0.5 6.4 1.6 1.4 1.5 3.5 3.2 6.2 8.8 4.8 5.4 6.3 8.1 7.2 3.1 8.3 5.7 7.0 8.9 5.3 1.4 4.6 9.3 3.2 17.9 14.9 35.1 19.5 12.8 7.5 6.0 11.9 9.9 11.0 6.0 7.7 6.2 7.4 4.4 22.0 4.9 0.0 140.5 34.2 3.5 23.6 1.6 0.0 3.1 159.1 13.5 2.5 0.0 2.2 2.1 4.3 9.6 5.8 0.9 2.7 36.5 135.5 11.6 6.9 86.4 6.6 6.2 1.7 1.0 9.2 13.8 3.2 5.8 7.1 1.7 25.2 0.0 10.3 10.2 2.5 5.5 1.1 6.7 5.5 3.3 RFX4 ENSG00000111783 "Regulatory factor X4" Q33E94 12 106582907-106762803 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 43.9;testis: 70.5" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 34.1;Late spermatids: 23.0;Spermatocytes: 99.6" "Cancer enriched" "Detected in single" 54 "glioma: 15.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "AF22: 33.3" "Low region specificity" "Detected in all" HPA050527 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA050527: AB_2681158" "unprognostic (3.67e-1)" "unprognostic (4.86e-2)" "unprognostic (1.76e-3)" "unprognostic (1.60e-2)" "unprognostic (1.09e-1)" "unprognostic (6.97e-2)" "unprognostic (7.97e-2)" "unprognostic (3.04e-1)" "unprognostic (6.80e-2)" "unprognostic (2.72e-3)" "unprognostic (1.66e-3)" "unprognostic (1.15e-2)" "unprognostic (1.30e-2)" "unprognostic (5.46e-2)" 1.3 1.2 13.8 1.2 14.5 1.2 1.2 7.6 20.6 1.2 1.2 21.0 0.0 1.2 1.2 1.3 1.2 1.3 1.3 1.3 15.7 9.9 1.3 1.2 1.3 1.3 12.0 8.6 1.2 1.4 1.2 8.0 1.2 20.6 1.4 1.2 0.0 1.2 1.3 1.2 1.2 1.3 1.2 43.9 1.2 1.3 70.5 13.7 0.0 1.4 0.0 1.2 1.2 0.1 0.5 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.2 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 13.8 14.5 7.6 13.6 15.7 9.9 12.0 8.6 20.6 13.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 34.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 99.6 3.1 0.0 0.0 0.0 0.0 0.0 RFX6 "dJ955L16.1, MGC33442, RFXDC1" ENSG00000185002 "Regulatory factor X6" Q8HWS3 6 116877212-116932163 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.4;intestine: 9.2;pancreas: 8.3;stomach 1: 11.8" "Cell type enriched" "Detected in some" 15 "Intestinal endocrine cells: 65.8" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 5.4;U-266/70: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA037696 Approved NA NA "HPA037696: AB_2675616" "unprognostic (2.92e-1)" "unprognostic (4.66e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.59e-4)" "unprognostic (2.59e-2)" "unprognostic (1.63e-1)" "unprognostic (1.25e-1)" 0.1 7.4 0.1 0.8 0.1 0.0 4.5 0.1 0.4 0.2 6.9 0.2 0.0 3.4 0.1 0.0 0.3 0.1 1.3 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.1 8.3 0.0 2.1 1.5 0.0 0.5 2.0 0.0 1.2 4.0 0.1 0.1 9.2 0.0 0.1 0.1 11.8 0.9 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 65.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56243266 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035462 Supported Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152" "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 6.6 6.6 4.2 4.1 7.1 6.7 5.0 28.2 11.7 4.4 3.5 8.6 3.0 4.3 4.4 4.9 5.1 4.1 3.1 4.2 4.7 3.6 4.4 4.2 4.1 7.1 4.5 8.3 4.7 6.3 7.1 10.6 4.1 8.1 3.9 3.9 2.7 5.3 7.1 13.7 9.8 4.6 4.1 6.4 6.0 4.1 6.0 6.8 15.4 4.2 3.7 7.2 4.9 4.8 1.3 1.5 4.6 0.8 1.4 2.6 0.5 3.9 6.1 14.6 11.1 6.3 7.2 3.8 2.9 4.1 3.9 6.2 4.3 2.9 11.1 4.8 4.3 3.3 10.1 8.8 5.6 5.3 5.9 3.5 13.1 8.3 9.3 6.5 10.6 2.3 5.9 13.3 3.5 8.8 6.9 7.0 11.3 6.1 5.8 6.6 4.6 8.9 4.3 6.9 3.2 2.3 9.9 9.4 10.1 5.7 10.1 8.1 10.2 3.7 4.3 5.2 11.1 3.3 8.6 5.8 10.7 5.4 2.7 6.3 5.5 5.2 12.6 3.8 11.4 4.7 4.6 0.5 0.9 1.2 0.8 1.6 1.2 1.8 1.9 0.9 1.3 1.0 1.3 0.0 1.4 0.4 1.5 2.6 0.5 4.2 7.1 28.2 11.7 4.7 3.6 4.5 8.3 8.1 6.8 6.0 11.2 5.4 4.2 11.8 15.8 5.3 2.5 6.7 4.5 7.0 9.8 3.5 3.3 3.0 16.3 6.2 3.0 23.3 4.0 1.2 5.4 5.4 11.6 7.6 4.7 15.9 4.6 8.0 11.3 9.1 6.1 5.6 5.0 1.8 5.6 4.1 3.0 6.5 9.9 3.7 7.4 0.0 3.6 6.6 5.8 15.4 1.4 6.4 6.2 5.1 RFX8 FLJ42986 ENSG00000196460 "RFX family member 8, lacking RFX DNA binding domain" Q6ZV50 2 101397361-101474703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8" "Group enriched" "Detected in some" 5 "Early spermatids: 14.4;Late spermatids: 6.0;Spermatocytes: 4.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 12 "basophil: 2.0" "Lineage enriched" "Detected in single" 12 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;hTEC/SVTERT24-B: 15.7;LHCN-M2: 7.5;U-87 MG: 10.4;U-937: 4.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059745 Approved "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA059745: AB_2684120" "unprognostic (1.02e-1)" "unprognostic (1.88e-2)" "unprognostic (1.24e-1)" "unprognostic (5.55e-2)" "unprognostic (2.56e-3)" "unprognostic (8.14e-2)" "unprognostic (3.63e-2)" "unprognostic (6.04e-2)" "unprognostic (4.93e-2)" "unprognostic (9.55e-2)" "unprognostic (1.51e-2)" "unprognostic (4.76e-2)" "unprognostic (4.73e-5)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" 2.1 0.6 0.4 0.8 0.7 10.0 7.5 0.2 2.3 0.9 0.5 0.8 1.3 0.4 0.7 1.7 0.7 0.2 1.0 0.8 0.4 0.9 0.6 0.7 0.7 0.9 0.7 1.6 0.7 0.6 1.0 2.2 0.9 1.6 0.5 0.1 0.8 0.9 0.1 0.5 1.4 0.3 0.8 0.8 0.4 0.4 2.6 0.0 7.8 1.5 0.0 0.3 0.6 2.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 2.0 1.4 1.4 1.4 0.0 3.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 2.1 0.0 15.7 0.1 0.0 0.0 0.5 0.0 0.0 7.5 0.0 0.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 1.9 2.8 0.0 0.0 0.0 10.4 4.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.2 2.3 0.4 0.9 0.7 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.5 4.7 0.7 0.0 1.1 0.0 0.0 0.1 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457559-41470882 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 109.9;lung: 120.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 621.5;Erythroid cells: 303.7;Glandular cells: 288.4;Hofbauer cells: 320.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 46.2" "Lineage enriched" "Detected in many" 26 "T-cells: 46.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 15.4;BJ hTERT+: 80.7;Daudi: 26.2;U-698: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 390000 Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 58.6 6.7 26.7 8.8 33.1 109.9 27.7 21.6 22.7 12.8 5.6 36.1 4.2 5.7 8.7 3.1 5.4 7.6 14.3 15.1 32.1 16.8 11.0 8.3 120.1 10.8 41.7 15.2 1.8 13.4 8.7 7.1 70.6 21.1 10.7 3.6 16.1 33.2 6.8 12.7 10.8 4.9 11.3 22.2 7.3 8.0 7.1 34.8 15.2 26.9 5.8 6.9 9.5 8.7 1.7 1.7 0.2 0.2 0.1 46.2 2.8 0.2 0.1 9.0 0.0 1.7 15.4 0.3 0.2 80.7 0.0 0.3 11.2 0.1 26.2 0.2 1.0 0.0 0.2 0.3 0.5 0.1 2.7 1.3 0.0 1.9 0.8 0.9 0.9 0.3 1.2 1.7 0.3 11.2 0.1 9.2 6.1 2.0 0.0 0.2 0.0 5.8 0.5 0.1 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.8 0.2 5.0 6.2 0.0 1.0 0.5 0.1 0.0 0.0 27.6 0.0 0.6 0.2 0.0 0.2 0.0 1.6 0.1 1.6 1.2 13.8 4.4 1.7 1.7 46.2 10.5 0.2 0.1 0.0 0.5 23.1 2.8 26.7 33.1 21.6 21.7 32.1 16.8 41.7 15.2 21.1 34.8 229.3 54.7 23.2 621.5 76.8 0.8 12.0 0.0 38.8 47.8 3.5 2.0 3.9 29.9 0.6 7.3 237.2 0.3 303.7 0.0 5.3 88.9 288.4 49.5 0.8 320.9 0.0 81.3 31.9 23.8 7.0 7.5 180.3 183.9 0.0 7.4 1.4 0.3 3.4 2.1 0.5 1.4 122.9 80.2 14.1 4.1 57.0 9.3 44.5 6.6 105.6 RGL3 FLJ32585 ENSG00000205517 "Ral guanine nucleotide dissociation stimulator like 3" Q3MIN7 19 11384341-11419342 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 65.1;thyroid gland: 38.2" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Muller glia cells: 28.8;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 14.8;CACO-2: 8.4;RT4: 17.4;SK-BR-3: 7.7;T-47d: 12.8" "Region enriched" "Detected in single" 6 "cerebellum: 10.1" "HPA042763, HPA043615, HPA064578" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA042763: AB_10968569, HPA043615: AB_10959470, HPA064578: " "prognostic favorable (7.35e-4)" "unprognostic (3.12e-2)" "unprognostic (2.92e-1)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (6.60e-2)" "unprognostic (3.82e-2)" "unprognostic (5.31e-2)" "unprognostic (1.24e-2)" "unprognostic (1.48e-2)" "unprognostic (3.19e-3)" "unprognostic (5.99e-2)" "prognostic favorable (6.61e-4)" "unprognostic (4.17e-2)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (7.12e-3)" 4.3 6.2 5.3 1.2 7.9 0.7 4.3 1.9 6.8 7.6 1.9 3.4 23.3 1.8 4.9 14.5 1.1 5.3 6.5 5.2 8.2 1.3 20.7 6.0 7.5 1.2 6.7 3.0 1.6 12.1 65.1 9.1 5.8 7.9 4.1 1.8 7.3 3.5 23.9 5.0 1.1 1.2 1.4 9.5 5.1 6.8 1.1 7.3 0.0 38.2 0.4 0.9 4.5 4.5 0.3 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.9 0.1 14.8 0.9 1.1 0.5 1.6 8.4 6.0 0.0 5.4 1.0 2.1 3.7 0.0 0.0 0.0 0.0 0.0 0.1 3.1 2.6 2.3 0.0 0.0 0.0 0.1 0.1 0.0 3.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.3 1.1 0.0 0.6 1.6 5.1 17.4 0.8 4.4 0.2 7.7 2.6 3.1 12.8 0.0 0.0 2.7 0.0 2.0 0.7 0.0 0.4 0.7 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 5.3 7.9 1.9 6.8 8.2 1.3 6.7 3.0 7.9 7.3 17.9 15.2 0.0 2.0 0.1 0.1 2.5 5.1 2.7 22.7 48.8 0.0 12.2 10.0 8.3 0.0 3.9 0.0 0.0 3.6 9.6 4.6 1.0 1.1 4.3 2.6 0.0 9.9 25.8 4.3 0.0 3.4 0.6 5.0 0.0 7.1 28.8 5.8 5.3 0.4 3.0 0.4 38.8 12.4 0.5 1.2 0.0 10.1 0.0 2.7 1.4 RGL4 Rgr ENSG00000159496 "Ral guanine nucleotide dissociation stimulator like 4" Q8IZJ4 22 23688136-23699176 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.3;bone marrow: 55.8" "Cell type enriched" "Detected in some" 7 "T-cells: 53.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "neutrophil: 81.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 81.3" "Group enriched" "Detected in many" 5 "MOLT-4: 15.1;U-937: 35.7" HPA035979 Uncertain Approved Centrosome "Intracellular and membrane" NA NA Centrosome "HPA035979: AB_10673227" "unprognostic (1.48e-4)" "unprognostic (2.75e-4)" "unprognostic (4.44e-2)" "unprognostic (1.11e-4)" "unprognostic (3.10e-1)" "unprognostic (2.93e-4)" "unprognostic (4.92e-2)" "unprognostic (2.06e-2)" "unprognostic (2.78e-1)" "unprognostic (3.11e-1)" "unprognostic (4.25e-2)" "unprognostic (3.80e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-2)" "unprognostic (1.26e-1)" "unprognostic (1.07e-3)" 1.6 1.0 0.5 9.8 0.6 55.8 0.6 1.0 0.8 0.4 1.0 0.2 0.0 1.3 1.0 1.0 1.1 1.2 1.8 10.8 0.5 0.5 0.8 1.5 6.7 19.9 0.6 0.0 1.4 1.0 0.0 0.7 0.8 0.5 0.5 0.2 0.4 2.2 0.0 0.8 1.9 4.1 0.0 0.6 21.6 0.9 18.4 0.3 11.1 1.0 0.3 8.9 1.1 3.6 0.9 0.8 81.3 12.0 4.8 17.8 5.8 0.9 0.3 3.5 1.5 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.7 0.6 1.1 0.3 0.0 0.6 1.7 0.0 0.0 0.0 1.1 2.2 0.5 1.2 0.2 0.0 1.9 2.3 0.0 0.0 0.0 0.0 1.8 0.0 1.2 1.2 1.8 0.0 0.5 15.1 2.1 0.2 0.3 0.4 5.4 1.2 0.8 0.0 1.0 1.1 1.7 1.0 2.2 0.3 2.0 0.7 1.2 1.5 2.0 1.2 1.3 0.6 3.2 0.5 0.8 1.1 35.7 0.9 11.8 0.4 58.6 9.5 2.9 9.8 0.9 12.4 10.9 0.8 0.7 17.8 15.9 81.3 4.8 12.0 0.1 17.0 5.8 0.5 0.6 1.0 0.5 0.5 0.5 0.6 0.0 0.5 0.3 0.0 7.9 5.0 0.0 0.8 0.5 0.4 0.0 0.0 2.3 0.0 2.0 0.0 0.0 1.9 4.4 0.0 0.0 0.0 1.5 0.1 0.2 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.8 0.4 0.0 0.0 1.7 0.0 0.0 0.0 2.1 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.3 0.0 53.2 0.0 0.0 RGMA "RGM, RGMa" ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 59.0;skeletal muscle: 85.5" "Group enriched" "Detected in many" 5 "Leydig cells: 110.1;Peritubular cells: 110.0;Spermatogonia: 37.2" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 31.0;BEWO: 9.1;MOLT-4: 9.2;NTERA-2: 13.9;REH: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 1400000 Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 12.2 3.3 17.4 17.6 24.7 1.8 9.3 11.0 59.0 21.0 22.2 22.2 0.9 9.1 21.8 9.4 23.1 12.1 9.5 7.7 19.3 16.2 2.3 1.6 2.8 3.1 23.0 12.8 16.6 9.1 1.9 2.1 2.5 30.9 5.5 6.5 2.3 16.2 7.0 85.5 4.9 12.3 46.9 36.8 2.2 26.6 15.8 23.1 0.2 2.9 12.2 5.6 4.1 8.8 1.3 0.7 1.7 1.0 0.7 0.5 0.2 1.2 0.2 31.0 0.5 6.5 3.6 9.1 0.2 0.0 0.0 0.0 0.3 0.4 0.1 0.1 0.2 0.0 2.0 5.2 0.1 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.1 0.1 3.8 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.6 9.2 0.1 13.9 0.0 0.0 8.0 7.1 0.0 0.0 0.3 3.3 1.8 0.3 0.1 0.0 1.7 2.5 1.6 0.1 0.0 6.7 0.3 0.0 0.1 0.0 0.1 0.1 0.1 0.8 1.4 0.7 0.6 0.4 1.0 0.3 0.6 0.5 0.5 0.1 1.3 0.4 0.5 1.7 0.7 0.4 0.7 0.3 0.2 17.4 24.7 11.0 21.3 19.3 16.2 23.0 12.8 30.9 23.1 0.0 1.0 0.0 15.6 4.8 0.2 3.2 0.0 1.4 2.3 0.0 2.0 3.8 0.0 4.7 0.8 1.1 0.0 0.0 0.6 1.0 7.4 13.3 0.0 0.0 1.8 0.0 0.0 3.1 3.7 2.6 110.1 1.1 3.3 0.0 0.0 4.1 0.6 0.0 110.0 0.0 1.1 12.9 12.3 0.7 37.2 2.5 2.1 0.7 0.0 12.0 RGN "RC, SMP30" ENSG00000130988 Regucalcin Q15493 X 47078355-47093314 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 51.0;liver: 118.8" "Cell type enhanced" "Detected in many" 13 "Distal tubular cells: 49.7;Hepatocytes: 141.5;Muller glia cells: 48.0;Peritubular cells: 65.4;Proximal tubular cells: 86.9" "Cancer enriched" "Detected in many" 6 "liver cancer: 47.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 16.5;fHDF/TERT166: 5.3;Hep G2: 24.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA029102, HPA029103, HPA029104" Enhanced Approved Cytosol NA NA 47000 Cytosol "HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: " "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (5.56e-3)" "unprognostic (8.22e-3)" "unprognostic (1.32e-2)" "prognostic favorable (7.55e-4)" "unprognostic (2.60e-3)" "unprognostic (2.23e-2)" "unprognostic (8.38e-2)" "unprognostic (3.37e-2)" "unprognostic (1.14e-2)" "prognostic favorable (5.10e-10)" "unprognostic (1.69e-2)" "unprognostic (2.43e-1)" "unprognostic (7.82e-2)" "unprognostic (5.22e-2)" 2.6 51.0 6.7 0.6 6.5 0.4 1.5 8.4 6.2 2.8 1.9 6.2 2.5 4.5 2.3 6.1 1.5 1.7 2.0 4.5 6.1 4.2 17.6 118.8 4.9 0.7 5.9 4.5 7.5 12.7 6.2 2.5 4.2 5.0 4.8 1.1 8.4 7.5 6.3 3.8 0.6 4.6 4.9 4.4 1.1 2.9 1.5 5.2 0.0 6.5 1.6 0.6 2.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.3 0.6 0.0 0.0 16.5 0.0 0.0 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.6 0.8 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.7 6.5 8.4 6.2 6.1 4.2 5.9 4.5 5.0 5.2 6.0 2.2 0.0 2.9 0.5 10.2 25.8 7.6 2.7 1.2 14.0 0.0 0.1 49.7 8.4 0.4 1.8 0.0 0.0 7.9 0.1 7.5 0.9 0.0 141.5 0.1 4.8 4.6 6.2 4.0 0.6 23.0 0.0 1.7 0.0 0.0 48.0 7.8 0.0 65.4 86.9 1.9 12.9 8.0 0.2 0.2 0.3 0.2 0.0 0.3 1.1 RGPD1 RGP1 ENSG00000187627 "RANBP2-like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.4;placenta: 8.0;testis: 17.7" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 1.6;Early spermatids: 1.9;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 8.8;MOLT-4: 13.2;NTERA-2: 4.0;RPMI-8226: 2.9;SuSa: 7.7" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.1 0.2 0.2 1.7 1.1 4.8 8.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.3 17.7 0.2 0.5 0.0 0.1 1.3 0.0 0.1 0.0 1.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 13.2 0.2 4.0 0.2 0.0 0.1 0.1 2.9 0.0 0.0 0.1 0.8 0.2 0.0 0.0 7.7 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.7 0.0 0.2 0.1 0.8 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 RGPD2 "RANBP2L2, RGP2" ENSG00000185304 "RANBP2-like and GRIP domain containing 2" P0DJD1 2 87755955-87825952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.3;testis: 12.3" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 5.7;Early spermatids: 4.3;Late spermatids: 2.3;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "T-reg: 11.3" "Lineage enriched" "Detected in single" 12 "T-cells: 11.3" "Cell line enhanced" "Detected in some" "BEWO: 10.7;JURKAT: 5.2;MOLT-4: 12.2;NTERA-2: 5.3;SuSa: 15.5;THP-1: 4.9" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.49e-2)" "unprognostic (1.99e-1)" "unprognostic (1.26e-2)" "unprognostic (2.04e-2)" "unprognostic (1.69e-1)" "unprognostic (2.05e-1)" "unprognostic (7.46e-3)" "unprognostic (1.71e-1)" "unprognostic (1.72e-2)" "unprognostic (4.10e-2)" "unprognostic (4.24e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-6)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (5.09e-2)" "unprognostic (2.59e-1)" 0.7 2.1 0.1 0.6 0.2 7.1 0.8 1.3 0.3 4.6 0.8 1.2 1.1 0.0 0.3 2.4 0.0 0.5 0.0 0.2 0.4 0.8 1.2 1.3 0.1 1.7 6.3 0.1 2.7 7.5 0.6 0.1 0.8 0.1 0.6 0.6 1.8 0.0 0.1 0.9 1.7 12.3 0.9 1.6 0.3 0.9 0.9 0.0 0.5 0.1 0.0 11.3 0.4 0.0 0.0 0.6 0.0 0.0 0.0 10.7 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.1 0.1 2.5 0.2 0.0 0.1 0.0 5.2 3.7 0.3 0.0 0.4 12.2 0.0 5.3 2.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 2.7 4.3 0.1 0.0 15.5 0.0 4.9 0.1 0.8 0.1 0.0 0.0 2.4 0.3 0.1 0.0 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.4 0.9 2.7 0.5 0.0 0.9 1.4 0.2 0.4 0.0 0.0 0.0 11.3 0.4 0.0 0.6 0.0 0.0 0.1 0.2 5.7 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.1 4.3 0.0 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.4 0.0 0.8 0.0 0.0 0.0 RGPD3 RGP3 ENSG00000153165 "RANBP2-like and GRIP domain containing 3" A6NKT7 2 106391290-106468376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 11.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 14.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HEL: 3.3;MOLT-4: 10.3;RPMI-8226: 3.3" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (5.51e-2)" "unprognostic (6.61e-2)" "unprognostic (2.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (6.86e-2)" "unprognostic (3.10e-1)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.44e-1)" "unprognostic (4.74e-3)" "unprognostic (5.05e-2)" "unprognostic (3.70e-1)" "unprognostic (3.42e-1)" "unprognostic (1.34e-1)" 0.2 0.1 0.3 0.0 0.5 0.4 0.4 0.3 0.9 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.4 1.4 0.7 0.1 0.1 0.6 0.2 0.2 0.7 0.7 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.4 0.7 0.1 11.6 0.1 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 1.2 0.2 0.4 0.5 0.5 0.4 0.3 0.5 0.1 0.4 0.5 0.4 0.3 0.5 0.0 0.0 0.1 0.4 1.4 0.3 1.2 0.1 0.7 0.3 0.1 3.3 0.3 0.6 0.3 0.1 0.1 0.1 0.3 1.1 0.4 0.4 0.3 0.7 0.6 0.0 0.5 0.2 10.3 0.1 0.4 0.0 0.1 0.0 0.1 3.3 0.1 0.6 0.5 0.1 0.4 0.0 0.2 0.3 0.1 0.3 0.2 0.3 0.2 0.6 0.5 0.7 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.1 0.6 0.5 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.2 1.2 0.2 0.0 1.4 0.0 0.0 0.1 0.0 1.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 2.1 0.0 0.0 0.0 0.0 0.0 RGPD4 "DKFZp686P0288, RGP4" ENSG00000196862 "RANBP2-like and GRIP domain containing 4" Q7Z3J3 2 107826937-107890841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 8.6" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 4.8;Early spermatids: 7.2;Late spermatids: 2.1;Spermatocytes: 2.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Cell line enriched" "Detected in single" 12 "U-266/70: 4.4" "HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (4.96e-2)" "unprognostic (3.04e-1)" "unprognostic (4.38e-1)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (1.29e-1)" "unprognostic (3.05e-3)" "unprognostic (7.79e-2)" "unprognostic (1.52e-1)" "unprognostic (4.47e-1)" "unprognostic (6.05e-2)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 RGPD8 "RanBP2alpha, RANBP2L1" ENSG00000169629 "RANBP2-like and GRIP domain containing 8" O14715 2 112370092-112434488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 14.0" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Cardiomyocytes: 6.9;Ciliated cells: 10.7;Early spermatids: 19.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.6;hTEC/SVTERT24-B: 12.4" "HPA045704, HPA049497, HPA051675, HPA067564" Uncertain Uncertain "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (1.05e-1)" "unprognostic (1.55e-1)" "unprognostic (3.62e-1)" "unprognostic (7.61e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-3)" "unprognostic (3.17e-3)" "unprognostic (3.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.57e-1)" "unprognostic (9.18e-3)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (1.05e-2)" 2.4 0.9 0.5 1.3 0.9 6.2 2.3 2.6 2.7 1.7 1.5 0.4 1.9 2.1 1.1 1.6 1.4 1.7 0.6 0.8 1.3 2.8 2.4 0.9 0.6 2.2 2.3 2.0 2.8 2.0 1.4 1.0 1.3 1.6 1.5 2.4 1.3 1.5 0.8 1.3 1.2 14.0 2.1 1.4 1.9 1.5 2.9 2.1 3.1 2.4 1.4 5.1 1.2 6.2 3.0 4.6 2.8 1.4 3.1 0.1 2.9 2.2 2.3 1.7 5.4 0.4 0.0 1.9 3.4 1.9 2.7 11.0 1.5 2.4 7.7 3.6 14.6 3.8 2.9 1.7 0.1 0.2 0.5 2.1 12.4 3.1 4.7 2.0 2.3 7.4 0.4 3.4 2.3 6.7 0.8 2.8 0.8 3.3 0.0 0.7 0.0 1.0 2.8 2.9 0.6 7.2 0.1 1.6 3.1 0.7 3.2 8.7 1.5 2.2 4.9 4.3 0.1 0.0 0.0 0.4 1.8 0.3 3.1 1.3 1.3 3.5 1.0 5.1 1.7 2.3 2.9 1.4 2.9 3.2 2.2 1.0 1.4 2.4 2.1 1.3 1.2 8.9 2.2 0.0 0.2 0.3 0.7 6.9 0.0 10.7 3.4 0.0 2.0 0.1 0.0 0.4 19.2 0.0 0.0 0.0 1.0 0.1 0.4 0.0 4.7 0.0 0.4 0.0 0.0 0.6 0.6 6.2 0.3 1.1 0.0 3.6 0.0 0.2 1.0 0.0 0.0 0.1 0.6 0.0 0.5 4.3 1.1 0.0 0.3 0.0 0.0 0.1 RGR RP44 ENSG00000148604 "Retinal G protein coupled receptor" P47804 10 84245053-84259960 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 228.3" "Cell type enriched" "Detected in some" 36 "Muller glia cells: 1479.5" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 4.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "midbrain: 30.1;olfactory region: 95.6;thalamus: 30.2" NA NA "unprognostic (9.28e-2)" "unprognostic (1.05e-1)" "unprognostic (1.37e-1)" "unprognostic (9.53e-2)" "unprognostic (4.57e-2)" "unprognostic (1.57e-1)" "unprognostic (1.59e-1)" "unprognostic (1.97e-1)" 0.4 0.4 6.6 0.5 6.1 1.3 0.6 0.4 18.1 0.5 0.4 0.6 0.0 0.3 0.5 1.1 0.6 0.3 0.3 0.3 3.0 2.2 0.4 0.4 0.4 0.6 3.2 1.3 0.5 0.3 0.2 0.4 0.4 1.1 0.5 0.6 228.3 0.6 0.4 0.6 1.1 0.5 0.2 0.2 0.5 0.4 1.2 0.7 0.0 0.4 0.0 0.3 0.3 0.0 0.9 0.9 2.2 0.8 1.0 0.7 0.1 0.6 0.7 0.8 1.6 0.5 0.5 0.4 0.4 0.4 1.0 0.4 1.5 0.2 0.8 0.7 1.2 1.3 1.2 0.3 0.7 0.2 0.5 0.2 0.3 3.0 1.0 0.2 1.4 1.7 0.3 0.7 0.5 1.2 2.6 0.3 0.7 0.6 1.4 0.0 1.2 0.5 0.9 1.5 0.2 0.2 0.5 0.5 1.5 0.0 1.5 0.3 0.4 1.0 0.7 1.4 1.2 0.2 0.1 4.0 1.6 2.1 0.8 0.3 1.2 0.2 1.2 0.3 1.3 1.0 1.0 0.8 0.8 0.6 0.8 0.4 0.8 0.7 0.5 0.3 0.9 0.6 0.6 2.2 1.0 0.4 0.9 0.2 0.1 6.6 6.1 0.4 7.3 3.0 2.2 3.2 1.3 1.1 0.7 0.0 0.0 0.0 0.0 0.0 19.7 0.3 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 7.9 0.3 0.0 0.0 0.0 0.0 1479.5 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RGS1 "1R20, BL34, IER1, IR20" ENSG00000090104 "Regulator of G protein signaling 1" Q08116 1 192575727-192580031 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 124.8" "Cell type enhanced" "Detected in many" 16 "granulocytes: 1329.7;Hofbauer cells: 403.4;Macrophages: 726.1;monocytes: 582.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 16.7;T-reg: 14.5" "Group enriched" "Detected in many" 5 "granulocytes: 16.7;T-cells: 14.5" "Cell line enriched" "Detected in some" 4 "U-266/70: 145.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074572 Approved NA NA "HPA074572: " "unprognostic (3.68e-3)" "unprognostic (1.14e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-1)" "unprognostic (4.37e-1)" "unprognostic (3.87e-3)" "unprognostic (6.61e-2)" "unprognostic (1.38e-1)" "unprognostic (3.23e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (4.91e-5)" "prognostic unfavorable (9.57e-4)" "unprognostic (4.01e-2)" "unprognostic (9.90e-2)" "unprognostic (4.56e-2)" 46.1 25.9 8.9 46.3 12.0 37.9 19.3 1.9 11.0 15.8 17.5 12.2 2.6 6.8 5.5 5.0 19.0 6.2 32.5 8.4 16.2 19.4 5.9 16.4 39.8 36.5 32.9 4.9 5.1 5.1 2.7 11.4 5.9 43.7 12.8 33.3 5.9 15.6 4.1 4.5 4.6 22.5 23.7 124.8 20.1 9.8 7.9 20.0 24.8 6.3 12.6 24.0 40.3 10.5 0.0 3.3 16.7 0.1 0.5 14.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 145.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 16.7 0.6 0.1 1.3 0.0 3.7 3.2 0.4 0.0 0.3 2.9 0.1 0.5 0.0 3.3 14.5 0.4 8.9 12.0 1.9 11.0 16.2 19.4 32.9 4.9 43.7 20.0 11.9 168.0 115.1 5.1 43.7 0.7 1.2 7.6 18.7 23.9 0.0 0.0 2.0 0.0 0.0 1.4 2.7 1.4 70.0 2.4 1.7 15.5 2.9 1329.7 0.8 403.4 0.0 4.6 3.1 135.8 6.5 2.8 726.1 237.8 582.5 0.4 1.0 0.2 3.5 0.7 1.0 1.5 19.4 9.8 0.4 1.1 35.1 5.0 265.3 0.4 6.4 RGS10 ENSG00000148908 "Regulator of G protein signaling 10" O43665 10 119499828-119542708 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.9;lymphoid tissue: 96.9" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 256.9;granulocytes: 281.0;Hofbauer cells: 444.1;Macrophages: 293.8;monocytes: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004559, HPA021305, HPA058485" Enhanced Supported Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732" "unprognostic (1.64e-2)" "prognostic favorable (6.81e-4)" "unprognostic (7.98e-2)" "prognostic favorable (6.32e-4)" "unprognostic (5.21e-2)" "unprognostic (6.19e-2)" "unprognostic (4.32e-3)" "unprognostic (6.35e-2)" "unprognostic (9.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.20e-10)" "unprognostic (2.50e-1)" "unprognostic (9.20e-2)" "unprognostic (7.70e-2)" "unprognostic (7.92e-3)" 9.6 7.7 11.9 28.2 12.1 23.6 15.4 2.8 12.4 25.8 44.0 17.0 5.3 12.5 15.3 13.1 21.9 10.8 18.8 11.7 12.0 10.5 8.3 3.9 13.5 47.6 17.4 6.7 10.3 3.9 0.8 6.6 16.9 10.5 17.8 18.9 6.4 18.1 8.2 13.2 9.3 23.1 19.1 28.5 18.7 12.8 3.7 11.1 96.9 14.7 11.1 34.3 17.9 20.0 6.9 40.2 20.5 26.3 7.6 77.9 63.0 30.1 5.6 0.4 53.0 7.6 49.0 5.0 14.1 21.4 8.5 13.7 1.7 7.2 12.9 7.5 10.9 8.3 6.7 7.9 8.5 22.6 6.3 9.1 34.6 1.6 4.1 12.3 7.0 94.1 19.0 11.4 16.5 15.4 29.1 16.1 12.7 8.8 10.5 9.8 13.7 40.9 24.5 2.4 3.7 15.3 8.0 0.0 4.8 4.3 7.1 2.1 1.7 2.7 34.7 49.6 6.8 6.6 12.5 21.3 4.9 4.2 7.0 12.0 0.5 8.1 4.7 1.5 30.7 2.1 20.5 21.5 0.2 15.0 26.3 15.7 6.9 32.5 25.8 40.2 3.6 77.9 58.5 9.9 7.6 21.6 23.9 35.0 63.0 11.9 12.1 2.8 12.4 12.0 10.5 17.4 6.7 10.5 11.1 0.0 19.1 64.8 23.8 32.6 0.0 1.2 0.0 2.7 11.4 1.8 0.0 10.7 51.4 0.7 1.8 5.3 4.2 256.9 5.6 30.7 57.9 75.3 281.0 0.4 444.1 0.0 18.0 14.7 196.4 3.9 46.3 293.8 89.4 273.3 63.2 1.4 8.0 5.8 8.9 3.8 0.8 12.9 31.9 0.2 1.7 24.6 8.5 117.2 14.2 34.9 RGS11 ENSG00000076344 "Regulator of G protein signaling 11" O94810 16 268301-275980 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.0" "Group enriched" "Detected in many" 8 "Bipolar cells: 66.5;Cone photoreceptor cells: 113.9;Rod photoreceptor cells: 70.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.8;ASC TERT1: 4.0;fHDF/TERT166: 3.6;HHSteC: 5.7;hTERT-RPE1: 4.3;SCLC-21H: 5.5;SH-SY5Y: 4.2;T-47d: 4.6" "Not detected" "Not detected" "HPA041692, HPA043039" Uncertain NA NA "HPA041692: AB_2677619, HPA043039: AB_2678282" "unprognostic (8.39e-2)" "unprognostic (1.97e-1)" "unprognostic (5.46e-2)" "unprognostic (4.55e-3)" "unprognostic (1.46e-1)" "unprognostic (8.50e-2)" "unprognostic (7.48e-2)" "unprognostic (2.02e-1)" "unprognostic (2.93e-1)" "unprognostic (6.56e-2)" "prognostic favorable (1.24e-4)" "unprognostic (1.70e-1)" "unprognostic (1.48e-3)" "unprognostic (6.91e-3)" "unprognostic (2.27e-1)" "unprognostic (1.20e-1)" "unprognostic (1.04e-1)" 10.9 7.6 10.7 2.0 8.4 0.5 1.9 50.0 19.8 2.4 5.0 14.1 5.3 10.5 2.0 2.9 5.1 2.5 3.4 16.7 11.0 12.7 1.4 0.8 4.3 1.1 9.3 8.3 0.8 17.7 2.1 15.6 4.7 9.7 6.1 1.6 10.4 5.6 5.0 1.7 1.9 7.4 2.5 13.3 2.0 7.9 0.9 7.4 0.0 0.8 0.8 0.6 3.1 2.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.8 4.0 0.0 1.2 0.1 0.0 0.0 0.5 0.1 0.0 2.7 3.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 1.5 0.1 0.0 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 2.5 0.0 0.0 0.0 0.2 0.0 0.0 5.5 4.2 2.5 0.3 0.8 0.0 4.6 0.1 2.9 0.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 8.4 50.0 14.8 11.0 12.7 9.3 8.3 9.7 7.4 0.0 0.0 0.0 0.2 0.1 66.5 7.0 0.0 0.0 0.0 0.0 113.9 0.1 0.0 0.1 0.0 0.0 2.0 0.0 0.9 0.1 5.0 0.5 0.0 0.0 0.2 9.5 9.9 5.5 0.0 0.0 0.9 0.0 1.7 1.0 0.1 3.0 0.7 2.3 1.8 0.0 70.8 0.0 5.2 0.4 1.1 0.5 0.7 0.0 1.2 0.1 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 118.6;Suprabasal keratinocytes: 96.1;Urothelial cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA054646: AB_2682555, HPA067421: AB_2685836" "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favorable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 4.0 5.1 10.3 7.4 3.5 2.7 4.3 4.3 3.5 4.5 3.3 4.1 2.4 1.0 2.7 3.8 6.6 3.9 2.0 13.9 1.5 0.1 1.6 0.4 2.9 10.0 3.1 0.3 5.7 2.3 9.5 2.3 3.2 4.1 9.9 3.6 4.7 0.2 4.1 3.4 0.7 10.8 4.9 2.3 4.9 10.2 4.0 3.3 2.3 12.0 11.7 12.0 2.7 1.9 9.1 2.6 4.7 6.9 7.4 8.8 5.8 1.8 4.6 5.1 4.0 2.3 5.1 6.0 6.2 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 6.0 8.3 0.5 118.6 75.0 19.0 7.5 15.3 29.4 20.5 5.2 27.5 5.3 3.3 9.0 3.8 21.1 5.1 0.0 9.2 1.0 10.0 34.2 13.9 22.7 19.8 9.5 14.3 25.8 6.1 4.2 13.8 19.0 16.9 5.4 9.9 38.9 11.1 0.0 7.4 18.1 18.7 0.0 8.8 20.2 14.9 96.1 5.6 4.5 8.0 169.4 RGS13 ENSG00000127074 "Regulator of G protein signaling 13" O14921 1 192636138-192660306 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.9" "Cell type enriched" "Detected in some" 9 "granulocytes: 489.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 35 "basophil: 9.2" "Lineage enriched" "Detected in single" 35 "granulocytes: 9.2" "Cell line enriched" "Detected in some" 17 "Daudi: 34.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA076656 Enhanced NA NA "HPA076656: " "unprognostic (1.99e-2)" "unprognostic (6.08e-3)" "unprognostic (3.25e-4)" "unprognostic (1.86e-1)" "unprognostic (2.31e-1)" "unprognostic (4.37e-5)" "unprognostic (1.93e-1)" "unprognostic (2.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (7.39e-2)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (3.42e-1)" "unprognostic (2.35e-1)" "unprognostic (6.86e-2)" "unprognostic (1.96e-1)" 2.2 0.1 0.1 46.9 0.6 0.2 1.3 0.1 0.1 2.4 4.2 0.0 1.1 2.2 1.5 1.3 1.3 0.4 3.5 0.4 0.1 0.4 0.5 0.2 3.6 31.7 0.2 0.0 0.2 0.7 0.0 0.8 0.0 0.1 3.9 1.0 0.5 1.4 1.6 0.3 1.9 11.9 2.9 0.2 1.2 1.9 0.7 0.0 0.6 0.6 1.7 22.9 1.4 1.8 0.2 0.1 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.4 0.2 0.0 0.1 0.0 3.0 53.5 3.7 2.5 1.6 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 489.4 0.0 0.3 0.0 6.8 0.0 0.8 0.0 0.0 4.6 6.8 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 1.3 0.3 0.0 RGS14 ENSG00000169220 "Regulator of G protein signaling 14" O43566 5 177357837-177372601 "Predicted intracellular proteins" "Cell cycle, Cell division" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.9;brain: 76.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 61.1;Proximal tubular cells: 68.0;Suprabasal keratinocytes: 100.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "basal ganglia: 76.1" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 40.7;HMC-1: 36.4;NB-4: 16.0;RPMI-8226: 21.0" "Group enriched" "Detected in many" 11 "amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5" "Low region specificity" "Detected in all" "HPA046847, HPA061819" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments" No No Nucleoplasm "Vesicles, Plasma membrane, Intermediate filaments" "HPA046847: AB_2679836, HPA061819: " "unprognostic (6.05e-3)" "unprognostic (1.65e-2)" "unprognostic (8.57e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.97e-4)" "unprognostic (7.27e-2)" "prognostic unfavorable (1.84e-6)" "unprognostic (1.95e-2)" "unprognostic (4.34e-2)" "unprognostic (2.04e-3)" "unprognostic (2.71e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" "unprognostic (3.17e-2)" "unprognostic (1.66e-1)" "unprognostic (1.17e-2)" "unprognostic (2.78e-2)" 1.9 1.5 7.7 12.5 76.1 17.5 1.3 0.4 8.8 1.7 2.6 1.9 0.6 5.1 1.3 1.4 3.2 6.6 3.4 0.7 17.1 1.9 2.1 6.9 4.3 15.5 2.5 3.6 0.8 1.5 0.1 0.9 1.0 0.8 1.2 0.5 0.7 5.2 1.8 1.6 3.5 5.7 1.2 0.7 12.8 3.7 0.7 4.4 24.2 4.3 1.7 12.9 4.9 1.6 9.2 12.2 43.9 12.3 6.5 20.7 12.4 1.9 0.4 0.7 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.2 1.2 3.8 4.8 2.7 0.0 0.4 3.9 0.0 1.2 0.0 40.7 0.1 7.5 0.1 1.5 0.2 5.8 36.4 0.6 0.3 0.2 0.2 0.0 0.2 5.5 1.3 9.8 0.0 0.1 7.8 16.0 0.6 1.9 1.0 3.6 0.0 21.0 0.4 0.1 0.1 0.7 0.0 0.1 3.0 0.0 1.3 9.2 0.3 0.0 0.7 0.0 3.5 5.2 2.5 2.1 0.6 11.0 0.9 18.6 12.3 43.9 20.5 11.4 20.7 9.2 19.1 18.7 12.2 8.0 16.0 14.3 43.0 6.5 11.6 5.4 18.2 12.4 7.7 76.1 0.4 8.8 17.1 1.9 2.5 3.6 0.8 4.4 6.0 4.1 20.7 25.0 61.1 0.4 1.6 40.8 14.7 4.5 10.4 2.0 3.2 26.6 10.5 0.5 6.0 7.5 0.0 14.4 8.2 5.3 12.3 24.3 55.7 21.0 0.0 4.6 7.4 13.7 0.8 2.6 16.9 20.3 0.0 5.3 8.0 12.8 14.4 2.1 68.0 1.9 0.0 5.1 0.0 15.1 100.6 2.7 40.0 3.3 13.7 RGS16 "A28-RGS14, RGS-r" ENSG00000143333 "Regulator of G protein signaling 16" O15492 1 182598623-182604408 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 67.5" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 519.8;Smooth muscle cells: 484.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 32.0;NB-4: 17.6;SCLC-21H: 33.4;U-266/70: 37.8;U-698: 47.2" "Region enriched" "Detected in many" 5 "thalamus: 87.4" "Group enriched" "Detected in many" 6 "midbrain: 92.1;pons and medulla: 72.2;thalamus: 126.3" "HPA053250, HPA055824" Uncertain Approved Cytosol NA NA Cytosol "HPA053250: AB_2682090, HPA055824: AB_2682934" "unprognostic (4.03e-2)" "unprognostic (6.08e-2)" "unprognostic (4.87e-2)" "unprognostic (1.08e-2)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (3.55e-2)" "unprognostic (2.01e-2)" "unprognostic (2.10e-1)" "unprognostic (4.69e-2)" "unprognostic (2.04e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.93e-2)" "unprognostic (3.65e-2)" "unprognostic (9.07e-3)" "unprognostic (5.39e-2)" 17.8 7.5 4.5 18.6 9.8 3.0 5.2 3.3 9.9 2.4 6.4 20.7 7.2 2.3 2.6 3.7 4.5 8.0 10.8 3.6 7.4 12.3 6.7 6.8 13.3 10.8 12.0 1.3 2.9 4.3 6.0 28.1 7.9 16.5 3.7 4.1 9.1 3.3 40.8 5.2 3.0 3.5 8.0 25.0 6.1 5.1 1.2 10.7 0.3 67.5 16.2 4.9 6.1 4.2 5.8 11.5 2.2 0.9 3.4 5.4 1.4 0.2 0.0 1.9 0.0 0.3 0.0 14.8 0.0 0.5 0.0 0.0 0.0 0.1 32.0 0.1 0.0 0.0 0.1 3.5 0.3 0.0 3.6 2.6 3.3 0.3 0.0 0.5 5.3 2.9 0.7 5.4 0.0 0.2 0.0 0.0 1.1 0.1 5.6 0.0 3.5 0.1 17.6 10.3 0.2 1.0 0.0 10.6 7.6 0.0 1.5 33.4 3.5 0.0 2.7 0.0 2.0 1.1 4.2 0.0 0.1 0.7 0.9 1.6 37.8 1.7 47.2 0.1 3.4 1.7 2.2 0.4 0.7 0.4 0.5 0.8 5.8 5.4 0.6 0.6 2.3 2.5 0.8 1.4 3.4 0.9 11.5 3.2 1.4 4.5 9.8 3.3 9.9 7.4 12.3 12.0 1.3 16.5 10.7 125.0 148.7 13.4 6.7 73.2 519.8 16.5 0.0 4.0 31.8 8.7 17.7 6.1 0.0 1.6 0.4 67.1 1.3 23.3 2.0 125.4 54.3 12.1 72.5 1.0 15.6 30.2 48.3 25.8 3.7 0.0 0.3 13.9 77.6 20.8 3.8 129.8 2.8 0.9 0.4 0.3 30.5 64.7 484.2 0.0 1.5 55.2 28.8 5.7 1.9 9.0 RGS17 "RGS-17, RGSZ2" ENSG00000091844 "Regulator of G protein signaling 17" Q9UGC6 6 153004459-153131249 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 17.3;Ductal cells: 11.7;Intestinal endocrine cells: 40.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.9;GAMG: 11.0;hTERT-HME1: 14.0;LHCN-M2: 13.9;RH-30: 10.0;U-87 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022276, HPA056493" Approved Approved Vesicles NA NA Vesicles "HPA022276: AB_10794628, HPA056493: AB_2683152" "unprognostic (2.77e-2)" "unprognostic (6.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (3.12e-1)" "unprognostic (3.79e-2)" "unprognostic (7.95e-3)" "unprognostic (1.92e-1)" "unprognostic (5.33e-2)" "unprognostic (5.96e-12)" "unprognostic (2.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 3.0 1.3 14.2 1.5 12.5 3.3 1.4 16.8 10.1 7.1 1.5 1.2 0.0 1.7 2.2 1.1 3.2 1.3 5.9 1.0 8.1 7.3 0.9 0.6 1.4 1.6 3.2 7.8 2.7 4.4 0.3 7.2 0.6 7.9 5.2 2.0 0.2 1.5 1.6 0.6 1.9 1.8 1.4 4.1 1.2 4.3 3.3 3.0 0.3 8.9 0.0 0.6 3.7 1.5 0.5 0.4 1.4 0.3 2.1 1.6 0.2 0.0 4.3 3.2 0.1 1.5 12.9 0.1 0.3 1.4 1.0 2.7 0.0 0.3 0.2 0.3 0.7 11.0 0.2 3.0 3.2 1.5 0.2 0.3 0.5 0.3 0.1 3.5 0.2 1.5 5.4 0.0 5.5 14.0 3.1 6.4 1.2 0.1 0.2 13.9 2.3 0.1 0.3 2.2 0.1 3.5 0.1 10.0 0.1 4.0 1.3 2.2 5.8 0.1 0.0 0.0 0.5 0.0 0.2 3.2 2.2 2.7 2.7 3.9 0.2 0.0 0.1 11.8 0.1 3.0 1.4 0.3 0.4 1.6 0.2 0.2 0.2 0.9 0.6 0.2 0.5 0.3 0.9 1.1 2.1 0.3 0.4 0.2 0.2 14.2 12.5 16.8 10.1 8.1 7.3 3.2 7.8 7.9 3.0 0.0 0.0 0.0 0.6 0.2 17.3 0.8 5.1 4.0 5.7 0.0 0.0 0.1 0.0 11.7 0.1 1.0 0.0 0.0 0.3 0.2 2.0 5.9 10.5 0.0 0.3 3.2 40.3 0.0 0.6 0.4 2.8 0.4 0.0 0.0 0.0 2.2 2.2 0.9 8.5 0.0 3.4 0.0 1.7 0.9 3.2 0.0 0.2 2.1 0.1 7.3 RGS18 RGS13 ENSG00000150681 "Regulator of G protein signaling 18" Q9NS28 1 192158457-192185815 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 66.0;lymphoid tissue: 37.3" "Cell type enhanced" "Detected in some" 26 "granulocytes: 24.3;Kupffer cells: 118.0;Macrophages: 42.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 66.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 66.0" "Group enriched" "Detected in some" 5 "HEL: 29.3;HL-60: 22.4;NB-4: 21.1;U-937: 19.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028727, HPA045780" Uncertain Approved "Golgi apparatus" NA NA 380000 "Golgi apparatus" "HPA028727: AB_2797219, HPA045780: AB_10962728" "unprognostic (3.09e-2)" "unprognostic (4.32e-2)" "unprognostic (8.66e-2)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-2)" "unprognostic (1.48e-1)" "unprognostic (2.18e-2)" "unprognostic (2.58e-1)" "unprognostic (1.87e-1)" "unprognostic (3.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.30e-3)" "unprognostic (8.21e-3)" "unprognostic (2.81e-4)" "unprognostic (1.73e-2)" "unprognostic (9.91e-2)" 3.9 1.9 4.8 11.4 4.6 9.9 1.8 0.9 3.1 2.0 2.2 1.0 0.0 2.3 1.1 2.3 2.0 2.2 4.5 7.5 3.6 2.5 2.7 4.2 16.1 23.0 4.9 0.8 1.6 1.2 0.0 1.2 3.8 4.2 1.8 2.3 0.6 1.6 0.8 0.9 0.9 4.8 2.3 9.2 37.3 1.4 1.3 4.4 3.0 1.3 0.4 3.5 4.6 1.3 0.0 9.8 66.0 14.9 0.1 1.3 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 27.4 9.8 66.0 0.1 12.9 1.3 0.0 0.1 0.2 9.8 0.0 0.0 0.0 32.4 0.1 14.9 2.3 0.0 16.4 4.8 4.6 0.9 3.1 3.6 2.5 4.9 0.8 4.2 4.4 6.0 0.0 2.2 0.0 0.2 0.0 0.4 0.0 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 24.3 0.4 7.6 0.0 0.0 0.6 118.0 0.2 0.3 42.4 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 12.9 0.0 0.1 0.2 0.1 0.1 7.1 0.0 0.0 RGS19 "GAIP, RGSGAIP" ENSG00000171700 "Regulator of G protein signaling 19" P49795 20 64073181-64079988 "Predicted intracellular proteins" Autophagy "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 73.1;Hofbauer cells: 121.6;Kupffer cells: 93.5;Macrophages: 101.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 49.8;NB-4: 39.2;THP-1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056384, HPA069984" Enhanced Supported "Nucleoli fibrillar center,Cell Junctions" NA NA "Cell Junctions" "Nucleoli fibrillar center" "HPA056384: AB_2732602, HPA069984: AB_2732145" "unprognostic (3.98e-2)" "unprognostic (2.32e-1)" "unprognostic (4.26e-3)" "unprognostic (8.42e-2)" "unprognostic (2.03e-1)" "unprognostic (9.94e-2)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.25e-2)" "unprognostic (2.41e-2)" "unprognostic (3.91e-1)" "unprognostic (3.22e-1)" "unprognostic (2.88e-1)" "prognostic unfavorable (2.06e-9)" "unprognostic (1.35e-1)" "unprognostic (2.68e-2)" "unprognostic (6.77e-2)" "unprognostic (4.66e-3)" 7.0 4.8 6.0 19.0 7.5 36.7 12.7 2.5 5.0 3.3 3.5 6.8 1.9 5.5 2.9 2.9 4.4 4.1 4.5 5.1 5.4 4.9 4.0 7.2 10.4 27.2 9.1 2.6 2.7 3.9 0.8 2.6 5.6 5.7 3.9 1.8 2.2 6.1 2.2 1.6 4.3 10.6 3.2 7.1 43.1 5.7 2.8 7.2 15.2 3.7 1.2 19.5 6.1 3.6 17.3 29.9 95.0 55.5 9.1 13.8 22.0 4.9 7.5 2.1 3.9 0.9 1.6 3.7 3.1 2.2 6.5 2.7 11.1 6.8 8.7 8.7 1.9 6.9 4.8 2.2 4.0 1.5 4.2 4.1 12.4 3.8 4.5 1.3 25.2 49.8 1.1 2.4 2.7 0.9 1.3 4.2 5.8 4.7 4.6 1.9 8.8 18.6 39.2 2.2 4.2 9.6 15.7 1.3 6.2 1.8 2.4 4.1 3.9 3.2 2.0 4.1 1.1 2.6 33.3 4.4 6.1 3.1 1.0 3.0 2.9 2.2 10.5 3.4 19.3 4.0 33.1 35.5 95.0 13.4 50.4 13.8 17.3 12.7 12.7 29.9 17.1 8.9 9.2 79.6 9.1 55.5 17.1 13.5 22.0 6.0 7.5 2.5 5.0 5.4 4.9 9.1 2.6 5.7 7.2 3.0 5.5 73.1 4.9 8.7 0.0 2.2 0.0 2.7 4.5 1.8 0.0 2.6 0.0 10.2 0.3 15.2 0.0 23.3 12.7 7.2 6.4 7.3 47.4 0.6 121.6 0.0 0.0 12.3 93.5 0.4 4.0 101.1 5.0 24.4 0.5 0.5 12.8 3.4 1.1 1.7 0.0 12.9 7.2 0.2 6.8 7.9 1.5 48.0 0.8 7.5 RGS2 G0S8 ENSG00000116741 "Regulator of G protein signaling 2" P41220 1 192809039-192812283 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Translation regulation" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.2" "Cell type enhanced" "Detected in many" 16 "granulocytes: 1743.9;Macrophages: 609.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 135.8;neutrophil: 234.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 234.2" "Cell line enhanced" "Detected in many" "hTCEpi: 39.9;hTERT-HME1: 27.6;Karpas-707: 26.2;PC-3: 63.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013385 Supported Cytosol NA NA Cytosol "HPA013385: AB_2668827" "prognostic favorable (2.43e-4)" "unprognostic (9.75e-2)" "unprognostic (1.28e-3)" "unprognostic (4.43e-2)" "unprognostic (1.79e-1)" "unprognostic (1.93e-1)" "unprognostic (2.09e-3)" "unprognostic (1.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.79e-2)" "unprognostic (1.36e-1)" "unprognostic (6.49e-2)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" 22.7 62.0 8.1 39.2 20.1 84.9 23.3 6.0 10.0 20.7 57.5 4.5 50.6 23.2 43.3 34.2 45.5 27.4 35.0 14.2 8.2 13.2 9.4 10.8 24.3 32.6 8.9 6.6 25.1 84.3 1.9 52.6 16.7 16.9 99.8 19.1 44.0 5.0 54.5 4.4 6.4 33.9 135.0 19.0 50.6 22.5 13.0 7.9 3.9 4.2 5.7 6.2 72.1 28.5 0.3 6.2 234.2 26.6 0.1 1.8 12.2 0.0 5.5 7.1 0.6 14.1 2.2 0.4 2.7 3.4 0.9 0.9 4.8 3.2 0.4 0.7 2.5 0.7 2.6 4.6 4.8 0.8 0.7 3.4 1.3 3.6 0.1 6.2 3.2 0.8 2.3 39.9 1.8 27.6 5.1 6.6 2.4 1.1 26.2 2.7 0.0 1.7 4.5 9.5 0.5 63.1 1.7 1.6 1.4 4.6 4.4 2.6 13.4 1.9 0.1 3.0 7.6 0.2 1.6 1.8 1.3 1.2 1.4 1.4 15.6 0.4 1.4 19.2 0.6 4.8 135.8 26.6 38.0 0.8 10.5 1.8 0.3 0.5 0.5 6.2 0.1 0.3 0.3 234.2 0.1 17.7 0.8 0.3 12.2 8.1 20.1 6.0 10.0 8.2 13.2 8.9 6.6 16.9 7.9 47.6 315.5 133.6 46.1 37.5 21.4 56.8 2.5 30.8 62.6 129.1 17.7 168.7 0.0 22.6 22.0 24.3 61.9 23.3 26.0 21.8 64.8 43.7 1743.9 2.1 326.0 20.6 335.5 23.9 383.7 13.9 15.3 609.2 84.4 77.5 43.4 36.4 13.0 20.1 59.1 2.2 35.7 0.0 69.0 5.0 9.4 27.1 103.9 144.7 17.8 7.5 RGS20 "RGSZ1, ZGAP1" ENSG00000147509 "Regulator of G protein signaling 20" O76081 8 53851808-53959303 "Plasma proteins, Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.0" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 29.5;Rod photoreceptor cells: 12.2" "Cancer enhanced" "Detected in many" "melanoma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 17.5;SK-MEL-30: 18.4;U-87 MG: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070193 Enhanced NA NA "HPA070193: AB_2732150" "unprognostic (2.14e-2)" "unprognostic (2.87e-2)" "unprognostic (1.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.48e-1)" "unprognostic (4.97e-2)" "unprognostic (1.91e-5)" "unprognostic (5.03e-5)" "unprognostic (2.15e-1)" "unprognostic (1.57e-2)" "unprognostic (8.86e-3)" "unprognostic (5.28e-2)" "unprognostic (2.75e-8)" "unprognostic (3.71e-3)" "unprognostic (9.78e-3)" "unprognostic (8.32e-2)" "unprognostic (1.69e-2)" 0.7 0.6 12.4 0.7 20.0 0.6 1.0 3.8 17.6 0.9 0.6 1.3 0.0 0.6 0.8 0.6 1.8 0.6 0.6 0.6 6.2 2.2 0.6 0.6 0.7 0.6 1.9 5.6 0.8 0.6 0.6 0.0 3.8 1.4 0.6 0.6 4.7 0.7 0.6 0.6 3.1 0.6 0.6 1.5 0.6 0.6 0.9 2.9 0.0 4.1 1.4 1.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 6.2 12.1 0.2 0.4 1.5 0.0 4.8 2.9 4.2 2.5 0.0 5.4 0.0 0.2 1.4 17.5 6.5 0.2 7.9 2.9 0.0 0.9 1.5 0.9 1.0 2.0 0.0 0.5 0.3 5.1 3.4 10.2 9.5 1.6 0.0 0.4 0.0 7.0 0.0 0.0 0.2 0.2 1.3 2.5 0.0 0.4 0.0 8.2 0.6 7.6 0.7 0.4 0.0 18.4 1.8 0.0 0.0 5.2 1.1 0.0 9.0 3.6 1.5 0.0 0.0 18.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 20.0 3.8 8.2 6.2 2.2 1.9 5.6 1.4 2.9 0.0 0.0 0.0 0.5 1.8 0.6 0.6 0.0 0.0 0.0 0.0 29.5 0.6 0.0 0.4 0.4 0.1 0.0 0.0 0.3 0.7 0.6 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 4.9 1.0 0.0 0.0 0.0 12.2 0.0 0.1 0.0 0.2 0.4 0.6 0.0 0.0 0.4 RGS22 "CT145, DKFZP434I092, PRTD-NY2" ENSG00000132554 "Regulator of G protein signaling 22" Q8NE09 8 99960936-100131268 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 43.3" "Group enriched" "Detected in some" 7 "Early spermatids: 519.1;Late spermatids: 1277.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.0;HL-60: 3.2;HMC-1: 2.2;RPMI-8226: 4.2;SCLC-21H: 1.8;U-2 OS: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053026 Supported "Nucleoli fibrillar center,Actin filaments,Cytosol" NA NA "Nucleoli fibrillar center" "Actin filaments, Cytosol" "HPA053026: " "unprognostic (3.04e-2)" "unprognostic (2.62e-2)" "unprognostic (4.61e-2)" "unprognostic (3.97e-1)" "unprognostic (3.47e-5)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (3.19e-2)" "unprognostic (1.47e-1)" "unprognostic (1.14e-2)" "unprognostic (1.05e-2)" "unprognostic (7.96e-3)" "unprognostic (1.98e-5)" "unprognostic (3.71e-2)" "unprognostic (1.31e-2)" "unprognostic (3.25e-3)" "unprognostic (8.36e-4)" 2.8 1.0 1.8 0.3 2.5 0.3 1.0 0.4 1.4 2.0 0.5 3.4 2.0 0.2 2.9 6.8 0.5 8.5 1.2 0.7 2.6 1.7 0.4 0.3 3.9 0.5 0.9 1.6 6.5 0.6 0.2 10.9 0.6 9.0 2.3 0.3 0.9 0.4 2.2 0.4 0.7 0.5 1.5 1.7 0.3 0.5 43.3 1.3 0.0 0.5 0.0 0.5 0.8 0.8 0.6 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 3.2 2.2 1.2 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.6 0.4 0.0 0.3 0.3 1.3 4.2 0.5 0.3 1.8 0.2 0.0 0.0 0.0 0.9 0.3 0.8 0.0 0.0 2.8 0.0 0.0 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.1 1.8 2.5 0.4 1.4 2.6 1.7 0.9 1.6 9.0 1.3 0.0 0.0 0.0 0.0 1.9 1.3 0.6 0.0 91.0 21.6 0.0 0.0 0.1 0.0 0.0 519.1 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1277.1 121.7 0.5 0.0 0.0 0.0 9.3 0.0 0.0 59.1 0.0 0.2 0.0 0.9 64.9 7.4 1.8 0.7 0.0 0.0 0.0 RGS4 SCZD9 ENSG00000117152 "Regulator of G protein signaling 4" P49798 1 163068775-163076802 "Disease related genes, Predicted intracellular proteins" "Signal transduction inhibitor" Schizophrenia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 88.0" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 10.1;Intestinal endocrine cells: 49.4;Muller glia cells: 14.1;Smooth muscle cells: 10.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 91.6;LHCN-M2: 36.1;SH-SY5Y: 71.9;TIME: 146.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030802 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA030802: AB_10602295" "unprognostic (1.03e-1)" "unprognostic (1.84e-1)" "unprognostic (3.02e-2)" "unprognostic (6.84e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.26e-2)" "unprognostic (1.27e-1)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (6.45e-2)" "unprognostic (2.12e-2)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.97e-4)" "prognostic unfavorable (1.92e-4)" "unprognostic (1.00e-1)" "unprognostic (8.33e-2)" "unprognostic (2.30e-2)" 2.9 20.9 9.1 2.1 45.3 0.5 1.4 1.1 88.0 4.0 1.7 1.0 0.0 2.9 4.8 1.4 6.3 4.9 11.2 4.7 13.9 10.1 1.5 2.6 2.1 2.3 12.1 36.2 1.1 2.7 1.2 6.2 1.3 16.0 3.3 1.8 1.0 0.9 3.9 0.7 0.6 1.6 3.0 1.9 1.5 3.7 2.1 2.1 0.0 1.5 0.2 0.7 2.8 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 3.5 18.5 0.0 12.5 13.6 1.8 4.8 0.0 0.0 0.0 5.5 8.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.0 19.7 2.4 91.6 19.1 0.0 0.0 0.0 36.1 0.0 0.0 0.0 1.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 71.9 0.0 0.0 0.0 0.7 0.0 0.0 146.6 14.9 0.7 2.9 20.7 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 9.1 45.3 1.1 78.8 13.9 10.1 12.1 36.2 16.0 2.1 0.0 0.0 0.0 0.8 0.2 0.2 0.5 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.1 10.1 0.5 0.0 0.0 0.2 0.0 1.7 0.5 0.0 0.0 0.4 0.0 49.4 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 14.1 4.1 0.0 0.0 0.0 1.6 0.0 10.3 0.0 0.2 0.3 0.1 0.0 0.0 0.1 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 9 "Early spermatids: 155.9;Late spermatids: 221.8" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "HEL: 8.3;Karpas-707: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles NA NA Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 30.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 0.0 0.0 0.0 0.0 0.2 1.4 19.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 155.9 0.7 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 221.8 1.7 0.0 0.0 8.2 0.0 0.0 0.0 0.0 7.1 0.1 0.4 12.9 20.2 1.2 1.0 0.1 0.7 0.0 0.0 0.4 RGS7 ENSG00000182901 "Regulator of G protein signaling 7" P49802 1 240775515-241357230 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.5;brain: 38.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 19.9;Horizontal cells: 58.8" "Cancer enhanced" "Detected in some" "glioma: 1.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.6" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.6" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 7.2;HaCaT: 6.9;hTERT-HME1: 8.4;RH-30: 7.4;SH-SY5Y: 6.5;U-2 OS: 7.4;U-251 MG: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB017561 Enhanced Supported Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB017561: AB_2285043" "unprognostic (6.48e-2)" "unprognostic (4.30e-2)" "unprognostic (4.67e-2)" "unprognostic (6.65e-2)" "unprognostic (7.84e-3)" "unprognostic (4.09e-2)" "unprognostic (1.49e-2)" "unprognostic (3.61e-1)" "unprognostic (1.42e-2)" "unprognostic (2.51e-4)" "unprognostic (3.54e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.64e-2)" "unprognostic (2.28e-1)" 0.7 11.5 9.1 0.8 18.3 0.7 0.9 27.6 38.1 0.9 0.8 1.6 1.7 1.0 1.0 0.8 0.9 0.7 1.3 0.7 11.5 8.3 4.2 0.8 0.9 1.1 3.6 8.9 1.3 1.4 0.7 2.8 0.7 4.7 0.8 0.9 1.3 0.7 1.4 0.7 0.9 0.9 0.7 1.4 1.0 4.6 7.8 1.8 0.0 0.7 0.0 1.0 0.7 0.1 0.7 3.6 0.1 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.3 0.9 0.0 2.7 5.3 7.2 0.5 0.0 0.0 0.0 0.4 3.7 4.0 6.9 0.0 0.1 3.6 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.4 0.5 0.5 0.0 0.0 0.0 2.2 0.0 0.0 0.0 3.9 0.3 0.2 0.0 7.4 0.0 0.0 0.0 6.0 6.5 0.4 0.3 0.3 0.2 0.0 0.0 2.8 0.0 7.4 0.4 8.0 0.0 4.3 0.0 1.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 9.1 18.3 27.6 20.7 11.5 8.3 3.6 8.9 4.7 1.8 0.0 0.0 0.8 0.0 0.0 19.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 58.8 6.9 0.6 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 2.0 0.0 0.0 6.4 9.3 0.0 0.0 0.0 0.0 0.0 RGS7BP R7BP ENSG00000186479 "Regulator of G protein signaling 7 binding protein" Q6MZT1 5 64506257-64612312 "Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.1" "Cell type enhanced" "Detected in some" 14 "Ito cells: 20.3;Leydig cells: 6.6;Peritubular cells: 13.1;Sertoli cells: 6.5;Smooth muscle cells: 7.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039600 Approved Uncertain "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039600: AB_2676591" "unprognostic (2.93e-1)" "unprognostic (3.39e-1)" "unprognostic (7.35e-2)" "unprognostic (4.77e-2)" "unprognostic (7.57e-2)" "unprognostic (8.59e-2)" "unprognostic (5.22e-2)" "unprognostic (8.81e-3)" "unprognostic (1.86e-2)" "unprognostic (7.64e-2)" "unprognostic (5.49e-3)" "unprognostic (1.83e-1)" "unprognostic (1.65e-3)" "unprognostic (3.39e-3)" "unprognostic (2.06e-3)" "unprognostic (6.46e-2)" "unprognostic (8.50e-3)" 2.8 4.7 10.2 1.1 22.6 0.4 1.1 10.4 31.1 6.0 1.3 1.5 0.5 1.6 3.7 5.7 2.7 10.9 2.7 3.7 10.8 4.3 3.3 1.7 2.2 0.8 4.0 16.0 3.8 0.8 0.7 1.7 0.4 8.2 7.8 1.4 1.8 2.7 10.9 0.7 1.0 1.7 2.3 1.9 1.3 1.5 1.5 6.7 0.0 1.0 0.0 0.6 2.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 22.6 10.4 25.1 10.8 4.3 4.0 16.0 8.2 6.7 0.0 0.0 0.0 0.1 0.0 4.3 1.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 0.0 1.3 6.6 0.0 0.0 0.0 0.0 2.5 0.0 0.0 13.1 0.0 1.7 6.5 7.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 RGS8 "MGC119067, MGC119068, MGC119069" ENSG00000135824 "Regulator of G protein signaling 8" P57771 1 182641816-182684576 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 29.8;thyroid gland: 15.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 66.1" "Group enriched" "Detected in some" 13 "glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.7;Daudi: 2.4;SCLC-21H: 18.6;U-698: 3.8" "Region enhanced" "Detected in all" "cerebellum: 477.3" "Low region specificity" "Detected in all" HPA076764 Enhanced NA NA "HPA076764: AB_2732321" "unprognostic (6.75e-2)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (9.29e-5)" "unprognostic (2.60e-1)" "unprognostic (2.37e-1)" "unprognostic (9.29e-3)" "unprognostic (1.16e-1)" "unprognostic (3.78e-1)" "unprognostic (2.40e-1)" "unprognostic (3.23e-2)" "unprognostic (7.08e-2)" "unprognostic (2.98e-2)" "unprognostic (6.37e-2)" "unprognostic (1.02e-1)" 0.3 2.6 2.0 0.4 23.3 0.3 0.3 3.7 7.5 0.3 0.3 2.7 0.0 0.5 0.3 0.4 0.5 0.3 0.5 0.3 1.4 3.3 0.4 0.4 0.4 0.6 3.9 2.0 1.2 0.3 0.3 0.5 0.3 29.8 0.3 0.4 1.3 0.6 0.3 0.3 0.3 0.3 0.6 2.6 0.3 0.4 5.7 7.1 0.0 15.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.0 3.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 23.3 3.7 3.5 1.4 3.3 3.9 2.0 29.8 7.1 0.0 0.0 0.0 0.0 0.0 66.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Group enriched" "Detected in some" 4 "HDLM-2: 23.2;HEL: 9.5" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in all" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: AB_2668943" "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favorable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.1 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.0 0.1 0.0 0.1 0.2 23.2 0.5 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 3.6 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 3.0 1.0 0.0 0.9 0.3 21.5 0.4 0.0 1.4 2.3 1.8 306.3 0.0 3.3 6.8 0.6 0.3 0.0 0.0 2.8 0.1 2.3 0.2 0.0 0.0 0.1 49.3 57.3 1.8 0.0 1.7 0.9 3.2 1.7 33.3 2.2 27.8 3.9 0.0 4.6 8.1 472.2 0.0 0.9 0.0 0.4 0.1 0.1 9.2 0.4 0.1 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 10.7;HMC-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA049791: AB_2680884" "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.4 0.2 0.2 0.3 0.4 0.5 0.1 0.5 0.1 1.8 0.1 0.1 0.5 0.2 10.7 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.2 0.0 0.1 0.9 1.5 0.2 0.5 0.0 1.7 0.0 0.1 2.0 0.2 0.4 0.2 0.0 0.1 0.4 0.1 0.0 1.1 0.1 0.0 1.1 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 0.0 0.0 0.0 0.1 0.0 30.8 3.9 0.0 0.0 0.0 1.8 53.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.6 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 70.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 RGSL1 RGSL2 ENSG00000121446 "Regulator of G protein signaling like 1" A5PLK6 1 182409192-182560599 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 22.6" "Group enriched" "Detected in some" 34 "Early spermatids: 91.5;Late spermatids: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.2;T-47d: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (1.33e-1)" "unprognostic (5.20e-2)" "unprognostic (2.07e-1)" "unprognostic (6.47e-2)" "unprognostic (4.45e-1)" "unprognostic (1.64e-1)" "unprognostic (2.69e-5)" "unprognostic (2.93e-1)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 91.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 RHAG "CD241, RH50A, SLC42A1" ENSG00000112077 "Rh associated glycoprotein" Q02094 6 49605158-49636884 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 54.1" "Cell type enriched" "Detected in some" 50 "Erythroid cells: 116.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 190 "HEL: 87.8;K-562: 86.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046051, HPA055331" Approved Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA046051: , HPA055331: AB_2682785" "unprognostic (8.16e-2)" "unprognostic (6.86e-2)" "unprognostic (1.25e-3)" "unprognostic (1.65e-1)" 1.2 0.2 0.0 1.1 0.5 54.1 3.2 0.0 0.1 2.3 1.0 0.5 1.7 0.2 0.4 0.1 2.6 0.5 0.8 5.3 0.0 0.0 0.1 0.7 3.3 0.1 0.0 0.0 0.1 0.2 0.1 0.1 5.8 0.1 1.3 0.2 0.0 0.2 0.5 0.4 0.1 0.9 0.1 0.0 4.5 0.6 0.2 0.0 1.7 1.8 0.0 0.1 0.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 116.8 0.2 0.3 0.0 0.0 2.3 0.0 0.4 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RHBDL1 "RHBDL, RRP" ENSG00000103269 "Rhomboid like 1" O75783 16 675666-678268 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 12.0;Cone photoreceptor cells: 11.8;Horizontal cells: 14.3;Rod photoreceptor cells: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.4" "Group enriched" "Detected in many" 20 "B-cells: 2.2;NK-cells: 1.3;T-cells: 3.4" "Cell line enhanced" "Detected in many" "HeLa: 9.3;MCF7: 9.8;U-266/70: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030359, HPA030360, HPA046593" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711" "prognostic favorable (8.12e-4)" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.45e-1)" "unprognostic (2.07e-1)" "unprognostic (1.58e-2)" "unprognostic (3.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.78e-1)" "unprognostic (6.60e-3)" "unprognostic (2.74e-2)" "unprognostic (3.97e-2)" "unprognostic (5.63e-3)" "unprognostic (5.89e-2)" "unprognostic (1.27e-1)" "unprognostic (8.30e-3)" "unprognostic (1.49e-2)" 1.7 6.3 10.0 1.1 8.3 2.3 0.7 21.3 14.5 1.3 2.2 1.3 2.2 5.8 1.3 1.7 1.1 1.0 1.2 2.4 8.4 9.9 3.9 1.2 0.8 1.1 5.5 7.2 0.9 6.2 2.2 4.4 1.1 4.6 1.5 1.1 1.5 6.1 2.6 0.8 3.1 5.9 0.7 2.2 0.6 4.5 2.2 1.9 0.7 0.6 0.6 0.5 0.8 0.5 2.2 0.1 0.0 0.0 1.3 3.4 0.7 1.8 2.3 1.3 2.0 1.0 2.7 6.9 0.8 1.3 0.4 0.1 4.8 1.3 0.7 1.6 0.5 0.2 1.2 0.1 0.4 0.0 1.7 8.7 1.0 9.3 1.9 1.0 1.7 1.3 1.8 3.3 0.3 0.0 1.0 0.1 3.1 1.3 1.3 0.1 9.8 0.4 4.7 1.3 2.5 0.7 8.3 1.2 1.8 0.1 1.6 1.7 2.3 1.0 0.5 2.2 0.9 3.6 4.9 0.5 2.8 2.6 0.9 0.6 11.9 1.6 2.3 1.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.4 0.3 0.0 0.5 0.5 0.2 0.0 1.3 0.0 0.1 1.2 0.7 10.0 8.3 21.3 14.5 8.4 9.9 5.5 7.2 4.6 1.9 0.0 0.0 0.0 4.2 1.9 12.0 0.8 0.0 8.1 1.2 0.0 11.8 0.2 0.0 0.7 2.0 0.0 3.9 0.0 0.5 0.2 0.9 1.4 0.0 0.8 0.3 14.3 2.4 0.6 1.2 1.1 1.4 0.0 0.0 0.0 4.5 2.0 1.0 3.6 2.5 7.4 35.2 0.0 0.5 0.7 2.1 1.6 0.2 0.0 4.7 1.6 RHBDL2 FLJ20435 ENSG00000158315 "Rhomboid like 2" Q9NX52 1 38885807-38941799 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 26.3;Pancreatic endocrine cells: 31.9;Suprabasal keratinocytes: 24.8;Undifferentiated cells: 31.4;Urothelial cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.2;CAPAN-2: 26.6;HaCaT: 13.8;RT4: 26.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043807 Approved NA NA "HPA043807: AB_10961118" "unprognostic (3.34e-2)" "unprognostic (2.96e-1)" "unprognostic (4.57e-2)" "unprognostic (2.56e-1)" "unprognostic (7.26e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (5.81e-2)" "unprognostic (2.36e-1)" "unprognostic (2.87e-1)" "unprognostic (4.07e-3)" "unprognostic (1.23e-1)" "unprognostic (7.47e-9)" "unprognostic (1.11e-2)" "unprognostic (2.46e-1)" "unprognostic (4.12e-2)" "unprognostic (4.20e-2)" 1.4 0.0 2.9 6.7 2.7 0.0 1.5 0.4 4.0 5.5 14.9 1.7 0.4 0.7 1.9 0.7 18.9 0.7 6.9 4.9 4.2 2.1 0.5 0.4 2.1 1.5 4.9 0.7 1.2 2.4 0.0 0.4 1.0 1.6 3.1 14.7 0.8 8.2 0.4 0.4 13.4 0.9 0.9 7.9 0.6 12.3 8.4 0.4 1.3 0.4 12.2 16.4 6.9 8.2 1.7 2.1 5.3 1.7 0.9 0.9 0.7 8.2 3.3 0.2 0.1 0.1 1.0 0.9 0.4 0.1 0.6 0.1 0.5 26.6 0.2 1.9 3.8 2.4 13.8 0.0 4.9 0.3 0.1 0.1 0.1 2.0 1.8 0.5 0.0 0.3 0.6 0.6 4.0 0.0 2.5 0.8 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.2 0.9 0.7 0.1 0.1 0.0 0.0 26.8 0.2 0.1 2.8 6.8 0.2 0.3 3.5 0.2 0.5 3.0 0.3 0.2 0.2 0.2 0.3 0.3 2.6 0.4 0.1 3.6 1.7 1.1 0.8 1.1 0.4 1.7 0.6 0.5 1.9 1.1 0.7 0.7 5.3 0.9 0.7 2.1 0.9 0.7 2.9 2.7 0.4 1.5 4.2 2.1 4.9 0.7 1.6 0.4 0.0 0.3 0.0 6.7 15.8 2.4 0.4 2.5 9.4 6.8 3.5 0.0 0.4 0.0 11.2 2.8 1.1 26.3 0.0 14.2 0.2 2.3 11.4 4.6 0.0 0.2 1.6 2.4 1.3 0.0 0.4 0.6 0.0 1.7 1.0 21.0 1.5 31.9 23.0 0.0 0.0 1.6 6.5 2.0 0.0 0.0 24.8 0.6 0.0 31.4 36.7 RHBDL3 "RHBDL4, VRHO" ENSG00000141314 "Rhomboid like 3" P58872 17 32266176-32324661 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7" "Group enriched" "Detected in some" 9 "Horizontal cells: 96.9;Rod photoreceptor cells: 33.8" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.9;AF22: 5.9;GAMG: 6.8;HDLM-2: 8.0;NTERA-2: 8.7;U-2 OS: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059607 Uncertain NA NA "HPA059607: AB_2684081" "unprognostic (7.70e-2)" "unprognostic (3.71e-2)" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.91e-1)" "unprognostic (2.83e-2)" "unprognostic (2.22e-1)" "unprognostic (1.93e-1)" "unprognostic (1.85e-3)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (1.75e-2)" "unprognostic (4.19e-2)" "unprognostic (2.18e-3)" "unprognostic (2.11e-1)" "unprognostic (1.23e-1)" "unprognostic (8.87e-2)" 1.0 8.2 6.8 1.2 7.4 0.7 1.1 11.3 23.7 1.4 1.2 2.9 3.3 0.9 2.0 1.9 1.3 4.4 0.9 9.7 10.1 6.6 0.8 0.6 0.7 0.7 9.1 4.6 3.4 1.1 0.6 1.9 1.0 6.7 2.1 1.4 3.9 1.0 5.6 0.6 0.9 0.9 1.8 3.6 0.6 0.9 2.5 4.0 0.0 0.6 0.0 0.8 1.9 1.1 0.8 0.0 0.0 0.0 0.0 0.3 0.3 0.0 5.9 5.9 4.6 0.9 0.0 0.1 0.3 0.6 1.9 1.9 0.1 0.0 0.0 0.4 0.7 6.8 0.1 1.6 0.0 0.5 8.0 2.3 1.0 4.0 0.3 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.3 0.0 0.3 0.5 0.0 0.5 0.1 0.2 0.0 8.7 0.0 0.0 1.0 0.0 0.0 0.0 3.2 0.1 1.5 0.8 0.1 0.1 2.2 0.4 0.1 0.0 0.0 6.1 0.2 2.9 0.0 0.0 0.0 0.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 6.8 7.4 11.3 15.6 10.1 6.6 9.1 4.6 6.7 4.0 0.0 0.0 0.0 0.6 0.3 6.0 4.3 0.0 0.0 0.0 0.0 5.9 1.3 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.4 96.9 0.0 0.6 0.8 1.5 0.9 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 33.8 0.0 1.0 0.0 0.9 0.1 0.5 0.0 0.0 0.5 RHBG SLC42A2 ENSG00000132677 "Rh family B glycoprotein (gene/pseudogene)" Q9H310 1 156369212-156385219 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.2;kidney: 16.9;ovary: 5.9" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6" "Group enriched" "Detected in some" 5 "liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1" "Region enriched" "Detected in some" 15 "cerebellum: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 65 "CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0" "Low region specificity" "Detected in all" "HPA042726, HPA048489" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA042726: AB_2678131, HPA048489: AB_2680417" "unprognostic (1.20e-1)" "unprognostic (2.05e-1)" "unprognostic (4.55e-3)" "unprognostic (5.04e-2)" "unprognostic (2.95e-2)" "unprognostic (3.76e-3)" "unprognostic (2.00e-1)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.45e-1)" "unprognostic (3.72e-1)" "unprognostic (3.63e-2)" "unprognostic (4.91e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-1)" "unprognostic (1.91e-3)" "prognostic favorable (8.06e-4)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 23.2 0.1 0.3 0.3 0.0 1.0 0.0 0.1 0.0 2.2 0.0 0.0 0.1 0.1 0.1 16.9 3.3 0.1 0.0 0.1 0.1 5.9 0.2 0.0 0.1 0.0 1.5 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.3 0.0 0.1 0.1 0.1 1.2 0.0 0.0 0.1 1.1 1.2 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.2 0.1 0.1 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 21.0 0.0 0.0 16.6 0.3 10.7 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 4.3 0.1 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 1.0 0.0 1.1 0.1 0.0 0.4 0.9 0.0 0.0 0.0 2.2 0.4 0.4 0.0 0.0 0.0 0.0 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell type enriched" "Detected in some" 33 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 5 "HEL: 44.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.1 0.0 0.1 0.1 0.2 0.0 44.7 0.0 0.0 0.6 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.3 8.7 0.2 0.2 0.4 0.0 0.3 0.9 0.3 0.2 0.1 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.5 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 0.0 0.0 0.0 0.5 0.5 3.3 0.4 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 0.0 0.0 210.2 0.2 0.4 0.2 0.4 4.6 0.4 0.2 6.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.7 0.0 2.5 6.5 0.0 2.8 5.1 1.3 0.7 0.0 0.1 0.7 RHCG "C15orf6, PDRC2, RHGK, SLC42A3" ENSG00000140519 "Rh family C glycoprotein" Q9UBD6 15 89471398-89496613 "Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8" "Group enriched" "Detected in some" 4 "Muller glia cells: 63.6;Urothelial cells: 75.2" "Cancer enhanced" "Detected in many" "cervical cancer: 152.9;head and neck cancer: 154.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.0;hTCEpi: 4.5;RT4: 4.5;SK-MEL-30: 2.7" "Region enriched" "Detected in some" 5 "olfactory region: 10.4" "Low region specificity" "Detected in many" "HPA041874, HPA043317" Enhanced NA NA "HPA041874: AB_2677719, HPA043317: AB_2678424" "unprognostic (1.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.52e-1)" "unprognostic (3.86e-3)" "unprognostic (1.98e-2)" "unprognostic (9.39e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.07e-1)" "unprognostic (9.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.84e-2)" "unprognostic (2.55e-3)" "unprognostic (2.68e-1)" "unprognostic (2.80e-2)" "unprognostic (2.27e-1)" "unprognostic (9.45e-3)" 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.0 0.5 60.6 0.2 0.0 0.0 0.2 4.4 0.2 304.0 0.3 0.3 0.3 0.2 0.0 8.6 0.3 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.0 0.2 0.1 0.3 0.2 0.1 37.3 0.3 0.2 0.7 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.0 0.2 115.4 185.9 0.5 91.8 0.6 0.3 0.0 0.2 0.0 0.6 0.0 0.0 8.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.6 1.6 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 4.5 0.3 0.3 0.8 0.0 2.7 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.4 0.6 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.6 0.1 0.1 0.6 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 8.8 1.1 0.8 0.4 0.0 0.0 0.0 14.0 0.0 0.0 13.3 1.1 1.6 0.0 0.0 0.0 0.3 0.0 0.1 7.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 63.6 1.2 4.0 0.0 0.0 2.4 0.0 0.4 0.1 0.1 15.6 0.0 0.0 0.0 75.2 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.0;bone marrow: 16.5;salivary gland: 7.1" "Cell type enriched" "Detected in some" 20 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.0" "Group enriched" "Detected in some" 6 "HEL: 28.2;K-562: 8.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.3 0.3 0.3 0.5 0.5 16.5 0.3 1.5 1.4 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.9 0.3 0.2 0.3 0.3 2.5 0.8 0.3 0.3 0.9 0.3 0.1 0.4 0.3 1.1 0.5 0.0 0.3 7.1 0.3 4.1 2.5 0.4 0.3 0.4 1.8 0.3 0.5 0.3 0.3 0.4 2.3 0.3 0.3 0.3 2.0 0.6 10.0 1.4 1.4 1.4 1.2 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 28.2 0.7 0.2 0.0 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 8.7 0.7 0.0 0.1 0.2 0.2 3.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.1 0.1 0.2 0.5 0.4 0.5 0.2 0.4 0.1 0.3 0.1 0.1 0.5 0.2 0.1 4.9 1.4 2.8 1.0 0.6 1.1 1.3 1.3 0.8 0.2 2.0 1.4 1.3 10.0 1.4 0.8 0.6 0.9 1.2 0.3 0.5 1.5 1.4 0.3 0.2 0.3 0.3 1.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 23.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 RHEBL1 "FLJ25797, MGC34869, RHEB2" ENSG00000167550 "RHEB like 1" Q8TAI7 12 49064685-49070025 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;brain: 9.5" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Erythroid cells: 23.3;monocytes: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.1;granulocytes: 10.6;T-cells: 10.1" "Cell line enhanced" "Detected in many" "HDLM-2: 16.7;U-266/84: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA053111, HPA061001" Uncertain Uncertain Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA053111: AB_2682047, HPA061001: AB_2684409" "unprognostic (2.94e-1)" "unprognostic (1.11e-3)" "unprognostic (2.36e-2)" "unprognostic (9.81e-3)" "unprognostic (8.76e-2)" "unprognostic (2.03e-2)" "unprognostic (3.03e-5)" "unprognostic (9.13e-2)" "unprognostic (9.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.98e-1)" "unprognostic (1.24e-1)" "unprognostic (1.13e-10)" "unprognostic (4.67e-2)" "unprognostic (1.11e-1)" "unprognostic (7.66e-2)" "unprognostic (2.07e-1)" 1.6 0.6 3.6 2.7 2.0 4.0 2.3 4.0 9.5 0.8 1.1 0.4 1.3 1.1 3.3 2.5 0.9 5.5 1.0 1.4 2.2 2.7 0.9 0.7 2.6 6.8 2.0 5.1 1.0 0.6 0.2 0.7 1.4 1.9 0.5 1.8 0.4 1.0 1.3 0.6 5.6 1.8 1.0 1.2 5.2 1.2 3.0 0.9 2.5 0.8 0.0 3.9 1.0 4.1 3.1 0.9 10.6 1.6 1.3 10.1 1.2 0.9 2.0 1.2 2.9 0.7 0.1 1.2 0.9 2.7 5.1 5.8 1.8 1.6 2.8 0.9 0.2 2.9 0.8 0.8 1.1 2.3 16.7 0.1 2.7 1.4 0.9 0.6 1.1 5.8 0.3 0.4 2.6 0.8 0.3 2.0 5.0 3.5 8.1 1.9 0.8 1.2 6.8 1.8 3.5 2.9 2.6 1.8 4.4 0.4 0.1 0.6 1.7 0.7 0.7 4.5 1.8 0.3 1.8 1.0 1.6 2.6 3.1 0.9 9.8 33.3 1.7 1.3 4.1 0.6 10.6 0.3 0.7 7.3 1.6 10.1 1.9 3.1 3.9 0.7 3.1 1.0 3.8 0.6 1.3 1.4 0.9 6.1 1.2 3.6 2.0 4.0 9.5 2.2 2.7 2.0 5.1 1.9 0.9 0.0 0.0 4.3 0.2 1.1 1.5 0.8 2.5 9.4 2.3 0.0 0.0 0.1 0.0 0.4 0.4 1.4 0.0 23.3 0.2 0.4 0.8 0.3 0.0 0.0 1.5 3.2 0.0 1.3 0.0 0.4 0.0 1.8 0.0 7.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 5.0 1.8 0.1 5.1 0.2 0.0 RHEX "C1orf186, FLJ16052" ENSG00000263961 "Regulator of hemoglobinization and erythroid cell expansion" Q6ZWK4 1 206052723-206102459 "Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 117.7" "Cell type enriched" "Detected in some" 14 "granulocytes: 308.1" "Cancer enhanced" "Detected in many" "endometrial cancer: 42.8;ovarian cancer: 41.1" "Cell type enriched" "Detected in some" 51 "basophil: 117.7" "Lineage enriched" "Detected in many" 51 "granulocytes: 117.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 189.5" "Low region specificity" "Detected in all" HPA037859 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA037859: AB_10697084" "unprognostic (9.26e-3)" "unprognostic (1.91e-2)" "unprognostic (9.66e-2)" "unprognostic (1.65e-2)" "unprognostic (2.06e-2)" "unprognostic (5.27e-3)" "unprognostic (9.55e-2)" "unprognostic (3.04e-3)" "unprognostic (2.36e-1)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (7.20e-3)" "unprognostic (1.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (3.77e-2)" "unprognostic (2.80e-3)" 4.3 0.0 0.0 3.9 0.0 0.0 1.8 0.0 0.0 13.1 3.1 0.0 12.1 0.9 6.2 8.2 3.4 1.6 16.2 0.4 0.0 6.8 1.8 5.2 4.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 9.4 3.3 2.9 0.0 16.9 1.5 0.2 4.0 7.0 0.0 0.4 2.4 1.1 0.0 0.6 0.0 1.7 2.5 4.3 10.0 0.3 2.2 117.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.1 0.0 8.6 189.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 38.1 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 117.7 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 19.2 0.0 1.5 1.7 2.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 308.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RHO "CSNBAD1, OPN2, RP4" ENSG00000163914 Rhodopsin P08100 3 129528640-129535169 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 151 "retina: 415.0" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 2822.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.6;cerebral cortex: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013440, CAB022486, CAB034887, CAB034888" Enhanced NA NA "CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844" "unprognostic (4.32e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (2.87e-1)" "unprognostic (1.94e-1)" "unprognostic (9.19e-11)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-1)" 0.2 0.0 0.0 0.0 0.3 0.0 0.1 1.6 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 415.0 0.3 0.2 0.0 1.8 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 2.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 290.1 0.6 0.0 0.0 0.0 0.0 428.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 206.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 393.2 0.0 0.0 0.0 0.0 2822.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;skeletal muscle: 63.5" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 127.6;Horizontal cells: 316.2;Syncytiotrophoblasts: 252.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;NK-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040205: AB_2676883, HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.6 9.8 2.7 2.0 5.8 0.5 4.5 0.8 5.0 8.8 4.7 7.2 16.5 3.4 10.2 4.9 1.9 6.8 6.3 6.6 3.7 2.5 20.5 3.4 5.4 1.4 6.7 2.3 6.9 6.0 7.4 2.2 50.9 4.6 4.9 2.6 13.3 1.4 20.3 63.5 1.9 3.5 7.7 3.8 7.4 11.7 8.5 5.7 0.6 2.3 5.2 0.9 5.0 5.2 0.5 1.6 0.7 0.6 1.3 0.0 1.3 0.1 6.2 9.5 0.0 4.5 4.0 0.0 2.7 2.5 2.3 3.5 0.3 0.1 0.0 11.7 14.5 1.1 0.1 2.8 0.8 2.7 0.0 2.5 0.5 4.5 34.5 4.9 0.7 0.2 5.7 1.6 1.4 1.4 8.8 10.8 2.0 5.1 0.0 10.1 0.2 2.6 0.0 4.1 0.1 4.1 2.3 13.3 3.2 7.5 0.3 2.6 10.2 3.3 3.6 3.6 6.2 0.7 1.2 9.6 4.4 11.7 0.1 3.0 0.0 0.0 0.0 2.2 2.0 2.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.7 1.3 0.6 0.0 0.0 1.3 2.7 5.8 0.8 5.0 3.7 2.5 6.7 2.3 4.6 5.7 14.9 8.3 0.0 0.8 1.5 2.7 24.9 2.5 12.0 3.4 1.8 127.6 49.5 1.7 3.2 49.1 7.1 0.6 0.0 13.6 3.6 9.0 1.0 0.0 1.8 10.1 316.2 7.9 16.5 12.3 26.5 7.5 3.2 1.7 0.0 6.7 20.9 14.1 3.4 4.6 30.1 26.0 6.5 4.1 1.6 1.0 1.3 252.8 0.0 2.3 0.2 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 86.0" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 367.9;Muller glia cells: 260.1;Peritubular cells: 295.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;T-cells: 2.9" "Cell line enhanced" "Detected in many" "EFO-21: 49.0;HaCaT: 62.3;SuSa: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000265 Uncertain Vesicles NA NA Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 38.7 21.4 27.0 6.4 25.8 4.0 12.8 11.8 23.1 16.4 12.0 26.9 11.8 8.2 7.5 15.5 9.8 7.8 11.0 17.6 26.2 12.8 16.4 11.5 9.5 3.6 20.1 21.3 46.6 59.2 24.1 11.0 86.0 13.0 16.4 11.7 21.7 21.0 12.2 15.3 7.4 9.0 11.2 18.2 6.0 12.1 12.4 21.3 1.8 11.1 4.1 1.6 10.9 12.8 0.8 1.2 10.1 1.5 0.5 2.9 0.9 9.8 4.0 9.9 10.5 37.3 21.6 0.1 17.3 16.4 6.7 10.6 19.1 1.8 0.0 49.0 8.8 17.6 62.3 5.3 1.2 11.6 0.4 6.8 3.4 37.9 5.5 29.4 0.8 4.9 35.0 0.9 10.0 0.1 28.8 5.1 3.0 13.5 2.6 26.7 2.8 1.0 2.7 3.7 6.2 6.2 1.4 19.4 1.2 5.6 7.1 17.5 22.7 13.5 5.9 16.0 64.3 4.5 4.9 8.2 9.0 38.9 6.0 6.5 2.6 5.0 0.4 2.8 0.2 14.8 0.1 0.9 10.1 2.9 0.5 1.2 0.8 2.1 2.5 0.2 0.2 2.9 0.6 0.7 0.5 1.5 1.2 1.1 0.9 27.0 25.8 11.8 18.6 26.2 12.8 20.1 21.3 13.0 21.3 163.8 14.1 3.7 50.7 9.6 69.6 74.7 38.2 41.5 47.8 134.3 19.6 42.1 51.4 57.7 7.8 11.7 11.8 0.0 94.5 117.9 62.8 65.1 97.1 69.3 27.2 6.4 88.2 13.5 15.6 6.5 367.9 11.7 40.5 4.6 63.7 260.1 55.3 49.1 295.9 3.4 33.3 32.3 54.7 1.7 1.9 24.0 96.3 10.1 77.7 76.4 RHOD "ARHD, Rho, RhoD, RhoHP1" ENSG00000173156 "Ras homolog family member D" O00212 11 67056818-67072013 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 76.5" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 93.3;Exocrine glandular cells: 125.9;Pancreatic endocrine cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.9;naive CD4 T-cell: 2.0" "Group enriched" "Detected in many" 16 "B-cells: 1.1;T-cells: 2.0" "Cell line enhanced" "Detected in many" "A-431: 36.1;CAPAN-2: 26.3;HaCaT: 32.4;HBEC3-KT: 42.9;hTCEpi: 50.8;T-47d: 36.0" "Region enhanced" "Detected in some" "cerebellum: 16.8" "Not detected" "Not detected" NA NA "unprognostic (2.12e-2)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.89e-3)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (3.10e-4)" "unprognostic (5.85e-2)" "unprognostic (4.39e-2)" "unprognostic (1.38e-3)" "unprognostic (8.89e-2)" "unprognostic (2.56e-2)" "unprognostic (2.24e-1)" "unprognostic (5.89e-2)" "unprognostic (2.40e-1)" "unprognostic (2.35e-2)" 4.7 0.7 1.3 1.7 1.4 0.0 7.3 1.5 1.0 9.9 5.0 0.8 7.6 6.0 4.0 4.6 51.5 3.2 11.0 30.4 1.8 0.4 10.2 76.5 3.1 3.3 1.0 0.7 6.7 19.2 11.6 5.1 34.3 4.3 6.4 0.7 6.4 14.9 10.5 10.5 16.8 6.6 3.0 0.7 0.8 7.2 2.8 0.7 0.9 14.0 45.9 22.4 4.3 16.8 1.1 0.0 0.0 0.0 0.0 2.0 0.3 36.1 2.9 0.2 3.8 0.5 0.4 5.6 3.2 5.4 2.0 2.0 2.7 26.3 0.0 6.0 3.8 0.0 32.4 0.3 42.9 0.3 0.0 0.1 0.0 15.7 0.3 5.4 0.0 0.0 5.3 50.8 0.6 13.3 2.4 2.0 0.0 0.0 2.5 0.6 23.4 0.0 0.0 4.3 3.9 15.1 0.0 0.0 0.0 18.3 2.6 0.2 0.0 16.9 0.9 1.3 0.7 36.0 0.1 1.2 0.0 0.1 0.5 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 1.9 0.2 0.2 0.0 0.0 1.1 2.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 1.3 1.4 1.5 1.0 1.8 0.4 1.0 0.7 4.3 0.7 14.9 4.1 0.8 25.9 29.2 0.1 23.8 28.1 9.4 10.3 15.7 0.0 22.9 38.1 93.3 7.0 4.6 54.0 0.0 125.9 22.8 13.0 27.4 0.0 38.6 3.1 0.0 4.1 3.7 1.0 7.4 10.9 2.0 8.5 1.0 3.0 6.3 184.3 28.1 20.8 21.6 0.2 0.0 6.8 0.5 2.5 50.4 30.1 2.2 5.3 70.1 RHOG "ARHG, MGC125835, MGC125836, RhoG" ENSG00000177105 "Ras homolog family member G" P84095 11 3826978-3840983 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 112.3;bone marrow: 109.5" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 257.1;Macrophages: 301.6;monocytes: 429.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 120.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039871 Enhanced NA NA 2300000 "HPA039871: AB_10673428" "unprognostic (2.39e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.26e-2)" "unprognostic (1.35e-1)" "unprognostic (4.21e-2)" "unprognostic (4.27e-3)" "unprognostic (7.28e-2)" "unprognostic (1.71e-2)" "unprognostic (3.28e-1)" "unprognostic (1.96e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (9.49e-8)" "unprognostic (9.38e-2)" "unprognostic (8.98e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" 22.9 14.0 14.5 36.6 24.4 109.5 22.0 4.9 21.4 14.6 15.9 49.7 9.2 21.0 17.8 10.1 28.2 15.8 16.5 12.6 19.8 13.5 13.7 17.3 30.2 65.1 34.8 11.6 15.6 12.2 8.8 9.9 22.3 23.3 13.2 14.0 9.3 14.4 14.9 17.9 17.3 27.0 18.6 44.5 63.8 15.1 9.4 26.5 38.6 11.0 15.9 30.4 19.6 18.6 9.6 35.3 112.3 58.4 10.3 22.6 31.4 13.4 18.4 3.7 6.4 14.5 16.5 4.1 8.9 11.2 14.1 15.0 11.3 14.7 13.7 4.8 16.5 14.3 15.9 5.8 12.6 9.1 12.1 14.1 31.2 8.9 10.4 14.7 27.1 120.1 15.9 11.6 8.8 8.5 8.1 16.1 18.7 18.2 15.3 11.4 15.8 22.7 37.6 5.9 9.8 14.8 11.6 4.0 8.1 10.0 9.4 2.0 5.1 6.3 14.7 7.2 4.5 7.7 20.5 12.5 17.1 8.6 18.1 10.4 8.6 11.7 7.7 15.6 24.8 9.5 40.8 38.9 80.1 14.0 51.7 12.2 9.6 15.3 15.4 35.3 9.2 10.9 12.5 112.3 10.3 58.4 8.8 22.6 31.4 14.5 24.4 4.9 21.4 19.8 13.5 34.8 11.6 23.3 26.5 17.9 28.7 63.7 52.7 61.0 0.8 4.6 12.7 8.1 21.6 19.2 0.0 94.3 13.3 58.1 1.5 58.5 96.4 0.0 49.1 70.0 45.9 49.5 199.3 16.2 223.5 3.2 15.5 33.7 257.1 2.5 35.6 301.6 50.6 429.2 25.4 14.9 63.3 105.2 33.9 20.7 3.1 19.4 42.4 8.4 23.6 51.9 103.9 119.9 24.7 76.6 RHOH "ARHH, RhoH, TTF" ENSG00000168421 "Ras homolog family member H" Q15669 4 40191053-40246967 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.8;lymphoid tissue: 94.7" "Group enriched" "Detected in many" 5 "B-cells: 118.6;granulocytes: 136.5;Melanocytes: 54.0;T-cells: 125.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 34.9;HMC-1: 26.8;JURKAT: 35.1;MOLT-4: 48.5;U-266/70: 18.8;U-266/84: 15.1;U-698: 32.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030345, HPA061314" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA030345: AB_10601607, HPA061314: " "unprognostic (4.00e-2)" "unprognostic (1.83e-4)" "unprognostic (1.24e-2)" "unprognostic (2.22e-5)" "unprognostic (1.35e-1)" "unprognostic (1.32e-3)" "unprognostic (1.16e-1)" "unprognostic (2.73e-2)" "unprognostic (2.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.07e-2)" "unprognostic (1.38e-1)" "unprognostic (3.31e-6)" "unprognostic (2.96e-1)" "unprognostic (3.91e-2)" "unprognostic (4.46e-2)" "unprognostic (2.44e-2)" 1.8 0.6 0.6 33.8 1.1 21.7 5.2 0.4 0.4 1.3 2.4 0.5 0.4 1.6 2.0 0.9 2.5 1.5 4.1 1.1 0.6 0.7 1.6 1.7 4.8 43.2 0.8 0.2 0.7 0.8 0.0 0.9 0.3 0.8 2.1 2.0 1.0 7.8 0.6 0.5 1.2 15.1 0.7 1.2 33.1 2.7 0.7 0.6 94.7 1.6 1.9 41.0 5.1 1.5 41.2 4.7 32.2 0.2 12.3 54.8 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.2 0.0 0.0 0.0 5.7 26.8 0.4 0.0 0.0 0.0 0.0 0.0 35.1 0.4 0.3 0.0 0.0 48.5 3.6 0.6 0.0 0.1 5.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.1 0.1 0.0 0.1 0.0 0.0 18.8 15.1 32.2 0.0 1.2 0.0 32.2 0.2 29.6 21.6 0.1 19.4 30.5 34.6 29.1 0.3 41.2 54.8 43.3 1.6 12.3 0.2 4.7 47.0 21.1 0.6 1.1 0.4 0.4 0.6 0.7 0.8 0.2 0.8 0.6 3.0 16.4 118.6 1.4 6.4 0.0 0.8 2.5 1.4 4.5 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 23.3 0.0 0.1 4.1 1.1 136.5 0.0 2.2 0.0 0.0 1.8 4.6 0.0 0.0 12.1 54.0 10.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 6.0 0.2 125.8 0.0 1.8 RHOU "ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, WRCH-1, WRCH1" ENSG00000116574 "Ras homolog family member U" Q7L0Q8 1 228735077-228746669 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 58.8" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 61.6;Extravillous trophoblasts: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 41.8;MOLT-4: 18.4;RT4: 17.7;THP-1: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049592 Approved NA NA "HPA049592: AB_2680827" "unprognostic (7.90e-2)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (8.26e-3)" "unprognostic (3.26e-2)" "unprognostic (2.57e-1)" "unprognostic (3.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.53e-1)" "unprognostic (6.21e-2)" "prognostic favorable (3.56e-5)" "unprognostic (4.20e-1)" "unprognostic (1.69e-1)" "unprognostic (1.52e-1)" "unprognostic (1.87e-2)" 15.3 8.7 21.4 6.0 27.8 7.6 15.9 3.2 23.4 15.9 15.2 58.8 11.0 24.0 9.0 8.5 6.9 16.4 25.5 8.0 28.2 13.8 3.9 26.6 8.4 5.7 32.1 16.5 16.5 19.1 21.1 4.7 17.9 24.5 13.4 10.9 9.5 12.1 12.1 21.0 3.9 26.2 9.3 37.3 10.4 14.5 8.8 30.5 1.1 12.6 1.7 1.7 12.7 8.9 0.0 1.6 1.3 1.8 0.5 3.1 0.5 0.4 1.0 3.3 0.2 0.7 0.4 41.8 0.2 0.4 0.2 0.1 4.4 6.1 0.0 2.4 0.5 0.2 0.2 1.2 0.0 0.2 6.4 2.3 0.0 0.3 1.3 4.7 3.2 0.4 0.2 0.3 0.1 0.2 0.0 0.0 1.6 0.0 0.0 0.2 1.0 18.4 3.4 1.0 5.5 0.4 0.1 1.0 0.5 0.1 17.7 1.2 3.7 0.3 2.8 0.0 7.5 0.0 12.2 0.3 0.0 0.5 0.0 0.0 1.0 4.1 0.0 0.0 8.3 2.1 0.0 1.2 1.3 1.6 1.8 3.1 0.0 1.2 2.2 1.6 0.0 0.2 0.9 0.1 0.5 0.7 1.5 0.0 0.5 21.4 27.8 3.2 23.4 28.2 13.8 32.1 16.5 24.5 30.5 14.9 16.0 0.0 3.2 4.0 4.3 61.6 25.5 25.4 26.1 1.8 0.0 15.8 0.0 3.5 0.4 35.0 51.9 0.0 7.6 76.5 24.5 24.5 0.0 32.6 17.7 7.9 2.9 29.4 28.1 1.9 1.7 19.2 15.1 1.0 8.2 6.0 5.0 24.6 1.1 0.6 0.9 0.0 10.0 0.7 2.2 2.9 28.4 3.3 7.5 10.5 RHOV "ARHV, Chp, WRCH2" ENSG00000104140 "Ras homolog family member V" Q96L33 15 40872214-40874289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 74.8;skin 1: 31.5;tongue: 29.2" "Cell type enhanced" "Detected in many" 10 "Paneth cells: 151.1;Suprabasal keratinocytes: 247.3;Urothelial cells: 237.2" "Cancer enhanced" "Detected in many" "cervical cancer: 91.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 84.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA053343 Enhanced NA NA "HPA053343: AB_2682122" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (8.29e-3)" "unprognostic (4.34e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (3.29e-3)" "unprognostic (1.05e-1)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (8.43e-3)" "unprognostic (5.63e-3)" 0.2 0.0 0.4 0.4 0.4 0.0 7.8 0.8 0.9 8.8 0.9 0.2 0.5 0.1 0.6 4.8 74.8 1.2 0.6 0.2 0.4 0.3 1.9 0.2 1.9 0.2 0.2 0.5 0.2 7.4 0.4 0.7 7.3 1.2 4.2 1.1 0.2 12.6 1.1 0.2 31.5 0.5 0.7 0.3 0.3 0.3 0.8 0.3 2.0 0.2 29.2 27.9 5.2 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.7 0.0 0.0 1.3 0.0 0.2 0.1 0.0 1.0 1.1 0.0 0.6 0.0 0.0 19.7 1.1 0.1 0.0 2.6 3.2 0.1 2.8 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.5 0.5 0.1 0.0 6.7 0.1 0.5 0.4 4.8 0.9 0.9 0.1 0.4 1.3 8.6 1.0 0.2 2.0 84.5 0.0 0.1 10.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.8 0.9 0.4 0.3 0.2 0.5 1.2 0.3 0.0 2.7 0.0 28.5 74.8 0.0 0.8 5.1 2.7 13.6 27.9 0.0 47.9 11.6 77.6 0.0 0.1 5.4 0.0 50.4 4.7 2.4 75.1 1.1 0.0 4.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 30.4 6.4 9.1 0.0 17.2 151.1 0.7 0.8 0.0 0.0 3.1 0.0 0.9 247.3 35.5 0.0 15.6 237.2 RHOXF1 "OTEX, PEPP1" ENSG00000101883 "Rhox homeobox family member 1" Q8NHV9 X 120109053-120115937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 8.1;brain: 9.2;testis: 27.8" "Cell type enriched" "Detected in some" 39 "Spermatogonia: 154.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 9.2" "Cell type enriched" "Detected in some" 6 "T-reg: 8.1" "Lineage enriched" "Detected in single" 30 "T-cells: 8.1" "Cell line enhanced" "Detected in some" "HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8" "HPA052560, HPA056506" Approved Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA052560: , HPA056506: AB_2683157" "unprognostic (5.03e-3)" "unprognostic (1.22e-2)" "unprognostic (5.22e-2)" "unprognostic (2.31e-2)" "unprognostic (8.65e-2)" "unprognostic (1.07e-3)" "unprognostic (2.46e-1)" "unprognostic (3.15e-1)" "unprognostic (3.89e-1)" "unprognostic (2.15e-1)" "unprognostic (7.50e-4)" "unprognostic (1.97e-1)" "unprognostic (5.85e-4)" "unprognostic (3.00e-1)" "unprognostic (7.96e-2)" "unprognostic (2.26e-1)" "unprognostic (1.73e-3)" 2.8 0.5 0.9 0.5 1.1 0.3 0.9 9.2 1.7 0.5 0.7 0.5 0.5 0.2 0.5 0.5 0.5 1.5 0.5 0.5 0.8 2.4 0.8 0.5 0.5 0.6 0.8 0.5 2.2 0.5 0.8 0.9 1.1 0.5 0.5 0.1 0.5 0.8 0.6 0.5 2.4 0.5 0.5 0.5 0.5 0.2 27.8 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 3.2 3.9 0.4 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.2 8.1 0.0 0.9 1.1 9.2 1.7 0.8 2.4 0.8 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 0.0 3.9 0.1 1.7 0.1 1.0 0.1 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.0 1.4 0.0 1.3 0.0 0.0 2.9 154.2 0.3 0.0 0.0 0.1 0.0 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158561-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.0" "Group enriched" "Detected in some" 60 "Spermatocytes: 5.2;Spermatogonia: 6.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 10.1;K-562: 62.2;NB-4: 46.0;THP-1: 17.3;U-266/84: 27.6" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.0 0.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.2 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.2 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.7 1.1 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 6.8 0.0 0.0 0.0 0.0 0.0 RHOXF2B ENSG00000203989 "Rhox homeobox family member 2B" P0C7M4 X 120070672-120077705 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.6;testis: 9.4" "Cell type enriched" "Detected in single" 20 "Spermatogonia: 2.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 348 "HL-60: 47.1;K-562: 47.2;NB-4: 76.4" HPA003314 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA003314: AB_1855193" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.2 0.0 9.4 0.0 0.0 0.0 0.0 1.0 1.6 2.6 1.3 1.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 76.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.7 0.8 0.5 0.9 1.0 0.7 0.5 0.7 0.7 1.0 0.7 0.7 1.4 1.7 1.3 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 RIBC1 FLJ32783 ENSG00000158423 "RIB43A domain with coiled-coils 1" Q8N443 X 53422690-53431120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 12.7;fallopian tube: 24.5;testis: 37.6" "Cell type enhanced" "Detected in many" 26 "Ciliated cells: 92.3;Early spermatids: 217.1;Late spermatids: 387.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 12.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 8.4;T-47d: 11.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001150 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA001150: AB_2666211" "unprognostic (1.08e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.25e-1)" "prognostic favorable (9.66e-4)" "unprognostic (1.11e-1)" "unprognostic (2.39e-3)" "unprognostic (9.88e-2)" "unprognostic (3.97e-4)" "unprognostic (2.25e-2)" "unprognostic (7.89e-3)" "unprognostic (3.79e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" 0.6 2.9 2.0 1.3 3.7 0.4 1.3 0.5 1.4 1.8 0.7 5.3 0.8 0.7 2.1 5.4 1.1 24.5 1.4 1.1 2.5 3.0 2.3 0.3 2.9 0.6 1.3 1.4 5.5 1.6 1.9 5.0 0.5 12.7 1.1 0.4 2.4 1.9 1.5 0.5 1.0 0.7 0.5 1.4 0.6 0.7 37.6 1.2 0.3 3.1 0.2 0.5 0.8 0.5 1.5 1.0 2.9 1.5 3.7 2.3 1.1 1.9 5.2 2.0 1.4 0.7 1.3 1.2 0.5 0.3 1.1 1.0 2.0 3.1 1.9 3.5 0.2 3.5 3.6 0.5 1.1 1.5 1.1 3.3 1.1 8.4 0.9 0.3 1.1 2.0 0.4 0.4 3.1 0.7 2.6 0.9 1.5 0.8 2.3 0.7 1.3 2.2 1.0 2.5 0.9 1.4 1.6 1.4 1.5 3.0 1.0 4.5 0.8 5.1 1.9 1.2 6.5 11.6 0.5 0.6 0.5 2.6 1.5 0.7 2.4 1.6 1.1 2.1 0.4 0.9 0.0 0.7 0.0 0.3 1.2 2.3 0.2 0.9 1.9 1.0 1.5 0.4 0.4 2.9 3.7 1.5 0.8 1.9 1.1 2.0 3.7 0.5 1.4 2.5 3.0 1.3 1.4 12.7 1.2 0.0 0.3 0.0 1.4 1.1 2.3 0.8 2.5 92.3 7.9 0.0 3.9 0.5 1.7 1.1 217.1 0.6 0.0 0.0 0.2 0.3 0.6 0.7 2.3 0.5 0.1 1.6 1.2 0.0 0.3 387.5 2.3 0.4 1.7 0.0 0.0 2.6 0.5 0.0 1.8 5.0 9.1 0.0 0.2 10.9 6.1 0.6 0.3 0.0 0.2 0.5 RIBC2 "C22orf11, DKFZp566F0546, FLJ25720" ENSG00000128408 "RIB43A domain with coiled-coils 2" 22 45413691-45432496 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.9;fallopian tube: 10.9;testis: 35.3" "Group enriched" "Detected in some" 6 "Ciliated cells: 129.8;Early spermatids: 135.0;Spermatocytes: 89.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 7.8;CAPAN-2: 8.0;MCF7: 9.2;SiHa: 13.4" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 8.5" HPA003210 Approved NA NA "HPA003210: AB_1078347" "unprognostic (2.55e-1)" "prognostic favorable (7.08e-8)" "unprognostic (3.58e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (1.71e-2)" "unprognostic (1.30e-3)" "unprognostic (9.51e-3)" "unprognostic (7.21e-3)" "unprognostic (7.34e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (9.95e-5)" "unprognostic (1.41e-1)" "unprognostic (5.32e-2)" "unprognostic (7.91e-2)" "unprognostic (1.13e-1)" 0.0 0.1 0.7 0.6 6.5 1.9 0.2 0.0 3.2 1.0 0.5 3.1 0.0 0.3 0.6 2.2 0.6 10.9 0.9 0.0 2.4 0.0 0.0 1.0 0.4 0.0 1.0 1.5 0.1 2.2 8.7 0.4 10.9 0.7 0.2 0.3 0.0 0.1 0.0 0.9 0.5 0.1 0.0 0.1 0.5 35.3 1.9 1.8 0.5 0.0 0.9 0.2 0.0 0.6 2.0 0.2 0.7 0.0 1.4 0.2 6.0 4.2 0.6 0.0 0.0 0.0 0.6 7.8 0.7 1.6 2.2 4.3 8.0 0.0 2.0 0.7 0.0 7.0 0.0 0.0 1.2 0.0 0.2 0.0 5.9 0.2 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.9 1.0 0.0 0.0 0.5 9.2 4.0 2.0 0.9 0.1 2.3 4.5 0.0 0.0 2.3 0.9 4.1 0.0 13.4 2.8 0.0 0.4 5.0 2.9 0.4 0.0 0.0 4.8 0.0 2.4 2.3 0.0 0.0 1.2 3.7 0.0 0.7 0.2 0.0 0.0 0.0 0.6 0.3 1.3 2.0 0.1 0.0 0.5 0.0 0.0 0.0 1.0 1.4 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.2 0.0 129.8 9.1 0.0 0.0 0.9 1.7 0.0 135.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 16.6 1.1 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.7 0.0 3.3 0.0 0.0 89.0 20.3 0.1 0.2 0.0 0.6 0.3 RIDA "HRSP12, P14.5, PSP, UK114" ENSG00000132541 "Reactive intermediate imine deaminase A homolog" P52758 8 98102344-98117241 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "kidney: 81.4;liver: 248.6" "Cell type enriched" "Detected in many" 5 "Proximal tubular cells: 1135.9" "Cancer enhanced" "Detected in all" "liver cancer: 162.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022856, HPA023489" Enhanced NA NA 5700000 "HPA022856: AB_1858253, HPA023489: AB_1858252" "unprognostic (1.67e-2)" "unprognostic (3.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (4.16e-1)" "unprognostic (2.20e-2)" "prognostic favorable (9.61e-6)" "unprognostic (6.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.81e-1)" "unprognostic (4.46e-1)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (2.04e-1)" "unprognostic (2.08e-2)" "unprognostic (1.51e-2)" 8.3 9.4 16.8 2.5 18.8 1.6 4.2 5.6 11.6 2.6 4.7 4.5 2.7 5.8 2.1 4.8 2.8 2.2 4.3 5.2 11.7 12.5 81.4 248.6 2.2 2.1 19.1 9.5 4.6 5.2 3.5 1.8 2.4 11.8 4.0 4.8 2.3 3.2 2.7 6.8 2.3 4.2 2.5 7.9 1.8 4.6 3.3 9.5 0.6 3.2 3.5 2.6 3.2 1.8 12.1 10.0 5.0 8.3 8.4 12.8 7.1 13.9 12.1 9.8 11.9 22.2 17.3 10.7 12.9 9.1 8.6 10.4 16.4 9.4 19.8 16.6 9.4 11.5 9.9 21.4 18.3 17.5 6.9 9.2 14.4 8.2 17.5 10.1 5.3 2.3 14.9 6.3 12.1 13.3 10.9 11.1 21.4 25.6 4.3 11.5 18.1 11.2 14.4 15.5 61.2 22.1 13.0 7.1 5.7 20.8 10.0 10.6 5.3 8.2 5.7 8.9 13.0 14.5 7.0 6.7 6.7 4.2 11.3 5.1 10.3 14.1 9.7 11.7 11.2 4.3 0.1 8.3 5.0 6.5 7.0 8.3 12.1 9.4 9.5 10.0 9.5 12.2 12.8 1.5 8.4 7.0 7.6 12.3 7.1 16.8 18.8 5.6 11.6 11.7 12.5 19.1 9.5 11.8 9.5 23.8 15.3 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.4 45.4 0.0 25.5 242.1 13.4 0.0 0.0 0.0 0.0 7.5 23.7 0.0 0.0 2.3 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 10.0 0.0 0.0 14.6 0.0 0.0 1135.9 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 RIIAD1 "C1orf230, FLJ36032, NCRNA00166" ENSG00000178796 "Regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1" A6NNX1 1 151710433-151729805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 43.4;pituitary gland: 29.2" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 113.8;Early spermatids: 62.9;Intestinal endocrine cells: 44.4;Late spermatids: 46.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "CACO-2: 6.6;SCLC-21H: 3.6;SH-SY5Y: 7.1;SK-BR-3: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045703 Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA045703: AB_10965795" "unprognostic (8.28e-3)" "unprognostic (3.42e-1)" "unprognostic (8.21e-2)" "prognostic favorable (5.46e-4)" "unprognostic (1.06e-2)" "unprognostic (3.09e-1)" "unprognostic (8.99e-2)" "unprognostic (3.20e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-2)" "unprognostic (3.65e-3)" "unprognostic (8.50e-2)" "unprognostic (1.57e-3)" "unprognostic (2.79e-2)" "unprognostic (3.06e-2)" "unprognostic (2.48e-4)" 0.5 2.7 4.0 0.5 9.3 0.5 1.1 0.5 5.6 1.6 1.1 0.8 1.2 0.6 2.1 6.1 0.7 43.4 0.9 0.5 4.6 5.1 0.6 0.5 3.1 0.5 2.5 5.2 2.6 1.2 1.1 29.2 0.5 3.6 1.0 1.3 1.2 0.5 1.9 0.5 0.6 0.8 1.1 0.5 0.5 2.0 14.7 2.1 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.6 7.1 0.0 11.2 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 9.3 0.5 5.6 4.6 5.1 2.5 5.2 3.6 2.1 17.9 1.0 0.0 0.0 0.0 6.7 14.0 0.0 113.8 15.9 5.2 15.7 0.0 3.3 3.1 62.9 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.1 0.0 44.4 0.0 0.0 46.5 0.6 0.3 3.3 0.0 2.0 0.8 0.2 0.0 1.4 2.2 2.7 0.0 1.0 14.9 7.8 0.0 0.0 0.0 0.8 0.0 RILP FLJ31193 ENSG00000167705 "Rab interacting lysosomal protein" Q96NA2 17 1646145-1650077 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 40.4" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 75.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 5.9;intermediate monocyte: 1.9;myeloid DC: 4.0;neutrophil: 5.2;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 7 "dendritic cells: 4.0;granulocytes: 5.2;monocytes: 5.9" "Cell line enhanced" "Detected in many" "HEL: 18.8;HMC-1: 9.9" "Low region specificity" "Detected in many" NA NA "prognostic favorable (7.97e-4)" "unprognostic (7.93e-2)" "unprognostic (3.11e-1)" "unprognostic (1.05e-1)" "unprognostic (4.11e-2)" "unprognostic (1.26e-1)" "unprognostic (1.50e-2)" "unprognostic (8.84e-3)" "unprognostic (1.61e-1)" "unprognostic (2.64e-1)" "unprognostic (2.24e-1)" "unprognostic (1.93e-1)" "prognostic favorable (8.51e-5)" "unprognostic (2.26e-1)" "unprognostic (4.73e-2)" "unprognostic (1.00e-1)" "prognostic favorable (7.12e-4)" 13.6 8.3 3.0 2.6 5.6 9.5 7.7 5.0 10.4 2.4 11.1 2.2 5.8 9.9 3.0 4.4 3.4 3.6 6.9 21.0 2.6 2.9 7.3 16.4 7.6 2.4 3.4 5.4 2.2 6.3 5.4 2.3 3.8 6.2 3.7 3.6 8.6 7.9 3.9 40.4 2.7 16.5 3.0 1.4 7.8 8.6 2.0 2.5 1.5 15.2 7.6 3.0 6.6 3.4 0.4 4.0 5.2 5.9 0.6 0.4 1.1 1.4 1.1 0.2 1.9 1.9 2.8 3.3 0.7 1.1 1.8 0.7 2.2 0.5 0.1 3.5 1.3 0.9 2.5 0.2 0.2 0.3 0.2 2.3 18.8 0.5 3.2 1.8 0.1 9.9 2.0 0.7 0.4 0.2 1.0 1.4 0.3 6.3 0.1 0.5 1.3 0.8 1.3 0.3 0.7 5.9 3.8 0.0 0.5 0.1 1.8 0.1 0.3 2.2 1.3 1.1 0.3 1.1 0.3 5.0 0.6 0.4 1.6 0.8 0.1 0.3 0.0 1.9 0.9 0.2 0.5 5.9 0.8 0.3 1.9 0.1 0.4 0.3 0.1 4.0 0.0 0.4 0.1 5.2 0.6 0.3 2.4 0.3 1.1 3.0 5.6 5.0 10.4 2.6 2.9 3.4 5.4 6.2 2.5 17.9 15.3 0.8 13.7 7.8 1.3 52.3 5.1 0.0 4.5 7.0 0.0 9.8 43.1 21.0 0.1 19.3 75.0 0.0 22.2 7.9 11.9 10.6 0.0 24.6 49.1 3.2 2.9 17.2 21.2 1.9 6.4 27.6 13.5 27.9 21.7 7.0 19.0 31.7 7.8 12.9 1.1 12.9 8.6 0.5 13.7 7.2 28.9 3.2 20.4 15.7 RILPL1 FLJ39378 ENSG00000188026 "Rab interacting lysosomal protein like 1" Q5EBL4 12 123470054-123533718 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 21.1;heart muscle: 43.8;skeletal muscle: 66.2" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 35.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041314 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA041314: AB_10795587" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (3.71e-2)" "unprognostic (5.36e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-3)" "unprognostic (1.94e-2)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (1.75e-1)" "unprognostic (2.30e-2)" "unprognostic (8.30e-2)" "unprognostic (4.25e-2)" "unprognostic (2.98e-1)" "unprognostic (2.32e-1)" "unprognostic (6.07e-3)" "unprognostic (2.81e-1)" 6.1 5.7 9.9 3.5 12.3 3.0 3.7 5.2 11.3 4.8 4.7 12.6 4.4 2.1 6.6 5.0 4.8 5.0 4.3 43.8 9.6 7.5 3.8 3.0 5.5 2.3 21.1 5.8 7.2 3.2 5.7 3.6 7.1 11.1 6.2 2.2 4.9 8.0 7.8 66.2 6.2 2.7 9.8 14.4 3.8 3.0 2.9 15.1 0.3 8.2 9.7 1.9 4.7 5.3 1.6 1.2 4.6 1.2 1.2 2.0 0.7 5.9 8.4 7.6 5.9 8.6 8.1 8.0 10.8 6.1 5.9 5.3 5.2 1.4 0.3 5.4 10.5 4.3 6.5 5.6 5.2 2.4 6.1 10.3 0.8 5.4 7.6 15.1 0.3 2.3 9.2 10.3 6.6 9.6 14.8 6.0 1.1 4.7 0.4 5.9 9.9 0.6 1.9 5.6 1.7 8.9 1.0 4.2 0.3 4.2 6.3 1.2 7.1 5.8 5.1 12.9 4.4 6.7 0.2 11.8 7.8 3.9 11.2 6.8 1.3 0.6 0.2 8.0 0.1 4.8 1.4 1.0 0.7 0.9 0.5 0.8 0.9 1.0 0.8 0.3 1.6 2.0 1.6 4.6 1.2 1.2 1.2 0.9 0.7 9.9 12.3 5.2 9.9 9.6 7.5 21.1 5.8 11.1 15.1 35.7 13.2 0.0 4.3 4.0 13.4 9.2 5.1 5.3 11.4 10.4 5.9 7.9 1.7 1.8 1.3 4.6 0.0 0.0 1.8 5.2 5.6 3.2 1.1 1.3 4.4 22.3 0.0 10.4 1.3 0.9 14.4 1.0 5.0 1.0 1.0 20.0 2.1 0.0 7.8 1.8 6.2 6.5 6.1 0.9 2.3 3.3 7.8 1.3 0.5 2.6 RIMBP2 "KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2" ENSG00000060709 "RIMS binding protein 2" O15034 12 130396137-130716281 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;parathyroid gland: 49.1;pituitary gland: 42.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 19.7;Cone photoreceptor cells: 29.5;Intestinal endocrine cells: 72.5;Rod photoreceptor cells: 13.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive B-cell: 2.7" "Lineage enriched" "Detected in single" 28 "B-cells: 2.7" "Group enriched" "Detected in some" 6 "SCLC-21H: 17.6;SH-SY5Y: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041494, HPA044114" Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA041494: , HPA044114: AB_2678815" "unprognostic (4.15e-4)" "unprognostic (9.77e-3)" "unprognostic (1.20e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-3)" "unprognostic (3.63e-1)" "unprognostic (1.32e-2)" "unprognostic (1.76e-1)" "unprognostic (1.47e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.86e-1)" "unprognostic (6.41e-3)" "unprognostic (5.27e-2)" "unprognostic (2.07e-1)" "unprognostic (1.03e-1)" "unprognostic (4.73e-2)" 0.9 11.9 14.1 1.1 13.0 0.6 0.6 1.1 24.7 6.1 1.5 1.6 0.0 2.5 2.5 2.4 0.8 6.6 1.1 0.4 15.3 11.0 2.8 0.6 0.7 0.5 5.6 12.9 2.1 2.3 49.1 42.7 0.4 4.9 1.3 1.8 4.1 0.6 1.4 0.5 2.4 2.3 2.3 5.6 1.1 5.2 2.3 1.6 0.0 0.9 0.0 0.5 0.8 0.7 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.2 4.2 0.0 0.0 17.6 34.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 13.0 1.1 24.7 15.3 11.0 5.6 12.9 4.9 1.6 0.0 0.0 0.0 0.0 1.8 19.7 0.8 0.0 1.4 0.0 0.0 29.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.5 72.5 0.0 0.0 1.7 0.9 0.0 0.0 0.0 1.2 3.1 0.1 0.0 0.7 0.0 13.7 0.0 0.0 1.1 1.2 0.5 0.0 0.0 0.6 0.0 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 6.0;THP-1: 6.5" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 0.1 0.2 0.0 0.7 1.1 0.9 1.0 1.7 2.5 1.1 0.8 2.8 1.2 0.9 1.6 0.8 0.1 1.0 3.1 1.4 1.5 0.1 0.0 0.7 1.2 0.3 0.8 0.8 0.6 0.0 0.3 2.8 0.9 1.3 0.8 1.2 0.1 4.0 0.1 0.3 0.1 0.6 0.0 0.3 0.0 2.4 0.6 0.7 1.2 1.4 6.0 3.1 1.2 1.2 0.3 2.4 3.5 0.4 0.4 0.2 1.6 0.3 2.5 0.0 0.5 0.2 0.3 6.5 0.2 2.1 1.5 1.1 0.5 0.2 0.8 0.6 1.2 1.4 2.3 0.0 1.0 0.9 1.0 0.6 2.5 0.7 1.4 1.4 1.1 0.6 1.8 0.9 0.3 1.7 0.4 0.1 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RH-30: 3.5;THP-1: 4.9" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.0 0.3 0.4 0.4 0.9 1.0 1.5 0.4 0.1 1.7 0.2 0.4 1.1 0.7 0.3 0.5 1.2 0.5 0.9 0.2 0.3 0.3 1.0 0.2 0.1 0.0 0.7 0.0 0.1 1.7 1.1 0.6 0.3 0.2 0.0 0.6 0.0 0.1 0.0 0.1 0.2 0.0 0.0 1.0 0.6 0.3 0.6 0.2 2.0 2.8 0.4 0.6 0.4 2.0 3.5 0.0 0.1 0.0 0.5 0.0 1.6 0.0 0.5 0.0 0.1 4.9 0.0 0.4 0.5 0.4 0.2 0.1 0.1 0.0 0.9 0.4 1.5 0.0 0.5 0.4 1.1 0.2 1.4 0.1 0.7 1.5 0.4 0.3 1.1 0.7 0.1 1.0 0.9 0.1 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545357-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 16.6" "Group enriched" "Detected in some" 18 "Early spermatids: 22.4;Late spermatids: 37.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 3.2;THP-1: 3.6" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 16.6 0.0 0.3 0.1 0.0 0.5 1.3 0.9 0.8 1.4 1.7 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.2 0.1 0.9 0.7 0.3 0.1 0.3 0.0 1.6 0.6 0.7 0.5 0.7 0.2 0.1 0.7 0.5 0.5 0.0 0.3 0.2 1.6 0.6 0.0 0.2 0.5 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.7 1.8 3.2 0.3 1.6 0.3 1.5 0.9 0.1 0.1 0.1 0.8 0.2 0.5 0.4 0.2 0.2 0.0 3.6 0.0 1.3 0.6 0.7 0.2 0.5 0.4 0.2 1.3 1.1 1.7 0.9 0.8 0.8 0.5 0.5 1.4 0.5 0.9 0.7 1.3 0.4 1.7 0.6 0.8 1.4 0.7 0.1 0.9 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 RIMKLA "FAM80A, MGC47816, NAAGS-II, RP11-157D18.1" ENSG00000177181 "Ribosomal modification protein rimK like family member A" Q8IXN7 1 42380795-42422578 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 41.2;Horizontal cells: 33.4;Rod photoreceptor cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 7.8;JURKAT: 6.3;Karpas-707: 9.1;SCLC-21H: 11.9;U-266/70: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027826 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA027826: AB_10603992" "unprognostic (4.04e-2)" "unprognostic (1.61e-1)" "unprognostic (3.68e-3)" "unprognostic (9.84e-2)" "unprognostic (2.49e-2)" "unprognostic (1.06e-1)" "unprognostic (2.63e-3)" "prognostic favorable (1.43e-4)" "unprognostic (8.89e-2)" "unprognostic (3.76e-1)" "unprognostic (9.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.22e-3)" "unprognostic (3.99e-2)" "unprognostic (7.07e-2)" "unprognostic (1.63e-2)" "unprognostic (3.44e-1)" 0.9 1.2 6.2 1.5 10.4 0.8 1.3 7.8 18.4 1.0 7.9 1.7 0.0 1.4 1.0 0.8 1.0 0.9 1.8 8.5 7.5 5.9 2.5 0.7 5.4 0.8 7.9 8.5 0.7 2.5 6.6 2.0 1.3 20.1 2.2 9.0 3.3 1.1 1.2 1.4 1.1 1.3 2.4 3.6 1.1 2.1 2.3 1.2 0.0 2.2 0.0 0.8 1.1 0.4 0.3 1.6 1.3 0.2 0.4 2.0 0.1 0.0 0.8 0.1 7.8 0.1 0.0 1.5 0.0 0.0 0.2 0.5 0.4 0.2 0.0 1.6 0.0 1.3 0.0 4.6 0.0 0.4 4.1 3.1 0.3 0.1 1.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 9.1 0.0 0.3 2.1 0.0 4.0 0.6 5.5 0.0 0.3 0.4 0.7 2.1 11.9 5.1 0.4 0.3 0.1 0.9 0.4 2.0 0.0 0.0 0.4 0.0 0.8 8.3 4.7 5.5 0.1 0.0 0.0 1.1 0.2 1.3 0.2 0.2 2.0 0.2 0.1 1.0 0.0 0.3 0.1 0.2 1.0 0.4 0.1 1.6 0.1 0.1 6.2 10.4 7.8 18.4 7.5 5.9 7.9 8.5 20.1 1.2 14.9 4.6 0.0 0.8 0.6 13.2 13.0 0.0 0.0 1.2 1.8 41.2 1.0 1.7 3.2 4.7 0.9 7.8 0.0 4.2 11.6 0.3 2.9 0.0 0.0 0.8 33.4 10.9 1.3 0.0 6.4 0.3 0.8 5.0 0.0 7.5 4.5 6.8 5.9 0.0 2.4 23.9 0.0 0.5 1.0 2.5 0.1 1.4 0.0 5.5 0.7 RIMS1 "CORD7, KIAA0340, RAB3IP2, RIM, RIM1" ENSG00000079841 "Regulating synaptic membrane exocytosis 1" Q86UR5 6 71886703-72403143 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 83.1" "Group enriched" "Detected in some" 4 "Bipolar cells: 58.2;Horizontal cells: 58.8;Muller glia cells: 101.2" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Region enriched" "Detected in all" 6 "cerebellum: 83.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 4.9;EFO-21: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 15.1;SH-SY5Y: 10.7;TIME: 5.2;U-138 MG: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076565 Enhanced NA NA "HPA076565: " "unprognostic (1.34e-3)" "unprognostic (3.47e-1)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (6.62e-2)" "unprognostic (1.16e-1)" "unprognostic (1.73e-2)" "unprognostic (8.57e-2)" "unprognostic (2.85e-1)" "unprognostic (7.76e-4)" "unprognostic (2.42e-2)" "unprognostic (2.29e-1)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (5.74e-2)" "unprognostic (1.07e-2)" 0.5 2.3 10.5 1.5 9.8 0.4 1.2 83.1 27.7 0.9 0.6 0.5 0.0 1.5 0.8 0.5 3.7 0.5 6.2 0.6 9.3 3.6 0.5 0.4 0.7 0.5 2.8 11.7 0.5 0.8 5.0 4.6 0.4 7.2 4.9 0.6 0.2 1.9 0.9 0.6 0.4 0.8 1.4 1.5 0.4 1.4 5.9 2.7 0.0 0.5 0.0 0.4 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.2 1.3 0.0 0.2 0.0 0.0 4.9 8.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.4 1.6 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.4 15.1 0.0 0.4 10.7 0.0 0.0 0.0 0.3 0.6 0.0 5.2 5.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 9.8 83.1 12.9 9.3 3.6 2.8 11.7 7.2 2.7 0.0 0.3 0.0 0.1 0.0 58.2 1.5 0.0 5.3 9.1 0.0 0.0 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.7 0.0 0.2 1.0 1.1 0.0 0.0 58.8 0.0 0.6 0.0 6.5 0.3 0.0 3.3 0.0 0.0 101.2 0.8 0.0 1.4 0.0 7.1 0.0 0.2 16.3 13.0 0.1 0.0 0.0 0.0 0.4 RIMS2 "KIAA0751, OBOE, RAB3IP3, RIM2" ENSG00000176406 "Regulating synaptic membrane exocytosis 2" Q9UQ26 8 103500748-104256094 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1;brain: 28.7" "Group enriched" "Detected in many" 10 "Bipolar cells: 397.4;Cone photoreceptor cells: 665.6;Rod photoreceptor cells: 1047.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.8;SuSa: 8.3" "Low region specificity" "Detected in all" "HPA046538, HPA066498, CAB079049" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB079049: , HPA046538: , HPA066498: AB_2685678" "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (4.47e-2)" "unprognostic (5.51e-2)" "unprognostic (2.82e-1)" "unprognostic (7.09e-3)" "unprognostic (2.02e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (8.01e-3)" "unprognostic (1.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.67e-5)" "unprognostic (8.12e-4)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" 0.9 51.1 15.8 1.0 21.8 1.1 1.8 14.5 28.7 8.5 0.9 0.5 0.9 1.2 1.4 1.7 1.0 6.3 1.7 0.9 10.3 4.9 1.1 0.9 1.0 1.1 3.1 17.5 2.8 1.6 0.9 12.4 1.1 8.6 2.8 1.0 5.8 1.0 1.8 1.0 1.0 1.4 2.0 4.0 0.9 1.7 3.9 8.7 0.0 2.9 0.0 1.0 1.5 1.6 0.7 0.7 2.9 0.6 1.6 0.6 0.2 3.7 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 1.4 0.1 0.3 11.7 0.1 0.0 1.2 0.3 1.8 0.7 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 2.1 0.0 1.3 0.1 0.5 0.0 0.5 0.8 0.0 4.6 0.0 0.6 0.0 0.0 0.0 0.0 8.4 20.8 5.1 0.0 0.1 0.5 8.3 0.3 0.2 0.0 0.0 5.6 0.1 0.1 1.5 0.0 0.1 0.4 0.2 0.2 2.7 0.6 0.6 0.6 0.3 0.4 0.4 0.3 0.4 0.1 0.7 0.3 0.5 2.9 1.6 0.4 0.7 0.3 0.2 15.8 21.8 14.5 28.7 10.3 4.9 3.1 17.5 8.6 8.7 26.8 32.3 0.0 1.6 0.2 397.4 0.7 2.5 18.7 29.6 0.0 665.6 0.5 1.7 0.0 29.0 0.5 0.0 0.0 0.0 0.2 0.8 4.9 15.1 0.0 0.2 63.5 8.1 0.6 0.3 13.5 66.7 0.4 1.7 0.0 0.2 71.8 0.4 0.0 27.6 0.1 1047.7 0.0 0.3 15.3 9.9 0.4 0.1 0.5 0.0 0.9 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA055285: AB_2682771" "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.9 3.1 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.3 0.0 0.0 1.4 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 0.1 13.2 1.8 1.4 0.0 3.4 5.5 0.2 1.8 0.3 0.2 2.5 2.6 6.9 0.5 0.5 10.0 17.7 0.4 1.8 1.2 4.0 0.4 10.4 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.2 16.3 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 6.0 0.0 0.0 0.2 0.5 6.3 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 10.7 0.1 1.7 0.0 1.3 0.1 0.3 0.4 1.1 0.0 2.4 4.8 0.0 0.0 2.1 23.5 0.0 1.1 0.0 1.0 1.9 12.8 2.3 0.8 0.7 0.3 0.6 0.0 2.2 3.3 1.1 0.1 0.2 0.0 0.6 0.1 RIMS4 "C20orf190, dJ781B1.3" ENSG00000101098 "Regulating synaptic membrane exocytosis 4" Q9H426 20 44751808-44810338 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.8;testis: 14.6" "Cell type enhanced" "Detected in some" 19 "Horizontal cells: 36.5;Peritubular cells: 12.4;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 13.1;MCF7: 8.8;SCLC-21H: 27.1;SH-SY5Y: 13.9;SiHa: 9.4;U-2 OS: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060928 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA060928: AB_2684387" "unprognostic (1.54e-1)" "unprognostic (1.98e-1)" "unprognostic (1.64e-1)" "unprognostic (9.46e-2)" "unprognostic (2.97e-1)" "unprognostic (1.90e-2)" "unprognostic (4.63e-3)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (4.21e-3)" "unprognostic (1.70e-1)" "unprognostic (8.60e-3)" "unprognostic (3.37e-2)" "unprognostic (1.28e-1)" "unprognostic (7.66e-3)" "unprognostic (2.94e-2)" 1.0 2.1 13.8 0.8 23.3 0.4 1.2 9.6 23.8 11.8 1.2 0.2 0.0 0.6 3.2 2.2 1.3 11.9 1.4 0.6 14.1 7.5 0.6 0.5 1.7 0.6 4.9 8.8 9.5 0.6 0.5 6.0 0.6 4.1 3.2 1.2 1.0 2.0 1.8 1.8 0.5 0.7 4.3 1.3 0.5 2.3 14.6 2.6 0.0 7.5 0.9 1.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 1.3 0.0 13.1 0.1 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 8.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.1 13.9 9.4 0.0 0.1 0.4 4.1 0.4 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 23.3 9.6 19.0 14.1 7.5 4.9 8.8 4.1 2.6 0.0 0.0 0.0 0.0 0.2 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 36.5 1.7 0.0 0.0 2.4 6.6 0.0 0.0 0.0 0.7 0.8 0.1 0.0 12.4 0.0 0.7 25.8 0.0 0.7 4.1 0.1 0.0 0.0 0.0 0.0 RIN1 ENSG00000174791 "Ras and Rab interactor 1" Q13671 11 66330242-66336840 "Predicted intracellular proteins, RAS pathway related proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 31.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.7;non-classical monocyte: 19.1" "Lineage enriched" "Detected in many" 6 "monocytes: 19.1" "Cell line enhanced" "Detected in many" "hTCEpi: 26.7;PC-3: 20.1;U-2197: 29.3" "Group enriched" "Detected in many" 6 "amygdala: 37.2;basal ganglia: 37.4;cerebral cortex: 29.2;hippocampal formation: 35.3;olfactory region: 16.6" "Group enriched" "Detected in many" 6 "amygdala: 9.1;basal ganglia: 17.1;cerebral cortex: 8.2;hippocampal formation: 12.4;olfactory region: 9.1" HPA035491 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA035491: AB_10601608" "unprognostic (1.25e-2)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "prognostic favorable (2.21e-4)" "unprognostic (1.11e-2)" "unprognostic (2.57e-1)" "unprognostic (6.82e-3)" "unprognostic (3.84e-2)" "unprognostic (1.11e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (9.34e-7)" "unprognostic (2.42e-2)" "unprognostic (1.14e-1)" "unprognostic (7.82e-3)" "unprognostic (2.46e-1)" 4.9 5.1 11.1 7.1 22.7 3.9 3.4 13.0 13.5 5.9 5.2 1.5 2.4 8.0 4.2 2.3 15.8 5.8 8.7 3.3 9.7 2.3 2.3 2.7 3.8 5.4 1.4 5.8 4.8 6.6 1.5 5.0 4.5 2.2 4.7 3.6 2.5 4.8 3.5 10.3 31.5 5.8 2.8 0.8 4.6 11.1 2.8 2.5 0.0 1.5 8.7 8.6 3.4 7.0 0.1 3.3 0.0 19.1 0.0 1.5 2.0 1.6 4.5 1.3 2.8 1.6 8.8 1.0 10.1 9.2 7.8 3.8 2.8 5.1 0.3 5.1 7.3 3.2 10.7 0.0 13.6 1.0 0.5 0.0 0.4 4.3 2.4 3.0 0.1 4.7 8.5 26.7 7.9 4.7 9.7 1.6 0.3 0.2 0.1 3.4 0.3 0.1 11.5 0.6 2.1 20.1 0.1 3.9 0.0 2.3 1.7 10.0 2.7 2.6 1.3 13.8 0.4 0.9 0.8 4.4 12.5 7.4 29.3 2.5 0.2 0.5 0.0 17.4 2.7 5.0 0.0 4.3 0.0 0.2 9.7 1.5 0.1 1.0 0.3 3.3 0.0 1.1 0.5 0.0 0.0 19.1 0.0 0.1 2.0 11.1 22.7 13.0 13.5 9.7 2.3 1.4 5.8 2.2 2.5 0.0 0.3 0.0 7.8 11.8 3.3 0.8 2.5 1.4 1.2 0.0 0.0 0.6 0.0 2.4 0.3 2.9 8.6 0.0 6.1 4.3 5.1 1.9 4.6 0.0 4.3 0.0 2.9 4.9 9.5 1.0 4.0 4.2 1.7 1.0 5.2 0.5 6.7 7.0 1.8 0.0 0.9 0.0 1.4 1.6 0.9 13.2 0.2 1.3 6.6 6.3 RIPK3 RIP3 ENSG00000129465 "Receptor interacting serine/threonine kinase 3" Q9Y572 14 24336021-24340045 "Enzymes, Predicted intracellular proteins" "Apoptosis, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 20.6;Exocrine glandular cells: 30.8;Paneth cells: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HDLM-2: 4.3;OE19: 11.3;SK-BR-3: 12.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-2)" "unprognostic (1.11e-1)" "unprognostic (5.26e-3)" "unprognostic (9.58e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-2)" 7.6 1.3 1.8 9.7 2.4 4.3 6.0 0.9 1.6 4.5 13.6 1.8 1.4 10.6 3.7 3.8 9.2 3.2 12.7 2.6 2.7 0.6 3.8 1.3 6.4 7.2 3.9 0.8 1.7 8.4 0.5 0.9 3.7 2.3 3.7 11.8 3.6 7.5 1.7 2.1 5.9 25.8 2.1 3.8 15.1 9.2 1.6 3.6 7.2 8.7 6.1 13.3 4.6 5.6 3.5 5.2 6.3 8.8 3.9 9.1 4.3 0.0 0.0 0.0 0.0 2.9 3.2 0.0 0.7 3.9 0.0 0.0 0.1 7.6 0.1 2.0 0.3 0.0 1.9 0.0 0.1 0.0 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.1 0.0 0.0 0.0 0.5 0.0 11.3 0.0 0.0 0.0 1.3 1.4 0.0 0.0 0.0 0.0 12.5 0.0 0.0 2.2 3.3 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 2.6 5.1 6.3 6.3 7.7 6.4 3.5 5.4 6.2 5.2 3.5 2.9 4.0 2.6 3.9 8.8 2.6 9.1 4.3 1.8 2.4 0.9 1.6 2.7 0.6 3.9 0.8 2.3 3.6 3.0 10.8 1.9 1.6 1.3 0.0 0.4 2.5 1.4 1.2 3.5 0.0 0.3 3.3 6.3 0.1 2.9 20.6 0.0 30.8 0.2 1.8 0.6 11.6 0.0 11.0 0.0 5.8 0.0 10.0 0.0 0.0 6.3 3.3 10.8 9.2 0.0 15.3 17.5 0.0 0.0 0.0 0.0 1.9 0.0 0.1 1.3 0.2 8.7 6.5 2.3 RIPK4 "ANKK2, ANKRD3, DIK, PKK, RIP4" ENSG00000183421 "Receptor interacting serine/threonine kinase 4" P57078 21 41739369-41767106 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "naive CD4 T-cell: 1.5;neutrophil: 2.2" "Group enriched" "Detected in many" 17 "granulocytes: 2.2;T-cells: 1.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.9;GAMG: 20.8;HaCaT: 23.5;hTCEpi: 15.8;RPTEC TERT1: 14.2;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030942 Enhanced NA NA "HPA030942: AB_2732462" "unprognostic (8.93e-2)" "unprognostic (2.67e-1)" "unprognostic (6.32e-3)" "unprognostic (7.87e-2)" "unprognostic (1.24e-1)" "unprognostic (5.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.22e-5)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.98e-2)" "prognostic favorable (6.52e-4)" "unprognostic (2.69e-1)" "unprognostic (2.95e-3)" "unprognostic (2.28e-1)" "unprognostic (2.78e-2)" 1.0 0.2 0.2 0.8 0.2 0.1 3.3 0.2 0.2 6.7 9.4 0.3 12.0 6.8 1.7 6.5 42.1 4.2 17.1 1.1 0.4 0.2 10.8 17.3 5.4 0.4 0.2 0.1 1.8 14.4 4.7 6.8 2.8 1.1 10.6 1.3 4.8 10.2 14.8 0.2 11.7 11.6 2.0 0.3 0.2 11.2 2.7 0.0 8.1 13.6 12.3 26.6 5.2 11.0 0.0 0.0 2.2 0.1 0.0 1.5 0.2 6.8 4.4 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.1 11.4 15.9 0.0 6.7 1.4 20.8 23.5 0.3 9.5 0.0 0.0 4.7 0.0 3.3 4.2 0.0 0.0 0.0 0.0 15.8 0.1 2.1 0.0 0.0 7.1 0.0 0.0 0.0 5.0 0.9 0.0 0.4 4.5 13.1 0.0 0.0 1.1 14.2 15.1 2.3 0.1 7.7 7.8 7.1 0.7 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 2.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.1 1.1 0.0 26.8 10.8 0.0 26.1 14.1 0.0 1.0 12.7 17.4 14.8 3.5 0.0 7.0 8.3 10.8 0.4 0.0 17.3 0.0 9.0 4.7 0.7 20.1 2.3 16.1 0.9 0.0 21.8 0.0 1.6 1.1 0.0 0.6 6.8 0.0 13.4 0.0 14.2 8.7 0.0 10.0 0.9 0.0 0.3 1.1 0.6 13.2 2.1 0.0 9.8 19.5 RIPOR2 "C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP" ENSG00000111913 "RHO family interacting cell polarization regulator 2" Q9Y4F9 6 24804281-25042170 "Disease related genes, Predicted intracellular proteins" "Cell adhesion, Chemotaxis, Differentiation, Hearing, Myogenesis" "Developmental protein, Signal transduction inhibitor" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 125.3;lymphoid tissue: 49.7" "Cell type enhanced" "Detected in some" 25 "Ciliated cells: 152.6;Club cells: 34.2;Syncytiotrophoblasts: 69.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 125.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 125.3" "Cell line enhanced" "Detected in many" "AF22: 14.3;Daudi: 33.6;fHDF/TERT166: 32.8;U-266/70: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.05e-3)" "unprognostic (1.34e-3)" "unprognostic (3.55e-2)" "unprognostic (1.91e-2)" "unprognostic (1.47e-2)" "unprognostic (1.75e-2)" "unprognostic (5.89e-4)" "unprognostic (2.62e-2)" "unprognostic (1.54e-1)" "unprognostic (4.40e-3)" "unprognostic (1.64e-1)" "unprognostic (1.74e-2)" "unprognostic (8.55e-2)" "unprognostic (3.33e-2)" "unprognostic (2.30e-2)" "unprognostic (9.79e-2)" "unprognostic (1.14e-1)" 8.2 2.5 6.7 38.0 14.9 14.7 4.7 1.8 11.4 8.6 2.5 1.9 1.4 1.9 33.8 4.2 3.4 8.8 5.5 7.3 6.1 6.2 2.7 2.8 13.2 49.7 3.6 9.1 2.5 1.8 0.8 16.9 17.8 2.9 4.4 2.7 3.3 12.5 3.0 12.9 4.0 11.9 10.7 2.2 39.1 3.8 4.1 2.4 21.5 2.5 1.2 42.7 7.7 5.4 25.8 9.1 125.3 21.1 15.8 24.6 18.1 0.4 0.0 14.3 0.2 0.1 0.1 5.2 3.7 7.1 1.7 2.5 0.2 0.2 33.6 0.9 32.8 0.2 0.4 0.0 0.0 0.3 3.4 0.1 8.1 0.5 0.1 0.3 0.2 0.6 1.5 0.1 0.0 0.1 0.1 0.0 1.4 0.4 5.8 0.1 0.1 7.5 0.3 1.1 0.5 0.9 8.0 1.3 0.3 0.0 0.1 0.7 0.1 0.2 0.1 2.5 5.1 0.1 0.2 0.1 0.3 1.5 0.3 0.4 12.2 0.3 1.1 0.3 0.4 2.3 43.1 12.9 41.8 18.1 16.7 19.1 25.8 18.5 18.9 9.1 25.0 24.6 19.1 125.3 15.8 21.1 7.5 15.9 18.1 6.7 14.9 1.8 11.4 6.1 6.2 3.6 9.1 2.9 2.4 3.0 20.0 0.0 0.0 0.0 0.0 0.0 0.0 152.6 34.2 5.2 0.0 1.2 1.7 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 11.6 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 69.2 0.0 0.0 0.0 RIPPLY1 ENSG00000147223 "Ripply transcriptional repressor 1" Q0D2K3 X 106900063-106903335 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 6.4;liver: 11.5" "Cell type enriched" "Detected in single" 4 "Hepatocytes: 2.9" "Group enriched" "Detected in some" 6 "liver cancer: 2.2;renal cancer: 3.6;testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RH-30: 12.3" "Low region specificity" "Detected in many" HPA052284 Uncertain "Intracellular and membrane" NA NA "HPA052284: AB_2681785" "unprognostic (1.48e-1)" "unprognostic (4.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.52e-3)" "unprognostic (7.00e-3)" "unprognostic (1.13e-2)" "unprognostic (1.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.42e-1)" "unprognostic (5.37e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-1)" "unprognostic (2.49e-3)" "unprognostic (1.97e-1)" "unprognostic (1.97e-1)" "unprognostic (1.97e-3)" "unprognostic (1.31e-1)" 0.2 0.9 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.0 6.4 11.5 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.0 2.4 0.2 1.8 0.4 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 12.3 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 RIPPLY2 "C6orf159, dJ237I15.1" ENSG00000203877 "Ripply transcriptional repressor 2" Q5TAB7 6 83853266-83857515 "Disease related genes, Predicted intracellular proteins" "Developmental protein" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 10.5;Cone photoreceptor cells: 3.9;Horizontal cells: 11.1;Rod photoreceptor cells: 8.0;Spermatogonia: 4.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 15.2;HEL: 4.7;SCLC-21H: 20.8;SH-SY5Y: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047454 Uncertain NA NA "HPA047454: AB_2680053" "unprognostic (2.09e-1)" "unprognostic (7.43e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-3)" "unprognostic (2.69e-3)" "unprognostic (3.66e-1)" "unprognostic (6.94e-3)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" 1.5 4.3 11.6 1.3 14.7 0.8 1.1 20.9 23.4 1.6 1.5 2.1 0.0 1.3 2.6 0.8 1.3 1.5 1.5 1.4 11.2 9.8 0.9 0.8 0.9 0.8 8.8 6.9 1.9 3.5 0.8 6.2 0.9 5.3 2.3 1.3 0.4 1.2 1.9 1.5 1.0 1.5 1.5 6.3 0.9 2.5 2.4 6.9 0.0 1.3 0.0 0.8 2.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.5 15.2 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.2 0.0 0.0 0.8 20.8 14.2 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 14.7 20.9 17.0 11.2 9.8 8.8 6.9 5.3 6.9 0.0 0.0 0.0 0.2 0.0 10.5 2.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 11.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 8.0 0.0 0.9 0.2 4.3 0.0 0.0 0.0 0.0 0.0 RIPPLY3 DSCR6 ENSG00000183145 "Ripply transcriptional repressor 3" P57055 21 37006150-37019659 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 9.6" "Cell type enhanced" "Detected in some" 11 "Extravillous trophoblasts: 2.6;Intestinal endocrine cells: 2.9;Ito cells: 2.5;Urothelial cells: 1.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;EFO-21: 1.8;PC-3: 2.3;RT4: 1.4;SCLC-21H: 7.1;T-47d: 4.3" "Not detected" "Not detected" HPA055541 Uncertain NA NA "HPA055541: AB_2682840" "unprognostic (1.77e-1)" "unprognostic (2.40e-2)" "unprognostic (3.01e-1)" "unprognostic (1.64e-2)" "unprognostic (2.43e-1)" "unprognostic (2.38e-3)" "unprognostic (2.19e-2)" "unprognostic (3.08e-1)" "unprognostic (1.91e-2)" "unprognostic (2.11e-2)" "unprognostic (2.17e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-2)" "unprognostic (3.58e-1)" "unprognostic (2.31e-1)" "unprognostic (1.57e-4)" "unprognostic (2.69e-1)" 0.1 0.3 0.0 0.1 3.4 0.1 0.1 0.9 0.6 0.7 0.2 0.0 3.7 0.1 0.7 9.6 0.9 0.1 0.1 0.1 0.0 0.0 0.7 0.4 1.9 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.8 0.0 2.0 0.1 2.8 1.9 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.5 1.8 0.0 0.2 0.0 1.6 2.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 2.3 0.0 0.0 0.0 1.2 1.4 7.1 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.8 0.0 0.0 0.1 0.0 2.9 2.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.0 1.1 RIT2 "RIBA, RIN" ENSG00000152214 "Ras like without CAAX 2" Q99578 18 42743227-43115691 "Predicted intracellular proteins" "Calmodulin-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 55.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 1.3;Muller glia cells: 1.2;Rod photoreceptor cells: 2.3;Syncytiotrophoblasts: 1.7" "Cancer enriched" "Detected in single" 49 "glioma: 4.7" "Region enhanced" "Detected in many" "cerebellum: 55.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.2;SH-SY5Y: 1.7;SuSa: 2.6" "Low region specificity" "Detected in all" HPA072174 Enhanced NA NA "HPA072174: AB_2732195" "unprognostic (1.37e-2)" "unprognostic (4.15e-1)" "unprognostic (2.14e-1)" 0.7 5.2 3.7 0.9 15.0 0.6 0.8 55.9 24.1 1.0 0.7 0.1 0.0 0.8 0.6 0.6 0.6 0.7 0.7 0.6 5.1 11.7 0.6 0.7 0.6 0.7 3.6 5.9 0.8 0.6 0.6 0.4 0.8 6.1 0.7 0.9 0.0 0.6 0.8 0.6 0.6 0.7 0.8 2.1 0.6 0.6 1.1 0.8 0.0 0.7 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.7 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 15.0 55.9 11.0 5.1 11.7 3.6 5.9 6.1 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell type enriched" "Detected in some" 43 "Muller glia cells: 2424.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2424.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.1 0.0 0.0 16.7 0.0 0.0 0.0 RLN1 H1 ENSG00000107018 "Relaxin 1" P04808 9 5334969-5339873 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "prostate: 25.4" "Cell type enhanced" "Detected in some" 14 "Glandular cells: 6.8;Intestinal endocrine cells: 4.6;Spermatocytes: 2.3;Spermatogonia: 2.0" "Cancer enriched" "Detected in some" 106 "prostate cancer: 67.0" "Region enhanced" "Detected in single" "hippocampal formation: 2.1" "Cell type enhanced" "Detected in single" "gdT-cell: 1.6" "Lineage enriched" "Detected in single" 13 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;HEL: 4.8;SK-BR-3: 1.1" "Secreted to blood" NA NA "unprognostic (7.12e-6)" "unprognostic (2.32e-1)" "unprognostic (7.29e-2)" "unprognostic (1.98e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (4.32e-2)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (4.08e-4)" "unprognostic (8.15e-2)" "unprognostic (2.89e-4)" "unprognostic (8.82e-3)" "unprognostic (3.23e-2)" "unprognostic (3.23e-2)" "unprognostic (1.53e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.1 0.9 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 1.2 0.0 0.0 0.0 0.4 0.2 0.0 6.8 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.8 0.0 0.0 2.3 2.0 0.1 0.9 0.5 0.2 0.0 RLN2 "bA12D24.1.1, bA12D24.1.2, H2, RLXH2" ENSG00000107014 "Relaxin 2" P04090 9 5299868-5304969 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.0" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 8.6;Spermatocytes: 10.5;Syncytiotrophoblasts: 11.3" "Cancer enhanced" "Detected in some" "prostate cancer: 6.7" "Region enriched" "Detected in single" 64 "basal ganglia: 44.0" "Group enriched" "Detected in many" 39 "gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0" "Group enriched" "Detected in many" 47 "B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5" "Cell line enhanced" "Detected in some" "Daudi: 5.2;HEL: 20.2;T-47d: 5.8;U-266/84: 9.2" "Secreted to blood" NA NA 24400 "unprognostic (1.63e-3)" "unprognostic (1.26e-1)" "unprognostic (2.09e-3)" "unprognostic (2.84e-1)" "unprognostic (2.03e-2)" "unprognostic (9.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (2.50e-3)" "unprognostic (9.18e-2)" "unprognostic (1.74e-6)" "unprognostic (2.36e-1)" "unprognostic (4.71e-2)" "unprognostic (1.88e-2)" "unprognostic (8.41e-4)" 0.6 0.0 0.6 1.6 44.0 0.0 3.2 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 7.5 0.6 0.6 0.6 0.6 2.0 0.6 0.7 3.5 0.6 0.6 0.6 0.9 5.2 5.8 0.7 0.6 6.2 0.3 0.6 0.6 0.7 0.6 0.4 0.8 0.6 0.6 1.4 0.4 4.2 0.6 0.6 0.9 0.6 3.0 0.6 0.6 2.8 0.0 0.0 0.0 4.9 6.5 1.4 2.8 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.9 0.3 1.5 5.2 0.4 0.0 0.0 0.9 0.0 2.7 0.7 4.1 1.9 20.2 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.5 0.0 0.0 0.2 0.1 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.6 2.7 2.9 0.0 0.6 0.1 0.2 5.8 0.1 0.2 0.0 0.5 0.0 0.1 1.3 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.5 2.8 4.3 3.5 0.0 2.1 6.2 4.6 0.0 4.9 0.0 0.0 2.0 1.4 0.6 44.0 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 3.0 1.1 0.5 2.3 0.5 1.5 1.6 0.0 4.0 1.2 1.8 0.0 6.0 6.6 2.5 7.4 0.3 0.0 0.0 1.4 1.7 0.2 1.3 0.0 0.0 0.5 3.2 3.5 0.0 0.0 3.4 0.6 0.0 0.0 0.0 1.2 8.6 0.7 0.0 0.4 0.8 1.8 0.0 0.1 10.5 2.8 1.1 11.3 2.9 1.0 0.3 RLN3 "H3, RXN3, ZINS4" ENSG00000171136 "Relaxin 3" Q8WXF3 19 14028148-14031042 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.7;parathyroid gland: 5.6;testis: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.0;K-562: 4.1;SCLC-21H: 1.5;THP-1: 2.3;U-266/70: 1.0;U-698: 1.2" "Group enriched" "Detected in some" 11 "midbrain: 14.0;pons and medulla: 28.5" "Region enriched" "Detected in many" 10 "pons and medulla: 34.0" "Secreted to blood" NA NA 60000000 "unprognostic (1.96e-2)" "unprognostic (2.54e-2)" "unprognostic (3.94e-1)" 0.3 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.9 1.3 0.1 0.0 5.6 0.2 0.0 0.7 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.0 1.0 0.1 5.0 0.0 0.4 0.2 0.0 2.7 1.8 0.0 1.3 0.0 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 1.1 0.0 0.9 0.9 1.8 2.7 2.0 1.2 0.0 0.0 0.3 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.4" "Group enriched" "Detected in many" 6 "Early spermatids: 207.9;Late spermatids: 131.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HSkMC: 17.7" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 38.4 6.1 8.7 6.8 1.9 8.9 6.2 8.2 6.3 9.7 1.8 5.9 6.8 7.0 9.2 3.7 4.3 5.5 4.6 5.9 3.5 6.6 24.0 8.2 3.3 3.2 5.1 3.2 4.2 3.2 8.6 3.1 4.6 8.1 8.7 5.2 5.7 10.2 5.0 2.9 14.7 7.7 4.8 14.1 4.6 15.6 4.0 2.1 4.7 3.6 2.1 4.3 9.0 7.5 6.0 4.8 8.0 6.3 6.1 2.3 3.4 3.9 2.7 1.7 12.1 12.4 1.6 7.3 9.3 3.6 3.8 1.0 11.4 2.4 3.2 10.8 2.3 3.9 0.9 4.9 4.6 4.7 2.7 4.0 1.6 3.4 6.3 0.0 4.1 17.7 3.8 5.0 0.7 6.1 2.0 1.2 4.8 2.0 6.5 1.3 0.8 4.1 5.2 6.6 3.9 0.0 0.7 0.4 9.5 3.1 2.1 7.9 5.7 0.6 6.4 2.3 1.2 5.5 2.8 5.1 5.4 2.7 2.8 3.9 6.8 4.8 6.0 0.9 5.1 0.0 4.9 1.0 4.0 8.0 6.1 7.5 1.9 2.5 3.3 5.0 2.0 4.3 4.8 6.3 6.1 6.0 0.2 2.3 6.1 6.8 6.2 8.2 5.9 3.5 3.2 5.1 4.6 4.0 26.8 23.5 5.4 7.2 2.2 3.7 3.6 7.6 13.4 27.3 5.2 2.0 1.7 6.6 4.2 207.9 3.6 21.2 0.0 3.4 0.8 7.3 2.5 15.1 12.9 4.4 4.8 4.6 3.7 6.5 131.8 8.6 4.4 5.0 1.8 11.2 5.8 2.4 7.0 5.6 5.9 2.2 6.5 3.9 3.9 3.7 2.0 0.7 3.8 15.9 2.0 RMI1 "BLAP75, C9orf76, FLJ12888" ENSG00000178966 "RecQ mediated genome instability 1" Q9H9A7 9 83980711-84004074 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 35.7" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 51.0;Late spermatids: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021661 Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA021661: " "unprognostic (9.59e-2)" "unprognostic (7.96e-2)" "unprognostic (6.72e-3)" "unprognostic (3.03e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.65e-1)" "unprognostic (3.39e-3)" "unprognostic (1.32e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.68e-3)" "unprognostic (3.42e-1)" "unprognostic (2.42e-1)" "unprognostic (9.24e-2)" 9.3 9.9 6.2 16.6 7.5 3.9 5.1 13.1 6.1 5.7 7.6 2.9 5.9 7.6 4.1 6.3 7.7 7.5 3.5 3.8 5.3 8.5 5.5 6.3 7.0 13.2 7.4 3.5 5.4 10.0 9.1 7.5 11.0 9.6 6.6 9.1 3.9 7.7 6.3 6.4 5.4 10.5 4.0 8.1 21.0 7.1 11.7 4.8 35.7 7.3 6.3 11.4 5.6 4.5 4.3 9.8 14.4 8.1 5.1 3.9 3.7 14.0 9.6 20.3 7.0 3.1 4.9 19.1 14.0 8.0 12.9 11.8 4.6 9.5 29.7 5.1 6.9 12.9 20.4 13.5 6.7 15.0 17.0 3.4 12.5 7.8 5.8 4.5 23.0 12.9 4.3 4.4 10.2 7.6 4.0 6.1 17.0 9.3 15.3 13.4 9.9 28.6 8.0 17.4 17.2 9.2 26.5 19.9 11.0 5.9 6.0 17.4 10.7 13.1 10.0 5.4 9.3 10.7 10.2 4.3 13.3 8.7 13.1 11.1 6.6 13.9 11.3 8.5 10.0 14.4 14.4 6.1 11.2 2.8 7.3 3.3 4.3 3.3 2.9 9.8 4.0 3.2 3.7 10.6 5.1 8.1 2.8 3.9 3.7 6.2 7.5 13.1 6.1 5.3 8.5 7.4 3.5 9.6 4.8 8.9 6.1 6.4 2.9 2.4 2.3 7.3 0.0 12.0 12.5 1.8 3.9 5.4 5.0 4.7 51.0 3.8 6.3 23.3 2.6 12.5 2.3 4.8 4.6 11.5 6.8 9.5 6.4 7.4 10.5 50.5 2.0 5.4 11.8 1.8 9.6 8.5 2.4 5.5 2.1 4.1 3.7 0.0 1.0 32.3 22.7 4.3 3.5 2.2 7.6 2.2 RMI2 "BLAP18, C16orf75, MGC24665" ENSG00000175643 "RecQ mediated genome instability 2" Q96E14 16 11249619-11351762 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.7;testis: 29.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 100.7;Peritubular cells: 40.0;Spermatogonia: 42.9;Syncytiotrophoblasts: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA040995 Uncertain Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles" Cytosol "HPA040995: AB_10795531" "unprognostic (2.76e-1)" "prognostic favorable (5.69e-5)" "unprognostic (1.17e-1)" "unprognostic (3.09e-3)" "unprognostic (1.69e-2)" "unprognostic (1.80e-3)" "prognostic unfavorable (2.77e-5)" "unprognostic (3.98e-1)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (3.44e-3)" "unprognostic (3.89e-1)" "unprognostic (2.18e-1)" "unprognostic (5.50e-2)" "unprognostic (3.68e-2)" "unprognostic (3.60e-3)" "unprognostic (1.03e-1)" 1.0 1.8 4.2 18.0 5.1 4.8 2.8 0.7 4.1 2.8 7.3 1.0 0.4 4.3 2.5 3.2 11.8 1.0 2.6 1.9 2.5 1.5 3.1 2.3 2.9 17.9 1.6 5.6 3.6 1.6 0.7 1.1 13.2 1.2 2.6 9.0 0.8 2.9 1.7 1.1 8.7 5.6 1.1 1.4 4.2 4.0 29.6 1.2 31.7 1.4 2.8 20.4 3.6 4.5 6.5 0.6 0.9 0.0 0.3 3.0 0.3 19.2 12.9 25.4 10.8 1.1 5.5 10.6 11.2 8.9 10.6 17.7 4.9 22.9 26.7 9.7 5.2 12.0 11.3 10.8 10.7 17.3 5.2 10.1 14.6 7.6 32.6 0.4 5.6 6.6 1.2 2.1 4.6 4.4 4.2 5.8 11.8 20.1 21.3 5.5 22.2 19.3 26.2 21.3 26.9 5.1 23.5 27.4 28.5 6.3 12.5 14.6 11.6 9.5 15.9 8.3 15.3 27.0 8.4 1.8 8.5 8.0 16.3 1.6 5.8 9.6 31.7 7.9 18.5 15.7 0.0 0.0 0.9 0.6 0.0 0.0 6.5 0.2 0.0 0.4 2.5 1.8 0.7 0.2 0.3 0.0 0.6 3.0 0.3 4.2 5.1 0.7 4.1 2.5 1.5 1.6 5.6 1.2 1.2 0.0 0.3 4.9 6.4 6.1 0.1 0.8 5.1 0.0 2.3 7.0 0.0 100.7 5.0 2.3 2.2 0.7 1.1 23.3 0.4 27.0 2.6 1.6 0.0 0.8 15.8 0.0 2.4 1.3 1.0 4.3 14.7 3.4 3.3 1.8 5.9 0.0 1.1 3.5 40.0 0.0 0.5 32.3 0.9 31.4 42.9 4.6 39.9 0.0 7.0 2.8 RNASE1 "RAC1, RNS1" ENSG00000129538 "Ribonuclease A family member 1, pancreatic" P07998 14 20801228-20803278 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "pancreas: 809.6" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 863.6;Alveolar cells type 2: 748.9;Hofbauer cells: 1257.5;Ito cells: 532.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.0;myeloid DC: 16.1" "Group enriched" "Detected in many" 9 "dendritic cells: 16.1;monocytes: 8.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 74.4;OE19: 16.9;RT4: 29.1;TIME: 38.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001140 Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1500000000 Vesicles Nucleoplasm "HPA001140: AB_1079816" "unprognostic (2.32e-2)" "unprognostic (3.16e-2)" "unprognostic (9.51e-3)" "unprognostic (7.77e-2)" "unprognostic (6.93e-2)" "unprognostic (1.28e-1)" "unprognostic (3.42e-3)" "unprognostic (6.59e-3)" "unprognostic (4.69e-2)" "unprognostic (7.92e-2)" "unprognostic (6.32e-2)" "unprognostic (3.56e-2)" "unprognostic (5.14e-3)" "unprognostic (1.11e-2)" "unprognostic (1.47e-1)" "unprognostic (2.43e-2)" "unprognostic (1.67e-1)" 79.2 48.4 28.7 12.0 38.5 1.6 59.7 4.0 32.2 21.3 33.7 57.8 63.6 16.8 13.6 49.1 19.3 24.3 37.5 70.3 41.2 21.6 33.8 8.6 94.3 23.5 39.0 16.0 19.2 809.6 6.7 4.1 79.0 25.1 23.0 39.8 106.4 15.9 35.6 31.7 10.8 20.6 26.6 52.3 34.5 87.9 86.5 27.1 7.8 11.2 14.3 7.2 29.0 10.9 0.0 16.1 1.3 8.0 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 74.4 0.0 7.2 0.1 0.0 0.0 0.0 0.5 0.3 16.9 0.0 0.0 0.0 0.3 0.0 29.1 0.3 0.3 0.0 0.2 0.0 0.5 0.0 0.0 38.7 0.0 0.7 0.5 0.0 0.1 0.0 0.0 1.0 0.0 1.0 1.3 8.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 2.0 28.7 38.5 4.0 32.2 41.2 21.6 39.0 16.0 25.1 27.1 863.6 748.9 16.1 0.9 31.6 0.0 58.9 40.8 58.9 295.7 15.7 0.0 12.0 0.0 8.2 17.6 308.3 107.7 0.0 270.1 10.2 30.9 1.4 23.3 4.9 1257.5 1.6 46.9 532.2 311.7 43.1 29.7 100.6 38.8 4.6 398.3 0.8 308.4 78.7 10.3 0.3 1.8 97.0 15.6 7.0 5.3 24.6 21.6 7.5 165.1 1.7 RNASE11 "C14orf6, RAJ1" ENSG00000173464 "Ribonuclease A family member 11 (inactive)" Q8TAA1 14 20583559-20609884 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 18 "epididymis: 106.3;testis: 33.6" "Group enriched" "Detected in some" 53 "Early spermatids: 32.3;Late spermatids: 41.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;NB-4: 2.8;RPMI-8226: 1.5;SH-SY5Y: 1.4;U-937: 1.2" HPA003724 Uncertain "Secreted in male reproductive system" NA NA "HPA003724: AB_1079817" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 106.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RNASE12 RAI1 ENSG00000258436 "Ribonuclease A family member 12 (inactive)" Q5GAN4 14 20590193-20590823 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 43 "epididymis: 143.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NB-4: 3.7;SH-SY5Y: 1.2" "HPA044175, HPA059465" Enhanced "Secreted in male reproductive system" NA NA "HPA044175: AB_10960390, HPA059465: AB_2732638" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 143.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE13 RAL1 ENSG00000206150 "Ribonuclease A family member 13 (inactive)" Q5GAN3 14 21032820-21034785 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "epididymis: 95.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NB-4: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted in male reproductive system" NA NA "unprognostic (2.54e-1)" "unprognostic (2.52e-1)" "unprognostic (2.86e-1)" "unprognostic (8.40e-2)" "unprognostic (1.93e-1)" "unprognostic (7.15e-2)" "unprognostic (1.63e-3)" "unprognostic (5.20e-4)" "unprognostic (1.47e-2)" 0.5 0.2 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 95.8 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.8 0.5 0.2 0.2 0.2 0.2 0.9 0.0 0.2 0.2 0.2 0.2 0.0 0.2 1.3 0.2 0.5 0.5 0.2 0.2 0.2 1.9 0.0 1.8 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE2 "EDN, RAF3, RNS2" ENSG00000169385 "Ribonuclease A family member 2" P10153 14 20955452-20956436 "Enzymes, Plasma proteins, Predicted secreted proteins" Chemotaxis "Endonuclease, Hydrolase, Lyase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "blood: 137.2;bone marrow: 236.7" "Cell type enriched" "Detected in some" 11 "Kupffer cells: 219.4" "Cancer enriched" "Detected in many" 7 "glioma: 14.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basophil: 37.8;eosinophil: 137.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 137.2" "Group enriched" "Detected in some" 318 "HL-60: 54.9;NB-4: 54.8;THP-1: 147.0;U-937: 133.3" HPA044983 Enhanced "Secreted to blood" NA NA 300000000 "HPA044983: AB_10963689" "unprognostic (6.66e-2)" "unprognostic (3.00e-1)" "unprognostic (6.85e-2)" "unprognostic (7.68e-2)" "unprognostic (2.73e-2)" "unprognostic (9.26e-2)" "unprognostic (4.94e-3)" "unprognostic (6.77e-2)" "unprognostic (9.54e-2)" "unprognostic (3.24e-2)" "unprognostic (3.25e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.28e-13)" "unprognostic (2.27e-2)" "unprognostic (7.14e-3)" "unprognostic (5.33e-2)" "unprognostic (1.50e-1)" 2.7 3.2 4.8 2.0 9.3 236.7 0.5 0.9 3.7 0.9 0.6 1.4 0.1 0.5 0.7 0.5 0.5 3.2 0.9 3.7 3.9 1.8 1.2 1.3 6.6 7.2 4.7 0.1 0.5 2.5 0.5 0.6 0.8 4.9 0.5 0.6 0.1 0.7 0.5 0.9 0.9 0.6 2.1 10.5 19.4 0.9 0.6 3.7 0.1 0.5 0.1 0.6 1.4 0.3 0.0 20.0 137.2 11.5 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 54.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 147.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 133.3 0.0 37.8 11.5 137.2 0.0 2.0 0.0 0.0 0.0 0.0 20.0 0.0 0.0 0.0 1.0 0.0 0.2 0.2 0.0 3.3 4.8 9.3 0.9 3.7 3.9 1.8 4.7 0.1 4.9 3.7 3.0 0.3 0.8 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.9 13.1 0.0 0.0 1.8 219.4 1.1 0.3 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 19.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RNASE3 "ECP, RAF1, RNS3" ENSG00000169397 "Ribonuclease A family member 3" P12724 14 20891399-20892348 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "blood: 60.9;bone marrow: 154.1" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 18.6;Kupffer cells: 6.6;Late spermatids: 7.4;Rod photoreceptor cells: 3.3" "Cancer enriched" "Detected in single" 8 "glioma: 2.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 21 "eosinophil: 60.9" "Lineage enriched" "Detected in many" 21 "granulocytes: 60.9" "Cell line enhanced" "Detected in some" "HL-60: 37.1;NB-4: 12.6;THP-1: 16.0;U-937: 75.8" HPA056183 Enhanced "Secreted to blood" NA NA 4200000 "HPA056183: AB_2683059" "unprognostic (2.54e-2)" "unprognostic (6.61e-2)" "unprognostic (1.84e-1)" "unprognostic (2.50e-1)" "unprognostic (1.37e-2)" "unprognostic (8.21e-2)" "unprognostic (6.45e-2)" "unprognostic (9.20e-3)" "unprognostic (1.20e-1)" "unprognostic (9.21e-2)" "unprognostic (8.62e-7)" "unprognostic (6.29e-2)" "unprognostic (1.03e-1)" "unprognostic (1.70e-1)" "unprognostic (2.37e-1)" 0.2 0.4 1.0 0.2 3.6 154.1 0.1 1.0 3.1 0.1 0.1 0.8 0.0 0.1 0.1 0.2 0.1 0.3 0.2 0.2 0.8 0.9 0.1 0.5 3.2 0.2 4.4 0.0 0.2 0.1 0.1 0.3 0.6 1.5 0.1 0.1 0.0 0.3 0.1 0.1 0.4 0.1 0.3 2.9 11.8 0.1 1.7 1.9 1.0 0.1 0.0 0.1 0.2 0.0 0.0 2.8 60.9 1.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.8 0.0 1.8 1.8 60.9 0.0 0.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.7 1.0 3.6 1.0 3.1 0.8 0.9 4.4 0.0 1.5 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.6 7.4 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 RNASE4 RAB1 ENSG00000258818 "Ribonuclease A family member 4" P34096 14 20684100-20701215 "Plasma proteins, Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 366.2" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 43.7;Intestinal endocrine cells: 64.6;Mucus-secreting cells: 108.1" "Cancer enhanced" "Detected in many" "liver cancer: 6.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 17.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 30.3;ASC TERT1: 34.3;Hep G2: 42.7;HSkMC: 20.4;OE19: 28.5" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 27000000 "unprognostic (1.07e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-2)" "unprognostic (3.18e-4)" "unprognostic (1.20e-1)" "unprognostic (7.05e-2)" "prognostic favorable (9.62e-5)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (6.88e-2)" "unprognostic (3.71e-2)" "unprognostic (1.29e-1)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (1.57e-1)" "unprognostic (9.16e-2)" "unprognostic (4.27e-2)" 29.6 1.7 1.5 5.7 1.8 0.2 28.7 1.0 1.2 25.2 16.3 2.5 12.3 4.9 19.2 18.4 14.7 15.7 23.4 10.3 2.3 1.0 18.9 366.2 12.8 5.2 3.0 1.4 30.8 16.3 3.8 3.0 4.4 2.7 30.4 15.0 10.5 35.0 14.2 7.1 10.6 13.6 17.4 3.8 3.2 19.2 13.2 1.9 0.3 8.4 10.5 7.3 25.1 26.3 4.0 9.7 0.5 17.0 0.4 2.5 5.0 0.8 4.0 0.8 0.0 30.3 34.3 0.1 3.3 7.5 0.5 1.4 1.0 1.1 0.0 0.8 7.5 1.9 0.7 0.4 0.8 0.6 5.3 0.4 0.0 0.9 42.7 3.4 0.4 0.1 20.4 1.9 0.5 3.4 10.9 3.9 1.2 0.0 3.7 2.2 0.5 0.2 0.0 0.1 28.5 3.3 0.1 0.6 1.1 0.7 0.7 0.0 0.1 1.2 0.6 0.8 1.4 0.9 0.1 4.0 0.9 0.5 1.2 0.1 0.7 0.9 0.1 1.4 0.3 0.8 0.1 17.0 0.0 0.6 0.9 0.8 4.0 1.1 0.4 9.7 2.2 0.2 0.4 0.5 0.4 0.1 2.3 2.5 5.0 1.5 1.8 1.0 1.2 2.3 1.0 3.0 1.4 2.7 1.9 35.7 15.5 4.2 1.3 2.5 0.0 0.3 22.9 16.0 6.8 3.5 0.0 0.2 0.0 22.2 0.1 1.3 33.7 0.0 19.7 0.3 4.8 1.8 1.1 43.7 1.7 0.0 64.6 5.5 10.3 0.0 11.5 1.9 3.3 1.0 108.1 0.8 15.7 14.0 3.9 8.4 0.2 0.0 7.2 0.2 0.0 3.6 0.3 1.0 34.8 1.0 RNASE6 "RAD1, RNaseK6, RNS6" ENSG00000169413 "Ribonuclease A family member k6" Q93091 14 20781051-20782467 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 117.6" "Cell type enhanced" "Detected in many" 23 "B-cells: 117.8;Hofbauer cells: 181.1;Kupffer cells: 514.5;Macrophages: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 117.6" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 33.8" "Low region specificity" "Detected in many" HPA000698 Approved "Secreted to blood" NA NA 2300000 "HPA000698: AB_2181340" "unprognostic (5.04e-2)" "unprognostic (5.21e-3)" "unprognostic (3.59e-2)" "unprognostic (4.05e-2)" "unprognostic (1.74e-1)" "unprognostic (7.31e-2)" "unprognostic (7.91e-2)" "unprognostic (2.29e-1)" "unprognostic (4.45e-1)" "unprognostic (1.65e-1)" "unprognostic (2.04e-1)" "unprognostic (2.73e-1)" "unprognostic (2.85e-3)" "unprognostic (9.62e-2)" "unprognostic (5.60e-3)" "unprognostic (3.46e-2)" "unprognostic (5.54e-2)" 25.0 10.8 7.8 19.3 10.3 7.3 11.9 1.8 7.7 10.7 9.1 7.9 4.6 5.7 5.5 25.9 4.7 7.2 14.6 11.2 7.0 6.5 10.6 8.2 16.4 51.0 10.9 3.3 4.3 4.9 1.3 4.1 13.9 9.8 6.0 10.8 6.9 9.5 5.6 2.7 4.9 23.4 7.2 24.0 49.3 5.8 5.7 10.3 12.8 4.2 3.3 25.5 14.7 4.5 42.2 117.6 33.8 52.0 3.6 1.4 26.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.8 2.5 0.3 0.1 0.0 0.0 1.0 2.2 0.0 0.0 0.0 0.1 0.0 33.8 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 33.8 52.0 1.1 0.5 12.2 1.2 28.9 1.4 0.6 49.4 42.2 0.6 0.1 19.0 3.6 0.1 117.6 0.1 26.8 7.8 10.3 1.8 7.7 7.0 6.5 10.9 3.3 9.8 10.3 6.0 12.7 117.8 0.1 3.9 0.0 0.4 22.9 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.6 2.2 0.8 23.3 0.0 1.5 2.7 0.3 0.0 2.1 181.1 0.0 0.0 11.1 514.5 0.7 2.6 188.7 20.3 1.8 0.3 0.0 0.0 10.5 0.7 0.4 0.4 12.9 0.7 0.0 0.8 3.3 1.8 8.9 2.8 0.8 RNASE7 RAE1 ENSG00000165799 "Ribonuclease A family member 7" Q9H1E1 14 21042226-21044234 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 38.3;lymphoid tissue: 41.0;tongue: 21.4" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 23.3;Cholangiocytes: 12.7;Urothelial cells: 17.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.4;hTCEpi: 6.7;hTERT-HME1: 33.4" "HPA005690, CAB062560, CAB068225" Enhanced "Secreted in other tissues" NA NA "CAB062560: AB_2665595, CAB068225: AB_2665594, HPA005690: AB_1079819" "unprognostic (1.13e-2)" "unprognostic (3.21e-1)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.71e-1)" "unprognostic (8.27e-2)" "unprognostic (7.80e-2)" "unprognostic (8.73e-2)" "unprognostic (3.28e-1)" "unprognostic (1.15e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.17e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "unprognostic (3.24e-1)" "unprognostic (3.42e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.3 38.3 0.0 4.0 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.5 0.2 0.0 3.5 0.2 0.2 14.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.3 0.1 21.4 41.0 0.6 7.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 15.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.8 0.0 0.4 12.7 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 4.5 0.0 0.0 17.0 RNASE8 RAE2 ENSG00000173431 "Ribonuclease A family member 8" Q8TDE3 14 21057822-21058455 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "salivary gland: 38.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SuSa: 1.0" "Secreted to digestive system" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASE9 "h461, RAK1" ENSG00000188655 "Ribonuclease A family member 9 (inactive)" P60153 14 20556093-20560931 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "epididymis: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.6;NB-4: 1.8" "Secreted in male reproductive system" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 56.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806556-12815201 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 44.8" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 97.8;Spermatocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favorable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavorable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 6.5 5.5 6.4 11.4 10.6 21.9 6.6 11.0 7.5 6.8 6.6 9.2 1.6 8.6 6.8 4.4 14.1 6.0 5.7 5.1 6.7 4.8 8.7 5.9 5.5 9.2 10.6 5.8 7.3 7.0 6.2 4.1 11.8 6.1 5.3 5.7 5.5 8.8 4.3 7.1 13.4 7.1 4.4 7.8 12.0 7.4 14.1 8.4 44.8 8.6 13.4 17.4 6.0 8.0 11.3 7.8 7.1 6.8 12.9 8.6 5.0 14.9 11.3 6.8 6.8 1.0 1.9 8.4 7.0 2.9 10.5 12.1 8.9 5.7 16.0 10.5 1.6 5.9 8.9 5.6 6.9 5.8 8.7 15.1 7.7 12.0 6.8 0.8 7.0 7.1 1.0 1.7 8.8 3.2 2.0 4.0 13.1 10.6 4.8 5.0 25.7 12.9 7.0 6.8 5.6 19.7 13.9 9.9 11.5 2.6 5.9 14.2 8.3 7.5 2.8 3.2 3.1 7.4 4.4 3.8 12.5 6.3 17.7 11.5 11.6 12.8 12.7 7.4 11.3 10.0 7.1 6.8 6.4 8.6 6.6 7.0 9.8 7.0 6.1 4.2 11.3 6.6 6.5 6.8 12.9 5.9 7.8 5.5 5.0 6.4 10.6 11.0 7.5 6.7 4.8 10.6 5.8 6.1 8.4 0.0 1.6 10.4 15.3 12.5 15.9 2.4 10.2 4.0 1.2 0.0 3.9 40.3 0.0 3.9 12.7 4.9 4.6 0.0 5.4 97.8 9.3 6.6 3.5 3.4 41.5 7.9 8.1 10.4 10.3 15.1 7.8 11.9 11.8 6.4 7.7 10.1 1.9 7.0 4.6 0.8 11.2 6.5 11.3 51.9 45.0 11.5 19.0 12.5 19.0 7.3 RNASEH2B "AGS2, DLEU8, FLJ11712" ENSG00000136104 "Ribonuclease H2 subunit B" Q5TBB1 13 50909678-51024120 "Disease related genes, Predicted intracellular proteins" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 120.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 68.3;REH: 57.1;THP-1: 51.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040084, HPA041469" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040084: AB_10697714, HPA041469: AB_2677496" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (2.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.59e-1)" "unprognostic (1.16e-1)" "unprognostic (8.33e-2)" "unprognostic (2.79e-2)" "unprognostic (2.50e-2)" "unprognostic (9.63e-3)" "unprognostic (1.13e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (2.54e-8)" "unprognostic (1.05e-1)" "unprognostic (3.13e-1)" "unprognostic (1.39e-2)" "unprognostic (3.34e-1)" 11.9 10.5 11.3 20.2 14.1 28.3 10.9 11.3 10.9 14.0 15.2 9.4 12.9 8.9 20.0 12.6 11.6 15.8 11.6 14.7 10.0 8.8 9.1 7.9 14.3 25.7 11.8 9.9 14.0 18.0 6.3 12.0 10.6 8.5 15.4 12.4 9.6 12.7 12.9 15.8 8.5 13.9 15.5 10.0 18.5 11.5 16.4 11.3 120.1 15.8 11.0 20.4 15.1 12.2 34.2 31.3 5.5 13.9 12.0 34.5 16.9 7.9 6.6 3.6 7.2 4.8 9.5 8.6 5.7 6.6 8.3 7.0 8.6 12.4 22.8 3.7 5.9 8.0 7.7 11.3 5.3 10.0 8.3 9.2 20.4 4.6 5.0 6.5 37.3 13.5 3.8 6.7 7.3 6.5 7.6 7.3 48.0 11.3 10.9 11.3 3.8 68.3 50.7 11.6 17.3 5.2 57.1 10.6 15.3 6.3 4.7 8.0 11.7 6.9 2.5 7.3 4.8 3.9 51.0 5.2 7.5 6.2 8.8 12.7 14.6 9.6 27.0 1.9 27.9 8.7 0.9 12.6 5.5 11.1 13.9 12.7 34.2 22.1 18.2 18.2 29.0 19.9 18.5 2.1 12.0 11.9 31.3 34.5 16.9 11.3 14.1 11.3 10.9 10.0 8.8 11.8 9.9 8.5 11.3 35.7 22.1 62.1 24.8 16.7 12.9 43.5 20.4 53.5 28.4 15.7 5.9 29.9 24.9 37.0 45.2 13.9 8.1 23.3 44.0 45.2 22.6 20.1 50.8 13.1 86.8 1.6 11.6 16.5 44.7 31.5 25.6 35.6 15.1 89.2 18.7 8.1 26.5 3.5 28.0 22.5 4.7 12.9 24.2 70.7 39.5 18.3 15.0 48.4 36.3 22.0 RNASEK-C17orf49 ENSG00000161939 "RNASEK-C17orf49 readthrough" 17 7012635-7017520 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.3" "Group enriched" "Detected in many" 8 "Alveolar cells type 1: 59.6;Alveolar cells type 2: 63.9;Ciliated cells: 103.1;Club cells: 56.9;granulocytes: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 5.3;THP-1: 6.3;U-87 MG: 6.9" "HPA022961, HPA024457" Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA022961: AB_1845592, HPA024457: AB_1845593" "unprognostic (4.08e-2)" "unprognostic (3.30e-1)" "unprognostic (1.58e-1)" "unprognostic (9.37e-5)" "unprognostic (4.19e-1)" "unprognostic (1.71e-1)" "unprognostic (7.91e-2)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.77e-3)" "unprognostic (8.26e-3)" "unprognostic (8.58e-3)" "unprognostic (3.00e-1)" "unprognostic (2.30e-1)" "unprognostic (1.19e-1)" "unprognostic (1.78e-1)" 4.8 4.8 2.8 3.5 3.5 5.3 2.9 3.6 4.0 2.0 2.8 0.4 1.5 1.4 4.9 3.3 2.3 2.7 3.2 6.3 2.5 3.3 6.6 14.5 16.7 20.3 2.9 2.4 2.4 7.9 1.4 4.7 2.5 1.8 1.8 1.4 0.4 1.6 5.0 4.2 1.9 6.3 2.3 1.7 9.1 1.6 6.4 0.7 4.1 2.0 4.6 3.4 2.3 1.6 1.9 4.0 7.5 4.3 0.9 1.7 2.8 1.2 3.6 0.5 0.5 0.0 0.0 1.1 2.3 1.9 2.8 2.2 2.3 1.1 1.9 0.2 0.0 0.3 0.6 0.7 5.3 0.8 0.0 4.4 0.0 2.9 1.0 2.8 0.0 0.6 0.0 0.0 1.6 0.0 0.4 0.7 0.2 0.6 0.0 0.0 1.2 1.9 2.3 2.3 0.5 1.2 1.4 0.0 0.0 0.8 0.7 0.5 1.8 0.0 0.0 0.2 0.3 0.6 6.3 0.0 0.0 0.2 3.5 1.0 0.0 0.8 0.2 6.9 0.5 0.0 3.6 4.3 3.4 1.2 3.0 1.7 1.9 1.5 0.8 3.8 1.8 1.4 1.2 7.5 0.9 3.1 4.0 0.9 2.8 2.8 3.5 3.6 4.0 2.5 3.3 2.9 2.4 1.8 0.7 59.6 63.9 0.0 0.0 0.3 0.0 0.0 0.0 103.1 56.9 0.0 0.0 0.2 3.3 6.7 0.0 0.1 2.9 0.0 7.0 0.1 0.2 0.1 55.8 0.0 0.6 0.0 5.2 0.6 1.2 0.0 0.3 1.0 0.0 8.2 4.7 0.0 6.7 6.8 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.7 0.0 2.7 0.1 RNASET2 "bA514O12.3, FLJ10907, RNASE6PL" ENSG00000026297 "Ribonuclease T2" O00584 6 166929504-166957191 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Endonuclease, Hydrolase, Lyase, Nuclease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 105.7" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 343.2;Kupffer cells: 367.0;Macrophages: 275.2;Paneth cells: 280.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 40.0;THP-1: 99.3" "HPA029013, HPA066509" Approved "Secreted to blood" NA NA 16000000 "HPA029013: AB_10602922, HPA066509: AB_2685682" "unprognostic (4.18e-2)" "unprognostic (2.57e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.13e-2)" "unprognostic (9.33e-2)" "unprognostic (1.76e-2)" "unprognostic (1.30e-1)" "unprognostic (1.15e-2)" "unprognostic (8.11e-2)" "unprognostic (1.79e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.70e-14)" "unprognostic (5.03e-2)" "unprognostic (7.34e-2)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" 13.0 9.9 27.8 21.9 23.7 29.4 13.9 3.7 18.6 46.0 21.0 26.3 35.5 15.4 13.8 40.5 10.6 37.6 22.9 8.8 24.9 18.7 12.3 14.3 15.1 45.7 36.0 9.2 13.4 39.5 11.6 12.1 12.9 24.9 18.0 25.0 9.1 30.7 53.1 2.9 10.1 24.6 7.5 43.2 84.7 25.7 5.7 34.5 16.7 22.2 6.3 25.0 13.2 13.9 20.9 56.6 105.7 57.0 4.5 28.0 22.3 3.2 2.7 2.5 7.5 11.7 8.3 2.3 3.3 4.1 1.4 1.4 6.5 4.0 2.4 40.0 8.0 3.3 8.9 4.1 3.6 0.8 4.1 8.0 1.9 4.1 15.9 3.9 31.8 8.9 4.8 6.7 0.8 0.5 6.1 1.9 4.3 5.0 18.6 2.1 8.4 2.7 24.7 1.4 26.9 2.9 6.0 3.4 29.8 26.9 1.9 1.0 7.0 6.9 20.1 1.6 4.7 2.5 99.3 3.9 3.0 2.2 9.6 3.2 4.0 4.5 0.2 6.6 30.6 2.0 16.6 28.7 105.7 5.0 44.5 9.2 20.9 28.0 12.5 36.7 17.6 21.5 6.8 78.7 4.5 57.0 56.6 13.9 22.3 27.8 23.7 3.7 18.6 24.9 18.7 36.0 9.2 24.9 34.5 17.9 34.3 199.1 101.2 38.5 10.0 8.7 48.4 20.1 19.4 36.6 0.0 45.4 19.9 56.6 8.7 19.9 139.7 0.0 24.1 40.5 36.8 50.6 70.4 20.7 343.2 12.7 72.4 20.9 367.0 8.0 32.8 275.2 55.6 38.7 135.0 25.1 53.1 280.5 27.6 13.9 6.8 25.8 14.1 7.1 12.2 30.2 23.2 107.8 184.1 89.4 RND1 "ARHS, Rho6, RHOS" ENSG00000172602 "Rho family GTPase 1" Q92730 12 48857145-48865898 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;liver: 50.6" "Group enriched" "Detected in many" 6 "Alveolar cells type 2: 240.1;Ductal cells: 153.1;Exocrine glandular cells: 130.1;Pancreatic endocrine cells: 223.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "SK-BR-3: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077800 Supported "Vesicles,Plasma membrane,Actin filaments" NA NA "Vesicles, Plasma membrane, Actin filaments" "HPA077800: AB_2686854" "unprognostic (5.60e-2)" "unprognostic (3.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.16e-1)" "unprognostic (6.90e-2)" "unprognostic (1.32e-3)" "unprognostic (3.59e-2)" "unprognostic (7.43e-2)" "unprognostic (2.21e-3)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (8.38e-3)" "unprognostic (6.18e-2)" "unprognostic (6.60e-2)" "unprognostic (3.35e-3)" 2.9 1.3 9.9 2.6 15.0 2.0 2.8 2.6 21.8 1.4 2.8 1.4 0.2 2.6 4.4 1.5 1.8 1.1 13.3 2.5 7.4 7.6 1.8 50.6 12.3 1.4 7.1 8.6 0.9 2.0 3.2 3.2 1.6 8.6 3.7 2.3 1.0 4.0 1.5 0.6 0.6 2.3 2.6 5.6 0.9 6.1 0.8 2.3 0.0 5.5 2.1 2.4 6.9 2.0 1.7 1.7 0.0 0.0 0.5 1.6 0.2 0.6 4.3 2.1 1.2 0.4 0.0 0.3 0.0 0.2 0.6 0.7 2.7 0.9 3.3 0.8 0.0 0.2 0.0 1.7 0.1 0.4 1.0 1.0 0.4 0.0 1.6 0.2 1.0 0.6 0.0 0.1 0.3 0.4 0.0 1.1 2.2 0.1 3.3 0.0 5.5 0.4 0.2 5.1 7.4 0.2 1.0 0.2 1.5 0.6 0.8 0.0 0.6 0.1 39.2 0.1 5.4 3.8 0.1 0.2 0.0 0.4 0.0 0.5 1.7 2.8 5.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.6 1.7 0.2 0.1 1.7 1.1 0.7 0.1 0.0 0.5 0.0 0.0 0.4 0.2 9.9 15.0 2.6 20.4 7.4 7.6 7.1 8.6 8.6 2.3 26.8 240.1 2.4 4.0 10.2 2.7 3.6 12.7 9.4 33.0 1.8 7.9 0.9 0.0 153.1 0.4 18.8 10.5 0.0 130.1 0.6 5.6 18.5 14.0 9.6 1.0 0.0 30.2 1.8 0.3 0.0 0.0 10.2 13.5 10.8 4.1 3.2 223.3 14.0 0.4 1.3 3.3 0.0 18.6 0.7 1.7 9.3 1.3 5.0 3.1 7.3 RND2 "ARHN, Rho7, RhoN" ENSG00000108830 "Rho family GTPase 2" P52198 17 43025241-43032036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;testis: 22.9" "Group enriched" "Detected in many" 17 "Early spermatids: 108.5;Late spermatids: 343.8" "Group enriched" "Detected in many" 5 "glioma: 44.4;testis cancer: 11.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.6;AN3-CA: 13.5;HAP1: 10.5;NTERA-2: 15.1;SH-SY5Y: 9.2;SuSa: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077757 Approved NA NA "HPA077757: AB_2732361" "unprognostic (2.19e-2)" "unprognostic (5.70e-2)" "unprognostic (1.65e-2)" "unprognostic (1.53e-1)" "unprognostic (2.02e-1)" "unprognostic (6.52e-2)" "unprognostic (2.44e-3)" "unprognostic (4.55e-2)" "unprognostic (7.44e-2)" "unprognostic (3.79e-1)" "unprognostic (1.22e-4)" "unprognostic (7.85e-2)" "unprognostic (8.17e-2)" "unprognostic (6.13e-3)" "unprognostic (9.92e-2)" "unprognostic (7.52e-2)" "unprognostic (5.57e-2)" 1.5 5.3 13.1 1.2 25.2 1.1 2.3 7.1 33.6 1.9 1.5 8.5 1.0 1.3 4.2 4.6 2.4 3.3 2.0 2.1 11.1 33.9 1.9 5.7 1.5 1.1 40.6 5.8 6.5 1.6 8.2 3.9 1.1 30.9 3.5 1.4 3.3 1.8 6.4 1.5 2.9 1.3 4.3 28.7 1.1 1.3 22.9 10.1 0.0 10.1 0.8 1.3 1.6 2.2 1.5 0.5 2.3 0.4 1.0 0.8 0.2 0.0 0.3 10.6 13.5 0.8 0.6 0.2 0.4 0.6 1.9 1.5 1.6 0.1 0.1 2.5 1.4 0.6 0.1 10.5 0.2 1.6 0.0 5.4 0.0 0.1 0.2 0.8 0.1 0.1 0.7 0.1 2.1 0.1 0.3 0.1 1.1 2.6 0.1 0.0 0.4 4.0 0.1 15.1 0.0 0.1 0.7 0.0 0.1 0.2 0.0 2.9 9.2 0.0 0.2 0.1 7.3 2.0 0.0 0.1 0.3 0.4 0.1 0.0 0.9 2.7 0.2 1.7 0.0 0.1 2.3 0.4 0.5 0.8 0.3 0.4 1.5 0.7 0.4 0.1 0.8 0.7 0.5 1.3 1.0 0.2 0.5 0.2 0.2 13.1 25.2 7.1 9.0 11.1 33.9 40.6 5.8 30.9 10.1 0.0 1.0 0.0 3.7 1.1 2.3 1.4 2.5 9.4 3.4 3.5 0.0 1.5 5.0 0.8 108.5 0.7 0.0 0.0 0.7 1.4 1.3 1.6 1.1 2.9 0.5 4.8 0.0 1.3 1.2 343.8 4.6 0.6 1.7 0.0 0.0 13.5 0.4 0.0 4.2 1.6 3.5 0.0 0.9 13.6 4.9 1.6 1.4 0.5 0.0 1.7 RNF112 "BFP, ZNF179" ENSG00000128482 "Ring finger protein 112" Q9ULX5 17 19411125-19417276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 3.2;Fibroblasts: 3.0;Muller glia cells: 7.7;Peritubular cells: 3.5;Sertoli cells: 6.5" "Cancer enriched" "Detected in some" 8 "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;fHDF/TERT166: 4.8;SCLC-21H: 4.8;SH-SY5Y: 8.4;U-87 MG: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015970 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA015970: AB_1859103" "unprognostic (1.16e-1)" "unprognostic (3.74e-1)" "unprognostic (8.43e-5)" "unprognostic (3.65e-2)" "unprognostic (2.96e-2)" "unprognostic (6.02e-2)" "unprognostic (1.27e-1)" "unprognostic (2.88e-1)" "unprognostic (4.26e-1)" "unprognostic (5.02e-2)" "unprognostic (3.17e-1)" "unprognostic (2.96e-1)" "unprognostic (1.31e-9)" "unprognostic (1.32e-1)" "unprognostic (1.07e-1)" "unprognostic (1.59e-1)" "unprognostic (4.24e-1)" 2.5 8.1 11.3 2.3 15.9 0.6 1.8 47.5 29.1 1.2 3.6 1.4 0.0 2.9 2.0 6.9 1.1 1.5 4.4 2.3 12.4 8.2 1.2 0.7 1.7 1.4 3.9 14.1 1.3 0.8 0.5 1.9 1.1 3.1 10.2 4.4 1.6 1.3 3.5 2.1 1.9 3.6 3.5 2.9 1.7 2.1 2.0 3.7 0.0 0.9 0.0 0.8 2.8 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.2 4.2 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 0.0 4.8 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 3.4 0.0 0.0 1.7 0.2 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.0 4.8 8.4 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 27.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 15.9 47.5 15.9 12.4 8.2 3.9 14.1 3.1 3.7 0.0 0.0 0.0 0.0 0.9 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.3 3.5 0.0 0.4 6.5 1.5 1.1 0.7 0.9 0.2 0.0 0.1 0.1 RNF113B "RNF161, ZNF183L1" ENSG00000139797 "Ring finger protein 113B" Q8IZP6 13 98175785-98177265 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 54.3" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 24.1;Late spermatids: 10.0;Spermatocytes: 42.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.5" "Cell line enriched" "Detected in single" 8 "U-266/84: 4.2" NA NA "unprognostic (3.69e-1)" "unprognostic (2.22e-1)" "unprognostic (1.78e-1)" "unprognostic (4.10e-2)" "unprognostic (1.38e-3)" "unprognostic (1.75e-1)" "unprognostic (7.48e-2)" "unprognostic (1.92e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.2 0.1 0.0 0.0 0.1 1.3 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.2 2.5 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 42.1 2.6 0.0 0.0 0.0 0.0 0.0 RNF122 FLJ12526 ENSG00000133874 "Ring finger protein 122" Q9H9V4 8 33547755-33567125 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 66.3" "Cell type enhanced" "Detected in many" 5 "Ito cells: 5.5;Kupffer cells: 6.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 39.7;Karpas-707: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003888 Uncertain NA NA "HPA003888: AB_1079822" "unprognostic (2.36e-2)" "unprognostic (3.13e-1)" "unprognostic (2.09e-2)" "unprognostic (9.19e-3)" "unprognostic (2.46e-1)" "unprognostic (8.78e-3)" "unprognostic (1.71e-2)" "unprognostic (5.46e-1)" "unprognostic (3.33e-1)" "unprognostic (1.82e-1)" "unprognostic (6.95e-2)" "prognostic favorable (5.37e-4)" "prognostic unfavorable (4.50e-7)" "unprognostic (4.45e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (7.15e-2)" 23.6 14.6 2.3 15.9 5.9 6.5 13.4 16.7 4.4 8.3 8.2 3.2 3.1 2.5 8.8 10.3 9.3 20.0 13.3 28.5 6.7 2.1 4.4 7.1 25.0 10.1 4.3 0.7 66.3 5.6 3.4 3.2 2.8 12.3 12.8 5.1 5.5 5.1 5.8 31.9 6.4 8.3 14.4 14.4 13.3 7.9 9.6 2.5 8.1 4.3 17.3 11.4 20.6 11.8 5.0 14.2 7.4 9.9 1.8 1.6 0.3 0.3 2.1 10.6 4.4 0.9 0.3 1.4 0.6 1.0 1.3 2.2 0.3 0.4 4.9 3.2 1.6 1.8 0.4 2.3 0.9 0.7 0.3 39.7 1.0 0.5 2.8 0.6 0.3 8.1 1.0 0.8 0.7 0.5 2.2 4.2 4.3 1.0 25.7 1.1 0.9 4.3 3.3 5.8 1.5 1.2 4.7 2.0 3.8 1.5 0.6 2.1 11.9 0.7 0.3 1.6 3.9 0.4 1.3 2.4 1.8 1.7 3.3 0.7 10.3 5.8 9.0 1.1 1.3 0.2 4.6 0.9 7.4 1.5 4.5 1.3 2.9 0.9 1.1 0.8 5.0 1.5 1.6 6.7 1.8 9.9 14.2 0.6 0.3 2.3 5.9 16.7 4.4 6.7 2.1 4.3 0.7 12.3 2.5 0.0 1.1 1.5 0.5 3.8 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.0 3.5 0.3 0.0 0.6 0.4 4.1 0.3 0.0 0.0 1.4 0.0 0.0 5.5 6.0 0.8 1.4 2.2 0.0 0.0 0.4 0.8 0.9 0.8 1.1 0.6 1.4 0.0 4.1 0.0 0.9 1.8 0.0 0.7 0.6 1.0 RNF123 "FLJ12565, KPC1" ENSG00000164068 "Ring finger protein 123" Q5XPI4 3 49689499-49721529 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065983, HPA071879" Supported Approved Cytosol NA NA Cytosol "HPA065983: AB_2685592, HPA071879: AB_2686468" "unprognostic (2.68e-1)" "unprognostic (3.34e-1)" "unprognostic (2.67e-1)" "unprognostic (1.04e-1)" "unprognostic (2.21e-1)" "unprognostic (9.51e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (5.03e-3)" "prognostic favorable (1.33e-8)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-2)" "unprognostic (3.83e-1)" 5.3 8.0 7.7 8.0 10.4 17.5 5.0 13.8 13.6 5.2 6.8 6.2 7.8 12.7 6.4 8.0 7.5 6.4 7.0 12.9 8.5 6.8 8.4 21.8 5.7 6.1 7.3 6.6 5.1 7.7 8.9 8.4 7.3 6.6 7.3 4.8 7.6 6.9 6.7 81.2 7.7 12.5 6.2 6.7 7.6 6.9 8.8 7.8 8.3 6.2 12.0 9.1 6.6 4.8 11.3 12.7 11.8 10.9 7.7 11.4 5.3 6.7 9.6 11.4 11.8 17.4 10.8 12.3 8.8 11.7 11.3 12.6 10.2 11.7 16.5 8.1 12.6 10.0 8.5 8.6 13.3 7.9 10.9 11.8 13.4 18.9 22.3 17.4 13.0 14.6 13.6 13.1 10.6 12.3 11.2 11.6 16.8 14.1 14.3 9.5 10.1 13.7 21.1 6.3 8.5 15.5 6.5 7.0 17.0 15.4 11.5 7.8 15.7 12.2 10.8 13.4 6.7 11.1 23.4 12.0 9.9 12.1 8.9 10.9 19.5 19.1 6.6 14.1 16.5 14.9 11.8 10.9 7.9 11.4 9.5 6.8 9.8 7.2 6.8 8.6 11.3 8.7 8.2 6.3 7.7 9.7 12.7 5.5 5.3 7.7 10.4 13.8 13.6 8.5 6.8 7.3 6.6 6.6 7.8 8.9 4.0 4.4 2.4 2.1 8.6 1.0 20.4 1.4 4.5 3.5 3.9 5.6 5.0 4.9 10.6 3.6 13.1 0.0 4.8 3.6 4.9 4.4 6.9 23.8 4.8 6.4 6.4 9.8 9.9 12.6 6.9 3.2 3.3 4.6 5.9 3.5 6.0 7.0 5.3 8.5 8.2 0.0 4.9 8.7 9.1 2.6 7.1 2.9 6.3 3.7 RNF128 "FLJ23516, GRAIL" ENSG00000133135 "Ring finger protein 128, E3 ubiquitin protein ligase" Q8TEB7 X 106693794-106796993 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.6;liver: 48.4;thyroid gland: 38.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 62.5;Cholangiocytes: 61.1;Enterocytes: 52.7;Hepatocytes: 73.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.5;CAPAN-2: 13.6;Hep G2: 11.6;OE19: 36.6;RPTEC TERT1: 12.0;RT4: 34.2;WM-115: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019675 Uncertain NA NA "HPA019675: AB_2670225" "unprognostic (1.78e-1)" "unprognostic (1.44e-2)" "unprognostic (1.23e-1)" "unprognostic (1.88e-3)" "unprognostic (1.92e-4)" "unprognostic (2.14e-3)" "unprognostic (2.37e-2)" "unprognostic (1.02e-1)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (1.55e-2)" "unprognostic (1.75e-2)" "prognostic unfavorable (1.07e-7)" "unprognostic (1.11e-2)" "unprognostic (7.61e-2)" "unprognostic (6.30e-2)" "unprognostic (5.30e-3)" 1.4 20.6 2.4 2.2 7.2 0.0 3.0 0.7 4.2 0.5 24.4 0.9 0.4 24.2 0.2 2.2 4.0 0.3 27.2 0.6 2.8 5.1 24.4 48.4 6.7 0.0 2.4 2.1 0.7 14.5 0.0 11.0 10.5 4.0 3.4 7.8 0.0 25.4 0.8 3.0 3.6 54.6 0.9 1.1 0.2 17.9 0.3 1.0 1.1 38.4 2.3 2.7 10.2 3.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 4.1 0.0 0.0 0.0 1.4 0.7 16.5 0.0 0.1 0.0 0.0 7.2 13.6 0.0 0.0 0.2 0.1 5.1 0.0 0.0 0.0 0.0 8.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 36.6 0.1 0.0 0.0 0.0 12.0 34.2 0.0 0.0 0.0 0.9 0.8 0.1 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 6.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 7.2 0.7 4.2 2.8 5.1 2.4 2.1 4.0 1.0 62.5 15.8 0.0 5.7 6.1 0.0 0.5 61.1 9.4 20.5 31.4 0.0 18.2 0.0 9.8 0.0 0.1 52.7 0.0 13.5 2.1 0.4 1.8 0.0 73.1 1.6 0.0 23.8 0.6 3.8 0.0 0.0 0.2 3.3 0.0 36.5 0.0 21.8 22.4 0.0 21.1 0.0 0.0 0.2 0.0 2.2 4.5 13.8 0.0 23.4 7.4 RNF133 ENSG00000188050 "Ring finger protein 133" Q8WVZ7 7 122697712-122699156 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 28.3" "Group enriched" "Detected in some" 104 "Early spermatids: 461.8;Late spermatids: 540.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;MCF7: 1.5;NTERA-2: 1.2;PC-3: 1.1;U-266/70: 1.1" "Not detected" "Not detected" NA NA "unprognostic (2.82e-1)" "unprognostic (2.52e-2)" "unprognostic (1.77e-1)" "unprognostic (3.04e-2)" "unprognostic (2.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.87e-3)" "unprognostic (3.56e-2)" "unprognostic (3.72e-1)" "unprognostic (3.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.02e-2)" "unprognostic (7.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.39e-1)" "unprognostic (2.37e-2)" "unprognostic (7.61e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.3 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 4.1 0.0 1.5 0.0 0.0 1.2 0.5 1.1 0.0 0.0 0.8 0.0 0.4 0.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 461.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 540.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.8 1.5 0.0 0.0 0.0 0.0 0.0 RNF138 "NARF, STRIN" ENSG00000134758 "Ring finger protein 138" Q8WVD3 18 32091855-32131561 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4" "Group enriched" "Detected in many" 16 "Early spermatids: 845.1;Late spermatids: 2984.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041101 Approved Mitochondria NA NA Mitochondria "HPA041101: AB_10805837" "unprognostic (2.37e-2)" "unprognostic (4.63e-3)" "unprognostic (2.03e-3)" "unprognostic (1.01e-1)" "unprognostic (2.34e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-2)" "unprognostic (9.64e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (6.90e-2)" "unprognostic (1.27e-2)" "unprognostic (6.15e-2)" "unprognostic (9.52e-3)" "unprognostic (2.77e-1)" "unprognostic (9.58e-2)" "unprognostic (1.90e-1)" 8.2 5.0 6.5 11.0 7.4 40.4 7.7 9.9 7.1 6.5 11.0 9.0 5.8 8.0 7.5 6.3 7.4 9.7 7.1 5.0 6.8 6.4 5.9 10.1 7.6 17.9 10.6 6.3 9.0 7.8 5.6 8.7 7.2 6.7 6.5 10.0 4.5 6.9 4.9 5.1 5.6 11.2 5.6 9.1 14.3 6.6 73.4 8.1 28.3 7.0 5.7 9.9 6.1 6.8 14.4 24.3 25.7 24.9 16.4 43.8 24.2 9.1 5.4 22.4 11.1 2.9 6.1 12.7 9.3 5.3 11.7 13.6 6.4 6.4 22.0 11.7 6.1 7.6 9.5 11.7 10.5 16.0 12.2 19.6 17.3 7.0 7.8 11.5 47.6 15.4 5.9 10.6 12.9 18.4 6.8 11.9 19.7 23.8 9.0 7.5 8.7 32.1 21.3 25.0 15.8 7.5 33.2 14.1 12.6 10.7 6.8 25.4 12.7 12.5 7.2 9.7 10.7 4.7 20.1 9.1 14.1 10.3 3.4 10.4 15.0 19.9 38.1 7.7 26.6 13.8 8.0 24.9 24.0 10.5 18.6 13.4 14.0 22.9 14.8 24.3 14.4 43.8 27.9 25.7 16.4 15.3 10.5 16.7 24.2 6.5 7.4 9.9 7.1 6.8 6.4 10.6 6.3 6.7 8.1 14.9 22.4 13.8 29.1 61.6 6.1 6.7 25.5 16.0 18.2 15.7 0.0 25.9 14.9 15.3 845.1 21.2 16.7 0.0 16.0 16.6 21.4 26.1 22.0 14.7 21.1 7.9 28.7 20.3 27.6 2984.7 27.3 30.7 25.3 10.8 21.0 8.0 10.5 20.1 20.8 10.7 4.8 32.3 25.9 118.9 102.4 45.7 7.4 27.7 27.0 31.8 RNF144A "hUIP4, KIAA0161, RNF144, UBCE7IP4" ENSG00000151692 "Ring finger protein 144A" P50876 2 6917392-7068286 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;T-cells: 4.1" "Cell line enhanced" "Detected in many" "HEL: 15.2;HMC-1: 51.6;SH-SY5Y: 15.7;SK-MEL-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049939 Approved Supported Vesicles NA NA Vesicles "HPA049939: AB_2680960" "unprognostic (1.78e-1)" "unprognostic (2.53e-3)" "unprognostic (8.37e-2)" "prognostic unfavorable (6.00e-4)" "unprognostic (6.57e-2)" "prognostic favorable (6.96e-4)" "unprognostic (7.04e-6)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "unprognostic (5.64e-1)" "unprognostic (9.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.30e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" 12.9 28.8 13.3 4.2 21.2 12.1 11.1 45.5 20.7 17.3 5.2 28.7 9.0 3.0 26.0 8.3 4.7 8.4 7.5 8.0 15.6 11.6 7.5 1.8 5.7 7.9 26.5 12.2 20.0 29.7 21.5 12.5 6.2 13.2 8.7 5.7 5.9 4.0 7.4 8.7 5.7 4.1 12.2 21.8 21.1 2.8 5.0 27.1 3.4 3.2 1.2 5.8 5.8 6.5 0.1 0.2 8.7 0.1 0.8 4.1 0.6 0.3 2.2 12.0 2.4 2.7 5.6 9.2 0.0 0.0 0.4 1.1 0.0 0.2 1.1 1.3 0.1 3.5 0.2 3.9 0.0 0.0 0.6 1.0 15.2 0.1 4.5 0.1 0.3 51.6 8.9 0.0 0.8 0.0 0.0 0.0 3.9 6.5 0.2 0.0 1.9 7.8 0.6 4.4 0.3 5.4 6.1 8.7 1.0 0.4 3.9 3.9 15.7 0.2 1.6 15.4 1.6 0.7 1.0 0.0 1.6 4.1 4.2 1.7 4.1 1.3 0.0 6.0 3.4 5.6 1.5 0.1 8.7 2.1 0.0 3.0 0.1 2.1 1.5 0.2 0.1 4.1 2.8 0.4 0.8 0.0 0.0 0.8 0.6 13.3 21.2 45.5 20.3 15.6 11.6 26.5 12.2 13.2 27.1 3.0 3.4 0.5 0.7 2.2 3.6 10.6 2.5 2.7 3.4 0.0 70.7 1.7 1.7 2.7 5.7 7.0 4.2 23.3 5.0 2.7 5.3 3.5 9.2 0.8 3.8 9.5 24.5 28.3 1.0 10.4 4.0 1.0 23.6 1.0 2.5 7.2 4.5 9.1 9.9 0.0 42.2 0.0 3.8 1.6 6.0 1.4 0.9 6.4 2.9 0.2 RNF148 MGC35222 ENSG00000235631 "Ring finger protein 148" Q8N7C7 7 122701664-122702967 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 31.0" "Cell type enriched" "Detected in some" 9 "Early spermatids: 297.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 7.4;MCF7: 2.8;OE19: 1.6;RPMI-8226: 1.8;SK-BR-3: 1.6" "Not detected" "Not detected" NA NA "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (3.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.85e-1)" "unprognostic (3.23e-2)" "unprognostic (1.04e-2)" "unprognostic (9.81e-2)" "unprognostic (8.48e-2)" "unprognostic (2.14e-2)" "unprognostic (2.18e-1)" "unprognostic (2.37e-1)" "unprognostic (3.33e-2)" "unprognostic (2.24e-2)" "unprognostic (1.24e-1)" "unprognostic (6.63e-2)" "unprognostic (1.09e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 31.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.3 0.0 0.0 7.4 0.0 2.8 0.0 0.0 1.0 1.6 0.8 0.0 0.0 1.8 0.0 0.6 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 1.3 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 297.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.0 34.3 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 0.0 0.0 6.5 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.1 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 255.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.7 5.8 4.4 5.5 16.5 16.6 25.7 12.1 15.9 16.4 18.5 14.5 25.8 2.9 14.7 11.9 21.7 19.9 6.2 12.3 15.3 8.4 8.5 6.0 5.1 24.5 22.1 6.5 9.8 15.1 20.3 19.4 12.9 12.6 29.8 6.4 5.3 9.1 16.4 8.3 8.7 6.5 3.0 13.2 10.5 5.7 7.3 11.2 19.3 23.9 5.8 4.3 7.3 18.1 17.5 5.0 4.9 8.8 19.7 8.3 4.7 12.4 2.6 18.4 10.8 0.1 2.7 9.1 6.1 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 44.7 56.9 34.7 63.4 68.3 20.3 10.6 48.4 24.1 23.9 52.4 53.0 48.5 1.7 48.9 61.2 33.8 33.9 0.0 36.5 60.6 44.7 62.7 37.1 38.9 76.7 7.9 8.2 28.8 255.2 27.7 28.4 171.2 38.8 16.2 35.9 11.9 49.2 36.6 18.4 25.1 19.7 58.2 44.3 31.2 36.2 80.0 107.1 69.8 31.9 137.0 RNF151 ENSG00000179580 "Ring finger protein 151" Q2KHN1 16 1966823-1968975 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "testis: 64.1" "Group enriched" "Detected in some" 131 "Early spermatids: 2032.5;Late spermatids: 1079.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "T-reg: 2.1" "Lineage enriched" "Detected in single" 8 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA055054 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA Cytosol "Nuclear speckles, Vesicles" "HPA055054: " "unprognostic (1.47e-1)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-2)" "unprognostic (4.01e-3)" "unprognostic (1.15e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-1)" "unprognostic (3.20e-1)" "unprognostic (4.39e-3)" "unprognostic (4.63e-1)" "unprognostic (1.98e-4)" "unprognostic (1.46e-1)" "unprognostic (4.19e-2)" "unprognostic (1.10e-1)" "unprognostic (2.43e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 64.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.2 0.6 1.2 0.6 0.0 0.0 0.9 0.3 0.0 0.0 0.3 0.6 0.0 1.6 0.2 0.5 0.0 2.0 0.0 0.0 0.0 0.2 2.0 0.4 1.7 1.6 0.0 0.6 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.0 1.2 0.0 1.6 0.8 0.3 0.9 0.0 0.0 2.5 0.0 0.0 0.8 0.1 0.0 0.6 0.3 0.2 1.4 0.0 0.0 1.1 1.1 0.7 0.8 0.2 0.9 1.4 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2032.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1079.9 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 6.5 0.1 11.9 5.1 0.0 0.0 0.0 0.0 0.0 RNF152 FLJ39176 ENSG00000176641 "Ring finger protein 152" Q8N8N0 18 61808063-61894247 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 53.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 71.0;Proximal tubular cells: 104.4;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 16.3;HBEC3-KT: 8.7;SH-SY5Y: 10.1;TIME: 10.1;U-138 MG: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.30e-2)" "unprognostic (1.97e-2)" "unprognostic (1.64e-1)" "unprognostic (8.55e-3)" "unprognostic (2.05e-1)" "unprognostic (2.09e-1)" "unprognostic (2.96e-3)" "unprognostic (3.62e-1)" "unprognostic (1.51e-2)" "unprognostic (8.13e-2)" "unprognostic (5.14e-2)" "unprognostic (6.73e-2)" "prognostic favorable (1.13e-8)" "prognostic unfavorable (2.85e-5)" "unprognostic (3.26e-2)" "unprognostic (2.82e-2)" "unprognostic (4.83e-2)" 8.3 3.9 2.4 2.3 6.8 1.5 8.8 19.1 3.8 8.5 7.4 4.0 6.2 2.2 8.6 10.4 4.5 3.9 8.0 6.5 2.5 3.1 53.7 28.3 7.8 1.2 4.1 1.4 3.8 3.1 4.7 2.6 6.6 7.7 4.7 6.7 3.4 11.8 6.8 4.6 9.6 9.8 4.6 4.2 1.3 5.7 3.9 4.5 0.0 5.1 4.9 2.0 5.0 11.6 0.5 0.4 1.7 0.4 0.6 0.4 0.2 0.0 0.0 3.5 0.8 3.4 0.5 0.0 2.3 7.1 0.5 0.4 0.0 0.1 0.1 0.7 3.6 0.1 16.3 4.4 8.7 1.0 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 0.5 6.0 2.8 1.7 1.6 6.5 0.0 0.0 0.0 1.0 0.7 0.6 0.0 0.2 0.5 0.0 0.2 2.3 0.0 0.3 2.6 3.0 10.1 0.0 6.4 1.1 3.2 3.9 0.0 10.1 16.5 1.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.3 0.3 0.3 0.3 0.2 0.5 0.4 0.4 1.5 0.6 0.4 0.4 0.3 0.2 2.4 6.8 19.1 3.8 2.5 3.1 4.1 1.4 7.7 4.5 0.0 0.0 0.0 21.4 37.5 13.4 2.5 12.7 0.0 2.3 19.2 0.0 0.4 39.7 2.0 0.2 16.3 37.1 0.0 2.4 0.1 8.3 7.3 0.0 71.0 0.1 20.6 15.5 5.5 2.2 0.0 8.1 2.2 27.0 0.0 4.9 3.7 1.1 31.6 17.3 104.4 3.6 64.7 48.4 0.1 0.1 28.4 0.2 0.0 11.8 18.8 RNF157 KIAA1917 ENSG00000141576 "Ring finger protein 157" Q96PX1 17 76142453-76240373 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;skeletal muscle: 52.2;testis: 24.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 118.6;Cone photoreceptor cells: 178.7;Horizontal cells: 170.0;Rod photoreceptor cells: 66.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.5;T-cells: 8.5" "Cell line enhanced" "Detected in many" "HDLM-2: 42.3;U-266/70: 22.4;U-266/84: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021854, HPA021991, HPA023922" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202" "unprognostic (4.21e-1)" "unprognostic (4.62e-2)" "unprognostic (1.55e-2)" "unprognostic (2.63e-3)" "unprognostic (4.93e-2)" "unprognostic (5.06e-2)" "unprognostic (2.07e-3)" "unprognostic (4.21e-1)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-3)" "unprognostic (4.02e-1)" "unprognostic (8.26e-2)" "unprognostic (8.69e-3)" "unprognostic (2.28e-1)" "unprognostic (2.75e-2)" "unprognostic (1.38e-1)" 10.5 3.5 21.0 3.4 19.4 2.3 2.5 10.7 36.5 1.5 7.6 8.0 0.4 8.2 1.9 3.6 1.5 2.4 1.8 3.6 26.4 15.5 5.1 1.4 1.4 4.5 19.7 12.0 1.4 3.6 8.8 2.7 2.1 25.3 1.8 6.6 6.8 1.9 2.0 52.2 1.5 7.3 2.2 11.3 3.0 2.4 24.7 5.9 0.0 3.8 1.5 2.8 1.5 0.5 0.7 0.4 2.5 0.3 1.1 8.5 1.4 0.1 3.4 12.7 4.6 4.0 2.0 5.9 0.1 3.9 0.8 0.4 1.4 1.4 0.0 1.8 0.3 3.1 0.1 11.2 0.0 0.7 42.3 3.8 0.0 1.2 1.9 0.6 0.5 4.8 1.1 0.0 1.5 0.0 0.7 0.1 2.1 6.6 0.1 1.6 3.4 1.8 0.3 2.1 2.3 9.0 0.0 0.1 0.0 1.5 1.3 2.2 10.5 2.3 0.0 5.0 3.0 0.3 2.1 0.0 0.8 1.1 6.2 3.9 22.4 18.0 0.0 0.3 0.0 6.4 2.5 0.3 0.4 2.3 0.2 4.9 0.3 5.1 4.0 0.2 0.7 8.5 5.5 1.7 1.1 0.3 0.4 2.1 1.4 21.0 19.4 10.7 36.5 26.4 15.5 19.7 12.0 25.3 5.9 3.0 3.5 1.5 0.7 1.8 118.6 8.4 15.3 0.0 2.3 1.8 178.7 0.6 0.0 1.5 22.3 4.4 12.7 0.0 1.0 0.4 1.5 0.8 0.0 4.3 0.3 170.0 2.4 0.6 0.6 21.5 10.6 2.3 1.7 0.0 3.4 34.2 0.1 2.5 13.1 8.2 66.3 0.0 1.0 21.9 22.5 1.9 0.2 12.7 11.0 1.0 RNF165 "ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Group enriched" "Detected in many" 8 "Bipolar cells: 36.3;Cone photoreceptor cells: 94.2;Horizontal cells: 76.3;Rod photoreceptor cells: 51.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 12.7;HaCaT: 7.0;HeLa: 6.9;RPMI-8226: 6.7;SCLC-21H: 13.2;SH-SY5Y: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041615: AB_2677582, HPA047798: AB_2680158" "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 1.9 1.7 9.9 1.0 9.5 0.9 2.1 28.6 13.8 1.0 0.8 1.7 1.7 0.4 1.0 8.4 2.7 3.0 1.0 2.5 6.1 4.4 2.3 8.3 1.0 0.9 2.2 7.2 0.5 1.0 13.1 4.8 0.8 2.0 3.6 0.6 2.7 1.4 3.9 3.6 3.5 1.0 0.7 1.7 5.3 0.7 1.3 1.0 1.7 8.8 1.2 1.3 1.2 1.0 0.0 1.5 0.5 0.0 3.9 1.1 0.0 1.5 0.1 12.7 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 7.0 0.5 1.0 0.0 0.0 1.0 0.1 6.9 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.2 0.0 0.2 0.0 0.0 2.3 1.0 1.7 0.3 1.2 2.4 0.5 6.7 0.8 2.1 13.2 15.0 2.3 0.0 0.0 0.9 0.3 0.6 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.5 0.0 0.0 9.9 9.5 28.6 13.8 6.1 4.4 2.2 7.2 2.0 1.0 3.0 1.7 0.0 8.3 2.4 36.3 7.9 0.0 0.0 3.4 0.0 94.2 0.1 3.3 0.0 2.7 1.9 0.0 0.0 0.0 0.2 1.5 1.7 0.0 5.7 0.1 76.3 0.0 0.6 0.8 3.1 2.3 0.0 1.7 0.0 0.0 3.7 0.1 0.0 3.9 0.0 51.7 0.0 0.8 0.5 0.5 1.8 0.2 2.9 0.0 1.6 RNF166 "MGC14381, MGC2647" ENSG00000158717 "Ring finger protein 166" Q96A37 16 88696495-88706421 "Predicted intracellular proteins" "Autophagy, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 63.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 44.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042970 Approved "Nucleoplasm,Plasma membrane,Cytosol" No No Nucleoplasm "Plasma membrane, Cytosol" "HPA042970: AB_10796682" "unprognostic (3.01e-2)" "unprognostic (6.98e-3)" "unprognostic (3.96e-2)" "unprognostic (5.36e-3)" "unprognostic (1.23e-1)" "unprognostic (2.71e-2)" "unprognostic (6.52e-2)" "unprognostic (5.86e-2)" "unprognostic (4.88e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.04e-4)" "unprognostic (3.22e-2)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.54e-1)" "unprognostic (3.91e-2)" "unprognostic (1.28e-1)" "unprognostic (2.69e-2)" 9.2 8.1 9.2 22.8 8.9 63.9 10.5 13.7 15.3 6.7 7.2 11.2 3.7 12.0 8.1 8.3 6.4 9.1 12.3 10.0 8.6 7.3 9.6 9.7 20.8 30.5 8.9 6.5 9.7 11.4 5.3 8.5 7.5 8.4 8.9 4.9 11.0 12.1 6.0 14.8 8.2 16.0 8.3 11.1 47.2 10.9 9.2 9.1 21.6 8.8 7.8 23.8 9.7 6.7 2.0 11.8 28.7 12.5 5.5 17.1 9.7 4.2 6.8 5.3 8.4 2.6 2.2 10.1 4.3 2.8 5.1 2.3 4.6 2.7 5.1 5.6 2.5 2.9 4.7 3.1 2.8 2.0 2.6 9.2 6.9 5.0 7.7 6.9 6.8 8.8 2.6 2.7 4.0 3.3 2.8 5.3 8.7 11.5 3.8 2.1 8.3 15.9 44.6 8.7 1.8 9.1 14.9 3.3 13.2 2.3 1.9 4.9 5.5 9.8 2.0 5.3 2.7 5.8 23.3 7.3 3.8 5.7 5.7 5.1 8.6 5.0 12.4 3.4 25.9 5.3 3.0 12.5 28.7 17.1 9.1 14.8 2.0 10.4 14.8 11.8 1.9 8.7 12.5 20.4 5.5 10.5 7.3 10.5 9.7 9.2 8.9 13.7 15.3 8.6 7.3 8.9 6.5 8.4 9.1 8.9 5.1 15.7 4.7 4.2 10.1 2.4 7.6 1.4 3.4 7.0 5.9 7.4 8.3 5.2 1.1 8.0 2.0 0.0 8.0 7.5 8.2 3.6 20.7 4.0 34.7 7.9 4.7 10.4 37.7 1.8 8.6 37.5 10.1 11.8 2.7 8.9 4.6 0.0 7.4 5.6 8.6 6.5 7.1 9.4 8.6 5.1 3.1 66.8 4.1 1.3 RNF17 "FLJ11045, Mmip-2, SPATA23, TDRD4" ENSG00000132972 "Ring finger protein 17" Q9BXT8 13 24764152-24879921 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 44.3" "Group enriched" "Detected in some" 16 "Early spermatids: 17.4;Late spermatids: 20.7;Spermatocytes: 39.8;Spermatogonia: 22.7" "Cancer enriched" "Detected in single" 41 "testis cancer: 4.9" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.1" "Group enriched" "Detected in some" 4 "BEWO: 2.6;HHSteC: 1.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 4 "olfactory region: 3.8" "HPA039699, HPA040111" Approved NA NA "HPA039699: AB_10795254, HPA040111: AB_10795414" "unprognostic (2.57e-1)" "unprognostic (1.87e-2)" "unprognostic (1.37e-1)" "unprognostic (4.44e-1)" "unprognostic (4.26e-1)" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (1.69e-1)" "unprognostic (8.61e-2)" "unprognostic (5.04e-1)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.22e-1)" 0.1 0.5 0.2 0.1 0.1 0.0 0.1 0.2 1.0 0.2 0.1 0.0 0.0 0.0 0.2 1.2 0.1 0.2 0.0 0.2 0.3 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.2 0.1 0.0 0.2 2.2 0.2 1.0 0.0 0.0 0.9 0.1 3.7 0.1 0.1 0.0 1.5 0.1 0.2 44.3 0.6 0.0 0.1 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 1.0 0.3 0.1 1.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 39.8 22.7 0.0 0.8 0.0 0.0 0.0 RNF175 FLJ34190 ENSG00000145428 "Ring finger protein 175" Q8N4F7 4 153710125-153760235 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3" "Cell type enriched" "Detected in some" 5 "Early spermatids: 52.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 26 "classical monocyte: 2.4;intermediate monocyte: 1.7;myeloid DC: 1.7;naive CD4 T-cell: 4.0;neutrophil: 4.5;non-classical monocyte: 3.6;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.9;HSkMC: 5.2;REH: 6.7;SH-SY5Y: 6.7;THP-1: 16.1;U-87 MG: 3.9" HPA035837 Uncertain NA NA "HPA035837: AB_10601609" "unprognostic (3.23e-2)" "unprognostic (4.12e-2)" "unprognostic (3.34e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (3.11e-4)" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-4)" "unprognostic (1.17e-1)" "unprognostic (2.96e-3)" "unprognostic (6.30e-3)" "unprognostic (1.42e-1)" "unprognostic (3.63e-4)" "unprognostic (7.25e-3)" "unprognostic (3.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" 2.7 4.8 8.6 5.4 14.3 9.5 1.3 9.3 17.3 5.4 0.8 1.4 0.8 0.8 0.8 2.0 1.5 0.6 2.2 4.4 9.0 12.1 0.6 0.5 2.2 2.2 6.4 9.8 0.5 1.1 0.4 3.0 0.6 13.0 4.7 0.6 0.6 3.4 6.7 0.5 1.6 0.9 0.6 2.5 3.4 0.8 2.8 1.8 0.0 0.6 0.3 1.3 1.8 1.5 0.0 1.7 4.5 3.6 0.0 4.0 1.2 0.1 0.0 7.9 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.7 0.0 0.0 6.7 0.0 0.3 0.0 0.1 0.0 6.7 0.0 0.0 0.2 0.1 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 2.4 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.7 0.0 4.0 0.1 4.5 0.0 3.6 0.0 1.1 1.2 8.6 14.3 9.3 17.3 9.0 12.1 6.4 9.8 13.0 1.8 0.0 0.3 0.0 0.0 0.3 0.2 1.7 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 52.2 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.1 10.2 0.0 1.4 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.3 1.4 1.4 0.3 0.0 0.0 0.0 0.1 RNF180 ENSG00000164197 "Ring finger protein 180" Q86T96 5 64165844-64372869 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 54.0" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 31.9;Muller glia cells: 32.9;Sertoli cells: 38.8" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006897 Approved Approved Cytosol NA NA Cytosol "HPA006897: AB_1856348" "unprognostic (7.46e-2)" "unprognostic (3.90e-3)" "unprognostic (3.19e-2)" "unprognostic (8.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.72e-1)" "unprognostic (5.57e-2)" "unprognostic (2.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (3.37e-3)" "unprognostic (3.68e-2)" "prognostic favorable (6.81e-5)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.81e-2)" "unprognostic (9.81e-3)" 8.1 8.1 9.9 3.1 12.8 1.6 6.3 6.0 13.0 10.1 7.1 5.5 20.1 3.4 12.7 11.8 6.9 8.1 7.3 10.4 7.4 10.6 12.4 7.2 6.1 3.4 9.4 9.3 12.0 6.6 54.0 16.1 2.0 10.7 11.5 3.0 11.3 7.3 16.4 4.4 6.6 3.2 15.0 11.0 5.1 5.0 8.1 7.1 0.0 20.6 2.5 2.4 10.9 7.9 2.4 1.0 4.2 1.8 2.0 4.2 0.3 0.0 0.1 1.3 0.0 0.0 0.0 0.3 1.1 0.5 1.1 0.6 0.0 0.1 0.0 0.1 0.8 0.6 0.2 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.1 2.7 0.0 0.1 5.0 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.5 0.0 1.3 0.1 3.3 25.4 1.9 0.3 0.3 0.1 0.0 0.3 0.0 1.7 1.3 0.1 0.1 0.0 3.2 0.1 2.9 0.0 0.0 0.0 0.5 0.0 3.6 3.0 1.8 4.2 1.9 0.6 2.5 1.4 3.0 3.2 0.6 2.4 4.2 3.9 2.6 2.0 0.8 1.0 1.8 0.3 9.9 12.8 6.0 11.7 7.4 10.6 9.4 9.3 10.7 7.1 14.9 10.5 0.0 6.5 4.0 16.5 9.6 12.7 2.7 7.9 15.7 13.7 0.0 6.6 4.5 3.7 5.6 0.0 0.0 2.3 0.1 2.5 5.0 0.0 5.4 0.1 11.1 1.2 12.3 1.2 5.5 31.9 0.2 5.0 0.0 1.6 32.9 2.8 0.6 23.7 14.3 17.3 38.8 17.9 15.4 9.7 6.5 0.0 0.0 0.1 3.8 RNF182 MGC33993 ENSG00000180537 "Ring finger protein 182" Q8N6D2 6 13924446-13980302 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 12.9;brain: 17.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.5;Horizontal cells: 14.3;Muller glia cells: 15.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 37.0;RPTEC TERT1: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012309 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Nucleoplasm, Golgi apparatus" Vesicles "HPA012309: AB_1856349" "unprognostic (1.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (4.66e-5)" "unprognostic (6.16e-2)" "unprognostic (2.08e-1)" "unprognostic (9.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.71e-2)" "unprognostic (4.21e-1)" "unprognostic (6.04e-2)" "unprognostic (1.42e-1)" "unprognostic (1.05e-1)" "unprognostic (9.33e-5)" "unprognostic (6.66e-3)" "unprognostic (1.33e-3)" "unprognostic (1.26e-1)" 1.2 0.7 7.6 0.6 6.2 12.9 1.2 16.6 17.6 1.2 0.7 7.5 2.0 0.8 1.6 2.5 1.0 2.7 0.9 1.0 11.0 7.3 2.6 0.5 5.7 0.8 6.8 8.5 1.1 3.6 0.5 2.0 2.9 14.3 0.9 0.6 2.2 1.9 4.7 0.9 0.8 1.1 1.0 5.1 0.5 0.6 7.0 2.9 0.0 3.0 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.8 5.3 0.0 1.8 2.3 0.3 2.7 3.7 7.5 7.3 0.1 0.0 0.0 0.0 2.9 8.2 0.0 6.2 0.0 13.8 0.0 2.0 0.1 37.0 0.0 0.0 0.0 0.0 1.2 0.0 11.6 0.1 8.7 0.1 1.5 0.2 0.0 5.2 0.0 0.0 0.9 3.0 0.0 10.3 1.5 1.3 0.4 29.7 0.0 6.4 6.1 0.2 0.0 10.4 2.0 0.0 1.0 2.8 9.2 2.0 0.1 6.1 0.0 0.0 0.0 6.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 6.2 16.6 12.1 11.0 7.3 6.8 8.5 14.3 2.9 0.0 0.0 0.0 0.0 0.2 16.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 14.3 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 15.3 0.1 0.0 0.0 0.5 1.2 6.5 0.8 3.0 1.9 0.0 0.2 0.0 0.0 0.0 RNF183 MGC4734 ENSG00000165188 "Ring finger protein 183" Q96D59 9 113297093-113303376 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 19.0;kidney: 9.5" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 7.6;Collecting duct cells: 5.2;Intestinal endocrine cells: 8.1;Proximal tubular cells: 18.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 20.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA057675 Uncertain NA NA "HPA057675: AB_2683499" "unprognostic (1.23e-2)" "unprognostic (3.17e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.95e-6)" "unprognostic (2.56e-1)" "unprognostic (1.75e-2)" "unprognostic (1.54e-3)" "unprognostic (1.27e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-2)" "unprognostic (3.27e-1)" "unprognostic (1.98e-1)" "prognostic favorable (3.51e-4)" "unprognostic (5.50e-2)" "unprognostic (8.84e-2)" "unprognostic (9.61e-2)" "unprognostic (2.53e-3)" 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.9 0.2 0.2 1.2 19.0 5.1 1.2 6.2 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.8 0.3 6.9 0.2 0.0 0.1 0.1 0.0 0.0 0.0 3.7 4.3 0.1 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.3 7.6 0.0 0.0 5.2 0.0 0.0 1.7 0.3 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.2 2.1 0.0 0.4 18.3 2.7 0.0 0.1 3.4 1.1 0.0 0.0 0.0 1.5 0.8 RNF186 FLJ20225 ENSG00000178828 "Ring finger protein 186" Q9NXI6 1 19814029-19815278 "Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 83.2;Mucus-secreting cells: 32.9;Paneth cells: 108.7;Proximal tubular cells: 98.1;Undifferentiated cells: 113.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPMI-8226: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034547, HPA035558" Enhanced NA NA "HPA034547: AB_10670975, HPA035558: AB_2674678" "unprognostic (1.66e-2)" "unprognostic (2.49e-2)" "unprognostic (3.89e-1)" "unprognostic (5.93e-3)" "unprognostic (1.77e-3)" "unprognostic (3.23e-1)" "unprognostic (3.05e-1)" "unprognostic (3.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (1.40e-1)" "unprognostic (8.60e-3)" 0.2 0.1 0.1 7.8 0.1 0.0 0.8 0.1 0.1 0.2 38.2 0.0 0.5 47.1 0.2 25.8 0.2 0.2 0.1 0.1 0.1 0.1 44.0 0.7 0.1 0.0 0.1 0.0 0.3 30.5 0.0 0.2 0.0 0.0 0.6 5.4 0.0 0.2 0.0 0.1 0.2 59.0 0.0 0.1 0.2 0.2 0.6 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 0.0 0.5 6.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 4.9 0.0 0.0 17.2 0.0 16.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 7.1 108.7 0.0 98.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.9 0.1 RNF19B "FLJ90005, IBRDC3" ENSG00000116514 "Ring finger protein 19B" Q6ZMZ0 1 32936445-32964685 "Enzymes, Predicted membrane proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 54.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 16.1" "Lineage enriched" "Detected in many" 8 "granulocytes: 16.1" "Cell line enhanced" "Detected in all" "Daudi: 39.3;Karpas-707: 47.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049587, HPA063640" Approved Approved Cytosol NA NA Cytosol "HPA049587: AB_2680826, HPA063640: " "unprognostic (2.83e-2)" "unprognostic (1.77e-2)" "unprognostic (1.86e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "prognostic favorable (3.39e-4)" "prognostic unfavorable (5.41e-6)" "unprognostic (8.78e-2)" "unprognostic (5.02e-1)" "unprognostic (1.69e-1)" "unprognostic (9.85e-2)" "unprognostic (1.38e-1)" "prognostic favorable (4.39e-5)" "unprognostic (2.58e-2)" "unprognostic (4.93e-2)" "unprognostic (3.30e-1)" "unprognostic (1.23e-2)" 8.6 11.3 8.0 13.1 10.5 36.4 12.0 14.1 14.1 9.9 13.2 10.1 4.8 14.1 10.8 6.9 23.3 7.9 10.1 8.5 6.0 7.2 12.0 6.5 13.8 12.9 9.6 9.3 7.1 7.0 6.4 5.7 9.4 10.2 7.4 15.3 9.0 10.8 5.7 10.2 13.6 15.5 10.6 8.0 9.0 7.4 54.7 8.3 6.8 8.2 11.1 16.7 11.3 12.8 1.3 1.3 16.1 2.0 0.8 1.6 0.7 6.7 5.2 4.5 4.1 2.7 3.9 30.0 3.1 3.8 5.7 6.1 6.1 20.3 39.3 5.5 4.1 7.0 9.7 5.5 7.5 5.2 14.4 3.6 3.4 4.1 6.1 8.8 5.2 7.2 3.1 14.0 12.5 15.4 6.6 11.9 3.9 4.2 47.3 5.5 2.2 3.4 6.4 7.2 7.7 5.9 4.6 6.4 4.0 4.4 9.8 7.1 3.6 10.0 3.4 22.4 11.5 2.9 7.6 13.0 3.1 4.3 7.8 5.4 11.3 5.7 13.9 4.5 5.3 4.6 5.3 2.0 3.5 1.6 1.8 1.2 1.2 1.4 0.8 1.3 1.3 0.4 0.6 16.1 0.8 1.5 0.6 1.5 0.7 8.0 10.5 14.1 14.1 6.0 7.2 9.6 9.3 10.2 8.3 11.9 4.1 1.9 20.3 41.0 4.4 12.0 15.3 6.7 2.3 7.0 2.0 11.0 1.7 9.3 30.1 8.7 34.3 0.0 9.9 5.4 7.1 22.8 4.6 3.4 12.6 3.2 10.9 3.7 20.2 18.4 2.0 28.7 5.0 43.3 16.5 2.0 19.2 17.5 3.5 7.1 7.4 0.0 5.4 29.3 12.6 28.4 6.2 3.2 10.5 35.3 RNF207 "C1orf188, FLJ32096, FLJ46380" ENSG00000158286 "Ring finger protein 207" Q6ZRF8 1 6205475-6221299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 24.2" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 28.2;Urothelial cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 2.7" "Lineage enriched" "Detected in single" 8 "monocytes: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.8;HaCaT: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028378, HPA042535" Uncertain Approved Cytosol NA NA Cytosol "HPA028378: AB_10601157, HPA042535: AB_2678042" "unprognostic (5.53e-3)" "unprognostic (1.23e-1)" "unprognostic (1.62e-2)" "unprognostic (4.46e-2)" "unprognostic (4.84e-2)" "unprognostic (5.91e-3)" "unprognostic (9.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.74e-2)" "unprognostic (9.93e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.76e-2)" "unprognostic (2.93e-2)" "unprognostic (1.89e-1)" "unprognostic (8.10e-3)" 1.6 2.1 0.6 6.6 1.5 0.3 1.9 5.6 1.8 5.7 5.8 0.9 13.3 2.8 3.6 3.8 4.4 4.7 6.6 24.2 0.7 2.1 5.9 4.3 2.0 2.2 0.7 0.2 3.3 5.3 3.3 4.0 9.2 0.9 7.7 2.4 10.6 6.1 16.6 2.5 1.1 8.2 7.6 1.2 1.9 3.5 1.2 0.6 1.4 6.4 2.8 8.7 5.0 5.0 0.0 0.0 0.0 2.7 0.0 0.3 0.1 2.3 4.5 0.4 3.2 0.2 0.4 2.9 1.5 1.1 0.3 0.4 2.3 17.8 0.3 1.2 1.2 0.0 7.6 0.4 1.1 0.1 2.4 1.8 0.1 5.5 2.3 1.5 1.8 0.1 1.3 0.3 0.0 0.0 4.4 0.1 0.4 0.6 3.9 0.1 1.7 0.2 0.3 0.2 0.4 4.1 0.0 0.8 3.2 2.6 4.0 0.5 1.2 2.4 1.6 1.1 0.8 2.9 0.1 0.5 0.0 0.7 0.5 0.0 3.8 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.2 0.1 0.6 1.5 5.6 1.8 0.7 2.1 0.7 0.2 0.9 0.6 8.9 3.8 0.5 28.2 0.2 3.0 14.6 12.7 4.0 15.9 17.4 2.0 11.4 0.0 13.4 0.7 0.7 6.8 0.0 8.6 5.7 3.7 17.2 0.0 3.4 1.0 3.2 3.5 1.8 0.0 0.0 0.0 1.7 0.0 3.6 9.2 6.5 12.5 2.9 1.1 1.9 18.7 6.5 5.0 0.1 2.3 0.4 4.7 0.5 6.0 32.3 RNF208 DKFZP761H1710 ENSG00000212864 "Ring finger protein 208" Q9H0X6 9 137220247-137221581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 21.6;Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 12.4;MCF7: 29.7;REH: 23.9;RPMI-8226: 13.2;T-47d: 10.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021256, HPA021429" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA021256: AB_1844331, HPA021429: AB_2180654" "unprognostic (2.97e-1)" "unprognostic (7.37e-2)" "unprognostic (1.46e-2)" "unprognostic (6.33e-3)" "unprognostic (9.99e-2)" "unprognostic (2.10e-3)" "unprognostic (3.52e-3)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.42e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.12e-8)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (7.66e-2)" "unprognostic (3.40e-2)" 3.7 7.1 17.3 1.2 13.3 0.7 4.3 10.1 27.4 1.9 1.7 1.5 1.2 2.0 1.7 2.7 4.6 3.4 1.2 6.2 18.1 10.8 3.7 8.1 1.8 3.4 9.4 4.6 1.5 8.8 5.7 3.0 1.2 3.5 4.0 0.6 1.8 11.4 5.5 13.2 6.6 2.4 1.2 3.3 1.8 3.4 3.1 2.1 1.2 2.1 3.2 1.2 2.1 1.3 0.6 0.0 0.8 0.7 0.0 1.2 0.8 0.8 1.5 1.1 1.8 0.7 0.1 3.2 0.4 0.6 0.7 0.7 4.5 2.8 0.4 2.3 0.5 0.1 2.3 2.5 0.1 0.1 1.1 0.9 3.1 5.2 12.4 2.4 0.6 1.1 0.5 0.8 0.7 0.3 2.8 0.7 4.6 4.4 0.2 0.3 29.7 1.6 1.4 1.3 2.9 3.3 23.9 0.2 13.2 0.8 0.1 3.0 10.6 0.3 0.9 0.6 0.6 10.7 2.3 0.3 0.5 0.7 1.1 0.0 0.4 0.4 0.1 1.4 0.2 0.6 0.0 0.4 0.2 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.8 17.3 13.3 10.1 27.4 18.1 10.8 9.4 4.6 3.5 2.1 6.0 2.1 1.5 1.1 0.3 8.2 8.2 5.1 4.0 0.0 7.0 11.8 0.2 21.6 3.9 0.5 1.4 4.0 0.0 1.9 0.2 0.9 1.6 0.0 6.8 1.1 15.9 7.5 1.3 0.3 0.5 1.1 0.0 1.7 1.8 3.9 5.5 3.5 4.2 3.2 8.8 3.2 0.0 0.9 1.7 2.2 1.6 0.2 0.8 3.3 0.7 RNF212 "FLJ38841, LOC285498" ENSG00000178222 "Ring finger protein 212" Q495C1 4 1056250-1113562 "Predicted intracellular proteins" "Meiosis, Ubl conjugation pathway" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 18.1" "Group enriched" "Detected in many" 4 "Distal tubular cells: 53.0;Spermatocytes: 40.2;Spermatogonia: 38.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 8.5;HeLa: 26.0;JURKAT: 13.1;SiHa: 15.6" HPA057527 Uncertain NA NA "HPA057527: AB_2683457" "unprognostic (2.75e-2)" "prognostic favorable (1.39e-4)" "unprognostic (1.55e-1)" "unprognostic (3.83e-2)" "unprognostic (1.10e-2)" "unprognostic (2.57e-2)" "unprognostic (4.49e-2)" "unprognostic (1.33e-1)" "unprognostic (2.09e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (8.36e-2)" "unprognostic (1.60e-1)" "unprognostic (5.52e-2)" "unprognostic (1.05e-1)" 2.9 1.9 3.1 1.7 8.4 4.5 3.9 11.4 4.7 4.6 2.4 4.3 2.0 1.2 2.7 4.3 2.4 4.0 2.1 1.3 2.4 1.6 4.7 0.6 2.9 2.7 3.4 1.1 8.8 13.0 0.8 18.1 1.0 5.3 3.3 1.8 3.6 4.2 1.4 1.9 4.4 1.8 2.2 4.1 1.9 2.6 12.1 2.1 0.5 8.2 1.0 1.9 1.4 3.0 2.1 1.2 0.1 0.7 0.4 3.8 0.9 8.5 0.5 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 3.8 0.1 0.0 2.2 0.0 2.1 0.0 0.0 0.0 13.1 0.1 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 2.9 0.0 15.6 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 2.2 0.7 1.8 0.6 3.8 1.0 1.2 2.1 3.8 1.2 0.0 0.4 0.0 0.4 1.1 0.9 3.1 8.4 11.4 4.7 2.4 1.6 3.4 1.1 5.3 2.1 3.0 5.8 0.0 5.2 2.5 2.3 0.5 0.0 2.7 10.3 0.0 2.0 0.0 53.0 2.7 3.4 0.5 0.1 0.0 0.8 0.1 5.8 3.6 4.6 0.0 0.5 0.0 4.7 0.0 0.0 5.1 7.8 1.6 0.0 1.0 2.3 4.5 1.0 1.4 0.7 6.0 5.7 0.0 2.0 40.2 38.5 2.8 0.2 0.5 0.7 3.8 RNF212B C14orf164 ENSG00000215277 "Ring finger protein 212B" A8MTL3 14 23185316-23273477 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "kidney: 24.3;testis: 7.5" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 25.0;Late spermatids: 7.6;Proximal tubular cells: 14.6;Spermatocytes: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;CAPAN-2: 2.6;Daudi: 3.8;hTERT-RPE1: 1.8;Karpas-707: 2.6;U-266/70: 3.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 9.3" HPA053574 Uncertain NA NA "HPA053574: AB_2682195" "unprognostic (2.88e-1)" "unprognostic (2.17e-1)" "unprognostic (4.65e-1)" "unprognostic (8.54e-2)" "unprognostic (1.30e-1)" "unprognostic (4.79e-1)" "unprognostic (4.48e-2)" "unprognostic (2.98e-2)" "unprognostic (3.82e-1)" "unprognostic (1.83e-2)" "unprognostic (4.96e-3)" "unprognostic (4.45e-1)" "unprognostic (7.33e-5)" "unprognostic (9.60e-2)" "unprognostic (3.40e-1)" "unprognostic (7.56e-2)" "unprognostic (5.39e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 7.5 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.5 1.2 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 2.6 3.8 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.3 0.2 2.6 0.0 0.8 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.1 0.2 0.0 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.6 0.9 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.4 14.6 0.2 0.0 0.1 14.2 4.2 0.0 0.0 0.0 0.0 0.0 RNF217 "C6orf172, dJ84N20.1, IBRDC1, MGC26996" ENSG00000146373 "Ring finger protein 217" Q8TC41 6 124962545-125092633 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 63.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.9;myeloid DC: 1.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029598 Uncertain NA NA "HPA029598: AB_10602297" "unprognostic (2.96e-2)" "unprognostic (2.34e-3)" "unprognostic (8.07e-2)" "unprognostic (8.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.06e-2)" "unprognostic (1.06e-1)" "unprognostic (7.22e-3)" "unprognostic (4.94e-2)" "unprognostic (6.69e-2)" "unprognostic (2.47e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (4.60e-5)" "unprognostic (8.29e-4)" "unprognostic (2.16e-1)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.92e-4)" 9.6 3.5 3.3 4.2 4.7 10.5 14.6 3.8 3.5 8.0 7.7 5.7 6.4 2.3 5.9 5.6 6.2 7.5 12.1 6.5 3.8 1.7 2.5 6.3 7.3 3.7 4.3 2.9 11.5 3.8 63.3 4.0 12.0 3.4 6.4 2.3 6.0 6.0 6.9 10.1 10.9 3.1 13.0 2.3 2.6 4.5 7.4 5.7 0.1 7.4 3.6 1.6 8.7 13.6 0.0 1.2 0.6 1.9 0.3 0.2 0.3 4.1 4.3 1.5 0.5 5.4 2.1 8.6 5.7 7.7 3.9 5.1 0.0 3.9 0.0 8.0 5.4 8.9 6.0 0.9 5.1 5.5 0.0 4.8 2.3 6.4 1.3 5.2 0.0 0.2 5.9 4.8 2.9 8.6 4.6 4.4 0.0 11.6 0.0 6.8 0.0 0.0 0.0 1.3 0.0 1.1 0.1 6.0 0.0 4.0 1.9 0.7 0.0 2.5 0.6 2.2 4.4 4.2 0.7 6.9 3.2 10.4 0.0 12.2 0.0 0.0 0.0 2.4 0.0 3.8 0.6 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.0 0.3 3.3 4.7 3.8 3.5 3.8 1.7 4.3 2.9 3.4 5.7 20.8 16.0 0.0 12.7 42.7 6.2 12.5 2.5 5.3 10.3 5.2 15.7 15.2 0.0 6.8 92.0 15.0 1.7 0.0 8.3 23.6 21.6 10.4 1.1 24.6 8.5 20.6 2.9 14.1 12.9 49.9 23.9 13.3 18.6 2.8 3.0 4.0 10.7 0.0 19.8 1.9 5.0 6.5 12.3 1.4 2.6 41.0 15.0 0.5 2.7 9.7 RNF220 "C1orf164, FLJ10597" ENSG00000187147 "Ring finger protein 220" Q5VTB9 1 44405194-44651724 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 37.2" "Low region specificity" "Detected in all" "HPA027577, HPA027578" Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA027577: AB_2672339, HPA027578: AB_10601482" "unprognostic (3.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.49e-2)" "unprognostic (2.56e-1)" "unprognostic (2.94e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.35e-6)" "unprognostic (1.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.13e-1)" "unprognostic (2.14e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.51e-2)" "unprognostic (1.98e-1)" "unprognostic (1.37e-3)" "unprognostic (6.46e-2)" 9.8 7.4 20.9 9.6 38.5 12.7 6.7 12.6 40.1 5.4 9.2 40.7 2.7 10.7 8.0 8.8 6.0 9.3 4.5 9.2 33.4 20.9 7.4 5.1 7.4 7.6 49.8 19.8 9.5 8.1 7.0 5.7 8.7 25.8 7.7 5.9 4.2 9.3 7.1 28.4 8.7 8.8 8.0 57.4 7.9 7.6 7.0 49.6 5.0 7.3 4.6 8.0 7.9 5.6 3.6 6.6 2.8 2.3 1.9 4.3 1.4 6.1 2.9 12.6 4.2 4.9 4.5 9.4 7.2 6.7 5.6 8.3 5.0 6.1 11.9 6.4 5.8 8.0 4.0 14.0 5.9 7.6 14.7 12.5 16.3 9.1 8.4 7.9 11.5 8.4 4.9 13.6 6.2 10.0 4.6 3.2 6.3 12.0 5.9 3.5 4.2 11.3 8.7 13.7 6.7 6.6 9.6 7.4 8.5 3.6 3.8 5.7 7.0 6.1 4.3 8.7 4.6 3.2 20.4 4.9 6.0 6.4 5.6 13.3 13.5 12.9 8.5 4.9 37.2 3.5 2.4 2.3 2.8 3.2 1.8 2.4 2.4 1.0 4.3 3.4 3.6 1.9 1.7 1.5 1.9 1.3 6.6 3.2 1.4 20.9 38.5 12.6 30.8 33.4 20.9 49.8 19.8 25.8 49.6 8.9 12.0 15.9 12.3 13.5 23.6 19.4 25.5 4.0 9.1 22.7 23.6 15.6 14.9 16.5 7.9 16.1 22.2 46.7 24.8 20.6 12.8 18.6 10.4 25.9 22.1 22.3 17.3 15.4 25.1 11.8 17.8 12.8 11.8 15.4 22.6 13.2 19.6 20.1 13.1 27.9 17.0 6.5 9.9 27.4 27.9 15.3 8.5 20.0 25.2 12.7 RNF222 ENSG00000189051 "Ring finger protein 222" A6NCQ9 17 8390704-8397826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 15.7;lymphoid tissue: 9.4;tongue: 13.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.2;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 1.3;Syncytiotrophoblasts: 1.0;T-cells: 1.0" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 12.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048916 Uncertain NA NA "HPA048916: AB_2680555" "unprognostic (2.49e-1)" "unprognostic (4.19e-2)" "unprognostic (2.32e-2)" "unprognostic (8.19e-4)" "unprognostic (2.81e-1)" "unprognostic (5.30e-2)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (9.55e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-3)" "unprognostic (5.82e-2)" "unprognostic (6.70e-2)" "unprognostic (5.98e-3)" "unprognostic (3.97e-2)" 0.1 0.0 0.1 0.1 0.1 1.8 0.5 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.6 0.1 15.7 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 1.8 0.1 0.1 6.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 13.6 9.4 0.1 5.5 0.4 0.5 2.0 0.5 0.2 1.0 0.1 1.2 0.0 0.0 0.2 0.1 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 12.6 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 1.6 0.5 1.0 0.3 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.6 1.0 2.0 0.2 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.2 0.0 0.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 1.3 1.0 1.0 0.0 0.9 RNF223 ENSG00000237330 "Ring finger protein 223" E7ERA6 1 1070966-1074307 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 16.4;Urothelial cells: 31.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 11.9;CAPAN-2: 8.9;HaCaT: 5.6;MCF7: 19.0;OE19: 5.5;SK-BR-3: 13.0;T-47d: 8.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (4.71e-1)" "unprognostic (2.79e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.08e-5)" "unprognostic (3.50e-1)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (3.91e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-3)" "unprognostic (1.50e-1)" "unprognostic (1.16e-1)" "unprognostic (4.58e-1)" "unprognostic (9.52e-3)" 0.0 0.0 0.0 1.4 0.0 0.4 0.8 0.0 0.5 8.3 1.4 0.0 0.0 0.4 1.0 0.3 28.8 0.2 1.9 0.0 0.0 0.0 0.6 0.3 0.9 0.1 0.0 0.0 0.0 1.0 0.1 0.0 6.5 0.0 4.2 0.8 0.0 3.3 0.4 0.7 3.5 0.2 2.6 0.0 0.2 7.8 0.1 0.0 0.0 0.2 14.8 17.1 4.9 9.3 0.6 0.6 1.9 0.4 0.3 0.4 0.0 11.9 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.4 8.9 0.0 0.1 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.0 0.0 0.1 0.0 5.5 0.2 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 13.0 0.2 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.4 0.2 0.3 0.1 0.1 0.3 0.2 0.4 0.0 0.6 0.2 0.4 0.9 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 6.4 0.5 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.2 0.0 6.7 0.0 0.0 5.1 0.0 2.8 16.4 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 9.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.2 0.0 2.8 31.4 RNF224 ENSG00000233198 "Ring finger protein 224" P0DH78 9 137227271-137229638 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "esophagus: 4.8;pituitary gland: 7.7" "Cell type enhanced" "Detected in single" 20 "Proximal tubular cells: 1.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;HeLa: 5.3;MCF7: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.45e-1)" "unprognostic (2.34e-3)" "unprognostic (7.01e-4)" "unprognostic (6.04e-2)" "unprognostic (5.26e-2)" "unprognostic (1.70e-3)" "unprognostic (3.87e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-3)" "unprognostic (4.57e-2)" "unprognostic (5.24e-2)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "unprognostic (4.95e-2)" "unprognostic (1.27e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 0.0 0.6 0.5 0.1 0.7 0.3 0.0 0.2 0.9 0.3 0.0 1.0 0.4 0.1 4.8 2.0 1.0 0.3 0.5 0.5 2.8 0.0 1.1 0.4 0.1 0.0 1.5 0.2 7.7 0.0 0.9 0.0 4.6 0.0 0.1 1.5 1.6 0.0 0.1 0.4 1.2 1.2 1.0 0.1 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.7 1.9 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 7.4 0.2 0.3 0.0 0.4 3.5 0.0 0.1 0.0 2.5 0.6 0.0 5.3 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.3 0.6 0.0 12.9 0.1 0.2 0.6 0.9 1.7 0.8 0.3 0.3 0.1 0.8 0.0 1.7 0.7 2.8 0.1 1.0 2.8 0.3 0.2 0.3 0.2 1.6 0.0 0.9 0.2 0.2 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RNF225 ENSG00000269855 "Ring finger protein 225" M0QZC1 19 58396090-58397079 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "esophagus: 31.6;lymphoid tissue: 16.5;tongue: 21.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;SCLC-21H: 1.1;T-47d: 3.3;U-266/84: 1.7" "Low region specificity" "Detected in many" NA NA "unprognostic (3.07e-1)" "unprognostic (6.94e-2)" "unprognostic (3.68e-3)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (1.75e-3)" "unprognostic (1.40e-1)" "unprognostic (3.42e-1)" "unprognostic (9.18e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 4.0 0.0 0.0 3.1 0.0 0.0 0.1 31.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 1.4 0.0 0.0 1.9 2.1 0.0 6.2 0.0 0.4 0.0 0.1 0.1 1.1 0.0 0.0 0.2 21.8 16.5 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.9 1.1 0.3 0.0 0.6 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RNF227 LINC02581 ENSG00000179859 "Ring finger protein 227" A6NIN4 17 7913324-7916276 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in all" 5 "blood: 13.5;skin 1: 40.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Ciliated cells: 4.0;Distal tubular cells: 1.7;monocytes: 2.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 13.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.85e-3)" "prognostic favorable (8.89e-5)" "unprognostic (1.50e-2)" "unprognostic (4.88e-2)" "unprognostic (3.72e-3)" "unprognostic (1.44e-2)" "unprognostic (2.02e-5)" "unprognostic (9.48e-2)" "unprognostic (9.22e-3)" "unprognostic (2.94e-2)" "unprognostic (3.11e-2)" "unprognostic (3.31e-2)" "unprognostic (7.96e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.30e-2)" "unprognostic (1.80e-2)" 2.1 2.8 4.4 2.9 5.8 1.3 4.2 4.1 5.8 2.2 1.5 2.8 4.2 2.9 3.5 4.0 2.4 4.2 2.4 1.5 3.7 1.6 1.0 2.4 1.9 2.2 4.7 4.4 5.6 2.0 2.3 1.9 3.1 2.5 1.8 3.7 2.3 1.9 1.1 40.6 2.0 2.3 3.1 2.3 1.9 4.1 3.3 1.1 1.7 1.8 2.2 3.6 1.2 2.4 2.3 13.5 1.5 3.0 4.6 1.6 7.5 1.6 2.9 2.9 2.3 2.1 2.5 7.2 3.0 2.0 2.2 4.5 2.3 1.4 4.3 2.8 1.8 5.6 1.7 3.6 3.7 0.9 1.9 2.0 5.3 0.3 4.4 4.1 3.8 2.6 10.5 3.3 3.5 1.0 0.5 7.6 2.2 1.4 4.5 0.8 5.4 5.2 2.0 2.3 1.1 2.6 7.2 1.6 2.9 1.0 1.2 4.1 15.5 0.6 3.0 0.9 1.9 3.0 0.5 0.1 4.1 3.5 1.4 2.0 0.7 2.1 4.4 4.5 5.5 13.5 1.5 0.5 2.1 1.1 2.8 2.4 2.4 2.7 2.3 1.8 4.6 3.1 1.0 3.0 0.8 1.6 1.7 1.6 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.2 1.7 0.7 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 RNF24 G1L ENSG00000101236 "Ring finger protein 24" Q9Y225 20 3927309-4015582 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.0;bone marrow: 59.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 59.0" "Lineage enriched" "Detected in all" 10 "granulocytes: 59.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011900 Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA011900: AB_10671089" "unprognostic (6.61e-2)" "unprognostic (6.56e-2)" "unprognostic (1.72e-1)" "unprognostic (1.17e-2)" "unprognostic (8.79e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (2.65e-1)" "unprognostic (5.87e-2)" "unprognostic (2.66e-2)" "unprognostic (5.19e-3)" "unprognostic (3.42e-1)" "prognostic unfavorable (2.67e-7)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (1.24e-1)" 9.1 9.3 13.1 11.6 13.0 59.4 14.8 12.3 16.2 9.2 6.6 8.4 17.0 4.7 9.1 20.6 8.1 8.0 9.3 7.4 13.0 10.5 9.5 3.2 14.5 14.1 10.5 9.9 9.3 5.9 5.3 8.2 5.6 9.4 9.9 5.8 5.4 9.8 14.9 3.2 11.4 5.3 9.0 12.8 14.8 7.6 6.3 7.6 6.3 8.8 4.5 6.0 9.4 15.5 1.1 4.6 59.0 5.8 1.7 1.8 2.4 8.1 3.8 5.5 4.9 21.2 36.2 2.0 6.9 14.8 7.0 10.0 2.5 8.1 1.8 1.5 13.9 10.8 5.5 2.1 7.7 11.7 1.2 1.7 15.3 6.6 2.0 18.6 30.4 6.0 12.0 2.4 18.6 15.8 7.8 6.4 5.3 19.3 4.2 11.2 2.3 5.0 7.5 8.4 7.5 5.4 5.7 4.8 1.4 3.9 4.5 5.3 4.3 19.4 11.8 5.1 8.4 4.1 10.9 9.9 17.4 5.8 11.8 8.2 3.5 3.7 0.7 9.0 10.7 5.4 20.7 5.8 11.8 0.9 2.1 0.9 0.3 1.8 1.4 4.6 1.1 1.2 1.4 59.0 1.7 2.8 0.2 0.8 2.4 13.1 13.0 12.3 13.5 13.0 10.5 10.5 9.9 9.4 7.6 3.0 18.4 11.5 30.7 43.4 16.7 2.0 0.0 2.7 13.6 47.1 15.7 1.6 6.6 30.3 16.2 12.8 1.8 0.0 22.0 5.7 31.1 50.5 4.6 0.9 5.2 36.5 12.5 17.8 24.4 16.4 33.9 23.2 37.1 3.6 4.6 11.8 24.3 2.9 56.6 1.2 8.2 19.4 37.7 13.0 19.4 47.6 2.4 10.1 4.3 39.4 RNF32 "FKSG33, HSD15, LMBR2" ENSG00000105982 "Ring finger protein 32" Q9H0A6 7 156640281-156677130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 55.2" "Group enriched" "Detected in many" 4 "Early spermatids: 227.1;Late spermatids: 367.1;Spermatocytes: 116.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 10.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 11.3;HDLM-2: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019516, HPA073560" Enhanced Supported "Nuclear bodies,Cytosol" NA NA Cytosol "Nuclear bodies" "HPA019516: , HPA073560: AB_2686616" "unprognostic (9.23e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.85e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "unprognostic (5.73e-3)" "unprognostic (1.71e-2)" "unprognostic (8.72e-3)" "unprognostic (6.08e-4)" "unprognostic (4.64e-2)" "unprognostic (2.06e-1)" "unprognostic (8.15e-3)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (3.81e-3)" "unprognostic (1.44e-1)" 1.1 1.0 2.2 0.8 2.6 0.9 0.8 1.0 2.2 0.6 1.2 4.7 0.8 1.0 0.6 7.7 0.6 2.2 1.6 0.4 2.0 1.9 1.5 0.8 1.0 1.2 1.8 2.2 1.8 2.6 0.8 2.6 0.9 2.0 1.5 1.0 0.7 1.4 0.6 0.6 1.4 0.9 0.1 2.8 0.8 1.9 55.2 1.9 1.1 1.7 0.0 0.9 0.6 0.6 3.7 3.5 10.5 0.6 0.6 2.8 0.9 4.2 2.2 0.4 1.1 1.0 0.6 0.6 0.7 0.1 1.1 0.9 11.3 4.9 6.9 5.4 0.7 1.2 0.1 0.0 0.2 2.2 12.5 2.9 0.6 0.8 0.4 1.0 1.9 4.0 1.7 0.8 0.6 2.3 0.7 0.5 6.1 9.9 1.9 3.4 7.4 2.7 4.8 2.4 7.1 5.5 2.7 0.1 3.1 1.6 1.4 7.1 5.5 4.2 0.4 2.1 1.1 1.2 1.4 1.8 0.0 0.1 0.9 0.5 10.1 4.3 3.9 0.8 4.5 1.7 10.5 0.5 1.8 0.6 0.3 2.2 3.7 2.3 0.6 1.4 2.6 0.6 0.7 0.1 0.6 0.6 3.5 2.8 0.9 2.2 2.6 1.0 2.2 2.0 1.9 1.8 2.2 2.0 1.9 6.0 1.6 0.5 1.9 0.2 2.3 1.2 5.1 54.9 7.9 3.5 0.0 0.0 5.0 1.8 227.1 0.1 2.1 0.0 2.9 0.4 0.6 1.8 5.7 2.1 0.3 1.6 4.1 1.3 0.0 367.1 6.1 1.1 1.7 0.0 2.9 2.7 2.3 0.0 3.9 4.1 2.0 0.0 0.5 116.1 17.9 0.5 0.1 0.0 2.1 0.8 RNF39 "HZFw1, LIRF" ENSG00000204618 "Ring finger protein 39" Q9H2S5 6 30070266-30075887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.3;skin 1: 26.4" "Group enriched" "Detected in many" 4 "Basal glandular cells: 43.3;Glandular cells: 56.0;Urothelial cells: 159.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "OE19: 8.8;U-266/84: 6.7" "Group enriched" "Detected in some" 4 "cerebral cortex: 8.0;hippocampal formation: 4.2" "Group enriched" "Detected in some" 5 "cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7" "CAB019278, HPA047115" Uncertain Approved "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "CAB019278: , HPA047115: AB_2679938" "unprognostic (1.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.53e-2)" "unprognostic (5.72e-3)" "unprognostic (3.08e-2)" "unprognostic (4.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.22e-2)" "unprognostic (1.59e-2)" "unprognostic (4.45e-3)" "unprognostic (3.61e-2)" "unprognostic (2.06e-4)" "unprognostic (5.61e-2)" "unprognostic (1.31e-1)" "unprognostic (2.04e-1)" "unprognostic (2.57e-2)" 0.3 0.2 0.1 0.3 0.3 0.4 5.1 0.3 0.9 7.3 0.7 0.0 1.1 0.9 0.8 0.3 28.3 0.8 1.1 0.2 0.2 0.1 0.3 0.3 3.6 0.3 0.2 0.0 0.6 2.3 0.4 0.4 9.7 0.3 8.1 0.4 0.6 10.2 0.6 0.4 26.4 0.4 1.0 0.2 0.2 4.3 0.8 0.0 0.3 0.4 10.1 11.7 7.8 12.4 0.0 0.0 1.3 0.0 0.2 0.0 0.0 2.4 0.0 0.6 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 1.4 0.0 1.2 0.0 0.4 2.2 1.0 0.2 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.1 1.4 0.0 1.8 0.6 0.5 0.0 0.8 0.0 1.1 0.0 8.8 0.0 0.3 0.3 0.0 1.6 0.3 0.2 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.4 0.5 0.0 0.2 1.6 6.7 0.6 0.5 0.1 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.2 0.1 0.2 0.0 0.3 0.0 3.0 2.4 0.0 43.3 15.9 0.5 0.3 5.1 1.4 3.4 0.0 0.0 0.0 0.0 5.5 0.4 0.0 0.4 0.0 2.9 0.0 0.4 56.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 1.0 1.7 0.0 14.8 0.0 1.1 0.0 0.5 0.0 0.9 0.0 0.2 20.8 0.6 0.0 0.5 159.5 RNFT1 PTD016 ENSG00000189050 "Ring finger protein, transmembrane 1" Q5M7Z0 17 59952240-59964761 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.5" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 175.4;Spermatocytes: 283.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013739 Approved Nucleoli NA NA Nucleoli "HPA013739: AB_1856382" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "prognostic favorable (6.57e-4)" "unprognostic (3.04e-2)" "unprognostic (6.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "prognostic favorable (7.48e-4)" "unprognostic (5.42e-2)" "unprognostic (3.45e-1)" "unprognostic (8.26e-3)" "unprognostic (9.44e-3)" "unprognostic (1.19e-3)" "unprognostic (1.44e-2)" "unprognostic (2.05e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.60e-1)" 7.9 6.2 2.8 5.3 4.3 3.8 4.2 5.1 3.7 3.1 4.0 2.4 3.7 5.3 2.7 8.1 4.6 3.2 3.1 4.1 3.1 2.2 4.7 12.0 5.0 4.4 2.9 3.1 3.5 7.5 4.7 6.1 4.4 3.4 4.5 4.8 4.2 5.1 3.0 6.7 2.7 7.6 3.0 3.4 4.1 3.9 45.5 3.0 5.9 6.1 4.3 6.0 5.1 3.7 9.5 10.1 20.2 17.1 8.9 7.7 7.9 4.8 2.2 2.3 3.1 7.6 5.7 4.5 6.2 3.3 4.9 6.0 6.9 1.9 7.2 10.4 5.2 11.1 5.6 7.3 4.7 8.5 6.8 7.9 6.1 5.8 6.2 5.7 9.4 9.4 6.3 2.5 4.6 2.0 2.5 4.9 1.7 17.4 4.5 4.1 6.3 3.8 4.5 0.9 6.6 5.1 5.2 17.5 4.2 3.9 3.5 1.4 2.7 8.9 2.2 12.4 3.2 10.3 17.9 3.5 9.5 8.4 5.5 5.3 6.5 18.1 4.3 6.6 5.3 4.7 17.3 11.8 20.2 5.6 13.9 7.7 9.5 5.2 6.3 10.1 6.1 6.8 6.1 5.7 8.9 17.1 6.7 6.5 7.9 2.8 4.3 5.1 3.7 3.1 2.2 2.9 3.1 3.4 3.0 0.0 6.1 15.9 13.3 10.1 7.7 5.6 2.5 16.0 6.8 8.7 19.6 29.6 5.0 12.0 175.4 7.8 14.4 0.0 12.5 30.4 15.3 14.5 18.5 27.2 40.4 17.5 4.1 11.6 25.1 60.1 8.3 27.8 16.9 36.9 7.6 4.5 12.5 19.3 11.0 8.6 6.8 19.4 8.6 283.8 42.4 8.4 24.1 16.0 10.1 7.2 RNFT2 "FLJ14627, TMEM118" ENSG00000135119 "Ring finger protein, transmembrane 2" Q96EX2 12 116738178-116853631 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.0" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.3;Cone photoreceptor cells: 15.7;Early spermatids: 40.0;Late spermatids: 40.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064161 Enhanced Approved Nucleoplasm,Cytosol No No Nucleoplasm Cytosol "HPA064161: AB_2685202" "unprognostic (1.56e-1)" "unprognostic (1.79e-2)" "unprognostic (1.54e-1)" "unprognostic (3.59e-1)" "unprognostic (3.98e-1)" "unprognostic (3.10e-2)" "unprognostic (8.14e-5)" "unprognostic (8.62e-2)" "unprognostic (6.28e-3)" "unprognostic (2.58e-1)" "unprognostic (9.25e-3)" "unprognostic (2.75e-1)" "unprognostic (7.61e-3)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.36e-3)" "unprognostic (4.01e-4)" 1.7 3.2 8.8 2.6 15.1 3.5 1.4 13.6 21.0 1.5 1.6 6.6 0.0 2.0 1.5 4.3 1.5 1.5 1.6 1.4 9.9 12.1 2.0 1.0 1.5 4.1 9.7 9.8 1.7 1.4 2.6 7.5 2.9 19.0 1.2 1.7 3.6 2.6 1.2 2.1 2.7 1.8 1.4 6.2 2.9 1.9 7.0 3.4 2.5 2.1 0.0 4.4 1.2 0.4 4.3 2.2 4.0 1.1 2.8 3.1 0.9 1.5 9.2 4.8 15.6 0.2 0.0 8.0 0.6 0.7 1.9 1.7 3.6 1.8 8.1 2.3 0.1 2.4 1.9 10.2 0.7 1.9 7.6 5.1 1.5 7.4 4.9 2.1 0.6 4.7 0.2 0.2 3.2 1.0 1.6 0.3 5.7 6.2 2.9 0.2 7.8 7.8 1.9 4.8 2.0 1.8 5.1 2.7 4.1 3.7 1.9 7.4 6.7 2.3 1.2 2.2 3.3 7.3 1.8 0.5 1.3 5.3 3.1 3.1 3.7 12.2 8.4 5.9 0.8 1.0 4.0 1.1 1.3 2.0 0.7 0.6 4.3 1.8 1.4 0.6 3.3 2.9 3.1 3.4 2.8 0.8 2.2 1.1 0.9 8.8 15.1 13.6 20.9 9.9 12.1 9.7 9.8 19.0 3.4 0.0 0.3 0.0 0.2 0.0 15.3 0.8 2.5 1.4 0.0 7.0 15.7 2.7 0.0 0.8 40.0 2.1 0.4 0.0 0.2 2.3 0.6 0.3 0.0 0.0 1.8 9.5 4.1 0.0 2.2 40.6 0.6 1.0 1.7 1.0 0.4 6.9 0.7 0.0 1.4 0.8 8.9 0.0 0.4 2.6 3.6 0.0 1.4 0.0 0.6 0.1 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.1" "Group enriched" "Detected in many" 4 "Bipolar cells: 34.7;Horizontal cells: 49.3" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 15.2;HEL: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013371 Approved Approved "Nucleoplasm,Centriolar satellite" NA NA 660000 "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391" "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 1.1 3.3 6.4 0.8 13.8 0.3 1.1 19.0 26.1 3.6 1.3 2.2 0.0 0.9 2.9 0.8 6.2 0.4 3.1 1.0 6.3 6.5 2.5 1.8 12.3 1.8 9.6 5.5 9.4 2.2 6.8 2.1 6.4 9.9 1.9 0.8 4.8 2.1 7.8 0.4 3.0 1.2 1.9 7.8 3.6 1.1 4.5 3.6 3.6 0.4 4.2 3.0 2.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.0 4.3 0.0 0.1 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 5.0 41.7 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.6 4.7 0.0 0.0 0.5 2.7 6.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 13.8 19.0 11.3 6.3 6.5 9.6 5.5 9.9 3.6 0.0 0.3 0.0 1.5 1.5 34.7 1.9 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.1 7.6 0.0 0.0 0.0 0.1 49.3 0.0 4.3 0.0 1.7 2.8 0.0 0.0 0.0 1.4 0.9 0.3 0.0 5.6 0.0 4.4 0.0 0.8 0.2 0.7 1.0 0.1 0.0 0.0 0.1 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865386-124881470 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.1" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 42.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "AF22: 20.5" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Low region specificity" "Detected in all" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.4 1.5 1.5 0.5 1.4 1.3 1.7 0.5 3.1 0.8 0.9 0.5 0.5 1.9 1.8 20.1 0.5 2.1 0.5 1.5 1.5 0.6 0.7 0.5 1.7 0.8 1.1 1.1 7.4 0.5 0.2 0.5 1.5 1.0 1.0 0.2 1.0 1.7 0.5 2.6 0.2 2.2 4.5 0.7 3.0 0.8 1.0 0.5 0.8 1.1 0.5 0.5 0.5 1.0 0.0 1.3 1.4 0.3 0.0 0.8 0.0 0.0 0.0 20.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.8 1.1 0.0 1.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.3 0.8 0.0 1.5 1.4 0.5 2.7 1.5 0.6 1.1 1.1 1.0 0.5 0.0 5.3 0.0 13.5 2.6 0.6 2.8 0.0 0.0 5.7 12.2 0.0 0.1 0.0 6.6 0.2 10.3 1.1 0.0 0.7 0.1 7.6 6.0 9.2 0.0 1.5 0.0 3.4 4.9 2.1 0.0 12.4 8.5 3.3 1.8 0.9 42.6 1.1 2.9 7.8 0.4 1.7 0.0 4.9 3.2 5.9 0.9 0.1 1.7 2.3 5.6 ROGDI FLJ22386 ENSG00000067836 "Rogdi homolog" Q9GZN7 16 4796968-4802950 "Disease related genes, Predicted intracellular proteins" "Amelogenesis imperfecta, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4" "Cell type enhanced" "Detected in all" 6 "Bipolar cells: 179.4;Rod photoreceptor cells: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 21.6;intermediate monocyte: 15.8;myeloid DC: 17.3;non-classical monocyte: 15.0;plasmacytoid DC: 8.1" "Group enriched" "Detected in many" 8 "dendritic cells: 17.3;monocytes: 21.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041000 Uncertain NA NA "HPA041000: AB_10794077" "unprognostic (1.74e-3)" "unprognostic (1.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.95e-1)" "unprognostic (3.13e-1)" "unprognostic (3.79e-3)" "unprognostic (3.22e-2)" "unprognostic (1.21e-1)" "prognostic favorable (9.71e-4)" "unprognostic (5.24e-2)" "prognostic favorable (2.67e-5)" "unprognostic (1.71e-1)" "unprognostic (7.16e-2)" "unprognostic (2.17e-1)" "unprognostic (3.08e-2)" 6.0 9.4 17.1 7.5 23.2 30.7 4.1 23.9 34.1 3.3 10.5 45.4 4.4 22.4 4.5 3.3 8.2 5.1 9.0 13.6 21.0 14.2 10.2 13.3 8.6 4.0 22.7 17.4 3.0 12.8 5.5 12.0 4.4 26.4 10.2 4.1 12.3 14.8 7.1 27.1 4.1 14.9 4.5 20.1 8.7 18.9 4.8 21.5 1.7 2.6 4.1 5.2 6.4 4.2 0.8 17.3 2.3 21.6 1.7 1.9 9.5 4.9 5.9 1.2 12.5 2.7 0.8 14.2 4.8 0.6 1.0 0.5 3.2 6.4 3.0 5.4 5.9 0.3 9.2 3.9 4.8 1.1 2.2 5.7 2.0 10.6 7.9 4.6 3.4 2.4 0.9 2.6 3.8 2.1 5.9 5.7 2.8 2.1 1.3 5.7 23.6 4.1 13.5 3.8 3.3 6.8 9.2 10.4 11.3 7.2 6.0 19.5 7.9 19.2 12.7 2.1 3.7 12.7 7.8 9.5 2.3 6.4 16.3 2.0 6.0 8.2 1.9 2.6 11.2 0.8 2.0 21.6 2.3 0.7 15.8 1.9 0.8 1.4 1.6 17.3 0.8 1.5 1.5 1.6 1.7 15.0 8.1 1.8 9.5 17.1 23.2 23.9 34.1 21.0 14.2 22.7 17.4 26.4 21.5 17.9 5.6 7.8 22.5 4.5 179.4 48.2 20.4 12.0 10.3 26.2 104.1 39.8 33.2 20.2 23.1 13.2 35.4 23.3 14.0 60.7 8.6 15.0 5.7 15.8 56.6 23.8 49.8 25.2 27.3 30.7 6.4 25.4 11.8 48.7 24.7 72.0 14.7 20.1 18.0 66.6 130.1 6.5 13.0 6.5 24.3 5.1 25.6 8.7 21.3 15.6 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 2384.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 17.9;U-266/84: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.7 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 1.3 2.8 1.0 2.8 0.8 3.6 1.8 1.8 5.4 2.6 9.3 0.7 0.6 17.9 4.1 3.2 6.4 10.5 4.8 0.9 2.7 4.6 6.2 5.4 1.1 1.5 0.5 1.1 3.3 1.1 1.8 12.8 3.4 1.2 2.3 3.4 3.5 4.1 1.6 0.3 5.6 0.9 5.4 5.1 1.9 6.0 1.6 2.1 18.8 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 0.0 4.1 0.0 4.4 3.3 268.3 2.4 0.0 2.7 1.2 5.2 559.6 0.8 1.7 1.3 2.1 8.0 1.6 0.0 2.7 0.2 3.5 2.6 1.1 0.6 1.0 162.1 4.1 11.1 1.8 5.9 17.5 1.0 3.3 1.0 2.8 315.6 1.7 3.4 5.3 4.0 2384.7 0.0 3.4 0.9 2.7 0.9 0.6 0.0 2.9 2.0 ROPN1 "CT91, ODF6, ROPN1A, ropporin" ENSG00000065371 "Rhophilin associated tail protein 1" Q9HAT0 3 123968521-123992178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 50.7" "Group enriched" "Detected in some" 8 "Early spermatids: 1101.7;Late spermatids: 384.4" "Group enriched" "Detected in some" 33 "breast cancer: 0.8;melanoma: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 24.9" HPA052530 Supported NA NA "HPA052530: AB_2681861" "unprognostic (1.75e-5)" "unprognostic (2.24e-1)" "unprognostic (4.77e-2)" "unprognostic (7.66e-2)" "unprognostic (1.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.08e-2)" "unprognostic (8.35e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.9 0.0 0.3 0.0 0.7 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1101.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 384.4 8.1 0.0 11.8 0.0 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 88.5 4.1 0.0 0.0 0.0 0.0 0.0 ROPN1B ENSG00000114547 "Rhophilin associated tail protein 1B" Q9BZX4 3 125969144-125983454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 64.4" "Group enriched" "Detected in some" 11 "Early spermatids: 1602.2;Late spermatids: 1647.5" "Cancer enhanced" "Detected in some" "melanoma: 4.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.0;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "SK-MEL-30: 33.3;WM-115: 12.0" HPA052530 Supported NA NA "HPA052530: AB_2681861" "unprognostic (7.73e-3)" "unprognostic (1.35e-2)" "unprognostic (2.22e-3)" "unprognostic (2.76e-2)" "unprognostic (7.19e-2)" "unprognostic (3.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (1.96e-2)" "unprognostic (1.09e-2)" "unprognostic (8.18e-2)" "unprognostic (5.91e-2)" "unprognostic (5.01e-2)" "unprognostic (1.74e-2)" "unprognostic (6.89e-3)" "unprognostic (3.78e-2)" 0.2 0.0 0.4 0.2 0.8 0.0 12.1 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.5 7.7 0.2 0.0 0.2 0.6 0.2 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.8 0.4 0.3 0.2 0.0 0.2 4.7 0.2 0.2 1.8 0.2 0.2 0.2 0.2 0.0 64.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 1.2 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 1.9 0.0 0.2 0.1 0.1 0.1 1.6 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.1 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.6 0.2 0.1 0.0 33.3 0.0 0.4 0.4 0.0 0.0 0.3 0.1 0.1 3.5 0.7 0.2 0.0 0.0 12.0 0.0 0.0 0.0 0.2 0.0 0.2 0.7 1.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.1 0.4 0.8 0.2 0.5 0.2 0.3 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.1 3.3 0.0 14.9 0.0 16.0 4.5 0.0 0.0 0.2 0.0 0.2 1602.2 0.7 0.0 0.0 0.2 1.2 0.2 0.7 0.0 0.2 0.1 3.2 0.0 0.0 0.0 1647.5 17.5 0.0 141.7 0.0 0.0 0.0 0.1 0.0 9.2 0.0 0.2 19.4 0.3 130.6 7.5 0.5 0.1 0.0 0.0 1.1 ROPN1L "ASP, FLJ25776, RSPH11" ENSG00000145491 "Rhophilin associated tail protein 1 like" Q96C74 5 10441524-10472029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 37.1;testis: 128.1" "Group enriched" "Detected in many" 6 "Early spermatids: 2516.4;Late spermatids: 2496.8" "Group enriched" "Detected in many" 5 "endometrial cancer: 9.6;ovarian cancer: 3.0" "Region enhanced" "Detected in many" "pons and medulla: 7.7" "Group enriched" "Detected in many" 11 "basophil: 12.6;eosinophil: 18.3;neutrophil: 37.1" "Lineage enriched" "Detected in many" 18 "granulocytes: 37.1" "Cell line enriched" "Detected in some" 5 "NB-4: 17.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039193, HPA041830" Enhanced NA NA "HPA039193: AB_10673415, HPA041830: AB_2677695" "unprognostic (2.39e-4)" "unprognostic (1.21e-1)" "unprognostic (3.78e-3)" "unprognostic (6.84e-3)" "unprognostic (3.59e-2)" "unprognostic (2.82e-1)" "unprognostic (5.88e-2)" "unprognostic (1.04e-2)" "unprognostic (2.53e-1)" "unprognostic (8.81e-2)" "unprognostic (2.07e-3)" "unprognostic (3.13e-1)" "unprognostic (1.32e-3)" "unprognostic (7.54e-3)" "unprognostic (1.58e-2)" "unprognostic (1.73e-2)" "unprognostic (3.22e-2)" 0.3 0.1 1.2 0.3 3.5 1.9 0.2 0.1 1.0 0.9 0.2 2.8 0.0 0.2 0.6 4.9 0.2 12.6 0.3 0.4 1.9 1.4 0.5 0.2 4.4 0.9 0.2 0.9 1.9 0.6 0.1 1.8 0.2 7.7 0.2 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.3 2.5 0.1 128.1 0.5 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 37.1 0.4 0.1 2.0 0.7 0.1 0.5 0.0 0.0 0.6 0.0 0.6 0.0 0.8 0.7 0.7 0.1 0.1 0.0 2.0 0.2 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.6 0.0 0.0 0.2 0.3 0.3 0.7 0.0 0.1 0.1 0.0 0.2 0.0 17.0 0.1 0.0 0.7 0.1 0.0 0.0 1.1 0.0 0.0 0.1 1.2 0.1 0.2 0.2 0.3 0.5 0.0 0.0 1.2 2.1 0.2 0.2 0.5 0.0 2.0 2.1 0.4 12.6 0.2 18.3 1.5 0.0 1.0 0.0 1.3 1.6 0.0 0.0 0.9 1.0 37.1 0.1 0.4 0.0 2.0 0.7 1.2 3.5 0.1 1.0 1.9 1.4 0.2 0.9 7.7 0.5 3.0 1.3 0.0 0.0 0.2 0.0 0.3 0.0 327.9 37.5 0.0 0.0 0.0 0.0 0.7 2516.4 2.9 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.0 0.1 3.2 0.0 7.4 1.6 2496.8 33.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 17.3 0.8 3.1 12.9 0.2 435.5 29.6 0.1 0.1 0.0 0.0 0.0 ROR1 NTRKR1 ENSG00000185483 "Receptor tyrosine kinase like orphan receptor 1" Q01973 1 63774022-64181498 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 31.2" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 47.6;Intestinal endocrine cells: 20.6;Leydig cells: 25.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "cerebellum: 13.0" "Group enriched" "Detected in some" 5 "NK-cell: 3.3;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.1;NK-cells: 3.3" "Cell line enhanced" "Detected in many" "ASC diff: 19.8;ASC TERT1: 24.8;CACO-2: 16.9;HHSteC: 18.8;HSkMC: 20.3;NTERA-2: 20.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057016 Approved Microtubules "Intracellular and membrane" NA NA 2800000 Microtubules "HPA057016: " "unprognostic (5.15e-2)" "unprognostic (1.19e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-2)" "unprognostic (6.24e-2)" "unprognostic (1.61e-1)" "unprognostic (7.11e-3)" "unprognostic (1.41e-1)" "unprognostic (4.06e-1)" "unprognostic (3.84e-1)" "unprognostic (3.20e-2)" "unprognostic (2.02e-2)" "unprognostic (3.64e-3)" "unprognostic (1.48e-2)" "unprognostic (1.52e-1)" "unprognostic (5.87e-2)" "unprognostic (5.15e-2)" 5.5 1.7 1.3 3.5 2.7 0.4 3.4 13.0 2.8 16.7 8.8 2.2 4.4 2.0 14.2 5.0 4.9 5.5 10.7 10.6 1.3 1.1 3.6 0.8 9.7 1.1 1.0 2.4 8.3 9.8 31.2 3.6 2.9 3.0 10.9 3.9 7.9 2.8 6.3 2.1 4.5 4.1 17.8 1.1 3.1 9.2 2.7 0.9 1.8 1.5 4.6 2.1 10.2 8.8 0.4 1.1 0.1 0.1 3.3 0.1 0.0 7.1 5.6 2.8 0.4 19.8 24.8 1.9 1.4 3.9 0.8 2.0 16.9 2.3 0.1 3.2 3.3 1.4 1.5 0.0 1.3 0.5 0.0 1.8 0.0 0.7 0.2 18.8 0.0 0.0 20.3 5.2 10.4 12.2 4.0 0.3 0.2 0.0 0.1 5.2 0.1 0.1 0.0 20.6 5.2 2.8 0.1 0.1 4.4 4.1 0.1 1.6 6.6 0.4 0.1 2.9 10.0 0.0 0.0 3.9 1.6 2.9 11.0 2.9 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 3.3 0.1 1.1 0.0 0.0 1.3 2.7 13.0 2.8 1.3 1.1 1.0 2.4 3.0 0.9 47.6 8.0 0.0 1.8 3.4 1.7 8.5 2.5 1.4 2.3 1.8 0.0 0.2 0.0 5.3 7.8 1.3 0.0 0.0 13.4 0.7 7.6 1.5 0.0 0.0 5.8 0.0 20.6 1.3 0.0 4.7 25.6 0.0 3.3 0.0 2.3 4.9 10.7 0.0 13.8 2.8 0.0 6.5 12.0 0.7 1.2 4.0 0.2 0.0 2.6 0.9 RORA "NR1F1, ROR1, ROR2, ROR3, RZRA" ENSG00000069667 "RAR related orphan receptor A" P35398 15 60488284-61229319 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 64.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 428.0;Suprabasal keratinocytes: 370.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 16.9" "Cell line enhanced" "Detected in many" "Karpas-707: 35.1;U-266/70: 20.1;U-266/84: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009861 Approved NA NA "CAB009861: AB_2180141" "unprognostic (1.57e-1)" "unprognostic (4.76e-2)" "unprognostic (2.22e-1)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (2.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (9.93e-2)" "unprognostic (1.34e-1)" "prognostic favorable (5.42e-6)" "unprognostic (6.94e-2)" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.62e-2)" 8.6 32.4 8.1 6.0 9.8 12.2 12.0 29.8 17.0 7.6 6.1 4.8 11.9 2.7 7.5 6.7 14.8 5.4 8.1 6.7 8.7 4.2 11.2 23.1 10.0 5.9 7.8 7.0 8.9 11.8 11.8 10.3 4.1 10.0 5.4 3.5 9.1 7.8 12.0 34.6 64.8 6.2 7.8 11.0 7.7 5.5 11.2 9.3 1.5 11.1 9.9 8.8 8.9 10.3 0.8 0.4 0.3 0.0 3.7 16.9 2.6 0.0 0.4 1.3 0.0 1.7 0.8 0.4 0.6 0.7 0.5 0.7 0.8 0.2 0.0 0.3 1.6 1.7 0.2 2.9 1.2 1.0 1.3 2.4 0.0 0.1 1.3 0.6 0.0 0.1 3.8 0.3 1.6 0.0 0.5 5.5 5.3 0.1 35.1 2.4 0.1 0.3 0.0 1.0 0.8 0.5 0.0 1.1 0.5 1.1 0.2 0.9 2.1 0.1 0.3 0.0 3.7 0.0 0.0 0.1 4.9 2.2 2.0 0.0 20.1 27.8 0.1 8.3 0.0 0.5 0.1 0.0 0.0 14.7 0.0 16.9 0.8 11.1 9.9 0.0 0.1 3.5 7.4 0.3 3.7 0.0 0.4 9.3 2.6 8.1 9.8 29.8 17.0 8.7 4.2 7.8 7.0 10.0 9.3 38.7 31.4 12.3 26.8 164.5 162.1 20.4 28.1 16.0 22.7 55.8 428.0 0.5 11.6 15.3 133.0 32.2 1.0 23.3 10.8 1.0 44.1 23.1 2.3 75.9 0.7 119.2 17.7 31.9 6.6 58.8 43.1 8.9 57.3 1.0 2.0 48.1 11.9 0.0 82.0 34.9 155.0 38.8 31.6 1.4 2.4 370.0 3.9 142.8 1.5 50.2 RORB "NR1F2, ROR-BETA, RZRB" ENSG00000198963 "RAR related orphan receptor B" Q92753 9 74497365-74693177 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Receptor" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.5;cervix, uterine: 20.8" "Group enriched" "Detected in many" 5 "Horizontal cells: 1322.1;Muller glia cells: 409.4" "Group enriched" "Detected in some" 5 "glioma: 2.1;prostate cancer: 2.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 18.3;HSkMC: 10.1;JURKAT: 18.1;MOLT-4: 5.1;SH-SY5Y: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008393 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008393: AB_1079830" "unprognostic (6.89e-3)" "unprognostic (4.06e-3)" "unprognostic (1.38e-1)" "unprognostic (3.97e-1)" "unprognostic (1.34e-1)" "unprognostic (1.05e-3)" "unprognostic (1.28e-1)" "unprognostic (1.18e-2)" "unprognostic (1.07e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (5.46e-2)" "unprognostic (8.81e-8)" "unprognostic (5.97e-3)" "unprognostic (2.17e-2)" "unprognostic (2.26e-2)" "unprognostic (4.00e-2)" 3.1 7.9 8.3 1.2 11.1 1.0 1.4 1.8 35.5 20.8 1.3 2.1 2.2 1.1 8.9 0.9 1.7 1.5 4.5 3.9 5.6 7.0 2.0 1.0 2.0 0.9 4.1 18.7 1.4 1.1 1.1 4.0 10.6 6.1 10.5 1.6 18.7 1.2 11.7 0.9 1.3 1.1 1.7 6.7 1.0 1.6 2.0 3.7 2.2 1.5 0.0 1.5 2.3 2.2 0.2 0.2 1.8 0.2 0.6 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.3 0.0 0.5 10.1 0.0 0.0 0.0 0.0 0.0 18.1 0.0 2.8 0.0 0.1 5.1 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.4 2.5 0.0 1.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.6 1.8 0.6 0.1 0.2 0.0 0.0 8.3 11.1 1.8 35.5 5.6 7.0 4.1 18.7 6.1 3.7 0.0 3.7 0.0 0.6 1.4 160.1 11.7 0.0 1.4 0.0 0.0 113.9 0.0 0.0 0.0 5.3 0.6 0.0 0.0 0.0 0.4 5.4 2.3 1.1 0.0 0.6 1322.1 0.0 1.3 0.0 0.5 0.0 1.3 1.7 0.0 0.0 409.4 0.1 0.0 0.0 5.7 181.1 0.0 3.1 0.5 0.1 0.4 0.1 0.8 0.0 0.8 RORC "NR1F3, RORG, RZRG, TOR" ENSG00000143365 "RAR related orphan receptor C" P51449 1 151806071-151831872 "Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.8;skeletal muscle: 63.8" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 29.9;Erythroid cells: 23.3;Hepatocytes: 48.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebellum: 7.0;pons and medulla: 2.4" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 28.3" "Lineage enriched" "Detected in single" 44 "T-cells: 28.3" "Cell line enhanced" "Detected in some" "HDLM-2: 21.5;Karpas-707: 11.2;MOLT-4: 5.7;RPMI-8226: 5.9;SK-BR-3: 5.1;T-47d: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA065620 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA065620: AB_2685521" "unprognostic (6.51e-2)" "unprognostic (7.78e-2)" "prognostic favorable (1.83e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-4)" "unprognostic (6.29e-5)" "unprognostic (1.13e-3)" "unprognostic (8.94e-2)" "unprognostic (1.67e-1)" "unprognostic (7.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.94e-5)" "unprognostic (2.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.80e-2)" 1.3 1.6 0.4 3.4 0.9 0.0 3.3 7.0 0.3 2.7 10.0 0.7 19.8 4.2 1.2 6.7 3.4 8.7 3.5 4.8 0.4 0.5 13.3 30.8 8.7 0.7 0.9 0.3 1.3 30.3 8.5 9.4 0.2 2.4 7.0 4.0 2.8 27.8 33.4 63.8 9.8 10.3 0.8 0.3 0.7 7.7 6.4 1.1 69.8 15.6 11.1 4.0 2.4 1.7 0.0 0.1 0.0 0.0 0.6 28.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 21.5 0.0 0.0 2.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 11.2 0.0 0.1 5.7 0.0 0.0 0.1 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.2 0.1 5.1 0.0 0.0 9.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.9 0.0 28.3 0.0 4.4 4.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 3.0 0.6 0.4 0.9 7.0 0.3 0.4 0.5 0.9 0.3 2.4 1.1 6.0 5.9 0.8 4.5 1.8 0.0 5.3 10.2 6.7 1.2 15.7 0.0 0.0 29.9 5.0 0.3 0.3 15.8 23.3 6.2 0.0 0.2 7.1 0.0 48.2 0.1 0.0 9.2 0.6 2.7 0.4 0.6 0.7 3.3 0.0 17.3 0.0 4.0 17.5 0.4 13.9 0.0 0.0 0.3 0.0 0.0 2.6 0.0 0.0 13.9 2.7 ROS1 "c-ros-1, MCF3, ROS" ENSG00000047936 "ROS proto-oncogene 1, receptor tyrosine kinase" P08922 6 117288300-117425855 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 38.6;lung: 20.2" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7" "Cancer enriched" "Detected in some" 13 "lung cancer: 6.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 7.4;olfactory region: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049098, HPA072424" Uncertain Approved Vesicles NA NA Vesicles "HPA049098: AB_2680628, HPA072424: AB_2686519" "unprognostic (8.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (7.57e-2)" "unprognostic (2.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (2.79e-2)" "unprognostic (1.00e-2)" "unprognostic (2.42e-1)" "unprognostic (5.20e-2)" "unprognostic (1.56e-12)" "unprognostic (1.09e-2)" "unprognostic (2.81e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" 0.3 0.2 0.2 0.0 0.4 0.0 0.2 0.2 7.4 0.2 0.4 0.0 7.9 0.0 0.2 38.6 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 20.2 0.0 0.2 2.5 0.2 0.2 0.0 0.3 0.7 0.0 0.2 0.3 0.0 0.2 2.3 0.2 0.7 0.3 0.0 0.2 0.2 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 8.7 18.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.6 0.0 2.2 1.4 0.1 1.7 0.0 0.0 0.0 1.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 7.4 0.2 0.2 0.2 2.5 0.0 0.0 14.9 56.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RP1 "DCDC4A, ORP1" ENSG00000104237 "RP1, axonemal microtubule associated" P56715 8 54509422-54871720 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 15.4;lung: 28.7;retina: 49.2" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 212.8;Cone photoreceptor cells: 314.2;Rod photoreceptor cells: 1078.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;HDLM-2: 7.1;hTERT-RPE1: 2.8;RPTEC TERT1: 14.5;U-2197: 3.3" "Not detected" "Not detected" HPA042257 Enhanced NA NA "HPA042257: AB_10797385" "unprognostic (3.19e-3)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.70e-1)" "unprognostic (9.16e-3)" "unprognostic (6.24e-2)" "unprognostic (4.56e-2)" "unprognostic (4.13e-5)" "unprognostic (2.48e-1)" "unprognostic (2.16e-5)" "unprognostic (8.92e-2)" "unprognostic (6.18e-2)" "unprognostic (1.89e-2)" "unprognostic (8.96e-2)" 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.4 0.3 0.1 15.4 0.0 0.1 0.1 0.1 3.6 0.1 28.7 0.0 0.1 0.0 3.9 0.1 0.0 0.6 0.3 0.1 0.1 0.0 49.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.3 0.6 1.7 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 2.3 0.0 0.2 0.0 1.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 14.9 3.7 0.0 0.0 0.0 59.5 0.4 0.0 212.8 55.7 5.2 314.2 0.0 3.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 83.8 0.2 0.0 0.0 0.2 1078.1 0.0 0.0 3.4 1.6 0.0 0.0 0.0 0.0 0.1 RP1L1 DCDC4B ENSG00000183638 "RP1 like 1" 8 10606349-10712187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 34.0" "Group enriched" "Detected in some" 22 "Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 62.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;TIME: 2.0;U-2 OS: 1.4" "HPA024686, HPA024744" Enhanced NA NA "HPA024686: AB_2671650, HPA024744: AB_2671668" "unprognostic (3.27e-1)" "unprognostic (9.97e-2)" "unprognostic (1.24e-1)" "unprognostic (6.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-5)" "unprognostic (3.57e-1)" "unprognostic (5.22e-2)" "unprognostic (2.08e-4)" "unprognostic (8.52e-2)" "unprognostic (5.77e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.82e-1)" 0.5 0.5 0.1 0.1 0.1 1.6 0.5 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.4 0.1 0.6 0.2 0.3 0.4 0.1 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.2 0.0 1.7 0.7 0.1 0.2 0.1 34.0 0.5 0.1 0.3 2.0 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.9 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.5 0.0 0.9 0.0 0.8 0.0 0.7 0.2 0.0 0.1 0.2 0.6 0.8 0.2 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.1 0.3 0.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.6 3.5 0.8 0.0 0.0 0.0 0.0 88.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.4 0.0 62.2 0.0 0.4 0.0 0.7 0.6 0.0 0.0 0.0 0.6 RPA4 HSU24186 ENSG00000204086 "Replication protein A4" Q13156 X 96883908-96885467 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.2" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 6.5;Spermatocytes: 7.6;Syncytiotrophoblasts: 8.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 3.0;HL-60: 3.0" HPA066010 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066010: AB_2685596" "unprognostic (6.23e-2)" "unprognostic (2.55e-2)" "unprognostic (1.17e-1)" "unprognostic (6.66e-6)" "unprognostic (1.33e-1)" "unprognostic (6.33e-2)" "unprognostic (9.75e-4)" "unprognostic (3.15e-1)" "unprognostic (7.61e-3)" "unprognostic (2.59e-3)" "unprognostic (1.55e-1)" "unprognostic (2.62e-1)" "unprognostic (2.47e-12)" "unprognostic (8.95e-3)" "unprognostic (6.05e-3)" "unprognostic (8.17e-2)" "unprognostic (4.59e-2)" 0.9 0.1 0.0 0.3 0.1 1.0 0.4 0.0 0.1 0.5 0.2 0.4 0.1 0.2 0.3 0.0 0.3 0.6 0.0 0.0 0.1 1.1 0.8 0.2 0.0 0.6 0.1 0.0 0.0 0.8 0.4 0.6 0.4 0.2 0.4 0.3 0.1 0.2 0.1 0.1 0.2 5.2 0.2 0.2 0.4 0.8 1.3 1.4 2.5 2.3 0.0 2.1 0.1 0.0 0.7 0.1 1.1 0.0 0.3 0.0 0.8 0.0 0.4 0.8 1.3 0.3 1.6 0.3 0.6 2.5 0.0 2.4 0.1 0.7 0.0 1.0 0.0 3.0 0.1 0.1 3.0 0.8 0.2 0.1 2.0 0.9 0.0 0.1 1.2 0.0 2.4 2.1 0.4 1.0 1.6 1.1 0.0 1.1 0.0 0.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.5 0.4 0.0 0.0 0.7 1.4 0.6 0.6 0.5 0.1 0.0 1.0 0.5 1.8 1.0 0.0 2.3 2.5 1.8 0.9 2.1 1.0 0.4 0.4 0.6 1.3 0.3 0.5 1.4 0.0 1.8 1.4 1.3 0.1 0.0 3.5 0.0 0.1 0.7 0.4 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.0 0.7 0.8 1.6 1.3 0.0 0.5 0.9 0.9 0.4 0.0 1.9 1.7 0.0 3.5 0.0 2.4 0.4 1.4 0.4 0.0 0.0 2.2 0.2 0.9 3.5 1.4 0.0 1.2 6.5 0.2 7.6 2.5 1.1 8.2 0.0 2.0 0.1 RPE65 "BCO3, LCA2, rd12, RP20" ENSG00000116745 "RPE65, retinoid isomerohydrolase" Q16518 1 68428822-68449959 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" "Hydrolase, Isomerase" "Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "retina: 268.3" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 17.3" "Group enriched" "Detected in some" 10 "glioma: 5.8;head and neck cancer: 1.5" "Group enriched" "Detected in many" 5 "hypothalamus: 6.0;midbrain: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.2;PC-3: 10.6;U-2 OS: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.59e-1)" "unprognostic (1.88e-1)" "unprognostic (3.15e-1)" "prognostic favorable (9.75e-4)" "unprognostic (4.55e-2)" "unprognostic (5.91e-2)" "unprognostic (6.59e-4)" "unprognostic (2.98e-2)" "unprognostic (1.57e-1)" "unprognostic (8.24e-2)" "unprognostic (3.21e-4)" "unprognostic (2.11e-1)" "unprognostic (2.05e-1)" "unprognostic (3.48e-2)" "unprognostic (8.40e-3)" 0.0 0.0 0.9 0.1 0.7 0.0 1.0 0.1 3.8 0.2 0.1 1.3 1.4 0.4 1.4 0.7 0.8 0.6 0.2 0.0 1.5 6.0 0.0 0.0 0.0 0.1 8.8 0.1 0.1 0.0 0.0 0.0 0.0 1.2 4.2 0.2 268.3 0.2 10.5 0.0 0.0 0.1 0.5 1.4 0.2 0.6 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.6 1.5 6.0 8.8 0.1 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 17.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 RPEL1 ENSG00000235376 "Ribulose-5-phosphate-3-epimerase like 1" Q2QD12 10 103245887-103248016 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.4;brain: 1.2;pituitary gland: 1.2" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;NB-4: 1.1" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (7.52e-2)" "unprognostic (1.69e-1)" "unprognostic (4.78e-2)" "unprognostic (1.54e-1)" "unprognostic (1.45e-1)" "unprognostic (1.83e-1)" "unprognostic (6.01e-2)" "unprognostic (1.15e-1)" "unprognostic (8.91e-2)" "unprognostic (6.59e-2)" "unprognostic (4.34e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (1.62e-1)" "unprognostic (6.72e-2)" "unprognostic (5.06e-2)" 0.0 0.1 0.1 1.0 0.3 0.1 0.1 1.2 0.2 0.0 0.0 0.3 0.4 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.8 0.0 1.2 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.4 1.0 0.3 0.7 1.4 0.6 0.2 0.5 0.5 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.4 0.7 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.3 1.1 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.2 1.1 0.7 0.2 0.0 0.0 0.1 0.3 0.5 0.2 0.3 0.1 0.3 0.4 0.2 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.2 0.3 0.1 0.3 0.7 0.4 0.1 0.3 0.7 0.2 0.5 0.7 0.5 0.4 0.4 0.3 1.0 0.4 0.5 0.6 0.0 1.4 0.4 0.3 0.4 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.5 0.0 0.0 1.2 0.0 7.9 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.2 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.2 0.3 0.3 0.0 0.7 0.0 RPGR "COD1, CORDX1, CRD, RP15, RP3" ENSG00000156313 "Retinitis pigmentosa GTPase regulator" Q92834 X 38269163-38327564 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Guanine-nucleotide releasing factor" "Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 55.4" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 156.6;Ito cells: 86.5;Rod photoreceptor cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.3" "Cell line enhanced" "Detected in many" "HL-60: 22.9" "HPA001593, HPA073455" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA001593: AB_1079835, HPA073455: AB_2686603" "unprognostic (3.22e-2)" "unprognostic (1.16e-2)" "unprognostic (5.04e-2)" "unprognostic (1.08e-1)" "unprognostic (3.20e-1)" "unprognostic (9.94e-2)" "unprognostic (3.46e-2)" "unprognostic (6.32e-2)" "unprognostic (2.04e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-6)" "unprognostic (1.93e-1)" "unprognostic (7.59e-2)" "unprognostic (8.96e-3)" "unprognostic (1.61e-3)" 16.4 5.9 6.1 7.1 9.0 17.4 13.8 7.2 7.0 8.3 8.4 7.1 2.5 5.1 8.8 9.4 5.4 20.8 9.4 6.3 7.2 9.4 4.9 4.9 10.7 7.8 8.9 4.2 7.9 7.2 3.8 55.4 6.3 14.6 5.9 6.4 6.3 3.7 4.8 13.3 4.3 6.2 8.3 9.9 5.1 4.9 11.6 5.7 5.8 8.3 3.6 5.4 7.7 10.9 1.9 2.6 15.3 2.6 1.6 3.1 1.7 3.3 4.5 2.6 2.4 2.9 4.2 2.0 4.3 5.0 3.2 3.7 2.0 1.7 5.0 1.5 2.8 2.5 3.3 3.0 1.4 4.3 5.3 5.6 1.8 2.1 4.0 2.7 22.9 4.4 6.0 1.8 6.3 7.2 1.2 14.3 5.6 2.3 0.0 4.3 1.3 6.7 12.9 6.6 2.0 5.7 4.9 8.7 4.7 2.8 2.3 1.9 3.8 4.7 1.9 5.1 4.2 1.3 3.9 16.7 3.5 6.1 8.2 5.1 1.5 2.7 4.4 8.1 4.5 4.6 1.4 2.6 5.7 1.4 2.3 3.1 1.9 1.7 1.8 2.6 1.8 2.5 2.0 15.3 1.6 1.8 1.8 1.9 1.7 6.1 9.0 7.2 7.0 7.2 9.4 8.9 4.2 14.6 5.7 14.9 31.2 9.5 11.0 7.0 26.2 6.9 5.1 156.6 26.1 1.8 58.9 4.9 3.3 12.1 36.9 67.6 7.8 0.0 7.4 6.2 8.1 11.2 19.7 8.2 6.8 33.4 16.7 86.5 16.2 4.2 7.2 11.0 5.0 5.4 11.3 13.0 9.1 8.6 4.2 2.2 89.0 0.0 7.5 22.8 22.7 5.1 6.9 13.8 8.8 9.4 RPGRIP1 "CORD13, LCA6, RGI1, RPGRIP" ENSG00000092200 "RPGR interacting protein 1" Q96KN7 14 21287939-21351301 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Cone-rod dystrophy, Disease mutation, Glaucoma, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "blood: 10.8;testis: 34.8" "Group enriched" "Detected in some" 15 "Cone photoreceptor cells: 217.9;Early spermatids: 139.5;Late spermatids: 75.5;Rod photoreceptor cells: 123.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 10.8" "Group enriched" "Detected in many" 11 "dendritic cells: 4.1;granulocytes: 10.8;monocytes: 4.4" "Cell line enhanced" "Detected in many" "RT4: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042955, HPA060190" Supported Supported NA NA "HPA042955: AB_2678239, HPA060190: AB_2684218" "unprognostic (9.02e-4)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" "unprognostic (1.86e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (2.92e-1)" "unprognostic (1.99e-1)" "unprognostic (3.94e-3)" "unprognostic (2.33e-1)" "unprognostic (7.31e-3)" "unprognostic (2.86e-2)" "unprognostic (2.87e-1)" "unprognostic (3.13e-1)" "unprognostic (1.83e-2)" 0.1 0.0 0.1 0.2 0.1 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.8 0.0 34.8 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 4.1 10.8 4.4 0.5 0.2 1.3 0.6 1.8 2.0 0.9 0.0 0.0 2.5 0.7 0.0 0.0 0.9 1.3 1.2 2.5 0.6 0.0 1.0 0.5 0.7 0.0 0.0 0.8 1.1 1.4 1.8 0.5 0.1 2.1 0.7 1.0 0.0 0.0 0.0 1.1 0.0 1.9 1.6 0.3 0.0 0.8 0.8 1.2 3.1 1.2 0.7 0.9 1.6 1.9 0.0 8.7 1.5 1.3 1.6 2.0 0.4 1.5 0.7 1.1 0.7 0.6 0.5 1.8 1.4 2.1 2.0 2.5 0.9 1.3 0.6 2.0 4.4 0.1 0.1 2.0 0.1 0.1 0.1 0.0 4.1 0.2 0.2 0.0 10.8 0.5 0.1 0.0 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 1.6 0.0 0.0 0.0 0.8 0.7 0.0 1.4 0.0 0.0 217.9 0.8 0.0 0.0 139.5 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.7 0.0 0.0 0.6 1.3 75.5 1.7 0.9 0.0 0.0 0.0 3.8 0.0 0.0 0.4 0.0 123.4 0.0 0.0 9.3 2.0 0.1 1.3 0.0 0.0 0.1 RPGRIP1L "CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134" ENSG00000103494 "RPGRIP1 like" Q68CZ1 16 53598153-53703938 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 109.7;Spermatocytes: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039405, HPA040530" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039405: AB_10794636, HPA040530: AB_2677023" "prognostic unfavorable (6.93e-4)" "unprognostic (1.52e-1)" "unprognostic (2.19e-3)" "unprognostic (2.26e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-4)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (5.22e-3)" "unprognostic (1.52e-1)" "unprognostic (4.92e-4)" "unprognostic (5.95e-2)" 3.0 6.5 8.0 3.8 13.8 2.7 6.1 5.3 12.7 6.3 3.3 2.4 6.8 2.4 7.3 7.8 3.9 11.7 4.9 3.3 9.1 9.9 5.5 2.2 3.5 3.1 5.9 13.2 6.5 3.2 18.5 25.8 3.8 9.0 5.2 3.5 1.7 3.4 5.3 2.3 3.6 2.0 6.3 3.5 1.9 3.5 20.9 4.7 3.1 7.6 2.3 3.1 4.4 3.6 4.9 2.0 1.8 1.0 2.1 5.6 1.3 9.1 11.3 10.2 9.4 12.3 12.0 4.5 10.2 6.7 9.5 2.7 6.2 7.4 6.1 7.4 10.4 6.4 10.6 8.5 9.7 16.9 3.7 5.9 2.2 9.6 6.2 5.1 5.5 4.2 7.5 6.0 10.6 6.6 10.4 7.1 8.5 5.6 3.5 14.0 3.5 9.0 3.9 6.5 3.2 5.4 15.4 14.0 7.3 12.3 2.4 17.8 6.7 12.6 5.3 4.6 6.5 8.0 4.4 6.4 10.4 7.4 8.5 9.0 4.6 5.3 10.8 15.7 3.3 6.1 1.7 0.9 1.1 3.6 1.0 3.5 3.2 2.6 3.3 0.8 4.9 2.6 5.6 1.8 2.1 1.0 2.0 2.1 1.3 8.0 13.8 5.3 12.7 9.1 9.9 5.9 13.2 9.0 4.7 6.0 3.7 3.2 2.8 4.0 5.1 7.3 0.0 109.7 19.4 10.4 7.9 4.6 14.9 6.5 13.1 2.5 0.1 0.0 2.7 6.2 9.3 1.4 6.9 3.8 2.4 3.2 0.0 3.7 1.2 9.0 4.4 2.8 1.7 2.8 3.8 6.1 3.5 0.0 6.0 14.2 8.4 6.5 4.1 38.1 11.0 4.6 1.4 1.0 3.8 2.1 RPH3A "exophilin-1, KIAA0985, rabphilin" ENSG00000089169 "Rabphilin 3A" Q9Y2J0 12 112570380-112898881 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.9;brain: 51.2" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 24.2;Early spermatids: 11.6;Late spermatids: 4.9" "Cancer enriched" "Detected in some" 5 "glioma: 4.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 8.3;SH-SY5Y: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002475 Enhanced NA NA "HPA002475: AB_1079837" "unprognostic (5.50e-2)" "unprognostic (3.19e-1)" "unprognostic (3.72e-3)" "unprognostic (5.90e-2)" "unprognostic (7.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (3.73e-2)" "unprognostic (1.42e-1)" "unprognostic (5.85e-2)" "unprognostic (3.92e-2)" "unprognostic (2.08e-2)" "unprognostic (2.70e-2)" "unprognostic (7.46e-2)" 0.9 3.5 15.5 1.6 27.4 15.9 1.2 32.9 51.2 0.7 1.2 3.6 0.0 1.2 1.6 2.7 1.3 1.1 2.2 1.0 14.0 13.2 1.0 1.2 1.0 3.2 6.4 19.9 1.4 2.5 0.9 0.2 1.5 9.9 1.2 1.6 0.2 1.3 0.9 1.0 2.5 1.4 1.6 5.0 1.9 1.0 1.6 5.9 0.0 1.8 0.0 2.1 1.7 0.2 1.8 0.9 3.5 9.2 0.9 0.8 2.3 0.9 0.9 0.9 1.6 0.3 0.6 2.7 0.0 0.5 0.5 0.0 0.7 1.3 1.3 0.5 0.0 0.7 2.4 0.4 0.6 1.2 0.4 1.4 2.3 3.3 2.2 0.5 1.4 2.2 0.6 0.2 1.5 1.7 0.8 0.0 0.5 0.1 3.5 2.0 1.4 0.6 1.7 1.4 0.2 1.3 0.0 1.0 8.3 0.0 1.9 1.6 19.1 0.2 0.1 0.1 1.9 0.8 0.1 0.1 1.8 1.4 1.8 1.0 1.7 0.3 1.3 1.2 0.8 0.6 1.3 9.2 0.5 0.7 4.2 0.4 0.8 0.4 0.6 0.9 1.8 0.5 0.8 3.5 0.9 5.7 0.5 0.1 2.3 15.5 27.4 32.9 51.2 14.0 13.2 6.4 19.9 9.9 5.9 0.0 0.0 0.0 0.0 0.0 24.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 4.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 RPH3AL Noc2 ENSG00000181031 "Rabphilin 3A like (without C2 domains)" Q9UNE2 17 212389-386254 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 58.9" "Cell type enhanced" "Detected in many" 5 "Intestinal endocrine cells: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 20.8;PC-3: 6.8;TIME: 6.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA024311 Approved NA NA "HPA024311: AB_1856429" "unprognostic (4.55e-2)" "unprognostic (1.66e-1)" "unprognostic (3.85e-2)" "unprognostic (9.43e-3)" "unprognostic (8.40e-2)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (6.71e-2)" "unprognostic (1.02e-1)" "unprognostic (2.24e-3)" "unprognostic (1.33e-2)" "prognostic favorable (1.03e-8)" "unprognostic (9.10e-2)" "unprognostic (1.63e-2)" "unprognostic (4.14e-1)" "unprognostic (3.59e-3)" 10.2 8.4 0.5 4.1 0.8 0.2 12.3 2.1 1.7 2.4 7.9 0.7 2.9 4.9 1.8 4.7 5.8 2.6 4.7 1.6 0.6 1.3 9.4 11.2 8.8 1.1 1.0 1.0 5.0 27.5 1.2 58.9 3.8 4.9 4.0 2.6 3.7 1.3 2.4 7.5 1.7 6.5 2.8 2.6 7.8 5.1 1.1 0.9 0.4 14.8 5.3 4.2 3.1 7.6 1.6 6.2 3.4 5.0 0.7 1.9 0.8 0.3 20.8 0.3 0.1 0.2 0.1 1.8 0.1 0.0 0.0 0.1 2.8 3.7 0.4 3.0 2.0 1.4 0.3 0.8 0.2 0.0 0.9 1.3 0.0 1.7 4.5 0.6 0.2 2.3 0.0 0.1 0.0 0.0 0.7 0.8 2.3 1.4 4.4 1.3 4.8 0.3 0.1 1.2 2.4 6.8 0.4 0.2 3.8 4.0 4.7 0.3 0.7 0.3 0.1 0.3 1.5 2.0 2.0 6.9 0.3 3.2 0.5 0.6 0.7 0.2 0.2 0.3 2.9 0.1 1.0 1.6 3.3 1.9 5.0 0.9 1.4 1.1 1.6 2.6 1.6 1.7 0.9 3.4 0.7 3.4 6.2 0.8 0.8 0.5 0.8 2.1 1.7 0.6 1.3 1.0 1.0 4.9 0.9 20.8 14.2 2.9 11.9 2.2 0.8 1.7 15.3 1.4 4.5 21.0 0.0 0.1 5.0 8.4 2.7 10.8 10.2 0.0 7.6 0.3 1.9 4.1 6.9 27.2 9.2 11.1 33.8 27.6 6.1 3.7 4.9 3.6 3.3 2.8 12.7 20.1 7.7 10.8 1.8 3.7 1.5 6.5 2.1 1.4 1.6 2.8 0.3 1.9 9.2 8.1 RPL10L ENSG00000165496 "Ribosomal protein L10 like" Q96L21 14 46651010-46651821 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "testis: 45.5" "Cell type enhanced" "Detected in many" 29 "Early spermatids: 439.0;Late spermatids: 154.0;Spermatocytes: 85.2" "Cancer enriched" "Detected in single" 15 "testis cancer: 6.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 45 "U-2 OS: 30.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011311 Uncertain Approved "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA011311: AB_1856431" "unprognostic (7.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.92e-2)" "unprognostic (4.18e-2)" "unprognostic (6.67e-2)" "unprognostic (2.92e-1)" "unprognostic (8.70e-4)" "unprognostic (4.69e-2)" "unprognostic (5.27e-3)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (1.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.83e-1)" "unprognostic (4.40e-2)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.3 0.6 0.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.4 0.3 0.5 1.0 0.6 0.8 0.2 0.7 0.9 0.9 0.0 0.4 0.2 0.4 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 8.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 439.0 0.6 0.2 0.0 0.0 0.2 1.7 5.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 154.0 5.8 2.0 10.1 0.0 1.8 0.0 0.0 0.0 2.1 0.0 0.0 6.5 4.7 85.2 11.5 16.4 0.2 0.0 2.3 2.6 RPL18A L18A ENSG00000105640 "Ribosomal protein L18a" Q02543 19 17859876-17864153 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 430.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055259 Approved Approved Nucleoli,Cytosol No No "Nucleoli, Cytosol" "HPA055259: AB_2682764" "unprognostic (3.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-2)" "unprognostic (1.09e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (5.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (1.36e-1)" 48.8 33.8 24.9 42.2 43.0 85.7 53.6 27.8 61.1 49.9 46.0 26.5 28.1 40.4 47.8 36.4 65.5 56.5 38.9 31.5 22.6 16.2 50.0 85.9 34.8 83.7 22.3 26.1 109.2 106.6 9.3 30.5 46.9 30.9 41.8 26.8 30.4 99.8 31.6 157.7 90.1 43.3 36.6 21.9 57.6 50.1 67.3 17.6 59.5 65.3 107.9 54.0 45.0 57.1 395.8 193.6 24.8 110.7 126.0 278.4 430.5 126.2 98.3 65.7 92.6 98.7 162.7 166.5 77.5 98.5 102.6 97.9 135.7 127.1 191.0 179.7 66.7 41.0 95.2 77.4 165.0 35.9 97.6 208.7 89.2 94.6 154.5 171.0 128.3 97.8 203.0 217.6 56.7 122.3 106.8 112.2 157.6 113.3 123.9 64.7 196.8 173.5 169.5 154.6 142.0 151.7 156.2 69.7 226.4 93.6 120.2 95.2 142.9 27.5 192.0 239.8 33.9 91.2 249.4 85.9 63.6 74.1 126.9 129.9 166.2 151.1 123.3 83.5 205.4 78.8 24.8 110.4 16.5 134.8 110.7 234.6 368.3 232.2 167.1 166.6 395.8 278.4 212.5 11.3 126.0 85.6 193.6 195.9 430.5 24.9 43.0 27.8 61.1 22.6 16.2 22.3 26.1 30.9 17.6 482.4 926.8 6413.8 4901.3 7713.4 240.4 390.4 1829.3 614.3 1162.5 875.9 119.8 4308.9 2022.7 2828.9 39.6 2919.7 1766.7 1097.9 7783.8 7254.8 3471.5 4168.2 1383.3 2046.3 2960.9 123.9 1772.7 2331.9 4202.4 100.2 3856.5 5199.5 4502.8 5216.5 3612.2 346.7 5814.1 2767.0 1530.2 2592.2 347.7 1235.3 4175.6 138.6 661.5 9733.7 3896.6 4323.4 4712.9 6201.7 RPL23A L23A ENSG00000198242 "Ribosomal protein L23a" P62750 17 28719393-28724359 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 261.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA051754, HPA077474" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 15000 "Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol" "HPA051754: AB_2681593, HPA077474: AB_2686841" "unprognostic (1.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (9.79e-2)" "unprognostic (7.76e-2)" "unprognostic (1.91e-3)" "unprognostic (1.23e-1)" "unprognostic (9.64e-2)" "unprognostic (2.70e-2)" "unprognostic (1.25e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (5.16e-6)" "unprognostic (3.91e-2)" "unprognostic (1.54e-1)" "unprognostic (3.98e-3)" "unprognostic (2.68e-1)" 49.1 38.5 48.6 43.3 62.1 67.9 87.0 40.6 75.5 63.8 47.0 27.3 48.5 34.8 53.2 44.0 56.5 64.1 35.1 48.8 56.6 28.7 39.5 93.2 62.3 108.0 42.6 39.6 142.1 63.3 21.4 45.3 51.0 40.5 44.9 48.8 27.6 61.3 41.7 64.9 70.5 44.6 39.8 63.4 59.1 47.8 108.1 35.7 56.1 44.4 78.8 84.9 51.1 61.0 261.4 139.2 30.6 75.3 142.1 254.7 206.1 59.4 121.4 73.5 91.1 97.3 156.9 71.6 55.8 98.0 94.6 80.0 123.5 57.7 134.5 52.6 77.5 49.4 81.4 96.7 124.6 98.1 71.1 267.4 64.2 119.3 131.4 88.7 133.4 67.3 152.5 160.5 75.3 119.1 137.4 102.4 62.4 83.4 91.3 94.6 98.2 148.9 176.0 69.9 152.8 74.0 88.2 132.7 158.9 102.5 121.5 75.9 88.6 39.6 288.0 125.0 107.5 143.2 156.7 60.7 52.1 74.2 60.6 98.7 113.9 105.2 78.5 82.6 73.8 57.4 30.6 66.3 19.4 156.5 75.3 232.3 261.4 227.4 203.4 108.7 227.4 254.7 229.5 9.4 142.1 59.6 139.2 154.0 206.1 48.6 62.1 40.6 75.5 56.6 28.7 42.6 39.6 40.5 35.7 801.0 1123.4 5775.1 4513.0 4612.6 216.8 263.3 2257.3 837.9 1637.9 820.0 66.8 3852.2 2612.9 1885.1 774.8 2545.4 1436.7 1541.8 4018.0 5653.9 2983.4 3636.7 1439.5 1994.3 2312.0 154.1 1776.5 2366.9 2960.5 235.1 4219.8 3481.8 2908.6 3701.6 2998.1 414.4 2891.2 3114.2 2224.7 2308.4 257.2 1681.6 3269.7 698.0 548.5 5416.5 4120.8 3800.4 4030.5 4740.6 RPL26 L26 ENSG00000161970 "Ribosomal protein L26" P61254 17 8377516-8383250 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 586.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030449, CAB037301" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "CAB037301: AB_796168, HPA030449: AB_10602125" "unprognostic (2.02e-2)" "unprognostic (3.73e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-1)" "unprognostic (6.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (3.95e-1)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (7.15e-2)" "unprognostic (1.96e-3)" "unprognostic (2.73e-1)" "unprognostic (1.08e-1)" "unprognostic (5.44e-2)" "unprognostic (2.38e-1)" 122.5 64.5 70.2 102.5 49.8 132.2 170.4 44.4 52.4 127.6 131.6 34.8 68.1 53.1 76.4 97.0 161.2 87.6 98.6 68.1 54.8 42.5 100.6 138.3 97.5 117.5 61.6 32.6 183.0 586.0 32.2 41.1 82.2 47.7 129.0 84.0 41.5 95.3 87.4 170.8 106.3 98.6 103.6 62.9 129.0 75.9 53.0 45.1 104.9 131.6 145.8 107.9 154.7 127.6 154.9 120.8 25.1 92.1 93.0 158.2 165.0 103.5 95.3 93.8 111.0 177.2 291.8 91.7 90.0 133.9 122.3 92.4 100.7 53.4 181.0 103.5 106.6 50.0 115.1 119.2 184.4 144.0 67.6 214.8 70.6 105.2 116.1 207.2 104.9 91.7 248.7 369.2 101.2 304.3 172.0 150.5 104.1 79.9 54.6 128.4 71.3 115.6 143.5 88.1 108.9 63.3 115.5 95.3 112.6 164.3 77.9 39.0 83.3 48.5 90.6 208.1 86.7 92.7 140.5 94.3 49.5 61.8 68.2 157.5 43.9 51.2 79.1 81.0 149.3 73.3 25.1 92.1 18.2 89.9 78.3 130.5 154.9 134.3 116.8 120.8 140.1 158.2 136.0 10.9 93.0 69.5 104.5 111.3 165.0 70.2 49.8 44.4 52.4 54.8 42.5 61.6 32.6 47.7 45.1 833.7 960.0 5357.4 2721.4 4954.5 234.8 252.2 2797.5 959.6 1909.7 952.6 125.7 3974.4 3344.0 2212.2 695.5 2535.1 1389.0 1425.0 4263.0 6092.8 2980.6 2437.9 1777.7 2307.8 2989.4 128.7 2198.5 2802.7 4762.9 1400.7 4423.2 3635.2 3033.3 3719.6 3654.9 300.8 3633.9 3236.9 2028.4 4497.4 340.9 1487.5 2382.4 569.4 578.1 6200.9 3820.5 3284.3 5356.2 2887.4 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.6" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 286.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 11.2 23.0 17.9 14.7 17.9 18.0 15.2 10.5 21.1 13.1 12.8 8.2 14.4 13.5 14.5 21.6 18.1 14.7 11.9 19.5 20.7 16.8 20.0 25.9 10.5 16.7 16.2 18.0 14.1 25.5 9.1 15.4 14.2 16.3 12.1 14.6 11.5 18.4 16.7 19.0 9.7 10.8 14.0 12.8 13.3 12.2 73.6 11.8 20.0 16.2 18.2 14.9 13.1 11.9 19.7 40.0 17.5 36.2 14.6 21.7 20.9 29.6 26.9 24.4 33.5 16.9 17.9 31.6 28.4 16.7 41.1 36.7 32.8 32.0 22.3 73.0 38.9 43.8 19.3 40.2 56.3 38.0 28.5 52.3 16.5 31.5 40.1 33.2 24.0 14.7 22.3 23.8 42.3 29.7 16.7 23.5 22.0 22.6 18.8 29.2 65.8 29.3 38.0 15.5 13.8 42.8 21.4 37.8 29.6 23.9 18.7 24.6 15.1 26.0 23.9 37.7 16.3 29.3 25.9 24.7 47.0 26.1 27.4 21.2 16.9 26.3 41.8 37.0 30.2 27.8 7.8 36.2 15.5 14.3 31.4 18.3 19.7 17.4 19.6 40.0 15.1 14.5 18.4 17.5 14.6 26.8 27.5 21.7 20.9 17.9 17.9 10.5 21.1 20.7 16.8 16.2 18.0 16.3 11.8 38.7 26.2 23.1 45.5 43.4 14.3 38.4 50.9 62.9 35.2 55.8 17.7 94.5 154.2 102.8 286.5 45.0 32.9 93.5 97.7 103.7 39.0 47.6 25.5 104.6 100.3 14.3 38.7 41.7 51.6 40.1 35.1 50.7 49.0 97.4 42.9 42.9 113.2 38.6 38.5 146.6 13.9 19.4 39.1 214.9 161.4 46.2 66.0 27.7 55.4 43.0 RPL27A L27A ENSG00000166441 "Ribosomal protein L27a" P46776 11 8682411-8714759 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 555.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060776, HPA063379" Supported Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA060776: AB_2684359, HPA063379: AB_2684997" "prognostic favorable (7.84e-5)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (9.94e-3)" "unprognostic (3.16e-1)" "unprognostic (1.25e-1)" "unprognostic (1.90e-3)" "unprognostic (2.85e-1)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (1.69e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (2.83e-10)" "unprognostic (2.28e-2)" "unprognostic (6.87e-2)" "unprognostic (3.37e-2)" "unprognostic (7.68e-2)" 65.9 58.8 49.6 116.1 81.5 146.4 149.4 47.8 80.5 69.7 69.9 25.1 64.2 60.1 73.2 74.9 98.4 76.4 88.5 103.5 59.9 33.9 57.0 71.3 111.1 316.9 44.5 49.3 132.2 278.5 10.4 54.6 64.8 64.0 70.1 75.7 42.1 115.8 70.1 124.6 97.9 69.2 109.2 47.1 92.0 72.4 56.8 28.5 74.6 89.3 127.5 120.5 71.0 128.7 341.9 188.5 71.3 122.3 161.9 351.8 555.6 169.7 118.2 75.5 90.6 104.1 199.1 114.2 110.4 139.5 126.6 97.4 149.4 158.7 240.8 87.3 96.5 54.0 124.3 99.6 154.0 95.5 87.9 214.1 106.0 115.4 184.3 172.7 192.0 124.8 217.5 275.3 19.9 211.4 174.9 125.4 144.2 109.1 76.0 106.9 127.9 143.0 289.5 122.7 126.4 123.8 125.3 79.3 146.3 118.9 170.2 86.5 155.5 40.9 157.2 171.4 83.3 69.5 220.1 113.9 41.3 111.3 106.0 139.4 86.6 189.8 197.0 94.8 131.6 74.8 71.3 122.3 37.8 208.1 119.1 266.8 341.9 295.7 244.4 188.5 301.2 351.8 290.3 29.7 161.9 108.1 180.0 198.2 555.6 49.6 81.5 47.8 80.5 59.9 33.9 44.5 49.3 64.0 28.5 1042.2 1639.1 5447.5 5197.7 4315.3 211.8 780.0 2010.1 1169.7 2127.0 936.9 108.0 4955.4 2420.5 2120.6 640.6 2975.9 1990.9 1378.3 4688.2 6270.1 2784.5 3963.3 2012.4 2288.9 3821.7 76.3 2038.1 2441.8 3815.0 1497.4 3355.1 4578.8 2687.5 3973.9 4593.3 390.8 4009.3 4780.0 1839.6 2272.7 251.4 1532.8 3189.9 395.7 439.9 5297.8 5030.9 4388.7 5800.0 5583.1 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993600-51995942 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 434.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: AB_2686077" "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 91.6 61.7 42.5 64.6 33.0 110.2 111.0 30.1 39.7 102.4 98.1 30.3 57.1 53.6 59.6 72.8 124.7 76.0 68.7 72.1 33.8 26.0 55.7 122.9 64.8 219.4 36.0 26.0 150.1 434.1 16.3 34.3 50.7 26.3 91.1 41.2 38.9 103.7 54.8 160.8 102.5 73.8 80.2 38.1 83.9 59.7 58.7 25.2 85.9 83.3 123.3 92.4 88.5 87.1 137.9 98.1 32.8 80.0 74.8 132.2 202.9 69.9 91.0 70.2 107.0 125.2 196.8 99.0 78.3 96.8 107.6 89.5 108.3 107.5 195.7 34.1 79.5 65.9 63.7 101.2 166.6 51.5 79.6 137.7 101.3 117.7 180.6 148.5 146.9 97.8 240.5 236.9 79.3 141.3 123.3 120.4 87.9 79.0 150.3 79.2 159.8 127.5 191.1 116.5 106.6 154.5 59.3 77.3 189.8 137.5 146.3 56.8 110.8 58.5 135.2 133.7 46.8 101.2 251.4 104.3 60.4 81.1 93.1 116.7 98.1 139.0 139.2 79.9 176.2 79.8 32.8 80.0 22.6 68.8 61.7 115.0 137.9 112.2 87.6 98.1 128.2 132.2 109.9 10.8 74.8 48.4 82.8 100.8 202.9 42.5 33.0 30.1 39.7 33.8 26.0 36.0 26.0 26.3 25.2 175.7 330.0 3392.7 4367.8 3531.6 218.0 72.2 1398.7 310.5 437.9 675.2 96.2 2332.5 1848.6 1477.5 867.6 2040.8 1839.8 957.8 3975.0 4390.8 2112.5 3132.4 683.0 1270.4 2074.0 101.7 1376.0 1509.4 2270.2 3389.8 3344.0 2646.2 2103.8 1980.2 2585.2 359.2 2990.7 2489.9 1488.6 2639.2 288.1 1125.4 2454.4 526.4 450.8 4436.8 2053.3 2519.7 3632.3 5133.1 RPL32 L32 ENSG00000144713 "Ribosomal protein L32" P62910 3 12834485-12841588 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 406.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047501, HPA051994" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 140000 "Endoplasmic reticulum, Cytosol" "HPA047501: AB_2680070, HPA051994: AB_2681686" "unprognostic (6.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.55e-1)" "unprognostic (4.58e-3)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (1.68e-2)" "unprognostic (2.20e-1)" "unprognostic (6.93e-2)" "unprognostic (1.94e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (8.36e-2)" "unprognostic (1.44e-2)" 80.5 42.2 62.9 55.4 44.5 106.7 109.0 33.2 50.8 101.5 58.9 34.9 38.3 37.3 63.1 91.5 94.8 82.3 49.5 53.5 46.5 36.5 68.4 132.9 63.7 117.4 50.1 41.1 167.0 406.2 20.4 38.6 48.6 32.8 62.6 68.4 41.8 67.9 43.3 121.4 90.5 48.6 78.0 48.4 77.7 52.0 55.9 30.7 103.9 66.9 87.7 121.5 91.2 68.9 230.3 119.2 38.8 86.1 104.4 281.7 293.2 74.3 89.4 78.1 99.5 122.9 220.1 258.1 61.4 114.5 129.9 89.1 118.1 76.3 129.7 56.2 88.2 42.7 46.7 88.5 127.7 106.9 59.8 148.2 75.4 113.4 127.6 183.7 121.4 76.5 197.5 278.9 99.1 191.7 128.7 113.3 95.8 92.5 120.7 106.1 224.3 136.5 209.9 131.5 107.3 169.8 109.0 70.2 168.9 131.2 123.8 49.6 99.3 41.4 111.2 132.1 73.0 162.7 234.2 65.3 56.4 72.1 74.0 112.7 81.6 128.1 226.8 71.8 174.4 83.9 38.8 86.1 22.9 99.1 66.7 178.3 230.3 197.2 143.1 119.2 214.7 281.7 213.1 12.7 104.4 53.6 118.2 147.0 293.2 62.9 44.5 33.2 50.8 46.5 36.5 50.1 41.1 32.8 30.7 994.6 1705.3 6619.8 6646.5 8194.1 323.1 436.2 2817.8 1037.3 2033.7 1385.3 157.1 4359.8 3864.6 2400.6 1607.7 4582.5 1755.3 1822.2 5640.8 6521.8 3945.6 4507.1 2255.6 2952.6 3734.4 170.0 2220.9 3848.6 5359.1 5126.5 6169.0 6114.9 4595.6 3626.7 4532.6 595.4 4264.1 3517.5 2818.3 4510.9 491.8 1933.8 4140.6 977.2 891.7 9583.4 4079.8 4680.5 6188.5 6735.9 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620566-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 400.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favorable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 68.5 52.6 65.9 77.6 63.7 118.0 165.2 43.7 52.9 82.0 70.1 25.5 57.5 47.3 106.0 111.1 76.4 75.2 61.9 59.2 53.7 41.4 60.2 98.4 56.1 110.1 54.6 49.7 157.4 305.1 17.8 68.3 63.8 59.0 74.3 61.0 35.2 129.9 60.2 87.1 77.6 57.6 87.5 57.5 70.8 60.3 43.2 32.2 63.3 82.2 109.5 95.4 67.6 102.3 300.5 153.8 56.2 116.4 134.2 331.0 400.6 59.2 43.3 78.7 111.9 170.9 270.5 77.5 91.6 116.4 75.6 63.3 109.7 105.5 180.4 55.2 89.0 37.8 42.3 84.6 142.9 99.3 66.5 135.5 75.3 91.0 167.9 143.9 188.8 84.4 240.5 204.2 61.7 140.4 146.0 135.9 100.8 131.9 103.6 124.5 115.1 115.6 230.6 90.3 132.9 87.7 106.2 84.6 109.2 157.8 100.0 84.5 108.2 37.4 218.5 128.3 65.5 72.6 172.7 100.3 51.9 70.4 54.2 80.9 77.4 100.9 145.4 70.7 118.0 63.4 56.2 116.4 35.6 122.0 86.8 207.8 300.5 247.8 165.5 121.2 257.1 331.0 244.9 24.9 134.2 74.9 153.8 176.2 400.6 65.9 63.7 43.7 52.9 53.7 41.4 54.6 49.7 59.0 32.2 1313.2 2435.5 8127.2 9688.6 11162.7 321.1 1043.1 4914.6 1694.4 3137.0 2053.6 70.7 5336.7 5859.0 3087.8 1166.8 4211.1 1851.3 2850.1 7573.3 5633.2 3960.7 4740.0 3107.4 4896.8 3604.2 146.2 2618.2 5127.8 6804.9 1575.7 6923.4 6371.5 5538.7 4548.4 5463.9 625.8 5524.0 4699.4 3790.7 6994.4 382.0 1882.0 3701.7 706.0 481.2 13381.8 5336.0 5116.7 7038.7 7765.2 RPL37 L37 ENSG00000145592 "Ribosomal protein L37" P61927 5 40825262-40835335 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 216.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-2)" "unprognostic (1.85e-1)" "unprognostic (8.27e-2)" "unprognostic (2.31e-1)" "unprognostic (1.35e-2)" "unprognostic (1.83e-1)" "unprognostic (6.40e-3)" "unprognostic (1.23e-1)" "unprognostic (8.03e-2)" "unprognostic (8.28e-2)" "unprognostic (4.98e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.67e-6)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (6.81e-2)" "prognostic favorable (6.34e-4)" 40.5 28.5 35.0 48.5 35.9 54.8 118.9 19.7 29.2 60.2 42.8 20.9 39.5 30.2 36.0 53.6 47.1 39.9 37.6 49.3 27.3 21.5 29.2 39.2 47.9 111.6 31.7 24.4 88.7 216.3 18.9 18.5 23.3 27.4 31.3 33.5 26.1 71.5 51.6 54.5 55.9 31.0 54.8 33.5 37.5 34.3 26.4 27.8 44.5 35.0 66.9 63.2 38.5 48.0 115.9 81.4 23.3 48.8 60.2 116.9 99.4 35.8 32.2 57.2 20.2 99.0 115.6 46.6 39.2 69.0 43.4 33.4 50.8 13.3 57.3 32.8 64.1 70.6 20.7 60.9 103.6 33.4 56.0 36.1 29.0 133.9 56.8 143.3 54.1 20.7 164.2 107.0 56.7 127.0 125.8 62.7 82.8 33.3 28.4 53.6 62.3 54.1 80.1 18.1 99.1 38.7 27.0 41.5 50.1 97.3 58.2 17.0 38.3 35.2 24.2 60.6 54.7 17.9 91.1 27.4 6.9 30.5 12.3 38.2 41.8 49.2 53.3 8.0 67.7 8.2 23.3 48.8 14.8 62.5 41.2 86.8 115.9 99.3 81.8 69.2 109.3 116.9 101.2 16.0 60.2 30.3 81.4 77.6 99.4 35.0 35.9 19.7 29.2 27.3 21.5 31.7 24.4 27.4 27.8 810.0 1374.8 4509.2 2139.9 3026.0 194.6 307.7 2328.6 758.8 1673.2 739.8 84.4 2561.0 1482.2 1798.4 796.7 1704.5 1592.3 1097.9 3910.9 4741.7 1794.6 1674.5 1527.5 2644.7 2259.5 103.3 1713.7 2618.6 3479.7 1615.9 4953.3 2555.7 1651.6 3301.2 3490.4 500.7 3779.1 2784.5 2098.8 2262.7 212.6 1325.8 1722.8 516.7 444.2 3512.8 2465.0 2926.5 4999.8 2144.8 RPL39 "L39, RPL39P42" ENSG00000198918 "Ribosomal protein L39" P62891 X 119786504-119791643 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 403.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047105 Uncertain NA NA "HPA047105: AB_2679933" "unprognostic (1.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-2)" "unprognostic (5.03e-2)" "unprognostic (3.23e-3)" "unprognostic (5.05e-2)" "unprognostic (1.75e-2)" "unprognostic (1.46e-1)" "unprognostic (2.72e-1)" "unprognostic (4.38e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.71e-9)" "unprognostic (3.26e-2)" "unprognostic (5.77e-2)" "unprognostic (1.81e-2)" "unprognostic (7.31e-3)" 78.3 56.7 39.3 73.7 42.7 121.2 154.3 48.9 52.9 73.4 68.8 17.1 67.4 44.3 50.3 83.0 80.3 61.3 55.6 149.7 32.5 27.7 50.8 74.6 159.8 403.2 40.3 42.5 139.3 190.8 9.0 31.1 41.7 38.8 54.7 65.2 33.7 68.3 63.6 86.9 104.5 59.5 97.6 56.8 84.3 57.0 31.5 33.5 87.2 72.7 125.9 97.1 65.7 71.9 224.4 140.6 53.6 118.6 94.2 236.1 246.4 144.3 91.6 132.1 107.0 225.9 290.8 126.0 135.7 154.5 155.5 138.8 93.7 108.9 226.2 142.2 133.4 103.9 119.5 203.6 175.6 158.3 80.8 318.2 108.0 135.5 134.3 191.5 188.2 89.5 278.1 313.3 120.0 225.5 211.8 175.8 152.4 132.3 160.7 140.7 194.7 129.5 341.7 208.8 329.0 205.6 122.2 173.2 278.5 174.6 115.3 78.7 161.4 174.5 157.9 230.6 128.6 83.0 204.0 137.0 57.0 56.7 153.3 216.9 102.2 172.9 241.4 85.1 272.3 67.5 53.6 118.6 38.7 91.9 82.0 146.2 224.4 202.4 138.0 126.3 208.8 236.1 183.4 28.0 94.2 73.6 140.6 128.7 246.4 39.3 42.7 48.9 52.9 32.5 27.7 40.3 42.5 38.8 33.5 804.0 1169.2 6063.1 3953.2 6613.4 184.6 560.2 2326.1 839.2 1666.3 889.8 80.5 3415.8 1770.7 2205.1 42.6 2936.9 1485.3 1752.0 5026.8 5622.1 3159.3 2774.9 1647.1 4947.8 3423.5 76.3 2341.4 4015.0 7005.9 129.9 5526.4 4346.8 3659.2 2662.8 4868.0 364.8 4110.7 4990.4 2078.0 2639.2 264.5 1474.6 2146.7 30.7 205.9 7588.5 3859.5 3990.0 7028.5 3640.2 RPL39L RPL39L1 ENSG00000163923 "Ribosomal protein L39 like" Q96EH5 3 187120948-187180908 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 23.7;testis: 90.1" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 387.1;Late spermatids: 163.8;Spermatocytes: 729.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA047105 Approved NA NA "HPA047105: AB_2679933" "unprognostic (1.01e-1)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (6.05e-4)" "prognostic unfavorable (1.30e-6)" "unprognostic (6.94e-2)" "unprognostic (9.75e-3)" "unprognostic (1.66e-3)" "unprognostic (8.02e-2)" "prognostic favorable (1.94e-4)" "unprognostic (1.19e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-3)" "unprognostic (9.51e-2)" "unprognostic (1.61e-1)" "unprognostic (8.21e-3)" "unprognostic (2.60e-1)" 2.5 1.0 4.1 4.6 4.7 3.4 5.8 2.3 5.0 4.6 3.6 2.2 0.9 1.2 3.8 2.3 2.9 3.4 2.2 5.2 3.3 3.2 1.9 1.5 1.9 5.2 2.9 2.7 1.7 1.7 2.4 2.3 2.5 2.8 3.3 1.7 1.8 2.6 3.4 0.6 3.5 1.8 4.0 2.9 2.6 2.5 90.1 2.0 9.2 1.2 2.6 6.1 3.0 3.4 18.2 6.5 2.3 5.7 8.0 23.7 13.5 44.3 15.6 5.5 8.7 2.6 3.9 5.1 13.9 10.1 12.7 13.8 1.0 7.8 18.8 38.8 7.9 24.8 15.3 11.3 2.6 19.5 32.5 2.1 0.2 12.7 0.1 4.9 3.9 5.0 3.1 2.0 10.5 9.0 9.7 12.9 23.5 9.9 22.5 4.7 15.0 0.2 15.7 34.8 15.6 25.9 16.5 7.7 14.0 4.1 1.0 13.5 14.2 10.9 29.9 32.0 13.2 29.4 13.3 5.8 0.1 14.5 11.9 13.9 29.7 31.6 35.8 7.7 16.6 29.0 2.3 5.7 1.3 13.7 5.3 7.0 18.2 14.3 12.2 5.7 12.9 10.2 14.5 0.8 8.0 3.7 6.5 23.7 13.5 4.1 4.7 2.3 5.0 3.3 3.2 2.9 2.7 2.8 2.0 3.0 10.3 39.5 29.2 22.1 3.0 43.1 20.4 4.0 3.4 3.5 0.0 14.1 6.6 11.3 387.1 9.3 0.9 0.0 2.2 80.7 21.7 27.0 6.9 7.3 32.1 6.4 0.0 33.2 26.4 163.8 20.1 13.8 21.9 0.0 3.3 10.4 7.3 0.0 11.0 1.8 1.8 6.5 26.2 729.2 137.8 18.4 12.5 13.8 6.0 19.0 RPL3L ENSG00000140986 "Ribosomal protein L3 like" Q92901 16 1943974-1957606 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7" "Cell type enriched" "Detected in some" 18 "Cardiomyocytes: 115.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.8;Karpas-707: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049136 Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049136: AB_2680648" "unprognostic (2.53e-1)" "unprognostic (2.63e-2)" "unprognostic (9.27e-4)" "unprognostic (6.38e-4)" "unprognostic (4.36e-2)" "unprognostic (3.48e-3)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.17e-1)" "unprognostic (1.19e-2)" "unprognostic (2.00e-1)" "unprognostic (2.46e-2)" "unprognostic (4.53e-3)" "unprognostic (3.32e-1)" "unprognostic (4.24e-1)" "unprognostic (8.32e-3)" "unprognostic (4.60e-2)" 1.1 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.5 1.4 0.0 0.1 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.8 0.0 148.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 36.7 2.1 0.0 0.0 1.8 1.7 4.9 1.5 0.9 1.4 0.5 2.1 2.5 0.6 2.3 0.1 0.1 1.5 1.0 0.0 0.1 0.0 7.8 4.2 1.3 1.4 0.0 1.9 2.1 0.2 0.2 0.0 1.0 1.3 0.8 1.7 2.7 0.0 0.5 0.9 0.2 0.3 0.2 0.2 1.5 0.0 1.4 0.8 5.8 0.1 1.3 1.6 1.9 1.3 2.3 5.0 0.7 0.7 1.8 0.3 0.8 3.4 1.0 1.0 2.8 1.2 1.5 1.4 1.1 1.2 1.2 2.9 1.6 0.8 2.5 1.2 1.2 1.7 0.6 0.4 1.6 1.5 1.3 1.4 1.1 0.9 1.4 1.1 1.2 0.5 1.8 1.2 1.4 4.9 0.9 1.0 1.7 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 115.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.3 0.4 0.0 0.0 0.0 0.4 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290267-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 536.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 638.4" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 170000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: AB_2683694" "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 54.7 36.5 54.6 37.9 49.3 67.6 86.9 55.9 54.1 57.5 46.2 36.4 41.0 33.6 54.9 50.6 59.5 50.6 26.5 36.7 32.1 22.0 46.4 67.6 40.3 53.3 55.9 20.5 125.8 87.5 22.9 67.7 33.4 55.0 43.6 44.9 44.1 51.8 36.6 61.9 72.7 37.0 49.5 46.9 46.5 51.2 135.1 54.9 33.7 42.6 69.0 66.6 50.8 58.5 338.1 231.5 66.1 171.7 205.0 464.0 536.3 99.7 72.5 78.0 93.8 159.2 204.1 76.7 109.7 88.2 75.0 59.2 87.2 104.6 296.9 89.8 88.4 51.2 95.8 102.9 140.1 117.1 79.8 85.4 162.5 94.9 89.7 95.7 114.5 83.4 191.0 165.6 69.4 217.2 138.4 121.5 100.9 144.9 112.7 106.4 84.7 181.7 175.2 90.9 182.4 78.0 122.9 89.3 115.7 116.9 100.1 108.0 78.7 51.5 638.4 153.6 67.0 161.3 150.6 114.0 57.7 88.3 73.3 101.3 65.2 92.3 191.6 60.3 142.3 94.7 66.1 171.7 41.1 179.1 138.9 322.3 338.1 314.4 232.5 231.5 282.6 464.0 327.0 22.3 205.0 118.6 192.4 237.0 536.3 54.6 49.3 55.9 54.1 32.1 22.0 55.9 20.5 55.0 54.9 759.3 1377.6 4083.1 8227.6 7155.0 251.0 580.3 2023.0 1007.8 1723.2 1244.0 117.8 3979.6 4725.1 2246.6 1393.0 2953.4 897.4 1004.5 4388.5 6073.2 3431.1 4195.6 1418.7 1830.9 2853.5 89.0 1556.2 2090.7 3232.1 609.0 3931.9 3610.7 3514.2 2982.9 2652.3 679.5 3206.0 2051.6 2172.0 4500.4 280.8 1435.8 4545.3 828.4 372.8 8292.9 4080.0 3000.7 4416.0 6170.5 RPLP0 "L10E, LP0, P0, PRLP0, RPP0" ENSG00000089157 "Ribosomal protein lateral stalk subunit P0" P05388 12 120196686-120201235 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 408.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA003512, HPA073501" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA003512: AB_1079844, HPA073501: " "unprognostic (2.39e-3)" "unprognostic (2.46e-1)" "unprognostic (1.78e-1)" "unprognostic (8.49e-3)" "unprognostic (2.99e-2)" "unprognostic (2.44e-1)" "unprognostic (2.54e-3)" "unprognostic (5.99e-2)" "unprognostic (1.67e-1)" "unprognostic (4.82e-2)" "unprognostic (2.34e-1)" "unprognostic (3.35e-1)" "prognostic unfavorable (7.66e-12)" "unprognostic (2.74e-1)" "unprognostic (2.39e-1)" "unprognostic (3.06e-1)" "unprognostic (1.47e-1)" 67.3 59.5 20.6 76.6 31.6 100.5 119.8 26.8 26.0 58.4 76.8 22.0 61.8 50.5 95.9 66.0 128.3 74.8 88.6 49.8 28.9 16.2 47.1 121.7 55.4 59.7 21.9 26.6 117.5 408.6 13.5 36.6 70.1 41.5 72.4 60.8 32.8 138.5 54.6 101.0 113.9 57.3 63.8 23.4 60.0 69.0 73.0 18.7 89.6 90.8 162.5 82.8 64.2 116.6 135.9 143.3 10.7 63.4 82.7 172.4 193.3 125.7 108.9 92.6 158.4 189.2 311.6 132.1 96.9 168.3 151.7 98.8 120.4 77.5 275.6 97.9 169.5 37.7 100.0 163.9 201.2 96.1 106.4 124.9 131.5 72.3 102.8 204.1 176.6 99.5 280.8 344.6 106.2 315.7 258.9 179.1 158.6 161.0 79.9 144.1 136.1 177.8 119.5 176.4 128.2 145.8 129.7 130.3 215.9 151.7 145.2 98.8 120.4 69.8 104.6 190.4 114.2 186.7 213.6 120.3 71.5 109.2 90.6 120.1 180.7 190.1 137.5 128.5 127.1 60.2 10.7 63.4 5.3 71.5 58.3 172.4 135.9 131.9 97.1 137.0 123.2 131.4 104.4 5.0 82.7 35.1 143.3 83.4 193.3 20.6 31.6 26.8 26.0 28.9 16.2 21.9 26.6 41.5 18.7 544.9 1103.9 2148.7 3806.4 3443.2 197.9 209.4 1085.3 926.2 1446.8 533.9 145.3 3866.1 1598.2 1545.3 333.2 1285.7 1169.7 864.3 4155.9 5327.9 1860.1 2549.8 765.8 1006.6 1782.0 89.0 1170.4 829.9 1076.1 733.9 1611.7 1293.2 1612.9 1872.0 2272.8 178.1 2945.4 1050.9 747.5 1579.0 330.6 413.9 1621.9 303.3 717.8 4153.8 3690.5 1762.1 3426.9 4264.4 RPLP1 LP1 ENSG00000137818 "Ribosomal protein lateral stalk subunit P1" P05386 15 69452784-69456194 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 1030.2" "Cell type enhanced" "Detected in all" 4 "Suprabasal keratinocytes: 24827.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003368 Supported "Endoplasmic reticulum,Cytosol" NA NA 1000000 "Endoplasmic reticulum, Cytosol" "HPA003368: AB_1079845" "unprognostic (5.04e-3)" "unprognostic (2.26e-2)" "unprognostic (2.02e-2)" "unprognostic (4.29e-2)" "unprognostic (6.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (2.79e-1)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.30e-9)" "unprognostic (7.75e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "unprognostic (5.83e-2)" 59.6 57.2 47.5 76.8 42.9 171.7 451.2 68.8 103.3 70.1 79.0 20.8 57.9 87.5 73.5 76.3 100.7 65.7 80.6 341.6 35.5 29.7 55.8 69.9 290.9 1030.2 42.4 33.3 134.3 209.0 8.6 36.0 52.3 45.6 71.0 33.3 61.3 102.8 60.7 262.9 155.2 74.3 128.2 38.8 77.4 77.1 45.7 32.7 73.0 50.8 146.9 71.8 72.3 95.5 329.0 226.3 79.6 176.1 169.8 267.2 368.8 83.9 85.9 38.5 88.8 55.3 66.7 82.8 73.9 43.9 41.4 33.1 87.1 85.6 117.5 110.5 38.8 38.0 114.9 59.3 58.1 9.1 117.8 181.4 99.0 98.7 85.0 96.8 87.5 90.4 83.8 101.9 30.1 56.5 67.8 49.8 104.3 93.0 100.2 29.2 78.6 95.5 258.3 144.0 52.7 82.8 98.0 125.9 171.9 39.8 90.9 61.8 120.3 74.2 91.8 301.5 36.5 75.8 201.8 87.5 60.0 134.3 71.6 120.0 205.5 327.6 99.6 71.8 223.7 49.5 79.6 176.1 60.4 119.5 124.7 220.2 329.0 247.2 162.7 215.0 278.5 267.2 223.0 26.2 169.8 70.2 226.3 202.7 368.8 47.5 42.9 68.8 103.3 35.5 29.7 42.4 33.3 45.6 32.7 1756.9 3079.2 10545.4 15462.2 21484.5 610.5 1535.2 3648.4 2472.0 4955.7 2149.5 329.9 7737.4 4357.0 4586.1 334.7 5371.3 2418.0 3387.3 6194.3 10107.4 5970.9 9644.5 2461.9 5669.3 7196.3 352.8 2817.1 4601.8 7392.9 1146.7 7821.5 8502.7 8585.5 10174.3 7223.7 1445.4 6675.7 4201.4 4449.0 6344.8 808.4 2490.0 6776.3 667.6 1530.1 24827.4 7946.7 8933.3 9955.9 14669.5 RPP14 P14 ENSG00000163684 "Ribonuclease P/MRP subunit p14" O95059 3 58306247-58324695 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036194 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036194: AB_10672082" "unprognostic (6.05e-2)" "unprognostic (2.02e-2)" "unprognostic (1.50e-3)" "unprognostic (1.36e-1)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (3.76e-2)" "prognostic favorable (3.07e-10)" "unprognostic (5.19e-3)" "unprognostic (2.36e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (5.78e-2)" 7.1 8.5 8.3 5.7 12.9 5.3 7.1 15.8 10.7 6.6 8.6 5.9 6.6 10.2 8.2 7.8 8.5 7.4 6.2 11.8 7.2 6.8 11.2 15.0 5.6 7.6 6.5 9.9 8.4 11.9 10.8 9.4 6.0 7.2 7.4 8.2 9.0 8.5 7.0 53.5 7.4 9.1 11.7 5.5 7.7 7.7 9.1 5.9 6.3 8.1 18.5 8.5 7.2 7.0 4.6 6.6 4.7 9.8 9.8 6.4 3.5 10.1 8.1 9.4 7.5 7.9 8.5 10.4 8.6 9.3 12.4 14.0 12.3 6.7 12.2 2.0 11.5 10.8 6.2 14.1 12.8 12.1 8.5 7.4 11.6 9.7 6.7 7.7 19.9 9.7 9.3 12.4 14.7 14.1 6.2 9.7 15.0 9.9 8.7 12.0 5.5 13.5 7.0 12.3 8.4 15.4 5.5 7.4 11.8 9.0 14.6 5.9 10.5 8.1 9.7 11.6 6.8 9.3 9.6 8.8 9.4 10.5 9.9 16.3 13.0 22.3 17.6 10.7 14.0 6.6 3.0 5.7 4.7 4.2 4.9 5.6 4.1 5.5 5.8 6.6 4.6 6.4 6.2 2.6 9.8 9.8 6.2 3.0 3.5 8.3 12.9 15.8 10.7 7.2 6.8 6.5 9.9 7.2 5.9 8.9 11.0 7.0 7.1 27.7 24.7 26.6 5.1 8.1 5.7 3.5 23.6 7.2 10.0 5.3 0.7 7.2 11.7 0.0 5.3 5.2 8.4 6.9 3.5 17.9 5.4 17.5 9.2 12.3 11.4 0.9 11.5 9.5 21.9 8.2 12.5 12.9 6.2 3.5 9.2 10.1 28.1 0.0 20.5 8.6 13.5 37.6 8.6 7.0 13.4 6.2 RPP25L "bA296L22.5, C9orf23, MGC29635" ENSG00000164967 "Ribonuclease P/MRP subunit p25 like" Q8N5L8 9 34610486-34612104 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052187, HPA059698" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052187: AB_2681755, HPA059698: AB_2684106" "unprognostic (1.56e-1)" "unprognostic (1.43e-2)" "unprognostic (7.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.78e-1)" "unprognostic (4.78e-2)" "unprognostic (2.56e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-2)" "unprognostic (3.39e-2)" "unprognostic (2.44e-1)" "prognostic favorable (3.01e-9)" "unprognostic (4.63e-3)" "unprognostic (6.20e-2)" "unprognostic (3.40e-1)" "prognostic favorable (8.21e-4)" 7.4 10.1 11.1 7.9 13.8 4.9 9.3 8.6 14.0 8.2 18.0 7.2 14.0 15.4 9.9 11.4 13.3 11.8 10.9 19.9 9.8 8.8 11.1 19.9 9.3 10.1 10.1 9.1 11.7 20.4 6.3 7.6 11.0 7.5 14.4 8.2 6.4 15.7 9.5 56.0 9.7 18.4 9.3 7.1 11.4 8.6 10.9 6.1 14.4 14.8 21.9 11.3 11.0 10.4 40.7 30.1 41.5 35.4 32.5 41.7 24.8 18.8 24.6 10.0 9.8 10.3 9.5 10.0 8.1 8.5 13.5 15.5 10.8 12.8 14.6 12.7 4.9 6.3 12.7 15.1 20.4 4.8 29.5 20.3 8.7 18.3 15.8 22.0 8.9 13.3 16.9 19.7 11.2 26.2 11.7 14.1 20.4 13.9 15.7 10.3 20.2 18.6 33.7 9.2 19.3 22.4 16.5 10.6 14.6 14.5 9.9 6.7 3.9 14.9 16.8 9.5 5.2 15.3 15.8 6.4 4.2 12.4 10.2 6.7 7.6 13.3 16.6 12.9 18.7 20.3 41.5 35.4 33.3 25.6 28.8 31.6 34.9 30.2 26.9 30.1 40.7 35.5 33.5 32.9 32.5 33.6 24.5 41.7 24.8 11.1 13.8 8.6 14.0 9.8 8.8 10.1 9.1 7.5 6.1 0.0 13.7 24.8 44.7 9.8 7.9 31.3 28.1 13.4 13.6 19.2 2.0 52.4 84.6 22.9 2.2 12.0 59.6 46.7 17.3 31.1 14.9 29.7 10.3 68.6 28.4 0.0 32.3 26.4 34.1 4.5 20.8 12.1 11.8 25.2 40.0 19.0 18.3 51.8 14.5 51.9 9.3 6.5 17.4 49.2 25.4 12.9 35.0 22.7 46.6 41.5 RPRD1A "FLJ10656, HsT3101, P15RS" ENSG00000141425 "Regulation of nuclear pre-mRNA domain containing 1A" Q96P16 18 35984387-36067576 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 88.6" "Group enriched" "Detected in many" 5 "Early spermatids: 215.3;Late spermatids: 274.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040602 Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA040602: AB_10673137" "unprognostic (2.06e-1)" "unprognostic (9.14e-2)" "unprognostic (1.41e-3)" "unprognostic (2.22e-1)" "unprognostic (9.92e-3)" "unprognostic (2.69e-1)" "unprognostic (2.93e-3)" "unprognostic (1.68e-1)" "unprognostic (2.80e-2)" "unprognostic (3.94e-3)" "unprognostic (1.13e-1)" "unprognostic (1.89e-1)" "unprognostic (5.50e-3)" "unprognostic (7.95e-2)" "unprognostic (6.78e-3)" "unprognostic (1.49e-1)" "unprognostic (4.30e-1)" 16.8 27.0 32.1 12.0 32.0 7.8 19.0 28.5 36.9 16.9 18.1 22.8 26.3 14.4 20.0 88.6 18.4 19.7 14.4 21.3 30.2 27.6 20.8 16.5 14.5 13.8 27.5 31.3 19.3 17.6 20.2 24.0 13.7 30.2 23.3 16.1 13.2 20.2 23.4 36.1 15.3 13.5 21.2 27.8 16.0 14.9 20.3 23.5 10.2 24.4 11.1 14.3 20.6 20.1 8.6 10.7 5.0 8.4 9.3 7.6 4.3 12.1 13.4 22.9 24.3 12.6 14.8 14.3 22.0 21.6 12.8 18.1 3.6 13.5 17.0 23.2 15.9 6.8 20.3 25.3 22.1 18.2 15.1 14.5 18.1 20.2 14.3 22.2 30.0 9.8 11.3 29.6 12.1 34.7 16.1 18.2 20.4 16.2 18.7 16.3 15.1 16.0 12.8 18.4 6.3 9.7 13.4 7.3 27.2 19.5 26.2 40.0 33.7 18.3 10.2 18.7 19.5 14.0 21.7 22.1 13.4 8.4 7.1 17.8 21.2 29.2 17.7 13.6 25.0 13.4 0.9 6.3 3.0 4.4 8.4 6.5 7.5 5.8 5.0 10.7 8.6 7.6 5.8 5.0 9.3 5.5 7.4 3.1 4.3 32.1 32.0 28.5 36.9 30.2 27.6 27.5 31.3 30.2 23.5 29.8 16.5 47.2 28.5 30.6 50.7 32.9 15.3 13.4 13.6 33.2 29.5 13.9 23.2 18.7 215.3 21.0 12.2 0.0 17.2 14.7 15.0 35.2 12.7 22.1 8.8 35.0 27.6 19.6 16.8 274.1 20.4 15.7 28.7 5.4 18.5 29.4 17.3 23.7 21.5 21.4 49.7 12.9 26.9 34.1 37.7 33.4 12.2 20.1 19.5 29.4 RPRD1B "C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60" ENSG00000101413 "Regulation of nuclear pre-mRNA domain containing 1B" Q9NQG5 20 38033546-38127780 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 113.9" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066290, HPA070590, HPA072645" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA066290: AB_2685650, HPA070590: , HPA072645: " "unprognostic (3.14e-2)" "unprognostic (3.30e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (2.68e-2)" "unprognostic (4.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.20e-2)" "unprognostic (1.14e-1)" "unprognostic (5.25e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (5.77e-2)" "unprognostic (1.36e-2)" "unprognostic (3.47e-1)" 8.8 9.4 7.5 14.5 8.3 20.9 9.6 9.8 10.0 9.0 10.2 12.5 11.4 7.3 12.9 10.7 10.7 11.5 10.4 16.4 7.6 6.5 10.2 113.9 8.9 13.4 7.9 7.6 10.5 16.2 13.7 8.6 9.4 8.3 10.7 8.6 11.0 9.1 15.5 24.3 9.6 10.2 9.6 7.5 10.7 9.1 10.2 7.2 11.4 10.4 8.4 19.3 12.7 9.0 5.5 8.3 7.3 10.7 5.6 8.9 6.3 15.7 7.1 13.6 6.9 8.9 12.3 14.0 11.4 9.2 12.8 11.5 36.5 14.9 13.2 16.7 7.6 12.5 19.0 12.1 18.5 15.3 6.2 6.9 22.3 9.4 18.2 10.7 16.9 7.6 9.6 18.4 13.2 15.4 8.8 8.0 13.5 19.4 10.6 9.7 11.1 25.0 12.1 7.8 16.5 15.1 16.1 27.8 13.3 6.9 13.2 14.9 10.2 19.8 29.6 13.8 8.7 15.8 15.4 9.3 25.9 15.2 9.7 12.5 13.3 12.5 24.3 15.4 9.9 8.5 0.7 8.3 7.3 7.0 9.4 8.9 5.5 6.8 6.3 8.3 5.1 8.7 7.8 6.7 5.6 10.7 4.4 4.0 6.3 7.5 8.3 9.8 10.0 7.6 6.5 7.9 7.6 8.3 7.2 14.9 21.6 13.0 10.6 14.1 16.1 40.8 20.4 20.1 10.3 17.4 17.7 12.4 13.3 6.5 6.3 13.4 11.7 0.0 7.4 10.0 12.1 16.6 12.7 67.0 10.7 17.5 22.5 28.3 18.8 7.9 9.8 10.9 10.1 3.6 20.1 11.4 7.9 10.5 12.4 14.1 16.2 6.5 8.2 12.6 12.0 16.3 13.0 12.8 13.4 13.6 RPRM "FLJ90327, REPRIMO" ENSG00000177519 "Reprimo, TP53 dependent G2 arrest mediator homolog" Q9NS64 2 153477338-153478808 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.9" "Cell type enhanced" "Detected in some" 12 "Distal tubular cells: 11.6;Sertoli cells: 12.9" "Group enriched" "Detected in many" 8 "glioma: 6.7;testis cancer: 28.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "T-reg: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Group enriched" "Detected in some" 4 "HEK 293: 18.3;MCF7: 20.4;NTERA-2: 14.6;SCLC-21H: 5.4;SH-SY5Y: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (6.66e-2)" "unprognostic (2.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-1)" "unprognostic (1.62e-2)" "unprognostic (5.19e-1)" "unprognostic (5.51e-2)" "unprognostic (3.09e-3)" "unprognostic (2.58e-1)" "unprognostic (6.19e-2)" "unprognostic (6.38e-4)" "unprognostic (5.21e-2)" "unprognostic (1.25e-2)" "unprognostic (8.61e-2)" 2.8 14.6 21.9 0.7 5.3 0.5 0.6 0.4 17.7 14.2 9.6 1.3 4.2 0.6 17.6 7.3 1.2 4.8 0.5 0.6 4.0 11.2 1.2 0.5 1.3 0.6 1.6 4.2 10.5 0.5 0.5 11.5 0.6 3.8 11.0 1.0 4.2 14.3 9.2 0.6 0.9 0.9 15.8 1.5 1.5 5.3 1.6 1.5 0.0 1.6 0.0 0.6 1.7 1.9 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 18.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 20.4 0.0 0.0 14.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 5.4 6.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 21.9 5.3 0.4 10.5 4.0 11.2 1.6 4.2 3.8 1.5 3.0 0.0 0.0 0.7 0.1 4.1 0.3 0.0 1.4 1.2 1.8 0.0 0.3 11.6 0.0 0.4 0.2 0.0 0.0 1.6 0.6 1.3 1.0 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.7 0.0 1.6 12.9 0.8 0.1 1.7 0.3 0.7 0.0 0.0 1.0 RPRML MGC43894 ENSG00000179673 "Reprimo like" Q8N4K4 17 46978156-46979248 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 27.0" "Cell type enriched" "Detected in some" 9 "Intestinal endocrine cells: 30.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "naive B-cell: 1.3" "Lineage enriched" "Detected in single" 13 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 2.6;Daudi: 16.2;HEK 293: 5.0;NTERA-2: 2.5;SCLC-21H: 2.5" "Group enriched" "Detected in many" 13 "amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9" "Region enhanced" "Detected in many" "basal ganglia: 311.4" HPA062668 Uncertain NA NA "HPA062668: AB_2684827" "unprognostic (7.79e-4)" "unprognostic (1.66e-2)" "unprognostic (8.35e-2)" "unprognostic (2.42e-2)" "unprognostic (2.31e-1)" "unprognostic (8.93e-4)" "unprognostic (2.78e-2)" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" 0.8 0.6 6.6 0.6 27.0 0.6 0.8 3.6 16.5 0.6 0.8 0.0 0.0 0.8 0.6 2.5 0.6 0.7 0.6 0.6 4.9 1.3 0.7 0.6 0.6 0.6 0.8 10.1 0.6 0.6 0.6 0.1 0.6 0.0 0.8 0.6 0.4 0.7 0.6 3.9 1.0 0.8 0.6 0.0 0.7 1.3 0.7 2.7 0.0 0.6 0.0 0.6 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.0 0.6 0.9 0.3 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 27.0 3.6 11.6 4.9 1.3 0.8 10.1 0.0 2.7 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 30.5 0.6 0.0 0.0 0.3 0.0 1.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.2 0.0 RPS14 "EMTB, S14" ENSG00000164587 "Ribosomal protein S14" P62263 5 150442635-150449756 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 708.0;pancreas: 483.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018504 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 540000 "Endoplasmic reticulum, Cytosol" "HPA018504: AB_1856463" "unprognostic (5.70e-3)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (8.17e-3)" "unprognostic (7.51e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.36e-1)" "unprognostic (1.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (3.26e-1)" "prognostic unfavorable (8.69e-4)" "unprognostic (1.47e-1)" "unprognostic (8.81e-2)" "unprognostic (2.29e-1)" "unprognostic (8.14e-2)" 60.9 43.2 50.1 64.3 39.1 92.8 111.6 22.6 37.2 85.1 70.3 28.0 50.6 33.6 59.6 86.4 79.4 91.7 57.2 59.2 35.7 30.3 53.6 74.7 57.0 96.6 39.8 32.5 115.1 483.0 17.4 38.9 62.0 35.3 69.7 61.5 41.1 61.8 50.8 93.4 95.0 60.6 67.0 37.0 68.4 58.3 48.5 33.8 84.5 93.9 71.2 83.6 87.1 65.2 360.5 205.3 51.0 166.0 157.4 465.9 708.0 89.3 163.8 85.3 173.6 130.6 245.7 140.0 68.6 115.1 112.0 102.2 223.2 115.2 202.7 101.1 129.6 97.8 71.6 127.5 305.2 76.2 94.0 154.0 73.7 152.0 167.5 185.8 210.2 76.3 186.5 119.5 114.1 269.2 114.3 155.6 135.1 97.1 80.3 141.7 241.1 90.7 177.3 87.8 132.7 139.2 89.1 98.2 217.1 146.5 164.3 94.0 107.1 49.8 249.0 197.0 72.6 109.7 230.7 96.4 60.6 50.9 51.2 92.3 108.9 153.2 133.2 75.6 206.1 39.9 51.0 166.0 36.7 186.2 114.2 261.9 360.5 313.3 226.8 181.1 299.4 465.9 319.4 25.7 157.4 97.0 205.3 196.8 708.0 50.1 39.1 22.6 37.2 35.7 30.3 39.8 32.5 35.3 33.8 1241.7 2223.5 5848.4 7839.1 10367.0 470.3 1738.9 3103.1 1474.9 2518.3 1402.8 174.7 6156.5 3836.4 2863.1 930.3 4248.1 1996.7 1495.1 7588.8 7324.6 4606.0 5276.5 2165.3 3416.6 4101.9 192.3 2300.5 3299.3 4925.3 1358.8 4034.1 6269.0 6141.0 5451.9 4847.3 751.5 5031.6 4334.6 2100.9 3824.8 499.4 1578.1 4450.7 718.4 798.9 13425.3 5960.1 3922.9 6829.3 8560.7 RPS18 "D6S218E, HKE3, KE-3, KE3, S18" ENSG00000231500 "Ribosomal protein S18" P62269 6 33272010-33276510 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 484.7" "Cell type enhanced" "Detected in all" 5 "Suprabasal keratinocytes: 27922.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050159, HPA055007" Approved Supported Cytosol NA NA 90000 Cytosol "HPA050159: AB_2681035, HPA055007: AB_2682668" "prognostic favorable (9.81e-4)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (7.74e-2)" "unprognostic (4.00e-2)" "unprognostic (3.95e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (4.63e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.15e-10)" "unprognostic (7.00e-2)" "unprognostic (4.00e-2)" "unprognostic (2.85e-1)" "unprognostic (9.19e-2)" 67.0 49.1 43.4 126.4 32.2 109.6 132.5 20.9 37.7 99.8 105.5 17.8 48.6 44.6 83.1 109.2 120.3 66.7 92.9 71.5 31.2 26.1 48.1 69.1 69.1 263.7 34.5 35.4 154.5 484.7 8.9 33.0 56.3 26.6 95.9 65.2 37.0 168.4 53.7 107.6 140.4 56.9 99.6 35.8 89.9 56.8 40.2 32.3 94.1 94.3 155.9 90.6 101.6 114.8 98.8 55.7 7.8 30.3 49.6 92.4 130.1 52.1 30.2 40.1 105.2 68.8 136.2 64.6 52.3 76.2 68.8 52.1 76.1 30.5 171.9 56.4 55.4 33.0 38.4 62.9 82.8 54.1 53.8 98.9 64.1 36.0 100.1 134.2 110.7 34.2 147.1 164.0 52.5 157.0 65.0 65.2 51.3 85.1 54.0 60.6 87.3 55.8 123.3 55.2 61.5 43.6 66.8 64.8 115.1 63.3 67.6 46.1 68.0 20.4 104.8 164.4 30.3 71.8 193.0 53.9 32.4 37.8 34.4 68.4 64.8 131.5 131.7 18.1 120.7 39.4 7.8 30.3 3.9 42.7 27.4 72.8 98.8 83.0 60.9 55.7 80.2 92.4 78.5 3.1 49.6 20.2 50.6 61.4 130.1 43.4 32.2 20.9 37.7 31.2 26.1 34.5 35.4 26.6 32.3 1375.7 2198.7 12042.6 13399.3 18243.0 341.9 558.4 4063.7 1350.4 3447.5 1746.4 217.9 7435.2 4327.1 3565.1 899.4 6848.9 2783.6 2266.0 11029.6 11450.2 6671.8 8883.4 2873.3 3644.3 5551.7 151.0 2974.8 4982.4 5437.2 2221.6 9162.8 7322.1 8013.6 5403.2 6713.5 580.3 7620.3 4990.4 3813.6 4409.9 516.0 1972.6 5953.7 913.9 1583.7 27922.0 7341.1 7120.5 12043.3 13812.9 RPS19 "DBA, S19" ENSG00000105372 "Ribosomal protein S19" P39019 19 41859918-41872926 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 546.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063217 Supported Nucleoplasm NA NA 52000 Nucleoplasm "HPA063217: AB_2732699" "unprognostic (8.02e-3)" "unprognostic (9.04e-2)" "unprognostic (5.93e-2)" "unprognostic (1.14e-1)" "unprognostic (7.32e-3)" "unprognostic (1.32e-1)" "unprognostic (2.69e-2)" "unprognostic (9.14e-2)" "unprognostic (1.06e-1)" "unprognostic (6.68e-2)" "unprognostic (5.78e-2)" "unprognostic (9.96e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.16e-1)" "unprognostic (7.55e-2)" "unprognostic (1.58e-1)" "unprognostic (1.72e-2)" 63.2 51.5 41.6 67.3 38.6 116.3 98.2 20.5 36.2 62.3 86.8 29.7 48.4 64.8 89.9 47.7 134.3 75.2 66.9 43.2 31.9 26.5 52.0 110.8 53.6 104.9 48.4 38.1 139.4 121.2 11.7 38.5 69.8 38.4 88.3 53.3 28.9 117.8 41.3 64.7 110.0 62.7 44.9 35.7 110.4 61.4 79.0 36.3 103.3 81.6 95.2 94.4 70.0 138.8 420.3 255.5 23.6 255.6 250.5 376.5 546.5 138.8 201.1 128.9 114.0 168.1 222.6 143.0 108.3 129.4 139.3 124.7 155.6 95.5 205.5 123.1 97.0 67.2 74.0 110.8 184.6 64.9 84.4 204.3 101.3 62.7 159.3 289.1 168.3 105.1 315.1 377.6 83.6 163.2 228.5 139.0 197.4 112.1 143.9 113.3 160.0 154.8 118.8 148.9 395.4 83.6 172.6 103.4 98.8 127.4 150.0 91.9 113.2 59.7 203.9 150.6 203.0 115.1 275.2 107.6 89.8 142.1 59.8 170.2 162.0 169.4 191.3 98.2 145.9 101.9 23.6 116.2 12.4 221.3 206.9 333.3 403.7 329.8 286.1 186.0 420.3 376.5 337.2 17.0 250.5 255.6 255.5 248.1 546.5 41.6 38.6 20.5 36.2 31.9 26.5 48.4 38.1 38.4 36.3 1527.6 2084.4 8605.5 7900.9 11848.7 270.9 645.2 2677.7 1311.6 2599.0 1357.4 119.8 5889.1 2238.2 3795.7 354.1 3914.2 2329.1 1845.5 7458.5 8187.3 3822.9 5482.6 1732.0 2563.4 4139.5 128.7 2143.3 3174.7 4844.3 1450.2 3737.8 5327.2 4322.3 6508.7 4064.5 386.9 6711.2 3300.0 1779.1 2720.9 355.9 1558.7 4061.9 516.1 1479.2 14818.6 5464.6 5600.3 7205.6 6831.8 RPS2 "LLREP3, S2" ENSG00000140988 "Ribosomal protein S2" P15880 16 1962052-1964860 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 284.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055133 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA 140000 "Endoplasmic reticulum, Cytosol" "HPA055133: AB_2682708" "unprognostic (2.98e-2)" "unprognostic (2.44e-1)" "unprognostic (8.43e-2)" "unprognostic (3.49e-2)" "unprognostic (4.15e-2)" "unprognostic (4.39e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (7.43e-2)" "unprognostic (3.17e-1)" "unprognostic (7.23e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-1)" "prognostic unfavorable (3.04e-7)" "unprognostic (1.61e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.47e-1)" 46.1 41.0 28.0 101.8 40.4 97.6 65.9 34.7 30.7 48.2 47.0 22.2 28.8 39.9 45.7 27.1 100.7 61.7 55.7 38.2 19.5 16.0 34.2 107.4 71.1 104.2 36.6 18.6 112.6 284.3 9.6 32.2 45.4 30.1 43.6 32.5 18.3 53.6 28.9 67.3 78.3 47.5 25.8 22.4 131.9 47.8 18.9 28.1 115.2 50.3 114.5 78.3 51.6 77.6 137.5 69.0 18.2 44.9 53.6 125.4 54.7 82.1 119.4 69.2 222.4 100.5 248.0 122.5 56.4 135.8 148.3 105.4 212.5 57.6 157.7 90.4 97.6 49.6 103.4 99.8 189.4 55.8 99.4 197.5 53.2 133.2 190.4 245.5 124.7 87.7 331.0 271.7 123.9 206.3 151.2 143.8 142.6 108.6 89.6 102.3 381.5 156.5 218.6 219.8 106.7 107.9 191.9 112.1 188.6 135.4 78.3 124.1 112.7 55.3 173.7 133.8 63.0 117.1 219.0 65.6 80.0 105.5 19.2 118.1 34.9 57.3 200.7 43.1 108.1 100.4 4.9 37.6 18.2 50.7 44.9 84.6 137.5 99.9 78.4 68.7 117.9 125.4 93.8 7.6 53.6 36.0 69.0 68.1 54.7 28.0 40.4 34.7 30.7 19.5 16.0 36.6 18.6 30.1 28.1 482.4 958.5 7786.3 8744.5 10604.5 334.0 200.5 2094.2 638.4 1375.2 863.7 176.7 7309.9 2722.3 3301.1 203.5 3456.8 1531.9 1775.4 9857.9 13493.6 4843.2 5941.0 994.5 1678.5 5355.9 262.2 2031.1 2492.1 3769.8 337.5 3898.8 5677.6 4852.0 6570.0 4025.4 405.5 5646.9 1494.2 1481.1 1482.6 356.9 1235.3 5926.4 173.6 2431.8 13172.5 6844.1 5004.5 6746.1 10161.2 RPS27 "MPS-1, MPS1, S27" ENSG00000177954 "Ribosomal protein S27" P42677 1 153990755-153992155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 778.4;lymphoid tissue: 769.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "prognostic favorable (9.69e-4)" "unprognostic (1.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.35e-1)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (8.62e-2)" "unprognostic (5.88e-3)" "unprognostic (2.05e-2)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "unprognostic (6.81e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (2.44e-1)" "unprognostic (8.81e-2)" 120.7 72.5 74.9 188.7 118.6 186.7 268.2 51.3 91.4 172.5 114.2 35.9 136.4 58.1 169.0 135.6 107.5 129.0 144.1 176.5 59.6 50.1 98.6 102.5 167.8 769.0 92.1 76.0 317.8 227.2 44.6 91.5 67.5 71.2 117.6 113.6 63.5 248.2 116.1 243.8 160.1 115.9 254.3 65.6 159.3 111.5 119.0 81.9 118.2 113.0 224.0 270.9 162.9 286.0 720.2 296.5 132.9 139.9 324.1 750.5 778.4 103.7 121.7 160.9 87.6 378.8 373.5 99.8 125.8 301.7 169.5 153.2 243.8 114.7 236.3 105.7 181.5 56.5 104.6 141.7 208.3 143.3 114.7 182.7 93.1 161.4 158.1 251.1 206.9 122.8 362.6 409.8 134.8 248.4 252.8 138.9 197.5 113.6 128.5 160.9 260.8 222.5 131.0 194.8 347.8 177.5 142.6 117.8 183.8 156.6 210.3 85.5 190.7 72.1 254.0 218.7 229.1 141.6 415.8 82.0 58.6 97.1 93.4 125.7 258.2 263.2 286.4 101.7 116.2 80.3 132.9 139.9 68.1 393.0 138.9 473.7 720.2 594.4 502.0 179.5 637.3 750.5 579.6 32.4 324.1 127.0 296.5 397.8 778.4 74.9 118.6 51.3 91.4 59.6 50.1 92.1 76.0 71.2 81.9 2045.7 3610.2 12664.6 4456.3 11098.6 390.9 812.1 5699.4 2137.4 3923.0 2044.8 182.6 5213.2 3755.2 3414.7 2254.7 2990.8 2165.3 4461.9 9085.2 5382.4 5444.6 3827.3 4020.8 6408.4 3759.0 181.1 2910.0 5208.2 8634.5 6446.8 6571.4 6944.5 5609.6 8769.4 6097.0 734.9 5926.8 6112.7 3330.7 4371.1 465.9 2690.5 3231.1 1566.2 1451.5 12519.6 5337.4 8309.1 7958.0 4025.9 RPS29 S29 ENSG00000213741 "Ribosomal protein S29" P62273 14 49570984-49599164 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 526.9;pancreas: 892.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004107 Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "HPA004107: AB_1079848" "prognostic favorable (2.66e-4)" "unprognostic (1.38e-1)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (4.40e-3)" "unprognostic (4.13e-2)" "unprognostic (9.95e-2)" "unprognostic (4.21e-2)" "unprognostic (2.98e-2)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (1.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.18e-2)" "unprognostic (1.66e-1)" "unprognostic (7.48e-3)" "unprognostic (7.71e-2)" 59.9 53.6 54.5 108.8 58.9 140.0 155.5 34.4 88.2 68.6 89.6 17.9 67.6 71.4 54.9 67.9 75.3 56.1 63.5 108.2 43.1 33.8 54.5 75.3 74.3 232.1 64.3 56.2 128.3 892.4 8.5 41.6 44.5 53.1 50.6 58.9 29.2 86.0 67.9 177.4 102.6 70.9 76.3 74.6 98.1 63.3 94.0 60.6 53.2 45.6 136.9 101.6 47.1 83.8 303.1 164.3 62.9 102.0 123.1 363.7 526.9 145.4 96.5 101.0 90.4 116.2 198.2 133.8 99.9 85.3 91.3 74.9 97.4 135.0 132.8 114.5 83.9 45.1 127.6 116.0 142.1 101.6 86.6 209.6 104.0 87.5 169.4 142.4 265.3 90.5 204.9 232.7 59.9 175.0 161.0 129.9 232.4 115.9 174.6 88.3 193.6 181.0 165.4 123.2 244.9 272.8 152.2 125.9 152.0 110.0 130.4 76.6 88.3 70.9 131.2 231.4 102.1 171.0 232.2 119.8 70.0 187.8 64.9 88.2 201.8 223.9 179.8 49.3 109.6 67.3 62.9 102.0 46.1 175.8 81.1 219.7 303.1 322.1 227.3 122.6 281.3 363.7 295.6 24.4 123.1 73.4 164.3 181.8 526.9 54.5 58.9 34.4 88.2 43.1 33.8 64.3 56.2 53.1 60.6 1051.1 2086.9 7098.8 857.1 3036.7 210.9 491.6 2858.6 1213.9 2286.2 1018.9 121.7 2892.9 2054.1 2102.7 1067.1 1733.4 2036.9 2266.0 6120.8 4195.6 1983.5 887.8 2827.7 5978.4 2666.5 101.7 2573.6 3469.9 4942.1 2443.6 3469.6 4021.8 1899.7 4276.1 6903.3 431.8 4513.7 4892.2 1520.7 2216.4 241.3 1073.6 1689.2 1106.2 954.6 4278.5 3071.9 5097.1 8179.1 1080.6 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099573-151104652 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 440.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" No No 63000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 71.7 46.9 48.4 69.2 47.7 124.7 160.3 40.4 43.5 114.1 98.4 30.4 61.9 45.0 75.3 84.4 142.8 73.3 53.9 51.1 36.8 33.3 72.8 94.2 79.4 102.5 42.6 43.5 179.5 143.8 18.1 49.3 70.5 38.0 113.3 62.4 39.0 113.8 48.5 116.8 97.1 73.5 62.0 43.1 94.2 64.2 61.9 30.7 120.4 126.8 111.6 90.6 111.4 86.3 211.6 187.7 44.3 92.8 142.9 282.7 440.7 80.5 59.3 113.1 111.1 145.6 285.0 115.5 85.9 132.7 121.8 75.4 114.6 117.8 365.6 43.0 93.6 43.0 53.5 114.6 143.5 115.8 80.5 110.9 78.9 73.3 132.3 168.6 187.3 81.9 211.3 296.1 74.9 199.3 172.0 144.4 137.0 126.9 191.5 144.6 120.4 202.3 222.6 106.1 129.0 45.9 148.2 110.4 122.3 141.0 97.9 108.8 107.7 38.6 141.4 189.2 83.4 94.6 227.8 87.6 59.6 78.9 65.7 94.5 148.9 239.5 223.9 76.5 136.8 70.6 44.3 92.8 27.2 120.6 74.5 203.9 211.6 203.1 157.9 156.5 185.7 282.7 226.9 15.1 142.9 62.1 187.7 145.5 440.7 48.4 47.7 40.4 43.5 36.8 33.3 42.6 43.5 38.0 30.7 902.2 1351.4 4981.2 6887.5 5470.3 389.5 334.4 1689.1 1088.1 1918.8 783.4 113.9 3954.4 3630.9 1946.8 1331.3 2405.0 1231.3 1425.0 3246.4 6519.9 2822.1 4092.8 1400.9 1318.9 2985.4 154.1 2072.9 2006.5 3842.5 3230.8 4100.5 4536.3 3092.4 3236.3 3439.0 634.6 3016.2 2304.0 2436.9 3691.6 432.9 1739.7 3595.7 655.4 688.2 5905.5 3840.1 4239.4 5672.4 6561.2 RPS4Y2 RPS4Y2P ENSG00000280969 "Ribosomal protein S4, Y-linked 2" Q8TD47 Y 20756164-20781032 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 10.7;prostate: 6.8;salivary gland: 3.8;testis: 3.3" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 2.9;Smooth muscle cells: 2.2;Spermatogonia: 2.3;Suprabasal keratinocytes: 5.1" "Cancer enriched" "Detected in single" 9 "prostate cancer: 1.8" "Cell type enriched" "Detected in some" 5 "neutrophil: 10.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.7" "Cell line enriched" "Detected in some" 5 "U-266/84: 6.4" HPA000857 Uncertain NA NA "HPA000857: AB_1079849" "unprognostic (1.50e-2)" "unprognostic (3.63e-1)" "unprognostic (6.39e-6)" "unprognostic (5.92e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 10.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 2.2 0.1 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 1.5 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 1.1 2.3 5.1 0.2 0.0 0.0 0.9 RPS6KA1 "HU-1, p90Rsk, RSK, RSK1" ENSG00000117676 "Ribosomal protein S6 kinase A1" Q15418 1 26529761-26575030 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 45.2" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 85.8;monocytes: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 29.9;U-937: 32.2" "Region enriched" "Detected in all" 5 "cerebellum: 60.4" "Low region specificity" "Detected in all" "CAB003852, HPA007981" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB003852: AB_289590, HPA007981: AB_1079850" "unprognostic (1.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.61e-3)" "prognostic favorable (7.20e-7)" "unprognostic (7.35e-2)" "unprognostic (3.69e-1)" "unprognostic (6.93e-3)" "unprognostic (1.12e-2)" "unprognostic (1.09e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (9.64e-2)" "prognostic favorable (1.84e-4)" "prognostic favorable (4.58e-4)" "unprognostic (4.77e-2)" "unprognostic (7.61e-2)" "prognostic favorable (8.33e-4)" 11.0 8.2 6.3 24.2 9.7 15.8 5.0 14.4 6.3 4.9 23.2 11.1 4.4 24.5 2.1 3.6 8.9 6.0 8.0 3.4 5.3 5.1 13.6 5.4 26.1 32.7 10.3 3.5 2.1 10.1 10.0 7.4 3.3 8.6 8.6 15.8 3.6 19.0 5.5 1.1 9.0 45.2 2.8 7.9 27.0 9.7 2.7 9.0 15.9 13.9 4.9 17.3 6.2 4.5 5.0 22.0 40.1 18.0 7.9 8.3 17.1 9.9 3.5 2.8 3.7 0.1 0.0 3.8 0.8 1.6 4.2 4.1 4.0 8.2 18.5 4.6 0.5 5.1 11.7 6.4 22.9 3.0 15.3 4.1 20.3 8.6 7.1 1.3 23.9 29.9 0.7 8.4 3.9 7.0 1.9 1.8 7.4 3.4 6.7 0.2 5.5 0.8 23.6 7.3 19.3 11.1 12.8 3.6 8.1 12.1 2.7 4.1 1.6 7.0 6.6 3.2 3.1 4.2 20.6 1.2 0.2 5.4 0.7 3.3 4.2 4.9 10.1 2.5 32.2 4.1 9.6 18.0 40.1 8.3 16.4 6.9 4.9 6.1 7.3 22.0 5.0 3.9 5.5 34.5 7.9 17.3 8.6 6.0 17.1 6.3 9.7 14.4 6.3 5.3 5.1 10.3 3.5 8.6 9.0 14.9 23.5 13.7 7.4 16.6 1.3 1.2 10.2 10.7 5.7 8.7 3.9 1.2 6.6 15.5 1.8 4.2 85.8 0.0 16.3 14.5 1.9 13.9 32.2 3.8 43.9 0.0 15.6 12.3 57.1 0.5 0.0 36.8 1.7 68.5 34.3 0.4 21.8 41.9 0.0 13.6 1.7 6.5 2.1 1.1 2.7 10.2 3.4 41.5 32.9 6.8 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.7 3.6 0.0 3.4 3.4 0.0 7.7 4.1 3.4 2.9 2.8 3.0 0.0 0.0 4.1 0.0 0.1 9.1 6.1 8.1 0.0 4.6 0.0 0.1 0.0 3.1 0.0 0.0 1.9 0.0 0.0 3.8 3.8 0.8 0.0 0.0 0.2 2.7 0.0 1.3 0.1 11.0 0.0 11.9 0.0 14.6 0.0 0.6 8.5 0.0 11.7 0.0 4.2 0.0 5.2 2.0 0.0 0.0 0.1 4.4 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 8.9 2.4 2.0 4.4 0.2 19.9 2.0 12.7 6.7 3.4 17.4 23.6 2.1 1.7 0.4 0.4 0.6 3.4 0.0 1.1 0.6 0.3 7.4 0.0 1.5 0.2 1.6 24.0 1.3 0.0 0.0 4.0 0.0 0.0 0.0 5.0 2.8 1.3 2.9 5.6 3.3 18.2 0.0 0.6 3.7 6.3 0.4 1.9 0.0 5.3 4.2 RPS6KL1 MGC11287 ENSG00000198208 "Ribosomal protein S6 kinase like 1" Q9Y6S9 14 74903954-74923396 "Enzymes, Predicted intracellular proteins" "Kinase, Ribonucleoprotein, Ribosomal protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 67.9;Cone photoreceptor cells: 78.5;Horizontal cells: 38.1;Rod photoreceptor cells: 72.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 2.0;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.0;plasmacytoid DC: 5.4" "Group enriched" "Detected in many" 26 "B-cells: 2.0;dendritic cells: 5.4;T-cells: 2.0" "Cell line enhanced" "Detected in many" "HMC-1: 13.0;SCLC-21H: 24.9;SK-BR-3: 14.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027451, HPA027794" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA027451: AB_10599304, HPA027794: AB_10602098" "unprognostic (2.71e-2)" "unprognostic (9.33e-3)" "unprognostic (3.36e-1)" "unprognostic (1.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.44e-2)" "unprognostic (7.49e-4)" "unprognostic (2.06e-1)" "unprognostic (1.54e-1)" "unprognostic (4.09e-3)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.03e-2)" "unprognostic (7.52e-2)" 4.2 7.5 14.7 2.3 13.6 4.2 5.7 18.2 29.1 2.1 4.8 9.0 2.2 3.8 5.1 8.8 5.3 2.5 3.7 10.2 14.3 13.7 2.3 2.1 2.5 2.5 11.1 15.3 1.5 6.7 4.0 10.6 1.4 8.4 2.8 5.6 5.9 3.2 5.4 12.7 1.2 2.8 6.9 8.8 1.7 2.0 11.4 6.8 0.0 3.8 1.2 2.5 1.9 0.8 2.0 5.4 0.1 0.0 0.0 2.0 0.1 2.3 0.3 1.0 3.8 0.1 0.0 4.5 0.4 0.2 1.8 0.5 5.6 1.6 0.0 3.5 0.7 0.5 0.3 1.8 0.3 2.4 0.0 0.8 1.9 0.8 4.2 4.7 2.2 13.0 0.3 3.2 2.0 0.0 0.0 5.9 0.0 2.7 0.7 0.1 7.6 0.0 0.8 0.8 0.7 3.7 1.8 0.0 7.2 1.8 0.0 24.9 3.0 0.3 14.4 2.4 2.0 1.4 1.5 4.0 0.1 0.2 3.1 0.0 10.1 5.3 5.3 1.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 2.0 0.4 0.1 0.0 0.4 1.9 2.0 0.1 0.0 0.0 5.4 0.0 0.1 14.7 13.6 18.2 18.2 14.3 13.7 11.1 15.3 8.4 6.8 0.0 0.0 0.0 1.8 0.7 67.9 5.1 0.0 5.3 0.0 3.5 78.5 1.4 1.7 1.2 6.5 2.6 2.0 0.0 5.3 1.1 1.0 1.6 0.0 2.1 3.0 38.1 6.4 1.3 0.0 5.6 2.0 1.2 3.3 0.0 1.5 4.0 3.1 1.5 2.5 0.8 72.2 6.5 2.7 22.3 15.8 1.1 1.1 1.3 2.5 1.3 RPTN FLJ39117 ENSG00000215853 Repetin Q6XPR3 1 152153595-152159228 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 33.2;skin 1: 19.5;tongue: 71.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 3.7;hTCEpi: 1.9" "HPA030483, HPA030485" Enhanced "Secreted to extracellular matrix" NA NA "HPA030483: AB_2673495, HPA030485: AB_10601159" "unprognostic (1.37e-2)" "unprognostic (5.06e-2)" "unprognostic (2.35e-1)" "unprognostic (4.54e-2)" "unprognostic (4.00e-2)" "unprognostic (5.23e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 71.0 33.2 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridylate synthase domain containing 4" Q96CM3 11 126202094-126211692 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 7.5 6.8 5.1 7.7 7.8 6.0 7.8 8.2 9.6 6.3 6.0 4.8 7.6 6.4 7.0 6.8 7.8 7.2 5.2 13.2 5.1 4.9 6.3 10.2 5.0 7.7 6.5 8.1 10.1 16.1 5.7 5.1 4.5 7.2 6.9 6.9 5.2 9.5 8.2 72.0 8.9 5.9 8.3 4.8 7.6 9.3 7.0 7.1 6.2 7.7 18.2 9.3 6.2 12.0 9.8 11.0 1.0 8.5 8.4 15.2 8.7 6.6 6.7 8.0 9.6 12.6 16.5 5.7 7.5 10.5 8.2 7.3 20.5 13.2 15.7 7.4 6.7 11.4 11.7 18.3 11.5 8.7 13.1 10.1 36.6 7.1 19.2 8.3 19.2 8.4 15.1 17.4 8.9 11.2 12.3 16.4 12.9 22.8 11.6 9.6 6.5 12.0 22.2 8.8 22.7 11.8 14.1 12.2 14.5 12.5 9.7 13.9 9.5 9.6 14.3 7.0 8.7 21.4 10.2 9.9 9.2 6.4 6.9 8.8 4.9 5.2 13.5 4.2 21.9 9.4 1.0 8.5 0.8 10.8 7.7 14.0 9.8 13.3 10.3 11.0 9.5 15.2 12.2 0.7 8.4 8.3 4.7 12.2 8.7 5.1 7.8 8.2 9.6 5.1 4.9 6.5 8.1 7.2 7.1 3.0 6.7 16.7 17.9 24.5 8.9 30.7 12.7 8.1 5.7 7.0 7.9 11.7 8.3 10.7 1.1 11.3 9.7 0.0 16.9 13.7 10.1 10.5 5.7 11.1 11.8 11.1 14.9 8.6 10.2 1.4 8.9 8.5 10.1 21.6 9.3 4.5 13.0 7.0 8.1 11.8 7.6 6.5 10.8 7.7 15.4 21.0 11.1 15.9 15.7 13.3 RRAD "RAD, REM3" ENSG00000166592 "RRAD, Ras related glycolysis inhibitor and calcium channel regulator" P55042 16 66921679-66925644 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 246.0" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 183.7;Cardiomyocytes: 231.4;Sertoli cells: 109.9;Smooth muscle cells: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HDLM-2: 62.2;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA041755 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Golgi apparatus" "HPA041755: AB_2677655" "unprognostic (1.40e-2)" "unprognostic (2.78e-2)" "unprognostic (9.77e-2)" "unprognostic (3.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.11e-1)" "unprognostic (3.74e-2)" "unprognostic (2.37e-1)" "unprognostic (1.66e-1)" "unprognostic (2.46e-2)" "unprognostic (2.12e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-3)" "unprognostic (3.46e-2)" "unprognostic (3.33e-2)" "unprognostic (2.04e-2)" "unprognostic (4.80e-3)" 7.3 2.1 0.4 2.4 2.7 1.3 5.0 1.2 1.7 4.7 2.0 3.2 1.8 1.2 3.3 8.5 20.4 6.3 4.1 61.2 0.7 0.6 5.6 0.8 6.3 1.3 1.5 0.8 4.7 0.7 1.0 2.0 10.7 4.6 4.2 0.4 3.9 4.3 1.4 246.0 2.2 1.2 5.7 1.7 0.8 1.7 2.3 1.2 0.3 3.9 14.7 4.3 4.5 5.7 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 2.8 0.0 0.0 0.0 0.3 0.1 1.6 0.1 0.2 1.4 0.7 1.9 0.0 1.6 0.1 0.5 0.1 0.0 0.1 0.2 62.2 0.1 0.0 0.0 0.7 2.8 0.0 0.2 0.8 0.3 5.0 0.0 1.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 0.2 1.5 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.1 2.0 0.0 0.1 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.7 1.2 1.0 0.7 0.6 1.5 0.8 4.6 1.2 65.5 183.7 3.5 1.9 8.4 12.5 231.4 0.0 83.0 19.4 64.6 9.8 1.0 19.9 33.7 1.5 14.0 4.9 0.0 2.7 2.7 26.9 9.8 33.5 0.0 1.3 1.6 10.2 1.3 1.5 0.4 0.6 14.2 21.9 1.0 2.7 1.5 34.5 1.7 4.9 5.8 3.0 109.9 182.3 1.7 1.9 8.8 4.7 2.2 3.0 2.6 RRAGD "bA11D8.2.1, DKFZP761H171" ENSG00000025039 "Ras related GTP binding D" Q9NQL2 6 89364636-89412270 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 118.0;Distal tubular cells: 99.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.3" "Group enriched" "Detected in many" 7 "granulocytes: 6.3;monocytes: 3.9" "Cell line enhanced" "Detected in many" "Karpas-707: 28.2;SCLC-21H: 14.8;U-266/70: 35.7;U-266/84: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068664 Approved Approved Nucleoplasm,Vesicles,Centrosome NA NA Nucleoplasm "Vesicles, Centrosome" "HPA068664: AB_2686016" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.53e-3)" "unprognostic (1.09e-1)" "unprognostic (2.03e-1)" "unprognostic (2.09e-1)" "prognostic unfavorable (7.80e-4)" "unprognostic (3.75e-2)" "unprognostic (1.66e-2)" "unprognostic (4.33e-2)" "unprognostic (1.11e-2)" "unprognostic (1.00e-1)" "prognostic favorable (8.47e-8)" "unprognostic (8.41e-3)" "unprognostic (1.23e-1)" "unprognostic (9.46e-2)" "unprognostic (4.40e-2)" 8.1 8.4 9.2 2.6 12.8 8.9 8.8 22.4 16.3 8.7 3.3 7.9 3.1 2.2 2.1 6.6 12.8 11.9 3.7 29.9 8.6 7.4 21.8 5.0 6.4 2.8 8.5 7.9 2.2 6.4 16.0 11.5 3.4 10.7 5.9 2.4 12.8 38.7 4.2 60.0 5.5 2.1 7.5 12.6 4.4 2.3 6.1 9.2 4.1 23.3 13.9 5.2 9.2 9.3 0.1 0.7 6.3 3.9 0.1 0.6 0.3 0.0 0.7 1.9 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.7 0.0 10.0 0.0 10.7 0.0 0.0 0.0 5.3 2.4 0.0 0.0 0.8 7.1 8.5 0.2 0.6 0.0 0.0 0.0 0.0 7.4 0.2 28.2 0.0 0.7 3.4 3.5 1.6 0.0 0.7 7.1 10.3 0.1 2.6 0.2 14.8 0.8 0.2 1.0 12.0 0.6 0.3 5.6 0.0 0.8 1.2 5.1 1.3 35.7 16.5 0.0 2.7 5.4 0.8 3.9 1.2 2.6 0.0 1.1 0.1 0.1 0.4 0.0 0.7 0.0 0.3 0.6 6.3 0.1 3.9 0.6 0.0 0.3 9.2 12.8 22.4 9.1 8.6 7.4 8.5 7.9 10.7 9.2 8.9 11.8 7.5 12.1 14.3 18.0 118.0 15.3 13.4 5.7 14.0 29.5 0.4 99.5 14.2 15.2 3.6 0.0 0.0 14.9 1.2 6.0 29.7 4.6 8.6 46.1 44.5 1.2 3.1 19.9 10.4 2.8 8.5 37.1 5.4 0.3 18.0 12.3 0.0 3.9 15.6 14.2 0.0 6.6 8.4 25.7 19.7 0.6 1.5 0.0 25.7 RRBP1 "ES/130, hES" ENSG00000125844 "Ribosome binding protein 1" Q9P2E9 20 17613678-17682295 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 136.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 18.8;plasmacytoid DC: 23.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009026, HPA011924" Enhanced Enhanced "Endoplasmic reticulum" NA NA 44000 "Endoplasmic reticulum" "HPA009026: AB_1079852, HPA011924: AB_1856476" "unprognostic (1.56e-3)" "unprognostic (2.26e-3)" "unprognostic (8.46e-2)" "prognostic favorable (1.41e-4)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (6.63e-2)" "unprognostic (9.21e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.38e-4)" 19.9 18.3 6.7 16.1 11.2 5.9 13.8 4.9 7.4 22.1 23.6 17.8 49.5 18.5 16.3 24.4 17.1 12.3 37.3 15.8 7.8 6.3 27.1 88.9 20.5 10.6 13.0 5.6 23.4 136.1 24.7 18.4 51.4 10.4 19.4 16.7 14.8 84.2 56.0 7.7 11.0 32.2 13.0 13.3 20.4 30.0 12.1 12.2 5.0 32.8 11.6 19.2 18.7 18.9 0.9 23.5 18.8 4.7 5.7 2.5 1.5 30.4 21.7 6.5 14.6 30.1 32.7 34.4 47.8 40.2 20.2 27.5 48.3 28.8 11.8 16.1 45.1 20.9 30.7 7.0 38.8 16.6 5.4 5.4 13.6 6.3 49.8 43.3 5.0 17.2 43.1 11.7 32.7 19.4 30.0 19.9 4.2 5.6 11.5 30.3 13.8 1.9 11.5 7.6 67.9 21.0 3.5 17.3 40.5 17.1 10.4 3.3 2.5 27.2 64.6 19.6 14.5 11.3 7.7 35.7 43.3 16.1 22.4 15.7 21.1 16.0 3.9 16.4 5.4 22.0 5.4 4.7 18.8 2.5 2.9 1.7 0.5 0.8 1.4 2.4 0.9 0.8 0.9 4.2 5.7 4.0 23.5 0.7 1.5 6.7 11.2 4.9 7.4 7.8 6.3 13.0 5.6 10.4 12.2 89.3 202.0 34.3 70.6 52.5 17.0 30.9 147.7 131.2 145.6 90.7 29.5 233.8 38.1 171.5 35.2 132.5 313.0 0.0 359.4 194.5 183.3 135.6 113.5 227.0 102.0 23.8 93.1 135.1 51.8 28.3 117.6 73.6 67.4 86.6 259.3 193.4 291.3 208.5 78.1 62.7 35.4 32.3 138.2 74.8 93.6 48.8 445.7 36.3 168.2 180.5 RRH peropsin ENSG00000180245 "Retinal pigment epithelium-derived rhodopsin homolog" O14718 4 109827994-109844604 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "retina: 66.3" "Cell type enriched" "Detected in single" 53 "Muller glia cells: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.3" "Lineage enriched" "Detected in single" 7 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "hTCEpi: 4.1;U-266/84: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.59e-1)" "unprognostic (2.47e-2)" "unprognostic (4.94e-2)" "unprognostic (1.96e-2)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "unprognostic (7.56e-2)" "unprognostic (8.47e-2)" "unprognostic (2.33e-1)" "unprognostic (1.86e-2)" "unprognostic (2.03e-2)" "unprognostic (1.62e-3)" "unprognostic (4.65e-1)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-1)" "unprognostic (3.18e-2)" 0.4 1.4 1.3 0.5 1.2 0.3 2.1 3.7 1.8 0.8 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.4 0.4 1.2 1.2 1.9 1.0 0.4 0.5 1.2 0.6 0.6 0.5 0.7 0.5 0.4 0.4 0.9 0.8 66.3 0.5 0.7 0.7 2.3 0.4 0.4 0.8 0.5 0.4 0.7 0.4 0.4 0.9 0.4 0.4 0.4 0.4 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.2 0.9 0.7 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.2 0.3 0.9 0.8 0.3 0.0 0.0 2.2 0.1 0.2 1.0 0.9 0.1 0.0 0.3 0.1 1.5 0.0 0.0 4.1 0.0 0.3 0.4 0.2 0.7 1.0 0.3 0.7 0.1 1.2 1.6 0.5 0.7 0.2 1.0 0.2 0.6 2.1 0.2 1.1 0.3 0.0 0.4 0.1 0.5 0.8 0.5 0.4 0.0 0.3 0.5 0.1 0.6 4.7 0.0 0.3 0.5 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.3 1.2 3.7 1.4 1.2 1.2 1.2 0.6 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 RRM1 ENSG00000167325 "Ribonucleotide reductase catalytic subunit M1" P23921 11 4094707-4138876 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA replication" "Allosteric enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022093, HPA057265, HPA064297" Enhanced Supported Cytosol NA Yes 13000 Cytosol "CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236" "unprognostic (4.47e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-3)" "unprognostic (3.65e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (1.31e-2)" "unprognostic (3.43e-2)" "unprognostic (6.90e-2)" "unprognostic (1.06e-3)" "unprognostic (4.21e-2)" "unprognostic (6.88e-3)" "unprognostic (9.20e-3)" "unprognostic (6.16e-2)" "unprognostic (8.41e-2)" "unprognostic (9.93e-3)" 13.9 25.3 8.0 15.2 12.2 18.5 14.4 18.0 12.6 15.7 15.9 11.1 11.5 11.9 13.0 9.8 25.4 10.7 8.7 11.9 7.9 9.0 9.2 13.1 11.0 20.2 9.0 10.3 13.6 10.7 24.2 11.2 22.7 18.4 14.0 18.9 12.0 15.4 10.7 28.3 26.8 12.5 17.5 10.7 12.4 13.8 10.5 9.1 78.6 9.8 28.0 27.1 17.5 18.5 5.6 4.3 3.3 8.3 5.7 24.3 6.0 46.1 25.1 41.1 23.9 6.3 12.6 16.0 42.5 21.1 48.4 50.0 22.5 35.1 50.0 10.3 21.2 21.0 37.1 38.1 30.6 57.3 24.5 40.4 25.4 37.6 17.5 2.5 43.4 18.6 5.9 8.3 26.5 19.1 10.6 23.2 30.2 33.1 23.6 40.3 20.9 51.1 9.4 26.0 32.1 25.5 41.4 32.1 17.8 13.3 13.1 35.2 19.3 37.4 22.6 6.8 17.3 22.3 15.2 13.2 45.5 23.8 45.1 31.2 15.5 21.4 54.6 25.3 29.1 28.2 3.3 2.5 2.6 7.7 6.5 13.3 5.6 14.2 10.7 4.3 3.5 11.3 9.2 0.0 5.7 8.3 2.7 24.3 6.0 8.0 12.2 18.0 12.6 7.9 9.0 9.0 10.3 18.4 9.1 17.9 11.8 16.4 16.8 29.8 14.7 30.7 17.8 17.4 21.6 17.4 5.9 33.4 6.6 22.3 59.0 10.8 9.7 70.0 19.4 48.6 21.4 12.0 6.9 14.8 24.3 17.5 17.3 11.6 8.6 43.8 12.0 10.6 10.1 9.0 17.5 21.8 14.0 11.8 15.6 6.3 20.0 12.9 21.5 60.8 31.3 25.3 33.2 15.8 24.7 13.6 RRM2 ENSG00000171848 "Ribonucleotide reductase regulatory subunit M2" P31350 2 10120698-10131419 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA replication" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 120.9" "Cell type enhanced" "Detected in many" 19 "Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Lineage enriched" "Detected in many" 6 "T-cells: 10.4" "Low cell line specificity" "Detected in many" HPA056994 Enhanced Supported Cytosol Yes Yes Cytosol "HPA056994: AB_2683304" "unprognostic (2.10e-2)" "unprognostic (1.62e-1)" "unprognostic (6.40e-3)" "unprognostic (4.42e-3)" "unprognostic (5.70e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.39e-5)" "unprognostic (1.04e-3)" "unprognostic (6.67e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.11e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.05e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-1)" "unprognostic (2.09e-2)" 4.7 2.2 0.4 32.6 0.4 29.0 4.2 0.4 0.9 3.5 9.3 0.4 0.4 5.2 2.1 1.7 21.6 0.7 5.0 3.3 0.4 0.5 2.0 3.9 5.7 16.4 0.6 0.1 0.9 2.9 0.0 0.7 5.4 0.3 1.0 10.6 0.1 2.9 0.0 0.5 2.8 11.3 3.2 0.8 19.8 5.4 8.0 0.0 120.9 0.8 22.3 33.1 3.8 5.2 1.4 0.3 0.6 0.2 1.8 10.4 2.6 29.5 17.9 25.4 17.4 2.2 4.1 25.1 48.3 24.0 34.5 37.6 29.9 14.1 27.1 6.7 15.1 35.0 14.5 41.0 24.9 42.3 60.8 15.8 52.3 17.2 26.3 0.1 38.7 25.1 1.5 0.5 42.2 3.6 5.7 27.9 21.0 21.9 80.5 42.9 22.3 42.7 20.8 20.5 30.4 21.0 32.2 55.4 18.6 17.0 22.5 25.1 20.7 39.7 28.2 4.9 11.0 15.2 6.9 9.7 26.5 38.5 19.8 67.7 52.3 41.0 55.4 18.8 32.9 38.0 0.3 0.1 0.1 3.7 0.0 0.0 1.4 2.6 2.9 0.2 0.4 0.2 1.2 0.6 1.8 0.2 0.3 10.4 2.6 0.4 0.4 0.4 0.9 0.4 0.5 0.6 0.1 0.3 0.0 3.0 1.0 2.2 1.0 9.3 0.0 1.2 2.5 5.3 1.2 0.0 0.0 5.4 1.7 0.5 3.0 0.3 2.6 93.5 0.0 192.1 3.6 1.1 5.7 1.7 40.1 0.0 0.0 5.5 5.9 5.7 0.3 3.5 0.0 0.0 7.9 0.0 0.5 0.0 0.4 1.6 0.0 0.0 0.3 5.2 44.5 1.4 40.7 7.2 13.0 2.0 RRP12 KIAA0690 ENSG00000052749 "Ribosomal RNA processing 12 homolog" Q5JTH9 10 97356358-97426076 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 62.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 19.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049945, HPA074403" Supported "Nucleoli,Vesicles,Plasma membrane,Cytosol" No No Nucleoli "Vesicles, Plasma membrane, Cytosol" "HPA049945: AB_2680965, HPA074403: " "unprognostic (2.79e-1)" "unprognostic (7.65e-2)" "unprognostic (5.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.42e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.12e-8)" "unprognostic (2.64e-1)" "unprognostic (1.30e-2)" "unprognostic (1.54e-1)" "unprognostic (3.94e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.54e-5)" "unprognostic (2.58e-2)" "unprognostic (3.32e-1)" "unprognostic (4.81e-2)" "unprognostic (6.99e-3)" 7.1 8.4 5.9 7.4 11.9 62.6 4.6 3.8 15.7 4.1 4.0 5.4 2.9 5.2 6.4 3.9 7.1 6.4 6.4 8.4 4.4 7.2 4.4 9.3 5.6 6.0 5.9 6.1 6.0 16.4 9.6 10.6 3.9 9.6 5.5 3.6 4.1 6.6 3.9 31.7 8.2 3.8 5.3 3.2 7.1 5.3 13.9 6.1 4.6 4.9 7.2 5.4 4.2 4.3 3.4 4.3 19.3 11.1 1.2 2.4 3.7 15.9 21.4 5.7 12.3 4.4 5.2 12.5 10.1 6.1 10.5 8.2 23.2 14.8 17.6 13.2 6.4 9.4 20.6 15.6 11.7 7.1 9.6 18.7 13.6 8.0 18.0 7.3 21.1 17.9 5.4 16.6 25.8 23.9 11.9 5.9 9.9 19.4 11.8 5.9 20.8 14.3 13.6 24.5 8.5 14.5 15.7 7.8 17.4 7.3 8.9 7.7 16.4 8.1 7.8 10.1 4.6 18.8 11.0 7.7 7.1 12.2 15.8 31.9 24.2 21.0 20.7 10.1 27.2 7.5 0.2 7.3 4.6 2.0 9.3 2.4 2.9 1.2 1.6 4.3 3.4 1.9 2.1 19.3 1.2 11.1 3.6 0.8 3.7 5.9 11.9 3.8 15.7 4.4 7.2 5.9 6.1 9.6 6.1 32.8 39.8 13.7 10.9 20.8 6.2 9.5 7.6 25.4 34.2 14.0 39.3 4.4 0.0 9.1 5.6 6.7 3.9 0.0 7.4 5.9 7.6 10.1 39.4 6.8 10.4 4.8 20.6 4.9 10.8 3.6 3.4 8.4 6.8 1.0 7.2 2.2 7.8 5.1 2.5 6.8 12.3 0.0 6.1 9.9 18.4 17.1 7.7 4.4 7.8 12.4 RS1 "RS, XLRS1" ENSG00000102104 "Retinoschisin 1" O15537 X 18639910-18672109 "Disease related genes, Predicted secreted proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 54.9" "Group enriched" "Detected in some" 8 "Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 121.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA059546 Enhanced "Secreted in other tissues" NA NA "HPA059546: AB_2684058" "unprognostic (8.31e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (4.80e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-2)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.77e-3)" "unprognostic (4.14e-1)" "unprognostic (7.03e-2)" "unprognostic (1.06e-1)" "unprognostic (3.06e-2)" "unprognostic (5.12e-2)" "unprognostic (2.04e-4)" 0.1 0.0 1.0 0.1 2.3 0.0 0.1 0.6 3.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.4 0.4 0.1 5.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 54.9 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.1 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.1 0.0 1.0 2.3 0.6 2.4 1.0 0.4 0.1 0.1 0.1 0.1 6.0 0.0 0.0 0.0 0.0 12.9 0.8 0.0 0.0 0.0 0.0 151.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 RSAD2 "cig5, vig1, viperin" ENSG00000134321 "Radical S-adenosyl methionine domain containing 2" Q8WXG1 2 6865806-6898239 "Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" Atherosclerosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 31.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 32.8;Ciliated cells: 17.4;granulocytes: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 24.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 24.3" "Group enriched" "Detected in some" 5 "BJ hTERT+ SV40 Large T+: 31.1;BJ hTERT+ SV40 Large T+ RasG12V: 48.0;HMC-1: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA041160, HPA049409" Approved Supported "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA041160: AB_10795489, HPA049409: AB_2680751" "unprognostic (8.91e-2)" "unprognostic (3.85e-2)" "unprognostic (7.89e-2)" "prognostic unfavorable (4.60e-4)" "unprognostic (3.27e-1)" "unprognostic (3.25e-1)" "unprognostic (1.95e-1)" "unprognostic (2.29e-1)" "unprognostic (3.32e-2)" "unprognostic (3.66e-3)" "unprognostic (9.47e-3)" "unprognostic (4.06e-2)" "unprognostic (1.27e-2)" "unprognostic (3.98e-2)" "unprognostic (4.54e-3)" "unprognostic (4.47e-2)" "unprognostic (1.79e-1)" 31.8 3.1 4.8 10.1 8.7 12.5 4.1 1.1 7.8 7.2 5.6 4.7 2.1 3.4 4.8 7.8 2.9 5.5 6.2 5.3 5.3 5.8 6.1 3.6 15.3 7.7 4.8 5.6 3.5 2.1 1.2 6.2 10.1 12.5 3.7 3.1 7.5 20.2 2.5 5.5 1.0 4.9 5.2 6.1 10.8 7.2 2.3 2.0 11.5 10.2 3.5 2.8 4.0 2.0 0.4 2.7 24.3 5.1 1.6 3.2 2.2 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.5 31.1 48.0 0.0 1.0 0.5 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 22.4 0.0 0.0 2.1 0.0 0.0 0.0 1.3 0.5 0.4 0.0 0.0 2.8 0.6 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.5 0.1 14.6 3.6 24.3 1.8 5.1 2.2 0.2 1.9 1.7 2.7 0.4 3.2 2.4 14.4 1.6 4.5 0.2 0.9 2.2 4.8 8.7 1.1 7.8 5.3 5.8 4.8 5.6 12.5 2.0 32.8 4.6 0.0 2.8 0.5 0.2 2.5 5.1 17.4 3.4 0.0 2.0 0.6 0.0 3.3 0.9 9.1 2.5 0.0 5.3 0.7 1.5 3.3 23.1 0.4 7.8 0.0 8.6 11.1 2.4 0.4 1.4 7.4 0.0 2.8 1.6 6.2 5.4 0.3 2.1 0.0 0.6 0.0 3.1 0.2 0.4 0.3 2.4 2.2 0.4 6.3 RSPH1 "CILD24, FLJ32753, RSP44, RSPH10A, TSGA2" ENSG00000160188 "Radial spoke head 1 homolog" Q8WYR4 21 42472486-42496354 "Disease related genes, Predicted intracellular proteins" Meiosis "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.4;fallopian tube: 85.5" "Cell type enriched" "Detected in many" 8 "Ciliated cells: 938.2" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 6.7" "Lineage enriched" "Detected in single" 11 "dendritic cells: 6.7" "Group enriched" "Detected in some" 4 "MCF7: 7.6;OE19: 27.9;RPTEC TERT1: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016816, HPA017382" Enhanced Supported Centrosome NA NA Centrosome "HPA016816: AB_1858393, HPA017382: AB_1858392" "unprognostic (1.76e-3)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.12e-3)" "unprognostic (5.48e-2)" "unprognostic (2.43e-1)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" "unprognostic (2.53e-1)" "unprognostic (1.46e-1)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (1.10e-2)" "unprognostic (8.41e-2)" "unprognostic (2.58e-2)" "unprognostic (5.22e-3)" "unprognostic (1.99e-1)" 0.6 2.5 11.5 0.9 16.4 0.7 1.7 1.2 4.7 4.5 2.6 15.9 3.1 4.5 3.6 22.5 1.0 85.5 3.8 0.6 11.6 15.0 3.8 0.8 17.4 0.7 4.8 4.5 12.9 2.2 4.8 21.4 0.6 38.4 2.2 2.5 1.0 0.9 2.4 0.9 2.4 4.1 1.1 4.6 0.6 3.4 21.9 7.7 0.2 4.8 0.0 0.7 1.5 0.2 0.6 6.7 0.5 0.3 0.0 0.3 0.3 1.1 0.9 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.4 0.1 0.4 0.0 0.3 1.4 0.0 0.4 0.0 0.1 0.0 3.8 0.4 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 7.6 0.1 0.2 0.2 27.9 0.4 0.0 0.2 0.0 11.4 0.9 1.8 0.7 1.8 2.7 0.2 0.0 3.1 0.3 0.1 0.0 0.1 0.1 0.0 0.3 1.7 0.1 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.2 0.1 0.4 0.3 0.3 0.3 0.6 0.3 0.2 0.2 0.0 0.1 6.7 0.2 0.3 11.5 16.4 1.2 4.7 11.6 15.0 4.8 4.5 38.4 7.7 0.0 3.8 0.5 4.2 4.5 10.6 0.6 22.9 938.2 117.2 17.4 35.3 0.0 33.2 9.3 60.0 0.8 10.6 0.0 3.4 0.0 0.4 12.6 0.0 0.0 0.1 3.2 8.6 0.0 0.0 85.8 1.7 0.3 0.0 1.8 9.8 10.5 2.3 10.5 2.5 14.3 26.5 0.0 0.3 90.5 12.3 4.0 0.7 0.0 8.5 5.8 RSPH10B ENSG00000155026 "Radial spoke head 10 homolog B" P0C881 7 5925550-5970683 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "fallopian tube: 9.6;testis: 20.8" "Group enriched" "Detected in some" 16 "Ciliated cells: 69.6;Early spermatids: 44.5;Late spermatids: 98.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enhanced" "Detected in some" "hTCEpi: 2.9" HPA049182 Supported NA NA "HPA049182: AB_2680666" "unprognostic (4.96e-2)" "unprognostic (1.67e-1)" "unprognostic (3.47e-1)" "unprognostic (5.31e-2)" "unprognostic (9.41e-3)" "unprognostic (2.80e-1)" "unprognostic (2.88e-3)" "unprognostic (1.11e-3)" "unprognostic (2.93e-3)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (1.76e-3)" "unprognostic (1.75e-2)" "unprognostic (4.06e-2)" "unprognostic (5.80e-2)" "unprognostic (1.31e-3)" 0.0 0.1 1.1 0.0 1.3 0.0 0.0 0.2 0.2 0.8 0.0 0.0 0.3 0.2 0.0 9.6 0.0 0.0 1.5 1.6 0.0 0.2 1.4 0.0 0.1 0.0 0.0 2.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 20.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.7 0.1 0.2 1.0 0.0 0.4 0.2 0.0 0.0 0.2 0.1 0.1 0.4 0.2 0.4 0.8 0.3 0.2 0.0 0.1 0.6 1.1 0.4 0.2 1.9 0.6 0.0 0.5 0.4 2.9 0.1 0.5 0.0 0.1 0.1 1.0 0.7 1.0 0.2 0.5 0.4 1.6 0.0 0.7 0.4 0.4 0.1 0.0 0.0 0.0 0.6 0.1 0.7 0.1 1.2 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.9 1.3 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 69.6 4.5 0.0 0.0 0.0 0.0 0.0 44.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 98.8 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.9 0.3 0.0 0.0 0.0 0.0 RSPH10B2 ENSG00000169402 "Radial spoke head 10 homolog B2" B2RC85 7 6754109-6799365 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 10.7;testis: 19.3" "Group enriched" "Detected in some" 7 "Ciliated cells: 84.3;Early spermatids: 26.3;Late spermatids: 46.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.0;SH-SY5Y: 1.4;U-266/84: 3.3" HPA049182 Supported NA NA "HPA049182: AB_2680666" "unprognostic (7.74e-2)" "unprognostic (1.60e-1)" "unprognostic (2.28e-2)" "unprognostic (5.35e-3)" "unprognostic (3.41e-1)" "unprognostic (3.05e-3)" "unprognostic (2.58e-2)" "unprognostic (4.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" "unprognostic (1.13e-1)" "unprognostic (1.69e-5)" "unprognostic (1.66e-1)" "unprognostic (4.38e-2)" "unprognostic (8.27e-3)" "unprognostic (7.02e-2)" 0.0 0.0 0.4 0.0 0.9 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.3 0.0 10.7 0.0 0.0 0.9 1.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.1 0.4 0.8 0.0 0.1 2.0 0.1 0.0 0.2 0.0 0.1 0.0 0.8 0.0 0.0 0.5 0.0 1.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.1 1.0 0.1 0.1 1.1 0.0 0.3 0.0 0.9 0.0 0.3 0.2 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.4 0.2 0.0 0.3 3.3 0.0 0.4 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 84.3 7.9 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;testis: 24.8" "Group enriched" "Detected in some" 6 "Ciliated cells: 53.5;Early spermatids: 109.2;Late spermatids: 198.9" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Cell line enhanced" "Detected in many" "GAMG: 6.5;RPTEC TERT1: 6.9;U-266/70: 7.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA018420, HPA050425" Approved Uncertain Nucleoli NA NA Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favorable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.8 3.0 4.8 0.5 6.8 0.4 0.5 1.2 8.8 1.4 0.7 2.6 0.9 0.4 1.3 4.9 0.6 15.3 1.8 0.3 4.7 4.7 9.3 0.3 1.8 0.5 2.9 3.3 5.5 0.6 0.9 3.1 0.4 6.4 1.1 0.5 1.0 1.0 2.4 0.9 1.6 0.4 0.6 1.6 0.4 0.8 24.8 1.6 0.0 2.7 0.0 0.5 0.6 0.3 0.1 0.0 10.8 2.0 0.2 0.3 0.6 0.4 3.9 3.5 3.3 0.0 1.6 0.2 0.0 0.8 0.7 0.6 0.7 1.2 0.8 1.2 0.0 6.5 0.1 0.2 0.0 0.0 0.0 0.2 0.4 0.2 1.5 0.2 0.2 1.7 0.0 0.4 0.6 0.0 2.0 0.0 1.4 0.1 1.7 0.0 0.5 0.8 0.6 0.0 1.0 0.1 0.2 0.1 3.7 6.9 0.0 4.5 2.1 0.1 0.1 0.2 0.2 0.7 0.8 0.0 3.1 0.8 0.2 0.0 7.9 3.0 2.2 2.5 0.4 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 10.8 0.2 2.0 0.0 0.1 0.6 4.8 6.8 1.2 8.8 4.7 4.7 2.9 3.3 6.4 1.6 0.0 0.0 0.0 0.6 0.0 0.8 0.0 2.5 53.5 6.8 0.0 3.9 0.0 6.6 0.7 109.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 11.1 0.0 0.6 0.0 198.9 2.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 1.8 13.9 4.5 0.0 0.0 21.7 7.5 0.0 0.0 0.0 0.0 0.3 RSPH4A "CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B" ENSG00000111834 "Radial spoke head 4 homolog A" Q5TD94 6 116616479-116632985 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7" "Cell type enriched" "Detected in many" 10 "Ciliated cells: 365.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.6" "Group enriched" "Detected in many" 4 "basal ganglia: 9.4;pons and medulla: 19.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 7.6;U-266/84: 5.5" "Low region specificity" "Detected in many" "HPA031196, HPA031197, HPA031198" Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025" "unprognostic (9.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (9.69e-3)" "unprognostic (9.37e-2)" "unprognostic (1.13e-3)" "unprognostic (4.52e-1)" "unprognostic (1.07e-1)" "unprognostic (1.06e-1)" "unprognostic (5.08e-2)" "unprognostic (9.56e-5)" "unprognostic (2.87e-1)" "unprognostic (2.69e-4)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (3.55e-2)" "unprognostic (5.21e-2)" 0.5 0.7 1.8 0.5 9.4 0.9 0.7 1.2 0.9 2.2 0.4 10.2 0.4 0.5 1.9 13.3 0.4 35.9 0.8 0.5 3.0 3.3 0.7 0.4 11.1 0.5 0.5 1.1 13.7 0.6 2.8 16.7 0.3 19.8 0.6 0.4 0.2 0.4 0.5 1.0 0.6 0.4 0.6 0.7 1.0 0.8 6.6 1.8 0.0 1.0 0.0 0.5 0.4 0.1 0.8 0.1 1.3 0.2 0.2 1.0 0.0 0.1 0.2 1.4 3.2 0.1 0.1 0.3 0.4 0.8 0.6 0.8 0.7 1.1 1.0 0.3 0.1 1.2 0.2 0.3 0.6 0.6 0.8 1.1 0.4 0.5 1.2 0.0 0.8 1.1 0.4 0.2 1.0 0.2 0.1 0.0 0.9 0.2 0.1 0.6 0.2 0.7 0.1 0.6 0.1 0.1 0.8 1.6 7.6 3.2 0.4 2.8 1.2 0.2 0.2 0.5 0.3 0.5 0.6 0.5 0.4 0.7 0.5 0.5 0.5 5.5 0.4 0.1 0.4 0.5 1.3 0.2 0.8 1.0 0.1 0.1 0.4 0.3 0.0 0.0 0.8 0.2 0.5 0.0 0.2 0.1 0.1 0.0 0.0 1.8 9.4 1.2 0.7 3.0 3.3 0.5 1.1 19.8 1.8 3.0 4.3 0.0 0.0 0.0 3.0 0.4 0.0 365.4 35.2 0.0 2.0 0.0 1.7 0.4 18.2 0.1 0.0 0.0 0.3 0.1 0.0 0.1 2.3 0.0 0.1 1.6 0.0 2.5 0.0 8.7 0.3 0.0 1.7 0.0 0.0 1.7 0.2 0.0 0.0 0.0 3.2 0.0 0.4 4.4 1.5 0.1 0.2 0.0 0.0 0.0 RSPH6A "RSHL1, RSP4, RSP6, RSPH4B" ENSG00000104941 "Radial spoke head 6 homolog A" Q9H0K4 19 45795710-45815319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 48.1" "Cell type enriched" "Detected in some" 10 "Early spermatids: 57.7" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "RPMI-8226: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA045382 Enhanced NA NA "HPA045382: AB_10959735" "unprognostic (1.99e-1)" "unprognostic (3.23e-1)" "unprognostic (6.55e-2)" "unprognostic (1.57e-1)" "unprognostic (2.72e-3)" "unprognostic (4.16e-4)" "unprognostic (2.33e-1)" "unprognostic (5.89e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-5)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (5.99e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.8 0.6 0.0 0.1 0.0 0.0 0.0 RSPH9 "C6orf206, CILD12, FLJ30845, MRPS18AL1" ENSG00000172426 "Radial spoke head 9 homolog" Q9H1X1 6 43645046-43672599 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.9;testis: 48.4" "Group enriched" "Detected in many" 6 "Ciliated cells: 240.9;Early spermatids: 153.2;Spermatocytes: 76.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 5.4;U-87 MG: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031703 Enhanced NA NA "HPA031703: AB_10602126" "unprognostic (2.54e-2)" "unprognostic (1.85e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" "unprognostic (7.28e-2)" "unprognostic (6.62e-2)" "unprognostic (1.81e-3)" "unprognostic (2.78e-3)" "unprognostic (6.42e-2)" "unprognostic (7.27e-2)" "unprognostic (6.89e-3)" "unprognostic (1.33e-1)" "unprognostic (2.62e-4)" "unprognostic (1.48e-1)" "unprognostic (2.42e-2)" "unprognostic (1.16e-2)" "unprognostic (3.73e-2)" 0.6 1.1 3.6 0.7 2.9 1.3 0.6 1.3 3.8 1.4 0.6 2.7 2.4 0.8 2.6 4.1 0.7 15.9 1.0 1.0 2.0 3.0 0.8 0.5 8.7 0.7 0.5 1.4 3.3 0.7 1.2 3.8 1.1 7.0 1.5 0.5 1.8 1.1 0.9 0.6 0.8 0.6 1.1 0.6 0.8 1.3 48.4 0.4 0.0 0.7 0.4 0.5 0.8 0.9 4.9 2.4 3.7 2.3 2.4 2.8 3.1 0.7 0.4 1.5 1.4 0.3 4.4 1.4 1.8 0.5 0.0 0.0 2.8 0.4 0.3 0.6 0.8 1.1 0.9 0.2 0.2 0.0 0.6 1.4 1.0 0.8 0.9 3.4 1.4 0.7 1.3 0.0 1.4 0.2 0.6 0.2 1.0 1.5 1.5 0.0 2.0 0.9 2.0 0.9 5.4 1.4 0.8 1.2 1.2 0.0 1.5 2.0 2.1 0.0 1.3 1.4 1.6 0.7 1.6 0.5 1.1 0.9 1.0 0.6 1.8 2.7 1.5 5.5 1.1 1.8 2.0 2.3 1.5 2.8 1.2 2.3 3.1 2.1 1.8 2.4 4.9 2.3 2.1 3.7 2.4 0.8 1.4 2.0 3.1 3.6 2.9 1.3 3.8 2.0 3.0 0.5 1.4 7.0 0.4 0.0 4.5 0.5 0.6 0.5 0.2 0.6 0.0 240.9 28.4 0.0 2.0 0.3 0.0 0.5 153.2 1.0 0.2 0.0 0.0 2.4 4.7 0.3 3.5 0.0 0.5 1.6 1.2 0.0 0.0 16.3 2.6 0.6 6.8 1.8 0.3 5.7 0.5 0.0 1.4 0.1 1.9 0.0 3.1 76.9 2.2 0.3 0.5 0.0 0.2 0.0 RSPO1 "FLJ40906, RSPONDIN" ENSG00000169218 "R-spondin 1" Q2MKA7 1 37611350-37634923 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 17.3;endometrium 1: 26.6" "Cell type enhanced" "Detected in some" 18 "Fibroblasts: 4.7;Melanocytes: 1.7;Smooth muscle cells: 4.1" "Cancer enriched" "Detected in some" 13 "ovarian cancer: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HHSteC: 1.8;NTERA-2: 4.6;THP-1: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046154, HPA062923" Uncertain Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA046154: AB_10964912, HPA062923: " "unprognostic (1.50e-2)" "unprognostic (1.97e-3)" "unprognostic (5.99e-3)" "unprognostic (2.22e-1)" "unprognostic (1.76e-1)" "unprognostic (3.75e-6)" "unprognostic (1.84e-2)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (2.08e-1)" "unprognostic (1.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.76e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-2)" 5.0 0.1 0.2 1.9 0.3 0.0 5.8 0.5 0.6 17.3 2.1 0.2 0.2 0.6 26.6 3.0 1.8 15.8 12.2 0.4 0.2 0.0 0.7 0.2 4.5 1.9 0.2 0.2 7.5 1.6 0.0 0.2 1.3 0.4 3.0 0.2 2.3 1.5 1.4 0.2 4.0 3.1 10.9 0.2 0.7 2.0 1.0 0.2 0.2 0.2 1.3 6.1 1.3 8.8 0.4 0.3 0.7 0.5 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 4.7 0.4 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.7 0.2 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.1 0.7 0.0 0.5 0.3 0.3 0.0 0.2 0.3 0.5 0.6 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 RSPO2 MGC35555 ENSG00000147655 "R-spondin 2" Q6UXX9 8 107899316-108083648 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" "Developmental protein, Heparin-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;placenta: 20.1" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.4;Late spermatids: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.6" "Lineage enriched" "Detected in single" 17 "monocytes: 1.6" "Cell line enhanced" "Detected in some" "HEK 293: 3.6;HEL: 3.3;NTERA-2: 2.0;U-138 MG: 3.6;U-266/70: 10.7" "Group enriched" "Detected in some" 7 "amygdala: 8.2;cerebral cortex: 18.2;hippocampal formation: 23.2" "Group enriched" "Detected in many" 5 "amygdala: 23.3;cerebral cortex: 18.0;hippocampal formation: 24.1;midbrain: 33.2" "HPA024764, CAB025900, HPA053068" Uncertain "Secreted in other tissues" NA NA "CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031" "unprognostic (1.10e-2)" "unprognostic (2.18e-1)" "unprognostic (3.97e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.19e-1)" "unprognostic (8.33e-3)" "unprognostic (1.82e-1)" "unprognostic (9.48e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (8.45e-2)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" 0.4 0.5 3.9 1.4 6.3 0.5 0.2 1.9 27.0 3.6 12.0 4.2 3.6 5.1 0.3 3.6 8.9 0.2 4.8 0.5 5.8 10.5 0.2 1.1 9.3 0.2 15.7 5.4 1.1 0.2 0.2 2.8 20.1 2.0 11.6 10.1 15.5 0.2 3.4 0.3 0.3 5.8 0.7 1.3 0.2 8.3 2.0 1.7 0.0 0.2 0.0 0.2 2.2 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.6 0.2 0.1 0.0 10.7 0.0 0.0 1.1 0.4 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.3 1.9 27.0 5.8 10.5 15.7 5.4 2.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 RSPO4 "C20orf182, dJ824F16.3" ENSG00000101282 "R-spondin 4" Q2I0M5 20 958452-1002264 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.5;lung: 12.0" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 6.3;Fibroblasts: 1.8;Late spermatids: 4.5;Melanocytes: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.4;EFO-21: 3.3;fHDF/TERT166: 3.5;NTERA-2: 9.1;SK-BR-3: 6.3;U-2 OS: 10.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA048887 Uncertain "Secreted in other tissues" NA NA "HPA048887: AB_2680545" "unprognostic (2.36e-1)" "unprognostic (3.60e-3)" "unprognostic (2.88e-2)" "prognostic unfavorable (2.98e-6)" "unprognostic (8.93e-2)" "unprognostic (1.14e-3)" "unprognostic (1.05e-2)" "unprognostic (1.47e-1)" "unprognostic (6.50e-2)" "unprognostic (2.02e-2)" "unprognostic (5.26e-3)" "unprognostic (2.96e-1)" "unprognostic (5.68e-9)" "unprognostic (6.65e-3)" "unprognostic (4.41e-2)" "unprognostic (6.18e-3)" "unprognostic (2.22e-2)" 1.0 0.8 2.0 1.7 6.2 0.2 1.7 0.5 2.4 2.0 0.3 1.6 0.0 0.7 0.3 4.2 2.3 3.1 1.5 1.1 2.8 9.0 0.3 0.5 12.0 0.4 4.5 0.8 0.4 0.4 0.4 1.7 0.9 17.5 0.6 0.3 3.7 0.3 0.9 0.2 3.1 0.4 1.8 2.0 0.3 0.5 3.4 1.4 0.0 5.4 0.6 1.3 0.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.7 0.0 0.1 0.0 0.0 0.0 1.2 3.3 3.5 0.4 0.1 0.0 0.2 0.5 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.3 0.0 0.0 0.1 0.1 0.0 0.0 10.8 0.0 0.0 2.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.5 1.6 2.8 9.0 4.5 0.8 17.5 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 1.1 0.4 0.2 0.0 0.0 0.0 RTBDN FLJ36353 ENSG00000132026 Retbindin Q9BSG5 19 12825478-12835428 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 17.3;pituitary gland: 25.8;retina: 57.0" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 1.7;neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8" "Not detected" "Not detected" HPA052511 Approved "Endoplasmic reticulum" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "HPA052511: AB_2797243" "unprognostic (4.55e-4)" "unprognostic (3.94e-3)" "unprognostic (2.18e-1)" "unprognostic (1.54e-4)" "unprognostic (3.33e-2)" "unprognostic (2.18e-1)" "unprognostic (1.08e-2)" "unprognostic (2.45e-2)" "unprognostic (2.02e-2)" "unprognostic (3.55e-1)" "unprognostic (6.48e-2)" "unprognostic (7.04e-3)" "unprognostic (7.66e-9)" "unprognostic (3.55e-2)" "unprognostic (1.00e-1)" "unprognostic (7.05e-2)" "unprognostic (2.24e-2)" 0.3 6.9 10.2 0.5 3.4 0.9 0.3 2.7 17.3 0.2 0.9 0.4 0.0 1.0 0.3 1.5 0.3 0.3 0.4 0.3 7.3 5.1 0.2 0.4 0.5 0.4 2.8 2.8 0.3 2.5 0.2 25.8 0.3 4.0 0.4 0.9 57.0 0.3 0.3 0.3 0.5 1.0 0.6 1.0 0.4 2.5 3.5 0.0 7.0 0.4 0.0 0.4 0.3 0.0 0.3 0.2 1.8 0.2 0.4 0.2 0.0 0.9 0.1 0.1 0.6 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 0.1 0.9 0.9 0.0 0.6 0.2 0.3 0.0 0.0 0.1 0.1 0.0 0.4 0.9 0.0 0.1 2.4 0.0 0.0 0.4 0.2 0.0 0.0 0.1 1.2 2.7 0.0 0.1 0.0 0.0 0.9 0.7 1.1 0.7 0.1 1.0 0.0 0.0 8.2 5.4 0.1 0.1 0.4 0.4 2.7 0.7 0.0 0.8 1.0 0.7 0.1 1.2 21.1 4.0 4.8 0.0 0.0 1.7 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.2 1.8 0.4 0.2 0.2 0.1 0.0 10.2 3.4 2.7 8.6 7.3 5.1 2.8 2.8 4.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 1.4 0.0 0.0 0.0 0.0 329.9 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 45.9 0.1 0.0 0.0 0.0 289.4 0.0 0.0 11.5 5.1 0.0 0.0 0.0 0.0 0.0 RTKN2 "bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1" ENSG00000182010 "Rhotekin 2" Q8IZC4 10 62183035-62268707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lung: 67.6" "Cell type enriched" "Detected in many" 4 "Alveolar cells type 1: 1628.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 7 "T-reg: 15.4" "Lineage enriched" "Detected in single" 47 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "A-431: 25.5;HaCaT: 20.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037946, HPA038446" Enhanced Approved Nucleoplasm,Mitochondria NA NA Nucleoplasm Mitochondria "HPA037946: AB_10795398, HPA038446: AB_10796218" "unprognostic (2.33e-1)" "unprognostic (2.59e-1)" "unprognostic (2.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.26e-1)" "unprognostic (8.92e-3)" "unprognostic (6.66e-5)" "unprognostic (7.81e-3)" "unprognostic (2.33e-2)" "unprognostic (3.24e-1)" "unprognostic (3.72e-2)" "unprognostic (9.48e-4)" "unprognostic (3.70e-11)" "unprognostic (3.95e-2)" "unprognostic (9.34e-3)" "unprognostic (4.68e-3)" "unprognostic (1.55e-1)" 0.3 0.1 0.7 1.8 0.8 0.5 0.7 0.1 1.6 1.5 1.1 0.0 0.1 0.7 0.6 0.1 7.1 0.2 0.4 0.2 0.5 0.2 0.5 0.2 67.6 2.3 0.2 0.5 0.3 0.2 0.2 0.8 0.7 0.1 0.7 1.2 0.1 1.6 0.1 0.1 0.7 1.1 0.3 0.2 0.8 0.7 5.3 0.1 6.9 0.8 1.3 4.1 0.7 3.0 0.3 0.2 0.3 0.1 0.2 15.4 0.2 25.5 1.4 13.7 6.3 0.0 0.1 3.3 3.7 4.3 4.2 6.7 10.6 5.1 0.1 1.6 1.4 4.3 20.5 7.6 0.6 4.4 3.6 5.2 4.2 3.1 4.4 0.0 5.7 3.3 0.2 0.3 5.2 0.5 2.3 0.6 6.8 0.2 0.2 5.6 3.2 11.0 7.3 5.8 3.8 5.2 9.5 14.6 0.0 2.7 11.1 7.5 8.6 2.4 8.6 3.5 4.2 7.8 3.1 0.0 1.9 12.5 0.1 9.3 0.1 0.0 9.8 2.5 0.0 3.0 0.1 0.1 0.1 1.3 0.0 0.1 0.1 2.1 0.4 0.0 0.3 0.8 0.3 0.3 0.2 0.1 0.2 15.4 0.2 0.7 0.8 0.1 1.6 0.5 0.2 0.2 0.5 0.1 0.1 1628.8 44.5 0.9 8.3 4.1 0.6 0.4 0.0 4.0 15.9 0.0 0.0 3.0 0.0 1.4 376.8 0.1 0.4 0.0 1.4 4.9 2.5 7.0 3.5 0.0 2.1 0.0 1.7 1.8 0.6 65.6 2.0 2.2 1.7 0.0 5.9 0.4 9.1 0.0 1.8 1.4 0.5 0.0 1.9 21.3 23.6 1.6 1.7 12.7 3.3 87.2 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100880655-100884847 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 5.0;brain: 7.6;placenta: 8.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SH-SY5Y: 121.1" "Region enhanced" "Detected in single" "hypothalamus: 2.1" "HPA066979, HPA077601" Enhanced Approved Cytosol No NA Cytosol "HPA066979: AB_2685759, HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 1.8 1.3 0.1 0.0 0.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL3 "FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5" ENSG00000179300 "Retrotransposon Gag like 3" Q8N8U3 X 78656069-78659328 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;GAMG: 3.2;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4" "HPA051991, HPA053174, HPA075136" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA Nucleoplasm "Golgi apparatus, Plasma membrane" "HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737" "unprognostic (3.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.29e-1)" "unprognostic (6.74e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (1.23e-1)" "unprognostic (1.69e-2)" "unprognostic (2.85e-1)" "unprognostic (4.00e-6)" "unprognostic (1.53e-2)" "unprognostic (3.64e-1)" "unprognostic (2.49e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 2.6 0.2 2.5 0.2 0.5 0.4 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.5 0.7 0.0 0.1 0.3 1.1 2.7 0.0 0.0 3.2 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 2.4 2.6 0.0 0.0 0.0 0.1 4.0 3.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.9 0.0 0.6 0.0 0.6 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.8 0.0 0.1 1.4 0.2 3.4 0.2 0.0 0.0 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL4 "FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16" ENSG00000187823 "Retrotransposon Gag like 4" Q6ZR62 X 112454500-112457112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "kidney: 3.5;liver: 4.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "testis cancer: 1.4;thyroid cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003272 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA003272: AB_2257414" "unprognostic (9.86e-2)" "unprognostic (2.04e-4)" "unprognostic (6.35e-2)" "unprognostic (5.33e-3)" 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 3.5 4.7 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTL9 "KIAA1318, Mar9, Mart9, RGAG1, SIRH10" ENSG00000243978 "Retrotransposon Gag like 9" Q8NET4 X 110358816-110456334 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 5.5;U-2197: 4.3;U-87 MG: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001242 Enhanced NA NA "HPA001242: AB_1079804" "unprognostic (6.03e-2)" "unprognostic (5.59e-2)" "unprognostic (6.74e-2)" "unprognostic (1.85e-4)" "unprognostic (8.17e-2)" "unprognostic (3.04e-1)" "unprognostic (9.65e-3)" "unprognostic (1.13e-1)" "unprognostic (2.26e-2)" "unprognostic (1.45e-2)" "unprognostic (8.05e-3)" "unprognostic (1.03e-1)" "unprognostic (7.61e-3)" "unprognostic (6.98e-4)" "unprognostic (2.02e-1)" "unprognostic (3.37e-1)" "unprognostic (1.10e-2)" 0.1 0.2 0.4 0.1 2.0 0.0 0.1 0.7 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.4 0.5 0.1 2.1 0.1 0.4 0.1 0.1 1.1 0.1 1.1 0.1 0.0 0.2 1.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 38.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.5 0.3 0.1 1.6 0.8 0.7 1.9 0.2 0.0 0.0 0.8 2.1 0.3 0.0 0.4 1.7 0.4 0.3 0.1 0.1 0.0 0.0 1.6 0.0 0.2 0.8 0.1 5.5 0.8 0.5 0.0 0.0 0.7 0.0 0.5 0.0 0.1 0.0 0.6 0.0 2.1 0.0 1.9 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.8 0.7 4.3 1.3 0.0 0.1 0.0 3.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 0.7 0.1 0.1 2.1 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870966 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 144.6" "Cell type enriched" "Detected in many" 4 "Horizontal cells: 227.2" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9" "Group enriched" "Detected in many" 15 "dendritic cells: 7.9;monocytes: 4.6" "Group enriched" "Detected in some" 4 "HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" NA NA 140000 "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874" "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favorable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 6.3 8.3 27.4 6.1 46.3 1.6 3.0 98.5 144.6 2.6 2.9 11.0 0.0 2.7 2.1 1.6 2.3 8.6 4.4 1.9 32.3 50.7 2.3 1.9 4.8 2.7 21.3 45.9 1.7 3.6 19.2 10.3 2.7 35.1 5.0 3.0 1.2 2.3 2.6 1.6 2.3 3.4 2.7 12.1 10.6 3.6 2.6 10.5 0.0 2.7 0.0 2.3 2.5 0.9 0.0 7.9 0.4 4.6 0.0 0.0 1.0 0.0 0.0 0.3 0.4 1.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.8 23.2 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.2 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 28.7 46.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.1 0.0 2.1 0.0 0.0 0.0 7.7 1.6 0.2 0.0 4.5 0.0 0.0 4.6 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 1.0 27.4 46.3 98.5 94.7 32.3 50.7 21.3 45.9 35.1 10.5 0.0 0.6 0.0 0.4 4.2 26.8 0.8 2.5 1.4 1.2 0.0 23.6 0.8 0.0 0.0 13.2 0.5 0.2 0.0 0.0 0.7 2.1 6.2 0.0 0.4 15.8 227.2 51.9 0.0 15.9 14.4 2.6 24.4 10.1 1.8 0.0 13.1 2.2 0.0 1.1 0.3 29.4 0.0 2.1 2.1 2.5 5.6 2.1 0.0 0.2 0.3 RTN2 "NSP2, NSPL1, SPG12" ENSG00000125744 "Reticulon 2" O75298 19 45485289-45497061 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "skeletal muscle: 155.7;tongue: 43.2" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 109.9;Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 9.1;eosinophil: 3.5;plasmacytoid DC: 2.4" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 9.1" "Cell line enhanced" "Detected in many" "RH-30: 23.6;RT4: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034941, HPA034948" Approved Approved "Nuclear speckles" NA NA 16000 "Nuclear speckles" "HPA034941: AB_10671358, HPA034948: AB_2674375" "unprognostic (3.08e-1)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (5.07e-3)" "unprognostic (1.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.89e-2)" "unprognostic (3.09e-1)" "unprognostic (6.44e-2)" "unprognostic (5.10e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.58e-6)" "unprognostic (4.34e-1)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.03e-1)" 3.4 3.1 6.9 1.9 9.0 1.3 3.4 5.9 10.4 2.5 4.2 1.0 3.7 1.8 3.4 6.7 5.4 2.0 3.5 5.4 7.4 4.8 1.4 1.7 2.6 2.2 4.8 3.7 1.0 2.5 2.2 1.6 11.4 4.6 5.1 1.6 2.6 6.5 4.8 155.7 2.6 1.8 3.3 1.4 2.6 1.9 1.2 1.0 0.0 1.8 43.2 3.5 4.2 1.5 0.1 2.4 9.1 0.5 0.3 0.0 0.5 1.9 2.7 4.6 3.6 7.9 9.8 9.1 4.4 10.7 2.8 5.4 5.4 1.7 1.7 6.2 4.8 2.3 3.7 3.0 2.1 0.8 4.0 4.4 11.8 2.0 4.0 3.4 0.7 13.5 10.7 1.1 1.2 2.2 4.9 5.1 0.4 6.4 3.3 8.3 1.5 0.0 2.2 3.4 8.8 3.5 2.0 23.6 9.4 1.6 23.4 13.0 12.5 0.9 21.7 6.8 4.5 17.1 4.7 4.5 7.9 2.4 0.2 0.9 1.9 4.4 3.9 2.1 2.7 4.0 9.1 0.2 3.5 0.0 0.5 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.3 0.5 2.4 0.0 0.5 6.9 9.0 5.9 10.4 7.4 4.8 4.8 3.7 4.6 1.0 3.0 7.2 0.0 21.5 5.7 8.9 3.9 5.1 1.4 2.3 3.5 5.9 109.9 0.0 16.6 0.0 10.8 0.3 0.0 6.1 125.7 7.6 19.7 16.1 2.4 23.2 22.3 10.9 20.9 10.0 0.0 5.2 10.6 21.9 10.0 2.0 8.5 9.1 0.0 6.3 0.1 10.6 12.9 10.0 0.4 3.0 3.0 100.5 0.0 0.4 19.5 RTN3 "ASYIP, HAP, NSPL2, NSPLII, RTN3-A1" ENSG00000133318 "Reticulon 3" O95197 11 63681446-63759891 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 122.2;brain: 149.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 122.2" "Group enriched" "Detected in all" 6 "granulocytes: 122.2;monocytes: 42.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015649, HPA015650" Enhanced Supported "Endoplasmic reticulum" NA NA 620000 "Endoplasmic reticulum" "HPA015649: AB_1856498, HPA015650: AB_1856499" "unprognostic (8.11e-3)" "unprognostic (8.51e-2)" "unprognostic (3.61e-2)" "unprognostic (7.88e-3)" "unprognostic (1.41e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (5.49e-2)" "unprognostic (1.25e-1)" "unprognostic (1.07e-2)" "unprognostic (2.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.87e-4)" "unprognostic (1.60e-2)" "unprognostic (2.54e-1)" "unprognostic (2.73e-2)" "unprognostic (1.57e-2)" 43.6 19.6 72.2 11.9 71.6 22.3 21.5 55.9 149.6 21.7 20.0 50.2 9.3 12.3 14.8 19.7 12.4 21.0 13.1 12.8 78.3 72.9 22.0 19.9 17.7 7.3 72.6 53.5 11.9 20.7 36.4 14.0 14.1 109.9 12.9 18.8 12.7 30.4 18.9 10.8 22.6 14.6 18.6 66.0 9.2 12.8 10.3 39.2 6.8 40.9 5.1 10.7 13.1 8.9 3.3 14.7 122.2 42.2 4.6 7.4 28.1 31.4 23.3 28.1 26.7 52.0 37.0 11.2 28.6 30.5 25.3 27.2 20.2 69.8 37.2 49.0 42.8 24.4 32.4 40.1 14.1 33.5 29.9 21.4 47.6 34.1 14.1 43.3 42.3 38.4 24.3 41.9 30.8 34.4 42.5 34.2 32.8 26.9 60.5 22.2 25.8 22.4 47.1 32.7 25.7 26.4 29.8 19.6 68.6 49.9 17.8 59.5 34.6 46.4 51.2 53.4 21.0 56.4 34.9 31.8 15.1 20.5 52.5 21.9 38.5 33.2 29.8 58.2 35.3 15.9 40.1 42.2 52.8 4.9 21.1 5.3 3.3 5.0 4.9 14.7 2.3 3.7 4.0 122.2 4.6 25.1 8.8 7.4 28.1 72.2 71.6 55.9 118.2 78.3 72.9 72.6 53.5 109.9 39.2 125.0 58.7 40.2 86.8 128.3 148.4 30.7 73.9 174.0 93.3 232.1 66.8 60.7 24.9 121.1 28.8 64.2 94.1 46.7 101.6 81.1 86.1 70.4 76.1 65.2 130.9 77.9 95.7 66.3 177.0 55.9 73.4 125.9 108.0 117.2 63.4 133.1 92.8 64.7 84.5 45.4 75.4 77.6 79.5 130.3 150.5 127.8 72.3 60.9 84.0 86.5 RTN4R NOGOR ENSG00000040608 "Reticulon 4 receptor" Q9BZR6 22 20241415-20283246 "Disease related genes, Predicted membrane proteins" Receptor "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.0;brain: 33.2" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.0" "Lineage enriched" "Detected in many" 9 "T-cells: 12.0" "Cell line enhanced" "Detected in many" "NB-4: 20.5;REH: 28.8;SCLC-21H: 17.6;SK-MEL-30: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB012443 Supported "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA 1300000 "Plasma membrane, Focal adhesion sites" "Actin filaments" "CAB012443: " "unprognostic (1.28e-1)" "unprognostic (1.28e-2)" "unprognostic (8.29e-2)" "unprognostic (6.58e-2)" "unprognostic (3.49e-1)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.19e-1)" "unprognostic (1.56e-1)" "unprognostic (3.44e-1)" "unprognostic (8.90e-3)" "unprognostic (1.21e-2)" "unprognostic (9.89e-2)" "unprognostic (1.80e-2)" "unprognostic (1.34e-2)" "unprognostic (1.30e-1)" "unprognostic (5.02e-2)" "unprognostic (3.07e-1)" 0.8 1.1 10.9 1.2 7.0 1.3 0.7 33.2 24.6 0.8 1.7 1.2 0.3 3.9 4.9 0.5 0.9 1.3 0.6 1.4 8.8 3.1 0.9 4.0 1.7 1.1 1.4 6.8 1.1 2.7 0.6 1.6 1.1 4.9 1.2 0.6 0.7 1.3 1.2 0.8 5.2 1.8 0.7 2.8 5.9 2.3 1.1 0.5 0.1 1.1 0.4 0.7 0.7 0.7 0.1 1.3 0.0 0.0 0.7 12.0 1.7 4.2 2.0 1.3 3.0 0.0 0.0 0.7 0.4 0.0 0.3 0.1 3.2 1.2 0.2 1.4 0.0 2.1 6.9 0.8 1.8 0.0 0.1 7.4 0.1 1.8 0.4 0.7 0.1 0.2 0.0 2.3 0.0 0.2 0.0 0.0 2.0 0.2 0.2 0.0 5.9 2.2 20.5 4.8 1.2 3.7 28.8 0.0 0.2 0.2 1.8 17.6 2.8 2.0 1.5 13.7 0.3 1.7 0.6 0.0 0.2 8.2 0.0 0.1 0.0 0.5 0.5 0.2 4.2 0.0 0.0 0.0 0.0 5.1 0.0 12.0 0.0 4.5 5.1 0.2 0.1 2.7 5.7 0.0 0.7 0.0 1.3 3.1 1.7 10.9 7.0 33.2 20.1 8.8 3.1 1.4 6.8 4.9 0.5 3.0 0.0 0.0 3.6 4.5 5.3 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 2.4 2.0 1.4 1.3 0.0 3.7 4.3 0.5 3.1 0.0 0.9 1.3 6.4 0.0 0.6 0.0 0.0 0.3 0.0 1.7 1.0 1.4 9.8 2.4 0.0 0.0 0.0 4.8 0.0 0.6 0.0 1.3 4.8 0.0 1.0 1.6 2.6 RTN4RL1 "DKFZp547J144, NgR3, NGRH2" ENSG00000185924 "Reticulon 4 receptor like 1" Q86UN2 17 1934677-2025345 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.3" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 17.9;Cone photoreceptor cells: 35.3;Horizontal cells: 31.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 10.8;HaCaT: 10.8;hTCEpi: 10.3;T-47d: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044428 Uncertain Approved "Nucleoplasm,Plasma membrane,Actin filaments,Midbody" "Intracellular and membrane" NA NA "Actin filaments" "Nucleoplasm, Plasma membrane, Midbody" "HPA044428: AB_10963229" "unprognostic (5.23e-1)" "unprognostic (3.52e-2)" "unprognostic (2.06e-1)" "unprognostic (2.12e-1)" "unprognostic (2.93e-2)" "unprognostic (7.25e-2)" "unprognostic (2.61e-3)" "unprognostic (1.17e-1)" "unprognostic (8.97e-3)" "unprognostic (6.21e-2)" "unprognostic (2.55e-3)" "unprognostic (6.32e-3)" "prognostic unfavorable (7.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.05e-1)" "unprognostic (7.01e-2)" "unprognostic (3.15e-2)" 8.3 5.0 6.8 1.2 8.0 0.6 7.0 4.6 19.3 3.4 1.3 0.6 7.2 0.8 1.9 1.0 1.4 3.6 2.9 2.7 9.6 2.7 2.6 3.2 3.9 0.8 1.3 7.9 1.6 3.8 2.0 6.5 1.3 0.7 6.1 0.8 8.4 9.8 5.3 3.9 11.3 1.2 1.2 1.0 2.7 1.2 1.3 0.1 0.0 1.5 0.8 0.9 1.4 3.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.4 1.6 1.8 2.5 2.1 0.3 0.0 0.1 1.1 0.3 0.0 0.0 0.0 0.0 0.1 10.8 0.2 10.8 4.7 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 10.3 0.0 3.7 0.0 0.0 2.6 0.1 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.3 0.8 0.3 1.2 0.0 0.0 2.3 0.1 0.3 0.8 1.8 0.3 13.5 0.1 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 8.0 4.6 19.3 9.6 2.7 1.3 7.9 0.7 0.1 0.0 2.1 0.0 0.2 2.4 17.9 2.6 0.0 2.7 2.3 3.5 35.3 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 2.1 1.4 31.8 0.0 6.7 0.0 0.9 0.0 0.0 3.3 0.0 0.0 1.5 0.1 0.0 0.0 0.0 10.0 0.0 0.5 0.0 0.1 2.5 0.0 0.0 0.0 0.2 RTN4RL2 "NgR2, NGRH1" ENSG00000186907 "Reticulon 4 receptor like 2" Q86UN3 11 57460549-57477534 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 44.3;liver: 38.1;thyroid gland: 24.9" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 6.2;Cholangiocytes: 15.3;Hepatocytes: 12.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 11 "amygdala: 17.7;basal ganglia: 17.9;cerebral cortex: 44.3;hippocampal formation: 12.4;olfactory region: 17.6" "Group enriched" "Detected in some" 4 "classical monocyte: 1.0;intermediate monocyte: 2.5;MAIT T-cell: 1.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 24 "dendritic cells: 3.4;monocytes: 2.5;T-cells: 1.1" "Cell line enhanced" "Detected in many" "HMC-1: 17.3;Karpas-707: 26.2;REH: 15.8;RPMI-8226: 50.4" "Group enriched" "Detected in many" 4 "amygdala: 23.2;basal ganglia: 10.6;cerebral cortex: 29.8;hippocampal formation: 23.6" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 25000000 "unprognostic (6.27e-3)" "unprognostic (2.02e-2)" "unprognostic (4.57e-2)" "unprognostic (8.40e-2)" "unprognostic (8.51e-2)" "unprognostic (7.64e-2)" "unprognostic (6.83e-2)" "unprognostic (3.72e-2)" "unprognostic (7.27e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-2)" "unprognostic (3.28e-1)" "prognostic unfavorable (3.05e-7)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" "unprognostic (5.16e-3)" "unprognostic (2.18e-2)" 2.7 0.9 17.7 0.9 17.9 1.4 2.4 1.6 44.3 1.5 1.0 1.0 0.0 1.8 1.5 0.8 1.2 1.2 3.8 2.1 12.4 1.5 2.0 38.1 1.9 1.0 2.0 17.6 1.0 2.8 5.4 2.5 2.7 1.0 1.9 0.7 1.9 2.8 1.0 2.3 5.3 1.2 1.4 0.7 1.3 1.9 1.5 0.1 1.0 24.9 0.5 1.0 1.3 1.2 0.0 3.4 0.0 2.5 0.0 1.1 0.0 2.7 3.8 2.9 5.0 1.2 1.7 0.4 0.0 1.1 0.1 1.1 0.5 0.5 0.1 0.1 0.1 1.6 0.0 4.6 0.0 0.0 0.6 1.8 0.8 0.3 2.7 1.7 0.6 17.3 4.7 0.5 0.4 0.4 0.5 0.0 4.9 0.6 26.2 0.0 0.5 0.1 2.0 5.2 0.2 2.9 15.8 2.1 50.4 0.0 0.1 5.5 0.5 0.4 0.2 2.9 0.2 3.3 0.7 0.0 0.2 9.1 1.2 0.9 1.6 3.3 0.5 6.6 2.7 2.2 0.0 1.0 0.0 0.2 2.5 1.1 0.0 0.3 0.0 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 17.7 17.9 1.6 44.3 12.4 1.5 2.0 17.6 1.0 0.1 0.0 0.0 0.0 0.4 5.0 6.2 0.2 15.3 0.0 0.0 0.0 0.0 0.0 3.3 0.9 1.3 1.3 0.0 0.0 0.5 1.7 0.6 0.8 0.0 12.4 0.4 0.0 1.7 1.3 0.0 0.0 0.3 0.0 1.7 0.0 0.3 0.8 1.2 0.0 1.1 1.0 1.3 6.5 2.3 0.9 1.8 2.5 0.0 0.0 0.0 0.1 RTP1 "MGC35450, Z3CXXC1" ENSG00000175077 "Receptor transporter protein 1" P59025 3 187197486-187201465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.5;testis: 1.9" "Group enriched" "Detected in some" 14 "Early spermatids: 1.9;Late spermatids: 1.1;Spermatocytes: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "SuSa: 9.2;T-47d: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.29e-1)" "unprognostic (1.91e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-1)" 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 1.3 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.8 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 RTP2 "MGC78665, Z3CXXC2" ENSG00000198471 "Receptor transporter protein 2" Q5QGT7 3 187698259-187702557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "skeletal muscle: 5.7;testis: 3.1" "Cell type enhanced" "Detected in some" 34 "Distal tubular cells: 1.7;Early spermatids: 8.7;Late spermatids: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SK-BR-3: 6.4" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 27 "olfactory region: 0.3" NA NA "unprognostic (5.86e-2)" "unprognostic (1.12e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497491-46500949 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 91 "liver: 43.3" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 59.6" "Group enriched" "Detected in some" 17 "liver cancer: 22.9;testis cancer: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SiHa: 15.1" HPA075932 Uncertain Mitochondria NA NA Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 15.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 59.6 0.0 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 RTP5 "C2orf85, CXXC11, FLJ33590, Z3CXXC5" ENSG00000188011 "Receptor transporter protein 5 (putative)" Q14D33 2 241869600-241873823 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "brain: 44.8" "Cell type enriched" "Detected in some" 7 "Early spermatids: 7.7" "Cancer enriched" "Detected in single" 10 "glioma: 1.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "MOLT-4: 3.7;SCLC-21H: 7.4" HPA050902 Enhanced NA NA "HPA050902: AB_2681268" "unprognostic (3.26e-2)" "unprognostic (5.38e-4)" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.01e-1)" "unprognostic (9.40e-4)" "unprognostic (8.68e-3)" "unprognostic (2.04e-1)" "unprognostic (6.34e-4)" "unprognostic (3.30e-1)" "unprognostic (9.01e-3)" "unprognostic (3.91e-1)" "unprognostic (9.08e-8)" "unprognostic (1.81e-1)" "unprognostic (1.77e-1)" "unprognostic (2.68e-2)" "unprognostic (3.72e-2)" 0.8 0.8 27.9 1.1 44.8 1.9 0.7 0.2 13.5 0.7 0.7 2.1 0.0 0.9 0.7 0.7 0.7 0.7 0.8 0.8 32.9 24.9 0.7 0.7 0.8 2.4 3.1 4.8 0.7 0.9 0.7 0.0 0.7 7.3 0.7 0.7 0.0 0.9 0.7 0.7 0.7 0.7 0.7 2.1 1.1 0.8 0.7 1.5 0.0 0.7 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 44.8 0.2 12.7 32.9 24.9 3.1 4.8 7.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RUBCNL "C13orf18, FLJ21562, KIAA0226L" ENSG00000102445 "RUN and cysteine rich domain containing beclin 1 interacting protein like" Q9H714 13 46342000-46438190 "Predicted intracellular proteins" "Autophagy, Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.1;lymphoid tissue: 24.0" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 9.6;Club cells: 4.5;Hofbauer cells: 13.4" "Cancer enriched" "Detected in many" 5 "colorectal cancer: 17.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "memory B-cell: 29.9;naive B-cell: 31.1;neutrophil: 31.1;plasmacytoid DC: 22.5" "Group enriched" "Detected in many" 17 "B-cells: 31.1;dendritic cells: 22.5;granulocytes: 31.1" "Group enriched" "Detected in some" 5 "Daudi: 40.0;U-698: 66.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026614 Approved Approved Cytosol NA NA Cytosol "HPA026614: AB_10602693" "unprognostic (3.35e-2)" "unprognostic (2.61e-1)" "unprognostic (1.94e-3)" "prognostic favorable (3.76e-5)" "unprognostic (1.09e-2)" "unprognostic (8.30e-4)" "unprognostic (7.83e-2)" "unprognostic (2.62e-3)" "unprognostic (1.07e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (2.28e-1)" "unprognostic (5.95e-5)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (7.47e-2)" "unprognostic (7.00e-3)" 3.7 1.6 4.5 21.2 4.3 15.0 5.7 2.9 3.6 5.5 8.1 2.9 1.3 1.5 3.0 3.2 1.0 2.0 3.8 1.5 3.4 3.7 1.5 1.7 5.5 20.2 4.5 2.7 0.9 1.2 0.1 2.7 3.3 5.2 2.2 11.2 3.0 6.5 1.8 0.8 2.7 14.9 2.8 8.8 24.0 1.6 15.9 3.7 10.1 2.2 0.2 21.7 2.9 2.0 31.1 22.5 31.1 1.6 0.3 0.0 1.2 0.1 0.0 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 1.5 0.0 40.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.4 11.5 0.1 1.6 0.0 0.0 0.8 0.0 0.1 0.0 0.6 2.3 0.0 9.2 0.0 0.0 0.3 0.0 0.1 0.2 9.2 66.1 0.4 0.1 0.0 0.0 1.0 0.0 0.0 1.6 0.0 29.9 0.0 0.0 1.0 31.1 0.0 0.0 31.1 0.3 0.9 22.5 0.0 1.2 4.5 4.3 2.9 3.6 3.4 3.7 4.5 2.7 5.2 3.7 3.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 2.3 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 RUFY3 "KIAA0871, RIPx, Singar1, ZFYVE30" ENSG00000018189 "RUN and FYVE domain containing 3" Q7L099 4 70704204-70807315 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 80.2" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022952, HPA022970" Enhanced Supported Cytosol NA NA Cytosol "HPA022952: AB_2671005, HPA022970: AB_1856307" "unprognostic (4.33e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-1)" "unprognostic (3.96e-3)" "unprognostic (1.38e-1)" "prognostic favorable (1.28e-4)" "prognostic unfavorable (8.95e-4)" "unprognostic (1.69e-2)" "unprognostic (2.00e-1)" "unprognostic (3.50e-2)" "prognostic favorable (8.02e-5)" "unprognostic (7.90e-3)" "unprognostic (1.31e-3)" "unprognostic (1.26e-1)" "unprognostic (1.21e-2)" "unprognostic (7.45e-3)" "unprognostic (5.41e-1)" 10.9 24.5 39.1 11.8 53.4 6.9 12.5 36.4 66.3 12.3 8.7 24.1 6.7 8.1 20.6 16.3 15.3 9.3 12.7 8.9 64.5 34.4 15.5 13.6 14.8 13.6 37.0 51.3 25.5 9.8 8.5 61.4 12.0 54.2 13.8 11.4 12.8 10.1 11.5 15.4 29.9 9.9 15.1 80.2 16.0 12.8 25.3 32.5 7.1 31.6 5.9 11.5 9.3 12.3 3.5 6.0 0.0 3.1 2.2 2.8 1.0 3.7 2.6 31.2 7.3 15.1 17.6 12.4 12.2 4.7 4.0 4.5 4.5 9.2 15.0 5.1 10.1 8.9 3.8 4.7 5.4 6.4 8.1 6.0 3.2 3.6 4.9 8.6 3.7 1.9 12.4 8.4 5.3 6.2 18.6 8.4 16.2 8.8 15.5 8.7 4.6 23.2 3.9 7.5 6.6 3.4 5.7 9.7 6.8 7.8 3.6 29.2 14.4 4.4 7.9 7.4 12.6 5.4 1.8 7.1 13.6 9.5 4.0 2.8 17.3 7.8 16.0 14.1 2.7 2.7 0.0 3.1 0.0 2.2 3.0 2.8 3.5 1.5 2.0 6.0 3.1 1.5 1.6 0.0 2.2 2.8 4.8 1.0 1.0 39.1 53.4 36.4 66.3 64.5 34.4 37.0 51.3 54.2 32.5 32.8 68.4 13.4 19.5 17.2 119.8 18.3 10.2 34.8 45.5 22.7 249.4 12.7 6.6 12.7 57.5 30.2 8.7 0.0 17.9 5.7 21.6 29.3 20.7 21.8 9.7 131.9 14.5 34.4 31.8 95.1 43.7 29.7 40.5 83.8 8.3 45.6 18.9 3.5 47.7 12.8 190.1 25.8 29.9 13.4 29.3 25.2 6.4 8.7 8.3 16.0 RUFY4 "FLJ46536, ZFYVE31" ENSG00000188282 "RUN and FYVE domain containing 4" Q6ZNE9 2 218034960-218090581 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 6.6;lymphoid tissue: 5.1" "Cell type enhanced" "Detected in some" 20 "Kupffer cells: 2.2;Macrophages: 1.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 13 "Karpas-707: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA037980 Uncertain NA NA "HPA037980: AB_10672501" "unprognostic (1.27e-3)" "unprognostic (4.60e-3)" "unprognostic (9.39e-3)" "unprognostic (6.79e-2)" "unprognostic (5.92e-2)" "unprognostic (6.57e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-2)" "unprognostic (1.31e-3)" "unprognostic (1.50e-1)" "unprognostic (6.09e-2)" "unprognostic (1.55e-1)" "unprognostic (2.41e-14)" "unprognostic (1.36e-2)" "unprognostic (1.13e-3)" "unprognostic (3.45e-1)" "unprognostic (1.43e-5)" 0.3 0.4 0.6 2.2 1.9 1.8 0.3 0.3 1.0 0.3 0.4 0.3 0.3 1.9 0.3 0.3 0.9 0.4 1.2 0.3 3.1 0.3 0.5 0.3 6.6 2.8 0.4 0.3 0.3 0.3 0.0 0.4 0.3 0.3 2.6 1.5 0.3 1.4 0.3 0.3 0.7 1.8 0.3 0.3 5.1 1.5 0.3 0.3 1.1 0.3 0.3 2.2 0.6 0.6 0.0 1.9 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.6 0.6 0.0 0.0 0.6 1.9 0.3 1.0 3.1 0.3 0.4 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 1.4 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 RUNDC3A "RAP2IP, RPIP8" ENSG00000108309 "RUN domain containing 3A" Q59EK9 17 44308413-44318671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 92.6" "Group enriched" "Detected in many" 6 "Bipolar cells: 54.0;Early spermatids: 20.0;Horizontal cells: 30.2;Intestinal endocrine cells: 37.5;Late spermatids: 59.4;Rod photoreceptor cells: 15.2" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Group enriched" "Detected in some" 6 "SCLC-21H: 35.0;SH-SY5Y: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023548, HPA070733" Enhanced Supported Enhanced Vesicles NA NA Vesicles "HPA023548: AB_1856069, HPA070733: AB_2732162" "unprognostic (3.66e-2)" "unprognostic (3.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.58e-3)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (3.87e-3)" "unprognostic (2.29e-1)" "unprognostic (4.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.42e-3)" "unprognostic (1.34e-1)" "unprognostic (8.87e-3)" "unprognostic (1.07e-2)" "unprognostic (5.17e-2)" "unprognostic (9.39e-2)" "unprognostic (1.84e-1)" 1.4 12.9 40.5 1.6 28.5 2.8 1.5 33.0 92.6 1.3 1.8 4.8 0.0 2.2 1.6 1.5 1.5 1.5 1.6 1.8 40.9 20.6 1.7 1.3 1.5 1.4 22.0 23.2 1.7 4.3 2.4 16.1 2.5 15.6 1.5 1.8 1.6 1.4 1.6 1.3 4.1 2.2 1.8 8.0 1.5 3.3 5.2 4.4 0.0 2.4 0.0 1.4 1.5 0.0 0.3 0.1 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.4 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.1 0.0 35.0 22.3 0.2 0.0 0.2 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.3 0.3 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 40.5 28.5 33.0 49.2 40.9 20.6 22.0 23.2 15.6 4.4 0.0 1.1 0.0 0.2 0.2 54.0 1.1 0.0 0.0 0.0 0.0 5.9 0.0 3.3 0.9 20.0 0.0 0.0 0.0 2.8 0.0 0.2 0.4 0.0 0.0 0.2 30.2 37.5 0.0 0.0 59.4 1.4 0.5 0.0 0.0 0.0 5.0 1.4 0.3 3.2 0.5 15.2 0.0 0.5 0.9 1.3 0.4 0.1 0.0 0.0 0.3 RUNDC3B "RPIB9, RPIP9" ENSG00000105784 "RUN domain containing 3B" Q96NL0 7 87627548-87832296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 13.2;brain: 16.4" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 13.7;Hepatocytes: 16.6;Spermatocytes: 20.2;Spermatogonia: 21.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1;memory CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.0;HEK 293: 2.5;SCLC-21H: 6.7;SH-SY5Y: 3.0;U-138 MG: 2.5;U-266/70: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056968, HPA057155, HPA075760" Uncertain Uncertain Vesicles,Cytosol NA NA Cytosol Vesicles "HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: " "unprognostic (2.49e-1)" "unprognostic (1.99e-1)" "unprognostic (2.12e-1)" "unprognostic (1.83e-1)" "unprognostic (2.20e-2)" "unprognostic (1.77e-3)" "unprognostic (1.19e-2)" "unprognostic (4.16e-2)" "unprognostic (2.56e-1)" "unprognostic (1.19e-1)" "unprognostic (9.42e-5)" "unprognostic (4.44e-1)" "prognostic favorable (2.62e-6)" "unprognostic (1.97e-2)" "unprognostic (2.41e-1)" "unprognostic (2.32e-1)" "unprognostic (9.55e-2)" 1.1 13.2 3.6 0.8 9.4 0.1 1.4 16.4 7.9 2.7 3.7 1.0 1.0 4.7 3.4 1.2 1.0 2.0 1.7 1.4 2.8 5.1 3.3 9.7 0.8 0.4 2.8 4.8 2.3 0.5 0.5 2.0 0.2 7.9 1.1 2.7 0.7 0.9 0.8 1.1 0.9 5.2 3.8 2.2 0.4 0.6 3.1 1.0 0.0 0.6 0.1 0.5 1.6 1.1 0.1 0.0 0.4 0.0 0.0 2.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 3.0 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 2.5 0.1 1.5 1.0 0.1 1.2 0.4 0.0 0.7 0.0 0.4 0.0 1.2 0.0 1.2 0.0 0.0 1.3 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.2 6.7 3.0 0.0 0.2 0.1 0.1 0.1 0.0 0.4 2.5 0.0 0.2 0.0 3.9 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.4 2.1 0.0 0.8 0.1 0.0 1.7 0.0 0.1 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.1 3.6 9.4 16.4 6.5 2.8 5.1 2.8 4.8 7.9 1.0 0.0 0.0 0.0 0.1 4.2 8.0 2.2 5.1 0.0 0.0 0.0 5.9 0.5 1.7 0.9 2.0 13.7 9.7 0.0 0.2 0.3 0.1 0.1 0.0 16.6 0.1 11.1 0.0 1.8 0.0 1.0 3.7 0.0 3.3 0.0 2.9 0.7 0.8 5.8 1.4 8.7 7.6 0.0 1.2 20.2 21.5 2.6 1.0 0.0 3.8 0.0 RUNX1 "AML1, AMLCR1, CBFA2, PEBP2A2" ENSG00000159216 "Runt related transcription factor 1" Q01196 21 34787801-36004667 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 54.3;lymphoid tissue: 58.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 61.2;HMC-1: 36.9;JURKAT: 56.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA004176, HPA037912" Enhanced Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA004176: AB_1078412, HPA037912: AB_2675733" "unprognostic (4.06e-3)" "unprognostic (2.35e-2)" "unprognostic (1.42e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-3)" "unprognostic (2.62e-1)" "unprognostic (5.87e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-3)" "unprognostic (2.33e-2)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.44e-15)" "unprognostic (1.48e-1)" "unprognostic (1.50e-1)" "unprognostic (6.17e-2)" "unprognostic (5.47e-2)" 11.5 3.2 5.2 14.8 7.3 29.8 54.3 1.0 4.3 12.5 4.7 3.8 4.0 3.8 2.9 7.4 6.5 4.6 12.4 7.6 6.1 2.0 4.2 6.7 17.9 13.9 8.5 1.1 6.5 5.8 1.6 5.5 6.4 6.0 9.9 5.1 3.5 29.8 8.8 14.4 8.3 5.1 6.8 12.3 10.6 12.7 2.9 6.6 58.6 4.6 5.7 14.2 11.0 9.1 3.2 3.4 17.0 3.9 1.3 4.8 2.0 12.2 0.9 0.0 0.0 3.2 4.1 8.1 6.9 7.1 3.9 2.9 0.6 9.4 6.1 0.4 6.1 6.5 11.1 0.7 8.3 5.6 9.3 0.9 61.2 2.4 2.8 5.9 7.0 36.9 8.0 5.0 11.8 11.7 5.4 2.2 56.6 4.1 3.5 8.2 2.6 28.5 11.2 0.5 6.7 3.6 28.9 21.4 3.7 5.2 4.9 0.3 0.0 7.2 1.8 2.5 1.8 3.7 16.6 9.1 6.4 8.3 9.5 10.4 11.8 4.8 5.7 8.0 15.5 9.3 17.0 3.2 6.3 3.4 1.4 3.3 3.2 3.1 3.2 0.9 3.1 4.8 3.8 3.5 1.3 3.9 3.4 4.0 2.0 5.2 7.3 1.0 4.3 6.1 2.0 8.5 1.1 6.0 6.6 50.6 30.7 14.5 44.6 37.0 2.1 2.2 38.2 56.2 39.8 19.2 0.0 0.8 1.7 35.7 16.8 5.8 12.0 0.0 24.4 19.6 25.7 45.4 16.3 4.3 57.2 0.0 5.8 4.9 79.5 21.7 4.4 63.0 27.0 31.5 10.8 0.5 63.1 12.7 4.2 1.2 0.6 0.0 31.5 23.0 24.9 17.7 2.1 37.4 14.4 53.7 RUNX1T1 "AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2" ENSG00000079102 "RUNX1 translocation partner 1" Q06455 8 91954967-92103286 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 57.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 122.4;Ito cells: 87.8;Leydig cells: 89.2;Peritubular cells: 93.0;Sertoli cells: 64.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 57.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 13.2;fHDF/TERT166: 11.2;HEL: 24.1;HSkMC: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049852, HPA070951" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049852: AB_2680914, HPA070951: AB_2686326" "unprognostic (2.37e-1)" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.35e-1)" "unprognostic (1.62e-1)" "unprognostic (3.37e-4)" "unprognostic (2.29e-4)" "unprognostic (5.56e-3)" "unprognostic (1.24e-2)" "unprognostic (1.62e-2)" "unprognostic (2.11e-2)" "unprognostic (2.37e-1)" "unprognostic (5.70e-4)" "unprognostic (8.98e-3)" "unprognostic (6.78e-2)" "unprognostic (1.51e-1)" "unprognostic (7.80e-3)" 9.6 4.6 7.7 4.5 11.5 0.4 6.9 57.8 13.0 14.0 7.8 1.1 2.0 2.0 11.8 5.9 4.1 7.7 7.8 12.3 5.8 4.0 2.5 1.3 6.0 2.0 3.6 9.6 7.7 1.8 1.7 8.6 8.7 4.2 4.2 4.0 5.3 4.7 4.1 5.5 3.6 3.6 10.3 3.0 2.9 4.2 5.6 3.7 0.0 5.2 3.3 1.8 5.7 5.9 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.3 3.5 5.1 0.0 5.2 7.9 3.5 5.4 0.0 0.0 13.2 0.0 11.2 0.0 0.0 2.8 0.3 2.3 0.0 2.2 24.1 0.0 0.0 1.4 0.0 0.0 9.7 0.0 5.8 0.3 0.0 7.4 0.0 0.1 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 4.2 0.0 0.0 0.0 5.7 0.0 0.0 0.8 0.3 0.0 0.6 0.0 2.6 0.0 4.2 0.5 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 7.7 11.5 57.8 13.0 5.8 4.0 3.6 9.6 4.2 3.7 0.0 0.6 0.0 0.1 5.6 122.4 43.1 0.0 0.0 1.2 0.0 15.7 1.1 1.7 0.0 2.0 49.6 0.0 0.0 0.2 0.2 62.1 0.3 1.1 0.5 1.7 33.4 45.7 87.8 4.9 4.0 89.2 0.8 10.1 0.0 0.0 3.9 0.3 0.0 93.0 0.0 7.1 64.7 41.5 3.0 13.0 4.3 0.9 0.0 0.0 0.0 RUNX3 "AML2, CBFA3, PEBP2A3" ENSG00000020633 "Runt related transcription factor 3" Q13761 1 24899511-24965121 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.5;lymphoid tissue: 47.6" "Cell type enhanced" "Detected in many" 17 "B-cells: 38.9;granulocytes: 46.0;Macrophages: 35.5;Melanocytes: 43.9;monocytes: 68.5;T-cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 39.5;Karpas-707: 53.2;SK-MEL-30: 29.5;U-266/70: 18.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004195, CAB025416, HPA059006" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Vesicles" Cytosol "CAB025416: , HPA004195: , HPA059006: AB_2683877" "unprognostic (7.75e-3)" "unprognostic (6.51e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.42e-1)" "unprognostic (7.60e-2)" "unprognostic (1.81e-2)" "unprognostic (6.51e-2)" "unprognostic (6.95e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-2)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "prognostic unfavorable (5.59e-5)" "unprognostic (1.10e-1)" "unprognostic (4.42e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" 3.0 1.1 0.9 25.4 1.1 31.5 3.4 0.5 1.0 11.9 8.0 1.2 0.3 2.5 1.7 1.4 3.5 1.7 6.2 1.3 0.9 1.1 2.2 2.3 11.7 28.8 2.8 0.7 1.3 1.0 0.0 1.0 1.3 1.8 2.3 2.3 2.8 6.5 2.2 2.2 9.5 13.7 1.3 1.8 30.6 2.7 2.1 0.8 14.2 1.8 3.1 47.6 8.9 2.2 4.5 1.0 4.3 4.6 18.1 15.1 3.1 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 6.3 6.2 5.4 0.0 0.1 3.7 0.0 0.2 39.5 0.6 0.1 0.6 0.0 0.0 1.4 13.7 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 53.2 0.0 0.0 0.4 12.2 0.2 0.0 1.0 0.0 0.0 7.4 0.0 0.1 1.2 0.0 2.4 0.0 29.5 1.0 0.0 8.5 0.0 0.0 0.6 0.0 0.1 18.4 12.8 6.0 0.0 13.8 1.5 0.4 0.7 4.3 15.1 3.0 8.1 4.5 5.7 13.2 0.9 3.8 2.8 10.3 0.9 18.1 4.6 1.0 5.7 3.1 0.9 1.1 0.5 1.0 0.9 1.1 2.8 0.7 1.8 0.8 0.0 5.1 38.9 0.7 6.8 0.0 2.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.2 0.1 1.2 0.7 46.0 0.8 4.9 0.0 0.0 1.8 17.0 0.8 0.0 35.5 43.9 68.5 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 4.7 0.2 2.7 5.1 0.2 144.9 0.0 0.4 RUVBL2 "ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b" ENSG00000183207 "RuvB like AAA ATPase 2" Q9Y230 19 48993448-49015995 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 59.0" "Group enriched" "Detected in all" 4 "Ciliated cells: 184.7;Early spermatids: 493.7;Late spermatids: 663.3;Spermatocytes: 292.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012432, HPA042880, HPA067966" Enhanced Supported Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933" "unprognostic (1.71e-1)" "unprognostic (9.06e-3)" "unprognostic (3.51e-1)" "unprognostic (3.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (9.28e-4)" "unprognostic (7.06e-3)" "unprognostic (6.25e-2)" "unprognostic (3.28e-1)" "unprognostic (8.13e-2)" "unprognostic (7.58e-2)" "unprognostic (2.81e-2)" "unprognostic (2.21e-2)" "unprognostic (7.61e-3)" "unprognostic (1.61e-1)" "unprognostic (2.58e-1)" 6.9 5.3 6.7 7.5 7.1 13.4 4.8 8.2 10.4 4.8 9.9 7.6 6.3 11.2 8.3 5.5 16.1 5.5 7.2 9.1 6.9 6.0 7.6 10.3 5.5 8.2 7.7 8.1 6.5 8.7 1.6 6.4 5.5 6.7 6.0 3.2 6.5 10.0 6.6 27.8 7.7 10.0 3.7 7.1 6.9 10.7 59.0 5.8 14.6 8.8 9.4 8.1 6.4 12.9 12.6 16.4 5.6 14.3 11.0 12.5 15.2 28.9 29.8 3.5 20.0 1.5 2.7 9.4 15.7 6.8 18.0 11.8 15.4 12.6 27.2 12.1 3.1 5.1 15.4 2.2 10.3 2.1 16.5 12.2 17.7 9.0 7.8 5.0 34.8 12.4 3.1 2.1 4.0 2.1 3.3 6.6 23.0 30.7 11.6 1.6 5.9 30.7 4.1 10.8 6.0 4.4 25.5 16.1 17.5 3.2 11.2 14.3 20.6 15.8 13.2 5.6 1.1 11.6 13.4 9.7 11.4 16.8 7.5 38.7 23.5 26.8 28.1 8.4 17.1 16.3 5.6 14.3 4.2 11.1 11.1 11.2 10.9 11.1 9.1 16.4 12.6 12.2 8.0 1.0 11.0 10.8 12.5 12.5 15.2 6.7 7.1 8.2 10.4 6.9 6.0 7.7 8.1 6.7 5.8 11.9 20.2 23.7 40.9 24.6 15.0 38.6 28.1 184.7 36.4 31.4 31.4 91.2 39.7 59.0 493.7 24.1 23.6 23.3 61.9 63.4 32.5 34.0 12.7 31.1 44.6 17.5 16.8 27.6 18.3 663.3 33.4 26.7 25.3 43.3 33.6 23.6 48.7 31.6 40.3 61.6 24.1 19.4 37.1 292.2 46.3 24.1 96.9 25.3 49.4 33.5 RWDD2B "C21orf6, GL011" ENSG00000156253 "RWD domain containing 2B" P57060 21 29004384-29019378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 23.0" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018316 Uncertain NA NA "HPA018316: AB_1845702" "unprognostic (1.96e-1)" "unprognostic (1.89e-2)" "unprognostic (1.42e-1)" "unprognostic (6.14e-2)" "unprognostic (6.67e-2)" "unprognostic (5.02e-2)" "unprognostic (1.75e-1)" "unprognostic (2.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.92e-2)" "unprognostic (2.07e-1)" "unprognostic (2.15e-1)" "unprognostic (1.16e-1)" "unprognostic (6.77e-2)" "unprognostic (2.38e-1)" "unprognostic (1.98e-1)" "unprognostic (2.75e-2)" 3.7 5.0 5.0 3.9 6.2 1.6 4.2 4.1 8.8 4.0 3.0 1.9 5.2 1.7 3.4 6.2 3.4 3.4 3.6 8.4 5.4 5.5 4.3 9.2 2.7 4.0 4.4 3.9 3.3 23.0 3.9 4.9 3.9 3.1 3.8 3.5 1.3 5.5 4.2 12.9 5.4 2.9 4.6 3.4 3.1 3.2 4.4 0.8 2.6 4.8 9.3 3.6 4.1 2.9 2.5 1.8 5.9 2.1 1.4 1.9 1.0 2.2 1.3 2.0 3.0 8.6 3.6 0.6 2.3 3.5 2.9 3.5 2.4 1.9 4.1 2.5 3.9 1.9 1.4 2.5 2.8 2.7 2.6 1.9 5.6 1.4 1.7 4.9 0.6 0.3 3.9 2.6 3.5 4.9 3.4 3.7 1.6 2.2 3.7 4.0 4.2 1.1 2.2 2.7 6.7 2.0 0.9 2.5 5.0 3.3 2.6 3.5 5.0 5.8 2.8 5.6 1.4 5.3 3.1 2.8 4.0 2.3 2.9 1.1 5.3 4.8 2.3 3.1 3.6 3.4 5.9 1.6 1.3 1.9 1.5 1.5 2.5 1.4 1.7 1.3 2.2 1.2 1.3 3.6 1.4 2.1 1.8 0.8 1.0 5.0 6.2 4.1 8.8 5.4 5.5 4.4 3.9 3.1 0.8 14.9 11.0 9.0 2.8 3.0 3.2 26.3 20.4 2.7 6.8 12.2 0.0 10.4 24.9 8.1 7.8 7.1 3.9 0.0 8.1 8.7 8.4 3.8 1.1 18.3 7.4 0.0 11.5 3.7 7.1 8.2 10.3 5.0 8.5 14.4 7.4 4.6 8.3 6.0 12.7 20.9 1.5 6.5 11.3 36.5 17.5 4.1 5.4 4.6 6.0 2.0 RXFP1 "LGR7, RXFPR1" ENSG00000171509 "Relaxin/insulin like family peptide receptor 1" Q9HBX9 4 158315311-158653372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;placenta: 12.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "endometrial cancer: 3.9" "Group enriched" "Detected in many" 6 "basal ganglia: 10.4;cerebral cortex: 18.5;olfactory region: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 24.2;HEL: 8.0;RPTEC TERT1: 11.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA027067 Approved NA NA "HPA027067: AB_10602127" "unprognostic (3.07e-3)" "unprognostic (3.02e-3)" "unprognostic (1.05e-1)" "unprognostic (2.53e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-3)" "unprognostic (6.13e-2)" "unprognostic (6.18e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-6)" "unprognostic (8.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.33e-4)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (6.22e-3)" 0.5 6.5 2.1 0.5 10.4 0.2 0.4 0.4 19.7 4.0 0.5 0.0 1.1 0.3 9.0 1.6 0.5 1.3 1.2 0.4 2.0 1.7 2.9 2.1 5.1 0.7 0.8 12.4 0.8 0.6 0.2 0.6 12.2 0.0 1.0 0.3 0.6 0.4 4.2 0.4 0.4 0.9 1.3 0.4 0.6 0.6 0.6 0.0 0.0 2.4 0.0 0.6 0.5 2.2 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.1 10.4 0.4 18.5 2.0 1.7 0.8 12.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.1 0.0 0.0 0.0 RXFP2 "GPR106, GREAT, INSL3R, LGR8, RXFPR2" ENSG00000133105 "Relaxin/insulin like family peptide receptor 2" Q8WXD0 13 31739542-31803388 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.3;epididymis: 28.4" "Cell type enriched" "Detected in single" 32 "Early spermatids: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 8.3" "Cell type enriched" "Detected in single" 11 "classical monocyte: 5.0" "Lineage enriched" "Detected in single" 23 "monocytes: 5.0" "Group enriched" "Detected in some" 6 "U-2197: 2.1;U-87 MG: 4.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 7 "basal ganglia: 2.0" NA NA "unprognostic (1.77e-2)" 0.5 3.3 1.5 0.1 8.3 2.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.9 28.4 0.0 1.5 0.1 0.5 0.6 0.5 0.3 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.6 0.0 0.2 0.0 3.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 1.5 8.3 0.0 0.5 0.6 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RXFP3 "GPCR135, RLN3R1, RXFPR3, SALPR" ENSG00000182631 "Relaxin/insulin like family peptide receptor 3" Q9NSD7 5 33936386-33938237 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 3.1;brain: 1.1;pancreas: 1.7;pituitary gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPTEC TERT1: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027833 Uncertain NA NA "HPA027833: AB_1849247" "unprognostic (1.93e-2)" "unprognostic (3.66e-1)" "unprognostic (2.89e-1)" "unprognostic (2.86e-1)" "unprognostic (9.68e-2)" "unprognostic (1.72e-1)" "unprognostic (8.67e-3)" 0.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RXFP4 "GPCR142, GPR100, RLN3R2, RXFPR4" ENSG00000173080 "Relaxin/insulin like family peptide receptor 4" Q8TDU9 1 155941710-155942949 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 1.8;bone marrow: 1.3;intestine: 5.4" "Cell type enriched" "Detected in some" 16 "Intestinal endocrine cells: 56.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;NB-4: 2.0;OE19: 2.7;SK-MEL-30: 1.9;T-47d: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (3.64e-2)" "unprognostic (1.84e-3)" "unprognostic (2.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.17e-2)" "unprognostic (4.73e-2)" "unprognostic (2.87e-1)" "unprognostic (8.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (3.08e-3)" "unprognostic (1.40e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (3.86e-2)" 0.2 0.0 0.0 0.5 0.1 1.3 0.1 0.7 0.0 0.0 5.2 3.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 0.1 0.1 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.6 0.4 1.8 1.4 0.7 0.8 0.2 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.3 1.1 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.3 0.5 0.2 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.2 0.1 2.0 0.2 2.7 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.9 1.9 0.0 2.1 0.0 0.6 0.1 0.0 0.0 0.0 0.1 1.2 0.6 1.1 0.2 0.1 0.0 0.9 1.8 0.0 1.1 0.0 0.0 0.5 0.8 0.4 0.6 0.0 0.1 1.1 0.7 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 RXRG NR2B3 ENSG00000143171 "Retinoid X receptor gamma" P48443 1 165400917-165445355 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 23.6;Melanocytes: 27.0;Muller glia cells: 9.1;Sertoli cells: 12.9" "Group enriched" "Detected in many" 13 "melanoma: 25.7;thyroid cancer: 34.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 29.0" "Region enriched" "Detected in many" 5 "basal ganglia: 89.8" "Low region specificity" "Detected in all" "CAB002615, HPA012933" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB002615: , HPA012933: AB_2732406" "unprognostic (2.29e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.66e-1)" "unprognostic (4.29e-2)" "unprognostic (6.19e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.13e-2)" "unprognostic (6.86e-2)" "unprognostic (2.95e-2)" "unprognostic (5.41e-3)" "unprognostic (2.52e-2)" "unprognostic (6.12e-3)" "unprognostic (1.18e-1)" "prognostic favorable (9.40e-5)" "unprognostic (5.03e-2)" 1.9 3.9 5.4 1.0 14.9 0.6 1.0 0.3 5.9 4.0 2.5 5.3 0.6 1.3 1.8 1.3 1.7 3.6 1.2 5.8 7.5 8.9 0.7 0.8 3.4 0.8 4.1 4.3 1.7 2.7 0.8 29.8 1.3 14.1 1.1 2.7 13.5 1.9 2.1 44.8 2.9 2.0 1.8 8.9 1.0 1.1 1.5 5.4 0.0 1.1 2.5 0.6 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 29.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 14.9 0.3 5.9 7.5 8.9 4.1 4.3 14.1 5.4 0.0 0.0 0.0 0.0 0.6 0.3 2.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.9 4.6 0.0 27.0 0.0 0.0 9.1 0.1 0.0 2.1 0.0 4.0 12.9 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 RYR1 "CCO, MHS, MHS1, PPP1R137, RYR" ENSG00000196218 "Ryanodine receptor 1" P21817 19 38433699-38587564 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 231.0" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 46.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 5.3;monocytes: 6.3" "Cell line enhanced" "Detected in some" "A549: 5.7;HaCaT: 14.0;hTCEpi: 5.7;RH-30: 11.5;SiHa: 22.8;U-2 OS: 9.6" "Low region specificity" "Detected in some" HPA056416 Enhanced Approved "Golgi apparatus,Vesicles,Cytosol" NA NA "Golgi apparatus, Vesicles" Cytosol "HPA056416: AB_2683121" "unprognostic (2.22e-3)" "unprognostic (1.91e-3)" "unprognostic (9.59e-2)" "unprognostic (5.34e-4)" "unprognostic (2.50e-1)" "unprognostic (6.00e-2)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "unprognostic (1.18e-1)" "unprognostic (3.20e-3)" "unprognostic (3.52e-1)" "unprognostic (2.35e-1)" "unprognostic (1.07e-5)" "unprognostic (1.13e-2)" "unprognostic (8.10e-2)" "unprognostic (6.62e-3)" "unprognostic (1.34e-1)" 5.3 0.7 3.0 0.6 1.9 0.4 0.6 2.7 1.7 0.6 0.4 2.7 0.0 0.4 0.4 6.7 3.0 0.6 0.5 0.4 1.8 4.0 0.5 0.4 0.7 0.6 1.5 1.3 0.4 0.4 0.3 0.3 0.6 1.9 0.9 0.4 0.4 2.2 0.6 231.0 2.4 0.5 0.4 1.1 0.6 0.5 1.6 1.9 0.0 1.6 55.1 3.2 0.6 0.5 0.7 5.3 0.1 6.3 0.0 0.6 0.6 0.0 5.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.0 0.3 0.3 4.8 0.0 0.0 14.0 0.2 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.4 1.3 5.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.0 11.5 1.1 0.6 0.0 0.0 1.1 22.8 0.0 0.0 0.4 0.5 4.3 0.0 0.0 9.6 0.2 0.0 0.3 1.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.4 3.2 0.5 0.4 0.3 0.6 5.3 0.7 0.0 0.0 0.1 0.0 6.3 0.0 0.6 0.6 3.0 1.9 2.7 1.7 1.8 4.0 1.5 1.3 1.9 1.9 0.0 0.6 0.0 3.4 10.1 4.1 3.4 0.0 0.0 0.0 0.0 2.0 0.1 5.0 0.1 5.2 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.0 0.0 7.1 1.6 0.0 0.6 1.9 4.7 2.8 4.5 0.0 0.0 0.0 46.0 0.0 0.0 1.8 0.0 1.5 0.0 0.3 5.5 6.9 4.1 0.2 0.0 0.0 0.1 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell type enriched" "Detected in many" 30 "Cardiomyocytes: 1960.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.3 0.0 0.0 0.3 0.6 0.0 0.0 7.8 10.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 2.7 4.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 0.0 0.3 0.0 0.0 0.3 65.2 1960.0 0.0 1.4 2.3 1.8 9.8 0.0 0.0 0.0 15.8 1.5 0.0 0.0 2.5 0.0 2.1 0.0 0.0 0.0 0.1 1.6 3.4 1.3 0.0 10.2 1.1 0.0 8.5 0.0 0.0 1.5 0.3 0.0 0.0 0.0 4.7 0.0 18.6 3.2 0.9 0.0 0.0 0.0 0.0 0.0 RYR3 ENSG00000198838 "Ryanodine receptor 3" Q15413 15 33310945-33866121 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 28.8;skeletal muscle: 26.8" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 14.6;granulocytes: 13.9;Horizontal cells: 65.2;Late spermatids: 25.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "basophil: 4.0" "Lineage enriched" "Detected in single" 31 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0;SuSa: 4.8" "Low region specificity" "Detected in many" HPA062004 Approved Vesicles NA NA Vesicles "HPA062004: AB_2797267" "unprognostic (5.85e-2)" "unprognostic (1.57e-1)" "unprognostic (5.30e-2)" "unprognostic (1.35e-1)" "unprognostic (1.26e-2)" "unprognostic (8.03e-4)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.85e-2)" "unprognostic (7.10e-2)" "unprognostic (8.25e-3)" "unprognostic (2.36e-1)" "unprognostic (2.48e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" 1.8 2.0 9.9 1.1 15.4 2.5 2.9 4.9 12.4 2.8 4.5 6.0 0.2 1.5 10.2 1.0 2.7 3.9 1.6 1.0 13.3 3.5 1.2 0.9 1.2 0.9 5.6 6.9 1.7 0.8 28.8 1.2 1.0 10.7 1.8 2.9 0.6 1.4 3.9 26.8 1.2 1.3 7.4 5.9 1.4 1.6 1.6 7.9 0.0 1.1 1.5 1.4 2.1 2.6 0.1 0.0 4.0 0.0 0.0 0.1 0.0 0.3 7.0 1.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.1 0.4 0.6 0.0 2.3 0.2 0.0 0.0 0.0 0.4 0.2 1.4 0.2 0.0 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.4 2.6 0.0 0.4 0.2 0.3 1.1 0.4 0.1 0.5 10.6 0.2 5.0 0.5 0.1 0.5 0.8 0.0 0.2 4.8 0.1 0.3 0.9 0.2 0.1 0.0 0.7 0.3 1.2 0.7 0.5 2.3 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 15.4 4.9 12.4 13.3 3.5 5.6 6.9 10.7 7.9 0.0 0.6 0.0 0.0 0.3 2.4 1.7 0.0 10.7 1.2 0.0 0.0 0.5 0.0 0.0 14.6 0.7 0.0 0.0 0.0 0.6 0.3 0.0 13.9 0.0 0.8 65.2 0.0 0.0 0.0 25.1 0.3 0.4 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 1.0 0.5 0.1 0.0 0.0 0.0 S100A1 "S100-alpha, S100A" ENSG00000160678 "S100 calcium binding protein A1" P23297 1 153627926-153632039 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 465.5;skeletal muscle: 423.5" "Cell type enhanced" "Detected in many" 22 "Collecting duct cells: 146.5;Distal tubular cells: 137.6;Hofbauer cells: 149.3;Melanocytes: 323.9;Proximal tubular cells: 712.0" "Group enriched" "Detected in all" 5 "melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Hep G2: 43.7;SK-MEL-30: 149.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002599, HPA006462" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 240000 Cytosol "Nucleoplasm, Golgi apparatus" "CAB002599: AB_2315307, HPA006462: AB_1079857" "unprognostic (6.13e-2)" "unprognostic (7.60e-2)" "unprognostic (5.96e-5)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.19e-1)" "unprognostic (3.24e-2)" "unprognostic (2.36e-1)" "unprognostic (2.34e-3)" "unprognostic (6.83e-3)" "unprognostic (5.22e-1)" "unprognostic (5.04e-3)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.68e-1)" "unprognostic (4.56e-2)" "unprognostic (2.70e-3)" "unprognostic (9.74e-4)" 27.7 3.2 70.0 2.8 67.3 2.2 14.3 4.1 42.5 2.0 2.4 47.3 0.0 3.5 2.6 8.5 14.1 8.8 2.6 465.5 44.9 42.9 20.0 2.6 2.4 2.5 85.0 30.7 2.2 4.5 2.0 4.3 4.5 31.4 6.3 2.1 4.3 99.3 3.7 423.5 4.0 2.9 2.1 87.7 2.4 3.3 2.8 31.8 0.0 29.0 57.6 4.7 2.9 0.1 0.6 0.6 2.1 1.0 0.3 0.5 0.5 0.7 0.3 0.5 4.6 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.9 0.4 0.5 19.6 0.0 0.2 1.1 0.0 0.0 0.0 0.5 0.4 1.0 0.6 43.7 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 3.5 0.5 0.0 1.2 0.1 0.5 0.2 0.5 0.4 3.1 0.4 1.1 0.8 1.7 0.7 0.2 0.3 1.4 149.9 1.4 4.5 2.3 0.4 0.4 0.3 0.3 0.4 0.7 0.7 0.7 0.3 0.8 0.2 2.1 0.3 0.0 0.1 0.3 0.1 0.0 0.2 0.5 0.0 0.6 0.3 0.0 0.0 0.3 1.0 0.6 0.0 0.5 70.0 67.3 4.1 42.5 44.9 42.9 85.0 30.7 31.4 31.8 0.0 0.0 0.0 1.1 8.7 0.6 57.3 5.1 0.0 0.0 146.5 2.0 0.9 137.6 0.7 0.5 2.1 0.9 0.0 3.4 0.8 2.3 1.2 0.0 3.2 149.3 0.0 1.7 13.5 0.6 1.5 6.1 1.3 323.9 0.0 2.2 60.1 1.1 0.0 8.5 712.0 2.2 0.0 2.1 0.9 0.7 1.9 2.9 0.0 1.5 0.6 S100A10 "42C, ANX2LG, CAL1L, CLP11, P11" ENSG00000197747 "S100 calcium binding protein A10" P60903 1 151982915-151994390 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 148.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4" "Cell line enhanced" "Detected in many" "OE19: 273.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003340, CAB025484" Enhanced Approved Mitochondria Yes No 230000 Mitochondria "CAB025484: , HPA003340: AB_1856531" "unprognostic (2.13e-1)" "unprognostic (1.51e-3)" "unprognostic (1.01e-1)" "unprognostic (3.15e-1)" "unprognostic (6.20e-2)" "prognostic unfavorable (3.33e-4)" "prognostic unfavorable (1.00e-4)" "prognostic unfavorable (2.66e-5)" "unprognostic (1.09e-2)" "unprognostic (9.48e-2)" "prognostic unfavorable (3.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (3.84e-4)" 36.7 19.9 7.3 12.1 9.4 4.5 30.7 7.3 10.7 19.0 42.3 8.4 7.3 23.4 7.3 10.1 87.1 8.5 10.7 16.7 7.3 4.4 19.1 10.2 33.5 7.3 7.3 7.3 11.5 7.3 1.6 7.3 18.7 11.1 8.5 49.8 9.5 21.1 7.3 7.3 21.8 21.7 14.0 9.6 7.3 8.6 61.4 7.3 7.3 7.3 22.1 13.6 8.1 37.7 17.8 148.1 21.4 89.2 25.9 85.4 74.8 63.5 65.2 0.2 13.5 73.8 98.4 48.6 36.0 48.7 32.3 32.8 117.1 88.5 0.0 35.0 62.8 38.3 111.1 18.5 140.1 30.1 11.4 5.3 7.7 29.7 27.4 26.4 2.9 6.7 25.5 118.1 35.2 40.5 29.0 71.4 4.2 0.1 0.1 42.9 55.1 0.5 18.6 8.8 273.2 72.5 0.0 12.6 1.2 136.1 18.9 0.5 0.5 58.8 21.1 27.4 77.4 46.6 7.4 75.8 15.5 38.8 73.4 25.1 1.7 0.3 10.9 91.1 2.6 54.2 21.4 89.2 21.0 33.3 54.4 35.2 17.8 52.6 42.3 148.1 8.6 19.6 29.5 3.2 25.9 46.5 24.2 85.4 74.8 7.3 9.4 7.3 10.7 7.3 4.4 7.3 7.3 11.1 7.3 2373.2 509.0 165.5 824.9 1416.6 10.1 91.6 634.4 507.3 913.4 902.0 3.9 1028.8 1291.5 1817.5 320.0 1052.4 1898.6 46.7 1882.2 473.9 2108.7 1493.1 280.8 168.1 1060.4 15.9 1037.0 742.7 952.8 225.8 599.2 1623.9 1548.8 1432.9 1679.7 14.1 2865.9 3115.1 60.8 287.0 25.8 142.3 345.1 12.6 80.7 1085.7 314.3 441.6 1750.5 1802.8 S100A11 S100C ENSG00000163191 "S100 calcium binding protein A11" P31949 1 152032506-152047907 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 485.8;esophagus: 373.9" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 5098.8;Pancreatic endocrine cells: 5004.9;Urothelial cells: 5957.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 485.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034320, HPA042745" Enhanced NA NA 11000000 "CAB034320: AB_2183487, HPA042745: AB_2678142" "unprognostic (1.85e-2)" "unprognostic (9.20e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-1)" "unprognostic (3.12e-2)" "unprognostic (7.61e-2)" "prognostic unfavorable (3.64e-5)" "unprognostic (3.34e-2)" "unprognostic (8.48e-2)" "unprognostic (1.80e-2)" "unprognostic (1.28e-3)" "unprognostic (5.92e-2)" "prognostic unfavorable (3.24e-6)" "unprognostic (2.91e-1)" "unprognostic (2.75e-1)" "unprognostic (2.43e-3)" "unprognostic (8.86e-2)" 98.4 18.7 9.2 32.7 17.3 24.9 48.0 2.7 9.2 96.3 22.2 14.7 41.3 12.1 42.2 48.0 373.9 42.1 45.6 30.2 7.4 6.5 107.9 17.2 74.6 73.4 16.5 3.4 35.1 23.4 77.0 20.1 197.6 14.3 60.8 22.9 29.6 108.3 49.0 23.9 65.3 31.0 31.2 19.4 89.9 38.7 16.9 11.3 46.7 44.3 181.3 272.3 71.0 130.7 9.2 81.7 485.8 124.5 18.4 39.3 110.7 92.1 73.5 3.6 27.5 101.4 127.2 59.8 90.3 130.8 72.8 74.7 34.1 104.0 0.1 81.0 115.9 58.8 130.5 3.6 161.3 41.3 44.7 7.4 8.0 43.5 19.6 78.5 7.2 56.6 96.4 163.5 79.9 101.0 42.5 55.3 0.0 16.3 17.9 106.0 147.7 0.9 33.8 26.2 199.2 74.6 0.1 38.8 69.9 216.4 156.9 0.1 5.9 68.7 91.5 60.9 92.7 70.0 79.9 79.3 39.1 27.7 60.8 47.9 0.1 0.8 0.3 88.6 23.8 46.1 173.6 124.5 187.4 20.4 119.9 26.9 9.2 39.3 24.1 81.7 5.3 11.7 13.2 485.8 18.4 120.9 28.3 32.6 110.7 9.2 17.3 2.7 9.2 7.4 6.5 16.5 3.4 14.3 11.3 128.1 149.6 114.3 3094.0 1963.3 0.8 19.8 593.6 871.3 419.7 2166.9 0.0 2722.8 863.7 4107.8 286.6 483.3 363.8 23.3 3796.2 5098.8 949.9 2329.5 431.4 7.2 3646.0 0.0 266.8 383.0 1219.9 479.5 297.1 2024.9 1179.3 2541.0 305.3 0.8 5004.9 526.1 242.9 548.1 2.2 207.0 593.3 5.1 23.4 2467.0 3138.8 205.4 310.2 5957.2 S100A12 "CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6" ENSG00000163221 "S100 calcium binding protein A12" P80511 1 153373706-153375649 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Antibiotic, Antimicrobial, Fungicide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 139.8;bone marrow: 329.6;lymphoid tissue: 94.7" "Cell type enriched" "Detected in some" 33 "Kupffer cells: 1264.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 51.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "classical monocyte: 91.9;neutrophil: 139.8" "Group enriched" "Detected in many" 12 "granulocytes: 139.8;monocytes: 91.9" "Group enriched" "Detected in some" 7 "hTCEpi: 6.6;SK-BR-3: 2.2;THP-1: 4.2" "Not detected" "Not detected" "HPA002881, CAB025872" Enhanced "Secreted to blood" NA NA 28500000 6200000 "CAB025872: , HPA002881: AB_1848175" "unprognostic (1.33e-1)" "unprognostic (4.51e-2)" "unprognostic (7.49e-2)" "unprognostic (1.36e-1)" "unprognostic (7.30e-2)" "unprognostic (4.36e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-3)" "unprognostic (9.04e-2)" "unprognostic (3.14e-2)" "unprognostic (1.58e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (5.03e-4)" "unprognostic (3.68e-3)" "unprognostic (1.05e-1)" "unprognostic (1.31e-2)" "unprognostic (7.70e-2)" 6.7 0.5 0.9 8.9 1.7 329.6 0.8 0.3 1.0 3.5 1.1 0.2 0.0 0.6 0.5 0.4 9.2 3.3 1.1 41.2 0.7 0.8 1.6 4.0 34.4 27.4 3.3 0.0 1.5 5.0 0.4 0.7 3.9 2.8 0.8 0.4 0.7 1.9 0.4 1.3 0.8 0.5 4.4 0.8 94.7 1.4 3.4 0.5 3.9 4.5 15.3 4.9 1.7 36.0 0.2 9.6 139.8 91.9 0.0 0.1 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 2.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 91.9 0.3 0.1 3.3 0.0 0.2 0.0 0.1 9.6 0.0 0.0 0.0 139.8 0.0 0.7 0.6 0.1 59.2 0.9 1.7 0.3 1.0 0.7 0.8 3.3 0.0 2.8 0.5 17.9 38.5 0.0 0.2 0.1 0.0 0.4 7.6 13.4 10.3 1.8 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 12.8 3.0 9.0 0.0 0.0 11.1 1264.6 0.7 0.0 35.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.0;tongue: 189.3" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA 110000 "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 0.6 0.0 0.6 4.3 0.6 0.0 6.4 0.6 0.6 38.0 19.2 0.6 3.9 21.4 5.7 2.6 256.0 1.2 7.9 0.6 0.6 0.0 2.4 1.2 7.5 0.6 0.6 0.6 0.7 4.6 6.6 0.8 1.4 0.7 1.9 19.6 0.7 41.8 3.1 0.6 41.4 23.8 1.0 0.6 0.6 9.4 0.9 0.6 8.9 9.6 189.3 71.0 2.2 79.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.6 11.1 0.0 0.1 0.0 0.0 84.7 0.0 120.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 179.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 129.5 0.1 0.0 0.0 0.2 0.6 4.0 0.0 0.0 0.1 126.4 0.1 3.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.7 0.6 56.6 133.0 0.5 298.4 2079.3 0.0 4.4 214.0 18.7 91.0 33.2 0.0 0.6 41.4 164.9 0.0 0.2 1153.1 0.0 59.6 1.7 22.4 341.3 28.7 5.8 0.3 0.0 147.3 1.3 0.0 0.0 0.0 5.3 229.5 3.6 470.4 0.0 202.6 775.0 0.0 3.1 0.0 0.0 33.3 0.0 0.0 3157.3 0.2 0.7 410.3 819.7 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 223.9;tongue: 102.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 117.9;SK-BR-3: 142.9" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" NA NA 92000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (3.18e-4)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 20.1 5.5 9.3 8.0 7.2 0.0 11.9 3.4 8.3 37.2 21.1 8.3 3.2 16.2 8.7 7.2 223.9 7.6 18.2 9.5 6.7 5.4 14.3 27.0 18.3 7.5 7.1 5.7 15.3 4.1 6.5 3.3 14.9 7.2 9.3 14.5 5.1 35.5 5.4 9.8 43.1 31.2 10.6 5.9 13.4 10.6 12.3 4.6 3.2 11.3 102.1 87.5 11.3 51.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 56.4 27.2 1.4 3.2 9.4 35.7 3.7 32.3 29.7 26.6 23.6 25.5 31.6 0.0 51.9 48.3 6.0 41.5 0.0 72.5 15.6 0.1 0.0 0.0 23.7 7.5 10.8 0.0 0.0 16.9 69.7 64.4 50.7 34.8 117.9 0.0 0.6 0.0 58.5 75.0 0.0 0.1 6.0 100.1 73.6 0.0 16.4 0.1 100.2 20.3 0.0 0.1 23.8 142.9 4.7 12.9 44.4 0.3 63.2 16.0 25.6 15.4 73.0 0.0 0.2 0.1 47.6 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 7.2 3.4 8.3 6.7 5.4 7.1 5.7 7.2 4.6 35.7 18.0 15.1 744.7 563.0 0.4 29.7 119.8 26.8 103.5 102.9 2.0 12.3 61.3 584.7 3.2 283.5 336.2 0.0 172.2 7.2 105.8 697.0 19.5 109.5 4.7 0.0 133.3 333.3 22.5 10.0 62.2 11.1 106.3 12.6 178.6 38.3 790.1 294.7 57.7 126.7 1.8 6.5 41.5 1.7 1.2 794.3 6.9 12.8 201.3 1359.9 S100A2 "CAN19, S100L" ENSG00000196754 "S100 calcium binding protein A2" P29034 1 153561108-153567890 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 224.8;tongue: 246.5" "Cell type enhanced" "Detected in many" 20 "Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 1229.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 11.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 11.9" "Group enriched" "Detected in some" 5 "HBEC3-KT: 671.5;RT4: 262.5" "Not detected" "Not detected" "CAB002600, CAB047340, HPA062451" Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane,Cytosol" NA NA 130000 "Nucleoplasm, Cytosol" "Nucleoli, Plasma membrane" "CAB002600: , CAB047340: , HPA062451: AB_2684767" "unprognostic (8.47e-3)" "unprognostic (5.54e-2)" "unprognostic (1.57e-2)" "unprognostic (1.42e-3)" "unprognostic (1.98e-1)" "unprognostic (3.20e-1)" "unprognostic (4.21e-4)" "unprognostic (9.00e-2)" "unprognostic (1.64e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.52e-2)" "unprognostic (8.91e-2)" "unprognostic (1.35e-1)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" 0.4 0.0 0.4 0.5 0.4 0.0 2.1 0.4 0.5 16.9 0.4 0.4 0.9 0.0 1.8 1.9 224.8 0.5 0.4 0.4 0.4 0.0 16.6 0.4 1.6 0.4 0.4 0.4 0.4 0.4 0.0 0.5 0.6 0.6 3.3 0.0 0.4 23.3 2.1 0.7 27.5 0.4 1.5 0.5 0.4 0.0 0.5 0.4 0.7 1.0 246.5 48.4 36.2 43.8 0.5 2.6 11.9 0.6 0.0 2.9 0.7 25.4 0.2 0.0 0.0 0.3 0.1 0.0 0.3 0.3 0.2 0.2 0.0 0.8 0.0 13.5 0.5 0.5 63.2 0.0 671.5 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.0 0.0 0.2 89.4 0.7 102.0 0.7 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.6 4.9 0.0 16.0 0.0 15.9 262.5 0.5 0.0 1.1 0.1 0.2 0.2 0.1 0.1 0.1 0.4 22.2 2.9 8.6 0.0 0.0 0.1 0.8 0.0 0.7 11.9 0.5 0.0 2.9 0.0 1.8 0.5 2.0 1.6 0.4 0.0 0.6 0.5 5.0 0.0 0.6 2.6 1.8 0.7 0.4 0.4 0.4 0.5 0.4 0.0 0.4 0.4 0.6 0.4 8.9 15.9 2.2 2667.8 10183.7 0.0 2.0 2.5 307.9 1714.1 207.6 0.0 0.1 1039.5 26.2 3.0 3.6 1.3 0.0 24.2 0.9 117.2 609.3 16.2 0.0 1.8 0.0 1.7 0.6 1.5 3.8 0.6 38.5 720.4 9.0 1.7 1.0 390.7 2.9 0.7 9.8 0.0 0.0 213.2 0.2 2.3 3170.0 0.2 1.3 1.5 4604.3 S100A3 S100E ENSG00000188015 "S100 calcium binding protein A3" P33764 1 153547329-153549372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 44.7" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 19.6;Exocrine glandular cells: 21.7;Pancreatic endocrine cells: 15.4;Smooth muscle cells: 12.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 26.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 10 "dendritic cells: 8.9;monocytes: 6.9" "Cell line enhanced" "Detected in many" "A549: 33.9;HBEC3-KT: 18.1;HeLa: 22.1;U-2197: 19.8" "Low region specificity" "Detected in some" "HPA042674, HPA056140" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" NA NA 390000 Cytosol "Golgi apparatus, Plasma membrane" "HPA042674: AB_10796581, HPA056140: AB_2683050" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (4.53e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-1)" "unprognostic (2.36e-1)" "unprognostic (2.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.34e-3)" "unprognostic (3.97e-3)" "prognostic unfavorable (1.61e-6)" "unprognostic (8.13e-2)" "unprognostic (3.46e-1)" "unprognostic (6.21e-2)" "unprognostic (8.10e-2)" 4.7 0.6 0.6 3.3 3.1 1.5 2.2 0.6 1.7 3.7 1.2 1.3 0.1 0.4 2.4 1.6 7.4 1.6 1.6 7.9 0.5 0.7 10.2 0.1 14.2 4.6 1.7 0.1 1.2 5.3 0.0 0.3 5.6 3.5 3.6 1.0 0.3 2.0 1.6 2.5 44.7 1.0 1.8 1.5 2.1 0.7 1.4 0.4 0.5 1.7 2.1 4.9 3.7 4.0 0.7 8.9 0.0 6.9 0.0 0.3 0.4 2.9 33.9 0.0 0.0 3.3 2.1 0.0 2.3 12.4 2.9 4.9 1.0 1.1 0.0 7.6 5.9 4.3 9.0 0.0 18.1 1.6 0.1 0.0 0.1 22.1 6.1 0.8 0.0 0.1 1.6 9.3 7.2 8.2 1.8 0.6 0.0 0.0 0.0 16.0 0.2 0.0 0.0 0.2 0.0 4.1 0.0 2.4 1.8 9.9 7.3 0.5 0.0 2.1 2.5 0.7 10.1 0.1 0.2 3.0 1.2 1.9 19.8 2.5 0.6 0.6 0.0 15.9 0.2 7.5 0.0 0.2 0.0 0.0 3.6 0.3 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.9 8.9 0.1 0.4 0.6 3.1 0.6 1.7 0.5 0.7 1.7 0.1 3.5 0.4 3.0 0.3 0.0 1.2 9.2 0.0 0.1 2.5 0.0 4.5 0.0 0.0 0.2 1.7 19.6 0.0 7.0 0.0 0.0 21.7 1.6 8.1 0.6 0.0 0.0 0.3 0.0 0.0 3.7 0.0 0.0 3.7 0.9 1.7 6.4 0.0 0.0 15.4 0.0 0.4 0.0 0.0 0.0 12.7 0.0 0.0 5.6 1.3 0.0 0.0 1.7 S100A4 "18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98" ENSG00000196154 "S100 calcium binding protein A4" P26447 1 153543613-153550136 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 419.2" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 1794.8;Kupffer cells: 3413.1;Macrophages: 4385.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 115.2;ASC diff: 149.4;BJ hTERT+: 287.5;fHDF/TERT166: 205.6;RPMI-8226: 108.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228" Enhanced Enhanced "Plasma membrane" NA NA 13000000 "Plasma membrane" "CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007973: AB_1079858" "unprognostic (1.56e-1)" "unprognostic (6.10e-2)" "unprognostic (2.84e-2)" "unprognostic (8.20e-2)" "unprognostic (6.21e-2)" "prognostic favorable (4.03e-5)" "unprognostic (8.35e-2)" "unprognostic (4.81e-2)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "unprognostic (2.78e-2)" "unprognostic (3.39e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.05e-1)" "unprognostic (3.05e-1)" "unprognostic (2.76e-2)" "unprognostic (3.16e-2)" 125.9 10.1 2.6 29.2 8.3 75.2 171.6 2.2 4.6 52.1 33.9 2.7 25.8 7.3 26.8 52.2 58.6 27.9 34.7 59.9 3.0 1.7 27.8 6.1 80.7 53.2 10.8 3.1 12.7 6.7 0.0 3.0 46.9 6.6 49.5 28.0 19.3 29.8 13.4 25.4 44.5 25.5 38.5 8.9 55.9 17.2 18.2 6.2 8.5 23.7 57.5 26.4 34.9 58.2 18.6 213.1 281.6 293.3 17.3 162.7 419.2 0.5 115.2 0.5 3.3 149.4 103.1 0.1 73.0 287.5 1.4 6.5 0.8 8.1 0.0 13.3 205.6 0.1 2.9 0.4 1.0 1.1 16.4 0.0 49.2 25.6 2.5 0.2 4.3 83.3 16.0 1.1 2.8 0.6 0.2 0.1 0.0 0.4 0.1 104.7 0.4 0.1 51.0 0.3 8.4 44.2 2.6 0.1 108.6 4.5 3.1 4.4 0.5 1.3 55.6 0.4 18.7 3.3 61.7 0.1 0.3 0.6 98.1 0.4 3.6 24.5 0.5 0.2 54.8 5.6 49.5 293.3 30.8 141.2 201.4 147.2 18.6 127.2 112.3 213.1 6.2 22.4 66.5 281.6 17.3 253.9 37.4 162.7 419.2 2.6 8.3 2.2 4.6 3.0 1.7 10.8 3.1 6.6 6.2 455.6 554.5 203.3 20.0 686.7 0.6 8.4 30.6 108.4 174.0 847.9 0.0 45.2 94.5 21.8 4.3 34.1 4.4 116.8 21.4 168.0 716.5 10.9 1330.4 13.0 1794.8 42.9 4.6 120.3 3413.1 10.7 218.3 4385.9 1132.0 911.7 7.1 3.9 22.9 14.4 43.2 14.3 2.7 148.8 785.1 1.6 3.6 606.6 44.6 1190.0 8.0 60.2 S100A5 S100D ENSG00000196420 "S100 calcium binding protein A5" P33763 1 153537147-153541765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 7.6;thyroid gland: 9.1" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Distal tubular cells: 3.3;Extravillous trophoblasts: 7.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 3.7;thyroid cancer: 11.7;urothelial cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 24.3;PC-3: 7.1;RPTEC TERT1: 8.6;RT4: 14.2;SCLC-21H: 12.7" "Region enriched" "Detected in single" 85 "olfactory region: 1210.8" "Region enriched" "Detected in single" 30 "olfactory region: 16.8" HPA064184 Approved Nucleoplasm Yes NA Nucleoplasm "HPA064184: AB_2685206" "unprognostic (6.09e-2)" "unprognostic (2.92e-2)" "unprognostic (8.92e-2)" "unprognostic (1.63e-5)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (4.11e-2)" "unprognostic (2.69e-1)" "unprognostic (7.39e-3)" "unprognostic (3.08e-2)" "unprognostic (2.20e-2)" "unprognostic (1.07e-2)" "unprognostic (9.53e-2)" "unprognostic (5.70e-2)" "unprognostic (4.68e-3)" 0.5 0.1 0.8 2.4 0.2 0.9 0.4 0.2 0.9 0.6 0.3 0.2 0.2 2.3 1.0 0.2 1.3 0.7 1.6 0.2 0.4 0.1 2.3 0.2 3.0 4.6 0.2 0.2 0.2 0.2 0.0 0.4 1.1 0.2 1.5 0.0 0.2 3.8 0.2 0.2 6.0 0.5 0.2 0.2 1.1 1.9 0.2 0.2 1.6 9.1 0.2 2.6 1.8 0.6 0.9 4.6 2.3 1.2 0.0 7.6 1.2 1.5 4.1 0.0 0.0 0.4 0.3 0.3 0.7 0.9 0.5 1.0 0.4 3.0 0.0 2.7 1.5 0.3 1.2 0.1 0.7 0.6 0.3 0.0 1.9 1.5 0.1 0.3 0.0 2.5 0.0 0.8 2.0 0.6 0.3 0.4 0.0 0.5 0.1 2.2 0.1 0.3 0.9 0.1 24.3 7.1 0.0 1.3 0.7 8.6 14.2 12.7 0.0 0.1 6.5 0.6 1.2 0.0 0.4 0.3 0.1 0.9 1.9 1.2 0.0 0.6 0.0 0.4 0.5 0.2 0.0 1.2 2.3 2.0 0.2 7.6 0.9 4.2 2.2 2.8 0.5 2.4 1.1 1.9 0.0 0.6 4.6 6.1 1.2 0.8 0.2 0.2 0.9 0.4 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 0.2 7.2 0.7 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.0 0.3 0.3 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.2 0.0 0.0 0.4 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 78.3;Syncytiotrophoblasts: 22.1" "Group enriched" "Detected in many" 5 "cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 7.4;SK-BR-3: 17.3" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 17000000 Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.1 2.2 0.1 0.1 45.2 0.1 0.1 0.1 0.0 3.7 3.9 116.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 6.2 0.1 0.1 45.7 0.1 0.2 0.1 0.1 0.0 0.3 0.1 1.2 0.1 409.9 156.7 0.2 85.3 0.0 0.4 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 7.4 0.0 2.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.2 0.4 0.0 0.0 0.0 0.8 17.3 0.0 1.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 78.3 22.1 0.0 0.0 0.4 S100A7A "S100A15, S100A7f, S100A7L1" ENSG00000184330 "S100 calcium binding protein A7A" Q86SG5 1 153416524-153423225 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "tongue: 178.1" "Group enriched" "Detected in some" 6 "Early spermatids: 1.1;Late spermatids: 1.6;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SK-BR-3: 3.4" HPA006997 Supported Uncertain Cytosol NA NA Cytosol "HPA006997: AB_1079860" "unprognostic (2.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.73e-2)" "unprognostic (4.65e-2)" "unprognostic (1.40e-1)" "unprognostic (1.77e-1)" "unprognostic (1.17e-1)" "unprognostic (4.40e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 178.1 12.5 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 S100A7L2 s100a7b ENSG00000197364 "S100 calcium binding protein A7 like 2" Q5SY68 1 153437058-153439949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057828 Uncertain NA NA "HPA057828: AB_2683540" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391188 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1" "Cell type enriched" "Detected in many" 13 "Kupffer cells: 10543.8" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 320.7;neutrophil: 720.9" "Group enriched" "Detected in many" 8 "granulocytes: 720.9;monocytes: 320.7" "Group enriched" "Detected in some" 28 "hTCEpi: 28.2;SK-BR-3: 103.3;THP-1: 54.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" NA NA 10900000 530000000 "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 14.0 0.8 0.8 30.5 2.6 718.8 1.1 0.5 1.6 123.0 2.8 0.7 0.4 0.4 12.0 1.2 532.3 5.5 2.1 36.7 1.5 0.5 1.4 4.3 26.2 37.3 3.3 0.4 2.1 2.7 0.1 0.9 4.7 3.3 1.4 0.4 1.3 92.4 0.3 2.5 6.2 1.0 9.0 1.8 72.4 2.0 1.9 0.9 2.6 4.6 597.1 257.6 5.0 224.1 0.6 63.7 720.9 320.7 0.3 0.6 244.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.7 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 28.2 0.0 0.9 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.4 103.3 0.0 0.0 0.7 54.9 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 1.6 0.0 8.2 320.7 38.9 0.4 26.5 0.6 0.6 0.3 0.2 63.7 0.3 0.3 0.3 720.9 0.3 6.4 2.5 0.4 244.7 0.8 2.6 0.5 1.6 1.5 0.5 3.3 0.4 3.3 0.9 208.4 808.2 43.2 0.7 17.4 0.0 2.9 56.0 117.8 215.0 14.0 0.0 4.1 0.0 0.1 217.1 1.6 0.0 23.3 0.8 8.6 1.6 0.4 209.3 16.4 431.8 0.0 0.0 84.7 10543.8 69.5 3.7 783.2 0.0 0.0 0.0 0.0 0.9 0.0 1.4 14.7 0.0 0.0 1.0 2.2 0.5 99.0 5.6 20.3 0.0 19.6 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 11072.0" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 233.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 36.6 0.0 0.0 2.2 0.0 15.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.8 0.0 0.0 0.0 0.7 0.3 0.0 2.9 0.0 0.3 0.0 0.2 0.0 0.0 0.5 7.7 0.0 9.5 0.1 0.0 0.3 233.1 0.1 0.1 3.6 29.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.7 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 214.4 574.2 57.1 52.5 17.7 0.0 2.5 66.2 112.4 185.4 34.9 0.0 111.0 5.0 49.4 1.3 7.0 0.5 23.3 32.9 44.2 7.1 19.6 151.1 16.4 1627.6 0.0 0.0 71.2 11072.0 2.2 5.5 1162.8 0.0 4.6 2.1 0.0 10.3 0.8 0.0 16.3 0.2 0.0 2.5 0.3 1.3 29.1 1033.7 24.9 1.9 291.7 S100B S100beta ENSG00000160307 "S100 calcium binding protein B" P04271 21 46598962-46605208 "Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 342.0" "Cell type enhanced" "Detected in some" 16 "Kupffer cells: 25.7;Macrophages: 53.7;Melanocytes: 94.5;monocytes: 55.9" "Group enriched" "Detected in all" 58 "glioma: 463.5;melanoma: 495.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 78.0" "Lineage enriched" "Detected in many" 7 "T-cells: 78.0" "Group enriched" "Detected in some" 7 "SK-MEL-30: 82.9;WM-115: 163.0" "Low region specificity" "Detected in all" "CAB000073, HPA015768, CAB078196" Enhanced Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA 120000 "Nucleoplasm, Cytosol" Vesicles "CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538" "unprognostic (5.67e-3)" "unprognostic (6.39e-3)" "unprognostic (2.08e-3)" "unprognostic (2.08e-2)" "unprognostic (4.54e-3)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (6.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (8.57e-3)" "unprognostic (6.70e-2)" "unprognostic (4.41e-7)" "unprognostic (3.55e-2)" "unprognostic (7.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" 67.7 14.0 60.9 5.6 51.0 2.0 13.2 39.4 151.2 5.2 9.1 101.0 3.0 4.7 1.5 7.6 8.6 2.1 8.3 6.6 74.6 65.4 1.5 1.6 2.9 9.8 152.0 36.5 2.4 3.0 1.1 3.1 1.4 90.3 3.0 8.3 7.4 10.1 15.3 1.3 5.7 7.5 4.3 342.0 5.7 4.3 1.5 46.4 0.0 1.3 1.8 10.8 8.2 1.6 0.1 3.4 0.7 1.9 11.0 78.0 10.6 0.1 0.0 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 82.9 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.0 163.0 0.0 0.1 0.0 78.0 1.8 22.4 0.0 0.2 14.5 3.4 0.1 0.6 33.3 0.7 11.0 1.9 0.8 0.0 10.6 60.9 51.0 39.4 37.6 74.6 65.4 152.0 36.5 90.3 46.4 3.0 7.4 0.9 0.2 14.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.2 7.6 0.0 0.0 4.9 25.7 0.4 5.2 53.7 94.5 55.9 0.0 9.7 0.1 0.0 0.0 0.0 4.0 0.0 2.1 0.0 0.1 11.0 0.1 0.5 0.0 0.1 S100G "CABP1, CABP9K, CALB3" ENSG00000169906 "S100 calcium binding protein G" P29377 X 16650158-16654670 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "intestine: 74.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "breast cancer: 4.7;renal cancer: 0.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 5 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;PC-3: 2.2;RPMI-8226: 7.0;SH-SY5Y: 1.3" "Region enriched" "Detected in single" 5 "pons and medulla: 1.2" "Low region specificity" "Detected in many" "CAB017688, HPA028920, HPA055873" Enhanced Approved Cytosol NA NA Cytosol "CAB017688: AB_1119899, HPA028920: , HPA055873: AB_2682952" "unprognostic (2.68e-2)" "unprognostic (2.78e-1)" "unprognostic (9.88e-3)" 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.2 18.0 0.0 0.0 74.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 7.0 0.0 0.0 0.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.4 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100P ENSG00000163993 "S100 calcium binding protein P" P25815 4 6693069-6697170 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6" "Group enriched" "Detected in many" 5 "Syncytiotrophoblasts: 2319.4;Urothelial cells: 3591.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 564.7" "Group enriched" "Detected in some" 41 "basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9" "Lineage enriched" "Detected in many" 68 "granulocytes: 89.9" "Cell line enhanced" "Detected in some" "BEWO: 28.5;Hep G2: 30.0;hTCEpi: 33.4;OE19: 130.4;RT4: 61.3;SK-BR-3: 34.3" "HPA019502, HPA075251" Enhanced Supported Nucleoplasm NA NA 1200000 Nucleoplasm "HPA019502: AB_1856530, HPA075251: " "unprognostic (1.46e-1)" "unprognostic (1.50e-1)" "unprognostic (7.52e-2)" "unprognostic (1.44e-1)" "unprognostic (2.22e-1)" "unprognostic (7.34e-2)" "unprognostic (1.60e-3)" "unprognostic (3.92e-2)" "unprognostic (7.19e-2)" "unprognostic (9.24e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.87e-2)" "unprognostic (1.96e-2)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (3.65e-1)" "unprognostic (1.12e-2)" 0.1 0.0 0.0 1.1 0.0 42.8 0.0 0.0 0.0 0.3 5.2 0.1 0.0 0.0 23.3 0.3 1.0 0.0 0.0 0.0 0.0 1.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 16.4 4.8 5.4 1.1 0.0 0.0 3.9 0.5 0.1 0.0 4.4 70.0 0.0 0.0 2.5 47.6 5.1 0.0 0.0 89.9 1.3 0.0 0.0 0.4 3.8 2.4 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.4 0.0 0.0 4.7 0.0 0.0 0.0 1.8 0.0 0.0 2.7 30.0 0.0 1.7 0.1 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 3.5 0.0 130.4 4.3 0.0 0.0 0.0 0.0 61.3 0.0 0.0 5.6 34.3 0.0 1.2 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 47.8 1.3 24.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.1 0.0 0.0 0.4 8.9 66.8 2.9 152.0 1.0 0.0 0.8 43.3 224.9 151.2 1.8 0.0 512.0 0.0 0.2 11.8 0.5 133.5 0.0 27.6 604.2 12.6 292.8 30.1 1.1 61.5 0.0 16.0 1.8 14.1 5.6 0.0 3.6 8.5 2.8 160.2 0.0 481.5 254.0 0.0 0.1 0.0 0.0 2.1 0.0 0.2 5.5 2319.4 2.2 48.0 3591.7 S100Z "Gm625, S100-zeta" ENSG00000171643 "S100 calcium binding protein Z" Q8WXG8 5 76850001-76921650 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.7;lymphoid tissue: 9.5" "Group enriched" "Detected in some" 5 "B-cells: 3.4;Hofbauer cells: 6.4;Kupffer cells: 13.2;Macrophages: 5.5;Melanocytes: 3.3" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 17.6;eosinophil: 15.0;intermediate monocyte: 15.9;myeloid DC: 9.5;neutrophil: 5.9;non-classical monocyte: 18.7" "Group enriched" "Detected in many" 6 "dendritic cells: 9.5;granulocytes: 15.0;monocytes: 18.7" "Cell line enriched" "Detected in some" 6 "U-698: 42.4" "Region enriched" "Detected in single" 5 "olfactory region: 1.6" "Low region specificity" "Detected in all" HPA051929 Approved NA NA "HPA051929: AB_2732571" "unprognostic (4.17e-3)" "unprognostic (4.10e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-4)" "unprognostic (1.86e-1)" "unprognostic (4.62e-2)" "unprognostic (1.37e-1)" "unprognostic (1.31e-1)" "unprognostic (8.89e-2)" "unprognostic (2.17e-1)" "unprognostic (3.54e-3)" "unprognostic (1.32e-1)" "unprognostic (9.47e-5)" "unprognostic (3.39e-4)" "unprognostic (8.94e-2)" "unprognostic (6.85e-2)" "unprognostic (1.62e-1)" 1.0 1.0 3.5 5.3 3.3 5.7 1.1 0.6 2.2 0.6 0.9 3.8 0.4 1.0 0.8 0.4 0.8 0.7 1.9 0.7 4.1 1.7 1.0 1.0 5.1 6.2 2.1 2.6 0.6 2.4 0.2 0.7 3.2 3.2 1.0 1.4 0.3 1.1 0.5 0.9 0.6 2.3 1.5 6.2 9.5 1.1 0.7 4.5 2.1 0.7 0.0 6.2 1.8 0.9 2.5 9.5 15.0 18.7 0.3 0.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 42.4 1.8 0.0 0.0 1.4 17.6 15.0 0.4 15.9 0.1 2.5 0.3 0.0 9.5 0.6 0.0 0.0 5.9 0.3 18.7 0.1 0.3 4.6 3.5 3.3 0.6 2.2 4.1 1.7 2.1 2.6 3.2 4.5 0.0 0.0 3.4 0.1 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.6 13.2 0.0 0.0 5.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 1.0 0.0 0.0 S1PR1 "CD363, D1S3362, edg-1, EDG1" ENSG00000170989 "Sphingosine-1-phosphate receptor 1" P21453 1 101236888-101241518 "Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.9" "Group enriched" "Detected in many" 5 "Endothelial cells: 89.9;Ito cells: 114.2;Muller glia cells: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 19.4;HUVEC TERT2: 54.9;TIME: 30.5;U-251 MG: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010104, HPA075568" Supported Supported Vesicles No NA Vesicles "CAB010104: AB_2238920, HPA075568: AB_2686758" "unprognostic (1.41e-1)" "unprognostic (9.35e-2)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (9.78e-2)" "unprognostic (4.49e-3)" "unprognostic (1.34e-3)" "unprognostic (1.99e-1)" "unprognostic (1.36e-1)" "unprognostic (9.12e-2)" "unprognostic (2.34e-2)" "unprognostic (2.23e-1)" "unprognostic (5.82e-3)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.78e-4)" 72.3 8.4 24.7 16.6 26.2 9.7 46.3 21.6 21.8 13.3 10.5 9.5 2.5 5.7 12.1 5.0 14.7 11.5 17.6 43.5 22.9 15.4 8.9 20.5 35.7 24.5 23.2 14.0 7.9 11.0 13.4 4.7 29.6 21.2 8.9 7.0 9.3 7.5 5.6 21.7 8.2 9.8 19.0 11.0 35.2 8.0 5.8 13.9 4.4 17.0 8.7 15.7 15.2 18.5 27.4 0.2 88.9 0.2 33.4 49.8 30.8 3.6 0.0 3.9 0.0 0.4 9.3 0.0 19.4 3.5 11.8 4.2 0.0 0.1 0.0 4.8 6.7 0.0 0.0 0.5 0.2 7.9 1.3 0.4 1.3 0.1 0.0 1.8 0.0 0.8 12.5 0.0 0.0 0.9 0.5 54.9 1.1 0.0 4.0 3.7 0.0 4.6 0.0 1.0 0.1 1.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 30.5 2.0 0.7 0.4 37.6 0.3 0.0 0.2 0.2 0.0 0.1 88.9 0.1 4.9 49.8 0.1 40.2 25.1 45.3 44.1 0.2 27.4 35.7 36.2 1.4 33.4 0.2 0.2 26.8 30.8 24.7 26.2 21.6 16.8 22.9 15.4 23.2 14.0 21.2 13.9 0.0 12.8 17.1 0.1 6.8 0.0 16.9 2.5 0.0 2.3 0.0 0.0 5.5 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.3 8.4 0.5 7.0 6.0 7.6 0.0 0.0 114.2 6.9 0.0 0.9 1.5 5.0 14.4 0.0 38.0 0.0 0.0 0.0 0.0 1.0 0.0 1.4 0.4 0.7 4.4 2.2 9.2 0.0 0.4 S1PR4 EDG6 ENSG00000125910 "Sphingosine-1-phosphate receptor 4" O95977 19 3172346-3180332 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9" "Cell type enhanced" "Detected in many" 15 "B-cells: 50.4;Hofbauer cells: 26.6;Kupffer cells: 27.5;T-cells: 64.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 11.0;HL-60: 14.7;NB-4: 14.5;REH: 41.0;U-937: 14.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA060601, HPA067232" Supported Mitochondria NA NA Mitochondria "HPA060601: AB_2797261, HPA067232: AB_2797271" "prognostic favorable (3.13e-4)" "prognostic favorable (1.33e-4)" "unprognostic (2.58e-2)" "prognostic favorable (2.22e-4)" "unprognostic (2.98e-2)" "prognostic favorable (1.45e-6)" "unprognostic (1.27e-2)" "unprognostic (8.73e-2)" "unprognostic (1.21e-3)" "unprognostic (6.64e-3)" "unprognostic (3.59e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (2.06e-1)" "unprognostic (6.15e-3)" 2.0 0.5 0.7 8.3 0.3 14.9 1.3 0.6 0.7 0.5 0.9 0.4 0.2 0.8 0.7 0.7 1.2 1.4 0.7 2.1 0.3 0.2 1.2 1.4 6.4 35.9 0.3 0.4 0.7 0.3 0.0 0.2 1.7 0.6 0.7 0.0 1.0 1.3 0.2 1.1 0.4 7.1 0.2 0.5 34.2 3.9 0.3 0.3 10.2 1.5 0.2 10.7 1.9 0.6 14.1 7.3 44.2 15.3 5.4 23.1 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 4.7 0.1 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.1 0.0 41.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 14.0 0.0 16.4 10.4 27.4 11.8 11.6 10.5 11.3 14.7 11.4 7.3 14.1 12.4 11.9 44.2 5.4 15.3 6.6 23.1 7.2 0.7 0.3 0.6 0.7 0.3 0.2 0.3 0.4 0.6 0.3 3.0 5.8 50.4 0.2 1.1 0.0 0.4 0.0 0.0 2.3 1.8 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.1 0.1 0.2 5.7 0.0 26.6 0.0 0.0 3.1 27.5 0.0 0.0 13.2 1.7 1.8 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 64.7 0.0 0.3 S1PR5 "Edg-8, EDG8" ENSG00000180739 "Sphingosine-1-phosphate receptor 5" Q9H228 19 10512742-10517931 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;brain: 37.8;skin 1: 25.4" "Cell type enriched" "Detected in some" 12 "T-cells: 52.4" "Group enriched" "Detected in many" 5 "cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 62.0;MAIT T-cell: 38.0;memory CD8 T-cell: 29.2;naive CD8 T-cell: 23.2" "Lineage enriched" "Detected in many" 8 "T-cells: 62.0" "Cell line enhanced" "Detected in many" "HaCaT: 21.9;HBEC3-KT: 8.4;RT4: 14.3;T-47d: 9.1;U-2 OS: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029683 Enhanced NA NA "HPA029683: AB_10603237" "unprognostic (9.07e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-2)" "unprognostic (5.55e-4)" "unprognostic (4.21e-1)" "unprognostic (4.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.55e-1)" "unprognostic (3.48e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.71e-7)" "unprognostic (2.46e-2)" "unprognostic (2.90e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-1)" 1.4 1.0 10.0 1.6 17.4 21.0 1.1 1.9 15.1 2.7 1.0 37.8 0.0 0.9 1.1 6.9 6.5 1.0 1.0 0.9 15.7 8.0 1.1 2.7 3.0 1.7 28.8 9.3 0.7 0.8 0.6 0.2 2.8 13.9 2.0 0.8 0.7 1.3 1.4 1.4 25.4 1.0 0.9 26.2 11.6 0.9 0.9 21.0 0.0 0.8 0.2 3.3 3.1 5.0 0.1 0.1 0.8 0.1 8.1 62.0 10.2 1.4 2.2 0.4 0.0 0.0 0.1 0.1 0.5 0.3 0.7 0.4 0.2 0.1 0.0 6.0 0.2 1.0 21.9 1.4 8.4 1.6 0.0 1.4 0.2 1.8 0.0 0.0 0.0 0.1 0.0 4.0 2.4 0.4 0.1 0.0 0.0 0.2 0.0 0.0 2.8 0.8 0.0 3.5 0.4 0.4 0.0 1.6 0.0 0.0 14.3 0.0 0.0 3.6 0.0 0.4 1.6 9.1 2.5 0.0 1.1 8.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 62.0 0.0 38.0 0.1 7.8 29.2 0.1 0.1 2.4 23.2 0.8 8.1 0.1 0.1 0.1 10.2 10.0 17.4 1.9 15.1 15.7 8.0 28.8 9.3 13.9 21.0 3.0 3.4 0.0 1.6 3.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.2 0.2 0.9 0.2 2.3 0.0 0.2 0.0 0.0 1.3 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.1 52.4 0.0 0.4 SAA1 "PIG4, SAA, TP53I4" ENSG00000173432 "Serum amyloid A1" P0DJI8 11 18266174-18269977 "Disease related genes, Predicted secreted proteins" "Acute phase" Heparin-binding Amyloidosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 216.6;liver: 849.2" "Cell type enriched" "Detected in many" 26 "Hepatocytes: 59557.7" "Cancer enriched" "Detected in many" 16 "liver cancer: 1249.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.1;intermediate monocyte: 2.6;memory B-cell: 2.1" "Group enriched" "Detected in many" 6 "B-cells: 2.1;monocytes: 2.6;T-cells: 1.1" "Cell line enriched" "Detected in some" 5 "HBEC3-KT: 163.9" "Secreted to blood" NA NA 300000000 22000000000 "unprognostic (2.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (1.50e-1)" "unprognostic (4.54e-3)" "unprognostic (1.79e-2)" "unprognostic (1.63e-2)" "unprognostic (7.04e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-2)" "unprognostic (8.95e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.57e-12)" "unprognostic (5.15e-2)" "unprognostic (9.78e-2)" "unprognostic (9.23e-3)" "unprognostic (1.64e-1)" 216.6 4.3 0.8 17.4 0.8 0.0 31.9 0.8 0.8 28.5 3.2 0.8 0.8 0.0 0.8 1.1 1.0 1.0 2.9 1.0 0.8 0.0 1.1 849.2 1.7 2.4 0.8 0.8 0.8 4.7 0.0 1.0 0.9 0.8 1.1 0.3 0.8 50.3 1.0 11.5 1.2 1.2 1.5 0.8 0.8 0.6 0.8 0.8 1.0 1.0 1.1 1.1 1.1 1.3 2.1 0.3 0.0 2.6 0.0 1.1 0.0 11.1 0.0 0.0 0.0 8.1 0.0 4.4 0.3 0.2 0.0 0.0 0.0 3.9 0.0 9.0 0.0 3.0 10.5 0.0 163.9 0.0 0.1 0.0 0.1 0.0 0.0 35.7 0.2 0.0 14.5 19.5 0.0 18.9 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.6 0.2 0.0 0.0 0.9 1.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 2.6 0.0 2.1 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 6.0 3.2 650.1 44.2 8.2 0.0 0.0 1340.1 38.8 118.3 52.4 0.0 0.9 0.0 161.5 0.0 0.0 2.5 1565.2 69.5 20.1 0.8 164.4 2.3 59557.7 0.9 0.0 1.7 2316.5 1468.3 0.0 0.0 0.1 49.0 4.6 0.0 0.0 82.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 1.7 34.8 0.0 187.8 SAA2 ENSG00000134339 "Serum amyloid A2" P0DJI9 11 18239223-18248643 "Disease related genes, Predicted secreted proteins" "Acute phase" Amyloidosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 752.1" "Cell type enriched" "Detected in many" 23 "Hepatocytes: 22104.6" "Cancer enriched" "Detected in many" 22 "liver cancer: 150.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 15.5;EFO-21: 11.9;GAMG: 11.3;HaCaT: 14.6;HBEC3-KT: 31.6;HSkMC: 10.3" "Secreted to blood" NA NA 11000000000 "unprognostic (1.73e-3)" "unprognostic (4.42e-2)" "unprognostic (2.63e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-3)" "unprognostic (7.12e-2)" "unprognostic (7.45e-2)" "unprognostic (2.15e-2)" "unprognostic (1.57e-1)" "unprognostic (2.86e-2)" "unprognostic (2.78e-2)" "unprognostic (6.13e-2)" "prognostic unfavorable (1.30e-8)" "unprognostic (1.53e-1)" "unprognostic (9.72e-2)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" 68.6 1.7 0.7 16.3 0.7 0.0 9.8 0.7 0.7 33.1 0.7 0.7 0.7 0.0 0.7 0.7 0.7 0.3 1.2 0.7 0.7 0.0 0.7 752.1 0.8 0.7 0.7 0.7 0.7 0.7 0.0 0.7 0.7 0.7 0.8 0.0 0.7 46.0 0.7 5.2 0.3 0.7 0.7 0.7 0.7 0.2 0.7 0.7 1.1 0.7 0.7 0.7 1.1 0.7 2.0 1.0 3.1 1.2 0.6 0.9 0.4 15.5 0.0 0.1 0.1 0.6 0.0 2.2 0.0 0.5 0.0 0.2 0.0 6.9 0.1 11.9 0.1 11.3 14.6 0.0 31.6 0.1 0.6 0.0 0.5 0.2 0.0 4.6 0.4 0.1 10.3 4.4 0.0 5.2 0.3 0.1 0.0 0.0 0.7 0.8 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.4 0.0 7.1 0.7 0.1 0.0 1.1 4.9 0.0 0.3 0.2 0.3 0.1 0.1 0.7 0.3 0.6 0.2 0.4 1.0 0.0 0.6 0.2 3.0 1.2 1.0 0.6 0.6 0.9 0.8 0.6 0.4 0.3 2.0 0.4 0.6 3.1 0.6 1.0 1.0 0.9 0.4 0.7 0.7 0.7 0.7 0.7 0.0 0.7 0.7 0.7 0.7 0.0 1.0 517.5 4.2 0.9 0.0 0.2 578.4 18.7 30.7 3.5 0.0 0.2 0.0 35.2 1.3 0.0 1.4 864.3 29.6 1.8 0.2 32.1 0.0 22104.6 0.3 0.0 0.0 951.4 647.2 0.4 0.0 0.4 8.5 1.8 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 4.8 0.0 62.9 SAA2-SAA4 ENSG00000255071 "SAA2-SAA4 readthrough" 11 18231423-18248635 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 15.9;cervix, uterine: 10.6;liver: 44.4" "Group enriched" "Detected in some" 28 "Ciliated cells: 1.4;Club cells: 4.5;Hepatocytes: 2.6" "Cancer enriched" "Detected in many" 13 "liver cancer: 39.9" "Cell type enriched" "Detected in single" 10 "memory B-cell: 1.0" "Lineage enriched" "Detected in single" 10 "B-cells: 1.0" "Cell line enhanced" "Detected in some" "A-431: 6.7;EFO-21: 3.9;GAMG: 3.1;HaCaT: 2.6;SiHa: 1.5" HPA060139 Uncertain NA NA "HPA060139: AB_2684210" "prognostic favorable (4.56e-4)" "unprognostic (1.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.44e-1)" "unprognostic (1.23e-3)" "unprognostic (9.41e-3)" "unprognostic (1.96e-2)" "unprognostic (1.96e-1)" "unprognostic (8.27e-3)" "unprognostic (3.17e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (2.92e-8)" "unprognostic (1.92e-1)" "unprognostic (2.72e-1)" 15.9 0.6 0.0 0.7 0.0 0.0 2.7 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 44.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.5 0.0 3.9 0.0 3.1 2.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAA4 "C-SAA, CSAA" ENSG00000148965 "Serum amyloid A4, constitutive" P35542 11 18231349-18236893 "Plasma proteins, Predicted secreted proteins" "Acute phase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 132 "liver: 263.3" "Cell type enriched" "Detected in some" 47 "Hepatocytes: 1790.2" "Cancer enriched" "Detected in many" 141 "liver cancer: 118.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "memory B-cell: 1.9" "Lineage enriched" "Detected in single" 20 "B-cells: 1.9" "Cell line enriched" "Detected in some" 18 "Hep G2: 22.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026061, HPA060139" Supported "Secreted to blood" NA NA 65000000000 72000000000 "CAB026061: , HPA060139: AB_2684210" "unprognostic (4.70e-4)" "unprognostic (1.17e-1)" "unprognostic (1.17e-1)" "unprognostic (4.83e-1)" "unprognostic (4.15e-2)" "unprognostic (6.05e-2)" "unprognostic (3.63e-3)" "unprognostic (5.94e-2)" "unprognostic (2.40e-2)" "unprognostic (1.41e-1)" "unprognostic (7.35e-2)" "unprognostic (2.54e-8)" "unprognostic (2.49e-1)" "unprognostic (6.46e-2)" 0.7 0.0 0.1 0.1 0.1 0.0 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 263.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.2 0.0 22.6 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 14.7 0.0 0.0 0.0 0.0 25.5 0.0 4.5 0.0 0.0 0.0 0.0 3.5 0.4 0.0 0.0 23.3 1.1 0.0 0.0 0.1 0.0 1790.2 0.1 0.0 0.0 32.5 38.1 0.7 0.0 0.0 1.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 SAC3D1 "HSU79266, SHD1" ENSG00000168061 "SAC3 domain containing 1" 11 65040901-65044828 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 26.3" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 67.9;Late spermatids: 96.5;Spermatocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042677 Uncertain Approved Cytosol NA NA Cytosol "HPA042677: AB_10797506" "unprognostic (1.35e-1)" "unprognostic (5.45e-3)" "unprognostic (5.00e-1)" "unprognostic (8.01e-2)" "unprognostic (3.56e-1)" "unprognostic (3.53e-2)" "prognostic unfavorable (9.67e-6)" "unprognostic (4.11e-1)" "unprognostic (1.70e-1)" "unprognostic (4.45e-2)" "unprognostic (4.71e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (2.97e-3)" "unprognostic (5.71e-1)" "unprognostic (4.53e-2)" "unprognostic (2.49e-1)" 6.3 6.1 5.1 5.1 5.8 7.1 10.9 7.1 8.4 3.7 7.7 3.0 5.0 5.8 4.3 4.2 5.1 4.0 6.4 4.2 4.8 4.5 3.7 6.6 4.7 4.4 5.1 3.0 3.2 8.6 2.6 4.1 3.0 6.5 4.2 3.5 1.4 6.7 5.7 12.4 6.4 3.9 4.9 4.4 4.5 5.0 26.3 4.6 16.2 3.3 6.2 4.8 3.6 4.6 2.3 3.6 0.4 3.6 0.1 2.7 0.8 18.7 11.1 7.7 7.3 4.1 2.9 4.8 12.2 3.2 9.4 7.9 7.9 4.9 10.0 8.5 4.7 10.2 10.4 6.3 8.9 1.3 12.4 10.4 7.9 7.2 14.1 3.0 5.3 2.9 0.8 8.0 7.2 3.2 2.3 3.3 11.4 11.0 5.6 3.2 10.3 8.3 21.7 2.5 6.7 22.6 6.2 5.5 11.0 4.0 4.3 9.5 7.9 9.3 10.3 6.8 2.2 8.1 7.6 3.2 4.5 13.7 14.6 7.8 13.4 9.4 7.5 2.7 7.0 2.0 0.0 3.1 0.4 1.6 2.6 1.5 2.3 1.9 1.2 1.5 2.2 2.7 1.8 0.3 0.1 3.6 3.6 2.2 0.8 5.1 5.8 7.1 8.4 4.8 4.5 5.1 3.0 6.5 4.6 3.0 0.3 5.2 5.1 7.7 6.8 5.2 5.1 1.4 1.2 8.7 0.0 15.5 6.6 1.8 67.9 5.8 14.6 0.0 1.4 37.0 8.9 8.3 5.7 13.1 25.4 4.8 6.9 4.3 16.1 96.5 16.4 8.3 10.1 2.8 12.1 12.7 2.3 11.9 13.1 10.3 6.9 0.0 8.2 199.6 43.9 6.8 5.6 9.6 20.7 3.1 SACS "ARSACS, DKFZp686B15167, DNAJC29, KIAA0730, PPP1R138, SPAX6" ENSG00000151835 "Sacsin molecular chaperone" Q9NZJ4 13 23328826-23433740 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 38.5" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB017714 Uncertain NA NA "CAB017714: " "unprognostic (1.22e-1)" "unprognostic (2.18e-1)" "unprognostic (2.02e-3)" "prognostic unfavorable (9.04e-4)" "unprognostic (1.26e-2)" "unprognostic (1.66e-1)" "unprognostic (2.05e-3)" "unprognostic (2.59e-2)" "unprognostic (2.49e-1)" "unprognostic (4.14e-2)" "unprognostic (5.05e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.21e-6)" "unprognostic (2.84e-1)" "unprognostic (4.06e-2)" "unprognostic (3.67e-2)" "unprognostic (7.65e-4)" 6.3 6.0 15.9 7.9 20.3 9.6 7.1 7.7 20.2 5.6 6.4 7.8 2.6 2.8 8.8 6.3 5.5 5.1 5.2 7.4 13.5 10.2 2.8 2.8 4.0 8.1 12.5 11.5 8.6 4.6 38.5 7.5 3.4 21.4 8.0 4.0 2.4 6.0 5.4 13.6 4.8 4.3 13.5 11.6 8.3 4.7 7.8 15.2 6.6 3.2 8.7 7.4 6.9 6.7 2.5 2.0 1.0 0.9 1.3 2.8 0.5 3.9 5.1 10.8 3.3 3.4 12.8 1.6 9.1 11.7 3.6 2.9 2.5 2.1 2.7 3.8 19.4 4.6 0.8 15.5 5.4 11.7 6.3 6.4 10.2 3.9 3.6 2.5 18.5 4.0 4.1 1.2 22.6 11.0 4.9 11.5 8.6 5.8 1.3 16.0 1.9 6.6 7.1 8.9 1.3 4.2 7.8 19.8 8.2 6.1 0.4 7.9 7.5 5.0 1.8 4.0 5.2 1.0 4.9 24.9 10.9 9.0 5.9 17.1 2.6 2.7 6.7 5.1 6.6 9.5 0.0 0.8 1.0 1.1 0.9 2.0 1.1 1.7 0.8 2.0 2.5 1.2 1.4 0.0 1.3 0.3 1.7 2.8 0.5 15.9 20.3 7.7 20.2 13.5 10.2 12.5 11.5 21.4 15.2 0.0 2.2 7.8 3.3 5.5 14.1 16.1 2.5 0.0 1.2 1.8 0.0 0.2 0.0 8.5 8.9 8.4 0.0 0.0 8.7 1.2 13.3 6.7 2.3 0.8 3.0 23.8 1.2 4.9 4.5 9.4 3.7 7.2 8.5 2.8 0.2 13.8 14.1 0.0 4.9 0.7 4.9 12.9 20.8 19.1 7.0 4.4 0.0 8.9 0.6 3.3 SAG "ARRESTIN, RP47" ENSG00000130561 "S-antigen visual arrestin" P10523 2 233307816-233347055 "Disease related genes, Predicted intracellular proteins" "Congenital stationary night blindness, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "retina: 215.8" "Cell type enriched" "Detected in some" 6 "Rod photoreceptor cells: 5320.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 39 "basal ganglia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA004946 Enhanced NA NA "HPA004946: AB_2667304" "unprognostic (4.76e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (3.95e-1)" "unprognostic (8.54e-2)" "unprognostic (2.89e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.54e-1)" "unprognostic (4.57e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-9)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-1)" "unprognostic (1.03e-5)" 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 215.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 490.5 0.8 0.0 0.0 0.0 0.0 818.8 1.4 0.0 0.0 32.2 0.4 0.6 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.1 319.4 0.0 0.0 1.9 85.0 0.9 0.3 0.0 0.0 0.0 667.1 0.0 0.0 0.0 0.0 5320.5 12.9 0.5 1.5 1.1 0.5 0.3 1.0 0.0 1.3 SAGE1 "CT14, SAGE" ENSG00000181433 "Sarcoma antigen 1" Q9NXZ1 X 135889205-135913061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 10.9" "Cell type enriched" "Detected in single" 26 "Spermatogonia: 8.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 15.1;K-562: 10.9;Karpas-707: 18.8;U-2 OS: 5.3;U-266/70: 6.6;U-266/84: 16.4" "HPA003033, HPA003208" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA003033: AB_1079865, HPA003208: AB_1079863" "unprognostic (1.11e-1)" "unprognostic (5.26e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (2.37e-1)" "unprognostic (7.12e-4)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.6 16.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 SALL1 "Hsal1, TBS, ZNF794" ENSG00000103449 "Spalt like transcription factor 1" Q9NSC2 16 51135975-51151367 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.9;kidney: 26.8;liver: 32.0" "Group enriched" "Detected in some" 14 "Cholangiocytes: 7.6;Collecting duct cells: 8.7;Cone photoreceptor cells: 23.6;Distal tubular cells: 10.0;Hepatocytes: 27.2;Proximal tubular cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;BJ hTERT+: 12.9;NTERA-2: 24.6;RPTEC TERT1: 20.9;U-87 MG: 24.1" "Region enriched" "Detected in many" 5 "olfactory region: 64.6" "Low region specificity" "Detected in many" "HPA049829, HPA074673" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nucleoli, Nuclear speckles, Cytosol" "HPA049829: AB_2680902, HPA074673: " "unprognostic (9.91e-2)" "unprognostic (9.42e-2)" "unprognostic (1.82e-6)" "prognostic favorable (1.28e-4)" "unprognostic (2.55e-1)" "unprognostic (1.17e-1)" "unprognostic (1.96e-2)" "unprognostic (4.41e-3)" "unprognostic (1.71e-2)" "unprognostic (2.88e-1)" "unprognostic (1.48e-1)" "unprognostic (3.96e-1)" "prognostic favorable (1.91e-7)" "unprognostic (1.86e-1)" "unprognostic (2.14e-1)" "unprognostic (3.03e-2)" "unprognostic (1.76e-1)" 0.8 0.7 12.2 1.2 14.5 0.7 0.9 1.7 18.9 16.1 3.1 31.9 0.0 1.6 17.8 1.5 0.8 10.4 1.1 1.2 13.6 5.5 26.8 32.0 0.6 0.6 21.8 9.1 5.2 1.6 0.9 4.3 4.3 17.6 1.3 3.2 0.0 0.9 2.3 0.6 0.7 1.4 9.4 19.7 0.7 3.0 2.2 19.4 0.0 23.7 0.0 0.6 2.2 4.8 1.0 1.9 2.3 3.1 0.1 1.1 1.1 0.0 0.8 15.2 0.1 0.4 0.3 0.0 5.0 12.9 0.3 0.7 0.0 0.0 0.0 5.8 7.1 4.5 0.0 9.4 0.0 0.4 0.0 5.7 0.0 0.0 9.1 0.3 0.0 4.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 1.8 0.9 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 24.1 0.0 5.0 0.6 3.1 2.3 0.7 2.0 0.7 1.0 1.0 0.9 1.9 0.8 0.6 0.6 1.8 0.1 1.5 1.9 1.1 1.1 12.2 14.5 1.7 10.3 13.6 5.5 21.8 9.1 17.6 19.4 0.0 0.0 0.0 0.0 0.2 0.0 1.1 7.6 0.0 0.0 8.7 23.6 0.0 10.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.2 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 16.7 0.2 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 SALL2 "Hsal2, KIAA0360, ZNF795" ENSG00000165821 "Spalt like transcription factor 2" Q9Y467 14 21521081-21537216 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9;parathyroid gland: 36.0" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 14.3;Cone photoreceptor cells: 7.9;Horizontal cells: 12.7;Muller glia cells: 11.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 3.8" "Cell line enhanced" "Detected in many" "AF22: 46.7;NTERA-2: 35.3;SCLC-21H: 15.9;SuSa: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004162 Approved Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA004162: AB_2667155" "unprognostic (5.73e-2)" "unprognostic (7.88e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (4.58e-3)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "prognostic favorable (1.23e-4)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "unprognostic (5.28e-3)" "unprognostic (2.03e-1)" "unprognostic (3.75e-2)" "unprognostic (1.86e-1)" 2.6 4.7 11.5 1.6 12.7 0.5 5.3 30.9 21.9 7.5 4.5 10.4 2.9 2.3 10.5 6.0 3.5 11.6 4.0 3.7 11.7 8.9 4.2 1.7 4.8 1.9 7.4 9.3 19.5 3.7 36.0 10.9 1.5 13.5 5.8 2.4 4.3 3.3 10.0 2.1 2.2 3.1 10.5 9.5 2.1 3.2 1.9 11.4 3.7 12.0 0.1 1.9 4.6 4.8 0.3 1.7 0.0 0.0 0.5 3.8 0.6 0.0 0.8 46.7 11.6 0.8 0.7 0.0 1.1 1.5 3.7 3.1 0.8 0.7 0.0 1.0 1.3 1.4 0.1 11.4 1.2 4.3 0.7 6.4 0.0 0.4 1.0 1.4 0.0 0.0 3.1 0.3 1.5 0.0 8.1 0.9 5.0 7.6 0.0 2.9 0.8 7.2 0.0 35.3 0.0 0.2 6.8 1.1 0.0 3.4 4.9 15.9 8.9 0.0 0.2 0.1 15.3 4.6 0.1 0.0 0.5 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.8 0.0 1.0 0.1 1.5 1.2 0.2 0.3 1.8 3.8 0.0 0.5 0.0 1.7 1.6 0.6 11.5 12.7 30.9 14.3 11.7 8.9 7.4 9.3 13.5 11.4 3.0 2.2 0.0 0.4 0.6 14.3 0.8 2.5 0.0 2.3 5.2 7.9 0.1 1.7 1.6 0.2 0.2 0.0 0.0 0.0 0.1 2.0 0.3 0.0 0.0 0.1 12.7 0.0 1.8 0.0 0.0 4.6 0.0 0.0 0.0 0.0 11.0 0.5 0.0 5.6 1.0 2.8 0.0 1.4 0.0 0.2 0.5 0.1 0.0 0.0 0.1 SALL3 ZNF796 ENSG00000256463 "Spalt like transcription factor 3" Q9BXA9 18 78980275-79002677 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.6;vagina: 6.6" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 45.2;Horizontal cells: 23.8" "Cancer enriched" "Detected in some" 6 "glioma: 6.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.8;HEK 293: 4.0;NTERA-2: 13.8;SuSa: 2.5" "Region enriched" "Detected in many" 4 "olfactory region: 15.4" "Low region specificity" "Detected in many" HPA016656 Uncertain NA NA "HPA016656: AB_1856546" "unprognostic (3.96e-2)" "unprognostic (3.41e-3)" "unprognostic (8.16e-2)" "unprognostic (1.87e-2)" "unprognostic (2.37e-1)" "unprognostic (4.23e-1)" "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (3.22e-1)" "unprognostic (5.86e-3)" 0.7 0.7 7.3 0.7 7.6 0.7 0.7 0.3 11.6 0.9 0.7 8.3 0.0 0.7 0.7 2.1 0.7 0.7 0.7 1.2 7.1 5.4 4.4 0.7 0.7 0.7 5.7 3.3 0.7 0.7 0.7 1.1 0.8 6.8 6.0 0.7 0.2 0.7 1.2 0.7 0.7 0.7 0.7 8.8 0.7 0.7 2.4 4.6 0.0 0.9 0.0 0.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.8 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 7.6 0.3 6.6 7.1 5.4 5.7 3.3 6.8 4.6 0.0 0.0 0.0 7.0 0.0 0.5 1.4 0.0 0.0 0.0 1.8 45.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.3 23.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 6.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.2 SALL4 "dJ1112F19.1, ZNF797" ENSG00000101115 "Spalt like transcription factor 4" Q9UJQ4 20 51782331-51802520 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 25.4" "Cancer enriched" "Detected in many" 11 "testis cancer: 22.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "NK-cell: 6.3" "Lineage enriched" "Detected in single" 9 "NK-cells: 6.3" "Cell line enhanced" "Detected in some" "AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015291, HPA015791" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "HPA015291: AB_1856548, HPA015791: AB_1856547" "unprognostic (1.30e-1)" "unprognostic (2.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.09e-3)" "unprognostic (3.55e-2)" "unprognostic (7.43e-2)" "unprognostic (3.63e-2)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (9.23e-2)" "unprognostic (2.50e-2)" "unprognostic (2.39e-2)" "unprognostic (2.42e-8)" "unprognostic (5.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.00e-5)" "unprognostic (7.41e-2)" 0.3 0.4 0.3 0.3 0.9 1.2 0.3 0.8 0.9 0.4 0.7 0.3 2.2 0.1 0.3 0.8 0.3 0.2 0.3 0.3 0.3 0.1 0.5 1.9 0.3 0.3 0.3 0.3 0.3 4.6 8.8 0.6 0.3 0.9 3.1 0.2 4.5 2.2 0.4 0.3 0.3 0.7 0.3 0.3 0.8 0.3 11.7 0.3 0.3 8.6 0.3 0.3 0.9 0.3 0.1 0.1 0.6 0.1 6.3 0.2 0.0 0.0 0.8 13.1 9.1 0.0 0.0 17.5 0.0 0.1 0.0 0.1 4.5 0.1 0.0 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.2 0.0 0.0 3.0 0.2 0.1 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 31.5 0.1 0.2 1.2 0.0 0.0 0.0 0.2 3.0 1.6 8.0 0.0 0.7 22.0 0.0 0.5 0.0 0.5 1.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.6 6.3 0.1 0.1 0.0 0.0 0.3 0.9 0.8 0.9 0.3 0.1 0.3 0.3 0.9 0.3 0.0 1.3 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.2 0.0 0.4 1.1 0.0 0.0 0.2 25.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.7 0.0 0.0 0.0 0.0 1.0 SAMD1 ENSG00000141858 "Sterile alpha motif domain containing 1" 19 14087840-14091036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 79.1" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041662, HPA049059" Uncertain Approved Mitochondria,Cytosol "Intracellular and membrane" NA NA Cytosol Mitochondria "HPA041662: AB_2677605, HPA049059: AB_2680616" "unprognostic (2.93e-2)" "prognostic favorable (7.41e-4)" "unprognostic (8.43e-2)" "unprognostic (3.30e-1)" "unprognostic (1.56e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (2.66e-1)" "unprognostic (9.92e-2)" "unprognostic (3.86e-3)" "unprognostic (9.26e-3)" "unprognostic (4.00e-1)" "prognostic unfavorable (7.98e-5)" "prognostic favorable (8.31e-4)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" "unprognostic (2.45e-1)" 16.0 9.5 23.5 17.4 20.2 19.6 47.9 17.2 21.2 15.3 21.3 19.7 12.2 20.6 14.7 9.8 18.2 14.0 12.8 16.8 21.2 17.9 13.1 11.1 15.9 20.1 20.9 10.3 14.5 20.3 7.2 7.3 11.3 16.5 12.7 15.5 7.8 15.4 16.1 27.2 25.9 21.5 12.4 21.3 18.0 16.7 11.4 16.1 79.1 14.8 10.8 17.9 12.9 20.5 3.5 2.3 4.5 2.9 8.0 2.7 1.5 22.8 17.4 15.4 21.7 9.7 9.9 23.5 12.6 3.0 12.9 10.4 13.1 11.3 39.9 17.2 8.1 6.1 18.6 16.8 9.4 6.5 26.7 13.8 17.4 23.1 23.6 8.6 10.2 10.9 6.9 15.6 8.9 3.0 12.5 7.6 25.6 21.1 10.9 7.4 34.4 21.7 40.3 31.6 16.7 15.5 29.6 13.6 28.6 10.9 11.1 28.3 28.3 11.1 15.1 8.4 8.7 9.5 22.0 8.2 22.6 20.8 22.6 15.9 20.7 17.8 32.9 13.5 28.0 9.1 0.3 2.9 4.5 1.7 0.9 2.0 3.5 1.9 2.0 2.3 2.1 2.7 2.0 0.5 8.0 1.0 1.8 2.1 1.5 23.5 20.2 17.2 19.6 21.2 17.9 20.9 10.3 16.5 16.1 3.0 7.9 9.7 3.5 10.2 27.7 10.1 20.4 2.7 2.3 10.4 5.9 1.6 1.7 9.4 0.3 9.0 29.0 23.3 9.6 7.2 8.0 6.8 8.1 13.5 13.4 49.3 23.8 14.7 17.4 0.5 17.8 9.4 10.1 9.0 25.3 18.6 10.9 17.3 17.7 5.0 8.6 12.9 8.4 0.7 16.2 15.1 1.5 4.9 24.7 3.9 SAMD10 C20orf136 ENSG00000130590 "Sterile alpha motif domain containing 10" Q9BYL1 20 63974113-63980008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.9;T-cells: 6.2" "Cell line enhanced" "Detected in many" "HMC-1: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040973 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040973: AB_10794258" "unprognostic (5.89e-3)" "unprognostic (1.16e-3)" "unprognostic (6.27e-2)" "unprognostic (3.19e-1)" "unprognostic (2.28e-1)" "unprognostic (2.84e-3)" "prognostic unfavorable (4.60e-4)" "unprognostic (2.69e-2)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.96e-2)" "unprognostic (1.08e-1)" "unprognostic (5.83e-2)" "unprognostic (4.97e-3)" "unprognostic (4.20e-1)" "unprognostic (1.28e-1)" "unprognostic (6.94e-3)" 2.4 2.8 6.4 6.1 14.5 3.4 5.4 25.7 10.4 2.3 4.4 1.6 9.2 7.3 1.4 3.0 10.3 4.7 8.8 3.2 5.5 5.0 6.5 4.4 3.6 10.1 3.5 3.5 0.5 5.6 5.3 3.3 3.3 3.2 4.8 3.7 2.7 9.7 6.5 1.7 9.3 6.8 1.5 1.9 5.7 10.2 3.2 2.4 5.7 3.1 2.7 12.3 5.4 4.2 2.9 1.0 0.6 0.4 1.0 6.2 1.6 5.9 0.0 2.0 0.2 0.5 0.6 0.1 1.9 1.6 3.9 1.8 5.7 11.6 0.4 4.0 0.9 0.2 8.1 1.9 2.4 2.0 12.1 4.0 2.0 5.9 8.6 0.8 10.0 16.2 0.5 4.4 2.1 0.3 2.9 1.8 4.3 4.8 4.9 0.7 4.5 4.5 9.3 3.2 8.5 9.2 6.3 0.1 10.5 6.4 10.5 2.2 4.7 1.3 11.3 2.4 0.8 7.6 5.0 1.7 1.2 2.8 0.0 0.3 1.0 0.7 3.3 3.8 8.1 1.1 0.0 0.2 0.6 4.9 0.2 2.7 2.9 3.3 2.9 0.6 1.3 5.6 6.2 0.0 1.0 0.4 1.0 2.5 1.6 6.4 14.5 25.7 10.4 5.5 5.0 3.5 3.5 3.2 2.4 3.0 0.0 2.2 2.2 0.9 6.1 2.0 0.0 2.7 1.2 8.7 2.0 2.3 1.7 3.4 0.0 1.0 2.6 0.0 3.0 0.4 0.3 2.6 0.0 0.6 1.1 0.0 4.7 2.5 1.5 0.0 0.0 0.7 1.7 2.8 4.2 2.7 5.2 1.9 0.0 3.1 2.6 0.0 0.8 0.5 1.3 1.6 2.3 4.4 2.2 3.4 SAMD13 ENSG00000203943 "Sterile alpha motif domain containing 13" Q5VXD3 1 84298366-84389957 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.4" "Cell type enhanced" "Detected in many" 10 "Mucus-secreting cells: 19.6;Paneth cells: 35.1;Spermatocytes: 20.4;Undifferentiated cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "basophil: 11.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 10.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058929 Enhanced Approved Mitochondria NA NA Mitochondria "HPA058929: AB_2683855" "unprognostic (3.78e-2)" "unprognostic (4.93e-2)" "unprognostic (8.51e-3)" "unprognostic (7.55e-2)" "prognostic favorable (1.14e-8)" "unprognostic (1.78e-1)" "unprognostic (1.65e-6)" "unprognostic (2.05e-1)" "unprognostic (5.50e-2)" "unprognostic (2.80e-3)" "unprognostic (9.42e-2)" "unprognostic (3.29e-1)" "unprognostic (1.98e-7)" "unprognostic (3.99e-2)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.56e-3)" 1.2 5.2 4.9 1.0 12.9 2.1 2.0 9.1 5.8 1.5 16.6 7.4 0.6 2.6 1.8 4.5 1.1 3.7 1.4 1.7 4.8 2.3 1.7 0.4 0.7 0.8 7.9 6.5 0.5 2.3 1.0 2.3 0.5 4.5 3.4 19.4 0.4 13.6 1.9 7.6 1.2 3.0 2.1 5.1 1.5 5.6 12.4 8.5 3.5 8.6 2.0 0.4 2.7 0.7 0.6 1.4 11.2 0.8 0.7 0.5 0.3 0.7 2.5 1.2 4.0 4.3 4.3 2.7 0.3 0.3 0.3 0.3 0.2 4.0 4.2 7.5 0.2 0.8 0.8 0.4 1.3 0.6 2.2 2.1 1.5 1.8 0.3 1.1 4.8 0.1 1.5 1.9 0.1 1.2 3.0 10.1 9.5 0.6 1.2 1.2 1.2 6.2 0.6 4.0 3.2 2.6 0.7 3.1 1.6 7.9 2.7 1.6 6.2 0.1 0.2 9.2 1.7 1.2 4.5 1.6 1.4 0.4 0.4 1.1 3.2 0.6 7.2 0.5 4.3 1.2 11.2 0.4 0.0 0.1 0.8 0.3 0.2 0.1 0.1 0.9 0.6 0.5 0.5 0.2 0.7 0.3 1.4 0.0 0.3 4.9 12.9 9.1 5.8 4.8 2.3 7.9 6.5 4.5 8.5 0.0 1.1 0.0 0.6 0.3 1.0 1.2 5.1 1.4 1.2 1.8 0.0 3.4 5.0 1.3 3.9 1.3 6.2 0.0 0.6 0.6 2.0 2.8 5.7 0.0 1.4 0.0 10.9 1.8 1.6 3.1 1.7 0.9 8.5 0.0 19.6 2.6 0.9 35.1 2.5 2.2 0.0 0.0 0.1 20.4 2.0 0.3 0.7 0.0 16.6 1.3 SAMD14 FLJ36890 ENSG00000167100 "Sterile alpha motif domain containing 14" Q8IZD0 17 50110040-50129882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 45.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 42.7;Horizontal cells: 11.1;Intestinal endocrine cells: 12.2" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 2.3" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.3" "Cell line enhanced" "Detected in some" "HDLM-2: 10.9;HEL: 6.9;HMC-1: 23.2;SH-SY5Y: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051916 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA051916: AB_2681662" "unprognostic (2.33e-2)" "unprognostic (6.05e-2)" "unprognostic (2.85e-1)" "unprognostic (2.10e-1)" "unprognostic (3.24e-1)" "unprognostic (2.31e-1)" "unprognostic (8.84e-3)" "unprognostic (6.77e-2)" "unprognostic (1.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-2)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (7.48e-4)" 2.8 3.8 18.3 3.9 19.5 2.0 1.0 45.8 18.5 2.4 2.2 3.1 1.1 2.0 3.2 4.3 1.6 1.3 2.2 1.5 15.4 10.3 2.9 1.7 5.4 2.2 7.9 16.1 1.7 1.5 2.9 2.1 3.9 10.9 3.9 1.8 4.3 1.3 4.0 6.1 1.6 2.6 2.8 6.8 3.0 3.2 4.6 6.9 0.0 1.3 0.0 3.2 2.2 0.9 0.0 0.0 2.3 0.0 0.3 0.0 0.4 0.0 0.1 4.0 0.0 1.1 0.2 0.0 2.5 0.9 0.0 0.0 0.5 0.0 0.1 3.7 1.0 0.0 0.1 0.2 0.0 0.1 10.9 0.1 6.9 0.2 0.0 0.6 0.0 23.2 0.3 0.0 0.0 0.0 0.4 0.6 0.0 0.2 0.3 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 10.9 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.4 1.4 0.3 0.0 0.2 0.0 0.0 2.0 0.0 0.8 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 18.3 19.5 45.8 18.5 15.4 10.3 7.9 16.1 10.9 6.9 0.0 0.3 0.0 0.1 0.3 42.7 1.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 2.1 2.9 0.0 0.0 0.3 0.1 1.4 0.1 2.3 0.0 0.1 11.1 12.2 4.9 0.3 1.9 1.4 0.8 0.0 2.8 0.0 1.4 0.3 0.0 3.2 0.8 3.1 0.0 2.2 1.4 1.1 0.1 0.3 0.0 0.0 0.0 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 65.6;Cone photoreceptor cells: 58.9;Early spermatids: 61.5;Late spermatids: 75.0;Rod photoreceptor cells: 75.7;Spermatocytes: 45.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 10.8" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.6 4.9 1.9 4.1 0.5 2.1 1.8 1.5 1.3 4.0 3.6 3.5 3.3 4.0 1.6 1.5 3.5 3.5 1.4 2.0 5.5 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.3 2.0 1.3 3.4 0.4 1.7 2.7 2.0 0.4 1.2 1.6 10.8 0.9 0.4 0.8 0.9 1.6 1.7 1.9 0.2 6.9 2.0 4.3 2.7 5.1 0.8 0.7 0.8 6.4 1.2 1.0 3.7 2.2 3.9 1.9 0.7 3.3 2.6 4.7 0.2 1.9 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 0.0 0.0 0.0 0.4 0.2 9.7 0.8 2.5 65.6 2.3 0.0 58.9 0.2 1.7 2.4 61.5 0.3 0.0 0.0 0.6 0.2 0.6 0.5 0.0 0.0 0.1 3.2 3.5 0.0 0.0 75.0 1.4 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 3.4 75.7 0.0 0.3 45.6 6.0 0.0 0.2 0.0 0.0 0.1 SAMD3 "bA73O6.2, FLJ34032" ENSG00000164483 "Sterile alpha motif domain containing 3" Q8N6K7 6 130144315-130365425 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8" "Cell type enriched" "Detected in some" 7 "T-cells: 87.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 31 "gdT-cell: 32.8;MAIT T-cell: 25.7;memory CD4 T-cell: 11.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 8.4;naive CD8 T-cell: 20.4;NK-cell: 31.9;T-reg: 10.8" "Group enriched" "Detected in many" 47 "NK-cells: 31.9;T-cells: 32.8" "Cell line enhanced" "Detected in some" "HBF TERT88: 4.0;HDLM-2: 7.1;hTEC/SVTERT24-B: 4.7;hTERT-RPE1: 4.3;NTERA-2: 3.7;PC-3: 2.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 2.7" "HPA028992, HPA028993" Uncertain NA NA "HPA028992: AB_10598914, HPA028993: AB_10601891" "unprognostic (2.91e-3)" "unprognostic (5.35e-3)" "unprognostic (4.15e-2)" "unprognostic (2.70e-2)" "unprognostic (1.50e-2)" "unprognostic (2.48e-4)" "unprognostic (1.20e-2)" "unprognostic (2.42e-3)" "unprognostic (2.39e-2)" "unprognostic (2.46e-2)" "unprognostic (5.61e-2)" "unprognostic (1.98e-1)" "unprognostic (5.07e-6)" "unprognostic (7.09e-2)" "unprognostic (1.14e-1)" "unprognostic (6.62e-2)" "unprognostic (3.45e-2)" 3.3 4.1 3.2 11.4 0.9 4.6 2.1 1.8 1.0 2.8 1.4 0.6 0.5 0.6 11.7 3.6 1.2 2.4 4.1 1.4 4.4 3.1 2.0 3.0 9.8 12.0 1.2 0.7 3.3 1.4 0.0 8.0 3.0 1.6 4.1 3.0 4.8 5.3 1.2 0.9 0.6 2.2 2.3 1.4 13.9 2.0 4.4 0.4 16.4 1.5 2.7 12.6 3.8 1.5 0.6 0.1 0.6 0.1 31.9 32.8 10.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.8 0.3 0.8 0.9 0.1 0.0 0.1 0.7 0.4 0.0 0.0 0.0 4.0 7.1 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.5 0.0 4.7 0.3 4.3 0.2 0.9 0.3 0.0 0.2 0.0 0.2 0.0 3.7 0.0 2.5 0.0 0.1 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 32.8 0.1 25.7 0.6 11.7 28.9 0.1 0.0 8.4 20.4 0.6 31.9 0.1 0.1 10.8 10.0 3.2 0.9 1.8 1.0 4.4 3.1 1.2 0.7 1.6 0.4 0.0 2.9 0.0 0.0 0.3 2.3 0.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 3.5 2.5 3.4 5.6 0.6 0.6 5.0 0.0 0.1 0.0 0.0 1.1 1.8 0.5 0.1 0.0 0.4 0.5 0.6 0.4 0.0 87.3 0.7 0.0 SAMD4A "DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA" ENSG00000020577 "Sterile alpha motif domain containing 4A" Q9UPU9 14 54567097-54793315 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 48.7;testis: 44.6" "Group enriched" "Detected in many" 6 "Early spermatids: 1164.1;Late spermatids: 1577.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.9;non-classical monocyte: 3.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043061, HPA065309" Approved Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions" Cytosol "HPA043061: AB_2678299, HPA065309: AB_2685462" "unprognostic (1.46e-1)" "unprognostic (8.10e-3)" "unprognostic (9.66e-3)" "unprognostic (1.18e-4)" "unprognostic (2.79e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-1)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (1.09e-2)" "unprognostic (2.83e-2)" "unprognostic (8.27e-2)" "unprognostic (5.41e-2)" "unprognostic (1.51e-1)" 7.5 2.9 7.8 9.0 6.0 0.5 4.0 5.6 7.0 8.9 10.1 8.0 3.0 2.3 11.1 5.5 5.4 4.2 6.5 28.2 5.5 7.3 2.5 7.6 6.4 2.9 10.6 5.2 2.1 4.1 4.8 2.0 6.0 10.8 7.7 3.3 3.4 2.4 6.3 48.7 2.6 3.3 23.8 26.5 4.6 3.9 44.6 6.1 0.7 2.4 1.3 4.8 15.9 5.8 0.9 2.6 0.0 3.9 0.0 0.4 0.8 17.0 1.7 3.4 1.7 7.2 11.4 6.3 14.9 21.3 11.8 12.0 17.5 4.1 1.0 7.6 20.6 5.2 11.8 3.3 7.4 16.6 9.7 1.6 0.0 2.0 3.6 4.1 0.0 0.1 6.4 2.5 8.5 12.6 3.3 9.2 0.0 1.3 0.0 5.5 1.1 0.2 0.0 1.7 0.1 4.1 0.5 6.8 0.0 5.5 5.5 0.5 5.6 2.3 2.9 7.7 7.2 11.2 0.2 18.6 14.0 23.1 3.4 4.6 0.1 0.0 0.0 4.0 0.3 4.5 0.0 2.3 0.0 0.0 3.9 0.0 0.3 0.0 0.0 2.6 0.9 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.8 7.8 6.0 5.6 5.7 5.5 7.3 10.6 5.2 10.8 6.1 23.8 1.0 3.2 34.8 35.1 0.5 244.5 12.7 0.0 5.7 17.4 7.9 7.5 3.3 8.2 1164.1 32.1 4.2 0.0 6.7 1.7 65.1 37.0 22.0 48.2 10.0 9.5 5.8 12.3 13.0 1577.3 13.6 11.7 23.6 0.0 1.3 1.0 14.6 5.8 22.3 19.2 4.2 12.9 48.5 12.7 7.2 21.2 1.6 1.0 1.3 37.6 SAMD7 DKFZp686E1583 ENSG00000187033 "Sterile alpha motif domain containing 7" Q7Z3H4 3 169911572-169939175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "retina: 34.7" "Group enriched" "Detected in some" 13 "Cone photoreceptor cells: 45.2;Rod photoreceptor cells: 125.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Daudi: 2.4;U-698: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.27e-3)" "unprognostic (5.46e-2)" 0.0 0.3 0.1 0.0 0.2 0.6 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 34.7 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.5 0.1 1.2 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.5 0.0 0.8 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 4.2 0.0 0.1 0.0 0.4 0.1 0.4 0.2 0.0 0.2 0.4 0.1 0.2 0.0 0.5 0.2 0.1 0.8 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.7 0.1 0.0 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 125.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 SAMD9 "C7orf5, FLJ20073, KIAA2004" ENSG00000205413 "Sterile alpha motif domain containing 9" Q5K651 7 93099513-93118023 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.6;lymphoid tissue: 35.4" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 59.6;T-cells: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 29.4;GAMG: 28.8" "Low region specificity" "Detected in all" "HPA021318, HPA021319" Approved Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA021318: AB_2183383, HPA021319: AB_1856554" "unprognostic (3.66e-2)" "unprognostic (5.35e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (8.96e-2)" "unprognostic (1.38e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (4.76e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (8.31e-5)" "unprognostic (6.00e-2)" "prognostic unfavorable (8.40e-7)" "unprognostic (5.91e-2)" "unprognostic (1.37e-2)" "unprognostic (2.18e-2)" "unprognostic (3.64e-1)" 9.6 4.0 2.3 9.2 2.4 5.2 2.6 1.0 1.6 9.3 6.8 0.6 0.9 4.3 2.8 3.0 34.6 2.7 4.3 2.5 1.3 1.5 6.3 3.5 7.8 10.8 2.5 1.1 6.3 2.3 0.1 6.4 11.3 3.1 5.3 7.0 0.7 5.7 1.6 2.4 1.5 12.7 2.2 2.5 21.7 6.3 2.5 1.7 35.4 3.3 9.9 9.5 4.8 9.7 5.5 3.0 15.6 9.8 7.4 7.6 2.6 11.7 1.5 0.4 0.1 5.3 6.8 0.1 4.6 19.3 22.2 29.4 0.0 13.1 4.9 7.3 11.4 28.8 13.9 0.0 4.2 7.5 16.8 0.5 7.2 7.9 0.0 2.4 8.0 10.0 3.0 6.1 7.3 2.0 1.2 3.3 5.5 0.5 12.3 4.6 0.0 11.9 6.6 0.0 0.0 3.3 3.9 3.9 5.6 0.1 1.5 1.9 0.2 3.6 1.4 3.8 0.0 0.4 3.9 14.2 5.2 1.9 15.5 2.5 7.4 1.4 4.6 5.4 4.7 5.1 15.6 3.6 12.7 7.6 7.0 7.3 5.0 5.9 6.5 3.0 5.5 6.3 5.7 15.5 7.4 9.8 2.1 7.2 2.6 2.3 2.4 1.0 1.6 1.3 1.5 2.5 1.1 3.1 1.7 8.9 3.0 23.2 7.5 2.1 1.6 0.9 2.5 20.1 9.1 14.0 0.0 1.5 0.0 20.9 0.0 24.8 12.1 0.0 10.8 4.6 8.3 6.6 41.7 1.0 10.7 6.4 2.9 8.0 24.0 0.2 14.1 26.3 3.3 13.6 20.9 2.0 32.1 59.6 11.7 2.1 0.0 12.9 9.2 0.2 0.0 1.6 0.3 50.7 3.3 25.5 SAMSN1 "HACS1, NASH1, SASH2, SH3D6B, SLy2" ENSG00000155307 "SAM domain, SH3 domain and nuclear localization signals 1" Q9NSI8 21 14485228-14658821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6" "Group enriched" "Detected in many" 6 "granulocytes: 1107.2;monocytes: 1399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 53.6;eosinophil: 49.9" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HEL: 60.9;K-562: 72.4;Karpas-707: 31.6" "Region enriched" "Detected in some" 7 "olfactory region: 25.4" "Low region specificity" "Detected in all" "HPA010645, HPA017055, HPA046639" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732" "unprognostic (7.62e-3)" "unprognostic (1.46e-2)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.13e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (9.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.17e-1)" "unprognostic (1.68e-2)" 14.4 3.9 5.8 33.0 10.4 72.1 4.2 1.1 5.1 2.9 4.7 4.9 0.0 3.1 3.4 4.6 4.1 6.8 10.1 5.1 4.4 3.4 5.9 7.2 27.9 28.3 11.1 1.4 3.3 2.3 1.0 2.7 6.7 6.7 4.1 7.0 3.4 3.4 1.2 1.6 1.9 13.6 4.7 17.5 43.6 5.0 2.4 7.1 12.6 2.6 2.8 16.7 11.8 4.5 6.5 5.6 53.6 17.3 3.7 12.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.1 0.0 60.9 0.0 0.0 0.0 7.1 2.9 0.0 0.0 0.0 9.0 2.4 0.8 1.1 72.4 31.6 0.0 0.0 3.4 8.7 0.0 0.0 0.0 5.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 7.9 0.0 0.0 0.0 0.0 13.6 0.1 0.0 0.3 4.6 0.0 53.6 8.8 49.9 5.3 11.6 3.6 6.5 10.3 7.8 5.6 2.6 6.6 4.6 11.0 3.7 17.3 0.2 12.9 6.8 5.8 10.4 1.1 5.1 4.4 3.4 11.1 1.4 6.7 7.1 20.8 87.5 39.7 0.8 13.9 54.7 1.2 2.5 14.7 20.5 34.9 0.0 0.4 0.0 0.4 0.0 7.1 0.0 23.3 5.4 0.5 6.2 0.4 1107.2 0.9 57.4 0.0 0.0 3.1 159.2 0.0 0.6 220.5 20.3 1399.5 0.1 1.5 0.6 0.0 0.0 0.4 4.2 0.0 3.3 0.0 0.0 11.5 0.5 120.4 0.0 0.7 SAP130 FLJ12761 ENSG00000136715 "Sin3A associated protein 130" Q9H0E3 2 127941217-128028120 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 54.0;Late spermatids: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034664 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA034664: AB_10603238" "unprognostic (2.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.85e-1)" "unprognostic (1.33e-1)" "unprognostic (5.45e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (7.89e-4)" "unprognostic (2.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.43e-1)" "unprognostic (3.92e-2)" "unprognostic (6.77e-2)" "unprognostic (3.75e-2)" "unprognostic (5.26e-2)" "unprognostic (4.41e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" 9.3 8.7 8.9 10.4 11.3 18.0 7.8 12.2 14.1 9.7 9.3 13.8 6.6 8.2 11.7 9.5 9.9 9.4 8.2 8.0 9.6 8.5 6.8 7.8 7.9 9.1 9.7 9.0 11.6 8.4 16.3 13.8 10.4 9.6 9.1 9.8 8.8 11.3 8.5 10.5 11.6 8.9 10.3 8.9 8.3 9.0 50.3 9.9 17.1 8.8 6.9 11.9 9.9 9.5 5.8 6.8 15.6 8.5 3.5 6.2 3.5 20.5 11.4 21.5 17.3 14.3 9.9 23.6 13.2 12.9 20.5 16.2 27.0 8.6 17.3 11.9 14.8 10.7 14.5 23.7 13.6 21.3 9.6 15.2 17.1 10.3 21.0 17.2 14.8 13.6 9.3 10.2 27.0 17.0 10.8 16.3 14.6 20.7 12.8 17.1 23.0 20.5 11.7 22.2 12.2 12.8 14.2 17.7 11.5 10.9 18.3 11.4 13.7 13.9 13.2 8.2 14.2 9.9 10.2 13.9 19.8 21.6 18.4 13.9 18.0 17.7 20.6 16.3 10.1 12.7 2.4 4.2 4.8 6.2 3.0 4.8 2.4 4.4 4.0 3.7 5.8 3.2 3.5 15.6 3.5 8.5 6.8 3.0 3.5 8.9 11.3 12.2 14.1 9.6 8.5 9.7 9.0 9.6 9.9 0.0 10.4 3.2 1.9 7.0 4.2 11.9 5.1 4.0 1.2 1.8 7.9 9.4 0.0 3.7 54.0 5.3 6.6 0.0 4.1 10.7 4.7 4.4 1.1 5.1 6.6 7.9 6.4 7.4 11.0 34.3 7.8 5.7 5.0 1.0 6.5 4.1 4.3 7.0 7.8 2.9 5.8 6.5 5.0 17.9 16.6 9.2 16.1 5.0 6.6 3.0 SAP25 FLJ00248 ENSG00000205307 "Sin3A associated protein 25" Q8TEE9 7 100572228-100573820 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 50.2" "Group enriched" "Detected in many" 5 "Bipolar cells: 19.4;Cone photoreceptor cells: 66.8;Horizontal cells: 20.6;Rod photoreceptor cells: 58.2;Spermatocytes: 18.4;Spermatogonia: 71.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 12.8;NB-4: 28.2;OE19: 47.3;U-937: 11.0" HPA062610 Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA062610: AB_2684806" "unprognostic (1.70e-1)" "unprognostic (7.87e-2)" "unprognostic (1.09e-5)" "unprognostic (6.89e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-3)" "unprognostic (9.96e-2)" "unprognostic (4.26e-2)" "unprognostic (2.83e-1)" "unprognostic (5.04e-2)" "unprognostic (6.57e-3)" "unprognostic (1.71e-2)" "unprognostic (7.52e-6)" "unprognostic (7.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.39e-1)" "unprognostic (4.18e-3)" 2.4 2.5 2.0 9.5 2.5 15.2 2.0 5.0 2.6 3.1 2.3 2.3 2.0 3.5 2.2 2.7 2.0 2.5 2.6 2.0 2.4 1.2 5.1 2.0 4.7 15.2 2.0 2.0 7.9 2.0 0.5 4.8 2.8 2.3 3.2 0.6 2.0 5.2 3.6 2.0 3.3 6.7 2.0 3.0 19.6 2.6 50.2 2.0 2.0 5.7 2.0 4.5 2.0 2.2 0.2 1.2 3.8 1.9 0.0 0.9 0.2 1.5 0.5 1.1 0.6 0.1 0.1 2.7 1.3 0.2 0.8 0.3 1.3 1.6 0.8 0.7 0.0 0.1 1.7 0.2 0.4 0.1 1.5 1.0 1.5 1.1 0.4 0.2 1.7 12.8 0.3 0.8 0.4 0.1 0.6 0.2 3.3 1.8 3.2 0.1 3.6 3.1 28.2 1.8 47.3 0.6 6.7 0.4 1.2 0.1 0.5 0.7 2.1 0.1 1.5 1.7 1.3 2.3 6.4 1.4 1.2 2.5 1.1 1.1 5.4 1.3 0.6 0.3 11.0 1.2 2.2 0.8 0.0 0.9 1.9 0.2 0.2 0.5 0.1 0.2 0.2 0.6 0.8 3.8 0.0 0.7 1.2 0.0 0.2 2.0 2.5 5.0 2.6 2.4 1.2 2.0 2.0 2.3 2.0 0.0 5.5 1.9 1.3 0.0 19.4 0.0 2.5 0.0 2.3 0.0 66.8 2.1 0.0 1.6 1.4 0.0 1.3 0.0 0.6 0.5 0.8 2.2 1.1 1.1 2.9 20.6 0.0 1.8 9.4 3.4 3.1 4.5 0.0 3.6 2.6 9.2 1.5 1.9 1.1 0.2 58.2 6.5 0.0 18.4 71.9 0.0 3.0 4.9 1.5 1.4 SAPCD1 "C6orf26, NG23" ENSG00000228727 "Suppressor APC domain containing 1" Q5SSQ6 6 31762799-31764851 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 8.8;skin 1: 14.7" "Cell type enriched" "Detected in single" 27 "Ciliated cells: 2.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 7.3;JURKAT: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071699 Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA071699: AB_2686433" "unprognostic (9.25e-4)" "unprognostic (1.32e-1)" "unprognostic (3.41e-2)" "unprognostic (3.28e-1)" "unprognostic (9.34e-2)" "unprognostic (8.02e-4)" "unprognostic (1.63e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (8.16e-3)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "unprognostic (8.15e-10)" "unprognostic (2.65e-2)" "unprognostic (4.45e-1)" "unprognostic (3.57e-1)" "unprognostic (7.98e-5)" 0.8 0.3 0.7 1.6 1.0 4.8 1.8 0.7 1.3 2.0 1.0 1.3 0.7 0.2 1.2 0.8 0.7 1.8 2.5 0.7 0.7 0.8 3.2 0.9 1.4 2.5 1.9 0.7 1.6 0.7 0.2 2.9 3.3 3.9 2.6 1.1 8.8 0.7 1.6 0.7 14.7 1.5 0.7 3.1 2.1 0.8 1.2 0.7 0.7 0.7 0.7 0.7 0.8 0.7 0.0 0.5 0.2 0.1 0.0 0.7 0.0 0.5 0.0 0.0 0.5 0.4 0.8 0.8 0.4 0.2 0.2 0.0 2.8 1.0 0.8 0.1 0.2 0.0 1.6 0.0 0.7 0.1 0.0 3.1 3.8 7.3 1.0 0.2 0.3 0.1 0.2 0.0 1.1 1.4 0.3 0.5 6.4 0.4 1.1 0.0 3.7 2.8 2.3 0.0 0.3 0.8 0.4 0.9 0.0 0.6 0.7 1.2 0.6 0.3 0.7 0.4 0.9 0.3 0.0 0.2 0.1 2.9 0.0 0.3 2.1 2.0 2.0 0.2 2.7 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.7 1.0 0.7 1.3 0.7 0.8 1.9 0.7 3.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in some" 7 "Basal keratinocytes: 3.8;Mucus-secreting cells: 6.4;Paneth cells: 4.9;Undifferentiated cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA Yes Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavorable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.0 8.7 3.4 10.2 0.1 0.2 18.5 2.6 1.8 2.8 1.3 16.4 7.4 16.8 8.6 1.3 2.6 22.8 10.8 3.0 0.6 11.5 12.4 7.3 9.6 18.3 0.0 8.3 12.7 0.0 0.5 1.0 1.8 0.7 4.6 8.6 10.1 7.6 0.8 37.7 2.4 22.4 6.4 37.2 19.8 25.6 13.1 18.6 3.5 4.6 17.9 10.6 10.2 28.6 3.9 0.8 23.1 15.8 2.9 2.6 8.8 7.7 13.0 2.6 7.6 8.1 6.0 9.9 8.1 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 0.0 0.0 0.0 0.6 3.8 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.3 0.0 0.0 0.4 0.0 0.0 2.7 0.6 2.1 0.0 0.0 2.5 0.0 0.0 0.6 3.0 0.0 0.0 1.8 0.0 0.0 6.4 0.6 0.3 4.9 0.0 0.0 0.5 0.0 0.3 0.0 1.2 2.4 0.5 1.0 4.5 0.5 SARDH "DMGDHL1, SDH" ENSG00000123453 "Sarcosine dehydrogenase" Q9UL12 9 133663560-133739955 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 25.3;liver: 52.8;pancreas: 39.4" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 94.3" "Cancer enriched" "Detected in many" 8 "liver cancer: 18.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7" "Lineage enriched" "Detected in single" 15 "T-cells: 9.7" "Cell line enhanced" "Detected in many" "AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA057267, HPA058086" Approved Approved Mitochondria NA NA 190000 Mitochondria "HPA057267: AB_2683388, HPA058086: AB_2683601" "unprognostic (3.64e-2)" "unprognostic (4.87e-2)" "unprognostic (2.31e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.62e-4)" "unprognostic (5.83e-2)" "unprognostic (1.42e-3)" "unprognostic (2.21e-1)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "unprognostic (7.74e-3)" "unprognostic (2.78e-1)" "unprognostic (3.48e-1)" "unprognostic (9.73e-2)" "unprognostic (1.30e-2)" 0.5 1.1 1.7 1.0 1.8 0.3 0.4 0.8 1.9 0.9 0.5 1.1 2.9 0.8 1.4 25.3 0.3 0.9 1.2 1.1 1.1 1.4 5.8 52.8 1.3 1.7 1.2 2.1 3.4 39.4 2.0 1.9 0.3 1.2 1.4 0.1 3.7 8.2 0.9 0.3 0.2 0.6 0.6 0.6 0.7 1.2 1.1 0.8 2.2 0.8 0.2 1.2 0.6 0.6 0.4 0.3 0.6 0.1 0.1 9.7 1.6 0.0 0.1 0.9 11.1 0.0 0.3 1.5 0.1 0.4 0.5 0.7 0.2 0.1 0.0 1.5 0.2 1.4 0.0 0.0 0.2 0.4 0.0 0.2 1.5 0.0 18.7 1.2 0.0 0.2 2.6 0.0 1.3 0.0 0.3 0.1 8.3 0.0 0.2 7.0 1.9 13.5 1.4 1.7 1.0 0.1 0.9 11.6 23.4 0.0 0.1 1.0 9.3 0.0 0.3 2.3 0.5 1.5 0.1 0.0 2.1 2.0 0.2 0.0 0.1 0.0 0.8 1.3 0.8 0.0 0.1 0.1 0.1 0.4 0.0 1.0 0.0 4.1 1.0 0.0 0.4 8.4 1.5 0.6 0.1 0.0 0.3 9.7 1.6 1.7 1.8 0.8 1.9 1.1 1.4 1.2 2.1 1.2 0.8 0.0 3.4 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 1.0 0.2 1.1 94.3 0.1 0.0 1.2 2.5 2.4 0.2 4.4 0.2 0.0 0.0 0.0 2.1 0.2 0.0 2.8 14.7 0.2 0.0 1.0 0.1 0.9 0.1 0.0 2.9 0.0 0.1 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779979-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3" "Cell type enhanced" "Detected in some" 12 "B-cells: 45.6;Hofbauer cells: 45.7;Kupffer cells: 59.2;T-cells: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 43.6;JURKAT: 31.2;MOLT-4: 31.1;NB-4: 23.7;REH: 23.3;U-698: 39.8;U-937: 30.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favorable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 7.8 3.4 2.8 34.6 5.2 33.2 2.7 0.7 2.2 2.0 3.3 4.0 0.2 3.9 1.9 2.1 2.9 3.4 3.6 2.0 3.3 2.4 3.3 3.0 10.6 38.2 5.2 1.1 1.3 1.8 0.2 1.8 2.5 4.2 2.7 3.5 1.6 7.8 0.8 0.9 1.1 18.8 2.4 6.2 55.7 4.2 0.8 4.0 85.3 2.5 2.0 38.6 7.0 2.0 22.0 27.6 53.7 44.2 33.4 46.9 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.2 0.0 3.7 0.0 0.0 31.1 23.7 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.1 0.0 0.0 0.0 8.8 39.8 0.0 30.9 0.0 7.9 29.4 53.7 46.9 44.1 38.7 19.1 26.7 43.1 27.6 22.0 19.3 30.0 29.1 33.4 44.2 12.7 32.3 61.8 2.8 5.2 0.7 2.2 3.3 2.4 5.2 1.1 4.2 4.0 0.0 5.1 45.6 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 23.3 0.0 0.5 0.4 0.0 21.9 0.9 45.7 0.0 0.0 3.7 59.2 0.0 0.3 20.3 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 75.2 0.0 0.0 SAT2 SSAT2 ENSG00000141504 "Spermidine/spermine N1-acetyltransferase family member 2" Q96F10 17 7626234-7627876 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 73.2" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 851.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022136, HPA057096" Enhanced NA NA "HPA022136: AB_1856592, HPA057096: AB_2683334" "unprognostic (2.61e-2)" "unprognostic (1.27e-2)" "unprognostic (3.23e-2)" "prognostic favorable (8.76e-6)" "unprognostic (2.18e-2)" "unprognostic (2.32e-1)" "unprognostic (7.20e-2)" "prognostic favorable (6.71e-4)" "unprognostic (4.14e-2)" "unprognostic (2.75e-1)" "prognostic favorable (6.05e-5)" "unprognostic (1.83e-1)" "unprognostic (6.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.86e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" 11.3 43.9 14.8 6.3 16.7 6.4 11.0 11.3 17.4 12.5 33.4 9.2 10.8 51.5 11.7 14.9 8.9 10.2 11.3 14.5 13.4 9.8 49.6 73.2 9.1 8.9 18.3 17.1 19.9 20.0 11.3 13.7 5.5 15.2 11.5 9.2 13.9 16.2 13.6 12.0 7.9 47.9 10.1 10.5 12.5 13.3 11.7 16.8 2.7 18.5 11.9 7.3 9.9 13.3 8.6 18.4 5.5 25.6 6.6 11.8 12.9 7.5 11.7 10.2 19.4 15.2 18.8 1.3 5.4 18.6 11.7 15.2 3.8 3.9 1.5 3.1 5.1 13.9 6.8 6.4 5.1 7.5 2.2 19.5 1.7 6.3 19.4 19.8 0.0 5.5 24.5 12.5 6.9 4.8 14.9 17.2 1.6 1.0 2.4 12.4 0.6 0.1 1.6 4.1 4.4 8.0 3.0 5.1 1.8 17.6 8.7 1.1 10.2 5.2 10.3 9.7 9.0 6.5 1.7 8.4 5.6 4.1 0.1 7.8 5.0 4.3 0.2 20.1 2.3 8.6 4.6 25.6 5.5 8.9 17.1 10.5 8.6 7.7 9.1 18.4 8.3 11.8 8.4 1.6 6.6 8.8 8.3 11.2 12.9 14.8 16.7 11.3 17.4 13.4 9.8 18.3 17.1 15.2 16.8 41.7 99.3 62.4 77.5 73.4 114.0 50.8 193.6 53.5 58.0 76.8 64.8 62.2 358.1 104.4 10.1 65.2 92.1 0.0 57.1 27.9 82.7 93.0 60.1 279.6 138.9 122.3 127.3 98.8 132.8 13.8 168.2 127.9 89.4 60.5 87.9 109.7 92.6 97.9 112.1 851.6 143.3 71.1 82.1 26.5 3.6 49.1 66.2 70.8 92.5 80.2 SATB1 ENSG00000182568 "SATB homeobox 1" Q01826 3 18345387-18445588 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "lymphoid tissue: 331.6" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 37.9" "Group enriched" "Detected in many" 6 "NK-cells: 18.6;T-cells: 37.9" "Cell line enhanced" "Detected in many" "HDLM-2: 91.1;JURKAT: 44.0;REH: 25.4;THP-1: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051769, CAB056144, HPA070534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: " "unprognostic (2.16e-1)" "unprognostic (3.99e-1)" "unprognostic (7.13e-2)" "unprognostic (3.58e-1)" "unprognostic (9.15e-2)" "unprognostic (4.22e-3)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (2.90e-2)" "unprognostic (6.14e-2)" "prognostic favorable (8.97e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.96e-7)" "unprognostic (1.92e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-3)" 6.7 5.3 11.8 11.7 11.0 16.4 5.9 10.1 22.7 5.6 15.1 3.6 16.1 6.8 5.9 11.1 5.3 8.0 7.7 10.9 10.8 8.1 5.4 7.2 7.6 25.9 10.0 15.6 6.2 14.8 22.4 12.9 1.8 6.6 10.1 8.2 5.9 17.9 26.2 35.7 9.2 11.3 12.1 8.1 11.5 10.4 2.9 4.5 331.6 11.3 4.6 11.8 18.7 11.0 4.7 1.2 4.7 0.6 18.6 37.9 7.9 0.4 0.0 2.6 0.0 3.6 3.6 0.2 0.7 2.5 0.6 2.0 0.1 4.7 0.9 0.0 0.8 0.2 0.0 9.5 1.1 1.2 91.1 5.8 0.0 0.2 0.0 0.5 5.3 0.8 1.5 0.8 0.0 0.1 7.4 0.6 44.0 0.1 5.0 0.4 0.0 21.2 6.8 3.8 0.3 0.3 25.4 1.3 0.9 1.0 3.1 1.2 7.2 0.0 0.8 0.0 2.2 20.4 38.9 0.3 2.6 1.7 1.2 0.7 0.2 0.0 2.0 2.1 20.5 1.1 4.7 0.5 1.3 14.3 0.6 25.8 0.5 9.7 7.4 1.0 4.7 37.9 22.6 1.2 18.6 0.3 1.2 1.7 7.9 11.8 11.0 10.1 22.7 10.8 8.1 10.0 15.6 6.6 4.5 23.8 26.4 13.7 11.8 12.7 10.1 57.9 22.9 46.8 14.8 29.6 82.5 0.4 1.7 10.0 4.8 11.7 11.0 23.3 10.8 0.1 8.7 29.4 22.0 18.8 9.1 0.0 31.2 31.3 44.9 3.5 7.8 19.2 10.1 1.0 32.6 14.2 11.1 28.1 7.8 7.3 62.2 6.5 9.5 0.7 2.5 19.3 0.2 62.3 25.2 14.4 SATB2 "FLJ21474, KIAA1034" ENSG00000119042 "SATB homeobox 2" Q9UPW6 2 199269500-199471266 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.1;intestine: 33.2;lymphoid tissue: 11.0" "Group enriched" "Detected in many" 7 "Enterocytes: 72.1;Intestinal endocrine cells: 95.8;Mucus-secreting cells: 76.0;Paneth cells: 48.9;Undifferentiated cells: 85.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 10.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 19.8;K-562: 21.6;THP-1: 29.5" "Group enriched" "Detected in some" 9 "amygdala: 7.9;cerebral cortex: 29.7;hippocampal formation: 19.7" "Group enriched" "Detected in many" 10 "cerebral cortex: 52.6;hippocampal formation: 45.2" "HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737" "unprognostic (1.77e-2)" "unprognostic (1.90e-1)" "unprognostic (8.53e-3)" "unprognostic (4.77e-2)" "unprognostic (1.07e-1)" "unprognostic (9.39e-3)" "unprognostic (1.80e-1)" "unprognostic (5.54e-3)" "unprognostic (8.26e-2)" "unprognostic (3.75e-1)" "unprognostic (2.04e-2)" "unprognostic (1.13e-1)" "prognostic favorable (5.37e-8)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (7.95e-6)" "unprognostic (1.08e-3)" 2.4 5.0 4.5 11.0 10.0 0.5 2.0 0.5 26.1 2.3 27.9 0.4 0.4 1.4 1.7 1.1 0.9 1.1 1.4 0.7 5.6 1.6 3.6 2.8 0.8 0.6 2.3 15.5 1.9 3.4 3.1 1.1 0.8 4.6 1.9 33.2 0.1 1.5 2.6 2.1 1.7 5.0 2.9 4.9 0.7 1.0 2.4 0.0 0.0 1.6 2.4 1.0 1.6 3.1 0.2 0.0 0.0 0.7 0.0 0.5 0.1 1.2 0.8 8.9 4.1 4.3 5.2 0.6 3.0 4.5 2.2 2.9 0.2 2.9 0.4 0.1 6.6 3.5 0.2 7.0 1.8 3.6 4.5 6.1 19.8 1.7 2.4 0.9 9.0 8.8 2.5 3.3 4.4 2.9 5.8 0.2 3.0 21.6 0.0 6.5 0.4 0.4 11.2 1.6 1.0 1.4 0.8 3.0 0.1 3.4 0.3 1.9 0.0 1.5 0.0 4.6 1.6 1.8 29.5 3.0 16.3 3.0 5.1 8.1 1.3 4.2 13.0 11.2 7.2 12.8 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 4.5 10.0 0.5 26.1 5.6 1.6 2.3 15.5 4.6 0.0 0.0 0.6 0.0 2.4 1.5 1.8 1.4 0.0 0.0 0.0 0.0 3.9 0.1 1.7 0.1 0.8 0.6 72.1 0.0 2.3 0.3 0.3 3.9 0.0 4.0 0.7 0.0 95.8 1.3 2.8 0.9 2.3 1.6 5.0 0.0 76.0 0.8 1.2 48.9 1.1 4.4 0.5 0.0 11.4 4.6 4.2 2.6 0.1 0.0 85.8 1.7 SATL1 ENSG00000184788 "Spermidine/spermine N1-acetyl transferase like 1" Q86VE3 X 85092287-85243961 "Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 2.7;brain: 5.4;pituitary gland: 7.2;testis: 4.8" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 11.7;Ciliated cells: 17.4;Club cells: 12.5;Late spermatids: 10.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.3;HAP1: 3.5;HEL: 1.2;RH-30: 1.5;SH-SY5Y: 1.4;SuSa: 1.0" HPA060369 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060369: AB_2684265" "unprognostic (1.77e-1)" "unprognostic (2.06e-1)" "unprognostic (4.69e-3)" "unprognostic (7.88e-2)" 0.3 2.7 2.9 0.4 2.6 0.4 0.4 5.4 4.6 0.4 0.4 0.2 0.0 0.3 0.4 0.3 0.3 0.4 0.3 0.5 2.2 2.0 1.1 0.4 0.3 0.3 1.1 2.7 0.4 0.3 0.3 7.2 0.4 2.2 0.5 0.4 0.0 0.4 0.3 0.7 0.6 0.3 0.3 1.4 0.4 0.3 4.8 0.4 0.0 0.4 0.2 0.3 0.4 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 3.5 0.0 0.0 0.0 0.6 1.2 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 0.5 1.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.6 5.4 4.6 2.2 2.0 1.1 2.7 2.2 0.4 11.9 11.7 0.0 0.0 0.0 0.0 0.0 0.0 17.4 12.5 0.0 0.0 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SAXO1 "C9orf138, FAM154A, MGC35182" ENSG00000155875 "Stabilizer of axonemal microtubules 1" Q8IYX7 9 18927658-19049354 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 47.2" "Cell type enriched" "Detected in some" 14 "Early spermatids: 471.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "HEL: 1.8;T-47d: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023899 Enhanced NA NA "HPA023899: AB_1845813" "unprognostic (4.23e-4)" "unprognostic (1.59e-1)" "unprognostic (3.38e-1)" "unprognostic (3.17e-2)" "unprognostic (5.28e-3)" "unprognostic (8.64e-2)" "unprognostic (3.89e-1)" "unprognostic (2.90e-3)" "unprognostic (1.38e-2)" "unprognostic (4.97e-3)" "unprognostic (1.51e-1)" "unprognostic (3.61e-1)" "unprognostic (1.24e-1)" "unprognostic (8.02e-2)" "unprognostic (2.79e-1)" "unprognostic (4.36e-2)" "unprognostic (5.40e-2)" 0.2 0.2 0.2 0.5 0.5 0.1 0.2 0.2 0.8 0.2 0.2 1.5 0.0 0.2 0.3 3.1 0.2 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.2 0.3 0.2 1.7 0.1 0.8 0.5 0.1 1.3 0.6 1.0 0.2 0.3 0.2 0.1 0.6 0.2 0.2 47.2 0.3 0.5 0.2 0.0 0.5 0.2 0.2 0.2 0.4 0.1 0.1 0.2 2.1 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 1.8 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.9 1.0 0.6 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.6 0.0 1.1 0.2 0.5 0.8 0.2 0.2 1.1 2.1 0.0 0.2 0.0 0.4 0.3 0.1 0.2 0.5 0.2 0.8 0.3 0.2 0.2 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 471.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 1.5 33.4 4.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 2.5 0.5 0.0 0.0 0.0 6.1 2.3 0.0 0.1 0.0 0.0 0.1 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 46.8" "Cell type enhanced" "Detected in many" 28 "Ciliated cells: 370.7;Early spermatids: 61.6;Late spermatids: 100.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 12.3;K-562: 11.2;SCLC-21H: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.3 4.1 1.3 5.4 0.7 2.8 4.4 5.3 2.7 1.2 3.5 5.0 0.9 2.1 14.8 0.7 46.8 1.9 1.4 5.5 2.8 2.3 1.1 9.1 1.1 3.1 2.8 9.2 2.6 4.7 11.5 0.7 5.6 2.4 1.8 1.6 2.3 3.0 1.2 1.9 1.6 0.9 2.3 1.3 2.3 18.0 3.7 1.0 3.1 0.1 1.6 1.0 1.2 6.7 1.3 5.3 0.2 3.2 2.7 0.5 1.6 2.2 1.3 4.9 1.1 2.2 0.6 0.5 0.4 0.9 1.8 0.2 2.7 1.6 1.2 0.0 2.6 12.3 2.1 1.8 2.1 1.1 8.0 0.6 3.8 0.0 0.1 0.4 0.5 1.5 2.6 1.7 1.4 2.8 1.9 3.4 11.2 0.9 1.2 1.1 0.6 0.0 3.2 0.6 0.9 1.5 0.6 1.0 0.9 1.1 9.4 1.5 1.3 0.0 1.7 0.8 4.7 0.5 0.2 2.4 1.4 5.0 0.9 2.6 2.8 1.0 2.3 0.6 1.6 0.0 0.1 5.3 1.1 0.0 1.4 2.5 0.4 2.7 0.1 6.7 1.8 0.8 0.1 3.2 0.2 1.3 0.1 0.5 4.1 5.4 4.4 5.3 5.5 2.8 3.1 2.8 5.6 3.7 0.0 2.4 0.0 1.7 0.0 2.6 1.1 2.5 370.7 44.3 3.5 3.9 0.4 1.7 0.4 61.6 0.5 0.0 0.0 0.4 0.4 0.2 1.8 1.1 0.0 0.1 0.0 2.4 0.0 0.0 100.5 2.3 0.0 0.0 0.0 2.1 3.3 0.3 0.0 2.1 3.5 4.9 6.5 0.1 40.5 7.2 0.0 0.2 0.0 0.6 1.2 SAYSD1 "C6orf64, FLJ11101" ENSG00000112167 "SAYSVFN motif domain containing 1" Q9NPB0 6 39104064-39115189 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 85.1;Spermatocytes: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007959 Approved Supported Vesicles NA NA Vesicles "HPA007959: AB_1078359" "unprognostic (2.65e-1)" "unprognostic (1.49e-2)" "unprognostic (2.03e-2)" "unprognostic (2.58e-1)" "unprognostic (3.70e-1)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (1.96e-2)" "unprognostic (6.50e-2)" "unprognostic (1.82e-3)" "unprognostic (5.08e-2)" "unprognostic (9.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.27e-1)" "unprognostic (2.00e-3)" 8.2 7.2 7.2 5.7 8.7 5.9 11.2 7.1 9.0 7.9 7.3 8.1 6.9 8.8 7.9 10.5 6.5 8.1 9.3 6.7 7.3 6.9 8.1 8.3 6.3 8.2 9.3 6.5 8.4 9.5 4.9 6.1 6.1 7.0 8.5 7.2 6.4 11.1 8.0 5.6 6.6 8.6 6.3 7.0 6.8 6.9 52.7 7.3 18.2 8.4 5.1 9.0 6.2 7.7 14.8 9.3 19.4 12.2 11.7 19.1 9.5 11.4 7.4 6.7 7.9 11.1 14.7 6.9 5.3 5.8 6.4 6.8 10.6 8.1 10.4 7.6 6.9 9.1 7.9 5.8 5.0 6.8 6.5 10.5 6.8 4.5 9.2 9.0 7.7 10.3 10.1 12.4 2.5 6.4 4.5 5.9 15.8 11.5 6.4 7.1 15.7 12.2 12.8 5.8 7.5 3.8 1.7 8.1 4.1 13.4 8.1 18.8 7.6 9.2 8.0 8.1 5.6 13.1 10.2 7.6 8.5 6.2 2.6 6.8 0.1 3.2 12.8 4.9 11.2 6.2 7.6 9.0 19.4 12.2 12.2 14.2 13.1 13.3 11.0 9.3 14.8 19.1 15.8 4.3 11.7 11.9 7.4 17.3 9.5 7.2 8.7 7.1 9.0 7.3 6.9 9.3 6.5 7.0 7.3 3.0 5.9 9.3 11.4 13.7 5.5 17.5 17.8 12.0 5.7 17.4 7.9 28.7 14.9 19.4 85.1 11.3 11.8 0.0 18.9 26.3 17.4 17.9 8.1 18.7 23.2 6.4 8.1 3.1 15.6 40.0 19.0 12.2 11.8 9.0 15.0 13.7 14.7 7.0 18.0 23.0 3.6 6.5 10.3 202.1 11.9 14.4 10.3 10.2 18.4 11.5 SBK1 Sbk ENSG00000188322 "SH3 domain binding kinase 1" Q52WX2 16 28292519-28323849 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6" "Cell type enriched" "Detected in many" 8 "Cone photoreceptor cells: 76.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4" "Group enriched" "Detected in many" 10 "NK-cells: 1.4;T-cells: 4.3" "Cell line enhanced" "Detected in some" "AF22: 15.3;AN3-CA: 11.0;NTERA-2: 15.8;REH: 16.7;SCLC-21H: 24.3;SH-SY5Y: 22.9" "Region enriched" "Detected in all" 5 "cerebellum: 306.7" NA NA "unprognostic (5.15e-2)" "prognostic favorable (6.88e-4)" "unprognostic (2.08e-1)" "unprognostic (6.22e-2)" "unprognostic (1.81e-1)" "unprognostic (1.71e-2)" "unprognostic (5.71e-3)" "unprognostic (3.66e-3)" "unprognostic (1.17e-1)" "unprognostic (1.62e-2)" "unprognostic (2.87e-2)" "unprognostic (6.38e-2)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (3.50e-2)" "unprognostic (7.91e-2)" "unprognostic (5.03e-3)" 0.9 2.0 8.0 1.8 7.3 2.0 1.7 31.1 17.5 1.7 1.2 1.5 0.0 1.1 1.9 1.3 1.5 1.6 1.0 1.8 9.9 5.6 1.6 0.9 1.8 2.7 6.0 4.0 1.1 2.7 4.2 4.1 0.8 8.3 2.6 1.2 1.4 3.8 1.0 39.6 1.4 1.1 0.9 3.1 2.8 1.6 2.3 3.1 22.1 2.6 0.0 1.7 1.2 0.3 0.2 0.2 0.2 0.1 1.4 4.3 0.4 0.1 0.2 15.3 11.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.3 0.3 4.6 0.1 0.0 1.5 0.5 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.1 5.8 0.0 1.0 0.0 1.8 7.0 0.1 15.8 1.0 0.1 16.7 0.8 0.1 0.1 0.9 24.3 22.9 0.4 1.4 0.2 1.9 1.7 0.0 0.4 0.0 2.4 0.2 0.1 0.2 0.0 0.2 0.1 0.2 0.9 0.2 0.1 0.1 4.3 0.0 1.4 0.0 1.2 2.4 0.0 0.2 1.4 3.0 0.1 1.4 0.1 0.2 1.4 0.4 8.0 7.3 31.1 17.5 9.9 5.6 6.0 4.0 8.3 3.1 3.0 0.3 0.0 0.8 0.6 9.4 3.1 2.5 2.7 3.4 0.0 76.6 0.0 1.7 6.1 1.0 0.0 0.0 0.0 4.8 0.0 0.4 1.5 0.0 0.2 0.1 0.0 5.8 0.0 0.0 3.1 0.6 0.0 0.0 0.0 0.3 4.2 4.7 0.0 0.0 0.5 2.7 0.0 0.3 1.4 2.3 0.1 0.1 2.5 0.8 0.3 SBK2 SGK069 ENSG00000187550 "SH3 domain binding kinase family member 2" P0C263 19 55529733-55537089 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "heart muscle: 45.7;tongue: 20.8" "Group enriched" "Detected in some" 6 "Early spermatids: 1.3;Late spermatids: 1.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.4;Hep G2: 3.2;MCF7: 4.5;NTERA-2: 8.9;RH-30: 8.3;U-2 OS: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030631 Enhanced NA NA "HPA030631: AB_10602088" "unprognostic (1.33e-1)" "unprognostic (1.85e-3)" "unprognostic (4.57e-1)" "unprognostic (3.49e-1)" "unprognostic (5.43e-3)" "unprognostic (4.18e-3)" "unprognostic (2.08e-1)" "unprognostic (6.58e-2)" "unprognostic (1.05e-1)" 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.7 20.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.4 1.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.0 8.9 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SBK3 SgK110 ENSG00000231274 "SH3 domain binding kinase family member 3" P0C264 19 55540656-55545543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 24.2" "Cell type enriched" "Detected in single" 25 "Cardiomyocytes: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.4;CACO-2: 3.3;CAPAN-2: 5.6;NTERA-2: 2.5;RH-30: 4.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA078322 Approved Mitochondria NA NA Mitochondria "HPA078322: AB_2732379" "unprognostic (2.15e-1)" "unprognostic (1.99e-3)" "unprognostic (2.71e-1)" "unprognostic (1.39e-3)" "unprognostic (7.52e-2)" "unprognostic (2.83e-1)" "unprognostic (5.47e-5)" "unprognostic (4.64e-3)" "unprognostic (7.24e-2)" "unprognostic (1.65e-1)" "unprognostic (3.38e-1)" "unprognostic (3.08e-3)" "unprognostic (1.21e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-1)" 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.1 24.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.8 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.3 3.3 5.6 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.0 0.0 0.0 2.5 0.1 0.6 0.2 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 1.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SBNO1 "FLJ10701, FLJ10833, MOP3, Sno" ENSG00000139697 "Strawberry notch homolog 1" A3KN83 12 123289109-123364843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 57.1" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 294.5;Spermatogonia: 190.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042388 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA042388: AB_10795704" "unprognostic (1.61e-2)" "unprognostic (9.61e-2)" "unprognostic (5.12e-2)" "unprognostic (2.54e-3)" "unprognostic (3.50e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (1.48e-1)" "unprognostic (5.33e-2)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (6.61e-3)" "unprognostic (2.06e-1)" "unprognostic (3.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-2)" 7.6 7.6 12.9 9.8 12.2 21.4 9.0 24.3 15.9 9.4 8.6 6.4 6.9 7.4 10.9 6.4 10.7 9.3 6.4 7.5 11.3 9.2 9.5 11.0 7.4 12.7 12.1 10.9 10.4 9.5 13.7 15.6 11.8 12.2 10.2 9.5 5.3 7.2 9.1 11.2 8.6 10.1 10.0 9.7 9.4 8.7 57.1 12.3 19.5 14.6 4.8 12.0 8.6 10.4 11.6 8.1 13.8 13.5 7.9 14.7 6.7 11.3 22.1 8.9 16.5 12.7 9.9 18.5 10.4 10.4 9.3 7.8 15.6 7.4 24.5 12.5 11.9 10.4 13.5 18.8 11.6 15.4 18.0 7.1 23.8 13.8 12.6 6.5 29.0 20.7 7.8 9.2 13.0 12.8 10.1 9.1 13.6 29.2 8.0 16.0 11.5 16.0 11.7 13.5 9.8 11.5 17.2 13.0 12.6 7.2 29.6 15.1 6.4 18.1 12.8 9.6 10.9 22.2 10.1 12.0 12.6 16.0 14.9 9.2 8.1 17.2 31.3 7.2 17.3 14.2 8.3 8.2 10.9 12.6 9.6 14.7 11.6 12.2 12.5 8.1 9.7 12.0 12.9 13.8 7.9 13.5 7.6 9.4 6.7 12.9 12.2 24.3 15.9 11.3 9.2 12.1 10.9 12.2 12.3 26.8 18.8 38.5 40.3 56.2 86.0 31.1 22.9 37.5 33.0 34.9 74.6 55.8 19.9 28.9 42.5 25.9 21.1 0.0 23.7 43.8 36.7 29.8 28.8 23.6 23.9 60.4 38.6 28.3 35.1 26.7 23.6 31.9 32.1 54.1 22.7 48.9 30.2 17.5 57.0 23.2 55.9 25.8 44.2 294.5 190.1 53.6 88.7 42.7 36.6 41.3 SBSN "HLAR698, UNQ698" ENSG00000189001 Suprabasin Q6UWP8 19 35523367-35528351 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 105.1;skin 1: 241.3;tongue: 338.1" "Cell type enriched" "Detected in some" 11 "Suprabasal keratinocytes: 889.6" "Group enriched" "Detected in many" 9 "cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 35.2;HSkMC: 47.6;U-2197: 16.3;U-87 MG: 38.5" "Low region specificity" "Detected in some" "HPA062568, HPA067734" Enhanced Approved Vesicles "Secreted - unknown location" NA NA 62000000 Vesicles "HPA062568: AB_2684794, HPA067734: AB_2685894" "unprognostic (1.10e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (1.23e-3)" "unprognostic (3.45e-3)" "unprognostic (2.56e-1)" "unprognostic (4.83e-4)" "unprognostic (4.31e-4)" "unprognostic (6.97e-2)" "unprognostic (9.08e-14)" "unprognostic (6.37e-2)" "unprognostic (6.51e-3)" "unprognostic (2.09e-1)" "unprognostic (1.36e-3)" 0.3 0.0 0.2 0.2 1.6 0.1 11.2 0.2 0.2 65.1 0.2 0.2 0.2 0.0 3.5 0.2 105.1 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.7 0.2 0.2 0.0 0.2 26.8 0.2 1.3 241.3 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.8 0.2 338.1 51.7 0.4 51.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 20.2 35.2 0.0 1.6 2.2 0.7 0.2 0.0 0.0 0.0 0.3 1.4 0.5 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 47.6 2.6 9.5 2.3 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 5.9 1.2 16.3 0.4 0.1 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 3.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 13.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 889.6 0.2 0.0 0.0 0.1 SBSPON "C8orf84, RPESP" ENSG00000164764 "Somatomedin B and thrombospondin type 1 domain containing" Q8IVN8 8 73064540-73124088 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.7;urinary bladder: 47.9" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 40.1;Muller glia cells: 43.4;Peritubular cells: 25.1;Smooth muscle cells: 30.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 10.0;RPTEC TERT1: 18.1;SuSa: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029595 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 19000 Vesicles "HPA029595: AB_10600763" "prognostic favorable (7.18e-4)" "unprognostic (5.08e-3)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (2.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.65e-2)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (9.54e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (6.14e-2)" "unprognostic (3.54e-1)" "unprognostic (2.12e-2)" "unprognostic (6.25e-2)" 6.7 3.0 0.6 1.7 0.7 0.3 6.7 2.6 0.7 6.5 4.2 2.9 16.5 0.8 4.9 18.1 9.6 8.2 3.0 3.5 1.1 0.8 14.4 0.6 5.0 2.4 2.5 0.9 9.0 1.2 0.0 1.7 9.3 5.4 19.4 1.1 4.3 4.3 25.4 1.1 1.8 2.6 66.7 15.7 1.1 9.9 5.6 0.7 0.1 3.2 2.5 0.9 47.9 7.6 0.9 1.2 1.1 0.4 1.5 0.8 0.3 0.3 0.2 0.5 0.6 0.0 0.0 1.4 10.0 0.0 0.0 0.0 0.1 0.2 0.4 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.3 0.0 0.0 0.4 0.3 1.0 0.5 0.2 0.2 0.2 0.0 18.1 0.1 0.6 0.5 1.1 0.4 0.1 3.6 0.2 0.1 0.5 0.2 1.7 0.2 0.2 0.1 0.0 0.1 0.2 0.2 0.2 0.7 0.4 0.4 0.6 0.0 0.1 0.4 0.6 0.7 0.1 0.9 0.4 0.8 1.1 1.5 0.4 1.2 0.2 0.3 0.6 0.7 2.6 0.7 1.1 0.8 2.5 0.9 5.4 0.7 8.9 0.0 0.0 4.1 1.1 2.6 1.1 7.6 0.0 0.0 40.1 2.0 0.2 1.7 1.0 5.8 1.5 0.0 0.0 0.0 0.2 14.3 1.6 0.0 0.0 0.4 0.0 0.0 0.6 0.0 1.6 11.2 0.0 3.3 0.0 0.0 43.4 0.8 0.0 25.1 0.7 1.8 6.5 30.8 10.3 2.1 1.1 0.3 0.0 0.0 0.3 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase O75845 11 121292453-121308694 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 143.5" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 117.3;Ito cells: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066283, HPA070248" Enhanced Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" No No "Nucleoplasm, Endoplasmic reticulum" "Plasma membrane, Cytosol" "HPA066283: AB_2685648, HPA070248: AB_2686240" "unprognostic (4.78e-2)" "unprognostic (7.29e-2)" "unprognostic (2.26e-2)" "unprognostic (2.36e-1)" "unprognostic (3.98e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (2.79e-2)" "unprognostic (7.96e-2)" "prognostic unfavorable (3.98e-4)" "unprognostic (4.03e-2)" "unprognostic (3.18e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.07e-7)" "unprognostic (4.29e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.98e-1)" 10.9 15.3 16.9 5.5 18.4 2.7 23.3 10.4 26.9 9.4 9.4 17.8 24.5 17.4 6.8 30.1 19.5 7.2 7.4 9.4 18.7 19.6 19.7 143.5 10.1 5.5 20.8 17.8 7.8 8.9 17.5 14.7 6.3 40.8 40.3 8.6 8.2 9.5 24.0 3.9 7.7 13.4 7.6 43.4 4.1 8.8 9.7 16.0 3.7 10.4 8.2 8.1 14.0 14.6 6.0 9.8 7.5 6.3 6.8 10.0 3.8 6.8 3.4 51.8 11.0 20.1 17.5 7.3 7.7 14.5 5.2 9.2 21.6 25.5 6.5 24.4 8.4 41.5 25.7 16.1 19.5 5.1 3.2 22.0 9.6 22.6 17.2 16.4 6.0 3.3 14.3 16.0 16.4 16.9 4.4 7.8 6.4 6.2 9.4 24.0 7.1 2.4 7.9 16.1 19.8 11.0 3.4 13.0 5.5 36.5 30.8 13.7 7.7 17.7 4.0 10.1 36.2 16.2 10.4 14.9 5.0 8.1 8.8 3.6 1.8 2.9 8.7 1.9 13.4 8.6 7.5 4.8 1.2 5.0 6.3 8.5 6.0 6.8 6.0 8.5 6.0 10.0 9.5 0.4 6.8 4.5 9.8 6.9 3.8 16.9 18.4 10.4 26.9 18.7 19.6 20.8 17.8 40.8 16.0 17.9 26.4 26.2 53.7 8.7 21.9 17.8 15.3 14.7 18.2 19.2 29.5 13.8 5.0 17.3 2.2 8.4 23.5 0.0 25.4 14.2 17.3 59.7 17.3 117.3 17.9 22.3 13.8 163.9 25.6 1.0 17.8 15.1 18.6 22.6 12.7 40.5 14.5 11.4 15.9 14.6 29.6 12.9 16.7 6.0 13.0 13.6 15.6 21.7 11.9 45.5 SCAI "C9orf126, FLJ36664, NET40" ENSG00000173611 "Suppressor of cancer cell invasion" Q8N9R8 9 124942608-125143506 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 34.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 65.5;Cone photoreceptor cells: 188.5;Rod photoreceptor cells: 114.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020632 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA020632: AB_1845804" "unprognostic (1.93e-1)" "unprognostic (1.88e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (6.90e-2)" "unprognostic (3.34e-3)" "unprognostic (7.75e-2)" "unprognostic (4.54e-3)" "unprognostic (5.69e-2)" "unprognostic (2.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.47e-1)" "unprognostic (1.87e-2)" "unprognostic (3.57e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (1.26e-3)" 4.5 6.5 9.5 6.4 14.3 6.8 5.4 9.5 19.1 5.0 4.5 3.5 3.1 3.3 5.9 4.6 4.1 6.1 3.7 3.7 7.1 7.9 4.4 3.8 8.5 7.2 4.6 12.0 7.6 4.6 5.7 4.6 2.7 4.8 5.5 5.0 12.4 3.7 3.3 4.2 6.6 4.0 4.0 4.0 5.0 4.4 5.2 5.1 34.4 5.3 2.1 6.2 4.2 4.5 2.9 3.1 1.5 1.7 2.5 2.6 1.3 3.7 2.9 3.9 3.7 2.2 5.3 6.5 2.3 4.9 2.5 3.6 3.7 3.6 6.7 1.8 2.3 3.0 6.3 5.0 2.6 5.2 4.7 1.8 4.4 5.3 3.2 3.0 4.7 3.4 2.0 2.3 3.9 2.6 4.3 3.6 12.2 6.2 7.9 3.8 4.0 14.9 3.2 3.8 7.2 3.2 9.4 6.2 5.8 1.7 5.1 4.0 2.5 5.5 3.1 2.9 4.4 7.6 2.1 3.7 2.3 4.3 3.8 4.0 4.4 8.3 6.4 2.8 3.8 3.4 0.8 1.2 0.2 1.1 1.7 1.2 2.0 1.9 1.3 0.8 2.9 2.6 1.8 1.5 2.5 0.6 3.1 2.6 1.3 9.5 14.3 9.5 17.0 7.1 7.9 4.6 12.0 4.8 5.1 65.5 23.3 13.0 7.7 2.5 39.5 3.9 17.8 9.4 12.5 17.4 188.5 5.6 1.7 3.0 9.2 6.8 5.0 0.0 1.8 4.3 5.4 6.4 4.7 7.6 3.5 15.9 12.6 13.5 5.6 4.1 8.9 3.2 3.3 1.8 7.1 32.7 2.2 6.6 5.6 1.9 114.6 0.0 3.8 27.2 20.4 3.8 2.2 8.7 8.6 3.7 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021496 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 87.0" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 110.4;Cone photoreceptor cells: 117.8;Horizontal cells: 66.7;Intestinal endocrine cells: 60.0;Rod photoreceptor cells: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 24 "plasmacytoid DC: 20.0" "Lineage enriched" "Detected in single" 24 "dendritic cells: 20.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 40.3;SH-SY5Y: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced NA NA "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favorable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favorable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 2.1 11.1 29.2 2.5 35.7 1.7 2.1 57.5 87.0 1.5 3.3 7.5 0.0 20.6 3.3 2.4 1.3 3.1 3.3 2.8 32.4 32.1 8.9 2.6 1.9 4.0 23.9 27.8 3.6 16.7 27.0 7.4 3.8 31.1 2.6 3.1 10.7 4.1 1.9 0.8 1.6 14.7 2.1 11.9 3.6 8.2 5.6 5.6 0.0 3.8 0.0 5.3 5.5 0.7 0.2 20.0 0.8 0.1 0.3 0.2 0.2 0.6 8.1 1.7 5.7 0.1 0.1 0.2 0.2 0.2 1.8 0.6 2.1 4.0 12.2 3.9 0.4 1.5 0.5 6.9 0.5 0.6 1.9 0.8 1.5 0.8 11.2 1.2 0.3 5.2 0.6 0.9 0.4 0.1 1.2 0.7 4.5 0.1 10.0 0.4 6.6 0.5 4.4 6.0 0.9 3.2 0.2 1.4 2.9 0.4 3.8 40.3 22.5 8.8 6.1 12.2 1.3 3.4 14.8 0.5 0.5 3.9 0.8 0.5 0.9 1.0 1.1 1.4 9.4 2.1 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.2 0.0 0.8 0.3 0.1 20.0 0.0 0.2 29.2 35.7 57.5 64.8 32.4 32.1 23.9 27.8 31.1 5.6 0.0 0.6 2.2 0.6 0.2 110.4 2.4 10.2 2.7 0.0 5.2 117.8 0.1 1.7 4.0 0.4 0.7 4.2 0.0 36.9 0.1 0.8 0.9 0.0 0.6 10.4 66.7 60.0 9.2 4.7 0.6 2.0 0.5 1.7 0.0 2.0 20.0 9.3 5.8 6.0 10.7 156.4 0.0 1.0 1.7 3.4 0.1 0.1 0.0 1.9 0.4 SCARA3 "APC7, CSR, CSR1, MSLR1, MSRL1" ENSG00000168077 "Scavenger receptor class A member 3" Q6AZY7 8 27633868-27676776 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 52.2" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 62.8;Cytotrophoblasts: 37.1;Muller glia cells: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 50.6;HeLa: 55.7;HUVEC TERT2: 38.6;U-2 OS: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029861, HPA047386" Uncertain Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029861: AB_2673225, HPA047386: AB_2680024" "unprognostic (2.24e-1)" "unprognostic (5.36e-3)" "unprognostic (2.68e-3)" "unprognostic (1.36e-1)" "unprognostic (1.48e-2)" "unprognostic (1.17e-1)" "unprognostic (4.31e-1)" "unprognostic (1.60e-1)" "unprognostic (3.58e-2)" "unprognostic (1.45e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (3.41e-2)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (6.31e-3)" "unprognostic (6.03e-3)" 7.5 4.6 16.4 9.0 27.3 0.4 10.6 10.3 26.8 19.9 11.2 7.7 14.2 3.4 33.8 9.4 14.5 52.2 18.4 4.8 16.2 13.0 3.8 2.7 7.8 7.4 16.4 10.3 13.1 2.8 2.2 3.6 11.8 21.2 12.4 5.4 8.6 13.7 42.6 1.1 6.0 5.1 40.5 21.8 2.0 5.9 3.9 12.1 3.2 19.2 4.7 13.2 11.3 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 16.5 2.6 0.0 13.8 50.6 11.5 6.6 10.4 7.2 5.4 6.1 4.3 0.0 15.6 13.3 5.8 12.4 0.0 12.2 3.4 0.0 1.4 4.8 55.7 0.2 1.4 0.0 0.0 21.2 0.7 11.1 0.6 9.6 38.6 1.2 0.0 0.0 4.0 3.0 0.0 0.0 3.5 0.0 6.3 0.0 0.0 0.0 2.2 7.3 0.0 1.7 1.5 8.7 0.0 1.3 8.6 0.1 13.7 5.9 35.7 21.9 3.5 0.0 0.0 0.0 10.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 27.3 10.3 22.5 16.2 13.0 16.4 10.3 21.2 12.1 0.0 0.3 0.0 13.3 3.2 0.4 2.0 7.6 4.0 7.9 62.8 0.0 37.1 0.0 0.2 2.4 3.3 0.0 0.0 0.7 14.6 12.8 2.8 0.0 0.2 4.0 0.0 0.0 12.3 0.3 1.1 14.7 0.8 16.9 1.0 0.0 54.2 1.6 0.0 6.0 0.0 1.1 6.5 13.7 0.2 1.0 3.3 6.9 0.0 0.0 8.6 SCARB1 "CD36L1, CLA-1, CLA1, SR-BI, SRB1" ENSG00000073060 "Scavenger receptor class B member 1" Q8WTV0 12 124776856-124882668 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 173.1;liver: 93.7;placenta: 65.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 24.9" "Group enriched" "Detected in many" 5 "dendritic cells: 24.9;monocytes: 6.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066285, CAB070124, HPA072449" Enhanced Approved "Vesicles,Lysosomes,Rods & Rings" NA NA Vesicles "Lysosomes, Rods & Rings" "CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201" "unprognostic (9.70e-3)" "unprognostic (4.94e-3)" "unprognostic (1.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.65e-3)" "unprognostic (4.21e-3)" "prognostic unfavorable (1.83e-5)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.49e-5)" "unprognostic (3.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" 21.2 173.1 7.9 3.5 21.4 1.8 25.0 4.3 10.1 4.7 28.6 13.4 1.1 8.8 4.3 3.5 2.8 4.7 8.0 3.2 7.4 5.1 2.2 93.7 5.8 5.3 6.3 5.1 14.3 2.9 3.3 4.4 65.9 9.4 4.3 4.9 10.7 8.6 2.3 3.0 6.3 21.3 4.4 5.7 5.0 2.7 7.7 11.4 0.5 4.0 1.1 5.6 3.6 10.0 3.1 24.9 1.2 6.5 0.2 0.4 2.5 9.3 22.6 7.4 29.1 4.9 10.5 0.0 6.6 7.5 8.2 5.2 27.0 29.9 27.0 19.0 4.4 13.4 14.2 18.8 44.3 3.9 12.9 18.9 7.6 22.4 43.5 16.6 13.0 6.6 17.9 9.0 15.6 11.1 14.0 22.3 4.9 14.3 11.6 1.5 18.5 4.0 17.4 6.7 11.6 23.4 16.9 5.9 53.9 0.7 13.1 13.9 5.4 35.8 48.4 33.5 4.5 27.1 14.7 2.1 1.3 8.8 6.6 10.1 2.7 1.1 4.4 5.3 15.8 12.8 0.0 6.5 0.0 0.2 3.7 0.2 3.1 0.1 0.4 8.2 1.7 0.1 0.1 1.2 0.2 0.5 24.9 0.0 2.5 7.9 21.4 4.3 10.1 7.4 5.1 6.3 5.1 9.4 11.4 3.0 2.4 18.5 3.1 4.9 5.0 4.8 12.7 4.0 1.2 3.5 27.5 8.8 3.3 5.1 13.9 11.2 9.2 23.3 6.6 9.3 5.9 10.5 1.1 105.2 42.5 15.9 10.3 15.4 14.0 10.8 8.3 10.1 45.5 5.4 14.0 52.5 5.9 14.2 4.9 2.4 7.4 0.0 2.1 27.8 1.7 2.8 36.3 2.5 8.8 3.8 SCARF1 "KIAA0149, SREC, SREC1" ENSG00000074660 "Scavenger receptor class F member 1" Q14162 17 1633858-1645747 "Predicted intracellular proteins" "Cell adhesion" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 28.9" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 20.8;Endothelial cells: 35.9;Ito cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 8.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.3" "Cell line enhanced" "Detected in some" "HEL: 4.7;HUVEC TERT2: 15.9;REH: 8.1;TIME: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072936 Enhanced "Intracellular and membrane" NA NA 940000 "HPA072936: AB_2686559" "unprognostic (1.94e-1)" "unprognostic (2.84e-1)" "unprognostic (2.53e-3)" "unprognostic (2.88e-1)" "unprognostic (3.28e-1)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (1.91e-1)" "unprognostic (1.62e-2)" "unprognostic (3.76e-1)" "unprognostic (1.32e-1)" "unprognostic (2.13e-2)" "unprognostic (3.22e-2)" "unprognostic (1.38e-1)" "unprognostic (6.39e-2)" 15.3 3.4 2.3 6.8 2.8 3.7 15.6 3.5 2.4 6.7 3.8 2.4 2.3 3.9 8.7 5.7 2.9 4.1 4.8 10.1 2.1 2.2 5.4 6.1 12.6 8.5 2.9 3.1 4.5 3.1 2.5 2.8 7.6 3.4 5.0 1.8 5.3 2.7 3.4 5.7 2.4 3.8 3.6 2.4 28.9 3.4 3.4 1.3 1.5 13.5 4.6 2.5 4.7 12.4 0.0 1.1 8.3 1.7 0.0 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.1 15.9 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.5 2.3 2.8 3.5 2.4 2.1 2.2 2.9 3.1 3.4 1.3 20.8 14.5 0.0 0.4 3.1 0.5 2.8 0.0 4.0 4.5 3.5 3.9 0.2 1.7 0.4 0.1 35.9 3.5 0.0 0.2 0.2 1.4 0.5 3.5 1.8 7.3 0.0 0.0 73.1 12.9 0.2 1.1 11.7 3.3 0.0 3.5 1.4 0.2 0.0 1.1 0.0 1.6 0.0 0.8 0.5 0.8 2.4 1.0 0.0 1.7 0.9 SCART1 CD163c-alpha ENSG00000214279 "Scavenger receptor family member expressed on T cells 1" Q4G0T1 10 133453928-133523558 "Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.6" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 5.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HMC-1: 7.2;NB-4: 6.7;THP-1: 2.2;U-266/84: 7.3" "Not detected" "Not detected" HPA043101 Supported NA NA "HPA043101: AB_10797026" "unprognostic (4.32e-2)" "unprognostic (2.15e-2)" "unprognostic (1.13e-2)" "unprognostic (2.40e-2)" "unprognostic (7.42e-2)" "unprognostic (8.20e-4)" "unprognostic (1.29e-3)" "unprognostic (4.28e-3)" "unprognostic (2.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.91e-1)" "unprognostic (2.24e-2)" "unprognostic (6.24e-5)" "unprognostic (8.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.03e-2)" "unprognostic (1.94e-1)" 0.3 0.2 0.0 0.3 0.5 1.6 0.0 0.4 4.8 0.1 0.3 0.2 0.0 1.3 0.9 0.0 0.4 0.0 0.9 0.0 5.6 0.7 0.2 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.3 0.3 0.0 0.2 0.8 0.4 0.2 0.2 0.7 1.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.1 0.2 0.2 0.0 0.4 0.3 0.8 0.4 0.2 1.2 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.3 0.4 0.8 0.1 0.0 0.0 0.2 7.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.3 6.7 0.2 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 2.2 0.0 0.1 0.4 0.0 0.4 0.5 7.3 1.1 0.0 0.0 0.3 0.8 0.2 0.3 0.3 0.1 1.2 0.3 0.4 0.6 0.1 0.4 0.3 0.4 0.2 0.2 0.4 0.3 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCCPDH "CGI-49, NET11" ENSG00000143653 "Saccharopine dehydrogenase (putative)" Q8NBX0 1 246724047-246768137 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 95.3" "Group enriched" "Detected in many" 5 "Early spermatids: 1022.4;Spermatocytes: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 17 "basophil: 95.3" "Lineage enriched" "Detected in all" 22 "granulocytes: 95.3" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 53.5" "Low region specificity" "Detected in all" "HPA050775, HPA076030" Enhanced Approved Vesicles NA NA 2100000 Vesicles "HPA050775: AB_2681231, HPA076030: " "unprognostic (4.25e-1)" "unprognostic (3.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (2.83e-2)" "unprognostic (6.43e-2)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (5.51e-2)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (2.70e-2)" "unprognostic (9.63e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" 14.1 25.8 15.7 6.4 17.5 13.4 11.3 11.3 20.5 10.9 11.7 24.7 8.5 15.1 12.0 8.5 4.8 14.4 9.7 15.8 15.6 19.8 23.0 67.3 9.3 7.3 26.1 15.0 10.6 12.7 15.0 12.7 14.1 21.7 18.1 12.2 7.3 7.4 16.7 23.9 10.7 15.3 10.8 62.1 5.1 12.4 65.1 17.5 8.5 18.2 7.3 4.8 25.0 13.2 1.4 2.3 95.3 3.2 4.2 3.0 2.1 13.1 12.8 9.4 5.6 11.3 14.2 0.1 10.3 14.4 17.4 14.6 7.8 37.0 7.0 13.5 11.8 9.7 4.3 7.9 3.0 17.9 9.7 2.9 11.8 11.7 15.6 10.6 22.9 10.2 9.5 1.4 11.8 1.2 16.5 18.6 14.7 14.7 0.0 17.3 3.1 23.8 29.1 14.1 7.1 10.2 20.1 12.1 0.0 53.5 30.9 10.7 12.0 13.9 0.6 9.1 5.2 10.4 23.9 12.1 8.1 7.2 19.6 26.5 34.7 11.9 4.1 13.8 31.3 10.6 95.3 3.2 5.5 2.5 2.8 3.0 1.4 0.7 2.1 1.3 1.1 1.0 3.0 0.8 4.2 1.8 2.3 0.5 2.1 15.7 17.5 11.3 20.5 15.6 19.8 26.1 15.0 21.7 17.5 6.0 11.5 8.0 36.7 26.8 29.6 33.1 50.9 52.2 17.0 144.8 17.7 28.0 26.6 57.2 1022.4 20.2 47.9 0.0 61.3 13.6 42.0 76.7 57.5 163.4 83.3 6.4 43.0 21.5 44.3 154.3 44.0 20.4 45.5 15.4 25.1 52.2 56.6 28.1 44.6 51.6 30.6 19.4 27.8 461.4 68.6 59.8 70.7 16.7 53.2 149.1 SCD "FADS5, SCDOS" ENSG00000099194 "Stearoyl-CoA desaturase" O00767 10 100347124-100364834 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 300.1;Hepatocytes: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 204.0;CAPAN-2: 141.3" "Low region specificity" "Detected in all" "HPA012107, HPA063921" Approved Enhanced "Endoplasmic reticulum" No Yes "Endoplasmic reticulum" "HPA012107: AB_1856610, HPA063921: AB_2685154" "unprognostic (2.10e-1)" "unprognostic (2.62e-3)" "unprognostic (7.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (1.13e-1)" "unprognostic (3.88e-2)" "unprognostic (6.53e-2)" "unprognostic (2.72e-1)" "unprognostic (1.47e-1)" "unprognostic (1.69e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (7.18e-2)" "unprognostic (3.27e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (7.79e-5)" 245.0 21.3 59.8 11.4 32.7 5.5 94.0 12.7 83.9 5.3 10.8 63.6 0.1 21.4 3.7 7.0 13.4 1.7 18.3 109.2 61.5 43.4 5.0 130.8 32.2 23.1 65.1 23.6 12.7 6.1 7.7 1.5 5.3 34.5 24.4 10.1 4.5 24.9 3.7 2.4 3.4 6.1 4.6 130.0 4.2 5.9 12.2 35.4 1.4 2.0 6.9 5.4 3.7 5.0 2.0 5.3 0.2 3.3 2.9 5.1 2.1 31.0 28.6 61.1 41.9 204.0 117.7 12.5 3.3 73.7 8.0 42.8 24.6 141.3 13.1 2.6 7.8 36.6 55.6 33.6 119.4 7.0 4.4 13.9 7.3 18.2 49.2 39.4 10.2 8.0 64.0 36.2 31.1 54.8 21.6 15.2 29.1 20.4 40.1 3.2 48.6 11.6 12.2 21.2 9.1 8.2 5.4 22.6 41.1 34.9 34.9 3.8 14.7 6.6 31.2 64.1 18.5 35.0 22.0 6.0 0.8 9.5 0.7 6.8 11.2 6.0 20.2 14.6 32.0 5.1 0.0 1.5 0.0 3.0 3.3 5.1 1.3 1.2 1.6 5.3 2.0 1.0 2.9 0.2 2.9 0.0 3.0 0.0 2.1 59.8 32.7 12.7 27.9 61.5 43.4 65.1 23.6 34.5 35.4 50.6 300.1 34.7 3.9 3.3 4.0 2.9 35.7 9.4 23.9 0.0 5.9 2.0 0.0 12.5 52.9 9.3 13.7 0.0 59.1 53.1 9.3 26.0 5.8 153.5 29.3 25.4 24.8 41.7 97.6 68.6 3.4 8.2 55.6 17.2 15.7 11.8 21.6 2.9 1.4 3.8 4.7 0.0 4.4 0.9 1.1 1.9 14.5 5.2 16.8 3.5 SCD5 "ACOD4, FADS4, FLJ21032, HSCD5, SCD4" ENSG00000145284 "Stearoyl-CoA desaturase 5" Q86SK9 4 82629539-82798857 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 69.1;brain: 137.3;epididymis: 44.5;ovary: 42.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 92.6;Horizontal cells: 95.3;Muller glia cells: 134.1" "Group enriched" "Detected in all" 6 "glioma: 152.4;thyroid cancer: 38.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 27.5;RPTEC TERT1: 36.3" "Low region specificity" "Detected in all" HPA042380 Uncertain NA NA "HPA042380: AB_10794797" "unprognostic (3.23e-2)" "unprognostic (3.84e-2)" "unprognostic (2.86e-1)" "unprognostic (6.98e-2)" "unprognostic (1.58e-1)" "unprognostic (2.95e-1)" "unprognostic (2.83e-1)" "unprognostic (3.82e-2)" "unprognostic (6.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.04e-1)" "unprognostic (2.37e-2)" "prognostic favorable (2.32e-5)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.88e-3)" "unprognostic (2.92e-2)" 3.0 69.1 61.2 2.7 48.6 2.5 3.0 33.5 137.3 5.9 3.0 50.4 1.8 3.0 6.7 44.5 3.7 9.3 5.1 3.5 49.6 43.4 15.4 2.3 7.5 2.3 58.2 36.3 42.7 18.1 2.2 6.9 4.4 42.0 6.9 3.0 6.3 5.6 12.4 1.7 4.8 3.7 6.2 57.1 3.0 4.3 14.8 43.4 1.2 16.4 0.0 3.0 3.8 2.0 0.9 1.3 3.0 1.2 2.0 7.2 1.8 4.5 2.9 14.7 7.5 8.1 5.3 0.3 27.5 13.6 12.0 9.3 0.3 0.7 8.9 9.6 5.7 3.3 8.0 4.3 3.0 15.2 1.7 1.9 0.4 3.5 0.4 1.2 3.9 2.9 4.1 12.4 2.4 2.1 12.5 19.3 10.4 0.6 1.1 6.3 1.8 16.2 0.9 1.2 0.1 2.0 13.9 8.7 7.0 36.3 4.5 8.3 4.7 4.6 0.4 2.6 1.6 0.6 2.0 23.6 13.0 7.6 4.9 7.4 2.5 1.0 0.9 6.3 4.1 3.7 3.0 1.2 0.4 7.2 0.5 4.6 0.5 1.7 4.3 0.5 0.9 1.5 5.1 2.0 2.0 0.9 1.3 0.4 1.8 61.2 48.6 33.5 41.2 49.6 43.4 58.2 36.3 42.0 43.4 41.7 3.8 0.5 14.0 9.5 79.3 2.0 12.7 12.0 31.8 26.2 23.6 0.7 11.6 71.1 92.6 7.1 0.0 0.0 42.3 0.1 14.4 9.5 0.0 0.0 1.0 95.3 7.5 6.7 1.2 73.6 50.9 1.8 3.3 1.8 0.0 134.1 11.2 0.0 54.8 20.8 12.4 6.5 11.3 3.3 1.4 6.4 0.1 3.9 0.8 8.6 SCEL "FLJ21667, MGC22531" ENSG00000136155 Sciellin O95171 13 77535674-77645263 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 145.6;skin 1: 70.8;tongue: 62.2" "Cell type enriched" "Detected in many" 13 "Alveolar cells type 1: 631.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA039737, HPA040154" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Plasma membrane" "Nucleoplasm, Cytosol" "HPA039737: AB_10805485, HPA040154: AB_10795359" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-1)" "prognostic unfavorable (4.07e-4)" "unprognostic (5.91e-2)" "unprognostic (4.54e-2)" "unprognostic (6.62e-2)" "unprognostic (3.51e-1)" "unprognostic (8.08e-3)" "prognostic unfavorable (1.24e-4)" "unprognostic (4.57e-2)" "prognostic favorable (6.87e-4)" "unprognostic (1.81e-1)" "unprognostic (2.82e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (1.73e-5)" 0.4 0.0 0.1 0.2 0.4 0.0 4.9 0.1 0.2 15.2 0.2 0.2 0.1 0.0 0.8 0.2 145.6 0.0 0.3 0.1 0.1 0.0 0.4 0.1 27.8 0.1 0.1 0.1 0.2 0.1 0.0 0.1 3.7 0.2 0.1 0.4 0.1 11.8 0.1 0.3 70.8 0.2 0.1 0.2 0.1 0.0 0.5 0.1 0.4 0.5 62.2 35.1 0.4 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.7 0.0 0.0 23.3 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 6.3 0.0 0.0 0.0 45.3 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 631.3 30.6 0.0 0.0 9.5 0.0 0.2 0.0 6.7 42.1 0.0 0.0 0.3 0.0 4.1 5.8 0.0 0.0 0.0 0.2 0.0 0.3 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.6 1.7 0.0 4.3 1.5 26.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.7 48.8 0.1 0.0 0.0 2.6 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602503 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 124.4;Intestinal endocrine cells: 272.8" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 54000 "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favorable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 3.5 133.0 13.3 11.0 94.1 0.9 0.9 5.6 55.9 1.4 5.4 5.8 0.0 17.3 2.1 0.9 1.0 0.8 2.2 1.4 10.5 79.4 1.0 0.8 1.9 0.9 21.7 11.0 1.3 10.7 1.1 76.5 1.1 57.7 2.1 5.5 1.5 0.9 1.3 0.8 1.0 8.0 5.2 10.3 0.8 8.0 0.9 5.0 0.0 3.1 0.0 0.8 1.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.8 4.0 1.1 25.5 0.1 0.2 0.9 1.8 4.7 0.2 0.4 0.0 0.4 0.3 2.9 0.1 0.1 0.0 2.4 0.0 0.2 0.0 0.2 0.0 0.3 0.3 2.1 21.8 0.1 2.7 0.9 21.8 0.0 0.0 0.1 0.2 2.3 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 22.2 9.7 0.0 0.2 1.1 0.8 0.0 0.0 0.0 2.5 1.0 0.1 1.6 0.0 0.0 0.1 0.7 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.3 94.1 5.6 23.0 10.5 79.4 21.7 11.0 57.7 5.0 6.0 0.0 0.0 0.2 0.0 124.4 0.2 0.0 1.4 2.3 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 0.0 0.0 0.1 7.9 272.8 1.3 0.8 0.0 0.6 0.0 1.7 0.0 0.7 11.9 24.2 2.9 0.4 0.0 12.7 0.0 0.5 0.1 0.2 0.1 0.1 0.0 0.3 0.6 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681353-51721031 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 118.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 115.1;Cone photoreceptor cells: 96.2;Horizontal cells: 139.8;Intestinal endocrine cells: 142.5;Rod photoreceptor cells: 63.1" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NTERA-2: 20.4;SCLC-21H: 48.9;SH-SY5Y: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" NA NA 4800000 Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239" "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 1.7 12.9 29.6 2.1 25.4 1.7 1.7 33.4 118.3 1.5 2.4 6.5 0.0 2.9 1.5 1.6 1.6 1.6 1.6 1.5 22.6 23.5 1.5 1.5 1.8 1.7 13.6 37.7 1.5 11.5 1.4 23.7 1.5 27.1 1.6 2.8 1.3 1.5 1.4 1.5 1.8 2.6 1.7 13.2 1.5 8.7 2.9 7.3 0.0 2.1 0.0 1.5 1.6 0.1 0.9 1.2 1.9 0.5 0.3 0.8 0.2 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 20.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 48.9 23.1 0.1 0.1 0.0 6.6 0.0 1.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.1 4.3 0.4 0.4 0.6 0.8 0.2 0.5 0.9 0.6 0.4 0.4 0.7 0.5 0.6 1.9 0.3 0.5 1.2 0.2 0.2 29.6 25.4 33.4 40.6 22.6 23.5 13.6 37.7 27.1 7.3 0.0 0.0 0.0 0.0 0.2 115.1 0.2 0.0 0.0 0.0 0.0 96.2 0.0 1.7 0.4 13.3 0.6 0.0 0.0 0.9 0.0 0.2 0.5 0.0 0.0 0.4 139.8 142.5 1.8 0.0 9.2 0.0 0.0 1.7 11.8 0.2 11.7 8.7 0.0 0.4 0.0 63.1 0.0 0.1 15.8 4.9 0.0 0.0 0.0 0.2 0.0 SCG5 "7B2, SGNE1, SgV" ENSG00000166922 "Secretogranin V" P05408 15 32641676-32697098 "Predicted secreted proteins" Transport "Chaperone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6" "Cell type enriched" "Detected in many" 6 "Intestinal endocrine cells: 452.1" "Cancer enhanced" "Detected in many" "pancreatic cancer: 82.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 28 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "HHSteC: 15.0;HSkMC: 18.6;NTERA-2: 8.4;SCLC-21H: 17.2;SH-SY5Y: 19.9;U-87 MG: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013136, HPA074618" Enhanced "Secreted to blood" NA NA 22000 "HPA013136: AB_1856657, HPA074618: AB_2732262" "unprognostic (1.71e-1)" "unprognostic (9.87e-2)" "unprognostic (7.94e-2)" "unprognostic (1.30e-2)" "unprognostic (3.59e-3)" "prognostic unfavorable (9.64e-4)" "unprognostic (2.69e-1)" "unprognostic (1.27e-3)" "unprognostic (4.69e-2)" "unprognostic (1.97e-1)" "unprognostic (5.62e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (4.51e-9)" "unprognostic (3.57e-2)" "unprognostic (8.13e-2)" "unprognostic (3.08e-3)" "unprognostic (8.88e-2)" 1.2 30.7 24.0 2.2 47.2 0.9 2.5 36.4 71.1 1.0 4.4 13.0 0.0 9.0 3.4 21.8 1.0 2.4 3.4 1.0 30.5 36.9 1.2 2.2 2.5 1.3 25.2 23.1 2.0 63.5 60.1 74.6 0.9 30.5 3.2 5.5 15.4 0.7 1.2 0.7 1.3 3.3 3.9 24.1 1.0 21.0 3.0 9.5 0.0 1.8 0.0 0.9 2.5 0.5 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.2 0.1 0.1 0.1 0.3 2.5 0.0 2.2 0.2 0.2 0.2 0.1 0.0 0.2 1.1 0.2 0.9 0.6 0.3 0.1 0.6 0.3 0.1 0.3 0.0 0.0 15.0 0.1 0.4 18.6 0.1 0.4 0.2 0.5 0.3 0.5 0.1 0.3 0.4 0.0 0.1 0.2 8.4 0.0 0.4 0.0 0.2 0.3 0.2 0.0 17.2 19.9 0.1 0.0 0.1 0.2 0.0 0.2 0.0 2.9 1.9 0.1 0.2 0.3 1.2 0.2 26.1 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.3 0.2 24.0 47.2 36.4 50.8 30.5 36.9 25.2 23.1 30.5 9.5 0.0 0.3 0.0 0.2 0.6 53.1 0.3 0.0 0.0 4.5 0.0 2.0 0.1 0.0 0.5 43.4 0.1 0.4 0.0 71.7 0.2 2.6 1.8 2.3 13.0 6.3 47.7 452.1 0.6 1.2 72.8 2.0 1.2 3.3 1.0 3.1 11.2 35.0 0.0 7.4 0.0 20.6 0.0 0.4 6.4 0.9 0.3 0.2 0.0 0.7 0.1 SCGB1A1 "CC10, CC16, CCSP, UGB" ENSG00000149021 "Secretoglobin family 1A member 1" P11684 11 62405103-62423195 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Phospholipase A2 inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "lung: 508.4" "Group enriched" "Detected in some" 11 "Ciliated cells: 14233.6;Club cells: 50441.2" "Cancer enriched" "Detected in many" 8 "lung cancer: 215.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 69 "HaCaT: 212.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025686, HPA031828" Enhanced "Secreted in other tissues" NA NA 17000000 "CAB025686: , HPA031828: AB_2674061" "unprognostic (2.40e-3)" "unprognostic (1.55e-2)" "unprognostic (5.46e-2)" "unprognostic (2.70e-2)" "unprognostic (4.69e-3)" "unprognostic (2.12e-2)" "unprognostic (1.23e-2)" "unprognostic (2.31e-2)" "unprognostic (2.63e-2)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 28.7 0.0 0.1 0.0 0.1 0.0 0.0 508.4 0.0 0.1 0.0 9.4 0.2 0.0 7.4 0.0 0.1 7.6 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.3 4.8 0.1 0.1 0.0 0.8 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 212.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 1045.2 3052.9 0.0 40.1 0.0 0.0 0.0 0.0 14233.6 50441.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 57.7 637.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 571.9 SCGB1C1 RYD5 ENSG00000188076 "Secretoglobin family 1C member 1" Q8TD33 11 193080-194573 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 7.0;pancreas: 5.9;salivary gland: 7.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "basophil: 5.0;neutrophil: 2.4" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.0" "Cell line enhanced" "Detected in some" "Karpas-707: 1.1;RPMI-8226: 1.8;SK-BR-3: 2.2;U-266/70: 2.0;U-266/84: 1.0" "Secreted - unknown location" NA NA "unprognostic (5.09e-3)" 0.1 0.7 0.1 0.1 0.1 2.5 0.4 0.3 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.1 0.1 0.0 1.8 0.1 0.3 0.1 0.1 0.1 0.1 5.9 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.7 0.1 0.1 0.0 0.1 0.1 0.1 0.7 0.1 0.6 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 5.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 7.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCGB1C2 ENSG00000268320 "Secretoglobin family 1C member 2" P0DMR2 17 137526-139067 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "blood: 4.5;pancreas: 3.6" "Cell type enhanced" "Detected in single" 34 "Muller glia cells: 2.8" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.5" "Group enriched" "Detected in some" 18 "basophil: 2.2;neutrophil: 1.4" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.2" "Group enriched" "Detected in some" 6 "PC-3: 1.4;U-266/70: 2.2" "Secreted - unknown location" NA NA "unprognostic (4.65e-2)" 0.0 0.0 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCGB1D1 "LIPA, LPHA, MGC71958" ENSG00000168515 "Secretoglobin family 1D member 1" O95968 11 62190216-62193539 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 5.4;fallopian tube: 3.2;lymphoid tissue: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 40 "endometrial cancer: 23.3;ovarian cancer: 16.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "SCLC-21H: 11.9" "Secreted in other tissues" NA NA "unprognostic (6.95e-3)" "unprognostic (9.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 5.4 0.1 0.1 0.1 0.0 1.1 0.1 1.4 3.2 0.1 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.1 2.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCGB1D2 "LIPB, LPHB" ENSG00000124935 "Secretoglobin family 1D member 2" O95969 11 62242210-62244808 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 101.5;cervix, uterine: 315.2" "Cell type enriched" "Detected in some" 25 "Melanocytes: 781.1" "Group enriched" "Detected in many" 6 "breast cancer: 625.1;endometrial cancer: 226.0" "Region enriched" "Detected in some" 6 "pons and medulla: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 14.7" HPA035318 Approved "Secreted in other tissues" NA NA "HPA035318: AB_10610421" "unprognostic (8.76e-2)" "unprognostic (2.14e-1)" "prognostic favorable (3.46e-6)" "unprognostic (2.39e-2)" "unprognostic (5.89e-2)" "unprognostic (4.72e-2)" "unprognostic (1.99e-1)" "unprognostic (6.43e-2)" "prognostic favorable (8.03e-6)" "unprognostic (1.55e-1)" "unprognostic (1.15e-2)" 1.8 0.4 0.8 0.2 0.6 0.0 101.5 0.9 0.5 315.2 0.2 0.9 6.2 0.0 18.4 43.8 0.8 8.5 0.4 1.0 1.2 0.4 1.1 0.2 0.2 0.2 1.0 0.5 1.1 2.9 0.0 1.0 0.6 7.3 1.1 0.0 1.2 9.5 0.5 2.4 59.6 0.2 0.2 0.4 0.2 0.0 1.6 0.5 0.2 0.3 2.1 1.2 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.7 0.2 0.0 2.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.9 0.5 1.2 0.4 1.0 0.5 7.3 0.5 0.0 0.0 0.0 5.0 24.4 0.5 6.5 0.0 0.0 0.0 7.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 31.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 781.1 0.0 0.0 17.0 0.0 0.0 0.0 13.2 0.6 0.0 0.3 0.0 0.0 6.0 0.1 0.0 0.0 1.0 SCGB1D4 IIS ENSG00000197745 "Secretoglobin family 1D member 4" Q6XE38 11 62296277-62299064 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8" "Group enriched" "Detected in some" 14 "Early spermatids: 8.7;Late spermatids: 7.4" "Cancer enriched" "Detected in some" 57 "endometrial cancer: 100.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HL-60: 3.2;Karpas-707: 1.0;RPMI-8226: 1.8" "Secreted in female reproductive system" NA NA "unprognostic (2.26e-3)" "unprognostic (3.20e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 27.5 0.1 0.1 9.9 0.0 9.5 27.9 0.1 36.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 5.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208668-62213939 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix, uterine: 191.8;epididymis: 135.9" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 61.1;Ciliated cells: 107.1;Glandular cells: 36.8;Intestinal endocrine cells: 35.6;Mucus-secreting cells: 60.0" "Group enriched" "Detected in many" 10 "endometrial cancer: 971.9;ovarian cancer: 208.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 14.0" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.2 0.5 0.2 0.0 6.8 0.2 0.3 191.8 1.0 0.3 20.8 0.0 40.8 135.9 1.0 28.7 2.5 0.4 0.2 0.3 1.2 0.4 0.9 0.2 0.2 0.3 5.6 2.2 0.0 1.5 0.7 0.5 1.2 1.3 0.2 18.8 1.4 0.2 2.3 0.3 0.2 0.2 0.2 4.3 4.5 0.2 0.3 0.8 1.1 3.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.1 0.0 1.1 0.2 0.0 2.6 0.6 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.5 0.2 0.0 3.7 0.0 4.1 0.1 0.0 0.0 61.1 107.1 11.4 15.7 0.0 0.1 3.3 4.8 0.0 0.0 2.6 0.0 4.7 0.0 0.0 36.8 0.0 0.0 3.7 0.0 35.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 60.0 0.0 14.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.4 3.9 SCGB2A2 "MGB1, MGC71974, UGB2" ENSG00000110484 "Secretoglobin family 2A member 2" Q13296 11 62270155-62273156 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "breast: 300.8" "Cell type enriched" "Detected in some" 38 "Melanocytes: 1671.9" "Cancer enriched" "Detected in many" 23 "breast cancer: 823.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 118 "SK-BR-3: 20.3" CAB026270 Enhanced "Secreted in female reproductive system" NA NA "CAB026270: AB_912980" "unprognostic (2.38e-1)" "unprognostic (7.28e-2)" "prognostic favorable (9.57e-8)" "unprognostic (4.17e-1)" "unprognostic (3.75e-1)" 2.9 0.0 0.2 0.2 0.2 0.0 300.8 0.2 0.2 34.4 0.2 0.2 0.2 0.0 0.6 0.2 7.2 0.0 0.2 0.5 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 13.9 0.2 0.2 75.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.6 5.9 0.2 0.9 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1671.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 SCGB2B2 "SCGB4A2, SCGBL" ENSG00000205209 "Secretoglobin family 2B member 2" Q4G0G5 19 34593329-34675699 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "epididymis: 4.1;pancreas: 12.7;skin 1: 5.9;testis: 15.9" "Group enriched" "Detected in some" 5 "Early spermatids: 7.3;Late spermatids: 26.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 4.4" HPA046806 Uncertain "Secreted - unknown location" NA NA "HPA046806: AB_10962373" "unprognostic (9.99e-2)" "unprognostic (3.62e-1)" "unprognostic (9.51e-2)" "unprognostic (1.38e-5)" "unprognostic (4.80e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (1.79e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-3)" "unprognostic (3.67e-1)" "unprognostic (3.52e-2)" "unprognostic (2.90e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" 0.6 0.7 0.7 0.6 0.6 0.0 1.2 0.6 0.9 0.6 0.6 0.6 0.6 0.7 0.6 4.1 1.3 0.7 0.6 0.6 0.7 0.7 0.6 0.7 0.7 0.6 0.6 0.6 0.6 12.7 0.3 0.6 0.6 1.0 0.6 0.2 0.6 0.6 0.6 1.1 5.9 0.6 0.6 0.9 0.6 0.4 15.9 0.6 0.6 1.0 0.6 0.6 1.0 0.6 0.6 0.3 1.4 0.3 0.3 0.8 0.1 0.7 1.4 1.2 0.7 0.8 0.4 1.4 0.8 0.8 0.3 0.4 4.0 0.6 0.5 0.7 0.1 0.6 0.7 1.4 1.2 0.3 1.5 0.6 0.7 2.2 1.0 0.4 0.3 0.9 0.5 1.3 0.1 0.7 1.4 0.0 2.1 0.2 4.4 0.4 1.3 0.6 2.0 0.5 1.1 0.7 1.0 1.0 0.5 0.8 1.5 1.2 1.1 0.8 0.7 0.6 0.7 1.3 0.5 0.8 1.5 1.1 1.0 0.3 3.9 1.8 1.4 0.5 0.2 2.3 1.4 0.3 0.1 0.8 0.0 0.4 0.3 0.5 0.3 0.3 0.6 0.8 0.5 0.3 0.3 0.1 0.1 0.3 0.1 0.7 0.6 0.6 0.9 0.7 0.7 0.6 0.6 1.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 SCGB3A1 "HIN-1, HIN1, LU105, PnSP-2, UGRP2" ENSG00000161055 "Secretoglobin family 3A member 1" Q96QR1 5 180590103-180591540 "Plasma proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6" "Group enriched" "Detected in many" 8 "Ciliated cells: 4434.1;Club cells: 12751.6" "Group enriched" "Detected in many" 7 "endometrial cancer: 114.2;lung cancer: 288.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "non-classical monocyte: 25.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 6.4;T-47d: 2.3;U-2197: 2.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to blood" NA NA 8000000 "unprognostic (7.70e-3)" "unprognostic (4.90e-1)" "unprognostic (1.53e-2)" "unprognostic (1.08e-2)" "unprognostic (3.03e-1)" "unprognostic (1.36e-2)" "unprognostic (7.87e-3)" "unprognostic (2.00e-2)" "unprognostic (3.20e-1)" "unprognostic (4.88e-2)" "unprognostic (3.55e-2)" "unprognostic (7.19e-2)" "unprognostic (8.74e-3)" "unprognostic (5.43e-2)" "unprognostic (4.62e-1)" "unprognostic (4.50e-1)" "unprognostic (1.50e-2)" 0.2 0.1 0.1 0.1 0.3 0.1 23.5 0.1 0.2 56.1 0.1 0.1 0.1 0.1 2.3 1.6 12.1 5.7 113.1 0.3 0.1 0.6 0.1 0.5 176.2 0.1 0.1 0.1 1.5 2.9 0.0 1.6 0.1 0.2 4.5 0.0 0.3 196.6 0.6 0.2 0.4 0.1 0.1 0.1 1.6 9.6 0.3 0.1 0.2 0.2 8.4 19.9 3.9 0.1 0.7 5.3 10.3 25.1 0.0 7.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 6.4 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.0 0.4 2.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.3 1.5 8.2 7.2 0.7 1.9 2.5 5.3 0.0 3.3 2.6 0.0 0.0 25.1 0.1 2.2 1.2 0.1 0.3 0.1 0.2 0.1 0.6 0.1 0.1 0.2 0.1 160.8 1144.5 0.0 27.2 0.5 0.0 0.3 677.7 4434.1 12751.6 0.0 0.0 0.0 0.0 2.1 0.1 5.5 0.0 0.0 1.4 0.2 0.3 164.9 32.5 0.0 0.3 0.0 0.0 35.6 0.0 0.0 0.6 6.2 5.0 0.0 0.0 0.0 85.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.0 4.3 0.0 398.4 SCGB3A2 "LU103, PNSP1, UGRP1" ENSG00000164265 "Secretoglobin family 3A member 2" Q96PL1 5 147870682-147882191 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "lung: 248.0" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 3186.5;Club cells: 12064.6" "Cancer enriched" "Detected in some" 10 "lung cancer: 211.2" "Region enriched" "Detected in single" 7 "pons and medulla: 1.0" "Cell type enriched" "Detected in single" 40 "basophil: 30.1" "Lineage enriched" "Detected in single" 40 "granulocytes: 30.1" "Cell line enhanced" "Detected in some" "A-431: 22.2;EFO-21: 13.9;NTERA-2: 15.9;PC-3: 78.6;SuSa: 33.3" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (3.85e-1)" "unprognostic (1.77e-1)" "unprognostic (2.99e-2)" "unprognostic (3.51e-2)" "unprognostic (1.84e-2)" "unprognostic (3.17e-2)" "unprognostic (1.05e-2)" "unprognostic (1.90e-8)" "unprognostic (9.31e-3)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (9.11e-2)" 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 248.0 0.1 0.1 0.1 0.1 0.3 0.0 0.6 0.1 1.0 0.1 0.0 0.1 1.7 0.4 0.1 0.4 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.7 0.2 0.2 0.1 0.1 0.2 0.3 30.1 0.5 0.7 0.2 0.0 22.2 0.3 0.3 0.5 0.3 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.3 0.1 13.9 0.0 0.2 0.2 0.6 0.3 0.1 0.0 0.4 0.8 2.4 0.0 0.0 0.1 0.8 0.3 0.2 0.1 0.0 0.5 0.0 0.0 0.6 0.3 0.0 0.4 0.2 0.2 15.9 0.0 78.6 0.0 0.2 0.0 0.3 0.1 1.1 0.3 3.1 0.3 0.0 33.3 0.3 0.1 0.4 0.3 9.3 0.4 0.3 0.4 0.3 0.1 0.1 0.3 1.0 30.1 0.5 0.1 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.1 574.7 3186.5 0.0 0.0 0.0 0.0 0.0 0.0 1145.6 12064.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SCGN "CALBL, DJ501N12.8, SECRET, SEGN" ENSG00000079689 "Secretagogin, EF-hand calcium binding protein" O76038 6 25652201-25701783 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.3;pancreas: 39.7;pituitary gland: 47.9" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 576.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 38.2" "Group enriched" "Detected in many" 11 "cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 23.6" "Region enriched" "Detected in single" 16 "olfactory region: 100.5" "Region enriched" "Detected in some" 9 "olfactory region: 282.4" "CAB004005, HPA006641, CAB044060, CAB062563, CAB068232" Enhanced Supported Supported Cytosol "Intracellular and membrane" NA NA Cytosol "CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874" "unprognostic (8.15e-2)" "unprognostic (4.31e-3)" "unprognostic (1.46e-1)" "unprognostic (1.25e-2)" "unprognostic (4.70e-1)" "unprognostic (1.78e-2)" "unprognostic (2.01e-1)" "unprognostic (5.14e-2)" "unprognostic (5.41e-2)" "unprognostic (9.45e-2)" "unprognostic (1.19e-1)" 1.5 2.1 0.7 6.0 0.8 0.1 2.0 22.3 1.5 0.4 10.5 0.5 0.9 7.2 0.1 0.3 0.3 0.0 0.5 5.0 6.2 22.0 3.8 2.5 0.4 0.1 0.5 1.2 0.2 39.7 0.0 47.9 1.8 1.4 1.1 11.7 1.8 3.7 3.0 0.1 0.3 8.0 0.7 1.0 0.1 12.5 0.6 0.1 0.5 1.1 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 23.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 22.3 1.5 6.2 22.0 0.5 1.2 1.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 99.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 0.1 0.0 4.7 0.0 0.0 0.1 0.0 576.5 1.8 0.0 0.0 0.6 0.0 0.0 1.8 2.8 0.0 7.8 2.9 0.0 2.2 0.0 12.9 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 11.3;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 9.7" "Group enriched" "Detected in many" 58 "dendritic cells: 9.7;granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 3.9 30.1 1.5 22.0 2.0 1.9 23.9 55.0 3.7 3.6 21.1 0.0 2.2 4.7 2.0 4.2 3.4 3.0 65.9 29.6 17.9 3.5 1.9 3.1 1.7 22.8 24.1 1.8 1.6 1.4 6.0 10.3 15.6 6.2 2.3 0.7 2.9 2.6 54.5 1.4 1.9 5.9 28.9 5.1 2.0 2.7 24.3 0.0 2.0 7.6 1.6 1.9 0.6 0.0 9.7 3.1 0.0 0.1 0.0 0.1 0.0 0.0 9.5 17.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.4 0.1 4.0 0.1 20.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 59.6 0.0 0.0 0.0 2.6 0.0 1.0 3.7 0.2 0.5 0.1 0.8 0.7 0.0 0.0 0.2 0.7 0.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 9.7 0.0 0.1 30.1 22.0 23.9 28.9 29.6 17.9 22.8 24.1 15.6 24.3 6.0 1.7 0.0 4.6 0.3 4.2 11.3 0.0 4.0 3.4 3.5 2.0 1.0 0.0 0.2 0.0 4.6 0.0 0.0 0.2 0.4 0.6 0.5 0.0 0.5 0.2 14.3 0.0 1.8 0.0 0.0 0.0 0.0 3.3 0.0 0.0 4.9 0.9 0.0 0.0 0.7 0.5 0.0 1.8 0.0 0.4 0.5 0.7 0.0 0.0 1.4 SCIMP "C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783" ENSG00000161929 "SLP adaptor and CSK interacting membrane protein" Q6UWF3 17 5208961-5234860 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 49.6;lymphoid tissue: 84.9" "Group enriched" "Detected in some" 5 "B-cells: 45.2;Hofbauer cells: 24.0;Kupffer cells: 93.1;Macrophages: 61.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 22.3;intermediate monocyte: 47.8;memory B-cell: 30.6;myeloid DC: 16.8;naive B-cell: 23.0;non-classical monocyte: 49.6" "Group enriched" "Detected in many" 8 "B-cells: 30.6;dendritic cells: 16.8;monocytes: 49.6" "Cell line enhanced" "Detected in many" "HeLa: 6.9;U-698: 14.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA006117 Enhanced NA NA "HPA006117: AB_1858633" "unprognostic (2.53e-2)" "unprognostic (7.88e-3)" "unprognostic (1.26e-2)" "unprognostic (5.79e-3)" "unprognostic (1.10e-1)" "unprognostic (3.87e-2)" "unprognostic (7.96e-2)" "unprognostic (1.73e-2)" "unprognostic (4.93e-2)" "unprognostic (2.99e-1)" "unprognostic (1.35e-1)" "unprognostic (8.05e-2)" "unprognostic (3.33e-2)" "unprognostic (2.07e-1)" "unprognostic (4.42e-2)" "unprognostic (1.77e-1)" "unprognostic (9.95e-2)" 6.1 2.8 1.3 19.5 1.5 1.7 1.7 0.9 1.1 1.5 2.3 3.2 0.2 2.0 1.4 2.2 3.8 2.0 3.1 2.5 1.3 1.5 3.2 10.0 10.8 55.1 2.1 0.2 2.4 1.6 0.0 1.5 2.2 3.6 1.9 1.8 2.2 4.5 0.2 1.4 1.1 9.9 2.3 3.9 84.9 1.8 1.0 1.0 3.0 1.5 0.7 31.9 3.6 1.3 30.6 16.8 4.0 49.6 1.1 0.4 11.1 1.2 2.0 3.2 4.7 0.1 0.0 3.4 1.4 0.0 0.0 0.0 0.9 2.7 6.4 1.3 0.0 2.4 1.5 0.0 0.0 0.0 0.9 2.8 2.5 6.9 0.8 0.0 0.4 1.0 0.0 0.3 0.0 0.3 1.8 0.0 5.6 0.1 1.7 0.0 2.1 3.0 1.0 1.5 0.4 2.0 2.7 0.7 0.7 0.0 0.8 2.5 1.1 2.4 0.8 1.7 1.2 3.4 3.1 0.4 0.5 1.7 1.9 0.8 1.0 0.5 14.2 1.9 0.7 0.9 2.5 22.3 0.5 0.3 47.8 0.3 30.6 0.2 0.2 16.8 23.0 0.4 0.3 4.0 1.1 49.6 0.7 0.2 11.1 1.3 1.5 0.9 1.1 1.3 1.5 2.1 0.2 3.6 1.0 0.0 4.1 45.2 0.3 0.3 2.5 0.4 0.0 2.7 1.2 0.0 11.8 0.2 0.0 0.6 0.9 0.6 0.0 0.0 0.7 0.2 0.8 0.4 1.1 1.0 24.0 1.6 0.0 1.8 93.1 0.6 0.3 61.4 0.0 1.0 0.0 0.8 0.4 0.0 0.4 0.7 4.1 0.0 0.4 0.2 0.6 0.4 0.1 0.0 0.0 0.3 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660179 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 317.6;Early spermatids: 90.6;Enterocytes: 121.7;Paneth cells: 111.2" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 38.6;SK-BR-3: 41.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA020518, HPA024264" Enhanced Enhanced "Plasma membrane" No No "Plasma membrane" "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favorable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 4.1 1.0 14.5 2.3 30.3 1.0 0.9 1.5 13.3 1.2 11.2 7.5 1.0 16.2 1.2 0.7 14.5 3.6 2.0 0.5 11.1 4.2 30.3 0.6 3.4 0.6 22.8 2.3 0.8 0.9 1.1 3.1 46.0 20.0 2.3 10.2 0.6 9.0 1.0 0.6 2.5 31.7 1.0 27.9 0.6 12.2 4.3 23.4 0.0 1.0 2.7 8.2 5.5 1.1 4.5 1.5 3.5 1.5 2.1 1.9 0.8 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.1 8.5 0.2 0.2 0.1 0.6 0.1 2.2 1.3 0.1 0.2 0.0 38.6 1.4 1.7 0.0 0.4 41.8 0.0 0.3 4.4 0.3 0.0 0.1 0.3 0.8 0.1 1.4 0.1 0.1 0.0 0.1 0.1 3.5 1.5 1.0 1.7 1.3 1.5 4.5 1.5 1.4 1.0 2.5 1.6 1.9 2.5 2.1 1.4 1.5 1.0 0.8 14.5 30.3 1.5 13.3 11.1 4.2 22.8 2.3 20.0 23.4 0.0 20.5 0.0 1.3 2.5 0.4 0.8 7.6 22.7 6.8 317.6 0.0 14.0 69.6 0.7 90.6 0.7 121.7 0.0 0.2 3.7 1.3 4.5 38.2 0.0 76.4 0.0 8.7 0.0 0.6 64.0 0.3 3.1 10.1 2.8 36.1 0.5 5.2 111.2 1.1 1.8 2.5 0.0 0.0 3.9 5.4 5.6 55.0 0.0 13.5 7.1 SCML4 dJ47M23.1 ENSG00000146285 "Scm polycomb group protein like 4" Q8N228 6 107704104-107824317 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;lymphoid tissue: 24.6" "Group enriched" "Detected in many" 21 "Early spermatids: 71.9;Late spermatids: 104.1;T-cells: 35.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "gdT-cell: 19.5;MAIT T-cell: 18.0;memory CD4 T-cell: 27.3;memory CD8 T-cell: 24.3;naive CD4 T-cell: 26.9;naive CD8 T-cell: 23.9;NK-cell: 17.6" "Group enriched" "Detected in many" 5 "NK-cells: 17.6;T-cells: 27.3" "Cell line enriched" "Detected in some" 5 "HDLM-2: 37.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA063326, HPA065958" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA063326: AB_2684986, HPA065958: AB_2685587" "unprognostic (4.00e-5)" "unprognostic (2.10e-3)" "unprognostic (4.71e-2)" "unprognostic (4.24e-3)" "unprognostic (1.38e-3)" "unprognostic (4.75e-4)" "unprognostic (3.84e-3)" "unprognostic (6.65e-3)" "unprognostic (4.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.13e-4)" "unprognostic (3.68e-1)" "unprognostic (3.77e-4)" "unprognostic (8.65e-2)" "unprognostic (3.68e-2)" "unprognostic (2.52e-3)" "unprognostic (5.09e-3)" 1.3 0.6 0.5 13.9 0.6 2.7 1.4 0.3 0.5 1.2 5.4 0.3 0.3 10.1 0.9 4.9 1.3 1.2 2.4 0.6 1.7 0.9 1.7 2.7 3.2 24.6 0.4 0.0 0.7 1.4 0.0 3.9 0.3 0.5 1.2 2.1 1.6 5.7 0.0 0.3 0.9 12.4 0.4 0.9 11.5 2.4 10.4 0.2 23.9 1.5 1.3 24.5 2.3 1.3 4.5 0.3 3.6 0.1 17.6 27.3 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.4 0.0 2.1 19.5 0.0 18.0 4.5 27.3 24.3 0.0 3.5 26.9 23.9 3.6 17.6 0.1 0.3 2.6 9.4 0.5 0.6 0.3 0.5 1.7 0.9 0.4 0.0 0.5 0.2 0.0 0.0 0.9 0.0 1.3 0.0 0.8 0.0 1.4 0.0 0.0 0.0 1.0 0.0 0.6 71.9 0.3 1.0 0.0 0.0 0.0 0.6 0.0 1.1 1.7 0.2 1.6 0.0 1.3 0.0 104.1 0.9 0.8 3.3 1.0 1.6 0.0 0.1 0.3 0.7 0.0 0.0 0.0 1.0 1.1 0.5 0.1 0.1 35.9 2.9 0.0 SCN10A "hPN3, Nav1.8, PN3, SNS" ENSG00000185313 "Sodium voltage-gated channel alpha subunit 10" Q9Y5Y9 3 38696807-38816217 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 1.5;testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HUVEC TERT2: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.57e-2)" "unprognostic (7.85e-2)" "unprognostic (2.09e-4)" "unprognostic (1.42e-1)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCN11A "NaN, Nav1.9, SCN12A, SNS-2" ENSG00000168356 "Sodium voltage-gated channel alpha subunit 11" Q9UI33 3 38845769-38950561 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.5;placenta: 5.2" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 4.0;Early spermatids: 5.4;Sertoli cells: 6.5;Spermatocytes: 3.9;Spermatogonia: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;HDLM-2: 5.0;SCLC-21H: 1.1;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA036746, HPA036747" Uncertain NA NA "HPA036746: AB_10696785, HPA036747: AB_2675287" "unprognostic (6.11e-2)" "unprognostic (5.16e-1)" "unprognostic (1.66e-1)" "unprognostic (4.75e-2)" "unprognostic (4.21e-2)" "unprognostic (2.34e-2)" "unprognostic (2.79e-2)" "unprognostic (5.66e-2)" "unprognostic (4.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.30e-4)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (5.02e-2)" "unprognostic (2.95e-1)" "unprognostic (3.12e-2)" "unprognostic (8.30e-4)" 0.9 0.2 0.8 0.5 0.8 0.0 0.6 0.1 0.3 0.0 1.1 0.4 0.0 1.4 0.0 0.1 0.1 0.0 0.4 0.5 0.4 0.3 0.0 0.2 0.4 0.0 0.1 0.0 0.4 5.2 0.1 1.3 0.0 0.0 0.1 0.8 1.0 0.5 0.6 7.5 0.0 2.6 0.1 0.1 3.4 0.1 0.2 0.4 0.9 0.1 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.1 5.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.1 0.6 0.0 0.0 0.0 1.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.8 0.0 4.0 1.2 0.0 0.0 0.2 0.0 0.0 5.4 0.6 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.2 0.3 0.0 0.0 2.5 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.4 6.5 0.9 3.9 6.0 0.6 0.2 0.0 0.0 0.9 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 33.9" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 26.9;Bipolar cells: 33.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 11.6;Hep G2: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: AB_2686888" "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 1.1 1.3 5.2 1.1 13.6 1.0 1.1 10.3 26.6 1.1 1.1 2.3 0.0 1.0 1.1 1.1 1.0 6.8 1.0 1.1 6.9 8.3 1.1 1.1 5.6 1.0 5.7 9.7 1.0 1.0 1.1 2.9 1.2 33.9 1.1 1.1 0.3 1.0 1.0 1.2 1.1 1.1 1.1 3.6 1.1 1.1 1.4 4.2 0.0 1.1 0.0 1.0 1.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 11.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 5.2 13.6 10.3 26.6 6.9 8.3 5.7 9.7 33.9 4.2 6.0 26.9 0.0 0.0 0.0 33.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SCN1B ENSG00000105711 "Sodium voltage-gated channel beta subunit 1" Q07699 19 35030466-35040449 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 78.5;skeletal muscle: 161.9" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 35.4;Hofbauer cells: 24.6;Ito cells: 19.0;Kupffer cells: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.6;EFO-21: 10.1;TIME: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (8.18e-2)" "unprognostic (1.30e-1)" "unprognostic (1.30e-2)" "unprognostic (6.40e-2)" "unprognostic (1.17e-2)" "unprognostic (2.69e-2)" "unprognostic (4.40e-2)" "unprognostic (1.20e-1)" "unprognostic (3.34e-2)" "unprognostic (4.72e-3)" "prognostic favorable (1.38e-4)" "unprognostic (2.25e-1)" "unprognostic (2.05e-2)" "unprognostic (9.68e-3)" "unprognostic (5.81e-2)" "unprognostic (4.12e-2)" "unprognostic (4.78e-2)" 5.0 5.4 9.3 2.6 16.4 2.1 2.9 45.8 78.5 5.2 2.8 4.5 0.3 2.0 2.7 3.5 5.0 4.3 3.3 24.9 12.7 7.3 2.2 3.3 2.7 2.4 14.3 7.4 2.6 2.4 10.5 2.6 3.5 33.6 2.7 2.4 3.5 2.5 2.9 161.9 2.1 2.5 3.2 7.0 6.7 2.7 2.0 3.0 0.0 2.4 16.1 1.6 3.9 1.5 1.3 1.5 7.0 0.8 1.7 1.7 1.8 0.3 13.6 0.1 0.8 4.2 6.5 0.2 5.5 4.9 2.7 0.7 0.5 0.1 0.2 10.1 5.6 2.5 0.2 0.8 0.6 1.3 0.1 0.7 0.2 1.9 3.4 5.6 0.1 0.1 2.1 0.1 0.3 0.2 5.4 9.1 0.2 0.3 0.1 1.7 1.3 0.2 0.1 0.7 1.2 4.0 0.7 1.4 0.1 0.4 0.1 6.5 3.5 0.7 0.1 1.0 0.5 1.3 0.4 20.4 5.4 5.4 0.2 3.5 0.3 0.4 0.8 3.1 0.6 3.8 7.0 0.8 0.9 1.1 0.4 1.7 0.6 0.6 0.4 1.5 1.3 0.5 0.7 3.1 1.7 0.4 1.1 0.7 1.8 9.3 16.4 45.8 78.5 12.7 7.3 14.3 7.4 33.6 3.0 0.0 3.5 0.0 0.8 1.5 35.4 15.5 0.0 1.4 0.0 0.0 2.0 0.3 8.3 0.3 0.3 5.7 0.0 0.0 2.3 0.6 4.1 1.0 2.3 1.0 24.6 7.9 0.0 19.0 17.1 0.0 6.9 2.9 3.3 4.6 1.1 12.6 1.0 0.0 2.1 1.1 15.5 0.0 2.3 0.3 0.4 1.0 0.8 0.0 0.9 0.1 SCN2A "HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2" ENSG00000136531 "Sodium voltage-gated channel alpha subunit 2" Q99250 2 165194993-165392310 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.0" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 48.0;Cone photoreceptor cells: 45.2;Horizontal cells: 14.3" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 3.4;SH-SY5Y: 3.1;U-138 MG: 5.8;U-266/84: 12.0;U-87 MG: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022567 Enhanced NA NA "CAB022567: " "unprognostic (1.16e-1)" "unprognostic (3.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.97e-1)" "unprognostic (8.62e-3)" "unprognostic (1.18e-1)" "unprognostic (7.25e-3)" "unprognostic (1.40e-1)" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (4.88e-2)" "unprognostic (2.14e-1)" 1.3 3.0 19.1 1.3 36.4 1.1 2.2 68.0 50.3 1.5 1.3 1.1 0.0 1.5 1.9 2.6 1.2 1.3 2.3 1.3 30.3 8.2 4.0 1.4 1.5 1.2 3.8 23.5 1.5 1.3 1.1 8.2 1.3 9.9 1.3 1.3 0.0 1.5 1.8 1.1 1.2 1.5 2.0 3.7 1.3 1.5 1.5 4.1 0.0 1.1 0.0 1.2 1.3 0.5 1.4 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.8 0.0 0.0 2.8 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.5 0.1 1.0 0.7 0.0 0.4 0.0 0.4 0.0 0.2 3.4 0.1 0.3 0.0 2.4 0.0 0.0 0.0 0.3 1.5 0.0 0.2 0.0 2.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 2.9 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 5.8 0.4 0.3 0.0 0.5 12.0 0.0 3.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.1 36.4 68.0 43.7 30.3 8.2 3.8 23.5 9.9 4.1 0.0 1.7 0.0 0.1 0.2 48.0 0.6 0.0 0.0 0.0 10.4 45.2 0.1 5.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.0 3.7 0.5 0.0 5.6 0.0 3.4 0.0 0.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 SCN2B ENSG00000149575 "Sodium voltage-gated channel beta subunit 2" O60939 11 118161951-118176673 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;heart muscle: 17.5;skeletal muscle: 9.7" "Group enriched" "Detected in some" 5 "Bipolar cells: 7.9;Cardiomyocytes: 14.0;Horizontal cells: 12.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.1" "Group enriched" "Detected in some" 5 "HBEC3-KT: 1.5;U-2 OS: 2.6;U-2197: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (9.01e-2)" "unprognostic (3.50e-2)" "unprognostic (7.58e-2)" "unprognostic (2.12e-2)" "unprognostic (1.41e-2)" "unprognostic (4.02e-1)" "unprognostic (2.71e-4)" "unprognostic (5.17e-2)" "unprognostic (8.59e-2)" "unprognostic (2.77e-1)" "unprognostic (7.89e-2)" "unprognostic (1.61e-2)" "unprognostic (3.51e-2)" "unprognostic (1.27e-2)" "unprognostic (4.35e-2)" "unprognostic (4.55e-1)" "unprognostic (2.88e-3)" 1.8 3.0 14.7 1.4 31.5 1.0 1.9 31.1 37.0 2.9 2.0 3.1 0.0 1.7 3.2 2.9 3.6 2.9 2.7 17.5 22.5 11.6 1.6 1.0 2.5 1.0 8.7 30.6 2.8 1.1 1.0 0.8 1.0 12.8 2.4 1.9 0.4 1.8 2.7 9.7 1.4 2.5 3.5 13.9 1.1 1.3 1.3 6.9 0.0 1.9 0.7 1.0 1.5 0.6 0.3 0.2 2.1 0.3 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 1.5 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.1 2.6 6.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 2.1 0.3 0.9 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.2 0.2 1.3 0.2 0.0 0.2 0.1 0.0 14.7 31.5 31.1 37.0 22.5 11.6 8.7 30.6 12.8 6.9 0.0 0.0 0.0 0.5 0.3 7.9 14.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.1 0.0 1.4 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 SCN3A Nav1.3 ENSG00000153253 "Sodium voltage-gated channel alpha subunit 3" Q9NY46 2 165087522-165204067 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 13.6;brain: 28.5;pituitary gland: 13.7" "Cell type enriched" "Detected in some" 4 "Early spermatids: 55.3" "Cancer enriched" "Detected in some" 6 "glioma: 3.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "memory B-cell: 8.4;naive B-cell: 13.6" "Lineage enriched" "Detected in single" 38 "B-cells: 13.6" "Cell line enhanced" "Detected in some" "JURKAT: 4.9;Karpas-707: 8.7;MOLT-4: 24.4;RPTEC TERT1: 12.3;SH-SY5Y: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035396 Approved NA NA "HPA035396: AB_2674607" "unprognostic (1.80e-3)" "unprognostic (1.84e-2)" "unprognostic (1.20e-3)" "unprognostic (1.50e-2)" "unprognostic (6.69e-2)" "unprognostic (1.10e-2)" "unprognostic (4.96e-4)" "unprognostic (2.46e-1)" "unprognostic (1.48e-1)" "unprognostic (1.90e-1)" "unprognostic (1.21e-4)" "unprognostic (4.55e-2)" "unprognostic (5.87e-3)" "unprognostic (2.88e-2)" "unprognostic (6.85e-2)" "unprognostic (2.66e-1)" "unprognostic (4.93e-2)" 2.6 4.0 16.7 1.9 28.5 1.0 2.5 19.6 19.7 2.1 2.1 0.8 0.0 1.2 1.4 0.7 1.5 1.4 1.8 2.1 9.8 11.3 1.8 1.0 1.0 2.7 4.8 9.8 1.8 1.7 2.3 13.7 0.8 9.1 0.9 2.1 0.0 0.7 1.4 0.9 0.5 1.9 1.7 4.0 1.8 2.7 1.8 4.9 2.0 1.3 0.0 3.5 1.7 0.5 13.6 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.2 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 0.0 4.9 0.0 8.7 0.1 0.0 24.4 0.0 0.0 0.1 2.0 0.1 1.1 0.0 12.3 0.0 3.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.7 0.0 1.3 0.4 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 13.6 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.1 16.7 28.5 19.6 17.2 9.8 11.3 4.8 9.8 9.1 4.9 0.0 0.3 1.9 0.1 0.0 0.8 3.2 0.0 0.0 0.0 1.8 11.8 0.0 0.0 0.1 55.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 8.5 0.0 0.0 5.4 0.3 0.0 1.7 0.0 0.0 0.6 0.2 0.0 0.7 0.0 0.7 12.9 5.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 SCN3B HSA243396 ENSG00000166257 "Sodium voltage-gated channel beta subunit 3" Q9NY72 11 123629187-123655244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 70.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 15.3;Early spermatids: 12.8;Horizontal cells: 19.1;Late spermatids: 24.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTCEpi: 9.6;RH-30: 4.3;SCLC-21H: 9.5;SH-SY5Y: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041707 Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA041707: AB_2732493" "unprognostic (1.41e-1)" "unprognostic (8.72e-2)" "unprognostic (8.13e-4)" "unprognostic (3.93e-3)" "unprognostic (7.05e-2)" "unprognostic (3.29e-3)" "unprognostic (5.64e-2)" "unprognostic (3.34e-4)" "unprognostic (1.72e-1)" "unprognostic (1.13e-2)" "unprognostic (9.16e-4)" "unprognostic (4.01e-1)" "unprognostic (1.89e-4)" "unprognostic (2.01e-2)" "unprognostic (9.01e-2)" "unprognostic (8.23e-2)" "unprognostic (1.43e-2)" 2.2 8.5 17.7 1.5 23.5 1.3 2.0 2.8 70.3 1.6 1.5 1.2 0.0 1.6 1.5 1.5 1.5 1.8 1.4 1.9 26.2 13.2 1.6 1.0 1.4 1.2 5.2 18.8 1.7 1.9 3.9 12.6 1.1 3.8 1.8 1.6 3.7 1.2 1.4 5.8 1.7 1.5 2.1 1.5 1.3 1.4 2.2 1.2 0.0 3.7 0.0 1.2 1.1 0.4 1.2 1.3 2.7 0.6 1.1 0.8 0.1 0.0 0.2 0.3 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.0 3.0 0.1 0.3 1.5 0.4 3.1 0.2 1.0 0.1 0.2 0.1 0.6 0.0 0.5 0.3 0.1 0.0 0.6 0.4 9.6 0.1 0.1 0.0 0.3 0.3 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.3 0.1 0.2 4.3 0.0 0.0 0.2 9.5 7.2 0.6 0.1 0.0 1.0 0.1 0.0 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.6 0.6 0.5 0.6 0.4 0.4 0.7 0.7 0.7 0.3 1.2 0.5 0.8 2.7 1.1 0.5 1.3 0.4 0.1 17.7 23.5 2.8 39.5 26.2 13.2 5.2 18.8 3.8 1.2 0.0 0.3 0.0 0.8 5.0 15.3 1.4 0.0 0.0 0.0 1.8 5.9 0.1 0.0 0.3 12.8 8.7 0.0 0.0 0.9 0.1 1.1 1.0 0.0 0.0 0.2 19.1 4.1 0.6 0.0 24.3 0.0 0.5 0.0 0.0 0.0 8.3 0.4 0.0 0.4 0.1 5.9 6.5 0.7 0.3 1.5 4.8 0.0 0.0 0.0 0.4 SCN4A "HYKPP, HYPP, Nav1.4, SkM1" ENSG00000007314 "Sodium voltage-gated channel alpha subunit 4" P35499 17 63938554-63972918 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skeletal muscle: 53.7" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 3.4;Ito cells: 3.1;Late spermatids: 2.9" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.2" "Cell type enhanced" "Detected in single" "naive B-cell: 1.9" "Lineage enhanced" "Detected in single" "B-cells: 1.9" "Group enriched" "Detected in some" 11 "REH: 10.1;RH-30: 31.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA053992 Approved "Nucleoplasm,Centriolar satellite" NA NA Nucleoplasm "Centriolar satellite" "HPA053992: AB_2797249" "unprognostic (2.47e-1)" "unprognostic (1.74e-1)" "unprognostic (1.57e-2)" "unprognostic (1.78e-3)" "unprognostic (2.80e-2)" "unprognostic (1.63e-2)" "unprognostic (3.87e-4)" "unprognostic (3.84e-3)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (1.59e-3)" "unprognostic (3.15e-2)" "unprognostic (2.70e-2)" "unprognostic (4.38e-3)" "unprognostic (3.46e-1)" "unprognostic (4.15e-1)" "unprognostic (6.45e-2)" 5.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.5 0.0 53.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 10.1 31.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.1 0.0 0.0 0.0 0.0 SCN4B LQT10 ENSG00000177098 "Sodium voltage-gated channel beta subunit 4" Q8IWT1 11 118133377-118152888 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;skeletal muscle: 25.6" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.9;HBEC3-KT: 3.0;NTERA-2: 4.4;SH-SY5Y: 1.7;U-2 OS: 4.0" "Region enriched" "Detected in many" 11 "basal ganglia: 731.2" "Region enhanced" "Detected in many" "basal ganglia: 122.8" HPA017293 Approved NA NA "HPA017293: AB_2184174" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.45e-1)" "unprognostic (1.07e-1)" "unprognostic (9.82e-3)" "unprognostic (9.17e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-2)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-3)" "unprognostic (1.53e-1)" "unprognostic (5.31e-4)" 20.5 5.4 1.9 1.2 36.4 0.1 6.1 11.7 21.7 2.4 2.6 2.0 0.5 2.4 3.7 1.8 5.4 5.5 3.2 11.0 3.1 2.9 1.4 0.6 8.7 2.0 5.3 2.1 0.7 5.0 6.4 2.4 1.9 28.7 2.1 2.2 4.3 2.8 2.6 25.6 3.8 4.6 7.0 5.5 0.5 3.0 0.8 8.7 1.5 10.4 9.5 1.1 3.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.6 0.3 3.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 36.4 11.7 21.7 3.1 2.9 5.3 2.1 28.7 8.7 0.0 0.0 0.0 0.3 1.1 1.1 2.8 0.0 6.7 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 3.3 2.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.3 45.3 10.8 0.0 0.6 1.0 0.0 0.0 0.0 0.1 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 66.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 22.0;RH-30: 18.3" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.4 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.9 0.9 2.7 0.0 0.4 0.0 1.2 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 1.7 3.6 0.4 0.0 0.0 22.0 1.1 0.0 0.0 2.0 0.0 0.0 0.0 18.3 0.0 0.0 2.4 0.3 2.4 0.0 0.0 0.0 0.7 0.0 0.0 4.4 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 3.1 66.1 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.3 0.9 0.0 0.0 0.0 0.0 1.0 SCN7A "NaG, Nav2.1, Nav2.2, SCN6A" ENSG00000136546 "Sodium voltage-gated channel alpha subunit 7" Q01118 2 166403573-166494326 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 51.9" "Group enriched" "Detected in many" 8 "Leydig cells: 93.5;Peritubular cells: 150.3;Sertoli cells: 148.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 2.1" "Lineage enhanced" "Detected in single" "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "MOLT-4: 2.9;SH-SY5Y: 1.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA072715 Approved NA NA "HPA072715: " "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (9.72e-2)" "unprognostic (7.43e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-1)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (5.21e-2)" "unprognostic (6.84e-3)" "unprognostic (6.88e-2)" "unprognostic (1.27e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-2)" "unprognostic (1.47e-2)" "unprognostic (1.35e-1)" "unprognostic (1.22e-4)" 4.9 6.0 1.0 10.4 0.7 0.0 2.9 0.3 0.7 16.2 23.3 0.0 13.0 2.0 24.6 8.1 28.1 7.8 6.8 16.0 0.7 3.6 1.8 1.3 51.9 1.6 3.6 0.5 33.3 3.1 0.3 1.1 8.1 2.6 18.4 6.1 14.0 4.9 11.3 3.7 1.5 6.2 10.5 4.3 5.5 6.4 6.9 0.1 0.5 1.3 4.9 0.2 9.7 7.6 0.0 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.5 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.0 0.7 0.3 0.7 0.7 3.6 3.6 0.5 2.6 0.1 0.0 1.4 0.0 0.1 0.2 11.4 15.4 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 2.0 0.7 0.0 0.0 0.0 0.0 11.0 0.1 16.1 0.0 0.2 0.0 0.0 16.0 0.0 1.6 93.5 0.0 5.0 0.0 0.0 5.2 0.2 0.0 150.3 0.3 1.6 148.8 0.9 0.5 0.1 1.0 0.0 0.0 0.0 0.3 SCN8A "CerIII, CIAT, MED, NaCh6, Nav1.6, PN4" ENSG00000196876 "Sodium voltage-gated channel alpha subunit 8" Q9UQD0 12 51590266-51812864 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 27.6;pituitary gland: 9.7" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022169, HPA043937, HPA073590" Approved "Vesicles,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Vesicles, Cell Junctions" "CAB022169: , HPA043937: , HPA073590: " "unprognostic (2.96e-2)" "unprognostic (8.49e-2)" "unprognostic (6.93e-2)" "unprognostic (3.52e-6)" "unprognostic (8.13e-2)" "unprognostic (1.51e-2)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (5.44e-2)" "unprognostic (1.16e-1)" "unprognostic (4.73e-4)" "unprognostic (1.69e-2)" "unprognostic (1.29e-5)" "unprognostic (4.38e-1)" "unprognostic (1.56e-1)" "unprognostic (2.37e-1)" "unprognostic (4.75e-2)" 1.1 3.0 9.1 1.5 18.1 1.9 1.9 16.7 27.6 1.0 2.0 1.6 0.0 1.1 1.5 2.0 0.9 1.1 2.5 0.9 12.6 4.5 1.9 4.3 1.0 1.3 3.2 13.7 1.8 3.2 1.5 9.7 0.9 14.8 1.8 2.5 0.9 1.7 1.2 1.0 1.1 1.2 1.0 2.2 1.7 2.7 3.8 1.6 0.0 1.7 0.0 1.2 1.0 0.6 0.4 0.2 0.0 0.0 0.0 1.0 0.0 1.4 1.0 12.0 0.1 1.6 12.7 0.2 6.8 11.2 7.9 7.3 2.0 1.4 0.3 1.6 8.9 3.5 0.0 1.9 0.0 9.3 1.2 0.6 0.1 0.1 0.2 0.1 0.2 0.9 1.7 0.0 5.2 1.1 3.1 8.4 2.8 0.1 0.1 4.9 0.8 2.0 0.1 4.1 0.7 3.8 0.0 0.6 0.0 0.0 0.4 4.8 2.0 3.5 1.8 0.2 1.8 0.3 0.1 2.2 7.7 5.1 2.8 4.3 0.1 0.1 0.0 1.5 1.6 11.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 1.0 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 9.1 18.1 16.7 25.0 12.6 4.5 3.2 13.7 14.8 1.6 0.0 0.0 0.0 0.4 0.0 13.7 1.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.2 0.0 3.4 0.0 4.8 10.9 1.3 0.0 0.2 0.0 0.0 0.0 0.0 1.3 5.3 0.5 0.0 0.7 0.5 10.5 0.0 0.3 1.9 10.0 0.0 0.0 0.0 0.6 0.1 SCNN1A "ENaCalpha, SCNN1" ENSG00000111319 "Sodium channel epithelial 1 alpha subunit" P37088 12 6346843-6377730 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 100.4" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 108.2;Mucus-secreting cells: 167.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 8 "pons and medulla: 9.4" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3" "Group enriched" "Detected in many" 5 "dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 71.8;HBEC3-KT: 48.2;hTCEpi: 20.7;RPTEC TERT1: 25.2;RT4: 27.0;SK-BR-3: 23.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA012743 Enhanced NA NA "HPA012743: AB_1856627" "unprognostic (1.68e-1)" "unprognostic (4.16e-2)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (5.16e-2)" "unprognostic (6.77e-3)" "unprognostic (3.09e-2)" "unprognostic (2.62e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.86e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (5.56e-2)" "prognostic favorable (9.21e-8)" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" 0.9 3.7 0.4 7.5 0.4 0.0 10.1 0.4 0.9 22.0 20.6 2.2 60.9 5.6 8.1 15.7 47.3 19.3 7.0 0.4 1.1 0.1 100.4 2.2 53.6 0.4 0.5 0.4 5.9 14.2 0.0 10.2 1.6 9.4 15.0 21.5 6.2 53.1 55.5 0.6 14.4 11.8 1.0 0.4 0.4 20.3 2.8 0.4 0.9 74.7 21.1 41.3 10.3 13.8 0.0 3.0 4.4 0.5 0.0 1.7 0.3 5.0 0.9 0.0 0.4 0.0 0.1 4.3 0.0 0.0 0.0 0.0 1.4 71.8 0.0 0.1 0.0 0.0 3.3 0.0 48.2 0.0 0.0 0.0 0.0 4.0 0.7 5.2 0.0 0.0 1.2 20.7 0.0 15.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 4.2 9.1 0.1 0.0 0.0 0.1 25.2 27.0 0.3 0.0 0.5 23.3 0.0 4.3 5.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.0 0.0 0.2 0.6 0.5 0.0 1.7 0.3 4.4 0.0 0.1 3.0 1.3 0.3 0.4 0.4 0.4 0.9 1.1 0.1 0.5 0.4 9.4 0.4 68.5 63.0 0.0 21.9 1.6 0.8 0.8 68.8 26.8 47.8 108.2 3.9 1.2 5.0 41.1 0.4 1.4 57.4 0.0 30.8 0.2 2.4 31.3 2.3 2.4 0.3 1.6 26.0 0.6 1.9 0.2 1.7 2.1 0.0 1.8 167.5 0.3 24.0 47.5 1.4 4.2 1.6 0.0 1.0 1.4 2.1 7.8 1.4 1.9 31.6 33.3 SCNN1B ENaCbeta ENSG00000168447 "Sodium channel epithelial 1 beta subunit" P51168 16 23278231-23381299 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 92.3;Club cells: 66.0;Collecting duct cells: 54.1;Enterocytes: 54.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 26.4" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 19.4;RT4: 10.4;U-266/70: 32.0;U-266/84: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015612 Uncertain NA NA "HPA015612: AB_1856629" "unprognostic (7.45e-2)" "unprognostic (1.76e-3)" "unprognostic (1.39e-1)" "unprognostic (6.74e-3)" "unprognostic (1.74e-2)" "unprognostic (5.11e-3)" "unprognostic (7.74e-2)" "unprognostic (5.49e-3)" "unprognostic (2.60e-1)" "unprognostic (2.40e-1)" "unprognostic (3.68e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.32e-1)" "unprognostic (4.66e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-2)" 35.1 0.2 0.1 4.0 0.2 0.0 21.2 1.1 0.1 28.3 27.2 0.0 1.3 1.3 2.9 2.5 42.4 1.3 3.3 0.6 0.0 0.0 13.0 0.0 31.1 1.3 0.0 0.0 2.0 0.8 0.3 1.6 25.2 0.3 5.7 19.7 0.5 29.7 2.4 3.9 13.2 1.7 4.2 0.1 1.9 8.9 1.6 0.0 0.6 16.2 17.8 15.5 5.6 19.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.9 0.0 10.4 0.1 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 92.3 27.0 2.2 14.0 2.7 0.0 0.8 0.0 10.7 66.0 54.1 0.0 0.7 0.0 0.0 0.0 0.7 54.8 0.0 0.4 0.2 0.2 4.3 8.1 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 10.1 0.0 7.9 0.0 0.2 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 4.6 1.8 0.0 7.6 17.0 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 gamma subunit" P51170 16 23182715-23216883 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.9;salivary gland: 26.8" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enriched" "Detected in some" 6 "cerebellum: 9.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Group enriched" "Detected in some" 7 "hTCEpi: 31.4;RT4: 14.2" "Region enriched" "Detected in single" 13 "cerebellum: 2.8" "Low region specificity" "Detected in all" HPA071194 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071194: AB_2686359" "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 1.1 0.3 0.6 0.2 0.0 0.4 2.5 9.7 0.4 14.0 5.5 0.0 4.8 0.2 3.2 1.7 10.3 0.5 0.2 0.2 1.5 0.0 42.9 0.2 15.6 0.2 0.0 0.3 0.2 3.8 0.2 6.5 0.7 0.7 10.2 1.1 0.0 26.8 12.8 2.2 6.6 0.2 0.3 0.3 0.2 6.9 0.3 0.0 1.5 25.5 3.3 3.9 1.7 11.3 0.3 0.3 1.8 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 14.2 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 1.8 0.2 0.1 0.3 0.1 0.0 0.6 0.0 9.7 0.4 1.5 0.0 0.0 0.3 0.7 0.0 17.9 3.4 0.0 4.0 0.3 0.0 0.8 0.0 2.7 21.6 85.5 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 SCO2 ENSG00000284194 "SCO2, cytochrome c oxidase assembly protein" 22 50523568-50526439 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 17.6;bone marrow: 13.0" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 107.9;Paneth cells: 129.8;Suprabasal keratinocytes: 86.4" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 13.6" "HPA046943, HPA056254" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046943: AB_2732536, HPA056254: AB_2683080" 2.4 1.1 0.7 6.3 0.6 13.0 6.7 0.6 1.2 1.5 2.3 0.0 1.1 0.6 0.6 0.7 4.6 0.8 2.4 4.3 0.1 2.8 4.2 3.7 9.3 0.4 0.0 1.2 0.8 0.0 0.0 0.9 0.6 1.6 0.5 0.1 4.2 0.2 0.7 1.8 3.5 1.6 1.7 5.7 1.9 0.4 0.6 10.6 1.0 1.4 2.6 1.6 0.7 10.3 17.6 10.4 12.6 4.0 10.3 10.7 4.0 2.8 0.1 2.6 0.0 0.5 2.3 2.8 1.9 2.5 1.9 0.4 3.8 7.0 2.0 0.9 1.4 2.5 1.0 0.0 0.0 1.3 10.7 3.6 0.7 0.4 4.9 9.4 2.9 3.3 1.2 1.3 0.5 0.8 0.5 0.0 4.5 9.5 1.4 1.5 1.1 9.9 1.4 0.2 4.1 6.5 0.8 13.6 1.8 1.1 0.6 2.4 1.2 0.4 9.6 0.3 1.4 7.3 3.2 1.7 3.7 2.9 2.4 8.1 2.5 9.7 4.0 2.1 1.7 8.4 12.6 8.7 7.2 7.3 8.7 10.3 9.4 7.8 17.6 8.9 6.9 5.5 10.4 4.0 6.8 12.6 10.3 10.7 3.0 2.4 30.9 16.7 76.1 6.2 14.5 22.9 1.4 2.3 0.0 2.0 0.0 0.0 0.0 13.8 19.1 107.9 0.0 0.0 0.0 13.8 24.3 16.1 48.9 0.0 11.1 24.8 19.0 25.2 16.0 15.3 20.8 40.5 0.0 50.5 4.2 0.1 129.8 10.3 0.0 6.9 0.0 21.5 12.0 26.6 86.4 0.0 15.0 77.7 19.3 SCP2 ENSG00000116171 "Sterol carrier protein 2" P22307 1 52927229-53051703 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 168.3" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 1150.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027101, HPA027135, HPA027317" Supported Supported Nucleoplasm,Peroxisomes NA NA 370000 Peroxisomes Nucleoplasm "HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422" "unprognostic (7.51e-2)" "unprognostic (5.23e-2)" "prognostic favorable (7.05e-5)" "unprognostic (9.68e-2)" "unprognostic (1.53e-2)" "unprognostic (5.53e-2)" "unprognostic (1.87e-3)" "unprognostic (1.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.59e-1)" "unprognostic (4.53e-2)" "unprognostic (6.16e-2)" "prognostic favorable (7.85e-8)" "unprognostic (1.49e-2)" "unprognostic (1.09e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-2)" 29.1 26.2 21.8 19.9 21.2 14.0 30.3 12.0 19.7 24.4 51.9 15.9 28.1 49.2 19.0 28.8 32.2 18.1 32.1 29.3 20.0 20.0 54.2 168.3 21.8 14.0 25.6 17.8 22.8 24.6 16.7 24.1 17.1 21.9 25.5 40.5 18.9 21.8 23.3 22.0 18.8 80.1 20.6 27.1 20.9 33.9 16.7 19.4 23.0 28.2 28.6 17.6 22.3 20.5 36.4 57.1 67.8 50.7 40.8 49.2 61.2 25.6 14.1 19.0 34.8 62.4 53.4 20.6 30.6 45.9 20.1 29.2 12.6 27.8 24.4 33.1 44.8 23.5 18.0 13.0 28.6 30.8 35.5 18.9 26.2 20.3 25.9 41.6 37.7 44.2 43.3 39.0 23.8 11.9 44.1 56.9 28.9 23.3 12.7 40.6 14.8 42.0 32.8 20.8 65.1 27.7 22.0 33.5 33.3 55.8 43.6 15.7 19.0 26.7 54.2 25.6 44.1 27.7 43.2 44.0 27.4 14.2 47.7 24.4 21.3 27.0 28.5 35.5 37.5 25.3 55.4 48.7 67.8 49.2 50.7 39.9 36.4 39.2 48.6 57.1 29.8 33.2 47.1 7.5 40.8 46.8 37.1 47.1 61.2 21.8 21.2 12.0 19.7 20.0 20.0 25.6 17.8 21.9 19.4 125.0 163.3 99.5 107.7 133.6 35.0 136.8 201.2 147.2 103.5 176.2 29.5 158.8 401.3 140.3 42.8 125.8 592.0 70.0 143.6 134.4 129.4 170.2 138.2 1150.9 181.7 39.7 225.9 115.4 211.6 39.0 170.6 166.5 182.2 152.3 388.8 98.9 131.8 498.1 161.5 617.2 27.0 77.6 119.7 10.6 19.8 149.3 112.0 172.0 297.8 155.6 SCP2D1 "C20orf79, dJ1068E13.2, HSD22" ENSG00000132631 "SCP2 sterol binding domain containing 1" Q9UJQ7 20 18813726-18814392 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 82 "testis: 30.5" "Group enriched" "Detected in some" 158 "Early spermatids: 915.6;Late spermatids: 727.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 915.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 727.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.9 2.8 0.0 0.0 0.0 0.0 0.0 SCPEP1 RISC ENSG00000121064 "Serine carboxypeptidase 1" Q9HB40 17 56978105-57006768 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 113.9" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 200.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 60.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 80.9;U-266/70: 53.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039102, HPA057200" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA "Golgi apparatus" "HPA039102: AB_10673605, HPA057200: AB_2683365" "unprognostic (5.83e-3)" "unprognostic (7.43e-3)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (9.26e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.00e-3)" "unprognostic (1.68e-1)" "unprognostic (1.70e-1)" "unprognostic (3.56e-3)" "unprognostic (1.40e-1)" "unprognostic (3.25e-1)" "unprognostic (7.28e-2)" "unprognostic (8.89e-2)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" 29.5 54.1 14.7 12.6 10.2 17.8 25.8 8.8 14.8 21.5 17.6 12.8 50.1 8.8 17.5 24.1 25.9 14.6 20.7 25.0 10.2 11.8 24.8 8.7 25.6 24.5 12.2 14.3 19.9 9.4 113.9 13.6 7.6 14.2 24.6 9.5 13.4 31.5 37.6 6.4 17.8 15.9 23.2 13.9 22.3 20.8 7.7 10.8 2.4 62.7 14.1 25.3 24.7 20.8 14.1 23.4 60.8 44.8 4.6 3.0 20.3 9.7 6.0 9.3 8.6 80.9 18.1 5.2 4.7 23.7 8.3 16.6 2.8 6.2 13.2 27.6 11.2 14.4 9.5 4.4 21.2 8.8 17.7 7.7 3.9 6.0 1.6 18.5 8.1 40.3 21.9 9.1 10.7 8.3 7.7 13.8 5.0 1.1 47.3 11.9 4.2 3.6 20.2 4.2 3.0 8.7 5.1 11.4 8.5 1.8 30.2 2.9 7.2 11.9 9.0 7.0 11.2 4.0 20.7 7.4 25.2 6.7 14.8 5.3 53.4 39.1 7.2 17.6 5.8 6.9 0.3 44.8 60.8 3.0 27.1 1.9 12.9 2.1 1.9 23.4 14.1 2.9 2.9 7.3 4.6 25.3 4.5 2.5 20.3 14.7 10.2 8.8 14.8 10.2 11.8 12.2 14.3 14.2 10.8 41.7 48.6 36.6 158.5 21.1 14.6 27.4 12.7 200.8 135.4 90.7 15.7 8.4 16.6 13.6 0.9 22.1 2.6 23.3 6.1 13.6 64.4 62.4 8.1 19.2 144.9 9.5 23.4 64.4 136.9 1.1 59.5 105.4 23.6 80.2 3.1 27.2 6.2 1.5 64.0 24.5 16.3 51.8 42.2 3.2 7.9 17.3 9.3 20.8 3.5 121.2 SCRG1 SCRG-1 ENSG00000164106 "Stimulator of chondrogenesis 1" O75711 4 173384701-173406380 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.4" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 148.4" "Cancer enriched" "Detected in many" 6 "glioma: 35.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 13 "HSkMC: 6.8;WM-115: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012882 Approved "Secreted in brain" NA NA "HPA012882: AB_1856635" "unprognostic (1.09e-1)" "unprognostic (1.83e-2)" "unprognostic (2.60e-5)" "unprognostic (2.58e-1)" "unprognostic (3.22e-2)" "unprognostic (7.51e-2)" "unprognostic (3.58e-2)" "unprognostic (1.14e-3)" "unprognostic (2.08e-1)" "unprognostic (2.25e-2)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (3.95e-10)" "unprognostic (4.86e-2)" "unprognostic (2.21e-1)" "unprognostic (4.34e-3)" "unprognostic (8.74e-4)" 5.8 3.1 19.2 2.6 18.6 2.2 2.3 6.0 30.6 2.1 2.9 15.9 4.0 2.5 2.5 7.7 2.3 2.1 5.1 3.6 19.9 12.0 1.5 1.4 1.5 1.5 24.9 12.9 1.6 1.8 1.2 1.1 1.6 20.5 6.4 2.7 0.0 3.4 11.6 1.9 2.0 2.0 15.6 33.4 2.4 2.8 16.3 22.5 0.0 1.5 0.3 1.3 4.1 1.0 1.4 1.3 4.4 1.8 1.6 1.0 0.4 0.1 0.0 0.9 0.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.8 0.2 0.2 6.8 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.1 19.8 3.9 1.8 1.2 0.8 1.2 0.6 0.8 0.6 0.7 0.7 1.4 0.8 1.0 4.4 1.6 1.3 1.3 0.5 0.4 19.2 18.6 6.0 16.7 19.9 12.0 24.9 12.9 20.5 22.5 0.0 4.0 0.5 1.0 3.2 11.8 0.8 0.0 1.4 1.2 0.0 35.3 0.2 0.0 0.2 14.9 2.0 0.0 0.0 0.0 0.2 5.2 1.4 9.2 0.0 0.5 15.9 1.2 6.2 3.1 21.8 24.2 1.6 21.9 0.0 0.0 148.4 0.1 0.0 19.4 0.0 30.2 12.9 10.9 1.9 2.2 2.3 0.6 3.9 0.2 0.7 SCRN1 KIAA0193 ENSG00000136193 "Secernin 1" Q12765 7 29920103-29990289 "Enzymes, Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.8" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 65.2;Muller glia cells: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024517 Enhanced Approved Cytosol No No 110000 Cytosol "HPA024517: AB_2184811" "prognostic unfavorable (8.32e-4)" "prognostic unfavorable (8.46e-4)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.00e-5)" "unprognostic (1.87e-2)" "unprognostic (2.43e-1)" "unprognostic (1.13e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (1.09e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.15e-5)" "unprognostic (2.57e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (2.60e-4)" 6.8 14.8 32.0 6.3 31.5 3.6 7.6 62.8 55.4 12.4 8.1 23.2 4.5 3.4 13.3 8.8 10.0 13.9 8.5 9.8 26.6 30.7 12.8 1.5 8.3 6.7 42.7 26.6 17.5 18.5 42.9 12.1 8.0 26.3 15.0 5.6 7.8 8.4 20.2 1.0 5.7 5.0 17.7 42.9 5.2 7.1 11.4 23.3 8.2 7.1 1.5 10.6 9.4 5.8 10.4 7.8 6.9 16.7 4.8 8.1 2.2 21.8 15.8 25.8 10.4 18.3 28.2 0.1 20.4 27.4 22.2 24.0 18.2 17.4 2.7 18.2 26.1 49.4 9.9 29.3 8.7 32.5 0.1 6.1 9.0 10.6 11.7 23.4 0.0 0.1 23.5 12.6 20.1 10.8 30.3 20.4 5.9 0.1 7.1 31.2 12.3 3.1 0.0 23.5 0.0 17.0 0.0 27.5 0.2 15.5 10.8 9.4 22.4 21.1 13.7 23.6 33.9 18.5 1.4 22.5 28.9 24.9 0.3 25.8 2.3 35.4 0.2 13.6 0.1 69.6 2.2 2.3 6.9 0.6 10.2 8.1 10.4 0.1 0.8 7.7 5.0 0.6 1.0 0.4 4.8 16.7 7.8 0.0 2.2 32.0 31.5 62.8 43.1 26.6 30.7 42.7 26.6 26.3 23.3 26.8 13.1 8.2 9.7 2.7 63.5 12.6 20.4 21.4 22.7 31.4 43.2 0.3 13.3 18.8 49.3 5.8 0.0 0.0 21.5 1.6 7.7 14.1 8.1 0.5 4.8 65.2 11.6 2.5 10.0 48.7 12.7 10.6 6.8 4.6 0.9 76.1 21.8 17.3 19.8 1.8 39.0 6.5 8.5 2.3 12.3 1.5 0.8 4.3 1.0 17.0 SCRT1 "DKFZp547F072, ZNF898" ENSG00000261678 "Scratch family transcriptional repressor 1" Q9BWW7 8 144330565-144336281 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 20.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 39.7;Early spermatids: 39.5;Horizontal cells: 33.4" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045265 Uncertain Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA045265: AB_10959521" "unprognostic (7.70e-2)" "unprognostic (7.97e-2)" "unprognostic (6.96e-3)" "unprognostic (6.88e-4)" "unprognostic (2.43e-2)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (1.97e-1)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.83e-4)" "unprognostic (5.02e-2)" "unprognostic (7.05e-2)" "unprognostic (2.78e-1)" "unprognostic (2.35e-1)" "unprognostic (2.66e-3)" "unprognostic (1.04e-1)" 0.3 2.3 2.1 0.3 6.6 0.3 0.3 5.7 20.3 0.3 0.3 0.0 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 2.2 0.3 0.3 0.3 0.3 0.0 3.8 0.4 0.7 0.3 0.0 0.3 4.2 0.3 0.3 0.0 0.3 0.3 0.5 0.3 0.3 0.3 0.4 0.3 0.3 1.2 2.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 1.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 SCRT2 ZNF898B ENSG00000215397 "Scratch family transcriptional repressor 2" Q9NQ03 20 661596-676179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.9;retina: 6.1" "Cell type enriched" "Detected in some" 51 "Horizontal cells: 57.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.0" "Group enriched" "Detected in many" 4 "cerebellum: 8.8;cerebral cortex: 17.9" "Cell type enriched" "Detected in single" 25 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 25 "granulocytes: 2.4" "Group enriched" "Detected in some" 5 "Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA067697 Approved Nucleoplasm NA NA Nucleoplasm "HPA067697: AB_2685890" "unprognostic (9.71e-2)" "unprognostic (2.03e-1)" "unprognostic (6.97e-2)" "unprognostic (9.70e-2)" "unprognostic (1.70e-1)" 0.3 0.3 0.7 0.3 0.7 0.3 0.3 8.8 17.9 0.3 0.3 0.6 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.6 0.3 0.3 0.3 0.3 1.9 0.0 0.3 1.3 0.3 0.0 0.4 3.2 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.6 0.3 0.7 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 3.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 8.8 17.9 0.7 0.6 1.9 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCT ENSG00000070031 Secretin P09683 11 626431-627143 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 39.8;intestine: 52.3" "Cell type enriched" "Detected in some" 44 "Intestinal endocrine cells: 257.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 152 "plasmacytoid DC: 39.8" "Lineage enriched" "Detected in single" 152 "dendritic cells: 39.8" "Cell line enhanced" "Detected in some" "A549: 2.3;HSkMC: 5.5;U-266/70: 2.9" "Low region specificity" "Detected in many" HPA050961 Enhanced "Secreted to blood" NA NA 571000 "HPA050961: AB_2681291" "unprognostic (5.28e-2)" "unprognostic (6.18e-2)" "prognostic unfavorable (3.70e-4)" "unprognostic (2.72e-1)" "unprognostic (7.91e-2)" "unprognostic (1.73e-1)" "unprognostic (2.43e-3)" "unprognostic (4.19e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-2)" "unprognostic (1.88e-1)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (8.37e-2)" "unprognostic (5.45e-1)" "unprognostic (6.09e-2)" "unprognostic (1.13e-1)" 0.2 0.1 0.2 0.4 0.3 0.5 0.2 0.5 0.4 0.2 52.3 0.3 0.2 30.4 0.3 0.5 0.2 0.1 0.2 2.3 0.3 0.4 0.4 0.4 3.1 1.1 0.3 0.2 0.3 0.2 0.0 2.6 0.5 0.4 1.0 0.1 3.6 1.4 0.2 11.5 0.1 10.5 0.2 0.5 3.9 0.7 3.5 0.2 0.2 0.6 1.6 0.7 0.4 0.2 0.0 39.8 0.0 0.0 0.2 0.0 0.1 0.4 2.3 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.9 0.6 0.6 0.2 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.7 0.0 0.5 0.0 0.7 0.0 0.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.0 0.2 0.1 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.7 0.6 0.2 0.2 0.0 0.0 0.6 1.0 0.0 0.4 2.9 1.0 0.3 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 39.8 0.0 0.1 0.2 0.3 0.5 0.4 0.3 0.4 0.3 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 3.5 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.2 0.0 257.8 0.6 0.0 0.6 1.4 0.0 0.0 0.0 3.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.2 0.4 1.6 0.1 0.0 0.0 1.2 0.1 SCTR ENSG00000080293 "Secretin receptor" P47872 2 119439843-119525301 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 13.5;pancreas: 35.3" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 64.4;Ductal cells: 72.3;Exocrine glandular cells: 84.2;Pancreatic endocrine cells: 51.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.3" "Cell type enhanced" "Detected in some" "basophil: 3.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.8" "Cell line enriched" "Detected in some" 5 "Karpas-707: 8.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "midbrain: 1.2;pons and medulla: 1.3;thalamus: 1.5" HPA007269 Uncertain NA NA "HPA007269: AB_1856640" "unprognostic (1.51e-1)" "unprognostic (2.22e-1)" "unprognostic (4.99e-2)" "unprognostic (5.82e-2)" "unprognostic (1.71e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (1.09e-1)" "unprognostic (1.68e-2)" "unprognostic (9.08e-2)" "unprognostic (7.35e-2)" "unprognostic (2.38e-2)" "unprognostic (6.11e-3)" "unprognostic (1.65e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (4.38e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.2 4.1 0.0 0.0 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.2 0.2 0.0 0.0 0.0 0.5 0.1 3.8 0.3 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 8.2 0.7 0.5 0.1 0.0 0.9 0.3 0.0 0.1 0.0 1.5 0.3 0.5 0.0 0.3 0.0 0.3 0.0 0.3 0.0 1.1 0.0 0.0 0.4 0.6 0.0 0.9 0.3 0.1 0.0 0.0 0.1 3.8 0.3 0.9 0.3 0.2 0.4 0.3 0.3 0.0 0.0 0.5 0.3 0.2 1.2 0.3 0.3 0.1 0.4 0.0 0.0 64.4 0.0 0.2 0.0 0.0 3.1 0.0 0.0 3.4 5.2 0.0 0.0 10.0 72.3 0.4 0.0 0.0 0.0 84.2 0.0 0.0 0.0 2.3 0.0 0.5 4.8 2.4 0.0 0.0 1.1 0.0 0.0 0.0 2.8 0.0 0.2 51.5 0.0 0.0 0.2 1.1 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 SCUBE1 ENSG00000159307 "Signal peptide, CUB domain and EGF like domain containing 1" Q8IWY4 22 43197283-43343388 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 35.8;retina: 48.1" "Cell type enriched" "Detected in many" 5 "Peritubular cells: 42.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.4" "Group enriched" "Detected in some" 4 "HMC-1: 32.9;THP-1: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003190 Approved "Secreted to blood" NA NA 2170000 130000 "HPA003190: AB_1079882" "unprognostic (5.29e-2)" "unprognostic (7.15e-6)" "unprognostic (6.03e-3)" "unprognostic (8.33e-2)" "unprognostic (3.65e-1)" "unprognostic (4.55e-2)" "unprognostic (1.34e-1)" "unprognostic (5.76e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-2)" "unprognostic (1.02e-2)" "unprognostic (2.70e-1)" "unprognostic (2.30e-1)" "unprognostic (6.87e-3)" 3.3 5.3 0.4 1.1 2.0 0.1 3.5 0.3 2.3 1.3 5.5 0.9 1.3 5.9 1.3 0.7 14.8 1.2 0.8 1.0 0.5 0.7 3.4 4.6 7.5 0.1 3.4 1.9 35.8 0.4 0.3 3.8 3.5 1.9 6.4 2.0 48.1 5.3 0.5 8.0 0.6 7.6 1.0 3.5 6.9 7.3 8.5 0.1 0.0 3.1 0.5 0.1 4.2 6.3 0.3 0.3 2.4 0.3 0.5 0.3 0.1 0.0 0.0 1.4 5.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.1 32.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.2 0.0 13.0 0.0 0.2 0.1 0.4 0.0 1.4 2.5 0.0 0.3 0.0 0.1 2.4 0.2 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.1 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.2 0.1 0.4 2.0 0.3 2.3 0.5 0.7 3.4 1.9 1.9 0.1 8.9 1.7 0.0 0.0 0.2 0.0 1.1 0.0 1.4 1.2 0.0 0.0 0.1 1.7 0.0 2.3 0.6 0.0 0.0 0.0 8.9 0.9 0.0 1.1 1.1 0.7 0.0 0.0 0.6 0.0 2.6 7.2 0.0 0.0 0.0 0.0 5.2 0.1 0.0 42.8 0.1 0.2 0.0 0.0 3.0 1.5 0.1 0.3 0.0 0.0 0.0 SCUBE3 "CEGF3, FLJ34743" ENSG00000146197 "Signal peptide, CUB domain and EGF like domain containing 3" Q8IX30 6 35214419-35253079 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.0" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Intestinal endocrine cells: 10.4;Rod photoreceptor cells: 6.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.6;ASC diff: 32.4;ASC TERT1: 43.5;HSkMC: 20.3;hTEC/SVTERT24-B: 12.4;U-138 MG: 12.1;WM-115: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040606 Uncertain Approved "Plasma membrane" "Secreted to blood" NA NA 1890000 110000 "Plasma membrane" "HPA040606: AB_10795383" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (2.22e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (2.00e-2)" "unprognostic (7.41e-2)" "unprognostic (1.57e-1)" "unprognostic (2.64e-2)" "unprognostic (4.83e-8)" "unprognostic (1.54e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.06e-3)" 1.6 2.6 0.5 1.1 0.4 0.2 0.3 0.3 0.7 1.6 3.3 0.0 2.8 0.2 1.3 7.0 1.5 0.7 0.7 6.4 0.3 0.5 2.3 0.2 1.3 0.2 0.4 0.6 0.9 0.2 0.3 1.6 0.9 0.6 7.0 1.1 6.8 1.1 5.3 0.8 0.7 0.8 13.8 0.6 0.3 1.2 1.7 0.0 0.0 38.0 0.3 0.3 11.4 2.5 1.1 1.6 2.5 0.7 1.1 1.1 0.1 0.0 0.0 10.6 0.1 32.4 43.5 0.1 2.6 1.3 0.0 0.0 0.2 0.0 0.0 0.4 6.2 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.3 0.0 12.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.3 0.7 4.4 0.2 0.0 0.6 12.1 0.5 0.0 0.1 0.0 0.0 0.0 1.9 0.0 10.2 1.4 0.7 1.3 1.1 0.5 0.3 0.8 0.7 0.3 0.1 1.1 0.8 0.8 2.5 1.1 0.5 1.6 0.8 0.1 0.5 0.4 0.3 0.7 0.3 0.5 0.4 0.6 0.6 0.0 0.0 1.1 0.0 0.2 0.0 2.5 3.3 0.0 1.4 3.4 1.8 2.0 0.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 1.0 0.1 1.1 0.0 0.3 9.5 10.4 0.0 1.2 2.2 0.9 0.0 1.7 0.0 0.0 2.0 0.1 0.0 3.5 0.0 6.1 0.0 4.7 0.2 1.9 0.0 0.6 0.0 0.0 0.1 SCX "bHLHa41, bHLHa48, SCXA, SCXB" ENSG00000260428 "Scleraxis bHLH transcription factor" Q7RTU7 8 144266560-144268481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "skeletal muscle: 18.8;thyroid gland: 33.2" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 15.8;Horizontal cells: 15.9;Muller glia cells: 8.1;Spermatogonia: 10.7" "Group enriched" "Detected in all" 6 "endometrial cancer: 12.8;ovarian cancer: 34.4;thyroid cancer: 37.7" "Cell type enriched" "Detected in single" 6 "memory B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Cell line enhanced" "Detected in many" "BEWO: 8.0;HaCaT: 8.6" "Region enhanced" "Detected in some" "cerebellum: 12.0" "Region enriched" "Detected in single" 4 "cerebellum: 4.7" HPA043183 Uncertain NA NA "HPA043183: AB_2678357" "unprognostic (5.32e-2)" "unprognostic (1.06e-2)" "unprognostic (7.37e-3)" "unprognostic (1.87e-3)" "prognostic unfavorable (2.86e-4)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-2)" "unprognostic (6.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (1.23e-1)" "unprognostic (7.89e-3)" 0.5 1.1 0.4 1.3 0.0 0.8 0.0 3.0 0.9 4.8 2.8 0.0 0.0 1.4 2.2 4.5 1.7 0.2 3.7 5.5 0.0 0.4 0.1 0.4 0.7 0.0 0.0 0.9 2.8 2.7 2.3 0.3 10.3 1.8 0.3 4.2 3.3 0.5 18.8 1.6 1.8 0.9 0.0 1.3 2.3 4.7 0.0 7.6 33.2 4.5 0.5 1.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.8 0.2 0.9 0.0 0.1 8.0 0.2 0.1 0.2 0.1 0.3 2.4 2.3 2.4 0.4 0.5 8.6 0.0 0.0 0.0 1.2 1.5 0.5 2.8 0.4 0.3 0.2 3.7 0.1 0.9 0.1 0.4 1.2 0.0 0.5 0.4 1.0 0.2 5.1 0.9 1.8 2.0 0.7 3.8 2.8 0.4 1.4 0.2 3.5 0.3 1.5 0.9 3.2 3.4 0.2 4.0 1.6 0.5 0.7 6.0 2.8 0.5 2.6 0.8 0.5 1.5 3.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 1.1 0.0 15.8 4.8 2.5 0.0 2.3 3.5 0.0 1.1 1.7 0.6 0.2 0.5 0.4 0.0 1.2 0.5 0.3 1.8 0.0 0.2 0.4 15.9 2.4 0.6 0.6 0.0 0.3 0.0 0.0 0.0 3.1 8.1 1.0 2.5 0.7 0.0 1.6 0.0 1.1 1.2 10.7 0.0 0.9 0.0 1.6 0.9 SDC1 "CD138, SDC, SYND1, syndecan" ENSG00000115884 "Syndecan 1" P18827 2 20200797-20225433 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 113.2;placenta: 228.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 17 "memory B-cell: 3.9" "Lineage enriched" "Detected in single" 40 "B-cells: 3.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2" "Group enriched" "Detected in some" 4 "cerebellum: 10.7;olfactory region: 5.9" "Not detected" "Not detected" "CAB002424, HPA006185, HPA067477" Enhanced Approved "Focal adhesion sites" "Secreted to blood" NA NA 63100000 1600000 "Focal adhesion sites" "CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: " "prognostic unfavorable (2.22e-4)" "unprognostic (6.80e-3)" "unprognostic (6.80e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (4.02e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (3.66e-1)" "unprognostic (2.27e-3)" "unprognostic (1.79e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (4.27e-1)" "unprognostic (1.62e-2)" "unprognostic (1.52e-1)" 0.8 3.4 0.5 5.4 0.6 0.0 4.5 0.8 0.7 21.4 18.3 0.5 3.5 14.3 2.3 8.7 103.7 1.6 55.3 0.3 0.4 0.5 68.5 113.2 15.8 6.3 1.9 0.4 1.6 7.0 0.6 0.6 228.8 0.7 13.3 6.2 1.5 16.0 5.2 0.5 69.5 21.9 4.3 0.4 3.7 16.3 2.6 0.4 1.5 3.5 62.3 48.4 30.0 37.7 3.9 0.0 0.0 0.0 0.0 0.0 0.5 31.4 17.6 5.6 14.0 1.5 0.2 17.7 8.8 8.5 8.2 7.0 3.7 19.2 0.0 3.2 6.2 4.5 31.1 2.4 62.1 5.5 0.1 1.6 0.0 1.6 18.8 1.3 1.3 0.1 0.8 57.5 7.4 17.6 11.5 0.9 0.0 0.7 12.3 4.4 18.8 0.0 0.3 5.0 24.0 34.2 0.6 2.0 23.8 10.6 47.2 1.6 13.1 6.6 44.8 2.0 2.3 4.4 0.3 1.3 32.7 10.5 1.2 59.2 61.4 129.2 0.1 9.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.8 0.7 0.4 0.5 1.9 0.4 0.7 0.4 86.4 91.4 3.0 135.6 101.2 0.1 0.8 298.1 2.7 63.7 40.1 0.0 2.4 26.6 54.9 0.0 1.1 102.7 23.3 19.0 43.0 9.7 42.4 5.8 520.4 2.2 20.6 10.4 6.7 9.6 0.0 0.6 5.4 20.3 1.0 72.0 0.0 67.3 73.7 1.1 68.3 0.0 0.0 7.1 0.7 12.8 200.1 209.7 4.4 66.5 356.0 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493351-96611780 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.1;thyroid gland: 111.2" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 194.4;Hepatocytes: 184.9;Smooth muscle cells: 188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.9" "Cell line enhanced" "Detected in many" "AF22: 102.6;EFO-21: 48.2;fHDF/TERT166: 44.4;RPTEC TERT1: 53.6;U-138 MG: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB025123: , HPA044416: AB_2678934" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 43.2 9.9 13.9 9.1 16.9 2.5 17.0 12.7 8.4 43.4 18.7 7.3 21.2 5.8 21.9 15.3 13.3 21.0 15.0 19.1 12.0 12.6 23.9 115.1 14.4 4.4 9.7 9.3 45.9 16.8 1.6 24.0 31.3 10.7 25.9 10.7 51.4 6.3 28.1 9.4 6.5 9.6 34.3 9.5 7.5 11.9 8.7 9.3 0.5 111.2 13.8 3.5 35.9 26.3 0.0 1.3 13.9 1.9 0.0 0.2 0.5 0.0 0.0 102.6 0.0 37.1 34.7 0.1 14.8 17.6 8.6 9.6 3.0 0.0 0.0 48.2 44.4 1.2 0.0 17.7 0.2 7.4 0.0 6.9 0.0 9.9 37.7 1.2 0.2 0.4 13.3 0.4 19.5 0.5 33.3 0.3 0.0 9.7 0.0 3.6 0.8 0.0 2.5 10.8 0.0 0.1 0.1 16.1 0.3 53.6 8.7 3.0 8.0 0.0 0.0 0.7 35.9 4.4 11.4 8.0 49.7 15.2 0.2 8.2 0.9 0.0 0.1 15.8 0.0 15.5 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.9 0.0 0.1 0.0 0.0 0.5 13.9 16.9 12.7 8.4 12.0 12.6 9.7 9.3 10.7 9.3 53.6 30.2 4.7 67.2 47.9 22.0 25.8 33.1 5.3 3.4 54.1 11.8 1.8 24.9 11.7 25.6 10.2 0.1 23.3 13.2 2.0 194.4 44.9 1.1 184.9 114.7 4.8 3.4 20.3 22.0 14.5 48.6 87.0 59.1 118.2 0.5 18.4 12.7 0.0 98.6 44.8 10.2 32.3 188.5 3.2 57.1 34.4 3.2 3.2 1.2 14.5 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.1" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 450.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 75.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 15.9 26.2 19.9 15.7 24.3 3.5 40.5 6.9 20.1 20.4 24.8 19.2 9.0 13.3 17.6 14.7 42.4 27.4 26.2 19.5 19.8 12.1 56.6 141.1 56.7 4.8 23.5 20.5 14.7 36.6 6.2 12.5 23.0 30.9 19.5 22.3 21.8 47.6 17.5 25.5 45.5 13.8 38.7 23.0 9.0 46.9 33.7 15.7 2.0 26.5 25.2 23.5 34.4 16.4 0.7 2.8 2.0 3.1 1.4 8.1 1.2 23.0 3.0 1.6 0.1 41.2 25.4 71.1 29.5 40.3 33.5 24.0 35.1 58.9 0.0 13.2 37.1 33.8 30.0 1.2 75.0 40.8 6.6 1.1 0.7 2.4 13.7 44.9 0.1 1.2 34.1 50.4 13.8 33.8 18.6 4.4 0.5 1.1 0.0 19.2 22.9 0.0 2.0 3.0 20.1 9.3 0.0 14.9 0.0 55.0 30.8 0.6 2.3 40.6 25.2 7.2 19.6 18.2 1.4 8.2 25.6 21.3 2.5 19.0 1.2 0.9 0.1 40.2 2.3 15.2 2.0 3.1 0.7 1.3 1.1 4.1 0.6 4.1 1.6 2.8 0.7 0.9 1.1 1.6 1.4 1.1 2.5 8.1 1.2 19.9 24.3 6.9 20.1 19.8 12.1 23.5 20.5 30.9 15.7 271.0 364.7 7.8 299.2 332.0 10.3 49.5 201.2 113.8 195.7 179.7 11.8 27.4 54.7 239.6 0.5 9.0 87.8 0.0 450.4 202.4 50.9 254.2 12.8 232.3 18.5 0.0 52.9 14.7 15.1 2.9 3.7 36.5 72.6 56.9 103.4 8.5 443.3 93.4 4.9 128.2 23.3 0.0 42.6 0.9 2.8 413.3 56.3 18.8 79.5 364.0 SDCBP2 "SITAC18, ST-2" ENSG00000125775 "Syndecan binding protein 2" Q9H190 20 1309909-1329239 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 104.7" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 454.6;Pancreatic endocrine cells: 472.7;Paneth cells: 448.9;Urothelial cells: 654.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.2;OE19: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005804, HPA064490" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA005804: , HPA064490: AB_2732713" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (2.37e-1)" "unprognostic (5.85e-2)" "unprognostic (2.54e-1)" "unprognostic (2.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (1.01e-1)" "unprognostic (3.78e-3)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.17e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.37e-4)" 1.7 0.4 5.2 10.6 6.7 0.2 1.5 1.5 4.9 6.6 59.4 1.2 0.9 46.1 1.5 9.1 32.4 0.9 35.1 1.3 3.5 3.6 2.5 3.8 3.7 0.9 2.8 1.0 1.2 4.4 0.2 1.4 1.9 1.4 3.7 19.0 1.0 6.4 1.9 1.1 13.4 104.7 2.5 1.1 1.1 34.0 1.5 1.6 1.0 4.0 12.5 24.3 17.0 9.8 1.2 2.6 4.4 2.0 2.1 5.3 1.8 6.3 0.3 0.9 0.3 3.7 3.3 0.6 1.9 3.9 1.8 1.7 1.3 11.2 0.7 1.3 0.7 1.2 5.0 0.3 9.3 0.9 0.2 0.6 0.5 0.4 0.9 3.7 0.6 0.7 1.1 6.6 1.4 1.4 3.8 6.1 1.2 0.9 0.5 0.7 1.5 1.0 1.8 0.9 33.8 0.4 1.0 0.4 1.2 0.7 8.7 1.5 1.2 1.0 5.7 2.1 0.4 0.3 0.5 4.1 0.9 0.4 1.8 0.7 1.7 1.6 0.6 0.4 2.5 0.5 0.4 2.0 4.4 2.4 0.7 1.8 0.6 3.2 2.5 2.6 1.2 2.7 4.7 2.2 2.1 1.3 1.7 5.3 1.8 5.2 6.7 1.5 4.9 3.5 3.6 2.8 1.0 1.4 1.6 14.9 6.2 5.0 56.0 49.5 0.7 0.7 81.5 4.0 6.8 15.7 0.0 1.3 23.2 94.6 12.4 13.0 454.6 0.0 187.2 0.8 4.4 102.5 9.2 4.9 0.9 1.6 34.4 4.9 1.6 1.1 1.4 2.2 8.5 3.6 127.5 1.0 472.7 448.9 0.0 1.3 1.0 0.0 4.2 1.7 6.6 83.6 1.4 2.5 60.5 654.3 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-256700 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 100.1;skeletal muscle: 114.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria No No 780000 Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavorable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favorable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 17.6 31.4 15.3 11.5 20.3 10.6 12.8 18.8 29.0 10.2 29.4 17.3 10.0 44.3 11.3 12.1 15.3 12.6 14.8 100.1 15.8 14.5 36.5 55.4 10.7 11.7 19.6 19.3 14.5 14.7 23.2 9.5 9.2 29.7 10.7 24.6 14.5 17.3 12.0 114.0 11.5 39.9 16.5 13.2 13.9 21.2 14.6 14.8 15.7 12.5 39.6 12.5 13.2 11.1 28.3 31.9 29.1 29.2 27.1 48.9 32.4 18.7 30.4 12.5 20.4 21.6 16.2 34.0 14.5 18.4 25.0 25.5 32.9 25.6 23.2 45.8 16.5 18.9 24.3 22.1 29.6 14.8 49.4 20.2 11.8 84.1 42.8 13.4 14.7 15.4 16.1 19.0 18.6 9.9 19.9 27.0 16.6 19.0 19.3 11.7 28.7 19.4 39.7 4.3 20.5 38.6 25.1 18.2 45.0 53.1 24.9 13.8 7.9 68.2 44.1 17.9 8.1 26.7 18.6 19.5 18.5 18.2 11.0 11.9 20.6 8.8 17.1 17.9 21.2 11.7 17.8 24.4 29.1 36.4 29.2 32.1 28.3 34.8 35.1 31.9 24.5 34.5 31.7 5.9 27.1 24.1 20.5 48.9 32.4 15.3 20.3 18.8 29.0 15.8 14.5 19.6 19.3 29.7 14.8 32.8 63.8 52.9 58.0 54.4 45.7 238.2 76.5 58.9 40.9 71.5 96.2 94.1 121.0 78.8 32.8 37.6 207.8 0.0 39.4 87.2 53.2 29.4 42.7 135.6 60.4 95.3 45.6 43.0 39.1 20.2 63.3 43.9 86.0 78.5 75.8 40.3 44.9 92.8 52.3 129.8 77.8 77.6 45.0 66.5 55.1 31.5 129.4 59.9 128.8 78.3 SDK2 "FLJ10832, KIAA1514" ENSG00000069188 "Sidekick cell adhesion molecule 2" Q58EX2 17 73334384-73644089 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 13.6" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 14.2;Horizontal cells: 19.1;Intestinal endocrine cells: 14.3;Late spermatids: 15.3;Spermatocytes: 12.4;Syncytiotrophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.7;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 2.7;dendritic cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 14.7;BEWO: 12.1;RPMI-8226: 4.8;SuSa: 8.1;U-2 OS: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014725 Approved Nucleoplasm NA NA 2000000 Nucleoplasm "HPA014725: AB_2183303" "unprognostic (7.22e-4)" "unprognostic (5.57e-2)" "unprognostic (1.70e-1)" "unprognostic (7.00e-3)" "unprognostic (1.62e-2)" "unprognostic (3.18e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.98e-1)" "unprognostic (1.49e-1)" "unprognostic (8.80e-4)" "unprognostic (7.69e-2)" "unprognostic (3.89e-2)" "unprognostic (1.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.37e-2)" "unprognostic (6.64e-2)" 0.4 0.6 2.1 5.3 1.2 0.7 2.6 0.5 2.7 8.9 0.5 0.6 0.0 0.0 3.1 5.1 0.9 3.5 1.4 3.5 1.7 4.1 1.1 0.5 4.2 4.8 1.6 0.0 0.8 0.4 0.0 1.9 3.7 1.9 2.6 0.3 2.2 2.0 1.4 0.4 0.5 0.5 0.3 3.0 3.6 0.6 13.6 0.0 0.1 1.8 1.1 2.9 0.7 7.2 2.7 2.3 0.0 0.0 0.2 0.5 0.0 0.0 2.1 14.7 4.2 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 3.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 1.9 0.0 0.0 0.5 0.0 4.8 0.0 0.0 3.3 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 4.4 1.8 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 2.7 0.5 0.4 0.0 0.2 0.0 2.3 0.0 0.0 2.1 1.2 0.5 2.5 1.7 4.1 1.6 0.0 1.9 0.0 0.0 2.4 4.5 3.7 0.8 3.5 2.0 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.2 10.9 0.3 0.0 0.0 0.2 14.2 1.9 2.3 1.1 0.0 0.6 19.1 14.3 0.0 0.0 15.3 0.6 0.0 1.7 1.8 0.2 7.8 0.0 0.0 0.0 0.0 0.6 0.0 0.9 12.4 3.5 0.1 14.9 0.0 0.0 0.3 SDR16C5 "EPHD-2, RDH-E2, RDHE2" ENSG00000170786 "Short chain dehydrogenase/reductase family 16C member 5" Q8N3Y7 8 56300010-56320776 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "memory B-cell: 9.1;naive B-cell: 2.5" "Lineage enriched" "Detected in single" 56 "B-cells: 9.1" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025224 Enhanced NA NA "HPA025224: AB_1856163" "unprognostic (1.66e-1)" "unprognostic (8.88e-2)" "unprognostic (9.46e-2)" "unprognostic (4.18e-4)" "unprognostic (8.83e-3)" "prognostic favorable (7.88e-4)" "unprognostic (1.66e-1)" "unprognostic (2.51e-1)" "unprognostic (2.42e-1)" "unprognostic (1.78e-3)" "unprognostic (2.39e-1)" "unprognostic (2.48e-5)" "unprognostic (2.55e-1)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" 0.3 0.2 2.0 2.0 1.9 0.0 7.4 0.9 6.2 8.1 5.9 0.2 0.0 1.7 0.2 0.0 27.5 0.2 1.5 0.2 0.6 1.2 0.2 0.2 34.0 0.3 1.4 2.9 0.2 0.3 0.0 0.5 0.0 10.6 0.3 3.0 0.2 9.2 0.0 0.3 35.9 16.9 0.2 0.4 0.2 12.9 0.5 0.2 0.0 0.2 25.8 21.1 1.0 11.5 9.1 0.0 0.0 0.0 0.0 0.1 0.1 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 9.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 21.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 1.9 0.9 6.2 0.6 1.2 1.4 2.9 10.6 0.2 44.7 125.1 0.0 5.5 45.3 0.2 0.1 10.2 48.2 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 0.0 1.2 0.0 1.5 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 3.3 1.0 7.1 9.9 58.7 3.2 0.0 0.0 1.4 0.0 0.3 0.2 4.1 63.1 0.0 0.0 4.5 19.5 SDR42E2 ENSG00000183921 "Short chain dehydrogenase/reductase family 42E, member 2" A6NKP2 16 22165583-22191754 "Predicted membrane proteins" Oxidoreductase "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 6.0;fallopian tube: 5.0;testis: 3.3" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 22.2;Erythroid cells: 23.3;Muller glia cells: 18.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 6.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.0" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.03e-3)" "unprognostic (2.80e-1)" "unprognostic (2.06e-1)" "unprognostic (1.72e-4)" "unprognostic (1.85e-1)" "unprognostic (7.07e-2)" "unprognostic (8.77e-2)" "unprognostic (3.72e-1)" "unprognostic (4.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.32e-3)" "unprognostic (2.01e-1)" "unprognostic (7.09e-2)" "unprognostic (4.76e-2)" "unprognostic (8.78e-2)" "unprognostic (1.09e-1)" "unprognostic (6.61e-2)" 0.1 0.1 1.0 0.2 2.1 0.1 0.0 0.0 1.1 0.5 0.0 0.6 0.1 0.1 0.0 5.0 0.2 0.0 1.7 2.4 0.2 0.0 0.4 0.3 0.0 0.3 0.5 0.1 2.2 0.2 0.2 0.1 0.2 0.0 1.5 0.6 0.2 0.0 0.3 0.5 0.1 3.3 0.1 0.0 0.1 0.0 0.8 0.3 6.0 0.8 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.3 0.3 0.4 0.5 0.3 0.4 0.1 0.8 0.3 0.4 6.0 0.3 0.1 0.3 0.3 0.2 0.0 3.7 11.9 0.2 0.7 7.7 1.6 5.1 2.7 0.0 0.0 0.0 0.7 0.0 0.6 1.6 2.1 22.2 23.3 0.4 0.2 1.1 0.9 2.3 3.2 2.1 4.8 2.4 3.7 11.0 1.1 5.5 3.1 1.7 8.2 9.0 18.4 0.2 3.5 1.4 0.2 3.6 0.0 1.0 0.6 0.1 1.5 1.1 8.6 4.7 0.3 SDR9C7 "RDHS, SDR-O" ENSG00000170426 "Short chain dehydrogenase/reductase family 9C member 7" Q8NEX9 12 56923154-56934405 "Disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 31.4;tongue: 27.8" "Cell type enhanced" "Detected in single" 38 "Suprabasal keratinocytes: 3.4" "Group enriched" "Detected in some" 6 "cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hTCEpi: 1.1;SK-BR-3: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.75e-2)" "unprognostic (1.42e-1)" "unprognostic (7.90e-5)" "unprognostic (7.93e-2)" "unprognostic (4.20e-3)" "unprognostic (1.26e-1)" "unprognostic (4.74e-2)" "unprognostic (9.31e-2)" "unprognostic (3.78e-2)" "unprognostic (3.08e-1)" "unprognostic (2.46e-1)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (3.27e-1)" "unprognostic (1.74e-3)" 0.1 0.0 0.1 0.1 0.4 0.0 2.4 0.2 0.1 9.6 0.1 0.1 0.1 0.0 0.7 0.1 8.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.7 0.1 0.0 0.1 2.0 0.1 0.5 31.4 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.6 0.1 27.8 9.9 0.1 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 SDS SDH ENSG00000135094 "Serine dehydratase" P20132 12 113392445-113426301 "Enzymes, Plasma proteins, Predicted intracellular proteins" Gluconeogenesis Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 276.9" "Group enriched" "Detected in many" 4 "Hepatocytes: 317.5;Hofbauer cells: 211.0;monocytes: 169.5" "Cancer enriched" "Detected in all" 31 "liver cancer: 165.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "myeloid DC: 12.8" "Lineage enriched" "Detected in single" 15 "dendritic cells: 12.8" "Cell line enhanced" "Detected in some" "HMC-1: 5.5;SK-BR-3: 3.4" "Low region specificity" "Detected in single" HPA039230 Uncertain Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "HPA039230: AB_10674281" "unprognostic (1.31e-1)" "prognostic favorable (5.24e-4)" "unprognostic (6.37e-3)" "unprognostic (6.94e-2)" "unprognostic (9.19e-3)" "unprognostic (2.65e-2)" "unprognostic (2.35e-2)" "unprognostic (8.85e-2)" "unprognostic (1.79e-1)" "unprognostic (2.55e-1)" "unprognostic (4.89e-2)" "unprognostic (3.20e-1)" "unprognostic (4.08e-3)" "unprognostic (2.12e-1)" "unprognostic (2.07e-2)" "unprognostic (4.35e-1)" "unprognostic (2.99e-2)" 0.9 0.9 2.2 1.4 5.9 0.5 0.4 0.6 2.1 0.5 0.9 0.8 0.0 0.7 0.4 0.2 0.2 0.2 1.4 0.2 1.7 2.5 0.2 276.9 0.6 0.6 4.2 0.7 0.3 0.4 0.1 0.0 1.0 2.8 0.3 0.8 1.3 0.3 0.2 0.2 0.2 0.7 0.3 1.3 0.5 0.9 0.3 0.8 0.1 0.3 0.0 0.3 0.8 0.0 0.0 12.8 0.6 0.8 0.2 0.0 0.3 0.0 0.4 0.2 1.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.2 0.4 2.3 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.5 1.3 0.6 0.6 0.1 0.8 5.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.6 0.0 1.4 0.1 0.4 0.8 0.0 0.9 0.0 0.8 0.1 0.2 0.6 0.1 0.1 1.6 3.4 0.7 0.1 1.2 1.7 0.6 0.0 0.9 1.1 0.3 0.7 0.4 0.2 1.1 0.8 0.3 0.1 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.6 0.2 0.1 1.3 0.0 0.3 2.2 5.9 0.6 1.6 1.7 2.5 4.2 0.7 2.8 0.8 0.0 1.1 21.2 0.2 2.2 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.7 0.0 2.1 0.0 0.3 0.0 23.3 0.3 0.7 0.8 0.2 0.0 317.5 211.0 0.0 0.0 10.4 27.7 0.0 0.0 55.6 1.7 169.5 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 2.8 2.1 3.3 0.0 0.0 SDSL "cSDH, SDS-RS1" ENSG00000139410 "Serine dehydratase like" Q96GA7 12 113422237-113438276 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 53.2" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 118.4;Hofbauer cells: 93.1;monocytes: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 6.5;intermediate monocyte: 7.1;myeloid DC: 13.2;plasmacytoid DC: 12.8" "Group enriched" "Detected in many" 8 "dendritic cells: 13.2;monocytes: 7.1" "Cell line enhanced" "Detected in many" "HMC-1: 22.6;MCF7: 38.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005740 Approved Approved Cytosol NA NA Cytosol "HPA005740: AB_10601486" "unprognostic (1.34e-1)" "unprognostic (8.33e-2)" "unprognostic (3.62e-2)" "unprognostic (3.54e-2)" "unprognostic (2.24e-2)" "unprognostic (6.17e-3)" "unprognostic (1.57e-1)" "unprognostic (6.46e-2)" "unprognostic (8.22e-2)" "unprognostic (2.00e-2)" "prognostic favorable (8.58e-4)" "unprognostic (2.93e-1)" "prognostic favorable (3.09e-5)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (7.33e-2)" 3.1 15.3 4.2 3.8 5.1 1.4 2.8 1.5 7.1 2.6 7.1 5.5 6.2 10.0 2.5 9.7 1.3 4.6 5.2 7.2 3.6 6.1 15.5 53.2 2.8 2.8 9.5 4.2 4.6 15.3 5.0 7.6 3.1 7.8 4.2 5.0 4.6 4.9 4.5 2.1 0.7 7.8 2.9 8.8 3.0 5.2 7.0 2.6 1.5 20.3 1.3 1.6 4.0 1.5 1.1 13.2 0.3 7.1 1.3 0.2 1.7 3.6 14.2 2.0 6.0 0.4 0.9 1.4 2.1 0.5 2.2 1.9 6.1 3.8 0.2 10.7 3.4 6.2 3.7 0.9 4.8 0.8 8.6 3.6 9.1 3.4 2.6 12.0 1.1 22.6 1.9 6.8 5.5 8.2 2.6 3.3 0.0 7.1 2.8 2.7 38.7 0.0 4.5 2.1 3.9 6.1 0.0 3.0 6.8 5.9 4.4 0.6 0.2 8.8 10.0 8.5 1.9 12.3 10.4 3.0 2.7 5.3 12.1 1.8 0.6 0.5 0.1 11.6 3.7 3.3 0.1 6.5 0.0 0.0 7.1 0.0 1.1 0.0 0.0 13.2 0.1 0.0 0.0 0.3 1.3 0.9 12.8 0.2 1.7 4.2 5.1 1.5 7.1 3.6 6.1 9.5 4.2 7.8 2.6 0.0 6.1 8.6 2.1 0.8 0.2 15.7 25.5 0.0 0.0 27.9 2.0 11.4 66.3 30.4 0.4 2.9 43.5 23.3 17.7 2.6 3.8 6.0 43.8 118.4 93.1 3.2 30.5 4.9 12.3 1.1 2.6 14.9 3.3 174.9 28.9 19.5 17.4 40.3 5.3 76.8 1.5 0.0 5.7 0.0 0.2 0.5 6.1 4.3 25.5 4.3 SEBOX "OG9, OG9X" ENSG00000274529 "SEBOX homeobox" 17 28364268-28365244 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "liver: 2.6;pancreas: 1.1;testis: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;CACO-2: 3.3;HL-60: 1.0;T-47d: 1.2" "Region enhanced" "Detected in some" "cerebellum: 40.5" "Not detected" "Not detected" HPA045689 Uncertain NA NA "HPA045689: AB_2679419" "unprognostic (8.66e-2)" "unprognostic (3.10e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.5 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEC11C "SEC11L3, SPC21, SPCS4C" ENSG00000166562 "SEC11 homolog C, signal peptidase complex subunit" Q9BY50 18 59139477-59158836 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 132.6" "Cell type enhanced" "Detected in all" 5 "Glandular cells: 405.9;Muller glia cells: 440.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 59.5;Karpas-707: 64.1;RPMI-8226: 129.8;U-266/70: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026816, HPA047533" Approved Approved "Nuclear membrane,Golgi apparatus" NA NA "Nuclear membrane" "Golgi apparatus" "HPA026816: AB_10602089, HPA047533: AB_2680078" "unprognostic (1.47e-2)" "unprognostic (2.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.44e-2)" "unprognostic (3.13e-3)" "unprognostic (4.48e-3)" "unprognostic (2.95e-1)" "unprognostic (2.32e-2)" "unprognostic (1.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.80e-2)" "unprognostic (1.72e-1)" "unprognostic (6.25e-2)" "unprognostic (3.83e-2)" "unprognostic (4.63e-2)" "unprognostic (2.58e-1)" "unprognostic (1.15e-1)" 5.9 18.4 30.1 18.6 29.7 11.3 16.0 14.9 25.2 12.2 18.7 24.4 27.8 27.5 9.1 58.0 10.7 9.2 11.1 7.2 27.7 33.9 19.0 66.8 13.0 22.0 41.8 21.3 7.0 96.8 14.6 46.6 8.1 27.1 48.8 16.4 10.0 132.6 34.1 4.3 7.9 21.1 6.6 51.3 23.6 28.4 6.4 25.3 7.3 35.9 8.6 23.4 18.9 5.9 33.6 50.0 10.6 17.6 17.3 34.4 32.6 8.8 10.7 5.8 9.0 3.6 0.6 7.4 8.0 6.9 9.9 6.0 7.5 4.8 20.3 12.7 4.8 7.3 9.5 9.1 6.0 5.7 59.5 12.5 6.5 7.4 22.9 10.8 21.5 9.9 2.0 14.4 6.1 16.6 2.1 3.2 8.7 7.5 64.1 3.5 10.4 8.8 8.6 5.9 14.7 6.6 8.0 5.7 129.8 6.4 7.4 27.1 10.8 4.8 19.5 27.1 3.3 8.8 15.8 2.6 12.0 5.0 4.2 9.6 65.4 48.1 19.9 12.0 14.6 14.7 10.6 13.1 9.4 25.9 15.5 33.1 33.6 27.3 25.2 13.5 17.4 14.3 19.5 2.0 17.3 17.6 50.0 34.4 32.6 30.1 29.7 14.9 25.2 27.7 33.9 41.8 21.3 27.1 25.3 26.8 96.0 46.9 40.1 29.0 63.6 51.8 132.5 95.0 89.9 57.6 47.1 59.9 74.6 117.2 35.1 52.2 73.8 23.3 229.6 80.5 24.9 405.9 46.2 201.1 102.0 47.7 325.7 35.6 28.2 14.8 11.5 58.2 243.0 32.5 93.2 440.4 146.8 74.8 21.5 86.0 65.5 6.5 40.9 97.2 84.1 39.6 125.2 74.3 75.9 57.4 SEC14L2 "C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1" ENSG00000100003 "SEC14 like lipid binding 2" O76054 22 30396857-30425317 "Predicted intracellular proteins" "Transcription, Transcription regulation, Transport" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 43.0;liver: 112.3" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 123.4;Muller glia cells: 99.0;Pancreatic endocrine cells: 69.1;Rod photoreceptor cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 8 "T-cells: 7.1" "Cell line enhanced" "Detected in many" "HBEC3-KT: 37.7;hTCEpi: 20.5;hTERT-RPE1: 24.0" HPA064466 Approved Supported Nucleoplasm,Cytosol NA NA 190000 Nucleoplasm Cytosol "HPA064466: AB_2685270" "prognostic favorable (3.05e-4)" "unprognostic (1.47e-1)" "unprognostic (1.98e-1)" "unprognostic (5.59e-3)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.63e-6)" "unprognostic (1.25e-3)" "unprognostic (3.76e-3)" "unprognostic (2.23e-1)" "unprognostic (2.40e-1)" "unprognostic (2.76e-2)" "unprognostic (5.63e-3)" "unprognostic (1.17e-3)" "unprognostic (1.17e-1)" "unprognostic (1.52e-1)" "unprognostic (1.34e-3)" "unprognostic (2.01e-1)" 1.9 1.2 13.6 1.9 14.2 2.4 22.7 7.3 15.0 2.2 5.7 12.6 7.3 10.1 2.4 43.0 8.0 2.3 4.3 1.1 10.8 10.4 3.6 112.3 1.8 2.1 16.1 10.4 1.3 1.9 3.7 5.0 1.5 10.6 25.7 1.4 24.2 4.0 7.8 1.0 2.9 13.5 2.4 8.9 1.0 3.4 1.2 10.4 1.1 4.3 0.6 2.7 1.8 2.9 0.8 0.9 0.5 0.2 0.1 7.1 1.5 9.8 2.4 1.9 2.7 2.9 7.4 0.1 8.0 6.4 4.7 4.9 0.6 6.6 0.2 2.4 9.6 8.0 7.6 1.2 37.7 5.2 0.9 1.9 0.1 2.4 3.5 4.0 0.0 2.5 5.1 20.5 4.3 7.7 24.0 11.8 1.8 0.0 0.2 9.4 1.7 1.0 0.2 0.0 5.1 3.3 0.4 3.4 0.2 8.3 3.3 1.2 1.3 4.9 1.1 4.4 0.1 6.4 0.1 17.9 6.6 4.2 2.7 4.8 0.1 0.0 0.3 14.5 0.0 5.2 0.1 0.2 0.4 0.9 0.2 0.4 0.8 2.6 0.6 0.1 0.6 7.1 4.7 0.5 0.1 0.1 0.9 1.1 1.5 13.6 14.2 7.3 13.4 10.8 10.4 16.1 10.4 10.6 10.4 3.0 4.3 0.5 13.2 3.7 7.5 1.0 20.4 1.4 4.5 0.0 15.7 2.6 5.0 21.9 6.6 1.5 1.7 0.0 16.4 0.2 3.6 18.3 5.7 123.4 0.4 12.7 1.2 4.3 4.7 7.5 1.1 0.0 6.8 0.0 0.5 99.0 69.1 0.0 0.7 6.1 51.4 0.0 2.0 0.5 1.0 1.8 2.5 5.3 0.2 7.0 SEC14L3 TAP2 ENSG00000100012 "SEC14 like lipid binding 3" Q9UDX4 22 30447959-30472049 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.8;liver: 6.0;thyroid gland: 3.5" "Group enriched" "Detected in some" 6 "Ciliated cells: 40.2;Muller glia cells: 22.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "WM-115: 3.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059450 Uncertain NA NA "HPA059450: AB_2684024" "unprognostic (2.42e-1)" "unprognostic (2.56e-1)" "unprognostic (1.42e-1)" "unprognostic (5.35e-2)" "unprognostic (2.00e-4)" "unprognostic (3.62e-3)" "unprognostic (6.68e-2)" "unprognostic (3.19e-1)" "unprognostic (2.41e-10)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (4.10e-1)" 0.0 0.1 0.0 0.0 0.3 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 6.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.4 3.5 0.0 0.0 0.0 0.5 0.3 1.3 0.1 0.1 0.3 0.0 0.2 0.2 0.1 1.1 0.6 0.0 0.9 0.3 0.0 0.1 0.2 0.0 0.8 0.2 0.3 0.0 0.1 0.6 0.3 0.0 0.2 0.3 1.6 0.1 0.6 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.6 1.3 0.4 0.6 0.1 0.3 0.3 0.1 0.2 0.3 0.3 0.4 0.4 0.3 0.6 1.1 0.1 0.3 0.0 0.3 0.3 0.7 0.0 0.9 0.4 0.7 0.1 0.2 0.2 0.3 0.0 0.9 3.2 1.3 0.1 0.1 0.2 0.0 0.1 0.2 0.3 0.1 0.0 0.5 0.1 0.1 0.7 0.1 0.1 0.3 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SEC14L4 "dJ130H16.5, TAP3" ENSG00000133488 "SEC14 like lipid binding 4" Q9UDX3 22 30488913-30505711 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 35.8;testis: 13.4" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 8.6;Cholangiocytes: 15.3;Hepatocytes: 13.9;Muller glia cells: 8.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 3.1;neutrophil: 2.6" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.1" "Cell line enriched" "Detected in some" 4 "BEWO: 29.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.0" HPA069748 Approved Centrosome NA NA 44000 Centrosome "HPA069748: AB_2686187" "unprognostic (6.98e-4)" "unprognostic (2.72e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.07e-2)" "unprognostic (9.88e-2)" "unprognostic (4.93e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (1.88e-2)" "unprognostic (8.87e-2)" "unprognostic (4.06e-8)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" "unprognostic (5.98e-2)" 0.1 1.1 0.1 0.1 0.1 6.7 0.1 0.2 0.4 0.4 0.2 0.1 0.1 0.0 0.1 1.0 0.3 0.2 0.4 0.1 0.1 0.1 0.3 35.8 8.5 0.1 0.1 0.1 0.2 0.2 6.7 0.2 0.3 0.1 0.3 0.0 0.2 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.5 0.4 13.4 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.7 0.5 3.1 0.4 0.4 0.4 0.1 1.7 5.6 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 6.9 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 3.1 0.4 0.4 0.3 0.2 0.2 0.4 0.3 0.2 0.1 0.7 0.3 0.4 2.6 0.4 0.3 0.5 0.1 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.1 20.8 8.6 0.0 0.5 0.1 0.1 0.6 15.3 1.4 2.3 1.8 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.0 0.2 0.2 0.4 1.1 13.9 0.1 1.6 0.0 0.6 0.3 0.0 0.6 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 SEC14L5 "KIAA0420, PRELID4B" ENSG00000103184 "SEC14 like lipid binding 5" O43304 16 4958317-5019158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0" "Cell type enriched" "Detected in some" 9 "Cone photoreceptor cells: 80.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;RPMI-8226: 4.2;SCLC-21H: 6.5;T-47d: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041492, HPA041825" Uncertain "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA041492: AB_10794519, HPA041825: AB_10794526" "unprognostic (1.90e-3)" "unprognostic (4.08e-2)" "unprognostic (5.93e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (5.68e-2)" "unprognostic (7.33e-3)" "unprognostic (8.71e-4)" "unprognostic (6.87e-2)" "unprognostic (1.56e-4)" "unprognostic (1.01e-3)" "unprognostic (7.12e-2)" "unprognostic (1.07e-1)" "unprognostic (5.61e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" 1.1 1.7 7.4 1.3 17.5 1.5 1.2 2.2 22.1 2.8 1.7 29.4 0.0 1.4 0.9 1.2 2.0 2.2 1.1 7.5 13.5 6.1 1.1 0.8 1.0 1.4 25.8 8.8 1.7 1.8 0.8 1.7 1.3 15.2 1.7 2.1 0.3 1.9 1.1 11.0 2.9 1.1 0.9 25.2 1.2 3.7 1.4 15.6 0.0 0.9 0.5 1.7 0.9 0.4 0.1 0.4 1.6 0.0 0.1 0.2 2.9 0.0 0.4 0.6 0.3 0.6 4.2 0.6 0.1 0.0 0.1 0.0 0.5 0.2 0.2 0.3 0.5 0.1 0.6 0.2 0.1 0.0 0.0 0.5 2.0 0.4 1.1 0.3 0.0 0.4 0.6 0.9 0.1 0.1 0.3 0.1 0.2 0.2 0.4 0.1 0.3 0.0 0.2 1.3 1.0 0.3 0.1 0.4 4.2 0.3 0.1 6.5 0.2 0.4 0.3 0.5 0.7 4.3 0.0 0.5 0.2 0.4 0.3 0.0 0.2 0.0 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 1.6 0.1 0.0 0.4 0.0 2.9 7.4 17.5 2.2 20.0 13.5 6.1 25.8 8.8 15.2 15.6 0.0 0.0 0.0 0.1 0.2 3.7 8.9 0.0 0.0 0.0 0.0 80.5 0.6 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 SEC14L6 ENSG00000214491 "SEC14 like lipid binding 6" B5MCN3 22 30522799-30546682 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 15.4;parathyroid gland: 20.9" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.0;Club cells: 6.8;Collecting duct cells: 12.2;Muller glia cells: 14.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "K-562: 11.2;RPTEC TERT1: 21.1;SiHa: 6.2" HPA067695 Approved Nucleoplasm NA NA Nucleoplasm "HPA067695: AB_2685889" "unprognostic (3.49e-2)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (4.09e-2)" "unprognostic (3.04e-2)" "unprognostic (1.12e-1)" "unprognostic (7.28e-3)" "unprognostic (3.88e-2)" "unprognostic (3.13e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (9.25e-2)" "unprognostic (8.69e-2)" "unprognostic (8.20e-2)" "unprognostic (2.12e-1)" "unprognostic (2.48e-2)" "unprognostic (6.02e-2)" 0.7 0.7 3.3 0.0 3.6 1.1 2.4 1.1 2.1 2.3 0.0 0.1 2.0 15.4 0.0 0.9 2.8 0.0 2.4 3.4 7.2 0.0 7.9 0.0 4.0 1.7 3.5 20.9 1.8 0.0 1.0 0.0 0.0 1.6 0.0 7.3 0.0 1.3 3.9 0.0 0.6 3.8 0.0 0.1 0.1 0.0 1.2 0.9 2.7 0.8 1.9 2.2 0.3 0.2 0.1 0.9 0.3 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.2 0.5 0.3 1.1 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 2.8 0.3 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.7 0.0 0.1 11.2 0.2 0.0 0.4 0.1 0.4 0.5 0.0 0.1 0.2 0.0 0.1 21.1 0.2 0.2 0.1 6.2 0.1 0.0 0.2 1.7 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.3 0.1 1.9 0.8 0.7 0.6 0.6 1.6 0.7 0.5 0.5 0.2 1.2 0.6 0.9 2.7 1.9 0.7 0.9 2.2 0.3 11.9 8.0 0.0 0.3 0.1 0.0 0.3 5.1 0.0 6.8 12.2 0.0 0.0 1.7 5.1 0.0 0.4 0.0 0.0 0.7 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 14.0 1.9 0.0 0.7 2.6 0.3 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.1 SEC16B "LZTR2, PGPR-p117, RGPR, Sec16S" ENSG00000120341 "SEC16 homolog B, endoplasmic reticulum export factor" Q96JE7 1 177923956-177984303 "Predicted intracellular proteins" "ER-Golgi transport, Peroxisome biogenesis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 43.4;liver: 47.4" "Group enriched" "Detected in many" 4 "Hepatocytes: 57.2;Late spermatids: 36.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.5;CAPAN-2: 9.0;EFO-21: 6.9;HDLM-2: 6.9;Karpas-707: 6.1;RPMI-8226: 7.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA054292, HPA072913" Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Actin filaments" NA NA "Endoplasmic reticulum, Plasma membrane" "Actin filaments" "HPA054292: AB_2682439, HPA072913: AB_2732213" "unprognostic (2.31e-1)" "unprognostic (1.90e-1)" "unprognostic (6.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.33e-1)" "unprognostic (6.39e-3)" "unprognostic (1.22e-1)" "unprognostic (2.27e-2)" "unprognostic (1.50e-2)" "unprognostic (4.76e-3)" "unprognostic (2.43e-1)" "unprognostic (7.34e-4)" "unprognostic (6.67e-2)" "unprognostic (1.66e-1)" "unprognostic (1.37e-1)" "unprognostic (1.05e-1)" 1.4 1.8 1.1 3.2 0.9 0.0 1.5 0.9 2.3 1.7 19.6 0.9 0.9 14.3 1.3 0.9 0.9 1.6 2.5 2.2 0.9 0.4 2.5 47.4 0.9 0.9 0.9 0.9 1.8 4.8 0.1 1.4 0.9 1.0 0.9 1.6 0.9 1.4 0.9 3.9 0.9 43.4 0.9 0.9 2.7 4.0 0.9 0.9 0.9 1.4 0.9 1.0 0.9 1.0 0.0 0.7 0.0 0.7 0.0 0.0 0.2 2.3 1.9 0.1 1.9 2.5 8.5 0.1 1.9 0.6 0.1 0.9 1.3 9.0 0.8 6.9 1.5 0.1 0.0 0.5 0.2 0.1 6.9 0.1 0.0 0.0 4.2 0.2 0.1 0.0 5.0 0.6 0.3 0.1 0.2 2.7 0.0 0.0 6.1 4.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 7.8 0.1 0.2 0.8 1.6 0.1 0.2 1.0 0.0 0.1 1.6 0.9 1.3 0.2 0.8 0.0 2.0 0.8 0.1 3.4 0.3 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 1.1 0.9 0.9 2.3 0.9 0.4 0.9 0.9 1.0 0.9 0.0 1.3 0.5 0.2 0.2 1.0 0.4 10.2 2.7 2.3 1.8 2.0 0.3 0.0 0.4 9.0 1.4 1.0 0.0 1.0 0.0 0.8 0.1 1.1 57.2 0.6 11.1 3.5 4.3 2.7 36.6 2.3 0.6 1.7 0.0 4.4 0.8 1.2 3.7 1.1 1.7 4.3 0.0 1.4 0.3 0.9 0.9 0.0 0.0 4.3 0.1 SEC61A1 ENSG00000058262 "Sec61 translocon alpha 1 subunit" P61619 3 128051641-128071683 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022076 Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB022076: " "unprognostic (1.84e-1)" "unprognostic (8.00e-2)" "unprognostic (8.21e-2)" "prognostic favorable (7.82e-4)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (2.84e-2)" "unprognostic (4.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.85e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.84e-9)" "unprognostic (2.73e-2)" "unprognostic (3.18e-2)" "unprognostic (8.33e-2)" "unprognostic (2.51e-2)" 28.6 38.2 15.2 23.2 16.2 18.5 38.4 12.8 16.2 45.0 24.2 15.9 77.9 22.1 32.6 52.8 31.1 28.3 34.4 27.6 14.3 13.5 37.6 132.2 33.2 44.9 17.4 10.3 28.5 178.4 31.5 36.5 51.6 15.2 26.2 26.0 19.0 87.1 81.7 22.7 22.7 32.5 31.3 15.4 28.8 33.8 21.2 15.4 22.9 35.5 28.8 36.6 24.2 26.4 13.8 35.6 40.0 25.1 18.7 39.3 29.0 40.1 21.1 21.2 37.7 60.3 52.1 39.1 64.8 75.2 56.5 61.0 40.0 29.3 26.8 39.1 83.6 42.3 35.7 33.2 45.8 54.8 24.2 18.2 30.5 23.6 42.1 88.9 38.7 34.8 57.1 55.4 53.2 68.8 42.8 49.6 18.7 20.0 65.7 65.5 36.6 19.9 12.8 28.6 35.6 29.6 21.0 19.0 52.5 29.4 35.2 24.2 23.7 32.0 30.5 40.8 25.6 28.4 33.1 48.7 44.6 25.3 51.7 30.2 60.1 28.6 38.6 72.9 25.2 57.5 40.0 25.1 19.1 28.3 23.0 39.3 13.8 20.5 24.8 24.7 8.5 13.0 15.0 6.6 18.7 22.4 35.6 13.1 29.0 15.2 16.2 12.8 16.2 14.3 13.5 17.4 10.3 15.2 15.4 29.8 34.5 23.1 22.5 32.7 16.8 12.9 35.7 10.7 20.5 47.1 33.4 56.4 3.3 77.1 35.8 35.6 73.5 23.3 133.3 103.4 63.4 59.6 25.4 101.3 67.9 25.4 70.7 53.4 26.8 17.6 38.0 27.4 32.1 25.2 85.2 24.5 95.2 53.4 41.1 22.6 14.1 32.3 34.0 9.3 15.8 25.7 107.0 25.4 63.1 30.3 SEC61A2 FLJ10578 ENSG00000065665 "Sec61 translocon alpha 2 subunit" Q9H9S3 10 12129637-12169961 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.5" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 33.4;Late spermatids: 23.8;Spermatocytes: 28.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.83e-2)" "unprognostic (2.76e-2)" "unprognostic (1.48e-2)" "unprognostic (1.01e-3)" "unprognostic (4.18e-2)" "unprognostic (1.84e-2)" "unprognostic (1.28e-3)" "unprognostic (1.55e-2)" "unprognostic (2.97e-1)" "unprognostic (3.95e-2)" "prognostic favorable (1.08e-5)" "unprognostic (3.14e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (6.41e-2)" "unprognostic (4.95e-2)" "unprognostic (6.18e-2)" "prognostic favorable (8.75e-4)" 4.0 5.6 14.3 5.1 19.7 14.1 5.3 16.5 33.5 3.8 3.8 20.3 3.2 3.7 7.8 9.2 3.9 4.1 5.2 11.3 16.8 22.1 3.1 7.8 3.8 5.8 15.6 14.6 5.8 3.3 5.5 9.4 4.5 22.7 6.0 5.9 5.7 2.7 6.3 6.9 8.6 3.3 5.9 21.1 4.8 3.6 17.3 9.9 5.0 5.2 1.3 6.1 4.1 3.6 1.3 5.8 4.1 0.5 2.0 2.7 0.4 5.9 10.8 14.1 8.7 6.0 3.7 4.7 6.0 3.3 11.8 12.5 10.2 4.0 2.2 3.3 9.4 15.9 4.9 19.5 7.8 10.2 6.6 7.4 2.7 12.6 7.2 5.9 1.6 6.5 5.5 4.7 21.5 3.4 5.2 3.0 13.3 3.2 6.5 10.0 5.2 5.4 2.7 13.9 5.3 3.3 5.8 5.8 1.4 7.3 6.2 6.7 9.9 8.8 4.7 4.3 11.5 9.0 2.7 5.4 10.3 12.0 13.1 4.1 6.0 8.5 3.5 8.0 2.2 3.1 0.0 0.4 0.3 2.1 0.1 1.9 0.7 1.3 1.3 1.0 1.3 2.7 1.7 4.1 2.0 0.5 5.8 1.9 0.4 14.3 19.7 16.5 26.4 16.8 22.1 15.6 14.6 22.7 9.9 3.0 3.2 7.5 2.3 1.5 13.1 6.5 2.5 1.4 3.4 8.7 7.9 2.8 0.0 2.4 15.5 2.7 1.1 0.0 2.0 2.1 4.1 2.8 2.3 13.2 2.3 33.4 1.2 3.7 1.9 23.8 6.4 2.5 5.0 1.8 1.6 6.9 1.7 2.9 4.2 1.3 13.8 0.0 3.8 28.9 13.9 1.3 2.9 1.9 1.0 1.4 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.1" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 183.4;Syncytiotrophoblasts: 594.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favorable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 13.2 12.6 30.1 8.5 32.2 14.4 14.3 18.1 38.0 15.2 10.8 40.7 12.1 7.2 14.1 17.4 13.2 14.4 11.1 11.1 38.4 23.8 19.3 13.9 27.3 9.5 38.8 24.8 15.5 10.9 42.0 12.7 29.4 36.7 16.3 9.2 8.1 30.8 14.8 10.1 8.3 8.5 11.5 66.1 10.6 13.6 9.9 35.6 6.7 18.2 6.7 9.8 10.8 10.3 14.7 8.1 14.6 6.0 7.8 11.1 4.0 4.7 5.1 11.5 9.6 16.4 12.7 6.8 16.8 14.1 14.3 17.7 5.7 4.3 3.3 8.0 12.8 15.0 4.0 14.4 4.2 16.9 19.2 3.5 9.5 7.4 4.5 8.6 5.2 10.8 10.0 5.5 12.2 6.9 15.2 13.5 8.0 5.7 8.5 16.5 2.0 5.4 5.0 4.1 3.1 4.6 5.5 12.6 13.0 18.4 10.2 2.0 7.8 10.9 20.0 15.9 20.4 5.8 6.1 16.2 12.5 6.0 11.8 7.8 7.0 12.4 6.0 9.9 7.6 16.6 9.3 5.1 14.6 9.0 4.9 8.5 12.2 8.1 6.1 3.6 14.7 11.1 8.7 9.2 7.8 6.0 8.1 5.8 4.0 30.1 32.2 18.1 31.5 38.4 23.8 38.8 24.8 36.7 35.6 107.2 183.4 25.3 14.0 13.2 33.9 35.8 15.3 99.0 61.4 31.4 25.5 71.2 13.3 23.4 8.2 29.2 20.7 0.0 16.3 30.7 28.0 30.9 31.3 22.1 23.2 54.0 9.2 26.4 13.7 6.9 31.1 18.1 43.9 28.9 14.2 35.2 29.3 14.0 34.3 32.1 25.4 6.5 21.7 17.4 27.8 11.8 594.9 17.5 9.9 31.0 SECTM1 K12 ENSG00000141574 "Secreted and transmembrane 1" Q8WVN6 17 82321024-82334074 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.9;intestine: 103.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 42.8;Kupffer cells: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 45.9" "Group enriched" "Detected in many" 13 "granulocytes: 45.9;monocytes: 16.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.3;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+: 21.2;BJ hTERT+ SV40 Large T+ RasG12V: 20.9;PC-3: 21.8;SiHa: 37.5;SK-BR-3: 20.4;U-2197: 28.6" HPA051214 Approved "Secreted - unknown location" NA NA 26000000 "HPA051214: AB_2732565" "unprognostic (2.42e-1)" "unprognostic (2.95e-2)" "unprognostic (1.56e-1)" "unprognostic (2.69e-2)" "unprognostic (4.29e-2)" "unprognostic (1.15e-2)" "unprognostic (4.55e-2)" "unprognostic (9.39e-2)" "unprognostic (3.17e-3)" "unprognostic (7.75e-3)" "unprognostic (2.10e-2)" "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (4.31e-3)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" 13.5 1.8 1.1 15.7 2.1 3.7 10.6 0.7 2.1 6.4 33.2 1.0 1.3 26.2 6.1 4.9 6.1 6.5 4.7 6.1 2.3 0.8 16.8 3.9 11.2 21.7 1.5 0.6 7.8 2.5 0.0 1.3 6.1 3.5 8.6 9.4 2.1 20.2 2.2 4.9 6.6 103.1 5.5 4.2 24.0 9.4 2.1 1.4 2.3 5.1 7.0 7.7 7.8 16.2 0.0 2.3 45.9 16.2 0.0 0.1 1.1 6.0 1.3 0.0 0.4 10.7 27.3 0.5 3.0 27.5 21.2 20.9 0.6 12.5 0.0 0.1 8.9 0.3 18.5 0.0 1.2 0.8 1.9 0.0 2.5 9.5 1.7 8.3 0.0 0.0 11.6 2.8 1.1 0.5 1.5 0.6 0.0 0.0 0.0 13.4 0.2 0.0 0.0 0.0 1.6 21.8 0.0 0.1 0.3 6.1 0.0 1.4 0.1 37.5 20.4 0.4 0.0 1.6 0.5 0.1 2.3 0.2 28.6 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 9.6 0.0 0.1 16.2 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 45.9 0.0 14.8 1.0 0.0 1.1 1.1 2.1 0.7 2.1 2.3 0.8 1.5 0.6 3.5 1.4 11.9 3.7 3.9 4.6 8.4 0.0 0.8 0.0 2.7 2.3 1.8 0.0 0.1 0.0 5.2 0.0 1.6 42.8 0.0 8.3 0.7 6.8 16.9 1.1 0.0 6.9 0.0 0.0 1.8 39.9 0.2 4.9 17.6 1.7 1.8 2.3 0.0 8.7 17.5 0.0 2.2 0.0 0.0 3.3 0.0 0.2 3.0 0.2 0.0 1.0 12.0 SEL1L "IBD2, SEL1L1" ENSG00000071537 "SEL1L ERAD E3 ligase adaptor subunit" Q9UBV2 14 81471549-81533861 "Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 121.3" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 116.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 78.4;U-266/84: 66.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024267 Enhanced "Intracellular and membrane" NA NA "HPA024267: AB_1856659" "unprognostic (4.94e-1)" "unprognostic (8.69e-2)" "unprognostic (1.09e-2)" "unprognostic (1.91e-1)" "unprognostic (5.93e-2)" "unprognostic (1.16e-1)" "unprognostic (3.29e-1)" "unprognostic (2.78e-1)" "unprognostic (9.97e-2)" "unprognostic (2.58e-2)" "unprognostic (2.76e-3)" "unprognostic (4.86e-1)" "unprognostic (3.31e-2)" "unprognostic (1.30e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-2)" "unprognostic (1.25e-2)" 13.2 8.5 9.5 9.2 11.3 4.9 9.1 6.6 9.4 7.5 10.8 8.4 7.1 11.3 10.9 6.1 6.4 7.7 7.0 8.5 8.1 7.1 9.8 33.5 9.0 7.0 10.4 9.0 7.3 121.3 10.0 6.3 18.2 10.2 10.3 10.2 4.9 9.1 8.3 10.9 7.3 10.7 9.0 10.7 11.2 10.6 3.9 10.5 6.5 17.0 4.3 8.8 10.3 11.4 8.9 12.1 29.3 16.4 10.5 11.4 8.4 7.7 15.6 6.3 8.1 14.2 13.9 11.2 12.3 11.9 7.2 7.7 5.9 12.1 7.9 13.6 14.1 8.8 7.4 4.3 6.9 13.1 12.3 3.1 5.8 5.1 7.3 20.3 11.7 13.9 11.2 16.6 7.2 15.8 10.6 11.7 6.6 3.5 44.7 8.8 9.5 6.6 3.3 2.0 13.0 6.7 4.6 8.9 6.2 5.5 12.1 3.6 5.9 9.6 9.0 10.2 5.6 15.6 7.9 19.5 20.4 11.6 11.3 7.6 78.4 66.2 7.9 22.5 5.4 7.8 16.6 12.9 15.4 11.4 16.4 9.4 8.9 9.0 9.0 12.1 8.3 8.4 9.0 29.3 10.5 13.6 8.9 8.7 8.4 9.5 11.3 6.6 9.4 8.1 7.1 10.4 9.0 10.2 10.5 11.9 32.8 16.4 13.5 23.8 22.8 56.5 20.4 22.7 17.0 26.2 29.5 18.1 5.0 19.4 3.0 31.8 32.5 0.0 39.5 16.9 29.4 37.3 33.5 116.9 28.8 28.6 20.7 41.7 52.2 4.0 21.9 36.6 50.6 18.0 34.9 25.3 38.4 33.7 26.5 19.6 16.4 45.3 26.4 11.1 17.5 22.8 35.0 20.8 23.5 28.0 SEL1L2 "C20orf50, DKFZp434C1826" ENSG00000101251 "SEL1L2 ERAD E3 ligase adaptor subunit" Q5TEA6 20 13849247-13996443 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 13.7" "Group enriched" "Detected in some" 8 "Early spermatids: 138.6;Late spermatids: 119.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA059121 Approved NA NA "HPA059121: AB_2683911" "unprognostic (6.70e-2)" "unprognostic (1.64e-2)" "unprognostic (2.72e-3)" "unprognostic (2.19e-1)" "unprognostic (8.51e-2)" "unprognostic (5.33e-2)" "unprognostic (2.13e-2)" "unprognostic (2.54e-1)" "unprognostic (1.36e-1)" "unprognostic (2.77e-2)" "unprognostic (2.43e-2)" "unprognostic (3.62e-2)" "unprognostic (3.12e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 138.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 119.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 15.6 4.2 0.0 0.0 0.0 0.0 0.0 SEL1L3 KIAA0746 ENSG00000091490 "SEL1L family member 3" Q68CR1 4 25747427-25863760 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 48.0" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 74.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 45.9" "Group enriched" "Detected in many" 5 "memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9" "Group enriched" "Detected in many" 4 "B-cells: 20.8;dendritic cells: 17.9" "Cell line enhanced" "Detected in many" "Daudi: 65.9;OE19: 49.9;U-698: 43.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 191.0" "HPA040045, HPA058792" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA040045: AB_10796116, HPA058792: AB_2683822" "unprognostic (1.01e-2)" "unprognostic (2.03e-1)" "unprognostic (3.06e-3)" "unprognostic (1.44e-2)" "unprognostic (2.43e-3)" "unprognostic (1.80e-1)" "unprognostic (1.26e-2)" "unprognostic (1.39e-1)" "unprognostic (5.33e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (5.11e-1)" "unprognostic (4.77e-2)" "unprognostic (7.21e-3)" "unprognostic (1.32e-1)" "unprognostic (2.28e-2)" "prognostic favorable (4.33e-4)" 5.4 3.3 4.0 36.3 5.6 2.3 3.8 45.9 6.4 13.7 19.3 1.5 1.5 19.3 2.2 18.1 6.2 3.6 22.0 2.4 3.3 2.8 6.9 3.6 14.3 27.7 2.1 1.7 3.1 48.0 10.9 2.9 13.7 3.0 4.2 16.7 12.9 23.1 1.0 1.3 1.7 30.3 3.4 2.1 33.5 24.6 2.2 1.1 2.8 12.5 3.8 46.7 14.8 2.2 20.8 17.9 0.4 0.1 3.7 4.3 1.4 4.8 5.3 3.9 1.3 0.6 0.8 0.6 2.4 6.6 1.8 6.0 3.3 22.7 65.9 11.7 16.6 15.9 3.1 2.9 10.5 2.5 3.5 1.7 0.7 8.8 4.5 17.1 9.0 0.4 1.3 8.5 6.6 2.6 7.5 24.8 1.3 4.3 0.0 1.3 3.7 0.0 0.6 11.4 49.9 4.7 0.3 21.7 9.1 14.5 16.4 9.8 1.9 16.1 0.2 1.6 5.7 0.8 11.2 10.8 0.1 7.9 0.1 6.9 0.4 0.1 43.0 30.0 3.8 4.5 0.4 0.1 0.0 2.8 0.0 3.4 20.8 3.5 3.1 0.7 20.8 1.5 2.4 0.3 3.7 0.1 17.9 4.3 1.4 4.0 5.6 45.9 6.4 3.3 2.8 2.1 1.7 3.0 1.1 11.9 29.0 65.6 3.0 0.8 2.1 1.2 63.7 8.1 55.7 3.5 0.0 23.3 0.0 64.6 46.5 8.4 31.3 23.3 28.5 1.3 1.5 12.0 2.3 1.7 4.6 0.0 11.1 13.5 16.0 58.1 1.4 6.4 8.5 15.4 74.5 32.9 37.4 24.6 0.4 9.7 29.0 0.0 1.4 0.6 2.4 1.4 13.7 26.1 35.6 4.2 SELE "CD62E, ELAM, ELAM1, ESEL" ENSG00000007908 "Selectin E" P16581 1 169722641-169764705 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 50.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 41.0;Endothelial cells: 101.9;Melanocytes: 43.9;Suprabasal keratinocytes: 41.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HUVEC TERT2: 5.3" "Not detected" "Not detected" CAB002143 Enhanced NA NA 8140000 640000000 "CAB002143: AB_563608" "unprognostic (2.39e-1)" "unprognostic (2.16e-2)" "unprognostic (1.37e-2)" "unprognostic (2.09e-2)" "unprognostic (1.61e-1)" "unprognostic (1.40e-2)" "unprognostic (1.59e-1)" "unprognostic (2.94e-1)" "unprognostic (3.63e-1)" "unprognostic (3.88e-1)" "unprognostic (9.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.56e-2)" "unprognostic (8.13e-3)" "unprognostic (4.69e-2)" "unprognostic (4.63e-2)" "unprognostic (2.55e-1)" 14.9 2.7 0.9 30.4 1.2 0.2 8.3 0.3 1.0 13.7 2.7 1.9 4.4 0.4 18.1 3.2 6.7 20.1 7.4 4.4 0.9 0.9 2.5 4.9 10.6 2.0 1.2 0.0 9.8 1.4 21.0 3.1 0.9 5.4 21.2 1.9 4.3 2.0 4.6 2.2 3.7 2.4 13.1 4.8 0.2 3.4 5.6 0.5 0.9 9.0 50.0 15.5 16.4 4.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.9 1.2 0.3 1.0 0.9 0.9 1.2 0.0 5.4 0.5 0.0 6.7 0.0 1.0 41.0 0.0 5.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.3 101.9 0.0 0.0 0.0 0.0 12.4 3.2 1.1 5.9 0.0 0.0 0.0 1.8 0.0 1.6 0.0 0.2 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 41.8 0.0 0.0 0.0 0.6 SELENBP1 "hSBP, hSP56, LPSB" ENSG00000143416 "Selenium binding protein 1" Q13228 1 151364302-151372733 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 112.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 401.2;Enterocytes: 467.1;Hepatocytes: 434.3;Paneth cells: 327.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "myeloid DC: 4.8" "Lineage enriched" "Detected in many" 4 "dendritic cells: 4.8" "Cell line enhanced" "Detected in many" "ASC diff: 38.5;HEL: 28.5;HSkMC: 19.8;OE19: 23.2;SK-BR-3: 68.7" "Low region specificity" "Detected in all" "HPA005741, CAB008366, HPA011731" Enhanced Supported Nucleoli NA NA 57000000 Nucleoli "CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663" "unprognostic (1.51e-1)" "unprognostic (7.01e-2)" "unprognostic (8.52e-3)" "unprognostic (6.25e-3)" "unprognostic (6.28e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.08e-2)" "unprognostic (1.21e-2)" "unprognostic (3.78e-3)" "unprognostic (2.86e-1)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-2)" "unprognostic (6.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.86e-2)" "unprognostic (6.86e-3)" 27.9 5.1 17.2 28.9 16.4 17.6 18.4 6.5 11.9 15.1 105.1 10.4 15.8 17.2 13.5 23.1 11.0 32.4 28.8 11.7 18.5 5.1 20.8 56.3 64.9 5.6 10.9 14.9 13.2 7.2 1.4 4.1 5.6 11.3 19.1 112.3 27.9 14.5 15.4 15.9 6.4 29.1 22.9 6.5 13.0 29.1 4.1 13.0 0.0 52.9 18.3 6.0 15.8 8.1 0.0 4.8 0.0 1.1 0.0 0.0 5.5 0.0 4.3 8.0 0.4 38.5 15.4 2.0 1.6 0.8 0.8 1.6 4.3 1.3 0.0 7.4 2.6 0.0 0.0 0.0 0.1 0.6 0.0 3.7 28.5 14.4 6.9 8.1 0.0 0.0 19.8 0.2 1.3 0.0 0.1 4.8 0.0 2.8 0.0 2.0 3.2 0.0 0.0 6.4 23.2 8.1 0.0 0.4 0.1 1.8 0.0 0.1 0.1 0.0 68.7 0.0 6.8 11.8 0.4 0.4 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 17.2 16.4 6.5 11.9 18.5 5.1 10.9 14.9 11.3 13.0 273.9 401.2 14.3 27.8 9.6 0.2 107.6 81.5 93.7 100.1 5.2 0.0 2.2 97.8 10.9 0.6 13.2 467.1 280.4 7.9 1.9 45.2 28.8 26.5 434.3 11.9 0.0 149.0 21.5 23.4 2.0 61.5 8.5 32.1 0.0 88.1 35.2 8.1 327.6 76.0 115.0 1.0 51.8 66.0 0.0 0.2 8.7 3.3 6.9 282.5 68.5 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 248.3;liver: 403.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9" "Cancer enhanced" "Detected in all" "liver cancer: 116.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 92.9;HSkMC: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Uncertain "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 2220000000 2300000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 53.8 31.4 17.5 13.5 54.6 2.2 41.1 11.9 24.0 34.9 56.8 52.8 24.2 40.9 22.3 39.0 20.5 26.2 44.4 26.6 27.6 17.5 57.5 403.8 55.0 30.4 106.2 16.1 49.1 15.3 18.2 21.4 62.7 63.6 30.5 48.5 27.1 19.5 41.2 16.4 18.1 248.3 16.1 137.1 87.1 21.6 19.6 70.3 6.3 24.5 14.7 11.3 30.0 33.0 2.2 3.6 2.2 0.7 2.7 2.4 1.4 0.1 0.3 1.4 0.1 7.7 2.1 1.4 0.6 1.9 0.0 0.0 2.0 11.0 0.3 6.9 0.2 0.2 0.3 0.0 0.0 0.0 0.4 8.9 0.5 0.0 92.9 4.7 0.5 0.0 81.3 0.1 0.0 0.0 0.3 0.0 0.3 1.0 2.2 4.0 0.2 0.1 1.1 5.4 3.1 0.1 0.2 0.3 15.9 2.1 1.3 0.3 0.5 0.5 2.8 0.2 10.6 21.7 0.1 0.1 0.5 0.3 0.9 0.1 1.5 0.2 0.3 0.3 1.0 0.2 0.3 0.6 1.8 2.2 0.6 2.4 1.6 1.6 1.7 1.2 2.2 2.4 2.0 2.2 2.7 0.7 3.6 1.5 1.4 17.5 54.6 11.9 24.0 27.6 17.5 106.2 16.1 63.6 70.3 416.9 429.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 187.7 118.7 0.0 169.8 167.5 38.5 0.0 0.0 0.0 0.0 45.9 18.4 0.0 0.0 24.4 0.0 658.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 47.6 0.0 0.0 719.9 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 SELENOV SELV ENSG00000186838 "Selenoprotein V" P59797 19 39515113-39520686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 21.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.1;NTERA-2: 1.7;REH: 2.3;SCLC-21H: 1.3" HPA059274 Uncertain NA NA "HPA059274: AB_2683964" "unprognostic (1.38e-3)" "unprognostic (2.70e-2)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.43e-4)" 0.0 0.0 0.2 0.0 0.8 0.3 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.2 0.2 0.0 0.8 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 21.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.0 0.1 1.1 0.2 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.8 0.1 0.4 1.7 0.0 0.0 2.3 0.0 0.1 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.5 0.8 0.0 0.5 0.1 0.2 0.4 0.0 0.5 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.7 0.3 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SELENOW "SELW, SEPW1" ENSG00000178980 "Selenoprotein W" P63302 19 47778572-47784686 "Predicted intracellular proteins" Antioxidant "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 258.1" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 558.1;Club cells: 403.8;Distal tubular cells: 537.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 63.7;HUVEC TERT2: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.03e-1)" "unprognostic (8.98e-3)" "unprognostic (7.21e-2)" "unprognostic (2.98e-2)" "unprognostic (6.28e-2)" "unprognostic (4.17e-2)" "unprognostic (4.46e-3)" "prognostic favorable (5.44e-4)" "unprognostic (1.73e-1)" "unprognostic (2.42e-1)" "unprognostic (1.36e-1)" "unprognostic (6.78e-2)" "unprognostic (1.45e-3)" "unprognostic (4.58e-2)" "unprognostic (1.36e-1)" "unprognostic (3.46e-2)" "unprognostic (3.27e-1)" 30.7 18.5 106.3 17.3 78.4 7.0 34.2 39.9 70.6 41.7 56.4 42.9 14.5 22.7 28.1 28.7 41.8 46.7 37.6 151.1 102.1 59.3 17.2 13.2 29.7 16.0 86.3 52.7 27.3 22.6 13.6 17.7 23.7 59.1 37.5 29.2 27.9 34.2 45.2 258.1 45.6 30.4 62.3 63.3 18.3 26.1 11.9 47.6 6.3 28.5 60.2 11.9 42.6 28.3 27.3 25.4 64.4 40.3 27.8 62.2 56.6 11.1 10.4 20.1 19.5 14.5 33.9 6.8 11.8 7.5 9.9 7.0 3.3 8.0 0.0 9.9 16.5 8.7 8.4 32.2 50.1 11.3 32.9 7.7 4.5 5.6 3.7 17.8 1.0 19.9 32.7 63.7 14.9 11.7 17.3 74.9 14.1 6.3 4.2 37.1 13.5 19.3 13.6 10.1 19.1 9.4 3.8 2.6 3.0 19.7 9.6 10.4 7.1 12.0 29.4 10.1 29.2 16.8 5.0 30.2 10.3 23.1 7.5 20.6 7.2 22.7 2.0 11.2 13.6 24.1 35.5 28.9 64.4 49.4 33.2 41.2 27.3 52.8 48.8 22.6 23.3 53.5 45.9 3.1 27.8 40.3 25.4 62.2 56.6 106.3 78.4 39.9 70.6 102.1 59.3 86.3 52.7 59.1 47.6 309.7 243.8 0.0 0.0 0.0 0.0 0.0 0.0 558.1 403.8 146.5 0.0 144.2 537.2 262.2 0.0 0.0 0.0 0.0 213.6 290.6 0.0 0.0 110.5 0.0 217.6 0.0 0.0 0.0 0.0 0.0 0.0 50.4 0.0 273.3 0.0 0.0 230.0 0.0 0.0 301.2 0.0 0.0 0.0 0.0 0.0 0.0 152.5 0.0 0.0 0.0 SELL "CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR" ENSG00000188404 "Selectin L" P14151 1 169690667-169711698 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 227.5;lymphoid tissue: 77.8" "Group enriched" "Detected in many" 6 "B-cells: 178.5;Kupffer cells: 97.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 7.0;EFO-21: 6.8;JURKAT: 18.6;MOLT-4: 12.8;U-266/70: 24.1;U-698: 11.2;U-937: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002144, HPA051972" Enhanced Uncertain Cytosol NA NA 8100000000 Cytosol "CAB002144: AB_563862, HPA051972: AB_2797242" "prognostic favorable (3.76e-4)" "prognostic favorable (2.25e-4)" "unprognostic (1.52e-2)" "unprognostic (2.89e-2)" "unprognostic (7.87e-3)" "prognostic favorable (6.43e-4)" "unprognostic (1.39e-3)" "unprognostic (3.43e-1)" "unprognostic (2.70e-3)" "prognostic favorable (3.14e-4)" "unprognostic (1.42e-1)" "unprognostic (4.21e-2)" "prognostic unfavorable (4.96e-5)" "unprognostic (4.76e-2)" "unprognostic (8.71e-3)" "unprognostic (9.57e-2)" "unprognostic (1.01e-1)" 6.9 0.9 2.0 25.1 4.6 30.3 1.5 1.1 2.5 0.9 1.4 1.1 0.0 0.4 1.0 1.1 4.2 3.2 5.4 4.1 2.5 2.2 2.3 2.5 11.4 77.8 5.2 0.2 0.8 1.0 10.7 7.9 3.4 2.7 1.2 1.3 3.8 12.1 0.1 0.9 0.8 8.8 2.9 5.2 67.7 1.7 1.0 2.3 43.8 1.9 1.3 64.0 8.1 6.1 40.4 40.7 227.5 49.7 130.8 69.5 90.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.2 7.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.8 0.8 0.3 0.0 0.0 0.0 0.0 1.2 18.6 0.0 0.9 0.0 0.8 12.8 0.1 0.0 0.2 0.2 4.9 0.1 0.3 3.9 0.2 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.1 0.0 11.2 1.3 7.0 0.1 170.8 49.7 88.6 16.5 11.2 4.5 33.8 30.7 17.0 40.7 40.4 69.5 39.6 227.5 130.8 4.5 32.8 52.7 90.1 2.0 4.6 1.1 2.5 2.5 2.2 5.2 0.2 2.7 2.3 8.9 20.2 178.5 0.3 0.3 0.0 0.3 2.5 2.7 3.4 10.4 0.0 9.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.6 0.8 0.0 9.3 0.4 5.6 0.0 0.0 1.8 97.5 0.0 0.6 7.5 1.7 0.0 0.0 2.3 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 23.8 20.3 0.0 0.5 SELPLG "CD162, PSGL-1" ENSG00000110876 "Selectin P ligand" Q14242 12 108622277-108633959 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 126.9;lymphoid tissue: 60.5" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 35.0;Kupffer cells: 84.7;Macrophages: 58.3;monocytes: 101.8;T-cells: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 28.5;HMC-1: 27.7;JURKAT: 22.6;Karpas-707: 43.3;RPMI-8226: 60.2;U-266/70: 70.7;U-266/84: 44.0" "CAB002431, HPA069062" Enhanced NA NA "CAB002431: AB_563509, HPA069062: " "unprognostic (2.32e-2)" "prognostic favorable (1.46e-4)" "unprognostic (3.64e-3)" "unprognostic (1.02e-2)" "unprognostic (6.32e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.52e-1)" "unprognostic (1.29e-1)" "prognostic favorable (2.92e-4)" "unprognostic (2.26e-1)" "unprognostic (2.12e-2)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (5.88e-2)" "unprognostic (2.37e-2)" "prognostic favorable (2.74e-4)" "unprognostic (5.44e-2)" 10.6 5.5 11.3 25.3 8.9 10.7 4.2 2.2 12.5 5.8 5.4 27.2 0.1 5.0 2.9 4.1 5.0 6.8 9.6 5.9 12.1 9.6 4.6 3.9 23.3 46.8 16.2 5.4 2.1 2.9 1.3 3.1 7.3 11.5 3.0 5.2 3.4 5.2 2.5 1.8 2.7 10.3 6.7 19.6 60.5 6.0 2.1 13.5 26.0 3.1 2.8 18.0 14.8 3.0 2.2 50.9 126.9 68.4 28.1 63.2 77.1 0.1 0.0 0.3 0.1 0.1 0.3 0.1 1.0 1.0 0.4 0.3 0.0 0.4 0.1 0.3 1.5 0.4 0.0 0.0 0.0 0.3 28.5 0.0 10.1 0.0 0.0 0.0 7.1 27.7 0.4 0.1 0.5 0.1 1.1 0.0 22.6 0.1 43.3 1.3 0.0 5.7 4.1 0.0 0.0 0.3 0.0 0.1 60.2 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.0 9.1 0.3 0.5 0.1 0.7 0.2 70.7 44.0 1.2 0.3 15.2 0.4 126.9 28.1 88.8 43.8 49.5 35.8 2.0 41.8 37.4 29.4 2.2 32.4 34.1 125.8 28.1 68.4 50.9 63.2 77.1 11.3 8.9 2.2 12.5 12.1 9.6 16.2 5.4 11.5 13.5 3.0 18.0 6.0 0.1 3.1 0.0 2.0 5.1 9.4 4.5 0.0 0.0 0.4 0.0 0.3 6.1 1.1 0.0 0.0 0.2 2.1 3.0 0.1 27.8 0.9 35.0 0.0 0.0 1.8 84.7 7.2 0.3 58.3 6.8 101.8 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 1.4 0.1 0.3 1.6 0.8 37.9 0.0 0.0 SEMA3A "coll-1, Hsema-I, SEMA1, SEMAD, SemD" ENSG00000075213 "Semaphorin 3A" Q14563 7 83955777-84492724 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 24.5" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 18.7;Club cells: 20.5;Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 65.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 15 "monocytes: 4.7" "Cell line enhanced" "Detected in many" "AF22: 42.8;BJ: 33.3;fHDF/TERT166: 36.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029447, HPA052235" Approved Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA 1200000 Vesicles Nucleoplasm "HPA029447: AB_10602302, HPA052235: AB_2681770" "unprognostic (1.20e-1)" "prognostic unfavorable (2.69e-5)" "unprognostic (1.51e-1)" "unprognostic (5.82e-2)" "unprognostic (1.37e-2)" "unprognostic (5.98e-3)" "unprognostic (2.92e-3)" "unprognostic (6.05e-3)" "unprognostic (1.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.44e-2)" "unprognostic (6.18e-12)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.61e-2)" "unprognostic (1.47e-4)" 9.6 1.1 2.9 5.2 14.6 0.3 3.7 1.0 6.0 7.4 17.8 1.4 0.7 2.3 1.5 3.3 8.6 3.5 8.6 3.7 2.0 2.1 1.3 1.1 4.9 12.9 1.6 6.5 1.4 1.0 1.3 12.0 14.7 11.1 5.0 8.7 8.2 1.5 0.8 1.0 2.7 5.3 24.5 3.3 17.9 5.4 1.8 1.8 0.0 4.2 1.4 2.4 11.9 2.1 0.0 0.2 0.0 4.7 0.3 0.3 0.0 3.7 10.2 42.8 0.0 1.3 1.0 2.8 33.3 19.6 2.8 1.7 3.6 10.0 0.0 1.6 36.2 0.3 18.5 0.1 7.9 3.9 0.0 1.4 0.0 1.9 0.0 1.1 0.8 0.0 1.3 0.0 6.0 1.4 8.7 10.4 0.0 0.0 0.0 1.1 0.2 0.0 0.0 16.0 0.1 3.7 0.7 18.2 1.0 6.2 0.2 3.3 1.7 0.2 0.0 0.3 7.1 0.2 0.3 5.8 3.7 3.9 10.7 4.8 2.5 1.7 0.0 3.8 1.4 7.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 4.7 0.0 0.0 0.0 2.9 14.6 1.0 6.0 2.0 2.1 1.6 6.5 11.1 1.8 3.0 1.7 0.0 0.0 0.8 10.3 4.1 0.0 18.7 20.5 0.0 43.2 0.3 0.0 0.0 0.1 2.7 0.0 0.0 1.8 0.1 4.7 0.3 1.1 0.0 1.0 3.2 0.0 0.6 0.3 0.0 2.3 0.0 1.7 0.0 0.0 16.0 3.2 0.0 0.0 0.0 65.3 0.0 1.0 1.6 1.7 1.1 0.2 0.0 0.0 0.3 SEMA3B "LUCA-1, SemA, sema5, SEMAA, semaV" ENSG00000012171 "Semaphorin 3B" Q13214 3 50267558-50277546 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 147.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 151.8;Enterocytes: 193.7;Syncytiotrophoblasts: 93.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "eosinophil: 3.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "HeLa: 23.0;Hep G2: 34.8;SK-BR-3: 18.1;WM-115: 56.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA030651 Uncertain "Secreted in other tissues" NA NA 29000 "HPA030651: AB_10602224" "prognostic favorable (1.27e-4)" "unprognostic (6.48e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.68e-1)" "unprognostic (4.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.85e-2)" "unprognostic (4.27e-1)" "unprognostic (7.99e-2)" "unprognostic (7.78e-2)" "unprognostic (3.89e-1)" "unprognostic (8.87e-3)" "unprognostic (1.69e-2)" 3.3 18.8 2.5 2.0 7.4 0.0 1.0 0.3 9.2 9.2 6.0 18.6 2.3 13.3 4.4 3.5 2.5 3.4 5.6 3.4 3.6 7.7 0.0 8.1 0.0 12.9 4.9 2.6 5.6 3.5 0.0 147.6 8.2 2.8 2.8 8.5 1.2 6.8 1.5 0.5 19.7 3.9 5.9 0.3 11.9 0.5 9.5 0.0 1.6 0.6 0.0 1.9 0.6 0.0 0.4 3.3 0.0 0.0 0.0 0.0 4.0 2.6 0.2 2.6 0.2 0.3 0.6 5.3 7.3 1.5 2.6 2.0 10.1 0.0 4.9 5.1 0.0 0.6 0.1 8.5 0.6 0.0 0.2 0.0 23.0 34.8 5.8 0.0 0.2 1.7 0.1 1.7 1.3 6.8 0.0 0.0 0.0 0.6 0.2 7.2 0.0 0.2 0.3 7.5 1.4 0.1 0.4 0.1 2.5 0.4 0.3 1.2 1.3 18.1 2.7 0.8 1.3 0.0 0.1 0.4 5.3 1.4 1.7 1.4 0.0 0.0 2.7 0.0 56.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 151.8 18.1 2.7 7.9 0.0 3.7 11.6 43.3 9.4 34.2 61.1 0.0 3.3 1.7 32.0 9.1 3.6 193.7 0.0 20.4 0.9 22.9 9.4 11.5 0.9 1.7 0.0 9.9 8.0 2.6 14.9 3.7 1.3 0.0 1.0 31.6 18.8 31.2 56.1 2.8 45.3 1.6 6.5 2.1 4.9 4.7 0.0 93.4 0.0 25.9 27.1 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.8;thyroid gland: 33.0" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "amygdala: 17.1" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 5 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" NA NA 77000 "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 4.1 2.2 17.1 1.9 2.3 0.1 4.3 0.8 2.8 4.6 2.9 1.8 2.5 1.4 1.9 7.4 1.3 3.9 1.4 2.0 3.6 2.7 3.0 1.0 3.6 6.1 2.4 3.1 4.1 0.8 0.4 1.5 0.6 5.4 6.2 2.6 2.6 5.6 2.9 0.7 2.1 2.7 3.2 4.8 33.8 2.4 4.3 2.5 0.0 33.0 0.6 1.1 4.7 3.9 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 4.6 5.0 5.4 2.6 0.0 0.0 0.0 1.4 17.0 0.1 17.3 1.9 0.0 3.6 0.0 3.5 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.4 6.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 4.5 1.2 5.5 4.0 1.7 0.0 0.1 0.6 0.0 0.0 0.2 8.9 0.2 0.0 26.5 0.0 1.7 0.2 0.0 3.3 1.9 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 17.1 2.3 0.8 2.2 3.6 2.7 2.4 3.1 5.4 2.5 0.0 3.5 0.8 2.3 3.2 1.5 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 137.5 5.2 0.0 0.0 0.2 0.0 6.7 7.1 2.3 0.0 0.9 1.6 25.4 1.8 0.0 14.9 48.6 0.8 11.8 0.0 0.0 0.9 0.0 0.0 58.7 4.5 4.1 0.0 2.1 0.7 0.7 2.0 0.0 0.0 0.1 0.4 SEMA3G "FLJ00014, sem2" ENSG00000010319 "Semaphorin 3G" Q9NS98 3 52433053-52445085 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 46.2;breast: 89.1" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 8.2;Endothelial cells: 9.0;Intestinal endocrine cells: 9.2;Syncytiotrophoblasts: 6.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "T-reg: 4.5" "Lineage enriched" "Detected in single" 18 "T-cells: 4.5" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;Hep G2: 6.3;HUVEC TERT2: 6.7;THP-1: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001761 Uncertain "Secreted to blood" NA NA 4400000 "HPA001761: AB_1079902" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "unprognostic (7.08e-2)" "unprognostic (1.47e-2)" "unprognostic (2.85e-1)" "unprognostic (5.79e-4)" "unprognostic (5.20e-3)" "unprognostic (9.14e-2)" "unprognostic (5.54e-2)" "unprognostic (5.64e-2)" "unprognostic (1.34e-3)" "unprognostic (4.14e-1)" "prognostic favorable (8.86e-5)" "unprognostic (5.63e-2)" "unprognostic (2.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.14e-1)" 46.2 1.6 3.1 2.4 5.0 0.2 89.1 11.5 5.3 3.5 5.4 2.8 1.5 2.1 3.3 3.0 3.5 3.2 4.5 8.0 3.8 3.3 8.8 0.7 30.4 1.2 5.5 2.5 2.0 2.2 1.1 1.1 19.3 3.1 2.9 2.8 6.8 13.6 2.1 8.0 5.2 6.7 3.2 3.6 7.2 2.7 2.0 1.1 0.4 3.5 4.7 1.4 3.7 5.3 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.1 0.2 23.9 0.2 2.7 0.0 0.0 0.0 0.0 0.7 0.4 3.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 3.5 0.2 6.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 6.7 2.4 0.0 0.3 0.0 0.2 0.2 4.1 1.2 0.6 0.1 0.0 0.0 3.8 0.0 0.2 0.6 0.6 0.0 0.3 0.5 0.1 2.0 5.9 2.5 0.0 2.5 0.0 0.0 0.5 1.7 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.1 5.0 11.5 5.3 3.8 3.3 5.5 2.5 3.1 1.1 3.0 2.2 0.0 0.0 0.3 0.5 8.2 0.0 0.0 0.0 3.5 0.0 1.4 0.0 0.0 2.1 9.0 0.0 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.2 0.0 9.2 1.3 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 6.3 0.0 0.1 0.0 SEMA4A "CORD10, FLJ12287, SEMAB, SemB" ENSG00000196189 "Semaphorin 4A" Q9H3S1 1 156147366-156177752 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Angiogenesis, Differentiation, Immunity, Neurogenesis" "Developmental protein" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 46.8" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 61.4;Collecting duct cells: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 26.4;eosinophil: 25.2;intermediate monocyte: 29.5;myeloid DC: 40.3;neutrophil: 46.8;non-classical monocyte: 15.6" "Group enriched" "Detected in many" 12 "dendritic cells: 40.3;granulocytes: 46.8;monocytes: 29.5" "Cell line enhanced" "Detected in many" "Karpas-707: 55.9;U-698: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA069136 Supported NA NA 2400000 "HPA069136: AB_2686093" "unprognostic (1.90e-1)" "unprognostic (2.39e-2)" "unprognostic (4.24e-1)" "unprognostic (5.20e-2)" "unprognostic (8.04e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.97e-1)" "unprognostic (2.50e-2)" "unprognostic (3.51e-1)" "unprognostic (1.60e-2)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (8.20e-4)" "unprognostic (8.77e-2)" "unprognostic (4.63e-2)" "unprognostic (6.06e-2)" "unprognostic (1.28e-2)" 4.5 1.0 19.2 21.4 17.6 23.1 6.5 2.9 19.2 5.6 4.7 2.5 10.3 2.6 2.1 37.0 19.8 5.7 8.3 2.9 8.4 12.7 11.6 1.7 11.7 28.7 6.3 12.2 3.6 2.9 1.4 2.5 7.4 4.8 10.2 4.4 24.6 19.5 13.7 1.9 21.6 3.0 2.7 2.7 17.5 7.1 2.5 3.5 11.0 24.0 9.3 30.8 7.3 10.1 3.1 40.3 46.8 29.5 0.9 1.9 11.4 4.5 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 2.9 0.1 0.2 0.0 4.3 0.3 3.6 0.1 1.2 0.0 0.1 0.0 0.1 0.1 6.5 0.4 0.2 3.4 0.0 0.1 0.8 0.3 1.0 0.4 55.9 0.2 5.4 0.0 2.3 1.3 4.4 0.0 0.2 0.1 1.8 6.6 8.8 0.0 0.1 0.0 7.1 0.3 0.6 8.1 8.4 0.3 0.0 0.0 0.0 0.0 10.8 1.0 24.3 0.2 6.3 0.1 3.0 26.4 25.2 0.9 29.5 1.9 3.1 0.3 1.8 40.3 2.8 0.0 0.3 46.8 0.9 15.6 5.8 0.3 11.4 19.2 17.6 2.9 19.2 8.4 12.7 6.3 12.2 4.8 3.5 17.9 61.4 10.7 21.4 20.8 1.0 4.5 10.2 12.0 10.3 38.4 0.0 0.7 1.7 4.9 4.1 3.8 1.0 0.0 0.6 0.4 12.7 13.0 17.3 0.0 15.8 0.0 3.5 7.4 18.6 3.7 1.7 34.4 15.1 16.2 20.4 5.8 1.0 3.5 1.1 0.7 0.3 0.0 5.3 1.9 0.5 24.1 1.5 1.9 18.3 12.4 SEMA4D "C9orf164, CD100, coll-4, FLJ39737, SEMAJ" ENSG00000187764 "Semaphorin 4D" Q92854 9 89360787-89498130 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.1;skeletal muscle: 43.3" "Cell type enhanced" "Detected in many" 6 "granulocytes: 41.5;T-cells: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.5;HMC-1: 32.8;JURKAT: 29.4;MOLT-4: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015662, HPA023277" Approved NA NA 4100000 "HPA015662: AB_1856671, HPA023277: AB_1856672" "unprognostic (2.94e-2)" "prognostic favorable (4.17e-4)" "unprognostic (1.12e-2)" "unprognostic (8.22e-2)" "unprognostic (1.41e-1)" "unprognostic (1.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.58e-1)" "unprognostic (7.79e-2)" "unprognostic (2.74e-1)" "unprognostic (3.18e-3)" "unprognostic (1.50e-2)" "unprognostic (2.29e-3)" "unprognostic (3.05e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-1)" "prognostic favorable (4.06e-5)" 3.9 5.6 18.0 18.6 20.7 14.3 3.6 7.7 20.9 4.0 5.9 54.0 3.1 6.1 3.9 7.4 9.3 6.6 7.2 4.9 28.2 18.8 8.4 2.0 6.7 32.0 42.6 15.0 4.1 4.6 4.9 5.3 3.2 27.5 4.9 5.8 2.9 6.7 4.2 43.3 8.8 9.6 3.3 107.1 19.2 9.4 6.1 23.3 25.3 4.9 3.1 27.6 8.3 5.3 2.6 4.6 21.2 4.1 4.7 14.0 7.8 4.0 3.0 2.8 4.1 0.1 0.2 6.4 0.4 0.2 0.8 0.6 2.0 4.5 15.3 1.7 0.0 3.3 2.1 2.5 1.2 0.3 42.5 2.5 6.4 1.0 0.2 0.5 8.5 32.8 0.1 0.9 0.2 0.1 0.1 1.6 29.4 1.5 10.4 0.0 6.6 38.5 10.7 6.9 8.0 0.1 12.3 0.9 4.3 5.5 4.2 6.6 4.4 1.1 3.6 0.1 4.1 3.3 4.6 1.0 0.0 2.6 0.3 1.9 11.7 5.0 2.2 1.9 10.3 2.5 7.3 4.1 20.4 13.3 3.8 8.0 2.6 10.6 11.1 1.5 1.6 12.2 14.0 21.2 4.7 4.1 4.6 9.5 7.8 18.0 20.7 7.7 20.9 28.2 18.8 42.6 15.0 27.5 23.3 6.0 21.5 24.2 2.9 4.0 10.2 14.8 5.1 5.3 9.1 10.4 2.0 7.5 3.3 5.0 1.7 4.9 0.5 0.0 2.9 1.8 4.8 6.7 41.5 1.7 17.0 31.8 1.7 5.5 26.2 2.2 6.9 21.6 1.7 5.4 6.4 8.6 3.2 0.0 14.2 14.4 4.8 0.0 2.1 0.7 22.6 4.6 3.1 50.3 3.3 6.7 SEMA4G "FLJ20590, KIAA1619" ENSG00000095539 "Semaphorin 4G" Q9NTN9 10 100969518-100985871 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.0;liver: 33.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 42.3;Hepatocytes: 52.1;Mucus-secreting cells: 37.8;Paneth cells: 25.9;Undifferentiated cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.1;CACO-2: 12.5;Hep G2: 45.8;OE19: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038362, HPA077752" Uncertain Uncertain "Vesicles,Lipid droplets" "Intracellular and membrane" NA NA 840000 "Vesicles, Lipid droplets" "HPA038362: AB_10669524, HPA077752: " "unprognostic (3.90e-3)" "unprognostic (9.43e-3)" "unprognostic (2.84e-1)" "unprognostic (1.13e-2)" "unprognostic (5.55e-2)" "unprognostic (8.11e-2)" "unprognostic (3.28e-1)" "unprognostic (3.71e-2)" "unprognostic (3.63e-1)" "unprognostic (1.41e-2)" "unprognostic (3.09e-2)" "unprognostic (3.14e-1)" "unprognostic (3.93e-2)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.17e-1)" "unprognostic (3.05e-2)" 1.2 5.0 8.2 9.2 5.6 0.2 1.9 17.8 9.0 2.5 34.3 4.9 3.2 25.9 2.1 16.6 1.8 3.1 25.9 1.6 4.9 5.0 9.5 33.9 2.9 1.2 4.2 4.6 9.2 21.3 3.7 4.4 2.2 7.8 8.6 42.3 4.8 4.3 6.1 1.2 7.1 44.0 2.5 2.5 1.8 10.4 2.5 3.7 0.1 9.8 0.5 0.5 2.3 2.4 2.4 1.0 0.4 0.4 0.0 1.3 0.0 0.0 13.1 3.4 1.4 2.1 0.7 2.8 0.5 1.4 0.7 0.7 12.5 2.1 0.2 1.7 0.6 0.2 0.8 3.3 0.6 0.6 0.2 2.0 0.6 1.0 45.8 5.4 0.5 0.4 3.6 0.7 0.6 0.3 9.5 1.8 1.4 1.3 0.1 1.0 0.8 0.2 0.5 0.5 28.1 0.7 1.2 0.3 0.6 3.1 0.4 1.0 5.3 0.4 0.9 1.3 3.9 3.6 0.6 1.2 0.4 1.6 0.4 0.1 0.4 0.2 0.2 0.4 0.4 0.4 0.0 0.4 0.4 0.3 0.0 0.2 2.4 0.4 1.3 1.0 0.6 0.4 0.2 0.0 0.0 0.2 0.3 0.1 0.0 8.2 5.6 17.8 9.0 4.9 5.0 4.2 4.6 7.8 3.7 3.0 1.4 2.9 0.3 0.0 0.7 0.9 17.8 2.7 0.0 0.0 0.0 6.0 0.0 1.8 0.2 0.1 42.3 0.0 2.2 1.2 0.4 2.9 0.0 52.1 0.7 11.1 8.2 2.5 4.6 0.0 2.0 0.0 1.7 0.0 37.8 1.1 2.2 25.9 1.1 5.6 1.2 0.0 0.3 0.1 0.7 0.1 2.4 0.0 30.7 0.4 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909193-123028605 "Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;heart muscle: 11.7" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 2.5;Cardiomyocytes: 3.2;Cholangiocytes: 2.5;Ito cells: 3.1;Muller glia cells: 10.6" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 42.4;NTERA-2: 8.2;SH-SY5Y: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol NA NA Cytosol "HPA066548: AB_2685689" "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.5 1.2 12.0 0.7 12.3 0.3 1.1 0.8 13.6 2.1 1.5 4.3 0.4 1.9 2.8 5.5 1.5 3.0 4.7 11.7 13.0 3.3 6.1 1.4 2.2 1.1 2.5 3.3 1.3 3.1 1.1 2.5 5.0 2.0 1.8 1.8 6.0 0.9 3.1 1.6 1.2 1.3 3.8 1.7 0.5 0.7 1.1 5.7 0.1 2.2 2.5 1.3 3.3 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 42.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 11.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.0 12.3 0.8 13.2 13.0 3.3 2.5 3.3 2.0 5.7 0.0 0.6 0.0 0.0 0.0 2.5 3.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.3 0.0 0.0 1.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 2.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443616-116574934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.2" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 93.0;Horizontal cells: 130.3;Ito cells: 160.2;Syncytiotrophoblasts: 291.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.9;HAP1: 15.1;NTERA-2: 33.8;SuSa: 68.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" NA NA 180000 Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 12.7 37.4 12.6 4.9 34.7 3.6 10.6 18.7 26.5 6.9 19.6 31.2 0.8 19.2 6.1 3.4 3.9 6.2 12.8 5.0 17.2 12.9 6.1 6.0 17.8 4.5 35.9 13.9 13.1 10.3 2.2 4.4 30.2 32.2 6.6 17.5 2.6 15.1 3.2 7.6 5.6 24.0 6.3 48.2 8.2 5.4 6.6 31.4 0.5 6.7 1.6 2.7 4.6 5.9 1.6 0.7 0.1 0.4 0.0 1.3 0.0 0.1 0.0 10.9 12.9 0.0 0.0 11.3 0.2 0.1 0.0 0.0 0.6 0.4 0.4 0.5 0.1 0.2 0.1 15.1 0.0 0.0 0.4 2.2 0.2 0.2 3.6 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.2 1.1 33.8 0.0 0.1 1.9 7.1 0.5 5.6 9.7 3.0 1.1 0.0 0.2 5.8 68.7 4.2 0.7 0.2 1.0 0.9 0.1 0.4 0.2 0.1 0.2 0.1 0.5 4.0 0.0 0.4 0.0 1.2 0.0 0.1 1.6 1.3 0.0 0.3 1.2 0.4 0.5 0.1 0.0 0.2 0.7 0.1 0.0 12.6 34.7 18.7 24.0 17.2 12.9 35.9 13.9 32.2 31.4 0.0 1.1 0.8 0.7 5.8 8.1 6.7 48.4 0.0 0.0 14.0 2.0 93.0 0.0 26.5 9.7 56.5 45.5 0.0 1.1 3.7 16.0 1.5 0.0 0.6 10.8 130.3 26.9 160.2 15.5 1.4 6.1 1.3 23.6 0.0 31.1 5.1 2.5 42.1 1.8 3.7 3.2 0.0 6.2 0.5 1.4 3.6 291.1 1.3 32.4 0.5 SEMA6B "SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ" ENSG00000167680 "Semaphorin 6B" Q9H3T3 19 4542593-4559808 "Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 42.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 55.5;Ciliated cells: 32.1;Club cells: 35.2;Endothelial cells: 25.1;granulocytes: 27.8;Horizontal cells: 17.5;Ito cells: 38.1;Macrophages: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 36.4;HMC-1: 60.2;HUVEC TERT2: 24.6;TIME: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025157, HPA055778, HPA058523" Enhanced NA NA 180000 "CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741" "unprognostic (4.03e-1)" "unprognostic (9.69e-3)" "unprognostic (6.38e-3)" "unprognostic (2.15e-1)" "unprognostic (1.15e-1)" "unprognostic (7.94e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-3)" "unprognostic (6.61e-2)" "unprognostic (1.90e-1)" "unprognostic (4.21e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (1.26e-1)" "unprognostic (1.81e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (9.55e-2)" 23.2 9.3 27.2 12.1 24.2 7.9 9.7 16.9 42.9 3.8 4.7 1.7 0.3 4.8 4.1 3.1 3.6 2.5 7.0 12.8 30.3 11.5 3.7 5.2 13.1 18.6 9.5 0.8 5.1 4.8 1.7 3.1 9.9 11.0 4.3 1.8 2.7 1.4 2.2 9.3 3.3 4.8 7.9 6.4 17.5 2.5 2.5 8.8 0.0 6.0 3.7 2.0 8.3 24.4 0.0 0.0 0.7 0.4 0.0 0.0 0.0 2.0 7.3 0.6 6.3 0.0 0.3 0.1 0.0 0.2 0.7 0.2 0.0 0.6 0.0 7.0 0.0 1.1 1.3 1.8 0.0 0.2 0.0 0.3 0.0 0.1 36.4 0.1 0.0 60.2 2.2 0.0 0.0 0.0 7.5 24.6 0.0 0.4 0.1 0.2 1.8 0.0 0.0 7.9 0.5 0.1 0.1 14.3 0.1 0.5 0.0 5.3 0.5 0.0 0.6 3.8 0.6 0.9 0.3 31.0 0.9 11.6 0.1 5.2 0.4 0.0 0.1 0.2 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 27.2 24.2 16.9 27.9 30.3 11.5 9.5 0.8 11.0 8.8 26.8 55.5 1.4 1.0 4.1 4.3 1.5 2.5 32.1 35.2 1.8 3.9 0.6 0.0 0.7 0.9 25.1 0.0 0.0 0.2 0.6 5.7 0.9 27.8 5.8 2.9 17.5 0.0 38.1 5.4 0.0 0.6 22.3 6.8 1.0 0.0 1.7 0.1 0.0 0.7 0.1 4.2 0.0 2.2 0.5 2.2 4.4 0.2 3.2 0.0 0.9 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 124.1;tongue: 43.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 290000 "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favorable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 3.2 1.9 2.3 1.5 3.0 1.3 3.4 16.8 5.8 4.2 2.6 1.5 0.8 6.7 4.1 3.5 3.2 2.9 3.9 12.7 2.3 3.5 3.0 3.3 1.9 3.4 1.7 3.3 4.8 1.7 1.7 4.3 1.6 2.7 2.8 1.6 3.4 3.1 1.9 124.1 3.4 5.2 3.6 1.1 1.3 1.6 15.0 0.6 0.5 1.3 43.4 2.9 2.2 3.6 0.9 0.6 0.7 0.0 0.1 1.4 0.2 0.8 0.8 11.9 4.6 5.1 1.7 1.1 0.8 0.4 0.8 1.1 0.2 0.5 0.5 3.4 2.7 1.7 1.2 1.1 0.4 0.7 1.0 3.5 6.2 0.5 1.0 0.7 0.1 2.3 2.9 1.4 1.0 0.5 2.4 20.9 3.4 0.5 0.6 2.0 0.4 1.0 0.8 5.4 0.1 1.4 7.4 2.6 0.3 0.4 0.3 6.1 7.9 1.1 0.5 1.0 3.1 1.3 1.0 9.7 2.0 2.9 3.0 0.4 5.0 0.9 5.1 0.5 0.2 0.7 0.0 0.0 0.7 0.1 0.0 1.4 0.0 0.2 0.0 0.0 0.9 0.5 0.0 0.5 0.1 0.0 0.6 0.3 0.2 2.3 3.0 16.8 5.8 2.3 3.5 1.7 3.3 2.7 0.6 0.0 3.2 1.7 0.8 1.4 4.2 15.3 2.5 0.0 1.2 0.0 19.6 0.2 0.0 0.3 0.5 3.1 0.3 0.0 0.4 0.4 2.1 0.5 0.0 2.4 0.3 6.4 0.0 4.9 1.6 2.1 5.2 0.0 1.7 0.0 0.0 1.7 0.4 0.0 2.5 2.7 6.9 0.0 2.0 2.8 1.1 0.9 0.1 0.0 0.2 0.5 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.2 0.0 1.3 1.1 0.2 0.5 13.4 0.3 0.0 0.3 0.1 1.8 0.0 3.4 0.0 7.0 2.8 0.9 0.0 0.9 1.6 0.0 4.1 0.0 3.6 0.0 0.1 1.0 7.3 0.0 0.4 0.0 0.9 4.8 0.1 2.9 0.4 0.7 2.2 0.5 4.2 0.0 0.0 1.3 0.0 2.0 1.0 0.9 11.9 11.0 0.1 0.9 3.7 13.2 0.4 0.0 0.0 6.2 0.3 0.2 0.0 8.8 0.0 2.0 1.6 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 47.6 1.0 0.0 4.0 1.8 3.3 9.4 0.0 0.0 3.4 10.4 108.0 14.7 5.0 1.0 0.1 6.7 37.0 0.0 0.2 1.2 6.7 0.9 3.5 0.8 2.3 74.7 16.7 4.9 0.0 0.0 21.6 0.0 8.5 0.0 2.6 14.3 0.4 6.0 12.7 0.2 2.0 0.0 12.2 0.7 5.1 1.0 3.9 0.0 9.8 1.4 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 64.8;Extravillous trophoblasts: 51.6;monocytes: 49.5;Pancreatic endocrine cells: 55.5;Rod photoreceptor cells: 57.4;Syncytiotrophoblasts: 139.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 8.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "HMC-1: 101.9;hTEC/SVTERT24-B: 40.0;U-251 MG: 58.8;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles NA NA 29000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.2 1.9 5.4 10.4 13.8 12.8 1.4 22.9 27.3 1.3 1.8 19.9 1.4 2.7 4.3 1.8 3.2 1.2 3.3 1.4 10.8 5.7 1.4 1.5 4.4 19.0 28.5 5.7 5.9 0.9 6.4 1.9 54.0 28.6 1.4 1.8 7.8 1.7 3.5 1.4 4.7 6.0 2.0 36.4 34.7 3.7 23.6 15.4 9.0 1.1 0.4 19.7 4.6 1.7 1.4 1.8 8.9 0.0 0.8 0.2 0.0 5.8 0.0 1.7 0.5 2.2 7.6 14.6 27.1 10.9 5.7 8.8 2.3 9.6 0.0 1.6 12.2 4.6 1.7 0.5 1.7 5.9 0.4 0.3 10.6 0.0 2.9 0.5 0.3 101.9 5.3 0.0 40.0 2.2 14.4 0.0 0.7 6.0 3.7 18.5 0.4 1.4 3.4 1.9 0.1 4.1 0.2 1.2 1.5 2.4 2.5 0.1 0.1 0.2 4.9 2.2 1.6 0.3 2.1 1.0 10.7 7.1 5.1 58.8 0.6 0.4 0.1 34.3 1.2 0.5 3.9 0.0 8.9 0.2 0.0 0.2 1.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.0 1.8 0.0 0.0 5.4 13.8 22.9 27.3 10.8 5.7 28.5 5.7 28.6 15.4 3.0 0.0 2.7 0.5 0.3 10.9 0.8 0.0 0.0 2.3 1.8 64.8 20.3 0.0 17.3 0.5 2.4 0.0 0.0 12.1 51.6 0.8 1.9 8.1 0.8 6.4 1.6 0.0 0.6 0.8 1.5 3.4 1.2 8.5 49.5 0.0 4.2 55.5 0.0 1.8 0.0 57.4 0.0 0.9 0.7 0.4 1.3 139.1 2.5 0.0 25.3 SEMG1 "CT103, SEMG" ENSG00000124233 "Semenogelin I" P04279 20 45206997-45209772 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 26 "ductus deferens: 2077.7;seminal vesicle: 1931.9" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 14 "prostate cancer: 20.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 192 "eosinophil: 19.2" "Lineage enriched" "Detected in single" 192 "granulocytes: 19.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.3;NB-4: 1.7;NTERA-2: 3.3;THP-1: 7.9" "HPA042476, HPA064892" Enhanced "Secreted in male reproductive system" NA NA 1700000 "HPA042476: AB_10794799, HPA064892: AB_2732724" "unprognostic (3.71e-1)" "unprognostic (2.92e-2)" "unprognostic (1.44e-1)" "unprognostic (3.32e-1)" "unprognostic (1.11e-2)" 0.2 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.2 0.0 2077.7 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 76.5 0.0 0.0 0.2 1931.9 0.2 0.2 0.2 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 19.5 0.1 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SEMG2 SGII ENSG00000124157 "Semenogelin II" Q02383 20 45221300-45224458 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "ductus deferens: 1137.0;seminal vesicle: 1095.3" "Cell type enhanced" "Detected in single" 34 "Collecting duct cells: 3.5" "Cancer enriched" "Detected in single" 25 "prostate cancer: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042767, HPA042835" Enhanced "Secreted in male reproductive system" NA NA 920000 "HPA042767: AB_10959312, HPA042835: AB_10964060" "unprognostic (1.39e-1)" "unprognostic (2.17e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 1137.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 46.2 0.0 0.0 0.1 1095.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 8.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SENP1 ENSG00000079387 "SUMO1/sentrin specific peptidase 1" Q9P0U3 12 48042898-48106308 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 64.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011765, HPA046491" Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA011765: AB_1079907, HPA046491: AB_2679672" "unprognostic (2.66e-2)" "unprognostic (6.51e-2)" "unprognostic (3.14e-1)" "unprognostic (5.69e-2)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.72e-5)" "unprognostic (6.48e-2)" "unprognostic (2.44e-3)" "unprognostic (8.20e-3)" "unprognostic (2.57e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.37e-4)" "unprognostic (7.61e-2)" "unprognostic (3.02e-1)" "unprognostic (1.01e-1)" "unprognostic (1.28e-1)" 5.7 3.3 3.0 9.0 4.0 8.4 5.2 5.3 3.2 5.5 4.9 3.8 3.5 3.4 6.2 4.3 5.7 5.2 3.8 3.6 2.7 3.3 3.8 3.9 4.3 7.3 3.0 2.3 6.2 4.4 6.1 11.4 8.1 3.0 4.4 4.7 5.1 20.0 4.7 6.8 6.6 4.5 5.8 4.3 6.4 4.5 60.2 3.6 15.0 5.2 4.8 8.3 5.7 6.3 5.3 3.8 7.1 2.6 3.8 5.5 2.3 7.1 9.2 11.5 8.6 3.4 5.1 8.5 7.7 8.6 13.2 10.8 11.3 11.6 19.4 6.7 7.0 5.2 7.0 14.2 6.8 13.5 17.6 6.4 17.0 8.9 5.4 5.7 15.8 11.5 4.1 5.6 11.9 10.6 5.9 6.9 13.2 14.9 9.3 6.8 5.7 19.7 5.0 10.5 4.9 7.0 18.7 12.1 9.5 3.6 8.8 12.1 8.3 11.1 6.8 4.5 6.8 10.7 7.6 6.3 11.2 10.1 6.5 8.1 9.6 15.5 19.0 6.9 36.8 5.1 2.0 1.8 7.1 4.3 2.6 5.5 2.4 4.2 3.9 3.3 5.3 3.6 4.1 3.8 3.8 2.0 3.8 5.0 2.3 3.0 4.0 5.3 3.2 2.7 3.3 3.0 2.3 3.0 3.6 8.9 6.2 5.6 4.2 3.3 8.2 2.1 7.6 5.3 10.3 3.5 3.9 3.1 3.3 3.0 10.2 6.3 2.5 0.0 5.6 2.8 3.7 3.6 5.8 6.6 3.8 14.3 3.4 7.4 10.0 3.3 5.8 4.8 1.7 5.4 3.7 4.8 4.5 2.0 6.3 3.4 8.3 0.0 3.1 64.4 24.9 5.4 2.3 4.4 3.6 3.0 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO/sentrin peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143688 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.5" "Group enriched" "Detected in many" 11 "Early spermatids: 71.2;Late spermatids: 177.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 2.5 4.8 6.4 3.4 8.1 5.0 4.4 5.7 8.0 4.0 4.0 3.9 6.4 3.8 3.9 6.7 4.8 5.1 4.2 7.7 7.3 6.9 9.3 5.0 3.3 3.1 6.2 7.7 5.3 6.2 3.9 12.7 3.7 8.0 5.9 4.3 4.2 5.6 6.6 11.0 3.5 3.3 4.2 5.0 3.1 4.3 26.5 4.3 2.2 12.0 4.5 2.7 4.9 3.0 3.0 5.7 2.1 5.6 7.1 3.7 2.1 1.9 3.3 6.4 5.0 7.7 9.3 3.6 5.0 3.2 3.1 2.8 2.7 4.6 1.9 7.5 3.2 5.4 4.6 9.8 7.8 4.5 2.1 5.3 3.1 4.6 2.2 5.4 3.6 1.7 4.5 7.9 1.9 8.5 4.0 2.8 5.9 4.6 3.7 7.2 4.9 3.7 4.8 5.1 4.5 3.3 2.4 5.4 4.1 8.0 3.4 7.8 2.6 5.3 4.4 5.3 8.0 6.8 2.8 2.9 6.2 2.3 10.2 2.6 3.0 3.6 2.3 2.9 5.0 4.4 2.1 1.9 1.4 1.6 3.9 2.3 3.0 2.8 2.5 5.7 1.4 3.1 3.7 0.7 7.1 5.6 1.7 2.1 2.1 6.4 8.1 5.7 8.0 7.3 6.9 6.2 7.7 8.0 4.3 6.0 4.0 0.0 2.0 0.2 4.0 5.2 2.5 8.1 5.7 1.8 3.9 6.1 11.6 2.8 71.2 0.9 1.6 0.0 1.6 3.1 2.1 1.4 0.0 1.0 1.9 1.6 1.2 1.8 1.5 177.0 1.7 2.1 0.0 4.6 1.3 7.2 1.4 1.9 1.1 5.7 3.2 0.0 0.5 10.4 11.4 0.4 6.5 0.5 2.1 0.9 SEPHS2 "SPS2, SPS2b" ENSG00000179918 "Selenophosphate synthetase 2" Q99611 16 30443631-30446181 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 52.8;liver: 111.2" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 326.6;Proximal tubular cells: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 96.4" "Low region specificity" "Detected in all" HPA047931 Approved Approved Nucleoplasm No No Nucleoplasm "HPA047931: AB_2680216" "unprognostic (5.33e-2)" "unprognostic (2.02e-1)" "unprognostic (1.92e-2)" "unprognostic (9.85e-2)" "unprognostic (2.67e-2)" "unprognostic (6.29e-2)" "unprognostic (5.67e-2)" "unprognostic (7.69e-3)" "unprognostic (2.38e-1)" "unprognostic (9.86e-2)" "unprognostic (9.66e-3)" "unprognostic (1.49e-1)" "prognostic favorable (4.35e-8)" "unprognostic (2.24e-2)" "unprognostic (1.35e-1)" "unprognostic (3.25e-2)" "unprognostic (3.62e-2)" 9.0 9.0 4.9 6.9 6.4 4.0 6.7 6.3 8.4 5.3 25.6 5.2 5.5 26.6 7.6 6.1 6.0 6.1 12.6 5.3 5.2 5.1 32.8 111.2 5.8 7.6 5.5 3.8 5.2 10.0 7.3 6.4 7.5 7.7 6.6 13.1 6.2 10.6 4.7 11.1 5.5 52.8 4.9 4.4 10.5 12.1 3.0 4.6 14.1 11.9 6.4 9.5 8.1 4.4 14.6 15.3 20.5 13.7 23.2 18.9 8.9 14.8 13.4 4.8 16.5 14.7 9.4 12.5 10.3 12.7 10.1 12.6 8.3 11.4 21.3 15.9 10.9 9.2 8.3 8.8 9.4 10.3 13.6 27.2 21.3 7.3 39.0 18.6 11.8 96.4 11.9 20.1 9.5 17.7 6.4 9.2 15.8 17.2 13.9 8.9 21.9 17.7 24.4 11.8 11.2 10.2 17.3 8.3 16.3 12.5 13.4 10.1 8.7 8.8 25.8 33.4 10.0 22.6 39.5 7.7 10.6 7.5 10.2 6.2 12.0 19.2 11.1 9.2 22.1 11.8 6.1 12.9 20.5 11.2 11.2 17.1 12.4 15.9 16.1 15.3 14.6 18.9 12.9 12.9 23.2 13.7 10.9 15.1 8.9 4.9 6.4 6.3 8.4 5.2 5.1 5.5 3.8 7.7 4.6 41.7 32.3 26.8 1.1 33.3 0.8 46.2 0.0 21.4 21.6 61.1 0.0 1.1 326.6 80.1 0.0 17.5 13.1 0.0 72.7 0.9 24.9 1.7 30.1 6.7 1.2 0.0 34.0 0.6 2.4 0.0 0.0 34.5 42.2 64.1 1.1 0.2 55.5 3.5 0.0 285.3 0.8 0.0 54.6 0.7 0.7 37.3 1.0 20.8 1.4 0.6 SEPSECS "SLA, SLA/LP" ENSG00000109618 "Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase" Q9HD40 4 25120014-25160442 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "RNA-binding, Transferase, tRNA-binding" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 34.2" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070409 Approved Vesicles NA NA Vesicles "HPA070409: AB_2686265" "unprognostic (1.83e-1)" "unprognostic (4.09e-2)" "unprognostic (6.37e-3)" "unprognostic (5.86e-2)" "unprognostic (9.63e-2)" "unprognostic (4.61e-3)" "unprognostic (1.82e-3)" "unprognostic (6.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.34e-1)" "unprognostic (2.52e-1)" "unprognostic (3.56e-2)" "unprognostic (4.45e-3)" "unprognostic (4.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-3)" 7.0 6.1 3.8 8.5 6.4 11.8 7.4 5.4 6.0 5.3 13.5 7.8 8.9 11.8 6.7 9.6 5.3 6.5 8.9 5.6 4.8 3.6 10.5 34.2 9.4 9.7 7.2 4.9 8.5 11.3 7.3 5.1 4.4 5.4 4.7 7.8 5.2 6.2 9.2 5.5 10.9 15.3 3.7 7.0 7.5 7.4 8.9 6.8 12.3 7.7 4.8 8.0 6.8 5.5 5.7 5.9 3.2 4.0 3.4 5.5 2.2 2.9 1.6 6.2 3.3 5.7 7.9 5.4 3.0 4.1 3.4 3.4 1.3 7.2 5.4 3.0 3.4 3.8 3.6 4.8 3.6 3.8 2.7 1.6 6.6 5.6 2.6 6.4 5.8 8.7 7.4 5.7 2.5 5.6 5.2 3.6 12.2 10.4 5.5 2.7 1.7 9.3 16.3 2.9 2.4 6.1 4.8 7.4 4.8 4.7 3.1 4.7 4.4 2.7 2.2 5.2 4.6 4.2 5.6 3.7 5.2 2.7 1.6 2.9 8.6 9.6 6.0 3.2 9.6 3.1 2.4 4.0 2.2 3.6 3.4 3.5 3.4 4.5 4.9 3.4 5.7 4.6 5.5 3.2 3.4 2.4 5.9 2.6 2.2 3.8 6.4 5.4 6.0 4.8 3.6 7.2 4.9 5.4 6.8 0.0 7.4 4.1 1.5 2.2 2.6 3.9 25.5 9.4 3.4 15.7 0.0 4.7 6.6 4.2 17.7 6.3 8.5 0.0 4.1 3.2 4.0 2.3 3.5 35.0 5.4 4.8 5.8 6.7 6.9 13.0 3.1 5.8 3.3 6.4 6.4 3.1 4.6 7.0 6.0 17.4 2.2 0.0 1.8 13.4 18.5 2.9 4.9 4.9 7.3 1.1 SEPT1 "DIFF6, PNUTL3" ENSG00000180096 "Septin 1" 16 30378133-30395991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "blood: 54.4;lymphoid tissue: 89.8" "Cell type enhanced" "Detected in many" 9 "B-cells: 61.6;T-cells: 135.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 17.7;JURKAT: 23.1;MOLT-4: 30.1;REH: 17.9;U-266/70: 10.4;U-266/84: 15.1;U-698: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041566, HPA060339, HPA073635" Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA041566: AB_10794671, HPA060339: , HPA073635: " "unprognostic (3.65e-3)" "prognostic favorable (9.72e-5)" "unprognostic (5.06e-2)" "prognostic favorable (3.04e-5)" "unprognostic (3.32e-4)" "prognostic favorable (6.63e-4)" "unprognostic (2.08e-1)" "prognostic favorable (7.24e-5)" "unprognostic (1.24e-2)" "unprognostic (6.52e-3)" "prognostic favorable (2.22e-4)" "unprognostic (3.46e-2)" "prognostic unfavorable (2.40e-7)" "unprognostic (1.48e-1)" "unprognostic (1.41e-1)" "unprognostic (3.95e-1)" "unprognostic (1.72e-2)" 1.1 0.8 0.8 20.1 1.6 0.3 0.7 1.1 0.6 1.5 2.8 0.2 0.1 3.9 1.2 0.8 2.0 1.4 1.4 0.8 0.7 0.6 1.2 0.9 3.7 16.0 0.9 0.1 1.5 1.0 0.2 0.5 0.4 0.3 0.8 0.0 0.9 6.6 0.6 0.4 0.9 6.2 0.4 0.7 16.7 3.6 0.4 0.2 89.8 0.9 1.7 32.9 0.9 0.9 28.2 43.5 16.1 0.4 34.4 54.4 38.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.4 0.0 0.0 0.1 0.0 2.3 0.5 0.1 0.0 0.0 0.0 0.3 0.0 23.1 0.1 8.0 0.0 0.0 30.1 0.6 0.0 0.0 0.3 17.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.4 15.1 10.4 0.2 3.3 0.0 16.1 0.4 15.3 54.4 0.3 41.9 28.2 49.5 49.3 1.5 27.6 46.6 46.9 1.4 34.4 0.2 43.5 50.7 38.1 0.8 1.6 1.1 0.6 0.7 0.6 0.9 0.1 0.3 0.2 0.0 12.7 61.6 0.0 23.1 18.4 1.2 17.8 0.0 6.8 15.7 7.9 9.6 31.5 0.0 0.6 4.1 10.9 0.0 0.0 3.4 8.9 0.0 12.7 22.9 8.1 17.5 16.7 6.7 17.3 1.3 44.0 10.3 32.1 0.0 15.6 14.8 0.0 9.9 29.4 44.4 14.7 12.9 0.7 0.5 1.1 19.4 4.1 135.7 17.8 0.0 SEPT12 FLJ25410 ENSG00000140623 "Septin 12" Q8IYM1 16 4777669-4788521 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 99.8" "Cell type enriched" "Detected in some" 5 "Early spermatids: 274.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Region enriched" "Detected in single" 8 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 2.6;SCLC-21H: 1.3;SK-BR-3: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA041128 Uncertain Microtubules NA NA Microtubules "HPA041128: AB_10796568" "unprognostic (2.11e-2)" "unprognostic (1.11e-1)" "unprognostic (1.56e-2)" "unprognostic (2.29e-2)" "unprognostic (2.71e-1)" "unprognostic (5.45e-2)" "unprognostic (7.40e-2)" "unprognostic (1.39e-1)" "unprognostic (3.80e-2)" "unprognostic (1.61e-1)" "unprognostic (1.49e-8)" "unprognostic (7.41e-2)" "unprognostic (9.87e-2)" "unprognostic (8.36e-3)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 99.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 2.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 274.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 1.0 0.0 0.0 56.9 1.5 0.0 0.1 0.0 0.0 0.0 SEPT14 FLJ44060 ENSG00000154997 "Septin 14" Q6ZU15 7 55793544-55862789 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "pituitary gland: 6.5;testis: 25.5" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 1.7;Extravillous trophoblasts: 1.1;Late spermatids: 4.5;Spermatogonia: 3.8" "Cancer enriched" "Detected in some" 10 "glioma: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA073255 Enhanced NA NA "HPA073255: AB_2686590" "unprognostic (1.29e-1)" "unprognostic (3.50e-1)" "unprognostic (1.98e-2)" "unprognostic (1.57e-1)" 0.3 0.2 0.3 0.7 0.3 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.4 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.4 1.4 0.3 0.3 0.3 0.3 0.5 0.3 1.0 6.5 0.4 0.3 0.5 0.2 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.3 0.5 0.2 25.5 0.3 0.3 0.5 0.3 0.3 0.3 0.3 1.2 0.7 2.5 0.6 2.0 0.6 0.3 1.9 0.6 2.1 4.8 2.1 1.8 10.2 1.4 1.2 1.1 1.5 0.5 1.3 1.6 0.4 0.8 2.3 1.8 2.3 1.6 2.9 2.5 1.2 1.0 3.2 3.6 4.7 2.1 2.4 1.8 2.9 1.4 2.5 2.0 1.1 3.7 3.6 2.2 1.7 1.0 2.8 2.8 1.8 3.2 0.4 1.1 2.0 2.2 1.7 1.5 1.7 2.2 0.6 1.3 1.9 2.4 1.4 2.9 0.9 1.5 1.5 1.4 1.0 2.8 8.8 2.2 1.1 7.3 2.2 2.5 0.6 0.5 0.6 0.4 0.5 0.6 0.5 0.5 0.3 1.2 0.6 0.6 1.8 2.0 0.6 0.7 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.5 3.8 0.0 0.0 0.0 0.0 0.0 SEPT3 SEP3 ENSG00000100167 "Septin 3" Q9UH03 22 41969475-41998221 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 101.6" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 17.5;Early spermatids: 10.9;Extravillous trophoblasts: 21.5;Horizontal cells: 14.3;Late spermatids: 20.4" "Cancer enhanced" "Detected in many" "glioma: 24.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 1.2;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 13.8;SCLC-21H: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003548, CAB017633" Supported Supported Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Nucleoplasm, Plasma membrane" "Actin filaments" "CAB017633: AB_2301476, HPA003548: AB_1079908" "unprognostic (2.10e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.56e-2)" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (2.37e-1)" "unprognostic (2.67e-3)" "unprognostic (3.09e-2)" "unprognostic (1.30e-2)" "unprognostic (6.30e-2)" "unprognostic (2.51e-2)" "unprognostic (9.15e-2)" "unprognostic (6.68e-2)" "unprognostic (5.50e-2)" "unprognostic (1.04e-1)" 1.3 4.4 31.3 1.4 26.9 1.3 2.0 35.9 101.6 1.4 1.5 5.6 0.0 1.4 1.4 2.2 1.3 1.2 1.5 1.2 28.9 17.2 1.4 1.2 1.7 1.5 13.2 24.3 1.2 2.0 10.7 1.0 4.9 13.4 2.1 1.5 1.0 1.3 1.2 1.2 2.2 1.4 1.4 7.3 1.3 1.5 2.4 5.3 0.0 1.7 0.0 1.5 1.4 0.1 0.3 1.2 2.1 0.0 0.1 0.2 0.0 0.7 0.8 13.8 10.3 0.1 0.0 6.9 0.1 0.1 0.9 0.4 0.2 1.6 11.1 0.4 0.1 5.9 0.0 7.2 0.0 0.3 4.6 2.3 0.0 0.2 0.0 0.1 0.0 0.5 0.1 0.5 0.0 0.0 0.0 0.0 6.2 0.0 1.7 0.0 1.2 1.8 0.1 9.4 0.1 0.3 8.9 0.0 0.6 0.0 1.3 37.2 7.7 5.5 0.0 9.1 1.4 1.3 3.3 0.0 0.0 4.9 0.4 0.5 7.3 6.4 0.1 0.1 4.5 1.4 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.2 0.0 31.3 26.9 35.9 42.1 28.9 17.2 13.2 24.3 13.4 5.3 0.0 0.0 0.0 0.0 0.3 17.5 0.4 0.0 0.0 2.3 0.0 3.9 1.5 0.0 0.0 10.9 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 1.4 14.3 1.2 0.0 0.0 20.4 0.3 0.3 1.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.3 4.6 0.0 0.0 0.0 SEPT4 "ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2" ENSG00000108387 "Septin 4" O43236 17 58520250-58540818 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 77.8;brain: 94.8" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 2070.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 11.0;hTERT-RPE1: 14.9;SK-MEL-30: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006855, HPA021587, HPA022905" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687" "unprognostic (1.12e-1)" "unprognostic (5.54e-2)" "unprognostic (8.36e-3)" "unprognostic (8.01e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-2)" "unprognostic (6.88e-3)" "unprognostic (2.73e-2)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (1.97e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (6.40e-3)" "unprognostic (1.58e-1)" "unprognostic (8.26e-2)" "unprognostic (8.75e-3)" 14.8 77.8 70.5 2.6 80.0 0.9 7.2 44.3 82.7 4.0 3.3 92.4 0.0 2.7 3.5 3.9 3.2 2.7 8.3 14.3 84.8 49.9 8.5 25.0 9.5 5.9 94.8 32.3 5.4 3.9 4.8 2.4 9.9 49.7 2.5 3.1 10.0 4.4 3.8 4.2 3.9 2.9 6.0 84.0 18.0 2.8 7.3 56.5 0.0 4.5 0.5 3.8 5.1 1.3 1.7 5.5 2.9 5.5 1.4 7.6 5.6 0.0 0.4 0.9 2.6 1.1 0.1 0.4 0.1 0.3 1.6 1.9 0.1 0.1 0.0 3.9 0.6 2.4 0.2 1.4 1.1 0.4 0.1 0.7 0.9 0.2 5.5 11.0 0.1 0.5 5.7 2.2 0.4 2.0 14.9 0.5 1.4 0.0 2.6 0.1 0.0 0.0 0.1 0.5 0.0 0.7 0.1 0.0 1.2 0.0 0.0 2.8 1.6 0.0 0.1 24.2 1.3 0.4 0.3 0.0 0.1 1.2 0.0 1.0 0.8 0.4 0.0 0.9 0.0 0.3 0.0 5.5 1.1 7.6 0.7 2.4 1.7 1.6 2.0 5.5 0.6 2.9 2.3 2.9 1.4 0.0 0.3 1.0 5.6 70.5 80.0 44.3 50.5 84.8 49.9 94.8 32.3 49.7 56.5 0.0 0.6 0.0 0.0 5.5 93.8 45.3 0.0 0.0 0.0 7.0 329.9 3.6 14.9 0.0 62.0 12.7 0.0 23.3 0.0 0.3 7.0 0.0 1.1 20.8 4.7 2070.5 0.0 27.6 2.4 56.2 6.6 1.6 65.8 0.0 0.0 56.1 0.0 0.0 13.1 0.5 325.4 181.1 84.9 3.6 1.7 2.5 3.8 0.0 0.0 0.0 SEPT5 "H5, HCDCREL-1, PNUTL1" ENSG00000184702 "Septin 5" Q99719 22 19714464-19724224 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.2;parathyroid gland: 86.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 9.2;Late spermatids: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "eosinophil: 11.9;neutrophil: 4.4" "Lineage enriched" "Detected in single" 46 "granulocytes: 11.9" "Cell line enhanced" "Detected in many" "K-562: 67.2;THP-1: 21.5" "CAB016120, HPA029095, HPA063885" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA 1600000 "Nucleoplasm, Cytosol" "Actin filaments" "CAB016120: AB_628240, HPA029095: AB_2672904, HPA063885: AB_2685141" "unprognostic (4.07e-2)" "unprognostic (1.47e-1)" "unprognostic (6.78e-3)" "unprognostic (1.39e-2)" "unprognostic (3.92e-1)" "unprognostic (1.86e-1)" "unprognostic (2.50e-2)" "unprognostic (3.77e-1)" "unprognostic (5.66e-2)" "unprognostic (6.19e-2)" "unprognostic (1.88e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (6.87e-6)" "unprognostic (3.39e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (3.30e-2)" 4.2 6.4 60.7 2.3 62.9 12.5 5.1 31.2 86.2 12.2 3.0 5.5 1.1 2.2 7.4 17.0 15.0 14.1 5.5 50.9 52.9 14.6 2.0 1.1 3.7 3.0 12.4 38.7 9.0 5.5 86.4 11.1 4.4 14.9 4.3 2.7 5.3 3.6 4.0 2.8 42.9 2.5 6.4 3.6 2.2 3.4 6.2 9.5 1.9 6.7 4.1 3.1 3.5 5.6 0.0 0.2 11.9 0.1 0.0 0.2 6.3 0.1 3.1 12.2 18.9 1.2 4.0 0.1 4.7 5.9 5.3 3.1 0.2 1.6 0.4 1.8 10.4 7.8 1.7 8.9 1.7 2.7 3.2 1.1 0.2 0.6 0.0 4.9 0.2 13.0 5.3 2.2 1.7 0.7 1.5 2.2 6.7 67.2 0.2 8.3 1.2 1.3 7.5 1.6 0.3 3.3 13.6 0.4 2.1 0.3 0.4 19.6 16.0 0.7 1.0 0.8 3.2 4.9 21.5 0.8 14.0 18.8 0.6 0.9 1.3 0.0 0.1 1.7 0.6 4.5 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 4.4 0.0 0.0 0.2 0.0 6.3 60.7 62.9 31.2 86.2 52.9 14.6 12.4 38.7 14.9 9.5 0.0 3.4 0.0 0.0 0.8 4.8 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 9.2 0.5 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.1 3.2 5.1 1.3 0.0 35.9 2.6 0.0 3.3 0.0 0.0 1.9 0.0 0.0 3.2 0.0 0.3 0.0 7.2 2.3 2.7 7.0 0.0 0.0 0.0 0.0 SEPT6 "KIAA0128, MGC16619, MGC20339, SEP2, SEPT2" ENSG00000125354 "Septin 6" Q14141 X 119615724-119693370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 145.4" "Cell type enhanced" "Detected in many" 6 "B-cells: 130.4;Horizontal cells: 100.1;T-cells: 146.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 52.7;MOLT-4: 56.0;REH: 51.6;SH-SY5Y: 78.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003459, HPA005665" Supported Approved Cytosol NA NA 10000000 Cytosol "HPA003459: AB_1856696, HPA005665: AB_1079910" "unprognostic (6.35e-3)" "unprognostic (1.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.09e-1)" "unprognostic (1.73e-1)" "unprognostic (6.23e-2)" "unprognostic (2.13e-1)" "unprognostic (7.24e-2)" "unprognostic (6.27e-2)" "unprognostic (1.46e-1)" "unprognostic (1.95e-1)" "unprognostic (2.55e-1)" "unprognostic (2.88e-1)" "unprognostic (1.92e-1)" "unprognostic (2.60e-2)" 5.1 39.1 6.9 34.0 6.5 20.6 5.6 23.6 13.1 6.1 22.5 3.8 5.6 5.4 6.7 7.2 9.5 7.3 9.9 8.8 6.7 17.2 8.2 9.8 7.0 42.9 9.5 6.9 6.0 2.2 3.4 5.5 14.1 13.3 6.5 7.3 8.4 12.4 16.7 2.3 3.8 17.6 9.3 5.4 31.8 9.5 24.7 3.3 145.4 4.3 4.5 43.8 9.8 5.3 24.3 22.6 13.0 12.9 27.5 38.5 16.8 1.2 1.9 7.5 13.4 0.7 1.5 10.6 3.6 8.1 6.2 10.8 0.6 2.8 24.9 2.9 4.6 6.5 0.7 11.7 2.3 4.3 15.2 2.7 11.0 4.0 4.4 1.8 12.4 5.8 2.8 0.5 4.9 0.1 2.6 9.0 52.7 8.1 13.4 3.6 0.9 56.0 7.0 7.9 0.3 6.0 51.6 6.2 20.1 6.6 1.3 3.3 78.6 9.5 3.5 4.0 8.4 4.7 6.4 5.6 1.7 3.5 5.4 0.9 6.7 2.6 33.0 0.1 13.2 1.2 9.8 5.6 13.0 22.3 9.4 23.3 24.3 28.4 25.6 12.0 22.9 30.5 26.0 4.4 27.5 12.9 22.6 38.5 16.8 6.9 6.5 23.6 13.1 6.7 17.2 9.5 6.9 13.3 3.3 8.9 16.2 130.4 0.0 6.4 23.2 7.3 2.5 13.4 9.1 21.0 45.2 40.1 46.4 0.0 2.3 21.7 1.2 0.0 0.0 43.9 20.5 0.0 41.6 14.7 47.3 100.1 7.5 25.8 33.0 6.5 31.1 58.0 15.1 0.0 2.6 32.6 0.0 2.9 71.8 1.1 34.4 25.8 7.4 1.4 9.8 6.0 35.9 146.6 5.3 0.0 SEPT8 "KIAA0202, SEP2" ENSG00000164402 "Septin 8" Q92599 5 132750817-132807241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 150.3" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 154.1;Muller glia cells: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005665, HPA036534" Enhanced Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA005665: AB_1079910, HPA036534: AB_2797226" "unprognostic (2.06e-2)" "unprognostic (1.13e-1)" "unprognostic (9.24e-2)" "unprognostic (7.10e-3)" "unprognostic (2.70e-1)" "unprognostic (2.15e-2)" "unprognostic (2.86e-2)" "unprognostic (1.41e-2)" "unprognostic (1.58e-2)" "unprognostic (2.97e-2)" "unprognostic (2.38e-2)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.86e-2)" "unprognostic (4.30e-1)" "unprognostic (8.04e-3)" "unprognostic (2.70e-1)" 9.5 8.4 43.1 7.0 49.4 2.9 7.1 27.8 74.9 9.3 10.2 66.8 5.2 10.7 6.7 8.2 13.4 7.0 10.7 13.1 56.3 37.0 9.2 4.3 8.4 5.6 76.1 29.3 10.9 9.4 15.9 5.0 18.5 45.8 8.1 11.5 7.9 13.6 9.3 4.1 20.4 10.5 9.0 150.3 5.9 11.0 2.9 64.1 1.5 9.5 5.2 7.5 18.3 6.2 0.8 2.4 1.1 2.0 0.3 5.2 1.7 17.0 8.3 11.9 24.4 16.7 16.4 39.3 18.5 17.8 17.6 21.6 14.5 12.4 0.1 16.5 17.8 10.5 13.3 22.4 30.3 19.5 21.9 16.1 16.8 10.5 12.4 12.2 5.9 24.4 11.8 9.8 8.1 11.6 17.3 24.4 14.9 25.6 3.3 9.4 16.3 19.1 5.5 6.3 10.4 5.4 17.6 14.0 1.4 10.3 44.2 16.0 10.0 15.7 3.6 10.4 36.2 32.1 7.8 25.4 19.7 12.9 4.8 13.1 4.6 4.3 0.6 12.5 8.8 14.7 1.1 2.0 0.0 4.1 1.1 4.2 0.8 3.4 5.2 2.4 0.3 0.9 2.2 0.0 0.3 0.5 0.0 3.6 1.7 43.1 49.4 27.8 44.6 56.3 37.0 76.1 29.3 45.8 64.1 11.9 6.7 1.4 0.0 8.9 15.4 15.7 15.3 5.3 6.8 47.1 13.7 26.2 11.6 0.0 1.1 15.7 16.8 0.0 0.0 9.8 22.2 0.0 12.7 6.7 10.4 154.1 11.6 16.5 4.3 1.5 14.4 7.2 15.1 0.0 16.9 82.2 0.0 20.3 19.4 9.4 18.4 45.3 25.0 4.7 4.8 15.1 8.5 6.9 17.2 0.0 SERHL2 ENSG00000183569 "Serine hydrolase like 2" Q9H4I8 22 42553617-42574382 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "breast: 155.6" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 15.9;Ito cells: 15.4;Sertoli cells: 19.4" "Group enriched" "Detected in all" 5 "breast cancer: 8.0;prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 4.1;naive B-cell: 8.9;plasmacytoid DC: 4.5" "Group enriched" "Detected in many" 11 "B-cells: 8.9;dendritic cells: 4.5" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 79.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.14e-1)" "unprognostic (1.56e-2)" "unprognostic (8.61e-2)" "unprognostic (2.52e-2)" "unprognostic (3.27e-1)" "unprognostic (7.24e-2)" "unprognostic (1.25e-3)" "unprognostic (1.47e-2)" "unprognostic (1.55e-3)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.92e-1)" "unprognostic (7.04e-2)" "unprognostic (4.08e-2)" "unprognostic (2.06e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" 1.4 1.8 2.4 1.1 11.9 1.3 155.6 1.1 10.9 2.2 1.4 5.0 10.5 0.9 1.8 14.0 1.6 2.5 1.3 2.3 4.5 3.4 1.5 3.1 1.3 1.8 13.9 2.2 9.5 0.9 2.6 0.7 1.0 8.7 7.3 1.2 0.9 3.9 6.1 1.2 10.9 1.4 1.5 4.3 1.3 1.8 1.9 14.1 0.0 1.7 0.6 1.2 2.3 4.4 8.9 4.5 0.5 0.1 0.2 0.4 0.3 0.0 0.0 0.4 0.8 1.1 2.5 0.1 0.5 0.5 0.6 0.7 0.0 0.1 0.3 0.3 1.6 0.3 0.3 0.4 0.2 0.3 0.1 0.1 0.2 0.0 0.7 0.5 0.2 0.5 2.6 0.4 0.4 0.0 0.4 0.1 0.0 2.9 0.0 0.6 1.1 7.3 0.3 0.0 0.1 0.0 3.5 0.0 0.1 0.2 0.1 0.1 0.1 0.1 79.5 0.0 0.8 0.2 0.4 0.5 0.2 0.0 0.2 0.0 0.3 0.0 3.3 0.3 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.2 4.1 0.1 0.4 0.1 8.9 0.0 0.1 0.0 0.2 0.1 4.5 0.0 0.3 2.4 11.9 1.1 10.9 4.5 3.4 13.9 2.2 8.7 14.1 3.0 0.0 3.0 5.5 1.1 1.3 0.4 0.0 1.4 1.2 12.2 0.0 4.2 3.3 1.1 3.2 1.9 0.4 0.0 0.2 3.6 2.5 15.9 0.0 1.0 1.0 1.6 0.0 15.4 2.2 2.2 4.9 2.1 5.0 0.0 1.3 4.5 0.4 0.0 6.3 0.6 1.4 19.4 2.9 4.2 7.8 1.4 6.8 0.5 1.3 4.2 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favorable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavorable (2.11e-4)" "prognostic unfavorable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 13.0 3.1 2.7 8.9 6.0 8.1 7.6 25.2 18.7 1.6 2.0 4.7 47.3 8.6 33.2 23.6 2.0 53.9 0.3 85.2 0.3 0.8 2.0 0.0 2.7 2.4 6.8 0.0 10.1 7.4 48.5 10.4 22.9 7.2 1.0 1.0 0.3 0.0 2.8 2.1 0.3 0.3 2.8 26.1 6.6 0.0 5.4 2.9 9.0 58.3 1.2 6.7 6.4 48.8 1.0 1.4 28.5 1.5 6.2 0.4 2.1 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.1 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 14.9 6.2 0.5 97.8 11.0 0.0 0.6 127.4 8.1 21.6 111.7 0.0 323.0 61.3 546.6 3.9 4.4 427.6 0.0 288.5 86.2 3.3 137.4 0.0 45.6 43.7 0.0 111.9 8.6 7.6 6.6 2.0 6.8 38.8 83.8 168.4 0.6 386.0 170.9 0.0 57.4 0.0 0.0 1.4 0.6 3.6 18.4 373.5 0.0 116.2 257.8 SERINC4 FLJ40363 ENSG00000184716 "Serine incorporator 4" A6NH21 15 43794162-43800221 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 24.5" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 41.2;Early spermatids: 27.9;Late spermatids: 27.6;Rod photoreceptor cells: 53.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;OE19: 1.9;RT4: 1.4;SCLC-21H: 3.0;U-138 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.5 0.0 0.6 0.2 0.1 0.6 0.4 0.0 0.4 0.3 0.0 0.7 0.7 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.4 0.0 0.4 0.2 0.8 0.0 0.3 0.0 0.0 0.1 0.2 1.8 0.3 0.3 24.5 0.1 0.1 0.2 0.0 0.3 0.0 0.8 0.0 0.1 5.8 0.0 0.0 0.2 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.6 0.1 0.0 0.0 1.4 3.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.3 0.3 0.3 0.8 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.1 4.6 0.0 0.0 0.0 0.0 0.0 41.2 0.1 0.0 0.0 27.9 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.2 4.8 0.0 0.6 0.3 27.6 0.3 0.0 0.0 1.0 0.3 5.5 0.1 0.0 0.0 0.0 53.4 0.0 0.0 4.7 2.6 0.0 0.3 0.0 0.0 0.3 SERP2 "bA269C23.1, C13orf21" ENSG00000151778 "Stress associated endoplasmic reticulum protein family member 2" Q8N6R1 13 44373665-44397714 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.7" "Group enriched" "Detected in many" 13 "Early spermatids: 499.5;Late spermatids: 180.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "basophil: 6.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "LHCN-M2: 5.9;SH-SY5Y: 8.3;U-2197: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (6.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (2.06e-1)" "unprognostic (9.62e-2)" "unprognostic (1.72e-2)" "unprognostic (2.85e-1)" "unprognostic (3.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "unprognostic (1.34e-3)" "unprognostic (1.12e-2)" "prognostic favorable (1.94e-4)" "unprognostic (1.48e-1)" "unprognostic (6.60e-2)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" 1.7 3.2 30.0 2.0 34.1 0.8 4.0 14.3 40.7 2.7 2.3 3.9 1.3 4.2 4.8 12.4 1.7 3.0 1.8 14.6 24.8 20.9 2.6 1.8 2.0 2.3 19.0 15.6 5.9 2.8 1.9 2.4 1.2 10.1 4.1 2.1 2.0 2.0 5.8 1.4 1.4 3.2 3.4 10.4 1.1 2.4 15.3 6.4 1.2 2.1 0.4 2.1 1.4 1.0 0.0 0.0 6.0 0.0 1.3 0.3 0.2 0.0 0.0 3.4 0.0 0.5 2.9 0.0 0.6 1.0 3.7 2.5 0.0 0.0 0.0 2.9 2.7 0.0 0.1 0.0 0.0 3.6 0.0 0.1 0.6 0.0 0.2 3.2 0.1 0.0 0.4 0.0 2.6 0.0 0.7 0.5 0.0 0.0 0.0 5.9 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.9 8.3 0.0 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.2 7.6 0.0 0.0 0.2 0.0 1.7 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 30.0 34.1 14.3 37.2 24.8 20.9 19.0 15.6 10.1 6.4 0.0 1.0 0.0 3.9 1.5 18.6 13.2 7.6 0.0 1.2 8.7 13.7 2.4 14.9 9.3 499.5 2.7 2.9 0.0 11.6 2.3 6.0 5.6 18.4 5.6 0.2 14.3 13.8 2.5 0.0 180.5 12.0 0.6 11.8 1.0 1.9 14.7 4.4 1.7 18.0 5.8 15.3 25.8 5.6 7.9 11.3 0.9 1.7 5.0 2.5 1.4 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 3314.2" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 29973.4" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0" "Group enriched" "Detected in many" 5 "granulocytes: 139.3;monocytes: 203.0" "Cell line enriched" "Detected in some" 8 "Hep G2: 326.1" "Region enriched" "Detected in many" 6 "cerebellum: 334.2" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 2070000000000 210000000000 Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favorable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 0.9 0.4 0.7 4.9 1.4 3.0 2.4 0.2 0.7 2.6 7.5 0.5 3.1 6.3 0.8 8.6 0.4 0.7 14.2 1.0 0.4 0.5 74.1 3314.2 13.6 5.3 1.0 0.2 0.6 7.4 0.0 0.4 0.8 0.8 0.6 4.1 0.6 0.9 3.6 0.2 0.3 36.2 1.4 1.3 8.9 7.0 0.8 0.8 0.5 0.8 0.2 0.9 0.5 0.6 0.3 33.5 139.3 203.0 0.2 0.3 100.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 12.9 41.0 0.1 1.1 0.0 0.1 0.1 0.0 0.8 0.0 5.0 0.0 0.2 0.1 326.1 0.0 1.1 0.1 0.3 0.4 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.5 0.1 1.1 0.1 22.1 0.2 0.0 0.1 0.4 0.1 0.1 0.0 19.4 0.2 0.1 0.1 5.1 0.1 0.6 0.2 0.1 0.5 0.3 2.8 0.0 0.4 110.2 29.1 0.2 165.9 0.3 0.3 0.1 0.2 33.5 0.1 0.2 0.1 139.3 0.2 203.0 0.7 0.2 100.0 0.7 1.4 0.2 0.7 0.4 0.5 1.0 0.2 0.8 0.8 32.8 233.5 435.3 1.1 2.1 0.0 2.8 4603.8 45.5 60.3 143.1 0.0 1.4 58.0 1848.5 0.1 6.6 53.3 817.7 189.3 1.7 1.6 5.0 1.1 29973.4 171.4 0.0 11.6 922.6 1276.8 0.0 0.0 188.6 1.7 107.4 659.1 0.3 1376.2 37.4 0.0 447.0 0.2 0.0 5.1 0.0 0.1 1.5 5.4 46.5 24.7 7.1 SERPINA10 "PZI, ZPI" ENSG00000140093 "Serpin family A member 10" Q9UK55 14 94280455-94293271 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 223 "liver: 169.5" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 200.2" "Cancer enriched" "Detected in some" 51 "liver cancer: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 8 "Hep G2: 21.2" "Not detected" "Not detected" HPA048739 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 3960000000 5900000000 Nucleoplasm Cytosol "HPA048739: AB_2797237" "unprognostic (7.14e-2)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-1)" "prognostic favorable (9.00e-4)" "unprognostic (6.11e-2)" "unprognostic (2.81e-4)" "unprognostic (2.31e-4)" "unprognostic (2.77e-2)" "unprognostic (2.91e-3)" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (7.93e-3)" 0.1 0.0 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 169.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.7 0.1 0.1 0.2 0.0 0.6 0.3 2.1 0.8 0.8 0.8 0.5 0.6 0.6 1.0 0.9 2.6 0.6 2.3 0.4 0.4 0.2 0.3 2.4 0.6 1.5 0.9 1.5 2.1 0.7 21.2 0.5 1.7 1.2 0.7 0.5 0.3 0.8 1.2 1.1 1.1 0.6 1.4 1.1 0.3 1.4 1.1 0.9 0.2 0.6 1.0 1.1 0.9 0.6 0.7 1.0 0.9 0.5 0.5 0.2 1.2 1.5 0.9 0.6 0.8 0.4 0.7 0.6 1.2 0.5 1.0 1.0 1.9 0.5 0.7 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.9 0.0 0.0 0.2 0.4 2.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 200.2 0.0 0.0 6.3 4.3 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA11 ENSG00000186910 "Serpin family A member 11" Q86U17 14 94442464-94452790 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 140 "liver: 189.6" "Cell type enriched" "Detected in some" 50 "Hepatocytes: 255.3" "Cancer enriched" "Detected in some" 9 "liver cancer: 94.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 460000000 "unprognostic (2.50e-2)" "unprognostic (3.26e-1)" "unprognostic (9.00e-2)" "prognostic favorable (6.30e-4)" "unprognostic (7.44e-2)" "unprognostic (2.02e-2)" "unprognostic (1.70e-1)" "unprognostic (3.44e-1)" "unprognostic (5.14e-2)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 189.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 255.3 0.0 0.0 0.0 3.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SERPINA12 "OL-64, Vaspin" ENSG00000165953 "Serpin family A member 12" Q8IW75 14 94487274-94517844 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skin 1: 81.9" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 4.6;Suprabasal keratinocytes: 18.2" "Cancer enhanced" "Detected in some" "liver cancer: 1.8;melanoma: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 7.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "cerebellum: 0.2" "Secreted in other tissues" NA NA 570000 "unprognostic (1.82e-3)" "unprognostic (6.44e-2)" "unprognostic (3.25e-1)" "unprognostic (1.00e-2)" "unprognostic (5.98e-2)" "unprognostic (2.97e-2)" "unprognostic (7.64e-3)" "unprognostic (6.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 SERPINA3 "AACT, ACT" ENSG00000196136 "Serpin family A member 3" P01011 14 94612377-94624055 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 1244.8" "Cell type enhanced" "Detected in some" 17 "Ductal cells: 13.4;Exocrine glandular cells: 28.2;Pancreatic endocrine cells: 28.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "Hep G2: 98.6" "HPA000893, HPA002560, CAB016647" Enhanced "Secreted to blood" NA NA 697000000000 95000000000 "CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717" "prognostic favorable (8.92e-4)" "unprognostic (3.33e-3)" "unprognostic (9.21e-2)" "unprognostic (1.53e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (2.00e-2)" "unprognostic (1.00e-2)" "unprognostic (2.23e-1)" "unprognostic (9.60e-2)" "unprognostic (1.20e-2)" "unprognostic (9.92e-2)" "unprognostic (3.74e-12)" "unprognostic (6.47e-2)" "unprognostic (1.33e-2)" "unprognostic (2.02e-2)" 11.1 2.1 5.4 5.7 17.6 1.2 26.0 1.9 16.1 43.8 2.3 10.0 1.4 2.3 2.2 2.4 3.3 4.3 18.1 10.7 13.4 6.5 61.9 1244.8 4.9 53.0 16.3 0.8 8.3 182.4 1.0 14.0 2.7 34.2 18.3 2.6 10.2 62.1 7.9 6.8 1.5 2.3 10.2 47.2 8.2 9.7 9.5 7.4 0.0 3.5 0.5 1.7 7.6 11.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.1 1.0 0.0 0.7 0.2 0.0 0.9 0.0 0.6 0.0 0.2 0.0 98.6 13.4 0.4 0.1 12.2 14.7 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.1 0.1 0.3 0.0 0.1 0.5 0.0 0.8 0.0 0.0 0.0 0.4 0.5 14.4 0.1 0.5 0.0 0.1 0.0 1.8 0.0 4.2 0.2 0.3 0.4 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 5.4 17.6 1.9 9.6 13.4 6.5 16.3 0.8 34.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 13.4 3.9 0.0 0.0 0.0 28.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.8 0.0 0.2 28.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA4 "KAL, kallistatin, KLST, KST, PI4" ENSG00000100665 "Serpin family A member 4" P29622 14 94561091-94569913 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 24.8;liver: 118.6;pancreas: 36.2" "Cell type enhanced" "Detected in some" 25 "Cholangiocytes: 219.1;Exocrine glandular cells: 80.9;Hepatocytes: 412.0;Pancreatic endocrine cells: 77.0" "Group enriched" "Detected in many" 8 "liver cancer: 94.8;pancreatic cancer: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 22.9" "Not detected" "Not detected" HPA003607 Approved "Secreted to blood" NA NA 14500000000 22000000000 "HPA003607: AB_1079914" "unprognostic (1.65e-3)" "unprognostic (4.13e-2)" "prognostic favorable (2.95e-4)" "unprognostic (2.09e-3)" "unprognostic (1.99e-3)" "unprognostic (2.82e-1)" "unprognostic (4.03e-3)" "unprognostic (1.02e-2)" "unprognostic (2.24e-4)" "unprognostic (1.08e-1)" "unprognostic (5.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.1 3.2 0.3 0.1 7.9 0.1 0.1 24.8 0.1 0.0 0.0 1.4 118.6 0.0 0.0 0.0 0.0 0.1 36.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 8.2 0.0 0.1 0.1 0.0 0.0 0.1 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 219.1 0.0 0.0 3.5 0.0 0.0 10.0 21.6 0.0 0.0 0.0 0.0 80.9 0.0 0.0 0.0 0.0 412.0 0.0 0.0 0.0 4.9 9.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 77.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA5 "PAI3, PCI, PLANH3, PROCI" ENSG00000188488 "Serpin family A member 5" P05154 14 94561442-94593120 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Fertilization, Lipid transport, Transport" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 267.5;Exocrine glandular cells: 111.0;Hepatocytes: 195.1;Late spermatids: 228.6;Peritubular cells: 135.8" "Cancer enhanced" "Detected in many" "liver cancer: 121.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "Hep G2: 76.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA078846 Enhanced "Secreted to blood" NA NA 2300000000 "HPA078846: " "unprognostic (5.94e-3)" "unprognostic (2.64e-4)" "unprognostic (1.13e-1)" "prognostic favorable (7.72e-4)" "unprognostic (3.34e-3)" "unprognostic (6.10e-3)" "unprognostic (3.94e-2)" "unprognostic (1.39e-3)" "unprognostic (5.36e-1)" "unprognostic (1.50e-1)" "unprognostic (6.16e-2)" "unprognostic (1.87e-2)" "unprognostic (8.39e-3)" "unprognostic (3.38e-3)" "unprognostic (9.92e-2)" "unprognostic (8.08e-2)" "unprognostic (3.23e-1)" 1.1 100.4 0.4 1.8 1.8 0.0 7.7 0.2 0.5 4.0 1.0 1.6 126.6 0.6 4.8 5.0 0.5 3.6 34.3 5.6 0.6 0.4 33.6 112.4 0.3 1.9 3.1 0.3 6.4 33.8 0.0 0.8 0.2 1.9 1.9 0.0 0.9 10.9 106.7 6.6 0.7 0.7 0.4 1.5 36.1 2.0 146.5 0.6 0.1 0.9 1.5 0.6 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 5.2 0.0 0.0 2.5 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.8 0.2 0.5 0.6 0.4 3.1 0.3 1.9 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.5 267.5 0.0 0.0 31.4 2.0 0.0 54.7 58.2 75.6 1.6 0.0 0.0 111.0 0.0 3.9 0.2 0.0 195.1 0.0 7.9 0.0 3.7 2.9 228.6 52.9 0.0 0.0 1.0 0.0 1.8 23.8 0.0 135.8 3.8 1.1 6.5 0.4 3.5 2.2 0.5 0.2 0.0 0.0 0.0 SERPINA6 CBG ENSG00000170099 "Serpin family A member 6" P08185 14 94304248-94323394 "Disease related genes, Plasma proteins, Predicted secreted proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "liver: 223.9" "Group enriched" "Detected in some" 11 "Cholangiocytes: 163.1;Hepatocytes: 335.8" "Cancer enriched" "Detected in many" 9 "liver cancer: 244.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "T-47d: 119.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA017864 Approved "Secreted to blood" NA NA 60800000000 59000000000 "HPA017864: AB_1856721" "unprognostic (2.82e-2)" "unprognostic (1.67e-1)" "unprognostic (1.02e-3)" "prognostic favorable (6.96e-5)" "unprognostic (2.93e-3)" "unprognostic (9.98e-3)" "unprognostic (4.43e-2)" "unprognostic (3.11e-1)" "unprognostic (4.80e-3)" "unprognostic (2.94e-1)" "unprognostic (2.47e-2)" "unprognostic (4.54e-2)" "unprognostic (1.43e-1)" "unprognostic (2.14e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 1.0 0.0 2.3 10.3 0.1 0.0 0.0 5.2 223.9 0.1 0.0 0.0 0.0 0.8 9.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 119.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.2 163.1 0.0 0.0 0.0 0.0 0.0 1.7 10.5 0.0 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 335.8 0.0 0.0 8.6 8.6 7.2 0.0 0.0 0.0 0.0 1.0 0.4 0.0 1.5 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 SERPINA7 TBG ENSG00000123561 "Serpin family A member 7" P05543 X 106032442-106038738 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 414 "liver: 101.8" "Cell type enriched" "Detected in some" 19 "Hepatocytes: 129.6" "Cancer enriched" "Detected in single" 203 "liver cancer: 82.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 478 "Hep G2: 48.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA002803 Approved "Secreted to blood" NA NA 39800000000 49000000000 "HPA002803: AB_1079915" "unprognostic (6.22e-2)" "unprognostic (1.63e-3)" "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (2.15e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 101.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 129.6 0.0 0.0 0.0 6.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINA9 "CENTERIN, GCET1, SERPINA11b" ENSG00000170054 "Serpin family A member 9" Q86WD7 14 94462717-94479689 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 37.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "stomach cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.2" "Lineage enhanced" "Detected in single" "monocytes: 1.2" "Cell line enriched" "Detected in single" 64 "Daudi: 39.7" "Region enriched" "Detected in single" 18 "basal ganglia: 64.3" "Secreted to blood" NA NA "unprognostic (1.32e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-2)" "unprognostic (3.89e-3)" "unprognostic (6.10e-2)" "unprognostic (6.67e-2)" "unprognostic (1.38e-2)" "unprognostic (1.16e-1)" 0.1 0.1 0.1 37.6 0.1 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.1 1.8 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.6 0.2 20.3 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.1 6.0 2.7 0.0 0.1 0.6 0.1 0.1 0.0 0.4 0.3 0.3 36.0 0.1 0.2 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERPINB1 "anti-elastase, EI, ELANH2, PI2" ENSG00000021355 "Serpin family B member 1" P30740 6 2832332-2842006 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 119.2;lymphoid tissue: 108.0" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 1231.2;Pancreatic endocrine cells: 832.6;Urothelial cells: 969.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 35.4;OE19: 44.9;U-937: 40.3" "Low region specificity" "Detected in many" "HPA018871, HPA018882, HPA052642" Enhanced Supported "Cytoplasmic bodies" NA NA 49000000 "Cytoplasmic bodies" "HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896" "unprognostic (1.13e-2)" "unprognostic (1.93e-1)" "unprognostic (6.07e-2)" "unprognostic (1.75e-2)" "unprognostic (5.14e-3)" "unprognostic (9.67e-2)" "unprognostic (3.59e-3)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.88e-2)" "unprognostic (1.08e-3)" "unprognostic (9.07e-2)" "unprognostic (1.05e-1)" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" 11.4 15.1 3.5 13.4 7.0 75.8 6.4 2.9 3.3 25.1 23.6 5.7 5.3 26.0 6.6 8.6 119.2 7.6 18.1 8.3 3.5 3.9 11.4 36.9 32.6 37.4 7.5 1.8 7.8 66.7 8.3 10.4 11.9 6.2 6.5 16.7 6.7 23.5 3.6 21.8 4.4 49.2 5.6 6.8 34.8 18.0 3.9 5.3 9.4 14.0 98.9 108.0 7.2 20.8 12.8 38.3 48.5 49.6 21.7 16.7 38.7 12.2 14.3 0.8 0.1 3.1 6.6 12.4 3.6 10.3 4.3 7.7 13.4 35.4 0.1 26.0 7.5 4.7 7.7 1.4 3.3 3.2 17.5 2.6 21.5 4.8 10.3 11.4 3.8 13.9 8.2 5.5 2.1 0.9 2.1 13.9 0.0 7.6 2.9 3.8 5.7 0.5 10.0 1.4 44.9 6.8 1.1 0.1 12.5 14.6 2.6 2.7 1.5 8.3 3.2 17.9 1.8 1.6 12.2 8.6 1.4 3.4 3.0 1.0 0.0 0.6 0.1 5.2 40.3 0.7 27.1 49.6 28.5 16.1 25.7 14.5 12.8 15.6 14.8 38.3 9.6 16.1 16.1 48.5 21.7 19.5 14.8 16.7 38.7 3.5 7.0 2.9 3.3 3.5 3.9 7.5 1.8 6.2 5.3 223.4 258.8 81.5 94.2 31.1 3.4 14.8 79.0 356.0 278.7 43.6 2.0 101.3 48.0 311.2 1.1 94.3 291.2 0.0 1231.2 123.8 51.6 118.4 423.5 23.6 168.5 9.5 92.5 77.3 370.6 2.2 32.2 222.8 67.4 532.0 195.5 45.7 832.6 135.3 26.2 60.4 14.9 12.9 48.9 1.9 5.5 33.2 83.4 85.3 160.0 969.8 SERPINB10 "bomapin, PI10" ENSG00000242550 "Serpin family B member 10" P48595 18 63897174-63936111 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 43.9;tongue: 15.3" "Group enriched" "Detected in some" 10 "Ciliated cells: 6.7;Club cells: 2.3;Kupffer cells: 3.2;monocytes: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 9 "dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2" "Cell line enriched" "Detected in some" 7 "U-937: 48.6" "Low region specificity" "Detected in all" "HPA015480, HPA059582" Uncertain Supported Nucleoplasm,Cytosol NA NA 42000 Nucleoplasm Cytosol "HPA015480: AB_1855456, HPA059582: AB_2684072" "unprognostic (4.66e-1)" "unprognostic (5.11e-2)" "unprognostic (1.33e-2)" "unprognostic (1.19e-1)" "unprognostic (9.56e-2)" "unprognostic (2.56e-1)" "unprognostic (4.59e-1)" "unprognostic (1.10e-1)" "unprognostic (3.64e-1)" "unprognostic (1.25e-4)" 1.3 0.1 0.0 2.3 0.2 43.9 0.1 0.3 0.1 1.1 0.7 0.0 0.0 0.1 0.2 0.3 3.1 0.1 0.1 5.5 0.0 0.0 0.0 0.2 3.8 0.2 0.0 0.0 0.0 0.1 0.1 0.0 4.8 0.2 0.1 0.1 0.0 1.0 0.1 1.3 2.5 0.1 0.1 0.0 2.8 0.1 0.1 0.1 4.0 0.9 15.3 1.5 0.1 1.3 0.3 2.1 3.3 4.2 0.3 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 48.6 0.0 0.2 4.2 3.3 0.2 0.1 0.1 0.2 0.1 0.1 0.4 0.3 0.1 0.1 1.8 0.3 0.0 2.1 0.1 0.9 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 SERPINB11 EPIPIN ENSG00000206072 "Serpin family B member 11 (gene/pseudogene)" Q96P15 18 63647579-63726432 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 19.5;lymphoid tissue: 19.1;prostate: 23.7;tongue: 32.1" "Cell type enhanced" "Detected in some" 21 "Ciliated cells: 8.1;Club cells: 12.5;Glandular cells: 4.0;Urothelial cells: 19.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.2;BEWO: 2.1;hTCEpi: 1.3" "Low region specificity" "Detected in all" NA NA "unprognostic (5.04e-3)" "unprognostic (4.76e-2)" "unprognostic (4.05e-2)" "unprognostic (3.44e-1)" "unprognostic (2.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 23.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 19.1 2.0 2.4 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 8.1 12.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 SERPINB12 YUKOPIN ENSG00000166634 "Serpin family B member 12" Q96P63 18 63556160-63567011 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 9.3;skin 1: 38.8;vagina: 16.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.4;CAPAN-2: 1.0;hTCEpi: 2.5;U-266/70: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 8500000 "unprognostic (7.35e-2)" "prognostic favorable (1.76e-4)" "unprognostic (1.57e-1)" "unprognostic (2.00e-1)" "unprognostic (8.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 9.3 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SERPINB13 "headpin, HUR7, hurpin, PI13" ENSG00000197641 "Serpin family B member 13" Q9UIV8 18 63586989-63604639 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1" "Group enriched" "Detected in some" 11 "Ciliated cells: 8.1;Club cells: 29.6;Urothelial cells: 8.5" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 132 "HaCaT: 65.6;hTCEpi: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052630, HPA057129" Enhanced Approved "Nuclear speckles,Cytosol" NA NA 59000 "Nuclear speckles, Cytosol" "HPA052630: AB_2681891, HPA057129: AB_2683347" "unprognostic (3.49e-2)" "unprognostic (3.73e-1)" "unprognostic (1.11e-1)" "unprognostic (7.27e-2)" "unprognostic (2.28e-1)" "unprognostic (4.29e-2)" "unprognostic (2.81e-1)" "unprognostic (6.04e-3)" 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.1 37.7 0.1 0.0 0.0 0.1 3.1 0.1 70.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 10.9 0.1 0.2 5.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 1.0 0.1 107.2 54.2 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 0.0 8.1 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 8.5 SERPINB2 "HsT1201, PAI2, PLANH2" ENSG00000197632 "Serpin family B member 2" P05120 18 63871692-63903890 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Plasminogen activation" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.6;placenta: 222.1" "Cell type enhanced" "Detected in many" 27 "Basal keratinocytes: 1993.2;Suprabasal keratinocytes: 920.9;Syncytiotrophoblasts: 367.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 16.3;eosinophil: 7.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 16.3" "Cell line enhanced" "Detected in some" "GAMG: 33.9;HaCaT: 81.3;U-138 MG: 97.3;U-2197: 147.8" "Region enriched" "Detected in single" 14 "cerebellum: 2.9" "Low region specificity" "Detected in all" "HPA015480, HPA076608" Enhanced "Intracellular and membrane" NA NA 110000 "HPA015480: AB_1855456, HPA076608: " "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.46e-2)" "unprognostic (1.36e-4)" "unprognostic (1.17e-1)" "unprognostic (1.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (9.69e-2)" "unprognostic (3.76e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-6)" "unprognostic (3.89e-2)" "unprognostic (3.94e-1)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.55e-5)" 6.0 0.0 0.1 2.9 0.2 8.7 2.6 0.2 0.1 6.4 0.8 0.1 0.1 0.0 0.7 0.4 70.6 3.1 0.1 0.4 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.1 0.6 0.3 0.0 0.1 222.1 0.2 0.3 0.0 0.1 11.3 0.2 0.3 25.7 0.2 0.3 0.1 0.3 0.1 0.2 0.1 0.9 0.2 49.0 37.7 1.1 13.8 0.0 0.2 16.3 3.9 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.7 21.0 0.7 1.5 0.1 0.0 0.0 0.0 0.7 33.9 81.3 0.0 16.7 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 9.7 4.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 1.6 97.3 0.0 147.8 0.0 0.0 0.0 0.0 2.6 0.2 11.3 16.3 3.9 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.3 0.0 2.4 1993.2 0.0 0.4 0.0 21.4 34.2 0.0 0.0 3.1 0.0 76.7 0.0 0.5 0.0 0.0 6.1 1.5 3.5 3.8 0.0 0.0 2.8 0.0 0.0 0.0 5.6 0.0 0.0 59.8 89.4 2.8 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 920.9 367.4 0.0 0.0 42.5 SERPINB3 "HsT1196, SCC, SCCA1, T4-A" ENSG00000057149 "Serpin family B member 3" P29508 18 63655197-63661963 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0" "Group enriched" "Detected in some" 8 "Ciliated cells: 141.8;Club cells: 465.2;Urothelial cells: 238.3" "Cancer enhanced" "Detected in many" "cervical cancer: 186.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;HaCaT: 9.1;HBEC3-KT: 2.2;SiHa: 5.6;U-2197: 11.6" "CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992" Enhanced Approved "Plasma membrane,Cytosol" NA NA 11000000 Cytosol "Plasma membrane" "CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (2.95e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (2.91e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (4.19e-3)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.7 0.2 0.2 0.2 0.0 3.8 0.2 140.0 0.0 0.2 0.2 0.2 0.0 0.2 0.2 5.4 0.2 0.2 0.2 0.2 0.2 0.0 2.4 0.2 0.2 1.1 0.0 0.2 13.0 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.2 21.3 3.1 13.1 80.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.2 9.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 10.3 0.0 15.8 0.0 0.0 0.0 0.0 141.8 465.2 0.0 0.0 0.0 0.0 3.7 24.6 0.0 0.0 0.0 7.4 0.0 0.0 36.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 33.0 1.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 238.3 SERPINB4 "LEUPIN, PI11, SCCA-2, SCCA1, SCCA2" ENSG00000206073 "Serpin family B member 4" P48594 18 63637259-63644298 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 32.5;esophagus: 48.4;tongue: 18.4;vagina: 41.4" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 26.8;Club cells: 89.9;Pancreatic endocrine cells: 31.8;Urothelial cells: 72.6" "Cancer enhanced" "Detected in many" "cervical cancer: 104.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 4.1;HSkMC: 2.1;SiHa: 3.2;U-2197: 11.1" "HPA048341, HPA049988, HPA055992" Supported NA NA 5700000 "HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (8.81e-3)" "unprognostic (9.43e-2)" "unprognostic (8.96e-3)" "unprognostic (4.38e-1)" "unprognostic (1.63e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (2.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.27e-2)" 0.1 0.0 0.1 1.4 0.1 0.0 0.1 0.1 0.1 32.5 0.1 0.1 0.1 0.0 1.8 0.1 48.4 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.1 7.0 0.1 0.3 4.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.1 18.4 2.3 8.7 41.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 26.8 89.9 0.0 0.0 0.0 0.0 14.6 1.1 0.0 0.0 0.0 18.1 0.1 0.0 17.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 72.6 SERPINB5 "maspin, PI5" ENSG00000206075 "Serpin family B member 5" P36952 18 63476761-63505085 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 99.3;skin 1: 60.7;tongue: 118.8" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 856.4;Suprabasal keratinocytes: 1062.2;Urothelial cells: 663.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 124.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 147.0;HBEC3-KT: 48.5;hTCEpi: 102.0;hTERT-HME1: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009570, HPA019025, HPA019132, HPA020136" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 660000 Vesicles "CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (9.24e-2)" "unprognostic (1.04e-3)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.36e-1)" "unprognostic (3.47e-3)" "prognostic unfavorable (5.71e-6)" "unprognostic (1.28e-1)" "unprognostic (1.84e-6)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (3.14e-1)" "unprognostic (8.38e-2)" 0.2 0.1 0.1 0.9 0.1 0.0 9.7 0.1 0.1 23.6 2.7 0.1 0.7 3.9 2.1 0.5 99.3 0.1 4.3 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 4.1 1.0 0.1 11.1 0.3 0.1 60.7 6.8 0.9 0.1 0.1 2.2 0.4 0.1 5.1 0.1 118.8 41.2 7.1 19.7 0.6 0.5 1.2 0.4 1.0 0.5 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.4 0.0 0.0 147.0 0.0 48.5 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 102.0 0.0 25.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.2 10.7 0.0 0.0 0.0 0.0 10.7 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.3 0.4 0.2 0.1 0.2 0.2 0.4 0.2 0.6 0.5 0.3 1.2 1.0 0.2 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 229.2 856.4 0.0 0.2 0.0 16.0 20.5 3.5 0.0 0.2 0.0 0.1 7.6 0.0 5.4 0.0 0.0 0.2 8.7 51.7 0.0 0.0 0.0 0.0 3.4 0.0 0.0 15.2 0.6 0.2 59.1 0.0 3.2 0.0 9.5 46.0 0.0 0.0 0.0 0.0 14.4 2.6 0.6 1062.2 0.1 0.0 7.0 663.3 SERPINB7 MEGSIN ENSG00000166396 "Serpin family B member 7" O75635 18 63752935-63805376 "Disease related genes, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 70.6;Ductal cells: 49.1;Extravillous trophoblasts: 68.8;Pancreatic endocrine cells: 169.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 46.7;fHDF/TERT166: 32.9;HaCaT: 80.4;HBEC3-KT: 25.6;HBF TERT88: 44.7;hTERT-HME1: 26.0;U-138 MG: 44.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024200 Enhanced Approved "Endoplasmic reticulum,Mitochondria" NA NA "Endoplasmic reticulum" Mitochondria "HPA024200: AB_1856730" "unprognostic (8.66e-3)" "unprognostic (6.31e-3)" "unprognostic (6.55e-2)" "unprognostic (4.03e-4)" "unprognostic (9.11e-2)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (9.99e-2)" "unprognostic (4.70e-2)" "prognostic unfavorable (3.03e-5)" "unprognostic (2.02e-1)" "unprognostic (6.81e-2)" "unprognostic (1.62e-1)" "unprognostic (3.37e-2)" "unprognostic (2.02e-1)" "unprognostic (1.76e-3)" 0.2 0.0 0.1 0.1 0.1 0.0 6.6 0.1 0.1 2.0 0.2 0.0 0.0 0.0 0.5 0.0 2.6 0.1 1.3 0.1 0.1 0.1 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.4 0.0 0.1 0.0 0.0 0.6 0.0 0.9 54.6 0.1 0.0 0.1 0.0 0.3 0.3 0.0 6.7 0.1 22.6 16.7 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.7 0.0 46.7 9.4 7.1 5.3 0.0 0.2 0.0 0.0 32.9 12.4 80.4 0.0 25.6 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.6 1.1 26.0 0.3 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 44.0 1.6 0.9 4.4 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 70.6 0.0 0.0 0.0 1.4 1.2 0.0 0.0 1.2 0.0 49.1 0.0 0.0 0.0 0.0 7.8 68.8 1.1 2.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.3 2.8 0.0 0.0 169.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 19.2 5.1 0.0 0.0 2.5 SERPINB8 "CAP2, PI8" ENSG00000166401 "Serpin family B member 8" P50452 18 63969925-64019779 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 36.6" "Cell type enhanced" "Detected in many" 5 "Suprabasal keratinocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB034300 Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB034300: AB_2186486" "unprognostic (8.49e-2)" "unprognostic (4.87e-2)" "unprognostic (4.10e-3)" "unprognostic (2.86e-2)" "unprognostic (1.52e-2)" "unprognostic (7.71e-2)" "unprognostic (4.50e-2)" "unprognostic (2.19e-1)" "unprognostic (2.67e-1)" "unprognostic (2.98e-3)" "unprognostic (6.58e-3)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (8.73e-2)" "unprognostic (3.48e-2)" "unprognostic (1.25e-1)" "unprognostic (1.90e-1)" 12.4 7.4 2.9 9.3 4.2 16.0 6.1 1.3 5.5 7.7 7.4 7.1 0.0 3.7 4.1 4.3 20.6 3.7 13.7 4.5 3.1 3.3 7.1 23.7 8.2 10.1 4.7 4.0 8.1 4.2 1.1 5.0 9.5 7.4 4.2 6.1 3.4 8.1 2.1 4.5 36.6 8.7 4.4 6.0 9.8 4.2 2.9 3.5 4.2 5.0 17.5 11.3 9.6 11.0 5.1 25.3 5.9 20.5 2.1 4.2 5.0 7.6 1.5 1.3 9.4 4.7 6.6 0.6 24.7 24.0 15.7 15.7 0.3 3.4 0.1 9.1 14.7 7.7 12.4 0.2 15.6 22.5 10.5 0.3 0.0 2.9 0.8 10.7 37.9 3.3 6.3 13.6 21.1 6.9 10.2 16.6 1.6 0.2 4.4 10.8 0.6 0.6 4.2 0.5 1.3 7.6 0.5 3.4 0.6 7.0 8.7 0.7 0.7 4.9 0.7 9.1 1.1 0.3 14.3 25.8 24.0 5.1 2.9 9.9 1.9 0.3 0.0 24.6 22.1 20.6 1.1 20.5 0.8 3.8 16.1 3.4 3.6 3.1 2.3 25.3 5.1 1.7 2.6 5.9 2.1 8.0 13.7 4.2 5.0 2.9 4.2 1.3 5.5 3.1 3.3 4.7 4.0 7.4 3.5 3.0 11.7 4.7 24.0 36.5 0.2 1.2 7.6 6.7 12.5 0.0 0.0 2.9 0.0 27.3 0.6 8.8 8.1 0.0 16.7 4.1 9.3 12.1 4.6 10.4 15.0 0.0 1.7 4.9 24.1 1.1 0.9 25.5 15.1 16.2 3.1 1.6 29.4 2.0 0.0 1.6 0.2 0.0 8.6 2.3 1.0 42.3 26.2 3.9 2.8 32.4 SERPINB9 "CAP3, PI9" ENSG00000170542 "Serpin family B member 9" P50453 6 2887266-2903280 "Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.0;lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 116.9;monocytes: 105.6;Syncytiotrophoblasts: 226.0" "Cancer enhanced" "Detected in all" "testis cancer: 46.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 59.1;SuSa: 62.4;U-698: 25.4" "Low region specificity" "Detected in all" HPA030067 Uncertain Approved Nucleoplasm,Cytosol NA NA 4900000 Nucleoplasm Cytosol "HPA030067: AB_2673295" "unprognostic (6.82e-3)" "unprognostic (8.59e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-1)" "unprognostic (4.06e-1)" "unprognostic (1.50e-1)" "unprognostic (3.12e-2)" "unprognostic (9.48e-2)" "unprognostic (2.12e-2)" "unprognostic (3.83e-3)" "unprognostic (1.06e-1)" "unprognostic (9.85e-2)" "prognostic unfavorable (1.66e-6)" "unprognostic (9.90e-2)" "unprognostic (8.56e-2)" "unprognostic (1.27e-1)" "unprognostic (3.76e-2)" 5.6 5.1 3.3 15.9 4.1 7.2 2.6 3.6 6.7 3.9 2.1 4.4 1.3 1.7 1.9 1.9 4.6 4.1 5.3 4.9 3.4 3.6 2.5 7.6 13.7 39.6 4.8 3.9 3.8 1.3 4.7 4.9 24.5 4.7 2.6 2.9 3.5 7.5 1.3 2.0 1.0 5.5 2.4 7.1 14.4 2.0 4.4 2.0 6.4 4.2 2.1 18.9 3.4 3.8 10.3 6.4 2.9 38.0 18.8 17.9 12.3 0.0 2.5 0.0 0.0 0.1 0.0 59.1 0.5 0.1 0.6 0.9 0.7 4.8 9.6 6.0 0.5 0.0 0.0 7.1 0.0 0.5 3.1 0.7 0.9 0.9 1.4 3.4 0.0 0.0 2.7 0.0 1.0 0.0 0.0 12.9 0.8 4.4 0.1 0.4 0.2 0.0 0.0 8.2 0.0 0.0 0.9 0.0 0.1 0.4 0.0 0.4 0.1 5.8 0.0 0.0 62.4 0.0 0.1 13.4 0.0 0.1 0.0 0.0 0.0 12.1 25.4 0.0 0.0 0.0 1.7 18.3 0.1 17.9 38.0 14.7 8.3 13.0 16.8 6.1 10.3 12.1 17.5 2.9 18.8 22.0 6.4 13.0 12.3 3.3 4.1 3.6 6.7 3.4 3.6 4.8 3.9 4.7 2.0 17.9 24.9 31.6 1.9 31.4 1.5 4.2 2.5 13.4 14.8 5.2 0.0 62.3 0.0 14.4 0.9 42.0 1.6 0.0 0.2 116.9 44.8 2.2 45.1 6.8 16.6 7.9 14.9 60.2 47.5 2.5 4.0 98.8 84.4 105.6 3.1 4.8 6.2 5.8 16.6 1.4 2.9 12.9 18.1 0.5 2.2 32.2 226.0 48.4 3.5 7.4 SERPINC1 "AT3, ATIII, MGC22579" ENSG00000117601 "Serpin family C member 1" P01008 1 173903804-173917378 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 203 "liver: 450.5" "Cell type enriched" "Detected in some" 54 "Hepatocytes: 2236.3" "Cancer enriched" "Detected in some" 871 "liver cancer: 1504.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enriched" "Detected in some" 35 "Hep G2: 42.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001816, CAB016790, HPA024007" Supported "Secreted to blood" NA NA 210000000000 "CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732" "unprognostic (1.28e-2)" "unprognostic (2.22e-1)" "unprognostic (3.83e-2)" "unprognostic (5.98e-2)" "unprognostic (6.91e-2)" "unprognostic (1.93e-2)" "prognostic favorable (3.40e-5)" "unprognostic (1.75e-2)" "unprognostic (8.67e-2)" "unprognostic (3.48e-2)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.36e-2)" "unprognostic (5.28e-3)" "unprognostic (5.80e-2)" "unprognostic (6.35e-2)" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 450.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 42.6 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.5 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 14.0 0.0 0.0 0.0 0.1 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2236.3 0.2 0.0 0.0 37.4 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.1 SERPIND1 "D22S673, HC-II, HC2, HCF2, HLS2" ENSG00000099937 "Serpin family D member 1" P05546 22 20773879-20787720 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Chemotaxis, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "liver: 170.8" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 223.1" "Cancer enriched" "Detected in many" 80 "liver cancer: 334.4" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "Hep G2: 64.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB008639, HPA055767" Supported Approved Vesicles "Secreted to blood" NA NA 94000000000 Vesicles "CAB008639: AB_1618010, HPA055767: AB_2682912" "unprognostic (1.68e-1)" "unprognostic (8.27e-2)" "unprognostic (4.40e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.42e-2)" "unprognostic (1.23e-1)" "unprognostic (1.12e-3)" "unprognostic (1.56e-1)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-9)" "unprognostic (2.01e-1)" "unprognostic (4.66e-2)" "unprognostic (8.36e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 2.3 0.0 0.2 0.6 0.9 0.3 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 170.8 0.3 0.0 0.0 0.7 0.3 0.0 3.6 0.1 0.2 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 1.9 2.7 0.7 0.4 1.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 64.2 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 5.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 4.4 0.0 0.4 0.0 1.0 0.2 1.7 0.4 0.5 0.6 0.1 1.9 0.9 0.7 0.7 1.3 0.2 2.7 0.7 0.1 0.0 2.3 0.6 0.9 0.0 0.0 0.0 0.7 2.6 0.5 0.0 13.7 0.0 0.0 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.7 0.0 1.1 223.1 0.1 0.0 0.0 4.9 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SERPINE1 "PAI, PAI1, PLANH1" ENSG00000106366 "Serpin family E member 1" P05121 7 101127089-101139266 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 253.6" "Cell type enhanced" "Detected in many" 22 "Pancreatic endocrine cells: 138.9;Syncytiotrophoblasts: 545.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "NK-cell: 10.8" "Lineage enriched" "Detected in single" 20 "NK-cells: 10.8" "Cell line enhanced" "Detected in many" "BJ: 142.8;HUVEC TERT2: 165.7;LHCN-M2: 160.0;TIME: 409.8;U-138 MG: 195.1;U-251 MG: 171.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA050039, CAB068501" Uncertain Approved Cytosol "Secreted to blood" No No 142000000 14000000 Cytosol "CAB068501: AB_1642775, HPA050039: AB_2680997" "unprognostic (5.02e-2)" "prognostic unfavorable (5.01e-4)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.10e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (2.84e-5)" "unprognostic (6.80e-3)" "prognostic unfavorable (4.41e-6)" "unprognostic (2.33e-1)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.88e-8)" "prognostic unfavorable (3.27e-6)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.51e-4)" 45.5 14.0 1.1 16.7 1.8 0.1 11.4 0.5 1.5 13.3 7.0 3.4 3.3 1.2 6.6 14.4 6.8 9.3 69.6 29.2 1.5 0.6 7.8 65.3 56.3 3.3 4.1 1.8 19.7 24.7 1.4 2.6 253.6 5.9 7.6 0.9 2.3 2.4 6.2 12.4 4.1 2.3 13.5 4.1 5.8 6.6 8.6 2.2 0.6 11.3 3.7 2.8 71.7 18.1 0.2 0.4 0.5 0.2 10.8 0.3 1.0 3.0 2.6 0.0 0.2 32.7 65.2 3.7 142.8 27.0 72.1 63.0 0.3 0.2 0.1 34.2 45.4 99.7 0.7 0.0 11.0 74.4 0.1 0.0 0.0 0.2 2.4 65.8 0.0 0.1 25.5 4.4 110.5 58.1 39.1 165.7 0.0 0.2 0.1 160.0 0.0 0.0 0.0 0.7 0.0 1.7 0.0 0.2 0.1 0.2 1.2 0.0 0.0 11.7 3.2 0.3 18.0 0.1 0.4 409.8 195.1 8.5 66.4 171.5 0.0 0.1 0.1 48.7 0.0 1.8 0.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.1 0.2 10.8 0.0 0.4 0.0 1.0 1.1 1.8 0.5 1.5 1.5 0.6 4.1 1.8 5.9 2.2 0.0 11.4 0.0 30.0 35.5 0.4 1.9 7.6 8.1 7.9 5.2 0.0 34.4 0.0 22.9 0.0 53.9 0.0 0.0 3.8 35.1 24.7 5.4 10.3 90.0 15.2 0.0 5.1 60.2 4.7 0.4 16.4 7.5 6.8 1.8 0.0 0.3 138.9 0.0 11.3 0.0 0.2 38.8 16.5 0.0 0.0 21.7 545.0 0.7 0.0 5.9 SERPINE2 "GDN, nexin, PI7, PN1, PNI" ENSG00000135919 "Serpin family E member 2" P07093 2 223975112-224039319 "Plasma proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 257.0" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 422.0;Fibroblasts: 240.4;Leydig cells: 371.6" "Cancer enriched" "Detected in all" 9 "melanoma: 271.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "naive CD4 T-cell: 10.5;naive CD8 T-cell: 5.3;NK-cell: 16.5" "Group enriched" "Detected in many" 13 "NK-cells: 16.5;T-cells: 10.5" "Cell line enhanced" "Detected in many" "BJ: 84.0;fHDF/TERT166: 358.5;SK-MEL-30: 159.8;WM-115: 123.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in female reproductive system" NA NA 490000 "unprognostic (1.73e-1)" "unprognostic (7.08e-3)" "unprognostic (8.49e-2)" "unprognostic (7.78e-3)" "unprognostic (2.57e-3)" "unprognostic (5.57e-2)" "unprognostic (1.49e-2)" "unprognostic (7.43e-3)" "unprognostic (4.41e-1)" "unprognostic (7.12e-2)" "unprognostic (7.56e-3)" "unprognostic (2.40e-1)" "unprognostic (1.97e-3)" "unprognostic (1.23e-2)" "unprognostic (1.31e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.48e-5)" 8.0 5.8 34.7 18.0 30.6 2.2 4.8 14.9 35.2 8.6 6.1 13.0 0.1 7.4 5.1 4.4 9.7 6.0 11.9 24.5 21.9 25.3 10.6 3.3 3.2 7.7 33.0 14.4 38.4 2.9 1.3 2.0 257.0 25.2 6.6 6.2 4.9 3.1 2.8 3.2 3.5 6.0 28.1 23.0 7.8 2.7 14.2 11.9 1.6 6.2 3.2 10.8 18.3 6.9 1.0 0.1 0.3 0.0 16.5 10.5 2.2 0.1 4.5 1.6 1.8 69.0 26.0 0.2 84.0 48.1 6.8 6.5 0.2 0.3 0.0 1.8 358.5 10.8 0.2 0.2 5.7 5.9 0.0 1.4 0.9 3.0 1.2 3.4 0.7 0.0 7.5 3.9 19.4 29.3 17.6 0.5 0.3 0.0 0.0 23.4 0.2 0.1 0.2 3.1 1.7 5.0 0.5 1.4 3.4 63.0 5.2 2.4 0.4 15.9 0.0 159.8 23.3 0.0 0.3 59.2 40.2 5.5 12.2 3.9 0.3 0.7 0.0 25.7 0.6 123.2 0.0 0.0 0.0 0.6 0.0 0.3 0.7 0.4 0.5 0.0 1.0 10.5 5.3 0.3 16.5 0.0 0.1 0.5 2.2 34.7 30.6 14.9 29.8 21.9 25.3 33.0 14.4 25.2 11.9 0.0 0.6 0.0 11.6 20.7 2.8 2.5 0.0 0.0 3.4 7.0 0.0 84.2 10.0 10.3 2.1 23.4 3.1 0.0 28.7 422.0 240.4 9.5 2.3 0.0 40.3 0.0 23.1 26.4 0.0 4.7 371.6 4.6 135.0 5.4 4.1 1.5 16.3 13.3 93.0 144.4 3.3 12.9 15.9 4.3 27.4 12.7 112.0 10.9 1.8 5.4 SERPINE3 ENSG00000253309 "Serpin family E member 3" A8MV23 13 51335773-51364735 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "retina: 49.3" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 1.7;Spermatocytes: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 2.7;TIME: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051904, HPA055804" Uncertain "Secreted in other tissues" NA NA "HPA051904: AB_2681659, HPA055804: AB_2682928" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (9.66e-2)" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (8.54e-3)" "unprognostic (2.67e-3)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.70e-2)" "unprognostic (1.07e-1)" "unprognostic (3.94e-6)" "unprognostic (1.29e-2)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" 2.6 0.9 0.6 1.2 0.8 0.2 0.6 1.9 1.7 0.6 0.8 0.6 0.6 0.8 1.1 2.0 1.1 0.9 1.4 1.9 0.7 0.5 0.8 1.2 0.6 1.4 0.6 0.6 1.0 5.7 0.1 0.6 0.6 1.2 0.6 0.1 49.3 0.9 0.6 0.6 4.0 3.2 0.6 1.1 0.8 0.8 1.0 0.6 0.6 1.1 0.6 0.6 0.9 0.9 1.6 0.0 0.1 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.2 0.8 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.9 0.1 0.9 2.7 0.2 0.0 2.0 0.9 0.0 0.0 0.0 0.0 1.0 0.1 0.5 0.1 0.1 0.0 0.2 0.4 0.3 0.9 0.9 2.3 0.0 0.3 0.0 0.0 1.3 1.1 0.3 2.1 0.1 0.2 0.2 1.1 2.2 2.9 0.7 1.9 0.2 1.4 0.4 0.7 0.2 1.5 0.2 1.4 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.8 0.1 0.0 1.6 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.8 1.9 0.6 0.7 0.5 0.6 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 SERPINF1 "EPC-1, PEDF, PIG35" ENSG00000132386 "Serpin family F member 1" P36955 17 1761959-1777574 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 360.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 695.7;Fibroblasts: 677.8;Hepatocytes: 664.1;Leydig cells: 1683.3;Peritubular cells: 982.9;Syncytiotrophoblasts: 447.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 8 "pons and medulla: 105.5" "Cell type enriched" "Detected in some" 18 "plasmacytoid DC: 143.3" "Lineage enriched" "Detected in many" 119 "dendritic cells: 143.3" "Cell line enhanced" "Detected in many" "ASC diff: 124.2;ASC TERT1: 96.9;Hep G2: 56.6;HHSteC: 41.5;HSkMC: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005825 Uncertain "Secreted to blood" NA NA 9290000000 85000000000 "HPA005825: AB_1079921" "unprognostic (3.85e-1)" "prognostic favorable (5.49e-4)" "unprognostic (9.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.32e-3)" "unprognostic (2.33e-1)" "unprognostic (7.88e-2)" "unprognostic (5.92e-2)" "unprognostic (1.69e-1)" "unprognostic (4.18e-2)" "prognostic unfavorable (1.40e-8)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (4.53e-3)" "unprognostic (1.25e-3)" 70.0 7.5 2.3 15.1 4.5 1.1 61.6 0.7 13.9 84.1 16.4 20.8 14.8 5.0 48.9 71.9 24.3 75.3 66.8 50.3 11.6 1.9 6.9 190.1 20.1 30.6 1.9 5.9 68.1 54.7 0.6 11.0 38.6 105.5 53.2 6.5 360.1 17.8 14.2 51.4 21.5 15.7 27.6 2.4 21.2 17.8 86.3 1.4 6.0 27.4 38.5 14.6 32.1 37.9 0.8 143.3 0.1 1.2 0.1 0.5 1.3 0.0 0.4 0.3 0.2 124.2 96.9 2.0 5.8 4.8 0.0 0.0 1.0 0.0 0.2 0.2 6.8 0.0 0.3 8.2 0.4 0.0 0.0 4.4 0.1 0.0 56.6 41.5 0.1 0.1 131.8 0.7 0.1 0.1 1.1 0.0 0.4 11.6 0.0 6.0 0.0 0.7 0.7 3.2 0.0 0.1 0.3 22.8 0.1 0.0 0.6 0.1 4.2 0.0 0.0 5.8 0.3 0.7 17.4 0.2 0.0 1.9 1.4 0.1 0.0 0.2 2.9 0.1 0.1 0.0 0.0 1.2 0.1 0.0 0.4 0.0 0.8 0.0 0.1 7.9 0.4 0.2 0.5 0.1 0.1 0.0 143.3 0.0 1.3 2.3 4.5 0.7 13.9 11.6 1.9 1.9 5.9 105.5 1.4 3.0 7.2 12.3 167.2 84.3 39.9 7.8 10.2 101.7 131.9 1.8 210.1 695.7 0.0 0.3 9.0 23.3 0.0 23.3 21.6 72.9 677.8 14.0 23.0 664.1 130.4 3.2 0.0 36.2 38.0 21.6 1683.3 71.6 102.9 131.7 0.0 6.1 9.4 0.0 982.9 12.9 32.6 19.4 143.0 6.5 5.6 68.6 447.3 7.5 0.0 47.8 SERPINF2 "A2AP, AAP, ALPHA-2-PI, API, PLI" ENSG00000167711 "Serpin family F member 2" P08697 17 1742836-1755268 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "liver: 417.7" "Cell type enriched" "Detected in many" 11 "Hepatocytes: 830.3" "Cancer enriched" "Detected in all" 6 "liver cancer: 450.6" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 19.8" "Lineage enriched" "Detected in single" 27 "dendritic cells: 19.8" "Cell line enriched" "Detected in some" 32 "Hep G2: 57.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA001885, CAB024863" Approved "Secreted to blood" NA NA 11900 110000000000 "CAB024863: , HPA001885: AB_1079922" "unprognostic (2.17e-3)" "unprognostic (2.56e-3)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (3.69e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.26e-5)" "unprognostic (1.44e-1)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.88e-3)" "unprognostic (2.18e-1)" "unprognostic (1.09e-3)" "unprognostic (7.05e-2)" "unprognostic (2.81e-1)" "unprognostic (7.68e-3)" "unprognostic (2.93e-1)" 0.9 0.0 0.2 0.6 0.2 0.0 1.8 0.2 0.2 0.6 0.3 0.2 6.6 0.0 0.7 17.2 0.2 2.1 0.2 0.3 0.2 0.0 10.2 417.7 1.3 3.4 0.2 0.2 0.7 0.8 0.0 0.2 0.2 0.8 2.1 0.0 1.8 0.5 9.0 0.2 0.4 1.0 0.2 0.2 0.6 0.2 1.7 0.2 0.2 0.7 0.2 0.5 0.6 0.4 0.2 19.8 0.5 0.7 0.4 0.0 0.4 0.3 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.3 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 57.1 0.4 0.1 0.0 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.2 0.0 0.2 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.4 0.0 19.8 0.0 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.8 0.2 3.0 15.8 13.7 5.7 1.3 0.1 0.6 25.5 5.3 4.5 1.8 5.9 0.1 8.3 0.0 0.5 0.6 1.0 23.3 4.4 0.1 1.9 2.5 1.1 830.3 7.4 0.0 4.1 10.4 21.5 0.0 31.4 11.4 1.7 16.2 1.0 0.0 5.7 3.5 25.1 73.8 0.4 0.0 2.3 0.2 0.5 1.4 0.2 4.4 1.7 1.0 SERPING1 "C1-INH, C1IN, C1NH, HAE1, HAE2" ENSG00000149131 "Serpin family G member 1" P05155 11 57597387-57614853 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 693.2" "Cell type enhanced" "Detected in many" 17 "Cholangiocytes: 749.1;Hepatocytes: 2308.4;Leydig cells: 680.9" "Cancer enhanced" "Detected in all" "liver cancer: 609.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5" "Group enriched" "Detected in many" 143 "dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0" "Group enriched" "Detected in some" 6 "ASC diff: 148.4;ASC TERT1: 76.8;HSkMC: 127.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026161, HPA048738" Supported "Secreted to blood" NA NA 38000000000 "CAB026161: , HPA048738: AB_2680505" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (4.26e-2)" "unprognostic (4.38e-2)" "unprognostic (2.32e-1)" "unprognostic (4.12e-3)" "unprognostic (2.13e-1)" "unprognostic (8.95e-2)" "prognostic favorable (8.03e-4)" "unprognostic (5.92e-3)" "unprognostic (3.76e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.60e-2)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.17e-1)" 88.8 16.3 3.6 18.2 5.4 1.6 75.0 3.8 6.3 62.7 37.8 7.3 16.7 6.2 63.4 58.8 58.3 63.4 61.6 55.5 3.4 3.0 53.4 693.2 73.8 22.4 5.7 4.1 116.4 38.1 8.0 18.4 33.1 14.9 70.3 11.9 82.6 20.7 33.2 36.5 23.1 20.3 38.7 17.3 42.7 30.3 39.2 3.6 1.8 41.5 24.4 16.8 68.7 122.2 0.0 28.5 32.1 11.0 0.1 0.0 2.8 0.0 0.0 5.6 0.0 148.4 76.8 1.0 9.4 6.7 2.0 3.6 0.3 0.0 0.0 11.3 4.8 0.0 0.0 0.0 0.6 1.2 0.0 0.0 4.6 0.0 0.2 19.6 0.2 0.9 127.4 1.9 0.7 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 5.7 0.0 0.0 0.7 0.5 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.1 5.1 0.1 0.4 0.0 0.3 3.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 8.9 0.1 0.0 11.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 32.1 0.1 4.4 28.5 0.0 2.8 3.6 5.4 3.8 6.3 3.4 3.0 5.7 4.1 14.9 3.6 110.2 95.0 7.0 53.1 67.3 0.6 19.8 749.1 34.8 102.4 150.1 0.0 17.1 36.5 333.2 3.5 154.2 0.0 0.0 39.3 87.1 278.1 25.0 7.0 2308.4 40.1 0.0 0.0 231.4 85.9 8.5 680.9 41.3 86.0 12.6 0.0 52.7 58.0 0.0 215.0 42.4 4.4 265.1 282.5 2.4 3.0 51.9 21.1 39.9 0.0 30.8 SERPINH1 "CBP1, CBP2, colligen, HSP47, SERPINH2" ENSG00000149257 "Serpin family H member 1" P50454 11 75562056-75572783 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 165.4" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 237.4;Extravillous trophoblasts: 249.1;Fibroblasts: 319.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 118.7;HHSteC: 105.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004441, HPA029198" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 730000 "Endoplasmic reticulum" "CAB004441: AB_627757, HPA029198: AB_10601712" "unprognostic (3.80e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (5.93e-2)" "unprognostic (2.81e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.39e-2)" "unprognostic (1.72e-3)" "unprognostic (2.35e-2)" "unprognostic (7.40e-2)" "unprognostic (1.57e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.22e-15)" "unprognostic (2.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.93e-2)" "unprognostic (1.96e-2)" 38.2 20.1 10.5 29.3 10.9 1.0 54.1 5.7 8.4 39.4 16.9 6.0 10.3 6.4 32.7 16.8 17.8 23.6 21.4 29.6 11.8 7.0 18.5 11.5 35.7 13.5 17.1 2.7 48.3 13.9 5.9 11.0 69.9 23.2 26.2 11.0 13.8 7.7 16.7 9.5 12.3 9.4 57.8 12.9 14.3 14.2 12.5 13.0 7.4 36.1 8.7 8.2 38.7 165.4 1.3 5.5 5.0 1.6 7.1 7.4 2.4 5.4 18.5 34.8 71.6 54.0 49.8 15.9 50.8 34.6 38.3 48.9 98.2 28.8 0.0 46.2 118.7 0.3 33.0 23.8 15.8 18.6 2.2 4.5 3.9 18.3 19.7 105.3 0.1 0.7 59.3 16.3 36.6 12.3 47.8 52.3 2.0 8.4 1.7 17.9 43.1 0.1 7.0 30.9 20.6 4.9 2.7 19.2 4.5 9.3 10.5 0.8 11.5 31.8 5.9 9.6 56.6 14.2 6.8 27.5 39.6 33.0 26.9 12.3 2.3 2.2 0.5 17.1 0.0 53.0 5.0 1.6 0.1 7.4 1.5 6.7 1.2 5.1 5.3 5.5 1.3 5.7 4.6 0.3 7.1 0.2 4.7 4.2 2.4 10.5 10.9 5.7 8.4 11.8 7.0 17.1 2.7 23.2 13.0 35.7 30.1 6.4 237.4 72.7 2.9 29.5 5.1 9.4 18.2 24.4 55.0 184.7 0.0 59.0 1.8 84.9 20.7 0.0 10.4 249.1 319.9 138.1 9.2 8.6 78.7 6.4 58.5 154.1 6.7 2.7 152.1 16.7 42.2 15.4 21.1 19.3 26.7 20.3 113.5 24.1 1.0 90.5 199.9 9.9 10.2 38.9 138.7 12.1 24.3 59.6 SERPINI1 "neuroserpin, PI12" ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825568 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 96.0" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 71.8;Muller glia cells: 71.6;Smooth muscle cells: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 15.9;HeLa: 16.5;Karpas-707: 18.5;U-266/84: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Uncertain Cytosol "Secreted in brain" NA NA 200000 Cytosol "HPA001565: AB_1079924, HPA056092: AB_2683036" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 5.9 8.2 31.9 2.4 27.9 1.3 6.1 3.6 96.0 4.2 2.8 7.1 0.4 1.5 4.3 4.3 3.2 3.9 3.4 6.4 35.9 35.3 14.5 2.5 3.4 2.3 36.9 35.7 4.0 16.3 3.7 10.3 3.5 22.9 5.8 2.5 2.4 9.9 3.6 1.7 2.1 2.5 3.1 51.6 4.1 3.6 7.0 15.9 0.0 5.2 0.3 3.8 3.1 1.6 15.4 4.4 1.0 0.4 6.0 16.0 3.4 0.4 2.0 3.2 0.2 6.0 1.6 0.2 1.2 1.8 0.8 1.3 0.7 3.9 15.9 6.1 0.8 2.7 0.9 2.1 2.2 0.9 5.0 4.5 5.4 16.5 6.7 0.4 0.8 0.6 2.3 0.8 0.4 0.8 1.8 0.2 6.1 10.1 18.5 0.7 1.5 0.4 1.1 2.0 2.5 2.5 1.8 0.1 2.0 6.9 0.5 1.3 8.4 2.3 4.3 5.1 7.8 6.6 2.4 0.5 3.5 0.3 0.3 5.7 13.9 17.1 11.6 2.9 4.1 2.0 1.0 0.2 0.5 6.2 0.4 4.5 12.7 6.5 6.6 0.3 15.4 4.7 5.7 0.6 6.0 0.3 4.4 16.0 3.4 31.9 27.9 3.6 78.9 35.9 35.3 36.9 35.7 22.9 15.9 6.0 1.0 8.0 12.2 3.3 71.8 7.3 0.0 13.4 7.9 5.2 13.7 5.0 6.6 1.5 0.3 9.2 0.0 0.0 15.6 4.7 5.2 9.8 2.3 0.6 2.3 4.8 4.6 3.1 0.8 1.8 3.7 1.9 6.8 1.8 0.1 71.6 4.6 0.0 2.5 31.2 31.4 25.8 68.9 1.8 13.2 1.5 4.2 5.3 0.0 1.6 SERPINI2 "MEPI, PANCPIN, PI14, TSA2004" ENSG00000114204 "Serpin family I member 2" O75830 3 167441789-167479004 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 73 "pancreas: 184.7" "Group enriched" "Detected in some" 5 "Ciliated cells: 29.4;Exocrine glandular cells: 82.5" "Cancer enriched" "Detected in some" 6 "pancreatic cancer: 7.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.5" "Lineage enhanced" "Detected in single" "dendritic cells: 2.5" "Cell line enriched" "Detected in some" 6 "THP-1: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to digestive system" NA NA "unprognostic (1.88e-2)" "unprognostic (2.23e-3)" "unprognostic (1.14e-1)" "unprognostic (5.27e-2)" "unprognostic (1.17e-2)" "unprognostic (1.29e-2)" "unprognostic (1.11e-2)" "unprognostic (2.04e-1)" "unprognostic (3.13e-1)" "unprognostic (1.76e-5)" "unprognostic (5.35e-2)" "unprognostic (4.16e-2)" 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 184.7 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 14.1 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.1 2.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.0 29.4 10.3 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 82.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SERTAD2 "KIAA0127, Sei-2, TRIP-Br2" ENSG00000179833 "SERTA domain containing 2" Q14140 2 64631621-64751005 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 53.8" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 157.8;Suprabasal keratinocytes: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019021, HPA020904" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA019021: AB_1856740, HPA020904: AB_1856741" "unprognostic (1.40e-2)" "unprognostic (7.41e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.15e-2)" "unprognostic (8.15e-2)" "unprognostic (3.39e-3)" "unprognostic (1.06e-1)" "unprognostic (9.55e-2)" "unprognostic (5.95e-3)" "unprognostic (1.98e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.21e-3)" "unprognostic (6.78e-2)" "unprognostic (4.98e-2)" "unprognostic (3.84e-1)" 14.3 5.5 4.3 11.3 5.5 52.1 10.4 6.4 5.9 12.4 8.6 9.1 5.6 4.6 9.6 7.6 24.7 7.8 8.4 10.9 4.7 3.5 6.7 11.0 11.8 12.5 7.2 4.4 12.1 5.8 8.4 6.2 17.4 6.0 8.6 6.5 10.2 18.4 7.5 10.8 18.8 9.9 9.5 6.7 24.5 7.2 7.4 8.4 53.8 7.6 16.7 25.7 22.0 16.7 5.4 8.8 3.8 3.1 2.6 4.2 1.4 14.6 4.3 8.2 8.1 7.0 18.0 9.4 11.8 11.4 7.0 6.6 11.1 11.3 12.4 6.5 19.2 9.8 5.8 5.3 7.2 14.9 1.1 8.0 8.2 4.1 8.0 1.5 7.2 4.2 12.2 9.5 16.0 10.5 10.5 4.2 6.2 5.1 6.9 16.3 3.5 7.7 7.9 4.5 8.1 11.6 6.8 14.0 4.8 9.5 13.5 9.5 3.7 8.3 5.8 14.8 8.0 3.9 5.8 12.7 38.0 19.6 22.2 9.5 11.9 4.5 14.4 14.1 13.3 14.8 2.3 2.7 3.8 1.8 2.8 1.1 4.7 1.8 2.0 2.8 5.4 4.2 3.1 3.8 2.6 3.1 8.8 0.9 1.4 4.3 5.5 6.4 5.8 4.7 3.5 7.2 4.4 6.0 8.4 6.0 23.4 29.1 32.3 157.8 20.0 20.7 38.2 14.7 23.9 8.7 17.7 31.4 1.7 11.5 39.6 24.5 17.4 46.7 8.6 22.2 26.8 30.6 8.1 23.2 19.8 9.5 10.9 25.2 34.9 27.3 15.8 37.9 37.1 12.6 14.8 16.7 14.4 17.5 9.9 7.8 23.0 12.9 34.0 5.4 2.7 129.6 50.2 17.5 11.5 61.7 SERTAD4 DJ667H12.2 ENSG00000082497 "SERTA domain containing 4" Q9NUC0 1 210232799-210246631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 36.3" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 14.8;Ciliated cells: 14.7;Extravillous trophoblasts: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 7.4;BEWO: 7.7;SCLC-21H: 7.7;SK-BR-3: 8.8;T-47d: 10.8;U-2 OS: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027344, HPA028514" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA027344: AB_10601770, HPA028514: AB_10611391" "unprognostic (1.75e-2)" "unprognostic (3.92e-2)" "unprognostic (3.83e-2)" "unprognostic (9.74e-2)" "unprognostic (1.98e-2)" "unprognostic (1.27e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-1)" "unprognostic (7.74e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-2)" "unprognostic (5.98e-2)" "unprognostic (6.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.85e-2)" "unprognostic (6.55e-2)" "unprognostic (4.24e-1)" 1.5 1.0 2.3 0.7 7.7 0.1 12.3 2.6 4.3 6.2 6.2 1.5 4.6 1.1 6.2 3.2 15.7 3.2 2.9 4.2 1.8 2.1 2.5 0.2 3.4 0.4 2.8 0.4 2.5 0.2 1.5 1.4 11.7 3.0 3.6 3.3 1.0 36.3 11.1 0.5 5.3 1.1 6.0 2.7 0.3 2.3 0.7 2.1 1.9 3.2 14.6 7.7 1.7 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.2 1.6 0.0 0.8 0.8 7.7 1.9 1.9 1.4 2.6 0.3 0.9 0.0 0.2 0.4 1.2 3.6 0.3 0.6 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 1.8 0.3 0.0 0.0 0.0 0.3 1.8 0.0 0.0 5.4 6.0 0.3 0.0 2.5 0.0 1.3 1.3 7.7 6.7 1.2 8.8 0.1 3.2 10.8 0.0 2.4 2.1 9.2 0.1 5.6 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 7.7 2.6 4.3 1.8 2.1 2.8 0.4 3.0 2.1 6.0 3.8 0.0 10.1 14.8 0.5 0.6 2.5 14.7 11.4 8.7 0.0 13.2 6.6 1.6 0.6 1.4 0.0 0.0 3.5 37.9 4.4 2.2 0.0 0.0 1.3 0.0 1.2 1.3 0.0 0.6 0.6 0.6 10.1 0.0 4.3 0.3 5.2 0.0 1.4 0.0 0.2 0.0 0.9 0.0 0.6 4.1 3.7 0.0 3.7 1.8 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36673912-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 8.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Group enriched" "Detected in many" 7 "amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 2.7;HEK 293: 3.2;NTERA-2: 8.0;SH-SY5Y: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Uncertain Enhanced Vesicles NA NA Vesicles "HPA054814: AB_2682611, HPA070485: AB_2686272" "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 5.0 1.8 13.9 0.5 10.1 0.5 1.2 0.3 30.2 16.4 0.7 1.3 1.8 0.6 30.9 13.5 0.5 25.3 0.5 0.6 26.5 2.0 0.6 0.5 5.6 0.5 1.5 11.6 14.5 0.8 1.0 11.2 0.5 2.4 0.9 0.5 8.2 0.5 1.2 0.5 0.6 0.6 17.4 0.9 0.5 0.9 1.5 0.0 0.0 9.3 0.0 0.5 1.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 3.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 10.1 0.3 21.6 26.5 2.0 1.5 11.6 2.4 0.0 8.9 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SERTM2 LINC00890 ENSG00000260802 "Serine rich and transmembrane domain containing 2" X 111511662-111522399 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "epididymis: 60.2;seminal vesicle: 38.7" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 5.8;granulocytes: 1.1" "Cancer enhanced" "Detected in some" "prostate cancer: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HMC-1: 19.6" "Region enhanced" "Detected in single" "basal ganglia: 3.0" NA NA "unprognostic (9.56e-2)" "unprognostic (1.63e-2)" "unprognostic (1.55e-1)" "unprognostic (2.42e-1)" "unprognostic (2.65e-1)" "unprognostic (3.79e-2)" "unprognostic (5.74e-2)" "unprognostic (1.93e-2)" "unprognostic (4.03e-2)" "unprognostic (3.51e-1)" "unprognostic (8.77e-3)" "unprognostic (3.86e-3)" "unprognostic (1.94e-1)" "unprognostic (2.26e-1)" "unprognostic (9.57e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.2 0.5 0.0 9.1 0.0 14.2 60.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.6 1.7 0.5 4.6 0.0 0.1 0.0 38.7 0.0 0.0 0.0 2.2 0.0 2.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SETD9 "C5orf35, MGC33648" ENSG00000155542 "SET domain containing 9" Q8NE22 5 56909260-56925532 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 23.8" "Group enriched" "Detected in many" 6 "Early spermatids: 523.2;Late spermatids: 284.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049936 Approved Nucleoplasm NA NA Nucleoplasm "HPA049936: " "unprognostic (1.13e-1)" "unprognostic (3.89e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.38e-1)" "unprognostic (1.05e-1)" "unprognostic (1.59e-1)" "unprognostic (2.29e-1)" "unprognostic (7.37e-2)" "unprognostic (8.75e-3)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-2)" "unprognostic (1.49e-1)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" 7.2 2.6 2.3 1.2 4.4 2.4 11.1 1.4 5.2 2.6 4.4 4.7 4.6 4.4 2.7 2.5 2.4 1.9 2.1 7.0 2.1 2.4 5.4 8.8 2.4 5.3 5.3 3.8 2.6 7.3 2.4 2.0 2.6 3.7 4.3 3.3 2.8 5.3 1.2 4.1 1.9 5.2 4.4 3.6 1.8 2.7 23.8 3.2 1.1 4.4 3.4 2.0 2.9 8.1 1.1 2.0 4.3 3.0 1.6 2.9 0.8 4.9 1.8 3.0 3.8 4.6 2.6 5.2 1.4 2.2 2.4 6.1 4.5 5.7 4.5 7.0 2.1 3.1 4.6 3.2 1.8 6.3 3.2 6.7 1.2 1.5 3.7 1.8 1.4 4.3 1.2 2.5 2.2 3.2 3.6 3.9 1.9 3.7 3.3 5.5 7.1 0.7 3.5 4.7 0.0 7.2 4.6 1.9 6.0 2.6 1.7 3.4 5.4 1.2 3.5 5.9 2.0 5.5 3.4 4.2 1.6 7.3 4.6 3.1 3.3 9.5 7.4 2.2 1.3 0.7 1.4 2.3 4.3 1.4 2.0 1.3 0.5 1.6 0.4 2.0 1.1 0.5 0.6 2.7 1.6 3.0 0.8 2.9 0.8 2.3 4.4 1.4 5.2 2.1 2.4 5.3 3.8 3.7 3.2 3.0 2.4 10.3 12.8 15.5 3.0 14.8 10.2 5.3 1.2 7.0 0.0 13.2 48.0 13.9 523.2 6.8 19.6 0.0 15.2 17.3 15.0 18.2 14.9 24.6 13.3 0.0 17.7 9.8 13.9 284.0 9.5 15.7 27.0 11.8 9.2 2.8 8.6 17.5 5.3 36.6 2.9 0.0 10.2 63.8 8.4 13.4 12.0 8.9 12.0 16.4 SETSIP SETP18 ENSG00000230667 "SET-like protein" P0DME0 1 92074533-92075441 "Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.8" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 3.1;granulocytes: 3.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MOLT-4: 2.3" HPA063683 Approved Supported "Nucleoplasm,Lipid droplets" NA NA Nucleoplasm "Lipid droplets" "HPA063683: AB_2685088" "unprognostic (2.31e-2)" "unprognostic (3.79e-3)" "unprognostic (7.59e-2)" "unprognostic (5.74e-2)" "unprognostic (5.60e-2)" "unprognostic (7.74e-2)" "unprognostic (1.88e-8)" "unprognostic (3.43e-1)" "unprognostic (1.65e-2)" "unprognostic (9.37e-2)" "unprognostic (4.35e-4)" "unprognostic (1.63e-2)" "unprognostic (2.58e-1)" "unprognostic (3.10e-2)" "unprognostic (4.93e-2)" "unprognostic (2.15e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.2 0.6 0.3 0.1 0.2 0.1 0.6 0.7 0.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 1.3 0.5 0.4 0.0 0.1 1.3 0.0 0.0 0.3 0.2 0.0 0.0 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.9 1.2 0.0 0.0 2.3 0.0 1.6 0.4 0.5 1.2 1.0 1.4 0.0 0.6 1.5 0.6 1.3 0.9 0.5 0.1 0.7 0.3 0.0 0.7 0.4 0.2 0.2 0.7 0.6 1.3 0.0 0.1 1.9 0.0 0.0 0.6 0.1 0.3 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 1.1 0.0 0.8 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 1.1 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.5 0.0 0.0 0.9 SEZ6 ENSG00000063015 "Seizure related 6 homolog" Q53EL9 17 28954901-29006440 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 60.4;Cone photoreceptor cells: 45.2;Horizontal cells: 41.3;Rod photoreceptor cells: 17.6" "Cancer enriched" "Detected in many" 11 "glioma: 16.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 2.8;neutrophil: 5.7" "Lineage enriched" "Detected in single" 6 "granulocytes: 5.7" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011777 Enhanced NA NA "HPA011777: AB_1856758" "unprognostic (3.99e-2)" "unprognostic (1.24e-1)" "unprognostic (5.75e-3)" "unprognostic (5.33e-3)" "unprognostic (1.84e-2)" "unprognostic (1.76e-3)" "unprognostic (2.82e-2)" "unprognostic (2.22e-2)" "unprognostic (3.07e-1)" "unprognostic (4.75e-2)" "unprognostic (1.22e-3)" "unprognostic (3.15e-3)" "unprognostic (3.63e-6)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 1.2 2.0 18.8 1.4 67.3 1.6 1.1 43.5 48.2 1.1 1.6 3.1 0.0 2.4 1.1 1.5 1.2 1.2 1.1 1.2 10.5 10.0 1.2 1.1 1.3 1.2 4.9 9.4 1.1 1.9 1.1 4.9 1.2 9.1 1.3 1.8 3.3 1.2 1.2 1.4 1.4 1.4 1.3 2.7 1.2 1.7 1.6 5.4 0.0 1.2 0.0 1.1 1.3 0.0 0.8 0.9 5.7 0.5 0.5 0.9 0.4 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 37.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.9 0.2 0.5 0.9 0.8 0.4 0.5 0.6 0.5 0.6 0.7 5.7 0.5 0.5 0.9 0.2 0.4 18.8 67.3 43.5 18.8 10.5 10.0 4.9 9.4 9.1 5.4 0.0 0.0 0.0 0.6 0.3 60.4 0.5 0.0 0.0 0.0 0.0 45.2 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.5 9.2 0.0 0.2 41.3 7.0 0.6 3.2 0.0 0.9 2.1 0.0 8.2 0.0 6.0 0.4 0.0 0.0 0.0 17.6 0.0 0.1 0.9 1.3 0.0 0.2 2.1 0.4 0.1 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169474-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 60.8" "Cell type enriched" "Detected in some" 6 "Horizontal cells: 20.6" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 73 "dendritic cells: 7.2;monocytes: 7.4" "Group enriched" "Detected in some" 7 "SCLC-21H: 30.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles NA NA 2400000 Vesicles "HPA045135: AB_2732518" "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 1.2 12.5 26.4 1.6 11.3 1.3 1.1 20.1 60.8 2.4 1.3 4.3 0.0 1.5 1.1 1.1 1.1 1.1 1.2 2.5 39.1 23.6 1.1 1.1 1.3 1.1 11.2 25.5 1.1 2.7 1.0 3.8 1.1 15.0 1.3 1.4 0.0 1.3 1.2 1.1 1.2 1.6 1.4 5.3 1.3 2.9 1.4 5.4 0.0 1.2 0.0 1.1 1.2 0.2 0.0 7.2 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 8.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 26.4 11.3 20.1 29.3 39.1 23.6 11.2 25.5 15.0 5.4 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 20.6 0.0 0.0 0.0 0.7 0.6 0.7 0.0 3.6 0.0 0.5 1.0 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 SEZ6L2 "FLJ90517, PSK-1" ENSG00000174938 "Seizure related 6 homolog like 2" Q6UXD5 16 29871159-29899547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 52.6;pituitary gland: 36.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 220.8;Cone photoreceptor cells: 174.7;Horizontal cells: 178.0;Intestinal endocrine cells: 127.3;Rod photoreceptor cells: 189.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064471 Enhanced NA NA 3900000 "HPA064471: AB_2685271" "unprognostic (2.56e-2)" "prognostic unfavorable (7.46e-4)" "prognostic unfavorable (1.31e-4)" "unprognostic (2.11e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.27e-1)" "unprognostic (1.67e-2)" "unprognostic (2.71e-2)" "unprognostic (8.22e-2)" "unprognostic (1.85e-1)" "unprognostic (1.43e-3)" "unprognostic (8.31e-2)" "unprognostic (1.04e-1)" "unprognostic (8.22e-2)" "unprognostic (2.30e-1)" "unprognostic (2.12e-1)" "unprognostic (1.08e-1)" 2.1 21.0 21.0 1.8 27.6 0.8 4.0 42.4 52.6 11.4 4.5 7.7 0.2 9.2 6.1 1.4 1.2 4.2 8.8 1.4 18.5 32.8 3.3 0.9 4.5 1.4 15.6 27.6 2.5 34.7 32.7 36.3 3.2 31.4 13.3 3.6 5.4 18.1 4.7 1.5 2.5 5.5 4.3 12.3 1.8 14.9 7.2 7.4 0.0 1.6 0.0 1.9 4.2 0.9 0.0 0.0 0.1 0.1 0.1 0.8 0.0 0.5 4.4 0.3 4.3 0.0 0.2 3.0 5.5 2.6 5.2 2.9 6.5 20.8 2.2 30.5 6.7 4.4 1.9 1.7 1.3 1.6 0.0 3.7 0.3 3.8 13.4 11.6 0.0 13.4 13.0 2.5 6.2 1.7 19.1 0.4 2.0 0.6 13.5 2.6 22.4 0.0 0.0 6.7 7.4 7.7 0.0 0.0 0.6 4.8 1.9 20.3 16.3 1.8 14.3 0.8 3.8 13.4 19.5 0.2 17.6 8.7 0.1 0.3 1.5 1.3 0.1 21.4 3.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.0 21.0 27.6 42.4 52.6 18.5 32.8 15.6 27.6 31.4 7.4 3.0 16.0 0.5 9.3 2.6 220.8 7.8 48.4 0.0 1.2 3.5 174.7 0.2 0.0 46.1 2.1 1.7 15.1 0.0 34.7 2.0 1.9 31.1 1.1 0.0 1.3 178.0 127.3 1.3 0.0 4.0 1.1 0.0 11.8 1.0 28.2 16.4 40.1 21.2 1.8 4.8 189.2 12.9 3.9 5.4 3.8 1.3 1.1 0.0 23.6 8.0 SFI1 "KIAA0542, PISD, PPP1R139" ENSG00000198089 "SFI1 centrin binding protein" A8K8P3 22 31488688-31618586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 112.8;Rod photoreceptor cells: 65.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.71e-2)" "unprognostic (3.27e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.10e-4)" "unprognostic (9.82e-3)" "unprognostic (3.51e-2)" "unprognostic (2.56e-1)" "unprognostic (1.77e-1)" "prognostic favorable (5.80e-4)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (2.11e-2)" "prognostic favorable (1.31e-4)" 3.9 7.3 6.9 14.4 12.1 17.9 5.6 34.0 9.2 5.1 5.7 5.6 11.9 12.7 6.3 6.5 5.1 7.3 5.7 3.2 6.3 6.5 6.7 3.8 5.9 16.0 6.7 6.1 6.5 6.1 6.7 17.5 3.9 7.7 6.4 4.0 10.0 6.9 7.2 2.2 8.9 11.0 5.5 5.5 11.9 8.3 13.6 7.3 22.2 7.6 2.4 22.1 5.7 5.1 4.0 1.7 6.0 4.5 9.6 11.0 4.9 9.4 6.0 5.6 6.9 3.1 3.2 3.4 7.5 3.2 5.5 6.6 5.5 6.6 14.6 3.0 2.4 3.5 8.9 2.7 4.8 3.7 12.3 8.8 3.5 13.0 6.5 4.2 13.9 11.8 2.2 3.2 5.8 4.1 4.3 4.7 13.9 4.6 7.2 4.4 14.3 9.9 8.8 2.5 6.8 3.5 11.0 6.6 10.5 3.4 9.5 8.6 4.7 6.7 9.5 6.1 2.2 7.1 6.0 9.0 7.7 6.9 6.8 5.3 8.7 6.4 7.7 7.7 7.8 6.0 5.7 1.2 3.1 9.7 1.3 4.5 4.0 7.9 11.0 1.4 3.7 10.7 9.4 6.0 9.6 4.5 1.7 6.0 4.9 6.9 12.1 34.0 9.2 6.3 6.5 6.7 6.1 7.7 7.3 6.0 28.7 11.5 6.7 3.5 43.2 2.2 10.2 28.1 23.9 15.7 33.4 6.2 1.7 6.3 11.2 9.0 24.2 0.0 4.5 2.1 4.8 6.0 19.7 2.6 4.5 112.8 10.9 4.3 7.3 4.0 4.9 5.7 3.3 4.6 13.2 9.2 6.0 10.5 1.8 2.4 65.6 0.0 2.2 27.8 27.7 2.9 15.8 26.2 8.0 5.5 SFMBT1 "DKFZp434L243, RU1, SFMBT" ENSG00000163935 "Scm like with four mbt domains 1" Q9UHJ3 3 52903572-53046750 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 30.2" "Cell type enhanced" "Detected in many" 10 "Spermatocytes: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036152, HPA064564" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA036152: AB_2674972, HPA064564: AB_2685288" "unprognostic (2.78e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.69e-1)" "unprognostic (2.71e-2)" "unprognostic (1.28e-2)" "unprognostic (9.39e-2)" "unprognostic (6.79e-2)" "unprognostic (3.55e-2)" "unprognostic (2.36e-1)" "unprognostic (2.57e-2)" "unprognostic (3.57e-3)" "unprognostic (7.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (3.55e-2)" 3.1 2.4 5.1 7.0 3.7 5.5 6.8 10.5 5.8 3.2 4.9 3.1 2.7 3.1 2.8 5.2 4.9 3.7 3.8 4.8 4.1 2.4 4.5 6.3 7.3 6.3 2.6 4.3 2.4 11.8 15.1 12.0 3.1 3.1 4.6 5.4 2.9 4.6 2.1 17.7 4.8 4.4 4.1 4.1 5.9 4.2 30.2 2.4 3.9 5.1 2.7 5.6 3.2 12.9 8.2 0.9 10.9 2.1 3.6 5.3 2.4 15.3 4.2 6.9 12.4 1.5 1.1 14.0 3.4 3.2 10.3 12.8 8.6 13.3 7.9 4.0 2.1 11.3 1.3 6.8 4.3 12.5 14.3 4.3 6.6 8.9 3.8 2.4 10.4 6.9 1.0 6.3 7.0 4.8 1.1 1.8 9.1 2.2 11.9 3.4 4.8 6.5 4.2 3.6 5.9 4.5 5.9 6.3 4.4 1.4 16.6 8.1 5.1 14.5 6.0 7.3 0.8 3.9 9.7 1.1 4.6 10.4 7.9 10.4 5.7 19.9 16.9 4.2 4.3 7.7 2.0 2.1 10.9 3.4 1.1 4.5 8.2 5.2 3.1 0.9 6.9 4.8 5.3 3.8 3.6 1.1 0.9 2.5 2.4 5.1 3.7 10.5 5.8 4.1 2.4 2.6 4.3 3.1 2.4 8.9 6.5 14.7 7.5 10.3 13.3 13.7 12.7 13.4 6.8 1.8 43.2 8.8 6.6 6.0 33.8 4.5 6.2 23.3 11.7 8.3 4.2 7.6 9.2 12.4 5.6 7.9 5.8 3.7 5.3 43.6 2.0 5.4 0.0 4.6 8.5 6.0 8.6 8.6 7.1 6.9 21.2 6.5 5.9 123.8 23.2 7.5 4.5 12.5 10.6 4.2 SFMBT2 KIAA1617 ENSG00000198879 "Scm like with four mbt domains 2" Q5VUG0 10 7158624-7411486 "Predicted intracellular proteins" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.7" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 76.6;Rod photoreceptor cells: 33.6;T-cells: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 16.4;REH: 14.7;RPMI-8226: 13.8;SH-SY5Y: 11.3;THP-1: 17.6;U-937: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035447, HPA035448, HPA070388" Uncertain Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA035447: AB_2674628, HPA035448: AB_10669904, HPA070388: " "unprognostic (4.36e-2)" "unprognostic (2.29e-2)" "unprognostic (4.36e-2)" "unprognostic (1.42e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-3)" "unprognostic (4.65e-1)" "unprognostic (4.56e-1)" "unprognostic (1.03e-1)" "unprognostic (6.51e-2)" "unprognostic (5.57e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.26e-1)" "unprognostic (9.17e-3)" "unprognostic (5.37e-3)" "unprognostic (7.29e-2)" 3.0 4.2 9.6 5.9 11.7 6.1 6.2 6.6 13.7 2.5 2.8 26.7 1.1 2.0 4.3 3.7 2.3 3.7 3.6 3.9 12.6 6.9 2.7 1.1 4.1 7.2 14.6 7.4 11.2 3.8 10.1 6.6 3.7 10.8 6.5 3.4 3.9 4.6 3.6 3.9 1.2 3.5 3.4 10.6 9.0 2.9 1.5 9.7 2.0 7.8 1.1 6.2 3.7 4.1 0.1 5.4 1.7 7.4 1.3 1.8 0.4 0.0 3.4 0.2 0.0 0.0 0.2 3.2 0.1 0.0 0.0 0.0 0.0 0.9 5.3 0.0 0.1 0.0 1.6 6.0 0.0 0.0 0.3 5.4 0.0 8.9 0.0 0.4 5.8 0.7 0.8 0.2 0.0 0.2 0.0 0.0 7.3 9.0 16.4 0.0 2.3 4.6 9.1 1.1 0.0 0.0 14.7 1.8 13.8 0.0 0.5 1.3 11.3 0.0 0.0 0.0 1.5 0.8 17.6 0.0 0.0 1.8 0.2 0.1 7.0 10.1 0.0 0.7 11.1 0.1 0.1 0.4 1.7 1.4 3.8 0.8 0.1 0.5 0.9 0.7 0.1 1.8 1.1 0.2 1.3 7.4 5.4 0.0 0.4 9.6 11.7 6.6 13.7 12.6 6.9 14.6 7.4 10.8 9.7 0.0 6.9 6.7 1.2 1.3 5.8 9.6 2.5 1.4 1.2 0.0 76.6 5.9 0.0 0.4 0.1 6.7 0.0 0.0 0.2 2.0 1.7 9.3 4.6 0.5 14.1 0.0 4.1 7.4 11.5 0.4 4.6 9.2 5.0 9.0 0.0 12.9 0.2 0.0 2.1 0.1 33.6 0.0 1.0 0.4 3.6 1.1 3.7 24.1 0.0 0.6 SFN YWHAS ENSG00000175793 Stratifin P31947 1 26863138-26864457 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4" "Cancer enhanced" "Detected in all" "head and neck cancer: 2526.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 7.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.1" "Cell line enhanced" "Detected in many" "A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4" "Low region specificity" "Detected in some" "CAB006268, HPA011105, CAB040552, HPA061603" Enhanced Supported "Nucleoli rim,Cytosol" "Secreted in other tissues" NA NA 54000000 Cytosol "Nucleoli rim" "CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: " "unprognostic (5.70e-2)" "unprognostic (1.26e-1)" "unprognostic (8.37e-2)" "prognostic favorable (1.92e-4)" "unprognostic (1.26e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (1.71e-2)" "unprognostic (2.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (7.45e-6)" "unprognostic (7.90e-3)" "unprognostic (3.25e-1)" "unprognostic (8.12e-2)" "unprognostic (2.06e-2)" 0.4 0.0 0.5 3.1 0.5 0.0 3.8 0.4 0.7 37.5 10.7 0.5 0.5 5.9 3.3 0.7 256.2 0.0 6.0 0.3 0.6 0.1 1.2 0.5 8.2 0.3 0.4 0.3 0.3 0.3 0.0 0.3 3.4 0.8 5.9 4.0 0.3 25.5 0.4 0.4 123.8 13.2 0.5 0.7 0.3 6.6 0.4 0.4 3.1 0.4 256.0 107.4 9.1 47.7 0.0 0.0 7.1 0.0 0.0 0.6 0.0 70.1 11.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.3 37.1 0.6 3.1 0.0 0.0 110.7 0.0 170.4 0.0 16.7 0.5 0.0 11.8 12.5 0.0 0.0 0.1 0.0 114.4 0.0 29.9 0.0 0.0 0.0 0.1 0.4 0.0 15.0 0.0 0.0 0.2 12.2 19.7 0.0 0.0 3.9 26.5 16.2 0.0 0.0 16.9 3.0 0.1 0.2 7.9 0.1 0.0 0.0 32.4 0.0 0.4 0.1 0.5 0.3 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.4 0.7 0.6 0.1 0.4 0.3 0.8 0.4 166.7 216.2 0.5 1339.8 6884.3 0.0 0.3 33.1 30.8 122.8 15.7 0.0 6.7 3.3 52.1 0.0 0.6 409.5 0.0 68.0 45.3 37.0 487.4 31.2 0.0 1.6 0.0 64.7 0.6 0.3 0.0 0.0 15.6 506.2 1.8 78.2 0.0 315.2 136.8 0.0 0.0 0.0 0.0 110.7 0.0 0.2 9365.4 5.0 0.0 146.1 2426.4 SFRP2 "FRP-2, SARP1, SDF-5" ENSG00000145423 "Secreted frizzled related protein 2" Q96HF1 4 153780592-153789120 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 102.5" "Group enriched" "Detected in some" 15 "Basal keratinocytes: 102.6;Fibroblasts: 163.9;Melanocytes: 113.1;Smooth muscle cells: 47.4;Suprabasal keratinocytes: 92.6" "Cancer enhanced" "Detected in all" "pancreatic cancer: 370.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "AF22: 53.5;ASC diff: 20.3;HSkMC: 33.5;NTERA-2: 74.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA002652 Approved "Intermediate filaments" "Secreted in other tissues" NA NA "Intermediate filaments" "HPA002652: AB_2732394" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (7.21e-3)" "unprognostic (1.80e-2)" "unprognostic (2.73e-1)" "unprognostic (8.80e-3)" "unprognostic (5.71e-3)" "unprognostic (2.62e-2)" "unprognostic (2.79e-1)" "unprognostic (7.47e-3)" "unprognostic (1.44e-2)" "unprognostic (5.29e-2)" "prognostic unfavorable (8.56e-6)" "unprognostic (9.29e-3)" "unprognostic (4.72e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.39e-4)" 42.9 4.0 3.4 17.6 1.7 0.2 70.0 1.3 8.0 10.9 20.6 11.3 18.2 4.4 6.4 64.4 51.5 18.5 74.9 42.2 8.5 1.2 1.9 0.2 21.3 2.6 2.8 5.6 7.9 22.5 1.6 23.2 0.3 4.6 33.4 10.8 8.4 23.9 19.5 2.5 26.1 13.7 72.3 5.4 0.3 11.4 13.2 5.0 0.3 29.1 29.4 6.8 102.5 37.4 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 53.5 0.0 20.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.4 1.7 1.3 5.7 8.5 1.2 2.8 5.6 4.6 5.0 3.0 1.1 0.0 0.6 102.6 0.0 0.3 0.0 5.3 3.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 163.9 0.3 1.1 0.0 3.3 0.0 0.0 0.0 0.0 0.2 3.7 2.2 113.1 1.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 47.4 0.0 0.2 92.6 0.1 0.0 0.0 1.0 SFRP4 "FRP-4, frpHE, FRZB-2" ENSG00000106483 "Secreted frizzled related protein 4" Q6FHJ7 7 37905932-38025695 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 144.9;endometrium 1: 100.7;retina: 123.0" "Cell type enriched" "Detected in some" 5 "Peritubular cells: 177.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;HSkMC: 5.5;U-937: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA009712, HPA050585" Enhanced "Secreted in female reproductive system" NA NA 1500000 "HPA009712: AB_1856778, HPA050585: AB_2681183" "unprognostic (5.93e-2)" "unprognostic (5.84e-3)" "unprognostic (2.75e-2)" "unprognostic (1.58e-3)" "unprognostic (2.61e-1)" "unprognostic (2.35e-2)" "unprognostic (4.02e-2)" "unprognostic (2.60e-1)" "unprognostic (1.21e-1)" "unprognostic (3.76e-2)" "unprognostic (2.12e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.36e-5)" "unprognostic (7.37e-3)" "unprognostic (1.61e-1)" "unprognostic (4.35e-3)" "unprognostic (1.89e-3)" 4.6 2.3 0.5 0.9 0.9 0.0 12.5 0.3 0.4 144.9 0.8 1.7 5.4 0.0 100.7 11.5 3.2 35.1 2.5 5.5 0.4 0.4 1.2 0.2 3.9 0.8 0.8 0.7 42.7 1.4 0.1 4.0 0.4 1.3 4.9 0.2 123.0 2.3 7.1 1.4 0.3 0.5 14.5 3.3 4.1 0.5 5.8 0.3 0.4 3.3 2.5 0.5 8.8 14.8 0.4 0.8 0.4 0.6 0.1 0.1 0.0 0.0 2.6 2.9 0.0 14.1 0.6 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.1 3.0 0.4 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.2 2.0 0.1 0.4 0.0 5.5 0.7 0.6 0.0 1.0 0.2 0.2 0.0 0.3 0.2 0.4 0.0 1.7 0.1 0.0 0.0 0.2 1.7 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.3 0.6 0.0 0.0 0.9 0.0 1.2 1.7 0.2 0.5 0.1 0.2 0.3 5.3 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.5 0.9 0.3 0.4 0.4 0.4 0.8 0.7 1.3 0.3 0.0 2.6 0.0 1.7 0.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.4 0.1 8.6 1.6 0.0 0.0 0.2 0.0 0.0 4.3 0.0 0.9 38.6 0.8 0.0 0.0 0.0 2.7 0.1 0.0 177.1 2.1 0.1 0.0 3.1 0.2 0.5 1.4 0.2 0.0 0.0 0.0 SFRP5 SARP3 ENSG00000120057 "Secreted frizzled related protein 5" Q5T4F7 10 97766751-97771952 "Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6" "Cell type enriched" "Detected in some" 15 "Cholangiocytes: 226.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 30.4" "Group enriched" "Detected in some" 5 "hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6" "Cell type enriched" "Detected in some" 5 "naive CD8 T-cell: 7.4" "Lineage enriched" "Detected in many" 5 "T-cells: 7.4" "Cell line enhanced" "Detected in some" "A549: 3.3;CACO-2: 16.3;RPMI-8226: 5.8;SCLC-21H: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (2.63e-4)" "unprognostic (3.03e-3)" "unprognostic (6.74e-2)" "unprognostic (3.43e-2)" "unprognostic (9.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.19e-1)" "unprognostic (2.85e-1)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.78e-1)" "unprognostic (4.51e-9)" "unprognostic (1.67e-2)" "unprognostic (1.57e-1)" "unprognostic (9.17e-2)" "unprognostic (1.62e-1)" 0.9 5.1 0.0 1.3 0.8 0.4 0.6 0.5 0.4 1.8 10.9 1.1 9.1 14.7 1.1 2.8 4.3 0.6 34.9 27.1 0.7 1.8 0.2 3.2 1.9 0.4 4.5 0.1 0.3 70.4 0.2 0.1 0.2 5.6 1.9 0.5 67.6 9.2 2.4 0.4 0.9 17.8 1.0 1.9 0.3 3.4 0.4 0.3 0.0 0.2 1.6 0.3 1.3 1.4 0.0 1.5 0.0 0.0 0.0 7.4 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.1 5.8 0.0 0.0 2.7 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 7.4 0.0 0.0 0.0 1.5 0.0 0.5 0.0 0.8 0.5 0.3 0.7 1.8 4.5 0.1 5.6 0.3 3.0 2.2 0.0 0.0 0.0 0.2 6.7 226.7 0.0 1.2 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 15.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 1.7 0.0 0.0 1.8 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 6.1 0.0 0.0 0.0 0.0 0.0 SFTA2 SFTPG ENSG00000196260 "Surfactant associated 2" Q6UW10 6 30931353-30955636 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "lung: 104.5" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 497.3;Alveolar cells type 2: 624.9;Cholangiocytes: 170.7;Club cells: 204.8" "Cancer enhanced" "Detected in many" "lung cancer: 121.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 11 "B-cells: 1.7;T-cells: 1.7" "Group enriched" "Detected in some" 5 "CACO-2: 13.8;CAPAN-2: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (5.82e-2)" "unprognostic (1.16e-1)" "unprognostic (7.20e-3)" "unprognostic (6.64e-2)" "unprognostic (3.12e-1)" "unprognostic (1.34e-1)" "unprognostic (6.37e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (1.26e-4)" "unprognostic (1.16e-1)" "unprognostic (3.96e-4)" "unprognostic (8.84e-2)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" "unprognostic (7.95e-2)" 0.1 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.1 1.2 0.1 0.1 0.5 0.0 0.2 0.1 13.6 1.4 6.3 0.2 0.1 0.0 1.6 0.1 104.5 0.1 0.1 0.1 0.3 1.1 0.4 0.1 0.6 0.2 0.2 0.0 0.1 1.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 2.0 1.3 0.1 0.1 1.0 0.4 0.3 0.1 5.4 1.7 0.1 0.1 0.0 0.0 1.7 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 7.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 1.5 0.5 0.1 1.7 1.3 1.7 0.1 0.0 0.0 0.0 0.4 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 497.3 624.9 0.0 0.1 0.1 0.4 0.0 170.7 14.7 204.8 50.6 0.0 0.0 3.3 18.0 2.9 0.7 0.0 0.0 32.4 0.0 0.2 0.3 11.6 0.0 0.1 0.0 0.0 0.0 0.0 7.4 0.3 0.2 0.0 0.0 0.0 1.1 57.0 0.0 0.4 0.3 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 1.3 SFTA3 "NANCI, SFTPH" ENSG00000229415 "Surfactant associated 3" P0C7M3 14 36473288-36513829 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "lung: 45.2;thyroid gland: 55.4" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 321.6;Alveolar cells type 2: 451.3;Club cells: 171.8" "Group enriched" "Detected in some" 238 "lung cancer: 18.4;thyroid cancer: 52.8" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 173 "SCLC-21H: 21.5" "Secreted in other tissues" NA NA "prognostic favorable (8.29e-4)" "unprognostic (3.95e-1)" "unprognostic (3.21e-3)" 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.1 321.6 451.3 0.0 0.0 0.0 0.0 0.0 0.0 53.5 171.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.0 0.0 0.0 0.0 SFTPA1 "COLEC4, SFTP1, SP-A, SP-A1" ENSG00000122852 "Surfactant protein A1" Q8IWL2 10 79610939-79615455 "Disease related genes, Predicted secreted proteins" "Gaseous exchange" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 66 "lung: 411.8" "Cell type enriched" "Detected in some" 12 "Alveolar cells type 2: 12618.9" "Cancer enriched" "Detected in some" 25 "lung cancer: 706.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 6.2" "Lineage enriched" "Detected in single" 63 "dendritic cells: 6.2" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 30.8" "CAB016793, HPA042638, HPA045752, HPA049368" Supported "Secreted in other tissues" NA NA "CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (5.83e-4)" "unprognostic (1.17e-1)" "unprognostic (3.38e-2)" "unprognostic (4.24e-1)" "unprognostic (3.47e-2)" "unprognostic (9.09e-2)" 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 411.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1077.9 12618.9 0.0 0.0 0.0 0.0 0.0 0.0 156.6 337.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 418.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SFTPA2 "COLEC5, SP-A2" ENSG00000185303 "Surfactant protein A2" Q8IWL1 10 79555852-79560402 "Disease related genes, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 225 "lung: 501.0" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 14379.1" "Cancer enriched" "Detected in many" 21 "lung cancer: 863.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 2.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 2.2" "Group enriched" "Detected in some" 21 "BEWO: 6.5;NB-4: 6.8;RPMI-8226: 21.7;U-2197: 13.1" "CAB002439, HPA042638, HPA045752, HPA049368" Enhanced "Secreted in other tissues" NA NA "CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731" "unprognostic (2.51e-1)" "unprognostic (4.87e-2)" "unprognostic (4.99e-2)" "unprognostic (4.38e-2)" "unprognostic (4.29e-2)" "unprognostic (1.05e-1)" "unprognostic (5.78e-2)" "unprognostic (5.08e-1)" "unprognostic (4.94e-2)" "unprognostic (1.68e-3)" "unprognostic (3.10e-1)" "unprognostic (3.56e-2)" "unprognostic (1.20e-1)" "unprognostic (1.33e-1)" "unprognostic (4.69e-3)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 501.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.2 0.0 0.1 0.4 0.3 0.1 0.0 0.2 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.8 0.4 0.0 0.0 0.2 0.0 21.7 0.0 0.3 0.2 0.3 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.2 13.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1479.9 14379.1 0.0 0.0 0.0 0.0 0.0 0.0 248.9 606.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.0 1.0 397.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 SFTPB "SFTP3, SP-B" ENSG00000168878 "Surfactant protein B" P07988 2 85657314-85668741 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "lung: 757.8" "Group enriched" "Detected in some" 18 "Alveolar cells type 1: 3391.6;Alveolar cells type 2: 11695.8;Club cells: 3546.5" "Group enriched" "Detected in many" 149 "lung cancer: 1306.7;thyroid cancer: 270.2" "Region enriched" "Detected in single" 17 "pons and medulla: 2.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.9;NB-4: 5.6;U-2197: 11.5;U-266/70: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002440, HPA034820, HPA062148" Enhanced "Secreted in other tissues" NA NA 71000000 "CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697" "unprognostic (6.46e-3)" "unprognostic (4.94e-2)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.71e-6)" "unprognostic (2.25e-3)" "unprognostic (4.57e-3)" "unprognostic (8.57e-3)" "unprognostic (6.45e-3)" "unprognostic (1.13e-1)" "unprognostic (3.04e-2)" "unprognostic (2.50e-2)" "unprognostic (1.89e-1)" "prognostic unfavorable (2.99e-6)" "unprognostic (2.37e-1)" "unprognostic (1.09e-1)" "unprognostic (7.90e-2)" "unprognostic (4.38e-2)" 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 757.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 44.1 0.0 0.0 0.0 0.0 1.1 1.4 2.6 4.1 0.8 1.5 1.2 0.2 0.4 0.4 0.8 0.5 0.9 4.9 0.4 0.3 0.1 0.1 0.5 1.1 0.2 0.4 0.1 0.5 3.3 0.4 0.1 0.1 0.6 0.4 0.5 1.1 0.4 0.1 0.2 2.4 0.0 0.5 0.3 0.2 0.9 0.0 0.7 0.4 0.8 0.2 0.5 1.8 5.6 2.7 0.8 0.7 2.1 0.4 0.5 0.3 0.5 0.7 0.5 0.1 0.8 0.3 0.6 0.6 0.5 0.1 0.3 1.1 11.5 0.2 4.2 0.9 0.3 1.0 0.8 0.2 0.9 2.5 0.8 0.9 4.1 0.7 1.0 1.0 0.8 1.4 1.1 1.4 0.8 2.6 0.8 2.5 0.7 1.5 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 3391.6 11695.8 0.0 0.1 0.0 0.0 0.4 0.0 341.3 3546.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 241.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 SFTPC "BRICD6, PSP-C, SFTP2, SMDP2, SP-C" ENSG00000168484 "Surfactant protein C" P11686 8 22156913-22164479 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Gaseous exchange" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 718 "lung: 664.5" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 2: 80228.9" "Cancer enriched" "Detected in some" 218 "lung cancer: 226.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.4;NB-4: 10.7;SCLC-21H: 4.6;U-2197: 22.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA010928 Enhanced "Secreted in other tissues" NA NA "HPA010928: AB_1857425" "unprognostic (1.84e-1)" "unprognostic (1.96e-1)" "unprognostic (1.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.97e-1)" "unprognostic (4.97e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-2)" 0.1 0.8 0.2 0.3 0.5 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.3 0.1 0.1 0.1 664.5 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.0 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.7 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.2 0.3 0.1 0.4 0.1 0.9 0.1 7929.7 80228.9 0.0 0.0 1.5 0.0 0.3 0.0 623.7 2602.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 909.1 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 SFTPD "COLEC7, SFTP4, SP-D" ENSG00000133661 "Surfactant protein D" P35247 10 79937740-79982614 "Predicted secreted proteins" "Gaseous exchange, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lung: 127.0" "Group enriched" "Detected in many" 14 "Alveolar cells type 1: 408.0;Alveolar cells type 2: 1544.2" "Cancer enriched" "Detected in many" 16 "lung cancer: 106.4" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 11 "intermediate monocyte: 6.4;non-classical monocyte: 21.6" "Lineage enriched" "Detected in many" 17 "monocytes: 21.6" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HaCaT: 2.4;HMC-1: 2.7;hTCEpi: 7.6;MCF7: 3.4;U-2197: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB004578, HPA044582, HPA056768" Enhanced "Secreted in other tissues" NA NA 5500000 "CAB004578: AB_628276, HPA044582: AB_2679004, HPA056768: AB_2683232" "unprognostic (3.81e-5)" "unprognostic (7.00e-2)" "unprognostic (1.19e-2)" "unprognostic (1.41e-2)" "unprognostic (4.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.66e-3)" "unprognostic (6.83e-2)" "unprognostic (3.85e-1)" "unprognostic (2.23e-1)" "unprognostic (5.29e-2)" "unprognostic (2.57e-1)" "unprognostic (4.70e-2)" "unprognostic (2.57e-2)" "unprognostic (2.38e-1)" "unprognostic (1.45e-1)" "unprognostic (8.86e-2)" 0.3 0.3 0.6 0.3 1.1 3.9 0.3 0.3 0.6 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.5 0.3 0.3 127.0 0.3 0.3 0.3 0.3 0.9 0.3 0.7 0.3 0.3 0.3 0.0 0.3 0.4 0.3 0.3 1.6 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 1.2 0.4 0.3 0.3 0.3 0.0 1.2 0.4 21.6 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.2 0.8 0.0 2.4 0.3 0.1 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.2 2.7 0.0 7.6 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 3.4 0.1 1.8 0.8 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.7 0.8 0.1 0.6 0.0 0.4 1.0 0.7 1.5 0.0 0.2 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 6.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.5 0.6 1.1 0.3 0.6 0.5 0.5 0.3 0.3 0.3 0.3 408.0 1544.2 0.0 0.8 0.8 1.8 0.5 0.0 17.4 68.2 5.2 0.0 0.0 1.7 1.0 5.2 0.3 0.0 0.0 5.2 2.3 1.9 0.8 18.6 0.8 0.1 0.0 0.0 0.0 0.0 8.9 1.1 1.4 0.0 0.0 0.0 2.3 2.0 0.0 0.4 0.2 0.3 0.0 0.2 0.4 0.1 1.6 0.1 0.0 0.0 0.3 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "granulocytes: 34.2;T-cells: 16.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Approved Enhanced Mitochondria NA NA Mitochondria "HPA019543: AB_1856789, HPA063745: AB_2685111" "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 5.6 14.0 15.2 12.0 20.9 12.9 8.1 20.7 24.5 6.5 18.8 7.9 5.3 13.2 6.5 6.0 12.6 6.6 7.1 9.4 14.5 18.3 28.3 66.8 5.3 17.0 15.3 17.0 13.6 9.7 7.4 11.8 10.4 15.1 7.6 12.5 5.7 7.7 8.0 11.7 6.3 13.4 8.1 15.0 8.2 10.1 5.0 11.0 13.9 7.7 7.3 17.8 11.3 9.1 4.5 3.0 34.2 2.6 4.8 16.0 5.6 10.2 32.6 16.7 18.1 5.7 12.4 26.9 26.3 11.1 22.2 21.5 40.8 20.8 21.5 20.5 13.7 27.4 13.2 31.9 45.8 24.1 52.5 26.7 15.8 29.4 17.8 8.4 30.8 20.0 10.1 9.0 24.6 10.8 13.2 17.0 20.0 22.6 17.1 16.1 36.0 35.9 2.4 13.1 17.4 10.7 30.2 17.1 23.0 8.4 40.4 28.5 18.2 25.3 24.0 12.8 14.4 11.6 10.2 16.5 17.6 27.9 12.9 34.2 21.8 25.6 49.1 28.9 27.8 18.3 34.2 2.1 10.4 11.3 2.6 9.4 4.5 16.0 12.6 3.0 3.8 12.7 12.9 0.6 4.8 1.7 1.4 12.7 5.6 15.2 20.9 20.7 24.5 14.5 18.3 15.3 17.0 15.1 11.0 3.0 15.7 26.8 27.4 17.3 52.5 14.8 12.7 13.4 11.4 17.4 45.2 35.0 21.6 24.5 0.9 12.0 58.5 23.3 16.4 61.7 22.4 20.3 9.2 86.9 14.8 73.1 30.0 7.4 9.4 2.0 43.7 8.0 10.1 7.2 18.2 24.5 26.6 17.5 32.9 46.2 47.8 25.8 27.4 3.0 3.0 18.9 25.9 42.7 18.0 23.5 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 28.3;liver: 31.4" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 100.9;Late spermatids: 111.2;Muller glia cells: 76.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: AB_2683261" "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favorable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 4.0 10.1 26.1 4.9 24.6 12.8 3.1 10.1 28.3 3.4 6.6 12.9 3.7 7.6 3.2 18.4 2.7 5.2 4.4 3.6 25.3 12.7 12.7 31.4 3.7 3.6 16.0 18.6 2.9 2.7 3.4 3.1 4.5 14.9 5.2 6.8 2.6 2.1 5.4 6.3 3.2 7.3 4.5 9.6 5.2 5.1 2.9 13.3 1.6 4.3 1.7 3.7 5.0 2.1 3.0 4.2 6.4 8.9 5.8 1.3 2.1 3.4 7.4 11.8 9.1 2.8 1.9 4.3 7.0 4.0 11.2 5.9 11.4 8.9 2.1 7.3 7.3 8.1 3.0 9.1 10.1 5.3 8.5 5.9 8.6 7.3 14.9 3.6 4.3 9.4 4.9 2.8 7.8 0.9 4.0 6.5 2.6 7.4 1.8 3.0 6.7 1.2 6.6 14.5 6.7 4.7 8.1 9.7 2.6 6.5 8.2 7.6 2.1 6.5 3.3 2.7 6.7 1.7 2.2 4.7 3.4 11.2 4.8 8.0 3.0 2.9 2.5 11.7 8.1 4.0 4.8 8.9 4.2 0.9 3.9 1.3 1.6 0.5 1.0 4.2 3.0 0.6 0.8 6.4 5.8 4.3 2.9 1.0 2.1 26.1 24.6 10.1 26.3 25.3 12.7 16.0 18.6 14.9 13.3 0.0 4.1 8.8 4.0 4.1 24.0 5.4 5.1 0.0 4.5 34.9 31.4 7.6 3.3 4.4 100.9 6.0 15.1 23.3 7.9 1.9 7.5 2.9 0.0 53.3 10.6 19.1 13.2 8.6 4.0 111.2 9.8 7.0 8.5 10.0 5.8 76.6 6.2 5.3 10.6 20.2 38.4 12.9 7.7 7.9 13.0 8.2 3.5 5.7 6.8 1.6 SGCA "A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1" ENSG00000108823 "Sarcoglycan alpha" Q16586 17 50164214-50175931 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 144.7" "Cell type enhanced" "Detected in many" 27 "Cardiomyocytes: 113.3;Early spermatids: 135.9;Late spermatids: 458.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 7 "cerebellum: 3.0" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.4;memory B-cell: 5.3;myeloid DC: 3.8;naive B-cell: 5.2;non-classical monocyte: 3.1" "Group enriched" "Detected in many" 19 "B-cells: 5.3;dendritic cells: 3.8;monocytes: 3.1" "Cell line enriched" "Detected in some" 15 "LHCN-M2: 42.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007537 Uncertain "Intracellular and membrane" NA NA "HPA007537: AB_1079944" "unprognostic (1.34e-1)" "unprognostic (2.30e-2)" "unprognostic (1.89e-3)" "unprognostic (1.25e-1)" "unprognostic (9.87e-2)" "unprognostic (2.43e-2)" "unprognostic (9.25e-2)" "unprognostic (1.22e-2)" "unprognostic (1.15e-1)" "unprognostic (1.91e-1)" "unprognostic (7.01e-2)" "unprognostic (2.57e-1)" "unprognostic (2.07e-3)" "unprognostic (4.96e-2)" "unprognostic (2.16e-1)" "unprognostic (2.95e-1)" "unprognostic (1.15e-2)" 2.8 0.6 0.1 2.5 0.2 0.2 0.8 3.0 0.4 6.8 10.0 0.0 8.6 1.6 7.9 10.5 10.8 3.4 10.7 32.2 0.2 0.1 0.6 0.9 5.7 0.3 0.2 0.3 3.4 0.5 0.2 0.1 1.9 0.4 10.9 1.1 7.1 2.3 8.0 144.7 2.6 3.0 30.3 0.3 0.7 5.7 1.4 0.0 0.0 1.6 39.8 2.3 20.1 4.3 5.3 3.8 0.2 3.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 42.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.8 0.2 0.0 2.4 0.0 5.3 0.0 0.0 3.8 5.2 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.7 0.1 0.2 3.0 0.1 0.2 0.1 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.2 7.7 0.0 113.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 135.9 2.1 0.0 0.0 5.2 0.1 41.4 0.2 0.0 0.0 0.5 0.0 0.0 1.8 0.0 458.2 2.8 1.4 8.5 0.0 0.0 0.0 2.4 0.0 3.5 1.4 0.0 12.9 49.5 2.1 1.5 8.7 0.2 0.0 0.0 0.1 SGCD "CMD1L, DAGD, LGMD2F" ENSG00000170624 "Sarcoglycan delta" Q92629 5 155870344-156767788 "Disease related genes, Predicted membrane proteins" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 32.6" "Cell type enhanced" "Detected in many" 18 "Cardiomyocytes: 97.2;Cone photoreceptor cells: 51.1;Melanocytes: 23.6" "Cancer enhanced" "Detected in many" "melanoma: 10.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.5;naive CD8 T-cell: 3.1" "Lineage enriched" "Detected in single" 32 "T-cells: 3.1" "Cell line enhanced" "Detected in some" "BJ: 12.7;fHDF/TERT166: 20.2;LHCN-M2: 9.3;RH-30: 15.6;SK-MEL-30: 20.2;U-138 MG: 20.1" "Low region specificity" "Detected in many" NA NA "unprognostic (2.23e-1)" "unprognostic (3.82e-2)" "unprognostic (9.11e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (9.55e-2)" "unprognostic (2.63e-1)" "unprognostic (1.66e-1)" "unprognostic (6.53e-2)" "unprognostic (2.25e-1)" "unprognostic (1.75e-1)" "unprognostic (6.99e-2)" "unprognostic (4.10e-2)" "unprognostic (9.65e-3)" "unprognostic (5.37e-2)" "unprognostic (5.60e-3)" "unprognostic (3.66e-3)" 4.7 5.0 3.5 2.0 4.2 0.1 2.9 1.3 3.1 9.0 7.8 10.8 3.2 1.6 19.8 4.9 7.9 3.8 8.6 32.6 4.5 2.3 1.2 1.9 5.2 0.5 9.2 3.4 10.4 1.0 6.3 1.9 0.6 8.1 7.1 3.5 12.2 2.4 4.9 28.5 2.0 3.9 12.3 10.8 1.4 3.8 1.5 8.2 0.0 16.1 13.9 0.9 7.4 4.1 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 6.2 0.0 0.0 4.4 7.7 0.0 12.7 4.1 0.0 0.1 0.0 0.0 0.0 0.0 20.2 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 20.2 0.0 0.0 0.0 0.0 20.1 0.0 3.5 0.0 0.0 0.0 0.0 3.2 0.0 8.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 3.5 4.2 1.3 3.1 4.5 2.3 9.2 3.4 8.1 8.2 0.0 0.3 0.0 0.0 3.2 1.2 97.2 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 9.7 0.8 0.0 1.0 0.2 20.6 1.7 4.3 0.0 8.9 17.5 0.9 23.6 0.0 0.0 0.2 0.0 0.0 14.5 0.3 1.1 0.0 4.9 0.0 0.0 2.8 0.1 0.0 0.0 0.0 SGCG "A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE" ENSG00000102683 "Sarcoglycan gamma" Q13326 13 23180952-23325165 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 116.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "fHDF/TERT166: 38.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA007476 Enhanced NA NA "HPA007476: AB_1079946" "unprognostic (5.19e-2)" "unprognostic (8.28e-2)" "unprognostic (5.15e-3)" "unprognostic (1.64e-4)" "unprognostic (3.00e-3)" "unprognostic (3.61e-2)" "unprognostic (8.14e-3)" "unprognostic (1.46e-1)" "unprognostic (2.29e-1)" "unprognostic (4.49e-1)" "unprognostic (6.05e-2)" "unprognostic (2.23e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (2.98e-3)" "unprognostic (1.07e-1)" 8.6 0.1 0.1 0.2 0.1 0.0 2.9 0.2 0.6 0.1 0.4 0.1 0.1 0.0 0.1 3.8 2.6 0.3 0.3 40.9 0.3 0.1 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.1 1.6 0.1 0.1 0.1 1.2 0.1 0.5 2.1 0.1 53.3 1.3 0.2 0.1 0.1 0.1 0.4 0.6 0.1 0.1 0.7 44.3 3.3 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 38.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.4 0.0 0.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.0 0.0 116.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.4 6.9 0.2 5.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.4 1.4 12.1 0.9 0.0 0.0 0.0 0.0 SGCZ ZSG1 ENSG00000185053 "Sarcoglycan zeta" Q96LD1 8 14089864-15238339 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;ovary: 11.3;pituitary gland: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;REH: 2.5" "Low region specificity" "Detected in many" HPA017585 Uncertain NA NA "HPA017585: AB_1856799" "unprognostic (3.83e-1)" "unprognostic (1.41e-1)" "unprognostic (5.87e-4)" "unprognostic (1.21e-1)" 1.1 0.4 5.6 0.5 9.5 0.6 2.6 21.2 6.8 0.8 0.7 0.0 0.0 0.7 0.9 1.4 0.4 0.5 0.7 0.5 1.4 2.2 1.0 0.7 0.4 0.4 1.3 2.3 11.3 0.7 0.4 7.3 0.5 5.3 0.8 0.5 0.1 0.4 0.6 0.4 0.9 0.5 0.9 3.2 0.5 0.7 1.4 1.1 0.0 0.4 0.0 0.5 1.5 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.6 9.5 21.2 6.8 1.4 2.2 1.3 2.3 5.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SGIP1 DKFZp761D221 ENSG00000118473 "SH3 domain GRB2 like endophilin interacting protein 1" Q9BQI5 1 66533383-66748299 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 91.2;Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 347.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 17.0;BJ hTERT+: 22.0;fHDF/TERT166: 13.9;hTERT-RPE1: 9.2;RPTEC TERT1: 16.2;SH-SY5Y: 8.8;U-138 MG: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017963 Approved Approved Mitochondria NA NA Mitochondria "HPA017963: AB_10964882" "unprognostic (1.74e-2)" "unprognostic (2.77e-1)" "unprognostic (2.86e-1)" "unprognostic (1.07e-1)" "unprognostic (1.74e-1)" "unprognostic (9.04e-2)" "unprognostic (9.51e-2)" "unprognostic (7.64e-2)" "unprognostic (1.86e-1)" "unprognostic (1.61e-1)" "unprognostic (1.83e-1)" "unprognostic (1.95e-1)" "unprognostic (3.48e-7)" "unprognostic (1.77e-2)" "unprognostic (1.29e-1)" "unprognostic (4.25e-2)" "unprognostic (9.63e-2)" 6.2 7.5 19.6 3.8 30.2 1.3 2.7 26.2 36.5 7.5 2.7 11.4 1.3 3.4 17.1 8.0 5.2 4.7 8.1 6.8 22.9 12.4 14.0 1.7 9.6 2.0 10.8 26.3 3.6 1.2 1.9 7.0 3.9 26.4 5.4 3.4 5.8 3.5 9.1 3.2 1.7 3.2 7.0 11.3 1.4 5.1 7.4 14.9 0.0 8.0 0.8 1.5 6.1 5.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.4 0.0 17.0 22.0 1.3 2.0 0.0 0.0 0.0 0.0 13.9 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 3.9 0.0 0.0 2.4 0.0 1.3 0.0 9.2 6.4 0.1 0.0 0.0 7.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.4 8.8 0.0 0.0 0.0 0.3 0.0 0.6 1.1 16.1 0.0 0.4 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 19.6 30.2 26.2 35.0 22.9 12.4 10.8 26.3 26.4 14.9 0.0 0.0 0.0 0.2 0.9 91.2 1.6 2.5 0.0 0.0 8.7 329.9 0.0 6.6 0.3 0.5 11.1 0.0 0.0 0.0 0.0 4.1 0.4 9.3 0.0 0.2 69.9 0.0 0.6 0.0 0.5 2.0 0.0 10.1 0.0 0.0 55.4 0.0 0.0 10.6 0.0 347.4 12.9 52.6 0.0 0.0 0.9 0.2 0.0 0.0 0.3 SGK1 SGK ENSG00000118515 "Serum/glucocorticoid regulated kinase 1" O00141 6 134169246-134318112 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 141.3" "Cell type enhanced" "Detected in many" 5 "Ito cells: 455.4;Syncytiotrophoblasts: 484.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2" "Group enriched" "Detected in many" 7 "granulocytes: 45.9;monocytes: 11.7" "Cell line enhanced" "Detected in many" "HHSteC: 51.2;RPTEC TERT1: 78.5;SK-MEL-30: 50.9;TIME: 61.1;U-266/84: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022085, CAB025148, HPA051251" Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "CAB022085: , CAB025148: , HPA051251: AB_2681407" "unprognostic (2.05e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.12e-1)" "unprognostic (5.09e-3)" "unprognostic (2.76e-1)" "unprognostic (4.20e-2)" "unprognostic (4.53e-2)" "unprognostic (5.62e-2)" "unprognostic (4.03e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (2.55e-1)" "unprognostic (5.82e-3)" "unprognostic (9.10e-2)" "unprognostic (3.81e-2)" "unprognostic (1.79e-1)" "unprognostic (6.59e-2)" 45.6 35.5 16.8 12.8 43.2 15.8 22.9 10.6 25.0 18.4 62.3 51.7 10.8 14.2 14.9 11.2 30.0 16.1 47.8 12.5 22.9 9.6 37.5 51.1 31.2 8.4 48.8 16.6 47.2 47.8 141.3 4.7 19.2 28.3 18.3 11.3 45.8 26.2 18.4 12.4 25.8 131.8 13.6 40.3 7.6 31.1 12.2 50.1 6.2 22.3 24.8 20.4 26.1 31.7 0.6 4.0 45.9 11.7 0.9 0.7 3.1 0.6 1.1 0.7 0.0 8.8 2.2 1.0 12.6 26.3 16.5 13.5 1.9 1.7 2.1 1.9 13.0 8.1 0.4 1.1 2.0 12.2 0.0 0.5 0.1 31.4 1.4 51.2 0.1 1.1 13.2 12.6 16.2 21.0 6.6 27.6 0.3 4.0 32.0 5.9 0.1 0.1 0.4 0.8 3.2 1.3 0.4 1.5 0.2 78.5 0.2 0.3 3.1 39.6 0.1 50.9 7.6 0.1 0.3 61.1 4.8 2.1 29.5 2.7 6.0 56.0 6.5 4.5 1.9 6.5 0.6 11.7 45.9 0.2 6.8 0.5 0.6 0.4 0.2 4.0 0.4 0.5 0.6 26.2 0.9 3.7 0.2 0.7 3.1 16.8 43.2 10.6 25.0 22.9 9.6 48.8 16.6 28.3 50.1 35.7 233.2 40.3 98.2 162.8 10.8 19.4 96.8 24.1 99.0 64.6 33.4 39.9 18.3 60.3 7.2 107.9 230.9 0.0 151.5 27.8 58.7 45.7 257.3 17.5 283.4 0.0 10.2 455.4 148.5 5.6 14.1 322.4 254.8 6.4 46.9 4.3 52.7 129.6 14.9 92.1 28.6 12.9 39.1 48.4 7.5 101.6 484.9 9.6 6.4 68.4 SGK2 ENSG00000101049 "SGK2, serine/threonine kinase 2" Q9HBY8 20 43558968-43588237 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.1;kidney: 39.1;liver: 32.9" "Cell type enhanced" "Detected in many" 15 "Distal tubular cells: 64.6;Enterocytes: 26.9;Hepatocytes: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.3;CAPAN-2: 8.0;Hep G2: 10.4;OE19: 34.0;RPTEC TERT1: 14.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008859, HPA011387" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA008859: AB_2668159, HPA011387: AB_1856744" "unprognostic (1.82e-1)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.86e-1)" "unprognostic (6.27e-2)" "unprognostic (2.98e-4)" "unprognostic (2.05e-2)" "unprognostic (1.35e-1)" "unprognostic (4.30e-2)" "unprognostic (2.60e-1)" "unprognostic (1.05e-1)" "unprognostic (5.72e-4)" "unprognostic (4.15e-2)" "unprognostic (1.38e-1)" "unprognostic (2.56e-1)" "unprognostic (3.11e-2)" "prognostic favorable (5.65e-4)" 11.4 0.7 2.8 4.3 9.9 0.2 3.1 1.0 10.2 1.4 21.3 33.1 0.9 17.8 1.0 19.7 0.7 1.6 7.9 0.7 4.3 2.5 39.1 32.9 0.6 0.5 6.9 5.1 3.2 14.1 0.5 1.7 0.5 13.7 1.4 23.4 0.0 0.9 1.8 0.4 3.2 20.7 1.0 14.2 0.7 11.9 1.0 6.0 0.0 1.0 0.2 0.2 3.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 8.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 10.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 34.0 0.0 0.0 0.0 0.0 14.7 1.7 0.1 0.4 0.0 0.7 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 9.9 1.0 10.2 4.3 2.5 6.9 5.1 13.7 6.0 0.0 0.0 0.0 0.1 0.1 0.8 2.2 12.7 0.0 0.0 10.4 0.0 3.4 64.6 3.9 0.1 0.1 26.9 0.0 5.4 1.0 0.2 0.1 0.0 26.9 0.6 6.4 1.7 1.3 1.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 2.6 8.4 0.4 15.7 0.8 0.0 0.0 0.0 0.2 0.1 14.3 0.0 5.9 0.1 SGK494 ENSG00000167524 "Uncharacterized serine/threonine-protein kinase SgK494" 17 28607964-28614200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 89.8;Rod photoreceptor cells: 106.4;Spermatocytes: 85.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA046590 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA046590: AB_2679710" "unprognostic (1.83e-1)" "unprognostic (9.42e-2)" "unprognostic (2.84e-2)" "unprognostic (2.30e-2)" "unprognostic (2.11e-1)" "unprognostic (2.06e-3)" "unprognostic (9.33e-3)" "unprognostic (2.63e-1)" "unprognostic (8.62e-4)" "unprognostic (2.09e-2)" "unprognostic (6.81e-2)" "unprognostic (3.45e-5)" "unprognostic (1.20e-7)" "unprognostic (2.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-3)" 1.6 4.7 10.3 3.5 25.3 10.6 2.3 17.8 25.8 1.9 1.8 0.9 0.4 0.7 2.0 4.5 1.3 2.4 0.8 2.1 8.6 3.7 5.6 1.6 3.2 3.3 2.5 10.7 3.7 1.3 2.0 5.6 3.1 11.2 2.3 4.0 6.3 1.9 3.2 3.8 6.3 2.3 1.9 2.9 3.4 1.3 8.5 4.1 0.1 2.5 0.1 3.5 1.9 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 5.1 6.1 5.7 1.9 2.5 4.4 0.8 0.3 2.1 1.9 6.1 0.7 7.0 0.9 2.8 3.1 3.1 4.5 2.4 2.7 3.9 6.7 7.3 4.0 3.6 0.2 9.8 5.2 1.2 7.3 7.4 4.2 1.7 2.3 9.7 7.0 0.6 1.3 7.1 2.4 6.5 6.1 3.2 0.9 7.1 8.7 4.6 1.2 6.7 3.7 3.5 4.3 2.4 3.6 8.6 3.6 5.5 3.0 4.1 3.5 4.1 5.0 3.8 3.6 8.5 3.0 7.1 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 25.3 17.8 25.8 8.6 3.7 2.5 10.7 11.2 4.1 0.0 1.3 5.2 5.5 0.0 89.8 0.3 10.2 0.0 1.2 5.2 21.6 5.6 0.0 2.0 10.6 2.9 4.2 0.0 1.3 2.0 1.0 5.8 0.0 5.8 3.6 33.4 1.2 8.6 5.7 2.2 2.0 3.2 0.0 3.6 2.7 6.8 1.9 7.0 1.8 1.4 106.4 0.0 0.3 85.6 14.7 0.0 20.7 5.0 3.2 3.4 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186292 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 40.1" "Cell type enhanced" "Detected in some" 27 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.6 0.6 0.4 9.1 0.4 8.9 1.0 0.4 1.5 0.9 3.4 0.3 0.6 2.7 0.8 0.5 4.0 0.3 1.7 0.4 0.3 0.4 0.8 1.0 0.9 6.9 0.4 0.1 0.5 0.5 0.0 0.4 3.7 0.2 0.6 3.5 0.1 1.0 0.1 0.3 1.1 3.4 0.8 0.4 4.9 1.5 8.6 0.2 40.1 0.5 2.4 7.4 1.2 1.5 9.0 4.5 8.3 0.2 0.3 2.7 0.6 9.5 10.9 14.9 9.1 0.7 1.3 10.1 10.3 5.3 15.0 16.5 7.7 11.8 14.6 5.2 4.2 10.6 5.6 14.0 5.7 19.0 18.6 9.3 16.6 7.5 6.1 0.1 15.1 14.3 0.1 0.4 16.5 7.0 2.1 8.9 17.4 14.2 26.2 12.4 9.4 23.7 8.5 15.8 10.2 8.3 15.2 19.1 8.5 3.8 7.0 7.4 7.8 11.4 14.1 6.8 11.6 9.1 10.6 2.4 11.4 13.7 10.2 20.5 11.3 26.2 17.0 6.2 15.3 17.1 8.3 0.1 1.5 0.3 0.2 0.1 8.6 0.7 0.8 0.4 9.0 0.2 0.4 1.6 0.3 0.2 4.5 2.7 0.6 0.4 0.4 0.4 1.5 0.3 0.4 0.4 0.1 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 5.4 0.0 1.1 0.0 0.0 0.0 0.0 1.6 33.5 0.0 0.0 1.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 SGO2 "FLJ25211, SGOL2, TRIPIN" ENSG00000163535 "Shugoshin 2" Q562F6 2 200510008-200583782 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 12.6;lymphoid tissue: 25.7;testis: 27.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 14.7;Club cells: 11.4;Extravillous trophoblasts: 24.6;granulocytes: 10.5;Hofbauer cells: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035163, HPA040817" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA Yes Nucleoplasm "Nuclear bodies" "HPA035163: AB_10602397, HPA040817: AB_2677149" "unprognostic (3.43e-1)" "unprognostic (1.70e-1)" "unprognostic (7.06e-3)" "unprognostic (6.71e-3)" "unprognostic (1.90e-1)" "unprognostic (1.77e-1)" "unprognostic (7.55e-6)" "unprognostic (1.12e-2)" "unprognostic (1.98e-3)" "unprognostic (4.87e-2)" "unprognostic (1.37e-4)" "unprognostic (9.49e-2)" "unprognostic (8.07e-9)" "unprognostic (5.21e-2)" "unprognostic (5.43e-2)" "unprognostic (9.86e-2)" "unprognostic (2.02e-1)" 5.3 1.7 1.5 8.6 2.3 5.3 3.5 4.0 3.1 1.6 2.7 0.7 0.3 2.1 1.6 1.0 3.7 1.6 1.3 1.4 1.9 1.5 1.8 1.0 1.9 6.5 2.7 3.7 2.2 1.2 1.1 0.9 2.2 3.2 1.4 2.9 0.1 1.7 1.5 1.0 2.0 2.8 1.7 3.5 3.9 1.7 27.9 2.3 25.7 1.5 4.1 7.0 2.0 1.8 3.8 2.1 12.6 1.9 2.4 4.2 1.4 15.7 7.4 17.9 8.0 2.4 3.9 11.1 18.1 7.6 15.6 15.7 11.4 10.7 10.3 8.5 8.6 16.5 11.8 15.7 9.4 26.7 20.6 7.8 19.4 10.7 8.1 0.7 20.2 15.7 1.5 1.1 15.7 8.1 3.8 13.8 14.7 14.9 15.2 29.5 7.0 16.2 8.3 12.7 11.2 18.5 12.8 23.6 9.4 6.5 6.2 10.5 7.2 13.3 6.5 7.9 15.1 6.9 11.9 8.3 16.4 16.3 15.0 15.8 6.9 14.4 22.4 10.3 13.6 23.4 12.6 1.8 5.1 2.8 1.7 1.9 3.0 3.2 2.8 1.0 3.8 2.4 3.0 1.3 2.4 1.9 2.1 4.2 1.4 1.5 2.3 4.0 3.1 1.9 1.5 2.7 3.7 3.2 2.3 3.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 14.7 11.4 0.0 0.0 3.2 3.3 3.1 0.0 0.0 0.0 0.0 2.3 24.6 0.0 0.0 10.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 2.8 0.0 0.0 2.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684214-63728039 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.4" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8;Kupffer cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.9;U-698: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053149: AB_2682057, HPA064908: AB_2797270" "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 10.5 12.1 12.1 15.7 11.6 4.3 7.6 14.3 12.9 9.2 9.6 15.1 3.9 6.2 8.4 10.3 5.7 5.9 8.9 5.5 13.1 12.6 24.7 29.4 10.3 18.5 13.0 7.0 7.4 14.1 15.5 6.4 49.4 11.1 9.0 8.7 6.7 5.7 7.0 4.4 4.8 8.9 7.9 19.6 16.5 5.8 8.2 9.8 15.4 7.8 3.7 19.1 8.6 7.3 3.2 0.5 8.8 3.3 0.5 2.0 0.5 10.5 3.4 1.7 4.8 6.2 5.8 20.3 8.7 6.1 5.4 6.1 1.5 6.0 23.9 2.6 4.4 4.5 11.3 2.7 5.1 8.8 9.3 3.1 2.2 2.0 2.4 7.6 3.9 6.9 4.2 8.3 4.7 7.5 5.5 2.6 4.5 1.2 0.7 7.8 3.9 4.5 0.0 1.1 1.7 7.3 1.1 4.7 1.9 8.6 5.3 1.0 2.8 6.1 5.7 4.5 5.4 7.4 1.4 2.9 7.6 5.2 5.3 4.3 5.7 3.5 31.1 5.5 0.0 3.2 8.8 0.3 2.8 1.0 2.3 1.0 3.2 1.0 0.7 0.5 0.8 1.5 1.1 0.4 0.5 3.3 0.3 2.0 0.5 12.1 11.6 14.3 12.9 13.1 12.6 13.0 7.0 11.1 9.8 11.9 14.4 11.2 4.9 8.7 3.5 3.2 25.5 2.7 3.4 48.8 0.0 19.1 0.0 5.2 1.6 5.4 6.7 0.0 7.7 24.8 16.2 8.0 10.5 37.6 19.7 9.5 17.9 8.0 53.2 0.8 5.8 20.6 16.9 3.6 9.4 7.3 11.2 11.6 15.9 20.9 5.1 6.5 19.4 6.7 2.7 11.8 27.6 7.5 8.1 4.8 SGSM1 "KIAA1941, RUTBC2" ENSG00000167037 "Small G protein signaling modulator 1" Q2NKQ1 22 24806169-24927578 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1;parathyroid gland: 20.7" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 25.4;Intestinal endocrine cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 2.1;OE19: 6.5;RPMI-8226: 4.9;SCLC-21H: 4.8;SH-SY5Y: 3.1;U-266/84: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003986 Approved NA NA "HPA003986: AB_1856513" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (1.97e-2)" "unprognostic (1.40e-4)" "unprognostic (4.79e-3)" "unprognostic (6.43e-2)" "unprognostic (1.39e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.50e-2)" "unprognostic (2.23e-3)" "unprognostic (1.37e-1)" "unprognostic (2.61e-6)" "unprognostic (1.46e-1)" "unprognostic (4.66e-1)" "unprognostic (2.25e-2)" "unprognostic (3.93e-2)" 1.3 6.2 8.2 1.3 15.4 0.8 2.2 22.1 15.8 2.5 2.6 3.5 0.2 1.3 1.6 2.4 1.2 8.5 1.7 17.2 6.5 18.4 3.4 0.8 2.4 1.2 7.9 9.2 3.7 6.4 20.7 9.4 2.3 12.7 2.7 3.3 1.6 1.7 2.1 1.5 5.7 1.9 2.5 5.9 1.1 5.7 3.2 4.3 0.0 2.9 0.0 1.1 1.7 5.0 1.1 0.2 0.6 0.1 1.4 2.5 0.4 0.1 1.3 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.1 0.6 6.5 0.8 0.0 0.0 4.9 0.0 0.8 4.8 3.1 0.1 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.3 0.1 0.0 2.5 0.0 0.0 0.8 0.6 1.1 0.0 1.1 1.3 1.0 0.6 1.4 0.0 0.2 0.2 0.4 8.2 15.4 22.1 12.9 6.5 18.4 7.9 9.2 12.7 4.3 3.0 8.6 0.0 7.8 3.4 1.8 25.4 0.0 2.7 2.3 5.2 3.9 0.3 3.3 1.1 0.4 2.9 0.7 0.0 1.7 0.1 2.9 4.4 1.1 0.0 1.4 1.6 16.6 8.0 0.0 0.0 0.3 2.6 10.1 0.0 7.1 2.3 1.5 5.5 0.4 0.6 0.8 12.9 2.7 0.3 6.0 3.3 0.2 1.9 3.4 4.2 SGTB "FLJ39002, Sgt2" ENSG00000197860 "Small glutamine rich tetratricopeptide repeat containing beta" Q96EQ0 5 65665928-65723035 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.8" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 66.7;Muller glia cells: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044689, HPA063674" Enhanced Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044689: AB_10960838, HPA063674: AB_2685084" "unprognostic (9.94e-2)" "unprognostic (2.28e-1)" "unprognostic (9.58e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (5.92e-5)" "unprognostic (4.27e-2)" "unprognostic (2.86e-1)" "unprognostic (2.41e-1)" "unprognostic (1.64e-2)" "unprognostic (5.35e-2)" "unprognostic (2.54e-3)" "unprognostic (6.82e-2)" "unprognostic (1.87e-1)" "unprognostic (6.34e-2)" "unprognostic (3.05e-3)" 5.9 4.0 14.5 9.4 17.1 11.1 4.0 14.0 40.8 4.6 3.2 4.2 0.2 2.4 6.5 3.2 4.3 2.9 4.4 5.6 13.4 13.4 3.8 3.7 5.3 9.3 14.8 11.9 4.4 2.8 3.7 3.9 5.1 16.9 6.8 3.8 3.0 2.4 3.3 3.5 3.1 2.6 7.2 12.2 6.0 2.7 2.8 4.9 3.1 5.8 0.9 6.4 5.1 3.0 1.5 2.4 8.5 6.6 1.0 13.4 3.1 4.7 3.0 5.8 5.9 8.8 11.6 5.7 19.9 6.2 6.7 9.2 4.1 2.0 6.4 10.8 15.4 11.8 4.8 8.3 7.6 10.9 4.8 8.1 2.8 8.4 8.2 22.8 2.1 4.7 8.6 6.7 14.5 19.2 4.7 6.4 5.1 4.8 4.4 10.4 1.7 4.5 3.3 3.9 0.4 1.6 5.4 10.2 6.6 3.0 1.7 9.1 4.9 8.1 1.4 9.3 6.1 2.0 3.2 9.6 8.8 9.5 9.4 4.4 3.5 5.3 8.7 4.5 6.1 3.4 8.5 5.7 1.3 2.9 6.6 2.7 1.5 6.8 3.8 2.4 1.4 7.4 4.2 6.1 1.0 5.5 0.6 13.4 3.1 14.5 17.1 14.0 29.9 13.4 13.4 14.8 11.9 16.9 4.9 14.9 5.6 1.4 2.4 5.7 6.0 3.2 5.1 2.7 6.8 1.8 0.0 1.3 0.0 2.7 1.9 6.8 0.0 0.0 1.7 3.5 7.5 3.6 20.7 3.8 20.5 66.7 1.7 1.8 20.2 1.4 3.7 16.4 11.8 19.0 1.5 59.7 3.6 1.4 3.9 1.8 4.2 12.9 10.8 4.1 4.8 4.0 1.0 10.2 0.6 1.3 SH2B2 APS ENSG00000160999 "SH2B adaptor protein 2" 7 102285091-102321711 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 37.8" "Cell type enhanced" "Detected in many" 13 "B-cells: 20.7;Extravillous trophoblasts: 58.6;Syncytiotrophoblasts: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 5.2;neutrophil: 3.9" "Group enriched" "Detected in many" 5 "B-cells: 5.2;granulocytes: 3.9;monocytes: 3.3" "Cell line enhanced" "Detected in many" "Daudi: 23.5;Karpas-707: 22.9;RPMI-8226: 16.8;U-266/70: 21.3;U-266/84: 37.3;U-698: 31.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051131 Uncertain Approved Cytosol NA NA Cytosol "HPA051131: AB_2681354" "unprognostic (2.01e-2)" "unprognostic (4.00e-1)" "unprognostic (2.43e-2)" "unprognostic (7.32e-3)" "unprognostic (4.65e-2)" "unprognostic (1.07e-1)" "unprognostic (4.95e-3)" "unprognostic (2.42e-1)" "unprognostic (3.65e-1)" "unprognostic (1.29e-1)" "unprognostic (8.29e-2)" "unprognostic (2.00e-2)" "prognostic unfavorable (6.99e-7)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "unprognostic (2.02e-3)" "unprognostic (3.42e-2)" 5.5 1.3 4.2 11.8 5.1 3.9 2.4 6.5 4.3 2.9 2.0 1.3 0.0 3.1 3.3 1.1 2.3 2.9 2.2 1.7 2.7 5.0 3.2 1.1 9.2 12.6 3.6 1.5 2.2 2.6 1.9 1.9 5.7 4.3 2.9 1.1 0.9 2.0 1.5 37.8 2.4 3.5 1.9 5.0 16.7 2.9 2.2 4.1 0.6 2.8 2.6 10.4 3.1 3.9 5.2 0.7 3.9 3.3 0.0 0.2 0.1 1.3 1.0 1.1 2.4 0.2 0.1 10.4 0.4 0.1 0.3 0.2 0.3 0.2 23.5 2.4 0.1 1.0 1.3 0.2 0.3 0.1 2.9 1.0 0.0 0.6 0.2 0.2 0.1 0.8 0.2 0.3 0.2 0.0 0.4 0.0 0.6 0.1 22.9 0.4 2.5 0.1 4.1 2.6 0.8 4.3 2.9 1.2 16.8 0.8 0.3 1.2 4.3 0.8 2.1 0.5 0.9 0.3 3.0 0.0 0.4 2.4 4.1 0.4 21.3 37.3 31.7 1.5 0.8 0.5 0.0 0.6 0.0 0.2 3.3 0.0 1.4 0.0 0.0 0.7 5.2 0.0 0.0 3.9 0.0 1.3 0.0 0.0 0.1 4.2 5.1 6.5 2.9 2.7 5.0 3.6 1.5 4.3 4.1 0.0 0.0 20.7 2.1 2.3 5.9 1.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.1 0.3 3.5 0.0 0.0 0.0 58.6 1.8 2.8 0.0 0.8 7.1 4.8 1.7 1.3 7.1 0.7 0.6 6.4 6.8 0.0 0.6 8.5 0.1 0.0 0.4 10.3 1.4 0.0 2.5 0.9 12.6 1.4 48.6 0.0 1.2 1.8 SH2D1A "DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD" ENSG00000183918 "SH2 domain containing 1A" O60880 X 124227868-124373197 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 163.1" "Cell type enriched" "Detected in some" 15 "T-cells: 101.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 53 "gdT-cell: 27.3;MAIT T-cell: 36.5;memory CD4 T-cell: 20.6;memory CD8 T-cell: 40.1;naive CD4 T-cell: 21.0;naive CD8 T-cell: 25.2;NK-cell: 31.7;T-reg: 25.3" "Group enriched" "Detected in many" 67 "NK-cells: 31.7;T-cells: 40.1" "Group enriched" "Detected in some" 5 "HDLM-2: 22.6;JURKAT: 48.8;Karpas-707: 50.8;MOLT-4: 60.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "prognostic favorable (2.03e-4)" "unprognostic (1.18e-3)" "unprognostic (4.35e-3)" "unprognostic (9.66e-5)" "unprognostic (1.60e-1)" "unprognostic (1.86e-3)" "unprognostic (9.25e-3)" "unprognostic (3.34e-2)" "unprognostic (1.88e-2)" "unprognostic (2.80e-3)" "unprognostic (9.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.94e-6)" "unprognostic (1.27e-1)" "unprognostic (9.00e-2)" "unprognostic (2.36e-1)" "unprognostic (3.14e-3)" 2.5 0.5 0.4 5.8 0.6 2.5 1.0 0.2 0.3 0.8 1.0 0.4 0.5 0.6 0.7 0.8 0.9 0.6 2.6 0.6 0.5 0.4 1.1 1.7 4.1 21.3 0.6 0.2 0.6 0.3 0.0 0.4 0.4 0.3 1.0 0.7 0.7 1.9 0.3 0.3 0.4 4.0 0.3 1.0 12.2 1.3 0.4 0.3 163.1 1.3 0.7 10.2 4.2 1.1 0.2 0.1 0.5 0.2 31.7 40.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.8 0.0 50.8 0.0 0.0 60.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 7.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 27.3 0.1 36.5 0.2 20.6 40.1 0.1 0.0 21.0 25.2 0.5 31.7 0.2 0.1 25.3 17.2 0.4 0.6 0.2 0.3 0.5 0.4 0.6 0.2 0.3 0.3 3.0 6.6 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.5 0.5 0.1 0.0 0.0 4.9 4.6 0.0 0.0 1.9 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.9 0.1 101.4 0.0 0.0 SH2D1B EAT2 ENSG00000198574 "SH2 domain containing 1B" O14796 1 162395266-162412138 "Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 67.4" "Cell type enriched" "Detected in some" 7 "T-cells: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "NK-cell: 67.4;non-classical monocyte: 27.0" "Group enriched" "Detected in many" 34 "monocytes: 27.0;NK-cells: 67.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.9;EFO-21: 5.6;Karpas-707: 9.2;PC-3: 1.7;TIME: 2.7" "Low region specificity" "Detected in all" HPA054791 Uncertain NA NA "HPA054791: AB_2682600" "unprognostic (7.82e-3)" "unprognostic (6.06e-3)" "unprognostic (1.41e-1)" "unprognostic (2.52e-2)" "unprognostic (1.43e-3)" "unprognostic (2.55e-3)" "unprognostic (1.89e-2)" "unprognostic (6.54e-2)" "unprognostic (5.96e-2)" "unprognostic (4.35e-1)" "unprognostic (1.12e-1)" "unprognostic (4.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.72e-1)" "unprognostic (3.80e-1)" "unprognostic (8.45e-2)" "unprognostic (1.15e-3)" 1.2 0.2 0.4 2.2 0.3 5.3 0.5 0.2 1.1 2.7 3.7 0.1 0.0 1.2 3.0 0.7 3.2 0.3 0.7 1.0 0.5 0.3 0.6 3.9 9.1 6.8 0.4 0.0 0.6 0.2 0.0 0.4 3.7 0.1 1.4 0.6 2.6 1.6 0.9 15.0 0.3 2.6 0.1 1.0 14.8 0.3 0.6 0.0 1.3 0.3 0.4 2.6 0.4 1.7 0.0 1.3 0.6 27.0 67.4 1.3 10.7 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.9 0.0 5.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.2 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 1.3 5.9 0.0 0.0 0.0 0.3 1.3 0.0 0.1 0.2 0.6 67.4 27.0 0.1 0.0 10.7 0.4 0.3 0.2 1.1 0.5 0.3 0.4 0.0 0.1 0.0 3.0 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 1.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 21.9 0.0 0.0 SH2D2A "F2771, TSAd" ENSG00000027869 "SH2 domain containing 2A" Q9NP31 1 156806243-156816862 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.5;lymphoid tissue: 41.2" "Cell type enriched" "Detected in many" 8 "T-cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "gdT-cell: 26.5" "Group enriched" "Detected in many" 30 "NK-cells: 10.1;T-cells: 26.5" "Cell line enhanced" "Detected in some" "HDLM-2: 21.4;HMC-1: 16.1;Karpas-707: 38.9;RPMI-8226: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074482 Enhanced NA NA "HPA074482: " "prognostic favorable (4.96e-4)" "unprognostic (2.76e-2)" "unprognostic (7.50e-2)" "unprognostic (3.03e-3)" "unprognostic (1.14e-3)" "unprognostic (2.73e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (3.08e-1)" "unprognostic (1.64e-1)" "unprognostic (9.34e-3)" "unprognostic (1.70e-1)" "prognostic unfavorable (5.26e-12)" "unprognostic (1.67e-1)" "unprognostic (2.09e-1)" "unprognostic (1.79e-1)" "prognostic favorable (1.31e-4)" 4.1 1.4 0.6 14.3 2.3 4.3 2.0 0.8 1.8 2.6 2.6 1.1 0.5 3.0 2.1 3.8 1.8 2.0 6.2 3.4 0.7 0.8 2.6 2.9 10.3 14.1 1.3 0.4 1.7 1.5 0.0 2.6 1.0 1.4 3.5 2.6 3.1 3.1 2.4 1.3 0.6 9.1 2.0 1.6 20.5 3.4 0.6 1.0 41.2 2.2 2.5 16.0 5.2 1.8 0.3 0.0 0.6 0.0 10.1 26.5 5.9 1.2 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 3.3 0.0 0.0 0.0 0.2 0.6 0.0 21.4 0.0 3.1 0.3 0.4 0.1 0.2 16.1 0.2 0.0 0.1 1.6 0.0 0.1 5.6 0.8 38.9 0.0 0.1 2.6 0.3 2.3 1.9 4.0 0.4 0.0 11.3 0.0 0.1 3.6 0.0 0.7 0.4 0.3 0.2 0.1 0.6 1.0 0.0 0.0 0.1 0.2 5.6 7.4 3.9 0.0 3.2 0.1 0.3 0.0 0.0 26.5 0.0 24.8 0.3 11.2 16.2 0.0 0.1 4.3 11.1 0.6 10.1 0.0 0.0 12.8 5.9 0.6 2.3 0.8 1.8 0.7 0.8 1.3 0.4 1.4 1.0 3.0 2.9 0.8 0.1 1.9 2.7 0.6 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.6 1.0 1.4 0.2 8.1 0.6 1.0 0.0 1.2 1.3 0.6 0.0 0.0 1.0 0.0 0.0 0.9 0.4 3.6 0.3 0.0 0.0 1.2 0.0 1.4 0.0 3.4 1.1 0.1 62.3 1.3 0.4 SH2D4B ENSG00000178217 "SH2 domain containing 4B" Q5SQS7 10 80537902-80646560 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.8;bone marrow: 2.5;epididymis: 2.4" "Cell type enhanced" "Detected in single" 22 "Spermatogonia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enriched" "Detected in single" 87 "REH: 24.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA040022 Uncertain NA NA "HPA040022: AB_10805601" "unprognostic (1.19e-2)" "unprognostic (4.51e-3)" "unprognostic (4.45e-2)" "unprognostic (2.94e-2)" "unprognostic (3.31e-1)" "unprognostic (1.09e-1)" "unprognostic (2.36e-1)" "unprognostic (2.87e-2)" "unprognostic (3.80e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-1)" "unprognostic (2.65e-6)" "unprognostic (9.37e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-3)" "unprognostic (3.81e-1)" 0.6 0.0 0.2 0.2 0.3 2.5 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.0 1.3 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 SH2D5 ENSG00000189410 "SH2 domain containing 5" Q6ZV89 1 20719732-20732837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.5;placenta: 14.8;testis: 9.4" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 4.2;Suprabasal keratinocytes: 1.9;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.3;hTERT-HME1: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030182 Approved Cytosol NA NA Cytosol "HPA030182: AB_10670431" "unprognostic (2.32e-1)" "unprognostic (2.80e-2)" "unprognostic (3.85e-2)" "unprognostic (5.37e-3)" "unprognostic (1.20e-4)" "unprognostic (4.41e-2)" "unprognostic (1.80e-6)" "unprognostic (1.11e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-3)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-2)" 0.4 0.9 4.5 1.3 19.5 0.4 0.3 0.5 19.2 0.6 0.5 0.3 0.0 1.2 1.4 0.3 0.5 0.5 0.6 0.3 3.9 4.1 0.4 0.3 0.4 0.3 1.5 7.3 1.7 0.3 0.6 0.1 14.8 2.1 0.5 0.3 0.0 0.4 1.8 0.3 0.6 0.5 1.2 0.3 0.4 0.6 9.4 0.7 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.7 3.9 0.8 0.0 0.0 0.0 0.1 4.6 6.6 4.6 3.1 1.6 1.6 0.0 1.2 1.4 10.0 0.4 3.3 25.3 1.9 0.0 1.7 0.0 0.5 1.2 3.8 0.0 0.0 0.2 5.3 8.6 32.4 1.6 0.1 0.8 0.0 0.0 1.9 0.9 0.5 0.0 1.5 0.5 5.0 0.1 0.1 0.2 4.8 0.6 1.5 0.2 0.3 0.1 1.5 0.7 0.0 0.0 0.0 5.6 9.9 8.3 2.2 0.0 0.0 0.4 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.5 19.5 0.5 12.3 3.9 4.1 1.5 7.3 2.1 0.7 0.0 0.0 0.0 1.0 4.2 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.9 1.9 4.2 0.0 0.0 0.3 SH2D6 FLJ35993 ENSG00000152292 "SH2 domain containing 6" Q7Z4S9 2 85418721-85437029 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 4.2;pancreas: 1.7;testis: 6.4;thyroid gland: 2.4" "Group enriched" "Detected in some" 6 "Intestinal endocrine cells: 10.2;Proximal tubular cells: 14.7;Spermatocytes: 7.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.6;LHCN-M2: 6.7;RH-30: 2.4;SCLC-21H: 1.5" "Low region specificity" "Detected in many" HPA053873 Uncertain NA NA "HPA053873: AB_2682286" "unprognostic (4.70e-1)" "unprognostic (3.55e-2)" "unprognostic (3.30e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-2)" "unprognostic (7.95e-3)" "unprognostic (1.22e-2)" "unprognostic (1.30e-1)" "unprognostic (1.46e-1)" "unprognostic (2.70e-1)" "unprognostic (2.49e-1)" "unprognostic (5.06e-7)" "unprognostic (2.54e-1)" "unprognostic (8.65e-2)" "unprognostic (1.23e-2)" "unprognostic (5.65e-3)" 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.3 0.4 0.0 1.9 4.2 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.2 0.3 0.2 0.0 0.0 0.6 0.0 1.7 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.8 6.4 2.4 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.6 0.3 0.0 0.1 0.6 0.2 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.2 0.1 0.2 0.4 0.3 0.0 1.6 0.0 0.2 6.7 0.0 0.0 0.0 0.1 0.4 0.4 0.1 2.4 0.0 0.7 0.0 1.5 0.5 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 1.3 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.3 0.1 0.0 0.5 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 10.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.1 0.2 0.4 14.7 0.0 0.0 0.2 7.0 0.7 0.0 0.1 0.0 0.3 0.0 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 7 "testis: 37.1" "Group enriched" "Detected in some" 4 "Early spermatids: 17.9;Late spermatids: 23.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;AN3-CA: 2.8;BEWO: 2.6;HEK 293: 2.0;SCLC-21H: 2.4;SH-SY5Y: 4.4;SuSa: 2.3" "Low region specificity" "Detected in all" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.1 0.2 0.6 0.5 0.4 0.0 0.1 0.5 0.5 0.1 4.3 0.1 0.1 5.0 0.1 0.1 0.1 0.0 1.0 0.2 0.4 0.4 0.1 0.1 0.6 0.1 0.3 0.1 0.1 0.3 0.0 0.2 0.3 0.1 0.2 0.5 0.2 0.2 0.1 0.1 0.1 4.2 0.1 0.3 0.1 0.3 37.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 2.1 2.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 1.1 1.4 0.0 0.0 0.4 2.4 4.4 0.4 0.6 0.2 2.3 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.5 0.5 0.4 0.4 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.5 0.0 0.0 0.0 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 219.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 161.5;Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.6;U-87 MG: 48.5" "Group enriched" "Detected in many" 5 "cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7" "Low region specificity" "Detected in all" "CAB003685, HPA030690" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB003685: AB_425682, HPA030690: AB_2673570" "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 2.4 5.2 7.2 1.2 7.3 0.9 2.9 1.1 4.3 2.9 6.1 3.0 2.0 1.9 2.1 6.6 5.3 2.1 5.0 30.0 6.6 5.4 3.2 2.8 1.5 0.9 7.5 5.0 1.8 2.8 2.1 4.5 1.1 6.1 5.8 2.0 1.2 3.2 5.2 219.7 0.9 1.4 12.4 7.9 1.2 2.9 3.7 5.9 0.1 3.9 41.5 2.2 7.3 8.6 2.7 11.5 2.6 1.7 2.8 4.0 1.2 1.1 1.3 1.7 2.5 3.8 4.4 0.5 2.0 0.9 0.9 0.7 0.7 2.2 3.4 5.2 5.1 7.0 0.1 0.9 1.5 1.4 2.0 3.5 3.4 0.6 1.4 7.7 1.2 0.7 3.6 6.3 3.2 6.4 3.2 1.0 6.5 2.6 4.4 3.6 4.1 2.2 2.0 1.7 2.9 2.9 3.6 6.5 2.1 4.7 0.8 5.0 2.1 3.0 2.4 3.1 1.6 9.2 0.6 0.8 2.6 0.3 1.5 3.8 15.6 3.3 3.4 48.5 3.0 3.3 2.3 0.7 0.0 1.2 1.7 3.1 2.7 1.1 1.8 1.9 1.4 4.0 3.0 2.6 2.8 1.7 11.5 0.7 1.2 7.2 7.3 1.1 4.3 6.6 5.4 7.5 5.0 6.1 5.9 3.0 3.8 0.9 6.0 2.4 2.1 161.5 5.1 5.3 2.3 5.2 3.9 3.1 39.7 3.5 91.7 1.8 1.3 0.0 19.1 1.3 3.5 3.4 4.6 6.4 2.2 4.8 1.2 1.8 2.1 20.4 2.0 1.3 11.8 1.8 1.9 14.0 5.8 1.9 5.3 11.9 6.1 6.5 27.4 23.3 21.1 1.5 1.6 1.9 3.2 4.8 SH3BGRL2 ENSG00000198478 "SH3 domain binding glutamate rich protein like 2" Q9UJC5 6 79631283-79703659 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 104.4" "Cell type enhanced" "Detected in many" 4 "Mucus-secreting cells: 75.8;Paneth cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 7.4;neutrophil: 2.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.4" "Cell line enhanced" "Detected in many" "CACO-2: 33.0;HEL: 16.8;OE19: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047486 Approved Supported Nucleoplasm NA NA 4700000 Nucleoplasm "HPA047486: AB_2680065" "unprognostic (3.48e-2)" "unprognostic (1.95e-1)" "unprognostic (1.75e-2)" "unprognostic (2.28e-2)" "unprognostic (4.21e-1)" "unprognostic (7.77e-2)" "unprognostic (1.07e-1)" "unprognostic (1.60e-2)" "unprognostic (6.92e-2)" "unprognostic (6.53e-3)" "unprognostic (2.78e-1)" "unprognostic (7.94e-2)" "prognostic favorable (2.24e-4)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" "unprognostic (2.11e-2)" "unprognostic (1.33e-1)" 21.0 3.9 11.6 6.5 10.7 1.1 29.3 9.7 18.3 14.6 24.7 2.6 7.9 17.3 9.1 13.0 29.8 9.3 14.2 7.4 12.3 13.8 8.2 27.6 8.0 4.1 14.6 7.8 3.5 11.6 17.9 12.6 14.4 22.4 13.8 24.1 9.6 104.4 6.4 8.3 7.1 17.3 8.2 13.9 3.8 34.1 3.7 2.4 0.4 38.3 11.1 15.0 8.7 12.6 0.0 0.2 7.4 0.3 0.0 1.2 10.8 3.4 0.6 3.2 0.6 2.8 2.4 7.6 0.2 2.3 0.8 1.7 33.0 6.7 0.0 4.8 0.2 0.6 1.6 2.9 3.7 2.8 0.0 4.2 16.8 0.7 6.3 1.2 0.6 0.4 1.3 3.0 2.4 1.4 1.1 9.8 0.0 6.6 0.0 0.2 0.5 0.0 0.0 2.7 40.3 1.1 0.0 0.9 0.0 0.8 11.1 8.5 9.4 0.2 1.0 0.2 4.5 0.1 1.4 5.5 2.2 1.4 0.0 1.9 5.0 2.3 0.0 0.3 0.0 0.7 7.4 0.3 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1.2 2.7 0.0 0.0 0.2 0.0 10.8 11.6 10.7 9.7 18.3 12.3 13.8 14.6 7.8 22.4 2.4 6.0 19.0 0.9 3.7 1.9 12.6 5.2 66.2 25.4 27.3 21.0 7.9 33.0 0.0 15.1 10.8 29.8 58.0 0.0 11.3 1.9 3.6 27.2 0.0 61.0 3.7 12.7 12.1 35.0 4.1 14.7 0.6 1.1 15.1 1.8 75.8 8.3 14.8 69.1 4.2 8.4 11.7 0.0 5.3 1.7 0.9 0.6 44.1 0.0 59.5 25.7 SH3BGRL3 ENSG00000142669 "SH3 domain binding glutamate rich protein like 3" Q9H299 1 26279176-26281522 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 309.8" "Cell type enhanced" "Detected in all" 5 "Hofbauer cells: 2380.9;Urothelial cells: 2379.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-87 MG: 134.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030848, HPA076219" Enhanced Approved "Nuclear bodies" NA NA 73000000 "Nuclear bodies" "HPA030848: AB_10602398, HPA076219: AB_2686787" "unprognostic (4.97e-2)" "unprognostic (9.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.73e-3)" "unprognostic (4.95e-2)" "unprognostic (8.68e-2)" "unprognostic (4.29e-3)" "unprognostic (3.16e-1)" "unprognostic (3.62e-2)" "unprognostic (4.32e-1)" "unprognostic (1.98e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.17e-10)" "unprognostic (1.66e-1)" "unprognostic (1.59e-1)" "unprognostic (6.35e-2)" "unprognostic (4.43e-2)" 97.7 26.9 37.3 82.0 37.2 80.9 33.5 11.3 43.2 33.6 65.8 32.3 19.1 31.9 22.9 124.4 84.0 22.9 42.9 31.3 34.6 32.3 36.6 35.1 58.7 98.4 40.5 19.9 26.8 33.6 7.5 22.2 39.9 31.1 23.9 78.2 21.6 36.3 18.3 16.2 51.8 41.3 34.8 32.6 101.4 40.8 13.7 19.3 80.5 26.6 66.0 95.0 41.1 41.5 75.1 184.4 237.0 211.4 68.2 155.1 309.8 28.8 11.2 11.9 15.8 37.8 94.2 1.8 49.5 58.7 44.2 29.2 8.4 26.2 6.0 18.2 92.5 16.5 10.8 5.5 47.2 33.3 10.3 4.1 51.0 10.7 8.7 28.7 15.9 87.2 38.9 27.4 45.7 36.3 67.9 52.9 13.4 5.3 25.6 80.4 13.0 11.1 25.8 13.2 25.0 73.5 19.7 13.4 9.2 35.9 9.8 7.2 11.3 18.2 20.3 21.9 13.6 3.7 26.6 79.5 62.9 22.6 91.7 24.1 8.1 12.4 5.7 134.9 42.2 31.3 107.5 211.4 188.4 143.1 191.7 106.2 75.1 127.2 140.7 184.4 66.0 55.5 108.8 237.0 68.2 180.6 96.8 155.1 309.8 37.3 37.2 11.3 43.2 34.6 32.3 40.5 19.9 31.1 19.3 89.3 227.2 487.6 666.7 874.2 12.9 5.3 206.4 127.2 135.4 349.0 3.9 99.7 265.2 1062.3 13.2 348.4 756.2 70.0 895.1 379.2 363.5 911.1 977.5 102.7 2380.9 15.9 325.9 311.8 2032.0 36.2 128.9 1759.5 738.9 502.3 1235.8 41.9 1651.6 517.4 152.4 317.2 12.4 148.8 259.2 6.6 24.7 925.4 189.9 897.8 380.7 2379.6 SH3BP4 ENSG00000130147 "SH3 domain binding protein 4" Q9P0V3 2 234951973-235055714 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 50.2" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 4.0;plasmacytoid DC: 6.3" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037533, HPA037534" Uncertain NA NA "HPA037533: AB_10672903, HPA037534: AB_2675528" "unprognostic (2.16e-3)" "unprognostic (1.43e-1)" "unprognostic (2.83e-2)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (5.38e-1)" "unprognostic (2.73e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.89e-2)" "unprognostic (1.61e-1)" "unprognostic (4.30e-1)" "prognostic favorable (2.07e-6)" "unprognostic (2.86e-2)" "unprognostic (5.08e-2)" "unprognostic (6.91e-2)" "unprognostic (1.17e-2)" 7.7 6.5 8.6 3.2 14.8 0.6 20.4 2.6 9.5 12.9 7.9 19.1 16.3 9.9 9.2 9.9 5.6 10.6 11.3 7.1 8.3 5.4 13.4 17.7 8.3 1.3 18.0 6.3 13.9 35.0 3.9 3.1 11.9 12.1 12.5 8.1 10.0 50.2 15.2 6.5 10.8 6.9 8.1 9.4 4.1 14.8 9.2 16.5 1.8 7.9 7.6 4.8 5.3 5.2 0.3 6.3 1.3 0.2 0.3 0.0 0.2 13.9 8.9 23.0 1.7 10.3 6.8 10.4 20.4 19.6 16.3 14.7 6.8 8.4 0.0 5.7 40.8 38.0 7.6 6.7 13.8 19.7 0.0 3.0 0.0 12.1 18.4 17.0 0.0 0.0 13.3 20.8 22.9 12.5 15.7 17.2 0.0 0.1 0.0 23.9 10.8 0.0 0.0 12.6 16.2 4.9 0.0 4.7 2.6 14.9 2.9 14.3 5.8 4.6 29.9 12.5 17.3 3.5 0.0 13.7 18.0 15.9 13.9 13.1 0.0 0.0 0.0 16.7 0.0 26.2 1.3 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 4.0 0.1 0.0 0.0 0.0 0.3 0.0 6.3 0.0 0.2 8.6 14.8 2.6 9.5 8.3 5.4 18.0 6.3 12.1 16.5 3.0 7.8 0.0 43.2 13.2 0.8 5.7 20.4 20.1 22.7 7.0 5.9 7.1 8.3 22.0 2.0 17.3 1.4 0.0 21.4 22.5 9.3 60.5 1.1 22.7 1.9 3.2 6.3 17.8 0.3 1.9 7.5 6.9 23.6 1.0 7.6 0.8 34.7 5.8 8.9 1.4 0.6 0.0 6.6 0.5 3.0 9.7 31.0 0.0 18.3 24.9 SH3D21 "C1orf113, FLJ22938" ENSG00000214193 "SH3 domain containing 21" A4FU49 1 36306387-36324886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 26.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 13.1;Late spermatids: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2" "HPA042212, HPA042456, HPA066168" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627" "prognostic favorable (2.60e-4)" "unprognostic (8.35e-3)" "unprognostic (3.86e-3)" "unprognostic (9.01e-2)" "unprognostic (2.07e-3)" "unprognostic (7.32e-3)" "unprognostic (2.04e-4)" "unprognostic (7.47e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.38e-3)" "prognostic unfavorable (1.76e-6)" "unprognostic (8.88e-2)" "unprognostic (2.25e-1)" "unprognostic (7.99e-2)" "unprognostic (8.59e-2)" 1.6 1.1 11.6 3.4 9.5 1.9 10.1 12.2 11.3 4.4 5.3 1.1 1.4 16.6 2.8 2.7 7.1 1.9 3.0 2.2 5.2 2.2 8.6 1.4 4.5 2.8 1.9 7.0 4.0 1.0 1.3 2.2 19.4 7.4 7.0 6.0 12.4 12.7 2.6 1.0 16.2 24.3 2.0 2.4 1.6 2.3 6.6 1.9 0.0 26.2 4.1 4.5 3.7 6.7 0.1 0.3 2.0 0.5 2.7 0.6 0.0 8.3 0.2 1.6 1.9 0.5 1.0 9.1 4.0 0.8 3.0 1.3 4.7 3.4 1.5 4.4 1.7 0.3 13.5 1.4 3.0 2.5 0.4 0.6 1.3 2.9 3.7 1.3 0.7 2.0 0.5 2.5 2.0 1.5 22.0 1.1 4.1 0.2 2.6 1.4 4.9 1.4 0.7 1.0 2.2 1.6 2.0 0.1 1.0 3.4 1.0 3.4 1.7 0.9 10.1 3.1 11.2 0.3 0.3 2.3 1.2 0.7 4.0 0.4 3.0 0.9 1.7 3.4 0.7 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.0 11.6 9.5 12.2 11.3 5.2 2.2 1.9 7.0 7.4 1.9 0.0 1.3 0.8 1.5 2.7 5.2 0.9 0.0 0.0 0.0 5.2 0.0 2.5 1.7 0.5 13.1 0.9 11.8 0.0 0.3 2.1 1.4 2.0 1.1 0.0 7.0 11.1 0.0 0.6 3.2 38.8 1.1 4.7 3.3 3.6 2.0 1.0 2.7 0.8 2.5 0.8 1.1 0.0 1.7 2.1 1.5 2.8 4.8 0.0 1.6 1.1 SH3GL2 "CNSA2, EEN-B1, SH3D2A, SH3P4" ENSG00000107295 "SH3 domain containing GRB2 like 2, endophilin A1" Q99962 9 17579082-17797129 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 83.0" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 74.6;Cone photoreceptor cells: 21.6;Late spermatids: 36.0;Rod photoreceptor cells: 24.1" "Cancer enhanced" "Detected in many" "glioma: 8.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.7;HeLa: 13.8;JURKAT: 12.1;RT4: 26.7;SCLC-21H: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010056, HPA026685, HPA063573" Enhanced Supported Approved "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes No Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045" "unprognostic (4.78e-2)" "unprognostic (3.24e-2)" "unprognostic (1.68e-2)" "unprognostic (5.05e-5)" "unprognostic (4.23e-2)" "unprognostic (3.40e-1)" "unprognostic (1.21e-1)" "unprognostic (5.90e-2)" "unprognostic (3.90e-1)" "unprognostic (5.07e-3)" "unprognostic (8.76e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.68e-12)" "unprognostic (2.65e-2)" "unprognostic (8.29e-2)" "unprognostic (2.25e-2)" "unprognostic (8.44e-2)" 1.1 1.2 16.7 1.1 17.3 1.0 1.1 68.4 83.0 3.1 1.5 1.6 0.0 1.2 2.8 2.1 1.4 2.6 1.1 4.1 17.1 11.3 13.7 1.1 1.9 1.0 9.1 22.2 2.5 3.4 1.2 6.6 1.0 12.8 2.5 1.6 1.6 1.0 1.1 1.1 1.1 1.5 2.4 6.3 1.1 4.5 5.8 2.2 0.0 2.2 0.0 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 4.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.7 0.0 13.8 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 1.5 0.0 0.0 0.0 0.0 26.7 17.3 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.9 0.0 0.2 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 17.3 68.4 41.1 17.1 11.3 9.1 22.2 12.8 2.2 0.0 0.0 0.0 0.3 0.1 74.6 1.6 0.0 0.0 0.0 7.0 21.6 0.0 10.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 12.7 5.1 0.0 0.0 36.0 1.1 0.0 0.0 0.0 0.7 6.5 0.3 0.0 0.4 18.3 24.1 0.0 0.1 2.1 2.5 0.0 0.1 0.0 0.2 0.4 SH3GL3 "CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13" ENSG00000140600 "SH3 domain containing GRB2 like 3, endophilin A3" Q99963 15 83447228-83618743 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 30.3;testis: 31.6" "Group enriched" "Detected in many" 10 "Early spermatids: 502.6;Late spermatids: 937.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 21.8;HEK 293: 10.8;K-562: 17.0;RH-30: 6.7;SuSa: 9.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039381, HPA077877" Enhanced Approved Mitochondria NA NA Mitochondria "HPA039381: AB_10794635, HPA077877: AB_2686863" "unprognostic (1.10e-3)" "unprognostic (6.62e-2)" "unprognostic (4.25e-2)" "unprognostic (1.86e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-1)" "unprognostic (9.76e-2)" "unprognostic (2.26e-1)" "unprognostic (8.20e-3)" "unprognostic (2.72e-3)" "unprognostic (1.43e-6)" "unprognostic (4.42e-2)" "unprognostic (3.59e-2)" "unprognostic (2.93e-1)" "unprognostic (5.78e-4)" 1.1 1.3 12.5 1.1 26.6 1.4 1.3 6.3 30.3 1.2 1.1 28.2 0.0 1.2 1.8 2.0 2.9 3.5 1.1 1.2 14.2 9.9 2.3 1.1 4.1 1.3 25.5 14.6 1.2 1.0 1.1 0.7 1.8 17.6 1.7 1.2 0.0 1.0 1.8 1.0 1.6 1.2 1.2 16.7 1.1 1.2 31.6 26.0 1.2 1.2 0.5 1.9 1.6 0.7 0.4 0.7 0.7 0.3 0.0 0.4 0.3 0.0 0.0 1.8 1.3 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 21.8 1.3 0.0 0.0 10.8 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 4.5 17.0 0.0 0.0 0.6 1.3 0.0 2.6 0.0 0.8 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 9.5 0.0 0.0 0.3 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.3 0.7 0.0 0.1 0.7 0.2 0.3 12.5 26.6 6.3 18.5 14.2 9.9 25.5 14.6 17.6 26.0 8.9 1.7 0.0 1.3 0.8 4.1 0.4 0.0 1.4 0.0 3.5 0.0 0.6 0.0 0.4 502.6 0.0 0.0 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.3 73.1 0.0 0.0 0.0 937.4 8.6 0.0 1.7 0.0 0.0 2.5 0.5 0.0 3.9 0.0 1.1 0.0 0.2 9.5 6.8 0.1 0.6 0.0 0.0 0.1 SH3RF2 "FLJ23654, Hepp1, POSHER, PPP1R39, RNF158" ENSG00000156463 "SH3 domain containing ring finger 2" Q8TEC5 5 145936579-146081791 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.8" "Cell type enriched" "Detected in many" 5 "Late spermatids: 7204.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basal ganglia: 11.5;cerebral cortex: 2.9" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "dendritic cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in many" "CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2" "Region enriched" "Detected in single" 14 "basal ganglia: 23.9" "Region enhanced" "Detected in some" "basal ganglia: 14.5" "HPA035903, HPA058119" Uncertain Enhanced Nucleoplasm NA Yes Nucleoplasm "HPA035903: AB_10696515, HPA058119: AB_2683611" "unprognostic (8.90e-3)" "unprognostic (2.00e-3)" "unprognostic (5.11e-3)" "unprognostic (1.66e-2)" "unprognostic (1.45e-3)" "unprognostic (1.47e-2)" "unprognostic (9.96e-3)" "unprognostic (8.22e-2)" "unprognostic (3.92e-1)" "unprognostic (7.37e-3)" "unprognostic (2.44e-3)" "unprognostic (1.66e-1)" "unprognostic (2.98e-2)" "unprognostic (5.21e-2)" "unprognostic (1.46e-1)" "unprognostic (2.64e-2)" "unprognostic (4.13e-3)" 2.6 0.6 1.2 6.2 11.5 0.0 2.9 0.2 2.9 6.4 19.1 0.4 0.4 9.2 2.9 2.2 22.2 3.6 40.8 23.5 0.8 0.3 0.8 4.6 1.9 0.0 0.3 1.1 1.0 14.3 0.0 3.3 0.3 0.1 2.2 8.5 0.9 16.9 1.0 21.7 33.1 21.4 1.2 0.5 0.2 11.9 6.4 0.6 0.6 3.8 19.6 16.1 0.9 10.0 0.0 1.4 0.3 0.1 0.0 1.6 0.3 10.2 2.8 0.1 0.6 0.0 0.0 0.0 0.1 0.8 2.1 0.8 34.6 9.5 0.0 5.4 0.4 15.3 9.5 0.0 11.2 2.0 0.1 0.1 0.0 4.1 4.6 0.6 0.0 0.0 0.1 6.0 3.2 7.6 17.2 0.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.8 8.5 0.7 0.0 0.1 0.0 4.4 1.0 0.0 0.0 0.6 0.2 0.2 0.5 3.3 0.0 4.9 0.4 8.9 0.7 3.3 0.0 0.0 0.0 5.5 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.7 1.4 0.0 0.0 1.5 0.2 0.0 0.1 0.0 0.8 0.3 1.2 11.5 0.2 2.9 0.8 0.3 0.3 1.1 0.1 0.6 14.9 2.9 0.0 4.5 48.9 0.6 414.9 2.5 2.7 2.3 1.8 0.0 0.0 0.0 6.5 1412.5 1.5 27.7 0.0 7.6 0.0 0.5 1.3 1.1 8.3 0.2 0.0 1.2 0.6 0.0 7204.3 23.9 0.0 8.5 1.0 12.2 1.9 13.6 17.5 32.5 0.6 0.0 12.9 1.4 32.0 16.2 43.7 0.0 0.0 27.1 6.4 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell type enhanced" "Detected in many" 14 "Rod photoreceptor cells: 24.7;Syncytiotrophoblasts: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.2;RT4: 9.9;SK-MEL-30: 8.9;WM-115: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA037683: AB_2675608, HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.3 0.5 0.2 6.2 5.1 0.0 5.6 0.3 1.7 4.3 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.8 1.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 3.1 5.7 0.0 3.9 0.0 2.1 9.9 0.0 0.0 0.0 0.3 8.9 0.2 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 3.0 5.9 0.0 0.6 0.8 1.1 1.7 2.5 1.4 4.5 0.0 3.9 0.7 0.0 0.7 4.8 1.4 0.0 0.0 0.2 0.2 0.9 1.0 2.3 0.0 0.3 0.0 0.0 1.3 2.4 1.5 0.3 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 24.7 0.0 0.4 1.4 0.8 0.6 10.0 0.0 0.0 2.6 SH3YL1 "DKFZP586F1318, Ray" ENSG00000035115 "SH3 and SYLF domain containing 1" Q96HL8 2 217730-266398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 94.7" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 402.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 65.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030926, HPA030927" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030926: AB_10670148, HPA030927: AB_10669874" "unprognostic (1.54e-1)" "unprognostic (1.33e-1)" "unprognostic (5.10e-2)" "unprognostic (2.28e-3)" "unprognostic (5.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.46e-1)" "unprognostic (6.57e-3)" "unprognostic (9.25e-2)" "unprognostic (6.40e-2)" "unprognostic (1.71e-2)" "unprognostic (2.81e-1)" "prognostic favorable (7.70e-4)" "unprognostic (1.95e-3)" "unprognostic (1.10e-1)" "unprognostic (1.47e-1)" "unprognostic (3.22e-3)" 3.6 11.7 10.3 8.7 10.1 2.6 16.0 8.7 9.7 9.6 12.9 8.6 16.1 9.8 7.9 12.4 17.4 12.8 22.9 4.1 10.5 8.0 42.5 3.8 14.9 10.4 10.9 11.8 9.9 94.7 13.9 20.7 11.4 7.9 17.7 15.8 7.3 35.3 26.9 3.2 21.5 32.1 7.6 13.1 5.5 23.6 6.0 8.2 5.7 22.5 15.3 14.4 18.0 9.5 7.2 3.3 14.0 2.3 12.4 20.6 5.2 3.6 0.7 4.1 1.8 5.6 5.3 2.7 4.7 5.3 1.8 1.8 9.9 13.9 0.1 2.3 4.1 1.2 15.5 1.0 20.3 1.7 3.1 0.7 0.9 1.1 3.1 4.5 0.4 1.2 5.9 21.0 1.0 3.4 8.8 2.6 5.1 0.2 0.6 3.6 10.7 3.9 2.0 1.3 65.8 0.8 1.8 1.2 0.2 12.6 21.0 1.7 2.8 0.7 19.6 3.3 5.7 13.4 3.1 1.9 0.9 0.2 5.2 2.0 0.5 0.0 0.3 9.0 6.2 3.0 14.0 1.3 1.0 2.6 1.6 8.4 7.2 13.3 6.7 3.3 5.5 20.6 11.9 0.8 12.4 2.3 2.9 16.2 5.2 10.3 10.1 8.7 9.7 10.5 8.0 10.9 11.8 7.9 8.2 53.6 103.8 28.7 161.2 73.5 18.5 5.7 280.2 57.6 78.5 96.0 21.6 132.4 247.1 104.8 113.4 15.7 68.8 0.0 125.5 61.0 27.7 132.4 15.1 6.8 23.1 25.4 47.1 18.4 6.9 92.8 33.9 14.8 69.2 14.4 79.9 7.7 99.4 91.2 38.5 402.5 8.7 25.8 18.6 61.2 23.6 100.7 206.5 17.5 106.3 210.4 SHANK1 "SPANK-1, SSTRIP, synamon" ENSG00000161681 "SH3 and multiple ankyrin repeat domains 1" Q9Y566 19 50661827-50719450 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 35.7" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 5.3;Cardiomyocytes: 3.0;Cone photoreceptor cells: 2.0;Horizontal cells: 7.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 7.5;SH-SY5Y: 3.6;U-138 MG: 4.2;U-2 OS: 10.6;U-87 MG: 4.0;U-937: 4.4" "Low region specificity" "Detected in all" "HPA032129, HPA032130" Uncertain Supported "Plasma membrane" NA NA "Plasma membrane" "HPA032129: AB_10602796, HPA032130: AB_2674169" "unprognostic (1.62e-1)" "unprognostic (4.40e-2)" "unprognostic (7.83e-3)" "unprognostic (4.62e-2)" "unprognostic (1.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.35e-2)" "unprognostic (5.02e-2)" "unprognostic (1.61e-1)" "unprognostic (7.51e-2)" "unprognostic (3.27e-1)" "unprognostic (3.65e-2)" "unprognostic (1.61e-2)" "unprognostic (5.14e-2)" "unprognostic (4.66e-3)" "unprognostic (1.29e-3)" 0.9 2.6 27.9 0.9 10.0 1.2 0.9 13.6 35.7 1.3 0.9 1.1 0.0 0.9 1.3 1.0 0.9 2.2 1.1 0.9 25.6 12.3 0.9 0.8 0.8 0.9 6.0 11.1 0.9 0.9 2.1 2.8 1.0 4.1 1.0 0.8 0.2 0.9 1.0 1.0 1.2 0.9 1.1 2.2 0.9 0.8 1.4 3.5 0.4 0.9 0.0 0.9 0.9 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 1.3 1.2 0.1 0.1 0.0 0.0 0.0 2.0 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.6 0.9 0.0 0.0 0.7 0.1 0.1 0.8 1.2 0.0 0.1 7.5 0.0 0.8 0.0 0.0 0.0 3.6 0.0 0.0 1.1 0.0 0.0 3.2 2.3 4.2 10.6 0.0 0.0 0.0 0.0 0.0 4.0 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 27.9 10.0 13.6 23.0 25.6 12.3 6.0 11.1 4.1 3.5 0.0 0.0 0.0 0.0 0.0 5.3 3.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SHANK2 "CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3" ENSG00000162105 "SH3 and multiple ankyrin repeat domains 2" Q9UPX8 11 70467856-71252577 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 38.7;Horizontal cells: 128.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.1" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.1" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9;MCF7: 9.7;RT4: 15.6;T-47d: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008174, HPA017220" Approved Uncertain "Nucleoplasm,Nuclear speckles,Vesicles" NA NA Nucleoplasm "Nuclear speckles, Vesicles" "HPA008174: AB_1856822, HPA017220: " "unprognostic (3.08e-1)" "unprognostic (1.31e-3)" "unprognostic (1.79e-1)" "unprognostic (1.51e-2)" "unprognostic (1.51e-1)" "unprognostic (7.23e-5)" "unprognostic (1.24e-1)" "unprognostic (6.67e-2)" "unprognostic (1.83e-2)" "unprognostic (8.42e-2)" "unprognostic (4.87e-2)" "unprognostic (4.01e-1)" "prognostic favorable (1.94e-6)" "unprognostic (3.46e-2)" "unprognostic (2.34e-1)" "unprognostic (4.03e-2)" "unprognostic (4.80e-2)" 2.1 1.7 16.8 0.8 22.6 0.0 7.3 6.1 24.1 2.8 3.1 2.3 1.9 2.4 1.8 3.1 5.1 7.9 1.1 0.2 12.2 8.1 7.0 4.7 5.5 0.3 3.6 12.9 0.2 11.3 0.0 7.3 2.7 8.7 4.6 2.8 1.4 12.7 3.3 0.1 1.2 2.0 0.6 1.5 1.5 4.7 1.2 3.7 0.0 8.5 0.0 0.5 2.3 0.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 7.8 4.3 0.0 0.5 0.7 3.1 0.6 0.3 0.0 0.0 8.2 2.9 5.1 1.5 0.0 0.2 0.8 0.0 2.9 0.0 0.0 0.2 0.0 0.0 8.5 0.0 0.0 1.7 0.2 1.5 0.0 0.0 1.1 0.0 0.1 0.0 16.9 1.6 9.7 0.0 0.0 3.3 7.4 0.3 0.0 7.7 7.6 3.9 15.6 2.5 1.0 0.0 6.2 0.0 3.6 12.0 0.0 0.0 0.1 1.2 0.3 0.0 0.1 0.6 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.8 22.6 6.1 24.1 12.2 8.1 3.6 12.9 8.7 3.7 38.7 14.2 0.0 2.7 0.0 16.0 2.4 10.2 20.1 5.7 7.0 0.0 9.5 3.3 7.0 1.4 1.0 0.9 0.0 1.9 2.4 0.6 8.4 2.3 19.0 1.0 128.7 0.0 0.0 0.0 1.6 0.0 0.5 5.0 0.0 8.2 5.0 7.6 3.5 0.7 8.7 0.9 0.0 1.4 0.6 0.7 0.5 12.2 0.0 5.2 3.8 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell type enriched" "Detected in some" 5 "Ito cells: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.4;TIME: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 9.5 5.4 23.5 1.3 26.1 2.6 8.7 13.0 32.4 3.5 2.0 2.4 0.1 5.2 3.8 3.4 2.5 2.8 1.1 4.4 21.6 2.4 2.9 5.1 5.3 2.9 2.5 18.1 1.6 7.6 7.9 1.0 1.7 2.6 1.9 1.9 0.6 8.5 3.4 3.6 3.1 6.6 1.5 2.0 12.3 1.3 3.4 6.4 0.2 4.1 1.4 2.6 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.6 2.9 0.5 0.5 0.0 0.6 0.0 0.2 0.0 0.6 1.7 0.0 1.2 0.2 1.7 0.6 0.9 0.4 0.0 0.0 0.0 6.4 0.4 1.7 1.5 0.8 0.3 1.6 1.1 0.1 0.3 0.1 2.0 0.7 0.1 0.1 0.1 0.9 0.5 0.2 1.3 0.7 1.8 1.7 0.0 0.7 0.3 0.5 1.3 1.9 1.7 0.0 0.8 0.4 0.3 0.4 10.2 0.2 1.7 0.7 0.4 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.1 13.0 32.4 21.6 2.4 2.5 18.1 2.6 6.4 0.0 1.4 0.0 0.0 0.2 0.5 19.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.8 16.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 5.6 0.3 0.0 2.4 90.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.4 0.7 0.0 0.0 0.9 0.2 0.4 0.3 0.0 0.0 0.0 0.3 SHARPIN "DKFZP434N1923, SIPL1" ENSG00000179526 "SHANK associated RH domain interactor" Q9H0F6 8 144098633-144108124 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 99.4" "Group enriched" "Detected in many" 5 "Early spermatids: 302.5;Late spermatids: 974.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024825, HPA044453" Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Golgi apparatus, Cytosol" "HPA024825: , HPA044453: AB_10962490" "unprognostic (4.91e-2)" "unprognostic (3.47e-2)" "unprognostic (1.35e-2)" "unprognostic (7.88e-2)" "unprognostic (3.32e-2)" "unprognostic (9.54e-2)" "unprognostic (1.31e-3)" "unprognostic (6.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.13e-3)" "unprognostic (5.44e-2)" "unprognostic (7.91e-2)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.55e-1)" "unprognostic (2.24e-1)" "unprognostic (1.00e-1)" 12.0 14.5 15.8 7.9 11.7 13.2 10.9 9.0 15.3 11.3 12.3 13.7 17.3 11.5 11.4 14.7 11.4 12.9 10.3 14.7 14.0 8.9 14.1 25.7 10.0 9.3 14.6 11.3 11.9 14.0 11.7 10.2 9.6 13.3 12.2 7.2 10.5 16.8 11.8 25.5 13.5 10.7 9.4 9.2 12.5 12.0 99.4 12.3 6.1 10.9 10.8 7.1 10.1 9.5 12.7 22.4 26.1 21.2 17.3 22.1 11.0 8.7 12.8 7.2 5.6 11.7 12.0 8.3 8.1 9.6 10.8 10.8 9.0 14.1 3.8 14.9 9.8 6.3 10.0 3.5 12.2 3.1 11.3 9.6 9.5 14.6 10.7 20.7 3.3 8.8 13.5 20.2 9.1 10.3 13.3 11.5 12.2 6.3 8.9 9.9 14.3 11.2 9.4 2.9 18.4 46.6 7.8 5.4 12.6 11.4 10.0 7.3 11.3 13.9 21.0 13.3 6.1 22.0 12.2 9.7 8.5 13.5 12.1 10.9 11.0 8.3 5.0 12.4 8.1 6.7 12.5 18.1 26.1 16.7 21.2 18.6 12.7 16.6 22.1 16.6 12.3 13.8 15.0 9.3 17.3 18.4 22.4 16.5 11.0 15.8 11.7 9.0 15.3 14.0 8.9 14.6 11.3 13.3 12.3 8.9 17.8 26.6 26.7 21.3 23.2 18.2 17.8 4.0 9.1 33.2 3.9 48.0 101.2 49.2 302.5 33.1 72.2 0.0 43.4 40.8 41.3 29.5 12.7 33.1 51.8 46.1 34.0 30.7 32.4 974.5 45.5 32.9 43.9 73.9 40.9 35.3 67.6 63.1 41.1 69.5 24.9 51.8 34.4 141.6 64.2 28.2 36.0 45.7 50.7 29.1 SHBG "ABP, MGC126834, MGC138391, TEBG" ENSG00000129214 "Sex hormone binding globulin" P04278 17 7613946-7633383 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 14.2;liver: 51.1" "Group enriched" "Detected in some" 7 "Early spermatids: 42.1;Late spermatids: 103.5" "Cancer enriched" "Detected in some" 28 "liver cancer: 14.3" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 7.9;Hep G2: 5.1;HSkMC: 7.7" "Region enhanced" "Detected in single" "olfactory region: 0.4" "Secreted to blood" NA NA 15000000000 "unprognostic (3.35e-3)" "unprognostic (6.47e-2)" "unprognostic (5.65e-2)" "unprognostic (2.35e-1)" "unprognostic (8.84e-2)" "unprognostic (3.08e-1)" "unprognostic (3.50e-1)" "unprognostic (2.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.32e-3)" "unprognostic (3.58e-3)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (7.83e-3)" "unprognostic (4.35e-1)" "unprognostic (5.50e-3)" "unprognostic (1.06e-1)" 0.5 0.9 1.0 0.0 1.3 0.1 0.2 0.4 0.8 0.6 2.7 0.4 0.0 3.5 0.3 0.6 0.2 0.5 0.4 0.9 0.9 0.5 2.3 51.1 0.3 0.1 0.8 0.7 0.5 0.8 0.3 1.4 0.3 1.1 0.3 0.2 1.1 0.3 0.3 0.5 0.0 14.2 0.2 1.1 0.2 0.2 8.0 1.0 0.0 0.6 0.0 0.1 0.2 0.1 0.0 1.2 0.0 0.6 0.0 0.0 0.0 0.2 4.1 3.9 0.6 7.9 3.7 0.2 1.0 1.6 1.7 0.9 1.6 0.6 0.0 0.9 1.4 2.2 0.6 0.2 0.3 0.9 0.2 0.6 0.0 1.0 5.1 2.5 0.0 0.1 7.7 0.6 2.9 1.4 1.4 0.1 0.0 0.4 0.3 0.4 0.9 0.0 0.4 0.6 0.0 0.0 0.1 0.3 0.5 0.6 0.5 0.2 0.6 3.2 0.0 0.4 1.6 0.7 0.0 1.4 0.8 0.0 0.0 0.3 0.6 0.6 0.3 1.9 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.4 0.8 0.9 0.5 0.8 0.7 1.1 1.0 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.4 42.1 0.0 0.3 0.0 0.2 0.1 0.3 0.4 0.0 9.6 0.3 0.0 0.0 1.3 0.3 103.5 0.9 0.0 0.0 0.0 0.2 2.3 0.1 0.2 0.7 9.8 1.1 6.5 0.0 3.1 0.9 0.0 0.2 0.0 0.3 0.3 SHC2 "SCK, SHCB, SLI" ENSG00000129946 "SHC adaptor protein 2" P98077 19 416583-460996 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 44.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 51.6;Horizontal cells: 46.1;Ito cells: 57.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;HHSteC: 6.5;SCLC-21H: 14.1;SH-SY5Y: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006136 Approved Approved Cytosol NA NA Cytosol "HPA006136: AB_1856827" "unprognostic (2.54e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (4.58e-4)" "unprognostic (6.40e-2)" "unprognostic (1.64e-1)" "unprognostic (1.50e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.36e-1)" "prognostic favorable (8.53e-4)" "unprognostic (4.45e-2)" "unprognostic (5.30e-2)" "unprognostic (1.99e-2)" "unprognostic (3.37e-1)" "unprognostic (8.86e-2)" "unprognostic (4.43e-2)" 9.8 11.3 18.5 2.7 15.1 1.0 6.8 5.0 17.6 7.9 6.3 10.2 3.7 8.9 11.7 5.9 2.6 8.1 14.6 7.9 15.7 15.2 3.8 20.6 6.5 2.8 15.2 11.3 5.1 44.8 7.8 18.6 10.7 15.6 13.7 1.4 9.9 19.5 8.2 3.4 8.5 6.2 4.7 9.6 11.5 10.5 6.0 15.0 0.0 9.7 0.7 1.3 3.8 6.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.7 0.5 2.8 0.3 0.0 0.0 0.5 0.0 5.6 0.0 1.4 0.4 1.3 0.0 0.0 1.2 1.8 0.0 0.0 3.0 6.5 0.0 2.1 0.3 0.0 0.0 0.0 2.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 2.1 0.0 14.1 12.7 0.0 0.0 0.0 2.7 0.3 2.1 0.0 0.6 3.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.5 15.1 5.0 17.6 15.7 15.2 15.2 11.3 15.6 15.0 6.0 12.0 0.0 1.8 1.6 4.3 7.7 20.4 0.0 0.0 0.0 2.0 0.1 0.0 20.6 1.9 11.9 0.0 0.0 32.6 0.1 4.3 12.6 0.0 51.6 0.8 46.1 8.1 57.7 6.5 6.0 8.3 0.5 8.5 1.8 3.4 28.9 30.9 0.0 10.6 0.3 2.7 0.0 5.0 15.4 8.2 2.8 0.0 1.7 0.1 3.3 SHC3 "N-Shc, NSHC, SHCC" ENSG00000148082 "SHC adaptor protein 3" Q92529 9 89005771-89178767 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.1" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 16.0;Bipolar cells: 7.0;Muller glia cells: 6.1" "Cancer enhanced" "Detected in some" "glioma: 5.1" "Group enriched" "Detected in many" 4 "amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 17.1;hTERT-RPE1: 18.9;RT4: 6.3;SH-SY5Y: 6.3;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031427, HPA046656, HPA072448" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521" "unprognostic (6.22e-2)" "unprognostic (5.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-1)" "unprognostic (9.07e-4)" "unprognostic (2.70e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (3.09e-1)" "unprognostic (2.72e-3)" "unprognostic (7.39e-2)" "unprognostic (1.53e-7)" "unprognostic (8.33e-2)" "unprognostic (1.05e-1)" "unprognostic (9.01e-2)" "unprognostic (9.84e-4)" 1.6 10.8 15.7 0.8 20.8 0.5 1.8 0.8 35.1 7.3 1.2 2.3 0.0 1.1 1.5 1.7 1.5 2.2 2.7 1.0 14.2 4.7 1.4 0.6 6.0 0.8 3.1 24.7 0.7 4.4 10.4 1.0 0.8 5.2 1.5 1.4 0.0 6.4 1.4 0.9 1.8 0.9 1.8 1.5 0.6 0.8 1.0 1.3 0.0 1.3 0.0 0.8 1.7 3.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 17.1 0.0 3.8 1.2 0.0 1.2 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.4 0.2 0.0 2.6 0.0 1.7 0.0 18.9 4.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 2.2 0.2 0.2 0.2 0.0 3.5 3.7 6.3 2.3 6.3 0.4 0.0 0.0 0.1 0.0 0.3 2.6 0.7 0.1 1.0 0.1 0.0 0.0 0.0 9.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 20.8 0.8 31.5 14.2 4.7 3.1 24.7 5.2 1.3 0.0 16.0 0.0 0.2 0.1 7.0 0.8 0.0 1.4 1.2 0.0 0.0 0.1 1.7 0.0 0.8 0.1 0.0 0.0 0.8 0.1 1.1 0.0 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.9 1.4 0.0 1.7 0.0 0.0 6.1 0.1 0.0 3.5 0.3 0.4 0.0 0.8 0.2 0.1 0.5 0.3 0.0 0.0 0.9 SHC4 "RaLP, SHCD" ENSG00000185634 "SHC adaptor protein 4" Q6S5L8 15 48823735-48963444 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;testis: 19.5" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 4.0;Ductal cells: 4.1;Melanocytes: 6.8;Spermatocytes: 6.0" "Cancer enhanced" "Detected in some" "melanoma: 9.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "eosinophil: 2.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.5" "Cell line enhanced" "Detected in some" "AN3-CA: 9.6;SK-MEL-30: 17.9;WM-115: 15.3" "Low region specificity" "Detected in all" HPA074146 Approved Cytosol NA NA Cytosol "HPA074146: AB_2686667" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.05e-3)" "unprognostic (1.23e-2)" "unprognostic (3.47e-2)" "unprognostic (2.59e-1)" "unprognostic (2.21e-2)" "unprognostic (3.80e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-5)" "unprognostic (9.84e-3)" "unprognostic (3.26e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-2)" 1.5 2.3 9.0 2.3 24.8 0.7 3.7 2.0 15.8 2.5 2.5 18.9 0.3 1.1 1.3 2.5 1.5 1.9 3.2 6.6 11.2 6.2 1.2 0.8 1.2 1.1 25.7 9.4 1.6 0.9 0.7 1.1 1.3 13.2 1.3 1.6 1.7 4.8 3.3 2.0 1.3 1.1 1.9 16.2 0.9 1.0 19.5 23.8 0.0 1.1 0.0 0.8 1.7 0.9 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 0.3 0.9 9.6 0.4 1.3 0.0 1.4 2.7 0.6 1.1 0.0 0.2 0.1 2.4 0.5 0.1 0.0 0.2 0.4 0.8 1.9 0.1 0.6 0.0 0.0 1.0 0.0 0.1 1.8 0.0 1.2 0.1 1.2 0.1 0.9 0.0 0.2 1.3 1.5 0.3 0.2 0.1 0.0 3.5 0.2 2.5 0.3 2.0 0.4 0.5 0.7 0.2 0.1 17.9 0.9 0.0 0.1 0.0 0.8 0.4 0.6 1.0 0.7 0.1 0.0 0.8 0.5 15.3 0.2 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 24.8 2.0 13.4 11.2 6.2 25.7 9.4 13.2 23.8 0.0 0.0 0.0 0.0 0.2 0.5 1.8 0.0 4.0 2.3 0.0 0.0 0.6 0.0 4.1 2.2 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.1 1.6 0.0 1.3 0.0 3.6 1.1 0.0 6.8 0.0 0.0 2.7 0.1 0.0 3.2 0.0 0.7 0.0 0.2 6.0 2.8 0.3 0.7 0.0 0.0 0.0 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46580554-46621626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 24.1;Spermatocytes: 27.0;Spermatogonia: 30.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 1.5 0.8 1.0 17.3 3.0 18.9 0.9 2.4 1.3 0.8 2.2 0.6 0.3 1.3 1.5 2.0 5.7 0.4 1.1 1.5 1.0 0.7 5.0 0.3 1.7 11.2 0.7 0.7 1.2 0.3 0.2 0.8 2.8 0.7 0.9 2.5 0.3 2.6 0.3 1.4 3.8 2.3 1.9 1.1 9.9 1.4 14.1 0.9 22.9 0.6 3.0 12.9 2.0 1.6 4.6 2.0 1.8 5.4 0.3 3.4 2.1 15.3 16.4 6.2 7.5 1.3 3.2 8.6 31.4 12.4 30.7 14.3 7.8 10.1 13.5 14.2 14.3 12.4 10.2 13.6 10.2 38.0 8.6 9.1 14.8 12.4 13.2 0.0 13.0 18.9 0.6 0.6 22.5 9.2 3.0 16.0 7.1 6.1 14.3 33.3 10.2 11.6 10.8 4.8 7.2 17.5 21.2 41.6 21.6 6.3 4.8 2.6 3.4 21.7 11.5 4.9 5.6 6.3 10.7 9.2 22.5 14.6 21.7 24.9 11.3 14.9 21.6 10.3 14.0 22.6 0.3 0.8 1.8 0.5 1.3 0.1 4.6 0.8 0.4 1.2 1.9 0.1 0.3 0.8 0.3 5.4 2.0 3.4 2.1 1.0 3.0 2.4 1.3 1.0 0.7 0.7 0.7 0.7 0.9 0.0 1.4 0.0 0.5 1.4 0.2 1.4 2.5 0.0 2.3 0.0 0.0 3.1 0.0 0.3 6.4 0.3 0.4 0.0 0.0 24.1 1.0 0.4 0.0 0.0 10.7 0.0 0.0 2.5 2.9 1.5 0.6 3.9 1.7 2.8 0.2 1.0 0.1 0.0 0.4 0.0 0.3 0.0 0.5 27.0 30.1 0.5 3.1 0.7 0.6 0.9 SHCBP1L C1orf14 ENSG00000157060 "SHC binding and spindle associated 1 like" Q9BZQ2 1 182899865-182953525 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 198 "testis: 87.2" "Group enriched" "Detected in some" 13 "Early spermatids: 410.2;Spermatocytes: 552.4" "Cancer enhanced" "Detected in single" "cervical cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "BEWO: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA036124, HPA036125, HPA064821" Enhanced NA NA "HPA036124: AB_2674953, HPA036125: AB_10671834, HPA064821: AB_2685360" "unprognostic (1.29e-3)" "unprognostic (1.03e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (6.44e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 410.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.8 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 12.9 0.0 552.4 4.3 0.0 0.1 0.0 0.0 0.0 SHD ENSG00000105251 "Src homology 2 domain containing transforming protein D" Q96IW2 19 4278601-4290724 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 14.8;brain: 23.1;heart muscle: 17.3" "Group enriched" "Detected in some" 5 "Enterocytes: 82.3;Hepatocytes: 45.0;Mucus-secreting cells: 54.3;Paneth cells: 66.4;Undifferentiated cells: 41.3" "Cancer enhanced" "Detected in some" "glioma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 148 "plasmacytoid DC: 14.8" "Lineage enriched" "Detected in single" 148 "dendritic cells: 14.8" "Group enriched" "Detected in some" 46 "RH-30: 19.2;SH-SY5Y: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017955 Uncertain Uncertain "Centriolar satellite,Cytosol" NA NA "Centriolar satellite, Cytosol" "HPA017955: AB_1856828" "unprognostic (2.41e-3)" "unprognostic (7.68e-3)" "unprognostic (4.77e-3)" "unprognostic (3.67e-2)" "unprognostic (3.48e-2)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "unprognostic (1.43e-1)" "unprognostic (5.93e-2)" "unprognostic (3.73e-1)" "unprognostic (2.47e-2)" "unprognostic (3.76e-1)" "unprognostic (3.48e-1)" "unprognostic (1.21e-1)" "unprognostic (5.21e-2)" "unprognostic (9.69e-2)" "unprognostic (8.16e-4)" 0.5 0.7 4.0 1.4 2.5 1.2 0.4 4.1 23.1 0.4 0.9 2.4 0.0 0.7 0.4 0.4 0.4 0.4 0.6 17.3 3.3 4.5 0.4 1.7 0.5 1.2 4.7 2.3 0.4 0.5 0.4 0.2 0.4 6.1 0.5 0.7 0.0 0.5 0.4 0.8 0.4 0.6 0.4 2.5 0.6 0.4 0.5 1.1 0.0 0.4 0.0 0.8 0.5 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.1 62.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 4.0 2.5 4.1 20.4 3.3 4.5 4.7 2.3 6.1 1.1 0.0 0.0 0.0 0.0 0.0 1.3 7.5 0.0 0.0 0.0 0.0 0.0 1.4 1.7 0.0 0.1 0.0 82.3 0.0 0.0 0.4 0.0 0.0 9.2 45.0 0.3 9.5 12.7 0.6 0.3 0.0 0.0 0.0 0.0 0.0 54.3 0.4 0.0 66.4 0.0 0.0 0.2 0.0 0.0 0.0 2.7 0.0 3.7 0.0 41.3 0.0 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 84.3" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 46.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 84.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.7;SH-SY5Y: 22.6" "Region enriched" "Detected in all" 5 "cerebellum: 269.9" HPA057381 Approved Nucleoplasm NA NA Nucleoplasm "HPA057381: AB_2683423" "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 2.9 19.3 6.9 3.3 10.4 0.6 3.3 84.3 14.5 7.3 6.3 3.9 2.2 10.5 8.5 4.0 4.1 6.2 5.3 4.5 5.9 7.2 1.8 18.9 2.9 1.8 4.5 6.7 20.5 2.5 2.5 3.5 1.5 7.1 5.3 4.4 6.3 5.3 5.2 2.6 6.5 7.9 6.3 5.2 2.3 2.9 4.1 3.2 1.6 4.9 2.4 1.8 5.8 5.5 3.3 2.6 2.5 1.9 5.1 4.2 1.5 0.0 0.6 10.0 0.3 0.7 0.4 4.7 1.2 0.8 2.8 4.0 1.4 4.7 0.5 4.0 1.7 2.7 0.8 3.8 0.3 1.3 0.8 1.7 0.3 0.9 9.8 0.4 0.0 3.3 0.9 0.2 0.3 0.0 2.1 2.1 4.9 1.9 0.2 3.9 1.6 2.1 0.3 3.9 1.8 0.2 6.0 7.9 0.2 0.9 0.2 50.7 22.6 0.3 0.3 0.2 3.2 0.5 0.9 0.1 0.3 4.3 0.3 0.1 0.4 0.3 0.4 0.1 0.2 1.5 0.3 1.9 1.2 3.8 1.7 4.2 2.4 1.6 2.4 1.8 3.3 2.2 1.7 2.5 5.1 1.7 2.6 0.3 1.5 6.9 10.4 84.3 12.1 5.9 7.2 4.5 6.7 7.1 3.2 0.0 1.1 0.0 4.9 3.2 46.9 2.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 6.1 3.7 4.2 0.0 1.1 0.4 3.0 2.5 2.3 9.7 0.6 9.5 12.5 3.7 1.0 9.8 4.0 2.8 8.5 0.0 8.6 5.7 0.5 5.8 3.9 1.0 4.5 6.5 5.0 4.7 2.7 2.3 0.6 0.7 4.5 7.1 SHH "HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS" ENSG00000164690 "Sonic hedgehog" Q15465 7 155799986-155812273 "Disease related genes, Predicted intracellular proteins" "Developmental protein, Hydrolase, Protease" "Disease mutation, Holoprosencephaly, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;liver: 18.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 12.7;Collecting duct cells: 8.7;Hepatocytes: 16.4;Urothelial cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "EFO-21: 6.2;GAMG: 28.0;OE19: 6.8;RT4: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 3600000 "unprognostic (7.17e-2)" "unprognostic (7.68e-3)" "unprognostic (6.70e-2)" "prognostic favorable (8.62e-5)" "unprognostic (1.59e-1)" "unprognostic (2.50e-2)" "unprognostic (2.39e-3)" "unprognostic (1.82e-2)" "unprognostic (1.83e-1)" "unprognostic (2.16e-2)" "unprognostic (3.47e-1)" "unprognostic (1.56e-1)" "unprognostic (1.77e-3)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (3.43e-2)" "unprognostic (2.66e-2)" 0.3 11.9 1.1 1.0 2.4 0.2 0.2 0.6 2.5 6.1 1.7 0.4 4.7 1.9 0.9 9.5 0.3 0.3 27.7 0.2 0.9 3.0 3.8 18.4 2.9 0.1 1.9 0.9 0.2 0.4 0.1 0.4 0.1 5.7 6.0 1.5 0.0 0.2 2.7 0.2 0.4 1.8 5.2 1.7 0.2 13.6 0.3 0.6 0.0 0.2 0.0 0.1 14.1 3.1 0.2 0.8 1.5 0.4 0.4 0.4 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.6 0.0 6.2 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 6.8 2.8 0.0 0.0 0.0 1.4 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.4 0.1 0.2 0.4 0.2 0.2 0.2 0.1 0.2 0.2 0.3 1.5 0.4 0.4 0.8 0.2 0.3 1.1 2.4 0.6 2.5 0.9 3.0 1.9 0.9 5.7 0.6 3.0 5.6 0.0 5.8 0.0 0.4 0.6 12.7 0.0 2.3 8.7 0.0 0.0 0.0 1.3 2.9 0.0 2.5 0.0 0.7 0.1 0.0 0.7 0.0 16.4 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 6.7 0.0 7.4 0.0 0.4 5.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 7.8 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26051031 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 9.6;Basal glandular cells: 8.8;Urothelial cells: 18.2" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 18.9;JURKAT: 13.2;LHCN-M2: 13.2;NTERA-2: 9.6;RH-30: 30.7;U-2197: 19.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: AB_2681041" "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.3 0.0 0.7 0.0 2.0 0.0 12.9 0.0 0.5 1.5 0.0 0.4 0.0 7.9 0.0 0.0 0.3 0.0 2.0 0.6 3.0 0.0 3.7 0.1 1.1 0.0 0.0 0.0 1.7 0.0 0.4 0.0 1.9 0.0 10.2 1.0 0.3 0.0 3.5 0.0 1.6 0.9 20.8 0.3 0.0 0.0 0.8 0.6 2.2 1.1 1.0 5.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.2 2.5 1.0 0.0 0.0 1.2 18.9 0.7 13.2 0.0 0.0 13.2 0.7 1.3 0.3 9.6 5.5 4.8 0.0 30.7 0.1 1.2 4.3 0.3 0.0 0.2 0.0 3.4 2.0 0.4 0.1 1.0 0.0 0.5 19.2 4.2 0.0 0.0 0.0 0.0 0.0 2.6 2.2 0.4 1.7 0.6 0.7 1.0 0.6 1.7 0.7 0.3 0.8 3.9 5.6 1.6 1.0 1.1 0.6 0.7 0.4 0.0 9.6 0.0 8.8 4.7 0.0 0.4 0.0 1.4 0.0 3.5 0.0 0.2 0.0 4.0 1.5 1.2 0.0 0.0 0.2 0.3 0.7 2.4 0.0 0.0 0.6 0.0 0.0 1.8 0.0 0.7 0.0 0.2 1.7 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 1.2 0.3 3.6 1.5 0.1 0.0 0.0 18.2 SHISA3 hShisa3 ENSG00000178343 "Shisa family member 3" A0PJX4 4 42397839-42402487 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 30.0" "Group enriched" "Detected in some" 9 "Distal tubular cells: 36.5;Ito cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 23 "memory B-cell: 2.1;naive B-cell: 2.4" "Lineage enriched" "Detected in single" 25 "B-cells: 2.4" "Group enriched" "Detected in some" 7 "AN3-CA: 70.7;PC-3: 41.0" "Region enriched" "Detected in single" 24 "olfactory region: 63.3" "Low region specificity" "Detected in some" HPA054754 Approved "Lipid droplets,Cytosol" NA NA Cytosol "Lipid droplets" "HPA054754: AB_2682593" "unprognostic (9.04e-3)" "unprognostic (3.47e-3)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.26e-1)" "unprognostic (6.78e-3)" "unprognostic (1.26e-2)" "unprognostic (2.86e-1)" "unprognostic (3.04e-1)" "unprognostic (1.37e-3)" "unprognostic (3.42e-2)" "unprognostic (1.95e-1)" "unprognostic (5.99e-2)" "unprognostic (5.32e-2)" "unprognostic (3.10e-2)" "unprognostic (1.64e-1)" "unprognostic (4.99e-3)" 4.5 2.1 1.0 2.3 3.5 0.1 1.8 0.7 1.3 0.9 5.0 0.1 2.9 2.9 0.3 6.2 8.6 0.4 4.2 12.9 0.9 1.5 30.0 1.0 4.7 15.4 8.3 0.7 1.4 0.3 0.1 0.5 0.2 3.3 2.6 4.1 0.3 1.2 1.5 3.4 0.4 8.4 10.7 1.0 0.6 3.5 2.0 2.2 0.0 4.6 2.6 1.1 6.8 4.7 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 3.1 0.0 41.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 3.5 0.7 1.3 0.9 1.5 8.3 0.7 3.3 2.2 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 36.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 23.9 0.8 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SHISA4 "C1orf40, hShisa4, TMEM58" ENSG00000198892 "Shisa family member 4" Q96DD7 1 201888680-201892306 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 175.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8" "Group enriched" "Detected in many" 9 "granulocytes: 18.3;monocytes: 7.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061273, HPA067885" Uncertain NA NA "HPA061273: AB_2684460, HPA067885: " "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (1.48e-3)" "unprognostic (2.12e-3)" "unprognostic (6.59e-2)" "unprognostic (8.29e-3)" "unprognostic (7.06e-2)" "unprognostic (5.00e-2)" "unprognostic (2.32e-1)" "unprognostic (1.44e-1)" "unprognostic (8.29e-2)" "unprognostic (2.32e-2)" "unprognostic (1.63e-3)" "unprognostic (1.20e-1)" "unprognostic (1.82e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-1)" 5.2 15.8 22.2 3.8 18.8 2.5 3.3 9.6 34.8 4.7 3.3 29.1 2.1 2.7 4.4 4.5 4.0 3.9 4.7 14.7 17.5 14.6 4.1 3.8 4.0 2.7 19.2 14.8 6.8 4.1 4.1 3.8 3.8 21.3 6.2 2.9 7.2 12.1 5.1 175.2 4.2 3.2 4.7 14.0 3.4 3.2 4.2 8.2 0.0 6.3 18.8 2.7 3.9 2.6 0.0 0.7 18.3 7.8 0.0 1.5 0.5 1.1 8.8 1.0 6.3 9.5 5.7 0.9 7.7 12.6 3.2 4.5 1.5 2.3 0.0 10.5 9.5 12.6 2.2 0.1 1.3 2.1 0.9 0.5 0.1 2.6 1.0 6.7 0.0 5.6 5.8 2.8 4.1 2.0 16.6 5.8 0.1 0.0 0.3 5.6 1.0 0.0 0.0 0.6 0.6 10.7 0.1 0.0 1.7 3.1 3.4 0.4 5.7 2.7 1.3 7.8 5.3 3.6 0.7 5.9 4.6 4.5 2.5 3.9 1.5 1.2 0.0 7.4 0.0 7.9 0.0 1.4 18.3 1.5 6.4 0.6 0.0 0.3 0.3 0.7 0.0 0.0 0.3 8.2 0.0 7.8 0.0 0.0 0.5 22.2 18.8 9.6 34.8 17.5 14.6 19.2 14.8 21.3 8.2 0.0 1.7 0.0 3.6 12.6 9.2 18.3 7.6 0.0 2.3 10.4 3.9 1.5 28.2 22.4 0.5 7.4 0.0 0.0 13.5 19.0 16.6 9.5 1.1 3.4 2.9 4.8 1.7 11.6 2.9 1.5 14.7 4.2 21.9 6.4 0.0 19.3 10.6 0.0 27.6 5.0 3.4 19.4 13.3 1.4 0.7 5.9 2.3 2.2 0.0 1.8 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Group enriched" "Detected in some" 4 "Late spermatids: 9.9;Peritubular cells: 27.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 34.1" "Low region specificity" "Detected in many" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 0.0 0.0 0.0 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 9.9 4.6 0.0 1.7 0.0 0.0 0.4 0.0 0.0 27.3 0.0 0.1 0.0 0.1 0.5 1.9 0.1 0.0 0.0 0.0 0.1 SHISA7 ENSG00000187902 "Shisa family member 7" A6NL88 19 55428740-55442863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 24.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.8;Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 9 "glioma: 2.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 6.7;HMC-1: 7.0;THP-1: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA058935 Uncertain Approved Cytosol NA NA Cytosol "HPA058935: AB_2683857" "unprognostic (3.98e-2)" "unprognostic (5.81e-2)" "unprognostic (1.16e-1)" "unprognostic (1.28e-1)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.08e-1)" "unprognostic (4.40e-1)" "unprognostic (7.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.22e-2)" "unprognostic (6.87e-7)" "unprognostic (7.53e-3)" "unprognostic (2.82e-1)" "unprognostic (3.29e-4)" "unprognostic (4.04e-1)" 0.7 1.7 11.3 0.7 16.7 2.6 0.7 4.0 24.9 0.7 0.8 7.2 0.0 0.7 0.7 0.7 0.7 0.7 0.7 0.7 11.2 8.2 0.7 0.7 0.7 0.7 8.3 3.1 0.7 0.8 0.7 2.4 0.7 5.5 0.7 0.8 0.0 0.7 0.7 0.7 0.8 0.8 0.7 4.0 0.7 0.8 2.2 14.6 0.0 0.7 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 6.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 1.2 0.6 0.0 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 16.7 4.0 10.9 11.2 8.2 8.3 3.1 5.5 14.6 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 SHISA8 "C22orf17, Orf26" ENSG00000234965 "Shisa family member 8" B8ZZ34 22 41909554-41914667 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 42.2" "Cell type enriched" "Detected in some" 114 "Horizontal cells: 451.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 15 "cerebellum: 42.2" "Cell type enhanced" "Detected in single" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 17 "B-cells: 1.7" "Cell line enriched" "Detected in some" 7 "HEK 293: 20.9" "Group enriched" "Detected in some" 5 "cerebellum: 8.7;olfactory region: 19.4" "Group enriched" "Detected in all" 4 "cerebellum: 61.4;olfactory region: 45.2" HPA059173 Uncertain NA NA "HPA059173: AB_2683938" "unprognostic (8.76e-2)" "unprognostic (2.98e-4)" "unprognostic (1.03e-1)" "prognostic favorable (2.76e-4)" "unprognostic (4.42e-2)" "unprognostic (1.45e-3)" "unprognostic (4.40e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.45e-3)" "unprognostic (2.16e-1)" "unprognostic (1.12e-1)" "unprognostic (8.59e-2)" "unprognostic (2.60e-2)" "unprognostic (6.22e-4)" "unprognostic (7.84e-2)" 0.1 9.4 0.5 1.6 0.5 0.2 0.1 42.2 2.7 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.3 0.3 0.5 0.2 0.2 0.1 0.1 3.0 0.3 1.7 0.1 0.1 0.1 0.8 0.0 2.2 0.2 0.0 1.5 1.8 0.2 0.8 0.5 0.8 0.0 0.3 2.7 0.7 0.2 0.0 0.0 0.1 0.0 3.8 0.4 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 20.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 42.2 2.7 0.5 0.2 0.3 1.7 2.2 0.0 0.0 0.0 2.7 0.0 0.0 4.0 3.6 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 451.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.0 0.0 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901620-13240413 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.5" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.3;Ciliated cells: 21.4;Club cells: 12.5;granulocytes: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "EFO-21: 29.8;LHCN-M2: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072399 Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA072399: AB_2686517" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 1.2 4.8 17.2 1.6 23.5 2.7 1.3 0.9 21.3 0.9 3.4 3.6 0.4 1.6 1.1 2.3 1.2 0.7 0.9 1.3 10.2 6.7 3.4 1.4 0.7 1.0 3.3 12.6 1.1 1.3 0.6 1.9 1.0 10.2 6.9 1.8 0.6 1.7 1.4 4.2 1.9 1.7 1.2 2.1 1.0 1.3 1.6 4.0 0.0 3.5 0.0 0.8 0.8 0.9 2.0 1.2 3.9 0.9 1.2 0.9 0.0 0.6 0.3 0.5 0.5 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.3 0.5 0.5 29.8 0.1 0.6 0.5 0.1 0.1 0.1 0.5 0.2 0.7 0.6 0.3 0.0 0.5 0.8 0.9 0.0 0.1 2.1 0.3 0.1 0.5 0.4 1.2 24.2 3.3 0.4 0.7 6.4 0.5 0.3 0.6 0.4 0.3 6.6 1.1 6.4 0.5 0.3 1.0 0.4 3.1 0.8 0.4 0.4 0.6 3.9 0.6 0.4 1.2 1.2 0.6 0.4 0.2 0.8 3.9 0.9 0.4 0.8 0.5 0.6 1.1 0.7 0.8 0.3 2.0 0.9 0.8 3.2 1.2 0.7 1.2 0.7 0.0 17.2 23.5 0.9 18.8 10.2 6.7 3.3 12.6 10.2 4.0 23.8 15.3 0.0 0.5 0.1 0.6 0.8 0.0 21.4 12.5 1.8 0.0 0.0 1.7 0.7 3.8 0.3 0.0 0.0 0.0 0.0 0.2 1.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.2 0.0 0.0 0.0 0.5 0.1 2.9 0.0 0.9 0.3 0.0 0.0 0.2 0.9 0.1 0.1 0.0 0.3 0.5 SHISAL1 KIAA1644 ENSG00000138944 "Shisa like 1" Q3SXP7 22 44243667-44312851 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SiHa: 17.0;U-2197: 38.7;U-87 MG: 22.5;WM-115: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051178 Uncertain Approved Vesicles,Cytosol No No "Vesicles, Cytosol" "HPA051178: AB_2681374" "unprognostic (4.07e-3)" "unprognostic (9.01e-2)" "unprognostic (1.83e-1)" "unprognostic (1.14e-1)" "unprognostic (6.54e-2)" "unprognostic (1.22e-1)" "unprognostic (7.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.10e-3)" "unprognostic (1.93e-3)" "unprognostic (1.33e-1)" "unprognostic (1.99e-1)" "unprognostic (1.51e-7)" "unprognostic (1.48e-2)" "unprognostic (2.41e-1)" "unprognostic (1.99e-4)" "unprognostic (1.10e-4)" 0.7 1.3 13.8 1.3 3.6 0.0 0.5 1.6 13.0 22.5 7.7 0.5 6.9 1.4 34.2 4.5 1.5 1.9 2.3 0.5 5.4 9.1 0.5 0.5 0.6 0.5 3.6 0.5 1.7 0.6 0.1 0.8 5.7 0.5 5.8 1.5 0.5 0.5 8.9 0.5 0.4 0.8 31.9 0.5 0.5 0.5 1.5 0.5 0.5 0.5 0.5 0.5 11.9 3.3 0.0 0.1 0.7 0.0 0.2 0.1 0.0 0.0 0.1 1.7 0.6 0.0 0.0 0.0 0.4 1.1 1.1 0.6 0.0 0.0 0.0 0.0 1.0 7.0 0.0 2.3 0.1 0.1 0.0 1.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.9 5.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.2 0.0 17.0 0.0 0.1 0.2 0.0 0.1 0.0 6.4 1.0 38.7 0.2 0.0 0.0 0.0 22.5 0.0 12.9 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.0 0.0 13.8 3.6 1.6 11.8 5.4 9.1 3.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHISAL2A "FAM159A, MGC52498" ENSG00000182183 "Shisa like 2A" Q6UWV7 1 52633344-52669683 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 10.8;lymphoid tissue: 25.4" "Cell type enhanced" "Detected in single" 26 "Hofbauer cells: 1.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hypothalamus: 8.8" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9" "Cell line enhanced" "Detected in some" "Daudi: 5.4;Karpas-707: 13.0;NB-4: 3.7;RPMI-8226: 17.1" "Region enhanced" "Detected in single" "hypothalamus: 4.7" "Low region specificity" "Detected in many" HPA030744 Uncertain NA NA "HPA030744: AB_10963060" "unprognostic (7.94e-6)" "unprognostic (8.50e-3)" "unprognostic (8.29e-3)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (9.67e-4)" "unprognostic (1.98e-1)" "unprognostic (1.18e-2)" "unprognostic (2.22e-2)" "unprognostic (4.45e-2)" "unprognostic (2.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-3)" "unprognostic (7.27e-2)" "unprognostic (2.79e-1)" "unprognostic (6.50e-2)" "unprognostic (2.64e-2)" 0.6 0.4 1.0 25.4 1.4 3.5 0.5 1.3 2.0 1.3 1.2 1.2 0.0 1.0 1.1 1.9 1.0 0.9 1.3 0.3 0.9 8.8 0.8 0.4 1.2 20.4 2.8 0.2 0.2 0.7 0.0 3.2 0.5 1.2 0.7 0.9 0.6 3.7 1.0 0.7 0.2 5.7 0.6 2.1 12.1 1.2 1.2 0.7 3.5 1.3 0.3 24.0 3.2 0.4 10.8 0.1 1.9 0.0 5.7 7.9 1.8 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 3.7 2.2 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.5 0.0 1.1 0.0 0.0 0.4 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 7.9 0.0 4.5 10.7 7.2 6.4 0.1 10.8 5.0 3.1 0.0 5.7 0.0 0.1 2.2 1.8 1.0 1.4 1.3 2.0 0.9 8.8 2.8 0.2 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SHISAL2B FAM159B ENSG00000145642 "Shisa like 2B" A6NKW6 5 64690308-64718090 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 7.3;pancreas: 16.1;stomach 1: 7.7" "Cell type enriched" "Detected in single" 16 "Pancreatic endocrine cells: 1.6" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 3.9" "Group enriched" "Detected in some" 14 "basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "NTERA-2: 5.9;RPTEC TERT1: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA011778 Enhanced NA NA "HPA011778: AB_1848382" "unprognostic (5.83e-2)" "unprognostic (9.32e-2)" "unprognostic (1.40e-1)" "unprognostic (1.84e-2)" "unprognostic (3.25e-1)" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.97e-1)" "unprognostic (4.84e-2)" "unprognostic (5.36e-5)" "unprognostic (1.44e-1)" "unprognostic (1.98e-1)" "unprognostic (5.60e-1)" "unprognostic (6.99e-2)" 0.1 0.0 0.3 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.2 0.0 0.2 0.0 0.2 0.0 0.2 16.1 0.0 0.1 0.5 4.9 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.7 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 12.4 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.2 0.3 7.3 0.2 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SHKBP1 "PP203, Sb1" ENSG00000160410 "SH3KBP1 binding protein 1" Q8TBC3 19 40576851-40591399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041887 Uncertain Approved "Cell Junctions" NA NA "Cell Junctions" "HPA041887: AB_10794639" "unprognostic (1.26e-1)" "unprognostic (7.55e-2)" "unprognostic (1.38e-1)" "unprognostic (4.52e-2)" "unprognostic (8.24e-2)" "unprognostic (9.14e-2)" "unprognostic (1.66e-3)" "unprognostic (3.53e-2)" "unprognostic (6.98e-2)" "unprognostic (6.69e-3)" "unprognostic (1.42e-1)" "unprognostic (6.87e-2)" "unprognostic (5.29e-2)" "unprognostic (6.15e-2)" "unprognostic (2.67e-1)" "unprognostic (1.65e-1)" "unprognostic (8.64e-2)" 12.1 13.0 9.8 25.4 15.2 40.1 19.5 2.7 11.3 12.1 10.7 11.7 9.0 12.7 14.1 12.1 17.8 13.4 12.2 10.7 7.5 5.2 16.5 14.7 20.0 53.5 17.8 5.9 11.4 14.6 9.9 9.2 11.7 11.0 13.6 7.4 9.0 12.7 10.3 5.8 12.1 17.0 11.8 11.1 51.8 15.2 7.5 15.1 33.9 14.0 11.1 25.3 14.4 13.5 14.9 28.4 81.8 40.7 12.2 19.3 30.6 23.1 36.0 7.2 10.2 6.3 7.1 13.7 9.1 13.6 14.2 19.6 15.7 16.0 24.5 18.0 14.2 12.1 10.2 9.3 17.2 6.7 37.7 22.2 17.8 9.8 10.5 13.7 16.6 51.0 11.6 12.5 13.0 8.2 10.4 20.6 28.0 9.9 20.6 10.8 20.4 17.0 23.4 5.2 21.0 13.4 30.7 9.4 18.3 11.7 19.1 6.0 14.0 13.9 7.7 8.1 7.3 12.1 27.5 15.5 14.3 18.9 22.3 17.9 19.4 9.2 16.5 23.0 19.6 12.7 35.8 37.1 37.0 14.3 36.0 11.6 14.9 13.8 14.6 28.4 13.1 8.2 9.4 81.8 12.2 40.7 8.5 19.3 30.6 9.8 15.2 2.7 11.3 7.5 5.2 17.8 5.9 11.0 15.1 11.9 24.0 64.1 17.4 7.6 2.2 3.5 2.5 8.1 14.8 27.9 5.9 20.8 24.9 36.5 7.3 22.4 28.0 0.0 34.0 44.6 14.1 13.1 51.8 11.3 69.2 3.2 21.9 22.7 78.8 12.5 13.6 55.0 21.9 80.2 16.2 6.0 31.1 31.6 11.7 23.2 1.5 0.0 12.3 1.8 18.8 8.5 24.7 51.1 18.9 18.8 SHMT1 "CSHMT, MGC15229, MGC24556, SHMT" ENSG00000176974 "Serine hydroxymethyltransferase 1" P34896 17 18327860-18363563 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 57.8;liver: 108.3" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 213.8;Proximal tubular cells: 332.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023314, HPA078682" Enhanced Supported Nucleoplasm,Cytosol NA NA 240000 Cytosol Nucleoplasm "HPA023314: AB_1856830, HPA078682: " "unprognostic (4.76e-2)" "unprognostic (1.98e-2)" "unprognostic (5.46e-2)" "unprognostic (3.76e-1)" "unprognostic (2.45e-1)" "unprognostic (8.44e-3)" "prognostic favorable (2.52e-4)" "unprognostic (7.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.42e-1)" "unprognostic (2.14e-1)" "unprognostic (1.70e-1)" "prognostic favorable (8.54e-6)" "unprognostic (1.70e-2)" "unprognostic (2.66e-1)" "unprognostic (2.57e-3)" "unprognostic (4.04e-2)" 10.9 3.2 2.2 4.9 4.1 2.1 10.4 6.5 3.0 4.6 15.2 5.3 7.3 12.3 2.8 7.4 16.3 3.9 4.0 2.0 2.6 1.8 57.8 108.3 4.3 3.8 3.5 1.9 4.1 3.5 30.1 1.6 2.8 3.6 3.4 3.5 7.2 9.8 8.0 5.7 6.2 15.1 2.3 2.9 8.6 3.9 6.3 3.8 11.1 10.9 10.8 8.7 4.3 6.3 8.6 6.7 6.2 10.6 13.0 18.7 7.9 22.6 23.0 7.3 11.4 18.6 11.6 27.0 4.8 5.9 16.1 17.8 22.8 10.1 17.6 14.3 4.1 11.7 22.4 15.2 19.3 9.2 10.5 22.2 7.9 18.0 17.2 4.7 5.2 8.6 9.7 7.6 12.5 5.6 6.5 11.0 22.7 6.6 4.0 5.7 16.7 26.1 7.3 9.1 34.5 7.5 21.4 28.9 14.9 25.6 15.4 10.0 5.3 32.6 6.2 8.2 38.7 25.4 7.5 2.6 3.1 9.3 28.4 15.1 8.2 7.8 7.1 6.1 12.4 7.4 6.0 8.2 6.2 10.1 10.6 17.1 8.6 12.3 12.8 6.7 6.9 12.3 13.0 0.1 13.0 7.5 3.1 18.7 7.9 2.2 4.1 6.5 3.0 2.6 1.8 3.5 1.9 3.6 3.8 11.9 26.5 19.1 16.8 9.2 2.8 2.2 25.5 2.7 9.1 34.9 3.9 17.7 69.6 11.6 4.9 4.3 8.4 0.0 7.0 62.1 4.8 6.6 8.1 213.8 31.1 0.0 1.2 10.4 27.9 4.1 5.5 5.0 11.8 5.4 10.3 31.2 5.1 7.0 2.8 332.8 3.9 19.4 3.8 15.6 21.8 9.3 7.1 10.0 29.5 4.8 SHMT2 SHMT ENSG00000182199 "Serine hydroxymethyltransferase 2" P34897 12 57229327-57234935 "Enzymes, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 103.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 158.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 212.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020543, HPA020549" Enhanced Supported Microtubules,Mitochondria NA NA 160000 Mitochondria Microtubules "HPA020543: AB_1856833, HPA020549: AB_1856834" "prognostic unfavorable (8.37e-5)" "unprognostic (1.24e-1)" "unprognostic (1.90e-1)" "unprognostic (2.65e-2)" "unprognostic (1.65e-1)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (9.83e-2)" "unprognostic (1.11e-2)" "unprognostic (2.67e-2)" "unprognostic (4.00e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.84e-8)" "unprognostic (3.05e-1)" "unprognostic (2.30e-1)" "unprognostic (2.72e-1)" "unprognostic (4.74e-2)" 13.0 13.5 5.9 15.0 7.1 12.6 9.5 9.6 9.5 10.5 11.5 6.1 5.0 13.4 10.2 8.5 22.1 8.6 10.3 11.0 6.5 5.4 15.5 103.1 11.8 18.7 8.7 4.6 17.9 38.9 4.5 8.1 16.8 6.5 10.3 9.4 7.1 44.6 5.7 16.5 13.7 11.5 9.9 7.6 23.5 13.4 5.4 6.3 26.1 13.2 19.0 25.6 11.2 13.8 33.6 14.5 6.5 11.7 9.7 48.7 12.3 25.1 11.7 11.8 31.2 9.3 14.3 23.4 13.6 22.2 18.3 16.8 16.7 12.2 46.6 22.6 16.8 7.6 16.1 21.3 22.2 9.9 26.0 19.0 19.2 7.2 11.8 68.7 31.7 17.0 18.3 32.2 14.7 49.2 16.6 18.1 24.8 20.0 44.3 13.8 16.5 25.2 17.4 10.1 10.1 19.0 17.0 212.4 43.1 9.1 11.6 25.3 12.1 7.1 16.8 49.3 4.5 22.8 39.0 11.4 7.4 15.1 9.6 18.5 59.5 32.5 39.5 16.0 29.6 13.3 6.5 9.8 5.9 6.9 11.7 8.0 33.6 12.1 7.4 14.5 32.4 5.3 5.4 0.5 9.7 7.5 4.8 48.7 12.3 5.9 7.1 9.6 9.5 6.5 5.4 8.7 4.6 6.5 6.3 8.9 13.1 58.9 19.1 30.8 6.2 7.5 20.4 9.4 12.5 3.5 0.0 53.0 11.6 41.7 0.4 13.5 11.0 46.7 41.3 42.8 21.6 14.9 28.8 158.5 43.3 7.9 9.2 20.3 38.1 0.2 16.7 22.7 37.1 27.1 21.6 42.4 40.1 21.0 15.2 48.7 4.9 6.5 22.6 2.1 7.2 28.4 31.2 26.2 37.7 17.6 SHOX "GCFX, PHOG, SHOXY, SS" ENSG00000185960 "Short stature homeobox" O15266 X 624344-659411 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.3;breast: 13.9" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 1.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 6.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "BJ: 19.5;BJ hTERT+: 9.0" "HPA035141, HPA060931" Enhanced Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA035141: AB_2674489, HPA060931: AB_2684388" "unprognostic (7.51e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-1)" "unprognostic (6.82e-2)" "unprognostic (2.45e-2)" "unprognostic (2.34e-1)" "unprognostic (9.24e-2)" "unprognostic (9.95e-2)" "unprognostic (5.67e-6)" "unprognostic (1.99e-1)" "unprognostic (1.71e-1)" "unprognostic (9.14e-2)" "unprognostic (1.38e-1)" 3.8 1.0 0.3 0.7 0.3 3.0 13.9 1.8 0.8 0.3 0.4 0.2 0.2 1.4 0.3 0.6 0.3 0.4 0.4 0.4 0.7 0.3 0.3 0.3 0.3 0.6 0.3 1.4 0.3 0.9 0.0 0.3 4.8 6.3 0.8 0.3 0.2 1.4 0.2 2.8 1.4 1.0 0.2 0.4 1.6 0.4 0.4 0.2 0.2 0.5 0.2 0.2 0.3 0.3 2.2 1.9 5.5 1.8 2.5 1.5 0.8 0.1 0.2 0.1 0.2 0.2 0.1 3.2 19.5 9.0 2.9 3.2 0.3 0.3 0.3 0.1 0.4 0.8 0.3 0.2 0.0 1.0 0.2 0.1 0.1 1.3 0.1 0.1 0.1 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.8 0.1 0.2 0.1 0.2 0.1 0.0 0.4 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.6 0.0 0.1 0.3 0.2 0.1 0.1 0.9 0.1 0.3 0.1 0.2 0.1 5.5 1.8 1.8 1.4 1.1 1.5 1.6 1.1 1.2 0.5 2.2 1.5 1.5 5.2 2.5 1.5 1.9 1.0 0.8 0.3 0.3 1.8 0.4 0.7 0.3 0.3 1.4 6.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 SHROOM1 "APXL2, KIAA1960" ENSG00000164403 "Shroom family member 1" Q2M3G4 5 132822141-132830898 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7;urinary bladder: 37.8" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 81.2;Hepatocytes: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 3.7" "Lineage enriched" "Detected in single" 5 "monocytes: 3.7" "Cell line enhanced" "Detected in many" "RT4: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037690, HPA037691" Uncertain Approved Vesicles NA NA Vesicles "HPA037690: AB_2675613, HPA037691: AB_2675614" "unprognostic (2.50e-1)" "unprognostic (1.06e-1)" "unprognostic (4.52e-2)" "unprognostic (2.66e-1)" "unprognostic (1.45e-2)" "unprognostic (3.47e-1)" "unprognostic (9.26e-2)" "unprognostic (1.33e-2)" "unprognostic (3.74e-1)" "unprognostic (3.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.72e-6)" "unprognostic (8.22e-2)" "unprognostic (2.91e-2)" "unprognostic (2.88e-2)" "unprognostic (2.26e-3)" 5.5 2.4 8.2 2.9 13.5 0.7 3.5 8.3 9.6 4.2 12.0 26.3 23.8 6.5 6.4 2.7 2.2 3.8 7.2 2.4 9.5 5.3 3.2 42.7 4.6 1.0 23.8 7.9 2.6 6.7 7.6 3.1 12.4 12.3 35.9 11.9 8.8 6.3 17.0 1.8 1.5 10.0 4.9 13.8 1.3 10.5 1.3 20.5 0.0 3.0 0.6 1.0 37.8 11.6 0.1 0.2 0.7 3.7 0.3 0.1 0.6 6.8 4.2 0.7 0.6 1.2 3.5 7.5 7.0 6.4 5.9 6.6 9.0 4.7 1.2 10.1 4.0 3.1 0.7 2.5 4.7 3.6 7.0 8.0 0.2 6.5 8.2 3.6 0.5 2.5 1.5 2.5 4.1 2.6 4.1 3.9 0.1 5.5 6.7 5.0 3.6 0.2 3.1 1.1 5.4 5.8 0.4 0.0 0.6 1.0 19.6 4.8 1.2 6.9 0.6 3.8 4.0 4.2 2.4 3.7 6.8 9.2 1.0 9.0 7.3 5.1 0.1 6.7 0.0 2.1 0.5 3.7 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.6 8.2 13.5 8.3 9.6 9.5 5.3 23.8 7.9 12.3 20.5 23.8 27.8 1.5 12.6 1.1 2.3 2.0 33.1 12.0 17.0 8.7 9.8 4.7 1.7 5.9 0.6 9.3 81.2 0.0 9.3 3.9 4.2 47.7 8.1 58.6 5.7 15.9 21.9 12.9 10.5 0.9 4.4 4.0 0.0 0.0 27.1 20.3 6.7 35.1 4.6 2.1 12.0 25.8 3.6 8.4 4.1 1.8 2.4 2.2 27.4 13.9 SHROOM3 "APXL3, KIAA1481, SHRM, ShrmL" ENSG00000138771 "Shroom family member 3" Q8TF72 4 76435100-76783253 "Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 47.0" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 105.8;Paneth cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 19.2;AF22: 18.8;BJ hTERT+: 18.0;EFO-21: 19.9;OE19: 19.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047784 Enhanced NA NA "HPA047784: AB_2680155" "unprognostic (1.96e-1)" "unprognostic (2.50e-1)" "unprognostic (1.57e-2)" "unprognostic (5.33e-2)" "unprognostic (1.61e-2)" "unprognostic (3.33e-2)" "unprognostic (7.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.92e-1)" "unprognostic (2.90e-1)" "unprognostic (1.45e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.64e-13)" "unprognostic (2.87e-2)" "unprognostic (2.25e-1)" "unprognostic (9.06e-2)" "unprognostic (1.87e-2)" 1.0 1.5 3.3 3.0 4.5 0.0 9.0 7.4 6.4 3.9 11.3 2.3 4.9 8.5 2.5 21.2 18.2 9.1 16.7 2.6 5.6 1.1 5.9 6.2 6.3 0.3 5.5 2.5 0.8 4.6 11.1 4.4 2.1 6.8 6.3 10.0 9.4 47.0 4.7 0.3 3.0 12.1 5.3 6.6 6.8 12.7 0.6 1.2 0.6 2.8 14.6 14.8 4.7 2.4 0.2 0.1 1.0 0.0 0.1 0.1 0.0 19.2 3.8 18.8 12.3 0.0 0.3 0.7 6.0 18.0 0.4 0.8 3.2 12.8 0.3 19.9 16.6 1.5 9.8 2.4 8.6 0.3 0.0 3.3 0.0 3.7 0.0 0.1 0.0 0.0 0.1 2.1 0.6 3.3 4.8 0.3 0.1 0.0 4.7 0.4 1.7 0.3 0.0 7.9 19.2 2.3 1.6 3.1 3.0 2.9 0.4 7.4 9.8 2.5 13.8 1.0 12.0 3.3 0.0 0.0 3.2 2.8 0.1 2.6 5.9 6.1 0.0 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.1 0.0 0.1 0.0 0.0 3.3 4.5 7.4 6.4 5.6 1.1 5.5 2.5 6.8 1.2 83.4 41.9 1.4 4.5 0.8 16.4 9.5 86.6 46.8 46.6 33.2 70.7 0.3 0.0 28.7 4.8 0.3 105.8 0.0 31.2 0.2 6.1 44.1 0.0 34.7 0.2 1.6 83.4 1.3 1.6 3.3 0.3 0.1 3.3 2.8 82.5 9.5 55.3 101.7 0.0 4.5 32.0 0.0 4.2 3.4 2.2 0.3 0.1 0.0 59.4 4.9 SHROOM4 KIAA1202 ENSG00000158352 "Shroom family member 4" Q9ULL8 X 50591647-50814302 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.3" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.2;Endothelial cells: 36.5;Ito cells: 31.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "EFO-21: 6.1;HUVEC TERT2: 23.3;RH-30: 4.5;RPTEC TERT1: 5.0;TIME: 8.7;WM-115: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010089, HPA010565" Uncertain Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA "Focal adhesion sites" "Nucleoplasm, Vesicles" "HPA010089: , HPA010565: AB_1079961" "unprognostic (2.55e-2)" "unprognostic (1.43e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (8.37e-4)" "unprognostic (1.34e-1)" "unprognostic (1.60e-2)" "unprognostic (4.30e-3)" "unprognostic (4.55e-2)" "unprognostic (2.13e-1)" "unprognostic (2.93e-1)" "unprognostic (1.52e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (7.30e-2)" "unprognostic (2.83e-1)" "unprognostic (1.74e-2)" "unprognostic (2.75e-1)" 13.1 3.5 5.9 3.6 12.1 2.4 10.1 1.9 7.7 6.4 2.9 27.3 1.6 2.4 6.8 3.6 5.2 4.3 5.7 8.5 8.3 4.8 9.7 1.9 21.4 1.9 15.9 6.5 2.5 1.9 3.6 3.7 15.3 13.0 3.6 3.0 4.8 3.5 3.7 6.0 3.2 2.6 7.4 19.7 2.1 2.4 1.5 15.8 0.0 6.3 6.7 2.1 4.8 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.1 0.0 6.1 0.8 0.0 0.6 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.5 0.0 5.0 2.2 0.1 0.0 0.0 0.8 1.3 3.3 0.0 0.1 8.7 0.0 0.0 0.0 0.6 0.4 0.0 0.0 1.2 0.2 4.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 12.1 1.9 7.7 8.3 4.8 15.9 6.5 13.0 15.8 23.8 15.2 0.0 1.7 3.2 0.1 2.5 0.0 2.7 2.3 5.2 0.0 0.4 3.3 0.6 0.0 36.5 0.3 0.0 0.2 2.3 1.9 0.8 3.5 1.0 0.5 0.0 2.9 31.3 3.8 0.0 1.1 1.5 0.0 0.0 2.3 2.8 1.3 0.0 1.1 2.6 0.3 0.0 1.4 0.0 0.9 2.8 0.2 0.0 2.6 1.4 SHTN1 "KIAA1598, shootin-1, shootin1" ENSG00000187164 "Shootin 1" A0MZ66 10 116881482-117126586 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 31 "classical monocyte: 14.0;intermediate monocyte: 8.8;myeloid DC: 13.2;non-classical monocyte: 4.0;plasmacytoid DC: 8.9" "Group enriched" "Detected in many" 43 "dendritic cells: 13.2;monocytes: 14.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037942, HPA037943" Enhanced Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA037942: AB_2675748, HPA037943: AB_10671637" "unprognostic (1.00e-1)" "unprognostic (2.50e-2)" "unprognostic (6.77e-3)" "unprognostic (2.81e-1)" "unprognostic (7.85e-2)" "unprognostic (1.61e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.56e-1)" "unprognostic (1.35e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.08e-6)" 3.5 6.5 51.5 6.8 50.1 1.6 8.7 9.8 34.1 5.5 7.0 42.3 0.3 6.7 4.4 8.4 5.4 5.2 6.5 2.6 58.9 37.0 7.8 12.1 9.8 4.5 67.8 22.7 6.8 10.9 18.6 20.4 5.4 36.3 7.3 8.6 2.0 9.9 3.0 0.9 9.6 7.8 3.8 67.4 7.0 9.0 9.9 54.5 0.4 11.9 1.4 4.1 4.0 2.4 0.0 13.2 0.3 14.0 0.0 0.2 3.5 15.8 8.9 0.9 1.9 0.0 0.0 8.9 1.3 3.5 2.7 5.2 10.0 10.5 0.0 2.7 4.9 8.1 8.2 7.1 6.0 2.8 0.0 7.4 0.0 9.4 6.2 1.2 2.8 2.5 0.4 5.3 2.7 5.2 7.2 6.6 4.3 4.3 0.0 1.9 6.3 0.0 0.1 3.4 3.0 6.0 0.0 12.0 3.5 7.4 2.2 9.9 3.9 10.7 15.6 9.7 10.9 12.5 2.5 11.3 0.9 6.7 0.0 7.8 1.7 0.0 0.0 4.9 0.0 4.9 0.0 14.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.3 0.0 4.0 8.9 0.2 3.5 51.5 50.1 9.8 30.2 58.9 37.0 67.8 22.7 36.3 54.5 71.5 33.1 2.4 13.5 0.0 78.9 3.4 28.1 33.5 43.3 22.7 58.9 35.1 18.3 40.5 5.8 1.3 14.6 0.0 45.7 25.7 3.1 31.7 2.3 42.7 35.4 46.1 16.4 3.1 79.2 9.0 10.3 62.9 0.0 91.0 20.8 13.1 41.7 50.9 4.9 44.5 55.6 12.9 3.5 17.4 41.4 0.0 16.7 0.0 17.7 11.9 SI ENSG00000090402 Sucrase-isomaltase P14410 3 164978898-165078495 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 123 "intestine: 181.4" "Group enriched" "Detected in some" 7 "Enterocytes: 48.7;Mucus-secreting cells: 79.9;Paneth cells: 46.3;Undifferentiated cells: 29.8" "Cancer enhanced" "Detected in some" "stomach cancer: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 4.1;HeLa: 3.2;NB-4: 3.4;RPMI-8226: 4.9;SH-SY5Y: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011897 Enhanced NA NA "HPA011897: AB_1856840" "unprognostic (2.71e-2)" "unprognostic (1.62e-2)" "unprognostic (2.68e-1)" "unprognostic (2.05e-1)" "unprognostic (4.41e-2)" 0.1 0.1 0.1 1.4 0.1 0.0 0.1 0.1 0.1 0.1 93.3 0.0 0.0 94.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 5.4 0.0 0.1 0.0 0.1 0.1 181.4 0.0 0.1 0.1 0.1 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 3.8 0.0 0.0 0.0 0.0 79.9 0.0 0.0 46.3 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 29.8 0.0 SIAH1 hSIAH1 ENSG00000196470 "Siah E3 ubiquitin protein ligase 1" Q8IUQ4 16 48356364-48448402 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 102.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018724 Enhanced Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB018724: AB_2188865" "unprognostic (7.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-3)" "unprognostic (1.25e-2)" "unprognostic (7.93e-3)" "unprognostic (1.12e-2)" "unprognostic (9.22e-3)" "unprognostic (3.26e-1)" "unprognostic (8.02e-2)" "unprognostic (7.84e-3)" "unprognostic (7.67e-3)" "unprognostic (4.38e-2)" "unprognostic (4.00e-1)" "unprognostic (9.55e-2)" "unprognostic (1.26e-2)" 20.6 11.4 11.9 11.0 13.5 19.2 25.5 15.5 16.6 14.6 13.1 15.0 6.5 12.8 16.8 13.4 12.7 12.9 12.9 11.4 12.6 11.6 12.1 17.5 13.9 10.0 12.8 11.6 16.7 11.4 13.1 9.1 102.6 14.1 14.2 12.2 32.1 13.2 12.1 17.0 16.6 16.0 18.6 12.7 11.3 12.5 17.9 13.0 17.5 14.5 9.3 11.5 15.9 14.8 12.6 8.3 21.9 5.2 5.3 6.1 3.5 8.6 7.8 16.9 15.1 14.6 12.8 17.3 8.1 11.0 12.1 5.9 5.9 11.3 11.2 9.0 10.2 8.4 10.1 11.6 11.8 14.9 4.5 9.4 6.0 6.1 15.4 20.4 5.9 9.3 15.3 21.3 7.0 16.4 13.5 10.1 10.5 9.7 10.7 9.8 5.9 15.9 12.1 20.6 9.6 12.1 18.6 25.4 11.8 11.2 10.9 19.3 17.1 24.0 12.0 20.7 15.2 7.6 13.7 10.7 12.9 11.7 7.0 8.6 14.0 5.8 20.6 9.6 7.4 11.6 6.9 5.2 21.9 2.7 2.2 3.0 12.6 3.0 4.2 8.3 12.1 6.1 4.5 2.9 5.3 1.3 7.9 1.6 3.5 11.9 13.5 15.5 16.6 12.6 11.6 12.8 11.6 14.1 13.0 11.9 11.9 16.4 51.3 76.1 18.3 12.0 10.2 9.4 10.3 15.7 7.9 161.7 26.6 21.4 60.8 27.0 18.8 0.0 19.9 25.3 52.6 43.7 4.6 19.5 29.5 33.4 21.7 28.8 18.3 53.9 21.0 23.2 47.2 38.7 18.3 30.7 19.2 14.4 18.4 21.1 16.5 19.4 37.1 68.6 47.5 66.1 624.0 13.4 16.7 38.7 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777243-45851736 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 10.2;fallopian tube: 11.8" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.0;Ciliated cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 0.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 6 "EFO-21: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.6 1.3 5.1 0.9 8.3 0.9 0.6 5.6 10.2 4.1 0.6 0.0 0.1 0.8 1.7 2.0 0.6 11.8 0.7 0.6 4.0 2.8 1.7 0.6 0.8 0.8 3.4 6.6 0.7 0.6 0.5 0.4 0.5 8.9 0.6 0.7 2.8 1.7 3.6 0.6 0.8 0.8 0.8 1.3 0.8 0.7 0.8 0.7 0.4 0.6 0.0 0.9 0.7 0.4 0.1 0.1 0.5 0.1 0.2 1.5 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.0 5.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.7 0.5 0.2 0.0 0.1 0.0 0.0 5.1 8.3 5.6 10.2 4.0 2.8 3.4 6.6 8.9 0.7 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 4.0 0.0 1.8 2.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIDT1 "FLJ20174, SID-1" ENSG00000072858 "SID1 transmembrane family member 1" Q9NXL6 3 113532296-113629578 "Predicted membrane proteins, Transporters" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.6" "Cell type enhanced" "Detected in many" 8 "B-cells: 13.7;Mucus-secreting cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 11.6;OE19: 12.3;PC-3: 16.4;RT4: 11.4;T-47d: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035862 Approved NA NA "HPA035862: AB_10671110" "unprognostic (4.23e-1)" "prognostic favorable (3.78e-4)" "unprognostic (3.43e-3)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (6.64e-4)" "unprognostic (2.93e-4)" "unprognostic (1.50e-1)" "unprognostic (4.02e-1)" "unprognostic (3.29e-3)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (2.50e-1)" "unprognostic (3.02e-1)" "unprognostic (5.86e-2)" "unprognostic (1.32e-2)" "prognostic favorable (4.09e-5)" 1.8 4.1 7.5 13.6 5.9 4.1 7.8 17.3 11.7 4.7 8.4 5.5 3.7 2.8 1.2 0.7 2.7 2.8 5.1 1.1 7.9 9.2 1.6 1.1 2.7 17.6 4.7 8.5 0.9 1.7 1.5 12.8 1.6 4.7 7.2 14.0 0.4 13.2 9.7 0.8 1.3 8.4 1.3 4.5 11.6 4.9 1.8 1.2 13.2 1.3 0.7 13.3 6.8 1.9 4.9 21.6 0.2 0.4 5.9 4.9 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.1 0.0 0.4 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 3.4 0.0 11.6 3.1 0.1 0.0 12.3 16.4 4.7 0.0 0.4 0.0 11.4 0.1 0.1 0.0 3.3 0.1 0.0 10.8 0.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 4.9 0.1 4.9 4.9 3.2 3.9 0.9 4.3 4.2 3.5 0.1 5.9 0.0 21.6 2.5 2.1 7.5 5.9 17.3 11.7 7.9 9.2 4.7 8.5 4.7 1.2 6.0 3.5 13.7 1.6 0.3 0.0 0.8 2.5 9.4 3.4 1.8 0.0 0.0 0.0 0.3 2.8 0.7 4.3 0.0 1.0 0.1 0.3 6.3 3.5 0.0 8.7 0.0 9.8 0.6 3.5 1.3 0.0 2.5 5.0 2.8 20.6 0.0 0.7 2.9 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.1 8.9 6.3 1.4 SIDT2 CGI-40 ENSG00000149577 "SID1 transmembrane family member 2" Q8NBJ9 11 117178733-117197445 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 83.9" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 25.6;non-classical monocyte: 41.6" "Lineage enriched" "Detected in many" 6 "monocytes: 41.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052352 Approved NA NA "HPA052352: AB_2681797" "unprognostic (3.83e-1)" "unprognostic (4.30e-2)" "unprognostic (9.92e-2)" "unprognostic (1.03e-1)" "unprognostic (3.01e-2)" "unprognostic (1.69e-1)" "unprognostic (3.34e-1)" "unprognostic (1.84e-1)" "unprognostic (1.39e-1)" "unprognostic (3.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (4.18e-5)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.36e-2)" "unprognostic (5.22e-3)" 23.9 12.1 9.6 12.5 15.9 7.0 23.5 16.2 18.0 12.7 19.2 28.0 19.4 27.1 16.6 14.3 8.7 13.0 15.6 14.9 11.2 10.0 10.0 21.2 29.7 21.3 15.0 14.5 30.6 83.9 12.0 17.4 13.8 17.4 24.5 14.9 14.1 25.5 16.7 11.1 19.5 31.7 18.2 25.4 17.3 35.4 13.8 13.0 6.2 15.4 8.4 12.5 16.1 9.7 7.3 3.5 0.5 41.6 0.4 0.6 2.8 4.2 4.5 5.5 7.8 18.7 16.8 18.4 7.7 10.2 5.0 4.6 12.0 17.2 4.5 12.4 20.3 6.2 4.7 5.3 6.0 4.1 6.7 6.5 3.0 7.9 8.8 9.7 2.7 8.2 20.7 6.7 6.4 6.9 15.3 10.0 5.9 5.9 10.1 11.6 9.3 3.7 3.1 2.6 23.4 3.4 2.8 3.8 12.8 6.5 4.7 1.7 4.1 8.2 20.1 1.3 6.5 16.2 3.2 6.2 6.6 4.3 4.4 1.7 7.1 2.6 4.7 3.7 5.6 4.8 0.1 4.2 0.1 0.6 25.6 0.5 5.7 0.3 0.4 3.5 7.3 0.5 0.4 0.5 0.4 41.6 1.9 0.4 2.8 9.6 15.9 16.2 18.0 11.2 10.0 15.0 14.5 17.4 13.0 6.0 10.5 12.3 19.3 60.1 10.5 6.3 2.5 2.7 4.5 10.4 5.9 7.7 0.0 4.2 5.7 9.5 22.0 0.0 8.4 30.1 16.8 21.1 2.3 17.3 15.7 17.5 10.9 14.7 39.4 8.5 12.4 23.2 18.6 4.6 24.8 7.1 6.8 10.5 12.7 1.5 11.3 19.4 18.9 3.6 4.2 37.5 27.0 7.9 10.2 13.2 SIGIRR "IL-1R8, TIR8" ENSG00000185187 "Single Ig and TIR domain containing" Q6IA17 11 405716-417455 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 67.0" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 346.4;Proximal tubular cells: 462.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023188 Approved Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center, Cytosol" "HPA023188: AB_1856856" "unprognostic (6.21e-3)" "prognostic favorable (7.44e-5)" "unprognostic (7.30e-2)" "prognostic favorable (1.34e-5)" "unprognostic (6.85e-2)" "prognostic favorable (9.08e-4)" "unprognostic (4.03e-1)" "unprognostic (1.39e-2)" "unprognostic (8.44e-2)" "unprognostic (1.67e-1)" "unprognostic (2.32e-2)" "unprognostic (1.31e-1)" "prognostic favorable (7.61e-6)" "unprognostic (1.00e-3)" "unprognostic (1.76e-1)" "unprognostic (7.63e-2)" "prognostic favorable (1.54e-5)" 11.0 3.2 11.8 19.3 12.3 18.1 17.7 2.4 12.3 10.7 16.9 11.2 16.2 18.6 11.0 14.5 13.7 16.3 12.8 12.9 11.1 10.1 29.4 67.0 14.9 25.6 11.7 8.5 9.6 22.7 10.0 7.3 6.2 15.6 14.2 9.2 15.2 22.1 13.4 6.4 4.5 20.4 11.2 17.7 28.7 17.7 7.4 10.2 12.4 15.4 8.8 18.0 11.3 13.3 11.4 12.9 17.4 16.7 27.8 38.9 22.8 7.9 21.8 1.3 7.6 1.2 6.5 16.0 1.2 1.8 3.7 3.3 10.0 50.0 2.2 5.9 6.9 0.4 11.5 3.5 4.1 0.6 6.8 13.2 4.3 4.3 0.2 4.0 3.6 7.6 3.5 0.8 0.6 0.5 2.1 10.6 8.7 4.4 0.1 1.0 26.7 10.5 12.3 7.9 16.2 11.9 13.6 0.0 7.8 2.6 5.4 13.5 6.6 0.1 7.4 9.5 3.5 9.4 3.0 12.3 1.2 1.5 1.8 0.0 2.7 4.6 5.5 5.0 8.4 4.2 17.4 13.0 11.2 38.9 13.9 30.9 11.4 32.5 33.7 12.9 8.6 29.8 28.9 7.0 27.8 16.7 4.9 29.9 22.8 11.8 12.3 2.4 12.3 11.1 10.1 11.7 8.5 15.6 10.2 26.8 33.8 47.6 28.4 14.4 8.9 15.9 56.0 56.2 20.5 52.4 11.8 14.2 53.0 49.0 1.0 55.6 127.0 0.0 64.0 7.7 36.0 31.6 40.3 346.4 43.4 25.4 75.7 73.6 54.3 2.9 29.1 39.7 81.0 27.1 78.4 65.1 64.4 129.8 28.0 462.2 18.5 25.8 33.1 7.0 66.2 11.2 8.5 121.8 72.6 38.0 SIGLEC1 "CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN" ENSG00000088827 "Sialic acid binding Ig like lectin 1" Q9BZZ2 20 3686970-3707128 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Endocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.7" "Group enriched" "Detected in some" 10 "Hofbauer cells: 61.4;Kupffer cells: 69.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "classical monocyte: 4.1;intermediate monocyte: 2.5;myeloid DC: 1.9;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.9;monocytes: 4.1" "Cell line enriched" "Detected in single" 18 "THP-1: 6.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA053457 Supported "Intracellular and membrane" NA NA 110000 "HPA053457: AB_2682158" "unprognostic (2.05e-1)" "unprognostic (9.27e-3)" "unprognostic (3.83e-4)" "unprognostic (4.87e-3)" "unprognostic (3.40e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (6.98e-2)" "unprognostic (2.27e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (8.69e-5)" "unprognostic (8.71e-2)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" 11.6 8.0 1.5 4.5 2.0 7.0 4.7 1.5 1.9 1.5 4.4 1.5 1.5 2.9 1.5 1.5 3.1 4.2 5.3 3.5 1.5 0.1 2.9 4.9 9.7 35.7 2.1 1.5 1.6 1.5 0.0 1.5 12.2 3.0 1.5 4.1 1.8 6.3 1.5 3.2 1.5 5.9 4.6 1.5 12.0 2.9 1.5 1.5 2.8 1.9 3.4 1.8 4.8 1.7 0.0 1.9 0.0 4.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 2.5 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 1.5 2.0 1.5 1.9 1.5 0.1 2.1 1.5 3.0 1.5 3.0 4.1 0.0 0.0 0.3 0.2 2.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.6 0.0 0.0 0.0 61.4 0.0 0.0 0.0 69.1 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 SIGLEC10 "MGC126774, PRO940, SIGLEC-10, SLG2" ENSG00000142512 "Sialic acid binding Ig like lectin 10" Q96LC7 19 51410021-51417803 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 99.9;lymphoid tissue: 74.6" "Group enriched" "Detected in some" 5 "B-cells: 17.9;granulocytes: 39.2;Kupffer cells: 67.4;Macrophages: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7" "Group enriched" "Detected in many" 14 "granulocytes: 99.9;monocytes: 66.7" "Cell line enhanced" "Detected in some" "Daudi: 21.3;HDLM-2: 6.5;HEL: 10.9;HMC-1: 8.7;NB-4: 6.7;U-698: 15.7;U-937: 9.0" "CAB025807, HPA027093" Enhanced Supported "Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane, Actin filaments" "CAB025807: , HPA027093: AB_1856858" "unprognostic (7.18e-2)" "unprognostic (3.90e-3)" "unprognostic (1.11e-2)" "unprognostic (3.67e-2)" "unprognostic (3.95e-2)" "unprognostic (9.41e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (3.16e-2)" "unprognostic (1.83e-1)" "unprognostic (1.63e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.73e-1)" "unprognostic (1.69e-2)" "unprognostic (1.39e-1)" "unprognostic (9.05e-2)" 2.6 6.2 4.5 24.6 9.8 9.1 1.4 0.7 4.9 2.7 3.7 5.7 0.0 5.3 1.3 0.7 2.2 2.7 2.7 1.6 3.3 3.0 2.6 7.2 7.7 74.6 6.6 1.8 1.2 2.4 0.2 2.5 1.1 7.7 2.6 3.3 0.7 2.3 0.7 0.6 0.9 9.6 3.2 7.4 37.0 3.1 0.9 4.8 2.0 1.2 0.2 13.2 4.8 1.3 5.8 5.1 99.9 66.7 0.0 0.1 4.4 0.1 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.0 21.3 0.6 0.0 0.3 0.4 0.0 0.1 0.0 6.5 1.6 10.9 0.2 0.1 0.0 4.9 8.7 0.0 0.0 0.1 0.0 0.1 0.0 1.3 0.5 1.1 0.0 0.4 0.1 6.7 0.6 0.5 0.3 1.4 0.1 0.4 0.0 0.2 0.3 0.3 0.3 0.1 0.2 0.4 0.1 4.0 0.5 0.6 1.0 0.4 0.2 1.0 0.2 15.7 0.4 9.0 0.3 1.5 5.6 99.9 0.1 33.9 0.0 5.8 0.0 0.0 5.1 3.6 0.0 0.0 11.5 0.0 66.7 0.2 0.1 4.4 4.5 9.8 0.7 4.9 3.3 3.0 6.6 1.8 7.7 4.8 3.0 2.2 17.9 0.9 0.1 1.4 0.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.1 0.3 1.0 39.2 0.5 7.8 0.0 0.0 0.6 67.4 0.0 0.0 34.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.3 1.1 0.1 2.2 0.0 0.8 SIGLEC11 ENSG00000161640 "Sialic acid binding Ig like lectin 11" Q96RL6 19 49948985-49961172 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 11.3;ovary: 36.6" "Cell type enhanced" "Detected in some" 16 "Distal tubular cells: 16.6;Hofbauer cells: 6.3;Ito cells: 8.6;Kupffer cells: 19.6" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 15 "HEL: 15.4" "HPA052132, HPA060278" Approved Uncertain "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA052132: , HPA060278: AB_2684240" "unprognostic (1.07e-1)" "unprognostic (2.85e-3)" "unprognostic (1.56e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (3.35e-2)" "unprognostic (9.93e-2)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.20e-1)" "unprognostic (8.79e-4)" "unprognostic (2.11e-1)" "unprognostic (1.41e-1)" "unprognostic (9.95e-3)" "unprognostic (5.38e-2)" 0.4 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 36.6 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 11.3 1.8 0.5 0.0 0.0 0.3 0.0 0.6 0.5 2.6 3.3 0.8 0.2 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.2 15.4 0.3 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.1 0.4 0.2 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.0 0.2 0.2 0.5 1.0 2.6 0.1 3.3 0.1 0.5 0.2 0.1 0.5 0.6 0.1 0.2 1.4 0.8 3.3 0.3 0.0 0.3 0.0 1.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 6.3 0.0 0.0 8.6 19.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.1 0.0 0.0 0.0 SIGLEC12 "S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG" ENSG00000254521 "Sialic acid binding Ig like lectin 12 (gene/pseudogene)" Q96PQ1 19 51491357-51501789 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 13.1;lymphoid tissue: 29.6" "Group enriched" "Detected in some" 14 "granulocytes: 2.3;Hofbauer cells: 1.8;Kupffer cells: 2.8;Macrophages: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HMC-1: 54.1;U-937: 28.9" NA NA "unprognostic (1.46e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-2)" "unprognostic (9.13e-2)" "unprognostic (9.58e-4)" "unprognostic (1.38e-1)" "unprognostic (3.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (3.73e-1)" "unprognostic (1.29e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-5)" "unprognostic (2.45e-1)" "unprognostic (1.14e-1)" "unprognostic (3.64e-1)" "unprognostic (1.57e-1)" 2.8 1.0 0.2 6.2 1.2 1.3 0.3 0.1 0.3 0.3 1.5 0.2 0.6 0.4 0.4 0.5 0.6 0.4 1.6 0.7 0.2 0.2 0.4 13.1 5.3 3.9 0.2 0.0 0.3 0.3 0.0 0.2 0.0 0.3 0.5 2.6 0.6 1.2 0.0 0.2 0.2 2.5 3.4 0.3 29.6 0.5 1.4 0.0 2.4 0.2 1.0 1.7 0.6 0.3 0.7 0.8 3.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.9 0.0 0.0 2.0 3.0 0.0 0.9 0.0 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 1.2 0.1 0.3 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SIGLEC14 ENSG00000254415 "Sialic acid binding Ig like lectin 14" Q08ET2 19 51642553-51646801 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6" "Cell type enhanced" "Detected in some" 22 "Hofbauer cells: 16.1;Kupffer cells: 31.5;Macrophages: 9.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 6 "dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "HPA014377, HPA014428" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA 18000000 Vesicles "Plasma membrane" "HPA014377: AB_2189277, HPA014428: " "unprognostic (3.05e-1)" "unprognostic (1.75e-1)" "unprognostic (6.47e-3)" "unprognostic (1.60e-1)" "unprognostic (3.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (9.77e-3)" "unprognostic (9.28e-2)" "unprognostic (6.73e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-3)" "unprognostic (8.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" 1.6 1.6 0.6 13.0 0.5 13.3 0.5 0.0 0.3 0.6 0.6 0.0 0.4 0.0 0.2 1.7 1.0 0.8 0.6 0.6 0.4 1.4 5.1 6.2 1.3 0.1 0.3 0.0 0.1 0.9 0.4 0.4 0.7 0.1 0.0 0.0 4.0 0.9 1.9 21.6 0.7 1.3 0.2 7.0 2.2 0.2 4.9 15.9 48.7 29.7 0.1 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.7 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 3.6 25.8 0.4 0.0 29.7 0.0 4.9 0.0 0.0 15.9 4.8 0.0 0.0 48.7 0.1 21.3 2.9 0.0 7.6 0.0 1.4 0.9 0.0 0.0 0.0 0.1 2.5 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 16.1 0.0 0.0 0.0 31.5 0.0 0.3 9.8 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SIGLEC15 "CD33L3, HsT1361" ENSG00000197046 "Sialic acid binding Ig like lectin 15" Q6ZMC9 18 45825512-45844080 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 5.9" "Cell type enhanced" "Detected in some" 16 "Hofbauer cells: 8.2;Pancreatic endocrine cells: 2.1;Urothelial cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 5.9;myeloid DC: 2.1" "Group enriched" "Detected in many" 40 "dendritic cells: 2.1;monocytes: 5.9" "Group enriched" "Detected in some" 7 "PC-3: 8.7;U-87 MG: 26.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053509 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA053509: " "unprognostic (3.89e-3)" "unprognostic (1.87e-2)" "unprognostic (1.77e-1)" "unprognostic (7.18e-3)" "unprognostic (2.27e-1)" "unprognostic (8.07e-2)" "unprognostic (5.91e-2)" "unprognostic (2.71e-1)" "unprognostic (9.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.77e-2)" "unprognostic (7.65e-2)" "unprognostic (6.55e-2)" "unprognostic (1.42e-1)" "unprognostic (6.06e-2)" "unprognostic (4.40e-2)" "prognostic favorable (9.14e-5)" 1.1 0.3 0.1 4.3 0.1 0.0 3.0 0.2 0.1 2.1 0.2 0.0 0.0 1.6 0.3 0.0 0.3 0.3 3.4 1.9 0.1 0.1 0.5 1.4 2.0 0.9 0.1 0.0 0.5 0.2 0.0 0.1 1.1 0.0 1.1 0.1 0.1 0.2 0.2 0.7 0.3 2.5 3.2 0.1 3.7 0.9 0.3 0.0 1.2 0.2 0.0 2.6 4.2 0.2 0.0 2.1 0.0 5.9 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.9 0.1 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.4 0.0 0.0 0.0 26.3 0.6 0.0 0.0 5.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.0 8.2 1.6 0.0 1.8 1.8 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 2.2 SIGLEC5 "CD170, CD33L2, OB-BP2, SIGLEC-5" ENSG00000105501 "Sialic acid binding Ig like lectin 5" O15389 19 51611927-51645545 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 46.7;bone marrow: 13.5" "Group enriched" "Detected in some" 10 "granulocytes: 8.1;Hofbauer cells: 4.6;Kupffer cells: 8.5;Macrophages: 3.2" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.7" "Cell type enhanced" "Detected in many" "neutrophil: 46.7" "Group enriched" "Detected in many" 6 "granulocytes: 46.7;monocytes: 13.7" "Group enriched" "Detected in some" 6 "HMC-1: 35.8;U-937: 14.8" "HPA009085, CAB024900" Supported NA NA "CAB024900: , HPA009085: AB_1079965" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (2.02e-2)" "unprognostic (1.03e-2)" "unprognostic (4.39e-2)" "unprognostic (1.62e-2)" "unprognostic (1.73e-1)" "unprognostic (1.01e-1)" "unprognostic (3.28e-1)" "unprognostic (7.44e-2)" "unprognostic (1.01e-1)" "unprognostic (4.05e-1)" "unprognostic (3.71e-4)" "unprognostic (4.37e-2)" "unprognostic (3.55e-3)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" 1.2 0.4 0.4 6.4 0.5 13.5 0.2 0.1 0.2 0.1 0.3 0.0 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.2 0.2 1.2 1.5 2.5 0.5 0.1 0.2 0.0 0.2 0.5 0.2 0.4 0.4 0.0 0.0 0.1 3.4 0.5 0.7 5.9 0.3 0.7 0.2 1.9 0.8 0.1 0.8 4.7 46.7 13.7 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 3.6 6.4 0.1 0.0 7.5 0.0 0.8 0.0 0.0 4.7 0.7 0.0 0.0 46.7 0.2 13.7 1.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 4.6 0.0 0.0 0.0 8.5 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 56.9;granulocytes: 52.1;Syncytiotrophoblasts: 157.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 103.0" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 103.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 52.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.8 0.0 0.0 0.0 SIGLEC7 "CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2" ENSG00000168995 "Sialic acid binding Ig like lectin 7" Q9Y286 19 51142299-51153526 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 51.5;lymphoid tissue: 29.4" "Group enriched" "Detected in some" 5 "Hofbauer cells: 29.4;Kupffer cells: 51.3;Macrophages: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Karpas-707: 31.5;RPMI-8226: 18.3;U-937: 19.4" HPA075513 Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Plasma membrane" Vesicles "HPA075513: " "unprognostic (3.14e-1)" "unprognostic (5.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (4.95e-2)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.27e-2)" "unprognostic (6.61e-2)" "unprognostic (1.14e-3)" "unprognostic (2.58e-1)" "unprognostic (2.26e-2)" 6.9 3.7 1.6 10.0 5.8 3.7 3.0 0.3 2.2 0.9 1.6 1.0 0.6 1.4 0.9 2.1 1.1 1.8 2.4 1.9 0.8 1.0 2.8 9.8 4.7 18.4 3.3 0.0 1.3 0.9 0.2 0.9 5.9 2.9 1.0 2.3 0.7 2.3 0.2 0.4 0.5 2.3 3.5 3.3 29.4 1.1 1.8 2.5 0.7 1.0 0.0 2.1 3.2 1.7 0.6 14.9 51.5 32.0 20.0 4.4 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.1 19.4 0.0 0.5 32.0 51.5 2.5 23.0 4.4 0.6 0.0 1.1 14.9 0.0 0.0 1.0 26.8 20.0 9.1 0.6 0.0 15.8 1.6 5.8 0.3 2.2 0.8 1.0 3.3 0.0 2.9 2.5 0.0 2.1 1.4 0.0 0.1 0.0 0.0 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.6 29.4 0.0 0.0 7.4 51.3 0.0 1.4 24.5 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.0 SIGLEC8 "MGC59785, SAF2, SIGLEC-8, SIGLEC8L" ENSG00000105366 "Sialic acid binding Ig like lectin 8" Q9NYZ4 19 51450847-51458456 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 63.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 42.8" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 42 "eosinophil: 63.0" "Lineage enriched" "Detected in single" 623 "granulocytes: 63.0" "Cell line enriched" "Detected in some" 45 "HMC-1: 58.8" HPA012556 Uncertain Uncertain Cytosol NA NA Cytosol "HPA012556: AB_1856869" "unprognostic (1.27e-1)" "unprognostic (1.88e-4)" "unprognostic (1.28e-1)" "unprognostic (6.70e-2)" "unprognostic (2.97e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-2)" "unprognostic (2.51e-2)" "unprognostic (2.72e-2)" "unprognostic (2.17e-1)" "unprognostic (1.10e-1)" "unprognostic (4.19e-1)" "unprognostic (8.62e-3)" "unprognostic (7.18e-2)" "unprognostic (6.02e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" 0.6 6.7 5.8 2.4 8.4 0.7 2.3 0.7 7.0 1.4 2.9 7.4 0.0 2.9 1.0 1.1 1.1 1.1 2.7 0.3 8.6 4.8 0.4 1.6 4.1 9.6 8.3 3.6 0.3 0.7 0.7 1.2 0.1 7.5 1.0 2.8 0.1 1.1 0.9 0.3 0.8 4.5 1.5 14.8 9.2 2.1 0.5 6.2 0.6 0.7 0.0 4.1 2.0 0.7 0.0 0.0 63.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.5 0.1 63.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.8 8.4 0.7 5.6 8.6 4.8 8.3 3.6 7.5 6.2 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 42.8 0.0 0.3 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SIGLEC9 CD329 ENSG00000129450 "Sialic acid binding Ig like lectin 9" Q9Y336 19 51124908-51136651 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.7;lymphoid tissue: 25.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 38.7;Kupffer cells: 36.5;Macrophages: 29.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 11 "classical monocyte: 40.6;intermediate monocyte: 36.5;myeloid DC: 34.1;neutrophil: 42.7;non-classical monocyte: 22.9" "Group enriched" "Detected in many" 12 "dendritic cells: 34.1;granulocytes: 42.7;monocytes: 40.6" "Group enriched" "Detected in some" 10 "Karpas-707: 21.2;RPMI-8226: 14.4" HPA010682 Uncertain NA NA 220000 "HPA010682: AB_1079968" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.03e-2)" "unprognostic (1.36e-1)" "unprognostic (4.69e-2)" "unprognostic (6.86e-2)" "unprognostic (5.10e-2)" "unprognostic (2.10e-1)" "unprognostic (1.31e-1)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (7.03e-3)" "prognostic unfavorable (6.17e-5)" "unprognostic (6.56e-2)" "unprognostic (7.38e-3)" "unprognostic (2.95e-1)" "unprognostic (1.73e-1)" 8.5 5.7 6.6 17.0 12.6 7.6 7.4 0.9 5.0 1.7 2.5 4.0 0.0 1.6 1.4 2.8 1.1 3.7 4.9 2.9 6.2 2.3 4.5 5.5 9.0 15.8 8.4 0.7 3.2 1.8 5.8 1.5 7.5 8.1 1.6 2.4 1.3 2.3 0.9 0.8 0.9 2.6 6.1 8.8 25.1 2.0 1.9 9.6 0.8 1.4 0.0 2.3 3.7 1.2 0.0 34.1 42.7 40.6 0.5 3.2 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 21.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.8 1.3 0.0 2.5 40.6 0.3 3.2 36.5 1.8 0.0 0.5 1.2 34.1 0.0 0.1 0.6 42.7 0.5 22.9 1.8 0.1 14.4 6.6 12.6 0.9 5.0 6.2 2.3 8.4 0.7 8.1 9.6 0.0 0.3 0.9 0.0 0.5 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.8 38.7 0.0 0.0 4.3 36.5 0.0 4.6 29.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.2 1.0 0.0 0.0 SIGLECL1 "C19orf75, FLJ40235, SIGLEC23P, SIGLECP7" ENSG00000179213 "SIGLEC family like 1" Q8N7X8 19 51246348-51269330 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 29.7" "Group enriched" "Detected in some" 6 "Early spermatids: 33.0;Late spermatids: 49.4;Spermatocytes: 25.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Group enriched" "Detected in many" 19 "dendritic cells: 2.6;monocytes: 1.0" "Cell line enhanced" "Detected in some" "HDLM-2: 2.2;HEL: 2.6;HMC-1: 2.8;NB-4: 2.2;U-937: 1.8" HPA079471 Enhanced NA NA "HPA079471: " "unprognostic (5.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 2.6 0.0 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 1.8 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 49.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 25.1 6.3 0.0 0.0 0.0 0.0 0.0 SIGMAR1 "OPRS1, SR-BP1" ENSG00000147955 "Sigma non-opioid intracellular receptor 1" Q99720 9 34634722-34637809 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Receptor "Amyotrophic lateral sclerosis, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.1" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 82.3;Hepatocytes: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013470, HPA018002, HPA024071" Enhanced NA NA "CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (8.06e-2)" "unprognostic (3.71e-2)" "unprognostic (4.89e-2)" "unprognostic (2.50e-2)" "unprognostic (2.58e-2)" "unprognostic (2.01e-3)" "unprognostic (3.88e-2)" "unprognostic (4.28e-1)" "unprognostic (2.78e-2)" "unprognostic (2.46e-1)" "unprognostic (2.39e-1)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.42e-4)" 15.3 19.7 9.2 9.8 14.5 8.5 13.0 9.4 16.1 17.0 18.2 13.4 13.3 23.0 18.6 13.4 18.6 17.4 17.1 12.1 9.4 12.0 14.2 89.1 9.6 14.5 10.7 10.7 20.1 22.9 15.0 8.3 17.8 14.0 18.9 13.2 15.7 12.0 19.6 7.7 16.8 24.9 15.1 9.2 9.8 14.6 9.4 9.3 9.6 11.8 15.0 15.8 16.4 15.2 14.0 23.8 12.4 19.3 13.1 32.6 20.1 41.1 36.5 12.7 41.4 47.0 32.6 16.4 30.0 20.3 26.5 24.5 22.9 18.0 20.2 17.8 32.5 16.8 25.8 16.2 34.0 5.8 35.1 43.7 19.3 54.4 25.0 30.9 33.1 16.8 32.9 36.4 29.1 36.2 14.0 20.0 26.7 7.2 37.4 28.3 0.2 20.1 48.0 15.9 21.8 47.5 23.5 14.2 56.8 24.1 8.2 14.9 16.8 29.8 21.3 15.7 5.2 25.2 22.6 16.8 22.0 17.6 23.2 4.4 10.4 16.4 0.5 22.8 28.8 45.5 10.5 19.1 12.4 22.2 18.4 24.2 14.0 32.6 26.7 23.8 10.8 27.8 22.6 5.4 13.1 19.3 17.5 29.9 20.1 9.2 14.5 9.4 16.1 9.4 12.0 10.7 10.7 14.0 9.3 3.0 9.9 15.9 14.7 16.4 7.7 7.3 15.3 8.1 6.8 7.0 0.0 35.2 0.0 30.9 0.6 12.4 34.1 23.3 29.3 82.3 26.6 19.8 6.9 84.9 34.7 4.8 9.9 14.7 11.0 1.1 25.3 7.9 18.6 11.8 22.5 12.7 25.2 28.5 24.1 11.0 6.2 19.4 20.6 5.7 10.0 18.7 30.6 11.7 37.5 11.6 SIK1 "msk, SNF1LK" ENSG00000142178 "Salt inducible kinase 1" P57059 21 43414483-43427189 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell cycle, Differentiation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 34.5" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 2: 112.3;Basal keratinocytes: 268.2;Melanocytes: 91.1;Suprabasal keratinocytes: 369.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "B-cells: 2.0;dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "HBEC3-KT: 16.9;HeLa: 28.1;hTCEpi: 21.8;LHCN-M2: 21.9;U-266/84: 15.9" "CAB023801, HPA038211, HPA078064" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB023801: , HPA038211: AB_2675894, HPA078064: " "unprognostic (4.06e-2)" "unprognostic (9.38e-2)" "unprognostic (3.31e-3)" "unprognostic (3.00e-1)" "unprognostic (5.02e-2)" "unprognostic (7.97e-3)" "unprognostic (1.51e-1)" "unprognostic (7.30e-3)" "unprognostic (2.35e-3)" "unprognostic (4.97e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-1)" "unprognostic (3.89e-1)" "unprognostic (9.94e-3)" "unprognostic (3.88e-2)" "unprognostic (2.89e-1)" "unprognostic (1.82e-1)" 8.8 2.3 3.0 3.6 3.0 5.9 7.5 3.0 3.0 13.5 3.0 3.0 3.0 0.0 3.0 3.0 12.9 5.5 10.7 7.1 3.0 0.8 3.0 12.3 5.4 3.0 3.0 3.0 13.7 7.3 3.5 5.7 8.2 3.0 3.9 0.1 3.0 4.6 9.8 5.0 34.5 3.0 3.3 3.0 4.0 5.3 3.0 3.0 3.0 3.9 3.0 3.0 10.5 6.1 2.0 1.6 0.0 0.1 0.0 0.1 0.1 0.5 1.7 2.0 0.0 0.1 0.8 0.8 0.9 0.3 1.7 1.3 2.4 0.0 2.5 0.7 0.2 9.5 11.2 1.6 16.9 1.0 0.1 0.5 0.7 28.1 0.9 2.3 0.7 0.1 1.0 21.8 0.4 5.2 9.9 0.3 0.0 0.1 0.5 21.9 0.1 0.4 1.7 0.8 0.0 1.5 0.0 0.3 2.5 1.9 6.3 0.0 0.0 11.0 1.9 0.4 0.3 1.1 0.3 3.7 0.4 2.0 0.1 0.0 4.3 15.9 0.5 4.7 2.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 0.5 0.9 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 3.0 3.0 3.0 3.0 3.0 0.8 3.0 3.0 3.0 3.0 26.8 112.3 2.4 0.6 268.2 0.2 9.3 7.6 9.4 17.0 12.2 0.0 0.5 0.0 2.8 0.0 2.2 14.2 0.0 1.8 1.0 5.2 0.4 18.5 7.8 1.7 0.0 26.6 1.8 3.7 0.0 0.0 4.0 91.1 2.8 15.1 0.5 5.0 23.0 0.0 0.0 0.1 0.0 10.8 0.0 0.5 369.5 2.1 1.3 18.6 1.0 SIM1 bHLHe14 ENSG00000112246 "Single-minded family bHLH transcription factor 1" P81133 6 100385015-100464929 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5" "Group enriched" "Detected in some" 4 "Collecting duct cells: 19.2;Distal tubular cells: 6.6" "Cancer enhanced" "Detected in single" "renal cancer: 1.8" "Region enriched" "Detected in single" 21 "hypothalamus: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7" "Region enriched" "Detected in single" 7 "hypothalamus: 6.1" "Group enriched" "Detected in some" 5 "basal ganglia: 2.6;hypothalamus: 5.2" HPA024385 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024385: AB_1856879" "unprognostic (1.04e-1)" "unprognostic (4.34e-3)" "unprognostic (2.24e-1)" "unprognostic (1.51e-1)" "unprognostic (4.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "unprognostic (4.64e-2)" "unprognostic (3.76e-2)" "prognostic favorable (5.32e-7)" "unprognostic (1.00e-1)" "unprognostic (1.19e-1)" 5.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 13.2 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 2.2 21.6 0.5 0.0 0.0 0.1 0.0 0.0 5.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 17.5 4.7 0.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 8.0 0.0 12.8 18.7 5.8 5.4 0.0 0.0 0.0 0.0 4.0 1.2 0.0 0.0 0.0 4.9 5.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 19.2 0.0 0.0 6.6 3.0 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 1.6 0.0 0.4 0.0 0.0 0.0 0.0 SIM2 "bHLHe15, MGC119447, SIM" ENSG00000159263 "Single-minded family bHLH transcription factor 2" Q14190 21 36699133-36749917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 8.9;Collecting duct cells: 8.7;Distal tubular cells: 8.3;Glandular cells: 6.5" "Cancer enhanced" "Detected in many" "prostate cancer: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.3;PC-3: 23.0;RPTEC TERT1: 28.9;RT4: 17.4" "Region enhanced" "Detected in single" "hypothalamus: 0.5" "Not detected" "Not detected" HPA029295 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA029295: AB_10610425" "unprognostic (1.17e-3)" "unprognostic (6.46e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (8.62e-2)" "unprognostic (1.43e-2)" "unprognostic (8.30e-2)" "unprognostic (5.46e-3)" "unprognostic (1.65e-2)" "unprognostic (1.09e-1)" "unprognostic (5.16e-3)" "unprognostic (9.18e-2)" "unprognostic (9.18e-7)" "unprognostic (2.98e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "prognostic favorable (2.88e-4)" 0.5 0.3 0.8 0.1 2.3 0.0 0.1 2.4 2.3 2.8 0.2 0.2 0.0 0.1 0.3 1.5 31.3 0.3 0.2 0.1 2.5 1.1 16.1 0.1 0.1 0.1 1.4 0.7 0.1 0.1 1.2 1.7 0.1 0.3 6.8 0.0 0.2 0.4 0.0 15.7 0.3 0.1 0.0 0.4 0.1 5.5 0.2 1.3 0.0 0.2 11.0 28.7 1.5 0.4 0.3 0.7 0.0 0.0 0.0 0.8 0.0 3.2 5.0 0.2 0.2 0.0 0.0 5.0 0.1 0.0 0.4 0.0 2.6 7.6 0.1 4.6 0.1 9.0 1.7 2.5 0.0 0.2 3.9 7.9 0.1 7.2 0.2 0.0 0.0 0.0 0.8 0.7 0.0 1.4 13.3 0.0 0.1 0.1 0.0 8.4 1.9 0.0 0.0 0.2 3.2 23.0 0.0 0.1 0.1 28.9 17.4 0.2 0.3 8.2 0.0 0.7 0.8 2.1 0.2 0.3 0.0 1.4 0.5 0.2 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 2.3 2.4 2.3 2.5 1.1 1.4 0.7 0.3 1.3 0.0 0.0 0.0 8.9 0.2 0.2 2.0 0.0 0.0 0.0 8.7 0.0 0.0 8.3 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.2 0.2 0.4 0.0 0.0 0.0 1.8 SIMC1 "C5orf25, FLJ44216, OOMA1, PLEIAD" ENSG00000170085 "SUMO interacting motifs containing 1" Q8NDZ2 5 176238367-176345991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 29.3;testis: 41.5" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037889, HPA037890" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA037889: AB_2675720, HPA037890: AB_2675721" "unprognostic (1.15e-1)" "unprognostic (9.97e-2)" "unprognostic (3.81e-3)" "prognostic unfavorable (2.32e-6)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.20e-2)" "unprognostic (5.59e-2)" "unprognostic (2.75e-1)" "unprognostic (1.97e-3)" "unprognostic (1.60e-1)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (2.52e-2)" "unprognostic (1.21e-1)" "unprognostic (2.53e-1)" "unprognostic (3.59e-2)" "unprognostic (9.20e-2)" 3.1 15.1 5.4 5.0 3.9 2.0 3.3 10.2 5.4 7.5 4.5 2.0 2.9 3.9 8.0 6.8 3.1 9.3 5.3 2.0 6.2 4.4 1.8 5.1 3.1 3.5 2.5 3.0 29.3 3.4 4.2 7.6 3.3 3.4 6.1 4.9 4.0 3.8 4.7 5.5 2.3 5.1 6.2 3.0 5.5 5.1 41.5 3.7 4.5 2.1 2.7 3.4 4.4 5.4 7.1 8.1 10.5 5.3 10.8 6.3 3.5 1.8 5.0 16.3 13.0 8.5 8.4 8.2 6.9 6.8 7.2 9.0 17.5 5.4 0.0 8.6 8.0 14.8 1.7 17.6 12.3 9.0 3.1 13.1 8.8 3.3 2.2 19.1 9.6 6.8 5.6 5.1 4.8 8.7 5.3 6.7 3.2 22.0 8.5 8.5 8.6 9.4 7.6 5.9 2.3 5.5 14.0 10.8 12.1 4.8 3.7 10.7 11.6 7.6 1.1 6.6 5.9 4.4 18.4 4.7 8.8 4.7 8.0 5.9 2.1 2.4 13.8 3.5 6.4 5.0 7.0 5.3 10.5 5.2 5.2 6.3 7.1 6.3 4.0 8.1 6.9 5.3 4.1 0.7 10.8 4.0 3.9 4.1 3.5 5.4 3.9 10.2 5.4 6.2 4.4 2.5 3.0 3.4 3.7 8.9 3.5 2.7 4.8 2.6 15.3 3.1 2.5 2.7 3.4 1.8 3.9 0.2 1.7 3.2 27.6 2.1 5.3 0.0 3.2 2.1 4.3 3.7 0.0 7.5 2.0 17.5 12.7 4.9 4.1 9.8 27.6 2.8 5.0 4.6 9.3 5.8 4.1 7.0 32.5 2.1 4.5 32.3 5.3 64.2 24.7 2.3 0.7 5.0 8.9 2.6 SIPA1 SPA1 ENSG00000213445 "Signal-induced proliferation-associated 1" Q96FS4 11 65638097-65650930 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020833, HPA039867" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane" NA NA Nucleoli "Nucleoplasm, Golgi apparatus, Plasma membrane" "CAB020833: , HPA039867: AB_2676716" "unprognostic (6.10e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.42e-4)" "unprognostic (1.35e-2)" "unprognostic (2.93e-1)" "unprognostic (2.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.09e-1)" "unprognostic (3.30e-2)" "unprognostic (6.44e-2)" "unprognostic (5.85e-2)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.60e-1)" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-1)" 10.5 9.1 7.5 27.1 12.0 29.8 10.0 2.6 8.7 8.9 10.8 9.4 2.9 7.7 10.9 3.0 7.6 9.0 9.9 8.0 8.4 4.6 9.5 7.8 17.6 33.2 11.5 4.7 7.7 4.6 2.7 4.2 11.9 10.3 8.6 3.9 8.2 8.7 6.8 5.4 4.2 17.2 9.0 14.3 47.1 8.1 3.0 10.5 25.3 7.7 4.6 32.7 8.5 7.8 6.6 2.8 14.1 5.2 5.8 7.4 3.0 0.7 6.2 4.5 9.6 2.6 5.5 10.6 7.2 6.1 5.6 5.5 1.9 6.9 9.9 16.2 3.5 0.2 3.6 1.6 2.4 1.9 10.7 4.0 24.2 9.2 3.4 4.7 9.8 10.5 5.6 1.1 7.8 1.0 5.6 16.4 10.4 13.7 4.6 2.8 2.7 3.9 16.7 3.0 2.5 5.8 17.8 2.5 8.8 2.1 0.5 1.7 10.3 3.5 6.1 14.6 4.3 4.6 15.1 23.0 6.9 14.1 7.6 1.4 6.9 5.4 22.3 9.5 15.6 20.1 4.0 4.1 10.2 7.4 4.8 5.5 5.3 3.7 4.8 2.8 6.6 2.9 4.4 14.1 5.8 5.2 2.7 3.5 3.0 7.5 12.0 2.6 8.7 8.4 4.6 11.5 4.7 10.3 10.5 6.0 6.9 45.9 21.9 6.1 1.7 3.7 25.5 0.0 2.3 22.7 0.0 7.8 31.5 18.4 2.6 16.8 17.3 23.3 13.0 17.8 8.2 22.9 6.9 19.8 31.9 4.8 20.2 39.9 38.3 5.4 7.5 26.7 10.1 10.8 11.7 4.8 23.9 11.5 12.4 14.6 1.6 12.9 14.0 0.7 17.9 9.7 11.3 33.2 11.4 27.8 SIRPA "BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2" ENSG00000198053 "Signal regulatory protein alpha" P78324 20 1894167-1940592 "CD markers, Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.2" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 89.1;Macrophages: 65.8;monocytes: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 10.1;eosinophil: 20.9;myeloid DC: 6.3;neutrophil: 23.5" "Group enriched" "Detected in many" 134 "dendritic cells: 6.3;granulocytes: 23.5;monocytes: 10.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 42.9;RPTEC TERT1: 31.1;SK-MEL-30: 36.1" "CAB002776, CAB015122, HPA054437, HPA058511" Enhanced NA NA 170000000 "CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738" "unprognostic (9.78e-2)" "unprognostic (2.67e-1)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (5.56e-2)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (4.19e-3)" "unprognostic (3.48e-2)" "unprognostic (2.84e-3)" "unprognostic (3.69e-1)" "unprognostic (3.33e-2)" "unprognostic (2.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.55e-2)" "unprognostic (3.55e-2)" "unprognostic (2.24e-2)" 23.2 21.7 36.9 24.9 38.8 19.9 14.0 39.1 69.2 9.5 6.7 22.8 3.0 14.1 6.4 11.2 7.2 9.1 14.6 11.9 29.3 18.5 9.6 16.1 22.0 10.3 18.8 50.3 9.7 6.1 2.2 5.5 13.8 14.7 4.9 8.2 9.5 15.0 8.9 5.5 13.6 11.7 11.4 18.0 9.6 5.2 3.9 20.4 1.0 4.1 2.2 8.8 13.2 6.9 0.0 6.3 23.5 10.1 0.0 0.0 3.4 3.4 7.6 3.8 7.1 9.3 8.8 0.5 18.3 15.6 5.0 1.5 4.8 0.1 0.0 4.4 42.9 13.5 3.5 3.0 21.3 2.1 0.0 2.1 0.0 0.9 2.6 11.2 7.1 8.8 7.8 10.1 4.2 5.2 14.4 15.5 0.0 0.4 4.7 6.7 0.2 0.0 10.0 4.2 0.0 3.4 0.0 6.8 4.7 31.1 0.0 0.5 1.1 2.5 0.0 36.1 1.4 1.2 22.9 23.1 22.2 11.5 14.3 9.0 0.0 0.0 0.0 6.9 23.0 2.5 0.1 10.1 20.9 0.0 2.7 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 23.5 0.0 1.0 0.4 0.0 3.4 36.9 38.8 39.1 68.6 29.3 18.5 18.8 50.3 14.7 20.4 3.0 9.2 1.9 10.4 12.7 9.3 9.7 30.6 4.0 5.7 8.7 13.7 16.4 1.7 22.9 0.5 10.8 3.8 0.0 1.8 1.6 22.0 5.7 17.3 23.1 89.1 14.3 9.2 17.8 49.1 0.4 4.6 65.8 21.9 84.8 3.3 21.8 15.8 6.5 1.8 12.8 25.2 6.5 5.2 0.3 7.9 5.8 30.6 1.0 3.0 6.5 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1563521-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 137.6" "Cell type enhanced" "Detected in some" 19 "Hofbauer cells: 14.8;Kupffer cells: 35.5;Macrophages: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 137.6" "Group enriched" "Detected in many" 6 "granulocytes: 137.6;monocytes: 43.6" "Group enriched" "Detected in some" 4 "HMC-1: 25.3;NB-4: 33.6;THP-1: 26.0" HPA047463 Uncertain Uncertain Vesicles NA NA 33000000 Vesicles "HPA047463: AB_2680057" "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 23.7 1.8 2.3 18.7 5.4 31.9 1.8 2.7 3.2 1.1 1.4 1.9 0.1 1.0 1.0 0.5 0.9 2.5 7.6 7.2 2.3 1.6 1.5 7.5 19.4 19.5 6.6 0.7 1.9 0.9 0.1 1.5 3.8 3.7 1.2 1.2 1.7 1.8 0.6 0.9 0.9 2.6 2.1 7.2 28.7 1.2 1.2 3.9 2.5 0.9 0.4 2.9 4.1 1.9 0.2 15.2 137.6 43.6 0.7 1.0 19.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 3.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 25.3 0.0 0.1 0.1 0.0 3.7 0.2 0.5 0.0 0.1 0.2 0.0 0.0 33.6 0.1 0.0 1.5 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 26.0 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.5 6.1 0.1 0.5 43.6 72.5 0.6 36.3 0.9 0.2 0.6 0.5 15.2 0.2 0.8 0.5 137.6 0.7 29.5 14.5 1.0 19.2 2.3 5.4 2.7 3.2 2.3 1.6 6.6 0.7 3.7 3.9 3.0 6.9 0.5 0.0 0.0 0.2 0.4 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.9 0.0 14.8 0.0 0.0 3.1 35.5 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SIRPB2 "dJ776F14.2, PTPN1L, PTPNS1L3" ENSG00000196209 "Signal regulatory protein beta 2" Q5JXA9 20 1470741-1491587 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.5;lymphoid tissue: 21.2" "Cell type enhanced" "Detected in some" 24 "Hofbauer cells: 4.4;Kupffer cells: 18.9;Macrophages: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 13 "classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7" "Group enriched" "Detected in many" 194 "dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8" "Cell line enhanced" "Detected in some" "A-431: 5.3;HBEC3-KT: 4.5;HMC-1: 9.3;hTCEpi: 10.0;HUVEC TERT2: 5.0;THP-1: 8.8;TIME: 4.4;U-937: 9.4" "Low region specificity" "Detected in all" "HPA011548, HPA048032" Uncertain Approved "Nuclear bodies" NA NA 100000 "Nuclear bodies" "HPA011548: AB_2668514, HPA048032: AB_2680236" "unprognostic (3.22e-2)" "unprognostic (5.57e-2)" "unprognostic (2.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (3.50e-5)" "unprognostic (3.59e-3)" "unprognostic (9.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" 8.1 4.2 5.8 15.8 11.0 8.1 5.2 0.8 6.5 2.8 2.4 3.3 0.0 1.3 1.9 4.5 2.6 3.1 5.2 2.7 5.9 3.1 2.6 2.5 9.5 17.3 9.2 1.7 1.4 1.6 0.7 1.4 10.0 7.9 1.8 2.5 2.4 2.8 1.0 1.2 1.5 3.3 5.5 13.1 21.2 2.0 1.8 9.1 1.0 1.7 0.3 4.3 6.4 3.9 0.0 8.8 29.5 19.8 0.0 0.0 6.4 5.3 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 1.3 0.0 4.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.2 9.3 0.0 10.0 0.0 0.2 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 8.8 4.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 9.4 0.1 1.2 19.8 12.3 0.0 12.8 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 29.5 0.0 9.7 0.3 0.0 6.4 5.8 11.0 0.8 6.5 5.9 3.1 9.2 1.7 7.9 9.1 0.0 0.6 0.5 0.7 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.6 0.4 1.1 0.0 4.4 0.0 0.0 0.6 18.9 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.5 SIRPD "dJ576H24.4, PTPNS1L2" ENSG00000125900 "Signal regulatory protein delta" Q9H106 20 1534251-1558843 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "blood: 19.9;testis: 64.2" "Group enriched" "Detected in some" 90 "Early spermatids: 387.0;Late spermatids: 441.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 19.9" "Group enriched" "Detected in many" 4 "granulocytes: 19.9;monocytes: 12.5" "Cell line enhanced" "Detected in some" "HL-60: 2.6;HMC-1: 3.5;NB-4: 4.6;THP-1: 9.9;U-937: 2.2" HPA042663 Enhanced "Secreted in male reproductive system" NA NA "HPA042663: AB_2678102" "unprognostic (4.91e-2)" "unprognostic (1.51e-2)" "unprognostic (3.01e-2)" "unprognostic (4.47e-1)" "unprognostic (2.49e-1)" "unprognostic (1.02e-1)" "unprognostic (1.48e-2)" "unprognostic (2.79e-1)" "unprognostic (3.66e-8)" "unprognostic (2.14e-1)" "unprognostic (3.32e-2)" "unprognostic (9.57e-3)" "unprognostic (2.44e-2)" 0.1 0.1 0.1 1.9 0.1 1.7 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.2 0.0 0.2 0.1 0.1 0.0 0.1 0.1 1.3 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.9 0.0 64.2 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.0 4.0 19.9 12.5 0.0 0.1 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.5 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 12.5 11.2 0.0 7.3 0.1 0.0 0.0 0.1 4.0 0.0 0.0 0.0 19.9 0.0 3.1 2.3 0.1 3.6 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 387.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.6 441.6 3.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 1.7 0.0 0.0 0.0 0.0 0.0 SIRPG "bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma" ENSG00000089012 "Signal regulatory protein gamma" Q9P1W8 20 1629152-1657779 "CD markers, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 60.1;lymphoid tissue: 44.0" "Group enriched" "Detected in some" 14 "Early spermatids: 20.5;Late spermatids: 9.7;T-cells: 18.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 60.1" "Lineage enriched" "Detected in many" 6 "T-cells: 60.1" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 5.5;JURKAT: 12.1;NB-4: 15.0;RT4: 4.0;THP-1: 2.6" NA NA "unprognostic (3.35e-3)" "unprognostic (4.09e-3)" "unprognostic (7.32e-3)" "prognostic favorable (1.05e-6)" "unprognostic (4.23e-3)" "prognostic favorable (2.24e-4)" "unprognostic (4.49e-2)" "unprognostic (1.30e-2)" "prognostic favorable (7.36e-7)" "unprognostic (1.62e-2)" "unprognostic (6.90e-2)" "unprognostic (2.52e-1)" "prognostic unfavorable (1.47e-6)" "unprognostic (1.03e-1)" "unprognostic (2.18e-1)" "unprognostic (1.40e-2)" "unprognostic (2.95e-3)" 0.8 0.4 0.3 11.7 0.3 1.5 0.5 0.3 0.4 0.7 2.3 0.1 0.4 0.9 0.5 0.6 1.4 0.7 2.1 0.4 0.3 0.3 1.1 1.1 1.4 20.5 0.3 0.1 0.7 0.4 0.0 0.3 0.4 0.2 0.9 1.8 0.6 4.6 0.9 0.4 0.4 8.8 0.6 0.4 14.0 1.6 0.4 0.1 44.0 1.3 0.7 21.3 2.9 0.8 0.1 1.1 1.0 0.2 9.5 60.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 5.5 0.0 12.1 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.1 12.3 0.1 34.1 0.1 38.4 29.0 0.1 0.1 40.5 33.3 1.0 9.5 0.1 1.1 60.1 16.7 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 9.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 18.7 0.0 0.0 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 174.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.2 5.2 4.4 11.1 25.6 17.6 3.0 6.1 10.9 9.5 12.3 9.3 5.3 2.9 13.3 11.3 7.3 4.5 8.1 13.1 5.8 13.2 8.4 5.6 5.9 5.6 18.1 3.9 12.4 18.4 15.8 7.8 9.4 11.8 16.7 9.4 5.2 22.9 14.5 4.7 7.8 3.0 0.7 14.1 7.3 10.4 12.6 8.0 7.7 7.4 11.3 5.1 7.1 9.5 6.7 3.9 4.3 10.1 15.8 12.9 2.8 19.9 9.0 9.4 4.5 6.6 10.3 9.8 11.9 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 14.9 20.8 11.4 27.5 45.8 26.8 30.8 7.6 29.4 20.5 12.2 33.4 28.9 31.5 27.0 174.5 26.3 34.2 23.3 15.3 12.8 23.1 19.4 25.3 16.2 56.7 28.6 16.8 23.9 33.7 57.6 28.7 34.2 43.9 14.4 20.4 20.6 21.1 18.6 38.5 23.3 27.0 19.4 35.0 12.7 5.9 52.6 35.4 43.6 15.8 22.6 SIT1 SIT ENSG00000137078 "Signaling threshold regulating transmembrane adaptor 1" Q9Y3P8 9 35649295-35650950 "Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 56.9;lymphoid tissue: 80.9" "Group enriched" "Detected in some" 11 "B-cells: 66.3;T-cells: 47.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 42 "gdT-cell: 21.3;MAIT T-cell: 36.3;memory B-cell: 37.1;memory CD4 T-cell: 45.0;memory CD8 T-cell: 39.8;naive B-cell: 30.9;naive CD4 T-cell: 31.5;naive CD8 T-cell: 31.0;plasmacytoid DC: 33.9;T-reg: 56.9" "Group enriched" "Detected in many" 50 "B-cells: 37.1;dendritic cells: 33.9;T-cells: 56.9" "Group enriched" "Detected in some" 5 "Daudi: 40.3;HDLM-2: 24.9;JURKAT: 21.4;U-698: 36.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA018506 Enhanced NA NA "HPA018506: AB_2669896" "unprognostic (4.28e-3)" "prognostic favorable (6.56e-4)" "unprognostic (8.01e-3)" "prognostic favorable (1.94e-6)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-4)" "unprognostic (1.75e-2)" "unprognostic (9.34e-3)" "prognostic favorable (8.17e-4)" "unprognostic (2.00e-2)" "unprognostic (1.55e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.23e-1)" "unprognostic (1.47e-1)" "unprognostic (8.87e-2)" "unprognostic (6.34e-2)" 0.8 0.4 0.2 13.8 0.2 0.7 0.6 0.2 0.2 0.6 1.3 0.3 0.5 1.3 0.8 0.4 1.8 0.5 1.3 0.9 0.2 0.2 1.2 0.5 1.6 25.4 0.2 0.2 0.4 0.4 0.0 0.3 0.2 0.3 0.7 1.0 0.4 2.3 0.3 0.4 0.4 11.9 0.2 0.4 23.5 2.1 0.3 0.1 80.9 0.9 0.7 17.9 2.6 0.7 37.1 33.9 0.8 0.2 0.1 56.9 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 6.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.1 0.2 0.1 21.3 0.1 36.3 37.1 45.0 39.8 0.3 30.9 31.5 31.0 0.8 0.1 0.1 33.9 56.9 19.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.0 0.0 66.3 0.0 4.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.0 0.0 5.3 0.0 0.0 2.5 0.6 0.0 0.0 1.2 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.2 47.5 0.0 0.0 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643415-60658259 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0" "Cell type enhanced" "Detected in some" 19 "Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "olfactory region: 1.2;pons and medulla: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 7.1 0.4 0.3 0.1 0.5 0.1 4.7 0.3 0.6 7.4 0.2 0.2 0.0 0.1 0.2 2.1 1.3 0.5 0.4 0.4 0.3 0.3 0.3 0.2 1.8 0.3 0.4 1.2 0.3 0.3 16.8 39.1 0.1 4.5 8.7 0.1 2.0 55.1 0.2 59.0 0.4 0.2 0.7 0.5 0.2 0.5 1.6 0.0 6.5 2.4 22.5 3.0 1.4 9.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.9 0.2 11.9 6.9 8.1 0.1 2.0 4.5 2.3 2.0 0.0 3.8 0.0 1.1 0.4 1.1 2.7 3.9 3.6 0.8 0.0 9.5 0.9 0.8 2.7 0.0 0.0 0.1 6.0 1.8 1.6 0.3 14.3 0.1 0.7 2.6 0.0 53.4 1.3 0.0 0.2 0.0 0.0 4.8 0.0 29.2 0.0 2.3 6.5 1.1 0.1 2.3 0.1 2.4 0.2 1.4 0.2 6.8 3.2 3.2 3.7 3.0 0.2 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.5 0.3 0.3 0.4 1.2 4.5 0.0 3.0 1.0 0.0 23.3 0.1 0.0 0.8 0.0 65.6 33.0 1.8 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.7 0.4 0.8 24.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 1.1 0.0 0.3 0.0 0.2 0.0 2.5 0.1 0.2 0.0 0.0 14.9 SIX2 ENSG00000170577 "SIX homeobox 2" Q9NPC8 2 45005161-45009430 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 23.3;skeletal muscle: 21.0" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 2.2;Exocrine glandular cells: 1.9;Melanocytes: 1.7;Pancreatic endocrine cells: 1.2;Smooth muscle cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.9;LHCN-M2: 22.0;RH-30: 15.1;SCLC-21H: 25.8;U-2197: 16.7;U-698: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA056958 Supported "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA056958: AB_2683287" "unprognostic (1.14e-3)" "unprognostic (2.73e-2)" "unprognostic (3.09e-6)" "unprognostic (1.28e-2)" "unprognostic (3.28e-1)" "unprognostic (8.77e-2)" "unprognostic (4.06e-3)" "unprognostic (9.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.96e-1)" "unprognostic (1.02e-2)" "unprognostic (1.07e-2)" "unprognostic (4.53e-9)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-5)" "unprognostic (1.05e-1)" 5.8 0.2 0.2 0.2 0.4 0.1 3.4 0.5 0.4 13.3 0.4 0.2 0.0 0.1 1.1 0.8 0.8 0.1 0.1 0.8 0.1 0.0 0.4 0.1 0.3 0.2 0.9 1.8 0.3 4.6 5.7 13.5 0.3 1.4 5.2 0.1 9.3 23.3 1.3 21.0 0.3 0.1 0.4 0.8 0.1 7.4 1.1 0.0 3.9 0.7 4.0 0.8 1.7 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 6.3 23.9 0.0 0.1 1.1 0.4 0.0 0.2 0.0 0.0 1.0 0.0 0.1 0.0 2.2 3.9 0.2 0.0 1.2 0.0 7.7 0.0 0.0 0.0 2.1 1.1 0.0 4.9 0.0 0.1 0.7 0.2 0.1 0.0 22.0 0.8 0.0 1.3 0.2 0.0 4.8 0.0 15.1 0.0 0.0 1.2 25.8 0.2 3.3 0.1 0.0 0.2 0.1 1.9 0.3 0.4 1.3 16.7 0.0 0.5 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.1 0.0 0.9 1.8 1.4 0.0 0.0 0.0 0.0 0.4 0.8 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.1 0.6 0.0 0.0 0.0 0.1 SIX3 HPE2 ENSG00000138083 "SIX homeobox 3" O95343 2 44941898-44946077 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5" "Group enriched" "Detected in some" 18 "Bipolar cells: 197.9;Horizontal cells: 174.8;Muller glia cells: 357.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "basal ganglia: 40.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 34.3;SCLC-21H: 31.9;SH-SY5Y: 12.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 38.7" HPA067988 Approved Nucleoplasm NA NA Nucleoplasm "HPA067988: AB_2685939" "unprognostic (1.19e-3)" "unprognostic (1.05e-2)" "unprognostic (4.76e-1)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-2)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (1.44e-1)" "unprognostic (6.82e-2)" "unprognostic (1.22e-1)" "unprognostic (2.49e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-2)" 0.4 0.4 3.7 0.5 40.2 0.5 0.5 0.7 0.7 1.5 0.4 1.5 0.0 0.5 0.4 0.4 0.5 0.4 0.5 0.4 1.6 7.2 0.4 0.4 0.5 0.5 1.1 2.7 0.4 1.0 32.1 30.9 0.4 0.1 0.4 0.4 66.5 0.4 0.4 1.1 0.5 0.4 0.4 0.0 0.4 0.5 0.8 6.5 0.0 0.4 0.0 0.4 0.4 0.0 1.1 1.1 4.5 2.2 1.9 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.3 0.0 5.9 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 34.3 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 31.9 12.7 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 1.2 1.0 1.1 1.7 1.1 1.1 0.8 0.8 1.1 1.3 1.4 1.7 1.9 2.2 1.1 1.3 0.7 3.7 40.2 0.7 0.7 1.6 7.2 1.1 2.7 0.1 6.5 0.0 0.0 0.0 0.0 0.0 197.9 0.8 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 174.8 1.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 357.8 0.0 0.0 0.0 0.6 13.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 SIX4 AREC3 ENSG00000100625 "SIX homeobox 4" Q9UIU6 14 60709528-60724348 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 9.2;Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Glandular cells: 15.2;Urothelial cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 20.7;hTERT-RPE1: 15.9;RH-30: 21.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA031794 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031794: AB_10602928" "unprognostic (2.23e-1)" "unprognostic (9.50e-2)" "unprognostic (2.63e-4)" "unprognostic (9.74e-2)" "unprognostic (2.69e-2)" "unprognostic (1.03e-1)" "unprognostic (5.39e-2)" "unprognostic (1.28e-2)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (4.39e-2)" "unprognostic (5.38e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.08e-1)" 2.0 1.5 0.9 0.6 0.9 0.3 4.8 4.3 4.5 3.3 0.7 0.1 3.3 0.4 1.6 1.3 0.5 3.5 1.1 1.5 1.0 1.0 1.4 0.5 2.1 0.2 1.0 2.2 2.9 3.3 20.4 6.3 2.1 3.6 4.0 0.3 0.8 16.4 2.7 19.3 0.5 0.5 0.9 1.8 0.3 2.0 0.7 1.1 0.8 3.9 2.4 1.4 1.7 14.3 0.2 0.1 1.0 0.1 0.3 0.2 0.0 20.7 1.5 1.2 5.6 4.9 6.2 9.8 4.7 7.1 1.4 2.0 1.0 6.6 0.0 3.1 2.3 1.4 7.9 5.6 3.8 3.3 1.6 4.6 0.6 2.1 1.4 1.6 2.1 0.2 2.9 1.8 1.3 6.6 15.9 1.2 0.4 4.1 0.0 7.2 5.2 0.0 0.2 3.6 0.1 8.9 1.3 21.0 0.0 2.5 11.9 3.4 0.3 3.0 4.7 1.2 2.0 6.4 0.1 4.1 4.4 9.7 2.9 4.2 1.4 0.0 0.0 1.5 0.0 0.8 0.3 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.1 1.0 0.3 0.1 0.1 0.0 0.0 0.9 0.9 4.3 4.5 1.0 1.0 1.0 2.2 3.6 1.1 3.0 0.3 0.0 9.2 0.3 0.2 1.6 0.0 20.1 6.8 1.8 19.6 4.7 0.0 0.1 0.0 0.3 0.0 0.0 0.9 3.3 1.9 15.2 1.1 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.3 0.1 1.7 0.0 0.0 1.7 2.7 0.0 1.4 0.3 0.4 0.0 0.3 0.1 0.9 0.5 2.6 0.0 0.0 10.5 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60508951-60512850 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 43.3" "Cell type enhanced" "Detected in some" 33 "Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Region enriched" "Detected in single" 8 "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 9.3;MOLT-4: 29.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "hypothalamus: 2.5" HPA001403 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.4 0.0 10.6 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 29.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SKA1 "C18orf24, MGC10200" ENSG00000154839 "Spindle and kinetochore associated complex subunit 1" Q96BD8 18 50374995-50394173 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.5;testis: 28.0" "Cell type enhanced" "Detected in some" 14 "Erythroid cells: 23.3;Extravillous trophoblasts: 8.2;Spermatocytes: 15.8;Spermatogonia: 8.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebellum: 2.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 31.2" "Not detected" "Not detected" HPA045495 Approved Supported Microtubules NA Yes Microtubules "HPA045495: AB_10960405" "unprognostic (2.18e-2)" "unprognostic (7.85e-3)" "unprognostic (7.66e-3)" "unprognostic (5.93e-3)" "unprognostic (1.91e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (9.60e-8)" "unprognostic (1.03e-3)" "unprognostic (1.16e-2)" "unprognostic (1.20e-2)" "unprognostic (1.18e-4)" "unprognostic (3.91e-3)" "unprognostic (0.00e+0)" "unprognostic (4.50e-3)" "unprognostic (4.66e-2)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" 1.3 1.5 0.3 6.3 0.3 12.1 1.5 2.2 0.5 1.2 1.9 0.1 0.0 1.7 0.5 0.8 6.1 0.3 1.1 0.4 0.5 0.4 0.6 0.8 1.3 5.2 0.5 0.4 0.4 2.8 0.1 0.3 3.3 0.4 0.4 2.8 0.2 1.2 0.0 0.6 1.5 2.0 1.4 1.0 4.4 1.5 28.0 0.0 27.5 0.4 5.9 8.7 0.9 1.6 2.1 0.6 2.5 0.9 1.7 1.9 1.1 9.9 3.9 6.4 6.2 0.5 0.9 3.8 11.1 4.7 13.0 12.9 6.5 3.6 8.9 2.9 3.4 9.1 8.9 9.1 4.5 12.3 12.5 3.1 10.7 3.1 6.8 1.1 17.0 10.7 0.5 0.4 11.2 6.6 1.0 7.3 10.8 13.6 31.2 10.6 3.5 12.0 3.8 4.7 2.7 3.1 5.9 8.2 8.7 2.5 1.1 5.5 3.5 6.7 3.5 5.1 5.2 5.0 5.9 3.9 13.0 7.1 4.5 11.8 13.5 21.7 15.2 5.7 13.9 11.0 1.9 0.9 0.5 0.9 0.4 0.6 1.7 1.2 1.9 0.5 2.1 0.7 0.8 2.5 1.7 0.5 0.6 1.5 1.1 0.3 0.3 2.2 0.5 0.5 0.4 0.5 0.4 0.4 0.0 0.0 2.1 0.8 0.1 0.9 0.3 0.3 0.0 0.0 1.2 0.0 2.0 0.9 0.0 0.1 2.7 0.3 0.0 23.3 0.0 8.2 0.4 0.3 0.0 0.0 4.4 0.0 1.2 1.3 0.3 1.5 0.3 0.3 0.0 0.0 0.3 0.5 0.2 0.0 0.0 0.0 0.6 0.0 0.0 15.8 8.6 0.3 1.3 1.3 1.0 0.7 SKA3 "C13orf3, MGC4832, RAMA1" ENSG00000165480 "Spindle and kinetochore associated complex subunit 3" Q8IX90 13 21153595-21176602 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 41.6;testis: 12.6" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "T-reg: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 1.9;T-cells: 2.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039272, HPA039356, HPA061534" Approved Supported "Mitotic spindle,Centrosome,Cytosol" Yes Yes "Mitotic spindle, Centrosome" Cytosol "HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: " "unprognostic (3.46e-2)" "unprognostic (7.21e-2)" "unprognostic (2.15e-1)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (9.73e-6)" "unprognostic (2.03e-3)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.39e-2)" "unprognostic (0.00e+0)" "unprognostic (2.24e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" 0.8 0.6 0.6 6.4 0.6 6.2 0.9 0.4 1.6 0.8 2.8 0.3 0.0 1.1 1.0 0.8 5.1 0.2 0.3 0.4 0.8 0.5 0.8 0.5 1.0 6.1 0.6 0.3 0.5 0.4 0.0 0.6 2.6 0.8 0.4 4.0 0.2 0.9 0.0 0.5 2.4 3.1 1.1 0.5 2.6 1.4 12.6 0.3 41.6 0.3 5.7 6.4 0.5 1.4 0.4 0.2 0.3 0.3 1.9 2.3 0.6 11.3 6.0 10.8 9.1 0.0 2.3 8.5 15.3 6.5 19.4 13.2 9.8 12.2 15.5 4.6 8.4 8.3 10.7 14.4 6.2 21.2 13.3 7.4 20.6 3.9 5.6 0.0 16.0 8.0 0.4 0.4 15.5 5.2 1.8 9.4 13.2 10.7 6.6 12.8 8.8 24.3 14.4 12.5 17.2 11.2 16.0 23.2 7.2 4.3 4.4 13.8 5.1 5.1 8.0 3.2 7.5 7.1 12.3 3.8 7.7 11.1 7.1 18.4 4.0 8.5 15.6 1.9 12.5 22.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.8 1.4 0.2 0.0 0.8 0.3 0.0 1.9 0.3 0.0 2.3 0.6 0.6 0.6 0.4 1.6 0.8 0.5 0.6 0.3 0.8 0.3 0.0 0.0 2.2 0.5 1.8 0.0 0.6 0.0 2.7 2.3 0.0 0.0 1.3 0.0 0.9 5.1 0.8 0.2 0.0 1.2 19.6 0.8 0.4 0.0 0.2 4.6 0.0 0.0 2.5 1.9 6.0 1.4 2.2 0.0 1.0 0.3 0.2 0.6 0.9 1.1 0.3 0.0 0.0 0.9 18.7 13.5 2.5 1.8 1.0 2.7 0.1 SKAP1 "SCAP1, SKAP55" ENSG00000141293 "Src kinase associated phosphoprotein 1" Q86WV1 17 48133440-48430275 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9;lymphoid tissue: 52.1" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 48.5;granulocytes: 113.6;Late spermatids: 118.7;T-cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 19.3;HDLM-2: 9.9;HMC-1: 8.5;JURKAT: 14.5;Karpas-707: 10.5;RPMI-8226: 12.4;RPTEC TERT1: 15.4;U-266/70: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002969, CAB025882, CAB055513" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" Cytosol "CAB025882: , CAB055513: , HPA002969: AB_1079870" "prognostic favorable (5.07e-4)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" "unprognostic (1.80e-2)" "unprognostic (2.28e-2)" "unprognostic (1.43e-2)" "unprognostic (2.61e-2)" "unprognostic (1.57e-2)" "unprognostic (8.39e-2)" "unprognostic (1.81e-1)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (5.71e-2)" "unprognostic (6.20e-2)" "unprognostic (2.72e-1)" "unprognostic (1.94e-1)" "prognostic favorable (3.14e-4)" 1.9 9.4 0.5 28.0 0.6 2.9 4.5 0.4 0.6 5.9 3.8 0.6 10.9 1.1 2.2 10.6 2.1 8.0 6.2 2.1 1.3 1.1 12.9 2.0 5.2 20.0 0.7 0.4 2.4 2.8 11.6 17.5 0.7 1.2 3.0 2.4 1.6 10.2 7.4 0.5 1.2 6.1 1.2 1.9 11.7 2.2 7.8 0.6 52.1 1.8 1.3 27.7 5.1 4.3 11.9 0.1 2.1 0.2 22.3 50.9 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 19.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 10.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 15.4 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 9.6 6.8 0.0 0.0 0.0 0.0 2.1 0.1 0.3 35.9 0.0 30.1 2.8 29.6 32.2 0.1 11.9 26.1 28.9 0.7 22.3 0.2 0.1 50.9 22.3 0.5 0.6 0.4 0.6 1.3 1.1 0.7 0.4 1.2 0.6 3.0 14.6 10.4 0.1 1.8 0.0 0.6 0.0 2.7 5.7 8.7 0.0 0.1 39.7 0.2 48.5 1.6 0.3 0.0 1.6 0.1 1.3 0.3 113.6 25.1 0.2 0.0 1.2 6.2 3.7 118.7 1.4 1.7 1.7 0.0 0.6 2.0 1.5 0.0 0.7 1.1 0.3 6.5 0.3 34.8 4.1 1.1 0.2 123.7 0.1 0.4 SKI ENSG00000157933 "SKI proto-oncogene" P12755 1 2228695-2310119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Craniosynostosis, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010449, HPA066567" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "CAB010449: AB_2187342, HPA066567: AB_2685692" "unprognostic (3.99e-2)" "unprognostic (3.81e-2)" "unprognostic (1.44e-1)" "unprognostic (5.42e-2)" "unprognostic (4.66e-2)" "unprognostic (7.32e-2)" "unprognostic (1.88e-1)" "unprognostic (9.14e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (4.94e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-3)" "unprognostic (1.88e-1)" "unprognostic (7.82e-2)" "unprognostic (9.69e-2)" "unprognostic (5.24e-3)" 12.5 4.7 11.8 7.1 22.5 4.8 8.1 34.5 21.2 9.8 8.2 5.5 3.1 4.6 11.9 4.4 5.9 9.1 8.0 9.0 11.0 4.1 4.4 6.1 11.1 6.9 6.2 10.1 10.4 9.6 4.2 6.2 7.4 8.5 8.4 3.5 4.0 12.0 11.9 6.8 11.7 5.9 9.3 5.3 9.3 6.0 7.2 5.3 3.6 6.9 8.1 5.1 7.6 7.8 0.8 0.3 3.0 0.6 1.3 0.6 0.4 10.3 6.0 14.5 14.1 24.3 14.6 9.6 15.5 8.7 9.7 7.1 9.1 8.0 6.5 11.7 19.9 4.0 12.2 8.1 12.6 9.0 7.2 17.6 16.5 9.1 12.8 16.3 9.2 17.8 15.7 7.0 14.6 10.9 18.0 11.8 2.8 9.3 5.1 11.9 6.6 1.1 10.3 14.7 6.8 11.6 5.1 9.2 5.4 8.2 4.1 20.9 13.6 15.1 13.5 15.0 9.7 4.6 12.0 21.4 16.7 10.5 23.5 12.0 4.0 2.8 6.1 8.9 16.2 6.8 0.6 0.5 0.3 0.5 0.6 0.5 0.3 0.4 0.5 0.3 0.8 0.6 0.5 3.0 1.3 0.3 0.1 0.4 0.4 11.8 22.5 34.5 21.2 11.0 4.1 6.2 10.1 8.5 5.3 8.9 9.3 3.9 12.4 41.8 8.0 12.0 15.3 2.7 6.8 7.0 0.0 6.2 1.7 6.9 0.5 30.3 7.0 23.3 5.9 13.9 21.2 11.5 12.7 18.7 12.5 11.1 5.8 34.4 12.9 2.4 46.1 20.1 15.1 1.0 13.5 10.3 9.7 9.3 51.9 5.0 4.4 45.3 30.6 2.6 13.4 39.4 13.6 13.8 9.3 8.4 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" 10 21513478-21526368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 9.6" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 13.7;Early spermatids: 13.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 23.1;AN3-CA: 5.9;BEWO: 10.7;SH-SY5Y: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.9 1.9 1.9 0.4 3.3 1.7 2.2 3.1 5.9 1.3 1.7 0.0 0.0 0.3 1.0 1.0 0.9 1.7 0.6 5.5 2.5 1.8 4.1 4.3 1.0 0.3 1.4 3.4 4.2 1.5 7.3 1.8 2.5 3.0 1.1 0.6 4.1 2.6 2.0 0.5 2.9 0.5 1.0 1.2 0.4 0.6 4.6 0.3 0.9 9.6 0.7 0.3 1.1 1.1 0.6 0.5 1.5 0.6 0.5 0.3 0.1 0.4 1.0 23.1 5.9 0.5 0.2 10.7 0.5 0.3 0.0 0.0 2.1 0.1 0.2 0.9 0.3 0.1 1.4 2.1 0.4 0.0 0.0 2.6 0.1 1.0 0.2 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.2 0.1 0.9 0.7 0.1 1.4 0.0 0.0 0.3 0.7 0.0 0.4 0.6 2.5 5.3 0.8 4.0 0.1 2.0 0.4 4.6 0.3 0.2 0.7 0.2 0.5 0.1 0.0 0.3 1.4 0.0 0.2 1.5 0.3 0.5 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.6 0.3 0.3 1.3 0.5 0.6 0.5 0.2 0.1 1.9 3.3 3.1 5.9 2.5 1.8 1.4 3.4 3.0 0.3 0.0 1.0 0.0 0.8 1.3 13.7 5.2 5.1 0.0 2.3 1.8 0.0 4.6 6.6 0.1 13.5 3.5 0.0 0.0 0.6 3.1 1.7 0.6 1.1 8.9 2.4 1.6 0.0 3.1 1.5 6.6 1.4 0.0 0.0 0.0 0.0 6.8 0.5 0.0 2.1 5.1 4.0 6.5 0.6 4.8 3.2 1.6 2.9 0.0 0.0 0.2 SKOR1 "CORL1, FUSSEL15, LBXCOR1" ENSG00000188779 "SKI family transcriptional corepressor 1" P84550 15 67819704-67834561 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 17.8" "Group enriched" "Detected in some" 6 "Early spermatids: 16.7;Late spermatids: 23.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 8 "cerebellum: 17.8;pons and medulla: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 5.9;U-266/84: 4.7;U-698: 5.1" "Group enriched" "Detected in some" 11 "cerebellum: 4.2;pons and medulla: 1.3" "Region enriched" "Detected in some" 5 "cerebellum: 9.0" HPA071150 Enhanced NA NA "HPA071150: " "unprognostic (8.98e-2)" "unprognostic (4.15e-2)" "unprognostic (5.44e-7)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-3)" "unprognostic (8.40e-5)" "unprognostic (5.51e-3)" "unprognostic (1.00e-1)" "unprognostic (8.13e-2)" "unprognostic (9.31e-2)" "unprognostic (1.93e-1)" "unprognostic (4.28e-5)" "unprognostic (1.96e-1)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" 1.1 0.6 0.7 0.4 1.3 1.7 0.7 17.8 2.4 0.5 0.7 0.4 0.4 1.4 1.0 0.5 0.4 0.6 0.7 0.4 0.6 1.1 0.5 0.4 0.7 0.4 0.5 0.4 1.2 1.3 0.1 1.3 0.9 4.4 0.8 0.3 0.4 0.7 0.9 1.5 0.7 0.9 0.6 5.4 0.7 0.4 2.4 0.4 0.4 0.5 0.4 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.4 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.5 0.2 0.1 0.0 0.1 0.2 0.4 0.0 0.4 0.9 1.0 0.3 0.0 0.2 2.4 0.7 0.1 0.2 0.0 0.1 0.4 0.0 1.8 0.1 0.8 0.0 0.2 0.5 1.0 0.0 0.2 0.2 0.6 0.3 1.3 0.0 0.1 0.2 2.1 0.1 0.0 0.4 0.3 0.3 1.1 0.3 0.1 0.5 0.2 0.3 5.9 4.7 5.1 0.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 1.3 17.8 1.2 0.6 1.1 0.5 0.4 4.4 0.4 0.0 0.0 0.0 0.0 0.1 0.6 3.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.5 0.2 0.4 0.0 0.0 0.0 0.0 SKOR2 "CORL2, Fussel-18, FUSSEL18" ENSG00000215474 "SKI family transcriptional corepressor 2" Q2VWA4 18 47206322-47251603 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.5;testis: 3.3" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 1.9;Spermatocytes: 1.8;Spermatogonia: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "NTERA-2: 9.5" "Region enriched" "Detected in single" 5 "cerebellum: 2.7" "Region enhanced" "Detected in single" "cerebellum: 1.3" HPA046206 Uncertain NA NA "HPA046206: AB_2679588" "unprognostic (1.53e-1)" "unprognostic (1.93e-1)" "unprognostic (1.92e-1)" "unprognostic (6.31e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.5 0.0 0.0 0.0 0.0 0.0 SKP2 "FBL1, FBXL1, p45" ENSG00000145604 "S-phase kinase associated protein 2" Q13309 5 36151989-36184319 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 117.2;Extravillous trophoblasts: 184.7;Syncytiotrophoblasts: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 75.1;RH-30: 94.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013491, CAB013533, HPA051196, HPA054633" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550" "unprognostic (2.32e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" "unprognostic (5.74e-2)" "unprognostic (9.56e-2)" "unprognostic (1.52e-2)" "unprognostic (1.21e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.72e-7)" "prognostic favorable (8.57e-4)" "unprognostic (5.06e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (4.77e-15)" "unprognostic (2.50e-2)" "unprognostic (3.73e-1)" "unprognostic (1.63e-1)" "unprognostic (2.19e-1)" 6.5 6.9 7.8 8.0 7.5 12.9 6.5 11.5 9.0 7.5 7.7 10.3 3.7 10.2 9.9 6.3 13.5 8.1 4.9 4.1 7.3 5.1 4.2 14.0 5.8 9.4 8.8 7.4 7.7 6.1 3.9 12.5 49.1 6.5 7.2 9.5 6.1 6.3 5.4 3.4 7.6 7.7 6.4 7.4 9.4 5.3 3.9 7.4 19.5 5.0 7.5 11.7 7.9 8.4 6.5 16.0 14.7 7.9 7.7 8.5 5.0 7.6 3.8 16.2 18.0 3.9 6.4 75.1 9.9 7.5 25.4 19.2 21.0 6.0 11.0 2.7 8.0 4.6 8.0 18.0 12.5 27.3 4.9 10.4 6.4 14.1 9.9 1.9 14.2 2.9 5.8 3.3 4.6 3.2 2.6 7.0 9.9 11.0 2.5 9.1 3.7 16.5 8.2 14.7 7.5 5.8 16.3 94.3 7.0 1.8 8.0 13.9 16.6 31.0 6.8 4.3 12.4 6.8 8.0 3.2 9.5 11.0 3.5 6.8 3.2 3.0 13.6 4.3 17.5 6.8 10.3 7.9 14.7 5.4 7.2 8.5 5.6 5.7 5.8 16.0 6.5 7.9 6.0 1.5 7.7 4.1 4.3 5.3 5.0 7.8 7.5 11.5 9.0 7.3 5.1 8.8 7.4 6.5 7.4 20.8 9.9 6.7 3.2 3.3 7.4 1.1 2.5 6.7 0.0 1.8 9.8 117.2 1.7 2.4 0.4 3.6 2.3 0.0 2.6 184.7 4.7 0.7 2.3 8.6 29.3 0.0 2.9 1.3 9.2 0.0 3.7 2.6 1.7 7.2 3.6 2.3 2.6 3.5 6.0 1.1 6.8 0.0 2.3 0.7 4.0 3.4 70.1 6.4 7.4 0.9 SLA "hSLAP, SLA1, SLAP, SLAP-1" ENSG00000155926 "Src like adaptor" Q13239 8 133036724-133103054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 61.6;lymphoid tissue: 152.5" "Cell type enhanced" "Detected in many" 14 "Hofbauer cells: 59.4;Kupffer cells: 193.1;Macrophages: 141.0;T-cells: 117.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 14.1;JURKAT: 59.1;Karpas-707: 37.9;U-266/84: 21.3;U-937: 14.9" "Group enriched" "Detected in many" 5 "amygdala: 14.8;basal ganglia: 9.9;cerebellum: 44.5;cerebral cortex: 11.2;hippocampal formation: 11.6" "Low region specificity" "Detected in all" "HPA012296, HPA074192" Enhanced Approved "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "HPA012296: AB_1856946, HPA074192: AB_2686673" "unprognostic (1.19e-2)" "unprognostic (6.29e-3)" "unprognostic (2.73e-3)" "unprognostic (6.07e-3)" "unprognostic (1.66e-2)" "unprognostic (1.10e-2)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (9.25e-2)" "unprognostic (3.03e-2)" "unprognostic (2.73e-1)" "unprognostic (2.80e-3)" "unprognostic (2.66e-1)" "unprognostic (3.05e-2)" "unprognostic (8.60e-2)" "unprognostic (1.65e-1)" 6.8 3.6 2.5 21.3 2.7 24.0 2.6 1.6 3.3 2.7 2.2 1.5 1.7 1.6 2.1 1.6 2.4 3.2 5.3 2.6 2.8 1.7 3.2 3.5 11.2 18.2 2.5 2.7 1.7 1.4 0.0 1.4 3.4 2.0 2.1 1.7 1.5 4.0 1.4 1.6 1.3 8.4 2.8 4.1 33.3 2.5 1.6 1.4 152.5 9.2 2.1 18.3 4.3 1.6 11.2 18.4 61.6 31.7 29.2 27.5 29.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 1.7 14.1 0.2 0.0 0.1 0.0 0.0 0.0 59.1 0.0 37.9 0.0 0.0 10.0 2.4 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.0 0.1 0.0 0.0 2.0 21.3 0.0 0.2 14.9 0.0 0.1 24.3 45.0 21.2 28.1 26.7 9.5 19.5 21.1 18.4 11.2 18.6 18.9 61.6 29.2 31.7 1.4 27.5 29.6 2.5 2.7 1.6 3.3 2.8 1.7 2.5 2.7 2.0 1.4 8.9 25.0 32.9 0.3 1.9 7.0 2.0 2.5 9.4 19.4 0.0 0.0 0.4 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.7 2.3 0.1 34.8 1.7 59.4 0.0 0.0 11.1 193.1 0.9 0.3 141.0 5.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 6.5 0.9 0.0 0.0 2.4 0.1 117.6 0.0 0.1 SLA2 "C20orf156, FLJ21992, SLAP-2" ENSG00000101082 "Src like adaptor 2" Q9H6Q3 20 36612318-36646216 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.7;lymphoid tissue: 36.5" "Cell type enriched" "Detected in some" 8 "T-cells: 31.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 6 "gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9" "Group enriched" "Detected in many" 8 "dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9" "Group enriched" "Detected in some" 7 "HEL: 41.9;JURKAT: 24.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA053746, HPA058217" Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Nucleoplasm, Golgi apparatus, Vesicles" "HPA053746: AB_2682246, HPA058217: AB_2683641" "unprognostic (4.16e-3)" "prognostic favorable (7.36e-4)" "unprognostic (4.52e-4)" "unprognostic (2.30e-6)" "unprognostic (3.37e-2)" "unprognostic (3.79e-3)" "unprognostic (2.15e-3)" "unprognostic (1.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.84e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.77e-8)" "unprognostic (8.48e-2)" "unprognostic (1.73e-1)" "unprognostic (1.98e-2)" "unprognostic (6.45e-3)" 2.3 0.8 0.7 15.1 0.8 11.3 1.3 1.5 0.5 1.5 3.9 0.2 2.3 2.8 2.0 1.1 1.7 1.4 4.8 1.6 0.7 0.7 1.5 1.9 6.9 17.1 0.7 0.0 1.6 0.8 0.0 1.1 1.6 0.8 1.5 1.8 1.8 6.3 0.4 0.9 0.7 7.5 1.5 1.1 15.9 2.5 1.0 0.3 36.5 1.5 1.1 18.4 3.8 1.3 0.2 21.7 2.3 0.3 16.5 14.9 11.6 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 0.2 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.1 4.9 3.5 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.5 0.0 0.8 0.2 1.6 13.9 0.3 11.7 0.2 11.5 12.9 0.1 0.1 10.8 14.5 2.3 16.5 0.0 21.7 14.9 11.6 0.7 0.8 1.5 0.5 0.7 0.7 0.7 0.0 0.8 0.3 0.0 3.8 0.0 0.1 0.3 0.2 0.3 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 1.1 0.0 0.2 0.0 0.0 1.3 1.5 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.1 0.1 31.9 0.1 0.3 SLAIN1 "C13orf32, FLJ30046" ENSG00000139737 "SLAIN motif family member 1" Q8ND83 13 77697854-77764242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 89.3" "Group enriched" "Detected in many" 4 "Early spermatids: 44.5;Muller glia cells: 87.9" "Cancer enhanced" "Detected in many" "glioma: 25.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 2.2;T-cells: 4.7" "Cell line enhanced" "Detected in many" "HEK 293: 20.8;HL-60: 27.6;MOLT-4: 31.7;REH: 22.1;SCLC-21H: 21.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (8.76e-5)" "unprognostic (1.78e-2)" "unprognostic (3.11e-1)" "unprognostic (3.25e-3)" "unprognostic (1.60e-1)" "unprognostic (3.78e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (6.20e-2)" "prognostic favorable (9.07e-4)" "unprognostic (4.80e-3)" "unprognostic (3.83e-3)" "unprognostic (2.16e-2)" "unprognostic (4.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (1.97e-2)" 1.4 6.0 27.6 3.0 41.5 8.7 4.1 14.2 73.1 3.6 1.7 74.8 0.3 1.9 4.4 7.4 2.6 10.2 2.4 3.7 39.1 20.7 5.1 4.5 6.0 5.8 56.7 19.6 4.8 6.5 7.5 2.7 2.4 38.3 4.5 2.0 1.3 5.6 3.8 1.9 1.3 1.6 3.2 89.3 4.6 6.6 17.6 51.9 4.1 6.5 0.0 6.0 2.5 1.0 0.7 2.2 0.0 0.2 0.8 4.7 1.0 0.1 1.2 15.3 0.3 0.0 0.0 2.6 0.1 0.0 0.0 0.0 1.4 3.1 11.6 0.8 0.0 0.0 0.1 14.4 0.0 0.0 14.5 20.8 9.9 2.8 0.2 0.4 27.6 0.7 0.0 0.0 0.0 0.0 1.7 0.5 16.5 0.3 15.6 0.0 0.3 31.7 2.8 5.8 10.2 4.6 22.1 1.3 0.0 7.1 1.2 21.9 11.1 0.0 4.2 2.8 5.3 0.0 12.6 0.1 0.2 0.6 0.1 4.0 15.1 6.8 14.0 1.7 3.3 0.9 0.0 0.1 0.0 2.1 0.2 3.0 0.7 2.5 2.3 0.2 0.6 2.7 4.2 0.0 0.8 0.2 2.2 4.7 1.0 27.6 41.5 14.2 26.2 39.1 20.7 56.7 19.6 38.3 51.9 11.9 9.6 3.4 2.7 0.7 8.2 3.6 10.2 0.0 3.4 3.5 15.7 1.4 1.7 2.0 44.5 1.5 0.0 0.0 2.3 0.1 1.9 4.1 0.0 4.9 0.2 3.2 8.6 3.1 0.8 12.1 1.4 0.7 6.8 0.0 0.5 87.9 2.7 0.0 0.7 3.3 3.0 0.0 2.3 3.6 2.0 1.1 0.3 5.1 0.0 3.0 SLAMF1 "CD150, SLAM" ENSG00000117090 "Signaling lymphocytic activation molecule family member 1" Q13291 1 160608100-160647295 "CD markers, Predicted membrane proteins, Predicted secreted proteins" "Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 97.8" "Cell type enhanced" "Detected in some" 18 "Melanocytes: 13.5;monocytes: 38.7;T-cells: 20.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "MAIT T-cell: 24.1" "Group enriched" "Detected in many" 10 "B-cells: 8.8;T-cells: 24.1" "Cell line enriched" "Detected in single" 111 "HDLM-2: 58.4" "CAB002438, HPA069319" Enhanced "Secreted to blood" NA NA 590000 "CAB002438: AB_564011, HPA069319: AB_2732129" "unprognostic (2.99e-3)" "unprognostic (3.33e-4)" "unprognostic (2.93e-4)" "unprognostic (1.38e-4)" "unprognostic (5.87e-2)" "unprognostic (6.06e-5)" "unprognostic (1.64e-2)" "unprognostic (1.70e-3)" "unprognostic (1.69e-2)" "unprognostic (2.74e-4)" "unprognostic (6.12e-2)" "unprognostic (3.58e-1)" "unprognostic (1.24e-7)" "unprognostic (2.46e-1)" "unprognostic (8.46e-2)" "unprognostic (1.22e-1)" "unprognostic (2.18e-2)" 2.5 0.3 0.3 14.2 0.3 4.4 1.4 0.2 0.3 1.2 2.3 0.4 0.5 2.2 0.5 1.2 2.2 0.8 2.3 1.3 0.2 0.2 2.0 1.0 4.0 14.8 0.2 0.1 0.6 0.9 0.0 0.5 2.3 0.3 1.1 2.1 0.6 4.1 0.6 0.8 1.1 7.6 1.0 0.5 10.6 2.4 0.4 0.2 97.8 1.5 1.9 26.3 3.5 1.1 8.8 1.6 0.2 0.1 0.0 24.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.0 4.2 0.0 24.1 6.2 17.2 12.1 0.1 8.8 6.6 1.6 0.2 0.0 0.0 1.6 21.5 3.5 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.1 0.3 0.2 0.0 6.9 8.1 0.1 1.8 0.0 0.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.3 0.0 0.0 0.0 1.2 6.2 0.0 5.0 13.5 38.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.5 0.1 20.2 0.0 0.0 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 51.9" "Cell type enhanced" "Detected in some" 15 "B-cells: 8.3;Early spermatids: 9.3;Late spermatids: 16.5;T-cells: 20.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 33.3;U-698: 49.0" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051363: AB_2681454, HPA051903: AB_2681658" "prognostic favorable (9.42e-4)" "prognostic favorable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favorable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favorable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 3.9 0.8 0.4 21.0 0.4 1.2 1.0 0.4 0.4 1.1 3.8 0.3 0.4 1.1 1.0 0.6 2.3 1.6 2.8 1.2 0.4 0.4 2.1 1.6 4.7 51.9 0.6 0.4 0.6 0.8 0.0 0.6 1.7 0.7 1.4 1.5 1.5 5.6 1.0 0.5 0.7 11.9 0.4 0.8 29.6 2.3 0.9 0.2 12.9 1.8 0.6 30.4 4.1 1.3 15.2 0.3 8.4 1.0 15.9 28.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 0.0 8.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 49.0 0.0 0.2 0.0 2.5 0.1 8.4 22.9 0.3 15.8 14.7 14.6 28.6 0.1 15.2 8.2 16.4 1.0 15.9 1.0 0.3 16.8 7.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 0.7 0.2 0.0 2.2 8.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.8 0.9 0.0 0.0 3.7 3.8 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 20.8 0.0 0.0 SLAMF7 "19A, CD319, CRACC, CS1" ENSG00000026751 "SLAM family member 7" Q9NQ25 1 160739057-160754821 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.9;lymphoid tissue: 45.0" "Cell type enriched" "Detected in many" 5 "monocytes: 204.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "U-266/70: 80.7" "Low region specificity" "Detected in all" "CAB015445, HPA055945, HPA061654" Enhanced Approved Vesicles NA NA 620000 Vesicles "CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (1.84e-3)" "unprognostic (2.12e-3)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (7.87e-2)" "unprognostic (7.19e-2)" "unprognostic (2.46e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.08e-1)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.57e-5)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-2)" 5.5 1.0 0.7 28.6 0.7 2.3 3.4 0.6 0.7 4.1 11.9 0.2 0.4 11.1 1.9 1.3 6.7 1.6 6.2 1.0 0.7 0.7 2.4 3.1 10.2 24.6 0.8 0.4 2.5 2.2 0.0 0.9 1.3 0.6 1.8 10.2 2.9 15.1 4.8 0.9 2.0 15.8 0.8 1.2 45.0 11.0 1.5 0.4 5.9 2.1 4.2 38.7 11.5 2.6 3.7 27.4 1.1 14.9 17.3 32.9 8.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.2 0.0 0.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 80.7 6.8 0.0 2.2 0.0 0.0 0.0 1.6 0.3 32.9 11.0 25.4 3.7 3.5 22.4 7.2 0.6 1.1 13.6 1.1 17.3 14.9 27.4 0.0 8.7 0.7 0.7 0.6 0.7 0.7 0.7 0.8 0.4 0.6 0.4 8.9 8.9 20.2 1.4 0.7 0.0 0.8 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 23.3 2.3 0.1 1.1 1.8 8.1 0.0 8.9 0.0 0.0 0.6 6.0 0.0 0.0 12.8 18.6 204.6 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 39.5 0.0 3.0 SLAMF8 "BLAME, CD353, SBBI42" ENSG00000158714 "SLAM family member 8" Q9P0V8 1 159826750-159837249 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.1" "Group enriched" "Detected in some" 10 "Hofbauer cells: 37.6;Kupffer cells: 13.7;Macrophages: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 12.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.2;HL-60: 3.6;U-138 MG: 5.0;U-87 MG: 2.8;U-937: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA067601 Enhanced NA NA "HPA067601: AB_2685870" "unprognostic (1.04e-1)" "unprognostic (8.80e-3)" "unprognostic (5.12e-2)" "unprognostic (2.14e-3)" "unprognostic (3.07e-2)" "unprognostic (3.22e-2)" "unprognostic (7.87e-2)" "unprognostic (4.29e-1)" "unprognostic (2.20e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.50e-1)" "unprognostic (4.42e-2)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" 16.9 4.6 1.5 20.1 3.4 0.4 5.4 8.2 1.6 3.1 6.0 1.4 0.6 4.6 1.8 4.2 3.1 3.6 6.1 7.1 5.2 1.7 7.8 2.2 19.6 44.1 4.1 0.7 3.8 2.0 0.1 4.2 5.4 5.0 2.7 7.1 3.0 4.2 1.0 2.2 3.1 7.0 5.4 4.1 22.7 3.1 2.4 2.7 9.7 4.8 3.0 12.7 8.6 2.8 0.0 12.1 0.5 6.6 8.1 3.8 2.8 0.0 0.1 0.0 0.0 0.5 4.2 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 1.8 0.0 0.0 0.0 3.6 0.7 1.4 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.8 0.2 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.7 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.0 2.8 2.6 0.0 0.0 5.1 0.0 3.2 6.6 0.2 0.0 1.1 3.8 12.1 0.0 0.2 2.6 0.5 8.1 0.4 0.1 0.0 2.8 1.5 3.4 8.2 1.6 5.2 1.7 4.1 0.7 5.0 2.7 0.0 2.9 0.0 0.0 1.5 0.2 0.2 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 37.6 0.0 0.0 0.0 13.7 0.0 0.3 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.5 0.8 0.0 0.0 SLAMF9 "CD2F-10, CD84-H1, SF2001" ENSG00000162723 "SLAM family member 9" Q96A28 1 159951492-159954254 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "adipose tissue: 20.3;blood: 5.5" "Group enriched" "Detected in some" 5 "Early spermatids: 8.9;Hofbauer cells: 7.2;Late spermatids: 22.7;Macrophages: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "myeloid DC: 5.5" "Lineage enriched" "Detected in single" 9 "dendritic cells: 5.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 6.7;HEL: 9.1;PC-3: 3.7;SK-MEL-30: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035153 Uncertain NA NA "HPA035153: AB_10670586" "unprognostic (1.05e-1)" "unprognostic (1.54e-5)" "unprognostic (6.12e-2)" "unprognostic (2.84e-1)" "unprognostic (1.58e-1)" "unprognostic (7.44e-2)" "unprognostic (1.15e-1)" "unprognostic (2.22e-2)" "unprognostic (2.46e-1)" "unprognostic (3.54e-4)" "unprognostic (5.27e-4)" "unprognostic (5.47e-2)" "unprognostic (6.17e-5)" "unprognostic (8.97e-3)" "unprognostic (1.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" 20.3 0.0 0.1 2.3 0.1 1.1 0.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.7 1.0 0.1 0.4 0.1 0.0 0.1 2.6 1.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.7 0.2 2.9 0.1 0.5 0.1 0.7 0.5 2.9 0.5 0.1 5.5 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 6.7 0.0 0.0 0.0 9.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.6 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 3.7 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 4.0 1.0 0.7 1.5 0.0 1.3 1.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 5.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.9 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 2.4 7.2 0.0 0.0 0.0 1.8 22.7 0.3 7.3 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.5 0.0 0.0 0.0 0.6 SLC10A1 NTCP ENSG00000100652 "Solute carrier family 10 member 1" Q14973 14 69775417-69797289 "Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 121.2" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 130.2" "Cancer enriched" "Detected in some" 79 "liver cancer: 65.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042727 Approved NA NA "HPA042727: AB_10960691" "unprognostic (3.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.51e-2)" "unprognostic (2.11e-2)" "unprognostic (1.93e-2)" "unprognostic (6.51e-3)" "prognostic favorable (9.53e-6)" "unprognostic (6.07e-3)" "unprognostic (8.95e-2)" "unprognostic (2.17e-1)" "unprognostic (5.75e-3)" "unprognostic (1.22e-1)" "unprognostic (1.71e-2)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" "unprognostic (2.45e-1)" "unprognostic (5.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 2.7 0.5 0.1 0.6 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 4.3 0.1 0.6 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.5 0.6 0.3 0.6 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.9 0.1 0.1 0.8 0.5 0.0 0.1 0.4 0.5 1.1 0.1 0.6 0.0 0.3 0.0 0.1 0.9 0.1 0.6 0.1 0.0 0.3 1.7 0.5 0.3 0.4 0.8 0.5 0.2 0.3 1.0 0.6 0.4 2.7 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.4 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 130.2 0.1 0.0 0.0 1.8 2.7 3.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SLC10A2 "ASBT, ISBT" ENSG00000125255 "Solute carrier family 10 member 2" Q12908 13 103043998-103066846 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 40.9" "Group enriched" "Detected in some" 29 "Enterocytes: 5.1;Proximal tubular cells: 6.4" "Cancer enriched" "Detected in single" 11 "renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;HAP1: 2.5;NB-4: 1.2;U-2197: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA004795 Approved NA NA "HPA004795: AB_1856953" "unprognostic (2.82e-2)" "prognostic favorable (5.78e-5)" "unprognostic (1.64e-2)" "unprognostic (1.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 2.5 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC10A4 MGC29802 ENSG00000145248 "Solute carrier family 10 member 4" Q96EP9 4 48483343-48489196 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 12.3;brain: 19.0" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 1.4" "Cancer enhanced" "Detected in many" "glioma: 5.9" "Group enriched" "Detected in many" 7 "basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "HAP1: 10.6;HEL: 4.6;K-562: 10.6;SH-SY5Y: 28.2;THP-1: 4.6" "Group enriched" "Detected in many" 5 "basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5" HPA028835 Uncertain Supported NA NA "HPA028835: AB_10603025" "unprognostic (4.06e-1)" "unprognostic (1.19e-1)" "unprognostic (1.06e-1)" "unprognostic (3.05e-3)" "unprognostic (2.49e-1)" "unprognostic (3.46e-2)" "unprognostic (5.41e-2)" "unprognostic (3.67e-1)" "unprognostic (1.86e-1)" "unprognostic (4.08e-3)" "unprognostic (9.98e-3)" "unprognostic (1.46e-1)" "unprognostic (3.50e-1)" "unprognostic (5.14e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (8.73e-2)" 0.4 12.3 1.4 2.7 7.3 3.4 0.5 0.5 6.4 2.9 1.6 0.7 0.0 0.8 0.4 0.2 0.4 0.4 0.6 0.6 1.2 6.3 0.3 0.2 1.1 0.3 19.0 0.8 0.3 0.3 0.4 7.5 0.4 15.3 0.4 1.5 4.0 4.9 0.9 0.9 0.4 1.3 0.6 1.1 0.4 0.8 1.2 0.7 0.0 1.5 0.0 0.3 0.4 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 2.1 0.0 10.6 0.0 0.1 0.0 2.3 4.6 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.2 3.1 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.7 28.2 0.5 0.0 0.1 0.6 0.0 4.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.3 0.5 6.3 1.2 6.3 19.0 0.8 15.3 0.7 0.0 2.7 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.5 0.2 0.0 0.2 0.0 0.0 0.0 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693607-81696174 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;liver: 10.3" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025966 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.0 0.3 0.9 0.1 2.3 0.0 0.2 5.1 1.8 0.3 2.5 2.9 0.3 0.9 0.2 0.3 1.4 0.1 0.9 2.1 1.8 10.3 0.3 0.0 0.8 0.4 1.0 0.3 1.9 0.0 0.5 3.5 0.3 0.2 0.1 0.4 3.5 0.2 0.3 0.3 3.4 0.0 0.8 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.7 0.3 0.9 0.9 0.7 1.4 0.7 0.9 0.4 0.3 0.5 0.4 0.5 0.9 1.3 0.2 0.2 0.9 1.1 0.8 1.3 0.7 2.4 1.8 2.6 1.4 0.4 0.1 0.3 0.4 2.2 0.7 1.7 1.5 0.4 0.6 1.6 1.2 1.3 0.7 0.5 1.2 0.4 6.5 0.5 0.3 0.3 0.6 1.2 3.1 2.1 0.9 0.7 0.6 0.3 0.5 1.6 0.6 0.9 1.1 1.5 1.4 1.4 1.5 2.2 0.1 1.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 6.7 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 5.2 0.0 1.0 0.1 0.0 0.2 0.0 2.1 0.0 0.0 3.5 0.6 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.5 1.7 0.0 1.8 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.4 SLC10A6 SOAT ENSG00000145283 "Solute carrier family 10 member 6" Q3KNW5 4 86823468-86849263 "Predicted membrane proteins" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 20.3;breast: 15.2;skin 1: 17.7" "Group enriched" "Detected in some" 5 "Early spermatids: 62.9;Late spermatids: 160.4" "Group enriched" "Detected in many" 5 "cervical cancer: 3.5;head and neck cancer: 6.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.0;BJ: 4.9;BJ hTERT+: 4.0;HaCaT: 3.7;HBEC3-KT: 1.6;U-266/84: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA016662 Enhanced NA NA "HPA016662: AB_1669899" "unprognostic (2.79e-2)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (8.31e-3)" "unprognostic (5.88e-2)" "unprognostic (8.87e-3)" "unprognostic (1.32e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.84e-4)" "unprognostic (1.54e-1)" "unprognostic (2.06e-1)" "unprognostic (9.22e-2)" "unprognostic (5.89e-4)" 20.3 0.5 0.6 0.9 0.7 0.0 15.2 0.1 0.6 3.7 1.6 0.0 2.1 0.1 2.0 0.8 12.5 0.8 1.4 1.2 0.4 0.2 0.2 0.2 1.2 0.1 2.7 0.0 0.4 1.1 0.9 3.7 0.3 0.9 0.9 0.4 0.0 2.0 0.5 2.3 17.7 0.4 2.4 1.6 0.3 0.5 4.9 1.1 0.0 1.4 11.2 2.9 4.6 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 2.0 0.1 0.2 4.9 4.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 3.7 0.2 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.7 0.1 0.6 0.4 0.2 2.7 0.0 0.9 1.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.4 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.4 21.8 0.0 0.0 0.0 0.1 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.6;lymphoid tissue: 23.8" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0" "Group enriched" "Detected in many" 11 "dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 3.7;NB-4: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 13.5 4.7 4.3 14.9 13.3 11.6 2.6 0.6 9.3 1.7 1.8 4.6 0.0 1.3 1.3 2.1 1.4 4.1 3.0 6.5 15.0 2.6 2.1 3.2 37.6 19.9 17.1 0.7 2.4 3.3 1.2 1.9 6.2 11.3 1.7 1.0 1.7 2.0 1.2 2.0 1.0 1.2 4.6 18.1 23.8 1.7 2.4 10.3 0.0 1.8 0.2 1.0 7.1 1.3 0.4 2.4 6.0 7.9 0.2 0.4 2.6 0.3 0.7 0.0 0.4 0.1 0.1 0.9 0.0 0.0 0.1 0.2 1.0 2.1 0.2 0.2 0.0 0.3 0.8 0.0 0.0 0.0 0.7 0.1 3.8 0.6 0.7 0.1 0.0 3.7 0.3 0.1 0.0 0.2 0.3 0.0 1.2 1.0 0.7 0.1 1.3 0.2 3.1 0.0 0.6 0.2 0.2 0.6 0.4 0.1 0.3 0.8 0.2 0.5 0.4 0.4 0.2 0.3 1.1 0.3 0.7 0.4 0.2 0.0 0.3 0.3 0.7 0.2 0.4 0.4 0.3 7.9 0.6 0.4 5.8 0.3 0.1 0.2 0.2 2.4 0.4 0.4 0.3 6.0 0.2 7.0 0.2 0.2 2.6 4.3 13.3 0.6 9.3 15.0 2.6 17.1 0.7 11.3 10.3 20.8 52.4 3.0 3.9 0.8 3.6 6.3 5.1 17.4 22.7 8.7 0.0 1.6 8.3 0.8 1.2 4.7 1.2 0.0 1.8 7.2 2.4 5.7 24.3 4.7 110.2 1.6 1.2 8.6 163.4 0.4 2.0 201.4 1.7 1.0 4.0 7.6 0.6 0.9 0.7 6.8 3.0 19.4 5.0 0.5 1.7 0.9 6.8 1.7 2.2 2.7 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 177.4" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 36.6 0.0 0.0 177.4 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189688 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 50.7;salivary gland: 61.2" "Cell type enhanced" "Detected in many" 8 "Glandular cells: 203.2;Mucus-secreting cells: 402.7;Undifferentiated cells: 269.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: AB_2685094" "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favorable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 5.5 11.0 10.8 9.4 24.1 2.7 26.2 11.4 18.1 5.1 28.5 37.2 0.0 24.6 5.7 1.9 3.8 4.1 50.7 4.1 15.5 9.9 4.5 2.9 6.5 3.5 36.1 13.5 5.6 5.3 11.2 5.5 3.3 30.0 14.8 36.3 8.5 61.2 2.1 8.5 23.0 28.8 6.6 27.7 2.9 36.3 5.5 26.7 2.0 5.6 6.8 18.3 4.2 3.6 3.6 9.8 0.5 1.2 3.6 3.0 0.4 4.8 24.1 24.8 9.6 6.2 4.0 5.1 4.5 3.4 3.2 3.4 9.6 7.7 7.2 6.1 3.9 2.9 14.7 4.7 5.2 5.0 7.2 5.9 2.0 4.3 1.4 1.9 2.6 3.6 4.2 1.9 7.2 4.3 2.4 5.3 3.1 3.3 4.9 5.0 5.1 4.6 2.2 2.9 55.9 7.9 2.5 7.0 2.9 3.8 16.5 4.4 2.8 9.1 4.0 3.5 2.8 2.2 1.3 8.8 8.1 5.4 6.1 5.7 4.1 3.7 8.0 4.2 1.5 6.5 0.5 0.7 0.2 1.9 1.2 3.0 2.7 1.8 2.3 0.9 3.6 2.0 2.7 0.3 3.6 0.8 9.8 1.6 0.4 10.8 24.1 11.4 18.1 15.5 9.9 36.1 13.5 30.0 26.7 14.9 37.4 13.4 18.3 20.4 45.1 14.0 99.3 10.7 38.7 31.4 119.8 0.9 1.7 45.3 45.7 23.6 29.9 0.0 41.4 2.1 14.8 203.2 18.4 7.4 3.6 76.3 71.5 6.7 7.3 70.8 79.1 10.2 194.0 0.0 402.7 27.8 49.2 77.2 27.3 9.6 76.9 71.1 24.5 27.0 21.5 26.2 1.1 12.1 269.5 16.9 SLC12A3 NCCT ENSG00000070915 "Solute carrier family 12 member 3" P55017 16 56865207-56915850 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 88.6" "Group enriched" "Detected in some" 9 "Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 7.2" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 14.6" "Group enriched" "Detected in some" 10 "BEWO: 10.2;HAP1: 5.6;HeLa: 11.4;SuSa: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA028748 Enhanced NA NA "HPA028748: AB_10603886" "unprognostic (1.54e-3)" "unprognostic (7.09e-5)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "unprognostic (2.91e-1)" "unprognostic (2.38e-4)" "unprognostic (1.81e-1)" "unprognostic (9.70e-2)" "unprognostic (1.34e-1)" "unprognostic (7.25e-2)" "unprognostic (6.84e-2)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.38e-1)" "unprognostic (1.40e-2)" "unprognostic (1.70e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 88.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 14.6 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.7 5.6 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.4 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 14.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC12A5 "KCC2, KIAA1176" ENSG00000124140 "Solute carrier family 12 member 5" Q9H2X9 20 46021690-46060152 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 64.6" "Group enriched" "Detected in many" 13 "Bipolar cells: 205.2;Cone photoreceptor cells: 361.3;Rod photoreceptor cells: 172.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 13.7;NB-4: 28.3;SK-BR-3: 14.3;U-2 OS: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072058 Enhanced NA NA "HPA072058: AB_2686485" "unprognostic (2.01e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" "unprognostic (9.44e-4)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.48e-1)" "unprognostic (5.16e-3)" "unprognostic (3.61e-1)" "unprognostic (2.49e-1)" "unprognostic (6.63e-2)" "unprognostic (3.72e-3)" "unprognostic (5.61e-4)" "unprognostic (8.78e-4)" "unprognostic (3.25e-2)" "unprognostic (9.22e-2)" "unprognostic (1.99e-1)" "unprognostic (2.34e-2)" 1.4 11.2 21.1 2.0 28.8 1.5 1.7 52.1 64.6 2.3 2.1 2.7 0.0 2.2 1.6 2.2 1.3 1.7 1.9 2.1 20.5 19.2 1.4 2.2 2.7 3.1 9.5 32.1 2.0 3.6 1.5 4.8 3.3 15.3 1.5 2.1 4.9 1.9 1.8 1.5 1.5 2.1 1.6 6.3 2.8 3.1 3.4 5.8 0.0 1.3 0.0 2.6 1.2 0.5 1.3 0.2 0.1 1.5 0.7 5.7 1.3 0.0 8.6 3.8 2.8 0.3 0.0 0.8 0.3 0.0 0.0 0.3 1.1 0.0 3.2 13.1 0.2 3.4 0.8 2.5 1.3 0.2 2.0 3.3 2.7 1.6 13.7 1.5 0.0 3.8 0.5 0.0 0.0 0.2 5.9 0.8 3.1 5.1 0.0 0.0 13.0 1.9 28.3 1.4 1.2 4.4 3.2 2.4 0.7 1.3 0.0 4.7 6.7 1.7 14.3 4.1 3.7 5.2 8.1 1.3 1.5 16.3 0.1 0.6 0.0 2.1 4.5 3.5 3.3 0.1 0.0 1.5 0.0 2.6 0.8 1.0 1.0 0.3 0.4 0.2 1.3 5.7 3.2 0.1 0.7 0.2 0.0 3.5 1.3 21.1 28.8 52.1 36.4 20.5 19.2 9.5 32.1 15.3 5.8 0.0 0.0 0.0 0.0 0.5 205.2 0.8 0.0 0.0 0.0 0.0 361.3 1.1 1.7 0.0 1.6 1.6 0.0 0.0 0.2 2.6 0.4 0.4 0.0 0.5 15.2 12.7 19.1 3.7 0.6 3.4 0.0 3.2 5.0 1.0 0.4 12.9 0.5 0.0 0.0 0.2 172.9 0.0 0.4 1.4 2.5 0.5 1.4 0.0 0.4 0.0 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4;thyroid gland: 20.5" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HHSteC: 18.2;OE19: 17.3;U-2197: 35.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.1 1.1 11.1 0.7 19.4 0.0 2.0 0.8 7.0 1.2 3.0 1.7 0.4 4.9 0.4 2.9 3.5 1.7 8.1 0.5 3.8 1.2 2.1 5.7 1.9 0.4 1.0 3.6 0.5 9.0 8.2 1.9 2.2 8.6 2.5 4.1 6.2 10.0 0.4 1.8 1.0 3.4 0.4 1.3 0.4 3.8 4.6 2.0 0.4 20.5 0.4 0.7 1.9 1.7 0.2 0.2 1.8 0.5 0.0 0.2 0.0 8.2 0.0 1.4 0.0 1.7 2.4 4.1 0.4 1.0 0.4 0.9 10.7 3.9 0.0 1.0 3.7 1.4 5.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 18.2 0.0 0.6 4.7 5.0 1.4 0.5 9.7 0.0 0.0 0.0 0.3 0.6 2.2 0.0 0.0 5.7 17.3 0.4 0.0 0.1 0.0 4.2 0.6 2.4 0.0 4.8 5.1 0.1 0.6 9.1 0.2 0.1 0.1 0.7 35.3 0.0 0.1 1.0 2.7 1.7 0.0 0.7 1.8 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 19.4 0.8 7.0 3.8 1.2 1.0 3.6 8.6 2.0 0.0 0.3 0.0 1.1 0.9 0.0 1.0 0.0 0.0 1.2 22.7 0.0 0.3 0.0 3.9 0.2 0.0 2.0 0.0 2.9 6.2 1.3 5.0 18.4 6.4 0.8 0.0 5.2 0.0 0.0 0.0 0.0 0.6 0.0 3.6 28.6 0.0 4.3 2.9 0.0 1.1 0.0 0.0 0.3 0.7 0.4 0.3 2.5 0.0 5.0 0.9 SLC13A1 "NAS1, NaSi-1" ENSG00000081800 "Solute carrier family 13 member 1" Q9BZW2 7 123113531-123199986 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sulfate transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 67.5" "Cell type enriched" "Detected in some" 17 "Proximal tubular cells: 400.4" "Cancer enriched" "Detected in single" 219 "renal cancer: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 1.0" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Low region specificity" "Detected in all" "HPA053615, HPA062714" Enhanced NA NA "HPA053615: AB_2682207, HPA062714: AB_2684846" "unprognostic (1.86e-1)" "prognostic favorable (8.95e-5)" "unprognostic (1.71e-1)" "unprognostic (3.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 67.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.9 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.1 0.0 0.8 0.1 0.6 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 23.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 400.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC13A2 NaDC-1 ENSG00000007216 "Solute carrier family 13 member 2" Q13183 17 28473293-28497781 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 181.4" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 28.1;Enterocytes: 37.5;Mucus-secreting cells: 25.2;Proximal tubular cells: 82.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.0;RPMI-8226: 2.4;SH-SY5Y: 1.2;SK-BR-3: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA014963 Enhanced NA NA "HPA014963: AB_1857096" "unprognostic (8.47e-2)" "unprognostic (7.63e-3)" "unprognostic (4.36e-3)" "unprognostic (2.06e-1)" "unprognostic (2.36e-3)" "unprognostic (3.06e-1)" "unprognostic (2.28e-4)" "unprognostic (1.50e-1)" "unprognostic (1.74e-1)" "unprognostic (1.00e-2)" "prognostic favorable (9.00e-4)" "unprognostic (2.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.50e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 1.4 0.1 0.1 0.1 142.8 0.0 10.7 34.6 0.1 0.5 0.1 0.1 3.4 0.1 0.1 0.1 12.5 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 1.8 0.0 14.9 17.1 0.1 2.1 181.4 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.7 0.1 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 28.1 0.0 0.0 3.5 11.8 0.0 8.3 0.0 0.0 0.0 37.5 0.0 6.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.2 0.0 0.2 8.6 0.0 82.9 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 13.9 0.3 SLC13A3 "NADC3, SDCT2" ENSG00000158296 "Solute carrier family 13 member 3" Q8WWT9 20 46557823-46684467 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 128.6" "Cell type enhanced" "Detected in many" 25 "Cytotrophoblasts: 97.7;Proximal tubular cells: 272.5;Syncytiotrophoblasts: 66.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.0;EFO-21: 11.4;Hep G2: 32.6;HHSteC: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014333, HPA014353, HPA014736" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970" "unprognostic (1.07e-2)" "unprognostic (7.40e-2)" "unprognostic (5.59e-2)" "unprognostic (1.19e-2)" "unprognostic (3.34e-1)" "unprognostic (3.19e-2)" "unprognostic (2.15e-1)" "unprognostic (2.82e-2)" "unprognostic (1.66e-2)" "unprognostic (9.50e-2)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" "unprognostic (8.94e-2)" "unprognostic (3.87e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" 0.7 0.9 2.6 0.5 6.2 0.4 0.9 2.5 3.6 0.9 0.5 15.1 0.0 0.4 0.9 0.7 0.6 1.1 0.9 0.6 3.4 3.1 128.6 7.0 0.8 0.5 9.3 2.1 1.8 3.0 0.4 0.6 12.9 6.5 2.3 0.5 8.1 1.7 0.6 0.6 1.0 0.4 0.9 7.8 0.5 1.7 2.7 5.6 0.0 0.8 0.0 0.6 1.0 0.4 0.6 2.4 2.7 0.4 0.7 0.9 0.0 0.0 0.0 0.9 3.3 5.1 4.8 10.0 2.1 1.2 1.1 0.9 0.0 0.0 0.1 11.4 0.1 0.0 1.2 0.0 1.5 2.7 0.0 0.3 3.9 0.2 32.6 11.4 0.0 2.9 6.5 4.5 6.6 3.3 3.2 0.0 0.0 8.7 0.2 0.0 0.3 0.0 0.4 6.1 0.2 0.0 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.0 2.4 0.5 0.6 1.7 0.1 0.1 0.1 2.4 5.2 0.0 0.3 0.6 0.0 0.4 0.0 0.2 2.7 0.4 0.3 0.9 0.2 0.2 0.4 0.3 0.3 0.1 0.6 0.6 0.6 1.3 0.7 0.3 2.4 0.3 0.0 2.6 6.2 2.5 3.6 3.4 3.1 9.3 2.1 6.5 5.6 0.0 2.1 0.0 1.1 1.1 0.7 0.5 0.0 5.3 0.0 7.0 0.0 97.7 13.3 0.1 17.2 0.2 0.0 0.0 0.8 4.5 1.1 3.2 0.0 11.6 8.1 0.0 0.0 0.0 0.8 22.8 2.8 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 272.5 0.2 0.0 0.3 1.1 0.9 0.5 66.4 0.0 0.0 0.5 SLC13A4 "SUT-1, SUT1" ENSG00000164707 "Solute carrier family 13 member 4" Q9UKG4 7 135681237-135729258 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 85.4;placenta: 44.8;retina: 23.5" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 657.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 85.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048582 Enhanced NA NA "HPA048582: AB_2680450" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (9.70e-3)" "unprognostic (1.78e-1)" "unprognostic (7.69e-2)" "unprognostic (3.96e-6)" "unprognostic (3.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.56e-3)" "unprognostic (9.23e-2)" "unprognostic (2.89e-1)" "unprognostic (1.87e-1)" "unprognostic (2.30e-6)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" 0.3 0.4 0.7 0.3 1.4 0.3 0.4 4.0 8.9 1.2 0.3 34.0 0.0 0.3 0.4 0.3 4.1 0.8 0.4 0.4 12.3 0.8 0.3 0.4 0.4 0.3 1.4 5.4 0.4 0.5 0.4 1.4 44.8 85.4 0.3 0.3 23.5 1.0 0.4 0.3 0.4 0.3 0.4 5.1 0.3 0.3 5.4 0.5 0.0 0.3 0.0 1.9 0.3 1.8 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.4 4.0 8.9 12.3 0.8 1.4 5.4 85.4 0.5 0.0 0.0 0.0 0.5 0.0 2.6 1.6 0.0 6.7 0.0 0.0 3.9 99.4 0.0 0.1 0.4 0.3 0.0 0.0 0.0 5.3 1.1 0.4 0.0 0.0 13.1 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.2 0.1 657.3 0.0 0.0 0.3 SLC13A5 "INDY, NACT" ENSG00000141485 "Solute carrier family 13 member 5" Q86YT5 17 6684713-6713567 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 65 "liver: 150.4;salivary gland: 153.9" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 374.3" "Cancer enriched" "Detected in some" 15 "liver cancer: 27.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 61 "Hep G2: 35.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044343 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA044343: AB_10961771" "unprognostic (8.46e-3)" "unprognostic (3.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.75e-2)" "unprognostic (7.33e-2)" "unprognostic (1.07e-1)" "unprognostic (6.79e-2)" "unprognostic (8.79e-3)" "unprognostic (1.32e-1)" "unprognostic (3.23e-1)" "unprognostic (1.26e-3)" "unprognostic (1.30e-3)" "unprognostic (3.78e-11)" "unprognostic (2.42e-2)" "unprognostic (2.46e-1)" "unprognostic (2.05e-2)" "unprognostic (2.04e-1)" 0.2 0.8 1.0 0.1 1.9 0.1 0.2 0.6 2.3 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.3 0.9 0.1 0.1 0.9 0.7 0.4 150.4 0.1 0.2 0.8 1.2 0.3 0.2 0.1 0.2 0.1 0.6 0.1 0.1 0.0 153.9 0.1 0.1 0.1 0.1 0.1 0.2 0.9 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.9 0.6 2.3 0.9 0.7 0.8 1.2 0.6 0.0 0.0 0.0 7.0 0.6 0.5 0.2 0.6 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 23.3 0.4 0.1 0.0 0.3 0.0 374.3 0.0 0.0 0.0 15.4 21.0 0.0 0.6 0.3 0.0 0.0 0.0 7.4 9.8 0.0 0.0 0.0 1.4 0.0 0.0 0.9 1.5 0.4 0.1 0.0 0.0 0.2 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Group enriched" "Detected in some" 10 "Basal glandular cells: 246.2;Erythroid cells: 93.5;Glandular cells: 129.8;Urothelial cells: 212.7" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Group enriched" "Detected in some" 5 "GAMG: 79.4;RT4: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" NA NA "Plasma membrane" "HPA059570: AB_2684066, HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 79.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 1.1 0.0 0.0 0.7 0.3 0.3 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 0.0 1.1 1.3 246.2 0.2 0.3 6.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.7 0.0 93.5 0.2 0.0 0.1 129.8 0.0 0.0 0.1 0.0 0.0 17.8 1.2 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 5.7 0.0 212.7 SLC14A2 "HUT2, UT2" ENSG00000132874 "Solute carrier family 14 member 2" Q15849 18 45212995-45683686 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.3;kidney: 5.7" "Cell type enriched" "Detected in some" 5 "Collecting duct cells: 73.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.1" "Cell type enhanced" "Detected in some" "eosinophil: 3.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "U-266/70: 7.2" "Region enriched" "Detected in some" 4 "basal ganglia: 17.9" "Not detected" "Not detected" NA NA "unprognostic (2.33e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.54e-2)" "unprognostic (7.80e-2)" "unprognostic (1.11e-2)" "unprognostic (7.89e-3)" "unprognostic (3.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-3)" "unprognostic (8.96e-2)" "unprognostic (3.50e-3)" "unprognostic (1.20e-1)" "unprognostic (7.64e-2)" "unprognostic (7.52e-2)" "unprognostic (6.62e-2)" 1.8 1.0 0.0 0.1 0.4 0.6 0.9 0.0 0.7 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.3 0.1 0.1 5.7 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.4 1.2 0.0 0.0 0.2 0.1 1.3 1.0 0.0 0.1 0.1 0.4 0.4 3.3 0.3 0.4 0.8 0.1 0.2 0.4 0.4 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.4 0.4 0.8 0.2 0.1 0.4 0.3 0.0 0.0 0.1 0.4 0.2 0.4 0.7 0.0 0.1 1.1 0.4 0.1 0.1 0.1 0.1 0.4 0.2 0.4 0.3 0.6 0.0 0.3 0.4 0.5 0.3 0.2 0.4 0.3 0.1 0.7 0.1 0.4 0.6 0.1 0.2 0.1 0.1 0.2 0.1 0.3 0.3 0.4 0.3 1.0 0.4 7.2 0.4 0.3 0.4 1.1 0.3 1.4 0.3 3.3 0.3 0.2 0.2 0.4 0.2 0.3 0.1 0.4 0.2 0.3 0.8 0.4 0.2 0.4 0.8 0.1 6.0 14.8 0.0 0.5 0.6 1.2 0.5 0.0 2.7 3.4 73.3 2.0 0.3 0.0 0.0 0.9 0.7 1.1 0.0 0.0 0.2 1.1 0.3 3.5 0.0 0.3 1.6 0.0 1.8 0.3 1.0 0.6 0.8 1.7 0.0 0.3 0.8 0.1 0.0 0.7 0.0 1.7 0.0 0.0 0.5 0.4 0.1 0.7 0.0 0.0 0.4 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752654 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "intestine: 134.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 30.1;SK-BR-3: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 1.1 51.7 0.2 0.3 42.7 1.9 2.2 0.9 0.1 16.6 0.1 0.1 0.1 6.3 8.2 0.2 0.1 0.1 0.1 0.2 7.1 4.3 0.3 1.0 0.3 0.9 0.5 0.2 0.3 0.3 0.1 9.9 134.9 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.7 0.4 0.5 1.9 1.1 1.1 2.3 0.7 1.2 0.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.9 30.1 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 6.8 0.0 0.0 0.0 1.7 1.7 0.6 0.1 0.3 0.0 29.9 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.7 0.9 0.3 0.8 0.8 0.7 0.7 0.2 1.1 0.9 0.8 2.2 1.2 0.4 1.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 3.0 0.0 0.0 0.1 0.1 0.0 0.4 30.6 1.4 2.3 1.8 0.0 0.0 1.7 9.1 0.0 0.0 51.2 0.0 0.7 0.0 0.0 0.8 0.0 29.9 0.1 0.0 3.5 0.6 0.3 0.0 0.0 0.0 1.7 0.0 1.7 0.0 2.9 5.8 0.0 9.8 0.0 0.0 0.2 0.0 0.2 0.6 0.1 0.0 1.7 0.3 SLC15A2 PEPT2 ENSG00000163406 "Solute carrier family 15 member 2" Q16348 3 121894089-121944102 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 35.2;ductus deferens: 35.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 92.3;Club cells: 31.8;Muller glia cells: 64.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 8.4;U-937: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (4.72e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.50e-2)" "prognostic favorable (6.96e-4)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.74e-4)" "unprognostic (3.21e-1)" "unprognostic (1.28e-1)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-2)" "unprognostic (4.60e-2)" 1.0 1.2 13.8 1.9 15.0 3.3 3.2 4.0 15.3 35.2 1.8 7.6 35.8 1.5 1.5 26.2 3.6 7.4 4.2 2.0 14.6 5.3 7.4 1.1 12.9 3.6 5.3 12.9 1.0 3.6 2.4 3.6 1.6 6.8 26.5 2.1 15.1 14.6 25.1 0.8 0.7 2.2 0.9 4.0 6.1 1.1 3.9 6.7 0.0 4.6 0.5 3.8 3.6 2.6 4.2 1.6 2.4 2.5 0.3 0.3 0.3 1.9 0.9 1.1 0.4 1.3 0.7 1.4 0.2 0.1 0.5 0.6 1.8 3.2 3.5 0.2 0.1 0.6 2.1 0.8 1.9 0.6 2.8 0.6 5.0 1.3 0.8 0.2 5.3 5.0 1.1 5.5 0.6 0.4 0.6 0.3 1.0 0.8 1.5 0.6 1.4 1.0 8.4 5.8 2.1 0.5 1.2 0.5 1.0 1.3 1.2 0.4 0.4 0.5 0.3 0.1 1.7 0.3 4.7 0.1 0.4 0.3 0.4 0.4 1.9 0.5 5.0 0.6 7.1 0.5 2.4 1.1 0.4 0.3 0.4 0.3 3.3 0.3 0.2 0.3 4.2 0.3 0.3 0.6 0.3 2.5 1.6 0.2 0.3 13.8 15.0 4.0 11.0 14.6 5.3 5.3 12.9 6.8 6.7 92.3 21.4 4.4 2.1 0.5 1.0 1.9 7.6 12.0 31.8 10.4 0.0 2.1 3.3 0.3 0.3 0.8 0.2 0.0 7.5 0.6 0.6 22.7 3.5 0.0 2.1 0.0 0.0 1.3 10.0 0.6 6.1 3.8 0.0 1.0 1.0 64.9 2.6 0.0 4.9 1.1 2.4 0.0 0.1 0.5 0.1 0.5 1.1 0.0 0.6 8.2 SLC15A5 ENSG00000188991 "Solute carrier family 15 member 5" A6NIM6 12 16188485-16277685 "Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 12 "adipose tissue: 1.9;brain: 1.6;breast: 1.2;testis: 1.4" "Cell type enhanced" "Detected in single" 35 "Early spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041638 Uncertain NA NA "HPA041638: AB_2677590" "unprognostic (3.68e-3)" "unprognostic (1.64e-1)" "unprognostic (4.89e-6)" "unprognostic (1.34e-1)" "unprognostic (1.72e-3)" 1.9 0.0 1.1 0.0 0.7 0.0 1.2 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC16A10 "MCT10, TAT1" ENSG00000112394 "Solute carrier family 16 member 10" Q8TF71 6 111087503-111231194 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.1;skeletal muscle: 33.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 26.2;Melanocytes: 42.2" "Cancer enriched" "Detected in many" 6 "testis cancer: 4.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.7" "Lineage enriched" "Detected in single" 5 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "HAP1: 29.4;HEK 293: 12.7;RPMI-8226: 24.2" "Low region specificity" "Detected in many" HPA016860 Approved Supported "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA016860: AB_2189211" "unprognostic (2.03e-1)" "unprognostic (2.08e-1)" "unprognostic (6.11e-2)" "unprognostic (3.56e-4)" "unprognostic (2.24e-1)" "unprognostic (2.15e-1)" "unprognostic (1.64e-1)" "unprognostic (1.89e-1)" "unprognostic (1.86e-3)" "unprognostic (5.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-3)" "unprognostic (2.73e-1)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 7.6 4.9 1.8 2.4 5.4 0.4 1.1 9.5 2.0 0.8 4.8 1.7 1.7 7.6 0.7 1.6 0.7 1.1 1.0 2.8 1.8 1.0 8.1 9.8 6.1 1.8 0.8 0.5 1.2 25.1 8.9 1.5 17.4 5.6 1.2 1.3 3.6 3.5 6.0 33.4 12.1 6.0 0.8 1.0 2.7 3.9 3.5 0.8 19.6 2.2 1.5 0.9 4.4 1.4 0.5 0.3 0.8 0.2 0.3 4.7 0.3 0.6 0.6 0.2 1.3 0.0 0.0 2.4 0.0 0.1 0.5 0.8 5.1 0.2 4.1 0.9 0.1 1.4 0.0 29.4 0.0 0.5 0.1 12.7 4.7 0.3 4.8 0.0 5.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 6.8 0.8 0.1 0.0 2.0 6.2 0.7 9.0 0.1 1.9 3.5 4.3 24.2 0.0 0.4 6.8 2.1 0.1 0.6 1.1 2.3 1.2 0.8 0.0 0.1 1.1 0.3 1.6 2.0 0.0 1.1 0.2 3.8 0.5 0.8 0.2 0.1 0.2 0.2 0.2 0.2 1.1 0.3 0.0 0.5 4.7 4.0 0.8 0.3 0.1 0.3 4.0 0.3 1.8 5.4 9.5 2.0 1.8 1.0 0.8 0.5 5.6 0.8 8.9 26.2 0.9 10.0 8.7 6.2 7.7 0.0 1.4 5.7 5.2 2.0 1.1 1.7 0.1 7.2 0.7 3.9 0.0 11.1 1.7 2.5 2.8 1.1 19.7 20.5 1.6 6.3 5.5 13.5 5.2 0.0 14.3 42.2 1.0 2.8 1.7 3.1 0.0 0.0 15.2 0.6 0.0 1.0 9.8 9.8 12.9 1.0 0.5 5.0 0.9 SLC16A12 MCT12 ENSG00000152779 "Solute carrier family 16 member 12" 10 89430299-89556641 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 28.0;kidney: 55.6" "Cell type enhanced" "Detected in many" 12 "Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2" "Cancer enriched" "Detected in many" 10 "renal cancer: 18.0" "Region enriched" "Detected in many" 6 "pons and medulla: 11.7" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "ASC TERT1: 22.8;HSkMC: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037587 Approved Mitochondria NA NA Mitochondria "HPA037587: AB_2732475" "unprognostic (5.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.79e-2)" "unprognostic (2.28e-2)" "unprognostic (3.51e-1)" "unprognostic (5.35e-2)" "unprognostic (2.45e-1)" "unprognostic (1.32e-1)" "unprognostic (1.78e-2)" "unprognostic (2.42e-1)" "unprognostic (9.60e-2)" "unprognostic (2.31e-1)" "prognostic favorable (4.50e-12)" "unprognostic (3.84e-2)" "unprognostic (7.91e-2)" "unprognostic (8.29e-2)" "unprognostic (1.84e-3)" 2.3 1.3 1.0 0.1 0.7 0.0 2.4 1.3 0.6 4.9 1.6 2.6 6.2 0.1 2.0 28.0 0.5 2.2 0.1 4.0 1.8 0.8 55.6 1.0 3.3 0.1 0.8 0.3 1.8 13.3 0.0 5.0 5.9 11.7 1.4 0.1 16.3 0.9 7.9 4.4 1.1 0.8 0.5 0.6 0.1 1.7 2.4 0.3 0.0 3.8 0.7 0.0 1.8 1.5 0.7 0.5 1.8 0.3 0.9 0.3 0.0 0.2 0.0 0.1 0.1 3.0 22.8 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.4 0.1 3.7 0.0 0.0 8.1 0.2 1.1 1.4 1.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.8 0.0 2.7 0.1 0.1 0.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.3 0.3 0.2 0.3 0.2 0.3 0.2 0.2 0.0 0.7 0.2 0.3 0.8 0.9 0.1 0.5 0.0 0.0 1.0 0.7 1.3 0.6 1.8 0.8 0.8 0.3 11.7 0.3 3.0 3.8 0.0 1.5 0.0 0.0 2.0 2.5 8.1 4.5 14.0 0.0 14.3 13.3 0.0 3.0 1.1 0.0 0.0 3.7 0.6 1.1 0.8 1.1 1.7 1.1 3.2 17.4 0.6 0.0 3.0 25.0 1.0 0.0 0.0 0.0 0.0 3.5 0.0 25.1 55.2 0.3 12.9 1.4 0.1 0.2 0.3 7.6 0.0 0.0 1.4 SLC16A13 MCT13 ENSG00000174327 "Solute carrier family 16 member 13" Q7RTY0 17 7036075-7040121 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 55.9" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 5.2;Hepatocytes: 6.8;T-cells: 4.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 16.9;GAMG: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065245 Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA065245: AB_2685443" "unprognostic (5.61e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (1.78e-1)" "unprognostic (2.22e-3)" "unprognostic (9.53e-2)" "unprognostic (1.62e-1)" "unprognostic (8.72e-2)" "unprognostic (1.81e-1)" "unprognostic (2.60e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.44e-2)" "unprognostic (7.31e-3)" "unprognostic (9.70e-3)" "unprognostic (3.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.14e-1)" 2.5 1.3 1.4 3.5 0.8 0.2 1.6 1.5 1.0 1.8 4.9 0.7 1.2 8.0 1.1 1.4 5.0 1.5 3.2 1.3 1.2 0.7 12.0 55.9 2.9 7.6 0.8 0.5 1.7 2.8 2.7 1.0 3.3 0.7 1.5 1.3 1.8 3.5 1.5 0.5 4.5 10.2 0.7 0.6 4.8 1.6 0.7 0.3 3.6 3.0 2.4 5.8 1.8 2.4 6.8 2.8 2.4 2.2 2.7 3.9 1.3 9.5 16.9 4.0 2.4 2.5 1.4 1.7 1.0 2.5 2.2 5.0 5.4 10.7 6.1 1.6 1.5 20.0 15.0 3.1 5.2 0.9 7.5 2.1 2.5 1.3 13.0 2.8 0.8 5.8 1.6 6.0 3.3 2.7 2.9 8.9 5.5 2.8 1.7 2.3 4.7 3.6 1.5 1.6 4.9 1.3 1.7 1.4 1.0 2.1 2.7 0.1 1.1 3.0 1.7 1.3 6.2 4.6 1.3 3.3 1.4 3.3 2.3 1.4 3.0 6.3 0.3 4.1 2.2 0.6 0.0 2.0 2.2 3.2 1.9 2.3 2.3 2.9 3.9 2.1 6.8 3.1 2.9 2.4 2.7 2.2 2.8 3.0 1.3 1.4 0.8 1.5 1.0 1.2 0.7 0.8 0.5 0.7 0.3 0.0 1.0 2.2 0.7 0.5 0.1 0.3 0.0 1.4 0.0 5.2 0.0 1.6 0.0 0.8 0.0 1.8 1.5 0.0 0.2 0.4 0.4 0.7 3.5 6.8 0.4 3.2 0.0 2.5 0.3 0.0 0.9 1.7 0.0 1.0 0.3 0.9 0.5 0.0 0.0 1.0 0.4 0.0 0.4 0.0 0.0 1.4 2.1 4.3 0.4 0.9 SLC16A2 "AHDS, DXS128, MCT7, MCT8, MRX22, XPCT" ENSG00000147100 "Solute carrier family 16 member 2" P36021 X 74421461-74533917 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 50.8;Peritubular cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "BJ: 34.4;GAMG: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072719 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA072719: AB_2686552" "prognostic unfavorable (8.88e-5)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-3)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (1.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (2.54e-1)" "unprognostic (5.67e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (2.15e-2)" "unprognostic (1.89e-1)" "unprognostic (6.89e-3)" "prognostic unfavorable (3.16e-4)" 13.5 24.4 10.9 5.4 12.2 0.7 4.9 5.9 14.3 9.9 5.5 8.4 1.8 4.1 9.4 2.7 5.2 6.7 10.5 10.7 8.0 5.9 9.4 43.6 6.0 1.6 4.2 8.0 14.7 6.6 12.7 12.6 10.0 8.2 9.2 2.6 11.1 5.8 7.0 3.5 2.2 3.0 7.6 4.1 1.9 4.2 1.8 5.1 6.4 13.6 4.3 3.0 5.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 4.0 2.9 16.6 7.9 4.2 0.0 34.4 10.6 14.0 8.0 0.0 0.3 0.0 0.5 13.3 27.0 0.6 0.4 14.6 8.2 2.3 1.3 0.0 0.0 0.0 0.6 0.0 0.0 6.2 3.5 7.2 8.5 5.3 0.0 0.0 0.0 0.0 3.2 0.0 0.2 1.0 11.0 0.0 3.0 6.6 7.9 0.0 6.9 0.0 0.7 5.1 3.8 19.3 0.1 1.0 0.2 0.4 0.0 13.6 3.6 14.9 17.1 0.0 0.0 0.0 15.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 12.2 5.9 14.3 8.0 5.9 4.2 8.0 8.2 5.1 0.0 1.1 0.0 3.2 0.7 4.5 3.5 5.1 4.0 3.4 3.5 0.0 4.2 3.3 3.7 0.0 2.7 0.0 0.0 2.1 2.7 4.8 3.2 2.3 50.8 0.8 3.2 8.1 2.5 1.5 0.0 14.1 0.0 3.3 1.0 0.0 6.1 3.1 0.0 19.4 5.4 1.1 12.9 5.6 0.1 0.0 1.1 1.7 0.0 0.0 4.8 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavorable (1.19e-7)" "prognostic unfavorable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.5 5.8 0.1 0.1 2.6 8.3 11.5 48.2 29.7 34.3 38.9 2.7 30.2 0.1 38.0 34.0 29.7 4.1 4.1 69.9 14.4 20.7 0.2 22.0 42.9 50.4 44.2 32.3 27.2 17.1 10.3 23.0 10.6 45.1 18.6 0.4 0.1 6.8 29.7 3.1 0.3 31.8 0.4 4.8 47.0 0.1 0.5 7.6 18.1 0.5 0.7 0.3 46.4 41.3 0.6 4.8 6.0 27.2 32.2 68.4 1.1 1.0 50.3 22.1 0.3 1.0 33.5 20.4 0.6 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 8.9 12.7 14.3 34.8 5.8 9.7 4.8 7.6 14.7 14.8 54.1 3.9 56.0 0.0 116.4 3.0 22.8 93.3 0.0 16.0 1393.3 24.4 12.4 75.9 0.8 262.7 120.8 20.1 17.2 103.7 2.7 2.8 101.0 13.5 232.6 23.8 21.4 199.4 84.2 3.5 3.8 7.4 0.0 14.7 1.6 7.1 5.8 626.2 40.6 16.6 118.3 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362848-110391082 "Predicted membrane proteins" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.4;placenta: 76.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 68.0;Proximal tubular cells: 176.8" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.0" "Group enriched" "Detected in many" 4 "B-cells: 5.0;granulocytes: 1.3" "Cell line enhanced" "Detected in many" "BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.8 2.4 1.9 2.1 2.8 0.6 3.4 2.3 1.7 2.7 4.5 2.9 2.7 4.7 2.3 11.9 4.3 2.4 9.6 4.0 2.6 2.1 61.4 7.9 6.1 1.4 2.7 1.4 21.3 0.8 0.5 3.5 76.5 6.9 3.7 0.9 17.3 1.9 3.2 1.1 0.8 14.0 1.8 3.6 2.0 2.5 4.0 1.8 0.0 8.0 1.3 1.3 3.1 3.0 5.0 0.1 1.3 0.6 0.0 0.7 0.3 0.2 5.5 1.2 1.8 4.0 7.8 11.6 3.0 11.7 1.0 2.9 1.7 17.3 0.3 3.3 9.4 0.1 0.3 0.0 1.1 1.1 0.3 1.4 0.3 1.1 1.7 11.6 0.3 0.3 5.7 0.1 1.7 0.1 25.2 2.4 0.4 0.2 0.6 1.9 0.5 0.2 0.3 0.3 0.0 0.2 0.1 0.8 0.1 2.0 0.2 0.7 0.4 0.3 5.6 17.8 5.6 0.3 0.0 0.2 0.7 0.4 0.2 0.8 0.3 0.0 0.9 0.6 0.2 3.2 0.0 0.6 0.3 0.5 0.2 0.2 5.0 0.6 0.1 0.1 1.0 0.6 0.7 1.3 0.0 0.2 0.0 0.2 0.3 1.9 2.8 2.3 1.7 2.6 2.1 2.7 1.4 6.9 1.8 11.9 17.3 3.2 5.2 2.7 11.1 1.1 15.3 0.0 5.7 68.0 5.9 28.5 3.3 2.9 0.4 4.4 1.3 23.3 0.8 29.3 13.9 2.7 4.7 4.5 3.7 3.2 3.4 3.1 1.0 1.1 16.7 0.8 10.1 1.0 0.9 2.3 1.3 0.2 11.0 176.8 17.7 0.0 5.2 3.0 2.0 3.1 29.4 4.6 0.5 5.0 SLC16A6 "MCT6, MCT7" ENSG00000108932 "Solute carrier family 16 member 6" O15403 17 68267026-68291267 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.5" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 21.6;Kupffer cells: 17.4;Rod photoreceptor cells: 39.6" "Group enriched" "Detected in many" 6 "breast cancer: 10.9;melanoma: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "SK-MEL-30: 107.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054459, HPA066328" Uncertain Approved Vesicles NA NA Vesicles "HPA054459: AB_2682494, HPA066328: AB_2685660" "unprognostic (2.53e-2)" "unprognostic (2.09e-3)" "unprognostic (8.41e-2)" "unprognostic (6.94e-2)" "unprognostic (3.10e-1)" "unprognostic (5.26e-3)" "unprognostic (5.08e-3)" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.44e-2)" "unprognostic (8.78e-2)" "unprognostic (2.23e-1)" "unprognostic (8.16e-3)" "unprognostic (2.09e-2)" "unprognostic (9.46e-2)" 7.8 3.4 3.0 6.6 6.3 8.1 6.2 3.7 6.2 2.2 0.8 3.1 9.8 0.9 2.8 32.5 12.4 1.5 1.6 1.4 3.2 4.2 0.9 1.4 9.7 4.6 4.7 1.4 1.8 1.2 0.4 2.4 2.4 6.9 0.8 1.0 13.0 3.5 11.0 10.3 4.2 1.2 0.9 2.7 6.3 1.1 2.2 0.9 1.5 3.3 6.6 7.9 3.7 3.3 0.6 2.7 8.5 4.7 1.1 2.9 1.2 0.4 0.3 0.1 0.1 0.1 0.1 3.1 0.1 3.9 0.3 0.2 0.1 0.5 3.5 0.3 0.0 0.0 0.1 0.6 0.0 0.1 1.0 0.2 0.2 0.4 4.5 0.7 1.2 0.2 0.1 0.0 0.2 0.2 0.3 0.1 0.5 0.2 0.8 0.0 3.9 1.6 0.7 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.1 2.1 107.0 0.8 3.1 0.7 0.5 1.2 0.2 0.1 0.3 0.8 3.1 3.2 8.1 0.9 0.5 1.1 4.7 0.3 2.9 4.4 1.5 0.6 1.2 2.3 2.7 0.3 0.8 1.6 8.5 1.1 2.2 0.6 2.6 1.2 3.0 6.3 3.7 6.2 3.2 4.2 4.7 1.4 6.9 0.9 0.0 4.5 0.8 0.1 0.2 4.8 0.6 0.0 2.7 6.8 8.7 21.6 0.1 0.0 0.0 0.5 0.9 0.0 0.0 0.0 8.6 0.9 0.2 1.1 0.0 5.5 0.0 0.0 1.3 17.4 0.0 0.0 12.8 10.1 1.0 0.0 5.8 0.0 0.0 1.8 0.2 39.6 0.0 0.1 1.6 0.4 0.4 0.3 5.7 0.0 0.0 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.7 16.3 0.1 9.9 6.4 3.4 3.1 0.2 5.9 5.1 2.3 16.7 3.2 0.5 0.6 1.2 5.2 1.4 0.3 9.2 10.4 0.3 5.6 14.9 0.1 8.4 3.2 0.9 9.8 6.1 1.2 6.2 0.1 11.2 5.5 2.1 4.3 2.2 0.6 1.0 3.1 0.3 0.0 2.4 7.6 14.4 2.6 0.6 0.0 0.2 4.7 0.6 0.3 1.8 0.0 8.1 2.7 14.8 0.3 10.8 0.1 8.6 9.3 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 26.8 21.3 14.7 5.7 9.0 23.7 116.7 104.4 24.1 15.9 43.6 9.8 0.2 19.9 46.2 85.1 7.1 0.7 0.0 57.0 0.2 12.5 1.9 9.3 10.5 3.0 7.9 0.0 11.1 27.7 90.6 6.4 8.4 3.3 1.8 24.4 1.3 30.7 0.0 9.6 1.0 5.3 6.5 16.0 4.1 3.0 11.0 0.6 20.8 0.9 2.8 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 70.9" "Cell type enhanced" "Detected in some" 9 "Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075017 Enhanced Approved "Intermediate filaments,Focal adhesion sites" No NA "Focal adhesion sites" "Intermediate filaments" "HPA075017: AB_2732276" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 1.6 2.6 1.9 0.8 5.1 1.2 0.8 0.8 3.3 0.8 0.8 0.8 0.8 0.5 1.3 0.8 1.1 1.2 2.7 2.9 2.7 2.9 0.8 0.8 0.8 0.9 2.8 0.8 0.8 2.1 0.0 2.6 0.8 1.3 4.0 0.0 70.9 10.0 0.8 1.9 4.2 0.8 0.8 3.7 1.8 2.3 2.0 0.8 0.8 0.9 0.8 0.8 1.6 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.4 0.7 1.2 0.2 0.0 0.0 6.1 0.5 0.0 0.0 0.0 1.3 3.5 0.4 1.7 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.9 0.3 1.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 1.6 0.0 4.0 0.0 0.0 1.4 0.1 0.1 2.0 0.0 0.0 0.0 4.5 2.0 0.3 6.5 0.3 1.0 0.6 7.8 0.2 0.0 0.0 3.6 0.3 0.0 11.5 1.6 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 5.1 0.8 1.2 2.7 2.9 2.8 0.8 1.3 0.8 0.0 0.0 0.0 0.5 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.0 0.0 1.3 0.3 1.6 4.0 0.0 5.0 0.0 0.0 0.9 0.2 0.0 2.1 0.0 0.5 0.0 0.9 0.9 4.1 0.6 0.0 0.0 0.0 0.1 SLC16A9 "C10orf36, FLJ43803, MCT9" ENSG00000165449 "Solute carrier family 16 member 9" Q7RTY1 10 59650761-59736002 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 58.0;kidney: 70.9" "Cell type enriched" "Detected in many" 7 "Proximal tubular cells: 218.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049286 Approved Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA049286: AB_2680699" "unprognostic (3.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.30e-1)" "unprognostic (1.27e-1)" "unprognostic (1.60e-3)" "unprognostic (1.76e-2)" "unprognostic (5.96e-2)" "unprognostic (3.50e-3)" "unprognostic (5.01e-2)" "unprognostic (2.11e-3)" "unprognostic (5.99e-2)" "unprognostic (4.60e-2)" "prognostic favorable (2.56e-6)" "unprognostic (7.57e-3)" "unprognostic (1.27e-2)" "unprognostic (3.72e-1)" "unprognostic (1.94e-1)" 0.7 58.0 5.7 2.0 4.6 0.7 0.9 9.9 4.4 8.2 4.6 9.6 1.6 0.3 12.6 2.2 5.3 8.6 3.3 1.4 10.0 2.6 70.9 1.1 0.6 0.8 6.7 5.5 13.4 1.3 11.8 6.4 0.2 8.2 3.2 6.4 5.2 1.6 4.2 9.2 0.5 0.8 3.0 6.0 14.3 2.4 3.4 6.5 0.0 11.2 4.4 3.1 0.9 4.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 4.2 5.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.7 8.7 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.1 1.8 0.0 0.4 0.1 0.0 2.3 0.1 0.3 4.4 6.1 0.1 0.4 3.3 2.3 0.0 16.4 1.6 7.5 2.7 0.2 5.7 0.0 0.2 2.8 7.9 0.1 0.3 0.0 8.8 2.8 3.6 2.6 0.4 0.9 0.1 8.3 0.0 0.0 0.0 0.0 14.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.7 4.6 9.9 4.3 10.0 2.6 6.7 5.5 8.2 6.5 0.0 0.0 0.0 1.1 0.1 4.7 2.8 0.0 4.0 9.1 7.0 0.0 0.0 21.6 0.7 0.1 0.0 17.7 0.0 0.0 0.8 1.2 12.7 0.0 0.0 0.1 3.2 19.3 0.0 10.5 0.4 12.7 0.0 3.3 1.0 15.5 11.2 0.2 30.3 11.3 218.2 0.8 0.0 2.8 0.3 0.1 0.1 0.0 0.0 12.8 5.7 SLC17A1 "NAPI-1, NPT1" ENSG00000124568 "Solute carrier family 17 member 1" Q14916 6 25782897-25832059 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 56 "kidney: 67.6;liver: 17.9" "Cell type enriched" "Detected in some" 4 "Proximal tubular cells: 44.6" "Group enriched" "Detected in some" 150 "liver cancer: 7.6;renal cancer: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 389 "RPTEC TERT1: 38.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA050513 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA050513: AB_2681152" "unprognostic (6.98e-2)" "unprognostic (2.99e-1)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-3)" "unprognostic (1.32e-1)" "unprognostic (2.37e-1)" "unprognostic (4.74e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 67.6 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 44.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A2 NPT3 ENSG00000112337 "Solute carrier family 17 member 2" O00624 6 25912754-25930726 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 333 "liver: 80.2" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 29.7" "Cancer enriched" "Detected in some" 8 "liver cancer: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "Hep G2: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA038270 Uncertain NA NA "HPA038270: AB_10672511" "prognostic favorable (8.54e-4)" "unprognostic (1.90e-2)" "unprognostic (4.14e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SLC17A3 NPT4 ENSG00000124564 "Solute carrier family 17 member 3" O00476 6 25833066-25882286 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 62.3" "Cell type enriched" "Detected in some" 10 "Proximal tubular cells: 127.1" "Cancer enriched" "Detected in some" 17 "renal cancer: 57.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Cell line enriched" "Detected in single" 217 "RPTEC TERT1: 51.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.31e-3)" "unprognostic (1.56e-2)" "unprognostic (2.51e-1)" "unprognostic (4.65e-2)" "unprognostic (5.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.07e-1)" "unprognostic (2.34e-1)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 62.3 13.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.4 0.0 0.0 0.0 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A4 KIAA2138 ENSG00000146039 "Solute carrier family 17 member 4" Q9Y2C5 6 25754699-25781191 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2" "Group enriched" "Detected in some" 4 "Cholangiocytes: 86.6;Enterocytes: 45.7;Hepatocytes: 37.5;Paneth cells: 43.2" "Group enriched" "Detected in some" 6 "liver cancer: 11.0;renal cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 7 "RPTEC TERT1: 5.8" "Not detected" "Not detected" HPA055564 Approved NA NA "HPA055564: AB_2682852" "unprognostic (6.52e-2)" "unprognostic (5.64e-3)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (1.19e-3)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (7.27e-3)" 0.2 0.0 0.2 1.8 0.2 0.0 0.2 0.2 0.2 0.2 12.8 0.2 0.2 14.8 0.2 0.4 0.2 0.1 14.9 0.2 0.2 0.1 2.2 27.2 0.2 0.2 0.2 0.2 0.2 14.2 0.0 0.2 0.2 0.2 0.2 14.2 0.2 0.2 0.2 0.2 0.0 24.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 1.3 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.4 0.0 0.1 0.8 5.8 0.0 0.2 0.4 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.3 0.0 0.2 0.1 0.1 0.2 0.0 0.3 0.0 0.1 1.3 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 86.6 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.8 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 37.5 0.1 0.0 12.6 0.6 1.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.2 43.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 SLC17A5 "AST, ISSD, NSD, SD, SIALIN, SIASD, SLD" ENSG00000119899 "Solute carrier family 17 member 5" Q9NRA2 6 73593379-73654155 "Disease related genes, Predicted membrane proteins" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 155.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 41.7;ASC TERT1: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044479 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA044479: " "unprognostic (6.48e-3)" "unprognostic (7.95e-3)" "unprognostic (9.23e-2)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.59e-3)" "unprognostic (4.44e-2)" "unprognostic (4.18e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (8.29e-2)" "unprognostic (4.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.09e-1)" 7.2 5.8 6.4 2.9 6.8 2.9 9.6 6.3 6.8 4.9 7.8 4.7 12.5 6.5 5.1 17.2 5.0 3.4 6.2 6.2 4.5 6.7 24.3 13.2 7.6 4.9 5.0 4.5 3.4 8.7 155.6 9.3 12.6 6.7 6.9 8.6 6.6 15.5 8.6 3.5 4.8 12.9 4.6 5.9 4.3 6.0 4.1 4.7 3.0 30.5 2.6 7.1 5.9 4.3 5.2 9.9 12.4 10.6 12.0 9.4 6.0 2.8 3.8 3.9 6.2 41.7 31.1 5.2 9.3 23.5 2.5 8.9 2.5 6.9 2.6 4.5 13.1 5.9 5.0 5.4 2.3 4.5 1.8 6.3 1.1 2.1 5.9 8.4 2.1 4.4 14.2 3.5 5.7 4.0 10.7 6.4 3.5 2.7 2.9 8.8 1.9 0.8 1.2 2.8 11.9 2.3 1.9 4.8 11.1 6.6 7.9 1.5 2.7 1.9 5.6 5.4 6.0 2.5 13.2 9.3 1.2 1.1 5.0 2.2 8.2 11.4 0.7 4.2 4.6 3.7 12.4 10.6 4.2 8.5 9.7 8.3 5.2 9.4 8.1 9.9 3.7 7.8 8.6 7.4 12.0 6.0 7.4 8.2 6.0 6.4 6.8 6.3 6.8 4.5 6.7 5.0 4.5 6.7 4.7 20.8 20.2 7.8 12.1 8.5 7.8 5.3 15.3 14.7 9.1 48.8 27.5 14.4 3.3 12.2 27.9 15.0 21.9 0.0 11.9 12.0 22.1 30.0 13.9 31.0 53.7 0.0 11.6 25.8 26.5 32.1 6.9 22.4 10.1 7.2 42.3 7.3 16.7 17.5 10.6 30.8 24.7 0.0 8.0 11.1 2.3 9.8 19.1 7.9 15.0 18.6 SLC17A6 "DNPI, VGLUT2" ENSG00000091664 "Solute carrier family 17 member 6" Q9P2U8 11 22338097-22379503 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 75.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.3;Horizontal cells: 1.6;Muller glia cells: 1.3;Rod photoreceptor cells: 2.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "hypothalamus: 20.2;pons and medulla: 75.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 222 "SCLC-21H: 26.6" "Group enriched" "Detected in many" 5 "basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7" "Low region specificity" "Detected in all" "CAB037130, HPA039226, CAB078204" Supported Supported NA NA "CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" 0.5 0.5 7.6 0.5 1.1 0.5 0.5 0.2 13.8 0.5 0.5 1.3 0.0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 1.1 20.2 0.5 0.5 0.5 0.5 7.1 2.1 0.5 1.5 0.5 5.3 0.5 75.2 0.5 0.5 1.4 0.5 0.5 0.5 0.5 0.5 0.5 5.9 0.5 0.5 0.5 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 1.1 0.2 8.4 1.1 20.2 7.1 2.1 75.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC17A7 "BNPI, VGLUT1" ENSG00000104888 "Solute carrier family 17 member 7" Q9P2U7 19 49429401-49442360 "Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "brain: 150.0" "Group enriched" "Detected in some" 27 "Bipolar cells: 377.4;Cone photoreceptor cells: 347.5;Rod photoreceptor cells: 343.9" "Cancer enriched" "Detected in some" 6 "glioma: 7.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 21.2;K-562: 6.7;REH: 3.9;SCLC-21H: 4.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6" "CAB037183, HPA050458, HPA063679" Enhanced Supported NA NA "CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086" "unprognostic (1.79e-1)" "unprognostic (3.35e-1)" "unprognostic (1.29e-1)" "unprognostic (1.52e-2)" "unprognostic (9.12e-2)" "unprognostic (3.03e-2)" "unprognostic (1.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.30e-1)" "unprognostic (2.70e-3)" "unprognostic (8.32e-2)" "unprognostic (6.61e-2)" "unprognostic (4.26e-12)" "unprognostic (8.36e-4)" "unprognostic (4.27e-1)" "unprognostic (1.35e-2)" "unprognostic (6.17e-3)" 2.1 1.2 58.3 1.0 27.6 1.0 1.7 52.7 150.0 1.3 1.3 1.5 0.0 1.1 1.2 1.2 1.4 1.3 1.3 1.4 74.3 1.7 1.1 1.0 1.1 1.3 6.0 36.4 1.0 1.0 1.0 0.1 1.0 20.0 1.0 1.2 9.1 1.1 1.1 1.4 1.6 1.3 1.2 0.9 1.0 1.1 1.5 0.0 0.0 1.2 0.0 1.2 1.2 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 1.7 0.3 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.2 0.3 0.5 1.3 0.1 1.9 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.1 0.3 0.0 0.4 0.0 0.3 6.7 1.0 0.0 0.2 0.0 0.1 0.0 0.2 0.3 3.9 0.1 0.1 0.0 0.0 4.9 0.4 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.3 2.4 0.9 0.0 0.4 0.3 0.3 0.6 2.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 27.6 52.7 76.0 74.3 1.7 6.0 36.4 20.0 0.0 0.0 0.0 0.0 0.1 1.1 377.4 2.4 0.0 0.0 0.0 0.0 347.5 0.1 0.0 0.0 4.0 0.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 11.1 0.0 0.0 0.0 0.0 6.1 0.3 1.7 0.0 0.0 13.3 0.1 0.0 0.4 0.0 343.9 6.5 2.8 1.0 2.3 0.5 0.0 0.0 0.0 0.0 SLC17A8 "DFNA25, VGLUT3" ENSG00000179520 "Solute carrier family 17 member 8" Q8NDX2 12 100357079-100422059 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9" "Group enriched" "Detected in some" 4 "Enterocytes: 4.1;Extravillous trophoblasts: 1.7;Kupffer cells: 3.5;Paneth cells: 1.4" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 2.1;RPTEC TERT1: 1.1;SuSa: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB079058 Supported NA NA "CAB079058: " "unprognostic (4.52e-3)" "unprognostic (2.18e-1)" "unprognostic (8.56e-2)" "unprognostic (1.32e-3)" "unprognostic (3.65e-1)" "unprognostic (7.67e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-2)" "unprognostic (8.89e-2)" "unprognostic (3.55e-1)" 0.1 0.3 2.0 0.1 3.7 0.1 0.1 0.0 10.7 0.1 1.1 0.0 0.0 1.8 0.4 0.2 0.1 1.0 0.1 0.1 6.9 2.2 0.3 1.2 0.2 0.1 0.8 1.0 0.2 0.2 0.1 0.4 1.0 3.6 0.1 1.0 1.7 0.1 0.1 0.1 0.1 12.4 0.1 0.5 0.1 0.2 0.4 0.1 3.9 0.1 0.0 0.1 0.6 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.4 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 2.0 3.7 0.0 10.7 6.9 2.2 0.8 1.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 SLC17A9 "C20orf59, FLJ23412, VNUT" ENSG00000101194 "Solute carrier family 17 member 9" Q9BYT1 20 62952647-62969585 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Exocytosis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 11 "B-cells: 28.5;Hepatocytes: 35.4;Hofbauer cells: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 16.0;CACO-2: 14.8;Hep G2: 30.7;NB-4: 16.5;RPMI-8226: 15.9;U-937: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA047470 Approved Nucleoplasm NA NA Nucleoplasm "HPA047470: AB_2680060" "unprognostic (2.65e-3)" "unprognostic (2.13e-1)" "unprognostic (7.08e-2)" "unprognostic (1.97e-1)" "unprognostic (4.33e-3)" "unprognostic (5.33e-2)" "unprognostic (6.03e-2)" "unprognostic (6.84e-3)" "unprognostic (1.00e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavorable (2.78e-15)" "unprognostic (6.06e-3)" "unprognostic (5.51e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 4.2 1.3 1.6 11.4 3.4 11.9 2.2 0.4 1.4 1.9 4.8 0.6 0.1 6.4 1.7 1.2 1.5 2.1 7.3 1.5 1.5 0.7 1.5 42.7 5.7 6.6 4.8 0.0 1.9 3.4 0.0 2.5 1.9 3.4 1.6 3.8 1.1 3.6 1.2 3.4 0.9 3.9 1.4 3.9 10.5 10.7 0.8 2.9 0.5 1.4 0.5 11.8 5.6 2.4 4.0 4.2 0.0 2.7 7.3 1.3 1.2 0.0 0.0 0.0 0.1 0.1 1.3 0.0 16.0 4.6 5.3 8.4 14.8 0.0 11.5 0.0 12.8 0.0 0.0 2.3 0.0 1.2 0.0 0.0 5.0 0.4 30.7 3.6 9.0 0.0 1.2 0.0 6.3 0.0 0.0 3.4 0.0 0.0 6.7 0.0 0.0 0.3 16.5 0.0 5.7 0.0 11.9 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 1.1 0.0 0.0 0.5 0.0 2.3 0.1 6.2 0.0 19.4 0.0 0.0 1.6 0.0 1.3 2.7 0.9 4.0 0.0 0.6 4.2 3.2 0.0 0.6 0.0 7.3 0.6 0.0 0.1 1.2 1.6 3.4 0.4 1.4 1.5 0.7 4.8 0.0 3.4 2.9 0.0 0.6 28.5 0.0 0.8 0.2 1.2 12.7 0.0 1.2 0.0 0.0 0.3 0.0 0.2 0.6 0.7 1.6 0.0 0.3 0.6 5.8 0.5 4.7 35.4 16.2 0.0 2.9 2.5 4.0 0.0 1.1 9.1 5.0 1.0 7.7 0.0 1.1 0.0 0.7 0.0 0.0 0.0 3.1 0.3 0.9 1.0 0.7 4.1 9.1 0.4 SLC18A1 "CGAT, VAT1, VMAT1" ENSG00000036565 "Solute carrier family 18 member A1" P54219 8 20144855-20183206 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 25.4;intestine: 10.8" "Cell type enriched" "Detected in some" 37 "Intestinal endocrine cells: 133.5" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.8" "Region enriched" "Detected in single" 4 "midbrain: 2.0" "Group enriched" "Detected in some" 12 "intermediate monocyte: 2.3;non-classical monocyte: 6.0" "Lineage enriched" "Detected in single" 18 "monocytes: 6.0" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 39.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA006877, HPA063797" Enhanced NA NA "HPA006877: AB_2667690, HPA063797: AB_2685125" "unprognostic (8.03e-4)" "unprognostic (1.02e-1)" "unprognostic (3.75e-3)" "unprognostic (3.50e-1)" "unprognostic (6.61e-2)" "unprognostic (3.09e-3)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (3.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-2)" "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (2.06e-1)" "unprognostic (1.05e-1)" 0.0 25.4 0.2 0.8 0.1 0.0 0.0 0.0 0.2 0.2 8.8 1.3 1.3 1.4 0.4 0.0 0.0 0.0 0.7 0.1 0.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 1.0 2.7 0.0 0.0 2.8 0.0 0.0 10.8 0.0 0.1 0.3 1.1 0.2 0.0 0.2 0.2 0.0 0.1 1.3 0.4 0.0 0.3 0.2 6.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 2.2 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.3 0.2 0.1 0.0 0.2 0.1 0.4 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 133.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 SLC18A2 "SVAT, SVMT, VMAT2" ENSG00000165646 "Solute carrier family 18 member A2" Q05940 10 117241073-117279430 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.3;brain: 28.3;cervix, uterine: 31.2" "Cell type enriched" "Detected in some" 22 "granulocytes: 603.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 10 "hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5" "Cell type enriched" "Detected in some" 13 "basophil: 26.3" "Lineage enriched" "Detected in many" 13 "granulocytes: 26.3" "Cell line enriched" "Detected in some" 20 "HMC-1: 91.2" "Region enhanced" "Detected in many" "midbrain: 75.4" "Group enriched" "Detected in all" 5 "midbrain: 143.8;pons and medulla: 34.7" HPA073224 Enhanced Approved Vesicles,Centrosome NA NA "Vesicles, Centrosome" "HPA073224: AB_2732222" "unprognostic (1.49e-1)" "unprognostic (2.48e-1)" "unprognostic (2.33e-3)" "unprognostic (9.00e-2)" "unprognostic (2.85e-1)" "unprognostic (5.33e-3)" "unprognostic (2.23e-1)" "unprognostic (1.71e-2)" "unprognostic (1.40e-1)" "unprognostic (4.55e-2)" "unprognostic (2.00e-1)" "unprognostic (6.06e-3)" "unprognostic (7.94e-5)" "unprognostic (2.95e-2)" "unprognostic (2.31e-1)" "unprognostic (2.43e-1)" "unprognostic (3.57e-2)" 1.7 13.9 1.7 3.1 2.0 2.0 2.0 1.7 1.6 31.2 2.3 0.5 2.2 1.5 11.2 4.9 3.0 1.1 15.9 1.0 1.9 9.0 1.1 3.3 7.6 1.5 28.3 0.2 9.7 3.7 0.5 1.6 2.1 26.5 10.8 3.4 3.1 1.0 4.0 1.1 5.8 2.5 5.4 2.9 0.5 3.5 1.5 0.3 14.1 0.6 3.4 2.9 3.1 5.4 0.0 2.0 26.3 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.6 0.0 0.0 0.0 0.2 91.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.1 0.0 0.1 0.4 0.0 26.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.0 0.0 1.1 1.7 2.0 1.7 1.6 1.9 9.0 28.3 0.2 26.5 0.3 8.9 27.6 0.0 0.0 1.6 0.6 0.2 0.0 1.4 4.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.4 603.6 0.0 0.7 0.0 8.5 11.6 1.8 0.0 0.6 0.6 1.7 0.0 0.0 0.3 0.1 0.0 4.6 0.0 0.7 0.0 0.2 0.2 0.1 2.4 0.0 0.0 0.0 0.0 SLC18A3 VACHT ENSG00000187714 "Solute carrier family 18 member A3" Q16572 10 49610301-49612720 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.9" "Cell type enhanced" "Detected in some" 18 "Cardiomyocytes: 1.1;Syncytiotrophoblasts: 1.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 7 "basal ganglia: 8.8;hypothalamus: 3.4;pons and medulla: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 12.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 14 "basal ganglia: 17.7;pons and medulla: 20.9" CAB079011 Supported NA NA "CAB079011: " "unprognostic (2.14e-4)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (9.39e-2)" "unprognostic (4.55e-2)" "unprognostic (3.00e-1)" "unprognostic (5.85e-3)" "unprognostic (7.56e-2)" "unprognostic (1.16e-1)" 0.1 0.3 0.0 2.2 8.8 0.1 0.1 0.0 0.5 0.1 1.5 0.0 1.1 1.3 0.3 0.1 0.1 0.1 0.2 0.1 0.0 3.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.7 3.4 11.9 0.4 0.3 1.4 0.4 0.6 0.2 0.1 1.9 1.5 3.1 0.1 1.2 0.2 1.2 0.2 0.1 0.0 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 12.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.8 0.0 0.5 0.0 3.4 0.1 0.0 11.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45544411 "Cancer-related genes, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 133.1;Syncytiotrophoblasts: 303.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 37.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavorable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 9.0 7.8 7.1 8.2 13.5 10.5 12.5 9.6 8.9 5.0 9.7 6.0 9.4 31.2 4.3 4.6 2.3 4.6 3.5 3.2 7.1 6.1 4.7 14.1 13.9 14.1 8.7 4.4 8.1 5.4 1.8 3.5 32.9 11.5 4.7 2.0 17.8 6.0 3.5 3.5 6.1 16.5 2.3 5.9 11.7 5.7 3.4 3.4 11.8 9.6 2.8 4.1 3.1 3.1 0.9 4.9 37.6 6.4 0.4 1.1 2.4 10.6 9.7 1.9 7.9 0.6 0.8 15.9 5.0 0.8 4.6 2.9 22.4 9.9 9.9 9.9 1.2 3.9 5.5 3.9 3.6 1.1 9.1 19.3 20.8 5.2 15.5 2.7 13.5 3.2 1.0 2.8 4.9 1.6 1.3 3.8 10.6 24.8 4.3 1.6 11.9 18.3 12.6 11.4 4.7 11.3 25.0 2.2 28.7 2.1 6.4 11.8 10.4 5.6 9.3 4.3 2.7 7.0 16.0 4.6 6.0 7.5 1.6 8.1 1.8 6.6 9.0 2.7 22.1 4.8 0.6 6.4 8.5 0.3 6.0 1.1 0.9 0.5 0.7 4.9 0.3 0.8 0.5 37.6 0.4 3.7 1.5 1.0 2.4 7.1 13.5 9.6 8.9 7.1 6.1 8.7 4.4 11.5 3.4 44.7 4.6 0.8 1.7 2.2 18.0 2.4 2.5 1.4 10.3 0.0 0.0 133.1 0.0 7.8 3.3 2.8 9.3 0.0 4.2 16.2 2.9 3.6 1.1 10.9 24.0 7.9 0.0 1.8 11.6 3.2 6.1 5.9 3.3 0.0 3.1 8.6 6.8 5.3 10.6 1.9 3.6 0.0 3.8 1.2 4.1 1.4 303.1 2.2 7.6 0.9 SLC19A2 "THTR1, TRMA" ENSG00000117479 "Solute carrier family 19 member 2" O60779 1 169463909-169486003 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.7" "Cell type enhanced" "Detected in many" 12 "Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006119, HPA016599" Uncertain Approved Cytosol NA NA Cytosol "HPA006119: AB_1079996, HPA016599: AB_1857005" "prognostic favorable (8.41e-4)" "unprognostic (8.82e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-3)" "prognostic favorable (2.90e-4)" "unprognostic (4.45e-2)" "unprognostic (9.69e-2)" "unprognostic (1.45e-1)" "unprognostic (2.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.70e-5)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (3.60e-2)" "unprognostic (2.14e-2)" 23.1 11.1 1.9 5.3 4.4 4.8 14.2 7.4 6.1 5.9 5.4 2.8 2.7 2.1 5.0 9.0 7.5 10.0 17.5 14.8 2.7 2.1 8.6 23.4 9.2 3.1 2.8 1.7 10.3 14.4 6.8 16.3 22.1 4.7 9.4 2.8 16.4 10.4 4.6 75.7 7.5 6.6 11.3 3.7 1.8 9.4 7.3 1.8 3.6 7.9 21.6 3.9 10.4 9.8 1.4 1.9 3.0 4.6 2.6 3.3 0.7 4.5 3.2 7.3 5.7 22.8 8.4 16.2 3.6 2.7 3.0 4.2 13.1 4.8 4.0 4.2 2.4 5.5 4.9 8.8 5.4 3.3 11.5 8.2 3.8 10.4 11.9 12.4 9.6 3.8 9.9 7.9 4.8 12.3 4.2 4.4 7.1 15.4 2.6 5.0 3.0 4.9 4.3 16.6 8.8 4.9 0.0 15.8 4.6 7.9 9.7 6.4 8.6 5.0 8.7 17.8 8.7 5.5 6.3 3.7 3.6 5.0 4.4 7.1 3.6 3.3 1.3 5.3 3.7 4.7 0.0 1.7 3.0 0.9 0.7 3.3 1.4 1.1 2.1 1.9 1.2 3.1 3.0 1.1 2.6 4.6 0.7 1.0 0.7 1.9 4.4 7.4 6.1 2.7 2.1 2.8 1.7 4.7 1.8 8.9 17.1 0.9 13.6 26.3 4.7 24.0 7.6 13.4 11.4 5.2 2.0 19.6 0.0 7.1 4.4 2.3 6.3 0.0 4.6 3.0 20.6 10.4 10.3 23.1 6.2 6.4 8.6 0.6 3.7 0.4 6.4 5.7 20.3 0.0 4.4 2.6 8.2 5.7 4.6 1.8 4.7 0.0 9.4 3.4 3.4 44.2 130.8 1.5 4.7 21.3 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.3 0.4 7.4 0.1 0.2 0.3 0.6 18.7 0.5 0.4 0.2 0.1 4.6 0.5 0.5 0.5 0.8 0.1 1.2 0.1 1.0 0.8 1.7 0.2 0.2 3.3 0.4 0.1 0.9 0.3 0.0 0.3 0.2 0.9 0.0 1.8 0.1 0.7 3.2 0.6 0.3 0.3 0.2 0.2 0.2 0.3 1.1 0.1 0.6 2.1 0.5 2.7 0.3 0.2 0.5 0.5 0.5 4.2 0.4 0.2 0.1 0.7 1.4 0.3 0.5 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 8.9 3.2 0.0 0.4 0.0 2.9 0.3 0.0 0.0 0.0 1.8 0.0 45.5 1.7 1.7 0.3 0.5 6.4 0.0 0.0 7.0 0.9 0.3 0.0 11.4 4.6 0.0 1.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.6 0.0 0.0 2.2 0.1 0.0 1.0 0.0 0.1 0.0 134.3 0.0 5.6 0.3 SLC1A1 "EAAC1, EAAT3" ENSG00000106688 "Solute carrier family 1 member 1" P43005 9 4490444-4587469 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.4;kidney: 31.2" "Cell type enhanced" "Detected in many" 19 "Alveolar cells type 1: 151.8;Cholangiocytes: 35.7;Enterocytes: 37.3;Hepatocytes: 62.7;Proximal tubular cells: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.9" "Lineage enriched" "Detected in single" 30 "T-cells: 2.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.9;HDLM-2: 31.6;HUVEC TERT2: 14.9;RPTEC TERT1: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062356 Enhanced NA NA "HPA062356: " "unprognostic (1.28e-2)" "unprognostic (2.37e-2)" "unprognostic (6.83e-3)" "unprognostic (3.07e-3)" "unprognostic (2.04e-2)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (4.28e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-1)" "unprognostic (1.35e-2)" "unprognostic (1.25e-2)" "prognostic favorable (2.86e-8)" "unprognostic (2.68e-1)" "unprognostic (9.49e-2)" "unprognostic (7.78e-2)" "unprognostic (2.64e-1)" 3.3 1.4 8.6 3.4 10.2 0.3 2.9 4.7 12.4 4.0 17.9 2.7 0.5 21.0 4.0 28.8 1.7 1.9 16.3 2.0 10.0 10.2 31.2 29.1 12.8 1.8 8.6 5.8 0.7 1.8 0.4 5.2 5.1 6.7 4.3 6.6 1.9 3.1 2.4 2.2 1.2 40.4 5.6 5.3 0.5 3.4 0.8 4.4 0.0 25.0 1.8 5.0 3.5 1.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.9 0.7 4.4 11.5 13.9 3.9 4.7 9.8 1.5 1.4 7.8 0.2 6.1 0.3 2.4 1.8 0.0 1.6 2.6 1.3 31.6 2.1 0.0 6.6 0.0 0.4 0.4 0.0 0.9 0.1 5.6 0.0 0.7 14.9 0.1 0.0 0.0 1.0 0.1 0.0 0.1 1.9 4.7 0.8 0.0 0.0 0.0 31.0 2.7 1.0 0.9 0.3 1.7 0.0 3.7 0.6 0.2 8.0 2.3 0.1 4.4 1.3 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 8.6 10.2 4.7 11.7 10.0 10.2 8.6 5.8 6.7 4.4 151.8 2.7 0.8 1.0 0.0 0.7 0.8 35.7 4.0 9.1 0.0 0.0 0.0 3.3 5.5 3.5 7.0 37.3 0.0 0.7 0.0 0.9 1.7 0.0 62.7 0.1 0.0 0.0 3.1 2.1 6.1 0.3 0.1 0.0 0.0 6.5 0.8 5.8 8.6 0.0 37.2 0.9 0.0 1.1 0.0 0.2 0.5 0.1 0.8 4.8 0.2 SLC1A2 "EAAT2, GLT-1" ENSG00000110436 "Solute carrier family 1 member 2" P43004 11 35251205-35420063 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 160.9" "Cell type enhanced" "Detected in many" 14 "Cone photoreceptor cells: 139.4;Early spermatids: 85.3;Rod photoreceptor cells: 160.3;Syncytiotrophoblasts: 225.3" "Cancer enriched" "Detected in some" 5 "glioma: 28.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.5;BJ hTERT+: 4.9;fHDF/TERT166: 3.4;Hep G2: 5.7;NTERA-2: 6.4;SCLC-21H: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002574, HPA009172, HPA067499" Enhanced NA NA "CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: " "unprognostic (8.00e-2)" "unprognostic (5.71e-3)" "unprognostic (1.39e-1)" "unprognostic (2.77e-2)" "unprognostic (1.33e-1)" "unprognostic (5.65e-3)" "unprognostic (1.39e-2)" "unprognostic (9.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.65e-2)" "unprognostic (1.79e-3)" "unprognostic (2.35e-1)" "unprognostic (8.33e-4)" "unprognostic (6.34e-2)" "unprognostic (8.06e-2)" "unprognostic (5.24e-2)" "unprognostic (3.49e-2)" 1.7 4.1 65.1 1.9 79.4 1.8 3.7 7.2 160.9 2.0 1.7 9.8 0.0 1.8 2.1 1.8 1.7 1.7 1.7 2.1 47.6 11.7 1.7 20.5 1.9 2.5 15.2 43.1 1.6 4.2 1.6 0.4 2.1 27.6 1.7 1.7 0.0 3.9 1.7 1.7 2.3 1.6 1.8 17.2 1.8 2.6 2.4 16.3 0.0 1.7 0.0 2.4 1.7 0.3 1.1 0.7 3.9 0.7 1.2 0.9 0.4 0.0 0.2 1.1 0.1 0.5 4.5 0.0 1.1 4.9 0.2 0.3 0.2 0.0 0.1 0.1 3.4 0.2 0.3 0.0 0.0 0.4 0.0 0.0 0.4 0.5 5.7 0.2 0.6 0.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 2.2 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.3 0.5 0.0 2.3 0.0 0.3 1.1 0.0 0.6 0.2 0.2 0.5 0.1 0.6 0.0 0.0 1.1 0.0 0.3 3.9 0.7 0.8 0.5 0.3 0.3 0.4 0.5 0.4 0.7 1.1 0.9 0.7 2.1 1.2 0.4 0.6 0.4 0.4 65.1 79.4 7.2 64.9 47.6 11.7 15.2 43.1 27.6 16.3 3.0 3.7 0.0 0.0 2.6 48.2 2.8 0.0 1.4 0.0 0.0 139.4 14.9 0.0 0.1 85.3 0.3 0.0 0.0 2.9 0.8 2.6 0.4 0.0 5.4 3.1 6.4 0.0 0.0 0.0 59.1 0.0 0.5 1.7 55.1 0.0 10.6 0.7 0.0 0.0 0.0 160.3 0.0 1.0 0.2 1.2 1.0 225.3 0.0 0.0 0.1 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36606355-36688334 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 188.6" "Cell type enriched" "Detected in many" 9 "Muller glia cells: 579.8" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4" "Group enriched" "Detected in many" 39 "dendritic cells: 3.4;monocytes: 4.3" "Cell line enhanced" "Detected in many" "AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Mitochondria NA NA Mitochondria Nucleoli "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 17.3 10.3 76.1 5.9 70.6 3.1 6.3 45.8 188.6 6.9 3.2 26.3 0.0 2.1 2.8 2.3 7.2 5.4 5.9 12.0 57.9 27.3 3.1 3.6 4.7 8.6 32.7 39.6 8.6 4.0 2.6 3.7 12.7 28.5 3.3 2.6 1.9 3.0 4.4 7.6 5.5 2.3 4.1 29.4 5.8 2.9 2.7 33.6 0.0 2.6 0.7 4.5 4.8 1.2 0.0 3.4 0.0 4.3 0.0 0.0 0.8 0.4 0.1 21.5 1.9 2.2 6.0 13.8 0.0 0.0 0.8 1.9 34.7 1.7 0.0 10.5 0.3 0.3 26.3 6.3 2.8 0.9 0.3 12.9 0.0 0.1 0.0 0.4 0.4 0.1 11.1 13.0 5.3 2.2 0.4 0.0 0.4 0.0 0.1 3.6 0.0 0.0 0.1 2.5 0.0 2.2 0.0 0.1 0.0 0.0 1.4 1.8 0.0 2.1 6.3 0.3 10.5 0.0 1.0 0.0 1.9 3.2 0.0 7.6 0.0 0.0 0.0 8.8 14.5 4.9 0.0 4.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.8 76.1 70.6 45.8 57.8 57.9 27.3 32.7 39.6 28.5 33.6 3.0 0.3 0.5 10.4 9.5 7.7 33.9 0.0 5.3 1.2 0.0 2.0 25.3 0.0 0.4 0.6 1.1 0.0 0.0 0.0 13.5 11.8 3.2 0.0 0.2 38.2 3.2 0.0 1.3 63.4 1.9 4.0 11.0 6.8 3.6 0.0 579.8 0.3 0.0 0.0 0.0 11.3 6.5 4.7 0.2 0.1 6.1 7.7 0.0 0.0 3.3 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.1 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.2 6.6 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.5 0.0 0.3 5.4 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.6 0.0 1.1 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.6 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 0.0 0.0 0.0 0.6 2.9 12.3 1.6 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 29.3 0.0 0.0 0.0 0.3 8.5 1.0 0.2 0.0 0.0 0.4 22.3 0.0 0.0 0.0 27.3 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.7 0.0 0.3 1.7 1.5 5.9 33.4 0.0 0.0 0.1 SLC1A7 EAAT5 ENSG00000162383 "Solute carrier family 1 member 7" O00341 1 53087179-53142632 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "retina: 70.1" "Group enriched" "Detected in some" 17 "Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6" "Cancer enhanced" "Detected in many" "lung cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 58 "T-cells: 5.7" "Cell line enriched" "Detected in some" 9 "HHSteC: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049124 Enhanced NA NA "HPA049124: AB_2680643" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (9.48e-4)" "unprognostic (2.31e-1)" "unprognostic (8.73e-2)" "unprognostic (1.52e-2)" "unprognostic (6.26e-3)" "unprognostic (4.35e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-1)" "unprognostic (7.65e-2)" "unprognostic (1.19e-3)" "unprognostic (2.58e-3)" "unprognostic (5.43e-2)" "unprognostic (8.12e-2)" "unprognostic (4.70e-3)" 2.0 0.2 1.1 0.6 0.6 0.0 1.2 0.6 0.7 0.9 1.0 0.7 0.6 4.1 1.3 1.2 2.1 2.2 9.6 2.9 1.7 1.1 0.7 2.8 0.9 0.6 1.2 0.6 3.8 0.6 0.0 0.6 0.6 1.1 0.9 0.0 70.1 0.6 0.6 2.1 1.2 5.3 0.6 1.3 0.6 1.1 0.9 0.6 0.6 0.6 0.6 0.6 2.5 0.9 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.6 0.6 0.7 1.7 1.1 1.2 0.6 1.1 0.6 0.0 0.6 0.0 0.0 0.0 228.0 0.4 0.0 0.0 0.0 0.0 66.8 0.1 0.0 0.0 0.0 0.0 7.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.7 5.2 0.0 2.9 1.1 0.2 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC20A2 "Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1" ENSG00000168575 "Solute carrier family 20 member 2" Q08357 8 42416475-42541926 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 90.6" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 151.7;Urothelial cells: 128.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026540 Approved NA NA "HPA026540: AB_1855408" "prognostic unfavorable (7.67e-4)" "unprognostic (3.22e-1)" "unprognostic (3.24e-2)" "unprognostic (2.27e-2)" "unprognostic (2.12e-2)" "unprognostic (2.95e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-1)" "unprognostic (2.95e-1)" "unprognostic (7.62e-2)" "unprognostic (2.06e-1)" "unprognostic (3.43e-2)" "prognostic favorable (1.01e-4)" "unprognostic (2.13e-1)" "unprognostic (1.27e-1)" "unprognostic (5.86e-2)" "unprognostic (4.95e-2)" 7.3 5.2 12.2 6.3 17.8 2.3 8.0 24.2 22.2 8.5 14.2 28.6 4.9 28.0 10.9 6.8 19.4 15.4 9.4 37.3 16.7 17.3 11.3 23.1 9.3 4.1 22.4 14.4 5.7 30.2 15.1 8.1 8.3 32.8 8.4 11.8 19.0 90.6 11.6 69.9 12.6 18.2 12.1 21.6 4.7 8.8 11.1 18.3 5.6 48.6 19.8 10.5 14.6 11.5 3.2 5.2 3.1 3.0 9.6 7.5 4.1 18.0 5.0 6.9 5.7 3.9 3.3 15.3 16.6 28.9 8.6 21.5 13.4 48.3 6.1 19.6 14.9 4.9 29.7 3.8 16.9 15.3 1.5 3.1 9.7 1.8 7.6 5.6 3.4 4.4 3.6 15.4 8.9 8.8 6.1 4.2 4.9 9.3 5.0 16.3 5.0 6.1 5.6 6.8 17.6 3.2 5.2 7.5 6.4 7.9 17.8 1.8 7.1 4.5 7.8 4.5 5.7 6.3 6.0 13.1 18.7 6.4 4.4 9.0 3.3 7.4 4.4 5.8 6.8 10.1 3.1 3.0 0.3 5.6 2.2 6.3 3.1 6.0 5.2 5.2 3.2 7.5 5.6 1.2 9.6 1.9 3.0 5.8 4.1 12.2 17.8 24.2 19.9 16.7 17.3 22.4 14.4 32.8 18.3 26.8 15.2 6.4 151.7 87.8 13.6 54.5 15.3 64.3 14.8 15.7 15.7 19.5 11.6 26.9 7.6 15.8 30.9 0.0 26.9 19.4 12.7 56.3 3.5 28.4 9.1 6.4 11.5 6.2 7.6 7.5 6.6 6.9 10.1 9.0 10.7 16.4 37.9 12.9 11.0 5.0 10.0 6.5 16.0 3.6 4.3 65.0 21.3 8.5 10.0 128.7 SLC22A1 OCT1 ENSG00000175003 "Solute carrier family 22 member 1" O15245 6 160121789-160158718 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "liver: 175.8" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 709.2" "Cancer enriched" "Detected in some" 81 "liver cancer: 83.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "neutrophil: 7.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 7.3" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 0.7" "Not detected" "Not detected" HPA029846 Approved NA NA "HPA029846: AB_10603026" "unprognostic (8.28e-2)" "unprognostic (2.10e-1)" "unprognostic (7.80e-2)" "unprognostic (2.68e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-2)" "prognostic favorable (1.35e-5)" "unprognostic (2.28e-1)" "unprognostic (8.61e-2)" "unprognostic (3.35e-1)" "unprognostic (9.11e-2)" "unprognostic (9.94e-2)" "unprognostic (1.46e-7)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (4.72e-2)" "unprognostic (8.07e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 175.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 7.3 0.3 0.0 0.5 0.0 0.0 0.9 0.9 1.8 1.6 0.6 0.7 0.4 0.2 0.5 0.5 1.4 0.4 0.5 1.0 0.1 3.1 0.3 0.0 1.8 0.7 1.5 0.9 0.6 0.6 2.4 0.0 1.5 1.1 0.0 2.0 0.0 1.0 0.3 0.1 0.9 0.5 0.3 0.3 0.2 0.0 1.1 0.0 0.3 0.7 0.0 1.8 1.5 0.2 0.9 0.6 0.0 2.5 0.0 1.6 1.5 0.3 0.1 0.0 0.6 0.7 1.7 1.2 1.4 2.8 0.9 0.2 1.0 0.3 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.1 7.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.3 43.3 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 709.2 0.1 0.0 0.0 14.1 12.6 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.7 1.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 2.9 0.0 0.1 SLC22A10 "hOAT5, OAT5" ENSG00000184999 "Solute carrier family 22 member 10" Q63ZE4 11 63137867-63369718 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "liver: 41.7" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 15.5" "Cancer enriched" "Detected in single" 14 "liver cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.17e-2)" "unprognostic (9.77e-2)" "unprognostic (7.07e-3)" "unprognostic (7.46e-4)" "unprognostic (7.62e-3)" "unprognostic (2.87e-1)" "unprognostic (1.56e-1)" "unprognostic (6.52e-2)" "unprognostic (4.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A11 OAT4 ENSG00000168065 "Solute carrier family 22 member 11" Q9NSA0 11 64555626-64572875 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "epididymis: 22.2;kidney: 47.6;placenta: 64.7" "Group enriched" "Detected in some" 17 "Cytotrophoblasts: 554.5;Syncytiotrophoblasts: 1271.5" "Group enriched" "Detected in some" 14 "liver cancer: 3.7;renal cancer: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4;SuSa: 1.9" "Not detected" "Not detected" HPA026076 Enhanced NA NA "HPA026076: AB_1854756" "unprognostic (8.21e-5)" "unprognostic (3.29e-2)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.20e-2)" "unprognostic (4.57e-3)" "unprognostic (3.48e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (4.51e-2)" "unprognostic (7.56e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.68e-5)" "unprognostic (4.62e-2)" "unprognostic (6.52e-2)" "unprognostic (3.50e-2)" "unprognostic (8.24e-3)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 4.4 0.0 0.1 22.2 0.1 0.1 0.0 0.1 0.1 0.1 47.6 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.1 64.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 554.5 5.0 0.0 1.0 0.0 0.0 0.0 0.3 13.6 0.6 0.0 0.0 0.0 44.6 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 54.2 0.0 0.0 0.0 0.0 0.1 0.0 1271.5 0.0 0.0 0.0 SLC22A12 "OAT4L, RST, URAT1" ENSG00000197891 "Solute carrier family 22 member 12" Q96S37 11 64590641-64602353 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 349 "kidney: 70.1" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 149.1" "Group enriched" "Detected in some" 207 "liver cancer: 4.0;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA024575 Enhanced NA NA "HPA024575: AB_1858650" "unprognostic (5.88e-2)" "unprognostic (2.33e-1)" "prognostic favorable (2.63e-4)" "unprognostic (6.19e-2)" "unprognostic (3.91e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 149.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A13 "OAT10, OCTL1, OCTL3, ORCTL3" ENSG00000172940 "Solute carrier family 22 member 13" Q9Y226 3 38265812-38278315 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 16.4" "Cell type enriched" "Detected in single" 23 "Proximal tubular cells: 6.5" "Cancer enriched" "Detected in single" 7 "renal cancer: 0.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.3" "Lineage enriched" "Detected in single" 5 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "HeLa: 2.2" "Low region specificity" "Detected in all" "HPA035603, HPA035962" Enhanced NA NA "HPA035603: AB_10672869, HPA035962: AB_2674890" "unprognostic (2.73e-2)" "unprognostic (6.70e-2)" "unprognostic (2.80e-1)" "unprognostic (5.68e-2)" "unprognostic (7.13e-3)" "unprognostic (3.50e-3)" "unprognostic (6.83e-2)" "unprognostic (1.49e-1)" "unprognostic (3.48e-1)" "unprognostic (2.09e-1)" "unprognostic (3.04e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-5)" "unprognostic (3.39e-1)" "unprognostic (1.96e-2)" "unprognostic (5.24e-2)" "unprognostic (2.74e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 16.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.1 0.3 0.0 2.3 0.0 0.2 0.5 0.1 0.7 0.4 0.5 0.1 0.3 0.0 0.2 0.3 0.0 0.5 0.9 0.2 0.1 0.6 0.8 0.5 0.7 0.1 0.4 0.1 0.0 2.2 0.0 0.1 0.0 0.8 0.0 0.5 0.1 1.5 0.8 0.0 0.9 0.0 0.1 1.1 0.1 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.0 0.5 0.0 0.4 0.1 0.1 0.0 0.3 0.7 1.2 0.3 0.3 0.4 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.3 0.4 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A14 "OCTL2, ORCTL4" ENSG00000144671 "Solute carrier family 22 member 14" Q9Y267 3 38282294-38318575 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 13.2" "Group enriched" "Detected in some" 44 "Early spermatids: 57.6;Late spermatids: 81.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "neutrophil: 1.4;plasmacytoid DC: 1.2" "Group enriched" "Detected in many" 13 "dendritic cells: 1.2;granulocytes: 1.4" "Cell line enhanced" "Detected in some" "hTCEpi: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (6.26e-2)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.17e-1)" "unprognostic (6.25e-2)" "unprognostic (4.78e-2)" "unprognostic (2.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.07e-1)" "unprognostic (4.97e-2)" "unprognostic (4.81e-2)" "unprognostic (1.69e-1)" "unprognostic (3.57e-4)" "unprognostic (2.19e-1)" "unprognostic (4.02e-2)" "unprognostic (1.69e-1)" "unprognostic (2.35e-1)" 0.1 0.0 0.2 0.0 0.3 0.5 0.0 1.6 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.2 13.2 0.0 0.0 0.0 0.0 0.0 1.2 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.7 0.7 1.3 0.2 0.1 0.6 0.4 1.0 1.6 0.1 0.0 0.4 0.9 0.5 0.8 0.0 0.0 0.1 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 1.9 2.9 0.0 0.8 1.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.4 0.7 0.1 1.4 0.0 0.0 1.9 0.0 1.1 0.6 0.3 0.3 0.3 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 57.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 81.6 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.1 SLC22A15 FLIPT1 ENSG00000163393 "Solute carrier family 22 member 15" Q8IZD6 1 115976498-116070054 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.6;brain: 27.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 10.7;Cone photoreceptor cells: 9.8;Kupffer cells: 8.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 7 "granulocytes: 3.9;monocytes: 2.9" "Cell line enhanced" "Detected in many" "hTCEpi: 21.1;hTERT-HME1: 27.9;NB-4: 15.2;THP-1: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019785 Uncertain NA NA "HPA019785: AB_1857011" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.01e-3)" "unprognostic (5.62e-2)" "unprognostic (5.22e-2)" "unprognostic (5.85e-5)" "unprognostic (8.91e-3)" "unprognostic (1.81e-1)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (9.06e-2)" "unprognostic (7.29e-3)" "unprognostic (8.78e-3)" "unprognostic (3.44e-1)" "unprognostic (9.97e-4)" "unprognostic (1.30e-1)" 2.9 4.5 7.0 3.2 14.1 34.6 2.3 8.6 11.1 2.6 2.1 27.8 0.7 1.7 1.9 2.2 5.5 2.4 2.9 6.1 9.9 8.0 4.9 1.3 6.3 1.7 20.0 8.1 2.0 4.2 7.5 4.5 2.9 15.1 2.8 2.7 2.5 4.6 2.7 0.8 11.8 1.7 1.7 14.1 3.5 4.8 1.8 17.6 0.0 4.0 0.8 1.9 2.5 4.6 0.5 0.3 3.9 2.9 0.2 0.0 0.3 1.6 0.1 1.2 0.0 2.2 2.7 0.8 2.7 3.9 1.6 2.9 0.0 0.3 1.8 2.9 1.3 1.4 2.5 2.0 5.5 1.6 0.0 1.3 1.8 1.9 0.2 7.3 2.7 2.5 2.7 21.1 0.0 27.9 0.1 0.0 0.0 0.1 0.0 2.7 1.5 0.0 15.2 1.7 1.5 1.3 0.0 0.0 0.0 2.3 0.9 1.3 1.1 4.6 0.9 7.8 1.9 0.2 16.5 0.0 2.9 1.6 0.5 0.6 2.8 2.6 0.2 3.1 4.5 4.6 1.0 2.5 0.9 0.0 0.7 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 3.9 0.2 2.9 0.0 0.0 0.3 7.0 14.1 8.6 11.1 9.9 8.0 20.0 8.1 15.1 17.6 0.0 10.7 0.8 2.9 2.5 2.1 7.5 0.0 4.0 2.3 5.2 9.8 0.5 1.7 1.1 0.6 0.0 0.0 0.0 0.3 0.3 1.3 0.8 1.1 0.0 2.9 7.9 8.1 1.3 8.6 0.0 0.9 5.9 1.7 1.0 0.2 0.8 1.7 0.2 0.4 0.1 2.0 0.0 1.0 0.2 0.2 2.6 0.0 0.5 0.4 0.9 SLC22A16 "CT2, FLIPT2, OAT6, OKB1" ENSG00000004809 "Solute carrier family 22 member 16" Q86VW1 6 110424687-110476641 "Predicted membrane proteins" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4" "Group enriched" "Detected in some" 5 "Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 0.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 9.5" "Group enriched" "Detected in many" 66 "dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5" "Group enriched" "Detected in some" 18 "NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4" "Low region specificity" "Detected in all" HPA036902 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036902: AB_10672274" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (5.11e-3)" "unprognostic (2.19e-3)" "unprognostic (2.70e-4)" "unprognostic (1.45e-1)" "unprognostic (8.15e-2)" "unprognostic (6.93e-2)" "unprognostic (1.48e-2)" "unprognostic (4.98e-2)" "unprognostic (1.02e-3)" "unprognostic (2.49e-1)" "unprognostic (2.61e-6)" "unprognostic (5.78e-4)" "unprognostic (2.72e-2)" "unprognostic (2.74e-2)" "unprognostic (2.65e-2)" 3.5 0.2 0.2 0.4 0.2 16.0 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 4.9 0.8 0.1 0.3 0.7 0.1 0.2 0.1 1.1 0.3 1.6 0.0 0.2 0.0 0.9 0.1 9.6 0.1 0.3 0.2 0.2 0.0 0.0 0.6 0.0 0.2 0.3 0.1 1.6 0.2 0.8 0.2 26.4 0.0 2.2 0.1 0.8 0.1 0.1 0.1 0.0 5.1 5.0 9.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 18.4 0.0 5.0 9.5 1.6 0.0 2.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 23.3 0.0 0.1 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.2 23.1 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 35.7 0.2 0.4 0.0 0.0 0.0 0.0 SLC22A17 "BOCT, BOIT, NGALR" ENSG00000092096 "Solute carrier family 22 member 17" Q8WUG5 14 23346306-23352912 "Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 112.4" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 190.7;Muller glia cells: 81.5;Rod photoreceptor cells: 64.5" "Cancer enhanced" "Detected in all" "glioma: 51.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 26 "T-cells: 3.6" "Cell line enhanced" "Detected in many" "AN3-CA: 20.8;ASC diff: 17.3;SH-SY5Y: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002728 Uncertain NA NA "HPA002728: AB_1079998" "unprognostic (9.34e-2)" "unprognostic (2.34e-1)" "unprognostic (2.31e-2)" "unprognostic (6.23e-3)" "unprognostic (2.85e-2)" "unprognostic (1.07e-1)" "unprognostic (2.31e-2)" "unprognostic (1.26e-2)" "unprognostic (4.23e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.73e-4)" "unprognostic (1.78e-1)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (3.50e-2)" "unprognostic (1.23e-2)" "unprognostic (3.87e-2)" 6.0 24.2 32.9 4.0 63.4 1.6 7.0 40.7 112.4 12.1 5.6 27.4 2.4 4.5 8.0 10.1 4.7 10.2 7.6 9.1 35.6 69.4 8.6 2.0 5.0 3.8 28.5 27.3 11.0 14.5 13.3 39.4 5.3 33.1 21.9 3.5 13.2 20.5 24.4 2.1 6.6 6.6 7.7 21.8 3.6 6.1 6.6 22.1 0.0 10.8 0.1 2.6 4.2 4.8 0.1 0.0 0.0 0.0 0.0 3.6 0.2 0.0 1.2 13.0 20.8 17.3 9.1 2.0 4.5 8.9 1.7 1.3 0.1 1.2 0.0 1.7 8.4 4.0 0.2 0.6 0.5 0.1 0.0 0.7 2.9 0.0 0.1 9.3 0.0 2.9 11.8 0.8 2.0 0.0 7.5 0.5 5.6 0.0 0.1 2.7 1.9 0.1 0.1 7.1 0.0 0.0 0.0 0.5 0.1 0.0 1.2 12.3 24.2 3.7 0.0 0.0 2.8 2.4 0.4 0.0 1.9 5.6 10.4 0.0 0.0 2.0 0.0 1.2 0.0 7.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.1 3.6 1.8 0.0 0.0 0.0 0.0 0.0 0.2 32.9 63.4 40.7 64.3 35.6 69.4 28.5 27.3 33.1 22.1 0.0 2.4 0.0 18.6 11.2 49.9 9.0 5.1 5.3 9.1 19.2 41.2 1.8 1.7 0.6 0.3 6.8 0.0 0.0 1.2 4.1 14.9 27.1 4.6 0.8 0.8 190.7 20.0 17.8 0.8 1.3 19.5 2.2 6.8 1.0 0.0 81.5 2.4 0.0 40.3 13.5 64.5 0.0 20.0 0.9 2.1 9.5 4.0 0.0 0.0 4.6 SLC22A18 "BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5" ENSG00000110628 "Solute carrier family 22 member 18" Q96BI1 11 2899721-2925246 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 71.4;liver: 44.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 511.8;Late spermatids: 354.1;Paneth cells: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.6;Karpas-707: 20.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA067812, HPA071461" Enhanced NA NA "HPA067812: AB_2685902, HPA071461: AB_2686401" "unprognostic (1.10e-1)" "unprognostic (1.14e-1)" "unprognostic (4.80e-1)" "unprognostic (7.75e-2)" "unprognostic (7.92e-3)" "unprognostic (2.67e-1)" "unprognostic (8.25e-2)" "unprognostic (4.21e-1)" "unprognostic (2.56e-2)" "unprognostic (3.48e-2)" "unprognostic (9.35e-2)" "unprognostic (8.60e-2)" "unprognostic (8.36e-2)" "unprognostic (9.51e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-1)" "unprognostic (2.82e-1)" 3.5 1.6 0.5 11.4 1.2 1.4 3.2 0.1 2.0 2.6 36.6 0.8 2.9 36.7 3.1 15.2 6.1 4.7 21.9 8.5 0.9 1.1 18.2 44.3 8.7 8.3 1.0 1.7 2.9 3.0 4.1 1.5 4.9 1.3 4.0 3.7 4.2 8.6 4.3 1.0 6.5 71.4 3.7 1.2 4.7 8.1 2.8 0.8 3.1 8.1 7.6 5.4 4.5 4.4 2.1 8.9 21.7 15.0 2.7 4.6 6.0 1.4 8.7 0.0 4.9 0.9 1.4 3.6 2.9 5.2 1.7 3.0 5.1 21.6 0.6 9.2 3.9 3.7 4.7 0.2 0.4 0.4 4.3 0.7 0.1 2.1 4.6 9.6 0.0 4.0 4.0 0.9 1.4 0.3 1.5 0.0 3.0 0.1 20.1 0.9 4.4 0.1 0.6 0.5 7.0 1.9 1.5 0.0 2.7 0.8 3.0 0.1 1.6 1.1 12.6 10.4 0.1 2.4 2.5 0.2 1.3 2.8 4.0 0.2 3.6 0.8 0.2 5.3 2.7 5.0 15.3 15.0 12.6 3.5 14.3 2.0 2.1 2.8 2.5 8.9 1.3 1.5 2.2 21.7 2.7 10.8 6.4 4.6 6.0 0.5 1.2 0.1 2.0 0.9 1.1 1.0 1.7 1.3 0.8 6.0 8.1 3.9 17.1 6.5 1.2 8.6 71.4 16.0 9.1 26.2 0.0 70.1 6.6 24.6 135.4 3.2 511.8 0.0 7.7 17.5 12.2 13.4 16.1 138.4 40.5 0.0 19.0 6.2 27.6 354.1 9.8 18.7 18.6 14.4 72.1 5.0 15.7 245.4 7.1 76.4 1.0 0.0 11.3 1.9 2.4 7.8 151.6 15.3 106.9 17.1 SLC22A18AS "BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS" ENSG00000254827 "Solute carrier family 22 member 18 antisense" Q8N1D0 11 2887780-2903740 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 20.1;kidney: 13.4;liver: 13.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 89.5;Paneth cells: 107.4;Proximal tubular cells: 73.1;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 9.1" "Group enriched" "Detected in many" 10 "dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1" "Cell line enhanced" "Detected in some" "A549: 7.1;CAPAN-2: 7.0;MCF7: 13.2;OE19: 6.7;SK-MEL-30: 24.5;WM-115: 11.0" HPA068288 Enhanced Approved Nucleoplasm No NA Nucleoplasm "HPA068288: AB_2685969" "unprognostic (1.43e-1)" "unprognostic (9.21e-2)" "unprognostic (3.36e-1)" "unprognostic (8.05e-2)" "unprognostic (1.33e-3)" "unprognostic (3.16e-2)" "unprognostic (5.14e-3)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.10e-2)" "unprognostic (1.48e-2)" "unprognostic (9.52e-2)" "unprognostic (1.77e-1)" "unprognostic (2.39e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" 1.4 0.3 0.2 6.0 0.7 0.0 0.6 0.2 2.2 0.5 13.7 0.6 0.2 12.8 0.8 1.2 1.1 0.4 4.9 0.3 0.2 0.3 13.4 13.6 0.6 0.2 1.3 1.5 0.4 0.2 0.0 0.3 2.0 1.6 0.7 9.8 0.2 4.2 0.2 0.4 1.0 20.1 0.6 1.6 0.8 1.4 0.6 0.4 0.2 0.3 1.6 0.3 0.5 0.9 0.0 4.9 5.2 9.1 0.5 0.6 2.7 0.8 7.1 0.1 0.3 0.0 0.0 0.7 0.4 0.3 0.0 0.2 1.6 7.0 0.0 0.6 0.0 0.4 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.6 4.1 0.5 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.2 0.4 0.0 0.7 0.0 13.2 0.0 0.3 0.1 6.7 0.3 0.2 0.0 0.6 0.6 0.0 0.1 0.2 0.3 0.3 24.5 0.1 0.0 0.7 1.4 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.2 1.9 11.0 5.2 9.1 1.6 0.3 5.1 0.1 0.0 0.1 0.3 4.9 0.0 0.0 0.1 2.2 0.5 3.5 0.0 0.6 2.7 0.2 0.7 0.2 2.2 0.2 0.3 1.3 1.5 1.6 0.4 0.0 0.3 1.3 1.1 0.5 0.0 0.1 2.5 0.0 0.0 7.0 0.0 16.4 8.3 0.8 0.0 0.0 89.5 0.0 0.7 8.2 0.8 1.4 1.1 18.4 15.6 0.0 8.7 1.8 4.1 0.0 0.3 5.4 3.3 3.6 25.4 0.0 1.5 107.4 0.0 73.1 0.0 0.0 0.6 0.0 0.2 1.0 67.5 0.0 23.7 2.3 SLC22A2 OCT2 ENSG00000112499 "Solute carrier family 22 member 2" O15244 6 160171061-160277638 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "kidney: 61.8" "Group enriched" "Detected in some" 13 "Distal tubular cells: 77.9;Proximal tubular cells: 187.0" "Cancer enriched" "Detected in single" 493 "renal cancer: 30.8" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.8;SuSa: 1.0;U-2197: 3.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA008549, CAB068236, CAB068237" Enhanced NA NA "CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: " "unprognostic (1.01e-1)" "unprognostic (3.67e-1)" "unprognostic (2.26e-1)" "unprognostic (3.67e-2)" "unprognostic (4.24e-1)" "unprognostic (3.33e-1)" "unprognostic (2.51e-2)" "unprognostic (3.30e-1)" "unprognostic (1.42e-2)" "unprognostic (1.15e-4)" "unprognostic (1.41e-1)" "unprognostic (3.68e-1)" "prognostic favorable (1.85e-7)" "unprognostic (1.65e-2)" "unprognostic (8.20e-2)" "unprognostic (4.11e-1)" "unprognostic (2.45e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.2 0.1 61.8 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.3 0.2 1.9 0.1 0.0 2.7 0.0 0.6 0.3 0.0 0.1 0.1 6.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 1.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.4 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.2 1.0 0.2 0.1 0.0 0.2 0.0 3.8 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.5 0.0 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.5 0.0 0.3 0.1 0.0 0.0 0.2 0.6 0.3 0.2 0.1 0.8 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.4 0.0 0.0 77.9 0.6 4.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 187.0 0.0 0.0 0.3 0.0 0.1 0.3 0.1 0.0 0.0 0.0 SLC22A24 "MGC34821, NET46" ENSG00000197658 "Solute carrier family 22 member 24" Q8N4F4 11 63079940-63144221 "Predicted membrane proteins, Transporters" "Ion transport, Lipid metabolism, Steroid metabolism, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 10.5" "Cell type enriched" "Detected in single" 30 "Proximal tubular cells: 8.4" "Cancer enriched" "Detected in single" 11 "renal cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045015 Uncertain NA NA "HPA045015: AB_2679183" "unprognostic (5.72e-3)" "unprognostic (1.80e-7)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A25 "HIMTP, MGC120420, UST6" ENSG00000196600 "Solute carrier family 22 member 25" Q6T423 11 63163776-63229652 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 165 "liver: 16.5" "Cell type enriched" "Detected in single" 9 "Hepatocytes: 5.8" "Cancer enriched" "Detected in single" 66 "liver cancer: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039390 Uncertain NA NA "HPA039390: AB_10671996" "unprognostic (3.19e-2)" "unprognostic (2.38e-1)" "unprognostic (4.51e-1)" "prognostic favorable (7.04e-4)" "unprognostic (1.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A3 "EMT, OCT3" ENSG00000146477 "Solute carrier family 22 member 3" O75751 6 160348268-160452581 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 98.6" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029750 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA029750: AB_10603888" "unprognostic (8.61e-2)" "prognostic unfavorable (7.19e-5)" "unprognostic (4.14e-1)" "unprognostic (1.49e-2)" "unprognostic (1.38e-1)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (3.36e-2)" "unprognostic (9.74e-2)" "unprognostic (9.36e-4)" "unprognostic (1.33e-2)" "unprognostic (2.58e-2)" "unprognostic (7.28e-2)" "unprognostic (7.96e-2)" "unprognostic (5.21e-2)" "unprognostic (8.13e-4)" "prognostic unfavorable (7.26e-4)" 4.1 6.9 1.0 2.1 1.3 0.0 5.2 1.8 0.9 7.6 4.1 0.9 4.1 0.2 14.2 11.8 4.1 9.0 9.0 1.1 1.2 1.3 2.4 15.2 12.7 9.7 2.2 0.9 10.3 1.3 0.0 0.9 17.8 1.9 18.9 0.6 0.9 34.5 23.0 98.6 5.1 2.7 10.8 4.4 0.3 2.9 3.4 0.6 0.4 3.4 5.7 2.1 3.2 7.3 0.0 0.0 0.8 0.0 0.1 1.5 0.0 0.0 17.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.2 0.0 0.0 0.0 23.6 14.7 0.8 0.0 0.0 0.5 4.5 2.2 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 7.5 4.9 0.0 0.0 0.0 9.0 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.0 0.0 0.0 0.0 1.0 1.3 1.8 0.9 1.2 1.3 2.2 0.9 1.9 0.6 14.9 62.8 0.0 0.3 4.1 0.0 1.6 5.1 1.4 10.3 0.0 0.0 0.4 5.0 9.1 0.4 0.3 0.7 0.0 2.5 0.2 11.0 3.4 2.3 56.3 0.6 0.0 0.0 0.0 0.6 0.9 31.4 1.5 3.3 0.0 0.4 0.0 33.9 0.0 23.0 2.1 0.0 0.0 11.4 0.2 0.1 5.8 0.3 0.0 0.4 0.7 SLC22A31 ENSG00000259803 "Solute carrier family 22 member 31" 16 89195761-89201664 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 21 "brain: 39.3;lung: 50.7;pancreas: 69.7" "Cell type enriched" "Detected in some" 6 "Alveolar cells type 2: 129.3" "Group enriched" "Detected in many" 9 "liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4" "Region enriched" "Detected in some" 23 "cerebellum: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 23.7;Hep G2: 19.0;NB-4: 9.7;RPMI-8226: 11.4;THP-1: 6.2" NA NA "unprognostic (2.71e-3)" "unprognostic (2.53e-1)" "unprognostic (5.02e-3)" "unprognostic (6.82e-2)" "unprognostic (8.20e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-2)" "unprognostic (1.93e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-1)" "unprognostic (8.98e-2)" "unprognostic (1.09e-1)" "unprognostic (8.26e-4)" "unprognostic (2.74e-1)" "unprognostic (2.05e-1)" "unprognostic (2.72e-3)" "unprognostic (1.89e-1)" 0.1 0.3 0.0 0.3 0.4 1.1 0.1 39.3 0.1 0.3 0.5 0.0 0.0 0.6 0.2 0.5 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.3 50.7 2.5 0.0 0.0 0.7 69.7 0.1 0.0 0.1 1.7 0.2 0.1 0.4 0.7 0.2 0.1 0.3 0.3 0.1 0.3 1.0 0.5 1.1 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.6 0.7 0.0 0.0 0.0 1.1 0.0 0.0 23.7 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.0 9.7 0.6 0.2 2.4 0.0 2.6 11.4 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.1 0.2 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 39.3 0.1 0.1 0.0 0.0 0.0 1.7 0.0 6.0 129.3 0.0 0.0 0.0 0.0 0.4 0.0 4.0 14.8 0.0 0.0 0.0 0.0 0.1 20.8 0.0 0.0 0.0 4.2 0.1 0.0 0.2 8.1 0.2 0.6 0.0 0.0 0.6 0.3 23.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 2.8 0.1 0.0 0.0 0.0 0.0 SLC22A5 "CDSP, OCTN2, SCD" ENSG00000197375 "Solute carrier family 22 member 5" O76082 5 132369752-132395614 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.3;skeletal muscle: 93.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 22.3;SiHa: 23.0" HPA063062 Approved Mitochondria NA NA Mitochondria "HPA063062: AB_2684934" "unprognostic (3.88e-1)" "unprognostic (1.69e-1)" "unprognostic (2.19e-2)" "prognostic favorable (2.87e-5)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.50e-2)" "unprognostic (9.24e-2)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (7.36e-4)" "unprognostic (3.53e-2)" "prognostic favorable (8.36e-4)" "unprognostic (1.12e-2)" "unprognostic (2.98e-2)" "unprognostic (2.17e-2)" "unprognostic (1.17e-2)" 3.0 4.7 4.0 1.9 4.9 0.6 4.4 9.0 4.2 4.4 10.6 3.6 15.0 11.8 3.6 12.6 2.5 7.4 5.2 7.2 3.8 3.8 42.3 4.5 2.3 1.5 3.5 3.2 3.9 5.2 17.9 8.5 8.1 3.9 8.2 8.3 5.9 4.2 21.8 93.6 3.5 19.6 2.9 3.8 1.7 4.4 2.5 2.7 1.0 5.0 3.2 2.4 3.9 3.2 1.4 6.4 0.4 4.1 1.5 4.0 2.1 3.6 8.7 0.5 7.0 2.8 1.3 12.1 1.6 1.8 2.8 3.9 6.4 7.5 1.7 3.8 1.6 8.1 8.7 5.8 4.3 3.3 2.2 7.1 0.9 22.3 2.9 4.7 1.4 1.5 1.3 8.1 1.9 9.9 4.8 0.7 3.2 4.0 1.1 2.6 6.2 2.1 1.4 0.6 6.3 3.8 0.8 0.0 9.4 8.4 9.1 3.0 2.1 23.0 18.0 4.4 1.9 8.3 1.8 0.4 0.5 2.5 5.9 2.0 3.8 7.4 0.1 1.8 3.6 1.6 0.0 4.1 0.0 2.6 2.2 2.8 1.4 2.4 3.1 6.4 1.4 2.6 3.0 0.4 1.5 0.7 0.6 4.0 2.1 4.0 4.9 9.0 4.2 3.8 3.8 3.5 3.2 3.9 2.7 8.9 5.1 2.7 5.9 6.8 6.5 5.2 20.4 6.7 3.4 15.7 11.8 16.6 1.7 8.8 1.4 3.0 46.4 0.0 4.5 4.8 4.0 12.8 0.0 5.9 4.0 9.5 6.9 1.3 8.7 2.3 6.1 2.6 5.0 0.0 12.6 8.7 5.4 25.9 3.9 23.2 7.4 0.0 1.9 7.2 2.5 5.5 6.9 2.9 16.1 7.8 SLC22A6 "OAT1, PAHT, ROAT1" ENSG00000197901 "Solute carrier family 22 member 6" Q4U2R8 11 62936385-62984983 "FDA approved drug targets, Predicted membrane proteins, Transporters" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "kidney: 94.2" "Cell type enriched" "Detected in some" 14 "Proximal tubular cells: 213.4" "Cancer enriched" "Detected in single" 102 "renal cancer: 18.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA074559, CAB075704" Enhanced NA NA "CAB075704: , HPA074559: AB_2732260" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (4.43e-1)" 0.2 0.2 0.8 0.2 1.3 0.2 0.2 0.4 1.4 0.2 0.2 0.7 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 1.8 94.2 0.2 0.2 0.2 2.4 0.6 0.2 0.2 0.2 0.1 0.2 4.1 0.2 0.2 9.4 0.2 0.2 0.2 0.2 0.2 0.2 2.4 0.2 0.2 0.2 0.5 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.4 1.4 0.8 1.8 2.4 0.6 4.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 213.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A7 "NLT, OAT2" ENSG00000137204 "Solute carrier family 22 member 7" Q9Y694 6 43295694-43305538 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 88.9" "Group enriched" "Detected in some" 16 "Hepatocytes: 185.6;Proximal tubular cells: 86.1" "Cancer enriched" "Detected in some" 37 "liver cancer: 81.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 4 "B-cells: 1.2" "Cell line enriched" "Detected in single" 19 "Hep G2: 14.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA030220 Approved NA NA "HPA030220: AB_10603027" "unprognostic (9.17e-2)" "unprognostic (9.73e-4)" "unprognostic (2.13e-1)" "prognostic favorable (5.48e-6)" "unprognostic (1.45e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-2)" "prognostic favorable (8.98e-4)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.8 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.3 2.5 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 185.6 0.0 0.0 0.0 1.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A8 OAT3 ENSG00000149452 "Solute carrier family 22 member 8" Q8TCC7 11 62989154-63015839 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Detoxification, Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 341 "brain: 33.7;kidney: 127.3;retina: 93.5" "Cell type enriched" "Detected in some" 30 "Proximal tubular cells: 197.4" "Cancer enhanced" "Detected in single" "renal cancer: 0.6" "Region enriched" "Detected in some" 25 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "EFO-21: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044174 Enhanced NA NA "HPA044174: AB_10963058" "unprognostic (5.35e-4)" "unprognostic (4.66e-1)" "unprognostic (6.88e-3)" "unprognostic (1.72e-1)" "unprognostic (2.20e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1.0 0.1 0.1 3.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.1 127.3 0.1 0.1 0.1 0.1 1.3 0.1 0.1 0.1 0.2 0.1 33.7 0.1 0.1 93.5 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 0.7 0.1 0.1 1.3 33.7 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.0 0.0 5.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 197.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A9 "FLJ23666, OAT4, OAT7, UST3" ENSG00000149742 "Solute carrier family 22 member 9" Q8IVM8 11 63369789-63410294 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 32.2" "Cell type enhanced" "Detected in some" 30 "Cholangiocytes: 2.5;granulocytes: 4.6;Hepatocytes: 12.7" "Cancer enriched" "Detected in single" 166 "liver cancer: 19.3" "Region enhanced" "Detected in single" "cerebral cortex: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 2.1;Karpas-707: 1.9;U-266/70: 2.4" NA NA "unprognostic (2.45e-1)" "unprognostic (7.24e-2)" "unprognostic (8.86e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (2.17e-1)" "unprognostic (2.71e-1)" "unprognostic (3.09e-2)" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 2.8 0.8 0.9 0.5 0.3 0.4 0.5 0.0 0.6 0.2 0.0 0.9 0.0 0.3 0.1 0.2 0.2 0.4 0.5 0.2 0.1 0.1 0.4 0.0 0.5 0.1 1.3 0.3 0.3 0.5 2.1 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.3 1.9 0.1 0.6 0.3 0.9 0.7 0.1 0.2 0.1 1.1 0.1 0.0 0.5 0.1 0.2 0.0 0.3 0.2 0.0 0.4 0.5 0.0 0.5 0.3 0.6 0.3 2.4 0.5 1.0 0.3 0.6 0.3 2.8 0.8 0.7 0.4 0.5 0.2 0.5 0.2 0.3 0.2 1.0 0.4 0.5 2.2 0.9 0.2 0.6 0.3 0.3 0.4 0.1 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.6 12.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 SLC23A1 "SLC23A2, SVCT1, YSPL3" ENSG00000170482 "Solute carrier family 23 member 1" Q9UHI7 5 139367196-139384553 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 24.8;intestine: 94.3;liver: 25.4" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 18.7;Hepatocytes: 17.5;Proximal tubular cells: 25.1" "Group enriched" "Detected in many" 5 "endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 7.8;Hep G2: 11.1;JURKAT: 13.0;Karpas-707: 9.2;RPMI-8226: 9.0;U-266/70: 14.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA047612 Enhanced NA NA "HPA047612: AB_2680102" "unprognostic (4.00e-3)" "unprognostic (2.66e-3)" "unprognostic (2.63e-2)" "unprognostic (1.75e-3)" "unprognostic (1.93e-1)" "unprognostic (6.36e-6)" "unprognostic (7.41e-2)" "unprognostic (6.55e-2)" "unprognostic (5.88e-2)" "unprognostic (3.90e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.51e-2)" "unprognostic (4.16e-2)" "unprognostic (1.55e-2)" "unprognostic (3.65e-3)" 0.3 0.0 0.3 0.5 0.5 0.8 0.3 0.3 0.3 2.3 22.1 0.3 0.8 11.6 0.3 1.6 0.3 24.8 1.8 0.3 0.3 0.3 18.0 25.4 0.6 0.4 0.3 0.3 0.4 0.9 0.0 0.3 0.3 0.4 2.7 0.3 0.3 1.0 0.6 0.3 1.0 94.3 0.3 0.3 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.2 4.4 0.7 0.1 0.0 0.3 0.0 0.2 1.8 0.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 7.8 1.0 4.7 2.5 0.0 0.1 0.2 0.0 0.0 0.1 6.7 0.1 0.1 0.6 11.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 13.0 0.1 9.2 0.0 0.1 4.6 0.8 0.1 0.7 0.1 5.6 0.2 9.0 0.4 0.3 0.2 0.3 0.2 1.6 0.0 0.6 4.3 0.1 0.3 0.3 0.2 0.1 0.0 14.3 1.7 6.2 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 1.2 0.2 0.0 0.7 0.0 0.1 4.4 0.3 0.0 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 18.7 3.4 0.0 3.9 0.4 5.0 0.1 0.0 0.0 5.1 0.0 0.2 0.0 0.0 1.3 0.0 17.5 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.5 0.0 25.1 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.1 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 215.7;Cone photoreceptor cells: 108.0;Horizontal cells: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA052825: AB_2681965, HPA059314: AB_2683975" "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favorable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favorable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.08e-5)" 6.6 55.6 14.7 6.1 17.5 5.4 6.3 15.9 27.2 8.6 4.6 19.3 4.0 5.0 9.5 7.1 4.6 12.4 7.8 5.4 14.4 14.5 6.0 27.7 7.4 7.2 14.9 16.6 29.4 7.5 15.1 12.5 25.1 16.4 9.0 5.0 22.1 4.2 8.4 2.6 8.5 6.3 7.8 17.5 11.7 7.1 8.5 11.4 5.3 18.6 2.2 7.4 18.7 6.4 4.2 6.0 3.1 2.5 0.8 2.8 2.0 10.7 12.7 17.0 6.4 12.0 6.8 21.7 4.6 6.3 5.4 5.1 6.5 12.3 4.9 5.0 6.4 15.5 10.4 4.7 12.6 10.3 3.0 8.5 6.8 2.2 24.4 6.8 9.5 4.0 5.7 7.3 13.7 8.2 11.5 7.9 8.1 4.6 4.2 7.2 4.0 10.3 5.3 6.0 8.6 7.8 9.6 11.2 7.3 3.0 17.6 5.7 6.4 8.8 9.3 32.7 6.3 5.1 5.6 6.8 12.3 5.7 14.7 8.8 5.9 10.9 13.2 4.3 5.7 19.3 0.0 2.5 0.2 2.8 1.8 2.6 4.2 2.2 2.0 3.6 2.9 2.1 2.1 3.1 0.8 2.1 6.0 1.3 2.0 14.7 17.5 15.9 25.3 14.4 14.5 14.9 16.6 16.4 11.4 6.0 7.4 9.5 4.0 6.5 215.7 5.5 20.4 4.0 13.6 14.0 108.0 3.6 0.0 4.0 3.5 7.7 0.5 0.0 4.7 4.8 8.9 5.5 8.1 58.7 9.5 81.0 6.9 22.1 27.3 7.0 18.7 8.3 15.1 7.2 1.5 26.4 2.9 5.1 27.6 1.3 64.3 12.9 5.6 0.5 9.6 5.4 3.3 7.1 3.1 10.1 SLC23A3 "FLJ31168, SVCT3, Yspl1" ENSG00000213901 "Solute carrier family 23 member 3" Q6PIS1 2 219161465-219170095 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "intestine: 36.5;kidney: 32.4" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 6.7;Proximal tubular cells: 8.9" "Cancer enriched" "Detected in some" 9 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 9.0;U-266/70: 6.6" "Region enhanced" "Detected in some" "cerebral cortex: 1.3" "Not detected" "Not detected" HPA019059 Approved "Nucleoplasm,Cell Junctions" NA NA Nucleoplasm "Cell Junctions" "HPA019059: AB_1857017" "unprognostic (2.49e-2)" "unprognostic (6.65e-2)" "unprognostic (2.05e-4)" "unprognostic (6.97e-2)" "unprognostic (8.41e-2)" "unprognostic (1.22e-2)" "unprognostic (9.07e-2)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (4.35e-2)" "unprognostic (3.10e-1)" "unprognostic (6.12e-4)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (2.41e-2)" "unprognostic (3.34e-1)" "unprognostic (6.52e-5)" 0.4 0.0 0.3 2.3 0.3 0.0 0.5 0.3 0.5 0.8 14.9 0.3 0.3 5.3 1.1 0.3 0.9 0.5 0.3 0.3 0.3 0.0 32.4 3.1 0.7 0.3 0.3 0.3 1.0 0.4 0.5 0.3 0.5 0.3 1.4 0.8 0.3 0.4 0.3 0.3 1.1 36.5 0.3 0.3 0.4 0.5 0.3 0.3 0.3 1.3 0.3 0.4 0.6 1.3 0.8 0.0 0.0 0.8 0.0 0.5 0.0 0.9 0.4 0.2 1.1 4.0 2.2 0.8 2.2 0.6 0.4 1.3 2.4 1.6 0.5 0.8 1.5 0.1 3.2 0.7 0.3 0.6 1.9 1.8 2.1 1.9 0.2 0.7 0.2 0.9 0.7 9.0 0.9 2.9 3.6 1.2 1.2 0.3 0.9 0.6 0.3 0.1 1.0 0.0 0.8 0.2 0.5 0.6 0.8 3.1 3.7 0.5 1.0 0.2 0.0 2.4 1.1 0.9 1.1 2.6 2.1 1.4 2.2 0.7 6.6 0.3 2.9 0.6 0.7 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.3 0.3 0.3 0.5 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 2.0 1.1 1.3 0.8 0.3 2.5 0.0 0.0 1.8 0.0 0.2 1.7 0.2 0.0 0.7 6.7 0.0 0.0 0.1 0.6 1.4 0.0 0.5 0.2 0.0 1.7 0.6 0.3 0.0 1.4 0.4 1.7 1.0 2.8 1.9 0.2 3.1 1.1 8.9 0.1 0.0 0.8 0.0 0.1 1.4 0.3 0.0 1.6 0.7 SLC24A1 "CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX" ENSG00000074621 "Solute carrier family 24 member 1" O60721 15 65611366-65660995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision" "Congenital stationary night blindness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "retina: 91.1" "Cell type enriched" "Detected in many" 11 "Rod photoreceptor cells: 301.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039370 Enhanced Approved Microtubules NA NA Microtubules "HPA039370: AB_10960279" "unprognostic (9.47e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.66e-3)" "unprognostic (6.39e-3)" "unprognostic (4.64e-1)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (4.69e-2)" "unprognostic (3.94e-1)" "unprognostic (2.01e-1)" "unprognostic (9.91e-2)" "prognostic favorable (2.33e-6)" "unprognostic (8.45e-2)" "unprognostic (9.22e-2)" "unprognostic (3.04e-2)" "unprognostic (1.96e-2)" 6.2 5.3 4.5 7.7 5.0 2.6 9.3 7.0 3.4 8.9 5.0 5.6 7.5 3.7 10.6 12.2 4.2 9.0 6.2 4.1 4.7 4.1 7.9 4.7 12.0 6.0 5.3 2.6 9.7 6.6 6.5 6.1 8.9 4.0 6.0 4.1 91.1 6.4 8.3 3.8 8.5 4.5 5.0 6.8 7.8 4.2 10.8 3.2 6.9 9.0 4.6 4.8 6.0 5.3 3.8 2.6 4.7 1.5 2.3 1.8 0.4 1.5 3.1 3.3 3.0 5.0 8.4 4.1 3.9 4.2 3.8 2.5 1.4 6.6 2.1 12.9 3.7 1.3 4.2 3.9 4.2 2.3 2.1 2.9 4.6 2.3 6.8 7.2 3.0 6.3 7.1 6.2 2.1 12.8 5.4 6.6 4.9 4.8 7.2 6.2 6.4 1.9 2.8 4.3 13.5 1.2 2.0 1.0 1.4 5.8 6.0 1.6 2.3 1.0 2.9 8.0 4.8 6.2 4.2 9.4 3.9 3.9 1.5 2.6 2.9 5.2 2.5 4.1 6.5 3.3 4.7 1.5 2.1 1.4 1.3 1.8 1.4 1.5 1.2 1.1 3.8 1.1 1.5 1.7 2.3 0.6 2.6 0.3 0.4 4.5 5.0 7.0 3.4 4.7 4.1 5.3 2.6 4.0 3.2 6.0 3.2 1.4 1.2 1.3 26.9 1.9 0.0 4.0 5.7 0.0 25.5 3.3 0.0 1.1 1.1 7.0 2.8 0.0 1.1 2.0 1.5 1.1 2.3 1.5 1.7 19.1 1.7 4.3 2.2 1.8 2.8 1.5 1.7 0.0 2.2 23.4 1.7 0.0 2.1 0.5 301.7 0.0 1.4 10.4 6.4 0.9 2.1 0.8 2.1 0.8 SLC24A2 NCKX2 ENSG00000155886 "Solute carrier family 24 member 2" Q9UI40 9 19507452-19786928 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 31.8" "Group enriched" "Detected in some" 18 "Bipolar cells: 68.2;Cone photoreceptor cells: 257.2;Horizontal cells: 92.2" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "K-562: 5.7;NTERA-2: 2.0;SCLC-21H: 5.2;U-87 MG: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.30e-1)" "unprognostic (8.57e-2)" "unprognostic (4.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.33e-2)" "unprognostic (1.48e-2)" "unprognostic (8.46e-2)" "unprognostic (8.37e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-2)" "unprognostic (6.51e-2)" "unprognostic (1.57e-2)" "unprognostic (2.08e-4)" "unprognostic (1.58e-1)" "unprognostic (2.11e-3)" "unprognostic (1.51e-2)" 0.2 6.1 4.0 0.2 11.2 0.3 0.1 2.4 31.8 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.3 0.2 8.9 4.0 0.3 0.2 0.1 0.2 8.2 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 10.7 0.2 0.2 0.4 0.2 0.1 0.2 0.0 1.2 1.0 2.6 1.3 1.7 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 5.7 0.2 0.1 0.3 0.0 0.1 2.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 5.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.2 0.0 0.0 6.8 0.0 0.1 2.6 0.8 0.9 0.7 0.8 1.0 0.9 0.8 0.6 0.5 1.2 1.1 1.0 2.0 1.7 1.3 1.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 68.2 1.7 0.0 0.0 0.0 0.0 257.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.1 92.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.4 0.0 7.7 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 SLC24A4 NCKX4 ENSG00000140090 "Solute carrier family 24 member 4" Q8NFF2 14 92322581-92501483 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.6;brain: 28.1" "Group enriched" "Detected in some" 8 "Bipolar cells: 223.9;Cone photoreceptor cells: 188.5" "Group enriched" "Detected in some" 5 "glioma: 0.5;melanoma: 0.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4" "Lineage enriched" "Detected in many" 5 "monocytes: 11.6" "Cell line enhanced" "Detected in some" "Daudi: 2.7;SCLC-21H: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063206 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA063206: " "unprognostic (1.53e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (3.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.04e-3)" "unprognostic (3.40e-2)" "unprognostic (1.32e-1)" "unprognostic (2.48e-3)" "unprognostic (3.21e-1)" "unprognostic (1.48e-3)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.58e-2)" 1.8 1.0 4.9 3.8 6.0 8.6 0.6 1.1 11.7 0.8 0.9 9.6 6.3 0.9 0.6 0.7 0.8 0.8 1.9 0.9 4.7 3.2 0.5 0.7 2.3 2.7 10.8 4.7 1.0 0.6 0.5 1.8 1.2 28.1 0.7 1.0 4.6 0.7 1.2 2.4 0.8 1.2 1.4 14.2 5.0 0.9 2.9 5.7 0.0 0.6 0.0 1.4 1.5 0.8 0.1 2.3 1.3 11.6 0.2 0.2 2.0 0.1 0.2 0.1 0.3 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.6 2.7 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.7 0.4 0.4 0.2 0.0 0.2 0.3 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.1 0.6 0.0 0.4 0.0 0.3 1.1 0.0 0.3 0.1 0.1 0.3 0.0 0.3 5.2 0.0 0.2 0.2 0.5 0.1 0.3 1.2 0.6 0.2 1.5 0.3 0.1 0.4 0.1 0.1 0.2 0.3 0.3 0.2 7.9 0.0 0.0 11.6 0.2 0.0 0.0 0.0 2.3 0.1 0.0 0.0 1.3 0.2 9.4 0.4 0.0 2.0 4.9 6.0 1.1 7.3 4.7 3.2 10.8 4.7 28.1 5.7 0.0 3.4 0.0 0.1 0.0 223.9 1.2 0.0 1.4 0.0 0.0 188.5 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 3.5 0.0 0.0 1.8 26.6 4.6 0.3 4.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 SLC24A5 "JSX, OCA6" ENSG00000188467 "Solute carrier family 24 member 5" Q71RS6 15 48120972-48142672 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" Albinism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 71.9" "Cell type enriched" "Detected in some" 4 "Melanocytes: 72.6" "Cancer enriched" "Detected in single" 162 "melanoma: 8.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 751 "SK-MEL-30: 75.0" "Group enriched" "Detected in some" 5 "hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7" "Low region specificity" "Detected in all" NA NA "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" 0.1 0.1 0.5 0.1 0.6 0.1 0.6 1.5 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.4 0.1 0.5 1.0 0.3 0.1 0.2 0.1 1.7 0.1 0.1 0.1 0.1 1.5 0.1 0.4 0.1 0.1 71.9 0.2 0.1 0.1 15.4 0.7 0.1 0.6 0.1 0.1 3.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.6 1.5 0.5 0.5 1.0 1.7 0.1 0.4 0.4 0.0 0.3 0.0 0.0 2.2 6.1 0.3 0.0 1.4 0.0 0.0 2.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 3.8 0.0 0.0 72.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 SLC25A10 DIC ENSG00000183048 "Solute carrier family 25 member 10" Q9UBX3 17 81712236-81721016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 51.8" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 50.4;SK-BR-3: 38.8" HPA023048 Supported Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA023048: AB_2301950" "unprognostic (7.17e-2)" "unprognostic (2.38e-2)" "unprognostic (2.36e-2)" "unprognostic (1.36e-1)" "unprognostic (9.50e-2)" "prognostic favorable (2.56e-4)" "unprognostic (5.66e-2)" "unprognostic (2.11e-1)" "unprognostic (1.78e-2)" "prognostic favorable (8.14e-4)" "unprognostic (6.73e-2)" "unprognostic (1.33e-1)" "unprognostic (6.02e-2)" "unprognostic (6.32e-2)" "unprognostic (2.76e-1)" "unprognostic (2.05e-1)" "prognostic favorable (1.31e-4)" 10.2 4.9 2.7 5.9 3.2 5.2 6.3 3.3 5.2 4.2 9.5 3.9 7.5 13.9 1.3 3.8 12.2 5.4 8.2 4.3 2.1 2.5 21.0 51.8 3.3 4.6 3.7 4.6 2.4 17.4 10.7 2.1 2.1 3.5 5.6 4.4 4.7 16.8 6.6 2.0 5.9 11.2 1.8 4.7 1.6 7.4 21.8 2.5 7.8 3.3 7.7 8.7 4.3 3.4 0.9 0.7 0.0 1.2 3.6 1.9 0.7 14.2 26.4 2.5 12.6 0.9 0.7 5.0 6.0 2.0 7.8 5.9 16.0 6.1 6.4 4.7 1.4 3.8 9.2 3.6 6.3 1.4 4.7 20.4 5.2 16.1 50.4 1.1 11.7 6.4 0.5 3.3 5.5 1.1 1.5 4.5 9.1 8.7 8.1 2.6 26.8 17.1 12.4 2.6 6.0 19.9 13.0 5.4 20.2 6.9 12.9 16.7 11.3 5.7 38.8 1.3 0.7 16.6 6.5 1.9 6.0 19.8 8.7 11.0 5.0 2.5 3.7 2.6 12.4 5.2 0.0 0.9 0.0 0.8 1.2 1.5 0.1 0.5 1.9 0.7 0.9 0.5 0.4 0.0 3.6 0.2 0.4 1.0 0.7 2.7 3.2 3.3 5.2 2.1 2.5 3.7 4.6 3.5 2.5 0.0 2.1 0.0 5.5 0.0 2.9 3.3 17.8 13.4 5.7 14.0 0.0 11.3 21.6 15.4 23.8 0.5 9.3 0.0 20.3 4.7 0.9 3.9 0.0 37.7 6.8 0.0 4.7 3.1 0.3 65.6 2.0 0.3 0.0 1.0 15.4 1.5 9.6 24.6 1.8 75.1 3.8 0.0 0.2 8.4 2.3 0.0 3.5 1.5 28.8 4.3 SLC25A11 "OGC, SLC20A4" ENSG00000108528 "Solute carrier family 25 member 11" Q02978 17 4937130-4940251 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021167 Approved NA NA 17000 "HPA021167: AB_1857021" "unprognostic (8.58e-2)" "unprognostic (4.06e-3)" "unprognostic (9.43e-2)" "unprognostic (2.47e-2)" "unprognostic (1.75e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (4.86e-1)" "unprognostic (9.48e-2)" "prognostic favorable (6.41e-6)" "unprognostic (2.84e-1)" "prognostic favorable (2.84e-9)" "unprognostic (1.26e-1)" "unprognostic (1.37e-1)" "unprognostic (1.70e-2)" "unprognostic (1.09e-1)" 11.8 17.5 17.8 11.9 20.8 10.3 11.7 18.2 34.3 11.1 15.7 16.3 10.3 17.3 12.4 10.1 18.9 16.1 14.3 82.1 19.8 17.7 24.2 22.6 10.6 13.3 19.5 16.3 12.1 15.3 16.0 12.3 13.3 18.7 12.0 13.7 22.2 16.8 15.6 100.8 16.9 14.6 13.0 13.8 12.8 12.3 5.2 9.6 17.4 14.6 42.4 14.0 15.1 10.5 26.9 50.1 39.3 53.9 42.7 32.4 51.4 16.5 44.9 22.9 22.4 22.6 14.0 16.2 18.8 19.3 33.0 27.4 28.1 8.3 25.8 25.6 18.3 16.1 33.2 29.7 34.0 13.1 32.5 37.7 28.3 24.9 24.3 23.1 12.1 34.5 20.1 22.2 29.1 24.7 16.0 22.8 27.9 12.4 25.1 27.8 29.9 39.0 12.0 12.0 18.4 30.1 35.5 14.1 23.3 25.4 17.4 20.5 21.3 23.7 26.8 21.5 12.0 24.8 19.3 15.3 14.8 9.7 20.0 35.9 13.4 8.1 9.7 29.2 20.6 36.4 32.7 53.9 39.3 32.4 53.0 30.0 26.9 25.1 28.9 50.1 23.0 25.3 27.5 35.1 42.7 47.8 33.3 29.1 51.4 17.8 20.8 18.2 34.3 19.8 17.7 19.5 16.3 18.7 9.6 23.8 21.8 25.3 43.8 33.9 56.9 133.9 56.0 21.4 10.3 62.8 15.7 118.0 157.5 53.9 10.7 38.3 80.6 23.3 47.0 120.4 39.9 34.3 39.2 56.3 97.1 44.5 26.5 28.3 40.3 16.2 28.1 40.6 49.0 141.5 43.6 45.0 38.7 50.7 36.0 151.2 45.3 51.8 41.5 14.1 30.9 38.8 85.7 41.5 73.0 33.1 SLC25A12 Aralar ENSG00000115840 "Solute carrier family 25 member 12" O75746 2 171784370-171999859 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.7" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035333, HPA035334" Enhanced Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA035333: AB_10603028, HPA035334: AB_2674577" "unprognostic (3.24e-2)" "unprognostic (2.52e-2)" "unprognostic (4.07e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.65e-2)" "unprognostic (7.27e-2)" "unprognostic (4.21e-3)" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (4.96e-2)" "unprognostic (7.76e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.91e-8)" "unprognostic (8.64e-3)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (2.70e-1)" 6.4 6.7 8.8 6.2 18.2 2.9 9.2 17.9 25.0 10.6 12.2 5.7 5.2 4.2 10.4 7.1 11.5 6.9 5.9 42.4 9.9 13.4 10.7 1.9 5.2 6.5 10.4 12.4 10.0 3.5 16.4 14.7 4.7 15.2 10.6 10.0 11.0 21.7 14.8 84.7 7.6 5.7 14.3 7.1 5.6 9.0 4.3 6.2 5.8 10.1 23.8 8.4 10.0 6.7 6.4 3.6 5.1 4.6 6.6 8.1 2.9 7.2 5.3 5.6 13.0 16.7 18.9 0.1 9.2 15.7 12.6 12.1 2.8 6.8 22.9 6.1 10.8 9.8 9.1 11.8 11.6 15.8 14.0 11.1 10.0 7.7 6.7 6.4 20.0 10.0 16.5 11.5 14.6 4.2 6.8 13.0 9.1 6.9 10.5 8.0 4.4 14.1 8.4 4.5 6.1 7.5 14.7 8.1 11.9 13.2 6.3 7.9 2.5 5.8 13.7 7.3 3.8 5.0 5.9 8.9 10.5 4.6 11.6 6.3 14.2 9.1 23.2 14.5 10.6 7.1 5.1 3.0 1.6 6.5 3.9 7.3 6.4 4.5 6.8 3.6 3.9 6.3 8.1 0.2 6.6 4.6 0.6 4.5 2.9 8.8 18.2 17.9 25.0 9.9 13.4 10.4 12.4 15.2 6.2 0.0 6.0 1.5 11.2 6.2 25.4 94.4 0.0 13.4 22.7 17.4 23.6 6.0 16.6 1.5 2.5 7.0 5.6 23.3 2.9 1.2 7.0 4.3 10.4 0.2 4.0 35.0 13.8 8.6 7.3 1.7 11.5 5.4 15.1 6.4 7.0 18.3 1.3 3.5 23.0 10.9 22.1 12.9 11.8 3.2 9.0 6.8 1.0 8.7 7.4 4.6 SLC25A13 "ARALAR2, CITRIN, CTLN2" ENSG00000004864 "Solute carrier family 25 member 13" Q9UJS0 7 96120220-96322147 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 79.1" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 124.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA018997 Enhanced Supported Mitochondria NA NA Mitochondria "HPA018997: AB_1857023" "unprognostic (3.61e-2)" "unprognostic (7.99e-2)" "unprognostic (6.99e-2)" "unprognostic (7.19e-2)" "unprognostic (1.14e-1)" "unprognostic (3.44e-2)" "unprognostic (1.42e-2)" "unprognostic (6.67e-2)" "unprognostic (2.31e-2)" "unprognostic (5.46e-2)" "unprognostic (1.01e-1)" "unprognostic (6.99e-2)" "prognostic favorable (9.14e-4)" "unprognostic (1.15e-1)" "unprognostic (1.05e-1)" "unprognostic (3.32e-1)" "unprognostic (7.09e-2)" 7.7 10.3 4.2 4.9 11.8 4.1 6.7 3.0 7.5 5.4 12.5 21.1 15.6 8.9 5.1 8.0 6.9 5.9 6.7 4.5 5.6 5.3 17.7 79.1 5.5 4.9 14.5 4.8 5.9 7.3 8.2 8.8 8.9 12.4 5.9 10.2 12.6 5.7 17.3 4.6 8.2 9.7 5.0 13.1 7.2 7.9 4.3 12.6 1.8 7.9 3.0 4.8 5.0 5.3 3.7 8.9 3.1 6.7 2.8 2.4 2.1 16.1 14.3 16.5 5.7 2.8 2.3 23.2 4.1 3.1 10.0 10.1 25.6 15.2 7.3 19.6 2.6 21.8 9.7 18.5 5.9 11.8 2.8 12.2 8.3 13.5 19.9 6.7 10.5 6.5 6.1 6.3 8.5 7.7 3.8 11.4 1.1 23.3 2.8 4.8 17.8 0.0 9.8 29.1 17.3 8.9 4.1 9.8 16.8 23.8 15.3 7.9 26.0 14.2 30.2 24.3 28.7 9.0 8.1 6.6 7.4 16.6 17.5 12.4 5.7 14.3 4.6 9.1 10.1 12.2 0.6 4.6 3.1 2.2 6.3 2.4 3.7 1.8 2.0 8.9 2.0 1.2 1.5 0.8 2.8 6.7 4.7 1.8 2.1 4.2 11.8 3.0 7.5 5.6 5.3 14.5 4.8 12.4 12.6 8.9 9.3 10.5 6.9 6.5 34.3 7.1 38.2 14.7 6.8 17.4 51.1 25.9 23.2 17.3 9.5 16.9 23.5 0.0 16.5 20.5 14.8 9.8 13.9 124.1 20.1 9.5 36.2 12.3 22.7 6.7 12.0 19.6 20.3 2.8 19.4 22.1 18.9 24.6 14.9 50.8 47.6 12.9 8.3 5.4 9.1 6.9 16.7 5.7 23.3 12.2 SLC25A15 "D13S327, HHH, ORC1, ORNT1" ENSG00000102743 "Solute carrier family 25 member 15" Q9Y619 13 40789412-40810111 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 26.0;liver: 66.4;pancreas: 24.9" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 37.5;Hepatocytes: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042146 Approved NA NA "HPA042146: AB_2677874" "unprognostic (4.17e-1)" "unprognostic (4.50e-2)" "unprognostic (2.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.85e-1)" "prognostic favorable (2.16e-4)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (2.37e-2)" "prognostic favorable (1.74e-4)" "unprognostic (4.04e-3)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (5.46e-4)" 1.0 1.1 1.4 4.7 1.7 1.6 2.6 1.0 2.0 1.3 13.2 1.0 0.2 16.3 1.6 1.5 1.8 1.2 3.1 1.9 1.3 1.6 4.0 66.4 1.6 2.0 1.6 0.9 1.8 24.9 0.8 1.0 1.8 1.5 1.0 2.6 0.9 1.4 1.6 2.5 1.3 26.0 1.5 1.4 1.5 2.0 3.8 1.0 2.7 8.0 2.9 3.8 1.2 1.1 1.7 3.4 0.0 3.1 2.4 5.0 1.6 5.0 9.9 9.9 13.5 3.6 4.8 12.5 3.8 1.9 4.2 2.7 10.5 9.7 32.1 4.3 6.2 8.3 8.3 15.4 10.3 3.7 7.6 7.7 24.2 4.9 13.6 6.9 8.6 3.1 5.2 4.5 5.3 13.0 2.6 6.5 14.7 12.4 5.1 6.5 16.4 6.4 3.8 21.2 18.8 5.1 15.9 8.1 6.9 5.1 4.6 5.5 13.6 6.9 10.9 5.9 6.9 9.1 12.8 6.2 5.3 8.5 8.1 10.7 5.8 5.5 18.8 5.6 7.0 10.6 0.0 1.3 0.0 4.3 3.1 2.7 1.6 2.9 2.8 3.4 1.7 3.0 5.0 0.0 2.4 1.0 0.7 1.8 1.6 1.4 1.7 1.0 2.0 1.3 1.6 1.6 0.9 1.5 1.0 3.0 0.3 0.0 1.0 0.2 1.1 1.2 2.5 0.0 0.0 0.0 0.0 2.0 6.6 1.7 3.6 0.4 1.3 0.0 3.8 37.5 0.5 1.5 0.0 30.8 1.6 0.0 1.2 0.6 1.9 5.4 0.6 0.6 1.7 0.0 0.2 0.3 2.2 0.6 0.0 3.1 1.8 0.0 0.8 4.1 7.7 0.1 1.3 0.0 3.0 0.8 SLC25A18 ENSG00000182902 "Solute carrier family 25 member 18" Q9H1K4 22 17563439-17590994 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 13.1;brain: 49.0;liver: 50.0" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6" "Group enriched" "Detected in some" 5 "glioma: 10.6;liver cancer: 11.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 5.7;BEWO: 12.9" "Low region specificity" "Detected in all" HPA068110 Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA068110: " "unprognostic (2.15e-1)" "unprognostic (6.07e-2)" "unprognostic (4.95e-2)" "unprognostic (1.01e-1)" "unprognostic (3.79e-1)" "unprognostic (3.98e-2)" "unprognostic (1.00e-1)" "unprognostic (1.89e-1)" "unprognostic (1.45e-2)" "unprognostic (2.72e-2)" "unprognostic (8.70e-4)" "unprognostic (1.44e-1)" "unprognostic (3.92e-2)" "unprognostic (1.67e-2)" "unprognostic (1.29e-1)" "unprognostic (5.24e-2)" "unprognostic (1.62e-1)" 13.1 2.2 33.2 1.5 28.0 1.2 2.7 7.5 49.0 1.4 1.4 13.3 0.0 1.5 1.7 1.4 1.5 1.7 2.1 2.3 33.3 15.7 1.8 50.0 1.5 1.5 25.6 19.1 1.9 1.8 1.7 0.0 1.3 17.8 4.8 1.3 0.0 1.6 1.6 2.5 1.4 1.4 1.8 14.9 1.9 1.5 3.4 21.6 0.0 1.5 0.0 1.3 1.4 0.0 0.4 0.4 2.1 0.6 0.0 0.5 0.1 0.5 0.9 3.4 0.6 5.7 0.0 12.9 0.4 0.0 0.0 0.0 0.3 0.3 0.3 0.4 0.0 3.7 1.1 0.1 0.0 0.0 0.4 1.4 0.5 0.4 0.8 2.3 0.5 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.6 0.4 0.0 0.6 0.1 0.8 2.9 1.3 2.1 4.2 1.2 0.0 0.1 0.6 1.2 0.5 0.4 0.6 1.0 2.6 3.7 1.4 0.2 0.2 0.5 0.3 0.4 1.4 1.7 0.0 2.7 0.3 0.5 0.0 0.4 2.1 0.4 0.6 0.0 0.4 0.5 0.1 0.3 0.2 0.1 0.3 0.5 0.0 0.2 0.4 0.1 0.1 33.2 28.0 7.5 25.7 33.3 15.7 25.6 19.1 17.8 21.6 26.8 15.9 0.0 0.2 0.0 0.5 1.4 0.0 28.1 12.5 0.0 0.0 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.5 4.6 5.8 67.6 0.2 0.0 0.0 2.5 4.6 0.6 0.9 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.5 0.6 3.2 0.0 0.0 2.7 4.8 0.1 1.5 0.0 0.0 0.1 SLC25A19 "DNC, MCPHA, MUP1, TPC" ENSG00000125454 "Solute carrier family 25 member 19" Q9HC21 17 75272981-75289510 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 35.5" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 59.5;monocytes: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.28e-1)" "unprognostic (7.05e-3)" "unprognostic (8.21e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.21e-7)" "unprognostic (6.71e-2)" "unprognostic (2.73e-1)" "unprognostic (2.85e-1)" "unprognostic (7.72e-2)" "unprognostic (1.77e-3)" "unprognostic (2.71e-3)" "unprognostic (3.58e-2)" "unprognostic (4.44e-2)" "unprognostic (1.17e-1)" "unprognostic (2.13e-1)" 8.1 18.5 9.9 14.0 15.7 6.7 5.7 9.0 10.9 6.5 7.9 4.3 2.6 8.5 5.8 3.1 6.8 6.0 5.8 7.9 7.1 6.0 9.1 9.2 10.7 19.3 9.6 5.7 5.4 10.6 4.5 4.1 10.8 9.2 5.1 8.5 3.2 5.4 3.8 10.6 4.5 6.8 6.6 12.3 12.2 8.0 35.5 8.7 9.3 7.7 3.9 16.8 7.8 5.8 19.4 18.2 1.2 14.7 5.3 10.4 8.3 9.4 11.7 2.1 6.3 4.8 2.5 6.9 6.2 2.4 7.1 7.3 20.2 6.0 30.3 4.5 2.2 6.2 8.4 15.0 7.1 8.9 8.8 24.1 13.8 14.0 19.3 4.1 19.6 15.7 2.1 4.0 11.1 9.0 1.6 11.7 15.4 16.8 14.5 2.2 19.7 20.2 19.7 4.6 18.6 23.1 15.8 6.9 28.7 4.9 6.6 21.3 5.3 6.6 17.7 7.6 3.7 11.1 15.9 4.1 4.3 8.5 8.2 16.5 36.0 17.3 31.8 3.3 22.6 5.3 0.2 12.7 1.2 10.4 14.7 10.4 19.4 8.1 9.6 14.8 16.3 9.3 9.6 1.1 5.3 8.4 18.2 9.8 8.3 9.9 15.7 9.0 10.9 7.1 6.0 9.6 5.7 9.2 8.7 6.0 7.9 29.8 9.4 13.5 1.3 0.6 2.5 2.7 7.9 7.0 2.0 5.7 19.9 5.9 12.0 7.1 5.1 0.0 4.6 59.5 8.6 6.2 11.5 2.8 41.1 3.2 2.9 3.1 11.0 18.8 2.8 30.8 23.6 62.3 4.8 1.5 4.6 5.5 3.2 4.7 5.8 6.5 7.2 33.0 10.5 11.3 7.4 13.1 9.7 6.4 SLC25A2 ORNT2 ENSG00000120329 "Solute carrier family 25 member 2" Q9BXI2 5 141302629-141304045 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 12.6" "Group enriched" "Detected in some" 9 "Early spermatids: 8.6;Late spermatids: 8.3;Spermatocytes: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA042146 Uncertain NA NA "HPA042146: AB_2677874" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "unprognostic (4.63e-2)" "unprognostic (4.30e-1)" "unprognostic (1.71e-1)" "unprognostic (1.30e-1)" "unprognostic (4.72e-3)" "unprognostic (2.81e-1)" "unprognostic (2.62e-2)" "unprognostic (6.69e-2)" "unprognostic (1.17e-1)" "unprognostic (8.82e-10)" "unprognostic (2.56e-1)" "unprognostic (1.87e-1)" "unprognostic (1.26e-2)" "unprognostic (1.14e-1)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 12.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.4 0.0 0.5 0.1 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 2.2 0.7 0.0 0.0 0.0 0.0 0.0 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856931-48898993 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.8;liver: 58.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 35.4;RPMI-8226: 48.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA 13000 "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 11.9 13.7 6.7 5.6 7.3 3.4 10.2 3.0 5.6 3.3 19.7 4.7 5.2 25.0 4.7 3.1 3.3 5.0 9.9 37.1 7.3 4.6 16.8 58.3 6.6 4.9 8.5 5.1 2.7 16.8 5.9 5.1 3.3 5.8 5.0 9.1 5.4 7.4 3.7 27.4 4.0 32.2 5.7 5.5 8.8 7.5 4.4 6.6 9.1 5.5 5.5 5.9 4.5 9.8 9.4 33.3 57.8 29.0 17.3 28.4 24.7 1.4 4.5 3.6 5.0 11.5 4.4 0.7 8.0 4.3 5.6 5.8 5.6 6.9 6.6 5.7 12.6 6.8 1.4 8.8 3.5 4.2 16.8 4.2 9.2 7.0 7.1 5.2 9.6 17.8 5.6 4.0 7.5 1.2 2.2 7.2 10.1 8.2 35.4 7.3 3.7 10.5 4.8 1.8 8.1 10.2 3.8 2.1 48.7 6.0 3.5 1.4 5.1 7.4 0.0 4.0 5.2 11.3 4.5 5.8 6.4 1.1 9.3 5.8 13.1 9.1 7.7 9.1 6.8 8.4 13.8 29.0 57.8 28.4 21.0 18.1 9.4 16.1 20.8 27.0 7.8 12.7 21.3 13.5 17.3 21.4 33.3 16.1 24.7 6.7 7.3 3.0 5.6 7.3 4.6 8.5 5.1 5.8 6.6 6.0 2.4 7.5 2.3 1.5 1.1 31.1 7.6 5.3 2.3 0.0 5.9 1.7 3.3 3.2 1.1 3.1 38.0 0.0 3.7 1.9 4.1 2.4 1.1 55.2 15.8 0.0 7.0 9.2 13.2 1.0 9.8 7.5 1.7 40.5 10.8 2.8 4.0 13.5 11.7 12.5 1.1 0.0 2.2 7.1 7.0 1.1 1.0 13.8 12.8 2.0 SLC25A21 "ODC, ODC1" ENSG00000183032 "Solute carrier family 25 member 21" Q9BQT8 14 36678431-37172866 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.6" "Cell type enriched" "Detected in many" 11 "Erythroid cells: 93.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "K-562: 15.5;Karpas-707: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000662 Uncertain NA NA "HPA000662: AB_1080000" "unprognostic (6.81e-3)" "unprognostic (6.98e-2)" "unprognostic (7.21e-2)" "unprognostic (2.45e-1)" "unprognostic (2.78e-2)" "unprognostic (2.20e-1)" "unprognostic (2.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.32e-2)" "unprognostic (6.86e-2)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (6.70e-4)" "unprognostic (9.09e-3)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (1.07e-1)" 1.3 2.1 1.1 1.0 2.0 8.8 1.4 0.4 2.5 3.0 1.9 0.7 0.1 1.1 4.0 1.4 2.9 1.8 1.2 2.2 1.1 1.4 2.8 1.1 1.9 0.1 1.4 0.7 4.6 5.2 0.9 1.8 0.4 1.7 3.1 0.4 3.6 2.9 0.9 9.6 0.9 2.4 3.0 1.2 0.9 2.6 25.6 1.0 0.2 3.3 2.2 1.3 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.8 0.7 0.2 2.0 0.0 0.6 0.0 0.3 0.5 1.0 0.4 0.1 0.7 0.0 0.9 0.2 0.0 0.7 0.0 0.4 0.4 0.5 5.9 0.6 0.6 0.6 0.6 0.0 0.0 0.5 0.8 0.0 0.3 0.6 2.4 0.0 15.5 34.0 0.5 1.8 0.0 0.0 1.3 0.0 2.5 0.0 0.0 0.0 0.5 2.4 1.5 0.0 1.6 0.1 0.8 0.3 2.2 0.0 1.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 2.0 0.4 2.5 1.1 1.4 1.4 0.7 1.7 1.0 0.0 0.0 0.0 1.7 0.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.7 1.0 0.4 0.0 93.5 8.3 0.0 0.8 2.3 0.0 0.0 0.2 1.6 1.7 1.3 0.0 0.0 1.4 0.0 0.0 0.0 0.2 3.4 5.4 0.0 0.7 3.1 1.5 0.0 1.0 3.0 2.1 0.6 0.0 0.0 0.8 0.6 SLC25A22 "EIEE3, FLJ13044, GC1, NET44" ENSG00000177542 "Solute carrier family 25 member 22" Q9H936 11 790475-798333 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.0;pancreas: 43.0" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 147.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 44.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014662 Approved Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA014662: AB_10600808" "unprognostic (1.01e-2)" "unprognostic (2.12e-1)" "unprognostic (7.28e-2)" "unprognostic (4.68e-2)" "unprognostic (2.09e-3)" "unprognostic (1.43e-1)" "unprognostic (2.72e-3)" "unprognostic (8.67e-3)" "unprognostic (4.19e-2)" "unprognostic (3.70e-1)" "unprognostic (2.46e-2)" "unprognostic (1.16e-1)" "unprognostic (8.97e-3)" "unprognostic (2.61e-2)" "unprognostic (8.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" 4.9 5.2 23.3 8.3 19.0 5.7 2.7 32.2 45.0 3.5 4.1 3.4 2.5 10.3 3.2 2.3 4.4 5.0 3.8 3.2 27.8 13.2 4.1 14.2 4.6 7.5 9.6 22.8 4.8 43.0 4.0 13.4 4.4 13.5 5.2 2.9 4.6 11.4 4.2 1.1 5.8 8.5 3.3 2.8 5.3 6.8 6.6 2.6 3.5 3.1 3.0 5.1 4.5 2.4 2.5 3.1 4.0 5.7 3.6 7.2 2.3 23.4 15.2 8.9 8.0 3.8 6.8 8.4 11.2 9.4 12.5 7.9 15.0 16.1 7.0 8.4 9.3 14.2 20.8 9.8 13.5 2.8 13.2 18.1 6.4 7.5 9.2 16.2 10.4 10.9 6.8 8.2 9.5 10.2 3.9 5.7 8.3 13.1 11.1 5.5 14.2 10.8 9.8 19.3 14.5 23.4 12.8 4.9 16.6 7.4 3.9 44.3 19.9 6.4 15.5 8.0 1.4 7.5 5.3 5.6 14.0 9.4 6.4 10.5 9.7 5.7 9.0 16.8 9.3 8.3 0.0 2.4 4.0 6.6 5.6 4.2 2.5 4.1 7.2 3.1 2.1 2.5 4.2 1.5 3.6 5.7 0.9 2.2 2.3 23.3 19.0 32.2 37.4 27.8 13.2 9.6 22.8 13.5 2.6 6.0 10.4 2.2 6.3 11.2 147.0 1.8 5.1 2.7 4.5 8.7 31.4 5.9 3.3 22.2 11.5 4.9 7.0 0.0 17.0 8.9 7.4 13.6 2.3 15.3 4.0 41.3 12.5 1.8 1.8 5.6 4.4 2.6 3.3 6.4 7.3 13.4 14.1 7.0 4.6 5.6 29.9 0.0 6.1 1.4 6.3 11.7 2.6 5.2 5.0 8.1 SLC25A23 "APC2, FLJ30339, MGC2615" ENSG00000125648 "Solute carrier family 25 member 23" Q9BV35 19 6436079-6465203 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 100.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009675, HPA050883" Approved Supported Mitochondria NA NA Mitochondria "HPA009675: AB_2668252, HPA050883: AB_2681260" "unprognostic (3.51e-1)" "unprognostic (1.53e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.05e-2)" "unprognostic (3.65e-3)" "unprognostic (3.43e-2)" "unprognostic (1.31e-3)" "unprognostic (1.27e-1)" "unprognostic (3.82e-1)" "unprognostic (1.30e-1)" "unprognostic (3.25e-1)" "prognostic favorable (1.10e-12)" "unprognostic (8.95e-2)" "unprognostic (3.20e-1)" "unprognostic (5.44e-2)" "unprognostic (4.22e-1)" 12.1 13.0 68.2 5.2 97.6 0.4 6.3 21.5 51.7 12.5 22.3 17.6 10.3 18.2 13.0 11.9 31.2 16.1 10.1 36.2 66.2 25.1 17.9 13.0 11.3 4.0 25.6 33.1 15.8 10.0 24.5 5.5 2.2 28.0 14.3 23.5 12.2 32.1 20.3 37.0 11.9 18.6 30.7 16.9 4.3 9.9 3.7 25.9 1.2 29.2 9.7 14.1 16.8 9.3 2.5 0.9 0.8 0.0 0.7 4.5 0.9 20.0 8.1 11.8 37.1 15.9 7.0 5.4 5.8 9.6 11.4 13.8 20.4 13.4 11.2 14.3 14.7 12.5 17.1 24.0 14.0 9.1 0.0 20.2 8.1 17.2 16.2 14.8 0.5 19.2 20.0 12.3 10.1 4.4 23.3 11.9 12.5 23.3 14.3 2.2 14.6 7.0 11.5 8.5 21.6 25.0 3.4 3.2 17.2 30.5 3.6 0.8 11.6 4.2 25.8 10.7 13.4 13.5 17.8 4.1 3.6 15.4 0.9 3.8 2.6 3.5 9.9 1.6 19.1 5.6 0.8 0.0 0.0 4.5 0.0 1.1 2.5 2.7 2.3 0.4 1.0 4.0 3.4 0.0 0.7 0.0 0.9 2.6 0.9 68.2 97.6 21.5 51.7 66.2 25.1 25.6 33.1 28.0 25.9 8.9 18.1 7.0 8.3 9.3 9.8 34.8 48.4 1.4 4.5 43.6 7.9 1.2 16.6 52.9 16.5 5.5 100.4 0.0 24.8 1.5 5.8 13.9 6.9 27.0 2.1 7.9 13.3 12.9 2.1 45.5 17.5 2.2 16.9 1.8 35.6 14.6 40.3 35.4 27.6 22.6 16.4 12.9 6.2 0.3 3.2 20.5 0.7 4.3 23.9 24.3 SLC25A29 "C14orf69, FLJ38975" ENSG00000197119 "Solute carrier family 25 member 29" Q8N8R3 14 100291111-100306547 "Predicted intracellular proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 83.5" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 116.9;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030781 Uncertain NA NA "HPA030781: AB_10603029" "unprognostic (8.64e-3)" "unprognostic (1.20e-3)" "unprognostic (2.39e-2)" "unprognostic (1.32e-1)" "unprognostic (2.23e-1)" "unprognostic (3.63e-3)" "unprognostic (3.39e-3)" "unprognostic (2.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.00e-1)" "prognostic favorable (2.90e-4)" "unprognostic (1.32e-3)" "unprognostic (1.17e-1)" "unprognostic (2.97e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "prognostic favorable (5.26e-4)" 6.3 11.1 9.0 4.3 15.2 8.3 10.5 7.0 14.0 13.5 4.4 29.7 9.5 5.9 9.8 32.0 6.8 22.7 8.7 7.8 10.3 9.7 19.5 6.3 10.5 5.2 29.7 10.3 10.9 5.9 5.7 13.1 4.9 25.4 12.9 4.3 22.1 20.9 9.8 6.2 14.1 5.2 6.3 30.9 6.5 8.3 9.6 23.1 2.4 83.5 3.9 5.4 5.1 5.1 1.2 2.8 4.9 2.8 0.3 2.4 0.7 4.6 10.2 13.6 17.9 3.2 1.2 8.1 3.6 4.1 7.8 4.7 2.3 3.0 0.0 9.4 1.2 3.9 5.2 5.8 1.9 2.6 1.8 2.7 4.7 14.1 4.4 7.6 2.7 6.1 3.6 6.0 3.5 3.3 11.9 10.7 16.3 1.5 0.5 2.2 15.0 16.5 14.8 6.9 4.3 10.9 21.0 5.7 0.3 25.8 3.4 19.9 24.8 8.6 6.2 6.7 6.1 15.0 4.6 11.0 2.8 5.5 3.9 5.7 1.4 0.6 0.6 3.2 6.7 3.4 3.6 2.8 4.9 2.3 0.4 0.0 0.4 1.1 2.4 2.8 1.2 0.3 1.6 3.2 0.3 0.1 1.3 1.6 0.7 9.0 15.2 7.0 14.0 10.3 9.7 29.7 10.3 25.4 23.1 8.9 27.4 0.5 16.0 5.8 18.5 1.2 12.7 34.8 25.0 116.9 70.7 3.9 14.9 25.9 15.8 14.7 4.0 0.0 10.3 0.8 5.3 29.3 13.9 7.4 6.6 20.6 20.1 21.5 3.4 34.1 2.3 9.0 10.1 8.2 7.4 18.3 13.9 14.4 5.6 10.5 82.2 12.9 6.6 2.6 4.1 5.6 15.6 1.5 12.7 10.3 SLC25A3 PHC ENSG00000075415 "Solute carrier family 25 member 3" Q00325 12 98593591-98606379 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 233.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045709 Supported Mitochondria NA NA 5500000 Mitochondria "HPA045709: AB_10965843" "unprognostic (1.16e-2)" "unprognostic (4.68e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (1.56e-2)" "unprognostic (6.38e-2)" "unprognostic (3.25e-3)" "unprognostic (9.41e-2)" "unprognostic (4.98e-2)" "unprognostic (6.43e-2)" "unprognostic (5.65e-2)" "unprognostic (7.40e-2)" "prognostic favorable (8.11e-7)" "unprognostic (3.45e-1)" "unprognostic (2.99e-1)" "unprognostic (8.66e-3)" "unprognostic (4.72e-2)" 35.7 71.2 23.6 38.3 27.2 24.6 48.9 25.1 50.2 29.8 69.6 22.4 33.8 53.9 38.5 35.9 54.6 30.1 55.1 233.5 22.9 25.3 60.2 72.6 47.0 75.5 27.8 26.0 39.6 59.7 55.5 29.1 34.2 31.6 33.8 53.3 30.9 53.5 33.5 190.6 33.8 76.0 46.7 19.6 35.6 51.4 16.9 15.1 42.0 41.5 125.8 44.4 38.5 31.9 46.8 82.3 33.4 78.5 43.3 56.6 76.3 74.7 58.4 77.5 64.2 70.6 117.4 99.9 65.6 87.5 85.1 71.2 104.8 39.3 102.2 39.0 79.5 38.5 64.4 78.6 88.7 89.8 38.4 62.7 60.9 43.1 69.5 86.9 71.3 48.4 111.0 79.4 61.8 88.9 128.1 120.1 53.0 65.6 30.3 101.4 55.8 66.1 79.6 71.7 64.7 96.0 75.6 80.8 113.4 110.0 75.1 39.8 53.4 78.5 70.7 108.3 68.5 95.5 78.0 80.7 47.4 44.8 52.0 65.6 51.4 60.4 71.5 37.4 42.1 61.0 24.4 59.5 33.4 40.1 77.2 47.4 46.8 45.7 44.3 82.3 33.3 47.9 45.3 26.4 43.3 78.5 50.3 56.6 76.3 23.6 27.2 25.1 50.2 22.9 25.3 27.8 26.0 31.6 15.1 199.5 265.4 295.0 454.5 334.1 211.9 1401.5 384.7 145.9 192.2 204.1 74.6 677.0 741.1 434.4 31.9 273.0 744.3 163.5 762.2 755.9 400.5 371.4 205.5 373.5 527.3 276.5 300.1 249.2 430.8 19.5 236.2 288.2 415.0 543.8 392.0 226.4 536.4 501.2 241.1 802.3 176.2 297.5 387.5 94.1 178.4 316.8 681.4 269.7 620.6 559.0 SLC25A30 ENSG00000174032 "Solute carrier family 25 member 30" Q5SVS4 13 45393316-45418455 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 38.0;skeletal muscle: 43.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 39.7;Hepatocytes: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045260 Approved Nucleoplasm NA NA Nucleoplasm "HPA045260: AB_10962505" "unprognostic (9.23e-2)" "unprognostic (9.92e-2)" "unprognostic (1.05e-1)" "unprognostic (4.28e-2)" "unprognostic (1.96e-1)" "unprognostic (2.63e-1)" "unprognostic (1.35e-2)" "unprognostic (3.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (5.69e-2)" "unprognostic (1.58e-1)" "prognostic favorable (9.91e-8)" "unprognostic (2.24e-1)" "unprognostic (5.19e-2)" "unprognostic (4.12e-1)" "unprognostic (6.19e-3)" 7.7 6.3 6.2 4.7 5.7 5.3 7.1 3.6 6.3 6.5 4.2 2.1 9.7 2.5 7.7 7.2 5.3 3.9 4.5 38.0 5.8 3.8 24.6 19.5 5.9 9.3 5.4 4.3 10.8 7.5 2.4 5.7 3.4 8.1 8.0 3.5 9.5 6.8 9.1 43.1 4.4 3.5 9.4 7.6 6.1 4.0 5.0 4.9 1.2 6.5 6.7 4.4 6.6 9.0 1.6 5.3 4.3 3.4 1.7 2.7 1.1 2.3 5.1 3.0 13.1 15.4 9.8 1.0 10.9 6.4 9.5 5.7 5.3 6.3 0.0 9.6 11.1 7.0 4.5 7.0 11.0 11.3 7.6 5.7 8.6 3.3 14.1 9.1 12.3 11.7 6.4 7.5 13.9 10.4 11.2 16.4 8.7 5.2 0.0 19.1 2.7 4.5 8.5 4.5 2.7 6.5 11.2 5.1 4.5 20.5 1.9 0.6 3.1 6.1 9.4 8.7 5.5 7.3 16.6 6.0 8.9 5.1 9.8 7.5 2.3 4.5 0.1 9.7 11.7 13.6 0.0 2.8 4.3 2.2 3.4 1.5 1.6 2.2 2.2 4.0 1.5 2.7 1.2 0.0 1.7 1.5 5.3 0.8 1.1 6.2 5.7 3.6 6.3 5.8 3.8 5.4 4.3 8.1 4.9 6.0 2.1 1.5 1.9 11.4 1.7 39.7 10.2 0.0 1.2 14.0 3.9 0.7 19.9 2.2 7.6 4.1 1.4 0.0 1.2 0.8 2.2 2.8 4.7 38.9 3.7 0.0 2.4 7.4 10.0 2.3 4.6 5.9 5.0 6.4 3.9 0.8 2.4 0.0 6.0 22.1 1.1 6.5 2.2 0.0 1.4 5.4 0.5 4.4 3.3 1.1 SLC25A31 "ANT4, DKFZP434N1235" ENSG00000151475 "Solute carrier family 25 member 31" Q9H0C2 4 127730378-127774299 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 687 "testis: 68.6" "Cell type enriched" "Detected in some" 9 "Spermatocytes: 113.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "hTCEpi: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015064, HPA016841, HPA046835, HPA071684" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (8.15e-2)" "unprognostic (1.62e-1)" "unprognostic (2.70e-1)" "unprognostic (5.32e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 113.2 11.9 0.0 0.0 0.0 0.0 0.0 SLC25A34 DKFZp781A10161 ENSG00000162461 "Solute carrier family 25 member 34" Q6PIV7 1 15736405-15741396 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 38.8;skeletal muscle: 22.2" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 16.0;Paneth cells: 5.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 10.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069806 Approved Mitochondria NA NA Mitochondria "HPA069806: AB_2686202" "unprognostic (2.06e-1)" "unprognostic (4.72e-1)" "unprognostic (1.15e-1)" "unprognostic (2.43e-1)" "unprognostic (2.58e-1)" "unprognostic (8.08e-3)" "unprognostic (1.98e-2)" "unprognostic (9.92e-2)" "unprognostic (1.55e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-4)" "unprognostic (5.74e-2)" "unprognostic (6.10e-2)" "unprognostic (4.02e-1)" "unprognostic (1.82e-1)" "unprognostic (4.04e-2)" "unprognostic (2.40e-4)" 2.5 2.4 1.2 0.9 1.9 2.8 0.7 10.4 1.8 1.1 25.9 0.8 0.5 13.5 1.7 1.4 1.6 1.3 3.6 13.3 1.5 1.2 7.3 3.9 1.1 1.1 0.7 1.8 2.4 18.6 0.6 2.1 1.2 1.5 1.1 1.9 3.7 11.1 0.8 22.2 0.8 38.8 1.0 1.1 1.9 1.4 2.3 1.2 0.5 1.9 11.0 1.9 0.7 1.1 0.7 0.5 2.0 0.5 2.2 4.1 1.1 0.7 0.5 3.5 1.6 1.7 0.7 1.5 0.5 0.3 0.8 0.6 1.4 1.9 0.9 0.8 0.7 1.8 0.7 0.6 0.6 0.8 1.2 0.7 1.5 1.1 0.5 0.6 0.4 2.2 0.8 2.7 1.0 0.5 2.2 0.4 4.6 0.6 3.2 0.6 1.8 3.7 2.0 2.9 0.4 1.0 1.9 3.1 1.0 0.3 0.1 0.7 2.8 0.8 1.0 7.4 3.4 1.9 2.5 1.7 1.7 2.2 2.3 0.6 3.8 3.5 0.7 0.6 2.2 1.4 1.2 0.5 0.4 1.4 0.2 3.1 0.5 3.0 2.0 0.2 0.7 4.1 2.3 2.0 2.2 0.2 0.5 1.3 1.1 1.2 1.9 10.4 1.8 1.5 1.2 0.7 1.8 1.5 1.2 0.0 0.0 0.0 0.3 0.2 2.5 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.7 16.0 0.0 0.2 0.2 0.7 0.3 0.0 2.1 1.2 3.2 3.4 2.5 2.6 0.4 0.9 0.1 0.0 1.8 2.4 1.7 0.2 5.3 0.4 3.0 1.4 0.0 0.9 0.5 0.6 0.1 1.1 0.0 4.1 0.4 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295343 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.4" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051720 Uncertain Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA051720: AB_2681584" "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favorable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favorable (1.91e-5)" 6.8 8.2 4.0 10.2 8.3 7.4 8.1 2.6 6.0 13.0 7.2 11.1 18.2 8.3 14.1 11.6 5.3 8.6 7.5 4.4 8.2 3.7 14.4 4.4 7.2 8.2 8.9 5.2 3.4 9.6 6.6 12.9 44.4 9.2 8.2 7.9 11.3 6.2 24.9 3.4 4.2 7.2 6.0 9.7 9.4 9.8 20.2 7.2 9.0 9.1 4.1 7.1 7.2 4.6 3.8 7.2 9.0 11.1 3.2 5.6 2.9 4.5 12.5 2.1 9.4 7.2 2.8 5.2 2.9 2.7 3.3 3.6 1.5 11.7 5.2 3.1 3.4 6.7 10.1 2.7 3.6 1.8 2.8 3.3 4.4 9.2 1.8 2.7 0.5 11.9 5.9 2.1 6.2 1.1 2.3 5.1 6.1 1.2 1.8 2.7 2.5 4.7 2.4 0.7 3.1 4.2 5.1 1.5 2.3 2.5 11.6 1.1 2.8 8.6 5.2 3.7 2.3 11.6 3.3 6.7 2.2 1.7 5.3 2.5 4.0 2.4 1.8 5.7 7.8 5.6 4.5 7.3 9.0 5.5 11.1 4.3 2.6 4.8 5.6 7.2 3.8 1.7 3.5 1.4 3.2 7.8 3.6 4.9 2.9 4.0 8.3 2.6 6.0 8.2 3.7 8.9 5.2 9.2 7.2 0.0 4.8 5.4 1.5 0.7 3.7 1.2 2.5 0.0 1.2 10.4 7.9 7.3 10.0 2.4 2.4 2.2 2.5 0.0 6.2 2.0 1.3 1.8 4.7 2.4 5.9 1.6 8.6 2.5 3.7 3.6 1.4 2.7 0.0 8.2 2.7 6.8 2.6 3.1 1.1 5.7 8.9 0.0 0.7 27.9 0.7 0.3 14.5 3.8 3.0 1.1 SLC25A37 "HT015, MFRN, MFRN1, MSCP" ENSG00000147454 "Solute carrier family 25 member 37" Q9NYZ2 8 23528805-23575463 "Predicted intracellular proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.8" "Cell type enriched" "Detected in all" 5 "Erythroid cells: 3550.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 18 "neutrophil: 28.9" "Lineage enriched" "Detected in many" 18 "granulocytes: 28.9" "Cell line enhanced" "Detected in many" "HEL: 47.7;hTERT-RPE1: 27.9" "Low region specificity" "Detected in all" HPA045680 Uncertain Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA045680: AB_10963693" "unprognostic (6.15e-3)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.38e-1)" "unprognostic (5.12e-2)" "unprognostic (1.35e-1)" "unprognostic (1.68e-1)" "unprognostic (3.58e-2)" "unprognostic (1.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.37e-6)" "unprognostic (8.27e-2)" "unprognostic (1.71e-1)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 8.2 18.3 5.8 13.7 8.3 88.8 13.1 4.2 8.2 13.4 16.4 6.5 11.7 39.7 10.3 6.8 8.2 9.5 8.5 16.8 6.2 5.2 9.4 11.8 25.7 18.5 12.2 5.1 17.2 14.8 15.6 8.8 23.9 10.3 17.1 5.8 7.9 21.1 17.4 13.8 7.6 17.6 7.9 10.2 28.7 8.0 15.0 8.6 1.9 9.0 5.9 5.7 13.9 33.0 1.2 1.4 28.9 1.6 0.7 1.2 0.8 3.8 4.2 4.5 4.1 5.9 7.3 6.6 3.0 3.9 2.2 2.5 4.1 8.2 6.2 3.7 2.5 14.5 4.9 4.1 8.2 3.0 1.0 2.2 47.7 7.0 1.4 4.9 2.7 1.9 6.2 8.0 4.8 4.8 27.9 3.4 5.0 10.5 3.1 3.5 1.6 3.2 11.3 2.3 4.7 3.3 3.3 2.2 2.4 6.8 2.1 1.4 1.9 4.1 6.4 3.0 4.4 1.8 4.1 5.5 10.9 1.6 6.4 5.8 2.5 0.9 3.9 10.2 6.5 6.8 0.6 1.6 1.4 0.6 0.6 0.6 1.2 0.4 0.3 1.4 0.8 1.2 0.7 28.9 0.7 0.8 0.4 0.7 0.8 5.8 8.3 4.2 8.2 6.2 5.2 12.2 5.1 10.3 8.6 35.7 79.2 39.5 104.8 82.9 35.3 31.5 48.4 21.4 84.2 73.3 64.8 32.1 13.3 81.9 645.6 82.4 66.7 3550.9 197.4 63.8 90.2 258.9 35.8 34.3 36.1 6.4 19.5 100.7 50.6 772.4 48.6 101.8 65.8 8.2 33.2 41.6 177.5 34.5 35.0 24.5 60.7 19.4 95.7 12.5 47.1 47.0 15.3 22.7 43.1 139.3 SLC25A4 "ANT1, PEO2, PEO3, T1" ENSG00000151729 "Solute carrier family 25 member 4" P12235 4 185143241-185150382 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 4236.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (4.19e-2)" "unprognostic (1.06e-2)" "unprognostic (3.11e-1)" "unprognostic (8.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.90e-3)" "unprognostic (8.25e-2)" "unprognostic (1.26e-2)" "unprognostic (7.87e-2)" "unprognostic (1.60e-1)" "prognostic favorable (3.41e-4)" "unprognostic (2.05e-1)" "prognostic favorable (0.00e+0)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (8.28e-3)" 3.0 4.2 6.9 2.0 10.8 1.4 3.1 19.4 14.4 2.6 6.6 3.7 2.9 2.8 3.0 3.4 6.7 3.7 3.5 163.7 7.4 7.3 8.3 4.3 3.0 2.0 6.3 6.1 3.6 3.0 4.6 4.6 2.2 12.8 6.2 3.4 7.9 4.4 8.5 92.5 2.3 4.1 5.5 4.5 2.1 5.3 3.1 2.3 0.0 4.6 62.4 3.4 4.4 2.1 3.5 3.0 0.4 0.0 0.7 4.1 1.5 0.7 3.3 2.7 5.5 3.0 0.3 5.0 2.7 0.9 3.3 3.3 7.1 1.8 2.4 2.0 3.3 2.6 2.6 10.4 2.9 2.2 4.0 8.9 1.6 4.9 8.3 6.1 1.4 1.6 2.2 7.1 5.1 1.4 7.8 2.4 4.2 3.8 1.9 2.0 5.1 1.6 3.2 4.4 2.3 7.1 2.6 1.4 3.3 7.5 5.1 8.8 6.7 3.2 1.4 12.6 5.1 2.6 1.2 1.8 0.2 1.5 1.7 3.5 7.9 3.6 3.1 2.4 0.3 3.0 0.0 0.0 0.0 4.1 0.0 3.1 3.5 1.4 3.5 0.1 2.2 1.2 3.0 0.4 0.7 0.0 3.0 1.2 1.5 6.9 10.8 19.4 14.1 7.4 7.3 6.3 6.1 12.8 2.3 80.4 55.4 33.5 125.8 39.2 174.4 4236.1 140.1 112.4 42.1 68.0 98.2 59.7 837.3 68.4 15.8 25.9 41.2 0.0 65.1 47.9 24.6 55.0 11.5 83.9 50.1 151.0 51.6 24.5 7.6 7.7 43.1 7.9 180.5 15.4 35.7 473.2 51.1 24.6 106.1 140.9 178.4 103.5 194.8 24.0 35.3 15.8 33.9 10.7 48.8 46.9 SLC25A41 "APC4, FLJ40442, MGC34725" ENSG00000181240 "Solute carrier family 25 member 41" Q8N5S1 19 6426037-6433779 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.1;testis: 26.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 91.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.3;HMC-1: 7.1;K-562: 2.1;U-937: 4.2" "Low region specificity" "Detected in single" HPA043591 Uncertain NA NA "HPA043591: AB_10964585" "unprognostic (1.87e-3)" "unprognostic (2.52e-3)" "unprognostic (6.81e-2)" "unprognostic (8.75e-2)" "unprognostic (2.67e-1)" "unprognostic (8.29e-4)" "unprognostic (4.43e-3)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.85e-2)" "unprognostic (2.19e-3)" "unprognostic (3.11e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" "unprognostic (3.63e-2)" "unprognostic (2.11e-1)" "unprognostic (1.24e-1)" 0.3 0.2 2.4 0.3 6.3 0.0 0.5 8.1 3.2 0.3 0.5 0.3 0.3 0.4 0.3 0.8 1.7 0.4 0.3 1.6 2.6 1.3 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.5 0.9 1.3 1.2 0.3 0.5 0.6 0.3 0.0 26.5 0.3 0.3 0.4 0.3 0.3 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.1 0.4 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.4 0.0 0.0 2.3 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 7.1 0.7 1.7 0.0 0.0 0.4 0.0 0.4 2.1 0.0 0.0 0.9 0.0 1.7 0.0 0.0 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.4 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 6.3 8.1 2.7 2.6 1.3 0.6 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.2 91.3 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 11.5 0.9 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 0.1 1.2 0.0 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.1 SLC25A42 MGC26694 ENSG00000181035 "Solute carrier family 25 member 42" Q86VD7 19 19063999-19112888 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9" "Group enriched" "Detected in many" 6 "B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1" "Cell line enhanced" "Detected in many" "K-562: 17.5" "Low region specificity" "Detected in all" HPA049449 Approved Supported Mitochondria Yes No Mitochondria "HPA049449: AB_2680772" "unprognostic (2.27e-1)" "prognostic favorable (5.04e-4)" "unprognostic (5.79e-2)" "unprognostic (5.67e-2)" "unprognostic (1.35e-1)" "unprognostic (3.42e-3)" "unprognostic (1.27e-3)" "prognostic favorable (4.11e-4)" "unprognostic (6.89e-2)" "unprognostic (2.73e-1)" "unprognostic (1.37e-3)" "unprognostic (3.04e-2)" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.39e-2)" "unprognostic (4.17e-2)" "unprognostic (2.03e-2)" 4.8 5.7 13.8 4.5 12.2 7.5 4.9 22.5 15.4 7.0 4.8 5.9 4.5 5.7 6.8 4.4 4.5 7.4 4.7 8.9 9.7 7.8 26.7 42.3 5.4 8.5 5.9 7.8 13.8 7.4 6.5 9.6 3.2 7.9 7.6 3.0 12.2 11.0 6.3 26.7 5.2 5.6 5.7 6.1 7.3 4.6 4.5 8.1 6.6 17.1 7.3 12.2 5.5 5.4 6.2 0.7 0.2 0.6 2.8 5.1 1.5 6.2 0.8 1.6 2.8 6.1 5.1 2.5 3.0 4.6 4.7 5.4 1.2 12.5 4.5 7.1 2.8 4.7 1.1 3.2 2.5 2.7 1.1 6.2 1.5 1.7 10.0 4.9 0.7 3.2 5.1 1.8 3.6 2.2 3.8 2.1 14.7 17.5 8.1 2.5 5.6 7.5 7.1 0.9 1.7 6.5 5.8 2.8 8.6 1.8 1.1 1.8 1.3 3.2 0.1 1.3 2.2 5.7 3.5 1.9 3.5 2.0 7.3 2.9 9.4 5.1 3.5 3.7 9.6 1.8 0.0 0.2 0.2 5.1 0.5 2.8 6.2 2.9 4.3 0.3 5.1 1.9 2.8 0.0 2.8 0.6 0.7 2.9 1.5 13.8 12.2 22.5 15.4 9.7 7.8 5.9 7.8 7.9 8.1 0.0 9.6 8.9 2.4 2.9 68.0 8.9 2.5 1.4 3.4 8.7 17.7 5.7 11.6 1.4 1.2 3.5 5.4 0.0 2.7 2.7 3.6 2.6 3.5 44.5 1.5 3.2 8.1 4.3 0.3 0.6 4.6 1.1 3.3 0.0 4.0 11.9 1.9 2.9 6.0 27.0 42.5 6.5 5.7 7.9 6.4 2.5 3.9 11.4 2.9 1.3 SLC25A45 ENSG00000162241 "Solute carrier family 25 member 45" Q8N413 11 65375192-65383701 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 60.5" "Cell type enhanced" "Detected in many" 5 "B-cells: 32.2;T-cells: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA050821 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA050821: AB_2681249" "unprognostic (3.73e-2)" "unprognostic (2.19e-3)" "unprognostic (8.44e-4)" "unprognostic (6.17e-3)" "unprognostic (2.57e-2)" "unprognostic (2.84e-7)" "unprognostic (7.57e-3)" "unprognostic (4.59e-2)" "unprognostic (1.44e-1)" "unprognostic (4.06e-2)" "prognostic favorable (2.83e-4)" "unprognostic (1.96e-1)" "unprognostic (1.08e-2)" "unprognostic (1.45e-1)" "unprognostic (1.54e-1)" "unprognostic (6.18e-2)" "unprognostic (1.43e-1)" 2.2 1.8 2.1 4.0 2.3 3.1 3.2 1.0 2.6 1.7 4.5 4.0 4.7 4.1 1.0 5.4 1.5 1.3 1.3 2.8 2.5 1.1 3.9 7.7 5.3 9.4 1.8 2.3 1.3 60.5 4.2 4.7 1.2 2.3 2.5 1.2 3.5 5.0 1.3 4.1 2.0 11.0 1.5 2.3 9.6 1.9 2.4 2.0 5.8 9.0 2.8 8.2 1.9 1.7 10.8 19.2 6.0 10.1 13.5 11.4 2.5 0.3 4.7 0.2 6.9 1.3 0.6 3.5 0.8 2.1 0.4 0.4 1.0 2.2 4.1 3.9 1.9 1.8 0.6 0.5 0.3 0.0 13.8 1.0 4.5 2.5 0.3 0.8 1.4 4.8 1.6 0.1 0.5 0.4 0.4 0.7 8.0 0.6 18.7 0.7 1.5 3.3 0.1 0.3 0.2 2.2 6.1 0.9 13.6 0.7 0.0 2.3 3.1 1.4 3.7 0.7 0.4 1.9 0.7 1.3 0.5 1.8 4.5 0.3 7.8 4.9 1.2 1.4 1.0 2.7 6.0 5.5 3.9 7.9 9.0 8.4 8.9 7.0 7.5 5.7 10.8 11.4 8.5 3.3 13.5 10.1 19.2 6.3 2.5 2.1 2.3 1.0 2.6 2.5 1.1 1.8 2.3 2.3 2.0 0.0 3.5 32.2 5.2 2.5 9.0 5.5 10.2 17.4 4.5 12.2 0.0 1.4 0.0 4.9 5.2 2.9 23.9 0.0 4.7 1.0 3.3 7.8 4.6 12.1 6.3 6.4 6.4 7.4 7.0 3.3 6.4 13.8 5.0 18.0 12.9 7.7 4.3 8.6 3.5 6.2 0.3 6.5 2.5 2.3 0.2 1.8 1.3 35.9 7.4 3.5 SLC25A47 C14orf68 ENSG00000140107 "Solute carrier family 25 member 47" Q6Q0C1 14 100323337-100330378 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 88 "liver: 127.2" "Cell type enriched" "Detected in some" 21 "Hepatocytes: 185.9" "Cancer enriched" "Detected in single" 273 "liver cancer: 56.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "Hep G2: 5.7;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" NA NA "unprognostic (2.54e-3)" "unprognostic (2.57e-3)" "unprognostic (5.12e-2)" "unprognostic (2.27e-2)" "unprognostic (6.07e-2)" "unprognostic (1.30e-2)" "unprognostic (4.25e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (2.50e-1)" "unprognostic (1.96e-3)" "unprognostic (4.46e-1)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (5.64e-2)" "unprognostic (1.02e-2)" "unprognostic (1.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 5.7 0.0 1.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.1 2.0 0.2 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 185.9 0.0 0.0 0.0 4.3 8.8 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 SLC25A48 "FLJ44862, HDMCP" ENSG00000145832 "Solute carrier family 25 member 48" Q6ZT89 5 135579202-135889770 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.4;kidney: 11.7;skeletal muscle: 12.8" "Cell type enhanced" "Detected in some" 26 "Distal tubular cells: 8.3;Enterocytes: 4.5;Proximal tubular cells: 27.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 5.0;HEK 293: 4.2;HEL: 4.1;RPMI-8226: 3.7;SCLC-21H: 3.9;U-2 OS: 5.1" HPA014674 Uncertain Approved "Intermediate filaments,Actin filaments" NA NA "Intermediate filaments" "Actin filaments" "HPA014674: AB_1859512" "unprognostic (2.09e-1)" "unprognostic (2.24e-1)" "unprognostic (6.34e-2)" "unprognostic (1.21e-1)" "unprognostic (1.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.96e-2)" "unprognostic (1.36e-1)" "unprognostic (4.62e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-7)" "unprognostic (9.13e-2)" "unprognostic (1.10e-1)" "unprognostic (1.21e-1)" "unprognostic (1.20e-1)" 1.0 0.8 10.8 1.0 13.0 0.9 1.6 1.3 18.8 0.9 2.0 10.3 0.0 2.0 1.0 0.7 1.3 0.7 0.9 0.9 11.9 8.1 11.7 1.3 0.7 1.0 22.4 4.1 0.7 3.3 0.8 0.4 1.1 5.6 1.3 1.8 0.0 3.5 0.6 12.8 3.2 4.1 0.7 5.4 0.9 0.8 1.2 15.2 0.0 1.0 0.5 0.7 0.8 0.3 0.6 1.0 2.1 1.0 0.8 0.7 0.2 0.4 0.3 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.4 0.7 0.1 0.4 0.0 0.1 0.5 5.0 0.0 0.0 0.7 4.2 4.1 0.6 0.8 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.1 0.0 0.0 1.7 0.8 0.0 0.1 0.1 0.0 3.7 0.3 0.6 3.9 0.4 0.7 0.5 1.0 1.3 1.8 0.6 0.5 0.4 5.1 0.3 0.2 1.7 0.5 0.2 0.4 0.4 0.3 2.1 0.3 0.7 0.5 0.5 0.6 0.5 0.5 0.4 0.3 0.6 0.6 0.7 1.5 0.8 1.0 1.0 0.5 0.2 10.8 13.0 1.3 9.9 11.9 8.1 22.4 4.1 5.6 15.2 0.0 0.0 0.0 0.0 2.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 4.5 0.0 0.0 0.1 0.8 0.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.2 0.1 2.9 0.0 27.1 0.1 0.0 0.0 0.1 0.5 0.6 0.1 0.0 1.6 0.1 SLC25A52 MCART2 ENSG00000141437 "Solute carrier family 25 member 52" 18 31759562-31760880 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 18.2" "Group enriched" "Detected in some" 10 "Early spermatids: 41.8;Late spermatids: 77.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.5" "HPA046388, HPA058261" Uncertain Approved Mitochondria NA NA Mitochondria "HPA046388: AB_2679649, HPA058261: AB_2683657" "unprognostic (8.97e-2)" "unprognostic (4.85e-2)" "unprognostic (2.93e-1)" "unprognostic (4.87e-1)" "unprognostic (2.50e-1)" "unprognostic (9.05e-2)" "unprognostic (2.97e-2)" "unprognostic (1.30e-4)" "unprognostic (7.15e-3)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.41e-1)" "unprognostic (3.34e-2)" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.3 0.4 0.4 0.0 0.8 0.4 0.5 1.3 0.4 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.3 1.2 0.5 0.0 0.4 1.1 0.0 0.3 0.2 0.5 0.0 0.9 2.5 0.6 0.0 1.5 1.1 0.0 0.2 0.0 0.3 0.0 0.0 0.9 0.7 1.0 0.0 0.0 1.3 0.1 0.3 0.3 0.0 1.1 0.9 0.0 0.0 0.4 0.7 1.5 0.8 1.0 0.2 0.1 0.6 1.7 1.3 0.6 0.6 0.5 0.7 1.3 1.5 0.7 0.8 0.6 1.2 0.8 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.4 0.4 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.9 0.0 0.0 0.0 0.0 0.0 SLC25A6 "ANT3, ANT3Y, MGC17525" ENSG00000169100 "Solute carrier family 25 member 6" P12236 X 1386152-1392724 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Apoptosis, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 7200000 Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.13e-1)" "unprognostic (1.65e-2)" "unprognostic (4.79e-2)" "unprognostic (1.45e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.01e-3)" "unprognostic (1.34e-1)" "unprognostic (8.07e-2)" "unprognostic (1.48e-1)" "unprognostic (1.37e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.69e-1)" "unprognostic (2.85e-1)" "unprognostic (4.57e-3)" 18.5 19.7 12.1 12.2 14.0 23.7 14.4 8.2 12.2 9.8 16.5 28.9 14.3 4.8 16.4 10.4 7.0 9.4 10.3 8.2 18.4 5.4 11.1 14.4 9.4 25.6 38.7 10.1 14.0 8.6 12.4 8.8 45.0 12.5 6.1 14.9 23.3 7.7 5.8 15.4 19.2 2.4 16.3 9.5 14.2 11.2 62.2 85.7 3.7 69.0 30.1 43.6 71.2 22.2 48.7 34.6 35.3 24.0 46.8 37.5 34.1 32.7 25.2 25.1 64.4 27.2 82.8 27.6 22.4 38.0 14.5 23.2 40.7 7.9 20.7 73.8 45.2 33.4 73.5 56.3 32.5 55.2 77.2 75.0 19.7 29.0 32.7 37.3 26.1 31.5 19.5 24.6 47.4 60.1 62.3 43.9 8.8 65.7 30.4 28.6 64.2 30.7 56.0 56.6 88.9 23.1 70.1 97.0 21.0 38.9 67.0 42.7 25.7 14.4 50.2 34.0 50.6 8.1 55.8 3.8 31.4 13.9 2.4 58.1 3.7 29.4 69.0 43.6 62.2 40.4 34.8 85.7 47.5 38.1 37.2 3.0 30.1 67.9 41.0 38.7 71.2 137.0 195.3 871.5 1042.4 1022.6 282.9 87.0 257.4 128.5 280.9 300.1 92.3 1322.2 1405.9 633.0 8.9 418.0 863.0 303.7 1275.3 963.9 807.0 855.9 337.0 132.8 1090.5 228.8 892.0 411.9 1235.3 26.5 618.4 976.3 715.3 1354.4 1107.0 100.8 835.0 866.6 344.4 1021.3 199.6 336.3 860.1 13.3 52.8 1155.2 1458.6 553.5 1380.0 1328.6 SLC26A1 "EDM4, SAT-1" ENSG00000145217 "Solute carrier family 26 member 1" Q9H2B4 4 979073-993440 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 17.1;liver: 45.4" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA041654 Uncertain Approved Microtubules NA NA Microtubules "HPA041654: AB_10796350" "unprognostic (1.96e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-1)" "unprognostic (4.91e-2)" "unprognostic (1.74e-1)" "unprognostic (2.67e-4)" "unprognostic (5.13e-2)" "unprognostic (5.82e-2)" "unprognostic (2.16e-1)" "unprognostic (3.88e-2)" "unprognostic (1.53e-3)" "unprognostic (2.92e-2)" "prognostic favorable (1.19e-4)" "unprognostic (1.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.27e-1)" "unprognostic (1.65e-3)" 1.1 6.5 1.4 1.7 1.7 1.5 1.6 4.6 2.7 1.3 7.4 1.1 1.1 6.5 1.4 1.9 1.1 1.1 2.6 1.1 1.4 1.5 17.1 45.4 1.1 1.7 1.1 1.1 1.6 4.0 0.0 2.1 1.1 1.1 1.8 0.0 1.1 4.2 1.1 1.5 3.1 10.5 1.1 1.1 2.4 4.0 1.1 1.1 1.1 2.0 1.1 1.1 1.1 1.1 0.4 0.3 7.0 0.6 1.1 1.8 0.7 1.3 2.3 0.0 1.8 0.2 0.4 4.2 1.9 0.1 0.0 0.0 4.5 2.6 0.7 2.3 0.0 1.8 1.3 0.1 0.0 0.0 2.6 0.9 3.4 3.1 13.3 0.2 2.1 9.1 0.6 0.2 0.1 0.0 1.0 0.3 2.9 3.5 0.0 0.4 2.9 1.3 3.6 1.0 1.7 7.2 7.3 0.0 0.3 0.7 5.1 0.2 1.4 0.5 0.2 1.2 0.4 9.2 1.4 2.1 4.8 1.0 4.8 1.3 7.0 3.2 1.2 1.7 4.4 2.1 7.0 0.6 0.4 0.4 0.3 0.8 0.4 1.2 0.9 0.2 0.1 0.8 1.8 0.0 1.1 0.3 0.3 1.6 0.7 1.4 1.7 4.6 1.6 1.4 1.5 1.1 1.1 1.1 1.1 0.0 0.6 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 1.3 0.0 0.3 3.3 0.2 0.1 1.1 9.0 0.6 0.0 0.0 1.3 0.3 0.0 0.9 0.0 1.7 0.0 0.6 0.2 0.6 0.2 0.4 8.5 0.1 0.0 0.3 0.0 0.1 0.1 0.7 0.0 0.6 0.1 SLC26A10 ENSG00000135502 "Solute carrier family 26 member 10" Q8NG04 12 57619527-57626151 "Predicted membrane proteins, Transporters" "Antiport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 8.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 9.1;Peritubular cells: 4.9" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Region enhanced" "Detected in single" "cerebellum: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.0;HEK 293: 3.5;NTERA-2: 5.6;RH-30: 4.4;SH-SY5Y: 7.9;U-266/70: 5.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA044719 Uncertain NA NA "HPA044719: AB_10962362" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (1.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.45e-1)" "unprognostic (3.12e-2)" "unprognostic (1.89e-1)" "unprognostic (6.12e-5)" "unprognostic (3.22e-3)" "unprognostic (2.65e-12)" "unprognostic (1.28e-2)" "unprognostic (3.80e-1)" "unprognostic (7.34e-3)" "unprognostic (1.40e-1)" 2.0 0.7 0.4 0.5 0.9 0.0 0.4 3.8 0.9 0.4 0.8 0.4 0.4 0.0 2.9 1.2 0.4 1.9 1.8 8.5 0.4 0.2 0.4 0.4 0.4 0.5 0.4 0.4 0.9 0.4 0.0 0.4 0.4 0.4 2.1 0.5 0.4 0.8 1.6 2.6 0.1 1.1 1.9 0.4 0.7 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 3.0 0.0 0.0 0.5 1.1 0.2 0.7 0.3 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.7 0.0 0.2 0.0 3.5 0.4 0.2 0.7 0.7 0.0 0.1 0.0 0.0 0.5 0.0 0.4 0.0 0.0 1.0 1.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 4.4 0.0 0.0 0.0 2.3 7.9 0.0 0.0 0.5 0.4 0.1 0.6 0.0 0.6 1.3 0.7 0.0 5.4 0.5 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 3.8 0.9 0.4 0.2 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.3 9.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 4.9 0.0 0.8 0.0 1.7 0.5 0.2 0.4 0.1 0.0 0.0 0.0 SLC26A2 "DTD, DTDST" ENSG00000155850 "Solute carrier family 26 member 2" P50443 5 149960737-149993455 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 81.9" "Cell type enriched" "Detected in many" 4 "Syncytiotrophoblasts: 676.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041957, HPA058090" Enhanced Approved Vesicles NA NA Vesicles "HPA041957: AB_10795646, HPA058090: AB_2683602" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "unprognostic (3.03e-2)" "prognostic favorable (7.29e-4)" "unprognostic (2.59e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (1.19e-1)" "unprognostic (7.43e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.70e-1)" "unprognostic (1.77e-1)" "unprognostic (8.12e-2)" "unprognostic (1.06e-1)" 8.5 15.6 2.6 23.2 3.7 1.3 4.7 6.3 2.3 3.8 81.9 3.0 29.4 5.4 4.8 14.2 8.3 3.1 2.6 3.1 2.5 2.6 3.8 1.6 6.8 5.3 3.7 2.3 5.1 2.9 21.4 11.1 16.9 7.6 6.1 75.0 4.9 27.9 36.7 11.2 6.0 13.4 4.3 5.5 3.0 2.4 2.8 3.0 5.2 2.7 4.4 13.0 4.1 2.8 1.6 1.7 7.0 3.3 2.5 3.0 1.1 3.3 3.0 3.8 6.2 4.6 3.3 0.9 3.1 2.8 2.5 3.1 15.7 1.8 2.5 24.2 3.3 6.1 2.4 3.6 7.3 4.6 2.0 2.3 3.2 2.4 1.8 3.5 5.9 5.5 3.6 4.3 4.2 5.5 6.3 6.0 3.2 0.8 2.6 10.6 1.0 2.2 3.1 1.2 1.1 4.8 3.3 5.9 1.3 55.5 14.7 1.1 2.9 5.5 1.3 9.4 3.1 2.6 3.5 28.5 5.9 4.4 5.1 3.7 1.8 2.4 1.5 5.4 7.2 8.4 7.0 1.1 0.8 2.5 0.8 3.0 1.3 1.5 2.1 1.7 1.6 2.1 2.2 1.0 2.5 3.3 1.7 2.6 1.1 2.6 3.7 6.3 2.3 2.5 2.6 3.7 2.3 7.6 3.0 41.7 13.7 7.5 12.5 4.0 16.1 6.7 7.6 6.7 14.8 31.4 15.7 160.9 1.7 5.2 17.7 15.3 151.8 0.0 8.6 5.2 16.0 21.5 87.8 2.4 26.4 6.4 20.3 16.5 13.8 9.9 16.1 12.2 86.0 16.2 37.7 15.0 9.4 147.9 11.7 4.4 80.3 0.0 10.2 9.2 10.2 4.4 676.5 9.6 53.2 4.9 SLC26A3 "CLD, DRA" ENSG00000091138 "Solute carrier family 26 member 3" P40879 7 107765467-107803225 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8" "Cell type enriched" "Detected in some" 11 "Enterocytes: 543.6" "Cancer enriched" "Detected in many" 14 "colorectal cancer: 52.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;CACO-2: 1.9;NB-4: 1.5;RPMI-8226: 7.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA036055 Approved NA NA "HPA036055: AB_10602401" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" "unprognostic (1.12e-2)" "unprognostic (2.69e-1)" "unprognostic (4.02e-1)" "unprognostic (4.09e-2)" "unprognostic (3.05e-3)" "unprognostic (6.31e-2)" "unprognostic (1.68e-2)" "unprognostic (1.20e-1)" "unprognostic (1.14e-1)" "unprognostic (2.05e-2)" "unprognostic (8.85e-2)" "unprognostic (8.01e-2)" "unprognostic (5.52e-2)" "unprognostic (2.54e-2)" "unprognostic (3.58e-3)" 0.3 0.3 0.3 42.8 0.3 0.0 6.1 0.3 0.3 0.4 110.1 0.2 0.3 58.4 0.3 1.2 0.3 0.6 53.5 0.3 0.3 0.3 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.3 0.0 0.3 0.2 0.2 0.5 92.7 0.2 0.3 14.4 0.3 0.3 106.5 1.2 0.3 0.3 0.4 0.3 0.2 0.2 0.3 0.2 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 543.6 0.0 0.0 0.0 0.0 0.2 27.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 26.7 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.4 0.0 SLC26A4 "DFNB4, PDS" ENSG00000091137 "Solute carrier family 26 member 4" O43511 7 107660635-107717809 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "thyroid gland: 79.2" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8" "Cancer enriched" "Detected in some" 8 "thyroid cancer: 37.6" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "naive B-cell: 3.1" "Lineage enriched" "Detected in single" 5 "B-cells: 3.1" "Cell line enhanced" "Detected in some" "HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6" "Region enriched" "Detected in some" 4 "hippocampal formation: 10.6" "Low region specificity" "Detected in all" HPA042860 Approved NA NA "HPA042860: AB_10796680" "unprognostic (1.19e-2)" "unprognostic (4.84e-2)" "unprognostic (5.44e-2)" "unprognostic (8.44e-2)" "unprognostic (3.25e-2)" "unprognostic (3.26e-2)" "unprognostic (6.69e-2)" "unprognostic (1.85e-1)" "unprognostic (5.72e-2)" "unprognostic (9.58e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-2)" "unprognostic (1.39e-1)" 0.1 0.0 0.8 0.2 0.5 0.0 0.2 0.0 2.9 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.2 3.3 0.0 0.2 0.0 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.0 1.8 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 79.2 0.0 0.1 0.8 0.1 3.1 0.1 0.1 0.2 0.1 0.5 0.3 0.7 0.3 0.5 0.0 0.7 1.5 0.4 0.3 0.2 0.3 0.1 0.0 0.1 0.1 2.5 0.3 0.0 0.2 0.5 0.2 0.1 3.5 0.9 0.0 0.3 0.2 0.4 0.4 1.1 0.0 0.9 0.4 0.0 8.3 0.1 0.8 0.0 0.4 4.6 0.7 0.0 0.4 0.0 0.0 0.8 0.2 1.3 0.0 0.0 0.1 2.5 0.1 0.0 0.0 1.7 0.2 0.0 0.4 0.7 0.7 0.5 0.2 2.8 0.7 0.7 0.3 0.8 0.4 1.7 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 3.1 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.3 0.8 0.5 0.0 1.4 0.5 0.2 0.1 0.6 0.0 0.0 3.0 11.4 0.0 0.6 1.4 5.6 0.7 0.0 1.4 4.5 0.0 2.0 0.2 0.0 0.1 2.6 0.7 0.0 0.0 0.0 0.1 1.1 8.7 4.7 0.0 0.2 1.6 7.0 0.6 0.3 2.0 0.9 1.4 6.8 1.0 0.0 0.4 0.1 0.0 1.1 0.0 1.1 0.0 0.9 1.7 0.3 1.3 0.0 1.0 0.0 1.2 SLC26A5 "DFNB61, PRES" ENSG00000170615 "Solute carrier family 26 member 5" P58743 7 103352730-103446177 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell shape, Hearing" "Motor protein" "Deafness, Non-syndromic deafness" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 8 "cerebellum: 20.4" "Cell type enriched" "Detected in single" 8 "basophil: 2.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in some" 8 "basal ganglia: 9.5" NA NA "unprognostic (3.86e-2)" "unprognostic (5.13e-2)" "unprognostic (6.38e-3)" "unprognostic (2.76e-2)" "unprognostic (1.02e-2)" "unprognostic (5.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.56e-4)" "unprognostic (4.21e-3)" "unprognostic (8.92e-3)" "unprognostic (2.82e-1)" "unprognostic (2.97e-1)" "unprognostic (3.67e-5)" "unprognostic (3.05e-1)" "unprognostic (2.81e-1)" "unprognostic (2.94e-2)" "unprognostic (2.69e-3)" 1.3 1.0 0.6 0.3 0.7 2.3 3.1 20.4 0.8 0.6 0.3 0.5 0.0 0.9 0.5 0.0 0.2 0.4 0.2 0.4 0.8 0.4 0.7 0.9 2.2 1.2 1.3 0.4 0.4 0.7 2.5 4.6 0.1 2.6 3.1 0.1 0.9 1.4 1.0 0.6 2.2 0.5 1.2 2.9 0.9 3.2 0.9 0.2 0.0 1.8 0.0 0.2 3.2 0.4 0.2 0.0 2.7 0.1 0.3 0.1 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.1 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 2.9 0.0 1.2 0.8 0.3 0.1 0.5 2.6 0.3 0.1 0.4 0.0 0.8 0.9 1.5 0.3 0.3 0.0 0.6 0.7 0.0 0.0 0.6 0.6 1.8 0.4 0.8 0.4 0.4 0.2 0.2 0.3 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.7 20.4 0.8 0.8 0.4 1.3 0.4 2.6 0.2 6.0 1.6 0.0 0.0 0.2 0.1 0.8 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 SLC26A7 SUT2 ENSG00000147606 "Solute carrier family 26 member 7" Q8TE54 8 91209494-91398152 "Predicted membrane proteins" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "thyroid gland: 194.5" "Group enriched" "Detected in some" 5 "Collecting duct cells: 22.7;Distal tubular cells: 11.6;Intestinal endocrine cells: 43.5;Ito cells: 15.4" "Group enriched" "Detected in some" 11 "renal cancer: 8.7;thyroid cancer: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 3.0;HEK 293: 1.7;U-266/70: 3.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (5.84e-2)" "unprognostic (8.04e-3)" "unprognostic (4.15e-3)" "unprognostic (1.51e-1)" "unprognostic (2.39e-3)" "unprognostic (2.94e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (8.26e-2)" "unprognostic (4.82e-2)" "unprognostic (3.31e-2)" "unprognostic (2.07e-1)" "unprognostic (5.19e-3)" "unprognostic (6.83e-3)" 0.3 0.1 0.1 0.4 0.1 0.0 0.2 0.1 0.2 1.6 0.2 0.0 0.2 0.0 1.4 0.2 0.3 0.1 0.1 0.3 0.1 0.1 13.0 0.1 0.1 1.7 0.1 0.0 0.1 0.3 0.1 0.3 4.4 0.7 0.1 0.0 8.6 0.8 0.1 0.2 0.2 0.1 0.0 0.3 0.1 1.5 0.2 0.0 0.0 194.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 1.3 0.0 0.0 0.0 3.0 0.1 0.2 0.0 1.7 0.3 0.1 0.0 0.0 0.0 1.2 0.3 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.8 0.0 0.6 3.1 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.0 0.0 1.0 0.0 0.3 0.2 0.0 0.8 0.0 0.0 0.0 22.7 0.0 0.0 11.6 0.0 4.4 0.6 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.1 0.0 43.5 15.4 0.6 1.0 3.4 0.0 3.3 0.0 0.7 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.2 0.0 SLC26A8 ENSG00000112053 "Solute carrier family 26 member 8" Q96RN1 6 35943514-36024868 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 65.2" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 26.1;Late spermatids: 8.8;Spermatocytes: 42.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;RT4: 2.9;T-47d: 1.0;THP-1: 2.3;TIME: 1.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038081 Enhanced NA NA "HPA038081: AB_10670653" "unprognostic (8.18e-2)" "unprognostic (1.74e-1)" "unprognostic (6.71e-2)" "unprognostic (1.31e-2)" "unprognostic (2.46e-1)" "unprognostic (7.07e-3)" "unprognostic (2.93e-1)" "unprognostic (6.31e-2)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.85e-1)" "unprognostic (3.78e-1)" "unprognostic (4.63e-6)" "unprognostic (7.14e-2)" "unprognostic (4.24e-1)" "unprognostic (2.31e-1)" "unprognostic (5.24e-8)" 0.3 0.2 1.3 0.5 2.2 3.7 0.3 4.2 1.8 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.8 2.1 0.2 0.2 0.2 1.1 0.7 1.7 0.2 0.3 0.2 0.1 0.2 1.9 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.6 0.9 0.2 65.2 0.1 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.2 5.4 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.4 0.0 0.0 0.8 2.9 0.8 0.0 0.0 0.0 0.1 0.2 1.0 2.3 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 1.3 2.2 4.2 1.8 0.8 2.1 0.7 1.7 1.9 0.1 3.0 1.4 0.0 0.3 0.3 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.8 0.1 0.0 0.0 0.6 1.2 8.8 0.9 0.4 1.7 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 42.9 0.3 0.1 0.2 0.0 0.0 0.1 SLC26A9 ENSG00000174502 "Solute carrier family 26 member 9" Q7LBE3 1 205913048-205943460 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "salivary gland: 108.4" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA051485 Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA051485: AB_2681503" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-1)" "unprognostic (1.83e-2)" "prognostic favorable (8.55e-5)" "unprognostic (1.26e-1)" "unprognostic (1.68e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (8.85e-2)" "unprognostic (3.41e-1)" "unprognostic (2.43e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-1)" "unprognostic (7.45e-3)" "unprognostic (2.01e-1)" 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.3 0.1 6.4 0.1 0.1 0.0 0.1 0.1 5.5 0.1 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.1 0.1 0.0 0.1 108.4 0.1 0.1 1.9 0.1 0.1 0.1 0.1 17.8 0.1 0.1 0.2 0.4 1.1 2.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 3.0 51.6 0.0 0.0 0.0 0.0 25.8 0.0 4.0 4.5 1.8 0.0 0.0 1.7 2.9 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236395 "Enzymes, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 168.1" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 27 "basophil: 27.3" "Lineage enriched" "Detected in many" 27 "granulocytes: 27.3" "Cell line enhanced" "Detected in many" "A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 6 "hippocampal formation: 2.5" HPA026089 Enhanced NA NA "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favorable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.40e-4)" 1.1 8.1 0.7 4.1 0.8 1.2 3.4 1.5 1.0 0.5 4.2 0.4 1.3 2.5 0.2 17.5 1.2 2.6 1.3 0.2 1.1 1.1 39.4 168.1 1.7 0.8 0.3 1.0 0.7 6.3 2.0 10.4 7.4 3.0 1.2 4.0 3.2 0.6 0.3 0.2 0.6 5.3 0.1 0.3 0.4 0.4 0.7 0.1 0.1 1.0 0.2 1.3 1.4 0.8 0.1 0.0 27.3 0.0 1.0 0.5 0.2 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.5 9.3 2.5 0.0 0.2 0.4 0.2 32.2 8.2 0.2 0.8 12.6 10.1 13.2 16.6 8.3 0.1 23.1 9.5 0.0 0.7 0.0 0.0 0.0 0.0 6.1 4.0 0.0 0.0 2.9 0.6 15.6 0.6 36.0 0.6 0.0 0.0 0.6 1.7 16.3 14.9 0.9 3.1 0.4 0.0 0.4 1.7 8.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 27.3 0.0 0.4 0.4 0.0 0.4 0.1 0.4 0.4 0.0 0.1 0.1 0.1 0.2 1.0 0.0 0.0 0.5 0.2 0.7 0.8 1.5 1.0 1.1 1.1 0.3 1.0 3.0 0.1 0.0 0.6 0.9 0.8 0.9 0.7 0.3 0.0 54.9 6.8 8.7 0.0 236.8 10.0 0.3 0.4 0.1 20.6 0.0 1.7 2.6 0.0 1.8 5.8 188.9 14.3 1.6 4.1 3.7 2.5 0.0 0.3 0.1 0.0 0.0 18.6 0.5 1.6 28.1 0.0 112.0 1.5 0.0 0.1 1.8 2.5 0.3 45.9 4.3 21.1 4.4 SLC27A4 "ACSVL4, FATP4" ENSG00000167114 "Solute carrier family 27 member 4" Q6P1M0 9 128340646-128361470 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 56.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007293, CAB009771" Approved Approved Vesicles NA NA Vesicles "CAB009771: AB_2270540, HPA007293: AB_1857062" "unprognostic (7.25e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-3)" "unprognostic (3.74e-2)" "unprognostic (2.03e-1)" "unprognostic (1.85e-3)" "unprognostic (1.31e-3)" "unprognostic (4.51e-1)" "unprognostic (4.69e-2)" "unprognostic (7.72e-2)" "unprognostic (5.07e-2)" "prognostic favorable (2.61e-5)" "unprognostic (7.29e-3)" "unprognostic (2.11e-1)" "unprognostic (3.45e-2)" "unprognostic (8.01e-3)" 7.7 7.1 9.9 7.0 13.6 2.5 4.9 9.4 26.5 6.5 25.7 15.8 5.2 54.0 6.6 5.6 26.1 4.4 9.8 7.7 11.6 15.9 17.7 20.8 5.8 5.0 14.8 9.6 5.6 11.3 9.8 5.4 5.8 21.9 5.7 8.3 6.7 7.5 7.3 6.7 24.3 56.1 8.1 11.6 5.1 8.6 13.2 7.9 6.8 12.7 15.2 14.9 8.5 9.5 3.7 7.2 2.6 6.2 1.9 8.1 3.3 10.2 20.1 10.3 13.2 15.7 4.8 11.8 8.7 5.5 10.1 7.3 14.4 10.1 9.6 7.0 9.3 12.1 35.2 12.4 10.0 3.1 9.6 19.1 5.7 17.7 12.5 8.5 10.5 9.2 6.3 13.7 10.4 8.3 4.5 11.4 13.0 13.5 6.7 9.2 25.2 12.4 10.1 4.6 23.2 32.0 15.2 10.1 17.8 17.2 15.5 17.9 9.8 14.5 26.7 9.5 5.4 13.3 4.0 16.7 12.1 11.8 13.2 10.7 6.0 8.5 3.1 12.3 6.3 13.6 0.0 4.1 2.6 8.1 5.6 6.1 3.7 5.2 6.4 7.2 1.7 4.1 4.3 1.6 1.9 6.2 6.4 3.6 3.3 9.9 13.6 9.4 26.5 11.6 15.9 14.8 9.6 21.9 7.9 0.0 1.4 3.0 1.2 2.5 9.3 2.8 7.6 1.4 0.0 8.7 11.8 4.9 1.7 12.4 2.2 3.3 75.1 0.0 13.8 5.7 3.8 2.4 9.2 15.5 9.9 7.9 12.6 4.9 7.1 3.6 1.1 2.9 1.7 12.6 14.0 4.8 20.8 31.7 3.9 8.1 6.2 6.5 2.7 8.8 6.9 5.4 4.3 1.7 12.4 2.6 SLC27A5 "ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2" ENSG00000083807 "Solute carrier family 27 member 5" Q9Y2P5 19 58479512-58512413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" "Ligase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 157.6" "Group enriched" "Detected in many" 6 "Early spermatids: 114.0;Hepatocytes: 338.0;Late spermatids: 303.5" "Cancer enriched" "Detected in all" 26 "liver cancer: 49.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA007292, CAB056160, CAB068239" Enhanced NA NA "CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064" "unprognostic (5.97e-2)" "unprognostic (9.12e-2)" "unprognostic (9.95e-2)" "unprognostic (6.36e-3)" "unprognostic (2.52e-1)" "unprognostic (7.46e-2)" "prognostic favorable (1.57e-4)" "unprognostic (1.04e-1)" "unprognostic (1.85e-2)" "unprognostic (2.46e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.66e-4)" "unprognostic (2.27e-1)" "unprognostic (3.33e-2)" "unprognostic (7.80e-2)" "unprognostic (2.16e-1)" 1.3 2.0 5.4 1.4 5.3 1.1 2.0 1.9 3.9 1.7 1.0 1.7 1.2 1.0 1.1 1.1 1.4 2.6 1.1 1.3 3.7 3.8 1.9 157.6 0.9 1.4 4.3 2.5 1.4 2.6 1.1 1.3 0.8 3.4 1.4 0.8 1.3 2.7 2.1 1.4 1.1 0.9 1.5 2.7 1.1 1.1 2.3 3.0 1.4 1.8 0.6 1.4 1.1 1.6 13.3 10.8 2.2 3.0 9.6 18.7 8.9 16.0 22.0 3.9 4.1 3.7 3.9 2.4 0.9 2.1 3.1 4.3 1.7 3.5 20.9 2.7 1.1 0.6 3.4 4.5 14.1 1.3 9.7 14.9 14.0 22.9 18.3 5.6 7.3 5.0 4.5 2.4 0.4 8.5 5.3 1.5 15.9 12.9 0.0 3.7 13.1 18.1 15.5 2.4 13.5 12.9 9.1 0.1 28.4 10.1 7.6 5.4 7.3 0.0 21.7 4.7 1.1 6.4 6.4 1.2 0.0 2.8 0.0 1.8 13.8 15.4 8.5 4.5 13.7 0.8 0.0 2.4 2.2 8.7 3.0 18.7 13.3 11.2 11.4 6.5 8.9 13.9 14.3 0.3 9.6 2.1 10.8 13.3 8.9 5.4 5.3 1.9 3.9 3.7 3.8 4.3 2.5 3.4 3.0 0.0 8.2 11.5 13.1 8.0 11.5 5.6 22.9 9.4 5.7 5.2 0.0 6.4 33.2 10.3 114.0 11.9 1.3 0.0 13.3 2.3 7.6 17.0 4.7 338.0 9.1 9.5 9.7 15.4 11.3 303.5 10.0 8.9 15.1 1.8 3.5 6.1 7.4 0.0 8.9 39.7 7.6 6.5 15.5 8.8 13.2 12.3 2.9 10.2 4.7 12.1 SLC27A6 "ACSVL2, FACVL2, FATP6, VLCS-H1" ENSG00000113396 "Solute carrier family 27 member 6" Q9Y2P4 5 128538013-129033642 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 23.2" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 22.4;Cytotrophoblasts: 39.8;Extravillous trophoblasts: 30.2;Muller glia cells: 39.4;Syncytiotrophoblasts: 23.0" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 19.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "BEWO: 31.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA008987 Approved Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA008987: AB_1857065" "unprognostic (5.39e-5)" "unprognostic (4.79e-2)" "unprognostic (1.04e-1)" "unprognostic (3.15e-1)" "unprognostic (3.55e-1)" "unprognostic (1.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" "unprognostic (2.14e-1)" "unprognostic (2.54e-2)" "unprognostic (9.66e-4)" 0.5 23.2 6.3 0.5 6.8 0.3 2.9 0.6 2.8 4.1 0.9 8.2 0.0 0.6 4.2 0.5 7.2 19.5 2.7 20.6 3.2 3.3 0.2 0.3 0.9 0.4 10.4 0.0 9.7 0.3 0.2 7.7 19.6 13.3 3.7 1.8 1.7 3.9 0.4 0.5 2.2 1.1 1.0 12.7 0.3 0.6 11.3 15.1 5.4 3.9 8.7 5.5 1.5 3.2 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 31.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.6 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 2.4 0.0 2.2 1.5 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.2 3.1 0.0 3.7 0.0 2.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 6.8 0.6 2.8 3.2 3.3 10.4 0.0 13.3 15.1 0.0 0.0 0.0 1.0 2.9 0.0 22.4 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.0 6.2 0.0 0.0 0.0 0.0 30.2 0.9 0.1 0.0 0.0 3.4 3.2 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.0 0.6 23.0 0.0 0.0 0.0 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945796 "Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 25 "intestine: 32.7;kidney: 35.6;liver: 43.8" "Group enriched" "Detected in some" 5 "Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 5.0 0.1 0.1 17.3 0.1 1.5 0.1 0.1 0.1 0.5 0.1 0.1 35.6 43.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.4 0.0 32.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.5 0.0 0.9 0.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.1 0.4 0.1 1.8 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 7.6 1.4 0.0 7.0 0.0 0.4 10.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 34.1 40.6 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 88.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 SLC28A2 "CNT2, HCNT2, HsT17153, SPNT1" ENSG00000137860 "Solute carrier family 28 member 2" O43868 15 45252230-45277845 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "gallbladder: 28.7;intestine: 49.3" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 26.0;Paneth cells: 17.3;Undifferentiated cells: 59.6" "Cancer enhanced" "Detected in many" "stomach cancer: 3.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 4.3;NB-4: 2.3" "Low region specificity" "Detected in all" "HPA046068, HPA055623" Enhanced NA NA "HPA046068: AB_2679523, HPA055623: AB_2682866" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (6.85e-2)" "unprognostic (6.31e-2)" "unprognostic (1.59e-2)" "unprognostic (1.61e-1)" "unprognostic (6.40e-4)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.44e-2)" "unprognostic (8.95e-2)" 0.1 0.3 0.2 0.1 0.2 0.0 0.2 0.2 0.2 0.8 18.5 0.2 0.1 25.7 0.4 0.1 0.3 0.2 28.7 0.1 0.2 0.2 1.0 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.2 1.6 0.1 0.2 13.8 0.1 0.1 0.1 0.1 0.2 49.3 0.1 0.2 0.1 8.5 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.6 0.2 1.3 0.5 0.6 0.7 0.0 0.1 0.3 0.1 0.1 0.0 0.1 4.3 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.5 0.6 0.2 0.0 0.0 0.7 0.0 0.1 0.2 0.6 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 1.5 0.0 0.1 0.3 2.3 0.2 0.9 0.3 0.2 0.4 1.3 0.0 0.2 1.1 1.6 0.0 0.1 0.3 0.6 0.2 0.6 0.3 0.4 0.5 1.2 0.2 0.8 0.2 0.3 0.4 0.6 0.3 1.3 0.2 0.1 0.4 0.1 0.2 0.5 0.3 0.1 0.2 0.6 0.4 0.7 0.2 0.6 0.5 0.1 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 7.2 0.9 0.2 0.1 2.7 0.4 12.7 8.1 7.9 0.0 2.0 11.0 0.0 0.0 0.4 0.4 26.0 0.0 0.0 1.6 0.4 0.2 8.1 0.0 0.8 1.6 13.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.6 0.5 0.0 17.3 0.7 0.3 4.6 0.0 0.0 1.9 1.7 0.3 3.9 0.9 59.6 0.1 SLC28A3 CNT3 ENSG00000197506 "Solute carrier family 28 member 3" Q9HAS3 9 84275457-84340683 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 7.6;Ductal cells: 17.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 16 "pons and medulla: 6.0" "Cell type enhanced" "Detected in single" "intermediate monocyte: 2.7" "Lineage enriched" "Detected in single" 6 "monocytes: 2.7" "Cell line enriched" "Detected in some" 7 "HMC-1: 36.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023311, HPA024729" Approved NA NA "HPA023311: AB_1857067, HPA024729: AB_1857069" "prognostic favorable (3.37e-4)" "unprognostic (1.28e-2)" "unprognostic (3.01e-1)" "unprognostic (2.50e-1)" "unprognostic (2.79e-1)" "unprognostic (1.82e-3)" "unprognostic (3.74e-1)" "unprognostic (2.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.20e-1)" "unprognostic (5.06e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-7)" "unprognostic (1.03e-1)" "unprognostic (9.87e-2)" "unprognostic (8.75e-2)" "unprognostic (4.03e-2)" 5.1 0.0 0.1 0.8 0.3 9.9 10.2 0.1 0.1 1.2 1.3 0.7 34.8 1.0 0.8 2.8 4.5 2.6 12.2 0.6 0.3 0.2 0.2 0.4 1.1 0.1 0.1 0.1 2.0 24.6 0.0 2.5 0.1 6.0 1.0 2.9 0.6 12.5 29.1 0.1 9.8 2.0 0.1 0.1 0.4 0.8 0.5 0.1 0.9 0.2 6.4 3.3 0.3 1.4 0.2 0.0 0.0 2.7 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 3.9 0.4 0.9 0.5 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 36.9 0.0 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.3 0.0 5.5 0.0 0.1 3.7 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.3 0.2 0.1 0.1 6.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.7 7.6 4.0 1.2 1.8 0.0 0.1 0.0 17.3 1.0 0.0 0.3 0.0 2.6 0.1 0.1 0.1 1.1 0.0 1.9 0.0 2.9 0.0 2.4 1.3 0.0 0.7 0.0 1.8 3.4 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.1 0.0 2.4 0.1 SLC29A1 ENT1 ENSG00000112759 "Solute carrier family 29 member 1 (Augustine blood group)" Q99808 6 44219505-44234151 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 117.2" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 192.2;Extravillous trophoblasts: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 25 "eosinophil: 117.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 117.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012384 Approved NA NA "HPA012384: AB_1857073" "unprognostic (1.82e-2)" "unprognostic (1.41e-2)" "unprognostic (1.81e-1)" "unprognostic (2.49e-3)" "unprognostic (2.76e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (1.38e-2)" "unprognostic (4.60e-2)" "unprognostic (9.02e-2)" "unprognostic (1.34e-1)" 42.9 40.9 5.8 9.4 9.6 17.9 57.2 10.4 15.2 21.2 35.8 5.9 6.9 5.2 19.8 11.7 22.8 14.9 24.4 46.8 5.4 6.4 14.7 23.2 15.3 14.4 5.5 8.4 12.5 35.8 8.7 15.2 23.2 9.8 21.4 7.4 18.0 15.7 8.4 53.0 23.8 12.4 39.0 5.3 11.4 33.0 8.8 4.8 53.9 18.8 17.2 11.1 28.7 20.7 0.5 4.7 117.2 4.5 0.3 0.9 0.7 16.5 16.5 11.8 19.0 18.2 1.7 70.5 12.2 4.8 17.1 11.7 18.0 6.8 33.7 12.3 3.6 10.6 20.6 21.1 14.7 10.4 19.1 19.4 29.1 11.4 23.3 2.9 32.7 28.1 2.2 3.8 25.1 8.8 34.8 42.9 27.6 39.3 19.9 9.3 18.2 26.9 21.9 17.9 42.9 11.1 18.0 23.8 40.8 10.0 9.7 15.2 19.6 3.5 11.9 8.6 12.7 16.1 20.7 64.9 9.4 15.4 12.7 23.1 13.6 17.7 43.0 5.7 26.7 11.3 1.8 1.4 117.2 0.6 4.5 0.4 0.5 0.3 0.4 0.8 0.3 0.1 0.3 0.2 0.3 3.6 4.7 0.9 0.7 5.8 9.6 10.4 15.2 5.4 6.4 5.5 8.4 9.8 4.8 0.0 10.9 0.8 7.7 9.5 9.0 38.3 20.4 8.1 6.8 7.0 13.7 192.2 3.3 21.3 0.4 24.6 0.5 0.0 50.3 188.6 38.1 6.0 8.1 12.1 53.2 4.8 30.0 19.6 23.3 1.5 30.5 11.7 33.7 11.8 2.4 4.7 45.0 3.1 50.5 0.9 10.8 90.5 16.5 0.3 10.0 13.7 35.1 3.5 5.3 6.8 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.9" "Cell type enhanced" "Detected in many" 10 "Cytotrophoblasts: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1" "Cell line enhanced" "Detected in many" "BEWO: 16.7;CAPAN-2: 21.4;K-562: 16.1;T-47d: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 5.4 1.3 2.5 2.8 3.2 1.2 13.2 10.3 5.1 1.9 4.0 3.1 4.8 5.6 1.2 5.2 2.7 3.0 3.2 9.0 2.9 3.3 6.4 1.5 3.4 2.5 3.3 3.5 1.0 7.8 11.3 5.9 3.3 7.0 4.2 2.3 2.2 6.0 6.3 68.9 1.9 4.3 0.9 1.7 2.0 6.6 0.9 2.0 1.6 4.2 18.0 2.5 1.5 2.2 1.6 1.6 0.2 0.1 0.1 4.1 1.2 5.8 4.4 3.5 0.7 0.3 0.0 16.7 0.2 0.0 0.2 0.3 7.0 21.4 2.6 5.5 0.0 1.1 5.9 3.3 4.2 0.0 0.1 9.6 5.7 5.4 0.5 0.7 9.5 0.1 0.3 1.7 0.6 1.9 1.7 0.3 2.0 16.1 0.0 0.0 12.1 0.7 13.4 10.1 7.3 4.6 0.7 0.0 12.1 8.9 4.4 7.1 3.2 0.3 9.2 0.6 0.4 26.0 2.1 0.0 0.1 5.8 0.1 0.0 0.1 0.3 0.2 0.4 0.2 0.2 0.0 0.1 0.0 3.5 0.0 1.1 0.6 2.2 4.1 0.8 1.6 4.1 4.1 0.2 0.1 0.1 1.6 0.4 1.2 2.5 3.2 10.3 5.1 2.9 3.3 3.3 3.5 7.0 2.0 3.0 4.6 1.4 4.4 0.6 2.5 9.7 5.1 5.3 7.9 14.0 11.8 40.5 3.3 4.3 0.0 0.7 2.1 0.0 5.8 12.3 1.0 2.8 4.6 0.5 3.8 4.8 2.4 0.0 0.6 0.0 0.0 0.0 0.0 1.0 8.5 2.3 3.2 3.5 0.4 0.6 3.3 0.0 2.3 0.1 0.2 0.0 11.3 1.3 10.7 2.5 SLC29A4 "ENT4, FLJ34923" ENSG00000164638 "Solute carrier family 29 member 4" Q7RTT9 7 5274369-5306870 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.7" "Group enriched" "Detected in many" 8 "Horizontal cells: 158.9;Intestinal endocrine cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052829 Approved "Microtubules,Cytokinetic bridge" Yes No "Microtubules, Cytokinetic bridge" "HPA052829: AB_2681967" "unprognostic (6.04e-2)" "unprognostic (1.22e-2)" "unprognostic (8.49e-5)" "unprognostic (2.53e-1)" "unprognostic (1.47e-3)" "unprognostic (4.24e-2)" "unprognostic (9.59e-3)" "unprognostic (2.05e-1)" "unprognostic (2.55e-2)" "unprognostic (5.73e-2)" "prognostic favorable (4.52e-4)" "unprognostic (2.06e-1)" "unprognostic (3.02e-2)" "unprognostic (3.24e-2)" "unprognostic (2.63e-2)" "unprognostic (1.29e-3)" "unprognostic (6.60e-2)" 35.7 8.3 7.6 2.5 6.4 0.8 6.5 4.2 9.7 2.0 2.5 2.0 0.3 4.5 2.4 5.3 1.3 4.2 1.8 1.7 9.4 15.7 3.4 3.8 1.2 1.8 12.2 5.4 3.2 13.0 0.5 1.6 0.8 7.0 3.0 2.0 11.5 1.1 1.0 2.1 1.4 5.4 2.0 3.1 1.1 7.1 1.3 1.1 0.3 4.3 0.3 0.7 2.3 0.5 1.3 1.1 4.3 1.1 4.3 1.3 0.3 0.0 10.6 6.3 24.5 0.3 0.1 1.2 0.9 0.0 0.8 0.4 6.0 0.2 0.0 1.2 0.9 4.1 0.1 2.4 0.2 0.2 0.0 1.3 0.1 0.3 8.7 1.9 0.1 1.5 0.8 8.2 0.1 0.4 1.5 0.7 2.2 1.7 0.1 0.6 5.2 0.9 0.4 8.0 0.7 0.6 4.0 1.0 0.9 1.6 0.2 4.2 35.6 0.6 2.2 0.4 5.7 2.7 2.8 0.3 8.8 12.3 0.8 0.2 0.5 0.0 0.0 1.1 0.3 3.9 2.0 1.1 0.6 0.8 0.5 1.3 0.7 0.5 0.7 0.4 1.3 0.7 0.9 4.3 4.3 0.5 1.1 0.3 0.3 7.6 6.4 4.2 9.7 9.4 15.7 12.2 5.4 7.0 1.1 3.0 0.3 0.0 0.2 0.1 1.8 2.3 0.0 1.4 0.0 0.0 15.7 0.2 0.0 4.3 0.0 0.0 1.3 0.0 0.2 0.2 1.1 2.2 0.0 0.6 0.4 158.9 98.9 0.0 0.0 0.4 0.3 0.0 0.0 0.0 2.2 4.4 1.9 0.0 0.4 0.0 1.3 0.0 0.9 0.3 6.0 0.3 0.2 0.0 0.6 0.0 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925375-42959176 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 194.0" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" No No 36000000 "Plasma membrane" "CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734" "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavorable (3.65e-8)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.05e-4)" 4.2 3.7 12.4 3.9 16.9 45.2 4.1 6.7 15.5 15.2 4.8 15.1 4.3 2.4 7.6 3.4 28.8 8.5 8.6 5.0 15.4 13.7 7.6 2.1 2.4 5.3 18.2 5.0 3.4 3.7 7.3 2.9 194.0 15.5 5.2 3.3 44.2 8.4 7.9 1.8 42.1 2.9 2.5 17.8 3.4 5.5 2.5 12.5 1.8 4.0 11.5 12.0 22.2 24.5 8.4 14.7 1.3 0.2 3.0 7.5 2.7 10.7 15.6 12.8 3.2 1.5 0.5 44.8 7.1 15.4 8.8 12.9 72.7 30.1 4.1 21.2 2.1 6.2 10.1 2.8 16.5 3.9 2.4 2.6 6.7 9.0 49.6 4.5 3.6 1.9 1.9 12.7 5.5 5.9 26.0 1.4 3.5 15.0 0.9 3.9 19.2 1.7 2.5 8.2 5.3 3.9 1.6 4.1 5.7 8.0 5.2 6.8 4.8 8.3 26.3 3.1 19.2 1.1 4.6 3.2 8.0 5.8 1.4 16.0 0.7 1.5 2.5 15.8 2.6 6.5 0.3 0.2 1.3 7.5 0.2 6.9 8.4 4.1 5.1 2.9 7.3 3.2 4.7 1.0 3.0 0.1 14.7 4.7 2.7 12.4 16.9 6.7 15.5 15.4 13.7 18.2 5.0 15.5 12.5 0.0 2.6 23.8 35.5 254.3 8.1 23.0 25.5 28.1 9.1 26.2 62.8 686.5 5.0 47.8 4.0 9.9 16.8 303.7 10.3 412.9 42.1 25.5 5.8 1.3 74.8 4.8 17.6 0.6 1.3 0.0 7.2 3.2 20.3 61.3 13.7 394.9 72.4 18.7 13.8 1.6 31.1 0.0 20.2 0.0 1.7 208.3 2076.2 17.3 9.0 98.7 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709487-46736347 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 51.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 44 "basophil: 13.8" "Lineage enriched" "Detected in single" 44 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041015 Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA041015: AB_2677252" "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 4.7 4.6 2.6 4.3 3.3 0.1 8.7 2.1 3.1 11.4 6.7 2.7 6.7 2.6 5.4 6.6 4.8 5.6 10.2 6.7 3.3 1.4 2.6 51.5 4.8 3.4 2.2 2.0 7.1 22.9 15.0 4.2 8.3 3.8 18.0 8.8 9.8 11.5 11.0 2.1 2.4 3.0 9.7 2.3 1.9 12.4 3.4 1.0 0.8 18.1 4.5 4.6 7.1 5.7 0.0 0.0 13.8 0.0 0.3 0.0 0.0 0.0 0.0 4.7 4.8 19.5 16.7 14.3 9.1 12.4 4.2 5.1 0.3 16.0 0.0 6.9 16.5 0.0 0.1 0.0 0.4 2.0 0.0 0.1 1.3 0.0 7.6 13.8 0.0 0.0 24.2 0.4 2.6 0.0 4.9 1.7 0.0 0.1 0.0 7.2 16.6 0.0 0.4 1.7 20.0 1.2 0.0 0.7 0.0 0.0 4.3 0.0 0.7 1.8 3.0 24.8 3.5 2.3 3.7 1.0 9.1 4.0 7.2 1.1 0.1 0.0 0.0 0.0 0.0 1.9 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.6 3.3 2.1 3.1 3.3 1.4 2.2 2.0 3.8 1.0 6.0 4.6 0.0 6.8 0.6 0.0 2.2 10.2 33.5 11.4 1.8 0.0 1.9 0.0 5.2 0.1 4.1 2.2 0.0 4.9 12.8 11.7 28.1 5.8 41.2 0.9 0.0 3.5 9.2 2.8 0.9 24.5 0.3 1.7 0.0 60.1 5.6 5.1 2.9 16.3 0.7 0.5 12.9 3.9 0.4 0.2 0.9 1.7 0.0 6.6 10.2 SLC2A12 "GLUT12, GLUT8" ENSG00000146411 "Solute carrier family 2 member 12" Q8TD20 6 133988697-134052636 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.6" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.0" "Group enriched" "Detected in many" 6 "dendritic cells: 1.0;monocytes: 1.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031593, HPA031594" Approved Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA031593: AB_10600810, HPA031594: AB_2673948" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.69e-2)" "unprognostic (5.55e-3)" "unprognostic (2.18e-1)" "unprognostic (6.02e-2)" "unprognostic (2.24e-3)" "unprognostic (2.54e-2)" "unprognostic (2.08e-2)" "unprognostic (3.69e-2)" "unprognostic (2.38e-1)" "unprognostic (1.83e-1)" "unprognostic (2.33e-3)" "unprognostic (3.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.55e-3)" 0.9 1.2 5.2 0.4 6.7 0.1 1.5 14.6 5.5 4.8 3.0 7.1 4.9 8.1 9.7 2.6 7.0 3.4 3.0 11.4 6.5 2.8 6.7 7.9 3.4 0.2 3.4 5.2 1.5 1.3 1.2 2.5 1.9 19.7 27.0 1.4 46.6 5.2 11.2 4.2 3.9 11.9 14.8 1.6 0.3 14.4 0.5 3.3 0.6 0.6 1.9 2.7 6.7 2.0 0.0 1.0 0.0 1.3 0.0 0.1 0.1 2.1 0.7 1.8 0.0 1.4 0.7 0.1 1.3 5.4 0.7 3.0 0.0 7.4 0.2 1.1 0.1 5.5 5.6 0.0 0.5 1.0 0.0 4.7 0.0 0.6 0.1 0.2 0.0 0.0 1.0 0.5 0.6 0.1 13.5 0.4 0.3 0.4 0.6 0.1 0.6 0.1 0.1 1.6 0.0 0.5 0.0 0.9 2.0 1.6 0.7 0.2 0.5 0.0 1.7 0.0 22.1 0.0 0.0 0.0 0.2 8.0 0.2 0.7 2.8 2.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 5.2 6.7 14.6 5.5 6.5 2.8 3.4 5.2 19.7 3.3 0.0 4.8 0.0 0.8 1.8 0.1 5.7 0.0 9.4 2.3 0.0 0.0 1.9 3.3 1.2 0.0 0.4 0.0 0.0 0.2 0.5 0.3 11.7 0.0 0.9 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.8 2.9 1.4 0.3 0.5 0.0 0.1 0.0 0.0 1.6 30.7 0.0 0.3 1.4 SLC2A13 HMIT ENSG00000151229 "Solute carrier family 2 member 13" Q96QE2 12 39755021-40106089 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.7;parathyroid gland: 43.0" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 87.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006584, HPA061679" Enhanced Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA006584: AB_1849755, HPA061679: " "unprognostic (1.66e-1)" "unprognostic (2.52e-1)" "unprognostic (1.11e-1)" "unprognostic (9.62e-2)" "unprognostic (1.04e-1)" "unprognostic (3.31e-1)" "unprognostic (4.06e-2)" "unprognostic (1.20e-1)" "unprognostic (5.71e-2)" "unprognostic (1.83e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-2)" "unprognostic (2.12e-3)" "unprognostic (4.07e-2)" "unprognostic (6.34e-2)" "unprognostic (1.24e-2)" "unprognostic (9.16e-2)" 3.8 7.2 9.8 3.3 18.0 1.2 3.0 4.0 27.7 13.0 7.4 2.8 0.3 6.0 5.9 5.3 3.7 2.9 4.0 4.9 8.2 14.1 10.7 6.2 3.7 1.9 14.9 11.0 3.1 5.0 43.0 11.1 4.6 4.8 3.0 6.8 2.4 4.2 2.6 1.2 2.1 8.3 4.7 2.7 2.3 5.6 2.0 4.1 0.6 2.2 0.9 1.4 3.9 3.9 2.0 0.1 1.5 0.5 0.6 0.9 0.0 0.6 3.6 2.6 1.2 18.5 7.7 5.3 5.8 4.1 2.6 3.4 0.0 1.7 2.2 4.3 4.6 3.6 0.3 1.8 1.8 2.2 1.9 5.4 1.7 9.1 1.3 2.9 4.9 2.9 3.8 1.7 1.2 2.2 1.5 1.2 2.2 0.7 5.7 5.9 0.6 0.7 4.1 2.9 0.0 2.5 0.0 4.0 1.2 4.8 2.2 3.3 3.4 2.3 4.5 1.5 4.1 2.5 4.3 1.1 3.5 1.3 12.4 3.4 4.5 0.1 1.4 6.4 2.8 2.2 0.0 0.5 1.5 0.4 0.2 0.3 0.1 0.4 0.9 0.0 2.0 0.2 0.5 0.8 0.6 0.1 0.1 0.1 0.0 9.8 18.0 4.0 19.8 8.2 14.1 14.9 11.0 4.8 4.1 8.9 17.1 4.7 1.7 3.7 4.3 3.5 10.2 5.3 2.3 8.7 0.0 5.0 0.0 4.3 2.5 5.2 35.1 0.0 10.9 2.1 7.1 2.7 10.3 8.5 7.2 87.4 19.5 8.0 7.9 2.1 21.3 7.4 15.1 6.4 21.3 2.0 8.7 29.4 7.1 6.4 1.3 6.5 6.1 0.9 1.9 4.5 3.1 4.4 11.1 1.4 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 60.6" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2" HPA006539 Supported Approved "Plasma membrane" NA NA "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.3 0.3 0.2 0.2 0.6 12.6 0.0 0.0 0.0 0.2 20.4 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.1 0.5 5.3 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.9 0.1 0.0 0.1 0.1 0.1 2.3 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.4 0.0 25.2 0.0 1.3 0.3 0.1 0.5 0.3 0.1 0.1 0.1 0.2 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 0.0 0.6 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 3.7 2.3 0.0 0.0 1.3 0.9 1.9 0.0 9.2 0.4 0.2 0.0 0.0 8.0 4.4 0.9 0.3 3.1 1.7 0.0 0.0 0.0 0.5 5.8 2.5 0.0 0.4 0.0 4.2 60.6 2.7 0.1 0.3 3.2 0.0 0.0 SLC2A2 GLUT2 ENSG00000163581 "Solute carrier family 2 member 2" P11168 3 170996348-171026750 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 77.4;liver: 172.8" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 433.3" "Cancer enriched" "Detected in some" 12 "liver cancer: 105.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 68 "CACO-2: 7.3;Hep G2: 24.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB010444, HPA028997" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB010444: AB_641068, HPA028997: AB_2672860" "unprognostic (9.56e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.63e-5)" "unprognostic (3.10e-1)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (6.31e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 27.9 0.0 0.0 10.8 0.1 0.2 0.1 0.1 3.8 0.1 0.1 0.1 15.3 172.8 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 77.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 24.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.6 0.0 0.0 0.0 0.0 0.0 1.7 0.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.3 0.0 0.0 0.0 6.7 8.9 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 SLC2A3 GLUT3 ENSG00000059804 "Solute carrier family 2 member 3" P11169 12 7919230-7936275 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 166.3" "Cell type enhanced" "Detected in many" 7 "granulocytes: 462.0" "Cancer enriched" "Detected in all" 7 "testis cancer: 107.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 30.2;neutrophil: 55.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 55.6" "Group enriched" "Detected in many" 5 "BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9" "CAB002763, HPA006539" Approved Approved "Plasma membrane" NA NA 33000000 "Plasma membrane" "CAB002763: , HPA006539: AB_1078984" "unprognostic (9.20e-2)" "unprognostic (9.63e-3)" "prognostic unfavorable (8.58e-4)" "unprognostic (2.65e-1)" "unprognostic (5.29e-3)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (8.27e-2)" "unprognostic (2.35e-1)" "unprognostic (3.83e-2)" "unprognostic (8.47e-3)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.36e-8)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.70e-1)" "unprognostic (1.14e-2)" "unprognostic (2.91e-3)" 48.8 10.0 9.5 25.2 10.5 166.3 26.4 13.1 24.3 9.4 10.0 6.8 1.8 4.2 10.3 8.2 13.2 8.0 25.6 22.8 10.8 13.6 10.3 14.1 32.4 12.8 13.3 3.3 18.8 6.1 6.9 10.9 43.9 13.7 15.0 6.9 14.8 3.8 3.9 13.6 7.4 5.8 18.7 15.4 16.4 7.0 10.6 12.5 3.3 15.7 7.0 13.6 51.8 10.5 1.8 2.4 55.6 4.6 3.6 6.4 3.5 0.0 0.7 6.6 2.5 2.4 8.5 143.6 2.3 2.5 2.3 5.4 154.0 1.0 0.1 0.0 1.6 3.2 0.0 0.2 0.3 4.2 4.5 0.1 8.9 0.6 20.2 6.7 3.2 13.0 3.5 0.2 6.1 2.8 5.4 2.1 0.7 4.1 2.1 2.1 0.0 0.2 3.4 29.1 0.1 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.0 113.9 0.0 0.4 2.1 2.9 1.5 5.6 0.2 0.0 6.2 0.4 8.5 1.5 1.5 30.2 4.6 7.0 6.4 0.5 5.3 1.8 4.4 4.9 2.4 1.7 2.8 3.8 55.6 3.6 0.2 0.1 5.8 3.5 9.5 10.5 13.1 13.3 10.8 13.6 13.3 3.3 13.7 12.5 134.0 147.7 116.7 2.9 115.1 27.9 8.4 7.6 18.7 48.9 3.5 58.9 41.5 0.0 0.2 2.4 227.7 0.0 0.0 0.0 218.4 149.1 3.8 462.0 1.0 97.9 4.8 1.2 85.3 85.8 1.9 9.5 229.2 173.7 1.0 0.0 19.2 0.8 0.2 7.4 1.2 68.8 116.4 236.4 1.4 0.6 71.6 93.1 133.8 0.0 2.8 SLC2A4 GLUT4 ENSG00000181856 "Solute carrier family 2 member 4" P14672 17 7281667-7288257 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5" "Cell type enhanced" "Detected in many" 26 "Cardiomyocytes: 120.2;Sertoli cells: 32.3;Smooth muscle cells: 25.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Lineage enhanced" "Detected in single" "dendritic cells: 1.7" "Cell line enriched" "Detected in some" 4 "Hep G2: 10.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB016544 Enhanced NA NA "CAB016544: AB_629533" "unprognostic (2.53e-1)" "unprognostic (7.40e-3)" "unprognostic (2.27e-1)" "unprognostic (8.12e-4)" "unprognostic (2.40e-1)" "unprognostic (6.28e-2)" "unprognostic (1.70e-2)" "unprognostic (1.66e-2)" "unprognostic (1.35e-1)" "unprognostic (3.83e-2)" "unprognostic (9.66e-2)" "unprognostic (2.24e-2)" "unprognostic (1.34e-3)" "unprognostic (4.23e-2)" "unprognostic (3.10e-1)" "unprognostic (2.30e-2)" "unprognostic (2.07e-2)" 9.9 1.4 0.6 1.8 0.7 1.1 6.4 0.0 0.6 4.7 13.9 0.2 4.0 1.0 4.2 7.0 11.8 3.2 2.9 37.2 0.3 0.1 0.7 1.2 0.5 0.7 0.8 0.1 1.9 0.4 2.9 1.2 0.8 0.5 6.3 1.4 6.4 4.6 3.8 76.8 0.9 3.3 23.5 0.2 0.2 3.8 1.5 0.0 0.0 1.2 33.5 1.6 18.6 1.6 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.8 1.5 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.1 1.2 0.2 0.0 0.8 0.8 0.3 0.2 0.1 0.0 1.8 0.0 0.3 10.8 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 1.1 0.6 0.2 0.0 0.4 0.0 0.2 0.8 0.2 0.1 2.4 0.6 0.8 0.0 0.1 0.0 1.0 0.0 1.3 0.0 1.8 0.8 0.1 0.0 0.0 1.5 0.0 0.2 0.6 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.7 0.0 0.6 0.3 0.1 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.7 1.5 0.0 120.2 0.0 0.0 0.0 0.0 0.0 0.3 6.6 0.1 5.7 1.5 0.8 0.0 0.0 0.0 0.4 0.5 0.0 2.0 0.1 0.0 0.0 1.8 0.0 3.6 0.0 0.0 6.8 0.0 0.5 5.6 0.1 0.2 8.1 0.2 0.0 32.3 25.1 2.1 2.7 1.0 0.8 0.0 1.0 0.3 SLC2A5 GLUT5 ENSG00000142583 "Solute carrier family 2 member 5" P22732 1 9035107-9088478 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.7;intestine: 84.1" "Group enriched" "Detected in many" 4 "Early spermatids: 42.2;Late spermatids: 12.6;Paneth cells: 28.8;Proximal tubular cells: 18.8;Spermatocytes: 44.4" "Group enriched" "Detected in many" 6 "glioma: 11.0;renal cancer: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "naive B-cell: 19.7" "Lineage enriched" "Detected in many" 7 "B-cells: 19.7" "Group enriched" "Detected in some" 5 "Daudi: 51.3;THP-1: 13.0;U-266/70: 41.3;U-698: 48.2;U-937: 18.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005449, HPA075145" Enhanced NA NA "HPA005449: AB_1078985, HPA075145: " "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (8.00e-3)" "unprognostic (2.25e-2)" "unprognostic (6.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.47e-2)" "unprognostic (5.35e-2)" "unprognostic (4.18e-1)" "unprognostic (6.85e-2)" "unprognostic (3.77e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.44e-5)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (8.19e-3)" "unprognostic (8.61e-2)" 5.2 2.2 10.3 4.1 15.0 36.7 3.7 1.1 9.9 2.4 50.4 9.2 0.7 44.8 0.8 4.9 2.5 1.5 0.6 1.4 8.6 6.0 16.2 0.6 0.9 8.1 14.1 2.4 1.6 0.6 0.5 1.9 2.1 10.4 6.7 1.6 0.8 1.8 2.4 25.1 3.1 84.1 1.9 17.8 3.1 0.7 30.2 15.4 0.0 0.8 3.7 7.3 1.8 2.5 19.7 0.7 3.0 2.1 0.6 0.3 0.8 0.1 0.0 0.0 0.1 0.2 0.3 0.2 0.0 0.2 0.0 0.1 0.4 0.0 51.3 0.0 0.1 0.0 0.1 0.4 0.0 0.1 6.6 0.0 0.0 0.9 0.0 0.1 0.8 0.5 0.8 0.7 0.1 0.0 0.8 0.0 0.0 0.1 0.7 0.0 0.0 0.3 2.8 0.0 0.0 0.0 1.3 0.0 1.6 0.0 0.6 0.1 0.1 0.1 0.1 0.2 0.0 0.0 13.0 0.0 0.8 0.2 0.1 0.0 41.3 0.0 48.2 0.1 18.5 0.1 3.0 2.1 0.2 0.2 0.5 0.1 3.4 0.2 0.2 0.7 19.7 0.3 0.2 2.2 0.6 0.1 0.4 0.1 0.8 10.3 15.0 1.1 9.9 8.6 6.0 14.1 2.4 10.4 15.4 0.0 0.0 6.7 1.8 1.8 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.1 42.2 0.5 2.6 0.0 0.0 1.0 0.5 0.6 1.1 0.0 4.2 0.0 1.2 0.0 1.2 12.6 2.6 1.8 0.0 1.0 2.2 0.2 0.4 28.8 0.4 18.8 0.0 6.5 0.3 44.4 3.4 0.5 0.5 0.0 2.5 0.1 SLC2A6 "GLUT6, GLUT9, HSA011372" ENSG00000160326 "Solute carrier family 2 member 6" Q9UGQ3 9 133471095-133479137 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.7;brain: 17.3" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 49.1;granulocytes: 45.2;monocytes: 68.5;Rod photoreceptor cells: 45.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 27.7" "Group enriched" "Detected in many" 4 "dendritic cells: 7.0;granulocytes: 15.6;monocytes: 27.7" "Cell line enhanced" "Detected in many" "HDLM-2: 15.7;HMC-1: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042272, CAB046014" Uncertain NA NA "CAB046014: AB_2270444, HPA042272: AB_2677924" "unprognostic (2.12e-1)" "unprognostic (1.49e-1)" "unprognostic (1.87e-3)" "unprognostic (1.71e-3)" "prognostic unfavorable (1.39e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.26e-1)" "unprognostic (2.23e-1)" "unprognostic (5.93e-2)" "unprognostic (1.05e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (1.02e-11)" "unprognostic (7.24e-2)" "unprognostic (3.43e-2)" "unprognostic (9.36e-2)" "unprognostic (6.28e-3)" 3.8 3.1 7.2 12.7 8.3 10.5 2.1 8.1 16.3 1.4 2.5 4.3 0.0 3.3 2.3 3.1 1.8 1.4 3.6 3.0 9.1 12.1 2.3 2.7 7.4 10.8 12.4 9.1 1.7 3.2 1.1 1.8 2.5 17.3 1.6 2.1 2.9 2.2 2.2 2.1 1.9 4.9 3.3 7.3 10.6 4.0 2.2 2.4 1.7 1.6 0.0 7.1 4.9 1.1 4.0 7.0 15.6 27.7 0.4 0.6 3.1 2.5 4.7 1.7 5.1 1.0 1.5 1.3 2.6 4.5 2.7 2.7 2.3 3.7 2.1 6.6 2.6 12.6 4.1 1.1 3.2 0.6 15.7 0.8 2.6 3.5 2.7 3.4 0.0 37.0 2.1 0.5 4.0 0.5 0.2 2.7 2.5 0.4 2.2 1.9 6.1 1.5 2.7 2.5 1.2 5.6 1.0 2.8 11.7 3.8 7.5 2.0 2.7 3.9 2.1 1.3 1.0 8.0 1.1 6.9 6.5 2.5 6.8 2.1 1.1 0.8 3.0 1.6 0.6 1.4 15.6 7.2 0.7 0.6 14.6 0.4 4.0 0.1 0.4 6.4 3.9 0.2 0.5 0.4 0.4 27.7 7.0 0.1 3.1 7.2 8.3 8.1 16.3 9.1 12.1 12.4 9.1 17.3 2.4 3.0 5.5 19.9 1.3 0.3 24.3 2.0 5.1 2.7 0.0 3.5 49.1 0.3 0.0 32.4 6.3 4.7 1.8 0.0 7.9 0.5 1.9 1.1 45.2 0.0 4.6 22.3 3.5 2.5 19.2 1.3 0.9 31.5 3.3 68.5 1.5 3.9 16.6 31.7 0.0 0.0 45.6 32.3 7.2 2.2 6.6 0.4 0.2 3.8 1.2 0.5 SLC2A7 GLUT7 ENSG00000197241 "Solute carrier family 2 member 7" Q6PXP3 1 9003300-9026345 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "intestine: 19.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in single" "Daudi: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039931 Uncertain NA NA "HPA039931: AB_10671046" "unprognostic (4.19e-2)" "unprognostic (3.68e-1)" "unprognostic (1.96e-2)" "unprognostic (2.20e-1)" "unprognostic (1.05e-2)" "unprognostic (3.43e-1)" "unprognostic (9.05e-2)" "unprognostic (5.69e-4)" "unprognostic (5.09e-2)" "unprognostic (7.12e-2)" "unprognostic (1.60e-1)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 7.2 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 19.3 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC2A9 "Glut9, GLUTX, URATv1" ENSG00000109667 "Solute carrier family 2 member 9" Q9NRM0 4 9771153-10054936 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 43.4" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 16.4;Proximal tubular cells: 47.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 20.6;myeloid DC: 16.7" "Group enriched" "Detected in many" 31 "dendritic cells: 16.7;monocytes: 20.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 29.6;Hep G2: 14.2;hTCEpi: 12.5;THP-1: 12.5;U-937: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA066229, HPA075669" Enhanced NA NA "HPA066229: AB_2685639, HPA075669: " "unprognostic (3.21e-1)" "unprognostic (8.99e-3)" "unprognostic (1.25e-2)" "unprognostic (2.01e-1)" "unprognostic (2.14e-2)" "unprognostic (2.56e-2)" "unprognostic (8.94e-2)" "unprognostic (6.94e-2)" "unprognostic (2.86e-2)" "unprognostic (1.28e-2)" "unprognostic (3.16e-1)" "unprognostic (2.23e-1)" "prognostic favorable (1.32e-11)" "unprognostic (1.01e-1)" "unprognostic (3.88e-2)" "unprognostic (3.17e-3)" "unprognostic (1.20e-1)" 5.6 2.8 1.0 1.3 2.0 1.2 3.2 0.6 1.2 2.6 10.4 2.3 5.7 7.8 1.7 12.0 5.8 2.6 1.7 2.7 1.0 0.9 43.4 17.7 4.7 2.8 1.9 0.7 1.5 1.3 1.5 1.8 8.8 2.1 4.6 1.1 4.1 10.8 15.6 1.1 2.4 12.0 1.4 4.1 3.0 1.2 1.3 2.3 3.0 2.9 3.4 3.9 7.1 3.9 0.2 16.7 0.6 20.6 0.1 0.2 4.9 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.2 1.5 0.0 2.2 0.4 0.0 4.5 0.0 29.6 0.0 4.8 0.1 0.0 0.0 14.2 1.0 0.1 4.0 2.2 12.5 0.0 3.1 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.2 1.4 0.0 0.2 0.1 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 20.6 0.4 0.1 4.1 0.2 0.2 0.2 0.0 16.7 0.1 0.1 0.0 0.6 0.1 0.4 6.6 0.1 4.9 1.0 2.0 0.6 1.2 1.0 0.9 1.9 0.7 2.1 2.3 0.0 0.0 1.4 11.1 0.8 0.0 2.1 0.0 4.0 3.4 3.5 2.0 16.4 3.3 0.4 3.9 1.4 2.9 0.0 0.9 1.3 1.1 1.0 1.1 4.9 9.3 0.0 0.0 2.5 6.5 2.8 0.0 10.2 0.0 1.0 0.8 0.8 0.4 0.0 0.4 47.2 0.4 0.0 1.0 0.7 1.2 0.5 7.1 0.5 1.0 8.8 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211578742 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 53.3" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: AB_2680593" "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 11.4 16.6 9.3 7.5 11.4 15.5 17.3 5.2 13.6 13.0 15.3 6.9 4.9 17.2 7.1 7.6 9.0 9.2 12.9 6.1 9.7 7.9 13.4 53.3 12.0 3.5 9.5 8.0 9.5 8.9 8.8 4.8 9.3 8.7 7.3 8.9 7.7 5.9 9.2 3.6 13.9 28.1 7.5 8.3 10.7 6.4 12.5 5.5 3.1 11.0 5.2 4.4 7.7 8.4 0.5 2.5 3.9 4.2 1.3 1.7 1.0 4.7 6.9 3.8 4.9 16.6 7.7 33.7 13.0 9.6 6.9 6.9 3.0 22.6 2.6 11.4 11.9 9.6 8.1 5.7 7.5 8.3 6.7 4.3 2.1 14.1 6.9 9.3 7.4 4.8 11.5 19.0 8.8 14.4 10.4 4.2 1.6 8.4 12.5 8.5 4.3 1.4 4.6 11.7 5.1 5.5 4.5 1.8 9.6 21.5 12.7 3.8 6.7 12.7 6.7 29.0 7.5 3.4 9.7 6.8 5.2 12.1 17.3 10.3 5.5 8.4 2.2 4.8 7.5 4.5 3.9 3.9 1.3 1.2 4.2 1.7 0.5 0.9 0.8 2.5 0.3 0.9 1.2 0.4 1.3 3.2 1.7 0.8 1.0 9.3 11.4 5.2 13.6 9.7 7.9 9.5 8.0 8.7 5.5 8.9 9.8 5.1 7.2 25.3 10.9 17.9 17.8 6.7 2.3 34.9 5.9 9.8 1.7 5.4 21.7 18.0 37.9 46.7 10.7 27.0 15.0 12.6 4.7 83.9 29.4 6.4 9.1 15.4 33.3 2.8 9.2 15.1 20.3 5.4 23.6 26.5 7.9 31.7 7.1 29.5 8.5 6.5 11.6 33.0 9.4 40.4 20.5 10.2 20.5 11.4 SLC30A10 "DKFZp547M236, ZnT-10, ZNT8, ZRC1" ENSG00000196660 "Solute carrier family 30 member 10" Q6XR72 1 219685427-219958647 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 33.4" "Group enriched" "Detected in some" 6 "Early spermatids: 23.4;Enterocytes: 12.9;Hepatocytes: 19.8;Late spermatids: 27.7" "Cancer enriched" "Detected in some" 14 "liver cancer: 7.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.4;HEL: 2.2;Hep G2: 4.3;K-562: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064547 Enhanced NA NA "HPA064547: AB_2732715" "unprognostic (7.88e-2)" "unprognostic (1.07e-2)" "unprognostic (1.02e-1)" "unprognostic (7.25e-2)" "unprognostic (1.75e-2)" "unprognostic (3.74e-3)" "unprognostic (6.96e-2)" "unprognostic (3.72e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-2)" "unprognostic (5.10e-2)" "unprognostic (3.10e-3)" "unprognostic (4.47e-7)" "unprognostic (3.16e-1)" "unprognostic (6.11e-2)" "unprognostic (6.19e-3)" "unprognostic (5.72e-2)" 0.3 0.3 2.9 0.7 3.5 0.4 0.3 1.8 3.9 0.3 7.1 1.9 0.0 5.9 0.3 0.3 0.3 0.3 0.5 0.3 3.5 1.6 0.3 33.4 0.3 0.3 1.7 1.7 0.6 0.3 0.3 0.4 0.4 2.5 0.3 1.7 0.6 0.3 0.3 0.3 0.3 6.8 0.3 0.8 0.3 0.3 1.9 1.9 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.4 2.2 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.5 1.8 3.9 3.5 1.6 1.7 1.7 2.5 1.9 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.4 0.0 12.9 0.0 0.0 0.2 0.0 0.0 0.0 19.8 0.1 0.0 0.0 0.6 0.6 27.7 1.1 0.0 1.7 0.0 0.1 3.4 0.0 3.2 1.4 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.2 0.0 0.6 0.0 SLC30A2 ZNT2 ENSG00000158014 "Solute carrier family 30 member 2" Q9BRI3 1 26037252-26046133 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 78.0;placenta: 20.0" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 19.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Not detected" "Not detected" HPA017979 Approved Vesicles NA NA Vesicles "HPA017979: AB_1857085" "unprognostic (4.87e-2)" "unprognostic (6.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.79e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-2)" "unprognostic (2.25e-2)" "unprognostic (2.59e-1)" "unprognostic (3.67e-2)" "unprognostic (1.02e-1)" "unprognostic (6.99e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.86e-6)" "unprognostic (9.38e-2)" "unprognostic (3.50e-2)" "unprognostic (1.17e-1)" "unprognostic (3.01e-2)" 0.1 0.7 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.0 1.3 1.1 0.1 0.1 4.0 2.2 0.1 0.1 10.4 0.1 0.2 0.1 0.1 0.1 0.1 78.0 0.1 0.1 20.0 0.1 0.3 0.0 2.0 1.0 1.4 1.7 0.4 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 12.8 0.2 0.1 0.5 0.1 1.5 1.1 3.1 1.0 1.5 0.9 0.4 0.2 0.2 0.2 1.0 0.3 0.1 4.7 0.4 0.2 0.1 0.1 0.9 1.0 0.2 0.9 0.1 0.2 0.9 0.2 0.3 0.1 0.6 0.3 0.6 0.7 0.1 0.1 0.6 0.7 0.0 0.2 0.1 0.1 0.3 0.0 0.3 0.6 1.5 0.1 0.8 0.5 0.9 0.8 0.4 0.2 0.3 0.7 0.7 10.6 0.4 0.9 0.5 0.6 1.1 0.4 1.6 0.7 0.5 0.6 0.7 1.2 0.6 0.3 1.1 0.6 0.8 0.5 0.6 6.5 3.1 1.0 0.4 0.9 0.4 0.5 0.7 0.6 0.8 0.2 1.5 0.6 0.8 3.1 1.5 0.5 1.1 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.0 4.0 0.0 0.7 0.3 2.4 5.1 15.3 0.0 0.0 8.7 0.0 23.2 5.0 6.8 0.0 0.5 0.4 0.0 18.5 2.4 0.6 0.6 4.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.8 0.1 0.5 5.4 0.0 0.0 27.2 1.8 6.5 0.9 0.2 0.4 0.6 71.2 0.0 0.6 0.7 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875" "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 8.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.1 0.7 2.4 1.4 0.0 0.1 3.8 0.0 0.3 1.5 0.2 0.0 19.0 9.9 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.2 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 29.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.3 18.7 9.4 0.1 0.1 0.0 0.0 0.0 SLC30A4 ZNT4 ENSG00000104154 "Solute carrier family 30 member 4" O14863 15 45479611-45522807 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 47.7" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 59.6;Late spermatids: 60.4" "Cancer enriched" "Detected in all" 20 "prostate cancer: 34.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018178 Uncertain NA NA "HPA018178: AB_1857087" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-1)" "unprognostic (9.49e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (9.74e-2)" "unprognostic (7.38e-3)" "unprognostic (1.51e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.66e-2)" "unprognostic (4.72e-3)" "unprognostic (1.29e-2)" "unprognostic (9.83e-2)" "unprognostic (8.28e-3)" "unprognostic (2.01e-3)" 3.7 2.9 6.2 4.5 11.3 1.6 4.1 6.7 8.1 3.7 8.8 7.0 2.3 8.5 4.3 4.1 5.6 3.4 3.1 3.0 5.2 3.8 5.5 3.6 2.9 3.6 6.9 4.9 3.9 2.8 6.8 3.0 4.6 5.1 47.7 4.4 3.1 2.7 3.5 2.4 3.6 19.9 4.7 4.5 4.0 3.0 15.8 9.0 1.0 6.2 1.8 4.5 3.1 4.4 7.1 0.5 2.6 0.3 2.4 4.3 1.0 2.0 2.6 0.7 5.6 10.2 7.2 0.5 5.4 4.9 3.3 4.7 0.3 1.8 8.0 1.8 5.5 1.3 1.5 2.4 2.5 3.0 1.9 2.2 0.2 2.6 0.2 6.6 0.2 4.2 6.0 4.1 4.3 1.1 5.1 3.8 3.8 1.2 4.6 6.1 0.9 2.7 0.4 0.2 0.4 0.5 4.2 4.8 1.2 2.7 0.5 1.9 2.8 3.5 4.0 0.9 0.9 3.5 0.3 7.1 4.9 2.8 5.9 1.8 8.6 6.2 2.0 2.1 0.3 3.7 2.6 0.3 0.3 4.3 0.2 3.9 3.8 2.9 2.4 0.3 7.1 2.9 4.2 1.1 2.4 0.3 0.5 0.4 1.0 6.2 11.3 6.7 8.1 5.2 3.8 6.9 4.9 5.1 9.0 3.0 3.8 3.2 2.0 6.1 2.6 2.3 0.0 1.4 0.0 1.8 15.7 0.7 0.0 1.0 59.6 5.0 13.6 0.0 1.0 0.2 7.2 30.7 1.1 2.4 2.5 12.7 1.2 7.4 1.8 60.4 5.8 5.8 6.8 9.0 5.1 4.9 0.6 14.4 7.8 8.4 2.2 6.5 5.9 29.4 16.8 5.6 0.2 4.4 2.9 1.4 SLC30A8 "ZnT-8, ZNT8" ENSG00000164756 "Solute carrier family 30 member 8" Q8IWU4 8 116950273-117176714 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 37.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 3.0;Late spermatids: 5.4;Pancreatic endocrine cells: 8.2;Spermatogonia: 3.0" "Group enriched" "Detected in some" 28 "breast cancer: 10.6;pancreatic cancer: 15.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "U-266/70: 30.5;U-266/84: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076165 Enhanced NA NA "HPA076165: AB_2732304" "unprognostic (2.14e-2)" "unprognostic (1.48e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.57e-2)" "unprognostic (4.38e-1)" "unprognostic (3.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.66e-2)" "unprognostic (6.51e-3)" "unprognostic (2.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (9.16e-3)" 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.1 0.1 0.1 37.1 0.0 0.3 0.1 0.1 0.1 0.0 5.0 6.4 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.6 2.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 30.5 21.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 1.5 0.0 0.0 0.0 1.4 3.0 0.0 0.0 0.0 0.0 0.0 SLC31A1 "COPT1, CTR1, hCTR1" ENSG00000136868 "Solute carrier family 31 member 1" O15431 9 113221562-113264492 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.7;salivary gland: 57.9" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 81.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 13.0;intermediate monocyte: 16.2;myeloid DC: 9.9;neutrophil: 5.0;non-classical monocyte: 17.0" "Group enriched" "Detected in all" 4 "dendritic cells: 9.9;granulocytes: 5.0;monocytes: 17.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013810 Approved NA NA "HPA013810: AB_1857095" "unprognostic (1.22e-2)" "unprognostic (1.74e-1)" "unprognostic (4.29e-2)" "unprognostic (5.48e-3)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" "unprognostic (7.58e-2)" "unprognostic (2.30e-1)" "unprognostic (2.51e-1)" "unprognostic (7.18e-2)" "unprognostic (3.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (1.22e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.51e-2)" 7.8 12.1 5.0 4.9 6.1 4.6 6.0 3.7 6.7 10.6 16.2 6.7 21.2 20.7 4.9 7.8 9.8 4.8 5.7 5.8 5.0 4.9 15.4 55.7 8.8 3.5 5.6 4.0 6.3 11.4 5.8 9.4 7.9 7.4 10.3 8.1 8.5 57.9 21.7 3.0 14.3 41.8 4.6 5.8 8.6 9.3 4.7 5.0 2.6 6.3 6.8 9.8 5.8 5.2 1.0 9.9 5.0 17.0 2.5 2.0 4.3 8.2 8.9 7.3 16.0 16.7 12.0 26.9 14.6 22.3 10.1 11.9 12.6 7.2 6.4 5.9 12.5 12.9 20.4 13.7 8.3 11.4 5.6 7.7 5.3 7.9 14.1 40.9 9.6 8.1 14.4 18.9 13.1 21.5 6.8 9.2 7.5 12.0 12.0 9.6 8.7 6.5 4.9 11.8 31.6 10.0 6.8 19.1 6.4 9.3 10.3 6.9 9.0 14.1 28.3 38.2 10.7 14.4 8.3 8.4 7.6 4.7 15.2 8.7 7.2 14.7 9.0 12.6 9.1 8.9 1.3 13.0 1.5 1.5 16.2 2.0 1.0 1.0 1.5 9.9 0.9 1.2 1.1 5.0 2.5 17.0 1.4 1.1 4.3 5.0 6.1 3.7 6.7 5.0 4.9 5.6 4.0 7.4 5.0 32.8 31.0 8.2 8.3 13.5 12.2 7.0 17.8 25.4 40.9 5.2 31.4 14.3 8.3 15.5 0.2 8.4 47.6 0.0 23.5 21.7 15.1 32.7 4.7 81.5 41.2 6.4 8.6 12.3 27.6 0.5 5.8 27.2 11.8 11.8 14.4 11.3 18.9 11.8 6.7 23.2 11.2 6.5 12.2 11.9 34.9 13.8 18.8 2.5 16.6 16.2 SLC31A2 "COPT2, CTR2, hCTR2" ENSG00000136867 "Solute carrier family 31 member 2" O15432 9 113150942-113164137 "Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.2;salivary gland: 125.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2" "Group enriched" "Detected in many" 36 "dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014861 Approved Approved "Nuclear speckles,Plasma membrane,Intermediate filaments" NA NA "Nuclear speckles" "Plasma membrane, Intermediate filaments" "HPA014861: AB_1857098" "unprognostic (2.26e-1)" "unprognostic (7.20e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (5.63e-2)" "unprognostic (3.31e-2)" "unprognostic (2.24e-1)" "unprognostic (3.44e-2)" "unprognostic (1.47e-1)" "unprognostic (1.86e-1)" "unprognostic (6.05e-3)" "unprognostic (1.76e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" "unprognostic (8.89e-2)" 15.7 8.0 10.0 8.1 20.5 7.0 8.5 3.2 15.0 3.0 8.4 45.1 27.1 5.2 2.0 6.0 4.6 3.0 4.5 3.4 18.2 9.4 9.8 11.2 10.0 6.2 34.3 10.5 2.8 7.8 17.9 1.2 10.2 22.3 2.1 4.4 1.0 125.5 21.8 6.7 18.5 9.9 3.8 48.5 14.1 4.5 5.4 26.2 1.2 2.8 2.9 5.8 3.9 4.1 0.3 21.2 54.5 60.2 0.2 1.2 13.4 5.5 2.5 1.4 2.0 22.2 9.1 4.8 4.2 5.4 5.1 4.9 1.8 1.7 0.3 0.8 3.5 8.3 20.6 2.0 12.0 4.8 2.8 0.8 0.3 1.2 2.9 8.5 2.2 1.2 10.2 33.7 11.9 23.1 2.7 2.7 2.7 1.6 3.0 26.6 5.3 2.1 1.3 0.7 2.8 2.3 0.4 20.1 0.4 1.7 3.4 1.3 2.2 5.8 17.8 1.7 1.2 6.4 2.0 2.5 2.8 1.9 9.2 3.6 1.9 3.9 0.2 8.8 2.9 2.8 0.8 36.6 3.6 0.9 50.5 1.2 0.2 1.0 1.0 21.2 0.3 0.8 0.8 54.5 0.2 60.2 0.5 0.6 13.4 10.0 20.5 3.2 15.0 18.2 9.4 34.3 10.5 22.3 26.2 8.9 8.6 18.0 5.3 33.0 6.9 0.4 2.5 10.7 5.7 1.8 33.4 80.2 3.3 10.7 2.3 6.7 17.4 0.0 6.6 5.8 13.3 7.9 0.0 18.7 55.9 6.4 3.4 17.2 82.1 2.0 14.7 93.6 0.0 89.2 3.2 8.2 13.8 7.0 8.9 17.4 9.1 19.4 8.9 30.6 5.1 33.5 36.0 8.3 3.5 4.2 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724462-38729372 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 38.3" "Cell type enriched" "Detected in some" 14 "Horizontal cells: 55.6" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 1.9" "Group enriched" "Detected in some" 12 "MOLT-4: 5.5;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported NA NA "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 1.0 1.1 4.6 1.0 38.3 1.5 1.0 4.9 25.8 1.0 1.0 0.8 0.0 1.0 1.0 1.0 1.0 1.1 1.0 1.0 3.9 9.7 1.0 1.0 1.0 1.0 4.4 6.8 1.0 1.1 1.0 4.1 1.0 10.4 1.0 1.0 0.7 1.0 1.0 1.0 1.0 1.1 1.0 4.4 1.0 1.0 1.6 7.9 0.0 1.0 0.0 1.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 4.6 38.3 4.9 11.9 3.9 9.7 4.4 6.8 10.4 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 SLC34A1 "NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2" ENSG00000131183 "Solute carrier family 34 member 1" Q06495 5 177379235-177398848 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "kidney: 94.5" "Cell type enriched" "Detected in some" 16 "Proximal tubular cells: 128.7" "Cancer enriched" "Detected in single" 12 "renal cancer: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Group enriched" "Detected in some" 12 "HEL: 6.7;U-937: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051255, HPA077175" Approved Approved "Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol" Yes NA "Nuclear speckles, Plasma membrane" "Nucleoplasm, Mitotic spindle, Cytosol" "HPA051255: AB_2681409, HPA077175: " "unprognostic (1.17e-1)" "unprognostic (3.33e-3)" "unprognostic (1.49e-1)" "unprognostic (3.49e-2)" "unprognostic (1.56e-3)" "unprognostic (2.28e-1)" "unprognostic (4.50e-2)" "unprognostic (4.43e-3)" "unprognostic (1.91e-1)" "unprognostic (1.14e-1)" "unprognostic (5.95e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (2.01e-1)" "unprognostic (1.28e-2)" "unprognostic (4.66e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.2 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 7.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SLC34A2 NAPI-3B ENSG00000157765 "Solute carrier family 34 member 2" O95436 4 25648011-25678748 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lung: 259.9;seminal vesicle: 69.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 585.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 81 "BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037989, HPA066474" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA037989: AB_10670536, HPA066474: " "unprognostic (1.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.38e-1)" "unprognostic (4.25e-2)" "unprognostic (7.33e-2)" "unprognostic (9.83e-2)" "unprognostic (2.37e-2)" "unprognostic (6.60e-3)" "unprognostic (6.27e-2)" "unprognostic (1.89e-2)" "unprognostic (5.77e-2)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (3.25e-1)" "unprognostic (6.75e-2)" "unprognostic (2.57e-2)" "unprognostic (1.93e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 3.2 0.2 0.1 13.0 0.1 0.0 24.7 2.9 6.9 2.1 0.5 13.0 3.4 0.1 0.1 0.1 10.8 0.5 259.9 0.0 0.1 0.0 2.9 4.4 0.0 0.6 2.6 0.8 0.3 0.0 1.6 27.4 69.1 0.1 0.7 2.1 0.0 0.1 0.1 0.4 0.5 0.0 0.4 27.9 0.1 1.9 0.0 0.1 0.4 0.2 1.9 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 1.9 0.5 0.2 0.3 0.3 0.1 0.2 0.1 0.1 0.0 0.4 0.3 0.2 1.5 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.8 0.0 443.7 1050.6 0.0 0.1 0.0 0.0 0.6 40.8 125.8 178.6 19.2 0.0 1.6 5.0 57.7 3.5 0.0 0.0 0.0 7.1 0.0 0.0 3.5 26.7 0.0 0.2 0.0 0.0 0.0 0.0 14.0 1.1 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.1 SLC34A3 "FLJ38680, NPTIIc" ENSG00000198569 "Solute carrier family 34 member 3" Q8N130 9 137230757-137236554 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 10.4;kidney: 14.8" "Cell type enriched" "Detected in some" 12 "Proximal tubular cells: 20.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA023776 Enhanced NA NA "HPA023776: AB_1857102" "unprognostic (2.69e-1)" "unprognostic (4.16e-1)" "unprognostic (9.08e-3)" "unprognostic (1.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-3)" "unprognostic (1.75e-2)" "unprognostic (1.05e-2)" "unprognostic (9.84e-3)" "unprognostic (2.05e-2)" "unprognostic (2.20e-2)" "unprognostic (5.94e-2)" "unprognostic (1.94e-2)" "unprognostic (9.12e-2)" "unprognostic (5.80e-2)" "unprognostic (2.20e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 3.6 0.5 0.2 0.2 0.2 0.0 14.8 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 1.6 0.2 0.2 0.2 0.0 0.2 1.2 0.2 0.2 0.3 10.4 0.2 0.2 0.2 0.4 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.7 0.7 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 6.0 0.4 0.2 0.0 0.1 3.0 0.0 0.0 0.0 3.7 0.2 0.0 4.0 2.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.4 0.7 0.0 9.7 0.1 0.1 0.6 1.1 1.2 1.3 0.5 0.0 0.0 0.5 0.0 1.5 0.6 1.4 0.3 0.7 3.4 0.1 0.4 0.5 0.4 1.9 0.1 1.1 0.5 0.4 0.8 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35C1 "FLJ11320, FUCT1" ENSG00000181830 "Solute carrier family 35 member C1" Q96A29 11 45804072-45813015 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.7" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 49.8;Enterocytes: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064001 Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA064001: AB_2685171" "unprognostic (2.62e-2)" "unprognostic (5.16e-2)" "unprognostic (7.82e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (8.22e-2)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "unprognostic (4.09e-2)" "unprognostic (2.73e-1)" "unprognostic (7.68e-2)" "unprognostic (1.83e-3)" "unprognostic (2.18e-1)" "prognostic favorable (3.64e-4)" "unprognostic (2.30e-2)" 14.9 4.8 5.1 7.2 4.5 1.5 14.3 4.4 7.3 7.0 13.8 4.4 4.9 17.4 7.1 3.2 22.5 6.1 8.8 5.3 5.4 3.9 6.0 74.7 7.1 7.1 3.9 3.6 4.9 11.4 4.9 7.8 10.5 5.6 6.0 9.8 3.6 15.5 7.0 8.5 3.4 17.4 6.8 5.0 6.5 13.4 7.4 4.8 5.6 5.2 7.0 10.9 9.4 8.6 4.7 8.3 9.9 10.5 4.3 16.7 8.6 5.2 13.7 3.1 8.0 10.2 10.3 10.5 11.6 10.0 6.7 7.5 6.2 8.7 5.0 5.5 13.1 10.0 14.0 6.5 6.8 3.2 13.0 7.8 2.8 11.0 11.2 22.4 5.5 8.7 12.3 8.2 5.1 5.6 8.1 8.8 5.1 6.3 7.5 7.1 11.5 2.8 4.2 13.9 19.4 19.4 3.8 5.2 11.8 7.5 13.3 3.1 4.5 8.6 8.3 4.7 3.4 7.4 2.9 13.3 14.1 8.2 24.8 8.2 5.5 12.9 2.5 10.1 7.2 7.7 5.0 10.2 9.9 10.2 10.5 11.1 4.7 16.7 13.4 8.3 3.6 8.5 7.4 1.6 4.3 6.9 7.2 10.8 8.6 5.1 4.5 4.4 7.3 5.4 3.9 3.9 3.6 5.6 4.8 0.0 9.1 3.0 8.5 3.2 1.7 49.8 25.5 8.1 4.5 5.2 2.0 12.0 0.0 18.1 3.4 7.6 46.6 0.0 37.1 12.3 11.0 8.0 2.3 37.2 13.3 3.2 9.2 6.7 7.1 4.1 6.1 5.3 1.7 9.0 30.4 2.5 36.3 43.2 5.3 3.5 1.0 0.0 5.2 4.3 3.3 2.0 12.8 5.2 19.9 16.9 SLC35D1 "KIAA0260, UGTREL7" ENSG00000116704 "Solute carrier family 35 member D1" Q9NTN3 1 66999332-67054099 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 84.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.91e-2)" "unprognostic (3.69e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.63e-1)" "unprognostic (6.53e-2)" "unprognostic (2.49e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (2.12e-3)" "unprognostic (6.39e-2)" "unprognostic (6.75e-2)" "unprognostic (2.07e-1)" "unprognostic (7.65e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.08e-3)" "unprognostic (3.20e-1)" 4.0 6.3 5.1 7.5 7.0 4.7 4.7 6.6 5.5 6.2 16.2 7.5 4.8 9.9 5.4 3.8 5.3 4.4 4.4 3.8 4.7 3.8 8.1 50.4 3.8 5.7 7.4 4.0 6.4 7.2 6.4 8.7 6.0 5.4 5.6 17.3 7.1 3.9 4.0 6.9 6.2 14.3 5.4 4.0 4.0 8.0 4.1 5.6 11.1 5.1 4.0 6.4 5.8 6.5 2.3 1.8 9.7 2.4 5.1 4.3 1.4 5.0 2.9 8.9 7.5 9.3 10.8 10.6 11.3 15.0 8.2 5.8 6.2 1.2 15.6 5.0 8.9 9.7 7.7 6.1 7.2 10.4 15.5 2.8 11.6 6.1 12.2 7.8 13.1 7.7 10.5 16.1 9.7 6.9 13.3 3.1 6.6 7.0 8.3 19.9 1.7 8.0 4.1 3.7 13.6 4.0 6.2 18.4 1.7 3.8 9.6 1.1 4.0 17.1 5.3 7.2 5.2 4.4 9.8 3.4 15.4 3.6 9.4 10.8 17.4 9.0 8.7 11.0 2.0 6.5 9.7 1.5 4.0 3.4 1.1 4.2 2.3 2.6 2.7 1.8 1.7 3.7 3.3 0.3 5.1 2.4 1.0 4.3 1.4 5.1 7.0 6.6 5.5 4.7 3.8 7.4 4.0 5.4 5.6 6.0 2.1 4.3 4.7 4.8 6.9 2.6 33.1 6.7 2.3 5.2 11.8 30.4 0.0 2.8 37.3 4.2 36.7 23.3 8.6 4.0 7.2 5.6 4.6 84.4 6.2 6.4 14.5 6.7 9.2 6.6 5.8 3.8 1.7 1.0 14.9 21.0 7.2 14.4 4.2 8.4 8.7 0.0 3.9 7.6 6.7 6.8 13.6 6.9 13.4 7.4 SLC35D3 FRCL1 ENSG00000182747 "Solute carrier family 35 member D3" Q5M8T2 6 136922264-136925639 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;retina: 16.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.3" "Group enriched" "Detected in some" 4 "basal ganglia: 9.9;hypothalamus: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 18.7" "Group enriched" "Detected in many" 5 "basal ganglia: 26.6;olfactory region: 10.4" "Region enriched" "Detected in many" 6 "basal ganglia: 24.4" "HPA030431, HPA067497" Uncertain Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA030431: AB_10601716, HPA067497: AB_2685854" "unprognostic (6.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (5.45e-2)" "unprognostic (1.08e-1)" "unprognostic (5.84e-2)" "unprognostic (2.48e-1)" "unprognostic (9.94e-2)" "unprognostic (7.36e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.62e-1)" "unprognostic (4.45e-1)" "unprognostic (1.03e-1)" 0.1 4.9 0.0 0.4 9.9 1.2 0.1 0.0 0.4 2.0 0.4 0.4 0.0 0.7 0.1 0.0 0.6 0.1 0.1 0.4 0.0 4.8 4.0 0.0 2.1 0.0 1.7 0.0 0.8 1.2 0.0 0.0 0.1 0.5 4.3 0.6 16.4 0.2 0.1 0.0 0.2 1.3 0.3 0.0 0.2 3.2 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 18.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 9.9 0.0 0.4 0.0 4.8 1.7 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 SLC35E4 ENSG00000100036 "Solute carrier family 35 member E4" Q6ICL7 22 30635652-30669016 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 20.2;testis: 22.5" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 93.5;Late spermatids: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049558 Approved Approved Cytosol NA NA Cytosol "HPA049558: AB_2680817" "unprognostic (2.09e-1)" "unprognostic (1.88e-1)" "unprognostic (2.05e-1)" "unprognostic (1.01e-2)" "unprognostic (4.99e-2)" "unprognostic (2.04e-1)" "unprognostic (3.03e-4)" "unprognostic (5.71e-2)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-2)" "unprognostic (2.39e-2)" "unprognostic (3.45e-7)" "unprognostic (2.77e-3)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (8.05e-3)" 4.0 2.5 5.6 3.3 11.8 3.4 2.6 4.0 11.4 2.7 5.9 8.1 2.1 2.7 4.2 3.5 4.5 3.1 2.9 5.6 5.2 4.7 2.0 1.1 2.4 2.1 13.0 6.3 2.8 4.1 3.1 2.8 1.6 6.6 2.9 4.2 2.4 2.6 3.5 20.2 7.3 2.5 3.5 2.6 2.4 3.8 22.5 10.1 0.0 2.0 6.6 2.1 3.6 7.6 0.7 3.6 1.6 2.8 2.1 3.2 0.9 6.5 2.9 1.1 2.2 3.0 7.7 0.6 4.3 3.8 3.0 2.8 0.2 1.8 0.4 2.3 4.4 4.2 4.2 1.9 2.5 1.5 15.0 2.1 0.1 2.1 0.2 4.3 0.3 1.8 2.4 1.1 11.9 3.7 4.7 10.1 0.5 0.6 2.0 4.6 1.9 0.2 1.3 1.3 1.9 10.9 1.2 2.2 0.2 1.4 0.5 6.0 2.3 4.4 1.9 2.1 0.5 1.3 0.5 13.4 12.7 4.0 14.5 4.1 0.6 0.5 0.2 15.5 0.2 3.3 1.6 2.1 0.3 0.9 2.8 1.4 0.3 2.1 3.2 3.6 0.7 2.1 1.7 0.8 2.1 2.2 1.0 2.3 0.9 5.6 11.8 4.0 11.4 5.2 4.7 13.0 6.3 6.6 10.1 0.0 1.0 0.9 2.0 12.9 8.8 1.6 0.0 8.1 1.2 1.8 21.6 0.0 0.0 3.2 93.5 4.9 2.6 0.0 2.1 0.4 3.7 1.5 1.1 0.0 1.7 11.1 2.4 4.9 0.3 68.4 3.1 4.5 3.3 2.8 2.6 17.3 1.9 5.7 3.5 0.3 9.3 0.0 4.1 21.8 3.4 16.7 0.1 2.5 4.4 1.4 SLC35F1 "C6orf169, dJ230I3.1" ENSG00000196376 "Solute carrier family 35 member F1" Q5T1Q4 6 117907526-118317676 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 41.9" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9" "Group enriched" "Detected in some" 16 "glioma: 15.1;melanoma: 3.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "AF22: 23.9;WM-115: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019576 Enhanced Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA Nucleoplasm "Centriolar satellite, Cytosol" "HPA019576: AB_2190216" "unprognostic (1.46e-1)" "unprognostic (5.67e-2)" "unprognostic (7.08e-2)" "unprognostic (1.37e-3)" "unprognostic (3.31e-1)" "unprognostic (4.99e-2)" "unprognostic (1.39e-1)" "unprognostic (4.04e-1)" "unprognostic (3.64e-2)" "unprognostic (3.04e-2)" "unprognostic (4.44e-3)" "unprognostic (2.19e-1)" "unprognostic (8.83e-4)" "unprognostic (3.04e-3)" "unprognostic (6.03e-2)" "unprognostic (8.32e-2)" "unprognostic (2.02e-1)" 2.8 2.7 13.8 2.1 14.5 0.9 1.2 3.6 41.9 1.7 3.5 4.3 0.0 1.6 2.7 5.5 1.8 1.5 1.8 5.3 10.4 10.2 1.7 1.0 1.1 1.0 9.3 15.3 1.4 1.4 1.0 0.6 1.0 5.6 2.3 2.3 2.6 1.7 2.9 1.2 1.6 1.8 2.6 4.1 1.6 1.4 1.8 5.6 0.0 1.8 0.0 1.0 1.4 2.6 0.2 0.6 1.0 0.1 0.3 0.9 0.1 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.2 0.0 2.9 3.4 0.0 0.0 0.1 0.0 40.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 1.0 0.3 0.0 0.6 0.0 0.1 13.8 14.5 3.6 17.4 10.4 10.2 9.3 15.3 5.6 5.6 0.0 0.0 0.0 0.0 0.3 11.0 4.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.2 0.9 0.0 0.0 0.1 15.9 0.0 0.0 0.0 17.4 0.6 0.0 13.5 0.0 0.0 27.9 0.0 0.0 1.1 0.0 1.8 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 SLC35F2 FLJ13018 ENSG00000110660 "Solute carrier family 35 member F2" Q8IXU6 11 107790991-107928293 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 43.2" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 54.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048185, HPA050695, HPA060150" Enhanced Approved Mitochondria NA NA Mitochondria "HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: " "unprognostic (7.73e-2)" "unprognostic (3.28e-3)" "unprognostic (8.37e-3)" "unprognostic (5.77e-2)" "unprognostic (1.38e-3)" "unprognostic (3.07e-2)" "unprognostic (7.26e-2)" "prognostic unfavorable (4.03e-4)" "unprognostic (6.22e-2)" "unprognostic (8.20e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (1.24e-1)" "unprognostic (4.10e-2)" "unprognostic (1.34e-1)" "unprognostic (7.33e-2)" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" 3.0 2.5 2.4 7.4 2.2 1.3 2.7 2.1 2.4 7.4 8.1 1.8 3.8 8.4 2.6 4.8 5.0 6.2 5.9 2.4 3.7 2.6 5.6 2.0 4.0 7.7 2.4 2.2 3.4 3.4 0.3 2.6 9.7 1.9 10.6 9.8 5.2 43.2 2.7 2.3 8.5 7.4 1.8 4.2 2.7 2.8 3.7 2.3 1.8 3.2 6.7 6.9 3.4 3.7 9.3 5.9 0.5 0.2 2.9 11.2 1.6 8.5 5.6 0.6 7.9 4.7 7.0 8.1 2.0 1.1 5.3 6.8 24.2 9.0 14.2 20.3 5.9 28.6 17.9 11.3 18.1 10.5 11.8 10.4 7.9 5.5 10.0 7.7 18.5 4.0 4.8 10.5 17.5 37.9 15.9 27.6 11.3 20.7 5.9 3.7 5.1 7.6 17.8 6.0 18.9 54.7 15.5 7.2 18.6 28.3 7.8 13.8 5.8 6.4 14.9 3.9 7.9 11.0 3.9 20.5 9.7 16.1 0.2 20.4 15.4 17.4 15.6 6.2 5.9 6.3 0.1 0.2 0.0 2.8 0.1 7.3 9.3 4.8 4.9 5.9 6.1 1.8 2.5 0.5 2.9 0.0 0.3 11.2 1.6 2.4 2.2 2.1 2.4 3.7 2.6 2.4 2.2 1.9 2.3 8.9 1.0 11.1 30.1 40.9 1.1 0.5 0.0 0.0 15.9 3.5 11.8 0.7 3.3 10.1 0.3 5.8 14.0 0.0 7.2 13.5 5.1 19.0 2.3 0.0 5.0 0.0 5.8 0.0 0.8 0.9 0.9 3.9 21.9 6.4 10.2 1.3 17.0 10.5 2.5 5.5 7.5 6.5 4.1 0.3 4.9 44.0 3.8 2.5 22.6 15.2 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904933-234324516 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in some" 9 "Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 49 "plasmacytoid DC: 7.1" "Lineage enriched" "Detected in single" 69 "dendritic cells: 7.1" "Cell line enriched" "Detected in some" 7 "HDLM-2: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.8 3.5 4.6 1.3 26.0 0.7 6.8 25.1 16.7 1.4 0.8 0.5 0.0 0.8 1.0 2.5 1.6 1.7 0.8 0.6 5.4 4.6 1.6 0.6 1.2 2.4 4.8 6.6 0.6 3.6 4.6 2.8 0.7 4.1 2.0 0.8 0.0 6.6 1.1 1.1 0.8 0.9 1.1 4.8 1.0 2.5 1.1 4.3 0.5 1.9 0.3 1.9 0.8 0.6 0.0 7.1 0.0 0.1 0.0 0.0 0.0 1.4 3.9 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.1 0.3 0.0 3.6 0.0 49.4 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.4 0.0 0.0 0.0 3.6 0.0 2.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 4.6 26.0 25.1 11.6 5.4 4.6 4.8 6.6 4.1 4.3 0.0 0.0 0.0 2.4 0.3 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.8 0.6 0.0 0.0 0.0 3.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.0 SLC35F4 "C14orf36, FLJ37712" ENSG00000151812 "Solute carrier family 35 member F4" A4IF30 14 57563922-57982194 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 29.5;seminal vesicle: 10.5" "Cell type enhanced" "Detected in some" 24 "Cone photoreceptor cells: 3.9;Early spermatids: 5.9;Peritubular cells: 2.8;Rod photoreceptor cells: 14.2" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "cerebellum: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.5;U-87 MG: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043853 Uncertain Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA043853: AB_10963083" "unprognostic (2.37e-1)" "unprognostic (2.10e-1)" "unprognostic (3.56e-1)" "unprognostic (2.66e-4)" "unprognostic (4.88e-2)" "unprognostic (8.64e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-2)" "unprognostic (3.94e-2)" "unprognostic (1.39e-1)" "unprognostic (4.03e-3)" "unprognostic (3.50e-2)" "unprognostic (1.05e-2)" "unprognostic (9.68e-3)" "unprognostic (9.23e-2)" 0.1 0.1 1.2 0.1 4.9 0.1 0.1 29.5 1.1 1.0 0.2 0.1 0.5 0.2 1.5 0.2 0.1 0.2 0.5 0.1 0.9 2.2 0.4 0.1 0.1 0.1 0.8 1.2 0.3 0.1 0.1 0.2 0.1 2.9 3.5 0.1 2.4 0.1 10.5 0.1 0.1 0.4 1.1 1.3 0.1 0.1 2.7 0.7 0.0 2.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 29.5 1.1 0.9 2.2 0.8 1.2 2.9 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 2.8 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35G1 "C10orf60, FLJ33990, TMEM20" ENSG00000176273 "Solute carrier family 35 member G1" Q2M3R5 10 93893973-93956062 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 73.5;retina: 24.6" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 34.2;Peritubular cells: 34.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.6;T-cells: 3.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.94e-2)" "unprognostic (1.90e-1)" "unprognostic (9.48e-2)" "unprognostic (1.65e-1)" "unprognostic (7.90e-4)" "unprognostic (8.89e-2)" "unprognostic (9.01e-3)" "unprognostic (1.15e-2)" "unprognostic (9.47e-2)" "unprognostic (7.90e-2)" "unprognostic (2.09e-1)" "unprognostic (4.30e-2)" "unprognostic (1.65e-2)" "unprognostic (2.29e-3)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" "unprognostic (2.30e-1)" 1.4 1.7 0.7 2.7 1.9 0.5 1.1 1.2 1.4 1.0 29.0 0.8 0.7 52.2 1.9 0.9 2.2 1.1 1.1 2.4 0.8 0.6 0.8 5.1 1.1 1.5 0.6 1.0 1.9 11.6 1.0 3.7 0.9 4.5 1.1 4.7 24.6 2.1 0.9 1.3 2.2 73.5 1.9 0.7 1.4 3.3 4.4 0.4 1.5 2.1 1.6 1.0 1.4 1.5 0.6 0.3 2.6 0.4 0.0 3.8 1.0 7.9 7.7 3.6 4.4 1.1 3.3 5.3 7.3 8.4 6.3 8.5 6.0 5.9 5.1 3.1 4.5 4.7 14.0 8.0 2.6 10.5 6.6 9.2 4.1 4.7 4.7 1.9 7.9 8.2 3.2 2.6 5.4 3.1 2.2 2.8 4.4 3.8 3.1 4.3 2.6 3.9 1.4 4.8 2.7 9.8 0.0 6.1 2.0 3.2 7.1 4.5 4.2 9.7 4.6 5.7 3.3 5.0 2.3 3.8 5.4 9.1 9.3 7.1 3.6 3.4 1.8 3.4 0.0 3.8 0.0 0.4 2.6 0.4 0.4 1.6 0.4 3.0 1.8 0.3 0.6 3.2 2.0 0.2 0.0 0.0 0.3 3.8 1.0 0.7 1.9 1.2 1.4 0.8 0.6 0.6 1.0 4.5 0.4 3.0 3.8 0.5 1.9 2.7 3.9 2.8 5.1 1.4 1.2 7.0 3.9 2.7 3.3 2.4 15.6 3.5 34.2 0.0 8.3 5.0 3.5 1.0 0.0 5.5 1.9 1.6 4.1 4.9 3.7 6.8 15.8 0.7 5.0 3.6 3.6 5.0 3.0 10.2 34.3 1.3 2.4 0.0 1.7 7.7 8.3 1.6 0.7 2.2 4.3 1.6 SLC35G3 "AMAC1, FLJ40154, TMEM21A" ENSG00000164729 "Solute carrier family 35 member G3" Q8N808 17 35192520-35194523 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.1;skeletal muscle: 1.4;testis: 6.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 16.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.1" "Lineage enriched" "Detected in single" 31 "T-cells: 3.1" "Not detected" "Not detected" NA NA "unprognostic (1.88e-1)" "unprognostic (2.67e-1)" "unprognostic (6.17e-3)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 3.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 SLC35G4 "AMAC1L1, SLC35G4P" ENSG00000236396 "Solute carrier family 35 member G4" P0C7Q5 18 11609596-11610612 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC35G5 "AMAC, AMAC1L2" ENSG00000177710 "Solute carrier family 35 member G5" Q96KT7 8 11330888-11332208 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 5.5" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 8.2;Rod photoreceptor cells: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "TIME: 2.4" NA NA "unprognostic (7.00e-2)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (9.67e-2)" "unprognostic (2.60e-4)" "unprognostic (6.48e-3)" "unprognostic (4.09e-1)" "unprognostic (5.79e-2)" "unprognostic (1.06e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-2)" "unprognostic (3.44e-1)" "unprognostic (2.06e-6)" "unprognostic (7.88e-2)" "unprognostic (1.63e-1)" "unprognostic (2.34e-1)" "unprognostic (2.04e-3)" 0.0 0.2 0.4 0.7 0.5 1.3 0.0 0.5 0.4 0.3 0.6 0.1 0.2 0.2 0.4 0.2 0.5 1.1 0.5 0.6 0.5 0.3 0.5 0.8 0.6 0.2 0.9 0.0 0.8 0.1 1.1 0.2 0.3 0.0 1.9 1.2 0.6 0.1 0.5 1.4 0.5 5.5 0.6 0.5 0.3 0.4 0.4 1.7 0.1 0.8 0.0 2.1 0.0 0.3 0.0 0.2 0.8 0.7 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.3 0.2 0.8 0.8 0.3 0.6 0.1 0.2 0.2 0.4 0.1 0.5 1.5 0.1 0.0 0.1 0.8 1.1 0.4 0.0 0.0 0.3 0.1 0.7 0.8 0.7 1.1 0.8 0.3 0.3 0.5 0.4 0.7 0.6 0.5 0.6 0.1 0.7 0.9 1.4 1.6 0.1 0.2 0.5 0.5 0.0 2.4 0.5 0.8 0.7 0.3 0.5 0.6 1.0 0.3 0.4 0.7 0.1 0.3 0.0 2.1 0.1 0.2 0.0 0.8 0.0 0.6 0.4 0.4 0.1 0.1 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.2 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.4 1.6 0.0 1.8 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.3 0.3 0.0 0.4 0.0 3.2 0.0 0.0 1.1 0.4 0.1 0.0 0.0 0.4 0.3 SLC35G6 "AMAC1L3, TMEM21B" ENSG00000259224 "Solute carrier family 35 member G6" P0C7Q6 17 7481332-7483496 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 8.5" "Cell type enriched" "Detected in some" 6 "Early spermatids: 26.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.1;HeLa: 3.7;U-138 MG: 1.2" NA NA "unprognostic (3.81e-2)" "unprognostic (5.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.11e-3)" "unprognostic (1.37e-2)" "unprognostic (1.65e-3)" "unprognostic (3.29e-1)" "unprognostic (9.19e-3)" "unprognostic (1.69e-1)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (5.21e-2)" "unprognostic (3.79e-2)" "unprognostic (2.01e-2)" 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.0 0.0 0.0 1.1 0.9 1.1 0.3 0.0 0.3 0.0 0.0 0.7 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.1 3.7 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 1.2 0.1 0.6 0.4 0.1 0.2 0.1 0.4 0.2 0.1 0.0 0.3 0.0 0.1 0.2 0.1 0.0 0.3 0.0 0.1 1.1 0.3 0.1 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 1.0 0.3 0.1 0.0 0.0 0.0 0.0 SLC36A1 "LYAAT-1, PAT1, TRAMD3" ENSG00000123643 "Solute carrier family 36 member 1" Q7Z2H8 5 151437046-151492381 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.3" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 49.3;Enterocytes: 37.0;Kupffer cells: 22.4;Late spermatids: 21.6;Paneth cells: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5" "Group enriched" "Detected in many" 5 "granulocytes: 15.9;monocytes: 6.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035937 Approved NA NA "HPA035937: AB_10672995" "unprognostic (5.49e-2)" "unprognostic (4.04e-2)" "unprognostic (1.24e-1)" "unprognostic (8.27e-3)" "unprognostic (1.91e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (6.30e-5)" "unprognostic (1.86e-1)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (5.08e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.83e-6)" "unprognostic (2.66e-2)" "unprognostic (1.03e-2)" "unprognostic (2.49e-1)" "unprognostic (1.42e-1)" 5.6 4.7 5.1 6.0 11.1 19.3 4.4 43.3 15.3 3.8 11.1 5.0 11.6 32.5 4.6 3.8 5.4 3.8 8.3 3.7 4.2 4.1 7.3 3.5 6.0 4.5 6.0 6.8 4.0 6.5 32.1 6.3 4.4 13.9 9.9 17.5 4.1 5.1 7.6 7.6 3.9 28.7 5.2 4.1 9.2 4.8 11.2 5.0 7.1 3.7 3.6 4.2 7.2 4.5 1.7 2.1 15.9 6.6 0.3 1.9 0.8 3.9 6.8 3.6 2.4 9.0 6.6 19.3 11.5 6.4 8.0 9.0 15.6 5.8 9.1 6.8 13.7 8.5 9.7 11.3 7.1 7.9 2.5 9.8 2.8 11.1 5.2 11.6 6.7 15.5 4.8 8.3 6.7 4.4 2.2 7.0 5.0 6.4 8.0 6.7 4.3 1.9 3.4 3.5 4.9 6.4 0.0 8.6 3.6 2.1 5.9 3.2 6.2 7.1 8.6 4.1 7.6 6.5 9.8 7.0 10.7 6.0 17.3 6.4 3.8 5.3 5.9 6.8 11.8 7.0 15.9 6.6 2.5 1.2 2.8 0.8 1.6 1.1 1.9 2.1 1.7 0.9 0.8 14.5 0.3 2.8 0.4 1.1 0.8 5.1 11.1 43.3 15.3 4.2 4.1 6.0 6.8 13.9 5.0 0.0 1.7 0.0 1.0 1.3 1.2 2.2 7.6 0.0 1.2 1.8 2.0 0.5 0.0 1.6 49.3 1.0 37.0 0.0 1.7 7.2 2.3 2.8 1.1 1.7 12.1 1.6 0.0 4.9 22.4 21.6 4.6 3.8 1.7 1.0 6.1 0.8 1.6 21.0 11.0 3.9 0.8 0.0 1.9 0.5 1.9 1.1 0.2 2.1 6.9 1.8 SLC36A2 "PAT2, TRAMD1, tramdorin" ENSG00000186335 "Solute carrier family 36 member 2" Q495M3 5 151314978-151347590 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 44.0" "Cancer enriched" "Detected in single" 9 "renal cancer: 0.5" "Region enhanced" "Detected in single" "midbrain: 1.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.9;NB-4: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA044002, HPA062229" Enhanced NA NA "HPA044002: AB_10964214, HPA062229: AB_2684717" "unprognostic (3.47e-1)" "unprognostic (3.40e-1)" "unprognostic (2.26e-2)" "unprognostic (6.23e-2)" "unprognostic (8.38e-3)" "unprognostic (4.66e-3)" "unprognostic (3.03e-1)" "unprognostic (7.73e-2)" "unprognostic (1.92e-2)" "unprognostic (2.11e-1)" "unprognostic (1.92e-1)" "unprognostic (1.20e-3)" "unprognostic (1.43e-1)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (3.89e-2)" 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 2.6 0.5 0.1 0.0 0.2 0.1 0.1 60.3 0.1 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 1.1 2.0 0.0 36.8 0.1 0.1 0.0 0.2 0.1 0.1 0.7 0.0 0.0 0.1 16.1 1.4 0.1 0.1 2.1 1.5 4.3 0.8 1.5 0.9 0.3 0.1 0.3 0.4 0.7 0.3 0.1 1.0 0.4 0.0 0.1 0.0 0.6 0.3 0.8 0.3 0.2 0.3 0.4 0.0 0.7 0.0 1.5 1.5 0.3 0.8 0.3 0.0 1.9 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.1 1.4 0.2 0.3 0.4 2.0 1.2 0.0 0.2 0.5 0.4 0.2 0.2 0.1 0.4 0.4 0.1 1.2 0.0 0.2 0.3 0.3 0.5 0.2 0.2 1.2 0.2 0.5 0.2 0.4 0.3 0.3 0.1 3.2 0.8 0.9 0.7 0.6 0.6 1.1 0.6 0.6 0.2 2.1 0.7 0.9 4.3 1.5 0.6 1.5 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC36A3 "PAT3, TRAMD2, tramdorin2" ENSG00000186334 "Solute carrier family 36 member 3" Q495N2 5 151276762-151303766 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "testis: 14.5" "Group enriched" "Detected in some" 57 "Early spermatids: 47.0;Late spermatids: 85.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (5.41e-1)" "unprognostic (5.38e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-1)" "unprognostic (2.20e-2)" "unprognostic (3.98e-1)" "unprognostic (2.57e-2)" "unprognostic (2.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SLC37A1 ENSG00000160190 "Solute carrier family 37 member 1" P57057 21 42496008-42581440 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 45.9" "Group enriched" "Detected in many" 4 "Early spermatids: 254.9;Late spermatids: 218.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 48.5;MCF7: 19.3;OE19: 20.9;SK-BR-3: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030418, CAB034154" Approved NA NA "CAB034154: AB_2190373, HPA030418: AB_10601602" "unprognostic (1.44e-2)" "unprognostic (2.93e-2)" "unprognostic (2.12e-1)" "prognostic favorable (9.22e-5)" "unprognostic (1.59e-2)" "unprognostic (1.42e-1)" "unprognostic (1.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-1)" "unprognostic (7.99e-2)" "unprognostic (5.94e-2)" "unprognostic (1.86e-2)" "unprognostic (2.16e-1)" "unprognostic (4.08e-2)" "unprognostic (7.94e-2)" "prognostic favorable (3.43e-5)" "unprognostic (1.61e-2)" 4.7 6.6 7.2 15.8 5.3 7.5 7.3 8.0 6.1 6.3 28.6 2.7 5.1 31.0 2.4 10.6 9.8 6.9 18.4 2.3 3.4 4.9 4.7 4.0 8.0 6.1 3.5 4.6 3.9 4.8 2.2 14.0 9.7 3.9 10.8 13.7 5.5 14.5 9.0 6.4 4.6 45.9 3.0 7.1 7.0 16.7 16.8 3.3 9.3 9.3 4.4 16.2 7.1 5.9 7.8 13.1 23.0 10.5 4.1 6.7 4.0 5.2 2.1 0.5 1.0 0.0 0.1 4.6 0.2 0.0 0.2 0.1 1.2 10.7 3.7 5.5 0.0 3.3 2.1 1.0 2.7 0.0 1.7 2.6 48.5 1.8 0.1 1.3 1.0 4.8 0.2 1.6 0.0 0.1 0.0 1.6 4.2 0.9 5.2 0.0 19.3 3.6 2.6 3.7 20.9 1.2 3.7 0.0 0.1 4.5 10.0 5.7 0.7 3.1 16.9 1.2 0.5 6.3 5.4 2.8 0.0 1.0 0.0 0.0 10.0 6.1 3.6 0.0 8.0 0.5 2.1 3.2 23.0 5.2 8.6 6.7 7.8 3.6 4.6 4.6 5.4 3.1 4.3 3.8 4.1 10.5 13.1 1.8 4.0 7.2 5.3 8.0 6.1 3.4 4.9 3.5 4.6 3.9 3.3 17.9 23.0 14.6 7.2 1.9 2.7 3.2 20.4 22.7 10.3 12.2 5.9 5.4 0.0 21.7 254.9 4.6 47.1 0.0 27.2 4.9 3.2 22.1 1.1 4.9 7.7 3.2 28.9 4.9 6.4 218.7 6.6 5.1 6.8 21.6 37.8 37.2 27.4 56.0 2.5 1.1 4.1 0.0 3.3 25.0 4.6 1.4 7.2 7.5 35.5 16.1 SLC37A2 FLJ00171 ENSG00000134955 "Solute carrier family 37 member 2" Q8TED4 11 125063067-125090312 "Predicted membrane proteins, Transporters" "Antiport, Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.2;salivary gland: 85.6" "Group enriched" "Detected in many" 7 "Hofbauer cells: 32.3;Kupffer cells: 15.9;Macrophages: 9.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 12 "dendritic cells: 3.7;monocytes: 11.9" "Cell line enhanced" "Detected in some" "A-431: 12.7;CAPAN-2: 27.2;hTCEpi: 12.2;hTERT-HME1: 29.3;U-138 MG: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014948 Uncertain NA NA "HPA014948: AB_2190374" "unprognostic (8.47e-2)" "unprognostic (4.85e-1)" "unprognostic (9.64e-2)" "unprognostic (2.91e-2)" "unprognostic (7.88e-2)" "unprognostic (2.84e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-2)" "unprognostic (1.30e-1)" "unprognostic (2.15e-2)" "unprognostic (3.11e-1)" "unprognostic (6.61e-2)" "unprognostic (1.94e-3)" "unprognostic (1.66e-3)" "unprognostic (7.01e-2)" "unprognostic (3.24e-2)" 7.1 26.4 1.0 47.2 1.4 0.0 3.4 0.4 1.0 2.5 3.6 3.5 0.5 3.7 0.7 2.0 7.2 1.0 2.4 2.3 1.3 0.7 1.0 2.7 7.2 6.4 1.5 0.3 1.8 0.7 0.0 0.6 3.2 1.5 2.0 4.6 2.4 85.6 0.6 0.4 16.3 4.6 1.3 1.7 10.2 0.8 0.7 1.2 1.4 0.6 3.3 3.1 6.6 6.5 0.1 3.7 0.6 11.9 0.0 0.0 3.1 12.7 0.0 0.2 0.0 0.3 0.4 0.0 0.4 1.2 0.4 1.2 0.1 27.2 0.0 3.9 0.1 1.0 6.7 0.2 7.2 1.8 0.3 0.2 2.9 0.2 0.6 0.0 0.0 0.1 0.3 12.2 1.2 29.3 0.7 0.7 0.2 0.1 0.1 1.3 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.9 0.2 0.3 6.6 0.0 0.1 2.3 0.0 0.8 0.2 0.0 0.6 1.5 20.9 0.0 0.2 0.5 0.3 0.4 0.0 0.7 0.7 1.6 0.0 8.0 0.0 0.0 9.9 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.6 0.0 11.9 0.0 0.0 3.1 1.0 1.4 0.4 1.0 1.3 0.7 1.5 0.3 1.5 1.2 0.0 1.1 1.4 1.2 0.2 1.4 0.8 0.0 0.0 2.3 0.0 2.0 0.5 0.0 0.1 1.3 0.8 0.0 0.0 0.0 0.6 0.3 0.8 2.3 0.0 32.3 0.0 0.0 1.8 15.9 1.7 0.9 9.3 0.0 0.0 0.0 0.5 0.1 0.0 1.1 0.0 0.7 0.0 0.4 2.2 1.0 0.6 2.9 0.7 0.0 2.6 SLC37A4 "G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d" ENSG00000137700 "Solute carrier family 37 member 4" 11 119024114-119030906 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.2" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 183.4;Hepatocytes: 134.8;Muller glia cells: 96.7;Proximal tubular cells: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 16.4;HEK 293: 17.3;Hep G2: 21.6;MCF7: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038939, HPA038940" Enhanced Approved Mitochondria NA NA Mitochondria "HPA038939: AB_2676279, HPA038940: AB_2676280" "unprognostic (4.77e-2)" "unprognostic (3.49e-1)" "unprognostic (2.08e-2)" "unprognostic (2.35e-2)" "unprognostic (4.70e-2)" "unprognostic (6.95e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (4.08e-2)" "unprognostic (8.27e-3)" "unprognostic (4.72e-2)" "unprognostic (3.89e-1)" "unprognostic (1.98e-1)" "unprognostic (4.04e-2)" "unprognostic (2.60e-1)" "unprognostic (4.34e-2)" "unprognostic (5.39e-2)" 2.1 3.7 4.8 4.8 3.7 1.4 3.7 7.8 5.9 1.7 5.0 2.7 13.6 26.0 2.6 15.9 2.5 4.0 6.9 4.6 3.7 4.9 29.6 42.2 3.3 4.7 3.7 3.1 3.3 15.5 5.9 2.2 3.3 2.3 4.3 5.3 3.0 4.6 13.6 27.7 2.0 6.7 1.9 3.1 3.4 1.8 4.5 1.4 2.9 3.3 3.3 2.4 1.7 2.3 1.2 0.7 2.7 3.7 2.0 4.1 1.2 0.4 7.2 2.6 1.9 4.7 1.9 1.5 0.2 5.9 1.6 4.1 16.4 1.2 1.8 4.0 2.3 3.4 0.4 1.1 8.2 2.5 2.1 17.3 5.4 1.6 21.6 1.7 3.1 0.9 0.0 2.3 0.8 4.4 6.6 5.4 0.4 2.1 4.8 2.7 15.1 0.1 6.9 0.1 1.6 8.6 4.4 0.0 8.5 1.8 7.6 3.3 3.3 0.0 0.4 2.7 3.5 3.2 2.3 0.0 0.0 2.6 0.1 2.8 0.8 1.3 0.5 0.7 7.9 0.7 0.0 1.9 2.7 3.3 3.7 2.8 1.2 1.9 4.1 0.7 1.1 1.6 2.3 0.0 2.0 1.5 0.2 2.1 1.2 4.8 3.7 7.8 5.9 3.7 4.9 3.7 3.1 2.3 1.4 3.0 5.6 6.7 7.2 1.5 6.4 3.6 183.4 8.1 4.5 15.7 0.0 22.4 26.6 25.4 9.2 6.3 26.5 23.3 22.1 16.5 3.7 9.0 0.0 134.8 24.5 15.9 23.7 21.5 9.1 1.9 8.9 7.0 3.3 16.2 17.5 96.7 18.6 24.6 9.9 134.4 11.0 0.0 4.1 7.1 22.6 2.4 12.7 4.6 37.7 5.1 SLC38A11 "AVT2, FLJ39822" ENSG00000169507 "Solute carrier family 38 member 11" Q08AI6 2 164896186-164955525 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 35.6" "Cell type enhanced" "Detected in some" 27 "Intestinal endocrine cells: 167.1;Sertoli cells: 71.1;Smooth muscle cells: 32.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 7.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 54 "memory B-cell: 2.7;naive B-cell: 7.9" "Lineage enriched" "Detected in single" 79 "B-cells: 7.9" "Cell line enriched" "Detected in some" 9 "BJ hTERT+: 75.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043432 Uncertain NA NA "HPA043432: AB_10793948" "unprognostic (1.52e-1)" "unprognostic (2.59e-1)" "unprognostic (4.14e-1)" "unprognostic (1.41e-1)" "unprognostic (1.41e-1)" "unprognostic (1.69e-2)" "unprognostic (6.28e-3)" "unprognostic (3.53e-2)" "unprognostic (2.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.15e-3)" "unprognostic (1.99e-1)" "prognostic favorable (2.00e-8)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (2.43e-2)" "unprognostic (2.36e-2)" 1.8 3.9 5.1 1.4 8.0 0.4 1.1 1.4 9.7 2.7 1.5 2.7 6.5 5.4 2.1 35.6 1.3 1.2 19.1 1.1 5.6 4.0 7.2 2.5 0.6 2.8 5.8 2.6 0.6 2.7 2.1 11.7 0.5 22.1 9.9 2.7 15.6 1.0 15.9 1.8 0.8 2.6 2.1 2.4 11.2 10.2 1.1 3.2 0.0 2.1 2.9 1.4 2.1 1.5 7.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.7 75.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 8.0 1.4 9.7 5.6 4.0 5.8 2.6 22.1 3.2 0.0 0.0 2.0 0.2 0.0 0.0 0.7 20.4 0.0 0.0 3.5 0.0 0.4 0.0 1.6 1.4 0.0 0.5 0.0 0.5 0.4 0.2 4.0 0.0 3.0 0.0 0.0 167.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 1.2 2.9 0.0 1.9 0.0 71.1 32.0 0.0 0.0 0.3 1.3 0.0 0.4 0.1 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 107.8" "Group enriched" "Detected in many" 7 "Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Cell type enhanced" "Detected in some" "basophil: 5.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Hep G2: 32.4;SCLC-21H: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol NA NA Cytosol Microtubules "HPA031871: AB_2674080" "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 0.7 0.3 3.4 0.3 5.2 0.5 0.7 2.4 10.5 0.3 0.3 10.3 0.0 0.7 0.4 0.4 0.6 0.4 0.4 2.0 4.1 1.5 107.8 0.3 0.4 3.4 4.0 2.4 11.6 1.8 0.7 0.6 7.8 0.4 0.3 22.2 0.9 0.3 10.4 0.5 0.4 0.3 4.7 0.3 0.9 0.7 5.2 0.0 0.6 1.9 0.4 0.3 0.0 1.1 1.0 5.6 0.8 1.5 0.8 0.2 0.0 0.0 0.8 4.9 0.0 0.0 1.3 0.0 0.0 0.9 0.4 2.9 0.1 0.1 0.8 0.0 0.2 0.0 1.3 0.0 0.6 0.1 0.4 0.0 0.6 32.4 0.1 0.3 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.4 0.5 0.1 0.0 0.4 0.3 0.0 0.1 0.2 10.8 0.9 0.5 0.1 0.0 1.5 1.3 0.2 0.0 0.2 0.9 0.0 0.7 0.3 0.0 0.1 0.1 0.2 0.1 5.6 0.8 0.9 0.6 0.2 0.4 0.7 0.5 0.4 0.2 1.1 0.6 0.8 3.3 1.5 0.2 1.0 0.4 0.2 0.0 0.0 1.9 0.1 0.0 86.1 2.8 15.3 0.0 0.0 0.0 176.7 0.2 0.0 0.7 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 93.4 0.1 7.9 3.4 0.0 3.3 0.0 2.0 0.0 0.0 1.0 0.0 75.9 0.8 0.0 0.4 1.4 112.3 0.0 0.0 1.0 1.8 0.0 1.1 0.0 0.0 0.0 SLC38A4 "ATA3, NAT3, PAAT" ENSG00000139209 "Solute carrier family 38 member 4" Q969I6 12 46764761-46832408 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "liver: 128.2" "Cell type enriched" "Detected in some" 16 "Hepatocytes: 251.9" "Cancer enriched" "Detected in many" 14 "liver cancer: 61.0" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 3.0;NK-cell: 1.9" "Group enriched" "Detected in many" 8 "granulocytes: 3.0;NK-cells: 1.9" "Cell line enhanced" "Detected in some" "ASC diff: 8.8;LHCN-M2: 21.7;RH-30: 7.2;RT4: 42.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (3.81e-2)" "unprognostic (7.46e-3)" "unprognostic (5.22e-3)" "unprognostic (1.75e-2)" "unprognostic (3.12e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.37e-4)" "unprognostic (3.06e-2)" "unprognostic (2.57e-3)" "unprognostic (1.75e-2)" "unprognostic (1.95e-1)" "unprognostic (6.06e-2)" "unprognostic (2.84e-2)" "unprognostic (1.89e-2)" "unprognostic (8.28e-2)" "unprognostic (6.31e-3)" "unprognostic (2.21e-2)" 0.2 0.1 0.1 1.4 0.0 0.0 0.1 0.1 0.2 0.1 0.9 0.0 0.3 0.0 1.7 0.1 0.6 0.1 0.3 1.1 0.0 0.0 5.9 128.2 0.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 1.0 0.1 0.4 0.2 0.1 0.3 0.0 2.9 0.4 0.1 1.4 0.0 0.3 0.0 0.2 0.0 0.2 0.2 0.4 0.2 0.7 0.0 0.1 0.3 3.0 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 8.8 1.1 1.7 1.0 2.8 0.9 0.9 0.5 2.0 0.0 1.7 3.7 0.0 0.5 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 21.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.2 0.0 0.0 42.4 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.3 15.3 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.4 1.9 0.4 0.0 251.9 0.4 0.0 0.0 3.1 3.9 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.6 0.0 SLC38A5 "JM24, SN2" ENSG00000017483 "Solute carrier family 38 member 5" Q8WUX1 X 48458537-48470256 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pancreas: 87.7" "Cell type enhanced" "Detected in many" 14 "Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047411 Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Plasma membrane" Cytosol "HPA047411: AB_10964355" "unprognostic (2.81e-1)" "unprognostic (4.87e-2)" "unprognostic (7.92e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-3)" "unprognostic (1.26e-1)" "unprognostic (7.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.52e-1)" "unprognostic (3.80e-3)" "prognostic unfavorable (2.13e-4)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.27e-3)" "unprognostic (1.45e-1)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" 1.5 0.9 5.3 4.7 7.1 17.3 0.9 3.5 11.6 4.0 4.9 7.7 0.1 5.1 1.8 1.3 3.7 2.0 1.5 2.4 6.9 5.7 0.7 0.4 9.4 3.3 7.0 2.7 3.7 87.7 0.4 0.4 2.8 14.6 5.1 6.4 1.5 4.4 3.7 0.4 8.0 3.5 2.8 7.3 4.8 4.5 0.5 4.6 2.4 7.9 3.6 3.4 4.8 3.1 7.4 8.3 0.3 0.4 5.4 16.2 5.7 23.0 0.0 0.0 0.2 0.4 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 24.2 0.0 10.2 0.0 35.6 27.6 54.3 0.0 7.7 0.0 13.1 53.5 16.6 4.0 26.8 0.0 3.8 40.4 0.5 0.1 0.0 0.4 5.9 24.1 47.8 5.4 0.0 5.8 9.3 12.5 0.0 0.1 21.3 0.1 87.9 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.1 0.0 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 8.7 0.2 0.1 0.1 0.0 0.2 0.2 11.5 0.4 16.2 7.4 12.6 10.8 1.5 4.7 6.0 7.7 0.3 5.4 0.0 8.3 13.0 5.7 5.3 7.1 3.5 11.6 6.9 5.7 7.0 2.7 14.6 4.6 0.0 1.1 0.8 1.6 23.7 0.6 0.4 0.0 1.4 0.0 5.2 17.7 0.1 0.0 4.9 0.4 3.1 2.3 23.3 67.4 0.4 5.6 0.9 4.6 0.4 2.5 0.0 0.0 0.0 0.0 0.7 2.3 1.1 8.5 2.8 12.3 0.0 93.7 3.5 1.1 0.0 0.2 0.0 1.0 0.0 0.0 7.4 0.0 8.5 19.1 0.9 SLC38A8 ENSG00000166558 "Solute carrier family 38 member 8" A6NNN8 16 84009667-84042636 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.1;liver: 4.5" "Group enriched" "Detected in some" 8 "Early spermatids: 2.8;Late spermatids: 9.5" "Cancer enriched" "Detected in single" 14 "melanoma: 6.5" "Group enriched" "Detected in some" 5 "amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.5;HMC-1: 2.2;SCLC-21H: 8.7;SK-MEL-30: 1.3;SuSa: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (9.69e-2)" "unprognostic (6.16e-2)" "unprognostic (8.00e-3)" "unprognostic (6.40e-2)" "unprognostic (1.03e-1)" "unprognostic (8.20e-3)" "unprognostic (1.89e-1)" "unprognostic (7.70e-2)" "unprognostic (2.59e-1)" "unprognostic (2.16e-2)" "unprognostic (3.54e-2)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" 0.2 0.1 6.1 0.2 0.6 0.0 0.2 0.2 2.9 0.2 0.2 0.2 0.2 0.3 0.2 2.2 0.2 0.0 0.2 1.4 0.6 2.5 0.2 4.5 0.2 0.2 0.7 0.2 0.2 1.3 0.5 1.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 2.3 2.4 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.1 0.0 0.0 1.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.6 0.2 2.6 0.6 2.5 0.7 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 9.5 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 SLC38A9 FLJ90709 ENSG00000177058 "Solute carrier family 38 member 9" Q8NBW4 5 55625845-55773194 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.2" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 168.8;Early spermatids: 189.6;Syncytiotrophoblasts: 518.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043785, HPA061702" Uncertain Supported Vesicles NA NA Vesicles "HPA043785: AB_10961859, HPA061702: " "unprognostic (4.80e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.49e-1)" "unprognostic (8.19e-2)" "unprognostic (8.35e-2)" "unprognostic (7.95e-2)" "unprognostic (5.47e-2)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" "unprognostic (4.87e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-1)" "unprognostic (2.25e-1)" "unprognostic (2.84e-2)" "unprognostic (1.12e-1)" 7.2 6.3 8.2 6.9 8.0 5.2 6.8 9.9 9.7 6.4 7.5 9.2 6.7 6.6 7.5 5.9 9.0 5.8 7.1 3.9 6.2 6.4 6.7 13.5 6.4 8.4 9.4 6.4 6.9 18.2 10.1 11.8 44.2 8.6 5.9 8.5 6.7 7.6 5.3 5.2 6.2 7.1 7.2 8.8 8.9 7.7 15.8 8.5 13.3 7.1 5.7 11.4 8.7 6.9 10.8 10.8 7.4 11.8 8.9 10.0 6.4 8.1 8.3 6.9 9.3 9.6 9.9 49.9 6.8 9.6 8.3 13.7 13.3 11.2 13.3 11.6 5.6 13.6 10.1 9.3 8.0 10.9 7.1 8.7 4.2 8.9 8.9 15.4 7.5 5.1 12.0 9.7 9.2 10.8 6.0 9.3 8.7 9.1 8.9 7.7 6.9 9.4 7.2 12.8 3.1 7.5 7.2 11.6 13.4 11.2 6.5 3.8 6.1 7.0 4.3 11.6 10.1 9.4 15.3 12.6 1.7 5.6 12.2 7.1 9.6 19.6 8.0 4.3 7.7 4.7 4.8 11.8 7.4 7.8 10.2 10.0 10.8 6.3 9.0 10.8 6.2 9.2 7.7 2.9 8.9 7.5 10.8 8.1 6.4 8.2 8.0 9.9 9.7 6.2 6.4 9.4 6.4 8.6 8.5 6.0 1.9 9.5 3.9 2.9 5.4 2.0 15.3 4.0 7.9 8.7 7.9 168.8 1.7 7.8 189.6 6.8 4.0 0.0 9.9 52.8 5.4 4.1 2.3 18.4 23.0 1.6 4.1 9.8 10.6 73.4 6.9 8.2 5.0 8.2 5.0 5.1 9.5 7.0 4.6 5.7 7.9 6.5 4.5 14.0 4.3 3.0 518.4 8.7 5.2 4.2 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613" "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favorable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 2.9 9.9 18.9 5.2 3.7 8.8 9.8 13.7 6.7 6.6 3.3 14.8 10.6 4.1 20.9 7.8 5.1 4.2 11.5 12.6 8.4 2.1 8.6 4.6 15.4 12.1 4.1 16.8 1.9 5.2 1.8 7.3 8.4 23.4 14.8 4.2 13.3 5.8 10.6 2.8 4.8 5.2 22.0 17.2 7.8 11.3 6.6 10.2 28.8 4.9 7.3 10.0 13.7 28.0 7.2 34.5 4.5 10.5 14.5 12.1 14.0 7.9 7.1 2.0 1.2 2.4 9.7 7.9 12.2 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 3.0 10.9 18.2 9.3 22.8 21.9 7.3 7.6 6.7 29.6 34.9 7.9 41.3 1.7 17.6 23.2 27.0 2.9 23.3 9.5 54.8 20.3 18.5 12.7 2.5 21.6 7.9 15.0 24.5 18.1 11.5 17.5 29.7 6.8 8.2 5.1 15.6 17.5 2.9 17.7 14.9 19.9 12.9 13.8 47.8 27.0 17.9 19.6 21.5 4.5 6.4 SLC39A12 FLJ30499 ENSG00000148482 "Solute carrier family 39 member 12" Q504Y0 10 17951839-18043292 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "brain: 42.3;retina: 19.2" "Cell type enriched" "Detected in some" 30 "Muller glia cells: 85.4" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-2)" "unprognostic (2.67e-1)" "unprognostic (3.30e-1)" "unprognostic (8.70e-2)" "unprognostic (1.02e-1)" "unprognostic (8.35e-2)" "unprognostic (1.33e-1)" "unprognostic (3.40e-6)" "unprognostic (1.94e-1)" "unprognostic (8.11e-2)" "unprognostic (3.76e-2)" 1.2 1.0 13.7 1.0 14.6 0.9 2.3 2.2 31.2 0.9 1.0 14.8 0.0 0.9 0.9 0.9 0.9 0.9 0.9 1.0 21.4 5.5 0.9 0.9 1.0 0.9 9.9 5.6 0.9 1.2 0.9 1.5 1.1 42.3 1.0 1.1 19.2 1.0 0.9 0.9 0.9 0.9 1.0 1.5 1.0 0.9 1.4 8.7 0.0 0.9 0.0 0.9 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.3 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 14.6 2.2 17.5 21.4 5.5 9.9 5.6 42.3 8.7 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.5 0.3 0.0 0.0 0.0 0.0 85.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367249-22434129 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 135.5;pancreas: 77.2" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 491.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 66.5" "Low region specificity" "Detected in all" "HPA016508, HPA056732" Enhanced Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" NA NA 950000 "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148, HPA056732: " "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favorable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 15.0 16.1 2.6 7.7 5.4 0.1 45.5 2.4 6.1 3.6 13.7 1.9 2.8 31.6 6.7 2.8 3.9 5.6 9.8 41.1 2.8 2.4 10.4 135.5 4.8 5.3 3.7 1.9 10.6 77.2 3.0 6.4 4.0 9.2 5.1 11.4 4.1 20.2 4.4 46.1 4.4 18.2 14.1 4.7 2.3 16.2 5.9 2.8 0.7 25.1 2.1 1.4 11.3 19.0 5.0 1.8 2.5 0.5 2.9 8.7 3.9 10.4 13.9 3.9 7.8 14.0 11.8 8.5 15.0 66.5 23.5 37.1 46.2 9.9 10.4 8.5 17.6 61.2 11.5 19.2 18.7 38.8 10.8 11.0 8.3 11.1 46.5 33.3 5.7 9.1 12.5 15.3 41.6 29.1 11.9 10.4 7.5 7.2 10.7 11.9 4.8 8.6 3.6 23.7 16.6 10.7 12.3 7.3 22.2 8.6 4.5 6.6 10.3 15.3 6.6 31.0 8.7 5.2 8.3 5.7 29.2 14.9 18.4 15.4 6.2 5.6 13.6 41.3 7.6 17.0 0.0 0.5 2.5 8.3 0.1 8.7 5.0 4.8 6.3 1.8 2.6 5.7 7.6 0.2 2.9 0.1 0.8 3.8 3.9 2.6 5.4 2.4 6.1 2.8 2.4 3.7 1.9 9.2 2.8 3.0 4.8 3.7 8.8 29.7 7.1 50.1 50.9 0.0 3.4 7.0 2.0 0.2 1.7 48.7 0.4 31.6 63.6 0.0 63.9 2.1 30.9 17.2 0.0 491.4 1.5 46.1 32.0 31.9 15.9 1.8 22.2 1.6 42.2 4.6 51.4 4.6 55.6 28.8 39.3 21.4 7.4 0.0 46.7 0.0 2.4 18.3 0.5 4.9 33.7 9.8 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 21.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 67 "HaCaT: 23.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 1.3 0.3 0.4 5.6 1.2 0.0 44.3 0.0 0.8 0.0 13.0 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.2 1.0 0.2 8.5 0.8 0.4 2.7 50.6 0.1 23.8 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.3 0.1 6.1 3.3 1.2 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.8 4.2 SLC39A4 "AEZ, AWMS2, ZIP4" ENSG00000147804 "Solute carrier family 39 member 4" Q6P5W5 8 144409742-144416895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 77.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 153.2;Proximal tubular cells: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CAPAN-2: 17.7;Hep G2: 45.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.59e-1)" "unprognostic (2.35e-3)" "unprognostic (9.16e-2)" "unprognostic (3.84e-2)" "unprognostic (5.63e-3)" "unprognostic (1.46e-1)" "unprognostic (5.40e-2)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "prognostic favorable (9.04e-4)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (9.04e-3)" "unprognostic (1.87e-1)" 0.2 0.0 0.5 1.1 0.2 0.1 0.2 0.2 1.1 0.2 73.9 0.2 0.2 42.1 0.2 0.4 0.2 0.3 0.7 0.2 0.2 0.0 8.3 0.4 1.3 0.2 0.2 0.2 1.5 0.6 0.0 0.3 0.4 0.2 0.4 0.1 0.2 0.5 0.2 0.2 0.0 77.7 0.2 0.2 0.2 1.2 0.4 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 17.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.4 0.7 0.1 45.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.0 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.2 0.4 0.9 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 17.9 22.7 23.4 28.9 16.7 0.1 5.6 22.9 26.8 13.6 40.1 0.0 15.3 43.1 36.9 1.1 9.8 153.2 23.3 37.2 53.2 13.5 30.9 36.9 22.7 29.1 3.2 40.9 7.4 15.7 1.3 7.5 21.5 20.3 27.1 76.6 7.1 53.4 115.8 6.0 139.9 1.0 6.5 11.4 1.6 32.4 26.2 9.4 12.9 78.9 35.2 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 51 "CACO-2: 22.8;Hep G2: 32.9" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Not detected" "Not detected" HPA018423 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favorable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 22.8 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.9 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 2.2 0.0 0.6 0.6 0.2 12.7 0.0 0.0 3.5 110.0 0.0 16.6 0.3 0.4 0.1 260.0 0.0 17.7 0.0 0.1 0.1 0.0 140.6 0.1 0.0 24.3 2.5 1.3 0.0 0.0 0.0 0.0 1.0 92.0 0.5 12.1 142.5 0.0 149.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 142.6 0.0 SLC39A8 BIGM103 ENSG00000138821 "Solute carrier family 39 member 8" Q9C0K1 4 102251041-102431258 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 67.3;salivary gland: 54.6" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038832, HPA038833" Approved NA NA "HPA038832: AB_2676226, HPA038833: AB_10670910" "prognostic favorable (6.69e-4)" "unprognostic (1.29e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (6.50e-2)" "unprognostic (9.59e-2)" "unprognostic (6.07e-2)" "unprognostic (2.74e-1)" "unprognostic (1.20e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-3)" "unprognostic (2.78e-2)" "prognostic favorable (6.34e-6)" "unprognostic (3.25e-1)" "unprognostic (6.54e-2)" "unprognostic (6.40e-2)" "unprognostic (7.13e-3)" 22.0 2.0 3.7 11.4 5.5 10.3 6.1 2.8 4.3 31.4 18.1 2.2 1.1 2.1 3.9 7.3 1.7 7.2 2.6 17.8 4.3 3.5 6.2 18.4 67.3 8.6 5.1 1.6 5.4 42.1 25.7 6.7 44.8 5.9 5.7 14.9 4.3 54.6 2.3 1.8 5.1 3.4 3.0 8.8 6.5 2.5 2.3 3.2 7.5 4.9 2.3 5.6 5.8 6.0 3.1 2.7 1.0 1.5 11.5 10.5 3.4 5.5 5.5 1.2 0.0 4.6 10.6 2.9 0.6 45.5 1.7 2.7 0.2 20.6 5.4 6.0 0.1 5.7 0.4 3.8 1.2 1.0 9.3 11.3 14.1 11.6 0.1 1.8 33.1 4.8 5.6 1.4 0.8 2.6 4.5 0.6 13.4 14.1 49.4 8.8 3.7 11.9 15.5 3.7 7.5 5.4 3.0 0.0 17.6 9.6 2.1 1.6 4.0 15.5 0.2 1.5 1.1 3.8 12.4 3.1 5.5 2.1 11.2 8.7 22.1 9.2 25.6 9.1 21.7 5.0 0.0 1.5 1.0 5.6 1.0 9.8 1.3 10.5 9.0 2.7 3.1 7.9 5.4 0.1 11.5 0.3 1.0 3.9 3.4 3.7 5.5 2.8 4.3 4.3 3.5 5.1 1.6 5.9 3.2 723.6 227.4 10.4 9.5 10.4 0.8 22.6 7.6 1.4 27.3 5.2 3.9 12.1 10.0 1.9 0.3 8.0 3.3 23.3 28.2 184.5 25.7 10.8 3.5 22.1 43.3 3.2 23.1 6.7 29.8 0.4 1.1 25.3 27.0 16.2 72.2 4.5 16.3 7.0 1.1 8.1 1.2 6.5 14.6 2.7 5.9 6.0 50.7 13.8 56.9 6.8 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 66.0;kidney: 191.5;pancreas: 36.8" "Cell type enriched" "Detected in many" 4 "Proximal tubular cells: 256.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 17 "RPTEC TERT1: 49.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" NA NA Mitochondria "Nuclear bodies" "HPA038360: AB_2675975, HPA071102: AB_2732171" "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favorable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.2 0.1 0.2 0.7 0.2 0.0 0.2 0.7 0.2 0.3 28.4 0.1 0.1 18.8 1.3 4.6 0.2 0.2 17.9 0.1 0.2 0.2 191.5 5.3 0.2 0.1 0.2 0.1 0.2 36.8 0.0 0.2 0.5 0.1 0.3 3.7 0.2 0.1 0.1 0.2 0.2 66.0 0.1 0.2 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.1 0.2 0.2 4.0 1.3 2.0 1.3 1.6 2.7 0.3 0.0 0.9 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.9 0.2 0.0 0.1 0.2 49.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.1 1.3 1.3 1.0 2.6 1.3 1.9 1.9 2.5 1.4 0.4 4.0 2.5 2.7 2.0 1.6 0.6 1.3 0.9 0.3 0.2 0.2 0.7 0.2 0.2 0.2 0.2 0.1 0.1 0.1 3.0 1.0 1.5 0.2 0.0 12.5 0.3 63.7 0.0 0.0 40.1 9.8 0.0 53.0 18.3 10.9 0.0 32.7 0.0 12.6 0.0 0.2 1.4 0.0 2.8 0.1 20.6 0.0 0.6 0.0 3.3 1.1 0.0 0.0 2.8 3.8 1.6 3.4 7.2 0.4 256.0 11.9 0.0 0.1 0.7 0.3 0.1 0.1 0.0 8.0 0.5 SLC40A1 "FPN1, HFE4, IREG1, MTP1, SLC11A3" ENSG00000138449 "Solute carrier family 40 member 1" Q9NP59 2 189560579-189583758 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 126.4;lymphoid tissue: 170.2" "Group enriched" "Detected in many" 5 "Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 64.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065634 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA065634: AB_2685524" "unprognostic (1.28e-2)" "unprognostic (1.73e-2)" "unprognostic (9.41e-2)" "unprognostic (1.83e-2)" "unprognostic (8.00e-3)" "unprognostic (1.36e-2)" "unprognostic (1.66e-1)" "unprognostic (6.22e-2)" "unprognostic (6.65e-2)" "unprognostic (1.84e-1)" "unprognostic (6.43e-2)" "unprognostic (6.44e-2)" "prognostic favorable (8.55e-5)" "unprognostic (4.66e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.11e-2)" 18.2 126.4 3.9 10.1 5.5 3.9 47.4 1.8 3.5 20.0 25.7 3.7 13.9 34.4 24.7 24.3 6.3 25.9 25.2 37.1 4.1 4.3 14.4 42.1 45.9 170.2 5.1 1.9 50.9 24.0 4.6 9.8 51.3 6.4 18.4 15.8 11.6 10.2 16.6 12.3 4.9 44.7 13.6 5.8 76.4 11.3 16.2 3.5 17.0 20.8 6.4 8.8 11.1 20.4 0.1 22.7 64.7 20.8 0.8 17.3 20.1 0.0 1.3 0.1 0.0 93.2 0.6 4.5 0.0 1.1 0.3 0.5 21.3 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.3 75.5 0.3 7.8 0.3 0.2 19.9 6.5 0.0 0.2 0.0 2.1 2.2 2.9 7.7 0.2 1.1 0.0 3.1 4.9 0.2 16.0 0.3 0.0 0.8 0.4 0.9 3.1 0.1 0.9 0.1 6.2 0.0 7.4 36.8 1.1 0.0 0.1 2.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.3 20.8 32.9 0.4 4.7 0.6 0.0 11.3 1.0 22.7 0.1 17.3 3.7 64.7 0.8 0.4 3.7 1.0 20.1 3.9 5.5 1.8 3.5 4.1 4.3 5.1 1.9 6.4 3.5 116.1 32.3 28.1 45.3 8.1 3.7 37.5 142.7 53.5 39.8 31.4 3.9 335.3 41.4 23.9 6.9 30.8 119.4 70.0 64.9 10.7 46.3 32.2 9.2 223.5 72.3 6.4 17.9 211.8 1044.2 4.7 112.2 26.2 8.5 1.8 50.3 9.6 51.2 77.2 55.2 100.1 43.2 64.7 18.1 5.0 0.9 7.0 2060.1 8.4 30.8 19.7 SLC41A1 MgtE ENSG00000133065 "Solute carrier family 41 member 1" Q8IVJ1 1 205789093-205813748 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 78.1;pancreas: 36.8" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014721, HPA015138" Uncertain Approved Mitochondria NA NA Mitochondria "HPA014721: , HPA015138: AB_1857160" "unprognostic (1.18e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.77e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (2.37e-3)" "unprognostic (5.23e-2)" "unprognostic (5.53e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-2)" "unprognostic (4.46e-2)" "unprognostic (3.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (1.65e-1)" 6.0 7.2 6.2 4.0 7.3 3.3 3.4 9.0 8.3 3.6 3.9 10.8 4.0 1.6 5.0 5.9 3.8 7.3 4.7 78.1 7.2 3.8 6.1 1.2 5.3 4.5 7.8 4.9 7.5 36.8 5.8 3.6 2.6 6.9 5.1 1.5 5.8 2.8 4.8 26.5 2.6 2.7 4.0 8.5 3.3 6.6 11.6 7.3 2.1 11.2 11.9 4.5 5.2 5.0 1.8 0.0 0.1 0.3 1.0 4.6 2.0 10.8 9.6 6.1 9.7 7.6 7.5 8.3 11.2 11.0 11.4 10.1 4.8 6.2 15.7 7.1 10.2 9.5 11.3 5.9 8.2 3.9 28.8 9.0 3.8 9.5 0.7 7.3 0.0 11.0 9.5 6.9 13.0 9.3 9.5 7.0 12.8 7.0 6.6 9.1 6.7 7.0 1.1 7.2 2.9 4.4 8.3 18.3 3.8 2.6 13.5 5.1 6.5 8.6 7.7 7.0 5.3 5.5 4.0 8.7 13.6 8.8 12.4 11.6 22.0 14.6 5.2 10.6 5.0 8.4 0.0 0.1 0.1 3.6 0.3 4.6 1.5 3.4 3.4 0.0 1.8 3.2 3.3 0.0 1.0 0.0 0.0 3.3 2.0 6.2 7.3 9.0 8.3 7.2 3.8 7.8 4.9 6.9 7.3 3.0 16.5 12.6 19.3 18.4 12.9 157.4 10.2 9.4 12.5 0.0 47.1 1.7 1.7 8.2 1.5 20.4 0.0 0.0 9.4 12.7 8.0 15.4 6.9 1.8 2.7 17.5 5.8 4.3 2.2 1.7 9.2 3.2 8.5 0.0 0.8 18.0 8.8 0.6 8.9 13.7 21.3 0.0 19.4 6.8 15.0 15.8 2.6 8.5 1.0 20.0 SLC41A2 DKFZP434K0427 ENSG00000136052 "Solute carrier family 41 member 2" Q96JW4 12 104802553-104958744 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.1;liver: 54.1" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 33.6;Hepatocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 4.4;plasmacytoid DC: 13.0" "Lineage enriched" "Detected in single" 14 "dendritic cells: 13.0" "Cell line enhanced" "Detected in many" "HDLM-2: 29.6;SK-BR-3: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038658 Approved NA NA "HPA038658: AB_10671747" "unprognostic (7.19e-2)" "unprognostic (4.38e-3)" "unprognostic (1.94e-2)" "unprognostic (2.38e-1)" "unprognostic (6.06e-3)" "unprognostic (3.05e-2)" "prognostic favorable (9.94e-4)" "unprognostic (1.35e-1)" "unprognostic (3.68e-1)" "unprognostic (3.65e-1)" "unprognostic (4.20e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (1.50e-1)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "unprognostic (5.30e-2)" 6.1 7.0 3.8 5.2 3.9 0.5 7.1 9.2 5.4 4.9 19.9 2.3 15.9 14.5 3.0 7.9 1.6 2.1 6.8 3.0 2.9 5.5 4.6 54.1 4.5 2.0 2.8 4.0 4.2 12.0 5.7 21.5 16.1 3.4 2.2 7.2 2.0 5.9 14.9 0.9 1.6 37.1 4.0 2.4 1.9 16.8 4.3 2.1 1.0 5.8 0.3 2.7 2.2 2.7 0.6 13.0 0.3 0.2 0.3 0.9 0.3 6.0 13.8 0.5 2.9 11.8 8.6 5.5 4.3 7.0 3.0 5.1 8.6 5.9 2.5 4.7 8.4 11.0 0.6 3.1 1.4 5.6 29.6 7.8 0.2 5.5 3.8 2.6 0.9 3.4 2.9 1.2 3.2 0.9 6.5 3.8 1.6 0.2 6.5 0.5 2.8 1.2 0.0 1.3 10.9 4.4 0.5 6.0 5.9 11.9 0.2 5.5 1.4 7.3 24.4 1.2 2.2 9.5 0.0 1.1 4.5 3.2 4.8 4.8 7.8 9.6 3.2 7.2 0.5 3.1 0.2 0.2 0.0 0.2 0.1 0.9 0.6 0.2 0.1 4.4 0.3 0.4 0.2 0.3 0.3 0.1 13.0 0.1 0.3 3.8 3.9 9.2 5.4 2.9 5.5 2.8 4.0 3.4 2.1 17.9 8.1 6.0 2.6 2.2 2.8 0.8 20.4 1.4 4.5 7.0 0.0 1.4 0.0 23.5 21.0 1.4 29.0 0.0 33.6 15.7 9.3 3.9 0.0 45.9 5.4 4.8 1.2 1.3 2.2 3.4 2.0 9.7 0.0 31.5 8.3 2.6 26.2 8.7 6.0 6.2 0.0 0.0 5.0 2.9 1.9 1.9 7.6 1.0 9.7 4.7 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515786 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 27.0;liver: 91.8;pancreas: 100.5" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 40.8;Hepatocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 23.8;NB-4: 28.3;U-937: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favorable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (7.30e-2)" 4.7 3.3 0.8 2.2 0.8 9.3 7.4 0.7 1.3 6.0 4.8 0.9 3.9 2.5 5.0 6.8 4.1 3.3 27.0 3.2 0.7 0.6 3.4 91.8 2.9 3.3 0.8 1.1 6.5 100.5 0.1 1.3 1.8 0.7 6.2 2.8 11.4 14.9 2.1 7.5 5.6 2.6 7.0 0.9 2.5 7.6 3.1 0.7 0.8 7.4 2.9 3.1 7.6 3.5 3.1 8.2 8.1 6.0 6.9 11.1 5.2 0.4 0.6 0.7 8.0 10.5 7.7 0.1 4.2 5.4 1.2 3.1 2.5 1.1 23.0 1.1 3.1 1.5 0.3 7.1 0.4 1.5 1.1 1.8 11.8 0.2 23.8 13.8 20.7 2.9 9.7 1.7 2.0 9.3 2.9 5.3 13.8 16.5 4.3 1.5 0.8 0.1 28.3 2.6 10.4 5.4 19.7 3.9 10.2 0.2 0.0 9.4 1.4 0.7 0.1 9.2 0.2 0.6 10.5 2.1 1.2 2.9 10.6 0.6 4.8 1.5 13.5 0.6 27.3 1.6 8.1 6.0 0.7 11.1 2.4 9.5 3.1 5.2 8.0 8.2 1.7 5.1 7.2 0.5 6.9 0.1 1.9 9.1 5.2 0.8 0.8 0.7 1.3 0.7 0.6 0.8 1.1 0.7 0.7 0.0 8.2 0.8 1.6 6.3 5.0 4.9 40.8 1.4 1.2 0.0 0.0 0.1 3.3 2.5 22.9 4.6 0.9 23.3 30.5 0.4 5.4 1.9 3.5 109.6 6.1 0.0 5.8 14.7 7.6 11.8 14.4 1.8 5.0 0.0 6.1 0.0 18.0 0.0 7.4 0.0 0.3 6.5 6.2 0.5 0.4 3.1 0.1 6.4 9.8 0.9 SLC43A2 MGC34680 ENSG00000167703 "Solute carrier family 43 member 2" Q8N370 17 1569267-1628886 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 92.7" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 312.2;Syncytiotrophoblasts: 788.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021564 Enhanced NA NA "HPA021564: AB_1857169" "unprognostic (5.95e-3)" "unprognostic (4.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.42e-2)" "unprognostic (2.58e-2)" "unprognostic (2.80e-2)" "unprognostic (1.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.96e-1)" "prognostic favorable (5.40e-5)" "unprognostic (1.84e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-1)" "unprognostic (2.20e-1)" 5.5 2.7 5.4 13.7 5.7 12.2 3.6 14.8 11.9 2.6 2.6 5.0 2.1 7.0 2.1 4.1 1.4 5.9 3.9 1.6 5.6 7.2 15.8 3.0 6.8 8.3 5.1 3.8 2.3 1.6 1.5 6.2 92.7 5.8 2.8 2.4 4.9 4.0 3.5 23.2 1.3 11.6 4.7 3.5 8.9 2.8 1.5 1.3 5.0 5.8 2.2 3.5 5.0 1.3 1.3 3.1 15.0 5.4 0.5 0.3 2.0 0.9 2.6 0.8 7.6 1.6 1.3 10.4 0.5 0.3 1.8 0.8 15.5 1.7 4.5 5.2 0.8 0.7 1.8 4.6 0.9 0.3 0.0 0.4 0.8 2.3 3.9 1.9 0.1 1.4 1.6 1.4 1.1 0.5 0.2 7.3 0.5 1.9 0.0 0.3 3.6 9.2 0.9 0.8 2.4 0.3 2.6 0.0 5.3 3.5 8.9 3.1 1.6 2.3 6.3 0.2 3.4 6.3 5.4 9.5 0.2 1.1 2.0 0.6 0.5 9.4 2.2 0.4 0.9 0.2 2.5 5.4 5.3 0.3 4.6 0.1 1.3 0.2 0.2 3.1 1.2 0.2 0.2 15.0 0.5 4.5 1.7 0.2 2.0 5.4 5.7 14.8 11.9 5.6 7.2 5.1 3.8 5.8 1.3 14.9 40.5 18.3 5.4 4.2 22.8 2.7 15.3 21.4 22.7 34.9 23.6 312.2 16.6 21.0 2.9 4.5 16.2 0.0 6.3 29.6 10.2 7.2 11.5 1.3 81.4 19.1 10.9 16.5 88.0 1.9 10.0 84.8 0.0 73.9 12.2 23.6 6.4 21.6 8.5 19.3 35.8 0.0 5.7 3.1 3.2 3.8 788.9 3.8 10.0 4.2 SLC43A3 "DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1" ENSG00000134802 "Solute carrier family 43 member 3" Q8NBI5 11 57406954-57427580 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 149.9;thyroid gland: 69.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4" "Region enriched" "Detected in many" 4 "olfactory region: 12.7" "Low region specificity" "Detected in all" "HPA030551, HPA077244" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA030551: AB_10604094, HPA077244: AB_2732335" "unprognostic (2.64e-1)" "unprognostic (7.63e-2)" "unprognostic (9.67e-3)" "unprognostic (7.41e-3)" "unprognostic (6.59e-3)" "unprognostic (5.30e-3)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (1.36e-1)" "unprognostic (2.26e-1)" "unprognostic (5.73e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (3.97e-13)" "unprognostic (8.16e-2)" "unprognostic (1.77e-1)" "unprognostic (8.34e-2)" "unprognostic (1.00e-1)" 32.3 6.3 2.5 12.4 4.3 18.8 16.8 2.2 3.0 11.9 9.6 3.6 2.4 2.7 10.1 6.5 12.6 8.9 11.4 12.5 3.1 1.5 4.2 149.9 16.5 8.8 4.0 1.8 16.0 7.2 1.2 1.8 5.1 3.4 11.6 4.2 9.4 12.2 3.1 15.4 11.0 6.2 10.3 4.7 11.6 6.9 6.8 2.3 10.4 69.0 11.5 13.8 20.3 15.4 2.7 23.6 6.1 36.8 1.1 7.8 14.0 40.0 0.0 2.3 0.0 7.8 11.5 0.1 3.1 13.3 4.6 7.9 0.0 8.8 23.1 1.4 7.3 2.4 23.1 6.7 4.1 9.3 0.1 0.0 36.0 13.7 0.0 15.9 71.0 62.7 34.5 0.1 44.6 0.5 3.3 12.9 10.7 41.1 22.4 17.8 0.0 14.9 45.6 3.5 0.0 0.7 30.9 0.4 80.1 11.0 0.0 5.5 0.0 8.8 0.2 37.4 0.2 3.4 10.8 6.8 0.2 12.0 30.4 8.7 0.0 0.1 5.8 27.5 25.8 76.4 3.2 28.8 6.1 5.7 34.5 6.5 2.7 4.0 7.8 23.6 2.0 3.1 3.2 2.5 1.1 36.8 23.6 6.9 14.0 2.5 4.3 2.2 3.0 3.1 1.5 4.0 1.8 3.4 2.3 14.9 41.4 4.5 6.7 41.6 0.5 2.8 30.6 5.3 34.2 1.8 0.0 0.5 0.0 47.0 1.0 23.3 0.0 0.0 5.5 2.2 20.2 3.4 63.7 53.8 71.5 0.0 0.0 11.6 17.3 1.4 9.2 55.1 28.7 0.0 0.5 0.9 10.9 0.0 11.7 0.0 0.0 64.7 18.4 1.0 0.2 15.4 0.7 15.0 0.6 2.5 SLC44A1 "CD92, CDw92, CHTL1, CTL1" ENSG00000070214 "Solute carrier family 44 member 1" Q8WWI5 9 105244622-105439171 "CD markers, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 111.6" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.5;ASC TERT1: 58.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064714, HPA074007" Enhanced Supported Nucleoplasm,Mitochondria NA NA 270000 Mitochondria Nucleoplasm "HPA064714: AB_2685334, HPA074007: " "unprognostic (3.49e-1)" "unprognostic (2.25e-1)" "unprognostic (1.27e-1)" "unprognostic (6.54e-3)" "unprognostic (4.77e-2)" "unprognostic (1.74e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.49e-4)" "unprognostic (2.48e-1)" "unprognostic (1.95e-1)" "unprognostic (1.64e-3)" "unprognostic (6.20e-2)" "prognostic favorable (1.85e-4)" "unprognostic (2.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-2)" 8.7 7.4 40.0 6.4 48.8 5.3 14.6 7.2 37.0 9.9 26.7 69.5 10.2 12.0 8.8 18.4 10.1 8.5 11.0 6.9 50.0 29.6 12.0 20.3 9.8 4.6 64.3 21.3 8.0 8.0 20.5 3.9 12.3 38.2 6.6 26.9 4.6 6.0 14.8 4.8 11.4 14.0 9.5 111.6 4.8 18.9 2.3 59.4 2.3 24.0 5.1 7.9 12.4 7.9 2.4 3.7 2.5 5.4 8.7 1.8 1.6 6.9 5.8 1.6 1.9 73.5 58.1 5.0 5.8 15.3 3.8 5.1 6.2 18.5 9.2 3.0 22.0 4.3 13.8 4.7 8.4 6.5 8.0 3.8 11.5 4.1 7.7 4.9 2.2 5.9 32.2 6.9 7.3 6.6 9.8 12.0 4.8 0.3 19.2 4.3 9.8 9.1 2.6 8.9 12.3 5.6 1.9 6.1 6.9 5.2 16.3 7.7 3.0 8.2 9.1 8.2 9.9 9.0 6.9 10.2 3.8 3.4 4.1 4.2 14.8 9.8 6.9 7.4 5.0 5.0 2.5 5.4 1.1 1.1 2.1 0.8 2.0 1.2 0.8 3.7 2.4 1.8 0.6 1.0 8.7 1.2 1.3 1.1 1.6 40.0 48.8 7.2 29.8 50.0 29.6 64.3 21.3 38.2 59.4 32.8 21.6 15.9 31.4 62.7 7.6 9.3 56.0 14.7 9.1 101.2 221.9 44.4 3.3 16.4 2.4 38.4 140.4 0.0 31.4 7.9 49.9 25.3 98.1 132.6 20.0 6.4 151.0 54.0 50.8 2.9 101.8 39.6 70.9 122.6 158.5 6.7 33.4 123.8 75.0 23.3 44.8 38.8 27.0 1.4 1.7 65.0 59.0 15.3 134.8 29.5 SLC44A4 "C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT" ENSG00000204385 "Solute carrier family 44 member 4" Q53GD3 6 31863192-31879046 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 34.6;intestine: 65.7" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 245.0;Enterocytes: 364.2;Exocrine glandular cells: 194.5;Glandular cells: 195.5;Mucus-secreting cells: 268.8;Paneth cells: 234.4" "Cancer enhanced" "Detected in many" "prostate cancer: 222.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 2.0" "Cell line enriched" "Detected in some" 5 "OE19: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA046977, HPA054176" Enhanced NA NA "HPA046977: AB_2679887, HPA054176: AB_2682404" "unprognostic (5.84e-2)" "unprognostic (4.90e-2)" "unprognostic (3.86e-3)" "unprognostic (4.85e-3)" "unprognostic (2.75e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.65e-3)" "unprognostic (2.44e-3)" "unprognostic (3.08e-1)" "unprognostic (2.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.06e-6)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (4.54e-2)" "prognostic favorable (6.06e-4)" 0.3 2.4 0.2 11.2 0.3 0.2 2.1 0.2 0.3 5.9 43.6 0.3 7.6 23.7 2.9 3.0 0.6 10.9 34.6 0.2 0.2 0.0 20.4 0.3 9.1 0.6 0.2 0.2 4.9 7.3 0.0 5.0 5.1 0.5 25.7 8.6 0.3 12.0 4.4 0.2 0.1 65.7 1.2 0.2 0.6 23.7 0.8 0.2 0.4 0.5 0.7 4.2 6.3 1.9 0.0 2.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 13.2 0.0 0.1 0.0 0.4 0.0 2.0 0.0 0.2 0.0 1.1 0.0 0.1 0.4 0.3 2.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.0 0.2 0.2 0.5 0.2 20.8 29.0 6.7 17.5 0.5 0.0 0.3 30.6 245.0 54.6 62.8 0.0 0.2 3.3 91.8 2.2 0.5 364.2 0.0 194.5 0.3 1.8 195.5 2.3 0.0 0.5 0.0 44.9 0.0 0.0 2.9 1.4 2.0 0.0 2.8 268.8 0.4 123.2 234.4 0.4 56.6 0.6 0.0 0.4 0.2 0.2 0.4 0.6 0.0 158.0 88.5 SLC44A5 "CTL5, MGC34032" ENSG00000137968 "Solute carrier family 44 member 5" Q8NCS7 1 75202131-75611116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.6" "Group enriched" "Detected in some" 7 "Early spermatids: 63.4;Late spermatids: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047455, HPA051011" Uncertain Approved Cytosol NA NA Cytosol "HPA047455: AB_2680054, HPA051011: AB_2681309" "unprognostic (9.00e-2)" "unprognostic (1.91e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-3)" "unprognostic (4.57e-1)" "unprognostic (1.69e-1)" "unprognostic (1.77e-2)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (5.78e-3)" "unprognostic (6.41e-2)" "unprognostic (9.19e-2)" "prognostic unfavorable (6.52e-4)" "unprognostic (1.70e-3)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" "unprognostic (4.30e-1)" 1.0 0.4 2.4 1.0 1.5 0.0 6.3 1.0 3.6 1.0 1.8 1.0 1.0 0.9 1.0 1.0 7.7 3.7 1.0 2.2 2.8 2.8 2.0 1.0 1.0 1.0 2.3 1.0 1.0 1.8 5.6 3.7 3.8 1.0 1.0 2.9 1.0 1.6 1.0 1.5 11.3 1.0 1.0 1.0 1.0 1.3 32.6 1.0 1.0 1.0 1.0 1.8 2.2 1.9 3.2 0.3 0.6 0.3 0.5 1.1 0.3 0.2 0.2 4.5 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 2.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 4.5 0.6 1.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.8 0.4 2.4 2.6 0.0 0.0 1.7 0.0 4.5 2.9 0.6 0.0 0.0 2.1 7.1 4.8 1.0 11.1 0.0 4.6 0.0 11.8 0.2 0.0 13.7 0.4 1.2 0.0 1.4 2.0 1.9 3.0 0.2 0.0 0.7 0.4 0.3 0.2 0.4 0.1 0.9 3.2 0.8 1.1 0.1 2.4 0.6 0.4 0.6 0.5 0.2 0.3 0.6 0.3 2.4 1.5 1.0 3.4 2.8 2.8 2.3 1.0 1.0 1.0 0.0 0.6 0.0 0.6 1.6 3.7 0.6 0.0 2.7 1.2 0.0 0.0 6.8 0.0 0.1 63.4 0.4 0.4 0.0 0.8 3.2 0.2 0.8 0.0 0.0 1.0 0.0 2.4 3.1 0.0 27.3 0.9 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 5.8 3.2 0.0 0.2 3.1 SLC45A1 DNB5 ENSG00000162426 "Solute carrier family 45 member 1" Q9Y2W3 1 8317826-8344167 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Symport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.0" "Cell type enhanced" "Detected in some" 7 "Bipolar cells: 6.7;Horizontal cells: 9.5;Muller glia cells: 5.7;Peritubular cells: 5.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 7.1" "Group enriched" "Detected in many" 7 "monocytes: 7.1;T-cells: 1.8" "Cell line enhanced" "Detected in some" "ASC diff: 5.9;GAMG: 4.2;HHSteC: 7.8;U-87 MG: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078818 Enhanced NA NA "HPA078818: " "unprognostic (1.77e-3)" "unprognostic (1.37e-2)" "unprognostic (4.32e-3)" "unprognostic (8.32e-2)" "unprognostic (3.22e-3)" "unprognostic (1.56e-1)" "unprognostic (4.96e-2)" "unprognostic (2.09e-1)" "unprognostic (1.20e-1)" "unprognostic (1.43e-1)" "unprognostic (1.39e-3)" "unprognostic (3.18e-1)" "unprognostic (5.67e-2)" "unprognostic (8.53e-3)" "unprognostic (2.16e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-3)" 5.0 6.6 8.5 2.4 15.3 1.1 2.6 13.8 24.0 6.0 4.4 5.4 2.1 2.5 6.8 3.6 3.9 5.2 4.3 3.1 6.0 7.9 4.3 1.1 2.0 2.1 6.1 12.4 4.4 4.1 4.1 8.1 1.9 13.1 4.9 2.2 3.2 1.5 7.7 4.0 1.7 2.8 4.3 4.6 4.4 2.6 3.8 4.6 0.0 2.4 0.8 1.5 3.6 3.3 0.6 0.2 0.0 7.1 0.0 1.8 0.7 0.0 2.7 0.5 1.1 5.9 3.9 0.1 0.2 1.2 0.4 0.8 0.0 0.4 0.0 0.2 0.8 4.2 0.0 0.1 0.3 0.1 2.3 0.0 0.0 0.2 0.0 7.8 0.0 2.2 2.0 0.2 0.9 0.0 1.4 0.6 0.6 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.0 1.7 0.0 1.2 0.0 0.0 0.0 2.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 2.5 0.1 0.5 2.3 0.4 0.0 0.0 0.0 10.1 0.0 0.1 0.0 0.2 0.0 1.3 1.3 1.8 0.6 0.9 0.9 0.2 0.1 0.6 0.6 0.0 0.0 7.1 0.0 0.6 0.7 8.5 15.3 13.8 24.0 6.0 7.9 6.1 12.4 13.1 4.6 0.0 0.0 0.5 1.2 0.3 6.7 0.8 0.0 0.0 0.0 1.8 3.9 0.0 0.0 0.5 1.9 0.9 0.0 0.0 0.2 0.0 0.9 1.0 0.0 0.0 0.1 9.5 0.0 1.3 0.0 4.0 3.1 0.0 0.0 0.0 0.0 5.7 0.1 0.0 5.3 0.6 4.4 6.5 2.9 0.2 0.0 0.3 0.0 0.0 0.0 0.3 SLC45A2 "AIM-1, MATP, OCA4" ENSG00000164175 "Solute carrier family 45 member 2" Q9UMX9 5 33944616-33984730 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Sensory transduction, Vision" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 39.9" "Cell type enhanced" "Detected in some" 31 "Early spermatids: 2.4;Late spermatids: 3.1;Melanocytes: 11.8" "Cancer enriched" "Detected in some" 18 "melanoma: 47.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 27 "SK-MEL-30: 37.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.97e-1)" "unprognostic (3.99e-2)" "unprognostic (3.55e-1)" "unprognostic (2.39e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (8.45e-2)" "unprognostic (5.34e-3)" "unprognostic (4.06e-2)" "unprognostic (8.45e-2)" "unprognostic (7.39e-4)" "unprognostic (1.40e-2)" "unprognostic (1.84e-3)" "unprognostic (1.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.48e-2)" "unprognostic (3.39e-1)" 0.2 0.0 0.3 0.2 0.4 0.0 0.2 0.7 0.4 0.2 1.1 0.2 0.2 0.0 0.5 0.2 0.2 0.4 0.3 1.5 0.4 0.6 0.8 3.1 0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.8 1.2 39.9 0.2 0.2 0.4 4.5 0.2 0.3 0.4 0.2 0.6 2.8 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 37.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.7 0.4 0.4 0.6 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 11.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 SLC45A3 "IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein" ENSG00000158715 "Solute carrier family 45 member 3" Q96JT2 1 205657851-205680459 "Cancer-related genes, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "prostate: 115.0" "Group enriched" "Detected in many" 11 "Glandular cells: 50.8;granulocytes: 117.6" "Cancer enriched" "Detected in all" 49 "prostate cancer: 539.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 226 "basophil: 22.6" "Lineage enriched" "Detected in single" 226 "granulocytes: 22.6" "Cell line enriched" "Detected in some" 30 "HMC-1: 141.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA019073, HPA019075" Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA019073: AB_1857177, HPA019075: AB_1857179" "unprognostic (1.80e-1)" "unprognostic (1.08e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.04e-5)" "unprognostic (6.93e-2)" "unprognostic (2.36e-2)" "unprognostic (1.15e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-2)" "unprognostic (1.18e-1)" "unprognostic (3.03e-2)" "unprognostic (3.16e-1)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.33e-5)" 0.8 1.5 2.5 1.5 6.2 0.7 0.8 0.4 5.8 1.9 2.1 19.0 0.0 2.1 0.9 0.6 0.9 1.1 1.8 0.7 4.2 2.0 1.1 4.0 1.7 1.6 13.2 1.6 1.0 0.7 0.5 1.9 0.6 7.2 115.0 1.6 0.2 0.9 0.7 2.2 0.9 2.1 0.8 12.4 5.0 6.4 1.4 11.1 0.0 0.5 0.7 0.7 1.5 0.4 0.0 0.0 22.6 0.0 0.0 0.0 0.2 1.5 0.5 0.4 0.4 0.0 0.0 0.3 0.2 0.0 0.5 0.4 1.1 2.9 0.4 0.7 0.0 0.5 0.5 0.2 0.5 0.0 0.6 0.4 4.7 0.1 0.3 0.3 0.8 141.5 0.0 0.1 0.3 0.0 0.3 1.6 0.7 0.7 0.2 0.2 0.3 0.1 1.3 2.0 2.7 1.7 0.1 0.7 0.2 0.6 2.2 0.2 0.5 0.2 3.5 0.6 0.4 0.8 0.2 1.5 0.2 1.6 0.5 1.1 0.0 0.1 0.0 0.3 0.2 1.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 6.2 0.4 5.8 4.2 2.0 13.2 1.6 7.2 11.1 0.0 5.6 1.3 1.1 0.0 0.2 1.7 5.1 2.7 1.2 1.8 0.0 0.4 0.0 1.8 0.1 0.6 3.4 0.0 0.5 0.1 0.6 50.8 117.6 4.9 2.0 0.0 0.0 0.0 0.6 0.0 1.7 0.9 0.0 1.0 7.4 0.2 2.4 7.0 1.4 1.8 0.0 6.5 1.0 0.0 1.5 0.1 0.0 0.0 4.4 0.8 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394756-28407197 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.7" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "CACO-2: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 3.1 17.8 4.6 2.5 7.0 1.3 5.1 13.2 5.2 2.9 43.8 5.2 9.4 45.4 2.2 4.5 1.8 6.7 3.0 2.2 4.4 6.0 3.8 17.9 3.2 4.9 4.0 4.0 4.4 5.0 8.1 7.8 5.0 5.0 3.7 2.7 6.1 5.7 5.8 2.0 2.0 52.7 2.6 4.6 4.9 2.3 2.2 4.2 2.2 4.0 0.4 1.2 2.4 2.4 2.7 2.6 7.1 5.9 2.9 1.7 0.8 1.7 7.4 2.5 4.1 2.0 0.4 7.8 2.1 1.5 1.7 2.0 67.6 2.1 0.2 1.2 1.1 5.0 5.8 2.8 4.7 1.5 4.3 6.6 0.0 4.6 5.7 0.7 0.0 3.4 1.0 8.7 1.8 5.4 2.4 0.1 0.6 2.8 0.4 0.3 2.3 0.0 0.2 1.5 1.7 1.0 0.1 2.0 0.8 1.3 3.9 6.6 3.5 14.5 6.8 0.9 3.6 5.3 1.1 0.2 0.2 3.0 0.4 2.2 3.1 3.5 0.1 0.4 0.4 1.6 7.1 1.6 1.1 0.8 5.9 1.4 2.7 0.9 0.7 2.6 1.7 1.0 1.7 2.3 2.9 4.3 1.1 1.6 0.8 4.6 7.0 13.2 5.2 4.4 6.0 4.0 4.0 5.0 4.2 11.9 4.0 3.2 1.9 0.3 25.6 1.8 15.3 4.0 1.2 7.0 3.9 16.6 0.0 2.8 3.4 1.0 1.3 0.0 3.9 7.3 3.1 2.2 1.1 24.9 21.1 19.1 1.2 2.5 13.0 13.5 3.7 3.9 0.0 1.0 2.1 1.6 3.5 0.9 3.2 4.1 5.6 6.5 1.0 0.0 0.2 0.3 3.7 0.0 1.2 1.4 SLC46A2 "Ly110, TSCOT" ENSG00000119457 "Solute carrier family 46 member 2" Q9BY10 9 112878920-112890913 "Predicted membrane proteins, Transporters" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 35.7;Kupffer cells: 13.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "classical monocyte: 17.0;intermediate monocyte: 8.7" "Lineage enriched" "Detected in many" 4 "monocytes: 17.0" "Cell line enhanced" "Detected in some" "U-138 MG: 1.1;U-2197: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA020098 Approved NA NA "HPA020098: AB_2670363" "unprognostic (1.26e-1)" "unprognostic (5.15e-3)" "unprognostic (1.10e-2)" "unprognostic (1.53e-3)" "unprognostic (3.57e-3)" "unprognostic (2.10e-2)" "unprognostic (4.56e-1)" "unprognostic (2.18e-1)" "unprognostic (8.10e-2)" "unprognostic (1.50e-3)" "unprognostic (3.50e-1)" "unprognostic (1.38e-1)" "unprognostic (1.77e-2)" "unprognostic (2.37e-1)" "unprognostic (2.71e-2)" "unprognostic (1.83e-1)" "unprognostic (7.82e-2)" 0.2 0.1 0.1 0.5 0.1 0.0 1.0 1.1 0.5 17.7 0.1 0.0 21.1 0.0 3.6 10.4 1.4 0.1 0.3 0.1 0.1 0.3 0.2 0.2 17.1 1.9 0.1 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.8 0.0 0.1 0.4 9.9 0.1 22.3 0.2 0.6 0.2 1.0 0.1 1.5 0.0 31.8 0.1 0.0 0.3 5.4 0.7 0.0 3.8 0.2 17.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.0 1.1 0.0 1.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 6.5 0.1 0.0 4.1 0.1 0.1 1.1 0.5 0.1 0.3 0.1 0.2 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.4 2.5 1.4 2.3 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.6 13.2 1.6 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SLC46A3 "DKFZp686A1775, FLJ42613" ENSG00000139508 "Solute carrier family 46 member 3" Q7Z3Q1 13 28700064-28718970 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 62.9;liver: 50.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 58.8;Hepatocytes: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.5;T-47d: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039930 Approved Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Cytosol" "Actin filaments" "HPA039930: AB_10673263" "unprognostic (5.16e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (2.61e-1)" "unprognostic (3.88e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "prognostic favorable (7.09e-4)" "unprognostic (3.13e-1)" "unprognostic (3.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.69e-2)" "unprognostic (7.35e-2)" "unprognostic (1.14e-1)" "unprognostic (5.60e-2)" "unprognostic (9.14e-3)" "unprognostic (6.47e-3)" 6.9 14.2 3.8 5.9 5.7 1.4 6.4 7.6 6.5 8.3 19.6 6.9 2.8 24.0 5.2 7.4 3.1 4.1 12.7 8.1 4.2 4.2 10.4 50.0 6.0 11.4 4.7 3.9 5.0 5.5 4.2 18.2 5.0 6.6 5.3 10.1 17.4 10.3 5.6 8.2 4.0 62.9 4.5 5.1 11.6 4.8 9.3 3.7 11.8 6.8 3.0 6.9 6.1 4.7 9.1 10.4 22.6 15.9 5.6 11.2 7.4 0.0 2.0 0.0 5.5 4.5 1.8 0.1 2.0 11.1 2.2 3.2 0.1 4.7 3.8 3.7 2.8 8.4 0.4 2.5 1.0 3.3 2.8 4.9 2.5 0.0 0.0 8.4 0.0 3.3 7.2 2.1 3.3 5.4 2.2 4.0 11.3 2.7 0.0 10.5 2.0 6.2 0.4 0.2 5.6 1.7 2.6 9.9 0.1 20.5 0.6 0.9 0.3 0.0 10.2 4.0 2.4 15.0 3.3 1.5 1.1 2.1 0.3 11.7 3.1 1.5 0.5 0.6 0.0 2.0 22.6 8.0 3.0 9.8 11.5 8.4 6.6 7.9 9.6 10.4 9.1 11.2 10.6 8.2 5.6 15.9 9.7 9.2 7.4 3.8 5.7 7.6 6.5 4.2 4.2 4.7 3.9 6.6 3.7 0.0 4.8 5.1 0.0 1.6 22.0 7.7 17.8 10.7 1.2 8.7 7.9 0.5 1.7 11.8 3.0 8.9 58.8 0.0 4.9 0.2 5.4 0.6 24.4 50.6 9.7 20.6 3.5 19.6 25.4 1.7 1.4 14.5 6.8 4.6 7.0 14.1 3.8 5.8 2.1 8.4 9.5 0.0 2.8 2.3 0.5 1.5 0.6 10.0 10.0 0.1 SLC47A1 "FLJ10847, MATE1" ENSG00000142494 "Solute carrier family 47 member 1" Q96FL8 17 19495385-19579034 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.6;kidney: 51.1;liver: 44.9" "Group enriched" "Detected in many" 4 "Hepatocytes: 40.8;Proximal tubular cells: 54.2" "Cancer enhanced" "Detected in many" "renal cancer: 37.4" "Region enhanced" "Detected in many" "pons and medulla: 11.4" "Group enriched" "Detected in some" 7 "eosinophil: 12.2;plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.9;granulocytes: 12.2" "Cell line enhanced" "Detected in many" "A549: 13.2;AN3-CA: 10.6;Hep G2: 25.4;U-266/70: 19.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021987 Enhanced NA NA "HPA021987: AB_1857185" "unprognostic (1.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.54e-8)" "unprognostic (7.87e-2)" "unprognostic (8.34e-2)" "unprognostic (2.92e-2)" "prognostic favorable (1.88e-5)" "unprognostic (4.84e-2)" "unprognostic (6.89e-2)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic favorable (1.06e-5)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.91e-2)" "unprognostic (9.40e-2)" 2.2 45.6 0.8 0.4 2.2 1.1 0.6 1.0 3.1 13.2 1.2 3.7 1.3 0.7 7.6 12.2 0.9 2.4 1.7 3.5 4.7 0.5 51.1 44.9 3.0 3.5 0.9 2.5 5.0 0.2 0.2 7.2 0.3 11.4 2.6 0.5 4.3 1.1 5.5 12.1 10.4 0.6 3.5 2.3 1.9 0.5 15.5 0.6 0.9 4.7 5.7 1.2 0.6 4.5 0.1 6.9 12.2 1.3 0.0 0.7 0.4 0.0 13.2 0.4 10.6 0.3 0.0 0.0 0.4 0.3 1.6 1.5 0.0 0.4 0.1 2.5 1.9 5.3 0.0 4.7 0.3 0.4 0.0 6.2 0.1 7.0 25.4 0.1 0.1 0.3 0.2 2.4 1.2 0.2 1.8 3.7 0.0 0.0 0.0 0.0 1.8 0.0 0.2 1.4 0.1 0.5 0.1 0.1 0.1 0.0 0.8 2.5 2.2 4.3 0.0 1.1 3.7 4.5 1.2 0.0 0.1 0.5 0.2 1.2 19.8 7.8 0.0 0.5 0.1 2.3 0.2 1.3 12.2 0.3 1.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.7 0.3 0.0 0.2 6.9 0.0 0.4 0.8 2.2 1.0 3.1 4.7 0.5 0.9 2.5 11.4 0.6 6.0 3.0 0.0 2.2 4.1 0.3 3.8 5.1 1.4 0.0 1.8 0.0 0.0 3.3 0.1 11.3 0.7 0.0 0.0 0.0 0.0 2.3 1.3 5.7 40.8 1.5 0.0 0.0 0.0 1.6 2.7 3.4 0.6 1.7 0.0 0.0 1.2 0.0 0.0 1.4 54.2 0.7 6.5 1.0 0.2 0.7 5.8 0.0 0.0 0.0 1.3 SLC47A2 "FLJ31196, MATE2, MATE2-K" ENSG00000180638 "Solute carrier family 47 member 2" Q86VL8 17 19678288-19718979 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 55.5" "Cell type enriched" "Detected in some" 13 "Proximal tubular cells: 69.0" "Cancer enhanced" "Detected in some" "renal cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.9;HeLa: 1.5;hTCEpi: 6.7" "Not detected" "Not detected" NA NA "unprognostic (4.52e-3)" "unprognostic (8.28e-3)" "unprognostic (1.54e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (5.22e-2)" "unprognostic (2.72e-1)" "unprognostic (1.99e-2)" "unprognostic (3.29e-2)" "unprognostic (1.51e-1)" "unprognostic (1.36e-3)" "unprognostic (7.77e-2)" "unprognostic (1.04e-3)" "unprognostic (4.33e-2)" "unprognostic (1.61e-1)" "unprognostic (6.44e-2)" "unprognostic (5.71e-2)" 0.2 0.3 3.0 0.1 4.4 0.1 0.3 0.2 0.4 0.1 0.2 10.3 0.6 0.2 0.2 6.5 0.2 8.6 0.1 0.3 6.2 5.5 55.5 0.1 0.1 0.1 1.1 0.1 0.6 0.1 0.1 0.0 0.1 12.8 0.1 0.1 0.7 0.1 0.3 0.7 1.8 0.4 0.2 2.0 0.1 0.1 0.2 2.8 0.0 0.3 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 1.2 0.0 0.2 1.9 0.0 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.8 0.0 0.3 0.0 0.1 0.3 0.5 0.2 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 3.0 4.4 0.2 0.4 6.2 5.5 1.1 0.1 12.8 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 5.2 0.0 0.1 5.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 69.0 0.2 0.0 0.3 0.5 0.2 0.3 0.0 0.0 0.0 0.1 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 42.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles NA NA Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favorable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favorable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 16.2 13.5 27.8 5.0 33.5 7.7 10.7 12.5 39.5 13.1 8.3 90.7 6.7 5.6 11.9 12.7 13.9 21.9 11.5 12.8 32.7 20.8 18.5 6.3 11.7 4.9 44.1 27.9 35.6 10.6 24.3 6.4 13.2 38.6 9.3 8.2 7.4 13.2 18.1 16.7 14.7 5.3 12.7 44.5 11.3 7.7 5.1 39.7 4.9 35.6 6.1 6.0 9.9 7.6 7.1 8.5 23.7 11.9 1.2 5.4 4.0 4.5 14.2 2.2 17.0 14.9 6.4 5.0 3.3 7.3 3.1 3.2 4.5 12.4 2.8 42.7 9.1 6.3 18.2 2.9 3.8 2.4 23.1 2.8 19.3 11.9 6.1 8.5 5.1 11.5 3.8 7.7 4.5 5.5 16.4 8.8 7.9 5.0 11.3 2.0 9.5 2.4 5.2 1.5 8.5 7.0 2.4 0.6 15.1 12.6 12.2 2.9 1.3 4.4 5.5 3.1 4.3 18.4 4.8 4.8 4.5 6.0 8.4 2.3 9.1 5.6 0.8 5.8 24.5 2.6 0.0 11.9 7.8 3.6 8.5 3.2 7.1 4.4 3.7 8.5 6.3 5.4 4.4 23.7 1.2 4.8 1.6 3.4 4.0 27.8 33.5 12.5 39.5 32.7 20.8 44.1 27.9 38.6 39.7 8.9 9.1 3.7 8.4 6.0 10.5 14.3 10.2 1.4 5.7 48.8 2.0 8.0 19.9 8.5 7.7 21.5 6.7 0.0 8.5 1.7 9.9 11.0 1.1 10.4 20.5 14.3 8.1 12.9 14.9 10.4 30.2 9.3 5.0 40.5 12.9 19.3 6.7 7.0 21.5 27.0 10.3 6.5 8.5 4.3 9.6 10.5 3.0 2.5 7.6 10.1 SLC4A1 "AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR" ENSG00000004939 "Solute carrier family 4 member 1 (Diego blood group)" P02730 17 44248385-44268141 "Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Blood group antigen" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 95.7;placenta: 32.7" "Cell type enriched" "Detected in some" 66 "Erythroid cells: 1261.4" "Cancer enriched" "Detected in single" 91 "renal cancer: 16.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 0.4" "Low region specificity" "Detected in all" "HPA015584, CAB034438, HPA063911" Enhanced NA NA 160000000 "CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-2)" "unprognostic (2.32e-2)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (6.72e-3)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (1.93e-2)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (2.13e-1)" 0.9 0.1 0.3 0.2 0.4 95.7 0.2 0.8 0.2 0.1 0.1 0.6 0.0 0.2 0.1 0.4 0.6 0.2 0.2 2.6 0.2 0.3 18.6 1.3 12.9 0.8 0.6 0.1 2.8 0.1 0.0 0.6 32.7 0.9 0.6 0.1 1.2 0.1 0.1 1.2 0.2 0.1 0.0 1.0 8.4 0.1 0.3 0.0 0.7 1.9 0.0 0.2 3.9 11.8 1.8 1.4 6.3 1.2 2.9 1.5 0.7 1.3 0.5 1.4 1.7 0.6 0.7 1.0 0.3 0.4 0.3 0.8 1.4 3.2 0.7 0.6 0.3 0.4 1.4 0.5 0.5 1.1 1.3 1.3 1.7 1.6 2.2 0.0 0.8 2.3 0.8 0.5 0.8 0.8 0.5 0.2 0.6 4.8 3.5 0.4 0.6 1.0 3.5 0.9 0.7 0.5 2.5 0.7 1.9 0.3 0.8 2.2 1.0 1.3 1.4 0.5 0.7 2.5 1.8 1.0 2.4 2.1 1.4 1.4 1.0 2.3 1.1 1.6 2.2 1.1 6.1 1.0 2.0 1.1 0.9 1.0 1.1 1.0 0.9 0.5 1.8 1.5 1.2 6.3 2.9 1.2 1.4 0.7 0.7 0.3 0.4 0.8 0.2 0.2 0.3 0.6 0.1 0.9 0.0 6.0 1.1 0.0 0.9 0.0 0.4 0.7 0.0 0.0 1.2 19.2 0.0 0.3 3.3 0.0 0.5 0.0 0.0 1261.4 0.0 0.9 0.3 0.4 0.0 0.0 1.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.9 0.4 0.0 0.7 0.0 0.0 0.5 SLC4A10 "NBCn2, NCBE" ENSG00000144290 "Solute carrier family 4 member 10" Q6U841 2 161424332-161985282 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 31.2;brain: 48.1" "Cell type enriched" "Detected in some" 12 "Bipolar cells: 116.7" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "MAIT T-cell: 31.2" "Lineage enriched" "Detected in single" 78 "T-cells: 31.2" "Cell line enriched" "Detected in some" 11 "Karpas-707: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034755, HPA076725" Enhanced NA NA "HPA034755: AB_10670296, HPA076725: " "unprognostic (4.64e-4)" "unprognostic (3.88e-1)" "unprognostic (2.88e-2)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "unprognostic (7.89e-3)" "unprognostic (5.99e-4)" "unprognostic (1.12e-1)" "unprognostic (2.27e-1)" "unprognostic (1.64e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" "unprognostic (5.65e-2)" "unprognostic (9.23e-3)" "unprognostic (1.87e-1)" "unprognostic (2.10e-3)" "unprognostic (2.26e-1)" 1.0 3.7 21.6 1.9 24.1 1.2 1.3 14.9 48.1 1.1 3.3 2.1 0.0 1.4 1.0 2.8 1.0 1.8 1.5 1.0 20.4 10.8 1.0 1.3 1.1 1.1 4.3 29.6 1.0 2.9 1.0 4.4 1.0 17.7 1.3 2.7 1.7 1.0 1.1 1.0 1.0 1.5 1.1 1.9 3.0 1.3 1.4 3.5 0.0 1.0 0.0 1.5 1.3 0.3 0.0 0.0 0.0 0.0 0.4 31.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.2 0.0 31.2 0.0 0.6 3.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 21.6 24.1 14.9 37.9 20.4 10.8 4.3 29.6 17.7 3.5 0.0 0.0 0.0 0.0 0.0 116.7 0.4 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 1.8 1.2 8.4 0.0 0.0 0.0 0.0 2.2 2.4 0.1 0.0 0.0 0.0 6.7 0.0 0.0 0.9 0.2 0.0 0.0 4.4 0.0 0.0 SLC4A11 "BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1" ENSG00000088836 "Solute carrier family 4 member 11" Q8NBS3 20 3227417-3239559 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Symport, Transport" "Corneal dystrophy, Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 34.4;thyroid gland: 42.7" "Cell type enriched" "Detected in some" 4 "Collecting duct cells: 106.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.4;T-reg: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 36.0;Hep G2: 21.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA018120, HPA058377" Uncertain Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA018120: AB_1857186, HPA058377: " "unprognostic (2.33e-1)" "prognostic favorable (9.03e-4)" "unprognostic (1.18e-2)" "unprognostic (3.05e-2)" "unprognostic (1.00e-1)" "unprognostic (6.52e-2)" "unprognostic (9.66e-3)" "unprognostic (3.73e-2)" "unprognostic (3.10e-3)" "unprognostic (1.52e-3)" "unprognostic (2.94e-1)" "unprognostic (2.64e-1)" "prognostic favorable (6.21e-6)" "unprognostic (7.37e-2)" "unprognostic (4.30e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-3)" 0.8 3.1 3.3 0.8 4.9 0.3 2.4 2.1 2.8 8.6 0.2 1.3 0.8 0.1 0.9 2.0 7.5 1.1 2.2 0.5 3.0 0.6 11.4 0.1 1.3 0.9 1.4 1.1 0.6 0.1 0.4 2.4 0.3 1.8 2.2 0.3 1.1 34.4 5.8 3.5 5.3 0.3 0.2 1.4 0.3 1.9 3.2 1.2 0.2 42.7 3.3 5.1 2.6 2.1 0.0 0.7 0.0 1.4 0.0 1.1 0.4 5.4 7.8 0.9 4.1 2.7 0.7 11.1 2.7 1.7 1.4 0.8 0.5 7.2 0.0 3.2 0.9 3.4 36.0 4.2 8.5 0.2 0.0 1.7 0.3 3.4 21.0 1.7 1.9 7.0 0.3 3.5 1.7 1.6 1.2 3.6 5.0 0.7 5.0 1.4 3.5 0.2 0.2 6.2 6.7 10.6 1.2 5.3 1.7 8.7 15.3 0.4 2.5 1.4 9.0 0.2 2.9 3.4 3.4 6.1 1.1 3.7 0.2 1.3 0.2 0.3 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.7 0.0 0.3 0.0 0.0 0.0 1.4 0.0 1.1 0.4 3.3 4.9 2.1 2.8 3.0 0.6 1.4 1.1 1.8 1.2 0.0 0.0 0.0 1.7 0.7 0.1 1.2 0.0 5.3 2.3 106.4 0.0 0.0 0.0 0.7 3.5 0.3 0.0 0.0 0.4 0.1 0.3 2.0 0.0 0.0 0.3 0.0 0.0 1.8 0.3 1.5 0.0 0.0 0.0 1.0 0.1 0.0 2.2 0.6 0.4 0.3 0.0 25.8 0.5 0.6 5.2 0.4 0.0 0.0 0.0 2.6 SLC4A2 "AE2, BND3L, EPB3L1, HKB3, NBND3" ENSG00000164889 "Solute carrier family 4 member 2" P04920 7 151057210-151076527 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.2;retina: 100.7" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 76.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "pons and medulla: 73.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA019339 Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Nuclear speckles, Plasma membrane" Cytosol "HPA019339: AB_1844825" "unprognostic (1.19e-1)" "unprognostic (3.33e-3)" "unprognostic (8.12e-3)" "unprognostic (1.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.04e-6)" "unprognostic (1.24e-1)" "unprognostic (4.23e-1)" "unprognostic (3.30e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.26e-4)" "unprognostic (4.67e-3)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.36e-2)" 9.9 13.5 4.7 10.4 7.4 6.7 10.5 3.0 8.6 12.4 18.6 29.0 6.0 12.1 16.2 6.3 7.7 10.8 14.1 11.9 10.1 3.8 35.5 94.2 12.3 7.2 10.4 4.8 12.6 34.1 30.6 5.3 31.4 73.3 10.5 4.0 100.7 11.9 8.3 8.7 9.5 26.0 10.7 10.4 10.1 27.1 6.5 8.5 8.8 9.7 7.0 5.9 11.7 10.6 2.5 5.6 2.1 4.2 0.5 2.7 1.9 15.9 52.8 10.4 21.4 10.4 6.1 23.8 19.4 10.5 15.9 13.8 30.0 25.6 9.6 42.6 9.2 23.4 15.7 10.6 9.4 2.9 27.6 15.8 12.6 25.7 15.2 17.0 6.5 40.6 8.9 8.3 18.0 4.6 17.1 8.8 13.6 38.9 8.1 12.3 30.6 18.6 11.2 24.7 21.5 19.6 14.7 5.7 11.2 13.0 12.1 8.6 31.2 17.7 33.5 16.5 8.2 13.8 12.8 19.0 21.4 10.9 21.0 28.5 8.8 11.8 5.4 32.7 16.3 42.9 0.0 4.2 2.1 2.7 3.9 1.9 2.5 2.1 1.8 2.4 1.0 2.4 2.4 1.0 0.5 2.5 5.6 1.0 1.9 4.7 7.4 3.0 8.6 10.1 3.8 10.4 4.8 73.3 8.5 8.9 10.9 6.7 4.5 9.8 7.9 3.6 17.8 1.4 2.3 19.2 23.6 28.5 14.9 31.0 0.6 9.8 17.3 0.0 30.9 9.0 16.2 5.0 48.3 31.4 23.1 14.3 26.5 14.7 15.1 1.3 12.7 9.9 25.3 9.0 11.1 22.3 39.3 14.0 18.7 18.9 8.8 12.9 15.5 3.2 7.7 6.0 76.5 8.3 18.9 3.1 SLC4A3 "AE3, SLC2C" ENSG00000114923 "Solute carrier family 4 member 3" P48751 2 219627327-219641980 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 103.6;ovary: 30.2" "Group enriched" "Detected in many" 17 "Cardiomyocytes: 201.0;Horizontal cells: 527.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "myeloid DC: 2.3;plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 58 "dendritic cells: 8.9" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063498 Approved Nucleoplasm NA NA Nucleoplasm "HPA063498: AB_2685025" "unprognostic (9.49e-2)" "unprognostic (5.72e-3)" "unprognostic (8.92e-4)" "unprognostic (1.77e-2)" "unprognostic (6.61e-3)" "unprognostic (1.47e-1)" "unprognostic (2.60e-1)" "unprognostic (2.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-1)" "unprognostic (8.15e-3)" "unprognostic (1.97e-1)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.12e-4)" 1.8 5.4 11.8 1.6 22.5 1.2 2.0 8.8 22.0 2.8 1.3 3.0 0.4 1.4 3.4 2.6 2.9 2.7 2.3 103.6 10.4 8.2 1.6 1.0 1.3 1.4 6.5 9.0 30.2 2.7 4.5 9.9 2.5 24.1 4.2 1.1 4.9 3.1 4.3 1.2 1.6 1.3 3.1 1.6 2.6 1.4 4.2 3.5 0.0 1.5 0.0 1.3 1.6 0.9 0.0 8.9 0.0 0.1 0.0 0.0 0.0 6.2 0.2 2.2 6.5 0.4 0.4 4.4 3.9 4.1 5.3 3.8 4.5 3.6 0.0 1.5 1.4 9.2 3.6 1.1 7.1 1.6 0.0 1.0 0.0 0.0 0.1 1.1 0.1 0.3 3.1 6.7 0.0 2.1 13.4 0.0 0.0 0.2 0.0 1.5 2.1 0.0 0.0 3.6 0.2 5.3 0.0 0.0 0.0 3.6 1.5 1.3 6.4 2.5 6.8 3.3 7.5 0.6 1.6 0.0 3.3 5.8 0.0 3.1 0.0 0.0 0.0 2.7 0.0 8.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 11.8 22.5 8.8 22.0 10.4 8.2 6.5 9.0 24.1 3.5 0.0 0.0 0.0 0.6 0.2 8.9 201.0 0.0 0.0 1.2 1.8 0.0 10.5 1.7 2.8 2.0 0.1 0.0 0.0 1.5 2.5 2.2 0.3 0.0 0.0 1.6 527.6 0.0 0.0 0.0 11.9 14.1 1.1 0.0 1.0 0.0 7.0 1.3 0.0 21.2 0.3 6.7 6.5 1.4 0.5 1.1 0.6 11.6 0.0 0.0 0.0 SLC4A4 "hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5" ENSG00000080493 "Solute carrier family 4 member 4" Q9Y6R1 4 71186757-71572087 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.4;pancreas: 113.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5" "Group enriched" "Detected in many" 5 "glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.8;memory CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 5 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022493, HPA035628, HPA035629, HPA079220" Enhanced NA NA "CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: " "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "prognostic favorable (7.69e-4)" "unprognostic (5.32e-2)" "unprognostic (1.01e-1)" "unprognostic (5.09e-2)" "unprognostic (4.24e-2)" "unprognostic (7.49e-2)" "unprognostic (1.46e-1)" "unprognostic (9.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.74e-1)" "prognostic favorable (1.18e-4)" "unprognostic (7.00e-2)" "unprognostic (2.92e-1)" "unprognostic (2.05e-3)" "unprognostic (2.04e-1)" 2.4 0.9 14.3 4.3 19.9 0.7 1.1 18.1 15.2 5.8 17.2 4.5 0.1 22.4 0.8 0.7 1.1 1.0 24.9 2.9 13.1 8.1 47.4 9.4 5.8 0.6 9.7 11.2 1.0 113.8 10.0 4.1 1.6 18.1 14.6 17.1 11.1 1.5 1.1 1.3 0.7 10.4 1.3 21.6 0.9 8.3 0.7 8.0 0.0 9.5 0.0 0.6 2.6 0.9 0.0 0.1 0.0 0.0 0.5 2.8 0.3 0.0 3.6 1.0 0.0 0.0 0.0 0.1 13.9 1.9 2.3 1.8 0.0 0.1 0.0 0.1 6.3 0.6 0.0 0.2 0.0 5.7 0.0 1.8 0.9 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 6.0 0.0 0.9 0.0 0.6 1.2 0.0 4.7 0.2 0.1 0.2 0.0 0.0 0.0 0.9 14.9 4.2 1.0 0.1 0.0 0.0 0.2 1.2 0.0 0.0 0.0 7.9 0.7 5.7 0.6 0.0 0.0 0.0 5.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 1.4 0.0 0.8 2.4 0.1 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.3 14.3 19.9 18.1 12.4 13.1 8.1 9.7 11.2 18.1 8.0 3.0 32.5 1.3 4.2 0.0 0.0 20.1 107.0 14.7 31.8 24.4 0.0 0.2 13.3 81.5 6.6 1.9 173.4 0.0 21.6 0.1 1.1 63.3 1.1 31.7 0.2 0.0 8.2 1.8 0.6 1.0 0.0 1.0 1.7 1.8 66.7 3.3 19.9 56.6 0.0 149.5 1.1 6.5 2.5 0.1 0.4 0.0 0.2 6.9 42.6 7.0 SLC4A5 NBC4 ENSG00000188687 "Solute carrier family 4 member 5" Q9BY07 2 74216242-74343414 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Anion exchange, Ion transport, Sodium transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 109.1" "Cell type enhanced" "Detected in some" 28 "Cone photoreceptor cells: 33.4;Horizontal cells: 158.9;Rod photoreceptor cells: 43.4" "Cancer enriched" "Detected in single" 11 "thyroid cancer: 3.3" "Group enriched" "Detected in many" 5 "cerebellum: 3.4;pons and medulla: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 14.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA036621 Uncertain NA NA "HPA036621: AB_10696779" "unprognostic (1.30e-1)" "unprognostic (3.78e-2)" "unprognostic (2.75e-2)" "unprognostic (1.83e-4)" "unprognostic (3.38e-1)" "unprognostic (2.36e-2)" "unprognostic (2.56e-3)" "unprognostic (5.37e-4)" "unprognostic (1.39e-1)" "unprognostic (2.55e-1)" "unprognostic (1.55e-3)" "unprognostic (3.24e-2)" "unprognostic (1.72e-5)" "unprognostic (1.57e-1)" "unprognostic (1.06e-2)" "unprognostic (8.47e-2)" "unprognostic (9.27e-4)" 1.2 0.4 1.0 0.8 0.8 1.6 1.1 3.4 1.2 0.7 0.8 2.5 0.6 0.3 0.9 1.7 0.6 1.4 0.8 0.7 1.2 1.0 0.7 3.2 1.7 1.0 1.0 0.6 1.3 0.9 1.5 2.3 0.6 9.0 0.9 0.3 109.1 1.3 0.8 1.1 3.7 0.7 0.9 1.6 0.7 0.5 16.1 0.7 1.0 21.4 0.6 0.7 0.9 0.9 2.5 5.8 6.1 0.9 1.7 2.5 0.6 0.4 0.8 1.4 1.4 1.5 2.6 1.9 0.4 1.4 0.8 1.2 0.4 1.0 2.2 0.4 0.0 0.5 0.1 1.6 0.2 0.3 1.9 0.9 3.3 1.4 0.8 0.2 1.1 2.3 0.7 2.0 0.1 0.3 0.7 0.5 1.6 0.7 2.4 0.3 5.2 0.5 2.2 1.1 1.0 0.3 1.1 1.4 0.0 0.3 1.0 1.0 2.1 0.5 1.7 2.3 1.4 1.6 2.2 0.0 1.5 2.4 1.6 0.5 14.6 2.0 1.7 0.9 1.2 0.3 6.1 0.9 0.9 1.5 0.8 1.0 1.8 2.3 2.0 0.6 2.5 2.1 2.5 4.2 1.7 0.3 5.8 2.4 0.6 1.0 0.8 3.4 1.2 1.2 1.0 1.0 0.6 9.0 0.7 3.0 6.7 0.0 0.6 0.6 12.6 0.4 2.5 4.0 4.5 0.0 33.4 0.0 0.0 0.3 0.4 0.8 0.0 0.0 0.6 0.0 0.4 0.8 0.0 0.0 0.1 158.9 0.0 0.0 0.0 0.0 1.1 0.2 1.7 0.0 0.1 2.9 0.2 0.0 0.4 0.0 43.4 0.0 0.4 1.7 1.4 0.4 0.0 0.0 0.0 0.5 SLC4A7 "NBC3, SBC2, SLC4A6" ENSG00000033867 "Solute carrier family 4 member 7" Q9Y6M7 3 27372721-27484420 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 48.5" "Group enriched" "Detected in many" 10 "Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 38.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB022494, HPA035857" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Plasma membrane" "Focal adhesion sites, Cytosol" "CAB022494: , HPA035857: AB_10795135" "unprognostic (2.94e-2)" "unprognostic (6.34e-2)" "unprognostic (1.80e-3)" "unprognostic (1.91e-1)" "unprognostic (8.48e-3)" "unprognostic (2.68e-1)" "unprognostic (6.79e-4)" "unprognostic (4.13e-2)" "unprognostic (1.40e-1)" "unprognostic (1.64e-1)" "unprognostic (1.83e-1)" "unprognostic (8.58e-3)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.09e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-1)" "unprognostic (7.26e-2)" 14.5 5.0 3.2 10.5 4.6 3.3 17.0 4.0 4.8 10.8 38.2 5.0 8.8 48.5 8.1 12.6 8.4 6.5 12.5 9.3 5.0 3.8 15.3 3.7 9.3 10.3 4.8 1.9 9.0 3.3 2.4 4.4 5.6 4.5 10.3 6.9 20.0 8.3 8.4 5.6 5.6 43.4 18.2 5.8 9.7 7.8 6.1 5.5 6.8 6.3 14.7 15.5 15.0 14.9 1.8 2.0 0.1 0.9 2.4 3.9 0.7 5.9 11.1 10.0 4.6 4.7 8.4 7.1 20.2 9.4 7.8 6.1 3.0 3.1 13.5 1.7 7.8 7.5 2.6 9.5 9.8 12.4 11.4 3.1 6.2 7.6 3.2 8.1 14.0 5.4 6.7 4.3 11.8 38.2 16.5 12.8 8.9 4.1 4.8 16.0 2.1 13.9 3.2 6.6 0.7 11.0 9.5 7.9 2.7 18.3 4.2 2.5 6.3 9.2 6.8 3.1 8.9 15.5 5.4 8.9 18.4 5.1 12.7 15.6 1.8 1.9 7.7 16.1 9.9 8.4 0.0 0.5 0.0 3.0 0.6 2.0 1.2 3.8 3.9 1.4 1.8 1.5 2.7 0.1 2.4 0.9 2.0 3.2 0.7 3.2 4.6 4.0 4.8 5.0 3.8 4.8 1.9 4.5 5.5 0.0 12.8 13.2 28.2 26.1 65.7 18.7 15.3 5.3 25.0 59.3 691.1 4.5 8.3 13.6 6.7 25.3 5.8 0.0 6.2 23.0 30.2 41.3 23.1 5.9 16.9 6.4 36.7 14.7 33.1 5.9 8.3 36.7 33.7 20.8 50.6 45.2 13.6 12.7 9.2 10.5 667.4 38.8 32.8 32.4 21.7 26.8 6.8 33.0 12.2 33.6 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Predicted membrane proteins" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 20.0;testis: 15.3" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 85.2;Cone photoreceptor cells: 168.9;Horizontal cells: 109.7;Spermatocytes: 91.6" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 17.6;HMC-1: 12.4;SCLC-21H: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 1.0 6.5 5.8 2.2 13.3 1.7 3.1 9.2 22.9 2.7 1.1 9.8 0.0 1.4 1.2 5.4 0.7 3.7 1.1 1.0 10.9 5.6 3.2 0.8 2.8 3.0 6.0 9.3 7.3 2.4 1.0 20.0 1.0 28.6 1.4 1.4 2.2 1.5 1.7 0.8 1.0 2.0 1.1 4.7 2.2 3.0 15.3 5.1 0.0 0.8 0.0 2.7 1.0 0.7 1.1 2.6 3.4 3.1 1.7 1.7 0.7 0.2 0.8 9.9 0.1 0.4 0.5 17.6 2.7 4.5 4.4 2.8 5.8 0.2 3.6 0.4 3.6 2.4 0.1 3.9 0.2 4.1 0.7 0.5 1.8 0.3 0.0 0.0 0.6 12.4 0.1 0.2 2.2 0.5 2.6 5.1 1.6 0.1 6.4 2.2 2.1 5.2 1.1 4.3 1.1 2.9 0.1 0.0 0.0 0.5 0.1 13.2 8.9 1.0 1.4 0.0 3.2 1.6 0.4 4.7 2.8 1.5 0.2 3.4 3.2 1.0 0.2 3.9 0.5 0.4 1.3 2.1 3.4 1.7 1.4 0.4 0.6 0.6 1.6 2.6 1.1 0.6 1.0 2.3 1.7 3.1 1.0 0.3 0.7 5.8 13.3 9.2 22.9 10.9 5.6 6.0 9.3 28.6 5.1 0.0 8.3 0.5 0.6 0.0 85.2 1.7 0.0 38.8 9.1 1.8 168.9 1.0 6.6 0.1 48.8 1.1 0.3 0.0 1.2 4.3 0.5 1.0 7.0 0.0 2.1 109.7 5.8 0.6 1.2 22.8 2.6 3.3 1.7 0.0 0.2 13.6 0.1 2.9 3.5 0.8 18.4 0.0 0.8 91.6 6.4 0.1 0.3 2.5 0.0 1.0 SLC4A9 AE4 ENSG00000113073 "Solute carrier family 4 member 9" Q96Q91 5 140360202-140375143 "Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "kidney: 26.7" "Cell type enhanced" "Detected in single" 21 "Distal tubular cells: 1.7" "Cancer enriched" "Detected in single" 8 "renal cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 3.8;U-698: 2.0" "Region enhanced" "Detected in single" "pons and medulla: 1.0" "Low region specificity" "Detected in all" HPA051307 Uncertain NA NA "HPA051307: AB_2681434" "unprognostic (1.68e-1)" "unprognostic (4.22e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "unprognostic (1.02e-2)" "unprognostic (3.28e-3)" "unprognostic (2.78e-1)" "unprognostic (2.47e-1)" "unprognostic (4.78e-2)" "unprognostic (1.19e-1)" "unprognostic (4.24e-2)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (5.04e-2)" "unprognostic (1.82e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 26.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.2 0.2 0.0 0.7 0.6 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 3.8 0.0 0.8 0.0 0.4 0.0 0.2 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.0 1.0 0.5 2.0 0.0 0.1 0.2 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.0 0.1 SLC51A OSTalpha ENSG00000163959 "Solute carrier family 51 alpha subunit" Q86UW1 3 196211487-196243178 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "intestine: 53.9;liver: 59.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.2;Leydig cells: 57.0;Peritubular cells: 95.5;Sertoli cells: 142.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 15.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.7;neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "REH: 8.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA045488 Enhanced NA NA "HPA045488: " "unprognostic (1.63e-2)" "unprognostic (1.27e-3)" "unprognostic (2.80e-1)" "unprognostic (7.66e-2)" "unprognostic (5.16e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.02e-2)" "unprognostic (1.07e-1)" "unprognostic (5.98e-3)" "unprognostic (5.41e-2)" "unprognostic (2.90e-2)" "unprognostic (2.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-5)" 0.5 2.3 0.3 3.8 0.3 2.4 0.4 0.3 0.4 0.5 12.3 0.4 0.7 13.6 0.4 2.8 0.5 0.5 0.5 0.5 0.3 0.1 2.2 59.5 0.8 0.3 0.3 0.3 0.6 0.3 1.4 0.5 0.3 0.3 0.5 0.1 0.3 0.6 0.3 0.5 1.0 53.9 0.3 0.3 0.8 0.2 1.8 0.3 0.6 0.8 0.3 0.5 0.3 0.7 0.2 0.0 1.7 0.6 0.4 0.6 0.1 1.1 1.7 1.4 1.7 0.0 1.1 0.1 0.8 0.0 0.1 0.0 0.7 0.5 0.1 2.0 1.1 0.1 0.9 0.2 0.0 0.0 0.7 2.9 1.0 0.8 1.8 0.2 1.4 1.4 0.3 0.0 0.2 1.3 1.5 0.2 0.3 0.2 3.3 0.0 0.6 0.1 1.2 0.1 0.4 2.0 8.1 0.1 0.5 0.0 0.9 0.3 0.5 0.5 3.3 0.3 0.4 2.4 0.5 0.6 1.7 0.7 1.3 0.9 3.3 4.0 0.6 1.1 0.7 0.6 0.0 0.2 1.7 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.6 1.6 0.4 0.5 0.0 0.1 0.1 0.3 0.3 0.3 0.4 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.3 0.0 1.9 3.0 0.5 3.3 2.5 10.7 4.5 0.0 3.9 0.5 3.3 0.3 16.2 1.8 130.2 23.3 0.2 0.3 3.1 1.4 0.0 38.6 0.5 1.6 0.0 4.3 3.8 10.3 57.0 3.3 3.3 0.0 0.4 0.3 0.1 8.6 95.5 4.9 0.9 142.3 2.0 2.1 1.1 2.3 0.8 2.6 0.5 2.6 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 beta subunit" Q86UW2 15 65045370-65053396 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 85.0" "Cell type enriched" "Detected in many" 6 "Enterocytes: 518.3" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria No NA Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favorable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.4 0.5 0.4 3.8 0.6 0.0 0.4 0.4 0.8 14.0 34.9 0.4 0.4 28.1 0.9 3.3 0.4 1.0 0.5 0.4 0.5 0.6 7.5 2.4 1.6 0.4 0.6 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.8 9.5 0.4 0.4 0.8 0.4 0.1 85.0 0.4 0.4 0.4 0.2 4.1 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.7 0.1 0.0 0.5 0.3 0.0 1.4 0.2 0.8 0.0 0.1 0.4 0.0 0.0 0.2 0.0 16.9 0.0 0.1 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 14.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.4 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.8 0.4 0.0 0.6 0.5 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.3 0.4 0.6 0.4 0.4 0.5 0.6 0.6 0.4 0.4 0.4 0.0 0.6 1.5 0.1 0.0 0.0 0.0 2.5 10.7 0.0 0.0 0.0 0.0 11.6 0.0 48.8 0.0 518.3 0.0 0.0 0.0 0.0 0.0 4.6 1.5 0.1 0.0 1.7 0.6 0.0 9.7 0.3 0.0 0.0 0.0 7.7 0.0 0.0 84.2 0.0 54.0 0.0 6.5 0.0 1.5 0.4 0.0 0.1 0.0 19.7 0.0 SLC52A1 "FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1" ENSG00000132517 "Solute carrier family 52 member 1" Q9NWF4 17 5032600-5052009 "Disease related genes, Predicted membrane proteins" Transport "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 25.6;placenta: 34.6" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 685.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.5;BEWO: 3.8;EFO-21: 3.6;HMC-1: 9.0;SK-BR-3: 5.1;T-47d: 3.0" NA NA "unprognostic (8.81e-3)" "prognostic favorable (9.54e-4)" "unprognostic (9.34e-2)" "unprognostic (7.30e-4)" "unprognostic (6.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.82e-3)" "unprognostic (1.72e-1)" "unprognostic (2.36e-1)" "unprognostic (1.15e-1)" "unprognostic (7.19e-2)" "unprognostic (5.17e-5)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (4.07e-2)" "unprognostic (6.60e-2)" 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.3 0.6 1.0 20.0 0.2 0.6 24.4 0.5 0.1 1.5 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.2 0.1 1.0 0.1 34.6 0.3 1.4 0.1 0.1 0.5 0.3 0.1 7.4 25.6 0.1 0.1 0.6 0.0 0.7 0.1 0.6 0.2 0.4 0.7 2.5 1.0 1.4 0.6 3.7 0.6 1.4 1.2 0.3 0.2 4.5 0.1 0.2 0.2 0.2 3.8 0.0 0.0 0.6 0.6 0.1 0.2 0.3 3.6 0.1 0.7 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.7 0.3 0.1 0.1 9.0 0.1 0.1 0.2 0.1 0.2 0.2 0.7 0.1 1.2 0.0 0.3 0.5 0.4 0.4 0.1 0.2 0.1 0.0 0.3 0.1 1.4 0.1 0.3 0.8 5.1 0.1 0.2 3.0 1.4 0.6 0.3 1.1 0.1 0.2 0.3 0.1 0.3 0.2 0.1 0.5 2.6 0.6 0.9 0.7 0.4 0.6 0.6 0.9 1.2 0.2 1.4 1.1 0.8 3.7 1.4 0.4 0.6 0.5 0.3 0.1 0.2 0.3 0.6 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.0 1.3 1.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 134.6 0.0 0.0 0.1 0.1 5.7 0.0 0.0 10.3 1.1 0.3 0.0 0.0 13.6 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.5 685.8 0.0 1.1 0.7 SLC52A3 "bA371L19.1, C20orf54, hRFT2, RFVT3" ENSG00000101276 "Solute carrier family 52 member 3" Q9NQ40 20 760080-776015 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 32.5" "Cell type enhanced" "Detected in many" 11 "Collecting duct cells: 22.7;Cytotrophoblasts: 15.8;Enterocytes: 25.3;Syncytiotrophoblasts: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 25.9;OE19: 17.9;RT4: 6.0;SK-BR-3: 9.5;T-47d: 11.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049391, HPA059078" Approved NA NA "HPA049391: AB_2680743, HPA059078: AB_2732630" "unprognostic (4.53e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (7.84e-2)" "unprognostic (1.29e-1)" "unprognostic (9.03e-3)" "unprognostic (2.12e-3)" "unprognostic (1.43e-3)" "unprognostic (1.15e-2)" "unprognostic (4.36e-2)" "unprognostic (4.39e-3)" "unprognostic (4.82e-2)" "unprognostic (2.04e-3)" "prognostic favorable (5.51e-6)" "unprognostic (3.04e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" 2.0 0.4 7.3 1.4 5.9 0.5 2.8 3.5 9.0 2.6 9.6 2.1 12.0 13.1 1.8 1.9 4.6 2.0 3.0 3.3 6.6 4.2 10.0 0.4 1.4 0.7 5.6 1.3 1.2 2.2 0.6 0.5 6.7 7.3 7.9 6.3 0.5 5.5 15.8 1.0 1.7 16.3 1.5 4.7 0.4 5.2 32.5 6.0 0.0 0.7 1.2 0.9 4.7 2.2 1.1 0.7 2.4 0.6 1.1 0.8 0.4 3.3 0.9 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.3 25.9 0.0 3.8 0.0 0.2 3.8 0.0 2.8 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 17.9 2.3 0.0 0.0 0.3 0.0 6.0 0.0 0.1 3.8 9.5 0.0 0.4 11.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.5 0.4 0.2 0.4 0.5 0.4 0.4 0.1 1.1 0.4 0.8 2.2 1.1 0.4 0.7 0.3 0.4 7.3 5.9 3.5 9.0 6.6 4.2 5.6 1.3 7.3 6.0 8.9 1.9 0.0 2.2 0.6 0.4 0.4 0.0 0.0 3.4 22.7 2.0 15.8 1.7 5.6 0.7 2.9 25.3 0.0 1.6 0.7 0.2 5.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 0.9 0.3 1.7 0.0 4.9 0.0 4.1 14.4 0.4 0.0 0.0 0.0 0.2 0.5 0.7 1.0 43.6 0.0 9.3 6.2 SLC5A1 "D22S675, NAGT, SGLT1" ENSG00000100170 "Solute carrier family 5 member 1" P13866 22 32043032-32113029 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "intestine: 274.9" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 27.0" "Region enriched" "Detected in single" 26 "cerebellum: 8.6" "Not detected" "Not detected" "CAB015467, HPA051805, HPA055106" Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" "Nuclear membrane, Cytosol" "CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (2.24e-2)" "prognostic favorable (2.59e-4)" "unprognostic (3.85e-2)" "unprognostic (2.75e-2)" "unprognostic (1.60e-2)" "unprognostic (2.15e-1)" "unprognostic (9.22e-2)" "unprognostic (4.83e-2)" "unprognostic (6.21e-2)" "unprognostic (9.53e-2)" "prognostic favorable (6.97e-7)" "unprognostic (4.68e-3)" "unprognostic (1.98e-1)" "unprognostic (6.00e-2)" "unprognostic (1.45e-2)" 0.2 0.0 0.2 1.3 0.2 0.0 1.5 0.2 0.2 2.2 181.5 0.2 2.9 95.5 0.3 0.8 1.9 0.0 14.1 24.5 0.2 0.0 1.0 0.9 0.3 0.2 0.2 0.2 0.2 0.4 0.0 1.0 0.2 0.2 0.8 1.6 0.2 5.7 3.5 0.2 4.6 274.9 0.2 0.2 0.7 1.2 0.8 0.2 0.2 0.2 3.5 1.5 0.2 2.0 0.3 0.1 0.6 0.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 27.0 0.0 0.0 0.0 1.6 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.2 0.6 0.3 0.8 0.1 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 1.8 0.6 0.0 111.5 117.2 0.0 4.5 0.0 0.0 0.0 0.0 2.4 40.8 0.0 26.1 0.0 1.2 0.0 0.2 19.7 0.0 0.0 0.0 0.0 24.5 0.0 0.0 54.9 1.1 0.0 0.0 0.0 8.7 0.0 0.6 14.7 1.4 1.9 0.0 0.0 0.0 4.2 0.5 4.8 0.0 0.0 19.6 4.8 SLC5A10 SGLT5 ENSG00000154025 "Solute carrier family 5 member 10" A0PJK1 17 18950345-19022595 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 70.6" "Group enriched" "Detected in some" 4 "Late spermatids: 20.1;Proximal tubular cells: 51.2" "Cancer enriched" "Detected in some" 11 "renal cancer: 6.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 3.0;non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 7 "monocytes: 7.9" "Cell line enriched" "Detected in some" 5 "U-937: 11.0" "Not detected" "Not detected" HPA052014 Uncertain NA NA "HPA052014: AB_2681694" "unprognostic (3.74e-1)" "unprognostic (2.92e-1)" "unprognostic (3.04e-2)" "unprognostic (6.11e-2)" "unprognostic (6.56e-2)" "unprognostic (3.36e-4)" "unprognostic (7.36e-2)" "unprognostic (2.39e-1)" "unprognostic (1.52e-1)" "unprognostic (8.94e-2)" "unprognostic (3.24e-2)" "unprognostic (1.53e-1)" "unprognostic (1.09e-2)" "unprognostic (3.43e-2)" "unprognostic (2.61e-2)" "unprognostic (2.75e-2)" "unprognostic (2.11e-1)" 0.1 0.1 0.1 0.5 0.1 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.7 0.1 0.0 70.6 0.4 0.3 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 15.1 0.1 0.1 0.1 0.7 1.1 0.1 0.2 3.1 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.4 1.2 0.1 7.9 0.0 0.6 0.5 0.0 0.0 0.1 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.1 1.8 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.1 2.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 11.0 0.0 0.1 0.0 0.0 0.1 3.0 0.0 0.4 0.3 0.0 1.2 0.3 0.6 0.2 0.0 0.0 7.9 0.0 0.2 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.3 8.7 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.0 20.1 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 51.2 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 SLC5A11 "KST1, SGLT6, SMIT2" ENSG00000158865 "Solute carrier family 5 member 11" Q8WWX8 16 24845841-24911628 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 48.0;intestine: 21.8" "Group enriched" "Detected in some" 4 "Enterocytes: 1.7;Paneth cells: 2.9;Proximal tubular cells: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 18.9;Karpas-707: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035331 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA035331: AB_10601489" "unprognostic (2.57e-1)" "unprognostic (7.90e-3)" "unprognostic (1.34e-2)" "unprognostic (2.65e-2)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.90e-2)" "unprognostic (8.08e-2)" "unprognostic (2.85e-1)" "unprognostic (2.85e-3)" "unprognostic (6.68e-2)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (1.58e-1)" "unprognostic (8.07e-2)" "unprognostic (1.45e-3)" 0.6 0.6 4.3 0.6 21.8 0.5 2.8 1.9 11.2 0.6 1.7 29.7 0.0 10.9 0.6 0.5 0.5 0.6 1.4 0.7 12.1 7.4 9.9 1.0 0.6 0.7 48.0 2.4 0.6 0.5 0.5 0.2 0.5 18.3 0.6 0.8 0.0 0.6 0.8 0.7 0.5 21.8 0.5 34.7 0.6 0.6 0.8 22.9 0.0 0.6 0.0 0.7 0.6 0.1 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.3 21.8 1.9 8.0 12.1 7.4 48.0 2.4 18.3 22.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 5.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667019-26723427 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 60.8;kidney: 90.3" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 145.9" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Region enriched" "Detected in single" 7 "basal ganglia: 1.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 11.3 0.0 0.2 1.7 0.0 18.5 0.0 0.0 0.0 3.4 0.1 0.1 90.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.8 1.0 0.7 0.9 0.7 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.6 0.8 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.4 5.2 0.1 0.3 0.2 0.5 3.8 0.7 0.1 0.1 0.0 0.6 0.1 1.1 2.0 0.3 1.7 0.2 0.0 7.8 2.8 0.5 0.6 0.4 0.2 0.4 0.2 2.3 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.1 0.6 0.7 0.4 1.1 0.4 0.4 0.5 1.5 0.7 0.6 0.4 0.9 0.6 0.8 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.5 0.0 0.1 8.3 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.3 0.0 145.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 SLC5A2 SGLT2 ENSG00000140675 "Solute carrier family 5 member 2" P31639 16 31483002-31490860 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Sugar transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "kidney: 33.7" "Group enriched" "Detected in some" 11 "Early spermatids: 46.9;Late spermatids: 103.8;Proximal tubular cells: 139.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.6" "Group enriched" "Detected in many" 16 "NK-cells: 1.4;T-cells: 1.6" "Cell line enhanced" "Detected in some" "BEWO: 1.2;EFO-21: 2.0;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041603 Enhanced NA NA "HPA041603: AB_10960540" "unprognostic (1.61e-1)" "unprognostic (2.95e-1)" "unprognostic (2.84e-1)" "unprognostic (3.00e-2)" "unprognostic (8.04e-2)" "unprognostic (8.23e-3)" "unprognostic (1.49e-1)" "unprognostic (2.25e-3)" "unprognostic (2.57e-1)" "unprognostic (1.12e-2)" "unprognostic (6.43e-2)" "unprognostic (2.47e-1)" "unprognostic (1.42e-3)" "unprognostic (5.88e-2)" "unprognostic (2.14e-1)" "unprognostic (4.18e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 0.6 0.1 0.4 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.3 1.2 0.1 0.0 0.0 1.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.6 0.5 0.0 0.0 0.5 0.1 0.0 1.4 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.2 0.0 0.3 0.0 1.4 0.0 8.7 0.0 0.2 6.6 0.7 46.9 0.0 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 103.8 2.0 0.4 0.0 0.0 0.2 0.0 0.7 0.0 1.4 139.8 0.0 0.0 0.0 3.2 0.9 0.3 0.1 0.0 0.6 0.0 SLC5A3 "SMIT, SMIT1" ENSG00000198743 "Solute carrier family 5 member 3" P53794 21 34073570-34106262 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 46.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 130.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029791 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA029791: AB_10601892" "unprognostic (9.70e-2)" "unprognostic (4.99e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.54e-2)" "unprognostic (4.48e-3)" "unprognostic (1.63e-1)" "unprognostic (3.02e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (8.60e-2)" 10.1 9.5 10.5 7.3 11.0 3.6 26.6 8.0 10.1 6.5 7.6 4.6 9.4 5.0 11.3 9.1 7.5 8.5 4.9 6.8 11.6 6.8 46.0 9.5 8.5 7.6 11.7 4.7 9.0 5.8 6.3 6.6 15.8 13.6 7.0 8.8 11.3 6.4 6.9 7.8 10.1 7.4 5.9 14.7 4.9 7.8 10.6 9.0 5.9 42.7 4.4 8.0 6.5 22.1 0.8 2.3 0.7 1.0 1.0 2.6 0.7 6.3 5.7 11.9 8.4 10.0 8.2 5.7 7.2 22.1 4.5 6.9 9.4 13.9 10.2 5.9 14.6 8.5 3.3 14.4 4.1 7.7 10.6 3.7 10.6 5.3 3.1 2.6 4.5 4.5 3.9 10.7 12.3 4.9 13.9 2.7 8.5 10.4 2.4 11.6 4.3 4.8 3.7 6.0 2.4 5.6 4.9 2.1 4.6 17.8 8.9 6.2 2.9 15.0 4.0 3.4 7.4 2.4 4.8 2.6 8.9 6.9 16.9 2.9 12.7 10.9 7.7 17.9 6.6 5.9 0.0 1.0 0.2 2.6 0.9 2.1 0.8 1.4 1.7 0.9 0.8 1.9 2.6 0.7 1.0 0.4 2.3 0.4 0.7 10.5 11.0 8.0 10.1 11.6 6.8 11.7 4.7 13.6 9.0 14.9 12.2 8.0 40.9 0.0 28.5 7.6 12.7 16.0 23.9 130.9 19.6 21.2 18.3 3.4 8.6 4.5 28.0 0.0 4.5 15.7 10.7 71.1 41.4 15.3 12.8 35.0 47.1 6.7 12.1 5.2 6.1 9.8 0.0 24.4 48.3 6.0 5.8 46.0 19.4 6.5 20.8 12.9 2.2 12.1 18.9 0.0 23.6 17.3 26.6 32.3 SLC5A4 "DJ90G24.4, SAAT1, SGLT3" ENSG00000100191 "Solute carrier family 5 member 4" Q9NY91 22 32218476-32255341 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "intestine: 73.6" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 10 "melanoma: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "SK-MEL-30: 25.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.93e-1)" "unprognostic (1.57e-1)" "unprognostic (3.10e-3)" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.85e-3)" "unprognostic (2.97e-2)" "unprognostic (3.80e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-3)" "unprognostic (4.50e-1)" "unprognostic (1.99e-5)" "unprognostic (2.34e-1)" "unprognostic (1.63e-1)" "unprognostic (2.28e-1)" "unprognostic (2.69e-1)" 1.2 0.1 0.4 0.4 0.4 0.1 1.6 0.4 0.5 1.2 41.7 0.4 0.4 18.0 1.8 0.4 0.4 1.2 0.6 0.9 0.5 0.6 1.0 0.4 2.5 0.4 0.6 0.4 0.4 0.6 0.4 0.4 0.4 0.4 0.9 0.1 0.4 0.4 0.4 0.4 0.3 73.6 1.5 0.6 0.6 0.2 0.7 0.4 0.4 2.4 0.4 0.4 0.4 1.3 0.0 0.3 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 25.2 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.5 0.5 0.6 0.6 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SLC5A5 NIS ENSG00000105641 "Solute carrier family 5 member 5" Q92911 19 17871973-17895174 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 31.5;salivary gland: 66.8;stomach 1: 32.7" "Group enriched" "Detected in some" 6 "Ciliated cells: 5.3;Club cells: 7.9;Spermatogonia: 7.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 12 "pons and medulla: 31.5" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "BEWO: 16.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022364, HPA049055" Enhanced NA NA "CAB022364: , HPA049055: AB_2680614" "unprognostic (2.72e-2)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (4.02e-2)" "unprognostic (2.57e-1)" "unprognostic (1.94e-2)" "unprognostic (3.07e-1)" "unprognostic (2.01e-2)" "unprognostic (3.03e-1)" "unprognostic (3.93e-2)" "unprognostic (5.51e-8)" "unprognostic (1.07e-2)" "unprognostic (1.69e-1)" "unprognostic (1.54e-2)" "unprognostic (3.23e-1)" 0.0 0.0 0.1 0.1 0.4 0.1 0.1 2.4 2.3 5.1 0.1 9.0 0.0 0.0 0.1 0.0 0.2 0.1 0.4 0.0 1.7 0.1 0.1 0.0 0.2 0.2 0.3 2.7 0.0 0.1 0.0 0.2 0.0 31.5 0.1 0.0 5.5 66.8 0.0 0.2 0.2 0.3 0.0 1.9 0.2 32.7 0.4 0.1 0.0 7.1 0.0 0.1 0.0 0.1 1.3 0.8 2.5 1.4 1.0 4.3 0.9 0.0 0.0 0.1 0.1 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.5 0.0 0.2 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.1 0.5 0.0 0.2 1.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 3.7 0.0 2.5 0.6 0.4 1.1 1.4 1.3 1.0 3.2 0.6 0.8 1.3 4.3 3.2 2.2 1.0 0.4 0.4 2.0 0.9 0.1 0.4 2.4 2.3 1.7 0.1 0.3 2.7 31.5 0.1 0.0 1.1 0.0 0.0 0.3 0.0 0.6 0.0 5.3 7.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 7.9 0.3 0.0 0.5 0.0 0.0 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 69.3;SK-BR-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.7 17.4 11.1 14.6 10.3 3.7 69.3 6.1 4.1 9.3 6.4 25.6 6.0 11.6 9.3 3.3 10.1 9.4 23.7 7.0 6.5 9.0 13.9 20.6 7.4 39.2 12.2 26.4 10.8 12.9 6.0 11.4 8.9 2.6 8.3 9.5 30.1 4.8 5.9 34.4 8.9 12.9 32.0 19.4 6.4 15.1 13.1 16.8 5.3 16.1 9.4 13.9 6.6 74.6 8.8 11.3 16.6 5.7 3.8 10.3 14.1 6.2 16.3 8.0 18.3 18.5 5.6 18.6 14.4 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 0.0 4.1 13.4 6.8 7.1 4.5 5.9 7.6 4.0 2.3 7.0 3.9 98.8 1.7 9.6 11.6 3.8 6.0 0.0 7.0 89.2 5.4 7.1 0.0 36.0 19.5 11.1 5.2 7.4 10.0 25.3 6.6 6.5 0.0 78.5 6.8 3.9 6.2 2.9 13.1 3.6 3.4 12.9 5.9 31.1 18.5 5.5 190.6 7.5 13.3 6.4 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 45.1" "Group enriched" "Detected in some" 13 "Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Group enriched" "Detected in some" 13 "basal ganglia: 13.8;pons and medulla: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "RT4: 8.9;SCLC-21H: 2.6" "Group enriched" "Detected in many" 4 "basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1" "Region enhanced" "Detected in some" "pons and medulla: 26.3" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" NA NA "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.3 2.4 0.1 1.6 13.8 0.0 0.3 0.1 0.4 3.3 5.2 0.1 0.3 2.3 1.6 0.7 1.0 0.2 0.5 1.2 0.2 2.2 0.9 0.2 0.9 0.0 0.3 0.5 0.8 0.5 0.0 0.1 0.0 45.1 0.8 2.5 1.0 0.9 4.2 0.1 0.1 2.5 3.1 10.0 0.1 1.7 0.3 0.8 0.0 4.0 0.3 0.1 4.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.8 0.1 0.4 0.2 2.2 0.3 0.5 45.1 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 SLC5A8 AIT ENSG00000256870 "Solute carrier family 5 member 8" Q8N695 12 101155493-101210407 "Predicted membrane proteins" "Apoptosis, Ion transport, Sodium transport, Symport, Transport" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix, uterine: 14.3;kidney: 13.8;thyroid gland: 21.2" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 7.7;Horizontal cells: 9.5;Intestinal endocrine cells: 30.3;Proximal tubular cells: 10.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SK-BR-3: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "prognostic favorable (9.04e-6)" "unprognostic (1.84e-1)" "unprognostic (1.17e-2)" "unprognostic (1.27e-3)" "unprognostic (1.24e-1)" "unprognostic (5.20e-1)" "unprognostic (1.16e-2)" "prognostic favorable (1.97e-4)" "unprognostic (6.16e-2)" "unprognostic (2.30e-2)" "unprognostic (2.87e-2)" 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 14.3 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.8 0.0 1.9 0.0 0.0 0.3 1.0 0.0 0.0 0.1 0.0 0.6 0.9 0.0 1.4 3.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 21.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.6 0.0 0.0 7.7 0.0 0.0 0.0 4.0 0.6 0.0 1.4 1.2 1.8 0.0 0.0 1.7 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 9.5 30.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 SLC5A9 SGLT4 ENSG00000117834 "Solute carrier family 5 member 9" Q2M3M2 1 48222685-48248644 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 77.3" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9" "Cancer enhanced" "Detected in many" "liver cancer: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "Hep G2: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA050263 Approved "Actin filaments,Cytosol" NA NA "Actin filaments" Cytosol "HPA050263: " "unprognostic (3.09e-3)" "unprognostic (1.89e-1)" "unprognostic (6.75e-2)" "unprognostic (5.66e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-3)" "unprognostic (3.64e-2)" "unprognostic (4.59e-2)" "unprognostic (3.60e-2)" "unprognostic (1.59e-1)" "unprognostic (7.42e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (4.56e-1)" "unprognostic (2.11e-1)" "unprognostic (4.30e-3)" "unprognostic (1.06e-2)" 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 33.0 0.1 0.8 26.0 0.1 7.2 0.1 0.2 2.2 0.1 0.0 0.0 3.1 4.9 2.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.4 0.0 1.0 77.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 1.0 0.0 0.0 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 1.7 0.4 5.8 0.0 0.7 0.0 0.2 0.0 0.0 0.1 4.6 4.5 0.1 0.0 0.0 0.0 1.2 7.9 0.3 0.0 0.0 0.0 0.6 0.0 0.1 1.1 0.4 3.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039249 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 56.2;liver: 75.6" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced Uncertain Mitochondria No NA Mitochondria "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.8 2.1 32.2 1.6 31.0 3.0 1.8 15.1 56.2 2.0 1.7 25.4 0.0 1.7 1.9 3.9 4.3 2.4 2.3 3.3 22.2 16.6 2.1 75.6 2.5 1.7 22.7 25.3 2.4 1.4 9.3 1.0 2.0 17.0 2.1 1.8 1.7 1.6 5.0 3.3 1.7 1.7 1.8 13.7 1.9 1.7 4.4 14.3 0.5 1.9 0.0 1.7 1.9 0.9 1.0 0.8 1.2 0.3 0.2 0.8 0.2 0.8 0.6 1.9 1.3 1.5 0.4 1.1 0.7 0.2 0.8 1.1 1.5 1.0 1.6 0.3 0.4 1.8 1.3 2.3 0.9 0.7 0.2 1.8 1.3 4.6 2.8 0.7 2.2 2.3 1.1 0.2 0.2 1.3 0.5 0.3 1.7 1.1 3.7 0.2 1.1 0.7 1.8 0.8 1.2 1.4 1.2 0.2 0.1 0.6 1.8 0.8 0.3 1.0 0.7 0.2 1.1 1.0 1.0 0.3 0.8 0.5 0.7 0.7 1.1 0.3 1.2 0.9 1.7 0.4 0.3 0.3 1.1 0.5 0.1 0.8 0.9 0.6 0.5 0.3 1.0 0.3 0.5 1.2 0.2 0.3 0.8 0.3 0.2 32.2 31.0 15.1 41.5 22.2 16.6 22.7 25.3 17.0 14.3 0.0 0.3 0.0 0.0 0.2 1.8 1.4 17.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 24.5 0.0 0.0 0.0 0.0 1.0 0.2 5.2 0.0 0.0 0.0 0.0 41.9 0.0 0.0 9.6 0.1 3.3 12.9 2.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816200-10940733 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 37.0;esophagus: 10.5;skin 1: 11.5" "Cell type enhanced" "Detected in some" 19 "Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.8 0.8 11.5 0.7 14.1 0.8 2.9 3.1 23.0 0.9 0.8 5.0 0.0 0.7 1.7 1.1 10.5 1.8 0.7 0.8 8.4 24.5 0.7 0.9 0.8 0.7 37.0 5.9 0.8 1.0 0.7 0.2 1.6 35.4 2.3 0.8 0.4 1.1 0.7 1.0 11.5 0.8 1.0 10.4 1.5 0.7 3.4 9.2 0.0 0.8 0.2 1.1 1.3 0.7 0.5 0.3 1.2 0.4 0.2 0.3 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 12.7 0.0 2.1 0.0 0.0 0.2 0.2 0.0 14.6 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.8 4.4 3.7 0.1 0.0 0.1 4.8 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.3 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.5 0.2 0.2 1.2 0.2 0.4 0.3 0.3 0.0 11.5 14.1 3.1 14.7 8.4 24.5 37.0 5.9 35.4 9.2 0.0 0.0 0.0 0.2 1.1 7.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.2 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 3.1 0.0 0.0 0.0 0.0 21.8 0.3 0.0 6.3 0.0 1.3 0.0 0.0 0.2 1.5 3.1 0.8 0.0 0.0 1.5 SLC6A12 BGT-1 ENSG00000111181 "Solute carrier family 6 member 12" P48065 12 190077-214570 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.1;liver: 59.3" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2" "Cancer enhanced" "Detected in many" "renal cancer: 11.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 57 "classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 51 "dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034973 Approved Approved Vesicles NA NA Vesicles "HPA034973: AB_10610427" "unprognostic (3.48e-1)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.70e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-2)" "unprognostic (8.30e-2)" "unprognostic (6.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.85e-2)" "unprognostic (3.68e-1)" "prognostic favorable (2.70e-6)" "unprognostic (2.30e-1)" "unprognostic (4.92e-4)" "unprognostic (3.35e-1)" "unprognostic (4.31e-4)" 0.6 0.8 6.3 1.3 12.9 0.6 0.8 6.6 14.7 0.9 1.0 4.3 0.0 3.7 1.3 5.6 0.5 3.0 1.2 0.7 7.2 4.6 22.1 59.3 2.2 0.8 8.1 4.9 0.7 1.3 0.6 0.3 0.9 9.4 0.6 1.8 0.2 0.6 0.5 0.5 0.7 1.1 1.2 3.1 0.8 2.3 1.6 8.8 0.0 4.5 0.0 0.7 0.9 0.2 0.0 2.9 3.7 8.6 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 17.0 0.1 0.0 0.5 0.0 0.0 0.1 3.7 0.3 0.5 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 6.6 0.0 0.0 6.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.7 0.0 8.6 0.0 0.0 1.9 6.3 12.9 6.6 14.7 7.2 4.6 8.1 4.9 9.4 8.8 0.0 0.3 0.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 43.6 0.0 0.0 1.7 0.0 3.6 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 17.4 2.4 0.0 0.0 1.3 0.3 3.4 0.6 1.8 0.0 17.2 1.2 6.3 0.0 0.0 0.0 6.8 0.2 6.5 0.0 0.5 1.7 0.4 0.7 0.0 0.8 0.0 SLC6A13 GAT2 ENSG00000010379 "Solute carrier family 6 member 13" Q9NSD5 12 220621-262873 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 77.6;retina: 95.9" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 261.2" "Cancer enriched" "Detected in some" 18 "renal cancer: 32.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 10.0;SuSa: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036449, HPA052726" Supported Nucleoplasm,Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Nucleoli, Cytosol" "HPA036449: AB_2675130, HPA052726: AB_2681927" "unprognostic (8.45e-3)" "unprognostic (4.20e-1)" "unprognostic (5.44e-2)" "unprognostic (1.64e-5)" "unprognostic (1.13e-1)" "unprognostic (8.02e-2)" "unprognostic (1.32e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (7.21e-4)" "unprognostic (2.93e-1)" "unprognostic (1.25e-3)" "unprognostic (3.79e-2)" "unprognostic (2.62e-1)" "unprognostic (6.23e-2)" "unprognostic (1.91e-1)" 0.6 0.5 3.0 0.4 5.8 0.5 0.5 2.1 5.8 0.5 0.5 2.5 0.0 1.8 0.5 0.9 0.4 4.2 0.5 1.0 3.1 2.4 77.6 13.2 0.9 0.5 3.4 4.1 0.5 0.4 0.4 1.0 0.5 4.8 0.5 0.5 95.9 0.5 0.5 0.6 0.6 0.8 0.4 5.7 0.5 0.5 1.1 2.1 0.0 4.9 0.0 0.5 0.5 0.0 0.4 0.0 0.0 0.0 0.6 0.9 0.3 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 1.3 0.2 0.1 0.0 0.0 0.3 0.0 0.5 0.4 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 10.0 0.1 0.1 0.0 0.1 0.0 0.9 3.7 0.0 0.0 0.3 0.2 1.0 0.0 0.4 1.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.6 0.0 0.0 0.0 0.3 3.0 5.8 2.1 5.8 3.1 2.4 3.4 4.1 4.8 2.1 0.0 1.1 0.5 0.0 0.0 0.2 1.3 0.0 1.4 0.0 17.4 2.0 0.0 41.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 19.7 0.0 0.0 0.0 0.6 0.6 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 261.2 0.8 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.0 0.0 SLC6A14 ENSG00000268104 "Solute carrier family 6 member 14" Q9UN76 X 116436622-116461458 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.8;Hep G2: 8.2;OE19: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA003193 Uncertain Approved Vesicles NA NA Vesicles "HPA003193: AB_2190122" "unprognostic (3.06e-2)" "unprognostic (3.55e-2)" "unprognostic (8.49e-2)" "unprognostic (1.00e-3)" "unprognostic (1.30e-3)" "unprognostic (1.49e-2)" "unprognostic (7.41e-3)" "unprognostic (3.67e-3)" "unprognostic (2.66e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 5.9 0.0 0.0 6.3 0.8 0.0 11.8 0.4 0.1 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.2 0.5 0.3 0.0 26.3 5.8 0.0 1.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 23.5 1.2 1.0 1.0 0.4 0.2 1.1 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 3.8 8.2 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 1.4 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.5 0.4 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.0 20.8 100.3 0.0 0.1 0.1 0.0 0.2 0.0 10.7 33.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.2 0.0 28.5 0.0 0.0 5.2 3.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.1 0.0 101.5 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.0 3.2 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859488-84913615 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2" "Cancer enhanced" "Detected in some" "melanoma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles NA NA Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 1.4 4.5 18.0 2.2 16.2 1.0 2.3 17.8 31.0 1.7 2.2 5.4 0.0 1.4 2.8 1.1 6.7 1.2 1.3 1.0 10.9 18.2 1.5 1.0 1.3 1.1 10.3 16.9 2.1 1.0 1.0 5.6 8.9 14.7 1.8 1.8 9.2 1.4 1.5 1.0 4.9 2.1 1.6 4.9 1.1 1.3 3.6 12.8 0.0 2.0 1.8 1.8 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 31.1 19.2 0.0 0.0 6.5 0.5 0.3 0.0 0.0 0.0 0.0 0.2 4.1 0.4 0.0 8.3 0.0 0.0 9.5 0.0 1.5 0.0 11.5 0.0 0.2 10.7 16.0 4.2 43.9 8.5 0.1 0.0 0.0 0.0 7.9 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 7.8 0.0 9.9 22.1 0.1 0.0 0.0 0.0 4.7 2.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.0 16.2 17.8 18.6 10.9 18.2 10.3 16.9 14.7 12.8 0.0 0.0 0.0 0.0 2.4 18.0 0.4 0.0 0.0 0.0 0.0 5.9 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.2 0.0 0.0 30.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 10.2 0.0 0.2 0.1 0.4 0.5 0.2 0.0 0.0 0.0 SLC6A16 NTT5 ENSG00000063127 "Solute carrier family 6 member 16" Q9GZN6 19 49289638-49325225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "testis: 102.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 81.2;Late spermatids: 36.5;Spermatocytes: 90.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.3;SuSa: 10.0" HPA076812 Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA076812: AB_2686816" "unprognostic (1.98e-1)" "unprognostic (7.15e-3)" "unprognostic (6.39e-3)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.83e-3)" "unprognostic (7.89e-2)" "unprognostic (7.92e-2)" "unprognostic (1.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.55e-3)" "unprognostic (1.63e-1)" "unprognostic (3.23e-2)" "unprognostic (3.31e-1)" "unprognostic (2.10e-1)" "unprognostic (8.93e-2)" "unprognostic (4.18e-2)" 1.5 0.4 0.8 1.1 0.9 1.9 1.0 0.8 0.8 1.3 1.1 0.8 0.8 0.3 1.5 1.0 0.8 2.0 1.0 0.8 0.8 0.3 2.0 3.6 1.6 3.1 0.8 0.8 2.9 2.6 0.7 0.8 1.3 0.8 1.8 0.3 0.9 0.8 1.2 0.8 0.7 1.2 0.8 0.8 1.7 1.0 102.2 0.8 0.8 1.1 0.8 2.4 0.8 1.2 7.8 2.1 4.8 3.7 3.8 3.1 2.2 0.0 6.8 17.3 6.2 0.3 2.8 3.1 0.9 1.4 0.6 1.9 0.4 0.5 8.0 1.1 0.7 0.3 0.2 1.9 0.3 2.1 1.3 2.0 0.7 0.7 1.5 1.3 0.5 2.9 2.7 1.1 1.3 0.9 5.1 1.5 1.4 1.5 1.1 2.2 1.5 0.4 0.5 6.1 0.3 0.9 0.3 4.2 1.5 0.9 0.0 0.2 0.3 2.7 0.1 0.6 10.0 2.8 0.2 8.6 1.4 6.6 4.0 0.0 3.8 4.0 7.2 0.1 1.9 0.4 0.4 0.8 4.8 3.1 2.2 3.0 7.8 1.1 3.1 0.8 4.5 2.7 1.8 4.0 3.8 3.7 2.1 1.7 2.2 0.8 0.9 0.8 0.8 0.8 0.3 0.8 0.8 0.8 0.8 0.0 0.6 3.7 0.8 1.3 6.3 1.2 2.5 17.4 0.0 1.8 2.0 0.0 10.0 0.6 81.2 3.9 0.0 0.0 0.5 0.0 1.6 0.4 1.1 4.9 0.7 0.0 0.0 1.3 0.3 36.5 3.4 0.8 5.0 0.0 0.0 0.5 0.3 0.0 3.2 0.0 1.3 0.0 7.2 90.2 2.1 1.1 0.0 0.5 0.0 0.2 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008043, HPA008044" Enhanced Approved Mitochondria NA NA Mitochondria "HPA008043: , HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.3 0.4 1.7 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.6 4.8 1.5 28.3 0.8 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.7 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 0.0 0.0 0.0 0.0 0.5 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 10.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 3.6 0.0 0.4 0.0 1.1 0.4 0.1 0.0 0.0 0.0 SLC6A18 "FLJ31236, Xtrp2" ENSG00000164363 "Solute carrier family 6 member 18" Q96N87 5 1225355-1246189 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 32 "kidney: 14.1" "Group enriched" "Detected in some" 71 "Distal tubular cells: 6.6;Proximal tubular cells: 21.3" "Cancer enriched" "Detected in single" 44 "renal cancer: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA011885 Enhanced NA NA "HPA011885: AB_1857198" "unprognostic (2.02e-1)" "unprognostic (5.69e-3)" "unprognostic (2.90e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.4 0.6 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC6A19 ENSG00000174358 "Solute carrier family 6 member 19" Q695T7 5 1201595-1225117 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 167.3" "Group enriched" "Detected in some" 6 "Cholangiocytes: 63.7;Enterocytes: 25.3;Proximal tubular cells: 65.4" "Cancer enhanced" "Detected in many" "renal cancer: 7.9;stomach cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 14.4;HEL: 17.6;OE19: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037415, HPA043207" Enhanced NA NA "HPA037415: AB_10672346, HPA043207: AB_2678363" "unprognostic (1.26e-1)" "unprognostic (1.01e-3)" "unprognostic (6.04e-2)" "unprognostic (3.64e-1)" "prognostic favorable (4.14e-6)" "unprognostic (1.37e-1)" "unprognostic (7.36e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 55.3 0.0 0.0 44.6 0.1 0.0 0.1 0.1 30.0 0.1 0.1 0.1 28.7 0.5 0.1 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.5 1.7 0.0 0.1 0.0 0.1 0.1 167.3 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 4.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.8 63.7 0.0 1.2 1.8 0.0 0.0 1.7 0.0 0.1 0.0 25.3 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 5.8 0.0 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;placenta: 41.8" "Group enriched" "Detected in some" 5 "Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in single" 27 "pons and medulla: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 107.1" "Region enriched" "Detected in some" 4 "pons and medulla: 8.2" "Region enriched" "Detected in single" 32 "pons and medulla: 23.1" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 2.4 20.4 0.3 0.1 0.1 0.0 1.8 0.1 0.3 3.2 0.3 0.3 0.1 0.0 4.5 7.2 0.8 0.4 0.4 0.1 0.1 0.0 0.4 1.0 0.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 41.8 9.7 0.5 0.1 0.1 1.6 1.7 0.1 11.4 0.4 1.0 0.2 0.1 0.2 8.3 0.2 0.1 0.2 0.9 0.5 0.5 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 107.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 9.7 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.9 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.4 4.7 0.0 0.0 0.0 SLC6A20 "XT3, Xtrp3" ENSG00000163817 "Solute carrier family 6 member 20" Q9NP91 3 45755450-45796535 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 14.3;intestine: 25.5;retina: 51.3" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HaCaT: 3.1;OE19: 7.1;SuSa: 10.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029873 Uncertain NA NA "HPA029873: AB_10602403" "unprognostic (1.57e-1)" "unprognostic (5.26e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "unprognostic (1.48e-1)" "unprognostic (9.43e-3)" "unprognostic (3.26e-2)" "unprognostic (4.33e-3)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (1.46e-1)" "prognostic favorable (1.55e-5)" "unprognostic (2.87e-1)" "unprognostic (1.23e-1)" "unprognostic (7.55e-2)" "unprognostic (2.09e-2)" 0.3 0.1 0.3 0.6 0.8 0.5 0.7 1.5 2.2 2.4 11.2 3.0 0.4 22.3 1.3 1.7 0.1 0.4 14.3 0.1 0.5 0.4 3.3 0.2 1.9 0.2 1.0 1.7 0.1 5.1 0.0 2.0 0.1 6.1 1.0 0.2 51.3 1.3 0.1 0.9 0.6 25.5 0.3 1.5 0.1 4.7 0.4 0.3 0.0 0.1 0.4 0.1 0.2 0.3 0.8 0.7 2.6 0.2 0.5 0.4 0.1 0.2 0.4 0.4 0.4 0.1 0.0 0.5 0.1 0.0 0.0 0.0 1.6 1.4 0.2 1.1 0.0 0.3 3.1 0.1 0.0 0.2 0.1 0.2 1.3 1.2 0.2 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.2 0.0 0.5 0.2 0.5 0.0 0.3 0.5 0.3 1.4 7.1 0.3 0.5 0.1 0.4 0.2 0.3 0.4 0.4 1.5 0.2 0.0 10.3 0.3 0.1 0.1 0.5 0.4 0.4 0.3 0.8 0.3 0.1 0.2 0.3 0.1 1.0 0.2 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.8 0.4 0.3 2.6 0.5 0.1 0.7 0.1 0.1 0.3 0.8 1.5 2.2 0.5 0.4 1.0 1.7 6.1 0.3 0.0 5.3 0.0 0.4 0.5 0.0 0.8 12.7 0.0 2.3 0.0 0.0 0.0 0.0 10.1 0.5 0.0 2.6 0.0 0.2 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 6.2 0.0 1.1 1.4 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.4 0.4 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392790-1445430 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 48.4" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 2.9" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 47 "midbrain: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8" "Group enriched" "Detected in some" 8 "midbrain: 96.4;thalamus: 31.8" "Region enriched" "Detected in single" 138 "midbrain: 362.2" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles NA NA Vesicles "CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.3 1.1 0.8 0.1 0.8 0.6 0.1 0.0 0.6 0.3 0.0 3.4 0.0 48.4 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.7 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 0.0 2.4 2.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 0.1 3.8 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 48.4 0.0 1.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 SLC6A4 "5-HTT, HTT, OCD1, SERT1" ENSG00000108576 "Solute carrier family 6 member 4" P31645 17 30194319-30236002 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 25.0;lung: 50.5" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.3" "Region enriched" "Detected in single" 36 "pons and medulla: 11.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7" "Region enriched" "Detected in some" 5 "midbrain: 69.9" "Low region specificity" "Detected in all" "HPA054723, HPA071354, HPA074728" Supported Supported Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA054723: , HPA071354: , HPA074728: AB_2686708" "unprognostic (7.45e-2)" "unprognostic (7.13e-2)" "unprognostic (2.26e-1)" "unprognostic (3.72e-4)" "unprognostic (2.07e-1)" "unprognostic (8.42e-3)" "unprognostic (2.73e-2)" "unprognostic (3.39e-2)" "unprognostic (3.37e-3)" "unprognostic (1.17e-3)" "unprognostic (2.70e-3)" "unprognostic (1.16e-1)" "unprognostic (8.78e-2)" "unprognostic (4.98e-2)" "unprognostic (1.76e-1)" "unprognostic (4.05e-2)" "unprognostic (7.18e-2)" 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.1 6.3 0.1 0.3 1.6 0.9 0.1 0.7 0.1 0.1 0.3 0.1 50.5 0.1 0.1 0.1 0.1 0.6 0.0 0.1 11.3 11.2 0.1 0.0 0.2 0.7 0.1 0.1 0.4 25.0 0.4 0.1 0.1 0.5 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.0 0.1 1.0 0.2 0.4 0.3 2.3 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 14.7 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.0 1.0 0.0 0.7 0.8 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.0 0.4 0.2 0.1 0.0 2.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 11.2 0.1 14.9 5.3 0.0 0.4 0.1 0.2 0.8 0.0 1.4 3.4 1.8 0.0 90.5 0.0 0.0 2.3 0.5 1.0 0.0 0.0 7.0 1.6 0.3 2.3 0.0 8.4 0.0 0.0 2.5 0.6 1.0 0.3 0.4 0.0 0.0 0.0 0.5 0.5 0.0 0.4 0.3 0.9 0.0 1.4 0.0 0.4 0.3 89.0 0.0 0.0 0.3 SLC6A5 "GLYT2, NET1" ENSG00000165970 "Solute carrier family 6 member 5" Q9Y345 11 20599400-20659285 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 21.3" "Group enriched" "Detected in some" 27 "Early spermatids: 20.8;Late spermatids: 40.6" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "pons and medulla: 21.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 2.6" "Region enriched" "Detected in some" 9 "pons and medulla: 51.6" "Region enriched" "Detected in some" 9 "pons and medulla: 33.2" CAB079052 Supported NA NA "CAB079052: " "unprognostic (6.94e-2)" "unprognostic (2.28e-1)" "unprognostic (4.75e-2)" 0.0 0.1 0.1 0.1 0.0 0.0 0.0 3.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 5.1 0.1 0.1 0.0 0.0 0.0 0.0 2.2 0.0 21.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 6.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.4 0.3 0.1 0.1 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 76.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 33.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.2" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.2 25.9 5.7 18.0 16.5 46.4 8.1 11.1 12.2 11.3 9.5 8.7 3.6 8.5 14.5 4.4 7.0 7.0 14.5 23.2 5.6 4.6 16.6 2.3 18.6 12.9 18.0 7.6 31.3 2.8 3.8 9.6 18.0 13.3 5.0 4.1 76.4 15.7 7.7 26.6 16.8 22.2 8.2 11.1 20.3 14.0 4.0 12.6 6.2 10.4 11.3 11.2 8.8 6.1 1.6 1.9 33.2 6.9 0.7 3.9 2.3 4.6 17.3 6.2 4.7 8.1 2.5 12.8 7.0 27.8 8.3 6.1 6.3 8.0 13.5 6.4 11.0 12.0 3.7 4.2 5.7 7.4 1.5 5.2 12.8 22.7 9.4 0.2 3.5 27.8 1.3 1.7 7.6 2.0 7.2 9.0 6.3 7.1 2.7 7.3 4.9 9.8 6.8 9.6 6.5 5.0 7.0 7.4 21.1 45.5 9.7 11.5 4.1 5.2 2.8 1.5 24.4 10.7 1.9 22.7 10.6 5.7 2.6 5.0 3.0 3.4 5.0 24.7 6.9 32.4 2.5 5.1 5.0 1.3 4.2 0.7 1.6 1.4 1.7 1.9 0.9 0.2 0.3 33.2 0.7 6.9 0.7 3.9 2.3 5.7 16.5 11.1 12.2 5.6 4.6 18.0 7.6 13.3 12.6 6.0 22.1 4.7 11.2 43.8 102.1 3.6 2.5 12.0 12.5 19.2 538.0 2.2 0.0 9.6 17.0 16.1 0.7 0.0 7.1 12.8 16.4 5.5 12.7 0.4 26.7 9.5 13.8 11.6 62.5 13.3 16.1 47.4 16.9 129.0 2.9 28.2 21.5 2.9 16.3 26.3 502.9 0.0 8.2 0.5 1.5 20.8 4.2 22.4 1.2 10.6 SLC6A7 PROT ENSG00000011083 "Solute carrier family 6 member 7" Q99884 5 150189957-150222788 "Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 40.2" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 2.1;Intestinal endocrine cells: 3.5;Mucus-secreting cells: 4.8;Paneth cells: 8.6;Undifferentiated cells: 3.4" "Cancer enhanced" "Detected in single" "colorectal cancer: 0.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.6;HeLa: 1.8;SK-BR-3: 1.4;U-87 MG: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028907 Uncertain NA NA "HPA028907: AB_10602404" "unprognostic (3.01e-1)" "unprognostic (1.97e-2)" "unprognostic (3.70e-2)" "unprognostic (1.42e-3)" "unprognostic (1.09e-2)" "unprognostic (1.82e-4)" "unprognostic (6.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.55e-1)" "unprognostic (3.50e-1)" "unprognostic (3.73e-4)" "unprognostic (8.11e-2)" "unprognostic (5.46e-2)" "unprognostic (2.73e-1)" "unprognostic (3.70e-3)" 0.5 0.4 3.9 1.0 9.7 0.4 0.5 40.2 22.4 0.6 5.7 0.3 0.0 2.6 0.5 0.6 0.4 0.4 0.5 0.5 6.5 4.5 0.4 0.4 0.5 0.7 1.3 14.5 0.4 0.5 0.4 0.2 0.4 1.6 0.4 7.7 0.0 0.8 0.4 0.5 0.5 4.9 0.7 1.4 0.4 0.4 0.5 0.0 0.0 0.4 0.0 0.7 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 9.7 40.2 22.4 6.5 4.5 1.3 14.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.8 0.0 0.1 8.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 3.4 0.1 SLC6A9 GLYT1 ENSG00000196517 "Solute carrier family 6 member 9" P48067 1 43991500-44031467 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.2;skin 1: 38.2" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 26.6;Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.4" "Lineage enriched" "Detected in single" 5 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "HaCaT: 23.9;hTCEpi: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013977 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA013977: AB_1849835" "unprognostic (2.73e-2)" "unprognostic (1.92e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (9.50e-4)" "unprognostic (5.98e-2)" "unprognostic (6.83e-3)" "unprognostic (3.06e-2)" "unprognostic (9.72e-2)" "unprognostic (1.85e-2)" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (5.72e-2)" "prognostic unfavorable (5.93e-4)" "unprognostic (5.36e-3)" "unprognostic (1.59e-1)" "unprognostic (2.53e-1)" "unprognostic (1.20e-2)" 2.9 22.8 8.8 4.6 18.3 8.6 5.4 5.5 14.3 6.0 7.9 38.1 2.6 2.5 6.2 1.5 16.5 9.6 4.9 1.3 9.9 10.0 2.0 4.9 5.6 1.4 29.5 4.5 4.0 7.8 2.1 1.0 1.7 26.8 2.6 6.2 24.0 7.9 6.1 1.3 38.2 5.6 8.9 42.2 1.1 3.5 1.2 26.3 0.0 4.9 7.2 4.3 6.6 10.9 0.2 0.0 0.2 0.1 0.0 1.4 0.2 7.3 5.5 2.7 7.0 4.4 1.5 6.2 5.9 15.9 9.6 11.9 1.8 2.9 0.1 0.6 16.3 0.0 23.9 4.2 4.7 1.9 0.0 0.7 6.5 13.1 2.1 20.2 1.4 0.3 4.5 41.9 4.7 11.2 6.0 0.2 4.7 5.0 18.8 0.4 4.0 1.0 0.0 2.1 2.8 7.4 0.8 0.0 8.4 0.9 0.8 1.7 1.6 3.0 13.7 2.7 0.7 3.6 3.9 0.1 1.1 4.5 0.9 3.0 20.8 14.3 1.6 3.6 0.0 1.4 0.0 0.0 0.2 0.4 0.1 0.2 0.2 0.4 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 0.0 0.0 0.2 8.8 18.3 5.5 9.4 9.9 10.0 29.5 4.5 26.8 26.3 0.0 1.3 0.9 0.7 6.6 26.6 0.6 5.1 8.1 0.0 1.8 15.7 0.4 0.0 3.2 5.8 0.4 9.8 70.0 7.9 0.7 0.9 1.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.4 1.4 0.0 3.3 1.8 2.9 1.2 4.2 2.0 1.4 1.0 10.2 6.5 6.3 0.0 0.4 11.3 0.5 0.0 1.3 2.5 SLC7A1 "ATRC1, CAT-1, ERR, HCAT1, REC1L" ENSG00000139514 "Solute carrier family 7 member 1" P30825 13 29509410-29595688 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 42.8" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039721, HPA077838" Approved NA NA "HPA039721: AB_10672893, HPA077838: " "unprognostic (1.85e-1)" "unprognostic (1.04e-3)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (1.36e-3)" "unprognostic (2.02e-3)" "unprognostic (4.98e-2)" "unprognostic (1.23e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.20e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (7.37e-3)" 5.7 4.5 8.5 9.0 11.7 8.6 7.0 8.7 19.6 8.1 8.7 10.7 7.5 9.0 7.3 9.6 42.8 6.9 4.8 6.2 12.2 10.4 4.3 2.4 4.4 7.1 11.4 7.7 5.3 26.6 2.9 6.4 12.9 20.0 7.2 6.8 6.1 16.2 12.6 2.1 14.8 12.9 8.1 11.9 5.7 10.0 8.8 6.9 5.3 8.6 27.7 16.2 6.4 8.3 2.0 3.7 0.5 2.8 0.8 3.3 1.7 12.2 9.9 8.7 17.5 4.5 9.0 9.9 26.2 17.5 22.7 16.9 20.0 21.6 24.3 7.1 39.9 25.4 56.3 15.1 18.5 30.0 22.8 9.0 18.2 10.8 10.8 23.4 26.4 12.0 11.4 39.6 25.2 29.9 5.3 11.1 27.8 11.6 11.4 9.5 16.5 19.2 7.1 8.3 21.8 6.6 13.3 18.0 13.9 14.4 8.2 29.7 14.1 14.9 14.6 23.7 5.7 6.4 22.5 10.4 17.9 12.5 15.7 18.7 12.8 9.2 27.7 14.3 10.7 18.0 0.0 1.1 0.5 3.3 1.2 2.7 2.0 2.4 2.7 1.8 1.4 1.9 3.1 0.0 0.8 2.8 3.7 1.9 1.7 8.5 11.7 8.7 15.9 12.2 10.4 11.4 7.7 20.0 6.9 0.0 5.3 14.9 42.8 44.3 15.1 6.7 10.2 5.3 12.5 68.0 15.7 0.4 1.7 19.5 0.2 14.3 16.1 23.3 49.3 31.4 9.3 41.6 6.9 0.8 6.1 23.8 29.9 3.7 4.3 0.4 5.8 5.2 8.5 4.6 28.0 3.4 45.4 24.5 3.5 0.0 17.8 6.5 9.9 0.5 2.1 30.6 3.3 4.9 24.5 38.1 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.9;brain: 13.6;breast: 15.6" "Group enriched" "Detected in some" 5 "Muller glia cells: 1.8;Spermatogonia: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 40.9 1.0 9.8 1.9 13.6 1.0 15.6 2.4 12.1 1.0 2.2 0.8 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.1 4.7 6.2 1.3 1.0 1.0 1.2 7.6 5.0 1.0 1.2 1.0 0.0 1.2 9.0 1.0 1.0 8.4 2.3 1.0 1.0 1.1 1.0 1.1 0.8 1.0 1.0 1.4 1.8 0.0 1.4 0.0 1.4 1.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 8.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.8 13.6 2.4 12.1 4.7 6.2 7.6 5.0 9.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.0 0.0 SLC7A11 xCT ENSG00000151012 "Solute carrier family 7 member 11" Q9UPY5 4 138164097-138242349 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2" "Cell type enhanced" "Detected in many" 13 "Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 8 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064215 Approved Vesicles NA NA Vesicles "HPA064215: AB_2685213" "unprognostic (3.55e-3)" "unprognostic (4.64e-3)" "unprognostic (2.43e-2)" "unprognostic (7.18e-3)" "unprognostic (2.59e-1)" "unprognostic (8.80e-3)" "unprognostic (2.07e-8)" "unprognostic (1.98e-2)" "unprognostic (1.09e-2)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (2.22e-8)" "unprognostic (3.81e-2)" "unprognostic (3.76e-2)" "unprognostic (2.29e-2)" "unprognostic (1.54e-2)" 1.1 0.9 16.3 4.7 15.8 2.2 1.5 8.2 26.0 2.4 2.0 17.9 0.0 1.5 1.3 13.4 3.3 8.9 3.8 2.5 17.4 6.9 0.9 0.9 2.3 1.5 12.6 16.8 1.7 5.4 1.0 1.2 2.1 17.2 2.0 2.8 0.3 1.6 1.0 0.8 1.9 1.4 1.0 27.2 1.4 9.2 2.2 14.0 0.0 8.9 6.0 2.2 4.0 0.8 0.1 3.8 0.4 0.0 0.1 0.0 0.0 1.6 13.8 6.2 4.8 1.3 1.7 1.7 7.6 5.3 1.7 4.0 1.5 5.8 3.1 10.0 26.5 9.4 2.2 3.3 6.5 7.4 5.9 0.7 2.2 13.1 3.4 20.6 5.8 2.1 4.1 28.6 4.9 22.1 2.6 21.6 3.2 3.0 8.2 9.1 1.2 0.8 0.5 1.2 8.1 3.9 0.9 2.0 3.6 1.0 6.6 2.5 0.5 3.3 0.9 11.7 1.4 1.5 12.4 31.4 2.3 6.5 3.4 6.0 6.9 3.1 3.2 3.9 3.2 46.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 3.8 0.0 0.0 16.3 15.8 8.2 15.9 17.4 6.9 12.6 16.8 17.2 14.0 0.0 5.9 3.7 7.0 4.0 4.0 3.6 2.5 1.4 3.4 0.0 2.0 2.2 0.0 3.6 2.1 1.6 1.1 0.0 21.4 0.5 1.0 37.7 4.6 0.4 0.5 1.6 25.9 3.7 0.0 0.4 2.3 9.0 5.0 90.2 5.4 48.4 27.4 1.1 2.1 0.0 1.9 0.0 1.0 0.7 0.7 2.8 0.9 0.0 1.3 11.1 SLC7A13 "AGT-1, XAT2" ENSG00000164893 "Solute carrier family 7 member 13" Q8TCU3 8 86214052-86321146 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "kidney: 31.7" "Cell type enhanced" "Detected in some" 31 "Collecting duct cells: 1.8;Distal tubular cells: 3.3;Proximal tubular cells: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in single" "RPMI-8226: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.34e-1)" "unprognostic (2.62e-1)" "unprognostic (1.12e-1)" "unprognostic (2.96e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 31.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.1 0.0 1.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459584-170586074 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.4;pituitary gland: 14.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 31.5;Horizontal cells: 27.0" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 1.1 5.8 12.1 1.9 17.7 1.4 1.1 14.9 33.4 1.0 1.8 8.0 0.0 1.6 1.1 1.2 1.1 1.1 1.3 1.1 11.5 12.1 1.3 1.2 1.1 1.1 6.7 12.8 1.3 2.4 1.1 14.5 1.1 11.8 1.2 1.9 0.1 1.1 1.1 1.2 1.3 1.7 1.3 9.0 1.1 1.5 1.3 6.3 0.0 1.1 0.0 1.1 1.1 0.3 1.0 0.6 2.1 0.5 0.7 0.6 0.1 0.0 0.0 0.4 0.1 1.3 2.0 0.1 0.6 0.2 0.8 0.8 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 1.8 0.0 0.1 1.3 0.8 0.2 0.1 0.0 0.2 7.2 0.0 0.0 0.2 1.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 7.2 2.1 0.0 0.1 0.0 0.3 0.1 0.1 1.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 2.1 0.5 0.5 0.4 0.3 0.3 0.8 0.3 0.3 0.1 1.0 0.6 0.5 1.2 0.7 0.3 0.6 0.3 0.1 12.1 17.7 14.9 16.9 11.5 12.1 6.7 12.8 11.8 6.3 3.0 2.1 0.0 0.3 0.3 31.5 0.8 0.0 5.3 4.5 0.0 2.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.2 2.3 1.0 0.0 27.0 1.7 0.0 0.0 0.4 2.0 0.9 3.3 0.0 0.0 1.8 0.1 0.0 2.5 0.0 3.9 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 SLC7A2 "ATRC2, CAT-2, HCAT2" ENSG00000003989 "Solute carrier family 7 member 2" P52569 8 17497088-17570573 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 230.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 67.7;RT4: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009277 Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA009277: AB_2668229" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-2)" "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (7.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.76e-1)" "unprognostic (4.49e-1)" "unprognostic (1.34e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.65e-7)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.46e-2)" "unprognostic (8.98e-2)" "unprognostic (1.79e-1)" 10.6 3.8 8.6 1.4 3.4 0.1 18.0 2.5 8.3 11.5 2.5 2.4 2.9 0.8 6.4 11.8 3.7 13.6 5.1 9.7 6.8 0.9 3.8 68.1 3.3 2.8 4.4 3.5 35.1 32.2 78.2 3.0 29.0 9.1 4.9 1.5 13.0 2.4 3.3 57.8 3.3 2.0 4.3 10.9 1.8 3.3 7.7 3.5 0.0 14.3 10.4 1.2 3.4 6.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.9 0.3 10.4 0.0 0.1 11.3 0.0 7.0 0.5 0.6 3.3 0.0 0.0 2.4 0.0 1.5 0.0 7.5 1.7 2.4 0.0 3.9 0.0 8.1 7.2 67.7 3.1 0.0 9.1 1.4 8.8 8.4 0.0 3.2 0.0 0.0 0.0 7.9 11.0 0.4 3.6 3.8 2.3 0.9 0.0 5.2 5.4 0.8 17.4 0.1 1.4 0.5 0.2 3.1 8.0 0.0 0.3 7.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.6 3.4 2.5 8.3 6.8 0.9 4.4 3.5 9.1 3.5 11.9 63.8 0.0 6.1 7.3 1.8 14.3 33.1 84.3 27.3 7.0 33.4 17.0 0.0 4.5 10.8 5.2 0.1 0.0 79.6 13.8 18.2 28.5 2.3 230.6 4.7 0.0 84.5 6.7 6.9 17.4 35.1 1.5 3.3 1.0 2.2 15.0 29.6 0.0 26.2 1.8 38.5 58.2 52.8 0.4 0.4 3.3 21.7 2.5 2.6 1.8 SLC7A3 "ATRC3, CAT-3, FLJ14541" ENSG00000165349 "Solute carrier family 7 member 3" Q8WY07 X 70925582-70931125 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 45.5" "Group enriched" "Detected in some" 6 "Early spermatids: 5.3;Late spermatids: 1.9" "Cancer enriched" "Detected in some" 12 "testis cancer: 43.0" "Region enhanced" "Detected in many" "hypothalamus: 6.7" "Cell type enriched" "Detected in single" 16 "naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Group enriched" "Detected in some" 4 "HAP1: 20.7;NTERA-2: 42.6;SuSa: 53.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.42e-4)" "unprognostic (4.30e-4)" "unprognostic (3.59e-3)" "unprognostic (1.81e-2)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (3.66e-1)" "unprognostic (9.18e-3)" "unprognostic (1.89e-1)" "unprognostic (7.99e-5)" "unprognostic (1.31e-2)" "unprognostic (5.42e-4)" "unprognostic (3.57e-2)" 0.1 0.0 1.0 0.1 1.0 1.3 1.4 0.1 2.1 2.0 0.1 1.1 0.8 0.1 9.1 6.2 0.7 2.7 0.1 0.0 1.2 6.7 0.2 0.0 0.1 0.5 0.5 0.5 1.7 0.0 0.0 0.6 0.0 1.2 10.4 0.0 0.5 0.2 9.4 0.0 0.0 0.3 4.6 0.2 0.1 5.6 2.4 0.4 45.5 0.0 0.2 0.5 4.0 1.4 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 42.6 0.0 0.0 8.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 1.0 1.0 0.1 2.1 1.2 6.7 0.5 0.5 1.2 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 SLC7A4 "CAT-4, HCAT3, VH" ENSG00000099960 "Solute carrier family 7 member 4" O43246 22 21028718-21032840 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.6;testis: 29.1" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Cytotrophoblasts: 9.1;granulocytes: 4.6;Mucus-secreting cells: 7.9;Syncytiotrophoblasts: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.4;naive CD8 T-cell: 2.4" "Group enriched" "Detected in many" 18 "NK-cells: 1.0;T-cells: 2.4" "Cell line enriched" "Detected in some" 21 "BEWO: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031023 Enhanced NA NA "HPA031023: AB_10669669" "unprognostic (1.02e-3)" "unprognostic (4.34e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.82e-2)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.91e-2)" "unprognostic (3.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (9.69e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" 2.7 3.5 2.2 0.4 3.8 0.1 2.6 6.0 5.9 2.8 1.8 0.4 1.4 1.7 1.5 0.7 8.5 1.6 4.1 1.2 2.7 7.1 0.2 0.3 1.4 1.2 2.4 4.3 0.3 0.4 0.1 5.1 19.6 2.4 4.1 1.4 3.3 4.3 5.3 0.6 1.9 2.0 0.6 0.6 0.9 2.4 29.1 0.4 0.2 0.1 1.3 2.1 2.4 0.7 0.0 0.0 0.0 0.0 1.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.4 0.0 0.2 1.2 0.0 0.0 0.1 2.4 0.0 1.0 0.0 0.0 0.0 0.8 2.2 3.8 6.0 5.9 2.7 7.1 2.4 4.3 2.4 0.4 6.0 3.4 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 2.8 0.1 0.4 4.6 0.0 1.2 0.0 1.2 1.8 0.0 1.3 1.7 0.0 0.0 0.0 7.9 1.8 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 8.5 0.0 0.6 0.1 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869488 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 71.2" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 15.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA052673: AB_2681909, HPA056077: AB_2683031" "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 8.2 3.2 18.3 14.7 24.5 71.2 4.3 15.9 45.8 7.9 4.6 16.7 8.9 6.2 5.3 30.4 38.7 3.3 6.4 8.2 19.8 22.1 3.6 9.7 3.8 11.1 23.9 9.6 5.1 12.1 1.5 9.0 28.4 23.4 4.3 3.4 34.9 11.5 15.4 11.2 10.7 5.7 4.8 17.7 6.4 12.7 34.9 19.8 3.7 4.2 16.7 15.0 11.5 7.7 0.5 15.9 0.6 0.0 0.2 1.4 0.4 14.9 56.6 1.1 15.9 0.4 0.9 40.8 12.0 4.3 7.3 4.7 36.9 21.4 13.7 10.6 15.2 2.5 67.4 11.7 108.7 5.1 14.3 5.9 11.2 53.1 26.4 17.1 10.4 20.7 3.0 186.8 9.0 66.8 2.4 1.4 48.5 16.7 15.3 5.8 101.2 12.5 15.3 5.2 9.4 13.8 12.2 4.3 20.9 8.1 1.2 9.1 3.6 153.4 30.7 32.9 10.8 14.1 13.8 1.1 2.6 17.1 10.6 9.3 20.0 16.3 59.1 10.1 25.9 24.4 0.6 0.0 0.0 1.0 0.0 1.2 0.5 0.5 0.8 0.3 0.0 0.1 0.4 0.1 0.2 0.0 15.9 1.4 0.4 18.3 24.5 15.9 28.1 19.8 22.1 23.9 9.6 23.4 19.8 0.0 1.1 16.4 11.1 65.1 12.7 2.8 2.5 0.0 0.0 1.8 15.7 12.4 0.0 16.8 0.8 4.3 1.7 70.0 8.0 28.4 10.4 13.9 68.9 14.5 8.2 9.5 82.6 2.5 3.5 4.0 1.7 6.6 37.1 2.8 2.8 13.3 19.5 0.2 1.4 0.5 50.1 0.0 85.8 1.7 2.5 32.9 89.8 8.6 1.6 26.1 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA050713: AB_2681218" "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.84e-4)" 25.9 7.6 5.4 12.9 6.7 6.9 18.7 9.0 8.0 5.3 7.1 3.4 6.7 3.6 5.5 14.0 4.0 7.1 4.7 13.1 5.3 3.3 5.4 2.3 9.8 16.3 3.3 4.6 3.0 3.2 2.5 11.1 16.3 5.4 6.6 10.8 9.0 5.8 5.1 58.8 8.4 9.4 8.3 3.4 9.4 5.3 5.2 3.7 31.8 15.0 8.0 19.6 5.7 8.0 7.2 16.2 5.9 3.6 6.7 12.6 1.7 9.4 9.7 7.2 7.7 21.4 12.8 20.3 11.1 8.1 16.6 13.9 41.3 7.2 18.8 8.8 14.2 4.8 14.5 14.0 13.9 18.1 3.8 10.0 10.0 19.1 13.1 3.9 11.8 9.1 8.6 12.2 12.9 6.5 5.3 11.1 9.8 14.7 3.4 9.0 5.1 15.3 8.2 5.4 6.4 3.5 19.5 4.5 15.8 5.8 8.3 10.6 5.8 32.1 9.0 3.8 6.3 13.5 6.4 16.3 11.0 8.4 9.2 13.9 7.2 13.5 21.5 7.0 8.7 7.4 2.5 3.6 3.0 4.9 1.7 6.1 6.6 7.3 4.6 3.4 7.2 12.6 7.4 5.9 6.7 1.4 16.2 3.1 1.7 5.4 6.7 9.0 8.0 5.3 3.3 3.3 4.6 5.4 3.7 38.7 16.8 11.1 8.0 17.4 3.7 17.3 0.0 8.1 3.4 17.4 35.3 20.4 0.0 3.0 4.0 9.0 4.2 0.0 3.4 1.6 10.5 3.0 4.6 1.3 12.0 9.5 2.4 7.4 6.7 14.6 5.5 7.5 10.1 3.6 8.9 2.1 4.1 6.2 3.5 0.3 2.6 0.0 7.3 14.2 9.4 19.2 40.0 17.5 6.9 2.3 SLC7A7 "LPI, y+LAT-1" ENSG00000155465 "Solute carrier family 7 member 7" Q9UM01 14 22773222-22829820 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 63.8;intestine: 93.5;kidney: 67.3" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 200.4;Kupffer cells: 312.3;Macrophages: 142.1;Proximal tubular cells: 254.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 59.5;non-classical monocyte: 63.8" "Lineage enriched" "Detected in many" 4 "monocytes: 63.8" "Cell line enhanced" "Detected in some" "BEWO: 44.5;CACO-2: 72.0;EFO-21: 15.6;OE19: 63.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036227 Enhanced NA NA "HPA036227: AB_10696653" "unprognostic (1.34e-1)" "unprognostic (7.65e-2)" "unprognostic (4.25e-2)" "unprognostic (2.52e-1)" "unprognostic (6.12e-2)" "unprognostic (3.69e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.60e-3)" "unprognostic (7.15e-2)" "prognostic unfavorable (6.28e-6)" "unprognostic (2.68e-3)" "unprognostic (1.86e-2)" "unprognostic (2.61e-1)" "unprognostic (1.12e-1)" 10.4 2.8 1.9 8.3 3.1 3.6 3.2 0.7 2.7 2.6 48.0 4.1 0.2 24.1 2.7 2.3 2.1 4.6 7.6 3.0 2.2 1.6 67.3 6.5 15.3 20.5 3.7 1.0 2.6 2.7 26.3 1.0 6.5 3.2 2.7 3.4 2.1 3.3 0.9 1.6 1.8 93.5 3.5 4.5 32.4 3.0 13.4 2.7 2.1 2.8 0.8 5.7 4.1 3.6 3.0 14.6 5.4 63.8 0.0 0.1 17.8 0.0 2.4 0.2 0.1 0.4 0.8 44.5 0.5 3.6 0.1 0.3 72.0 7.3 3.5 15.6 0.3 0.2 2.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.7 2.1 0.3 0.3 1.6 0.2 0.2 0.1 0.3 5.5 0.2 0.0 2.8 0.5 0.1 0.0 0.3 0.7 63.3 0.0 0.6 7.8 2.1 0.1 0.2 0.0 0.1 0.1 0.1 0.5 2.1 0.1 1.7 0.3 0.1 0.3 0.1 0.1 0.6 0.1 1.8 0.2 0.1 0.0 0.0 41.2 0.1 0.0 59.5 0.0 3.0 0.0 0.0 14.6 2.3 0.1 0.0 5.4 0.0 63.8 0.5 0.1 17.8 1.9 3.1 0.7 2.7 2.2 1.6 3.7 1.0 3.2 2.7 11.9 10.3 23.7 0.1 0.9 0.0 0.8 58.6 9.4 4.5 3.5 0.0 1.0 10.0 6.7 40.8 4.5 8.6 0.0 5.8 4.5 4.8 0.2 1.1 1.3 200.4 0.0 1.2 22.1 312.3 7.5 3.4 142.1 5.0 34.3 0.4 0.5 7.3 0.0 0.0 254.4 1.2 6.5 2.8 12.2 1.7 0.4 1.5 5.0 0.3 0.0 SLC7A8 "LAT2, LPI-PC1" ENSG00000092068 "Solute carrier family 7 member 8" Q9UHI5 14 23125295-23183674 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 204.0" "Cell type enhanced" "Detected in many" 6 "Ito cells: 97.0;Kupffer cells: 71.7;Proximal tubular cells: 98.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 46 "granulocytes: 13.2;T-cells: 3.5" "Cell line enhanced" "Detected in many" "AF22: 21.2;ASC diff: 22.3;BEWO: 38.9;CACO-2: 21.5;K-562: 40.6;NTERA-2: 21.2;SuSa: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046015, HPA051950, HPA060672" Enhanced NA NA "CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340" "unprognostic (1.50e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-1)" "unprognostic (1.03e-2)" "unprognostic (1.12e-2)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.97e-4)" "prognostic favorable (3.15e-4)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (1.39e-3)" "unprognostic (9.44e-2)" "unprognostic (7.00e-2)" "unprognostic (2.96e-2)" "unprognostic (8.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.52e-4)" 10.5 5.9 4.6 3.0 6.6 1.3 11.0 10.9 10.7 12.7 5.9 2.5 28.2 11.7 23.0 7.2 13.2 21.7 6.2 3.1 7.8 3.0 37.6 3.0 6.2 5.8 2.4 5.6 33.7 9.1 204.0 16.7 19.8 6.9 13.0 5.1 31.2 9.5 50.9 23.6 11.2 8.8 7.5 1.9 10.0 19.3 10.5 4.7 0.3 12.8 5.2 4.9 15.2 14.5 0.1 0.0 13.2 0.1 0.0 3.5 1.7 0.4 0.0 21.2 0.0 22.3 2.7 38.9 2.1 8.5 0.0 0.6 21.5 1.1 0.1 0.3 4.6 2.2 3.6 2.8 1.1 0.1 0.0 2.0 0.1 0.0 0.0 8.7 0.0 12.1 19.2 10.7 0.3 0.2 5.0 1.7 1.9 40.6 0.0 0.4 0.3 0.0 0.2 21.2 4.0 15.8 0.0 0.2 4.0 0.2 7.9 2.6 0.1 0.0 3.7 10.0 25.5 13.5 0.1 0.1 0.7 0.5 0.2 0.0 0.1 4.6 0.0 2.4 0.0 0.1 7.6 0.1 13.2 0.0 0.1 1.1 0.1 0.9 0.1 0.0 0.0 0.9 3.5 0.4 0.0 0.0 0.0 0.5 1.7 4.6 6.6 10.9 10.7 7.8 3.0 2.4 5.6 6.9 4.7 14.9 16.7 2.9 22.2 2.7 28.0 5.1 0.0 0.0 13.6 15.7 0.0 14.7 5.0 1.3 1.8 1.3 12.9 0.0 2.1 2.2 8.7 34.8 4.7 0.4 47.4 25.4 31.8 97.0 71.7 1.7 8.9 9.7 18.6 0.0 30.8 48.5 3.9 3.5 7.4 98.9 4.2 0.0 3.1 0.3 0.6 2.6 34.6 1.3 18.9 31.8 SLC7A9 CSNU3 ENSG00000021488 "Solute carrier family 7 member 9" P82251 19 32830509-32869766 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 63.3;kidney: 26.4" "Cell type enriched" "Detected in some" 5 "Proximal tubular cells: 55.5" "Group enriched" "Detected in some" 7 "liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042591 Enhanced NA NA "HPA042591: AB_10962500" "unprognostic (4.12e-2)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" "unprognostic (3.37e-3)" "unprognostic (1.69e-1)" "unprognostic (1.54e-1)" "unprognostic (4.17e-2)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" "unprognostic (2.39e-1)" "unprognostic (9.69e-2)" "unprognostic (5.97e-2)" "unprognostic (3.20e-1)" "unprognostic (4.94e-3)" "unprognostic (5.10e-5)" 0.1 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.2 0.2 20.1 0.1 0.1 30.5 0.1 1.1 0.1 0.2 0.1 0.1 0.1 0.1 26.4 11.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 63.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 4.9 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.0 2.7 0.0 5.2 3.9 0.1 1.7 0.0 0.7 0.0 0.0 0.0 6.6 6.5 0.0 0.0 0.0 10.5 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 55.5 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 67.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 601.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 25.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 25.2" "Cell line enhanced" "Detected in many" "BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: AB_2686227" "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 3.9 2.9 7.7 4.4 14.3 1.4 2.0 3.5 15.3 5.5 7.3 1.8 7.1 3.3 12.2 3.9 4.0 3.9 5.3 67.7 7.7 6.6 11.0 2.2 3.7 2.5 5.2 8.2 2.1 1.5 1.1 1.9 6.8 7.6 12.2 3.4 1.0 1.5 17.2 1.5 2.1 3.6 20.5 2.8 4.4 2.5 1.4 2.5 0.1 1.6 0.0 1.3 9.8 2.8 0.0 2.4 25.2 6.0 0.0 0.0 0.5 1.5 1.2 1.1 0.1 1.7 3.6 0.0 15.4 6.0 5.1 3.3 0.0 2.5 0.0 1.2 37.3 5.5 0.6 0.3 2.5 5.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 5.9 10.9 2.3 0.4 0.0 0.0 0.2 6.5 0.0 0.4 0.0 0.8 0.1 2.1 4.1 8.1 0.0 1.8 0.2 1.7 0.3 0.0 0.0 0.0 5.6 0.0 0.3 5.2 4.8 0.1 0.0 1.6 0.8 0.0 0.0 0.8 0.9 0.7 0.0 4.9 0.0 0.0 5.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 25.2 0.0 6.0 0.1 0.0 0.5 7.7 14.3 3.5 15.3 7.7 6.6 5.2 8.2 7.6 2.5 3.0 3.2 2.9 0.0 1.1 50.8 601.5 2.5 0.0 1.2 33.2 3.9 0.4 0.0 0.0 0.8 3.3 0.0 0.0 0.0 1.4 4.8 0.1 0.0 0.0 28.3 0.0 0.0 20.3 56.6 0.7 0.0 46.7 1.7 1.0 0.6 35.9 0.1 0.0 7.8 0.1 6.9 12.9 19.6 0.2 0.4 2.8 0.9 0.0 0.0 0.0 SLC8A2 "KIAA1087, NCX2" ENSG00000118160 "Solute carrier family 8 member A2" Q9UPR5 19 47428017-47472168 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.9" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 16.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 4.4;SCLC-21H: 12.5;SH-SY5Y: 6.7;SiHa: 5.2;U-2 OS: 8.1" "Group enriched" "Detected in many" 4 "amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1" "Low region specificity" "Detected in all" "HPA050818, HPA054671" Enhanced NA NA "HPA050818: AB_2681248, HPA054671: AB_2682568" "unprognostic (3.75e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (4.32e-2)" "unprognostic (1.34e-1)" "unprognostic (6.00e-3)" "unprognostic (1.38e-1)" "unprognostic (2.79e-1)" "unprognostic (1.34e-1)" "unprognostic (8.95e-2)" "unprognostic (4.77e-2)" "unprognostic (2.04e-2)" "unprognostic (2.81e-3)" "unprognostic (6.13e-2)" "unprognostic (9.40e-2)" "unprognostic (1.53e-1)" "unprognostic (1.63e-2)" 1.2 4.0 16.6 1.0 18.1 0.9 0.9 50.9 50.7 1.0 2.4 1.8 1.0 1.3 5.4 1.0 2.3 2.2 1.1 0.9 21.4 6.8 1.0 0.9 0.9 0.9 2.1 21.1 0.9 10.3 0.9 3.2 1.0 2.0 1.4 1.4 0.0 1.2 4.4 0.9 1.0 1.2 5.5 2.0 1.0 1.3 1.9 1.2 0.0 1.0 0.0 0.9 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 4.4 0.6 0.0 0.0 0.0 0.0 0.4 0.1 12.5 6.7 5.2 0.6 0.4 0.4 0.2 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 18.1 50.9 34.6 21.4 6.8 2.1 21.1 2.0 1.2 0.0 0.0 0.0 0.1 0.0 16.2 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.9 0.0 0.3 1.1 1.7 0.0 0.1 0.0 0.0 0.1 SLC8A3 NCX3 ENSG00000100678 "Solute carrier family 8 member A3" P57103 14 70044217-70189070 "Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 17.0;skeletal muscle: 32.1" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 33.9" "Cancer enriched" "Detected in single" 8 "glioma: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;LHCN-M2: 7.3;SH-SY5Y: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.65e-1)" "unprognostic (5.53e-2)" "unprognostic (1.18e-2)" "unprognostic (1.51e-2)" "unprognostic (2.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.69e-1)" "unprognostic (3.46e-3)" "unprognostic (4.74e-2)" "unprognostic (1.64e-1)" "unprognostic (1.45e-3)" "unprognostic (8.53e-2)" "unprognostic (5.86e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.38e-1)" 0.7 2.8 6.1 1.2 6.1 1.0 0.9 3.8 17.0 1.4 1.1 3.1 0.0 1.1 0.9 1.0 1.1 0.7 1.3 1.5 5.8 8.2 0.6 0.6 1.6 1.0 4.7 7.1 0.6 1.0 0.6 1.5 0.7 6.4 1.2 1.1 1.5 0.6 0.8 32.1 0.8 1.2 1.2 2.8 0.7 1.2 0.8 1.9 0.0 0.6 4.9 0.9 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 4.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 23.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 6.1 6.1 3.8 10.6 5.8 8.2 4.7 7.1 6.4 1.9 0.0 1.1 0.0 0.0 0.1 33.9 1.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 8.1 0.0 0.1 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC9A1 "APNH, NHE1, PPP1R143" ENSG00000090020 "Solute carrier family 9 member A1" P19634 1 27098815-27166981 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 60.7" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022371, HPA048532, HPA052891" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981" "unprognostic (6.18e-2)" "unprognostic (1.59e-1)" "unprognostic (2.21e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.47e-4)" "unprognostic (2.70e-2)" "unprognostic (4.33e-3)" "unprognostic (3.18e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (7.10e-4)" "unprognostic (3.44e-2)" "unprognostic (6.95e-2)" "unprognostic (2.05e-2)" "unprognostic (1.27e-2)" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-2)" 7.1 11.3 7.5 9.9 10.1 7.3 8.4 11.7 18.9 8.7 14.0 5.0 26.9 20.7 10.6 6.8 10.3 7.1 24.4 13.4 4.6 5.3 7.3 2.4 11.2 5.8 5.0 6.7 6.9 6.4 13.4 8.0 42.5 14.8 8.5 10.2 10.1 60.7 55.4 3.8 9.2 24.7 8.1 3.9 10.5 45.6 8.3 4.9 6.0 8.0 6.5 9.0 18.8 8.4 0.9 0.6 5.5 1.5 0.4 4.2 1.8 13.7 4.7 4.5 4.5 10.2 7.4 27.6 11.3 17.3 9.9 10.8 5.7 9.0 6.2 9.7 14.7 4.8 17.2 4.4 28.0 6.2 7.4 4.1 9.5 3.1 2.4 31.1 5.5 7.2 9.2 13.6 16.7 23.3 7.2 16.4 4.4 2.6 6.1 14.5 8.2 2.8 2.9 6.2 17.0 9.8 5.1 4.0 2.9 5.2 20.8 5.2 1.6 9.5 13.0 5.7 4.8 6.0 3.5 17.6 10.6 4.2 9.8 6.2 5.5 3.5 1.8 11.3 6.2 6.1 0.1 1.5 1.5 1.9 0.9 4.2 0.2 2.2 2.0 0.6 0.9 1.4 1.7 5.5 0.4 1.5 0.1 0.8 1.8 7.5 10.1 11.7 18.9 4.6 5.3 5.0 6.7 14.8 4.9 6.0 17.9 5.2 16.2 27.7 6.3 11.3 10.2 0.0 3.4 10.4 0.0 30.0 0.0 8.5 26.9 7.1 52.0 0.0 10.9 16.2 11.0 8.8 26.5 1.0 11.5 19.1 12.0 8.0 4.9 9.7 8.6 6.6 6.8 1.8 12.3 10.8 19.4 22.0 12.4 1.3 3.6 6.5 8.7 1.4 3.4 22.0 44.3 6.7 14.3 16.3 SLC9A2 NHE2 ENSG00000115616 "Solute carrier family 9 member A2" Q9UBY0 2 102619707-102711318 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 19.1;Enterocytes: 23.6;Late spermatids: 22.4;Mucus-secreting cells: 26.9;Paneth cells: 40.3;Undifferentiated cells: 31.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.8;OE19: 25.9;RT4: 11.9;SK-BR-3: 10.5;T-47d: 13.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035121, HPA035122" Approved Supported "Cell Junctions" NA NA "Cell Junctions" "HPA035121: AB_10602894, HPA035122: AB_2674477" "unprognostic (1.53e-2)" "unprognostic (8.05e-3)" "unprognostic (6.00e-2)" "unprognostic (3.00e-3)" "unprognostic (3.12e-1)" "unprognostic (1.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.86e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-1)" "unprognostic (2.37e-2)" "unprognostic (1.97e-1)" "unprognostic (1.40e-3)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.70e-1)" 0.2 0.4 0.9 10.8 1.4 0.0 1.0 0.5 1.9 1.0 15.0 0.6 8.4 4.6 0.2 5.8 0.5 0.2 16.8 0.2 1.5 1.0 4.6 0.2 0.2 0.0 0.9 0.7 0.2 0.2 0.1 1.7 0.0 1.8 4.5 16.1 0.9 3.7 11.7 4.4 1.3 9.5 0.4 1.3 0.2 19.8 5.3 0.6 1.0 0.6 1.8 3.1 2.8 0.2 0.0 0.0 0.3 0.0 0.3 0.1 0.0 6.8 4.3 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.7 0.1 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.3 2.1 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 5.3 0.0 0.0 0.1 25.9 3.6 0.0 0.0 0.0 0.8 11.9 0.0 0.0 0.0 10.5 0.0 0.0 13.2 0.0 0.0 0.0 0.5 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.9 1.4 0.5 1.9 1.5 1.0 0.9 0.7 1.8 0.6 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.0 8.7 0.0 0.4 0.0 0.2 19.1 0.0 23.6 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 9.4 0.0 0.0 22.4 0.6 0.0 0.0 0.0 26.9 0.5 4.9 40.3 0.0 1.0 0.0 0.0 0.3 0.7 0.1 0.5 0.2 0.0 31.4 0.7 SLC9A3 NHE3 ENSG00000066230 "Solute carrier family 9 member A3" P48764 5 470458-524332 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 65.8;intestine: 85.1;kidney: 43.6" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 28.2" "Region enriched" "Detected in single" 14 "cerebellum: 4.6" "Not detected" "Not detected" "HPA036493, HPA036669" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA036493: AB_10673353, HPA036669: AB_10670843" "unprognostic (1.27e-1)" "unprognostic (4.88e-1)" "unprognostic (9.35e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (3.35e-1)" "unprognostic (2.51e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (8.49e-4)" "unprognostic (5.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.69e-2)" "unprognostic (3.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-1)" 0.6 0.6 0.5 16.2 1.0 0.0 0.6 4.2 0.9 0.9 27.5 0.7 1.1 12.7 0.9 3.4 2.4 0.8 65.8 0.6 0.6 0.6 43.6 0.5 0.5 0.9 0.9 0.7 0.8 1.1 0.6 0.9 0.5 1.2 1.4 2.3 1.2 2.1 0.8 0.7 4.2 85.1 1.1 0.6 0.5 22.7 1.1 0.5 0.6 0.7 2.4 2.7 0.8 2.0 1.9 2.0 0.2 1.2 3.5 6.8 2.9 4.2 3.8 7.0 7.4 1.7 2.0 5.5 4.2 2.5 5.2 3.3 9.3 4.9 10.2 5.5 1.9 3.8 7.0 3.9 2.5 2.5 28.2 7.3 4.6 16.5 3.4 2.6 3.4 5.9 2.7 5.2 2.3 3.5 2.6 1.5 4.2 6.1 5.4 1.8 6.6 3.7 16.7 2.6 12.2 6.3 5.6 6.6 5.3 1.8 3.6 7.9 3.3 12.6 3.5 2.6 3.2 8.0 2.7 1.9 6.0 5.3 4.1 2.7 9.1 3.6 5.8 3.8 15.3 3.8 0.0 1.2 0.1 4.3 0.5 3.8 1.6 5.6 4.1 1.4 1.9 6.8 5.2 0.2 3.5 0.4 2.0 4.2 2.9 0.5 1.0 4.2 0.9 0.6 0.6 0.9 0.7 1.2 0.5 14.9 4.3 0.0 0.0 0.0 0.0 0.6 0.0 5.3 10.3 15.7 0.0 0.0 5.0 7.5 0.0 0.0 1.0 0.0 7.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 8.2 0.0 0.0 6.5 0.0 0.0 38.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 24.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;OE19: 11.4;RT4: 7.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Not detected" "Not detected" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.4 0.1 2.4 0.0 0.3 0.3 0.0 0.0 0.0 3.9 0.1 0.2 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.1 0.1 1.1 11.4 0.4 0.2 0.5 0.3 0.0 7.1 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.1 0.5 0.4 1.1 0.7 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 3.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 2.7 1.2 24.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 1.7 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 6.3 0.7 1.2 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.2 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 0.9 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 3.0 3.2 0.0 0.1 0.6 1.9 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.1 0.6 0.4 0.0 0.0 0.1 15.9 1.2 2.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.4 0.0 2.1 0.0 0.6 0.0 0.7 1.7 1.1 0.6 0.0 0.0 0.2 0.1 SLC9A6 "KIAA0267, NHE6" ENSG00000198689 "Solute carrier family 9 member A6" Q92581 X 135973841-136047269 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059445, HPA059590" Enhanced Supported Vesicles NA NA Vesicles "HPA059445: AB_2684021, HPA059590: AB_2684075" "unprognostic (1.35e-1)" "unprognostic (8.28e-3)" "unprognostic (4.36e-1)" "unprognostic (4.93e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (2.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (4.49e-2)" "unprognostic (5.06e-2)" 4.3 5.7 16.4 4.7 27.6 4.0 3.1 15.3 35.1 5.2 5.2 7.8 1.6 7.5 5.7 3.2 5.6 5.2 4.8 7.2 19.1 24.3 6.2 3.9 5.7 4.7 15.0 15.6 7.4 3.3 9.3 8.6 4.0 22.3 3.6 5.5 4.6 3.3 4.6 5.5 4.1 6.5 6.5 9.5 4.8 5.2 5.1 4.0 3.6 5.9 1.7 5.8 4.7 3.2 5.3 6.8 3.2 8.4 5.9 13.9 6.0 13.2 7.0 7.4 2.7 10.5 10.2 13.3 10.7 11.5 9.2 19.5 6.1 10.6 9.9 24.4 12.3 13.7 7.9 9.6 9.6 13.4 7.7 8.7 2.7 11.2 3.6 5.5 7.7 9.4 5.6 8.5 15.2 7.5 6.6 7.8 9.7 4.9 14.1 10.1 5.8 10.2 2.2 4.2 4.9 9.5 6.9 11.0 10.0 6.6 6.6 6.6 5.0 7.7 0.8 6.2 6.6 3.2 6.0 11.1 11.5 8.2 17.0 13.7 6.8 15.1 8.7 7.0 13.2 6.4 2.2 6.0 3.2 8.1 8.4 13.9 5.3 9.5 7.9 6.8 4.0 10.6 7.9 2.6 5.9 6.6 4.3 8.0 6.0 16.4 27.6 15.3 25.9 19.1 24.3 15.0 15.6 22.3 4.0 3.0 4.8 4.2 1.3 6.6 13.4 8.1 17.8 0.0 1.2 12.2 7.9 2.2 0.0 4.0 0.6 4.6 8.0 0.0 5.1 2.1 4.7 2.1 1.1 7.8 8.9 46.1 10.3 8.6 12.9 0.9 5.2 8.8 8.5 2.8 3.4 13.2 4.6 5.8 4.2 4.9 7.0 0.0 4.9 5.0 12.3 5.9 2.4 7.7 5.0 2.2 SLC9A7 NHE7 ENSG00000065923 "Solute carrier family 9 member A7" Q96T83 X 46599252-46759172 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Potassium transport, Sodium transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 42.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048938, HPA075385" Approved Supported Vesicles NA NA Vesicles "HPA048938: AB_2680565, HPA075385: AB_2686747" "unprognostic (2.77e-1)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.58e-4)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.16e-2)" "unprognostic (2.73e-3)" "unprognostic (5.26e-3)" "unprognostic (1.28e-2)" "unprognostic (9.25e-2)" "unprognostic (5.30e-2)" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (7.20e-2)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" 1.7 7.2 4.4 3.8 42.0 4.4 7.9 7.0 12.4 1.8 1.2 1.8 1.2 1.7 1.2 3.8 3.2 2.5 2.2 2.3 3.3 7.1 3.3 4.1 1.8 7.8 3.6 4.3 6.3 4.6 11.5 13.6 1.4 12.7 6.5 1.3 2.3 7.3 2.9 10.0 2.9 2.7 1.0 2.7 4.7 8.2 1.3 8.2 2.8 6.9 1.7 8.2 2.3 2.2 4.3 6.0 2.1 0.6 1.4 0.7 0.5 7.0 5.4 0.8 2.4 0.9 5.4 3.1 6.7 8.4 4.0 3.3 5.5 7.7 15.5 2.1 10.7 7.9 3.3 5.2 7.6 7.4 8.1 2.8 1.6 2.1 2.2 3.3 0.7 12.8 3.4 1.0 11.4 7.6 19.2 5.7 5.4 0.1 0.3 5.5 10.6 1.7 0.8 3.7 3.4 6.5 6.9 0.3 0.2 3.1 7.9 5.8 0.7 3.4 5.2 1.5 6.8 6.9 0.3 0.3 8.7 2.9 1.3 3.9 1.6 0.4 7.8 12.3 0.1 2.8 1.0 0.6 0.3 0.6 0.6 0.4 3.4 0.7 0.3 2.4 4.3 0.4 0.5 2.1 1.4 0.6 6.0 0.7 0.5 4.4 42.0 7.0 8.3 3.3 7.1 3.6 4.3 12.7 8.2 3.0 8.0 17.9 7.5 0.6 10.1 4.5 2.5 0.0 3.4 15.7 3.9 5.5 0.0 15.3 0.0 0.5 0.0 0.0 12.2 0.3 0.4 18.2 0.0 4.9 6.6 12.7 2.4 0.6 4.7 0.4 0.9 9.1 1.7 9.0 1.0 6.6 12.5 0.0 0.4 1.7 3.4 6.5 0.8 0.0 0.9 0.9 6.1 0.5 0.8 11.2 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Group enriched" "Detected in many" 7 "Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" NA NA Mitochondria "Centriolar satellite" "HPA058971: AB_2683865, HPA065520: AB_2685502" "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.4 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 0.9 1.3 4.5 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.5 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 1.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 3.0 1.0 1.9 0.5 1.1 1.9 0.8 0.0 0.0 0.0 0.0 15.7 0.4 1.7 0.3 118.1 0.7 0.0 0.0 0.4 0.2 1.5 0.8 0.0 0.0 1.1 3.2 0.0 0.6 4.1 86.8 4.9 0.8 1.7 1.8 0.0 2.7 0.7 0.0 2.8 0.6 5.0 0.0 1.4 121.2 8.1 0.5 0.5 1.0 0.0 0.5 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA047008: AB_2679901" "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.3 7.9 8.8 6.3 13.3 5.3 5.5 16.5 24.5 5.6 5.0 5.2 0.4 2.0 8.5 4.2 4.7 5.9 9.8 5.5 8.9 12.5 1.9 45.6 3.3 7.2 10.3 13.4 8.0 2.4 1.2 8.8 5.2 20.8 5.6 3.9 8.3 2.1 6.7 4.5 3.7 3.0 9.8 9.8 4.6 5.7 4.8 4.7 2.5 2.6 1.8 6.9 5.5 8.5 5.6 1.7 0.0 0.1 12.2 6.3 1.8 2.6 1.3 3.1 6.5 15.7 13.1 0.0 12.0 4.8 2.0 1.9 1.3 1.7 16.9 2.1 13.9 2.7 0.8 7.1 5.0 2.8 14.8 4.9 16.9 4.2 12.2 8.4 11.8 5.3 11.5 6.8 4.2 14.7 6.7 8.6 4.8 5.7 12.4 6.2 1.0 9.5 7.3 2.4 0.0 3.8 0.0 3.4 7.4 5.8 1.0 10.8 9.7 5.4 1.4 3.5 0.9 1.5 7.9 10.5 4.5 2.7 7.0 4.1 10.6 7.6 12.3 5.3 10.4 1.7 0.0 0.1 0.0 5.1 0.0 6.3 5.6 5.6 4.5 0.9 3.6 3.4 4.2 0.0 12.2 0.1 1.7 2.4 1.8 8.8 13.3 16.5 21.2 8.9 12.5 10.3 13.4 20.8 4.7 0.0 0.3 6.5 2.6 4.2 8.9 2.4 7.6 0.0 1.2 0.0 25.5 0.3 0.0 5.5 10.6 8.7 0.0 0.0 60.7 2.0 8.8 2.0 1.1 33.1 1.3 7.9 2.9 4.3 1.5 5.0 5.2 2.3 10.1 6.4 0.6 0.6 60.5 0.0 4.9 1.0 2.0 6.5 10.5 1.8 4.3 3.3 0.2 4.6 0.0 0.9 SLC9C1 "NHE, SLC9A10" ENSG00000172139 "Solute carrier family 9 member C1" Q4G0N8 3 112140887-112294258 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 25.5" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 12 "B-cells: 1.2" "Cell line enhanced" "Detected in some" "AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (4.79e-2)" "unprognostic (2.92e-1)" "unprognostic (1.57e-3)" "unprognostic (9.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.98e-2)" "unprognostic (1.65e-2)" "unprognostic (8.32e-2)" "unprognostic (5.89e-2)" "unprognostic (9.62e-3)" "unprognostic (3.25e-1)" 0.3 0.1 0.1 1.4 0.2 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.4 0.0 0.2 0.1 0.1 0.3 1.7 0.5 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.3 1.2 0.0 0.8 0.7 0.4 0.1 0.1 0.3 0.2 1.1 0.1 4.0 1.0 0.2 0.3 0.4 0.3 25.5 0.0 1.0 0.5 0.5 0.4 0.3 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.4 0.0 0.3 0.0 0.0 0.0 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500464-173603094 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 24.9" "Cell type enhanced" "Detected in some" 13 "Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Group enriched" "Detected in some" 4 "BEWO: 1.8;THP-1: 3.7" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.4 0.1 0.3 0.0 1.3 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.7 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.1 0.0 0.4 0.8 0.3 0.1 0.4 0.5 0.5 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.3 1.0 0.3 24.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 1.3 0.0 1.6 0.5 0.3 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 4.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.1 0.0 0.0 0.0 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell type enriched" "Detected in some" 9 "Alveolar cells type 1: 32.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" No No "Plasma membrane" "HPA071152: AB_2686350" "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.0 0.5 0.8 0.2 0.0 0.0 2.7 0.0 0.0 0.0 0.0 2.9 1.7 0.1 2.1 0.1 0.0 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.4 1.1 0.0 0.3 0.2 0.0 1.3 0.1 0.1 1.2 0.1 0.4 3.4 1.4 0.0 2.0 0.3 0.1 13.3 1.5 0.1 0.1 0.2 9.2 0.0 2.0 1.8 2.3 0.0 0.2 0.2 14.2 2.6 0.7 0.0 0.0 1.4 0.6 0.3 19.8 8.0 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 32.8 1.9 0.0 0.0 0.0 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.1 0.0 0.0 0.0 SLCO1B1 "LST-1, OATP-C, OATP1B1, SLC21A6" ENSG00000134538 "Solute carrier organic anion transporter family member 1B1" Q9Y6L6 12 21131202-21239246 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 618 "liver: 121.0" "Cell type enriched" "Detected in some" 39 "Hepatocytes: 71.0" "Cancer enriched" "Detected in some" 96 "liver cancer: 52.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.2;A549: 1.9;HeLa: 2.9;NTERA-2: 2.6;RPMI-8226: 3.5;SuSa: 5.6" HPA050892 Supported NA NA "HPA050892: AB_2681265" "unprognostic (5.45e-1)" "unprognostic (1.82e-4)" "unprognostic (2.43e-3)" "unprognostic (1.96e-3)" "unprognostic (1.80e-1)" "unprognostic (2.41e-1)" "unprognostic (8.82e-2)" "unprognostic (5.63e-2)" "unprognostic (3.86e-2)" "unprognostic (3.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.7 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.8 0.0 0.4 0.0 0.8 0.0 0.0 1.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.0 0.0 0.0 0.0 1.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SLCO1B3 "OATP1B3, OATP8, SLC21A8" ENSG00000111700 "Solute carrier organic anion transporter family member 1B3" Q9NPD5 12 20810702-20916911 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 88.1" "Cell type enriched" "Detected in some" 20 "Hepatocytes: 91.8" "Cancer enhanced" "Detected in many" "liver cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5" "HPA004943, HPA050892" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA004943: AB_1854758, HPA050892: AB_2681265" "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (6.95e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-2)" "unprognostic (7.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.54e-2)" "unprognostic (7.37e-2)" "unprognostic (1.50e-1)" "unprognostic (6.61e-3)" "unprognostic (2.36e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 88.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.1 0.0 2.5 0.0 7.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 91.8 0.0 0.0 0.0 0.6 1.9 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 SLCO1B7 "LST3, SLC21A21" ENSG00000205754 "Solute carrier organic anion transporter family member 1B7 (putative)" G3V0H7 12 21015696-21092745 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "breast: 28.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.0;A549: 4.1;CAPAN-2: 4.4;HeLa: 4.2;U-2 OS: 3.0" HPA050892 Uncertain NA NA "HPA050892: AB_2681265" "unprognostic (8.82e-3)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 28.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.0 4.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.4 0.2 0.7 0.6 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 3.0 0.5 0.3 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLCO1C1 "OATP-F, OATP1, OATP1C1, SLC21A14" ENSG00000139155 "Solute carrier organic anion transporter family member 1C1" Q9NYB5 12 20695355-20753386 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 32.4;retina: 15.3" "Group enriched" "Detected in some" 4 "Early spermatids: 5.8;Late spermatids: 10.3;Muller glia cells: 4.9" "Cancer enriched" "Detected in single" 17 "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "HeLa: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (8.18e-4)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (4.64e-1)" "unprognostic (3.16e-2)" "unprognostic (1.76e-1)" "unprognostic (7.32e-2)" "unprognostic (8.89e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-2)" "unprognostic (2.70e-2)" "unprognostic (2.37e-4)" "unprognostic (1.56e-3)" "unprognostic (1.51e-1)" "unprognostic (3.35e-1)" "unprognostic (1.76e-2)" 3.5 1.2 11.6 1.0 16.2 0.9 1.2 1.1 32.4 0.9 1.4 6.2 0.0 1.1 0.9 1.3 1.2 0.9 2.1 1.5 10.4 2.8 1.1 0.9 1.2 1.2 6.5 8.0 0.9 1.0 1.5 5.5 1.0 20.3 1.0 1.3 15.3 1.1 1.0 0.9 1.2 1.6 1.2 4.9 0.9 1.0 3.3 8.1 0.0 1.7 0.2 1.4 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 16.2 1.1 11.5 10.4 2.8 6.5 8.0 20.3 8.1 0.0 0.0 0.0 0.0 0.1 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 10.3 1.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.4 0.0 0.1 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 SLCO2A1 "MATR1, OATP2A1, PGT, SLC21A2" ENSG00000174640 "Solute carrier organic anion transporter family member 2A1" Q92959 3 133932696-134052184 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 112.9;seminal vesicle: 147.1" "Group enriched" "Detected in many" 5 "Endothelial cells: 38.0;Ito cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Cell line enriched" "Detected in some" 4 "EFO-21: 45.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA013742 Enhanced NA NA "HPA013742: AB_2668877" "unprognostic (4.39e-3)" "unprognostic (2.84e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.69e-4)" "unprognostic (8.53e-2)" "unprognostic (2.32e-3)" "prognostic favorable (9.24e-5)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (7.60e-2)" "unprognostic (2.04e-2)" "unprognostic (6.87e-2)" "unprognostic (5.63e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (3.07e-2)" 9.3 14.7 1.0 6.0 1.0 0.0 6.2 0.4 1.6 13.9 8.1 1.5 112.9 3.7 18.4 4.5 7.8 11.5 15.3 10.1 0.7 0.5 32.9 4.2 56.8 10.6 0.7 1.2 7.2 9.2 16.1 6.5 40.3 1.8 13.7 7.2 15.1 8.2 147.1 1.5 4.5 10.1 13.6 3.0 17.7 8.3 3.0 0.6 4.6 33.6 8.6 9.0 10.5 7.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 2.0 0.2 0.0 0.0 0.0 0.0 45.0 0.4 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.2 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 2.8 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 2.1 0.7 0.0 1.9 0.0 0.0 10.5 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 1.0 1.0 0.4 1.6 0.7 0.5 0.7 1.2 1.8 0.6 0.0 4.5 3.2 8.7 4.5 0.0 2.2 2.5 1.4 2.3 3.5 0.0 0.2 0.0 0.9 0.6 38.0 7.4 0.0 2.9 2.0 1.0 1.5 1.1 0.2 0.2 0.0 1.2 74.3 1.0 0.8 0.3 0.2 0.0 0.0 1.5 0.0 10.3 3.6 0.0 1.7 0.0 0.0 1.0 0.5 0.2 1.5 0.7 0.0 0.4 2.0 SLCO2B1 "OATP-B, OATP2B1, SLC21A9" ENSG00000137491 "Solute carrier organic anion transporter family member 2B1" O94956 11 75100563-75206549 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 98.1" "Group enriched" "Detected in many" 5 "Hepatocytes: 171.3;Hofbauer cells: 103.0;Kupffer cells: 116.2;Macrophages: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 36.0;GAMG: 8.9;Hep G2: 8.1;HMC-1: 10.9;OE19: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020659 Uncertain NA NA "HPA020659: AB_1857219" "unprognostic (8.25e-2)" "unprognostic (5.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.57e-1)" "unprognostic (3.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (2.00e-3)" "unprognostic (1.99e-1)" "unprognostic (2.09e-1)" "unprognostic (9.75e-3)" "unprognostic (2.54e-2)" "unprognostic (4.57e-3)" "unprognostic (1.04e-1)" "unprognostic (3.87e-2)" 21.4 15.2 15.0 13.4 23.1 1.4 7.8 4.8 15.8 8.6 12.9 22.8 0.8 18.0 5.8 7.7 8.8 8.3 12.3 7.1 15.6 11.9 9.6 98.1 24.9 21.4 23.9 7.4 4.9 9.6 3.7 4.0 18.3 17.7 4.9 10.4 9.1 6.3 4.7 2.6 3.0 21.2 10.9 24.1 23.6 6.5 4.4 21.3 4.0 6.8 3.6 11.8 12.5 4.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.4 0.0 5.9 0.3 8.1 0.0 0.4 10.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 3.6 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 1.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 23.1 4.8 15.8 15.6 11.9 23.9 7.4 17.7 21.3 0.0 12.8 1.5 0.0 1.6 1.6 2.0 20.4 1.4 3.4 0.0 0.0 0.6 1.7 0.0 2.4 12.9 20.2 0.0 0.2 2.1 1.8 0.0 23.0 171.3 103.0 0.0 0.0 3.1 116.2 1.1 10.0 55.1 0.0 3.6 4.4 0.3 0.1 14.0 9.9 7.0 0.2 0.0 0.3 0.5 0.2 0.4 2.1 0.7 9.3 0.0 SLCO4C1 "OATP-H, OATP4C1, OATPX, SLC21A20" ENSG00000173930 "Solute carrier organic anion transporter family member 4C1" Q6ZQN7 5 102233986-102296549 "Predicted membrane proteins, Transporters" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 55.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3" "Cancer enriched" "Detected in many" 5 "renal cancer: 22.4" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3" "Cell line enhanced" "Detected in some" "Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058249 Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Nucleoplasm, Cytosol" "HPA058249: " "unprognostic (1.63e-2)" "unprognostic (2.47e-2)" "unprognostic (4.48e-4)" "unprognostic (5.70e-6)" "unprognostic (7.43e-2)" "unprognostic (7.71e-3)" "unprognostic (3.24e-3)" "unprognostic (2.05e-3)" "unprognostic (2.13e-1)" "unprognostic (7.12e-2)" "unprognostic (3.87e-3)" "unprognostic (5.83e-2)" "prognostic favorable (1.12e-4)" "unprognostic (3.29e-2)" "unprognostic (1.07e-1)" "unprognostic (5.91e-2)" "unprognostic (8.22e-2)" 0.4 0.4 0.3 0.7 0.7 5.4 0.3 0.2 1.8 0.3 1.9 0.0 5.2 1.4 0.2 0.6 0.3 0.3 1.6 1.1 0.3 0.4 55.9 5.2 11.0 0.2 0.3 1.0 0.3 0.9 0.0 0.7 0.1 0.2 0.4 0.5 0.0 3.2 11.8 0.3 0.6 2.1 0.0 0.3 1.6 0.4 1.3 0.0 1.5 1.0 0.3 0.1 0.7 1.1 0.1 0.4 10.0 1.1 2.6 4.3 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.1 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.5 45.9 0.0 0.3 0.2 0.0 0.1 0.0 1.1 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 11.6 0.0 7.9 1.1 7.5 4.3 0.0 0.4 0.0 0.7 2.3 0.4 0.1 0.2 1.5 10.0 2.6 0.0 0.3 0.0 1.0 0.3 0.7 0.2 1.8 0.3 0.4 0.3 1.0 0.2 0.0 6.0 38.8 0.0 0.1 0.0 0.0 0.3 0.0 4.0 6.8 5.2 0.0 0.0 1.7 0.2 8.3 0.0 1.2 0.0 0.7 0.0 0.0 0.0 5.7 5.5 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 28.3 0.0 0.0 0.0 1.7 0.7 0.0 0.0 2.2 1.2 0.3 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667047-69835064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2" "Group enriched" "Detected in many" 6 "Bipolar cells: 12.4;Cardiomyocytes: 13.6;Glandular cells: 10.0;Intestinal endocrine cells: 15.0;monocytes: 36.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 9.0;NTERA-2: 6.0;RPMI-8226: 5.7;SCLC-21H: 6.5;U-266/70: 3.5" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory region: 8.2" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.7 0.2 0.5 1.5 0.7 1.5 0.2 0.1 0.8 0.3 0.4 0.1 0.0 0.4 0.5 1.5 1.0 0.5 0.4 21.4 0.7 0.7 0.2 0.4 0.3 4.1 0.3 0.3 0.2 0.7 0.0 4.7 0.0 0.5 4.2 0.7 0.6 0.9 0.0 13.9 0.3 0.7 0.2 0.2 0.8 0.3 0.4 0.0 9.5 0.5 16.2 1.7 0.9 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.0 0.0 0.0 2.4 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 6.0 0.0 0.9 1.0 0.9 5.7 0.1 0.0 6.5 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 1.2 3.5 0.6 0.0 0.3 0.0 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.0 1.7 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.7 0.1 0.7 0.7 0.7 0.3 0.3 0.5 0.0 3.0 0.0 1.9 1.1 0.2 12.4 13.6 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.5 0.4 0.7 0.0 0.0 1.2 0.0 0.6 10.0 0.0 0.0 0.1 1.6 15.0 0.0 0.0 0.4 0.0 0.3 0.0 36.9 1.6 0.3 2.4 0.0 0.0 0.0 0.2 0.0 1.0 0.9 1.7 0.4 0.0 0.0 0.9 0.7 SLCO6A1 "CT48, MGC26949, OATP6A1, OATPY" ENSG00000205359 "Solute carrier organic anion transporter family member 6A1" Q86UG4 5 102371782-102499016 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 93 "testis: 39.2" "Group enriched" "Detected in some" 6 "Early spermatids: 111.3;Spermatocytes: 59.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.8;SuSa: 4.2;U-266/84: 1.4" "Low region specificity" "Detected in some" HPA054126 Enhanced NA NA "HPA054126: AB_2682390" "unprognostic (1.17e-1)" "unprognostic (2.59e-1)" "unprognostic (4.37e-2)" "unprognostic (4.65e-1)" "unprognostic (1.84e-1)" "unprognostic (2.60e-2)" "unprognostic (6.70e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.6 1.8 0.1 0.7 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 59.8 2.6 0.0 0.0 0.0 0.0 0.0 SLFN12L ENSG00000205045 "Schlafen family member 12 like" Q6IEE8 17 35464249-35537861 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.4" "Cell type enriched" "Detected in some" 7 "T-cells: 20.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 9.5;MAIT T-cell: 8.8;memory CD4 T-cell: 6.3;memory CD8 T-cell: 8.0;naive CD4 T-cell: 4.8;naive CD8 T-cell: 5.2;NK-cell: 6.8;T-reg: 4.7" "Group enriched" "Detected in many" 7 "NK-cells: 6.8;T-cells: 9.5" "Cell line enhanced" "Detected in some" "HDLM-2: 19.9;Karpas-707: 14.1;U-266/70: 5.0;U-266/84: 4.4" HPA024447 Uncertain NA NA "HPA024447: AB_1856614" "unprognostic (1.93e-3)" "unprognostic (2.10e-4)" "unprognostic (3.77e-2)" "unprognostic (2.67e-2)" "unprognostic (8.18e-3)" "unprognostic (2.98e-5)" "unprognostic (4.59e-3)" "unprognostic (2.75e-2)" "unprognostic (6.82e-2)" "unprognostic (1.67e-2)" "unprognostic (9.51e-2)" "unprognostic (1.78e-1)" "unprognostic (2.25e-6)" "unprognostic (2.30e-1)" "unprognostic (3.88e-2)" "unprognostic (7.02e-2)" "unprognostic (8.88e-3)" 7.2 0.9 1.0 11.2 1.2 6.6 2.7 0.8 1.4 1.6 3.0 0.9 1.2 3.9 3.6 3.0 2.3 2.0 3.8 1.4 1.1 1.1 1.8 1.8 9.1 10.6 1.7 0.5 1.3 1.2 0.5 1.0 0.6 2.9 1.8 2.0 2.1 6.2 1.3 0.9 1.2 7.0 1.1 1.9 18.4 3.0 0.8 1.1 5.8 2.8 2.1 16.3 2.3 2.0 0.4 0.3 1.1 0.4 6.8 9.5 1.9 0.5 0.2 0.2 0.2 0.1 0.0 0.2 0.2 0.0 0.6 1.5 0.1 0.4 0.5 0.1 0.0 0.1 0.3 0.0 0.0 0.8 19.9 0.1 1.2 0.7 0.1 0.0 0.4 0.2 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.3 14.1 0.1 0.0 0.4 0.3 0.2 0.0 0.1 0.1 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.1 0.1 0.2 0.1 1.9 0.5 0.3 1.2 0.5 0.2 5.0 4.4 0.1 0.2 0.3 0.6 0.8 0.4 0.9 9.5 0.1 8.8 0.3 6.3 8.0 0.3 0.4 4.8 5.2 1.1 6.8 0.1 0.3 4.7 1.9 1.0 1.2 0.8 1.4 1.1 1.1 1.7 0.5 2.9 1.1 3.0 2.4 0.0 0.5 0.2 0.0 0.8 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 20.6 0.0 0.2 SLFN13 FLJ31952 ENSG00000154760 "Schlafen family member 13" Q68D06 17 35435096-35448837 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 50.6" "Cell type enhanced" "Detected in many" 22 "Cholangiocytes: 22.9;Ciliated cells: 81.7;Club cells: 18.2;T-cells: 15.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 8.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 14.7;HL-60: 46.9;Karpas-707: 13.7;REH: 26.9;U-266/70: 23.7" "HPA022532, HPA023064" Uncertain Approved "Cytokinetic bridge" Yes No "Cytokinetic bridge" "HPA022532: AB_1856615, HPA023064: AB_1856616" "unprognostic (1.11e-1)" "prognostic favorable (3.82e-4)" "unprognostic (4.73e-2)" "unprognostic (6.12e-2)" "unprognostic (2.00e-1)" "unprognostic (5.74e-2)" "unprognostic (9.38e-3)" "unprognostic (1.32e-2)" "unprognostic (3.34e-1)" "unprognostic (3.55e-1)" "unprognostic (5.06e-3)" "unprognostic (2.33e-1)" "unprognostic (1.33e-1)" "unprognostic (3.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 3.0 1.0 1.1 6.4 1.7 11.8 4.8 0.5 1.0 5.2 6.5 2.6 4.8 4.0 5.6 6.0 6.5 12.4 6.1 1.8 1.3 0.7 5.1 1.7 5.2 4.8 0.9 0.5 2.7 2.0 14.3 3.2 1.2 2.0 2.4 3.1 0.9 50.6 2.0 1.4 1.5 5.7 1.8 1.5 11.3 5.7 1.5 1.1 24.8 12.7 5.4 12.9 2.0 2.0 1.4 0.4 6.5 0.5 8.1 1.9 0.5 0.0 2.5 5.1 0.0 0.1 0.5 0.0 0.6 0.1 2.5 4.0 0.0 0.0 0.0 14.7 0.4 0.1 4.3 0.5 1.8 2.8 1.4 0.8 13.4 2.2 0.0 0.2 46.9 0.4 0.1 0.2 1.3 0.0 0.0 0.8 0.1 0.0 13.7 0.0 0.0 0.3 10.2 2.5 0.0 0.0 26.9 0.1 1.3 4.3 12.4 0.0 0.0 0.0 2.3 0.1 0.3 3.6 7.5 0.1 0.0 0.7 3.8 0.2 23.7 3.2 0.0 0.0 7.5 0.3 5.0 0.4 6.5 1.9 0.5 1.5 1.4 0.9 1.0 0.4 1.3 0.8 0.6 1.4 8.1 0.2 0.1 0.7 0.5 1.1 1.7 0.5 1.0 1.3 0.7 0.9 0.5 2.0 1.1 0.0 3.0 2.2 3.1 0.9 0.0 0.6 22.9 81.7 18.2 5.2 0.0 0.4 1.7 1.1 0.1 0.7 0.5 0.0 0.3 0.2 0.8 1.0 3.5 0.4 1.3 0.0 2.9 3.1 0.6 0.0 0.9 1.6 0.0 1.8 2.7 0.2 1.1 0.0 0.4 0.8 0.1 0.0 0.6 0.2 0.1 1.0 0.0 15.7 3.9 1.0 SLFN14 ENSG00000236320 "Schlafen family member 14" P0C7P3 17 35548125-35558098 "Disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.0;lymphoid tissue: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022994, HPA023065" Uncertain NA NA 13000 "HPA022994: AB_10670035, HPA023065: AB_2671055" "unprognostic (4.27e-3)" "unprognostic (4.72e-4)" "unprognostic (1.21e-1)" "unprognostic (6.43e-2)" "unprognostic (1.07e-3)" "unprognostic (6.50e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-1)" "unprognostic (5.33e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-1)" "unprognostic (7.59e-8)" "unprognostic (1.21e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-1)" "unprognostic (1.13e-3)" 0.2 0.0 0.0 0.5 0.0 9.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.2 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.0 0.0 3.0 0.3 0.3 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 21.9 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLFNL1 FLJ23878 ENSG00000171790 "Schlafen like 1" Q499Z3 1 41015597-41023237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 49.7" "Group enriched" "Detected in some" 83 "Early spermatids: 200.0;Late spermatids: 500.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 10.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054956 Approved Cytosol NA NA Cytosol "HPA054956: AB_2682649" "unprognostic (7.01e-3)" "unprognostic (1.62e-1)" "unprognostic (1.54e-3)" "unprognostic (4.35e-2)" "unprognostic (3.39e-1)" "unprognostic (4.11e-4)" "unprognostic (8.98e-3)" "unprognostic (1.02e-3)" "unprognostic (8.40e-3)" "unprognostic (1.50e-1)" "unprognostic (2.51e-1)" "unprognostic (3.71e-4)" "unprognostic (2.70e-3)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (3.26e-1)" "unprognostic (2.43e-1)" 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.4 0.3 0.2 0.4 0.2 0.2 0.2 0.5 2.6 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.8 1.9 0.2 0.2 0.2 0.6 0.3 0.1 0.3 0.2 0.2 0.6 0.0 0.2 3.4 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.1 49.7 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.4 1.3 0.0 0.0 0.7 0.0 1.0 1.6 0.7 1.1 0.0 0.3 4.9 2.1 0.1 0.0 0.1 10.2 1.0 1.8 1.8 0.1 0.3 1.8 0.1 0.0 0.0 1.3 3.0 1.3 2.4 1.3 0.7 1.9 1.2 0.2 0.2 0.1 0.0 0.5 0.2 1.5 1.1 2.2 0.1 0.9 1.1 2.0 1.9 0.2 2.6 2.5 1.3 1.1 0.0 2.8 1.3 0.6 0.4 0.9 0.8 0.9 0.6 1.2 0.8 2.0 2.4 1.0 1.5 1.1 0.6 2.3 0.3 2.2 0.4 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.4 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 3.2 0.0 0.1 0.2 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 200.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 500.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 4.2 2.4 0.1 0.0 0.0 0.0 0.0 SLIT1 "MEGF4, SLIL1, Slit-1, slit1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185920 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.3" "Group enriched" "Detected in some" 6 "Early spermatids: 27.2;Late spermatids: 15.4" "Group enriched" "Detected in many" 10 "glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "JURKAT: 12.4;MOLT-4: 41.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" NA NA "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 1.2 0.8 13.4 0.9 16.1 0.9 0.8 0.4 44.3 0.8 0.9 0.5 0.0 0.9 0.8 0.7 0.8 1.0 0.8 0.8 13.9 10.5 0.8 0.7 1.0 0.9 4.6 13.2 0.8 1.4 0.8 8.0 0.8 2.2 1.1 0.8 0.3 0.8 0.7 0.9 0.8 0.9 0.8 1.4 0.9 1.1 2.0 0.3 3.3 3.6 0.0 0.9 0.8 0.0 0.0 1.6 0.4 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.3 0.0 0.1 41.4 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 1.6 0.0 0.2 13.4 16.1 0.4 24.8 13.9 10.5 4.6 13.2 2.2 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.7 0.0 0.3 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 3.4 1.4 0.0 0.0 0.0 0.0 0.1 SLITRK1 "KIAA1910, LRRC12" ENSG00000178235 "SLIT and NTRK like family member 1" Q96PX8 13 83877205-83882393 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 30.6" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 6.6" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 7.6;AF22: 3.2;LHCN-M2: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074835 Enhanced "Secreted in brain" NA NA 270000 "HPA074835: " "unprognostic (2.29e-1)" "unprognostic (4.32e-1)" "unprognostic (4.71e-2)" "unprognostic (1.01e-1)" "unprognostic (1.65e-2)" "unprognostic (7.95e-2)" 0.9 1.3 16.7 0.9 9.5 0.9 1.0 2.0 30.6 1.2 1.0 6.3 0.0 1.0 1.0 1.0 0.9 0.9 1.0 0.9 16.9 7.3 1.0 0.9 0.9 0.9 7.3 14.9 0.9 3.1 0.9 3.1 0.9 5.8 0.9 1.0 0.1 1.0 1.4 1.0 0.9 0.9 0.9 3.7 0.9 1.0 1.0 8.5 0.0 0.9 0.0 0.9 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 3.2 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 9.5 2.0 21.5 16.9 7.3 7.3 14.9 5.8 8.5 0.0 0.0 0.0 0.0 0.0 6.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLITRK2 "CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257" ENSG00000185985 "SLIT and NTRK like family member 2" "Q9H156, O96002" X 145817832-145829856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.1" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 226.8" "Cancer enhanced" "Detected in some" "glioma: 5.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 35 "HAP1: 21.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 26000 "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" "unprognostic (2.73e-3)" "unprognostic (6.79e-6)" "unprognostic (3.39e-1)" "unprognostic (1.68e-1)" "unprognostic (2.89e-4)" "unprognostic (6.23e-2)" "unprognostic (3.60e-1)" "unprognostic (1.29e-1)" "unprognostic (1.50e-2)" "unprognostic (3.53e-2)" "unprognostic (4.13e-8)" "unprognostic (3.12e-3)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (1.14e-2)" 1.6 1.5 12.8 1.2 16.4 0.9 1.2 4.3 25.1 1.7 1.2 13.3 0.0 1.1 1.1 1.1 1.1 4.9 1.1 1.6 12.1 3.5 1.4 1.0 2.2 1.6 11.3 9.2 1.1 1.8 0.9 1.1 0.9 10.4 1.4 1.4 5.6 1.3 8.5 1.2 3.9 1.3 1.5 12.6 7.4 1.0 1.2 11.5 0.0 1.1 0.0 0.9 1.3 1.1 0.3 0.3 1.5 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.2 0.2 0.3 0.1 0.2 0.2 0.0 0.3 0.3 0.2 0.6 0.4 0.3 0.3 0.2 0.0 12.8 16.4 4.3 14.6 12.1 3.5 11.3 9.2 10.4 11.5 0.0 0.0 0.0 0.0 1.0 4.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 6.4 1.7 1.8 0.0 0.0 0.0 0.0 25.3 0.0 0.0 226.8 0.0 0.0 0.0 0.0 9.5 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;liver: 12.8" "Group enriched" "Detected in some" 9 "Bipolar cells: 4.5;Hepatocytes: 2.4" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.6;HAP1: 5.5;Karpas-707: 1.6;SCLC-21H: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria No NA 1400000 Mitochondria "HPA017636: AB_1857232, HPA048042: AB_2732542" "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.6 0.6 7.4 2.0 12.0 0.4 0.5 10.6 17.4 9.9 3.0 1.5 0.3 1.1 12.1 2.0 7.6 12.6 0.8 1.0 13.2 5.5 0.6 12.8 0.9 0.5 3.7 6.5 2.5 0.4 0.4 0.3 0.4 4.2 3.3 3.1 0.3 0.8 9.6 0.9 0.5 1.5 6.2 2.3 0.4 0.8 1.0 2.4 0.0 0.6 0.0 0.5 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 12.0 10.6 15.7 13.2 5.5 3.7 6.5 4.2 2.4 0.0 0.0 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLITRK4 DKFZp547M2010 ENSG00000179542 "SLIT and NTRK like family member 4" Q8IW52 X 143622790-143635777 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.7;brain: 21.8" "Cell type enhanced" "Detected in many" 14 "Leydig cells: 46.1;Melanocytes: 20.3;Peritubular cells: 15.2;Sertoli cells: 25.8" "Cancer enhanced" "Detected in many" "renal cancer: 3.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "basophil: 11.4;classical monocyte: 4.7;intermediate monocyte: 3.0;myeloid DC: 3.7;non-classical monocyte: 3.2" "Group enriched" "Detected in many" 67 "dendritic cells: 3.7;granulocytes: 11.4;monocytes: 4.7" "Cell line enhanced" "Detected in some" "HeLa: 8.2;HHSteC: 4.3;LHCN-M2: 3.1;T-47d: 12.5;U-2 OS: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000431 Enhanced Uncertain Microtubules NA NA 320000 Microtubules "HPA000431: AB_2665991" "unprognostic (1.72e-1)" "unprognostic (2.11e-2)" "unprognostic (2.63e-2)" "unprognostic (1.15e-3)" "unprognostic (4.09e-1)" "unprognostic (1.75e-2)" "unprognostic (3.79e-3)" "unprognostic (1.21e-1)" "unprognostic (1.97e-2)" "unprognostic (1.86e-1)" "unprognostic (3.64e-2)" "unprognostic (9.61e-2)" "unprognostic (6.02e-2)" "unprognostic (1.02e-5)" "unprognostic (1.29e-2)" "unprognostic (7.75e-2)" "unprognostic (9.23e-3)" 5.9 15.7 13.6 0.6 12.1 1.7 3.3 21.3 21.8 8.5 1.0 0.2 0.1 0.3 2.1 4.7 1.1 1.1 0.6 3.0 17.0 1.2 5.1 0.8 1.1 0.6 1.2 16.1 6.1 1.5 0.1 0.8 0.7 5.0 2.6 0.6 0.0 1.7 2.3 6.9 3.3 1.0 1.6 2.7 0.9 1.0 1.8 1.7 0.0 1.3 0.0 0.2 1.1 1.1 0.0 3.7 11.4 4.7 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 4.3 0.6 0.8 2.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 1.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 4.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.9 13.6 12.1 21.3 21.8 17.0 1.2 1.2 16.1 5.0 1.7 0.0 0.0 0.0 0.5 10.6 1.8 1.0 0.0 0.0 0.0 3.5 0.0 0.0 1.7 0.0 0.2 0.3 0.0 0.0 1.3 0.0 5.1 1.3 0.0 0.0 3.3 0.0 0.0 0.0 6.5 1.5 46.1 4.9 20.3 0.0 0.0 0.0 1.0 0.0 15.2 0.8 0.3 25.8 8.2 0.3 0.6 10.2 0.0 0.0 0.0 0.5 SLITRK5 "bA364G4.2, KIAA0918, LRRC11" ENSG00000165300 "SLIT and NTRK like family member 5" O94991 13 87672615-87696272 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 11.5;Horizontal cells: 20.6;Muller glia cells: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 11.2;HeLa: 5.5;hTERT-RPE1: 5.1;U-138 MG: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013843 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA013843: AB_1857233" "unprognostic (1.92e-1)" "unprognostic (1.01e-2)" "unprognostic (3.82e-1)" "unprognostic (7.11e-4)" "unprognostic (6.94e-2)" "unprognostic (8.57e-3)" "unprognostic (1.63e-1)" "unprognostic (8.58e-3)" "unprognostic (1.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.10e-2)" "unprognostic (1.81e-2)" "unprognostic (2.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" 0.1 0.3 3.3 0.1 6.8 0.1 0.2 3.1 9.2 0.4 0.2 0.0 0.1 1.0 0.2 6.7 0.1 0.1 4.8 4.2 0.0 0.0 0.2 0.1 2.6 0.6 0.8 0.0 0.0 0.0 1.8 0.3 7.4 3.1 0.2 0.2 0.0 0.0 1.0 0.1 0.5 0.2 2.0 0.3 0.0 0.4 0.7 1.4 1.6 0.3 1.4 0.4 0.1 0.0 1.2 11.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 2.0 1.3 5.5 0.0 0.8 0.0 0.0 2.5 0.2 0.0 1.0 5.1 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 2.7 0.0 1.4 1.0 0.3 0.2 0.4 0.0 1.7 0.3 0.0 0.3 0.0 0.0 0.8 2.6 0.0 3.9 0.0 0.0 0.6 1.7 0.0 0.0 3.5 0.1 1.1 1.1 0.3 0.4 0.4 0.2 0.4 0.4 0.4 0.3 0.1 0.7 0.4 0.3 1.6 1.4 0.3 1.4 0.2 0.1 0.0 0.6 0.0 1.7 0.1 11.5 1.6 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 2.1 1.1 0.0 0.0 20.6 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 1.5 6.5 0.0 0.0 4.6 0.0 1.6 0.0 0.1 5.0 0.1 0.0 0.0 0.0 0.0 0.9 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792787-85806683 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 14.0;Ciliated cells: 69.6;Club cells: 25.0" "Cancer enhanced" "Detected in many" "breast cancer: 21.1" "Group enriched" "Detected in many" 4 "basal ganglia: 11.1;cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 13.5;OE19: 10.9;RT4: 46.2;WM-115: 10.9" "Region enhanced" "Detected in many" "thalamus: 24.7" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" NA NA 9500 "Plasma membrane" "HPA014491: AB_10601603, HPA014513: AB_2669026" "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.4 0.3 0.3 2.7 11.1 0.0 2.9 4.9 0.3 1.0 4.5 0.0 0.2 2.8 0.7 3.4 3.6 0.3 1.1 1.9 0.3 1.3 0.3 1.1 3.1 0.0 0.6 0.0 0.3 0.4 0.0 0.4 4.1 0.8 24.2 5.8 1.7 22.8 1.8 0.3 4.5 7.2 22.4 0.4 0.2 1.2 0.5 1.8 0.0 0.6 3.4 0.7 27.8 5.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 13.5 0.0 1.6 1.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 10.9 0.9 0.1 0.0 0.0 0.0 46.2 0.4 0.5 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 4.9 0.3 0.3 1.3 0.6 0.0 0.8 1.8 0.0 2.6 0.0 4.8 3.4 14.0 0.3 0.0 69.6 25.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 8.9 0.0 0.0 0.0 0.4 1.1 1.1 0.0 0.4 0.0 1.4 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 3.1 SLMAP "KIAA1601, SLAP" ENSG00000163681 "Sarcolemma associated protein" Q14BN4 3 57755450-57929168 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 133.6;urinary bladder: 114.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 272.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002357, HPA002358" Enhanced Approved "Endoplasmic reticulum" NA NA 12000 "Endoplasmic reticulum" "HPA002357: AB_1080023, HPA002358: AB_1080021" "unprognostic (3.70e-1)" "unprognostic (2.87e-2)" "unprognostic (1.82e-3)" "unprognostic (3.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.18e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.59e-3)" "unprognostic (1.06e-1)" "prognostic favorable (1.58e-6)" "unprognostic (8.18e-2)" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (6.08e-2)" 10.6 10.7 7.0 22.4 11.1 7.4 12.0 10.2 7.2 26.5 50.3 5.8 24.7 9.8 43.0 19.5 44.0 21.3 15.0 58.2 6.5 5.6 8.0 7.8 8.0 7.2 6.9 6.0 21.4 5.8 16.0 8.0 7.7 6.8 47.8 12.2 8.7 8.6 37.7 26.1 9.4 23.3 133.6 6.0 7.2 27.2 14.9 6.8 11.2 11.1 12.1 6.3 114.2 26.4 5.9 5.1 15.8 5.5 7.1 5.9 4.5 22.1 12.5 10.7 15.4 16.1 16.2 14.6 20.5 21.2 14.4 13.9 30.0 33.0 14.9 9.8 16.3 25.8 12.2 19.1 27.3 18.9 16.4 10.9 25.8 17.7 23.5 15.7 25.5 14.4 11.7 21.9 17.7 33.0 18.6 16.4 15.1 21.0 13.5 14.7 7.2 17.4 13.1 16.1 16.1 24.3 7.2 11.7 14.8 29.4 24.2 6.1 7.2 26.7 20.3 12.6 14.7 11.0 16.2 19.4 15.9 12.7 20.1 26.5 15.7 26.7 20.3 14.3 22.3 14.9 7.5 5.5 15.8 5.9 3.6 4.9 5.9 4.6 5.0 5.1 4.5 5.4 5.5 13.4 7.1 3.6 2.9 5.1 4.5 7.0 11.1 10.2 7.2 6.5 5.6 6.9 6.0 6.8 6.8 35.7 34.1 6.2 37.6 81.7 24.0 272.3 33.1 29.4 29.6 31.4 47.1 15.6 16.6 39.8 28.6 23.2 38.0 0.0 29.8 10.7 23.5 70.4 3.5 20.3 13.9 30.2 13.8 16.0 19.4 17.7 30.2 18.8 27.0 11.8 24.3 98.5 46.3 29.2 67.5 24.5 32.2 51.8 116.9 81.2 26.8 64.1 13.6 23.0 23.4 106.8 SLN "MGC12301, MGC125854, MGC125855" ENSG00000170290 Sarcolipin O00631 11 107707378-107719693 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 446.6" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 248.9;Muller glia cells: 330.7" "Group enriched" "Detected in many" 13 "glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5" "Region enhanced" "Detected in some" "basal ganglia: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.7;HSkMC: 6.0;Karpas-707: 2.8;PC-3: 2.7;SuSa: 6.2;U-2 OS: 2.7" "Region enriched" "Detected in some" 5 "basal ganglia: 19.0" "Not detected" "Not detected" CAB011628 Approved Microtubules NA NA Microtubules "CAB011628: AB_2195046" "unprognostic (6.85e-2)" "unprognostic (6.18e-8)" "unprognostic (2.60e-1)" "unprognostic (3.66e-2)" "unprognostic (2.40e-3)" "unprognostic (4.12e-3)" "unprognostic (5.28e-3)" "unprognostic (1.31e-2)" "unprognostic (2.76e-1)" "unprognostic (6.35e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.52e-9)" "unprognostic (3.27e-2)" "unprognostic (2.54e-1)" "unprognostic (5.09e-4)" "unprognostic (3.77e-2)" 4.8 0.5 0.2 0.0 1.9 0.0 0.1 0.4 1.0 0.0 0.2 0.0 0.0 0.0 0.0 5.3 9.1 0.1 0.0 72.9 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.1 0.1 2.3 0.0 0.4 4.3 0.0 446.6 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 1.9 40.1 6.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.1 0.6 1.1 0.1 0.2 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.3 0.3 6.0 0.0 0.8 0.0 0.4 0.0 0.0 0.1 2.8 0.0 0.4 0.3 0.4 0.1 0.1 2.7 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.0 0.0 2.7 0.0 0.2 1.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 1.9 0.4 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.7 248.9 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 7.3 0.0 0.0 0.0 0.4 1.7 0.5 0.0 0.0 0.0 0.3 3.2 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 330.7 0.2 0.0 0.4 0.1 14.1 0.0 0.4 0.0 0.0 1.3 4.8 0.0 0.0 0.0 SLPI "ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4" ENSG00000124107 "Secretory leukocyte peptidase inhibitor" P03973 20 45252239-45254564 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 1679.4;Alveolar cells type 2: 2934.9;Basal glandular cells: 1025.0;Cholangiocytes: 1719.7;Ciliated cells: 2255.1;Club cells: 3002.8;Collecting duct cells: 3252.2;Urothelial cells: 2991.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 11 "pons and medulla: 4.7" "Cell type enriched" "Detected in single" 90 "neutrophil: 68.8" "Lineage enriched" "Detected in single" 90 "granulocytes: 68.8" "Cell line enhanced" "Detected in some" "EFO-21: 157.0;hTCEpi: 184.3;OE19: 67.0;SiHa: 55.2;THP-1: 46.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB002303, HPA027774" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 26400000 2600000 "Golgi apparatus" "CAB002303: AB_564008, HPA027774: AB_10602405" "unprognostic (2.31e-2)" "unprognostic (3.07e-1)" "unprognostic (3.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.16e-2)" "unprognostic (9.98e-2)" "unprognostic (2.90e-1)" "unprognostic (3.23e-1)" "unprognostic (1.83e-3)" "unprognostic (4.01e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (6.91e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-1)" "unprognostic (8.81e-2)" "unprognostic (8.31e-2)" 9.2 0.4 0.0 2.4 0.0 10.0 10.0 0.1 0.2 934.9 3.4 0.1 268.3 0.2 11.9 5.5 51.3 23.3 19.6 3.5 0.0 0.0 17.3 20.1 81.5 1.3 0.3 0.4 5.5 5.4 0.1 25.9 1.4 4.7 13.4 3.6 2.0 480.2 548.7 41.3 9.6 0.7 3.9 0.9 0.7 5.2 7.1 0.0 2.3 2.0 86.2 53.0 17.7 24.0 0.0 0.1 68.8 0.7 0.0 0.0 1.1 0.4 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 28.4 0.0 157.0 0.0 2.1 11.7 0.0 5.6 0.0 0.7 0.0 0.0 21.0 0.0 30.3 0.0 0.0 0.8 184.3 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 67.0 10.7 0.0 0.0 0.0 32.0 1.2 0.0 0.0 55.2 11.8 0.1 0.0 0.2 46.6 0.0 0.0 0.7 0.1 0.0 0.1 0.7 0.4 0.0 2.8 0.0 0.5 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 68.8 0.0 0.7 0.0 0.0 1.1 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.4 4.7 0.0 1679.4 2934.9 5.2 1025.0 89.4 0.0 0.9 1719.7 2255.1 3002.8 3252.2 0.0 1.3 0.0 285.2 390.2 5.3 69.3 23.3 231.9 0.9 101.8 495.3 70.9 353.5 5.8 0.0 192.4 19.6 6.7 55.8 23.6 30.6 37.1 9.0 72.4 0.0 552.6 410.1 0.0 1.1 0.0 0.0 22.7 1.0 1.6 121.5 1.7 5.3 161.1 2991.2 SLURP1 "ANUP, ARS, ArsB, LY6LS, MDM" ENSG00000126233 "Secreted LY6/PLAUR domain containing 1" P55000 8 142740944-142742411 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Cytokine "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5" "Cell type enriched" "Detected in some" 24 "Suprabasal keratinocytes: 57.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 66.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 3.4;hTCEpi: 2.3;MCF7: 3.8;RT4: 2.7;T-47d: 6.6" "Not detected" "Not detected" HPA050967 Approved "Secreted in other tissues" NA NA 5400000 "HPA050967: AB_2681293" "unprognostic (1.22e-2)" "unprognostic (5.08e-2)" "unprognostic (1.16e-2)" "unprognostic (1.42e-2)" "unprognostic (1.84e-1)" "unprognostic (7.32e-2)" "unprognostic (5.99e-2)" "unprognostic (1.33e-4)" "unprognostic (1.58e-1)" "unprognostic (2.98e-1)" "unprognostic (1.43e-1)" 0.1 0.1 0.1 0.1 0.1 0.1 2.5 0.1 0.1 17.3 0.1 0.1 0.1 0.1 1.1 0.1 137.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 7.7 0.1 0.4 91.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 107.5 93.7 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.8 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 3.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.5 0.0 0.0 0.0 0.7 SLURP2 ENSG00000283992 "Secreted LY6/PLAUR domain containing 2" P0DP57 8 142764338-142769844 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 112.1;lymphoid tissue: 60.7;tongue: 105.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HaCaT: 24.7" "Secreted in other tissues" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.8 0.0 112.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 24.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 105.8 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.1 5.5 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLX1A GIYD1 ENSG00000132207 "SLX1 homolog A, structure-specific endonuclease subunit" Q9BQ83 16 30193887-30197561 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.2;intestine: 26.0" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 10.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 44.5" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (3.46e-2)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (1.84e-1)" "unprognostic (5.60e-2)" "unprognostic (6.04e-2)" "unprognostic (1.88e-1)" "unprognostic (1.41e-1)" "unprognostic (1.75e-1)" "unprognostic (2.67e-1)" "unprognostic (1.26e-6)" "unprognostic (2.52e-1)" "unprognostic (3.21e-1)" "unprognostic (1.53e-1)" "unprognostic (3.86e-1)" 3.4 5.2 2.9 7.7 1.7 7.7 3.7 0.7 1.9 2.0 8.2 26.0 1.6 0.0 5.4 1.0 2.7 4.2 2.7 2.5 7.1 13.1 3.5 5.4 3.0 0.5 6.7 0.9 2.3 2.9 1.8 2.6 2.9 1.5 4.9 3.1 19.6 1.5 2.8 9.5 12.6 0.3 2.1 3.7 3.7 1.9 19.4 35.8 41.6 44.2 17.7 30.6 26.4 15.5 9.8 3.6 3.9 1.0 0.8 22.1 3.5 3.3 1.4 1.4 2.0 11.2 6.4 14.2 2.2 3.9 12.4 1.0 1.8 1.6 11.5 11.3 6.6 3.3 19.3 2.2 7.9 18.1 0.9 3.0 1.2 1.7 2.9 1.3 2.4 5.8 12.4 1.3 15.7 10.2 27.3 11.3 7.2 6.6 30.1 0.6 34.3 3.4 5.0 7.1 19.1 0.0 30.5 7.2 1.2 5.4 6.8 0.0 9.4 10.7 9.3 5.2 44.5 17.1 5.9 10.4 8.2 6.4 5.8 44.2 41.6 23.5 40.9 16.7 19.4 17.6 19.1 35.8 18.1 8.8 14.9 16.1 17.7 32.5 18.3 30.6 26.4 0.0 0.6 0.0 0.9 0.6 0.7 2.0 0.0 0.0 0.0 3.5 0.0 5.1 0.0 5.4 0.2 1.6 4.9 0.0 10.4 1.8 1.5 0.8 0.0 2.5 2.5 0.0 3.5 1.8 7.5 0.0 0.9 3.3 6.8 2.8 3.6 0.2 7.8 5.8 0.0 2.4 0.2 0.0 2.3 0.3 0.4 1.9 3.4 3.8 4.0 0.4 SLX1B "GIYD2, MGC5178" ENSG00000181625 "SLX1 homolog B, structure-specific endonuclease subunit" Q9BQ83 16 29454501-29458219 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 26.5" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 10.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA047038 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047038: AB_2679913" "unprognostic (2.93e-1)" "unprognostic (1.11e-1)" "unprognostic (2.16e-2)" "unprognostic (5.12e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (7.20e-2)" "unprognostic (2.72e-2)" "unprognostic (2.35e-3)" "unprognostic (3.63e-1)" "unprognostic (1.22e-1)" "unprognostic (3.64e-2)" "unprognostic (2.51e-7)" "unprognostic (4.84e-2)" "unprognostic (1.96e-1)" "unprognostic (4.44e-1)" "unprognostic (5.25e-3)" 4.6 2.9 0.2 3.9 0.5 8.8 4.9 2.0 2.7 5.6 6.6 14.1 5.4 2.7 3.0 4.4 1.1 2.2 0.4 0.5 3.3 11.1 5.7 3.0 0.6 4.2 3.1 3.4 2.2 5.4 4.0 4.6 8.0 5.4 11.2 5.7 13.4 2.9 1.8 6.3 4.7 0.0 6.1 6.6 5.7 3.9 3.2 20.8 26.5 24.7 3.7 6.5 6.7 6.8 5.9 15.4 0.7 3.2 4.6 21.2 6.4 15.0 14.6 12.4 1.6 10.5 17.3 5.6 4.5 2.3 2.6 5.7 9.2 3.5 1.0 4.3 7.1 3.1 9.2 9.9 7.2 2.9 6.1 6.6 9.6 6.5 9.2 16.2 20.4 3.7 7.1 6.8 9.7 1.3 7.2 1.3 15.4 8.6 7.0 12.2 15.5 12.3 4.2 2.5 14.8 2.7 30.2 1.4 2.4 1.4 4.1 10.8 4.9 1.5 2.9 1.1 3.2 20.1 11.0 5.4 5.5 2.1 3.3 24.7 26.5 2.8 20.7 0.8 3.2 2.5 2.8 20.8 2.5 1.2 1.6 14.8 3.7 11.9 1.2 6.5 6.7 0.0 0.3 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.1 1.0 0.0 1.3 0.6 0.4 0.2 0.0 0.5 1.0 0.0 0.0 0.6 1.2 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.8 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.9 0.1 0.1 SLX4 "BTBD12, FANCP, KIAA1784, KIAA1987" ENSG00000188827 "SLX4 structure-specific endonuclease subunit" Q8IY92 16 3581181-3611598 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 19.9;testis: 25.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049421, HPA066238" Approved Supported "Nucleoplasm,Cell Junctions,Cytosol" NA NA Nucleoplasm "Cell Junctions, Cytosol" "HPA049421: AB_2680759, HPA066238: AB_2685642" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (4.06e-2)" "unprognostic (2.65e-2)" "unprognostic (4.62e-1)" "unprognostic (6.08e-3)" "unprognostic (8.28e-5)" "unprognostic (6.52e-2)" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.97e-2)" "unprognostic (1.50e-1)" "unprognostic (4.32e-2)" "unprognostic (8.39e-3)" "unprognostic (1.20e-1)" "unprognostic (1.43e-3)" "unprognostic (5.74e-2)" 2.9 3.1 5.3 6.1 8.5 6.0 2.4 19.9 11.8 2.5 2.9 9.8 2.5 4.9 6.5 3.3 3.4 3.0 2.8 2.2 7.4 4.3 2.9 2.7 3.0 8.6 3.8 8.1 2.7 3.1 3.7 8.6 2.6 7.4 3.3 2.2 5.4 3.0 2.6 5.5 4.2 4.0 3.1 3.3 4.8 3.7 25.0 3.2 5.8 2.6 1.0 6.5 3.1 2.7 0.6 0.2 3.0 1.1 0.6 0.6 0.7 3.0 9.3 6.1 7.5 2.3 2.4 6.3 4.8 2.4 5.6 6.2 4.6 3.7 10.9 4.8 2.4 4.3 6.7 4.1 3.4 3.3 9.1 5.1 7.5 6.7 2.9 2.0 7.2 10.6 1.8 2.5 5.2 2.9 1.4 4.0 6.2 7.1 6.0 4.4 5.1 4.4 6.3 5.0 1.8 3.5 8.9 10.0 3.0 2.2 2.1 5.2 4.6 4.2 3.0 1.5 3.3 7.3 5.7 4.7 6.5 9.0 5.5 5.6 5.4 4.2 12.8 2.1 7.4 6.3 3.0 0.4 0.0 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.6 0.3 0.5 0.5 0.6 1.1 0.2 0.3 0.7 5.3 8.5 19.9 11.8 7.4 4.3 3.8 8.1 7.4 3.2 0.0 2.9 4.5 0.8 0.7 7.7 1.4 2.5 2.7 4.5 0.0 2.0 1.3 0.0 1.4 3.5 1.1 1.5 0.0 2.1 1.5 1.5 0.4 0.0 0.9 2.3 0.0 0.0 1.8 1.6 1.6 2.0 3.2 0.0 1.0 2.2 1.7 1.6 0.0 1.8 0.4 10.9 0.0 1.8 18.6 10.0 0.5 0.8 3.5 1.7 0.5 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702228-66782848 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.1" "Cell type enriched" "Detected in many" 6 "Ito cells: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.8 1.9 2.5 3.1 4.6 0.6 5.1 0.8 2.8 6.3 4.7 2.6 2.1 3.8 5.2 1.9 3.1 4.4 11.6 21.6 3.0 2.0 6.1 6.2 37.1 1.2 3.6 2.3 5.1 3.1 2.3 2.8 13.8 4.5 9.7 2.5 18.5 1.6 22.1 1.8 1.6 3.8 3.1 2.9 3.2 8.0 1.7 2.0 0.0 16.7 0.6 0.8 6.8 7.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.9 7.0 1.1 2.4 4.3 1.1 6.7 4.9 0.1 0.8 0.0 1.4 3.1 0.5 21.2 4.2 0.6 12.6 1.5 0.0 0.1 1.5 5.8 10.9 17.4 1.1 0.5 0.0 0.8 1.4 0.0 0.0 0.0 2.4 0.9 3.6 0.9 0.7 0.3 1.3 0.1 3.0 2.1 7.1 2.6 0.0 1.3 1.5 2.4 5.5 2.6 1.1 2.7 3.0 0.5 4.3 1.0 2.0 4.2 3.1 4.0 12.3 0.9 0.4 1.2 0.2 2.2 3.9 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.5 4.6 0.8 2.8 3.0 2.0 3.6 2.3 4.5 2.0 11.9 5.9 1.4 1.0 0.7 0.0 4.5 5.1 0.0 4.5 1.8 2.0 0.5 3.3 4.3 2.8 19.4 2.8 0.0 5.0 0.7 4.3 1.5 4.6 2.8 1.7 0.0 0.0 107.4 9.5 1.0 2.6 0.8 0.0 1.0 2.0 11.1 5.6 0.0 7.8 1.5 0.3 0.0 1.0 0.2 0.6 0.1 0.7 0.5 5.3 0.3 SMAD9 "MADH6, MADH9, SMAD8, SMAD8/9" ENSG00000120693 "SMAD family member 9" O15198 13 36844831-36920765 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.9" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 26.8;Intestinal endocrine cells: 49.5;Ito cells: 47.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8.8;SH-SY5Y: 28.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009119, HPA031162" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB009119: AB_2286517, HPA031162: AB_2673767" "unprognostic (2.88e-1)" "unprognostic (1.38e-1)" "unprognostic (9.68e-3)" "unprognostic (3.50e-3)" "prognostic favorable (5.99e-4)" "unprognostic (1.30e-1)" "unprognostic (1.34e-1)" "unprognostic (3.71e-3)" "unprognostic (4.23e-2)" "unprognostic (6.62e-2)" "unprognostic (4.07e-3)" "unprognostic (3.74e-2)" "unprognostic (9.70e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (2.47e-2)" 4.4 3.1 7.0 3.2 6.2 0.6 4.1 10.7 11.8 6.3 8.2 14.3 4.1 2.6 10.0 11.3 5.8 5.1 7.4 6.9 15.0 6.2 5.0 1.4 5.3 2.6 10.7 8.9 10.1 1.3 3.0 6.2 6.7 10.2 14.9 6.0 11.9 17.7 12.4 13.8 2.1 4.0 8.4 15.5 1.5 5.9 2.7 11.0 0.0 38.9 1.9 3.4 7.7 12.6 1.7 1.7 1.1 0.8 0.7 1.4 0.2 0.0 0.1 0.5 5.9 1.8 0.8 0.2 6.8 0.7 1.9 1.1 0.0 0.1 0.2 4.3 8.8 0.6 0.3 5.9 0.1 2.0 0.2 8.4 0.0 3.0 4.7 1.8 0.5 0.1 3.0 0.5 0.0 0.0 4.0 3.6 0.8 0.0 0.0 4.3 0.4 0.1 0.5 0.9 0.2 0.6 0.1 6.4 0.0 0.0 1.0 5.3 28.2 1.4 0.2 0.3 1.7 0.4 0.2 6.4 2.8 2.2 1.6 1.6 0.1 0.0 0.0 1.9 0.2 0.4 1.1 0.4 0.3 1.2 0.8 0.8 1.0 1.2 1.3 0.2 1.7 1.2 1.4 0.9 0.7 0.5 1.7 0.4 0.2 7.0 6.2 10.7 7.8 15.0 6.2 10.7 8.9 10.2 11.0 26.8 7.8 0.0 4.2 2.5 8.3 4.2 0.0 2.7 11.4 10.4 3.9 0.1 1.7 0.2 0.1 21.5 0.0 0.0 0.2 0.4 6.6 17.1 0.0 0.0 0.1 0.0 49.5 47.9 2.4 0.0 17.3 0.0 0.0 0.0 13.7 16.3 0.7 3.5 14.2 4.3 3.2 0.0 7.9 0.2 4.7 1.6 0.2 0.9 5.7 0.9 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.4;OE19: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 23.3 7.2 0.8 0.8 3.2 12.7 39.4 18.0 18.1 9.2 5.7 14.2 24.6 0.2 3.2 11.1 3.4 8.3 5.1 6.9 12.9 1.1 4.1 3.1 0.9 4.7 8.9 0.7 3.0 8.2 5.3 19.9 18.0 21.1 22.1 6.0 2.4 1.3 14.8 20.6 3.8 2.8 3.6 47.5 27.9 0.2 0.3 0.8 13.3 5.4 0.9 1.1 3.9 15.8 2.8 9.9 13.6 1.2 7.7 10.3 9.8 0.5 10.9 0.4 0.6 0.4 15.1 7.7 5.5 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 0.0 18.8 28.2 46.4 19.3 1.2 1.1 53.5 8.1 12.5 15.7 0.0 1087.3 41.4 27.1 6.5 53.4 61.6 0.0 95.9 65.5 13.8 46.6 12.7 5.8 83.3 1.6 19.7 38.1 5.4 2.1 12.0 6.7 13.5 5.4 100.2 2.5 97.3 73.7 9.2 15.3 1.2 25.8 8.1 5.2 28.8 26.0 704.6 15.2 97.4 72.3 SMAP2 SMAP1L ENSG00000084070 "Small ArfGAP2" Q8WU79 1 40344850-40423326 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.9" "Cell type enhanced" "Detected in all" 7 "B-cells: 177.5;Kupffer cells: 237.9;Macrophages: 148.9;monocytes: 250.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "THP-1: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021466, HPA024424" Approved NA NA "HPA021466: AB_2239737, HPA024424: AB_1857259" "unprognostic (1.65e-1)" "prognostic favorable (6.55e-4)" "unprognostic (7.17e-2)" "unprognostic (1.40e-3)" "unprognostic (4.32e-1)" "prognostic favorable (5.34e-5)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.05e-2)" "unprognostic (2.27e-1)" "unprognostic (2.24e-1)" "unprognostic (4.00e-3)" "unprognostic (2.65e-1)" "unprognostic (1.02e-2)" "unprognostic (1.88e-2)" "unprognostic (5.45e-2)" "unprognostic (6.23e-2)" "unprognostic (1.24e-1)" 24.3 9.4 21.3 47.3 25.9 26.1 12.7 17.0 35.1 17.8 12.2 12.4 2.7 6.6 6.8 5.8 10.0 11.8 17.7 6.6 20.0 19.1 8.2 26.3 21.6 90.9 15.7 15.6 6.9 8.9 9.5 16.0 13.9 18.2 7.2 12.5 9.1 11.4 7.7 12.0 11.4 34.3 15.0 14.2 79.2 15.0 6.2 13.8 35.1 7.0 4.3 70.0 16.7 6.9 14.4 11.7 47.4 42.7 6.9 8.4 10.5 6.1 2.3 5.6 5.6 8.2 15.8 3.1 9.6 8.7 10.0 9.8 2.9 4.2 22.9 4.7 8.5 4.1 2.5 10.3 7.3 13.8 43.2 8.6 12.7 3.6 6.2 7.4 13.1 39.4 13.5 6.2 12.9 5.6 4.9 5.6 18.0 22.8 24.2 11.8 4.1 19.0 12.5 3.4 6.0 21.0 7.3 5.2 23.4 4.8 7.2 9.4 4.3 4.5 11.7 7.3 4.5 3.7 74.7 3.1 11.0 4.5 10.2 7.3 7.9 8.8 18.8 10.0 13.1 7.1 2.7 21.1 23.2 3.7 36.8 4.6 10.6 5.9 5.5 11.7 14.4 8.4 7.7 47.4 6.9 42.7 2.2 8.1 10.5 21.3 25.9 17.0 35.1 20.0 19.1 15.7 15.6 18.2 13.8 23.8 34.5 177.5 8.3 16.0 30.6 9.0 17.8 87.0 30.7 7.0 21.6 4.7 5.0 9.9 11.7 9.2 9.6 46.7 16.2 8.4 16.8 13.3 26.7 55.0 37.0 25.4 9.1 46.6 237.9 16.5 4.9 148.9 27.0 250.7 9.1 13.0 14.0 3.5 4.6 6.9 23.7 32.3 18.4 11.8 8.7 15.6 3.4 91.2 8.6 10.8 SMARCD3 "BAF60C, CRACD3, Rsc6p" ENSG00000082014 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3" Q6STE5 7 151238764-151277896 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 59.6;Peritubular cells: 83.1;Sertoli cells: 64.7;Smooth muscle cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 8.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8" "Cell line enhanced" "Detected in many" "AN3-CA: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063955, HPA065517" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063955: AB_2685159, HPA065517: AB_2685500" "unprognostic (1.23e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.38e-3)" "unprognostic (4.67e-1)" "unprognostic (1.41e-3)" "unprognostic (2.24e-2)" "unprognostic (3.52e-2)" "unprognostic (1.63e-1)" "unprognostic (3.50e-1)" "unprognostic (2.08e-3)" "unprognostic (9.18e-2)" "unprognostic (1.02e-1)" "unprognostic (2.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.35e-3)" "unprognostic (1.29e-1)" 9.7 16.0 34.2 4.0 40.3 4.9 9.8 25.4 36.8 12.9 5.6 7.8 7.9 2.9 8.6 11.4 6.7 14.5 10.7 38.5 22.2 24.7 4.9 2.0 8.3 4.0 18.7 18.8 19.2 7.5 6.8 14.7 4.6 13.3 10.8 3.6 7.6 6.6 18.1 75.2 5.7 3.4 10.0 14.1 4.3 4.8 9.0 11.6 0.0 7.4 9.5 2.5 10.1 4.8 0.2 2.6 3.1 8.8 0.0 0.8 2.1 0.3 2.8 9.4 33.3 15.0 6.7 0.7 6.1 6.2 3.6 2.1 2.1 1.9 3.6 2.2 9.6 1.4 0.6 7.5 0.6 1.4 1.1 4.6 0.0 1.9 0.6 12.9 0.1 6.1 15.9 0.8 1.2 0.1 15.7 0.7 9.3 7.2 1.2 19.0 3.8 0.6 4.7 2.9 0.9 1.2 0.2 14.8 0.1 3.2 0.0 5.4 11.0 5.8 1.0 4.4 1.5 0.8 9.3 1.1 2.3 3.7 7.1 2.0 7.9 0.0 3.0 6.6 8.2 10.3 0.6 8.8 0.0 0.2 1.9 0.1 0.2 0.8 0.0 2.6 0.0 0.5 0.8 3.1 0.0 0.4 0.0 0.7 2.1 34.2 40.3 25.4 27.9 22.2 24.7 18.7 18.8 13.3 11.6 6.0 20.8 0.0 31.9 9.5 12.7 59.6 17.8 6.7 5.7 10.4 3.9 0.4 26.6 14.9 1.8 4.7 0.0 0.0 2.1 0.2 19.3 7.3 2.3 0.4 3.4 11.1 3.4 2.5 17.1 8.9 46.9 6.4 6.8 1.0 0.0 23.4 4.3 0.0 83.1 1.7 4.6 64.7 51.5 1.7 9.5 4.1 0.9 0.9 0.0 8.1 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 46 "testis: 35.4" "Group enriched" "Detected in some" 5 "Spermatocytes: 487.9;Spermatogonia: 418.0" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.2;EFO-21: 4.4;SiHa: 19.1;U-266/70: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA001500 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.2 0.0 0.5 0.0 9.2 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.2 0.1 0.0 19.1 0.1 0.0 0.0 0.1 1.6 0.1 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.0 0.3 2.0 0.0 0.2 0.7 0.4 0.0 0.4 0.0 0.2 0.5 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.1 0.1 0.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 63.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 28.8 5.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.2 0.0 1.0 97.0 0.0 487.9 418.0 0.0 0.7 0.0 0.0 0.1 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141417 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.1" "Cell type enhanced" "Detected in many" 5 "Spermatogonia: 96.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Yes No Nucleoplasm Nucleoli "HPA071309: AB_2686385" "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 7.4 6.1 6.6 10.1 10.5 15.2 6.1 8.1 9.1 7.9 7.5 4.0 5.1 7.0 6.1 5.2 11.4 5.1 3.6 7.1 6.5 6.8 8.6 5.7 5.5 14.2 8.2 5.2 6.0 4.1 5.2 6.5 7.5 10.7 5.2 8.5 3.0 5.9 4.7 4.2 6.8 6.9 5.4 8.6 13.7 5.9 12.3 8.7 56.1 7.2 12.9 14.7 6.1 6.3 8.9 5.1 12.0 8.3 8.0 7.4 2.8 18.3 14.2 16.0 14.8 3.4 5.0 15.0 17.0 8.1 15.3 12.9 12.3 14.3 35.2 8.3 8.7 13.2 31.2 23.1 11.0 20.7 22.3 9.7 21.2 22.7 7.9 0.9 12.8 21.4 3.2 2.3 20.7 8.4 5.2 10.8 22.7 17.0 29.0 13.8 8.9 33.3 6.6 13.8 14.9 11.2 22.3 45.9 13.2 6.5 6.7 15.1 11.7 20.3 9.5 5.0 7.0 19.1 8.7 8.6 18.6 19.6 25.7 21.2 10.6 35.7 20.6 12.1 18.8 22.5 12.0 2.8 2.8 6.2 7.1 7.0 8.5 5.7 6.2 3.0 8.9 6.7 7.4 0.4 8.0 8.3 5.1 6.9 2.8 6.6 10.5 8.1 9.1 6.5 6.8 8.2 5.2 10.7 8.7 23.8 11.0 20.1 9.5 24.3 34.1 38.9 7.6 10.7 14.8 15.7 7.9 30.9 29.9 16.5 27.3 15.5 6.5 0.0 17.9 78.9 14.2 5.9 21.9 6.8 37.8 27.0 4.7 19.6 12.1 20.4 17.3 20.0 6.8 27.1 11.4 14.5 14.2 7.0 11.7 13.3 18.4 12.9 17.5 56.4 96.0 20.3 21.6 14.9 24.7 6.7 SMC4 "CAP-C, hCAP-C, SMC4L1" ENSG00000113810 "Structural maintenance of chromosomes 4" Q9NTJ3 3 160399274-160434962 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.2" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 332.4;Spermatogonia: 238.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029449, CAB055509" Approved Supported "Nuclear speckles,Cytosol" NA Yes "Nuclear speckles, Cytosol" "CAB055509: , HPA029449: AB_10603891" "unprognostic (2.63e-1)" "unprognostic (1.01e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.54e-2)" "unprognostic (2.18e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (4.20e-5)" "prognostic unfavorable (9.00e-4)" "prognostic unfavorable (8.05e-7)" "unprognostic (3.03e-2)" "unprognostic (4.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" 4.8 5.5 3.0 25.4 4.4 15.1 4.0 3.1 3.2 5.3 10.1 1.7 5.3 6.5 5.2 4.9 19.3 4.6 7.0 5.7 2.4 1.7 4.4 6.3 7.9 16.5 3.1 1.3 4.7 4.2 1.7 10.8 7.4 2.6 4.4 6.9 2.7 5.7 6.9 5.9 4.6 7.0 6.2 3.1 13.1 5.7 20.7 3.2 70.2 5.1 7.6 14.3 7.8 6.3 8.8 6.1 30.5 7.6 7.8 15.8 4.8 63.3 11.7 26.7 12.3 5.1 5.2 12.3 31.6 14.9 36.6 31.7 14.8 36.5 40.1 18.5 13.0 24.3 36.6 30.3 15.3 58.8 53.1 21.1 38.8 20.1 4.7 2.8 25.7 31.8 2.6 2.2 19.3 15.8 13.3 15.5 17.1 22.3 46.7 21.8 11.4 31.5 6.4 15.7 15.7 27.6 32.0 41.9 29.1 6.8 7.9 16.1 16.7 24.1 22.3 11.0 13.1 26.8 19.2 14.6 23.4 19.6 21.3 57.6 31.2 31.8 73.2 16.8 26.4 25.9 30.5 3.2 12.1 6.7 4.7 6.5 8.8 10.5 8.0 3.5 7.2 6.7 6.0 5.7 7.8 7.6 6.1 15.8 4.8 3.0 4.4 3.1 3.2 2.4 1.7 3.1 1.3 2.6 3.2 98.3 146.6 24.2 16.6 36.2 14.2 31.9 22.9 32.1 44.3 33.2 7.9 29.7 3.3 18.2 26.7 45.6 21.1 116.8 12.6 126.9 41.4 11.7 76.3 15.6 51.1 0.0 28.9 39.3 26.0 21.5 23.3 45.4 16.9 37.9 24.6 9.8 11.3 20.1 45.3 6.2 24.1 129.4 30.3 332.4 238.9 31.1 28.5 48.4 46.6 17.6 SMCO1 "C3orf43, DKFZp313B0440, FLJ41923" ENSG00000214097 "Single-pass membrane protein with coiled-coil domains 1" Q147U7 3 196506877-196515366 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 22 "heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9" "Cell type enriched" "Detected in single" 76 "Cardiomyocytes: 71.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 5 "NK-cells: 2.1" "Cell line enhanced" "Detected in some" "MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (4.86e-2)" "unprognostic (1.62e-1)" "unprognostic (1.51e-2)" "unprognostic (6.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-2)" "unprognostic (2.95e-1)" "unprognostic (2.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 48.6 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 2.1 0.0 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 66.9 2.5 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.4 0.6 0.9 0.3 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.0 0.2 0.2 0.0 0.7 0.2 0.4 0.2 0.8 0.2 1.5 0.7 0.1 1.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.3 0.3 0.4 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.0 1.3 0.5 0.5 0.4 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 71.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 SMCO2 "C12orf70, LOC341346" ENSG00000165935 "Single-pass membrane protein with coiled-coil domains 2" A6NFE2 12 27466810-27502185 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.3;testis: 3.1" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 9.8;Late spermatids: 3.6;Urothelial cells: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;HDLM-2: 5.6" "Not detected" "Not detected" HPA014366 Uncertain NA NA "HPA014366: AB_1845544" "unprognostic (2.64e-2)" "unprognostic (3.11e-1)" "unprognostic (1.33e-2)" "unprognostic (4.10e-2)" "unprognostic (4.44e-3)" "unprognostic (1.98e-2)" "unprognostic (7.86e-3)" "unprognostic (5.44e-3)" "unprognostic (2.81e-1)" "unprognostic (8.86e-2)" "unprognostic (9.21e-5)" "unprognostic (2.59e-1)" "unprognostic (7.02e-3)" "unprognostic (5.48e-2)" "unprognostic (3.01e-1)" "unprognostic (3.65e-1)" "unprognostic (1.69e-1)" 0.2 0.3 0.2 1.7 0.1 0.1 0.4 0.3 0.5 0.1 0.4 0.0 0.1 0.0 2.3 0.0 0.8 0.0 0.3 0.4 0.0 0.7 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.1 2.1 0.0 0.4 0.0 0.0 1.5 3.1 0.0 1.9 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.2 0.1 0.0 0.2 2.5 0.2 0.1 0.1 1.8 0.0 3.8 0.0 0.9 0.0 1.3 0.6 0.2 0.6 1.1 5.6 0.0 0.2 1.0 0.0 0.0 2.1 0.4 1.2 0.6 0.8 3.2 1.0 2.0 0.8 0.0 1.6 0.0 0.3 0.9 2.3 1.0 1.5 2.0 0.9 0.0 0.0 0.6 0.8 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.1 0.7 1.7 0.7 1.9 3.1 0.1 0.3 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 9.8 0.0 0.0 0.0 0.7 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 1.7 SMCO3 "C12orf69, LOC440087" ENSG00000179256 "Single-pass membrane protein with coiled-coil domains 3" A2RU48 12 14804650-14814182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 13.3" "Group enriched" "Detected in some" 6 "Collecting duct cells: 1.8;Distal tubular cells: 5.0;Ito cells: 5.5;Proximal tubular cells: 6.1" "Cancer enhanced" "Detected in some" "prostate cancer: 3.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "AN3-CA: 6.4;HHSteC: 2.1;HUVEC TERT2: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA040574, HPA047804" Uncertain NA NA "HPA040574: AB_2677026, HPA047804: AB_2680160" "unprognostic (1.16e-1)" "unprognostic (2.09e-4)" "unprognostic (2.40e-4)" "unprognostic (5.10e-2)" "unprognostic (3.88e-2)" "unprognostic (6.45e-2)" "unprognostic (4.43e-2)" "unprognostic (2.86e-2)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (7.31e-2)" "unprognostic (3.66e-2)" "unprognostic (1.48e-8)" "unprognostic (2.85e-1)" "unprognostic (7.53e-3)" "unprognostic (2.05e-1)" "unprognostic (1.38e-1)" 1.3 0.8 0.2 0.2 0.2 0.3 0.6 0.2 0.4 13.3 0.6 0.2 0.2 0.0 1.3 0.7 0.8 0.8 3.7 2.3 0.2 0.1 6.6 2.8 4.3 0.9 0.6 0.7 1.2 0.6 3.1 0.7 4.0 1.4 2.1 0.1 5.1 0.2 3.2 2.2 0.3 0.4 0.2 2.5 3.3 0.4 0.6 0.2 0.2 8.5 0.9 0.2 1.1 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.1 0.5 6.4 0.7 0.0 0.6 0.8 0.0 0.0 0.0 0.3 0.7 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.3 0.5 0.6 0.3 2.1 0.0 0.1 1.5 0.0 0.0 0.6 0.4 1.9 0.7 0.3 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.5 0.3 0.0 0.3 0.2 0.2 0.2 0.0 0.5 1.1 1.6 0.4 0.0 0.5 0.7 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.2 0.2 0.2 0.4 0.2 0.1 0.6 0.7 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 5.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMCO4 "C11orf75, FN5" ENSG00000166002 "Single-pass membrane protein with coiled-coil domains 4" Q9NRQ5 11 93478472-93543508 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 124.3" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 49.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041120 Uncertain NA Yes "HPA041120: AB_2677309" "unprognostic (7.45e-2)" "unprognostic (1.70e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-2)" "unprognostic (1.58e-1)" "unprognostic (6.47e-2)" "unprognostic (8.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.43e-1)" "unprognostic (5.51e-1)" "unprognostic (4.23e-2)" "unprognostic (9.45e-2)" "prognostic unfavorable (5.81e-7)" "unprognostic (1.61e-1)" "unprognostic (3.05e-1)" "unprognostic (1.55e-2)" "unprognostic (5.01e-2)" 6.1 19.0 4.3 10.0 7.3 1.6 6.2 2.5 4.5 5.0 10.6 4.5 11.5 16.1 5.4 4.6 5.5 9.4 9.3 13.4 4.5 7.9 10.9 33.5 9.0 9.1 6.2 4.0 6.4 17.9 1.1 15.7 3.5 5.7 13.1 8.0 6.0 124.3 10.3 6.2 5.5 21.2 4.8 5.0 16.7 12.2 9.9 4.5 5.4 34.3 3.1 8.6 3.7 5.1 4.2 29.7 11.4 57.3 5.6 5.4 15.7 3.3 6.3 9.3 2.7 3.5 5.5 6.2 9.1 2.6 4.3 7.8 11.2 14.6 9.1 11.3 8.4 6.4 1.9 8.5 1.1 2.5 25.6 7.7 2.2 11.8 25.7 3.6 8.8 11.3 5.4 5.1 2.0 1.6 4.9 7.0 32.0 5.3 49.1 1.4 7.0 8.9 17.4 9.9 25.4 9.3 17.2 5.9 4.6 7.9 8.3 1.5 7.9 7.5 11.0 0.7 11.7 4.3 12.2 3.9 4.5 16.8 15.0 8.2 1.9 0.2 7.1 3.3 17.2 1.7 6.8 51.3 1.2 0.8 57.3 3.5 4.2 5.4 1.5 28.8 3.0 0.7 0.6 11.4 5.6 52.1 29.7 2.0 15.7 4.3 7.3 2.5 4.5 4.5 7.9 6.2 4.0 5.7 4.5 23.8 20.2 13.7 30.3 29.1 1.9 27.1 56.0 8.1 15.9 47.1 0.0 3.7 179.1 29.8 88.0 22.2 95.7 0.0 61.8 8.5 23.4 137.8 2.3 84.7 133.0 3.2 43.1 12.9 81.9 100.6 11.8 67.0 28.7 35.1 107.8 4.5 39.2 115.8 9.9 48.8 1.4 6.5 11.8 5.9 41.5 18.6 4.0 10.2 59.6 20.7 SMCP MCSP ENSG00000163206 "Sperm mitochondria associated cysteine rich protein" P49901 1 152878317-152885047 "Predicted intracellular proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 121.7" "Group enriched" "Detected in some" 86 "Early spermatids: 3104.1;Late spermatids: 10668.6" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BJ hTERT+: 4.3;hTERT-HME1: 4.1;U-2197: 2.1" "HPA035105, HPA077113" Enhanced NA NA "HPA035105: AB_10601590, HPA077113: " "unprognostic (5.51e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3104.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10668.6 78.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 25.8 0.0 79.8 45.2 0.0 0.0 0.0 0.0 0.0 SMIM10L2A "LED, LINC00086, LINC0086, MGC39606, NCRNA00086" ENSG00000178947 "Small integral membrane protein 10 like 2A" P0DMW4 X 135421943-135428074 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.2;brain: 16.3;epididymis: 13.3" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 7.3;Collecting duct cells: 5.2;Distal tubular cells: 6.6;Proximal tubular cells: 10.9;Rod photoreceptor cells: 6.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.8;CACO-2: 3.3;HAP1: 13.7;hTCEpi: 7.3" NA NA "unprognostic (4.22e-2)" "unprognostic (4.72e-2)" "unprognostic (4.50e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (8.62e-3)" "unprognostic (5.83e-2)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (9.55e-3)" "unprognostic (1.36e-1)" "prognostic favorable (8.28e-8)" "unprognostic (5.29e-2)" "unprognostic (3.26e-1)" "unprognostic (7.37e-3)" "unprognostic (2.28e-2)" 0.4 15.2 3.6 0.1 9.6 0.0 1.4 1.6 16.3 0.9 0.0 1.9 0.2 0.0 1.1 13.3 0.6 1.9 0.2 2.4 4.5 3.8 0.0 1.6 0.2 0.4 7.2 4.1 2.5 2.1 0.2 0.0 5.7 1.7 0.1 0.7 2.3 1.5 0.0 1.8 0.0 0.5 1.3 2.3 0.7 5.3 1.4 0.0 3.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.3 6.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 1.0 0.1 2.6 0.0 13.7 1.7 0.0 0.0 1.2 0.2 0.0 0.0 0.2 0.0 0.5 0.6 7.3 0.0 0.1 0.0 0.2 1.6 0.0 0.0 0.0 0.1 0.2 0.0 1.4 0.6 3.2 0.1 0.0 0.0 2.1 0.2 0.4 1.3 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.7 0.0 7.3 2.8 2.5 0.0 0.0 5.2 0.0 0.0 6.6 0.7 0.3 0.3 0.0 0.0 0.4 0.0 0.0 0.5 1.1 0.0 0.0 3.2 1.2 2.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.6 1.0 0.0 0.7 10.9 6.1 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.3 SMIM10L2B "LINC00087, NCRNA00087, RP11-85L21.2" ENSG00000196972 "Small integral membrane protein 10 like 2B" P0DMW5 X 135094987-135098634 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 17.5;heart muscle: 9.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 3.9;Cardiomyocytes: 4.0;Horizontal cells: 11.1;Muller glia cells: 4.5;Peritubular cells: 3.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.1;GAMG: 4.7;HHSteC: 4.3;HSkMC: 6.7;NTERA-2: 3.6" NA NA "unprognostic (2.60e-2)" "unprognostic (3.08e-1)" "unprognostic (3.16e-2)" "unprognostic (1.18e-3)" "unprognostic (7.25e-3)" "unprognostic (9.55e-2)" "unprognostic (5.90e-2)" "unprognostic (6.02e-2)" "unprognostic (4.54e-2)" "unprognostic (7.05e-2)" "unprognostic (4.69e-2)" "unprognostic (1.13e-2)" "prognostic favorable (2.41e-5)" "unprognostic (2.03e-3)" "unprognostic (1.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.98e-2)" 1.0 3.6 4.9 0.2 8.6 0.0 1.0 2.8 17.5 1.8 0.4 1.3 0.0 0.2 2.2 2.2 0.9 2.7 0.6 9.5 6.6 2.9 0.5 1.2 0.1 0.0 7.5 5.0 0.7 5.0 0.0 0.1 12.3 3.4 0.2 1.3 3.0 2.3 0.6 1.5 0.1 1.3 1.6 0.6 0.5 3.6 0.9 0.0 1.5 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.9 2.6 4.1 0.6 1.4 0.9 0.4 0.4 0.7 1.2 0.0 0.0 0.5 0.5 4.7 0.3 0.9 1.0 0.1 0.0 0.9 0.1 0.2 0.1 4.3 0.0 0.2 6.7 0.4 0.1 0.3 0.8 0.3 1.4 0.1 0.0 0.3 0.1 0.8 0.1 3.6 0.7 0.4 0.0 0.8 0.1 1.6 0.5 1.3 0.4 0.5 0.3 0.0 3.0 0.0 0.5 0.0 0.2 1.1 0.3 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.9 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.8 0.0 11.1 1.2 1.3 0.8 0.6 2.8 0.0 0.0 0.0 0.0 4.5 0.6 0.0 3.5 1.4 1.5 0.0 0.8 0.9 0.1 0.0 0.2 0.0 0.0 0.5 SMIM11B ENSG00000273590 "Small integral membrane protein 11B" Q8TCY0 21 7744962-7777853 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 19.7" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 14.9;Ciliated cells: 20.1;Club cells: 7.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA051321 Uncertain Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA051321: AB_2681440" "unprognostic (1.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.35e-1)" 2.2 1.9 1.4 1.4 2.5 0.6 1.8 1.0 2.3 2.8 4.9 1.5 0.3 1.1 5.8 4.0 4.0 0.3 2.2 3.4 0.9 0.0 0.2 1.8 0.0 1.1 2.1 5.4 0.8 0.7 0.9 0.8 1.7 0.0 1.1 0.4 1.2 19.7 11.2 10.3 11.6 9.5 17.6 10.5 14.3 0.5 8.6 17.5 13.2 16.2 10.4 8.0 11.5 5.7 6.5 0.5 4.0 12.4 4.8 11.3 9.4 2.1 16.2 12.7 2.5 4.6 9.5 20.3 10.7 8.3 13.8 22.0 8.9 16.1 9.1 6.4 10.7 9.7 3.6 10.2 23.5 20.6 7.5 5.9 10.5 16.6 12.7 10.5 0.1 9.6 5.3 17.8 18.2 3.4 15.7 0.8 16.3 7.6 13.1 5.9 6.7 6.9 9.4 0.4 6.7 3.6 2.4 10.5 9.1 19.2 11.7 29.0 9.2 5.0 11.6 10.3 14.1 8.7 16.1 16.0 14.7 14.8 11.2 19.7 17.6 15.7 3.1 9.5 9.1 10.8 13.9 10.5 14.9 3.5 0.0 0.5 0.0 0.8 0.0 0.0 20.1 7.9 0.0 0.0 0.2 3.3 0.4 0.2 0.0 0.1 0.0 0.3 0.2 0.0 0.2 4.7 0.4 0.4 0.0 0.0 0.6 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.4 1.0 0.1 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.4 0.3 SMIM13 C6orf228 ENSG00000224531 "Small integral membrane protein 13" P0DJ93 6 11094033-11138733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 66.6;Syncytiotrophoblasts: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065706 Enhanced Approved "Nucleoplasm,Nuclear membrane,Golgi apparatus" NA NA "Nucleoplasm, Nuclear membrane, Golgi apparatus" "HPA065706: AB_2685539" "unprognostic (6.89e-2)" "unprognostic (1.22e-1)" "unprognostic (1.58e-1)" "unprognostic (7.11e-3)" "unprognostic (4.01e-1)" "unprognostic (2.57e-1)" "unprognostic (3.59e-2)" "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (6.66e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.04e-2)" "unprognostic (2.76e-1)" "unprognostic (9.22e-2)" "unprognostic (3.45e-2)" 5.7 4.2 7.5 2.8 13.0 2.0 4.5 13.3 26.4 4.3 3.2 7.7 1.1 3.1 4.6 3.2 8.5 3.0 3.7 5.7 6.5 2.8 3.9 8.7 5.2 2.3 9.5 8.3 3.8 3.2 7.6 2.8 11.4 14.3 4.3 3.3 2.8 5.3 4.6 9.1 13.7 3.9 4.7 4.9 5.1 3.4 9.4 8.1 1.7 3.9 2.1 2.6 3.3 4.9 0.5 2.4 1.3 0.4 1.2 1.0 0.4 5.7 5.0 7.8 6.5 8.1 9.2 8.1 16.2 7.0 8.4 9.4 6.6 1.9 7.3 22.1 5.2 8.3 5.1 16.1 5.7 15.1 4.0 11.7 7.5 5.6 5.2 10.8 13.9 1.8 11.0 15.9 8.6 11.3 6.6 8.8 6.6 10.6 3.0 15.8 3.2 5.9 8.1 3.6 3.9 4.4 7.9 14.3 10.1 5.1 4.6 18.1 10.0 3.4 11.2 18.9 11.3 2.7 5.8 12.5 12.7 9.2 5.2 10.8 5.6 18.7 10.4 3.0 5.9 19.4 1.3 0.3 0.3 1.0 0.4 0.8 0.5 0.4 0.5 0.6 0.3 0.1 0.9 0.1 1.2 0.3 2.4 0.6 0.4 7.5 13.0 13.3 19.6 6.5 2.8 9.5 8.3 14.3 8.1 11.9 1.0 11.2 14.5 66.6 17.0 10.5 5.1 1.4 2.3 10.4 19.6 24.9 3.3 4.9 6.3 10.5 4.0 0.0 6.5 30.2 12.4 11.5 10.4 20.8 12.3 28.6 3.5 7.4 5.3 3.8 2.6 9.5 15.1 4.6 6.9 7.1 7.9 3.5 3.9 6.6 13.9 0.0 10.3 11.3 17.0 34.5 54.5 6.9 7.4 14.0 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643145-56655766 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "brain: 26.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 5.4;HEK 293: 5.3;RH-30: 4.2;SCLC-21H: 4.9" "HPA071857, HPA071861" Enhanced Approved Vesicles NA NA Vesicles "HPA071857: AB_2686461, HPA071861: AB_2686462" "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 1.8 1.2 7.0 0.6 10.4 0.8 2.4 4.5 17.3 0.9 1.1 0.9 0.0 1.0 2.2 4.8 1.2 1.5 1.0 1.7 6.0 13.8 1.3 0.8 1.3 0.7 5.9 7.7 1.8 1.2 0.5 2.2 1.1 26.5 1.7 1.2 0.4 1.3 2.6 1.1 1.9 0.7 1.4 2.7 1.0 0.7 1.6 0.1 0.0 1.1 0.0 0.8 0.5 0.5 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.3 0.0 5.4 1.5 1.2 0.9 1.1 0.7 0.6 1.3 0.3 0.0 0.2 0.4 0.8 0.3 0.5 0.3 0.1 0.4 0.7 0.0 5.3 3.1 0.6 0.8 0.8 2.5 0.4 1.7 0.7 0.0 1.5 1.1 0.5 2.9 0.1 0.0 1.1 0.0 2.8 0.4 0.0 0.0 0.6 1.5 4.2 0.1 0.7 0.0 4.9 1.0 1.3 0.1 0.8 0.9 0.0 0.8 0.8 1.9 0.2 0.5 0.5 0.3 0.8 1.3 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 10.4 4.5 17.3 6.0 13.8 5.9 7.7 26.5 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM18 ENSG00000253457 "Small integral membrane protein 18" P0DKX4 8 30638600-30646064 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 18.8;pituitary gland: 10.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 9.9;Horizontal cells: 4.8;Rod photoreceptor cells: 2.7" "Cancer enriched" "Detected in single" 8 "glioma: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066648 Supported Uncertain Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA066648: AB_2685697" "unprognostic (2.19e-2)" "unprognostic (9.37e-2)" "unprognostic (3.31e-1)" "unprognostic (4.24e-2)" "unprognostic (1.66e-1)" "unprognostic (2.60e-1)" "unprognostic (7.29e-2)" "unprognostic (4.70e-1)" "unprognostic (8.91e-3)" "unprognostic (1.05e-1)" "unprognostic (2.36e-1)" "unprognostic (6.08e-2)" "unprognostic (4.01e-3)" "unprognostic (1.33e-1)" "unprognostic (3.25e-1)" "unprognostic (4.14e-1)" 0.6 3.2 5.2 0.7 6.6 2.7 0.6 18.8 18.7 0.6 0.7 0.4 0.0 0.6 0.7 0.6 0.7 0.7 0.8 0.9 10.9 10.7 2.9 0.7 0.6 0.6 5.7 7.5 0.7 1.8 0.6 10.7 0.6 11.7 0.7 0.8 0.2 0.6 0.6 0.6 0.7 0.7 0.6 4.6 0.7 0.8 0.7 1.4 0.0 0.7 0.0 0.6 0.6 0.0 2.9 4.1 3.0 2.3 0.2 4.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 1.4 0.0 0.0 0.0 3.0 1.9 1.9 3.7 1.3 3.6 2.9 2.3 2.1 0.9 2.9 3.0 4.3 2.1 0.2 2.3 4.1 2.9 0.3 5.2 6.6 18.8 9.7 10.9 10.7 5.7 7.5 11.7 1.4 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143543-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 15.9" "Cell type enriched" "Detected in some" 8 "Early spermatids: 36.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 4.4;OE19: 12.1" "Low region specificity" "Detected in many" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.2 0.8 0.9 0.1 2.9 0.1 0.2 0.3 1.2 0.2 0.2 0.9 0.4 0.1 0.0 0.2 0.1 0.7 0.0 0.3 0.2 0.2 0.0 0.6 0.0 1.0 0.1 2.2 0.2 0.2 0.1 0.4 15.9 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.2 1.8 0.4 0.0 0.9 0.8 0.9 0.2 0.0 0.0 1.1 0.0 4.4 1.0 0.0 1.5 0.2 1.7 1.1 0.0 1.2 2.7 0.0 1.7 1.2 0.0 1.7 0.0 1.9 0.0 1.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.2 1.1 0.0 0.7 12.1 1.2 1.0 0.0 0.2 0.0 0.5 2.3 1.2 3.4 1.5 2.2 1.9 0.0 0.2 0.4 0.0 0.8 1.2 0.2 0.0 0.0 0.7 1.3 0.4 0.8 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 0.0 0.0 0.0 SMIM21 C18orf62 ENSG00000206026 "Small integral membrane protein 21" Q3B7S5 18 75409476-75427703 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 48 "testis: 8.2" "Group enriched" "Detected in some" 53 "Early spermatids: 54.0;Late spermatids: 36.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 1.3;U-87 MG: 5.1" HPA041686 Enhanced NA NA "HPA041686: AB_10961179" "unprognostic (7.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.3 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 SMIM22 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 1586.1;Mucus-secreting cells: 1138.7;Paneth cells: 989.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "CAPAN-2: 68.7;OE19: 58.6;RT4: 25.3;SCLC-21H: 17.9;SK-BR-3: 51.6" "Not detected" "Not detected" HPA077331 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA077331: AB_2686834" "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 0.8 0.0 0.8 14.4 0.8 0.2 10.9 0.8 0.8 10.8 47.0 0.9 37.8 27.5 2.5 12.1 2.6 18.0 28.1 0.8 0.8 0.0 6.2 0.9 6.8 0.8 0.8 0.8 2.8 36.2 0.0 12.1 4.1 0.8 10.2 28.1 0.8 42.2 35.3 0.8 2.2 54.3 1.7 0.8 0.8 41.7 27.2 0.8 1.0 0.9 2.8 4.5 18.5 3.6 1.9 1.5 3.9 1.3 0.9 1.6 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 68.7 0.0 1.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.1 0.2 58.6 0.0 0.1 0.1 5.8 0.3 25.3 17.9 0.3 0.1 51.6 0.0 0.1 4.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.1 3.9 1.3 1.6 1.3 0.5 0.6 0.7 1.3 0.6 0.3 1.9 1.6 0.7 3.3 0.9 0.6 1.5 0.9 0.3 0.8 0.8 0.8 0.8 0.8 0.0 0.8 0.8 0.8 0.8 44.7 91.2 2.2 16.6 1.9 3.3 0.4 239.5 456.4 104.6 237.3 0.0 3.6 21.6 209.7 33.3 0.4 1586.1 0.0 336.4 0.4 0.3 47.7 18.4 0.0 0.3 1.6 452.3 0.0 0.0 89.0 0.6 2.7 21.9 9.0 1138.7 0.5 428.0 989.0 1.1 55.8 4.1 0.0 0.2 15.1 0.4 1.9 3.1 0.0 572.8 123.6 SMIM23 "C5orf50, LOC644994" ENSG00000185662 "Small integral membrane protein 23" A6NLE4 5 171782432-171796126 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 166 "testis: 21.6" "Cell type enriched" "Detected in some" 5 "Early spermatids: 170.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2197: 1.5;U-266/70: 1.0" NA NA "unprognostic (6.47e-3)" "unprognostic (1.71e-1)" "unprognostic (7.80e-2)" "unprognostic (1.15e-2)" "unprognostic (3.79e-2)" "unprognostic (2.72e-1)" "unprognostic (5.36e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 170.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 SMIM24 "C19orf77, HSPC323" ENSG00000095932 "Small integral membrane protein 24" O75264 19 3473986-3480542 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 160.8;intestine: 204.2;kidney: 76.9" "Cell type enriched" "Detected in many" 6 "Proximal tubular cells: 1384.0" "Cancer enhanced" "Detected in many" "renal cancer: 78.4" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "NK-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7" "Low region specificity" "Detected in many" "HPA045046, HPA056027" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA045046: AB_10964444, HPA056027: AB_2683012" "unprognostic (2.18e-4)" "unprognostic (4.63e-1)" "unprognostic (5.68e-2)" "unprognostic (9.60e-2)" "unprognostic (1.93e-1)" "unprognostic (6.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.61e-1)" "unprognostic (1.64e-1)" "unprognostic (2.85e-1)" "unprognostic (2.84e-1)" "unprognostic (1.07e-1)" "prognostic favorable (4.13e-10)" "unprognostic (1.68e-2)" "unprognostic (2.14e-1)" "unprognostic (8.36e-2)" "unprognostic (3.11e-2)" 0.2 0.1 0.7 0.6 0.9 7.0 0.3 0.2 2.2 0.2 137.0 0.4 2.4 71.4 0.2 160.8 0.3 0.3 46.7 0.3 0.4 0.5 76.9 7.2 0.3 0.3 0.4 0.6 0.3 1.6 0.0 0.9 0.2 0.3 0.3 2.0 0.2 0.3 0.4 0.2 0.3 204.2 0.2 0.6 0.4 24.8 1.2 0.3 8.8 0.2 0.2 0.2 0.2 0.2 3.2 2.4 3.0 0.0 8.6 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 42.4 0.1 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 20.0 0.2 31.7 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.3 0.0 0.0 0.0 30.2 4.2 0.0 50.3 0.0 16.6 0.0 1.1 0.4 0.0 0.4 0.6 0.0 0.0 0.4 0.1 0.0 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.0 23.7 0.0 3.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.7 1.7 0.0 8.6 0.0 2.4 2.1 1.1 0.7 0.9 0.2 2.2 0.4 0.5 0.4 0.6 0.3 0.3 0.0 0.0 1.7 0.1 0.0 12.1 0.2 229.3 0.0 0.0 55.8 25.5 0.0 202.2 3.9 5.0 0.0 64.6 23.3 11.3 0.1 0.0 0.3 1.1 8.5 0.1 0.0 133.5 0.6 0.8 11.2 0.3 0.0 0.0 1.0 34.7 2.7 11.1 51.8 0.0 1384.0 32.6 0.0 0.0 0.7 0.4 0.0 0.0 1.0 35.7 0.2 SMIM26 "LINC00493, LOC388789" ENSG00000232388 "Small integral membrane protein 26" A0A096LP01 20 18567347-18569563 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 330.0;Proximal tubular cells: 358.7" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068733 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA068733: AB_2686024" "unprognostic (1.20e-2)" "unprognostic (5.85e-2)" "unprognostic (2.83e-1)" "unprognostic (8.06e-2)" "unprognostic (2.68e-1)" "unprognostic (1.65e-1)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.67e-3)" "unprognostic (2.16e-1)" "unprognostic (2.68e-2)" "unprognostic (2.40e-2)" "unprognostic (2.02e-1)" "unprognostic (3.18e-1)" "prognostic favorable (7.84e-5)" 6.8 13.2 8.4 6.8 11.6 9.9 15.6 9.2 13.2 8.8 8.8 5.0 11.9 8.6 9.0 20.4 9.3 11.2 10.8 15.0 9.2 13.2 16.4 6.7 13.4 9.2 10.9 17.2 29.4 6.9 10.6 7.4 14.7 9.5 9.7 6.9 16.8 15.7 32.3 7.7 10.9 11.7 8.9 6.2 8.3 5.4 10.8 7.7 12.0 18.7 9.6 11.4 12.6 49.2 52.0 75.1 42.9 29.6 49.8 37.5 23.6 30.7 23.0 24.2 21.3 29.3 27.3 17.7 20.9 20.5 23.5 19.0 27.3 23.4 20.3 18.9 36.9 26.0 21.7 28.8 23.3 10.0 27.5 31.1 14.3 62.5 40.8 20.4 23.9 24.9 38.5 23.2 37.5 35.7 30.7 29.0 22.8 22.0 25.3 29.0 24.0 56.3 13.3 44.5 37.2 15.7 27.3 32.0 45.9 23.7 23.2 24.7 18.5 35.8 68.1 21.3 26.2 30.1 16.0 14.5 15.3 17.9 18.5 21.4 51.7 26.0 13.1 13.2 10.9 34.8 42.9 32.2 33.2 36.2 34.7 49.2 45.0 37.6 52.0 45.1 49.8 46.7 75.1 29.6 33.3 48.6 45.4 37.5 119.1 61.5 0.0 0.0 0.0 0.0 0.0 0.0 160.6 66.0 162.3 0.0 177.5 330.0 123.9 0.0 0.0 0.0 0.0 185.9 113.7 0.0 0.0 32.5 0.0 161.8 0.0 0.0 0.0 0.0 0.0 0.0 33.4 0.0 115.4 0.0 0.0 172.0 0.0 0.0 358.7 0.0 0.0 0.0 0.0 0.0 0.0 173.9 0.0 0.0 0.0 SMIM27 "C9orf133, TOPORS-AS1" ENSG00000235453 "Small integral membrane protein 27" 9 32551144-32568621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "blood: 102.4" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 54.9;Distal tubular cells: 101.2;Proximal tubular cells: 50.5" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 102.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 102.4" "Low cell line specificity" "Detected in all" NA NA "prognostic favorable (4.18e-5)" "prognostic favorable (6.11e-4)" "unprognostic (1.47e-1)" "unprognostic (5.30e-2)" "unprognostic (4.88e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-1)" "unprognostic (4.74e-3)" "unprognostic (8.58e-2)" "prognostic favorable (8.39e-4)" "prognostic favorable (7.33e-5)" "unprognostic (1.30e-1)" "prognostic favorable (3.46e-4)" "unprognostic (7.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.38e-2)" "unprognostic (2.14e-3)" 4.0 6.9 5.0 4.3 12.2 7.9 5.6 4.8 11.0 4.0 4.0 2.4 4.4 4.8 2.2 7.8 2.3 4.0 2.1 8.6 5.1 6.2 3.9 5.6 8.8 5.7 5.8 3.7 11.5 3.7 5.5 2.1 8.9 4.4 1.6 4.0 5.9 4.6 13.8 2.1 3.9 4.5 11.4 6.6 5.1 16.2 6.1 4.5 2.8 4.7 4.1 2.6 0.0 18.4 8.4 102.4 7.6 13.3 22.0 9.9 7.1 4.1 7.5 6.7 3.3 10.0 4.1 3.8 5.6 2.9 5.9 1.0 2.0 5.5 5.5 5.4 5.3 2.9 5.1 3.3 4.2 10.7 11.4 27.2 12.4 9.1 7.6 6.7 4.7 7.3 5.3 2.8 6.7 8.4 6.6 18.1 3.8 14.0 5.2 5.5 11.8 27.5 9.2 7.3 7.8 6.2 3.5 9.8 6.8 3.8 5.6 6.9 9.0 3.5 4.6 9.5 2.8 5.9 3.8 2.1 5.6 2.7 3.7 15.7 12.0 19.5 12.5 4.1 1.8 13.6 7.3 47.4 12.7 7.2 16.9 17.6 18.3 14.7 6.1 18.4 22.0 19.0 102.4 13.3 7.6 8.4 18.3 9.9 26.8 29.6 0.0 0.0 0.0 0.0 0.0 0.0 54.9 17.0 27.9 0.0 21.4 101.2 16.2 0.0 0.0 0.0 0.0 28.2 10.1 0.0 0.0 23.3 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 10.8 0.0 0.0 21.1 0.0 0.0 50.5 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 SMIM28 ENSG00000262543 "Small integral membrane protein 28" A0A1B0GU29 6 138377905-138383075 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "intestine: 6.2;lymphoid tissue: 2.4;smooth muscle: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;SCLC-21H: 2.4" NA NA "unprognostic (2.50e-2)" "unprognostic (5.48e-2)" 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 1.5 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM29 "C6orf1, LBH, MGC57858" ENSG00000186577 "Small integral membrane protein 29" Q86T20 6 34246380-34249470 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 67.8" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 61.3;Ductal cells: 41.8;Hofbauer cells: 88.6;monocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA037659, HPA037660" Uncertain NA NA "HPA037659: AB_2675591, HPA037660: AB_10671881" "unprognostic (2.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.35e-2)" "unprognostic (2.10e-1)" "unprognostic (3.23e-1)" "unprognostic (1.93e-3)" "unprognostic (1.36e-2)" "unprognostic (2.62e-1)" "unprognostic (4.12e-2)" "prognostic favorable (7.98e-4)" "unprognostic (9.32e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (3.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.66e-1)" 9.6 18.5 42.0 10.4 21.8 9.9 12.4 14.8 36.8 10.5 7.6 15.2 4.6 7.1 9.1 24.4 13.3 11.5 12.3 19.0 34.6 34.4 7.9 6.0 13.3 13.5 35.7 16.5 8.8 10.7 7.0 12.2 10.0 25.7 9.7 4.8 12.5 7.5 13.6 7.8 29.2 6.7 8.3 23.9 15.2 9.4 5.2 14.0 5.8 15.2 8.3 11.0 16.0 9.3 22.4 10.4 67.8 15.0 9.8 15.8 11.0 8.9 9.9 2.0 11.7 24.7 20.6 2.0 9.2 19.5 8.5 10.4 2.4 3.4 5.0 7.4 8.2 16.1 5.5 3.7 8.8 2.5 12.9 6.4 3.7 2.5 6.8 13.7 4.4 23.3 11.2 8.4 12.0 12.8 10.8 13.6 3.8 4.8 25.0 19.3 5.7 4.6 8.0 0.7 10.9 7.3 1.6 1.3 7.7 10.2 11.5 9.5 4.5 0.9 6.6 24.0 1.7 4.8 5.2 10.0 19.4 5.3 22.4 7.7 15.9 22.4 1.6 11.4 8.7 28.3 15.3 15.0 67.8 15.8 10.7 10.3 22.4 12.6 13.5 10.4 21.8 8.7 12.5 38.7 9.8 7.6 8.8 15.3 11.0 42.0 21.8 14.8 36.8 34.6 34.4 35.7 16.5 25.7 14.0 8.9 9.9 0.0 0.0 0.0 0.0 0.0 0.0 18.7 12.5 29.6 0.0 30.4 61.3 41.8 0.0 0.0 0.0 0.0 20.4 10.4 0.0 0.0 11.6 0.0 88.6 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 77.5 0.0 0.0 25.6 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 SMIM3 "C5orf62, MSTP150, NID67" ENSG00000256235 "Small integral membrane protein 3" Q9BZL3 5 150777946-150796734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7" "Cell type enhanced" "Detected in many" 8 "granulocytes: 87.8;Sertoli cells: 135.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 64.2;ASC TERT1: 31.4;LHCN-M2: 29.1;U-87 MG: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075345 Approved Vesicles NA NA Vesicles "HPA075345: AB_2686744" "unprognostic (2.33e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "unprognostic (9.45e-2)" "unprognostic (5.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.47e-1)" "unprognostic (3.90e-1)" "unprognostic (2.05e-2)" "unprognostic (9.71e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.15e-8)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.46e-3)" 24.4 5.4 6.1 3.3 5.6 11.4 3.9 3.3 6.2 2.2 3.1 1.8 0.7 1.3 3.0 2.9 2.2 3.0 3.3 3.4 2.6 1.2 2.9 1.1 3.6 0.7 3.0 1.0 3.2 45.7 1.2 1.8 6.4 6.2 3.2 2.3 1.3 1.8 3.3 2.5 2.2 3.9 3.7 2.6 1.9 2.9 1.7 4.3 1.8 2.7 0.7 0.7 3.8 1.8 0.3 18.4 22.3 13.3 3.6 7.2 11.6 2.0 0.6 1.1 9.4 64.2 31.4 2.4 8.0 17.2 2.9 11.9 3.1 5.4 0.0 0.4 8.2 2.0 1.6 1.8 1.7 4.4 0.0 0.5 2.9 0.4 1.4 11.4 2.9 21.2 26.3 3.6 8.3 3.8 19.3 0.9 7.2 0.8 0.0 29.1 1.5 4.1 4.0 0.5 1.6 1.9 2.3 0.1 0.0 3.1 1.5 0.2 0.7 1.1 0.1 2.3 1.3 3.9 18.1 1.5 13.2 2.4 10.3 4.1 0.0 0.0 0.0 47.7 11.1 1.6 17.9 13.3 22.3 7.2 5.3 4.3 0.3 5.1 4.9 6.2 0.0 5.0 4.3 13.9 3.6 4.8 18.4 0.7 11.6 6.1 5.6 3.3 6.2 2.6 1.2 3.0 1.0 6.2 4.3 6.0 10.4 0.5 56.6 0.0 0.7 6.6 10.2 0.0 4.5 7.0 0.0 7.7 11.6 6.6 0.6 6.7 2.3 0.0 28.1 4.8 19.3 11.1 87.8 0.4 39.0 0.0 4.6 12.9 26.7 0.6 13.0 15.3 0.0 34.3 34.3 42.1 14.9 0.0 34.6 7.1 0.7 135.8 63.1 0.0 0.5 0.0 6.8 10.2 6.2 43.2 SMIM31 LINC01207 ENSG00000248771 "Small integral membrane protein 31" 4 164754064-164803795 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "intestine: 42.7" "Group enriched" "Detected in some" 5 "Exocrine glandular cells: 81.2;Pancreatic endocrine cells: 87.7" "Cancer enhanced" "Detected in many" "prostate cancer: 8.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 3.3;RPTEC TERT1: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (2.84e-1)" "unprognostic (1.18e-1)" "unprognostic (2.47e-2)" "unprognostic (1.87e-4)" "unprognostic (2.95e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-2)" "unprognostic (4.82e-1)" "unprognostic (9.47e-2)" "unprognostic (5.63e-3)" 0.0 0.0 0.1 4.0 0.0 0.2 0.6 0.0 0.0 3.1 25.4 0.0 0.0 13.7 0.7 0.2 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 9.8 9.8 0.0 2.1 0.0 0.0 0.0 42.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 1.1 1.4 3.1 0.5 1.3 0.5 0.0 0.4 3.3 0.2 0.8 0.2 0.4 0.9 0.3 0.1 0.3 0.3 1.2 0.4 0.6 0.3 0.2 0.2 0.8 0.1 0.4 0.1 0.3 0.4 0.1 0.4 0.3 0.4 0.6 0.9 0.3 0.3 0.2 0.2 0.1 0.0 0.5 0.5 1.5 0.0 0.6 0.4 1.4 0.4 1.7 0.1 0.6 0.2 1.4 4.5 0.6 0.5 0.2 0.4 0.5 0.6 0.5 0.4 0.7 0.4 0.5 0.2 0.8 0.5 1.8 0.4 0.7 0.8 0.7 1.2 3.1 0.5 0.6 0.4 0.3 0.4 0.4 0.4 0.4 0.2 1.1 0.5 0.5 2.8 1.3 0.4 1.4 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 18.7 17.0 3.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 81.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMIM32 ENSG00000271824 "Small integral membrane protein 32" 5 136191468-136193134 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2" "Cell type enriched" "Detected in some" 8 "Proximal tubular cells: 233.2" "Cancer enhanced" "Detected in many" "renal cancer: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HaCaT: 2.3;SCLC-21H: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.35e-5)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (7.79e-2)" "unprognostic (2.11e-2)" "unprognostic (9.13e-2)" "prognostic favorable (1.63e-4)" "unprognostic (1.86e-2)" "unprognostic (1.75e-2)" "prognostic favorable (6.13e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-3)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 1.2 2.2 0.0 0.0 0.0 7.8 0.0 5.1 0.0 0.0 12.3 0.0 0.0 0.0 0.0 9.8 0.0 0.6 26.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.4 0.1 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 1.5 0.0 1.4 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 6.1 0.6 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 28.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 233.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMIM33 ENSG00000283288 "Small integral membrane protein 33" 5 139470778-139474772 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.5;intestine: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 2.2;T-cells: 3.5" "Cell line enhanced" "Detected in some" "JURKAT: 2.0;U-937: 2.7" "Not detected" "Not detected" NA NA 0.0 0.0 0.4 0.4 0.0 0.0 1.2 3.9 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 2.2 0.3 0.1 0.6 3.5 0.5 0.5 0.5 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.5 0.4 0.3 0.0 0.4 0.2 0.1 0.0 0.6 0.3 0.3 0.1 0.3 0.1 0.0 0.3 0.4 0.1 0.0 0.1 0.1 0.0 2.0 0.1 0.3 0.1 0.4 1.2 0.9 0.1 0.2 0.1 0.6 0.0 0.2 0.2 0.2 0.7 0.4 0.1 0.9 0.0 0.1 0.6 0.7 1.1 0.0 0.3 0.4 0.2 0.3 0.1 0.2 0.1 2.7 0.5 0.1 0.1 0.0 2.3 0.0 3.5 0.3 3.1 2.2 0.0 0.1 0.8 0.4 0.3 0.6 0.0 2.2 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM34A ENSG00000243627 "Small integral membrane protein 34A" A8MWV9 21 34418715-34423966 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 4.5;SK-MEL-30: 1.2;U-87 MG: 1.0" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.3 0.1 0.3 0.3 0.5 0.2 2.9 1.6 0.3 0.4 0.3 0.3 0.3 0.0 0.3 0.3 0.3 2.1 0.3 0.6 0.3 0.2 9.6 0.5 0.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.3 0.7 1.0 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 1.6 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM34B ENSG00000278961 "Small integral membrane protein 34B" A8MWV9 21 7784482-7793954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 4.5;kidney: 16.1" "Group enriched" "Detected in some" 7 "Ciliated cells: 12.0;Distal tubular cells: 5.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.1;myeloid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 6.5;SK-MEL-30: 2.7;U-87 MG: 2.5" HPA029085 Uncertain NA NA "HPA029085: AB_10669867" 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.7 0.0 0.4 16.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 3.1 0.6 0.0 0.0 0.4 1.1 0.2 0.2 0.0 0.0 0.0 0.3 0.2 1.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 2.7 0.0 1.2 0.3 0.0 0.0 0.5 0.4 0.0 1.2 0.1 0.0 2.5 0.3 0.1 0.0 0.5 3.1 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM35 TMPRSS4-AS1 ENSG00000255274 "Small integral membrane protein 35" 11 118003634-118088299 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Group enriched" "Detected in some" 7 "blood: 4.6;bone marrow: 3.1;kidney: 3.4;lymphoid tissue: 1.7" "Cell type enriched" "Detected in single" 18 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Karpas-707: 14.6;RPMI-8226: 9.1" "Group enriched" "Detected in some" 5 "basal ganglia: 1.1;olfactory region: 4.3" NA NA "unprognostic (8.83e-2)" "unprognostic (3.42e-2)" "unprognostic (2.64e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-4)" "unprognostic (2.92e-1)" "unprognostic (1.09e-1)" "unprognostic (1.64e-1)" "unprognostic (1.88e-1)" 0.0 0.0 1.2 3.1 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.4 0.1 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.5 0.0 1.7 0.8 0.1 0.5 1.2 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 9.1 0.0 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.0 0.9 0.0 0.0 1.7 0.7 1.1 0.7 0.4 0.0 0.6 0.1 1.2 0.5 0.8 4.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM36 ENSG00000261873 "Small integral membrane protein 36" 17 55448433-55511444 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 5 "retina: 29.3" "Group enriched" "Detected in some" 18 "Ciliated cells: 1.4;Club cells: 2.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in some" NA NA "unprognostic (2.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.8 2.9 0.8 1.2 0.7 0.6 0.1 0.5 0.2 0.2 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.0 0.3 0.9 0.0 0.0 0.0 0.3 0.0 0.4 1.0 0.9 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.3 0.8 0.0 0.0 0.4 0.3 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.8 0.5 0.7 0.6 0.1 0.0 0.6 0.6 0.0 1.3 0.5 0.4 0.5 0.3 0.4 0.2 0.5 0.4 0.7 0.2 2.9 0.8 0.8 0.6 0.6 0.5 0.5 0.5 0.5 0.3 1.4 0.6 0.7 2.4 1.2 0.7 0.8 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM37 "LINC00116, NCRNA00116" ENSG00000175701 "Small integral membrane protein 37" Q8NCU8 2 110211529-110245420 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 39.5;skeletal muscle: 119.5" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 113.4;Distal tubular cells: 213.9;Proximal tubular cells: 184.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.74e-2)" "unprognostic (1.86e-1)" "unprognostic (7.68e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "unprognostic (3.49e-3)" "unprognostic (8.20e-2)" "unprognostic (9.10e-2)" "unprognostic (6.08e-2)" "unprognostic (5.08e-3)" "unprognostic (8.27e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-2)" "unprognostic (1.04e-1)" "unprognostic (8.80e-2)" "unprognostic (1.95e-2)" 5.1 4.6 3.6 3.3 5.1 1.2 6.3 1.6 5.7 3.1 4.8 0.9 2.8 7.0 1.9 9.8 6.6 2.4 2.5 15.0 3.3 7.4 8.4 2.9 3.9 3.2 3.3 2.2 5.2 2.4 1.2 2.0 4.8 4.2 1.9 1.9 5.9 6.2 119.5 2.8 5.4 2.9 2.3 3.5 4.3 2.5 2.8 1.8 6.1 19.2 2.5 3.9 3.8 31.8 39.5 3.4 28.8 20.4 37.1 20.0 0.1 37.5 4.2 4.6 4.4 5.4 25.1 15.2 11.6 18.1 11.9 25.3 11.8 5.0 29.7 4.0 25.2 15.8 3.9 16.6 2.8 21.4 15.8 3.0 9.2 20.8 18.7 10.3 15.5 14.2 19.9 15.2 0.0 9.8 15.6 15.2 8.3 12.4 8.4 37.6 14.4 35.6 10.3 11.7 11.0 1.5 8.5 14.9 10.7 22.9 9.1 6.0 8.4 29.0 16.6 2.7 8.0 17.7 12.5 17.9 24.9 17.3 22.6 21.2 13.5 1.4 18.7 16.4 12.6 2.4 28.8 3.4 31.0 28.5 34.8 27.9 34.8 33.2 29.0 31.8 37.1 37.0 1.4 20.4 16.7 39.5 29.9 20.0 32.8 32.1 0.0 0.0 0.0 0.0 0.0 0.0 45.5 25.0 113.4 0.0 38.5 213.9 61.0 0.0 0.0 0.0 0.0 87.3 23.9 0.0 0.0 31.4 0.0 71.3 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 50.5 0.0 0.0 80.6 0.0 0.0 184.3 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 90.6" "Cell type enhanced" "Detected in many" 4 "Cardiomyocytes: 211.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA047771: AB_2680150" "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favorable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favorable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 11.1 47.3 6.8 9.3 12.0 4.1 15.9 10.3 13.4 6.0 8.7 3.2 16.0 7.5 5.2 16.3 5.5 5.0 13.0 90.6 8.4 6.1 12.2 9.3 21.7 26.5 8.5 6.9 19.1 28.3 6.2 22.1 4.1 17.4 10.6 6.7 10.5 25.8 19.1 66.8 6.7 7.9 17.0 9.1 5.7 8.5 14.1 7.6 1.8 17.3 30.8 5.3 7.0 5.3 13.7 26.2 8.8 24.7 11.0 16.9 10.4 23.0 8.1 9.5 24.0 11.2 5.8 19.4 10.5 4.9 12.1 10.6 9.9 6.2 10.0 4.8 4.4 12.2 12.2 3.1 8.4 4.9 6.6 24.6 9.4 23.2 19.9 17.0 11.1 13.1 12.5 5.2 10.2 7.4 6.6 11.0 11.0 12.4 15.0 8.1 10.0 10.3 15.6 16.1 12.7 17.3 7.1 9.1 19.7 6.7 10.1 10.3 13.0 20.5 6.8 19.8 5.6 7.0 9.4 9.7 6.7 22.0 31.6 21.3 17.5 19.0 21.9 36.8 20.9 9.2 3.5 24.7 8.8 10.8 18.7 10.5 13.7 15.6 13.2 26.2 12.5 16.9 15.2 0.9 11.0 7.5 14.0 14.9 10.4 6.8 12.0 10.3 13.4 8.4 6.1 8.5 6.9 17.4 7.6 44.7 44.8 30.4 29.5 24.2 16.1 211.3 61.1 62.9 77.3 50.6 11.8 35.0 180.8 36.8 15.8 36.5 60.3 0.0 74.3 16.7 27.7 17.7 56.7 143.5 98.6 3.2 76.2 60.8 84.6 8.0 60.1 52.8 35.4 17.2 57.4 43.6 50.1 28.1 95.1 134.6 12.7 45.3 51.1 7.7 15.8 30.2 23.1 25.9 67.6 18.2 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2" "Group enriched" "Detected in many" 5 "Collecting duct cells: 118.7;Distal tubular cells: 77.9;Erythroid cells: 233.6;Urothelial cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 51 "plasmacytoid DC: 54.2" "Lineage enriched" "Detected in many" 51 "dendritic cells: 54.2" "Cell line enhanced" "Detected in some" "HEL: 3.1;MCF7: 14.3;OE19: 3.8;SK-BR-3: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA065332: AB_2685471, HPA071268: AB_2686377" "unprognostic (6.97e-2)" "prognostic favorable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favorable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 0.4 0.6 2.1 1.8 10.7 9.9 1.4 1.1 7.5 4.0 4.4 23.5 2.1 9.8 0.7 0.8 14.3 5.5 4.7 5.1 3.7 2.2 13.6 0.5 2.5 1.1 8.8 4.8 1.3 1.1 0.4 1.1 1.9 16.9 1.9 2.8 2.5 8.4 2.2 0.4 7.8 9.5 2.1 10.1 2.4 11.0 0.9 8.9 0.4 9.3 0.9 3.6 4.4 7.3 0.0 54.2 1.0 0.0 0.0 0.0 4.0 2.5 1.7 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.2 3.1 0.4 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.2 14.3 0.1 0.1 0.1 3.8 0.2 0.4 0.5 0.1 0.0 2.8 1.2 0.1 0.0 6.4 0.0 0.5 0.9 0.2 0.1 0.3 0.2 0.1 0.2 0.3 0.0 0.1 0.1 0.7 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 54.2 0.0 4.0 2.1 10.7 1.1 7.5 3.7 2.2 8.8 4.8 16.9 8.9 8.9 6.5 0.0 6.3 1.0 1.2 19.3 10.2 25.4 2.3 118.7 2.0 1.2 77.9 1.8 0.1 1.3 13.2 233.6 0.5 4.2 2.4 6.1 0.0 0.0 0.6 0.0 13.8 2.5 0.0 0.0 0.6 0.6 6.8 0.0 8.2 3.2 6.4 10.5 1.4 0.8 1.8 0.0 0.4 0.5 0.4 7.3 27.5 1.3 1.7 102.7 SMIM6 C17orf110 ENSG00000259120 "Small integral membrane protein 6" P0DI80 17 75646243-75647977 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6" "Group enriched" "Detected in many" 4 "Early spermatids: 508.7;Late spermatids: 1038.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 22.0" "Lineage enriched" "Detected in single" 46 "dendritic cells: 22.0" "Cell line enhanced" "Detected in some" "A549: 12.6;CACO-2: 4.1;EFO-21: 9.8;HEL: 7.1;OE19: 11.6;RPTEC TERT1: 4.5" HPA065721 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA065721: AB_2685546" "unprognostic (4.34e-2)" "unprognostic (3.08e-2)" "unprognostic (7.07e-2)" "prognostic favorable (1.49e-4)" "unprognostic (3.42e-1)" "unprognostic (1.22e-2)" "unprognostic (6.53e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-3)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "unprognostic (8.06e-2)" "prognostic favorable (4.09e-4)" "unprognostic (2.77e-1)" "unprognostic (1.38e-1)" "unprognostic (2.58e-2)" "prognostic favorable (1.64e-4)" 0.2 0.1 2.4 0.6 4.1 0.6 0.1 0.6 6.1 1.8 5.3 12.3 3.2 7.9 0.9 2.2 0.2 19.1 15.8 0.1 4.0 2.1 13.5 5.2 1.8 0.3 5.3 4.1 0.4 7.3 1.7 0.1 0.4 5.4 0.3 5.5 0.1 0.2 2.9 0.1 0.2 9.4 0.0 9.1 0.2 26.5 20.6 3.1 0.0 0.1 0.2 0.2 1.1 0.8 0.0 22.0 0.0 0.0 0.4 0.0 0.2 0.7 12.6 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.1 3.9 0.0 9.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 7.1 0.3 3.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.4 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.2 4.5 2.1 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 22.0 0.0 0.2 2.4 4.1 0.6 6.1 4.0 2.1 5.3 4.1 5.4 3.1 3.0 1.9 0.8 3.2 0.1 0.0 0.0 30.6 44.2 6.8 33.2 0.0 0.0 116.0 27.9 508.7 0.1 26.2 0.0 14.7 2.6 0.2 1.8 0.0 5.4 0.6 0.0 189.1 0.0 0.0 1038.8 6.1 1.0 0.0 2.8 36.2 0.0 37.4 84.2 1.8 15.7 0.0 6.5 0.1 4.9 2.1 0.0 3.4 0.0 3.1 8.4 SMIM9 CXorf68 ENSG00000203870 "Small integral membrane protein 9" A6NGZ8 X 154823348-154834662 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 4 "testis: 4.1" "Group enriched" "Detected in some" 7 "Early spermatids: 19.8;Late spermatids: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.6" HPA060970 Uncertain NA NA "HPA060970: AB_2684399" "unprognostic (2.63e-5)" 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.9 0.0 0.0 0.0 SMKR1 ENSG00000240204 "Small lysine rich protein 1" H3BMG3 7 129502479-129512932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 65.7" "Group enriched" "Detected in many" 36 "Early spermatids: 1715.8;Late spermatids: 4654.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7" "Cell line enhanced" "Detected in many" "MCF7: 12.8;SCLC-21H: 22.5" "Low region specificity" "Detected in all" HPA078358 Approved Nucleoli NA NA Nucleoli "HPA078358: AB_2686883" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (9.24e-2)" "unprognostic (4.05e-2)" "unprognostic (2.00e-1)" "unprognostic (6.30e-2)" "unprognostic (1.72e-6)" "unprognostic (1.67e-2)" "unprognostic (1.11e-2)" "unprognostic (6.40e-2)" "unprognostic (3.67e-2)" 0.3 1.0 3.1 0.5 6.3 0.3 1.5 0.8 3.3 0.6 0.3 0.1 0.0 0.5 0.4 1.7 0.4 4.6 0.4 0.2 2.7 2.2 0.7 0.2 0.5 0.7 1.1 2.7 0.3 2.6 2.9 2.7 0.9 1.0 0.5 0.4 0.0 0.3 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.5 65.7 0.7 0.0 0.7 0.1 0.7 0.2 0.0 2.9 0.0 0.2 0.0 1.3 3.7 0.4 8.8 8.6 0.2 7.5 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 2.3 0.0 0.8 0.5 4.9 1.1 1.5 0.0 1.1 8.2 0.9 0.0 1.7 0.0 1.6 0.1 5.7 0.0 3.8 2.3 1.6 1.0 0.3 5.3 0.5 0.2 0.4 12.8 1.6 0.8 1.1 2.3 7.7 0.8 0.0 1.9 3.2 0.0 22.5 6.1 6.4 0.7 0.5 1.5 2.0 1.1 0.1 0.0 0.2 5.0 1.9 2.2 2.8 0.1 3.1 0.3 0.6 0.0 0.0 0.0 3.7 0.0 1.7 2.9 0.7 1.9 0.0 1.5 1.5 1.4 0.2 1.3 0.0 0.0 0.0 0.4 3.1 6.3 0.8 3.3 2.7 2.2 1.1 2.7 1.0 0.7 3.0 0.0 0.0 2.1 0.1 1.4 0.0 0.0 8.1 1.2 5.2 0.0 0.0 8.3 1.7 1715.8 0.1 0.0 0.0 5.3 0.2 0.6 1.0 0.0 0.0 0.1 0.0 8.6 0.6 0.0 4654.0 34.8 0.0 1.7 1.0 0.0 1.0 3.1 0.0 25.8 1.1 0.2 0.0 0.0 89.2 28.0 0.3 0.1 5.0 0.0 0.7 SMLR1 ENSG00000256162 "Small leucine rich protein 1" H3BR10 6 130827406-130837135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 33.8;liver: 67.3" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 193.4" "Cancer enriched" "Detected in some" 20 "liver cancer: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "Hep G2: 42.5" "Low region specificity" "Detected in all" HPA066060 Uncertain NA NA "HPA066060: AB_2685607" "unprognostic (1.73e-1)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.32e-2)" "unprognostic (2.35e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (6.43e-3)" "unprognostic (2.68e-3)" "unprognostic (3.29e-1)" 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 14.0 0.0 0.0 7.8 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.1 2.3 67.3 0.1 0.0 0.1 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 193.4 0.1 0.0 0.0 1.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 15.3 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SMOC1 ENSG00000198732 "SPARC related modular calcium binding 1" Q9H4F8 14 69854131-70032366 "Disease related genes, Predicted secreted proteins" Differentiation "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;liver: 48.0" "Group enriched" "Detected in many" 4 "Hepatocytes: 78.8;Peritubular cells: 125.2;Syncytiotrophoblasts: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 50 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "AF22: 19.8;HeLa: 54.5;HSkMC: 16.0;SiHa: 32.1;SK-BR-3: 14.1;U-266/70: 20.3;U-87 MG: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004153, CAB034427" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 27000 "Plasma membrane" "CAB034427: AB_2193382, HPA004153: AB_1080035" "unprognostic (3.31e-1)" "unprognostic (2.17e-3)" "unprognostic (8.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.09e-3)" "unprognostic (4.76e-2)" "unprognostic (2.80e-2)" "unprognostic (5.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.09e-2)" "unprognostic (3.92e-1)" "unprognostic (2.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" 7.4 10.7 23.0 1.4 10.8 1.1 2.9 5.2 62.2 8.6 2.2 32.0 19.4 3.0 2.2 10.3 1.3 7.1 1.5 4.7 22.6 16.2 2.1 48.0 1.4 1.8 23.8 8.5 1.8 26.4 1.1 2.4 9.0 21.7 42.9 2.0 14.7 3.6 35.8 8.7 1.2 2.3 1.9 15.0 19.5 3.5 24.7 16.9 0.0 2.9 0.6 1.5 1.7 3.6 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 19.8 0.0 4.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 7.7 0.0 54.5 8.0 0.0 0.0 0.0 16.0 4.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.8 0.1 32.1 14.1 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.0 0.0 20.3 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 23.0 10.8 5.2 11.2 22.6 16.2 23.8 8.5 21.7 16.9 0.0 0.0 0.9 0.0 0.2 1.5 1.7 10.2 1.4 0.0 0.0 15.7 18.5 0.0 0.2 4.1 1.3 0.0 0.0 1.9 0.8 4.2 0.0 0.0 78.8 2.5 0.0 15.0 2.5 2.7 13.2 7.2 0.0 0.0 0.0 0.0 0.2 5.8 0.0 125.2 0.0 0.2 0.0 0.7 1.5 3.3 0.4 33.6 0.0 0.0 0.0 SMPD3 NSMASE2 ENSG00000103056 "Sphingomyelin phosphodiesterase 3" Q9NY59 16 68358325-68448688 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Lipid metabolism, Sphingolipid metabolism" "Developmental protein, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0" "Cell type enriched" "Detected in many" 6 "Horizontal cells: 284.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "plasmacytoid DC: 44.5" "Lineage enriched" "Detected in many" 7 "dendritic cells: 44.5" "Cell line enhanced" "Detected in some" "HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1" "Region enhanced" "Detected in many" "basal ganglia: 103.1" "Low region specificity" "Detected in all" "CAB033885, HPA065535, HPA069383" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB033885: AB_1126788, HPA065535: , HPA069383: " "unprognostic (1.21e-1)" "prognostic favorable (7.72e-4)" "unprognostic (5.61e-3)" "prognostic favorable (3.86e-4)" "unprognostic (2.46e-1)" "unprognostic (5.85e-4)" "unprognostic (7.87e-2)" "unprognostic (8.12e-3)" "unprognostic (2.77e-2)" "unprognostic (1.30e-1)" "unprognostic (1.75e-1)" "unprognostic (1.81e-1)" "unprognostic (1.04e-3)" "unprognostic (5.02e-3)" "unprognostic (2.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.93e-3)" 3.5 2.3 6.0 3.1 18.3 1.8 1.6 9.4 15.4 1.0 9.6 2.5 0.0 46.4 1.7 0.7 1.8 2.7 17.2 1.2 8.7 3.6 0.9 3.8 2.1 3.5 2.5 5.0 2.7 1.9 0.7 10.7 0.8 3.9 2.2 5.8 4.3 2.2 0.9 1.8 8.1 42.7 1.2 1.4 3.0 18.6 4.2 4.4 73.0 1.3 1.3 4.3 1.6 1.2 0.6 44.5 6.1 0.0 0.0 0.7 0.3 0.3 0.7 0.3 0.1 0.0 0.0 5.3 0.4 0.0 0.4 0.1 2.9 0.9 0.4 0.5 0.2 0.2 1.1 0.0 0.0 0.1 0.3 0.7 0.1 2.1 0.3 0.0 0.0 9.6 0.0 0.0 0.0 0.2 0.5 0.0 0.9 0.8 0.3 0.3 0.2 13.6 2.6 0.6 4.6 0.1 0.6 0.2 11.3 0.0 0.1 13.1 2.6 0.4 1.5 0.6 0.3 1.0 0.9 0.0 0.4 0.8 1.4 0.1 2.2 1.1 0.2 0.2 0.9 0.2 1.0 0.0 6.1 0.7 0.0 0.1 0.6 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 44.5 0.5 0.3 6.0 18.3 9.4 15.4 8.7 3.6 2.5 5.0 3.9 4.4 3.0 0.6 0.0 1.4 0.1 39.5 2.5 5.1 16.0 1.2 0.0 0.0 0.0 0.0 0.9 6.0 0.0 51.1 0.0 0.8 0.2 0.3 3.7 0.0 5.0 0.2 284.4 24.8 0.0 0.6 13.0 14.1 0.0 0.0 0.0 25.6 0.8 1.2 43.0 43.2 0.0 3.3 0.0 0.0 5.4 0.3 0.9 0.0 5.0 18.7 4.7 SMPDL3B ASML3B ENSG00000130768 "Sphingomyelin phosphodiesterase acid like 3B" Q92485 1 27934993-27959157 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 24.4;Enterocytes: 33.4;Pancreatic endocrine cells: 24.8;Paneth cells: 43.2;Undifferentiated cells: 29.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.6" "Group enriched" "Detected in some" 7 "eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8" "Group enriched" "Detected in many" 8 "dendritic cells: 2.7;granulocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 23.1;CAPAN-2: 17.8;NTERA-2: 13.7;RPMI-8226: 14.3;SK-BR-3: 23.0;T-47d: 16.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030561 Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 330000 Cytosol "Golgi apparatus" "HPA030561: AB_10604095" "unprognostic (1.22e-2)" "unprognostic (4.45e-1)" "unprognostic (4.58e-3)" "unprognostic (3.83e-2)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.50e-1)" "unprognostic (2.68e-1)" "unprognostic (3.95e-1)" "unprognostic (6.02e-2)" "unprognostic (1.64e-1)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.48e-1)" "unprognostic (4.40e-2)" "unprognostic (3.09e-3)" 1.3 0.2 1.1 2.7 1.4 0.6 2.7 5.6 1.2 1.3 14.0 0.5 0.5 12.5 1.1 8.6 1.1 3.5 3.6 0.5 0.8 0.5 5.8 0.8 7.3 2.0 0.3 0.9 1.3 48.0 5.0 1.5 1.0 1.0 2.3 12.6 1.3 25.5 0.5 0.3 0.9 25.0 0.8 0.8 1.6 9.1 1.0 0.3 0.7 24.4 1.4 3.5 1.4 0.5 0.5 2.7 6.3 0.3 0.5 0.2 0.2 2.6 1.2 0.0 0.1 0.0 0.0 23.1 0.0 0.5 0.3 1.7 5.9 17.8 0.8 4.2 0.0 0.3 2.9 1.9 1.6 0.3 0.0 11.8 3.8 0.2 1.4 0.0 1.2 0.0 0.1 1.4 3.5 0.2 0.5 0.5 0.1 0.5 0.2 0.0 9.3 0.0 0.4 13.7 2.0 2.1 0.2 0.1 14.3 12.4 4.6 11.9 0.2 0.0 23.0 0.6 2.5 16.6 0.7 0.0 0.0 3.9 0.0 0.0 0.1 6.0 0.3 0.4 0.0 0.0 0.4 0.3 6.3 0.0 0.3 0.0 0.5 0.1 0.0 2.7 0.5 0.2 0.0 3.8 0.5 0.0 0.1 0.0 0.2 1.1 1.4 5.6 1.2 0.8 0.5 0.3 0.9 1.0 0.3 8.9 13.2 2.2 2.4 0.1 0.0 0.3 2.5 4.0 15.9 8.7 0.0 2.2 0.0 24.4 0.2 0.1 33.4 0.0 19.9 0.1 0.0 5.5 0.0 0.0 0.3 0.0 19.7 0.6 0.0 0.0 0.0 0.8 0.0 0.0 23.2 0.0 24.8 43.2 0.0 6.7 0.0 0.0 0.8 0.0 0.1 0.1 6.4 1.3 29.8 2.5 SMPX "DFN6, DFNX4" ENSG00000091482 "Small muscle protein, X-linked" Q9UHP9 X 21705972-21758163 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5" "Cell type enriched" "Detected in single" 2069 "Cardiomyocytes: 810.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "GAMG: 22.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA077360 Approved "Plasma membrane" NA NA 45000 "Plasma membrane" "HPA077360: AB_2732342" "unprognostic (7.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.39e-2)" "unprognostic (7.46e-2)" "unprognostic (5.27e-1)" "unprognostic (1.96e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (2.82e-1)" "unprognostic (8.38e-2)" 1.4 0.0 0.1 0.6 0.1 0.0 0.2 0.6 0.9 0.1 4.0 0.0 0.0 0.1 0.1 4.7 4.0 0.1 0.1 108.8 0.1 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.5 0.0 3.6 0.1 155.8 0.0 0.9 1.8 0.1 0.0 1.5 0.1 0.0 0.0 1.0 74.5 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.9 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 810.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 SMR3A "PBI, PRL5, PROL5" ENSG00000109208 "Submaxillary gland androgen regulated protein 3A" Q99954 4 70360761-70367158 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 52 "salivary gland: 186.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 13 "EFO-21: 1.3" HPA044567 Enhanced "Secreted to digestive system" NA NA "HPA044567: AB_10796114" "unprognostic (2.06e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 186.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMR3B "P-B, PRL3, PROL3" ENSG00000171201 "Submaxillary gland androgen regulated protein 3B" P02814 4 70370093-70390244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 2372 "salivary gland: 6520.0" "Group enriched" "Detected in some" 60 "Early spermatids: 8.1;Late spermatids: 3.8" "Cancer enriched" "Detected in some" 22 "breast cancer: 32.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 35 "EFO-21: 9.8" "Secreted to digestive system" NA NA 4500000 "unprognostic (3.72e-1)" 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 6520.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMTN ENSG00000183963 Smoothelin P53814 22 31064105-31104757 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 99.3" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 267.0;Ito cells: 149.1;Sertoli cells: 181.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "WM-115: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB001721, HPA051778, HPA058590" Enhanced Supported "Nucleoplasm,Actin filaments" No Yes 11000 Nucleoplasm "Actin filaments" "CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765" "unprognostic (1.36e-2)" "unprognostic (4.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (1.08e-3)" "unprognostic (2.05e-2)" "unprognostic (4.56e-1)" "unprognostic (2.15e-1)" "unprognostic (7.22e-2)" "prognostic unfavorable (2.73e-5)" "unprognostic (2.75e-2)" "unprognostic (1.84e-1)" "unprognostic (8.41e-3)" "unprognostic (6.34e-2)" 17.4 3.3 5.0 8.3 3.8 1.5 13.2 12.7 4.7 34.3 99.3 2.0 7.5 10.3 72.4 12.5 26.4 23.5 32.5 27.6 4.3 1.3 7.0 4.7 9.1 1.7 3.6 2.2 18.2 6.8 1.3 2.0 6.0 5.3 34.5 10.6 14.9 4.6 66.7 28.8 6.4 20.3 91.7 1.7 16.9 36.7 6.2 4.0 1.8 5.1 16.8 2.2 61.3 21.4 4.1 1.3 0.3 2.8 0.3 3.1 1.9 19.9 6.0 2.0 7.7 3.2 5.0 16.6 30.0 14.0 24.7 16.9 8.4 6.4 8.9 2.7 16.5 5.0 2.9 2.0 17.7 11.7 2.9 16.5 9.5 4.8 9.9 2.8 14.0 16.6 4.1 1.6 32.7 5.4 8.4 21.2 3.4 10.1 7.4 16.9 17.9 1.6 3.1 2.3 10.0 25.5 5.5 5.9 9.4 9.9 6.5 3.2 3.6 9.4 4.5 4.4 2.2 5.3 2.2 33.4 18.2 17.2 17.0 22.2 7.1 8.6 5.2 26.4 5.5 56.8 0.0 2.8 0.0 0.5 0.7 0.2 4.1 0.5 1.2 1.3 0.2 3.1 1.7 0.3 0.3 0.7 0.7 0.1 1.9 5.0 3.8 12.7 4.7 4.3 1.3 3.6 2.2 5.3 4.0 6.0 3.5 0.8 24.1 57.9 30.5 32.0 5.1 1.4 2.3 8.7 267.0 9.1 8.3 12.2 0.7 45.4 5.1 0.0 17.0 57.4 41.7 20.3 0.0 2.0 5.1 4.8 28.0 149.1 9.2 1.3 20.8 4.5 13.5 1.0 23.0 35.7 47.3 10.5 45.6 18.6 46.9 181.1 111.4 6.5 5.1 60.6 18.3 3.1 23.8 13.4 SMTNL1 CHASM ENSG00000214872 "Smoothelin like 1" A8MU46 11 57542641-57550274 "Predicted intracellular proteins" "Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "skeletal muscle: 118.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 2.5;HDLM-2: 2.8;U-266/70: 5.1;U-266/84: 2.9" "Not detected" "Not detected" NA NA "unprognostic (1.35e-2)" "unprognostic (3.90e-1)" "unprognostic (1.10e-1)" "unprognostic (1.79e-3)" "unprognostic (3.09e-1)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (8.41e-2)" "unprognostic (1.41e-1)" "unprognostic (3.53e-3)" "unprognostic (4.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.04e-6)" "unprognostic (1.21e-1)" "unprognostic (1.10e-1)" "unprognostic (4.49e-1)" "unprognostic (1.44e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 118.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 4.3 1.7 0.7 2.4 0.5 0.1 0.2 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.5 1.3 1.3 0.1 0.0 2.0 0.0 0.0 0.0 0.0 2.8 0.0 0.9 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 1.4 0.0 0.4 1.9 1.1 0.7 0.0 0.1 1.6 0.4 0.8 0.0 0.0 0.0 0.9 0.6 0.1 0.5 0.2 0.3 0.0 0.0 0.2 0.4 0.5 0.0 5.1 2.9 0.1 0.5 1.3 0.0 2.5 1.2 2.7 1.8 1.4 1.9 1.1 1.2 1.9 0.8 1.2 2.4 1.8 4.3 0.7 1.7 0.8 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMTNL2 FLJ42461 ENSG00000188176 "Smoothelin like 2" Q2TAL5 17 4583999-4608319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 99.7" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 7.2;Collecting duct cells: 8.7;Distal tubular cells: 28.2;Fibroblasts: 7.7;Proximal tubular cells: 27.5;Sertoli cells: 25.8" "Cancer enhanced" "Detected in many" "renal cancer: 10.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 2.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "CACO-2: 32.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (8.62e-2)" "unprognostic (5.40e-2)" "unprognostic (7.13e-2)" "unprognostic (2.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-2)" "unprognostic (4.89e-3)" "unprognostic (2.73e-1)" "unprognostic (3.73e-3)" "unprognostic (7.33e-2)" "unprognostic (1.55e-1)" "unprognostic (5.89e-2)" "prognostic favorable (1.28e-4)" "unprognostic (3.43e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-3)" "unprognostic (2.22e-1)" 3.0 0.1 0.1 0.5 0.2 0.1 0.5 0.1 0.5 1.0 0.3 0.0 0.0 0.1 0.9 4.7 3.4 1.8 2.4 4.8 0.8 0.1 17.9 0.1 1.0 0.1 0.1 0.0 5.3 0.1 0.2 0.6 1.4 0.1 2.7 0.2 0.1 1.4 0.4 99.7 0.2 0.2 2.1 0.1 0.2 0.3 0.6 0.0 0.0 0.8 24.6 1.1 3.3 0.7 0.0 0.4 0.0 2.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.2 0.0 0.5 0.0 1.8 0.0 0.4 0.0 1.9 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.0 0.0 0.0 0.0 3.6 0.0 7.8 0.0 0.0 0.0 0.0 7.2 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.5 0.8 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.1 0.0 7.2 0.0 0.0 1.2 8.7 0.0 0.8 28.2 0.0 0.0 0.8 0.0 0.0 0.0 1.0 7.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 25.8 4.4 0.0 0.7 0.0 0.5 0.0 0.0 0.0 SMYD1 "BOP, KMT3D, ZMYND22" ENSG00000115593 "SET and MYND domain containing 1" Q8NB12 2 88067780-88113387 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4" "Cell type enriched" "Detected in single" 1107 "Cardiomyocytes: 207.9" "Cancer enhanced" "Detected in some" "stomach cancer: 1.6" "Region enriched" "Detected in single" 4 "cerebral cortex: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HSkMC: 5.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA062282 Enhanced NA NA "HPA062282: AB_2684736" "unprognostic (1.93e-2)" "unprognostic (2.49e-1)" "unprognostic (4.09e-2)" "unprognostic (8.51e-3)" "unprognostic (2.74e-1)" "unprognostic (3.91e-1)" "unprognostic (8.81e-3)" "unprognostic (1.40e-1)" 2.7 0.0 0.1 0.1 0.3 0.0 1.2 0.0 1.4 0.0 4.6 0.0 0.0 0.4 0.0 3.4 2.5 0.0 0.2 45.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.9 0.4 0.0 1.5 0.0 103.7 0.0 4.4 6.3 0.1 0.0 2.6 0.1 0.0 0.0 0.2 36.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 207.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMYD2 "HSKM-B, KMT3C, ZMYND14" ENSG00000143499 "SET and MYND domain containing 2" Q9NRG4 1 214281102-214337131 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 75.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029023 Uncertain Approved "Intermediate filaments,Mitochondria,Cytosol" NA NA Cytosol "Intermediate filaments, Mitochondria" "HPA029023: AB_10601605" "unprognostic (8.53e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (5.98e-2)" "unprognostic (1.00e-2)" "unprognostic (8.55e-2)" "unprognostic (2.53e-2)" "unprognostic (2.24e-2)" "unprognostic (1.72e-2)" "unprognostic (1.90e-3)" "unprognostic (1.65e-1)" "unprognostic (9.44e-2)" "unprognostic (2.77e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (8.10e-2)" "unprognostic (6.37e-2)" 5.9 5.7 8.8 5.6 7.3 2.7 10.0 5.0 23.9 4.9 4.7 2.1 3.1 4.8 3.8 6.7 7.3 10.4 4.5 75.7 7.0 8.4 7.7 9.7 8.1 8.0 5.3 10.0 4.7 7.8 2.9 7.5 10.6 6.9 4.6 5.8 3.1 6.2 3.0 29.5 4.3 4.7 3.8 4.7 6.2 6.2 8.9 2.2 8.0 7.8 5.1 5.6 5.2 4.0 9.3 5.5 8.1 5.9 17.6 14.5 7.3 24.5 7.1 9.7 6.8 10.0 17.5 41.3 13.9 11.5 17.6 20.0 28.0 21.0 12.7 14.3 15.7 9.6 11.6 9.2 25.8 17.1 10.6 10.7 4.1 12.0 22.3 9.0 17.8 2.9 18.7 14.6 12.2 9.7 12.2 12.7 12.2 12.9 3.2 15.7 12.8 12.4 11.2 8.7 14.4 9.7 7.7 23.5 10.8 17.4 18.0 9.6 22.4 10.8 38.9 28.6 23.3 30.3 11.9 14.6 13.7 20.2 7.5 21.5 13.1 4.9 14.6 17.8 14.2 15.6 6.7 5.9 8.1 9.5 3.2 11.2 9.3 14.5 12.7 5.5 4.8 12.7 11.6 0.6 17.6 1.2 3.8 14.5 7.3 8.8 7.3 5.0 23.9 7.0 8.4 5.3 10.0 6.9 2.2 17.9 11.9 11.2 14.0 18.3 3.8 109.6 22.9 48.2 12.5 3.5 0.0 142.7 26.6 32.4 113.6 10.8 12.7 0.0 17.4 93.2 12.2 8.9 3.5 15.5 33.9 14.3 4.1 22.1 17.4 93.5 10.9 9.9 15.1 10.8 15.2 15.2 22.5 10.5 3.5 27.8 4.6 12.9 15.7 15.2 43.7 15.7 71.9 12.8 20.8 7.6 SNAI3 "SMUC, Zfp293, ZNF293" ENSG00000185669 "Snail family transcriptional repressor 3" Q3KNW1 16 88677682-88686493 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 25.5;skeletal muscle: 33.9" "Cell type enhanced" "Detected in some" 9 "B-cells: 8.0;granulocytes: 9.2;Hofbauer cells: 7.0;Kupffer cells: 14.2;Macrophages: 10.3;T-cells: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NB-4: 14.7;RPMI-8226: 23.2" "Region enhanced" "Detected in single" "basal ganglia: 1.3" "Not detected" "Not detected" HPA071127 Approved Nucleoplasm NA NA Nucleoplasm "HPA071127: AB_2686346" "unprognostic (1.03e-2)" "prognostic favorable (1.39e-4)" "unprognostic (2.20e-2)" "unprognostic (6.19e-4)" "unprognostic (3.05e-1)" "unprognostic (2.85e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (3.24e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.58e-4)" "unprognostic (9.09e-2)" "unprognostic (1.62e-1)" "unprognostic (8.46e-2)" "unprognostic (6.57e-2)" "unprognostic (1.11e-1)" "unprognostic (7.47e-2)" 0.9 0.8 2.4 6.3 2.3 2.3 0.8 1.9 2.9 1.3 3.4 2.1 0.2 2.2 0.8 1.3 1.3 1.4 2.6 2.4 2.5 1.7 1.3 1.0 5.3 4.5 3.1 0.8 1.5 6.1 2.1 1.0 0.9 2.2 1.6 0.8 1.4 3.6 0.7 33.9 1.1 4.6 1.1 2.4 9.2 3.5 2.1 2.2 2.1 3.0 9.5 13.0 2.7 2.4 4.6 9.2 25.5 7.7 0.5 11.6 5.4 0.2 0.8 0.2 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.1 2.9 0.2 1.9 0.5 0.0 0.7 0.6 0.2 0.2 0.0 0.3 1.1 0.9 0.1 0.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.2 1.7 3.6 0.0 2.6 0.1 14.7 0.3 0.3 0.3 3.2 0.2 23.2 0.0 0.4 1.4 0.2 0.6 0.0 0.2 0.4 1.0 1.8 0.3 0.1 0.9 0.2 0.0 0.6 3.3 3.3 0.2 4.0 0.4 2.8 7.7 25.5 6.1 2.9 10.9 4.6 9.9 5.7 9.2 3.8 6.1 3.8 17.1 0.5 0.7 6.5 11.6 5.4 2.4 2.3 1.9 2.4 2.5 1.7 3.1 0.8 2.2 2.2 3.0 0.0 8.0 0.1 0.5 0.2 2.0 0.0 0.0 1.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.1 9.2 0.0 7.0 0.0 0.0 0.6 14.2 0.0 0.0 10.3 5.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.4 0.0 0.8 0.0 1.1 0.3 0.1 10.9 0.0 0.0 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 356.9" "Cell type enhanced" "Detected in many" 23 "Bipolar cells: 497.2;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 186.3" "Group enriched" "Detected in many" 6 "glioma: 28.9;pancreatic cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "Karpas-707: 11.0;SCLC-21H: 36.6;SH-SY5Y: 21.8;U-87 MG: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 2.2 16.4 81.0 3.3 60.0 2.1 3.4 202.9 356.9 2.2 2.8 3.4 3.7 3.2 4.6 6.4 2.2 4.0 2.8 2.4 86.5 37.1 2.5 2.3 2.6 2.2 46.7 65.2 3.7 4.1 2.1 5.5 2.3 97.7 3.1 2.8 4.0 2.2 11.9 2.1 2.2 3.3 4.7 13.9 2.1 4.3 3.2 7.4 0.0 2.3 0.0 2.2 2.6 0.1 0.0 1.6 0.7 0.0 0.0 0.6 0.3 0.0 2.1 1.8 0.0 0.2 0.0 0.0 0.9 0.0 2.2 0.6 0.0 0.0 0.0 2.0 0.0 1.6 0.4 0.2 0.0 4.5 0.2 0.1 0.0 3.0 0.3 1.6 0.0 0.2 2.1 0.0 1.8 0.0 5.0 0.0 1.3 0.0 11.0 0.7 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 36.6 21.8 0.3 0.0 0.0 1.1 0.0 2.9 0.0 2.3 3.1 0.0 1.0 0.0 5.6 0.0 26.3 0.0 2.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.3 81.0 60.0 202.9 163.5 86.5 37.1 46.7 65.2 97.7 7.4 0.0 0.0 0.0 1.7 0.7 497.2 0.4 7.6 0.0 0.0 0.0 100.1 0.0 0.0 0.1 16.5 0.6 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.1 62.0 41.6 0.0 0.0 56.7 15.8 0.2 1.7 0.0 0.0 42.9 1.6 0.2 64.7 1.4 186.3 0.0 1.0 0.9 0.3 0.6 0.0 0.0 0.0 0.0 SNAP91 "AP180, CALM, KIAA0656" ENSG00000065609 "Synaptosome associated protein 91" O60641 6 83552880-83709691 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 81.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 46.7;Cone photoreceptor cells: 58.9;Early spermatids: 16.0;Horizontal cells: 30.2;Rod photoreceptor cells: 59.2;Spermatocytes: 25.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.3" "Group enriched" "Detected in some" 11 "GAMG: 6.7;SCLC-21H: 21.5;SH-SY5Y: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009745, HPA029632, HPA029633" Enhanced Uncertain Centrosome,Cytosol NA NA "Centrosome, Cytosol" "CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615" "unprognostic (1.07e-2)" "unprognostic (1.74e-1)" "unprognostic (7.55e-3)" "unprognostic (3.68e-2)" "unprognostic (1.03e-1)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.17e-1)" "unprognostic (4.54e-4)" "unprognostic (6.99e-2)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (2.15e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" 1.2 8.0 17.8 1.9 25.5 1.1 1.7 44.2 81.9 2.1 1.7 3.4 0.0 1.4 1.7 1.2 1.3 1.8 2.0 1.3 19.2 19.9 1.2 1.1 1.4 3.3 14.3 20.5 3.1 2.4 1.1 9.3 1.6 34.7 3.9 1.7 4.5 1.6 1.7 1.2 1.3 1.7 1.8 7.0 2.2 1.9 10.8 2.9 0.0 2.0 0.0 2.7 1.3 0.2 0.0 6.3 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.9 0.0 0.0 0.3 1.3 0.5 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.1 0.2 21.5 13.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.1 17.8 25.5 44.2 43.6 19.2 19.9 14.3 20.5 34.7 2.9 0.0 0.0 0.0 0.0 0.0 46.7 0.8 0.0 0.0 0.0 0.0 58.9 1.0 0.0 0.0 16.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 30.2 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 8.9 0.5 0.0 1.1 0.0 59.2 0.0 0.0 25.0 2.4 0.0 3.7 0.0 0.0 0.0 SNCA "NACP, PARK1, PARK4, PD1" ENSG00000145335 "Synuclein alpha" P37840 4 89724099-89838315 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Alzheimer disease, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 31.2;bone marrow: 91.0;brain: 121.3" "Group enriched" "Detected in many" 7 "Erythroid cells: 630.8;Melanocytes: 334.0" "Cancer enriched" "Detected in many" 8 "melanoma: 37.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 25.4;plasmacytoid DC: 31.2" "Group enriched" "Detected in many" 4 "dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5" "Cell line enhanced" "Detected in many" "HEL: 43.9;HUVEC TERT2: 53.5;RT4: 28.3;SK-MEL-30: 52.4;TIME: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005459, CAB010877" Enhanced "Intracellular and membrane" NA NA 23000000 "CAB010877: AB_261518, HPA005459: AB_2667324" "unprognostic (4.80e-2)" "unprognostic (1.52e-1)" "unprognostic (8.13e-2)" "unprognostic (1.05e-3)" "unprognostic (2.65e-2)" "unprognostic (1.54e-2)" "unprognostic (1.78e-2)" "unprognostic (3.44e-2)" "unprognostic (1.73e-2)" "unprognostic (3.85e-3)" "unprognostic (1.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.57e-1)" "unprognostic (2.51e-3)" "unprognostic (1.68e-1)" "unprognostic (3.93e-4)" "unprognostic (7.48e-3)" 3.9 5.4 38.9 4.7 26.1 91.0 4.3 41.7 121.3 6.2 4.7 9.0 0.0 2.3 15.5 2.5 4.5 3.2 3.2 9.0 35.2 22.5 4.2 1.9 4.5 1.8 36.2 49.6 13.6 1.6 1.2 5.4 12.1 26.3 4.6 3.9 5.3 4.9 5.3 1.1 7.6 2.9 15.1 21.4 4.0 1.7 2.2 15.1 0.0 5.2 1.2 2.9 4.1 4.4 0.9 31.2 10.1 20.5 4.8 0.6 19.5 0.1 0.1 8.3 0.0 0.1 0.0 0.1 0.0 8.7 0.3 0.6 0.0 0.0 0.0 2.4 0.0 0.0 1.8 10.8 20.0 0.3 0.0 4.8 43.9 24.8 0.0 18.0 0.0 0.3 0.4 7.7 0.0 22.6 24.8 53.5 0.4 0.3 0.1 0.0 0.0 0.3 0.0 2.1 0.0 0.9 0.0 3.2 0.0 0.0 28.3 4.7 3.1 0.0 0.0 52.4 6.3 0.0 0.0 61.2 0.2 1.6 0.0 0.1 0.0 0.0 0.0 1.7 0.0 17.6 10.1 20.5 0.0 0.0 8.1 0.0 0.9 0.6 0.1 25.4 0.5 0.3 0.2 3.7 4.8 2.3 31.2 0.0 19.5 38.9 26.1 41.7 55.1 35.2 22.5 36.2 49.6 26.3 15.1 0.0 1.1 2.7 16.7 68.1 4.0 6.2 0.0 5.3 9.1 10.4 0.0 9.1 1.7 0.0 0.3 16.5 0.0 630.8 0.2 2.7 7.8 6.3 0.0 0.0 54.2 9.5 1.7 1.8 8.8 1.3 2.0 48.8 334.0 15.4 0.0 15.1 0.3 0.0 0.0 1.2 6.1 12.9 3.3 4.2 3.0 19.7 2.9 0.0 0.0 2.7 SNCAIP SYPH1 ENSG00000064692 "Synuclein alpha interacting protein" Q9Y6H5 5 122311354-122464219 "Disease related genes, Predicted intracellular proteins" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 22.6;ovary: 32.3" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 26.8;Early spermatids: 55.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 9.9" "Lineage enriched" "Detected in single" 21 "granulocytes: 9.9" "Cell line enhanced" "Detected in some" "AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.7;OE19: 5.8;RPMI-8226: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064687 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Cytoplasmic bodies" Nucleoplasm "HPA064687: AB_2685324" "unprognostic (7.28e-3)" "unprognostic (1.02e-2)" "unprognostic (3.01e-1)" "unprognostic (6.56e-2)" "unprognostic (2.18e-2)" "unprognostic (1.56e-1)" "unprognostic (1.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.95e-2)" "unprognostic (3.73e-1)" "unprognostic (3.52e-2)" "unprognostic (3.00e-1)" "unprognostic (5.98e-2)" "unprognostic (1.82e-3)" "unprognostic (5.77e-2)" "unprognostic (2.82e-1)" "unprognostic (2.44e-1)" 3.9 1.2 2.2 2.1 5.8 0.7 4.1 15.4 6.4 16.0 1.6 3.7 4.0 1.6 22.6 4.3 0.9 4.5 2.4 1.5 3.4 2.2 1.6 0.4 1.4 4.5 1.6 2.4 32.3 0.7 0.3 1.6 2.1 3.2 2.6 1.1 2.3 0.8 2.7 0.7 1.9 1.1 10.6 1.5 6.1 1.2 11.6 2.1 0.5 1.2 3.3 1.4 4.6 4.1 0.4 0.4 9.9 0.3 0.1 0.4 0.0 0.0 0.1 7.7 0.2 0.0 0.5 0.5 3.4 7.4 1.3 0.4 0.5 0.6 0.1 0.2 3.3 0.7 0.2 3.0 0.5 4.7 2.8 1.0 0.0 0.6 0.4 0.1 0.0 0.4 0.6 0.1 0.6 0.4 0.0 2.2 0.3 0.0 2.0 0.0 0.0 0.2 0.1 3.6 5.8 0.6 0.2 0.0 7.9 0.3 1.0 1.5 0.3 0.0 0.7 0.0 2.4 0.6 0.2 0.8 0.4 1.0 0.5 0.8 0.2 0.2 0.3 0.4 0.0 0.5 9.9 0.3 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.4 0.2 0.4 1.7 0.1 0.1 0.4 0.1 0.0 2.2 5.8 15.4 4.3 3.4 2.2 1.6 2.4 3.2 2.1 0.0 0.3 0.0 3.7 1.5 0.0 0.8 0.0 26.8 2.3 0.0 0.0 0.0 0.0 6.2 55.3 6.8 0.0 0.0 0.0 0.1 2.5 1.8 1.1 0.0 0.2 0.0 0.0 9.2 0.3 11.7 4.9 0.2 1.7 0.0 0.0 0.3 0.6 0.0 5.3 0.0 0.0 0.0 1.7 1.4 1.6 2.4 0.1 0.0 0.0 1.2 SNCB ENSG00000074317 "Synuclein beta" Q16143 5 176620084-176630556 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 24 "brain: 134.8" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 71.1;Cone photoreceptor cells: 15.7;Horizontal cells: 47.7;Rod photoreceptor cells: 33.9" "Cancer enriched" "Detected in some" 8 "glioma: 11.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "naive B-cell: 3.1" "Lineage enriched" "Detected in single" 12 "B-cells: 3.1" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 36.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002681, HPA035876" Enhanced Supported NA NA "CAB002681: , HPA035876: AB_10670592" "unprognostic (3.55e-2)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-2)" "unprognostic (3.41e-3)" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (3.41e-1)" "unprognostic (2.39e-1)" "unprognostic (2.29e-3)" "unprognostic (3.31e-1)" "unprognostic (5.41e-5)" "unprognostic (1.31e-3)" "unprognostic (8.57e-2)" "unprognostic (2.81e-1)" "unprognostic (8.42e-3)" 1.6 3.9 53.7 1.6 24.9 1.5 1.6 64.1 134.8 1.5 1.7 2.2 0.0 1.6 1.6 1.5 1.5 1.6 1.6 1.8 39.4 31.0 1.6 1.5 1.5 1.7 27.5 30.0 1.5 2.1 1.5 1.9 1.6 31.5 1.6 1.6 5.6 1.5 1.5 2.7 1.6 1.6 1.6 7.4 1.6 1.6 1.7 1.5 0.0 1.5 0.0 1.6 1.6 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.5 0.0 3.8 0.1 1.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 1.1 0.6 0.0 0.0 2.8 0.0 1.6 0.0 0.0 0.2 0.0 0.0 36.9 1.3 0.0 0.1 3.5 0.1 1.6 0.1 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 53.7 24.9 64.1 87.6 39.4 31.0 27.5 30.0 31.5 1.5 0.0 0.0 0.0 0.0 0.0 71.1 1.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 0.0 0.0 33.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 SNCG "BCSG1, persyn, SR" ENSG00000173267 "Synuclein gamma" O76070 10 86958618-86963260 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6" "Cell type enhanced" "Detected in many" 12 "Smooth muscle cells: 114.4;Urothelial cells: 347.2" "Group enriched" "Detected in all" 8 "ovarian cancer: 84.1;urothelial cancer: 301.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;naive CD4 T-cell: 1.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 95.9;RT4: 79.0" "Region enhanced" "Detected in many" "pons and medulla: 292.8" "Low region specificity" "Detected in many" "CAB001452, HPA014404, CAB040581" Enhanced Supported Supported Centrosome NA NA Centrosome "CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715" "unprognostic (2.06e-1)" "unprognostic (2.58e-1)" "unprognostic (6.87e-3)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (4.76e-3)" "unprognostic (8.99e-2)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-3)" "unprognostic (3.75e-1)" "prognostic unfavorable (2.29e-8)" "prognostic unfavorable (7.15e-4)" "unprognostic (2.35e-1)" "unprognostic (2.36e-2)" "unprognostic (3.77e-3)" 74.1 78.3 82.3 5.3 20.8 1.0 28.9 12.3 44.5 9.5 5.8 4.6 6.4 4.8 6.1 12.0 11.0 26.5 6.2 9.0 40.0 92.9 4.1 1.9 4.6 4.9 72.9 35.1 15.0 3.5 1.6 1.7 4.9 100.1 11.9 2.7 10.8 10.9 44.4 6.6 8.5 5.4 5.8 35.2 20.2 2.6 2.9 5.3 0.2 3.4 3.3 9.6 76.6 18.3 0.0 0.7 0.0 2.4 0.0 1.8 0.6 0.2 1.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 95.9 0.0 2.0 0.1 0.0 8.0 0.0 0.3 0.0 0.0 0.0 0.6 18.6 0.3 0.1 0.0 0.1 0.4 7.5 0.0 0.0 0.0 6.8 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 79.0 0.0 0.0 0.7 1.0 0.1 0.0 20.8 0.0 17.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.6 82.3 20.8 12.3 44.5 40.0 92.9 72.9 35.1 100.1 5.3 0.0 0.0 0.0 64.9 25.5 30.2 1.4 0.0 1.4 5.7 52.4 5.9 12.2 106.1 3.7 0.4 107.8 0.0 0.0 1.0 0.4 12.1 11.4 0.0 0.2 4.3 82.6 0.0 108.1 1.6 0.6 54.7 2.9 21.9 1.0 0.0 45.4 2.9 0.0 9.2 0.9 69.6 90.5 114.4 0.5 0.5 17.2 5.1 0.0 0.0 347.2 SNN ENSG00000184602 Stannin O75324 16 11668414-11679159 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 71.3;Muller glia cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 31.5;REH: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011055 Approved Uncertain Cytosol NA NA Cytosol "HPA011055: AB_1857326" "unprognostic (1.94e-1)" "unprognostic (7.26e-2)" "unprognostic (2.40e-1)" "unprognostic (1.84e-1)" "unprognostic (2.44e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (1.85e-6)" "unprognostic (4.51e-2)" "unprognostic (3.45e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.83e-5)" "unprognostic (4.91e-2)" "unprognostic (2.09e-1)" "unprognostic (3.58e-1)" "unprognostic (4.72e-2)" 29.2 16.6 34.7 10.0 51.5 11.0 13.7 27.2 52.2 6.9 4.4 11.2 1.8 4.9 6.8 11.5 10.5 5.9 12.0 13.2 33.0 15.5 7.0 5.1 9.2 15.0 29.8 25.2 9.8 4.7 4.5 4.6 4.5 15.6 8.1 3.3 6.9 9.9 12.9 29.1 4.5 4.4 6.6 15.2 17.4 4.6 2.2 11.4 6.1 9.5 4.8 14.2 9.3 6.1 7.0 9.0 24.1 20.3 0.3 3.0 7.4 3.0 2.9 31.5 8.5 20.9 6.0 3.0 1.3 2.8 3.8 3.8 4.7 2.1 3.1 12.9 4.3 6.7 6.0 9.4 3.7 2.9 0.8 2.1 10.4 3.2 6.2 5.6 0.7 6.3 5.2 17.2 2.0 4.2 5.4 7.0 9.3 1.6 5.0 3.5 5.1 8.3 2.3 16.3 3.8 2.1 29.4 4.2 21.7 3.5 9.0 18.8 7.6 7.1 9.4 4.6 12.9 3.8 6.2 6.2 4.4 9.2 25.7 1.3 2.0 1.3 7.4 2.6 8.9 5.5 0.0 9.5 6.9 0.3 16.3 0.3 7.0 1.6 0.7 9.0 6.8 3.0 2.1 24.1 0.3 20.3 3.6 0.9 7.4 34.7 51.5 27.2 39.3 33.0 15.5 29.8 25.2 15.6 11.4 0.0 6.7 34.4 17.9 16.4 6.5 14.3 10.2 4.0 3.4 5.2 0.0 1.0 21.6 15.0 0.6 14.3 0.0 0.0 16.3 19.9 8.2 15.5 13.8 2.4 17.7 6.4 5.1 20.3 27.0 0.0 4.6 26.4 20.3 71.3 0.2 90.5 13.6 0.0 14.5 4.4 5.9 6.5 26.7 0.3 2.1 16.7 1.1 5.7 0.4 9.1 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.9;breast: 19.6" "Group enriched" "Detected in some" 4 "Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "basophil: 6.3" "Lineage enriched" "Detected in single" 18 "granulocytes: 6.3" "Cell line enriched" "Detected in some" 14 "Hep G2: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.4 1.5 4.8 0.8 6.4 1.5 19.6 2.8 9.0 0.3 2.4 9.3 0.0 2.7 0.7 2.0 0.3 0.4 0.3 0.4 8.8 7.8 1.2 2.1 1.3 1.7 11.9 7.0 0.5 4.2 0.7 0.3 0.9 9.1 3.0 1.1 0.0 3.2 0.6 2.8 10.8 2.0 0.6 27.9 1.4 1.3 6.2 7.4 0.0 0.9 0.0 0.5 0.5 0.0 0.0 0.0 6.3 0.0 0.0 0.3 0.0 0.6 0.0 0.2 0.9 0.6 1.0 1.5 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.4 0.1 0.3 0.3 0.0 0.0 0.0 0.4 1.3 0.3 0.2 36.4 0.5 0.0 1.1 0.0 0.9 0.2 0.5 0.4 1.0 0.4 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 1.4 0.2 0.3 0.2 0.0 0.5 0.1 0.5 0.2 0.0 1.3 0.6 0.0 1.6 0.5 0.1 0.5 0.5 0.4 2.4 2.5 0.1 0.0 0.8 0.2 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 6.4 2.8 9.0 8.8 7.8 11.9 7.0 9.1 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 SNPH bA314N13.5 ENSG00000101298 Syntaphilin O15079 20 1266316-1309328 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.2" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.5;Horizontal cells: 28.6;Rod photoreceptor cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 9 "T-cells: 3.5" "Cell line enhanced" "Detected in many" "GAMG: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049393 Approved Uncertain "Cytokinetic bridge,Mitochondria" Yes No Mitochondria "Cytokinetic bridge" "HPA049393: AB_2680744" "unprognostic (1.43e-2)" "unprognostic (2.55e-2)" "unprognostic (2.28e-1)" "unprognostic (8.84e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.56e-2)" "unprognostic (5.33e-2)" "unprognostic (3.08e-2)" "unprognostic (3.15e-2)" "prognostic favorable (6.97e-5)" "unprognostic (1.03e-1)" "unprognostic (6.94e-3)" "unprognostic (2.45e-2)" "unprognostic (1.55e-1)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" 2.9 5.0 26.7 3.0 22.5 1.6 1.8 14.4 36.2 3.5 3.5 3.1 5.9 3.1 4.5 3.9 3.6 4.7 4.8 4.7 26.8 15.3 2.1 0.9 2.6 3.1 12.8 17.5 2.4 6.1 6.2 5.8 1.7 17.1 5.5 2.2 3.1 9.9 19.2 6.1 1.9 3.1 8.1 3.8 2.1 5.1 2.7 4.4 0.1 4.5 0.1 2.0 3.6 1.6 0.1 0.4 0.0 0.0 0.0 3.5 1.2 2.2 6.6 0.1 6.7 8.0 4.4 0.0 4.0 5.3 4.5 2.1 0.2 0.7 0.4 2.4 4.9 11.2 1.2 1.0 5.7 0.8 1.4 1.8 4.2 1.1 0.1 4.2 0.0 6.9 2.8 2.8 4.5 0.9 4.5 5.7 4.5 0.8 0.2 4.1 0.0 0.4 0.2 2.4 0.0 5.6 0.0 1.4 0.1 6.0 3.2 0.4 2.0 3.9 0.2 5.8 0.7 0.3 0.1 9.7 7.3 5.4 6.4 1.1 0.6 1.2 0.0 3.9 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.6 0.1 0.8 0.9 0.1 0.1 3.5 3.2 0.0 0.0 0.0 0.4 0.4 1.2 26.7 22.5 14.4 36.2 26.8 15.3 12.8 17.5 17.1 4.4 0.0 0.0 0.0 0.1 0.1 19.5 4.3 5.1 0.0 0.0 3.5 5.9 0.0 0.0 0.4 8.3 0.6 0.0 0.0 0.5 0.0 0.8 0.9 0.0 0.0 0.2 28.6 8.1 1.8 0.0 3.2 1.4 0.0 0.0 0.0 0.9 2.9 1.7 0.0 3.9 1.3 19.9 6.5 1.0 0.6 0.1 0.1 0.0 0.0 1.3 0.0 SNRNP25 "C16orf33, U11/U12-25K" ENSG00000161981 "Small nuclear ribonucleoprotein U11/U12 subunit 25" Q9BV90 16 53010-57669 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 56.9;skeletal muscle: 63.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 56.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041183, HPA044248" Uncertain Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes No Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041183: AB_2677353, HPA044248: AB_2678873" "unprognostic (7.87e-2)" "prognostic favorable (1.95e-4)" "unprognostic (6.04e-2)" "unprognostic (5.03e-2)" "unprognostic (2.04e-1)" "unprognostic (5.99e-2)" "unprognostic (1.17e-1)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (8.99e-2)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.51e-1)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" "unprognostic (6.03e-3)" 7.1 10.1 31.4 11.5 25.4 15.6 7.4 15.7 31.2 7.1 9.7 6.8 5.4 7.2 6.6 9.6 8.8 8.8 6.3 28.7 25.0 22.6 11.7 16.4 5.4 16.4 28.1 20.3 10.9 10.8 7.7 10.8 4.9 24.7 9.8 10.1 7.5 12.6 8.4 63.7 4.3 6.4 8.6 13.5 6.6 10.2 6.4 7.7 9.4 9.4 11.0 16.4 6.8 4.8 18.0 56.9 23.2 9.9 5.2 6.5 5.7 11.6 26.5 14.7 17.1 5.3 6.3 7.2 9.9 6.4 22.2 18.8 35.6 11.4 37.0 11.8 8.1 11.9 12.0 26.9 18.2 17.1 13.3 20.9 21.4 37.0 35.6 5.6 39.1 25.5 8.0 6.5 19.7 5.5 4.8 11.9 22.4 32.0 8.8 12.6 55.2 20.5 16.3 17.6 20.8 13.0 33.1 15.7 44.2 11.7 8.2 16.2 10.5 22.3 29.0 4.8 15.1 18.7 19.1 9.3 9.8 12.3 12.6 15.8 9.2 21.7 57.4 5.2 21.0 15.0 2.8 6.6 23.2 4.0 9.9 5.0 17.5 4.2 4.9 12.8 18.0 4.5 4.5 4.5 5.2 8.5 56.9 6.5 5.7 31.4 25.4 15.7 31.2 25.0 22.6 28.1 20.3 24.7 7.7 11.9 11.0 47.7 21.4 16.6 18.1 96.8 15.3 44.2 9.1 31.4 3.9 47.2 132.6 34.7 1.7 16.8 21.9 23.3 44.3 49.4 26.3 35.5 4.6 52.5 99.3 11.1 42.3 11.6 18.6 4.5 19.8 52.0 59.1 138.9 29.1 45.5 30.9 42.9 28.0 74.2 12.0 6.5 32.0 32.0 47.5 19.2 21.9 20.1 45.1 16.3 SNTA1 "LQT12, SNT1, TACIP1" ENSG00000101400 "Syntrophin alpha 1" Q13424 20 33407955-33443892 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 67.6;skeletal muscle: 130.8" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 153.6;Muller glia cells: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.7;plasmacytoid DC: 11.1" "Group enriched" "Detected in many" 4 "B-cells: 6.7;dendritic cells: 11.1" "Cell line enhanced" "Detected in many" "ASC diff: 32.8" "Low region specificity" "Detected in all" "CAB037059, HPA067154" Approved NA NA "CAB037059: AB_261497, HPA067154: " "unprognostic (2.25e-2)" "unprognostic (1.29e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (5.68e-2)" "unprognostic (6.48e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.16e-1)" "prognostic favorable (3.72e-4)" "unprognostic (1.99e-1)" "unprognostic (8.09e-2)" "unprognostic (5.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.29e-2)" "unprognostic (7.60e-2)" 13.7 6.5 28.8 3.3 36.2 2.1 4.8 5.9 28.4 6.4 4.3 14.4 2.9 4.4 4.5 5.3 12.2 5.6 4.8 67.6 20.0 15.9 8.5 5.1 3.7 3.8 23.6 19.1 8.5 7.5 7.6 2.5 2.7 11.9 7.3 2.7 10.0 16.0 10.7 130.8 3.8 4.2 9.4 8.8 2.6 4.8 6.7 11.8 0.3 33.0 22.0 3.7 8.6 5.4 6.7 11.1 0.0 0.0 0.0 2.2 0.4 6.0 3.1 1.4 13.5 32.8 6.5 1.3 4.6 6.5 8.8 7.4 7.8 2.0 4.3 5.6 7.9 16.2 8.0 4.0 2.5 1.5 0.8 5.1 0.2 7.5 11.0 9.3 0.4 0.7 5.9 3.2 3.8 1.5 4.9 1.3 4.2 10.3 1.6 4.4 0.7 8.0 1.0 0.8 0.8 17.8 5.1 10.0 4.7 1.8 5.4 5.9 5.1 18.2 5.5 9.1 1.1 8.5 0.7 2.2 4.4 8.7 17.4 4.2 10.3 5.3 2.6 9.5 0.8 0.6 0.0 0.0 0.0 1.0 0.0 2.2 6.7 1.0 1.0 0.0 2.7 0.3 0.8 0.0 0.0 0.0 11.1 1.2 0.4 28.8 36.2 5.9 28.4 20.0 15.9 23.6 19.1 11.9 11.8 3.0 1.3 3.2 3.7 2.9 4.9 153.6 7.6 0.0 1.2 1.8 3.9 1.0 33.2 1.6 0.7 2.3 1.7 0.0 2.2 1.3 6.8 7.5 0.0 7.9 1.5 0.0 4.1 3.7 1.5 1.1 23.3 1.4 5.0 0.0 1.0 54.5 2.8 0.9 26.5 25.4 33.6 25.8 21.4 1.8 3.8 2.5 0.7 5.0 1.7 5.0 SNTB1 "59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43" ENSG00000172164 "Syntrophin beta 1" Q13884 8 120535745-120813273 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 43.7;liver: 53.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 62.1;Kupffer cells: 27.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 32.4;OE19: 28.9;U-266/70: 34.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA024659 Uncertain "Intracellular and membrane" NA NA 200000 "HPA024659: AB_1857713" "unprognostic (1.32e-1)" "unprognostic (2.77e-2)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (6.41e-3)" "unprognostic (2.07e-1)" "unprognostic (3.88e-1)" "unprognostic (1.31e-1)" "unprognostic (4.72e-1)" "unprognostic (2.00e-2)" "unprognostic (5.08e-2)" "unprognostic (5.88e-2)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" 6.9 43.7 4.7 4.9 5.1 8.1 12.4 2.1 3.0 4.9 4.1 5.0 1.1 2.8 2.8 2.1 7.7 2.9 5.4 2.2 5.9 3.8 6.2 53.4 14.5 5.0 4.5 2.9 2.4 22.4 0.2 2.3 3.8 6.8 3.3 3.1 6.9 27.4 1.7 12.7 5.9 3.2 4.3 3.3 10.8 11.3 4.2 4.9 3.6 33.8 7.8 4.6 4.8 4.9 1.5 1.6 6.8 1.6 3.1 5.4 1.5 0.0 0.8 0.2 0.0 4.2 8.7 0.0 2.4 13.7 0.7 1.2 5.5 0.6 0.0 4.9 2.7 0.0 0.0 0.8 0.0 0.5 2.7 2.8 0.0 0.3 32.4 0.4 6.1 0.0 4.4 0.0 4.5 0.0 5.4 0.1 4.1 0.0 12.5 2.1 1.4 0.0 4.8 0.9 28.9 3.8 0.0 17.0 0.0 12.7 0.9 0.0 0.2 1.0 4.5 11.0 0.2 0.5 10.9 0.0 9.5 0.7 0.0 0.7 34.0 13.3 14.0 7.5 18.5 10.9 4.3 1.6 6.8 5.4 0.8 1.3 1.5 1.1 2.8 1.6 0.7 3.0 3.0 0.5 3.1 0.6 0.1 0.0 1.5 4.7 5.1 2.1 3.0 5.9 3.8 4.5 2.9 6.8 4.9 11.9 22.7 0.0 0.5 0.3 1.2 1.4 5.1 20.1 13.6 5.2 2.0 0.7 8.3 1.7 6.8 2.1 0.0 0.0 9.6 1.8 4.1 1.4 1.1 62.1 10.7 0.0 0.0 16.0 27.2 2.8 4.4 7.2 1.7 0.0 2.7 16.0 6.1 0.0 12.4 1.1 0.3 12.9 16.8 0.4 0.1 0.9 0.2 8.7 3.3 0.1 SNTG1 "G1SYN, SYN4" ENSG00000147481 "Syntrophin gamma 1" Q9NSN8 8 49909789-50796691 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 22.7;lymphoid tissue: 7.8;pituitary gland: 10.4" "Group enriched" "Detected in some" 15 "Bipolar cells: 32.4;Early spermatids: 17.8;Late spermatids: 45.0" "Cancer enhanced" "Detected in single" "glioma: 2.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "RH-30: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072282 Enhanced NA NA "HPA072282: AB_2686506" "unprognostic (4.60e-2)" "unprognostic (1.72e-2)" "unprognostic (2.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.94e-2)" "unprognostic (2.03e-1)" "unprognostic (1.16e-3)" 0.7 1.9 7.4 0.6 13.3 1.6 0.7 2.4 22.7 0.7 0.8 1.1 0.0 0.7 0.7 2.0 0.6 0.9 0.8 0.5 11.9 4.7 1.6 1.9 0.8 0.8 3.3 9.1 0.7 1.4 0.6 10.4 0.7 3.3 0.8 1.0 0.0 0.8 1.0 0.6 1.1 0.7 0.8 2.1 7.8 0.8 3.1 3.8 0.0 0.8 0.0 0.6 2.3 0.3 1.3 0.8 2.3 1.2 0.5 1.0 0.5 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.0 0.4 0.2 0.1 0.3 1.4 0.0 0.3 0.8 0.1 0.0 0.0 0.1 10.9 0.0 0.4 0.3 0.5 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.2 0.4 0.1 0.2 2.3 0.5 0.5 0.7 0.5 0.7 1.3 0.8 0.8 0.3 1.3 1.0 0.8 1.1 0.5 1.2 0.8 1.0 0.5 7.4 13.3 2.4 22.7 11.9 4.7 3.3 9.1 3.3 3.8 0.0 0.3 0.0 0.0 0.0 32.4 0.3 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 45.0 0.6 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.2 0.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 SNTN "FLJ44379, S100AL" ENSG00000188817 "Sentan, cilia apical structure protein" A6NMZ2 3 63652668-63679020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5" "Cell type enriched" "Detected in some" 13 "Ciliated cells: 823.1" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "OE19: 3.1;RH-30: 2.4;SH-SY5Y: 3.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA043322, HPA058399" Enhanced NA NA "HPA043322: AB_10793945, HPA058399: AB_2683705" "unprognostic (9.70e-3)" "unprognostic (3.67e-1)" "unprognostic (4.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.34e-3)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (8.43e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 1.1 26.6 0.0 73.9 0.0 0.0 0.6 0.3 0.0 0.0 29.5 0.0 0.0 0.0 18.5 0.1 0.0 1.4 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.1 5.8 0.0 0.1 0.0 0.0 0.9 0.4 1.6 0.2 0.4 0.5 0.1 0.3 0.2 0.6 0.8 0.1 1.4 0.5 0.0 0.0 0.0 0.3 0.2 0.8 0.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.5 0.0 0.0 0.2 0.4 0.2 3.1 0.0 0.3 2.4 0.2 0.1 0.3 0.3 3.4 0.1 0.3 0.0 0.6 0.1 0.3 0.0 0.6 0.6 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.6 1.6 0.2 0.2 0.3 0.2 0.3 0.1 0.2 0.3 0.0 0.9 0.5 0.4 1.1 0.4 0.2 0.4 0.2 0.1 0.1 0.2 0.0 0.0 0.6 0.3 0.0 0.0 0.6 0.0 3.0 3.4 0.0 0.0 0.0 0.0 0.2 0.0 823.1 64.8 0.0 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 SNURF ENSG00000273173 "SNRPN upstream reading frame" Q9Y675 15 24954986-24977850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 140.9" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 6.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 58.4;U-698: 30.9" HPA065733 Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA065733: AB_2685548" "unprognostic (2.08e-1)" "unprognostic (2.88e-2)" "unprognostic (6.82e-2)" "unprognostic (4.59e-3)" "unprognostic (4.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.39e-2)" "unprognostic (6.89e-3)" "unprognostic (1.56e-2)" "unprognostic (6.74e-2)" "unprognostic (8.91e-4)" "unprognostic (3.77e-1)" "unprognostic (1.77e-2)" "unprognostic (6.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" 11.9 20.8 47.6 10.9 50.2 16.7 9.7 59.3 140.9 8.1 19.1 16.7 13.7 5.5 13.2 72.6 9.9 8.1 20.4 32.1 47.7 47.8 23.6 20.1 15.5 14.8 45.6 40.9 15.4 19.4 23.9 40.9 6.4 44.4 21.8 6.3 16.0 12.3 13.9 69.6 7.6 10.8 7.9 28.4 23.9 17.8 7.3 18.9 9.5 40.4 6.5 11.3 9.7 6.7 13.4 11.8 6.1 1.4 10.1 22.0 9.5 0.0 3.6 19.5 13.3 0.9 1.2 0.0 11.2 1.0 1.2 0.8 2.0 10.6 0.1 6.1 0.7 1.9 4.2 0.0 2.5 1.0 3.9 0.0 20.1 14.6 0.5 3.4 21.1 7.5 3.0 0.6 2.3 0.0 8.0 1.4 7.4 2.1 0.0 2.1 0.0 15.2 0.1 58.4 0.0 0.5 15.4 24.1 0.2 0.9 24.3 11.3 8.7 0.0 1.0 5.6 27.5 11.4 2.0 20.7 8.5 8.9 0.2 2.4 17.0 20.8 30.9 12.8 9.4 7.0 6.1 0.8 3.0 8.3 0.4 16.2 11.1 17.3 14.9 1.5 13.4 22.0 20.0 0.9 10.1 1.4 11.8 17.1 9.5 47.6 50.2 59.3 65.9 47.7 47.8 45.6 40.9 44.4 18.9 3.0 3.0 3.4 0.6 0.5 1.5 3.2 0.0 6.7 1.2 0.0 0.0 0.0 3.3 2.1 0.3 0.1 0.4 0.0 2.0 0.0 0.2 0.9 1.1 0.8 0.3 3.2 0.0 1.3 1.5 0.0 0.6 0.0 0.0 1.0 2.7 0.3 2.9 2.9 0.4 0.6 1.3 0.0 2.3 0.3 0.9 0.3 0.0 0.7 1.0 0.1 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules NA NA "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: AB_2685349" "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.9 1.3 0.0 2.6 0.0 0.0 15.2 0.0 1.0 0.0 0.0 0.1 4.7 6.1 11.0 0.0 9.6 0.4 3.5 0.9 0.0 8.4 3.3 0.6 0.1 9.2 0.0 13.0 2.3 0.1 1.4 0.0 1.1 0.0 0.2 7.9 0.3 0.0 0.0 2.4 5.4 13.7 4.0 0.1 1.3 0.0 0.0 0.3 27.2 3.0 6.0 1.8 3.0 2.2 15.8 5.0 4.0 18.6 0.0 0.0 3.3 0.0 3.4 4.7 3.7 4.1 0.1 22.3 77.5 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 3.0 17.1 49.9 1.0 4.7 17.7 1.6 20.4 1.4 7.9 22.7 2.0 11.6 242.1 51.3 0.9 5.6 2.6 23.3 23.5 64.7 3.6 2.8 31.1 90.6 146.8 33.4 9.1 2.5 156.1 0.7 1.1 186.4 8.5 49.5 2.5 262.3 22.1 0.0 0.0 123.2 20.4 0.0 3.3 1.6 28.0 2.6 24.0 38.8 9.7 0.9 SNX20 "SLIC-1, SLIC1" ENSG00000167208 "Sorting nexin 20" Q7Z614 16 50666300-50681353 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 58.5;lymphoid tissue: 42.5" "Cell type enhanced" "Detected in some" 7 "B-cells: 16.1;Cardiomyocytes: 14.3;Hofbauer cells: 16.3;Kupffer cells: 17.3;Macrophages: 22.2;monocytes: 17.2;Sertoli cells: 12.9;T-cells: 22.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 13.3;HMC-1: 37.2;NB-4: 21.6;RPMI-8226: 9.2;THP-1: 9.7;U-266/70: 12.1;U-937: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043649 Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA043649: AB_10965697" "unprognostic (1.53e-2)" "prognostic favorable (9.07e-4)" "unprognostic (5.58e-2)" "unprognostic (5.06e-3)" "unprognostic (9.03e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.97e-1)" "unprognostic (1.26e-2)" "unprognostic (1.78e-2)" "unprognostic (1.04e-1)" "unprognostic (4.06e-2)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.00e-6)" "unprognostic (3.24e-1)" "unprognostic (3.37e-2)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" 2.0 1.4 2.5 12.7 5.7 10.7 1.3 1.2 2.7 1.3 1.7 1.4 0.1 1.8 1.2 2.4 1.7 1.7 3.1 2.7 1.5 1.5 1.9 1.5 5.7 21.1 2.6 0.2 1.1 1.0 0.1 1.1 1.8 3.1 1.8 2.3 1.3 3.0 0.2 0.7 1.4 7.4 1.6 3.0 23.6 2.1 0.6 3.3 42.5 1.5 0.8 22.3 4.7 1.2 5.5 27.9 58.5 30.7 11.1 30.1 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.3 0.0 2.3 0.0 0.0 0.0 3.3 37.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 1.1 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 12.1 6.3 2.9 0.0 12.9 0.0 58.5 15.1 45.5 10.1 26.6 12.6 5.5 18.0 12.2 27.9 5.2 14.0 9.5 14.1 11.1 30.7 7.7 30.1 15.8 2.5 5.7 1.2 2.7 1.5 1.5 2.6 0.2 3.1 3.3 0.0 0.0 16.1 0.0 0.7 0.0 14.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.4 0.0 4.7 0.0 16.3 1.6 0.0 0.0 17.3 0.0 0.0 22.2 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.5 0.3 22.4 0.0 0.0 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;thyroid gland: 41.1" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 140.2" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 6.6;naive B-cell: 11.5" "Lineage enriched" "Detected in many" 9 "B-cells: 11.5" "Cell line enriched" "Detected in some" 4 "Daudi: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA038470: AB_10673174" "prognostic favorable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.74e-2)" 1.1 1.5 11.9 7.6 8.9 10.2 1.2 3.4 16.5 0.7 1.1 23.2 11.8 1.5 1.2 3.5 0.9 0.8 1.3 7.9 13.4 9.0 1.1 1.9 4.7 11.4 13.7 8.1 1.3 1.6 0.4 2.2 1.0 12.3 3.0 0.7 0.0 3.6 8.4 0.7 2.0 2.2 0.9 17.0 6.1 2.1 1.0 6.6 1.6 41.1 0.0 13.3 2.1 0.3 11.5 1.2 0.0 0.2 0.1 0.1 1.6 0.2 0.4 0.9 0.8 0.1 0.0 0.7 0.8 0.0 0.0 0.2 0.4 0.9 19.9 0.5 0.1 0.5 0.4 1.7 0.0 0.0 0.1 2.4 0.4 2.2 2.5 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.6 3.3 0.0 1.2 0.2 0.0 1.4 0.5 0.3 4.1 0.3 1.2 0.8 0.8 4.6 0.9 0.2 0.7 0.0 0.8 2.0 0.0 0.0 1.1 1.4 0.3 0.5 4.3 1.8 4.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1.2 11.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 1.6 11.9 8.9 3.4 9.3 13.4 9.0 13.7 8.1 12.3 6.6 26.8 9.1 15.2 1.7 1.3 0.8 14.2 0.0 0.0 1.2 0.0 3.9 2.7 0.0 0.4 1.1 0.7 0.7 140.2 3.2 6.1 3.6 3.9 2.3 3.4 4.0 0.0 0.0 2.5 2.2 1.7 0.6 2.7 3.3 1.8 0.8 0.5 1.8 0.0 0.4 1.8 1.8 0.0 1.0 1.1 1.2 2.5 3.3 2.1 0.6 1.4 SNX31 MGC39715 ENSG00000174226 "Sorting nexin 31" Q8N9S9 8 100572882-100663415 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0" "Cell type enriched" "Detected in some" 5 "Early spermatids: 73.9" "Cancer enriched" "Detected in many" 22 "urothelial cancer: 24.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.0" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 50 "RT4: 42.9" "Region enriched" "Detected in single" 5 "thalamus: 2.9" "Region enhanced" "Detected in single" "olfactory region: 3.1" "HPA024284, HPA053466" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus" Cytosol "HPA024284: AB_1853894, HPA053466: AB_2682161" "unprognostic (1.39e-1)" "unprognostic (3.83e-2)" "unprognostic (7.99e-2)" "unprognostic (1.52e-1)" "unprognostic (7.20e-5)" "unprognostic (1.04e-1)" "unprognostic (1.01e-2)" "unprognostic (2.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.21e-1)" "unprognostic (2.09e-2)" "unprognostic (1.69e-1)" "unprognostic (7.79e-3)" "unprognostic (1.66e-1)" "prognostic favorable (1.47e-4)" "unprognostic (2.54e-1)" "unprognostic (4.05e-2)" 0.5 0.0 0.6 0.1 0.7 0.1 0.4 0.6 2.3 1.7 0.3 0.3 0.1 0.2 0.3 0.2 6.2 0.3 0.9 1.8 0.8 0.7 0.3 0.4 0.3 0.3 0.9 0.3 0.3 0.2 0.1 0.2 0.1 0.6 13.8 0.1 0.4 1.4 0.1 1.0 0.5 0.1 7.4 0.8 0.1 0.6 3.3 0.5 0.1 0.4 2.6 21.4 25.4 16.0 1.1 0.3 3.0 0.5 1.6 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.1 2.5 0.5 0.2 0.3 0.2 0.1 1.1 0.1 0.2 0.2 0.5 0.1 0.3 3.0 1.6 0.0 0.3 0.0 0.0 0.6 0.7 0.6 0.3 0.8 0.7 0.9 0.3 0.6 0.5 0.0 0.0 0.0 3.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 73.9 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.4 0.4 0.4 0.0 0.0 0.0 1.0 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833641-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 10.4;Late spermatids: 8.2;Spermatocytes: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 8.0;REH: 2.6;SH-SY5Y: 3.1;U-266/70: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" NA NA "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.8 1.0 9.0 1.1 16.6 1.3 1.3 3.5 16.1 1.6 2.2 1.6 0.0 3.4 2.0 1.3 0.9 2.5 2.8 0.9 10.2 5.0 0.9 0.7 0.8 1.0 3.6 10.9 1.3 0.8 0.8 0.3 0.9 3.4 0.8 1.9 0.1 0.7 0.9 0.6 1.1 1.5 2.0 1.8 0.9 0.9 3.5 3.7 0.0 0.7 0.0 1.3 1.0 0.2 1.0 1.2 0.2 0.3 0.1 3.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.7 8.0 0.1 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 2.6 0.0 2.3 0.1 0.0 0.0 3.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 9.3 1.6 0.0 0.7 0.0 0.3 0.0 0.1 0.0 1.2 0.3 3.0 0.3 1.6 1.2 1.2 1.0 1.4 0.6 0.2 0.1 0.0 0.7 1.2 0.4 9.0 16.6 3.5 15.4 10.2 5.0 3.6 10.9 3.4 3.7 0.0 1.1 0.0 0.3 0.3 1.7 0.8 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.8 0.0 0.0 0.1 0.6 0.1 3.5 0.0 0.3 0.0 0.0 0.6 0.0 8.2 0.3 0.0 1.7 0.0 0.3 0.8 0.1 0.0 1.1 0.2 0.5 0.0 0.3 4.4 1.3 0.4 0.0 0.0 1.2 0.1 SOAT1 "ACAT, SOAT, STAT" ENSG00000057252 "Sterol O-acyltransferase 1" P35610 1 179293714-179358680 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 87.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009533, HPA047171" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "CAB009533: AB_633499, HPA047171: AB_2679967" "unprognostic (3.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.81e-3)" "unprognostic (7.81e-3)" "unprognostic (3.29e-1)" "unprognostic (9.00e-2)" "unprognostic (9.84e-2)" "unprognostic (1.06e-1)" "unprognostic (5.45e-3)" "unprognostic (7.02e-3)" "unprognostic (4.67e-3)" "unprognostic (9.64e-2)" "unprognostic (4.67e-2)" "unprognostic (1.82e-1)" 23.9 87.4 4.1 8.3 5.7 7.0 9.6 2.9 4.0 6.8 7.2 5.6 7.8 5.5 8.2 6.0 3.4 8.3 9.8 5.7 5.5 4.1 12.1 8.8 18.6 13.0 6.2 2.3 10.8 15.5 8.1 14.6 11.6 4.9 13.1 6.9 9.6 51.1 8.9 4.1 5.8 7.0 7.5 10.5 13.6 8.1 6.8 4.9 4.0 6.2 2.9 7.2 9.4 8.7 6.6 24.3 19.8 26.8 18.5 16.0 14.8 20.4 9.6 7.9 11.7 30.9 16.9 42.5 9.9 17.5 22.0 25.7 9.8 23.4 11.6 15.7 18.0 26.8 7.5 25.1 5.9 23.8 13.2 5.2 5.4 8.1 10.2 12.7 9.2 2.1 13.3 3.8 25.7 22.1 9.3 9.4 14.3 11.6 6.0 34.2 4.3 9.8 3.0 3.8 3.3 3.2 12.2 10.3 6.8 19.4 12.8 2.4 6.2 15.3 6.5 5.7 9.8 6.8 6.3 8.9 26.2 12.6 28.6 21.8 8.5 31.0 9.9 10.4 5.0 48.5 19.6 26.8 0.7 14.0 17.0 13.5 6.6 13.1 13.1 24.3 5.5 12.7 12.6 19.8 18.5 11.1 4.4 16.0 14.8 4.1 5.7 2.9 4.0 5.5 4.1 6.2 2.3 4.9 4.9 20.8 33.1 10.4 8.5 8.9 7.2 5.6 22.9 48.2 14.8 19.2 13.7 14.8 1.7 33.4 19.5 13.0 7.9 0.0 21.9 46.9 18.6 33.8 13.9 21.9 69.5 6.4 57.5 21.5 66.9 10.8 30.2 63.1 21.9 44.1 27.7 6.8 20.1 10.5 24.4 12.8 13.0 25.8 13.0 5.6 8.2 4.5 7.3 27.9 16.8 6.5 SOAT2 ACAT2 ENSG00000167780 "Sterol O-acyltransferase 2" O75908 12 53103518-53124538 "Enzymes, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "intestine: 60.8" "Cell type enhanced" "Detected in single" 15 "Club cells: 1.2" "Group enriched" "Detected in some" 8 "liver cancer: 5.2;testis cancer: 5.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5" "Lineage enriched" "Detected in single" 7 "T-cells: 3.7" "Group enriched" "Detected in some" 5 "CACO-2: 9.8;Hep G2: 21.4;U-266/70: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.53e-1)" "unprognostic (2.72e-3)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (1.30e-4)" "unprognostic (3.88e-3)" "unprognostic (9.26e-2)" "unprognostic (4.20e-2)" "unprognostic (1.32e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (9.05e-2)" "unprognostic (2.37e-1)" "unprognostic (7.58e-3)" "unprognostic (3.28e-1)" 0.5 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.2 0.9 16.4 0.2 0.2 12.3 0.7 0.3 0.2 0.9 0.4 0.2 0.2 0.0 0.6 4.2 0.2 0.6 0.2 0.2 0.4 0.2 0.0 0.3 0.2 0.2 0.6 0.0 0.2 0.4 0.2 0.2 0.4 60.8 0.2 0.3 2.2 0.3 0.2 0.2 0.2 0.4 0.2 0.3 0.3 1.1 0.0 0.0 0.0 0.3 0.5 3.7 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.4 0.4 9.8 0.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.9 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.3 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.1 1.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.7 0.0 1.5 2.7 0.0 0.0 0.4 1.5 0.0 0.5 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SOCS1 "Cish1, JAB, SOCS-1, SSI-1, TIP3" ENSG00000185338 "Suppressor of cytokine signaling 1" O15524 16 11254405-11256200 "Cancer-related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.3;lymphoid tissue: 58.3" "Cell type enhanced" "Detected in many" 5 "T-cells: 63.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 6 "cerebellum: 15.2" "Cell type enhanced" "Detected in many" "basophil: 12.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "HDLM-2: 48.3" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010355, HPA074108" Approved Supported "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "CAB010355: AB_2193144, HPA074108: AB_2686661" "unprognostic (4.50e-3)" "unprognostic (3.30e-2)" "unprognostic (1.24e-1)" "unprognostic (1.66e-2)" "unprognostic (1.25e-2)" "prognostic favorable (1.10e-4)" "unprognostic (1.71e-2)" "unprognostic (4.09e-3)" "unprognostic (5.31e-3)" "unprognostic (4.82e-2)" "unprognostic (1.17e-1)" "unprognostic (5.39e-2)" "prognostic unfavorable (1.08e-6)" "unprognostic (1.56e-1)" "unprognostic (5.68e-2)" "unprognostic (6.08e-2)" "unprognostic (1.67e-1)" 10.9 2.8 0.7 19.2 1.5 13.9 37.9 15.2 1.1 15.8 6.3 0.3 2.2 3.3 4.9 7.6 5.6 4.2 11.0 3.6 0.6 1.0 11.1 42.3 9.6 25.8 0.8 0.0 9.3 3.8 0.7 16.8 9.3 2.4 5.3 1.8 3.2 3.7 3.9 2.3 6.0 11.0 6.5 1.1 14.7 6.6 7.1 0.4 58.3 5.1 4.8 14.7 5.4 8.3 4.4 1.3 12.9 0.1 5.5 2.7 0.4 1.2 0.2 0.5 0.1 1.6 0.2 1.9 1.0 7.5 0.4 0.6 0.3 0.2 2.9 2.2 0.4 1.4 0.5 0.2 0.1 0.1 48.3 0.3 0.8 0.0 3.9 0.7 0.0 8.9 0.7 0.1 1.0 0.1 0.2 0.1 0.3 6.4 0.8 0.0 1.1 3.2 1.8 5.4 0.0 0.8 0.3 0.3 0.3 0.5 0.2 0.7 0.1 0.2 1.7 0.5 1.5 0.0 0.4 0.0 0.6 3.2 0.4 0.6 0.2 0.2 4.5 1.2 0.3 0.6 12.9 0.1 8.8 2.2 0.0 2.0 1.4 2.5 2.7 0.0 4.4 2.7 2.5 0.3 5.5 0.0 1.3 2.6 0.4 0.7 1.5 15.2 0.6 0.6 1.0 0.8 0.0 2.4 0.4 0.0 4.1 11.5 14.7 10.9 1.9 9.2 5.1 2.7 0.0 48.8 5.9 21.5 19.9 11.3 40.7 3.6 23.6 0.0 7.3 4.3 30.9 5.9 54.0 2.4 4.0 0.0 25.0 10.4 6.5 17.6 6.6 8.4 28.7 24.4 12.9 7.4 6.9 9.1 39.3 7.0 4.2 0.0 16.5 0.9 2.0 5.9 48.3 63.1 6.6 10.8 SOCS7 "NAP4, NCKAP4" ENSG00000274211 "Suppressor of cytokine signaling 7" O14512 17 38352228-38405593 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.9;testis: 19.7" "Group enriched" "Detected in many" 6 "Early spermatids: 232.7;Late spermatids: 410.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004475 Approved Approved Cytosol NA NA Cytosol "HPA004475: AB_2667194" "prognostic unfavorable (7.49e-4)" "unprognostic (7.93e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.87e-4)" "unprognostic (7.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.43e-3)" "unprognostic (1.23e-1)" "unprognostic (1.77e-1)" "unprognostic (4.12e-3)" "unprognostic (1.97e-3)" "unprognostic (6.62e-2)" "unprognostic (4.91e-3)" "unprognostic (1.55e-2)" "unprognostic (1.53e-1)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" 2.4 1.9 6.1 2.5 6.7 2.1 3.2 22.9 7.8 2.6 2.3 3.5 3.3 2.2 3.6 4.2 3.5 3.2 2.3 2.7 5.1 2.4 0.9 2.6 1.8 3.3 5.1 5.1 9.1 5.1 0.9 2.2 2.9 3.1 2.7 2.9 3.6 3.2 6.0 5.2 2.1 3.6 1.4 1.7 1.4 19.7 4.3 4.7 5.2 1.8 2.8 2.4 2.4 0.8 1.0 0.2 0.9 0.7 2.6 0.3 8.9 10.1 11.3 8.8 6.4 5.4 9.4 3.9 3.4 4.8 3.9 7.9 2.7 6.1 6.0 6.2 6.8 6.0 9.6 2.8 6.1 11.4 8.6 6.5 11.4 8.2 2.2 14.2 11.2 3.3 11.3 5.0 6.9 6.0 4.0 3.2 5.3 4.2 5.9 4.9 12.2 9.4 3.7 9.8 1.6 12.2 19.0 5.6 3.2 11.0 20.0 10.9 9.7 6.3 6.9 10.0 11.7 8.0 4.0 4.8 4.3 8.6 12.0 14.7 10.2 9.0 6.4 7.2 9.7 0.2 0.9 0.1 2.1 0.5 2.6 0.8 0.7 0.3 0.4 0.7 0.4 0.6 0.2 0.7 0.5 1.0 1.1 0.3 14.9 8.5 0.8 6.0 0.7 43.1 19.2 2.5 9.4 14.8 1.8 27.5 7.8 1.7 5.2 232.7 3.6 3.6 0.0 5.6 4.0 4.3 6.6 0.0 7.8 2.8 33.4 4.7 7.4 7.0 410.0 9.8 2.2 1.7 2.8 6.1 12.0 5.6 7.0 8.5 2.2 16.6 0.0 2.6 58.3 22.2 0.6 6.8 6.9 6.3 6.8 SOD1 "ALS, ALS1, IPOA" ENSG00000142168 "Superoxide dismutase 1" P00441 21 31659622-31668931 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antioxidant, Oxidoreductase" "Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 282.6" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 2529.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001401, CAB008670" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 44900000 91000000 "Nucleoplasm, Plasma membrane, Cytosol" "CAB008670: AB_1623312, HPA001401: AB_1080132" "unprognostic (1.73e-1)" "unprognostic (1.18e-2)" "unprognostic (4.43e-1)" "unprognostic (6.19e-2)" "unprognostic (1.39e-1)" "unprognostic (9.59e-3)" "unprognostic (8.34e-2)" "unprognostic (2.30e-1)" "unprognostic (3.47e-1)" "unprognostic (5.28e-2)" "unprognostic (9.33e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.66e-1)" "unprognostic (1.74e-2)" "unprognostic (1.57e-1)" "unprognostic (3.26e-2)" 39.2 86.5 71.1 29.1 74.3 24.6 108.6 35.6 74.9 26.8 37.7 19.1 35.4 62.5 24.6 42.2 25.8 36.0 46.8 96.5 77.8 73.1 84.0 282.6 23.0 26.8 80.2 67.0 53.9 27.2 27.1 30.4 29.7 96.1 35.1 32.6 19.3 19.7 39.3 83.9 20.5 45.5 45.2 88.2 19.2 25.8 22.2 43.8 12.3 30.1 34.7 25.6 25.4 124.0 57.6 32.3 24.9 57.2 29.6 95.6 55.6 56.2 49.2 34.5 34.5 46.2 32.3 28.7 47.5 28.3 32.3 24.4 63.7 35.8 67.3 50.0 43.7 58.6 20.4 49.5 34.9 26.6 49.7 61.4 108.7 64.6 91.1 30.6 47.9 40.7 33.4 26.6 45.2 25.2 36.8 36.2 51.6 74.9 86.2 38.9 91.3 51.4 48.4 51.9 89.1 52.5 44.3 69.6 104.7 63.1 34.6 37.8 31.7 87.9 46.5 45.6 32.5 53.5 42.4 42.4 25.1 55.7 33.9 34.9 65.8 142.4 79.8 51.3 70.0 33.3 22.1 21.9 24.9 45.0 30.2 51.6 57.6 73.1 56.9 28.6 40.9 76.2 59.3 5.1 29.6 57.2 32.3 95.6 55.6 71.1 74.3 35.6 74.9 77.8 73.1 80.2 67.0 96.1 43.8 273.9 132.0 321.6 545.9 436.4 220.9 652.4 591.1 509.9 249.1 371.6 45.2 624.2 1382.7 369.6 242.1 264.2 846.2 327.1 713.9 544.4 341.5 540.9 215.8 2529.1 314.9 267.0 277.0 292.2 203.5 693.0 483.3 265.6 398.1 397.7 279.9 378.3 307.6 522.5 496.4 1894.8 157.7 433.4 418.2 79.3 538.3 305.8 607.1 266.4 526.4 451.3 SOD2 ENSG00000112096 "Superoxide dismutase 2" 6 159669057-159745186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 254.9;skeletal muscle: 475.1" "Cell type enriched" "Detected in some" 8 "Hofbauer cells: 286.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 11 "neutrophil: 254.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 254.9" "Cell line enhanced" "Detected in all" "BJ hTERT+: 182.1;GAMG: 70.6;HSkMC: 80.3" "HPA001814, CAB002013" Supported Enhanced Mitochondria NA NA Mitochondria "CAB002013: , HPA001814: AB_1080134" "unprognostic (2.47e-2)" "unprognostic (2.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.57e-2)" "unprognostic (1.31e-1)" "unprognostic (1.69e-1)" "unprognostic (1.49e-1)" "unprognostic (3.10e-2)" "unprognostic (1.37e-1)" "unprognostic (6.67e-2)" "unprognostic (2.76e-2)" "unprognostic (7.14e-2)" "prognostic unfavorable (1.72e-4)" "unprognostic (8.12e-2)" "unprognostic (4.14e-2)" "unprognostic (5.99e-2)" "unprognostic (1.82e-1)" 77.8 28.6 6.2 82.8 13.8 147.9 32.5 3.6 12.5 13.1 25.6 5.7 3.6 9.1 13.3 16.6 20.3 12.6 19.9 42.4 5.8 6.4 157.4 197.5 33.9 52.7 14.3 2.6 31.8 24.9 6.9 7.0 10.0 16.1 27.1 6.1 6.4 39.9 7.4 475.1 9.0 8.1 27.9 25.5 18.4 13.8 13.6 7.3 3.0 36.8 20.8 11.8 43.4 52.8 2.3 5.8 254.9 22.7 0.9 4.5 15.0 3.6 4.6 4.1 9.4 26.6 44.5 2.1 5.3 182.1 6.5 15.1 9.5 2.1 7.5 16.0 5.9 70.6 6.3 4.3 4.6 4.9 7.3 8.9 7.9 7.8 16.2 19.8 7.5 3.4 80.3 7.7 20.6 15.4 4.6 3.3 4.8 10.8 9.0 6.2 3.9 6.2 4.8 6.9 4.4 5.8 8.4 5.6 6.9 12.1 6.0 7.8 3.0 11.2 5.7 2.3 1.6 3.5 3.6 3.1 19.2 6.9 10.1 9.2 3.8 9.8 9.0 21.1 5.8 2.4 6.2 19.2 9.4 2.2 14.9 2.4 2.3 3.1 2.2 5.8 1.8 2.6 2.1 254.9 0.9 22.7 0.8 4.5 15.0 6.2 13.8 3.6 12.5 5.8 6.4 14.3 2.6 16.1 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.0 286.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 SOD2 ENSG00000285441 "Superoxide dismutase 2" P04179 6 159679119-159762529 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.2;bone marrow: 4.9;seminal vesicle: 3.5" "Cell type enhanced" "Detected in many" 8 "Glandular cells: 2400.7" "Cell type enhanced" "Detected in single" "memory B-cell: 3.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.0" NA NA 140000000 0.0 0.0 0.0 0.2 0.4 4.9 0.3 0.0 1.7 0.0 0.1 1.6 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.3 1.0 0.6 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.6 0.5 0.2 1.0 0.1 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.7 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.4 0.9 0.4 0.2 0.8 0.2 0.0 0.3 0.4 0.4 1.4 1.3 0.5 0.1 2.0 0.8 1.4 0.5 0.2 0.1 0.4 0.4 0.7 0.3 1.0 1.8 0.5 0.2 0.0 0.2 0.4 0.7 0.6 0.1 0.1 1.0 1.4 1.6 0.0 0.0 0.1 1.0 0.2 0.6 0.4 0.0 0.7 0.1 0.1 0.1 0.0 0.5 0.3 0.4 0.4 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.3 0.0 0.6 0.6 0.2 0.2 0.2 0.1 0.6 0.4 0.4 0.7 0.2 0.1 3.2 0.6 0.4 0.4 0.9 0.8 0.4 0.9 0.2 0.4 0.2 0.5 0.2 187.6 839.5 86.8 908.7 608.2 42.9 372.0 290.4 132.5 254.8 225.1 43.2 0.0 72.9 1002.5 235.6 199.1 118.6 0.0 1172.3 0.0 582.9 2400.7 104.5 344.0 0.0 30.2 76.4 57.7 302.5 83.4 53.8 537.1 494.3 311.0 86.3 39.8 850.4 109.4 61.2 221.1 55.3 38.8 714.8 49.3 44.9 596.0 0.0 49.4 100.0 611.0 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777442-36863686 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.2 11.4 10.8 4.5 10.6 1.4 6.0 55.5 12.5 11.3 8.3 20.5 7.2 2.5 8.8 5.3 7.2 9.4 9.9 6.7 9.9 7.5 4.7 1.3 6.1 3.0 12.7 8.9 12.6 3.7 11.5 4.4 7.9 8.7 10.7 3.9 6.7 4.4 12.3 2.9 11.0 4.6 14.1 7.9 5.3 5.3 14.8 14.7 0.9 16.0 4.7 4.1 8.0 10.5 1.0 2.1 1.4 0.7 0.7 0.2 0.2 7.5 10.3 12.5 13.5 7.3 6.7 3.3 6.6 7.2 9.5 5.6 4.1 1.2 3.3 2.5 11.6 8.2 10.2 10.0 6.2 10.0 0.5 2.0 5.4 9.6 5.4 3.8 1.2 5.3 3.8 7.6 9.0 6.4 4.1 6.1 3.7 3.8 0.7 10.3 7.3 3.8 2.8 3.2 0.8 8.0 9.0 11.7 1.3 5.5 2.3 15.0 9.4 13.8 15.2 4.4 5.8 19.3 8.1 9.3 23.8 4.6 11.6 14.4 1.4 0.3 3.4 10.1 1.6 15.0 1.4 0.7 0.2 0.1 0.4 0.2 1.0 0.1 0.1 0.4 1.0 0.2 0.2 1.4 0.7 0.3 2.1 0.1 0.2 10.8 10.6 55.5 12.0 9.9 7.5 12.7 8.9 8.7 14.7 0.0 2.6 1.4 4.8 11.2 18.8 12.1 0.0 2.7 7.9 19.2 35.3 12.5 1.7 3.4 0.4 10.5 1.7 0.0 1.3 8.6 11.0 5.2 10.4 0.2 8.5 22.3 5.8 9.8 5.3 1.5 11.2 6.0 5.0 1.0 1.3 19.4 1.8 0.0 17.7 1.2 3.7 12.9 11.3 0.7 1.0 14.1 2.7 1.0 2.5 2.5 SOGA3 "C6orf174, dJ403A15.3" ENSG00000214338 "SOGA family member 3" Q5TF21 6 127472794-127519191 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;pituitary gland: 11.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 1.4;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 6 "T-cells: 2.3" "Cell line enhanced" "Detected in some" "AF22: 7.5;SCLC-21H: 24.3;SH-SY5Y: 13.9" "HPA035388, HPA035389" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA035388: AB_2674601, HPA035389: AB_10669857" "unprognostic (1.70e-1)" "unprognostic (3.56e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-2)" "unprognostic (1.19e-1)" "unprognostic (8.58e-3)" "unprognostic (8.45e-2)" "unprognostic (7.31e-4)" "unprognostic (5.65e-3)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" "unprognostic (1.59e-1)" "unprognostic (3.30e-2)" "unprognostic (1.72e-1)" "unprognostic (8.26e-3)" 0.8 2.8 5.0 1.8 5.3 0.4 0.4 11.4 15.3 1.0 0.8 3.7 0.0 0.5 2.1 0.2 2.0 1.0 1.9 0.8 4.2 4.5 0.6 0.6 1.7 0.8 6.7 5.0 3.3 1.7 0.2 11.9 1.2 7.9 1.1 0.6 0.7 1.1 0.5 0.3 1.0 1.9 0.6 11.4 1.4 3.9 1.8 4.3 0.0 1.9 0.0 0.3 1.6 0.8 0.3 0.2 0.0 0.0 0.0 2.3 0.0 0.2 3.3 7.5 1.1 0.0 0.6 0.3 0.7 0.9 0.9 2.4 0.2 0.3 0.4 0.2 0.1 6.2 0.0 0.8 0.0 0.7 0.7 0.1 0.6 0.0 0.1 0.0 0.2 0.1 1.2 0.0 3.7 0.0 0.8 0.0 1.1 0.3 0.2 0.5 0.5 4.9 0.0 3.4 0.0 0.8 0.4 1.8 0.0 0.1 0.0 24.3 13.9 0.0 0.0 0.2 0.9 0.0 0.3 0.2 6.0 1.2 0.4 1.7 0.2 0.1 0.1 4.5 1.1 5.9 0.0 0.0 0.0 0.3 0.0 0.4 0.3 2.3 0.8 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.0 5.3 11.4 8.2 4.2 4.5 6.7 5.0 7.9 4.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SOHLH1 "bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2" ENSG00000165643 "Spermatogenesis and oogenesis specific basic helix-loop-helix 1" Q5JUK2 9 135693407-135699528 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 21.1;testis: 21.5" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 82.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 21.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "CACO-2: 14.8;U-266/84: 22.8" HPA059439 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA059439: AB_2684017" "unprognostic (2.93e-1)" "unprognostic (1.23e-3)" "unprognostic (9.85e-3)" "unprognostic (2.84e-2)" "unprognostic (3.55e-1)" "unprognostic (2.59e-3)" "unprognostic (4.98e-3)" "unprognostic (2.17e-1)" "unprognostic (1.63e-1)" 0.2 0.1 4.4 0.2 3.2 0.1 0.2 1.7 21.1 0.2 0.2 0.2 0.2 0.1 0.2 0.6 0.2 0.1 0.2 0.2 9.4 1.4 0.2 0.2 0.2 0.2 2.0 0.2 0.3 0.2 0.3 1.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.2 0.2 21.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 3.2 1.7 21.1 9.4 1.4 2.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 8.0 82.1 0.0 0.0 0.0 0.0 0.0 SOHLH2 "bHLHe81, FLJ20449, SPATA28, TEB1" ENSG00000120669 "Spermatogenesis and oogenesis specific basic helix-loop-helix 2" Q9NX45 13 36168208-36214615 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 23.6" "Group enriched" "Detected in some" 8 "Early spermatids: 52.6;Extravillous trophoblasts: 15.9;Late spermatids: 58.0;Spermatocytes: 19.1;Spermatogonia: 40.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.2;HL-60: 9.5;Karpas-707: 10.9;NB-4: 13.9;U-266/84: 13.9" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.99e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-2)" "unprognostic (3.01e-2)" "unprognostic (2.95e-1)" "unprognostic (7.88e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-3)" "unprognostic (2.10e-1)" "unprognostic (8.56e-2)" "unprognostic (7.44e-2)" "unprognostic (5.93e-2)" 0.3 0.3 0.9 0.3 2.1 0.5 0.4 0.3 3.5 0.3 1.8 0.3 0.3 0.2 0.3 2.0 0.3 0.2 0.3 0.9 1.2 1.2 0.6 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.2 0.3 3.5 0.3 1.8 0.0 0.3 0.3 1.2 0.4 0.2 0.3 0.4 0.6 0.3 0.1 23.6 0.3 0.3 0.4 0.3 0.3 1.3 0.3 1.0 0.3 0.5 0.3 0.0 0.5 0.0 7.2 0.2 0.8 0.0 0.6 1.2 4.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.1 9.5 0.0 2.1 0.6 0.0 0.0 0.4 0.9 0.2 0.4 10.9 2.2 0.1 0.0 13.9 0.2 0.0 0.0 0.2 0.2 0.8 1.0 0.7 0.1 1.3 0.0 0.0 0.0 2.7 0.1 0.6 0.0 0.0 0.8 0.5 0.5 1.4 13.9 0.2 0.8 5.1 0.5 0.0 0.3 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.3 3.5 1.2 1.2 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 52.6 0.0 0.0 0.0 0.0 15.9 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 1.1 0.3 0.0 0.0 19.1 40.2 0.1 2.9 0.0 0.0 0.1 SORBS1 "CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12" ENSG00000095637 "Sorbin and SH3 domain containing 1" Q9BX66 10 95311771-95561414 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 126.5" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 479.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 7.6;eosinophil: 2.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 7.6" "Cell line enhanced" "Detected in many" "CACO-2: 15.2;HMC-1: 26.6;SK-MEL-30: 22.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027559, CAB032850, HPA043084" Enhanced Supported "Plasma membrane,Focal adhesion sites,Centrosome" NA NA "Focal adhesion sites" "Plasma membrane, Centrosome" "CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307" "prognostic favorable (2.84e-4)" "unprognostic (3.53e-1)" "unprognostic (1.89e-1)" "unprognostic (7.85e-2)" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (2.98e-2)" "unprognostic (5.30e-2)" "unprognostic (1.95e-2)" "unprognostic (1.65e-2)" "unprognostic (3.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.40e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (2.55e-2)" "unprognostic (5.01e-3)" 95.0 6.4 23.0 16.4 21.6 1.8 23.5 16.8 22.5 14.9 70.2 18.7 22.1 8.1 41.8 12.5 45.0 25.1 28.9 83.7 20.9 8.3 5.9 14.7 8.7 1.4 13.4 14.1 9.8 7.3 17.5 3.5 9.9 19.2 42.0 20.0 6.4 7.2 65.7 46.4 6.3 15.5 126.5 20.6 2.9 40.0 5.5 19.3 0.0 4.0 12.7 1.2 63.9 31.4 0.1 0.0 7.6 1.2 0.6 1.0 0.2 0.7 0.7 6.4 1.6 2.4 0.1 0.9 0.2 0.1 0.2 0.0 15.2 5.7 0.0 1.2 0.1 2.4 0.3 1.2 0.3 0.1 1.8 2.3 3.7 0.2 9.1 0.8 0.0 26.6 0.4 0.2 0.3 0.1 0.1 2.6 0.9 6.0 1.2 0.6 0.4 0.0 0.3 3.0 2.8 1.4 0.5 2.2 0.2 7.2 10.0 2.8 2.0 0.9 0.3 22.8 4.6 1.2 0.2 0.2 0.0 2.3 0.1 1.2 0.8 0.2 0.1 2.8 0.2 6.4 7.6 0.2 2.2 0.7 1.2 1.0 0.1 0.3 0.4 0.0 0.1 0.3 0.1 0.2 0.6 0.2 0.0 0.5 0.2 23.0 21.6 16.8 20.7 20.9 8.3 13.4 14.1 19.2 19.3 20.8 18.1 0.5 5.1 10.3 5.9 479.0 12.7 0.0 2.3 1.8 2.0 17.9 3.3 4.4 61.7 19.0 1.0 0.0 2.6 1.9 15.3 5.3 15.1 42.9 2.7 6.4 5.8 38.6 4.9 26.4 6.9 1.1 13.5 1.0 14.0 18.2 2.8 3.5 72.2 4.3 5.4 0.0 64.3 2.8 4.7 10.9 24.7 0.0 5.2 3.3 SORBS2 "ARGBP2, KIAA0777" ENSG00000154556 "Sorbin and SH3 domain containing 2" O94875 4 185585444-185956652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 141.4;urinary bladder: 126.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 512.4;Cone photoreceptor cells: 726.5;Muller glia cells: 377.2;Rod photoreceptor cells: 785.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 68.1;TIME: 36.7;WM-115: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.30e-2)" "unprognostic (5.09e-2)" "unprognostic (1.20e-1)" "prognostic favorable (6.07e-5)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "prognostic favorable (1.47e-5)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (1.20e-1)" "unprognostic (8.30e-2)" "unprognostic (1.72e-1)" "prognostic favorable (3.10e-6)" "unprognostic (1.26e-1)" "unprognostic (2.42e-1)" "unprognostic (2.79e-3)" "unprognostic (2.51e-2)" 10.3 45.6 6.3 13.7 11.3 0.4 10.0 4.3 9.9 16.5 27.4 2.7 16.7 2.9 11.1 13.7 44.5 9.9 26.6 141.4 5.6 4.7 8.7 31.8 5.1 1.5 4.4 5.4 8.2 28.9 46.9 12.8 17.0 7.9 52.7 6.9 43.3 17.9 21.9 6.5 3.1 6.1 111.0 3.6 6.5 15.3 4.4 2.8 2.4 71.2 9.0 4.5 126.4 29.0 1.3 0.0 0.5 0.0 0.0 0.2 1.3 0.1 0.1 68.1 0.0 9.7 17.1 3.4 0.1 0.0 0.0 0.1 1.8 5.3 0.0 7.3 0.6 0.4 0.0 0.0 2.4 0.0 0.0 1.0 0.9 5.3 4.3 0.0 0.0 0.0 6.3 0.7 10.2 0.7 9.0 12.6 1.8 0.0 0.0 0.7 0.0 0.0 0.1 6.4 0.0 0.0 6.3 0.0 0.0 9.3 1.6 8.5 2.5 0.0 0.0 3.8 6.9 2.0 0.0 36.7 5.1 0.6 0.0 2.5 0.0 0.0 0.0 11.3 0.0 20.4 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 6.3 11.3 4.3 9.9 5.6 4.7 4.4 5.4 7.9 2.8 20.8 33.8 0.0 14.9 5.8 53.0 512.4 206.4 61.6 31.8 61.1 726.5 10.0 5.0 115.9 2.7 68.1 8.5 46.7 96.6 2.9 9.5 34.8 2.3 158.4 1.4 4.8 40.2 19.6 2.7 4.6 5.2 3.4 18.6 5.4 11.7 377.2 65.8 21.0 3.5 15.4 785.5 116.4 294.8 0.2 0.9 4.8 9.2 0.0 27.3 12.4 SORCS1 sorCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 18.5" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 59.3" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "intermediate monocyte: 2.4" "Lineage enriched" "Detected in single" 24 "monocytes: 2.4" "Group enriched" "Detected in some" 12 "RH-30: 33.9;SH-SY5Y: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 1.4 5.8 6.0 4.5 14.1 0.4 1.8 0.5 13.2 2.2 10.7 1.1 1.9 1.4 2.1 1.2 2.0 3.2 2.8 4.2 2.6 4.7 8.0 0.5 0.5 1.9 2.1 6.6 1.2 3.0 0.6 1.2 0.4 3.3 2.7 3.6 6.5 2.4 4.9 0.8 2.3 4.5 2.7 2.1 1.7 3.4 2.3 2.7 0.2 18.5 1.1 2.7 4.7 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.0 44.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 0.5 11.3 2.6 4.7 2.1 6.6 3.3 2.7 0.0 0.3 0.0 0.0 0.6 1.8 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 14.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.3 3.4 0.0 0.0 1.7 0.0 0.0 59.3 0.1 0.0 0.4 2.2 1.7 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 SORCS2 KIAA1329 ENSG00000184985 "Sortilin related VPS10 domain containing receptor 2" Q96PQ0 4 7192538-7742836 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1" "Cell type enhanced" "Detected in many" 19 "Bipolar cells: 66.5;Muller glia cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.6;HaCaT: 16.6;HMC-1: 12.5;RPMI-8226: 7.4;SiHa: 12.0;THP-1: 7.0;U-937: 7.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061916 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA061916: AB_2684636" "unprognostic (1.38e-1)" "unprognostic (6.32e-2)" "unprognostic (1.91e-2)" "unprognostic (4.37e-2)" "unprognostic (4.91e-3)" "unprognostic (1.82e-2)" "unprognostic (4.60e-2)" "unprognostic (1.14e-2)" "unprognostic (1.49e-3)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.52e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.17e-3)" "unprognostic (5.37e-2)" "unprognostic (2.09e-1)" "unprognostic (7.27e-3)" 4.9 2.6 12.0 6.4 16.6 3.3 1.8 4.8 22.4 13.8 4.0 32.1 3.2 3.1 6.0 8.2 4.7 3.5 7.1 3.2 10.7 6.9 7.4 5.2 8.3 2.0 9.9 11.2 7.4 1.7 0.8 2.7 0.9 11.2 7.5 2.6 7.5 2.6 5.3 2.4 1.9 4.2 11.5 11.2 1.3 1.9 3.4 11.3 0.8 6.2 2.2 2.7 5.2 3.7 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.9 1.1 0.2 0.1 0.0 0.0 0.2 0.0 1.4 0.4 0.1 0.5 0.0 6.6 4.2 1.1 16.6 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.2 0.1 0.0 12.5 0.2 3.7 5.2 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.7 0.0 1.3 7.4 0.2 0.0 0.7 0.6 12.0 0.0 0.0 0.7 0.0 7.0 0.0 4.3 1.3 0.0 0.1 0.0 0.0 0.0 1.4 7.3 0.2 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 12.0 16.6 4.8 17.7 10.7 6.9 9.9 11.2 11.2 11.3 3.0 13.7 0.0 0.2 0.1 66.5 2.0 0.0 2.7 7.9 5.2 0.0 0.0 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.3 10.2 11.8 0.3 1.7 0.0 0.0 31.9 0.7 0.0 7.4 0.7 2.4 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.4 SORCS3 "KIAA1059, SORCS" ENSG00000156395 "Sortilin related VPS10 domain containing receptor 3" Q9UPU3 10 104641101-105265235 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 5.8;brain: 19.1" "Cell type enriched" "Detected in some" 7 "Early spermatids: 11.2" "Group enriched" "Detected in some" 13 "glioma: 1.8;renal cancer: 2.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "naive CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;RPTEC TERT1: 4.6;SH-SY5Y: 1.0;SuSa: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.39e-2)" "unprognostic (8.47e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-1)" "unprognostic (1.98e-1)" "unprognostic (3.63e-1)" "unprognostic (4.78e-1)" "unprognostic (1.84e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.63e-2)" "unprognostic (1.97e-1)" 1.1 5.8 5.4 0.8 15.5 0.7 0.9 2.9 19.1 1.2 0.9 2.3 0.0 0.7 1.0 0.7 0.8 0.7 1.1 0.7 6.3 8.5 1.3 0.6 0.6 0.7 2.0 8.1 2.7 0.6 0.6 3.0 0.6 3.4 0.8 0.9 0.0 0.9 0.9 0.6 1.0 1.1 1.1 2.3 0.6 0.9 2.9 2.0 0.0 0.6 0.0 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.1 1.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.4 15.5 2.9 12.7 6.3 8.5 2.0 8.1 3.4 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.0 0.0 SORD ENSG00000140263 "Sorbitol dehydrogenase" Q00796 15 45023104-45077185 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3" "Cell type enhanced" "Detected in many" 17 "Hepatocytes: 654.8;Proximal tubular cells: 226.9" "Cancer enhanced" "Detected in all" "prostate cancer: 72.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "eosinophil: 36.4" "Lineage enriched" "Detected in many" 13 "granulocytes: 36.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040260, HPA040621" Enhanced Approved Cytosol NA NA 430000 Cytosol "HPA040260: AB_10794872, HPA040621: AB_10795384" "unprognostic (8.18e-2)" "unprognostic (7.58e-2)" "unprognostic (8.19e-2)" "unprognostic (1.51e-1)" "unprognostic (5.69e-3)" "unprognostic (3.90e-2)" "prognostic favorable (6.14e-5)" "unprognostic (3.33e-3)" "unprognostic (1.67e-1)" "unprognostic (4.95e-2)" "unprognostic (7.04e-3)" "unprognostic (1.40e-1)" "unprognostic (4.26e-2)" "unprognostic (1.23e-2)" "unprognostic (8.53e-2)" "unprognostic (2.31e-2)" "unprognostic (1.56e-1)" 1.4 10.2 3.0 1.5 3.2 1.0 7.1 3.1 3.8 66.3 5.5 6.2 39.2 2.6 2.6 3.2 6.7 3.5 3.9 3.4 3.0 3.0 20.9 98.4 1.6 2.2 4.2 2.3 1.6 7.3 1.2 1.8 0.5 5.0 48.5 3.8 2.3 7.6 46.7 1.4 8.0 8.7 2.0 5.0 2.4 5.6 2.5 3.9 3.1 116.3 3.8 3.5 4.2 4.4 1.6 2.4 36.4 2.7 0.4 1.0 1.3 15.6 13.8 3.5 11.3 3.0 5.3 3.7 4.3 3.0 9.9 8.4 11.5 8.6 2.0 9.8 5.3 10.7 23.6 18.1 16.4 7.9 34.0 11.2 15.7 18.1 25.3 2.3 27.3 26.4 6.8 12.5 5.7 9.1 4.8 9.3 24.2 17.6 5.6 9.3 6.3 16.5 14.8 13.5 26.5 14.7 0.0 22.8 7.6 7.2 15.3 24.8 13.0 8.9 14.0 6.6 3.9 20.2 11.2 8.3 7.9 7.0 17.6 10.4 1.0 6.9 2.0 12.8 24.1 20.6 5.0 2.7 36.4 0.6 2.5 1.0 1.2 0.6 0.8 2.4 1.6 0.5 0.6 1.4 0.4 2.5 1.3 0.6 1.3 3.0 3.2 3.1 3.8 3.0 3.0 4.2 2.3 5.0 3.9 0.0 1.9 16.8 20.6 6.9 9.5 2.8 38.2 28.1 28.4 31.4 0.0 1.0 24.9 52.5 26.1 3.8 9.1 0.0 118.4 3.9 5.8 134.4 8.1 654.8 14.4 3.2 81.4 20.9 21.2 17.1 3.4 8.2 15.1 8.2 29.3 6.8 90.9 13.3 5.6 226.9 3.6 0.0 9.2 6.5 2.5 17.8 0.8 6.4 32.6 87.8 SORT1 "Gp95, NT3" ENSG00000134243 "Sortilin 1" Q99523 1 109309568-109397951 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Endocytosis, Osteogenesis, Transport" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.1;epididymis: 75.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 9.0;non-classical monocyte: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006889, CAB011498" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 7170000 "Golgi apparatus, Cytosol" "Plasma membrane" "CAB011498: AB_2192606, HPA006889: AB_1080056" "unprognostic (2.10e-2)" "unprognostic (7.46e-2)" "prognostic favorable (7.74e-6)" "unprognostic (4.12e-1)" "unprognostic (9.41e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.34e-3)" "unprognostic (4.27e-2)" "unprognostic (9.44e-2)" "unprognostic (2.42e-2)" "unprognostic (1.28e-2)" "unprognostic (1.23e-3)" "unprognostic (1.45e-2)" "unprognostic (2.15e-1)" "unprognostic (3.95e-1)" "unprognostic (4.46e-3)" 22.9 6.5 24.0 6.2 35.5 10.1 15.5 6.4 40.6 10.1 15.2 50.3 18.1 11.5 11.9 75.2 22.0 14.8 9.5 31.8 45.2 19.8 21.1 3.7 19.2 3.6 57.9 22.8 3.6 9.3 24.2 5.7 22.9 27.1 10.3 14.4 12.2 11.8 24.8 36.4 8.3 11.3 14.6 71.1 5.4 9.5 21.6 42.2 1.1 22.5 5.1 5.4 8.7 8.2 0.0 4.5 2.3 10.0 0.4 0.0 1.7 11.8 4.7 11.9 14.5 34.8 6.9 34.3 8.8 14.1 8.7 9.3 12.2 4.4 0.1 11.3 3.7 6.4 2.9 14.0 6.9 12.5 0.3 6.6 3.2 7.7 13.1 13.6 0.0 10.7 17.3 1.1 10.6 2.3 23.3 1.3 9.9 24.4 1.2 12.1 12.5 8.3 0.2 4.4 5.3 2.0 9.3 28.1 5.7 16.6 8.6 12.2 7.0 5.2 34.5 37.0 17.7 14.5 2.0 0.3 1.8 7.1 0.3 14.7 11.8 9.6 0.0 3.1 0.0 7.6 0.0 7.1 2.3 0.0 9.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 1.9 0.4 10.0 1.6 0.0 1.7 24.0 35.5 6.4 33.9 45.2 19.8 57.9 22.8 27.1 42.2 35.7 42.8 0.0 4.2 1.1 14.6 83.1 33.1 22.7 18.2 71.5 33.4 26.8 5.0 23.3 53.4 7.3 49.9 0.0 20.8 26.7 6.1 10.7 7.0 22.5 27.9 12.7 16.1 4.3 36.7 56.4 8.1 24.8 20.3 20.8 30.9 20.4 21.0 17.5 46.7 9.9 42.2 32.3 31.1 51.1 20.4 1.6 30.8 1.8 19.9 10.8 SOST "DAND6, VBCH" ENSG00000167941 Sclerostin Q9BQB4 17 43753731-43758788 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" Heparin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 17.1;retina: 7.2" "Cell type enriched" "Detected in single" 6 "Collecting duct cells: 1.8" "Group enriched" "Detected in some" 8 "head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5" "Group enriched" "Detected in some" 6 "basal ganglia: 1.0;cerebral cortex: 3.1" "Cell type enhanced" "Detected in single" "eosinophil: 2.3" "Lineage enriched" "Detected in single" 23 "granulocytes: 2.3" "Group enriched" "Detected in some" 34 "HaCaT: 10.2;SuSa: 6.3" "Group enriched" "Detected in some" 11 "basal ganglia: 1.7;cerebellum: 1.1" "Region enhanced" "Detected in some" "basal ganglia: 1.1" "Secreted to extracellular matrix" NA NA "unprognostic (1.26e-1)" "unprognostic (4.06e-2)" "unprognostic (6.57e-2)" "unprognostic (2.55e-3)" "unprognostic (3.37e-1)" "unprognostic (4.67e-2)" "unprognostic (1.16e-1)" "unprognostic (8.35e-2)" "unprognostic (1.38e-2)" "unprognostic (1.20e-1)" "unprognostic (8.92e-2)" "unprognostic (1.56e-1)" "unprognostic (7.90e-2)" 0.3 0.1 0.1 1.4 1.0 0.1 0.1 0.1 3.1 0.2 0.1 0.0 1.1 0.1 0.1 0.1 0.1 0.1 0.1 2.9 0.1 0.1 17.1 0.1 2.4 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 7.2 1.1 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.5 0.1 0.1 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 3.1 0.1 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SOSTDC1 "DAND7, DKFZp564D206, USAG1" ENSG00000171243 "Sclerostin domain containing 1" Q6X4U4 7 16461481-16530580 "Predicted secreted proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.1;retina: 74.8;stomach 1: 32.3" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4" "Cancer enhanced" "Detected in many" "renal cancer: 25.9" "Region enriched" "Detected in many" 9 "pons and medulla: 51.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8" "Group enriched" "Detected in many" 5 "basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8" "Low region specificity" "Detected in many" HPA042856 Uncertain "Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "Nucleoli, Nucleoli rim, Vesicles" "HPA042856: " "unprognostic (2.08e-2)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (6.17e-3)" "unprognostic (5.59e-3)" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (1.41e-2)" "prognostic favorable (8.69e-4)" "unprognostic (2.59e-1)" "unprognostic (2.62e-1)" "prognostic favorable (3.22e-5)" "unprognostic (7.01e-2)" "unprognostic (1.23e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (8.72e-4)" 0.4 0.4 2.0 1.4 1.9 0.0 9.5 0.5 5.8 2.6 5.9 7.0 0.2 6.1 2.5 2.4 2.7 2.7 0.4 3.7 3.5 1.6 12.8 0.2 22.0 0.1 0.7 5.3 0.6 1.1 0.0 2.9 0.0 51.1 1.1 8.4 74.8 12.5 6.4 0.3 13.7 4.8 0.5 1.0 0.2 32.3 1.9 0.0 0.0 4.7 3.1 4.9 1.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 11.2 0.0 0.0 0.2 0.4 0.0 0.0 0.1 2.2 4.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 0.3 0.1 0.0 0.0 0.7 0.8 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.0 1.9 0.5 5.8 3.5 1.6 0.7 5.3 51.1 0.0 0.0 0.0 0.0 4.5 4.9 0.4 1.0 0.0 0.0 3.4 14.0 0.0 0.0 24.9 0.0 14.4 0.2 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 28.6 2.4 0.6 0.0 9.4 6.6 0.0 30.4 0.0 0.0 15.0 0.2 0.0 2.5 14.4 0.4 0.0 0.4 2.7 0.9 6.4 0.0 0.0 2.1 0.3 SOWAHA ANKRD43 ENSG00000198944 "Sosondowah ankyrin repeat domain family member A" Q2M3V2 5 132813587-132816797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 52.0;intestine: 35.0" "Cell type enhanced" "Detected in some" 22 "Enterocytes: 43.3;Horizontal cells: 125.5;Muller glia cells: 24.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 11.5;T-47d: 27.3" "Group enriched" "Detected in many" 5 "amygdala: 59.1;basal ganglia: 89.2;cerebral cortex: 40.5;hippocampal formation: 66.1" "Low region specificity" "Detected in all" HPA064621 Approved NA NA "HPA064621: AB_2685302" "unprognostic (1.59e-1)" "unprognostic (5.58e-2)" "unprognostic (3.75e-3)" "unprognostic (5.34e-3)" "unprognostic (8.28e-2)" "unprognostic (3.05e-3)" "unprognostic (1.18e-1)" "unprognostic (5.99e-2)" "unprognostic (1.27e-1)" "unprognostic (2.65e-2)" "prognostic favorable (4.03e-4)" "unprognostic (3.92e-2)" "prognostic favorable (9.38e-5)" "unprognostic (4.36e-1)" "unprognostic (3.00e-1)" "unprognostic (2.53e-3)" "unprognostic (1.42e-1)" 0.7 1.2 27.5 1.0 52.0 0.4 0.9 5.1 16.3 0.7 7.9 3.4 2.2 33.4 0.5 6.5 0.5 1.8 2.0 0.4 20.1 3.1 5.1 2.1 0.5 0.5 6.0 11.1 0.6 2.3 2.4 0.8 0.6 2.8 2.9 6.7 0.7 3.4 3.3 0.4 0.5 35.0 0.5 3.7 0.4 5.2 0.6 11.0 0.1 1.6 0.0 0.5 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.4 1.2 0.0 0.6 0.0 0.1 0.0 2.2 0.3 0.0 0.0 2.4 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.8 1.4 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.6 11.5 0.5 0.1 0.0 0.0 1.4 27.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 52.0 5.1 16.3 20.1 3.1 6.0 11.1 2.8 11.0 0.0 0.0 0.0 0.4 0.0 0.6 0.2 10.2 0.0 0.0 5.2 0.0 0.2 0.0 0.4 0.0 0.0 43.3 0.0 1.0 0.0 0.0 3.3 0.0 1.7 0.1 125.5 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 24.2 0.4 20.1 0.4 3.7 3.4 0.0 0.0 0.2 0.9 0.0 0.1 0.0 14.0 0.1 SOWAHB ANKRD56 ENSG00000186212 "Sosondowah ankyrin repeat domain family member B" A6NEL2 4 76894928-76898147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 16.3" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 1.4;Distal tubular cells: 1.7;Urothelial cells: 4.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.9;BEWO: 8.8;CACO-2: 4.2;OE19: 6.7;RT4: 18.9;T-47d: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036809, HPA036810" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA036809: AB_10672479, HPA036810: AB_2675327" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-2)" "unprognostic (1.02e-2)" "unprognostic (1.02e-2)" "unprognostic (3.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.51e-2)" "unprognostic (3.06e-1)" "unprognostic (2.85e-2)" "unprognostic (1.46e-1)" "prognostic favorable (1.22e-15)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "unprognostic (2.03e-2)" "unprognostic (3.73e-3)" 0.3 0.6 1.2 2.1 1.1 0.0 0.9 0.5 7.9 1.7 6.9 0.2 7.4 5.1 0.3 0.7 9.7 0.9 4.3 0.2 1.0 1.1 6.9 16.3 1.6 0.0 0.7 2.0 0.2 7.3 5.6 0.9 0.6 1.4 2.2 5.8 0.3 11.1 2.7 0.2 2.2 12.6 0.0 0.4 0.2 4.2 0.2 0.2 0.0 3.9 2.3 4.9 3.6 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.3 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 4.2 2.6 0.0 0.1 0.0 0.0 0.1 0.4 0.6 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.0 0.5 18.9 0.1 0.0 0.0 1.4 0.0 0.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.5 7.9 1.0 1.1 0.7 2.0 1.4 0.2 0.0 0.3 0.0 1.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.1 1.7 0.1 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.2 SOWAHD ANKRD58 ENSG00000187808 "Sosondowah ankyrin repeat domain family member D" A6NJG2 X 119758613-119760164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.1;lymphoid tissue: 12.6" "Cell type enhanced" "Detected in some" 15 "B-cells: 8.5;Extravillous trophoblasts: 27.9;Hofbauer cells: 15.7;Syncytiotrophoblasts: 7.9" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 11.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.2;NB-4: 3.9;SK-BR-3: 4.6;THP-1: 11.5;U-937: 10.2" "Not detected" "Not detected" HPA065955 Uncertain NA NA "HPA065955: AB_2685586" "unprognostic (1.78e-2)" "unprognostic (9.37e-2)" "unprognostic (3.10e-2)" "unprognostic (8.88e-2)" "unprognostic (1.67e-1)" "unprognostic (4.38e-2)" "unprognostic (2.03e-1)" "unprognostic (7.20e-2)" "unprognostic (3.45e-2)" "unprognostic (6.07e-2)" "unprognostic (5.80e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-5)" "unprognostic (5.82e-2)" "unprognostic (3.14e-2)" "unprognostic (9.22e-2)" "unprognostic (3.74e-3)" 0.7 0.9 1.0 3.9 2.5 4.2 0.5 0.7 2.1 0.6 1.8 4.0 2.0 4.6 0.4 0.0 0.6 0.8 1.5 1.1 0.9 0.9 1.3 0.8 3.5 6.7 2.5 1.1 0.8 2.2 0.3 0.5 9.6 1.5 0.9 1.1 0.9 5.0 1.0 0.4 0.6 6.7 0.2 3.0 12.6 1.8 8.0 2.0 0.7 0.4 1.1 3.2 0.8 0.5 11.1 2.3 3.7 3.6 0.3 1.9 0.7 0.6 0.0 0.2 0.1 0.0 0.0 6.2 0.1 0.0 0.7 1.0 1.3 0.2 0.3 0.8 0.0 0.7 0.1 0.0 0.0 0.1 1.0 0.7 0.1 0.1 1.6 0.4 1.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.1 0.1 0.6 0.0 3.9 1.3 1.1 0.4 3.4 0.1 0.2 0.1 0.2 0.4 0.2 1.3 4.6 0.2 0.5 0.8 11.5 0.1 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.0 10.2 0.1 0.0 3.4 1.9 0.1 3.6 0.0 9.0 0.5 0.4 2.3 11.1 1.9 1.0 3.7 0.3 3.0 1.1 0.0 0.7 1.0 2.5 0.7 2.1 0.9 0.9 2.5 1.1 1.5 2.0 0.0 0.0 8.5 0.1 0.0 0.5 0.4 0.0 0.0 0.0 3.5 0.0 5.6 0.0 0.2 0.4 0.0 4.1 0.0 0.4 27.9 0.2 0.0 0.0 0.0 15.7 1.6 0.0 0.0 4.7 0.4 0.0 4.5 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.1 6.7 0.0 0.0 0.0 0.4 0.1 7.9 0.0 1.8 0.0 SOX1 ENSG00000182968 "SRY-box 1" O00570 13 112067647-112070488 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.9;testis: 3.7" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 3.6;Melanocytes: 3.3;Spermatogonia: 2.1" "Group enriched" "Detected in some" 6 "colorectal cancer: 0.9;glioma: 2.3;melanoma: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 31.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (1.71e-3)" "unprognostic (6.03e-2)" "unprognostic (6.41e-2)" "unprognostic (4.85e-1)" "unprognostic (5.93e-2)" 0.5 0.5 5.3 0.5 5.8 0.4 0.9 2.5 9.9 0.4 0.6 2.6 0.0 0.7 0.4 0.4 0.4 0.4 0.4 0.4 3.5 7.0 0.4 0.4 0.4 0.4 2.5 2.4 0.4 0.4 0.4 0.2 0.4 3.1 0.4 0.5 2.7 0.6 0.5 0.4 1.5 0.4 0.4 4.8 0.4 0.5 3.7 0.3 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.8 2.5 7.8 3.5 7.0 2.5 2.4 3.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 SOX10 "DOM, WS2E, WS4" ENSG00000100146 "SRY-box 10" P56693 22 37970686-37987422 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Deafness, Disease mutation, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 64.4;salivary gland: 98.4" "Cell type enriched" "Detected in some" 12 "Melanocytes: 33.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 704 "SK-MEL-30: 62.9;WM-115: 90.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003171, HPA068898" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB003171: AB_2195374, HPA068898: AB_2686054" 3.3 4.0 21.0 3.7 33.1 1.6 18.7 3.2 32.8 3.2 8.1 64.4 0.5 2.9 1.8 2.8 2.8 1.9 3.4 3.9 26.9 15.2 1.7 1.7 1.6 1.6 41.3 13.7 2.4 2.2 1.7 0.7 1.6 24.7 2.3 3.9 22.8 98.4 7.1 1.8 15.8 3.8 3.2 46.6 1.8 2.4 3.1 42.5 0.0 1.7 0.0 1.6 2.5 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 33.1 3.2 24.6 26.9 15.2 41.3 13.7 24.7 42.5 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.0 0.0 0.0 0.0 SOX11 ENSG00000176887 "SRY-box 11" P35716 2 5692667-5701385 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.1;Ductal cells: 2.5" "Group enriched" "Detected in many" 6 "breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 26.5;NTERA-2: 12.9;REH: 9.4;RH-30: 10.1;SCLC-21H: 16.3;SH-SY5Y: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000448, HPA000536, CAB056152, CAB056153" Approved Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060" "unprognostic (2.17e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-2)" "unprognostic (7.35e-6)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (4.04e-8)" "unprognostic (2.79e-2)" "unprognostic (7.27e-2)" "unprognostic (3.17e-1)" "unprognostic (3.35e-3)" "unprognostic (2.42e-1)" "unprognostic (8.45e-8)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.50e-3)" "unprognostic (7.47e-2)" 0.5 0.5 4.2 0.5 7.1 0.6 0.6 0.3 12.3 0.4 3.3 5.8 0.0 0.6 0.7 0.6 0.5 0.5 0.6 5.3 4.4 5.1 0.5 0.5 0.6 0.5 3.3 5.0 0.5 0.4 0.5 0.7 0.5 4.5 0.5 0.8 0.0 0.9 0.4 1.0 0.6 0.7 1.3 6.3 1.0 0.6 3.7 3.6 0.0 0.6 0.0 0.6 0.5 0.1 1.1 0.8 3.1 1.5 1.6 1.1 0.5 0.0 0.0 26.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 2.4 0.0 0.0 0.0 12.9 0.0 0.0 9.4 10.1 0.4 0.0 0.0 16.3 24.6 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.8 0.3 0.6 0.0 0.0 6.1 3.1 0.5 1.0 0.5 0.8 1.1 1.1 0.6 0.7 0.6 0.7 0.9 0.9 1.6 1.6 1.5 0.8 0.9 0.5 4.2 7.1 0.3 6.4 4.4 5.1 3.3 5.0 4.5 3.6 0.0 0.0 0.0 0.0 0.0 1.3 10.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 2.5 0.7 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 SOX14 SOX28 ENSG00000168875 "SRY-box 14" O95416 3 137764284-137766338 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.4;placenta: 15.1;prostate: 3.1" "Cell type enriched" "Detected in some" 4 "Cytotrophoblasts: 12.6" "Cancer enhanced" "Detected in many" "prostate cancer: 2.8" "Group enriched" "Detected in many" 15 "hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hypothalamus: 2.1;midbrain: 5.9" "Group enriched" "Detected in many" 7 "midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5" NA NA "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.88e-2)" "unprognostic (2.49e-3)" "unprognostic (5.08e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 15.1 4.4 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 5.4 1.6 0.0 4.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 SOX15 "SOX20, SOX26, SOX27" ENSG00000129194 "SRY-box 15" O60248 17 7588178-7590170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9" "Cancer enhanced" "Detected in many" "testis cancer: 67.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.1;non-classical monocyte: 10.8" "Lineage enriched" "Detected in many" 4 "monocytes: 10.8" "Group enriched" "Detected in some" 7 "A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA067196, HPA074049" Enhanced Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles" Yes NA Nucleoplasm "Nucleoli, Golgi apparatus, Vesicles" "HPA067196: AB_2685802, HPA074049: AB_2686656" "unprognostic (5.79e-3)" "unprognostic (6.65e-2)" "unprognostic (1.40e-2)" "unprognostic (2.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.60e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (5.00e-2)" "unprognostic (8.50e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (8.61e-3)" "unprognostic (1.03e-1)" "unprognostic (1.96e-1)" "unprognostic (2.95e-2)" "unprognostic (2.97e-1)" 1.0 0.8 4.6 1.0 4.1 2.1 1.3 7.2 5.0 7.5 2.6 1.1 1.0 0.7 4.4 1.7 62.7 3.7 1.0 2.9 3.1 4.1 1.3 1.0 1.5 1.0 2.6 1.0 7.0 1.0 0.1 2.0 2.0 3.5 4.1 0.6 1.4 3.4 7.0 1.9 30.0 1.0 1.6 1.4 1.0 0.7 1.3 1.0 1.8 1.0 59.0 38.7 3.6 7.8 0.0 2.4 0.2 10.8 0.0 0.0 0.5 41.8 1.0 0.6 0.3 0.0 0.1 3.2 0.5 0.1 0.3 0.6 0.8 0.2 0.1 0.4 0.0 0.1 47.0 0.0 18.8 0.1 1.1 1.3 0.1 0.5 0.1 0.0 0.1 0.9 0.0 18.6 0.2 4.2 1.3 0.0 0.8 0.9 0.3 0.0 0.3 0.2 0.5 1.3 0.1 0.2 0.5 0.6 0.3 0.8 0.2 0.3 0.7 0.5 0.1 0.2 1.9 0.3 0.3 0.5 0.4 0.8 0.5 1.4 0.3 0.5 0.6 1.5 0.6 1.1 0.2 2.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 10.8 1.2 0.0 0.5 4.6 4.1 7.2 4.4 3.1 4.1 2.6 1.0 3.5 1.0 0.0 0.0 0.0 39.1 185.8 11.0 2.8 0.0 10.7 5.7 1.8 13.7 0.3 1.7 0.0 0.1 1.6 0.2 0.0 0.4 1.5 6.1 15.1 0.0 0.0 0.4 9.5 1.2 1.8 2.7 0.6 29.1 1.1 25.3 1.8 0.0 33.2 0.3 0.0 34.6 0.0 6.2 32.3 8.9 0.4 8.7 148.4 0.9 0.0 0.2 76.9 SOX18 ENSG00000203883 "SRY-box 18" P35713 20 64047582-64049641 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 53.3" "Group enriched" "Detected in many" 15 "Endothelial cells: 106.0;Ito cells: 165.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 15.5;NB-4: 25.5;REH: 6.1;TIME: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA073703 Approved Nucleoplasm NA NA Nucleoplasm "HPA073703: AB_2686628" "unprognostic (2.51e-1)" "unprognostic (3.23e-1)" "unprognostic (9.98e-3)" "unprognostic (6.30e-2)" "unprognostic (1.07e-1)" "unprognostic (2.88e-2)" "unprognostic (2.71e-2)" "unprognostic (4.35e-3)" "unprognostic (1.62e-1)" "unprognostic (3.45e-2)" "unprognostic (1.33e-3)" "unprognostic (1.76e-1)" "unprognostic (1.13e-3)" "unprognostic (9.63e-3)" "unprognostic (1.41e-1)" "unprognostic (2.46e-1)" "unprognostic (5.40e-2)" 53.3 6.2 3.1 9.9 5.0 1.8 27.5 2.5 5.2 18.3 9.4 3.1 4.3 7.4 26.0 10.0 16.4 15.0 15.8 29.7 3.2 3.1 10.1 6.8 29.3 17.7 4.8 2.3 11.2 3.6 4.6 3.2 12.4 6.1 12.3 2.7 13.1 8.1 5.8 20.3 7.9 7.2 7.0 3.4 13.7 7.2 6.9 1.2 2.9 13.8 20.5 5.8 8.4 18.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.8 0.0 2.1 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 2.6 0.0 0.0 0.5 0.0 25.5 0.1 0.0 0.2 6.1 0.0 0.4 0.0 1.0 0.4 0.5 0.2 0.0 0.3 0.0 0.4 1.2 7.0 0.1 2.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.0 2.5 5.2 3.2 3.1 4.8 2.3 6.1 1.2 0.0 1.1 3.4 0.1 0.9 0.8 6.2 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 8.8 106.0 0.0 0.0 0.0 0.0 0.9 0.2 4.6 0.2 0.1 0.0 0.0 165.7 8.9 2.1 1.1 0.8 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 1.0 1.8 1.5 1.0 0.2 0.0 0.0 0.4 SOX2 ENSG00000181449 "SRY-box 2" P48431 3 181711924-181714436 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 80.1" "Cell type enriched" "Detected in some" 9 "Muller glia cells: 455.6" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 1.8 2.5 30.3 2.0 25.8 1.5 1.6 13.9 80.1 1.8 2.3 24.3 0.0 2.0 1.5 1.8 15.9 5.0 1.8 1.7 36.0 19.2 1.5 1.5 3.4 1.5 19.4 18.5 1.7 1.6 1.5 5.8 1.5 18.6 3.9 2.0 1.0 6.3 1.9 1.6 1.8 2.3 1.7 18.4 1.6 9.7 3.0 22.4 0.0 1.5 2.1 6.9 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.2 68.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.1 29.3 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 56.2 2.9 0.1 0.0 0.1 0.0 7.6 0.1 0.1 0.3 0.0 0.0 0.0 11.9 0.4 0.0 0.0 0.0 1.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 25.8 13.9 20.0 36.0 19.2 19.4 18.5 18.6 22.4 0.0 5.9 0.0 41.2 0.2 3.5 0.4 0.0 52.2 38.7 3.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 4.9 1.1 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.6 0.2 3.3 0.0 0.0 455.6 0.0 0.0 0.0 0.0 8.2 0.0 0.1 1.5 0.2 0.4 0.2 0.0 0.0 7.0 SOX21 SOX25 ENSG00000125285 "SRY-box 21" Q9Y651 13 94709622-94712399 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.2;skin 1: 18.3;stomach 1: 38.7" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 4.7;Suprabasal keratinocytes: 8.0" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.6;NTERA-2: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048337, HPA064084" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA048337: AB_2732547, HPA064084: AB_2685187" "unprognostic (3.33e-1)" "prognostic favorable (7.60e-4)" "unprognostic (7.96e-2)" "prognostic favorable (8.79e-5)" "unprognostic (1.54e-2)" "unprognostic (3.87e-1)" "unprognostic (9.02e-2)" "unprognostic (2.11e-1)" "unprognostic (1.50e-1)" "unprognostic (2.90e-2)" "unprognostic (1.93e-1)" "unprognostic (6.05e-2)" "unprognostic (1.11e-1)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" 0.6 0.6 11.0 0.7 10.1 0.6 1.5 2.5 13.2 0.7 0.6 7.5 0.0 0.6 0.7 0.6 8.3 0.7 0.7 0.6 10.9 5.5 0.6 0.6 0.8 0.6 6.0 8.2 0.6 0.6 0.6 0.1 0.6 5.8 1.2 0.6 0.0 1.7 0.6 0.7 18.3 0.6 0.7 6.1 0.6 38.7 0.8 9.8 0.0 0.7 1.0 4.3 1.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 3.3 6.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.1 2.5 12.3 10.9 5.5 6.0 8.2 5.8 9.8 0.0 0.0 0.0 1.2 4.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 8.0 0.0 0.0 0.0 0.7 SOX3 PHP ENSG00000134595 "SRY-box 3" P41225 X 140502985-140505116 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 18.2;testis: 12.4" "Cell type enriched" "Detected in single" 8 "Muller glia cells: 4.3" "Cancer enhanced" "Detected in some" "glioma: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.8;HEK 293: 8.3;NTERA-2: 18.6;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054720, HPA075003" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA054720: AB_2682584, HPA075003: AB_2686727" "unprognostic (6.04e-2)" "unprognostic (3.75e-1)" "unprognostic (8.62e-3)" "unprognostic (8.03e-2)" "unprognostic (1.57e-1)" "unprognostic (5.27e-3)" 0.3 0.5 2.6 0.3 2.7 0.3 0.3 0.6 2.6 1.5 0.3 5.0 0.0 0.3 0.6 0.3 0.3 18.2 0.3 0.3 2.2 5.0 0.3 0.3 0.3 0.3 2.0 1.8 4.7 0.3 0.4 3.2 0.3 3.6 0.3 0.3 0.5 0.3 0.3 0.4 0.3 0.3 0.3 2.3 0.3 0.3 12.4 0.6 0.0 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 0.6 2.6 2.2 5.0 2.0 1.8 3.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 SOX30 ENSG00000039600 "SRY-box 30" O94993 5 157625679-157671480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 42.5" "Cell type enriched" "Detected in some" 7 "Early spermatids: 287.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 4.2;CACO-2: 2.8;HDLM-2: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006159, CAB009382" Enhanced NA NA "CAB009382: AB_2195963, HPA006159: AB_1080062" "unprognostic (3.51e-2)" "unprognostic (4.72e-2)" "unprognostic (7.31e-2)" "unprognostic (4.70e-4)" "unprognostic (2.53e-2)" "unprognostic (6.12e-2)" "unprognostic (4.47e-2)" "unprognostic (2.22e-2)" "unprognostic (5.33e-2)" "unprognostic (1.36e-1)" "unprognostic (4.73e-2)" "unprognostic (7.85e-2)" "unprognostic (4.64e-4)" "unprognostic (5.88e-2)" "unprognostic (1.64e-1)" "unprognostic (3.72e-2)" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.6 2.3 1.7 0.4 0.0 1.7 0.4 4.2 0.1 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.4 0.3 2.8 1.8 0.0 0.1 0.1 0.2 0.5 0.0 0.0 0.2 9.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.2 0.5 0.3 0.3 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.9 0.0 0.9 0.0 0.0 0.4 0.3 0.0 0.2 0.1 0.0 0.5 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.9 0.0 0.0 0.3 1.7 0.4 1.6 0.7 0.3 0.3 1.1 1.4 1.1 0.0 1.6 1.4 1.1 0.1 0.0 0.0 2.3 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 287.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 27.0 8.5 0.0 0.0 0.0 0.0 0.0 SOX4 ENSG00000124766 "SRY-box 4" Q06945 6 21592768-21598619 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 21.8" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 757.4;Pancreatic endocrine cells: 1059.7" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 21.8" "Group enriched" "Detected in all" 4 "dendritic cells: 21.8;granulocytes: 12.8;monocytes: 10.0" "Cell line enhanced" "Detected in many" "AN3-CA: 55.4;MOLT-4: 47.6;SH-SY5Y: 31.2" "Region enriched" "Detected in many" 4 "olfactory region: 66.5" "Low region specificity" "Detected in many" HPA029901 Approved Supported Nucleoplasm,Mitochondria NA Yes Nucleoplasm Mitochondria "HPA029901: AB_10601592" "unprognostic (4.01e-2)" "unprognostic (3.06e-1)" "unprognostic (9.28e-2)" "unprognostic (5.18e-2)" "unprognostic (5.00e-2)" "unprognostic (1.08e-2)" "prognostic unfavorable (2.57e-5)" "unprognostic (1.78e-1)" "unprognostic (8.01e-3)" "unprognostic (1.98e-2)" "unprognostic (3.88e-3)" "unprognostic (1.18e-1)" "unprognostic (8.73e-3)" "unprognostic (3.66e-2)" "unprognostic (3.31e-1)" "unprognostic (2.01e-1)" "unprognostic (9.27e-2)" 4.2 0.7 2.0 1.9 0.9 6.0 6.3 3.0 6.3 6.7 2.8 3.0 18.0 4.1 2.3 4.2 5.5 2.0 1.1 1.8 4.3 1.3 5.1 0.8 0.6 18.1 5.3 0.0 1.8 1.0 4.1 3.7 9.6 1.4 0.3 4.1 2.7 4.9 0.3 1.0 4.4 2.5 3.4 1.4 6.2 3.6 3.1 21.8 12.8 10.0 3.3 1.1 2.0 1.8 5.2 13.3 55.4 4.9 1.2 21.7 0.8 1.7 1.0 0.9 3.5 3.5 0.6 22.2 1.3 0.7 5.4 6.9 3.8 0.7 7.6 14.5 0.5 2.4 2.3 0.8 1.8 0.4 2.1 3.9 0.4 1.6 14.2 15.6 30.0 0.1 0.0 1.1 4.3 47.6 4.5 9.9 2.6 5.0 21.0 1.1 0.0 9.6 16.7 17.4 31.2 7.7 9.0 2.9 17.3 4.4 6.5 11.9 1.5 5.2 0.3 3.9 0.3 0.0 15.4 0.5 6.5 6.1 12.8 9.8 0.9 0.2 5.5 0.0 2.8 0.1 0.1 4.1 3.1 1.1 0.8 0.4 3.3 10.0 21.8 0.9 2.0 184.6 59.8 33.5 82.0 99.9 88.8 228.6 341.4 161.9 235.4 146.5 11.8 61.5 56.3 757.4 3.9 238.0 78.0 0.0 523.0 358.6 243.9 126.1 56.8 5.8 33.0 46.1 327.2 70.6 85.2 8.3 11.2 56.1 231.2 80.2 156.9 228.7 1059.7 155.6 10.6 77.4 25.8 6.5 198.6 3.7 175.2 81.3 25.3 23.5 265.6 178.0 SOX5 "L-SOX5, MGC35153" ENSG00000134532 "SRY-box 5" P35711 12 23529500-24562544 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 52.0" "Group enriched" "Detected in many" 4 "Early spermatids: 153.3;Late spermatids: 165.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 4.3;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 6 "B-cells: 4.3" "Cell line enhanced" "Detected in many" "AF22: 12.0;Daudi: 12.0;HDLM-2: 25.2;K-562: 10.9;WM-115: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060499 Supported Nucleoplasm NA NA Nucleoplasm "HPA060499: AB_2684294" "unprognostic (9.11e-4)" "unprognostic (4.64e-3)" "unprognostic (3.23e-1)" "unprognostic (6.83e-2)" "unprognostic (1.67e-1)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (1.03e-3)" "unprognostic (1.36e-1)" "unprognostic (8.40e-2)" "unprognostic (1.70e-4)" "unprognostic (6.95e-2)" "unprognostic (4.53e-4)" "unprognostic (3.12e-3)" "unprognostic (2.37e-1)" "unprognostic (9.59e-2)" "unprognostic (2.75e-2)" 8.5 2.4 9.2 3.1 5.4 0.7 4.4 3.8 10.5 10.6 2.9 3.0 2.7 1.1 8.7 1.8 2.6 4.5 3.8 3.6 10.0 2.8 2.9 12.9 3.3 4.2 4.1 6.4 9.1 2.5 0.7 6.9 9.9 7.2 2.8 1.8 5.2 4.0 4.9 2.7 7.1 2.7 4.3 5.1 2.5 2.9 52.0 5.5 0.0 3.3 1.6 3.7 2.9 5.4 4.3 0.7 0.1 0.0 0.7 0.1 0.2 0.1 0.1 12.0 0.0 6.8 3.6 0.0 0.1 0.0 0.1 0.4 2.1 0.1 12.0 0.6 0.0 0.0 0.1 6.8 0.0 0.1 25.2 1.7 2.5 0.0 5.6 4.6 0.0 0.1 1.9 0.0 0.6 0.0 1.5 0.0 0.4 10.9 0.5 0.3 0.0 4.6 0.1 3.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.5 0.0 0.0 4.9 3.3 0.2 2.4 0.0 0.2 1.6 0.0 1.1 0.3 0.0 0.7 2.7 0.0 10.2 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 3.7 0.0 0.1 0.1 0.7 0.0 0.7 0.0 0.2 9.2 5.4 3.8 10.5 10.0 2.8 4.1 6.4 7.2 5.5 6.0 8.3 1.3 0.1 11.7 11.5 2.8 2.5 25.4 5.7 3.5 0.0 0.1 0.0 0.1 153.3 1.5 0.0 0.0 0.0 0.1 7.4 0.2 1.1 18.1 0.3 0.0 5.2 4.3 1.2 165.2 9.5 0.0 11.8 10.0 0.0 17.5 0.0 0.0 6.3 0.5 1.8 19.4 11.7 38.4 1.2 10.7 0.2 0.0 0.0 0.1 SOX6 ENSG00000110693 "SRY-box 6" P35712 11 15966449-16739591 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.1;kidney: 28.4" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 221.4;Erythroid cells: 116.8;Muller glia cells: 66.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "neutrophil: 5.4" "Lineage enriched" "Detected in single" 30 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "AF22: 4.4;CACO-2: 5.9;HAP1: 4.9;hTCEpi: 5.6;SK-MEL-30: 5.0;WM-115: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001923, HPA003908" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA001923: AB_1080065, HPA003908: AB_1080063" "unprognostic (3.40e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-1)" "unprognostic (1.68e-1)" "unprognostic (4.17e-3)" "unprognostic (1.05e-2)" "unprognostic (6.47e-3)" "unprognostic (1.25e-2)" "unprognostic (1.31e-1)" "unprognostic (7.89e-4)" "unprognostic (9.08e-2)" "unprognostic (7.37e-3)" "prognostic favorable (6.47e-12)" "unprognostic (9.90e-2)" "unprognostic (5.02e-2)" "unprognostic (1.15e-1)" "unprognostic (3.04e-2)" 1.4 0.9 3.9 0.8 3.5 17.7 0.8 0.8 5.7 1.4 30.5 0.8 2.3 5.0 0.8 4.9 1.6 3.3 6.3 2.5 2.6 2.5 28.4 3.8 2.0 0.8 3.0 0.8 1.7 14.5 0.0 2.9 1.9 0.9 0.8 0.8 1.1 0.8 0.8 8.1 4.5 70.1 0.8 1.4 1.1 0.6 10.3 1.0 0.8 2.8 1.4 0.8 0.8 0.8 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.0 0.6 4.4 4.2 0.0 0.0 0.0 0.3 1.4 0.1 0.1 5.9 0.0 0.0 3.8 0.0 0.0 0.1 4.9 1.3 0.0 0.0 0.5 0.0 0.0 0.2 0.7 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.8 0.0 2.2 0.0 0.0 0.1 0.4 0.0 5.0 0.5 0.0 0.0 0.0 2.9 2.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 0.0 0.0 3.9 3.5 0.8 2.5 2.6 2.5 3.0 0.8 0.9 1.0 3.0 4.6 0.0 4.2 35.6 2.1 18.7 25.5 12.0 5.7 34.9 9.8 1.0 8.3 12.3 221.4 3.5 3.2 116.8 3.3 0.5 16.2 2.6 0.0 2.8 1.0 0.0 7.5 3.7 0.3 43.5 3.1 2.2 33.7 0.0 1.5 66.8 6.2 8.6 2.1 17.2 3.3 0.0 13.3 20.1 3.5 14.1 0.5 0.0 0.9 2.8 SOX7 ENSG00000171056 "SRY-box 7" Q9BT81 8 10723768-10730512 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 37.2" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 57.2;Basal keratinocytes: 54.4;Endothelial cells: 70.1;Ito cells: 42.4;Suprabasal keratinocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 9.4;hTCEpi: 17.4;HUVEC TERT2: 20.3;TIME: 5.4" "Low region specificity" "Detected in many" HPA009065 Approved Approved "Nuclear speckles,Golgi apparatus" NA NA "Nuclear speckles" "Golgi apparatus" "HPA009065: AB_1857390" "unprognostic (1.21e-1)" "unprognostic (1.08e-1)" "unprognostic (1.15e-3)" "unprognostic (1.29e-2)" "unprognostic (1.60e-1)" "unprognostic (1.65e-1)" "unprognostic (3.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.74e-2)" "unprognostic (7.26e-2)" "unprognostic (7.44e-2)" "unprognostic (1.09e-1)" "unprognostic (7.71e-3)" "unprognostic (2.45e-3)" "unprognostic (2.38e-1)" "unprognostic (5.41e-3)" "unprognostic (4.84e-3)" 17.4 1.8 3.5 3.4 3.3 0.7 7.0 1.7 4.2 16.0 3.4 2.1 1.0 0.8 7.1 6.8 19.7 3.0 6.1 12.5 2.6 2.2 3.0 7.4 37.2 2.9 2.6 1.5 2.6 4.5 2.7 4.2 26.4 3.6 5.8 2.2 7.6 7.1 5.0 12.5 11.7 2.1 4.2 3.0 2.2 2.2 1.9 3.2 0.6 4.7 22.7 14.5 8.8 23.1 1.9 0.3 0.8 0.4 0.2 1.2 0.1 4.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.5 9.4 2.8 3.4 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.2 0.1 17.4 0.0 3.6 0.0 20.3 0.0 0.4 0.2 0.0 0.1 0.1 0.1 1.3 0.7 2.6 0.9 0.0 0.0 0.0 1.7 0.5 2.7 1.7 0.0 0.0 1.2 0.0 0.0 5.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.5 0.4 0.1 0.2 0.2 1.2 1.9 0.3 0.1 0.1 0.3 0.2 0.4 0.8 0.2 0.1 0.3 0.1 0.1 3.5 3.3 1.7 4.2 2.6 2.2 2.6 1.5 3.6 3.2 0.0 18.1 2.7 57.2 54.4 1.1 2.8 2.5 2.7 3.4 0.0 3.9 4.1 0.0 0.1 0.2 70.1 0.0 0.0 0.2 0.2 2.8 12.5 3.5 4.5 0.5 0.0 0.0 42.4 1.5 0.0 0.9 1.1 3.3 0.0 0.1 0.5 0.2 0.0 0.4 0.0 2.4 0.0 4.1 2.6 1.5 35.5 10.4 0.0 0.4 20.7 SOX8 ENSG00000005513 "SRY-box 8" P57073 16 981808-986979 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 64.9" "Cell type enriched" "Detected in some" 22 "Muller glia cells: 120.0" "Cancer enriched" "Detected in many" 6 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 23 "T-cells: 2.2" "Cell line enriched" "Detected in some" 5 "RH-30: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041640, HPA058665" Enhanced Nucleoplasm No NA Nucleoplasm "HPA041640: AB_10964357, HPA058665: AB_2683792" "unprognostic (1.40e-2)" "unprognostic (2.56e-3)" "unprognostic (1.59e-1)" "unprognostic (3.10e-2)" "unprognostic (4.58e-2)" "unprognostic (7.16e-3)" "unprognostic (6.05e-3)" "unprognostic (3.01e-2)" "unprognostic (2.53e-1)" "unprognostic (1.16e-1)" "unprognostic (4.53e-3)" "unprognostic (4.46e-2)" "unprognostic (1.20e-3)" "unprognostic (8.50e-2)" "unprognostic (6.18e-2)" "unprognostic (5.47e-1)" "unprognostic (9.09e-2)" 1.6 1.5 18.4 1.8 25.1 1.0 2.5 3.2 64.9 1.2 1.4 20.9 0.0 1.1 1.1 1.1 1.2 1.1 1.5 1.8 22.6 14.5 1.0 1.0 1.0 2.7 26.5 5.4 1.0 1.5 1.0 0.1 1.4 12.0 1.3 1.5 0.9 8.6 1.4 1.3 1.3 1.2 1.2 27.1 1.8 1.7 1.9 30.4 0.0 1.1 0.0 3.1 1.1 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.3 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.7 0.1 0.0 51.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 2.2 1.1 0.0 0.0 0.0 0.0 0.0 0.2 18.4 25.1 3.2 11.8 22.6 14.5 26.5 5.4 12.0 30.4 0.0 0.0 0.0 0.4 0.3 1.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.2 0.1 2.1 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 3.1 0.0 1.7 1.0 0.0 120.0 0.1 0.0 1.8 0.0 5.3 0.0 0.8 0.0 4.3 0.9 0.0 0.0 0.0 0.1 SOX9 "CMD1, CMPD1, SRA1" ENSG00000125398 "SRY-box 9" P48436 17 72121020-72126420 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 63.4" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 178.3;Muller glia cells: 170.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 28.5;Hep G2: 34.1;OE19: 26.3;U-251 MG: 23.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001758, CAB022456, CAB068240" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067" "unprognostic (6.92e-2)" "unprognostic (1.73e-2)" "unprognostic (4.47e-3)" "unprognostic (4.43e-2)" "unprognostic (2.55e-2)" "unprognostic (7.96e-3)" "unprognostic (4.32e-3)" "prognostic unfavorable (2.07e-4)" "unprognostic (4.87e-2)" "unprognostic (3.31e-1)" "unprognostic (8.92e-3)" "unprognostic (1.21e-1)" "unprognostic (3.26e-3)" "unprognostic (2.77e-3)" "unprognostic (1.15e-1)" "unprognostic (8.88e-2)" "unprognostic (1.21e-2)" 3.1 2.6 32.2 4.3 31.6 1.1 23.4 20.3 32.4 7.4 14.6 28.4 8.1 16.6 3.5 1.9 7.7 7.4 11.7 9.5 35.5 15.7 11.7 3.9 3.4 1.9 14.6 13.7 1.2 31.9 1.2 7.0 1.4 21.3 21.7 15.7 12.9 63.4 14.4 3.0 13.1 12.9 2.1 15.6 1.3 35.2 25.2 20.2 0.0 17.8 5.3 5.0 1.9 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 6.9 14.3 28.5 1.4 0.4 0.0 1.7 1.5 3.0 1.6 9.6 14.8 0.0 1.1 0.4 16.2 11.2 0.0 6.7 2.8 0.0 0.9 0.0 1.5 34.1 0.1 0.0 0.0 0.2 0.6 3.5 3.3 17.4 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.5 26.3 10.6 0.0 11.6 0.1 12.9 0.7 0.7 0.7 1.4 1.7 0.0 8.1 6.1 0.1 0.0 5.9 15.9 3.1 23.5 0.0 0.0 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 31.6 20.3 26.7 35.5 15.7 14.6 13.7 21.3 20.2 11.9 3.5 2.2 77.1 49.2 1.4 13.8 178.3 26.8 20.5 34.9 0.0 0.2 6.6 53.5 3.4 1.4 28.2 0.0 41.0 0.0 3.8 85.0 4.6 3.9 0.2 0.0 57.4 0.0 0.0 7.1 4.0 2.6 11.8 1.8 90.5 170.2 39.9 21.0 0.4 46.9 6.5 6.5 6.2 12.5 1.5 15.6 0.1 0.5 78.3 71.8 SP110 "IFI41, IFI75" ENSG00000135899 "SP110 nuclear body protein" Q9HB58 2 230167293-230225729 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 65.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 40.1" "Low region specificity" "Detected in all" HPA058554 Supported Nucleoplasm No No Nucleoplasm "HPA058554: AB_2683754" "unprognostic (9.72e-2)" "unprognostic (1.15e-2)" "unprognostic (5.02e-2)" "unprognostic (8.33e-4)" "unprognostic (2.93e-1)" "unprognostic (1.80e-1)" "unprognostic (6.65e-2)" "unprognostic (9.44e-2)" "unprognostic (9.68e-2)" "unprognostic (1.46e-2)" "unprognostic (4.11e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.38e-1)" "unprognostic (2.66e-2)" "unprognostic (2.99e-3)" "unprognostic (9.50e-3)" 21.4 8.9 6.5 29.9 12.1 17.6 12.3 3.1 7.5 10.2 8.9 11.6 3.2 7.6 13.5 8.0 11.1 8.1 11.7 8.6 6.0 5.7 10.0 10.4 14.6 43.4 10.7 4.6 12.7 10.0 8.9 13.0 11.2 8.9 12.2 9.4 9.3 10.3 5.4 8.0 7.9 18.6 9.5 12.7 45.2 9.2 4.0 10.3 32.7 8.4 5.7 35.1 14.3 13.2 36.0 21.3 65.9 31.7 13.2 16.5 10.4 3.1 1.7 1.0 1.8 5.6 9.3 3.3 5.9 11.9 28.0 40.1 0.0 4.9 13.4 5.5 6.0 26.5 2.0 3.7 9.1 10.5 12.0 2.2 5.6 2.5 3.3 5.8 8.2 6.8 13.2 4.6 8.1 11.7 5.2 9.6 9.1 1.9 4.8 7.9 1.8 12.3 16.0 3.4 1.5 2.0 7.6 10.0 5.0 22.5 4.3 0.2 2.2 2.2 4.8 11.9 0.4 3.7 7.0 7.1 5.1 3.2 1.2 2.8 5.2 1.7 6.7 5.7 7.8 4.1 18.6 12.0 29.1 14.7 20.4 12.6 36.0 14.1 12.9 10.6 34.5 14.6 15.2 65.9 13.2 31.7 21.3 16.5 10.4 6.5 12.1 3.1 7.5 6.0 5.7 10.7 4.6 8.9 10.3 41.7 22.1 109.7 4.3 8.9 0.2 3.2 7.6 20.1 14.8 10.4 0.0 2.8 11.6 18.1 4.1 15.5 9.2 0.0 24.9 10.5 12.5 3.9 36.9 4.9 23.3 0.0 6.4 18.4 45.6 3.6 10.9 46.0 18.6 25.2 8.7 10.4 21.2 10.2 9.6 10.3 4.5 6.5 10.3 5.2 2.6 8.8 3.9 59.7 5.2 2.6 SP140 "LYSP100-A, LYSP100-B" ENSG00000079263 "SP140 nuclear body protein" Q13342 2 230203110-230313215 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.2;lymphoid tissue: 46.8" "Group enriched" "Detected in many" 4 "B-cells: 77.6;Erythroid cells: 23.3;T-cells: 44.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 36.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 18.0;HDLM-2: 30.1;Karpas-707: 15.0;RPMI-8226: 9.3" "HPA006162, HPA067493" Enhanced Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" Mitochondria "HPA006162: AB_1857403, HPA067493: AB_2685851" "unprognostic (8.15e-3)" "unprognostic (2.25e-3)" "unprognostic (3.90e-3)" "unprognostic (5.72e-4)" "unprognostic (5.66e-2)" "unprognostic (3.33e-4)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (6.05e-2)" "unprognostic (1.12e-3)" "unprognostic (3.89e-2)" "unprognostic (2.88e-1)" "unprognostic (1.20e-9)" "unprognostic (9.12e-2)" "unprognostic (8.50e-2)" "unprognostic (3.66e-1)" "unprognostic (9.30e-3)" 1.9 0.8 0.9 39.1 1.1 2.9 1.1 0.5 0.7 0.7 2.3 0.5 0.0 1.4 0.6 0.9 3.5 0.8 1.4 0.8 0.9 1.0 1.1 1.1 6.3 26.9 1.4 0.0 0.7 0.4 0.0 0.9 0.6 0.6 1.0 2.0 1.0 8.9 0.1 0.3 0.7 13.1 0.3 2.0 34.9 2.3 1.3 0.7 4.0 1.3 1.7 46.8 4.8 0.9 36.2 3.0 12.6 3.6 5.1 10.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 18.0 0.0 0.0 3.1 0.0 0.0 0.0 1.1 30.1 0.0 0.0 0.0 0.4 0.1 2.5 0.1 0.3 0.0 0.3 0.4 0.2 0.0 0.1 0.0 15.0 0.3 0.0 0.0 0.8 0.8 0.0 0.0 0.0 1.7 9.3 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.8 0.0 0.0 5.5 2.2 0.6 1.3 0.4 0.0 0.0 1.3 4.1 9.0 2.6 10.0 36.2 9.0 9.7 3.0 25.1 4.6 6.1 12.6 5.1 3.6 0.2 7.8 3.6 0.9 1.1 0.5 0.7 0.9 1.0 1.4 0.0 0.6 0.7 0.0 2.9 77.6 0.0 0.8 0.7 0.4 0.0 2.7 1.2 0.0 7.9 0.1 0.0 0.0 10.8 0.6 0.0 23.3 0.0 0.1 0.9 0.1 0.0 0.8 10.0 0.0 0.0 3.1 6.3 3.0 0.0 10.1 6.8 10.0 0.0 0.5 0.2 0.0 1.1 0.3 1.6 0.0 0.4 1.4 0.4 1.0 0.2 44.0 0.0 0.1 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SP7 "osterix, OSX" ENSG00000170374 "Sp7 transcription factor" Q8TDD2 12 53326575-53345315 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.0;lymphoid tissue: 3.3;testis: 4.2" "Cell type enhanced" "Detected in single" 28 "Cone photoreceptor cells: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;HSkMC: 2.1;MCF7: 1.0" "Region enriched" "Detected in single" 13 "olfactory region: 34.5" "Low region specificity" "Detected in all" HPA063202 Enhanced NA NA "HPA063202: AB_2684961" "unprognostic (6.02e-1)" "unprognostic (6.28e-3)" "unprognostic (6.37e-2)" "unprognostic (2.49e-2)" "unprognostic (7.75e-2)" "unprognostic (3.02e-1)" "unprognostic (1.49e-1)" "unprognostic (2.11e-1)" "unprognostic (1.04e-2)" "unprognostic (6.02e-1)" "unprognostic (3.93e-7)" "unprognostic (6.04e-2)" "unprognostic (1.65e-1)" "unprognostic (5.15e-2)" "unprognostic (1.95e-1)" 1.0 0.2 1.7 0.0 2.8 0.4 0.1 0.3 4.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.5 0.0 0.1 1.1 0.5 0.1 0.0 0.2 3.3 0.7 0.0 0.2 0.0 1.9 0.0 0.1 0.0 0.0 0.0 1.7 0.4 0.1 0.1 0.1 0.0 0.2 1.6 0.3 0.3 4.2 0.0 0.0 1.7 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 1.7 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.4 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.6 0.1 1.7 2.8 0.3 4.0 1.1 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SP8 ENSG00000164651 "Sp8 transcription factor" Q8IXZ3 7 20782283-20786886 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 14.3" "Cell type enhanced" "Detected in some" 16 "Basal glandular cells: 2.9;Glandular cells: 2.4;Spermatocytes: 1.2;Spermatogonia: 1.6" "Cancer enhanced" "Detected in many" "testis cancer: 7.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HUVEC TERT2: 5.9;NTERA-2: 12.2;PC-3: 20.6" "Group enriched" "Detected in some" 13 "basal ganglia: 15.7;olfactory region: 66.8" "Region enriched" "Detected in some" 11 "olfactory region: 72.4" HPA054006 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA054006: AB_2682340" "unprognostic (1.56e-1)" "unprognostic (1.49e-1)" "unprognostic (2.91e-2)" "unprognostic (1.35e-1)" "unprognostic (7.90e-4)" "unprognostic (3.46e-1)" "unprognostic (5.49e-1)" "unprognostic (1.73e-2)" "unprognostic (2.42e-2)" "unprognostic (3.38e-1)" "unprognostic (7.44e-2)" 0.1 0.1 2.3 0.1 2.8 0.1 0.2 0.1 3.2 0.3 0.3 1.9 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.5 0.3 0.1 0.2 0.1 0.1 1.7 0.1 0.1 0.1 0.1 0.2 0.7 14.3 0.1 0.0 0.1 0.1 0.1 2.4 0.8 0.1 0.2 0.2 0.3 0.5 0.7 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.0 4.3 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.8 12.2 0.1 20.6 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.4 0.8 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.8 0.1 3.2 2.4 0.5 0.1 1.7 0.7 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.0 0.0 0.0 0.7 SP9 ZNF990 ENSG00000217236 "Sp9 transcription factor" P0CG40 2 174334946-174338492 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.4;fallopian tube: 5.1;skin 1: 4.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.0;fHDF/TERT166: 6.8;HEK 293: 2.8;THP-1: 14.4" "Group enriched" "Detected in some" 6 "basal ganglia: 6.0;olfactory region: 14.4" "Region enriched" "Detected in many" 4 "olfactory region: 44.8" HPA062616 Uncertain Approved Mitochondria NA NA Mitochondria "HPA062616: AB_2684808" "unprognostic (2.04e-2)" "unprognostic (6.94e-3)" "unprognostic (1.44e-1)" "unprognostic (3.95e-1)" "unprognostic (7.55e-3)" "unprognostic (8.54e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" 0.7 0.3 4.6 0.3 12.4 0.3 1.1 0.0 6.1 0.6 0.3 0.4 0.0 0.3 0.4 0.3 0.3 5.1 0.3 0.3 2.3 2.2 0.3 0.3 0.3 0.4 1.1 4.3 0.3 0.3 0.3 0.0 1.1 1.0 0.3 0.3 0.0 0.4 0.3 0.6 4.5 0.3 0.3 0.5 0.3 0.3 2.0 1.4 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 9.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 6.8 0.0 0.1 0.2 0.0 0.0 0.0 2.8 0.6 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 12.4 0.0 6.1 2.3 2.2 1.1 4.3 1.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 SPA17 "CT22, SP17" ENSG00000064199 "Sperm autoantigenic protein 17" Q15506 11 124673798-124697518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.2;testis: 82.1" "Cell type enhanced" "Detected in many" 22 "Ciliated cells: 459.0;Early spermatids: 1302.0;Late spermatids: 1861.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA037568 Enhanced Approved Vesicles NA NA Vesicles "HPA037568: AB_10672905" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (2.39e-3)" "prognostic favorable (1.03e-4)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-4)" "unprognostic (2.64e-1)" "unprognostic (3.80e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.71e-3)" "unprognostic (6.78e-2)" "unprognostic (9.78e-3)" "unprognostic (8.52e-2)" "unprognostic (2.71e-1)" 1.3 2.2 5.6 1.3 6.0 2.3 3.5 1.0 5.8 3.5 3.5 4.3 2.8 1.9 2.7 13.7 2.1 28.2 2.8 2.0 5.6 6.8 5.9 1.1 4.5 1.3 3.9 4.3 3.2 1.8 4.4 8.1 1.4 20.1 2.2 3.9 0.8 1.6 2.7 0.7 1.3 1.6 1.9 3.6 1.0 2.2 82.1 2.7 2.6 7.6 1.6 1.7 1.8 1.3 0.5 3.7 4.2 6.0 0.4 1.3 1.8 11.6 8.7 20.0 8.3 6.4 9.6 10.4 8.6 13.1 8.8 7.5 2.8 24.6 5.3 5.8 12.3 10.1 8.3 8.3 14.6 13.9 5.7 6.0 8.3 1.6 5.3 4.6 1.8 3.6 3.9 7.8 15.7 8.1 7.9 8.8 10.9 11.6 4.8 19.6 10.1 1.2 0.4 9.2 14.7 8.3 6.8 3.1 0.0 21.0 5.4 13.3 8.9 19.1 6.4 5.3 10.0 40.0 8.7 8.5 10.2 9.3 4.9 10.9 2.1 1.7 3.3 8.9 1.7 10.8 4.2 4.5 0.8 0.7 3.5 0.6 0.4 1.3 0.8 3.7 0.5 1.1 0.8 0.2 0.4 6.0 1.7 1.2 1.8 5.6 6.0 1.0 5.8 5.6 6.8 3.9 4.3 20.1 2.7 3.0 9.3 0.0 4.4 2.4 2.6 1.9 15.3 459.0 71.7 19.2 3.9 5.3 16.6 24.9 1302.0 4.5 10.5 0.0 13.6 8.5 3.0 3.1 0.0 1.1 10.2 0.0 6.9 2.5 4.0 1861.1 25.9 7.1 1.7 1.8 7.9 8.2 12.0 10.5 17.0 38.2 0.9 12.9 3.4 239.9 61.1 1.9 2.3 1.8 9.4 5.1 SPAAR "LINC00961, SPAR" ENSG00000235387 "Small regulatory polypeptide of amino acid response" A0A1B0GVQ0 9 35909483-35937153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.2;breast: 13.7;testis: 16.5" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.1;Club cells: 1.2;Proximal tubular cells: 2.7" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Group enriched" "Detected in some" 13 "HUVEC TERT2: 22.6;TIME: 26.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.17e-1)" "unprognostic (2.19e-2)" "unprognostic (1.91e-2)" "unprognostic (7.00e-3)" "unprognostic (4.23e-2)" "unprognostic (2.61e-3)" "unprognostic (6.95e-2)" "unprognostic (1.00e-1)" "unprognostic (3.40e-3)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (7.72e-2)" "unprognostic (7.12e-3)" "unprognostic (1.67e-2)" "unprognostic (3.04e-1)" "unprognostic (1.27e-1)" "unprognostic (3.22e-1)" 12.2 0.6 1.4 0.7 2.4 0.0 13.7 0.3 1.2 0.2 0.9 0.3 0.8 0.3 0.5 0.3 0.6 0.4 0.8 5.6 1.4 3.5 1.3 4.6 0.4 1.4 0.1 0.2 0.5 0.1 0.4 6.9 1.9 0.3 0.4 0.9 0.8 0.5 6.2 0.0 0.6 0.8 1.3 0.4 0.3 16.5 1.4 0.0 1.1 1.2 0.0 0.3 2.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.0 0.0 22.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 26.4 0.0 0.6 1.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA1 SAMP32 ENSG00000118434 "Sperm acrosome associated 1" Q9HBV2 6 88047789-88066832 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 99 "testis: 49.2" "Cell type enriched" "Detected in some" 26 "Early spermatids: 646.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HSkMC: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA026744, HPA043297" Enhanced NA NA "HPA026744: AB_2194642, HPA043297: AB_2678413" "unprognostic (4.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 646.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.5 0.0 22.2 4.4 0.0 0.0 0.0 0.0 0.0 SPACA3 "ALLP17, CT54, LYC3, LYZL3, SLLP1" ENSG00000141316 "Sperm acrosome associated 3" Q8IXA5 17 32970376-32997877 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "pancreas: 15.0;testis: 45.6" "Group enriched" "Detected in some" 70 "Early spermatids: 974.2;Late spermatids: 721.4" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 3.9" "Lineage enriched" "Detected in single" 4 "B-cells: 3.9" "Cell line enriched" "Detected in some" 17 "U-266/70: 47.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023633 Enhanced "Secreted in male reproductive system" NA NA "HPA023633: AB_1857407" "unprognostic (6.48e-2)" "unprognostic (2.83e-1)" "unprognostic (1.30e-1)" "unprognostic (7.08e-2)" "unprognostic (1.16e-2)" "unprognostic (1.31e-2)" "unprognostic (3.37e-1)" "unprognostic (5.91e-2)" "unprognostic (1.68e-1)" "unprognostic (5.70e-4)" "unprognostic (3.86e-2)" "unprognostic (1.79e-1)" "unprognostic (4.63e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 15.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 45.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.9 0.9 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 974.2 0.0 0.7 0.0 0.9 0.0 0.1 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 721.4 12.0 0.0 1.7 0.0 0.6 0.0 0.7 0.3 4.6 0.0 0.0 6.5 0.0 8.8 5.1 0.0 0.0 0.0 0.6 0.0 SPACA4 SAMP14 ENSG00000177202 "Sperm acrosome associated 4" Q8TDM5 19 48606743-48607714 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 65.9" "Cell type enriched" "Detected in some" 7 "Early spermatids: 804.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.1;AN3-CA: 1.8;MCF7: 2.7;NTERA-2: 2.4;OE19: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041927, HPA061302" Enhanced NA NA "HPA041927: AB_10794162, HPA061302: AB_2684475" "unprognostic (2.48e-2)" "unprognostic (6.37e-4)" "unprognostic (6.59e-2)" "unprognostic (4.52e-2)" "unprognostic (2.09e-3)" "unprognostic (9.43e-6)" "unprognostic (6.67e-3)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (2.78e-1)" "unprognostic (3.43e-1)" "unprognostic (2.88e-1)" "unprognostic (4.47e-1)" "unprognostic (2.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.1 0.1 0.1 2.3 0.1 0.4 0.7 0.0 0.8 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.1 1.0 1.8 0.1 0.1 0.1 2.9 65.9 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 1.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 2.7 0.0 1.1 2.4 3.2 1.4 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.6 0.5 0.0 0.6 1.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 804.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 4.2 2.5 1.4 0.0 0.0 0.0 0.1 SPACA5 "dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288" ENSG00000171489 "Sperm acrosome associated 5" Q96QH8 X 48004336-48009729 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 15.1" "Cell type enriched" "Detected in single" 29 "Early spermatids: 2.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;JURKAT: 1.3;NB-4: 3.9;U-266/70: 1.2;U-266/84: 2.1" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" NA NA "HPA044747: AB_2679071, HPA047149: AB_2679955" 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.8 0.0 0.3 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.5 0.4 0.3 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.0 0.0 15.1 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.9 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.3 3.9 0.9 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.5 1.1 0.0 0.0 0.4 0.0 0.7 0.0 1.2 2.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA5B LYZL5B ENSG00000171478 "Sperm acrosome associated 5B" Q96QH8 X 48130657-48132613 "Enzymes, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 18.3" "Cell type enriched" "Detected in single" 12 "Early spermatids: 1.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "T-reg: 1.9" "Lineage enriched" "Detected in single" 19 "T-cells: 1.9" "Not detected" "Not detected" "HPA044747, HPA047149" Supported "Secreted in male reproductive system" NA NA "HPA044747: AB_2679071, HPA047149: AB_2679955" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA6 "LET7EH, LINC00085, NCRNA00085, SPACA6P" ENSG00000182310 "Sperm acrosome associated 6" W5XKT8 19 51689128-51712387 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.6;testis: 9.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 5.0;Collecting duct cells: 17.4;Distal tubular cells: 6.6;Proximal tubular cells: 13.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "memory CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.9;HEK 293: 6.4;HeLa: 2.2;U-87 MG: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.43e-1)" "unprognostic (6.12e-2)" "unprognostic (5.80e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (7.13e-2)" "unprognostic (1.45e-1)" "unprognostic (8.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.10e-3)" "unprognostic (1.06e-1)" "unprognostic (2.82e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (1.98e-10)" "unprognostic (6.64e-3)" "unprognostic (1.98e-1)" "unprognostic (6.05e-2)" "unprognostic (1.14e-2)" 1.3 0.7 2.3 0.2 2.8 0.2 0.2 6.6 1.8 0.6 0.5 2.0 0.0 0.2 4.0 0.9 0.8 0.7 0.6 0.2 2.5 0.7 0.2 1.4 0.5 2.3 0.8 1.3 1.7 0.2 2.9 3.2 3.1 1.6 0.4 0.0 0.5 1.3 1.6 0.2 0.6 1.4 1.2 0.7 0.5 9.0 1.2 0.0 0.3 0.3 0.2 0.4 1.3 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.9 0.8 0.6 0.0 0.0 0.0 0.3 0.7 0.0 0.6 2.9 0.0 1.1 0.0 0.4 0.0 0.1 2.2 0.2 0.6 0.0 0.0 6.4 0.7 2.2 0.0 0.8 0.0 0.7 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.1 0.0 0.0 1.1 0.6 1.3 0.8 1.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 17.4 0.0 0.0 6.6 1.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 1.4 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPACA7 C13orf28 ENSG00000153498 "Sperm acrosome associated 7" Q96KW9 13 112376319-112434689 "Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 68.5" "Group enriched" "Detected in some" 137 "Early spermatids: 1028.4;Late spermatids: 637.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.6" HPA048349 Enhanced "Secreted in male reproductive system" NA NA "HPA048349: AB_2732548" "unprognostic (3.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 68.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.5 4.5 0.8 0.6 0.5 0.2 0.6 0.9 0.5 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.1 1.2 1.0 0.0 0.8 0.5 0.0 0.3 0.0 0.8 0.0 0.6 1.7 0.0 0.0 0.4 1.2 0.0 0.0 0.0 0.0 0.1 0.2 1.1 2.2 1.1 0.0 1.0 1.1 0.7 0.6 0.3 0.9 0.8 0.1 0.3 0.0 0.8 2.6 0.8 0.3 0.8 0.9 0.3 0.5 1.2 0.0 0.7 0.4 1.8 0.3 0.9 1.1 1.0 0.2 0.2 0.4 3.2 0.8 0.7 0.5 0.5 0.2 0.2 0.2 0.2 0.2 0.7 0.3 0.5 4.5 0.6 0.5 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1028.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 637.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 5.4 3.4 0.0 0.0 0.0 0.0 0.0 SPACA9 "C9orf9, Mast" ENSG00000165698 "Sperm acrosome associated 9" Q96E40 9 132878027-132890201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "epididymis: 55.8;fallopian tube: 29.1;testis: 53.8" "Cell type enriched" "Detected in some" 4 "Ciliated cells: 116.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "JURKAT: 32.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA022243, HPA051600" Enhanced Approved Mitochondria No No Mitochondria "HPA022243: AB_1845844, HPA051600: AB_2681546" "unprognostic (2.69e-1)" "unprognostic (2.14e-3)" "unprognostic (8.00e-3)" "prognostic favorable (8.61e-4)" "unprognostic (1.59e-1)" "unprognostic (5.73e-2)" "unprognostic (3.76e-3)" "unprognostic (2.60e-1)" "unprognostic (6.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.15e-2)" "unprognostic (9.51e-2)" "prognostic favorable (8.31e-4)" "unprognostic (5.11e-2)" "unprognostic (1.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" 2.7 6.0 7.8 1.6 8.4 1.7 3.9 4.3 9.3 5.1 4.8 8.5 7.9 1.7 5.3 55.8 5.3 29.1 4.5 7.0 7.0 8.9 7.0 1.8 4.6 2.1 7.2 7.3 9.2 2.8 2.7 5.8 3.0 6.9 4.1 2.1 5.7 7.7 6.2 1.5 8.0 1.7 4.3 7.7 2.3 3.1 53.8 5.1 6.2 10.2 3.6 3.0 2.9 3.8 6.0 3.0 5.6 3.3 7.8 3.5 1.6 1.9 2.1 3.2 2.7 4.6 5.9 3.9 1.2 2.3 1.7 1.9 0.5 6.1 0.5 2.9 5.7 3.7 2.8 1.3 3.6 1.6 2.3 2.6 0.5 1.5 0.7 6.7 1.4 0.2 6.7 7.7 4.3 4.8 7.3 2.0 32.5 0.5 1.7 4.7 4.2 4.9 5.6 0.7 3.7 2.0 2.3 0.7 1.4 7.1 0.7 0.9 3.2 5.3 0.9 4.2 2.5 7.0 0.5 1.9 3.8 2.6 3.6 0.5 0.7 1.1 1.7 7.0 0.5 1.8 5.6 2.2 3.6 2.2 2.0 2.5 6.0 2.4 1.3 3.0 4.7 2.9 2.6 3.1 7.8 3.3 1.0 3.5 1.6 7.8 8.4 4.3 9.3 7.0 8.9 7.2 7.3 6.9 5.1 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 116.4 9.1 22.7 0.0 14.2 28.2 6.2 0.0 0.0 0.0 0.0 6.2 10.9 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 5.4 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 SPAG11A "EDDM2A, HE2" ENSG00000178287 "Sperm associated antigen 11A" Q6PDA7 8 7847876-7868867 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 225 "epididymis: 332.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 10.4" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 332.8 1.4 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG11B "EDDM2B, EP2, EP2C, EP2D, HE2" ENSG00000164871 "Sperm associated antigen 11B" Q08648 8 7442684-7463674 "Predicted intracellular proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 232 "epididymis: 362.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 5.7;NB-4: 12.6;RPMI-8226: 5.8;SH-SY5Y: 5.1" "HPA023842, HPA057479" Supported Approved "Golgi apparatus" "Secreted in male reproductive system" NA NA "Golgi apparatus" "HPA023842: AB_2732429, HPA057479: " 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 362.2 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.6 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPAG17 "CT143, FLJ34497, PF6, RP4-776P7.2" ENSG00000155761 "Sperm associated antigen 17" Q6Q759 1 117953861-118185223 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.1;epididymis: 16.3;testis: 24.7" "Cell type enhanced" "Detected in many" 20 "Ciliated cells: 444.4;Early spermatids: 203.6;Late spermatids: 292.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 4 "pons and medulla: 24.1" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HL-60: 1.7;HMC-1: 1.5;RT4: 2.7;SCLC-21H: 3.1;SuSa: 2.8;U-2 OS: 1.1" "Low region specificity" "Detected in single" "Region enhanced" "Detected in many" "midbrain: 12.2" "HPA028597, HPA028666" Enhanced NA NA "HPA028597: AB_10600221, HPA028666: AB_10602281" "unprognostic (3.67e-2)" "unprognostic (4.86e-3)" "unprognostic (3.42e-1)" "unprognostic (1.50e-2)" "unprognostic (1.56e-2)" "unprognostic (6.35e-3)" "unprognostic (2.36e-2)" "unprognostic (4.20e-2)" "unprognostic (3.19e-2)" "unprognostic (2.89e-2)" "unprognostic (1.40e-1)" "unprognostic (1.79e-1)" "unprognostic (2.76e-5)" "unprognostic (4.81e-1)" "unprognostic (9.90e-2)" "unprognostic (8.23e-2)" "unprognostic (9.67e-2)" 0.8 0.1 1.4 0.2 5.6 0.2 1.3 0.0 0.2 2.0 0.2 7.4 2.2 0.2 0.9 16.3 8.6 11.8 0.7 0.2 2.6 3.0 3.0 0.1 6.1 0.1 0.1 0.3 7.8 0.7 0.3 9.2 0.3 24.1 0.2 0.2 0.6 0.3 0.4 0.5 0.3 0.2 0.2 0.4 0.2 0.9 24.7 1.5 0.0 1.4 0.1 0.8 2.1 2.7 0.0 1.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.7 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.7 3.1 0.0 0.1 0.0 0.0 2.8 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.6 0.0 0.2 2.6 3.0 0.1 0.3 24.1 1.5 6.0 3.8 0.0 0.1 0.3 0.4 0.6 0.0 444.4 78.5 10.4 31.4 1.7 1.7 0.4 203.6 0.1 0.0 0.0 0.6 0.5 0.6 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 292.1 1.4 0.2 0.0 0.0 0.0 1.0 0.3 0.0 1.1 0.6 0.0 0.0 0.1 43.2 5.6 0.3 0.6 0.0 0.0 0.7 SPAG4 "CT127, SUN4" ENSG00000061656 "Sperm associated antigen 4" Q9NPE6 20 35615892-35621049 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 54.3" "Group enriched" "Detected in many" 5 "Early spermatids: 155.3;Late spermatids: 107.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 16.9;hTERT-RPE1: 12.4;U-87 MG: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA048393, HPA061789" Approved NA NA "HPA048393: AB_2680385, HPA061789: AB_2684609" "unprognostic (1.05e-1)" "unprognostic (5.61e-2)" "prognostic unfavorable (1.09e-5)" "prognostic favorable (9.52e-8)" "prognostic unfavorable (6.31e-5)" "unprognostic (1.05e-1)" "unprognostic (2.56e-3)" "unprognostic (1.21e-2)" "unprognostic (2.29e-1)" "unprognostic (4.77e-2)" "unprognostic (4.49e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.28e-4)" "unprognostic (3.59e-2)" "unprognostic (1.66e-1)" "unprognostic (1.79e-1)" "prognostic favorable (6.66e-4)" 1.7 2.9 1.6 4.8 1.4 3.8 3.7 0.4 5.3 2.7 13.9 0.2 3.3 4.0 1.5 4.4 2.8 2.5 3.4 2.6 1.1 2.0 3.1 3.0 3.2 4.9 1.3 1.6 5.2 54.3 3.2 5.0 7.0 2.3 2.6 2.0 2.8 4.5 2.5 0.4 0.4 3.4 1.2 2.9 6.9 4.6 16.9 1.5 0.0 1.3 0.0 7.5 7.2 1.8 0.9 3.9 0.0 0.7 0.0 1.0 0.4 2.3 1.0 0.5 1.4 1.3 0.6 6.7 1.0 1.2 0.9 1.4 2.4 5.1 0.2 16.9 1.3 4.1 0.7 0.3 3.2 1.1 2.5 0.5 1.9 2.3 2.4 6.6 1.3 3.4 3.2 0.6 1.0 0.8 12.4 1.9 0.7 0.5 4.7 2.4 4.9 0.5 3.7 0.0 4.4 4.6 0.3 0.5 6.6 1.7 1.0 0.3 2.4 1.1 0.8 1.8 0.3 3.4 0.6 2.0 4.8 0.7 1.0 1.0 9.1 3.5 1.9 30.6 0.5 0.7 0.0 0.1 0.0 0.0 0.7 0.5 0.9 0.1 0.4 0.4 0.0 0.5 0.0 0.0 0.0 0.0 3.9 1.0 0.4 1.6 1.4 0.4 5.3 1.1 2.0 1.3 1.6 2.3 1.5 0.0 0.3 2.2 0.9 0.3 2.6 1.5 0.0 0.0 1.2 0.0 2.0 1.3 0.0 8.1 155.3 3.6 0.3 0.0 6.5 11.2 1.8 1.0 4.6 4.3 1.3 1.6 4.1 5.5 1.9 107.6 1.7 1.2 25.3 3.6 0.3 14.0 19.0 0.9 2.8 3.1 1.9 0.0 2.5 14.1 0.7 0.1 16.9 2.9 0.4 3.0 SPAG5 "DEEPEST, hMAP126, MAP126" ENSG00000076382 "Sperm associated antigen 5" Q96R06 17 28577565-28599279 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.3;testis: 94.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 101.5;Spermatocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 10.1;T-reg: 6.2" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;T-cells: 6.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA022008, HPA022479, HPA024418" Approved Supported "Nuclear bodies,Mitotic spindle,Cytosol" NA Yes "Nuclear bodies, Mitotic spindle" Cytosol "HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: " "unprognostic (4.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.31e-3)" "unprognostic (2.32e-3)" "unprognostic (3.50e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (5.43e-5)" "unprognostic (3.37e-3)" "unprognostic (4.84e-3)" "unprognostic (5.97e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.49e-2)" "prognostic unfavorable (5.43e-13)" "unprognostic (2.64e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-2)" "unprognostic (2.01e-1)" 2.1 1.1 2.3 7.6 3.8 16.5 1.7 2.7 3.4 1.7 5.1 0.8 0.5 3.9 2.0 1.9 3.8 0.5 1.8 1.7 1.8 3.7 12.7 9.5 2.6 6.5 1.5 0.7 1.4 1.9 0.4 1.9 3.3 1.3 1.3 5.3 1.3 1.4 0.9 0.8 2.5 7.1 1.5 1.9 5.8 1.7 94.2 1.0 27.3 3.9 5.5 11.2 1.8 1.3 1.2 0.4 10.1 0.7 1.0 6.2 1.2 23.8 25.3 30.3 23.5 1.5 2.5 12.4 19.3 12.2 28.7 23.2 19.7 7.3 16.8 10.5 13.4 27.0 20.8 32.9 12.2 30.7 30.2 21.1 17.8 25.2 23.9 0.2 23.1 22.5 0.8 1.1 23.1 12.0 4.2 15.0 26.2 19.2 29.7 23.3 15.7 30.4 27.5 16.3 19.2 12.8 20.3 42.2 20.0 8.6 12.7 23.0 13.5 27.7 33.4 9.6 26.1 23.8 21.2 7.4 16.6 27.9 13.7 32.9 13.8 21.1 25.9 11.2 17.7 26.4 10.1 0.0 0.3 0.6 0.7 1.1 0.9 1.8 1.3 0.1 1.2 1.5 1.4 0.6 1.0 0.4 0.4 6.2 1.2 2.3 3.8 2.7 3.4 1.8 3.7 1.5 0.7 1.3 1.0 3.0 1.7 2.2 1.1 1.8 4.7 0.4 0.0 10.7 2.3 0.0 0.0 1.7 1.7 0.5 101.5 1.0 6.2 23.3 0.3 10.6 1.1 0.6 1.1 3.9 5.3 3.2 12.5 4.3 1.8 14.4 0.9 3.6 0.0 1.0 2.3 0.6 0.3 0.8 0.0 10.9 3.3 6.5 1.7 43.6 23.0 0.9 3.2 2.5 2.7 0.5 SPAG6 "CT141, pf16, Repro-SA-1" ENSG00000077327 "Sperm associated antigen 6" O75602 10 22345445-22454224 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 31.1;fallopian tube: 29.5;testis: 70.6" "Group enriched" "Detected in some" 8 "Ciliated cells: 262.3;Early spermatids: 120.4;Spermatocytes: 275.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 31.1" "Cell type enhanced" "Detected in some" "eosinophil: 2.9" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 28 "U-937: 48.8" "Region enhanced" "Detected in many" "midbrain: 17.9" HPA038440 Enhanced NA NA "HPA038440: AB_10671742" "unprognostic (5.02e-2)" "unprognostic (9.52e-2)" "unprognostic (8.94e-6)" "unprognostic (2.21e-1)" "unprognostic (2.51e-2)" "unprognostic (4.91e-3)" "unprognostic (1.68e-1)" "unprognostic (2.38e-1)" "unprognostic (8.68e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-3)" "unprognostic (3.10e-2)" "unprognostic (2.78e-4)" 0.3 0.3 2.8 0.3 5.2 0.5 1.4 0.0 2.0 1.1 0.3 8.6 0.0 0.3 0.4 8.7 0.3 29.5 0.3 0.3 5.0 5.1 0.5 0.4 5.3 0.3 0.7 0.6 3.1 0.5 0.3 12.4 0.3 31.1 0.8 0.3 0.5 0.3 0.3 0.3 0.3 0.3 0.3 1.1 0.3 0.3 70.6 1.6 0.0 0.3 0.0 0.3 0.3 0.1 0.0 1.2 2.9 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 48.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.5 0.0 2.8 5.2 0.0 2.0 5.0 5.1 0.7 0.6 31.1 1.6 0.0 3.7 0.0 0.1 0.1 0.1 0.6 0.0 262.3 27.3 0.0 0.0 0.0 1.7 0.0 120.4 0.0 0.0 0.0 0.0 0.0 0.0 3.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 25.3 4.6 0.8 1.7 0.0 0.0 0.0 0.6 0.0 4.6 0.3 1.0 0.0 0.2 275.9 3.7 0.1 0.0 0.0 0.0 0.0 SPAG7 "ACRP, FSA-1, MGC20134" ENSG00000091640 "Sperm associated antigen 7" O75391 17 4959226-4967872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024032, HPA052394" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA024032: AB_1857410, HPA052394: AB_2681810" "unprognostic (7.10e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-2)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (2.92e-1)" "unprognostic (8.90e-2)" "unprognostic (9.83e-2)" "unprognostic (8.35e-2)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.79e-5)" "unprognostic (4.66e-3)" "unprognostic (5.51e-2)" "unprognostic (7.07e-3)" "unprognostic (2.72e-2)" 18.1 19.8 23.5 15.7 24.4 15.5 16.1 14.4 30.9 15.9 19.4 10.5 20.0 14.7 23.2 22.9 18.5 27.6 17.0 53.7 20.5 19.4 25.2 24.4 17.9 15.6 19.8 21.8 14.8 19.4 19.4 13.2 24.8 22.6 17.7 15.5 16.6 18.9 20.1 106.4 14.3 17.6 20.1 21.8 17.4 17.7 15.0 12.8 13.9 22.5 47.9 16.0 15.7 15.4 38.0 42.8 30.8 35.5 24.3 41.9 33.2 12.3 27.3 36.1 20.0 25.1 36.6 20.9 24.6 27.9 24.0 18.5 15.9 16.2 15.7 36.3 30.1 16.9 17.8 18.0 37.3 10.9 23.0 16.0 17.0 22.4 22.1 35.1 9.4 25.6 40.1 27.0 20.5 38.5 36.9 30.2 20.4 11.3 16.3 29.2 19.6 17.1 21.0 20.5 17.2 8.8 18.2 22.9 11.2 41.1 15.5 10.2 20.1 20.9 8.4 20.1 19.4 18.1 15.0 29.1 16.4 10.7 8.0 20.0 14.5 11.4 9.6 32.3 13.5 21.1 28.1 35.5 30.8 35.4 29.2 38.4 38.0 33.4 33.0 41.7 31.4 41.9 36.6 9.4 24.3 27.8 42.8 37.2 33.2 23.5 24.4 14.4 30.9 20.5 19.4 19.8 21.8 22.6 12.8 53.6 52.4 68.0 80.5 49.1 57.7 115.7 86.6 87.0 45.5 94.2 43.2 162.3 275.2 131.6 20.1 62.6 81.8 0.0 126.2 143.9 62.5 71.5 70.6 62.5 122.0 87.4 54.9 52.8 58.5 16.1 42.6 80.2 99.5 332.8 62.3 64.8 123.9 74.6 39.6 178.0 53.9 71.1 68.4 48.3 44.6 43.8 193.0 63.3 64.9 81.3 SPAG8 "BS-84, CT142, HSD-1, hSMP-1, SPAG3" ENSG00000137098 "Sperm associated antigen 8" Q99932 9 35808045-35812272 "Predicted intracellular proteins" "Cell cycle, Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.7;epididymis: 9.7;fallopian tube: 30.0;testis: 23.6" "Cell type enhanced" "Detected in many" 18 "Ciliated cells: 95.0;Early spermatids: 32.1;Late spermatids: 22.4;Spermatocytes: 42.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basal ganglia: 8.6;pons and medulla: 32.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 4.2" "Low region specificity" "Detected in all" HPA068012 Enhanced NA NA "HPA068012: AB_2685941" "unprognostic (1.01e-4)" "unprognostic (3.52e-3)" "unprognostic (6.36e-3)" "prognostic favorable (2.15e-4)" "unprognostic (2.62e-1)" "unprognostic (5.04e-2)" "unprognostic (1.65e-2)" "unprognostic (1.47e-2)" "unprognostic (1.59e-1)" "unprognostic (4.65e-2)" "unprognostic (1.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.22e-2)" "unprognostic (5.41e-2)" "unprognostic (1.33e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-3)" 1.0 1.4 2.4 0.9 8.6 1.1 1.1 1.1 3.5 3.7 1.3 9.1 2.7 1.4 1.6 9.7 1.2 30.0 1.6 2.6 4.1 3.2 1.2 0.8 2.9 1.2 1.6 2.8 2.5 1.2 2.2 3.9 1.0 32.7 1.4 0.8 2.5 1.3 3.5 1.3 1.1 1.0 1.0 2.2 1.2 1.2 23.6 4.4 0.9 2.9 0.4 0.9 1.7 0.7 1.3 3.0 4.2 1.8 2.3 2.7 1.0 0.1 0.2 0.0 0.4 4.2 1.4 0.0 0.4 0.2 1.4 0.5 0.8 0.2 0.0 0.0 0.2 0.6 1.0 0.4 1.9 0.2 0.9 0.3 1.3 0.2 0.1 0.3 0.0 0.4 1.1 0.8 1.6 0.8 2.5 1.2 0.1 0.1 1.5 1.5 0.8 0.3 0.1 0.4 0.0 0.8 0.4 0.5 1.3 1.5 0.0 1.5 0.9 0.1 0.1 0.4 0.3 0.9 1.5 1.2 0.3 0.6 0.7 0.1 0.5 0.6 0.1 2.1 1.2 0.8 4.2 1.8 0.0 1.6 1.2 0.5 0.2 1.3 1.8 3.0 1.3 0.9 2.5 0.0 2.3 0.1 0.1 2.7 1.0 2.4 8.6 1.1 3.5 4.1 3.2 1.6 2.8 32.7 4.4 0.0 1.0 0.0 1.0 0.3 4.8 2.9 0.0 95.0 10.3 5.2 7.9 0.3 1.7 0.3 32.1 0.6 0.0 0.0 0.0 0.1 0.8 1.0 1.1 0.0 0.9 3.2 2.9 1.8 0.3 22.4 1.4 1.8 0.0 1.8 0.0 5.0 0.1 0.0 1.1 1.1 8.0 0.0 1.2 42.2 2.1 0.5 0.1 0.8 0.0 0.2 SPAM1 "HYAL5, PH-20, SPAG15" ENSG00000106304 "Sperm adhesion molecule 1" P38567 7 123925237-123971414 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 38 "testis: 19.6" "Group enriched" "Detected in some" 58 "Early spermatids: 169.9;Late spermatids: 83.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;SuSa: 1.5" "Not detected" "Not detected" HPA017984 Enhanced NA NA "HPA017984: AB_1857413" "unprognostic (2.44e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 169.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 83.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 1.1 0.0 2.2 0.0 0.0 0.0 SPANXA1 "CT11.1, NAP-X, SPAN-Xa, SPAN-Xb, SPANX" ENSG00000198021 "Sperm protein associated with the nucleus, X-linked, family member A1" Q9NS26 X 141583674-141585011 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 28 "testis: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXA2 SPANX ENSG00000203926 "SPANX family member A2" Q9NS26 X 141589435-141590772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 22 "testis: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;PC-3: 1.5;U-2 OS: 5.7;U-2197: 1.2" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXB1 "CT11.2, SPANXB2, SPANXF1, SPANXF2" ENSG00000227234 "SPANX family member B1" Q9NS25 X 141002591-141003706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 38.5" "Group enriched" "Detected in some" 136 "Early spermatids: 450.0;Late spermatids: 1630.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 41.1;GAMG: 8.8;U-2 OS: 14.4" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (8.55e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 41.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 14.4 1.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 450.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1630.4 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 7.6 4.0 0.0 0.0 0.0 0.0 0.0 SPANXC "CT11.3, CTp11" ENSG00000198573 "SPANX family member C" Q9NY87 X 141241463-141242496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 27.3" "Group enriched" "Detected in some" 194 "Early spermatids: 365.4;Late spermatids: 1260.1" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 13.3;U-2 OS: 6.5" "HPA046423, HPA073647" Supported Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" "unprognostic (3.56e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 13.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.8 6.5 0.0 0.5 0.0 0.0 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 365.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1260.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 4.2 2.0 0.0 0.0 0.0 0.0 0.0 SPANXD "CT11.4, SPANXE" ENSG00000196406 "SPANX family member D" Q9BXN6 X 141697411-141698739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 216 "testis: 21.5" "Group enriched" "Detected in some" 148 "Early spermatids: 386.5;Late spermatids: 1076.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 5.1;U-2 OS: 9.8" "HPA046423, HPA073647" Supported Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA046423: AB_2679660, HPA073647: AB_2732232" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 9.8 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 386.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1076.8 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.1 1.5 0.0 0.0 0.0 0.0 0.0 SPANXN1 "CT11.6, SPANX-N1" ENSG00000203923 "SPANX family member N1" Q5VSR9 X 145246828-145256112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 4.7" "Group enriched" "Detected in some" 6 "Early spermatids: 5.4;Late spermatids: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 1.0;U-138 MG: 2.5;U-2 OS: 1.7;U-251 MG: 2.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.7 0.0 2.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPANXN2 "CT11.7, SPANX-N2" ENSG00000268988 "SPANX family member N2" Q5MJ10 X 143711955-143721423 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Group enriched" "Detected in some" 121 "Early spermatids: 41.8;Late spermatids: 95.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA045652: AB_2679408" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 SPANXN3 "CT11.8, SPANX-N3" ENSG00000189252 "SPANX family member N3" Q5MJ09 X 143508735-143517475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 28.4" "Group enriched" "Detected in some" 116 "Early spermatids: 353.2;Late spermatids: 183.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2 OS: 6.6" HPA045652 Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA045652: AB_2679408" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.6 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 353.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 183.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.0 0.0 SPANXN4 "CT11.9, SPANX-N4" ENSG00000189326 "SPANX family member N4" Q5MJ08 X 143025918-143034702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 23.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 233.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Cell line enhanced" "Detected in some" "HEL: 2.4;HeLa: 4.2;hTERT-HME1: 1.0" "HPA045730, HPA059094" Uncertain Approved "Nuclear membrane,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "Nuclear membrane" "HPA045730: AB_10961036, HPA059094: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 4.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 233.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 SPANXN5 "CT11.10, SPANX-N5" ENSG00000204363 "SPANX family member N5" Q5MJ07 X 52796144-52798101 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 78 "testis: 15.8" "Group enriched" "Detected in some" 12 "Early spermatids: 252.2;Late spermatids: 65.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;LHCN-M2: 1.0;U-2 OS: 2.9" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.3 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 12.9 0.0 1.9 1.6 0.0 0.1 0.0 0.0 0.0 SPATA1 SP-2 ENSG00000122432 "Spermatogenesis associated 1" 1 84506300-84566194 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 4.6;testis: 6.9" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.7;Cardiomyocytes: 2.9;Club cells: 4.5;Collecting duct cells: 5.2;monocytes: 2.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 1.8;REH: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (6.00e-3)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.94e-1)" "unprognostic (6.72e-2)" "unprognostic (2.46e-2)" "unprognostic (4.82e-2)" "unprognostic (8.84e-3)" "unprognostic (7.54e-2)" "unprognostic (2.77e-3)" "unprognostic (5.52e-4)" "unprognostic (2.03e-1)" "unprognostic (5.81e-8)" "unprognostic (1.63e-1)" "unprognostic (5.34e-1)" "unprognostic (7.71e-2)" "unprognostic (3.79e-4)" 0.0 0.0 0.7 4.6 3.5 0.9 0.1 0.0 0.6 1.2 0.0 0.7 0.0 0.0 0.6 0.9 0.0 0.1 0.0 0.5 0.0 2.0 0.9 1.9 0.3 0.0 0.9 0.8 0.8 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.4 0.2 6.9 0.0 0.9 0.8 0.0 0.8 0.5 0.0 0.7 0.3 2.6 0.3 0.0 0.4 0.1 0.3 0.0 0.6 0.6 0.3 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.5 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.9 0.1 1.3 0.2 1.2 0.1 0.3 0.4 0.4 0.2 0.3 0.4 1.8 0.7 0.2 0.1 1.0 0.3 0.1 0.6 2.3 0.1 0.0 0.1 0.1 0.0 0.5 0.2 0.8 0.6 0.5 0.1 0.5 1.2 1.0 0.0 0.6 0.3 0.0 0.0 0.0 0.4 1.1 0.1 0.6 0.3 0.0 0.1 0.3 0.0 0.7 0.1 0.0 0.1 0.5 0.1 0.1 2.6 0.0 0.0 0.3 0.4 0.1 6.0 3.7 2.2 0.0 0.0 0.0 2.9 0.0 1.4 4.5 5.2 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 2.8 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060441-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Group enriched" "Detected in some" 125 "Early spermatids: 496.6;Late spermatids: 837.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.0" "Lineage enriched" "Detected in single" 10 "monocytes: 1.0" "Cell line enhanced" "Detected in some" "GAMG: 5.4;HUVEC TERT2: 2.4;RH-30: 3.1" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.2 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.1 0.8 0.1 0.3 2.4 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.3 0.0 0.2 0.0 0.1 0.1 0.0 0.1 1.1 0.1 0.4 26.6 0.0 0.0 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.5 0.5 0.0 5.4 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.6 0.0 0.0 1.1 0.2 0.5 0.0 0.0 1.1 2.4 0.0 0.0 0.6 0.2 0.1 0.0 0.0 1.5 1.2 1.5 0.0 3.1 0.1 2.0 1.2 0.0 0.0 0.2 0.0 1.3 0.6 0.0 0.0 0.8 0.0 2.0 0.4 0.3 0.0 0.2 1.0 0.6 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 496.6 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.3 837.5 4.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 5.3 0.0 0.0 0.0 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.3 SPATA16 NYD-SP12 ENSG00000144962 "Spermatogenesis associated 16" Q9BXB7 3 172889358-173141268 "Disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 49.2" "Group enriched" "Detected in some" 20 "Early spermatids: 184.3;Late spermatids: 101.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "GAMG: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA037884 Enhanced NA NA "HPA037884: AB_2675717" "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.0 7.0 1.5 0.0 0.0 0.0 0.0 0.0 SPATA17 IQCH ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 48.0" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 161.9;Early spermatids: 584.1;Late spermatids: 424.1;Spermatocytes: 138.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.5 0.6 1.4 0.3 5.2 2.4 0.9 0.5 1.2 1.0 0.5 2.7 2.9 0.6 0.7 9.7 0.5 6.8 0.8 1.1 2.3 2.2 2.8 0.4 3.0 0.3 0.8 1.6 3.3 0.6 3.0 10.8 0.4 11.1 0.7 0.3 1.2 0.6 1.2 2.9 1.0 0.7 0.2 0.7 0.4 0.6 48.0 1.4 0.0 3.1 0.3 0.2 0.5 0.5 1.3 0.6 2.3 0.6 0.6 1.0 0.1 0.6 1.2 1.2 1.2 0.3 2.0 0.9 0.5 0.7 0.6 0.3 0.8 3.2 0.6 1.0 0.4 0.4 2.2 0.8 1.1 0.7 0.6 1.2 0.5 1.5 0.8 0.6 0.3 0.5 0.7 2.3 1.2 1.2 1.4 0.1 0.7 0.7 1.3 0.6 2.5 0.4 1.0 2.3 1.6 1.2 0.4 0.4 0.4 2.3 0.9 4.8 1.9 0.7 0.8 0.6 2.0 1.5 0.6 0.6 0.8 0.6 0.9 0.5 1.3 0.8 0.3 1.9 0.5 1.1 2.3 0.5 0.5 0.9 0.5 0.8 0.7 0.7 0.7 0.3 1.3 0.9 1.0 1.5 0.6 0.6 0.6 0.3 0.1 1.4 5.2 0.5 1.2 2.3 2.2 0.8 1.6 11.1 1.4 3.0 0.0 0.0 0.8 0.6 0.4 1.4 0.0 161.9 25.0 3.5 19.6 0.7 5.0 1.7 584.1 0.5 0.0 0.0 0.6 0.5 0.7 1.6 0.0 0.0 0.2 0.0 1.7 0.0 0.0 424.1 8.1 0.7 1.7 0.0 1.0 5.1 0.2 0.0 6.3 8.4 18.5 0.0 0.1 138.2 8.1 0.9 0.2 0.0 0.6 0.4 SPATA18 FLJ32906 ENSG00000163071 "Spermatogenesis associated 18" Q8TC71 4 52051331-52097292 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 41.7;testis: 65.7" "Group enriched" "Detected in many" 10 "Early spermatids: 536.7;Late spermatids: 1836.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 12.5" "Cell type enriched" "Detected in single" 23 "naive B-cell: 2.2" "Lineage enriched" "Detected in single" 23 "B-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 20.1;BEWO: 15.1;BJ hTERT+: 9.7;HSkMC: 18.5;hTCEpi: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036854, HPA036855" Enhanced Supported Mitochondria NA NA Mitochondria "HPA036854: AB_10670927, HPA036855: AB_2675352" "unprognostic (6.54e-2)" "unprognostic (1.90e-1)" "unprognostic (1.46e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.27e-2)" "unprognostic (4.49e-2)" "unprognostic (1.76e-1)" "unprognostic (2.73e-1)" "unprognostic (3.13e-1)" "unprognostic (3.13e-2)" "prognostic favorable (3.73e-9)" "unprognostic (4.38e-1)" "unprognostic (1.39e-1)" "unprognostic (1.01e-2)" "unprognostic (4.00e-2)" 2.1 4.2 2.6 1.2 3.3 0.0 3.7 0.1 1.1 6.8 2.3 3.6 5.3 1.2 2.5 9.9 4.9 41.7 11.5 1.5 3.1 2.8 3.7 4.4 12.0 0.3 0.6 0.6 7.6 1.6 4.2 6.1 1.8 12.5 3.5 3.5 1.4 13.2 6.0 1.1 4.3 2.8 1.8 0.8 0.5 2.9 65.7 0.8 1.3 1.6 4.1 3.1 2.3 2.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.1 0.0 8.0 20.1 15.1 5.6 9.7 0.3 0.4 0.0 0.9 0.0 0.0 7.4 0.1 0.1 0.0 4.3 0.2 0.0 0.6 0.0 0.0 4.7 7.1 0.0 0.0 18.5 17.8 0.6 2.8 3.2 4.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 1.2 0.6 0.0 0.0 6.3 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.3 0.1 1.1 3.1 2.8 0.6 0.6 12.5 0.8 8.9 4.0 0.0 6.6 4.6 0.0 2.4 7.6 115.1 18.2 0.0 0.0 1.4 1.7 0.9 536.7 0.4 1.1 0.0 2.4 1.1 2.3 5.1 2.3 1.7 0.3 0.0 1.7 2.5 1.2 1836.3 10.0 1.2 0.0 0.0 1.6 0.0 1.2 2.9 10.3 5.4 0.0 0.0 1.8 11.7 6.8 6.6 0.7 0.0 3.8 6.4 SPATA19 "CT132, FLJ25851, SPAS1, spergen1" ENSG00000166118 "Spermatogenesis associated 19" Q7Z5L4 11 133840631-133845538 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 128 "testis: 46.8" "Group enriched" "Detected in some" 143 "Early spermatids: 721.0;Late spermatids: 1661.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;HBEC3-KT: 2.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA040082 Enhanced NA NA "HPA040082: AB_2676836" "unprognostic (9.90e-3)" "unprognostic (3.34e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 721.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1661.7 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 7.6 4.9 0.0 0.0 0.0 0.0 0.0 SPATA21 "spergen-2, spergen2" ENSG00000187144 "Spermatogenesis associated 21" Q7Z572 1 16387117-16437424 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 4.6;testis: 11.3" "Group enriched" "Detected in some" 7 "Early spermatids: 35.1;Late spermatids: 31.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "Hep G2: 11.0" HPA032080 Approved Vesicles,Cytosol No NA "Vesicles, Cytosol" "HPA032080: " "unprognostic (3.09e-1)" "unprognostic (8.26e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-1)" "unprognostic (2.37e-1)" "unprognostic (5.17e-3)" "unprognostic (1.16e-1)" "unprognostic (2.76e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" "unprognostic (5.33e-2)" "unprognostic (3.14e-1)" "unprognostic (2.74e-10)" "unprognostic (1.25e-1)" "unprognostic (1.88e-1)" "unprognostic (1.87e-1)" "unprognostic (9.71e-2)" 0.0 0.2 0.0 0.0 0.1 1.3 0.0 1.1 0.0 0.1 0.0 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.2 0.3 11.3 0.0 0.0 0.3 0.0 1.3 0.6 4.6 0.8 0.9 0.8 0.4 0.2 0.8 0.4 0.7 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 1.5 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 1.5 11.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.2 0.7 0.2 0.1 0.5 0.2 0.3 0.0 0.4 0.3 0.1 0.2 0.1 0.3 0.2 0.0 0.0 1.2 0.6 0.3 0.6 0.2 0.3 0.2 0.1 0.4 0.0 0.4 0.4 0.2 0.3 0.3 0.0 4.6 0.5 0.9 0.7 0.8 0.5 1.1 0.7 0.6 0.4 1.3 0.8 0.3 2.3 0.9 0.5 0.6 0.7 0.4 0.0 0.6 0.0 0.2 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 35.1 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.1 4.8 0.0 0.0 1.2 31.7 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 1.1 0.0 0.3 1.1 0.1 0.4 0.2 0.0 0.0 0.1 SPATA22 NYD-SP20 ENSG00000141255 "Spermatogenesis associated 22" Q8NHS9 17 3440019-3513852 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 75.9" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 958.8" "Cancer enriched" "Detected in single" 10 "testis cancer: 3.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "K-562: 9.8;TIME: 14.4" "Not detected" "Not detected" NA NA "unprognostic (4.09e-2)" "unprognostic (9.31e-2)" "unprognostic (2.54e-2)" "unprognostic (7.07e-2)" "unprognostic (9.05e-2)" "unprognostic (1.98e-2)" "unprognostic (6.79e-4)" "unprognostic (4.33e-1)" "unprognostic (1.87e-1)" "unprognostic (1.27e-1)" 0.4 0.2 0.3 0.1 0.3 0.0 0.4 0.4 0.6 0.2 0.1 0.3 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.2 0.3 0.3 0.3 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.0 0.1 1.2 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.0 0.1 0.1 0.4 0.2 0.0 75.9 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.8 0.0 1.3 0.9 2.6 0.4 0.0 0.0 0.2 1.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.3 1.0 0.0 0.4 0.1 0.0 0.1 2.3 2.6 0.0 0.9 0.4 0.8 0.0 0.4 0.3 0.3 0.4 0.6 0.3 0.3 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 175.6 0.0 0.0 0.0 0.0 14.5 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.2 154.8 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 12.9 0.0 958.8 28.8 0.1 1.0 0.0 0.0 0.0 SPATA24 "CCDC161, T6441" ENSG00000170469 "Spermatogenesis associated 24" Q86W54 5 139396563-139404088 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 52.2" "Group enriched" "Detected in many" 20 "Early spermatids: 924.4;Late spermatids: 2355.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044000 Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA044000: AB_10959668" "unprognostic (2.19e-3)" "unprognostic (1.18e-1)" "unprognostic (2.09e-1)" "unprognostic (9.30e-2)" "unprognostic (3.82e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.75e-4)" "unprognostic (1.26e-2)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (5.36e-3)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (1.24e-1)" "unprognostic (3.44e-1)" "unprognostic (1.46e-1)" "unprognostic (1.64e-1)" 1.0 2.8 3.6 1.0 3.2 0.3 1.4 1.5 2.7 1.3 1.6 2.7 1.8 2.5 1.6 9.4 1.4 6.4 2.9 8.5 3.4 2.6 6.2 1.9 1.9 2.5 2.4 2.1 1.6 2.2 6.1 7.0 1.0 3.2 2.2 0.9 1.7 3.2 1.5 8.7 0.9 2.6 1.9 2.7 1.9 1.5 52.2 2.1 1.8 2.9 3.4 1.9 1.8 3.5 5.7 3.6 2.0 3.1 2.4 7.7 2.5 6.5 4.1 5.9 3.1 1.7 3.3 4.7 1.6 3.1 3.4 6.1 9.4 8.7 10.4 4.9 3.2 11.7 3.6 4.4 7.2 3.8 41.6 5.1 3.2 7.7 7.1 6.5 0.7 5.7 2.8 3.6 5.1 6.2 3.9 4.1 6.7 3.1 18.3 4.6 3.7 6.5 5.0 4.3 2.6 3.6 15.4 3.9 14.1 8.1 3.3 4.5 4.1 6.3 12.3 2.9 14.8 3.5 7.2 7.6 2.0 2.8 3.9 4.7 4.5 4.2 9.6 4.0 5.4 1.7 0.0 3.1 2.0 4.6 2.3 6.5 5.7 4.9 5.5 3.6 3.3 5.5 7.7 0.2 2.4 0.9 2.1 2.4 2.5 3.6 3.2 1.5 2.7 3.4 2.6 2.4 2.1 3.2 2.1 0.0 2.6 9.0 5.0 1.4 0.2 20.1 7.6 24.1 3.4 5.2 7.9 5.0 11.6 4.0 924.4 4.2 3.2 0.0 1.6 2.8 2.1 3.1 0.0 3.4 4.1 1.6 0.0 4.9 2.1 2355.8 13.3 1.4 1.7 1.0 1.1 2.0 3.3 2.9 12.7 23.3 1.3 25.8 3.6 81.7 16.6 1.6 3.8 2.5 3.3 4.8 SPATA25 "C20orf165, dJ337O18.8, TSG23" ENSG00000149634 "Spermatogenesis associated 25" Q9BR10 20 45886489-45887635 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 18.4" "Cell type enriched" "Detected in some" 6 "Early spermatids: 226.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 10.2" "Not detected" "Not detected" HPA041386 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA041386: AB_2677446" "unprognostic (1.88e-1)" "unprognostic (2.66e-1)" "unprognostic (1.60e-1)" "unprognostic (4.92e-3)" "unprognostic (2.36e-1)" "unprognostic (1.84e-2)" "unprognostic (2.75e-3)" "unprognostic (1.57e-2)" "unprognostic (2.57e-2)" "unprognostic (3.45e-1)" "unprognostic (1.92e-3)" "unprognostic (1.67e-2)" "unprognostic (3.14e-1)" "unprognostic (5.07e-2)" "unprognostic (2.62e-1)" "unprognostic (5.93e-5)" "unprognostic (1.12e-1)" 2.4 1.4 1.6 1.6 1.6 0.0 1.6 2.8 1.6 1.8 1.7 1.6 1.6 3.7 2.5 1.6 1.6 2.2 1.6 2.3 1.6 0.8 2.5 3.8 1.6 1.6 1.6 1.6 5.8 1.6 2.3 1.6 1.6 1.6 1.6 1.4 1.6 1.7 2.5 7.9 1.8 2.3 2.9 1.6 1.6 1.1 18.4 1.6 1.6 2.2 1.6 1.6 2.7 1.6 1.2 0.5 0.0 0.1 0.0 0.7 0.0 0.9 3.2 2.4 2.7 3.7 2.2 2.8 0.7 2.8 1.5 0.5 10.2 5.7 1.9 0.9 1.2 3.0 4.4 1.2 0.8 0.5 0.6 2.2 0.9 7.9 6.6 2.8 0.2 1.7 5.2 1.5 0.6 0.8 3.8 1.0 3.1 1.3 2.4 1.1 2.1 1.2 0.1 1.4 0.9 1.8 2.4 1.6 1.2 0.2 1.4 4.6 2.6 2.9 2.1 2.9 1.0 3.5 2.4 0.8 1.8 2.0 1.3 0.9 2.2 1.3 0.5 2.4 1.8 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.6 2.8 1.6 1.6 0.8 1.6 1.6 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 226.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 35.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 SPATA3 TSARG1 ENSG00000173699 "Spermatogenesis associated 3" Q8NHX4 2 230990324-231025055 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "testis: 82.0" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3891.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.6;U-698: 1.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 11 "cerebellum: 11.0" HPA018254 Enhanced NA NA "HPA018254: AB_1857419" "unprognostic (6.94e-3)" "unprognostic (6.98e-2)" "unprognostic (9.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.2 0.2 0.3 0.0 0.1 0.3 0.2 0.1 0.0 0.2 3.6 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.5 0.1 1.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.4 0.3 0.1 0.0 0.1 0.0 0.9 0.0 0.2 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.8 0.0 0.3 0.2 0.0 1.1 0.3 0.1 0.1 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.4 0.2 0.3 0.2 0.2 0.1 0.3 0.3 0.0 0.2 0.5 0.0 0.0 1.5 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 761.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3891.5 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 6.5 0.0 21.5 10.9 0.0 0.0 0.0 0.0 0.0 SPATA31A1 "C9orf36, C9orf36A, DKFZP434B204, FAM75A1, FAM75A2, SPATA31A2" ENSG00000204849 "SPATA31 subfamily A member 1" 9 39355669-39361959 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 103 "testis: 10.2" "Cell type enriched" "Detected in some" 8 "Early spermatids: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "U-2197: 3.3" NA NA "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 SPATA31A3 "DKFZp434B204, FAM75A3" ENSG00000275969 "SPATA31 subfamily A member 3" Q5VYP0 9 66986304-66992583 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 81 "testis: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A5 FAM75A5 ENSG00000276581 "SPATA31 subfamily A member 5" Q5VU36 9 60914374-60920650 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 30 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A6 FAM75A6 ENSG00000185775 "SPATA31 subfamily A member 6" Q5VVP1 9 42183659-42189882 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 17 "testis: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.0" NA NA "unprognostic (2.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31A7 "FAM75A4, FAM75A7, SPATA31A4" ENSG00000276040 "SPATA31 subfamily A member 7" Q8IWB4 9 61190003-61196280 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 57 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D1 "FAM75D1, FLJ46321" ENSG00000214929 "SPATA31 subfamily D member 1" Q6ZQQ2 9 81988772-81995256 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "testis: 13.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 8.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HDLM-2: 3.7" HPA047897 Uncertain NA NA "HPA047897: AB_2680204" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 SPATA31D3 "FAM75D3, FLJ44082" ENSG00000186788 "SPATA31 subfamily D member 3" P0C874 9 81943586-81950038 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 99 "testis: 9.9" "Cell type enriched" "Detected in some" 13 "Early spermatids: 16.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31D4 "FAM75D4, FLJ43859" ENSG00000189357 "SPATA31 subfamily D member 4" 9 81928514-81934948 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 78 "testis: 7.8" "Cell type enriched" "Detected in some" 15 "Early spermatids: 29.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA31E1 "C9orf79, FAM75E1, FLJ35866" ENSG00000177992 "SPATA31 subfamily E member 1" Q6ZUB1 9 87882826-87888899 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 139 "testis: 18.6" "Group enriched" "Detected in some" 94 "Early spermatids: 42.3;Late spermatids: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.5;hTEC/SVTERT24-B: 1.2;Karpas-707: 1.1;SCLC-21H: 4.5" HPA024253 Enhanced NA NA "HPA024253: AB_1845839" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA32 "AEP2, C17orf46, FLJ25414, TEX34, VAD1.2" ENSG00000184361 "Spermatogenesis associated 32" Q96LK8 17 45254393-45262112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 51.7" "Group enriched" "Detected in some" 76 "Early spermatids: 162.9;Late spermatids: 433.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;naive CD4 T-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 3.8;EFO-21: 1.8;HDLM-2: 2.1;HeLa: 2.2;REH: 1.5;U-266/84: 2.0" HPA024549 Approved NA NA "HPA024549: AB_1845589" "unprognostic (5.27e-2)" "unprognostic (1.15e-1)" "unprognostic (5.88e-2)" "unprognostic (1.79e-4)" "unprognostic (7.84e-2)" "unprognostic (1.36e-2)" "unprognostic (3.58e-1)" "unprognostic (6.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-1)" "unprognostic (2.87e-3)" "unprognostic (8.93e-4)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (5.75e-4)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 51.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.5 0.0 0.1 2.2 1.4 1.3 3.8 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.8 0.0 0.7 0.0 0.0 0.0 0.0 2.1 0.0 0.0 2.2 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.4 0.7 2.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 2.0 0.8 0.4 0.0 0.3 2.2 0.9 0.5 0.1 0.0 0.3 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.4 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 162.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 433.4 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 2.8 1.3 0.0 0.0 0.0 0.0 0.0 SPATA33 "C16orf55, FLJ31606" ENSG00000167523 "Spermatogenesis associated 33" Q96N06 16 89657802-89671272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.4" "Group enriched" "Detected in many" 10 "Early spermatids: 1519.3;Late spermatids: 2991.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045648, HPA073096" Enhanced Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA045648: AB_2679405, HPA073096: AB_2686570" "unprognostic (1.05e-2)" "prognostic favorable (1.06e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (7.18e-3)" "unprognostic (1.37e-1)" "unprognostic (3.97e-1)" "unprognostic (3.63e-2)" "unprognostic (2.03e-3)" "unprognostic (8.82e-2)" "unprognostic (4.02e-2)" "unprognostic (4.52e-2)" "unprognostic (3.26e-1)" "unprognostic (2.04e-1)" "unprognostic (1.60e-1)" 2.0 2.7 6.9 2.8 7.3 3.3 3.2 7.8 7.7 2.9 2.9 4.3 1.8 4.8 3.2 9.2 2.7 14.8 3.7 2.1 6.0 5.7 5.3 2.9 4.3 2.3 4.7 6.5 2.1 3.0 4.0 7.3 1.9 5.3 3.2 3.4 2.5 2.4 2.8 1.5 4.1 5.7 2.6 3.6 3.0 3.8 70.4 4.3 2.4 5.1 2.2 3.1 2.1 2.5 5.7 5.5 5.8 3.3 7.3 6.3 3.6 10.3 9.9 12.3 4.4 3.3 2.9 4.3 7.0 2.9 10.2 4.4 9.3 8.7 1.1 3.8 4.7 6.9 14.0 5.4 3.8 7.7 2.0 7.6 1.7 12.0 13.7 1.5 2.2 4.2 3.0 4.5 7.0 3.0 3.9 2.3 9.6 11.1 1.5 6.6 12.1 6.5 5.6 6.8 6.2 7.6 13.3 6.8 3.4 6.0 3.5 11.5 6.3 15.6 2.9 3.8 5.8 12.7 3.0 2.1 7.9 9.8 6.6 5.6 3.6 5.3 4.1 7.7 12.4 2.8 5.8 3.3 5.4 5.2 3.2 6.3 5.7 4.7 6.2 2.6 3.2 5.2 4.1 4.1 7.3 2.9 5.5 3.5 3.6 6.9 7.3 7.8 7.7 6.0 5.7 4.7 6.5 5.3 4.3 6.0 8.9 5.1 7.9 6.4 17.7 5.2 10.2 109.7 13.6 27.9 60.9 3.2 19.9 12.3 1519.3 10.2 15.9 0.0 15.4 4.9 10.5 5.5 1.1 9.8 7.9 22.3 16.8 8.6 2.7 2991.1 28.1 7.3 16.9 4.6 8.9 16.6 11.2 8.6 22.3 26.7 69.1 12.9 12.3 232.7 101.0 6.1 1.1 12.5 12.0 5.5 SPATA4 "SPEF1B, TSARG2" ENSG00000150628 "Spermatogenesis associated 4" Q8NEY3 4 176184638-176195671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "testis: 84.3" "Group enriched" "Detected in some" 8 "Early spermatids: 888.4;Late spermatids: 383.1;Spermatocytes: 280.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 3.9;U-87 MG: 7.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA019220 Enhanced NA NA "HPA019220: AB_1857420" "unprognostic (1.97e-3)" "unprognostic (6.08e-2)" "unprognostic (2.83e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-2)" "unprognostic (1.87e-2)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (3.09e-3)" "unprognostic (9.77e-2)" "unprognostic (4.38e-6)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.96e-2)" "unprognostic (1.59e-1)" 0.0 0.2 0.4 0.0 2.3 0.0 0.3 0.1 0.7 0.2 0.2 0.7 0.1 0.0 0.1 2.2 0.2 3.9 0.1 0.2 0.5 0.6 1.0 0.0 0.9 0.0 0.4 1.5 0.7 0.2 0.1 1.3 0.0 0.8 0.1 0.0 0.2 0.1 0.2 0.5 0.0 0.1 0.1 0.4 0.0 0.1 84.3 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.9 5.2 1.3 1.5 1.0 0.6 0.2 1.0 0.1 0.0 0.4 1.2 0.0 0.5 0.8 0.2 1.0 0.5 0.5 0.2 0.0 0.5 3.9 0.0 0.0 1.6 0.4 0.1 0.0 0.0 0.4 0.3 0.7 0.0 0.2 0.2 2.3 0.9 0.9 1.2 0.0 0.5 0.1 0.6 0.7 0.1 0.2 0.3 0.2 0.1 0.7 0.1 1.2 0.1 0.8 0.0 0.8 0.4 1.4 0.1 0.1 0.4 0.2 0.0 0.0 0.5 0.4 0.2 0.8 0.1 0.1 0.0 7.1 0.0 0.2 5.2 0.5 0.9 0.5 0.8 1.0 0.8 0.7 0.6 0.6 0.8 0.8 0.8 1.5 1.5 1.3 0.9 0.8 0.6 0.4 2.3 0.1 0.7 0.5 0.6 0.4 1.5 0.8 0.2 0.0 0.3 0.0 0.1 0.0 0.6 0.2 0.0 64.3 3.4 0.0 0.0 0.0 5.0 0.3 888.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 383.1 10.6 0.0 0.0 0.0 0.0 1.0 1.0 0.0 7.8 5.1 3.3 0.0 0.1 280.2 8.8 0.0 0.0 0.0 0.0 0.1 SPATA45 "C1orf227, LOC149643" ENSG00000185523 "Spermatogenesis associated 45" Q537H7 1 212830141-212847649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 4.4;pancreas: 4.4;testis: 14.2" "Group enriched" "Detected in some" 23 "Early spermatids: 131.3;Late spermatids: 94.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 4.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA049921 Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles, Cytosol" "HPA049921: AB_2680953" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (4.71e-1)" "unprognostic (2.06e-1)" "unprognostic (4.05e-2)" "unprognostic (6.14e-2)" "unprognostic (4.39e-4)" "unprognostic (1.07e-2)" "unprognostic (1.70e-1)" "unprognostic (3.12e-3)" "unprognostic (1.64e-2)" "unprognostic (3.14e-1)" "unprognostic (2.06e-2)" "unprognostic (6.14e-3)" "unprognostic (1.32e-2)" "unprognostic (9.50e-2)" "unprognostic (2.67e-3)" 0.1 0.1 0.4 0.0 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.3 0.9 0.0 0.9 0.4 0.1 0.3 0.3 0.2 0.4 0.4 0.8 0.4 0.1 4.4 0.0 0.4 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.5 0.5 0.1 14.2 0.3 0.4 0.0 0.1 2.8 0.7 4.4 0.9 0.5 1.2 0.5 0.4 4.0 0.9 2.6 0.8 2.1 2.6 0.4 0.0 0.8 1.2 0.8 0.6 0.9 0.1 0.0 1.7 0.3 1.7 0.0 1.0 3.7 0.0 0.0 0.0 2.1 1.2 0.0 1.7 1.5 0.0 0.4 0.0 0.0 0.0 1.7 0.0 1.8 2.3 2.5 0.2 0.9 0.6 0.8 1.4 2.1 0.2 0.0 2.1 0.4 0.9 2.7 1.6 0.0 0.0 0.9 0.6 1.3 0.0 0.9 0.1 1.9 1.1 1.1 1.7 4.4 0.3 1.6 1.1 0.0 0.4 4.4 0.7 0.9 0.9 0.3 0.1 0.0 0.7 2.8 0.6 1.2 2.4 0.5 0.7 0.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 2.3 0.0 0.0 0.0 5.0 0.0 131.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 94.9 1.4 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 SPATA46 C1orf111 ENSG00000171722 "Spermatogenesis associated 46" Q5T0L3 1 162373203-162376870 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 60.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.8;AF22: 2.2;HaCaT: 1.8;SCLC-21H: 4.0;SH-SY5Y: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.71e-3)" "unprognostic (2.13e-2)" "unprognostic (1.40e-1)" "unprognostic (3.55e-1)" "unprognostic (1.10e-2)" "unprognostic (1.49e-3)" "unprognostic (6.42e-2)" "unprognostic (3.80e-2)" "unprognostic (1.32e-1)" "unprognostic (3.44e-1)" "unprognostic (2.38e-1)" "unprognostic (4.59e-4)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (5.22e-2)" "unprognostic (1.76e-2)" 0.1 4.2 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.5 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 60.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.8 0.0 2.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.4 0.0 0.5 0.0 0.0 0.8 4.0 2.4 0.4 0.0 0.0 0.5 0.4 0.0 0.3 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA48 C7orf72 ENSG00000164500 "Spermatogenesis associated 48" A4D263 7 50096036-50159830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 13.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enhanced" "Detected in single" "B-cells: 1.1" "Cell line enriched" "Detected in some" 12 "U-698: 15.3" "Low region specificity" "Detected in some" HPA026094 Uncertain NA NA "HPA026094: AB_1859516" 0.0 0.0 0.4 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPATA6 "FLJ10007, SRF-1, SRF1" ENSG00000132122 "Spermatogenesis associated 6" Q9NWH7 1 48295372-48472208 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 61.8" "Group enriched" "Detected in many" 31 "Early spermatids: 1331.5;Late spermatids: 2941.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 10.5;ASC TERT1: 17.7;HSkMC: 12.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028234 Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA028234: AB_2672532" "unprognostic (1.36e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (2.87e-2)" "unprognostic (3.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.77e-2)" "unprognostic (4.69e-3)" "unprognostic (2.40e-2)" "unprognostic (2.61e-2)" "unprognostic (8.41e-2)" "unprognostic (6.50e-2)" "unprognostic (3.41e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (7.89e-2)" "unprognostic (5.71e-3)" 5.8 8.9 6.2 3.0 12.9 1.5 8.4 2.4 8.9 7.5 5.0 12.9 10.1 3.3 6.9 7.9 4.1 16.2 5.9 4.7 7.8 5.6 6.9 2.4 7.5 7.0 14.9 3.9 9.0 5.2 12.8 21.5 5.3 8.5 6.4 4.6 6.6 6.9 12.2 3.8 5.0 3.7 8.3 10.0 4.1 7.3 61.8 13.4 1.1 10.3 2.4 2.2 6.5 12.2 0.2 1.7 5.2 8.2 0.3 0.6 0.7 0.1 0.9 9.5 10.5 8.8 17.7 1.3 1.0 4.0 0.8 0.7 0.1 0.7 0.0 0.6 1.7 5.1 0.2 0.8 2.3 0.7 0.7 1.3 0.1 0.4 0.4 1.8 0.0 0.7 12.6 1.8 1.5 0.5 5.2 3.8 1.5 0.1 0.0 4.0 0.3 0.1 0.1 4.0 0.7 1.0 2.9 0.0 0.9 5.8 1.6 2.3 5.2 3.8 0.4 9.1 8.2 2.3 0.5 1.1 1.4 1.4 2.2 1.5 0.0 0.0 0.0 5.8 0.1 6.3 0.0 1.8 5.2 0.1 4.3 0.0 0.2 0.4 0.0 1.7 0.1 0.6 0.5 0.3 0.3 8.2 0.8 0.0 0.7 6.2 12.9 2.4 8.9 7.8 5.6 14.9 3.9 8.5 13.4 3.0 7.7 0.0 15.5 4.9 17.1 2.8 15.3 68.3 17.0 15.7 43.2 0.3 14.9 7.4 1331.5 8.1 2.1 0.0 9.1 0.6 10.3 7.2 16.1 2.1 4.2 30.2 9.2 9.2 17.5 2941.6 33.9 13.4 18.6 1.8 5.2 21.5 4.5 3.4 23.7 7.7 44.9 19.4 9.2 58.1 20.0 4.5 0.2 0.9 5.2 8.8 SPATA6L "C9orf68, FLJ10058" ENSG00000106686 "Spermatogenesis associated 6 like" Q8N4H0 9 4553386-4666674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 23.0" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 96.7;Late spermatids: 69.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 18 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "BEWO: 3.4;CAPAN-2: 5.8;HDLM-2: 3.2;RPTEC TERT1: 4.4;SCLC-21H: 3.8" "Low region specificity" "Detected in all" HPA039585 Enhanced NA NA "HPA039585: AB_10674984" "unprognostic (8.18e-3)" "unprognostic (1.69e-1)" "unprognostic (4.10e-2)" "unprognostic (2.39e-3)" "unprognostic (5.65e-2)" "unprognostic (4.38e-2)" "unprognostic (3.23e-2)" "unprognostic (8.03e-3)" "unprognostic (4.10e-3)" "unprognostic (1.19e-2)" "unprognostic (1.65e-1)" "unprognostic (5.14e-2)" "unprognostic (2.28e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.27e-3)" 1.7 1.1 4.9 0.6 7.3 0.2 3.0 15.3 5.3 1.5 1.6 1.7 4.1 2.6 1.7 5.4 2.3 9.4 4.0 1.4 3.2 1.7 2.5 7.6 4.0 1.7 1.2 2.5 1.7 5.3 3.9 23.0 1.3 3.8 1.9 1.2 0.0 1.3 1.6 0.9 1.6 3.6 0.5 1.3 1.0 3.4 13.2 1.5 0.0 2.9 0.8 0.9 1.6 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.4 1.2 0.4 0.6 0.0 0.0 0.1 3.4 0.1 0.3 0.0 0.1 0.1 5.8 0.0 0.2 0.2 0.1 0.3 0.6 0.0 0.0 3.2 0.1 0.9 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 1.4 0.0 0.3 0.0 0.0 0.0 0.2 1.7 0.9 0.0 0.0 0.0 0.4 4.4 0.0 3.8 2.1 0.0 1.5 0.0 0.4 0.6 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 1.0 0.9 0.0 0.0 1.7 1.8 0.0 0.0 0.0 0.0 0.9 0.4 4.9 7.3 15.3 5.3 3.2 1.7 1.2 2.5 3.8 1.5 8.9 13.0 0.0 2.3 0.6 1.7 1.6 12.7 21.4 10.3 3.5 11.8 2.1 3.3 4.3 96.7 5.8 1.7 0.0 4.6 0.3 1.1 2.3 1.1 10.5 0.5 0.0 0.0 3.1 0.0 69.3 1.7 0.6 0.0 0.0 4.4 1.4 4.3 3.2 2.5 2.2 0.7 0.0 0.5 6.0 2.9 1.0 1.7 0.5 2.0 2.2 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Group enriched" "Detected in many" 24 "Early spermatids: 817.6;Late spermatids: 902.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.3 4.9 6.8 8.1 15.4 5.0 3.7 8.4 4.7 3.1 0.9 4.1 1.5 2.3 5.0 3.5 2.1 2.3 3.5 4.4 2.5 1.6 0.1 1.6 1.1 12.1 3.4 0.3 7.3 5.9 1.9 3.6 15.4 8.6 4.2 1.1 2.4 4.3 2.5 1.5 3.1 0.6 2.6 4.2 3.5 5.1 0.8 7.5 1.3 2.9 4.5 4.7 6.4 3.8 5.1 5.5 3.7 4.4 2.9 3.8 4.8 2.0 2.4 1.2 0.5 5.8 1.0 2.4 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 11.9 5.3 0.8 8.2 2.2 10.8 10.9 5.1 36.1 10.3 3.5 19.6 2.1 8.3 7.6 817.6 5.2 1.1 0.0 6.3 3.2 6.4 3.4 1.1 3.4 5.0 14.3 15.6 6.2 8.6 902.3 19.0 3.3 8.5 4.6 4.4 10.6 5.8 4.8 15.9 19.9 19.4 6.5 5.0 18.2 13.5 1.8 0.9 3.8 4.6 2.7 SPATA8 MGC44294 ENSG00000185594 "Spermatogenesis associated 8" Q6RVD6 15 96783389-96785615 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 292 "testis: 172.8" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 1040.7" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;U-2 OS: 1.5;U-2197: 1.1;U-87 MG: 1.6" NA NA "unprognostic (7.61e-3)" "unprognostic (8.45e-2)" "unprognostic (1.94e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 172.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.0 1.6 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.0 0.4 0.0 0.0 97.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.6 137.4 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.4 0.0 0.1 12.9 0.0 1040.7 4.1 0.0 0.1 0.0 0.0 0.0 SPATA9 "FLJ35906, NYD-SP16" ENSG00000145757 "Spermatogenesis associated 9" Q9BWV2 5 95652181-95698711 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.5" "Group enriched" "Detected in some" 15 "Early spermatids: 467.1;Late spermatids: 349.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 20 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HaCaT: 2.8;NB-4: 2.3;THP-1: 4.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA010848, HPA076967" Approved Approved Mitochondria NA NA Mitochondria "HPA010848: AB_1857422, HPA076967: " "unprognostic (4.46e-2)" "unprognostic (4.02e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (9.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.33e-2)" "unprognostic (2.08e-1)" "unprognostic (3.27e-2)" "unprognostic (7.58e-2)" "unprognostic (1.28e-2)" "unprognostic (3.08e-2)" "unprognostic (9.49e-13)" "unprognostic (3.39e-1)" "unprognostic (2.37e-1)" "unprognostic (1.26e-2)" "unprognostic (2.87e-2)" 0.9 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.0 2.7 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.3 0.8 2.8 0.0 0.0 0.0 0.2 0.5 1.8 0.2 0.0 0.6 0.6 0.5 1.6 0.0 0.6 0.0 0.9 0.6 1.1 1.7 0.0 2.1 0.0 0.7 2.3 0.8 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.4 0.5 0.0 4.0 0.0 0.7 0.2 0.5 0.4 0.0 0.2 0.0 0.0 0.4 1.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 467.1 0.0 0.0 0.0 0.0 27.7 0.4 0.2 0.0 0.0 1.1 1.6 0.0 0.0 0.3 349.3 3.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.2 0.0 0.2 0.0 0.5 3.6 2.9 0.1 3.5 0.0 0.0 0.1 SPATC1 "MGC61633, SPATA15, SPERIOLIN" ENSG00000186583 "Spermatogenesis and centriole associated 1" Q76KD6 8 144012414-144047085 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "bone marrow: 10.9;testis: 36.6" "Group enriched" "Detected in some" 24 "Early spermatids: 70.9;Late spermatids: 269.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 1.8" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "U-937: 13.4" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 30.1" NA NA "unprognostic (2.96e-1)" "unprognostic (1.41e-3)" "unprognostic (3.34e-1)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "unprognostic (4.59e-3)" "unprognostic (6.96e-2)" "unprognostic (4.30e-2)" "unprognostic (1.49e-2)" "unprognostic (2.77e-1)" "unprognostic (4.12e-2)" "unprognostic (4.39e-2)" "unprognostic (1.34e-3)" "unprognostic (2.74e-1)" "unprognostic (5.81e-3)" "unprognostic (2.19e-1)" "unprognostic (2.74e-1)" 0.2 0.1 0.2 2.2 0.3 10.9 0.1 0.2 0.3 0.1 0.1 0.5 0.0 0.1 0.0 0.7 0.5 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.7 0.7 0.1 0.0 0.0 0.1 0.0 0.9 0.3 0.4 0.5 0.0 0.5 0.5 0.0 0.1 0.0 0.6 0.1 0.6 1.8 0.2 36.6 0.0 0.9 0.1 0.3 1.9 0.5 0.1 1.8 1.3 0.8 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 13.4 0.0 0.0 0.5 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.5 1.8 0.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.2 0.3 0.2 0.3 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 269.9 2.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 SPATS1 "FLJ25442, SPATA8, SRSP1" ENSG00000249481 "Spermatogenesis associated serine rich 1" Q496A3 6 44342660-44377167 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "fallopian tube: 9.0;testis: 33.5" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 17.4;Early spermatids: 25.7;Late spermatids: 6.2" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-MEL-30: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030897, HPA049722" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA030897: AB_2673647, HPA049722: AB_2680861" "unprognostic (2.30e-3)" 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.4 0.3 0.0 1.5 0.0 0.0 0.1 4.8 0.1 9.0 0.0 0.0 0.7 0.7 0.0 0.0 1.5 0.0 0.4 0.0 1.6 0.0 0.2 0.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 1.0 0.0 0.4 0.7 0.7 0.4 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24, NDC80 kinetochore complex component" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.0" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 2.8 3.2 1.1 9.0 1.0 19.4 3.8 0.4 1.9 2.8 4.0 0.8 0.9 3.5 2.2 2.8 8.4 1.4 2.4 8.2 1.0 0.4 1.8 2.6 4.2 4.9 0.6 1.0 1.1 1.0 0.1 1.0 5.9 0.6 1.4 3.5 0.8 2.4 1.5 2.7 3.2 4.4 6.7 0.7 5.5 4.0 13.3 0.7 58.0 0.9 12.8 12.2 2.3 3.2 1.9 1.3 7.2 1.4 4.2 3.7 0.7 26.2 9.9 13.7 11.1 1.9 3.6 6.2 15.4 5.7 14.6 16.6 10.4 9.0 20.8 17.6 6.8 8.5 14.3 10.6 11.0 10.8 11.0 9.1 28.0 23.0 15.4 0.4 19.6 12.5 0.7 0.4 10.4 4.8 3.8 12.8 23.0 14.9 43.9 10.1 17.3 26.7 11.9 9.6 7.3 16.0 21.4 21.0 6.7 4.3 8.7 14.3 10.3 13.5 8.4 3.6 6.8 8.3 7.1 12.1 13.8 14.7 18.5 18.4 26.8 13.8 20.0 10.2 19.4 11.2 4.1 1.4 1.5 1.4 1.2 1.2 1.9 2.3 3.4 0.5 1.9 2.7 1.7 7.2 4.2 1.3 1.3 3.7 0.7 1.1 1.0 0.4 1.9 1.0 0.4 0.6 1.0 0.6 0.7 0.0 0.3 0.0 0.8 1.0 0.0 7.0 2.5 0.0 1.2 5.2 5.9 3.0 0.0 0.2 0.1 0.1 0.7 70.0 0.0 13.5 4.0 0.3 5.7 0.0 11.2 0.0 2.4 2.5 2.8 1.7 0.6 1.3 0.0 0.0 1.1 0.9 0.2 0.0 0.4 0.4 0.3 0.0 0.3 6.5 10.1 0.3 1.7 2.2 2.9 0.4 SPC25 "AD024, MGC22228, SPBC25" ENSG00000152253 "SPC25, NDC80 kinetochore complex component" Q9HBM1 2 168834132-168913371 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 31.3;Hofbauer cells: 12.6;Muller glia cells: 13.2;Spermatocytes: 21.2;Spermatogonia: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.5" "Group enriched" "Detected in many" 4 "B-cells: 1.1;T-cells: 2.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047144, HPA050544" Enhanced Enhanced Cytosol NA Yes Cytosol "HPA047144: AB_2679952, HPA050544: " "unprognostic (3.52e-2)" "unprognostic (2.28e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (4.74e-6)" "prognostic unfavorable (9.44e-5)" "unprognostic (1.84e-3)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.30e-2)" "unprognostic (1.11e-16)" "unprognostic (9.91e-3)" "unprognostic (1.85e-1)" "unprognostic (3.43e-1)" "unprognostic (1.57e-1)" 0.9 1.6 3.6 7.2 2.2 6.7 2.1 0.4 3.5 1.3 4.0 0.9 0.0 6.8 1.3 1.5 8.5 0.6 1.0 1.1 2.7 1.6 1.5 1.6 1.9 7.5 1.2 2.5 1.2 2.6 0.7 0.2 3.3 1.1 0.8 3.1 1.3 2.1 0.0 0.7 2.1 3.8 1.8 0.7 4.1 3.0 5.9 1.1 38.0 0.6 5.6 8.0 1.5 2.7 1.1 0.0 0.4 0.1 0.0 2.5 0.4 1.0 8.4 19.6 10.9 0.9 0.9 7.1 11.3 4.3 11.4 9.1 4.3 7.9 7.0 5.0 1.8 15.0 10.4 7.5 0.0 10.1 4.7 11.5 14.0 5.3 2.0 0.0 10.4 4.2 0.0 0.5 7.3 0.1 2.3 5.7 14.8 1.1 7.9 3.2 5.2 7.5 12.6 0.6 5.0 11.2 13.6 19.5 3.1 4.6 6.6 14.7 0.9 10.1 6.9 1.9 6.6 0.5 7.3 1.7 1.7 20.7 6.7 9.5 15.3 26.6 6.9 2.2 1.6 6.7 0.0 0.1 0.2 0.0 0.1 0.0 0.9 0.4 0.0 0.0 1.1 0.2 0.5 0.4 0.0 0.0 0.0 2.5 0.4 3.6 2.2 0.4 3.5 2.7 1.6 1.2 2.5 1.1 1.1 0.0 0.6 1.5 1.1 4.7 0.0 0.4 0.0 0.0 3.4 0.0 0.0 2.8 0.0 0.0 1.2 0.4 1.0 0.0 0.0 31.3 0.8 0.2 0.0 0.8 12.6 0.0 0.0 4.3 1.6 0.6 0.6 1.6 0.0 0.0 1.4 13.2 0.8 0.0 1.1 0.0 0.3 0.0 0.3 21.2 17.6 1.3 4.8 1.7 3.0 0.9 SPDEF "bA375E1.3, PDEF" ENSG00000124664 "SAM pointed domain containing ETS transcription factor" O95238 6 34537802-34556333 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 55.8;salivary gland: 98.0" "Group enriched" "Detected in many" 6 "Glandular cells: 80.8;Mucus-secreting cells: 228.3" "Group enriched" "Detected in many" 10 "breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 68.7;OE19: 28.3;SK-BR-3: 47.5;T-47d: 38.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055707 Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA055707: AB_2682894" "unprognostic (2.98e-1)" "unprognostic (9.68e-2)" "unprognostic (2.84e-1)" "prognostic favorable (9.26e-9)" "unprognostic (1.57e-1)" "unprognostic (7.10e-3)" "unprognostic (2.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.63e-1)" "unprognostic (7.39e-3)" "unprognostic (3.48e-3)" "unprognostic (2.92e-1)" "unprognostic (6.16e-11)" "unprognostic (8.04e-2)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-2)" 0.1 0.0 0.4 2.4 0.2 0.0 28.5 0.3 0.7 12.0 6.5 0.2 0.3 4.4 4.0 0.3 0.9 2.4 16.1 0.1 0.4 0.3 0.1 0.1 5.5 0.1 0.3 0.1 0.6 1.3 0.0 0.1 0.2 0.1 55.8 4.0 0.2 98.0 4.5 0.1 3.0 7.8 0.1 0.1 0.1 10.8 0.1 0.1 0.2 0.1 7.8 22.9 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.7 0.0 0.1 0.0 28.3 9.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 47.5 0.0 0.0 38.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.7 0.4 0.3 0.3 0.1 0.1 0.1 0.0 2.1 0.0 12.1 0.1 0.0 0.1 2.5 0.0 3.4 0.0 0.0 0.0 0.0 3.2 1.1 0.0 8.1 0.0 1.1 0.0 0.0 80.8 0.0 0.0 0.0 0.0 5.2 0.6 0.0 2.9 0.0 0.0 3.3 0.0 228.3 0.0 12.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 26.3 9.7 SPDL1 "CCDC99, FLJ20364, hSpindly" ENSG00000040275 "Spindle apparatus coiled-coil protein 1" Q96EA4 5 169583634-169604778 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.7" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 97.4;Spermatogonia: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA044700, HPA048146" Enhanced Approved Cytosol NA Yes Cytosol "HPA044700: AB_2679052, HPA048146: AB_2680284" "unprognostic (2.61e-2)" "unprognostic (1.94e-1)" "unprognostic (8.59e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.24e-1)" "unprognostic (1.23e-2)" "prognostic unfavorable (1.48e-6)" "unprognostic (2.63e-3)" "unprognostic (5.70e-3)" "unprognostic (8.27e-3)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.13e-6)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.93e-1)" 5.5 4.7 6.5 9.0 11.5 9.9 8.0 14.5 11.0 5.5 5.6 6.6 3.4 5.9 6.4 4.4 9.7 4.9 4.9 4.0 7.8 5.8 5.1 3.6 4.7 13.9 8.3 7.1 7.2 4.1 5.6 8.0 8.4 11.6 4.1 6.0 2.0 5.1 3.6 5.0 5.3 5.9 7.7 16.7 8.2 5.3 33.7 10.4 23.9 4.5 8.5 13.6 5.4 5.8 10.7 16.5 3.2 4.6 6.4 9.3 3.0 14.6 17.6 18.0 12.6 4.8 4.5 15.9 46.6 6.2 34.9 31.7 23.1 9.9 13.8 30.9 38.1 24.0 10.3 14.6 20.0 38.3 14.2 16.3 16.1 31.7 9.0 2.2 16.9 13.9 2.1 1.7 14.6 9.2 7.4 15.8 14.3 10.1 10.2 37.1 14.2 13.8 7.2 13.1 7.3 17.1 16.2 17.7 10.2 22.8 5.2 11.6 8.5 21.7 6.2 9.1 13.3 7.0 11.3 11.2 39.8 12.6 11.3 36.1 8.1 17.0 18.6 9.6 15.6 13.3 3.2 2.2 2.9 7.3 3.0 7.7 8.8 6.6 7.7 2.2 10.7 9.3 7.4 0.4 6.4 4.6 16.5 6.4 3.0 6.5 11.5 14.5 11.0 7.8 5.8 8.3 7.1 11.6 10.4 3.0 7.5 6.7 1.7 3.5 7.1 7.2 0.0 4.0 7.9 1.8 0.0 7.9 5.0 4.9 7.6 3.9 0.5 23.3 4.2 21.7 7.5 1.1 8.1 2.9 10.0 3.2 1.7 11.6 4.0 8.7 4.0 6.1 3.3 6.4 1.9 6.1 5.4 1.7 6.0 5.1 3.9 6.5 9.2 97.4 70.9 3.9 4.1 4.4 5.1 2.1 SPDYA "Ringo3, SPDY1, SPY1" ENSG00000163806 "Speedy/RINGO cell cycle regulator family member A" Q5MJ70 2 28782517-28850611 "Predicted intracellular proteins" "Cell cycle, DNA damage" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "testis: 93.4" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 226.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 6.1;THP-1: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035162, HPA066214" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA035162: AB_2674501, HPA066214: AB_2685636" "unprognostic (3.41e-2)" "unprognostic (3.20e-3)" "unprognostic (2.45e-1)" "unprognostic (3.53e-2)" "unprognostic (4.21e-2)" "unprognostic (4.04e-3)" "unprognostic (1.10e-4)" "unprognostic (3.04e-3)" "unprognostic (1.95e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.99e-2)" "unprognostic (1.66e-13)" "unprognostic (8.56e-2)" "unprognostic (1.07e-1)" "unprognostic (1.85e-1)" "unprognostic (5.55e-5)" 0.4 0.7 0.7 0.4 0.8 0.7 0.4 1.8 0.6 0.7 0.4 0.5 0.4 0.6 0.4 0.8 0.4 0.3 0.7 0.4 0.8 0.6 0.5 0.6 0.4 0.7 0.6 0.4 0.9 0.6 0.1 0.8 0.4 0.4 1.0 0.2 0.4 0.6 0.4 0.5 1.8 0.5 0.5 0.5 1.1 0.3 93.4 0.4 0.8 0.7 0.4 0.4 0.6 0.4 0.6 1.4 0.0 0.3 0.6 1.0 0.0 1.0 0.5 1.7 3.8 0.0 0.0 2.1 0.9 0.1 0.3 0.1 1.0 0.8 0.9 1.2 0.0 1.0 2.4 0.4 0.0 0.4 0.5 1.1 0.8 2.2 3.0 0.1 1.1 1.7 0.3 0.2 0.2 0.5 0.9 0.0 0.7 0.5 1.5 0.8 0.4 0.4 6.1 0.5 0.3 0.4 0.8 2.9 0.9 1.1 0.7 1.3 0.8 1.9 2.5 0.7 1.7 0.7 5.7 0.2 3.0 2.3 1.6 1.4 0.9 1.5 1.5 0.8 0.8 0.6 0.0 0.3 0.0 1.0 0.3 0.2 0.5 0.5 0.5 0.1 0.6 0.7 0.8 0.0 0.6 0.2 1.4 0.1 0.0 0.7 0.8 1.8 0.6 0.8 0.6 0.6 0.4 0.4 0.4 3.0 0.3 0.5 0.9 0.2 0.6 0.5 0.0 0.0 1.2 1.8 5.9 0.1 0.0 0.4 42.2 1.1 0.6 0.0 0.4 0.1 0.4 1.2 2.3 0.0 0.3 0.0 0.0 1.8 0.0 22.3 2.3 1.0 0.0 0.0 0.0 0.0 0.8 0.0 2.1 0.0 1.3 6.5 0.2 226.6 2.6 0.1 0.5 0.0 0.3 1.7 SPDYC Ringo2 ENSG00000204710 "Speedy/RINGO cell cycle regulator family member C" Q5MJ68 11 65170154-65173244 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "liver: 8.0;testis: 5.8" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 1.7;Extravillous trophoblasts: 3.2;Hepatocytes: 2.4;Late spermatids: 7.1;Spermatogonia: 3.2" "Cancer enhanced" "Detected in many" "breast cancer: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.9;HEL: 7.6;Hep G2: 3.3;K-562: 18.1" HPA039891 Uncertain NA NA "HPA039891: AB_10795260" "prognostic unfavorable (1.20e-5)" "unprognostic (7.35e-2)" "unprognostic (4.42e-2)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.93e-2)" "unprognostic (1.31e-3)" "unprognostic (5.08e-2)" "unprognostic (1.85e-2)" "unprognostic (1.97e-1)" "unprognostic (1.15e-1)" "unprognostic (4.75e-2)" "unprognostic (7.97e-2)" "unprognostic (2.53e-1)" "unprognostic (6.60e-4)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 8.0 0.7 0.1 0.1 0.0 1.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.3 0.0 0.1 0.2 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 7.6 0.0 3.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 18.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 1.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 2.4 0.3 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.2 0.0 1.6 0.0 0.0 0.0 SPDYE1 "Ringo1, SPDYE, WBSCR19" ENSG00000136206 "Speedy/RINGO cell cycle regulator family member E1" Q8NFV5 7 44000889-44010122 "Disease related genes, Predicted intracellular proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 10.2" "Group enriched" "Detected in some" 21 "Early spermatids: 56.7;Late spermatids: 38.3" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.0" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (2.16e-1)" "unprognostic (1.44e-1)" "unprognostic (3.98e-2)" "unprognostic (6.20e-2)" "unprognostic (1.22e-1)" "unprognostic (1.19e-1)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" "unprognostic (8.93e-2)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (4.69e-2)" "unprognostic (1.95e-6)" "unprognostic (2.68e-1)" "unprognostic (2.32e-1)" "unprognostic (1.55e-1)" "unprognostic (5.19e-2)" 0.1 0.2 0.1 1.1 0.2 1.7 0.2 0.5 0.5 0.3 0.2 0.8 0.3 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.3 1.0 0.1 0.5 0.5 0.0 0.3 0.2 0.4 0.0 0.6 0.0 1.5 2.2 0.9 0.0 0.1 0.8 0.5 10.2 0.5 0.0 0.3 0.3 2.9 2.3 3.0 1.6 1.0 1.5 0.6 1.6 1.0 1.4 2.5 0.0 0.0 1.7 1.9 0.0 0.0 0.0 0.8 1.8 1.7 0.9 0.0 0.8 2.5 0.0 0.0 0.0 1.4 1.3 0.8 3.0 0.7 0.0 1.5 2.1 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.9 5.0 0.0 1.3 1.3 1.7 2.0 1.1 0.6 2.6 0.8 1.7 0.0 2.2 1.6 1.0 1.6 1.0 0.1 1.6 1.6 0.7 1.5 2.3 2.0 1.0 2.3 2.7 1.8 1.7 0.7 2.1 3.0 3.0 1.6 1.9 1.5 1.6 1.5 1.5 1.3 0.4 0.6 2.9 1.0 1.5 2.8 1.0 1.0 2.3 0.3 0.6 0.0 0.6 0.0 0.0 0.3 1.0 0.8 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 56.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.3 38.3 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 2.2 0.0 0.0 0.5 0.2 0.3 0.1 0.0 0.0 0.0 SPDYE16 ENSG00000185040 "Speedy/RINGO cell cycle regulator family member E16" A6NNV3 7 76531319-76541459 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.8" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 11.8;Early spermatids: 19.4;Late spermatids: 20.9;Rod photoreceptor cells: 7.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 7.0;Karpas-707: 5.4" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (3.22e-1)" "unprognostic (2.79e-1)" "unprognostic (6.99e-3)" "unprognostic (1.70e-1)" "unprognostic (4.54e-2)" 0.0 0.0 0.9 1.1 0.0 0.6 0.0 0.3 1.0 0.4 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.0 1.7 1.3 0.0 1.3 0.7 1.0 0.2 0.0 0.3 1.7 2.6 3.8 1.3 0.8 1.2 0.5 2.0 1.7 0.4 1.2 0.0 0.1 1.8 1.5 0.0 0.0 0.0 0.5 1.1 1.2 0.6 0.0 0.6 1.1 0.0 0.0 0.0 0.6 0.5 0.5 7.0 0.2 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 1.2 5.4 0.0 0.8 0.5 1.0 1.0 0.2 0.2 0.9 0.4 1.9 0.0 0.7 0.7 0.3 1.5 0.6 0.5 1.3 0.4 0.9 1.4 2.1 1.1 1.6 0.7 1.0 0.8 2.3 0.9 1.8 0.7 1.0 0.4 1.4 0.8 1.3 0.7 1.7 0.8 0.9 0.2 0.9 1.1 1.2 3.8 0.8 0.5 2.6 0.7 0.5 0.0 3.5 0.0 0.1 0.0 3.3 0.4 0.0 1.4 1.2 1.8 11.8 0.1 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.0 0.4 3.2 0.0 0.0 0.6 20.9 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 7.1 0.0 0.0 0.4 0.4 0.0 0.6 0.0 0.1 0.1 SPDYE2 MGC119295 ENSG00000205238 "Speedy/RINGO cell cycle regulator family member E2" Q495Y8 7 102551232-102562308 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.7" "Cell type enhanced" "Detected in single" 25 "Suprabasal keratinocytes: 1.3" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 11.4;Karpas-707: 12.3" HPA051750 Approved NA NA "HPA051750: AB_2681590" "unprognostic (2.04e-2)" "unprognostic (8.58e-2)" "unprognostic (5.12e-2)" "unprognostic (1.84e-2)" "unprognostic (1.61e-1)" "unprognostic (2.54e-2)" "unprognostic (1.68e-1)" "unprognostic (5.11e-2)" "unprognostic (1.76e-2)" "unprognostic (3.37e-1)" "unprognostic (3.15e-2)" "unprognostic (6.49e-3)" "unprognostic (7.94e-4)" "unprognostic (2.32e-1)" "unprognostic (2.12e-1)" "unprognostic (2.52e-3)" "unprognostic (1.04e-1)" 0.5 0.6 0.2 3.1 0.5 5.4 0.6 1.4 2.3 0.8 0.6 1.8 1.3 0.0 1.1 0.9 0.7 0.9 0.3 0.4 1.0 0.6 1.2 2.9 0.2 1.4 1.4 0.0 1.1 0.5 1.2 0.0 1.2 0.0 6.4 4.6 1.5 0.0 0.3 2.5 1.3 10.7 1.8 0.0 1.2 1.0 4.8 4.4 5.4 3.9 0.8 3.7 0.7 2.9 5.0 2.3 1.8 0.0 0.0 4.0 2.0 0.0 0.0 0.0 3.0 1.7 4.0 2.0 0.0 0.4 4.0 0.0 0.0 0.0 2.5 1.2 1.4 11.4 1.4 0.0 4.5 1.3 0.0 0.0 0.0 0.0 0.7 0.0 1.8 4.9 12.3 0.0 6.2 2.7 2.9 1.9 1.3 0.6 3.7 0.4 4.1 0.0 4.4 2.8 1.7 7.8 1.4 0.8 4.1 2.0 1.0 2.2 7.3 2.3 3.5 3.3 2.3 1.9 2.5 1.9 4.3 2.7 4.9 3.9 0.8 3.7 1.6 2.3 2.8 2.7 2.0 1.2 4.8 2.5 2.2 5.4 0.8 1.8 4.4 1.3 0.7 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 SPDYE2B ENSG00000173678 "Speedy/RINGO cell cycle regulator family member E2B" A6NHP3 7 102650325-102661398 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 6.8;Karpas-707: 10.1" HPA051750 Supported NA NA "HPA051750: AB_2681590" "unprognostic (2.67e-1)" "unprognostic (4.29e-1)" "unprognostic (2.29e-1)" "unprognostic (2.09e-3)" "unprognostic (2.68e-3)" "unprognostic (1.48e-1)" 0.3 0.6 0.3 1.8 0.3 2.0 0.3 0.5 2.0 0.3 0.7 0.7 0.4 0.0 0.6 0.3 0.4 0.5 0.3 0.3 0.5 0.5 0.5 1.5 0.2 0.5 1.8 0.0 0.5 0.3 0.4 0.0 0.6 0.0 4.3 2.0 2.2 0.0 0.2 2.9 0.5 6.7 0.7 0.0 0.5 0.4 1.3 1.0 3.0 0.5 0.4 0.9 0.4 1.8 2.2 0.7 1.7 0.0 0.0 2.3 2.1 0.0 0.0 0.0 1.2 1.8 2.0 0.9 0.0 0.4 2.4 0.0 0.0 0.0 1.5 1.5 0.7 6.8 0.6 0.0 3.1 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.4 1.9 10.1 0.0 1.5 1.0 3.0 1.6 0.2 1.0 1.4 1.1 3.3 0.0 1.6 1.2 1.0 3.4 2.1 0.8 1.6 0.8 0.5 0.0 3.1 3.5 1.7 1.4 1.2 1.1 2.0 1.5 1.7 1.2 3.0 0.5 0.7 0.8 0.2 0.7 0.2 0.3 0.4 1.0 1.3 0.6 0.7 2.0 0.4 0.3 0.5 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE3 ENSG00000214300 "Speedy/RINGO cell cycle regulator family member E3" A6NKU9 7 100307702-100322196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 1.3;testis: 5.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 174.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4" HPA051750 Supported NA NA "HPA051750: AB_2681590" "prognostic favorable (8.73e-4)" "unprognostic (6.27e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (1.06e-2)" "unprognostic (1.54e-1)" "unprognostic (5.04e-2)" "unprognostic (2.96e-2)" "unprognostic (2.90e-1)" "unprognostic (6.91e-2)" "unprognostic (3.99e-2)" "unprognostic (7.32e-2)" "unprognostic (5.25e-2)" "unprognostic (9.08e-2)" "unprognostic (5.06e-2)" "unprognostic (9.17e-2)" "unprognostic (3.58e-1)" 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.1 5.2 0.1 0.0 0.0 0.0 1.3 0.7 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.2 1.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.3 0.0 1.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 2.4 0.0 0.1 0.2 0.8 0.5 0.1 0.1 0.3 0.3 0.1 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.5 0.4 0.0 0.0 0.5 0.5 0.5 0.3 0.6 0.6 1.1 0.1 0.6 0.3 0.0 0.1 0.0 0.2 0.1 0.2 1.3 0.2 0.1 0.0 0.8 0.2 0.2 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.6 1.4 5.3 1.8 0.0 1.4 1.2 0.0 9.8 0.1 0.0 0.0 174.4 0.6 0.0 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 36.7 2.0 0.6 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 3.5 0.0 1.9 3.3 0.9 1.5 0.1 1.3 0.0 0.7 SPDYE4 ENSG00000183318 "Speedy/RINGO cell cycle regulator family member E4" A6NLX3 17 8753106-8758559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "testis: 17.4" "Cell type enriched" "Detected in some" 12 "Early spermatids: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.6;HeLa: 4.7;NB-4: 2.9;RT4: 2.2" "HPA025704, HPA051750" Enhanced NA NA "HPA025704: AB_1853093, HPA051750: AB_2681590" "unprognostic (3.20e-1)" "unprognostic (7.16e-4)" "unprognostic (3.15e-3)" "unprognostic (2.79e-1)" 0.1 0.0 0.1 0.2 0.2 1.3 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.3 0.1 0.1 0.1 0.2 17.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.6 0.7 1.2 0.9 0.0 1.1 0.4 0.9 4.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.7 0.0 0.0 1.3 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.4 0.0 1.6 0.0 2.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.2 0.8 0.2 0.8 1.0 0.0 0.0 0.9 0.0 0.0 0.4 0.3 1.4 1.0 0.7 0.1 0.8 0.0 0.2 0.5 0.7 0.9 1.2 1.0 0.4 0.5 0.5 0.6 0.6 0.0 1.6 0.8 1.1 0.4 0.0 0.9 0.7 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE5 ENSG00000170092 "Speedy/RINGO cell cycle regulator family member E5" 7 75493625-75504304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.1;skin 1: 3.8;testis: 5.0" "Group enriched" "Detected in some" 6 "Early spermatids: 6.1;Horizontal cells: 4.8;Late spermatids: 5.1;Rod photoreceptor cells: 2.0" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 6.0;RT4: 5.1" HPA051750 Approved NA NA "HPA051750: AB_2681590" "unprognostic (2.22e-1)" "unprognostic (1.81e-1)" "unprognostic (7.87e-3)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (1.77e-2)" "unprognostic (7.25e-3)" "unprognostic (2.27e-2)" "unprognostic (6.34e-2)" "unprognostic (9.80e-2)" "unprognostic (2.43e-2)" "unprognostic (9.10e-4)" "unprognostic (1.51e-10)" "unprognostic (4.21e-2)" "unprognostic (1.87e-1)" "unprognostic (6.63e-2)" "unprognostic (3.08e-4)" 0.0 0.5 0.8 1.6 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.3 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.4 3.8 0.6 0.0 0.8 0.3 5.0 0.6 0.0 0.6 3.8 2.6 4.1 2.2 1.0 3.6 0.7 1.4 1.4 1.5 2.5 0.1 0.0 1.5 1.1 0.0 0.0 0.0 1.4 1.4 2.0 0.6 0.0 0.9 1.6 0.0 0.0 0.0 1.0 0.9 0.8 6.0 1.0 0.0 3.7 0.9 0.0 0.0 0.0 0.0 0.6 0.0 1.2 1.9 2.3 0.0 2.2 0.9 2.7 1.2 0.5 1.0 1.0 0.3 0.0 0.0 5.1 1.8 1.2 1.2 1.4 0.3 1.2 2.0 0.5 2.4 2.7 1.1 1.6 1.5 1.7 0.7 2.8 0.4 1.7 1.8 4.1 2.2 1.1 3.6 1.2 1.9 2.0 1.9 1.8 0.9 3.8 1.7 2.1 3.5 1.0 2.1 2.6 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 4.8 0.0 0.0 0.6 5.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 SPDYE6 ENSG00000260097 "Speedy/RINGO cell cycle regulator family member E6" 7 102347206-102356444 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.5;skin 1: 3.9;testis: 4.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 12.1" HPA051750 Approved NA NA "HPA051750: AB_2681590" "unprognostic (5.47e-2)" "unprognostic (3.61e-1)" "unprognostic (1.66e-1)" "unprognostic (4.89e-3)" "unprognostic (3.45e-1)" "unprognostic (1.23e-2)" "unprognostic (5.84e-3)" "unprognostic (9.81e-2)" "unprognostic (1.36e-2)" "unprognostic (4.09e-2)" "unprognostic (8.22e-3)" "unprognostic (3.49e-2)" "unprognostic (7.81e-6)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (1.73e-1)" "unprognostic (2.12e-1)" 0.0 0.2 2.0 3.2 0.0 0.0 0.0 0.3 0.7 0.3 0.0 0.8 0.0 0.1 0.2 0.1 0.0 0.0 3.3 0.0 1.1 0.0 0.3 0.0 0.0 1.1 0.0 4.5 3.9 0.8 0.0 1.5 0.9 4.2 1.1 0.0 0.4 3.0 1.1 1.3 1.9 0.4 2.2 1.1 2.9 1.4 1.6 3.1 0.0 0.0 5.3 4.5 0.0 0.0 0.0 1.2 2.5 4.9 1.6 0.0 0.6 1.4 0.0 0.0 0.0 1.0 4.2 2.6 7.9 0.8 0.0 2.2 2.4 0.0 0.0 0.0 0.0 0.2 0.0 1.9 3.4 12.1 0.0 4.5 1.1 2.7 1.6 0.8 0.0 3.6 0.5 2.9 0.0 5.6 3.1 1.8 5.9 2.4 1.2 3.6 1.2 2.0 1.4 5.3 1.7 3.2 2.5 3.0 2.2 2.8 1.0 4.3 2.3 0.1 0.9 1.3 2.2 1.6 2.1 0.6 1.4 0.9 0.5 3.0 1.4 2.0 0.9 0.4 1.9 1.1 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20009344-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.9" "Cell type enhanced" "Detected in many" 5 "granulocytes: 111.1;monocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.6;SuSa: 58.4" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 10.7 8.3 21.3 7.2 38.0 29.9 8.1 16.0 30.8 7.0 14.9 49.9 0.7 9.5 15.4 6.1 11.4 7.3 20.0 4.1 23.1 15.4 4.3 2.0 5.6 5.7 35.8 21.2 17.0 8.3 3.0 6.8 4.8 29.3 7.3 15.5 3.0 5.9 4.9 4.3 4.8 11.4 11.5 28.2 17.3 9.8 25.8 41.5 0.2 6.7 1.4 6.0 7.0 4.2 2.9 14.7 18.9 9.4 8.5 3.4 3.0 14.2 14.8 8.0 2.6 6.1 3.1 17.4 5.8 4.8 5.8 7.2 24.2 12.7 0.8 18.9 5.0 8.7 10.6 6.1 13.8 2.9 4.3 6.5 5.8 16.2 2.6 2.2 0.6 3.4 3.3 14.0 8.2 9.3 35.6 0.0 2.4 0.7 7.2 4.5 12.1 0.1 3.2 6.4 6.3 3.6 3.5 16.2 8.2 14.3 7.1 2.6 2.7 30.4 14.6 6.4 58.4 12.9 3.8 0.4 0.7 8.9 0.8 15.7 2.8 3.5 1.1 8.6 4.9 3.3 18.9 9.4 17.8 3.1 5.3 2.9 2.4 1.9 3.4 14.7 2.9 1.8 2.4 8.1 8.5 4.6 4.4 0.9 3.0 21.3 38.0 16.0 30.8 23.1 15.4 35.8 21.2 29.3 41.5 20.8 14.3 3.2 11.9 4.8 5.9 6.1 7.6 12.0 6.8 17.4 64.8 3.9 8.3 26.9 75.7 5.2 32.8 23.3 31.4 10.8 9.5 14.6 111.1 0.2 18.6 0.0 7.5 3.1 9.7 40.7 4.6 14.0 20.3 103.6 44.0 19.3 54.5 28.3 42.1 2.4 32.8 58.2 31.9 72.4 64.5 2.3 1.8 10.2 18.6 22.1 SPEF1 "C20orf28, CLAMP, DKFZP434I114, SPEF1A" ENSG00000101222 "Sperm flagellar 1" Q9Y4P9 20 3777504-3781448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.7;fallopian tube: 19.6;testis: 12.5" "Group enriched" "Detected in some" 4 "Ciliated cells: 29.4;Club cells: 12.5;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 21.0;Spermatocytes: 31.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.9;hTEC/SVTERT24-B: 3.0;MCF7: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050786 Enhanced NA NA "HPA050786: AB_2681238" "unprognostic (2.41e-2)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (4.91e-3)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.08e-3)" "unprognostic (8.12e-3)" "unprognostic (5.95e-2)" "unprognostic (8.41e-2)" "unprognostic (8.88e-3)" "unprognostic (1.69e-1)" "unprognostic (3.81e-3)" "unprognostic (1.83e-1)" "unprognostic (6.60e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (7.49e-2)" 0.4 0.7 4.0 0.4 16.7 0.5 0.6 0.0 3.9 1.0 0.4 3.2 0.0 0.4 0.7 6.0 0.4 19.6 0.5 0.4 6.9 3.0 1.8 0.4 4.3 0.4 1.7 1.7 1.8 0.8 1.0 1.4 0.4 11.5 0.4 0.4 1.3 0.5 0.6 0.4 0.4 0.4 0.4 0.4 0.4 0.5 12.5 1.7 0.0 2.6 0.0 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 2.5 5.9 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 1.5 0.6 0.5 0.2 0.3 0.6 0.2 0.5 0.3 0.7 0.3 0.0 0.0 1.2 0.0 0.1 0.0 0.3 0.7 3.0 0.0 0.1 0.0 1.1 0.1 0.1 0.0 4.3 1.2 0.6 0.5 0.3 0.5 0.0 0.4 0.4 1.6 0.0 1.1 0.9 0.2 1.2 1.6 0.1 1.6 0.0 0.0 0.9 0.5 1.3 0.4 0.4 0.1 0.4 2.1 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.5 0.0 0.0 0.0 0.0 0.5 0.2 4.0 16.7 0.0 3.9 6.9 3.0 1.7 1.7 11.5 1.7 0.0 0.0 0.0 0.1 0.3 1.4 0.3 0.0 29.4 12.5 3.5 15.7 0.0 5.0 1.0 2.7 0.1 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.2 0.0 0.0 1.3 0.0 2.5 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 5.1 21.0 0.0 0.0 31.1 2.0 0.1 0.1 0.0 0.1 0.0 SPEG "APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta" ENSG00000072195 "SPEG complex locus" Q15772 2 219434846-219498287 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 88.7" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 55.0;Late spermatids: 30.8;Sertoli cells: 45.3;Smooth muscle cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 27.9;U-87 MG: 14.6" "Low region specificity" "Detected in all" HPA018904 Enhanced Approved Vesicles NA NA Vesicles "HPA018904: AB_1844924" "unprognostic (3.70e-1)" "unprognostic (1.23e-2)" "unprognostic (5.05e-3)" "unprognostic (2.45e-4)" "unprognostic (2.04e-2)" "unprognostic (4.65e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (8.92e-3)" "unprognostic (2.29e-2)" "unprognostic (8.66e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-9)" "unprognostic (1.14e-1)" "unprognostic (7.01e-2)" "unprognostic (5.95e-4)" "unprognostic (1.28e-3)" 7.7 7.1 10.1 9.1 7.7 1.2 4.2 10.4 9.8 19.2 45.1 4.1 10.5 5.7 31.6 14.1 13.5 19.0 17.4 17.8 8.7 5.3 2.0 1.4 3.0 1.7 4.0 8.0 7.0 2.9 4.7 10.5 4.8 5.5 16.7 4.5 6.7 7.8 23.0 88.7 2.2 9.2 45.2 9.1 1.9 16.1 3.0 3.9 0.0 2.0 16.8 1.6 22.5 12.6 0.0 0.3 0.0 0.0 0.0 0.5 0.7 3.6 0.3 1.8 3.1 0.9 2.9 1.2 7.7 5.2 5.2 3.9 2.8 1.3 0.0 2.8 5.6 2.9 4.5 1.5 1.8 2.0 0.4 1.2 0.4 3.3 0.1 1.3 0.0 0.6 8.2 2.7 4.7 1.1 27.9 0.0 2.0 2.7 0.0 3.7 1.0 0.0 11.0 3.9 0.1 1.4 1.8 4.2 0.6 5.0 0.0 2.1 9.6 0.5 0.0 0.1 9.2 0.3 0.1 0.1 13.0 13.2 1.5 12.1 0.4 0.0 0.1 14.6 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.7 10.1 7.7 10.4 9.8 8.7 5.3 4.0 8.0 5.5 3.9 0.0 2.1 0.0 5.6 2.9 1.1 55.0 5.1 0.0 0.0 1.8 2.0 0.8 0.0 1.2 17.7 1.4 5.9 0.0 1.0 0.7 8.5 2.7 0.0 2.4 1.0 4.8 6.4 3.7 6.6 30.8 9.8 1.7 3.3 1.8 3.3 6.5 0.3 2.9 17.7 2.3 0.8 45.3 36.2 1.1 2.6 1.3 1.1 0.0 2.4 3.5 SPEM1 "C17orf83, FLJ40081" ENSG00000181323 "Spermatid maturation 1" Q8N4L4 17 7420360-7421632 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "testis: 61.9" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3850.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 3.3" "Low region specificity" "Detected in single" NA NA "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.5 0.2 0.0 0.3 0.0 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 3.3 0.4 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 833.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3850.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 6.5 0.0 11.5 4.0 0.0 0.0 0.0 0.0 0.0 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425615-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 45.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.3;hTEC/SVTERT24-B: 1.0;U-2 OS: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPEM3 ENSG00000283439 "SPEM family member 3" 17 7428863-7432762 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 73 "testis: 43.2" "Cell type enriched" "Detected in single" 17 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.1" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPERT "CBY2, NURIT" ENSG00000174015 "Spermatid associated" Q8NA61 13 45702311-45714559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 66.5" "Group enriched" "Detected in some" 81 "Early spermatids: 730.0;Late spermatids: 1376.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;HDLM-2: 3.5;hTCEpi: 1.2;JURKAT: 1.1;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039359, HPA040046" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA039359: AB_10794088, HPA040046: AB_10796117" "unprognostic (2.86e-1)" "unprognostic (3.38e-1)" "unprognostic (1.64e-2)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (4.19e-4)" "unprognostic (8.52e-2)" "unprognostic (8.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.56e-2)" "unprognostic (1.97e-2)" "unprognostic (4.15e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.8 0.8 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 730.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1376.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 12.9 0.0 7.4 5.3 0.0 0.0 0.0 0.0 0.0 SPESP1 SP-ESP ENSG00000258484 "Sperm equatorial segment protein 1" Q6UW49 15 68818221-68946811 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "placenta: 14.2;testis: 54.3" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 242.1;Spermatocytes: 320.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 11.1;BJ hTERT+ SV40 Large T+ RasG12V: 11.7;HBF TERT88: 13.7;HMC-1: 8.4;OE19: 9.5;RPTEC TERT1: 16.5;SCLC-21H: 12.5;WM-115: 19.4" "Not detected" "Not detected" "HPA045936, HPA051040" Enhanced "Intracellular and membrane" NA NA 13000 "HPA045936: AB_2679504, HPA051040: AB_2681322" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (9.82e-2)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (5.96e-2)" "unprognostic (2.79e-1)" "unprognostic (2.40e-1)" "unprognostic (8.99e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (9.67e-2)" 2.3 2.7 1.5 0.7 3.3 0.4 2.3 1.1 1.9 1.1 1.5 1.6 4.8 0.9 1.5 4.7 2.0 1.5 2.6 2.8 1.5 1.5 2.2 1.0 1.1 1.9 2.1 0.5 2.7 1.4 0.2 2.9 14.2 3.8 2.7 0.9 1.8 1.7 3.1 1.6 1.0 0.9 2.0 3.2 1.8 1.4 54.3 1.1 0.8 2.2 0.7 0.6 2.9 0.8 1.4 2.6 3.7 4.3 0.7 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 11.1 11.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.7 3.0 0.0 0.0 0.0 0.0 4.0 0.0 8.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.7 0.0 0.0 2.0 9.5 0.0 0.0 0.9 0.0 16.5 0.1 12.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 19.4 3.7 4.3 1.3 0.8 3.4 2.0 1.4 1.5 1.1 2.6 1.3 1.3 1.7 1.9 0.7 2.5 1.5 1.4 1.8 1.5 3.3 1.1 1.9 1.5 1.5 2.1 0.5 3.8 1.1 0.0 0.0 0.0 2.8 1.6 0.8 3.5 0.0 2.7 0.0 7.0 3.9 58.4 1.7 2.0 242.1 2.9 0.0 0.0 2.4 4.6 6.1 2.5 0.0 1.5 6.6 0.0 1.7 0.0 1.3 51.2 19.5 1.9 5.0 1.0 0.1 5.7 1.0 0.0 8.1 3.5 5.1 45.3 4.7 320.9 70.5 1.9 51.9 0.0 0.0 0.9 SPHAR ENSG00000213029 "S-phase response (cyclin related)" Q15513 1 229304857-229305504 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 31 "brain: 3.1" "Group enriched" "Detected in some" 13 "Alveolar cells type 2: 1.4;Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "Daudi: 2.0" NA NA 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPHKAP SKIP ENSG00000153820 "SPHK1 interactor, AKAP domain containing" Q2M3C7 2 227979950-228181645 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "brain: 64.0;heart muscle: 33.2" "Cell type enriched" "Detected in some" 13 "Cardiomyocytes: 75.1" "Not detected" "Not detected" "Region enriched" "Detected in many" 4 "cerebellum: 64.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 17 "BJ hTERT+: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042499, HPA048168" Enhanced NA NA "HPA042499: AB_2678027, HPA048168: AB_2680296" "unprognostic (4.91e-3)" "unprognostic (6.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-2)" "unprognostic (2.95e-2)" "unprognostic (2.09e-1)" "unprognostic (1.01e-3)" 0.5 0.6 10.7 0.5 5.1 0.4 1.4 64.0 14.8 0.5 0.5 2.1 0.0 0.5 0.5 0.4 0.5 0.5 0.5 33.2 15.1 3.7 0.5 0.4 0.6 0.5 1.6 4.5 3.2 0.5 0.4 0.1 0.5 3.8 0.5 0.5 0.5 2.7 0.5 0.4 0.5 0.5 0.5 1.1 1.0 0.5 0.7 0.9 0.0 0.5 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 32.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 5.1 64.0 8.5 15.1 3.7 1.6 4.5 3.8 0.9 0.0 0.0 0.0 0.0 0.1 5.6 75.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPI1 "OF, PU.1, SFPI1, SPI-1, SPI-A" ENSG00000066336 "Spi-1 proto-oncogene" P17947 11 47354860-47378576 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, RNA-binding" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 100.3;lymphoid tissue: 70.2" "Group enriched" "Detected in many" 5 "Hofbauer cells: 391.4;Kupffer cells: 374.7;Macrophages: 436.5;monocytes: 317.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 45.4;neutrophil: 24.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 45.4" "Cell line enhanced" "Detected in some" "HEL: 19.2;HL-60: 33.6;HMC-1: 62.7;NB-4: 56.7;THP-1: 44.2;U-698: 17.9;U-937: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004079, HPA044653" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "CAB004079: AB_10692379, HPA044653: AB_2679036" "unprognostic (4.45e-2)" "unprognostic (3.31e-3)" "unprognostic (2.92e-2)" "unprognostic (1.66e-2)" "unprognostic (5.97e-2)" "unprognostic (3.33e-2)" "unprognostic (5.28e-2)" "unprognostic (1.07e-1)" "unprognostic (2.35e-2)" "unprognostic (2.79e-1)" "unprognostic (3.36e-1)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.20e-1)" "unprognostic (4.95e-2)" "unprognostic (2.40e-1)" "unprognostic (4.92e-2)" 24.4 8.1 6.7 35.7 15.2 100.3 9.0 1.5 6.6 3.6 5.2 8.6 0.0 7.6 3.2 6.2 4.0 8.5 7.7 15.7 5.6 5.1 5.8 11.9 37.2 51.1 12.6 1.6 6.1 3.5 0.9 3.6 10.1 9.6 4.5 3.9 3.9 6.4 2.6 3.3 5.0 10.5 7.6 12.1 70.2 5.8 5.4 10.5 9.6 3.7 2.7 16.8 9.1 5.7 1.0 4.6 45.4 9.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 33.6 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 56.7 0.0 0.0 0.0 10.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 17.9 0.0 25.0 0.0 3.6 5.4 45.4 0.0 7.8 0.0 1.0 0.0 0.0 4.6 0.8 0.0 0.0 24.8 0.0 9.1 0.2 0.0 1.5 6.7 15.2 1.5 6.6 5.6 5.1 12.6 1.6 9.6 10.5 3.0 0.6 71.3 0.5 9.3 1.5 2.0 7.6 1.4 1.2 5.2 0.0 1.9 16.6 0.0 5.9 2.2 0.3 0.0 0.3 2.5 5.9 0.4 34.5 1.3 391.4 0.0 4.1 11.1 374.7 20.0 1.7 436.5 10.1 317.4 0.1 4.0 0.0 0.0 0.0 1.3 1.0 12.9 2.1 5.5 2.5 8.7 3.5 2.5 0.4 0.4 SPIB SPI-B ENSG00000269404 "Spi-B transcription factor" Q01892 19 50418938-50431313 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "blood: 83.3;intestine: 22.3;lymphoid tissue: 73.2" "Cell type enriched" "Detected in many" 4 "Paneth cells: 708.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 57 "memory B-cell: 47.4;naive B-cell: 39.9;plasmacytoid DC: 83.3" "Group enriched" "Detected in many" 105 "B-cells: 47.4;dendritic cells: 83.3" "Cell line enhanced" "Detected in some" "Daudi: 45.4;HDLM-2: 28.9;Karpas-707: 14.5;U-698: 63.1" HPA018523 Uncertain NA NA "HPA018523: AB_1857443" "prognostic favorable (4.76e-5)" "unprognostic (1.06e-5)" "unprognostic (9.15e-3)" "unprognostic (3.70e-2)" "unprognostic (9.72e-3)" "prognostic favorable (2.14e-5)" "unprognostic (2.33e-1)" "unprognostic (4.79e-3)" "unprognostic (1.18e-2)" "unprognostic (7.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (3.96e-8)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.75e-1)" "unprognostic (7.33e-2)" 0.6 0.4 0.4 73.2 0.4 1.9 0.5 0.4 0.4 0.4 18.9 0.1 0.1 4.6 0.4 0.0 2.3 0.5 0.7 0.6 0.4 0.4 1.1 0.5 3.7 33.0 0.4 0.0 0.4 1.5 0.0 0.5 0.2 0.3 1.1 6.7 0.4 7.7 0.0 0.6 0.4 22.3 0.0 1.2 26.9 2.4 0.6 0.0 9.3 1.0 1.5 53.7 2.2 0.6 47.4 83.3 0.4 0.0 0.6 0.0 2.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 45.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 28.9 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 14.5 0.0 0.1 0.0 0.1 0.4 0.0 0.0 3.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.2 0.0 0.8 0.0 0.0 1.3 0.9 63.1 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 47.4 0.0 0.0 1.0 39.9 0.0 0.0 0.4 0.6 0.0 83.3 0.0 2.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.3 0.0 0.0 2.6 160.0 2.1 1.5 1.0 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 15.4 0.0 1.0 0.1 1.3 0.7 4.6 0.8 1.3 0.0 19.0 0.0 0.8 0.0 0.0 6.4 6.8 0.0 6.9 0.8 0.0 708.4 0.4 0.3 0.9 0.0 1.0 0.1 1.1 1.1 0.2 1.3 17.2 1.4 SPIC "MGC40611, SPI-C" ENSG00000166211 "Spi-C transcription factor" Q8N5J4 12 101475421-101486997 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 74.6" "Cell type enriched" "Detected in single" 12 "Kupffer cells: 11.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "intermediate monocyte: 4.1;non-classical monocyte: 1.2" "Lineage enriched" "Detected in single" 7 "monocytes: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (9.82e-2)" "unprognostic (2.43e-2)" "unprognostic (9.03e-3)" "unprognostic (2.51e-1)" "unprognostic (4.85e-2)" "unprognostic (5.78e-2)" "unprognostic (5.30e-2)" "unprognostic (1.77e-1)" 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.1 0.1 0.1 4.7 0.1 16.7 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.3 0.0 0.1 74.6 0.1 0.1 0.0 3.1 0.1 0.0 2.4 0.1 0.1 0.0 0.0 0.0 4.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPIN4 "FLJ44984, TDRD28" ENSG00000186767 "Spindlin family member 4" Q56A73 X 63347228-63351344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 27.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA044559 Uncertain Approved Nucleoli,Cytosol NA Yes Cytosol Nucleoli "HPA044559: AB_10794171" "unprognostic (9.66e-2)" "unprognostic (2.00e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (3.12e-1)" "unprognostic (3.22e-4)" "unprognostic (3.30e-3)" "unprognostic (9.44e-3)" "unprognostic (8.62e-2)" "unprognostic (3.65e-3)" "unprognostic (9.39e-2)" "prognostic unfavorable (3.56e-6)" "unprognostic (1.74e-2)" "unprognostic (2.15e-1)" "unprognostic (2.57e-1)" "unprognostic (8.09e-2)" 3.9 3.2 4.2 5.1 4.4 13.8 13.7 2.3 5.4 5.1 5.9 6.7 2.0 3.5 6.7 4.7 16.8 3.9 3.5 3.2 4.7 6.1 3.3 2.4 16.8 7.6 4.5 2.3 6.6 4.2 4.8 4.7 12.3 5.2 7.2 6.9 4.8 27.4 2.9 1.2 3.5 4.9 5.8 5.2 5.9 3.9 3.4 3.5 11.2 5.6 6.4 11.8 4.3 8.2 1.2 1.4 3.7 2.1 6.0 1.5 0.8 16.0 4.1 9.6 7.8 2.1 3.0 6.9 8.0 3.4 4.7 5.7 2.7 16.0 0.0 3.5 3.7 5.4 5.4 12.3 5.8 8.6 6.9 3.9 20.6 5.5 2.5 0.9 17.8 16.1 1.4 2.0 7.8 4.2 2.3 5.1 3.6 6.2 20.1 10.7 5.4 5.9 9.6 9.9 2.6 6.0 8.3 20.7 4.4 3.4 4.3 0.0 5.3 14.4 4.2 1.5 20.8 9.1 8.5 2.2 9.5 10.7 15.7 5.0 4.4 5.1 10.6 5.0 14.7 5.6 1.7 1.8 3.7 1.5 2.1 0.7 1.2 0.8 0.9 1.4 1.1 0.5 1.0 0.0 6.0 1.7 0.0 0.5 0.8 4.2 4.4 2.3 5.4 4.7 6.1 4.5 2.3 5.2 3.5 0.0 1.3 0.5 1.3 3.0 5.2 1.2 0.0 4.0 2.3 3.5 2.0 5.5 1.7 0.6 0.0 2.7 1.7 0.0 1.2 5.8 3.1 2.6 9.2 0.8 2.2 1.6 6.4 8.6 1.3 0.0 2.8 1.7 5.0 0.0 7.2 1.2 1.3 7.0 3.2 1.0 2.4 0.0 1.6 0.0 0.2 5.5 2.7 3.2 6.0 4.7 SPINK1 "PCTT, PSTI, Spink3, TATI" ENSG00000164266 "Serine peptidase inhibitor, Kazal type 1" P00995 5 147824568-147831786 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "pancreas: 1767.1" "Group enriched" "Detected in many" 15 "Exocrine glandular cells: 43924.5;Pancreatic endocrine cells: 22474.2" "Cancer enhanced" "Detected in many" "pancreatic cancer: 513.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 44.0;RT4: 120.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026366, HPA027498" Enhanced "Secreted to digestive system" NA NA 7900000 "CAB026366: , HPA027498: AB_10603115" "unprognostic (1.05e-1)" "unprognostic (1.00e-1)" "unprognostic (9.96e-3)" "unprognostic (3.55e-1)" "unprognostic (6.12e-3)" "unprognostic (1.79e-4)" "unprognostic (8.34e-3)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "unprognostic (1.88e-1)" "unprognostic (3.82e-2)" "unprognostic (8.13e-2)" "prognostic unfavorable (5.44e-7)" "unprognostic (7.98e-2)" "unprognostic (2.07e-1)" "prognostic favorable (2.15e-5)" 0.3 0.0 0.3 1.6 0.3 0.0 0.3 0.3 0.3 0.3 6.0 0.3 0.3 6.3 0.3 0.3 0.3 0.0 1.5 0.3 0.3 0.0 2.0 13.3 0.4 0.3 0.3 0.3 0.3 1767.1 0.0 0.3 0.3 0.3 1.4 6.4 0.3 0.3 0.3 0.3 0.0 6.9 1.0 0.3 0.3 25.8 0.4 0.3 0.3 0.3 0.3 0.3 13.1 2.2 0.7 0.5 1.9 0.5 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.8 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 10.9 0.0 0.0 0.5 0.0 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 17.3 0.1 0.0 0.0 0.2 0.0 120.9 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.4 0.5 0.2 2.2 0.0 0.0 1.9 0.4 0.2 0.4 0.5 0.2 0.4 0.4 0.3 0.1 0.7 0.5 0.6 1.8 0.3 0.4 0.5 0.1 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 2.2 23.4 11.4 0.0 0.0 0.1 2119.8 1.4 19.4 357.6 0.0 0.0 72.9 1009.7 0.1 0.0 492.7 23.3 43924.5 0.1 0.0 96.7 4.6 2225.9 0.1 0.0 496.7 62.0 39.3 0.0 0.0 0.0 0.0 470.7 1572.1 0.0 22474.2 345.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.6 978.8 64.4 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor, Kazal type 13 (putative)" Q1W4C9 5 148268180-148286254 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7" "Group enriched" "Detected in some" 7 "Leydig cells: 36.8;Peritubular cells: 25.1" "Group enriched" "Detected in some" 6 "cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HeLa: 102.0" HPA036456 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.2 0.0 85.5 0.0 0.4 86.8 0.1 1.0 0.1 0.8 0.0 0.1 2.1 0.0 0.1 0.1 0.0 0.0 1.4 0.4 0.0 1.0 0.1 0.0 4.0 0.0 0.0 0.1 26.7 0.1 0.2 0.0 0.1 0.0 0.0 2.9 2.7 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 102.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPINK14 SPINK5L2 ENSG00000196800 "Serine peptidase inhibitor, Kazal type 14 (putative)" Q6IE38 5 148169733-148175398 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "breast: 2.7;intestine: 3.6;liver: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted - unknown location" NA NA "unprognostic (4.98e-2)" "unprognostic (3.44e-1)" "unprognostic (1.94e-2)" "unprognostic (2.96e-2)" "unprognostic (5.69e-1)" "unprognostic (1.48e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 3.6 1.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SPINK2 HUSI-II ENSG00000128040 "Serine peptidase inhibitor, Kazal type 2" P20155 4 56809860-56821742 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "epididymis: 376.2" "Group enriched" "Detected in many" 9 "Early spermatids: 772.8;Late spermatids: 1064.2;Spermatocytes: 1687.5" "Group enriched" "Detected in some" 5 "lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in many" 6 "NK-cell: 43.3" "Lineage enriched" "Detected in many" 6 "NK-cells: 43.3" "Cell line enriched" "Detected in some" 4 "U-266/70: 44.5" "CAB020824, HPA026813" Enhanced "Secreted to blood" NA NA "CAB020824: , HPA026813: AB_1857446" "unprognostic (5.56e-3)" "unprognostic (3.60e-1)" "unprognostic (7.54e-2)" "unprognostic (2.35e-2)" "unprognostic (1.54e-1)" "unprognostic (1.60e-1)" "prognostic favorable (2.82e-4)" "unprognostic (9.83e-2)" "unprognostic (6.62e-2)" "unprognostic (9.40e-3)" "unprognostic (2.06e-1)" "unprognostic (2.49e-1)" "unprognostic (4.10e-3)" "unprognostic (3.18e-2)" "unprognostic (2.19e-2)" "unprognostic (3.87e-2)" 0.2 0.1 0.2 0.5 0.2 0.7 0.3 0.1 0.3 0.4 0.4 0.0 85.2 0.0 0.2 376.2 0.1 0.2 0.0 2.2 0.3 0.3 0.2 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.0 1.4 0.0 1.1 1.1 0.1 0.0 0.6 49.9 0.5 0.2 0.5 0.0 0.2 0.6 0.2 85.5 0.0 0.3 0.2 0.0 0.2 1.3 1.3 3.9 0.4 1.3 0.0 43.3 7.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 1.3 8.6 0.2 0.0 0.0 0.0 0.0 2.0 0.0 2.8 0.1 1.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 44.5 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 0.0 0.2 2.3 1.7 1.8 0.4 3.9 3.9 7.3 0.3 43.3 0.0 0.2 0.1 2.0 0.2 0.2 0.1 0.3 0.3 0.3 0.2 0.0 1.1 0.0 0.0 0.0 4.5 12.1 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 772.8 0.1 0.2 0.0 0.0 0.2 0.5 9.5 1.1 0.0 0.1 0.0 1.7 0.0 0.0 1064.2 35.1 0.2 11.8 0.0 5.3 1.4 0.0 9.3 23.0 0.0 0.0 12.9 1.0 1687.5 136.3 0.3 0.0 7.5 1.7 2.2 SPINK4 "MGC133107, PEC-60" ENSG00000122711 "Serine peptidase inhibitor, Kazal type 4" O60575 9 33218365-33248567 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3" "Cell type enriched" "Detected in some" 24 "Mucus-secreting cells: 2251.6" "Group enriched" "Detected in many" 20 "colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 5.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 5.1" "Group enriched" "Detected in some" 11 "HMC-1: 38.2;OE19: 100.1" "Region enhanced" "Detected in single" "pons and medulla: 1.1" "Not detected" "Not detected" HPA007286 Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Secreted to digestive system" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA007286: AB_1080083" "unprognostic (3.49e-2)" "unprognostic (2.32e-1)" "prognostic favorable (8.85e-5)" "unprognostic (3.09e-4)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.66e-2)" "unprognostic (2.43e-1)" "unprognostic (1.24e-1)" "unprognostic (3.25e-1)" "unprognostic (2.42e-3)" 0.2 0.4 0.2 24.3 0.3 0.0 0.2 0.2 0.2 0.2 69.3 0.2 0.2 28.8 0.2 0.2 0.3 0.2 35.8 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.4 0.2 0.2 0.3 110.5 2.5 0.2 0.2 0.3 0.2 120.9 4.6 0.2 0.3 0.5 0.3 0.2 0.2 0.2 0.2 0.2 3.4 0.2 0.0 0.0 5.1 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 6.2 0.2 0.0 0.0 38.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.4 0.0 100.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 3.2 0.6 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 20.7 0.0 0.0 0.0 0.0 5.2 11.8 0.0 0.0 0.1 0.7 0.0 94.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 84.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2251.6 15.3 0.1 40.3 0.0 0.0 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.8 0.1 SPINK5 "DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI" ENSG00000133710 "Serine peptidase inhibitor, Kazal type 5" Q9NQ38 5 148025683-148137289 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 45.0;Basal keratinocytes: 47.7;Cholangiocytes: 58.6;Mucus-secreting cells: 32.9;Paneth cells: 66.2;Suprabasal keratinocytes: 56.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 12.3;HeLa: 18.1;Karpas-707: 16.0;SuSa: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009067, HPA011351, CAB015347" Enhanced Enhanced Vesicles "Secreted in other tissues" NA NA 28000000 Vesicles "CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447" "unprognostic (9.66e-3)" "unprognostic (1.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.42e-3)" "unprognostic (2.45e-2)" "unprognostic (6.85e-2)" "unprognostic (1.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.92e-3)" "unprognostic (4.56e-1)" "unprognostic (2.44e-1)" "unprognostic (7.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.87e-2)" "unprognostic (2.59e-1)" 0.1 0.0 0.2 0.1 0.1 0.0 2.8 0.1 0.2 101.6 0.7 0.2 0.1 0.0 3.2 0.2 313.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.2 1.7 0.2 18.1 0.1 0.2 48.6 0.1 0.1 0.1 0.1 0.7 0.2 0.1 3.6 0.3 97.4 65.3 0.3 64.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 1.5 0.0 0.0 12.3 0.0 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.7 16.0 0.0 1.7 0.0 0.0 2.2 1.6 0.2 0.0 0.0 0.0 0.0 4.7 2.4 0.0 0.5 0.0 0.0 5.9 3.8 0.0 0.0 0.0 0.1 0.0 0.0 4.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 8.9 45.0 0.0 1.4 47.7 0.0 0.8 58.6 6.7 9.1 0.0 0.0 1.7 0.0 0.0 9.3 6.4 13.4 0.0 1.1 1.6 1.0 0.6 1.1 0.0 0.1 0.0 4.1 1.3 0.6 2.7 0.6 0.6 3.3 0.0 32.9 0.0 4.6 66.2 0.0 0.0 0.0 0.0 0.9 0.6 1.9 56.2 1.3 0.0 20.3 2.3 SPINK6 "BUSI2, MGC21394, UNQ844" ENSG00000178172 "Serine peptidase inhibitor, Kazal type 6" Q6UWN8 5 148202794-148215137 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 1.3;Hofbauer cells: 2.6" "Group enriched" "Detected in many" 6 "cervical cancer: 21.4;head and neck cancer: 21.0" "Region enriched" "Detected in single" 78 "cerebellum: 10.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 84 "HeLa: 244.9;SiHa: 117.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011039 Uncertain "Secreted - unknown location" NA NA "HPA011039: AB_2668412" "unprognostic (2.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.65e-1)" "unprognostic (4.87e-2)" "prognostic favorable (7.16e-4)" "unprognostic (2.49e-2)" "unprognostic (4.04e-1)" "unprognostic (1.80e-2)" "unprognostic (2.09e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.29e-2)" 1.9 1.1 0.1 0.1 0.1 0.0 0.9 10.6 0.1 7.2 1.6 0.1 0.1 0.0 0.1 3.7 5.9 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.6 0.1 0.1 0.8 0.1 5.0 0.2 0.1 0.5 0.1 0.9 0.1 0.1 0.0 0.2 0.1 1.6 0.1 7.1 0.1 0.4 8.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 244.9 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 10.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 2.6 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 SPINK7 "ECG2, ECRG2" ENSG00000145879 "Serine peptidase inhibitor, Kazal type 7 (putative)" P58062 5 148312419-148315922 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 161.8;tongue: 124.0;vagina: 79.6" "Cell type enhanced" "Detected in single" 34 "Urothelial cells: 1.8" "Group enriched" "Detected in many" 6 "cervical cancer: 4.5;head and neck cancer: 15.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;HeLa: 2.2;hTCEpi: 3.9;PC-3: 3.2;SiHa: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036294 Enhanced "Secreted - unknown location" NA NA 90000 "HPA036294: AB_10671243" "unprognostic (2.82e-1)" "unprognostic (8.99e-3)" "unprognostic (8.52e-3)" "unprognostic (1.81e-1)" "unprognostic (1.12e-2)" "unprognostic (3.37e-2)" "unprognostic (9.10e-2)" "unprognostic (1.49e-1)" "unprognostic (6.86e-2)" "unprognostic (7.24e-2)" "unprognostic (4.22e-2)" 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 39.1 0.1 0.0 0.0 0.1 2.8 0.1 161.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 16.9 0.1 0.2 1.1 0.1 0.1 0.0 0.1 1.3 0.1 0.0 0.6 0.1 124.0 30.6 0.2 79.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.3 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 SPINK8 ENSG00000229453 "Serine peptidase inhibitor, Kazal type 8 (putative)" P0C7L1 3 48306842-48328341 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "breast: 33.5" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 1.1;Exocrine glandular cells: 1.2;Glandular cells: 2.2" "Group enriched" "Detected in some" 10 "breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4" "Group enriched" "Detected in some" 10 "eosinophil: 3.3;neutrophil: 4.5" "Lineage enriched" "Detected in single" 11 "granulocytes: 4.5" "Cell line enriched" "Detected in single" 62 "SK-BR-3: 41.2" "Region enriched" "Detected in some" 9 "hippocampal formation: 80.7" HPA053151 Uncertain "Secreted to blood" NA NA "HPA053151: AB_2682059" "prognostic unfavorable (8.47e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" 0.0 0.0 1.4 0.0 1.0 7.3 33.5 0.3 0.6 0.0 0.0 0.0 0.0 1.8 4.1 0.0 0.0 0.0 2.2 1.7 0.0 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.2 0.0 0.4 0.0 1.8 0.1 0.0 0.2 0.0 0.0 2.3 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 41.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 SPINK9 ENSG00000204909 "Serine peptidase inhibitor, Kazal type 9" Q5DT21 5 148321203-148339849 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "tongue: 65.0" "Group enriched" "Detected in some" 54 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 27.5;Ciliated cells: 26.8;Club cells: 27.3;granulocytes: 9.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 18.5;U-266/84: 19.6" "Low region specificity" "Detected in single" HPA038288 Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Nucleoplasm, Vesicles" "HPA038288: AB_10795400" "unprognostic (1.84e-1)" "unprognostic (4.87e-3)" "unprognostic (2.88e-1)" "unprognostic (9.02e-2)" "unprognostic (5.49e-3)" "unprognostic (3.04e-2)" "unprognostic (3.04e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "unprognostic (1.91e-2)" "unprognostic (3.93e-1)" "unprognostic (2.01e-1)" "unprognostic (3.99e-2)" "unprognostic (1.90e-1)" 1.0 2.3 2.3 2.2 4.0 6.2 1.0 1.3 3.2 1.0 1.2 1.0 1.0 1.1 2.0 1.5 1.5 0.5 1.0 2.3 2.2 3.3 1.3 1.0 1.0 1.9 1.5 1.0 1.4 1.4 0.5 1.4 2.5 1.0 1.8 1.2 1.0 1.0 1.0 2.4 2.7 1.7 1.0 1.1 1.1 2.0 3.8 1.0 2.7 1.0 65.0 1.1 1.2 1.0 3.4 2.7 10.7 2.9 5.8 2.8 0.2 11.1 2.1 2.9 3.0 0.4 1.1 2.4 3.0 0.1 0.2 0.5 4.6 8.6 3.3 18.5 0.2 1.6 2.3 0.9 0.6 0.8 4.7 2.2 6.5 6.9 2.0 0.2 2.3 2.7 0.1 0.6 0.3 0.1 1.7 0.0 2.3 3.9 14.4 0.4 9.5 2.2 3.4 11.4 4.2 4.4 2.9 2.9 3.6 1.4 9.1 5.2 6.0 3.0 6.5 2.0 8.3 10.6 2.1 7.0 3.4 10.7 3.3 3.5 9.1 19.6 3.3 2.8 2.0 4.6 10.7 2.9 1.3 1.8 1.6 2.1 1.3 2.0 2.1 0.7 3.4 2.6 2.8 10.5 5.8 2.8 2.7 1.3 0.2 2.3 4.0 1.3 3.2 2.2 3.3 1.5 1.0 1.0 1.0 14.9 27.5 0.0 0.1 0.0 0.0 0.3 0.0 26.8 27.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 121.0" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 3400000 "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.2 0.5 0.9 11.6 1.2 0.0 12.6 2.9 0.8 12.9 64.4 1.2 38.6 31.9 3.6 25.5 71.1 6.4 30.7 0.8 0.8 0.7 27.9 1.5 18.5 3.7 0.9 0.6 3.4 25.0 28.8 9.7 85.5 1.3 17.5 17.9 3.2 50.8 24.0 0.6 39.1 121.0 2.3 1.0 3.1 17.6 1.9 0.7 4.8 15.4 26.9 44.3 12.8 21.5 5.1 19.0 15.3 10.9 3.6 1.8 3.8 19.0 0.1 0.0 0.1 0.0 0.0 52.1 0.3 0.4 0.6 0.3 30.4 32.0 0.0 22.8 0.0 0.5 59.5 4.9 28.6 0.4 0.1 1.6 0.8 0.5 1.6 0.3 3.3 15.1 0.0 42.4 0.6 2.7 0.5 2.3 1.9 0.4 0.1 0.0 14.8 0.1 2.5 5.9 32.2 2.8 1.9 0.0 3.7 28.8 48.2 12.8 0.6 1.4 89.3 2.3 9.6 42.7 2.5 0.0 0.0 0.3 0.1 0.0 0.1 3.6 0.1 0.1 2.5 0.1 0.0 10.9 7.9 0.3 9.3 0.5 5.1 1.8 0.8 19.0 3.9 0.7 0.2 15.3 3.6 9.6 2.3 0.2 3.8 0.9 1.2 2.9 0.8 0.8 0.7 0.9 0.6 1.3 0.7 53.6 17.1 2.7 86.0 67.5 0.0 0.4 109.5 4.0 18.2 127.4 0.0 913.5 21.6 354.0 0.5 0.7 428.8 0.0 224.2 67.1 7.5 132.0 10.3 0.4 125.6 0.0 141.5 0.0 13.6 0.8 3.4 17.8 13.5 101.8 147.7 0.0 241.9 199.9 0.0 40.0 0.1 0.0 5.2 0.6 5.2 76.9 1399.8 2.2 145.0 168.6 SPINT3 HKIB9 ENSG00000101446 "Serine peptidase inhibitor, Kunitz type 3" P49223 20 45512461-45515624 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 113.9" "Cell type enhanced" "Detected in some" 19 "Suprabasal keratinocytes: 1.9;Urothelial cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "Karpas-707: 1.4;NTERA-2: 1.3" HPA026852 Enhanced "Secreted in male reproductive system" NA NA "HPA026852: AB_2732434" 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 113.9 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 16.7 0.0 4.8 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.3 SPINT4 "C20orf137, dJ601O1.1" ENSG00000149651 "Serine peptidase inhibitor, Kunitz type 4" Q6UDR6 20 45722351-45725830 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "epididymis: 134.6" "Cell type enriched" "Detected in single" 11 "Rod photoreceptor cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NB-4: 4.6;U-87 MG: 2.0" HPA046703 Enhanced "Secreted in male reproductive system" NA NA "HPA046703: AB_2732530" "unprognostic (3.61e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 11.5 0.0 0.1 134.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 40.0;Mucus-secreting cells: 37.2;Paneth cells: 34.2;Syncytiotrophoblasts: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 21.5;T-47d: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: AB_2677464, HPA049415: AB_2680755" "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.2 6.2 3.9 3.3 1.1 0.7 13.2 2.1 1.2 2.9 1.2 2.4 6.6 4.1 0.9 0.6 3.1 6.6 1.7 0.2 0.9 1.6 7.6 0.8 5.1 6.3 1.0 0.2 1.4 1.4 1.5 0.9 0.8 0.3 0.1 0.3 6.3 1.2 0.8 9.2 0.1 1.4 4.3 21.5 3.8 3.1 1.4 0.9 1.5 6.3 10.3 5.3 8.6 3.8 3.7 3.4 14.2 2.2 0.3 1.7 3.7 2.4 1.8 0.5 2.6 0.4 2.6 1.5 3.5 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 6.0 3.7 0.8 3.6 0.8 11.1 2.0 7.6 5.3 1.2 12.2 3.9 11.0 3.3 1.2 2.4 0.5 40.0 0.0 0.3 2.8 1.3 4.5 0.0 1.8 2.2 22.3 15.1 0.0 1.8 1.7 0.9 1.1 0.0 0.0 37.2 2.4 1.0 34.2 1.8 0.8 10.1 0.0 1.0 4.6 8.4 0.5 58.9 0.8 30.5 25.1 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 22.9;Erythroid cells: 23.3;granulocytes: 42.7;Hofbauer cells: 27.4;Kupffer cells: 21.5;Macrophages: 52.4;T-cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 52.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 56.1;HL-60: 49.8;HMC-1: 28.1;K-562: 17.4;MOLT-4: 19.3;REH: 17.4;THP-1: 27.0;U-937: 35.5" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB002666: , HPA055244: AB_2682756" "prognostic favorable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favorable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 5.7 1.0 1.2 12.9 2.7 33.1 1.6 0.7 1.5 1.3 2.8 2.6 0.0 2.3 1.5 0.6 1.9 1.7 2.8 3.9 1.2 1.4 1.8 1.9 25.0 18.3 3.7 0.2 1.0 1.6 0.2 1.0 0.8 2.3 1.6 2.6 1.6 5.0 0.6 0.8 1.6 6.8 1.0 4.6 15.9 2.0 0.6 1.9 79.7 1.6 1.7 17.4 2.6 1.4 1.0 8.8 3.5 52.1 17.5 26.5 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.1 0.0 0.4 0.0 49.8 28.1 0.0 0.0 0.0 0.0 0.0 0.0 10.9 17.4 13.7 0.1 0.0 19.3 12.5 0.0 0.0 0.0 17.4 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.1 0.0 0.0 0.0 0.0 0.1 1.0 7.3 0.0 35.5 0.0 2.4 5.5 3.5 26.5 24.3 14.5 1.0 10.7 18.1 8.8 0.3 7.6 13.2 0.9 17.5 52.1 7.0 9.1 10.7 1.2 2.7 0.7 1.5 1.2 1.4 3.7 0.2 2.3 1.9 8.9 22.9 9.3 0.5 1.9 0.6 5.1 0.0 2.7 4.5 1.8 0.0 0.2 0.0 0.0 0.0 0.7 0.0 23.3 0.0 0.3 2.6 0.4 42.7 0.9 27.4 1.6 0.0 4.3 21.5 0.0 0.0 52.4 1.7 1.8 0.0 0.4 0.0 0.0 0.0 0.3 1.9 0.0 1.7 0.2 0.6 1.8 0.2 85.3 0.0 0.7 SPNS2 ENSG00000183018 "Sphingolipid transporter 2" Q8IVW8 17 4498838-4539035 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.9" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 25.5;Collecting duct cells: 21.0;Endothelial cells: 25.3;Proximal tubular cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;NK-cell: 1.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;NK-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 11.0;RPTEC TERT1: 57.9;SK-BR-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068717 Uncertain NA NA "HPA068717: AB_2686021" "unprognostic (3.03e-2)" "unprognostic (4.76e-2)" "unprognostic (8.08e-2)" "unprognostic (3.53e-2)" "unprognostic (2.78e-1)" "unprognostic (6.30e-3)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.99e-2)" "unprognostic (2.98e-2)" "unprognostic (4.48e-2)" "unprognostic (2.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.19e-2)" "unprognostic (6.89e-2)" 9.8 2.1 10.3 5.8 13.6 7.9 8.6 5.3 19.5 8.2 4.9 22.6 0.0 13.1 5.4 2.1 45.9 4.6 13.8 7.2 11.0 7.8 31.2 3.3 16.1 5.4 21.3 10.9 1.8 7.3 2.3 1.3 9.0 25.0 3.2 3.2 11.6 11.2 3.2 5.0 13.8 8.5 5.8 12.3 9.1 21.7 2.0 15.7 0.0 5.2 10.9 15.7 8.4 13.1 0.0 0.2 1.2 0.0 1.2 0.2 0.0 3.2 0.4 0.0 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 4.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 0.0 0.0 0.0 1.3 0.0 5.7 0.0 6.0 0.1 0.2 0.0 0.1 57.9 0.2 1.9 0.0 0.0 26.9 0.0 1.9 0.9 2.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 1.2 0.0 0.0 0.0 0.0 10.3 13.6 5.3 19.5 11.0 7.8 21.3 10.9 25.0 15.7 6.0 8.8 0.0 0.2 1.5 0.6 0.8 25.5 1.4 12.5 21.0 0.0 0.1 1.7 14.3 0.2 25.3 1.3 0.0 2.7 14.8 1.7 4.6 0.0 5.6 0.9 6.4 0.0 14.7 0.8 0.0 0.6 0.7 1.7 0.0 10.8 0.3 11.9 0.0 0.4 23.7 0.7 0.0 2.3 0.5 0.4 2.0 1.6 0.0 0.4 1.4 SPNS3 MGC29671 ENSG00000182557 "Sphingolipid transporter 3 (putative)" Q6ZMD2 17 4433688-4488208 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 51.8;bone marrow: 23.1;lymphoid tissue: 15.1" "Group enriched" "Detected in many" 5 "Proximal tubular cells: 44.0;T-cells: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 51.8;plasmacytoid DC: 25.1" "Group enriched" "Detected in many" 24 "dendritic cells: 25.1;granulocytes: 51.8" "Cell line enhanced" "Detected in some" "JURKAT: 12.9;MOLT-4: 4.6;NB-4: 15.6;THP-1: 16.9;U-937: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023928 Uncertain NA NA "HPA023928: AB_1844393" "unprognostic (4.39e-2)" "unprognostic (8.10e-5)" "unprognostic (2.37e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.94e-4)" "unprognostic (2.86e-2)" "unprognostic (1.96e-2)" "unprognostic (1.81e-2)" "unprognostic (6.46e-2)" "unprognostic (1.37e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (6.18e-2)" "unprognostic (6.57e-2)" "unprognostic (4.13e-2)" "unprognostic (9.69e-2)" 0.3 0.5 1.1 2.0 0.9 23.1 0.3 0.5 1.6 0.4 1.3 3.7 0.0 0.6 0.5 0.1 0.4 0.7 0.7 0.7 1.2 1.6 0.4 0.3 1.2 1.3 2.4 0.1 0.2 0.3 0.1 0.5 0.1 2.0 0.5 0.2 0.0 1.3 0.5 0.1 0.5 0.8 0.2 4.2 2.9 0.3 1.3 2.2 15.1 0.2 0.0 1.6 0.3 0.3 0.0 25.1 51.8 1.5 0.0 0.2 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 1.0 0.0 0.0 4.6 15.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 13.0 0.0 0.0 1.5 51.8 0.1 0.3 0.1 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.2 0.0 0.0 25.1 0.0 1.0 1.1 0.9 0.5 1.6 1.2 1.6 2.4 0.1 2.0 2.2 3.0 1.4 3.2 0.1 1.1 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 3.3 1.8 0.6 0.0 1.0 0.0 0.0 4.2 0.1 0.4 0.0 0.0 1.2 0.0 0.0 0.6 3.3 1.5 0.0 7.6 1.7 0.0 1.4 0.0 0.7 0.3 0.0 44.0 0.0 0.0 0.4 0.0 0.0 0.4 0.2 27.1 1.2 0.4 SPO11 "CT35, SPATA43, TOPVIA" ENSG00000054796 "SPO11, initiator of meiotic double stranded breaks" Q9Y5K1 20 57329759-57343994 "Enzymes, Plasma proteins, Predicted intracellular proteins" Meiosis "DNA-binding, Hydrolase, Isomerase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 142 "testis: 14.2" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 58.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "Daudi: 1.7;SiHa: 1.3;U-698: 2.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.6 11.7 0.0 0.0 0.0 0.0 0.0 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell type enhanced" "Detected in some" 19 "Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008" "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favorable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.7 0.3 0.0 0.0 0.2 1.5 0.5 14.1 18.9 13.7 9.2 0.2 0.6 0.1 1.9 15.9 5.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.9 0.2 19.7 0.6 11.1 9.3 0.7 0.2 0.2 8.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.4 0.0 0.0 33.2 0.0 0.0 0.3 0.0 0.9 0.4 8.2 0.0 17.3 14.5 1.4 9.3 5.3 0.0 0.1 0.0 32.7 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 0.0 5.9 0.0 4.0 0.1 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.2 0.0 9.9 0.2 0.1 0.0 0.0 8.9 0.5 0.4 1.7 1.1 0.0 13.9 0.0 1.7 0.6 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.0 1.4 0.0 4.3 0.0 0.2 0.0 0.0 44.4 SPOCK1 "SPOCK, testican-1, TIC1" ENSG00000152377 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1" Q08629 5 136975298-137598379 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 92.2" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 54.3;Muller glia cells: 252.1;Peritubular cells: 141.1" "Cancer enriched" "Detected in all" 7 "prostate cancer: 83.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 2.5;myeloid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 2.5" "Cell line enhanced" "Detected in many" "ASC diff: 75.8;hTERT-RPE1: 144.5;HUVEC TERT2: 75.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007450, HPA026770" Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA007450: AB_10603116, HPA026770: " "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.08e-4)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.72e-4)" "unprognostic (9.09e-3)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.77e-5)" "prognostic unfavorable (9.40e-4)" "unprognostic (1.26e-1)" "unprognostic (2.21e-1)" "unprognostic (1.90e-2)" 11.3 31.0 20.6 4.0 30.4 1.5 9.3 68.2 92.2 20.5 7.4 36.0 5.1 2.1 20.5 26.1 5.6 6.8 14.3 38.6 29.9 16.6 18.0 1.4 1.9 1.7 35.5 29.0 3.2 3.7 1.4 3.7 7.6 19.6 48.9 3.6 5.2 2.9 20.7 5.6 3.2 2.6 23.2 21.7 6.8 3.7 15.9 36.0 0.1 3.3 0.0 1.6 8.1 11.5 0.0 1.6 0.4 2.5 0.0 0.0 0.6 0.5 0.1 38.2 0.0 75.8 15.5 0.0 12.4 11.5 27.0 15.2 0.0 0.0 0.0 0.0 25.9 6.8 0.5 0.1 8.9 8.4 2.1 0.0 0.0 2.3 0.0 0.5 0.0 0.0 27.0 3.6 16.6 2.9 144.5 75.8 0.0 0.0 0.0 7.7 0.0 0.0 0.0 2.4 0.0 3.5 0.0 0.0 0.0 18.0 1.2 0.4 1.8 6.1 0.1 0.0 4.8 0.0 0.1 12.1 38.5 1.3 13.1 3.5 0.0 0.0 0.0 20.9 0.5 17.4 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 20.6 30.4 68.2 28.5 29.9 16.6 35.5 29.0 19.6 36.0 0.0 0.0 0.0 1.7 1.5 5.0 54.3 0.0 0.0 0.0 21.0 2.0 0.4 1.7 0.7 8.2 2.1 0.0 0.0 1.2 0.4 9.5 48.4 0.0 0.0 0.8 7.9 33.7 1.3 2.4 8.9 16.1 1.1 6.8 1.0 0.0 252.1 1.5 0.0 141.1 1.7 3.2 12.9 12.8 7.5 5.9 1.3 0.1 0.0 0.1 2.1 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2" Q92563 10 72059035-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1;brain: 70.7;lung: 52.1" "Group enriched" "Detected in many" 9 "Alveolar cells type 1: 268.0;Bipolar cells: 102.9;T-cells: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5" "Lineage enriched" "Detected in many" 8 "T-cells: 47.1" "Group enriched" "Detected in some" 7 "Hep G2: 25.4;SCLC-21H: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" NA NA 42000 "HPA044605: AB_10965991" "prognostic favorable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favorable (4.72e-4)" "prognostic unfavorable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 4.2 29.8 31.9 24.9 47.8 27.9 2.0 70.7 63.2 2.5 4.2 9.8 0.0 6.2 2.5 2.7 2.8 4.7 9.9 4.7 27.5 49.5 18.8 2.5 52.1 36.4 36.0 32.1 3.7 1.5 1.7 12.8 2.9 47.9 3.0 4.1 5.4 2.8 4.5 3.6 1.9 9.3 3.4 22.3 16.9 8.3 13.6 9.2 43.4 3.3 0.6 27.0 8.0 1.4 5.6 0.7 2.9 0.2 2.8 47.1 10.3 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.4 0.1 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.1 0.6 25.4 0.9 0.2 0.6 0.1 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 36.2 2.2 0.0 0.8 0.2 0.2 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.4 0.8 3.8 0.1 0.0 0.1 0.0 0.1 0.0 27.5 0.2 47.1 5.6 27.7 21.9 0.0 4.5 21.5 21.2 2.9 2.8 0.0 0.7 37.5 10.3 31.9 47.8 70.7 42.0 27.5 49.5 36.0 32.1 47.9 9.2 268.0 14.3 16.4 0.2 3.4 102.9 2.5 0.0 2.7 5.7 14.0 5.9 0.1 0.0 0.4 6.3 9.0 0.7 0.0 0.7 0.0 2.4 0.4 3.5 0.0 0.2 3.2 4.7 6.7 2.6 8.2 4.9 2.0 5.0 0.0 0.3 3.8 0.0 0.0 5.6 0.0 12.4 0.0 4.2 3.6 0.6 3.9 0.3 96.9 0.0 0.3 SPOCK3 testican-3 ENSG00000196104 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3" Q9BQ16 4 166733384-167234796 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 46.8;parathyroid gland: 184.6" "Group enriched" "Detected in some" 4 "Bipolar cells: 45.8;Ciliated cells: 12.0;Club cells: 18.2;Early spermatids: 12.6;Horizontal cells: 14.3" "Cancer enhanced" "Detected in many" "prostate cancer: 7.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 3.3;intermediate monocyte: 1.8;myeloid DC: 4.5;plasmacytoid DC: 1.4" "Group enriched" "Detected in many" 12 "dendritic cells: 4.5;monocytes: 3.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.2;hTERT-RPE1: 9.9;PC-3: 3.9;RH-30: 10.4;SCLC-21H: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (3.54e-2)" "unprognostic (8.69e-2)" "unprognostic (2.90e-3)" "unprognostic (1.20e-1)" "unprognostic (4.09e-4)" "unprognostic (3.75e-1)" "unprognostic (1.97e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-1)" "unprognostic (3.94e-4)" "unprognostic (8.92e-2)" "unprognostic (4.18e-3)" "unprognostic (2.62e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-3)" "unprognostic (1.64e-1)" 1.2 10.0 21.7 1.3 30.4 1.1 1.1 5.8 23.2 1.4 1.4 32.2 2.2 1.4 2.2 8.0 1.2 1.5 1.2 1.2 31.3 21.4 1.2 1.2 1.2 1.2 45.4 15.9 7.8 1.3 184.6 0.3 1.1 27.4 28.1 1.3 0.0 1.2 14.1 1.2 1.1 1.6 2.1 46.8 1.2 1.4 1.3 42.9 0.0 1.1 0.9 1.2 1.9 0.3 0.0 4.5 0.0 3.3 0.3 0.0 1.1 0.0 2.4 0.3 0.0 0.0 0.0 0.4 0.0 3.2 0.1 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.1 0.6 0.2 0.3 0.0 1.6 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 9.9 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.0 3.9 0.0 10.4 0.6 0.0 1.5 4.5 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.3 0.0 3.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 1.1 21.7 30.4 5.8 22.8 31.3 21.4 45.4 15.9 27.4 42.9 0.0 0.0 0.0 1.1 0.0 45.8 0.9 0.0 12.0 18.2 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.1 0.0 4.0 1.1 0.0 0.1 14.3 0.0 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.4 0.0 5.1 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.6 SPON1 "f-spondin, KIAA0762" ENSG00000262655 "Spondin 1" Q9HCB6 11 13962689-14267884 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 40.2" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 163.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 199.1" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 74 "T-cells: 7.3" "Group enriched" "Detected in some" 35 "EFO-21: 42.0;RPTEC TERT1: 118.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038584, HPA077546" Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge" "Secreted to blood" Yes No 11500000 27000000 "Nucleoli, Microtubule ends" "Nucleoplasm, Actin filaments, Cytokinetic bridge" "HPA038584: AB_10697394, HPA077546: AB_2732351" "unprognostic (1.66e-1)" "unprognostic (1.03e-2)" "unprognostic (8.36e-2)" "unprognostic (8.72e-2)" "unprognostic (1.52e-1)" "unprognostic (3.76e-2)" "unprognostic (1.82e-1)" "unprognostic (8.20e-2)" "unprognostic (1.05e-1)" "unprognostic (5.93e-2)" "unprognostic (6.45e-2)" "unprognostic (1.07e-1)" "prognostic favorable (3.12e-4)" "unprognostic (7.22e-3)" "unprognostic (7.89e-2)" "unprognostic (4.65e-2)" "prognostic unfavorable (1.88e-4)" 16.8 5.1 8.3 5.2 12.5 0.0 3.3 4.8 10.7 15.7 9.7 7.6 0.0 9.6 12.0 4.6 5.3 20.3 40.2 4.9 7.2 5.4 0.1 8.1 0.7 5.1 8.8 12.0 0.8 0.0 2.0 12.3 7.5 7.2 15.0 8.5 0.9 2.5 0.0 1.6 12.4 15.7 3.2 1.8 3.9 0.8 5.7 0.0 0.8 0.6 0.0 15.6 9.9 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 118.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.3 0.0 1.3 0.7 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.9 10.4 12.6 0.0 8.9 1.2 2.5 1.4 0.0 0.0 2.0 2.6 3.3 3.3 1.3 1.0 19.8 0.0 1.8 3.1 18.3 5.0 2.3 0.0 1.6 1.6 16.0 3.7 0.3 1.2 4.0 0.0 0.0 0.0 18.6 163.5 4.5 10.5 28.3 0.8 29.7 6.5 5.4 0.2 0.6 0.0 4.1 5.0 35.1 8.0 SPP1 "BNSP, BSPI, ETA-1, OPN" ENSG00000118785 "Secreted phosphoprotein 1" P10451 4 87975650-87983426 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Biomineralization, Cell adhesion" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 303.9;kidney: 700.7;placenta: 331.0" "Cell type enriched" "Detected in many" 9 "Hofbauer cells: 50179.8" "Cancer enhanced" "Detected in all" "glioma: 1690.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 19.2" "Lineage enriched" "Detected in single" 192 "granulocytes: 19.2" "Cell line enhanced" "Detected in some" "EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9" "Region enhanced" "Detected in all" "pons and medulla: 331.4" "Low region specificity" "Detected in all" "HPA027540, HPA027541" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 114000000 54000000 "Golgi apparatus" "HPA027540: AB_10600222, HPA027541: AB_10601446" "unprognostic (4.74e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.13e-3)" "unprognostic (2.04e-1)" "unprognostic (2.31e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.84e-6)" "unprognostic (2.46e-3)" "unprognostic (7.86e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (4.31e-2)" "unprognostic (2.55e-1)" "unprognostic (7.19e-2)" "unprognostic (1.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.63e-2)" 20.7 4.1 25.5 8.3 42.7 1.1 8.7 4.3 61.0 4.7 2.7 27.3 0.0 2.1 17.3 2.3 1.5 4.2 303.9 2.6 37.2 26.4 700.7 3.9 3.2 2.0 97.0 9.1 3.1 23.6 1.3 1.5 331.0 52.3 2.4 1.9 3.9 7.3 3.9 2.5 1.1 2.1 5.6 147.9 2.1 2.0 2.4 58.9 0.0 1.7 0.0 1.6 5.3 0.3 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 218.9 0.1 17.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 107.8 0.0 0.3 0.2 0.0 0.0 1.5 0.0 5.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.9 10.1 0.0 0.0 0.1 0.0 51.4 477.9 0.0 0.0 0.0 0.0 0.0 14.4 21.2 0.0 0.2 0.0 0.5 1.1 0.0 1.1 0.0 0.3 0.4 20.0 0.0 20.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 25.5 42.7 4.3 28.8 37.2 26.4 97.0 9.1 52.3 58.9 3.0 6.6 20.0 2.2 1.3 34.3 4.3 1834.4 2.7 0.0 2071.0 25.5 256.7 850.5 3124.6 0.0 17.5 0.0 0.0 59.8 221.1 15.4 0.3 0.0 2.9 50179.8 742.1 0.0 6.7 63.8 0.4 0.9 93.6 1.7 120.8 0.0 3889.3 343.9 0.0 0.0 5328.4 135.9 0.0 4.4 0.3 0.2 0.9 558.5 1.5 0.0 12.7 SPP2 SPP24 ENSG00000072080 "Secreted phosphoprotein 2" Q13103 2 234050679-234077134 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 879 "liver: 113.0" "Cell type enriched" "Detected in some" 22 "Hepatocytes: 258.9" "Cancer enriched" "Detected in some" 112 "liver cancer: 65.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;RH-30: 3.5;RPTEC TERT1: 1.0;U-698: 1.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 540000000 "prognostic favorable (2.33e-6)" "unprognostic (7.02e-3)" "unprognostic (9.62e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 3.5 0.0 1.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 3.5 0.9 0.0 0.0 0.0 0.3 7.6 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.7 258.9 0.1 0.0 0.0 5.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPPL2C IMP5 ENSG00000185294 "Signal peptide peptidase like 2C" Q8IUH8 17 45844835-45847072 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "testis: 45.0" "Group enriched" "Detected in some" 132 "Early spermatids: 211.9;Late spermatids: 461.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "cerebellum: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.70e-4)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 211.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 461.7 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887360-72892158 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 61.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9" "Group enriched" "Detected in many" 13 "dendritic cells: 9.9;monocytes: 9.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol NA NA 52000 "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 13.3 22.6 6.3 6.1 8.2 0.0 36.2 2.0 6.4 6.0 17.1 3.1 8.9 11.4 5.7 19.1 13.4 13.2 11.4 16.1 6.4 6.0 20.3 43.5 7.2 5.3 7.9 5.0 8.7 61.7 16.7 5.5 3.9 7.9 17.3 16.2 4.5 20.9 8.8 16.0 3.3 15.1 9.5 4.9 4.7 15.4 4.9 7.2 1.0 31.7 6.2 3.6 9.5 41.4 0.0 9.9 0.7 9.3 0.0 0.4 2.5 13.5 38.0 0.2 5.9 15.6 5.7 9.5 6.4 9.3 4.8 4.5 24.2 14.1 9.9 7.7 7.5 24.1 12.9 17.0 10.2 4.0 2.8 13.2 14.9 9.4 24.8 5.8 2.3 4.1 5.0 11.4 5.2 5.9 9.8 12.5 7.4 15.3 2.0 6.2 28.5 0.9 8.8 3.2 40.2 36.4 0.0 24.7 5.8 25.2 21.2 2.4 4.4 11.7 26.5 8.7 5.2 11.9 2.8 15.3 5.2 12.8 9.1 11.2 2.2 4.8 0.6 7.5 5.0 9.1 0.0 9.3 0.7 0.4 2.6 0.4 0.0 0.2 0.1 9.9 0.0 0.2 0.4 0.0 0.0 1.0 0.9 0.0 2.5 6.3 8.2 2.0 6.4 6.4 6.0 7.9 5.0 7.9 7.2 11.9 5.3 1.9 19.7 7.4 0.6 40.5 40.8 6.7 7.9 40.1 0.0 14.2 18.3 46.9 0.2 17.6 68.6 0.0 71.1 9.3 12.5 27.5 4.6 52.9 35.3 1.6 10.9 11.6 4.7 0.9 8.6 9.4 13.5 34.3 31.7 8.6 48.5 51.8 5.3 75.1 0.5 6.5 12.5 0.3 6.6 5.6 3.7 1.7 50.4 13.2 SPRED3 ENSG00000188766 "Sprouty related EVH1 domain containing 3" Q2MJR0 19 38388421-38399587 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.7" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 7.3;Intestinal endocrine cells: 10.4" "Cancer enhanced" "Detected in many" "glioma: 3.6" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071521 Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA071521: " "unprognostic (1.09e-1)" "unprognostic (1.88e-3)" "unprognostic (8.71e-3)" "unprognostic (3.35e-3)" "unprognostic (3.70e-2)" "unprognostic (2.00e-3)" "unprognostic (2.09e-3)" "unprognostic (7.77e-3)" "unprognostic (1.49e-1)" "unprognostic (9.22e-3)" "unprognostic (1.69e-2)" "unprognostic (3.09e-2)" "unprognostic (1.40e-11)" "unprognostic (6.21e-4)" "unprognostic (3.67e-1)" "unprognostic (1.04e-3)" "unprognostic (8.45e-3)" 2.0 1.2 4.3 2.7 10.1 0.9 1.2 2.8 10.7 0.9 0.6 1.7 0.0 4.7 1.2 1.2 0.9 0.7 2.0 1.1 5.0 4.7 1.2 0.4 0.9 0.5 2.8 4.6 0.5 2.9 4.5 5.8 0.8 4.7 1.2 0.8 0.9 0.8 1.1 0.9 2.3 3.7 2.3 1.7 0.5 1.3 1.7 0.9 0.0 1.8 0.0 0.6 0.9 0.8 0.8 0.7 2.2 0.6 0.9 0.5 0.3 0.2 1.1 3.8 3.1 0.6 1.8 2.1 7.5 5.0 2.5 2.3 0.4 0.8 0.2 2.7 2.5 2.0 0.1 0.6 0.9 2.3 0.7 1.4 0.0 0.2 0.4 1.3 2.0 0.1 1.3 0.9 5.9 1.7 12.3 7.8 0.6 0.6 1.4 7.6 0.4 0.0 0.1 1.7 0.5 3.8 0.9 1.3 0.1 5.4 0.6 0.2 2.9 0.1 0.2 0.3 1.7 0.6 0.1 14.7 2.8 8.6 2.3 4.1 0.6 0.2 0.5 9.4 0.3 4.7 1.6 0.6 0.4 0.4 0.2 0.3 0.3 0.5 0.3 0.1 0.8 0.4 0.3 2.2 0.9 0.5 0.7 0.2 0.3 4.3 10.1 2.8 9.8 5.0 4.7 2.8 4.6 4.7 0.9 0.0 0.0 0.0 1.1 0.0 7.3 1.0 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.8 0.3 0.1 0.7 0.0 0.5 0.2 0.0 1.1 0.0 0.0 0.1 1.6 10.4 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 2.5 2.2 0.0 0.0 0.0 0.2 0.0 1.0 0.9 0.6 0.1 0.7 0.0 0.6 0.6 SPRN "bA108K14.1, FLJ41197, Shadoo, Sprn" ENSG00000203772 "Shadow of prion protein" Q5BIV9 10 133420666-133424572 "Predicted intracellular proteins, Transporters" Prion "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 20.7" "Cell type enhanced" "Detected in some" 15 "Cardiomyocytes: 1.2;Horizontal cells: 3.2;Ito cells: 2.5;Kupffer cells: 2.2" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 4.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (2.66e-1)" "unprognostic (1.64e-3)" "unprognostic (3.38e-3)" "unprognostic (1.95e-1)" "unprognostic (1.35e-1)" "unprognostic (3.31e-2)" "unprognostic (1.07e-1)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "prognostic favorable (1.54e-6)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (7.17e-2)" "prognostic favorable (1.58e-7)" 0.5 2.5 4.3 1.5 3.8 0.8 0.1 7.4 20.7 0.4 0.5 3.3 1.1 0.0 1.0 0.2 1.3 0.8 6.1 2.7 1.1 6.9 0.6 1.6 1.7 1.0 1.7 0.0 1.7 0.8 1.2 0.0 2.0 0.1 2.3 2.0 2.2 0.4 0.9 1.7 2.2 1.9 0.9 0.0 0.9 0.1 1.1 1.0 0.4 4.5 0.2 1.2 0.6 2.7 5.2 3.9 7.8 0.0 0.0 6.3 4.2 0.0 1.0 0.1 6.3 1.9 3.9 1.5 2.1 0.9 3.4 0.6 0.0 0.0 2.5 7.3 3.7 6.0 7.1 0.3 3.9 3.2 0.5 0.0 0.0 0.0 2.5 0.0 2.9 4.0 2.7 0.5 2.7 2.2 7.4 3.8 1.4 2.1 5.4 2.5 0.7 0.0 3.2 2.3 3.5 1.4 3.8 4.7 1.5 2.4 2.8 2.8 2.3 3.0 1.7 3.2 3.2 1.6 3.0 1.7 2.6 1.2 0.4 0.3 0.0 0.4 0.9 0.8 0.3 0.9 1.2 0.2 1.1 1.0 0.4 0.0 0.2 4.5 1.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 2.5 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 SPRR1A ENSG00000169474 "Small proline rich protein 1A" P35321 1 152985231-152985500 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "esophagus: 495.3" "Cell type enriched" "Detected in some" 10 "Suprabasal keratinocytes: 126.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 1736.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HaCaT: 13.0;hTCEpi: 38.1;RT4: 14.5" CAB011237 Enhanced NA NA "CAB011237: " "unprognostic (1.39e-1)" "unprognostic (5.45e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-2)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.96e-1)" "unprognostic (1.04e-1)" 0.4 0.0 0.4 0.4 0.4 0.0 0.7 0.4 0.4 72.3 0.4 0.4 0.4 0.0 0.4 0.4 495.3 0.0 3.8 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.4 52.5 0.4 0.4 11.7 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 70.7 47.3 0.5 111.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.5 0.0 0.0 0.0 13.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 14.5 0.2 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 126.6 0.0 0.0 0.0 13.1 SPRR1B "GADD33, SPRR1" ENSG00000169469 "Small proline rich protein 1B" P22528 1 153031202-153032900 "Cancer-related genes, Predicted intracellular proteins" Keratinization "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 264.7;lymphoid tissue: 188.6;tongue: 618.5" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 333.0;Urothelial cells: 93.4" "Group enriched" "Detected in many" 6 "cervical cancer: 468.6;head and neck cancer: 1812.5;melanoma: 425.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "hTCEpi: 92.1" NA NA "unprognostic (1.73e-1)" "unprognostic (2.39e-1)" "unprognostic (5.59e-2)" "unprognostic (9.68e-2)" "prognostic unfavorable (7.66e-5)" "unprognostic (2.22e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (7.64e-5)" "unprognostic (5.71e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.28e-4)" 0.1 0.1 0.1 0.1 0.1 0.2 1.0 0.1 0.1 94.9 0.1 0.1 0.1 0.1 9.5 0.2 264.7 0.2 2.2 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 48.7 0.1 0.2 33.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.9 0.1 618.5 188.6 0.2 113.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 9.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 92.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.0 34.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 333.0 0.2 0.0 0.0 93.4 SPRR2A ENSG00000241794 "Small proline rich protein 2A" P35326 1 153056113-153057537 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 393.4;lymphoid tissue: 173.5;tongue: 572.8" "Cell type enhanced" "Detected in some" 26 "Ductal cells: 13.4;Exocrine glandular cells: 48.7;Pancreatic endocrine cells: 7.5;Suprabasal keratinocytes: 10.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 743.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 6.8;hTCEpi: 8.4;hTERT-HME1: 11.1;Karpas-707: 13.5;U-266/70: 2.8" NA NA "unprognostic (3.15e-1)" "unprognostic (2.48e-1)" "unprognostic (3.11e-3)" "unprognostic (1.64e-2)" "unprognostic (6.80e-3)" "unprognostic (3.51e-1)" "unprognostic (3.36e-3)" "unprognostic (4.53e-2)" "prognostic unfavorable (1.37e-5)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 82.8 0.2 0.0 0.0 0.2 3.0 0.2 393.4 0.2 0.7 0.3 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 58.3 0.2 0.2 1.3 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.1 0.2 572.8 173.5 0.3 60.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 8.4 0.0 11.1 0.0 0.0 0.0 0.8 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.8 0.3 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.8 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 1.5 SPRR2B ENSG00000196805 "Small proline rich protein 2B" P35325 1 153070224-153070840 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2" "Cell type enriched" "Detected in single" 58 "Leydig cells: 5.8" "Cancer enriched" "Detected in many" 5 "head and neck cancer: 77.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.7;SiHa: 1.3;U-2197: 1.2" NA NA "unprognostic (1.52e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 11.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPRR2D ENSG00000163216 "Small proline rich protein 2D" P22532 1 153039725-153041931 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "esophagus: 246.4;tongue: 317.8" "Cell type enriched" "Detected in some" 6 "Suprabasal keratinocytes: 13.7" "Group enriched" "Detected in many" 5 "cervical cancer: 80.9;head and neck cancer: 353.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "hTCEpi: 26.2;hTERT-HME1: 23.0;SK-MEL-30: 11.3" NA NA "unprognostic (7.50e-2)" "unprognostic (1.84e-1)" "unprognostic (5.17e-2)" "unprognostic (5.14e-2)" "unprognostic (1.49e-3)" "unprognostic (3.58e-1)" "unprognostic (1.37e-3)" "unprognostic (6.85e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.62e-4)" 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.4 0.1 246.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 29.9 0.1 0.1 14.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 317.8 63.5 0.1 40.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 26.2 0.0 23.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.1 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.7 0.1 0.1 4.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.2 0.0 0.0 0.7 SPRR2E ENSG00000203785 "Small proline rich protein 2E" P22531 1 153093135-153106184 "Predicted intracellular proteins" Keratinization "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 210.2;skin 1: 94.0;tongue: 291.9" "Cell type enriched" "Detected in some" 22 "Suprabasal keratinocytes: 38.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 612.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "hTCEpi: 19.7" NA NA "unprognostic (2.27e-1)" "unprognostic (3.86e-2)" "unprognostic (5.04e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (9.47e-4)" 0.3 0.0 0.3 0.3 0.3 0.0 5.7 0.3 0.3 25.9 0.3 0.3 0.3 0.0 0.6 0.3 210.2 0.0 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 26.8 0.3 0.3 94.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.4 0.3 291.9 54.7 0.3 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 19.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 SPRR2F ENSG00000244094 "Small proline rich protein 2F" Q96RM1 1 153112114-153113515 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "tongue: 310.0" "Group enriched" "Detected in some" 6 "Ciliated cells: 2.7;Club cells: 5.7;Leydig cells: 9.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 53.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 7.6" NA NA "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-2)" "unprognostic (2.41e-2)" "unprognostic (4.37e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.96e-1)" "unprognostic (1.78e-3)" 0.4 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 4.5 0.1 0.1 0.1 0.0 0.2 0.3 66.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 28.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.1 0.2 0.2 0.5 0.1 0.1 0.1 0.1 0.0 2.2 0.1 0.1 0.1 310.0 24.8 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 5.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SPRR2G ENSG00000159516 "Small proline rich protein 2G" Q9BYE4 1 153149582-153150869 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 22 "skin 1: 128.3;tongue: 274.6" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 3.2;Extravillous trophoblasts: 11.6;Late spermatids: 6.4;Suprabasal keratinocytes: 4.8" "Group enriched" "Detected in many" 15 "head and neck cancer: 256.0;melanoma: 131.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.0" "Cell line enriched" "Detected in single" 17 "hTCEpi: 9.0" NA NA "unprognostic (3.93e-1)" "unprognostic (1.90e-1)" "unprognostic (3.25e-1)" "unprognostic (2.44e-1)" "unprognostic (1.69e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 5.4 0.1 0.1 0.6 0.1 0.1 0.1 0.0 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 4.1 0.1 0.1 0.0 0.1 0.8 0.1 0.1 128.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.4 0.1 274.6 9.3 0.1 5.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 6.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.7 0.0 0.0 0.0 SPRR3 ENSG00000163209 "Small proline rich protein 3" Q9UBC9 1 153001747-153003856 "Cancer-related genes, Predicted intracellular proteins" Keratinization "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 855.8;lymphoid tissue: 537.4;tongue: 389.6" "Cell type enriched" "Detected in some" 5 "Urothelial cells: 109.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 423.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.8;hTCEpi: 11.1;OE19: 4.2;RT4: 14.1;TIME: 4.0" HPA044467 Enhanced NA NA 15000 "HPA044467: AB_2678952" "unprognostic (2.78e-2)" "unprognostic (3.54e-1)" "unprognostic (8.77e-2)" "unprognostic (7.50e-3)" "unprognostic (9.67e-3)" "unprognostic (2.36e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (9.70e-2)" "unprognostic (4.66e-2)" "unprognostic (1.58e-2)" 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.2 157.6 0.2 0.0 0.0 0.2 11.5 0.2 855.8 0.2 1.8 0.5 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.2 0.2 0.2 0.0 1.2 0.0 0.2 0.2 0.0 93.4 0.2 0.4 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.0 0.0 0.2 389.6 537.4 0.6 163.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 6.8 3.5 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 1.3 0.0 0.0 14.1 0.0 0.0 0.4 3.3 0.0 0.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.9 0.0 0.0 0.0 0.0 3.4 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 109.5 SPRR4 ENSG00000184148 "Small proline rich protein 4" Q96PI1 1 152970666-152972574 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 51.9;tongue: 18.9" "Group enriched" "Detected in some" 27 "Early spermatids: 9.1;Late spermatids: 36.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 3.6;hTCEpi: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055963 Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA055963: AB_2682988" "unprognostic (4.40e-2)" "unprognostic (7.38e-3)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" 0.1 0.0 0.1 0.7 0.1 0.0 4.9 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.4 0.1 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 51.9 0.1 0.1 0.1 0.1 0.0 2.9 0.1 1.8 0.1 18.9 0.4 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 SPRR5 ENSG00000283227 "Small proline rich protein 5" A0A1B0GTR4 1 152947154-152949258 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "skin 1: 30.7;tongue: 32.7" "Cell type enhanced" "Detected in single" 38 "Exocrine glandular cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HaCaT: 4.1;hTCEpi: 10.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPRY1 hSPRY1 ENSG00000164056 "Sprouty RTK signaling antagonist 1" O43609 4 123396795-123403760 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 139.1" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 160.4;Leydig cells: 414.8;Muller glia cells: 173.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 29.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 30.2;AN3-CA: 61.1;ASC diff: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013538, HPA051369, HPA070554" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" Nucleoplasm "CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.06e-1)" "unprognostic (7.15e-2)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (1.36e-1)" "unprognostic (9.43e-2)" "unprognostic (6.99e-2)" "unprognostic (4.32e-1)" "unprognostic (4.06e-1)" "unprognostic (3.11e-2)" "unprognostic (8.77e-3)" "unprognostic (1.21e-3)" "unprognostic (4.48e-2)" "unprognostic (1.54e-2)" "unprognostic (1.27e-1)" 139.1 12.6 3.3 14.7 4.3 5.8 69.0 4.9 3.5 28.5 24.8 1.9 18.0 4.5 18.6 28.0 38.1 19.1 27.1 34.1 2.6 1.7 10.2 6.4 23.1 9.1 3.3 2.8 32.2 9.8 17.0 9.5 15.6 2.9 25.0 8.8 11.8 14.6 16.5 48.1 25.5 8.1 20.7 2.8 7.1 11.6 28.4 1.5 13.0 29.6 16.3 8.6 60.8 39.9 29.9 0.7 2.8 0.1 6.1 15.5 0.9 1.9 0.5 30.2 61.1 24.8 16.9 2.0 0.1 1.5 0.1 0.6 1.8 3.2 0.0 13.6 0.9 0.1 0.3 0.8 1.4 0.2 0.0 3.1 0.6 0.0 9.4 7.0 4.2 0.0 6.8 0.8 0.2 0.6 3.3 2.5 0.7 0.5 0.5 1.4 0.2 4.9 10.5 7.2 6.9 10.0 2.1 3.2 0.0 4.1 4.4 4.6 3.9 0.0 6.1 5.8 3.3 0.6 0.0 6.2 0.4 0.0 0.1 0.9 0.3 0.0 0.0 0.4 0.8 1.0 0.0 0.1 2.8 0.5 0.0 15.5 9.6 1.8 4.2 0.0 29.9 2.7 2.9 0.1 6.1 0.0 0.7 0.0 0.9 3.3 4.3 4.9 3.5 2.6 1.7 3.3 2.8 2.9 1.5 26.8 27.0 15.2 13.8 44.1 75.2 10.9 35.7 13.4 27.3 26.2 31.4 10.0 68.0 3.5 1.7 160.4 6.3 0.0 9.4 1.5 42.7 12.9 9.2 4.4 8.2 6.4 25.4 120.9 11.6 4.0 414.8 9.7 43.9 1.0 13.1 173.3 8.4 3.5 54.5 12.6 80.4 148.8 86.8 1.9 1.5 37.9 2.6 25.5 14.1 12.5 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155767812-155782459 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 3.5;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 8.6;EFO-21: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013505 Uncertain Approved Nucleoli,Cytosol NA NA Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 1.6 2.1 1.3 0.4 1.8 2.8 1.2 7.5 1.5 1.3 0.8 1.2 1.5 5.8 0.8 1.1 0.8 0.9 1.3 1.5 0.9 0.7 0.9 0.3 1.1 2.8 0.4 1.3 1.1 1.9 0.9 1.4 1.1 1.2 1.2 0.4 1.1 1.2 1.2 1.4 0.7 0.1 1.0 0.5 0.8 0.7 0.0 0.5 0.4 0.5 0.2 0.2 0.0 0.5 0.2 2.4 8.6 1.7 0.8 0.0 2.0 1.3 0.6 1.0 0.2 1.4 0.0 4.2 1.1 1.6 0.3 0.9 0.6 0.6 0.2 0.4 1.0 2.2 0.1 0.7 0.4 0.4 2.1 1.1 0.8 0.5 0.8 1.3 0.5 0.1 0.6 1.6 0.3 0.2 0.3 0.8 0.2 0.0 0.5 0.2 2.1 0.9 0.8 0.6 0.6 1.0 0.0 0.5 1.2 0.5 0.6 2.2 0.6 0.9 0.3 0.6 0.7 0.1 1.9 2.1 1.0 1.2 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.5 0.8 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.0 0.9 1.1 0.0 0.6 0.1 0.4 0.1 0.0 0.8 0.3 0.0 0.0 1.3 0.6 0.0 0.9 0.1 1.7 0.0 1.0 0.8 0.5 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.1 SPRYD4 DKFZp686N0877 ENSG00000176422 "SPRY domain containing 4" Q8WW59 12 56468567-56479707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 58.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 141.7;Proximal tubular cells: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053469 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA053469: AB_2682162" "unprognostic (1.14e-1)" "unprognostic (1.20e-1)" "unprognostic (8.00e-2)" "prognostic unfavorable (8.85e-5)" "unprognostic (7.76e-2)" "unprognostic (1.20e-1)" "unprognostic (3.06e-3)" "prognostic favorable (4.52e-4)" "unprognostic (5.59e-3)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (9.98e-2)" "unprognostic (1.27e-3)" "unprognostic (1.81e-1)" "unprognostic (1.69e-1)" "unprognostic (3.44e-1)" "unprognostic (1.14e-1)" 3.8 9.6 3.3 6.0 4.6 4.4 6.2 4.2 6.1 3.8 5.1 6.0 6.7 4.2 4.5 6.3 7.1 3.8 7.4 7.2 3.6 3.6 12.0 58.4 3.1 3.5 4.4 4.3 4.9 12.3 5.0 7.0 4.3 3.7 5.2 6.5 5.8 8.2 6.3 10.5 4.6 6.4 4.3 3.3 4.8 5.0 2.6 3.3 3.8 7.6 7.3 6.1 5.2 4.1 4.6 5.0 3.8 3.8 4.8 3.2 2.5 2.8 3.7 3.2 2.5 2.9 1.8 4.4 2.3 2.4 4.9 3.0 3.4 5.0 3.5 3.1 3.0 3.4 4.9 2.7 4.0 3.1 1.7 5.7 5.1 3.8 5.1 2.8 3.5 5.1 4.1 2.6 3.6 2.9 2.6 5.0 2.4 2.7 15.2 4.1 4.6 1.7 2.5 2.1 3.2 4.3 2.1 2.4 7.3 5.2 3.6 3.3 1.5 4.5 5.4 3.4 2.1 9.2 1.0 2.4 2.2 4.0 3.1 1.8 2.6 1.4 1.2 1.8 3.0 2.6 3.8 3.8 2.0 3.0 3.0 3.2 3.8 2.8 3.0 3.3 4.6 3.2 3.2 3.8 4.8 3.2 5.0 1.2 2.5 3.3 4.6 4.2 6.1 3.6 3.6 4.4 4.3 3.7 3.3 0.0 6.1 11.9 15.2 4.2 13.4 14.0 12.7 2.7 3.4 21.0 15.7 33.1 46.4 21.4 1.0 5.8 18.7 23.3 18.6 19.0 6.1 9.3 10.3 141.7 18.2 15.9 16.8 8.0 10.7 0.5 8.3 5.4 5.0 13.6 14.3 10.1 19.6 7.0 9.9 76.7 17.4 0.0 5.1 4.7 9.7 4.5 30.1 5.2 16.1 17.8 SPSB3 "C16orf31, SSB-3" ENSG00000162032 "SplA/ryanodine receptor domain and SOCS box containing 3" Q6PJ21 16 1776712-1793700 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 138.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046602 Uncertain Approved Mitochondria NA NA Mitochondria "HPA046602: AB_2679717" "unprognostic (1.18e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-1)" "unprognostic (1.15e-3)" "unprognostic (1.82e-1)" "unprognostic (8.91e-4)" "unprognostic (1.07e-2)" "unprognostic (8.31e-2)" "unprognostic (5.65e-2)" "unprognostic (8.43e-2)" "unprognostic (3.41e-2)" "unprognostic (4.83e-2)" "unprognostic (5.25e-7)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (3.77e-1)" "unprognostic (4.72e-4)" 8.5 19.4 7.8 8.2 8.3 12.8 9.5 25.3 11.3 10.5 10.4 10.1 11.0 10.0 7.6 9.5 14.1 9.0 17.7 9.1 6.7 5.7 8.2 138.5 8.3 7.8 11.1 8.8 15.9 19.5 7.5 5.6 7.6 8.4 9.3 4.2 10.6 14.0 12.9 29.4 18.1 8.3 9.4 6.9 8.3 8.6 5.8 8.3 16.3 10.5 6.5 8.9 8.5 9.3 18.0 15.9 32.6 16.8 15.6 34.5 17.0 3.4 5.3 6.5 7.6 9.1 8.9 10.6 4.3 7.0 7.6 8.3 3.8 11.7 1.7 8.6 3.9 2.7 7.0 3.2 6.6 1.2 6.1 7.8 3.4 7.6 5.0 12.6 1.3 6.0 7.8 17.3 4.9 5.7 11.6 11.5 12.0 3.9 9.2 3.7 12.6 8.8 8.6 4.4 6.8 2.6 14.8 2.5 14.1 6.7 0.7 8.5 8.4 5.5 17.2 15.8 4.9 8.5 8.1 8.1 3.5 5.3 6.2 2.9 13.6 15.7 4.4 2.8 4.9 4.0 32.3 16.8 29.7 26.1 15.2 32.6 18.0 24.4 24.1 15.4 16.8 17.6 18.4 32.6 15.6 13.3 15.9 34.5 17.0 7.8 8.3 25.3 11.3 6.7 5.7 11.1 8.8 8.4 8.3 35.7 28.0 37.1 47.6 87.3 69.1 0.2 22.9 26.8 21.6 52.4 37.3 52.7 44.7 43.7 41.0 35.3 65.2 23.3 41.4 63.9 36.6 44.8 33.6 50.8 28.6 85.8 46.8 45.4 33.5 65.6 71.4 44.0 72.6 62.3 50.2 76.4 42.2 71.9 70.4 41.0 84.0 38.8 49.2 18.6 35.8 112.0 53.9 76.1 48.8 50.3 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051402-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 22.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 18.4;Kupffer cells: 4.1;Late spermatids: 6.3;Spermatocytes: 7.6" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.2;NTERA-2: 4.6;RH-30: 5.5;SH-SY5Y: 4.6;U-2 OS: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062793 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA062793: AB_2732689" "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.8 0.9 1.0 0.2 1.5 0.2 0.2 0.2 2.0 0.1 0.3 0.7 0.0 0.2 0.1 0.3 0.2 0.1 0.2 2.2 1.1 1.1 0.4 0.3 1.3 3.2 1.5 0.6 0.1 22.0 0.1 4.6 0.2 1.2 0.2 0.1 0.0 0.1 0.1 1.7 0.2 0.2 0.2 1.9 2.5 0.1 3.6 0.2 0.1 0.1 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.2 0.3 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.5 1.1 0.0 4.6 0.0 0.0 0.0 5.5 0.8 0.0 0.0 1.4 4.6 0.0 0.0 0.0 2.7 0.3 0.4 0.0 0.0 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 1.5 0.2 1.2 1.1 1.1 1.5 0.6 1.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 7.6 0.7 0.0 0.1 0.0 0.0 0.0 SPTA1 EL2 ENSG00000163554 "Spectrin alpha, erythrocytic 1" P02549 1 158610706-158686715 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Actin capping, Actin-binding" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "bone marrow: 41.0" "Cell type enriched" "Detected in some" 42 "Erythroid cells: 70.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "K-562: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016193, HPA028048, HPA028253, CAB037246" Enhanced NA NA 45000000 "CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-2)" "unprognostic (1.94e-1)" "unprognostic (2.99e-1)" "unprognostic (1.34e-1)" "unprognostic (3.65e-3)" "unprognostic (1.50e-3)" "unprognostic (9.08e-2)" "unprognostic (2.58e-2)" "unprognostic (2.29e-1)" "unprognostic (9.09e-2)" "unprognostic (6.73e-8)" "unprognostic (6.08e-2)" "unprognostic (6.33e-2)" "unprognostic (1.76e-2)" "unprognostic (5.85e-3)" 0.6 0.0 0.0 1.1 0.0 41.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 8.1 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.6 4.6 0.0 2.2 0.0 0.3 0.9 0.0 0.0 0.0 2.8 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.1 0.0 70.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPTB ENSG00000070182 "Spectrin beta, erythrocytic" P11277 14 64746283-64879907 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6" "Cell type enhanced" "Detected in some" 22 "Erythroid cells: 46.7;Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 23.5;K-562: 28.1;U-937: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003394, HPA003398, CAB015169, CAB016232" Enhanced Approved Cytosol NA NA 43000000 Cytosol "CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074" "unprognostic (2.69e-1)" "unprognostic (4.72e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-3)" "unprognostic (1.71e-1)" "unprognostic (2.33e-2)" "unprognostic (1.49e-1)" "unprognostic (1.30e-3)" "unprognostic (2.66e-1)" "unprognostic (2.28e-2)" "unprognostic (1.55e-3)" "unprognostic (2.11e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-2)" "unprognostic (2.97e-1)" "unprognostic (3.44e-2)" "unprognostic (2.18e-2)" 1.9 1.6 3.2 0.7 11.6 32.2 0.7 25.2 10.4 0.8 0.7 0.8 0.3 0.6 0.7 5.2 1.8 0.8 0.8 14.7 3.1 3.2 1.2 0.6 0.9 0.6 2.8 3.5 0.7 2.2 6.5 4.7 4.7 16.4 1.5 0.7 1.1 1.9 1.3 67.6 0.7 0.7 1.0 1.7 1.1 0.7 1.0 1.4 0.0 0.7 17.4 0.6 0.8 0.5 0.0 0.6 0.9 0.0 0.0 0.2 1.5 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 1.4 3.9 0.1 0.0 0.2 2.3 23.5 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.9 28.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 1.3 0.0 0.0 0.1 0.0 0.1 3.8 1.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 4.3 0.0 0.4 0.9 4.4 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.5 3.2 11.6 25.2 10.4 3.1 3.2 2.8 3.5 16.4 1.4 0.0 0.0 0.0 0.4 0.7 8.1 5.5 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 46.7 0.2 0.2 0.3 0.5 2.3 0.0 0.2 15.9 2.9 0.0 0.0 0.0 0.3 0.2 1.7 0.0 0.0 6.5 0.4 0.0 1.1 0.0 1.9 6.5 3.8 0.1 0.2 0.4 0.1 0.0 0.0 0.5 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66685248-66729226 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7;skin 1: 36.9" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 82.0;Cone photoreceptor cells: 98.2;Late spermatids: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.3;NTERA-2: 23.5;SCLC-21H: 23.9;SK-BR-3: 16.7;T-47d: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA 4800000 "Plasma membrane" "Cell Junctions" "CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531" "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 0.8 4.9 26.2 1.0 38.3 1.7 4.5 29.6 46.7 9.6 0.9 2.0 0.0 1.0 1.1 1.2 12.7 2.6 1.2 0.7 19.7 8.2 12.7 7.1 0.9 0.5 6.5 24.7 0.8 8.3 12.2 3.9 0.7 14.4 6.8 0.7 1.7 13.4 3.1 0.7 36.9 0.9 1.2 1.9 0.9 1.2 18.9 6.2 0.0 0.5 0.1 3.3 1.1 3.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.5 3.4 1.6 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.2 8.1 0.0 1.8 0.0 0.3 7.8 11.9 1.1 0.0 0.0 4.7 0.0 20.3 1.1 0.3 3.3 0.3 0.1 5.5 0.0 3.5 1.9 2.9 2.4 3.3 0.0 0.0 12.8 2.6 1.5 23.5 9.2 10.5 10.9 1.3 6.7 4.5 1.1 23.9 14.1 6.6 16.7 1.5 1.3 19.1 0.9 0.6 0.0 4.2 0.6 5.2 0.3 1.2 7.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 26.2 38.3 29.6 46.7 19.7 8.2 6.5 24.7 14.4 6.2 3.0 0.6 0.0 1.7 3.3 7.4 1.6 2.5 1.4 2.3 82.0 98.2 0.8 0.0 2.4 24.4 0.6 0.0 0.0 8.7 0.3 0.5 3.1 0.0 20.2 0.1 0.0 2.9 1.3 0.0 50.4 1.7 0.0 0.0 1.0 1.6 1.4 6.9 0.0 1.4 1.2 21.0 0.0 0.0 2.7 8.6 10.9 0.2 0.0 0.6 1.4 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 36.3" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 55.4;Cone photoreceptor cells: 53.0;Horizontal cells: 69.9;Rod photoreceptor cells: 67.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 3.5;Karpas-707: 5.1;SCLC-21H: 8.0;SH-SY5Y: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054481: AB_2682502" "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 3.1 5.9 13.4 1.2 15.3 1.2 1.2 36.3 27.1 1.4 1.3 1.8 0.0 1.7 2.3 1.3 1.6 2.0 1.8 3.3 9.8 10.8 1.9 1.3 1.2 1.0 7.5 13.0 4.1 3.0 3.3 8.0 1.0 10.4 2.8 1.1 2.6 2.2 2.0 5.1 1.3 1.5 1.8 2.8 1.3 2.5 3.5 3.7 0.0 1.6 0.0 1.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.4 2.3 2.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 2.4 0.5 0.0 0.0 0.3 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.3 3.5 5.1 0.0 1.3 0.0 0.0 0.2 0.3 0.9 0.5 0.0 1.1 0.0 0.0 8.0 4.9 0.1 0.2 0.0 0.1 0.7 0.0 0.0 0.0 1.5 0.8 0.0 0.2 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 15.3 36.3 22.7 9.8 10.8 7.5 13.0 10.4 3.7 0.0 0.0 0.0 0.1 0.1 55.4 4.4 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.8 0.2 69.9 15.6 0.6 0.3 0.9 7.5 0.0 1.7 1.0 0.3 4.7 0.2 0.0 6.7 1.4 67.0 0.0 0.9 3.2 4.6 0.4 0.0 0.0 0.2 0.1 SPTBN5 "BSPECV, HUBSPECV, HUSPECV" ENSG00000137877 "Spectrin beta, non-erythrocytic 5" Q9NRC6 15 41848144-41894077 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Group enriched" "Detected in some" 22 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 225.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "cerebellum: 10.0;midbrain: 6.8;pons and medulla: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 4.6;SCLC-21H: 6.4;TIME: 16.5;WM-115: 5.2" "Not detected" "Not detected" HPA055283 Approved NA NA "HPA055283: " "unprognostic (5.46e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-2)" "unprognostic (5.84e-3)" "unprognostic (1.12e-1)" "unprognostic (6.84e-3)" "unprognostic (6.40e-3)" "unprognostic (2.25e-1)" "unprognostic (2.96e-2)" "unprognostic (6.92e-2)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.37e-2)" "unprognostic (1.11e-2)" 1.4 0.3 0.7 1.4 0.7 0.7 1.2 10.0 0.8 0.7 0.7 0.7 0.7 0.6 0.7 1.8 2.0 0.2 1.9 4.6 0.7 0.3 1.2 1.9 1.2 1.2 6.8 0.7 1.2 2.6 1.8 2.3 0.7 3.7 1.8 0.2 7.4 6.8 0.7 1.4 1.8 0.7 0.7 1.0 0.7 1.2 1.9 0.7 0.7 2.6 0.7 0.7 4.4 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 1.0 0.0 1.9 0.5 0.0 0.3 0.0 1.0 0.1 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.1 0.0 4.6 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.5 0.2 0.5 0.0 0.3 0.0 0.4 1.7 6.4 0.1 0.2 0.5 0.1 0.5 1.0 0.0 16.5 0.0 1.7 0.4 2.0 1.9 2.7 0.0 0.0 0.1 5.2 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.7 10.0 0.8 0.7 0.3 6.8 0.7 3.7 0.7 0.0 3.7 0.0 0.8 0.7 7.6 3.4 0.0 1.4 2.3 0.0 198.3 0.0 0.0 0.4 1.0 1.1 0.0 0.0 0.2 0.2 0.0 0.3 1.1 0.4 1.5 3.2 0.0 0.6 0.0 0.4 0.0 0.8 1.7 1.0 0.3 9.5 0.9 0.9 0.0 0.3 225.5 0.0 0.2 0.3 0.4 1.1 0.0 0.0 0.2 0.9 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008979-13169103 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 154.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 10.5" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.0;NK-cell: 4.1" "Group enriched" "Detected in many" 13 "NK-cells: 4.1;T-cells: 3.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA044247, HPA048079" Enhanced Approved Microtubules NA NA Microtubules "HPA044247: AB_2678872, HPA048079: AB_2680252" "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favorable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 3.2 4.5 1.3 1.6 2.2 0.0 4.3 1.7 1.7 4.3 5.0 2.2 4.4 8.3 4.8 9.6 5.6 3.4 5.8 4.8 2.0 1.5 15.6 11.9 5.7 0.7 2.5 2.2 4.3 3.8 10.2 4.2 154.0 10.5 4.5 3.8 3.8 7.8 5.8 1.0 25.1 9.0 3.0 6.9 1.9 2.2 4.2 1.4 5.7 24.3 3.6 1.9 4.8 6.0 0.0 0.2 0.1 0.0 4.1 3.0 0.2 0.7 1.1 0.9 0.0 7.1 10.3 5.5 0.0 1.5 1.0 4.1 8.9 4.5 0.0 0.5 0.2 9.0 12.2 0.0 3.4 1.4 0.0 0.0 0.0 2.8 12.6 0.6 0.0 0.1 5.8 10.7 4.0 1.4 3.8 0.7 2.1 0.0 16.4 11.5 0.2 0.0 0.0 0.0 1.0 1.4 1.1 2.0 7.2 21.8 8.7 0.0 0.1 0.1 1.1 0.0 1.6 9.1 0.2 1.6 4.6 1.5 15.2 1.0 0.1 0.0 0.0 28.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.4 0.1 0.0 0.0 0.7 0.1 0.1 4.1 0.0 0.2 0.0 0.2 1.3 2.2 1.7 1.7 2.0 1.5 2.5 2.2 10.5 1.4 6.0 18.2 0.0 4.8 2.2 0.0 15.1 5.1 4.0 6.8 8.7 0.0 22.9 6.6 2.2 15.0 2.2 4.9 0.0 3.8 10.5 7.2 3.4 1.1 18.7 2.5 0.0 0.0 0.6 2.5 8.5 3.4 0.9 0.0 0.0 4.7 13.6 2.5 8.0 2.5 11.9 0.0 0.0 0.3 0.9 0.1 1.9 38.6 1.3 6.1 1.8 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 68.6;skin 1: 27.5;stomach 1: 42.0" "Cell type enhanced" "Detected in some" 13 "Exocrine glandular cells: 42.0;Glandular cells: 74.2;Melanocytes: 43.9;Suprabasal keratinocytes: 31.9;Urothelial cells: 53.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 12 "NK-cell: 68.6" "Lineage enriched" "Detected in many" 12 "NK-cells: 68.6" "Group enriched" "Detected in some" 10 "MCF7: 159.0;RT4: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047712 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA047712: AB_2680127" "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.4 0.4 2.0 0.7 3.4 0.5 6.4 8.9 18.5 4.0 0.9 1.6 0.0 0.5 1.0 0.4 5.1 0.6 1.5 0.4 2.2 2.2 0.7 0.6 0.3 1.0 2.0 6.2 0.4 1.5 0.3 0.3 0.3 12.0 12.4 0.8 0.2 8.0 0.4 0.4 27.5 0.5 1.4 1.1 1.1 42.0 0.3 0.4 0.1 0.4 2.1 1.7 23.5 5.4 0.0 0.0 0.2 0.0 68.6 5.6 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.0 0.0 0.0 0.6 9.7 1.8 0.0 0.0 0.0 0.0 42.2 0.2 1.7 0.0 5.7 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.2 68.6 0.0 0.0 0.0 0.5 2.0 3.4 8.9 18.5 2.2 2.2 2.0 6.2 12.0 0.4 0.0 0.0 0.0 17.2 3.4 1.5 0.3 2.5 0.0 0.0 3.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 42.0 0.0 0.4 74.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 1.6 0.0 16.3 0.0 0.0 0.0 1.3 0.0 2.7 0.0 0.0 31.9 0.1 0.9 0.0 53.8 SPTY2D1OS SPTY2D1-AS1 ENSG00000247595 "SPTY2D1 opposite strand" 11 18588781-18610255 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 18 "testis: 70.2" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 5.2;Distal tubular cells: 19.9;Proximal tubular cells: 6.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 7.0;HeLa: 10.2" "Secreted in male reproductive system" NA NA "unprognostic (1.07e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-3)" "unprognostic (5.14e-2)" "unprognostic (6.61e-2)" "unprognostic (9.32e-2)" "unprognostic (4.44e-7)" "unprognostic (1.75e-1)" "unprognostic (1.39e-2)" "unprognostic (7.83e-2)" "unprognostic (5.36e-2)" "unprognostic (6.50e-3)" "unprognostic (5.41e-4)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.48e-2)" 0.1 0.2 0.1 0.1 0.1 0.0 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 1.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.1 3.9 0.1 0.1 0.1 0.1 0.0 70.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.6 2.6 1.0 1.0 2.4 0.8 0.7 7.0 2.8 3.8 2.5 3.7 3.5 0.5 0.8 1.4 1.7 5.2 2.0 1.2 0.4 0.6 1.5 1.4 0.0 0.0 0.0 2.1 2.5 0.7 10.2 6.5 0.4 0.9 2.3 1.4 0.5 0.3 2.3 1.9 1.4 0.0 1.9 0.6 0.5 2.4 0.4 2.6 1.9 1.6 4.3 0.3 0.9 0.4 2.8 2.8 0.9 0.5 2.6 0.1 0.1 1.0 1.4 0.4 1.4 2.7 2.2 1.5 0.3 0.1 0.3 0.0 1.1 1.3 1.8 1.3 1.0 2.6 1.0 0.2 2.4 0.3 0.6 0.3 0.2 0.9 0.4 0.6 2.4 1.0 0.5 0.6 1.5 0.8 3.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.3 5.2 0.0 0.8 19.9 2.9 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 2.7 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 SPX "C12orf39, MGC10946, NPQ, spexin" ENSG00000134548 "Spexin hormone" Q9BT56 12 21526307-21537377 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 34.3;brain: 14.4;breast: 23.1" "Group enriched" "Detected in some" 4 "Distal tubular cells: 72.9;Proximal tubular cells: 131.0" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Region enriched" "Detected in some" 9 "pons and medulla: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.1;HBEC3-KT: 7.2;hTERT-HME1: 9.8;SuSa: 11.2;U-2 OS: 4.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3" "Secreted to blood" NA NA 2650000 "unprognostic (2.78e-2)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (1.81e-2)" "unprognostic (2.13e-1)" "unprognostic (5.10e-2)" "unprognostic (1.86e-1)" "unprognostic (1.04e-1)" "unprognostic (2.11e-2)" "unprognostic (5.89e-2)" "unprognostic (1.21e-2)" "unprognostic (1.95e-1)" "prognostic favorable (1.31e-6)" "unprognostic (2.37e-3)" "unprognostic (9.78e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" 34.3 0.0 0.2 0.0 0.3 0.0 23.1 0.1 1.4 0.0 2.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 1.5 0.4 0.7 7.1 0.7 0.2 0.5 1.5 0.0 0.0 7.8 0.0 0.0 12.7 14.4 0.0 0.0 0.0 6.4 0.0 1.3 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.2 1.3 2.7 0.4 0.0 0.1 0.0 0.1 0.6 0.5 0.0 0.0 0.2 1.5 0.0 0.5 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.8 14.1 0.0 0.5 0.2 0.0 0.2 0.0 0.0 7.2 0.8 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.0 3.0 0.3 0.1 9.8 0.2 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.5 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.4 11.2 0.0 0.0 0.0 0.0 4.6 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.0 1.5 0.2 0.3 0.1 0.3 0.4 0.7 1.5 0.0 14.4 0.2 0.0 0.0 0.5 0.0 0.0 3.4 24.8 0.0 0.0 0.0 24.4 0.0 0.0 72.9 0.2 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 1.0 0.0 1.7 4.0 0.0 0.0 131.0 0.5 0.0 0.3 0.0 0.4 0.0 0.3 0.0 0.0 0.0 SPZ1 "FLJ25709, NYD-TSP1, PPP1R148" ENSG00000164299 "Spermatogenic leucine zipper 1" Q9BXG8 5 80319625-80321842 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 24.4" "Group enriched" "Detected in some" 30 "Early spermatids: 279.1;Late spermatids: 499.7" "Group enriched" "Detected in some" 20 "prostate cancer: 1.0;testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" "unprognostic (2.22e-1)" "unprognostic (2.73e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 279.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 12.9 0.0 3.9 2.0 0.0 0.0 0.0 0.0 0.0 SRA1 "SRA, STRAA1" ENSG00000213523 "Steroid receptor RNA activator 1" Q9HD15 5 140537340-140558252 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Activator, Receptor, Ribonucleoprotein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 26.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044598, HPA050153" Approved Supported Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA044598: AB_2679013, HPA050153: AB_2681033" "unprognostic (1.51e-1)" "unprognostic (1.04e-2)" "unprognostic (8.69e-2)" "prognostic favorable (8.01e-6)" "unprognostic (9.32e-2)" "unprognostic (2.56e-1)" "unprognostic (2.90e-1)" "unprognostic (2.43e-1)" "unprognostic (9.38e-2)" "unprognostic (7.41e-2)" "unprognostic (5.58e-3)" "unprognostic (2.61e-1)" "unprognostic (5.34e-2)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-1)" 4.8 9.9 2.5 4.8 3.0 5.6 2.7 13.3 3.5 2.5 3.3 3.1 3.0 4.1 2.5 2.6 3.5 4.3 2.7 3.0 3.5 14.4 4.4 3.5 2.2 4.9 2.7 4.5 7.7 3.7 3.7 3.0 5.5 4.4 4.4 3.9 3.4 3.4 2.1 5.7 4.6 6.8 4.1 3.1 2.3 2.3 9.0 15.6 26.9 16.4 7.5 11.3 14.2 6.2 15.0 8.0 8.3 3.9 5.3 11.2 10.7 6.1 7.0 7.4 27.4 3.9 5.3 7.9 4.1 3.7 4.2 1.4 7.9 2.8 8.2 9.3 4.7 16.3 10.4 8.3 8.4 6.4 10.2 4.1 3.7 1.9 6.2 3.2 9.2 4.7 8.2 4.6 19.1 6.8 13.2 2.4 3.4 12.1 7.6 6.8 5.1 3.6 7.5 5.7 6.6 6.2 5.7 7.2 2.9 7.0 9.6 5.0 6.7 3.5 5.7 8.6 10.3 6.8 5.6 8.2 11.0 4.3 8.1 16.4 12.0 7.0 14.3 6.5 9.0 6.8 6.7 15.6 7.4 5.6 6.4 26.9 7.5 13.3 9.3 11.3 14.2 6.0 53.3 35.8 43.2 46.5 23.0 70.0 68.8 34.8 30.7 31.4 7.9 84.2 96.2 79.1 75.5 39.4 72.4 0.0 128.7 102.6 52.4 64.7 66.9 57.8 81.7 14.3 36.9 43.6 67.7 108.8 23.3 67.0 64.1 111.0 51.7 47.0 131.8 77.2 28.0 111.7 19.5 25.8 48.6 45.0 29.2 40.1 149.7 55.1 40.7 117.5 SRARP "C1orf64, ERRF, MGC24047" ENSG00000183888 "Steroid receptor associated and regulated protein" Q8NEQ6 1 16004236-16008807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0;breast: 14.7" "Cell type enriched" "Detected in single" 763 "Distal tubular cells: 76.3" "Cancer enhanced" "Detected in some" "breast cancer: 7.7;prostate cancer: 6.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.3" "Group enriched" "Detected in some" 12 "Hep G2: 9.2;SK-BR-3: 16.5;T-47d: 5.3" "Low region specificity" "Detected in all" HPA026676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA026676: AB_1853866" "unprognostic (8.55e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.68e-6)" "unprognostic (3.32e-2)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (1.65e-3)" "unprognostic (6.32e-2)" 0.9 1.1 12.8 1.2 19.9 2.2 14.7 7.5 19.3 6.6 0.8 3.5 0.0 1.3 3.8 1.2 1.1 0.8 1.1 1.5 14.1 6.4 2.7 0.9 0.9 1.3 12.8 7.2 1.1 1.1 0.6 0.3 1.0 22.0 2.5 0.8 0.0 8.6 0.8 2.2 2.2 0.9 0.6 7.8 1.1 1.4 1.1 16.6 0.0 3.8 0.0 0.7 1.2 0.3 0.8 0.5 5.3 0.4 1.0 0.6 0.1 0.4 0.1 0.4 0.5 0.0 0.1 0.2 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.1 0.5 0.7 9.2 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.7 0.7 0.0 0.5 0.3 0.4 0.1 0.2 0.2 0.2 0.3 0.2 0.0 0.1 0.5 0.8 0.3 16.5 0.3 0.6 5.3 0.5 0.2 0.6 0.4 0.5 0.1 0.3 0.6 0.3 0.2 0.3 0.7 2.0 0.4 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.1 0.8 0.6 0.6 5.3 1.0 0.3 0.5 0.2 0.1 12.8 19.9 7.5 19.3 14.1 6.4 12.8 7.2 22.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRCIN1 "KIAA1684, p140Cap, SNIP" ENSG00000277363 "SRC kinase signaling inhibitor 1" Q9C0H9 17 38530016-38605930 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 21.2;salivary gland: 11.7;skin 1: 6.1" "Cell type enhanced" "Detected in many" 25 "Bipolar cells: 30.8;Cholangiocytes: 20.4;Horizontal cells: 96.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "Karpas-707: 5.3;SCLC-21H: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009701, HPA063795" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA009701: AB_1857324, HPA063795: AB_2685124" "unprognostic (4.53e-1)" "unprognostic (4.05e-1)" "unprognostic (2.45e-2)" "unprognostic (3.24e-4)" "unprognostic (4.10e-2)" "unprognostic (3.72e-3)" "unprognostic (1.53e-1)" "unprognostic (2.84e-2)" "unprognostic (9.95e-2)" "unprognostic (1.80e-1)" "unprognostic (1.16e-4)" "unprognostic (1.00e-1)" "unprognostic (5.07e-3)" "unprognostic (9.51e-2)" "unprognostic (6.50e-2)" "unprognostic (2.67e-2)" "prognostic favorable (1.76e-4)" 1.3 2.6 7.9 0.5 9.5 0.6 1.7 16.3 21.2 1.3 0.8 18.4 0.0 1.2 1.0 1.3 0.5 2.1 0.4 0.6 7.0 0.5 1.8 0.8 0.6 9.0 10.5 0.4 1.6 2.2 0.0 0.6 10.2 0.8 0.7 0.5 11.7 1.7 0.9 6.1 0.9 0.5 5.5 0.6 0.9 0.8 10.7 0.0 0.8 0.0 0.4 0.9 0.0 0.3 0.3 1.3 0.2 0.2 0.2 0.0 0.5 0.6 1.2 3.5 0.2 0.0 0.1 0.0 0.1 0.2 0.1 0.7 0.6 1.0 1.1 0.0 0.9 1.3 1.6 0.2 0.1 1.2 1.4 0.0 0.5 1.4 0.2 0.0 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.6 0.1 5.3 0.0 3.2 0.0 0.0 1.7 0.7 0.1 0.1 0.0 0.1 0.5 2.6 16.5 2.4 0.0 1.4 1.0 0.9 2.6 0.5 0.0 0.0 1.6 0.0 0.0 1.1 0.2 0.1 0.1 0.7 0.7 1.3 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.2 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.9 0.7 30.8 2.4 20.4 4.0 0.0 3.5 0.0 0.0 0.0 1.9 0.1 0.1 0.3 0.0 0.2 0.1 0.8 1.4 0.0 9.6 0.3 96.9 9.4 0.6 0.0 0.2 0.6 0.0 0.0 0.0 2.1 1.7 0.5 0.0 0.4 0.0 2.8 0.0 0.3 0.7 2.0 0.6 0.1 0.0 1.1 1.7 SRD5A1 ENSG00000145545 "Steroid 5 alpha-reductase 1" P18405 5 6633343-6674386 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 75.4;monocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051402 Approved NA NA "HPA051402: AB_2681470" "unprognostic (1.40e-2)" "unprognostic (1.33e-2)" "unprognostic (2.30e-3)" "prognostic unfavorable (8.73e-6)" "unprognostic (9.38e-3)" "unprognostic (8.90e-2)" "unprognostic (3.78e-2)" "unprognostic (5.90e-2)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.56e-3)" "unprognostic (3.01e-1)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.47e-2)" 2.4 3.3 7.7 2.9 8.2 3.2 14.8 9.2 11.8 5.6 5.2 5.3 0.7 5.7 3.1 4.6 24.2 2.9 4.0 1.9 9.3 7.5 6.4 42.4 3.0 3.5 6.2 5.5 4.1 4.3 3.0 1.9 2.1 13.4 2.6 3.6 2.4 5.0 2.1 2.2 17.5 10.4 2.6 3.1 2.9 3.9 2.7 2.9 3.3 2.4 15.3 12.1 2.6 10.1 1.9 3.7 7.0 3.3 1.3 1.3 1.3 5.6 5.5 7.4 6.3 7.1 7.0 3.4 5.4 4.2 5.4 3.4 5.5 5.0 6.8 9.0 7.9 8.8 9.1 6.0 3.6 5.8 4.2 2.6 2.1 13.9 3.4 3.3 3.0 1.8 5.1 10.4 3.8 3.0 4.0 2.6 2.7 3.6 6.3 6.9 6.6 1.4 3.5 4.7 3.7 4.4 4.7 5.7 2.0 7.2 5.2 14.0 6.3 16.6 7.4 5.1 7.7 3.0 0.9 5.5 8.2 4.1 13.3 6.8 3.4 4.5 2.4 6.8 3.6 7.4 7.0 3.3 1.4 1.0 2.4 0.7 1.7 1.0 1.3 3.7 1.9 0.9 1.0 2.0 1.3 2.6 1.8 1.1 1.3 7.7 8.2 9.2 11.8 9.3 7.5 6.2 5.5 13.4 2.9 3.0 2.4 8.2 5.5 16.5 4.4 2.4 5.1 8.1 2.3 5.2 3.9 0.7 6.6 9.1 7.8 3.1 7.8 0.0 4.1 6.1 3.7 6.5 1.1 75.4 12.0 6.4 2.4 4.3 19.6 1.9 3.1 7.9 6.8 55.1 5.6 3.5 6.5 8.7 7.4 19.5 3.7 0.0 4.2 2.7 2.6 26.6 0.7 4.4 11.7 9.6 SRD5A2 ENSG00000277893 "Steroid 5 alpha-reductase 2" P31213 2 31522480-31581067 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;liver: 30.9;prostate: 28.4" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 13.4;Early spermatids: 70.2;Hepatocytes: 14.7;Late spermatids: 41.4" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BJ hTERT+: 2.9;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.75e-3)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-3)" "unprognostic (5.92e-3)" "unprognostic (3.37e-2)" "unprognostic (2.79e-3)" "unprognostic (6.56e-2)" "unprognostic (9.10e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-3)" "unprognostic (6.61e-6)" "unprognostic (4.37e-2)" "unprognostic (2.04e-1)" "unprognostic (3.85e-1)" "unprognostic (3.48e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 10.1 0.0 0.2 17.9 0.0 10.4 0.0 0.0 0.0 0.0 30.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.4 2.5 13.4 1.2 0.0 0.0 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 14.7 0.0 0.0 0.0 0.0 0.0 41.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.2 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 4.7 SRGAP2 "ARHGAP34, FNBP2, KIAA0456, SRGAP2A" ENSG00000266028 "SLIT-ROBO Rho GTPase activating protein 2" O75044 1 206203345-206464443 "Disease related genes, Predicted intracellular proteins" Neurogenesis "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.1" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 53.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA028191, HPA028196, HPA078079" Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: " "unprognostic (2.57e-2)" "unprognostic (5.92e-2)" "unprognostic (2.40e-3)" "unprognostic (1.67e-2)" "unprognostic (5.20e-2)" "unprognostic (4.22e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.98e-1)" "unprognostic (2.02e-1)" "unprognostic (2.09e-2)" "unprognostic (3.06e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (4.61e-7)" "unprognostic (2.70e-2)" "unprognostic (5.02e-2)" "unprognostic (1.45e-1)" "unprognostic (4.18e-3)" 3.5 2.4 2.2 3.3 0.7 4.3 1.3 0.0 0.0 1.4 2.0 1.2 1.7 1.5 0.5 0.7 0.5 2.4 1.9 3.1 0.5 7.4 3.4 0.1 0.1 0.0 0.9 0.0 8.5 0.0 2.3 4.2 0.6 1.0 0.0 1.8 1.1 4.8 12.7 14.1 9.9 1.4 3.0 2.2 19.1 12.9 43.9 11.1 20.9 18.9 17.2 16.6 12.4 14.5 15.9 8.8 14.7 7.5 9.6 18.3 19.4 15.6 13.0 10.9 14.6 9.3 10.6 15.4 23.1 13.2 8.7 10.6 17.3 17.1 9.5 18.6 13.0 15.8 25.1 9.8 12.6 24.4 9.2 13.3 8.4 9.4 14.1 3.4 14.9 19.1 18.0 17.7 6.2 3.5 14.6 6.7 14.1 10.6 20.6 17.2 13.1 18.9 24.9 14.3 17.3 17.5 15.2 16.2 14.5 7.1 17.2 14.8 34.7 0.6 9.3 0.5 2.6 9.4 1.0 2.2 2.1 2.6 6.3 4.8 0.8 1.8 14.1 1.4 9.9 12.7 3.0 2.2 8.9 15.5 13.7 5.2 21.2 41.0 3.3 12.7 4.0 7.9 10.4 3.9 2.9 0.0 5.7 53.8 24.8 0.3 0.0 1.8 17.0 12.3 3.6 8.1 1.5 15.6 1.6 1.2 35.6 37.7 28.5 7.2 27.3 15.1 17.2 1.5 8.2 3.3 0.2 2.5 0.5 5.3 0.0 11.5 7.9 9.4 31.9 3.5 7.5 1.2 4.9 SRGAP2B SRGAP2P2 ENSG00000196369 "SLIT-ROBO Rho GTPase activating protein 2B" P0DMP2 1 144887265-145095528 "Predicted intracellular proteins" Neurogenesis "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 9.6" "Cell type enhanced" "Detected in many" 7 "Ito cells: 54.6;Kupffer cells: 49.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (1.13e-2)" "unprognostic (2.76e-1)" "unprognostic (1.48e-3)" "unprognostic (3.52e-3)" "unprognostic (1.66e-2)" "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (4.60e-2)" "unprognostic (3.13e-1)" "unprognostic (2.89e-2)" "unprognostic (7.27e-2)" "unprognostic (1.88e-1)" "unprognostic (2.16e-5)" "unprognostic (3.12e-1)" "unprognostic (5.43e-1)" "unprognostic (8.54e-2)" "unprognostic (2.38e-1)" 2.5 3.4 1.5 1.6 0.6 2.7 1.3 0.0 0.0 1.4 0.6 1.2 1.7 1.2 0.6 2.2 0.5 2.4 0.9 2.7 0.3 4.4 3.3 0.4 0.0 0.0 0.8 1.9 6.6 0.0 1.8 3.7 0.0 0.2 0.5 0.3 1.2 1.4 4.6 5.0 9.6 0.5 1.6 1.1 6.8 14.7 32.0 6.6 15.4 13.4 10.1 7.6 6.7 6.5 7.5 4.4 12.6 3.4 10.2 4.5 11.6 11.9 8.2 4.4 8.0 3.2 8.3 5.0 10.7 6.2 10.8 4.4 6.6 9.5 6.7 16.0 14.2 9.8 13.0 3.0 2.7 12.2 3.5 7.6 1.9 5.2 5.9 3.4 5.4 5.2 6.9 5.9 5.6 3.0 4.0 5.1 10.1 3.6 16.8 8.3 7.6 11.3 23.5 14.0 14.5 12.4 8.8 5.1 6.3 2.1 5.1 6.0 19.9 1.4 5.1 0.7 0.9 6.9 0.7 1.2 1.4 1.6 3.5 1.4 1.0 1.1 5.0 0.5 9.6 4.6 1.4 1.1 23.8 7.7 8.3 3.5 0.0 11.9 3.2 0.0 14.7 4.5 8.7 2.0 4.7 0.0 5.8 1.0 24.3 0.3 23.3 2.6 14.4 12.3 3.6 1.1 4.7 10.9 0.0 2.4 54.6 49.1 1.7 14.1 15.9 0.0 23.4 0.8 6.3 4.3 0.0 9.2 0.8 2.4 6.5 9.4 2.6 6.4 0.0 2.4 10.1 1.2 3.5 SRGAP2C SRGAP2P1 ENSG00000171943 "SLIT-ROBO Rho GTPase activating protein 2C" P0DJJ0 1 121184810-121392822 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 16.5" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 50.6;Erythroid cells: 70.0;Ito cells: 64.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "WM-115: 39.8" HPA078079 Approved Cytosol NA NA Cytosol "HPA078079: " "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (7.65e-3)" "unprognostic (1.48e-6)" "unprognostic (2.40e-2)" "unprognostic (1.11e-1)" "unprognostic (7.18e-4)" "unprognostic (6.10e-2)" "unprognostic (7.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (2.89e-1)" "unprognostic (3.71e-7)" "unprognostic (4.90e-2)" "unprognostic (2.10e-1)" "unprognostic (1.70e-1)" "unprognostic (7.66e-2)" 4.7 4.5 3.5 2.8 4.4 4.2 2.7 7.8 6.0 3.5 2.0 8.5 3.3 1.0 3.5 1.2 5.4 3.2 3.0 2.9 3.3 4.6 2.9 5.5 2.5 6.3 4.0 4.8 1.1 16.5 4.6 6.5 6.2 2.1 1.7 2.1 1.3 3.2 1.3 10.9 1.7 3.9 6.4 7.0 1.8 1.3 4.7 4.5 2.0 1.9 2.2 3.1 2.7 1.7 4.2 5.2 7.7 1.0 2.3 1.4 5.2 6.9 15.3 3.4 11.9 10.4 8.5 6.0 4.8 5.1 6.7 0.1 5.4 3.3 5.4 8.2 3.7 2.9 5.4 4.4 6.8 4.4 5.5 4.8 12.0 5.3 6.8 3.2 5.7 7.7 4.4 6.5 8.4 5.8 12.1 2.1 4.4 6.3 3.7 3.1 2.0 4.1 4.8 1.7 3.3 3.0 18.0 3.0 4.8 3.1 2.9 1.9 10.4 3.7 18.7 8.3 4.7 9.5 10.7 9.7 9.6 14.4 8.8 3.7 2.6 2.0 8.4 6.6 39.8 0.5 5.9 1.0 1.9 4.6 1.3 1.7 2.3 2.1 4.2 1.7 1.1 1.6 5.2 1.0 7.7 3.8 2.0 1.4 50.6 11.5 9.3 6.2 0.0 12.1 4.9 5.1 16.0 9.1 10.4 2.0 4.6 1.7 9.3 0.4 29.2 0.4 70.0 4.4 18.8 12.7 4.2 5.8 7.2 16.5 0.0 2.4 64.4 41.9 0.9 18.1 16.7 0.0 27.9 2.6 8.4 5.4 0.6 24.1 0.7 4.5 32.3 12.4 4.7 6.8 0.0 2.1 13.4 1.4 3.8 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.9" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 228.5;Cone photoreceptor cells: 257.2;Horizontal cells: 216.1;Muller glia cells: 117.0;Rod photoreceptor cells: 104.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.7;HBEC3-KT: 8.4;hTCEpi: 8.3;RT4: 11.2;T-47d: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Approved Cytosol NA NA Cytosol "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 1.8 6.1 10.6 1.7 20.4 1.2 3.2 32.4 34.9 9.7 2.1 10.5 0.0 1.9 4.4 3.4 2.6 18.5 2.3 2.7 10.0 11.2 4.9 1.4 2.2 2.3 7.5 9.8 7.2 2.4 2.7 5.7 1.9 15.5 4.7 2.5 4.8 5.7 3.2 2.5 4.0 1.7 2.0 6.1 1.7 2.9 4.4 4.8 0.4 3.3 0.6 2.1 6.7 1.4 0.0 1.9 1.9 0.4 1.0 1.3 0.1 0.5 0.5 9.7 0.4 0.7 1.3 1.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.5 0.0 0.2 4.9 0.2 8.4 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.2 0.8 8.3 0.7 0.8 0.3 0.0 2.2 0.0 0.0 0.0 0.1 0.2 2.1 0.9 1.7 0.7 1.1 0.0 0.0 4.2 11.2 1.1 1.3 0.2 3.0 0.1 2.5 10.8 0.0 0.0 0.0 0.4 0.1 0.1 2.9 0.1 0.0 0.8 1.7 0.3 1.2 0.4 1.9 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.2 0.0 0.0 1.0 0.1 0.5 1.3 0.1 10.6 20.4 32.4 34.9 10.0 11.2 7.5 9.8 15.5 4.8 3.0 6.4 0.0 23.8 3.7 228.5 8.1 0.0 52.2 27.3 73.3 257.2 1.8 5.0 1.8 18.5 1.8 0.4 0.0 0.4 0.7 4.0 9.9 1.1 1.6 10.6 216.1 2.9 0.6 9.9 15.3 2.3 3.8 1.7 1.0 3.7 117.0 0.5 0.0 1.1 1.0 104.8 0.0 1.4 5.4 4.9 5.1 1.1 2.9 2.2 27.1 SRGN "PPG, PRG, PRG1" ENSG00000122862 Serglycin P10124 10 69088106-69104811 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Biomineralization" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 259.2;bone marrow: 657.4" "Cell type enhanced" "Detected in many" 14 "granulocytes: 2209.7;Kupffer cells: 1775.9;Macrophages: 2336.3;monocytes: 4414.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 259.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 259.2" "Cell line enhanced" "Detected in many" "HL-60: 234.4;NB-4: 136.2;THP-1: 234.7;TIME: 141.6;U-937: 189.8" "Low region specificity" "Detected in many" HPA000759 Enhanced Supported "Golgi apparatus" "Intracellular and membrane" NA NA 50000000 "Golgi apparatus" "HPA000759: AB_1079675" "unprognostic (3.61e-2)" "unprognostic (1.62e-2)" "unprognostic (2.78e-2)" "unprognostic (1.28e-1)" "unprognostic (1.37e-1)" "unprognostic (4.50e-2)" "unprognostic (1.30e-1)" "unprognostic (1.70e-2)" "unprognostic (1.63e-1)" "unprognostic (8.22e-2)" "unprognostic (5.80e-2)" "unprognostic (9.82e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.65e-1)" "unprognostic (2.32e-2)" "unprognostic (4.07e-2)" "unprognostic (4.08e-2)" 51.3 12.3 11.0 74.4 18.7 657.4 27.0 5.7 11.8 11.6 13.8 9.7 3.4 8.1 11.6 10.5 13.3 19.6 31.6 31.9 21.0 14.0 29.1 23.2 107.8 87.1 18.4 3.0 11.9 7.4 6.5 13.2 33.0 32.9 12.7 12.6 15.7 8.4 6.8 15.1 3.7 16.8 21.1 42.4 129.8 11.7 10.7 12.6 28.2 15.2 6.5 31.1 46.1 16.2 3.3 28.4 259.2 46.1 40.8 22.7 53.1 0.2 2.2 0.0 0.0 43.7 42.8 0.0 5.1 3.4 12.8 15.7 0.0 0.9 0.4 6.4 0.2 7.3 0.0 0.0 1.0 44.6 27.8 0.0 4.5 1.8 0.0 17.9 234.4 51.3 17.4 0.0 35.7 2.2 12.3 66.7 0.6 4.1 23.1 67.7 0.0 0.9 136.2 0.0 0.0 4.4 0.1 0.1 23.5 0.0 0.3 0.0 0.0 0.1 0.0 0.8 0.0 0.1 234.7 141.6 10.6 0.6 0.2 1.0 27.0 26.1 3.0 6.3 189.8 0.0 82.5 46.1 116.7 22.7 34.3 14.8 3.3 11.0 16.9 26.1 1.6 6.2 13.2 259.2 40.8 29.7 28.4 17.1 53.1 11.0 18.7 5.7 11.8 21.0 14.0 18.4 3.0 32.9 12.6 104.2 308.1 287.9 9.6 156.3 0.7 10.0 25.5 83.0 102.4 31.4 0.0 6.4 0.0 1.9 2.9 366.4 0.0 46.7 8.1 6.8 94.4 8.3 2209.7 11.5 808.1 0.0 1.7 496.0 1775.9 3.4 6.9 2336.3 528.1 4414.9 0.4 1.0 1.5 0.3 17.0 3.6 4.8 71.1 133.9 0.7 2.0 124.0 11.9 1091.4 0.2 14.7 SRI ENSG00000075142 Sorcin P30626 7 88205118-88226993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 140.7" "Cell type enhanced" "Detected in all" 7 "Enterocytes: 1052.9;Paneth cells: 1613.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019004, HPA073666" Enhanced Supported Nucleoplasm,Cytosol No No 1400000 "Nucleoplasm, Cytosol" "HPA019004: AB_2670006, HPA073666: AB_2686623" "unprognostic (1.86e-2)" "unprognostic (2.31e-3)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-3)" "unprognostic (1.24e-3)" "prognostic favorable (3.08e-4)" "unprognostic (9.87e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.36e-1)" "unprognostic (2.10e-2)" "unprognostic (1.29e-2)" "unprognostic (9.87e-2)" "unprognostic (8.44e-2)" "unprognostic (3.14e-3)" 20.6 22.0 47.7 24.6 53.5 18.7 22.4 18.9 43.6 24.1 140.7 32.5 7.0 45.3 18.1 33.1 15.6 39.4 14.2 19.4 35.9 40.2 21.7 14.6 21.9 16.6 45.0 44.8 23.3 18.4 12.1 18.3 21.2 36.9 19.5 115.0 11.1 17.7 18.4 8.7 11.1 62.8 25.2 41.9 14.6 16.2 10.0 28.0 9.2 19.7 9.4 19.4 27.0 18.7 29.7 34.5 95.4 42.1 36.3 36.4 32.7 34.4 13.2 35.8 36.8 58.0 49.0 18.0 20.7 33.5 23.4 27.8 12.3 78.2 38.3 21.9 31.4 57.4 34.9 44.9 46.8 30.6 30.8 20.2 19.8 36.4 0.0 35.1 26.4 21.3 50.1 42.9 24.7 36.0 42.0 70.0 24.5 17.5 33.2 32.0 21.7 38.5 18.2 31.4 48.9 26.7 16.0 50.7 21.2 43.5 34.5 25.9 30.7 63.1 36.3 28.8 35.7 17.1 11.8 43.7 43.9 36.8 40.2 36.8 31.1 14.4 41.0 43.1 25.3 74.2 86.5 26.1 95.4 31.0 36.5 36.4 29.7 34.5 35.2 34.5 24.9 25.8 29.8 16.3 36.3 42.1 27.5 34.7 32.7 47.7 53.5 18.9 43.6 35.9 40.2 45.0 44.8 36.9 28.0 80.4 103.8 93.1 338.4 84.4 36.4 95.1 30.6 495.2 193.3 148.3 11.8 123.5 374.7 201.2 45.8 112.5 1052.9 210.2 371.4 826.3 181.0 282.1 132.7 33.9 132.6 44.5 90.6 92.1 77.3 23.0 159.3 104.1 99.5 215.6 393.6 112.7 336.5 1613.2 133.0 124.1 19.7 109.9 144.4 65.6 106.7 94.6 165.0 117.6 448.6 382.7 SRL ENSG00000185739 Sarcalumenin Q86TD4 16 4189374-4242080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 216.0" "Group enriched" "Detected in some" 5 "head and neck cancer: 1.5;thyroid cancer: 5.9" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 13 "HSkMC: 9.8" "Low region specificity" "Detected in some" "HPA041535, HPA045520" Enhanced "Intracellular and membrane" NA NA 26000 "HPA041535: AB_2677538, HPA045520: AB_2679358" "unprognostic (1.24e-2)" "unprognostic (1.36e-2)" "unprognostic (1.29e-1)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (8.11e-2)" "unprognostic (2.04e-7)" "unprognostic (1.41e-1)" "unprognostic (8.28e-2)" "unprognostic (7.40e-4)" "unprognostic (4.91e-2)" "unprognostic (8.70e-2)" "unprognostic (7.78e-4)" "unprognostic (3.33e-2)" "unprognostic (2.15e-1)" "unprognostic (1.51e-3)" "unprognostic (1.68e-4)" 3.1 0.1 0.2 0.2 0.2 0.0 0.4 0.1 1.0 0.8 0.3 0.0 1.2 0.1 0.9 4.2 2.9 0.8 0.4 70.9 0.2 0.2 0.5 0.1 0.3 0.1 0.3 0.2 0.4 0.1 0.1 0.1 0.3 0.4 1.3 0.2 0.1 2.1 0.6 104.1 0.2 0.4 0.8 0.2 0.4 0.3 0.5 0.1 0.2 0.9 48.3 3.4 0.9 0.7 0.6 0.3 2.4 0.5 0.8 0.5 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.0 0.2 0.2 9.8 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.4 0.0 2.4 0.2 0.8 0.5 0.5 0.2 0.3 0.3 0.3 0.1 0.6 0.4 0.4 1.3 0.8 0.3 0.3 0.3 0.9 0.2 0.2 0.1 1.0 0.2 0.2 0.3 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.6 216.0 0.0 0.0 0.0 1.8 7.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 3.1 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.1 0.0 3.5 0.0 11.6 6.5 32.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 SRM "SPS1, SRML1" ENSG00000116649 "Spermidine synthase" P19623 1 11054584-11060024 "Enzymes, Predicted intracellular proteins" "Polyamine biosynthesis, Spermidine biosynthesis" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 107.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 175.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015746 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA015746: AB_1857472" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (2.52e-2)" "unprognostic (1.75e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (2.25e-5)" "unprognostic (2.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-2)" "unprognostic (3.01e-1)" "unprognostic (3.45e-1)" "prognostic unfavorable (3.80e-8)" "unprognostic (1.74e-2)" "unprognostic (8.98e-3)" "unprognostic (1.36e-1)" "unprognostic (2.98e-2)" 26.7 17.7 20.3 29.0 35.4 15.2 16.9 10.2 30.8 14.3 13.3 14.0 11.5 10.8 18.8 9.8 17.7 15.8 14.2 24.9 19.6 16.9 13.9 45.3 14.0 31.0 15.3 15.0 22.8 107.4 8.0 14.5 14.8 15.6 13.1 11.7 15.0 36.0 17.6 43.6 18.2 9.8 22.9 11.7 21.1 14.5 14.4 14.1 17.9 11.9 21.2 20.8 20.2 19.8 10.7 10.2 0.3 6.0 5.0 10.3 2.0 24.9 36.4 12.1 40.4 24.2 26.2 19.0 38.8 19.9 55.5 29.8 44.8 15.1 48.3 22.9 33.6 17.4 19.6 38.6 31.2 18.5 23.7 58.4 30.4 40.3 50.4 35.6 51.0 27.9 26.2 22.6 53.7 47.2 13.0 23.4 31.6 49.4 40.9 27.0 54.8 43.5 44.5 26.4 23.0 70.5 32.7 12.5 78.8 19.7 9.9 23.3 22.3 20.1 43.3 30.3 9.8 15.1 25.9 19.4 36.3 28.6 62.8 43.5 33.0 33.3 72.3 25.2 68.6 41.7 0.0 5.4 0.3 7.0 6.0 10.3 10.7 7.1 9.1 6.4 9.3 8.4 9.7 0.2 5.0 3.1 10.2 7.5 2.0 20.3 35.4 10.2 30.8 19.6 16.9 15.3 15.0 15.6 14.1 0.0 2.9 57.4 63.7 84.3 27.7 26.4 30.6 2.7 1.2 27.9 19.6 62.5 64.6 20.3 3.4 46.6 5.1 23.3 36.6 175.3 66.1 60.8 27.5 47.6 85.0 28.6 26.4 35.6 21.8 10.5 66.4 35.3 64.1 8.2 27.0 28.1 26.0 7.0 49.8 69.0 12.3 0.0 49.9 12.8 74.2 98.9 30.1 23.5 26.6 92.1 SRMS "C20orf148, dJ697K14.1, PTK70, SRM" ENSG00000125508 "Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites" Q9H3Y6 20 63540810-63547504 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 10.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 8 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;MCF7: 4.7;OE19: 7.0;RT4: 9.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB044668, CAB044669, HPA073987" Uncertain Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Intermediate filaments" "Actin filaments, Cytosol" "CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650" "unprognostic (2.26e-2)" "unprognostic (1.26e-2)" "unprognostic (2.52e-3)" "unprognostic (8.32e-2)" "unprognostic (2.62e-1)" "unprognostic (5.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.28e-1)" "unprognostic (9.63e-2)" "unprognostic (6.48e-3)" "unprognostic (7.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.73e-3)" "unprognostic (2.58e-3)" "unprognostic (4.75e-2)" "unprognostic (4.97e-2)" "unprognostic (2.54e-3)" 0.3 0.0 0.3 0.5 0.3 0.0 1.1 1.1 0.3 0.3 1.8 0.3 0.3 0.4 0.3 10.2 0.4 0.0 0.3 0.3 0.3 0.0 0.9 0.3 0.3 0.3 0.3 0.3 0.3 2.7 0.0 0.3 0.3 0.3 2.2 0.0 0.3 2.5 0.3 0.3 1.7 0.8 0.3 0.3 2.5 4.2 0.9 0.3 0.3 0.3 0.3 0.8 1.5 0.3 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 5.5 0.2 2.2 0.0 0.0 2.5 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.7 0.0 0.2 0.0 7.0 0.8 0.0 0.2 0.0 0.0 9.7 0.8 0.9 0.3 2.0 0.4 0.0 2.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 1.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRPK2 SFRSK2 ENSG00000135250 "SRSF protein kinase 2" P78362 7 105110704-105399308 "Enzymes, Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.3" "Group enriched" "Detected in many" 6 "Early spermatids: 1076.1;Late spermatids: 1865.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 58.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 58.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015522, HPA020876" Enhanced Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA015522: AB_1857479, HPA020876: AB_1857480" "unprognostic (9.75e-2)" "unprognostic (1.68e-2)" "unprognostic (1.12e-1)" "unprognostic (4.64e-2)" "unprognostic (3.54e-1)" "unprognostic (1.30e-1)" "unprognostic (5.14e-2)" "unprognostic (1.54e-1)" "unprognostic (2.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" "unprognostic (2.31e-1)" "unprognostic (5.38e-2)" "unprognostic (7.95e-2)" "unprognostic (4.72e-2)" "unprognostic (2.87e-2)" "unprognostic (3.44e-1)" 9.9 12.1 24.8 10.1 27.6 7.1 13.3 28.4 47.1 12.7 9.4 21.0 7.8 8.2 13.2 11.9 11.9 10.9 11.6 10.4 26.4 28.6 10.3 10.1 9.2 11.5 27.2 30.2 13.0 10.5 11.9 15.3 12.0 27.3 14.0 10.9 7.9 10.1 11.1 7.9 16.9 8.2 13.3 23.1 12.0 11.3 69.3 32.3 22.1 11.3 4.7 14.0 13.6 9.7 12.2 7.3 58.2 8.1 10.0 11.9 6.0 13.3 8.9 14.2 28.1 15.2 17.2 7.9 13.1 15.3 13.1 15.3 6.9 11.4 8.5 16.7 16.9 14.7 8.0 14.3 13.8 16.8 14.7 12.7 12.0 8.4 6.0 17.6 11.4 18.0 11.9 25.7 11.1 20.9 12.7 22.5 20.3 11.8 34.8 14.5 25.2 42.2 8.7 11.7 7.6 9.7 13.7 15.6 18.4 18.9 20.7 20.8 14.4 14.8 22.3 13.8 19.6 8.3 8.0 14.7 24.2 17.6 23.0 12.2 38.2 37.6 20.9 9.5 11.8 18.0 11.2 8.1 26.0 11.9 5.5 7.1 12.2 9.0 8.9 7.3 11.6 8.5 9.7 58.2 10.0 6.2 6.4 10.1 6.0 24.8 27.6 28.4 38.7 26.4 28.6 27.2 30.2 27.3 32.3 26.8 28.5 33.3 51.2 189.1 70.3 20.1 33.1 48.2 27.3 22.7 47.1 40.1 23.2 44.1 1076.1 52.5 12.9 0.0 40.5 30.6 44.1 65.7 40.4 25.1 41.0 117.6 27.6 43.0 45.7 1865.0 71.1 31.8 55.6 40.5 32.1 65.3 32.7 21.0 90.2 21.7 65.2 45.3 45.3 237.2 50.3 90.3 53.9 56.8 23.6 46.7 SRPK3 "MSSK1, STK23" ENSG00000184343 "SRSF protein kinase 3" Q9UPE1 X 153776412-153785732 "Enzymes, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 73.4" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 23.8;Cone photoreceptor cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RH-30: 31.4;U-266/70: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.79e-3)" "unprognostic (6.21e-2)" "unprognostic (1.79e-2)" "unprognostic (7.24e-2)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.97e-1)" "unprognostic (4.47e-4)" "unprognostic (2.83e-1)" "unprognostic (1.71e-1)" "unprognostic (4.10e-4)" "unprognostic (8.70e-2)" "unprognostic (5.38e-7)" "unprognostic (1.97e-2)" "unprognostic (1.97e-1)" "unprognostic (3.83e-2)" "unprognostic (1.07e-4)" 1.6 1.8 1.3 0.9 1.8 0.8 0.3 7.7 1.5 0.9 4.5 1.1 0.2 1.3 2.5 3.3 2.6 0.7 1.7 16.7 2.0 1.8 0.2 0.2 0.4 0.8 2.0 0.7 0.7 0.7 1.0 5.8 0.3 1.1 2.8 0.8 0.9 2.9 0.5 73.4 2.3 1.3 4.0 2.0 0.8 1.3 0.5 0.9 0.3 0.6 18.3 1.6 2.0 0.8 0.4 2.6 0.9 0.3 0.1 0.6 0.3 3.2 4.4 0.8 2.2 0.0 0.1 1.0 0.4 0.0 0.2 0.0 3.7 0.6 3.3 0.4 0.4 0.3 0.9 0.0 0.1 0.0 2.8 3.1 1.7 2.7 0.6 0.0 0.8 5.1 2.8 0.0 0.0 0.0 0.2 0.0 4.7 2.2 3.9 0.9 7.0 0.6 4.8 0.8 0.2 1.2 1.5 31.4 0.9 0.0 1.5 5.3 2.5 0.0 2.3 1.0 0.3 2.9 3.8 0.1 1.2 2.8 2.3 0.4 13.0 2.1 2.2 0.6 6.2 1.6 0.8 0.3 0.2 0.5 0.1 0.6 0.2 0.1 0.1 0.0 0.4 0.1 0.1 0.9 0.1 0.0 2.6 0.0 0.3 1.3 1.8 7.7 1.5 2.0 1.8 2.0 0.7 1.1 0.9 0.0 0.0 0.0 1.0 0.6 2.2 23.8 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 1.6 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.7 0.0 0.0 2.8 0.0 0.2 0.0 2.7 0.0 0.1 0.4 0.0 0.0 0.2 0.3 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor beta subunit" Q9Y5M8 3 133784033-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 104.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" NA NA 54000 "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 10.4 15.7 8.7 10.2 9.3 5.8 12.5 5.2 10.2 14.4 11.3 5.1 33.2 8.9 8.0 25.6 16.8 9.1 11.0 10.9 9.0 10.7 17.2 56.3 9.2 17.3 10.4 7.7 8.9 104.0 11.7 15.6 7.7 8.8 9.5 13.4 7.6 53.3 29.9 10.6 8.6 7.4 10.3 7.4 9.5 12.5 14.7 5.4 6.3 16.5 10.2 13.7 8.7 10.4 15.4 20.0 3.8 15.2 14.3 29.0 18.0 12.1 9.9 6.3 20.0 26.3 18.3 11.8 25.8 13.5 14.4 12.5 18.0 9.5 23.1 38.2 19.7 14.5 17.8 19.6 13.9 13.7 15.6 15.7 20.7 9.8 17.0 32.0 32.3 16.8 16.5 23.5 13.1 38.8 8.0 12.2 11.8 17.5 26.9 15.4 17.7 11.1 15.4 11.9 32.4 17.1 13.5 11.7 49.3 17.3 8.4 20.8 8.6 19.8 18.4 7.2 5.0 20.9 15.0 12.1 14.2 8.4 22.3 13.8 34.7 34.5 34.9 12.7 21.5 15.8 3.8 11.6 1.4 21.4 15.2 29.0 15.4 18.3 19.0 13.2 13.4 18.0 21.2 0.8 14.3 9.9 20.0 10.6 18.0 8.7 9.3 5.2 10.2 9.0 10.7 10.4 7.7 8.8 5.4 14.9 22.3 15.6 21.0 33.5 6.2 22.2 43.3 20.1 19.4 34.9 11.8 58.0 10.0 42.5 49.3 24.9 15.5 0.0 58.0 60.5 38.5 38.7 32.3 77.2 46.0 6.4 30.9 17.8 19.9 31.5 29.7 19.3 33.7 10.0 36.2 15.6 40.9 21.0 26.2 24.9 8.8 12.9 23.7 52.8 41.9 27.6 43.3 20.8 32.9 21.4 SRPX ETX1 ENSG00000101955 "Sushi repeat containing protein, X-linked" P78539 X 38149336-38220924 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 82.4" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 130.2;Ito cells: 322.8;Leydig cells: 102.1;Melanocytes: 70.9;Peritubular cells: 89.5" "Group enriched" "Detected in all" 6 "glioma: 64.2;melanoma: 70.1;pancreatic cancer: 14.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 56 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in single" 56 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "ASC diff: 285.2;ASC TERT1: 63.7;HSkMC: 95.9;HUVEC TERT2: 59.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA 310000 "unprognostic (2.35e-1)" "unprognostic (1.09e-3)" "unprognostic (1.08e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (6.48e-2)" "unprognostic (3.83e-3)" "unprognostic (3.50e-2)" "unprognostic (2.31e-1)" "unprognostic (4.00e-1)" "unprognostic (1.10e-1)" "unprognostic (1.30e-1)" "unprognostic (2.22e-2)" "prognostic unfavorable (7.80e-13)" "unprognostic (6.94e-3)" "unprognostic (3.90e-2)" "unprognostic (2.71e-2)" "prognostic unfavorable (3.36e-4)" 56.2 11.9 2.2 8.5 5.0 0.0 82.4 6.6 4.8 14.1 23.1 7.7 10.1 3.1 17.7 35.5 15.1 37.1 23.3 28.9 5.3 2.9 4.1 6.6 14.2 27.7 9.6 1.9 11.6 7.8 1.4 1.5 34.1 13.4 22.1 10.2 4.7 9.5 6.6 9.9 8.7 14.4 27.8 18.9 0.6 13.3 14.9 7.3 0.9 17.8 5.3 5.1 29.6 54.6 0.0 10.5 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 285.2 63.7 0.0 2.5 5.0 0.8 1.5 0.0 0.2 0.0 0.0 5.3 8.9 0.1 0.1 2.2 0.7 0.0 1.0 0.0 0.0 0.0 12.8 0.2 0.0 95.9 0.2 8.5 4.3 9.9 59.1 0.1 0.0 0.0 9.5 0.1 0.0 0.0 0.7 0.1 1.8 0.0 3.2 0.4 0.0 0.1 0.1 0.1 0.1 0.0 11.9 2.4 0.0 0.0 25.3 6.2 3.2 8.0 7.4 0.0 0.0 0.0 17.9 0.2 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.5 0.0 0.1 2.2 5.0 6.6 3.2 5.3 2.9 9.6 1.9 13.4 7.3 3.0 2.2 0.0 2.5 13.6 0.1 10.0 0.0 0.0 0.0 1.8 0.0 3.2 0.0 0.3 0.4 25.6 0.5 0.0 0.3 3.5 130.2 1.2 0.0 1.0 5.4 0.0 0.0 322.8 15.8 1.9 102.1 1.6 70.9 0.0 1.4 0.2 1.0 0.0 89.5 0.1 0.1 25.8 30.6 0.5 0.7 6.4 5.9 0.0 0.4 0.7 SRPX2 SRPUL ENSG00000102359 "Sushi repeat containing protein, X-linked 2" O60687 X 100644166-100675788 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.2;breast: 57.3" "Cell type enhanced" "Detected in many" 20 "Fibroblasts: 13.4;Leydig cells: 14.7;Urothelial cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 75.6;ASC TERT1: 32.3;HSkMC: 29.0;HUVEC TERT2: 20.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038786 Approved "Secreted to blood" NA NA "HPA038786: AB_10672724" "unprognostic (4.10e-2)" "unprognostic (4.55e-2)" "unprognostic (2.08e-1)" "unprognostic (3.72e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (3.59e-3)" "unprognostic (5.41e-2)" "unprognostic (3.22e-2)" "unprognostic (1.26e-1)" "unprognostic (2.86e-2)" "unprognostic (2.29e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.84e-3)" "unprognostic (1.69e-1)" "unprognostic (8.67e-2)" "unprognostic (3.85e-1)" 60.2 5.2 0.4 8.0 2.4 0.3 57.3 0.9 1.1 10.2 5.7 0.9 3.8 1.6 5.6 8.4 15.4 5.0 4.3 10.9 0.9 0.4 5.0 3.5 10.3 2.2 4.3 1.0 9.9 2.9 0.4 1.3 11.6 2.2 7.7 3.0 2.7 3.9 5.5 6.0 2.6 3.4 6.2 5.0 10.1 3.4 5.6 1.2 0.1 7.1 9.1 5.8 17.4 17.8 0.5 0.5 1.2 0.8 0.3 0.3 0.5 3.0 0.5 0.7 0.0 75.6 32.3 0.0 6.8 5.1 2.1 6.7 0.4 4.7 0.0 0.2 4.1 2.0 0.1 0.0 3.9 2.2 0.0 0.0 0.0 0.2 0.7 7.7 0.0 0.2 29.0 0.0 7.2 0.2 6.4 20.4 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.6 0.0 2.9 11.5 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 10.9 4.5 3.2 2.9 0.2 0.0 0.0 0.0 5.3 0.0 2.4 1.1 0.7 0.2 0.3 0.8 0.1 0.4 0.2 0.2 0.1 0.5 0.2 0.3 1.2 0.3 0.6 0.5 0.1 0.5 0.4 2.4 0.9 1.1 0.9 0.4 4.3 1.0 2.2 1.2 0.0 1.1 0.0 2.2 0.3 0.0 0.6 0.0 2.7 6.8 0.0 0.0 0.2 0.0 1.1 2.8 1.4 0.0 0.0 0.0 0.2 13.4 1.1 0.0 0.0 0.8 0.0 0.0 8.0 0.0 2.1 14.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 5.6 0.0 0.0 0.0 2.1 0.2 0.0 0.4 0.5 0.0 0.2 46.0 SRRM3 FLJ37078 ENSG00000177679 "Serine/arginine repetitive matrix 3" 7 76201900-76287288 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "brain: 43.2" "Group enriched" "Detected in many" 13 "Bipolar cells: 127.8;Cone photoreceptor cells: 451.6;Horizontal cells: 162.1;Rod photoreceptor cells: 475.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SCLC-21H: 14.4;SH-SY5Y: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019337 Approved "Plasma membrane,Intermediate filaments,Microtubules" NA NA "Plasma membrane" "Intermediate filaments, Microtubules" "HPA019337: AB_1848909" "unprognostic (1.65e-1)" "unprognostic (1.96e-1)" "unprognostic (8.37e-3)" "unprognostic (4.93e-2)" "unprognostic (1.81e-1)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (6.51e-2)" "unprognostic (1.89e-3)" "unprognostic (1.62e-2)" "unprognostic (5.07e-3)" "unprognostic (6.37e-2)" "unprognostic (3.73e-3)" "unprognostic (5.05e-1)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.15e-2)" 0.6 6.2 8.1 0.7 18.1 0.4 0.4 43.2 14.6 0.4 0.6 0.0 0.0 0.9 0.7 1.1 0.5 0.5 0.5 0.5 5.1 0.5 0.4 0.5 0.4 0.0 10.9 0.6 0.5 0.5 4.4 0.4 10.0 0.5 0.7 1.8 0.6 0.5 0.6 0.5 0.6 0.5 0.6 0.4 1.6 2.9 2.9 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.3 0.2 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 10.6 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 1.8 127.8 6.9 0.0 0.0 0.0 0.0 451.6 0.3 0.0 1.4 18.9 0.0 0.0 0.0 2.1 7.0 2.7 1.2 0.0 0.0 0.4 162.1 11.6 0.6 0.0 23.9 2.0 0.0 3.3 0.0 0.0 14.5 1.2 0.0 2.1 0.3 475.2 0.0 1.4 5.4 2.6 1.0 1.8 0.0 0.0 4.7 SRRM4 "KIAA1853, nSR100" ENSG00000139767 "Serine/arginine repetitive matrix 4" A7MD48 12 118981495-119163051 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 62.1" "Group enriched" "Detected in some" 14 "Bipolar cells: 330.0;Cone photoreceptor cells: 404.5;Rod photoreceptor cells: 360.9" "Cancer enriched" "Detected in single" 7 "glioma: 1.3" "Region enhanced" "Detected in many" "cerebellum: 62.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 6.7;SCLC-21H: 7.7;SH-SY5Y: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052783 Uncertain NA NA "HPA052783: AB_2681945" "unprognostic (2.44e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.11e-1)" "unprognostic (1.61e-5)" "unprognostic (1.10e-2)" "unprognostic (1.75e-1)" "unprognostic (5.70e-3)" "unprognostic (2.23e-1)" "unprognostic (6.88e-2)" "unprognostic (1.61e-1)" 0.8 3.6 11.0 0.9 11.6 1.0 0.8 62.1 21.5 0.8 0.8 0.4 0.0 0.9 1.1 1.0 0.8 0.8 0.8 2.0 6.6 4.7 1.1 0.8 1.0 0.8 2.0 18.2 0.8 0.7 0.9 1.4 0.9 3.8 0.9 0.9 5.9 0.8 1.1 1.4 0.9 0.9 0.9 1.3 0.8 1.3 1.4 0.8 0.0 0.9 0.0 0.8 0.7 0.3 0.0 0.1 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 6.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.0 0.0 11.0 11.6 62.1 20.5 6.6 4.7 2.0 18.2 3.8 0.8 6.0 0.0 0.0 0.0 0.0 330.0 7.6 0.0 0.0 1.2 0.0 404.5 0.6 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 27.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 360.9 6.5 0.8 0.0 1.3 0.0 1.9 0.0 0.0 0.0 SRRM5 ENSG00000226763 "Serine/arginine repetitive matrix 5" B3KS81 19 43596617-43614497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "testis: 47.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 182.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.2" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" HPA047399 Uncertain NA NA "HPA047399: AB_10963088" "unprognostic (3.95e-3)" "unprognostic (7.56e-3)" "unprognostic (6.72e-2)" "unprognostic (3.40e-2)" "unprognostic (1.38e-1)" "unprognostic (2.41e-2)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.89e-2)" "unprognostic (3.69e-2)" "unprognostic (2.16e-2)" "unprognostic (2.68e-5)" "unprognostic (2.44e-1)" "unprognostic (3.31e-1)" "unprognostic (2.07e-1)" "unprognostic (1.00e-3)" 1.9 2.6 2.9 2.5 4.1 2.2 2.0 6.8 4.3 1.8 1.9 3.1 2.0 2.2 2.0 2.1 2.1 1.9 2.4 1.8 2.5 2.1 2.2 5.5 1.8 3.4 3.2 3.6 2.1 2.5 2.0 2.8 1.8 3.5 3.0 1.8 1.5 2.2 2.0 2.1 3.0 3.1 1.7 2.6 2.1 2.4 47.6 2.6 2.6 2.6 1.1 1.7 1.9 2.0 0.0 0.0 0.0 0.4 0.0 1.2 0.1 3.6 3.2 1.3 2.3 1.2 0.9 0.9 0.9 0.3 0.3 0.5 2.0 1.6 1.3 2.0 0.3 1.1 2.3 1.2 0.3 0.6 1.6 1.4 1.3 2.9 1.6 0.5 0.9 1.8 1.1 1.3 0.2 0.3 1.2 0.3 1.8 1.0 3.2 0.2 3.1 1.4 1.6 0.5 2.7 0.9 2.3 0.9 1.0 0.8 4.7 2.4 1.0 0.5 1.4 1.1 1.6 2.7 0.7 1.8 3.4 2.0 1.3 1.9 3.8 2.6 1.4 2.0 1.1 1.6 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 2.9 4.1 6.8 4.3 2.5 2.1 3.2 3.6 3.5 2.6 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 182.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 44.7 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.5 0.3 0.1 0.0 0.0 0.1 SRSF12 "SFRS13B, SFRS19, SRrp35" ENSG00000154548 "Serine and arginine rich splicing factor 12" Q8WXF0 6 89095959-89118081 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.4" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 130.7;Late spermatids: 165.7;Spermatogonia: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.7;AN3-CA: 9.9;HAP1: 7.8;HEK 293: 7.9;REH: 7.7;SCLC-21H: 8.6;SH-SY5Y: 8.4;SuSa: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049782 Approved NA NA "HPA049782: AB_2680880" "unprognostic (6.18e-2)" "unprognostic (1.23e-1)" "unprognostic (7.66e-3)" "unprognostic (1.58e-4)" "unprognostic (4.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.11e-3)" "unprognostic (4.17e-2)" "unprognostic (9.53e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-4)" "unprognostic (2.83e-1)" "unprognostic (9.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.78e-2)" "unprognostic (2.04e-1)" "unprognostic (9.96e-3)" 1.5 1.5 6.2 1.7 8.8 1.2 1.5 5.5 9.0 2.0 0.9 1.0 1.1 0.7 2.2 1.8 1.0 1.7 2.3 0.9 7.5 6.3 1.5 0.8 0.8 1.0 3.1 4.5 3.2 1.8 3.2 4.5 1.1 5.7 2.6 0.8 1.6 1.0 2.0 0.7 1.2 0.7 2.3 2.2 0.8 1.4 21.4 2.5 0.0 3.0 0.0 0.9 1.2 0.8 1.4 0.8 1.6 0.6 2.9 1.1 0.2 0.0 0.9 9.7 9.9 0.0 0.0 0.1 0.1 0.1 0.5 1.0 0.3 0.1 0.0 0.9 0.0 0.3 0.0 7.8 0.2 1.0 0.1 7.9 0.0 0.1 0.6 1.1 0.0 0.0 0.1 0.4 0.2 0.5 0.0 0.0 0.7 0.1 0.2 0.2 0.1 0.0 0.3 2.2 0.0 0.2 7.7 0.5 0.1 4.9 0.0 8.6 8.4 0.2 0.1 1.4 6.1 0.1 2.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 1.1 0.6 0.4 1.1 0.4 0.8 0.6 0.8 0.6 0.2 1.4 1.1 0.7 1.6 2.9 0.3 0.8 0.5 0.2 6.2 8.8 5.5 8.9 7.5 6.3 3.1 4.5 5.7 2.5 0.0 0.6 0.0 3.1 0.9 9.0 2.0 0.0 0.0 0.0 0.0 7.9 0.7 1.7 4.5 130.7 0.7 0.0 0.0 2.7 0.4 2.1 4.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 165.7 3.1 0.2 3.3 10.8 0.0 4.5 4.1 0.0 2.5 2.7 1.1 6.5 1.9 33.2 47.5 0.5 0.2 0.0 0.0 1.6 SRY TDF ENSG00000184895 "Sex determining region Y" Q05066 Y 2786855-2787699 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Activator, Calmodulin-binding, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 2.5;lymphoid tissue: 7.2;skin 1: 3.7;testis: 5.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.8;NTERA-2: 1.5;RT4: 6.7" NA NA "unprognostic (1.34e-1)" "unprognostic (5.53e-4)" "unprognostic (1.61e-1)" 0.3 0.7 0.1 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.6 0.9 0.1 0.0 0.1 0.8 2.5 0.0 0.1 0.1 0.3 0.5 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.4 0.1 0.0 0.1 0.1 0.1 0.1 3.7 0.1 0.1 0.1 0.1 0.0 5.5 0.1 7.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.5 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSBP2 HSPC116 ENSG00000145687 "Single stranded DNA binding protein 2" P81877 5 81413021-81751797 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.9" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 139.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 38.3;MOLT-4: 35.5;REH: 53.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020834, HPA068605, HPA071780" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "CAB020834: , HPA068605: AB_2732116, HPA071780: " "unprognostic (4.62e-2)" "unprognostic (1.96e-3)" "unprognostic (1.12e-1)" "unprognostic (1.46e-2)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.78e-3)" "unprognostic (2.36e-3)" "unprognostic (6.01e-2)" "unprognostic (1.01e-2)" "unprognostic (3.04e-3)" "unprognostic (6.56e-2)" "unprognostic (9.81e-2)" "unprognostic (4.39e-3)" 18.9 11.5 16.3 11.1 24.3 11.0 20.0 49.8 21.3 26.5 18.8 13.6 11.1 5.2 27.0 27.2 21.3 26.4 14.2 26.3 16.1 22.8 10.3 3.2 11.3 15.4 19.9 16.2 33.1 8.7 42.4 31.0 11.7 20.9 16.1 11.7 20.0 14.6 19.5 16.3 19.6 10.3 26.1 20.6 8.9 13.6 6.9 21.5 89.9 12.8 11.7 19.9 19.0 18.5 16.2 8.1 26.2 12.2 25.6 15.2 7.9 1.0 1.9 24.2 13.7 14.0 21.3 1.5 5.0 4.6 4.7 4.9 0.0 2.0 16.7 0.3 5.9 2.3 0.1 6.6 2.7 4.6 7.1 2.8 3.5 4.1 0.0 7.9 1.7 9.3 21.8 23.5 0.8 4.5 10.2 2.0 38.3 2.2 8.2 5.0 2.3 35.5 2.8 3.3 0.0 1.0 53.5 5.5 12.7 2.4 0.9 12.6 11.4 5.3 5.9 1.8 10.2 8.7 4.9 1.3 1.8 3.0 3.5 1.3 8.7 6.7 28.0 6.2 3.1 1.2 20.7 8.6 26.2 2.4 7.6 3.8 9.9 7.7 4.3 8.1 16.2 15.2 5.3 12.5 25.6 12.2 2.6 3.4 7.9 16.3 24.3 49.8 21.3 16.1 22.8 19.9 16.2 20.9 21.5 8.9 18.1 15.4 39.3 31.0 60.9 38.4 7.6 29.4 33.0 27.9 25.5 5.9 14.9 10.5 5.4 19.6 2.3 0.0 8.8 2.8 30.8 11.9 24.3 1.6 16.4 39.7 14.5 18.4 15.4 3.4 35.1 18.7 33.7 5.4 4.7 139.7 6.3 10.2 45.6 4.1 43.9 51.8 68.0 6.3 20.3 31.7 6.2 14.4 3.5 26.4 SSC4D "S4D-SRCRB, SRCRB-S4D, SRCRB4D" ENSG00000146700 "Scavenger receptor cysteine rich family member with 4 domains" Q8WTU2 7 76389334-76409695 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "salivary gland: 9.3;seminal vesicle: 9.5;thyroid gland: 8.6" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 10.4;Distal tubular cells: 3.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.6" "Lineage enriched" "Detected in single" 5 "monocytes: 1.6" "Group enriched" "Detected in some" 12 "EFO-21: 5.9;Hep G2: 8.1;SuSa: 9.9;U-2 OS: 23.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA062611 Uncertain "Secreted - unknown location" NA NA "HPA062611: AB_2684807" "unprognostic (3.39e-2)" "unprognostic (1.78e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (2.83e-6)" "prognostic unfavorable (7.08e-4)" "unprognostic (3.52e-2)" "unprognostic (3.78e-2)" "unprognostic (2.28e-1)" "unprognostic (1.49e-2)" "unprognostic (8.49e-3)" "unprognostic (3.18e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (4.71e-4)" "unprognostic (2.59e-1)" "unprognostic (3.90e-1)" "unprognostic (2.56e-2)" "unprognostic (1.73e-2)" 1.1 0.5 0.1 0.1 0.1 0.0 0.4 0.0 0.2 1.0 0.2 0.3 3.0 0.2 0.3 0.8 0.0 0.4 0.1 0.0 0.2 0.2 7.7 0.7 0.2 0.1 0.2 0.8 2.3 4.4 7.8 7.2 0.7 0.4 0.1 0.0 0.8 9.3 9.5 0.4 0.0 0.0 0.2 0.7 0.3 0.1 0.3 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.3 0.1 0.0 1.6 0.0 0.2 0.1 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.8 0.0 0.2 0.0 0.7 0.1 0.0 0.0 0.1 0.9 0.4 0.0 0.0 9.9 0.1 0.0 0.0 0.0 23.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.6 0.1 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.2 0.2 0.8 0.4 0.0 0.0 0.3 0.0 0.4 0.0 0.2 1.5 0.0 0.0 0.0 10.4 0.0 0.2 3.3 1.7 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.3 0.0 2.1 2.7 1.6 0.0 1.3 1.2 0.0 0.9 0.8 0.0 0.0 0.0 2.0 0.4 0.0 0.4 1.0 0.1 0.0 0.0 0.5 3.0 0.0 0.2 0.0 0.0 0.3 SSFA2 "CS-1, KIAA1927, KRAP, SPAG13" ENSG00000138434 "Sperm specific antigen 2" P28290 2 181891833-181930738 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 85.5" "Cell type enhanced" "Detected in many" 4 "Suprabasal keratinocytes: 167.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034665, HPA039989" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA034665: AB_2674271, HPA039989: AB_2676788" "unprognostic (1.68e-1)" "unprognostic (3.27e-2)" "unprognostic (2.17e-2)" "unprognostic (4.70e-2)" "unprognostic (8.77e-2)" "unprognostic (8.87e-2)" "unprognostic (2.13e-1)" "unprognostic (4.74e-2)" "unprognostic (5.63e-2)" "unprognostic (1.23e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.95e-2)" "prognostic favorable (2.91e-5)" "unprognostic (3.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (5.79e-5)" 14.2 10.1 23.3 11.8 27.0 16.1 21.6 25.8 22.5 17.7 24.4 26.2 9.4 17.5 13.0 8.9 12.0 10.7 18.7 13.6 23.7 19.1 22.8 36.0 23.0 11.2 31.3 17.7 7.2 85.5 10.5 10.2 40.9 24.8 18.1 24.1 22.3 29.2 10.0 16.6 50.6 19.5 14.2 27.8 14.7 26.0 16.7 23.8 9.3 19.6 12.2 7.9 14.3 23.5 1.2 3.8 8.1 6.4 1.0 1.4 1.8 16.4 8.2 24.0 4.0 21.0 17.4 6.8 29.2 28.4 10.3 13.7 8.5 19.1 0.4 9.5 20.5 12.7 14.3 5.8 14.0 19.9 7.5 6.6 16.6 35.3 6.8 15.5 8.5 15.6 10.3 20.7 17.7 24.1 24.4 53.7 8.0 7.4 9.2 28.6 8.3 7.5 11.9 1.6 15.3 19.4 5.6 9.7 5.7 29.0 5.0 4.2 3.7 17.1 6.1 26.1 9.5 4.4 18.6 21.3 24.4 11.8 8.7 15.1 6.3 2.7 6.6 11.4 5.1 18.2 8.1 3.9 5.7 1.4 3.9 0.9 0.6 1.0 0.9 3.8 1.2 1.3 1.1 6.6 1.0 6.4 3.1 0.6 1.8 23.3 27.0 25.8 22.5 23.7 19.1 31.3 17.7 24.8 23.8 134.0 40.6 11.2 36.2 97.1 18.5 23.0 35.7 33.5 35.2 31.4 35.3 19.9 14.9 15.8 9.0 52.6 132.6 0.0 62.2 21.0 25.9 46.7 22.0 89.3 18.4 25.4 105.7 36.8 47.5 13.4 17.5 29.8 55.6 15.4 57.0 17.2 54.1 41.9 16.3 36.3 33.6 38.8 24.5 22.3 25.4 167.2 27.9 12.9 39.3 84.6 SSH2 KIAA1725 ENSG00000141298 "Slingshot protein phosphatase 2" Q76I76 17 29625938-29930276 "Enzymes, Predicted intracellular proteins" "Actin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.6" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 119.4;Late spermatids: 117.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 37.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 37.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017189, HPA057099" Uncertain NA NA "CAB017189: , HPA057099: AB_2683336" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.44e-1)" "unprognostic (1.53e-1)" "unprognostic (3.00e-3)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (6.80e-2)" "unprognostic (9.80e-3)" "unprognostic (7.52e-2)" "unprognostic (1.48e-2)" "unprognostic (8.28e-2)" "unprognostic (7.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.86e-1)" 12.3 7.7 15.8 19.0 16.0 43.1 7.9 23.9 18.0 6.8 10.6 17.5 8.8 7.4 6.1 8.5 9.4 6.5 7.9 12.0 12.9 8.4 10.8 9.8 15.1 20.9 13.6 12.4 3.7 11.8 6.4 6.5 8.8 10.6 5.1 10.0 7.9 8.6 11.6 59.6 10.5 14.5 6.9 12.6 21.3 10.3 26.1 15.2 22.7 10.7 9.5 19.9 7.8 6.5 7.9 4.0 37.8 4.5 1.4 5.9 1.8 12.0 9.8 6.3 5.4 17.4 11.9 3.7 6.0 6.8 9.9 10.5 5.3 4.5 10.0 9.6 7.1 6.6 14.0 7.7 8.7 11.5 3.5 13.7 6.9 10.0 7.7 8.2 7.4 15.0 14.0 5.8 10.5 7.0 4.9 22.6 17.8 4.9 7.8 6.9 3.4 34.8 7.5 4.7 4.6 5.1 16.7 15.9 17.5 17.1 9.4 10.6 11.8 8.7 9.7 17.3 8.9 6.4 7.8 12.4 6.7 13.8 11.8 7.2 11.9 7.8 25.0 8.0 5.9 6.2 11.0 3.8 37.8 3.5 4.5 2.9 7.5 4.4 3.5 4.0 7.9 4.1 3.0 9.6 1.4 3.8 2.6 5.9 1.8 15.8 16.0 23.9 18.0 12.9 8.4 13.6 12.4 10.6 15.2 8.9 36.3 54.0 11.9 35.1 12.4 22.6 10.2 12.0 13.6 15.7 25.5 18.7 21.6 14.9 77.6 21.9 36.6 0.0 30.8 18.1 14.6 14.0 11.6 24.1 20.1 19.1 34.0 22.1 119.4 117.3 11.2 43.4 33.7 19.0 31.7 6.8 31.7 27.4 7.8 39.3 20.1 6.5 14.4 41.9 16.4 31.7 15.2 40.3 22.3 20.4 SSMEM1 "C7orf45, FLJ40316" ENSG00000165120 "Serine rich single-pass membrane protein 1" Q8WWF3 7 130207860-130216843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 31.7" "Cell type enriched" "Detected in some" 13 "Early spermatids: 346.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 1.7;U-87 MG: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.08e-1)" "unprognostic (1.79e-1)" "unprognostic (5.24e-1)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.3 0.2 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.4 0.8 0.9 0.1 0.2 0.2 0.3 0.2 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 346.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 9.3 2.7 0.0 0.0 0.0 0.0 0.0 SSPO "FLJ36112, KIAA0543, SCO-spondin" ENSG00000197558 SCO-spondin 7 149776042-149833979 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7;salivary gland: 1.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 24.9;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9;Muller glia cells: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;hTERT-RPE1: 1.4;RPMI-8226: 2.7" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 13 "midbrain: 44.5" "Secreted in brain" NA NA "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.95e-4)" "unprognostic (5.81e-3)" "unprognostic (3.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.41e-3)" "unprognostic (9.17e-2)" "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.59e-5)" "unprognostic (1.04e-1)" "unprognostic (2.65e-10)" "unprognostic (1.19e-1)" "unprognostic (2.94e-1)" "unprognostic (8.15e-3)" "unprognostic (2.46e-2)" 0.6 0.0 0.3 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 1.7 0.1 0.1 0.3 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.7 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.5 0.7 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 2.7 0.1 0.0 0.4 0.5 0.0 0.1 0.0 0.0 1.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.9 3.1 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 15.9 0.0 0.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 SSR4 TRAPD ENSG00000180879 "Signal sequence receptor subunit 4" P51571 X 153793516-153798505 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 699.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045209 Enhanced Supported "Endoplasmic reticulum" NA NA 600000 "Endoplasmic reticulum" "HPA045209: AB_10961407" "unprognostic (3.56e-2)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" "prognostic favorable (1.76e-4)" "unprognostic (8.74e-2)" "unprognostic (5.57e-2)" "unprognostic (7.99e-2)" "unprognostic (4.58e-2)" "unprognostic (2.10e-1)" "unprognostic (5.04e-3)" "unprognostic (5.74e-3)" "unprognostic (8.76e-2)" "prognostic unfavorable (5.51e-6)" "unprognostic (8.18e-2)" "unprognostic (2.24e-1)" "unprognostic (6.01e-2)" "unprognostic (5.33e-2)" 17.4 30.0 13.2 29.5 22.6 37.5 46.0 12.2 20.6 30.4 31.7 9.0 152.0 30.7 19.1 81.4 21.4 18.3 30.2 40.7 23.0 17.7 21.8 48.0 42.1 136.9 14.5 11.6 18.4 699.0 7.2 67.7 30.3 26.0 24.0 24.0 11.7 83.7 192.6 12.1 16.9 24.1 19.5 26.3 37.9 43.6 19.6 8.2 15.3 22.6 21.0 29.4 27.7 20.0 67.1 171.0 50.7 58.6 62.0 78.7 108.1 34.3 44.2 15.0 84.3 81.0 43.1 31.4 29.4 43.6 30.6 41.8 54.9 30.5 49.0 77.9 44.5 27.6 34.1 26.1 27.3 11.2 19.9 22.4 13.8 41.5 43.1 70.1 37.9 36.8 53.7 38.0 26.3 35.9 27.0 32.8 24.5 15.1 104.1 23.7 61.5 21.5 56.5 9.1 93.4 72.1 24.3 19.5 90.7 38.6 41.0 29.3 24.2 17.5 30.2 31.8 17.1 19.5 81.8 27.2 18.0 20.0 34.7 38.1 154.6 75.5 57.4 38.3 64.8 30.1 50.7 58.6 26.1 63.6 44.4 78.7 67.1 65.5 62.9 58.5 56.6 57.0 58.4 9.3 62.0 35.5 171.0 47.9 108.1 13.2 22.6 12.2 20.6 23.0 17.7 14.5 11.6 26.0 8.2 154.9 288.1 268.7 274.5 228.5 46.7 258.0 412.7 216.8 227.5 301.8 53.0 273.1 142.6 480.5 402.2 256.1 483.1 163.5 550.9 548.3 330.2 594.2 342.0 631.0 408.8 33.4 718.3 247.4 326.6 1155.6 311.8 347.4 1354.7 339.0 538.4 117.5 526.9 501.2 232.3 335.7 57.8 116.4 210.1 119.2 239.9 281.7 472.2 373.9 490.6 402.8 SST SMST ENSG00000157005 Somatostatin P61278 3 187668906-187670399 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4" "Cell type enriched" "Detected in some" 213 "Intestinal endocrine cells: 1353.8" "Group enriched" "Detected in many" 7 "ovarian cancer: 249.9;pancreatic cancer: 1039.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 15.6;U-2 OS: 29.0;U-251 MG: 4.8;U-698: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000075, HPA019472, CAB034105" Enhanced Supported "Secreted to blood" NA NA "CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360" "unprognostic (2.44e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.12e-3)" "unprognostic (1.54e-2)" "unprognostic (4.69e-1)" "unprognostic (3.31e-2)" "unprognostic (8.16e-3)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (8.47e-2)" "unprognostic (4.19e-1)" "unprognostic (3.27e-1)" "unprognostic (1.45e-1)" 2.0 13.0 28.6 1.9 53.8 1.7 0.7 0.1 47.9 0.7 45.1 1.8 21.9 105.2 0.9 0.7 1.1 0.7 1.0 0.9 17.5 102.8 2.5 0.7 0.7 1.0 6.2 15.4 0.8 105.6 0.7 1.5 0.7 16.1 1.5 7.4 0.4 0.7 7.5 0.7 3.1 36.1 1.4 18.4 0.7 90.4 0.7 8.6 0.0 0.9 0.0 0.7 4.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 29.0 0.3 4.8 0.0 1.7 6.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.6 53.8 0.1 47.9 17.5 102.8 6.2 15.4 16.1 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1353.8 0.0 0.0 0.0 0.0 0.0 0.0 6.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 SSTR1 ENSG00000139874 "Somatostatin receptor 1" P30872 14 38207999-38213067 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.0;intestine: 14.3;stomach 1: 22.8" "Group enriched" "Detected in some" 5 "Cholangiocytes: 5.1;Enterocytes: 9.0;Hepatocytes: 6.4;Intestinal endocrine cells: 17.4;Ito cells: 9.8;Mucus-secreting cells: 8.0;Paneth cells: 8.7;Undifferentiated cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 47.9;BJ hTERT+: 13.3;BJ hTERT+ SV40 Large T+: 8.8;fHDF/TERT166: 28.3;HeLa: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003207, HPA031506" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA003207: , HPA031506: AB_2673913" "unprognostic (1.40e-1)" "unprognostic (1.37e-1)" "unprognostic (3.36e-1)" "unprognostic (2.50e-3)" "unprognostic (4.34e-2)" "unprognostic (9.90e-2)" "unprognostic (3.66e-3)" "unprognostic (1.91e-1)" "unprognostic (6.16e-3)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (9.19e-2)" "prognostic favorable (4.28e-4)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" "unprognostic (3.28e-2)" 0.7 0.4 6.8 0.6 6.9 0.0 0.6 0.5 15.0 0.9 3.7 0.6 0.1 14.3 1.0 0.6 0.4 0.7 0.5 0.8 4.3 10.4 2.2 6.7 5.5 0.1 6.8 4.0 0.6 3.8 0.1 1.4 2.8 2.8 1.2 2.5 0.2 0.2 0.5 0.7 0.4 8.2 0.6 1.3 0.7 22.8 0.1 0.7 0.1 0.3 0.1 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 47.9 13.3 8.8 0.7 0.5 0.0 0.0 0.0 28.3 0.0 0.1 0.0 0.0 6.4 0.0 0.0 0.0 10.9 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 1.9 0.0 1.4 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.9 0.5 15.0 4.3 10.4 6.8 4.0 2.8 0.7 0.0 0.0 0.0 0.0 0.2 0.6 0.6 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.8 9.0 0.0 0.7 0.0 0.6 0.1 0.0 6.4 0.0 0.0 17.4 9.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.3 8.7 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 6.0 0.0 SSTR2 ENSG00000180616 "Somatostatin receptor 2" P30874 17 73165012-73176633 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.6" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 49.1;Intestinal endocrine cells: 34.5;Sertoli cells: 32.3;Smooth muscle cells: 97.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 17.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007264 Uncertain Supported Cytosol NA NA Cytosol "HPA007264: AB_1080053" "unprognostic (2.13e-3)" "unprognostic (2.61e-3)" "unprognostic (7.43e-2)" "unprognostic (9.37e-3)" "unprognostic (6.25e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-3)" "unprognostic (7.46e-2)" "unprognostic (2.96e-1)" "unprognostic (6.55e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.04e-7)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (3.71e-3)" "unprognostic (2.95e-2)" 4.5 7.4 6.1 2.3 15.8 2.5 4.2 23.1 26.6 1.4 2.2 0.5 0.6 3.3 1.9 4.1 1.5 2.3 1.8 2.2 9.3 5.3 13.6 3.3 1.4 2.7 2.6 13.1 1.5 2.0 1.4 5.7 1.0 4.9 2.8 2.7 1.1 1.8 3.6 1.7 1.9 2.5 2.2 3.3 8.3 7.2 1.4 1.9 0.3 2.3 0.0 2.9 2.0 1.9 1.4 1.0 4.7 0.9 0.9 1.0 0.3 0.3 0.5 0.6 1.2 0.2 0.2 0.7 0.2 0.3 0.5 0.5 0.5 0.5 0.7 0.3 0.1 1.4 0.5 0.1 0.1 0.2 0.6 1.0 0.6 1.1 0.5 0.1 0.4 2.3 0.2 0.1 0.2 0.1 0.3 0.0 0.7 0.7 1.2 0.2 0.6 0.4 1.3 1.6 0.2 0.6 0.7 0.9 0.4 0.4 0.6 17.2 1.5 0.3 0.3 0.2 1.0 2.2 0.3 0.3 0.4 2.2 0.6 0.3 0.8 0.4 1.6 0.3 1.8 0.4 3.8 0.9 1.2 1.0 0.7 0.8 0.8 0.8 0.8 0.3 1.4 0.8 0.9 4.7 0.9 0.8 1.0 0.5 0.3 6.1 15.8 23.1 22.1 9.3 5.3 2.6 13.1 4.9 1.9 6.0 2.4 0.0 3.0 1.0 49.1 2.6 0.0 1.4 2.3 1.8 3.9 0.4 0.0 0.0 7.0 4.0 0.0 0.0 0.0 0.3 2.2 3.0 2.3 0.8 1.1 6.4 34.5 3.7 1.0 3.0 0.9 2.6 5.0 1.8 7.2 1.7 0.6 0.0 0.7 17.4 3.9 32.3 97.1 0.7 1.9 1.0 0.8 1.5 0.4 3.1 SSTR3 ENSG00000278195 "Somatostatin receptor 3" P32745 22 37204238-37212322 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.1;lymphoid tissue: 29.6;testis: 11.3" "Cell type enriched" "Detected in single" 5 "Late spermatids: 1.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.9" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.9;naive CD8 T-cell: 3.0" "Lineage enriched" "Detected in single" 10 "T-cells: 3.9" "Group enriched" "Detected in some" 11 "RPMI-8226: 22.3;SCLC-21H: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022647 Approved NA NA "CAB022647: " "unprognostic (1.63e-2)" "unprognostic (5.58e-3)" "unprognostic (1.32e-2)" "unprognostic (3.18e-2)" "unprognostic (7.03e-2)" "unprognostic (6.26e-5)" "unprognostic (1.11e-1)" "unprognostic (1.72e-2)" "unprognostic (1.90e-2)" "unprognostic (8.95e-2)" "unprognostic (3.88e-3)" "unprognostic (2.93e-1)" "unprognostic (1.51e-7)" "unprognostic (1.55e-1)" "unprognostic (1.24e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-2)" 0.1 0.8 2.8 1.9 1.9 0.9 0.1 2.7 11.1 0.0 0.5 0.2 0.0 2.6 1.9 0.2 0.1 0.1 0.1 0.0 5.6 0.1 0.0 0.1 3.5 0.0 7.9 5.8 3.9 0.0 6.4 0.0 7.9 0.2 0.6 0.0 0.6 0.1 0.0 0.0 1.0 2.2 4.3 1.2 0.5 11.3 0.1 29.6 0.0 0.0 2.0 0.3 0.0 0.3 0.1 0.1 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 8.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.3 3.9 3.0 0.1 0.0 0.0 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 SSTR4 ENSG00000132671 "Somatostatin receptor 4" P31391 20 23035386-23036812 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Low region specificity" "Detected in many" HPA064252 Uncertain NA NA "HPA064252: AB_2685227" 0.0 0.0 1.7 0.0 1.1 0.0 0.0 3.0 3.8 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSTR5 ENSG00000162009 "Somatostatin receptor 5" P35346 16 1078781-1080142 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Hep G2: 9.4;PC-3: 35.0" "Group enriched" "Detected in some" 5 "basal ganglia: 4.2;hypothalamus: 2.7" "Low region specificity" "Detected in all" HPA066503 Supported "Plasma membrane" NA NA "Plasma membrane" "HPA066503: AB_2685679" "unprognostic (2.16e-2)" "unprognostic (7.31e-2)" "unprognostic (3.69e-2)" "unprognostic (2.39e-2)" "unprognostic (2.14e-1)" "unprognostic (9.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.72e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (4.09e-2)" 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.4 0.0 0.7 0.6 0.9 0.5 0.0 8.2 2.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 9.0 0.0 0.0 1.1 0.0 0.0 1.1 0.9 0.1 0.1 0.8 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 5.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 35.0 0.0 1.3 0.3 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P3 ENSG00000284546 "SSU72 pseudogene 3" 11 4329865-4330449 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEK 293: 2.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P4 ENSG00000283873 "SSU72 pseudogene 4" 11 4287499-4288083 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 24 "intestine: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 16 "U-2 OS: 1.5" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P5 ENSG00000284018 "SSU72 pseudogene 5" 11 4233288-4233872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "HEK 293: 4.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSU72P8 ENSG00000230268 "SSU72 pseudogene 8" 7 124476371-124476955 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 39 "testis: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.8;HeLa: 1.2;U-2 OS: 1.1" NA NA "unprognostic (2.29e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSUH2 "C3orf32, fls485, ssu-2" ENSG00000125046 "Ssu-2 homolog (C. elegans)" Q9Y2M2 3 8619400-8745040 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 45.1" "Group enriched" "Detected in some" 8 "Early spermatids: 51.3;Late spermatids: 35.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "Hep G2: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA049777 Approved NA NA "HPA049777: AB_2680876" "unprognostic (2.49e-1)" "unprognostic (7.62e-2)" "unprognostic (9.65e-2)" "unprognostic (1.68e-1)" "unprognostic (2.46e-1)" "unprognostic (8.86e-2)" "unprognostic (1.46e-3)" "unprognostic (9.79e-2)" "unprognostic (1.53e-1)" "unprognostic (4.09e-1)" "unprognostic (7.97e-3)" "unprognostic (1.52e-1)" "unprognostic (3.15e-3)" "unprognostic (1.31e-1)" "unprognostic (3.65e-2)" "unprognostic (4.96e-2)" "unprognostic (7.50e-2)" 0.7 0.3 0.3 0.4 0.6 0.0 0.6 0.3 0.4 0.7 37.3 0.3 0.2 8.5 1.0 0.2 0.3 0.7 1.4 2.8 0.3 0.3 1.1 0.5 0.2 0.2 0.2 0.3 0.3 0.2 0.0 0.3 0.5 0.5 0.4 0.3 0.3 1.7 0.2 0.3 0.2 45.1 0.8 0.2 2.0 0.4 5.6 0.2 0.2 1.1 1.5 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 24.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.3 0.4 0.3 0.3 0.2 0.3 0.5 0.2 0.0 0.0 0.0 0.1 0.2 0.0 1.7 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 51.3 0.6 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 1.1 0.0 1.7 0.0 0.9 0.0 0.1 0.3 0.4 0.3 0.0 0.0 0.9 0.6 0.9 0.1 0.0 0.0 0.4 0.0 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255317-48267444 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 12.6" "Group enriched" "Detected in some" 12 "Sertoli cells: 6.5;Spermatocytes: 9.8;Spermatogonia: 22.6" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 28.8;Karpas-707: 41.8;U-2197: 9.7" HPA045683 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.9 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.7 0.0 0.0 2.0 0.0 2.4 0.0 0.0 0.9 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 9.8 22.6 0.0 0.0 0.0 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 57 "testis: 24.1" "Cell type enriched" "Detected in single" 28 "Spermatogonia: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 3.2;U-2197: 1.9" "HPA045683, CAB046020" Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "CAB046020: AB_2194010, HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.6 0.1 0.6 1.9 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "testis: 13.5" "Cell type enriched" "Detected in single" 10 "Spermatogonia: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;HMC-1: 5.4;PC-3: 5.2;T-47d: 2.3;U-2197: 3.3" HPA045683 Supported Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.6 0.5 0.1 0.0 0.0 0.2 0.0 5.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 2.3 0.0 1.0 0.0 0.5 3.3 0.0 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.0 0.0 SSX2IP hMsd1 ENSG00000117155 "SSX family member 2 interacting protein" Q9Y2D8 1 84643707-84690803 "Predicted intracellular proteins" "Cell adhesion, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.4" "Cell type enhanced" "Detected in many" 16 "Cone photoreceptor cells: 245.4;Early spermatids: 718.3;Late spermatids: 850.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075946 Supported Approved "Cell Junctions" NA NA "Cell Junctions" "HPA075946: " "unprognostic (5.18e-3)" "unprognostic (2.13e-1)" "prognostic favorable (1.45e-4)" "unprognostic (2.83e-2)" "unprognostic (2.75e-1)" "unprognostic (3.29e-2)" "unprognostic (1.28e-3)" "unprognostic (7.73e-2)" "unprognostic (2.38e-1)" "unprognostic (3.37e-2)" "unprognostic (9.49e-2)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (7.23e-3)" "unprognostic (2.08e-2)" "unprognostic (2.45e-2)" "unprognostic (3.46e-2)" 1.8 2.0 10.6 2.8 25.2 6.5 2.7 17.7 25.7 3.9 7.9 1.6 3.0 22.2 5.1 12.4 3.8 3.8 4.6 4.9 9.8 5.0 9.0 7.5 2.2 3.1 3.8 12.4 1.6 3.7 5.6 10.2 3.2 6.9 7.0 4.2 5.2 3.8 6.6 3.1 3.3 13.3 5.6 3.1 2.7 3.7 51.4 5.1 4.8 4.4 1.7 3.2 3.1 3.0 1.5 5.8 4.8 3.2 5.4 11.0 5.0 16.2 8.1 6.5 11.9 2.2 7.0 8.0 27.9 14.3 12.3 10.0 5.7 3.6 16.1 4.9 23.5 15.9 9.1 11.5 9.0 17.4 3.2 9.7 15.2 9.8 4.9 4.6 13.2 1.2 3.0 14.8 13.9 8.8 8.3 4.1 6.2 31.3 6.1 7.8 6.2 9.2 5.2 9.6 3.1 12.7 6.2 28.6 7.1 12.9 9.4 12.8 16.0 7.8 12.8 14.0 4.3 7.4 6.9 1.2 11.8 17.3 16.0 27.5 6.4 7.5 17.6 9.8 11.9 7.2 1.1 1.1 4.8 11.0 2.4 6.2 1.4 3.7 4.5 4.4 1.5 4.6 6.9 1.5 5.4 3.2 5.8 2.0 5.0 10.6 25.2 17.7 25.7 9.8 5.0 3.8 12.4 6.9 5.1 3.0 4.0 3.7 6.9 9.3 28.4 19.4 17.8 17.4 10.3 10.4 245.4 3.2 6.6 5.7 718.3 3.6 10.2 46.7 10.4 1.7 6.6 5.7 4.6 12.5 2.3 19.1 8.1 3.7 1.3 850.2 14.7 4.7 5.0 2.8 7.3 174.8 7.0 3.5 10.6 33.8 147.0 0.0 4.1 42.7 52.8 8.5 0.5 5.3 7.4 2.5 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346428-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.0" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 144.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "Karpas-707: 6.9" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 1.6 0.2 0.4 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.0 1.6 0.5 0.2 0.2 0.0 0.0 1.6 0.2 0.8 0.3 0.1 0.2 0.8 0.3 0.4 0.0 0.9 0.4 0.4 0.2 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.7 144.8 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 3.6;Karpas-707: 8.8;U-266/70: 5.2;U-266/84: 9.5" HPA045683 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 6.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.8 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 5.2 9.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX5 ENSG00000165583 "SSX family member 5" O60225 X 48186220-48196763 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 4.3;thyroid gland: 2.9" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BEWO: 10.8" HPA045683 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418" "unprognostic (1.20e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" 0.4 0.0 0.1 0.1 0.4 1.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 0.0 0.5 0.2 0.1 0.8 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.1 1.6 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.6 0.2 0.1 0.1 0.8 0.0 4.3 0.1 0.1 2.9 0.1 0.1 0.1 0.1 0.5 0.2 0.9 0.2 0.6 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.7 1.3 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.4 0.3 0.4 0.1 0.5 0.1 0.4 0.9 0.6 0.0 0.2 0.2 0.0 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 ST14 "HAI, MT-SP1, PRSS14, SNC19, TMPRSS14" ENSG00000149418 "Suppression of tumorigenicity 14" Q9Y5Y6 11 130159562-130210376 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 94.1" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 295.9;Mucus-secreting cells: 176.7;Paneth cells: 178.5;Urothelial cells: 230.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 18.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 18.2" "Cell line enhanced" "Detected in some" "CACO-2: 36.0;CAPAN-2: 72.5;HaCaT: 50.8;OE19: 38.5;RPMI-8226: 47.5;SK-BR-3: 33.6;T-47d: 50.8;U-698: 34.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA047014 Approved Nucleoplasm,Vesicles NA NA 220000 "Nucleoplasm, Vesicles" "HPA047014: AB_2679902" "unprognostic (1.17e-1)" "unprognostic (1.15e-1)" "unprognostic (9.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.20e-1)" "unprognostic (3.97e-2)" "unprognostic (5.29e-1)" "unprognostic (3.21e-1)" "unprognostic (1.03e-3)" "unprognostic (2.25e-1)" "prognostic favorable (5.03e-11)" "unprognostic (1.92e-2)" "unprognostic (2.71e-1)" "unprognostic (1.28e-2)" "unprognostic (5.60e-2)" 10.1 1.8 0.7 21.9 1.8 0.5 5.5 0.8 1.4 8.9 48.6 0.5 23.8 33.8 2.8 16.9 38.9 9.7 32.4 1.1 0.5 0.5 30.5 3.2 9.5 7.5 1.8 0.6 3.6 34.3 8.4 9.5 12.7 1.5 12.1 15.4 0.7 25.1 15.8 0.7 17.8 94.1 1.2 1.8 4.0 16.7 2.1 1.5 5.2 24.0 20.1 28.4 8.3 14.9 3.8 18.2 2.3 2.7 0.0 0.1 0.8 26.4 0.0 0.0 0.1 0.0 0.0 14.4 0.0 0.0 0.0 0.0 36.0 72.5 26.1 2.7 0.0 0.0 50.8 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.1 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.1 0.2 38.5 0.1 0.0 0.0 47.5 4.7 21.7 2.9 0.0 0.2 33.6 0.0 0.2 50.8 5.1 0.0 0.0 0.4 0.1 0.1 0.0 0.0 34.6 0.0 8.0 0.0 0.0 2.7 2.3 0.0 1.5 0.1 3.8 0.0 0.0 4.5 2.3 0.0 0.0 0.3 0.0 0.2 18.2 0.0 0.8 0.7 1.8 0.8 1.4 0.5 0.5 1.8 0.6 1.5 1.5 29.8 25.8 9.3 31.0 36.4 0.0 0.8 38.2 17.4 20.5 59.3 0.0 40.3 3.3 108.8 27.9 0.4 295.9 0.0 80.1 11.6 2.6 89.5 11.5 1.9 60.1 0.0 118.5 0.0 25.4 11.5 1.7 19.0 6.8 8.2 176.7 0.0 114.4 178.5 0.7 10.5 0.0 6.5 1.4 0.2 0.1 38.3 33.2 1.3 155.8 230.3 ST18 "KIAA0535, NZF3, ZC2H2C3, ZC2HC10, ZNF387" ENSG00000147488 "ST18, C2H2C-type zinc finger" O60284 8 52110839-52460959 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 47.8" "Group enriched" "Detected in some" 6 "Bipolar cells: 109.9;Intestinal endocrine cells: 47.6" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.7" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.7" "Cell line enhanced" "Detected in some" "HAP1: 4.1;SCLC-21H: 14.6;U-87 MG: 2.4" "Region enhanced" "Detected in many" "cerebellum: 45.1" "Low region specificity" "Detected in all" HPA044919 Uncertain NA NA "HPA044919: AB_10959756" "unprognostic (3.66e-1)" "unprognostic (4.34e-2)" "unprognostic (7.47e-2)" "unprognostic (2.04e-2)" "unprognostic (2.78e-1)" "unprognostic (2.42e-2)" "unprognostic (1.22e-1)" "unprognostic (7.11e-2)" "unprognostic (2.12e-1)" "unprognostic (1.58e-1)" "unprognostic (1.55e-3)" "unprognostic (2.82e-1)" "unprognostic (2.53e-5)" "unprognostic (3.29e-1)" "unprognostic (1.35e-1)" "unprognostic (9.34e-2)" "unprognostic (9.84e-3)" 1.0 3.4 7.6 1.2 40.5 1.0 0.9 27.8 20.8 1.1 1.4 31.1 0.0 2.3 0.9 0.9 1.0 0.9 1.4 0.9 11.0 5.8 1.9 1.0 1.2 1.0 47.8 8.8 0.9 6.1 0.9 3.1 1.2 23.8 1.3 1.8 0.0 0.9 0.9 0.9 0.9 2.2 0.9 38.0 1.0 5.2 1.7 41.6 0.0 1.0 0.0 1.2 1.1 0.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 40.5 27.8 19.7 11.0 5.8 47.8 8.8 23.8 41.6 0.0 0.0 0.0 0.0 0.1 109.9 0.8 7.6 0.0 0.0 0.0 13.7 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 1.4 1.6 47.6 0.0 1.5 1.0 0.0 2.9 0.0 1.0 0.0 1.6 0.5 0.0 0.0 0.1 4.0 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 ST20 HCCS-1 ENSG00000180953 "Suppressor of tumorigenicity 20" Q9HBF5 15 79898840-79923702 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 69.3" "Cell type enhanced" "Detected in many" 10 "monocytes: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "eosinophil: 18.6;neutrophil: 69.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 69.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 28.7" NA NA "unprognostic (2.48e-1)" "unprognostic (1.28e-1)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (2.04e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (1.35e-3)" "unprognostic (4.21e-2)" "unprognostic (3.03e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (7.69e-8)" "unprognostic (6.49e-2)" "unprognostic (2.61e-2)" "unprognostic (9.88e-2)" "unprognostic (4.19e-2)" 7.5 5.4 9.9 15.0 10.7 7.9 8.6 15.4 8.0 5.5 8.2 6.4 4.5 4.0 6.5 16.3 6.0 8.3 10.3 9.3 8.8 8.2 12.3 23.1 12.7 13.1 10.8 5.3 7.1 6.2 9.2 12.7 7.7 10.1 13.3 5.4 8.6 11.5 8.4 5.6 12.6 9.8 5.4 10.7 22.9 5.5 10.8 6.1 9.0 12.2 5.7 10.5 5.5 10.1 4.0 3.0 69.3 5.3 3.9 2.1 2.6 4.8 10.4 4.4 5.5 7.6 6.4 10.0 5.0 3.3 2.6 3.3 2.2 7.9 6.1 3.3 3.6 8.6 8.3 9.2 2.8 1.9 8.6 8.6 6.9 7.1 3.4 7.2 2.5 3.9 7.2 3.9 1.8 5.4 7.3 2.8 11.1 5.9 3.6 4.0 15.8 3.5 17.9 10.4 14.9 6.9 5.1 1.4 3.8 6.6 4.0 6.6 7.2 9.8 6.1 28.7 12.0 5.1 16.5 3.6 6.7 1.8 0.0 4.1 4.1 20.0 9.2 5.2 14.3 3.4 0.5 3.9 18.6 1.9 2.2 1.5 4.0 2.1 2.1 3.0 3.8 2.1 1.9 69.3 3.9 5.3 1.8 1.8 2.6 9.9 10.7 15.4 8.0 8.8 8.2 10.8 5.3 10.1 6.1 6.0 17.0 5.4 6.4 4.2 7.1 10.4 2.5 6.7 5.7 14.0 7.9 10.0 19.9 15.2 10.0 3.8 9.6 0.0 10.4 9.3 6.1 9.1 6.9 35.0 35.3 1.6 18.6 6.2 11.2 3.6 6.6 12.0 5.0 137.1 10.6 7.7 12.5 17.3 4.6 32.7 4.4 6.5 3.8 19.4 20.6 3.8 36.0 6.4 10.0 3.9 ST20-MTHFS ENSG00000259332 "ST20-MTHFS readthrough" 15 79845150-79923754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 52.3" "Group enriched" "Detected in some" 5 "Club cells: 2.3;Collecting duct cells: 1.8;Hepatocytes: 1.0;Syncytiotrophoblasts: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 52.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 52.3" "Low cell line specificity" "Detected in many" HPA008067 Uncertain NA NA "HPA008067: AB_1078882" "unprognostic (9.84e-2)" "unprognostic (1.74e-2)" "unprognostic (2.06e-2)" "unprognostic (4.41e-2)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "unprognostic (3.75e-3)" "unprognostic (6.63e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-4)" "unprognostic (2.38e-1)" "unprognostic (5.26e-2)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (2.04e-1)" 5.4 7.7 9.2 12.1 8.4 9.1 5.4 12.5 7.2 5.9 6.4 4.9 3.3 5.0 6.3 7.3 4.4 7.2 8.1 7.2 7.4 8.3 14.1 18.8 10.3 7.6 8.6 4.1 5.1 4.1 11.5 10.2 6.3 7.9 9.8 5.4 6.6 7.8 6.5 4.8 4.0 8.3 4.5 8.4 9.3 8.8 8.3 4.7 7.0 9.6 4.3 7.4 6.7 7.8 5.8 3.9 52.3 9.2 7.3 5.0 4.6 4.4 10.5 4.2 4.5 13.0 6.0 9.9 6.2 6.4 6.2 6.6 4.9 8.2 7.6 3.7 3.4 7.5 9.5 11.2 5.2 5.3 9.2 11.4 8.1 9.1 4.3 5.9 5.0 3.4 7.1 0.9 2.1 11.2 6.1 2.1 9.8 9.5 3.9 2.8 9.3 3.5 7.7 6.1 11.2 7.1 9.5 2.4 3.2 2.5 4.8 10.8 8.6 10.6 5.6 14.6 11.4 6.7 7.4 5.9 5.4 6.5 0.2 5.3 5.9 15.3 6.6 3.8 17.3 5.6 8.2 6.2 17.4 3.2 4.7 3.3 4.5 3.7 3.4 3.9 5.8 4.4 5.0 52.3 7.3 9.2 3.6 4.2 4.6 9.2 8.4 12.5 7.2 7.4 8.3 8.6 4.1 7.9 4.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 ST3GAL3 "MRT12, SIAT6" ENSG00000126091 "ST3 beta-galactoside alpha-2,3-sialyltransferase 3" Q11203 1 43705824-43931165 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 71.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051102 Uncertain "Intracellular and membrane" NA NA "HPA051102: AB_2681344" "unprognostic (8.42e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.22e-1)" "unprognostic (3.20e-1)" "unprognostic (9.72e-2)" "unprognostic (7.01e-2)" "unprognostic (4.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.38e-3)" "unprognostic (7.00e-2)" "unprognostic (3.68e-3)" "unprognostic (1.67e-2)" "unprognostic (1.30e-1)" "unprognostic (4.35e-1)" "unprognostic (6.60e-2)" 11.6 9.0 13.0 8.9 16.5 9.9 12.8 15.5 20.4 9.0 10.3 9.0 8.0 3.2 10.8 10.7 8.7 8.3 7.2 16.9 12.8 13.9 6.7 9.1 7.2 7.6 12.0 10.4 13.3 7.5 6.9 10.9 6.7 11.6 8.8 5.1 9.0 8.0 13.9 71.5 7.4 3.8 15.9 7.7 6.0 5.9 14.5 10.3 3.2 8.1 17.8 4.8 8.1 7.0 7.1 7.0 5.8 4.2 4.7 7.6 6.1 2.4 1.9 14.2 6.7 11.2 14.2 1.8 9.3 19.4 8.7 8.4 1.6 4.0 4.5 4.8 11.9 4.8 2.3 1.2 6.1 10.5 5.3 3.2 8.6 6.0 4.6 9.4 3.9 4.3 7.5 4.6 6.4 14.0 16.7 6.8 11.2 5.1 8.4 16.1 1.6 4.0 7.4 5.6 0.6 5.0 6.7 1.9 3.0 7.0 1.6 5.8 8.5 3.7 1.4 8.1 6.0 2.1 18.8 6.5 5.2 2.4 8.5 9.4 6.7 3.8 4.2 7.7 9.4 9.6 2.9 4.2 2.5 6.8 2.5 6.1 4.5 4.4 5.1 3.0 7.1 7.6 5.7 5.8 4.7 3.7 7.0 5.2 6.1 13.0 16.5 15.5 20.4 12.8 13.9 12.0 10.4 11.6 10.3 6.0 20.0 0.9 2.8 3.0 8.5 22.8 2.5 6.7 3.4 3.5 0.0 2.1 5.0 2.6 16.4 7.4 0.2 0.0 2.1 1.2 7.4 2.0 23.1 9.0 2.6 17.5 2.4 4.3 2.4 10.2 3.4 4.6 3.3 3.6 1.2 3.9 2.3 0.0 11.0 5.6 16.1 19.4 7.2 5.2 3.8 1.1 0.8 3.5 1.6 7.9 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 74.2" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 804.9" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6" "Group enriched" "Detected in many" 11 "dendritic cells: 29.6;granulocytes: 31.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.3;WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049827 Approved "Intracellular and membrane" NA NA "HPA049827: AB_2680900" "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 7.8 38.0 6.2 6.5 12.2 7.8 12.9 4.0 13.6 8.3 27.0 26.4 5.1 2.0 6.0 42.1 25.5 6.0 11.4 26.5 8.6 6.2 16.7 11.5 12.4 9.0 18.7 9.0 39.3 5.1 0.8 5.6 74.2 13.8 12.1 31.5 35.7 14.4 8.0 1.9 5.6 3.8 11.0 23.0 17.0 4.8 18.8 12.4 2.2 6.1 4.3 10.1 21.1 13.2 0.1 29.6 31.3 2.6 1.2 1.7 1.8 4.9 4.1 3.2 2.7 9.5 7.9 8.0 5.7 11.1 5.2 3.6 2.4 8.5 1.4 4.3 9.0 17.7 7.7 6.7 3.7 4.1 5.3 1.9 12.6 10.2 2.7 6.2 15.0 25.8 6.3 6.0 7.8 12.4 9.6 6.9 5.5 7.8 3.8 6.4 20.2 4.7 15.4 2.0 31.9 26.8 4.9 9.9 0.6 1.2 14.2 6.1 3.9 6.3 38.2 45.3 2.2 13.3 10.0 2.5 12.5 2.8 8.8 10.7 0.3 0.8 0.7 5.7 23.0 102.8 31.3 1.6 0.2 1.7 2.6 1.6 0.1 0.6 1.1 6.6 0.0 0.1 0.8 22.8 1.2 1.2 29.6 0.0 1.8 6.2 12.2 4.0 13.6 8.6 6.2 18.7 9.0 13.8 12.4 8.9 1.1 3.7 5.3 9.4 4.2 26.6 7.6 1.4 4.5 29.6 9.8 90.3 41.4 4.3 1.1 9.8 34.8 0.0 5.6 59.0 44.0 13.8 41.5 8.9 16.2 4.8 5.1 36.8 4.1 3.8 70.5 7.2 74.2 10.8 43.5 5.0 7.3 93.0 88.1 3.4 8.3 12.9 23.6 1.4 3.8 5.8 804.9 12.2 8.8 13.1 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 80.4;Alveolar cells type 2: 105.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 26.2;RT4: 22.2;SK-MEL-30: 18.4;U-266/84: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles NA NA Vesicles "HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060" "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favorable (4.99e-4)" "prognostic favorable (4.48e-4)" 8.0 40.1 15.3 7.2 18.5 4.1 4.2 9.9 34.9 3.3 3.8 18.8 0.0 2.7 8.0 2.9 2.9 4.9 11.8 2.1 14.8 12.0 2.4 7.0 18.0 11.5 14.0 13.4 7.2 2.9 1.5 7.4 24.1 18.1 4.8 5.0 18.7 4.8 2.2 9.5 5.0 3.4 6.2 18.0 11.1 4.1 9.0 13.4 5.5 36.7 0.4 6.9 30.9 7.8 2.5 1.1 1.3 6.1 1.4 1.8 0.5 0.1 12.8 1.2 26.2 10.9 5.9 3.9 2.8 8.6 2.7 2.4 0.2 9.3 0.3 0.1 4.8 1.2 0.5 1.7 3.0 3.4 0.1 1.5 0.2 0.5 0.4 8.7 0.1 3.8 3.3 0.4 1.0 0.4 4.9 6.5 3.5 0.3 14.5 8.8 0.8 0.8 1.4 0.1 4.4 0.0 1.6 8.3 5.1 1.4 22.2 1.8 1.8 0.1 0.0 18.4 2.7 0.1 0.5 2.1 0.0 1.3 0.0 0.2 14.6 19.3 0.2 2.1 2.6 13.2 0.9 1.8 0.1 1.4 6.1 1.8 2.5 0.8 0.9 1.1 1.5 0.7 0.8 1.3 1.4 5.1 0.4 0.3 0.5 15.3 18.5 9.9 21.9 14.8 12.0 14.0 13.4 18.1 13.4 80.4 105.8 40.9 24.7 4.9 49.5 1.6 30.6 14.7 50.0 3.5 55.0 0.3 3.3 8.1 9.5 5.2 0.0 0.0 14.5 0.5 10.3 8.0 33.5 15.5 30.3 68.3 6.4 33.2 46.9 8.7 7.5 25.6 30.4 12.6 0.0 52.2 6.7 0.0 1.8 2.9 41.0 0.0 5.0 6.9 20.0 3.3 0.2 19.7 0.0 5.1 ST3GAL6 "SIAT10, ST3GALVI" ENSG00000064225 "ST3 beta-galactoside alpha-2,3-sialyltransferase 6" Q9Y274 3 98732236-98821201 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 46.7" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 61.5;Hepatocytes: 74.4;Melanocytes: 62.4" "Cancer enhanced" "Detected in many" "melanoma: 17.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 20.7;neutrophil: 25.8" "Group enriched" "Detected in many" 144 "dendritic cells: 10.6;granulocytes: 25.8;monocytes: 7.7" "Group enriched" "Detected in many" 4 "RPMI-8226: 36.4;SK-MEL-30: 43.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018792 Approved NA NA 3000000 "HPA018792: AB_10964349" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-3)" "unprognostic (4.17e-2)" "unprognostic (5.20e-3)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-3)" "unprognostic (2.40e-1)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "unprognostic (4.32e-1)" "unprognostic (3.91e-3)" "unprognostic (6.15e-3)" "unprognostic (9.44e-2)" "unprognostic (9.47e-3)" "unprognostic (6.79e-4)" 11.5 7.5 5.9 3.6 8.3 2.4 6.0 14.4 8.2 4.9 3.6 6.7 1.9 2.2 2.4 11.3 2.4 6.0 2.4 21.8 7.1 5.9 12.2 46.7 7.1 3.5 9.5 4.3 1.7 4.7 1.1 4.6 20.1 10.1 3.5 3.0 6.3 15.9 2.3 6.5 14.4 2.2 2.3 17.4 3.0 4.6 1.8 7.4 14.3 3.1 2.2 2.8 1.6 1.9 0.0 10.6 25.8 7.7 0.0 0.1 1.8 0.1 0.5 0.8 1.1 1.3 0.4 5.0 0.1 0.6 0.5 0.9 3.3 0.2 2.4 1.3 0.0 1.8 0.8 1.5 0.8 0.4 0.0 1.0 0.1 0.2 5.9 5.8 5.0 9.5 0.6 0.0 1.4 2.7 9.1 5.7 1.0 0.0 2.5 0.5 0.0 0.8 8.6 1.4 0.0 1.4 0.4 0.6 36.4 1.3 0.0 1.5 7.8 2.0 0.2 43.1 1.5 0.1 9.0 4.2 1.1 0.9 0.3 0.4 9.7 0.7 0.0 1.9 7.2 4.0 7.4 7.7 20.7 0.0 4.1 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.0 25.8 0.0 2.0 2.4 0.0 1.8 5.9 8.3 14.4 8.2 7.1 5.9 9.5 4.3 10.1 7.4 11.9 35.7 2.2 2.8 10.2 1.0 33.9 5.1 32.1 1.2 3.5 7.9 36.5 11.6 4.9 0.2 13.4 0.0 0.0 1.8 61.5 2.2 4.8 36.0 74.4 33.3 0.0 15.4 33.2 23.8 0.2 2.6 39.4 62.4 44.1 0.0 0.6 4.2 0.0 6.3 9.0 2.6 6.5 2.0 0.0 0.4 11.2 22.5 0.0 0.0 0.9 ST6GAL1 SIAT1 ENSG00000073849 "ST6 beta-galactoside alpha-2,6-sialyltransferase 1" P15907 3 186930485-187078553 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 161.4" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 225.1;Hepatocytes: 512.9;Ito cells: 264.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.6;U-266/70: 104.1;U-266/84: 133.1;U-698: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015018, CAB016122" Supported "Secreted to blood" NA NA 15000000 580000 "CAB015018: AB_629203, CAB016122: AB_627178" "unprognostic (5.85e-3)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.62e-1)" "unprognostic (2.64e-1)" "unprognostic (2.44e-2)" "unprognostic (1.38e-3)" "unprognostic (3.43e-2)" "unprognostic (3.17e-1)" "unprognostic (2.20e-1)" "unprognostic (3.99e-1)" "unprognostic (1.43e-1)" "unprognostic (1.91e-2)" "unprognostic (7.30e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-2)" 10.6 6.5 11.8 16.7 15.4 4.0 10.5 2.8 11.8 19.1 11.4 22.7 4.2 4.3 8.6 4.3 4.4 8.6 5.7 10.6 10.7 7.6 19.1 161.4 10.9 27.6 18.2 7.6 4.5 4.1 20.5 5.7 5.5 13.7 19.5 14.2 5.4 17.7 4.6 5.7 4.5 12.6 5.8 22.3 27.0 8.5 2.4 15.1 19.4 19.4 4.0 41.6 13.2 14.3 33.6 4.6 6.9 8.9 8.5 29.3 16.9 0.7 0.7 3.1 2.3 0.2 0.0 4.8 0.2 0.4 0.1 0.3 0.2 0.2 32.6 2.7 0.0 1.2 1.4 19.2 2.0 0.2 1.6 0.8 1.3 0.1 15.9 0.1 3.0 10.3 0.2 4.1 0.0 1.8 2.8 11.3 3.3 6.6 3.1 1.0 1.4 2.2 2.1 6.9 1.6 1.0 5.3 0.0 1.0 1.4 0.0 5.0 0.5 0.2 3.7 8.5 4.7 5.4 2.2 4.3 0.0 0.4 0.0 0.3 104.1 133.1 48.5 0.1 6.1 11.3 6.9 2.7 1.1 16.5 5.2 15.0 32.7 18.2 13.8 4.6 33.6 29.3 20.2 1.3 8.5 8.9 4.2 14.2 16.9 11.8 15.4 2.8 11.8 10.7 7.6 18.2 7.6 13.7 15.1 41.7 20.6 118.9 14.7 3.5 0.0 22.2 86.6 24.1 44.3 225.1 0.0 0.3 0.0 14.5 0.3 29.9 4.1 23.3 0.8 3.1 1.9 58.6 10.4 512.9 16.4 0.0 90.6 264.6 52.6 0.7 0.3 13.4 6.8 5.4 3.3 0.0 6.7 5.8 0.7 0.5 1.1 0.0 5.1 0.0 0.2 1.4 0.6 20.0 28.1 28.2 ST6GAL2 "KIAA1877, SIAT2, St6gal2, St6GalII" ENSG00000144057 "ST6 beta-galactoside alpha-2,6-sialyltransferase 2" Q96JF0 2 106801600-106887108 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;thyroid gland: 34.0" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 16.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014459 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA014459: AB_1857528" "unprognostic (2.08e-1)" "unprognostic (5.80e-2)" "unprognostic (1.55e-1)" "unprognostic (4.63e-2)" "unprognostic (6.44e-3)" "unprognostic (1.62e-1)" "unprognostic (2.35e-2)" "unprognostic (1.10e-2)" "unprognostic (1.29e-4)" "unprognostic (4.56e-3)" "unprognostic (7.04e-2)" "unprognostic (1.84e-2)" "unprognostic (7.01e-4)" "unprognostic (4.70e-4)" "unprognostic (4.06e-2)" "unprognostic (2.83e-1)" "unprognostic (2.07e-2)" 1.2 0.7 14.1 0.7 5.6 1.5 1.3 2.3 16.7 2.1 1.5 4.1 1.7 0.7 3.7 1.9 2.7 1.2 12.7 1.9 5.4 4.0 1.1 3.4 1.2 0.9 3.8 7.1 0.9 0.5 0.5 0.3 2.3 4.2 1.6 3.3 0.0 1.6 1.6 0.7 1.3 0.7 2.8 1.9 0.6 0.9 7.9 1.5 0.0 34.0 1.6 0.8 1.5 1.4 0.7 0.6 1.8 0.5 1.0 0.7 0.5 0.0 5.7 3.1 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.0 7.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 4.9 0.0 6.4 0.0 0.0 10.2 0.2 0.0 6.8 4.4 0.0 0.1 0.0 0.3 0.0 0.1 0.0 8.3 0.1 0.2 0.0 10.9 0.2 0.1 0.0 0.0 0.0 1.4 0.5 0.4 0.6 0.3 0.5 0.4 0.4 0.5 0.2 0.7 0.5 0.7 1.8 1.0 0.3 0.6 0.5 0.5 14.1 5.6 2.3 14.8 5.4 4.0 3.8 7.1 4.2 1.5 0.0 0.0 0.0 0.1 0.8 7.7 1.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.2 0.0 1.2 2.5 0.0 0.0 0.3 0.0 0.0 0.0 2.3 0.8 0.0 0.0 0.7 0.6 0.5 0.0 1.4 0.0 1.3 0.0 0.2 0.0 1.2 0.0 ST6GALNAC1 "SIAT7A, ST6GalNAcI" ENSG00000070526 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1" Q9NSC7 17 76624761-76643838 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 69.4" "Cell type enriched" "Detected in many" 6 "Mucus-secreting cells: 708.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 25 "T-cells: 11.2" "Group enriched" "Detected in some" 4 "K-562: 23.7;OE19: 44.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014767, HPA014975" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA 1200000 "Golgi apparatus" Nucleoplasm "HPA014767: , HPA014975: AB_1857529" "unprognostic (4.59e-2)" "unprognostic (8.60e-3)" "unprognostic (5.32e-3)" "unprognostic (1.86e-3)" "unprognostic (6.31e-3)" "prognostic favorable (2.54e-5)" "unprognostic (1.39e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-1)" "unprognostic (2.58e-2)" "unprognostic (8.64e-3)" "unprognostic (2.81e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (5.87e-3)" "unprognostic (5.58e-2)" 1.4 0.3 1.2 13.9 2.6 0.7 1.3 0.8 3.2 20.4 50.9 3.1 0.3 19.8 6.3 1.8 19.6 1.5 26.6 4.1 1.6 1.3 0.4 1.1 5.7 1.1 1.8 1.2 2.0 1.1 0.1 0.4 1.7 3.7 2.6 69.4 0.1 20.8 1.4 0.9 0.6 49.0 1.9 1.5 6.0 23.9 4.0 0.6 0.0 0.5 4.5 21.6 1.9 2.6 0.0 0.0 0.4 0.0 0.0 11.2 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.4 0.0 0.0 4.9 0.0 1.3 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 23.7 0.0 0.0 0.0 0.1 0.0 0.0 44.4 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.2 0.2 0.0 0.0 4.2 0.0 0.4 0.0 0.0 0.0 1.4 1.1 1.2 2.6 0.8 3.2 1.6 1.3 1.8 1.2 3.7 0.6 14.9 6.9 0.0 5.2 0.1 0.0 1.5 30.6 112.4 76.2 0.0 0.0 0.1 0.0 1.6 0.2 14.2 50.8 0.0 16.6 0.1 0.6 3.2 0.0 0.0 0.2 0.0 31.7 4.3 0.0 0.5 1.4 0.3 0.0 0.0 708.1 0.0 27.0 66.2 0.0 0.0 1.1 0.0 0.1 0.3 0.0 0.1 0.1 0.0 108.2 20.7 ST6GALNAC2 "SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM" ENSG00000070731 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2" Q9UJ37 17 76565379-76586956 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 78.2" "Group enriched" "Detected in many" 11 "Early spermatids: 447.7;Late spermatids: 1248.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 19.2" "Cell type enriched" "Detected in some" 9 "neutrophil: 23.5" "Lineage enriched" "Detected in many" 20 "granulocytes: 23.5" "Cell line enhanced" "Detected in some" "BEWO: 9.6;HaCaT: 11.8;HBEC3-KT: 10.7;hTCEpi: 30.0;MCF7: 11.6;SK-MEL-30: 39.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (8.93e-3)" "unprognostic (5.86e-3)" "unprognostic (1.67e-2)" "unprognostic (5.18e-3)" "unprognostic (3.37e-2)" "unprognostic (3.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.95e-1)" "unprognostic (5.37e-2)" "unprognostic (5.69e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.57e-1)" "unprognostic (5.17e-3)" "unprognostic (3.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 4.3 1.7 0.6 2.7 1.8 0.4 7.0 0.4 1.3 8.6 7.2 6.0 3.6 0.4 2.6 8.8 17.2 28.3 2.1 4.6 2.1 1.3 10.6 1.3 11.3 1.7 4.0 1.0 5.0 3.6 1.5 2.1 18.3 19.2 6.7 3.4 78.2 6.6 6.1 11.3 27.3 2.5 4.7 3.7 2.0 3.5 17.1 1.3 0.7 17.7 12.4 6.9 8.3 7.6 0.0 0.2 23.5 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.2 0.0 9.6 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.7 0.0 11.8 0.1 10.7 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 30.0 0.0 3.4 1.4 0.0 0.0 0.0 0.0 0.1 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 3.2 0.1 0.0 1.3 0.0 39.0 0.6 7.6 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.1 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.5 0.0 0.1 0.0 0.0 0.1 0.6 1.8 0.4 1.3 2.1 1.3 4.0 1.0 19.2 1.3 0.0 1.0 0.5 34.2 29.2 6.0 4.8 5.1 9.4 6.8 0.0 25.5 7.7 0.0 0.1 447.7 3.1 1.3 0.0 0.0 15.3 3.4 4.5 1.1 0.8 2.8 0.0 0.0 9.2 5.6 1248.1 6.9 2.4 62.4 1.0 3.4 71.0 0.1 0.0 6.7 0.3 74.9 19.4 3.1 8.4 4.4 26.5 8.8 2.2 1.5 31.0 ST6GALNAC4 "SIAT3C, SIAT7D, ST6GALNACIV" ENSG00000136840 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4" Q9H4F1 9 127907886-127917038 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;pancreas: 61.0" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "plasmacytoid DC: 58.8" "Lineage enriched" "Detected in many" 9 "dendritic cells: 58.8" "Cell line enhanced" "Detected in many" "HDLM-2: 35.5;RPMI-8226: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009042 Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA009042: AB_1079963" "unprognostic (2.05e-3)" "unprognostic (2.32e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-2)" "unprognostic (3.18e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.63e-7)" "unprognostic (1.62e-2)" "unprognostic (4.26e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.04e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.39e-4)" "unprognostic (1.30e-3)" "unprognostic (2.72e-1)" "unprognostic (2.64e-2)" "unprognostic (2.03e-2)" 8.0 7.8 5.6 7.9 5.6 26.2 12.1 9.8 8.5 9.2 9.3 4.8 28.9 11.7 8.7 9.6 6.9 8.7 12.2 18.4 5.2 3.4 9.4 5.0 13.5 9.7 4.2 4.7 14.9 61.0 2.4 9.4 4.3 4.8 6.1 5.4 4.8 9.3 30.0 12.6 4.0 9.7 6.1 3.9 18.2 7.2 4.3 4.7 4.7 6.3 5.9 12.5 8.9 8.3 6.7 58.8 0.8 3.2 4.3 3.4 2.4 3.2 5.5 1.4 7.0 9.9 7.6 1.0 5.6 6.2 5.7 3.3 3.1 5.9 20.5 8.5 7.0 8.1 7.9 2.9 5.9 0.9 35.5 2.4 6.5 17.6 11.6 12.1 0.5 6.8 9.2 6.3 5.1 4.6 4.6 15.2 3.9 4.6 13.7 2.7 1.5 1.2 0.7 1.6 10.5 13.6 6.2 3.7 50.3 5.8 0.1 12.0 2.7 8.1 17.6 1.0 0.5 3.6 4.2 10.8 4.7 5.4 14.6 8.7 22.4 11.5 6.4 9.4 2.9 0.6 0.8 2.1 0.0 2.9 1.9 3.3 6.7 1.8 3.4 2.8 4.9 2.3 3.1 0.2 4.3 3.2 58.8 3.3 2.4 5.6 5.6 9.8 8.5 5.2 3.4 4.2 4.7 4.8 4.7 8.9 24.5 43.4 11.9 1.9 2.4 10.3 10.2 5.3 4.5 1.8 0.0 0.9 1.7 14.0 0.1 10.8 19.6 23.3 12.5 14.4 11.9 2.0 8.1 1.5 22.1 0.0 65.1 4.9 11.4 0.0 16.1 8.5 6.8 12.6 13.1 14.1 11.9 6.5 40.3 17.3 1.7 12.9 8.9 0.2 1.3 2.8 3.8 10.2 16.4 10.0 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867441-77065711 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enriched" "Detected in some" 7 "Alveolar cells type 1: 50.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Group enriched" "Detected in many" 4 "amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA065593: AB_2685515, HPA070354: AB_2686260" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.7 10.1 22.1 5.2 22.3 0.4 4.2 0.6 12.7 2.9 3.4 0.3 0.0 1.4 0.9 0.7 3.7 6.9 12.6 1.4 29.4 2.7 0.7 0.6 12.1 1.6 3.0 14.2 6.5 0.8 0.4 8.5 0.9 4.7 4.2 2.7 5.8 1.5 1.6 0.6 1.0 2.1 10.2 0.8 1.0 3.7 1.2 0.2 0.0 0.6 0.0 1.4 4.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.4 0.0 9.1 0.0 0.0 0.0 0.0 0.8 3.2 2.6 0.8 0.0 0.2 0.0 0.0 10.9 0.0 5.2 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.7 0.6 0.0 0.1 2.5 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 9.0 0.0 5.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.1 22.3 0.6 12.7 29.4 2.7 3.0 14.2 4.7 0.2 50.6 0.3 0.0 0.0 0.0 7.3 0.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 ST7L "FAM4B, FLJ20284, ST7R, STLR" ENSG00000007341 "Suppression of tumorigenicity 7 like" Q8TDW4 1 112523518-112620825 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 49.0" "Group enriched" "Detected in many" 5 "Early spermatids: 151.6;Late spermatids: 193.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042324, HPA075418" Uncertain Approved Centrosome NA NA Centrosome "HPA042324: AB_10794273, HPA075418: AB_2686749" "unprognostic (2.99e-2)" "unprognostic (1.07e-2)" "prognostic favorable (8.34e-5)" "prognostic unfavorable (8.96e-4)" "unprognostic (3.30e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-6)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.16e-4)" "prognostic favorable (3.04e-5)" "unprognostic (2.98e-2)" "unprognostic (6.91e-2)" "unprognostic (5.72e-2)" "unprognostic (4.12e-3)" "unprognostic (3.68e-2)" "unprognostic (3.26e-2)" "unprognostic (3.27e-2)" 7.7 9.3 5.7 5.5 9.0 8.6 8.2 12.1 7.9 8.1 6.9 10.0 7.2 5.5 10.0 7.8 6.1 7.9 6.0 8.6 5.6 5.9 6.3 7.6 5.7 5.3 6.1 5.1 9.4 11.6 5.2 12.8 6.4 6.3 7.3 8.0 9.4 7.0 9.0 10.2 8.9 6.2 7.9 6.4 5.2 5.8 49.0 7.0 4.6 11.8 4.6 5.6 6.8 7.7 4.2 3.5 0.3 2.1 6.9 5.2 1.9 4.8 1.5 8.7 6.1 11.9 11.8 2.1 6.3 4.8 2.7 4.0 2.8 4.8 2.1 2.6 2.5 8.1 3.4 10.2 8.1 4.1 3.1 6.0 5.9 7.6 1.8 6.8 5.0 6.4 2.2 2.0 3.1 6.4 6.4 8.7 7.4 3.4 6.9 11.0 1.9 2.6 2.0 3.9 2.3 5.3 4.2 4.6 0.8 5.5 6.0 6.4 3.9 3.4 4.7 4.4 1.6 3.6 3.0 8.3 6.2 6.1 8.0 6.0 1.8 1.3 2.1 5.6 8.0 13.5 0.1 1.8 0.2 2.4 2.1 3.9 4.2 3.6 1.8 1.7 1.8 5.2 2.8 0.3 6.9 1.6 3.5 2.4 1.9 5.7 9.0 12.1 7.9 5.6 5.9 6.1 5.1 6.3 7.0 20.8 8.1 4.5 14.2 15.0 16.4 6.1 20.4 12.0 13.6 8.7 5.9 11.0 8.3 7.6 151.6 11.9 5.1 0.0 7.4 5.7 9.2 11.9 8.1 6.8 7.5 23.8 5.2 4.9 7.8 193.4 16.7 7.5 20.3 4.6 9.5 19.1 6.4 3.5 15.2 5.7 22.0 19.4 7.6 33.6 11.3 15.9 5.1 8.7 9.7 9.3 ST8SIA1 "SIAT8, SIAT8A" ENSG00000111728 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1" Q92185 12 22063773-22437041 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.2" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 43.2;granulocytes: 32.4;Muller glia cells: 41.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;T-cells: 3.0" "Cell line enhanced" "Detected in some" "AF22: 9.1;ASC TERT1: 6.0;hTERT-RPE1: 4.2;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026775 Approved NA NA "HPA026775: AB_1857534" "unprognostic (1.98e-1)" "unprognostic (5.76e-3)" "unprognostic (1.79e-1)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-3)" "unprognostic (1.76e-2)" "unprognostic (1.07e-2)" "unprognostic (3.07e-1)" "unprognostic (1.99e-1)" "unprognostic (6.37e-3)" "unprognostic (2.80e-2)" "unprognostic (1.07e-8)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (5.28e-2)" "unprognostic (3.16e-2)" 1.7 7.6 7.0 5.3 6.2 2.3 5.9 20.2 13.0 3.5 5.4 2.3 2.3 0.4 4.5 1.4 3.0 2.3 2.4 4.4 7.6 8.5 1.1 0.6 3.8 8.6 7.6 6.5 2.6 1.2 7.2 0.6 0.4 9.4 6.6 3.5 1.5 3.2 4.4 1.0 4.3 2.1 6.3 10.9 2.7 2.1 1.0 4.8 0.2 1.4 0.5 9.2 6.7 3.1 0.3 0.2 1.2 0.2 0.3 3.0 0.6 0.1 0.5 9.1 0.0 1.4 6.0 0.9 0.0 0.0 0.1 0.4 0.3 0.1 1.1 0.0 0.0 0.2 0.4 0.0 0.2 0.6 0.0 0.0 1.1 0.1 0.1 0.0 0.3 0.1 0.5 0.9 0.1 0.9 4.2 0.2 0.1 0.0 0.6 0.2 0.0 1.2 0.3 2.3 3.5 0.0 0.0 0.2 0.2 4.6 0.0 0.1 0.2 0.0 0.1 8.3 0.3 0.7 0.1 0.0 0.7 0.9 0.1 1.4 0.7 0.5 0.7 1.4 0.1 9.0 1.2 0.2 0.2 0.4 0.1 0.9 0.1 2.9 2.3 0.1 0.3 0.4 1.0 0.9 0.3 0.2 0.2 3.0 0.6 7.0 6.2 20.2 13.0 7.6 8.5 7.6 6.5 9.4 4.8 0.0 2.6 0.0 0.4 3.9 7.5 3.1 0.0 8.1 2.3 0.0 43.2 3.0 1.7 0.0 5.3 0.7 0.0 0.0 0.0 10.1 3.0 3.7 32.4 0.0 0.7 4.8 0.0 0.0 0.0 3.0 0.3 0.0 11.8 0.0 0.0 41.7 0.0 0.0 0.0 0.2 2.8 0.0 1.2 3.9 5.5 2.0 3.1 4.3 0.0 0.1 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393828-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 17.7;heart muscle: 10.0" "Group enriched" "Detected in some" 12 "Cardiomyocytes: 4.5;Muller glia cells: 2.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "pons and medulla: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.3 1.1 1.3 0.2 2.2 0.1 1.2 1.5 3.7 2.6 0.3 0.0 0.0 0.1 1.3 2.5 0.4 0.1 0.7 10.0 3.0 3.6 0.3 0.1 0.1 0.2 2.2 1.4 0.1 0.1 0.1 0.9 0.1 17.7 0.3 0.2 1.0 0.8 0.5 2.1 0.1 0.4 0.2 0.2 0.1 0.2 0.8 0.1 2.5 0.2 1.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.0 3.5 0.0 0.0 0.0 10.1 7.3 0.0 0.0 0.5 4.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.7 0.3 0.0 0.2 0.8 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.2 1.5 2.6 3.0 3.6 2.2 1.4 17.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ST8SIA3 SIAT8C ENSG00000177511 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3" O43173 18 57350813-57371731 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 24.0" "Group enriched" "Detected in some" 9 "Bipolar cells: 30.1;Horizontal cells: 60.4" "Group enriched" "Detected in some" 11 "glioma: 0.9;pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "NTERA-2: 6.0;SCLC-21H: 10.3;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063398, HPA066783" Enhanced Supported "Golgi apparatus" No NA "Golgi apparatus" "HPA063398: AB_2685004, HPA066783: AB_2685721" "unprognostic (1.75e-1)" "unprognostic (7.85e-2)" "unprognostic (1.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-2)" "unprognostic (1.82e-1)" 0.1 4.5 3.4 0.1 12.0 0.0 0.0 7.9 24.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 1.1 0.0 3.8 4.8 0.1 0.2 0.1 0.0 1.2 0.0 4.2 0.0 3.5 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 11.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 1.6 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 3.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 ST8SIA4 "PST, PST1, SIAT8D" ENSG00000113532 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4" Q92187 5 100806935-100903266 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.1;lymphoid tissue: 34.7" "Cell type enhanced" "Detected in many" 11 "Kupffer cells: 79.2;Macrophages: 44.4;monocytes: 119.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 37.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.1" "Cell line enhanced" "Detected in many" "AF22: 19.1;HDLM-2: 30.8;Karpas-707: 26.5;NB-4: 12.4;RPMI-8226: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051126, HPA053995" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA 580000 "Golgi apparatus" "HPA051126: AB_2681352, HPA053995: AB_2682336" "unprognostic (2.25e-1)" "unprognostic (2.04e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.14e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-1)" "unprognostic (5.46e-2)" "unprognostic (2.87e-1)" "unprognostic (1.49e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (7.80e-7)" "unprognostic (6.07e-2)" "unprognostic (4.38e-2)" "unprognostic (1.30e-1)" "unprognostic (1.23e-2)" 11.7 2.7 4.3 16.7 4.3 8.2 6.5 1.3 4.2 3.4 5.3 2.6 0.3 4.0 2.3 4.2 4.3 3.5 6.5 4.7 4.0 8.0 2.6 3.3 17.5 27.9 5.1 1.7 2.5 2.1 1.5 2.4 13.7 11.6 3.4 5.6 2.7 4.0 1.3 2.0 2.1 7.7 3.6 8.0 31.6 3.7 1.6 4.3 34.7 4.9 0.8 13.8 7.4 3.5 4.7 4.9 37.1 8.9 4.0 6.9 4.4 0.0 2.8 19.1 0.0 1.2 1.8 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.4 0.0 0.0 30.8 0.0 1.1 0.2 0.0 0.0 5.7 2.3 1.5 0.0 0.0 0.0 2.5 3.5 4.6 0.0 26.5 1.1 0.2 8.1 12.4 0.1 0.0 0.1 4.6 0.3 19.7 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 5.2 1.2 0.2 0.1 0.0 0.3 8.7 8.8 1.7 0.4 7.1 2.3 18.8 7.5 8.9 5.7 8.8 4.3 4.7 3.8 4.7 4.9 3.6 2.4 4.5 37.1 4.0 8.9 1.5 6.9 4.4 4.3 4.3 1.3 4.2 4.0 8.0 5.1 1.7 11.6 4.3 6.0 13.1 25.4 0.2 7.3 0.4 2.0 0.0 26.8 15.9 0.0 0.0 7.7 1.7 0.0 0.2 16.4 0.0 0.0 0.0 31.1 6.1 0.1 23.1 0.0 20.9 0.0 0.0 7.4 79.2 0.0 0.0 44.4 13.5 119.0 0.0 3.9 0.0 0.0 0.4 0.3 0.6 12.9 5.7 0.4 0.7 4.8 16.0 28.0 0.0 0.4 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "WM-115: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" NA NA "Plasma membrane, Midbody" "HPA043813: AB_2678683, HPA046771: AB_2679798" "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.1 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 52.9 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 0.0 0.0 0.0 0.0 0.0 1.0 6.9 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 ST8SIA6 SIAT8F ENSG00000148488 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6" P61647 10 17318383-17454330 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.5" "Group enriched" "Detected in some" 7 "Endothelial cells: 8.7;granulocytes: 10.3;Ito cells: 15.4;Melanocytes: 8.5" "Cancer enhanced" "Detected in some" "breast cancer: 5.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "HMC-1: 108.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011635, HPA072708" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA011635: AB_2194921, HPA072708: " "unprognostic (4.86e-3)" "unprognostic (7.01e-2)" "unprognostic (5.85e-3)" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (2.21e-2)" "unprognostic (1.11e-2)" "unprognostic (6.81e-2)" "unprognostic (2.32e-1)" "unprognostic (3.23e-2)" "unprognostic (7.53e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (3.26e-4)" "unprognostic (2.43e-1)" "unprognostic (2.22e-1)" "unprognostic (1.07e-3)" 1.8 0.9 3.1 1.0 5.0 4.0 14.4 2.5 3.4 1.1 1.7 3.3 0.4 1.0 1.6 10.4 2.4 1.3 1.9 9.1 3.7 4.4 2.5 2.4 17.5 0.8 8.8 1.7 1.1 0.5 0.3 1.3 3.5 5.5 4.3 1.8 13.7 1.9 0.6 2.0 2.8 1.3 1.3 4.3 1.5 1.0 1.2 2.5 0.0 1.8 0.5 2.0 1.1 3.9 0.9 0.7 3.8 1.4 2.1 5.6 0.9 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.0 13.3 0.0 0.1 0.0 0.0 108.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 2.5 0.1 0.9 1.3 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.4 1.3 2.5 0.4 0.5 0.3 1.2 1.4 0.7 0.9 1.0 1.7 2.9 2.1 0.7 0.6 5.6 0.9 3.1 5.0 2.5 3.4 3.7 4.4 8.8 1.7 5.5 2.5 0.0 0.0 0.0 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 8.7 0.0 0.0 0.0 0.0 0.2 1.6 10.3 0.0 0.1 0.0 0.0 15.4 0.8 0.4 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.0 0.0 0.0 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 90.8" "Cell type enriched" "Detected in many" 5 "Ito cells: 1114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 68 "classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8" "Group enriched" "Detected in many" 69 "dendritic cells: 2.8;monocytes: 10.8" "Group enriched" "Detected in some" 47 "HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 60000000 Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 39.5 37.6 8.0 26.7 12.8 6.5 41.3 3.2 6.8 13.1 23.4 6.9 4.2 16.1 13.6 26.4 9.7 15.5 16.8 19.7 5.4 4.2 19.2 35.8 21.7 80.7 9.1 2.7 9.9 7.1 4.9 11.9 32.1 10.2 13.5 18.0 23.7 10.4 9.7 8.0 5.1 18.7 18.3 7.2 90.8 11.6 9.7 8.7 2.6 11.9 11.4 11.1 15.9 15.4 0.0 2.8 0.0 10.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 33.9 0.0 0.1 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 6.6 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 8.0 12.8 3.2 6.8 5.4 4.2 9.1 2.7 10.2 8.7 0.0 6.7 12.3 0.5 5.4 1.0 2.0 12.7 0.0 0.0 3.5 0.0 1.3 0.0 0.0 0.4 14.5 0.0 46.7 0.0 1.5 3.8 0.0 17.4 8.3 103.3 0.0 1.2 1114.7 238.9 1.9 4.0 46.3 11.8 0.0 0.0 0.5 0.0 0.0 19.1 0.3 0.0 19.4 1.5 0.7 1.1 4.3 1.8 4.3 0.0 0.2 STAB2 "DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2" ENSG00000136011 "Stabilin 2" Q8WWQ8 12 103587273-103766727 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 71.3" "Cell type enriched" "Detected in some" 10 "Ito cells: 196.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 16.1;HaCaT: 4.4;RH-30: 2.5" "Not detected" "Not detected" "HPA026871, HPA072699" Enhanced Supported Cytosol NA NA 210000 Cytosol "HPA026871: AB_1857536, HPA072699: " "unprognostic (5.66e-3)" "unprognostic (7.51e-2)" "unprognostic (3.31e-1)" "unprognostic (3.84e-2)" "unprognostic (8.47e-2)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (5.72e-2)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.05e-1)" "unprognostic (9.72e-4)" "unprognostic (1.37e-2)" "unprognostic (5.00e-1)" "unprognostic (1.26e-1)" "unprognostic (2.06e-1)" 0.6 0.2 0.1 0.5 0.1 0.4 0.5 0.1 0.1 0.7 1.4 0.1 0.1 0.1 1.1 1.1 2.5 0.9 0.6 0.4 0.1 0.1 0.1 11.7 0.5 19.9 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.2 0.5 0.2 0.1 2.1 0.3 0.1 0.2 0.3 0.2 0.1 71.3 0.3 1.5 0.1 0.2 0.7 0.5 0.4 0.3 0.4 0.9 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.7 0.8 0.2 0.0 0.0 16.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.3 4.4 0.0 0.0 0.0 0.0 1.1 0.4 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 1.0 0.0 0.0 0.0 0.0 0.1 0.7 0.4 0.5 0.1 2.5 0.0 0.0 0.2 0.2 0.1 0.0 0.2 0.1 0.9 0.3 0.1 0.6 0.8 0.4 0.0 1.1 0.2 0.2 0.0 0.3 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.8 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 0.0 0.0 196.4 19.9 9.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 STAC2 24b2 ENSG00000141750 "SH3 and cysteine rich domain 2" Q6ZMT1 17 39210536-39225872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 94.0;seminal vesicle: 101.5" "Cell type enriched" "Detected in many" 11 "Muller glia cells: 446.6" "Group enriched" "Detected in many" 7 "breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076925 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076925: " "unprognostic (1.70e-3)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (4.05e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.42e-1)" "unprognostic (8.66e-2)" "unprognostic (2.94e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.12e-2)" "unprognostic (5.16e-2)" "unprognostic (2.35e-3)" "unprognostic (2.05e-2)" "unprognostic (1.94e-1)" "unprognostic (3.54e-2)" "unprognostic (3.17e-1)" 2.4 0.9 4.2 1.0 7.4 0.7 29.7 9.5 21.9 4.0 0.9 0.0 94.0 0.9 2.5 13.9 0.8 1.4 0.8 1.0 6.8 3.2 4.8 0.7 0.9 0.8 3.5 6.6 1.2 1.1 0.7 0.5 1.0 13.1 1.8 0.9 8.2 7.8 101.5 0.8 20.1 0.8 1.7 1.4 0.8 0.8 0.9 0.2 0.0 0.7 0.0 0.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 8.3 0.0 3.3 0.0 0.0 0.0 0.4 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.2 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 7.4 9.5 21.7 6.8 3.2 3.5 6.6 13.1 0.2 3.0 8.0 0.0 1.2 0.3 4.8 2.9 0.0 2.7 4.5 3.5 9.8 0.1 5.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.0 2.6 0.0 40.5 0.0 0.0 446.6 0.0 0.0 0.0 0.0 11.1 0.0 3.4 0.2 0.9 1.5 0.2 0.0 0.0 0.1 STAC3 MGC2793 ENSG00000185482 "SH3 and cysteine rich domain 3" Q96MF2 12 57243453-57251193 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 222.7;tongue: 107.8" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 36.5;Kupffer cells: 32.7;Macrophages: 17.2;monocytes: 16.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "intermediate monocyte: 8.0" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 8.0" "Cell line enriched" "Detected in some" 23 "RH-30: 230.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA039285, HPA039527" Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039285: AB_2676427, HPA039527: AB_10673424" "unprognostic (6.16e-2)" "prognostic favorable (2.01e-4)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (5.25e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (9.12e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (7.11e-6)" "unprognostic (4.58e-2)" "unprognostic (3.36e-1)" "unprognostic (2.09e-1)" "unprognostic (1.14e-3)" 3.7 0.2 0.1 0.6 0.1 1.6 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.1 10.3 3.2 0.2 0.1 0.1 0.1 0.1 0.2 0.4 0.6 0.7 0.2 0.0 0.1 0.1 0.4 0.2 0.2 0.0 2.3 0.2 0.1 5.4 0.0 222.7 0.2 0.3 0.1 0.3 1.1 0.1 1.2 0.0 0.1 1.2 107.8 3.8 0.1 0.1 1.1 4.9 0.5 8.0 0.0 0.3 1.8 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 2.7 0.0 0.0 0.0 1.6 9.8 1.0 0.1 0.0 0.0 0.1 0.0 0.6 0.2 0.2 0.7 0.5 0.1 3.5 0.0 0.0 0.1 1.2 230.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.9 0.1 3.2 0.0 0.0 6.1 0.5 0.0 8.0 0.1 1.1 0.0 0.3 4.9 0.5 0.0 0.1 0.3 0.0 4.0 1.4 0.3 1.8 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.1 0.5 0.4 1.3 6.4 0.2 2.5 1.4 0.0 0.0 2.0 0.9 0.0 0.8 9.3 0.0 1.1 0.0 0.9 0.5 0.9 0.6 5.7 0.6 36.5 1.6 2.4 2.5 32.7 7.6 1.1 17.2 0.0 16.2 1.1 2.2 1.0 0.0 0.7 0.5 1.9 0.0 0.3 2.4 1.1 0.3 1.1 1.3 1.1 0.3 STAG3 ENSG00000066923 "Stromal antigen 3" Q9UJ98 7 100177563-100221488 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Chromosome partition, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 85.4" "Cell type enhanced" "Detected in many" 10 "B-cells: 79.6;Spermatocytes: 87.4;Spermatogonia: 38.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 8 "memory B-cell: 4.8;naive B-cell: 7.6" "Lineage enriched" "Detected in single" 10 "B-cells: 7.6" "Group enriched" "Detected in some" 6 "BEWO: 27.0;HMC-1: 34.2;U-698: 9.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA049106, HPA058330" Enhanced Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA049106: AB_2680634, HPA058330: AB_2683681" "unprognostic (6.56e-4)" "prognostic favorable (8.45e-4)" "unprognostic (1.25e-2)" "unprognostic (7.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-3)" "unprognostic (3.59e-2)" "unprognostic (4.62e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-1)" "unprognostic (3.31e-4)" "unprognostic (4.26e-4)" "unprognostic (7.48e-2)" "unprognostic (6.80e-2)" "unprognostic (2.72e-1)" "unprognostic (3.13e-2)" "unprognostic (5.07e-4)" 0.4 0.7 0.4 0.9 1.0 0.3 0.2 0.6 3.8 0.3 0.3 1.1 0.5 0.1 0.5 0.4 0.3 7.8 0.4 0.5 0.6 0.2 0.2 3.9 0.3 1.2 0.5 0.6 0.4 1.4 0.0 0.2 0.4 0.5 0.3 0.2 0.5 0.2 0.5 4.1 0.5 2.2 0.4 0.7 5.1 0.1 85.4 0.8 0.7 0.3 0.2 1.6 0.3 0.2 7.6 0.5 0.2 0.7 0.2 0.5 0.3 0.0 2.0 0.8 0.1 0.1 0.0 27.0 1.4 0.0 0.1 0.1 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.0 0.1 0.0 3.8 0.4 0.0 0.0 0.6 0.0 0.0 34.2 0.0 0.0 0.6 0.1 0.0 0.1 0.8 0.4 0.0 0.0 0.5 1.6 0.1 0.8 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.5 1.5 0.6 0.4 0.0 0.4 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 9.8 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.7 0.1 4.8 0.2 0.5 0.5 7.6 0.4 0.3 0.2 0.2 0.3 0.1 0.0 0.3 0.4 1.0 0.6 0.7 0.6 0.2 0.5 0.6 0.5 0.8 0.0 2.4 79.6 8.0 6.1 7.0 1.8 2.5 14.7 1.2 7.0 2.0 1.7 11.6 0.1 19.3 2.9 1.1 0.0 0.2 2.7 3.3 7.0 1.1 22.9 2.1 19.1 1.2 3.7 2.1 18.4 4.4 4.8 5.0 4.6 4.1 3.2 0.2 0.0 1.8 3.4 7.3 0.0 7.5 87.4 38.7 7.4 2.4 10.4 1.6 9.6 STAMBPL1 "ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373" ENSG00000138134 "STAM binding protein like 1" Q96FJ0 10 88879734-88975153 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 18.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 37.8;Spermatocytes: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040202 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA040202: AB_10805708" "unprognostic (2.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.56e-2)" "unprognostic (4.25e-2)" "unprognostic (6.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-2)" "unprognostic (4.67e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (6.57e-2)" "prognostic unfavorable (1.08e-5)" "unprognostic (4.41e-2)" "unprognostic (4.06e-2)" "unprognostic (1.50e-1)" "unprognostic (4.40e-3)" 3.9 15.9 3.7 6.8 5.1 2.8 2.1 12.4 8.9 2.0 5.8 3.4 1.5 4.5 2.7 1.5 2.7 1.2 2.9 4.8 3.3 3.4 1.5 1.7 2.9 11.3 2.6 14.8 8.5 1.8 2.2 6.6 1.5 4.1 1.9 8.0 1.5 1.5 1.5 1.5 3.4 6.1 1.8 3.1 6.0 3.1 18.6 3.2 1.5 1.5 1.5 9.5 3.9 2.7 10.5 15.2 4.3 0.6 13.1 14.7 4.5 6.8 8.1 0.5 0.3 8.1 15.6 0.0 14.4 14.2 9.3 8.3 0.3 13.1 8.4 1.0 7.8 6.2 3.4 2.0 2.9 9.4 7.4 5.1 2.1 5.8 0.4 5.5 9.2 3.0 5.5 0.7 15.5 4.9 10.6 0.2 10.1 0.0 3.8 24.9 1.4 15.3 10.9 3.0 6.5 6.3 1.5 6.1 1.8 3.5 2.6 4.7 5.6 1.8 0.6 16.4 2.0 1.0 1.9 2.1 8.3 6.0 9.9 9.0 8.9 8.4 7.8 9.1 9.4 7.8 4.3 0.6 4.2 6.3 0.6 8.2 10.5 9.2 7.9 0.9 7.0 9.9 5.9 0.9 13.1 0.3 15.2 14.7 4.5 3.7 5.1 12.4 8.9 3.3 3.4 2.6 14.8 4.1 3.2 0.0 5.0 9.3 4.1 8.5 3.7 5.0 0.0 8.1 0.0 5.2 0.0 0.1 0.0 0.8 37.8 2.2 7.4 0.0 1.6 0.1 5.1 1.5 4.7 1.9 3.0 6.4 8.7 1.8 1.0 13.9 6.6 3.5 0.0 1.0 8.1 10.6 1.2 0.0 1.4 0.5 0.2 0.0 6.7 27.6 2.4 9.9 0.1 14.9 13.3 1.6 STAP1 "BRDG1, STAP-1" ENSG00000035720 "Signal transducing adaptor family member 1" Q9ULZ2 4 67558728-67607337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4" "Cell type enhanced" "Detected in some" 23 "B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1" "Cancer enriched" "Detected in many" 7 "renal cancer: 13.0" "Region enriched" "Detected in single" 7 "hippocampal formation: 3.2" "Cell type enhanced" "Detected in many" "memory B-cell: 28.1;naive B-cell: 36.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 63.5;U-698: 28.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.6" "Low region specificity" "Detected in many" HPA038529 Enhanced Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA038529: AB_10673011" "unprognostic (1.14e-4)" "unprognostic (1.49e-3)" "unprognostic (2.30e-2)" "unprognostic (2.17e-1)" "unprognostic (1.63e-3)" "unprognostic (6.30e-4)" "unprognostic (1.95e-3)" "unprognostic (6.95e-3)" "unprognostic (5.18e-2)" "unprognostic (6.38e-3)" "unprognostic (1.47e-1)" "unprognostic (8.43e-3)" "unprognostic (3.11e-2)" "unprognostic (1.49e-2)" "unprognostic (4.69e-2)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" 0.7 0.3 0.4 27.8 0.3 2.9 0.6 0.3 0.4 0.7 2.1 0.0 12.3 0.8 0.6 1.2 2.4 0.4 0.7 0.4 3.2 0.3 20.0 0.5 2.7 23.9 0.4 0.0 0.3 0.6 0.0 0.4 0.1 0.2 1.0 1.3 0.3 2.6 5.1 0.4 0.5 9.3 0.1 0.4 26.5 1.1 2.1 0.0 5.9 0.7 0.7 30.4 4.6 0.6 36.8 1.7 7.7 0.0 12.6 2.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 8.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 9.2 0.0 1.2 0.0 7.7 0.3 0.0 0.7 28.1 0.7 0.3 0.4 36.8 2.9 0.1 0.3 12.6 0.0 1.7 0.1 1.7 0.4 0.3 0.3 0.4 3.2 0.3 0.4 0.0 0.2 0.0 0.0 10.1 31.9 0.0 0.2 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.0 8.3 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.5 0.0 0.6 0.0 0.0 0.0 0.0 5.2 0.3 0.6 15.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 4.9 0.0 0.0 STAP2 "BKS, STAP-2" ENSG00000178078 "Signal transducing adaptor family member 2" Q9UGK3 19 4324043-4342786 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 281.0;Paneth cells: 282.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "NK-cell: 10.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;NK-cells: 10.8;T-cells: 3.4" "Cell line enhanced" "Detected in many" "A-431: 27.3;HaCaT: 22.7;MCF7: 32.5;RT4: 43.8" "Region enriched" "Detected in single" 13 "cerebellum: 32.8" "Low region specificity" "Detected in single" "HPA002375, HPA027761" Approved NA NA "HPA002375: AB_1078285, HPA027761: AB_1845364" "unprognostic (1.42e-1)" "prognostic favorable (2.76e-4)" "unprognostic (3.52e-1)" "prognostic favorable (3.03e-5)" "unprognostic (4.35e-2)" "unprognostic (9.35e-3)" "unprognostic (4.52e-1)" "unprognostic (7.81e-2)" "unprognostic (3.43e-1)" "unprognostic (2.00e-2)" "unprognostic (1.93e-2)" "unprognostic (9.05e-2)" "unprognostic (1.43e-3)" "unprognostic (1.38e-2)" "unprognostic (1.72e-1)" "unprognostic (3.00e-2)" "prognostic favorable (4.13e-4)" 2.5 6.6 0.7 12.6 1.1 0.0 5.8 0.9 1.0 8.8 26.0 0.7 23.3 28.4 4.9 12.0 31.6 5.4 10.9 1.7 0.7 0.4 12.9 24.7 6.8 4.0 0.7 0.6 7.0 12.5 6.4 2.5 7.6 1.5 12.8 21.7 3.3 23.9 19.4 1.6 24.0 54.9 2.5 0.7 1.2 8.3 1.7 0.8 5.1 13.3 28.1 21.9 7.6 12.8 0.9 2.9 0.3 0.2 10.8 3.4 1.2 27.3 0.1 2.1 2.0 0.1 1.5 11.8 0.5 3.0 0.9 0.8 16.4 11.4 0.0 4.6 0.9 6.2 22.7 0.3 16.2 0.5 4.8 0.2 0.0 0.1 11.4 3.9 0.0 0.2 1.2 14.0 1.6 4.2 2.4 3.0 0.7 1.0 6.3 0.5 32.5 0.4 0.2 1.6 17.6 6.8 1.1 0.2 0.7 9.6 43.8 0.7 1.2 0.0 8.8 4.7 0.8 19.9 0.1 4.3 0.0 0.4 0.2 0.6 0.0 0.4 0.4 0.1 0.1 2.0 0.3 0.2 0.0 0.8 0.0 3.4 0.9 1.1 0.1 0.9 0.2 3.4 1.9 0.2 10.8 0.0 2.9 3.3 1.2 0.7 1.1 0.9 1.0 0.7 0.4 0.7 0.6 1.5 0.8 8.9 15.6 5.6 42.4 35.9 0.4 5.3 38.2 14.7 17.0 27.9 0.0 13.4 21.6 117.7 0.9 7.4 281.0 0.0 89.4 1.7 3.8 76.9 9.2 28.4 1.6 0.0 82.5 3.1 3.3 0.5 4.4 2.3 18.6 21.6 127.6 1.0 113.4 282.0 1.8 66.6 0.7 0.0 4.0 0.5 1.5 54.1 10.4 4.9 144.6 95.3 STAR "StAR, STARD1" ENSG00000147465 "Steroidogenic acute regulatory protein" P49675 8 38143649-38151265 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Steroidogenesis, Transport" "Congenital adrenal hyperplasia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 311.3;ovary: 124.6" "Cell type enriched" "Detected in some" 5 "Leydig cells: 46.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.0" "Region enriched" "Detected in some" 8 "basal ganglia: 10.6" "Cell type enriched" "Detected in single" 11 "basophil: 5.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.7" "Cell line enriched" "Detected in some" 5 "K-562: 101.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA023644, HPA027318, CAB032598" Enhanced NA NA "CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574" "unprognostic (1.60e-4)" "unprognostic (3.20e-2)" "unprognostic (9.17e-2)" "unprognostic (3.28e-2)" "unprognostic (9.22e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.12e-5)" "unprognostic (3.30e-2)" "unprognostic (2.36e-1)" "unprognostic (1.77e-3)" "unprognostic (6.65e-2)" "unprognostic (4.75e-9)" "unprognostic (1.58e-1)" "unprognostic (1.33e-1)" "unprognostic (9.48e-2)" "unprognostic (6.16e-2)" 0.2 311.3 0.5 0.3 10.6 0.3 0.0 0.0 1.0 0.0 0.0 11.6 0.0 0.0 0.1 0.8 0.2 0.4 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.3 0.2 0.9 124.6 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.4 0.0 0.0 29.5 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.1 5.7 0.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.9 0.1 1.3 0.3 1.0 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 101.9 0.0 0.0 0.0 0.0 12.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 12.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 5.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.5 10.6 0.0 1.0 0.3 0.5 0.2 0.9 1.2 0.1 0.0 0.0 0.0 0.6 8.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.6 46.3 0.0 3.3 0.0 0.0 0.5 0.1 0.0 3.9 0.0 0.7 0.0 0.2 1.4 0.7 9.8 0.1 0.0 0.0 0.1 STARD10 "CGI-52, NY-CO-28, PCTP2, SDCCAG28" ENSG00000214530 "StAR related lipid transfer domain containing 10" Q9Y365 11 72754729-72794168 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 130.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 585.1;Late spermatids: 1716.5;Mucus-secreting cells: 590.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 75.1;OE19: 160.9;SK-BR-3: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026661 Uncertain Supported Cytosol NA NA Cytosol "HPA026661: AB_1857538" "prognostic favorable (6.92e-4)" "unprognostic (2.07e-1)" "unprognostic (8.03e-2)" "unprognostic (1.74e-3)" "unprognostic (3.71e-2)" "unprognostic (1.37e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "unprognostic (4.16e-1)" "unprognostic (4.69e-2)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (4.24e-3)" "unprognostic (8.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.12e-2)" "unprognostic (1.04e-1)" 4.5 34.0 11.3 6.8 16.0 2.0 16.0 17.6 15.9 18.6 42.8 5.5 16.6 11.5 6.5 26.2 10.9 6.2 28.7 15.5 10.3 6.8 11.1 130.6 10.0 3.1 10.6 5.4 8.2 47.3 16.4 9.5 22.6 10.1 17.6 46.0 9.1 21.7 12.1 15.0 12.7 15.0 6.7 4.4 4.6 47.4 40.0 14.8 3.3 21.3 12.0 9.3 7.8 10.2 2.9 2.0 15.8 1.8 5.6 1.3 0.6 6.1 1.9 0.9 3.6 1.2 1.2 12.4 0.6 3.2 2.2 2.2 25.9 4.5 0.5 2.1 2.3 5.3 3.9 2.9 5.8 2.5 3.4 1.1 0.7 1.3 26.4 4.5 0.1 1.1 0.8 16.1 2.4 3.4 6.0 2.2 1.2 1.4 2.7 0.4 75.1 0.5 1.3 0.4 160.9 2.5 0.5 1.6 0.4 2.9 7.5 1.6 1.2 1.0 53.7 7.6 4.3 29.6 0.7 1.6 2.2 1.4 0.7 1.2 2.7 2.2 0.9 0.5 0.7 0.7 7.9 1.8 11.4 1.2 0.9 1.0 2.9 1.1 1.3 0.8 2.3 1.1 1.3 15.8 5.6 0.4 2.0 1.2 0.6 11.3 16.0 17.6 15.9 10.3 6.8 10.6 5.4 10.1 14.8 32.8 67.8 18.8 64.0 27.9 9.3 39.6 239.5 24.1 33.0 52.4 21.6 163.2 104.5 65.2 406.8 12.9 92.8 0.0 83.1 75.5 15.7 146.3 25.3 585.1 23.0 31.8 290.1 26.4 19.3 1716.5 24.2 11.8 15.1 1.0 590.8 39.3 80.3 364.7 23.7 47.4 15.5 6.5 15.6 61.3 15.6 48.1 294.5 10.7 374.8 96.0 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.6" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 22.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 20.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 7.8;RPMI-8226: 7.8;U-266/70: 9.5;U-937: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 2.8 1.0 1.2 8.6 1.5 5.9 2.7 20.8 3.4 14.3 7.7 1.5 6.6 3.5 7.3 22.3 9.2 4.3 4.4 1.9 1.0 1.1 1.4 59.6 4.3 11.1 1.1 1.0 3.2 1.1 0.6 1.0 9.3 1.2 6.1 5.9 1.5 3.2 6.6 0.9 12.4 7.7 3.6 1.9 10.8 3.3 4.4 1.4 1.7 2.5 10.6 9.8 6.1 7.9 2.1 4.8 6.9 4.6 4.8 7.6 5.6 0.4 0.1 0.1 1.2 3.0 3.1 0.2 0.4 0.4 1.0 1.6 0.1 0.1 6.2 0.0 1.8 0.3 5.2 1.5 1.2 0.8 0.1 0.5 2.3 0.3 0.5 0.6 3.5 7.8 2.5 2.6 0.4 0.8 2.0 0.1 2.5 0.7 1.7 0.7 0.2 0.6 5.0 0.4 0.3 0.0 0.1 0.9 7.8 0.4 1.8 0.4 0.1 0.2 0.7 0.7 0.5 0.8 0.8 0.2 1.7 0.9 1.7 0.1 9.5 1.9 2.4 1.2 8.8 0.5 6.9 3.0 4.2 5.8 4.6 5.0 2.1 5.4 6.1 4.8 1.6 7.6 7.5 2.4 4.8 4.0 2.5 6.3 5.6 1.2 1.5 20.8 3.4 1.0 1.1 1.1 1.0 1.2 1.4 0.0 0.6 6.7 12.4 11.7 1.8 0.2 0.0 4.0 2.3 0.0 5.9 2.0 3.3 1.2 11.0 1.0 19.1 0.0 1.2 3.1 7.5 2.2 10.3 22.1 4.8 1.6 10.9 3.7 5.3 0.5 4.6 6.1 1.7 0.0 18.1 1.7 1.6 11.4 9.2 0.5 0.7 0.0 2.1 0.5 0.4 14.3 4.1 4.5 14.0 6.8 STARD6 ENSG00000174448 "StAR related lipid transfer domain containing 6" P59095 18 54324358-54357964 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 25.3" "Group enriched" "Detected in some" 4 "Early spermatids: 147.4;Late spermatids: 184.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 2.2;T-cells: 1.9" "Cell line enhanced" "Detected in some" "HDLM-2: 4.4;Karpas-707: 5.9;U-266/70: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" NA NA "unprognostic (7.81e-2)" "unprognostic (1.50e-1)" "unprognostic (5.56e-3)" "unprognostic (1.70e-1)" "unprognostic (3.25e-1)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (8.98e-3)" "unprognostic (6.98e-5)" "unprognostic (1.90e-1)" "unprognostic (2.33e-3)" "unprognostic (2.68e-1)" "unprognostic (9.97e-2)" "unprognostic (1.91e-3)" "unprognostic (1.16e-3)" 0.1 0.3 0.3 0.0 0.8 0.1 0.1 0.3 0.6 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.1 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.7 0.1 0.0 25.3 0.0 0.7 0.3 0.0 0.1 0.1 0.0 0.3 0.2 0.2 0.3 2.2 1.9 0.2 0.1 0.0 1.7 0.2 0.4 0.0 0.1 0.4 0.4 0.8 0.2 0.4 0.8 0.6 0.3 0.0 1.0 0.2 0.0 1.6 0.4 4.4 0.8 0.2 0.0 0.3 0.6 1.6 0.8 1.1 0.2 0.5 0.3 0.4 0.7 1.7 0.3 5.9 0.8 0.3 0.4 0.3 0.0 0.0 0.4 0.4 0.1 0.0 1.7 0.7 1.6 1.5 0.9 0.0 0.4 0.6 0.1 0.5 1.7 0.6 1.3 0.6 0.5 7.3 3.4 0.8 2.1 0.6 1.8 0.2 0.2 0.1 1.1 0.1 0.9 0.3 0.3 1.9 0.2 0.3 0.2 1.1 0.2 2.2 0.3 0.2 1.0 0.2 0.3 0.8 0.3 0.6 0.4 0.3 0.4 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 147.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 184.8 2.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.1 0.0 0.5 0.0 0.1 40.0 1.3 0.0 0.2 0.0 0.0 0.0 STAT4 ENSG00000138378 "Signal transducer and activator of transcription 4" Q14765 2 191029576-191151596 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.4;testis: 25.5" "Cell type enhanced" "Detected in many" 25 "Early spermatids: 201.0;Late spermatids: 43.8;T-cells: 84.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "NK-cells: 16.9;T-cells: 29.4" "Cell line enhanced" "Detected in some" "Karpas-707: 30.9;U-266/70: 17.4;U-266/84: 6.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA001860, CAB013108" Enhanced NA NA "CAB013108: , HPA001860: AB_1080104" "unprognostic (3.90e-5)" "unprognostic (1.30e-1)" "unprognostic (4.16e-2)" "unprognostic (6.45e-4)" "unprognostic (3.77e-2)" "unprognostic (4.79e-2)" "unprognostic (3.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.57e-1)" "unprognostic (1.49e-3)" "prognostic favorable (5.88e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.07e-8)" "unprognostic (2.65e-1)" "unprognostic (6.02e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-1)" 4.2 3.6 2.1 9.6 12.7 11.2 2.9 1.1 15.5 1.7 3.7 0.0 0.3 4.1 1.7 2.4 1.5 1.7 4.2 20.3 3.3 6.5 2.7 7.6 8.4 14.1 3.3 8.3 1.5 2.2 0.7 19.6 2.4 8.5 1.9 3.2 2.3 4.5 1.5 1.1 1.3 6.6 1.3 2.5 13.8 3.6 25.5 0.5 4.2 2.4 1.0 12.8 3.3 1.9 0.4 2.0 2.3 0.2 16.9 29.4 10.7 0.0 1.0 0.6 0.0 0.0 1.9 0.2 0.2 1.1 0.3 1.3 0.2 0.5 0.0 0.1 1.4 0.8 0.5 0.0 2.6 0.7 0.0 0.5 0.7 0.0 0.0 0.3 0.0 0.0 0.9 1.2 0.7 0.3 0.0 0.0 3.0 0.0 30.9 0.1 0.0 1.7 0.0 0.2 0.0 0.5 0.0 0.0 2.1 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 17.4 6.1 0.0 0.7 0.0 0.0 2.3 0.1 0.0 29.4 0.2 26.5 0.4 17.5 23.8 0.1 0.2 16.7 23.8 0.6 16.9 0.1 2.0 6.1 10.7 2.1 12.7 1.1 15.5 3.3 6.5 3.3 8.3 8.5 0.5 3.0 6.2 1.9 0.6 1.1 0.0 15.1 0.0 0.0 0.0 1.8 7.9 0.1 0.0 0.4 201.0 0.6 0.0 0.0 0.2 2.0 1.4 0.8 1.1 0.9 1.0 0.0 0.0 1.3 2.9 43.8 0.3 4.3 5.0 8.2 0.0 0.0 0.2 0.0 0.4 0.7 0.2 0.0 1.4 1.0 1.0 1.5 0.5 84.1 0.2 0.7 STATH STR ENSG00000126549 Statherin P02808 4 69995930-70002570 "Plasma proteins, Predicted secreted proteins, Transporters" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 162 "salivary gland: 5940.6" "Cell type enriched" "Detected in single" 7 "Early spermatids: 2.1" "Group enriched" "Detected in some" 14 "head and neck cancer: 3.5;lung cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HHSteC: 1.4" HPA044569 Enhanced "Secreted to digestive system" NA NA "HPA044569: AB_10966146" "unprognostic (2.00e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.3 1.5 0.0 0.1 0.1 0.0 0.5 0.0 0.0 5940.6 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 36.5 5.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STBD1 "FLJ41801, GENX-3414" ENSG00000118804 "Starch binding domain 1" O95210 4 76306026-76311599 "Plasma proteins, Predicted intracellular proteins, Transporters" "Autophagy, Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 12.0;Ductal cells: 5.3;Enterocytes: 4.9;Exocrine glandular cells: 3.5;Pancreatic endocrine cells: 3.5;Paneth cells: 3.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 15.0;Karpas-707: 31.5;U-266/70: 20.4" "Low region specificity" "Detected in many" "HPA011952, HPA012849" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA011952: AB_1847461, HPA012849: AB_1847460" "unprognostic (1.46e-1)" "unprognostic (1.02e-3)" "unprognostic (4.29e-2)" "unprognostic (1.95e-1)" "unprognostic (2.57e-1)" "unprognostic (4.72e-2)" "unprognostic (1.35e-2)" "unprognostic (6.84e-2)" "unprognostic (3.06e-1)" "unprognostic (1.03e-1)" "unprognostic (4.96e-3)" "unprognostic (4.42e-2)" "unprognostic (3.52e-2)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (2.84e-1)" "unprognostic (5.74e-2)" 16.1 1.2 0.1 0.7 0.0 1.9 3.7 0.0 0.5 1.2 2.7 1.2 2.3 0.0 1.6 1.2 1.0 7.1 0.0 0.5 0.7 14.3 2.6 0.0 0.3 1.3 1.9 0.4 0.2 1.2 2.1 1.6 1.2 1.1 34.5 0.0 3.9 2.4 0.6 0.0 2.3 0.5 0.1 0.0 3.4 1.4 0.2 3.2 5.9 3.6 3.7 3.6 1.4 3.8 1.8 0.2 2.4 5.3 1.4 3.3 4.2 2.5 1.6 1.9 1.8 4.5 0.0 3.4 2.7 3.7 2.4 0.7 0.9 0.6 15.0 1.0 0.2 2.3 2.2 0.7 2.1 2.8 0.8 2.7 1.3 0.7 4.1 0.0 0.0 0.1 31.5 2.8 2.5 0.2 1.8 0.4 2.7 2.0 0.0 0.9 2.6 0.9 1.9 0.8 4.4 3.3 4.2 0.0 0.4 1.1 0.7 0.7 3.2 2.0 7.5 2.3 20.4 3.7 0.0 4.4 1.4 1.0 0.3 3.6 5.9 2.7 3.3 1.7 0.2 3.6 3.4 3.2 0.0 0.6 1.1 0.7 3.7 1.6 0.2 0.6 1.4 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 4.9 0.0 3.5 1.1 0.3 0.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.0 0.0 3.5 3.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 1.5 0.6 STC1 STC ENSG00000159167 "Stanniocalcin 1" P52823 8 23841915-23854807 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 62.3" "Cell type enhanced" "Detected in many" 18 "Collecting duct cells: 92.5;Endothelial cells: 179.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 60.1;hTEC/SVTERT24-B: 35.4;U-251 MG: 24.5;U-87 MG: 110.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB018625, HPA023918" Approved "Secreted in other tissues" NA NA 120000 "CAB018625: AB_2197536, HPA023918: AB_1857566" "unprognostic (1.18e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (3.58e-2)" "unprognostic (2.13e-1)" "prognostic unfavorable (6.44e-5)" "prognostic unfavorable (6.32e-4)" "unprognostic (2.84e-2)" "prognostic unfavorable (1.53e-4)" "unprognostic (4.82e-2)" "unprognostic (1.44e-2)" "unprognostic (7.61e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.23e-6)" "prognostic unfavorable (5.55e-4)" "unprognostic (2.79e-1)" "unprognostic (1.19e-3)" "unprognostic (8.95e-3)" 62.3 2.0 3.5 1.9 8.3 0.3 27.4 2.9 15.9 37.8 6.6 0.7 2.5 1.3 22.8 8.3 7.0 4.2 10.6 23.3 1.6 3.4 9.5 2.9 5.8 0.6 3.5 0.0 7.1 9.5 7.7 19.6 19.3 11.0 8.8 1.5 10.9 6.8 6.0 12.7 2.2 2.0 5.3 8.2 0.6 6.2 4.6 3.2 0.0 38.2 8.8 2.7 20.9 22.4 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.2 0.2 0.3 0.0 2.3 2.5 0.0 3.5 60.1 1.1 5.6 0.0 0.0 0.0 5.3 1.1 20.6 0.2 0.1 0.8 10.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 11.7 0.0 35.4 0.0 17.0 0.4 0.0 0.1 0.1 5.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.1 0.0 5.4 0.3 0.3 0.4 3.7 0.0 4.6 14.6 0.5 0.2 24.5 0.0 0.0 0.0 110.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 3.5 8.3 2.9 15.9 1.6 3.4 3.5 0.0 11.0 3.2 3.0 12.8 0.0 0.4 20.1 1.2 3.0 25.5 0.0 3.4 92.5 0.0 0.9 0.0 26.0 0.0 179.1 0.0 0.0 0.2 1.4 36.7 5.4 1.1 0.0 2.0 7.9 0.0 11.6 0.8 0.0 4.6 0.0 16.9 0.0 0.0 0.8 4.7 0.0 0.0 0.0 1.3 0.0 9.9 0.0 0.0 18.1 1.6 0.0 0.0 2.5 STC2 STC-2 ENSG00000113739 "Stanniocalcin 2" O76061 5 173314713-173329503 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 68.5;pancreas: 51.8" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 33.9;Ductal cells: 28.6;Extravillous trophoblasts: 43.0;Leydig cells: 21.3" "Cancer enriched" "Detected in all" 6 "breast cancer: 91.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 115.7;T-47d: 109.8;U-138 MG: 45.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA045372 Uncertain Approved "Endoplasmic reticulum" "Secreted in other tissues" NA NA 15000000 "Endoplasmic reticulum" "HPA045372: AB_10961040" "prognostic favorable (7.40e-5)" "unprognostic (2.40e-2)" "unprognostic (9.03e-3)" "unprognostic (1.21e-1)" "unprognostic (1.89e-3)" "prognostic unfavorable (1.76e-6)" "prognostic unfavorable (3.07e-5)" "unprognostic (5.28e-3)" "unprognostic (6.12e-3)" "unprognostic (1.53e-1)" "unprognostic (2.13e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.17e-8)" "prognostic unfavorable (7.57e-4)" "unprognostic (8.56e-2)" "unprognostic (5.06e-2)" "unprognostic (7.93e-3)" 3.6 0.7 0.3 1.4 0.8 0.2 68.5 0.4 2.4 6.5 2.4 0.1 1.4 0.5 1.6 2.4 3.1 1.3 5.8 17.4 0.9 0.4 1.7 0.6 17.3 0.7 2.4 0.0 2.0 51.8 1.5 1.2 12.1 2.8 3.0 0.6 0.1 0.6 5.7 10.8 7.4 1.7 8.8 7.1 14.8 2.2 0.8 1.0 0.0 4.5 0.7 0.4 9.5 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 1.8 0.3 1.5 5.6 2.4 15.4 26.4 26.3 6.7 13.0 8.4 4.3 0.0 4.0 15.6 34.7 2.4 3.9 8.2 11.8 0.0 2.2 0.0 2.8 5.6 35.2 1.8 0.5 5.1 13.2 15.6 1.1 31.3 1.8 5.5 0.2 0.0 115.7 4.7 0.0 0.0 0.9 2.5 8.9 0.0 3.9 3.0 0.0 0.4 4.2 1.1 1.1 0.1 4.6 1.2 109.8 1.8 16.8 45.4 0.1 26.4 5.5 5.1 2.7 1.2 8.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.4 2.4 0.9 0.4 2.4 0.0 2.8 1.0 0.0 0.0 0.0 0.2 4.4 10.0 12.1 0.0 0.0 0.0 0.0 0.0 33.9 0.0 28.6 0.5 10.5 0.0 0.0 11.2 43.0 20.0 0.3 0.0 0.0 4.5 0.0 6.9 3.1 0.0 1.1 21.3 0.2 10.1 0.0 0.0 1.1 12.1 0.0 0.4 4.1 2.2 0.0 2.7 0.9 1.0 5.5 18.3 0.0 0.0 0.0 STEAP1 "PRSS24, STEAP" ENSG00000164647 "STEAP family member 1" Q9UHE8 7 90154375-90164829 "Cancer-related genes, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 44.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 43.1;Exocrine glandular cells: 33.5;Glandular cells: 64.3;Urothelial cells: 39.0" "Cancer enriched" "Detected in all" 6 "prostate cancer: 94.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 29.6;CAPAN-2: 35.5;U-138 MG: 45.1" HPA030985 Uncertain NA NA "HPA030985: AB_2673686" "unprognostic (2.88e-3)" "unprognostic (2.29e-1)" "unprognostic (1.19e-1)" "unprognostic (3.21e-3)" "unprognostic (9.20e-3)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" "unprognostic (6.74e-3)" "unprognostic (6.36e-2)" "unprognostic (6.45e-3)" "unprognostic (8.31e-3)" "unprognostic (3.79e-1)" "unprognostic (2.60e-2)" "unprognostic (4.39e-2)" "unprognostic (2.42e-1)" "unprognostic (6.09e-2)" "unprognostic (1.38e-1)" 19.8 1.5 2.9 16.5 1.4 0.0 26.0 0.9 6.3 5.5 10.0 0.1 0.7 2.7 3.0 4.4 10.0 7.3 8.4 7.1 1.4 0.5 5.3 21.2 9.3 2.9 0.5 2.7 12.4 6.5 0.2 5.8 0.5 1.4 44.7 7.3 1.2 9.8 5.3 3.9 3.3 7.4 13.7 1.4 2.8 7.4 2.1 0.7 0.0 4.6 6.5 3.7 12.5 16.1 0.8 1.7 0.0 0.0 0.0 0.0 0.2 6.8 13.9 0.8 2.5 29.6 24.6 0.2 4.7 5.8 0.6 0.8 10.3 35.5 0.0 0.2 7.7 12.6 1.4 6.0 6.6 1.3 0.0 2.2 0.0 0.1 3.4 1.1 0.0 0.0 17.3 1.0 19.6 10.4 4.6 25.4 2.1 0.3 19.8 8.1 0.1 0.0 0.1 4.2 0.3 6.7 0.0 0.0 0.0 5.6 1.4 0.0 0.3 1.8 0.0 3.1 0.5 7.8 0.1 13.0 45.1 2.3 22.7 5.7 3.7 0.1 0.0 22.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 1.4 0.9 6.3 1.4 0.5 0.5 2.7 1.4 0.7 0.0 0.3 0.0 43.1 3.8 0.0 0.8 0.0 6.7 2.3 1.8 0.0 0.0 0.0 2.1 0.3 2.2 3.5 0.0 33.5 0.1 15.0 64.3 0.0 30.1 0.5 0.0 6.9 1.8 1.0 1.0 0.9 1.8 6.8 0.0 4.1 9.4 29.2 10.5 1.4 13.9 0.2 6.5 5.6 12.6 30.9 1.9 0.2 0.0 13.5 39.0 STEAP1B ENSG00000105889 "STEAP family member 1B" Q6NZ63 7 22419444-22632925 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.6" "Cell type enhanced" "Detected in some" 16 "Horizontal cells: 11.1;monocytes: 20.8;Spermatocytes: 7.2;Spermatogonia: 13.0" "Cancer enhanced" "Detected in many" "melanoma: 5.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 88 "memory B-cell: 9.9;naive B-cell: 8.6" "Lineage enriched" "Detected in single" 94 "B-cells: 9.9" "Group enriched" "Detected in many" 4 "hTEC/SVTERT24-B: 29.7;HUVEC TERT2: 33.4;K-562: 19.4;WM-115: 36.7" NA NA "unprognostic (7.35e-2)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-3)" "unprognostic (3.96e-2)" "unprognostic (2.18e-1)" "unprognostic (2.31e-5)" "unprognostic (2.29e-3)" "unprognostic (4.96e-2)" "unprognostic (7.37e-3)" "unprognostic (7.38e-2)" "unprognostic (1.27e-2)" "unprognostic (2.85e-10)" "unprognostic (1.06e-4)" "unprognostic (3.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-3)" 3.5 1.8 5.3 3.9 14.5 0.6 1.8 0.6 9.3 2.3 1.6 13.5 0.8 0.5 0.7 1.4 1.7 1.0 2.2 1.4 5.2 2.9 0.4 0.7 1.4 5.9 14.9 2.7 0.5 1.1 0.8 1.0 3.6 9.0 1.5 1.5 1.0 1.4 2.1 3.2 1.1 1.0 1.9 8.6 6.4 1.1 7.5 15.6 0.6 0.8 0.3 5.5 2.1 3.6 9.9 0.0 0.0 0.0 0.0 0.1 0.4 4.1 0.0 2.9 0.0 1.8 1.9 0.0 2.9 0.4 0.0 0.1 0.0 0.1 0.4 0.9 5.7 1.0 0.0 4.2 0.0 0.2 0.3 0.4 0.0 0.1 0.0 0.2 0.0 0.0 3.5 0.0 29.7 0.0 3.5 33.4 0.1 19.4 1.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 2.4 0.4 0.0 0.0 3.4 0.4 0.1 4.5 0.0 0.4 3.8 3.9 7.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.3 14.5 0.6 9.3 5.2 2.9 14.9 2.7 9.0 15.6 0.0 0.0 4.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 11.1 0.0 0.6 0.3 1.3 0.0 0.1 3.3 20.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 7.2 13.0 0.1 0.1 0.0 0.0 0.1 STEAP2 "IPCA-1, PCANAP1, STAMP1, STMP" ENSG00000157214 "STEAP2 metalloreductase" Q8NFT2 7 90167590-90238137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "prostate: 100.2" "Cell type enriched" "Detected in many" 4 "Glandular cells: 110.4" "Cancer enriched" "Detected in many" 12 "prostate cancer: 88.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.4;CAPAN-2: 28.9;U-138 MG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029115, HPA055603" Uncertain Supported Vesicles NA NA Vesicles "HPA029115: AB_10603894, HPA055603: " "unprognostic (6.26e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-4)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (7.91e-2)" "unprognostic (1.70e-1)" "unprognostic (9.92e-2)" "unprognostic (1.34e-1)" "unprognostic (2.71e-2)" "unprognostic (9.73e-2)" "unprognostic (6.11e-2)" "unprognostic (9.86e-5)" "unprognostic (3.69e-2)" 10.7 4.1 6.2 9.7 14.5 1.3 13.6 8.7 18.2 7.0 8.3 2.3 2.2 5.7 5.4 3.6 9.1 7.5 8.8 9.4 5.1 5.2 6.5 3.6 10.8 1.6 3.2 11.1 19.5 6.4 10.3 17.6 1.4 6.0 100.2 7.0 3.8 6.8 6.7 2.3 3.5 5.9 9.0 2.9 3.0 9.2 2.3 1.6 1.6 5.8 1.2 2.5 10.4 19.9 1.1 0.4 1.3 0.4 0.3 0.2 0.0 1.8 13.4 0.3 3.8 7.2 7.0 0.2 1.6 3.5 0.2 0.5 2.5 28.9 0.0 0.2 4.4 5.4 1.1 2.9 2.1 0.5 0.0 2.9 0.0 0.0 0.7 0.6 0.0 0.0 5.1 0.4 7.0 1.4 5.8 3.6 0.0 0.0 0.2 4.0 0.0 0.0 0.4 5.5 0.0 1.5 0.0 0.0 0.1 6.3 3.9 0.3 1.3 2.1 0.0 0.1 0.6 10.2 0.0 3.0 16.8 3.8 2.3 1.4 0.0 0.0 0.0 7.3 0.0 0.7 1.3 0.4 0.5 0.2 0.2 0.1 1.1 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.3 0.2 0.4 0.0 0.0 6.2 14.5 8.7 18.2 5.1 5.2 3.2 11.1 6.0 1.6 0.0 0.6 0.0 20.8 4.2 5.1 11.6 17.8 16.0 13.6 12.2 2.0 0.0 0.0 0.6 0.4 1.8 11.8 0.0 6.6 0.0 17.5 110.4 0.0 4.9 0.0 1.6 15.1 2.5 0.0 0.4 14.4 1.7 0.0 0.0 12.5 26.2 8.6 25.8 14.5 8.6 1.2 0.0 6.2 1.0 3.4 4.6 0.0 0.0 12.7 19.6 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Predicted membrane proteins" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 82.3;parathyroid gland: 47.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 30.8;Exocrine glandular cells: 31.3;Hepatocytes: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.1;U-87 MG: 46.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol NA NA 28000 Cytosol Nucleoli "HPA050510: AB_2681151" "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 8.1 2.8 2.5 1.2 4.2 5.1 9.2 3.0 2.2 6.4 6.1 3.0 3.7 7.9 1.3 3.1 5.1 4.0 2.8 6.6 2.9 1.4 3.4 82.3 3.9 4.9 3.9 0.4 5.2 9.0 47.4 5.1 4.3 6.1 4.8 2.4 2.1 12.6 9.1 10.9 3.0 9.8 0.9 6.4 1.0 6.7 1.5 3.2 0.2 3.3 6.9 4.0 4.2 3.7 0.8 7.0 0.7 4.3 2.1 0.2 1.5 6.4 7.7 0.0 2.6 3.8 36.1 6.8 2.0 2.2 4.1 3.7 5.8 8.8 0.0 15.6 11.6 29.3 10.9 3.4 6.8 4.6 0.0 11.0 12.5 7.0 11.5 9.5 3.1 2.4 21.4 12.0 24.2 8.7 28.1 3.5 0.0 6.1 1.3 11.5 6.1 0.0 1.8 10.6 9.9 16.1 0.0 4.5 5.5 5.0 16.3 13.0 2.4 5.7 19.8 1.5 1.6 3.9 4.1 15.0 25.5 14.9 5.4 11.1 0.0 0.0 0.0 46.7 7.9 5.2 0.0 4.0 0.7 0.2 4.3 0.0 0.8 0.0 0.0 7.0 0.2 0.0 0.0 0.1 2.1 0.6 0.3 0.0 1.5 2.5 4.2 3.0 2.2 2.9 1.4 3.9 0.4 6.1 3.2 0.0 6.4 0.5 6.8 1.8 0.1 5.5 5.1 30.8 10.3 0.0 0.0 25.8 0.0 7.9 0.2 2.9 10.9 0.0 31.3 3.0 4.3 4.8 3.5 86.3 11.1 0.0 1.7 0.6 3.8 0.0 1.7 6.4 0.0 0.0 4.6 0.0 17.9 7.8 7.1 0.5 0.0 6.5 2.1 0.2 0.0 1.3 19.8 0.0 9.1 8.1 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306891 "Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 122.8" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Group enriched" "Detected in some" 5 "midbrain: 1.7;pons and medulla: 6.4" "Cell type enriched" "Detected in some" 13 "neutrophil: 48.9" "Lineage enriched" "Detected in many" 13 "granulocytes: 48.9" "Group enriched" "Detected in some" 6 "HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065201 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favorable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 122.8 29.3 0.3 12.7 0.8 2.4 55.6 0.6 0.7 15.9 14.0 1.1 5.3 1.4 10.7 22.3 23.7 17.1 9.3 18.7 0.5 0.3 10.8 71.7 27.5 49.4 1.7 0.2 17.8 13.3 12.0 35.1 45.0 6.4 25.8 3.9 4.9 14.6 4.6 22.1 10.5 5.2 13.9 1.8 5.3 5.7 27.3 0.4 0.4 40.9 8.4 5.2 28.4 26.3 0.0 0.3 48.9 3.8 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 39.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.9 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 52.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.6 0.7 0.5 0.3 1.7 0.2 6.4 0.4 50.6 320.5 0.0 6.3 8.4 1.1 4.0 0.0 97.7 178.6 0.0 2.0 0.3 0.0 11.7 12.9 8.9 0.0 0.0 8.2 9.0 11.1 62.8 15.1 0.4 2.1 0.0 0.0 19.0 5.1 1.9 106.4 7.7 5.0 0.0 0.0 2.4 16.5 0.0 8.5 0.0 0.2 452.7 115.4 0.9 0.2 16.4 9.2 0.0 0.0 12.2 STH MAPTIT ENSG00000256762 Saitohin Q8IWL8 17 45999250-45999694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.2;breast: 1.9;placenta: 1.6;skeletal muscle: 2.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 2.7;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.1;HDLM-2: 3.2;PC-3: 1.0;RPMI-8226: 1.0;RT4: 1.7" NA NA "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" 0.0 0.0 0.8 0.0 1.3 0.0 1.9 4.1 4.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 1.6 0.2 0.0 0.5 0.0 2.5 0.7 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 STIL "MCPH7, SIL" ENSG00000123473 "STIL, centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.0;testis: 23.8" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 18.6;Spermatogonia: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA046543 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA046543: AB_2679692" "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.2 1.4 1.3 10.8 2.4 11.0 2.9 1.4 2.2 1.2 4.1 0.9 2.5 3.6 1.5 2.2 5.8 0.9 1.7 2.0 1.4 1.2 1.5 1.6 1.7 5.0 1.3 1.5 1.2 1.5 0.9 0.9 5.5 1.1 1.7 6.4 0.8 3.6 0.5 0.8 4.2 4.0 1.3 1.2 3.4 2.2 23.8 1.0 36.0 1.1 3.5 7.1 1.3 2.1 1.9 1.6 5.4 0.7 3.3 1.2 0.5 16.9 9.1 13.1 11.7 0.9 2.3 8.4 15.0 7.2 16.8 17.7 9.8 8.4 20.0 7.1 7.5 17.3 11.3 15.3 7.9 18.1 14.9 6.9 22.5 11.3 8.6 0.5 18.2 11.5 0.8 1.3 14.4 9.4 2.1 11.1 15.3 15.9 19.1 12.6 7.7 17.6 5.7 15.9 9.4 7.5 11.5 21.4 9.6 4.7 10.2 11.7 7.0 16.1 11.9 7.8 16.3 7.7 10.4 6.5 15.9 16.1 11.4 20.3 6.3 13.1 19.7 7.4 13.9 14.7 4.3 0.7 1.1 1.1 0.4 0.5 1.7 1.2 1.0 0.5 1.9 0.8 0.8 5.4 3.3 0.3 1.6 1.1 0.5 1.3 2.4 1.4 2.2 1.4 1.2 1.3 1.5 1.1 1.0 3.0 0.3 2.2 0.5 0.8 1.2 0.5 0.0 6.7 2.3 0.0 3.9 1.2 0.0 1.2 0.7 0.9 1.8 0.0 0.4 3.8 0.8 1.2 2.3 0.5 2.3 0.0 1.7 1.8 1.9 1.3 0.3 1.2 0.0 4.6 4.3 0.8 1.8 1.5 0.7 0.3 0.7 0.0 0.0 18.6 17.8 2.0 0.7 0.8 3.4 1.4 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 168.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3700000 "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 27.3 49.7 32.2 32.0 40.5 25.8 41.5 45.3 41.9 28.3 25.5 29.2 20.6 19.2 30.1 25.2 31.5 36.2 21.6 34.4 32.2 42.8 24.7 27.8 25.4 31.9 47.7 22.5 34.1 24.1 39.1 38.3 37.0 40.7 30.1 28.5 20.3 22.6 29.5 51.9 27.6 20.7 33.2 39.7 26.5 24.4 56.4 49.0 29.8 46.1 23.4 41.2 26.0 168.2 32.2 26.8 20.9 39.6 39.5 35.9 39.5 49.3 77.1 48.7 40.5 27.1 18.1 43.8 44.9 24.2 65.2 38.0 56.4 42.4 59.1 52.9 35.5 77.2 52.5 122.1 44.9 71.8 46.4 49.8 83.2 51.8 51.9 23.6 43.9 52.6 18.4 28.3 54.0 40.7 26.6 45.9 44.1 82.2 34.0 37.4 72.3 66.0 59.9 58.6 47.6 65.2 65.0 46.4 59.8 45.5 43.8 39.7 35.3 51.2 54.2 41.7 53.4 57.6 30.4 41.1 41.5 51.3 54.1 60.4 31.0 66.9 62.4 53.7 44.2 59.6 19.0 25.3 20.9 35.9 36.2 35.7 32.2 27.2 32.0 26.8 26.0 30.5 33.8 7.7 39.5 39.6 22.2 24.0 39.5 32.2 40.5 45.3 41.9 32.2 42.8 47.7 22.5 40.7 49.0 41.7 29.9 44.0 125.4 71.4 35.5 38.9 30.6 104.4 56.9 19.2 39.3 105.5 41.4 70.8 21.1 33.5 27.4 23.3 47.8 125.3 57.5 60.1 78.4 24.1 80.9 60.4 64.5 15.4 15.0 52.9 25.3 54.0 59.1 71.3 20.5 32.1 57.8 21.6 37.4 29.8 29.8 25.8 88.2 82.3 133.5 63.0 176.4 42.1 24.4 89.5 STK10 "LOK, PRO2729" ENSG00000072786 "Serine/threonine kinase 10" O94804 5 172042073-172188386 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 78.5;T-cells: 70.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 27.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015083, CAB020840" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 24000 "Nucleoplasm, Plasma membrane" "CAB020840: , HPA015083: AB_2669151" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "prognostic favorable (2.76e-4)" "unprognostic (2.88e-1)" "unprognostic (6.96e-3)" "unprognostic (1.02e-1)" "unprognostic (5.25e-3)" "unprognostic (3.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.65e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" 15.0 4.7 2.6 25.8 4.4 38.3 13.5 27.5 3.0 3.6 5.0 4.8 3.4 4.7 4.4 4.4 3.6 4.2 11.0 9.0 2.4 2.5 5.3 4.5 15.4 40.9 5.4 1.9 3.5 4.1 2.5 3.7 16.2 4.5 4.3 4.0 5.6 7.8 2.5 3.1 9.0 12.2 5.7 4.6 33.0 6.2 13.1 3.5 20.6 4.6 3.1 23.7 9.5 11.3 5.0 10.3 22.3 30.8 7.4 18.0 15.6 7.8 7.3 4.5 6.8 5.3 6.6 11.6 10.2 8.5 7.4 6.9 3.8 10.4 9.5 5.4 12.6 15.7 9.2 2.0 12.5 4.8 12.3 3.4 11.4 3.0 2.1 7.6 11.5 13.5 6.5 2.7 10.1 8.4 2.7 6.4 3.7 1.0 13.3 5.2 12.6 8.2 25.8 1.8 3.9 5.8 13.6 3.6 6.2 3.0 9.9 3.1 3.8 5.9 8.3 28.0 5.9 2.9 24.4 8.9 8.3 4.2 5.8 5.5 11.2 16.5 6.0 10.9 17.7 52.3 7.1 10.8 10.0 18.0 21.4 13.3 5.0 9.4 12.8 10.3 4.4 5.6 9.6 22.3 7.4 30.8 3.2 12.2 15.6 2.6 4.4 27.5 3.0 2.4 2.5 5.4 1.9 4.5 3.5 3.0 12.8 25.0 7.9 6.0 3.8 3.6 2.5 5.3 5.7 1.8 5.9 2.8 1.7 4.4 1.7 17.8 8.4 0.0 5.3 25.1 7.4 6.7 26.7 2.1 30.8 44.5 11.5 20.3 78.5 2.7 2.6 39.2 8.5 9.0 15.0 3.1 7.9 7.0 1.4 1.5 2.2 12.9 8.2 5.7 6.8 3.6 4.2 70.5 4.7 9.5 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43626786 "Enzymes, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 549.3;Urothelial cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA018138, HPA037979" Uncertain Supported "Nuclear speckles,Plasma membrane" Yes No "Nuclear speckles" "Plasma membrane" "HPA018138: AB_2669784, HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 7.1 10.1 6.1 43.3 8.2 20.2 8.4 7.9 7.2 4.8 9.3 3.7 2.0 6.1 5.3 4.2 10.1 4.7 8.6 17.7 5.7 5.6 6.7 8.1 15.2 36.6 6.6 2.6 7.3 14.3 1.5 6.3 37.2 5.7 6.2 5.3 3.6 8.6 3.4 10.7 4.8 12.3 5.8 5.3 27.8 11.0 9.0 2.8 30.1 7.3 6.8 37.7 10.3 8.1 10.8 1.4 11.5 0.9 12.7 11.4 2.9 4.4 5.5 5.0 3.4 6.3 8.3 2.1 15.9 17.3 8.7 8.9 4.8 3.2 7.1 25.1 13.3 17.8 9.1 3.8 21.2 12.2 17.5 4.3 6.3 4.1 5.9 4.7 10.8 4.2 6.8 25.0 11.5 10.6 34.5 16.3 7.7 7.4 24.4 10.0 2.0 17.6 5.0 7.7 2.6 18.1 6.1 3.2 14.0 15.2 3.3 2.7 6.1 7.2 3.3 4.6 10.7 3.8 5.5 16.3 19.0 7.2 11.2 17.8 14.8 7.3 10.2 19.3 9.6 30.2 0.7 0.4 11.5 5.8 0.2 5.8 10.8 6.1 9.7 0.3 10.1 11.4 10.2 6.4 12.7 0.9 1.4 3.2 2.9 6.1 8.2 7.9 5.9 5.7 5.6 6.6 2.6 5.7 2.8 113.2 27.8 121.1 549.3 161.6 3.0 25.4 5.1 52.2 81.9 19.2 9.8 44.4 28.2 110.3 36.3 19.4 29.1 0.0 82.8 19.7 31.9 134.1 39.1 7.7 15.8 0.0 6.9 16.5 16.2 8.8 5.5 19.9 33.7 55.1 27.8 8.1 75.9 56.1 2.5 9.7 25.2 6.5 55.6 45.1 29.6 118.9 55.8 186.8 10.0 279.4 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133566-196176503 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2" "Cell type enhanced" "Detected in many" 5 "B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5" "Region enriched" "Detected in many" 6 "cerebellum: 71.1" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 21.0 4.1 3.2 42.8 3.8 103.4 10.1 3.2 3.3 8.2 18.8 1.1 3.8 8.5 3.4 3.9 8.9 6.3 8.6 5.7 3.3 2.2 7.2 2.9 26.2 53.7 2.3 1.8 3.1 5.0 0.7 3.8 6.5 1.7 6.8 5.7 3.5 16.7 6.1 3.4 10.9 31.8 5.3 2.7 59.3 6.0 4.6 1.4 72.2 7.5 7.0 56.2 11.3 6.0 16.9 13.6 62.0 27.0 10.3 28.4 19.0 3.2 2.2 3.4 1.2 15.0 5.7 3.8 7.7 11.6 8.5 8.9 6.8 1.1 36.3 7.1 4.4 2.2 2.2 1.4 3.3 10.4 6.4 3.8 3.4 2.9 0.6 4.5 13.7 36.8 7.2 3.3 10.5 5.5 12.1 3.5 8.6 2.6 34.1 21.1 1.7 17.8 31.0 1.9 5.9 5.2 2.9 20.7 11.0 5.0 7.6 1.3 1.3 1.9 1.9 1.6 5.5 1.3 7.2 4.2 8.3 4.1 5.9 4.3 14.0 22.6 39.5 6.2 4.7 3.6 35.9 19.7 40.2 12.0 20.7 15.3 13.3 21.5 14.5 13.6 16.9 28.4 23.1 62.0 10.3 27.0 9.7 18.5 19.0 3.2 3.8 3.2 3.3 3.3 2.2 2.3 1.8 1.7 1.4 83.4 80.3 158.6 22.9 53.1 0.3 2.2 10.2 34.8 52.4 10.4 0.0 5.9 3.3 5.2 4.6 11.6 59.1 46.7 2.5 20.9 21.2 28.7 189.5 2.4 23.5 0.0 2.9 7.4 142.8 2.0 5.2 145.8 55.6 40.5 11.0 0.9 7.9 38.6 4.2 1.4 0.2 6.5 20.5 28.6 24.9 55.5 4.2 178.5 10.5 39.9 STK25 "SOK1, YSK1" ENSG00000115694 "Serine/threonine kinase 25" O00506 2 241492674-241509730 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skeletal muscle: 164.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047147 Uncertain NA NA "HPA047147: AB_10966137" "unprognostic (1.75e-1)" "unprognostic (8.29e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.42e-2)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (3.91e-8)" "unprognostic (6.16e-2)" "unprognostic (7.15e-3)" "unprognostic (1.11e-1)" "unprognostic (2.58e-3)" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-1)" "unprognostic (3.19e-1)" "unprognostic (4.58e-1)" 17.8 13.6 22.3 14.2 26.0 16.3 12.9 22.3 35.3 16.4 17.1 17.0 13.0 14.6 17.7 15.9 19.3 15.4 16.7 19.0 19.4 20.0 17.3 13.5 13.4 13.5 16.3 20.4 17.5 19.2 18.9 17.1 15.6 16.4 15.1 12.9 13.5 14.2 17.6 164.2 15.3 14.2 17.3 12.6 15.8 16.1 16.8 14.4 15.2 20.0 24.6 12.6 14.6 16.6 15.0 13.6 13.7 16.4 21.5 19.9 10.6 18.7 11.9 23.9 29.6 29.4 20.6 36.7 31.3 21.1 23.9 27.4 13.3 16.6 7.1 8.8 41.7 21.7 16.0 33.6 34.1 29.1 26.7 35.3 20.0 25.3 34.3 26.7 12.1 15.5 29.5 24.5 23.1 18.6 29.4 53.9 26.4 30.8 6.4 43.7 19.7 18.0 18.9 33.3 17.5 17.2 30.3 30.4 10.7 21.0 15.9 40.2 18.4 15.2 11.5 19.6 28.3 9.2 21.6 62.8 18.1 22.1 20.7 22.2 13.2 2.9 12.1 17.5 10.0 20.5 13.7 14.8 11.5 16.9 13.4 15.5 14.5 15.5 17.5 13.6 15.0 12.0 11.6 5.5 21.5 16.4 10.7 19.9 10.6 22.3 26.0 22.3 35.3 19.4 20.0 16.3 20.4 16.4 14.4 20.8 36.6 14.1 25.2 22.7 49.3 31.3 33.1 16.0 19.4 24.4 25.5 71.0 23.2 38.2 10.6 44.7 31.6 46.7 29.7 65.7 31.3 25.3 25.3 21.2 39.2 30.2 34.0 44.8 29.8 9.6 30.2 21.3 18.6 65.9 34.9 46.4 36.1 52.6 37.4 37.8 36.1 45.3 29.9 72.8 32.6 26.6 43.8 25.4 41.9 24.5 STK31 "SgK396, TDRD8" ENSG00000196335 "Serine/threonine kinase 31" Q9BXU1 7 23710167-23832513 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 56.0" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 163.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "CACO-2: 20.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA023194 Enhanced NA NA "HPA023194: AB_1857590" "unprognostic (4.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (1.50e-2)" "unprognostic (1.09e-2)" "unprognostic (1.26e-1)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (2.42e-3)" "unprognostic (2.92e-1)" "unprognostic (1.29e-6)" "unprognostic (7.83e-2)" "unprognostic (9.21e-3)" "unprognostic (1.46e-1)" "unprognostic (3.65e-1)" 0.1 0.0 0.1 0.1 0.7 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 56.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 20.1 2.5 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.1 0.2 0.0 0.1 0.1 0.1 0.1 3.0 1.4 0.0 0.2 0.1 1.7 0.4 2.5 6.7 4.5 0.0 0.0 0.5 0.0 0.2 16.5 0.0 0.3 0.0 0.6 0.1 0.0 0.3 0.0 0.8 0.2 0.0 1.2 0.0 0.0 12.3 3.1 0.0 0.0 0.0 0.2 1.3 0.4 0.8 2.8 0.0 1.2 0.0 0.0 163.1 32.6 0.1 0.5 0.0 0.4 0.4 STK32A "MGC22688, YANK1" ENSG00000169302 "Serine/threonine kinase 32A" Q8WU08 5 147234963-147387852 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 19.7;brain: 21.1;retina: 31.9" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 5.0;Melanocytes: 15.1;Muller glia cells: 4.6" "Cancer enhanced" "Detected in many" "melanoma: 11.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "RT4: 9.8;SK-MEL-30: 34.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040236 Approved Centrosome NA NA Centrosome "HPA040236: AB_10795416" "unprognostic (1.90e-1)" "unprognostic (4.71e-4)" "unprognostic (5.32e-2)" "unprognostic (3.49e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "unprognostic (2.66e-2)" "unprognostic (2.96e-3)" "unprognostic (4.85e-2)" "unprognostic (2.36e-2)" "unprognostic (3.87e-1)" "unprognostic (8.38e-2)" "unprognostic (2.50e-3)" "unprognostic (5.53e-5)" "unprognostic (2.48e-1)" "unprognostic (3.20e-2)" "unprognostic (3.67e-3)" 2.1 19.7 4.8 1.3 7.1 0.4 2.3 21.1 7.7 1.2 1.8 6.2 0.6 1.2 1.6 5.6 1.0 1.3 4.3 1.6 4.9 12.6 6.3 0.6 2.1 0.5 12.1 2.2 5.1 4.2 0.4 8.5 0.7 20.7 2.1 1.1 31.9 1.2 1.8 0.6 2.9 1.1 1.4 12.4 0.8 1.4 2.1 6.9 0.0 15.7 0.5 0.5 4.1 2.1 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.1 3.8 9.8 0.9 0.4 0.0 0.1 34.7 0.1 0.0 0.0 0.1 0.0 0.6 0.4 0.4 1.1 0.2 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.8 7.1 21.1 2.3 4.9 12.6 12.1 2.2 20.7 6.9 0.0 1.6 0.0 0.2 1.3 1.2 0.4 0.0 0.0 1.2 1.8 0.0 0.0 1.7 1.2 5.0 0.0 0.0 0.0 2.4 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.9 0.0 15.1 0.0 0.0 4.6 4.1 0.0 3.9 3.0 0.9 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.6 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051442-5500998 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.6;lymphoid tissue: 33.6" "Cell type enhanced" "Detected in some" 25 "Distal tubular cells: 14.9;Early spermatids: 83.1;Late spermatids: 31.4;Proximal tubular cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive B-cell: 1.3;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "B-cells: 1.3;dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "GAMG: 11.9;HUVEC TERT2: 11.7;REH: 10.3;U-2197: 18.7;WM-115: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 5.2 0.8 6.0 2.1 4.8 2.3 7.3 1.0 5.8 6.0 2.1 5.2 1.6 1.2 5.7 1.6 2.3 2.5 4.7 0.9 4.5 7.6 23.6 0.5 1.3 2.8 5.3 2.2 1.2 4.9 0.8 0.8 5.1 4.2 2.3 2.2 3.0 2.9 1.9 2.1 3.6 1.6 7.0 3.9 0.6 9.5 7.1 2.9 33.6 2.8 2.1 1.9 4.2 6.1 1.3 3.5 0.0 0.5 0.0 0.0 0.0 0.0 5.8 0.3 0.0 0.2 0.4 0.0 4.0 0.5 2.7 0.1 0.0 0.0 0.0 0.9 8.2 11.9 0.0 0.6 0.0 1.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.1 11.7 0.6 0.0 0.0 1.4 0.0 0.0 0.8 1.7 0.0 0.0 10.3 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 3.5 0.3 0.0 0.0 3.0 0.0 1.2 18.7 0.0 0.4 0.0 0.0 0.0 0.0 47.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.0 4.8 1.0 5.8 4.5 7.6 5.3 2.2 4.2 2.9 0.0 0.6 0.0 0.1 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.8 83.1 1.6 0.0 0.0 0.0 0.1 3.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.4 1.4 0.9 5.0 0.0 0.0 0.0 0.3 0.0 1.1 13.3 0.0 0.0 0.3 0.9 3.0 0.9 0.0 0.0 0.0 0.0 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: AB_2683257" "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favorable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.7 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.1 0.0 14.0 7.3 0.3 5.5 0.0 4.3 1.3 3.7 0.0 11.9 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 14.2 0.3 6.9 0.0 13.1 0.1 0.0 0.2 0.0 6.9 0.0 0.0 5.2 1.3 8.8 3.8 0.0 14.7 3.9 0.0 0.0 0.1 2.7 0.0 0.8 0.0 0.0 6.6 0.1 14.8 3.1 12.4 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 17.9 12.6 5.4 1.1 0.0 19.2 34.4 10.2 245.0 47.8 19.2 66.8 0.1 3.3 7.5 72.9 1.3 0.0 0.0 4.4 2.7 0.3 0.2 1.1 0.0 0.2 1.6 8.7 0.0 0.0 113.1 4.0 0.4 0.0 0.0 1.3 30.6 4.5 0.0 15.9 11.9 83.4 0.0 0.2 126.9 25.1 0.0 0.0 0.0 2.9 0.0 STK35 "bA550O8.2, CLIK1" ENSG00000125834 "Serine/threonine kinase 35" Q8TDR2 20 2101611-2177038 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 27.8;testis: 37.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 169.1;Horizontal cells: 278.1;Late spermatids: 665.5;Muller glia cells: 155.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026452, HPA051673" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA026452: AB_2671861, HPA051673: AB_2681569" "unprognostic (2.25e-2)" "unprognostic (2.97e-1)" "unprognostic (2.87e-2)" "unprognostic (1.30e-2)" "unprognostic (3.25e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (9.46e-6)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (3.05e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-1)" "unprognostic (4.39e-2)" "unprognostic (1.74e-1)" "unprognostic (4.67e-1)" "unprognostic (1.40e-1)" "unprognostic (4.99e-2)" 5.3 6.0 10.3 3.6 14.3 4.3 5.1 6.1 13.7 3.7 4.3 3.1 2.5 4.2 4.5 3.5 8.0 5.1 4.3 5.2 5.9 4.8 4.4 5.7 4.2 3.3 4.4 7.6 3.9 5.9 5.3 6.5 3.5 4.0 3.8 5.2 27.8 6.1 4.0 3.5 6.3 4.6 4.9 4.5 4.1 4.1 37.6 4.4 1.7 5.4 6.1 4.5 4.1 3.7 1.8 2.0 3.2 1.4 0.8 2.7 1.2 15.1 12.9 10.0 17.2 4.6 6.4 12.2 6.2 7.7 8.3 8.6 16.9 11.8 10.4 5.1 7.7 13.0 22.9 11.8 14.3 9.5 4.1 5.6 9.9 4.5 18.3 5.9 8.9 4.6 5.5 12.6 13.3 11.5 7.7 7.9 10.1 9.5 8.6 5.4 6.7 11.1 12.6 18.6 12.1 8.7 9.7 9.0 6.6 7.5 15.2 16.7 8.1 11.1 19.9 9.9 12.2 9.8 8.9 6.6 14.3 9.8 7.1 9.8 7.6 9.8 7.3 7.6 9.7 6.2 0.0 1.2 0.7 1.9 1.0 2.5 1.7 2.7 1.3 2.0 1.8 2.6 2.2 3.2 0.8 1.4 1.7 1.3 1.2 10.3 14.3 6.1 13.7 5.9 4.8 4.4 7.6 4.0 4.4 11.9 9.8 1.9 4.0 10.3 110.1 11.0 0.0 0.0 6.8 3.5 141.4 6.0 1.7 5.5 169.1 7.7 8.1 0.0 5.9 9.9 6.4 5.1 9.2 7.8 5.0 278.1 5.8 4.3 6.0 665.5 6.4 3.9 6.8 1.8 7.6 155.8 8.1 11.5 5.6 3.1 88.5 0.0 4.6 14.9 11.5 10.3 4.8 6.4 9.9 5.1 STK36 "FU, KIAA1278" ENSG00000163482 "Serine/threonine kinase 36" Q9NRP7 2 218672026-218702716 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 20.1;Cone photoreceptor cells: 35.3;Spermatocytes: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027409, HPA027453, HPA030058" Approved Supported Cytosol NA NA Cytosol "HPA027409: AB_10600223, HPA027453: AB_10601893, HPA030058: AB_10601225" "unprognostic (8.11e-2)" "unprognostic (3.77e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-1)" "unprognostic (1.50e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (5.20e-4)" "unprognostic (1.55e-1)" "unprognostic (5.83e-3)" "unprognostic (9.04e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-2)" "unprognostic (3.52e-3)" "unprognostic (1.46e-1)" "unprognostic (2.60e-2)" "unprognostic (1.77e-1)" "unprognostic (1.99e-3)" 4.8 10.0 7.5 4.7 11.4 2.0 6.4 7.9 11.1 9.1 7.4 7.0 11.9 4.1 14.4 13.3 5.0 13.9 9.8 3.3 6.3 3.5 10.1 4.4 6.9 3.9 2.3 6.6 13.6 9.7 12.3 23.2 3.9 7.6 9.5 6.3 9.3 7.3 8.3 3.3 4.6 5.8 7.8 5.5 4.9 7.9 63.2 4.2 3.5 11.4 3.7 5.0 9.3 7.1 1.8 1.6 3.2 1.9 2.2 1.6 1.7 2.5 5.8 12.8 10.9 14.0 10.9 7.9 7.0 5.6 8.9 8.4 7.6 4.2 3.4 9.8 7.3 6.0 5.2 8.8 7.3 7.9 1.4 7.3 3.3 17.6 10.5 6.8 4.6 5.6 11.7 5.5 8.7 6.2 23.8 6.7 4.5 7.6 4.3 7.4 5.9 2.7 5.8 7.7 3.2 3.7 5.1 5.5 3.4 10.9 12.9 10.4 8.9 5.4 8.9 3.6 13.9 9.0 3.8 6.3 12.4 4.6 4.7 4.7 5.5 4.2 1.8 7.7 2.2 5.1 0.0 1.9 3.2 1.5 1.2 0.9 1.8 1.1 1.3 1.6 0.6 1.1 1.6 0.2 2.2 1.4 1.3 1.0 1.7 7.5 11.4 7.9 11.1 6.3 3.5 2.3 6.6 7.6 4.2 8.9 4.6 1.7 1.0 1.0 7.7 2.8 5.1 20.1 1.2 3.5 35.3 1.4 0.0 2.9 11.3 2.1 2.0 0.0 2.2 1.3 1.8 1.3 1.1 4.9 2.3 1.6 2.4 4.3 2.8 4.1 5.5 1.2 0.0 1.0 4.4 5.6 1.9 3.7 4.6 3.3 9.8 6.5 2.1 26.8 8.2 0.9 0.7 1.5 3.8 0.4 STK39 "DCHT, SPAK" ENSG00000198648 "Serine/threonine kinase 39" Q9UEW8 2 167954020-168248141 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 35.5" "Cell type enhanced" "Detected in many" 5 "Glandular cells: 65.7;Urothelial cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046022, HPA061803, HPA062802" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "CAB046022: AB_2196960, HPA061803: AB_2684616, HPA062802: AB_2684870" "prognostic favorable (3.96e-4)" "unprognostic (2.97e-2)" "unprognostic (4.40e-2)" "unprognostic (4.22e-2)" "unprognostic (4.36e-1)" "unprognostic (6.14e-2)" "prognostic unfavorable (5.67e-5)" "unprognostic (3.04e-2)" "unprognostic (8.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.20e-2)" "unprognostic (1.38e-1)" "unprognostic (2.06e-1)" "unprognostic (9.45e-2)" "unprognostic (8.61e-3)" "unprognostic (1.14e-1)" "unprognostic (6.20e-3)" 6.2 2.1 8.4 4.6 11.0 1.3 3.5 9.3 14.1 4.3 9.1 8.3 1.7 10.5 2.3 4.7 14.1 1.9 5.9 7.6 9.8 7.4 2.9 0.8 2.4 7.3 12.3 9.7 3.2 9.9 5.0 8.2 1.2 14.2 9.9 11.7 7.1 22.8 3.8 2.2 3.4 6.1 4.3 19.0 2.5 11.2 35.5 5.5 7.2 2.2 1.8 8.0 5.6 5.3 0.7 1.0 0.0 0.7 1.9 3.4 0.5 6.7 4.1 15.5 4.9 9.5 14.1 1.5 17.0 12.5 11.4 10.6 0.0 22.0 18.7 4.7 11.0 9.9 17.7 9.9 12.4 14.3 5.9 6.1 7.7 4.5 13.8 17.8 10.4 0.8 9.7 17.7 13.5 14.1 13.8 7.7 14.7 0.1 0.0 23.9 3.9 18.1 3.7 10.7 14.0 8.6 25.8 6.1 1.5 8.6 16.8 22.9 9.7 5.9 0.9 6.9 7.7 3.1 7.6 7.3 13.8 4.3 9.7 11.1 0.0 0.0 15.0 10.5 9.3 9.3 0.0 0.7 0.0 2.5 0.4 1.3 0.7 1.9 3.4 1.0 0.7 0.4 2.0 0.0 1.9 0.3 0.3 3.3 0.5 8.4 11.0 9.3 14.1 9.8 7.4 12.3 9.7 14.2 5.5 3.0 12.3 0.8 21.2 3.4 13.8 25.8 22.9 6.7 7.9 5.2 15.7 0.1 18.3 9.7 21.3 3.5 23.2 0.0 19.9 0.0 7.3 65.7 0.0 0.0 3.5 19.1 21.9 3.1 5.1 13.5 9.5 5.2 16.9 1.0 13.9 26.9 26.4 17.3 10.6 3.8 25.3 6.5 7.2 19.9 7.7 3.9 0.2 15.2 20.4 55.5 STKLD1 "C9orf96, MGC43306, SGK071" ENSG00000198870 "Serine/threonine kinase like domain containing 1" Q8NE28 9 133376367-133406096 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 16.2" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 27.3;Late spermatids: 39.6;Spermatocytes: 15.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA029902 Uncertain NA NA "HPA029902: AB_10603554" "unprognostic (6.65e-2)" "unprognostic (9.43e-3)" "unprognostic (7.54e-4)" "unprognostic (8.15e-2)" "unprognostic (9.51e-2)" "unprognostic (1.39e-2)" "unprognostic (1.99e-2)" "unprognostic (1.41e-3)" "unprognostic (6.05e-2)" "unprognostic (2.94e-4)" "unprognostic (1.92e-4)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "unprognostic (4.69e-2)" "unprognostic (3.65e-1)" "unprognostic (5.86e-2)" "unprognostic (4.52e-2)" 0.4 0.4 0.4 0.2 1.4 0.5 0.4 0.7 2.2 0.4 0.3 2.2 1.3 0.5 0.9 2.1 0.3 0.6 0.5 0.3 0.8 0.3 0.3 0.4 0.3 0.8 0.5 1.3 0.8 0.4 0.1 0.3 0.5 1.5 0.5 0.1 0.8 0.6 0.4 0.6 0.8 0.5 0.3 0.5 0.4 0.4 16.2 0.7 0.0 0.3 0.0 0.3 0.3 0.3 0.6 0.4 0.0 0.2 0.2 0.6 0.0 0.0 0.6 0.4 0.7 0.5 0.5 1.1 0.2 0.0 0.1 0.2 0.9 0.3 0.3 0.2 0.0 0.6 0.6 0.1 0.0 0.0 0.4 0.8 0.7 0.9 0.5 0.3 0.5 0.4 0.4 0.1 0.0 0.1 0.4 0.0 1.5 0.8 1.0 0.0 0.2 0.6 0.8 0.3 0.6 1.0 0.3 0.3 0.8 0.1 0.1 1.0 1.0 0.3 0.9 2.2 0.3 1.3 0.3 0.6 1.0 0.6 0.9 0.1 2.2 2.2 0.6 0.4 0.4 0.3 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.4 0.2 0.1 0.6 0.6 0.2 0.0 0.2 0.1 0.4 0.0 0.0 0.4 1.4 0.7 2.2 0.8 0.3 0.5 1.3 1.5 0.7 0.0 0.0 0.0 1.1 0.0 3.3 1.2 2.5 0.0 1.2 0.0 2.0 3.6 8.3 0.4 27.3 0.5 0.0 0.0 1.0 0.6 0.3 0.7 0.0 1.0 0.8 1.6 0.0 0.0 0.3 39.6 2.0 0.0 0.0 0.0 0.3 1.2 0.3 0.0 1.8 1.7 2.3 0.0 0.2 15.1 3.4 0.0 2.7 0.0 0.7 0.6 STMN1 "C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN" ENSG00000117632 "Stathmin 1" P16949 1 25884181-25906991 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 143.4;lymphoid tissue: 117.1" "Cell type enhanced" "Detected in all" 9 "Early spermatids: 782.4;Late spermatids: 1640.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 79.3" "Group enriched" "Detected in all" 5 "dendritic cells: 79.3;T-cells: 26.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010107, HPA068438" Enhanced Approved Cytosol NA NA 210000 Cytosol "CAB010107: AB_628297, HPA068438: " "unprognostic (6.30e-2)" "unprognostic (2.40e-3)" "unprognostic (5.31e-2)" "unprognostic (7.94e-2)" "unprognostic (1.89e-1)" "unprognostic (5.02e-2)" "prognostic unfavorable (9.90e-7)" "unprognostic (9.45e-2)" "unprognostic (1.39e-2)" "unprognostic (1.61e-2)" "unprognostic (1.78e-1)" "unprognostic (3.33e-3)" "unprognostic (1.02e-2)" "unprognostic (1.68e-1)" "unprognostic (4.46e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-2)" 7.3 13.2 91.7 17.5 47.4 40.7 10.9 54.1 124.8 6.2 16.7 47.0 2.5 12.7 24.7 7.8 13.0 7.3 9.4 9.5 67.9 88.4 13.2 6.4 11.0 42.8 86.5 58.0 33.6 3.5 4.6 12.1 21.7 43.4 5.2 20.7 7.7 5.3 6.3 3.8 9.5 15.9 18.8 143.4 10.9 9.7 58.2 27.1 117.1 6.1 7.2 43.1 13.0 8.1 8.6 79.3 4.0 1.5 10.1 26.2 9.3 68.4 15.4 153.8 61.4 9.2 8.9 15.6 53.4 42.4 76.4 73.9 10.6 70.4 84.3 30.0 38.9 29.9 20.9 42.6 30.9 114.9 25.5 21.1 52.2 27.3 36.8 3.7 65.7 37.4 5.4 4.5 30.8 35.1 28.6 57.4 109.3 70.5 84.1 98.9 17.8 216.1 96.6 94.3 41.6 20.7 127.9 119.9 50.0 36.9 6.1 104.3 90.5 48.5 24.3 42.6 51.3 34.9 83.8 27.6 51.3 60.9 44.4 44.5 49.6 78.7 104.6 25.3 128.5 55.2 2.0 0.7 4.0 10.4 1.5 6.3 6.4 9.3 13.1 4.2 8.6 15.3 13.7 0.3 10.1 0.7 79.3 26.2 9.3 91.7 47.4 54.1 124.8 67.9 88.4 86.5 58.0 43.4 27.1 38.7 43.0 57.6 148.3 179.2 299.1 70.0 30.6 60.2 76.2 165.7 60.9 218.8 192.3 136.4 782.4 74.2 13.5 140.2 17.6 493.5 139.8 37.1 251.1 7.8 436.3 184.3 240.7 76.1 70.3 1640.5 41.4 141.8 254.8 48.7 70.1 201.0 61.7 45.6 44.2 144.1 147.2 38.8 101.9 532.9 205.4 79.0 109.0 151.0 130.1 26.3 STMN2 "SCG10, SCGN10" ENSG00000104435 "Stathmin 2" Q93045 8 79610814-79666175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 153.3" "Cell type enhanced" "Detected in some" 26 "Horizontal cells: 139.8;Intestinal endocrine cells: 23.8;Rod photoreceptor cells: 40.3" "Group enriched" "Detected in many" 5 "glioma: 26.1;pancreatic cancer: 10.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 5.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 5.6" "Cell line enriched" "Detected in some" 9 "SH-SY5Y: 123.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026922 Approved "Endoplasmic reticulum,Vesicles" NA NA Vesicles "Endoplasmic reticulum" "HPA026922: AB_1857605" "unprognostic (4.41e-1)" "unprognostic (3.35e-2)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (8.20e-2)" "unprognostic (9.48e-2)" "unprognostic (1.82e-1)" "unprognostic (6.08e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-13)" "unprognostic (1.14e-1)" "unprognostic (3.86e-1)" "unprognostic (5.77e-3)" "unprognostic (9.59e-2)" 1.7 35.4 35.2 5.6 35.0 1.4 2.5 99.8 153.3 5.3 10.7 4.2 0.0 7.7 1.9 1.3 1.8 1.4 3.0 1.3 40.3 71.9 1.4 1.8 1.5 1.6 44.7 60.4 1.4 3.2 1.4 1.5 1.4 102.4 2.5 14.2 2.6 1.7 2.1 1.3 6.4 9.8 4.3 19.0 3.1 2.4 2.2 6.6 0.0 1.3 0.0 1.9 1.5 0.9 0.0 5.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 123.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.6 0.0 0.0 35.2 35.0 99.8 68.3 40.3 71.9 44.7 60.4 102.4 6.6 0.0 0.0 0.0 0.0 0.9 18.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 139.8 23.8 0.0 0.0 8.1 0.3 0.0 1.7 0.0 0.0 17.0 1.1 0.0 0.0 0.0 40.3 0.0 0.3 0.0 0.2 0.6 0.0 0.0 0.0 0.0 STMN3 SCLIP ENSG00000197457 "Stathmin 3" Q9NZ72 20 63639705-63657682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 90.9" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 100.2;Horizontal cells: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 3.3;MAIT T-cell: 3.5;memory CD4 T-cell: 6.8;memory CD8 T-cell: 5.8;naive CD4 T-cell: 8.3;naive CD8 T-cell: 6.8" "Lineage enriched" "Detected in many" 6 "T-cells: 8.3" "Cell line enhanced" "Detected in many" "AN3-CA: 32.3;MOLT-4: 34.9;REH: 35.9;SCLC-21H: 50.4;SH-SY5Y: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012947 Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA012947: AB_1857606" "unprognostic (7.59e-2)" "unprognostic (4.36e-1)" "unprognostic (5.28e-2)" "unprognostic (2.33e-1)" "unprognostic (3.60e-2)" "unprognostic (6.30e-2)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (2.92e-2)" "unprognostic (4.35e-2)" "unprognostic (1.65e-3)" "unprognostic (7.52e-2)" "unprognostic (2.52e-3)" "unprognostic (2.73e-2)" "unprognostic (9.87e-2)" "unprognostic (4.08e-2)" "unprognostic (9.08e-3)" 9.0 21.0 53.5 13.1 52.7 6.9 7.7 48.8 90.9 10.9 5.3 6.7 1.2 4.2 10.9 4.2 5.9 10.3 7.6 5.0 48.9 47.7 4.6 1.6 6.2 15.2 34.2 63.6 19.8 7.6 6.2 18.6 7.0 45.8 8.2 4.2 6.2 7.5 9.5 3.3 11.6 6.5 10.1 29.5 20.3 6.5 4.1 12.3 11.0 20.9 1.9 8.4 6.6 3.5 1.0 1.3 1.2 0.1 0.0 8.3 2.5 2.5 2.9 19.3 32.3 0.5 1.9 1.3 3.0 0.1 9.4 4.4 18.5 3.5 0.1 9.5 1.1 0.5 17.5 13.4 0.3 2.9 1.2 3.6 1.2 4.0 6.8 2.6 0.9 11.0 4.0 0.1 3.0 0.7 0.4 0.3 8.8 24.2 0.5 2.4 2.9 34.9 4.4 19.8 0.6 21.1 35.9 3.1 14.4 15.8 0.5 50.4 38.4 1.4 0.8 3.6 1.6 0.5 6.5 0.5 0.2 5.4 0.2 0.6 1.2 2.5 0.8 0.5 3.6 12.5 1.0 0.1 1.2 3.3 0.1 3.5 0.3 6.8 5.8 0.1 1.0 8.3 6.8 0.2 0.0 0.1 1.3 1.1 2.5 53.5 52.7 48.8 74.0 48.9 47.7 34.2 63.6 45.8 12.3 6.0 4.5 3.7 5.3 7.2 100.2 2.0 2.5 0.0 3.4 3.5 49.1 9.6 11.6 3.7 9.8 6.7 0.2 0.0 2.1 2.5 15.9 4.6 4.6 0.0 1.9 103.3 35.7 4.9 0.6 12.6 27.9 2.2 6.8 0.0 0.5 25.6 2.3 0.0 33.6 3.9 31.2 12.9 22.6 2.3 5.2 3.8 7.3 18.1 0.6 2.0 STMN4 RB3 ENSG00000015592 "Stathmin 4" Q9H169 8 27235323-27258420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 132.2" "Group enriched" "Detected in some" 6 "Bipolar cells: 43.7;Horizontal cells: 87.4" "Cancer enriched" "Detected in some" 27 "glioma: 14.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 26 "SCLC-21H: 45.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027765 Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus" Vesicles "HPA027765: AB_1857607" "unprognostic (1.52e-1)" "unprognostic (3.45e-2)" "unprognostic (2.37e-2)" "unprognostic (3.19e-6)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (8.27e-2)" "unprognostic (1.37e-1)" "unprognostic (3.57e-3)" "unprognostic (2.36e-1)" "unprognostic (2.31e-3)" "unprognostic (9.84e-2)" "unprognostic (1.68e-3)" "unprognostic (1.37e-2)" "unprognostic (5.96e-2)" "unprognostic (4.15e-1)" "unprognostic (7.63e-2)" 1.5 7.9 30.8 1.5 23.4 1.5 1.5 22.2 132.2 1.5 2.3 37.3 0.0 1.8 1.5 2.0 1.5 1.5 1.6 1.4 36.3 27.9 1.5 1.4 1.5 1.5 34.9 37.2 1.4 1.4 1.5 0.0 1.4 21.4 1.5 2.3 0.0 1.5 1.5 1.4 1.5 2.2 1.8 71.8 1.4 1.5 1.6 6.6 0.0 1.4 0.0 1.4 1.5 0.0 1.0 0.9 0.3 0.2 0.1 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.2 0.4 0.1 1.0 0.7 0.2 0.3 0.1 0.2 0.9 0.4 0.0 30.8 23.4 22.2 34.4 36.3 27.9 34.9 37.2 21.4 6.6 0.0 0.0 0.0 0.1 0.3 43.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 87.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 1.4 0.0 11.1 0.0 0.0 0.5 1.2 0.1 0.0 0.0 0.0 0.0 STMND1 FLJ23152 ENSG00000230873 "Stathmin domain containing 1" H3BQB6 6 17102258-17131372 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.8;pancreas: 9.1" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 48.2;Club cells: 10.3;Spermatogonia: 21.3" "Group enriched" "Detected in some" 6 "breast cancer: 4.1;endometrial cancer: 1.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEK 293: 4.1;SCLC-21H: 9.8;T-47d: 11.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA067970 Enhanced Approved "Actin filaments" NA NA "Actin filaments" "HPA067970: AB_2685934" "unprognostic (7.70e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-2)" "unprognostic (2.09e-3)" "unprognostic (6.88e-2)" "unprognostic (6.64e-2)" "unprognostic (4.29e-2)" "unprognostic (4.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.22e-1)" "unprognostic (9.72e-2)" "unprognostic (5.29e-4)" "unprognostic (7.14e-2)" "unprognostic (1.10e-2)" "unprognostic (2.19e-2)" 0.1 0.0 0.4 0.1 0.8 0.0 3.7 0.6 0.6 1.6 1.0 2.8 1.4 0.1 0.6 4.7 0.1 21.8 6.0 0.1 0.7 0.9 0.1 0.1 7.7 0.1 0.1 0.1 3.5 9.1 0.0 0.7 0.1 2.5 0.1 1.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.2 0.1 0.0 7.4 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.9 1.6 2.8 1.1 0.8 0.8 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.3 0.7 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.0 0.2 0.8 0.0 4.1 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 9.8 0.0 0.0 0.1 0.0 1.1 11.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 1.1 0.7 0.3 0.8 0.6 0.4 0.7 0.3 0.2 0.9 0.8 0.7 2.8 0.8 0.8 1.6 0.2 0.4 0.4 0.8 0.6 0.6 0.7 0.9 0.1 0.1 2.5 0.1 0.0 2.2 0.0 1.2 0.0 0.0 0.4 2.5 48.2 10.3 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.2 0.0 0.4 0.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.6 1.0 0.8 0.0 0.4 0.0 0.0 6.5 0.3 7.1 21.3 0.6 0.0 0.0 1.0 0.5 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978923-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.1 10.2 19.2 6.2 18.8 4.2 8.1 7.8 35.3 7.7 6.9 8.3 3.1 5.9 4.6 6.0 7.0 6.2 9.1 14.4 19.0 18.0 4.5 6.1 6.9 8.7 13.4 14.3 9.0 9.9 6.8 8.5 7.9 10.2 7.0 3.7 4.0 7.7 9.7 13.2 7.3 6.5 7.7 12.3 6.3 7.9 6.7 5.9 6.2 10.4 3.6 5.6 6.2 4.4 6.1 11.0 2.2 15.5 6.8 9.4 5.3 3.6 7.0 4.2 5.8 8.6 5.5 3.6 12.0 4.7 6.5 5.5 2.0 20.6 3.7 19.0 9.7 4.9 12.4 4.0 8.4 2.0 12.4 4.4 3.8 5.9 2.3 8.5 2.5 3.1 9.7 6.6 10.3 9.8 5.4 6.1 8.6 9.2 7.2 9.4 5.6 4.7 1.8 2.0 5.7 5.6 2.8 4.3 5.6 13.9 4.1 8.1 5.2 5.4 7.2 7.6 2.8 6.0 2.8 9.3 15.1 4.9 17.2 16.0 7.3 3.5 1.9 13.9 7.8 7.6 0.7 4.0 2.2 5.3 7.0 4.4 4.3 4.4 7.0 6.2 6.1 8.9 9.4 2.0 6.8 15.5 11.0 7.4 5.3 19.2 18.8 7.8 35.3 19.0 18.0 13.4 14.3 10.2 5.9 0.0 2.6 9.5 3.4 2.9 12.3 9.3 2.5 1.4 4.5 7.0 5.9 11.2 1.7 20.5 0.6 7.1 8.0 0.0 16.7 8.1 11.2 5.0 4.6 3.9 9.0 15.9 9.8 4.9 1.8 1.8 8.3 2.3 3.3 2.8 5.7 12.2 17.8 3.6 11.0 5.3 13.7 6.5 5.8 21.9 4.1 1.8 4.7 2.9 5.0 2.0 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell type enriched" "Detected in some" 24 "Ciliated cells: 133.8" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "AF22: 19.0" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA012892: AB_1857610, HPA071011: AB_2732169" "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favorable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 133.8 5.7 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 STON1-GTF2A1L SALF ENSG00000068781 "STON1-GTF2A1L readthrough" 2 48529925-48776517 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 31.6" "Group enriched" "Detected in some" 5 "Early spermatids: 5.8;Spermatocytes: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 6.3;midbrain: 3.2;pons and medulla: 12.0" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.6;ASC TERT1: 3.4;HSkMC: 2.4;hTERT-RPE1: 6.0;SuSa: 12.3" HPA005715 Uncertain NA NA "HPA005715: AB_1080113" "unprognostic (5.66e-3)" "unprognostic (8.85e-2)" "unprognostic (1.18e-3)" "unprognostic (8.26e-2)" "unprognostic (5.08e-2)" "unprognostic (3.53e-1)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "unprognostic (1.15e-1)" "unprognostic (7.59e-2)" "unprognostic (2.81e-1)" "unprognostic (1.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.46e-2)" 9.4 1.8 1.5 5.7 1.5 0.7 7.3 6.3 1.4 15.1 12.7 2.2 4.4 1.4 20.5 4.6 13.2 5.0 7.9 2.4 1.5 1.5 3.9 1.5 4.7 1.7 3.2 0.0 13.2 1.5 0.8 1.8 7.5 12.0 14.1 3.7 5.5 1.5 5.6 1.6 1.6 3.0 30.3 22.2 7.8 5.3 2.9 0.7 0.8 3.5 0.6 0.8 31.6 15.1 0.0 0.0 0.7 0.0 0.6 1.0 0.0 0.0 0.1 1.3 0.0 3.6 3.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.2 2.4 0.2 0.0 0.1 6.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.5 1.5 6.3 1.4 1.5 1.5 3.2 0.0 12.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.1 0.0 0.0 0.0 0.0 0.1 STOX1 "C10orf24, FLJ25162" ENSG00000165730 "Storkhead box 1" Q6ZVD7 10 68827541-68895432 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8;fallopian tube: 19.1" "Cell type enriched" "Detected in many" 4 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;T-cells: 3.0" "Cell line enhanced" "Detected in many" "AN3-CA: 10.9;HAP1: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037844, HPA037845" Uncertain Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" "Intracellular and membrane" No NA Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA037844: AB_2675700, HPA037845: AB_10671369" "prognostic favorable (3.37e-5)" "unprognostic (5.53e-3)" "unprognostic (6.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.63e-3)" "unprognostic (1.95e-2)" "unprognostic (2.24e-3)" "prognostic favorable (2.08e-4)" "unprognostic (1.52e-1)" "unprognostic (2.45e-3)" "unprognostic (5.33e-3)" "unprognostic (5.29e-2)" "unprognostic (3.87e-2)" "unprognostic (8.77e-2)" "unprognostic (3.06e-2)" "unprognostic (2.33e-1)" "unprognostic (3.46e-2)" 8.7 6.4 17.8 1.7 13.4 0.6 4.8 1.8 13.4 2.0 2.6 6.8 1.3 2.0 2.8 11.9 2.5 19.1 1.7 0.9 16.1 9.3 4.5 0.9 2.2 1.8 11.5 10.2 1.9 1.6 6.1 8.8 1.5 5.6 2.3 2.8 5.0 2.6 2.1 1.9 1.4 2.8 2.5 2.4 0.9 2.2 3.8 7.3 3.3 8.7 0.0 1.7 1.6 0.9 0.7 3.5 0.0 0.0 0.2 3.0 0.2 2.2 2.4 5.4 10.9 2.3 0.0 3.2 0.2 0.1 1.6 1.7 2.3 3.3 2.1 3.1 0.0 4.2 0.6 10.1 0.0 0.8 2.5 4.2 0.2 0.5 3.1 0.3 2.7 3.9 0.2 0.2 0.3 0.0 0.3 0.1 5.6 0.5 0.3 0.2 2.2 4.6 3.4 1.8 0.5 1.5 3.4 0.1 0.0 3.2 5.8 1.7 5.0 3.9 1.0 0.7 3.6 2.4 2.2 0.0 0.0 0.3 0.0 1.5 1.0 1.9 2.2 0.0 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.4 0.8 0.6 0.0 0.7 3.0 1.4 0.0 0.2 0.0 3.5 0.3 0.2 17.8 13.4 1.8 12.5 16.1 9.3 11.5 10.2 5.6 7.3 0.0 0.3 0.5 3.2 1.3 0.9 0.3 0.0 48.2 9.1 1.8 0.0 1.1 3.3 0.0 0.2 0.1 0.4 0.0 0.3 0.2 0.6 1.8 2.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 1.6 1.5 0.2 0.0 0.0 1.2 0.3 6.5 5.7 1.6 11.1 0.4 1.0 0.0 5.6 1.7 STPG1 "C1orf201, FLJ33340, MAPO2" ENSG00000001460 "Sperm tail PG-rich repeat containing 1" Q5TH74 1 24356999-24416934 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.2" "Group enriched" "Detected in many" 5 "Early spermatids: 225.3;Late spermatids: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA024301 Approved Nucleoplasm NA NA Nucleoplasm "HPA024301: AB_1845634" "unprognostic (2.63e-2)" "unprognostic (3.35e-1)" "unprognostic (1.36e-2)" "prognostic favorable (1.33e-4)" "unprognostic (6.06e-4)" "unprognostic (5.14e-2)" "unprognostic (2.91e-3)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (3.40e-2)" "unprognostic (1.08e-1)" "unprognostic (3.48e-2)" "prognostic favorable (2.31e-4)" "unprognostic (9.14e-2)" "unprognostic (3.93e-2)" "unprognostic (5.21e-2)" "unprognostic (1.42e-1)" 5.5 4.3 6.0 2.6 12.8 1.5 4.2 13.6 23.3 4.7 7.9 12.0 2.4 4.4 4.8 7.1 4.9 20.8 4.2 4.0 6.7 8.7 5.9 1.9 6.2 2.5 6.5 8.0 5.6 4.8 13.0 9.2 1.6 14.2 5.8 6.9 9.9 3.5 4.6 1.5 4.3 5.5 6.4 6.1 2.1 5.1 29.2 7.9 2.5 5.9 1.2 3.4 4.5 3.9 5.2 2.7 1.1 1.4 0.0 4.3 1.9 5.9 3.5 0.5 6.5 4.8 6.9 3.5 8.7 8.4 8.4 8.8 1.5 8.9 0.7 6.0 9.1 7.0 2.4 5.6 6.1 9.7 7.0 5.6 1.0 1.9 1.6 9.8 2.9 1.5 4.1 12.5 12.1 16.0 8.9 6.6 0.0 2.1 0.0 6.3 2.1 0.0 2.4 5.3 6.3 6.0 1.6 0.0 0.2 11.2 2.0 5.4 3.7 4.7 1.8 13.5 5.7 4.8 5.2 4.5 3.0 3.5 1.2 2.5 3.8 3.6 2.1 3.4 0.3 4.8 0.0 0.1 1.1 1.5 1.4 0.2 5.2 1.2 4.3 0.6 3.4 1.4 1.7 0.1 0.0 0.2 2.7 2.5 1.9 6.0 12.8 13.6 23.3 6.7 8.7 6.5 8.0 14.2 7.9 8.9 8.1 2.2 11.4 4.0 12.4 4.8 0.0 65.6 17.0 10.4 13.7 3.8 13.3 6.5 225.3 4.2 16.3 23.3 6.2 7.0 3.8 6.7 11.5 1.3 3.3 9.5 4.6 5.5 1.0 476.4 6.1 4.6 15.1 4.6 5.2 7.4 7.7 10.5 4.2 7.1 16.7 6.5 5.1 14.2 9.4 4.8 3.8 3.9 5.0 51.2 STPG2 "C4orf37, MGC46496" ENSG00000163116 "Sperm tail PG-rich repeat containing 2" Q8N412 4 97184093-98143240 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.0;testis: 11.1" "Cell type enhanced" "Detected in some" 15 "Cone photoreceptor cells: 5.9;Distal tubular cells: 3.3;Spermatocytes: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.1;plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 1.8;SuSa: 2.4;U-266/70: 2.1" "Low region specificity" "Detected in all" NA NA "unprognostic (3.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (6.12e-2)" "unprognostic (2.84e-2)" "unprognostic (1.24e-2)" "unprognostic (6.59e-3)" "unprognostic (8.87e-3)" "unprognostic (2.18e-1)" "unprognostic (2.05e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-3)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" "unprognostic (7.55e-3)" "unprognostic (5.78e-2)" 1.0 1.5 2.5 1.2 5.3 0.8 2.9 1.9 2.5 1.3 0.9 4.5 3.7 1.3 0.9 3.9 1.0 1.8 1.3 1.0 1.8 1.4 3.5 1.9 1.7 1.3 3.7 1.5 1.6 2.1 2.1 17.0 1.7 3.8 1.4 1.2 1.7 1.5 5.8 0.6 1.7 1.1 0.7 2.3 1.5 1.3 11.1 3.4 0.4 3.0 0.0 1.0 1.4 1.2 1.1 1.3 0.0 0.0 0.5 0.3 0.0 0.2 0.3 0.0 0.0 1.0 0.5 0.0 0.0 0.3 0.0 0.6 0.0 1.2 0.1 0.3 0.3 1.1 0.6 0.1 0.8 0.0 0.0 1.8 0.8 0.6 0.0 0.0 0.1 0.6 0.0 0.6 0.0 0.5 0.4 0.0 0.0 0.2 0.9 0.4 0.3 0.2 0.7 0.4 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.3 0.2 0.4 0.7 2.4 0.5 0.6 0.0 0.2 0.3 0.0 0.1 2.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 2.5 5.3 1.9 2.5 1.8 1.4 3.7 1.5 3.8 3.4 0.0 0.0 0.0 0.4 0.0 0.8 0.3 0.0 0.0 0.0 0.0 5.9 0.0 3.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.7 1.5 0.0 0.0 2.6 0.9 0.0 0.1 0.0 0.0 0.1 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 55.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.3;RPMI-8226: 3.0;SK-BR-3: 3.0;T-47d: 4.6;U-266/70: 2.9" HPA044352 Uncertain Vesicles NA NA Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.8 0.4 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.3 0.2 0.2 0.2 4.4 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 1.7 0.2 0.2 0.2 0.2 0.2 1.4 0.0 1.1 0.2 0.2 0.2 0.0 0.2 1.5 0.2 0.2 0.5 3.2 0.2 0.2 0.2 0.5 55.3 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 2.0 1.2 0.3 0.0 0.0 1.0 0.0 0.0 0.0 7.3 0.0 0.1 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.5 1.3 1.1 0.0 1.7 0.0 0.2 0.0 0.5 0.4 0.0 0.0 3.0 0.0 0.0 0.9 0.6 0.4 3.0 0.0 0.6 4.6 0.0 0.0 0.8 1.4 0.2 0.0 2.9 1.5 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STPG4 "C2orf61, FLJ40172" ENSG00000239605 "Sperm-tail PG-rich repeat containing 4" Q8N801 2 47045538-47155378 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;RT4: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047366, HPA052691" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA047366: , HPA052691: AB_2681918" "unprognostic (6.74e-3)" "unprognostic (5.81e-4)" "unprognostic (3.43e-2)" "unprognostic (1.23e-3)" "unprognostic (1.72e-1)" "unprognostic (1.55e-3)" "unprognostic (4.36e-2)" "unprognostic (3.03e-2)" "unprognostic (1.41e-1)" "unprognostic (2.78e-2)" "unprognostic (2.36e-3)" "unprognostic (6.23e-2)" "unprognostic (3.64e-6)" "unprognostic (5.14e-2)" "unprognostic (6.00e-2)" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 29.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.5 2.0 0.6 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.6 0.1 0.0 0.3 0.4 0.1 0.2 0.8 0.5 0.5 0.4 0.4 0.5 0.0 0.2 0.0 0.7 0.5 0.5 0.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 1.0 0.1 0.8 0.3 0.2 0.1 6.6 0.9 0.1 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.1 0.4 1.8 0.4 0.1 0.0 0.4 0.1 0.3 0.0 0.2 0.6 0.3 0.9 0.1 0.2 0.8 0.2 0.0 0.0 0.6 0.2 0.0 0.1 0.9 0.0 0.6 0.0 0.1 0.0 0.0 0.4 0.4 0.0 0.0 2.0 0.0 0.1 1.5 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STRA6 FLJ12541 ENSG00000137868 "Stimulated by retinoic acid 6" Q9BX79 15 74179466-74212267 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix, uterine: 22.7;placenta: 88.6;retina: 42.8" "Cell type enhanced" "Detected in some" 16 "Extravillous trophoblasts: 11.0;Leydig cells: 6.4;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 47.1;SH-SY5Y: 29.3;WM-115: 70.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040839 Approved NA NA "HPA040839: AB_10794881" "unprognostic (1.20e-2)" "unprognostic (4.99e-2)" "unprognostic (3.71e-2)" "unprognostic (3.55e-3)" "unprognostic (1.37e-1)" "unprognostic (2.09e-2)" "unprognostic (4.38e-3)" "unprognostic (1.67e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (5.35e-2)" "unprognostic (3.89e-1)" "unprognostic (7.91e-13)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" 0.2 1.6 0.2 0.5 0.3 0.0 1.1 0.2 0.5 22.7 0.1 0.3 1.6 0.0 6.9 2.8 1.0 5.0 0.7 0.3 0.4 0.2 7.3 0.0 0.3 1.1 0.1 0.3 0.6 0.2 0.0 5.3 88.6 0.7 5.0 0.0 42.8 0.6 2.6 0.1 0.4 0.2 0.3 1.5 0.3 0.1 2.8 0.1 0.9 0.2 1.4 1.9 1.8 2.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 16.6 1.0 0.0 0.0 0.0 2.8 0.5 0.1 0.0 0.0 5.7 47.1 0.0 11.4 0.0 0.4 1.6 0.9 0.0 0.0 0.0 0.1 1.4 0.6 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 3.0 0.2 1.5 0.0 0.0 0.2 0.0 0.0 0.0 1.5 8.9 29.3 0.0 1.7 0.0 1.9 0.1 0.0 0.0 0.1 3.9 0.3 0.7 0.1 0.1 0.0 0.3 0.0 70.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.4 0.2 0.1 0.3 0.7 0.1 0.0 0.0 0.0 1.0 0.3 0.0 1.0 0.0 4.0 3.4 0.0 0.0 2.0 1.7 0.2 1.2 0.4 0.0 0.0 0.0 11.0 0.9 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 6.4 0.0 1.7 0.0 0.0 0.0 2.8 0.0 3.9 4.1 0.0 0.0 0.4 0.5 0.4 0.0 22.1 0.0 0.0 0.9 STRA8 ENSG00000146857 "Stimulated by retinoic acid 8" Q7Z7C7 7 135231979-135258492 "Predicted intracellular proteins" "Differentiation, DNA replication, Meiosis, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.0;skin 1: 2.5;testis: 4.0" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 1.4;Early spermatids: 1.1;Spermatogonia: 3.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.7;K-562: 1.2;SK-BR-3: 2.3;THP-1: 6.9;U-266/84: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.84e-1)" "unprognostic (4.86e-2)" "unprognostic (3.89e-2)" "unprognostic (9.67e-4)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (1.26e-3)" "unprognostic (1.25e-1)" "unprognostic (8.55e-3)" "unprognostic (1.45e-1)" "unprognostic (2.69e-1)" 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.1 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 2.5 0.3 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.5 3.0 0.0 0.7 0.0 0.0 0.0 STRC DFNB16 ENSG00000242866 Stereocilin Q7RTU9 15 43599563-43618800 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 22.9" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 5.9;Horizontal cells: 3.2;Rod photoreceptor cells: 9.2;Spermatocytes: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.4;hTCEpi: 2.2;JURKAT: 1.7;SCLC-21H: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048083 Enhanced NA NA "HPA048083: AB_2732545" "unprognostic (8.60e-3)" "unprognostic (5.77e-3)" "unprognostic (6.14e-2)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-3)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.84e-2)" "unprognostic (5.92e-3)" "unprognostic (1.99e-4)" "unprognostic (1.58e-1)" "unprognostic (6.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-4)" 0.2 0.5 1.7 0.2 4.2 0.1 0.8 22.9 5.1 0.0 0.2 0.4 0.1 4.7 0.1 0.3 0.2 0.0 2.3 3.2 0.0 0.1 0.1 0.0 1.6 0.4 0.5 0.1 1.7 0.0 0.7 0.2 1.5 0.1 0.4 2.7 0.4 0.0 1.1 0.2 0.2 3.3 0.6 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.1 0.7 0.0 0.0 0.1 1.0 1.4 0.0 0.7 0.0 0.0 0.5 0.6 0.5 2.2 0.0 0.0 0.2 0.0 1.7 0.0 0.9 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.5 0.0 0.0 0.1 0.1 1.9 0.1 0.0 0.4 0.9 0.0 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.2 0.3 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 3.2 0.0 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.2 0.2 0.4 0.0 9.2 0.0 0.0 3.6 0.6 0.4 0.6 0.0 0.0 0.0 STRIP2 "FAM40B, FAR11B, KIAA1170" ENSG00000128578 "Striatin interacting protein 2" Q9ULQ0 7 129434433-129488399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.6;retina: 55.6;skeletal muscle: 27.4" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 37.1;Muller glia cells: 70.1;Spermatocytes: 32.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 36.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "LHCN-M2: 20.8;U-2197: 23.7;U-87 MG: 21.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019657 Approved Approved Cytosol NA NA Cytosol "HPA019657: AB_1848399" "unprognostic (1.95e-1)" "unprognostic (2.45e-1)" "unprognostic (2.11e-1)" "unprognostic (2.41e-1)" "unprognostic (4.32e-1)" "unprognostic (1.43e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (6.78e-4)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (8.99e-2)" "unprognostic (1.95e-1)" "unprognostic (2.87e-6)" "prognostic favorable (5.41e-4)" "unprognostic (4.06e-2)" "unprognostic (5.34e-2)" "unprognostic (7.50e-2)" 0.7 2.4 1.9 2.0 36.6 3.7 0.8 7.0 10.0 0.4 0.8 3.0 0.0 0.8 0.8 1.6 1.1 0.4 1.2 10.3 1.5 2.1 5.6 0.6 1.0 2.7 2.2 2.9 0.7 1.3 0.4 4.7 1.3 7.6 1.6 1.4 55.6 1.7 0.5 27.4 1.5 1.0 0.8 1.2 1.5 1.0 13.5 9.4 0.2 0.8 2.1 2.1 0.9 0.3 0.6 0.7 2.5 0.6 0.4 0.9 0.4 7.7 3.4 3.1 4.9 1.2 1.1 13.6 3.2 4.1 5.4 5.3 1.8 4.4 3.3 0.4 1.3 17.7 8.8 3.3 2.9 8.3 19.0 2.8 2.5 5.6 1.9 0.8 1.6 13.3 1.3 1.0 9.2 5.8 9.0 9.3 3.0 10.8 2.1 20.8 0.4 4.1 4.0 3.0 1.7 7.0 2.7 5.8 0.7 2.0 2.9 0.7 0.7 7.4 0.6 1.6 2.5 0.9 3.9 3.3 3.1 3.1 23.7 9.2 1.9 1.2 3.9 21.1 4.1 4.4 2.5 0.6 0.6 0.9 0.4 0.3 0.3 0.6 0.3 0.2 0.6 0.5 0.4 2.0 0.4 0.5 0.7 0.9 0.4 1.9 36.6 7.0 4.8 1.5 2.1 2.2 2.9 7.6 9.4 3.0 0.6 0.0 0.2 0.2 11.0 37.1 0.0 1.4 0.0 0.0 2.0 0.4 0.0 0.8 4.7 0.5 0.0 0.0 3.3 3.4 1.0 0.1 7.0 0.0 0.7 1.6 0.0 0.6 0.0 7.9 0.6 1.3 1.7 13.6 0.0 70.1 3.8 0.0 0.7 9.6 3.5 0.0 0.5 32.7 9.6 0.1 0.2 0.0 0.4 0.6 STS "ARSC, ARSC1" ENSG00000101846 "Steroid sulfatase" P08842 X 7219456-7354810 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Pregnancy, Steroid metabolism" Hydrolase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 258.8" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0" HPA002904 Enhanced NA NA "HPA002904: AB_1080116" "unprognostic (1.09e-1)" "unprognostic (3.90e-2)" "unprognostic (1.44e-2)" "unprognostic (2.75e-1)" "unprognostic (6.72e-2)" "unprognostic (1.94e-2)" "unprognostic (2.62e-1)" "unprognostic (1.84e-1)" "unprognostic (8.23e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.05e-2)" "unprognostic (2.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.56e-1)" "unprognostic (1.92e-2)" "unprognostic (1.34e-1)" 10.3 2.2 3.0 2.2 3.9 0.0 4.1 2.3 9.0 3.4 3.5 2.3 2.2 0.8 2.4 2.2 2.2 2.6 4.1 3.6 3.9 4.0 2.5 4.7 5.0 2.2 3.8 2.4 2.4 2.2 1.6 2.2 258.8 2.4 2.9 3.0 2.3 2.2 3.3 4.0 2.3 2.4 3.8 2.4 2.2 6.7 2.2 2.3 2.2 2.4 2.2 2.2 4.9 2.7 0.9 1.9 1.9 4.7 1.0 0.7 1.0 4.1 1.3 2.8 0.9 20.3 10.5 15.0 8.4 3.0 2.3 2.1 7.4 3.9 7.7 1.6 6.1 1.8 1.0 1.6 1.4 2.3 0.6 3.2 0.4 4.7 2.1 1.1 1.1 4.4 3.4 0.2 1.4 0.8 1.5 3.4 0.6 0.4 8.1 6.0 0.9 0.6 1.0 1.0 0.0 1.9 1.1 1.6 25.9 5.7 6.0 2.0 1.7 1.7 3.0 0.9 4.8 1.3 0.4 6.0 9.1 0.5 11.6 1.3 43.0 0.0 18.0 2.1 0.9 2.4 0.0 3.2 0.6 0.5 4.7 0.2 0.6 0.2 0.3 1.9 0.9 0.1 0.5 1.9 1.0 2.5 0.3 0.7 1.0 3.0 3.9 2.3 9.0 3.9 4.0 3.8 2.4 2.4 2.3 11.9 2.1 1.5 1.7 0.8 3.1 5.0 2.5 0.0 1.2 1.8 0.0 34.3 0.0 6.9 0.1 4.3 4.1 0.0 17.1 18.7 4.1 7.6 6.9 7.4 6.6 1.6 3.5 2.5 5.9 0.0 2.6 2.7 1.7 2.8 2.3 3.1 8.7 7.4 6.3 1.4 0.8 0.0 4.7 0.0 1.4 0.9 78.6 0.0 2.2 7.4 STT3A "ITM1, MGC9042, STT3-A, TMC" ENSG00000134910 "STT3A, catalytic subunit of the oligosaccharyltransferase complex" P46977 11 125591712-125625215 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 202.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030735 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Nucleoplasm, Cytosol" Vesicles "HPA030735: AB_10603342" "unprognostic (8.25e-3)" "unprognostic (5.45e-2)" "unprognostic (3.02e-2)" "prognostic favorable (1.32e-4)" "unprognostic (5.10e-2)" "unprognostic (1.72e-2)" "prognostic unfavorable (3.57e-4)" "unprognostic (8.40e-2)" "unprognostic (4.80e-2)" "unprognostic (1.16e-2)" "unprognostic (8.96e-3)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.60e-2)" "unprognostic (6.38e-2)" "unprognostic (1.28e-1)" "unprognostic (1.82e-2)" 20.6 20.5 8.3 13.1 11.7 8.3 16.9 10.7 13.9 27.8 19.3 17.7 39.6 12.0 30.5 41.4 19.6 20.8 15.1 19.5 8.3 9.1 26.2 67.1 18.7 14.9 9.3 7.7 30.1 59.0 202.3 27.5 35.9 11.6 22.2 17.4 20.8 50.7 41.4 9.5 12.9 19.8 17.1 12.3 21.8 17.7 17.1 6.7 19.2 38.6 13.6 20.8 19.5 18.0 15.0 53.2 27.0 15.5 17.2 27.5 13.4 21.0 19.2 24.5 33.6 46.2 35.8 26.3 38.5 46.0 31.3 39.2 58.2 56.9 27.4 46.7 56.6 44.4 38.9 33.9 33.7 41.7 21.3 18.0 64.5 13.2 40.2 51.1 38.6 30.3 27.6 24.5 43.4 84.8 36.9 34.9 12.3 27.1 41.1 39.5 15.5 15.5 12.3 15.7 42.1 20.9 18.4 20.9 41.2 34.2 32.7 15.2 13.2 27.2 44.5 13.7 30.0 52.2 27.8 31.2 45.2 16.3 19.0 30.2 12.9 15.1 21.1 17.4 39.1 35.8 27.0 15.5 11.6 19.7 14.8 27.5 15.0 19.1 18.2 21.6 11.6 13.8 16.0 5.4 17.2 13.0 53.2 14.1 13.4 8.3 11.7 10.7 13.9 8.3 9.1 9.3 7.7 11.6 6.7 26.8 23.5 18.2 11.3 14.3 10.2 18.6 12.7 14.7 14.8 15.7 19.6 40.7 1.7 26.7 7.6 11.9 13.5 23.3 23.5 56.2 25.7 16.7 16.2 32.7 27.0 1.6 15.0 33.2 22.3 2.6 19.8 13.2 23.6 8.2 32.3 15.2 29.5 14.0 17.7 11.9 13.8 19.4 10.3 29.9 10.9 12.9 38.1 13.3 22.9 12.9 STUM "C1orf95, DKFZp761P211" ENSG00000203685 "Stum, mechanosensory transduction mediator homolog" Q69YW2 1 226548800-226609214 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.2" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HEL: 25.6" "Group enriched" "Detected in many" 5 "amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4" "Low region specificity" "Detected in many" HPA074381 Approved Cytosol NA NA Cytosol "HPA074381: AB_2732253" "unprognostic (3.23e-3)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" "unprognostic (2.68e-2)" "unprognostic (2.64e-2)" "unprognostic (1.41e-3)" "unprognostic (3.07e-1)" "unprognostic (5.15e-2)" "unprognostic (7.62e-2)" "unprognostic (3.28e-2)" "prognostic favorable (6.40e-4)" "unprognostic (1.14e-2)" "unprognostic (9.04e-2)" "unprognostic (5.89e-2)" "unprognostic (1.79e-3)" 2.8 2.2 30.4 2.1 16.2 0.6 3.5 2.4 32.2 3.7 8.1 6.3 0.0 2.8 3.7 3.0 8.9 3.1 1.6 2.5 21.8 7.0 5.8 0.7 1.2 0.9 6.8 15.9 2.7 1.0 1.9 4.2 1.2 18.2 6.2 3.7 1.4 2.0 2.4 5.0 3.7 3.5 8.7 3.0 1.8 1.8 2.0 7.4 0.0 0.8 0.4 1.0 5.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 4.2 0.3 25.6 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.3 0.2 0.0 3.9 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 16.2 2.4 30.0 21.8 7.0 6.8 15.9 18.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 STX11 ENSG00000135604 "Syntaxin 11" O75558 6 144150526-144188370 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.5;bone marrow: 68.1;breast: 41.9" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 75.6;granulocytes: 91.9;Kupffer cells: 68.7;monocytes: 71.3;Suprabasal keratinocytes: 135.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 13.4;granulocytes: 45.5;monocytes: 40.8" "Cell line enhanced" "Detected in some" "HDLM-2: 25.5;Karpas-707: 13.9;RH-30: 8.9;TIME: 11.2;U-266/70: 16.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA007992 Approved NA NA 19000000 "HPA007992: AB_1857620" "unprognostic (1.30e-3)" "unprognostic (1.19e-1)" "unprognostic (1.68e-1)" "unprognostic (2.62e-2)" "unprognostic (3.73e-2)" "unprognostic (8.96e-2)" "unprognostic (3.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.85e-1)" "unprognostic (1.03e-2)" "unprognostic (8.65e-2)" "unprognostic (1.36e-1)" "unprognostic (4.47e-3)" "unprognostic (7.07e-2)" "unprognostic (3.91e-2)" "unprognostic (8.50e-3)" "unprognostic (1.07e-1)" 20.0 3.6 0.7 7.0 1.2 68.1 41.9 0.3 0.8 1.4 3.1 0.6 0.0 1.1 1.1 2.2 4.4 2.0 2.4 8.8 1.8 0.9 2.0 5.4 26.3 14.5 1.2 0.0 2.5 0.9 0.6 2.4 15.5 1.8 1.9 1.0 1.6 1.6 0.6 5.3 5.6 2.5 1.9 2.0 20.6 1.4 0.9 1.0 2.8 8.2 4.0 6.8 2.6 6.1 0.8 13.4 45.5 40.8 1.5 4.1 18.9 0.5 0.2 0.0 5.9 0.2 0.2 0.9 0.6 0.5 0.6 1.1 0.2 0.5 0.0 0.6 0.9 1.1 0.9 0.1 0.2 0.2 25.5 0.9 3.7 0.7 0.0 1.6 0.9 0.4 0.0 0.0 0.3 0.1 0.3 6.3 1.1 0.1 13.9 0.8 0.3 0.5 1.1 0.0 0.0 0.6 0.0 8.9 1.0 0.0 2.8 0.2 0.0 1.7 0.1 2.7 0.4 0.0 4.6 11.2 0.1 1.7 0.4 0.4 16.4 6.3 0.0 0.2 2.8 0.5 9.2 35.0 21.6 3.1 40.2 1.9 0.7 1.4 2.6 13.4 0.8 0.5 1.6 45.5 1.5 40.8 1.4 4.1 18.9 0.7 1.2 0.3 0.8 1.8 0.9 1.2 0.0 1.8 1.0 50.6 12.5 8.8 9.6 75.6 0.0 4.0 5.1 2.7 4.5 1.8 0.0 0.6 0.0 5.5 0.3 11.7 0.0 0.0 2.3 3.1 14.8 11.2 91.9 0.9 31.3 0.0 3.4 4.9 68.7 1.0 0.6 60.3 42.2 71.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 22.6 2.6 3.4 135.1 23.5 22.4 0.0 30.1 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 98.6" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.84e-4)" "prognostic favorable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favorable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favorable (4.69e-4)" 14.0 17.6 12.4 16.0 18.4 9.2 11.0 11.2 15.9 98.6 19.7 19.5 12.2 15.0 46.5 11.9 11.5 38.9 16.1 11.0 11.3 14.2 24.2 14.0 9.8 10.4 14.5 12.3 12.4 18.5 12.2 24.1 17.5 17.3 12.3 11.9 12.7 12.2 14.7 19.0 11.0 19.6 13.5 14.8 14.2 15.0 28.5 10.3 18.1 10.1 9.8 15.0 11.8 12.3 11.2 25.5 7.1 13.0 10.8 13.4 9.3 14.3 9.3 11.1 11.3 9.6 14.0 14.9 16.5 15.2 15.8 13.2 19.6 20.9 19.1 39.8 15.3 14.4 7.8 19.6 9.7 15.6 8.0 9.8 12.0 12.3 23.7 14.3 20.8 10.1 13.1 8.5 13.4 9.8 8.9 13.3 15.4 11.5 17.0 11.2 7.6 18.8 14.8 14.7 11.9 19.4 17.0 8.3 15.2 16.3 8.7 14.1 12.5 12.4 8.3 14.4 10.0 12.2 10.1 15.1 9.6 10.5 8.7 17.7 12.2 18.5 22.0 11.7 16.0 11.9 4.8 10.6 7.1 10.9 10.4 13.4 11.2 10.1 9.9 16.0 9.3 8.5 9.8 2.1 10.8 13.0 25.5 9.1 9.3 12.4 18.4 11.2 15.9 11.3 14.2 14.5 12.3 17.3 10.3 29.8 7.0 10.4 7.5 7.0 20.2 18.3 10.2 34.8 25.0 19.2 19.6 25.1 59.7 27.4 58.7 11.9 28.7 0.0 24.4 16.2 18.5 12.5 8.1 8.3 24.9 9.5 4.7 6.7 14.5 62.0 13.0 16.9 13.5 30.7 19.0 22.5 28.8 24.6 13.8 18.3 16.1 6.5 11.3 58.5 33.4 8.4 26.5 10.7 17.5 10.5 STX19 MGC21382 ENSG00000178750 "Syntaxin 19" Q8N4C7 3 94014369-94028610 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.9" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 24.1;Enterocytes: 18.8;Mucus-secreting cells: 26.4;Paneth cells: 34.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.5" "Cell type enhanced" "Detected in single" "memory B-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.6;HaCaT: 2.2;hTCEpi: 7.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA030604 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "HPA030604: AB_10601268" "unprognostic (7.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-1)" "unprognostic (5.17e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (9.04e-2)" "unprognostic (1.29e-2)" "unprognostic (4.32e-2)" "unprognostic (7.00e-3)" "unprognostic (1.19e-2)" "unprognostic (1.96e-1)" "unprognostic (2.12e-1)" "unprognostic (4.87e-3)" 0.4 0.2 0.3 7.0 0.4 0.0 4.0 1.8 3.5 3.9 11.7 0.1 1.5 5.7 0.5 13.6 12.8 0.8 2.3 0.3 0.5 0.3 1.0 0.4 7.1 0.1 0.3 0.7 0.5 7.7 7.1 0.5 0.7 0.1 4.3 10.6 0.1 9.8 3.2 0.2 6.9 20.9 0.1 0.4 1.0 6.0 0.4 0.1 0.4 0.4 5.0 1.5 0.7 4.1 1.2 0.0 0.0 0.3 0.0 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 10.6 0.1 0.1 0.0 0.2 2.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.3 0.0 0.1 7.3 0.0 0.8 0.1 0.0 0.4 0.3 0.0 0.0 0.1 0.1 0.1 0.2 0.5 0.1 0.1 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.4 0.0 1.2 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.3 0.5 1.2 0.7 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 1.8 3.5 0.5 0.3 0.3 0.7 0.1 0.1 14.9 12.8 0.0 2.2 1.4 3.5 0.0 0.0 24.1 7.9 0.0 11.8 0.1 1.7 3.2 1.1 0.0 18.8 0.0 7.3 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.4 6.7 34.8 0.7 0.0 16.1 0.0 0.3 0.2 0.0 1.6 0.2 0.0 13.9 1.0 STX1A "HPC-1, p35-1, STX1" ENSG00000106089 "Syntaxin 1A" Q16623 7 73699206-73719672 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Neurotransmitter transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 73.7;pituitary gland: 26.9" "Cell type enhanced" "Detected in many" 13 "Intestinal endocrine cells: 50.6;Pancreatic endocrine cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.5;T-reg: 2.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 50.8;U-87 MG: 33.8" "Group enriched" "Detected in many" 5 "amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5" "Group enriched" "Detected in all" 8 "amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3" "CAB008372, HPA069176" Enhanced Approved "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA Vesicles "Nuclear membrane" "CAB008372: AB_592786, HPA069176: AB_2686098" "unprognostic (5.12e-3)" "prognostic unfavorable (3.63e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.12e-3)" "unprognostic (1.88e-1)" "unprognostic (3.02e-8)" "unprognostic (1.11e-2)" "unprognostic (6.97e-2)" "unprognostic (3.52e-2)" "unprognostic (6.34e-2)" "unprognostic (7.70e-3)" "unprognostic (4.18e-6)" "unprognostic (2.65e-2)" "unprognostic (1.50e-1)" "unprognostic (1.14e-3)" "unprognostic (6.20e-2)" 1.4 5.6 27.4 2.4 20.9 7.6 1.4 33.7 73.7 1.7 2.6 1.3 0.8 3.7 2.8 1.8 1.7 2.3 5.5 1.2 22.0 8.3 1.1 1.2 1.8 1.4 4.0 28.0 2.2 5.7 1.5 26.9 2.2 2.6 1.9 2.1 0.1 1.9 1.8 1.1 1.9 3.5 2.6 1.3 1.3 6.2 2.0 0.7 0.0 1.6 0.0 1.1 2.8 1.1 0.4 0.0 0.1 0.2 0.0 2.5 2.7 1.6 7.5 1.2 3.6 1.6 4.2 0.8 5.1 3.4 2.1 1.4 2.6 4.3 1.9 0.7 3.6 11.8 1.3 1.8 3.2 1.6 3.5 1.4 0.6 2.6 1.5 1.8 0.8 1.8 2.5 1.4 14.8 5.2 9.6 3.7 0.3 1.6 2.3 4.0 3.7 0.6 7.3 0.9 2.8 17.0 0.0 0.8 1.9 1.7 1.3 50.8 8.0 1.5 4.2 1.0 1.5 1.4 0.6 13.8 10.5 3.5 8.1 13.5 1.3 0.8 0.9 33.8 0.7 12.3 0.0 0.2 0.0 2.5 0.0 0.9 0.4 0.4 0.6 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 2.4 2.7 27.4 20.9 33.7 49.9 22.0 8.3 4.0 28.0 2.6 0.7 0.0 3.2 0.0 11.2 3.8 4.5 2.2 5.1 2.7 3.4 1.8 3.9 0.4 0.0 3.1 0.0 0.5 1.8 0.0 3.2 1.6 2.4 9.7 15.0 0.2 0.6 7.9 50.6 1.3 0.8 0.0 1.7 1.7 3.3 0.0 2.4 0.8 18.8 0.3 1.4 0.4 1.8 0.0 2.3 1.7 3.3 2.4 0.6 2.2 1.5 12.9 STX1B "STX1B1, STX1B2" ENSG00000099365 "Syntaxin 1B" P61266 16 30989256-31010661 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 64.9" "Group enriched" "Detected in some" 4 "Horizontal cells: 36.5;Late spermatids: 9.9" "Cancer enriched" "Detected in some" 7 "glioma: 5.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 8.4;hTEC/SVTERT24-B: 10.3;hTERT-RPE1: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069176, CAB079008" Supported Approved Approved "Nuclear membrane,Vesicles" NA NA Vesicles "Nuclear membrane" "CAB079008: , HPA069176: AB_2686098" "unprognostic (1.43e-3)" "unprognostic (5.27e-2)" "unprognostic (2.40e-4)" "unprognostic (3.90e-3)" "unprognostic (3.98e-2)" "unprognostic (1.90e-2)" "unprognostic (2.21e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-1)" "unprognostic (3.72e-3)" "unprognostic (1.73e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (7.93e-2)" "unprognostic (1.57e-2)" 1.6 1.9 12.7 1.9 31.8 1.3 1.8 45.8 64.9 1.2 1.4 2.9 0.0 1.4 2.7 4.2 1.9 1.4 1.3 2.1 10.5 10.0 1.4 2.5 1.2 2.4 6.8 26.2 1.3 1.3 1.3 2.2 1.2 39.3 1.8 1.4 1.0 1.9 2.8 1.3 4.0 1.8 2.5 3.8 2.2 1.3 3.2 4.5 0.0 1.3 0.0 2.3 1.3 0.7 0.6 0.3 1.3 0.4 0.5 1.7 0.1 0.1 2.7 4.3 0.6 0.4 0.2 0.1 3.8 5.8 4.8 8.4 0.0 3.1 0.7 0.2 5.0 0.1 0.7 1.9 0.5 5.8 2.3 0.4 0.3 2.2 2.1 0.3 0.1 2.7 1.5 0.1 10.3 0.9 19.0 0.0 0.9 0.4 0.2 5.0 1.2 1.7 0.2 2.1 0.0 0.3 6.3 0.2 0.1 0.4 0.0 5.9 3.7 0.4 0.2 0.0 0.7 0.7 0.1 0.7 2.8 2.2 0.3 0.2 0.3 0.2 0.3 3.1 0.2 0.0 0.9 0.4 0.7 0.3 0.2 0.1 0.5 1.7 0.3 0.1 0.6 0.3 0.4 1.3 0.5 0.1 0.3 0.2 0.1 12.7 31.8 45.8 60.5 10.5 10.0 6.8 26.2 39.3 4.5 0.0 0.0 0.0 0.0 0.7 3.6 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 5.7 0.5 0.0 0.0 0.3 0.0 0.3 0.1 0.0 4.9 0.6 36.5 0.0 0.6 0.0 9.9 0.3 0.0 0.0 1.0 0.0 1.7 0.2 0.0 1.8 2.1 2.9 0.0 0.5 5.2 1.0 0.5 0.7 0.0 0.0 0.0 STXBP1 "hUNC18, MUNC18-1, rbSec1, UNC18" ENSG00000136854 "Syntaxin binding protein 1" P61764 9 127579370-127696027 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 127.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 111.5;Cone photoreceptor cells: 147.3;Horizontal cells: 79.4;Rod photoreceptor cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 3.4" "Lineage enriched" "Detected in single" 7 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008209, HPA023483, CAB034434" Enhanced Approved Nucleoplasm,Cytosol NA NA 6400 "Nucleoplasm, Cytosol" "CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625" "unprognostic (2.32e-2)" "unprognostic (7.33e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (4.78e-4)" "unprognostic (1.80e-1)" "prognostic unfavorable (1.47e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.87e-2)" "unprognostic (2.31e-1)" "unprognostic (3.08e-3)" "prognostic favorable (9.81e-4)" "unprognostic (1.30e-2)" "unprognostic (1.67e-1)" "unprognostic (2.68e-2)" "unprognostic (5.51e-2)" "unprognostic (7.66e-2)" "unprognostic (3.36e-3)" 14.1 16.0 32.4 4.7 42.2 1.5 5.1 86.8 127.4 8.1 4.6 6.5 1.9 3.7 13.2 4.7 6.3 17.9 6.7 12.7 35.0 31.5 7.1 2.7 16.8 3.7 24.6 55.5 14.3 13.2 8.1 22.3 7.9 61.9 6.5 5.3 12.6 8.1 6.6 5.0 5.6 4.6 11.7 13.3 5.9 5.2 5.4 5.3 0.0 10.7 0.9 4.3 5.7 7.6 0.0 0.5 0.0 0.4 0.0 3.4 0.6 4.1 8.6 8.3 9.3 18.8 16.2 7.5 14.5 7.4 8.7 7.7 0.4 4.9 4.0 8.1 9.4 24.3 1.5 7.2 8.9 10.7 9.3 4.9 5.5 23.4 1.5 9.5 0.5 4.8 12.2 5.0 22.8 11.1 14.0 10.3 13.9 5.5 6.3 14.6 7.6 3.9 1.7 7.1 6.7 11.9 2.3 3.9 9.8 7.2 0.2 47.7 23.2 24.4 12.1 41.2 7.7 1.8 1.7 15.4 9.9 5.0 19.5 5.4 13.6 22.3 5.5 19.5 5.9 9.1 0.0 0.4 0.0 0.8 0.1 0.3 0.0 2.2 3.4 0.5 0.0 1.4 1.7 0.0 0.0 0.1 0.3 0.3 0.6 32.4 42.2 86.8 87.7 35.0 31.5 24.6 55.5 61.9 5.3 23.8 57.7 0.8 7.5 10.3 111.5 13.2 0.0 17.4 12.5 3.5 147.3 2.1 6.6 12.0 1.6 21.6 0.0 0.0 7.4 4.6 12.7 9.7 4.7 0.4 3.7 79.4 43.8 20.9 2.7 1.5 19.0 3.2 10.1 1.0 8.8 24.1 5.7 0.0 41.8 8.6 147.7 12.9 12.3 17.7 6.8 6.6 20.5 0.9 0.6 5.5 STXBP2 "Hunc18b, UNC18B" ENSG00000076944 "Syntaxin binding protein 2" Q15833 19 7636881-7647873 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.5;lymphoid tissue: 101.5" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 332.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5" "Group enriched" "Detected in all" 6 "dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5" "Cell line enhanced" "Detected in many" "HMC-1: 56.3;U-937: 49.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015564, HPA063868" Approved Enhanced Cytosol No No 53000000 Cytosol "HPA015564: AB_1857626, HPA063868: AB_2685136" "unprognostic (1.20e-2)" "unprognostic (6.17e-3)" "unprognostic (2.85e-2)" "prognostic favorable (2.29e-4)" "unprognostic (2.54e-1)" "unprognostic (1.75e-3)" "prognostic unfavorable (4.65e-4)" "unprognostic (4.22e-3)" "unprognostic (2.35e-1)" "unprognostic (6.25e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (1.51e-1)" "unprognostic (4.62e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.68e-4)" "prognostic favorable (5.13e-6)" 7.2 7.9 5.5 17.9 9.9 49.5 9.9 2.0 5.8 6.5 17.7 5.4 15.9 19.0 3.0 10.4 23.4 9.6 14.3 18.4 5.2 2.0 20.2 19.0 46.4 61.5 12.2 1.3 4.6 28.0 10.9 9.8 24.9 5.8 16.4 10.5 8.7 24.6 9.7 1.5 15.3 32.0 3.7 16.9 101.5 20.6 22.5 8.0 73.4 19.5 5.4 17.8 11.4 18.0 6.7 30.2 45.6 101.5 9.0 9.9 31.9 24.5 8.7 0.2 0.1 0.0 0.2 17.3 3.1 0.3 0.6 1.7 20.5 15.6 6.5 12.7 2.5 11.4 16.9 0.9 15.0 0.6 27.0 10.5 28.0 10.4 12.1 15.0 18.0 56.3 1.0 15.4 3.0 8.7 0.0 13.2 16.8 17.4 22.3 0.0 15.5 8.8 42.0 6.5 16.0 15.4 9.1 0.0 24.9 12.5 28.5 2.6 0.1 7.6 11.3 0.5 8.5 14.0 46.7 13.8 0.1 5.1 0.3 0.1 24.9 12.3 8.4 0.2 49.4 0.6 25.5 58.1 35.5 9.6 73.1 7.7 6.3 7.3 8.6 30.2 6.7 5.2 6.2 45.6 9.0 101.5 11.5 9.9 31.9 5.5 9.9 2.0 5.8 5.2 2.0 12.2 1.3 5.8 8.0 0.0 7.7 46.2 41.5 20.9 3.5 0.7 40.8 5.3 3.4 33.2 2.0 85.8 28.2 91.9 74.2 5.9 162.4 23.3 104.4 107.0 3.1 43.4 72.5 17.3 155.4 0.0 57.4 21.5 332.1 169.0 1.7 76.6 13.5 138.9 84.0 0.8 109.9 133.3 1.8 54.9 3.9 6.5 1.4 29.3 18.1 18.6 127.9 56.4 58.5 59.5 STXBP4 "MGC50337, Synip" ENSG00000166263 "Syntaxin binding protein 4" Q6ZWJ1 17 54968727-55173632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 36.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 39.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007760, HPA022138, HPA022888, HPA024227" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630" "unprognostic (5.89e-2)" "unprognostic (2.50e-2)" "unprognostic (1.30e-3)" "unprognostic (9.27e-2)" "unprognostic (1.03e-3)" "unprognostic (1.48e-1)" "unprognostic (5.00e-5)" "unprognostic (4.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.28e-2)" "unprognostic (3.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" 7.7 6.4 5.5 4.3 6.0 3.4 5.2 10.6 4.7 9.9 6.4 4.2 7.5 6.3 12.0 7.2 5.1 7.3 6.6 5.9 6.7 4.7 14.5 3.8 8.0 3.2 4.2 4.5 9.9 5.4 19.3 36.3 4.7 6.8 9.5 4.6 7.6 4.5 9.4 4.0 3.7 5.1 13.2 8.6 5.0 5.5 5.6 5.1 7.2 7.9 2.7 3.5 9.6 8.2 3.2 2.9 4.0 1.2 5.1 2.9 0.7 5.5 8.3 7.7 6.8 6.5 6.4 3.1 4.3 4.2 5.7 5.6 4.9 3.0 3.8 9.3 4.3 5.0 3.3 9.8 4.3 10.5 5.7 5.6 4.9 5.7 10.0 2.7 3.1 1.5 7.3 1.3 8.1 2.0 2.6 5.6 3.3 7.9 3.0 6.7 2.5 10.2 2.0 5.5 4.7 6.0 4.3 8.9 2.3 10.0 3.4 7.4 5.6 6.7 1.1 3.6 4.3 9.7 2.1 4.3 8.0 6.3 4.9 4.5 2.7 2.5 6.5 5.2 4.1 4.7 4.0 1.1 0.1 2.6 0.8 2.9 2.1 2.3 1.7 1.4 3.2 2.1 2.7 0.3 5.1 1.2 2.9 2.1 0.7 5.5 6.0 10.6 4.7 6.7 4.7 4.2 4.5 6.8 5.1 0.0 7.8 0.8 2.2 0.8 5.5 8.1 5.1 22.7 6.8 8.7 39.3 1.3 8.3 5.7 5.2 2.1 2.6 0.0 2.3 1.7 2.8 2.6 7.0 4.0 1.9 7.9 5.8 6.2 2.5 4.6 16.4 2.6 6.8 1.8 1.6 6.6 3.3 2.3 11.0 6.3 19.0 32.3 3.9 8.6 5.8 2.6 0.2 2.9 3.0 1.0 STXBP5 "LLGL3, tomosyn" ENSG00000164506 "Syntaxin binding protein 5" Q5T5C0 6 147204425-147390476 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 82.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 11.2" "Lineage enriched" "Detected in many" 6 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "HEL: 56.6;HMC-1: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039991, HPA049727, CAB079016" Enhanced Supported Enhanced Cytosol NA NA 11000 Cytosol "CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863" "prognostic unfavorable (4.48e-4)" "unprognostic (4.60e-3)" "unprognostic (2.28e-3)" "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (1.52e-1)" "unprognostic (9.56e-4)" "unprognostic (6.01e-2)" "unprognostic (3.60e-1)" "unprognostic (2.74e-2)" "unprognostic (1.70e-2)" "unprognostic (6.37e-3)" "prognostic unfavorable (2.74e-7)" "unprognostic (8.01e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-1)" "unprognostic (1.35e-3)" 4.4 9.1 4.3 6.6 5.9 14.0 9.0 7.8 9.0 6.7 17.6 2.0 22.1 3.9 4.6 6.5 10.2 3.8 9.2 3.5 3.6 4.3 2.0 2.4 3.8 3.5 3.3 4.7 3.0 10.9 82.7 15.5 3.1 4.3 5.7 7.8 6.5 5.7 21.0 7.0 10.9 35.1 5.3 2.7 4.7 4.0 9.6 2.3 2.2 4.2 5.6 4.6 5.3 9.1 0.9 0.5 11.2 0.6 0.5 1.7 0.3 2.8 2.5 1.3 4.6 6.7 14.1 1.5 6.7 10.0 5.0 5.6 2.1 1.9 2.1 1.5 13.3 8.6 3.5 3.9 5.9 6.1 4.5 3.0 56.6 7.5 2.4 7.7 19.3 61.9 10.2 4.2 10.0 20.4 11.9 6.4 3.3 15.2 2.6 9.8 4.2 3.0 5.0 1.1 2.4 5.9 0.4 7.1 0.8 2.7 5.0 2.9 2.1 5.2 3.7 2.3 2.5 1.1 7.6 7.3 7.2 2.6 3.5 6.1 2.2 0.0 2.5 3.9 7.1 5.1 4.7 0.3 11.2 1.2 0.5 1.3 0.5 0.7 1.4 0.5 0.9 1.2 1.7 4.0 0.5 0.6 0.4 0.3 0.3 4.3 5.9 7.8 9.0 3.6 4.3 3.3 4.7 4.3 2.3 14.9 9.1 1.5 2.0 3.2 28.1 12.9 7.6 1.4 9.1 15.7 29.5 4.0 0.0 4.4 26.8 7.9 17.0 0.0 11.2 3.2 4.5 10.0 41.7 3.4 4.0 31.8 39.6 8.6 7.8 34.7 7.2 4.1 10.1 2.8 28.2 5.0 9.8 24.6 6.7 1.4 25.2 12.9 3.4 12.3 10.7 5.8 3.2 4.9 17.4 3.0 STXBP5L "KIAA1006, LLGL4" ENSG00000145087 "Syntaxin binding protein 5 like" Q9Y2K9 3 120908072-121424761 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.2;ovary: 19.7" "Group enriched" "Detected in some" 4 "Bipolar cells: 29.3;Cone photoreceptor cells: 70.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 8.2;HeLa: 6.0;MOLT-4: 7.9;NTERA-2: 4.1;RH-30: 4.1;SCLC-21H: 11.3;SH-SY5Y: 4.9;U-937: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.42e-1)" "unprognostic (9.47e-2)" "unprognostic (6.30e-2)" "unprognostic (2.85e-3)" "unprognostic (1.75e-1)" "unprognostic (2.89e-2)" "unprognostic (7.01e-2)" "unprognostic (1.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-3)" "unprognostic (2.52e-1)" "unprognostic (6.52e-3)" "unprognostic (5.13e-2)" "unprognostic (3.58e-1)" "unprognostic (1.86e-3)" "unprognostic (8.61e-3)" 0.9 4.3 9.1 0.9 15.4 0.8 0.8 55.2 22.6 1.8 1.6 1.3 1.3 1.3 2.6 0.8 1.4 1.1 0.9 0.8 13.9 3.4 0.8 0.8 0.9 0.8 3.1 17.1 19.7 1.2 0.8 12.6 0.9 22.4 5.2 1.2 0.0 0.9 7.4 0.8 0.8 1.4 2.5 2.1 0.8 1.7 4.3 2.5 0.0 16.1 0.0 0.8 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 6.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 7.9 0.0 4.1 0.0 0.9 0.0 4.1 0.0 0.0 0.8 11.3 4.9 0.0 0.0 0.1 0.0 1.1 3.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.0 2.2 4.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 15.4 55.2 22.6 13.9 3.4 3.1 17.1 22.4 2.5 0.0 0.0 0.0 1.0 0.1 29.3 0.5 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 9.5 11.6 0.0 0.0 10.0 2.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 1.4 0.0 0.4 3.6 2.5 0.0 0.0 0.0 0.0 0.1 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040468: AB_2676998, HPA048569: AB_2680446" "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 3.0 0.1 0.0 0.4 0.0 0.0 0.9 4.9 0.5 2.3 2.2 1.6 18.5 0.2 3.1 1.2 2.9 0.8 1.0 5.1 4.9 10.9 0.3 0.7 1.3 0.1 0.0 1.4 12.1 0.2 0.3 3.4 0.2 0.4 16.6 0.1 0.2 0.2 5.3 1.7 0.1 0.8 2.7 7.5 1.3 0.0 1.4 0.2 1.6 9.5 0.6 0.0 2.8 2.9 0.0 4.5 2.3 0.3 15.4 0.6 2.6 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 0.0 2.1 0.0 0.6 0.2 0.4 0.4 2.5 8.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 12.5 0.0 0.2 0.5 0.0 5.9 1.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 3.6 9.5 0.0 0.0 0.3 0.0 0.1 0.0 0.9 0.9 0.2 0.7 6.8 4.8 SUCLA2 ENSG00000136143 "Succinate-CoA ligase ADP-forming beta subunit" Q9P2R7 13 47745736-48037968 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 89.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 204.8;Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039435, HPA039536, HPA061528" Enhanced Supported Enhanced Mitochondria NA NA 6600 Mitochondria "HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553" "unprognostic (5.66e-3)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.76e-2)" "unprognostic (1.60e-1)" "unprognostic (3.45e-2)" "unprognostic (2.48e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.59e-14)" "unprognostic (3.53e-1)" "unprognostic (2.19e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.22e-4)" 21.6 18.5 19.2 8.6 22.1 5.2 17.5 29.7 32.4 15.3 15.7 11.7 15.6 24.5 12.7 12.1 14.6 11.3 9.4 42.1 20.0 21.6 34.0 12.9 7.9 11.4 22.6 19.1 14.4 10.8 19.8 14.9 12.2 28.7 16.2 16.5 8.9 13.9 14.8 89.0 10.0 22.7 14.7 18.3 9.7 12.3 8.0 15.4 15.6 16.9 25.6 10.2 11.0 12.6 17.1 29.5 12.4 25.0 23.4 25.2 17.2 15.7 18.3 23.3 13.9 26.7 20.1 14.0 24.2 27.1 25.2 17.1 32.5 18.0 22.2 18.5 23.6 15.1 22.0 30.7 23.0 31.9 21.2 26.3 24.9 17.4 21.0 18.6 25.1 14.6 19.0 27.1 17.1 20.3 21.0 18.5 25.7 16.8 8.0 25.0 10.9 25.9 28.8 24.1 54.9 23.4 22.1 21.3 17.2 36.4 15.3 12.9 15.4 20.1 18.7 14.2 26.8 16.5 22.4 14.1 14.0 9.0 19.9 16.7 8.4 13.0 25.8 8.7 18.4 20.5 5.7 24.5 12.4 17.6 25.0 21.2 17.1 19.7 21.6 29.5 16.3 25.2 24.9 4.5 23.4 20.0 24.3 21.6 17.2 19.2 22.1 29.7 32.4 20.0 21.6 22.6 19.1 28.7 15.4 23.8 12.6 14.3 29.8 28.7 43.5 135.6 17.8 20.1 17.0 29.6 11.8 41.8 139.3 28.6 204.8 21.5 31.6 0.0 15.6 35.7 34.0 31.8 33.4 11.5 26.3 42.9 18.5 18.4 16.2 235.9 34.2 23.7 40.5 27.9 17.8 38.6 17.5 36.8 43.5 98.7 33.0 38.8 40.8 31.2 27.2 27.7 43.6 13.1 28.8 31.9 SUCLG1 ENSG00000163541 "Succinate-CoA ligase alpha subunit" P53597 2 84423523-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 125.6" "Cell type enhanced" "Detected in all" 10 "Distal tubular cells: 792.5;Proximal tubular cells: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA 330000 Mitochondria "Plasma membrane, Cytosol" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavorable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 26.1 23.3 18.0 15.0 18.9 10.6 23.8 18.9 19.5 14.1 50.1 17.7 23.2 53.9 13.9 19.6 25.0 13.5 14.0 57.7 17.4 17.3 125.6 44.1 12.8 13.3 19.2 17.0 12.7 33.9 36.2 16.3 13.8 17.3 17.1 39.4 16.9 39.3 24.9 57.6 15.6 71.6 26.5 17.1 12.1 21.9 13.3 16.0 16.9 28.8 42.8 15.2 24.3 16.3 26.6 43.5 31.6 40.3 35.2 39.1 46.8 20.8 23.0 18.2 22.1 34.2 23.1 31.5 23.8 20.4 30.7 22.5 52.6 17.3 28.8 16.5 28.5 24.7 30.5 37.4 28.1 36.5 27.7 34.0 25.0 19.8 29.9 29.0 25.4 20.4 27.4 23.0 25.9 35.3 18.8 27.3 23.6 25.3 23.7 27.9 31.9 36.0 23.2 9.5 78.5 41.2 22.9 42.2 31.5 41.2 25.4 22.1 12.3 19.0 39.5 37.9 17.8 24.1 20.0 22.1 24.1 23.4 29.5 29.2 20.8 29.5 24.8 28.2 35.3 21.2 31.6 34.4 28.7 31.4 40.3 34.6 26.6 29.2 35.1 43.5 20.2 32.4 34.2 18.5 35.2 40.0 23.7 39.1 46.8 18.0 18.9 18.9 19.5 17.4 17.3 19.2 17.0 17.3 16.0 59.6 67.8 89.4 89.8 31.5 32.1 379.6 132.5 91.0 108.1 134.3 21.6 202.1 792.5 102.4 24.5 56.3 282.3 23.3 99.5 100.2 83.9 68.7 90.0 177.6 116.1 42.9 102.0 59.5 64.6 28.6 50.6 82.9 113.1 78.5 140.8 56.0 65.8 217.5 69.6 1327.5 31.0 51.8 72.6 79.7 46.4 36.1 157.6 70.5 304.8 88.9 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming beta subunit" Q96I99 3 67360460-67654614 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.9" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 290.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Approved "Plasma membrane,Mitochondria" NA NA 290000 Mitochondria "Plasma membrane" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favorable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 17.0 19.3 8.8 26.5 10.0 3.4 12.4 2.4 7.2 15.3 38.9 9.5 16.4 31.4 11.5 18.3 18.6 9.9 27.9 23.6 6.6 6.2 38.3 90.9 14.6 21.1 9.8 6.5 16.5 20.9 5.9 8.5 8.5 7.6 14.0 34.5 9.6 21.0 17.3 57.0 9.3 42.4 23.5 8.6 24.7 25.4 6.5 8.1 9.6 16.4 27.0 16.7 19.9 13.2 19.2 10.2 5.8 18.2 27.1 31.1 18.9 12.8 11.2 11.1 13.5 18.7 32.4 13.5 15.4 22.5 18.1 20.3 12.3 28.7 16.4 5.0 21.6 11.9 6.6 8.6 21.2 23.5 6.9 5.9 14.8 10.1 19.2 24.1 19.5 10.4 24.2 18.5 14.2 32.6 22.5 19.2 12.6 11.3 15.0 39.4 9.0 7.3 6.2 10.4 58.8 6.9 5.1 17.2 24.5 30.7 19.9 2.2 7.5 24.4 28.2 20.3 7.8 21.7 12.5 16.7 18.0 11.9 19.7 18.2 10.3 15.0 11.5 26.5 15.3 21.1 5.8 15.3 5.2 13.8 18.2 16.7 19.2 20.0 17.4 10.2 16.7 31.1 23.7 0.7 27.1 14.8 4.0 18.5 18.9 8.8 10.0 2.4 7.2 6.6 6.2 9.8 6.5 7.6 8.1 32.8 40.3 57.4 34.0 33.0 2.6 146.2 84.1 61.6 42.1 76.8 7.9 46.8 207.2 71.1 2.4 35.8 224.3 46.7 70.7 37.8 47.4 43.6 29.0 290.2 50.0 4.8 55.9 44.8 60.1 4.1 38.3 46.7 40.5 32.5 187.4 22.3 55.1 140.3 44.6 211.1 3.8 32.3 67.3 1.4 6.8 43.2 31.8 55.8 241.0 45.3 SUCNR1 GPR91 ENSG00000198829 "Succinate receptor 1" Q9BXA5 3 151873643-151884619 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 63.1;lymphoid tissue: 23.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 16.6;Hofbauer cells: 18.9;Kupffer cells: 22.2;Macrophages: 11.8;Proximal tubular cells: 31.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "eosinophil: 2.0;intermediate monocyte: 1.0;non-classical monocyte: 1.7;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 20 "dendritic cells: 2.2;granulocytes: 2.0;monocytes: 1.7" "Group enriched" "Detected in some" 5 "HEL: 28.0;NB-4: 16.2;U-937: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB022745 Uncertain NA NA "CAB022745: " "unprognostic (1.54e-1)" "unprognostic (2.65e-2)" "unprognostic (3.45e-2)" "unprognostic (6.94e-2)" "unprognostic (1.58e-1)" "unprognostic (6.01e-2)" "unprognostic (3.17e-1)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (8.92e-2)" "unprognostic (2.59e-1)" "unprognostic (1.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.14e-2)" "unprognostic (7.49e-2)" "unprognostic (1.58e-1)" 13.7 1.6 0.6 0.7 0.9 4.7 1.6 0.2 1.2 0.3 0.5 0.7 0.0 0.7 0.4 0.6 0.5 0.3 0.2 2.8 0.4 0.4 63.1 3.6 2.2 3.3 0.6 0.1 0.7 0.4 4.2 0.3 0.2 0.8 0.5 0.5 0.1 1.3 0.0 0.3 0.7 0.5 0.3 0.5 23.3 6.7 0.4 0.0 1.3 14.6 0.8 0.3 0.7 0.3 0.0 2.2 2.0 1.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 4.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.1 2.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 1.7 2.2 0.0 0.2 0.6 0.9 0.2 1.2 0.4 0.4 0.6 0.1 0.8 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 2.7 0.0 3.5 0.0 0.0 16.6 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.2 18.9 0.0 0.0 0.0 22.2 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 SUGCT "C7orf10, DERP13, FLJ11808, ORF19" ENSG00000175600 "Succinyl-CoA:glutarate-CoA transferase" Q9HAC7 7 40134977-40860763 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.1;liver: 27.6" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 24.1;Proximal tubular cells: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.0;LHCN-M2: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026698, HPA026704, HPA026705" Enhanced NA NA "HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003" "unprognostic (4.66e-3)" "unprognostic (3.45e-2)" "unprognostic (2.06e-2)" "unprognostic (3.32e-3)" "unprognostic (5.26e-2)" "unprognostic (1.06e-1)" "unprognostic (1.14e-3)" "unprognostic (1.75e-2)" "unprognostic (2.61e-1)" "unprognostic (1.80e-1)" "unprognostic (5.27e-3)" "unprognostic (7.65e-2)" "prognostic favorable (3.93e-7)" "unprognostic (2.62e-2)" "unprognostic (3.38e-1)" "unprognostic (3.41e-3)" "prognostic unfavorable (2.53e-4)" 2.7 13.5 3.2 5.1 4.6 0.7 4.0 1.1 3.1 4.4 5.0 1.1 0.7 1.4 9.6 2.9 3.2 2.7 4.5 6.9 4.3 2.4 42.1 27.6 1.2 3.9 2.8 2.4 5.7 3.8 3.8 3.5 1.2 4.8 3.4 2.9 5.4 2.4 4.3 11.3 1.6 5.6 13.9 5.0 1.3 1.8 4.1 4.1 0.0 2.4 6.3 1.5 2.9 3.5 1.4 0.2 1.1 0.2 0.0 4.6 0.7 0.5 0.0 3.1 2.3 3.3 7.7 1.2 1.6 2.9 2.2 2.5 1.3 0.6 2.1 0.8 2.2 2.3 0.1 1.0 28.0 3.5 0.0 1.4 1.8 0.2 4.5 4.2 0.2 0.2 9.8 6.4 2.4 1.4 4.5 0.6 0.9 2.4 0.3 16.9 0.0 0.1 0.3 5.3 0.0 2.4 1.9 0.3 0.0 4.8 0.0 0.2 1.8 2.5 1.1 3.5 5.5 0.1 0.4 2.3 9.6 2.7 0.1 0.6 0.2 0.0 0.1 1.8 0.8 2.2 0.0 0.1 0.3 0.7 0.0 1.2 1.4 2.0 1.0 0.1 1.2 4.6 2.7 1.1 0.0 0.2 0.2 0.0 0.7 3.2 4.6 1.1 3.1 4.3 2.4 2.8 2.4 4.8 4.1 3.0 0.3 2.2 1.8 1.8 0.8 4.3 0.0 0.0 5.7 1.8 7.9 1.4 14.9 1.5 24.1 0.6 7.9 0.0 0.7 2.1 2.0 0.7 0.0 15.3 0.3 0.0 3.5 0.0 1.5 12.2 5.8 0.4 3.3 0.0 1.3 5.2 0.6 3.2 2.8 61.7 4.3 6.5 5.6 2.1 2.5 0.5 0.7 0.0 5.2 0.6 SULT1A1 "P-PST, STP, STP1" ENSG00000196502 "Sulfotransferase family 1A member 1" P50225 16 28605196-28623625 "Enzymes, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 98.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 529.7;Hepatocytes: 206.6;Paneth cells: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 50.6;intermediate monocyte: 39.2;myeloid DC: 22.9;neutrophil: 47.7;non-classical monocyte: 22.3" "Group enriched" "Detected in many" 26 "dendritic cells: 22.9;granulocytes: 47.7;monocytes: 50.6" "Group enriched" "Detected in many" 4 "EFO-21: 42.4;Hep G2: 83.9" "HPA049500, HPA051051" Supported NA NA 3700000 "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (2.57e-2)" "unprognostic (2.80e-2)" "unprognostic (8.40e-2)" "unprognostic (1.30e-1)" "unprognostic (5.60e-3)" "unprognostic (7.63e-2)" "unprognostic (4.17e-2)" "prognostic favorable (7.02e-4)" "unprognostic (1.30e-1)" "unprognostic (2.40e-1)" "unprognostic (6.71e-2)" "unprognostic (2.07e-1)" "unprognostic (3.70e-3)" "unprognostic (1.49e-1)" "unprognostic (4.10e-2)" "unprognostic (7.39e-2)" "unprognostic (1.89e-2)" 10.2 36.1 12.0 7.2 15.4 9.3 5.7 15.8 19.8 4.6 21.4 4.5 15.5 54.2 3.7 14.4 3.1 6.6 5.4 9.7 14.7 10.4 11.0 98.1 26.7 8.4 9.2 14.9 3.5 9.6 6.7 10.0 5.6 10.3 3.7 17.5 12.2 11.5 22.5 4.9 1.4 41.1 5.2 6.3 23.2 7.2 5.1 4.6 4.0 13.4 2.6 3.7 6.3 2.2 0.3 22.9 47.7 50.6 0.9 1.5 19.3 1.6 0.6 0.8 2.8 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.3 10.5 0.2 42.4 0.0 0.4 0.6 0.8 2.9 0.1 0.3 7.5 2.8 3.2 83.9 5.0 0.0 3.2 0.2 0.2 0.1 0.0 0.1 0.8 3.2 1.1 1.4 0.8 9.9 0.2 2.2 0.7 0.4 0.0 3.1 0.3 5.5 0.7 0.9 2.6 0.2 0.7 13.8 0.3 3.9 8.2 8.1 5.5 0.2 2.1 0.2 0.1 3.3 1.9 0.4 0.7 15.5 0.0 4.9 50.6 0.9 0.6 39.2 0.7 0.3 0.6 0.5 22.9 0.1 0.9 0.6 47.7 0.9 22.3 1.7 1.5 19.3 12.0 15.4 15.8 19.8 14.7 10.4 9.2 14.9 10.3 4.6 178.6 77.7 8.2 7.0 1.0 16.8 12.3 43.3 46.8 22.7 15.7 9.8 2.0 109.5 9.9 94.0 8.0 529.7 0.0 18.0 1.1 16.2 2.7 47.5 206.6 32.1 7.9 19.1 43.0 192.8 26.4 47.5 39.4 1.7 16.2 39.6 65.5 6.2 294.5 32.5 16.8 3.5 19.4 9.9 20.2 4.5 0.3 1.6 7.5 70.4 5.8 SULT1A2 "HAST4, STP2" ENSG00000197165 "Sulfotransferase family 1A member 2" P50226 16 28591943-28597109 "Enzymes, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.5;liver: 26.2;seminal vesicle: 24.2" "Cell type enriched" "Detected in many" 5 "Enterocytes: 311.3" "Cancer enhanced" "Detected in many" "liver cancer: 6.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 7 "classical monocyte: 10.2;intermediate monocyte: 7.0;myeloid DC: 3.5;neutrophil: 12.6;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 16 "dendritic cells: 3.5;granulocytes: 12.6;monocytes: 10.2" "Cell line enhanced" "Detected in many" "BEWO: 6.9;EFO-21: 8.8;Hep G2: 32.6" "HPA049500, HPA051051" Supported NA NA "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (4.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.53e-1)" "unprognostic (6.13e-2)" "unprognostic (5.35e-2)" "unprognostic (1.43e-1)" "unprognostic (1.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.05e-1)" "unprognostic (2.49e-4)" "unprognostic (5.83e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (2.74e-1)" "unprognostic (2.98e-1)" "unprognostic (1.44e-1)" "unprognostic (8.52e-3)" 1.0 1.9 0.6 2.5 1.0 0.5 1.2 1.6 0.7 0.3 9.8 0.6 5.9 25.7 0.5 1.1 0.9 0.6 1.6 2.1 0.8 0.5 2.3 26.2 11.9 0.3 0.6 0.6 0.9 1.4 1.0 1.2 2.7 0.7 0.3 6.8 4.6 0.9 24.2 0.2 0.2 37.5 0.2 0.6 2.7 0.7 0.3 0.2 0.5 4.5 0.5 0.2 1.9 1.1 0.2 3.5 12.6 10.2 0.4 0.5 3.9 1.3 0.7 0.6 0.5 0.1 0.3 6.9 0.7 0.0 0.1 0.0 1.3 3.0 0.2 8.8 0.2 0.1 1.2 0.3 0.5 0.2 0.4 0.4 1.3 1.7 32.6 0.5 1.1 1.3 0.2 0.6 0.5 0.1 0.4 0.2 0.6 0.7 1.5 0.1 1.6 0.2 2.1 1.0 0.3 0.3 1.3 0.2 0.6 0.1 1.3 0.4 0.9 0.2 4.6 0.0 1.1 3.2 0.6 0.4 1.7 1.0 1.3 0.5 2.4 1.3 0.3 0.4 0.5 0.5 1.1 10.2 0.1 0.3 7.0 0.5 0.1 0.2 0.2 3.5 0.2 0.3 0.3 12.6 0.4 3.6 0.8 0.4 3.9 0.6 1.0 1.6 0.7 0.8 0.5 0.6 0.6 0.7 0.2 26.8 10.8 0.5 0.5 0.2 0.2 2.0 0.0 2.7 9.1 3.5 0.0 0.1 13.3 5.9 0.1 0.8 311.3 0.0 4.1 0.2 2.6 0.2 11.5 43.6 1.3 0.0 2.9 10.4 7.9 0.8 1.4 0.2 0.0 0.0 6.8 3.7 5.0 59.6 1.4 5.6 0.5 0.0 0.4 0.7 0.1 0.1 0.2 0.0 9.8 0.9 SULT1A3 "STM, TL-PST" ENSG00000261052 "Sulfotransferase family 1A member 3" P0DMM9 16 30199228-30204310 "Enzymes, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 27.8;intestine: 31.0" "Cell type enhanced" "Detected in many" 6 "Paneth cells: 24.9;Undifferentiated cells: 21.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 10 "classical monocyte: 27.8;intermediate monocyte: 24.0;myeloid DC: 16.2;non-classical monocyte: 11.1" "Group enriched" "Detected in many" 11 "dendritic cells: 16.2;monocytes: 27.8" "Cell line enhanced" "Detected in all" "CAPAN-2: 40.0;Hep G2: 54.8" "HPA049500, HPA051051" Supported NA NA 3200000 "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (2.61e-1)" "unprognostic (1.72e-3)" "unprognostic (1.98e-3)" "unprognostic (4.98e-2)" "unprognostic (1.34e-1)" "unprognostic (1.18e-1)" "unprognostic (7.27e-2)" "unprognostic (2.09e-2)" "unprognostic (2.99e-2)" "unprognostic (2.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.18e-8)" "unprognostic (2.34e-2)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (9.48e-5)" 1.4 3.8 5.6 4.3 4.9 7.5 2.5 14.0 6.3 2.1 6.7 31.0 2.5 4.5 4.0 3.7 2.0 1.7 5.6 5.2 6.6 10.1 3.8 3.2 4.3 2.9 4.3 8.1 8.0 3.0 5.8 6.1 5.3 5.2 1.5 5.6 17.9 4.0 3.4 5.7 2.7 2.1 6.4 5.8 3.6 2.4 1.5 16.2 1.4 27.8 0.4 2.0 11.2 4.9 10.3 10.3 7.1 9.4 5.4 13.7 5.5 4.6 5.5 6.2 4.3 40.0 5.0 29.0 5.2 3.7 12.9 10.6 4.3 5.4 4.6 7.6 4.0 14.1 54.8 3.8 3.3 9.4 7.6 7.0 6.0 2.1 12.3 6.3 7.0 1.2 31.6 3.7 15.2 2.6 20.9 6.0 10.7 6.0 11.2 4.1 9.1 7.1 4.4 4.0 5.3 1.5 16.2 2.4 3.3 6.1 7.4 2.4 10.9 5.3 8.0 3.2 9.4 8.7 3.1 3.9 5.8 6.4 1.4 27.8 0.1 2.0 24.0 0.3 1.5 0.3 0.6 16.2 0.3 0.3 0.3 0.4 0.4 11.1 0.2 0.3 11.2 11.9 8.1 5.2 1.9 1.8 5.0 1.5 5.1 2.7 11.4 0.0 7.9 4.6 0.0 2.5 1.0 4.5 15.0 0.0 3.6 2.1 2.0 2.8 1.1 2.4 1.3 1.6 1.2 3.1 3.5 0.4 0.9 2.8 1.7 3.6 10.7 2.6 4.3 24.9 1.8 0.3 5.7 0.0 2.0 0.6 0.2 2.4 2.5 3.2 21.1 1.6 SULT1A4 ENSG00000213648 "Sulfotransferase family 1A member 4" P0DMN0 16 29459889-29464976 "Enzymes, Predicted intracellular proteins" "Catecholamine metabolism, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 16.7;intestine: 38.8" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 6.0;Club cells: 6.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "classical monocyte: 11.3;intermediate monocyte: 16.7;myeloid DC: 11.3;non-classical monocyte: 5.0" "Group enriched" "Detected in many" 16 "dendritic cells: 11.3;monocytes: 16.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 31.5;EFO-21: 26.2;HEL: 21.4;Hep G2: 69.1;Karpas-707: 41.2" "HPA049500, HPA051051" Supported NA NA "HPA049500: AB_2680796, HPA051051: AB_2681327" "unprognostic (4.14e-2)" "unprognostic (1.04e-1)" 2.7 0.7 3.3 2.0 1.6 0.9 2.0 4.3 2.6 3.0 8.1 38.8 1.2 0.0 0.3 1.7 1.6 1.7 2.8 1.6 2.8 1.7 3.4 2.9 1.5 0.9 0.6 0.0 1.8 2.4 2.2 7.6 1.8 0.0 0.7 5.2 25.9 2.7 1.1 3.3 3.2 1.1 3.4 2.1 0.1 1.0 0.6 11.3 0.8 16.7 0.2 0.6 2.4 4.1 4.1 1.3 0.1 0.1 1.4 1.8 0.4 0.7 0.1 0.1 2.4 31.5 0.2 26.2 0.2 0.6 4.5 1.7 0.4 0.1 1.5 2.3 21.4 2.8 69.1 0.6 0.7 3.0 0.0 0.0 2.0 0.0 0.3 4.9 0.0 4.3 41.2 0.1 2.0 0.4 3.2 0.9 12.0 0.8 1.7 0.6 1.1 3.0 2.9 0.9 2.3 0.0 6.3 0.0 0.5 1.3 0.0 8.6 0.8 0.4 1.3 0.7 1.8 14.0 0.4 2.0 3.7 0.2 0.2 11.3 0.0 0.6 16.7 0.1 0.6 0.3 0.1 11.3 0.5 0.3 0.1 0.8 0.2 5.0 0.2 0.3 2.4 6.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 1.4 6.8 0.0 0.0 0.2 0.0 0.2 0.0 0.1 1.3 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 SULT1B1 ST1B2 ENSG00000173597 "Sulfotransferase family 1B member 1" O43704 4 69721162-69787961 "Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 137.6" "Group enriched" "Detected in many" 4 "Enterocytes: 232.6;Paneth cells: 154.2" "Group enriched" "Detected in some" 11 "colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 21.9" "Lineage enriched" "Detected in many" 6 "granulocytes: 21.9" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 48.3;OE19: 11.1;TIME: 15.6;U-2197: 13.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002107 Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA002107: AB_2666542" "unprognostic (9.58e-2)" "unprognostic (4.05e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-1)" "unprognostic (2.33e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "unprognostic (4.77e-2)" "unprognostic (5.14e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "unprognostic (3.27e-1)" "unprognostic (1.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.06e-2)" "unprognostic (6.93e-2)" "unprognostic (5.46e-2)" 1.2 0.6 0.9 9.3 1.8 1.3 1.1 0.5 1.5 1.1 38.6 0.5 0.7 31.8 0.8 0.6 1.0 1.5 1.2 1.2 0.9 0.9 1.1 24.8 2.4 12.9 1.2 0.7 0.7 0.5 0.0 0.4 0.6 2.0 0.6 20.3 1.3 0.6 0.2 0.4 0.4 137.6 1.4 3.6 13.3 13.9 0.5 0.7 2.0 0.6 0.3 2.0 0.7 1.2 0.2 1.8 21.9 3.2 1.8 3.6 1.6 0.3 0.2 0.3 0.4 0.8 0.9 0.6 0.4 0.2 0.1 0.1 0.3 0.3 0.6 0.3 0.4 0.4 0.5 0.0 0.1 0.3 0.7 0.4 0.5 0.5 0.2 1.2 0.6 0.7 5.5 0.0 0.1 0.2 0.5 48.3 0.7 0.3 1.1 0.4 0.3 0.3 0.5 0.4 11.1 0.2 0.2 1.7 0.3 0.1 0.8 0.7 0.4 0.2 0.2 0.2 0.3 0.7 0.3 15.6 0.5 0.8 13.9 0.3 0.9 0.4 0.2 0.2 1.4 0.6 5.8 3.2 0.8 0.7 1.9 0.2 0.1 1.1 0.3 1.8 0.2 3.6 1.7 21.9 1.8 2.2 0.2 0.5 1.6 0.9 1.8 0.5 1.5 0.9 0.9 1.2 0.7 2.0 0.7 17.9 17.3 2.2 0.0 0.2 0.0 0.4 0.0 22.7 12.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 232.6 0.0 4.0 0.1 0.2 0.1 15.1 42.3 0.3 0.0 32.4 4.3 35.4 0.0 0.0 5.4 0.0 0.0 38.4 0.0 11.4 154.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 3.8 43.0 0.1 SULT1C2 "ST1C1, SULT1C1" ENSG00000198203 "Sulfotransferase family 1C member 2" O00338 2 108288639-108309915 "Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 69.2;kidney: 58.4;stomach 1: 59.2" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 19.2;Distal tubular cells: 49.7;Proximal tubular cells: 60.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "RPTEC TERT1: 24.1;RT4: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA007190 Approved NA NA "HPA007190: AB_1857647" "unprognostic (3.31e-2)" "unprognostic (1.63e-2)" "unprognostic (3.41e-1)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (3.61e-2)" "unprognostic (3.78e-1)" "unprognostic (3.62e-2)" "unprognostic (8.74e-2)" "unprognostic (2.76e-1)" "unprognostic (3.19e-2)" "unprognostic (9.27e-2)" "unprognostic (6.28e-2)" "unprognostic (4.63e-2)" "unprognostic (9.96e-5)" 0.5 0.1 0.2 2.2 0.2 0.0 0.4 0.1 0.2 0.8 1.5 1.0 0.5 10.6 0.8 13.3 0.4 1.0 69.2 0.5 0.2 0.2 58.4 1.5 2.5 0.6 0.4 0.3 0.3 3.2 0.2 4.6 0.6 2.2 0.3 1.9 18.6 3.5 4.9 0.1 0.2 1.8 0.6 0.6 0.4 59.2 0.4 0.0 0.4 10.3 0.4 0.3 0.6 0.4 0.1 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.2 1.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.2 0.0 24.1 6.9 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.2 0.2 0.4 0.3 2.2 0.0 3.0 13.1 0.0 1.2 1.3 1.2 1.9 17.8 1.4 4.5 19.2 2.0 0.2 49.7 2.5 0.0 2.7 4.9 0.0 0.2 0.2 3.9 2.3 1.1 0.5 14.2 1.6 0.0 3.1 0.0 0.0 0.0 2.2 0.0 0.0 6.3 0.0 3.8 7.0 0.0 60.0 0.6 0.0 0.3 0.3 0.2 1.6 0.1 0.0 4.7 0.8 SULT1C3 ENSG00000196228 "Sulfotransferase family 1C member 3" Q6IMI6 2 108247195-108265351 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "breast: 91.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 3.7;U-87 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (4.13e-1)" "unprognostic (6.64e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 91.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SULT1E1 "EST, STE" ENSG00000109193 "Sulfotransferase family 1E member 1" P49888 4 69841212-69860152 "Cancer-related genes, Enzymes, Predicted intracellular proteins" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.8;liver: 26.2;vagina: 15.8" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 47.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 8 "pons and medulla: 3.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 16 "HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4" "HPA028213, HPA028728, CAB047344" Enhanced Uncertain "Nuclear membrane,Cytosol" NA NA "Nuclear membrane, Cytosol" "CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894" "unprognostic (5.60e-2)" "prognostic favorable (4.06e-4)" "unprognostic (2.48e-1)" "unprognostic (1.07e-3)" "unprognostic (2.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (3.22e-3)" "unprognostic (8.62e-2)" "unprognostic (6.48e-5)" "unprognostic (2.48e-1)" "unprognostic (4.11e-2)" "unprognostic (5.55e-2)" 0.1 9.8 0.1 0.1 0.3 0.1 1.1 0.1 0.4 13.1 8.9 0.5 0.1 19.8 0.4 3.7 0.4 0.1 1.2 0.1 0.1 0.0 1.5 26.2 2.0 0.1 0.3 0.3 0.2 0.1 0.0 0.4 0.1 3.3 1.0 0.1 0.3 4.7 0.3 0.1 10.9 37.8 0.5 0.3 0.1 1.3 0.4 0.1 0.6 0.2 0.1 1.0 0.4 15.8 0.6 0.2 1.7 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 38.0 0.0 0.0 17.2 14.3 0.0 0.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.1 0.1 0.3 0.2 0.2 0.1 0.6 0.2 0.1 1.7 0.3 0.3 0.2 0.0 0.0 0.1 0.3 0.1 0.4 0.1 0.0 0.3 0.3 3.3 0.1 0.0 0.0 0.0 1.0 10.5 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.2 0.1 0.0 0.0 47.0 0.2 0.0 0.0 1.8 1.0 0.0 0.3 0.0 1.7 0.0 0.2 0.0 0.5 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.3 0.0 0.0 0.1 SULT2A1 "DHEA-ST, STD" ENSG00000105398 "Sulfotransferase family 2A member 1" Q06520 19 47870466-47886397 "Enzymes, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 211.7" "Cell type enriched" "Detected in some" 24 "Hepatocytes: 1127.7" "Cancer enriched" "Detected in some" 52 "liver cancer: 244.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 34 "Hep G2: 26.6;RT4: 18.1" "Low region specificity" "Detected in all" "CAB018755, HPA041487, HPA063633" Enhanced Supported Cytosol NA NA 210000 Cytosol "CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066" "unprognostic (2.14e-1)" "unprognostic (6.79e-3)" "unprognostic (6.82e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-2)" 0.1 46.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 11.4 1.1 1.1 8.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 211.7 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 3.9 0.1 0.0 42.7 0.1 0.1 0.1 2.8 0.7 0.1 0.1 0.2 0.1 0.1 0.6 0.2 1.3 1.0 5.3 0.8 2.3 1.3 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 26.6 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.2 0.0 18.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 5.3 0.8 0.7 0.9 0.4 0.6 0.7 1.0 0.6 0.3 1.3 1.3 1.0 3.1 2.3 0.4 1.0 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 7.0 0.5 0.1 0.6 0.6 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.7 0.0 0.0 0.1 0.3 0.0 1127.7 0.0 0.0 0.0 38.6 31.7 0.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552075-48599425 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6" "Cell type enhanced" "Detected in many" 13 "Glandular cells: 53.7;Suprabasal keratinocytes: 120.1;Urothelial cells: 113.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 27.6;MCF7: 16.9;OE19: 44.8;T-47d: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA041724, HPA043539, HPA076510" Enhanced Supported Vesicles NA NA Vesicles "HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: " "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 4.0 0.1 0.2 28.7 0.8 0.0 9.2 2.9 2.2 5.2 91.8 0.3 2.3 0.0 0.1 0.1 2.5 0.1 6.5 0.0 0.2 0.0 0.1 0.2 0.8 0.1 11.4 0.0 6.9 0.0 0.0 12.4 6.9 0.2 45.7 13.4 0.0 0.1 0.0 0.7 0.2 0.0 0.5 1.1 79.6 78.6 0.6 32.0 0.7 1.5 2.5 1.0 1.1 3.1 0.9 4.5 5.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 27.6 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.9 0.0 0.2 0.0 44.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.3 0.1 0.0 13.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.8 0.4 2.1 0.9 3.1 0.4 1.8 1.4 0.7 0.7 0.6 1.2 1.4 1.1 1.0 1.5 1.1 0.9 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 17.9 0.3 0.0 28.4 21.4 0.0 0.6 2.5 4.0 13.6 8.7 0.0 2.8 0.0 11.1 0.0 0.3 8.6 0.0 1.0 2.7 2.0 53.7 0.0 0.0 0.6 0.0 4.6 0.0 0.0 0.2 0.3 0.2 11.8 0.0 7.1 1.2 10.8 7.0 0.0 0.8 0.6 0.0 2.8 0.2 7.5 120.1 1.6 0.0 2.6 113.8 SULT4A1 "hBR-STL-1, SULTX3" ENSG00000130540 "Sulfotransferase family 4A member 1" Q9BR01 22 43824509-43862503 "Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 20 "brain: 80.3" "Cell type enhanced" "Detected in some" 10 "Bipolar cells: 16.6;Early spermatids: 18.0;Horizontal cells: 22.3;Late spermatids: 21.7;Rod photoreceptor cells: 15.7" "Cancer enhanced" "Detected in many" "testis cancer: 6.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;OE19: 1.4;SuSa: 1.0;THP-1: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003129 Enhanced NA NA "HPA003129: AB_1080130" "unprognostic (2.61e-3)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "unprognostic (6.30e-2)" "unprognostic (6.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.63e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (2.48e-4)" "unprognostic (1.91e-2)" "unprognostic (6.10e-2)" "unprognostic (7.59e-4)" "unprognostic (7.89e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-3)" "unprognostic (8.34e-3)" 1.2 4.0 12.1 1.5 17.2 1.2 1.2 27.8 80.3 1.2 1.7 1.1 0.0 1.3 1.2 1.2 1.2 1.2 1.3 1.2 15.7 19.3 1.2 1.2 1.2 1.2 13.1 18.9 1.2 1.4 1.2 0.8 1.2 18.0 1.2 1.4 0.6 1.3 1.2 1.2 1.2 1.6 1.5 3.1 1.3 1.3 1.9 1.3 0.0 1.2 0.0 1.2 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.3 0.5 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 17.2 27.8 44.4 15.7 19.3 13.1 18.9 18.0 1.3 0.0 0.0 0.0 0.0 0.0 16.6 1.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 18.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 22.3 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.7 0.0 15.7 0.0 0.0 3.2 5.4 0.0 0.0 0.0 0.0 0.0 SULT6B1 ENSG00000138068 "Sulfotransferase family 6B member 1" Q6IMI4 2 37167820-37196598 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.4;fallopian tube: 2.0;testis: 7.1" "Cell type enhanced" "Detected in single" 25 "Late spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 6 "WM-115: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.86e-1)" "unprognostic (8.98e-2)" 0.1 0.1 0.1 0.1 0.3 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 7.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.2 2.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 SUN3 "MGC33329, SUNC1" ENSG00000164744 "Sad1 and UNC84 domain containing 3" Q8TAQ9 7 47987148-48029119 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 30.9" "Cell type enriched" "Detected in some" 8 "Early spermatids: 435.2" "Cancer enhanced" "Detected in single" "testis cancer: 2.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "GAMG: 7.2;U-2 OS: 21.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA008344, HPA076890" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA008344: AB_1857656, HPA076890: " "unprognostic (5.11e-2)" "unprognostic (4.96e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-4)" "unprognostic (2.31e-2)" "unprognostic (5.62e-2)" "unprognostic (1.35e-2)" "unprognostic (2.24e-2)" "unprognostic (1.59e-5)" "unprognostic (4.88e-1)" "unprognostic (1.47e-1)" "unprognostic (2.65e-1)" "unprognostic (1.81e-2)" "unprognostic (1.64e-1)" "unprognostic (3.48e-1)" "unprognostic (2.58e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.5 0.1 0.7 1.2 0.3 0.2 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 3.2 0.1 0.0 0.0 7.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.7 0.0 0.3 0.0 1.3 21.5 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.4 1.2 0.1 0.1 0.7 0.4 0.4 0.0 0.8 0.5 0.2 1.5 0.7 0.1 0.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 435.2 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 54.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.2 0.0 6.5 0.1 6.7 7.4 0.0 0.7 0.0 0.0 0.0 SUN5 "dJ726C3.1, SPAG4L, TSARG4" ENSG00000167098 "Sad1 and UNC84 domain containing 5" Q8TC36 20 32983773-33004433 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 361 "testis: 36.1" "Cell type enriched" "Detected in some" 8 "Early spermatids: 390.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048529 Enhanced NA NA "HPA048529: AB_2680428" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 390.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 2.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.7 1.7 0.0 0.0 0.0 0.0 0.0 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356552-133361169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 50.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 358.5;Late spermatids: 675.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 8.3 9.2 15.8 9.0 13.2 8.2 10.7 13.1 14.5 5.7 8.8 7.4 10.8 13.2 6.4 12.0 11.0 10.7 11.2 8.9 13.4 11.0 14.3 12.0 6.5 12.1 13.1 8.7 9.0 17.5 7.1 11.3 5.9 10.3 7.7 5.7 7.7 14.2 8.8 11.5 14.8 11.4 6.9 9.4 8.6 9.3 50.1 6.6 10.6 10.1 14.9 9.8 6.5 8.3 17.5 15.6 13.1 16.2 13.2 26.9 14.1 7.2 12.5 5.3 6.5 3.8 3.0 11.1 3.7 3.3 5.9 3.1 17.1 6.0 7.2 5.4 2.4 5.1 19.9 8.3 9.0 2.7 6.9 11.5 5.7 14.3 6.3 7.7 9.3 4.3 3.6 10.7 8.4 12.4 2.1 2.7 8.9 9.0 5.0 4.0 43.6 9.6 6.2 16.6 17.4 24.2 10.7 7.9 16.9 5.0 8.3 19.7 9.9 8.2 13.8 11.0 3.4 14.7 4.4 5.1 9.0 9.1 9.2 13.1 6.2 12.3 7.8 5.7 5.6 9.0 13.1 16.2 12.0 17.8 16.2 23.1 15.6 21.9 20.2 13.8 17.5 20.8 19.7 7.1 13.2 11.6 15.6 26.9 14.1 15.8 13.2 13.1 14.5 13.4 11.0 13.1 8.7 10.3 6.6 11.9 7.8 21.6 25.7 74.8 17.9 12.4 45.9 48.2 17.0 21.0 2.0 33.0 89.5 56.4 358.5 19.4 48.7 0.0 70.1 21.0 22.4 21.1 9.2 21.5 25.8 12.7 35.1 20.3 25.9 675.3 24.2 22.4 40.5 27.9 17.1 13.2 50.2 28.1 23.0 64.0 18.9 64.7 32.0 140.5 86.5 77.0 21.4 26.1 23.8 17.8 SUSD2 "BK65A6.2, FLJ22778" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181259-24189110 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.1" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 232.3;Alveolar cells type 2: 121.0" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Region enhanced" "Detected in many" "pons and medulla: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SK-BR-3: 138.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA004117 Enhanced Approved "Plasma membrane" NA NA 3600000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavorable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 6.0 4.2 0.3 1.4 0.9 0.5 11.3 3.8 1.4 10.5 10.5 2.5 1.3 7.8 7.1 8.3 2.8 6.9 5.3 10.8 0.6 2.9 19.5 1.2 100.1 1.4 0.6 2.6 2.6 2.4 1.3 3.6 3.5 9.6 2.8 1.0 2.2 7.9 4.0 3.0 11.8 32.4 2.4 3.0 1.6 2.5 1.9 0.7 0.1 12.7 5.9 1.5 2.3 4.7 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.7 1.5 0.0 0.0 3.0 3.9 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 1.2 0.0 0.0 3.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.1 0.1 138.9 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.8 1.4 0.6 2.9 0.6 2.6 9.6 0.7 232.3 121.0 0.0 0.2 0.2 0.0 2.8 0.0 5.3 33.0 1.8 0.0 14.1 5.0 0.0 0.0 0.3 1.6 0.0 0.0 0.4 3.5 0.8 3.5 0.0 0.9 0.0 1.7 4.3 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 24.9 0.0 0.0 15.1 0.9 0.9 2.4 22.1 0.0 0.0 0.5 SUSD3 MGC26847 ENSG00000157303 "Sushi domain containing 3" Q96L08 9 93058688-93085138 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 52.8;testis: 64.8" "Cell type enhanced" "Detected in many" 8 "B-cells: 27.5;Hepatocytes: 48.7;Hofbauer cells: 38.0;Proximal tubular cells: 50.4;T-cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 51.7;Karpas-707: 11.5;MCF7: 12.5;NB-4: 26.4;RPMI-8226: 28.0;THP-1: 11.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042310 Uncertain NA NA "HPA042310: AB_10796902" "prognostic favorable (5.13e-4)" "unprognostic (5.42e-2)" "unprognostic (3.65e-1)" "unprognostic (8.34e-3)" "unprognostic (9.06e-2)" "unprognostic (2.84e-2)" "unprognostic (2.94e-2)" "unprognostic (7.41e-3)" "unprognostic (5.06e-2)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (3.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.39e-3)" "unprognostic (5.33e-2)" 3.2 1.0 3.3 16.9 3.2 18.7 8.0 1.2 3.2 8.3 3.3 8.5 0.6 2.2 11.6 12.8 1.9 18.2 1.9 1.0 2.4 2.7 18.5 13.9 3.8 25.8 4.0 2.3 20.9 0.8 0.2 3.2 1.4 3.7 1.8 0.9 3.0 7.5 1.5 0.4 1.6 9.7 3.0 5.4 20.2 1.9 64.8 3.1 13.9 2.5 0.8 19.9 3.0 3.7 20.4 9.2 16.7 3.9 2.2 52.8 17.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.1 1.1 0.4 51.7 0.2 0.2 0.0 0.1 0.8 0.0 0.0 4.5 0.0 7.0 0.0 0.8 3.4 0.0 1.6 3.6 0.2 0.0 0.0 0.0 0.0 0.0 2.1 11.5 0.0 12.5 0.0 26.4 0.6 0.4 1.6 2.2 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 6.8 11.9 0.1 0.0 0.0 0.0 0.0 2.3 1.2 3.2 0.0 0.0 0.1 0.1 3.9 16.7 5.7 3.4 6.4 20.4 30.1 10.5 9.2 14.4 52.8 21.3 1.3 2.2 0.6 0.8 39.8 17.0 3.3 3.2 1.2 3.2 2.4 2.7 4.0 2.3 3.7 3.1 0.0 7.9 27.5 0.1 0.6 0.2 0.6 15.3 1.4 0.0 0.0 3.9 0.8 8.3 0.6 2.4 0.4 0.0 0.0 0.2 1.5 1.5 0.6 3.5 48.7 38.0 0.0 0.0 1.8 10.8 9.0 5.2 8.5 1.7 1.0 0.1 0.5 0.4 0.0 4.9 50.4 7.8 0.0 0.9 2.1 2.7 0.3 1.1 30.9 0.4 0.2 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 26.6;Horizontal cells: 20.6;Leydig cells: 19.0;Urothelial cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HaCaT: 7.1;RPTEC TERT1: 8.4;SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.3 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.7 0.5 4.5 1.3 0.0 1.4 0.1 0.0 7.1 0.2 1.1 0.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 5.0 0.4 0.0 0.3 3.2 3.1 0.0 0.1 2.1 0.9 0.0 0.1 0.0 8.4 2.0 29.0 0.3 0.0 2.4 0.0 0.6 1.8 0.2 0.0 1.3 5.2 0.0 2.6 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 0.0 4.5 0.0 5.3 0.6 15.9 9.1 0.0 8.1 12.5 15.7 9.8 0.0 26.6 0.6 2.5 0.4 0.0 0.0 6.3 0.0 0.7 6.8 0.0 1.5 2.1 20.6 1.2 0.0 0.0 2.8 19.0 0.1 5.0 0.0 0.0 1.1 2.7 0.0 11.7 0.2 6.1 0.0 1.0 0.5 5.9 1.5 0.0 1.3 0.0 26.8 SUV39H2 "FLJ23414, KMT1B" ENSG00000152455 "Suppressor of variegation 3-9 homolog 2" Q9H5I1 10 14878820-14904315 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Differentiation, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 22 "Early spermatids: 302.5;Late spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA045901, HPA057554" Enhanced Approved Mitochondria NA NA Mitochondria "HPA045901: AB_10960702, HPA057554: AB_2683466" "prognostic unfavorable (5.55e-4)" "unprognostic (1.45e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-3)" "unprognostic (6.80e-2)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.06e-1)" "unprognostic (9.15e-2)" "unprognostic (3.59e-3)" "unprognostic (2.42e-1)" "unprognostic (4.13e-3)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.71e-2)" "unprognostic (1.40e-1)" "unprognostic (5.55e-2)" "unprognostic (1.39e-1)" 3.0 2.9 4.7 3.4 7.4 4.9 5.2 20.0 8.6 3.1 3.8 1.6 2.1 3.2 3.8 2.3 4.0 3.0 3.2 2.4 5.4 2.8 3.5 3.8 2.7 3.6 3.3 4.4 4.2 2.4 2.4 6.3 5.1 3.3 3.9 4.7 1.6 2.4 3.6 2.4 3.3 2.9 3.7 3.0 3.4 2.7 41.8 4.4 10.3 2.8 4.9 4.0 3.3 2.8 0.8 3.1 0.5 1.8 5.6 4.0 0.8 13.7 13.1 22.0 12.5 4.1 5.0 8.6 7.5 4.6 14.0 19.9 19.6 7.9 11.1 6.8 4.5 12.3 9.7 16.3 9.1 17.3 11.3 10.8 16.7 9.3 12.1 2.4 7.5 8.0 2.4 3.2 14.2 4.4 3.1 9.6 18.9 21.5 7.5 10.3 13.5 14.8 2.1 13.6 12.6 3.5 18.4 14.5 8.9 5.9 6.6 7.3 8.1 11.7 7.3 6.3 13.5 12.9 6.5 5.6 10.1 16.3 12.3 11.9 4.3 16.1 25.5 6.2 8.2 6.5 0.5 0.4 0.3 2.8 1.8 4.0 0.8 2.4 3.5 2.2 0.6 3.8 3.6 0.3 5.6 0.5 3.1 3.7 0.8 4.7 7.4 20.0 8.6 5.4 2.8 3.3 4.4 3.3 4.4 0.0 1.0 0.0 7.0 7.3 7.4 2.4 0.0 4.0 7.9 1.8 9.8 11.4 5.0 3.5 302.5 5.2 0.9 0.0 1.8 20.4 5.5 6.6 2.3 2.9 4.3 11.1 3.4 1.8 1.8 78.4 4.4 2.4 1.7 1.0 2.8 2.4 2.2 1.1 2.5 5.0 9.8 6.5 6.6 37.0 52.7 7.8 7.4 1.8 3.9 10.9 SV2A "KIAA0736, SV2" ENSG00000159164 "Synaptic vesicle glycoprotein 2A" Q7L0J3 1 149903318-149917882 "FDA approved drug targets, Predicted membrane proteins" "Neurotransmitter transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3;parathyroid gland: 34.0" "Group enriched" "Detected in many" 6 "Bipolar cells: 95.8;Horizontal cells: 90.6;Muller glia cells: 25.1" "Cancer enriched" "Detected in many" 6 "glioma: 27.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002226, HPA007863" Enhanced Approved Cytosol NA NA Cytosol "CAB002226: AB_564144, HPA007863: AB_1080135" "unprognostic (8.05e-3)" "unprognostic (3.86e-3)" "unprognostic (2.24e-1)" "unprognostic (5.39e-2)" "unprognostic (2.66e-1)" "unprognostic (2.02e-1)" "unprognostic (6.24e-2)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (2.06e-1)" "unprognostic (9.00e-3)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.44e-2)" "unprognostic (9.86e-2)" "unprognostic (1.95e-2)" "unprognostic (4.81e-3)" 2.0 7.3 20.4 2.8 24.7 4.5 1.5 36.8 75.3 3.2 2.3 4.8 0.9 1.9 5.6 18.0 2.0 3.2 3.2 1.5 22.3 30.5 1.7 1.2 1.8 2.3 21.6 25.1 2.6 1.9 34.0 7.2 1.9 32.9 3.1 2.2 3.1 1.7 3.7 1.1 1.5 2.2 6.6 16.8 2.0 2.0 1.6 6.0 0.3 4.0 0.0 2.0 2.5 1.2 1.2 0.8 2.1 0.7 1.7 2.5 0.6 0.1 0.0 10.3 0.0 1.0 3.0 1.1 4.3 15.2 13.0 18.8 0.3 0.4 0.1 3.9 6.5 13.7 0.2 0.1 0.9 11.2 0.0 2.4 13.5 0.7 0.7 9.9 0.1 0.2 6.8 0.1 20.7 1.5 14.5 1.1 12.4 0.1 14.1 8.5 0.1 13.0 0.6 26.1 0.0 0.0 4.5 6.5 0.2 0.1 0.3 21.6 17.4 0.0 0.1 9.9 10.3 0.1 8.2 0.0 12.1 12.2 0.5 15.8 0.1 0.1 0.0 21.2 0.1 4.8 1.5 0.7 0.4 1.8 0.3 1.9 0.7 1.9 1.1 0.2 1.2 1.0 2.2 2.1 1.7 0.3 0.8 2.5 0.6 20.4 24.7 36.8 40.0 22.3 30.5 21.6 25.1 32.9 6.0 0.0 1.4 0.0 2.0 0.1 95.8 0.6 0.0 1.4 0.0 0.0 3.9 0.3 0.0 0.0 0.3 1.4 0.0 0.0 0.3 0.7 1.5 1.0 0.0 0.0 0.2 90.6 4.1 5.5 0.0 0.0 0.0 0.3 0.0 0.0 0.2 25.1 0.2 0.0 5.3 0.0 11.4 0.0 4.1 1.2 0.8 0.4 0.3 2.5 0.3 0.6 SV2B "HsT19680, KIAA0735" ENSG00000185518 "Synaptic vesicle glycoprotein 2B" Q7L1I2 15 91099950-91301309 "Predicted membrane proteins" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.2" "Group enriched" "Detected in some" 25 "Bipolar cells: 146.2;Cone photoreceptor cells: 141.4;Muller glia cells: 42.3;Rod photoreceptor cells: 121.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RPMI-8226: 4.7;SCLC-21H: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046247 Approved NA NA "HPA046247: AB_10963538" "unprognostic (2.92e-1)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (4.01e-5)" "unprognostic (2.66e-3)" "unprognostic (7.77e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.57e-2)" "unprognostic (9.89e-2)" "unprognostic (1.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-2)" "unprognostic (3.10e-4)" 3.5 2.7 13.1 1.4 16.8 1.1 1.6 26.2 44.2 1.2 1.4 1.4 0.0 1.2 1.2 1.3 1.2 1.3 1.4 1.8 19.7 3.3 1.3 1.3 1.4 1.6 5.1 21.3 1.1 3.1 1.1 1.3 1.4 25.6 2.2 1.6 7.3 2.4 1.2 1.7 1.4 1.6 1.3 1.5 1.3 1.4 2.2 0.2 0.0 1.2 0.0 2.7 1.2 0.6 0.6 0.4 1.2 0.3 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 4.7 0.0 0.1 9.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 0.1 0.2 1.0 0.4 1.2 0.3 0.3 0.2 0.1 0.1 0.6 0.3 0.3 0.0 0.6 0.4 0.3 1.1 0.7 0.1 0.4 0.1 0.0 13.1 16.8 26.2 31.3 19.7 3.3 5.1 21.3 25.6 0.2 0.0 0.0 0.0 0.1 0.3 146.2 2.4 2.5 0.0 0.0 0.0 141.4 0.0 0.0 2.9 4.5 2.5 0.0 0.0 4.6 0.0 0.8 0.2 0.0 0.0 0.1 3.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.1 0.0 0.0 0.0 121.8 0.0 0.0 3.9 0.2 0.1 0.0 0.0 0.0 0.1 SV2C ENSG00000122012 "Synaptic vesicle glycoprotein 2C" Q496J9 5 76083172-76353939 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Cell type enriched" "Detected in some" 4 "Intestinal endocrine cells: 19.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "basal ganglia: 52.2;pons and medulla: 26.6" "Cell type enriched" "Detected in single" 14 "basophil: 4.2" "Lineage enriched" "Detected in single" 21 "granulocytes: 4.2" "Group enriched" "Detected in some" 5 "Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040722, HPA040770" Supported Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA040722: AB_10795624, HPA040770: AB_10805828" "unprognostic (7.91e-2)" "unprognostic (2.33e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-2)" "unprognostic (1.07e-1)" "unprognostic (9.93e-2)" "unprognostic (1.09e-2)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (2.34e-2)" "unprognostic (1.60e-3)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" 0.5 5.5 0.8 1.3 52.2 0.7 1.2 1.2 9.5 0.7 0.8 0.5 0.0 1.0 0.7 0.9 0.6 1.8 0.6 0.8 0.6 8.3 0.4 0.4 0.4 0.5 5.6 1.9 2.6 0.8 0.9 0.8 0.4 26.6 1.0 1.1 1.1 1.7 1.2 0.3 0.7 1.3 1.0 5.8 0.6 1.6 1.0 6.7 0.0 0.5 0.0 0.4 0.6 0.4 0.1 0.1 4.2 0.2 0.1 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 12.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 11.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 4.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.2 0.2 0.8 52.2 1.2 9.5 0.6 8.3 5.6 1.9 26.6 6.7 0.0 0.0 0.0 0.5 0.0 3.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.1 1.1 0.0 0.0 0.1 0.0 19.0 0.6 0.0 0.7 0.0 0.0 3.3 0.0 0.5 0.8 0.0 0.0 0.0 0.0 4.4 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 1.1 SVEP1 "bA427L11.3, C9orf13, FLJ13529, POLYDOM" ENSG00000165124 "Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" Q4LDE5 9 110365251-110579880 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 141.1" "Group enriched" "Detected in some" 6 "Fibroblasts: 33.2;Leydig cells: 38.9;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 51.6;ASC TERT1: 30.0;BJ hTERT+: 21.1;HHSteC: 18.9;HSkMC: 23.4" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 7 "cerebellum: 31.1" "HPA020610, HPA021520" Enhanced "Intracellular and membrane" NA NA 160000000 "HPA020610: AB_2197021, HPA021520: AB_1855533" "unprognostic (4.47e-2)" "unprognostic (6.01e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.62e-2)" "unprognostic (9.13e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (3.31e-3)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (9.84e-2)" "unprognostic (2.21e-1)" "unprognostic (1.55e-3)" 18.8 2.5 1.0 3.9 1.8 0.0 11.9 6.7 0.9 7.1 8.6 0.5 3.6 0.6 6.1 7.8 4.7 4.4 5.4 4.4 1.1 0.7 2.1 1.5 8.6 5.8 1.1 0.5 4.2 2.7 2.2 0.7 141.1 0.7 4.3 3.1 1.5 2.2 1.3 7.4 3.5 3.3 5.7 0.6 3.4 3.6 4.0 0.9 0.0 3.5 2.3 1.3 9.6 7.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 51.6 30.0 0.0 5.4 21.1 0.4 0.6 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.1 0.3 0.0 0.1 0.0 0.4 0.0 18.9 0.0 1.0 23.4 0.0 4.1 1.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.7 0.0 3.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.4 0.8 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 6.7 0.9 1.1 0.7 1.1 0.5 0.7 0.9 0.0 0.3 0.0 0.5 5.0 0.0 1.2 7.6 0.0 0.0 0.0 0.0 7.6 0.0 0.6 0.2 2.1 0.0 0.0 0.2 1.1 33.2 0.2 0.0 0.0 2.7 0.0 0.0 3.1 0.0 0.0 38.9 0.0 6.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.1 1.4 2.9 56.3 0.0 0.0 0.1 SVIL ENSG00000197321 Supervillin O95425 10 29457338-29736781 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 235.1;tongue: 93.5" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 411.9;Peritubular cells: 245.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 15.2" "Group enriched" "Detected in many" 6 "granulocytes: 15.2;monocytes: 4.2" "Cell line enhanced" "Detected in many" "HaCaT: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010878, HPA020095, HPA020138" Approved Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane" "Actin filaments, Cytosol" "CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.06e-2)" "unprognostic (1.15e-2)" "unprognostic (3.47e-3)" "unprognostic (2.26e-2)" "unprognostic (4.12e-1)" "unprognostic (1.49e-1)" "unprognostic (4.28e-1)" "unprognostic (3.42e-3)" "unprognostic (1.55e-1)" "unprognostic (9.20e-2)" "unprognostic (2.38e-3)" "unprognostic (7.11e-3)" "unprognostic (1.51e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (5.70e-5)" 11.9 2.1 0.7 10.5 1.1 3.7 4.5 0.6 0.9 18.7 42.3 0.6 10.7 1.7 34.3 13.3 18.2 8.9 15.5 25.5 0.5 0.6 2.8 2.0 3.8 2.3 0.8 0.7 13.9 2.4 5.1 4.1 2.9 1.7 12.6 5.3 10.0 10.6 15.3 235.1 4.7 9.1 36.4 1.3 1.5 14.2 5.5 0.5 4.6 6.9 93.5 11.6 28.6 9.9 0.1 0.7 15.2 4.2 1.2 1.7 0.6 17.4 7.5 3.4 1.2 10.0 26.8 5.6 2.8 6.8 1.1 1.1 8.9 17.3 0.0 12.4 1.1 10.9 40.4 1.9 6.6 1.1 0.2 3.7 0.0 9.6 5.7 6.0 1.5 0.3 24.6 6.5 12.5 4.5 22.5 20.0 2.5 0.0 0.1 1.7 5.4 1.4 0.8 1.7 7.8 2.7 3.2 10.2 0.1 11.9 5.8 4.2 3.4 2.5 0.3 8.9 11.7 3.1 1.9 12.9 5.7 5.9 28.3 8.4 0.1 0.0 0.0 22.2 3.4 19.7 2.9 1.1 5.2 1.2 1.9 1.5 0.0 1.1 0.6 0.7 0.1 1.7 1.1 15.2 1.2 4.2 0.2 0.1 0.6 0.7 1.1 0.6 0.9 0.5 0.6 0.8 0.7 1.7 0.5 44.7 29.1 9.7 91.1 62.4 7.4 411.9 15.3 60.2 75.1 36.6 23.6 24.9 6.6 80.7 2.3 48.5 22.2 0.0 36.6 17.5 59.3 70.6 9.3 10.2 8.5 4.8 23.0 21.5 9.7 2.7 101.5 25.2 27.0 1.8 26.4 30.4 47.2 34.5 245.1 9.7 16.1 45.3 155.7 6.3 7.7 52.4 20.7 4.4 38.0 78.2 SVIP DKFZp313A2432 ENSG00000198168 "Small VCP interacting protein" Q8NHG7 11 22813799-22830299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.1" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 723.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039807 Approved NA NA "HPA039807: AB_10795232" "unprognostic (1.18e-2)" "unprognostic (2.05e-1)" "unprognostic (2.21e-1)" "unprognostic (2.72e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-2)" "unprognostic (2.34e-2)" "unprognostic (1.73e-1)" "unprognostic (8.80e-2)" "unprognostic (2.02e-2)" "unprognostic (9.31e-2)" "unprognostic (2.44e-1)" "prognostic favorable (1.77e-8)" "unprognostic (2.18e-2)" "unprognostic (1.24e-1)" "unprognostic (5.21e-2)" "unprognostic (1.16e-2)" 3.4 9.1 17.5 5.5 20.6 15.6 11.4 11.8 18.1 7.7 7.9 11.3 6.6 10.7 7.6 19.7 6.0 8.8 8.9 11.6 16.3 22.6 16.4 5.8 8.0 8.4 29.0 10.5 9.0 13.6 16.3 23.1 2.9 32.4 13.8 8.8 4.4 11.1 9.1 10.0 5.7 11.1 6.6 67.1 8.1 18.8 9.3 15.7 3.3 24.9 3.1 7.3 6.9 6.7 9.5 17.7 16.2 1.0 4.6 12.7 4.5 0.0 2.4 5.2 0.2 0.6 0.2 3.1 2.1 1.6 3.0 2.4 1.5 2.0 0.0 3.3 1.6 3.1 1.3 7.6 2.1 3.9 14.5 5.9 7.3 2.3 3.7 1.6 12.1 10.7 0.3 2.9 0.0 1.9 3.7 11.0 13.6 14.8 16.3 2.9 3.6 13.1 1.6 3.0 12.6 6.0 11.4 5.3 11.0 5.4 6.6 26.6 5.9 0.0 6.4 6.9 1.4 10.9 2.3 7.6 1.3 4.6 18.4 3.5 4.1 0.0 4.3 8.6 0.0 5.4 5.2 1.0 16.2 6.3 0.5 8.2 8.9 10.2 7.1 1.2 9.5 12.7 9.1 3.3 4.6 0.7 17.7 6.8 4.5 17.5 20.6 11.8 18.1 16.3 22.6 29.0 10.5 32.4 15.7 74.5 73.7 92.3 52.6 23.8 48.3 135.6 89.2 49.5 53.4 153.5 21.6 27.1 344.8 80.5 723.3 84.5 66.4 186.9 124.7 5.1 15.3 84.2 121.4 77.4 21.5 25.4 108.0 60.2 19.8 227.7 32.2 39.4 52.3 89.2 94.1 39.5 119.0 54.7 44.2 122.4 74.2 12.9 25.7 111.4 80.6 67.8 27.5 89.1 76.2 67.2 SVOP DKFZp761H039 ENSG00000166111 "SV2 related protein" Q8N4V2 12 108907741-109021240 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 30.3" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 39.3;Early spermatids: 59.5;Late spermatids: 90.9" "Group enriched" "Detected in some" 9 "glioma: 0.6;pancreatic cancer: 1.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 13 "Karpas-707: 6.3;RPMI-8226: 6.4;SCLC-21H: 3.5;SH-SY5Y: 3.1;U-266/84: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016573 Uncertain NA NA "HPA016573: AB_2197027" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (2.09e-1)" "unprognostic (6.51e-3)" "unprognostic (2.18e-2)" "unprognostic (3.79e-1)" "unprognostic (1.84e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "unprognostic (4.29e-3)" "unprognostic (3.07e-1)" "unprognostic (4.28e-3)" "unprognostic (3.94e-2)" "unprognostic (2.26e-2)" "unprognostic (6.17e-2)" 0.6 2.9 6.9 0.7 14.0 0.7 0.6 8.2 30.3 0.6 0.8 0.5 0.0 1.3 0.6 0.7 0.6 1.1 0.6 1.1 8.9 1.9 0.7 0.6 0.7 0.6 0.7 10.0 0.6 1.7 0.5 6.8 0.6 6.4 0.8 0.8 1.5 0.6 0.7 0.7 0.6 1.0 0.6 0.8 0.6 1.8 1.0 0.7 0.0 0.7 0.0 0.5 0.6 0.7 0.6 0.4 2.0 0.4 0.9 0.3 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 3.5 3.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 2.9 0.1 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.2 0.2 0.2 0.3 0.2 0.1 0.6 0.3 0.3 2.0 0.9 0.3 0.4 0.2 0.1 6.9 14.0 8.2 21.6 8.9 1.9 0.7 10.0 6.4 0.7 11.9 11.1 0.0 0.6 0.0 15.9 1.2 0.0 0.0 9.1 1.8 39.3 1.2 0.0 0.0 59.5 0.4 0.0 0.0 0.0 0.1 0.1 0.3 2.3 0.0 0.1 11.1 16.1 1.3 0.0 90.9 0.3 0.4 0.0 0.0 0.0 1.6 0.2 0.0 0.7 0.0 20.4 0.0 0.0 0.5 0.8 0.0 0.7 0.0 0.0 0.3 SVOPL MGC46715 ENSG00000157703 "SVOP like" Q8N434 7 138594285-138701352 "Predicted membrane proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 13.9;salivary gland: 6.5" "Cell type enriched" "Detected in some" 9 "granulocytes: 73.9" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 41 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 41 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "HMC-1: 8.3;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA018035 Uncertain NA NA "HPA018035: AB_2197028" "unprognostic (6.70e-5)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (2.49e-1)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "unprognostic (7.69e-3)" "unprognostic (2.59e-3)" "unprognostic (7.16e-2)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (5.03e-3)" "unprognostic (2.22e-4)" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (8.51e-2)" 0.0 2.1 0.5 0.0 1.1 0.0 1.2 0.0 0.1 0.3 0.9 0.0 0.0 0.7 0.0 2.3 0.0 0.0 1.0 0.8 2.7 0.0 0.2 0.0 0.2 0.7 0.3 13.9 1.8 0.5 0.1 0.1 6.5 0.7 0.0 0.4 0.0 0.0 0.8 0.0 0.0 1.5 1.0 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.3 0.0 0.0 1.0 0.0 0.3 0.0 1.9 0.1 1.0 0.0 0.8 0.0 0.7 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.1 0.1 0.6 1.7 0.0 1.4 2.3 1.8 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.4 0.0 73.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 8.0 0.0 0.0 0.7 0.2 0.1 1.6 0.0 0.2 0.3 SWT1 "C1orf26, FLJ20121, HsSwt1" ENSG00000116668 "SWT1, RNA endoribonuclease homolog" Q5T5J6 1 185157080-185291765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 99.9;Late spermatids: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024214, HPA027334" Enhanced Approved Cytosol NA NA Cytosol "HPA024214: AB_1845642, HPA027334: AB_1845643" "unprognostic (2.67e-3)" "unprognostic (1.32e-1)" "unprognostic (3.65e-1)" "unprognostic (4.26e-2)" "unprognostic (3.17e-3)" "unprognostic (8.41e-3)" "unprognostic (5.71e-3)" "unprognostic (9.26e-3)" "unprognostic (7.37e-2)" "unprognostic (2.68e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.97e-1)" "unprognostic (4.19e-2)" "unprognostic (4.50e-2)" "unprognostic (4.35e-2)" 5.0 4.8 4.1 3.4 6.0 8.7 8.4 6.5 5.9 5.0 5.8 5.7 7.1 5.6 6.6 5.4 3.8 4.1 4.5 4.4 4.2 4.7 5.7 4.7 5.4 7.6 5.2 4.6 7.7 12.4 5.8 9.9 18.1 6.8 5.7 4.1 3.2 6.7 7.9 5.0 3.9 5.4 4.0 9.1 4.8 6.1 39.1 6.5 7.6 6.1 3.2 3.6 5.2 9.1 4.5 1.5 12.0 4.8 1.0 7.2 1.5 1.9 1.7 4.7 2.6 7.9 6.1 4.0 1.9 3.3 2.4 3.8 1.4 1.6 1.9 3.9 1.5 2.5 1.6 2.8 2.6 3.1 5.1 1.9 2.0 1.2 1.8 3.9 0.6 1.7 4.4 2.7 2.7 2.4 4.2 5.9 3.9 4.3 9.6 2.5 0.6 2.2 1.8 5.1 5.1 1.0 1.7 4.2 4.6 2.3 1.1 1.0 7.4 1.6 2.4 6.7 11.6 2.8 1.3 2.8 3.2 2.1 3.1 1.2 17.5 13.3 0.7 3.6 1.2 1.2 12.0 2.5 3.4 2.0 2.2 3.7 3.1 4.0 3.0 1.5 4.5 3.9 2.9 7.2 1.0 4.8 1.4 7.2 1.5 4.1 6.0 6.5 5.9 4.2 4.7 5.2 4.6 6.8 6.5 3.0 0.6 2.2 1.7 0.9 3.9 7.0 2.5 1.4 4.5 5.2 3.9 2.8 0.0 2.2 99.9 3.4 3.5 0.0 2.3 5.4 4.1 2.4 2.3 3.2 3.0 7.9 0.0 8.6 5.7 37.0 4.4 2.8 1.7 3.6 2.9 2.4 1.6 8.6 5.3 5.0 4.4 0.0 1.9 22.7 11.5 0.5 5.6 2.1 2.4 1.6 SYBU "FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL" ENSG00000147642 Syntabulin Q9NX95 8 109573978-109691791 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 82.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 47.0;Horizontal cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 9.4;naive B-cell: 4.4" "Lineage enriched" "Detected in single" 29 "B-cells: 9.4" "Cell line enhanced" "Detected in many" "HaCaT: 13.5;PC-3: 15.2;SK-BR-3: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053057 Uncertain Supported Vesicles NA NA Vesicles "HPA053057: AB_2682028" "unprognostic (4.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-1)" "prognostic favorable (7.74e-4)" "unprognostic (1.22e-2)" "unprognostic (1.37e-1)" "unprognostic (2.16e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-1)" "unprognostic (6.05e-3)" "unprognostic (6.89e-2)" "unprognostic (4.27e-2)" 17.6 19.7 18.2 2.5 25.5 0.8 13.3 36.8 31.3 7.7 8.7 4.0 11.5 7.1 3.4 7.9 4.1 12.8 6.9 2.6 15.2 23.0 3.3 26.6 5.2 3.1 13.5 17.9 5.5 82.7 1.6 12.4 2.1 14.7 5.1 12.5 3.5 12.6 10.0 2.5 5.3 7.4 5.1 7.2 1.2 8.7 1.7 5.1 0.3 7.6 1.1 5.1 2.9 3.8 9.4 0.1 0.0 0.0 0.0 0.3 0.1 5.2 2.6 2.1 0.0 0.3 0.3 1.5 1.8 0.0 0.0 0.0 4.7 3.1 0.4 0.3 1.4 0.7 13.5 0.4 3.6 0.0 0.0 7.3 0.0 7.9 4.7 3.5 0.0 0.0 1.3 4.6 0.0 4.4 0.2 1.9 0.3 0.2 0.9 2.0 0.1 0.1 0.0 0.4 4.6 15.2 0.0 0.0 0.0 5.8 1.2 10.2 1.1 4.8 31.0 1.0 1.6 3.9 0.2 2.7 0.2 1.1 0.0 0.8 0.9 0.0 0.3 6.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 18.2 25.5 36.8 31.3 15.2 23.0 13.5 17.9 14.7 5.1 8.9 4.8 2.0 1.9 5.0 47.0 2.0 22.9 14.7 15.9 10.4 7.9 2.9 3.3 4.2 0.7 5.8 4.1 0.0 8.1 1.0 4.1 14.5 0.0 33.1 0.3 90.6 33.2 3.7 1.5 0.0 2.0 0.2 1.7 1.0 22.2 1.6 4.6 13.1 0.4 0.0 6.3 0.0 4.4 0.1 0.4 2.9 0.6 0.0 11.7 2.6 SYCE1 "bA108K14.6, C10orf94, CT76" ENSG00000171772 "Synaptonemal complex central element protein 1" Q8N0S2 10 133553901-133569835 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 75.4" "Group enriched" "Detected in some" 5 "Early spermatids: 103.1;Late spermatids: 85.3;Spermatocytes: 250.9;Spermatogonia: 112.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "K-562: 17.4;U-2 OS: 16.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040208 Enhanced Uncertain Nucleoplasm,Vesicles,Cytosol No No Nucleoplasm "Vesicles, Cytosol" "HPA040208: AB_10796450" "unprognostic (5.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.03e-2)" "unprognostic (1.85e-1)" "unprognostic (9.05e-2)" "unprognostic (1.61e-1)" "unprognostic (3.20e-1)" "unprognostic (5.75e-1)" "unprognostic (5.38e-2)" "unprognostic (3.36e-1)" "unprognostic (2.22e-2)" "unprognostic (7.17e-3)" "unprognostic (2.95e-2)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (2.42e-1)" 1.8 1.8 4.9 0.7 5.4 0.3 1.3 8.1 8.2 0.4 0.7 0.9 0.0 0.4 0.8 0.5 0.6 1.4 1.6 0.7 4.0 3.3 0.9 3.9 0.5 1.1 1.5 6.7 1.1 1.5 0.2 0.3 8.6 3.5 1.8 0.6 0.2 0.4 0.6 0.9 0.3 0.5 0.7 1.7 0.8 0.5 75.4 0.0 0.1 1.4 0.1 0.7 0.4 0.0 1.3 2.0 0.3 2.6 0.2 3.2 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.4 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 0.1 0.1 0.1 16.1 0.2 0.3 0.2 0.3 0.4 0.0 0.1 0.0 0.0 1.7 0.3 3.2 1.8 3.0 0.9 2.4 0.8 1.2 1.3 1.4 2.7 0.0 0.2 2.6 2.0 2.2 1.8 4.9 5.4 8.1 8.2 4.0 3.3 1.5 6.7 3.5 0.0 0.0 1.0 0.0 1.5 0.9 1.8 0.2 2.5 2.7 2.3 0.0 0.0 0.3 0.0 0.0 103.1 0.1 0.0 0.0 0.9 0.1 0.8 0.4 0.0 5.1 0.6 9.5 0.0 0.0 0.0 85.3 4.9 0.6 0.0 0.0 0.0 0.3 0.7 0.0 3.5 0.3 1.6 25.8 0.4 250.9 112.4 0.9 0.2 0.0 0.0 0.3 SYCE1L MRP2 ENSG00000205078 "Synaptonemal complex central element protein 1 like" A8MT33 16 77199397-77213215 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 22.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.0;U-698: 10.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062464, HPA066691" Enhanced "Intermediate filaments" No No "Intermediate filaments" "HPA062464: , HPA066691: AB_2685702" "unprognostic (5.54e-3)" "unprognostic (2.15e-1)" "unprognostic (1.65e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (3.48e-2)" "unprognostic (2.00e-3)" "unprognostic (6.28e-3)" "unprognostic (1.02e-1)" "unprognostic (7.48e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (9.27e-2)" "unprognostic (4.27e-1)" "unprognostic (2.68e-2)" "unprognostic (1.73e-2)" 3.5 3.4 2.8 4.1 2.7 2.9 3.7 5.2 2.4 8.7 5.0 0.4 11.5 2.1 7.8 7.6 4.4 2.8 1.8 7.0 2.8 3.0 4.3 1.4 1.9 4.5 2.1 1.4 8.5 2.7 2.3 2.3 1.6 1.5 6.6 1.6 5.4 11.1 8.7 1.7 4.3 4.6 2.0 2.5 4.2 2.3 22.4 0.4 6.4 8.0 2.0 2.4 2.3 4.4 3.5 12.2 12.0 2.2 2.7 10.5 3.4 2.8 1.1 2.8 1.3 0.3 0.0 0.5 0.8 0.3 0.5 0.9 0.6 5.7 1.9 3.8 0.6 0.2 4.1 0.2 0.0 0.3 1.7 13.0 0.4 1.0 0.0 1.9 0.9 1.2 0.1 0.4 0.1 0.3 0.5 2.0 2.6 0.7 0.2 0.3 4.2 0.7 1.3 1.9 0.4 4.5 6.7 0.7 0.6 2.5 0.8 2.9 3.4 0.4 0.3 0.0 0.3 0.1 1.2 6.5 0.4 6.5 0.9 0.2 5.5 2.1 10.1 2.8 0.7 0.2 4.0 1.3 12.0 6.1 2.2 7.3 3.5 7.9 8.4 1.6 2.6 8.7 8.0 1.3 2.7 1.6 12.2 10.5 3.4 2.8 2.7 5.2 2.2 2.8 3.0 2.1 1.4 1.5 0.4 3.0 3.0 6.0 9.6 15.3 3.7 2.0 30.6 1.4 5.7 26.2 9.8 5.2 13.3 23.2 19.5 7.5 6.9 0.0 24.3 3.8 9.0 15.6 1.1 10.6 2.1 1.6 21.6 16.5 13.5 35.7 12.7 3.1 18.6 2.8 30.3 14.0 19.1 22.4 6.3 17.9 35.5 6.5 4.2 34.7 8.1 14.9 2.4 13.4 29.9 5.7 SYCE2 CESC1 ENSG00000161860 "Synaptonemal complex central element protein 2" Q6PIF2 19 12898786-12919276 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 41.2" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 21.3;Late spermatids: 19.1;Sertoli cells: 25.8;Spermatocytes: 102.1;Spermatogonia: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 4 "NK-cell: 6.3" "Lineage enriched" "Detected in many" 4 "NK-cells: 6.3" "Cell line enhanced" "Detected in many" "EFO-21: 11.7;JURKAT: 10.3;MOLT-4: 10.5;SiHa: 11.5;U-266/70: 12.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA042080, HPA062919" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA042080: AB_10794411, HPA062919: AB_2684905" "unprognostic (3.00e-1)" "prognostic favorable (3.85e-5)" "unprognostic (9.99e-3)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.75e-1)" "unprognostic (3.48e-2)" "unprognostic (2.19e-1)" "unprognostic (1.75e-1)" "unprognostic (1.78e-1)" "unprognostic (8.28e-3)" "unprognostic (1.30e-2)" "unprognostic (8.39e-4)" "unprognostic (1.79e-10)" "unprognostic (7.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.09e-1)" "unprognostic (7.87e-5)" 0.4 0.4 0.3 0.3 0.4 2.9 0.3 2.0 1.6 0.5 0.4 0.3 0.3 0.2 0.3 0.6 0.3 0.4 0.3 0.3 0.5 0.2 0.3 1.1 0.5 1.0 0.3 0.3 0.8 0.4 0.0 0.4 0.8 0.4 0.6 0.1 0.3 0.6 0.3 0.3 1.1 0.3 0.3 0.4 0.5 0.3 41.2 0.3 2.6 0.4 0.3 0.7 0.5 0.4 0.1 0.2 1.4 0.1 6.3 0.6 0.1 5.6 1.1 2.9 1.8 0.3 0.8 3.2 1.3 0.6 0.8 1.0 0.2 0.8 4.4 11.7 0.8 1.0 1.1 1.0 0.3 0.9 1.6 0.7 1.2 2.5 0.5 0.1 2.8 4.0 0.8 0.2 0.3 0.6 1.4 0.2 10.3 1.1 1.3 0.5 2.3 10.5 1.9 1.9 0.2 3.3 3.2 1.4 1.1 0.5 0.8 2.1 1.4 11.5 0.6 0.6 0.9 2.2 3.0 0.8 0.8 1.5 4.3 0.3 12.1 1.5 4.9 1.0 3.8 5.4 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.6 0.0 0.2 0.1 0.2 0.4 0.0 6.3 0.0 0.0 0.5 0.1 0.3 0.4 2.0 0.6 0.5 0.2 0.3 0.3 0.4 0.3 0.0 0.0 0.5 0.3 1.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 21.3 0.1 0.0 0.0 0.3 1.6 0.4 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.6 19.1 2.8 0.0 0.0 0.0 0.0 0.7 0.1 0.0 1.1 0.0 0.2 25.8 0.2 102.1 38.1 0.4 0.2 0.0 0.0 0.1 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Group enriched" "Detected in many" 6 "Early spermatids: 349.3;Spermatocytes: 429.3;Spermatogonia: 109.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 8.8;Karpas-707: 7.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: AB_2797234" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.4 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.8 0.4 3.2 0.0 1.8 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 4.0 0.0 1.6 2.3 2.0 0.3 1.4 0.5 0.0 1.8 0.0 7.4 0.4 3.3 0.0 0.0 0.3 3.7 0.0 0.0 0.0 3.9 1.2 2.6 0.8 2.3 0.0 2.2 1.4 0.3 2.1 1.8 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 0.0 0.0 0.0 0.4 0.1 0.5 0.4 5.1 0.0 0.0 1.8 0.0 4.2 3.3 1.3 349.3 0.1 0.3 0.0 0.6 2.6 0.1 0.3 0.0 1.6 1.4 0.0 0.0 0.6 1.2 52.2 10.0 0.0 0.0 4.6 0.0 0.9 1.2 0.0 6.7 2.1 0.4 45.3 0.0 429.3 109.7 0.1 3.1 0.0 0.3 0.9 SYCN "FLJ27441, INSSA1, SYL" ENSG00000179751 Syncollin Q0VAF6 19 39202831-39204266 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 681 "pancreas: 1347.2" "Cell type enriched" "Detected in some" 4 "Exocrine glandular cells: 3381.8" "Cancer enriched" "Detected in single" 842 "pancreatic cancer: 369.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-2 OS: 1.3;U-266/84: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA047654 Enhanced "Intracellular and membrane" NA NA 1100000 "HPA047654: AB_2680112" "unprognostic (8.02e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1347.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 4.3 0.0 0.0 0.0 3381.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 1.1 0.0 0.0 17.2 0.0 0.0 825.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 SYCP1 "CT8, HOM-TES-14, SCP1" ENSG00000198765 "Synaptonemal complex protein 1" Q15431 1 114854803-114995370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 51 "testis: 30.6" "Cell type enriched" "Detected in some" 14 "Spermatocytes: 1077.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 93 "THP-1: 19.5" "Region enriched" "Detected in single" 51 "cerebellum: 16.5" "Not detected" "Not detected" HPA021083 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies, Cytosol" "HPA021083: AB_1857685" "unprognostic (2.91e-1)" "unprognostic (6.89e-3)" "unprognostic (4.87e-1)" "unprognostic (8.74e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.5 0.0 1077.5 21.3 0.0 0.0 0.0 0.0 0.0 SYCP2 SCP2 ENSG00000196074 "Synaptonemal complex protein 2" Q9BX26 20 59863563-59933655 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 11.1;testis: 41.7" "Cell type enriched" "Detected in many" 6 "Spermatocytes: 330.2" "Group enriched" "Detected in many" 6 "breast cancer: 6.7;cervical cancer: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062401, HPA065613" Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA062401: AB_2684752, HPA065613: AB_2685519" "unprognostic (8.10e-3)" "unprognostic (8.28e-3)" "unprognostic (1.62e-1)" "unprognostic (2.48e-2)" "unprognostic (1.57e-1)" "unprognostic (1.19e-3)" "unprognostic (2.50e-2)" "unprognostic (2.18e-1)" "unprognostic (4.11e-2)" "unprognostic (1.44e-1)" "unprognostic (3.74e-1)" "unprognostic (7.02e-3)" "unprognostic (4.84e-3)" "unprognostic (8.48e-2)" "unprognostic (2.46e-1)" "unprognostic (7.87e-3)" "unprognostic (1.21e-1)" 2.2 0.5 1.3 0.9 2.3 1.4 11.1 2.5 5.7 1.3 1.2 1.0 0.8 1.1 1.1 0.9 0.8 0.8 2.0 2.1 1.2 1.2 3.3 0.8 1.6 3.1 1.8 2.7 0.4 4.9 1.3 3.0 2.9 3.9 2.9 0.8 0.6 3.0 0.7 0.8 2.0 1.7 0.6 1.6 2.3 4.5 41.7 0.8 3.0 1.9 0.2 1.5 1.3 1.0 0.9 0.1 2.6 0.3 0.0 2.7 0.5 0.1 0.5 0.1 0.5 0.2 0.3 0.6 1.6 0.4 0.7 0.1 10.2 1.0 0.0 1.6 0.7 0.3 0.2 0.2 0.0 0.4 3.2 0.2 0.1 2.0 0.1 0.0 0.1 7.6 0.1 0.1 0.1 0.0 0.4 0.0 19.1 0.1 0.0 0.3 4.9 21.1 1.1 0.2 0.6 0.1 0.0 0.0 0.1 0.9 2.4 0.1 1.8 37.2 5.4 1.1 0.7 33.6 1.9 0.2 0.0 1.1 4.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 2.5 0.3 2.3 2.6 0.0 2.7 0.7 1.5 1.7 0.1 0.9 0.9 1.5 2.6 0.0 0.1 0.1 1.0 0.5 1.3 2.3 2.5 5.7 1.2 1.2 1.8 2.7 3.9 0.8 0.0 0.6 0.5 1.0 0.9 1.3 3.6 2.5 14.7 10.3 1.8 2.0 0.5 1.7 0.6 36.7 2.3 0.0 0.0 3.1 0.2 1.2 2.0 2.3 0.0 0.5 0.0 0.0 3.1 0.6 13.5 4.4 1.1 5.0 0.0 0.0 2.2 1.6 0.2 1.8 2.6 1.0 51.8 1.9 330.2 31.3 0.0 0.3 1.3 0.2 1.1 SYCP2L "C6orf177, dJ62D2.1, NO145" ENSG00000153157 "Synaptonemal complex protein 2 like" Q5T4T6 6 10886831-10979320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 54.0" "Cell type enhanced" "Detected in some" 10 "Early spermatids: 10.8;granulocytes: 10.4;Spermatogonia: 8.1" "Cancer enhanced" "Detected in single" "testis cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 2.9;eosinophil: 5.5;plasmacytoid DC: 7.6" "Group enriched" "Detected in many" 17 "dendritic cells: 7.6;granulocytes: 5.5" "Cell line enhanced" "Detected in some" "HL-60: 9.1;HMC-1: 28.4;K-562: 7.1;NB-4: 9.7;SuSa: 6.0;THP-1: 7.3" HPA034679 Supported Nucleoplasm NA NA Nucleoplasm "HPA034679: AB_10669729" "unprognostic (3.25e-1)" "unprognostic (2.58e-2)" "unprognostic (3.23e-1)" "unprognostic (3.72e-5)" "unprognostic (2.20e-1)" "unprognostic (1.21e-2)" "unprognostic (5.57e-3)" "unprognostic (4.23e-1)" "unprognostic (6.03e-2)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.04e-1)" "unprognostic (1.21e-3)" "unprognostic (1.07e-2)" "unprognostic (1.86e-1)" "unprognostic (3.85e-2)" "unprognostic (2.74e-2)" 0.9 0.4 0.9 0.8 1.0 0.7 0.7 2.6 1.5 0.5 1.1 0.8 3.7 0.4 1.1 8.9 0.6 0.5 0.7 3.0 0.8 0.7 1.6 0.4 10.1 0.5 1.0 0.5 1.5 5.5 54.0 0.7 4.0 0.6 0.8 0.4 2.9 1.2 0.5 1.9 0.6 0.3 0.5 0.9 0.6 0.4 5.1 0.6 0.7 2.5 0.0 2.2 0.5 0.3 0.0 7.6 5.5 0.3 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.1 0.0 3.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.1 0.1 4.3 0.0 0.0 0.0 0.0 9.1 28.4 0.0 0.6 0.0 0.0 0.1 0.0 0.3 7.1 0.0 0.0 0.0 2.3 9.7 0.5 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.4 2.5 0.0 2.4 0.0 6.0 0.1 7.3 0.0 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 2.9 0.1 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.9 1.0 2.6 1.5 0.8 0.7 1.0 0.5 0.6 0.6 0.0 2.2 0.0 0.0 0.1 2.4 0.3 0.0 1.4 0.0 0.0 0.0 2.1 0.0 0.1 10.8 0.1 0.0 0.0 0.2 1.6 0.3 0.3 10.4 0.0 0.4 3.2 0.0 0.0 0.0 2.3 1.1 0.9 0.0 0.0 0.0 0.5 0.6 0.0 1.4 0.0 0.0 0.0 0.0 3.9 8.1 0.0 1.1 0.0 0.0 0.1 SYCP3 ENSG00000139351 "Synaptonemal complex protein 3" Q8IZU3 12 101728648-101739472 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 47.0" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 654.5" "Cancer enriched" "Detected in single" 16 "testis cancer: 5.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;RPMI-8226: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB032978, HPA039635, HPA043938" Enhanced NA NA "CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740" "unprognostic (2.86e-3)" "unprognostic (3.91e-1)" "unprognostic (3.18e-1)" "unprognostic (9.61e-3)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" "unprognostic (7.15e-3)" "unprognostic (7.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.93e-2)" "unprognostic (2.24e-1)" "unprognostic (4.07e-2)" "unprognostic (5.86e-4)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 3.2 0.6 0.2 0.6 0.1 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.9 0.6 0.0 0.2 0.6 0.1 1.3 0.1 0.0 0.1 0.7 0.2 0.7 0.5 0.3 0.0 0.3 0.4 0.0 0.0 1.6 1.3 0.4 0.6 0.2 0.0 0.7 0.2 0.7 0.4 5.2 1.2 0.0 1.3 0.9 0.0 0.6 0.2 0.3 1.0 2.6 2.0 0.8 0.1 0.6 0.0 0.2 2.2 0.5 1.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 1.0 0.3 0.0 0.2 0.0 3.2 0.6 0.4 0.1 0.2 0.0 0.2 0.1 0.1 0.1 1.5 0.0 0.6 0.5 0.2 0.1 0.5 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 0.6 0.0 2.0 1.1 0.0 1.4 0.0 1.8 0.0 0.2 0.0 0.1 19.5 0.4 0.5 0.0 0.3 0.1 0.4 0.9 3.5 0.0 0.5 0.0 1.2 0.0 0.6 24.2 8.3 0.6 0.0 0.0 0.7 0.6 0.2 0.0 1.8 0.0 1.6 64.7 0.0 654.5 144.1 0.3 0.1 0.0 0.8 0.4 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107403-15114988 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.0" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 126.4;Sertoli cells: 84.1;Syncytiotrophoblasts: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.27e-4)" 15.6 7.7 3.5 5.9 4.3 0.1 19.9 2.0 3.5 19.5 13.9 4.4 3.8 4.3 18.6 6.8 10.7 12.2 10.5 9.3 4.0 1.8 9.6 3.3 9.4 4.9 3.1 2.4 17.9 4.6 2.3 3.8 60.0 5.0 11.8 2.9 22.0 3.3 13.6 5.9 4.4 5.7 14.2 2.5 7.6 7.9 7.4 4.3 0.9 8.2 5.8 2.8 12.9 12.8 0.2 0.3 0.0 0.0 0.0 0.5 0.0 4.1 6.4 3.5 9.0 7.9 7.3 2.7 17.5 12.9 17.2 14.7 1.4 2.5 0.0 11.6 17.6 5.9 2.6 2.7 3.1 9.7 0.1 3.0 0.6 11.9 2.8 15.0 0.0 0.0 12.7 2.3 10.3 4.7 10.5 3.1 0.0 0.0 0.0 12.8 2.0 0.0 0.0 5.7 0.1 6.6 0.0 8.6 0.0 4.2 0.5 0.1 6.9 9.8 6.0 11.7 3.5 0.7 0.4 6.6 41.5 12.6 19.0 18.8 0.0 0.1 0.0 11.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 2.0 3.5 4.0 1.8 3.1 2.4 5.0 4.3 3.0 1.4 0.5 0.6 2.2 0.3 3.9 2.5 0.0 1.2 1.8 0.0 4.9 0.0 3.9 8.8 12.6 0.0 0.0 0.3 126.4 14.7 0.5 0.0 0.0 3.0 1.6 0.0 19.0 1.3 12.0 27.3 0.8 13.5 0.0 0.0 13.2 1.5 0.0 39.6 5.5 0.4 84.1 29.9 1.2 0.5 2.3 112.5 0.0 0.0 0.1 SYK ENSG00000165025 "Spleen associated tyrosine kinase" P43405 9 90801787-90898549 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 38.5" "Cell type enhanced" "Detected in many" 6 "B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001384, CAB007773" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" No NA 1000000 "Plasma membrane, Cytosol" Vesicles "CAB007773: AB_562232, HPA001384: AB_1080144" "unprognostic (1.01e-1)" "unprognostic (5.45e-2)" "unprognostic (2.10e-1)" "unprognostic (2.69e-2)" "unprognostic (2.31e-1)" "unprognostic (7.92e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (6.41e-2)" "unprognostic (1.78e-2)" "unprognostic (7.20e-2)" "unprognostic (9.93e-2)" "unprognostic (2.55e-3)" "unprognostic (8.77e-2)" "unprognostic (5.36e-3)" "unprognostic (3.41e-2)" "unprognostic (1.06e-2)" 7.2 3.3 6.0 38.1 9.6 18.2 6.7 1.1 4.5 3.7 10.3 6.7 1.5 12.3 2.3 6.7 16.2 6.9 6.6 5.5 7.2 3.2 8.6 2.5 13.7 36.4 9.1 2.5 2.1 8.9 25.9 3.1 5.0 6.1 4.1 8.3 2.8 8.9 1.8 1.4 8.3 22.2 3.5 11.3 38.5 7.4 5.5 7.9 30.5 18.1 7.8 32.2 8.6 7.5 23.1 24.9 32.8 21.4 8.7 0.1 10.2 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 39.4 1.1 0.0 1.3 6.1 0.8 3.2 0.0 0.0 5.4 22.7 0.0 0.0 0.0 31.3 20.9 0.0 4.5 0.0 0.4 0.0 0.0 4.9 0.6 3.2 0.0 4.8 0.0 13.7 0.2 14.8 0.0 26.2 0.0 10.8 0.8 5.9 2.1 1.8 0.0 2.8 0.0 0.1 2.5 24.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.6 0.0 22.1 0.0 1.4 21.4 23.3 0.1 19.0 0.1 23.1 0.0 0.0 24.9 17.5 0.0 0.0 32.8 8.7 16.4 18.5 0.0 10.2 6.0 9.6 1.1 4.5 7.2 3.2 9.1 2.5 6.1 7.9 11.9 22.7 53.8 3.7 3.1 0.9 1.6 12.7 12.0 17.0 14.0 0.0 1.2 13.3 12.6 5.5 1.1 18.4 0.0 10.9 1.3 1.1 1.8 40.6 0.9 63.0 0.0 9.9 4.9 79.3 4.7 0.6 66.0 11.8 24.4 23.8 0.0 15.3 28.1 0.0 0.3 0.1 6.5 1.0 0.7 0.7 5.0 1.1 5.3 24.7 6.5 SYN1 ENSG00000008056 "Synapsin I" P17600 X 47571898-47619943 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 127.0" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 25.9;Cone photoreceptor cells: 9.8;Horizontal cells: 27.0" "Cancer enhanced" "Detected in many" "glioma: 11.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;HHSteC: 6.5;NTERA-2: 13.7;SCLC-21H: 24.0;SH-SY5Y: 6.2;SuSa: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000397, CAB021929" Enhanced NA NA "CAB021929: , HPA000397: AB_1080146" "unprognostic (1.22e-1)" "unprognostic (9.25e-2)" "unprognostic (2.16e-3)" "unprognostic (4.48e-3)" "unprognostic (3.05e-3)" "unprognostic (7.57e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-1)" "unprognostic (3.49e-2)" "unprognostic (6.68e-2)" "unprognostic (3.97e-3)" "unprognostic (1.32e-1)" "unprognostic (2.64e-4)" "unprognostic (2.73e-3)" "unprognostic (5.79e-2)" "unprognostic (2.95e-3)" "unprognostic (5.27e-2)" 1.7 7.1 31.8 2.9 33.3 2.0 1.3 34.4 127.0 1.7 1.9 2.1 0.0 1.4 1.6 1.9 1.5 2.1 2.5 7.6 33.6 24.9 1.4 1.8 1.7 1.3 13.3 27.1 2.5 2.0 2.1 6.1 3.4 24.0 2.0 2.1 0.9 1.3 2.0 1.5 1.7 2.0 2.0 3.7 1.3 1.9 2.4 2.1 0.0 1.2 0.0 1.5 1.9 0.1 0.0 0.8 0.0 0.6 0.0 0.9 0.0 0.0 0.0 3.9 0.6 0.1 0.8 0.0 0.7 0.1 1.1 0.3 0.0 0.0 0.0 1.3 0.1 1.2 7.0 0.4 0.0 0.3 0.5 0.1 0.3 0.0 0.0 6.5 0.0 1.7 1.5 0.0 1.2 0.3 0.0 0.0 0.5 0.4 0.2 0.2 0.2 0.2 0.2 13.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 24.0 6.2 0.0 0.0 0.1 6.0 1.7 0.0 0.2 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.6 0.8 0.0 0.0 31.8 33.3 34.4 56.9 33.6 24.9 13.3 27.1 24.0 2.1 0.0 0.0 0.0 0.6 0.8 25.9 2.8 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.6 0.0 0.8 0.2 27.0 4.1 3.1 1.5 0.4 2.6 2.7 0.0 8.2 0.0 3.2 0.4 0.0 3.2 0.0 7.5 6.5 1.6 1.0 1.9 0.5 0.0 0.0 0.2 0.3 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" 3 12004402-12191400 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 20 "brain: 72.5" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 14.6;Cone photoreceptor cells: 5.9;Horizontal cells: 12.7;Spermatocytes: 4.9;Spermatogonia: 6.6" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.5;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.2;SCLC-21H: 4.2;SH-SY5Y: 16.5;SuSa: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm NA NA Nucleoplasm "CAB079005: , HPA037012: AB_2675431" "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 3.7 2.7 28.2 0.7 23.3 0.5 1.4 9.2 72.5 1.0 0.8 0.2 0.0 0.8 1.2 1.2 0.5 0.8 0.7 0.7 15.4 1.4 0.4 0.8 0.5 0.0 33.4 1.5 0.5 1.8 0.0 2.3 15.3 0.7 0.9 0.0 0.9 0.6 0.9 0.9 1.2 1.9 2.2 0.8 1.2 2.4 1.6 0.0 0.5 0.0 0.5 0.5 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 0.7 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 3.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.0 0.1 0.4 0.0 0.5 1.5 0.0 0.4 0.0 0.0 0.0 0.0 5.2 0.1 0.4 0.0 0.0 0.0 0.0 0.2 4.2 16.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 14.6 1.0 0.0 0.0 0.0 0.0 5.9 1.4 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 12.7 0.0 0.0 1.6 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.0 2.3 2.6 0.0 0.0 4.9 6.6 0.0 0.7 0.0 0.0 0.1 SYN3 ENSG00000185666 "Synapsin III" O14994 22 32512552-33058372 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Group enriched" "Detected in some" 18 "Early spermatids: 50.5;Late spermatids: 177.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 29 "naive B-cell: 7.2" "Lineage enriched" "Detected in single" 29 "B-cells: 7.2" "Cell line enhanced" "Detected in some" "GAMG: 8.8;HAP1: 7.8;Hep G2: 4.5;NTERA-2: 5.3;SCLC-21H: 10.3;WM-115: 4.6" "Low region specificity" "Detected in all" HPA034566 Uncertain NA NA "HPA034566: AB_10603120" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (5.13e-3)" "unprognostic (2.34e-1)" "unprognostic (9.39e-2)" "unprognostic (3.24e-1)" "unprognostic (7.77e-2)" "unprognostic (8.91e-2)" "unprognostic (8.59e-2)" "unprognostic (7.44e-3)" "unprognostic (4.35e-3)" "unprognostic (1.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (3.52e-1)" 1.2 2.1 23.9 1.0 13.8 3.6 2.1 4.9 20.2 0.8 1.5 0.3 0.0 1.1 1.2 1.3 1.2 1.6 2.3 1.4 7.9 5.6 1.5 1.1 1.8 2.4 3.8 12.3 1.2 2.1 0.6 3.9 6.2 15.3 1.5 1.4 0.4 1.4 1.3 0.8 3.0 1.8 1.3 3.6 3.4 1.6 8.7 3.3 0.0 2.0 0.0 1.4 0.9 0.8 7.2 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.3 0.4 2.6 0.2 1.0 0.5 0.5 0.2 0.1 0.4 1.6 0.2 0.8 0.2 0.1 8.8 0.6 7.8 0.0 0.0 0.2 1.3 0.4 0.9 4.5 0.0 0.7 0.4 0.3 1.8 0.1 0.0 0.2 0.3 0.1 0.7 0.5 0.1 0.0 0.6 0.6 5.3 0.3 0.0 0.3 0.9 0.6 0.0 1.4 10.3 1.0 0.2 0.1 1.6 1.0 0.1 0.3 0.0 0.2 1.0 0.6 0.2 0.6 0.8 0.2 0.5 0.3 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 23.9 13.8 4.9 20.2 7.9 5.6 3.8 12.3 15.3 3.3 0.0 0.0 0.0 0.0 0.3 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 50.5 0.2 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.3 4.8 0.0 0.6 0.0 177.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 6.5 1.0 3.2 5.7 0.1 0.9 0.0 0.0 0.0 SYNC "SYNC1, SYNCOILIN" ENSG00000162520 "Syncoilin, intermediate filament protein" Q9H7C4 1 32680360-32703596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 51.0" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 69.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 5 "monocytes: 1.8" "Cell line enhanced" "Detected in many" "BJ hTERT+: 26.8;fHDF/TERT166: 38.9;hTERT-RPE1: 23.8;U-138 MG: 34.1;WM-115: 22.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028311, HPA063549" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus, Vesicles" "HPA028311: AB_2672554, HPA063549: " "unprognostic (3.99e-1)" "unprognostic (6.04e-3)" "unprognostic (2.02e-2)" "unprognostic (7.60e-3)" "unprognostic (1.99e-2)" "unprognostic (5.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.71e-1)" "unprognostic (1.32e-4)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (8.15e-4)" 4.2 3.2 3.7 5.8 3.9 0.1 6.8 1.1 4.2 5.9 7.2 3.7 1.2 1.5 7.7 7.7 15.6 5.3 4.8 7.9 3.5 3.9 1.4 1.1 4.6 0.6 3.6 2.6 7.9 0.9 2.7 2.8 1.1 3.5 6.1 4.8 4.6 4.1 8.4 51.0 1.6 4.0 28.5 4.5 1.9 6.5 5.4 1.9 0.0 1.9 23.6 2.3 7.8 2.5 0.0 0.3 0.0 1.8 0.0 0.3 0.0 0.0 1.3 0.1 0.0 6.5 10.2 0.0 10.5 26.8 9.1 6.6 0.1 0.1 0.0 0.5 38.9 11.0 0.4 0.3 0.2 5.5 0.0 0.0 0.2 4.4 0.9 5.2 0.0 0.0 15.7 0.9 10.1 0.3 23.8 2.9 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.1 0.1 0.9 0.0 2.0 0.0 10.6 0.0 0.1 0.1 10.6 2.2 0.0 2.1 0.6 0.0 1.7 34.1 1.5 18.1 2.7 0.0 0.0 0.0 9.5 0.1 22.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.7 3.9 1.1 4.2 3.5 3.9 3.6 2.6 3.5 1.9 8.9 6.0 18.0 11.4 19.6 44.6 0.8 17.8 5.3 13.6 8.7 37.3 7.3 5.0 10.7 8.6 8.7 7.8 23.3 4.7 7.6 12.4 10.4 21.9 16.1 4.8 69.9 7.0 20.3 20.5 12.4 38.6 9.9 32.1 4.6 7.0 16.9 6.8 8.0 60.5 7.8 52.5 19.4 12.0 30.1 26.0 19.4 4.2 21.3 8.9 8.5 SYNDIG1 "C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469199-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3;heart muscle: 28.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 5.0;Cardiomyocytes: 12.1;Distal tubular cells: 5.0;Peritubular cells: 6.7;Proximal tubular cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 8.2;RH-30: 23.3;RPMI-8226: 22.1;SCLC-21H: 5.4;U-87 MG: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles NA NA Vesicles "HPA044271: AB_2732515, HPA059267: AB_2683961" "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.16e-6)" "unprognostic (1.40e-3)" 2.6 1.7 12.5 2.1 12.0 0.7 0.8 21.3 22.7 4.5 1.5 23.3 0.3 1.9 2.6 1.5 0.9 5.1 10.0 28.2 12.8 8.8 6.2 0.7 1.1 2.5 14.5 12.9 1.3 1.4 0.9 0.6 0.9 11.5 3.2 1.6 0.5 0.8 14.8 0.6 0.8 2.8 3.1 22.4 1.4 2.2 1.3 16.6 0.1 5.1 0.0 3.1 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 8.2 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 23.3 22.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 12.0 21.3 19.7 12.8 8.8 14.5 12.9 11.5 16.6 0.0 0.0 0.0 0.0 0.0 5.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 6.7 5.4 0.4 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SYNDIG1L "capucin, IFITMD4, TMEM90A" ENSG00000183379 "Synapse differentiation inducing 1 like" A6NDD5 14 74405893-74426102 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 27 "brain: 78.1;epididymis: 20.1" "Group enriched" "Detected in some" 7 "Alveolar cells type 2: 2.4;Bipolar cells: 8.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 78.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.2;NTERA-2: 1.3;SuSa: 1.8;U-266/70: 1.7;U-266/84: 1.9" "Region enriched" "Detected in many" 8 "basal ganglia: 251.1" "Region enriched" "Detected in many" 6 "basal ganglia: 71.7" "HPA042594, HPA048487" Uncertain NA NA "HPA042594: AB_2678069, HPA048487: AB_2680416" "unprognostic (5.75e-2)" "unprognostic (9.96e-3)" "unprognostic (2.25e-2)" "unprognostic (5.51e-2)" "unprognostic (3.08e-3)" "unprognostic (5.72e-2)" "unprognostic (5.83e-2)" "unprognostic (4.51e-2)" "unprognostic (2.83e-2)" "unprognostic (5.74e-2)" "unprognostic (8.85e-2)" "unprognostic (1.63e-1)" "unprognostic (3.85e-2)" "unprognostic (8.56e-2)" "unprognostic (1.50e-1)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" 0.6 0.4 0.3 0.4 78.1 0.2 0.6 0.0 4.0 0.5 0.6 1.1 0.0 0.3 0.6 20.1 0.5 0.4 0.7 0.4 2.4 1.6 0.6 0.3 1.8 0.4 3.5 0.2 0.4 0.5 0.2 0.0 0.3 0.5 0.6 0.6 0.1 0.4 0.6 0.3 0.5 0.9 0.8 0.4 0.4 0.3 0.4 16.6 0.0 0.3 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.9 0.0 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.0 0.5 1.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.7 1.9 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.3 78.1 0.0 4.0 2.4 1.6 3.5 0.2 0.5 16.6 0.0 2.4 0.0 0.0 0.3 8.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 SYNE2 "DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2" ENSG00000054654 "Spectrin repeat containing nuclear envelope protein 2" Q8WXH0 14 63852983-64226433 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 111.4" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 579.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 6 "cerebellum: 15.8;pons and medulla: 16.3" "Cell type enhanced" "Detected in many" "eosinophil: 30.3" "Group enriched" "Detected in many" 10 "granulocytes: 30.3;T-cells: 16.3" "Cell line enhanced" "Detected in many" "Daudi: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003435, HPA050204" Enhanced Approved "Nuclear membrane,Intermediate filaments" No Yes "Nuclear membrane, Intermediate filaments" "HPA003435: AB_1080162, HPA050204: AB_2681051" "unprognostic (1.93e-2)" "unprognostic (3.72e-2)" "unprognostic (1.91e-1)" "unprognostic (2.33e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-3)" "unprognostic (9.04e-2)" "unprognostic (2.58e-3)" "unprognostic (1.99e-2)" "unprognostic (2.41e-2)" "unprognostic (1.25e-2)" "unprognostic (2.24e-1)" "prognostic favorable (3.56e-9)" "unprognostic (5.05e-3)" "unprognostic (3.14e-1)" "unprognostic (1.51e-2)" "unprognostic (4.80e-2)" 30.8 4.5 2.3 18.0 2.8 5.5 29.7 15.8 3.3 16.1 13.4 1.9 7.7 3.6 18.8 13.6 17.2 7.1 8.6 27.3 2.3 2.4 35.6 13.0 15.2 11.0 2.7 2.1 22.8 22.4 60.1 17.6 14.1 16.3 13.7 4.8 13.0 9.8 9.2 111.4 24.1 10.6 10.2 2.3 16.0 6.9 14.3 1.9 16.9 30.9 29.7 15.8 11.1 26.4 2.3 1.1 30.3 0.1 1.5 16.3 1.3 17.7 6.0 8.9 2.8 8.9 2.6 11.8 1.2 1.2 2.0 3.6 2.0 3.7 44.5 1.9 1.2 2.2 8.6 5.8 2.3 2.5 6.7 2.3 0.2 4.4 0.5 1.7 0.7 0.2 3.7 8.4 2.6 2.4 2.0 4.6 5.7 0.2 3.6 1.5 9.9 4.7 0.2 4.0 5.7 1.8 5.6 8.4 1.4 13.5 8.5 8.2 6.1 14.1 3.3 3.8 3.8 3.9 0.1 4.0 3.3 5.3 1.1 3.7 4.9 2.1 16.9 0.9 0.0 4.7 0.2 0.0 30.3 16.3 0.1 11.0 2.1 10.0 10.8 0.0 2.3 4.9 7.4 13.3 1.5 0.1 1.1 11.1 1.3 2.3 2.8 15.8 2.6 2.3 2.4 2.7 2.1 16.3 1.9 285.9 119.8 37.9 110.7 98.9 26.4 222.5 107.0 271.7 293.5 191.9 172.8 136.2 16.6 78.5 6.5 155.5 34.5 0.0 48.5 56.0 55.6 45.4 24.4 28.8 14.9 6.4 44.4 68.7 4.7 8.1 93.5 7.9 45.5 4.6 57.4 99.5 65.8 10.5 50.2 64.2 579.2 109.9 65.5 13.6 7.8 76.5 187.3 96.2 67.0 63.0 SYNE3 "C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53" ENSG00000176438 "Spectrin repeat containing nuclear envelope family member 3" Q6ZMZ3 14 95407266-95475836 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.2;bone marrow: 10.0" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 43.7;Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 109.0" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;ASC TERT1: 19.8;Karpas-707: 22.3;REH: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055227, HPA077140" Approved Supported "Nuclear membrane" NA NA "Nuclear membrane" "HPA055227: AB_2682747, HPA077140: AB_2686826" "unprognostic (4.63e-2)" "unprognostic (6.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.48e-3)" "unprognostic (7.15e-2)" "unprognostic (2.12e-3)" "unprognostic (2.45e-1)" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.87e-1)" "unprognostic (8.50e-2)" "unprognostic (3.32e-1)" "unprognostic (7.41e-6)" "unprognostic (1.31e-1)" "unprognostic (1.42e-1)" "unprognostic (6.95e-2)" "unprognostic (7.19e-2)" 12.2 2.4 1.2 2.7 1.3 10.0 6.5 0.3 1.2 2.1 1.0 0.6 1.2 0.6 1.1 2.0 1.2 2.8 1.6 1.1 0.4 1.0 2.7 4.0 1.6 3.0 0.1 0.0 0.5 2.1 0.6 1.6 1.9 0.4 1.1 2.8 1.5 1.2 2.6 2.7 0.9 1.6 1.7 4.3 1.6 2.8 3.4 2.6 5.4 5.1 0.9 3.7 2.2 0.6 0.1 0.3 0.5 25.2 19.8 7.6 2.8 4.9 2.7 2.1 4.0 0.7 3.2 0.5 1.3 0.8 0.1 0.6 2.1 1.2 10.6 0.4 2.2 0.5 1.1 3.3 3.3 5.5 5.5 0.7 3.4 2.0 0.2 4.7 1.0 0.1 22.3 2.0 0.7 1.9 3.7 0.1 0.1 1.3 17.6 12.3 6.8 0.3 0.3 0.5 2.7 0.1 0.0 1.3 0.3 1.1 4.9 4.2 2.0 1.2 2.6 0.3 2.7 5.4 3.0 3.9 7.5 14.7 5.4 5.1 0.4 2.2 4.0 2.8 3.4 2.9 2.3 2.1 3.3 3.7 3.0 2.4 0.9 4.1 2.6 2.3 2.2 8.9 19.4 15.7 0.2 2.1 4.2 43.7 0.0 12.0 1.2 0.0 58.9 1.4 0.0 0.0 2.9 11.7 2.1 0.0 0.3 13.8 7.1 0.8 11.5 4.5 3.9 6.4 1.2 3.1 18.0 1.5 12.0 13.3 5.0 1.0 4.1 5.2 0.5 5.8 0.4 0.3 109.0 6.5 9.2 0.5 0.9 0.9 1.6 8.5 1.6 0.2 SYNGAP1 "KIAA1938, RASA5, SYNGAP" ENSG00000197283 "Synaptic Ras GTPase activating protein 1" Q96PV0 6 33419661-33457541 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Autism, Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 21.8;Horizontal cells: 36.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.9" "Group enriched" "Detected in many" 6 "B-cells: 1.5;T-cells: 1.9" "Cell line enhanced" "Detected in many" "AF22: 20.9;HMC-1: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038373 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038373: AB_10670779" "unprognostic (3.72e-1)" "unprognostic (3.13e-2)" "unprognostic (4.74e-2)" "unprognostic (2.23e-2)" "unprognostic (4.35e-2)" "prognostic favorable (2.80e-4)" "unprognostic (3.66e-2)" "unprognostic (8.65e-2)" "unprognostic (4.02e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-2)" "unprognostic (9.81e-2)" "prognostic unfavorable (1.34e-6)" "unprognostic (9.48e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.47e-2)" 4.5 5.0 29.7 11.9 28.6 6.2 4.3 27.2 33.7 7.8 5.9 5.5 2.4 6.0 13.0 5.3 4.2 11.9 6.1 4.4 37.9 7.6 4.0 2.2 5.9 10.3 4.1 38.9 12.8 3.5 10.0 26.1 6.2 7.9 6.3 4.7 3.2 3.7 7.1 2.3 6.2 5.7 11.1 8.7 9.7 4.9 8.7 9.3 8.9 5.6 0.2 7.0 6.9 6.4 1.5 0.1 0.1 0.2 0.0 1.9 0.0 2.0 0.9 20.9 7.7 4.4 4.5 2.7 5.1 3.2 2.8 2.2 8.7 0.9 5.9 1.3 2.4 2.6 3.0 2.6 2.9 2.0 3.4 1.7 14.7 2.3 0.5 2.9 2.2 17.2 3.1 0.9 5.3 2.5 10.8 2.1 4.9 4.6 2.7 2.1 4.4 3.5 3.4 10.5 0.9 2.2 13.8 0.5 2.4 2.1 1.5 5.1 4.1 1.9 3.6 1.6 4.9 7.9 2.1 0.6 6.0 5.9 2.4 0.9 3.2 1.1 4.3 3.4 2.6 1.4 0.0 0.2 0.1 0.3 0.0 0.8 0.1 1.9 0.9 0.0 1.5 0.9 0.2 0.1 0.0 0.1 0.1 0.1 0.0 29.7 28.6 27.2 33.7 37.9 7.6 4.1 38.9 7.9 9.3 0.0 1.3 2.2 1.7 3.2 21.8 1.4 7.6 9.4 4.5 3.5 9.8 0.8 1.7 1.6 4.4 6.2 1.3 0.0 1.2 1.0 8.9 1.5 4.7 0.8 1.6 36.5 9.2 8.6 3.7 1.1 10.6 2.5 3.3 2.8 1.7 5.6 1.7 0.0 12.7 1.9 7.4 19.4 7.8 7.1 6.7 3.8 0.7 12.2 2.8 1.4 SYNGR1 ENSG00000100321 "Synaptogyrin 1" O43759 22 39349925-39385588 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.9" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 21.0;monocytes: 18.9;T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029673, CAB034277" Enhanced Supported Cytosol NA NA Cytosol "CAB034277: AB_2255766, HPA029673: AB_10670430" "unprognostic (2.68e-3)" "unprognostic (1.84e-3)" "unprognostic (5.90e-2)" "unprognostic (8.51e-2)" "unprognostic (3.74e-1)" "unprognostic (5.98e-3)" "unprognostic (7.39e-2)" "unprognostic (4.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.06e-2)" "prognostic favorable (2.41e-4)" "unprognostic (1.16e-1)" "prognostic favorable (4.98e-7)" "unprognostic (1.32e-3)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" "unprognostic (1.04e-1)" 4.4 11.4 19.4 2.7 31.4 39.9 8.0 66.9 62.0 15.6 6.3 8.5 1.0 3.3 9.2 6.5 17.3 9.8 6.1 21.6 31.6 22.3 5.5 2.0 3.3 3.8 17.4 35.1 38.8 14.5 10.3 4.1 3.7 23.5 10.9 2.6 19.5 23.5 10.4 13.4 26.2 3.0 7.2 7.0 4.1 4.8 7.2 5.4 0.7 4.6 4.6 5.2 7.8 9.0 2.4 21.0 0.8 18.9 2.6 15.2 7.8 2.6 4.8 8.7 15.7 0.8 2.3 3.8 11.6 20.5 14.8 13.7 1.0 0.3 0.1 2.7 3.0 1.7 3.7 5.9 0.2 4.5 0.0 18.4 0.2 0.3 0.5 2.5 0.7 5.4 3.4 0.9 4.0 0.0 10.5 0.7 3.4 5.2 0.3 2.3 6.1 2.3 2.1 1.8 2.3 9.3 6.8 0.0 0.7 0.4 7.4 13.8 2.9 3.0 12.6 12.0 3.8 18.6 13.6 0.2 0.0 10.2 0.1 0.0 3.2 0.1 7.3 0.4 14.8 15.8 0.2 18.9 0.3 15.2 5.5 0.9 2.4 0.6 4.4 21.0 2.2 0.7 8.2 0.8 2.6 0.2 15.3 0.1 7.8 19.4 31.4 66.9 62.0 31.6 22.3 17.4 35.1 23.5 5.4 8.9 1.4 11.2 51.4 27.0 109.4 55.7 68.8 1.4 11.4 62.8 25.5 19.6 13.3 38.6 27.1 6.7 0.0 46.7 10.4 12.0 41.0 29.2 2.3 5.0 13.5 44.5 0.0 13.5 15.0 64.1 123.4 10.0 133.3 1.0 0.0 35.9 25.8 0.0 112.1 9.8 36.1 19.4 28.1 74.9 12.1 32.6 11.0 22.3 0.2 63.3 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 3.9;Horizontal cells: 6.4;monocytes: 4.6;Spermatogonia: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Cell line enhanced" "Detected in many" "HDLM-2: 25.7;HMC-1: 16.6;Karpas-707: 14.0;SK-BR-3: 17.5;U-266/70: 22.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "CAB034278: AB_2200905, HPA042842: AB_2678198" "unprognostic (8.89e-3)" "prognostic favorable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favorable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 2.0 0.2 0.2 0.2 2.4 1.0 1.7 0.8 0.7 3.3 1.6 3.2 0.7 0.7 2.2 1.8 2.2 0.3 0.2 25.7 1.5 0.0 2.8 1.6 1.2 0.0 16.6 0.5 0.1 0.0 0.5 3.9 0.2 1.0 9.2 14.0 0.4 2.4 0.1 0.1 10.3 0.3 0.9 0.0 0.3 2.5 1.3 0.0 4.6 5.8 2.3 17.5 0.2 1.1 2.4 0.2 0.4 0.5 8.1 0.0 0.3 22.1 2.5 3.7 0.3 2.9 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 0.0 1.1 0.0 0.7 0.2 2.6 3.9 0.0 0.0 0.0 0.0 2.0 0.4 1.7 1.7 0.4 0.3 0.0 0.0 0.4 0.6 0.6 0.8 1.1 0.0 0.2 6.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.4 0.8 1.2 0.0 0.0 0.0 0.5 0.0 0.2 2.3 8.1 0.3 2.6 2.2 0.0 0.6 SYNGR4 ENSG00000105467 "Synaptogyrin 4" O95473 19 48364395-48376376 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 41.5" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 147.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 4.1" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "A549: 9.1;SCLC-21H: 22.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030075, HPA059286" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA030075: AB_10610559, HPA059286: AB_2683965" "unprognostic (1.58e-2)" "unprognostic (3.44e-2)" "unprognostic (3.18e-2)" "unprognostic (9.49e-4)" "unprognostic (2.51e-2)" "unprognostic (7.10e-2)" "unprognostic (2.52e-3)" "unprognostic (3.72e-3)" "unprognostic (2.87e-2)" "unprognostic (6.19e-2)" "unprognostic (6.69e-2)" "unprognostic (2.41e-2)" "unprognostic (2.02e-7)" "unprognostic (1.06e-2)" "unprognostic (1.74e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 4.1 2.0 0.0 0.2 0.0 0.9 0.1 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 0.7 3.0 0.2 0.2 0.3 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.1 0.0 41.5 0.0 0.3 0.1 0.0 0.2 0.2 0.0 1.3 0.7 0.1 0.5 0.0 0.9 0.6 0.1 9.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.5 2.9 0.5 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 3.4 0.1 0.2 0.5 0.2 0.0 0.6 1.7 0.6 0.0 2.6 0.0 0.0 22.9 0.6 0.1 0.4 0.0 0.0 0.4 0.1 0.1 0.0 0.8 0.0 0.0 3.1 1.0 0.7 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.0 0.0 1.3 0.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.7 4.1 0.9 0.2 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.0 8.7 0.0 0.0 18.9 0.9 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 6.5 0.0 147.5 4.5 0.0 0.0 0.0 0.1 0.1 SYNJ1 "INPP5G, PARK20" ENSG00000159082 "Synaptojanin 1" O43426 21 32628759-32728048 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, RNA-binding" "Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.0" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011916 Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA011916: AB_1857692" "unprognostic (6.84e-2)" "unprognostic (8.64e-2)" "unprognostic (5.76e-2)" "unprognostic (6.44e-2)" "unprognostic (1.27e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.45e-1)" "unprognostic (3.73e-3)" "unprognostic (1.63e-1)" "unprognostic (6.22e-3)" "unprognostic (1.84e-2)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-1)" "unprognostic (6.36e-2)" "unprognostic (5.97e-2)" "unprognostic (1.79e-1)" "unprognostic (2.92e-1)" 5.5 6.8 13.6 5.0 25.9 20.6 4.2 19.5 39.0 4.8 4.8 6.5 0.8 3.9 4.6 5.3 3.9 4.0 5.2 5.2 18.3 18.2 7.4 5.5 6.5 5.7 16.6 18.4 4.6 4.5 10.6 10.9 9.3 33.5 3.6 5.5 7.0 3.8 4.0 4.4 5.0 4.6 5.0 7.3 6.0 4.2 9.0 5.7 3.2 6.8 1.5 4.8 4.7 3.3 0.4 3.1 11.5 6.0 0.5 3.0 1.1 5.6 2.8 5.2 5.7 9.1 7.3 10.6 11.7 6.7 7.2 6.0 6.4 2.6 2.1 3.9 7.0 9.6 5.3 9.3 6.8 8.6 6.7 8.9 14.1 9.2 3.5 4.9 5.8 12.5 4.1 5.1 12.4 6.3 5.9 11.2 7.5 10.5 12.1 9.2 5.7 5.4 4.8 3.7 6.2 6.5 5.9 11.3 7.4 7.6 4.1 5.9 4.6 14.4 9.2 5.6 7.4 7.9 7.5 12.3 11.1 5.5 8.9 6.4 6.3 7.3 4.4 8.4 11.0 8.8 3.7 3.4 7.9 1.6 6.0 2.7 0.2 2.4 2.6 3.1 0.4 2.9 2.8 11.5 0.5 5.3 1.6 3.0 1.1 13.6 25.9 19.5 28.7 18.3 18.2 16.6 18.4 33.5 5.7 6.0 4.8 2.9 2.0 4.2 21.5 7.3 5.1 4.0 2.3 1.8 43.2 13.3 5.0 1.6 14.8 7.9 4.9 0.0 1.2 7.9 3.7 2.2 3.5 3.6 8.6 9.5 2.9 8.6 19.0 8.6 2.6 7.5 1.7 1.0 2.7 19.5 2.1 3.5 4.2 5.0 40.7 6.5 3.4 16.4 10.9 2.9 31.8 6.9 4.0 4.1 SYNJ2 INPP5H ENSG00000078269 "Synaptojanin 2" O15056 6 157981887-158099176 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 62.0" "Cell type enhanced" "Detected in many" 8 "Pancreatic endocrine cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 46.3;TIME: 37.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031575 Approved Approved Microtubules,Cytosol NA NA Microtubules Cytosol "HPA031575: AB_10604101" "prognostic unfavorable (2.63e-4)" "unprognostic (1.94e-2)" "unprognostic (7.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.48e-2)" "unprognostic (7.68e-2)" "unprognostic (1.24e-1)" "unprognostic (7.06e-2)" "unprognostic (2.91e-1)" "unprognostic (7.29e-3)" "unprognostic (1.26e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (1.66e-2)" "unprognostic (3.75e-2)" "unprognostic (1.75e-1)" "unprognostic (9.45e-2)" 2.8 3.9 12.2 4.9 25.1 15.3 6.7 3.0 18.7 3.9 8.7 50.5 3.7 5.8 5.2 9.4 6.0 4.6 8.0 8.5 17.8 10.9 3.2 4.0 2.8 4.4 46.8 8.8 2.9 6.6 1.1 2.9 2.6 33.0 5.3 8.9 1.4 13.5 5.1 4.3 3.1 5.6 6.6 62.0 3.3 7.0 6.5 24.4 3.0 4.4 1.4 5.3 5.9 3.0 3.2 1.1 9.3 1.3 2.4 3.8 0.8 5.4 19.2 1.6 2.5 1.2 4.0 8.5 10.1 20.5 12.1 14.3 9.8 4.6 0.1 6.9 19.4 46.3 5.2 3.4 6.3 14.1 7.6 3.2 10.6 10.0 10.3 2.3 3.7 11.6 2.0 3.4 18.4 4.3 16.4 21.0 5.6 8.1 2.4 5.5 2.5 4.6 4.1 1.8 17.1 10.7 2.0 6.6 4.9 4.0 6.3 12.2 0.7 7.8 4.9 1.9 6.3 3.8 2.3 37.1 9.2 9.4 21.2 12.2 1.0 2.6 0.2 17.2 5.9 6.3 4.5 1.3 1.1 1.9 0.6 3.8 1.9 2.6 1.7 1.1 3.2 2.2 1.7 9.3 2.4 0.8 1.1 2.1 0.8 12.2 25.1 3.0 18.7 17.8 10.9 46.8 8.8 33.0 24.4 3.0 3.5 2.7 16.6 19.3 0.0 10.4 10.2 10.7 6.8 17.4 0.0 5.3 3.3 36.4 22.7 10.5 15.3 0.0 30.7 4.2 14.6 30.3 4.7 4.5 1.9 0.0 16.7 7.4 3.4 37.2 1.1 4.6 10.1 10.8 14.5 1.5 88.4 3.5 6.0 1.4 0.4 0.0 6.6 0.7 1.1 15.1 13.3 5.3 14.5 32.4 SYNM "DMN, KIAA0353, SYN" ENSG00000182253 Synemin O15061 15 99098217-99135593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 111.2;smooth muscle: 147.5;urinary bladder: 85.2" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 422.4;Muller glia cells: 107.8;Smooth muscle cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 8 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 14.9;HeLa: 22.3;WM-115: 50.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017192, HPA040066, HPA044200, HPA077856" Enhanced Supported "Intermediate filaments" NA NA "Intermediate filaments" "CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (3.52e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.34e-2)" "unprognostic (6.75e-2)" "unprognostic (3.54e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-2)" "unprognostic (5.92e-3)" "unprognostic (3.26e-3)" 6.9 4.2 4.5 5.0 5.4 0.0 11.9 2.5 5.5 2.9 38.4 9.0 27.6 5.4 4.9 7.2 42.1 3.1 9.6 24.8 6.0 5.7 0.8 0.8 2.0 0.7 11.8 4.2 2.9 0.9 1.8 2.0 2.7 8.5 30.1 11.1 10.9 3.2 62.6 111.2 1.5 11.9 147.5 18.2 0.6 16.7 1.5 3.7 0.0 1.4 14.5 1.7 85.2 21.6 0.2 0.1 0.1 0.0 0.2 1.8 0.4 2.6 14.9 3.3 8.9 6.7 0.3 0.2 1.4 2.1 0.9 0.5 2.1 2.0 0.0 2.2 2.1 7.3 1.7 2.2 0.0 0.7 0.2 3.7 0.0 22.3 2.1 3.8 0.0 0.4 0.4 0.1 1.5 0.3 2.5 1.7 0.0 0.0 3.0 2.2 1.4 0.2 0.3 2.9 0.2 4.7 0.0 3.1 2.1 0.8 1.4 1.5 1.7 8.8 1.3 5.3 5.5 0.0 1.4 1.9 1.7 0.2 1.1 3.5 0.0 0.4 0.0 0.1 0.0 50.6 0.1 0.0 0.0 1.7 0.0 1.4 0.2 1.8 1.1 0.1 0.0 1.6 0.6 0.0 0.2 0.0 0.0 0.0 0.4 4.5 5.4 2.5 4.4 6.0 5.7 11.8 4.2 8.5 3.7 0.0 1.7 0.0 0.9 2.1 11.5 422.4 0.0 4.0 1.2 0.0 15.7 1.0 0.0 0.4 7.1 10.8 1.1 0.0 1.2 0.3 4.0 2.0 0.0 0.8 0.2 39.7 2.9 2.5 0.0 3.4 1.1 1.4 5.0 0.0 0.1 107.8 0.2 0.3 3.9 0.3 7.8 32.3 184.3 3.7 11.9 3.1 0.3 2.9 0.2 0.7 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659220 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 27 "B-cells: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9" "Group enriched" "Detected in many" 6 "amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179" "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 17.3 14.6 17.7 4.4 18.9 0.6 5.7 1.4 24.9 4.3 5.5 2.4 0.8 6.6 5.1 4.8 6.7 4.4 6.8 66.1 16.6 4.0 15.8 7.8 11.7 2.4 4.5 5.6 23.3 6.8 2.5 2.8 63.4 3.7 7.6 4.1 16.4 2.6 6.7 222.7 1.8 7.6 8.2 4.8 14.5 4.7 17.4 3.9 0.5 4.0 5.7 2.6 6.2 17.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 7.0 0.0 0.1 1.0 0.9 26.4 4.0 5.5 1.4 1.1 6.2 2.8 0.0 21.8 5.7 8.7 2.6 0.0 3.9 0.5 0.0 0.0 0.0 10.6 1.3 6.0 0.0 0.2 1.1 6.3 1.5 1.1 8.2 21.3 0.0 0.0 0.0 1.3 0.4 0.0 0.2 0.8 2.6 3.4 0.1 0.2 0.0 1.0 0.5 2.5 11.7 5.8 6.4 0.2 9.7 0.4 1.9 51.7 5.2 16.3 0.1 1.0 0.2 0.0 0.3 45.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.7 18.9 1.4 24.9 16.6 4.0 4.5 5.6 3.7 3.9 32.8 13.5 0.9 2.8 4.0 1.3 219.1 35.7 5.3 14.8 7.0 2.0 9.9 0.0 44.4 1.6 40.9 50.6 0.0 30.5 5.8 12.3 1.6 0.0 38.0 1.9 0.0 13.3 42.4 6.7 1.9 2.6 1.1 5.0 41.5 9.9 6.1 29.3 25.9 26.2 3.3 0.6 45.3 32.0 0.7 0.4 1.9 21.6 1.3 9.1 3.0 SYNPO2 MYOPODIN ENSG00000172403 "Synaptopodin 2" Q9UMS6 4 118850688-119061247 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 185.8" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 123.7;Peritubular cells: 95.5;Sertoli cells: 129.4;Smooth muscle cells: 291.5" "Cancer enhanced" "Detected in all" "stomach cancer: 27.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.4;LHCN-M2: 9.4;SH-SY5Y: 40.3" "Region enriched" "Detected in many" 5 "thalamus: 64.1" "Low region specificity" "Detected in many" "HPA030665, CAB037231, HPA049707, HPA068563" Enhanced Enhanced "Vesicles,Actin filaments" NA NA "Vesicles, Actin filaments" "CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006" "unprognostic (1.50e-2)" "unprognostic (1.73e-2)" "unprognostic (5.32e-2)" "unprognostic (1.50e-2)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (5.71e-4)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (3.52e-1)" "unprognostic (1.39e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (1.82e-2)" "unprognostic (1.35e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.91e-4)" 11.4 2.3 1.8 9.6 3.9 0.0 7.3 1.0 5.6 26.5 56.0 4.4 20.5 6.5 37.5 23.9 37.0 14.2 19.4 29.0 2.6 1.5 2.4 1.7 3.7 5.7 1.9 5.2 27.9 1.4 0.9 2.6 3.8 3.8 35.9 11.1 21.2 4.1 58.8 185.8 3.7 14.5 88.7 4.0 6.1 29.5 9.6 3.1 3.0 3.7 12.8 2.1 50.7 15.5 1.8 0.2 2.0 0.4 1.2 2.3 0.4 0.1 1.9 0.1 0.0 5.6 1.9 0.3 5.9 6.4 0.2 0.2 0.0 0.3 0.6 0.0 26.4 0.4 0.1 0.2 0.1 0.3 2.5 0.0 0.3 0.4 0.0 1.3 0.0 0.1 6.8 0.1 1.8 0.1 2.0 0.0 0.1 0.0 0.3 9.4 0.1 0.3 3.6 0.6 0.0 0.0 0.2 0.7 0.2 0.1 0.1 0.2 40.3 0.2 0.1 0.0 1.7 0.0 3.4 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.3 0.0 1.9 0.3 2.0 1.2 0.1 1.9 1.3 2.0 1.2 0.1 1.8 2.1 1.3 0.9 1.2 0.4 0.2 2.3 0.4 1.8 3.9 1.0 5.6 2.6 1.5 1.9 5.2 3.8 3.1 3.0 1.4 0.8 19.5 11.9 0.3 123.7 0.0 4.0 0.0 1.8 0.0 1.0 0.0 0.0 1.5 7.7 0.0 0.0 1.7 0.7 19.8 3.2 0.0 0.5 1.3 0.0 0.0 15.4 0.8 3.9 25.0 1.9 5.0 22.6 0.0 0.0 0.2 0.0 95.5 0.3 0.3 129.4 291.5 0.5 0.4 7.0 0.7 0.0 0.0 2.7 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3" "Cell type enriched" "Detected in some" 220 "Cardiomyocytes: 650.0" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" NA NA "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: AB_2682732, HPA057142: AB_2683348" "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 3.8 0.1 0.0 0.0 0.1 0.1 1.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 3.2 3.3 0.0 0.0 69.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.8 0.0 0.0 1.6 0.0 72.8 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.3 29.3 3.4 0.0 0.3 0.7 1.0 3.0 0.7 0.7 0.7 0.1 0.5 0.1 0.8 0.3 0.1 0.0 1.1 0.9 1.2 0.2 0.0 7.7 0.7 0.4 0.5 0.9 0.1 0.1 0.1 0.0 0.4 0.2 0.2 0.3 0.6 0.4 0.6 0.2 0.3 6.2 0.1 1.2 0.1 0.3 0.0 0.5 0.3 0.3 0.3 0.3 0.2 1.9 0.2 0.0 0.7 0.2 5.9 0.3 0.0 0.6 0.3 0.4 0.1 6.3 0.1 0.3 0.4 0.7 0.0 0.6 1.0 0.2 0.3 1.0 0.3 0.3 0.2 0.6 0.0 2.9 0.7 0.7 0.7 0.4 0.3 0.5 0.3 0.3 0.2 0.7 0.4 0.4 3.0 0.7 0.4 1.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.0 1.4 1.3 1.4 650.0 0.0 1.4 1.2 0.0 2.0 0.1 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.1 0.9 0.7 1.1 0.2 0.2 0.0 0.0 0.0 0.3 1.0 0.9 0.8 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.3 0.0 0.5 0.7 0.6 0.4 0.0 0.7 0.0 0.9 SYNPR "MGC26651, SPO" ENSG00000163630 Synaptoporin Q8TBG9 3 63228315-63616921 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 99.9" "Group enriched" "Detected in some" 12 "Horizontal cells: 100.1;Muller glia cells: 40.6" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Region enhanced" "Detected in all" "basal ganglia: 99.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;SCLC-21H: 4.3;SH-SY5Y: 1.2;SuSa: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051368, HPA061671" Enhanced NA NA "HPA051368: AB_2681456, HPA061671: AB_2684582" "unprognostic (1.69e-1)" "unprognostic (3.77e-2)" "unprognostic (3.14e-3)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.50e-1)" "unprognostic (5.32e-2)" "unprognostic (1.82e-1)" "unprognostic (1.89e-1)" 1.1 1.5 13.3 1.3 99.9 1.1 1.1 26.9 58.4 1.2 1.2 1.5 0.0 1.4 1.1 1.2 1.1 1.2 1.2 6.1 20.4 7.6 1.2 1.1 1.1 1.1 4.6 14.4 1.1 1.3 1.1 0.1 1.1 4.3 1.1 1.2 11.9 1.8 1.2 1.1 1.1 1.2 1.2 2.2 1.1 1.8 1.1 4.6 0.0 1.2 0.0 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.2 0.0 0.0 0.7 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 99.9 26.9 31.2 20.4 7.6 4.6 14.4 4.3 4.6 0.0 0.0 0.0 0.0 0.0 4.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 100.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.1 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYP MRX96 ENSG00000102003 Synaptophysin P08247 X 49187804-49200259 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 179.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 496.0;Cone photoreceptor cells: 514.4;Rod photoreceptor cells: 549.6" "Group enriched" "Detected in many" 6 "glioma: 12.8;pancreatic cancer: 5.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "K-562: 8.7;SCLC-21H: 46.8;SH-SY5Y: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000076, HPA002858, CAB055505, CAB078999" Enhanced Supported NA NA "CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153" "unprognostic (2.08e-1)" "unprognostic (8.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.37e-3)" "unprognostic (4.37e-2)" "unprognostic (2.11e-1)" "unprognostic (1.87e-1)" "unprognostic (6.46e-5)" "unprognostic (8.52e-3)" "unprognostic (1.62e-1)" "unprognostic (3.44e-3)" "unprognostic (8.26e-2)" "unprognostic (2.41e-2)" "unprognostic (1.95e-1)" "unprognostic (3.54e-1)" "unprognostic (1.79e-2)" "unprognostic (1.94e-1)" 2.7 21.4 34.5 3.2 42.5 1.9 1.9 53.8 179.2 2.0 3.6 7.2 0.0 7.4 2.2 2.6 2.2 2.0 2.0 2.3 44.4 45.3 2.7 1.8 2.8 2.0 25.5 39.0 2.1 5.2 1.9 17.4 2.0 46.7 2.1 3.5 11.5 2.0 2.1 2.4 2.3 8.1 2.5 15.5 2.4 3.9 2.0 4.0 0.0 2.1 0.0 1.9 1.8 0.2 1.3 1.6 5.3 0.8 0.5 0.7 0.1 0.4 1.7 1.3 2.6 1.5 0.2 0.2 0.1 0.0 0.3 0.3 1.6 0.9 1.4 0.2 0.0 2.0 1.3 1.4 0.1 0.3 2.8 1.6 2.1 0.5 0.5 0.0 0.2 4.8 0.2 0.0 0.2 0.3 0.2 0.1 1.2 8.7 3.4 0.3 0.5 0.7 0.1 4.3 1.1 0.3 0.3 0.2 0.6 0.1 0.2 46.8 16.9 0.5 0.2 0.6 0.4 0.8 0.8 0.2 0.3 1.4 0.4 0.2 0.2 2.8 0.3 0.7 0.5 1.4 1.7 0.8 0.4 0.2 0.7 0.4 0.7 0.5 0.7 0.4 1.3 0.5 0.5 5.3 0.5 0.4 1.6 0.3 0.1 34.5 42.5 53.8 84.8 44.4 45.3 25.5 39.0 46.7 4.0 0.0 3.8 0.8 2.5 2.3 496.0 1.2 5.1 6.7 4.5 8.7 514.4 0.9 0.0 0.8 8.8 5.4 7.8 0.0 2.1 0.5 2.1 1.2 8.1 0.6 1.0 116.0 111.7 6.7 2.4 9.9 3.7 4.5 3.3 2.8 18.4 54.5 1.6 2.3 3.5 0.4 549.6 6.5 4.4 0.4 2.5 2.3 1.1 3.2 6.3 0.8 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466628-109482137 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 102.5;tongue: 25.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA076657 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 0.9 3.9 0.8 0.3 0.7 0.1 1.4 0.5 1.2 1.6 1.9 0.3 0.8 0.3 2.5 4.3 1.6 0.4 1.1 7.4 0.8 0.2 6.0 4.7 0.6 0.3 0.3 0.0 1.1 3.2 3.7 0.4 1.2 0.8 1.2 0.5 1.7 1.6 2.2 102.5 0.2 0.6 3.5 0.1 0.4 1.1 6.0 0.2 0.0 5.1 25.6 1.2 2.5 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 20.2 8.5 0.0 8.6 27.3 2.7 1.0 0.0 0.0 0.0 0.0 14.1 0.3 0.0 7.3 0.0 0.5 0.0 3.1 0.0 0.2 0.1 0.4 0.0 0.7 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 2.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 1.2 0.8 0.2 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 1.5 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 4.9 0.0 0.0 2.3 0.4 1.5 0.0 0.1 0.0 0.0 0.0 SYT1 "P65, SVP65, SYT" ENSG00000067715 "Synaptotagmin 1" P21579 12 78863993-79452008 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Differentiation "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 141.7" "Group enriched" "Detected in many" 9 "Bipolar cells: 1152.5;Cone photoreceptor cells: 842.3;Muller glia cells: 363.8;Rod photoreceptor cells: 831.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 21.8;hTERT-RPE1: 20.4;LHCN-M2: 17.5;SH-SY5Y: 16.9;WM-115: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008394, HPA064788" Enhanced Supported NA NA "HPA008394: AB_1857696, HPA064788: AB_2685351" "unprognostic (1.02e-3)" "unprognostic (2.55e-1)" "unprognostic (4.21e-3)" "unprognostic (3.77e-2)" "unprognostic (3.16e-2)" "unprognostic (3.68e-5)" "unprognostic (2.78e-2)" "unprognostic (1.83e-2)" "unprognostic (7.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.11e-1)" "unprognostic (6.14e-3)" "unprognostic (3.05e-8)" "unprognostic (2.89e-2)" "unprognostic (8.26e-2)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" 1.3 11.5 23.9 2.1 31.8 1.3 1.4 44.3 141.7 1.8 2.3 1.8 0.0 1.8 5.6 1.4 1.4 1.4 1.7 1.1 32.4 22.9 2.0 2.0 1.5 1.2 23.1 38.6 3.6 1.2 1.1 1.4 2.3 28.9 4.3 2.5 2.7 1.2 3.8 1.1 1.2 2.6 12.9 2.5 2.2 1.8 1.4 3.6 0.0 1.2 0.0 1.2 1.3 0.7 3.4 0.9 0.0 2.3 0.0 0.0 0.1 0.0 10.2 7.7 0.0 0.7 2.3 0.0 0.7 0.9 0.5 0.6 0.5 0.3 0.0 1.5 0.1 2.8 0.3 0.1 1.2 0.9 0.1 0.4 0.6 0.2 0.0 2.0 0.0 0.1 0.6 0.7 2.8 21.8 20.4 7.3 0.3 0.4 1.2 17.5 1.6 0.9 0.0 5.6 1.1 2.9 0.0 8.0 0.0 0.0 2.9 10.3 16.9 0.0 1.3 0.2 5.5 3.8 0.0 2.9 1.1 0.4 0.0 3.2 1.9 4.1 0.0 2.5 0.0 15.8 0.0 2.3 0.0 0.0 0.2 0.0 3.3 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.9 31.8 44.3 74.8 32.4 22.9 23.1 38.6 28.9 3.6 0.0 1.1 3.7 0.0 0.8 1152.5 0.4 0.0 0.0 2.3 0.0 842.3 4.4 0.0 0.0 0.9 2.2 0.0 0.0 0.2 2.0 0.7 14.4 0.0 0.0 10.4 58.8 93.0 3.1 4.7 2.0 64.2 1.1 1.7 0.0 0.0 363.8 0.1 0.2 4.2 0.0 831.5 0.0 1.0 1.1 5.2 0.5 4.9 0.0 0.0 0.1 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;fallopian tube: 8.1" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 2.0;Club cells: 4.5;Distal tubular cells: 6.6;Ito cells: 2.5;Spermatogonia: 4.5" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;K-562: 2.2;MCF7: 7.7;NTERA-2: 1.9;RPTEC TERT1: 2.0;RT4: 3.0;SCLC-21H: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.3 1.5 0.6 0.7 10.1 0.1 0.3 0.2 4.1 2.9 3.6 0.9 3.0 1.0 0.3 0.8 0.3 8.1 0.4 0.5 0.8 3.1 3.3 1.4 0.2 0.1 0.6 3.4 0.4 0.2 0.1 5.8 0.2 14.6 1.6 1.6 0.1 1.8 3.2 0.2 0.2 1.3 0.6 2.7 0.2 1.6 0.6 0.3 0.0 0.2 0.0 0.1 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 7.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.0 4.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.1 0.2 4.1 0.8 3.1 0.6 3.4 14.6 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.5 0.0 1.4 4.5 0.0 0.0 0.0 6.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 4.5 0.0 0.1 0.0 0.0 0.0 SYT11 "DKFZp781D015, KIAA0080, MGC10881, MGC17226" ENSG00000132718 "Synaptotagmin 11" Q9BT88 1 155859509-155885199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 148.3" "Group enriched" "Detected in many" 5 "Bipolar cells: 79.9;Horizontal cells: 84.2;Muller glia cells: 149.4" "Cancer enriched" "Detected in all" 12 "glioma: 117.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 57.3;SCLC-21H: 22.9;SH-SY5Y: 24.9;U-87 MG: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064091 Enhanced NA NA "HPA064091: AB_2685189" "unprognostic (1.83e-1)" "unprognostic (5.99e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.93e-5)" "unprognostic (2.14e-1)" "unprognostic (8.02e-3)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (3.93e-1)" "unprognostic (1.16e-1)" "unprognostic (1.42e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (6.38e-2)" "unprognostic (1.10e-1)" "unprognostic (2.22e-3)" 6.0 13.3 34.4 6.2 52.0 3.3 2.7 35.4 148.3 9.3 5.1 44.5 0.0 3.4 11.5 8.6 4.7 5.2 7.9 8.9 32.9 32.3 4.5 2.4 6.0 7.2 35.9 32.2 9.6 3.2 2.4 11.8 7.0 48.3 8.7 5.4 4.4 2.6 11.3 2.8 2.3 4.3 12.7 42.0 6.9 3.8 4.7 29.0 0.0 2.8 0.0 6.5 7.3 3.3 1.6 5.6 4.1 6.1 5.8 14.4 5.7 0.0 0.2 14.7 0.3 10.8 5.7 0.0 2.7 7.4 2.9 5.3 0.0 0.4 2.8 1.2 9.8 4.5 0.2 1.2 0.0 4.4 13.7 0.2 2.7 0.4 0.0 3.1 1.5 8.5 3.6 0.0 10.5 0.2 16.6 9.3 0.1 0.0 57.3 3.9 0.0 0.1 0.7 9.6 0.0 0.0 0.5 1.5 0.0 0.4 0.0 22.9 24.9 0.4 0.0 3.3 0.3 0.0 0.3 6.9 5.5 3.5 3.7 3.4 15.3 7.4 5.8 27.6 0.0 4.2 4.1 3.8 0.1 14.4 4.8 4.0 1.6 7.6 9.9 5.6 1.4 0.8 7.8 2.1 5.8 6.1 0.3 13.3 5.7 34.4 52.0 35.4 59.4 32.9 32.3 35.9 32.2 48.3 29.0 0.0 0.0 1.7 0.1 0.5 79.9 9.7 0.0 1.4 0.0 1.8 21.6 0.0 0.0 0.8 0.0 13.5 0.0 0.0 0.9 0.1 3.1 0.2 11.5 0.0 4.7 84.2 4.6 2.5 7.9 0.4 2.6 7.9 3.3 12.6 0.0 149.4 2.3 0.0 14.9 0.8 12.7 19.4 8.2 1.1 1.1 0.9 0.0 7.1 0.0 0.2 SYT12 SRG1 ENSG00000173227 "Synaptotagmin 12" Q8IV01 11 67006778-67050863 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 29.9;parathyroid gland: 59.4" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.4;Cholangiocytes: 2.5;Hepatocytes: 4.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 8.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 26.3;MCF7: 18.1;SiHa: 23.3;SK-BR-3: 11.4;T-47d: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011006, HPA074255" Enhanced NA NA "HPA011006: AB_2286996, HPA074255: " "unprognostic (2.72e-2)" "unprognostic (2.77e-2)" "unprognostic (2.23e-2)" "unprognostic (1.12e-3)" "unprognostic (4.47e-3)" "unprognostic (3.88e-2)" "unprognostic (1.20e-1)" "unprognostic (3.73e-2)" "unprognostic (2.04e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (4.13e-4)" "unprognostic (2.75e-1)" "unprognostic (9.86e-4)" "unprognostic (4.21e-2)" "unprognostic (7.38e-2)" "unprognostic (2.42e-2)" "unprognostic (9.85e-2)" 1.1 2.2 4.3 0.8 7.9 0.6 4.2 29.9 16.2 0.7 0.6 0.8 3.5 1.2 0.7 6.2 0.9 3.7 1.1 0.8 5.4 4.7 0.7 10.2 0.6 0.7 2.6 5.4 0.7 0.7 59.4 3.4 4.1 6.8 0.9 0.6 0.1 1.8 2.5 0.8 1.2 0.8 0.6 1.3 0.6 0.7 1.3 0.5 0.0 0.6 0.0 0.7 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.8 1.9 0.7 0.1 0.8 0.1 2.7 0.0 0.0 0.2 0.0 26.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 18.1 0.0 0.0 0.5 0.1 0.9 0.0 0.0 0.0 0.3 0.0 0.2 0.0 23.3 11.4 0.0 0.0 11.4 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.3 7.9 29.9 16.2 5.4 4.7 2.6 5.4 6.8 0.5 0.0 0.0 0.0 3.4 1.1 0.6 1.1 2.5 0.0 2.3 1.8 0.0 0.2 0.0 2.2 0.2 0.0 0.0 0.0 0.0 1.2 0.4 1.2 0.0 4.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.7 0.0 0.4 0.7 0.4 1.0 1.6 0.0 0.0 1.2 SYT13 KIAA1427 ENSG00000019505 "Synaptotagmin 13" Q7L8C5 11 45240301-45286319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.1;gallbladder: 18.8" "Cell type enriched" "Detected in many" 8 "Intestinal endocrine cells: 323.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "A549: 11.5;NTERA-2: 5.4;RPTEC TERT1: 35.1;SCLC-21H: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046224, HPA056602" Uncertain Supported Vesicles NA NA Vesicles "HPA046224: AB_10961288, HPA056602: AB_2683185" "unprognostic (4.96e-2)" "unprognostic (1.06e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (7.79e-5)" "unprognostic (1.00e-2)" "unprognostic (4.17e-2)" "unprognostic (3.75e-2)" "unprognostic (9.83e-3)" "unprognostic (2.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.94e-2)" "unprognostic (1.76e-1)" "unprognostic (8.70e-2)" "unprognostic (5.13e-2)" 0.4 4.5 15.8 1.5 15.1 0.4 0.5 19.0 38.1 0.3 10.6 1.2 0.0 10.9 0.6 0.3 0.4 0.5 18.8 4.5 11.8 19.5 8.0 0.6 0.8 0.4 10.6 15.1 0.4 6.4 0.4 9.4 0.4 27.9 2.0 11.2 0.9 1.4 0.4 0.5 0.5 11.1 1.1 2.2 0.5 9.2 1.8 0.3 0.0 1.8 0.0 0.3 0.4 0.2 0.2 0.0 1.4 0.0 0.2 0.2 0.0 0.0 11.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 35.1 0.0 9.3 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 15.8 15.1 19.0 31.1 11.8 19.5 10.6 15.1 27.9 0.3 0.0 0.0 0.0 0.2 0.0 1.1 8.1 15.3 0.0 0.0 3.5 23.6 0.0 5.0 1.2 3.1 0.0 10.0 0.0 0.5 0.0 0.0 4.2 0.0 0.0 0.0 1.6 323.7 0.0 0.0 8.2 0.3 0.0 0.0 0.0 30.8 0.5 5.3 17.5 0.0 0.3 1.5 0.0 0.0 1.9 0.2 0.0 0.0 0.0 38.3 0.1 SYT14 "FLJ34198, sytXIV" ENSG00000143469 "Synaptotagmin 14" Q8NB59 1 209938174-210171389 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 28.8;Cone photoreceptor cells: 25.5;Horizontal cells: 49.3;Rod photoreceptor cells: 28.8;Spermatogonia: 19.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.0;GAMG: 8.8;SCLC-21H: 6.8;TIME: 10.8;U-138 MG: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036963 Supported Vesicles NA NA Vesicles "HPA036963: AB_10670378" "unprognostic (1.38e-4)" "unprognostic (8.62e-3)" "unprognostic (1.93e-1)" "unprognostic (3.90e-4)" "unprognostic (1.97e-1)" "unprognostic (4.43e-5)" "unprognostic (1.92e-1)" "unprognostic (1.88e-2)" "unprognostic (6.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.81e-1)" "unprognostic (4.85e-3)" "unprognostic (2.30e-4)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-3)" 0.7 3.2 5.9 0.8 7.4 0.8 0.6 17.4 10.2 0.6 0.7 3.8 0.0 0.7 1.4 0.8 0.6 0.6 0.6 0.6 4.5 2.6 0.9 0.6 0.7 0.7 3.3 5.9 0.8 1.2 0.6 31.1 0.6 5.0 0.8 0.8 1.1 0.6 0.6 0.7 0.7 0.7 0.7 2.4 0.7 0.9 9.5 3.0 0.0 15.9 0.0 0.6 0.6 0.4 2.0 0.8 2.1 0.5 1.1 0.8 0.1 3.3 0.1 0.0 0.0 0.3 0.0 0.0 2.7 13.0 2.7 1.4 0.0 0.2 0.0 0.1 0.3 8.8 4.1 0.0 0.0 3.3 0.5 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 1.9 5.7 1.7 0.5 0.0 0.0 0.0 4.9 0.0 0.0 0.0 4.5 0.0 1.8 0.0 0.1 0.1 0.2 3.0 6.8 3.1 0.0 0.0 5.6 1.0 0.0 0.1 10.8 8.2 3.9 0.7 1.4 0.1 0.1 0.0 0.7 0.0 1.9 2.1 0.4 0.6 0.8 0.2 0.4 0.6 0.5 0.4 0.3 2.0 0.4 0.6 1.8 1.1 0.5 0.8 0.4 0.1 5.9 7.4 17.4 10.2 4.5 2.6 3.3 5.9 5.0 3.0 0.0 0.0 0.0 0.1 0.0 28.8 1.6 0.0 0.0 0.0 0.0 25.5 0.0 3.3 0.1 12.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 49.3 0.0 0.0 0.0 3.2 0.6 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.3 28.8 0.0 0.0 4.9 19.3 0.0 0.0 0.0 0.0 0.1 SYT16 "CHR14SYT, Strep14, SYT14L, yt14r" ENSG00000139973 "Synaptotagmin 16" Q17RD7 14 61811974-62112550 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.8;testis: 6.8" "Group enriched" "Detected in some" 5 "Early spermatids: 26.4;Late spermatids: 10.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 10.6;hTERT-HME1: 4.3;PC-3: 5.5;RPTEC TERT1: 6.5;RT4: 17.1;U-2 OS: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004199, HPA076871" Enhanced Approved Cytosol NA NA Cytosol "HPA004199: AB_1080156, HPA076871: AB_2732324" "unprognostic (2.55e-2)" "unprognostic (1.43e-2)" "unprognostic (4.12e-1)" "unprognostic (8.88e-4)" "unprognostic (1.41e-1)" "unprognostic (9.08e-2)" "unprognostic (9.57e-2)" "unprognostic (9.95e-3)" "unprognostic (1.02e-1)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (3.41e-2)" "unprognostic (1.61e-2)" "unprognostic (3.06e-2)" "unprognostic (1.53e-3)" "unprognostic (2.15e-1)" 0.4 1.3 7.2 0.4 17.2 0.6 0.6 0.7 20.8 0.4 0.4 0.4 0.0 0.4 1.0 2.1 0.4 0.7 0.5 0.5 3.3 3.4 0.7 0.4 0.5 0.5 1.6 12.3 0.4 4.0 0.4 1.9 1.1 1.8 4.6 0.4 0.0 0.4 0.6 0.4 0.5 0.5 0.4 0.9 0.5 2.6 6.8 0.7 0.0 0.5 0.0 0.4 0.9 0.6 0.2 0.1 0.6 0.1 0.1 0.2 0.0 10.6 0.2 0.3 0.0 0.0 0.0 0.1 0.7 1.0 1.0 0.6 0.0 0.0 0.1 0.2 0.0 0.6 0.6 0.0 1.0 1.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 5.5 0.0 0.0 0.0 6.5 17.1 0.3 3.0 0.5 0.7 0.0 1.1 0.0 0.0 0.0 2.9 6.9 0.0 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.6 0.1 0.1 0.1 0.0 0.0 7.2 17.2 0.7 18.9 3.3 3.4 1.6 12.3 1.8 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 3.5 2.0 0.3 0.0 0.1 26.4 0.0 0.0 0.0 0.0 0.5 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 2.1 0.0 0.1 0.0 0.0 0.1 SYT17 ENSG00000103528 "Synaptotagmin 17" Q9BSW7 16 19167971-19268334 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.2" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 21.0;Distal tubular cells: 23.2;Intestinal endocrine cells: 20.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 4.1;memory B-cell: 5.1;naive B-cell: 14.7;non-classical monocyte: 13.4" "Group enriched" "Detected in many" 8 "B-cells: 14.7;monocytes: 13.4" "Cell line enhanced" "Detected in many" "BEWO: 10.4;CAPAN-2: 20.2;Daudi: 8.9;MCF7: 15.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042059 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA042059: AB_2677827" "unprognostic (3.43e-1)" "unprognostic (2.75e-1)" "unprognostic (2.29e-2)" "unprognostic (1.49e-2)" "unprognostic (2.74e-1)" "unprognostic (1.11e-2)" "unprognostic (9.31e-2)" "unprognostic (2.43e-1)" "unprognostic (6.76e-2)" "unprognostic (1.97e-1)" "unprognostic (3.15e-1)" "unprognostic (6.59e-2)" "unprognostic (3.00e-3)" "unprognostic (4.53e-2)" "unprognostic (3.38e-1)" "unprognostic (7.32e-2)" "unprognostic (4.95e-3)" 3.8 5.2 16.5 1.4 9.2 0.4 4.7 1.0 25.2 3.5 2.4 6.1 1.2 4.3 1.2 3.1 4.0 2.5 1.3 1.3 15.5 16.5 3.8 12.1 7.8 3.2 13.9 10.2 0.8 2.5 21.3 13.4 3.9 7.5 9.7 3.0 7.6 1.5 3.8 0.4 9.9 2.1 1.0 5.5 1.4 4.3 0.6 7.4 0.0 7.1 0.8 4.7 4.2 3.8 14.7 1.6 0.4 13.4 0.0 0.0 0.6 0.0 7.4 0.1 0.0 0.2 0.5 10.4 0.0 0.0 0.1 0.0 0.3 20.2 8.9 2.5 0.0 2.8 3.6 0.5 0.3 0.0 0.0 1.5 0.0 7.4 0.1 0.0 0.0 0.0 0.7 1.8 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.9 5.8 4.1 0.0 0.8 0.7 2.5 4.4 1.6 0.9 2.9 8.0 0.4 5.1 7.9 1.9 0.0 0.0 5.3 0.1 0.0 1.5 0.0 8.2 0.0 0.0 0.0 0.4 0.5 0.0 0.0 4.1 0.0 5.1 0.0 0.0 1.6 14.7 0.0 0.0 0.1 0.0 13.4 0.2 0.0 0.6 16.5 9.2 1.0 22.9 15.5 16.5 13.9 10.2 7.5 7.4 6.0 9.4 2.7 10.1 3.4 0.6 1.4 0.0 5.3 3.4 21.0 0.0 4.2 23.2 3.4 0.1 1.6 1.3 0.0 0.6 11.3 2.4 8.2 0.0 12.4 4.0 1.6 20.7 3.1 1.9 0.0 1.4 2.0 11.8 9.0 9.1 13.2 2.7 7.0 0.7 0.0 0.3 0.0 0.7 0.5 1.7 8.4 3.3 0.0 3.1 6.3 SYT2 ENSG00000143858 "Synaptotagmin 2" Q8N9I0 1 202590596-202710417 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" Differentiation "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 40.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 3.4;Cardiomyocytes: 2.4;Horizontal cells: 3.2;Leydig cells: 3.1;Rod photoreceptor cells: 4.1" "Cancer enriched" "Detected in some" 7 "testis cancer: 3.8" "Group enriched" "Detected in many" 5 "cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1" "Cell type enriched" "Detected in single" 8 "neutrophil: 2.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "AF22: 12.7;NTERA-2: 8.8;U-2 OS: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA063655 Enhanced Supported NA NA "HPA063655: AB_2685077" "unprognostic (1.32e-2)" "unprognostic (4.99e-2)" "unprognostic (4.89e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (2.24e-2)" "unprognostic (3.00e-1)" "unprognostic (2.35e-3)" "unprognostic (8.81e-3)" "unprognostic (1.17e-1)" "unprognostic (1.53e-2)" "unprognostic (6.33e-2)" "unprognostic (1.56e-2)" "unprognostic (6.23e-2)" "unprognostic (3.26e-1)" "unprognostic (2.54e-1)" "unprognostic (5.17e-3)" 1.1 6.1 0.4 1.1 5.9 0.5 0.3 36.2 14.7 0.6 0.7 0.3 0.0 1.1 1.7 4.1 0.4 0.8 1.1 1.5 0.6 1.5 0.5 0.4 0.6 0.7 5.5 0.4 3.1 0.4 0.2 0.3 0.5 40.1 0.9 0.7 1.6 1.1 0.5 1.1 0.7 1.3 0.5 7.1 1.2 0.7 2.4 1.1 0.0 0.6 0.0 0.5 1.0 0.3 0.1 0.0 2.4 0.1 0.1 0.2 0.0 0.0 0.2 12.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 8.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.4 5.9 36.2 14.7 0.6 1.5 5.5 0.4 40.1 1.1 0.0 0.0 0.0 1.3 0.5 3.4 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.0 4.1 0.0 0.0 0.2 1.3 0.5 0.1 0.0 0.2 2.0 SYT3 ENSG00000213023 "Synaptotagmin 3" Q9BQG1 19 50621307-50639827 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 24.2" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 4.0;Ciliated cells: 2.7;Collecting duct cells: 1.8;Cone photoreceptor cells: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 10.1;HMC-1: 7.1;JURKAT: 4.1;NTERA-2: 7.3;SH-SY5Y: 8.2;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (5.17e-2)" "unprognostic (1.90e-1)" "unprognostic (3.86e-3)" "unprognostic (1.57e-1)" "unprognostic (6.62e-2)" "unprognostic (4.36e-3)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-4)" "unprognostic (1.12e-1)" "unprognostic (3.49e-4)" "unprognostic (1.82e-4)" "unprognostic (3.40e-1)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" 0.9 1.8 8.7 1.0 8.8 0.7 0.8 16.1 24.2 1.0 0.9 1.0 0.0 1.0 0.9 1.1 0.9 0.9 0.8 0.7 10.9 8.9 1.2 0.8 1.1 0.9 6.7 6.6 0.7 2.1 1.0 2.2 2.3 6.3 1.2 0.8 0.3 1.4 1.7 0.8 0.8 1.0 0.9 2.4 0.8 0.8 2.7 2.2 0.0 1.3 0.0 0.9 1.0 0.0 0.0 1.3 0.1 0.0 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 3.1 0.0 0.5 0.1 0.4 0.0 0.0 0.1 10.1 0.0 0.0 0.0 0.4 0.0 7.1 0.3 0.0 0.0 0.0 0.0 0.2 4.1 1.2 0.0 0.0 3.0 0.0 0.0 7.3 0.2 0.0 2.5 0.0 0.1 0.0 0.0 0.1 8.2 0.4 0.0 0.2 0.1 0.2 2.3 0.0 0.0 5.2 0.0 0.0 0.8 0.1 0.0 0.3 3.7 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.1 8.7 8.8 16.1 16.3 10.9 8.9 6.7 6.6 6.3 2.2 0.0 4.0 0.0 0.0 0.0 1.4 0.5 0.0 2.7 0.0 1.8 3.9 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.9 0.9 0.0 0.1 0.0 0.0 0.0 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267878-43277650 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.8;pituitary gland: 31.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 60.4;Cone photoreceptor cells: 21.6;Intestinal endocrine cells: 27.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 74.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.4 17.5 5.7 2.2 24.1 1.0 0.9 60.8 54.6 0.9 1.7 0.9 0.0 1.7 0.9 0.9 1.0 0.9 1.0 1.4 12.9 19.9 1.0 0.9 1.8 1.0 5.9 16.0 1.3 4.7 0.9 31.5 1.0 22.3 1.5 1.7 0.4 1.0 9.8 0.9 1.0 1.7 1.5 5.0 0.9 4.6 2.4 1.4 0.0 1.3 0.0 0.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 74.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 24.1 60.8 35.7 12.9 19.9 5.9 16.0 22.3 1.4 0.0 1.4 0.0 0.0 0.1 60.4 2.8 0.0 1.4 4.5 0.0 21.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.8 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYT5 ENSG00000129990 "Synaptotagmin 5" O00445 19 55171199-55180441 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 73.0" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 12.6;Intestinal endocrine cells: 55.3;Late spermatids: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.3;HMC-1: 27.4;K-562: 9.6;OE19: 41.7;SCLC-21H: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA078390 Enhanced NA NA "HPA078390: AB_2732382" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (9.76e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (6.54e-4)" "unprognostic (9.85e-2)" "unprognostic (3.24e-3)" "unprognostic (5.94e-2)" "unprognostic (1.36e-3)" "unprognostic (1.82e-1)" "prognostic favorable (5.54e-4)" "unprognostic (1.15e-3)" "unprognostic (3.71e-7)" "unprognostic (7.09e-2)" "unprognostic (5.21e-2)" "unprognostic (4.42e-2)" "unprognostic (3.55e-1)" 1.2 9.8 20.0 2.7 30.9 1.4 1.0 1.3 73.0 1.8 1.7 1.0 0.0 2.2 1.2 1.0 1.2 1.3 1.3 1.1 22.0 18.8 1.1 1.1 1.2 1.2 6.1 19.8 1.1 2.6 1.1 16.3 1.1 8.3 1.1 1.7 0.0 1.1 1.0 1.2 1.4 1.8 1.5 1.9 1.2 2.9 3.5 3.6 0.0 1.2 0.0 1.3 1.1 0.0 1.0 1.8 3.6 0.8 1.1 0.5 0.5 0.1 0.1 0.2 0.1 0.4 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.5 0.7 12.3 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 27.4 0.3 0.1 0.0 0.0 0.0 0.2 0.2 9.6 1.7 0.0 0.2 0.2 0.0 0.0 41.7 1.7 0.0 0.1 0.1 0.0 0.0 7.2 3.2 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.6 0.6 0.8 0.0 0.1 0.5 0.3 0.2 0.0 0.1 3.6 0.8 1.1 0.4 0.5 0.4 0.7 0.3 0.5 1.8 1.0 0.4 0.5 3.4 1.1 0.4 0.8 0.3 0.5 20.0 30.9 1.3 36.6 22.0 18.8 6.1 19.8 8.3 3.6 0.0 0.0 0.0 0.1 0.6 1.2 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 12.6 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.2 6.4 55.3 0.6 0.0 27.9 0.3 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.4 0.0 0.3 0.0 0.4 4.5 2.6 0.1 0.0 0.5 0.3 0.3 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153919 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;kidney: 3.7;pancreas: 11.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 5.6;Late spermatids: 9.2;Melanocytes: 3.3;Proximal tubular cells: 2.4" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 21.1;WM-115: 14.9" "Group enriched" "Detected in many" 7 "basal ganglia: 27.9;olfactory region: 87.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles NA NA Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.3 2.2 2.6 0.8 6.5 0.3 2.1 0.2 10.4 0.4 0.3 5.1 0.0 0.9 0.4 0.2 0.2 0.3 0.5 0.3 2.3 14.9 3.7 0.3 0.4 0.3 2.8 1.3 2.3 11.1 0.7 0.3 1.4 3.9 1.5 0.6 0.9 1.1 0.2 0.4 0.4 0.5 0.3 4.2 0.3 0.3 0.9 3.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.6 6.5 0.2 9.3 2.3 14.9 2.8 1.3 3.9 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.2 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 SYT7 "IPCA-7, MGC150517, PCANAP7, SYT-VII" ENSG00000011347 "Synaptotagmin 7" O43581 11 61515313-61581148 "Predicted intracellular proteins, Predicted membrane proteins" Exocytosis Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.4;prostate: 36.9;salivary gland: 37.7" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 19.5;Cytotrophoblasts: 35.9;Glandular cells: 42.2;Hepatocytes: 51.0;Horizontal cells: 20.6;Intestinal endocrine cells: 47.8;Mucus-secreting cells: 24.7;Syncytiotrophoblasts: 55.5" "Cancer enhanced" "Detected in all" "prostate cancer: 54.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 15.3;hTERT-HME1: 40.0;RT4: 16.2;SCLC-21H: 12.9;SK-BR-3: 18.2;T-47d: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012869 Enhanced NA NA "HPA012869: AB_1857698" "unprognostic (7.09e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-1)" "unprognostic (2.10e-2)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (4.37e-2)" "unprognostic (5.08e-2)" "unprognostic (2.74e-3)" "unprognostic (1.79e-2)" "unprognostic (1.02e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (2.23e-3)" "unprognostic (2.47e-1)" 2.5 3.7 16.2 1.4 22.7 0.6 6.9 22.8 46.4 2.8 4.0 3.2 0.0 2.1 2.0 1.9 1.9 1.7 1.4 11.1 11.8 7.8 4.4 28.2 1.7 0.8 4.9 23.6 1.2 11.9 2.2 22.2 12.7 8.8 36.9 4.2 2.4 37.7 1.3 2.8 1.6 3.3 1.8 1.5 1.8 3.4 2.5 3.0 0.0 3.5 0.6 0.8 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.7 0.8 0.2 0.0 0.4 6.5 4.6 0.1 15.3 0.2 0.2 1.4 3.0 0.0 0.2 0.1 0.6 3.0 0.4 0.1 0.1 0.1 0.7 0.0 0.6 0.8 0.4 0.0 0.0 0.2 3.6 1.8 40.0 0.0 0.0 0.3 0.0 0.1 0.2 9.5 0.0 0.1 1.0 10.9 6.4 0.0 0.3 0.7 0.0 16.2 12.9 2.3 0.8 18.2 0.1 2.6 17.8 0.0 0.0 3.8 1.4 4.2 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 22.7 22.8 37.5 11.8 7.8 4.9 23.6 8.8 3.0 0.0 0.3 0.0 0.2 0.2 6.6 19.5 0.0 0.0 1.2 5.2 0.0 35.9 5.0 0.8 6.1 2.2 2.1 0.0 1.4 2.2 0.5 42.2 0.0 51.0 3.5 20.6 47.8 3.7 0.6 5.4 3.1 0.0 1.7 0.0 24.7 0.5 1.6 3.5 2.1 0.0 3.1 0.0 0.0 0.3 3.8 0.1 55.5 0.0 1.7 0.6 SYT8 DKFZp434K0322 ENSG00000149043 "Synaptotagmin 8" Q8NBV8 11 1828307-1837521 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.8;skin 1: 41.6;urinary bladder: 31.4" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 164.0;Cholangiocytes: 229.3;Extravillous trophoblasts: 178.7" "Cancer enhanced" "Detected in many" "urothelial cancer: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 27.8;hTCEpi: 44.2;T-47d: 11.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA052700 Uncertain NA NA "HPA052700: AB_2681920" "unprognostic (1.66e-3)" "unprognostic (2.42e-1)" "unprognostic (1.12e-2)" "unprognostic (2.14e-1)" "unprognostic (6.31e-2)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (1.36e-2)" "unprognostic (1.02e-1)" "unprognostic (8.25e-2)" "unprognostic (7.09e-2)" "unprognostic (2.48e-1)" "unprognostic (2.33e-6)" "unprognostic (2.87e-2)" "unprognostic (1.75e-1)" "unprognostic (5.52e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.7 0.9 0.0 6.8 0.7 0.1 7.3 19.9 0.6 61.8 0.1 0.1 0.0 0.5 0.3 2.3 0.0 0.0 0.0 0.1 7.8 0.0 0.1 5.7 0.0 5.6 0.1 0.3 11.8 4.2 0.1 41.6 3.6 6.3 0.1 0.1 3.1 0.1 0.0 0.0 0.1 19.4 13.3 31.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 27.8 0.0 0.0 0.0 0.5 0.5 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 44.2 0.0 5.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.1 0.9 0.0 0.2 0.0 2.4 0.0 0.0 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 3.8 0.0 5.8 164.0 0.0 0.6 229.3 60.2 42.1 5.2 0.0 22.5 0.0 23.0 0.0 0.1 4.5 0.0 8.3 178.7 5.2 0.8 1.1 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.1 0.0 0.6 0.0 21.6 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 41.3 30.8 0.0 1.0 22.4 SYT9 ENSG00000170743 "Synaptotagmin 9" Q86SS6 11 7238778-7469042 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.6" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 10.8;Early spermatids: 13.1;Hepatocytes: 5.0;Late spermatids: 15.3" "Cancer enhanced" "Detected in some" "breast cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEK 293: 8.9;RT4: 15.5;SH-SY5Y: 11.6;TIME: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.47e-1)" "unprognostic (9.41e-2)" "unprognostic (1.39e-5)" "unprognostic (1.63e-1)" "unprognostic (1.12e-1)" "unprognostic (5.50e-2)" "unprognostic (4.62e-2)" "unprognostic (1.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.67e-2)" "unprognostic (1.64e-2)" "unprognostic (1.81e-1)" "unprognostic (3.31e-3)" "unprognostic (4.35e-2)" "unprognostic (1.92e-4)" "unprognostic (1.22e-4)" 0.5 6.0 7.5 0.7 7.4 0.5 2.8 23.6 10.2 1.7 0.8 15.5 5.6 0.5 3.8 0.6 0.5 0.9 0.9 1.4 7.5 5.3 6.0 9.8 0.7 0.5 11.1 5.6 0.8 4.0 1.2 5.1 0.5 7.1 3.5 0.7 3.3 0.7 10.5 0.5 0.7 0.8 1.0 7.9 0.5 0.7 2.8 11.5 0.0 3.6 0.0 0.5 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.0 15.5 2.8 11.6 0.0 0.0 0.0 0.4 0.0 0.0 17.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 7.4 23.6 6.4 7.5 5.3 11.1 5.6 7.1 11.5 0.0 0.0 0.0 0.1 0.0 10.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 0.0 3.2 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.2 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 SYTL2 "CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2" ENSG00000137501 "Synaptotagmin like 2" Q9HCH5 11 85694224-85811159 "Plasma proteins, Predicted intracellular proteins, Transporters" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 65.2" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 139.2;granulocytes: 122.9;Mucus-secreting cells: 160.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 10.5;MAIT T-cell: 17.9" "Lineage enriched" "Detected in many" 6 "T-cells: 17.9" "Cell line enhanced" "Detected in many" "MCF7: 25.3;OE19: 41.5;RH-30: 51.1;RPTEC TERT1: 36.5" "Low region specificity" "Detected in many" HPA039651 Approved Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Nucleoplasm, Golgi apparatus" "Plasma membrane" "HPA039651: AB_10795153" "unprognostic (8.07e-3)" "unprognostic (6.72e-3)" "prognostic favorable (2.67e-4)" "unprognostic (9.34e-4)" "unprognostic (6.60e-3)" "unprognostic (2.19e-4)" "unprognostic (2.24e-2)" "unprognostic (5.37e-2)" "unprognostic (5.56e-2)" "unprognostic (5.45e-2)" "unprognostic (1.92e-2)" "unprognostic (2.97e-2)" "unprognostic (2.85e-2)" "unprognostic (4.03e-1)" "unprognostic (1.87e-2)" "unprognostic (9.72e-2)" "prognostic favorable (9.07e-4)" 12.8 5.5 27.6 11.8 13.9 1.8 9.7 6.8 32.0 6.5 26.3 6.8 2.1 11.4 7.6 11.8 9.6 6.3 15.0 5.7 13.8 9.0 14.5 3.9 8.1 5.7 8.4 21.5 3.7 2.5 7.2 5.5 9.8 12.4 9.9 39.8 5.7 8.4 5.8 3.7 4.6 17.7 7.8 12.8 5.4 65.2 3.2 5.1 5.8 4.2 5.0 3.8 17.2 11.3 0.1 0.7 0.0 0.0 3.0 17.9 1.7 0.9 2.2 3.5 0.3 0.8 4.6 0.0 8.6 11.3 7.6 17.4 9.7 1.3 0.2 3.2 6.0 11.1 6.3 0.2 0.7 10.1 0.6 0.0 0.0 0.0 0.1 0.5 0.7 0.1 5.8 1.1 16.5 0.2 1.8 0.0 0.2 0.1 0.1 9.6 25.3 0.0 0.2 5.9 41.5 3.9 0.3 51.1 0.0 36.5 13.2 0.1 0.1 1.9 1.5 0.8 3.1 0.1 0.1 0.0 12.0 4.6 7.5 0.4 0.0 0.0 4.5 12.3 0.1 7.3 0.0 0.0 0.0 10.5 0.0 17.9 0.0 2.1 6.3 0.0 0.1 1.7 3.1 0.0 3.0 0.0 0.7 0.8 1.7 27.6 13.9 6.8 32.0 13.8 9.0 8.4 21.5 12.4 5.1 20.8 30.4 1.4 10.2 3.2 8.3 1.6 10.2 139.2 38.7 64.6 7.9 0.7 0.0 8.4 1.1 3.6 40.7 0.0 14.7 0.2 9.3 37.7 122.9 0.4 0.5 1.6 18.5 7.4 4.7 0.4 1.7 3.9 10.1 1.0 160.5 13.4 13.2 34.8 28.3 7.7 8.1 32.3 29.7 3.3 2.1 5.0 0.3 30.0 35.7 46.4 SYTL3 "exophilin-6, SLP3" ENSG00000164674 "Synaptotagmin like 3" Q4VX76 6 158650014-158764876 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.6" "Group enriched" "Detected in many" 6 "Ciliated cells: 58.9;granulocytes: 129.6;T-cells: 171.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "basophil: 55.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 55.6" "Cell line enhanced" "Detected in many" "HMC-1: 16.8;SCLC-21H: 11.2;U-138 MG: 12.8;U-2 OS: 13.9;U-266/70: 19.6" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA030584, HPA030585, HPA030586" Approved Approved "Nucleoli fibrillar center,Vesicles" NA Yes "Nucleoli fibrillar center, Vesicles" "HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226" "unprognostic (3.56e-3)" "prognostic favorable (8.84e-5)" "unprognostic (6.37e-2)" "unprognostic (1.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.42e-1)" "unprognostic (7.76e-2)" "unprognostic (5.45e-3)" "unprognostic (9.33e-3)" "unprognostic (1.75e-1)" "unprognostic (3.07e-1)" "unprognostic (5.63e-2)" "unprognostic (8.58e-3)" "unprognostic (1.55e-1)" "unprognostic (6.28e-2)" "unprognostic (2.80e-2)" "unprognostic (1.83e-1)" 8.3 1.5 2.3 9.0 3.7 9.4 3.8 0.8 2.4 5.1 7.4 7.1 0.6 2.9 4.6 5.5 3.6 11.6 7.3 5.3 3.4 2.0 4.7 2.2 20.2 26.7 3.5 1.3 2.5 2.3 0.9 2.1 1.3 5.5 5.3 1.8 4.8 12.4 4.8 11.4 3.0 12.0 3.5 10.4 21.9 5.8 3.2 3.9 2.3 21.7 1.2 24.5 18.8 3.6 0.2 1.3 55.6 4.5 10.9 10.2 4.4 4.9 0.7 0.0 0.3 0.7 0.7 0.2 2.0 1.3 0.5 1.4 0.4 3.9 0.0 0.4 3.4 1.8 0.5 0.1 0.6 2.0 9.7 0.3 3.8 0.1 0.0 1.2 1.0 16.8 2.2 1.5 4.2 0.7 1.8 1.0 0.7 0.2 3.8 5.0 0.2 0.1 1.3 0.1 0.9 0.7 0.0 4.1 0.5 1.9 0.2 11.2 0.8 0.7 7.1 0.5 0.2 1.3 0.2 5.8 12.8 13.9 0.3 0.4 19.6 4.4 0.4 8.2 5.4 0.4 55.6 4.5 0.2 10.2 0.8 6.0 0.2 4.1 6.8 1.3 0.0 4.5 5.5 9.2 10.9 0.3 0.3 4.1 4.4 2.3 3.7 0.8 2.4 3.4 2.0 3.5 1.3 5.5 3.9 14.9 12.5 12.8 3.1 4.0 0.0 4.0 2.5 58.9 20.5 14.0 2.0 1.1 5.0 0.6 6.2 2.4 1.4 0.0 0.5 0.4 2.4 2.4 129.6 0.9 4.2 0.0 0.0 4.3 8.9 9.9 0.0 9.1 10.1 14.4 1.3 0.1 0.4 0.0 0.7 1.4 0.4 0.0 2.5 2.2 6.6 3.9 1.6 171.2 0.4 2.6 SYTL4 ENSG00000102362 "Synaptotagmin like 4" Q96C24 X 100674491-100732123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 67.3;Peritubular cells: 39.3;Sertoli cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.1" "Cell line enhanced" "Detected in many" "HAP1: 15.1;HMC-1: 31.3;RT4: 20.6;TIME: 17.7" "Region enriched" "Detected in single" 5 "hypothalamus: 35.1" "Low region specificity" "Detected in some" "HPA001475, HPA001589, HPA075138" Approved Approved Vesicles NA Yes 6100000 Vesicles "HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: " "unprognostic (7.82e-3)" "unprognostic (1.52e-1)" "unprognostic (3.43e-2)" "unprognostic (6.16e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (1.32e-1)" "unprognostic (3.35e-2)" "unprognostic (2.81e-1)" "unprognostic (1.07e-3)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.60e-2)" 3.8 3.1 9.1 2.8 9.5 1.6 4.4 4.3 8.4 18.1 5.3 6.6 4.8 1.7 36.2 5.4 2.6 10.0 2.9 2.1 11.9 6.0 4.2 7.1 3.0 0.7 9.8 2.7 47.3 8.8 1.3 41.9 2.6 9.4 9.2 6.8 1.3 3.8 6.0 4.5 1.4 3.0 22.5 7.8 2.3 5.3 7.8 9.5 0.0 6.2 1.1 1.4 4.3 9.4 0.5 0.3 5.1 0.3 0.5 0.4 2.3 0.1 3.0 0.8 0.0 4.5 2.5 0.0 3.9 2.5 4.2 7.5 0.3 3.9 0.0 1.0 2.7 3.6 3.5 15.1 1.3 4.4 0.0 1.3 0.0 5.1 0.2 1.1 0.0 31.3 0.9 0.3 3.8 0.2 1.6 10.5 0.0 1.4 0.0 1.9 1.0 0.0 0.0 0.6 10.6 0.0 0.0 1.2 0.0 3.7 20.6 7.6 0.3 1.5 5.9 0.8 1.6 3.7 0.3 17.7 2.2 4.7 10.8 0.9 0.0 0.0 0.0 2.7 0.0 2.4 1.1 0.3 0.5 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.5 0.4 0.2 5.1 0.5 0.2 0.3 0.1 2.3 9.1 9.5 4.3 8.4 11.9 6.0 9.8 2.7 9.4 9.5 26.8 1.7 0.0 6.9 0.1 0.1 3.6 22.9 6.7 6.8 3.5 0.0 0.2 3.3 5.5 1.6 9.5 15.8 0.0 2.0 0.2 6.3 15.5 3.5 32.1 1.0 0.0 0.0 12.3 1.6 2.0 67.3 0.9 3.3 0.0 18.0 4.6 5.4 25.4 39.3 1.6 0.4 51.8 6.2 1.4 4.6 0.6 0.0 0.7 8.1 7.6 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006582-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.0" "Cell type enhanced" "Detected in some" 11 "Club cells: 5.7;Mucus-secreting cells: 10.5;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;MCF7: 5.2;OE19: 7.5;SK-MEL-30: 13.4;SuSa: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.5 6.0 10.5 3.4 11.0 0.0 2.9 0.5 2.5 7.0 7.3 0.5 0.5 2.3 2.6 1.0 12.2 0.2 2.9 0.9 9.2 8.9 1.0 6.1 2.4 0.5 2.4 0.5 0.5 6.4 0.0 1.1 17.0 0.5 2.0 3.5 1.5 7.1 1.7 0.5 0.0 14.3 3.9 1.3 0.8 13.8 0.7 0.5 0.7 0.9 1.2 5.9 1.3 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 0.5 2.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.7 0.1 0.0 0.1 0.1 0.2 5.2 0.0 0.0 2.3 7.5 0.0 0.0 1.9 0.0 0.0 0.4 2.9 0.0 0.3 1.1 13.4 19.0 0.0 0.0 0.0 0.1 4.5 0.0 3.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 11.0 0.5 2.5 9.2 8.9 2.4 0.5 0.5 0.5 0.0 1.3 0.0 0.2 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.8 3.1 0.1 0.9 0.0 0.9 0.2 0.0 2.9 0.6 0.0 0.0 0.6 0.0 0.0 0.0 10.5 0.0 3.5 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.6 0.6 TAAR1 "TA1, TAR1, TRAR1" ENSG00000146399 "Trace amine associated receptor 1" Q96RJ0 6 132644984-132646003 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "stomach 1: 13.6" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;HBF TERT88: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA055614 Approved NA NA "HPA055614: AB_2682862" "unprognostic (2.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (2.68e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 13.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR2 GPR58 ENSG00000146378 "Trace amine associated receptor 2 (gene/pseudogene)" Q9P1P5 6 132617022-132624275 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 2.3" "Cell type enhanced" "Detected in single" 35 "Early spermatids: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAAR6 "TA4, TRAR4" ENSG00000146383 "Trace amine associated receptor 6" Q96RI8 6 132570322-132571359 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "kidney: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "REH: 1.0" "Not detected" "Not detected" NA NA "unprognostic (1.70e-1)" 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAC1 "NKNA, NPK, TAC2" ENSG00000006128 "Tachykinin precursor 1" P20366 7 97731908-97740472 "Predicted secreted proteins" "Neuropeptide, Neurotransmitter" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 61.3;lymphoid tissue: 62.9" "Group enriched" "Detected in some" 7 "Cholangiocytes: 7.6;Glandular cells: 3.3;Proximal tubular cells: 8.4;Smooth muscle cells: 2.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 61.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "U-266/70: 22.5" "Region enhanced" "Detected in many" "basal ganglia: 557.4" "Region enriched" "Detected in many" 9 "basal ganglia: 312.7" HPA014429 Enhanced "Secreted to blood" NA NA "HPA014429: AB_1857722" "unprognostic (9.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (2.08e-1)" "unprognostic (7.95e-2)" "unprognostic (3.24e-1)" "unprognostic (1.70e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (3.86e-2)" 1.8 6.5 4.1 7.7 61.3 0.3 1.7 0.3 39.8 0.7 3.7 0.1 0.0 6.0 0.9 1.6 0.3 0.7 4.9 0.5 9.3 21.5 1.6 0.6 0.3 0.3 8.0 4.5 0.3 0.7 0.3 0.3 0.3 24.5 1.0 2.9 0.3 4.5 2.0 0.4 1.2 7.6 5.3 6.7 62.9 0.9 0.6 9.4 0.0 1.6 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 61.3 0.3 9.2 9.3 21.5 8.0 4.5 24.5 9.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 8.4 0.0 0.0 2.1 0.1 0.4 0.1 0.0 0.0 0.5 0.1 TAC3 "NKB, NKNB, ZNEUROK1" ENSG00000166863 "Tachykinin 3" Q9UHF0 12 57010000-57028883 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 133.5" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 6.9;Extravillous trophoblasts: 8.1;Syncytiotrophoblasts: 15.3" "Cancer enriched" "Detected in many" 7 "urothelial cancer: 40.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "K-562: 15.0;SuSa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045919 Supported Supported Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA045919: AB_10960533" "unprognostic (4.53e-2)" "unprognostic (1.97e-2)" "unprognostic (8.41e-2)" "unprognostic (3.00e-2)" "unprognostic (3.61e-2)" "unprognostic (1.76e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "unprognostic (5.28e-2)" "unprognostic (4.71e-14)" "unprognostic (1.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" 0.5 0.6 3.9 1.5 20.0 0.8 0.5 0.0 11.0 0.5 1.2 0.1 0.0 1.5 0.6 0.5 0.5 0.5 0.6 0.5 4.4 9.5 0.5 0.5 0.5 0.5 0.8 2.1 0.5 0.7 0.5 0.0 133.5 1.5 0.5 1.0 0.3 0.5 0.5 0.5 0.7 3.2 2.0 9.4 0.5 8.1 0.8 0.2 0.0 0.5 0.0 0.6 2.2 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.4 0.0 1.1 0.3 0.0 2.9 0.0 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 15.0 0.4 0.0 0.0 0.0 0.2 2.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 2.5 0.7 0.0 0.9 0.0 15.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 20.0 0.0 11.0 4.4 9.5 0.8 2.1 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 8.1 0.0 0.0 0.0 0.0 2.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 15.3 0.0 1.7 0.0 TAC4 "HK-1, PPT-C, Pptc" ENSG00000176358 "Tachykinin 4" Q86UU9 17 49838309-49848017 "Predicted secreted proteins" "Hypotensive agent" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 4.7;pituitary gland: 10.4" "Group enriched" "Detected in some" 16 "Cardiomyocytes: 1.1;Smooth muscle cells: 2.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.5;BEWO: 10.7;CACO-2: 6.2" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "unprognostic (4.49e-2)" "unprognostic (8.14e-2)" "unprognostic (8.95e-2)" "unprognostic (1.71e-1)" "unprognostic (6.24e-2)" "unprognostic (8.15e-2)" "unprognostic (5.61e-2)" "unprognostic (6.05e-3)" "unprognostic (3.19e-1)" "unprognostic (2.00e-1)" "unprognostic (4.52e-2)" "unprognostic (4.69e-3)" "unprognostic (8.19e-5)" "unprognostic (8.69e-2)" "unprognostic (2.23e-1)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 0.4 0.6 0.4 0.5 0.4 1.2 0.4 0.4 0.4 0.5 0.4 0.4 0.4 0.3 0.4 0.4 1.4 0.2 0.4 2.2 0.4 0.1 0.4 4.7 0.5 0.7 0.4 0.4 0.4 0.4 0.0 10.4 0.4 0.4 0.4 0.0 0.4 1.0 0.4 0.4 4.0 0.4 0.4 0.4 1.3 0.7 0.5 0.4 0.4 1.1 0.4 0.4 0.9 0.4 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.1 0.7 0.0 0.0 10.7 0.0 0.0 0.0 0.0 6.2 0.4 0.0 1.9 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.7 1.2 0.2 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.2 1.0 0.3 0.4 0.6 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.1 0.1 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.8 1.7 0.6 0.5 0.0 0.9 0.4 0.3 0.2 0.3 1.0 0.4 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TACC2 AZU-1 ENSG00000138162 "Transforming acidic coiled-coil containing protein 2" O95359 10 121989174-122254545 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 109.4" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 186.1;Syncytiotrophoblasts: 191.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 36.6" "Low region specificity" "Detected in all" "HPA031020, HPA031021, HPA061394" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 110000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500" "unprognostic (3.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.75e-2)" "unprognostic (7.07e-2)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (9.15e-2)" "unprognostic (8.43e-3)" "unprognostic (1.14e-1)" "unprognostic (3.51e-1)" "unprognostic (2.13e-1)" "unprognostic (1.83e-2)" "prognostic favorable (2.50e-10)" "unprognostic (7.02e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (8.45e-4)" "unprognostic (1.61e-1)" 8.2 5.8 9.6 2.4 11.7 0.6 7.8 17.7 16.6 6.9 17.2 2.6 4.0 6.3 8.4 4.3 13.4 9.6 7.7 43.3 8.0 4.8 19.3 3.8 54.1 0.8 3.1 9.0 4.7 6.3 11.9 41.0 45.4 6.8 12.0 8.6 4.8 18.5 6.0 109.4 28.9 8.2 8.9 3.2 1.3 10.2 2.2 3.9 0.1 19.6 4.4 2.5 15.1 8.8 0.1 0.1 0.3 0.0 0.1 0.2 0.0 7.2 22.8 11.2 6.4 3.2 3.2 13.6 3.2 8.6 4.4 3.1 9.3 12.0 0.0 2.9 5.0 5.1 24.3 3.5 8.6 4.6 1.2 1.8 0.0 2.8 17.7 4.9 0.0 0.1 1.4 36.6 2.4 15.6 3.6 9.2 0.0 1.8 0.2 4.3 9.5 0.0 4.0 6.6 11.2 10.4 0.1 6.4 3.4 12.0 11.1 7.5 6.1 5.2 21.8 11.6 3.4 4.3 0.1 8.5 2.0 1.5 4.9 5.9 1.0 4.5 0.1 3.7 0.0 5.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 9.6 11.7 17.7 16.6 8.0 4.8 3.1 9.0 6.8 3.9 77.4 80.3 0.8 44.9 29.9 18.8 186.1 7.6 88.3 50.0 34.9 0.0 36.8 1.7 7.5 1.6 14.3 44.5 0.0 12.6 2.8 12.8 69.9 6.9 14.5 5.4 41.3 28.8 7.4 0.0 2.1 6.4 3.5 6.8 0.0 35.8 1.1 14.9 38.5 7.1 9.8 2.5 12.9 35.4 0.5 4.3 47.2 191.1 2.5 36.7 77.4 TACC3 ERIC1 ENSG00000013810 "Transforming acidic coiled-coil containing protein 3" Q9Y6A5 4 1721490-1745176 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 54.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005781, HPA006050, CAB010111, HPA022039" Enhanced Enhanced "Vesicles,Mitotic spindle,Centriolar satellite,Cytosol" Yes Yes "Mitotic spindle, Centriolar satellite, Cytosol" Vesicles "CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725" "unprognostic (2.95e-1)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (4.35e-2)" "unprognostic (6.58e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.30e-4)" "unprognostic (1.10e-3)" "unprognostic (4.61e-2)" "unprognostic (9.12e-2)" "unprognostic (2.91e-2)" "unprognostic (2.26e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.66e-2)" "unprognostic (2.09e-1)" "unprognostic (4.44e-3)" "unprognostic (9.75e-2)" 3.8 2.7 1.1 39.1 1.1 26.0 3.4 2.1 1.4 1.9 4.4 1.1 0.8 4.5 1.8 2.7 8.8 1.6 3.5 2.0 1.4 1.3 2.5 2.4 4.3 20.1 1.3 0.7 1.6 1.0 0.5 1.8 5.7 1.1 1.6 4.9 1.6 3.0 1.2 2.0 2.6 7.7 2.5 1.8 15.6 3.4 58.1 0.9 64.3 1.6 7.3 27.9 3.2 3.0 4.0 10.4 54.8 19.9 3.8 17.9 16.1 25.4 21.2 32.5 18.6 1.7 3.6 18.3 28.9 15.5 33.2 22.0 23.5 30.8 32.5 12.3 15.7 38.6 17.2 34.3 21.0 33.8 14.3 18.6 27.5 17.6 21.6 1.6 37.2 23.4 1.5 1.4 20.9 12.1 7.3 25.2 26.8 24.8 25.7 31.4 20.8 49.0 53.3 35.1 21.8 27.9 34.8 23.0 13.0 18.8 38.6 25.3 15.9 17.4 11.0 8.1 25.5 21.6 21.6 14.7 19.4 23.2 17.5 43.5 18.0 23.9 52.1 11.2 36.0 27.4 24.7 19.9 17.9 5.5 9.0 6.0 4.0 12.3 7.6 10.4 3.8 17.9 9.8 54.8 3.8 5.5 3.1 17.5 16.1 1.1 1.1 2.1 1.4 1.4 1.3 1.3 0.7 1.1 0.9 0.0 7.9 16.0 0.5 1.9 1.0 2.2 0.0 0.0 4.5 8.7 7.9 3.3 0.0 2.1 43.8 2.5 2.0 23.3 0.6 16.5 2.6 1.0 4.7 4.3 35.7 4.8 1.2 4.9 20.5 49.1 2.6 21.9 0.0 12.6 3.1 1.4 1.9 3.5 2.5 1.8 3.2 6.5 1.0 69.6 47.8 1.3 3.3 15.3 5.7 1.3 TACR1 "NK1R, NKIR, SPR, TAC1R" ENSG00000115353 "Tachykinin receptor 1" P25103 2 75046463-75199700 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.9" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 2.3;Cone photoreceptor cells: 2.0;Melanocytes: 6.8;Rod photoreceptor cells: 2.6;Suprabasal keratinocytes: 1.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 40 "basophil: 4.4" "Lineage enriched" "Detected in single" 40 "granulocytes: 4.4" "Cell line enhanced" "Detected in some" "BJ: 1.3;EFO-21: 3.2;fHDF/TERT166: 2.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074573 Enhanced NA NA "HPA074573: AB_2686701" "unprognostic (5.74e-4)" "unprognostic (2.41e-3)" "unprognostic (1.46e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (8.62e-3)" "unprognostic (1.10e-1)" "unprognostic (3.33e-2)" "unprognostic (4.38e-2)" "unprognostic (1.46e-1)" "unprognostic (2.14e-3)" "unprognostic (1.63e-2)" "unprognostic (5.91e-4)" "unprognostic (1.03e-2)" "unprognostic (2.75e-1)" "unprognostic (1.06e-1)" "unprognostic (2.76e-2)" 23.9 1.0 2.0 1.8 8.5 0.3 8.2 0.3 4.8 15.2 1.9 0.1 1.5 0.8 17.7 3.6 4.8 6.9 2.5 0.9 1.5 2.5 1.5 0.4 2.1 2.9 0.9 1.0 4.2 0.7 1.3 1.1 1.6 2.3 6.1 1.4 0.3 2.6 2.5 2.6 8.7 1.4 6.5 0.9 0.4 1.2 2.0 1.5 0.2 1.1 4.3 3.4 4.8 14.3 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 1.1 0.0 0.5 3.2 2.7 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.8 0.3 0.3 0.6 0.1 0.4 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 1.0 0.0 0.8 0.1 0.1 0.0 0.5 0.0 0.0 0.5 0.1 0.0 0.0 1.2 0.1 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 8.5 0.3 3.6 1.5 2.5 0.9 1.0 2.3 1.5 0.0 0.0 0.0 0.0 2.3 0.5 0.8 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.1 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416867 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.3;smooth muscle: 35.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 2.7;Horizontal cells: 6.4;Kupffer cells: 2.2;Leydig cells: 2.6" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SK-MEL-30: 8.7;U-87 MG: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" NA NA "Plasma membrane" "HPA076573: AB_2732313" "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 1.6 0.1 0.5 3.1 0.5 0.1 1.2 0.5 1.1 11.1 56.3 0.2 0.4 4.1 12.3 0.9 19.6 7.2 1.2 1.9 0.5 0.3 0.2 0.5 0.8 0.5 0.2 0.4 2.0 0.8 0.0 0.1 0.1 0.4 14.9 8.2 0.2 0.4 0.9 1.1 0.4 14.2 35.5 0.8 0.5 16.5 0.9 0.5 0.1 0.4 0.8 0.4 19.4 3.1 1.2 2.0 0.5 4.2 0.1 0.8 0.3 2.0 1.2 0.4 0.7 3.1 0.2 0.2 0.5 0.3 0.5 0.7 0.7 0.4 0.2 0.5 0.5 0.7 0.8 0.1 0.1 0.0 0.4 0.5 1.6 0.6 1.9 0.3 0.0 3.1 0.5 0.7 0.0 0.1 0.8 0.2 0.1 0.4 2.5 0.0 0.8 0.1 0.5 0.4 1.7 1.9 0.1 0.0 0.0 0.0 1.0 0.8 0.6 1.3 2.7 8.7 0.4 1.2 0.2 0.8 3.1 0.4 1.3 1.1 1.2 1.3 0.2 5.0 0.3 1.8 0.5 1.5 0.1 0.3 4.2 0.4 1.2 0.8 0.3 2.0 0.6 0.4 0.2 0.2 0.1 1.7 0.3 0.1 0.3 0.5 0.5 0.5 1.1 0.5 0.3 0.2 0.4 0.4 0.5 0.0 0.3 0.0 0.2 0.6 0.2 0.5 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 1.1 6.4 0.0 1.3 2.2 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.3 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.4 0.4 TACR3 NK3R ENSG00000169836 "Tachykinin receptor 3" P29371 4 103586031-103719816 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.4;urinary bladder: 5.5" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 1.1;Extravillous trophoblasts: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 14.4;hypothalamus: 4.1;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "BEWO: 12.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA009418 Uncertain NA NA "HPA009418: AB_1857727" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (3.21e-1)" "unprognostic (5.52e-1)" "unprognostic (3.80e-1)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 0.1 0.1 14.4 0.1 1.4 0.1 0.4 0.0 2.6 0.1 0.4 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.3 0.1 1.1 4.1 2.0 0.1 0.9 0.1 1.4 1.0 0.1 0.1 0.1 0.1 0.6 6.3 0.2 0.5 3.2 0.1 0.1 0.7 0.3 0.1 0.1 2.5 0.1 0.5 0.6 0.0 0.0 0.5 0.9 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 1.4 0.0 1.5 1.1 4.1 1.4 1.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell type enhanced" "Detected in many" 15 "Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Cell line enhanced" "Detected in some" "A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favorable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 75.7 0.0 0.0 0.1 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 9.9 6.4 0.0 102.9 0.0 18.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 1.1 0.0 4.3 0.0 0.0 0.1 0.0 16.3 0.0 0.1 0.0 16.7 0.1 0.0 0.0 0.0 13.8 35.5 0.0 0.0 3.3 27.4 0.1 0.3 17.9 0.1 4.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 321.6 110.2 1.3 5162.0 1324.0 0.0 0.3 287.9 277.1 312.8 1212.6 0.0 74.9 36.5 1546.3 0.0 14.3 0.4 0.0 1122.5 4.7 23.0 2977.4 8.1 0.6 7.6 0.0 0.0 0.6 0.3 0.0 0.0 32.3 108.0 54.1 2.9 0.0 1294.2 4.0 0.0 3.3 0.0 0.0 47.2 0.5 0.9 1339.0 65.6 0.0 0.9 7434.9 TAF1L ENSG00000122728 "TATA-box binding protein associated factor 1 like" Q8IZX4 9 32629454-32635669 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 6.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.8;Early spermatids: 3.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 11 "U-87 MG: 4.5" HPA056605 Uncertain NA NA "HPA056605: AB_2683186" "unprognostic (7.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.73e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-1)" "unprognostic (5.79e-2)" "unprognostic (4.35e-2)" "unprognostic (1.25e-1)" "unprognostic (9.13e-2)" "unprognostic (1.60e-1)" "unprognostic (9.55e-3)" "unprognostic (1.68e-1)" "unprognostic (8.33e-2)" "unprognostic (4.07e-1)" "unprognostic (4.86e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 0.3 1.2 0.2 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.3 0.2 0.0 4.5 0.1 0.0 1.0 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.3 0.2 0.4 1.2 0.4 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 13.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 1.7 0.9 0.0 0.0 0.0 0.0 0.0 TAF5 "TAF2D, TAFII100" ENSG00000148835 "TATA-box binding protein associated factor 5" Q15542 10 103367967-103389065 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.5" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 27.4;Spermatogonia: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006195, HPA006474" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA006195: AB_1080188, HPA006474: AB_1080185" "unprognostic (3.09e-2)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (3.18e-3)" "unprognostic (3.59e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "unprognostic (5.36e-3)" "unprognostic (2.21e-1)" "unprognostic (1.18e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (1.36e-9)" "prognostic favorable (7.39e-5)" "unprognostic (2.79e-2)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" 5.3 3.6 4.0 5.8 5.9 7.9 6.3 13.8 7.7 5.3 5.8 3.8 3.7 5.5 5.2 3.5 5.0 4.1 3.2 3.4 5.2 3.5 3.5 5.0 3.9 7.6 3.8 3.9 6.1 7.9 3.4 7.5 6.6 6.3 4.2 6.1 2.1 4.4 4.5 5.5 4.7 4.7 4.4 5.4 6.2 4.3 25.5 5.6 14.0 4.4 2.5 7.9 4.1 7.3 3.2 1.3 2.5 1.8 1.1 3.4 0.6 6.7 3.1 7.7 13.9 4.4 3.6 9.0 4.8 5.5 7.0 8.8 6.1 3.5 16.1 2.8 2.5 4.0 6.8 12.9 2.6 8.9 5.9 11.2 7.4 3.6 6.0 2.0 14.2 8.0 1.6 1.9 4.1 4.4 2.9 5.2 7.2 10.5 8.1 4.6 4.4 11.5 18.7 9.4 8.6 4.1 9.8 9.4 4.9 1.9 2.0 5.4 6.0 3.1 2.3 2.8 7.7 2.7 5.9 3.0 4.1 5.2 4.6 8.5 4.6 5.5 9.9 2.3 17.0 2.6 0.6 1.8 2.5 1.5 0.6 1.3 0.4 1.4 2.8 1.0 3.2 3.4 2.0 0.3 1.1 1.1 1.3 3.4 0.6 4.0 5.9 13.8 7.7 5.2 3.5 3.8 3.9 6.3 5.6 6.0 1.6 8.0 4.6 12.8 6.2 2.4 2.5 0.0 3.4 1.8 5.9 3.9 3.3 2.3 13.3 3.6 2.6 0.0 1.9 7.3 3.8 2.9 9.2 2.6 3.2 1.6 2.4 1.8 1.5 10.2 1.7 4.5 1.7 1.0 2.4 1.8 1.6 2.9 2.5 0.6 6.6 0.0 6.9 27.4 43.6 12.4 5.7 5.0 3.3 2.7 TAF7L "CT40, TAF2Q" ENSG00000102387 "TATA-box binding protein associated factor 7 like" Q5H9L4 X 101268253-101293057 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 36.1" "Group enriched" "Detected in some" 6 "Early spermatids: 20.1;Late spermatids: 11.5;Spermatocytes: 29.8;Spermatogonia: 20.2" "Cancer enhanced" "Detected in some" "cervical cancer: 2.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 10 "basophil: 1.6" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 17 "SiHa: 36.0" "Low region specificity" "Detected in all" "HPA001879, HPA072008" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA001879: AB_1857751, HPA072008: " "unprognostic (1.70e-2)" "prognostic favorable (8.71e-4)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (2.52e-2)" "unprognostic (4.97e-3)" "unprognostic (3.87e-3)" "unprognostic (1.72e-1)" "unprognostic (4.67e-3)" "unprognostic (2.16e-1)" "unprognostic (3.29e-1)" "unprognostic (1.36e-1)" "unprognostic (3.49e-3)" "unprognostic (6.76e-2)" "unprognostic (2.88e-1)" "unprognostic (5.97e-2)" "unprognostic (1.12e-2)" 0.1 0.0 1.4 0.1 1.7 0.2 0.1 0.1 0.6 1.6 0.5 0.2 0.1 0.0 0.7 3.5 0.1 0.0 0.1 0.1 0.8 0.2 0.3 0.5 0.1 0.1 0.1 0.8 0.1 0.1 2.5 0.2 0.4 0.3 1.8 0.0 0.4 0.1 1.8 0.1 0.6 0.3 0.1 0.4 0.1 0.1 36.1 0.1 0.1 0.1 0.1 0.1 0.2 0.5 0.1 0.1 1.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.7 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.6 0.0 0.1 0.2 0.1 1.7 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 36.0 0.2 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.4 1.7 0.1 0.6 0.8 0.2 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 20.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 2.4 0.1 0.0 0.0 0.6 0.0 11.5 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.2 29.8 20.2 0.1 1.4 0.0 0.0 0.0 TAGAP "ARHGAP47, FLJ32631, IDDM21" ENSG00000164691 "T cell activation RhoGTPase activating protein" Q8N103 6 159034468-159045152 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7" "Cell type enhanced" "Detected in many" 13 "B-cells: 68.1;Macrophages: 53.7;T-cells: 89.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.4;HMC-1: 21.0;Karpas-707: 21.9;U-266/84: 9.8;U-698: 20.2;U-937: 16.1" "Low region specificity" "Detected in all" "HPA031000, HPA039982" Uncertain Approved Cytosol NA NA Cytosol "HPA031000: AB_10610560, HPA039982: " "unprognostic (9.86e-3)" "unprognostic (7.55e-2)" "unprognostic (2.41e-2)" "unprognostic (1.56e-2)" "unprognostic (6.36e-2)" "unprognostic (3.10e-3)" "unprognostic (1.04e-1)" "unprognostic (5.25e-2)" "unprognostic (3.35e-3)" "unprognostic (8.39e-2)" "unprognostic (6.19e-2)" "unprognostic (2.41e-1)" "unprognostic (1.49e-1)" "unprognostic (7.25e-2)" "unprognostic (1.15e-1)" "unprognostic (5.24e-2)" "unprognostic (7.39e-2)" 4.4 2.3 1.5 16.9 2.1 55.6 2.5 0.9 2.0 1.9 2.5 7.9 1.3 1.7 9.7 1.8 2.7 2.1 4.1 2.0 1.9 3.7 2.2 2.4 8.4 32.7 5.0 1.1 1.9 1.0 0.4 1.4 2.8 3.9 1.9 3.6 3.2 3.2 1.8 0.8 1.4 11.8 12.2 9.2 22.1 2.7 1.7 3.0 32.6 2.2 4.0 32.1 6.8 1.9 14.9 7.8 47.9 7.7 12.0 22.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.2 0.0 0.0 0.0 7.4 21.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 21.9 0.0 0.0 1.9 3.9 5.9 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 3.4 0.1 0.0 0.0 0.0 0.0 2.4 9.8 20.2 0.0 16.1 0.0 38.7 7.7 23.6 16.4 5.5 18.5 13.9 22.0 19.0 7.8 14.9 17.4 12.1 47.9 12.0 7.0 2.6 15.5 14.4 1.5 2.1 0.9 2.0 1.9 3.7 5.0 1.1 3.9 3.0 3.0 10.0 68.1 0.2 2.5 0.1 0.4 0.0 1.4 1.2 0.0 0.0 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.4 3.7 0.4 18.5 0.8 23.7 0.0 0.0 1.8 19.5 0.9 1.1 53.7 27.0 0.0 0.0 0.3 0.0 0.0 21.2 0.2 0.1 0.0 0.3 0.0 0.1 2.4 0.7 89.6 0.0 0.3 TAGLN3 "NP22, NP25" ENSG00000144834 "Transgelin 3" Q9UI15 3 111998664-112013887 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 139.0" "Group enriched" "Detected in some" 5 "Bipolar cells: 84.8;Horizontal cells: 281.3" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 39.4;RPTEC TERT1: 16.1;SCLC-21H: 21.5;SH-SY5Y: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062620 Enhanced NA NA "HPA062620: AB_2684810" "unprognostic (1.55e-2)" "unprognostic (2.28e-1)" "unprognostic (1.81e-1)" "unprognostic (1.36e-3)" "unprognostic (4.28e-1)" "unprognostic (4.07e-1)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (8.92e-2)" "unprognostic (6.82e-3)" "unprognostic (2.51e-1)" "unprognostic (5.49e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (8.60e-2)" "unprognostic (7.67e-3)" 1.7 21.9 47.3 2.4 40.6 1.5 1.6 40.2 139.0 1.5 2.7 4.6 0.0 1.9 1.6 1.5 1.6 1.6 1.7 1.7 32.9 37.9 4.2 1.5 1.8 1.6 30.5 33.2 1.6 4.6 1.6 13.5 1.5 29.8 1.7 2.9 2.3 1.5 1.7 1.5 1.6 2.2 2.2 8.3 1.5 3.7 1.6 2.7 0.0 1.8 0.0 1.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.1 0.1 0.0 1.5 0.0 0.0 0.2 0.0 2.8 0.5 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.5 0.0 3.5 5.4 1.0 0.0 16.1 0.0 21.5 36.3 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 40.6 40.2 65.7 32.9 37.9 30.5 33.2 29.8 2.7 0.0 0.0 0.0 0.8 0.7 84.8 0.3 0.0 10.7 2.3 5.2 7.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.2 0.8 0.0 0.0 0.1 281.3 5.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 14.5 3.6 0.0 0.0 4.7 33.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 TAL1 "bHLHa17, SCL, TCL5" ENSG00000162367 "TAL bHLH transcription factor 1, erythroid differentiation factor" P17542 1 47216290-47232220 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 33.1" "Cell type enhanced" "Detected in some" 22 "Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 3.2;neutrophil: 1.2" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0" "Region enriched" "Detected in some" 5 "midbrain: 17.1" "Low region specificity" "Detected in many" "CAB017805, HPA047866, HPA073983" Approved Enhanced Nucleoplasm Yes NA Nucleoplasm "CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246" "unprognostic (2.63e-1)" "unprognostic (2.62e-2)" "unprognostic (1.22e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-1)" "unprognostic (8.80e-3)" "unprognostic (3.95e-3)" "unprognostic (1.33e-1)" "unprognostic (4.15e-2)" "unprognostic (1.99e-2)" "unprognostic (5.42e-3)" "unprognostic (3.68e-1)" "unprognostic (1.02e-2)" "unprognostic (2.76e-2)" "unprognostic (2.19e-1)" "unprognostic (1.51e-1)" "unprognostic (1.18e-2)" 9.1 2.7 7.0 1.8 5.7 33.1 7.1 1.6 6.9 3.3 2.4 12.0 2.3 1.6 3.7 3.3 2.5 4.1 4.2 3.9 8.8 3.5 4.5 2.4 14.6 2.2 11.1 4.4 1.5 1.3 2.2 2.1 9.8 7.3 2.4 2.4 2.1 1.4 3.0 3.1 2.0 3.3 4.4 9.4 8.5 2.1 1.8 9.2 0.0 6.7 4.1 1.5 2.5 5.5 0.3 0.1 3.2 0.3 0.4 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 11.0 21.1 16.5 0.0 0.0 0.0 8.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 1.2 0.4 0.1 0.1 0.1 2.2 7.0 5.7 1.6 6.9 8.8 3.5 11.1 4.4 7.3 9.2 0.0 0.0 0.0 0.0 0.8 0.0 1.7 2.5 0.0 2.3 1.8 0.0 0.1 0.0 0.0 4.8 18.0 0.0 93.5 0.0 0.1 0.9 0.0 35.8 0.0 7.9 0.0 0.0 30.7 2.1 10.2 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.4 0.9 0.0 0.0 0.0 0.0 TAL2 bHLHa19 ENSG00000186051 "TAL bHLH transcription factor 2" Q16559 9 105662457-105663112 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "blood: 8.8;kidney: 4.6;skeletal muscle: 17.3" "Cell type enhanced" "Detected in some" 16 "Cone photoreceptor cells: 3.9;Distal tubular cells: 6.6;Intestinal endocrine cells: 3.4;Muller glia cells: 1.8" "Cancer enhanced" "Detected in some" "renal cancer: 1.6" "Group enriched" "Detected in some" 21 "memory B-cell: 8.8;naive B-cell: 7.9;plasmacytoid DC: 2.2" "Group enriched" "Detected in many" 18 "B-cells: 8.8;dendritic cells: 2.2" "Cell line enhanced" "Detected in some" "CACO-2: 3.4;HAP1: 4.9;K-562: 12.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA030886 Uncertain Approved Cytosol NA NA Cytosol "HPA030886: AB_10601596" "unprognostic (3.89e-2)" "unprognostic (1.45e-1)" "unprognostic (8.51e-2)" "unprognostic (5.54e-2)" "unprognostic (2.24e-1)" "unprognostic (9.06e-2)" "unprognostic (4.98e-2)" "unprognostic (1.03e-1)" "unprognostic (2.70e-3)" "unprognostic (2.63e-1)" "unprognostic (7.00e-4)" "unprognostic (2.84e-2)" "prognostic favorable (2.69e-4)" "unprognostic (2.70e-2)" "unprognostic (1.24e-1)" "unprognostic (1.29e-1)" "unprognostic (7.39e-2)" 0.1 0.3 0.5 0.1 0.7 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.2 0.9 0.1 0.2 0.0 0.3 0.4 0.5 4.6 0.3 0.0 0.2 0.7 0.3 0.1 0.0 0.8 0.1 0.1 0.1 0.0 0.2 17.3 0.1 0.1 0.0 0.8 0.3 0.0 0.6 0.1 0.4 0.1 0.0 8.8 2.2 0.0 0.0 0.3 0.0 0.1 0.0 0.7 2.5 0.7 0.3 0.0 0.3 0.1 0.3 0.1 0.4 3.4 0.2 0.1 0.3 0.0 0.7 0.1 4.9 0.0 0.2 0.6 0.5 1.1 0.0 0.0 0.2 0.6 1.9 0.3 0.6 0.1 0.2 0.2 0.0 0.8 12.9 0.3 0.4 0.3 0.8 0.7 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 2.9 1.2 0.2 0.3 0.2 0.1 0.2 2.1 0.5 0.3 0.8 0.7 1.1 1.0 2.0 0.1 0.2 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.9 0.0 6.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 0.4 1.1 0.9 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 TALDO1 ENSG00000177156 "Transaldolase 1" P37837 11 747329-765024 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pentose shunt" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.6" "Cell type enhanced" "Detected in all" 6 "monocytes: 1009.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 148.6;neutrophil: 204.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048089 Approved Nucleoplasm,Cytosol NA NA 39000000 Nucleoplasm Cytosol "HPA048089: AB_2680260" "unprognostic (5.29e-2)" "unprognostic (1.78e-2)" "unprognostic (3.47e-1)" "unprognostic (9.65e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.78e-2)" "unprognostic (4.27e-2)" "unprognostic (1.74e-1)" "unprognostic (7.97e-3)" "unprognostic (2.94e-1)" "unprognostic (1.59e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (2.37e-1)" "unprognostic (1.16e-3)" 39.0 24.2 26.6 34.8 31.3 117.4 44.2 20.6 38.3 27.7 28.5 51.2 18.8 34.2 20.4 20.7 90.0 23.2 33.2 37.5 29.2 23.6 45.8 48.4 37.9 60.0 46.5 26.6 23.4 31.9 14.6 15.8 34.3 30.7 28.3 23.7 15.5 38.3 19.5 31.2 38.4 29.4 40.4 47.5 45.6 35.8 14.8 33.0 34.1 42.2 82.4 43.1 51.4 37.5 8.5 36.1 204.6 60.8 5.9 10.4 45.3 42.2 53.5 15.5 29.3 32.1 18.7 45.7 32.1 41.4 31.8 26.3 22.7 92.2 23.6 43.7 42.1 24.6 45.7 24.5 34.7 16.6 30.8 49.7 40.8 20.7 79.4 34.3 65.2 60.9 15.3 28.0 21.4 17.4 23.0 43.7 29.8 52.9 39.5 29.5 40.4 37.9 77.3 24.3 62.0 43.4 31.6 18.2 84.5 57.8 24.6 38.3 13.4 30.0 62.0 31.1 14.4 29.4 49.6 58.0 14.6 13.7 11.5 30.1 16.7 16.2 28.0 32.4 57.0 58.9 64.7 60.8 148.6 5.6 23.2 6.1 8.5 7.5 6.8 36.1 6.8 6.1 5.7 204.6 5.9 23.2 14.8 10.4 45.3 26.6 31.3 20.6 38.3 29.2 23.6 46.5 26.6 30.7 33.0 131.0 100.4 88.6 136.2 65.4 45.6 40.9 122.3 141.8 86.4 143.1 13.7 355.3 212.2 199.7 61.7 74.4 141.1 280.4 236.4 383.3 78.6 213.8 155.0 128.2 368.8 47.7 97.4 79.8 301.9 17.2 109.0 235.0 133.3 1009.1 137.9 126.1 238.1 181.4 97.9 218.5 43.3 71.1 73.5 122.7 154.7 72.6 440.3 79.1 199.9 251.7 TANC2 "DKFZP564D166, FLJ10215, FLJ11824, KIAA1148, KIAA1636, rols, ROLSA" ENSG00000170921 "Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2" Q9HCD6 17 63009556-63427699 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 31.6" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 43.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023274 Uncertain Approved Cytosol NA NA Cytosol "HPA023274: AB_2199727" "unprognostic (8.37e-2)" "unprognostic (4.15e-2)" "unprognostic (2.21e-2)" "unprognostic (1.57e-4)" "unprognostic (1.51e-1)" "unprognostic (4.09e-2)" "unprognostic (9.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.09e-2)" "unprognostic (5.52e-2)" "unprognostic (2.62e-1)" "unprognostic (2.69e-1)" "unprognostic (2.02e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-1)" "unprognostic (1.57e-1)" "unprognostic (2.01e-1)" 3.4 3.9 4.4 3.1 8.5 6.2 2.7 2.1 19.5 4.5 1.5 2.8 1.5 1.0 2.7 7.0 3.4 2.5 3.1 2.0 5.2 5.4 3.1 1.5 7.9 1.5 5.2 3.5 3.0 2.3 31.6 5.1 2.8 2.7 2.6 1.1 1.9 3.5 3.4 1.5 4.8 2.0 4.1 7.5 2.7 1.8 10.9 3.4 4.6 2.1 4.4 1.9 6.4 2.9 0.8 1.6 1.1 0.1 2.9 2.2 0.1 12.2 11.6 7.2 1.2 3.7 8.9 13.9 7.8 7.8 7.8 9.7 0.6 3.6 0.0 2.4 13.4 9.9 1.7 11.6 23.1 17.7 4.7 5.3 18.0 17.1 0.6 3.2 4.8 0.0 13.6 13.5 9.1 26.3 8.6 2.4 4.7 2.2 0.0 11.1 9.4 3.1 0.8 0.8 2.2 7.6 2.5 14.4 0.9 6.9 17.0 12.2 13.4 4.4 8.3 3.4 13.1 3.8 1.3 12.5 19.1 10.0 1.2 9.6 0.0 0.0 0.0 7.0 1.3 6.8 0.0 0.1 0.0 2.2 0.1 1.7 0.1 1.2 1.7 0.1 0.8 0.5 1.1 1.1 2.9 0.0 1.6 0.0 0.1 4.4 8.5 2.1 19.5 5.2 5.4 5.2 3.5 2.7 3.4 14.9 41.2 2.0 9.1 22.2 43.0 3.6 10.2 4.0 13.6 26.2 15.7 6.7 1.7 8.8 14.2 9.5 0.5 0.0 12.1 32.1 4.6 8.9 0.0 0.8 7.2 7.9 4.1 16.0 7.8 8.0 5.2 16.1 10.1 13.6 3.9 3.7 20.4 2.9 3.2 1.4 6.8 19.4 4.1 18.0 14.6 13.9 13.7 7.5 1.5 9.6 TANGO2 "C22orf25, DKFZp761P1121" ENSG00000183597 "Transport and golgi organization 2 homolog" Q6ICL3 22 20017014-20065926 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 54.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003080 Approved NA NA 120000 "HPA003080: AB_1078350" "unprognostic (4.05e-1)" "unprognostic (1.90e-3)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (3.48e-1)" "unprognostic (1.37e-1)" "unprognostic (2.64e-2)" "unprognostic (1.54e-2)" "unprognostic (6.13e-2)" "unprognostic (6.76e-2)" "prognostic favorable (3.01e-4)" "unprognostic (2.21e-1)" "unprognostic (1.83e-3)" "unprognostic (3.95e-2)" "unprognostic (5.49e-2)" "unprognostic (2.60e-1)" "unprognostic (2.62e-2)" 10.2 15.5 13.1 10.7 18.0 31.8 9.7 11.5 21.0 6.6 9.7 15.3 8.1 8.0 7.6 7.9 7.1 7.4 9.0 54.0 13.7 14.2 11.9 10.7 11.6 12.3 25.0 12.3 5.2 9.0 11.3 11.4 9.1 16.6 9.6 9.0 12.9 7.1 10.5 17.2 7.9 9.2 9.2 14.5 20.0 11.1 5.9 16.8 5.4 18.5 6.6 9.3 10.5 13.0 7.7 16.1 28.4 25.6 11.9 10.9 13.5 8.6 7.9 2.8 5.8 19.5 6.7 5.3 8.7 11.3 8.2 7.2 5.8 6.7 3.3 6.5 22.8 11.4 11.5 6.8 9.7 5.1 20.0 7.0 9.4 6.4 6.6 14.3 8.5 16.5 8.5 7.8 12.1 6.5 8.3 11.0 5.8 23.9 7.2 11.2 10.0 5.5 5.9 1.3 20.4 5.6 5.5 7.5 2.1 6.4 11.1 4.8 2.8 9.0 15.1 18.4 6.5 4.0 8.7 8.3 11.3 8.5 15.0 6.0 3.9 2.2 3.6 15.1 7.5 7.6 27.1 17.2 28.4 6.3 21.0 6.8 7.7 6.9 7.9 16.1 5.0 4.1 5.4 21.4 11.9 25.6 5.5 10.9 13.5 13.1 18.0 11.5 21.0 13.7 14.2 25.0 12.3 16.6 16.8 14.9 7.2 8.3 3.2 3.4 4.6 14.6 12.7 6.7 3.4 7.0 3.9 8.8 16.6 9.5 3.6 4.5 11.3 23.3 8.5 12.8 4.6 4.2 15.0 6.4 33.4 9.5 6.3 6.7 15.8 11.4 4.6 11.4 18.6 29.7 4.6 5.2 9.5 8.6 4.6 6.2 2.0 19.4 7.6 3.3 2.5 4.0 9.6 10.2 5.5 2.8 TAP1 "ABCB2, D6S114E, PSF1, RING4" ENSG00000168394 "Transporter 1, ATP binding cassette subfamily B member" Q03518 6 32845209-32853978 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Cell type enhanced" "Detected in many" 5 "monocytes: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB009516, HPA072354" Approved Approved "Endoplasmic reticulum,Centriolar satellite" NA NA 110000 "Endoplasmic reticulum, Centriolar satellite" "CAB009516: AB_2303048, HPA072354: AB_2686513" "unprognostic (3.59e-2)" "unprognostic (1.06e-1)" "prognostic favorable (9.01e-4)" "unprognostic (1.33e-1)" "unprognostic (1.84e-1)" "unprognostic (3.22e-2)" "unprognostic (4.92e-2)" "unprognostic (6.16e-3)" "unprognostic (2.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (3.02e-3)" "unprognostic (2.37e-1)" "prognostic unfavorable (6.58e-5)" "unprognostic (2.07e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" 10.7 7.9 3.8 20.4 5.2 6.1 8.7 3.1 4.9 6.5 12.6 4.5 1.9 9.1 8.2 3.9 10.5 6.4 9.6 6.5 3.5 3.3 6.5 6.4 17.6 26.9 6.4 3.6 5.0 4.4 3.0 3.6 8.7 6.0 9.0 5.4 6.6 9.4 4.4 7.5 15.3 19.5 5.7 5.2 24.2 12.6 5.8 4.9 20.8 13.1 8.9 20.3 6.6 7.6 22.7 8.8 45.3 10.9 14.4 25.3 21.0 2.8 1.8 0.0 1.7 0.9 1.2 16.8 1.5 3.4 7.0 9.5 0.1 3.0 6.0 4.0 1.1 6.5 5.5 1.2 2.5 0.4 10.2 1.6 6.7 1.4 2.3 4.4 0.0 2.4 1.3 2.1 1.9 1.2 0.0 1.7 2.2 0.4 5.7 0.8 1.7 1.1 13.3 0.0 0.6 2.0 5.9 1.2 4.0 9.0 0.5 0.0 0.3 1.6 4.3 5.8 0.3 3.9 12.0 0.9 2.6 1.0 6.4 0.0 7.6 10.6 1.7 1.7 4.0 1.8 27.7 10.6 44.2 15.5 10.9 16.3 22.7 17.5 16.4 8.8 20.9 25.3 19.4 45.3 14.4 10.5 7.2 21.7 21.0 3.8 5.2 3.1 4.9 3.5 3.3 6.4 3.6 6.0 4.9 23.8 29.5 66.8 38.2 66.3 4.1 5.3 35.7 8.1 17.0 5.2 0.0 3.2 5.0 68.6 0.4 41.7 52.4 0.0 65.7 73.1 29.1 47.1 26.5 9.7 45.6 14.3 16.1 26.4 22.4 0.0 12.0 40.0 21.9 144.3 54.7 32.1 71.9 35.1 9.9 5.0 3.0 6.5 44.0 0.9 0.7 66.9 4.0 91.4 30.7 39.7 TARM1 ENSG00000248385 "T cell-interacting, activating receptor on myeloid cells 1" B6A8C7 19 54069895-54081365 "Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.1;lymphoid tissue: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 2.8;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "Hep G2: 1.7" "HPA051022, HPA054401" Uncertain NA NA "HPA051022: AB_2681315, HPA054401: AB_2682476" "unprognostic (1.56e-1)" 0.1 0.7 0.1 0.0 0.1 1.2 0.2 0.1 0.4 0.0 0.1 0.0 0.4 0.0 0.1 0.3 0.8 0.1 0.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 2.4 0.2 0.7 0.7 0.1 0.0 0.1 0.5 0.3 3.1 0.5 0.6 0.3 0.2 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.3 0.3 0.0 0.0 0.6 1.1 0.4 0.4 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.4 0.8 0.8 1.7 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.7 0.0 1.0 0.2 0.8 0.4 0.3 0.4 0.2 0.0 0.0 0.6 0.2 1.5 0.4 1.2 0.2 0.0 0.5 0.6 0.0 0.9 0.2 0.1 1.1 0.1 1.1 0.4 0.3 0.0 1.0 0.2 2.8 0.5 0.6 0.3 0.4 0.2 0.1 0.2 0.1 0.2 0.5 0.1 0.3 3.1 0.6 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TARSL2 FLJ25005 ENSG00000185418 "Threonyl-tRNA synthetase like 2" A2RTX5 15 101653598-101724604 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.7" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 4 "B-cells: 9.7;NK-cells: 9.0;T-cells: 6.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066697 Enhanced Approved Cytosol NA NA Cytosol "HPA066697: AB_2685705" "unprognostic (9.33e-3)" "unprognostic (2.13e-2)" "unprognostic (1.88e-1)" "unprognostic (2.54e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (8.45e-2)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-2)" "unprognostic (2.26e-3)" "unprognostic (9.76e-3)" "unprognostic (4.00e-2)" "unprognostic (2.23e-1)" "unprognostic (7.52e-2)" "unprognostic (6.48e-3)" "unprognostic (2.79e-2)" 7.4 6.9 15.1 6.4 20.2 4.8 7.5 15.8 16.2 7.2 7.1 20.2 5.5 6.2 6.5 6.0 6.3 6.5 5.9 21.0 16.9 13.8 8.3 5.9 6.2 6.5 20.0 11.2 11.0 9.8 12.9 10.5 3.7 15.7 9.2 6.2 4.0 7.1 9.7 47.7 4.9 6.5 6.9 19.9 6.2 8.5 5.4 18.9 3.9 9.6 8.0 7.1 7.0 7.8 9.7 2.0 1.6 1.7 9.0 6.1 1.0 2.1 4.0 6.9 3.7 7.4 5.8 3.5 7.4 4.9 5.8 3.6 5.9 1.9 2.8 2.9 8.9 4.7 6.3 12.1 4.3 5.4 3.2 19.5 6.9 2.6 4.6 3.4 3.1 1.4 4.1 4.0 2.7 3.4 6.9 4.1 6.1 6.7 6.1 5.7 3.5 1.7 6.1 8.4 10.6 2.8 3.5 10.5 7.2 4.8 2.1 11.0 6.8 10.0 3.9 4.0 13.3 2.5 6.3 5.5 2.8 6.6 5.6 2.4 8.5 9.5 3.5 7.3 5.6 5.1 0.9 1.1 1.6 3.4 1.7 3.4 4.8 6.1 5.2 0.8 9.7 5.9 3.2 0.3 9.0 0.7 2.0 1.0 1.0 15.1 20.2 15.8 16.2 16.9 13.8 20.0 11.2 15.7 18.9 0.0 5.6 26.9 18.3 16.1 51.2 37.0 5.1 12.0 11.4 5.2 41.2 2.7 16.6 7.6 13.2 12.5 18.0 0.0 10.8 4.0 18.6 13.9 24.3 14.7 4.6 30.2 23.6 8.0 8.9 5.7 21.9 8.6 10.1 9.0 13.5 34.6 17.6 9.3 17.7 17.7 78.2 19.4 16.7 27.4 21.3 10.3 3.5 31.7 12.6 7.1 TAS1R1 "GPR70, T1R1, TR1" ENSG00000173662 "Taste 1 receptor member 1" Q7RTX1 1 6555181-6579757 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "salivary gland: 10.9;testis: 8.7" "Group enriched" "Detected in some" 6 "Early spermatids: 6.0;Late spermatids: 14.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.7;HDLM-2: 4.7;Hep G2: 4.6;LHCN-M2: 3.7;U-698: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034579, HPA034580" Approved NA NA "HPA034579: AB_2674232, HPA034580: AB_10671504" "unprognostic (2.03e-2)" "unprognostic (9.29e-3)" "unprognostic (5.60e-4)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (4.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.53e-4)" "unprognostic (3.89e-2)" "unprognostic (3.15e-1)" "unprognostic (3.26e-2)" "unprognostic (3.17e-1)" "unprognostic (5.45e-3)" "unprognostic (1.67e-1)" "unprognostic (8.26e-2)" "unprognostic (8.28e-2)" "unprognostic (6.22e-2)" 0.4 0.8 0.7 0.1 0.8 1.5 0.4 0.6 1.2 0.7 0.9 0.1 0.1 0.4 0.1 0.1 0.4 0.4 1.0 0.1 1.2 0.2 0.1 0.1 0.6 0.2 0.2 0.1 0.9 0.1 0.0 0.5 0.3 0.5 0.1 0.0 0.7 10.9 2.1 0.6 1.4 0.5 0.1 0.1 1.3 0.5 8.7 0.1 0.1 0.1 2.2 0.5 0.4 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.5 0.1 0.3 0.1 2.7 0.0 0.0 0.3 0.0 0.0 4.7 0.0 0.0 0.1 4.6 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.7 0.8 0.6 1.2 1.2 0.2 0.2 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.1 0.0 0.0 0.0 0.0 TAS1R2 "GPR71, T1R2, TR2" ENSG00000179002 "Taste 1 receptor member 2" Q8TE23 1 18839599-18859682 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "skin 1: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS1R3 T1R3 ENSG00000169962 "Taste 1 receptor member 3" Q7RTX0 1 1331314-1335306 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 35.2;salivary gland: 17.9" "Group enriched" "Detected in some" 16 "Cardiomyocytes: 3.1;Muller glia cells: 1.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 1.9" "Cell type enriched" "Detected in single" 37 "memory B-cell: 5.2" "Lineage enriched" "Detected in single" 37 "B-cells: 5.2" "Cell line enhanced" "Detected in some" "Karpas-707: 6.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA053439 Uncertain NA NA "HPA053439: AB_2682150" "unprognostic (1.35e-2)" "unprognostic (1.45e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-3)" "unprognostic (4.32e-2)" "unprognostic (2.05e-1)" "unprognostic (6.95e-2)" "unprognostic (4.22e-1)" "unprognostic (8.44e-3)" "unprognostic (7.59e-3)" "unprognostic (8.37e-2)" "unprognostic (1.18e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-3)" "unprognostic (1.04e-1)" 0.4 0.4 0.4 1.5 0.4 0.5 0.4 1.9 0.4 0.6 1.4 0.4 1.0 2.0 0.5 35.2 1.9 0.6 0.7 1.4 0.4 0.1 0.5 1.6 0.9 1.6 0.4 0.4 0.4 0.4 0.1 2.6 1.9 0.4 0.4 0.1 0.4 17.9 0.4 1.4 0.2 3.2 0.4 0.4 6.4 0.9 1.6 0.4 0.4 0.8 1.5 2.5 1.0 0.9 5.2 0.1 0.0 0.0 0.0 0.1 0.2 1.4 1.3 0.4 0.5 0.0 0.0 0.7 0.7 0.2 0.2 0.2 0.9 2.9 1.8 0.3 0.0 0.3 0.6 0.0 0.0 0.0 3.7 1.0 0.2 2.6 0.9 0.3 0.0 0.5 0.1 0.2 0.1 0.0 0.3 0.0 0.8 0.5 6.0 0.0 0.9 0.3 0.6 0.8 0.5 3.5 1.0 0.7 0.8 0.0 0.2 2.3 0.4 0.5 2.3 1.9 0.3 2.0 0.4 0.3 0.5 0.2 1.8 0.8 3.7 3.5 0.9 0.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 1.9 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TAS2R1 "T2R1, TRB7" ENSG00000169777 "Taste 2 receptor member 1" Q9NYW7 5 9628997-9712378 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 18 "testis: 13.0" "Group enriched" "Detected in some" 83 "Early spermatids: 40.2;Late spermatids: 54.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.5;OE19: 1.0;U-266/84: 1.8" "Low region specificity" "Detected in some" HPA051879 Uncertain NA NA "HPA051879: AB_2681649" "unprognostic (2.19e-1)" 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 TAS2R13 "T2R13, TRB3" ENSG00000212128 "Taste 2 receptor member 13" Q9NYV9 12 10907926-10909562 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "epididymis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.78e-1)" "unprognostic (3.66e-2)" "unprognostic (1.77e-1)" "unprognostic (5.48e-2)" "unprognostic (1.52e-3)" "unprognostic (6.66e-3)" "unprognostic (4.50e-2)" "unprognostic (8.80e-2)" 0.1 0.3 0.0 0.1 0.1 0.3 0.3 0.7 0.1 0.1 0.1 0.1 0.4 1.4 0.2 0.1 0.1 0.4 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.8 0.4 0.1 0.6 0.2 0.3 0.1 0.6 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.4 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R19 "T2R19, T2R23, TAS2R23, TAS2R48" ENSG00000212124 "Taste 2 receptor member 19" P59542 12 11021619-11022620 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 1.1" "Cell type enriched" "Detected in single" 5 "T-reg: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.3;HDLM-2: 1.1;hTERT-HME1: 2.9;SuSa: 1.2" NA NA "unprognostic (1.90e-2)" "unprognostic (9.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.84e-1)" "unprognostic (2.56e-1)" "unprognostic (1.50e-2)" "unprognostic (5.73e-2)" "unprognostic (2.35e-1)" "unprognostic (8.76e-2)" "unprognostic (8.26e-2)" "unprognostic (1.94e-2)" "unprognostic (1.57e-8)" "unprognostic (9.08e-2)" "unprognostic (1.58e-1)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" 0.3 0.5 0.4 0.3 0.4 0.5 0.7 3.4 0.7 0.5 0.4 0.6 1.1 0.1 0.2 0.7 0.6 1.4 0.6 0.5 0.4 0.2 0.4 0.2 0.4 3.0 0.4 1.1 1.9 0.4 0.6 0.3 0.3 0.6 1.1 0.5 0.3 0.5 0.7 0.4 0.3 0.8 1.0 0.3 0.4 0.5 0.0 0.1 0.0 0.2 0.1 1.0 0.0 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.0 0.4 0.3 0.7 0.2 0.1 1.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 1.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.1 0.4 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R38 "PTC, T2R61" ENSG00000257138 "Taste 2 receptor member 38" P59533 7 141972631-141973773 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.3;NB-4: 1.1;OE19: 1.6;SK-BR-3: 1.1;U-266/70: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA043862, HPA054366" Uncertain NA NA "HPA043862: AB_2678703, HPA054366: AB_2682464" "unprognostic (5.18e-3)" "unprognostic (6.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.58e-1)" "unprognostic (1.25e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-2)" "unprognostic (8.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.9 0.1 0.0 0.0 0.0 2.2 0.2 0.0 0.2 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R4 T2R4 ENSG00000127364 "Taste 2 receptor member 4" Q9NYW5 7 141778442-141780819 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 12.5;Bipolar cells: 8.9;Club cells: 12.5;granulocytes: 10.5;Horizontal cells: 7.9" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "basophil: 3.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 3.9;NB-4: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (6.15e-3)" "unprognostic (5.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.39e-2)" "unprognostic (2.25e-1)" "unprognostic (1.55e-3)" "unprognostic (1.00e-2)" "unprognostic (3.86e-2)" "unprognostic (7.95e-3)" "unprognostic (2.06e-1)" "unprognostic (3.76e-3)" "unprognostic (6.15e-3)" "unprognostic (1.04e-5)" "unprognostic (5.58e-2)" "unprognostic (1.35e-1)" "unprognostic (9.87e-2)" "unprognostic (1.18e-1)" 0.2 0.4 0.9 0.5 2.9 0.5 2.6 6.9 1.6 0.6 0.5 0.2 1.7 4.3 0.4 1.3 0.5 0.1 0.9 1.2 0.4 0.2 0.6 1.0 0.7 2.8 0.9 0.5 1.2 0.6 0.6 0.9 1.0 0.6 2.6 4.4 0.9 0.3 0.7 0.8 0.8 0.8 1.0 1.0 0.5 0.6 1.0 0.5 3.6 0.8 1.1 0.8 0.6 0.5 1.5 1.1 0.6 1.0 2.0 0.8 0.4 0.1 0.0 0.4 1.2 0.7 0.9 0.5 0.2 0.1 0.9 1.6 0.8 0.1 0.8 1.0 0.2 1.1 1.3 1.0 3.9 0.8 1.1 1.9 0.1 1.7 0.5 0.4 1.2 1.1 0.3 0.5 0.7 1.4 4.3 1.2 0.3 0.2 0.6 0.5 1.0 0.3 0.7 1.1 0.9 0.3 0.4 0.3 0.5 0.3 1.4 0.8 0.6 0.7 0.4 0.7 1.0 0.4 1.1 0.4 1.6 0.4 3.6 0.8 1.4 0.6 0.3 0.4 0.5 0.5 0.3 0.2 1.0 0.5 0.8 2.4 1.1 0.6 0.5 0.1 0.6 3.0 12.5 0.5 1.2 0.0 8.9 0.3 0.0 5.3 12.5 1.8 5.9 0.8 0.0 0.4 0.2 1.0 0.5 0.0 0.4 0.2 0.6 1.6 10.5 0.6 0.6 7.9 1.2 2.5 0.0 0.0 0.6 0.7 0.0 1.0 0.4 4.4 0.5 0.6 1.4 0.0 3.1 0.0 0.1 1.9 0.9 0.0 0.7 0.0 1.2 0.4 TAS2R40 GPR60 ENSG00000221937 "Taste 2 receptor member 40" P59535 7 143222037-143223079 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 6.3;lymphoid tissue: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "neutrophil: 6.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 6.3" "Cell line enhanced" "Detected in some" "PC-3: 1.0;SK-BR-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R42 "hT2R55, T2R24, T2R55, TAS2R55" ENSG00000186136 "Taste 2 receptor member 42" Q7RTR8 12 11185993-11186937 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA036149 Uncertain Approved "Nucleoplasm,Actin filaments,Focal adhesion sites" NA NA "Nucleoplasm, Actin filaments" "Focal adhesion sites" "HPA036149: AB_10672080" "unprognostic (2.45e-2)" "unprognostic (4.17e-2)" 0.0 0.7 0.2 0.2 0.4 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.6 0.0 0.7 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.2 0.4 0.1 0.0 0.0 0.0 0.7 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.4 0.7 0.1 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 10.6" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" NA NA "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.1 0.4 1.1 0.9 0.3 0.0 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.6 1.2 2.9 3.0 1.0 1.5 2.6 0.4 0.1 1.7 0.6 3.9 1.3 0.2 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.3 0.3 0.4 0.2 1.7 0.1 0.4 0.3 1.0 0.7 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R50 T2R51 ENSG00000212126 "Taste 2 receptor member 50" P59544 12 10985913-10986912 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.55e-2)" "unprognostic (4.25e-1)" "unprognostic (1.14e-1)" "unprognostic (1.78e-1)" "unprognostic (2.53e-2)" "unprognostic (2.94e-1)" "unprognostic (2.24e-1)" "unprognostic (1.73e-1)" 0.3 0.1 0.0 0.2 0.1 0.4 0.6 1.7 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.6 0.2 0.0 0.3 0.4 0.1 0.0 0.2 0.0 1.0 0.3 0.3 0.1 0.1 0.4 0.1 0.2 0.3 0.3 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.4 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.3 0.1 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R60 T2R60 ENSG00000185899 "Taste 2 receptor member 60" P59551 7 143443453-143444409 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;liver: 1.4;pancreas: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 2.4;U-937: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA030416 Uncertain NA NA "HPA030416: AB_10603344" "unprognostic (1.78e-2)" "unprognostic (7.98e-2)" 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.2 0.0 0.0 1.3 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 1.0 0.9 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 1.3 0.5 1.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R8 "T2R8, TRB5" ENSG00000121314 "Taste 2 receptor member 8" Q9NYW2 12 10806051-10807293 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.0 0.5 0.4 0.0 0.4 0.1 0.5 0.0 0.1 0.2 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAS2R9 "T2R9, TRB6" ENSG00000121381 "Taste 2 receptor member 9" Q9NYW1 12 10809094-10810168 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "cervix, uterine: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.8 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAT ENSG00000198650 "Tyrosine aminotransferase" P17735 16 71565660-71577130 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Aminotransferase, Transferase" "Disease mutation, Mental retardation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 387.0" "Cell type enriched" "Detected in some" 42 "Hepatocytes: 3069.2" "Cancer enriched" "Detected in some" 10 "liver cancer: 152.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 2.4;Hep G2: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.66e-3)" "unprognostic (1.29e-1)" "unprognostic (8.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "unprognostic (1.01e-2)" "prognostic favorable (6.51e-4)" "unprognostic (1.69e-1)" "unprognostic (9.32e-2)" "unprognostic (2.27e-1)" "unprognostic (3.73e-3)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (1.19e-1)" "unprognostic (1.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.05e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 387.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.9 2.6 1.5 0.4 0.2 0.5 0.2 0.1 0.2 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.2 7.3 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.9 0.0 0.2 0.4 0.0 0.1 0.0 0.7 0.9 0.0 0.1 0.3 0.1 0.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.5 0.2 0.5 0.0 0.3 0.2 1.5 0.4 0.2 0.3 0.1 0.4 1.2 0.5 0.4 0.2 1.9 0.5 0.5 1.5 0.2 0.1 2.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.0 0.0 0.2 0.3 73.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 1.0 23.3 0.6 0.0 0.0 0.0 0.0 3069.2 0.0 0.0 0.0 53.4 61.8 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.9 1.5 0.0 0.0 0.0 0.0 0.0 TBATA "C10orf27, FLJ32820, spatial" ENSG00000166220 "Thymus, brain and testes associated" Q96M53 10 70771239-70785401 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 34.7" "Group enriched" "Detected in some" 20 "Early spermatids: 96.6;Late spermatids: 232.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SK-BR-3: 9.6" "Group enriched" "Detected in many" 4 "cerebellum: 31.5;hippocampal formation: 18.1" "Low region specificity" "Detected in single" NA NA "unprognostic (2.54e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "unprognostic (6.24e-2)" "unprognostic (1.45e-1)" "unprognostic (4.88e-1)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 34.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 96.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 232.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 TBC1D10C "Carabin, EPI64C, FLJ00332" ENSG00000175463 "TBC1 domain family member 10C" Q8IV04 11 67403915-67410089 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 55.4;bone marrow: 16.0;intestine: 14.5;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 2: 31.1;B-cells: 94.5;T-cells: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 7.9;JURKAT: 12.6;MOLT-4: 23.2;NB-4: 27.9;U-937: 11.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069743 Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA069743: AB_2686186" "prognostic favorable (3.83e-4)" "prognostic favorable (4.20e-4)" "unprognostic (9.23e-2)" "unprognostic (3.84e-2)" "unprognostic (1.28e-3)" "prognostic favorable (1.86e-5)" "unprognostic (6.22e-3)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (3.55e-2)" "unprognostic (3.28e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (7.18e-2)" "unprognostic (3.81e-2)" 1.3 0.4 0.7 20.8 0.8 16.0 0.7 0.4 0.4 0.9 3.0 0.4 0.7 2.4 0.5 0.6 1.6 1.3 1.5 0.8 1.1 0.3 1.9 1.5 5.2 22.4 0.5 0.8 0.6 0.5 0.0 0.4 0.7 0.4 1.1 0.4 1.4 3.6 0.2 0.4 0.4 14.5 0.2 0.8 35.0 3.1 0.7 0.9 27.1 4.6 1.0 27.8 1.8 1.8 39.1 13.1 52.5 30.6 25.9 55.4 49.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.4 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.1 23.2 27.9 0.0 0.0 0.0 2.6 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.0 0.0 11.5 0.0 33.2 10.0 52.5 51.1 23.7 36.2 37.6 44.5 44.7 13.1 39.1 46.8 42.3 49.1 25.9 30.6 11.0 55.4 49.2 0.7 0.8 0.4 0.4 1.1 0.3 0.5 0.8 0.4 0.9 6.0 31.1 94.5 0.0 1.0 1.3 1.2 0.0 1.4 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.7 0.1 22.0 0.6 24.4 0.0 1.2 4.3 13.8 0.0 0.0 13.9 3.3 3.6 0.0 0.3 0.0 0.0 0.0 1.0 0.3 0.0 0.6 0.1 0.1 0.9 0.3 117.9 0.0 0.1 TBC1D12 KIAA0608 ENSG00000108239 "TBC1 domain family member 12" O60347 10 94402504-94535930 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.6" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 1.4;dendritic cells: 2.2;monocytes: 1.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038277, HPA038645" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA038277: AB_10672584, HPA038645: AB_10672650" "unprognostic (7.23e-3)" "unprognostic (1.58e-2)" "prognostic favorable (1.79e-5)" "unprognostic (7.83e-2)" "unprognostic (1.76e-1)" "unprognostic (4.91e-2)" "unprognostic (1.21e-2)" "unprognostic (7.34e-2)" "unprognostic (6.56e-2)" "unprognostic (9.43e-2)" "unprognostic (1.81e-1)" "unprognostic (1.59e-1)" "unprognostic (2.27e-2)" "unprognostic (9.43e-2)" "unprognostic (3.71e-1)" "unprognostic (1.29e-1)" "unprognostic (1.12e-1)" 6.9 4.9 8.9 4.0 18.1 1.2 8.1 7.5 14.8 5.3 8.4 39.2 7.1 6.2 5.6 4.0 4.7 4.3 5.1 4.4 12.4 8.5 5.8 4.1 5.2 3.0 25.5 8.7 5.8 7.1 16.8 3.2 7.8 23.1 6.0 9.7 5.9 3.6 6.5 4.3 5.7 6.9 6.0 41.6 5.6 4.2 10.9 21.3 0.2 4.3 1.5 3.5 5.7 4.9 1.4 2.2 0.0 1.1 0.0 0.1 0.2 7.6 3.4 4.5 6.7 6.3 7.7 5.9 5.0 10.3 5.6 5.3 13.6 3.4 0.0 3.0 7.3 5.5 4.3 5.4 3.7 7.2 0.0 6.1 2.4 3.1 4.3 4.8 0.0 1.9 5.2 4.7 5.9 7.6 9.5 6.0 0.0 3.5 8.0 9.0 4.2 0.0 0.0 1.4 5.5 3.6 0.0 5.8 4.0 5.0 3.4 1.9 4.5 5.0 4.3 4.0 4.3 9.4 4.6 5.9 3.9 5.4 6.3 3.9 5.7 5.4 0.0 3.9 0.0 2.1 0.0 1.1 0.0 0.0 0.7 0.0 0.5 0.0 0.0 2.2 1.4 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.9 18.1 7.5 13.4 12.4 8.5 25.5 8.7 23.1 21.3 8.9 4.0 4.5 4.9 17.3 17.2 4.8 2.5 2.7 4.5 8.7 9.8 14.8 0.0 5.2 13.8 10.5 13.6 0.0 4.4 10.7 13.8 9.3 5.7 3.4 16.5 7.9 8.1 9.2 18.7 7.4 7.8 18.3 15.1 10.8 7.6 8.1 6.2 10.5 9.9 5.2 26.8 12.9 11.8 44.7 10.8 16.8 20.4 0.0 11.2 7.6 TBC1D17 FLJ12168 ENSG00000104946 "TBC1 domain family member 17" Q9HA65 19 49877425-49888749 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068119 Uncertain NA NA "HPA068119: AB_2685958" "unprognostic (5.88e-2)" "unprognostic (8.04e-2)" "unprognostic (3.16e-3)" "unprognostic (4.33e-2)" "unprognostic (8.39e-2)" "prognostic favorable (7.18e-4)" "unprognostic (6.41e-2)" "unprognostic (8.48e-2)" "unprognostic (3.56e-1)" "unprognostic (1.49e-1)" "prognostic favorable (4.02e-4)" "unprognostic (1.41e-1)" "unprognostic (1.78e-2)" "unprognostic (2.17e-1)" "unprognostic (2.52e-1)" "unprognostic (2.38e-1)" "unprognostic (9.52e-2)" 17.3 13.9 16.8 8.3 18.4 5.9 11.7 14.3 27.5 16.5 13.2 23.5 10.2 12.1 15.3 11.2 11.6 15.2 11.2 18.5 16.5 14.4 11.2 23.2 12.1 8.2 16.4 13.4 22.7 22.7 14.3 10.6 16.4 18.0 14.0 6.0 13.0 24.0 17.1 72.8 20.3 10.9 11.0 16.6 11.1 12.5 8.3 16.8 10.0 17.8 11.0 8.4 16.5 10.2 11.9 5.6 11.0 4.4 12.1 10.0 6.2 6.3 12.8 4.0 5.4 18.5 13.1 9.3 7.3 23.9 8.4 13.4 6.5 9.0 3.9 7.2 13.6 14.2 6.8 3.7 10.2 4.6 9.7 10.0 4.4 10.3 7.7 16.1 2.3 6.5 15.2 10.2 7.9 5.9 14.4 7.9 6.2 5.0 19.1 6.8 7.3 3.1 4.2 7.5 6.7 11.0 4.5 5.9 9.5 10.5 11.2 7.2 8.4 9.9 10.0 6.3 5.3 9.5 3.0 9.2 18.4 6.5 6.8 3.7 12.8 16.0 2.6 19.9 2.5 6.7 11.0 4.4 8.8 9.4 4.3 8.6 10.0 8.7 10.0 4.3 11.9 9.0 7.3 6.0 12.1 4.0 5.6 5.0 6.2 16.8 18.4 14.3 27.5 16.5 14.4 16.4 13.4 18.0 16.8 11.9 12.6 14.3 16.0 12.9 28.1 7.8 20.4 1.4 4.5 19.2 37.3 43.1 21.6 13.0 1.9 12.3 22.2 0.0 16.3 14.7 15.5 13.3 4.6 21.9 11.8 46.1 46.8 18.4 9.7 3.2 25.3 7.4 13.5 28.9 23.5 21.6 11.4 17.5 29.4 19.4 49.6 12.9 15.1 7.9 9.1 11.3 55.5 15.8 12.8 8.9 TBC1D21 "MGC34741, MgcRabGAP" ENSG00000167139 "TBC1 domain family member 21" Q8IYX1 15 73873608-73889214 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 173 "testis: 40.3" "Group enriched" "Detected in some" 81 "Early spermatids: 309.8;Late spermatids: 736.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "RPMI-8226: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA043319 Enhanced NA NA "HPA043319: AB_10966214" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 309.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 736.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 5.4 2.6 0.0 0.0 0.0 0.0 0.0 TBC1D24 "DFNA65, DFNB86, KIAA1171, TLDC6" ENSG00000162065 "TBC1 domain family member 24" Q9ULP9 16 2475051-2509560 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 33.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 26.8" "HPA044712, HPA068080" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA044712: AB_10795619, HPA068080: AB_2685948" "prognostic unfavorable (3.22e-4)" "unprognostic (5.23e-2)" "unprognostic (4.02e-2)" "unprognostic (6.41e-2)" "unprognostic (3.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.40e-1)" "unprognostic (2.03e-2)" "unprognostic (1.68e-1)" "unprognostic (7.37e-2)" "unprognostic (4.37e-2)" "unprognostic (1.28e-1)" "unprognostic (4.66e-3)" "unprognostic (2.02e-2)" "unprognostic (8.19e-2)" "unprognostic (7.78e-3)" "unprognostic (1.61e-1)" 6.0 5.8 11.0 2.9 9.6 3.7 4.9 15.8 17.7 4.2 3.5 2.8 6.7 3.8 3.3 5.0 2.2 4.3 3.5 4.9 9.0 5.4 7.6 6.6 6.4 3.0 3.8 12.2 2.1 16.6 5.2 5.6 3.6 7.5 4.5 1.9 5.4 33.4 6.4 6.1 3.5 2.8 3.1 3.7 3.4 3.8 2.4 4.5 0.8 5.5 1.0 2.3 4.0 2.9 0.2 1.3 0.0 0.9 0.2 2.2 1.0 2.6 5.0 3.4 6.9 4.0 4.0 2.9 4.7 2.5 3.1 2.7 4.7 2.2 6.6 4.3 3.6 1.5 4.7 5.3 1.5 2.3 7.1 6.3 5.9 6.6 4.0 2.4 4.3 2.6 1.5 2.1 2.7 1.1 2.1 3.9 2.4 7.2 3.7 2.9 4.6 2.9 8.6 3.0 2.3 3.3 15.3 6.5 4.6 2.2 1.7 26.8 6.5 3.2 11.8 1.9 1.3 3.8 3.9 4.0 6.1 6.7 6.0 4.6 2.4 2.2 8.2 2.6 6.3 5.5 0.0 0.7 0.0 2.2 0.8 0.7 0.2 0.5 0.7 1.3 0.1 0.5 0.3 0.0 0.2 0.9 0.6 0.0 1.0 11.0 9.6 15.8 12.4 9.0 5.4 3.8 12.2 7.5 4.5 26.8 22.4 2.7 2.7 0.5 15.4 4.7 15.3 4.0 10.3 5.2 41.2 1.3 28.2 4.8 0.2 3.6 1.7 23.3 5.3 0.7 8.4 3.5 3.5 15.1 3.0 25.4 10.9 12.3 5.4 0.7 8.3 2.3 1.7 1.8 2.6 11.1 4.8 3.5 5.6 3.3 25.0 0.0 3.7 2.7 3.8 1.3 0.2 2.6 4.4 1.4 TBC1D26 MGC51025 ENSG00000214946 "TBC1 domain family member 26" Q86UD7 17 15732247-15749192 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 15.3" "Group enriched" "Detected in some" 62 "Early spermatids: 164.5;Late spermatids: 74.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.4;HMC-1: 1.9;SuSa: 1.8;U-698: 5.3" HPA050460 Uncertain NA NA "HPA050460: AB_2681136" "unprognostic (3.65e-2)" "unprognostic (2.31e-1)" "unprognostic (7.90e-2)" "unprognostic (3.22e-1)" "unprognostic (1.16e-1)" "unprognostic (3.20e-1)" "unprognostic (5.15e-9)" "unprognostic (9.32e-2)" "unprognostic (1.51e-1)" "unprognostic (3.24e-1)" "unprognostic (6.16e-2)" 0.1 0.0 1.5 0.1 3.3 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.0 15.3 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 1.4 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.9 0.2 0.0 1.9 0.0 0.3 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.8 0.0 0.2 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.3 0.0 1.8 0.0 1.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 TBC1D28 FLJ40244 ENSG00000189375 "TBC1 domain family member 28" Q2M2D7 17 18635006-18661950 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 64 "testis: 19.0" "Group enriched" "Detected in some" 73 "Early spermatids: 45.5;Late spermatids: 13.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;Karpas-707: 3.2;SuSa: 1.0;U-266/70: 2.5" NA NA "unprognostic (2.56e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 19.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 TBC1D29 DKFZP434O047 ENSG00000266733 "TBC1 domain family member 29" Q9UFV1 17 30557112-30563493 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 10.9" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 9.8;Early spermatids: 10.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-937: 4.1" HPA059178 Uncertain NA NA "HPA059178: AB_2683939" "unprognostic (5.64e-2)" "unprognostic (1.01e-1)" "unprognostic (8.58e-2)" "unprognostic (9.36e-2)" "unprognostic (1.01e-1)" "unprognostic (1.56e-1)" "unprognostic (3.69e-1)" "unprognostic (1.50e-1)" "unprognostic (7.96e-2)" "unprognostic (2.57e-1)" "unprognostic (3.49e-4)" "unprognostic (7.32e-2)" "unprognostic (2.97e-3)" "unprognostic (1.15e-1)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-4)" 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.5 0.1 0.0 0.0 0.1 0.0 1.5 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.2 0.1 0.3 0.8 0.1 0.0 0.1 0.2 0.2 10.9 0.3 0.3 0.2 0.0 0.9 0.3 1.1 0.2 0.0 0.4 0.0 1.5 1.4 1.1 0.5 0.5 0.5 2.0 0.6 0.2 0.4 0.7 0.8 1.3 0.5 0.5 0.1 0.3 2.5 0.4 0.3 0.4 0.5 1.2 0.8 2.8 0.1 0.0 1.1 1.5 1.0 0.8 1.1 0.3 1.3 0.2 0.9 0.2 1.5 0.2 0.6 0.2 1.2 0.4 0.2 0.7 0.7 0.8 0.9 0.3 2.2 0.4 0.7 0.1 0.2 0.2 1.3 1.6 0.2 0.6 0.6 1.3 0.8 0.3 1.6 1.2 0.1 0.4 4.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.9 0.0 0.4 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.1 0.0 0.0 0.0 1.8 9.8 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.0 0.9 TBC1D3 "DKFZp434P2235, PRC17, TBC1D3A" ENSG00000274611 "TBC1 domain family member 3" Q8IZP1 17 38181659-38192541 "Predicted membrane proteins" "GTPase activation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "AF22: 9.1;REH: 5.7;U-138 MG: 7.9;U-266/70: 12.4;U-266/84: 4.8;U-698: 6.2" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 1.9 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 5.5 0.0 3.5 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.9 0.0 0.0 0.0 12.4 4.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D30 KIAA0984 ENSG00000111490 "TBC1 domain family member 30" Q9Y2I9 12 64781193-64881032 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Group enriched" "Detected in many" 17 "granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3" "Cell line enhanced" "Detected in many" "MCF7: 23.0;OE19: 15.2;RPMI-8226: 13.6;RT4: 17.6;SCLC-21H: 16.5;SK-BR-3: 17.0;T-47d: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039772, HPA040043" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA039772: AB_10795409, HPA040043: AB_10795411" "unprognostic (1.85e-1)" "unprognostic (6.95e-2)" "unprognostic (2.66e-1)" "prognostic favorable (3.61e-5)" "unprognostic (9.35e-2)" "unprognostic (2.09e-1)" "unprognostic (2.65e-5)" "prognostic favorable (5.08e-4)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.44e-1)" "unprognostic (9.72e-2)" "unprognostic (7.32e-2)" "unprognostic (7.62e-3)" "unprognostic (8.72e-2)" "unprognostic (2.67e-3)" "unprognostic (7.80e-3)" 1.8 1.6 4.7 2.3 11.4 0.5 5.3 13.4 15.8 7.6 3.3 1.5 12.4 5.0 3.1 2.5 1.2 2.1 4.8 1.1 7.1 5.5 3.9 1.7 3.9 0.9 4.7 7.0 1.5 19.8 8.9 6.5 1.4 16.5 3.7 3.5 2.0 14.4 11.6 0.9 1.3 3.5 2.4 3.0 2.5 6.9 3.2 2.8 0.0 3.3 0.2 0.7 4.9 1.9 0.0 0.0 2.4 1.1 0.0 1.3 0.3 6.9 1.4 0.4 0.4 0.0 0.5 0.6 0.0 0.0 0.0 0.1 6.5 2.2 0.3 1.1 0.0 0.3 0.1 6.8 0.1 0.0 0.0 6.7 0.3 1.2 0.3 0.1 2.3 1.4 0.4 0.0 0.0 0.2 0.6 5.6 1.0 0.0 2.4 0.2 23.0 0.0 0.4 0.9 15.2 6.8 0.1 0.1 13.6 0.8 17.6 16.5 1.3 1.4 17.0 0.2 0.7 12.4 1.1 5.3 0.0 1.0 0.5 3.4 0.0 0.0 0.2 0.1 0.7 0.3 0.0 1.1 0.0 0.4 1.1 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.3 4.7 11.4 13.4 15.8 7.1 5.5 4.7 7.0 16.5 2.8 0.0 4.6 0.5 2.1 0.8 9.4 0.4 5.1 2.7 5.7 3.5 7.9 0.4 8.3 3.1 13.6 4.2 2.6 0.0 4.3 0.3 0.5 7.1 9.2 0.0 1.5 0.0 0.0 2.5 2.5 1.0 0.3 2.8 5.0 1.0 6.3 2.5 3.6 3.5 0.0 1.7 0.5 0.0 0.3 3.3 1.5 1.3 0.1 0.9 3.3 8.4 TBC1D31 "Gm85, MGC21654, WDR67" ENSG00000156787 "TBC1 domain family member 31" Q96DN5 8 123041968-123152153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 29.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 10.5;T-cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023710 Approved Approved Centrosome NA NA Centrosome "HPA023710: AB_1858819" "unprognostic (1.39e-1)" "unprognostic (5.44e-3)" "unprognostic (7.21e-2)" "unprognostic (3.18e-5)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.53e-2)" "unprognostic (6.59e-2)" "unprognostic (8.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.18e-4)" "unprognostic (1.78e-3)" "unprognostic (1.57e-1)" "unprognostic (1.76e-2)" "unprognostic (2.33e-1)" 3.8 4.4 6.7 9.7 10.9 7.3 3.6 13.5 7.7 3.2 5.2 4.5 5.2 6.9 3.8 2.4 4.6 7.5 3.6 5.3 7.2 5.7 4.4 3.8 3.9 11.0 5.5 5.6 2.9 5.4 5.5 8.4 2.7 7.5 3.4 6.3 5.6 3.6 4.1 3.7 4.7 5.9 4.8 4.7 7.4 3.9 9.2 4.7 29.0 5.1 5.2 10.3 5.2 4.1 2.4 2.6 3.0 3.3 9.5 16.8 4.0 10.8 4.6 8.2 6.4 2.8 3.1 4.0 5.9 3.5 7.8 7.1 4.3 4.8 5.0 4.6 2.5 4.9 7.0 7.8 3.9 10.9 10.3 7.7 11.9 4.9 3.7 4.4 5.4 8.4 2.5 2.3 6.4 6.6 2.1 5.5 14.6 9.9 12.1 5.5 8.7 16.9 3.6 6.3 13.7 7.9 8.3 7.3 5.3 5.2 2.9 7.6 5.9 13.1 39.2 4.0 5.6 6.2 4.5 2.9 6.1 12.6 5.0 8.6 9.5 13.7 6.0 5.0 9.8 9.1 2.7 3.1 3.0 8.3 3.3 16.8 2.4 3.8 6.3 2.6 2.3 4.7 5.3 1.6 9.5 1.4 1.6 3.0 4.0 6.7 10.9 13.5 7.7 7.2 5.7 5.5 5.6 7.5 4.7 0.0 4.3 2.2 0.9 0.5 3.1 10.5 0.0 2.7 1.2 1.8 5.9 1.1 0.0 1.4 3.5 1.0 0.9 0.0 1.0 2.1 1.8 0.5 7.0 1.7 3.3 0.0 2.9 0.6 7.5 1.7 1.4 2.1 1.7 3.6 1.9 1.0 0.9 0.0 1.4 1.8 5.7 0.0 2.3 8.4 2.4 1.1 0.1 12.8 2.7 0.3 TBC1D32 "bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235" ENSG00000146350 "TBC1 domain family member 32" Q96NH3 6 121079494-121334745 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.4" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 111.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013413 Uncertain Approved Mitochondria NA NA Mitochondria "HPA013413: AB_10602702" "unprognostic (3.31e-2)" "unprognostic (1.28e-1)" "unprognostic (9.12e-3)" "unprognostic (4.82e-2)" "unprognostic (2.44e-2)" "unprognostic (1.98e-2)" "unprognostic (3.60e-4)" "unprognostic (7.28e-2)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (8.14e-2)" "unprognostic (2.01e-2)" "unprognostic (3.73e-2)" "unprognostic (1.57e-2)" "unprognostic (7.62e-2)" "unprognostic (2.17e-1)" "unprognostic (2.06e-1)" 3.2 7.3 7.3 5.5 8.8 2.4 5.0 3.9 11.1 5.7 3.5 4.8 3.8 4.5 5.1 4.1 4.1 4.8 5.6 3.5 7.0 4.1 4.5 1.8 3.2 3.0 8.1 7.8 6.5 4.0 9.7 25.4 8.2 8.0 5.0 2.4 4.2 4.6 3.2 1.7 5.5 4.6 2.4 7.0 3.1 3.8 9.2 7.9 8.1 7.0 2.1 3.2 3.7 5.1 6.4 10.7 5.8 1.3 3.4 3.7 0.4 1.6 2.0 3.2 4.2 2.9 4.4 1.6 1.8 2.7 3.1 4.6 0.1 1.1 2.9 3.1 2.0 4.7 1.5 1.5 1.6 3.8 22.0 2.1 3.7 0.6 0.7 1.3 1.8 1.5 1.7 1.1 2.9 2.0 3.7 0.6 3.7 2.1 0.0 2.4 1.0 2.1 1.1 1.9 1.0 0.7 1.8 1.6 0.3 1.7 0.8 6.6 3.3 2.3 1.3 1.0 1.8 2.0 1.5 0.4 2.1 2.1 0.5 2.1 1.5 0.0 1.3 2.8 1.0 3.2 5.8 1.3 1.7 2.6 0.7 1.9 3.4 1.9 1.8 0.8 6.4 3.7 2.8 1.1 3.4 1.1 10.7 2.1 0.4 7.3 8.8 3.9 11.1 7.0 4.1 8.1 7.8 8.0 7.9 3.0 5.9 1.5 3.2 5.5 27.8 2.9 5.1 24.1 13.6 7.0 41.2 3.8 0.0 2.2 3.4 3.2 4.2 0.0 1.9 1.3 6.1 2.8 3.5 1.0 1.2 12.7 5.2 3.7 1.3 2.1 2.3 3.3 1.7 1.0 5.2 5.8 0.9 3.5 1.8 1.0 111.1 0.0 3.1 12.6 7.9 4.4 1.9 3.2 2.8 1.8 TBC1D3B "PRC17, TBC1D3I" ENSG00000274808 "TBC1 domain family member 3B" A6NDS4 17 36165681-36176636 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 6.6;testis: 3.5" "Cell type enriched" "Detected in some" 11 "Early spermatids: 11.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.5;HeLa: 9.8;T-47d: 8.0" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.94e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.11e-1)" "unprognostic (2.83e-1)" "unprognostic (2.51e-1)" "unprognostic (1.17e-1)" "unprognostic (7.15e-2)" "unprognostic (9.96e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-1)" "unprognostic (1.34e-1)" 0.0 0.1 1.0 0.4 0.4 0.1 0.0 0.1 1.2 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.2 0.0 0.8 0.8 1.2 6.6 0.5 0.0 2.0 1.9 3.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 1.0 0.4 0.1 1.5 2.5 1.5 1.8 1.5 1.8 4.9 1.2 0.7 1.3 2.1 0.5 11.5 0.2 1.0 0.7 0.6 5.0 0.7 1.1 0.5 2.0 3.9 0.8 9.8 0.7 0.9 0.3 1.4 1.5 2.3 1.6 0.2 3.3 1.0 1.2 0.7 1.1 0.5 0.1 1.0 4.4 0.5 0.4 0.5 1.5 0.4 0.2 1.6 1.5 1.0 1.3 1.1 0.7 0.9 2.0 8.0 1.0 2.7 0.5 0.4 4.0 0.5 1.6 1.2 0.5 1.5 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TBC1D3C MGC44903 ENSG00000278299 "TBC1 domain family member 3C" Q6IPX1 17 38057693-38068592 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.3;skin 1: 3.5;testis: 3.4" "Cell type enriched" "Detected in single" 8 "Early spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 27.5" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 1.2 0.5 0.1 0.0 1.8 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 3.5 0.0 0.1 0.0 1.5 3.4 0.0 0.9 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.3 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 1.0 0.0 0.0 2.8 5.6 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3D ENSG00000274419 "TBC1 domain family member 3D" A0A087WVF3 17 38003976-38014902 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 7.9;skin 1: 4.2" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.4;Cholangiocytes: 2.5;Club cells: 2.3;Cone photoreceptor cells: 5.9;Pancreatic endocrine cells: 2.5;Syncytiotrophoblasts: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;CAPAN-2: 11.6;HaCaT: 8.4;HeLa: 9.4;RPMI-8226: 5.0;RT4: 5.6" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.8 1.5 0.8 0.0 0.0 0.8 4.2 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 1.1 8.4 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 5.0 0.0 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.9 1.0 0.0 3.5 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.4 2.5 0.0 2.3 0.0 5.9 0.3 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TBC1D3E ENSG00000278599 "TBC1 domain family member 3E" A0A087X179 17 38127951-38138862 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HHSteC: 9.8" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.18e-1)" "unprognostic (3.35e-1)" "unprognostic (3.51e-1)" "unprognostic (4.22e-2)" "unprognostic (6.28e-2)" "unprognostic (1.87e-2)" "unprognostic (5.07e-3)" "unprognostic (1.32e-3)" 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 9.8 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3F ENSG00000275954 "TBC1 domain family member 3F" 17 36428618-36439566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.3" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3G ENSG00000260287 "TBC1 domain family member 3G" Q6DHY5 17 36323884-36334759 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "SiHa: 5.5;U-2197: 1.6" "HPA046969, HPA047745, HPA052553" Supported Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3H ENSG00000274226 "TBC1 domain family member 3H" P0C7X1 17 36377531-36388423 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "CAPAN-2: 11.5" "HPA046969, HPA047745, HPA052553" Approved Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3I ENSG00000274933 "TBC1 domain family member 3I" A0A087WXS9 17 36253456-36264553 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "skin 1: 1.3;testis: 3.0" "Cell type enriched" "Detected in some" 23 "Early spermatids: 30.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 11.1" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.5 0.0 1.3 0.9 0.0 0.3 0.1 3.0 0.0 0.1 0.2 0.1 0.2 0.7 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.6 0.0 0.1 0.1 0.2 0.1 11.1 0.1 0.6 0.0 0.0 1.7 0.0 0.1 0.0 0.1 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.9 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TBC1D3K ENSG00000273513 "TBC1 domain family member 3K" A0A087X1G2 17 37924415-37935365 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SiHa: 2.2;T-47d: 5.4" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3L ENSG00000274512 "TBC1 domain family member 3L" B9A6J9 17 37977972-37989048 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 10.8" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 1.8;Early spermatids: 2.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.7;hTERT-RPE1: 24.9" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (5.14e-2)" "unprognostic (8.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (6.34e-2)" "unprognostic (3.19e-1)" "unprognostic (9.50e-2)" "unprognostic (1.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.80e-2)" "unprognostic (6.63e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-3)" 0.5 2.4 1.8 0.6 1.8 1.3 0.2 1.2 2.4 0.0 2.9 2.4 1.2 0.8 0.0 0.0 0.6 1.0 1.8 0.5 0.3 0.1 0.3 1.4 1.1 3.3 1.3 4.1 10.8 1.0 0.2 2.7 1.8 0.9 0.0 0.3 1.2 0.6 0.3 3.8 0.8 1.0 1.0 0.4 7.0 9.3 3.8 5.7 7.2 6.6 22.7 3.2 2.2 2.9 3.4 5.1 0.1 2.4 0.1 4.1 2.6 11.6 3.4 3.1 1.9 7.0 8.8 0.0 15.1 2.2 5.1 0.9 8.9 5.5 7.6 3.8 2.2 24.9 3.9 4.6 1.8 8.4 4.8 3.8 4.2 21.0 3.6 5.4 2.1 2.8 4.4 0.0 9.2 9.7 5.2 7.2 0.0 3.8 4.2 9.3 5.5 1.5 8.9 0.0 5.1 3.9 4.4 5.9 2.6 0.0 5.9 3.0 3.3 0.0 0.8 0.9 0.3 0.6 0.0 0.1 0.3 0.9 0.1 0.6 0.6 1.0 3.8 1.0 0.8 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.4 0.0 TBC1D8 "AD3, GRAMD8, HBLP1, VRP" ENSG00000204634 "TBC1 domain family member 8" O95759 2 101007617-101252866 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 76.0;skeletal muscle: 66.3" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 32.5;Ciliated cells: 41.5;Glandular cells: 38.4;monocytes: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 16.6;non-classical monocyte: 20.6" "Lineage enriched" "Detected in many" 5 "monocytes: 20.6" "Cell line enhanced" "Detected in many" "ASC diff: 36.7;ASC TERT1: 26.1;BJ hTERT+: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015211, HPA037496" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB015211: , HPA037496: AB_2675507" "unprognostic (1.82e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (4.25e-3)" "unprognostic (3.98e-1)" "unprognostic (2.12e-2)" "unprognostic (1.08e-2)" "unprognostic (2.74e-1)" "unprognostic (5.80e-2)" "unprognostic (2.38e-1)" "unprognostic (8.53e-2)" "unprognostic (1.82e-1)" "unprognostic (2.25e-2)" "unprognostic (8.02e-2)" "unprognostic (1.26e-1)" "unprognostic (6.73e-2)" "unprognostic (7.98e-3)" 14.4 4.0 3.0 5.5 4.2 7.3 14.1 10.1 5.1 7.6 19.6 2.2 52.8 4.3 7.8 12.2 8.4 13.2 12.0 24.1 4.8 2.7 8.9 12.8 11.8 6.8 3.0 3.8 5.1 27.5 3.9 8.5 4.4 6.1 25.7 3.8 6.7 15.1 76.0 66.3 15.2 22.7 7.7 5.0 11.3 13.3 11.3 2.8 3.3 5.3 8.3 8.0 8.7 8.6 0.6 4.0 0.2 20.6 0.0 0.3 1.8 2.0 12.8 1.0 3.7 36.7 26.1 10.5 1.2 22.5 0.9 1.1 4.5 3.3 0.9 11.5 0.9 18.0 6.5 2.1 9.9 0.6 0.6 1.9 0.6 4.3 15.6 2.5 0.1 11.0 12.1 9.4 1.2 9.4 0.7 13.1 1.8 0.2 1.1 1.1 5.6 1.1 6.4 2.8 1.4 13.8 2.5 3.2 0.2 7.5 13.7 8.1 3.9 1.7 3.1 4.4 1.8 0.9 9.4 10.8 0.5 1.9 1.9 0.8 2.1 0.1 0.0 4.7 3.2 3.3 0.0 5.1 0.2 0.1 16.6 0.2 0.2 0.1 0.1 2.8 0.6 0.3 0.2 0.2 0.0 20.6 4.0 0.1 1.8 3.0 4.2 10.1 5.1 4.8 2.7 3.0 3.8 6.1 2.8 3.0 2.9 0.0 32.5 3.7 5.8 10.6 20.4 41.5 20.5 5.2 3.9 3.9 0.0 5.9 4.8 4.9 1.3 0.0 2.6 2.5 2.3 38.4 6.9 5.0 3.6 1.6 2.9 7.4 11.2 8.6 2.8 12.2 5.0 33.3 1.7 0.9 2.8 0.6 1.8 0.7 3.6 6.5 4.2 1.4 1.9 5.5 2.9 0.0 0.9 24.3 TBCB "CG22, CKAP1, CKAPI" ENSG00000105254 "Tubulin folding cofactor B" Q99426 19 36114289-36125947 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 101.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041428, HPA041722" Approved Supported Cytosol NA NA 340000 Cytosol "HPA041428: AB_10794517, HPA041722: AB_10804007" "unprognostic (3.88e-3)" "unprognostic (3.05e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-2)" "unprognostic (7.94e-2)" "unprognostic (1.25e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.15e-2)" "unprognostic (5.19e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.11e-4)" "unprognostic (4.54e-2)" "unprognostic (6.34e-3)" "unprognostic (9.20e-2)" "unprognostic (6.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.02e-1)" 23.0 30.2 59.1 26.0 48.8 23.2 20.0 30.9 67.6 22.1 22.3 64.3 14.3 16.8 20.7 20.9 18.0 27.7 14.9 29.2 55.8 56.7 21.0 14.1 19.9 20.7 63.5 43.8 33.9 11.2 15.1 23.1 19.0 49.7 20.0 17.4 14.7 12.2 22.7 34.5 12.8 17.6 29.8 85.5 21.0 16.3 24.1 44.4 15.0 12.2 13.7 23.9 16.2 15.0 64.6 73.4 79.4 101.2 59.7 96.3 80.6 32.4 95.7 37.0 24.8 26.3 27.9 13.0 25.3 19.5 44.1 30.7 42.0 17.6 24.0 47.6 41.8 34.7 15.5 30.8 27.0 26.6 56.0 29.8 21.4 26.7 64.0 28.6 25.0 48.2 26.3 20.4 35.3 24.8 31.2 25.5 40.4 9.3 40.8 39.1 49.1 38.4 27.8 22.2 39.6 31.4 35.7 19.1 23.1 41.2 31.6 37.2 38.5 22.8 32.5 28.9 32.5 17.1 33.6 28.0 45.7 47.9 26.9 52.1 18.5 47.1 28.2 40.0 24.3 24.2 66.4 65.0 79.4 78.8 85.2 53.0 64.6 73.6 69.1 70.9 54.8 44.0 55.2 27.6 59.7 101.2 73.4 96.3 80.6 59.1 48.8 30.9 61.4 55.8 56.7 63.5 43.8 49.7 44.4 56.6 30.1 79.2 71.3 59.4 55.0 42.3 66.2 91.0 51.2 130.9 11.8 122.5 152.5 129.6 118.3 85.4 49.9 46.7 98.1 167.7 130.9 58.0 83.0 30.6 140.7 68.3 103.0 70.6 73.2 193.4 83.4 107.5 123.2 354.3 52.1 89.1 105.9 92.1 95.1 144.2 59.8 64.7 127.8 113.8 172.0 59.1 69.1 96.9 55.1 70.7 TBCC CFC ENSG00000124659 "Tubulin folding cofactor C" Q15814 6 42744481-42746096 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035073, HPA035074" Approved Supported Cytosol NA NA Cytosol "HPA035073: AB_10602897, HPA035074: AB_2674448" "unprognostic (7.16e-2)" "unprognostic (9.88e-2)" "unprognostic (2.17e-1)" "unprognostic (4.23e-2)" "unprognostic (8.20e-2)" "unprognostic (6.79e-2)" "unprognostic (5.80e-3)" "unprognostic (1.41e-2)" "unprognostic (2.47e-1)" "unprognostic (3.96e-3)" "unprognostic (1.84e-2)" "unprognostic (1.92e-1)" "unprognostic (2.22e-1)" "unprognostic (2.28e-1)" "unprognostic (1.29e-1)" "unprognostic (6.31e-2)" "unprognostic (3.76e-3)" 5.8 6.1 8.6 9.4 8.0 19.0 6.2 10.9 15.7 7.6 7.6 7.9 6.9 7.4 8.7 7.1 6.4 8.5 8.5 8.0 6.6 7.1 7.0 5.6 5.9 14.1 7.7 8.4 8.0 7.8 3.0 7.3 7.2 10.9 6.9 5.0 6.0 7.4 6.8 13.5 8.7 7.9 5.5 6.6 8.5 7.4 8.4 6.6 9.4 7.8 4.1 10.0 7.7 6.6 31.6 46.3 54.8 30.2 52.1 48.8 49.5 15.4 5.1 7.9 14.7 11.5 7.7 10.4 10.7 12.1 11.9 13.0 7.9 6.1 14.0 8.6 10.3 9.9 13.6 10.6 10.6 6.7 7.6 11.6 7.3 7.6 13.3 13.1 7.9 12.0 12.6 13.0 9.2 7.6 10.7 9.3 7.9 16.7 12.8 10.6 19.0 6.5 15.3 7.4 42.3 14.1 6.6 9.5 9.1 11.3 8.5 30.5 13.2 6.9 12.0 18.3 7.6 13.2 27.1 10.0 11.4 10.2 9.2 14.6 17.0 19.1 23.6 5.6 10.9 10.9 37.6 30.2 54.8 37.2 25.3 37.7 31.6 39.4 40.3 27.3 30.7 46.1 42.6 53.4 52.1 22.6 46.3 48.8 49.5 8.6 8.0 10.9 15.7 6.6 7.1 7.7 8.4 10.9 6.6 3.0 29.5 40.3 21.8 22.2 53.4 5.9 25.5 9.4 4.5 10.4 39.3 18.0 28.2 33.2 18.6 16.2 21.8 0.0 27.2 20.1 17.5 13.9 30.1 8.3 16.4 17.5 43.4 19.6 10.0 7.0 16.4 15.1 27.0 33.3 15.6 48.9 25.4 25.9 19.4 19.2 46.6 19.4 22.1 30.9 24.0 21.8 17.6 63.3 16.6 22.1 TBL1Y TBL1 ENSG00000092377 "Transducin beta like 1 Y-linked" Q9BQ87 Y 6910686-7091683 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1;thyroid gland: 10.8" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "prostate cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Cell line enriched" "Detected in some" 6 "U-698: 14.5" "HPA050857, HPA060073" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA050857: , HPA060073: AB_2684196" "unprognostic (2.81e-3)" "unprognostic (2.94e-1)" "unprognostic (3.06e-1)" "unprognostic (7.76e-2)" "unprognostic (1.17e-2)" "unprognostic (1.28e-1)" "unprognostic (2.77e-2)" "unprognostic (1.47e-1)" "unprognostic (3.24e-2)" 1.0 0.0 0.1 0.2 0.5 0.1 1.0 0.1 0.4 0.0 0.4 0.5 0.0 0.2 0.1 1.5 1.3 0.1 3.8 0.1 0.1 0.2 1.4 3.3 3.0 0.8 0.1 0.0 0.1 15.1 0.0 0.1 0.3 0.7 7.2 0.4 1.6 5.8 0.7 1.3 0.6 0.3 0.1 0.0 0.1 0.7 3.5 0.0 0.1 10.8 2.9 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 2.2 0.0 2.4 1.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.4 0.1 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.0 TBL2 "DKFZP43N024, WBSCR13, WS-betaTRP" ENSG00000106638 "Transducin beta like 2" Q9Y4P3 7 73568932-73578791 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 70.5" "Group enriched" "Detected in many" 7 "Early spermatids: 291.7;Late spermatids: 375.4;Spermatocytes: 284.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007477, HPA051533" Supported Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA007477: AB_1080214, HPA051533: AB_2681523" "unprognostic (9.04e-2)" "unprognostic (6.61e-3)" "unprognostic (4.24e-2)" "unprognostic (1.10e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.24e-3)" "unprognostic (7.50e-2)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (1.74e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" 8.9 12.1 3.7 5.4 3.3 1.8 5.9 2.7 5.3 8.7 6.6 3.4 11.6 6.1 6.5 10.9 7.3 5.5 6.3 5.4 2.5 2.5 6.1 14.2 6.5 4.7 3.5 2.1 10.7 27.0 8.5 7.0 13.0 3.4 6.5 6.9 5.1 16.3 8.0 4.9 6.9 6.3 5.4 3.0 5.4 8.2 70.5 3.7 6.2 11.8 4.2 5.2 8.5 6.2 4.2 14.4 13.2 11.4 8.3 6.7 7.6 12.2 14.0 4.8 7.1 13.2 12.8 6.0 14.7 11.0 5.6 10.1 21.4 13.2 10.0 3.3 12.9 11.9 9.4 10.2 5.9 11.1 3.9 6.9 3.6 7.4 14.0 19.0 7.3 13.3 7.9 10.2 17.1 13.7 10.9 6.4 1.9 14.7 7.9 8.5 11.9 7.1 7.2 5.0 15.0 11.5 4.6 8.7 22.1 7.2 8.6 5.1 8.2 14.6 40.0 9.2 6.6 10.5 5.6 10.8 10.6 5.2 9.8 14.8 15.9 9.9 11.3 13.6 9.0 12.3 13.2 11.4 5.2 6.6 7.9 6.5 3.4 5.6 6.0 14.4 4.2 6.7 4.2 1.0 8.3 7.0 10.8 6.5 7.6 3.7 3.3 2.7 5.3 2.5 2.5 3.5 2.1 3.4 3.7 23.8 9.4 12.3 11.1 4.0 10.0 4.5 12.7 6.7 7.9 5.2 7.9 39.4 1.7 21.8 291.7 9.8 10.9 0.0 26.3 45.4 11.5 14.0 13.9 15.3 26.0 3.2 9.1 12.9 7.5 375.4 21.9 7.9 6.8 23.4 15.7 7.8 21.3 14.4 25.1 5.0 12.9 6.5 8.0 284.6 22.2 3.1 36.3 3.3 14.3 7.5 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 71.2" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA071810: AB_2686451, HPA071813: AB_2686452" "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favorable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavorable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 7.1 7.7 10.8 8.9 11.7 19.3 12.2 16.4 16.6 7.3 7.3 5.2 7.8 8.1 7.9 5.6 7.1 8.5 7.4 7.9 15.9 14.2 5.7 8.5 6.6 12.0 10.0 11.8 8.3 6.0 4.7 8.2 9.2 11.1 8.0 9.3 4.6 5.7 9.2 4.4 5.9 7.7 7.2 8.5 7.6 7.2 71.2 8.0 11.7 10.7 5.0 10.2 9.2 12.0 27.8 14.7 43.1 14.9 21.1 30.8 25.3 6.3 7.8 17.9 11.6 13.7 14.2 10.1 12.1 12.8 16.2 21.3 9.1 5.1 19.8 8.3 9.6 18.0 8.4 11.4 13.0 19.6 15.1 14.2 34.8 4.7 10.0 13.9 18.2 13.6 8.7 13.3 18.1 19.6 12.3 15.3 17.5 50.2 13.6 11.5 14.5 15.2 10.9 20.0 9.3 10.2 10.6 10.8 7.6 9.5 5.7 23.3 23.2 7.1 9.4 14.9 15.6 4.3 7.3 13.8 9.3 13.5 20.5 13.2 11.0 11.9 12.9 15.6 11.9 11.1 43.1 13.7 32.7 28.5 13.8 30.8 27.8 24.1 29.9 12.4 25.0 23.4 27.3 31.4 21.1 14.9 14.7 24.6 25.3 10.8 11.7 16.4 16.6 15.9 14.2 10.0 11.8 11.1 8.0 6.0 12.6 23.3 25.8 62.8 20.7 9.2 20.4 12.0 7.9 7.0 17.7 36.2 24.9 25.0 221.6 33.3 12.0 0.0 22.1 57.3 32.7 32.8 40.3 8.9 21.4 14.3 68.1 17.2 16.7 29.8 19.5 20.0 30.4 19.0 22.4 12.3 24.3 21.0 17.3 18.9 9.4 19.4 34.0 178.1 63.9 57.5 204.8 47.3 23.6 36.7 TBPL2 "TBP2, TRF3" ENSG00000182521 "TATA-box binding protein like 2" Q6SJ96 14 55413541-55456726 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 3.9" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "testis cancer: 2.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 9.1;HMC-1: 5.3;U-2 OS: 4.3;U-937: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056241 Uncertain NA NA "HPA056241: AB_2683076" "unprognostic (3.42e-1)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" "unprognostic (3.06e-4)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" 0.4 0.9 0.2 1.7 0.6 0.7 0.4 0.4 0.4 0.8 0.5 2.0 1.3 0.0 0.2 0.2 0.0 0.3 0.3 0.4 0.6 0.3 0.5 0.4 0.5 1.1 0.2 0.2 0.3 0.0 0.3 0.0 1.0 0.0 3.9 3.1 1.2 0.0 0.3 0.8 0.9 1.9 0.5 0.0 0.2 0.3 1.5 1.1 1.5 1.1 1.6 0.9 0.5 3.3 1.0 0.0 1.0 0.0 1.1 2.2 0.0 0.0 0.0 0.4 0.5 0.5 0.6 2.8 0.0 0.3 0.8 0.2 0.0 0.0 9.1 0.0 0.7 0.8 0.0 0.0 0.0 5.3 0.0 1.7 0.0 0.4 0.0 0.0 0.2 0.5 3.3 0.0 2.3 0.5 1.7 0.7 0.1 0.9 0.8 0.0 0.6 0.0 1.3 1.8 0.9 0.0 0.2 0.3 0.0 1.2 1.2 0.0 0.3 4.3 0.4 0.7 3.1 1.4 0.4 0.5 6.8 0.2 1.5 0.5 0.5 0.9 1.1 0.6 1.0 0.5 0.4 0.6 1.5 0.5 0.2 1.0 1.6 0.3 1.1 0.1 0.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 TBR1 ENSG00000136535 "T-box, brain 1" Q16650 2 161416094-161425870 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "brain: 34.9" "Group enriched" "Detected in some" 54 "Early spermatids: 32.1;Late spermatids: 41.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.7;HMC-1: 1.3;Karpas-707: 1.0;SCLC-21H: 1.8;U-266/84: 1.5" "Group enriched" "Detected in many" 6 "amygdala: 45.6;basal ganglia: 28.5;cerebral cortex: 70.3;hippocampal formation: 50.1" "Region enhanced" "Detected in many" "cerebral cortex: 63.6" "HPA051256, HPA078644, HPA078657" Enhanced Supported NA NA "HPA051256: , HPA078644: AB_2732387, HPA078657: AB_2732388" "unprognostic (3.08e-2)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "unprognostic (1.35e-2)" "unprognostic (7.43e-3)" "unprognostic (1.95e-1)" "unprognostic (1.83e-2)" "unprognostic (1.14e-1)" "unprognostic (1.39e-9)" "unprognostic (5.72e-2)" "unprognostic (1.72e-1)" "unprognostic (5.37e-2)" 0.6 0.5 11.2 0.5 13.7 0.5 0.5 0.3 34.9 0.6 0.5 0.0 0.0 0.5 0.5 0.6 0.5 0.6 0.5 0.5 6.1 1.3 0.5 0.5 0.5 0.5 0.8 21.0 0.5 0.6 0.6 0.3 0.5 0.0 0.5 0.6 0.0 0.5 0.7 0.5 0.5 0.5 0.5 0.4 0.5 0.5 1.3 0.0 0.0 0.5 0.0 0.5 0.5 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.7 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.5 1.5 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 11.2 13.7 0.3 34.9 6.1 1.3 0.8 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 41.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.4 0.1 0.0 0.7 0.0 0.0 0.0 TBX1 "CATCH22, VCF" ENSG00000184058 "T-box 1" O43435 22 19756703-19783593 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 36.5" "Group enriched" "Detected in many" 7 "Early spermatids: 42.8;Late spermatids: 139.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "basal ganglia: 3.0" "Group enriched" "Detected in some" 13 "basophil: 1.0;eosinophil: 2.7" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "HEK 293: 10.1;K-562: 48.7;NB-4: 11.5;TIME: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA029330 Approved "Nuclear bodies,Cytoplasmic bodies" NA NA "Nuclear bodies, Cytoplasmic bodies" "HPA029330: AB_2673002" "unprognostic (2.54e-1)" "unprognostic (4.28e-3)" "unprognostic (7.53e-3)" "unprognostic (1.59e-1)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (2.53e-1)" "unprognostic (5.48e-2)" "unprognostic (1.18e-1)" "unprognostic (4.42e-2)" "unprognostic (2.25e-2)" "unprognostic (8.30e-3)" "unprognostic (9.14e-2)" "unprognostic (4.44e-1)" "unprognostic (8.31e-2)" "prognostic favorable (8.90e-4)" 1.4 0.2 0.6 0.6 3.0 0.0 3.7 0.6 0.6 2.5 2.3 0.6 0.6 0.4 0.9 0.6 2.5 2.8 0.6 0.6 0.6 0.0 0.6 0.6 2.2 1.7 0.6 0.6 0.7 0.6 3.7 0.6 0.6 0.6 2.3 0.2 0.6 3.4 0.6 36.5 4.6 0.8 0.6 0.6 0.6 0.1 7.0 0.6 0.6 5.3 0.6 1.9 1.1 3.3 0.0 0.1 2.7 0.0 0.0 0.1 0.0 6.0 0.6 0.1 4.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.1 0.6 0.3 5.2 4.5 0.0 0.2 10.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 48.7 0.0 3.3 1.1 0.1 11.5 0.7 0.0 7.1 0.1 4.6 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 1.4 2.1 3.1 15.6 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.0 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.0 3.2 0.0 1.1 2.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 42.8 3.0 0.0 0.0 0.2 0.7 0.7 0.9 2.3 0.0 1.5 0.0 0.0 1.3 1.0 139.3 2.3 0.3 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.4 1.9 13.2 2.0 0.1 0.0 0.0 1.6 TBX10 "TBX13, TBX7" ENSG00000167800 "T-box 10" O75333 11 67631303-67639560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "intestine: 12.1" "Group enriched" "Detected in some" 8 "Enterocytes: 18.4;Mucus-secreting cells: 66.7" "Group enriched" "Detected in some" 5 "breast cancer: 0.8;colorectal cancer: 2.6;liver cancer: 0.5;prostate cancer: 1.9;stomach cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.9;NTERA-2: 6.8;RPMI-8226: 4.4;SK-BR-3: 15.9;U-2 OS: 3.4" "Region enriched" "Detected in single" 7 "pons and medulla: 0.4" "Low region specificity" "Detected in many" HPA047881 Uncertain "Intracellular and membrane" NA NA "HPA047881: AB_2680199" "unprognostic (4.66e-2)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (1.83e-4)" "unprognostic (3.12e-1)" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (4.90e-1)" "unprognostic (1.17e-10)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (2.95e-1)" "unprognostic (2.75e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 9.9 0.2 0.2 6.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.8 0.2 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.4 0.2 0.2 0.0 12.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.0 15.9 0.0 0.1 0.0 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 66.7 0.0 0.2 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 TBX15 TBX14 ENSG00000092607 "T-box 15" Q96SF7 1 118883046-118989556 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 23.3;skeletal muscle: 84.9;tongue: 37.5" "Group enriched" "Detected in some" 4 "Early spermatids: 6.3;Hepatocytes: 11.3;Melanocytes: 6.8;Smooth muscle cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 28.2;ASC TERT1: 12.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.8;fHDF/TERT166: 14.4;HSkMC: 20.3;RH-30: 15.3;U-2197: 14.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052245, HPA053713" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA052245: AB_2681771, HPA053713: " "unprognostic (1.94e-1)" "unprognostic (2.75e-3)" "unprognostic (1.92e-2)" "unprognostic (3.94e-2)" "unprognostic (5.72e-3)" "unprognostic (7.79e-2)" "unprognostic (5.82e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-3)" "unprognostic (1.39e-1)" "unprognostic (3.81e-3)" "unprognostic (5.03e-2)" "prognostic unfavorable (5.57e-8)" "unprognostic (2.63e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-3)" "unprognostic (2.31e-1)" 18.1 0.1 0.2 0.1 0.5 0.1 12.5 0.4 0.8 0.1 0.1 0.2 0.0 0.0 0.1 2.1 1.2 0.1 0.3 1.2 0.5 0.0 0.1 23.3 0.2 1.3 0.2 0.2 0.1 0.1 0.2 0.5 0.1 2.1 0.7 0.0 0.2 2.8 0.1 84.9 3.6 0.1 0.2 0.6 0.0 0.1 0.4 0.4 0.0 1.9 37.5 2.4 0.2 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 28.2 12.0 0.0 2.4 3.3 6.4 10.8 0.0 0.0 0.0 1.4 14.4 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 20.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.1 1.2 0.0 0.1 0.0 15.3 0.2 1.6 0.7 0.3 0.0 0.8 0.0 0.3 0.3 0.0 0.3 0.0 3.5 2.1 14.3 0.1 0.2 0.1 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.8 0.5 0.0 0.2 0.2 2.1 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 11.3 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 0.2 0.1 1.8 0.0 0.0 0.0 0.0 TBX18 ENSG00000112837 "T-box 18" O95935 6 84687351-84764519 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 23.3" "Cell type enhanced" "Detected in some" 16 "Basal keratinocytes: 4.8;Fibroblasts: 5.3;Melanocytes: 8.5;Smooth muscle cells: 16.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 26.5;ASC diff: 19.3;ASC TERT1: 20.2;RH-30: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006807 Supported Nucleoplasm NA NA Nucleoplasm "HPA006807: " "unprognostic (8.04e-2)" "unprognostic (7.06e-3)" "unprognostic (9.71e-2)" "unprognostic (2.31e-1)" "unprognostic (4.00e-1)" "unprognostic (1.62e-1)" "unprognostic (2.19e-1)" "unprognostic (3.24e-1)" "unprognostic (2.57e-1)" "unprognostic (7.92e-2)" "unprognostic (3.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.88e-14)" "unprognostic (4.81e-5)" "unprognostic (1.86e-1)" "unprognostic (3.07e-3)" "unprognostic (1.78e-1)" 14.5 4.9 1.7 2.1 4.0 0.3 16.1 1.8 3.6 4.4 1.9 4.1 0.5 0.5 2.4 2.1 7.3 2.7 3.6 9.9 3.4 1.8 1.0 0.8 0.7 3.9 6.3 5.5 5.0 1.4 1.3 2.6 4.1 5.0 4.9 1.3 8.9 3.9 2.9 2.5 8.0 2.7 11.1 4.0 0.3 1.0 2.5 1.8 0.0 2.8 2.0 3.0 7.6 23.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 19.3 20.2 0.0 10.9 5.4 8.3 8.0 0.1 0.0 0.0 0.0 4.5 0.0 1.4 0.0 6.4 6.8 0.0 10.8 0.0 0.0 0.0 2.5 0.0 11.0 8.3 0.6 5.7 12.3 0.0 9.5 0.0 13.7 0.1 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.1 0.0 0.1 0.5 0.0 0.4 4.2 0.7 0.0 14.3 8.4 0.0 2.3 8.4 0.0 0.1 0.0 0.0 5.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 1.8 3.6 3.4 1.8 6.3 5.5 5.0 1.8 0.0 0.0 0.0 0.0 4.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 2.6 1.1 0.0 8.5 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 16.7 0.3 1.9 3.9 0.1 0.0 0.0 0.0 TBX19 "dj747L4.1, TPIT" ENSG00000143178 "T-box 19" O60806 1 168281040-168314426 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "pituitary gland: 50.4" "Cell type enhanced" "Detected in many" 5 "granulocytes: 4.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 9.4;HDLM-2: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005800, HPA072686" Enhanced Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA005800: AB_1080219, HPA072686: AB_2732209" "unprognostic (2.47e-1)" "unprognostic (1.20e-2)" "unprognostic (8.76e-4)" "unprognostic (1.43e-2)" "unprognostic (3.09e-2)" "unprognostic (8.36e-2)" "unprognostic (7.14e-7)" "unprognostic (1.83e-1)" "unprognostic (2.04e-1)" "unprognostic (5.58e-2)" "unprognostic (9.78e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (8.57e-2)" "unprognostic (6.63e-2)" "unprognostic (9.06e-2)" "unprognostic (1.05e-2)" 1.0 0.4 1.0 1.0 1.0 0.5 2.5 1.0 1.0 1.5 1.3 1.0 1.0 0.8 5.3 1.0 1.1 2.0 1.4 1.0 1.0 0.8 1.0 1.0 2.2 2.1 1.0 1.0 2.9 1.0 0.2 50.4 1.0 1.0 1.2 1.1 1.0 2.2 1.4 1.0 1.9 1.0 3.6 1.0 2.1 0.6 1.0 1.0 1.0 1.0 1.0 1.3 1.3 1.2 1.6 6.3 2.7 2.4 2.6 3.1 1.3 1.6 0.1 1.4 5.3 2.5 1.2 1.7 2.9 1.5 1.0 1.6 2.4 1.7 1.5 2.9 1.1 1.5 9.4 0.8 0.7 1.4 8.1 1.4 0.3 1.7 0.7 2.9 2.6 3.6 2.2 2.6 0.3 1.5 2.6 1.2 0.6 1.8 2.4 1.3 0.3 1.4 2.4 0.4 5.6 1.0 2.2 0.7 0.5 2.3 0.7 1.9 2.8 1.6 1.2 1.6 2.4 0.4 2.2 2.1 1.0 2.4 2.0 2.9 1.6 1.3 1.2 0.2 0.8 2.8 0.5 1.8 0.8 3.1 1.3 1.4 1.2 2.2 2.0 1.8 1.6 1.5 1.3 2.7 2.6 2.4 6.3 2.0 1.3 1.0 1.0 1.0 1.0 1.0 0.8 1.0 1.0 1.0 1.0 0.0 0.3 0.0 1.1 2.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 2.7 0.9 0.0 0.3 0.2 2.3 3.4 4.6 0.5 1.1 0.0 1.2 0.0 2.1 0.4 3.1 2.8 0.0 2.8 0.7 0.8 1.4 0.0 2.5 0.3 0.0 0.0 0.8 0.5 0.7 2.9 0.1 1.8 0.8 2.0 TBX20 ENSG00000164532 "T-box 20" Q9UMR3 7 35202430-35254147 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 26.5;heart muscle: 46.4;prostate: 24.2;smooth muscle: 47.0;urinary bladder: 32.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.3;HHSteC: 4.8;HMC-1: 5.4;RH-30: 5.3;SH-SY5Y: 10.1;WM-115: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.20e-1)" "unprognostic (1.25e-2)" "unprognostic (1.87e-2)" "unprognostic (8.47e-2)" "unprognostic (3.95e-2)" "unprognostic (2.75e-1)" "unprognostic (1.74e-1)" "unprognostic (9.75e-2)" 0.2 4.3 0.2 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.2 0.2 26.5 46.4 0.2 0.2 0.2 0.6 0.2 0.1 0.2 0.0 0.2 0.2 0.1 1.8 15.1 0.0 24.2 0.1 2.7 0.2 0.1 0.2 0.2 0.2 47.0 0.2 0.2 0.2 0.4 0.0 0.0 0.2 0.0 0.1 32.3 14.4 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 3.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.3 3.1 0.0 0.6 0.0 0.2 0.3 4.3 0.0 0.1 2.2 3.5 4.3 1.4 0.0 4.8 0.0 5.4 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 5.3 0.0 0.1 0.0 0.3 10.1 0.5 0.0 0.0 2.7 0.0 3.8 0.0 0.0 0.2 3.7 0.0 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 TBX21 "T-bet, TBLYM" ENSG00000073861 "T-box 21" Q9UL17 17 47733244-47746119 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.5;bone marrow: 12.2;lymphoid tissue: 17.7" "Cell type enriched" "Detected in some" 9 "T-cells: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "gdT-cell: 13.5;NK-cell: 10.8" "Group enriched" "Detected in many" 8 "NK-cells: 10.8;T-cells: 13.5" "Cell line enriched" "Detected in single" 113 "HDLM-2: 19.1" "Region enriched" "Detected in single" 27 "olfactory region: 27.1" "Low region specificity" "Detected in all" "CAB009524, CAB030043" Enhanced NA NA "CAB009524: AB_2200557, CAB030043: AB_1595503" "unprognostic (3.31e-3)" "unprognostic (3.17e-3)" "unprognostic (1.17e-2)" "unprognostic (5.35e-6)" "unprognostic (3.93e-1)" "unprognostic (2.56e-4)" "unprognostic (5.86e-4)" "unprognostic (6.90e-2)" "unprognostic (3.63e-3)" "unprognostic (6.26e-4)" "unprognostic (1.43e-1)" "unprognostic (1.93e-2)" "unprognostic (3.04e-4)" "unprognostic (7.92e-2)" "unprognostic (2.67e-1)" "unprognostic (9.19e-3)" "unprognostic (4.43e-3)" 2.9 0.6 0.5 5.7 0.5 12.2 0.9 0.4 0.4 2.3 4.3 0.9 0.4 1.3 2.0 1.7 1.4 1.0 1.8 0.9 0.5 0.5 1.3 1.9 11.1 9.3 2.6 0.3 1.2 0.6 0.0 0.6 0.2 0.7 3.3 0.7 2.2 3.0 0.4 1.5 0.5 2.7 1.4 0.8 17.7 1.6 0.7 0.4 4.1 1.4 1.6 8.1 2.6 1.8 1.5 0.0 0.2 0.0 10.8 13.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 3.1 1.5 2.8 7.4 0.0 0.4 0.4 7.1 0.2 10.8 0.0 0.0 0.1 1.6 0.5 0.5 0.4 0.4 0.5 0.5 2.6 0.3 0.7 0.4 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.2 0.1 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.1 0.0 20.3 0.0 0.0 TBX22 "CLPA, CPX" ENSG00000122145 "T-box 22" Q9Y458 X 80014756-80031769 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Deafness, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "testis: 25.6;thyroid gland: 6.6" "Cell type enhanced" "Detected in single" 29 "Late spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 6.2" "Region enhanced" "Detected in single" "cerebral cortex: 0.4" "Low region specificity" "Detected in all" NA NA "unprognostic (6.58e-2)" "unprognostic (6.31e-2)" "unprognostic (1.18e-1)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 TBX3 "TBX3-ISO, UMS, XHL" ENSG00000135111 "T-box 3" O15119 12 114670254-114684164 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 117.7" "Cell type enriched" "Detected in many" 6 "Syncytiotrophoblasts: 513.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 34.0;BJ hTERT+: 32.4;RT4: 42.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA005799, HPA075876" Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005799: AB_1857817, HPA075876: " "unprognostic (3.27e-1)" "unprognostic (2.64e-1)" "unprognostic (2.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.40e-2)" "unprognostic (5.97e-3)" "unprognostic (1.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.43e-2)" "unprognostic (1.15e-1)" "unprognostic (3.35e-1)" "unprognostic (3.06e-1)" "unprognostic (3.64e-3)" "unprognostic (1.09e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "prognostic favorable (3.28e-4)" 4.3 60.5 0.9 3.3 1.9 0.0 19.9 0.7 2.3 18.2 12.2 1.7 69.6 14.2 13.1 18.7 1.9 7.5 5.0 6.2 1.2 1.5 4.1 15.1 12.6 0.8 1.2 0.5 15.6 1.1 0.3 5.3 67.8 1.6 32.3 1.5 2.6 7.3 117.7 4.2 4.8 19.4 9.7 1.4 2.6 2.2 3.5 1.2 0.5 36.3 7.3 3.5 24.6 25.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 6.0 0.0 0.0 9.0 12.4 13.5 34.0 32.4 13.2 13.1 5.3 1.4 0.0 0.5 5.9 0.8 1.5 2.8 1.2 16.3 0.0 4.1 0.0 1.5 15.5 2.9 0.0 0.0 5.5 0.8 4.4 9.1 0.0 0.1 0.0 1.2 0.0 1.1 0.5 0.0 0.1 0.0 17.2 1.8 0.0 0.0 0.8 0.0 42.4 2.2 6.6 4.8 2.2 1.1 15.8 1.7 0.0 0.0 4.0 2.6 2.3 11.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.7 2.3 1.2 1.5 1.2 0.5 1.6 1.2 0.0 3.4 0.9 88.0 8.8 6.3 9.8 0.0 0.0 0.0 33.2 3.9 39.8 0.0 0.4 1.3 26.5 25.4 0.0 0.0 5.9 9.5 74.0 0.0 31.0 5.4 1.6 4.7 0.6 1.6 1.8 4.9 0.8 3.3 0.0 13.8 1.5 0.5 23.0 5.6 0.0 2.0 38.8 34.1 0.1 4.7 8.5 513.4 0.7 4.5 62.6 TBX4 ENSG00000121075 "T-box 4" P57082 17 61452404-61485110 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6" "Group enriched" "Detected in some" 7 "Early spermatids: 5.7;Late spermatids: 11.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.4;Hep G2: 2.2;OE19: 2.2;THP-1: 10.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 1.6" "CAB032413, HPA044457" Uncertain Approved Vesicles NA NA Vesicles "CAB032413: AB_2200705, HPA044457: AB_2678948" "unprognostic (1.03e-2)" "unprognostic (2.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.63e-3)" "unprognostic (6.07e-2)" "unprognostic (3.80e-2)" "unprognostic (1.25e-2)" "unprognostic (4.14e-2)" "unprognostic (7.77e-3)" "unprognostic (7.41e-2)" "unprognostic (6.83e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-8)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-2)" 0.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.0 0.6 15.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 26.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 18.6 4.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.1 5.4 0.5 0.4 0.5 1.9 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 2.2 0.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.2 0.1 0.0 0.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.5 0.2 0.0 10.7 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TBX5 HOS ENSG00000089225 "T-box 5" Q99593 12 114353931-114408442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.5;lung: 14.0;placenta: 19.7" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 62.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hippocampal formation: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008786: AB_10601720, HPA064683: AB_2685320" "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 2.2 0.1 0.1 0.0 0.1 0.0 3.8 0.8 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 6.4 0.1 0.0 44.5 2.2 0.1 0.1 0.1 14.0 1.6 0.1 0.1 0.1 0.1 0.0 0.1 19.7 0.5 5.4 0.0 1.4 0.1 0.0 0.1 0.5 0.1 6.6 0.2 0.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 6.5 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.1 29.2 6.8 8.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 11.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.2 2.2 0.1 0.1 0.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 3.6 62.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 TBX6 ENSG00000149922 "T-box 6" O95947 16 30085793-30091887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 7.9;Sertoli cells: 6.5;Urothelial cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 9.9;U-266/70: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062498 Approved Nucleoplasm NA NA Nucleoplasm "HPA062498: AB_2732686" "unprognostic (2.47e-1)" "unprognostic (1.32e-3)" "unprognostic (5.62e-5)" "unprognostic (1.49e-1)" "unprognostic (4.76e-2)" "unprognostic (2.35e-2)" "unprognostic (3.35e-1)" "unprognostic (5.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (3.87e-1)" "unprognostic (2.76e-2)" "unprognostic (2.95e-1)" "unprognostic (4.21e-2)" "unprognostic (5.05e-3)" "unprognostic (4.26e-2)" 1.2 1.4 1.4 1.0 1.5 0.6 0.9 0.9 1.5 2.7 1.2 0.9 0.9 1.8 0.9 1.0 22.8 1.6 1.3 0.9 1.5 1.0 1.8 1.2 1.2 1.2 1.7 0.9 1.9 19.8 3.2 2.3 0.9 2.1 3.2 0.3 2.3 3.9 2.2 2.8 5.0 1.7 0.9 1.5 1.8 7.8 2.4 1.2 1.6 2.3 5.1 16.3 5.5 8.6 4.4 1.3 3.3 2.6 1.3 1.9 1.1 0.9 1.1 0.6 1.1 1.5 0.8 0.8 0.3 0.2 0.0 0.2 1.3 4.3 1.9 2.3 0.2 0.2 1.3 0.5 0.9 0.0 1.4 0.8 1.2 1.7 0.9 1.1 0.2 2.6 0.3 1.2 0.3 0.5 0.9 0.6 4.2 0.1 4.3 0.1 3.6 0.7 0.5 0.9 5.9 0.9 2.8 0.1 3.1 0.0 9.9 1.4 2.0 0.2 0.9 1.2 0.5 1.8 1.7 0.5 1.2 0.7 0.6 0.0 10.4 2.4 0.3 1.2 1.8 0.4 3.1 2.6 0.8 1.8 2.3 1.2 1.3 0.9 1.3 1.3 4.4 1.9 1.7 3.3 1.3 0.8 1.1 1.8 1.1 1.4 1.5 0.9 1.4 1.5 1.0 1.7 0.9 2.1 1.2 0.0 1.1 0.8 2.9 1.0 1.4 0.4 0.0 1.4 0.0 1.8 7.9 1.4 0.0 0.7 0.0 1.4 0.7 0.0 1.0 0.6 0.6 2.9 0.0 0.2 0.5 0.0 0.0 0.6 1.0 0.0 0.9 1.0 0.0 0.0 0.9 1.9 2.1 1.4 1.1 0.4 3.1 6.5 0.1 1.7 2.3 0.9 1.9 0.0 0.7 6.4 TBXAS1 "CYP5, CYP5A1, THAS, TS, TXAS, TXS" ENSG00000059377 "Thromboxane A synthase 1" P24557 7 139777051-140020325 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.1;lymphoid tissue: 51.7" "Group enriched" "Detected in many" 5 "granulocytes: 69.3;Hofbauer cells: 78.3;Kupffer cells: 159.9;Macrophages: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 13 "basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4" "Group enriched" "Detected in all" 20 "dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1" "Cell line enhanced" "Detected in some" "NB-4: 35.3;PC-3: 11.4;RPTEC TERT1: 10.1;U-937: 28.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA031257, HPA031258, HPA031259" Enhanced NA NA 32000000 "HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814" "unprognostic (4.46e-2)" "unprognostic (3.07e-1)" "unprognostic (8.80e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (9.41e-2)" "unprognostic (5.10e-2)" "unprognostic (3.12e-1)" "unprognostic (2.38e-1)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.52e-1)" "unprognostic (5.00e-3)" "unprognostic (8.53e-2)" "unprognostic (5.34e-2)" 13.5 7.7 6.6 17.6 8.9 13.8 5.4 1.5 5.6 3.7 6.3 13.9 0.8 6.5 3.2 4.1 3.4 5.0 13.9 3.7 7.6 5.7 6.1 8.1 20.3 43.9 12.6 2.0 2.5 3.1 1.4 3.5 9.0 9.0 5.2 8.6 4.4 8.2 2.6 1.6 1.9 9.3 7.9 19.3 51.7 7.1 2.0 12.7 7.5 2.4 2.2 6.1 9.3 2.5 1.3 18.7 45.2 67.1 1.5 2.2 25.1 0.1 3.0 0.1 0.0 0.6 1.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 4.6 0.4 8.3 0.0 0.0 0.8 2.8 7.4 1.0 0.0 0.0 0.4 0.5 1.1 0.0 0.2 1.0 0.3 0.0 1.0 35.3 0.1 8.3 11.4 1.3 0.0 0.5 10.1 0.0 0.1 0.5 0.1 0.0 0.3 0.0 0.0 6.7 0.9 0.3 0.1 0.7 0.5 2.4 0.4 0.1 0.2 28.7 0.9 38.1 44.5 45.2 1.1 67.1 1.7 1.3 2.2 0.6 18.7 0.5 0.3 0.2 38.8 1.5 56.4 3.3 2.0 25.1 6.6 8.9 1.5 5.6 7.6 5.7 12.6 2.0 9.0 12.7 3.0 16.2 6.0 0.9 0.3 1.0 0.8 7.6 1.4 2.3 1.8 5.9 0.4 8.3 4.3 0.4 2.9 0.1 0.0 8.4 0.6 0.8 7.4 69.3 4.0 78.3 3.2 1.7 18.4 159.9 0.4 0.3 116.3 3.3 16.2 2.0 3.2 3.9 7.0 0.0 4.6 3.8 19.4 0.9 0.4 0.4 0.5 0.5 14.9 2.7 1.0 TBXT T ENSG00000164458 "T-box transcription factor T" O15178 6 166157656-166168700 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "parathyroid gland: 12.2;pituitary gland: 5.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 22 "testis cancer: 6.2" "Region enhanced" "Detected in single" "pons and medulla: 3.0" "Group enriched" "Detected in some" 24 "naive B-cell: 2.3;NK-cell: 2.5" "Group enriched" "Detected in many" 24 "B-cells: 2.3;NK-cells: 2.5" "Cell line enriched" "Detected in some" 4 "HeLa: 18.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA003322 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA003322: AB_1080176" "unprognostic (5.68e-2)" "unprognostic (4.59e-2)" "unprognostic (6.21e-3)" "unprognostic (8.64e-3)" "unprognostic (9.34e-3)" 0.3 0.0 0.1 2.0 0.0 0.0 0.1 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 12.2 5.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.0 1.9 0.0 0.0 1.2 0.0 0.6 0.0 0.0 2.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 18.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.4 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.5 0.9 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779751-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 100.1" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 183.3;Pancreatic endocrine cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "MAIT T-cell: 32.2" "Group enriched" "Detected in many" 46 "NK-cells: 12.9;T-cells: 32.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 9.8;OE19: 31.5;RT4: 18.5;SK-BR-3: 22.5;T-47d: 11.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favorable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 6.6 1.5 0.9 15.8 0.9 1.9 12.3 0.4 1.9 8.9 10.2 0.6 16.7 5.4 7.6 7.0 11.6 5.4 24.9 4.7 0.9 1.0 3.7 6.8 13.5 11.3 0.8 0.5 5.5 100.1 12.4 8.4 13.1 1.6 9.3 7.0 6.6 29.8 20.1 2.1 6.9 11.7 3.2 1.1 12.3 10.8 4.9 0.1 8.7 10.3 5.8 27.9 8.3 9.5 0.2 0.0 0.4 0.0 12.9 32.2 7.7 4.5 0.7 0.0 0.0 0.8 0.0 6.3 0.0 0.1 0.0 0.0 3.2 9.8 3.0 0.2 0.0 0.1 0.5 4.5 4.6 0.0 0.0 2.4 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.7 0.0 0.2 0.0 0.0 0.2 0.0 2.4 0.0 8.1 0.0 0.0 0.6 31.5 0.0 0.0 0.0 0.0 2.2 18.5 3.4 0.0 0.4 22.5 0.0 1.3 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.7 0.0 32.2 0.2 16.2 18.6 0.0 0.1 13.3 11.0 0.4 12.9 0.0 0.0 5.2 7.7 0.9 0.9 0.4 1.9 0.9 1.0 0.8 0.5 1.6 0.1 38.7 70.6 6.7 26.4 47.5 0.0 0.7 30.6 68.3 59.1 24.4 0.0 0.9 1.7 55.7 12.8 4.0 23.4 0.0 183.3 3.0 10.8 49.3 6.9 0.8 0.2 0.0 30.5 5.5 1.0 21.7 52.6 2.2 57.3 1.0 54.7 3.7 110.5 40.8 12.0 7.7 0.0 0.0 4.3 35.2 8.1 72.1 4.6 54.6 33.0 58.8 TCAF2C ENSG00000283528 "TRPM8 channel associated factor 2C" 7 143639230-143647646 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.2;parathyroid gland: 1.9;placenta: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.2;T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.1;OE19: 1.5;U-266/70: 3.9;U-266/84: 1.8" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.0 0.0 1.8 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.9 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCAP "CMD1N, LGMD2G, T-cap, TELE, telethonin" ENSG00000173991 Titin-cap O15273 17 39664187-39666555 "Disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "heart muscle: 298.7;skeletal muscle: 708.2;tongue: 249.2" "Cell type enriched" "Detected in many" 230 "Cardiomyocytes: 2189.2" "Group enriched" "Detected in many" 8 "head and neck cancer: 20.2;prostate cancer: 11.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 6 "T-cells: 2.4" "Cell line enhanced" "Detected in many" "NB-4: 7.0;SK-BR-3: 12.1" "Region enhanced" "Detected in many" "cerebral cortex: 15.0" "Not detected" "Not detected" "CAB004591, HPA026477" Enhanced NA NA 68000 "CAB004591: AB_628340, HPA026477: AB_1857888" "unprognostic (5.29e-2)" "unprognostic (9.29e-2)" "unprognostic (2.40e-3)" "unprognostic (4.32e-3)" "unprognostic (8.79e-2)" "unprognostic (3.68e-2)" "unprognostic (1.61e-1)" "unprognostic (3.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.12e-4)" "unprognostic (2.62e-1)" "unprognostic (4.51e-2)" "unprognostic (8.59e-2)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "prognostic favorable (4.55e-4)" 3.2 0.2 0.2 0.1 0.5 0.2 0.2 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.1 11.1 8.6 0.1 0.1 298.7 0.2 0.2 0.1 0.1 0.2 0.2 0.6 0.0 0.1 0.2 0.1 0.2 0.1 0.0 4.1 0.1 0.0 12.3 0.1 708.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.0 5.8 249.2 11.5 0.2 0.1 0.3 0.0 0.0 0.2 0.3 2.4 0.1 0.2 3.2 2.5 3.6 0.5 0.5 0.8 0.5 0.2 0.5 0.8 1.2 2.1 1.3 2.6 0.3 2.7 1.3 1.1 0.1 0.2 1.1 3.2 1.4 1.6 0.4 0.7 0.7 0.4 1.0 0.6 1.0 0.3 1.4 0.2 1.7 2.4 0.8 0.2 1.4 1.0 7.0 1.7 1.3 0.8 1.1 2.5 0.8 0.5 0.4 1.6 2.5 1.7 12.1 1.4 2.4 0.9 1.4 1.2 1.0 1.8 2.2 0.8 5.3 3.0 0.7 1.1 1.8 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.4 2.4 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.5 0.4 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.5 1.4 1.3 2189.2 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.4 9.5 2.9 1.3 1.2 0.0 0.3 0.6 1.7 0.0 1.5 0.6 0.4 0.0 0.4 0.0 1.1 6.5 1.9 0.9 0.7 1.8 0.3 0.0 1.1 0.7 TCEA3 TFIIS.H ENSG00000204219 "Transcription elongation factor A3" O75764 1 23381061-23424740 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 114.0" "Cell type enhanced" "Detected in many" 6 "Mucus-secreting cells: 307.1;Undifferentiated cells: 204.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 8.5;naive CD4 T-cell: 14.3" "Lineage enriched" "Detected in many" 5 "T-cells: 14.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 10.0;Hep G2: 33.2;OE19: 17.1;SiHa: 11.0;T-47d: 17.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044960, HPA055811" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA044960: AB_10964053, HPA055811: AB_2682932" "unprognostic (1.58e-1)" "unprognostic (1.75e-3)" "unprognostic (9.18e-2)" "unprognostic (3.82e-2)" "unprognostic (2.77e-3)" "prognostic favorable (2.56e-4)" "unprognostic (2.86e-2)" "unprognostic (4.70e-3)" "unprognostic (7.37e-3)" "unprognostic (2.85e-1)" "unprognostic (2.22e-2)" "unprognostic (3.27e-1)" "unprognostic (2.23e-1)" "unprognostic (4.01e-1)" "unprognostic (5.20e-2)" "unprognostic (3.15e-1)" "unprognostic (5.58e-2)" 5.4 17.8 2.5 10.7 1.9 0.1 3.6 1.5 1.5 9.1 12.2 2.2 12.0 4.6 3.8 14.5 12.0 6.2 13.0 20.3 2.4 0.8 12.1 38.0 6.0 1.3 1.2 2.3 19.8 60.4 4.5 3.3 2.5 2.2 16.7 12.5 8.7 32.7 15.9 114.0 8.9 11.9 13.7 2.0 1.6 11.5 2.6 1.3 0.5 8.6 58.3 16.0 8.4 6.9 0.0 2.8 0.0 0.7 0.2 14.3 2.5 0.0 0.1 0.3 0.3 1.7 10.0 5.5 3.9 2.5 2.1 1.2 2.5 0.3 0.1 0.4 4.8 0.6 5.4 0.4 0.0 1.8 0.0 0.0 0.0 4.1 33.2 1.2 0.4 0.0 6.5 1.8 1.8 0.0 4.5 0.2 0.0 0.0 0.0 0.6 0.9 0.2 3.6 0.0 17.1 1.2 0.0 0.0 0.1 0.0 0.0 0.3 0.1 11.0 0.5 0.4 1.0 17.5 1.6 0.2 0.0 0.1 0.4 0.0 0.3 2.9 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.5 0.7 0.5 0.0 8.5 1.2 2.8 0.0 14.3 6.3 0.0 0.2 0.2 0.9 0.7 2.5 2.5 1.9 1.5 1.5 2.4 0.8 1.2 2.3 2.2 1.3 116.1 83.2 2.2 44.3 24.4 1.5 92.9 68.8 45.5 71.7 40.1 2.0 3.0 169.1 22.0 4.7 12.7 145.7 0.0 86.0 28.5 32.8 62.5 9.2 177.9 1.2 23.8 53.7 9.8 7.3 7.2 15.8 16.2 23.6 2.8 307.1 2.9 40.2 98.2 14.5 173.6 1.5 19.4 20.6 0.5 3.5 47.9 1.8 6.1 204.2 55.5 TCEAL2 "my048, MY0876G05, WEX1" ENSG00000184905 "Transcription elongation factor A like 2" Q9H3H9 X 102125688-102127711 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.0;ovary: 46.5" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 143.3;Distal tubular cells: 59.7;Horizontal cells: 92.2;Muller glia cells: 150.4" "Cancer enhanced" "Detected in many" "glioma: 22.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.1" "Group enriched" "Detected in some" 4 "HAP1: 7.4;SCLC-21H: 8.1;U-2 OS: 14.6" HPA076317 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA076317: AB_2686794" "unprognostic (2.34e-3)" "unprognostic (1.35e-2)" "unprognostic (7.59e-3)" "unprognostic (3.84e-3)" "unprognostic (2.07e-1)" "unprognostic (4.57e-2)" "unprognostic (4.27e-2)" "unprognostic (2.80e-2)" "unprognostic (3.47e-1)" "unprognostic (3.26e-1)" "unprognostic (7.07e-3)" "unprognostic (1.43e-1)" "unprognostic (1.56e-2)" "unprognostic (1.73e-2)" "unprognostic (7.76e-2)" "unprognostic (1.04e-1)" "unprognostic (4.11e-3)" 2.4 19.6 34.1 2.6 44.6 1.1 2.4 40.9 84.0 5.8 7.0 8.5 1.8 3.1 19.5 8.6 5.3 7.3 6.4 5.1 30.0 37.9 8.2 1.3 4.4 1.6 25.4 26.5 46.5 3.7 2.8 38.3 1.1 30.1 19.4 3.8 6.6 16.4 21.6 1.2 1.7 3.2 14.0 16.1 2.9 4.2 19.7 9.6 0.0 25.6 0.0 2.1 4.3 2.6 0.1 0.1 0.0 0.1 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 14.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.8 0.1 1.7 0.0 0.1 0.0 1.8 2.1 0.0 0.0 0.0 0.0 0.1 0.4 34.1 44.6 40.9 41.8 30.0 37.9 25.4 26.5 30.1 9.6 6.0 12.3 0.0 55.7 1.6 143.3 4.6 0.0 0.0 22.7 29.6 5.9 0.0 59.7 0.1 2.9 8.7 0.0 0.0 0.3 0.1 5.3 42.5 2.3 0.0 0.0 92.2 0.0 3.7 0.0 7.5 6.1 1.0 6.8 1.0 0.0 150.4 1.6 0.0 5.3 0.5 40.9 6.5 17.0 1.7 1.1 1.1 0.0 0.0 0.0 6.3 TCEAL5 WEX4 ENSG00000204065 "Transcription elongation factor A like 5" Q5H9L2 X 103273691-103276872 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;testis: 45.9" "Group enriched" "Detected in some" 4 "Bipolar cells: 41.1;Muller glia cells: 64.8;Peritubular cells: 33.6" "Cancer enhanced" "Detected in many" "glioma: 13.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SCLC-21H: 7.5;SH-SY5Y: 23.4" "HPA045564, HPA058982" Supported Approved Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (1.30e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (9.68e-2)" "unprognostic (8.75e-4)" "unprognostic (1.21e-1)" "unprognostic (8.11e-2)" "prognostic favorable (8.60e-4)" "unprognostic (1.28e-2)" "unprognostic (1.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.74e-1)" "unprognostic (6.30e-2)" "unprognostic (6.03e-4)" 2.0 11.2 21.9 2.1 31.8 1.3 3.3 32.7 56.4 4.7 2.2 6.6 0.0 1.9 6.0 7.8 1.5 1.6 2.0 2.0 22.3 23.1 1.5 1.3 1.5 1.3 13.0 24.0 5.0 2.1 1.3 23.1 1.3 19.8 3.7 2.0 1.4 2.3 5.4 1.4 1.3 2.4 4.3 11.0 1.3 1.5 45.9 8.4 0.0 3.4 0.0 1.3 2.1 1.1 0.7 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 21.9 31.8 32.7 31.9 22.3 23.1 13.0 24.0 19.8 8.4 0.0 0.0 0.0 0.3 0.1 41.1 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.6 0.4 0.0 0.0 0.0 0.3 0.6 0.2 0.0 0.0 0.2 1.6 0.0 0.0 0.0 11.5 7.8 0.6 0.0 0.0 0.0 64.8 0.0 0.0 33.6 0.0 5.6 0.0 0.9 2.8 1.7 0.3 0.3 0.0 0.0 0.1 TCEAL6 WEX2 ENSG00000204071 "Transcription elongation factor A like 6" Q6IPX3 X 102140476-102142970 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 14.3;brain: 48.4;pituitary gland: 20.7;testis: 21.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 30.0;Horizontal cells: 14.3" "Cancer enriched" "Detected in single" 9 "glioma: 3.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 1.1;SCLC-21H: 2.0" "HPA045564, HPA058982" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA045564: AB_2679369, HPA058982: AB_2683870" "unprognostic (5.43e-2)" "unprognostic (6.54e-2)" "unprognostic (1.87e-3)" "unprognostic (6.69e-3)" "unprognostic (1.39e-1)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (3.89e-2)" "unprognostic (1.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.33e-2)" "unprognostic (1.18e-1)" 1.1 14.3 16.6 1.3 15.2 1.0 1.1 31.4 48.4 1.2 1.4 2.5 0.0 1.3 5.3 2.8 1.1 3.2 1.1 1.1 11.3 26.0 1.2 1.0 1.0 1.0 15.2 7.5 6.1 1.3 1.1 20.7 1.0 12.5 1.9 1.3 2.0 3.1 1.9 1.0 1.0 1.3 1.9 7.5 1.0 1.0 21.9 2.8 0.0 1.8 0.0 1.0 1.0 1.7 0.7 0.6 0.1 0.5 1.3 0.7 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.6 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.0 0.0 0.7 0.0 0.3 0.1 0.5 0.1 0.5 0.3 0.7 0.4 0.2 0.3 0.5 0.7 0.4 0.6 0.0 1.3 0.0 0.6 0.6 0.6 16.6 15.2 31.4 26.0 11.3 26.0 15.2 7.5 12.5 2.8 0.0 0.0 0.0 0.2 0.1 30.0 4.0 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 2.6 2.3 0.0 1.7 0.0 0.0 2.0 0.7 0.0 0.7 0.0 4.3 0.0 1.9 1.1 0.8 0.3 0.0 0.0 0.0 0.0 TCEAL7 "MGC23947, WEX5" ENSG00000182916 "Transcription elongation factor A like 7" Q9BRU2 X 103330196-103332326 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 70.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 34.8;Horizontal cells: 46.1;Leydig cells: 40.6;Muller glia cells: 77.7;Peritubular cells: 36.7;Smooth muscle cells: 31.7" "Cancer enriched" "Detected in many" 10 "glioma: 39.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.3" "Lineage enhanced" "Detected in single" "NK-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 23.0;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;GAMG: 31.8;hTEC/SVTERT24-B: 23.0;SCLC-21H: 58.2;U-87 MG: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051507, HPA065080" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051507: AB_2681512, HPA065080: AB_2685419" "unprognostic (1.09e-2)" "unprognostic (4.36e-2)" "unprognostic (5.54e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (4.52e-2)" "unprognostic (2.17e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (1.12e-1)" "unprognostic (4.18e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (4.31e-4)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.62e-1)" "unprognostic (2.28e-2)" "unprognostic (1.35e-3)" 4.9 22.1 31.7 3.8 33.4 1.0 7.8 33.0 70.4 16.8 6.4 20.1 1.8 3.9 36.4 14.7 5.1 5.4 9.7 9.5 31.1 44.2 4.6 2.6 3.8 2.5 34.4 27.4 23.2 1.3 1.3 14.0 2.5 51.8 10.3 6.9 2.0 2.9 11.3 2.9 1.5 4.9 23.3 45.1 5.0 2.6 3.2 19.4 0.0 3.0 2.2 1.9 7.5 5.7 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 23.0 0.0 10.1 15.6 4.1 3.2 16.9 7.2 20.7 0.0 0.0 0.0 0.0 3.4 31.8 0.0 0.0 0.4 12.5 0.0 0.2 0.1 0.0 0.0 5.1 0.0 0.0 13.1 0.0 23.0 0.0 0.0 7.5 0.0 0.1 0.0 19.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.6 0.0 0.0 0.0 58.2 15.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 10.7 0.4 0.1 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 31.7 33.4 33.0 46.7 31.1 44.2 34.4 27.4 51.8 19.4 0.0 2.2 0.0 5.2 2.3 34.8 14.1 0.0 0.0 1.2 3.5 3.9 1.2 5.0 0.2 0.2 1.9 0.0 0.0 0.0 0.3 6.1 0.9 0.0 0.0 0.5 46.1 0.0 2.5 0.0 1.4 40.6 0.8 8.5 0.0 0.0 77.7 0.5 0.0 36.7 1.0 10.2 12.9 31.7 3.1 0.9 2.8 0.2 0.0 0.0 0.9 TCERG1L FLJ38950 ENSG00000176769 "Transcription elongation regulator 1 like" Q5VWI1 10 131092391-131311721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.7;thyroid gland: 24.1" "Cell type enriched" "Detected in some" 10 "Horizontal cells: 96.9" "Cancer enriched" "Detected in some" 14 "thyroid cancer: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA030816 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030816: AB_10601721" "unprognostic (6.61e-2)" "unprognostic (1.29e-1)" "unprognostic (8.99e-2)" "unprognostic (1.45e-2)" "unprognostic (3.03e-1)" "unprognostic (6.69e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-1)" "unprognostic (9.71e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.08e-5)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "unprognostic (2.96e-2)" "unprognostic (2.03e-1)" 0.4 1.9 2.7 0.4 4.1 0.4 0.6 3.0 9.7 0.5 0.4 0.0 0.0 0.4 0.6 1.1 0.6 0.4 0.4 0.4 3.8 3.5 0.4 0.4 0.5 0.4 0.9 3.9 5.5 0.8 0.4 4.8 0.4 1.5 1.4 0.4 3.8 0.3 1.3 0.3 1.2 0.4 0.4 2.2 0.6 0.5 1.8 0.0 0.6 24.1 0.0 0.6 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 4.1 3.0 9.7 3.8 3.5 0.9 3.9 1.5 0.0 0.0 0.0 0.0 0.1 0.6 4.5 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.6 0.0 0.0 0.0 96.9 0.0 0.0 0.0 0.0 4.4 0.0 10.1 0.0 0.0 0.8 0.1 0.0 4.2 0.0 3.6 0.0 0.0 0.1 4.7 0.5 0.1 0.0 0.0 0.0 TCF12 "bHLHb20, HEB, HsT17266, HTF4" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 89.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: AB_2685564" "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavorable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 20.9 14.3 24.9 12.6 37.5 10.9 18.4 32.7 41.8 48.2 16.5 33.6 14.0 16.0 28.1 15.0 14.8 28.2 21.4 15.7 28.4 16.4 17.0 14.4 17.3 13.7 33.9 15.3 26.2 12.5 29.2 15.7 19.1 27.9 26.3 17.9 14.7 20.1 17.5 18.1 16.0 15.8 25.8 25.3 13.6 17.3 14.7 41.3 89.4 17.0 9.6 15.8 23.3 21.2 11.8 15.9 16.0 19.3 12.2 17.6 10.2 6.5 12.3 54.1 17.4 24.7 21.7 9.5 13.5 23.7 12.0 15.9 7.9 5.3 9.0 11.1 20.4 8.6 7.9 21.1 9.7 15.3 11.8 7.9 18.0 13.3 9.5 17.0 11.3 9.5 19.0 17.6 11.0 29.2 16.0 21.4 40.5 20.1 11.3 16.2 2.2 26.7 6.3 14.6 6.8 5.3 36.5 62.8 8.4 16.5 12.2 11.0 32.0 14.5 5.3 13.1 18.0 8.2 22.3 16.4 19.3 14.8 8.2 19.6 6.5 11.6 15.0 10.8 22.1 23.1 16.0 11.2 8.7 15.0 14.3 12.4 10.8 12.2 13.6 15.9 11.8 14.1 12.7 1.3 12.2 19.3 6.6 17.6 10.2 24.9 37.5 32.7 26.9 28.4 16.4 33.9 15.3 27.9 41.3 50.6 15.8 14.2 18.0 23.7 12.8 14.5 20.4 16.0 27.3 15.7 33.4 8.5 11.6 15.2 19.4 27.4 15.8 0.0 10.3 12.7 31.5 19.7 22.0 16.0 23.5 12.7 8.6 22.7 34.0 15.6 23.9 26.0 13.5 10.0 16.5 26.9 13.8 17.5 32.5 13.6 25.1 45.3 20.6 18.9 12.5 29.5 10.9 16.0 16.4 15.6 TCF15 "bHLHa40, EC2, PARAXIS" ENSG00000125878 "Transcription factor 15" Q12870 20 603797-610398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 11.4;heart muscle: 19.4;skeletal muscle: 18.0" "Cell type enhanced" "Detected in some" 19 "Cardiomyocytes: 8.5;Endothelial cells: 4.3;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 10.9;HMC-1: 17.9;SuSa: 3.3;U-2 OS: 3.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050998, HPA060221" Approved Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA050998: AB_2681302, HPA060221: AB_2684225" "unprognostic (2.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.58e-2)" "unprognostic (3.55e-2)" "unprognostic (1.29e-1)" "unprognostic (4.62e-2)" "unprognostic (5.57e-2)" "unprognostic (2.33e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.52e-1)" "unprognostic (9.43e-2)" "unprognostic (1.27e-3)" "unprognostic (7.21e-2)" "unprognostic (8.56e-2)" "unprognostic (5.11e-1)" "unprognostic (6.99e-2)" 8.4 0.3 0.9 0.4 1.0 0.2 11.4 0.1 1.1 0.6 1.3 0.1 0.0 0.4 0.8 0.3 1.7 0.4 0.7 19.4 1.2 0.7 0.5 0.3 0.9 0.3 1.0 0.0 0.2 0.1 0.4 0.3 8.2 0.7 1.0 0.3 0.3 0.8 0.3 18.0 0.2 0.4 1.3 1.1 0.2 0.4 1.6 0.6 0.2 1.3 6.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 3.1 10.9 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 1.6 0.0 1.4 0.0 3.3 0.0 1.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 0.1 1.1 1.2 0.7 1.0 0.0 0.7 0.6 0.0 0.0 0.0 0.1 0.1 0.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 1.6 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 12.9 1.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 TCF19 SC1 ENSG00000137310 "Transcription factor 19" Q9Y242 6 31158542-31167159 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 31.3" "Cell type enhanced" "Detected in many" 4 "Spermatogonia: 12.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 33.2;GAMG: 19.8;HEK 293: 18.7;JURKAT: 17.0;Karpas-707: 16.2;SCLC-21H: 20.6;U-138 MG: 20.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA065994 Approved Nucleoplasm,Nucleoli NA Yes Nucleoplasm Nucleoli "HPA065994: " "unprognostic (1.41e-2)" "unprognostic (4.92e-2)" "unprognostic (4.00e-2)" "unprognostic (5.16e-3)" "unprognostic (1.99e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (7.04e-2)" "unprognostic (1.35e-2)" "unprognostic (5.92e-2)" "unprognostic (1.74e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (3.54e-10)" "unprognostic (3.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.36e-2)" "unprognostic (1.21e-1)" 4.3 1.5 1.3 12.4 4.1 2.3 5.2 8.2 3.9 7.0 5.6 2.3 3.7 9.2 4.2 6.2 11.2 3.2 3.8 3.4 1.7 1.1 4.3 1.6 4.8 18.0 3.0 1.0 4.6 3.6 0.4 0.9 1.5 2.0 5.5 4.0 2.3 4.1 6.7 2.5 11.5 6.0 3.9 1.8 8.6 5.9 3.1 1.8 31.3 2.8 14.4 13.8 4.8 6.7 2.0 0.9 0.2 0.3 1.2 3.8 1.2 33.2 0.3 0.3 0.0 2.3 3.0 0.3 0.2 0.0 0.0 0.0 2.1 0.0 0.0 7.5 8.2 19.8 0.0 0.0 12.4 0.0 0.2 18.7 2.9 1.9 0.8 0.0 0.1 8.8 1.2 0.0 0.9 0.0 1.8 7.4 17.0 0.0 16.2 3.2 0.1 0.4 5.3 0.0 0.0 0.0 0.4 2.0 0.2 2.9 0.1 20.6 0.2 0.2 0.0 0.2 2.7 0.0 2.4 0.0 20.6 0.1 0.1 0.1 5.3 6.0 10.2 0.0 0.1 0.1 0.0 0.3 0.0 0.7 0.0 3.8 1.6 1.9 3.4 0.9 2.0 2.4 0.9 0.2 1.2 0.1 0.0 2.6 1.2 1.3 4.1 8.2 3.9 1.7 1.1 3.0 1.0 2.0 1.8 3.0 1.1 6.0 2.1 4.5 2.6 1.2 0.0 0.0 3.4 3.5 0.0 0.6 6.6 1.6 0.3 3.3 1.1 0.0 1.6 7.2 2.7 1.0 1.1 0.2 7.5 1.6 1.2 1.3 1.9 0.4 4.6 4.3 11.8 10.0 3.3 3.3 0.8 0.0 6.0 0.3 0.5 0.0 6.8 0.5 12.8 3.3 0.3 5.1 7.7 0.9 TCF21 "bHLHa23, POD1" ENSG00000118526 "Transcription factor 21" O43680 6 133889138-133895553 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 74.4;ovary: 61.6" "Group enriched" "Detected in some" 5 "Leydig cells: 94.6;Peritubular cells: 110.0;Sertoli cells: 116.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HHSteC: 19.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA013189 Uncertain NA NA "HPA013189: AB_10601215" "unprognostic (2.43e-2)" "unprognostic (8.45e-2)" "unprognostic (2.22e-2)" "unprognostic (1.60e-1)" "unprognostic (8.60e-2)" "unprognostic (4.78e-5)" "unprognostic (2.58e-2)" "unprognostic (6.66e-2)" "unprognostic (9.74e-2)" "unprognostic (2.88e-2)" "unprognostic (2.91e-3)" "unprognostic (2.01e-2)" "unprognostic (8.48e-2)" "unprognostic (5.37e-2)" "unprognostic (2.95e-1)" 4.7 2.2 0.2 11.6 0.5 0.0 0.4 0.2 0.2 12.7 16.8 0.4 9.6 5.2 12.9 9.6 19.1 2.2 14.6 13.2 0.2 0.2 17.0 4.1 74.4 1.0 0.2 0.0 61.6 1.9 0.0 2.4 48.4 1.2 57.8 5.3 0.0 0.2 16.0 0.8 0.3 13.9 21.1 0.2 52.2 5.7 5.9 0.0 0.0 0.5 0.0 0.0 19.6 24.6 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.0 1.2 0.0 3.0 0.6 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 19.5 0.3 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 94.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 110.0 0.0 0.0 116.4 1.7 0.2 0.4 0.0 4.8 0.0 0.0 0.4 TCF23 "bHLHa24, OUT" ENSG00000163792 "Transcription factor 23" Q7RTU1 2 27149004-27156974 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9" "Group enriched" "Detected in some" 4 "Peritubular cells: 27.3;Sertoli cells: 51.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 10 "THP-1: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044596 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA044596: AB_10797258" "unprognostic (1.04e-1)" "unprognostic (2.47e-3)" "unprognostic (1.70e-2)" "unprognostic (4.21e-2)" "unprognostic (3.65e-2)" "unprognostic (2.68e-2)" "unprognostic (1.70e-2)" "unprognostic (4.07e-2)" "unprognostic (3.21e-1)" "unprognostic (1.74e-2)" "unprognostic (4.08e-2)" "unprognostic (8.58e-2)" "unprognostic (2.41e-5)" "unprognostic (7.58e-3)" "unprognostic (3.01e-1)" "unprognostic (8.58e-4)" "unprognostic (2.64e-2)" 0.3 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.1 28.0 0.5 0.0 0.5 0.0 56.4 7.2 0.1 14.0 0.4 0.6 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 49.9 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 16.7 0.1 6.2 0.1 7.5 0.0 0.0 0.1 0.0 0.0 0.7 1.5 1.8 1.4 4.4 1.0 1.3 1.2 0.2 0.2 0.2 0.1 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.5 0.1 0.6 0.3 0.0 0.1 0.9 0.1 0.7 0.0 0.3 0.2 0.1 0.2 0.3 0.1 0.3 0.3 8.8 0.0 0.2 0.2 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.0 4.4 1.0 0.9 1.0 0.5 0.8 1.1 1.1 0.8 0.2 1.8 1.2 1.0 3.9 1.3 0.5 1.4 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 2.1 0.0 0.5 0.0 0.1 0.6 0.0 0.0 1.2 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 1.8 0.3 0.7 9.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 27.3 0.0 0.5 51.8 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.5 TCF24 bHLHa25 ENSG00000261787 "Transcription factor 24" Q7RTU0 8 66946501-66962590 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "heart muscle: 8.0;kidney: 4.1;testis: 7.0" "Group enriched" "Detected in some" 25 "Cardiomyocytes: 4.4;Spermatocytes: 1.4;Spermatogonia: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.8;HEK 293: 9.5;HMC-1: 8.3;K-562: 2.5" "Low region specificity" "Detected in some" NA NA "unprognostic (1.07e-1)" "unprognostic (9.14e-3)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (8.30e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (2.25e-1)" "unprognostic (9.38e-3)" "unprognostic (9.36e-2)" "unprognostic (1.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.14e-1)" "unprognostic (1.09e-1)" 0.1 0.0 0.5 0.1 0.9 0.3 0.1 0.1 0.9 0.5 0.1 0.1 0.1 0.0 0.2 0.3 0.1 1.6 0.1 8.0 0.6 0.8 4.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.5 0.1 0.6 7.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.3 0.0 0.0 0.0 3.8 0.0 0.1 0.0 9.5 0.4 0.1 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.7 0.0 0.4 1.6 0.7 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.9 0.1 0.9 0.6 0.8 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.5 0.0 0.0 0.0 0.0 0.0 TCF4 "bHLHb19, E2-2, ITF2, SEF2-1B" ENSG00000196628 "Transcription factor 4" P15884 18 55222331-55664787 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 85.8" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 425.9;Muller glia cells: 397.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "memory B-cell: 29.7;naive B-cell: 22.0;plasmacytoid DC: 85.8" "Group enriched" "Detected in many" 36 "B-cells: 29.7;dendritic cells: 85.8" "Cell line enhanced" "Detected in many" "HDLM-2: 42.4;SH-SY5Y: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020722, HPA025958" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB020722: , HPA025958: AB_1857849" "unprognostic (2.11e-1)" "unprognostic (9.10e-2)" "unprognostic (8.69e-2)" "unprognostic (7.89e-3)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (3.03e-2)" "unprognostic (8.64e-2)" "unprognostic (1.79e-2)" "unprognostic (3.29e-2)" "unprognostic (2.77e-1)" "unprognostic (8.44e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (1.99e-3)" "unprognostic (2.68e-2)" "unprognostic (2.76e-3)" "prognostic unfavorable (9.95e-4)" 34.6 16.0 20.3 14.4 17.0 10.7 23.5 48.7 32.4 35.4 13.5 14.9 12.0 6.6 27.4 9.6 12.5 16.9 20.4 19.9 23.5 11.9 6.0 6.2 21.9 16.8 16.7 20.3 31.8 7.2 16.2 15.7 32.8 16.1 9.5 10.1 9.2 9.4 13.2 12.1 12.2 10.7 28.4 15.0 14.6 7.4 17.0 17.5 6.4 16.4 12.7 17.0 18.3 14.5 29.7 85.8 0.3 1.2 1.5 0.1 1.7 0.0 1.1 12.0 3.6 2.8 5.0 0.0 6.0 13.4 4.3 5.7 7.4 1.1 9.2 0.0 13.3 0.9 1.5 5.5 5.3 3.0 42.4 4.1 3.6 0.0 0.0 1.3 1.6 0.9 6.5 1.7 6.0 0.2 2.9 15.6 0.5 5.9 6.9 3.7 0.0 2.2 0.0 3.5 0.0 0.7 13.5 5.0 20.5 0.0 0.2 4.2 53.7 0.0 0.5 0.0 3.8 0.5 0.4 15.7 16.3 5.7 0.6 4.7 5.2 9.7 8.2 3.6 1.6 4.7 0.1 1.1 0.1 0.1 1.2 0.1 29.7 0.0 0.0 3.3 22.0 0.0 0.0 0.3 1.5 1.1 85.8 0.1 1.7 20.3 17.0 48.7 26.9 23.5 11.9 16.7 20.3 16.1 17.5 6.0 19.1 128.9 31.3 103.9 238.0 27.8 2.5 30.8 38.7 21.0 78.5 1.9 0.0 1.2 78.3 425.9 0.0 0.0 6.2 1.2 151.6 15.4 12.8 4.4 33.4 23.8 5.2 251.0 98.7 90.2 190.1 63.0 60.8 33.3 0.0 397.9 3.2 0.0 171.1 1.7 54.4 232.8 142.8 6.7 4.4 73.8 2.2 1.9 0.0 10.9 TCF7 TCF-1 ENSG00000081059 "Transcription factor 7" P36402 5 134114711-134151865 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "lymphoid tissue: 326.1" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2" "Group enriched" "Detected in many" 19 "NK-cells: 14.2;T-cells: 35.8" "Cell line enriched" "Detected in many" 6 "MOLT-4: 170.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB019403, HPA058863, HPA070505" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275" "unprognostic (3.63e-3)" "unprognostic (1.98e-3)" "unprognostic (1.03e-1)" "unprognostic (5.08e-3)" "unprognostic (1.70e-1)" "unprognostic (6.74e-2)" "unprognostic (1.12e-1)" "unprognostic (6.38e-2)" "unprognostic (2.31e-1)" "unprognostic (1.65e-1)" "unprognostic (5.35e-2)" "unprognostic (2.32e-1)" "unprognostic (3.04e-1)" "unprognostic (1.50e-2)" "unprognostic (2.33e-2)" "unprognostic (1.90e-1)" "unprognostic (4.10e-2)" 1.8 3.6 1.3 21.8 1.5 5.2 3.1 0.9 1.2 2.1 3.3 2.5 2.2 5.6 1.4 16.3 2.7 16.1 2.6 1.6 1.5 1.2 2.7 3.7 4.0 41.8 1.3 1.0 2.5 7.2 0.2 6.1 1.4 4.7 2.9 2.3 3.6 7.9 1.8 0.9 2.9 15.1 0.9 3.3 14.4 3.7 2.4 1.1 326.1 4.4 2.2 32.5 3.3 1.5 1.2 0.1 1.0 0.1 14.2 35.8 6.9 0.0 1.0 1.1 3.9 0.5 2.1 1.5 0.3 0.5 0.1 0.1 8.0 2.5 0.0 1.9 1.7 4.3 0.1 1.7 0.4 0.0 0.3 1.7 0.0 1.1 6.0 0.0 0.0 0.2 0.1 0.0 1.6 0.0 0.7 0.2 29.0 1.0 0.0 0.1 0.0 170.0 0.1 1.2 2.5 1.4 0.2 0.0 0.1 0.4 0.1 0.4 3.4 0.8 0.2 0.2 0.9 0.2 0.9 0.2 11.0 0.0 5.0 0.3 0.1 0.0 0.0 5.8 0.0 0.5 0.7 0.1 1.0 4.4 0.0 10.3 1.2 17.8 10.4 0.0 0.4 35.8 21.8 0.7 14.2 0.0 0.1 2.1 6.9 1.3 1.5 0.9 1.2 1.5 1.2 1.3 1.0 4.7 1.1 3.0 3.4 22.9 24.6 14.0 27.8 2.7 10.2 1.4 0.0 3.5 68.7 20.0 0.0 5.8 2.4 4.7 21.4 0.0 8.9 23.4 10.8 11.6 20.7 3.2 6.4 9.5 12.1 6.7 5.2 1.7 5.8 4.9 10.1 9.0 12.7 8.3 15.8 17.3 4.2 0.8 53.0 0.0 16.9 3.9 9.4 9.9 25.1 47.5 14.4 12.3 TCFL5 "bHLHe82, CHA, E2BP-1, Figlb" ENSG00000101190 "Transcription factor like 5" Q9UL49 20 62841115-62861763 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.9;testis: 55.7" "Cell type enriched" "Detected in many" 5 "Spermatocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055223, HPA076419" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA055223: AB_2682745, HPA076419: " "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (2.78e-1)" "unprognostic (2.72e-3)" "unprognostic (3.95e-2)" "unprognostic (1.09e-1)" "unprognostic (2.10e-1)" "unprognostic (2.79e-1)" "unprognostic (1.14e-1)" "unprognostic (3.88e-1)" "unprognostic (1.54e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-1)" "unprognostic (1.33e-3)" "unprognostic (1.01e-2)" 5.4 3.9 18.6 4.0 18.9 3.7 6.4 4.6 14.8 6.5 4.1 22.5 6.1 3.2 5.7 6.6 6.0 5.9 5.0 5.5 20.0 15.5 5.0 4.6 3.6 4.7 25.4 10.7 8.3 4.8 7.5 3.0 4.8 17.0 4.9 3.8 6.3 4.9 6.3 4.5 10.9 3.5 5.5 32.9 4.1 3.7 55.7 12.0 8.3 14.9 2.1 5.0 4.6 3.2 1.4 1.9 2.9 1.6 1.2 3.2 0.7 12.9 3.9 8.6 9.9 18.6 18.9 7.7 8.4 11.7 16.4 9.2 9.5 8.0 6.6 9.7 7.4 8.8 14.3 8.6 9.5 14.4 4.6 7.2 5.4 11.2 14.0 7.3 7.9 6.6 6.9 14.2 4.6 9.7 7.1 7.4 10.2 6.0 2.5 7.6 15.7 34.7 10.0 5.6 10.8 12.4 19.2 15.1 9.2 4.4 3.8 12.4 6.7 14.9 6.1 22.7 6.3 10.4 14.8 7.9 13.1 8.6 11.4 9.8 6.4 4.3 5.5 7.9 9.9 7.1 0.5 1.6 2.9 3.2 1.5 1.9 1.3 2.3 2.1 1.2 1.4 2.5 1.7 2.8 1.2 1.5 1.9 2.3 0.7 18.6 18.9 4.6 14.8 20.0 15.5 25.4 10.7 17.0 12.0 0.0 1.0 0.0 1.2 9.3 9.2 3.6 2.5 0.0 1.2 7.0 5.9 0.5 1.7 1.2 11.4 3.6 1.4 0.0 1.1 0.8 3.1 1.4 0.0 2.9 0.9 7.9 2.4 3.1 4.4 5.9 7.2 1.7 3.3 1.0 2.4 9.7 0.8 1.9 6.7 1.7 6.7 0.0 2.1 62.7 8.4 12.4 0.2 1.0 2.6 0.9 TCHH THH ENSG00000159450 Trichohyalin Q07283 1 152106317-152115454 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skin 1: 28.8;tongue: 40.9" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 6.4;Kupffer cells: 15.0;Macrophages: 7.1;monocytes: 6.4;Spermatogonia: 10.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.1;SCLC-21H: 2.5;THP-1: 4.4" HPA028375 Approved NA NA "HPA028375: AB_10601722" "unprognostic (7.70e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-3)" "unprognostic (1.14e-1)" "unprognostic (2.07e-1)" "unprognostic (2.30e-2)" "unprognostic (4.97e-3)" "unprognostic (2.15e-2)" "unprognostic (1.84e-2)" "unprognostic (7.12e-5)" "unprognostic (2.03e-1)" "unprognostic (6.55e-2)" "unprognostic (5.90e-6)" "unprognostic (5.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.71e-2)" "unprognostic (9.28e-7)" 0.7 0.4 0.2 0.2 0.2 0.0 1.7 0.2 0.6 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.2 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 3.5 0.2 0.2 0.0 0.2 0.7 0.2 0.2 28.8 0.3 0.2 0.2 4.7 0.0 1.9 0.2 0.6 0.2 40.9 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.4 1.5 0.6 0.0 1.6 0.1 0.0 8.1 0.0 0.1 0.0 0.4 0.2 0.4 0.0 0.0 0.0 0.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.2 2.1 0.2 0.3 2.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.4 0.7 0.0 0.1 0.6 4.4 0.1 0.2 2.1 0.4 0.2 0.0 0.0 0.0 0.0 2.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 5.7 0.5 1.7 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.2 1.4 0.0 0.0 0.2 6.4 0.4 1.5 0.0 0.0 0.5 0.0 1.7 3.1 15.0 0.0 0.3 7.1 0.0 6.4 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 2.0 2.9 10.4 2.0 4.3 0.0 0.0 0.0 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084144-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "epididymis: 1.7;skin 1: 3.8;tongue: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 59 "SK-BR-3: 10.7" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCL1A TCL1 ENSG00000100721 "T cell leukemia/lymphoma 1A" P56279 14 95709967-95714196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "blood: 179.4;lymphoid tissue: 63.7" "Group enriched" "Detected in some" 5 "B-cells: 166.3;Spermatogonia: 48.5" "Cancer enriched" "Detected in many" 18 "testis cancer: 64.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 381 "memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8" "Group enriched" "Detected in many" 487 "B-cells: 179.4;dendritic cells: 79.8" "Group enriched" "Detected in some" 157 "Daudi: 71.1;REH: 92.4;U-698: 94.4" "Not detected" "Not detected" "CAB004045, HPA016604" Enhanced Enhanced "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" Nucleoplasm "CAB004045: AB_2179419, HPA016604: AB_1857859" "unprognostic (1.27e-3)" "unprognostic (3.12e-4)" "unprognostic (2.61e-4)" "unprognostic (2.01e-2)" "unprognostic (1.27e-1)" "unprognostic (4.75e-4)" "unprognostic (7.70e-2)" "unprognostic (9.67e-3)" "unprognostic (1.03e-1)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-2)" "unprognostic (2.64e-2)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (2.06e-1)" "unprognostic (4.55e-1)" 0.4 0.2 0.2 53.4 0.2 4.8 0.3 0.2 0.2 0.2 0.9 0.0 0.2 0.0 0.3 0.0 0.8 0.3 0.6 0.3 0.2 0.2 1.1 0.4 3.2 63.7 0.2 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.4 0.2 0.1 2.9 0.0 0.2 0.2 10.4 0.1 0.2 33.5 0.5 5.3 0.0 4.7 0.8 1.2 53.6 3.6 0.3 179.4 79.8 0.2 0.1 0.0 0.1 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.5 94.4 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 45.6 0.0 0.0 0.1 179.4 0.1 0.0 0.2 0.0 0.1 79.8 0.0 6.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 2.2 166.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 20.6 48.5 0.0 0.0 0.0 0.0 0.0 TCL1B TML1 ENSG00000213231 "T cell leukemia/lymphoma 1B" O95988 14 95686417-95692643 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3" "Cell type enriched" "Detected in some" 13 "Syncytiotrophoblasts: 60.8" "Cancer enriched" "Detected in single" 72 "testis cancer: 8.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "naive B-cell: 13.0;plasmacytoid DC: 5.9" "Group enriched" "Detected in many" 23 "B-cells: 13.0;dendritic cells: 5.9" "Cell line enriched" "Detected in some" 7 "U-698: 104.8" "Not detected" "Not detected" HPA053163 Uncertain Approved Cytosol NA NA Cytosol "HPA053163: AB_2682064" "unprognostic (1.55e-1)" 0.1 0.2 0.1 0.9 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 1.4 0.4 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 5.3 0.1 0.0 0.2 0.1 0.0 0.1 12.7 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 1.8 0.1 7.3 0.0 0.0 0.1 0.0 5.4 0.1 0.1 13.0 5.9 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.3 0.4 0.0 5.9 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.7 0.0 60.8 0.0 0.0 0.0 TCN1 "TC1, TCI" ENSG00000134827 "Transcobalamin 1" P20061 11 59852800-59866575 "Plasma proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 152.9;salivary gland: 172.4" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 340.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 124.3" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 95 "basophil: 152.9" "Lineage enriched" "Detected in single" 1202 "granulocytes: 152.9" "Cell line enriched" "Detected in some" 21 "OE19: 59.1" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 3300000 "prognostic favorable (1.90e-4)" "unprognostic (1.17e-1)" "unprognostic (5.89e-2)" "unprognostic (3.61e-3)" "unprognostic (2.49e-2)" "unprognostic (5.28e-3)" "unprognostic (4.52e-3)" "unprognostic (3.11e-3)" "unprognostic (1.13e-1)" "unprognostic (7.56e-2)" "unprognostic (9.07e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.56e-8)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" 0.2 0.1 0.1 0.1 0.1 27.6 2.1 0.1 0.2 5.5 0.2 0.1 0.0 1.3 1.5 0.0 4.6 0.2 26.7 1.1 0.1 0.1 0.7 0.4 1.8 0.0 0.2 0.0 0.2 3.8 0.1 0.4 0.2 0.1 0.4 0.0 0.1 172.4 0.3 0.2 0.3 0.2 0.1 0.2 1.0 12.7 0.2 0.0 0.3 0.2 28.4 10.0 3.8 1.9 0.0 0.0 152.9 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.8 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 59.1 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.8 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 152.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.2 61.1 12.0 3.4 22.7 0.0 0.0 0.0 17.4 0.3 0.0 0.0 0.0 340.9 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 1.0 0.0 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 40.3 TCN2 "D22S676, D22S750, TC2" ENSG00000185339 "Transcobalamin 2" P20062 22 30606838-30627278 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cobalt transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 73.2" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 104.9;Ito cells: 111.1;Kupffer cells: 140.0;Proximal tubular cells: 115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 19.2;intermediate monocyte: 29.0;non-classical monocyte: 9.8" "Lineage enriched" "Detected in many" 8 "monocytes: 29.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 35.3;HUVEC TERT2: 41.4;Karpas-707: 53.8;RPTEC TERT1: 20.9;TIME: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000837 Approved Cytosol "Secreted to blood" NA NA 13000000 Cytosol "HPA000837: AB_1080235" "unprognostic (6.43e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.53e-3)" "unprognostic (3.17e-1)" "unprognostic (1.49e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (2.64e-4)" "unprognostic (1.52e-2)" "unprognostic (2.90e-1)" "unprognostic (1.07e-1)" "unprognostic (4.03e-2)" "unprognostic (1.59e-1)" "unprognostic (6.95e-3)" "unprognostic (4.94e-3)" "unprognostic (2.09e-2)" "unprognostic (1.30e-1)" "unprognostic (1.50e-1)" 39.8 15.2 6.5 7.2 8.1 2.2 30.0 3.4 10.9 13.1 14.8 9.2 9.6 10.9 15.0 23.9 7.0 11.2 31.7 15.8 6.6 7.3 73.2 8.7 21.7 43.3 8.6 8.5 7.8 6.3 5.7 7.9 8.7 10.7 9.6 13.5 13.5 6.8 23.0 5.4 4.5 30.4 17.6 9.0 24.8 8.4 9.7 5.1 1.9 12.8 4.8 4.6 11.6 10.9 0.0 3.4 0.6 29.0 0.0 0.3 6.5 0.0 2.6 12.1 0.0 7.2 35.3 0.4 0.8 8.8 2.2 3.7 1.2 6.1 0.1 13.4 1.7 0.2 0.4 1.0 0.6 0.7 0.0 0.6 0.0 0.3 0.5 17.3 0.1 9.9 5.8 0.7 1.7 1.5 2.5 41.4 0.0 0.2 53.8 3.6 0.0 0.0 0.9 4.7 3.3 0.3 1.3 1.7 18.1 20.9 0.3 4.2 0.5 0.0 0.1 3.5 0.8 0.1 0.5 24.2 7.8 1.0 0.9 0.3 1.4 0.3 0.0 2.7 0.4 0.1 0.0 19.2 0.0 0.0 29.0 0.3 0.0 0.3 0.2 3.4 0.0 0.1 0.2 0.6 0.0 9.8 0.6 0.1 6.5 6.5 8.1 3.4 10.9 6.6 7.3 8.6 8.5 10.7 5.1 3.0 3.8 6.0 0.8 4.6 7.3 5.0 35.7 2.7 4.5 12.2 19.6 0.4 6.6 5.9 0.8 59.1 104.9 0.0 5.2 0.7 11.2 2.0 4.6 5.0 40.3 1.6 6.4 111.1 140.0 1.0 9.8 32.3 21.9 7.2 23.3 6.0 5.6 49.1 9.2 115.0 28.1 12.9 4.7 0.7 7.8 4.5 0.3 2.1 10.0 2.4 TCP10 ENSG00000203690 "T-complex 10" Q12799 6 167357031-167384510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 16.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 50.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 2.5;SCLC-21H: 1.9" "HPA044709, HPA078219" Enhanced NA NA "HPA044709: AB_10961410, HPA078219: " "unprognostic (8.33e-2)" "unprognostic (1.52e-1)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 50.1 0.4 0.0 0.0 0.0 0.2 0.0 TCP10L PRED77 ENSG00000242220 "T-complex 10 like" Q8TDR4 21 32574841-32587373 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 75.3" "Group enriched" "Detected in many" 35 "Early spermatids: 933.5;Late spermatids: 1371.3;Spermatocytes: 390.7" "Cancer enhanced" "Detected in single" "liver cancer: 1.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 16.8" HPA044709 Approved NA NA "HPA044709: AB_10961410" "unprognostic (2.31e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-3)" "unprognostic (5.05e-2)" "unprognostic (1.03e-1)" "unprognostic (1.63e-1)" "unprognostic (1.33e-3)" "unprognostic (1.62e-1)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (1.05e-1)" "unprognostic (1.63e-1)" "unprognostic (8.41e-5)" "unprognostic (4.98e-2)" "unprognostic (5.94e-2)" "unprognostic (5.67e-2)" "unprognostic (1.64e-3)" 0.1 0.2 0.7 0.1 0.8 0.0 0.2 3.9 2.4 0.2 0.2 0.2 0.4 0.3 0.3 0.7 0.1 0.5 0.3 0.6 0.8 0.7 0.3 8.6 0.3 0.1 0.8 1.0 0.5 0.4 0.4 0.7 0.1 1.0 0.3 0.1 0.2 0.3 0.5 0.1 0.1 0.2 0.1 0.9 0.2 0.0 75.3 0.7 0.2 0.3 0.1 0.1 0.2 0.2 0.8 2.7 1.2 2.0 0.2 1.5 0.7 0.3 1.2 0.8 0.7 1.5 1.1 0.6 0.2 0.5 0.7 0.1 1.1 0.3 0.3 0.5 0.1 0.4 0.2 1.7 0.5 0.8 0.7 1.3 0.4 0.8 3.7 1.1 1.7 0.6 0.6 2.1 0.7 0.8 4.4 0.6 1.7 0.5 0.2 0.1 1.3 1.2 1.5 1.5 0.9 1.4 0.5 0.8 0.8 0.1 0.1 16.8 0.6 0.4 1.0 1.9 1.8 0.5 2.8 0.3 0.0 1.3 0.7 0.3 2.1 2.5 0.5 0.6 1.4 0.6 0.0 0.7 1.2 0.3 2.0 1.1 0.8 0.4 0.5 2.4 0.7 1.3 0.6 0.0 0.2 0.0 2.7 1.5 0.7 0.7 0.8 3.9 2.4 0.8 0.7 0.8 1.0 1.0 0.7 0.0 0.3 0.0 0.6 1.0 0.7 2.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.5 933.5 0.0 0.0 0.0 0.2 0.1 0.4 0.5 4.6 19.7 0.2 0.0 0.0 0.6 1.5 1371.3 15.5 0.0 0.0 0.0 0.3 3.0 0.3 0.0 9.6 1.4 0.9 25.8 0.9 390.7 5.9 1.3 0.2 0.0 0.2 0.0 TCP10L2 bA517H2.3 ENSG00000166984 "T-complex 10 like 2" B9ZVM9 6 167146414-167196913 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 9 "epididymis: 5.2;testis: 14.8" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 45.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.1" "CAB034197, HPA044709" Uncertain NA NA "CAB034197: AB_2202388, HPA044709: AB_10961410" "unprognostic (5.07e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-1)" "unprognostic (2.52e-1)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (5.40e-4)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.4 0.0 0.0 0.6 0.0 5.2 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 14.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 45.1 0.5 0.0 0.0 0.0 0.3 0.0 TCP11 "D6S230E, FPPR, KIAA0229" ENSG00000124678 "T-complex 11" Q8WWU5 6 35118071-35148610 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 64 "testis: 140.4" "Group enriched" "Detected in some" 19 "Early spermatids: 1576.7;Late spermatids: 5610.9" "Cancer enhanced" "Detected in some" "cervical cancer: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 4.8;WM-115: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA048311 Supported NA NA "HPA048311: AB_2680351" "unprognostic (1.35e-1)" "prognostic favorable (5.02e-4)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (6.43e-4)" "unprognostic (8.09e-7)" "unprognostic (4.06e-3)" "unprognostic (1.25e-1)" "unprognostic (9.98e-2)" "unprognostic (9.53e-2)" "unprognostic (2.95e-1)" "unprognostic (1.61e-1)" "unprognostic (5.54e-4)" "unprognostic (9.41e-2)" "unprognostic (4.56e-2)" "unprognostic (2.77e-2)" "unprognostic (2.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 1.7 0.5 1.0 1.2 0.0 0.5 0.0 0.0 0.0 1.6 0.6 0.2 0.0 0.1 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.8 0.0 4.8 0.4 0.8 0.5 0.3 0.0 0.0 1.2 0.0 0.0 0.6 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.7 0.8 0.0 0.9 1.3 0.2 0.2 0.5 0.2 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 5.3 2.3 0.0 0.0 0.0 1.7 0.0 1576.7 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5610.9 27.9 0.0 1.7 0.0 0.0 0.0 0.1 0.0 27.3 0.0 0.0 12.9 0.2 186.1 24.9 0.1 0.0 0.0 0.0 0.1 TCP11X1 ENSG00000268235 "T-complex 11 family, X-linked 1" X 102215301-102229532 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "adrenal gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048311 Uncertain NA NA "HPA048311: AB_2680351" 0.1 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCP11X2 ENSG00000215029 "T-complex 11 family, X-linked 2" Q5H9J9 X 102456862-102471842 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "fallopian tube: 3.5;pituitary gland: 3.3;testis: 3.6" "Group enriched" "Detected in some" 45 "Early spermatids: 2.5;Late spermatids: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "SCLC-21H: 5.1" HPA048311 Supported NA NA "HPA048311: AB_2680351" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCTE1 "D6S46, DRC5, FAP155, MGC33600" ENSG00000146221 "T-complex-associated-testis-expressed 1" Q5JU00 6 44278743-44297688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 17.3;testis: 48.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.7;Late spermatids: 222.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.2;U-266/70: 1.8;U-266/84: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031739 Uncertain Vesicles NA NA Vesicles "HPA031739: AB_10601269" "unprognostic (3.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (7.06e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.49e-2)" "unprognostic (1.17e-2)" "unprognostic (7.05e-2)" "unprognostic (2.23e-5)" "unprognostic (7.68e-2)" "unprognostic (3.13e-2)" "unprognostic (1.37e-3)" "unprognostic (2.68e-1)" 0.2 0.2 2.2 0.2 2.2 1.1 0.2 5.8 1.8 0.7 0.2 1.1 0.0 0.2 0.6 3.0 0.2 17.3 0.3 0.2 2.8 2.0 0.2 0.2 2.1 0.2 0.8 1.0 2.2 0.3 0.2 0.2 0.2 3.2 0.4 0.2 0.0 0.4 0.4 0.2 0.6 0.3 0.3 0.6 0.3 0.2 48.6 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.9 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.3 0.1 0.2 0.1 0.6 0.3 0.0 0.0 2.6 0.3 0.0 0.4 0.1 3.8 0.0 0.3 0.2 0.5 0.2 0.2 0.0 0.9 0.4 0.0 0.0 0.1 3.2 1.1 0.0 0.2 1.2 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 1.8 3.2 0.3 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.1 0.2 0.0 2.2 2.2 5.8 1.8 2.8 2.0 0.8 1.0 3.2 0.3 0.0 0.0 0.0 0.1 0.1 0.6 0.3 0.0 16.0 2.3 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 10.7 1.9 0.0 0.1 0.0 0.0 0.0 TCTE3 TCTEX1D3 ENSG00000184786 "T-complex-associated-testis-expressed 3" Q8IZS6 6 169740114-169751587 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 23.6" "Cell type enriched" "Detected in many" 5 "Early spermatids: 126.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.5;MCF7: 1.7" "Low region specificity" "Detected in many" NA NA "unprognostic (1.29e-1)" "unprognostic (1.70e-1)" "unprognostic (1.69e-1)" "unprognostic (2.22e-2)" "unprognostic (1.05e-2)" "unprognostic (6.15e-2)" "unprognostic (1.70e-2)" "unprognostic (2.63e-2)" "unprognostic (5.11e-2)" "unprognostic (1.87e-1)" "unprognostic (6.11e-5)" "unprognostic (1.58e-1)" "unprognostic (2.04e-10)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (3.56e-5)" 0.9 1.0 1.3 3.0 3.8 1.2 1.0 3.8 3.8 0.9 1.3 0.4 1.2 0.9 1.1 0.9 0.9 0.9 0.9 0.9 3.0 0.8 1.0 0.9 0.9 0.9 4.2 0.8 1.6 0.9 0.9 4.9 0.9 2.8 1.0 0.9 0.7 1.0 0.9 0.9 1.0 1.1 1.0 2.7 1.1 0.9 23.6 2.9 1.8 1.1 0.4 1.1 1.0 5.3 0.7 0.0 0.2 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.7 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.7 0.5 0.4 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 3.8 3.8 3.8 3.0 0.8 4.2 0.8 2.8 2.9 0.0 1.0 5.4 5.7 0.0 5.8 1.0 2.5 1.4 3.4 8.7 19.6 1.2 0.0 0.8 126.4 2.2 0.8 0.0 0.7 1.0 1.7 2.4 3.5 0.9 1.0 11.1 1.2 2.5 7.5 17.6 6.4 0.8 0.0 0.0 1.1 4.8 0.4 0.0 4.2 0.9 9.8 6.5 0.8 24.1 7.5 0.0 1.4 3.8 1.8 3.5 TCTEX1D1 FLJ40873 ENSG00000152760 "Tctex1 domain containing 1" Q8N7M0 1 66752459-66778787 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;fallopian tube: 18.2;liver: 13.5" "Cell type enriched" "Detected in some" 4 "Ciliated cells: 97.7" "Cancer enriched" "Detected in single" 10 "glioma: 3.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 14.1;HUVEC TERT2: 14.2;THP-1: 15.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028420 Uncertain NA NA "HPA028420: AB_10603995" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" "unprognostic (3.72e-4)" "unprognostic (1.22e-1)" "unprognostic (9.65e-3)" "unprognostic (1.81e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-2)" "unprognostic (1.01e-1)" "unprognostic (2.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.53e-6)" "unprognostic (9.28e-4)" "unprognostic (2.78e-2)" "unprognostic (6.13e-3)" "unprognostic (3.65e-2)" 1.8 1.1 5.3 1.2 7.2 7.4 1.1 2.1 3.7 1.5 1.0 9.5 0.0 0.8 0.8 7.5 0.8 18.2 1.1 1.9 8.2 10.4 0.7 13.5 4.0 0.4 3.3 2.4 3.4 0.8 0.7 0.9 11.5 28.4 0.8 1.1 0.7 0.5 1.7 1.9 1.3 1.1 1.3 2.6 0.4 0.8 0.5 2.2 0.0 0.6 0.2 0.6 1.5 0.8 0.0 0.1 0.9 0.6 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 2.5 0.0 0.3 0.7 0.3 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.6 0.0 0.0 14.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.6 5.3 7.2 2.1 3.7 8.2 10.4 3.3 2.4 28.4 2.2 0.0 2.7 0.0 0.0 1.1 0.0 0.4 0.0 97.7 15.9 0.0 0.0 0.0 1.7 0.0 0.2 6.7 0.0 0.0 0.0 0.0 0.5 0.3 24.4 3.4 2.3 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 5.7 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 TCTEX1D2 MGC33212 ENSG00000213123 "Tctex1 domain containing 2" Q8WW35 3 196291219-196318299 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 37.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 301.2;Distal tubular cells: 102.8;Early spermatids: 174.6;Spermatocytes: 192.1;Spermatogonia: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 16.6;dendritic cells: 10.9;T-cells: 18.3" "Cell line enhanced" "Detected in many" "T-47d: 38.9" HPA049555 Approved Cytosol NA NA Cytosol "HPA049555: AB_2680816" "unprognostic (1.16e-1)" "prognostic favorable (7.83e-4)" "unprognostic (5.34e-2)" "unprognostic (1.59e-2)" "unprognostic (1.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (4.61e-1)" "unprognostic (9.98e-3)" "unprognostic (3.99e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (6.23e-4)" "unprognostic (3.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" 4.3 7.4 20.5 5.1 21.6 5.3 7.0 15.0 18.3 5.2 5.3 7.0 7.2 4.7 8.4 10.4 10.7 37.4 6.3 6.3 15.4 18.6 11.8 2.3 9.1 9.1 12.1 15.8 8.7 6.6 6.8 18.8 4.1 10.6 6.4 4.9 6.8 7.6 6.2 3.1 9.2 3.0 5.3 8.7 4.1 5.2 24.2 8.1 6.8 11.2 5.1 6.5 4.9 5.9 16.6 10.9 1.4 2.3 2.9 18.3 5.6 13.6 10.2 15.7 10.2 4.1 8.1 2.2 5.6 3.2 6.0 6.7 3.5 16.7 8.8 10.3 4.0 2.3 14.4 6.4 5.1 5.6 7.7 5.7 3.4 10.1 1.4 4.5 2.2 0.3 4.0 13.5 4.9 6.2 10.9 3.5 17.2 4.9 4.4 11.5 33.5 11.5 11.3 11.1 12.7 19.4 14.5 3.1 3.6 12.8 5.6 19.8 16.7 12.7 6.4 11.2 6.5 38.9 6.5 7.9 5.8 2.5 2.3 6.5 7.5 14.3 18.9 17.4 4.3 9.9 0.0 2.3 1.2 9.2 0.8 5.6 16.6 11.6 7.3 6.0 9.5 7.4 7.3 1.4 2.9 0.6 10.9 18.3 5.6 20.5 21.6 15.0 18.3 15.4 18.6 12.1 15.8 10.6 8.1 8.9 6.9 10.0 18.9 14.7 17.4 5.0 30.6 301.2 39.8 34.9 9.8 24.1 102.8 23.6 174.6 10.5 4.0 0.0 9.4 7.0 11.6 10.3 8.1 3.4 13.5 28.6 24.6 14.7 3.2 30.9 16.1 6.3 18.6 19.8 9.5 29.8 9.2 3.5 29.4 35.2 18.4 12.9 7.3 192.1 110.5 15.9 5.1 11.5 11.9 14.4 TCTEX1D4 ENSG00000188396 "Tctex1 domain containing 4" Q5JR98 1 44805913-44806675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 7.9;epididymis: 3.1;fallopian tube: 12.4" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 45.5" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 12 "neutrophil: 7.9" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.9" "Cell line enhanced" "Detected in some" "BEWO: 3.4;EFO-21: 2.4;HDLM-2: 2.7;SK-MEL-30: 2.2;TIME: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA062652 Enhanced NA NA "HPA062652: AB_2684818" "unprognostic (3.12e-1)" "unprognostic (3.13e-1)" "unprognostic (1.81e-1)" "prognostic favorable (1.58e-4)" "unprognostic (5.28e-2)" "unprognostic (3.59e-2)" "unprognostic (2.85e-2)" "unprognostic (2.26e-1)" "unprognostic (3.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.26e-2)" "unprognostic (4.92e-2)" "unprognostic (4.70e-3)" "unprognostic (2.86e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.83e-3)" 0.0 1.1 0.2 0.4 0.2 0.8 0.2 0.0 0.1 1.0 0.2 0.5 0.8 3.1 0.2 12.4 0.7 0.2 0.3 0.4 0.3 0.5 1.8 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.6 0.3 0.1 0.2 0.5 0.0 0.1 0.0 1.2 0.1 0.5 0.0 0.2 0.0 0.0 0.0 7.9 0.6 0.0 0.2 0.3 1.4 1.2 0.3 0.0 0.0 0.0 3.4 1.5 0.0 0.0 0.2 0.0 1.2 0.0 2.4 0.0 0.5 1.9 0.0 0.0 0.0 2.7 0.0 0.3 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.6 0.5 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 2.2 0.2 0.0 0.0 3.4 0.2 1.9 0.2 0.7 1.4 1.2 0.0 0.2 0.4 0.6 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.2 0.0 0.2 2.5 45.5 5.7 1.8 0.0 0.1 0.0 0.9 0.0 0.0 1.4 0.0 3.5 0.2 0.2 0.2 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 1.0 1.2 0.0 1.3 2.9 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.5 TDGF1 "CR, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582463 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7" "Cell type enriched" "Detected in some" 18 "Distal tubular cells: 102.8" "Group enriched" "Detected in many" 9 "colorectal cancer: 6.4;testis cancer: 27.1" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0" "Group enriched" "Detected in many" 5 "cerebellum: 12.5;pons and medulla: 9.1" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.6 3.9 0.6 0.6 0.8 0.0 0.6 0.6 0.6 0.6 2.1 0.6 0.6 0.2 0.7 1.3 0.6 0.0 0.6 0.6 1.0 0.6 9.9 0.8 0.6 0.6 0.9 0.6 9.7 0.6 0.0 0.6 0.6 0.6 0.6 4.3 1.1 0.6 0.6 1.0 0.0 0.6 0.8 1.0 16.7 2.4 0.6 0.6 5.2 2.1 0.6 0.6 0.6 0.6 1.0 0.7 3.7 0.6 1.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 9.5 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.2 1.7 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 27.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.6 0.5 0.5 0.3 0.3 0.6 0.4 0.3 0.1 1.0 0.6 0.4 3.7 1.5 0.4 0.7 0.2 0.1 0.6 0.8 0.6 0.6 1.0 0.6 0.9 0.6 0.6 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 5.2 0.0 0.0 102.8 0.1 4.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 2.4 0.0 0.0 0.7 0.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 187.9" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 1048.1" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8" "Group enriched" "Detected in some" 9 "cerebellum: 7.0;hippocampal formation: 5.9" "Not detected" "Not detected" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.2 0.5 0.2 2.5 0.5 0.0 0.1 0.1 2.0 0.1 0.2 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 1.5 0.2 0.2 187.9 0.8 2.9 0.2 0.7 0.1 0.1 0.0 5.8 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.1 0.4 0.2 1.5 0.3 0.1 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.2 0.0 0.1 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.9 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 1.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.4 0.0 2.7 0.0 0.0 9.8 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 2.0 1.5 0.2 0.2 0.7 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.4 132.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 23.3 0.0 0.0 0.1 0.3 0.0 1048.1 0.9 0.0 0.0 25.2 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 TDP2 TTRAP ENSG00000111802 "Tyrosyl-DNA phosphodiesterase 2" O95551 6 24649977-24667033 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Hydrolase, Nuclease" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 57.3;intestine: 55.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 434.9;Paneth cells: 431.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 15.6;neutrophil: 57.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 57.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB073398, HPA074011" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" No No "Nucleoplasm, Nuclear bodies" "CAB073398: , HPA074011: AB_2686651" "unprognostic (2.46e-2)" "unprognostic (2.10e-3)" "unprognostic (1.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.58e-1)" "unprognostic (4.66e-3)" "unprognostic (4.13e-3)" "unprognostic (3.24e-1)" "unprognostic (5.78e-3)" "prognostic favorable (2.53e-7)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.70e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.47e-5)" 6.8 4.8 8.2 15.4 9.2 3.7 5.6 10.8 7.5 6.1 36.0 3.7 4.9 25.8 4.9 5.2 4.9 4.5 6.2 8.1 6.8 6.9 16.4 10.4 6.5 7.1 7.7 6.3 5.7 5.9 4.4 9.4 5.7 6.5 12.3 27.9 3.6 4.9 4.8 5.0 4.8 55.7 6.1 5.8 6.3 5.1 21.1 5.7 8.2 5.3 4.1 7.3 9.6 7.0 5.3 3.3 57.3 3.9 6.9 8.3 5.7 17.7 14.1 16.2 18.6 25.1 25.7 12.6 15.8 20.4 15.2 20.4 19.4 10.1 21.4 27.9 16.6 35.4 13.1 19.6 18.0 20.8 27.4 20.6 20.0 15.0 31.5 16.0 30.7 19.4 17.1 17.0 15.8 14.4 18.1 24.5 20.8 17.9 9.2 22.7 12.7 23.8 19.6 14.4 20.5 12.2 20.8 17.0 23.0 26.1 25.3 20.4 11.7 12.9 32.8 25.8 17.2 15.1 17.8 18.2 14.8 12.4 11.0 23.1 13.3 39.1 29.2 10.2 40.5 23.6 15.6 3.5 7.1 6.9 3.7 8.3 5.3 8.0 7.5 3.3 3.5 6.6 7.2 57.3 6.9 3.9 3.1 7.9 5.7 8.2 9.2 10.8 7.5 6.8 6.9 7.7 6.3 6.5 5.7 6.0 14.7 22.2 25.0 12.6 10.6 16.2 30.6 26.8 20.5 21.0 5.9 16.0 41.4 30.3 141.5 21.2 434.9 0.0 31.2 20.7 17.0 29.4 23.1 27.3 64.5 6.4 50.6 22.7 22.6 63.7 16.7 28.7 11.8 84.8 117.3 17.2 19.7 431.3 21.9 159.2 13.9 32.3 20.6 8.9 20.2 14.4 37.1 27.7 86.0 22.3 TDRD1 CT41.1 ENSG00000095627 "Tudor domain containing 1" Q9BXT4 10 114179270-114232304 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.3" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 5.9;Spermatocytes: 18.4;Spermatogonia: 21.3" "Cancer enhanced" "Detected in some" "prostate cancer: 4.1" "Region enriched" "Detected in single" 4 "cerebral cortex: 2.1" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 33.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA037729 Enhanced NA NA "HPA037729: AB_10670527" "unprognostic (6.77e-2)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (3.15e-2)" "unprognostic (6.13e-2)" "unprognostic (1.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (9.60e-2)" "unprognostic (3.98e-2)" "unprognostic (4.75e-1)" "unprognostic (1.68e-1)" 0.3 0.2 0.2 0.3 0.2 0.0 0.4 0.2 2.1 0.2 0.3 0.0 0.0 0.2 0.6 0.7 0.3 0.2 0.6 0.8 0.3 0.2 2.8 0.7 0.2 0.2 0.2 0.4 0.5 0.6 0.0 0.3 0.0 0.4 2.9 0.1 0.0 0.3 0.2 0.4 0.2 0.3 0.2 0.7 1.6 0.3 35.3 0.0 0.0 0.2 1.0 0.2 0.2 0.2 0.8 4.5 0.2 0.2 0.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 33.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.2 0.1 0.1 0.5 0.2 0.8 0.8 0.0 0.2 0.4 0.0 4.5 0.2 0.0 0.2 0.2 0.2 2.1 0.3 0.2 0.2 0.4 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 2.8 0.0 4.0 0.0 0.0 0.0 0.3 0.0 0.2 5.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.7 0.7 0.0 0.0 0.0 18.4 21.3 0.0 0.1 0.0 0.0 0.0 TDRD10 DKFZp434M202 ENSG00000163239 "Tudor domain containing 10" Q5VZ19 1 154502219-154548147 "Cancer-related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 48.4" "Group enriched" "Detected in some" 5 "Early spermatids: 47.9;Late spermatids: 66.1;Spermatocytes: 133.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 2.2;HUVEC TERT2: 7.7;RPMI-8226: 2.1;TIME: 4.1" "Low region specificity" "Detected in all" HPA054327 Approved Vesicles NA NA Vesicles "HPA054327: AB_2682452" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.33e-3)" "unprognostic (9.69e-3)" "unprognostic (5.80e-3)" "unprognostic (2.99e-1)" "unprognostic (5.97e-3)" "unprognostic (2.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.00e-3)" "unprognostic (1.61e-1)" "unprognostic (1.34e-3)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (8.04e-5)" "unprognostic (1.62e-1)" 4.1 1.4 0.7 1.1 0.9 0.0 2.6 0.7 1.4 1.3 0.8 0.9 1.4 0.5 2.1 2.0 1.0 2.1 1.2 2.3 0.7 0.0 1.0 1.5 3.3 1.6 0.9 1.2 4.6 0.7 0.8 0.8 1.4 1.2 1.1 1.1 0.7 0.7 1.0 1.1 0.7 1.0 1.4 1.2 3.5 0.5 48.4 0.8 0.7 4.9 1.5 1.0 1.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.1 4.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.9 0.7 1.4 0.7 0.0 0.9 1.2 1.2 0.8 3.0 7.9 0.0 0.0 0.6 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 47.9 4.7 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.3 0.0 0.0 6.2 3.5 66.1 2.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 133.2 17.2 0.3 0.0 0.0 0.0 0.0 TDRD12 "ECAT8, FLJ13072" ENSG00000173809 "Tudor domain containing 12" Q587J7 19 32719753-32829580 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 36.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 18.5;Spermatocytes: 43.5;Spermatogonia: 44.9" "Cancer enriched" "Detected in many" 9 "testis cancer: 10.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.8" "Lineage enriched" "Detected in single" 4 "T-cells: 1.8" "Group enriched" "Detected in some" 30 "HDLM-2: 12.8;NTERA-2: 42.6" "Low region specificity" "Detected in many" NA NA "unprognostic (5.43e-2)" "unprognostic (3.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.87e-7)" "unprognostic (5.44e-2)" "unprognostic (1.78e-1)" "unprognostic (6.79e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (1.40e-1)" "unprognostic (9.69e-2)" "unprognostic (1.90e-1)" "unprognostic (1.43e-4)" "unprognostic (2.09e-1)" "unprognostic (4.75e-2)" "unprognostic (3.08e-2)" "unprognostic (2.69e-2)" 0.2 0.7 0.2 0.1 0.4 0.0 0.4 0.2 0.5 0.9 0.3 0.2 0.6 0.0 1.1 8.5 0.2 1.1 0.3 0.3 0.1 0.2 0.9 0.1 0.2 0.8 0.3 0.1 1.8 0.1 0.0 0.2 0.2 0.6 0.2 0.0 0.3 0.2 0.6 0.1 1.7 1.2 0.1 0.1 0.9 0.2 36.1 0.1 0.6 0.9 0.1 0.6 0.5 0.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.5 0.1 0.6 0.0 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 12.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.2 0.5 0.1 0.2 0.3 0.1 0.6 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.6 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 18.5 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 9.0 2.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.4 0.2 0.3 0.0 0.1 43.5 44.9 0.1 0.2 0.0 0.2 0.0 TDRD15 ENSG00000218819 "Tudor domain containing 15" B5MCY1 2 21123917-21143272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 11.3" "Cell type enhanced" "Detected in some" 24 "Late spermatids: 7.8;Sertoli cells: 6.5;Spermatocytes: 22.8;Spermatogonia: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "U-266/70: 13.0;U-266/84: 4.7" "Not detected" "Not detected" "HPA051770, HPA054675" Uncertain NA NA "HPA051770: AB_2681601, HPA054675: AB_2682569" "unprognostic (4.20e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 1.3 0.0 7.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 22.8 4.5 0.0 0.0 0.0 0.0 0.0 TDRD5 "FLJ34823, TUDOR3" ENSG00000162782 "Tudor domain containing 5" Q8NAT2 1 179591613-179691272 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 37.7" "Cell type enhanced" "Detected in some" 25 "Early spermatids: 32.5;Late spermatids: 6.7;Spermatocytes: 20.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 3.6;SK-BR-3: 6.0;T-47d: 10.5;U-266/70: 14.7;U-266/84: 12.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA029418 Enhanced NA NA "HPA029418: AB_10603035" "unprognostic (1.87e-1)" "unprognostic (1.43e-1)" "unprognostic (2.08e-1)" "unprognostic (2.15e-4)" "unprognostic (3.96e-1)" "unprognostic (4.39e-3)" "unprognostic (4.41e-4)" "unprognostic (3.18e-1)" "unprognostic (4.30e-1)" "unprognostic (3.75e-2)" "unprognostic (1.18e-1)" "unprognostic (3.37e-1)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (2.78e-2)" "unprognostic (6.89e-2)" "unprognostic (2.31e-1)" 0.1 0.2 0.9 0.3 3.0 0.4 4.1 0.0 1.4 0.1 0.7 0.1 2.0 0.6 0.0 7.6 0.6 1.0 0.8 0.0 0.7 1.1 1.2 0.0 0.1 0.0 0.8 1.4 0.2 0.2 0.3 3.4 0.2 3.1 0.8 0.8 0.5 1.1 1.6 0.0 0.3 0.5 0.0 0.2 0.0 0.4 37.7 0.5 0.1 0.8 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.6 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.0 0.0 0.8 10.5 0.2 0.0 0.0 1.6 0.0 0.0 14.7 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.0 0.0 1.4 0.7 1.1 0.8 1.4 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 32.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.6 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 20.4 3.1 0.3 0.0 0.0 0.2 0.0 TDRD6 "bA446F17.4, CT41.2, NY-CO-45, SPATA36" ENSG00000180113 "Tudor domain containing 6" O60522 6 46687875-46704319 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 37.9" "Cell type enhanced" "Detected in many" 23 "Early spermatids: 172.1;Spermatocytes: 66.0;Spermatogonia: 30.6" "Cancer enhanced" "Detected in some" "prostate cancer: 2.1" "Region enriched" "Detected in many" 6 "cerebellum: 8.2" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;intermediate monocyte: 1.4" "Lineage enhanced" "Detected in single" "monocytes: 2.4" "Cell line enhanced" "Detected in some" "HEK 293: 1.6;HeLa: 4.0;hTCEpi: 2.3;PC-3: 3.4;SCLC-21H: 1.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA075923, HPA077353" Enhanced Approved "Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" Vesicles "HPA075923: , HPA077353: " "unprognostic (2.01e-1)" "unprognostic (7.41e-3)" "unprognostic (7.25e-3)" "unprognostic (3.88e-2)" "unprognostic (3.54e-1)" "unprognostic (4.10e-2)" "unprognostic (1.03e-1)" "unprognostic (4.32e-2)" "unprognostic (7.97e-2)" "unprognostic (2.50e-1)" "unprognostic (2.20e-3)" "unprognostic (2.20e-1)" "unprognostic (2.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.00e-1)" "unprognostic (2.16e-2)" "unprognostic (4.38e-3)" 0.7 1.4 0.7 2.6 1.3 0.0 0.7 8.2 1.3 0.7 0.7 0.7 0.7 0.3 0.7 2.9 0.7 0.3 1.7 0.7 1.0 0.8 0.7 1.3 0.7 3.0 1.1 0.7 0.7 0.7 0.4 1.8 1.1 0.7 1.6 0.0 0.9 0.9 0.7 1.5 2.9 0.7 0.7 0.9 1.9 0.3 37.9 0.7 0.7 5.2 0.7 0.7 1.6 0.7 0.0 0.7 0.1 2.4 0.0 0.0 0.4 0.0 0.0 0.2 1.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.1 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 3.4 0.0 0.0 0.0 0.9 0.7 1.7 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.3 0.6 0.1 0.0 1.1 0.0 0.4 0.0 0.0 0.7 0.0 2.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.7 1.3 8.2 0.9 1.0 0.8 1.1 0.7 0.7 0.7 8.9 0.3 0.0 0.4 0.5 8.3 2.9 0.0 0.0 6.8 7.0 5.9 0.0 1.7 0.1 172.1 0.6 0.0 0.0 0.2 0.0 0.5 0.5 0.0 1.6 0.1 4.8 4.1 0.0 0.3 17.5 3.7 0.0 3.3 0.0 0.0 1.4 0.1 0.0 4.2 0.0 6.2 12.9 0.5 66.0 30.6 1.4 0.0 0.0 0.5 0.1 TDRD9 "C14orf75, DKFZp434N0820, FLJ36164, NET54" ENSG00000156414 "Tudor domain containing 9" Q8NDG6 14 103928462-104052667 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein, Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "parathyroid gland: 19.9;testis: 48.0" "Group enriched" "Detected in many" 5 "Spermatocytes: 69.1;Spermatogonia: 37.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "classical monocyte: 4.6" "Lineage enriched" "Detected in single" 5 "monocytes: 4.6" "Cell line enhanced" "Detected in some" "HDLM-2: 11.1;HeLa: 9.7;HMC-1: 45.2;RPTEC TERT1: 12.3;SK-MEL-30: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.71e-1)" "unprognostic (3.02e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (1.91e-1)" "unprognostic (1.55e-1)" "unprognostic (2.74e-1)" "unprognostic (3.74e-1)" "unprognostic (1.55e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-4)" "unprognostic (1.60e-2)" "unprognostic (4.57e-3)" "unprognostic (8.97e-2)" "unprognostic (3.34e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.41e-2)" 0.4 0.4 0.7 0.4 1.5 1.2 0.5 1.5 1.5 0.3 0.3 0.8 0.6 0.1 0.3 0.3 0.2 0.7 2.1 0.6 0.8 0.7 1.8 0.5 1.0 0.3 0.8 1.3 0.3 0.7 19.9 0.9 0.4 3.4 0.3 0.1 1.8 0.9 1.0 0.1 0.1 0.3 0.4 1.6 2.8 0.6 48.0 0.5 0.2 4.2 0.0 0.8 0.4 0.2 0.0 0.8 0.0 4.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 9.7 0.0 0.0 0.0 45.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 4.1 0.0 0.0 0.3 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 1.5 1.5 1.5 0.8 0.7 0.8 1.3 3.4 0.5 6.0 1.3 0.0 0.0 0.0 3.1 9.7 0.0 0.0 1.2 0.0 3.9 0.0 1.7 0.6 11.1 0.7 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 1.8 6.4 0.0 0.0 2.4 6.0 0.9 0.2 0.0 0.0 0.0 0.5 0.5 0.0 2.1 1.9 1.7 6.5 0.5 69.1 37.7 0.0 0.0 0.0 0.0 0.0 TDRKH TDRD2 ENSG00000182134 "Tudor and KH domain containing" Q9Y2W6 1 151770107-151791416 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 46.5" "Cell type enhanced" "Detected in many" 10 "Late spermatids: 48.0;Spermatocytes: 46.8;Spermatogonia: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016419, HPA019625" Approved Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA016419: AB_1857870, HPA019625: AB_1857871" "unprognostic (2.27e-3)" "unprognostic (2.89e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.29e-1)" "unprognostic (1.10e-1)" "unprognostic (1.44e-2)" "unprognostic (2.63e-1)" "unprognostic (2.91e-1)" "unprognostic (2.06e-1)" "unprognostic (3.06e-2)" "unprognostic (1.10e-1)" "unprognostic (5.63e-2)" "unprognostic (8.70e-2)" "unprognostic (1.67e-1)" "unprognostic (1.59e-3)" "unprognostic (1.14e-1)" 2.7 3.5 8.8 4.2 10.9 1.6 4.6 18.0 9.9 2.6 3.3 6.3 7.5 2.5 2.0 6.2 2.1 2.4 2.3 3.6 8.8 8.9 3.1 3.7 4.4 5.4 8.1 7.8 1.4 3.5 46.5 5.5 3.7 15.9 6.2 4.3 2.9 6.4 6.7 4.5 2.5 2.5 3.1 7.6 5.9 3.1 19.3 4.9 8.0 7.3 1.0 5.2 3.7 2.0 3.8 5.3 5.3 7.0 7.3 13.1 4.2 6.3 5.5 4.9 11.4 0.3 0.5 4.8 1.1 0.6 3.4 2.3 3.6 9.2 7.4 10.1 0.4 8.1 3.9 7.2 7.5 5.3 19.2 5.1 7.4 1.6 2.5 2.2 1.4 1.2 0.6 3.0 7.3 3.1 1.0 3.6 14.7 5.7 6.7 1.0 17.2 11.7 2.2 3.8 9.5 9.6 1.4 3.1 15.4 6.0 3.1 7.2 11.8 7.9 6.4 7.4 9.4 13.9 5.6 1.4 1.6 2.9 5.0 6.1 13.8 16.9 8.3 7.4 6.0 2.2 5.3 0.9 1.9 8.8 4.3 13.1 3.8 8.2 8.8 2.0 3.6 6.0 7.5 0.7 7.3 7.0 5.3 9.4 4.2 8.8 10.9 18.0 9.9 8.8 8.9 8.1 7.8 15.9 4.9 3.0 8.8 0.9 1.9 0.2 3.4 2.6 0.0 1.4 2.3 7.0 3.9 2.2 1.7 2.5 17.5 1.0 0.1 0.0 2.2 2.5 0.4 1.7 4.6 0.6 4.4 6.4 0.0 1.3 1.3 48.0 0.3 1.3 1.7 3.6 0.9 1.5 1.8 0.0 2.1 1.3 3.0 12.9 1.2 46.8 21.1 0.1 2.1 1.3 1.0 0.9 TDRP "C8orf42, INM01, TDRP1, TDRP2" ENSG00000180190 "Testis development related protein" Q86YL5 8 489792-545781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 41.9" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 125.8;Syncytiotrophoblasts: 227.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 28.9;HBEC3-KT: 13.9;hTERT-RPE1: 12.3;SuSa: 14.8" "Low region specificity" "Detected in all" HPA008462 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA008462: AB_1845777" "unprognostic (1.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (4.13e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.37e-4)" "unprognostic (1.74e-1)" "unprognostic (3.43e-2)" "unprognostic (5.46e-4)" "unprognostic (2.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.50e-1)" 5.7 9.0 7.7 6.1 13.1 0.5 11.0 10.4 9.2 8.5 4.9 3.6 8.4 2.3 9.4 9.8 5.7 12.9 9.9 3.7 7.4 10.3 14.3 9.4 9.6 3.9 6.3 3.6 13.0 13.7 15.2 11.1 41.9 8.4 12.5 2.8 17.7 6.2 12.3 2.3 3.3 2.8 5.0 4.6 2.6 3.6 8.1 3.2 3.0 22.7 3.2 6.3 9.9 12.8 0.4 0.0 0.0 0.1 0.0 0.2 1.1 4.8 4.9 8.6 0.0 0.0 0.0 28.9 2.8 1.7 2.7 2.4 0.0 0.0 0.0 1.2 0.9 2.7 1.0 0.0 13.9 3.4 0.0 0.4 0.0 0.0 7.2 3.3 0.0 2.1 3.4 11.1 0.0 5.2 12.3 0.4 0.0 0.6 0.0 2.9 0.0 0.0 0.0 10.2 0.0 1.0 0.0 0.0 0.0 9.0 7.3 2.6 4.1 0.0 8.7 2.1 14.8 2.9 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 7.7 13.1 10.4 7.5 7.4 10.3 6.3 3.6 8.4 3.2 20.8 9.6 0.9 22.5 20.8 15.6 4.1 10.2 32.1 14.8 17.4 2.0 125.8 36.5 9.2 51.1 18.0 0.0 0.0 4.2 49.4 8.3 25.0 0.0 17.5 11.0 9.5 7.5 7.4 3.8 11.1 6.6 1.9 8.5 0.0 1.5 8.3 4.4 0.0 6.0 15.4 11.0 19.4 16.0 21.2 5.9 6.0 227.6 0.0 0.0 9.2 TEAD4 "EFTR-2, RTEF-1, TCF13L1, TEF-3, TEFR-1" ENSG00000197905 "TEA domain transcription factor 4" Q15561 12 2959330-3040673 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 60.1" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 37.4;Exocrine glandular cells: 32.8;Ito cells: 31.3;Syncytiotrophoblasts: 28.9" "Cancer enriched" "Detected in all" 5 "testis cancer: 78.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 86.2" "Region enriched" "Detected in single" 4 "cerebellum: 3.5" "Low region specificity" "Detected in some" HPA056896 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA056896: AB_2683268" "unprognostic (3.68e-1)" "unprognostic (3.98e-1)" "unprognostic (2.17e-1)" "unprognostic (1.55e-3)" "unprognostic (1.33e-1)" "unprognostic (3.68e-1)" "unprognostic (9.20e-3)" "unprognostic (2.21e-3)" "unprognostic (3.01e-1)" "unprognostic (1.24e-1)" "unprognostic (2.50e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (9.78e-9)" "unprognostic (5.05e-3)" "unprognostic (8.43e-2)" "unprognostic (2.42e-2)" "unprognostic (1.23e-3)" 7.6 1.9 1.2 4.5 1.8 0.5 11.1 2.0 2.5 3.6 3.1 0.7 7.4 3.2 4.4 5.1 4.2 3.1 4.3 9.7 1.4 1.1 9.2 5.5 10.3 5.3 2.4 0.4 4.4 27.5 1.1 1.5 6.8 3.2 3.8 2.9 3.9 3.5 7.1 60.1 6.2 5.2 5.7 1.9 7.2 3.6 2.2 1.4 0.5 16.4 13.3 2.5 3.1 10.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 8.6 12.2 3.1 8.6 0.9 2.1 33.4 6.9 3.7 12.0 6.7 23.2 9.2 0.0 5.4 5.2 8.1 12.4 12.1 86.2 11.2 0.0 9.8 13.7 10.0 20.0 4.6 2.9 2.6 3.0 3.5 10.4 16.1 5.0 10.2 5.5 8.7 0.1 4.1 12.2 0.1 0.0 23.9 11.0 7.2 6.3 17.7 6.7 5.6 3.6 1.8 3.2 8.6 21.6 6.3 23.6 14.6 5.0 11.6 7.0 24.4 4.8 3.6 0.0 0.0 0.0 5.6 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 2.0 2.5 1.4 1.1 2.4 0.4 3.2 1.4 11.9 6.6 0.0 9.5 10.9 0.0 1.7 7.6 1.4 2.3 7.0 0.0 37.4 5.0 11.6 0.1 19.7 6.5 0.0 32.8 12.7 8.2 15.2 5.7 0.0 4.5 0.0 0.0 31.3 1.5 1.3 0.0 0.4 8.5 0.0 3.2 0.0 21.6 0.0 0.4 14.3 0.0 0.0 12.7 0.2 6.4 6.8 28.9 0.0 4.1 3.1 TECPR1 "DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358" ENSG00000205356 "Tectonin beta-propeller repeat containing 1" Q7Z6L1 7 98214624-98252251 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 63.9" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021061 Approved Supported Vesicles NA NA Vesicles "HPA021061: AB_1847687" "unprognostic (8.10e-3)" "unprognostic (7.89e-2)" "unprognostic (9.05e-3)" "unprognostic (5.00e-3)" "unprognostic (2.03e-1)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.45e-2)" "unprognostic (1.72e-1)" "unprognostic (1.88e-1)" "prognostic favorable (8.12e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (1.38e-1)" "unprognostic (3.24e-1)" "unprognostic (9.46e-2)" "unprognostic (6.12e-2)" 6.5 4.7 11.5 8.9 10.6 5.2 6.3 9.0 15.8 4.1 5.9 6.2 5.1 8.4 4.5 5.5 5.8 4.8 7.6 5.9 10.4 9.0 4.6 5.4 9.0 11.0 6.8 12.8 4.0 63.9 4.2 10.2 7.7 9.8 6.9 4.9 8.0 29.5 5.0 6.9 5.4 8.1 4.6 8.5 11.2 9.3 3.3 7.0 6.4 5.9 5.9 6.4 5.1 5.4 3.4 4.1 6.1 7.4 1.6 8.7 3.1 3.0 4.2 5.9 12.8 5.1 3.1 4.4 6.3 3.5 5.0 6.2 4.0 3.8 2.5 10.2 7.2 6.2 1.9 4.0 2.9 2.1 5.9 5.7 3.6 5.9 4.2 6.1 4.3 7.0 5.4 2.4 4.8 3.8 4.7 17.5 10.5 2.3 14.1 3.8 4.9 6.2 4.5 2.3 6.0 4.1 5.2 6.0 17.6 3.8 3.3 10.7 11.9 3.7 11.2 5.9 4.5 3.4 6.2 17.9 4.8 8.2 12.2 5.2 18.0 6.4 1.2 9.9 3.8 8.9 2.6 4.7 1.4 3.9 5.2 2.4 3.4 5.1 3.1 2.9 3.2 8.7 7.2 6.1 1.6 7.4 4.1 5.1 3.1 11.5 10.6 9.0 15.8 10.4 9.0 6.8 12.8 9.8 7.0 8.9 17.3 10.5 1.9 2.1 33.6 8.2 7.6 5.3 6.8 5.2 100.1 4.4 1.7 5.7 2.0 17.9 11.8 0.0 11.4 7.4 4.1 5.1 8.1 6.7 11.2 30.2 28.2 18.4 21.9 1.6 6.6 7.6 1.7 10.8 20.9 10.0 9.0 11.4 3.2 2.9 66.4 0.0 4.4 4.2 3.8 1.6 2.9 10.2 6.0 2.5 TECRL "DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL" ENSG00000205678 "Trans-2,3-enoyl-CoA reductase like" Q5HYJ1 4 64275257-64409468 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 131.5" "Cell type enriched" "Detected in single" 16229 "Cardiomyocytes: 1622.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "OE19: 2.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 131.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.3 0.0 0.9 0.9 0.6 1.1 0.5 0.2 0.3 1.1 0.0 0.1 0.2 1.1 0.7 0.5 0.3 0.3 0.6 0.5 0.3 0.1 0.4 0.5 0.0 0.7 1.4 1.4 0.2 1.2 0.6 0.1 0.5 0.2 0.3 1.0 0.2 0.3 0.7 1.1 0.2 0.2 0.5 0.8 0.7 2.8 0.2 0.5 0.8 0.4 2.5 0.5 0.2 0.6 0.5 0.1 0.1 1.4 0.4 0.5 0.7 1.1 0.8 0.7 0.8 1.0 0.2 0.7 0.5 0.8 0.6 0.6 0.0 0.2 0.3 0.0 0.2 0.1 0.1 0.1 0.0 0.2 0.2 0.2 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1622.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TECTA "DFNA12, DFNA8, DFNB21" ENSG00000109927 "Tectorin alpha" O75443 11 121101173-121191493 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 5.5" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 1: 3.0;Cone photoreceptor cells: 3.9;Early spermatids: 5.6;Ito cells: 9.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.5;SH-SY5Y: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018870 Approved "Secreted in other tissues" NA NA "HPA018870: AB_1857879" "unprognostic (1.12e-3)" "unprognostic (2.42e-1)" "unprognostic (1.42e-2)" "unprognostic (1.45e-2)" "unprognostic (4.30e-2)" "unprognostic (3.11e-1)" "unprognostic (3.00e-2)" "unprognostic (3.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.14e-1)" "unprognostic (1.39e-6)" "unprognostic (1.22e-1)" "unprognostic (4.15e-3)" "unprognostic (6.97e-3)" "unprognostic (1.12e-1)" "unprognostic (3.28e-2)" "unprognostic (4.19e-2)" 0.6 1.6 1.1 0.4 3.5 0.4 0.6 2.9 5.5 0.4 0.5 0.2 0.6 1.8 0.1 0.6 0.7 2.1 1.3 2.6 0.7 0.9 1.1 0.2 1.4 1.6 0.7 4.2 2.5 0.6 0.9 0.3 0.5 1.6 1.0 0.2 0.2 0.6 1.0 0.4 0.4 2.0 1.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 3.5 1.8 0.1 0.2 0.5 0.5 0.3 0.1 0.2 0.3 0.0 0.2 1.7 0.2 0.2 0.0 0.7 0.0 0.2 0.7 0.9 0.5 0.1 0.0 0.3 0.5 0.3 0.4 0.6 0.1 0.0 0.5 0.4 0.7 0.0 1.2 0.4 0.2 0.2 1.3 0.7 0.0 0.1 0.1 0.6 0.1 0.5 0.1 2.4 5.5 0.3 0.2 0.3 2.3 0.3 0.5 0.0 0.4 0.5 0.2 0.4 1.3 1.3 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.3 0.0 0.1 0.0 1.9 1.7 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.3 5.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 9.8 0.3 1.6 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 TECTB ENSG00000119913 "Tectorin beta" Q96PL2 10 112283400-112305035 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "Hep G2: 7.4;U-2197: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Secreted in other tissues" NA NA "unprognostic (3.14e-2)" "unprognostic (2.84e-2)" "unprognostic (9.75e-3)" "unprognostic (1.65e-1)" "unprognostic (1.32e-2)" "unprognostic (5.54e-2)" "unprognostic (2.80e-2)" "unprognostic (8.10e-2)" 0.1 0.0 0.8 0.1 1.3 0.0 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.1 3.5 0.1 0.0 0.1 0.1 0.4 0.2 0.1 2.4 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 15.8 0.1 0.1 0.1 0.0 0.3 0.1 0.5 0.1 0.0 0.2 0.1 0.1 1.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.1 0.3 0.4 0.2 0.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TEDC2 "C16orf59, FLJ13909" ENSG00000162062 "Tubulin epsilon and delta complex 2" Q7L2K0 16 2460080-2464963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.3;testis: 12.5" "Cell type enhanced" "Detected in some" 16 "Cytotrophoblasts: 7.9;Extravillous trophoblasts: 12.0;Hofbauer cells: 3.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051394, HPA055389" Approved Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA051394: AB_2681465, HPA055389: AB_2732595" "unprognostic (3.23e-1)" "unprognostic (1.03e-2)" "unprognostic (2.14e-2)" "unprognostic (7.46e-3)" "unprognostic (1.27e-1)" "unprognostic (1.38e-3)" "prognostic unfavorable (2.43e-5)" "prognostic unfavorable (7.58e-4)" "unprognostic (4.04e-3)" "unprognostic (8.85e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (1.16e-4)" "unprognostic (1.28e-3)" "unprognostic (1.56e-1)" "unprognostic (1.24e-2)" "unprognostic (1.03e-1)" 0.8 1.8 2.3 6.2 4.1 9.3 1.1 2.8 4.6 1.2 2.6 0.8 0.0 4.3 1.2 1.4 4.5 1.2 1.4 1.3 2.3 2.7 2.2 1.7 1.0 5.6 2.1 1.9 1.0 1.9 0.3 2.4 3.8 2.0 1.3 2.2 1.0 1.3 0.8 1.0 2.6 3.8 1.1 1.4 2.5 2.2 12.5 0.8 15.3 0.9 4.2 3.9 0.6 2.2 1.2 1.4 0.0 1.0 0.0 2.1 0.7 5.2 16.7 9.6 11.2 0.1 0.6 9.7 4.2 2.5 6.8 6.6 11.5 4.4 7.3 7.0 1.8 3.7 8.1 6.9 4.2 1.6 8.1 9.2 6.6 11.8 11.8 0.2 6.4 8.9 0.6 0.5 6.0 1.6 0.5 3.1 12.3 11.3 2.8 2.3 10.1 11.2 11.9 21.3 5.1 6.1 27.4 8.3 16.6 1.4 2.3 9.1 14.9 4.9 5.2 3.6 2.6 7.6 7.4 1.1 7.3 10.6 6.9 9.5 6.2 10.2 14.7 3.7 6.4 9.9 0.0 0.0 0.0 0.1 0.1 0.0 0.6 2.1 0.0 0.3 1.2 0.7 1.3 0.0 0.0 1.0 1.4 1.9 0.7 2.3 4.1 2.8 4.6 2.3 2.7 2.1 1.9 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.9 1.7 2.8 0.0 0.0 0.0 0.0 1.1 12.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TEDDM1 "EDDM9, Epdd1, HE9, TMEM45C" ENSG00000203730 "Transmembrane epididymal protein 1" Q5T9Z0 1 182398117-182400616 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "epididymis: 128.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 1.3" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.2;NB-4: 4.3" "Not detected" "Not detected" NA NA "unprognostic (4.21e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (6.71e-4)" "unprognostic (4.43e-3)" "unprognostic (2.86e-2)" "unprognostic (4.57e-2)" "unprognostic (4.20e-1)" "unprognostic (7.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-2)" "unprognostic (2.47e-2)" "unprognostic (6.99e-3)" 0.1 0.0 0.1 0.1 0.2 0.0 0.4 1.3 0.1 0.5 0.1 0.1 1.8 0.0 0.4 128.3 0.1 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.3 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.9 0.4 3.8 0.5 0.4 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.4 0.1 4.3 0.2 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.4 0.3 0.4 0.2 0.1 0.2 0.4 0.4 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 1.3 0.5 1.0 0.6 0.1 0.4 0.1 0.2 0.1 0.1 0.9 0.5 0.3 3.8 0.4 0.5 0.4 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEKT1 ENSG00000167858 "Tektin 1" Q969V4 17 6789133-6831761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 40.1;testis: 25.7" "Group enriched" "Detected in some" 11 "Ciliated cells: 303.8;Early spermatids: 329.7;Late spermatids: 105.8" "Group enriched" "Detected in some" 7 "endometrial cancer: 4.6;glioma: 2.1;lung cancer: 0.9;ovarian cancer: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.4;HDLM-2: 2.6;JURKAT: 2.0;Karpas-707: 2.8;NB-4: 2.7;REH: 2.8;SK-MEL-30: 1.6;U-87 MG: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044444, HPA062285" Approved NA NA "HPA044444: AB_10961038, HPA062285: AB_2684737" "unprognostic (7.28e-3)" "unprognostic (7.24e-3)" "prognostic favorable (6.08e-4)" "unprognostic (2.88e-2)" "unprognostic (8.04e-2)" "unprognostic (3.73e-2)" "unprognostic (1.91e-1)" "unprognostic (4.22e-1)" "unprognostic (2.88e-2)" "unprognostic (1.62e-1)" "unprognostic (7.63e-6)" "unprognostic (6.28e-2)" "unprognostic (2.78e-2)" "unprognostic (9.53e-3)" "unprognostic (3.13e-1)" 0.2 0.2 2.3 0.2 9.9 0.6 0.2 0.0 0.8 2.1 0.2 10.2 0.0 0.1 1.1 13.0 0.9 40.1 0.9 0.6 3.8 3.7 0.2 0.2 8.2 0.4 0.4 0.3 10.7 0.1 0.1 3.1 0.2 13.7 0.2 0.1 0.0 0.4 0.2 0.1 1.7 0.1 0.2 0.7 0.3 0.2 25.7 2.0 0.0 0.4 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.0 2.0 0.0 2.8 0.0 0.0 0.0 2.7 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.7 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 9.9 0.0 0.8 3.8 3.7 0.4 0.3 13.7 2.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 303.8 21.6 0.0 0.0 0.0 0.0 0.0 329.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 105.8 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.4 3.3 0.0 0.0 0.0 0.0 0.0 TEKT2 TEKTB1 ENSG00000092850 "Tektin 2" Q9UIF3 1 36084075-36088275 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 41.4;testis: 33.3" "Group enriched" "Detected in some" 7 "Early spermatids: 414.8;Late spermatids: 228.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 45 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 45 "granulocytes: 4.4" "Cell line enriched" "Detected in some" 7 "NB-4: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA027248, HPA027461" Approved Uncertain Microtubules NA NA Microtubules "HPA027248: AB_1857884, HPA027461: AB_10600912" "unprognostic (1.02e-3)" "unprognostic (1.21e-2)" "unprognostic (2.96e-2)" "unprognostic (2.12e-3)" "unprognostic (2.64e-1)" "unprognostic (1.78e-2)" "unprognostic (1.98e-2)" "unprognostic (3.42e-2)" "unprognostic (1.35e-1)" "unprognostic (1.13e-3)" "unprognostic (5.28e-4)" "unprognostic (6.11e-2)" "prognostic favorable (1.98e-4)" "unprognostic (9.78e-2)" "unprognostic (8.35e-2)" "unprognostic (5.29e-2)" "unprognostic (7.68e-2)" 0.2 0.5 1.9 0.2 3.8 0.9 0.8 0.8 1.1 2.3 0.2 3.1 0.5 0.2 1.1 6.1 0.2 41.4 0.2 0.2 2.3 2.5 1.0 0.1 4.0 0.2 0.5 0.8 3.3 1.1 1.2 2.0 0.2 6.4 0.3 0.1 0.1 0.4 1.1 0.1 0.1 0.1 0.4 0.7 0.1 0.3 33.3 1.2 0.3 1.9 0.3 0.2 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 28.6 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 1.9 3.8 0.8 1.1 2.3 2.5 0.5 0.8 6.4 1.2 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 44.2 4.5 1.8 0.0 0.1 0.0 0.5 414.8 0.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 1.7 0.0 0.0 228.6 4.6 0.0 0.0 0.0 0.0 0.9 0.1 0.0 3.5 1.6 0.0 0.0 0.0 6.2 3.8 0.0 0.0 0.0 0.0 0.1 TEKT3 FLJ32828 ENSG00000125409 "Tektin 3" Q9BXF9 17 15303811-15341641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 36.7" "Group enriched" "Detected in some" 5 "Early spermatids: 329.8;Late spermatids: 272.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "basophil: 4.0" "Group enriched" "Detected in many" 5 "B-cells: 1.0;granulocytes: 4.0;NK-cells: 1.4" "Cell line enhanced" "Detected in some" "HMC-1: 4.1;SuSa: 7.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA044354, HPA073565" Enhanced NA NA "HPA044354: AB_10962623, HPA073565: " "unprognostic (1.85e-1)" "unprognostic (6.64e-3)" "unprognostic (9.73e-2)" "unprognostic (5.38e-4)" "unprognostic (4.59e-2)" "unprognostic (3.09e-2)" "unprognostic (9.07e-2)" "unprognostic (8.63e-3)" "unprognostic (4.91e-2)" "unprognostic (1.23e-1)" "unprognostic (9.67e-4)" "unprognostic (1.29e-1)" "unprognostic (1.09e-4)" "unprognostic (1.69e-2)" "unprognostic (3.00e-1)" "unprognostic (2.90e-3)" "unprognostic (7.85e-2)" 0.6 0.1 0.6 0.3 1.3 0.3 2.2 1.8 0.4 0.7 0.4 1.4 0.1 0.3 0.6 1.4 0.1 4.9 0.4 0.8 0.6 0.7 0.2 0.1 2.0 0.1 0.2 0.1 1.0 0.7 0.2 0.8 0.2 2.3 0.5 0.2 0.2 0.5 0.1 0.1 0.6 0.4 0.2 0.3 0.2 0.0 36.7 0.4 0.1 0.4 0.5 0.1 0.1 0.2 1.0 0.4 4.0 0.4 1.4 0.4 0.1 0.2 0.0 1.3 1.5 0.0 0.2 0.9 0.5 1.1 0.1 0.0 2.2 0.0 0.3 0.2 0.7 0.3 0.6 0.0 0.0 0.1 0.5 0.5 0.6 1.0 0.4 0.3 0.4 4.1 0.0 0.6 0.0 0.0 1.1 0.4 0.5 0.0 0.3 0.0 0.0 0.2 2.0 0.0 0.4 0.3 0.2 0.7 0.0 0.4 0.7 0.6 0.6 0.0 0.3 0.5 7.6 0.0 0.1 0.0 0.1 0.5 0.2 0.2 0.6 0.4 0.5 0.0 0.0 0.4 4.0 0.4 0.3 0.3 0.4 0.2 0.8 0.4 0.1 0.1 1.0 0.3 0.3 2.6 1.4 0.2 0.4 0.3 0.1 0.6 1.3 1.8 0.4 0.6 0.7 0.2 0.1 2.3 0.4 3.0 0.3 0.0 0.0 0.2 0.8 0.6 2.5 61.6 7.9 0.0 0.0 0.2 0.0 0.0 329.8 0.1 0.5 0.0 0.0 0.4 1.0 0.0 0.0 0.0 2.8 0.0 1.7 0.0 0.0 272.4 10.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 6.0 0.0 0.0 6.5 0.9 4.6 1.9 0.1 0.0 0.0 0.0 0.1 TEKT4 MGC27019 ENSG00000163060 "Tektin 4" Q8WW24 2 94871433-94876829 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 7.6;testis: 21.1" "Group enriched" "Detected in many" 14 "Ciliated cells: 66.9;Early spermatids: 109.5;Late spermatids: 99.2" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 2.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.0;fHDF/TERT166: 1.8;HEK 293: 1.0;HEL: 1.3;HMC-1: 1.0;MCF7: 1.5" "HPA048600, HPA053929, HPA069872" Enhanced Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA048600: AB_2680460, HPA053929: AB_2682314, HPA069872: " "unprognostic (1.49e-2)" "unprognostic (4.00e-1)" "prognostic favorable (1.29e-4)" "unprognostic (9.95e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (2.82e-3)" "unprognostic (2.15e-1)" "unprognostic (5.25e-2)" "unprognostic (5.00e-2)" "unprognostic (9.01e-2)" "unprognostic (5.25e-3)" "unprognostic (5.45e-3)" "unprognostic (2.33e-1)" "unprognostic (3.27e-2)" "unprognostic (7.56e-3)" 0.1 0.1 0.7 0.2 1.5 0.1 0.1 0.2 0.2 0.6 0.1 1.4 0.7 0.1 0.5 5.5 0.1 7.6 0.1 0.1 0.9 0.9 0.1 0.1 3.7 0.1 0.1 0.2 1.7 0.2 0.1 0.0 0.1 2.9 0.1 0.1 0.0 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 21.1 0.3 0.0 1.0 0.0 0.1 0.1 0.0 1.1 1.8 0.7 0.6 0.1 0.8 0.3 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.4 1.0 1.3 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.7 0.6 0.4 0.3 1.1 0.6 0.7 0.8 0.6 0.8 0.5 0.0 0.1 0.6 1.8 0.6 0.3 0.7 1.5 0.2 0.2 0.9 0.9 0.1 0.2 2.9 0.3 0.0 1.0 0.0 0.2 1.3 0.0 0.3 2.5 66.9 5.7 1.8 0.0 0.5 1.7 1.2 109.5 0.9 0.0 0.0 0.3 0.2 1.4 0.4 1.1 0.9 0.2 0.0 0.0 1.8 0.3 99.2 2.6 0.9 0.0 4.6 0.0 0.0 1.2 0.0 1.1 6.3 0.0 6.5 0.9 1.1 0.6 1.1 0.5 0.0 0.1 0.3 TEKT5 "CT149, FLJ32871" ENSG00000153060 "Tektin 5" Q96M29 16 10627501-10694945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "testis: 30.4" "Cell type enriched" "Detected in some" 4 "Early spermatids: 505.4" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.0" "Lineage enhanced" "Detected in single" "dendritic cells: 1.0" "Cell line enriched" "Detected in some" 13 "BEWO: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA043578 Approved "Actin filaments" NA NA "Actin filaments" "HPA043578: AB_10795772" "unprognostic (5.90e-2)" "unprognostic (1.37e-2)" "unprognostic (1.39e-2)" "unprognostic (7.53e-2)" "unprognostic (2.69e-2)" "unprognostic (9.76e-2)" "unprognostic (2.00e-1)" "unprognostic (1.39e-2)" "unprognostic (1.89e-1)" "unprognostic (5.09e-2)" "unprognostic (5.88e-2)" "unprognostic (5.02e-2)" "unprognostic (3.24e-7)" "unprognostic (3.80e-2)" "unprognostic (2.31e-1)" "unprognostic (3.76e-2)" "unprognostic (8.12e-5)" 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.9 30.4 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 17.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.9 0.2 0.4 0.2 0.0 0.2 1.3 0.3 0.0 0.3 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 505.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 114.5 3.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 3.2 1.1 0.3 0.0 0.0 0.0 0.3 TENM1 "ODZ1, ODZ3, TEN-M1, TNM" ENSG00000009694 "Teneurin transmembrane protein 1" Q9UKZ4 X 124375903-124963817 "Predicted membrane proteins" "Stress response, Transcription, Transcription regulation" "Neuropeptide, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;liver: 10.5" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 8.0;Glandular cells: 16.3;granulocytes: 7.0;Hepatocytes: 15.3" "Group enriched" "Detected in many" 5 "glioma: 1.6;prostate cancer: 2.2;renal cancer: 1.6;testis cancer: 1.4;thyroid cancer: 7.0" "Region enriched" "Detected in many" 4 "cerebellum: 17.0" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.0;hTERT-HME1: 2.7;MOLT-4: 9.8;RPTEC TERT1: 3.5;SCLC-21H: 3.4;U-138 MG: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002848 Uncertain NA NA "HPA002848: AB_1079523" "unprognostic (1.71e-3)" "unprognostic (8.25e-2)" "unprognostic (3.14e-1)" "unprognostic (8.68e-4)" "unprognostic (5.76e-3)" "unprognostic (3.51e-2)" "unprognostic (7.07e-2)" "unprognostic (2.68e-4)" "unprognostic (6.58e-2)" "unprognostic (1.71e-1)" "unprognostic (4.49e-3)" "unprognostic (3.58e-1)" "unprognostic (2.71e-2)" "unprognostic (4.41e-2)" "unprognostic (1.99e-1)" "unprognostic (3.25e-3)" "unprognostic (4.44e-2)" 1.9 3.0 1.4 0.4 2.4 3.5 1.0 17.0 4.4 0.4 1.1 0.9 0.4 0.1 1.4 2.3 0.4 1.5 2.0 0.4 2.3 2.7 1.8 10.5 0.9 0.9 1.0 4.2 0.4 0.4 0.0 3.5 0.4 3.3 4.8 0.3 1.5 0.9 3.8 0.5 1.6 0.7 1.1 2.6 0.6 0.5 2.3 0.4 0.4 3.1 0.4 0.7 0.4 0.4 0.0 0.0 2.4 0.1 0.6 1.6 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.7 0.0 0.0 2.3 0.0 1.2 0.0 0.0 9.8 0.0 0.5 0.0 1.5 0.0 0.0 0.1 3.5 0.0 3.4 0.0 0.0 0.7 0.0 2.3 0.8 0.0 0.0 5.8 0.2 0.0 0.4 0.3 0.7 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.6 0.0 0.9 0.0 0.9 1.0 0.0 0.0 1.6 1.1 2.4 0.6 0.0 0.0 0.2 0.1 1.4 2.4 17.0 3.9 2.3 2.7 1.0 4.2 3.3 0.4 0.0 0.0 0.0 0.1 3.0 8.0 0.8 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 5.4 16.3 7.0 15.3 0.0 6.4 0.0 0.6 0.6 0.0 4.6 0.3 3.3 0.0 0.0 0.5 0.0 0.0 0.0 2.9 0.5 0.0 0.5 0.0 3.4 1.6 0.0 1.0 0.0 0.1 TENM2 "KIAA1127, ODZ2, Ten-M2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.1;heart muscle: 24.7" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 142.6;Horizontal cells: 114.4;Peritubular cells: 58.0" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.7;HBEC3-KT: 17.5;HDLM-2: 17.1;U-138 MG: 31.3;U-2 OS: 27.2;U-251 MG: 20.0" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli No No Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019" "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavorable (7.52e-4)" 0.2 0.4 2.5 0.0 3.5 0.0 1.8 0.5 15.1 0.6 0.3 0.0 0.0 0.3 0.2 0.4 1.4 0.2 0.3 24.7 6.5 0.9 2.7 1.2 0.3 0.0 0.5 1.7 0.7 0.2 0.0 0.4 0.0 2.3 2.2 0.0 0.2 0.3 1.0 0.2 2.3 0.2 0.0 0.6 0.2 0.3 1.2 0.4 0.0 0.4 0.0 0.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 0.0 26.7 0.7 0.0 0.0 17.5 0.3 17.1 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.3 3.1 0.1 2.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 4.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.0 1.5 0.0 0.0 31.3 27.2 0.0 20.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.5 15.1 6.5 0.9 0.5 1.7 2.3 0.4 0.0 0.0 0.0 0.7 13.2 9.5 142.6 0.0 0.0 1.2 0.0 17.7 0.0 0.0 2.5 20.1 1.3 0.1 0.0 0.2 0.0 0.7 1.1 1.1 4.2 0.1 114.4 0.0 0.0 0.0 13.2 4.0 0.0 1.7 0.0 0.3 2.1 0.0 0.0 58.0 0.0 1.6 0.0 1.7 0.9 1.1 1.5 0.0 0.0 0.0 0.1 TENM4 "KIAA1302, ODZ4, Ten-M4" ENSG00000149256 "Teneurin transmembrane protein 4" Q6N022 11 78652831-79440948 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 23.0;parathyroid gland: 44.4" "Group enriched" "Detected in some" 5 "Early spermatids: 74.5;Late spermatids: 45.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HSkMC: 8.2;hTERT-RPE1: 8.5;PC-3: 9.4;REH: 8.9;SH-SY5Y: 15.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019521, HPA065961" Approved NA NA "HPA019521: AB_2670171, HPA065961: AB_2685588" "unprognostic (2.81e-1)" "unprognostic (9.25e-2)" "unprognostic (1.64e-1)" "unprognostic (2.96e-3)" "unprognostic (1.87e-1)" "unprognostic (2.48e-1)" "unprognostic (1.18e-2)" "unprognostic (1.24e-1)" "unprognostic (3.01e-1)" "unprognostic (3.79e-1)" "unprognostic (1.01e-1)" "unprognostic (4.71e-1)" "unprognostic (6.51e-3)" "unprognostic (5.40e-3)" "unprognostic (5.64e-2)" "unprognostic (7.07e-2)" "unprognostic (9.81e-3)" 3.2 2.8 14.7 2.2 13.0 1.0 1.6 1.4 16.9 4.4 1.4 3.6 0.0 1.1 2.7 1.2 3.1 3.7 1.5 1.3 11.4 6.3 2.9 1.0 1.4 1.5 3.3 5.7 23.0 1.3 44.4 12.0 1.1 8.3 1.4 1.4 4.8 1.5 1.3 1.4 5.1 1.2 2.2 12.5 1.3 1.5 2.9 5.7 0.6 8.2 2.1 2.5 1.6 2.3 0.3 1.4 0.6 0.6 0.3 0.1 0.0 0.0 0.0 3.0 0.0 3.4 5.5 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.9 5.7 0.0 1.8 4.4 4.6 0.0 3.8 0.8 0.0 0.0 0.0 0.1 0.0 0.0 8.2 2.0 2.2 4.1 8.5 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 1.6 0.2 9.4 8.9 0.0 0.0 5.9 1.0 6.4 15.6 0.0 0.0 0.0 5.8 0.0 0.1 0.4 0.1 1.1 0.1 5.1 0.0 0.0 0.1 6.2 0.0 0.0 0.5 0.6 0.0 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.3 0.0 0.0 0.6 0.3 0.3 0.3 0.1 0.0 14.7 13.0 1.4 16.9 11.4 6.3 3.3 5.7 8.3 5.7 0.0 0.0 0.0 0.4 0.8 2.6 1.6 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.4 74.5 0.0 0.0 0.0 0.0 0.1 0.7 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.3 45.5 4.9 0.2 0.0 0.0 0.0 13.2 0.0 0.0 1.8 0.0 0.3 0.0 0.4 1.7 0.7 1.8 0.1 0.0 0.0 0.5 TEPP ENSG00000159648 "Testis, prostate and placenta expressed" Q6URK8 16 57976435-57988116 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 46.3" "Group enriched" "Detected in many" 11 "Early spermatids: 286.9;Late spermatids: 318.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 4.5" "Lineage enriched" "Detected in single" 6 "T-cells: 4.5" "Cell line enhanced" "Detected in some" "BEWO: 2.9;HMC-1: 2.0;RPMI-8226: 2.4;TIME: 2.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062092 Enhanced "Secreted in male reproductive system" NA NA "HPA062092: AB_2684679" "unprognostic (4.86e-2)" "unprognostic (2.72e-1)" "unprognostic (4.12e-2)" "unprognostic (2.56e-2)" "unprognostic (1.79e-2)" "unprognostic (8.04e-2)" "unprognostic (3.67e-1)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (2.48e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.46e-1)" "unprognostic (3.97e-3)" "unprognostic (2.59e-1)" 0.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.4 0.1 0.0 0.1 0.5 0.3 0.6 0.1 0.3 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.3 0.7 0.1 0.0 0.1 0.1 0.4 0.3 0.0 0.1 0.2 1.2 0.1 0.1 0.1 0.1 0.3 0.1 0.0 46.3 0.2 0.1 2.6 0.1 0.2 1.6 0.5 0.7 0.2 0.3 0.0 0.2 4.5 1.3 0.0 0.0 0.6 0.0 0.0 0.0 2.9 0.0 0.4 0.5 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.6 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 2.5 0.1 3.0 2.0 0.0 0.7 2.9 4.5 0.0 0.2 0.0 0.2 1.4 1.3 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.3 0.4 0.2 11.9 5.1 0.0 8.2 0.1 0.0 27.4 2.5 1.4 11.4 1.8 0.0 2.1 0.0 0.0 286.9 0.7 0.0 0.0 0.5 3.1 1.5 0.6 2.3 0.0 0.4 0.0 0.0 1.8 0.0 318.3 3.4 0.2 1.7 0.0 0.0 0.6 0.1 0.0 0.4 0.0 1.3 0.0 1.4 2.1 2.3 0.0 0.9 0.0 0.0 3.3 TERB1 "CCDC79, FLJ35894" ENSG00000249961 "Telomere repeat binding bouquet formation protein 1" Q8NA31 16 66754976-66801620 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 23.2" "Group enriched" "Detected in some" 12 "Alveolar cells type 2: 1.1;Ciliated cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.15e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (2.29e-1)" "unprognostic (3.91e-2)" "unprognostic (9.75e-2)" "unprognostic (5.79e-2)" "unprognostic (1.03e-1)" "unprognostic (7.57e-5)" "unprognostic (6.49e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-2)" "unprognostic (6.81e-6)" "unprognostic (1.66e-1)" "unprognostic (2.56e-1)" "unprognostic (2.34e-1)" "unprognostic (6.14e-3)" 0.1 0.2 0.1 0.1 0.1 1.9 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.1 23.2 0.1 0.1 0.4 0.1 0.1 0.1 0.1 2.0 3.3 4.1 0.9 4.3 1.0 0.7 0.8 2.1 1.1 0.4 1.6 0.1 0.0 0.4 0.0 0.8 0.3 2.7 1.6 1.2 0.2 0.0 0.2 1.7 0.0 1.1 0.2 0.4 2.3 0.5 2.9 1.8 0.0 0.0 1.8 0.7 1.5 0.4 0.0 0.5 0.5 0.8 0.4 2.6 0.0 0.5 1.0 1.7 0.4 0.2 0.0 0.8 1.0 1.6 0.0 2.1 1.1 0.9 0.6 0.8 0.4 1.9 0.2 1.2 0.2 1.6 0.7 1.9 0.6 1.3 0.8 1.9 2.0 1.1 0.2 4.1 0.9 0.5 0.7 0.4 0.6 1.2 0.5 0.8 0.1 2.0 0.8 1.0 3.0 4.3 0.4 3.3 0.4 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956702-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "testis: 51.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TERT "EST2, hEST2, TCS1, TP2, TRT" ENSG00000164362 "Telomerase reverse transcriptase" O14746 5 1253147-1295069 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "DNA-binding, Nucleotidyltransferase, Ribonucleoprotein, RNA-directed DNA polymerase, Transferase" "Cancer-related genes, Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0" "Cell type enhanced" "Detected in some" 24 "Cardiomyocytes: 1.2;Spermatogonia: 1.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 62.6;fHDF/TERT166: 59.4;HBEC3-KT: 120.8;hTEC/SVTERT24-B: 76.3;LHCN-M2: 34.4;TIME: 98.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA054641, HPA065897" Supported Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA Nucleoplasm "Nuclear speckles, Cytosol" "HPA054641: AB_2682554, HPA065897: AB_2685576" "unprognostic (1.21e-2)" "unprognostic (2.88e-2)" "unprognostic (1.24e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-3)" "unprognostic (6.42e-3)" "unprognostic (1.85e-2)" "unprognostic (2.21e-1)" "unprognostic (6.91e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (9.16e-4)" "unprognostic (8.84e-11)" "unprognostic (1.92e-1)" "unprognostic (2.15e-1)" "unprognostic (3.35e-1)" 0.0 0.0 0.0 7.1 0.9 3.4 0.0 0.0 0.2 0.1 1.1 0.0 0.0 1.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 1.0 0.4 5.0 0.0 12.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 31.3 62.6 0.5 0.0 23.8 4.3 8.0 0.1 0.1 0.7 0.0 59.4 0.0 0.0 0.2 120.8 5.1 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.3 0.0 3.1 76.3 0.8 0.1 0.2 0.5 0.6 0.1 34.4 0.0 0.2 1.7 0.4 0.0 0.2 0.9 0.0 0.8 3.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 98.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 TESC "CHP3, FLJ20607, TSC" ENSG00000088992 Tescalcin Q96BS2 12 117038923-117099479 "Predicted intracellular proteins" "Differentiation, Protein transport, Transport" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.8;salivary gland: 92.6" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 186.0;Exocrine glandular cells: 427.3;Late spermatids: 257.6;Pancreatic endocrine cells: 170.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 55.8" "Lineage enriched" "Detected in all" 5 "monocytes: 55.8" "Cell line enhanced" "Detected in many" "HMC-1: 64.5;NB-4: 103.8;OE19: 43.8;U-937: 34.5" "Low region specificity" "Detected in all" HPA053200 Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053200: AB_2682079" "unprognostic (4.53e-3)" "unprognostic (5.98e-2)" "unprognostic (6.50e-2)" "unprognostic (2.23e-3)" "unprognostic (6.31e-2)" "unprognostic (2.05e-3)" "unprognostic (4.98e-3)" "unprognostic (3.35e-1)" "unprognostic (4.35e-1)" "unprognostic (1.62e-1)" "unprognostic (4.37e-2)" "unprognostic (7.43e-2)" "unprognostic (1.69e-2)" "unprognostic (8.65e-2)" "unprognostic (2.57e-1)" "unprognostic (1.56e-2)" "unprognostic (5.67e-3)" 1.8 8.4 5.0 2.4 12.1 25.5 2.3 1.2 6.8 1.8 1.2 1.8 19.4 1.8 1.3 32.9 1.3 1.3 45.8 13.2 6.2 2.2 4.6 1.9 2.9 1.8 2.4 3.3 1.5 40.5 0.7 4.0 2.5 2.2 2.5 0.7 0.3 92.6 24.4 1.3 1.8 1.7 1.4 1.6 2.7 34.4 5.0 2.2 1.2 2.1 1.2 2.5 6.5 2.3 1.9 8.5 11.3 55.8 2.5 2.3 3.9 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 2.3 0.7 0.0 0.0 0.1 1.2 0.0 0.0 6.3 4.1 17.7 1.4 12.1 0.0 7.5 64.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 8.4 0.1 0.0 0.3 14.6 103.8 1.4 43.8 0.0 0.0 0.0 8.3 9.0 2.3 2.7 0.9 0.0 0.0 0.5 0.1 0.0 8.1 0.0 0.0 0.2 0.0 0.0 2.7 6.1 0.0 0.0 34.5 0.0 0.0 11.9 11.3 1.8 14.9 0.1 1.3 0.6 2.3 8.5 1.9 0.0 1.0 3.0 2.5 55.8 0.6 0.7 3.9 5.0 12.1 1.2 6.8 6.2 2.2 2.4 3.3 2.2 2.2 0.0 0.0 14.1 0.2 2.4 0.6 39.2 186.0 0.0 1.2 12.2 0.0 0.4 63.0 131.7 86.8 9.5 0.0 116.8 427.3 0.6 1.2 3.9 71.4 0.2 36.5 0.0 1.7 1.8 23.5 257.6 2.8 6.3 69.2 10.0 0.1 0.0 170.4 0.0 3.2 2.8 1.4 142.3 48.4 44.5 16.4 1.8 1.0 33.7 0.2 0.7 TESMIN "CXCDC2, MTL5" ENSG00000132749 "Testis expressed metallothionein like protein" Q9Y4I5 11 68707440-68751564 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "testis: 81.0" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 5.0;Ductal cells: 5.8;Exocrine glandular cells: 3.4;Extravillous trophoblasts: 3.7;Pancreatic endocrine cells: 5.1;Proximal tubular cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 10.7;T-47d: 21.2" "Not detected" "Not detected" HPA018539 Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA018539: " "unprognostic (1.99e-1)" "unprognostic (3.97e-3)" "unprognostic (1.34e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (3.22e-2)" "unprognostic (6.71e-2)" "unprognostic (1.76e-2)" "unprognostic (6.99e-3)" "unprognostic (2.54e-1)" "unprognostic (5.33e-2)" "unprognostic (2.19e-2)" "unprognostic (8.47e-2)" "unprognostic (5.27e-2)" "unprognostic (6.39e-2)" "unprognostic (2.99e-1)" "unprognostic (9.85e-2)" "unprognostic (3.17e-1)" 0.3 0.5 0.3 1.6 1.4 4.8 3.3 0.1 0.6 0.6 1.9 0.0 3.8 1.0 0.5 1.2 1.3 1.3 1.0 0.4 0.2 0.9 3.2 0.3 0.4 0.9 0.6 0.4 0.8 2.6 2.6 1.9 0.4 1.8 1.7 2.2 0.6 2.5 5.2 0.1 0.5 1.2 0.3 0.7 1.2 0.6 81.0 0.1 5.5 1.5 0.9 2.0 0.5 0.7 0.4 0.1 2.8 1.1 0.0 1.1 0.4 6.2 2.7 1.2 0.0 0.0 0.0 3.2 1.4 0.7 2.0 0.9 0.8 6.3 2.5 1.4 0.2 0.0 3.0 0.9 1.2 1.6 2.6 2.2 1.8 0.9 0.0 0.0 1.3 10.7 0.0 3.4 0.1 2.0 2.7 0.6 3.0 3.8 4.8 0.3 4.1 0.7 3.6 6.5 2.9 2.8 1.6 0.3 0.7 2.3 0.1 4.0 4.3 0.0 1.3 0.0 3.5 21.2 8.7 2.3 0.2 0.4 0.1 0.1 1.9 1.7 2.4 0.1 3.7 1.7 0.0 1.0 1.0 0.3 0.4 0.6 0.0 1.1 0.2 0.1 0.4 0.4 0.3 2.8 0.0 1.1 0.1 0.8 0.4 0.3 1.4 0.1 0.6 0.2 0.9 0.6 0.4 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.2 0.0 0.0 0.7 5.0 5.8 0.0 0.0 0.0 0.0 3.4 3.7 0.0 0.0 2.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.1 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 TESPA1 KIAA0748 ENSG00000135426 "Thymocyte expressed, positive selection associated 1" A2RU30 12 54948018-54984746 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 45.1;brain: 56.9;lymphoid tissue: 27.8" "Group enriched" "Detected in some" 10 "granulocytes: 114.6;T-cells: 28.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 56.9" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 45.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 67.8;HMC-1: 55.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA058823 Approved NA NA "HPA058823: AB_2683828" "unprognostic (1.98e-5)" "unprognostic (3.70e-4)" "unprognostic (3.87e-4)" "unprognostic (1.13e-3)" "unprognostic (3.20e-2)" "unprognostic (4.55e-4)" "unprognostic (2.29e-3)" "unprognostic (5.34e-4)" "unprognostic (3.83e-4)" "unprognostic (1.35e-2)" "unprognostic (3.97e-2)" "unprognostic (5.89e-2)" "unprognostic (4.50e-2)" "unprognostic (4.11e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" 1.4 0.8 2.9 9.2 25.0 8.2 1.1 0.7 56.9 1.3 2.3 0.2 0.0 2.0 1.6 3.0 1.3 1.3 3.3 1.0 4.5 1.6 1.3 1.1 3.8 23.4 2.1 13.3 5.2 0.9 0.6 0.9 0.2 0.5 1.5 3.3 0.0 1.1 0.6 0.9 1.2 4.8 1.4 0.9 8.7 2.6 0.9 4.0 27.8 1.4 0.0 23.1 3.2 1.4 4.3 3.9 9.3 0.4 13.5 45.1 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 5.6 0.1 67.8 0.1 0.0 0.0 3.8 55.8 0.0 0.0 0.0 0.0 0.1 0.0 12.5 0.2 4.9 0.0 0.0 10.8 0.3 0.1 0.0 0.0 2.6 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 3.2 0.4 1.2 0.0 9.3 0.4 0.4 9.8 0.3 11.5 4.3 31.8 14.7 3.9 3.9 45.1 24.9 0.7 13.5 0.3 1.4 21.2 14.8 2.9 25.0 0.7 56.9 4.5 1.6 2.1 13.3 0.5 4.0 0.0 7.0 6.7 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 114.6 0.0 0.1 0.0 0.0 0.6 1.0 0.0 0.9 1.2 1.7 1.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.4 0.0 0.1 0.3 0.0 28.7 0.0 0.0 TET3 "hCG_40738, MGC22014" ENSG00000187605 "Tet methylcytosine dioxygenase 3" O43151 2 73986404-74108176 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Developmental protein, Dioxygenase, DNA-binding, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.0" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 44.0;Suprabasal keratinocytes: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050845 Uncertain Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA050845: AB_2681256" "unprognostic (1.07e-2)" "unprognostic (1.21e-2)" "unprognostic (3.08e-1)" "unprognostic (1.12e-2)" "unprognostic (4.44e-2)" "unprognostic (2.75e-2)" "unprognostic (1.72e-3)" "unprognostic (1.46e-1)" "unprognostic (1.01e-1)" "unprognostic (9.83e-2)" "unprognostic (7.74e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.58e-5)" "unprognostic (2.05e-1)" "unprognostic (5.30e-1)" "unprognostic (1.55e-2)" "unprognostic (1.10e-1)" 2.9 2.3 7.2 6.1 10.8 20.9 3.9 26.0 17.1 3.2 5.1 20.6 0.5 6.7 2.9 1.9 10.2 3.0 3.3 1.6 7.1 3.3 2.6 5.1 5.6 4.3 12.0 9.5 2.9 3.6 3.5 4.2 5.7 12.4 3.6 5.5 5.9 5.9 1.8 1.8 18.9 7.2 2.7 5.3 5.5 5.3 2.1 11.7 0.6 3.4 1.7 5.1 4.0 5.0 1.1 1.4 2.5 2.2 0.4 0.9 0.9 6.2 5.5 10.5 6.4 0.9 1.0 19.4 1.3 1.7 2.5 2.0 11.8 5.8 10.5 2.6 1.7 1.1 6.7 9.3 3.7 2.6 4.5 3.7 13.4 4.6 4.0 3.9 14.0 8.3 1.5 9.8 3.1 7.3 3.1 3.8 7.4 9.1 3.5 1.4 10.3 6.9 9.2 5.9 5.4 1.9 10.5 6.6 3.6 2.8 11.7 13.2 11.3 2.8 7.5 3.6 4.4 4.8 11.4 4.8 2.7 11.4 1.3 4.7 3.1 1.3 9.1 1.8 9.8 3.5 0.5 2.0 1.0 0.4 2.2 0.9 1.1 0.5 0.5 1.4 0.9 0.7 0.6 2.5 0.4 0.7 1.4 0.0 0.9 7.2 10.8 26.0 17.1 7.1 3.3 12.0 9.5 12.4 11.7 6.0 7.0 0.0 3.0 44.0 14.5 2.8 5.1 10.7 9.1 1.8 19.6 5.5 0.0 3.0 2.9 5.6 9.5 23.3 3.8 27.5 6.6 4.8 2.3 4.4 8.9 9.5 5.8 3.7 27.8 0.6 0.6 13.8 10.1 9.0 8.4 1.5 5.1 10.5 2.8 1.2 5.8 0.0 5.3 0.5 3.1 59.6 2.1 4.3 6.4 4.8 TEX101 "CT131, MGC4766, SGRG, SPATA44" ENSG00000131126 "Testis expressed 101" Q9BY14 19 43401496-43418597 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "blood: 24.5;testis: 56.6" "Cell type enriched" "Detected in some" 15 "Spermatocytes: 911.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 246 "basophil: 24.5" "Lineage enriched" "Detected in single" 246 "granulocytes: 24.5" "Cell line enhanced" "Detected in many" "THP-1: 4.9" "HPA041915, HPA042513" Enhanced "Secreted in male reproductive system" NA NA "HPA041915: AB_10795268, HPA042513: AB_10795507" "unprognostic (2.50e-2)" "unprognostic (5.67e-4)" "unprognostic (2.64e-1)" "unprognostic (6.89e-2)" "unprognostic (1.87e-1)" "unprognostic (5.78e-4)" "unprognostic (1.70e-1)" "unprognostic (2.84e-2)" "unprognostic (6.54e-2)" "unprognostic (4.06e-1)" "unprognostic (2.49e-2)" "unprognostic (1.67e-7)" "unprognostic (8.83e-2)" "unprognostic (2.24e-1)" "unprognostic (7.49e-2)" "unprognostic (7.04e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.0 56.6 0.1 0.1 0.1 0.1 0.4 0.1 0.3 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.9 0.6 1.3 0.7 1.0 2.4 0.7 0.4 0.6 1.0 1.0 0.2 0.4 0.4 1.0 1.6 1.1 0.4 0.4 1.0 0.7 1.2 0.0 0.3 1.3 0.4 2.0 0.4 0.9 1.2 1.6 0.1 1.0 0.9 2.0 1.1 0.3 1.0 1.1 0.2 0.6 1.0 0.7 0.8 1.0 2.7 0.2 1.3 2.3 0.2 0.9 0.4 0.3 0.8 2.3 0.7 0.3 4.9 0.4 0.8 0.8 0.8 1.4 1.0 1.2 0.6 0.9 0.7 0.6 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 32.3 0.0 911.6 62.4 0.0 0.0 0.0 0.0 0.0 TEX11 "TGC1, TSGA3" ENSG00000120498 "Testis expressed 11" Q8IYF3 X 70528940-70908731 "Disease related genes, Predicted intracellular proteins" Meiosis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "pancreas: 36.4;testis: 22.7" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 10.5;Late spermatids: 19.5;Paneth cells: 13.1;Spermatocytes: 19.9;Spermatogonia: 32.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.3;K-562: 3.8;NTERA-2: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002950 Approved NA NA "HPA002950: AB_1080249" "unprognostic (6.78e-3)" "unprognostic (3.57e-3)" "unprognostic (2.87e-3)" "unprognostic (7.77e-2)" "unprognostic (7.75e-3)" "unprognostic (2.14e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (1.74e-1)" "unprognostic (8.30e-2)" "unprognostic (5.74e-3)" "unprognostic (2.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.53e-1)" "unprognostic (3.03e-1)" "unprognostic (3.48e-1)" "unprognostic (1.56e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 36.4 0.0 0.1 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.2 22.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 1.0 0.2 0.8 2.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.7 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.8 0.2 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.1 0.1 1.0 0.8 0.1 0.1 2.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 19.5 0.6 0.0 0.0 1.0 0.5 0.0 0.9 13.1 0.7 0.1 0.0 0.0 0.0 19.9 32.6 0.1 0.0 0.0 0.3 0.0 TEX12 ENSG00000150783 "Testis expressed 12" Q9BXU0 11 112167372-112172559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 29.9" "Cell type enriched" "Detected in some" 7 "Spermatocytes: 158.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-698: 4.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038289, HPA038290" Enhanced NA NA "HPA038289: AB_10672742, HPA038290: AB_2675934" "unprognostic (1.49e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (2.92e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-3)" "unprognostic (2.03e-1)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (2.91e-1)" "unprognostic (9.20e-4)" "unprognostic (1.71e-2)" "unprognostic (2.97e-1)" "unprognostic (6.54e-2)" "unprognostic (4.10e-2)" "unprognostic (3.16e-3)" 0.3 0.0 0.1 0.6 0.2 0.3 0.4 0.1 0.4 0.2 0.2 0.3 0.1 0.6 0.2 0.5 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.9 0.7 0.4 0.2 0.1 0.2 0.2 29.9 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.5 0.5 1.5 0.5 0.0 0.9 0.3 0.1 0.0 0.6 0.3 1.1 0.7 0.2 0.3 0.4 0.5 1.1 0.4 1.5 2.5 0.6 0.7 0.5 0.0 0.5 0.4 0.8 1.5 0.0 1.2 0.0 0.0 1.5 1.4 0.9 0.9 0.6 1.0 0.4 0.2 0.1 0.8 0.3 1.2 0.0 0.0 1.1 2.5 0.1 1.3 0.9 0.8 0.3 2.2 1.1 0.1 0.3 0.4 0.0 1.5 0.0 0.0 0.1 2.6 0.0 0.4 1.5 0.8 0.5 0.3 0.2 4.9 0.6 1.3 0.0 0.0 0.1 1.5 0.1 0.5 0.0 0.5 0.5 0.9 0.0 0.0 0.0 0.3 0.8 0.0 0.4 0.5 0.0 0.3 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.6 0.5 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 6.5 0.1 158.2 23.2 0.4 0.0 0.0 0.0 0.1 TEX13A ENSG00000268629 "Testis expressed 13A" Q9BXU3 X 105218929-105220674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 100 "testis: 9.9" "Group enriched" "Detected in some" 66 "Early spermatids: 75.6;Late spermatids: 113.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 2.8;TIME: 1.0" HPA072257 Enhanced NA NA "HPA072257: AB_2732198" "unprognostic (3.70e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 TEX13B "TGC3B, TSGA5" ENSG00000170925 "Testis expressed 13B" Q9BXU2 X 107980864-107982370 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.0;SuSa: 3.3;U-138 MG: 1.2" NA NA "unprognostic (1.58e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.3 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 TEX13C ENSG00000282815 "TEX13 family member C" A0A0J9YWL9 X 125320120-125325214 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "testis: 5.9" "Group enriched" "Detected in some" 9 "Spermatocytes: 3.7;Spermatogonia: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "GAMG: 9.8" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.2 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 1.3 0.3 0.0 0.4 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.7 3.2 0.0 0.0 0.0 0.0 0.0 TEX13D ENSG00000282419 "TEX13 family member D" X 124246249-124336862 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 64 "testis: 6.4" "Group enriched" "Detected in some" 7 "Spermatocytes: 3.9;Spermatogonia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "NB-4: 3.7" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.4 0.0 0.0 0.0 0.0 0.0 TEX14 CT113 ENSG00000121101 "Testis expressed 14, intercellular bridge forming factor" Q8IWB6 17 58556678-58692055 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "testis: 52.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 13.5;Spermatocytes: 29.0;Spermatogonia: 15.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 9.1;Karpas-707: 11.9;MCF7: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030620, HPA077020" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Vesicles "HPA030620: AB_10601598, HPA077020: AB_2732327" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-1)" "unprognostic (9.49e-2)" "unprognostic (2.48e-1)" "unprognostic (1.23e-2)" "unprognostic (1.10e-1)" "unprognostic (6.17e-2)" "unprognostic (2.07e-2)" "unprognostic (1.61e-3)" "unprognostic (2.67e-2)" "unprognostic (8.10e-2)" "unprognostic (1.76e-9)" "unprognostic (1.77e-1)" "unprognostic (2.54e-1)" "unprognostic (5.00e-3)" "unprognostic (5.88e-2)" 0.1 0.1 0.2 0.1 0.3 1.5 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.5 0.2 0.0 52.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.2 0.1 0.0 0.2 2.6 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.4 0.0 0.2 9.1 1.4 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.1 0.0 0.5 0.1 11.9 0.0 4.8 0.4 0.1 0.6 0.1 0.1 0.5 0.4 1.8 0.0 0.1 1.4 0.2 0.0 0.1 0.6 0.4 0.4 0.1 0.0 0.1 0.3 0.0 0.0 2.1 0.5 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.8 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.1 0.4 0.1 0.0 0.0 0.0 1.2 0.8 0.4 1.4 5.1 0.0 2.3 1.8 0.0 0.9 0.0 0.0 13.5 0.2 0.0 0.0 0.0 0.7 0.6 0.6 1.1 0.4 3.1 0.0 0.0 1.8 1.2 3.6 0.3 2.4 3.3 0.0 0.0 0.5 0.1 0.0 0.4 0.0 1.1 0.0 0.9 29.0 15.8 0.1 0.9 0.0 0.0 0.3 TEX15 CT42 ENSG00000133863 "Testis expressed 15, meiosis and synapsis associated" Q9BXT5 8 30831544-30913003 "Predicted intracellular proteins" "Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3" "Group enriched" "Detected in some" 4 "Early spermatids: 73.5;Late spermatids: 38.7;Spermatogonia: 62.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 8.9;HEL: 20.1;K-562: 5.6;NTERA-2: 3.8;OE19: 4.1;SCLC-21H: 4.3" "Not detected" "Not detected" HPA036800 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036800: AB_10671714" "unprognostic (3.10e-1)" "unprognostic (2.56e-1)" "unprognostic (3.30e-4)" "unprognostic (3.54e-1)" "unprognostic (2.45e-2)" "unprognostic (2.15e-3)" "unprognostic (2.80e-3)" "unprognostic (4.52e-2)" "unprognostic (5.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-5)" "unprognostic (8.88e-3)" "unprognostic (1.39e-1)" "unprognostic (2.09e-1)" "unprognostic (4.92e-1)" 0.1 0.1 0.7 0.2 5.4 0.1 0.1 0.1 1.1 1.2 0.1 0.0 0.0 0.1 10.0 0.6 0.2 0.1 0.8 0.1 1.7 0.5 0.1 0.1 0.1 0.1 0.3 0.3 0.4 0.1 0.1 6.9 0.1 0.9 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.2 8.5 0.4 0.4 0.9 21.3 1.4 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.0 0.0 8.9 1.1 0.0 1.2 3.2 20.1 0.0 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 5.6 0.0 0.0 0.1 0.1 0.1 3.8 4.1 0.3 0.0 0.0 0.0 0.0 0.0 4.3 1.4 0.0 0.0 3.7 0.3 0.2 1.1 0.1 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 5.4 0.1 1.1 1.7 0.5 0.3 0.3 0.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 38.7 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 4.2 0.0 0.0 12.9 0.0 14.2 62.1 0.0 0.1 0.0 0.0 0.0 TEX19 FLJ35767 ENSG00000182459 "Testis expressed 19" Q8NA77 17 82359247-82363776 "Predicted intracellular proteins" "Differentiation, Meiosis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 114 "testis: 40.7" "Cell type enhanced" "Detected in some" 26 "Late spermatids: 3.6;Sertoli cells: 19.4;Spermatocytes: 5.4;Spermatogonia: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 18.5;HMC-1: 15.6;JURKAT: 7.3;MOLT-4: 12.9;U-266/70: 20.1;U-937: 7.2" HPA054577 Enhanced NA NA "HPA054577: AB_2682528" "unprognostic (3.58e-2)" "unprognostic (5.43e-2)" "unprognostic (8.63e-3)" "unprognostic (3.85e-2)" "unprognostic (2.43e-1)" "unprognostic (4.03e-2)" "unprognostic (4.51e-5)" "unprognostic (4.14e-1)" "unprognostic (2.72e-1)" "unprognostic (1.44e-1)" "unprognostic (3.59e-1)" "unprognostic (1.67e-15)" "unprognostic (2.15e-1)" "unprognostic (1.01e-1)" "unprognostic (3.43e-2)" "unprognostic (3.35e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.2 0.3 0.0 0.2 2.6 0.1 0.0 0.1 0.1 1.5 0.0 18.5 3.6 0.0 0.1 0.7 1.2 0.0 0.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 15.6 0.0 0.0 0.0 0.1 0.2 0.0 7.3 0.8 0.3 0.0 0.9 12.9 0.6 0.3 0.7 0.2 0.9 0.2 3.3 0.1 0.0 0.1 0.3 0.1 6.0 0.9 0.6 0.5 0.4 0.0 0.0 0.5 1.4 0.1 20.1 0.9 1.7 0.0 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 19.4 0.0 5.4 4.9 0.0 0.0 0.0 0.0 0.0 TEX22 ENSG00000226174 "Testis expressed 22" C9J3V5 14 105398579-105450106 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 25.4" "Group enriched" "Detected in some" 18 "Early spermatids: 235.7;Late spermatids: 433.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2;HDLM-2: 6.4;U-266/70: 5.4;U-937: 4.0" "Low region specificity" "Detected in all" HPA065576 Enhanced NA NA "HPA065576: AB_2685513" "unprognostic (3.99e-2)" "unprognostic (6.00e-2)" "unprognostic (1.30e-3)" "unprognostic (2.06e-1)" "unprognostic (3.36e-1)" "unprognostic (1.62e-2)" "unprognostic (7.48e-2)" "unprognostic (1.52e-2)" "unprognostic (3.95e-2)" "unprognostic (1.53e-5)" "unprognostic (1.42e-4)" "unprognostic (8.13e-2)" "unprognostic (5.96e-2)" "unprognostic (2.18e-2)" "unprognostic (5.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.91e-3)" 1.2 0.7 3.2 2.4 3.1 2.3 4.2 4.6 4.2 1.5 0.8 1.5 1.4 1.3 1.3 3.8 0.8 2.9 1.3 0.9 4.3 1.5 1.5 0.7 3.0 2.9 3.0 3.0 2.3 4.6 2.0 1.0 1.0 3.0 2.0 0.8 0.9 1.9 2.5 1.2 1.7 1.5 0.6 2.7 2.5 1.6 25.4 2.9 4.0 1.4 0.5 1.7 1.0 1.7 0.5 1.1 0.0 1.4 0.0 0.6 0.1 0.3 0.7 0.7 3.2 1.0 0.1 0.7 0.3 0.1 0.0 0.4 0.4 0.5 1.9 0.2 0.2 0.1 0.3 0.5 0.1 0.1 6.4 0.3 0.3 0.8 0.0 0.4 0.5 2.0 0.7 0.4 0.1 0.1 0.7 0.1 0.6 0.2 2.0 0.1 1.8 0.2 0.4 0.2 0.1 0.1 1.8 0.1 0.1 0.4 0.5 0.6 0.7 0.0 0.1 0.3 0.5 0.5 0.7 0.0 0.3 0.1 0.8 0.1 5.4 0.7 0.8 0.1 4.0 2.7 0.0 1.4 0.0 0.0 0.3 0.5 0.2 0.0 0.6 0.1 0.5 0.3 0.0 0.0 0.0 0.4 1.1 0.5 0.1 3.2 3.1 4.6 4.2 4.3 1.5 3.0 3.0 3.0 2.9 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.5 235.7 0.1 0.0 0.0 0.6 0.1 0.4 0.5 4.6 0.0 0.7 0.0 0.0 0.0 1.5 433.0 3.7 0.0 1.7 1.0 0.1 0.4 0.6 0.0 2.1 0.4 0.0 6.5 0.5 18.7 2.3 0.1 0.1 0.0 0.1 0.1 TEX26 "C13orf26, MGC40178" ENSG00000175664 "Testis expressed 26" Q8N6G2 13 30932703-30975502 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 19.7;testis: 29.3" "Group enriched" "Detected in some" 48 "Early spermatids: 816.5;Late spermatids: 1222.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.6" "Region enhanced" "Detected in many" "pons and medulla: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SuSa: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079709 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA079709: " "unprognostic (2.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (1.53e-2)" "unprognostic (9.27e-2)" 0.5 1.2 1.6 0.4 6.3 0.4 0.5 0.2 3.0 1.7 0.4 4.8 0.3 0.4 0.5 1.3 0.5 1.3 0.8 0.5 3.7 5.5 0.4 0.6 0.6 0.4 1.1 2.7 0.4 0.4 0.4 4.2 0.4 19.7 0.7 0.5 0.0 0.5 0.8 0.5 0.4 0.5 0.4 3.7 0.4 0.5 29.3 2.0 0.0 0.4 0.0 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 6.3 0.2 3.0 3.7 5.5 1.1 2.7 19.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 21.4 2.3 0.0 0.0 0.0 0.0 0.0 816.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1222.5 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 9.2 3.3 0.0 0.0 0.0 0.0 0.0 TEX28 "CXorf2, fTEX" ENSG00000278057 "Testis expressed 28" O15482 X 154271265-154295853 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 8.7" "Group enriched" "Detected in some" 41 "Early spermatids: 37.0;Late spermatids: 56.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 TEX29 "bA474D23.1, C13orf16, MGC35169" ENSG00000153495 "Testis expressed 29" Q8N6K0 13 111316184-111344249 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 36.8" "Cell type enriched" "Detected in some" 5 "Early spermatids: 596.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebral cortex: 6.1" "Cell type enhanced" "Detected in some" "eosinophil: 1.8;memory B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 54 "U-698: 22.4" NA NA "unprognostic (2.93e-1)" "unprognostic (2.26e-2)" "unprognostic (8.62e-4)" "unprognostic (4.56e-1)" "unprognostic (7.26e-2)" "unprognostic (4.93e-1)" "unprognostic (2.08e-2)" "unprognostic (8.51e-2)" "unprognostic (5.45e-2)" "unprognostic (2.43e-1)" "unprognostic (2.78e-2)" "unprognostic (7.86e-2)" "unprognostic (1.13e-9)" "unprognostic (3.41e-1)" "unprognostic (1.51e-1)" "unprognostic (5.07e-2)" "unprognostic (4.21e-2)" 0.3 0.2 2.7 0.3 1.7 0.0 0.3 0.3 6.1 0.3 0.3 0.3 0.3 0.1 0.3 0.5 0.4 0.1 0.3 0.3 0.9 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.1 0.5 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.5 0.1 0.4 0.3 0.3 0.3 0.2 36.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.3 0.6 1.8 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 22.4 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.1 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 2.7 1.7 0.3 6.1 0.9 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 596.2 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 114.3 4.4 0.0 0.0 0.0 0.2 0.0 1.7 0.2 3.9 0.0 0.0 0.0 1.2 1.9 3.1 0.4 0.5 0.0 0.0 0.4 TEX30 C13orf27 ENSG00000151287 "Testis expressed 30" Q5JUR7 13 102765990-102773811 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 64.1;testis: 71.9" "Cell type enhanced" "Detected in many" 19 "Early spermatids: 279.0;Spermatocytes: 887.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "basophil: 64.1;eosinophil: 16.4" "Lineage enriched" "Detected in all" 11 "granulocytes: 64.1" "Cell line enhanced" "Detected in many" "NB-4: 75.0;THP-1: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053545 Enhanced NA NA "HPA053545: AB_2682181" "unprognostic (5.26e-2)" "prognostic favorable (2.09e-5)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" "unprognostic (7.48e-2)" "unprognostic (1.54e-2)" "unprognostic (7.49e-2)" "unprognostic (9.86e-3)" "unprognostic (1.22e-1)" "unprognostic (1.25e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.10e-6)" "unprognostic (1.89e-2)" "unprognostic (1.79e-1)" "unprognostic (8.66e-3)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" 4.5 2.9 4.3 3.0 4.6 5.6 3.6 5.8 5.3 3.1 2.6 1.7 14.0 2.6 5.4 34.7 4.1 2.7 2.4 6.1 3.5 4.9 8.8 18.5 2.9 4.9 6.3 2.8 3.7 2.8 1.2 4.5 7.1 5.2 3.2 2.2 2.0 2.4 7.0 4.4 3.5 2.7 3.9 3.9 3.2 2.7 71.9 3.1 7.0 2.8 3.8 3.3 3.5 3.5 2.7 3.7 64.1 2.0 5.9 3.8 1.9 11.7 4.3 10.1 8.2 6.5 4.7 0.1 15.1 4.1 10.5 9.9 10.3 11.2 6.7 6.5 6.0 13.9 6.4 9.1 5.6 15.0 13.7 5.5 11.6 9.0 0.1 4.4 23.0 22.8 2.6 3.6 9.3 5.7 3.9 8.3 16.9 6.8 0.0 12.7 6.1 15.4 75.0 3.7 16.0 10.0 9.5 4.5 4.7 15.8 4.6 13.6 6.2 9.5 11.9 8.9 6.5 8.4 48.1 3.5 7.3 5.6 11.6 16.2 6.2 7.3 0.0 12.6 13.7 12.0 64.1 1.7 16.4 2.4 1.9 3.4 2.7 2.7 3.1 1.8 2.5 3.1 2.6 0.8 5.9 2.0 3.7 3.8 1.9 4.3 4.6 5.8 5.3 3.5 4.9 6.3 2.8 5.2 3.1 0.0 3.0 19.7 12.9 21.1 7.3 10.4 5.1 8.1 5.7 12.2 3.9 92.4 31.5 13.6 279.0 11.9 4.5 0.0 8.5 89.1 12.9 10.7 26.5 34.7 38.9 6.4 2.9 14.7 5.6 54.6 28.1 17.4 27.0 24.4 3.4 6.0 9.4 2.6 17.7 70.8 5.4 90.5 17.6 887.6 162.4 17.3 119.0 26.1 3.9 8.5 TEX33 "C22orf33, EAN57, MGC35206" ENSG00000185264 "Testis expressed 33" O43247 22 36991120-37007841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 465 "testis: 49.1" "Cell type enriched" "Detected in some" 5 "Early spermatids: 731.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA005998 Enhanced NA NA "HPA005998: AB_1078352" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 731.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 12.9 0.0 3.1 2.1 0.0 0.0 0.0 0.0 0.0 TEX35 "C1orf49, DKFZP564J047, TSC24" ENSG00000240021 "Testis expressed 35" Q5T0J7 1 178513077-178548602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 66.9" "Group enriched" "Detected in some" 127 "Early spermatids: 1093.6;Late spermatids: 1941.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA039190 Approved NA NA "HPA039190: AB_10794425" "unprognostic (2.20e-1)" "unprognostic (1.77e-2)" "unprognostic (1.26e-1)" "unprognostic (1.89e-2)" "unprognostic (8.92e-3)" "unprognostic (1.08e-2)" "unprognostic (7.04e-2)" "unprognostic (9.60e-2)" "unprognostic (1.21e-1)" "unprognostic (2.51e-3)" "unprognostic (2.01e-2)" "unprognostic (1.92e-1)" "unprognostic (5.23e-1)" "unprognostic (5.41e-2)" 0.2 0.1 0.2 0.2 0.3 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.4 0.2 1.0 0.2 0.1 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.2 0.6 66.9 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.7 1.0 3.4 0.9 0.4 1.1 0.0 1.4 0.8 2.9 3.9 2.4 3.6 8.5 1.5 2.3 1.4 0.8 2.0 1.0 2.5 1.5 1.1 2.0 1.2 2.7 0.8 1.2 2.1 1.0 2.6 3.3 3.7 0.5 3.3 1.4 3.0 1.3 1.7 3.5 2.0 0.6 2.5 2.2 2.3 1.1 1.0 1.9 2.2 5.2 1.7 1.5 1.7 1.3 2.0 2.2 2.1 2.2 1.7 2.9 3.5 0.8 2.6 1.5 2.2 2.3 3.4 2.4 2.1 2.1 2.7 3.2 2.0 2.6 2.5 0.8 0.9 0.8 1.2 1.0 0.3 0.3 0.9 0.9 0.7 0.5 1.7 1.1 0.7 3.4 0.4 0.9 1.0 0.5 0.0 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1093.6 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1941.7 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 6.5 0.0 11.8 4.3 0.0 0.0 0.0 0.0 0.0 TEX36 "bA383C5.1, C10orf122" ENSG00000175018 "Testis expressed 36" Q5VZQ5 10 125576522-125683144 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 52 "testis: 24.6" "Group enriched" "Detected in some" 43 "Early spermatids: 289.0;Late spermatids: 264.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2197: 14.0" "Region enriched" "Detected in single" 14 "cerebellum: 2.6" "Low region specificity" "Detected in all" NA NA "unprognostic (7.72e-3)" "unprognostic (3.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 289.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 264.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 6.5 0.0 3.4 1.3 0.0 0.0 0.0 0.0 0.0 TEX37 "C2orf51, FLJ25369, TSC21" ENSG00000172073 "Testis expressed 37" Q96LM6 2 88524651-88529584 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 221 "testis: 54.4" "Group enriched" "Detected in some" 176 "Early spermatids: 799.5;Late spermatids: 2063.1" "Cancer enriched" "Detected in single" 17 "testis cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "BEWO: 34.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043987, HPA070239" Enhanced Supported Cytosol NA NA Cytosol "HPA043987: AB_10961125, HPA070239: " "unprognostic (1.08e-3)" "unprognostic (2.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 34.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 799.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2063.1 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 6.5 0.0 7.7 8.1 0.0 0.2 0.0 0.0 0.0 TEX38 "ATPAF1-AS1, C1orf223, LOC374973, THEG4" ENSG00000186118 "Testis expressed 38" Q6PEX7 1 46668855-46673594 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 109.8" "Group enriched" "Detected in some" 114 "Early spermatids: 1833.7;Late spermatids: 4115.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;SK-BR-3: 2.2;TIME: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA073711 Uncertain Vesicles NA NA Vesicles "HPA073711: " "unprognostic (8.46e-2)" "unprognostic (1.99e-1)" "unprognostic (3.14e-2)" "unprognostic (8.86e-2)" "unprognostic (6.81e-3)" "unprognostic (3.50e-1)" "unprognostic (1.99e-1)" "unprognostic (9.21e-2)" "unprognostic (5.39e-2)" "unprognostic (4.15e-3)" "unprognostic (4.93e-4)" "unprognostic (2.64e-1)" "unprognostic (5.28e-2)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (7.84e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 2.5 0.3 0.1 1.6 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 1.3 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.8 0.3 0.0 0.5 0.4 0.0 0.6 0.6 0.5 0.1 0.0 0.4 0.1 0.9 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.9 0.0 0.6 0.6 2.0 1.4 1.0 2.2 0.0 1.8 0.8 0.0 2.5 0.3 0.0 1.0 0.2 0.9 0.3 0.6 0.2 0.0 0.2 0.0 0.3 2.5 1.2 0.2 1.6 0.9 0.1 0.9 0.4 0.4 0.9 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1833.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4115.3 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.4 6.5 0.0 24.7 13.3 0.0 0.0 0.0 0.0 0.0 TEX43 "C5orf48, FLJ27505, MGC163367, MGC163369, Tseg7" ENSG00000196900 "Testis expressed 43" Q6ZNM6 5 126631722-126636287 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 23.8" "Cell type enriched" "Detected in some" 5 "Early spermatids: 386.4" "Cancer enriched" "Detected in single" 7 "colorectal cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;HeLa: 1.1;SK-BR-3: 1.9" "Region enhanced" "Detected in single" "pons and medulla: 0.4" "Not detected" "Not detected" NA NA "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "unprognostic (4.06e-2)" "unprognostic (2.76e-1)" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 2.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 386.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.9 0.0 0.0 0.0 0.0 0.0 TEX44 "C2orf57, MGC35154" ENSG00000177673 "Testis expressed 44" Q53QW1 2 231592901-231594283 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 54 "testis: 98.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.3" "HPA049917, HPA056433" Enhanced NA NA "HPA049917: AB_2680951, HPA056433: AB_2683131" "unprognostic (5.42e-2)" "unprognostic (3.90e-1)" "unprognostic (6.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX45 "C19orf45, FLJ35784" ENSG00000198723 "Testis expressed 45" Q8NA69 19 7492976-7508450 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 40.1" "Group enriched" "Detected in some" 9 "Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" NA NA "unprognostic (7.96e-3)" "unprognostic (3.90e-2)" "unprognostic (5.17e-2)" "unprognostic (1.84e-3)" "unprognostic (7.44e-2)" "unprognostic (1.50e-2)" "unprognostic (3.74e-2)" "unprognostic (3.72e-2)" "unprognostic (6.42e-2)" "unprognostic (4.71e-2)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (4.72e-1)" "unprognostic (4.32e-2)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-3)" 0.2 0.6 0.3 0.2 0.3 2.2 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.1 0.3 0.4 0.2 0.1 0.4 0.2 0.4 0.3 0.2 0.2 0.3 0.2 0.5 0.2 0.2 0.2 0.0 1.2 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.2 2.7 1.5 0.2 0.6 0.2 0.2 40.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.6 1.0 3.0 0.8 0.4 0.9 0.2 0.4 0.0 0.5 1.7 0.0 0.0 0.1 0.9 0.0 0.8 0.5 1.2 1.5 0.3 0.7 0.5 0.3 1.1 0.2 0.0 0.0 0.4 0.9 0.0 1.3 0.8 0.1 0.0 2.5 0.0 1.1 0.0 0.6 0.1 0.0 1.0 1.2 2.4 0.3 1.9 1.6 1.0 0.4 2.2 0.4 0.3 0.3 1.0 0.1 1.1 2.9 0.7 1.4 1.6 0.0 0.4 1.5 2.9 0.8 0.2 0.9 0.6 0.9 1.3 0.3 1.2 1.0 1.4 0.0 3.0 0.4 0.5 0.9 0.8 0.7 1.0 0.6 0.5 0.1 1.6 0.8 0.7 1.7 0.4 0.3 1.0 0.3 0.2 0.3 0.3 0.3 0.2 0.4 0.3 0.5 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX46 C1orf234 ENSG00000227868 "Testis expressed 46" H3BTG2 1 23010834-23015850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 7 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "ASC diff: 3.1;HSkMC: 3.9" "Not detected" "Not detected" NA NA "unprognostic (3.11e-1)" "unprognostic (1.86e-1)" "unprognostic (9.04e-2)" "unprognostic (2.13e-1)" "unprognostic (1.24e-2)" "unprognostic (6.33e-2)" "unprognostic (2.84e-1)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (9.76e-2)" "unprognostic (8.12e-2)" "unprognostic (3.82e-3)" "unprognostic (2.29e-5)" "unprognostic (1.06e-1)" "unprognostic (1.15e-1)" "unprognostic (7.60e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 39.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 1.4 0.5 3.1 0.8 1.4 0.0 0.6 1.1 0.9 0.0 0.8 0.4 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 1.5 0.0 0.0 0.0 0.3 3.9 1.3 0.6 0.8 0.0 0.7 2.3 0.7 0.4 0.7 1.1 0.0 0.7 1.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 1.4 0.5 0.2 0.2 1.4 0.0 1.5 0.3 0.5 0.4 0.0 2.4 0.0 0.2 0.4 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX47 "C7orf62, MGC26647" ENSG00000164645 "Testis expressed 47" Q8TBZ9 7 88794106-88795721 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 158 "testis: 26.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA023817, HPA024163" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA023817: AB_1853868, HPA024163: AB_1853869" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX48 ENSG00000230601 "Testis expressed 48" A0A1B0GUV7 9 114666434-114682066 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.4" "Lineage enhanced" "Detected in single" "T-cells: 2.4" "Cell line enriched" "Detected in some" 4 "Karpas-707: 12.2" NA NA "unprognostic (2.70e-1)" "unprognostic (6.41e-2)" "unprognostic (7.83e-2)" "unprognostic (2.53e-1)" "unprognostic (5.10e-2)" "unprognostic (2.33e-2)" "unprognostic (1.70e-1)" "unprognostic (5.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 2.4 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.7 0.0 0.3 3.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 12.2 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.1 0.0 0.2 0.1 0.2 1.5 0.1 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX49 LINC00935 ENSG00000257987 "Testis expressed 49" A0A1B0GTD5 12 48727435-48765786 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 20.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "stomach cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "myeloid DC: 1.9" "Lineage enhanced" "Detected in single" "dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;MCF7: 2.9;OE19: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.63e-2)" "unprognostic (6.32e-3)" "unprognostic (8.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX50 ENSG00000232113 "Testis expressed 50" A0A1B0GTY4 1 173635333-173637134 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 176 "testis: 17.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "GAMG: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX51 ENSG00000237524 "Testis expressed 51" A0A1B0GUA7 2 126898864-126902097 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 79 "testis: 51.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-2197: 3.0" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX52 ENSG00000283297 "Testis expressed 52" A6NCN8 12 2849039-2857083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.5;testis: 18.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "NK-cell: 4.0" "Lineage enriched" "Detected in single" 8 "NK-cells: 4.0" "Cell line enhanced" "Detected in some" "HaCaT: 3.0;HeLa: 5.4;Karpas-707: 7.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA 0.2 0.0 0.2 1.1 0.2 0.8 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.5 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 1.2 0.2 0.2 0.2 1.3 0.0 0.2 0.2 0.2 0.2 0.0 0.2 1.9 0.2 3.2 5.5 1.1 0.2 0.2 1.0 0.3 18.1 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 4.0 0.4 0.0 0.4 1.8 0.5 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.6 0.3 0.7 0.3 0.0 0.0 3.0 0.0 0.0 0.2 1.4 2.0 0.3 5.4 2.1 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.3 7.0 0.0 1.3 0.2 1.1 0.6 0.0 0.0 1.4 0.2 0.2 0.0 1.5 0.1 0.5 0.0 0.2 0.3 1.2 0.8 0.1 0.7 0.3 1.7 0.8 0.5 1.2 0.2 1.0 0.3 1.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX53 ENSG00000230054 "Testis expressed 53" 9 114656304-114662374 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 36 "testis: 36.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;Karpas-707: 6.1;T-47d: 1.6;U-266/70: 1.8" NA NA "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (1.02e-1)" "unprognostic (8.79e-2)" "unprognostic (2.94e-1)" "unprognostic (2.85e-2)" "unprognostic (1.90e-2)" "unprognostic (6.83e-2)" "unprognostic (4.19e-2)" "unprognostic (8.18e-4)" "unprognostic (8.64e-6)" "unprognostic (9.94e-2)" "unprognostic (1.79e-1)" "unprognostic (1.94e-3)" 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 36.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.6 6.1 0.0 0.8 0.3 0.0 0.3 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 1.6 0.4 0.0 0.0 0.0 0.0 0.4 1.8 1.0 1.1 0.0 0.1 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX54 ENSG00000283268 "Testis expressed 54" 11 62832319-62832803 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 47.4;testis: 21.2" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 8 "neutrophil: 47.4" "Lineage enriched" "Detected in all" 16 "granulocytes: 47.4" "Low cell line specificity" "Detected in some" NA NA 1.0 0.0 0.0 0.1 0.9 0.4 0.0 0.0 4.2 0.0 0.6 1.5 0.0 0.0 0.8 1.2 0.7 0.0 0.0 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.0 0.0 0.0 0.8 0.5 0.0 1.0 0.2 0.5 21.2 0.7 0.0 0.5 0.0 0.5 1.5 0.0 2.3 2.3 47.4 2.9 1.3 2.9 0.3 0.3 0.0 2.3 2.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 2.7 0.8 0.4 0.0 0.4 2.7 0.0 0.0 0.0 2.5 0.8 0.0 2.7 0.9 0.8 0.0 1.0 0.0 0.0 0.6 0.0 0.6 0.0 1.6 0.0 1.5 0.0 0.0 1.4 1.3 0.4 0.0 1.6 1.0 0.0 2.8 0.0 0.5 1.0 0.0 0.0 1.9 0.3 0.5 0.7 0.0 1.5 0.7 0.7 2.0 0.0 2.5 0.8 1.1 0.0 0.0 1.8 6.1 2.9 5.9 1.6 2.0 2.7 1.7 1.7 1.4 0.8 2.3 2.9 2.1 47.4 1.3 0.8 2.3 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 49.7" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 165.9;Early spermatids: 67.3;Spermatocytes: 52.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8" "Group enriched" "Detected in many" 11 "B-cells: 14.4;granulocytes: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.7 5.4 5.3 9.0 14.8 2.0 7.6 4.0 2.3 7.0 4.6 7.8 6.0 8.5 5.7 11.6 7.3 21.6 6.2 1.6 6.1 7.5 11.9 1.2 5.8 4.1 4.0 3.2 7.5 4.1 13.5 49.7 1.0 25.2 5.4 3.5 9.2 9.0 4.5 0.9 4.1 9.6 2.3 4.9 5.5 9.0 19.3 4.0 2.0 14.8 2.0 8.2 2.7 2.2 14.4 0.3 4.1 0.6 0.4 0.8 0.8 5.8 5.3 11.7 10.4 2.9 8.5 1.5 1.3 4.9 3.7 4.4 1.4 5.2 11.7 5.6 0.9 6.4 5.2 5.0 5.5 4.3 1.4 6.1 6.7 5.4 3.8 0.9 3.0 1.3 4.6 10.2 4.1 3.1 5.3 0.1 8.4 3.8 1.3 1.9 3.3 4.8 2.6 5.6 9.7 2.3 1.9 5.5 4.2 12.3 3.3 18.7 7.5 6.5 4.0 4.0 9.0 11.1 3.4 0.6 15.7 4.8 5.0 4.7 1.6 11.8 8.9 6.2 1.3 3.0 4.1 0.1 0.1 0.3 0.6 0.1 14.4 0.4 0.3 0.2 6.8 0.2 0.8 0.3 0.4 0.3 0.3 0.5 0.8 5.3 14.8 4.0 2.3 6.1 7.5 4.0 3.2 25.2 4.0 6.0 6.9 13.7 6.8 3.8 5.1 0.4 2.5 165.9 35.2 10.4 11.8 1.4 18.3 11.8 67.3 2.6 2.6 0.0 6.1 0.4 2.3 2.9 1.1 0.0 1.1 1.6 7.5 1.8 0.0 28.6 4.4 1.1 3.3 1.8 2.5 4.8 3.9 4.3 3.5 15.3 35.9 0.0 3.1 52.4 32.6 1.9 0.2 0.0 3.0 5.2 TF "PRO1557, PRO2086" ENSG00000091513 Transferrin P02787 3 133745956-133796640 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Ion transport, Iron transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "liver: 711.5" "Group enriched" "Detected in many" 34 "Hepatocytes: 5940.2;Muller glia cells: 11013.4" "Cancer enriched" "Detected in many" 42 "liver cancer: 783.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 48 "Hep G2: 132.2" "Low region specificity" "Detected in all" "HPA001527, HPA005692, CAB009538" Enhanced "Secreted to blood" NA NA 19800000000000 120000000000 "CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354" "prognostic favorable (4.05e-4)" "unprognostic (2.45e-2)" "unprognostic (1.78e-1)" "unprognostic (1.50e-1)" "unprognostic (8.99e-2)" "unprognostic (5.18e-2)" "unprognostic (6.63e-2)" "unprognostic (8.46e-2)" "unprognostic (2.82e-1)" "unprognostic (3.08e-1)" "unprognostic (1.37e-1)" "unprognostic (7.60e-2)" "prognostic unfavorable (2.35e-13)" "unprognostic (2.17e-3)" "unprognostic (5.49e-2)" "unprognostic (3.47e-3)" "unprognostic (9.70e-2)" 7.8 1.3 6.7 1.2 26.7 1.3 1.9 3.7 20.4 1.4 1.3 57.2 0.0 1.2 1.3 1.3 1.8 1.3 1.3 2.4 11.3 7.4 1.5 711.5 1.3 1.3 50.8 12.3 1.4 1.6 1.4 0.8 1.3 40.2 1.5 1.3 14.0 4.0 1.3 1.3 1.3 1.2 1.3 46.9 1.3 1.3 2.4 39.9 0.0 1.4 0.0 1.4 1.3 0.6 1.1 1.0 2.6 1.1 0.9 0.8 0.4 0.3 0.2 0.3 0.2 0.9 0.6 0.1 0.3 0.3 0.1 0.1 0.5 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.2 0.1 0.1 2.7 0.4 132.2 0.2 0.7 0.4 0.4 0.6 0.1 0.3 0.3 0.3 0.1 1.0 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.5 0.2 0.2 0.5 0.3 0.2 0.4 0.4 1.0 0.2 0.3 0.2 0.4 0.4 0.2 0.2 0.1 0.3 0.4 0.2 0.3 0.2 0.2 2.6 1.1 0.7 0.6 0.7 0.6 0.6 0.6 0.6 0.6 1.1 0.8 0.8 2.4 0.9 0.7 1.0 0.4 0.4 6.7 26.7 3.7 19.6 11.3 7.4 50.8 12.3 40.2 39.9 14.9 26.7 55.9 6.2 0.9 74.3 2.5 132.5 40.2 35.2 0.0 86.4 0.1 1.7 0.7 5.3 0.5 0.0 46.7 1.0 0.1 0.2 14.8 16.3 5940.2 0.1 44.5 0.0 93.9 109.2 2.5 0.3 0.9 0.0 1.0 0.0 11013.4 0.9 0.0 0.4 0.2 250.7 0.0 0.4 0.4 0.1 0.0 0.2 6.9 0.0 2.0 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 130.5;retina: 48.1" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6" "Region enhanced" "Detected in single" "cerebellum: 4.3" "Region enhanced" "Detected in single" "cerebellum: 8.6" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.4 0.3 0.3 0.0 0.3 0.0 19.0 2.2 0.5 4.4 0.8 0.0 18.7 0.2 0.5 17.8 18.3 0.4 1.7 0.7 0.3 0.2 6.4 0.2 0.5 0.1 0.2 0.2 0.3 0.3 0.0 0.4 130.5 0.6 5.8 0.2 48.1 19.4 26.7 0.2 36.0 0.4 0.1 0.4 0.2 0.7 1.6 0.0 0.1 0.4 16.6 9.9 2.4 9.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 16.3 6.3 0.0 28.0 0.1 0.0 6.0 12.1 9.3 9.9 9.8 0.6 6.1 0.9 1.6 3.5 5.7 17.5 1.5 20.7 9.5 31.3 15.8 0.1 14.8 0.0 0.0 0.4 0.4 0.0 30.2 0.0 22.0 5.6 0.0 0.3 0.9 0.0 0.1 3.6 0.0 5.1 0.1 1.0 7.8 1.7 1.5 0.6 5.6 6.6 4.1 0.1 14.9 26.2 23.8 31.6 17.3 0.5 0.0 3.0 0.8 2.1 7.6 0.0 1.4 0.2 1.6 0.5 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.2 0.3 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 37.5 116.1 3.1 2.2 0.0 8.1 15.9 29.6 2.0 245.7 6.6 2.0 4.6 0.8 0.0 0.0 0.3 224.5 5.3 38.8 0.0 0.0 17.7 76.3 1.2 0.0 0.0 2.1 0.6 0.2 118.1 0.0 0.5 2.4 2.2 0.0 0.0 0.2 4.2 0.0 2.1 3.9 11.8 120.9 585.5 0.0 0.4 39.3 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847613 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 65.5" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 413.2" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in some" 41 "cerebellum: 4.7;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 32.4;SH-SY5Y: 60.4" "Region enhanced" "Detected in some" "cerebellum: 11.2" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA034683: AB_10670966, HPA062942: AB_2684909" "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.2 3.0 0.0 0.0 0.0 0.0 9.4 4.7 0.0 0.2 0.2 0.0 8.8 0.0 0.0 65.5 5.8 0.0 0.0 0.1 0.0 0.1 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 6.3 0.1 0.0 12.2 7.0 0.6 0.0 6.3 0.0 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 60.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 10.4 6.9 0.6 0.0 0.0 0.0 48.8 7.9 10.5 46.4 0.0 11.5 0.3 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 1.0 413.2 0.0 0.0 0.0 0.5 0.0 0.0 101.3 0.0 0.0 2.3 0.0 0.0 0.4 0.7 9.7 0.0 0.0 0.5 0.0 3.8 4.1 0.0 0.0 0.0 TFAP2C "AP2-GAMMA, ERF1, hAP-2g, TFAP2G" ENSG00000087510 "Transcription factor AP-2 gamma" Q92754 20 56629302-56639283 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 53.9;skin 1: 32.5" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 117.7;Cytotrophoblasts: 77.5;Extravillous trophoblasts: 49.1;Suprabasal keratinocytes: 130.6;Syncytiotrophoblasts: 88.3" "Cancer enhanced" "Detected in many" "testis cancer: 54.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "BEWO: 45.8;MCF7: 38.8;SK-BR-3: 73.8;T-47d: 20.6;WM-115: 27.1" "Region enriched" "Detected in single" 13 "olfactory region: 2.9" "Low region specificity" "Detected in many" "CAB016061, CAB016079, HPA055179, HPA057076" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329" "unprognostic (1.74e-2)" "prognostic favorable (6.90e-4)" "unprognostic (2.24e-2)" "unprognostic (2.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (2.54e-2)" "unprognostic (8.26e-2)" "unprognostic (2.97e-1)" "unprognostic (1.61e-1)" "unprognostic (3.14e-3)" "unprognostic (2.63e-1)" "unprognostic (9.04e-5)" "unprognostic (2.31e-1)" "unprognostic (1.85e-1)" "unprognostic (6.71e-2)" "unprognostic (3.28e-2)" 1.1 0.3 0.7 0.2 0.4 0.0 16.1 0.4 0.9 17.3 2.4 0.2 7.7 0.0 3.7 3.4 19.6 1.6 2.0 0.4 1.4 0.2 0.7 0.1 2.8 0.0 0.2 0.5 0.3 1.6 0.0 0.6 53.9 0.4 5.7 0.7 1.9 19.7 7.9 1.0 32.5 0.3 0.6 0.4 0.1 0.3 0.7 0.2 0.3 4.2 21.0 10.1 2.1 11.1 0.1 0.2 0.8 0.1 0.2 0.2 0.0 2.9 3.7 0.0 0.0 0.0 0.0 45.8 4.7 8.6 6.0 1.1 0.7 0.0 0.0 0.3 3.1 3.2 10.0 6.4 1.3 4.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 5.1 1.7 1.7 0.0 0.0 1.9 0.0 0.7 0.0 38.8 4.7 0.2 2.2 2.3 4.9 0.0 0.0 1.6 0.0 2.3 1.2 0.0 3.1 73.8 4.8 7.1 20.6 1.0 0.0 3.9 0.1 2.0 3.5 0.0 0.0 0.0 0.9 0.0 27.1 0.4 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.1 0.0 0.7 0.4 0.4 0.9 1.4 0.2 0.2 0.5 0.4 0.2 0.0 7.4 0.0 26.2 117.7 0.4 0.9 0.0 5.3 4.5 8.7 0.0 77.5 0.0 0.2 0.2 1.0 0.0 0.0 0.0 49.1 11.3 18.8 0.0 0.0 6.8 0.0 2.9 1.3 0.3 0.0 0.0 0.9 20.3 0.0 1.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.5 130.6 88.3 0.0 1.7 12.8 TFAP2D TFAP2BL1 ENSG00000008197 "Transcription factor AP-2 delta" Q7Z6R9 6 50713828-50772988 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 4.4" "Cell type enhanced" "Detected in single" 24 "Horizontal cells: 1.6" "Cancer enriched" "Detected in single" 10 "lung cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 5.2;U-2197: 1.6" "Region enriched" "Detected in many" 4 "midbrain: 14.1" "Region enriched" "Detected in many" 7 "midbrain: 16.3" HPA048962 Uncertain "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA048962: AB_2680573" 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TFAP2E AP2E ENSG00000116819 "Transcription factor AP-2 epsilon" Q6VUC0 1 35573370-35595328 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 22.0;skin 1: 11.4" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 3.3;Bipolar cells: 9.1;Rod photoreceptor cells: 5.1;Suprabasal keratinocytes: 3.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 22.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 10.5;SK-MEL-30: 5.7;THP-1: 5.0;U-937: 8.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (7.06e-4)" "unprognostic (1.96e-2)" "unprognostic (9.05e-2)" "unprognostic (2.29e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-2)" "unprognostic (1.05e-2)" "unprognostic (3.34e-2)" "unprognostic (3.27e-2)" "unprognostic (9.39e-2)" "unprognostic (4.02e-1)" "unprognostic (7.45e-2)" "unprognostic (1.67e-15)" "unprognostic (2.03e-1)" "unprognostic (4.83e-1)" "unprognostic (3.48e-2)" "unprognostic (7.40e-2)" 0.6 0.5 2.5 2.6 4.3 4.7 1.3 22.0 3.4 1.2 1.3 1.1 0.6 0.3 1.3 1.8 0.7 1.3 0.7 0.6 4.8 2.9 0.6 0.6 8.2 3.0 2.2 0.6 1.7 0.6 0.2 1.5 0.7 4.7 1.2 0.4 2.2 1.1 0.7 0.6 11.4 0.6 0.7 4.3 1.9 1.0 1.7 2.9 0.6 0.6 0.6 1.6 0.6 1.3 1.4 1.2 5.2 3.1 3.5 3.1 1.6 0.4 0.4 0.6 0.3 0.5 0.9 1.8 0.3 0.3 0.2 0.1 1.2 1.0 0.2 0.8 0.3 0.1 0.4 0.1 0.0 0.3 0.5 1.2 4.3 0.8 1.1 1.3 0.7 0.3 0.3 0.9 0.6 0.4 1.8 0.0 0.9 0.1 1.3 0.0 0.7 0.9 10.5 0.9 0.0 0.6 0.4 0.3 0.3 0.0 0.1 0.4 0.8 1.2 0.5 5.7 0.6 1.6 5.0 0.5 0.3 1.8 2.6 0.7 2.2 1.1 0.1 0.3 8.8 1.6 1.6 3.1 5.2 3.1 1.1 1.5 1.4 1.8 2.5 1.2 1.3 0.8 2.5 0.0 3.5 1.4 1.0 2.1 1.6 2.5 4.3 22.0 3.4 4.8 2.9 2.2 0.6 4.7 2.9 0.0 2.2 0.0 0.1 3.3 9.1 0.3 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.6 0.6 1.0 2.0 0.6 1.7 0.0 0.0 0.2 0.2 0.0 0.7 0.0 5.1 0.0 0.3 1.1 0.3 3.9 0.1 0.0 0.5 0.1 TFCP2L1 "CRTR1, LBP-9" ENSG00000115112 "Transcription factor CP2 like 1" Q9NZI6 2 121216587-121285207 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "pons and medulla: 7.0" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 7 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA029708 Uncertain Approved "Nucleoli fibrillar center,Mitochondria" Yes NA "Nucleoli fibrillar center" Mitochondria "HPA029708: AB_10602479" "unprognostic (8.85e-3)" "unprognostic (4.19e-1)" "unprognostic (1.06e-1)" "unprognostic (1.02e-2)" "unprognostic (1.48e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (3.25e-2)" "unprognostic (2.72e-3)" "unprognostic (1.20e-3)" "unprognostic (5.76e-2)" "prognostic favorable (7.72e-6)" "unprognostic (1.05e-1)" "unprognostic (2.39e-1)" "unprognostic (6.67e-3)" "unprognostic (2.01e-1)" 1.0 0.2 0.6 4.0 1.1 0.0 12.9 0.6 0.9 8.7 8.5 1.2 6.3 0.2 0.8 8.2 6.0 1.5 8.7 0.1 0.6 0.1 52.2 0.1 12.3 1.5 0.4 0.0 0.6 2.8 0.4 1.5 4.7 7.0 6.1 10.5 0.8 93.5 2.9 2.4 13.1 1.3 0.4 0.4 0.9 6.2 0.8 0.3 0.4 37.3 7.2 6.3 1.4 4.1 0.0 0.1 0.1 0.1 0.4 2.9 0.0 0.0 1.0 0.0 0.1 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.4 0.0 0.4 0.2 2.7 2.7 0.0 0.0 1.9 9.4 0.0 0.0 0.0 0.0 0.3 0.0 10.8 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.0 0.3 1.2 26.7 19.3 8.3 0.0 1.0 0.0 0.0 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 1.1 0.6 0.9 0.6 0.1 0.4 0.0 7.0 0.3 6.0 20.8 0.0 45.7 1.4 0.0 2.2 25.5 0.0 12.5 75.0 0.0 23.2 26.6 2.2 0.1 0.1 75.7 0.0 1.3 1.2 0.6 33.2 0.0 0.2 4.3 0.0 9.8 0.0 5.4 0.0 0.3 2.1 6.8 0.0 37.4 0.4 4.7 34.0 0.0 23.2 0.0 0.0 0.1 0.0 0.2 2.9 16.9 0.0 34.7 33.5 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 140.3" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 731.6;Late spermatids: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 42.8;MOLT-4: 80.4;REH: 42.9;U-698: 70.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes No Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favorable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 8.4 8.4 6.1 6.3 8.7 20.7 9.3 9.9 8.6 8.9 11.1 6.5 6.5 10.4 9.9 8.6 8.3 7.2 11.6 12.0 7.5 4.9 14.3 9.5 6.8 5.3 6.0 5.0 11.6 8.8 10.4 19.4 13.5 8.0 9.9 6.6 8.8 7.9 6.9 14.5 8.0 14.6 11.8 8.5 5.3 8.6 51.9 5.4 140.3 10.6 4.8 6.4 9.7 8.0 9.3 16.5 24.6 4.5 18.0 14.7 5.7 6.3 2.9 12.3 9.8 4.1 4.5 27.1 3.2 3.7 5.1 8.3 3.7 6.3 22.5 15.0 3.6 9.0 3.8 3.1 6.1 7.2 9.0 5.6 27.1 4.4 4.9 4.0 8.2 9.6 4.2 4.3 5.6 5.4 4.8 3.5 42.8 10.1 1.2 8.8 4.8 80.4 3.1 9.9 3.3 4.0 42.9 8.5 5.2 5.9 3.3 5.4 5.0 10.8 4.0 5.5 9.6 9.3 4.2 2.3 4.9 4.5 3.9 4.0 4.2 3.8 70.6 3.9 2.2 2.3 24.6 2.1 22.3 14.7 3.4 5.7 6.6 6.7 7.6 4.8 9.3 10.1 11.8 2.4 18.0 4.5 16.5 6.1 5.7 6.1 8.7 9.9 8.6 7.5 4.9 6.0 5.0 8.0 5.4 29.8 20.4 15.7 43.3 22.2 30.3 70.0 38.2 54.9 33.0 45.4 31.4 191.4 79.6 29.5 731.6 22.4 31.6 116.8 23.1 95.8 33.4 41.8 31.3 35.9 24.4 35.0 37.2 20.9 9.2 294.5 71.4 15.0 5.0 17.2 32.3 24.6 24.5 32.3 70.7 74.6 34.6 25.8 21.4 52.6 55.1 17.6 83.0 35.5 42.3 22.7 TFDP3 "CT30, E2F-like, HCA661" ENSG00000183434 "Transcription factor Dp family member 3" Q5H9I0 X 133216669-133218348 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 68 "testis: 17.7" "Group enriched" "Detected in some" 12 "Spermatocytes: 8.9;Spermatogonia: 24.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.22e-1)" "unprognostic (2.91e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 24.7 0.0 0.0 0.0 0.0 0.0 TFEC "bHLHe34, TCFEC, TFECL" ENSG00000105967 "Transcription factor EC" O14948 7 115935148-116159896 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.6" "Group enriched" "Detected in some" 6 "Hofbauer cells: 40.9;Kupffer cells: 42.8;Macrophages: 48.6;Proximal tubular cells: 52.2" "Cancer enhanced" "Detected in many" "renal cancer: 5.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 8.7;myeloid DC: 7.7" "Group enriched" "Detected in many" 32 "B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7" "Cell line enhanced" "Detected in some" "HEL: 12.3;HUVEC TERT2: 8.6;THP-1: 16.3;TIME: 9.6;U-937: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB032260, HPA063577" Approved Supported Nucleoplasm NA NA Nucleoplasm "CAB032260: AB_2202845, HPA063577: AB_2685047" "unprognostic (1.36e-1)" "unprognostic (1.08e-2)" "unprognostic (8.70e-2)" "unprognostic (1.91e-2)" "unprognostic (1.44e-1)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (8.26e-2)" "unprognostic (2.15e-1)" "unprognostic (6.54e-2)" "unprognostic (2.36e-1)" "unprognostic (1.72e-1)" "unprognostic (2.05e-3)" "unprognostic (2.92e-1)" "unprognostic (4.14e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-2)" 11.2 3.5 5.8 15.4 9.2 12.3 7.6 0.8 4.6 1.8 3.7 1.4 0.6 3.4 1.6 6.1 2.4 2.6 4.2 2.5 6.0 2.1 22.6 2.8 15.7 17.0 13.0 2.2 1.6 1.8 0.4 1.8 3.9 8.8 1.9 3.6 0.8 3.1 0.7 1.2 1.3 11.6 2.6 15.2 16.4 2.3 1.7 9.4 1.6 2.1 1.1 10.0 3.8 1.7 4.9 7.7 0.2 8.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.3 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 16.3 9.6 1.7 0.1 1.0 0.0 4.3 0.0 0.0 0.0 18.5 0.9 0.0 8.7 0.0 0.0 3.7 0.0 4.9 0.0 0.0 7.7 2.1 0.0 0.0 0.2 0.0 0.5 3.9 0.0 1.7 5.8 9.2 0.8 4.6 6.0 2.1 13.0 2.2 8.8 9.4 0.0 2.1 5.0 0.0 0.5 0.0 0.7 2.5 0.0 0.0 3.5 0.0 0.1 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.2 0.3 0.0 2.3 0.0 40.9 0.0 0.0 0.0 42.8 2.7 0.0 48.6 0.0 8.2 0.0 0.0 0.1 0.0 0.0 52.2 0.0 0.0 0.0 0.2 0.4 0.4 0.7 0.0 0.0 0.0 TFF1 "BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2" ENSG00000160182 "Trefoil factor 1" P04155 21 42362282-42366594 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "gallbladder: 247.7;stomach 1: 375.3" "Cell type enriched" "Detected in many" 10 "Pancreatic endocrine cells: 8493.3" "Group enriched" "Detected in many" 10 "breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 41 "MCF7: 478.7;OE19: 196.0" "Not detected" "Not detected" "CAB002170, HPA003425" Enhanced "Secreted to digestive system" NA NA 990000 "CAB002170: AB_563985, HPA003425: AB_1848260" "prognostic favorable (5.00e-4)" "unprognostic (8.81e-3)" "unprognostic (9.82e-2)" "prognostic favorable (5.67e-4)" "unprognostic (2.42e-1)" "unprognostic (1.72e-3)" "unprognostic (8.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.52e-1)" "unprognostic (6.62e-2)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (7.72e-3)" "unprognostic (1.07e-1)" 0.1 0.0 0.1 1.0 0.2 0.0 3.5 0.1 0.1 0.5 4.9 1.4 0.1 1.4 0.1 0.1 1.1 0.1 247.7 0.1 0.1 0.0 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 1.9 4.7 0.1 5.0 0.2 0.1 0.0 5.6 0.1 0.1 0.1 375.3 0.1 0.1 0.1 0.2 1.1 9.2 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 478.7 0.1 0.0 0.2 196.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 830.5 0.0 0.0 33.2 0.0 0.0 0.0 88.4 0.0 0.0 116.3 0.0 741.5 3.0 0.0 273.3 13.8 0.0 0.2 0.0 413.6 0.0 0.0 0.0 0.0 0.0 0.0 18.0 404.2 0.0 8493.3 152.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 47.2 76.6 TFF2 SML1 ENSG00000160181 "Trefoil factor 2" Q03403 21 42346357-42351128 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 361.8;stomach 1: 332.4" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 3630.5" "Group enriched" "Detected in many" 11 "pancreatic cancer: 320.9;stomach cancer: 244.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "CAPAN-2: 14.7;OE19: 21.5;PC-3: 52.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB025834, HPA036705" Enhanced "Secreted to digestive system" NA NA 670000 "CAB025834: , HPA036705: AB_2675263" "unprognostic (3.95e-2)" "unprognostic (9.87e-2)" "unprognostic (1.82e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (1.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.89e-2)" "unprognostic (5.55e-2)" "unprognostic (1.27e-9)" "unprognostic (1.99e-1)" "unprognostic (2.07e-1)" "unprognostic (1.28e-1)" "unprognostic (5.26e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.5 0.1 62.9 0.1 0.1 0.5 0.0 361.8 0.2 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.1 0.1 3.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 332.4 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.8 0.0 0.7 21.5 52.9 0.2 0.0 2.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 3630.5 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 85.8 0.2 0.0 0.6 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.0 1.0 17.1 0.0 484.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" 21 42311667-42315651 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 230.9;thyroid gland: 258.3" "Cell type enriched" "Detected in many" 21 "Mucus-secreting cells: 36697.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "eosinophil: 9.5" "Lineage enriched" "Detected in single" 63 "granulocytes: 9.5" "Cell line enhanced" "Detected in some" "MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9" "Region enriched" "Detected in single" 20 "cerebellum: 1.7" "Not detected" "Not detected" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" No NA 151000000 Nucleoplasm Nucleoli "CAB020681: , HPA035464: AB_2674636" "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favorable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 2.2 1.2 0.2 16.8 0.2 0.0 4.3 0.2 0.2 45.1 66.3 0.2 0.5 40.8 2.8 1.2 5.1 8.0 230.9 0.7 0.2 0.3 1.0 0.6 12.6 0.6 0.4 0.2 2.0 4.8 0.0 0.5 0.5 0.2 3.6 63.3 0.3 54.8 0.7 0.6 1.6 70.6 1.5 0.5 5.0 1.1 0.4 0.2 0.3 258.3 14.4 72.6 1.1 1.6 0.0 0.0 9.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 28.4 0.0 0.5 0.1 44.4 4.3 0.0 3.2 0.3 0.0 0.0 8.7 0.1 0.0 0.8 0.0 0.0 13.3 0.0 36.9 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 14.9 22.3 0.9 17.0 37.0 0.0 13.4 1110.8 464.4 316.2 21.0 0.0 0.3 0.0 9.0 0.0 51.4 1768.3 0.0 62.1 0.6 20.3 103.0 60.8 0.9 1.9 4.8 740.8 82.9 2.6 0.8 2.3 2.5 91.1 0.0 36697.4 0.0 28.0 1779.2 7.4 0.0 0.0 0.0 6.1 0.3 0.3 33.8 0.7 1.0 1243.2 29.6 TFPI "EPI, LACI, TFI, TFPI1" ENSG00000003436 "Tissue factor pathway inhibitor" P10646 2 187464230-187565760 "Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 98.2;placenta: 192.3" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 1654.1;Ito cells: 765.5;Syncytiotrophoblasts: 735.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.5;plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 56.4;HUVEC TERT2: 106.1;LHCN-M2: 65.0;TIME: 63.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005575, CAB020842" Supported "Secreted to blood" NA NA 95000000 "CAB020842: , HPA005575: AB_1080290" "unprognostic (8.75e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (7.95e-2)" "unprognostic (4.99e-2)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (3.05e-1)" "unprognostic (5.63e-2)" "unprognostic (3.86e-3)" "unprognostic (9.22e-2)" "unprognostic (2.43e-2)" "unprognostic (2.72e-2)" "unprognostic (7.05e-2)" "unprognostic (3.39e-3)" "unprognostic (4.05e-2)" "unprognostic (4.49e-2)" "unprognostic (5.81e-2)" 52.8 5.0 1.3 5.2 2.2 1.6 18.5 1.9 2.4 22.8 32.1 0.3 7.2 12.8 13.3 14.8 25.9 12.5 15.0 14.0 1.2 1.1 35.6 98.2 89.7 40.2 2.4 1.0 17.3 7.7 0.9 4.9 192.3 2.3 18.2 6.9 3.8 6.0 3.8 15.8 6.6 37.0 13.6 5.4 16.5 7.7 13.7 1.6 3.4 22.6 10.4 4.0 30.0 14.7 1.5 5.1 5.5 0.6 1.0 0.6 4.9 5.1 3.6 4.1 0.1 32.9 39.4 0.0 9.3 22.2 6.1 9.4 3.3 27.6 0.0 3.7 7.2 11.0 0.3 1.2 0.4 15.9 0.2 1.0 1.6 11.1 28.0 56.4 0.1 0.0 18.0 0.7 32.8 8.8 13.6 106.1 0.0 4.1 0.1 65.0 4.8 0.6 0.1 2.6 0.0 9.0 0.0 5.8 0.0 10.3 0.2 0.0 0.0 7.6 0.2 0.4 12.7 0.1 0.0 63.5 4.4 4.1 8.6 1.8 0.0 0.1 0.0 35.4 0.0 5.0 5.5 0.6 0.5 0.5 0.3 0.2 0.9 0.4 0.2 0.5 1.5 0.5 0.6 2.6 1.0 0.3 5.1 0.2 4.9 1.3 2.2 1.9 2.4 1.2 1.1 2.4 1.0 2.3 1.6 32.8 262.9 24.4 2.5 18.4 0.7 8.4 191.1 58.9 112.6 36.6 0.0 45.9 11.6 114.4 16.0 204.3 1.7 23.3 242.7 1654.1 163.0 4.2 12.8 338.6 44.3 1.6 101.1 765.5 77.7 9.8 159.0 19.5 25.3 57.7 1.2 31.4 108.2 2.9 65.7 100.4 1.1 213.4 163.5 1.1 0.4 16.2 735.3 15.4 1.3 6.0 TFPI2 "PP5, REF1, TFPI-2" ENSG00000105825 "Tissue factor pathway inhibitor 2" P48307 7 93885397-93890991 "Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "placenta: 1024.1" "Group enriched" "Detected in many" 4 "Ductal cells: 708.9;Syncytiotrophoblasts: 1826.6" "Cancer enhanced" "Detected in all" "renal cancer: 65.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 182.0;hTEC/SVTERT24-B: 90.4;U-138 MG: 87.8;U-2197: 78.3;U-87 MG: 148.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010142, HPA049158" Enhanced "Secreted to extracellular matrix" NA NA "CAB010142: AB_628166, HPA049158: AB_2680659" "prognostic favorable (8.33e-7)" "unprognostic (2.20e-2)" "unprognostic (2.10e-2)" "prognostic favorable (5.42e-4)" "unprognostic (5.19e-3)" "unprognostic (3.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-2)" "unprognostic (6.86e-2)" "unprognostic (7.54e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (3.38e-3)" "unprognostic (3.65e-2)" "unprognostic (1.97e-1)" "unprognostic (7.91e-2)" 21.5 14.6 0.6 5.1 0.7 0.0 4.8 0.6 0.6 1.0 1.0 0.6 0.9 0.0 4.8 1.3 0.7 5.4 2.2 3.3 0.6 1.5 4.7 3.1 3.5 0.6 0.6 0.6 14.9 10.0 0.0 4.4 1024.1 0.9 2.2 0.1 58.2 0.7 0.8 1.0 0.0 0.6 1.2 0.6 0.7 1.5 0.8 0.6 1.5 0.6 0.7 0.6 1.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 9.9 3.1 0.0 7.1 1.2 0.0 13.0 2.3 1.3 1.0 0.0 0.0 0.0 182.0 3.0 3.0 1.0 0.0 13.9 2.0 0.1 0.0 0.0 0.8 0.0 37.0 0.0 0.0 0.6 0.7 90.4 6.5 15.2 31.1 0.0 0.0 0.1 16.4 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 0.0 3.5 0.3 0.0 8.1 0.0 1.0 0.0 2.4 0.0 0.1 44.9 87.8 0.7 78.3 0.1 0.0 0.1 0.3 148.8 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.7 0.6 0.6 0.6 1.5 0.6 0.6 0.9 0.6 3.0 3.8 0.8 195.2 0.6 15.8 0.4 5.1 5.3 43.3 301.8 37.3 13.6 0.0 708.9 0.0 24.6 0.0 0.0 35.5 197.3 81.4 72.9 0.0 0.8 15.1 3.2 0.0 115.4 5.6 0.0 1.4 1.0 3.3 29.7 0.0 14.5 39.4 0.0 0.0 1.0 104.5 0.0 40.6 0.1 0.2 1.3 1826.6 0.0 0.0 22.3 TFPT "amida, FB1, INO80F" ENSG00000105619 "TCF3 fusion partner" P0C1Z6 19 54107013-54115675 "Disease related genes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.4" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034958, HPA058534" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA034958: AB_10603036, HPA058534: AB_2683745" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (5.13e-4)" "unprognostic (6.56e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.85e-1)" "unprognostic (2.85e-1)" "unprognostic (2.71e-1)" "prognostic favorable (3.13e-4)" "unprognostic (1.80e-2)" "unprognostic (1.15e-1)" "unprognostic (2.00e-2)" "unprognostic (2.61e-1)" "unprognostic (3.43e-1)" "unprognostic (3.66e-2)" 5.9 6.5 33.4 8.9 17.0 7.9 5.1 9.6 22.9 7.9 5.3 8.7 4.3 10.1 5.9 5.3 4.1 5.1 7.1 7.7 24.4 15.5 4.3 3.6 7.9 11.6 18.3 16.1 4.2 4.0 3.3 4.2 6.4 10.8 15.9 2.9 4.8 12.9 5.2 10.8 6.8 10.7 4.7 9.7 14.1 14.5 4.6 12.8 9.6 5.2 3.2 4.8 5.3 3.9 4.4 24.7 5.0 3.9 10.4 13.3 5.5 2.5 2.2 2.2 4.3 0.4 0.8 2.1 2.4 1.8 2.2 2.7 2.6 8.2 2.5 6.0 2.4 1.1 2.7 0.8 1.3 0.7 6.6 11.8 3.0 4.1 3.4 6.3 4.0 6.6 1.7 0.8 1.5 1.1 2.0 3.5 6.2 2.7 3.7 3.5 9.4 7.2 12.7 2.5 4.9 5.0 5.9 1.5 3.4 1.6 11.9 6.0 5.1 0.8 9.7 13.1 0.6 2.5 14.3 8.0 16.5 3.3 1.2 3.4 6.4 6.7 1.9 7.0 11.1 13.9 5.0 3.7 3.6 8.1 3.9 7.7 4.4 11.6 10.7 9.5 4.2 9.0 9.5 2.4 10.4 1.2 24.7 13.3 5.5 33.4 17.0 9.6 22.9 24.4 15.5 18.3 16.1 10.8 12.8 14.9 7.4 21.5 10.2 15.0 9.5 1.6 12.7 6.7 12.5 21.0 2.0 19.5 13.3 17.6 6.1 25.2 20.0 0.0 23.9 22.7 13.1 34.2 15.0 7.4 114.8 0.0 15.0 37.4 28.0 4.0 11.2 38.7 37.1 65.9 29.8 13.4 41.2 17.3 15.9 19.6 9.4 6.5 9.2 6.0 12.3 15.2 21.9 19.7 13.4 9.0 TFR2 "HFE3, TFRC2" ENSG00000106327 "Transferrin receptor 2" Q9UP52 7 100620416-100642779 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 112.6" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 379.7" "Cancer enriched" "Detected in many" 70 "liver cancer: 136.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 46 "basophil: 5.5;eosinophil: 3.9" "Lineage enriched" "Detected in single" 54 "granulocytes: 5.5" "Group enriched" "Detected in some" 11 "HEL: 28.5;HMC-1: 39.6;K-562: 26.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB016255, HPA017171, HPA073125" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "CAB016255: AB_628395, HPA017171: , HPA073125: " "unprognostic (4.18e-2)" "unprognostic (1.97e-2)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-2)" "unprognostic (4.13e-2)" "prognostic favorable (2.48e-4)" "unprognostic (2.29e-2)" "unprognostic (4.49e-2)" "unprognostic (9.26e-2)" "unprognostic (1.93e-1)" "unprognostic (2.90e-1)" "unprognostic (1.18e-9)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" "unprognostic (3.28e-1)" "unprognostic (8.18e-2)" 0.1 0.0 0.1 0.1 0.1 5.3 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.1 112.6 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 2.9 0.0 0.6 39.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 7.8 0.9 0.2 5.3 0.9 12.7 0.0 1.2 0.0 7.9 0.1 0.0 0.4 4.0 0.0 0.0 93.5 0.2 1.1 0.4 0.5 0.0 379.7 0.3 20.6 0.0 7.4 6.9 5.7 0.0 0.5 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 1.8 0.0 0.7 0.7 2.0 0.5 0.1 2.5 0.5 0.6 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082189 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 110.0" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" NA NA 1310000000 14000000 "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.62e-2)" 24.3 11.9 11.9 20.6 11.3 73.8 7.6 9.6 17.8 11.8 25.0 9.5 3.8 11.9 12.1 7.5 18.5 11.7 11.4 18.7 9.5 8.3 15.3 13.6 28.1 8.1 7.4 9.5 50.0 7.8 18.0 6.9 110.0 26.5 7.2 19.4 8.5 8.3 5.0 25.6 9.9 37.4 10.9 13.2 7.9 10.0 8.3 6.1 14.3 7.0 10.5 12.9 11.2 8.0 5.7 7.5 2.2 12.4 1.8 6.5 2.1 22.2 20.2 9.3 18.9 20.6 12.0 58.3 31.8 24.2 22.4 37.2 49.3 20.5 22.8 60.4 11.8 49.0 34.3 31.9 10.5 27.5 109.0 10.8 86.4 17.3 22.9 16.3 70.8 17.5 13.5 10.4 19.3 17.4 6.4 7.4 12.6 36.0 21.9 17.5 20.6 23.2 15.0 28.4 29.3 41.5 12.3 13.8 27.3 20.1 56.3 21.3 8.8 30.7 80.8 7.2 16.1 78.4 14.8 9.5 26.7 21.7 23.3 47.6 6.2 48.1 35.6 31.2 19.2 16.1 0.0 1.6 2.2 2.5 7.9 1.7 5.7 2.7 1.7 3.7 3.2 2.5 1.9 0.3 1.8 12.4 7.5 6.5 2.1 11.9 11.3 9.6 17.8 9.5 8.3 7.4 9.5 26.5 6.1 41.7 27.2 29.6 33.6 53.5 48.1 81.5 45.9 28.1 26.1 19.2 139.4 104.0 0.0 43.1 2.6 17.8 72.1 560.6 36.6 18.5 33.8 15.8 22.0 94.1 70.3 12.7 53.9 6.7 33.3 3.9 10.6 89.7 16.9 72.1 50.0 17.3 38.9 52.6 8.1 9.1 42.4 25.8 34.8 22.3 19.3 31.2 420.4 21.8 70.2 22.9 TG "AITD3, TGN" ENSG00000042832 Thyroglobulin P01266 8 132866958-133134903 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Thyroid hormones biosynthesis" "Hormone, Thyroid hormone" "Cancer-related genes, Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 247 "thyroid gland: 994.3" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 4.7;Cardiomyocytes: 2.8;Club cells: 2.3;Early spermatids: 2.1;Proximal tubular cells: 2.1" "Cancer enriched" "Detected in some" 1672 "thyroid cancer: 3072.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.5;HSkMC: 4.3;Karpas-707: 9.9;PC-3: 4.9;U-266/70: 3.6" "Region enriched" "Detected in single" 5 "cerebellum: 1.3" "Not detected" "Not detected" "CAB000077, HPA002740, CAB056155" Enhanced "Secreted in other tissues" NA NA 1000000 "CAB000077: , CAB056155: AB_2665573, HPA002740: AB_1080277" "unprognostic (1.18e-1)" "unprognostic (6.86e-2)" "unprognostic (7.40e-4)" "unprognostic (1.20e-2)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (2.77e-2)" "unprognostic (7.38e-2)" "unprognostic (4.96e-2)" "unprognostic (1.19e-1)" "unprognostic (3.08e-2)" "unprognostic (3.68e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.82e-1)" "unprognostic (5.11e-2)" "unprognostic (3.64e-2)" 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.6 0.1 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.0 0.1 3.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 994.3 0.1 0.1 0.1 0.1 0.3 1.2 4.0 0.6 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.9 1.4 0.6 0.0 1.8 0.0 0.1 0.9 0.0 0.0 0.2 0.4 0.0 0.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.3 3.0 1.1 0.0 0.9 0.0 1.3 0.0 9.9 0.2 0.0 0.1 0.0 0.0 0.0 4.9 0.1 0.0 0.4 0.2 2.8 0.3 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.2 0.6 0.0 3.6 3.0 0.0 0.2 1.3 0.0 0.0 0.6 0.7 0.2 0.0 0.9 0.0 0.4 0.0 0.0 0.3 0.3 0.2 4.0 0.0 0.3 1.2 0.4 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.1 0.0 4.7 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 2.1 0.0 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.0 1.4 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7916145-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 56.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 12.9;T-cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "PC-3: 5.7;REH: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074356 Enhanced Approved Vesicles NA NA Vesicles "HPA074356: AB_2686681" "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.3 2.0 1.6 0.2 2.8 0.6 0.3 1.9 6.4 5.0 0.6 0.0 0.3 6.0 2.8 0.5 0.3 0.7 0.2 2.1 0.7 0.8 3.7 4.0 0.3 0.1 0.5 1.7 0.3 0.3 0.9 56.6 0.4 1.9 2.5 0.1 0.6 0.8 0.7 0.3 0.5 5.7 2.0 0.6 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.1 1.1 0.8 0.1 0.3 0.0 0.1 0.0 2.9 0.1 0.1 0.2 0.1 0.5 0.1 0.0 3.3 2.7 0.0 0.2 0.0 0.5 0.0 0.1 3.0 0.1 0.0 2.0 0.0 0.0 0.0 3.4 1.1 0.5 0.2 0.6 0.2 1.7 0.4 0.2 0.1 0.0 0.0 0.3 0.0 3.0 0.7 0.5 0.0 1.5 1.2 0.2 0.6 0.2 5.7 13.8 0.0 3.1 0.2 0.0 1.0 2.5 0.3 0.0 0.7 0.0 0.9 0.6 0.2 1.8 2.9 2.0 0.9 0.8 0.9 0.8 0.4 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.6 0.1 0.9 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.1 1.6 2.8 1.9 6.4 0.7 0.8 0.5 1.7 1.9 0.0 0.0 0.0 0.8 3.2 1.3 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.5 0.0 0.0 0.0 0.2 0.5 1.7 0.6 0.0 2.8 0.2 0.0 0.0 2.5 0.0 3.3 1.1 0.5 5.0 0.0 0.0 2.7 0.4 0.0 1.1 4.4 2.4 12.9 4.2 0.2 0.9 1.3 0.3 6.9 0.0 0.4 TGIF2-C20orf24 ENSG00000259399 "TGIF2-C20orf24 readthrough" 20 36574553-36612384 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 22.1" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (7.38e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (5.58e-2)" "unprognostic (2.62e-2)" "unprognostic (1.94e-1)" "unprognostic (7.39e-2)" "unprognostic (2.22e-2)" "unprognostic (6.57e-3)" "unprognostic (3.97e-2)" "unprognostic (2.86e-3)" "unprognostic (1.72e-1)" "unprognostic (1.46e-2)" "unprognostic (2.69e-1)" "unprognostic (2.93e-1)" "unprognostic (3.70e-2)" "unprognostic (1.07e-1)" 2.1 1.4 1.9 8.5 1.9 4.9 2.3 0.9 3.1 3.1 2.1 1.7 0.6 2.1 4.1 2.6 1.4 4.2 1.7 2.2 1.4 1.1 2.0 5.3 2.2 1.8 2.5 1.7 3.8 22.1 3.1 1.3 2.7 1.9 1.9 1.5 2.0 3.2 2.2 2.7 1.5 1.6 4.7 1.6 3.0 1.4 6.1 1.3 4.1 4.0 1.4 5.7 1.3 2.8 3.4 3.6 2.8 2.2 1.9 3.3 0.9 3.7 1.6 20.9 10.5 3.1 1.6 1.5 0.7 4.8 7.3 5.6 8.9 7.8 1.7 2.1 4.3 3.1 1.6 17.7 2.6 11.1 4.8 2.1 4.6 5.4 10.1 1.5 5.4 1.1 1.2 2.9 3.9 7.3 9.3 4.9 9.8 1.3 10.7 1.9 9.4 12.4 2.9 4.4 4.1 0.4 9.3 2.1 7.6 2.9 4.5 2.6 7.0 1.2 9.3 5.3 3.7 8.3 14.9 1.3 2.7 0.9 0.2 2.8 2.4 1.2 6.9 0.2 6.2 4.4 0.0 1.9 0.0 2.6 2.2 2.4 3.4 0.6 0.5 3.6 3.4 3.2 3.3 2.8 1.9 0.4 2.6 0.5 0.9 1.9 1.9 0.9 3.1 1.4 1.1 2.5 1.7 1.9 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGIF2LX ENSG00000153779 "TGFB induced factor homeobox 2 like, X-linked" Q8IUE1 X 89921882-89922883 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 13.3" "Group enriched" "Detected in some" 57 "Early spermatids: 59.2;Late spermatids: 39.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "SH-SY5Y: 10.2;U-2 OS: 12.0;U-266/84: 18.5" HPA034543 Supported Approved Nucleoplasm No No Nucleoplasm "HPA034543: AB_10603037" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 12.0 0.3 0.0 1.0 18.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 TGIF2LY ENSG00000176679 "TGFB induced factor homeobox 2 like, Y-linked" Q8IUE0 Y 3579041-3580041 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 9.7" "Group enriched" "Detected in some" 32 "Early spermatids: 6.8;Late spermatids: 11.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "U-138 MG: 2.7;U-266/70: 4.2" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 TGM1 "ICR2, LI, LI1, TGASE, TGK" ENSG00000092295 "Transglutaminase 1" P22735 14 24249114-24264432 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 11.9;Club cells: 6.8;Distal tubular cells: 24.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 78.3" "Region enriched" "Detected in single" 11 "cerebellum: 3.0" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 13.1;HaCaT: 18.0;HeLa: 11.8;MCF7: 12.9;SK-BR-3: 16.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB015159, HPA040171" Enhanced Approved "Vesicles,Plasma membrane" NA NA 430000 "Vesicles, Plasma membrane" "CAB015159: AB_2202870, HPA040171: AB_2676869" "unprognostic (2.95e-2)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (1.89e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (3.01e-2)" "unprognostic (6.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.94e-7)" "unprognostic (7.11e-2)" "unprognostic (7.38e-2)" "unprognostic (2.22e-3)" "unprognostic (1.86e-2)" 2.9 0.2 0.2 0.4 0.2 0.2 0.7 3.0 0.3 10.1 1.0 0.2 0.2 0.3 0.5 2.0 106.0 1.3 0.2 0.6 0.2 0.0 0.6 0.3 0.9 0.4 0.2 0.2 0.7 1.3 0.2 0.2 0.9 0.2 0.5 0.3 0.4 12.8 1.4 0.7 9.3 0.3 0.2 0.2 0.4 0.2 0.4 0.2 0.5 0.4 86.8 70.0 0.4 17.2 0.4 0.5 0.0 0.5 0.0 1.1 0.2 0.8 1.5 0.8 0.7 0.0 0.6 13.1 0.3 0.2 0.7 1.3 0.9 1.3 0.8 1.7 1.0 0.2 18.0 2.1 1.5 0.5 1.4 2.5 1.0 11.8 4.1 0.6 0.6 1.1 1.1 7.1 0.4 1.5 0.4 0.5 2.5 0.7 0.8 0.5 12.9 0.5 1.4 0.2 0.8 1.6 0.8 0.1 0.8 0.5 1.5 0.9 1.2 0.2 16.0 0.0 1.1 1.1 0.8 0.6 0.8 3.8 1.5 0.6 1.1 1.2 0.2 0.3 1.5 0.9 0.0 0.5 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.2 0.2 3.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 11.9 1.4 0.0 4.2 0.2 0.8 0.8 0.0 0.0 6.8 0.0 0.0 1.1 24.9 1.9 0.1 0.0 0.0 0.0 0.8 0.6 0.6 3.1 4.6 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.4 0.1 0.6 0.0 0.3 0.0 0.8 1.6 1.0 0.0 0.0 4.6 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Group enriched" "Detected in many" 4 "CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.3 4.7 0.0 0.1 4.9 0.5 2.4 9.6 4.6 0.0 0.1 7.8 155.5 0.0 52.3 0.1 11.1 0.1 0.0 22.5 0.3 0.0 0.0 1.0 0.2 3.4 20.3 0.0 0.0 0.5 0.0 4.1 0.0 102.6 70.7 0.0 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.0 0.1 22.6 0.0 0.8 3.3 0.2 0.0 92.1 0.1 5.9 0.7 4.5 0.0 0.0 0.0 6.3 0.0 1.8 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 8.9 28.9 15.2 9.8 0.5 0.0 156.9 48.4 16.0 27.3 14.0 2.0 276.1 3.3 184.1 2.3 166.8 4.2 93.5 124.7 21.8 45.8 45.4 2.3 137.1 49.2 0.0 0.0 326.6 22.9 3.5 1.1 11.4 0.0 10.8 0.0 0.4 240.4 0.0 5.6 19.0 0.5 0.0 65.7 0.5 4.9 0.0 312.9 1.3 0.4 12.3 TGM3 TGE ENSG00000125780 "Transglutaminase 3" Q08188 20 2296001-2341078 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5" "Cell type enriched" "Detected in some" 6 "Intestinal endocrine cells: 44.4" "Cancer enriched" "Detected in many" 9 "head and neck cancer: 81.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 205 "neutrophil: 20.4" "Lineage enriched" "Detected in single" 205 "granulocytes: 20.4" "Cell line enriched" "Detected in some" 6 "EFO-21: 11.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA004728 Enhanced NA NA 14000000 "HPA004728: AB_1080360" "unprognostic (7.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.18e-2)" "unprognostic (3.23e-3)" "unprognostic (4.27e-2)" "unprognostic (4.20e-2)" "unprognostic (8.62e-2)" "unprognostic (4.21e-2)" "unprognostic (1.50e-1)" "unprognostic (8.00e-2)" "unprognostic (4.88e-3)" "unprognostic (1.35e-1)" "unprognostic (7.78e-8)" "unprognostic (1.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (9.67e-2)" 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.1 0.1 195.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 24.5 0.0 0.1 7.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 206.5 152.6 0.0 2.8 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.1 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.4 0.0 0.3 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 44.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 7.2 0.0 0.0 0.0 0.0 TGM4 TGP ENSG00000163810 "Transglutaminase 4" P49221 3 44874608-44914990 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "prostate: 107.8" "Cell type enriched" "Detected in some" 37 "Glandular cells: 201.3" "Cancer enriched" "Detected in single" 312 "prostate cancer: 75.4" "Region enriched" "Detected in single" 254 "cerebral cortex: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 9.7;hTERT-HME1: 2.6;NB-4: 5.2;RPMI-8226: 3.7;SH-SY5Y: 2.9" "Not detected" "Not detected" "CAB033571, HPA073290" Enhanced NA NA "CAB033571: AB_2287329, HPA073290: " "unprognostic (4.40e-2)" "unprognostic (4.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.17e-3)" "unprognostic (2.84e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.41e-2)" "unprognostic (1.65e-1)" "unprognostic (8.56e-3)" "unprognostic (5.08e-2)" "unprognostic (1.44e-8)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.68e-1)" "unprognostic (6.41e-2)" 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 25.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.8 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 2.6 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.0 0.7 0.7 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.5 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.2 0.2 201.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.8 0.0 0.0 2.6 TGM5 TGX ENSG00000104055 "Transglutaminase 5" O43548 15 43232595-43266857 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 3.1;Late spermatids: 2.6;Suprabasal keratinocytes: 5.8;Urothelial cells: 12.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HEL: 20.2" "Region enriched" "Detected in single" 11 "cerebellum: 2.9" "Not detected" "Not detected" NA NA "unprognostic (3.17e-2)" "unprognostic (1.03e-2)" "unprognostic (5.92e-2)" "unprognostic (2.65e-1)" "unprognostic (2.24e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.77e-1)" "unprognostic (1.44e-15)" "unprognostic (1.94e-1)" "unprognostic (3.14e-1)" "unprognostic (7.22e-3)" "unprognostic (5.71e-2)" 0.3 0.0 0.1 0.1 0.1 0.2 2.1 0.1 0.1 2.6 0.1 0.1 0.1 0.0 0.7 0.1 9.7 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.6 0.0 0.1 2.8 3.4 0.1 24.3 0.1 0.7 0.1 0.1 0.0 0.1 0.1 0.1 0.1 13.1 10.4 0.8 4.7 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 20.2 0.0 0.4 0.0 0.7 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 2.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.8 1.6 0.0 0.0 12.6 TGM6 "dJ734P14.3, SCA35, TGM3L, TGY" ENSG00000166948 "Transglutaminase 6" O95932 20 2380908-2432753 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 34 "lymphoid tissue: 5.7;skin 1: 3.3;tongue: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "SCLC-21H: 3.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 22 "cerebellum: 1.8" HPA059196 Uncertain NA NA "HPA059196: AB_2683943" "unprognostic (1.18e-1)" "unprognostic (2.84e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.2 5.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TGM7 TGMZ ENSG00000159495 "Transglutaminase 7" Q96PF1 15 43276280-43302255 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 5.9;testis: 2.9" "Cell type enriched" "Detected in some" 5 "Early spermatids: 60.4" "Cancer enriched" "Detected in single" 13 "endometrial cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 78 "EFO-21: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 5.9 0.0 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.4 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 2.8 TH DYT5b ENSG00000180176 "Tyrosine hydroxylase" P07101 11 2163929-2171877 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Catecholamine biosynthesis, Neurotransmitter biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 31 "adrenal gland: 83.5;brain: 41.4" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8" "Cancer enhanced" "Detected in some" "urothelial cancer: 4.0" "Group enriched" "Detected in many" 6 "hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "PC-3: 35.9;SK-BR-3: 12.8" "Region enhanced" "Detected in many" "olfactory region: 220.1" "Region enriched" "Detected in many" 19 "midbrain: 692.0" "CAB002522, HPA013768, HPA014010, HPA061003, CAB072340" Enhanced Supported Approved Cytosol NA NA Cytosol "CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374" "unprognostic (1.31e-1)" "unprognostic (1.30e-1)" "unprognostic (9.08e-2)" "unprognostic (1.75e-4)" "unprognostic (8.82e-3)" "unprognostic (5.88e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-3)" "unprognostic (3.83e-2)" "unprognostic (4.39e-4)" "unprognostic (4.97e-1)" "unprognostic (3.61e-2)" "unprognostic (1.92e-1)" "unprognostic (1.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.70e-2)" "unprognostic (2.18e-2)" 1.3 83.5 0.0 0.3 5.4 0.2 0.2 0.0 0.7 1.8 0.2 6.2 0.0 0.2 0.3 0.3 0.2 0.3 0.4 0.2 0.3 15.5 0.2 0.2 0.2 0.2 41.4 0.0 0.3 0.3 0.2 0.2 0.9 41.2 0.6 0.2 0.3 0.2 2.0 0.2 0.5 0.4 0.2 0.0 0.3 0.2 0.3 1.5 0.0 0.2 0.0 0.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 35.9 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.7 0.3 15.5 41.4 0.0 41.2 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.4 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.8 0.0 0.0 0.1 THBS2 TSP2 ENSG00000186340 "Thrombospondin 2" P35442 6 169215780-169254044 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 84.6;urinary bladder: 67.4" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 77.0;Fibroblasts: 41.1;Ito cells: 25.2;Melanocytes: 54.0;Smooth muscle cells: 28.6;Suprabasal keratinocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 83.6;ASC TERT1: 57.4;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HHSteC: 23.4;HSkMC: 31.0;hTEC/SVTERT24-B: 29.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB017716, HPA044304" Approved Approved "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 22000000 "Plasma membrane" "Nuclear speckles, Cytosol" "CAB017716: , HPA044304: AB_2678891" "unprognostic (2.85e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (8.90e-2)" "unprognostic (3.64e-2)" "unprognostic (8.73e-2)" "unprognostic (2.93e-1)" "unprognostic (5.10e-3)" "unprognostic (1.39e-1)" "unprognostic (4.71e-2)" "unprognostic (4.00e-2)" "unprognostic (2.56e-1)" "prognostic unfavorable (3.77e-6)" "unprognostic (2.19e-3)" "unprognostic (4.38e-2)" "unprognostic (4.16e-2)" "unprognostic (2.48e-3)" 43.5 4.0 4.3 10.1 7.8 0.4 84.6 1.1 9.0 24.3 17.0 6.3 3.3 1.9 26.1 16.1 9.8 14.8 43.0 21.9 5.5 3.6 4.6 5.9 8.4 3.8 8.1 1.4 26.2 5.9 1.5 4.4 2.0 14.8 10.5 3.4 0.7 3.9 2.8 14.6 22.7 3.8 22.0 16.0 2.8 2.6 12.5 5.2 0.0 13.2 10.6 4.8 67.4 29.4 0.4 0.7 0.2 0.8 0.1 0.3 0.0 0.0 0.0 0.6 0.3 83.6 57.4 0.0 15.9 21.9 22.1 27.8 0.1 0.0 0.0 0.0 19.0 0.1 0.0 0.7 0.8 12.6 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 31.0 0.0 29.8 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 3.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 10.1 0.1 22.5 1.9 0.0 0.3 0.0 6.2 0.1 0.5 0.0 0.8 0.2 0.2 0.5 0.0 0.4 0.1 0.0 0.2 0.3 0.1 0.3 0.0 0.1 0.5 0.7 0.2 0.0 4.3 7.8 1.1 3.1 5.5 3.6 8.1 1.4 14.8 5.2 6.0 0.0 0.0 1.2 77.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 41.1 1.1 0.0 0.0 0.2 0.0 0.0 25.2 0.0 0.0 7.5 0.9 54.0 0.0 0.0 0.3 0.8 0.0 15.2 0.3 0.3 0.0 28.6 0.0 0.0 36.9 0.1 0.0 0.0 0.7 THBS4 ENSG00000113296 "Thrombospondin 4" P35443 5 79991311-80083287 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Tissue remodeling, Unfolded protein response" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0" "Cell type enriched" "Detected in many" 9 "Sertoli cells: 485.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 51 "eosinophil: 8.0" "Lineage enriched" "Detected in single" 51 "granulocytes: 8.0" "Cell line enhanced" "Detected in some" "AF22: 5.1;SCLC-21H: 4.0;THP-1: 10.9;U-2 OS: 4.7;U-266/70: 4.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB004597, HPA042426" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 420000000 Vesicles "CAB004597: AB_628352, HPA042426: AB_2677992" "unprognostic (1.41e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-3)" "unprognostic (3.64e-2)" "unprognostic (9.94e-2)" "unprognostic (8.10e-2)" "unprognostic (5.64e-2)" "unprognostic (7.12e-2)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-3)" "unprognostic (2.74e-2)" "unprognostic (3.98e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (3.33e-4)" 69.8 1.0 7.6 2.1 8.3 3.7 9.7 0.8 4.6 1.1 21.4 2.6 1.2 1.3 12.2 13.6 6.5 1.4 4.1 59.0 6.4 6.4 0.8 0.6 1.0 0.9 8.5 1.9 2.1 23.0 5.5 7.8 0.6 10.7 3.7 3.7 4.9 19.8 2.6 61.7 1.5 1.4 94.0 11.5 0.6 4.0 5.5 2.6 2.0 9.9 39.3 4.1 3.4 2.7 0.1 0.0 8.0 0.0 0.0 0.1 0.0 0.2 0.0 5.1 0.3 0.4 2.2 0.5 0.1 0.2 1.5 0.5 0.1 0.6 0.2 0.2 0.4 1.3 0.2 0.2 0.6 1.3 0.2 0.7 0.5 0.0 0.3 2.8 0.0 0.1 1.6 0.3 0.1 0.3 0.5 0.0 0.1 0.0 0.3 0.3 0.7 0.1 0.1 3.9 0.0 0.1 0.0 1.6 0.0 0.4 0.1 4.0 1.2 0.1 0.0 0.4 2.3 0.0 10.9 0.0 0.1 4.7 0.3 0.3 4.2 0.1 0.7 1.8 3.5 0.9 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 8.3 0.8 4.6 6.4 6.4 8.5 1.9 10.7 2.6 0.0 0.6 0.0 0.0 0.2 1.2 5.0 0.0 0.0 1.2 3.5 53.0 0.0 0.0 0.1 28.0 2.2 0.0 0.0 0.0 0.0 2.7 0.8 0.0 0.0 0.1 1.6 8.6 0.6 0.0 3.2 0.9 0.0 1.7 0.0 0.0 1.9 0.0 0.0 41.1 0.6 1.9 485.0 2.2 16.9 1.4 0.9 0.0 0.0 0.0 0.0 THEG "CT56, THEG1" ENSG00000105549 "Theg spermatid protein" Q9P2T0 19 361747-376670 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 28.8" "Group enriched" "Detected in some" 101 "Early spermatids: 121.7;Late spermatids: 447.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 43.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (2.48e-1)" "unprognostic (6.37e-3)" "unprognostic (7.89e-3)" "unprognostic (2.34e-1)" "unprognostic (3.00e-1)" "unprognostic (5.17e-2)" "unprognostic (2.57e-1)" "unprognostic (5.57e-2)" "unprognostic (7.09e-4)" "unprognostic (1.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.14e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.3 0.3 2.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 3.5 0.1 0.3 0.1 0.1 0.0 28.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 447.8 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 2.8 1.4 0.0 0.0 0.0 0.0 0.0 THEGL ENSG00000249693 "Theg spermatid protein like" P0DJG4 4 56530609-56603507 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.9;vagina: 10.7" "Group enriched" "Detected in some" 58 "Early spermatids: 18.2;Late spermatids: 14.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 1.8;HSkMC: 3.7;hTEC/SVTERT24-B: 2.3;K-562: 3.0;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA066627, HPA068093" Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA066627: , HPA068093: AB_2685951" "unprognostic (4.33e-2)" "unprognostic (2.88e-3)" "unprognostic (7.97e-2)" "unprognostic (1.19e-1)" "unprognostic (3.69e-2)" "unprognostic (3.26e-1)" "unprognostic (1.90e-2)" "unprognostic (6.55e-2)" "unprognostic (1.61e-1)" "unprognostic (1.37e-1)" "unprognostic (4.70e-2)" "unprognostic (4.49e-2)" "unprognostic (1.73e-1)" "unprognostic (8.41e-2)" 0.1 0.2 0.6 0.1 0.5 0.8 1.9 0.1 1.1 1.7 0.7 0.6 1.0 0.1 0.4 1.3 0.2 0.4 0.8 0.1 0.2 0.4 0.1 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.0 0.3 0.0 0.8 0.7 0.1 0.2 0.2 0.5 0.1 1.2 0.2 1.8 0.2 0.1 0.3 8.9 0.4 0.0 0.1 0.0 0.1 3.0 10.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.3 3.7 0.0 2.3 0.0 0.5 0.4 0.0 3.0 0.0 0.9 0.0 0.8 0.0 0.2 0.0 0.4 0.4 0.4 0.0 0.0 0.0 0.1 2.0 0.8 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.1 0.3 0.8 0.1 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.1 1.1 0.2 0.4 0.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 THEM5 FLJ37964 ENSG00000196407 "Thioesterase superfamily member 5" Q8N1Q8 1 151847263-151853697 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skin 1: 59.8;tongue: 24.7" "Cell type enriched" "Detected in some" 18 "Suprabasal keratinocytes: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.2" "Lineage enriched" "Detected in single" 7 "T-cells: 4.2" "Cell line enriched" "Detected in some" 6 "HDLM-2: 39.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "basal ganglia: 20.0" NA NA "unprognostic (2.28e-2)" "unprognostic (1.21e-1)" "unprognostic (1.07e-1)" "unprognostic (3.41e-2)" "unprognostic (2.58e-3)" "unprognostic (9.55e-3)" "unprognostic (1.27e-1)" "unprognostic (1.93e-1)" "unprognostic (1.83e-1)" "unprognostic (7.86e-3)" "unprognostic (3.07e-3)" "unprognostic (9.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-1)" "unprognostic (5.34e-2)" "unprognostic (1.62e-2)" 0.1 0.6 0.3 0.5 0.2 0.0 1.8 0.2 1.6 3.6 0.1 0.2 0.1 0.3 0.8 0.1 4.4 0.1 1.0 1.1 0.3 0.2 0.3 0.2 0.3 1.9 0.2 0.8 0.1 0.3 0.0 0.2 5.8 0.1 0.1 0.0 0.1 1.5 0.1 0.2 59.8 0.1 0.1 0.3 0.1 0.5 0.3 0.1 0.4 0.1 24.7 1.7 0.6 1.1 0.0 0.5 0.5 0.2 0.0 4.2 5.6 4.4 0.0 0.0 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 39.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.0 1.2 0.1 0.0 4.7 0.7 0.3 0.0 0.2 0.5 0.0 0.0 0.3 0.1 6.0 1.4 0.8 1.0 1.0 1.4 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 1.8 0.2 4.2 0.0 1.6 1.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.5 1.9 5.6 0.3 0.2 0.2 1.3 0.3 0.2 0.2 0.8 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.9 0.0 0.0 0.0 THEMIS "bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA" ENSG00000172673 "Thymocyte selection associated" Q8N1K5 6 127708072-127918631 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 109.6" "Cell type enriched" "Detected in some" 6 "T-cells: 40.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 7.1" "Group enriched" "Detected in many" 23 "gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2" "Lineage enriched" "Detected in single" 88 "T-cells: 25.2" "Group enriched" "Detected in some" 4 "HDLM-2: 16.8;JURKAT: 28.7;MOLT-4: 26.2;RPMI-8226: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA031422, HPA031425" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031422: AB_2673874, HPA031425: AB_10670129" "unprognostic (1.47e-4)" "unprognostic (2.50e-3)" "unprognostic (1.31e-2)" "unprognostic (1.41e-4)" "unprognostic (1.41e-1)" "unprognostic (5.20e-3)" "unprognostic (7.48e-3)" "unprognostic (9.01e-3)" "unprognostic (1.47e-1)" "unprognostic (7.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.28e-1)" "unprognostic (2.65e-4)" "unprognostic (2.04e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-2)" 1.4 0.6 1.9 9.6 0.8 2.4 0.8 0.2 7.1 1.0 2.8 0.1 0.5 2.2 0.9 0.9 1.2 0.8 2.4 0.5 1.8 0.6 0.9 0.9 3.6 13.2 1.1 0.1 0.9 0.6 0.0 0.4 0.2 0.5 0.9 1.3 0.8 5.2 0.9 0.3 0.5 5.0 0.8 1.5 5.8 2.0 0.4 0.4 109.6 1.3 1.6 10.4 2.3 1.2 0.0 0.0 0.2 0.0 0.0 25.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.3 0.0 14.5 0.0 14.5 20.5 0.0 0.0 13.1 25.2 0.2 0.0 0.0 0.0 0.7 7.4 1.9 0.8 0.2 7.1 1.8 0.6 1.1 0.1 0.5 0.4 0.0 4.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.1 0.0 0.0 1.8 0.3 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 40.2 0.0 0.1 THEMIS2 "C1orf38, ICB-1" ENSG00000130775 "Thymocyte selection associated family member 2" Q5TEJ8 1 27872543-27886685 "Predicted intracellular proteins" "Immunity, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0" "Cell type enhanced" "Detected in many" 12 "Hofbauer cells: 60.6;Kupffer cells: 120.5;Macrophages: 117.1;monocytes: 154.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6" "Cell line enhanced" "Detected in many" "Karpas-707: 48.2;U-266/70: 37.4;U-937: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027513, HPA031096" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA027513: , HPA031096: AB_10599254" "unprognostic (7.38e-2)" "unprognostic (6.56e-2)" "unprognostic (5.07e-2)" "unprognostic (1.99e-3)" "unprognostic (4.51e-2)" "unprognostic (5.56e-3)" "unprognostic (4.13e-1)" "unprognostic (8.21e-2)" "unprognostic (1.77e-2)" "unprognostic (3.05e-2)" "unprognostic (1.38e-2)" "unprognostic (8.96e-2)" "unprognostic (7.21e-3)" "unprognostic (5.07e-2)" "unprognostic (1.42e-2)" "unprognostic (2.24e-3)" "unprognostic (4.52e-3)" 13.4 5.2 4.3 27.2 7.2 72.3 5.8 0.9 4.6 3.6 7.2 10.7 0.3 4.1 3.0 6.6 4.6 5.4 9.5 6.5 7.1 4.6 5.9 7.5 22.1 39.0 11.5 2.7 3.8 2.7 1.0 2.7 7.1 7.8 2.8 4.2 6.0 6.0 1.8 2.3 2.3 12.7 6.0 16.4 73.0 4.8 9.9 6.7 12.5 5.3 1.1 25.2 7.8 3.3 6.5 43.6 72.0 62.6 8.5 11.3 40.5 3.2 0.1 1.2 0.2 4.1 5.7 0.5 0.6 7.0 10.3 14.6 0.4 0.8 4.5 0.4 2.2 5.7 0.4 1.8 0.4 1.6 0.6 0.4 6.3 0.1 0.9 8.2 7.8 10.3 2.9 0.1 5.3 0.0 0.5 3.9 0.3 8.8 48.2 0.7 2.1 0.3 6.8 4.1 0.1 0.7 1.4 4.6 7.9 3.0 0.1 0.0 1.8 0.0 0.2 9.0 0.7 0.1 6.9 2.4 0.6 0.0 2.0 0.1 37.4 2.1 0.3 11.6 21.9 0.1 4.4 54.1 47.1 11.3 62.6 10.3 6.5 8.2 9.1 43.6 2.9 7.1 7.3 72.0 8.5 60.9 17.7 7.9 40.5 4.3 7.2 0.9 4.6 7.1 4.6 11.5 2.7 7.8 6.7 3.0 30.7 30.5 1.4 2.9 0.3 0.5 5.1 1.4 5.7 0.0 0.0 0.6 0.0 0.5 0.9 2.2 0.0 0.0 7.5 1.0 1.8 2.2 12.7 0.8 60.6 0.0 10.3 5.5 120.5 3.6 0.6 117.1 16.9 154.1 0.1 0.0 7.4 0.0 0.4 0.3 0.2 0.0 0.5 0.7 1.9 1.0 2.1 49.0 0.0 3.8 THNSL1 "FLJ22002, TSH1" ENSG00000185875 "Threonine synthase like 1" Q8IYQ7 10 25016658-25026664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037585 Uncertain Approved "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Cytosol" Mitochondria "HPA037585: AB_10696940" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (4.31e-2)" "unprognostic (5.26e-2)" "unprognostic (6.11e-2)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (9.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.71e-3)" "unprognostic (2.08e-1)" "unprognostic (3.21e-2)" "unprognostic (9.84e-3)" "unprognostic (3.06e-2)" 2.2 8.0 8.6 2.4 10.1 0.8 4.7 4.6 10.4 5.5 3.5 5.4 3.6 3.3 4.7 6.5 2.6 7.2 2.7 4.6 8.9 6.6 12.3 26.0 2.1 5.5 9.5 5.5 9.6 8.7 7.9 13.0 2.3 8.5 3.8 4.0 2.8 4.4 3.7 5.2 2.9 3.0 3.0 9.1 3.2 3.5 7.0 7.7 5.1 10.5 2.1 3.3 2.9 3.9 5.2 3.8 0.6 0.7 11.5 10.4 3.3 5.3 6.2 3.9 7.8 4.0 5.0 1.0 2.6 1.0 2.9 1.9 4.0 6.8 24.8 8.4 1.2 3.2 3.0 5.6 4.9 3.0 3.4 3.1 9.1 1.7 2.6 4.5 0.0 1.5 3.1 9.1 2.1 4.5 5.1 2.0 10.3 7.7 2.9 6.2 8.3 4.9 1.7 7.2 9.4 3.0 2.6 1.0 10.6 8.3 1.2 6.5 3.7 5.2 4.7 9.3 2.2 4.7 0.5 1.9 3.5 3.1 4.6 2.4 2.2 2.8 0.0 5.8 5.0 2.7 0.1 0.4 0.0 3.0 0.5 5.4 5.2 4.4 4.0 2.2 4.0 10.4 6.8 0.6 11.5 0.7 3.8 2.0 3.3 8.6 10.1 4.6 10.4 8.9 6.6 9.5 5.5 8.5 7.7 3.0 2.7 2.0 2.6 0.6 4.1 6.3 2.5 9.4 6.8 3.5 0.0 5.2 13.3 2.8 20.6 1.6 1.4 0.0 1.1 3.3 2.1 1.2 0.0 6.8 1.8 3.2 1.2 1.8 1.6 4.1 2.0 1.0 0.0 1.8 1.1 6.3 1.6 0.0 1.4 8.9 4.7 0.0 1.0 6.4 13.2 0.9 0.8 0.9 3.5 0.9 THOC3 "MGC5469, TEX1" ENSG00000051596 "THO complex 3" Q96J01 5 175917873-176034680 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 41.4" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 149.1;Spermatocytes: 102.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042764, HPA044009, HPA045071" Approved Enhanced Nucleoplasm,Vesicles No No Nucleoplasm Vesicles "HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461" "unprognostic (1.13e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-3)" "unprognostic (6.48e-3)" "unprognostic (8.60e-2)" "unprognostic (3.57e-2)" "unprognostic (3.06e-3)" "unprognostic (2.02e-2)" "unprognostic (3.41e-2)" "unprognostic (1.11e-2)" "unprognostic (1.04e-1)" "unprognostic (4.04e-2)" "unprognostic (8.80e-3)" "unprognostic (3.20e-1)" "unprognostic (2.86e-1)" "unprognostic (3.16e-2)" "unprognostic (2.91e-1)" 2.3 3.5 8.5 2.3 5.8 8.3 6.0 12.5 6.4 4.7 7.3 3.0 3.4 20.0 21.5 4.0 1.6 1.7 8.5 3.2 4.4 6.0 2.8 7.3 2.6 5.3 3.4 0.4 3.7 4.5 3.8 5.9 5.5 4.1 2.6 7.2 4.1 3.0 2.0 4.3 4.5 11.9 5.1 12.5 5.1 7.6 24.0 13.9 4.7 10.5 12.6 41.4 19.2 22.3 12.5 13.3 29.1 12.8 11.5 48.6 13.5 12.6 29.9 34.8 17.7 18.3 29.2 19.6 7.7 32.3 19.3 20.2 57.5 31.6 20.0 29.5 15.7 12.4 19.2 4.2 25.7 14.2 9.7 24.5 25.7 13.0 6.7 16.4 27.5 23.8 13.2 18.8 26.9 17.3 15.8 11.4 22.3 45.8 30.2 16.9 30.4 21.3 16.8 25.8 14.9 28.0 13.7 13.8 20.2 15.6 23.6 12.5 10.3 11.8 15.9 24.1 6.6 11.6 17.5 7.7 25.0 8.0 4.4 9.0 4.7 13.7 10.5 16.5 16.5 28.3 16.8 13.9 24.0 34.9 21.9 1.3 12.6 9.4 12.9 41.4 19.2 11.9 7.5 18.0 23.9 39.5 12.1 3.1 7.6 8.1 5.7 24.4 9.8 43.8 34.9 21.6 149.1 14.1 7.8 46.7 16.8 69.7 17.4 13.6 11.5 19.0 21.6 6.4 16.1 16.5 9.9 84.4 13.6 13.4 8.5 15.4 15.9 7.8 19.7 7.0 18.0 35.5 10.9 19.4 18.4 102.0 45.3 35.8 16.7 23.5 28.5 21.7 THPO "MGDF, MPLLG, TPO" ENSG00000090534 Thrombopoietin P40225 3 184371935-184381968 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cytokine, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 55.5" "Group enriched" "Detected in some" 5 "Hepatocytes: 11.1;Proximal tubular cells: 6.5" "Cancer enriched" "Detected in many" 5 "liver cancer: 8.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.9;Hep G2: 17.7;K-562: 3.1;RPMI-8226: 4.6;SuSa: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 1070000 "unprognostic (5.57e-2)" "unprognostic (3.15e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (1.37e-2)" "unprognostic (2.75e-1)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.48e-6)" "unprognostic (1.40e-3)" "unprognostic (4.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.25e-2)" 1.7 1.3 2.3 0.5 0.7 0.0 1.4 4.3 3.3 1.5 0.7 0.4 0.4 0.1 2.6 1.7 0.4 0.9 0.4 1.7 1.5 0.0 8.6 55.5 0.4 0.4 0.4 0.4 1.5 2.7 0.0 1.3 0.6 0.4 0.7 0.3 0.5 0.9 0.7 6.0 0.1 0.4 2.1 0.7 0.9 0.2 2.4 0.4 0.4 0.7 0.7 0.5 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.0 0.1 0.0 6.9 0.0 0.0 0.4 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 17.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.3 0.8 4.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 3.0 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.1 2.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 4.3 3.3 1.5 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 11.1 0.4 0.0 0.0 0.0 1.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 THRA "AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3" ENSG00000126351 "Thyroid hormone receptor, alpha" P10827 17 40058290-40093867 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 37.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009654, CAB023349" Approved Supported Cytosol NA NA Cytosol "CAB023349: AB_619577, HPA009654: AB_1854603" "unprognostic (2.75e-2)" "unprognostic (2.20e-1)" "unprognostic (6.64e-2)" "unprognostic (4.22e-2)" "unprognostic (8.78e-2)" "unprognostic (1.64e-1)" "unprognostic (3.41e-3)" "prognostic favorable (1.84e-4)" "unprognostic (1.47e-1)" "unprognostic (5.47e-2)" "unprognostic (7.85e-2)" "unprognostic (2.65e-2)" "prognostic favorable (6.05e-8)" "unprognostic (3.05e-1)" "unprognostic (1.35e-1)" "unprognostic (4.21e-1)" "unprognostic (1.88e-3)" 17.1 20.7 58.6 5.7 90.7 9.9 12.9 37.4 73.1 19.8 12.6 24.1 8.2 15.1 19.3 11.5 9.7 29.3 12.7 30.1 43.8 38.1 12.1 2.7 11.6 4.5 34.3 45.5 46.5 12.3 13.0 10.7 8.5 29.6 12.4 9.6 10.4 13.7 18.8 38.5 10.0 16.7 17.4 29.4 6.1 11.9 7.8 43.6 1.8 12.5 7.9 3.3 10.0 18.6 1.0 1.5 3.7 0.7 5.1 4.7 1.4 2.1 17.3 5.4 13.5 37.3 13.7 2.0 8.9 10.7 9.2 8.7 14.3 12.6 2.5 14.8 17.2 4.1 5.2 10.5 5.4 5.0 1.0 10.0 4.7 20.6 6.1 12.6 7.5 5.2 21.7 4.5 8.6 3.4 21.6 12.4 7.7 9.4 2.4 7.6 3.2 10.1 12.5 4.9 11.2 5.4 14.4 10.7 12.4 3.1 1.5 9.2 8.4 6.8 10.9 15.4 8.6 12.8 8.9 8.5 9.2 9.2 8.3 2.6 5.6 3.9 1.5 5.7 8.7 4.9 0.3 0.6 3.7 4.7 0.3 2.0 0.6 1.9 2.8 0.8 1.0 3.4 4.1 2.5 5.1 0.7 1.5 2.2 1.4 58.6 90.7 37.4 41.8 43.8 38.1 34.3 45.5 29.6 43.6 17.9 5.3 2.2 23.4 9.4 70.7 41.6 45.9 6.7 2.3 31.4 19.6 0.7 43.1 9.9 0.6 15.7 41.1 0.0 13.1 1.1 21.6 16.7 13.9 11.5 10.8 58.8 24.1 24.5 7.8 0.8 47.8 4.6 18.6 0.0 17.6 75.1 6.8 17.5 46.7 18.8 20.2 19.4 34.9 0.0 14.9 9.2 0.2 12.5 29.5 9.5 THRSP "Lpgp, LPGP1, S14, SPOT14, THRP" ENSG00000151365 "Thyroid hormone responsive" Q92748 11 78063861-78068351 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 65.3" "Cancer enhanced" "Detected in many" "liver cancer: 44.1" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Cell type enhanced" "Detected in some" "NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "ASC diff: 42.5" "Low region specificity" "Detected in all" HPA040642 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA040642: AB_10794878" "unprognostic (1.19e-1)" "unprognostic (2.88e-1)" "unprognostic (2.84e-1)" "unprognostic (2.73e-2)" "unprognostic (3.07e-1)" "unprognostic (9.91e-3)" "unprognostic (1.59e-2)" "unprognostic (9.60e-2)" "unprognostic (1.07e-2)" "unprognostic (8.23e-2)" "unprognostic (1.68e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (9.64e-2)" "unprognostic (1.57e-1)" "prognostic favorable (3.28e-4)" "unprognostic (1.69e-3)" 62.0 1.6 0.0 18.3 0.0 0.0 22.7 1.0 0.0 0.0 12.2 0.0 2.8 0.0 0.1 1.2 0.1 0.3 16.5 11.7 0.0 0.0 2.1 92.5 0.0 2.9 0.1 0.0 0.0 1.1 0.3 0.0 0.0 0.1 0.0 0.1 0.2 45.6 2.0 9.3 7.2 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 1.6 4.3 0.3 5.7 0.3 0.5 0.1 0.0 0.2 1.5 1.0 0.0 0.0 0.0 0.0 0.0 42.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.5 0.1 0.5 0.2 1.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 65.3 0.0 0.0 0.0 0.6 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 THSD4 "ADAMTSL6, FLJ13710, FVSY9334, PRO34005" ENSG00000187720 "Thrombospondin type 1 domain containing 4" Q6ZMP0 15 71096952-71783383 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 60.5" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 104.8;Cardiomyocytes: 53.7;Glandular cells: 73.8;Peritubular cells: 70.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 19.3;ASC TERT1: 18.1;BJ hTERT+: 23.0;T-47d: 18.8;TIME: 28.5;U-2197: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (3.14e-2)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.80e-2)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (3.01e-3)" 2.4 4.6 1.5 3.6 2.7 0.2 8.5 1.4 3.0 60.5 8.7 2.4 5.1 4.3 19.9 12.8 36.9 20.3 18.7 17.4 2.1 2.0 5.1 3.3 5.0 2.3 2.7 4.2 8.0 8.7 1.2 4.5 12.4 5.3 19.0 4.0 29.7 6.5 8.8 1.6 4.4 8.4 10.6 6.4 1.2 6.2 3.9 1.4 0.0 6.6 13.3 5.3 7.2 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 19.3 0.3 5.6 3.0 18.1 0.0 9.4 23.0 4.9 2.5 0.1 3.7 0.0 7.8 3.3 17.0 7.2 0.7 3.9 3.0 0.8 0.8 0.0 2.0 0.0 1.9 0.0 0.0 1.3 2.9 2.9 11.8 13.4 8.9 0.0 0.0 0.2 4.0 3.8 0.0 0.0 1.7 0.0 3.4 0.0 0.3 0.3 13.0 2.6 0.3 2.4 3.7 4.7 0.0 2.3 18.8 0.0 28.5 0.1 0.4 19.4 5.0 0.0 0.1 0.0 4.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.7 1.4 3.0 2.1 2.0 2.7 4.2 5.3 1.4 17.9 7.0 0.0 104.8 12.4 2.6 53.7 45.9 13.4 5.7 5.2 5.9 0.3 1.7 16.1 6.1 11.9 10.5 0.0 1.6 0.2 10.3 73.8 0.0 10.6 0.2 0.0 2.9 6.7 0.0 11.4 16.1 0.9 8.5 0.0 3.6 0.0 8.6 5.8 70.0 0.3 0.8 0.0 3.8 1.0 1.5 9.5 0.7 0.0 10.9 25.5 THSD7A KIAA0960 ENSG00000005108 "Thrombospondin type 1 domain containing 7A" Q9UPZ6 7 11370357-11832198 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.5" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 104.8;Cone photoreceptor cells: 106.0;Horizontal cells: 197.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 76 "basophil: 7.5" "Lineage enriched" "Detected in single" 76 "granulocytes: 7.5" "Cell line enhanced" "Detected in some" "A549: 9.7;HUVEC TERT2: 6.5;REH: 6.6;SH-SY5Y: 9.9;THP-1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000923 Supported "Secreted to blood" NA NA 3000000 "HPA000923: AB_1080271" "unprognostic (3.01e-1)" "unprognostic (7.90e-2)" "unprognostic (3.09e-2)" "unprognostic (1.96e-1)" "unprognostic (5.88e-1)" "unprognostic (3.33e-2)" "unprognostic (1.44e-1)" "unprognostic (9.66e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "prognostic favorable (2.24e-6)" "unprognostic (2.13e-3)" "unprognostic (1.66e-1)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" 9.6 2.2 4.7 2.1 5.7 0.6 5.2 2.0 7.2 8.4 2.7 1.0 0.9 1.2 8.3 2.7 1.7 4.8 6.2 2.1 3.8 4.7 17.7 2.0 3.0 1.2 4.6 3.6 6.4 1.4 2.6 9.4 22.5 3.5 8.4 2.1 4.4 1.7 5.5 0.9 1.7 1.5 5.9 4.3 2.3 1.7 2.2 1.9 0.0 4.9 2.5 1.1 4.5 6.8 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 9.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 6.6 0.0 0.0 0.3 0.1 0.7 9.9 0.0 0.3 0.0 1.6 0.1 17.9 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 5.7 2.0 7.2 3.8 4.7 4.6 3.6 3.5 1.9 20.8 8.0 0.0 1.6 2.4 104.8 1.1 22.9 0.0 4.5 52.4 106.0 14.0 6.6 5.5 1.0 31.5 0.0 0.0 1.9 4.9 9.8 2.1 0.0 1.0 2.0 197.0 40.1 21.5 1.9 0.2 22.5 0.8 11.8 0.0 0.0 22.3 4.4 1.5 1.4 8.6 7.4 0.0 1.4 1.7 0.4 2.0 43.4 0.0 0.5 0.6 THSD7B KIAA1679 ENSG00000144229 "Thrombospondin type 1 domain containing 7B" Q9C0I4 2 136765545-137677717 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.2;epididymis: 11.6;retina: 14.9" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 24.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Daudi: 10.3;SCLC-21H: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051416, HPA056745" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051416: AB_2681477, HPA056745: AB_2683224" "unprognostic (4.65e-3)" "unprognostic (2.25e-1)" "unprognostic (8.98e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-3)" "unprognostic (1.12e-1)" "unprognostic (6.50e-2)" "unprognostic (7.80e-3)" "unprognostic (2.89e-1)" "unprognostic (1.65e-1)" "unprognostic (3.20e-1)" "unprognostic (6.56e-2)" "unprognostic (4.47e-6)" "unprognostic (2.42e-3)" "unprognostic (1.89e-1)" "unprognostic (4.31e-2)" "unprognostic (4.30e-2)" 4.7 0.3 1.7 0.3 1.6 0.1 2.6 0.7 3.2 0.9 0.5 1.1 0.8 0.3 0.9 11.6 1.6 2.8 0.8 1.4 1.8 3.3 2.7 0.6 0.5 0.2 1.8 1.5 0.4 0.3 1.3 3.0 0.7 24.2 2.1 0.3 14.9 1.2 0.7 0.3 0.2 1.5 2.2 3.2 0.2 0.3 1.1 0.3 0.1 2.1 0.0 0.3 0.8 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.7 3.2 1.8 3.3 1.8 1.5 24.2 0.3 0.0 0.0 0.0 0.4 0.1 1.2 0.6 0.0 0.0 0.0 0.0 23.6 0.0 1.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 85.8 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 31.7 6.5 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.1 THSD8 ENSG00000284491 "Thrombospondin type 1 domain containing 8" 19 12802031-12813581 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "pancreas: 2.5;testis: 8.9" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "BEWO: 3.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 117.3;Leydig cells: 89.2;Muller glia cells: 84.4;Peritubular cells: 72.9;Proximal tubular cells: 127.2;Smooth muscle cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 53.5;BJ: 83.7;BJ hTERT+: 93.7;fHDF/TERT166: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 9800000 Nucleoplasm "Plasma membrane" "CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.5 0.0 53.5 38.7 0.0 83.7 93.7 30.0 33.3 0.0 0.0 0.0 0.0 146.5 14.5 0.1 0.4 0.1 22.9 7.1 0.0 4.4 1.5 0.0 16.5 0.0 0.0 28.7 0.0 38.1 1.3 41.7 0.0 2.6 0.0 0.0 23.1 0.0 0.0 0.0 20.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 2.1 5.7 0.0 0.0 0.0 4.0 0.1 0.2 0.0 43.2 14.4 12.4 12.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 0.0 2.6 0.0 0.4 15.8 13.9 0.8 0.0 0.0 0.0 8.7 0.0 1.5 18.3 1.1 0.8 14.3 0.0 0.0 0.0 2.3 117.3 0.2 1.1 0.0 3.6 30.2 0.0 27.0 0.0 0.9 89.2 1.4 16.9 0.0 0.0 84.4 0.5 0.0 72.9 127.2 19.0 32.3 114.6 0.4 0.4 15.4 3.3 0.0 0.0 0.1 TIAF1 ENSG00000221995 "TGFB1-induced anti-apoptotic factor 1" O95411 17 29073521-29078857 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 3.0;Bipolar cells: 1.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "OE19: 29.0" NA NA "unprognostic (1.16e-1)" "unprognostic (8.34e-2)" "unprognostic (7.16e-2)" "unprognostic (4.55e-2)" "unprognostic (1.42e-1)" "unprognostic (9.03e-3)" "unprognostic (4.14e-2)" "unprognostic (2.56e-1)" "unprognostic (1.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.07e-3)" "unprognostic (1.35e-1)" "unprognostic (3.97e-8)" "unprognostic (1.54e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" 1.0 1.4 2.5 1.7 3.3 1.9 1.1 10.0 4.7 1.1 1.3 2.5 1.5 4.2 1.8 0.7 1.7 3.0 3.8 2.7 0.8 4.7 0.7 2.2 4.3 1.1 0.8 1.8 1.2 1.1 1.5 2.0 1.8 1.5 8.3 7.4 1.9 1.8 4.7 1.7 1.4 1.1 0.7 2.8 0.6 1.8 1.8 1.9 3.0 1.1 0.9 1.5 0.2 0.4 0.2 0.8 0.4 0.5 0.6 0.6 0.6 0.2 0.3 0.4 0.6 0.6 0.4 0.4 0.7 0.7 1.3 0.6 0.5 0.7 0.5 0.3 0.1 0.9 0.5 0.2 0.6 0.6 0.4 0.3 0.8 0.2 1.6 0.2 1.3 1.4 0.9 0.4 0.4 0.6 1.5 0.1 29.0 0.5 5.4 0.4 0.6 0.9 0.3 0.6 0.3 0.3 2.7 0.2 1.7 0.4 2.3 0.1 0.5 0.5 0.2 0.4 0.3 0.6 0.3 0.6 0.6 0.4 1.1 0.9 0.4 1.1 0.4 1.5 0.9 1.2 0.8 0.4 1.8 0.8 1.1 3.0 0.9 1.1 1.9 0.3 0.2 3.0 1.3 0.0 0.3 0.3 1.9 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.6 0.8 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 1.0 6.5 0.2 0.3 0.2 0.3 0.0 0.0 0.0 0.7 TIAM1 ENSG00000156299 "T cell lymphoma invasion and metastasis 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 110.1" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 8 "cerebellum: 110.1" "Group enriched" "Detected in many" 5 "classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 574.6" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" NA NA "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 3.3 11.4 13.4 5.3 12.4 2.1 4.4 110.1 15.1 10.1 2.2 9.7 0.5 1.5 7.9 3.0 18.9 9.4 4.0 2.1 11.6 7.0 1.7 3.7 4.1 8.8 6.2 7.9 1.5 1.9 0.3 4.2 4.4 8.9 3.7 2.8 7.0 2.2 3.1 0.7 20.4 1.7 10.0 6.4 4.2 2.1 5.9 7.1 6.2 1.3 5.3 9.3 8.1 5.0 0.1 5.9 0.6 12.4 6.9 16.8 3.6 1.5 0.5 12.1 0.7 0.2 2.8 19.4 0.0 0.0 1.5 0.5 0.1 2.2 4.1 0.8 0.3 2.2 2.8 1.4 2.4 2.4 0.3 6.7 18.7 0.3 0.1 0.3 0.0 16.4 1.2 0.8 8.2 3.3 1.4 0.0 6.2 0.0 6.1 6.1 7.9 2.8 0.1 3.9 2.9 5.2 3.7 3.8 0.0 1.8 19.4 18.3 4.5 0.8 6.3 0.7 4.4 2.6 0.0 0.1 1.7 7.1 0.0 0.8 6.9 5.1 3.7 4.0 1.4 13.4 0.6 10.7 0.0 0.3 9.6 2.1 0.1 8.3 1.6 5.9 0.0 10.9 0.6 0.6 6.9 12.4 0.3 16.8 3.6 13.4 12.4 110.1 14.4 11.6 7.0 6.2 7.9 8.9 7.1 3.0 2.9 0.8 40.5 74.4 1.2 1.1 2.5 0.0 18.2 0.0 2.0 7.6 0.0 1.5 10.0 15.8 0.0 0.0 0.6 25.1 7.6 16.1 23.1 3.6 8.2 69.9 5.2 50.3 22.7 9.0 31.9 28.4 10.1 18.0 0.3 39.3 1.1 10.7 54.8 0.0 4.4 6.5 2.1 1.4 6.1 125.3 8.9 6.9 0.9 72.7 TIAM2 STEF ENSG00000146426 "T cell lymphoma invasion and metastasis 2" Q8IVF5 6 154832697-155257723 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 76.6;Early spermatids: 131.1;Late spermatids: 220.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 11.3" "Group enriched" "Detected in many" 4 "B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3" "Cell line enhanced" "Detected in many" "AF22: 35.1;HDLM-2: 15.0;RH-30: 22.9" "Group enriched" "Detected in many" 5 "amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6" "Low region specificity" "Detected in all" "HPA011134, HPA013903" Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" No No "Nucleoplasm, Nucleoli fibrillar center" Cytosol "HPA011134: AB_1858005, HPA013903: AB_1858004" "unprognostic (9.14e-2)" "unprognostic (5.79e-2)" "unprognostic (1.44e-1)" "unprognostic (6.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.69e-1)" "unprognostic (4.36e-2)" "unprognostic (1.89e-1)" "unprognostic (5.74e-2)" "unprognostic (1.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.36e-2)" "unprognostic (1.38e-3)" "unprognostic (1.82e-1)" "unprognostic (8.13e-2)" "unprognostic (6.04e-2)" "unprognostic (1.05e-1)" 0.6 2.1 5.3 1.7 9.4 0.7 1.5 7.9 21.1 1.5 11.6 0.7 0.1 11.0 1.2 0.8 1.0 1.2 4.0 3.5 4.7 2.0 0.7 0.7 0.9 2.0 1.7 9.5 0.9 1.8 0.2 1.8 0.8 0.6 3.0 1.1 1.3 2.4 3.6 3.0 1.0 27.4 1.4 0.9 1.2 4.0 15.6 1.9 0.0 7.8 0.0 2.5 2.3 1.2 3.3 0.9 8.3 11.3 0.8 1.8 0.4 4.3 0.8 35.1 4.1 1.5 4.3 0.4 1.8 1.1 1.7 2.9 0.5 2.6 1.0 1.9 3.2 0.6 0.7 1.2 0.0 1.2 15.0 1.9 0.3 0.6 2.0 0.9 0.3 1.1 2.9 0.1 0.6 0.1 1.6 2.4 0.5 0.5 0.1 3.9 0.4 0.4 0.9 2.5 0.2 1.0 4.5 22.9 0.4 0.1 0.2 0.9 8.0 0.1 0.4 0.2 6.9 0.3 0.5 0.8 0.3 8.9 0.3 0.9 0.2 1.7 0.2 0.1 0.5 2.2 0.4 0.2 3.1 0.2 3.2 0.3 3.3 0.5 0.3 0.9 1.0 0.6 0.4 8.3 0.8 11.3 0.3 1.8 0.4 5.3 9.4 7.9 21.1 4.7 2.0 1.7 9.5 0.6 1.9 3.0 1.6 8.1 16.3 2.7 13.8 7.3 7.6 2.7 1.2 1.8 76.6 1.2 0.0 4.7 131.1 3.0 2.9 0.0 2.7 2.1 4.7 7.7 19.6 0.9 1.7 22.3 0.0 7.4 2.1 220.7 9.2 4.7 11.8 14.4 4.2 6.9 4.2 2.0 7.4 0.7 25.2 0.0 3.8 5.2 5.5 2.3 0.3 4.8 2.6 7.4 TICRR "C15orf42, FLJ41618, MGC45866, SLD3, Treslin" ENSG00000140534 "TOPBP1 interacting checkpoint and replication regulator" Q7Z2Z1 15 89575482-89631056 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 1.6;Extravillous trophoblasts: 4.8;Spermatogonia: 5.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046746, HPA049454" Supported Nucleoplasm NA Yes Nucleoplasm "HPA046746: AB_2732533, HPA049454: AB_2680773" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (3.41e-1)" "unprognostic (1.10e-1)" "unprognostic (6.22e-5)" "unprognostic (7.73e-3)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.64e-1)" "unprognostic (1.31e-4)" "unprognostic (5.87e-2)" "unprognostic (0.00e+0)" "unprognostic (3.54e-2)" "unprognostic (7.38e-2)" "unprognostic (4.53e-2)" "unprognostic (3.59e-2)" 0.9 0.4 0.3 3.5 0.4 6.9 0.6 0.1 0.4 1.0 2.5 0.1 0.1 2.2 1.0 0.1 9.0 0.7 0.5 0.3 0.2 0.3 0.3 0.2 0.7 2.9 0.4 0.1 0.9 0.1 0.0 0.3 3.9 0.1 0.5 2.6 0.2 1.2 0.1 0.1 1.0 3.2 0.4 0.2 2.9 0.9 7.7 0.1 21.7 0.4 9.5 12.2 0.8 2.3 0.0 0.0 0.0 0.4 0.0 0.7 0.0 7.1 9.8 12.8 7.3 0.5 1.0 7.2 5.2 2.4 7.4 7.8 10.7 5.5 9.5 2.8 1.7 6.2 14.3 17.5 4.6 6.8 4.8 16.9 14.2 9.5 5.6 0.0 10.1 5.2 0.3 0.3 6.0 4.5 1.1 3.6 8.5 13.5 11.1 4.3 6.7 8.8 8.6 8.5 7.1 5.1 12.7 11.5 7.7 1.7 10.2 5.5 5.4 12.5 7.1 2.1 9.8 5.3 6.8 2.2 8.1 10.2 16.4 10.7 2.6 5.0 8.2 2.8 8.6 4.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.4 0.1 0.3 0.2 0.3 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.7 0.1 0.8 0.0 0.3 0.1 TIFAB ENSG00000255833 "TIFA inhibitor" Q6ZNK6 5 135444218-135452399 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.9;lymphoid tissue: 15.9" "Group enriched" "Detected in some" 4 "Early spermatids: 2.7;Hofbauer cells: 4.2;Late spermatids: 5.7;monocytes: 6.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "myeloid DC: 4.5;plasmacytoid DC: 13.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 13.9" "Cell line enriched" "Detected in some" 5 "THP-1: 14.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049372 Uncertain NA NA "HPA049372: AB_2680733" "unprognostic (1.33e-2)" "unprognostic (1.09e-2)" "unprognostic (1.63e-2)" "unprognostic (1.71e-2)" "unprognostic (1.35e-1)" "unprognostic (1.98e-5)" "unprognostic (3.87e-1)" "unprognostic (3.25e-3)" "unprognostic (5.29e-2)" "unprognostic (1.09e-2)" "unprognostic (6.08e-2)" "unprognostic (1.96e-1)" "unprognostic (1.01e-2)" "unprognostic (2.31e-1)" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (9.01e-2)" 0.6 0.3 0.4 13.9 0.4 0.5 0.4 0.3 0.4 0.4 1.2 0.7 0.0 1.4 0.3 1.3 1.1 0.3 0.9 0.3 0.4 0.3 0.5 0.4 4.2 11.1 0.5 0.0 0.3 0.3 0.0 0.6 0.4 0.2 0.4 2.3 0.0 2.5 0.6 0.3 1.3 3.0 0.3 0.6 4.5 0.9 2.0 0.0 11.6 0.5 0.7 15.9 2.6 0.5 0.0 13.9 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.2 0.4 0.4 0.3 0.4 0.4 0.3 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 5.7 0.0 1.1 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TIGD2 ENSG00000180346 "Tigger transposable element derived 2" Q4W5G0 4 89111500-89114899 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 34.1" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 20.3;Syncytiotrophoblasts: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 11.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054844, HPA071168" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA054844: AB_2682623, HPA071168: AB_2686353" "unprognostic (7.11e-2)" "unprognostic (8.02e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (5.42e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (8.47e-2)" "unprognostic (4.96e-2)" "unprognostic (9.83e-3)" "unprognostic (1.16e-1)" "unprognostic (8.94e-3)" "unprognostic (2.51e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.02e-4)" 4.0 3.7 3.3 3.5 4.0 2.5 11.2 7.2 5.3 4.8 5.7 3.5 2.3 7.4 3.4 4.8 4.7 2.9 5.4 3.2 3.2 3.6 6.3 34.1 4.2 8.5 3.9 2.7 2.6 5.8 12.9 14.1 27.2 4.0 5.0 4.7 8.1 14.4 4.3 3.3 4.1 7.9 2.8 3.4 4.9 4.8 4.6 4.0 11.3 6.3 2.1 4.9 6.0 4.3 1.8 2.2 11.1 2.6 3.2 2.8 1.2 9.8 4.6 5.0 6.1 5.6 4.3 2.3 6.0 7.3 5.7 4.9 9.3 9.6 4.8 3.2 2.4 4.1 3.1 5.6 9.2 7.9 8.1 1.8 5.6 5.0 4.4 16.7 2.6 4.0 10.7 9.2 2.3 8.4 5.4 2.1 6.4 7.0 8.4 7.1 3.7 4.8 3.0 6.1 10.6 1.5 7.4 8.9 6.4 5.1 19.0 24.4 4.9 5.7 18.9 7.4 7.0 6.6 5.3 1.7 7.5 7.0 2.4 4.5 13.3 4.1 3.7 6.5 4.5 6.3 11.1 1.8 0.2 2.8 2.6 1.4 1.8 1.5 2.2 2.2 1.6 1.4 2.2 0.0 3.2 1.4 0.3 1.5 1.2 3.3 4.0 7.2 5.3 3.2 3.6 3.9 2.7 4.0 4.0 0.0 0.3 1.7 5.1 0.2 3.3 2.5 5.1 1.4 6.8 3.5 9.8 13.6 1.7 2.2 1.2 1.6 1.3 0.0 4.9 7.0 0.5 2.3 0.0 20.3 4.1 0.0 2.4 2.5 2.1 0.5 1.4 2.6 0.0 5.4 2.9 2.3 3.8 2.0 1.1 9.8 6.3 0.0 2.0 1.8 7.9 0.4 32.6 1.9 3.1 1.4 TIGD3 ENSG00000173825 "Tigger transposable element derived 3" Q6B0B8 11 65354767-65357613 "Predicted intracellular proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 14.9;brain: 8.6" "Cell type enhanced" "Detected in some" 16 "Spermatocytes: 16.6;Spermatogonia: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 6.5;eosinophil: 8.4;neutrophil: 14.9" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.9" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA040016 Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA040016: AB_10805600" "unprognostic (1.33e-1)" "unprognostic (1.81e-2)" "unprognostic (1.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.15e-1)" "unprognostic (2.47e-3)" "unprognostic (9.04e-4)" "unprognostic (1.48e-4)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "unprognostic (3.94e-3)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (7.55e-3)" "unprognostic (1.01e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-3)" 0.1 0.7 1.8 0.8 2.7 1.3 3.0 8.6 4.6 0.3 4.1 0.9 0.0 2.6 0.4 0.8 0.4 0.5 0.6 0.4 2.0 1.9 0.8 0.7 1.1 1.1 1.2 0.0 1.0 1.5 1.5 1.9 0.4 3.1 0.5 0.4 1.1 0.5 0.5 0.3 0.2 6.4 0.3 2.0 2.6 1.0 6.9 0.4 3.0 0.4 1.0 0.8 0.6 0.0 0.3 1.2 14.9 1.2 0.1 0.1 0.1 1.4 2.6 2.3 6.0 0.0 0.0 0.8 0.1 0.3 0.6 0.8 2.1 0.3 1.0 1.0 0.2 1.0 1.4 2.3 0.1 0.2 1.8 2.3 0.4 1.4 4.7 0.1 0.9 4.4 0.0 0.2 0.3 0.0 0.1 0.3 2.3 1.4 3.1 0.0 3.4 2.9 1.9 1.3 1.3 1.1 4.2 1.0 4.0 0.1 1.3 6.7 4.2 1.7 2.6 1.1 0.2 4.3 1.4 0.0 0.2 1.1 1.6 1.0 6.4 4.1 1.3 0.1 1.8 0.7 6.5 0.5 8.4 0.0 0.3 0.0 0.3 0.0 0.0 0.8 0.2 0.1 0.0 14.9 0.1 1.2 1.2 0.0 0.1 1.8 2.7 8.6 4.6 2.0 1.9 1.2 0.0 3.1 0.4 0.0 0.6 0.0 0.2 1.3 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 2.2 0.0 1.0 0.0 0.5 0.3 0.3 0.6 0.0 0.2 0.2 0.0 0.0 0.0 0.8 1.8 0.0 0.9 1.7 1.0 0.3 1.0 0.6 0.0 0.4 0.5 3.8 0.0 0.8 16.6 5.3 1.4 0.7 0.0 0.4 0.1 TIGD4 ENSG00000169989 "Tigger transposable element derived 4" Q8IY51 4 152769354-152779764 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 14.1;testis: 11.8" "Group enriched" "Detected in some" 4 "Early spermatids: 76.3;Rod photoreceptor cells: 29.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 4.6;U-266/70: 6.8;U-266/84: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035649, HPA073768" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA035649: AB_10670956, HPA073768: " "unprognostic (1.71e-1)" "unprognostic (5.97e-2)" "unprognostic (4.01e-2)" "unprognostic (1.23e-4)" "unprognostic (6.19e-3)" "unprognostic (1.82e-2)" "unprognostic (1.61e-5)" "unprognostic (1.75e-1)" "unprognostic (1.14e-1)" "unprognostic (3.89e-3)" "unprognostic (1.16e-2)" "unprognostic (3.36e-2)" "unprognostic (1.43e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-2)" "unprognostic (4.47e-2)" 0.7 1.0 2.2 0.7 8.6 0.2 2.1 3.5 3.6 2.5 0.8 2.1 3.9 1.1 2.0 4.2 0.6 5.5 0.8 1.0 4.8 2.1 2.0 0.6 3.5 0.5 1.6 3.2 1.7 0.9 5.4 14.1 0.5 5.8 1.3 0.9 5.4 2.0 1.1 1.2 1.3 0.8 0.9 2.7 0.8 1.0 11.8 1.3 0.3 2.1 0.6 0.5 1.0 0.8 0.4 0.0 1.6 1.1 2.1 1.3 0.0 0.6 0.5 3.0 1.2 0.2 0.4 0.3 0.1 0.7 0.3 0.6 0.6 1.3 1.0 0.1 0.1 1.4 0.5 1.1 0.5 0.5 1.0 0.2 1.5 0.7 0.3 0.2 0.6 0.3 0.1 0.5 0.5 0.3 0.6 0.1 2.2 0.4 4.6 0.3 0.3 2.9 0.4 1.4 0.4 0.4 0.5 0.6 0.0 2.0 0.1 1.4 1.6 0.2 0.3 2.9 1.4 0.7 0.2 0.0 0.4 0.6 0.5 0.6 6.8 13.2 0.6 1.0 1.6 2.2 0.0 0.3 0.8 0.0 1.1 0.2 0.0 0.3 1.3 0.0 0.4 0.1 0.4 1.6 2.1 0.2 0.0 0.0 0.0 2.2 8.6 3.5 3.6 4.8 2.1 1.6 3.2 5.8 1.3 0.0 1.0 0.0 0.4 0.0 6.7 0.0 0.0 12.0 0.0 1.8 11.8 0.1 0.0 0.5 76.3 0.1 0.0 0.0 1.0 0.1 0.1 0.3 0.0 0.0 0.5 1.6 1.2 0.0 0.0 8.5 0.3 0.0 0.0 0.0 0.1 12.1 0.4 0.0 0.4 1.5 29.0 0.0 0.0 5.1 1.7 0.0 0.2 0.0 0.4 0.3 TIGIT "DKFZp667A205, FLJ39873, VSIG9, VSTM3" ENSG00000181847 "T cell immunoreceptor with Ig and ITIM domains" Q495A1 3 114276913-114310288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 49.8;lymphoid tissue: 25.9" "Cell type enriched" "Detected in some" 22 "T-cells: 83.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 49.8" "Lineage enriched" "Detected in many" 11 "T-cells: 49.8" "Cell line enhanced" "Detected in some" "HDLM-2: 4.9;Karpas-707: 1.7;NTERA-2: 1.9;U-266/84: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.24e-2)" "prognostic favorable (5.43e-4)" "unprognostic (1.22e-3)" "unprognostic (2.22e-6)" "unprognostic (9.84e-2)" "prognostic favorable (3.96e-4)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (5.50e-4)" "unprognostic (3.51e-3)" "unprognostic (1.78e-1)" "unprognostic (3.15e-1)" "unprognostic (2.30e-8)" "unprognostic (3.54e-2)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (6.18e-3)" 1.4 0.3 0.4 20.2 0.7 0.9 1.1 0.2 0.3 0.5 1.2 0.2 1.2 0.8 1.4 1.1 1.1 0.9 3.8 0.8 0.4 0.7 1.3 1.6 5.0 25.9 0.6 0.3 0.4 0.3 0.0 0.6 0.5 0.4 1.0 1.4 1.1 4.4 1.9 0.6 0.6 8.0 0.3 1.5 13.4 2.0 0.6 0.1 4.3 1.6 1.7 20.2 4.1 1.0 0.4 0.2 0.2 0.0 4.4 49.8 5.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.5 0.3 0.0 0.3 0.0 0.1 0.0 0.5 4.9 0.0 0.1 0.9 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.9 0.9 0.0 0.1 1.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.5 0.0 0.4 0.0 0.4 0.5 0.1 0.1 1.4 1.9 0.0 0.9 0.3 0.0 0.0 0.0 0.0 8.5 0.0 0.9 0.4 13.6 25.0 0.0 0.2 1.5 11.4 0.2 4.4 0.0 0.2 49.8 5.4 0.4 0.7 0.2 0.3 0.4 0.7 0.6 0.3 0.4 0.1 0.0 3.5 1.9 0.0 2.7 0.4 0.3 0.0 0.0 2.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 3.7 2.4 0.0 0.0 0.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.6 2.9 0.0 83.0 0.0 0.0 TIMD4 ENSG00000145850 "T cell immunoglobulin and mucin domain containing 4" Q96H15 5 156919282-156963255 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "liver: 32.0;lymphoid tissue: 83.9;testis: 58.9" "Group enriched" "Detected in some" 24 "Early spermatids: 1044.9;Late spermatids: 1409.2" "Cancer enriched" "Detected in some" 10 "renal cancer: 6.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4" "Lineage enriched" "Detected in single" 14 "T-cells: 6.4" "Group enriched" "Detected in some" 18 "U-266/70: 46.8;U-266/84: 12.7" "HPA015625, CAB026027" Approved Approved "Plasma membrane" NA NA 18000000 "Plasma membrane" "CAB026027: , HPA015625: AB_1858018" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.73e-1)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" "unprognostic (3.01e-2)" "unprognostic (1.10e-1)" "unprognostic (3.11e-1)" "unprognostic (3.42e-1)" "unprognostic (8.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.90e-2)" "prognostic favorable (3.37e-4)" "unprognostic (1.31e-2)" "unprognostic (4.07e-1)" "unprognostic (3.27e-2)" "unprognostic (2.08e-2)" 6.7 0.4 0.4 3.5 0.4 5.3 0.5 0.4 0.4 0.4 1.3 0.0 0.0 0.0 0.4 1.0 1.5 0.4 0.3 0.8 0.4 0.4 1.7 32.0 0.6 83.9 0.5 0.0 0.4 0.4 0.0 0.4 2.8 0.0 1.1 0.1 0.0 6.5 0.0 0.7 0.4 1.1 0.2 0.5 12.5 0.4 58.9 0.0 21.7 0.8 0.2 8.5 5.3 0.4 0.4 0.0 0.0 0.0 0.0 6.4 1.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 46.8 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 2.3 4.5 0.0 0.0 3.0 3.0 0.0 0.0 0.0 0.0 6.4 1.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 1044.9 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 34.7 0.0 0.0 0.0 52.0 1409.2 13.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.6 0.0 12.9 0.0 10.9 4.3 0.0 0.2 0.0 0.0 0.0 TIMM23 TIM23 ENSG00000265354 "Translocase of inner mitochondrial membrane 23" O14925 10 45972449-46003734 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA031408 Approved Supported Mitochondria NA NA Mitochondria "HPA031408: AB_10600828" "unprognostic (4.09e-2)" "unprognostic (1.31e-1)" "unprognostic (9.01e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (1.15e-2)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.74e-1)" "unprognostic (3.90e-2)" "prognostic favorable (6.79e-4)" "unprognostic (4.41e-2)" "unprognostic (7.30e-2)" "unprognostic (3.24e-1)" "unprognostic (7.78e-2)" "unprognostic (5.54e-2)" "unprognostic (7.20e-2)" "unprognostic (2.21e-1)" 5.7 4.6 1.2 6.8 3.8 6.0 13.6 4.1 8.6 2.6 4.2 1.5 5.8 6.1 2.9 7.3 4.2 2.4 3.2 11.5 5.3 6.6 8.3 4.8 9.9 1.6 2.5 2.2 2.8 3.0 3.4 8.1 5.5 3.4 4.1 2.6 7.5 5.2 16.2 2.4 3.5 3.6 2.2 2.5 2.8 17.2 1.4 4.5 4.5 4.0 4.4 3.3 1.7 29.5 39.7 18.5 45.3 26.7 29.8 39.6 40.7 43.0 28.6 28.8 23.8 22.3 27.9 33.7 40.5 41.1 43.7 54.2 32.5 36.5 28.0 35.4 29.5 35.2 43.6 36.0 40.8 27.0 43.0 23.3 32.3 58.2 38.4 43.2 26.1 26.7 32.2 35.1 50.0 17.1 37.9 31.9 41.1 20.6 36.0 40.8 38.5 60.1 34.5 30.2 13.4 29.9 27.6 26.7 46.1 28.6 33.6 30.9 18.7 41.7 33.7 23.1 44.1 25.9 27.8 19.9 34.7 25.4 47.9 22.1 36.4 51.3 37.0 62.6 16.5 15.7 35.6 18.5 28.0 45.3 28.7 29.5 27.1 29.8 39.7 27.9 24.6 27.2 8.2 26.7 39.3 32.8 29.6 39.6 8.9 17.4 24.2 12.4 19.5 13.0 86.5 30.6 28.1 19.4 12.2 7.9 39.3 38.1 39.5 62.9 13.7 15.7 23.3 26.2 38.0 14.2 16.2 26.6 23.3 30.2 0.0 9.8 17.8 17.5 15.7 16.4 18.4 21.9 33.3 15.8 22.1 29.8 14.0 11.0 47.3 9.2 6.5 16.5 85.7 48.5 18.9 29.7 13.8 23.3 16.0 TIMP1 "CLGI, EPO, TIMP" ENSG00000102265 "TIMP metallopeptidase inhibitor 1" P01033 X 47582313-47586789 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 293.3" "Cell type enhanced" "Detected in many" 7 "Ito cells: 2535.0;Leydig cells: 1644.5;Macrophages: 2104.1;Peritubular cells: 1468.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 164.6;ASC TERT1: 220.3;HSkMC: 150.9;U-87 MG: 142.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB022360, HPA053417" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 127000000 750000000 "Golgi apparatus" "CAB022360: , HPA053417: AB_2682142" "unprognostic (5.86e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.09e-4)" "unprognostic (4.68e-2)" "unprognostic (1.81e-2)" "unprognostic (1.07e-3)" "unprognostic (4.99e-2)" "unprognostic (8.24e-3)" "unprognostic (9.12e-3)" "unprognostic (9.69e-2)" "unprognostic (9.10e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (2.90e-11)" "unprognostic (1.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (2.66e-1)" 80.2 82.3 6.3 154.0 12.8 9.2 31.8 3.3 8.4 63.5 29.1 6.5 27.2 6.1 48.9 109.6 34.9 53.5 110.9 105.7 9.2 5.5 71.2 115.9 144.8 293.3 8.4 4.8 149.3 22.2 41.8 48.7 125.5 29.5 62.9 19.0 33.4 45.9 42.0 26.1 11.6 13.2 64.5 14.6 69.3 19.3 71.9 4.6 8.8 98.6 14.6 34.8 121.0 46.8 2.3 56.8 57.1 91.5 9.4 26.4 39.7 9.6 16.1 7.9 93.2 164.6 220.3 1.9 104.6 86.5 32.6 26.4 6.3 18.1 0.1 13.8 134.5 18.9 9.5 4.3 44.4 21.1 19.5 10.2 9.9 11.8 9.8 109.5 6.6 126.8 150.9 11.4 99.4 21.2 38.0 14.6 0.0 15.3 7.3 54.0 18.8 0.1 25.5 8.8 11.5 33.8 0.1 16.2 8.6 52.6 6.7 0.1 0.4 62.0 0.4 13.2 15.3 0.8 12.9 14.1 48.9 51.5 57.6 10.2 3.1 6.5 0.3 142.1 16.0 31.7 29.5 54.6 0.8 16.2 91.5 16.0 2.3 26.4 14.3 56.8 1.2 8.6 7.7 57.1 9.4 83.6 1.6 10.7 39.7 6.3 12.8 3.3 5.3 9.2 5.5 8.4 4.8 29.5 4.6 101.3 235.0 76.3 526.8 205.4 19.6 8.1 374.5 117.8 310.5 125.6 0.0 21.5 0.0 407.2 18.1 600.1 19.3 0.0 372.2 201.1 871.1 751.9 475.1 110.9 305.2 0.0 266.3 2535.0 691.3 38.8 1644.5 2104.1 485.9 250.7 58.9 120.3 535.0 52.1 1468.0 7.0 6.7 679.1 606.7 17.9 10.8 152.7 37.6 115.1 45.8 406.7 TIMP2 CSC-21K ENSG00000035862 "TIMP metallopeptidase inhibitor 2" P16035 17 78852977-78925387 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 269.8" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 344.4;Leydig cells: 327.4;Peritubular cells: 724.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in many" 4 "granulocytes: 13.3;monocytes: 5.0" "Cell line enhanced" "Detected in many" "ASC diff: 126.3;ASC TERT1: 155.4;BJ hTERT+: 88.3;fHDF/TERT166: 96.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010203 Approved "Secreted to extracellular matrix" NA NA 83000000 "CAB010203: AB_2204966" "unprognostic (1.03e-1)" "unprognostic (1.71e-2)" "unprognostic (9.81e-2)" "unprognostic (1.76e-3)" "unprognostic (3.24e-2)" "unprognostic (3.05e-1)" "unprognostic (4.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.38e-3)" "unprognostic (4.62e-2)" "unprognostic (2.05e-1)" "unprognostic (2.77e-3)" 75.2 35.1 30.9 17.7 18.9 3.4 45.6 4.6 25.8 95.8 40.5 36.8 28.2 12.9 87.9 41.5 37.4 39.8 72.3 38.5 23.2 29.6 21.1 12.2 38.4 15.4 25.3 23.2 182.4 14.4 15.8 17.2 269.8 34.0 44.6 20.3 49.7 16.9 51.6 24.5 38.4 22.0 70.7 32.6 37.9 24.2 51.7 26.1 28.4 25.3 24.0 11.3 60.2 58.1 0.2 2.1 13.3 5.0 0.2 0.3 0.8 15.0 7.6 8.6 16.4 126.3 155.4 4.6 53.3 88.3 26.1 20.8 2.7 26.4 0.0 18.8 96.8 28.7 3.0 2.6 2.3 27.4 0.3 1.5 0.0 15.4 4.2 37.5 0.2 0.1 61.0 1.1 25.7 4.1 67.7 34.5 4.9 0.0 0.0 26.8 1.7 15.4 2.6 1.5 3.0 11.3 10.5 19.8 6.4 16.6 0.2 4.4 27.1 33.3 15.8 67.9 10.9 8.0 3.7 40.9 70.0 13.4 40.6 9.2 7.8 6.4 0.1 16.0 2.8 33.7 0.0 5.0 6.8 0.0 3.3 0.0 0.1 0.1 0.0 2.1 0.2 0.3 0.3 13.3 0.2 3.8 1.4 0.1 0.8 30.9 18.9 4.6 25.8 23.2 29.6 25.3 23.2 34.0 26.1 104.2 39.6 4.5 8.0 87.8 30.2 35.8 50.9 0.0 22.7 24.4 7.9 2.7 0.0 76.1 113.2 98.4 11.2 0.0 19.1 82.6 213.2 14.6 6.9 3.2 177.9 3.2 7.5 284.2 170.2 344.4 327.4 101.4 261.5 11.8 7.5 36.2 71.2 1.5 724.5 0.6 11.7 90.5 173.1 5.9 4.5 66.4 12.4 4.9 1.5 6.0 TIMP3 SFD ENSG00000100234 "TIMP metallopeptidase inhibitor 3" P35625 22 32801701-32863043 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 392.5;retina: 247.1" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 1295.0;Peritubular cells: 1818.1;Sertoli cells: 2289.5;Smooth muscle cells: 1077.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 2.2" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC diff: 57.0;BJ: 127.4;BJ hTERT+: 56.3;fHDF/TERT166: 115.8;WM-115: 97.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (4.98e-2)" "unprognostic (1.77e-3)" "unprognostic (1.60e-1)" "unprognostic (8.53e-4)" "unprognostic (1.67e-2)" "unprognostic (1.05e-2)" "unprognostic (7.01e-2)" "unprognostic (3.22e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (3.92e-1)" "unprognostic (1.95e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.66e-3)" "unprognostic (1.44e-2)" "unprognostic (2.55e-3)" "unprognostic (3.11e-2)" 130.4 44.6 8.7 15.8 10.1 0.1 103.3 5.1 12.1 68.3 25.4 13.5 27.8 4.5 65.1 47.4 40.2 51.9 39.9 75.0 10.2 8.5 54.0 14.1 115.4 31.3 11.4 8.7 25.3 11.8 15.6 21.6 392.5 19.1 44.2 12.6 247.1 24.3 55.0 22.7 22.9 16.2 58.3 7.2 35.1 22.9 43.2 7.1 1.2 48.9 29.4 10.1 37.5 38.3 0.4 0.0 0.0 0.0 2.2 0.0 0.0 2.0 0.0 1.8 0.3 57.0 32.1 0.1 127.4 56.3 10.4 12.4 2.2 0.0 0.0 3.1 115.8 0.4 1.9 0.3 5.2 15.1 0.0 1.5 15.7 2.7 5.5 22.4 0.0 6.6 5.3 13.3 18.5 1.0 0.3 0.0 0.0 0.0 0.1 4.8 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 10.4 1.3 1.8 2.6 0.0 33.5 31.0 0.0 0.1 0.0 0.8 2.8 27.1 2.0 0.0 0.0 0.0 26.0 0.0 97.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.7 10.1 5.1 12.1 10.2 8.5 11.4 8.7 19.1 7.1 339.5 47.1 4.5 518.2 68.7 3.1 194.1 5.1 12.0 26.1 48.8 3.9 374.1 3.3 1.3 11.5 516.3 0.0 0.0 0.6 213.4 444.0 99.6 85.6 98.5 105.1 3.2 1.7 734.7 49.2 29.3 1295.0 27.8 72.6 1.0 0.0 169.4 1.1 0.0 1818.1 11.1 3.5 2289.5 1077.9 6.5 5.1 49.3 676.6 10.0 0.2 134.4 TIMP4 ENSG00000157150 "TIMP metallopeptidase inhibitor 4" Q99727 3 12153051-12159351 "Plasma proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 72.2;breast: 97.5" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 23.3;Ito cells: 14.7;Sertoli cells: 32.3" "Cancer enriched" "Detected in many" 13 "glioma: 66.4" "Region enriched" "Detected in all" 5 "cerebellum: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 54.7;ASC TERT1: 13.7;HSkMC: 23.7;NTERA-2: 13.6;U-87 MG: 13.9" "Region enhanced" "Detected in all" "cerebellum: 118.9" "Region enriched" "Detected in all" 5 "cerebellum: 100.1" "Secreted to extracellular matrix" NA NA "unprognostic (2.99e-2)" "unprognostic (5.14e-3)" "unprognostic (1.02e-2)" "unprognostic (2.10e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-4)" "unprognostic (9.33e-3)" "unprognostic (4.26e-3)" "unprognostic (1.36e-1)" "unprognostic (1.74e-2)" "unprognostic (3.78e-1)" "unprognostic (6.81e-2)" "unprognostic (4.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (6.66e-5)" "unprognostic (2.86e-1)" 72.2 4.3 1.9 2.2 1.6 0.7 97.5 17.8 11.2 2.6 11.7 2.4 0.7 1.1 1.9 0.9 3.2 1.6 2.9 10.9 1.7 1.5 1.9 0.8 2.6 6.0 3.1 1.5 1.2 1.5 1.2 3.2 4.6 3.8 2.9 2.4 2.4 3.1 1.6 7.7 1.7 2.4 2.4 2.9 0.8 2.3 1.8 1.2 0.1 6.1 3.8 0.6 3.7 9.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 6.0 0.2 0.0 54.7 13.7 6.7 0.2 2.2 0.2 0.3 0.1 0.0 0.0 0.5 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.0 0.0 3.5 0.2 8.5 0.0 0.0 23.7 0.5 1.4 0.0 0.4 0.0 0.0 0.1 4.4 0.0 0.1 0.0 0.0 13.6 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 13.9 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 17.8 1.3 1.7 1.5 3.1 1.5 3.8 1.2 0.0 0.0 0.0 1.2 0.1 0.3 4.8 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.7 1.1 2.9 0.7 23.3 2.4 1.9 1.4 5.6 0.0 0.0 2.9 0.0 6.3 14.7 0.6 4.8 11.2 0.1 3.3 0.0 2.6 0.7 2.7 2.8 2.5 0.3 0.0 32.3 3.4 0.0 0.0 0.1 0.1 0.0 2.3 2.0 TINAG ENSG00000137251 "Tubulointerstitial nephritis antigen" Q9UJW2 6 54307859-54390152 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "intestine: 27.2;kidney: 53.0" "Group enriched" "Detected in some" 6 "Enterocytes: 52.3;Proximal tubular cells: 176.4" "Cancer enhanced" "Detected in some" "renal cancer: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 34 "RPTEC TERT1: 46.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035427, HPA073753" Approved "Secreted to extracellular matrix" NA NA 26000 "HPA035427: AB_10601822, HPA073753: " "unprognostic (7.62e-3)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.05e-5)" "unprognostic (7.27e-2)" "unprognostic (5.99e-3)" "prognostic favorable (8.75e-5)" "unprognostic (7.10e-2)" 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.2 0.0 9.5 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 53.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.2 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 7.0 0.0 0.0 19.9 0.0 0.7 0.0 52.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 1.3 10.5 0.0 176.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 TINAGL1 "ARG1, LCN7, LIECG3, P3ECSL, TINAGRP" ENSG00000142910 "Tubulointerstitial nephritis antigen like 1" Q9GZM7 1 31576485-31587686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.4" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 1103.3;Syncytiotrophoblasts: 1627.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 58.8;CAPAN-2: 32.1;EFO-21: 74.1;HaCaT: 32.2;HBEC3-KT: 37.9;HUVEC TERT2: 31.4;TIME: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA048695 Approved "Secreted to extracellular matrix" NA NA 170000 "HPA048695: AB_2680497" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.80e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-3)" "unprognostic (8.29e-3)" "unprognostic (6.02e-3)" "unprognostic (4.18e-1)" "unprognostic (6.96e-2)" "unprognostic (7.02e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.65e-6)" "unprognostic (7.42e-2)" "unprognostic (6.64e-2)" "prognostic favorable (9.64e-4)" "unprognostic (3.43e-2)" 43.0 8.4 2.2 11.6 3.4 0.8 60.0 0.8 4.4 30.2 22.0 2.9 14.2 12.0 25.7 23.4 23.7 17.0 36.1 52.6 3.4 2.3 53.3 14.7 24.4 12.8 3.9 3.3 15.5 7.4 3.2 5.6 128.4 5.0 19.4 7.9 12.0 24.2 20.0 19.6 7.6 15.9 22.5 2.7 34.3 16.3 10.3 2.1 0.8 30.7 11.0 6.4 39.8 20.0 1.1 0.6 4.8 0.5 1.5 0.8 0.0 16.7 0.0 0.0 0.1 0.1 0.0 58.8 2.6 0.3 0.1 0.0 7.9 32.1 0.0 74.1 2.3 1.2 32.2 0.0 37.9 0.0 0.1 0.0 0.0 1.4 2.0 0.8 0.0 0.1 0.0 6.9 0.0 1.4 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 9.1 1.0 0.0 0.0 0.0 10.2 12.9 0.0 0.1 6.8 22.7 0.7 3.6 1.3 0.0 67.1 0.0 17.0 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.6 4.8 0.5 0.5 0.8 0.3 0.5 0.4 0.6 0.5 0.1 1.1 0.8 0.8 2.7 1.5 0.5 0.6 0.5 0.0 2.2 3.4 0.8 4.4 3.4 2.3 3.9 3.3 5.0 2.1 8.9 7.2 5.3 91.5 9.7 0.0 41.9 38.2 1.4 7.9 125.6 0.0 1103.3 1.7 361.6 1.2 133.2 75.1 0.0 83.6 184.7 19.9 41.9 14.9 1.1 78.0 0.0 10.9 249.8 10.8 0.4 6.9 5.7 21.9 3.6 27.7 0.3 206.9 37.7 3.9 67.7 0.4 420.4 356.4 0.2 0.9 5.6 1627.5 6.4 49.2 157.0 TINCR "FLJ90734, LINC00036, NCRNA00036, onco-lncRNA-16, PLAC2" ENSG00000223573 "TINCR ubiquitin domain containing" 19 5558167-5578349 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "placenta: 50.0;skin 1: 45.0" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 41.2;Cytotrophoblasts: 48.9;Extravillous trophoblasts: 85.0;Suprabasal keratinocytes: 80.7;Syncytiotrophoblasts: 171.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 28.1;HaCaT: 18.6;MCF7: 7.5;SK-BR-3: 29.5" "Low region specificity" "Detected in single" NA NA "unprognostic (4.75e-2)" "unprognostic (2.99e-2)" "unprognostic (7.78e-2)" "unprognostic (1.78e-3)" "unprognostic (3.69e-1)" "unprognostic (2.54e-3)" "unprognostic (3.38e-2)" "unprognostic (3.95e-1)" "unprognostic (3.07e-1)" "unprognostic (1.66e-2)" "unprognostic (8.87e-2)" "unprognostic (1.24e-1)" "unprognostic (0.00e+0)" "unprognostic (4.22e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (7.32e-2)" 0.0 0.4 1.0 0.0 0.7 0.6 1.7 0.0 1.0 1.7 0.4 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 1.8 50.0 0.6 1.5 0.6 0.1 0.2 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 5.3 3.8 0.3 0.4 2.4 3.0 5.7 1.1 1.6 1.3 0.3 1.0 0.8 0.1 0.2 0.3 0.5 28.1 0.1 0.0 0.0 0.1 0.4 3.3 0.2 0.3 0.1 0.3 18.6 0.4 0.2 0.2 0.3 0.6 0.2 1.0 0.2 0.1 0.3 0.3 0.2 6.1 0.1 0.1 0.2 0.0 1.5 0.1 0.5 0.0 7.5 0.1 0.4 0.5 0.7 1.4 0.6 0.2 0.6 0.0 1.9 0.4 0.1 2.0 29.5 2.9 2.8 3.5 0.2 0.0 0.3 0.2 0.6 0.0 0.7 0.2 0.5 0.1 0.3 0.6 5.0 1.1 1.2 1.0 0.7 0.7 1.9 0.9 0.9 0.3 2.4 1.0 1.3 5.7 1.6 0.9 3.0 1.0 0.3 11.9 1.7 0.0 4.8 41.2 3.4 0.9 2.5 1.4 2.3 1.8 0.0 48.9 10.0 0.0 0.2 1.1 0.4 0.0 0.4 85.0 2.6 4.8 0.0 0.0 5.7 0.0 1.7 1.8 2.7 0.0 0.6 1.2 6.8 0.0 2.7 3.8 0.1 5.1 0.7 0.1 2.4 0.0 1.2 0.5 1.9 80.7 171.1 0.0 0.4 8.3 TINF2 TIN2 ENSG00000092330 "TERF1 interacting nuclear factor 2" Q9BSI4 14 24239643-24242674 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "parathyroid gland: 268.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059061, HPA069807" Enhanced "Nuclear bodies" "Intracellular and membrane" NA NA "Nuclear bodies" "HPA059061: AB_2683895, HPA069807: AB_2686203" "prognostic favorable (4.96e-4)" "unprognostic (8.58e-2)" "unprognostic (1.53e-1)" "unprognostic (5.47e-2)" "unprognostic (3.20e-2)" "unprognostic (2.78e-2)" "unprognostic (4.75e-2)" "unprognostic (2.50e-1)" "unprognostic (4.70e-1)" "unprognostic (8.05e-2)" "unprognostic (1.05e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-3)" "unprognostic (2.04e-3)" "unprognostic (2.17e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" 15.8 27.8 10.4 17.0 11.3 13.3 18.2 10.1 16.7 14.5 13.1 17.9 12.9 9.5 16.8 16.1 22.4 12.6 13.7 12.4 9.3 8.9 14.8 11.4 18.8 27.0 13.7 9.8 15.4 17.1 268.9 11.9 15.3 10.9 13.5 12.5 11.3 14.8 15.5 14.9 13.9 12.9 15.1 11.7 21.0 14.5 7.7 12.4 26.1 16.6 12.6 19.5 14.9 14.2 27.3 17.7 46.9 21.4 25.4 27.4 28.8 11.8 10.8 15.7 8.2 17.4 13.0 8.0 12.2 15.5 17.9 16.8 4.7 13.4 17.4 7.0 17.2 12.9 11.6 8.8 10.8 11.3 22.1 4.5 10.9 10.0 18.6 15.0 11.5 15.7 14.2 17.6 14.4 13.7 16.8 19.3 16.7 4.2 22.3 14.4 13.0 17.2 5.7 3.6 12.6 13.5 14.2 10.0 12.6 15.9 17.0 9.7 9.0 12.7 12.1 10.9 10.9 8.6 7.4 15.4 8.4 10.3 14.2 9.5 17.2 12.2 9.9 10.1 6.5 12.4 41.6 20.6 46.9 27.4 21.4 21.8 25.7 21.6 25.5 17.7 27.3 22.8 22.8 26.0 25.4 19.6 15.0 25.2 28.8 10.4 11.3 10.1 16.7 9.3 8.9 13.7 9.8 10.9 12.4 14.9 26.0 52.5 56.3 14.9 21.3 12.1 5.1 4.0 25.0 17.4 7.9 26.9 29.9 28.2 6.3 25.4 18.8 0.0 41.1 22.6 22.4 33.0 39.3 16.3 32.0 14.3 12.6 20.3 21.3 7.8 21.9 28.3 20.3 43.3 15.6 37.8 31.0 23.0 28.0 18.7 15.9 25.8 31.1 21.2 20.9 22.0 35.4 55.8 15.2 48.8 TJP3 ZO-3 ENSG00000105289 "Tight junction protein 3" O95049 19 3708109-3750813 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.0" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 259.3;Enterocytes: 138.3;Paneth cells: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5" "Lineage enriched" "Detected in many" 6 "T-cells: 6.2" "Cell line enhanced" "Detected in some" "BEWO: 22.2;CAPAN-2: 22.3;MCF7: 9.8;OE19: 17.4;SK-BR-3: 13.0;T-47d: 27.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB013244, HPA046863, HPA053337" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.83e-6)" "unprognostic (2.78e-1)" "prognostic favorable (9.52e-4)" "unprognostic (1.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.52e-1)" "unprognostic (6.52e-2)" "unprognostic (2.15e-2)" "unprognostic (1.78e-1)" "prognostic favorable (9.36e-8)" "unprognostic (8.58e-3)" "unprognostic (5.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.62e-3)" 0.2 0.0 0.3 8.4 0.4 0.0 3.6 0.2 0.3 3.3 34.9 0.7 15.0 23.0 0.7 5.0 16.0 7.9 22.8 0.6 0.5 0.1 4.4 8.0 10.1 0.6 0.2 0.2 2.2 5.9 2.0 1.6 2.7 1.1 2.6 7.7 1.6 26.1 20.5 0.4 4.3 47.0 0.6 0.2 0.4 15.2 1.4 0.2 0.6 5.5 2.6 8.3 4.5 3.4 1.0 0.0 0.0 0.0 0.0 6.2 1.7 0.1 3.3 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 6.5 22.3 4.0 0.6 0.0 0.0 5.2 0.3 0.0 0.0 0.2 0.1 0.0 0.5 1.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.0 9.8 0.0 0.1 0.4 17.4 0.1 0.0 0.0 2.9 0.7 3.4 0.1 0.1 0.8 13.0 0.0 1.7 27.4 0.1 0.0 0.0 0.5 0.0 0.0 0.8 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 6.2 0.7 4.8 3.8 0.0 1.0 5.3 1.9 0.0 0.0 0.0 0.0 5.5 1.7 0.3 0.4 0.2 0.3 0.5 0.1 0.2 0.2 1.1 0.2 8.9 10.7 0.0 6.7 0.0 0.0 0.8 30.6 34.8 12.5 29.6 0.0 26.9 16.6 16.8 259.3 0.0 138.3 0.0 21.0 3.5 0.2 4.8 4.6 4.9 2.4 0.0 12.0 0.0 0.0 10.7 1.7 0.1 3.3 0.0 40.6 0.0 16.7 101.7 1.1 5.1 0.0 0.0 0.2 2.1 3.3 0.1 33.6 1.5 46.1 23.1 TK1 ENSG00000167900 "Thymidine kinase 1" P04183 17 78174075-78187233 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA synthesis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0" "Cell type enhanced" "Detected in many" 14 "Extravillous trophoblasts: 178.8;Hofbauer cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 21.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" CAB004683 Enhanced NA Yes "CAB004683: AB_437067" "unprognostic (7.09e-2)" "unprognostic (1.17e-3)" "unprognostic (1.82e-1)" "unprognostic (2.14e-3)" "unprognostic (3.22e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.87e-4)" "prognostic unfavorable (3.03e-5)" "unprognostic (4.05e-2)" "unprognostic (3.18e-3)" "unprognostic (6.64e-3)" "unprognostic (2.76e-2)" "prognostic unfavorable (6.50e-11)" "unprognostic (5.55e-3)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (4.94e-2)" 5.3 2.0 2.1 21.4 4.5 32.8 4.8 1.1 1.9 3.7 11.4 2.2 1.9 8.5 2.4 4.8 18.9 2.2 7.0 4.3 1.6 0.7 7.9 6.2 9.3 15.7 3.1 1.6 2.1 3.6 0.1 1.3 8.6 2.1 2.3 7.9 0.5 4.6 2.0 2.0 6.2 8.5 4.4 1.7 9.0 9.4 3.6 1.6 41.8 1.3 33.0 20.5 3.1 5.8 4.0 2.1 1.1 1.2 6.2 21.2 3.5 65.8 54.7 10.9 13.8 1.0 4.3 7.1 32.7 17.2 48.7 67.6 48.3 27.8 21.4 11.5 19.6 20.3 30.0 9.9 29.2 25.2 7.4 36.5 37.8 19.6 31.6 0.3 16.0 24.4 2.1 1.0 25.4 3.5 3.4 19.8 7.5 23.2 47.5 18.6 49.1 8.0 9.0 5.6 38.5 38.1 21.7 44.2 47.8 12.9 21.4 4.9 14.5 25.1 68.9 9.2 10.0 46.5 21.5 9.1 47.9 47.0 34.1 42.0 20.0 10.4 27.5 23.5 10.8 21.5 0.0 0.7 0.0 1.1 1.2 0.5 4.0 5.3 2.7 2.1 1.2 0.3 1.4 1.1 6.2 1.0 0.7 21.2 3.5 2.1 4.5 1.1 1.9 1.6 0.7 3.1 1.6 2.1 1.6 0.0 2.4 8.2 6.8 25.2 0.0 0.6 2.5 4.0 7.9 12.2 0.0 46.0 6.6 6.3 2.6 3.2 3.9 46.7 9.8 178.8 7.2 3.3 0.0 8.6 55.5 0.0 5.2 9.8 10.8 4.2 0.6 11.3 3.3 8.2 12.4 0.0 11.2 8.6 0.7 14.7 0.0 0.0 2.2 1.1 18.4 9.8 42.7 7.2 25.1 12.3 TKFC "DAK, DKFZP586B1621, NET45" ENSG00000149476 "Triokinase and FMN cyclase" Q3LXA3 11 61333210-61353295 "Enzymes, Predicted intracellular proteins" "Kinase, Lyase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.2;liver: 42.8" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Proximal tubular cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 40.5;RPMI-8226: 42.7;T-47d: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039486, HPA048186" Enhanced Approved Nucleoplasm,Cytosol NA NA 4800000 Cytosol Nucleoplasm "HPA039486: AB_10795402, HPA048186: AB_2680305" "unprognostic (4.00e-1)" "unprognostic (3.13e-1)" "unprognostic (7.42e-2)" "prognostic favorable (1.32e-5)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (3.02e-2)" "unprognostic (2.81e-3)" "unprognostic (1.49e-1)" "unprognostic (2.47e-1)" "unprognostic (1.51e-1)" "unprognostic (2.15e-1)" "prognostic favorable (8.38e-5)" "unprognostic (2.07e-2)" "unprognostic (8.96e-2)" "unprognostic (3.30e-1)" "unprognostic (4.02e-1)" 3.1 34.7 3.6 6.1 5.3 5.3 4.6 3.7 7.3 3.4 43.4 7.6 8.0 69.5 4.6 7.8 6.2 5.9 8.8 2.8 3.1 2.6 17.4 42.8 3.5 5.2 3.3 5.3 4.5 9.8 3.0 5.5 3.9 4.4 5.0 2.3 7.3 7.2 7.1 4.6 6.1 90.2 2.6 3.1 5.4 5.7 17.1 3.4 5.5 6.4 6.3 6.7 5.4 3.9 9.7 18.4 5.4 11.4 5.3 10.9 7.8 6.1 15.6 2.7 9.5 3.4 3.7 7.7 3.6 3.9 3.4 2.2 7.1 14.8 7.6 12.6 2.6 3.5 8.6 5.1 6.7 1.1 13.1 6.8 4.7 8.2 40.5 5.9 3.9 7.9 5.9 4.6 3.2 11.2 2.9 3.3 5.3 8.2 14.8 2.4 27.9 3.5 3.6 7.5 5.8 10.7 6.2 4.3 42.7 5.4 10.9 10.6 9.5 6.6 11.6 6.0 1.9 42.8 2.8 4.0 6.7 7.0 5.3 2.1 27.4 22.6 6.9 6.9 3.7 6.1 2.3 11.4 5.4 6.7 6.8 8.6 9.7 7.8 6.5 18.4 9.7 5.6 5.9 0.9 5.3 5.3 9.0 10.9 7.8 3.6 5.3 3.7 7.3 3.1 2.6 3.3 5.3 4.4 3.4 0.0 12.6 6.7 10.8 0.0 12.9 3.4 12.7 20.1 12.5 14.0 13.7 25.7 24.9 15.5 7.9 4.5 5.4 0.0 12.8 4.4 3.0 11.6 7.0 92.7 14.9 7.9 12.9 6.2 18.3 9.3 14.1 5.9 0.0 27.9 13.9 8.7 12.3 18.1 21.2 63.4 16.0 6.5 2.4 39.2 14.5 0.0 12.7 5.7 18.4 10.6 TKT ENSG00000163931 Transketolase P29401 3 53224707-53256052 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 216.3" "Cell type enhanced" "Detected in all" 5 "Kupffer cells: 587.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5" "Group enriched" "Detected in all" 8 "dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029480, HPA029481" Enhanced Enhanced Nucleoplasm NA NA 190000000 Nucleoplasm "HPA029480: AB_10599307, HPA029481: AB_10601895" "unprognostic (5.05e-2)" "unprognostic (3.34e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (7.21e-6)" "unprognostic (6.78e-2)" "unprognostic (1.70e-1)" "unprognostic (4.73e-2)" "unprognostic (3.06e-3)" "unprognostic (1.36e-2)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.07e-1)" "unprognostic (3.29e-1)" "unprognostic (9.90e-3)" 53.6 37.0 21.2 24.1 26.0 216.3 70.1 18.1 24.3 19.0 24.3 21.1 9.9 31.8 16.9 9.5 60.4 21.8 36.5 15.3 19.4 23.0 51.9 27.4 50.1 45.6 33.4 16.0 35.2 69.9 22.5 16.9 29.8 28.7 25.2 19.6 17.5 21.0 21.6 5.2 16.8 22.5 34.5 28.2 45.6 24.5 10.8 23.3 44.8 67.7 37.9 25.1 58.2 57.3 6.8 32.5 60.1 63.0 4.7 5.7 37.6 31.4 159.3 22.8 25.3 50.9 62.2 46.6 21.3 37.0 37.0 35.4 44.0 81.1 39.6 10.3 31.1 71.5 45.6 39.5 80.3 11.0 13.2 21.9 26.4 111.4 66.0 62.3 32.2 17.8 45.0 46.2 44.2 22.8 101.2 46.5 33.7 18.7 17.3 15.0 38.5 33.6 36.1 77.4 61.4 38.5 20.3 10.4 73.6 57.8 53.5 14.8 11.0 39.7 63.6 38.3 72.9 19.8 44.6 34.8 11.4 17.7 33.7 40.7 10.0 18.7 23.7 25.0 32.7 21.2 7.0 63.0 41.5 3.0 31.0 3.8 6.8 4.4 3.4 32.5 3.5 4.6 3.4 60.1 4.7 35.5 5.5 5.7 37.6 21.2 26.0 18.1 24.3 19.4 23.0 33.4 16.0 28.7 23.3 125.0 107.1 122.7 318.5 70.5 32.5 12.0 68.8 60.2 69.4 59.3 27.5 317.9 68.0 167.6 5.0 48.1 125.0 23.3 233.6 204.0 47.6 102.3 61.2 73.1 233.2 35.0 50.5 56.4 587.5 2.7 145.6 247.7 72.6 160.5 113.7 78.1 222.7 69.1 100.4 170.5 36.1 51.8 72.1 14.1 21.1 58.6 345.9 84.1 213.7 357.0 TKTL1 "TKR, TKT2" ENSG00000007350 "Transketolase like 1" P51854 X 154295671-154330350 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 50 "blood: 28.6;testis: 103.6" "Cell type enriched" "Detected in some" 14 "Spermatogonia: 515.6" "Cancer enriched" "Detected in many" 8 "testis cancer: 44.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "eosinophil: 28.6;gdT-cell: 12.0" "Group enriched" "Detected in many" 6 "granulocytes: 28.6;T-cells: 12.0" "Cell line enriched" "Detected in single" 157 "THP-1: 102.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA000505, HPA029155, CAB032191" Enhanced Enhanced Cytosol NA NA Cytosol "CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134" "unprognostic (2.69e-1)" "unprognostic (1.92e-1)" "unprognostic (1.98e-1)" "unprognostic (5.80e-3)" "unprognostic (2.43e-1)" "unprognostic (1.83e-1)" "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "unprognostic (2.10e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.34e-2)" "unprognostic (3.90e-2)" "unprognostic (5.04e-2)" "unprognostic (2.38e-1)" 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 103.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.6 0.1 3.3 12.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 102.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.8 0.0 28.6 12.0 0.1 1.8 0.0 1.4 1.1 0.0 0.0 3.1 2.7 0.4 3.3 0.1 0.1 1.5 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 23.8 0.0 0.0 0.0 16.9 3.7 1.3 0.0 0.0 0.0 5.3 0.0 0.0 1.8 0.0 1.1 25.8 1.4 35.6 515.6 0.1 0.0 0.5 0.0 0.0 TKTL2 "DKFZP434L1717, FLJ32975" ENSG00000151005 "Transketolase like 2" Q9H0I9 4 163471093-163473746 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 109 "testis: 66.8" "Group enriched" "Detected in some" 19 "Early spermatids: 47.2;Late spermatids: 27.7;Spermatocytes: 100.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (2.19e-1)" "unprognostic (1.55e-1)" "unprognostic (8.62e-2)" "unprognostic (2.05e-2)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (7.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.15e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 66.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 100.1 1.6 0.0 0.0 0.0 0.0 0.0 TLDC2 "C20orf118, dJ132F21.2" ENSG00000101342 "TBC/LysM-associated domain containing 2" A0PJX2 20 36876121-36894235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 54.9" "Cell type enhanced" "Detected in some" 11 "Enterocytes: 13.4;granulocytes: 14.0;Paneth cells: 13.3;Undifferentiated cells: 6.5" "Cancer enhanced" "Detected in many" "colorectal cancer: 9.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "basophil: 7.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.1" "Cell line enriched" "Detected in some" 6 "HMC-1: 28.0" "Region enriched" "Detected in many" 4 "cerebellum: 6.3" "Region enriched" "Detected in single" 12 "cerebellum: 15.5" HPA047468 Enhanced NA NA "HPA047468: AB_2680059" "unprognostic (9.06e-3)" "unprognostic (3.35e-4)" "unprognostic (4.60e-1)" "unprognostic (1.07e-3)" "unprognostic (1.40e-1)" "unprognostic (6.51e-3)" "unprognostic (1.09e-3)" "unprognostic (5.55e-2)" "unprognostic (1.62e-1)" "unprognostic (2.82e-2)" "unprognostic (3.67e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.97e-5)" "unprognostic (7.25e-2)" "unprognostic (6.20e-2)" "unprognostic (5.59e-2)" "unprognostic (4.87e-2)" 5.5 1.2 0.9 11.3 0.9 1.4 3.4 0.9 0.9 2.1 21.1 0.9 1.6 18.4 2.5 1.8 1.8 2.7 16.0 3.5 0.9 0.2 3.2 0.9 6.0 2.5 0.9 0.9 2.8 2.1 0.0 1.1 0.9 0.9 2.8 12.8 1.6 2.1 0.9 0.9 2.3 54.9 1.8 0.9 4.5 1.5 1.9 0.9 1.1 2.0 1.7 1.3 2.3 2.6 0.8 1.4 7.1 1.0 1.4 1.2 0.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.4 0.2 0.1 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.2 1.0 0.1 2.9 0.0 0.3 28.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.8 0.0 4.6 0.5 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.1 0.1 7.1 1.0 0.1 0.3 0.9 0.6 0.3 0.5 0.2 1.4 0.8 1.2 0.3 0.0 1.4 0.9 0.4 0.7 0.7 0.9 0.9 0.9 0.9 0.9 0.2 0.9 0.9 0.9 0.9 0.0 1.7 0.0 0.1 0.0 0.0 0.5 2.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.4 0.0 0.0 0.0 0.2 0.0 14.0 0.0 0.2 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.0 0.3 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 0.0 TLE2 "ESG, ESG2, FLJ41188, GRG2" ENSG00000065717 "Transducin like enhancer of split 2" Q04725 19 2997638-3047635 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 85.3" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 37.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 85.3" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 3.1;T-cells: 3.4" "Cell line enhanced" "Detected in many" "AN3-CA: 25.1;RT4: 20.0;T-47d: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049103 Enhanced Supported "Nuclear bodies,Focal adhesion sites" NA NA "Nuclear bodies" "Focal adhesion sites" "HPA049103: AB_2680631" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (2.89e-1)" "prognostic favorable (2.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.87e-3)" "unprognostic (6.40e-3)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "prognostic favorable (2.39e-6)" "unprognostic (2.12e-1)" "prognostic favorable (9.49e-6)" "unprognostic (2.66e-1)" "unprognostic (5.99e-2)" "unprognostic (2.60e-1)" "prognostic favorable (8.88e-4)" 13.4 9.6 9.2 4.6 5.7 1.3 38.3 85.3 16.5 10.9 11.4 4.9 28.6 8.1 15.7 6.6 5.5 13.3 8.5 19.9 5.5 7.6 11.9 3.5 12.5 5.4 8.3 5.3 12.4 16.5 13.8 6.4 7.3 9.7 12.9 4.6 20.6 55.5 27.1 38.5 6.4 5.3 26.2 13.3 10.9 7.4 6.3 4.8 1.1 17.5 5.7 3.2 19.2 27.6 3.1 0.0 0.3 0.0 0.0 3.4 0.7 0.3 1.6 0.1 25.1 4.0 0.7 5.5 0.2 0.0 1.3 0.6 7.8 2.8 0.1 3.5 1.7 0.7 4.4 4.1 1.5 0.3 0.7 1.2 0.0 1.8 0.3 5.1 0.0 0.2 5.6 0.7 2.9 0.0 1.4 10.1 7.1 9.0 0.1 0.1 8.4 0.2 0.1 0.1 0.8 1.6 2.0 1.2 2.3 3.3 20.0 1.3 6.5 1.6 12.5 0.7 0.5 14.6 0.0 6.7 8.2 8.6 0.4 0.2 0.3 0.2 1.6 0.2 1.9 1.5 0.0 0.0 0.3 3.2 0.0 2.3 3.1 2.0 1.0 0.0 0.5 3.4 2.1 0.0 0.0 0.0 0.0 0.7 0.7 9.2 5.7 85.3 16.5 5.5 7.6 8.3 5.3 9.7 4.8 17.9 14.5 0.5 30.2 3.2 37.8 24.4 12.7 5.3 1.2 34.9 2.0 1.3 1.7 9.4 3.3 5.9 3.8 0.0 2.4 3.5 6.9 26.7 0.0 3.0 0.6 1.6 13.3 14.7 0.8 7.6 10.9 1.4 5.0 0.0 12.7 18.3 3.3 8.6 14.2 1.1 2.9 0.0 13.3 1.0 3.4 1.9 5.6 1.5 24.3 27.4 TLE4 "E(spI), ESG, GRG4" ENSG00000106829 "Transducin like enhancer of split 4" Q04727 9 79571773-79726882 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 66.2" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 722.1;Late spermatids: 937.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 33.0;BJ hTERT+: 32.9;BJ hTERT+ SV40 Large T+: 31.0;fHDF/TERT166: 51.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065357 Supported Nucleoplasm NA NA Nucleoplasm "HPA065357: AB_2685479" "unprognostic (6.68e-2)" "unprognostic (8.50e-3)" "unprognostic (2.13e-3)" "unprognostic (2.92e-1)" "unprognostic (1.91e-1)" "unprognostic (9.79e-2)" "unprognostic (1.24e-2)" "unprognostic (4.83e-1)" "unprognostic (2.83e-1)" "unprognostic (1.62e-1)" "unprognostic (9.94e-3)" "unprognostic (1.04e-1)" "prognostic favorable (6.94e-4)" "unprognostic (1.49e-1)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.82e-1)" 6.1 11.6 11.6 11.6 25.3 40.0 6.9 22.5 21.2 7.4 7.3 28.8 3.6 6.0 11.4 5.5 12.8 10.3 13.0 6.2 14.7 11.3 5.6 4.4 8.9 10.8 28.9 15.0 26.1 5.3 14.0 45.2 14.6 20.4 4.9 8.6 8.6 7.5 7.1 23.8 13.5 8.0 11.2 31.2 12.4 10.5 66.2 30.3 18.8 8.1 5.1 14.2 12.2 9.3 1.2 2.2 17.3 4.7 2.3 4.8 2.0 0.0 5.9 24.1 0.1 4.4 3.7 7.4 33.0 32.9 31.0 12.3 0.8 3.4 2.7 0.0 51.5 4.5 6.9 1.6 5.8 15.0 11.8 10.2 0.0 2.9 0.1 4.7 7.0 4.3 4.2 4.3 8.8 1.7 8.8 8.0 4.7 0.5 7.2 10.3 0.2 9.1 3.0 7.6 4.2 1.5 8.3 12.7 2.3 1.9 0.9 9.9 14.7 4.6 0.6 0.0 11.8 0.0 8.1 11.5 12.0 0.0 0.2 1.6 4.7 7.6 3.5 4.2 6.1 5.5 17.3 3.4 12.9 3.9 4.7 4.8 1.1 2.1 2.9 2.2 1.2 1.2 2.1 9.2 2.3 3.6 0.8 0.5 2.0 11.6 25.3 22.5 21.2 14.7 11.3 28.9 15.0 20.4 30.3 6.0 20.8 54.1 48.8 107.4 74.6 15.3 61.1 24.1 25.0 14.0 119.8 55.1 3.3 11.6 722.1 49.7 119.6 0.0 19.5 58.1 45.9 27.8 20.7 12.8 42.0 206.6 24.2 36.8 152.5 937.0 97.8 71.8 40.5 27.9 68.5 23.4 25.3 203.4 43.9 15.3 271.5 71.1 60.8 39.3 150.1 79.4 54.3 87.1 54.2 84.6 TLE6 "FLJ14009, GRG6" ENSG00000104953 "Transducin like enhancer of split 6" Q9H808 19 2977446-2995184 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 7.5;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "hypothalamus: 3.1" "Cell type enhanced" "Detected in some" "NK-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 14.3;SK-BR-3: 11.4;U-266/70: 12.1;U-698: 12.7;U-937: 9.5" NA NA "unprognostic (1.32e-1)" "unprognostic (1.28e-2)" "unprognostic (1.63e-5)" "unprognostic (4.05e-3)" "unprognostic (4.36e-2)" "unprognostic (4.58e-2)" "unprognostic (3.85e-2)" "unprognostic (1.24e-1)" "unprognostic (4.85e-3)" "unprognostic (8.00e-2)" "unprognostic (2.62e-3)" "unprognostic (1.52e-1)" "unprognostic (3.31e-4)" "unprognostic (3.34e-1)" "unprognostic (2.81e-1)" "unprognostic (1.92e-2)" "unprognostic (7.60e-3)" 1.8 1.4 0.6 1.2 0.4 0.0 4.8 0.4 0.7 1.4 1.6 0.4 7.7 0.9 2.1 7.1 1.0 1.2 1.1 3.4 0.4 3.1 3.3 5.3 3.4 1.0 0.6 0.4 0.4 2.2 3.9 2.3 18.8 0.7 1.6 1.9 2.7 7.5 5.3 0.8 0.7 1.2 1.2 1.4 1.5 1.6 4.0 0.4 0.9 10.2 0.4 1.5 1.8 0.7 2.3 0.7 0.0 0.4 3.1 1.2 0.6 3.8 5.0 0.1 2.0 0.0 0.0 14.3 0.0 0.0 0.2 0.9 0.0 1.1 6.6 1.0 0.4 1.2 0.0 1.9 1.0 0.2 5.5 0.9 0.0 0.1 0.6 0.6 0.1 1.2 0.9 0.7 0.0 0.1 1.1 0.9 4.8 1.1 0.0 0.4 2.6 0.0 0.3 0.0 7.1 1.0 4.0 0.3 5.4 1.3 1.0 0.3 1.3 0.4 11.4 4.6 0.4 3.2 0.6 0.8 0.4 0.7 0.3 0.3 12.1 7.9 12.7 2.8 9.5 0.4 0.0 0.3 0.0 0.1 0.0 0.0 1.6 0.6 0.6 0.7 2.3 0.0 0.5 0.0 3.1 0.4 0.0 1.2 0.6 0.6 0.4 0.4 0.7 0.4 3.1 0.6 0.4 0.7 0.4 0.0 7.5 0.5 1.9 0.1 1.9 1.2 5.1 0.0 2.3 12.2 0.0 5.5 6.6 0.8 0.5 0.0 0.1 0.0 0.9 7.4 0.5 0.5 0.0 0.8 1.2 0.0 3.5 0.6 0.3 1.5 0.3 0.0 5.0 0.0 2.5 4.8 1.5 0.0 0.4 0.6 0.8 0.0 0.4 0.1 5.5 0.0 7.2 0.0 0.8 0.9 TLE7 chico ENSG00000260734 "Transducin like enhancer of split family member 7" 16 71430262-71442060 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 7.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 26 "testis cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.0" "Not detected" "Not detected" NA NA "unprognostic (2.29e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLK2 "MGC44450, PKU-ALPHA" ENSG00000146872 "Tousled like kinase 2" Q86UE8 17 62458658-62615481 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 47.9" "Cell type enhanced" "Detected in all" 5 "Late spermatids: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.50e-2)" "unprognostic (2.12e-1)" "unprognostic (7.06e-2)" "unprognostic (1.48e-2)" "unprognostic (9.53e-3)" "unprognostic (6.57e-2)" "prognostic unfavorable (9.40e-4)" "unprognostic (4.53e-2)" "unprognostic (5.28e-2)" "unprognostic (2.32e-1)" "unprognostic (2.82e-2)" "unprognostic (4.78e-2)" "unprognostic (5.32e-2)" "unprognostic (9.79e-2)" "unprognostic (4.32e-2)" "unprognostic (4.88e-1)" "unprognostic (7.30e-2)" 7.4 6.4 8.3 7.3 7.2 12.0 12.5 7.8 14.0 5.8 7.8 4.0 3.1 7.4 9.0 3.1 9.0 6.2 9.9 17.8 7.7 7.4 5.7 5.0 6.9 8.7 7.7 7.3 8.5 8.9 5.6 6.9 9.0 10.4 6.6 5.3 7.5 8.6 8.7 11.7 8.7 10.1 6.5 8.6 8.9 6.7 47.9 5.7 4.1 11.7 3.1 10.0 8.5 7.2 4.6 3.6 8.6 2.8 6.6 4.9 1.5 15.8 14.6 25.2 26.6 8.2 10.7 14.7 17.5 13.6 20.7 19.0 15.1 14.2 31.0 9.0 11.4 18.3 10.8 17.7 7.5 19.8 16.4 14.1 21.1 13.7 15.2 14.7 22.2 13.4 9.2 10.2 13.9 16.9 12.7 10.2 17.7 20.8 14.1 11.1 34.5 31.6 7.9 16.0 9.3 12.2 21.7 33.2 9.8 9.8 15.9 27.2 36.7 14.9 10.2 22.4 22.1 17.3 20.0 13.8 29.1 27.7 13.1 19.7 16.4 20.4 28.4 12.0 11.4 15.2 3.7 2.8 8.6 2.5 2.2 2.6 4.5 4.4 3.1 2.5 4.6 3.5 4.6 5.5 6.6 2.4 3.6 4.9 1.5 8.3 7.2 7.8 14.0 7.7 7.4 7.7 7.3 10.4 5.7 29.8 22.4 16.6 13.3 20.1 58.1 26.4 12.7 38.8 12.5 14.0 78.5 9.5 10.0 8.7 90.3 13.1 14.6 23.3 8.6 9.8 15.0 18.6 19.7 8.3 10.8 27.0 17.2 11.1 14.2 128.6 19.5 18.0 16.9 10.0 14.2 23.8 12.6 23.0 16.6 6.3 82.2 6.5 16.0 73.9 28.9 19.2 12.7 14.1 15.1 20.0 TLL1 ENSG00000038295 "Tolloid like 1" O43897 4 165873258-166103895 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 10 "cerebellum: 132.6" HPA060767 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA060767: AB_2684357" "unprognostic (2.17e-1)" "unprognostic (6.45e-4)" "unprognostic (8.60e-2)" "unprognostic (2.65e-5)" "unprognostic (9.85e-2)" "unprognostic (2.51e-4)" "unprognostic (3.37e-2)" "unprognostic (3.61e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-4)" "unprognostic (2.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.76e-2)" "unprognostic (6.91e-3)" "unprognostic (1.21e-5)" 10.1 1.3 1.2 2.6 2.8 0.0 7.9 40.6 2.9 5.0 5.4 0.2 4.2 1.4 3.0 2.7 2.5 2.4 5.4 2.4 2.2 1.7 3.3 0.5 3.1 3.0 1.1 0.6 1.6 4.6 1.1 2.2 13.8 8.5 3.1 2.2 3.3 1.9 1.9 1.6 2.7 4.4 3.3 0.9 0.4 1.7 1.5 0.1 0.0 3.2 1.4 1.6 3.6 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.2 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.6 1.5 0.0 1.8 0.0 1.4 0.0 0.0 13.6 0.0 0.0 0.0 0.2 1.2 0.0 4.9 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.8 40.6 2.9 2.2 1.7 1.1 0.6 8.5 0.1 0.0 1.1 0.0 0.2 1.5 15.1 4.1 0.0 1.4 1.2 0.0 0.0 3.9 0.0 1.5 0.0 11.3 0.0 0.0 1.9 0.9 1.6 0.8 0.0 0.0 0.2 7.9 0.0 1.8 0.0 0.0 2.8 0.0 1.7 0.0 0.0 0.0 0.1 0.0 4.2 0.8 0.5 0.0 0.3 0.1 0.0 1.5 1.6 0.0 0.0 0.1 TLL2 ENSG00000095587 "Tolloid like 2" Q9Y6L7 10 96364606-96513918 "Enzymes, Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 7.4" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 4.8;Early spermatids: 5.2;Late spermatids: 3.4;Syncytiotrophoblasts: 2.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "RPTEC TERT1: 21.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (1.28e-2)" "unprognostic (7.54e-4)" "unprognostic (1.50e-1)" "unprognostic (3.31e-3)" "unprognostic (2.67e-1)" "unprognostic (2.14e-3)" "unprognostic (1.31e-2)" "unprognostic (3.52e-4)" "unprognostic (7.08e-2)" "unprognostic (2.50e-1)" "unprognostic (6.71e-2)" "unprognostic (3.37e-2)" "unprognostic (4.98e-4)" "unprognostic (2.90e-1)" "unprognostic (8.41e-2)" "unprognostic (1.95e-4)" "unprognostic (2.30e-1)" 0.7 1.1 3.2 1.4 4.9 1.6 0.7 0.7 5.8 0.8 1.1 5.7 2.5 1.7 1.2 1.1 0.9 0.7 2.6 7.4 3.3 3.8 0.7 0.6 0.5 1.8 3.4 2.1 1.4 1.5 0.4 2.8 1.1 4.6 1.1 1.1 0.0 3.9 2.7 4.1 1.0 2.1 0.9 6.1 0.9 2.1 1.1 5.7 0.0 1.5 4.0 0.7 0.8 0.5 0.9 0.3 0.6 0.2 0.3 0.2 0.0 0.2 0.1 0.4 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.3 1.1 0.1 0.2 0.1 0.2 0.1 0.0 2.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.0 1.3 0.7 0.1 0.1 0.4 0.0 21.7 0.1 0.8 0.1 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.9 0.2 0.1 0.0 0.9 0.2 0.2 0.6 0.3 0.2 0.3 0.1 0.0 3.2 4.9 0.7 4.0 3.3 3.8 3.4 2.1 4.6 5.7 0.0 0.6 0.0 0.4 0.1 0.0 4.8 2.5 0.0 1.2 0.0 0.0 2.2 0.0 0.3 5.2 0.5 0.0 0.0 0.5 0.0 0.6 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.3 3.4 0.3 1.0 0.0 0.0 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.1 2.0 0.4 2.9 0.0 0.0 0.4 TLN2 "ILWEQ, KIAA0320" ENSG00000171914 "Talin 2" Q9Y4G6 15 62390526-62844631 "Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.9" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 46.1;Rod photoreceptor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 29.8;hTERT-HME1: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017194, HPA051828, HPA054787" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 81000000 "Focal adhesion sites, Cytosol" "CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587" "prognostic favorable (6.53e-4)" "unprognostic (2.61e-1)" "unprognostic (9.47e-2)" "unprognostic (8.95e-2)" "unprognostic (3.74e-1)" "unprognostic (1.43e-1)" "unprognostic (8.24e-2)" "unprognostic (9.94e-2)" "unprognostic (1.68e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (1.91e-1)" "prognostic favorable (1.81e-6)" "prognostic favorable (7.74e-4)" "unprognostic (1.34e-1)" "unprognostic (5.79e-2)" "unprognostic (2.30e-1)" 12.5 3.1 7.0 12.1 7.0 2.3 5.3 5.4 18.9 5.6 24.3 4.0 1.7 3.3 6.5 4.2 3.4 3.2 6.3 8.5 6.8 6.0 36.9 1.8 1.9 1.3 6.2 4.2 7.0 3.3 2.3 3.0 2.4 4.5 3.1 5.4 5.5 5.4 1.6 16.9 1.6 16.6 6.9 9.6 0.8 4.1 3.5 1.3 0.9 29.0 4.5 1.3 4.3 7.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.8 2.7 3.9 4.6 29.8 2.8 4.4 6.6 5.2 6.1 6.0 7.2 0.9 2.2 3.0 11.4 10.1 1.1 5.0 1.0 5.3 7.1 0.5 0.2 10.8 4.7 1.0 0.7 0.2 5.2 2.7 8.1 24.2 3.5 0.2 2.8 0.2 0.1 10.1 3.5 0.3 0.3 6.9 12.4 2.0 2.7 9.9 2.7 3.2 5.5 0.9 4.5 5.0 0.5 1.7 8.8 1.4 1.7 1.9 11.0 15.0 17.7 16.8 0.1 0.4 1.4 5.0 1.6 13.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 7.0 7.0 5.4 12.9 6.8 6.0 6.2 4.2 4.5 1.3 0.0 2.7 1.3 1.5 2.2 11.7 35.9 2.5 0.0 1.2 26.2 35.3 1.0 10.0 3.4 3.4 4.9 16.5 0.0 3.3 22.8 11.6 1.5 0.0 10.6 4.5 46.1 2.4 4.3 5.6 4.0 10.9 5.1 0.0 1.0 16.7 10.1 2.9 17.3 14.9 25.8 47.3 0.0 7.6 2.6 19.4 1.4 1.1 0.0 27.9 1.4 TLR1 "CD281, KIAA0012, rsc786" ENSG00000174125 "Toll like receptor 1" Q15399 4 38790677-38856817 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.3;lymphoid tissue: 40.4" "Cell type enhanced" "Detected in many" 14 "Hofbauer cells: 14.0;Kupffer cells: 33.2;Macrophages: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 43.3" "Group enriched" "Detected in all" 6 "granulocytes: 43.3;monocytes: 13.1" "Cell line enhanced" "Detected in many" "Daudi: 9.6;HUVEC TERT2: 11.0;RPMI-8226: 11.9;U-698: 17.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (7.82e-2)" "unprognostic (3.35e-3)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (1.71e-1)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (1.80e-1)" "unprognostic (3.88e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-2)" "unprognostic (1.76e-1)" "unprognostic (7.25e-3)" "unprognostic (4.08e-2)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (3.97e-2)" 10.9 4.6 7.1 17.9 11.4 21.0 5.4 2.0 6.0 3.4 3.7 5.9 0.5 4.2 5.8 3.9 3.2 5.3 6.5 4.0 6.5 3.4 4.6 5.8 9.8 26.4 12.9 2.6 7.4 7.7 1.0 4.2 6.6 10.6 3.9 4.6 2.2 11.0 2.5 1.7 3.1 6.7 6.5 19.4 40.4 4.2 1.6 10.9 10.1 2.4 1.7 13.1 6.3 2.8 2.3 4.5 43.3 13.1 1.8 1.1 2.4 0.2 1.7 0.1 0.0 0.2 1.3 0.0 0.0 0.4 0.1 1.0 0.2 4.7 9.6 1.0 0.0 4.7 0.3 0.1 1.2 0.2 1.1 0.5 1.2 0.4 0.0 0.0 1.8 0.5 0.4 0.2 0.4 0.0 0.4 11.0 0.2 1.3 2.9 1.4 0.0 0.4 3.9 0.0 0.0 0.0 6.5 0.1 11.9 1.1 0.0 0.0 1.4 0.0 0.1 0.4 0.1 0.1 2.3 2.8 1.0 0.4 0.1 0.6 1.1 0.1 17.8 2.5 6.6 0.3 0.0 6.8 2.6 1.0 10.4 0.8 2.3 1.1 0.8 4.5 2.0 1.1 0.6 43.3 1.8 13.1 1.5 0.4 2.4 7.1 11.4 2.0 6.0 6.5 3.4 12.9 2.6 10.6 10.9 0.0 1.0 6.4 0.5 0.2 0.2 0.0 0.0 8.1 2.3 1.8 0.0 0.1 1.7 3.9 0.0 2.1 0.2 0.0 3.8 0.2 0.7 1.0 3.5 2.5 14.0 0.0 0.0 0.0 33.2 0.0 0.0 18.2 0.0 2.8 0.3 1.7 1.9 0.0 2.5 1.2 0.2 0.0 0.0 0.1 0.1 0.5 0.1 4.4 1.5 0.9 TLR10 CD290 ENSG00000174123 "Toll like receptor 10" Q9BXR5 4 38772239-38782990 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6" "Cell type enriched" "Detected in some" 18 "B-cells: 39.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "memory B-cell: 23.5;naive B-cell: 14.9" "Lineage enriched" "Detected in many" 6 "B-cells: 23.5" "Group enriched" "Detected in some" 55 "Daudi: 38.2;REH: 12.8;U-698: 13.7" "Low region specificity" "Detected in all" HPA066755 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA066755: " "unprognostic (5.41e-5)" "unprognostic (2.41e-4)" "unprognostic (1.91e-3)" "unprognostic (8.22e-4)" "unprognostic (6.48e-2)" "unprognostic (9.98e-4)" "unprognostic (9.31e-2)" "unprognostic (8.76e-3)" "unprognostic (4.08e-3)" "unprognostic (7.26e-2)" "unprognostic (8.76e-2)" "unprognostic (6.90e-2)" "unprognostic (2.98e-3)" "unprognostic (3.90e-1)" "unprognostic (1.81e-2)" "unprognostic (3.14e-3)" "unprognostic (1.88e-2)" 0.8 0.5 4.2 24.5 9.4 0.9 0.6 0.6 3.5 0.6 1.0 2.5 0.0 0.9 0.5 0.3 1.7 0.9 1.0 0.5 3.2 1.8 0.8 0.7 1.2 27.0 5.5 0.5 0.5 0.6 0.1 0.7 0.2 4.8 0.8 1.4 0.0 2.6 0.3 0.5 0.5 11.2 0.3 11.3 24.4 1.8 0.4 7.4 2.7 0.9 0.0 31.6 3.2 0.6 23.5 4.0 0.7 1.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.1 0.2 0.4 0.0 1.5 0.0 23.5 0.0 0.0 3.6 14.9 0.0 0.0 0.7 0.0 1.8 4.0 0.0 0.9 4.2 9.4 0.6 3.5 3.2 1.8 5.5 0.5 4.8 7.4 0.0 1.4 39.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.7 0.0 1.2 0.6 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 TLR2 "CD282, TIL4" ENSG00000137462 "Toll like receptor 2" O60603 4 153684070-153705702 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4" "Group enriched" "Detected in many" 46 "dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5" "Cell line enhanced" "Detected in some" "HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA060231, HPA071546" Supported Nucleoplasm,Mitochondria No NA "Nucleoplasm, Mitochondria" "HPA060231: , HPA071546: " "unprognostic (4.15e-1)" "unprognostic (3.29e-2)" "unprognostic (5.32e-2)" "unprognostic (1.52e-2)" "unprognostic (3.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.39e-2)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-2)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.87e-2)" "unprognostic (3.80e-3)" "unprognostic (1.42e-1)" "unprognostic (5.93e-3)" 16.3 6.9 6.9 30.0 11.1 34.6 7.3 1.4 5.3 4.7 4.7 3.0 9.3 2.2 3.1 8.0 3.2 7.2 10.0 7.2 6.7 3.3 9.8 7.3 31.1 37.8 12.4 1.4 4.2 5.1 1.1 4.4 6.4 9.9 5.5 1.9 3.3 15.0 9.9 2.5 3.1 4.0 6.6 21.9 29.3 3.9 4.8 9.5 0.9 3.3 1.0 8.5 7.3 3.5 0.2 19.1 72.9 29.5 0.8 0.2 9.3 4.0 0.0 0.2 0.0 0.5 1.6 0.0 0.0 0.3 0.3 0.5 1.9 0.2 0.0 0.4 0.0 0.0 3.6 0.4 0.3 0.2 0.0 0.0 0.1 0.0 0.4 0.0 6.9 0.5 7.5 7.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.4 0.0 1.6 0.1 0.0 0.0 7.7 9.5 0.0 0.2 0.4 0.0 1.8 0.2 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.9 6.2 29.5 0.2 0.0 28.1 0.0 0.0 0.1 0.0 19.1 0.2 0.2 0.0 72.9 0.8 18.4 0.1 0.0 9.3 6.9 11.1 1.4 5.3 6.7 3.3 12.4 1.4 9.9 9.5 6.0 64.7 0.8 1.1 1.0 0.0 1.2 5.1 2.7 12.5 3.5 0.0 0.1 0.0 4.8 0.3 0.6 0.0 0.0 3.2 0.1 0.9 2.0 3.5 0.9 16.3 0.0 0.0 2.5 106.5 0.0 0.6 52.5 1.7 0.0 0.1 0.0 3.1 0.0 0.4 1.0 0.3 12.9 0.4 0.2 0.4 1.0 0.1 0.7 0.0 1.4 TLR3 CD283 ENSG00000164342 "Toll like receptor 3" O15455 4 186069152-186088069 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Receptor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 48.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 46.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 7.6;memory CD8 T-cell: 8.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.5;T-cells: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 11.6;ASC TERT1: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;CAPAN-2: 28.0;HSkMC: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025658 Enhanced "Intracellular and membrane" NA NA "CAB025658: " "unprognostic (2.13e-2)" "unprognostic (2.15e-1)" "unprognostic (7.26e-2)" "unprognostic (7.47e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-2)" "unprognostic (9.28e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (1.17e-1)" "unprognostic (4.72e-3)" "unprognostic (1.18e-1)" "unprognostic (4.52e-3)" "unprognostic (3.89e-2)" "unprognostic (1.83e-1)" 11.9 10.7 3.1 6.8 5.0 0.0 11.1 1.7 3.5 9.9 20.1 3.0 6.8 13.4 5.6 7.3 12.9 7.8 8.6 7.7 3.5 2.6 12.4 11.2 12.2 1.0 3.3 1.9 8.9 8.2 4.8 2.7 48.1 3.0 11.3 9.5 5.0 8.5 10.2 2.3 3.8 34.9 6.5 8.0 7.0 8.2 5.8 4.2 1.2 11.8 7.6 3.0 10.3 14.6 0.0 2.5 0.5 0.0 0.7 8.0 1.1 1.9 0.5 0.3 0.0 11.6 12.1 0.9 0.1 8.4 5.1 18.0 0.0 28.0 0.0 1.1 1.2 10.2 2.9 0.0 5.8 0.9 10.7 0.1 1.7 0.5 0.0 5.1 1.8 0.7 11.9 2.2 6.8 0.3 3.1 2.4 1.8 0.0 0.0 2.9 0.0 2.0 0.0 0.9 0.0 1.0 2.6 0.0 0.1 4.9 2.7 0.0 0.1 1.5 1.2 2.3 0.1 0.3 0.0 1.7 0.9 0.6 0.0 1.2 0.0 0.0 0.0 2.4 1.2 2.0 0.5 0.0 0.0 7.6 0.0 4.3 0.0 1.8 8.0 2.5 0.0 1.2 3.9 0.3 0.7 0.0 0.0 0.2 1.1 3.1 5.0 1.7 3.5 3.5 2.6 3.3 1.9 3.0 4.2 17.9 5.6 1.3 3.2 3.4 0.0 0.8 17.8 2.7 11.4 14.0 0.0 16.9 0.0 6.4 46.2 3.2 14.4 0.0 8.7 4.6 4.0 2.6 2.3 6.4 2.3 0.0 1.2 6.7 0.3 3.8 7.8 2.5 0.0 0.0 6.7 3.8 6.2 8.6 3.5 5.4 0.4 0.0 1.4 0.0 0.4 0.9 16.4 0.0 4.5 5.0 TLR6 CD286 ENSG00000174130 "Toll like receptor 6" Q9Y2C9 4 38823715-38856817 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.2;brain: 16.0;lymphoid tissue: 16.2" "Cell type enhanced" "Detected in some" 12 "B-cells: 5.0;Hofbauer cells: 5.9;Kupffer cells: 11.8;Macrophages: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 14.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 12.5;GAMG: 12.9;RPMI-8226: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062733 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA062733: AB_2684853" "unprognostic (9.82e-2)" "unprognostic (4.76e-2)" "unprognostic (3.30e-2)" "unprognostic (3.05e-2)" "unprognostic (1.91e-1)" "unprognostic (1.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.45e-2)" "unprognostic (9.26e-2)" "unprognostic (1.30e-1)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (7.62e-7)" "unprognostic (4.89e-2)" "unprognostic (1.02e-2)" "unprognostic (7.78e-2)" "unprognostic (2.12e-2)" 2.9 2.7 6.1 10.7 7.9 6.4 2.1 2.0 3.9 1.8 1.6 2.6 0.2 1.7 1.4 2.0 1.8 1.9 3.9 1.5 4.5 1.7 1.7 2.1 5.0 11.2 10.6 1.9 1.6 1.2 0.7 1.9 2.8 7.2 1.6 2.4 0.9 4.3 0.5 0.9 1.7 7.8 2.1 16.0 16.2 2.1 0.8 6.8 1.8 1.5 1.1 14.8 5.8 1.9 1.8 1.8 14.2 2.6 0.3 0.4 0.6 1.4 5.7 0.2 0.1 0.3 6.7 0.0 1.6 6.9 0.7 2.3 0.0 12.5 6.9 2.7 0.3 12.9 0.6 0.1 1.2 1.1 0.0 0.5 3.2 6.9 0.2 0.4 3.5 5.2 2.8 1.3 2.8 1.5 0.2 1.4 1.1 3.5 2.2 3.1 0.0 0.0 6.1 0.2 0.0 0.9 3.4 3.1 9.8 0.4 0.1 0.0 0.1 0.2 0.0 0.9 0.3 0.3 1.8 1.9 2.2 7.5 0.9 2.4 0.1 0.0 5.8 5.1 4.1 1.6 0.0 2.6 0.7 0.2 2.4 0.0 1.8 0.1 0.1 1.8 1.2 0.3 0.2 14.2 0.3 1.2 1.3 0.4 0.6 6.1 7.9 2.0 3.9 4.5 1.7 10.6 1.9 7.2 6.8 0.0 0.0 5.0 1.1 0.6 0.7 1.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 0.2 0.8 0.8 2.3 0.0 5.9 0.0 0.0 0.6 11.8 0.0 0.6 9.5 0.0 1.8 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.4 0.2 0.0 0.6 0.2 0.0 0.0 0.9 TLR7 ENSG00000196664 "Toll like receptor 7" Q9NYK1 X 12867083-12890380 "FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Cell type enhanced" "Detected in some" 16 "Hofbauer cells: 20.2;Macrophages: 14.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 16.0;U-266/70: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059613 Supported NA NA "HPA059613: AB_2684083" "unprognostic (1.22e-1)" "unprognostic (1.09e-2)" "unprognostic (2.36e-3)" "unprognostic (9.29e-2)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (8.27e-2)" "unprognostic (6.20e-3)" "unprognostic (3.75e-1)" "unprognostic (6.91e-2)" "unprognostic (3.55e-1)" "unprognostic (8.47e-2)" "unprognostic (2.54e-1)" "unprognostic (4.17e-3)" "unprognostic (1.19e-3)" "unprognostic (1.53e-3)" "unprognostic (1.34e-1)" 2.9 3.1 7.6 7.2 11.3 1.0 7.6 1.7 7.9 2.5 3.3 10.6 0.0 3.2 1.8 2.9 1.8 1.7 5.3 4.1 8.4 5.1 2.2 1.5 7.7 6.9 17.4 2.6 1.6 1.9 1.5 2.2 11.0 12.9 2.2 4.0 1.5 2.7 2.0 1.4 1.4 4.9 3.5 26.5 6.7 3.0 1.5 17.2 7.7 1.7 0.5 9.4 5.2 1.6 6.9 15.7 3.2 8.9 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 16.5 0.0 3.1 0.0 0.3 0.0 0.2 7.2 3.2 0.0 8.9 0.0 6.9 0.0 0.0 3.7 5.8 0.0 0.0 0.4 0.0 6.8 15.7 0.0 2.2 7.6 11.3 1.7 7.9 8.4 5.1 17.4 2.6 12.9 17.2 0.0 4.6 2.4 1.1 1.1 0.0 0.5 0.0 4.0 1.2 0.0 2.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 1.0 0.7 1.1 0.0 20.2 0.0 0.0 0.6 2.4 0.0 0.6 14.8 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.1 0.9 0.2 0.0 0.0 1.4 TLR8 CD288 ENSG00000101916 "Toll like receptor 8" Q9NR97 X 12906620-12923169 "CD markers, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 17.8;lymphoid tissue: 45.6" "Group enriched" "Detected in some" 6 "Kupffer cells: 48.1;Macrophages: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 94 "classical monocyte: 10.0;intermediate monocyte: 9.6;myeloid DC: 5.3;neutrophil: 17.8;non-classical monocyte: 9.2" "Group enriched" "Detected in many" 100 "dendritic cells: 5.3;granulocytes: 17.8;monocytes: 10.0" "Cell line enhanced" "Detected in some" "HMC-1: 1.2;PC-3: 2.8;THP-1: 1.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA001608 Enhanced NA NA "HPA001608: AB_1080295" "unprognostic (1.32e-1)" "unprognostic (6.94e-2)" "unprognostic (3.96e-3)" "unprognostic (4.43e-2)" "unprognostic (9.63e-2)" "unprognostic (2.48e-2)" "unprognostic (2.59e-1)" "unprognostic (6.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (3.72e-2)" "unprognostic (2.73e-1)" "unprognostic (1.74e-2)" "unprognostic (1.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.52e-1)" "unprognostic (5.66e-2)" 8.5 1.4 0.9 16.0 1.5 4.7 1.2 0.7 1.1 1.0 1.5 0.4 0.0 0.6 1.0 3.2 1.0 2.0 2.4 3.0 2.0 1.0 2.0 4.0 13.7 33.0 1.7 0.1 1.1 1.0 0.2 1.0 4.0 1.9 1.4 1.7 0.9 1.2 0.0 1.4 0.8 2.0 3.5 3.3 45.6 1.3 1.2 1.6 3.5 1.0 1.1 2.4 4.2 2.4 0.1 5.3 17.8 10.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.0 10.0 0.0 0.0 9.6 0.0 0.1 0.0 0.0 5.3 0.0 0.0 0.0 17.8 0.0 9.2 0.0 0.0 2.0 0.9 1.5 0.7 1.1 2.0 1.0 1.7 0.1 1.9 1.6 0.0 4.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 0.0 0.6 48.1 0.0 0.0 13.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLR9 CD289 ENSG00000239732 "Toll like receptor 9" Q9NR96 3 52221080-52226163 "CD markers, FDA approved drug targets, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 33.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 33.8" "Lineage enriched" "Detected in many" 10 "dendritic cells: 33.8" "Group enriched" "Detected in some" 12 "Daudi: 24.7;RPMI-8226: 15.7;U-698: 9.5" NA NA "unprognostic (6.03e-2)" "unprognostic (5.08e-2)" "unprognostic (3.58e-3)" "unprognostic (6.69e-7)" "unprognostic (1.16e-1)" "unprognostic (1.89e-2)" "unprognostic (2.69e-1)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (1.89e-1)" "unprognostic (4.40e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-3)" "unprognostic (2.44e-2)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (7.91e-3)" 0.5 0.2 0.0 2.8 0.5 2.5 0.4 4.9 0.4 0.8 1.2 0.7 0.9 0.0 0.2 1.0 0.9 0.3 0.2 0.3 0.3 0.1 0.6 6.5 0.1 2.5 0.0 0.0 0.3 0.1 0.9 0.1 1.4 0.4 1.8 0.1 2.2 0.1 0.4 3.9 0.5 0.3 0.7 3.9 1.2 1.2 3.3 33.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.0 0.7 9.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 33.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TLX1 "HOX11, TCL3" ENSG00000107807 "T cell leukemia homeobox 1" P31314 10 101130505-101137789 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "lymphoid tissue: 59.5;salivary gland: 19.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.4;HEK 293: 3.0;K-562: 15.4;SCLC-21H: 2.6;SH-SY5Y: 3.8;SiHa: 2.5" "Region enriched" "Detected in single" 13 "pons and medulla: 0.5" "Not detected" "Not detected" NA NA "unprognostic (8.67e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.06e-5)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (5.07e-1)" "unprognostic (1.57e-2)" "unprognostic (2.12e-2)" "unprognostic (2.69e-2)" "unprognostic (2.52e-3)" "unprognostic (1.81e-1)" "unprognostic (2.63e-1)" "unprognostic (3.26e-1)" "unprognostic (3.06e-1)" "unprognostic (7.35e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.1 0.2 0.0 0.0 19.5 0.0 0.1 0.0 0.6 0.0 0.0 59.5 0.0 0.1 0.1 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 3.8 2.5 0.0 0.0 0.3 0.2 0.5 0.2 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 TLX2 "Enx, HOX11L1, NCX, Tlx2" ENSG00000115297 "T cell leukemia homeobox 2" O43763 2 74513463-74517147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 8.0;brain: 4.3;retina: 3.8" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 19.6;Rod photoreceptor cells: 16.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "SH-SY5Y: 38.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA062254 Approved Nucleoplasm NA NA Nucleoplasm "HPA062254: AB_2684727" "unprognostic (7.30e-2)" "unprognostic (3.03e-4)" "unprognostic (9.54e-4)" "unprognostic (2.86e-2)" "unprognostic (2.33e-1)" "unprognostic (1.69e-2)" "unprognostic (6.77e-2)" "unprognostic (1.36e-1)" "unprognostic (9.00e-2)" "unprognostic (3.91e-2)" "unprognostic (1.39e-1)" "unprognostic (5.40e-1)" "unprognostic (3.92e-7)" "unprognostic (2.51e-1)" "unprognostic (6.86e-2)" "unprognostic (5.04e-2)" "unprognostic (1.18e-1)" 0.1 8.0 1.7 1.7 4.0 0.2 0.1 0.8 4.3 0.1 2.7 0.0 0.0 1.9 0.1 0.1 0.5 0.1 0.6 0.1 0.4 0.7 0.1 0.1 0.1 0.5 0.8 0.0 0.1 0.6 0.5 0.0 0.2 3.5 0.1 0.7 3.8 0.1 0.1 0.1 0.4 2.5 0.2 0.3 0.2 0.9 3.3 0.6 2.5 0.1 0.0 0.3 2.1 0.4 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.0 0.0 0.0 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.3 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 4.0 0.8 4.3 0.4 0.7 0.8 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.5 0.0 0.0 1.7 3.2 0.0 0.0 0.0 0.0 0.0 TLX3 "HOX11L2, RNX" ENSG00000164438 "T cell leukemia homeobox 3" O43711 5 171309284-171312134 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "brain: 46.6" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 5.2" "Cancer enhanced" "Detected in some" "cervical cancer: 1.7" "Region enriched" "Detected in some" 22 "cerebellum: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 24.6" "Region enriched" "Detected in single" 7 "cerebellum: 2.5" "Region enriched" "Detected in some" 10 "cerebellum: 48.1" "HPA030504, HPA060957, HPA069359" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130" "unprognostic (3.52e-2)" "unprognostic (2.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.11e-1)" "unprognostic (9.80e-2)" "unprognostic (2.76e-2)" "unprognostic (4.48e-2)" 0.4 0.5 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.0 0.0 24.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 TM4SF19 ENSG00000145107 "Transmembrane 4 L six family member 19" Q96DZ7 3 196319342-196338503 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "adipose tissue: 69.9" "Cell type enriched" "Detected in some" 9 "Hofbauer cells: 78.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4" "Lineage enriched" "Detected in single" 19 "T-cells: 14.8" "Cell line enriched" "Detected in some" 12 "GAMG: 100.5" NA NA "unprognostic (9.90e-2)" "unprognostic (1.17e-2)" "unprognostic (3.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.67e-1)" "unprognostic (7.19e-2)" "unprognostic (8.90e-5)" "unprognostic (8.86e-3)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.85e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-3)" "unprognostic (4.23e-2)" "unprognostic (4.20e-3)" "unprognostic (2.60e-1)" "unprognostic (1.18e-3)" 69.9 0.4 0.4 0.7 0.4 0.9 4.5 0.4 0.5 2.1 0.4 0.4 0.4 0.0 0.4 0.6 5.0 0.3 0.8 0.4 0.4 0.1 0.4 0.8 4.9 0.6 0.4 0.4 1.2 0.4 0.0 0.4 1.1 0.4 0.6 0.1 0.4 2.2 0.4 2.1 3.2 0.4 0.4 0.4 0.8 0.6 8.2 0.4 0.5 1.0 2.0 1.3 0.9 2.1 0.3 0.5 0.6 0.4 0.8 14.8 1.4 3.4 1.6 0.1 0.1 0.2 1.1 0.1 0.0 1.0 0.3 0.7 0.0 1.9 0.0 0.6 0.0 100.5 0.5 0.0 0.3 0.2 0.1 0.0 0.1 0.4 0.0 0.2 0.2 0.1 0.1 0.3 4.4 7.4 0.0 0.0 0.2 2.1 0.2 1.1 0.2 0.0 0.1 0.0 0.0 8.4 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.3 4.4 3.6 0.6 2.0 0.1 1.2 0.0 4.7 0.1 0.1 0.6 0.3 0.4 14.8 0.4 0.1 0.1 1.4 3.8 0.1 0.3 0.8 5.4 0.6 0.8 0.1 0.5 0.3 1.4 0.4 0.4 0.4 0.5 0.4 0.1 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 78.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 3.8 0.0 0.3 0.0 0.0 0.0 TM4SF20 "FLJ22800, TCCE518" ENSG00000168955 "Transmembrane 4 L six family member 20" Q53R12 2 227362156-227381995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 86 "intestine: 147.8" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 33.2;Enterocytes: 27.7;Late spermatids: 61.3;Paneth cells: 11.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 7.2;RPMI-8226: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051838, HPA063184, HPA065531" Uncertain Supported "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506" "unprognostic (4.68e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" "unprognostic (4.96e-2)" "unprognostic (2.84e-2)" "unprognostic (1.63e-1)" "unprognostic (2.51e-1)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-3)" "unprognostic (7.76e-2)" "unprognostic (2.60e-2)" "unprognostic (3.04e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 46.5 0.0 0.0 73.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.1 0.1 147.8 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 1.2 1.1 0.5 1.7 0.7 0.0 0.1 7.2 0.2 0.1 0.0 0.0 1.3 0.9 0.1 0.0 0.0 1.4 0.5 0.2 0.1 0.4 0.2 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.2 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.4 0.8 0.3 0.0 0.1 1.6 0.3 0.1 0.1 0.5 0.1 4.5 0.1 0.3 0.6 1.7 1.1 0.1 0.0 0.1 0.3 0.1 0.3 0.6 0.3 2.0 0.2 0.5 0.3 0.4 0.2 0.2 0.2 0.8 0.5 0.1 0.7 0.3 0.3 0.7 0.4 0.4 0.0 1.1 0.7 0.5 1.1 1.7 0.1 1.2 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 11.5 0.7 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.2 0.0 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149473974-149503281 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 196.0;intestine: 126.4;liver: 81.8" "Cell type enriched" "Detected in many" 5 "Cholangiocytes: 2236.9" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Group enriched" "Detected in some" 6 "A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046430: AB_2679662" "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 68.2 0.0 0.0 70.3 0.2 0.1 0.3 0.3 196.0 0.2 0.2 0.2 0.4 81.8 0.3 0.0 0.2 0.0 0.2 24.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.2 126.4 0.0 0.2 0.3 2.3 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.3 0.2 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.6 0.1 14.2 0.0 0.0 0.3 0.9 24.0 0.0 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 3.4 2236.9 0.0 1.2 0.0 0.0 0.0 0.0 20.8 0.8 0.0 2.6 23.3 1.7 0.1 0.0 0.0 0.0 475.7 0.1 0.0 2.9 8.0 11.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 7.6 0.0 0.0 2.1 0.0 0.0 1.1 3.6 0.1 0.0 0.1 0.0 0.1 0.1 TM4SF5 ENSG00000142484 "Transmembrane 4 L six family member 5" O14894 17 4771884-4783213 "Predicted membrane proteins" "Cell cycle" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "intestine: 80.9;liver: 69.8" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 219.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 1.1" "Lineage enriched" "Detected in single" 5 "monocytes: 1.1" "Group enriched" "Detected in some" 13 "CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA055674 Uncertain "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" Nucleoplasm "HPA055674: " "unprognostic (1.81e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (4.44e-2)" "unprognostic (9.33e-2)" "unprognostic (3.57e-2)" "unprognostic (1.95e-1)" "unprognostic (5.21e-3)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 45.1 0.1 0.1 50.5 0.1 0.2 0.1 0.1 7.0 0.1 0.1 0.1 3.1 69.8 0.1 0.1 0.1 0.1 0.1 0.9 4.1 0.1 0.6 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 80.9 0.1 0.1 0.1 8.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.4 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 40.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 25.7 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 25.5 0.0 0.0 1.8 0.0 0.0 5.0 1.1 1.5 0.0 55.9 0.0 8.1 1.2 0.0 0.0 4.6 125.4 0.1 0.0 110.5 6.2 3.2 1.3 0.0 0.0 0.0 0.0 76.1 0.0 4.9 190.0 0.0 47.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.9 34.5 0.0 TM6SF1 ENSG00000136404 "Transmembrane 6 superfamily member 1" Q9BZW5 15 83107407-83144854 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 44.3;skeletal muscle: 37.8" "Cell type enhanced" "Detected in many" 9 "granulocytes: 43.8;Hofbauer cells: 47.4;Kupffer cells: 39.6;Macrophages: 43.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 44.3;neutrophil: 26.4" "Lineage enriched" "Detected in many" 6 "granulocytes: 44.3" "Cell line enhanced" "Detected in some" "HEL: 9.3;HHSteC: 22.1;HUVEC TERT2: 11.7;JURKAT: 15.7;TIME: 30.4;U-698: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016051, HPA056857" Uncertain NA NA "HPA016051: AB_2203924, HPA056857: AB_2683259" "unprognostic (8.09e-2)" "unprognostic (1.31e-1)" "unprognostic (2.87e-2)" "unprognostic (4.67e-1)" "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (6.46e-2)" "unprognostic (3.52e-3)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.80e-1)" "unprognostic (2.55e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.15e-2)" "unprognostic (4.65e-3)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" 9.6 3.4 4.9 4.9 6.8 4.7 11.2 4.4 13.9 4.0 3.0 6.8 0.9 2.3 3.2 4.1 2.4 3.4 3.9 9.2 7.2 6.7 2.9 2.5 10.6 9.0 8.0 7.1 2.1 1.5 1.8 1.7 7.2 10.0 2.5 2.9 3.4 3.2 1.9 37.8 1.7 2.6 3.8 12.5 5.2 2.1 4.1 3.7 0.6 9.9 3.5 3.0 4.9 2.4 0.2 4.6 44.3 7.8 1.0 1.2 2.8 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.2 9.3 0.0 0.0 22.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 11.7 15.7 0.4 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.8 0.2 0.0 6.5 30.4 0.3 0.4 0.0 0.1 0.9 0.0 7.0 0.0 1.2 0.0 14.1 7.8 44.3 1.2 3.3 0.0 0.0 0.1 0.1 4.6 0.2 0.0 0.1 26.4 1.0 1.4 0.6 0.0 2.8 4.9 6.8 4.4 13.9 7.2 6.7 8.0 7.1 10.0 3.7 0.0 8.9 0.5 0.0 2.2 1.1 1.2 2.5 1.4 1.2 0.0 0.0 0.2 0.0 0.1 9.8 10.5 0.0 0.0 1.8 0.3 0.7 0.0 43.8 0.0 47.4 0.0 0.0 5.5 39.6 6.3 0.9 43.7 3.3 5.4 0.0 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.4 14.9 2.2 1.5 0.2 5.0 0.0 0.0 TM6SF2 Lpr4 ENSG00000213996 "Transmembrane 6 superfamily member 2" Q9BZW4 19 19264364-19273391 "Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 89.4" "Group enriched" "Detected in some" 6 "Enterocytes: 20.0;Hepatocytes: 25.1;Paneth cells: 34.5" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 3.4;HHSteC: 4.9;LHCN-M2: 3.8;NTERA-2: 2.6;SH-SY5Y: 4.4;SuSa: 2.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA066026 Uncertain NA NA "HPA066026: AB_2685598" "unprognostic (2.41e-1)" "unprognostic (4.81e-3)" "unprognostic (1.49e-1)" "unprognostic (1.15e-3)" "unprognostic (3.29e-1)" "unprognostic (2.35e-1)" "unprognostic (1.39e-3)" "unprognostic (4.00e-2)" "unprognostic (4.15e-2)" "unprognostic (4.53e-4)" "unprognostic (9.55e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.56e-2)" "unprognostic (1.51e-1)" "unprognostic (6.15e-2)" 0.1 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.3 0.6 43.2 0.2 0.2 36.8 0.4 1.7 0.2 0.2 1.0 0.4 0.2 0.5 3.2 18.5 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.5 0.5 0.9 0.4 0.2 0.4 0.0 0.1 89.4 0.2 0.1 0.1 1.1 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.4 0.1 2.1 1.2 1.0 1.3 1.0 0.1 0.0 1.0 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 3.4 4.9 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.9 4.4 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.3 0.2 0.5 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 20.0 0.0 0.2 0.2 0.6 0.0 4.6 25.1 0.1 0.0 0.0 1.3 0.3 0.0 0.6 0.0 1.7 0.0 1.1 0.0 0.1 34.5 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 TM7SF2 "ANG1, DHCR14A, NET47" ENSG00000149809 "Transmembrane 7 superfamily member 2" O76062 11 65111845-65116384 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 78.1" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 176.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 22.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 22.1;RPTEC TERT1: 25.4;T-47d: 49.4" "Low region specificity" "Detected in all" "HPA030691, HPA072704" Enhanced Supported "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA030691: AB_10602480, HPA072704: AB_2686551" "unprognostic (1.62e-1)" "unprognostic (5.23e-2)" "unprognostic (1.70e-2)" "unprognostic (1.78e-1)" "unprognostic (5.74e-2)" "unprognostic (1.10e-1)" "unprognostic (5.98e-2)" "unprognostic (6.06e-2)" "unprognostic (5.72e-2)" "unprognostic (1.74e-2)" "unprognostic (7.06e-2)" "unprognostic (1.69e-1)" "prognostic favorable (8.49e-8)" "unprognostic (8.77e-2)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.44e-2)" 27.7 78.1 6.9 2.2 12.5 2.0 10.0 5.6 21.7 4.7 3.1 22.4 5.1 4.8 1.5 11.0 11.5 6.4 8.5 28.2 7.4 6.6 8.3 38.6 5.1 1.7 10.3 9.6 13.5 22.6 11.8 6.2 2.2 13.2 19.8 2.3 5.4 28.5 3.3 3.3 17.9 2.8 1.3 7.3 1.9 8.8 5.3 8.8 1.9 7.4 13.6 10.4 2.6 6.1 7.4 22.6 1.8 1.0 7.3 7.6 3.0 2.6 3.6 8.5 12.2 3.4 0.2 5.4 0.6 1.3 1.0 1.1 8.8 12.4 5.4 9.6 0.4 0.3 4.3 3.7 6.0 0.7 5.2 1.9 3.3 1.0 17.7 6.9 1.3 3.7 1.5 1.8 4.9 0.6 4.0 0.9 10.3 1.9 4.2 0.3 22.1 2.3 5.8 4.6 5.6 4.1 7.2 0.4 12.7 25.4 3.9 9.6 10.8 0.4 9.3 2.1 5.6 49.4 3.6 0.6 0.1 1.3 1.2 0.8 9.6 6.0 3.1 0.8 2.1 0.3 0.5 1.0 1.8 5.5 0.8 4.3 7.1 3.5 4.5 0.9 7.4 7.6 5.5 0.7 7.3 0.5 22.6 3.1 3.0 6.9 12.5 5.6 21.7 7.4 6.6 10.3 9.6 13.2 8.8 8.9 36.6 11.1 5.3 1.6 15.6 89.9 50.9 6.7 5.7 41.8 9.8 64.7 14.9 20.7 26.9 4.5 21.7 0.0 24.2 1.7 3.3 37.3 6.9 79.7 12.7 23.8 57.1 4.3 6.3 49.4 9.2 3.5 11.8 13.6 16.5 176.3 28.8 11.5 2.1 62.4 21.2 12.9 2.3 10.9 9.4 6.0 68.7 8.5 12.4 8.4 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 38.7 54.0 76.1 41.7 82.7 72.5 49.8 41.7 55.8 35.3 49.0 22.6 44.7 37.8 28.4 72.6 43.0 30.5 40.3 49.8 61.4 61.6 50.3 50.3 36.6 50.3 63.6 46.0 41.7 59.5 21.6 45.4 28.7 53.3 36.9 47.0 39.2 39.6 37.4 107.4 28.4 41.1 36.5 57.4 41.5 39.0 35.0 41.0 37.9 38.3 67.6 56.6 29.9 37.7 125.7 139.0 192.1 98.7 79.4 146.7 204.3 65.2 47.4 76.9 55.0 63.8 62.3 53.0 54.0 42.6 51.8 51.5 38.5 47.3 42.7 38.6 46.9 67.6 25.6 67.0 60.9 57.9 52.5 57.1 80.5 102.1 98.1 49.7 91.3 54.0 57.0 65.5 48.9 47.7 50.8 65.3 76.4 43.0 45.7 73.8 67.6 106.2 124.3 102.5 71.0 76.5 30.4 48.2 72.3 89.0 88.5 25.3 64.3 60.8 44.5 81.2 74.5 42.9 135.7 48.8 44.0 79.1 67.9 105.3 76.3 112.4 102.9 56.4 88.3 45.5 141.0 98.7 192.1 110.7 89.8 119.5 125.7 146.7 132.9 104.9 100.5 146.3 140.0 188.5 79.4 87.7 139.0 143.8 204.3 76.1 82.7 41.7 55.8 61.4 61.6 63.6 46.0 53.3 41.0 223.4 369.4 511.1 446.0 636.3 196.3 594.9 570.7 348.0 349.2 854.9 100.1 706.5 1455.6 502.0 547.1 428.3 899.7 443.9 893.2 693.8 535.7 516.2 437.2 865.9 741.4 112.8 610.5 535.9 636.7 794.0 598.9 617.4 737.2 776.3 895.2 244.7 727.5 821.9 436.7 886.4 223.1 349.3 415.1 507.5 743.5 785.4 368.1 657.2 795.4 485.3 TMC1 "DFNA36, DFNB11, DFNB7" ENSG00000165091 "Transmembrane channel like 1" Q8TDI8 9 72521608-72838230 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Hearing, Ion transport, Transport" "Ion channel" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 3.0" "Cell type enhanced" "Detected in some" 8 "Cytotrophoblasts: 3.3;Early spermatids: 3.7;Glandular cells: 3.2;Urothelial cells: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;HAP1: 10.5;NTERA-2: 4.3;SuSa: 1.6;U-266/84: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.36e-2)" "unprognostic (1.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.19e-3)" "unprognostic (3.97e-1)" "unprognostic (5.67e-4)" "unprognostic (1.63e-1)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (3.74e-1)" "unprognostic (3.94e-2)" "unprognostic (2.12e-1)" "unprognostic (2.67e-3)" "unprognostic (1.80e-1)" "unprognostic (2.35e-1)" "unprognostic (3.94e-2)" "unprognostic (1.31e-1)" 0.2 0.0 0.9 0.0 0.7 0.0 0.2 0.2 1.1 3.0 0.0 0.0 0.2 1.3 0.7 0.7 0.2 0.0 0.7 0.5 1.4 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 1.5 0.0 0.0 1.1 0.0 0.3 1.6 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.3 10.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 3.3 0.0 0.1 3.7 0.4 0.0 0.0 0.5 2.1 0.4 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.0 1.0 0.0 0.9 0.4 0.0 0.0 2.9 0.0 0.0 0.4 1.2 3.0 0.0 2.2 0.0 0.0 5.9 TMC2 "C20orf145, dJ686C3.3" ENSG00000149488 "Transmembrane channel like 2" Q8TDI7 20 2536607-2641784 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 8.1;pituitary gland: 3.2" "Cell type enriched" "Detected in some" 6 "Late spermatids: 9.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Cell line enhanced" "Detected in single" "ASC diff: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (4.73e-2)" "unprognostic (1.87e-1)" "unprognostic (5.88e-2)" "unprognostic (8.30e-4)" "unprognostic (2.86e-3)" "unprognostic (3.00e-1)" "unprognostic (1.13e-2)" "unprognostic (1.07e-2)" "unprognostic (4.54e-1)" "unprognostic (1.41e-2)" "unprognostic (4.05e-5)" "unprognostic (2.90e-1)" "unprognostic (3.21e-7)" "unprognostic (2.47e-2)" "unprognostic (2.56e-1)" "unprognostic (1.93e-1)" "unprognostic (5.74e-2)" 2.3 0.4 0.3 0.3 0.8 0.0 0.7 8.1 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.2 0.9 0.0 0.2 0.9 0.0 0.0 3.0 0.2 0.1 0.5 0.1 0.1 3.2 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.0 2.5 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.1 0.2 0.4 0.3 0.2 3.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331217-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 15 "parathyroid gland: 66.9" "Cell type enhanced" "Detected in single" 24 "Distal tubular cells: 1.7" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Region enhanced" "Detected in some" "pons and medulla: 1.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040265, HPA040510" Enhanced Supported Cytosol NA NA Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.0 0.1 0.0 1.7 0.0 0.3 0.2 0.4 1.4 1.5 1.5 0.0 0.0 0.2 0.8 4.6 0.7 0.8 0.2 0.2 0.0 0.1 0.1 1.3 0.0 0.1 0.0 0.0 0.2 0.2 66.9 1.5 0.7 1.6 1.0 0.1 0.4 0.2 2.9 0.0 0.2 0.5 1.7 1.9 0.1 0.8 3.0 0.0 0.0 1.5 0.0 0.0 1.3 3.6 1.6 0.7 0.2 0.2 0.2 1.8 0.7 0.9 1.0 0.5 2.7 0.4 0.2 1.9 0.8 0.3 0.2 0.3 0.7 1.9 2.3 0.1 0.0 2.4 0.7 0.3 0.2 0.1 1.7 1.4 1.9 1.1 0.9 0.3 1.5 1.1 0.5 0.1 0.4 0.3 1.2 0.0 2.8 0.6 2.8 0.2 0.8 1.0 1.4 1.5 0.8 0.9 0.7 1.0 4.3 0.2 0.6 1.1 2.0 0.9 1.0 2.0 0.6 2.3 1.1 0.4 1.5 1.8 1.3 0.5 4.6 1.8 1.4 1.1 2.5 0.9 0.1 0.0 0.2 0.7 0.1 0.6 1.2 0.8 0.4 0.1 1.6 1.8 1.3 0.2 0.2 0.2 0.7 0.9 0.7 0.0 0.0 0.4 1.4 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 TMC4 ENSG00000167608 "Transmembrane channel like 4" 19 54160108-54173250 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 45.8;seminal vesicle: 49.1" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 180.2;Paneth cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "OE19: 13.2;T-47d: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048635 Approved Approved Vesicles NA NA Vesicles "HPA048635: AB_2680470" "unprognostic (7.55e-2)" "unprognostic (1.66e-1)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (7.04e-2)" "unprognostic (1.68e-1)" "unprognostic (4.82e-2)" "unprognostic (2.19e-2)" "unprognostic (1.03e-1)" "unprognostic (2.68e-3)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "prognostic favorable (1.54e-8)" "unprognostic (6.70e-2)" "unprognostic (2.48e-1)" "unprognostic (8.94e-2)" "unprognostic (1.79e-2)" 1.2 0.4 0.8 4.7 1.2 0.0 6.5 0.5 0.7 3.7 31.0 0.0 32.0 19.7 2.0 16.2 2.9 8.7 21.8 1.7 0.9 0.8 11.8 0.8 9.6 0.0 0.8 0.0 3.8 25.0 0.3 11.1 6.9 0.0 8.6 7.5 0.0 34.5 49.1 0.8 1.3 45.8 0.8 0.6 0.3 8.2 0.6 0.0 1.0 17.1 2.8 5.6 6.7 2.7 0.0 0.0 1.5 1.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.8 1.2 0.5 0.7 0.9 0.8 0.8 0.0 0.0 0.0 26.8 25.9 0.5 19.7 2.2 0.3 1.6 58.6 71.0 25.0 43.6 0.0 19.8 11.6 62.6 0.0 1.3 180.2 0.0 57.0 5.4 1.9 25.5 5.7 1.0 3.3 0.0 40.0 1.8 2.2 0.0 1.1 2.8 1.7 1.8 82.2 0.1 44.7 96.5 0.7 21.6 0.2 25.8 9.9 0.1 2.3 1.5 19.6 2.1 71.7 32.6 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.3;OE19: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.5 5.8 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.2 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 1.3 21.6 1.6 0.0 0.0 1.3 0.1 0.1 0.3 0.1 0.0 1.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 145.9 125.6 0.0 19.6 0.7 0.1 0.8 122.3 547.4 299.1 21.0 2.0 31.1 0.0 107.5 21.7 0.4 170.3 0.0 144.9 1.6 0.8 88.4 5.7 0.0 2.3 3.2 37.4 0.6 0.0 28.2 0.3 0.9 1.7 1.8 97.1 0.1 236.7 190.0 0.7 0.4 1.5 0.0 0.9 1.8 1.1 1.5 13.6 0.0 77.1 46.1 TMC6 "EVER1, EVIN1, LAK-4P" ENSG00000141524 "Transmembrane channel like 6" Q7Z403 17 78110458-78132407 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4" "Cell type enhanced" "Detected in many" 4 "monocytes: 77.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 34.4;SK-BR-3: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051430 Uncertain NA NA "HPA051430: AB_2681483" "unprognostic (6.34e-2)" "unprognostic (5.14e-2)" "unprognostic (5.55e-2)" "unprognostic (2.81e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" "unprognostic (5.36e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-1)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.70e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.20e-4)" 10.5 3.5 7.5 26.1 25.5 39.6 8.3 2.1 12.8 4.1 8.8 33.5 5.6 13.5 3.1 1.7 9.5 5.6 6.5 8.1 12.5 8.1 6.9 3.7 14.4 39.2 43.1 4.6 1.7 6.4 1.8 2.4 6.6 20.3 7.5 4.7 3.6 12.7 7.2 2.3 6.5 17.5 2.7 31.4 41.4 9.1 1.6 31.2 12.1 5.0 2.7 24.8 7.3 6.5 13.5 8.3 9.8 26.7 15.6 27.2 13.2 5.5 4.4 2.4 1.9 0.0 0.0 5.0 0.0 0.0 0.0 0.0 8.0 6.3 6.3 7.8 0.0 2.1 9.9 0.3 1.9 0.0 0.6 3.6 13.1 1.2 9.8 0.6 11.9 22.3 0.3 5.3 0.0 0.4 0.0 4.8 2.9 34.4 23.8 0.0 11.2 5.8 20.4 1.9 10.5 1.6 2.6 0.2 18.4 3.7 20.7 0.6 1.6 1.8 39.2 10.6 3.3 22.3 18.2 1.6 0.0 3.0 0.0 0.1 18.9 8.2 4.0 0.0 19.3 0.3 6.4 4.9 9.8 27.2 16.9 23.7 13.5 20.1 21.9 8.3 10.2 18.1 18.7 6.9 15.6 26.7 2.5 17.0 13.2 7.5 25.5 2.1 12.8 12.5 8.1 43.1 4.6 20.3 31.2 38.7 26.4 66.2 15.9 9.8 3.5 11.8 10.2 5.3 22.7 15.7 0.0 0.9 0.0 38.9 0.3 14.3 19.3 23.3 20.8 23.7 5.3 23.5 39.3 0.9 59.4 1.6 8.7 23.4 44.3 0.4 8.9 34.5 13.5 77.5 10.4 6.3 30.2 43.2 1.1 1.4 1.3 12.9 4.6 0.3 1.9 8.9 3.1 73.4 30.8 33.5 TMC7 FLJ21240 ENSG00000170537 "Transmembrane channel like 7" Q7Z402 16 18983934-19063942 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8;testis: 14.9" "Cell type enriched" "Detected in many" 4 "Early spermatids: 117.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029465 Uncertain Approved Vesicles NA NA Vesicles "HPA029465: AB_10600914" "unprognostic (1.80e-4)" "unprognostic (6.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-3)" "unprognostic (1.25e-1)" "unprognostic (1.19e-3)" "unprognostic (7.60e-5)" "prognostic unfavorable (3.20e-4)" "unprognostic (7.60e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.64e-4)" "unprognostic (3.39e-1)" "unprognostic (1.00e-1)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (5.66e-2)" "prognostic favorable (9.20e-4)" 3.6 0.7 6.2 1.9 11.4 0.7 2.0 8.5 11.1 1.1 6.7 24.8 0.0 4.4 1.5 1.3 0.9 1.0 2.6 1.6 9.7 5.3 1.0 0.7 5.2 0.7 15.7 6.6 0.7 0.9 1.4 0.7 7.7 12.8 2.8 8.2 0.6 0.7 1.9 1.6 2.0 4.9 2.2 15.7 1.1 5.4 14.9 12.8 0.0 1.6 0.0 0.6 9.6 1.3 1.6 1.2 2.9 0.8 1.6 1.0 0.2 1.9 4.0 1.2 2.0 0.2 1.7 5.3 0.7 1.1 0.7 1.8 1.3 9.3 0.2 8.9 0.7 2.0 7.3 3.2 3.1 0.9 0.1 2.3 0.2 3.2 5.7 0.2 0.2 0.1 0.4 4.5 7.2 8.1 2.4 3.0 4.1 2.2 0.7 3.2 4.5 0.3 0.3 3.4 12.1 5.9 0.2 3.5 0.3 1.3 9.7 0.7 2.0 2.2 6.1 0.6 5.6 1.8 0.7 2.6 1.2 2.0 1.4 3.5 0.5 1.0 0.3 6.2 0.3 1.0 2.5 0.8 0.8 0.9 0.6 0.5 0.9 0.9 0.7 0.3 1.6 0.9 1.0 2.9 1.6 0.4 1.2 0.5 0.2 6.2 11.4 8.5 8.3 9.7 5.3 15.7 6.6 12.8 12.8 3.0 3.8 0.0 2.5 0.3 0.6 0.8 2.5 0.0 1.2 0.0 0.0 0.1 0.0 2.8 117.6 3.0 3.9 0.0 10.0 1.5 0.4 2.0 0.0 0.2 0.2 0.0 1.2 4.3 0.0 29.3 1.1 1.2 0.0 0.0 5.4 0.2 9.6 6.8 0.4 0.0 2.5 0.0 1.0 5.4 10.0 0.9 0.2 0.0 3.3 15.2 TMC8 "EVER2, EVIN2" ENSG00000167895 "Transmembrane channel like 8" Q8IU68 17 78130770-78142968 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9" "Cell type enhanced" "Detected in many" 7 "B-cells: 29.6;granulocytes: 40.4;Hofbauer cells: 25.4;monocytes: 26.2;T-cells: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.7;HL-60: 20.9;HMC-1: 42.3;Karpas-707: 36.0;RPMI-8226: 22.2;U-266/70: 17.4;U-937: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047387, HPA054429" Uncertain Uncertain "Golgi apparatus" NA NA "Golgi apparatus" "HPA047387: , HPA054429: AB_2682485" "unprognostic (8.54e-3)" "prognostic favorable (8.45e-6)" "unprognostic (1.32e-1)" "unprognostic (2.33e-3)" "unprognostic (3.59e-1)" "prognostic favorable (4.19e-5)" "unprognostic (6.38e-3)" "unprognostic (6.47e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-1)" "unprognostic (6.06e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.24e-2)" "unprognostic (1.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" 3.6 1.6 2.3 30.1 4.6 33.6 1.9 0.7 2.3 1.7 4.4 3.5 0.1 4.2 2.5 2.1 2.5 2.1 6.2 1.5 2.3 1.7 3.4 3.1 10.7 38.7 4.0 0.8 0.9 1.2 0.1 1.3 1.5 2.8 2.4 1.9 2.6 10.2 1.0 0.6 1.7 23.2 1.0 5.1 52.9 4.1 0.7 3.7 49.7 3.1 1.8 36.6 3.9 2.5 5.0 2.1 5.5 6.6 6.7 13.1 4.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 15.7 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.2 0.0 20.9 42.3 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.3 36.0 0.0 0.4 7.1 0.9 0.0 1.1 0.1 0.4 0.1 22.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 2.3 4.3 0.0 0.0 0.0 0.0 0.0 17.4 0.7 1.5 0.0 17.7 0.0 2.3 1.8 5.5 13.1 3.1 9.4 5.0 10.5 12.9 2.1 5.0 9.4 8.4 3.0 6.7 6.6 1.9 5.7 4.2 2.3 4.6 0.7 2.3 2.3 1.7 4.0 0.8 2.8 3.7 3.0 15.1 29.6 9.3 4.7 0.0 1.6 0.0 1.4 7.9 0.0 0.0 0.3 0.0 0.9 0.3 1.4 2.1 0.0 1.1 1.0 1.5 2.2 40.4 0.4 25.4 0.0 1.2 6.2 22.6 0.0 0.0 15.6 6.8 26.2 0.8 0.2 0.4 3.1 0.4 0.3 0.0 0.0 1.7 0.4 0.5 4.0 0.5 39.2 2.2 11.7 TMCC2 "FLJ38497, HUCEP11" ENSG00000133069 "Transmembrane and coiled-coil domain family 2" O75069 1 205228176-205273343 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 83.6;brain: 25.9" "Cell type enhanced" "Detected in many" 23 "Erythroid cells: 140.2;Horizontal cells: 38.1;Rod photoreceptor cells: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Lineage enhanced" "Detected in single" "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "SCLC-21H: 27.3;WM-115: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014254 Approved NA NA "HPA014254: AB_1851326" "unprognostic (2.59e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (2.61e-2)" "unprognostic (4.18e-1)" "unprognostic (5.59e-2)" "unprognostic (2.46e-2)" "unprognostic (4.89e-2)" "unprognostic (2.53e-1)" "unprognostic (5.08e-2)" "unprognostic (1.05e-5)" "unprognostic (3.17e-1)" "unprognostic (1.39e-1)" "unprognostic (1.99e-3)" "unprognostic (3.06e-2)" "unprognostic (4.01e-1)" "unprognostic (3.43e-3)" 2.6 4.5 22.2 2.3 17.4 83.6 1.8 22.7 24.0 2.4 2.0 16.5 0.0 2.2 2.8 1.9 2.1 2.5 2.2 2.5 25.9 16.8 2.5 1.8 2.5 2.2 25.4 13.3 4.2 2.0 3.7 3.3 7.9 22.4 2.2 1.9 9.3 2.3 2.3 6.4 2.9 2.5 2.4 24.1 5.6 2.2 3.4 14.2 0.0 2.1 0.0 2.0 2.1 2.2 0.0 0.0 1.1 0.0 0.0 0.3 4.4 1.6 0.8 1.6 3.5 0.6 0.2 0.8 2.1 1.0 2.2 1.6 0.2 0.2 1.6 0.3 0.6 5.8 2.9 1.0 0.5 0.6 4.3 3.3 5.7 0.4 0.1 0.3 0.3 3.0 0.3 0.1 1.1 0.0 1.8 0.3 1.6 3.4 2.3 0.8 0.1 0.0 0.8 3.8 0.0 4.7 2.2 3.7 7.8 0.4 0.1 27.3 3.9 0.2 0.0 7.0 1.4 0.6 0.4 0.6 1.5 2.2 3.7 2.3 3.9 1.6 1.0 1.2 0.5 9.1 0.0 0.0 1.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 4.4 22.2 17.4 22.7 24.0 25.9 16.8 25.4 13.3 22.4 14.2 0.0 0.0 0.0 0.2 0.9 21.3 3.3 0.0 0.0 0.0 1.8 9.8 0.1 0.0 1.2 1.4 2.2 0.0 140.2 0.0 0.1 0.9 0.1 0.0 0.0 0.7 38.1 3.4 2.5 1.2 0.0 1.1 0.0 3.3 13.6 0.0 13.2 0.3 0.0 0.4 0.2 35.3 0.0 0.8 1.2 5.5 0.6 0.0 0.0 0.0 0.0 TMCO2 dJ39G22.2 ENSG00000188800 "Transmembrane and coiled-coil domains 2" Q7Z6W1 1 40245947-40251691 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 74.7" "Group enriched" "Detected in some" 81 "Early spermatids: 2374.6;Late spermatids: 756.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;NB-4: 1.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (5.30e-2)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.25e-1)" "unprognostic (3.93e-2)" "unprognostic (2.70e-5)" "unprognostic (6.16e-2)" "unprognostic (2.29e-1)" "unprognostic (1.62e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 2374.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 756.1 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 19.4 0.0 13.0 5.8 0.0 0.1 0.0 0.0 0.0 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "testis: 43.9" "Group enriched" "Detected in some" 135 "Early spermatids: 1004.2;Late spermatids: 3019.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.2;hTERT-HME1: 1.9" "Group enriched" "Detected in many" 4 "amygdala: 6.0;basal ganglia: 2.2;cerebral cortex: 5.7;hippocampal formation: 6.7" "Not detected" "Not detected" HPA056530 Enhanced NA NA "HPA056530: AB_2683167" "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1004.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3019.1 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 6.5 0.0 14.9 5.2 0.0 0.0 0.0 0.0 0.0 TMED3 "C15orf22, p24B, p24g4, p24gamma4" ENSG00000166557 "Transmembrane p24 trafficking protein 3" Q9Y3Q3 15 79311062-79427432 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 182.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049314, HPA076949" Enhanced Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA049314: AB_2680708, HPA076949: AB_2686820" "prognostic unfavorable (7.71e-4)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (8.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.03e-3)" "unprognostic (2.42e-2)" "unprognostic (2.49e-1)" "unprognostic (4.85e-1)" "unprognostic (9.06e-2)" "unprognostic (8.09e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.16e-1)" "unprognostic (2.88e-1)" "unprognostic (2.50e-1)" "unprognostic (1.52e-1)" 6.1 7.0 5.0 6.1 5.8 7.5 16.8 9.6 8.9 15.0 12.0 6.9 32.2 6.0 10.0 34.9 31.2 9.9 18.0 11.4 6.1 10.0 11.0 4.6 7.7 12.2 5.7 7.5 8.1 68.0 6.5 23.5 24.2 8.2 15.0 13.9 7.1 182.4 34.0 2.0 25.0 6.0 9.4 7.1 9.4 16.0 13.9 4.2 7.0 18.8 20.9 23.4 11.2 17.4 28.3 40.9 34.0 33.0 21.7 29.3 32.2 14.2 37.2 7.2 13.6 50.5 38.9 15.5 34.0 46.3 23.2 28.8 31.0 26.2 6.7 26.0 51.9 30.3 27.0 21.3 21.7 12.2 13.3 32.9 22.5 33.6 22.8 29.5 23.9 44.8 28.7 32.1 13.3 19.5 27.8 26.9 23.1 9.9 0.1 22.6 30.0 6.7 21.8 10.0 53.4 20.9 8.2 10.4 33.6 21.1 10.9 22.0 10.9 18.0 34.7 32.1 24.6 30.2 16.9 22.0 18.8 17.0 0.4 23.6 14.1 16.2 9.4 24.1 38.2 21.9 21.7 26.5 34.0 23.3 31.3 24.8 28.3 23.1 25.2 40.1 23.4 29.3 28.1 2.3 21.7 33.0 40.9 26.2 32.2 5.0 5.8 9.6 8.9 6.1 10.0 5.7 7.5 8.2 4.2 26.8 42.4 32.0 84.7 85.2 13.7 13.7 38.2 17.4 33.0 54.1 7.9 144.0 19.9 121.4 36.7 30.9 49.4 0.0 217.2 259.1 80.2 134.4 47.2 6.4 94.4 12.7 80.6 66.3 51.8 91.1 46.1 49.7 81.0 70.3 131.0 35.8 146.0 51.8 25.8 21.4 12.1 19.4 44.5 43.6 58.2 106.4 144.2 35.5 122.8 149.3 TMED6 "MGC23911, p24g5, p24gamma5" ENSG00000157315 "Transmembrane p24 trafficking protein 6" Q8WW62 16 69343248-69351809 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "pancreas: 144.2" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 31.9;Pancreatic endocrine cells: 21.0;Proximal tubular cells: 16.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 17.2;OE19: 8.2" HPA012532 Approved NA NA "HPA012532: AB_1858065" "unprognostic (6.85e-2)" "unprognostic (1.42e-1)" "unprognostic (6.31e-3)" "prognostic favorable (7.74e-5)" "unprognostic (9.84e-3)" "unprognostic (7.57e-2)" "unprognostic (2.40e-1)" "unprognostic (1.20e-1)" "unprognostic (7.94e-2)" "unprognostic (3.74e-1)" "unprognostic (2.94e-2)" "unprognostic (4.76e-2)" "unprognostic (4.58e-3)" "unprognostic (9.71e-2)" "unprognostic (1.50e-1)" "unprognostic (1.36e-1)" "unprognostic (4.52e-3)" 0.2 0.2 0.2 0.7 0.2 0.0 0.2 0.2 0.2 0.4 0.9 0.2 2.0 2.7 0.3 4.5 0.2 5.6 0.3 0.2 0.2 0.1 6.1 3.1 0.7 0.2 0.2 0.2 1.0 144.2 0.0 0.2 0.2 0.2 0.2 1.7 0.2 0.2 3.5 0.2 0.1 2.8 0.2 0.2 0.3 16.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.2 0.0 0.6 0.0 2.0 0.2 0.7 1.8 1.6 1.1 0.1 0.1 1.0 2.3 0.1 0.0 0.3 2.4 1.0 4.7 0.8 0.0 0.7 1.2 0.2 0.2 0.4 0.7 2.0 2.4 0.8 17.2 0.1 2.9 1.1 0.2 0.9 0.1 0.3 0.9 0.1 2.3 1.6 0.6 0.3 1.8 1.3 3.3 2.2 8.2 1.7 2.6 1.4 1.8 0.7 2.0 3.8 1.5 3.1 1.1 1.2 0.6 0.6 2.1 2.1 2.7 1.5 0.9 1.5 1.6 1.4 5.2 1.4 2.5 0.8 0.0 0.4 0.0 0.8 0.6 1.5 0.6 2.0 0.4 0.2 0.3 0.5 2.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.0 0.1 0.0 2.3 0.1 0.0 5.6 0.0 31.9 0.0 0.0 0.2 1.1 3.4 0.3 0.0 8.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 0.7 21.0 5.5 0.0 16.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.1 TMEFF1 "C9orf2, CT120.1, H7365" ENSG00000241697 "Transmembrane protein with EGF like and two follistatin like domains 1" Q8IYR6 9 100473113-100577636 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 21.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.9;BEWO: 9.8;NTERA-2: 19.8;REH: 13.3;SCLC-21H: 16.9;SH-SY5Y: 11.3" "Low region specificity" "Detected in all" HPA051501 Uncertain NA NA "HPA051501: AB_2681509" "unprognostic (1.96e-1)" "unprognostic (2.30e-1)" "unprognostic (9.69e-3)" "unprognostic (2.32e-2)" "unprognostic (9.02e-2)" "unprognostic (3.59e-2)" "unprognostic (2.87e-2)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (1.05e-1)" "unprognostic (5.04e-6)" "unprognostic (1.30e-4)" "unprognostic (1.52e-1)" "unprognostic (3.97e-2)" "unprognostic (3.44e-3)" 1.2 1.2 5.0 1.0 13.9 1.2 1.1 1.4 21.1 1.6 1.3 15.0 0.0 1.0 3.0 1.0 1.0 1.2 1.6 1.0 9.1 8.9 1.2 1.0 1.1 1.4 10.3 7.9 1.0 1.0 1.1 0.4 1.8 11.7 1.5 1.1 0.1 1.1 1.4 1.0 1.0 1.3 1.4 13.8 1.2 1.3 4.1 12.6 0.0 3.1 0.0 1.1 1.0 0.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.4 0.1 0.2 9.8 0.6 0.1 0.4 0.5 0.5 0.1 0.0 1.8 0.3 0.1 0.0 3.0 0.0 0.5 0.0 4.3 0.0 0.2 0.4 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.3 1.2 3.5 0.1 0.0 0.6 0.0 4.9 0.0 19.8 0.0 0.2 13.3 6.8 0.0 0.3 0.0 16.9 11.3 0.0 0.0 0.2 4.7 0.0 0.0 1.8 1.5 2.6 0.1 0.6 3.1 2.2 2.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 13.9 1.4 15.4 9.1 8.9 10.3 7.9 11.7 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 TMEFF2 "CT120.2, HPP1, TENB2, TPEF, TR" ENSG00000144339 "Transmembrane protein with EGF like and two follistatin like domains 2" Q9UIK5 2 191949043-192195709 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.6;prostate: 46.3;seminal vesicle: 17.5" "Group enriched" "Detected in some" 6 "Horizontal cells: 96.9;Leydig cells: 24.5" "Cancer enriched" "Detected in some" 21 "prostate cancer: 57.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 17.3;LHCN-M2: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015587 Approved "Secreted in male reproductive system" NA NA "HPA015587: AB_1858069" "unprognostic (2.12e-3)" "unprognostic (5.37e-1)" "unprognostic (3.10e-1)" "unprognostic (5.89e-7)" "unprognostic (4.96e-2)" "unprognostic (1.27e-1)" "unprognostic (8.82e-2)" "unprognostic (1.64e-1)" "unprognostic (1.86e-1)" "unprognostic (5.55e-2)" "unprognostic (2.09e-2)" "unprognostic (3.79e-2)" "unprognostic (4.17e-3)" "unprognostic (1.55e-2)" "unprognostic (2.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.20e-1)" 1.1 3.8 20.2 1.1 14.7 1.0 1.1 7.4 29.6 1.1 2.0 18.4 1.7 1.7 1.0 11.1 2.4 1.1 3.0 1.4 17.7 18.5 1.0 1.0 1.1 1.0 15.7 17.7 1.1 1.1 1.1 0.4 1.0 11.1 46.3 2.8 2.8 1.1 17.5 1.3 1.1 1.7 1.1 11.1 1.1 1.4 1.8 15.9 0.0 1.1 0.0 1.2 1.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 17.3 0.0 2.7 2.8 0.0 0.0 0.3 0.8 1.0 0.0 0.0 0.0 0.0 4.7 2.1 0.0 1.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 7.5 0.0 0.9 5.1 4.2 0.0 0.0 0.0 0.0 49.6 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.1 1.3 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 14.7 7.4 22.7 17.7 18.5 15.7 17.7 11.1 15.9 0.0 0.0 0.0 0.1 0.1 9.9 1.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.2 4.0 0.0 0.0 0.0 96.9 0.0 0.0 0.0 0.7 24.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.1 0.0 1.3 6.5 0.4 1.2 2.5 0.3 0.0 0.0 0.0 0.0 TMEM100 "FLJ10970, FLJ37856" ENSG00000166292 "Transmembrane protein 100" Q9NV29 17 55719627-55732121 "Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 52.8;lung: 99.5" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 20.4;Leydig cells: 37.7;Peritubular cells: 49.5;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 18.1;ASC TERT1: 12.3;HHSteC: 28.0;HSkMC: 12.9;U-87 MG: 8.5;WM-115: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055936 Approved Uncertain Nucleoplasm NA NA Nucleoplasm "HPA055936: AB_2682975" "unprognostic (1.35e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (4.02e-2)" "unprognostic (6.78e-3)" "unprognostic (3.07e-1)" "prognostic favorable (2.67e-5)" "unprognostic (5.74e-2)" "unprognostic (1.87e-2)" "unprognostic (4.66e-1)" "unprognostic (1.89e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.32e-4)" "unprognostic (4.91e-3)" "unprognostic (1.12e-1)" "unprognostic (2.07e-2)" "unprognostic (1.26e-3)" 24.7 2.0 3.4 1.5 3.9 0.0 52.8 0.7 5.3 5.1 10.5 0.7 8.8 2.7 1.6 16.7 4.6 3.6 4.8 5.8 1.6 2.8 1.2 5.8 99.5 1.5 3.4 0.6 10.1 1.9 0.0 3.3 23.5 2.6 7.4 5.1 2.6 2.2 11.7 7.0 1.3 6.6 5.2 1.4 2.3 10.7 3.9 0.6 0.5 3.8 3.7 1.3 5.3 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 18.1 12.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 28.0 0.0 0.0 12.9 0.0 0.9 0.1 0.1 0.0 0.2 0.5 0.1 0.3 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 1.2 2.4 0.0 0.5 0.0 0.1 8.5 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 0.7 1.7 1.6 2.8 3.4 0.6 2.6 0.6 0.0 5.1 0.0 0.3 2.3 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 14.1 0.0 0.0 0.0 0.0 20.4 0.1 1.1 13.9 0.1 0.0 0.0 7.4 0.0 0.0 37.7 0.6 6.8 0.0 0.0 0.0 0.2 0.0 49.5 0.5 0.0 32.3 12.2 0.0 0.0 2.3 0.1 0.0 0.0 0.1 TMEM105 FLJ38792 ENSG00000185332 "Transmembrane protein 105" Q8N8V8 17 81311270-81330674 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 7.5" "Cell type enhanced" "Detected in some" 9 "Hepatocytes: 4.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.3;MCF7: 3.3;OE19: 3.3;T-47d: 2.1;THP-1: 2.7;U-937: 5.1" NA NA "unprognostic (4.99e-3)" "unprognostic (6.49e-3)" "unprognostic (4.62e-2)" "unprognostic (3.67e-2)" "unprognostic (2.54e-1)" "unprognostic (3.65e-4)" "unprognostic (1.11e-1)" "unprognostic (1.10e-1)" "unprognostic (3.32e-3)" "unprognostic (7.49e-2)" "unprognostic (9.81e-4)" "unprognostic (1.33e-1)" "unprognostic (6.04e-6)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.48e-2)" "unprognostic (3.38e-1)" 0.1 0.8 0.1 0.1 0.1 0.6 0.7 0.0 0.1 0.5 1.7 0.0 0.0 0.5 0.1 0.2 2.4 0.7 5.0 0.0 0.1 0.0 2.4 7.5 4.7 0.1 0.1 0.0 0.2 0.1 0.0 0.1 1.0 0.5 0.8 0.4 0.7 4.0 0.0 0.5 1.1 2.0 1.3 0.2 1.3 0.3 0.2 0.0 0.0 2.4 3.3 2.4 3.3 1.0 0.5 1.0 1.9 0.4 0.8 0.4 0.1 0.5 1.1 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 3.3 0.0 0.2 0.0 3.3 0.1 0.0 0.5 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.0 0.1 2.1 2.7 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 5.1 0.0 0.6 0.4 0.3 0.3 0.1 0.2 0.3 0.2 0.3 0.0 0.5 0.2 0.4 1.9 0.8 0.1 1.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 2.1 0.0 0.4 0.5 0.0 0.4 2.5 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.6 0.0 2.6 0.0 0.2 1.1 0.2 0.4 0.0 4.3 0.3 0.0 0.0 1.3 0.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.0 2.3 0.0 6.5 0.3 0.0 0.0 0.6 0.1 0.0 2.9 0.4 TMEM106A MGC20235 ENSG00000184988 "Transmembrane protein 106A" Q96A25 17 43211835-43220041 "Predicted membrane proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 31.9" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 36.4;Kupffer cells: 35.3;Macrophages: 31.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 15.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "unprognostic (9.71e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (9.61e-5)" "unprognostic (4.95e-3)" "unprognostic (8.62e-2)" "unprognostic (1.79e-1)" "unprognostic (9.11e-2)" "unprognostic (1.76e-1)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (2.99e-2)" "unprognostic (6.08e-2)" "unprognostic (7.89e-3)" "unprognostic (1.39e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (8.30e-2)" 7.6 4.8 4.7 17.2 5.9 3.5 8.9 1.1 3.6 7.4 4.1 5.0 2.6 4.4 7.3 9.1 2.5 6.2 5.2 5.5 4.1 2.8 24.9 5.5 11.0 31.9 5.7 3.6 9.3 6.2 2.6 3.8 18.7 4.1 5.2 6.3 7.2 5.8 6.0 1.9 2.4 6.2 9.9 7.4 16.5 5.5 5.5 5.4 5.3 7.3 4.1 12.0 5.6 5.2 3.3 5.3 17.4 4.9 1.7 2.2 1.7 2.7 0.9 0.3 0.2 3.5 3.9 2.1 7.0 4.5 6.1 9.6 2.1 5.7 4.0 1.4 10.6 2.4 1.3 0.7 0.9 7.2 6.2 0.0 2.7 2.3 9.4 2.0 0.1 15.4 2.4 0.2 11.3 0.3 2.2 5.3 4.8 0.1 2.9 7.6 1.2 4.7 1.8 0.3 0.0 0.0 3.5 1.2 2.4 2.6 0.2 0.6 0.0 1.3 3.3 1.5 1.6 5.0 4.0 6.1 3.1 0.4 3.1 1.4 4.6 0.4 1.2 2.5 4.8 6.0 17.4 4.3 4.8 1.5 4.9 0.6 1.7 1.0 1.4 3.6 3.3 0.7 1.3 1.3 1.7 1.7 5.3 2.2 1.7 4.7 5.9 1.1 3.6 4.1 2.8 5.7 3.6 4.1 5.4 3.0 5.0 11.5 9.6 2.2 4.7 0.8 0.0 5.3 3.4 7.0 2.0 4.6 3.3 1.9 4.1 3.7 2.1 0.0 3.4 5.5 6.6 9.5 8.1 1.6 36.4 0.0 2.9 3.7 35.3 2.1 13.0 31.1 0.0 9.0 3.1 2.0 4.1 2.5 6.7 13.0 3.4 12.9 3.8 7.7 3.8 1.5 4.3 7.0 2.6 10.5 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397792 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.6" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 2.2 15.1 12.7 2.2 13.8 0.7 2.4 15.6 21.7 3.2 1.8 7.5 0.2 1.1 3.7 1.3 12.7 2.4 1.6 8.4 10.0 8.1 1.0 0.6 12.1 2.5 5.3 13.7 0.8 1.0 6.1 2.8 9.1 4.9 4.0 2.2 16.1 1.8 3.2 25.6 2.2 2.0 10.4 4.4 2.0 2.2 16.8 4.3 0.0 4.1 1.5 3.3 12.0 1.3 0.8 0.4 1.0 0.4 0.6 0.8 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.8 4.0 0.0 0.0 0.0 0.0 11.8 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 6.6 0.3 0.0 0.1 1.8 0.0 0.0 0.0 2.3 0.0 0.5 0.0 10.3 45.3 0.0 0.0 0.1 2.8 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.3 0.9 0.0 1.7 1.0 0.3 0.2 0.5 0.3 0.3 0.3 0.2 0.5 0.0 0.8 0.3 0.4 0.9 0.6 0.4 0.4 0.8 0.6 12.7 13.8 15.6 21.7 10.0 8.1 5.3 13.7 4.9 4.3 3.0 2.9 0.0 0.5 2.2 11.4 1.2 0.0 0.0 9.1 0.0 96.2 1.8 0.0 0.0 57.1 1.4 0.0 0.0 0.3 7.2 1.1 0.2 1.1 0.0 0.2 1.6 0.0 0.0 0.0 29.1 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 0.7 0.0 56.3 0.0 1.4 19.1 8.0 1.4 0.9 0.0 0.0 0.3 TMEM110-MUSTN1 ENSG00000248592 "TMEM110-MUSTN1 readthrough" 3 52833121-52897562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.0" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 2: 1.4;Cholangiocytes: 2.5;Club cells: 1.2;Exocrine glandular cells: 1.6;Ito cells: 1.3;Kupffer cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 8.3;Karpas-707: 9.1" HPA051855 Uncertain Approved Cytosol NA NA Cytosol "HPA051855: AB_2681639" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (5.95e-2)" "unprognostic (7.28e-2)" "unprognostic (5.35e-2)" "unprognostic (3.11e-4)" "unprognostic (4.73e-2)" "unprognostic (2.66e-2)" "unprognostic (1.59e-2)" "unprognostic (2.51e-2)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.01e-6)" "unprognostic (5.49e-2)" "unprognostic (7.31e-2)" "unprognostic (4.55e-2)" "unprognostic (5.09e-5)" 13.3 6.7 3.8 5.4 7.6 5.2 5.8 5.2 9.6 4.9 5.5 8.6 3.7 4.1 8.6 3.4 6.4 4.2 3.8 5.8 4.1 3.7 8.0 23.6 5.0 8.6 6.6 3.4 5.2 9.2 2.0 3.8 3.9 6.0 4.1 2.6 6.0 5.5 3.1 58.0 4.2 7.9 7.8 4.8 5.7 5.0 3.9 4.1 8.6 4.4 2.7 6.1 5.8 5.7 0.9 1.6 1.6 1.7 0.0 2.3 0.4 1.5 0.8 1.6 6.2 0.5 0.0 0.0 3.2 1.0 0.2 0.4 0.0 1.0 1.1 0.5 0.0 2.2 1.4 1.6 1.6 0.0 8.3 3.3 2.1 0.0 0.0 0.2 1.4 3.2 0.0 0.6 0.6 1.3 0.0 0.3 4.2 0.9 9.1 0.1 1.0 1.9 1.1 1.1 0.6 4.2 0.3 0.0 2.0 0.3 0.0 0.6 0.4 0.8 0.9 1.9 0.4 0.7 3.1 0.9 1.1 2.9 1.2 1.8 4.2 3.8 1.2 1.4 4.0 1.7 0.0 0.2 1.6 0.4 1.7 2.3 0.9 0.7 0.9 0.8 0.3 0.0 0.0 0.4 0.0 0.0 1.6 0.6 0.4 3.8 7.6 5.2 7.6 4.1 3.7 6.6 3.4 6.0 4.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.2 0.0 0.0 0.3 0.0 1.0 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 TMEM114 ENSG00000232258 "Transmembrane protein 114" B3SHH9 16 8537605-8590193 "Disease related genes, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "ductus deferens: 60.1;seminal vesicle: 24.7" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 19 "hypothalamus: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.5;U-2 OS: 2.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "hypothalamus: 9.6" NA NA "unprognostic (3.72e-5)" "unprognostic (2.26e-1)" "unprognostic (3.98e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.51e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.4 0.0 60.1 0.0 0.0 1.5 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.4 0.0 0.0 0.0 24.7 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 8.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM120A "NET29, TMPIT" ENSG00000189077 "Transmembrane protein 120A" Q9BXJ8 7 75986837-75994659 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 64.3" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 217.5;Late spermatids: 771.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 64.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.78e-2)" "unprognostic (3.35e-2)" "unprognostic (1.71e-2)" "unprognostic (4.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.99e-1)" "unprognostic (3.26e-1)" "unprognostic (2.75e-3)" "unprognostic (6.16e-2)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.02e-1)" "unprognostic (6.58e-2)" "unprognostic (6.61e-2)" "unprognostic (1.71e-1)" "unprognostic (5.15e-2)" 8.7 14.0 6.3 2.4 6.2 3.0 11.8 3.5 5.2 5.2 15.2 3.1 11.1 15.5 3.4 5.6 6.4 5.3 7.4 25.0 5.6 8.2 14.9 3.9 5.1 6.0 3.9 12.6 8.9 3.1 1.9 3.8 15.4 5.5 3.7 4.3 7.3 12.7 11.0 2.4 24.0 4.5 3.8 3.9 5.0 10.8 5.0 0.5 4.7 12.5 3.0 4.2 5.0 5.4 8.0 64.3 16.5 7.7 13.6 11.1 4.8 7.7 3.2 27.0 24.7 16.1 8.5 4.6 12.5 6.1 8.4 12.5 6.2 2.6 3.5 13.1 19.4 5.4 3.3 4.8 2.0 4.1 4.1 2.5 5.2 17.3 23.9 0.9 16.3 17.5 4.0 4.7 6.1 6.4 10.3 5.5 4.4 3.4 10.8 8.1 1.4 15.5 1.5 10.7 8.0 1.5 3.9 11.4 12.6 4.4 1.7 9.1 5.0 14.1 8.0 8.2 10.5 5.8 5.3 17.4 6.0 10.3 3.9 4.5 3.2 0.9 10.2 2.5 3.9 24.5 16.5 29.4 7.7 14.6 5.8 4.4 6.4 6.0 8.0 5.4 4.5 4.4 64.3 7.7 14.6 3.0 13.6 11.1 20.8 10.5 14.7 17.4 0.0 5.0 99.7 45.9 8.1 15.9 26.2 5.9 18.4 21.6 38.0 217.5 23.9 179.6 23.3 34.0 12.7 22.1 21.2 23.2 102.6 31.8 11.1 8.1 18.4 36.2 771.6 37.4 28.9 0.0 14.4 31.0 12.6 35.2 112.2 29.0 101.8 5.9 38.8 23.0 80.7 14.5 0.0 9.2 20.8 35.2 23.1 TMEM120B ENSG00000188735 "Transmembrane protein 120B" A0PK00 12 121712752-121783001 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 23.1;cerebellum: 35.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014066 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" Cytosol "HPA014066: AB_1845296" "unprognostic (8.80e-3)" "unprognostic (3.31e-2)" "unprognostic (1.95e-2)" "unprognostic (1.40e-2)" "unprognostic (3.10e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (3.62e-1)" "unprognostic (3.29e-1)" "unprognostic (5.54e-2)" "unprognostic (2.10e-2)" "unprognostic (1.25e-1)" "unprognostic (5.86e-2)" "unprognostic (8.02e-3)" "unprognostic (2.31e-1)" "unprognostic (2.13e-3)" "unprognostic (4.72e-2)" 7.9 7.0 5.6 4.7 23.1 9.3 5.6 35.6 6.9 11.1 4.4 3.3 8.6 4.2 10.0 5.4 2.8 12.2 4.5 3.9 5.9 3.8 4.5 4.7 5.3 4.0 4.5 4.3 5.0 14.3 5.9 11.6 2.4 6.0 5.2 3.1 5.5 14.9 6.2 17.2 5.7 3.8 8.0 2.9 4.3 4.9 3.4 5.8 1.9 10.6 4.0 3.8 3.6 7.1 4.1 4.0 3.6 1.6 2.4 3.4 1.3 4.8 16.6 3.9 11.4 4.9 6.5 8.0 6.4 7.4 6.2 5.0 10.5 5.6 5.2 4.0 6.5 6.1 8.3 9.1 7.7 3.3 3.1 8.4 7.2 5.2 6.5 6.7 5.1 5.7 6.0 6.9 7.0 5.1 11.0 3.8 11.6 6.4 3.8 3.7 7.8 8.4 7.0 7.0 3.3 10.3 10.0 16.1 6.9 3.2 5.3 15.0 10.7 6.3 5.0 5.6 7.5 11.3 4.1 5.3 8.3 9.4 5.3 5.6 8.9 3.1 3.8 10.6 6.6 8.3 3.1 1.4 1.7 3.4 1.6 2.8 2.9 3.3 2.7 1.6 4.1 2.4 2.8 3.6 2.4 1.5 4.0 2.8 1.3 5.6 23.1 35.6 6.9 5.9 3.8 4.5 4.3 6.0 5.8 23.8 12.6 12.3 4.4 5.8 35.4 6.1 12.7 4.0 7.9 10.4 21.6 5.6 6.6 7.6 14.5 4.9 21.9 0.0 10.8 5.8 6.5 5.4 4.6 2.9 5.1 12.7 6.3 1.8 4.0 26.1 6.1 8.5 1.7 36.9 3.0 2.5 19.5 4.5 6.0 4.9 21.7 6.5 7.1 6.2 4.9 6.0 9.5 28.8 3.6 3.9 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 9.5;Muller glia cells: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Cell line enhanced" "Detected in some" "EFO-21: 9.5;MCF7: 8.9;PC-3: 11.7;REH: 7.5;SCLC-21H: 6.1;WM-115: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.5 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.5 0.0 0.0 1.5 1.3 9.5 0.0 0.8 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.9 0.2 0.0 1.4 0.1 11.7 7.5 0.0 0.1 0.1 0.0 6.1 2.3 0.5 0.0 2.2 0.1 2.7 0.3 1.6 1.3 2.4 0.2 0.5 0.7 0.0 0.0 0.1 0.5 6.2 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 0.0 0.3 0.5 2.4 4.0 4.3 1.2 0.0 1.4 1.2 5.2 0.0 0.2 0.0 1.0 1.3 7.1 0.0 0.0 0.2 1.2 3.8 1.7 0.0 1.7 0.3 9.5 0.0 7.4 0.3 1.5 4.0 0.0 6.8 0.0 0.0 17.0 0.0 0.0 6.0 0.0 1.1 0.0 1.7 0.5 3.1 2.3 0.2 0.0 0.0 0.6 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Group enriched" "Detected in some" 8 "granulocytes: 1.1;Hofbauer cells: 2.2" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Cell line enhanced" "Detected in some" "AF22: 6.3;SCLC-21H: 15.0;THP-1: 12.1;U-937: 10.0" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: AB_2686036" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.1 0.3 0.0 0.8 3.2 2.2 0.0 0.1 0.2 3.1 0.0 0.3 0.1 15.0 2.3 0.0 0.0 0.3 0.9 0.0 12.1 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 10.0 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269994-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 73.6;salivary gland: 47.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 113.2;Alveolar cells type 2: 120.0;Enterocytes: 84.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 13.4;BEWO: 11.5;CACO-2: 10.5;CAPAN-2: 25.1;OE19: 16.0;SK-BR-3: 21.6;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015796 Approved Midbody,Cytosol NA NA "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favorable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.8 0.0 5.3 4.6 7.1 0.0 4.9 0.9 5.0 7.4 14.4 1.0 20.7 15.1 1.8 12.5 3.3 6.6 18.9 1.0 8.9 4.3 9.4 1.4 42.5 0.8 10.7 0.8 2.0 73.6 9.6 15.7 5.6 1.1 8.8 9.1 1.5 47.8 19.0 0.8 3.7 29.4 0.8 21.1 0.8 11.6 1.2 0.8 1.1 33.6 3.8 5.0 1.4 3.5 0.0 0.8 0.0 0.0 1.8 0.9 0.2 13.4 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 10.5 25.1 0.0 0.6 0.0 0.0 6.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.5 16.0 0.0 0.0 0.0 0.3 0.2 4.3 6.5 0.0 0.0 21.6 0.0 2.0 17.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.9 0.2 0.0 1.8 0.0 0.8 0.0 0.2 5.3 7.1 0.9 1.9 8.9 4.3 10.7 0.8 1.1 0.8 113.2 120.0 0.5 1.7 0.0 0.0 0.4 43.3 29.4 47.8 15.7 0.0 26.1 14.9 32.4 3.1 0.0 84.2 0.0 34.1 1.2 0.2 16.8 1.1 0.0 2.0 0.0 20.8 0.0 0.0 6.0 0.3 0.8 0.0 1.0 59.6 1.7 27.0 37.4 1.1 23.1 0.0 0.0 0.2 1.0 0.2 0.4 6.1 0.0 32.2 5.4 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4" "Cell type enriched" "Detected in some" 8 "Bipolar cells: 49.7" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 4.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 7.6;EFO-21: 7.4;GAMG: 8.0;hTERT-RPE1: 12.8;NTERA-2: 4.4;SH-SY5Y: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 1.3 28.2 27.3 2.0 53.8 1.4 1.8 14.1 82.2 3.5 1.8 2.8 0.0 1.6 1.8 8.0 2.2 1.7 2.2 1.4 29.3 47.0 2.8 1.1 5.4 2.4 13.4 35.1 1.7 1.6 1.5 24.0 1.3 25.8 2.7 1.9 1.0 1.3 6.2 2.1 1.3 2.1 1.6 9.2 1.4 1.4 26.4 3.9 0.1 1.4 0.0 1.2 1.7 1.2 1.0 0.6 4.8 0.9 1.0 0.7 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.2 3.4 7.6 0.6 0.5 0.1 0.1 0.1 7.4 1.9 8.0 0.1 0.0 0.0 0.1 0.2 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 12.8 0.3 0.1 0.1 0.6 0.4 0.6 0.1 0.1 4.4 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.5 9.1 0.1 0.1 0.0 3.0 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.4 0.2 0.1 0.3 0.4 0.1 2.2 0.9 0.6 0.5 0.4 0.4 0.7 0.5 0.4 0.2 1.0 0.7 0.6 4.8 1.0 0.6 0.6 0.4 0.3 27.3 53.8 14.1 44.2 29.3 47.0 13.4 35.1 25.8 3.9 0.0 0.0 0.0 0.3 0.3 49.7 0.8 2.5 0.0 3.4 1.8 2.0 0.1 0.0 0.0 1.3 0.3 0.0 0.0 0.2 0.1 1.1 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.9 0.9 0.2 0.0 0.0 0.0 1.3 0.0 0.0 6.3 0.0 3.7 0.0 0.3 0.4 0.7 0.3 0.2 0.0 0.0 0.1 TMEM131L "DKFZp586H1322, KIAA0922" ENSG00000121210 "Transmembrane 131 like" A2VDJ0 4 153466346-153636711 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.4" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 2: 11.1;Ciliated cells: 10.7;Exocrine glandular cells: 8.0;monocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.3;MOLT-4: 34.7;U-698: 44.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043472, HPA048443" Uncertain Approved "Nucleoli fibrillar center,Vesicles" NA NA Vesicles "Nucleoli fibrillar center" "HPA043472: AB_2678496, HPA048443: AB_2680395" "unprognostic (1.12e-1)" "prognostic favorable (6.69e-6)" "unprognostic (1.71e-1)" "unprognostic (3.75e-2)" "unprognostic (8.37e-2)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "unprognostic (3.30e-2)" "unprognostic (3.23e-2)" "unprognostic (4.11e-2)" "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (4.35e-3)" "unprognostic (2.92e-2)" "unprognostic (3.39e-2)" "unprognostic (3.94e-2)" "unprognostic (3.51e-2)" 7.5 1.9 2.1 37.9 6.0 27.3 6.6 0.5 3.0 6.5 5.6 2.3 3.5 1.5 11.9 7.9 6.6 5.0 4.3 5.6 2.5 1.6 3.4 13.0 6.1 27.6 2.2 1.6 4.9 23.0 0.8 6.4 2.5 2.1 5.3 3.1 5.3 10.3 3.2 17.5 5.2 10.0 8.1 3.0 26.5 6.0 3.2 3.9 69.4 4.1 5.5 36.8 7.1 5.8 18.5 13.3 13.6 23.7 14.9 17.9 10.3 2.0 1.3 5.7 6.0 3.4 3.0 0.1 2.9 1.4 2.1 2.6 9.2 1.3 37.3 0.7 3.9 2.3 2.0 4.4 5.1 3.1 3.4 3.2 7.3 2.5 2.3 2.2 8.0 0.4 2.7 3.2 2.7 2.5 2.3 5.2 6.9 6.8 0.1 2.0 3.7 34.7 5.8 5.1 0.0 1.9 12.1 5.6 2.4 1.4 0.8 4.3 3.3 2.3 5.2 3.0 3.1 2.0 5.9 4.1 2.8 5.0 3.3 2.4 4.1 4.1 44.2 0.8 4.8 2.2 6.1 12.4 13.1 8.5 23.7 11.2 18.5 10.7 7.9 13.3 17.3 17.9 12.0 13.6 14.9 18.6 1.3 12.9 10.3 2.1 6.0 0.5 3.0 2.5 1.6 2.2 1.6 2.1 3.9 6.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 10.7 3.4 0.0 0.0 0.5 1.7 1.9 0.0 0.0 0.0 0.0 8.0 0.2 0.0 0.0 4.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.9 0.0 0.0 5.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924463-60937159 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.1" "Cell type enhanced" "Detected in many" 13 "Horizontal cells: 240.0;Muller glia cells: 177.4;Rod photoreceptor cells: 141.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 46.0;MCF7: 45.5;SK-BR-3: 46.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Approved Mitochondria No No 1900000 Mitochondria "HPA051979: AB_2681681, HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favorable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 3.6 6.1 28.6 9.2 25.2 1.2 4.4 23.9 58.1 14.0 3.2 11.3 0.8 3.4 14.4 2.2 4.8 3.2 6.2 4.0 17.0 22.9 3.1 1.3 4.5 2.4 20.4 21.4 6.9 3.9 1.5 6.6 19.8 13.8 4.1 2.0 19.3 21.5 2.9 4.3 1.8 2.6 4.6 9.3 2.5 8.5 3.4 9.7 0.0 2.0 1.0 6.0 4.9 2.0 0.4 0.1 1.6 0.1 0.0 0.1 0.1 9.0 12.7 11.4 24.3 0.9 0.5 20.2 6.8 22.2 6.3 5.2 4.4 8.6 0.0 46.0 2.0 22.1 17.2 2.6 11.9 2.4 0.1 3.7 0.2 8.1 8.3 8.5 0.1 0.3 2.1 2.3 11.7 1.8 10.3 10.8 1.8 0.5 0.6 2.0 45.5 0.2 0.0 15.1 0.3 7.3 0.1 4.8 1.0 9.5 4.7 11.4 27.0 4.9 46.7 4.1 6.0 32.4 0.1 12.6 2.4 11.6 0.7 12.9 0.1 0.0 0.4 20.5 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.1 28.6 25.2 23.9 36.8 17.0 22.9 20.4 21.4 13.8 9.7 0.0 0.0 0.0 2.1 1.1 42.9 0.7 2.5 0.0 3.4 5.2 17.7 20.0 1.7 65.2 0.4 8.2 0.0 0.0 11.6 24.7 6.1 6.7 0.0 0.0 2.9 240.0 15.0 8.0 0.3 0.6 1.7 0.0 0.0 5.4 1.8 177.4 47.3 0.0 3.2 0.3 141.6 6.5 1.0 1.0 3.6 0.6 22.7 0.0 2.1 6.3 TMEM132B "KIAA1786, KIAA1906" ENSG00000139364 "Transmembrane protein 132B" Q14DG7 12 125186836-125662377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 19.3" "Group enriched" "Detected in some" 4 "Early spermatids: 22.6;Late spermatids: 28.8" "Cancer enriched" "Detected in single" 7 "glioma: 3.3" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.0" "Cell line enhanced" "Detected in some" "AF22: 3.6;HSkMC: 8.0;NTERA-2: 9.1;RPMI-8226: 3.9;U-138 MG: 14.2;U-937: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035661, HPA035662" Uncertain NA NA "HPA035661: AB_10669774, HPA035662: AB_2674726" "unprognostic (3.38e-3)" "unprognostic (4.39e-2)" "unprognostic (6.73e-2)" "unprognostic (6.33e-2)" "unprognostic (1.06e-1)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (1.26e-1)" "unprognostic (4.58e-1)" "unprognostic (1.12e-1)" "unprognostic (6.23e-3)" "unprognostic (1.29e-2)" "unprognostic (4.29e-4)" "unprognostic (1.20e-1)" "unprognostic (2.94e-2)" "unprognostic (1.06e-1)" "unprognostic (3.73e-3)" 0.2 0.2 6.1 0.1 7.5 0.0 0.1 0.2 19.3 0.6 0.3 0.2 0.8 1.0 0.5 0.2 0.3 0.7 5.1 2.6 0.1 0.0 0.0 0.1 2.6 0.1 0.2 0.0 1.1 0.2 0.4 0.4 2.8 0.6 0.5 2.4 0.2 0.2 0.5 0.0 0.3 0.8 2.7 0.3 0.1 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2.7 2.9 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 14.2 0.0 0.1 0.0 0.0 0.2 0.0 2.2 3.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 1.9 2.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 28.8 0.3 0.0 1.7 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.2 0.0 0.2 0.9 3.6 2.9 0.0 0.0 0.0 0.5 TMEM132C "DKFZp761O2018, PPP1R152" ENSG00000181234 "Transmembrane protein 132C" Q8N3T6 12 128267403-128707915 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.5" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 14.3;Cone photoreceptor cells: 5.9;Leydig cells: 8.3;Peritubular cells: 14.2" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.6;testis cancer: 4.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "gdT-cell: 5.4" "Lineage enriched" "Detected in single" 55 "T-cells: 5.4" "Group enriched" "Detected in some" 6 "AF22: 6.1;ASC diff: 8.7;Daudi: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015633, HPA015984" Approved Centrosome,Cytosol NA NA 110000000 "Centrosome, Cytosol" "HPA015633: AB_1858089, HPA015984: AB_1858088" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (7.34e-2)" "unprognostic (8.60e-2)" "unprognostic (2.37e-1)" "unprognostic (1.99e-3)" "unprognostic (5.48e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.85e-2)" "unprognostic (6.29e-2)" "unprognostic (7.97e-3)" "unprognostic (2.54e-1)" "unprognostic (5.71e-2)" "unprognostic (6.33e-3)" 37.5 4.2 9.6 1.1 7.0 0.8 23.3 5.0 6.6 22.0 2.5 4.2 8.9 1.2 5.9 5.7 4.7 13.4 5.1 3.5 5.0 3.8 1.3 0.8 1.6 2.0 4.9 3.1 7.9 4.1 0.9 0.6 5.1 4.6 3.7 1.3 5.3 2.9 9.1 1.9 2.2 1.4 2.1 3.9 1.1 1.5 2.1 5.4 0.0 1.1 0.9 1.3 3.8 10.5 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.0 6.1 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.6 7.0 5.0 6.6 5.0 3.8 4.9 3.1 4.6 5.4 0.0 0.0 0.0 0.0 0.3 14.3 0.7 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.3 0.0 1.7 0.0 0.0 0.4 0.1 0.0 14.2 0.0 2.1 0.0 1.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM132D "KIAA1944, MOLT, PPP1R153" ENSG00000151952 "Transmembrane protein 132D" Q14C87 12 129071725-129903666 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 18.0" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 2.3;Early spermatids: 1.9;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.5;Karpas-707: 1.7;MOLT-4: 9.3;NTERA-2: 3.6;SuSa: 1.4;U-266/84: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010739 Approved NA NA 150000 "HPA010739: AB_2204753" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.19e-1)" "unprognostic (2.07e-2)" "unprognostic (5.39e-1)" "unprognostic (1.47e-2)" "unprognostic (2.89e-1)" "unprognostic (3.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (4.31e-4)" 0.4 0.9 4.5 0.7 6.6 0.7 0.4 0.4 18.0 0.4 0.8 0.6 0.0 0.8 0.5 0.4 0.4 0.4 0.4 0.4 2.9 4.2 0.6 0.7 0.8 0.4 1.7 6.2 0.5 1.1 0.4 0.7 0.4 0.8 1.1 0.7 1.2 0.4 0.4 0.4 0.5 0.9 0.5 0.6 0.4 1.0 1.6 0.8 0.0 0.5 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.0 0.0 9.3 0.0 3.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 6.6 0.4 11.7 2.9 4.2 1.7 6.2 0.8 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 20.0;kidney: 8.8" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 9.0" "Group enriched" "Detected in some" 8 "glioma: 7.6;renal cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.6" "Group enriched" "Detected in many" 20 "NK-cells: 1.4;T-cells: 2.6" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 140000 "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.4 0.5 4.9 0.4 4.1 0.2 0.3 17.3 8.7 1.2 0.4 1.7 0.3 4.9 0.6 0.5 0.4 0.4 0.8 0.5 2.9 5.1 8.8 1.3 0.4 0.7 4.5 2.8 0.5 0.2 0.3 0.0 0.9 5.3 0.4 0.5 0.0 0.8 0.8 0.3 0.8 2.8 0.6 20.0 0.7 0.6 2.4 2.2 0.0 0.4 0.0 0.6 0.7 0.1 0.0 0.0 0.0 0.0 1.4 2.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.8 3.4 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.4 0.5 0.0 0.0 2.6 1.8 0.0 1.4 0.0 0.0 0.0 0.4 4.9 4.1 17.3 6.9 2.9 5.1 4.5 2.8 5.3 2.2 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.4 0.7 1.3 0.0 0.0 0.0 0.0 0.0 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.7 0.7 0.1 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 2.3 18.3 0.1 12.9 0.0 0.8 8.3 0.0 4.2 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.6 0.7 0.4 0.0 0.2 0.7 0.1 0.1 0.0 32.2 2.5 0.1 0.0 0.5 11.3 0.0 0.2 31.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 14.9 5.1 0.0 2.4 0.1 0.0 2.0 35.7 2.7 5.7 48.8 0.0 26.6 29.9 42.9 12.0 0.3 54.0 0.0 4.0 4.7 0.3 0.3 0.0 13.4 1.7 0.0 3.5 1.3 0.6 8.8 0.0 0.1 5.0 1.8 4.3 8.3 23.3 23.0 0.0 67.4 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 7.4 1.2 TMEM140 FLJ11000 ENSG00000146859 "Transmembrane protein 140" Q9NV12 7 135148072-135166215 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.1" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 54.0;neutrophil: 75.1" "Lineage enriched" "Detected in all" 9 "granulocytes: 75.1" "Cell line enhanced" "Detected in many" "ASC diff: 36.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (3.52e-2)" "unprognostic (2.34e-2)" "unprognostic (3.26e-1)" "unprognostic (3.11e-1)" "unprognostic (1.79e-1)" "unprognostic (3.37e-2)" "unprognostic (9.72e-2)" "unprognostic (7.65e-3)" "unprognostic (3.41e-1)" "unprognostic (7.59e-2)" "unprognostic (5.20e-2)" "unprognostic (7.19e-2)" "unprognostic (2.35e-2)" "unprognostic (3.17e-2)" "unprognostic (1.83e-2)" "unprognostic (1.37e-1)" "unprognostic (1.05e-1)" 39.1 13.6 4.6 12.4 19.9 6.4 27.9 2.4 14.2 9.0 10.4 15.2 9.2 11.9 13.5 7.3 6.3 6.5 12.9 13.8 6.5 5.0 16.9 32.9 18.8 15.6 30.7 4.8 10.8 10.0 2.5 4.0 22.7 15.4 9.7 5.7 9.9 11.4 7.5 51.6 6.1 11.4 8.0 31.4 17.6 8.3 6.3 22.1 4.4 7.6 3.7 10.7 16.7 14.5 7.7 2.0 75.1 5.1 6.1 8.3 10.1 5.0 12.3 4.4 8.8 36.1 7.1 4.0 3.9 5.9 3.0 7.7 4.7 5.1 6.7 5.1 1.6 21.0 5.0 0.0 0.1 0.5 13.1 5.7 4.0 5.1 4.7 7.6 9.3 6.4 1.8 0.3 1.2 0.0 7.5 4.7 5.1 8.9 22.8 0.9 4.4 8.9 4.2 9.0 7.4 7.0 6.3 6.4 14.3 1.8 7.8 5.0 7.9 3.7 5.6 9.6 3.2 2.3 8.5 4.8 3.7 2.6 8.1 4.8 25.4 19.0 10.0 11.2 11.1 8.9 54.0 4.8 18.0 8.2 4.0 6.0 6.1 6.8 8.0 2.0 7.7 7.7 8.3 75.1 6.1 5.1 0.3 8.3 10.1 4.6 19.9 2.4 14.2 6.5 5.0 30.7 4.8 15.4 22.1 3.0 1.1 20.4 0.4 1.5 0.8 3.0 20.4 2.7 2.3 8.7 0.0 6.9 3.3 14.1 9.1 24.8 10.2 23.3 3.3 1.7 4.8 0.9 4.7 21.7 16.2 3.2 5.1 22.1 6.7 2.0 9.8 6.7 25.3 14.4 1.9 0.1 5.8 17.3 4.9 14.7 0.5 0.0 2.1 0.0 0.1 1.9 40.5 20.8 0.6 0.9 TMEM143 FLJ10922 ENSG00000161558 "Transmembrane protein 143" Q96AN5 19 48332356-48364237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.1" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 22.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 20.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014476, HPA058645" Approved Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA014476: AB_1858092, HPA058645: " "unprognostic (1.23e-1)" "unprognostic (2.30e-2)" "unprognostic (5.23e-2)" "unprognostic (2.50e-1)" "unprognostic (5.94e-2)" "unprognostic (2.11e-3)" "unprognostic (4.50e-2)" "unprognostic (1.61e-1)" "unprognostic (4.08e-1)" "unprognostic (2.25e-1)" "unprognostic (7.29e-2)" "unprognostic (9.82e-2)" "prognostic favorable (1.53e-7)" "unprognostic (5.46e-2)" "unprognostic (1.24e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-1)" 6.2 5.6 3.3 3.5 5.7 2.7 3.2 5.1 6.6 2.6 4.4 4.4 4.1 4.3 4.1 3.8 4.0 3.0 3.2 27.0 3.4 2.7 6.1 9.7 2.9 3.5 4.7 4.5 3.2 4.2 3.1 3.2 3.0 3.9 3.4 3.1 4.7 4.5 4.1 70.1 4.8 4.8 5.3 3.2 4.6 3.7 2.5 4.3 5.4 3.9 16.5 5.1 3.7 2.5 5.0 3.4 3.6 2.3 7.6 5.7 2.7 3.6 5.7 1.9 3.5 3.9 6.3 3.8 3.4 2.0 2.4 3.1 5.0 4.7 6.6 6.5 2.3 1.1 4.1 1.9 2.5 1.4 9.1 4.3 4.0 4.6 8.3 3.3 3.2 3.9 5.4 3.1 1.2 3.4 2.8 1.9 10.4 2.9 9.9 3.0 2.1 4.4 12.3 2.4 6.7 2.1 7.1 1.4 11.0 3.2 2.7 7.2 7.0 1.9 2.5 1.5 2.3 3.5 2.8 2.3 2.8 3.2 2.0 1.7 20.9 6.2 5.4 2.3 4.3 2.4 3.6 2.3 2.7 4.7 1.5 5.7 5.0 3.7 4.0 3.4 3.4 5.5 3.3 1.7 7.6 2.3 1.3 2.3 2.7 3.3 5.7 5.1 6.6 3.4 2.7 4.7 4.5 3.9 4.3 3.0 0.6 0.8 3.1 0.2 3.2 22.1 0.0 6.7 0.0 1.8 7.9 8.4 11.6 2.4 0.5 1.5 4.3 23.3 2.1 5.0 4.1 0.9 1.1 6.7 4.7 0.0 2.9 0.6 1.0 0.4 2.3 2.2 8.5 2.8 3.0 4.0 1.2 5.8 1.1 12.7 6.5 0.0 3.1 4.7 5.5 0.9 3.1 4.4 3.9 0.8 TMEM144 FLJ11155 ENSG00000164124 "Transmembrane protein 144" Q7Z5S9 4 158201604-158255411 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "brain: 88.7" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 195.0;Late spermatids: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3" "Group enriched" "Detected in many" 10 "dendritic cells: 4.3;monocytes: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 23.7;hTCEpi: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063554 Approved Mitochondria NA NA Mitochondria "HPA063554: AB_2685039" "unprognostic (1.26e-2)" "unprognostic (7.05e-2)" "unprognostic (2.06e-2)" "prognostic favorable (2.89e-4)" "unprognostic (2.90e-1)" "unprognostic (1.71e-5)" "unprognostic (8.27e-2)" "unprognostic (3.32e-1)" "unprognostic (2.21e-1)" "unprognostic (3.33e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (9.34e-2)" "unprognostic (1.13e-2)" "unprognostic (1.35e-1)" "unprognostic (9.26e-2)" "unprognostic (3.88e-2)" "unprognostic (4.05e-2)" 4.7 6.7 20.7 2.0 60.9 1.5 9.2 4.7 37.7 4.7 7.4 88.7 0.2 14.3 3.7 8.3 3.1 3.9 6.8 8.2 31.5 18.3 1.9 1.7 3.5 0.9 80.4 26.6 8.6 3.8 3.0 1.4 3.5 48.9 5.4 8.6 0.0 3.1 7.2 1.4 1.9 9.6 4.2 79.2 2.2 5.4 15.8 67.4 0.0 9.2 0.0 0.8 5.1 1.9 0.0 4.3 0.1 3.3 0.4 0.1 0.7 2.6 7.1 0.1 1.4 5.2 7.8 23.7 1.2 1.9 1.1 1.7 8.9 9.8 0.0 1.4 0.3 5.1 1.2 3.3 11.0 1.5 0.0 3.2 4.4 2.2 7.9 1.8 5.5 1.4 5.6 13.6 4.6 1.6 0.3 5.9 1.1 2.9 0.1 8.2 3.0 0.0 0.0 1.8 7.3 1.7 0.0 0.0 0.3 2.0 7.5 1.1 0.0 0.2 9.6 2.7 4.3 6.8 1.5 1.2 2.2 1.8 0.4 1.3 0.0 0.6 0.6 3.0 0.8 1.5 0.0 3.3 0.0 0.0 1.4 0.1 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.4 0.7 4.3 0.0 0.7 20.7 60.9 4.7 35.1 31.5 18.3 80.4 26.6 48.9 67.4 8.9 7.8 0.0 6.7 2.7 0.0 10.6 17.8 5.3 4.5 0.0 0.0 11.5 0.0 9.5 195.0 3.6 34.8 0.0 11.4 5.8 2.0 5.7 4.6 1.0 24.1 0.0 4.7 3.1 19.9 77.6 9.8 10.7 3.3 3.6 17.2 1.3 10.6 14.7 8.5 5.6 0.0 0.0 2.2 1.2 1.7 4.4 7.3 0.0 14.5 4.2 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313325-42325062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 74.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 57.8;Cone photoreceptor cells: 27.5;Horizontal cells: 65.2;Rod photoreceptor cells: 30.8" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Region enriched" "Detected in all" 4 "cerebellum: 74.5" "Group enriched" "Detected in some" 8 "basophil: 4.5;neutrophil: 15.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 15.5" "Cell line enhanced" "Detected in many" "HMC-1: 11.9;PC-3: 8.8;SCLC-21H: 22.7;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles NA NA Vesicles "HPA060462: AB_2684285" "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.6 6.2 8.0 1.2 7.7 2.5 1.3 74.5 30.5 0.6 1.2 3.8 0.0 1.7 1.1 1.6 1.0 1.1 1.4 1.3 5.8 8.5 0.9 1.4 0.8 1.5 5.1 7.6 1.2 3.7 3.0 6.4 0.6 9.3 1.2 1.2 2.8 1.1 0.9 2.3 3.3 1.1 1.2 3.9 1.5 2.0 3.3 3.2 0.0 1.3 0.0 1.1 1.0 0.3 1.3 0.8 15.5 0.9 0.6 0.9 0.8 0.5 2.8 2.1 6.5 0.2 0.2 0.9 0.2 0.1 1.0 2.6 0.5 0.7 1.5 0.3 0.7 0.6 0.2 1.5 0.4 1.2 6.8 1.7 2.8 2.6 2.4 0.2 1.7 11.9 0.6 0.5 0.4 0.6 0.2 1.1 0.8 1.5 5.6 0.1 0.6 0.4 1.9 1.3 2.0 8.8 0.2 0.6 5.3 0.1 1.0 22.7 10.8 1.0 0.7 1.4 0.1 2.0 1.9 0.3 1.9 1.9 1.3 0.7 1.2 3.1 1.4 0.7 1.1 5.2 4.5 0.9 0.9 0.6 0.8 0.3 1.0 0.6 0.4 0.2 1.3 0.6 0.9 15.5 0.6 0.7 0.8 0.4 0.8 8.0 7.7 74.5 18.1 5.8 8.5 5.1 7.6 9.3 3.2 0.0 0.0 0.0 0.4 0.2 57.8 0.4 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.3 1.1 0.0 0.3 65.2 0.0 1.8 1.2 0.0 0.0 0.0 5.0 0.0 0.0 11.9 0.1 0.0 0.4 0.0 30.8 0.0 0.0 5.1 17.9 0.1 0.0 0.0 0.0 0.0 TMEM150B "TMEM224, TTN2" ENSG00000180061 "Transmembrane protein 150B" A6NC51 19 55312801-55334048 "Predicted membrane proteins" Autophagy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 37.0" "Cell type enriched" "Detected in some" 5 "Enterocytes: 30.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 9.3" "Group enriched" "Detected in many" 8 "granulocytes: 3.7;monocytes: 9.3" "Cell line enhanced" "Detected in some" "CACO-2: 9.1;HMC-1: 4.7;U-937: 20.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "unprognostic (5.76e-2)" "unprognostic (4.94e-2)" "unprognostic (5.33e-2)" "unprognostic (6.70e-2)" "unprognostic (5.51e-2)" "unprognostic (1.35e-1)" "unprognostic (5.35e-2)" "unprognostic (4.00e-2)" "unprognostic (4.74e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (6.14e-6)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (2.45e-1)" "unprognostic (1.18e-2)" 10.5 2.2 0.5 3.1 1.5 0.3 8.3 0.4 1.1 0.8 6.1 0.4 1.2 37.0 0.7 3.0 1.0 1.4 1.7 3.5 1.8 0.6 2.4 5.4 12.7 7.3 0.6 0.3 2.3 0.8 0.0 0.8 5.4 2.1 2.7 4.2 1.2 1.1 0.2 1.5 0.6 31.5 2.3 1.2 14.1 1.2 1.7 0.4 0.3 1.2 0.2 2.0 1.8 3.0 0.0 0.8 3.7 9.3 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 1.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.0 0.1 0.1 0.1 2.1 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 20.5 0.1 3.7 9.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 1.2 0.5 1.5 0.4 1.1 1.8 0.6 0.6 0.3 2.1 0.4 0.0 0.0 0.0 1.7 0.1 0.0 0.3 2.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.0 0.0 0.0 0.0 5.4 0.0 0.0 2.0 0.0 1.0 2.0 0.0 0.2 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.1 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 74.9" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 67.6;Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 9.1;MCF7: 25.1;SCLC-21H: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced NA NA "HPA052921: AB_2681988" "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favorable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favorable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favorable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 7.0 30.0 10.8 3.2 12.8 1.5 12.4 0.6 16.0 8.4 4.4 8.3 12.9 4.4 3.2 74.9 2.5 4.6 3.9 7.4 12.7 7.9 9.7 7.7 3.6 8.1 7.5 10.3 18.0 2.2 1.7 10.5 5.5 7.3 7.1 2.6 12.4 10.3 4.7 3.5 3.1 4.4 4.0 5.4 7.6 3.0 4.2 6.8 2.7 7.0 1.6 6.9 3.2 3.3 5.5 1.4 5.0 0.9 1.3 0.7 0.3 0.3 0.9 7.0 9.1 0.0 0.1 0.7 1.5 3.8 1.0 1.1 0.0 0.4 0.2 0.7 0.2 2.8 0.2 4.3 0.0 1.1 0.4 2.1 0.5 0.8 0.0 0.0 0.0 1.0 4.2 0.4 0.0 0.0 0.6 2.2 4.4 0.0 0.1 0.1 25.1 0.5 0.6 3.2 0.0 0.4 0.9 0.1 0.8 0.3 3.4 17.7 2.7 0.5 0.3 2.4 3.3 0.4 0.2 0.5 0.4 0.2 0.1 0.8 0.1 0.4 0.3 0.5 0.3 1.9 5.0 0.9 1.0 0.7 0.4 0.4 3.5 0.7 0.6 0.2 5.5 0.5 0.6 3.7 1.3 0.6 1.4 0.2 0.3 10.8 12.8 0.6 16.0 12.7 7.9 7.5 10.3 7.3 6.8 0.0 0.6 0.0 3.0 2.2 0.4 7.2 5.1 12.0 9.1 14.0 2.0 67.6 0.0 5.2 2.6 16.1 0.0 0.0 2.3 0.9 4.8 7.9 5.8 20.3 5.1 1.6 1.2 19.0 1.8 2.2 13.3 0.9 1.7 13.6 0.0 16.7 1.7 0.0 9.2 1.8 1.6 0.0 2.0 0.7 3.4 1.0 98.1 0.5 0.5 0.9 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291870-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 48.5" "Cell type enhanced" "Detected in some" 16 "Bipolar cells: 8.1;Cholangiocytes: 5.1;Horizontal cells: 14.3;Intestinal endocrine cells: 7.5" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 1.4 3.8 12.4 1.5 16.8 1.4 1.4 5.9 48.5 1.4 1.5 41.8 0.0 1.5 1.4 1.4 1.4 1.4 2.8 1.6 22.7 14.3 1.4 1.4 1.4 1.4 21.2 13.1 1.5 2.4 1.8 3.3 1.4 22.2 1.4 1.4 1.0 1.5 1.4 1.4 1.4 1.5 1.4 43.2 1.4 3.9 1.6 13.6 0.0 1.4 0.0 1.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 1.3 0.0 3.7 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.1 0.0 0.0 18.4 4.2 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.4 16.8 5.9 31.1 22.7 14.3 21.2 13.1 22.2 13.6 0.0 0.0 0.0 0.1 0.0 8.1 0.6 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 14.3 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 TMEM151B "bA444E17.5, C6orf137, TMEM193" ENSG00000178233 "Transmembrane protein 151B" Q8IW70 6 44270466-44307506 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 52.2" "Group enriched" "Detected in some" 6 "Bipolar cells: 4.5;Cardiomyocytes: 2.2;Horizontal cells: 4.8;Rod photoreceptor cells: 1.2" "Cancer enhanced" "Detected in single" "glioma: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 7 "T-cells: 1.0" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 25.3" "Low region specificity" "Detected in all" HPA055167 Uncertain NA NA "HPA055167: AB_2682723" "unprognostic (1.28e-3)" "unprognostic (6.25e-2)" "unprognostic (5.06e-2)" "unprognostic (7.02e-3)" "unprognostic (6.61e-2)" "unprognostic (1.22e-3)" "unprognostic (2.41e-2)" "unprognostic (3.01e-2)" "unprognostic (6.92e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-4)" "unprognostic (1.48e-1)" "unprognostic (4.56e-3)" "unprognostic (1.85e-1)" "unprognostic (9.15e-2)" "unprognostic (3.86e-2)" "unprognostic (1.66e-1)" 1.0 5.7 16.9 1.6 8.4 1.2 1.0 52.2 39.5 0.9 1.7 1.2 0.0 1.7 1.3 1.0 1.2 1.0 1.0 1.1 21.6 8.9 1.0 0.9 1.0 1.2 7.9 18.1 1.0 1.1 0.9 1.4 1.0 10.0 1.1 1.5 0.0 1.2 0.9 1.2 1.2 2.0 1.1 2.3 1.0 1.4 1.6 3.7 0.0 0.9 0.0 1.0 0.9 0.1 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 5.6 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.6 0.1 0.2 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.1 0.5 4.3 0.1 0.2 0.4 0.0 0.1 0.0 0.1 25.3 5.2 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.3 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 16.9 8.4 52.2 28.1 21.6 8.9 7.9 18.1 10.0 3.7 0.0 0.0 0.0 0.0 0.0 4.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA019184: AB_2670088, HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.2 0.0 0.1 0.0 0.2 3.5 5.6 3.1 11.5 3.4 6.5 0.1 1.6 12.6 1.3 2.8 3.7 9.0 0.0 24.7 6.3 0.0 0.0 0.7 0.1 0.0 3.7 9.7 28.5 3.4 11.9 10.9 9.5 0.0 8.4 7.8 0.0 22.2 0.2 0.8 3.8 3.0 0.6 0.0 2.9 0.4 0.0 0.0 19.5 7.5 0.0 0.5 0.7 2.4 0.4 3.5 0.3 6.9 3.4 0.5 2.0 0.3 4.3 27.8 9.4 6.9 4.7 22.1 2.6 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 11.9 22.9 42.2 7.7 65.9 0.0 1.4 0.0 60.2 19.4 21.0 2.0 21.8 0.0 6.1 0.0 5.7 0.0 0.0 3.3 12.7 5.5 5.3 97.2 3.9 4.2 3.2 1.2 0.6 8.7 0.0 0.6 15.0 5.0 0.0 0.6 0.0 12.8 9.1 0.0 0.3 0.4 0.0 1.9 0.0 0.2 169.9 21.6 15.8 3.1 23.5 TMEM155 FLJ30834 ENSG00000164112 "Transmembrane protein 155" Q4W5P6 4 121758933-121765427 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.6" "Cell type enriched" "Detected in some" 4 "Cytotrophoblasts: 15.1" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "cerebral cortex: 25.6" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.3;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 7.4;HAP1: 3.4;LHCN-M2: 10.5;MOLT-4: 6.3" HPA077585 Approved "Secreted in brain" NA NA "HPA077585: AB_2732353" "unprognostic (9.67e-3)" "unprognostic (3.25e-3)" "unprognostic (3.13e-2)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (5.73e-3)" "unprognostic (3.63e-2)" "unprognostic (1.49e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-3)" "unprognostic (4.40e-3)" "unprognostic (1.38e-1)" "unprognostic (3.82e-7)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.02e-2)" "unprognostic (2.04e-1)" 0.6 0.3 5.9 0.5 8.3 0.3 0.3 0.3 25.6 0.4 1.3 0.0 0.0 0.4 0.3 0.3 0.5 0.3 0.4 0.4 7.9 1.6 0.3 0.3 0.6 4.0 0.9 8.9 0.3 0.3 0.2 0.2 6.1 0.7 0.5 0.7 0.9 0.5 0.6 0.3 0.3 0.6 0.9 0.3 0.8 0.5 0.7 0.0 0.0 0.3 0.0 0.6 0.5 0.3 0.0 0.0 0.7 0.0 0.0 2.3 0.3 0.0 0.0 0.1 0.0 1.4 0.3 1.0 0.7 0.2 0.3 0.5 0.0 0.0 0.0 0.0 7.4 0.0 0.0 3.4 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 10.5 0.0 6.3 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.3 5.9 8.3 0.3 25.6 7.9 1.6 0.9 8.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 3.8 0.0 0.0 0.0 TMEM156 FLJ23235 ENSG00000121895 "Transmembrane protein 156" Q8N614 4 38966744-39032922 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 30.6;brain: 12.7;intestine: 8.3;lymphoid tissue: 23.7" "Cell type enhanced" "Detected in some" 23 "B-cells: 75.1;Cholangiocytes: 20.4;T-cells: 28.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 30.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 16.3;GAMG: 12.7;HBEC3-KT: 34.9;hTERT-HME1: 27.5;NB-4: 14.2;PC-3: 15.6;U-698: 18.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" NA NA "prognostic favorable (4.09e-4)" "unprognostic (7.36e-3)" "unprognostic (3.31e-3)" "unprognostic (4.17e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-3)" "unprognostic (4.10e-2)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (1.43e-1)" "unprognostic (9.45e-3)" "unprognostic (5.17e-2)" "unprognostic (8.73e-4)" "unprognostic (3.89e-1)" "unprognostic (1.74e-2)" "unprognostic (3.92e-4)" "unprognostic (9.06e-2)" 0.9 1.7 5.8 11.8 6.6 1.7 1.1 0.7 4.1 0.6 1.7 6.1 0.0 1.7 0.6 0.3 2.0 1.0 1.9 0.6 4.1 2.6 1.4 2.6 1.6 20.2 6.2 0.8 0.5 0.8 0.3 0.7 0.2 5.3 0.9 2.0 0.0 2.0 0.6 0.6 0.5 8.3 0.5 12.7 17.3 2.3 0.6 4.2 7.4 1.0 0.3 23.7 4.5 0.8 30.6 5.0 18.8 0.3 4.8 9.0 3.6 1.0 9.8 0.1 0.1 0.0 0.3 0.1 0.0 2.7 0.0 0.0 0.1 0.1 16.3 0.1 0.0 12.7 0.1 0.1 34.9 0.1 0.2 0.0 0.9 3.3 0.2 5.8 6.7 0.1 0.0 1.8 0.7 27.5 2.1 3.0 2.7 2.3 0.1 1.2 0.1 1.2 14.2 0.0 0.4 15.6 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 7.4 1.2 0.2 0.0 0.3 0.0 0.0 18.6 2.2 6.3 0.0 5.4 0.3 18.8 5.2 0.1 6.1 30.6 9.0 5.2 3.3 21.9 3.5 4.6 0.8 4.8 0.1 5.0 6.0 3.6 5.8 6.6 0.7 4.1 4.1 2.6 6.2 0.8 5.3 4.2 0.0 2.6 75.1 0.5 0.5 0.6 0.3 20.4 1.4 1.2 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.4 1.1 0.7 0.0 0.2 1.6 1.6 0.0 2.5 12.0 1.4 0.0 2.7 10.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.0 0.5 0.2 28.7 0.0 0.7 TMEM158 "p40BBp, RIS1" ENSG00000249992 "Transmembrane protein 158 (gene/pseudogene)" Q8WZ71 3 45224466-45226278 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.8;endometrium 1: 31.1" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 21.8;Muller glia cells: 57.5" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 66.1;GAMG: 22.4;U-138 MG: 28.0;U-87 MG: 91.7" "Region enhanced" "Detected in many" "basal ganglia: 85.5" "Low region specificity" "Detected in all" HPA074974 Approved NA NA "HPA074974: AB_2732274" "unprognostic (3.84e-1)" "unprognostic (9.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (3.77e-2)" "unprognostic (5.73e-2)" "unprognostic (3.31e-2)" "unprognostic (4.67e-3)" "unprognostic (6.23e-2)" "unprognostic (6.41e-2)" "unprognostic (1.84e-3)" "prognostic favorable (6.43e-5)" "prognostic unfavorable (5.42e-9)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (2.86e-2)" "unprognostic (4.49e-3)" 1.8 6.4 16.4 4.5 46.8 2.2 2.3 2.1 10.9 13.1 3.4 2.3 18.5 1.4 31.1 7.3 21.3 2.0 11.0 0.8 9.0 11.2 1.9 1.2 1.0 1.1 2.5 5.0 1.7 2.4 0.7 5.7 1.4 2.6 15.6 2.7 0.5 1.3 27.0 2.4 2.7 1.2 19.6 1.8 0.8 2.2 3.0 4.3 0.0 0.7 0.8 1.7 6.7 1.6 0.0 0.0 0.9 0.1 0.0 0.0 1.1 2.4 0.4 0.8 0.1 1.5 3.7 0.7 6.1 66.1 3.4 5.5 0.1 0.1 0.0 0.3 2.0 22.4 3.3 1.0 0.2 10.1 0.1 0.3 0.0 1.2 0.0 2.2 0.4 1.2 5.0 0.1 6.7 0.5 7.9 0.3 0.0 15.0 0.1 6.0 0.1 0.0 4.2 7.5 0.0 9.1 0.0 0.2 0.9 1.3 2.3 1.2 0.2 2.3 0.0 0.3 0.7 0.0 0.8 1.0 28.0 2.1 17.6 21.2 0.0 0.0 0.0 91.7 2.4 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 16.4 46.8 2.1 10.9 9.0 11.2 2.5 5.0 2.6 4.3 0.0 0.3 0.0 1.8 21.8 3.8 0.8 2.5 0.0 1.2 8.7 0.0 0.1 0.0 3.3 0.1 0.1 0.0 0.0 0.3 0.1 2.9 1.6 0.0 2.6 4.0 1.6 7.5 1.3 0.3 0.2 7.8 4.5 0.0 1.8 0.2 57.5 0.7 0.0 0.0 0.0 2.7 0.0 2.3 0.1 0.4 9.3 0.2 0.0 0.0 2.0 TMEM163 "DKFZP566N034, SV31" ENSG00000152128 "Transmembrane protein 163" Q8TC26 2 134455759-134719000 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;pancreas: 19.7" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 28.8;Exocrine glandular cells: 26.7;Pancreatic endocrine cells: 11.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5" "Cell line enhanced" "Detected in some" "HEL: 10.7;RPTEC TERT1: 37.0;SCLC-21H: 16.8;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007224 Uncertain NA NA "HPA007224: AB_2667780" "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (7.25e-3)" "unprognostic (3.18e-1)" "unprognostic (1.47e-1)" "unprognostic (2.25e-1)" "unprognostic (6.08e-3)" "prognostic favorable (7.94e-4)" "unprognostic (9.05e-2)" "unprognostic (9.62e-2)" "unprognostic (6.02e-2)" "unprognostic (2.04e-1)" "unprognostic (2.60e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" "unprognostic (6.75e-3)" "prognostic favorable (3.15e-4)" 3.8 6.4 8.1 5.4 5.7 0.5 1.5 31.8 13.4 0.5 0.8 5.8 0.0 0.9 0.8 0.7 0.4 3.4 10.4 7.2 9.1 13.7 1.8 1.7 16.4 10.9 6.9 3.8 1.2 19.7 0.4 11.2 4.2 14.8 0.5 0.9 2.6 3.5 0.5 0.6 0.4 0.8 0.7 13.9 1.9 8.3 6.9 5.0 0.0 1.3 0.0 17.4 9.9 0.3 1.6 0.3 0.1 0.0 2.0 2.5 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 3.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.9 0.5 1.2 0.0 0.0 0.0 37.0 5.4 16.8 0.6 0.0 0.0 0.9 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.8 0.9 0.0 0.0 0.0 6.7 0.7 0.0 0.0 0.0 1.3 0.0 1.7 1.6 0.5 2.4 0.3 0.6 0.1 0.5 0.1 2.0 0.0 0.0 2.5 0.8 8.1 5.7 31.8 9.7 9.1 13.7 6.9 3.8 14.8 5.0 3.0 28.8 0.0 0.0 0.0 2.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 3.5 0.3 0.0 0.0 26.7 0.2 0.3 0.0 0.0 0.0 4.0 1.6 0.0 0.0 1.0 1.8 0.0 1.3 0.0 4.6 0.1 1.0 11.4 0.0 0.4 0.1 4.0 0.0 0.3 1.5 0.2 0.4 0.1 0.0 0.0 0.5 TMEM164 "FLJ22679, RP13-360B22.2" ENSG00000157600 "Transmembrane protein 164" Q5U3C3 X 110002631-110182734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 69.7" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8" "Lineage enriched" "Detected in many" 15 "granulocytes: 25.9" "Cell line enhanced" "Detected in all" "HMC-1: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038784 Approved Approved "Vesicles,Cell Junctions" NA NA Vesicles "Cell Junctions" "HPA038784: AB_10670790" "unprognostic (2.14e-3)" "unprognostic (3.35e-1)" "unprognostic (1.50e-1)" "unprognostic (3.65e-3)" "unprognostic (7.94e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (8.17e-6)" "unprognostic (9.85e-3)" "unprognostic (5.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-2)" "unprognostic (3.95e-1)" "unprognostic (7.66e-2)" "prognostic favorable (3.14e-4)" "unprognostic (1.76e-1)" "unprognostic (1.81e-2)" "unprognostic (4.19e-3)" 15.0 8.6 9.2 6.1 10.9 11.1 9.2 2.6 6.8 3.9 17.0 6.0 36.3 14.5 4.5 4.1 10.5 5.5 8.8 14.7 6.6 5.9 8.4 1.7 35.8 7.6 4.6 3.5 11.9 17.2 11.1 8.7 6.6 7.0 6.2 14.8 18.7 7.6 69.7 32.0 15.2 33.1 4.6 2.9 6.9 9.9 2.2 5.1 4.5 11.4 6.0 5.8 5.0 5.1 0.4 1.4 25.9 1.7 1.1 0.9 0.8 4.8 11.1 9.1 5.9 11.3 8.3 5.5 2.4 5.7 5.2 3.3 8.6 7.6 3.8 16.5 3.7 12.7 7.1 7.9 12.8 5.1 10.6 5.4 26.3 6.0 3.6 6.7 11.5 37.6 11.5 22.6 9.3 12.9 14.2 10.0 7.0 8.1 4.7 9.1 9.7 12.0 14.7 8.1 16.6 8.0 5.5 7.0 3.2 8.2 5.1 8.5 9.5 15.5 15.3 7.1 8.8 4.4 11.5 22.3 4.4 3.2 5.1 3.4 2.8 3.4 3.1 11.5 14.5 11.6 25.9 1.7 7.2 0.3 1.5 0.9 0.1 0.4 0.3 1.4 0.4 0.2 0.3 8.8 1.1 0.9 0.2 0.5 0.8 9.2 10.9 2.6 6.8 6.6 5.9 4.6 3.5 7.0 5.1 3.0 26.0 3.2 3.3 4.2 0.2 19.7 10.2 1.4 6.8 15.7 2.0 1.9 3.3 4.0 0.3 5.2 32.2 0.0 9.9 4.7 3.4 7.9 3.5 1.5 12.0 0.0 26.6 6.2 25.0 0.5 1.7 5.8 1.7 21.6 12.9 0.8 9.8 14.4 1.4 3.0 0.9 0.0 3.1 0.2 0.0 6.9 2.3 4.3 17.8 6.4 TMEM169 FLJ34263 ENSG00000163449 "Transmembrane protein 169" Q96HH4 2 216081866-216102783 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 14.3;Cone photoreceptor cells: 21.6;Rod photoreceptor cells: 11.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.4;LHCN-M2: 6.9;RPTEC TERT1: 12.5;SCLC-21H: 10.7;SH-SY5Y: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062462, HPA062797, HPA070657, HPA074877" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Cytosol" Centrosome "HPA062462: AB_2732684, HPA062797: AB_2732690, HPA070657: AB_2686293, HPA074877: " "unprognostic (5.15e-2)" "unprognostic (2.93e-1)" "unprognostic (7.87e-3)" "unprognostic (4.69e-7)" "unprognostic (4.26e-2)" "unprognostic (1.17e-1)" "unprognostic (1.97e-1)" "unprognostic (4.43e-1)" "unprognostic (7.16e-2)" "unprognostic (5.72e-2)" "unprognostic (1.00e-1)" "unprognostic (1.35e-1)" "unprognostic (2.79e-2)" "unprognostic (7.51e-3)" "unprognostic (4.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.02e-1)" 1.7 2.9 5.9 2.5 6.2 1.3 0.9 9.7 16.8 2.1 1.3 3.9 1.6 1.9 1.1 1.9 0.9 2.9 2.5 1.1 5.5 6.3 4.9 4.2 2.1 2.4 5.5 4.8 1.1 1.0 0.8 2.4 0.7 9.1 1.4 1.2 4.9 0.9 1.1 1.5 1.6 1.7 1.2 6.6 2.6 1.0 1.3 2.5 0.7 6.7 0.0 2.0 1.1 0.7 3.0 0.2 4.3 5.7 0.7 6.3 1.3 0.1 0.4 8.4 0.2 1.0 0.1 0.0 0.3 0.2 0.2 0.8 0.4 2.5 0.1 6.3 0.4 0.5 0.2 1.1 0.0 0.2 1.2 0.4 2.7 0.1 1.5 1.8 0.2 0.6 0.6 0.6 0.6 0.8 2.0 0.0 0.9 0.0 0.4 6.9 0.7 0.2 0.3 4.4 0.0 0.1 1.5 2.5 0.2 12.5 0.0 10.7 15.4 0.3 0.2 6.1 4.2 0.4 1.1 0.1 0.2 0.5 0.2 0.4 1.9 2.0 0.4 1.9 0.2 1.6 1.3 1.8 0.3 2.3 1.5 1.7 2.4 4.0 2.7 0.0 3.0 4.2 1.9 4.3 0.7 5.7 0.2 6.3 1.3 5.9 6.2 9.7 11.5 5.5 6.3 5.5 4.8 9.1 2.5 0.0 0.0 0.5 0.0 0.0 14.3 0.6 5.1 0.0 0.0 5.2 21.6 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.3 0.0 4.7 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 2.4 11.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 TMEM170B ENSG00000205269 "Transmembrane protein 170B" Q5T4T1 6 11538278-11583524 "Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 31.1" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 23.8;Kupffer cells: 40.6;Macrophages: 21.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 9 "dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9" "Cell line enhanced" "Detected in many" "THP-1: 18.2;U-937: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055134 Uncertain Approved Centrosome NA NA Centrosome "HPA055134: AB_2682709" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (1.51e-1)" "unprognostic (2.71e-4)" "unprognostic (6.67e-2)" "unprognostic (2.51e-1)" "unprognostic (2.43e-1)" "unprognostic (4.62e-3)" "unprognostic (8.22e-2)" "unprognostic (6.82e-2)" "unprognostic (2.45e-5)" "unprognostic (3.49e-1)" "unprognostic (1.26e-1)" "unprognostic (4.27e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-4)" "unprognostic (3.97e-2)" 10.1 4.8 11.7 6.4 9.6 31.1 6.1 13.5 18.6 3.1 3.3 4.9 2.0 1.6 4.1 5.2 2.5 2.8 3.0 4.5 10.1 8.8 5.9 12.8 8.8 3.5 8.3 8.7 3.9 3.3 5.8 4.2 4.0 8.4 3.4 2.2 4.2 2.5 3.7 8.3 1.8 2.0 4.7 8.2 5.7 2.4 5.2 6.0 4.2 4.4 1.2 2.2 2.7 3.1 0.2 3.2 2.4 2.9 0.1 0.3 0.5 0.7 1.2 7.5 6.7 1.4 0.1 1.5 0.6 1.7 1.0 1.2 0.4 0.4 5.9 3.4 0.4 1.9 0.0 8.4 0.5 2.7 1.6 4.3 3.3 0.8 1.0 0.5 5.3 3.5 0.5 0.1 1.1 0.0 1.7 0.7 5.6 0.2 0.1 1.5 1.1 6.3 9.2 2.1 0.7 1.0 3.2 7.2 0.9 0.8 1.5 5.1 4.4 0.4 2.4 2.7 11.2 2.4 18.2 0.1 1.4 1.6 2.8 1.7 5.2 10.4 5.3 1.2 13.6 1.8 2.4 2.9 1.5 0.2 1.6 0.1 0.0 0.1 0.1 1.8 0.2 0.3 0.2 1.1 0.1 0.6 3.2 0.0 0.5 11.7 9.6 13.5 13.5 10.1 8.8 8.3 8.7 8.4 6.0 3.0 1.3 0.5 0.7 1.5 12.0 5.2 2.5 0.0 2.3 0.0 3.9 1.8 5.0 0.6 0.4 1.4 0.0 0.0 1.2 0.3 2.3 1.0 1.1 5.8 6.6 23.8 1.7 1.8 40.6 0.2 0.9 21.8 0.0 1.0 0.5 11.8 0.9 0.0 1.4 4.5 8.4 6.5 1.2 5.4 4.6 0.6 1.6 1.7 0.6 0.4 TMEM171 PRP2 ENSG00000157111 "Transmembrane protein 171" Q8WVE6 5 73120292-73131817 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;intestine: 20.1;kidney: 25.4;stomach 1: 16.7;thyroid gland: 25.9" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 20.4;Enterocytes: 49.5;Paneth cells: 44.1;Undifferentiated cells: 49.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "MAIT T-cell: 18.2;memory CD8 T-cell: 6.3" "Lineage enriched" "Detected in single" 86 "T-cells: 18.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 20.9;RPTEC TERT1: 16.0;WM-115: 58.5" "Region enriched" "Detected in single" 5 "hippocampal formation: 0.9" "Region enhanced" "Detected in single" "pons and medulla: 3.6" HPA042308 Approved NA NA "HPA042308: AB_10796901" "unprognostic (7.34e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (7.74e-3)" "unprognostic (2.81e-5)" "unprognostic (1.12e-1)" "unprognostic (1.40e-1)" "unprognostic (1.44e-3)" "unprognostic (1.77e-1)" "unprognostic (1.85e-1)" "unprognostic (4.20e-2)" "unprognostic (1.22e-1)" "prognostic favorable (3.93e-10)" "unprognostic (6.13e-3)" "unprognostic (2.43e-1)" "unprognostic (9.10e-3)" "unprognostic (1.57e-1)" 0.2 0.2 0.8 5.6 2.1 0.0 0.7 0.7 3.3 0.4 20.1 3.2 2.2 16.2 0.2 1.4 3.9 0.2 1.5 0.2 1.2 0.7 25.4 3.9 0.4 0.1 0.9 1.6 0.2 0.6 0.0 0.3 0.1 1.1 0.5 18.9 0.6 1.4 2.8 0.6 0.7 18.8 0.6 1.4 14.6 16.7 0.6 0.6 0.0 25.9 3.2 6.3 0.4 0.3 0.0 0.0 0.2 0.0 0.0 18.2 0.5 7.5 0.3 0.0 0.0 2.4 3.3 0.0 2.4 11.2 4.5 7.7 0.2 3.5 0.0 5.2 3.0 0.9 5.7 0.1 0.3 3.5 0.0 1.2 0.0 0.0 0.0 0.8 0.0 0.3 0.7 0.2 6.1 0.5 1.8 2.8 0.0 0.0 0.1 20.9 0.7 0.0 0.0 0.6 0.1 0.5 0.0 0.0 3.8 16.0 0.1 0.0 0.0 1.8 0.0 0.0 1.3 0.4 0.0 0.0 0.0 0.4 6.6 0.1 0.0 0.0 0.0 6.1 0.0 58.5 0.0 0.0 0.0 1.3 0.0 18.2 0.0 0.7 6.3 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.5 0.8 2.1 0.7 3.3 1.2 0.7 0.9 1.6 1.1 0.6 0.0 0.0 0.0 0.3 1.5 0.0 0.3 20.4 0.0 0.0 7.0 0.0 0.1 13.3 5.9 0.0 0.0 49.5 0.0 9.0 0.3 0.8 0.0 0.0 1.1 1.0 0.0 2.4 0.6 0.0 0.0 0.0 0.0 1.7 0.0 16.0 0.0 7.2 44.1 0.0 9.1 0.0 0.0 0.1 0.2 0.7 1.5 0.5 0.0 49.5 0.9 TMEM174 "FLJ31268, MGC13034" ENSG00000164325 "Transmembrane protein 174" Q8WUU8 5 73173195-73175143 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 282 "kidney: 61.5" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 143.8" "Cancer enriched" "Detected in single" 126 "renal cancer: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.7;RPTEC TERT1: 1.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA037975 Enhanced NA NA "HPA037975: AB_10672732" "unprognostic (8.11e-2)" "prognostic favorable (3.30e-6)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM176A "HCA112, MS4B1" ENSG00000002933 "Transmembrane protein 176A" Q96HP8 7 150800403-150805120 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 76.8;liver: 234.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 542.2;Hepatocytes: 864.2;monocytes: 525.8;Paneth cells: 691.0;Proximal tubular cells: 954.7" "Cancer enhanced" "Detected in all" "liver cancer: 210.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 38.4;intermediate monocyte: 27.1" "Lineage enriched" "Detected in many" 4 "monocytes: 38.4" "Cell line enriched" "Detected in some" 30 "HSkMC: 127.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008770 Approved Approved Mitochondria NA NA Mitochondria "HPA008770: AB_2256120" "unprognostic (4.70e-2)" "unprognostic (7.71e-2)" "unprognostic (5.71e-3)" "unprognostic (6.09e-2)" "unprognostic (3.96e-3)" "unprognostic (1.44e-2)" "unprognostic (2.51e-1)" "unprognostic (2.32e-1)" "unprognostic (4.19e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (4.37e-2)" "unprognostic (4.79e-1)" "unprognostic (1.23e-2)" "unprognostic (1.98e-2)" "unprognostic (2.64e-1)" "unprognostic (4.91e-2)" 10.5 4.9 5.8 17.1 6.0 0.7 7.8 1.2 4.3 6.2 32.2 4.8 2.0 16.1 3.6 12.8 7.5 6.3 34.2 15.0 5.2 4.5 76.8 234.5 8.8 23.5 6.9 3.4 19.0 5.0 0.4 2.2 8.9 6.6 6.3 22.3 22.8 3.9 2.0 3.1 3.3 51.2 6.5 6.9 17.3 7.1 3.7 5.4 2.1 4.8 4.8 9.2 13.5 9.1 0.4 9.3 3.3 38.4 0.0 0.1 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 127.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 3.3 0.1 27.1 0.1 0.4 0.0 0.1 9.3 0.0 0.0 0.0 0.5 0.0 12.9 0.6 0.1 10.7 5.8 6.0 1.2 4.3 5.2 4.5 6.9 3.4 6.6 5.4 0.0 6.9 29.6 0.4 6.5 48.5 19.4 150.3 14.7 15.9 190.1 3.9 0.5 129.3 42.7 0.1 9.6 542.2 0.0 23.6 0.8 57.1 2.4 26.7 864.2 53.0 0.0 71.1 29.4 40.2 0.5 55.8 35.8 5.0 525.8 156.3 73.3 68.7 691.0 7.1 954.7 4.4 0.0 20.0 0.7 1.5 7.3 1.1 7.2 159.5 0.9 TMEM176B "LR8, MS4B2" ENSG00000106565 "Transmembrane protein 176B" Q3YBM2 7 150791285-150801360 "Predicted membrane proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.3;liver: 247.9" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 572.0;Hepatocytes: 1056.4;monocytes: 841.4;Paneth cells: 725.5;Proximal tubular cells: 817.7" "Cancer enhanced" "Detected in all" "liver cancer: 537.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 92.3;intermediate monocyte: 68.0" "Lineage enriched" "Detected in many" 5 "monocytes: 92.3" "Group enriched" "Detected in some" 17 "HSkMC: 120.5;THP-1: 38.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047509 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Nucleoplasm, Plasma membrane" "HPA047509: AB_2680072" "unprognostic (5.21e-2)" "unprognostic (7.86e-2)" "unprognostic (1.30e-2)" "unprognostic (8.27e-2)" "unprognostic (3.35e-2)" "unprognostic (6.96e-2)" "unprognostic (7.23e-2)" "unprognostic (2.74e-2)" "unprognostic (5.31e-2)" "unprognostic (1.47e-1)" "unprognostic (5.72e-3)" "unprognostic (7.50e-2)" "unprognostic (3.11e-3)" "unprognostic (5.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.53e-1)" "unprognostic (4.05e-2)" 13.9 5.5 7.8 19.8 10.7 1.1 11.7 2.1 6.3 8.6 27.6 5.7 2.0 18.3 3.8 15.2 9.6 9.0 50.2 26.8 7.6 5.2 62.9 247.9 11.2 22.9 10.5 3.3 20.3 6.8 0.3 3.2 12.5 8.4 6.1 27.9 22.0 5.1 3.2 2.5 4.2 53.1 10.7 13.2 23.5 10.6 5.2 8.7 4.3 4.9 7.0 10.5 14.7 11.6 0.2 20.0 5.7 92.3 0.0 0.4 42.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 120.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 92.3 5.7 0.2 68.0 0.4 0.2 0.0 0.0 20.0 0.0 0.0 0.0 1.1 0.0 36.2 0.9 0.0 42.0 7.8 10.7 2.1 6.3 7.6 5.2 10.5 3.3 8.4 8.7 3.0 12.4 33.9 0.5 11.2 135.3 52.1 175.8 12.0 19.4 355.9 2.0 0.8 140.9 63.8 13.3 17.2 572.0 0.0 29.9 1.1 82.5 3.5 52.1 1056.4 94.1 6.4 123.0 27.0 68.8 9.8 40.3 84.1 15.1 841.4 193.4 69.9 82.8 725.5 3.2 817.7 17.3 0.0 22.6 3.2 3.4 13.7 2.3 14.6 213.0 1.0 TMEM178A "MGC33926, TMEM178" ENSG00000152154 "Transmembrane protein 178A" Q8NBL3 2 39664982-39717963 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 87.4" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8" "Cancer enhanced" "Detected in many" "prostate cancer: 19.0" "Region enriched" "Detected in all" 5 "cerebellum: 87.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052128 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA052128: AB_2681738" "unprognostic (3.35e-2)" "unprognostic (3.18e-1)" "unprognostic (5.94e-2)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (5.85e-2)" "unprognostic (3.24e-3)" "unprognostic (1.82e-3)" "unprognostic (2.22e-1)" "unprognostic (9.74e-2)" "unprognostic (5.11e-4)" "unprognostic (1.13e-1)" "unprognostic (6.01e-3)" "unprognostic (2.80e-3)" "unprognostic (3.46e-2)" "unprognostic (2.83e-2)" "unprognostic (3.01e-3)" 2.9 4.2 13.3 0.9 10.6 0.6 6.8 87.4 35.6 1.6 1.9 6.4 0.0 2.3 3.8 2.0 1.8 3.3 3.1 3.6 16.4 7.4 18.9 2.7 5.8 0.8 10.7 10.9 1.8 2.2 1.3 2.5 3.6 17.0 12.2 2.2 3.7 3.8 2.1 2.3 3.5 2.4 2.9 22.6 1.6 3.5 1.2 5.3 0.0 5.7 0.8 2.2 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 0.0 0.1 1.8 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 7.1 0.1 0.0 0.6 0.0 0.0 0.4 0.1 10.4 0.2 0.0 0.2 0.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 10.6 87.4 18.8 16.4 7.4 10.7 10.9 17.0 5.3 0.0 1.3 0.0 0.6 0.3 2.1 3.7 0.0 4.0 1.2 12.2 5.9 0.3 0.0 0.3 0.3 3.1 0.4 0.0 0.2 0.0 0.2 4.1 0.0 0.2 0.2 1.6 15.4 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.3 0.3 0.0 0.0 0.7 5.8 0.0 0.4 0.2 0.2 0.5 0.5 0.0 0.4 0.1 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074232-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 23.0;Cardiomyocytes: 39.1;Horizontal cells: 28.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 7.1;HDLM-2: 6.4;NTERA-2: 6.0;RPTEC TERT1: 9.8;SCLC-21H: 7.7;WM-115: 10.4" HPA048771 Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA048771: AB_2680517" "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favorable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.9 1.7 5.2 0.7 7.4 0.1 0.7 3.2 13.4 0.5 0.8 1.0 2.3 0.1 1.1 0.6 1.8 0.3 0.7 11.6 4.8 5.8 2.9 0.6 0.4 1.5 4.9 1.0 0.2 2.6 20.6 18.5 0.1 1.8 2.8 0.4 0.5 4.4 0.8 4.5 0.2 1.2 1.3 2.4 0.8 0.5 0.8 0.4 1.0 9.5 0.1 3.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.6 0.3 1.8 0.1 2.8 0.8 1.0 0.0 0.0 2.2 2.4 0.2 0.5 0.0 7.1 0.0 2.3 6.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 6.0 0.0 0.0 0.4 1.1 3.0 9.8 2.8 7.7 4.7 0.1 0.3 1.0 1.5 1.0 0.0 0.0 0.1 1.2 3.2 0.0 0.1 0.0 0.0 0.5 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 7.4 3.2 9.6 4.8 5.8 4.9 1.0 1.8 0.4 0.0 0.0 0.0 0.4 0.5 23.0 39.1 0.0 0.0 0.0 1.8 2.0 0.0 1.7 0.0 0.8 0.1 0.0 0.0 0.3 0.0 0.2 3.1 0.0 0.0 0.1 28.6 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 3.8 1.2 0.0 0.7 2.8 1.6 0.0 0.8 0.5 0.7 0.1 0.2 0.0 0.0 1.6 TMEM179 "C14orf90, FLJ42486, TMEM179A" ENSG00000258986 "Transmembrane protein 179" Q6ZVK1 14 104474678-104605647 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0" "Group enriched" "Detected in some" 12 "Bipolar cells: 41.7;Horizontal cells: 62.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 6.5;SCLC-21H: 28.3;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002942 Uncertain Mitochondria NA NA Mitochondria "HPA002942: AB_1078113" "unprognostic (8.65e-2)" "unprognostic (8.24e-2)" "unprognostic (3.10e-2)" "unprognostic (1.29e-2)" "unprognostic (1.90e-2)" "unprognostic (1.08e-2)" "unprognostic (3.46e-2)" "unprognostic (2.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (2.82e-3)" "unprognostic (1.09e-1)" "unprognostic (1.89e-4)" "unprognostic (8.68e-3)" "unprognostic (1.56e-1)" "unprognostic (9.71e-6)" "unprognostic (1.70e-2)" 1.1 20.2 11.8 1.5 18.9 0.9 0.9 10.3 30.4 1.0 1.8 3.4 0.0 1.4 1.0 1.6 1.1 1.1 1.1 1.2 12.4 21.7 1.0 1.1 0.9 0.9 13.7 7.2 1.0 4.8 1.0 23.0 2.3 8.3 1.4 1.4 2.2 1.1 1.3 1.0 1.0 1.8 1.4 6.1 0.9 1.8 3.1 4.5 0.0 1.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.3 8.9 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 18.9 10.3 16.7 12.4 21.7 13.7 7.2 8.3 4.5 0.0 0.0 0.0 0.0 0.0 41.7 1.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 62.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 4.3 0.0 0.1 0.6 3.2 0.0 0.0 0.0 0.0 0.0 TMEM181 "GPR178, KIAA1423" ENSG00000146433 "Transmembrane protein 181" Q9P2C4 6 158536436-158635428 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040189, HPA040228" Enhanced Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Vesicles "Nucleoplasm, Golgi apparatus" "HPA040189: AB_10793959, HPA040228: " "unprognostic (1.93e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (9.87e-2)" "unprognostic (6.51e-2)" "unprognostic (3.09e-1)" "unprognostic (1.49e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (4.07e-2)" "unprognostic (1.46e-1)" "unprognostic (1.93e-1)" "unprognostic (4.36e-1)" "unprognostic (3.26e-1)" 7.1 5.6 32.4 4.8 49.2 3.1 8.6 5.3 36.6 13.4 10.1 4.2 6.5 10.9 8.4 3.9 6.3 5.8 7.3 5.3 18.5 8.7 3.3 6.4 6.7 3.4 5.5 23.3 5.6 18.5 8.1 21.5 6.5 11.2 9.4 11.5 4.3 22.4 10.0 4.9 7.0 12.6 7.8 7.3 7.6 16.3 16.0 8.5 2.3 9.7 2.1 3.2 9.9 7.0 1.0 2.1 7.7 3.4 3.9 4.7 1.4 10.2 5.9 8.4 12.9 22.3 20.5 16.1 23.2 13.6 12.1 13.9 10.0 12.6 4.3 12.0 19.2 26.0 15.2 12.4 15.3 19.3 6.3 8.9 8.0 8.8 21.1 18.2 10.0 7.7 16.9 15.1 13.5 18.3 18.3 19.4 6.2 15.2 5.4 19.8 6.2 4.4 12.5 6.5 20.4 7.6 4.3 9.7 4.9 11.6 8.0 24.9 17.1 17.0 16.0 11.1 12.1 6.1 14.1 18.4 12.6 8.5 20.8 20.0 3.2 2.2 4.8 15.2 12.6 11.9 7.7 2.2 5.7 4.7 2.3 3.6 0.9 2.7 3.7 1.6 1.0 2.4 3.2 1.6 3.9 3.4 2.1 2.6 1.4 32.4 49.2 5.3 36.6 18.5 8.7 5.5 23.3 11.2 8.5 11.9 31.5 2.4 11.3 18.1 13.4 14.8 20.4 5.3 7.9 15.7 17.7 7.7 3.3 22.0 3.2 24.0 29.3 0.0 28.2 10.9 15.0 29.8 10.5 18.6 8.9 19.1 42.6 20.3 14.2 4.0 12.0 13.6 13.5 4.6 34.5 6.0 36.3 28.1 16.6 4.8 14.4 6.5 17.1 14.2 22.6 18.3 4.3 20.1 24.4 29.1 TMEM182 FLJ30294 ENSG00000170417 "Transmembrane protein 182" Q6ZP80 2 102736905-103019900 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA045861 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA045861: AB_2679475" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (5.10e-2)" "unprognostic (1.12e-4)" "unprognostic (5.35e-2)" "unprognostic (7.01e-2)" "unprognostic (1.13e-2)" "unprognostic (1.10e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-1)" "unprognostic (4.19e-2)" "unprognostic (3.42e-2)" "unprognostic (9.88e-2)" "unprognostic (4.61e-2)" "unprognostic (1.10e-1)" "unprognostic (3.53e-1)" "unprognostic (2.36e-2)" 2.4 1.1 1.2 1.0 1.3 0.3 1.1 1.7 1.8 1.4 1.0 0.5 1.5 1.0 0.6 2.3 1.8 1.1 0.8 40.3 1.2 1.9 1.4 1.7 0.6 0.8 1.2 0.5 1.0 1.1 1.5 6.8 0.8 2.8 1.9 1.0 0.9 3.8 1.2 53.9 0.5 0.9 1.1 1.2 0.8 1.0 0.8 0.4 1.8 2.0 37.8 4.0 1.2 0.7 4.4 3.1 0.3 0.3 2.4 4.1 1.1 4.9 2.8 2.1 6.6 2.7 2.7 7.7 2.7 2.4 2.7 3.9 9.2 6.9 4.1 9.2 0.9 4.4 2.9 2.3 3.7 5.7 9.1 1.8 6.1 1.3 5.8 3.2 5.5 4.9 3.4 6.8 4.3 3.8 1.9 0.4 5.9 4.3 1.6 2.7 3.6 2.9 5.3 3.6 4.7 3.0 3.1 5.6 3.9 3.8 4.3 5.5 1.9 3.6 3.9 8.6 2.9 3.3 2.9 0.3 4.3 3.1 3.3 3.3 4.0 10.0 3.4 4.4 9.1 6.5 0.0 0.0 0.3 3.9 0.3 3.2 4.4 2.8 2.2 1.3 1.9 3.8 4.1 0.1 2.4 0.3 3.1 0.8 1.1 1.2 1.3 1.7 1.8 1.2 1.9 1.2 0.5 2.8 0.4 20.8 10.5 5.9 0.8 0.3 0.1 134.4 0.0 17.4 23.9 3.5 0.0 1.9 0.0 1.3 0.6 0.0 0.4 23.3 2.9 2.1 1.0 1.0 3.5 1.9 1.0 0.0 6.3 0.0 0.6 0.4 0.6 0.7 6.8 0.0 2.2 2.3 1.7 0.0 0.7 2.4 0.3 0.0 0.9 0.9 2.2 0.5 0.9 1.0 1.7 2.7 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.2;intestine: 39.3" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 57.2;Mucus-secreting cells: 31.0;Paneth cells: 31.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 15.2;RT4: 17.3;SCLC-21H: 17.8;SK-BR-3: 27.6;T-47d: 24.4" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.1 0.2 3.5 0.2 0.1 1.6 0.2 0.3 8.6 15.6 0.2 8.0 15.1 1.7 2.9 40.2 4.4 9.6 0.2 0.2 0.1 5.3 18.0 1.5 0.2 0.2 0.3 0.9 24.7 3.1 5.4 14.3 0.4 5.1 4.0 0.3 10.3 12.0 2.3 17.9 39.3 1.2 0.2 0.2 7.5 3.8 0.2 0.5 0.3 22.9 31.9 10.0 15.8 0.8 0.8 2.0 0.5 0.4 0.5 0.0 9.7 6.6 0.0 0.0 0.0 0.0 2.2 0.3 0.1 0.4 0.0 8.9 11.7 0.2 3.4 0.1 3.6 7.5 0.0 4.4 0.1 0.1 0.2 0.0 6.0 4.0 0.1 0.0 0.0 0.0 4.3 0.1 3.9 0.2 0.0 2.9 0.1 0.0 0.0 15.2 0.0 0.0 0.3 6.0 8.6 0.2 0.0 4.7 3.3 17.3 17.8 0.0 2.9 27.6 0.0 0.2 24.4 0.0 0.0 0.0 3.7 4.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.2 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.8 0.4 0.3 2.0 0.4 0.2 0.8 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.4 0.2 3.0 4.1 0.8 5.3 3.5 0.9 2.5 17.8 13.4 10.3 8.7 0.0 6.6 1.7 11.9 0.0 0.7 57.2 0.0 9.6 7.7 1.3 11.9 1.1 12.4 0.7 0.0 6.9 0.0 1.2 0.0 0.0 1.7 0.0 1.0 31.0 0.0 12.3 31.6 0.0 3.8 0.4 0.0 1.0 0.0 0.0 8.2 14.1 0.0 13.3 11.3 TMEM184C "FLJ10846, TMEM34" ENSG00000164168 "Transmembrane protein 184C" Q9NVA4 4 147617383-147672044 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054013 Uncertain Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA054013: AB_2682343" "unprognostic (5.45e-3)" "unprognostic (2.49e-2)" "unprognostic (3.93e-3)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.32e-2)" "unprognostic (7.72e-3)" "unprognostic (1.48e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.37e-4)" "unprognostic (1.13e-1)" "prognostic favorable (2.31e-7)" "unprognostic (4.68e-2)" "unprognostic (3.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.31e-3)" 10.4 18.4 11.3 9.6 13.1 5.5 10.0 12.3 15.9 11.8 13.0 12.3 14.3 11.8 12.4 9.8 10.7 10.0 9.6 14.3 11.8 11.3 18.0 18.7 9.2 7.7 16.1 11.8 15.7 11.6 107.2 10.5 14.0 12.7 12.0 11.6 9.3 12.1 12.8 16.2 9.5 14.8 10.1 14.0 10.0 10.6 8.3 14.1 11.7 32.9 10.3 9.4 11.8 11.2 12.8 17.3 17.7 18.1 14.7 22.8 11.6 9.2 14.5 18.4 14.0 25.2 24.6 12.1 17.3 20.3 12.9 15.0 11.9 17.7 8.6 8.7 13.5 12.8 11.1 14.9 13.3 14.3 19.1 8.7 11.1 11.2 8.6 19.4 14.8 16.6 18.3 18.0 14.2 14.9 18.8 16.6 9.8 14.2 24.3 18.0 13.8 12.8 5.4 11.8 21.1 8.5 12.8 6.3 14.8 14.3 17.3 14.3 18.5 9.4 14.7 15.1 14.9 14.7 9.3 16.2 16.4 8.9 13.3 11.0 26.6 34.8 11.5 19.2 8.9 17.7 17.7 14.1 15.5 18.0 18.0 22.8 12.3 16.7 16.4 17.3 12.8 15.9 14.8 11.0 14.7 18.1 11.9 15.3 11.6 11.3 13.1 12.3 15.9 11.8 11.3 16.1 11.8 12.7 14.1 8.9 5.7 6.4 6.6 4.0 7.7 16.5 10.2 5.3 14.8 5.2 11.8 12.5 1.7 10.6 19.6 9.8 8.5 0.0 11.1 10.6 8.4 7.2 20.8 8.5 9.0 11.1 5.2 6.7 10.4 10.3 10.0 8.8 5.0 4.6 8.3 7.8 7.5 3.5 13.8 5.3 6.2 6.5 7.3 5.4 4.9 3.0 7.2 6.4 9.9 6.4 TMEM190 MDAC1 ENSG00000160472 "Transmembrane protein 190" Q8WZ59 19 55376836-55378244 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 63.6;ovary: 17.7;testis: 21.5" "Group enriched" "Detected in some" 9 "Ciliated cells: 338.6;Early spermatids: 390.3;Late spermatids: 112.4" "Group enriched" "Detected in many" 8 "endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 14.0;hTERT-RPE1: 5.0;SCLC-21H: 7.0" "Region enriched" "Detected in single" 7 "cerebellum: 0.9" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" NA NA "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (5.00e-2)" "unprognostic (6.58e-2)" "unprognostic (6.24e-3)" "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (5.02e-1)" "unprognostic (2.08e-1)" "unprognostic (4.95e-2)" "unprognostic (1.03e-1)" "unprognostic (5.38e-5)" "unprognostic (1.44e-1)" "unprognostic (1.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.93e-1)" 0.1 0.7 0.1 0.1 0.3 0.1 0.1 0.2 0.5 5.7 0.1 0.5 0.1 0.1 1.4 1.1 0.1 63.6 0.1 0.1 0.6 2.7 0.1 0.1 11.8 0.1 0.1 0.1 17.7 0.1 0.0 3.0 0.3 1.0 0.1 0.0 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.5 21.5 0.3 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.4 2.5 0.0 0.5 0.0 0.0 0.2 0.7 0.3 0.6 0.1 1.8 1.5 2.6 0.2 0.7 0.4 4.5 0.0 0.0 0.0 4.3 0.2 0.0 2.7 14.0 0.9 0.0 0.1 0.2 0.0 0.1 0.0 5.0 0.0 0.2 0.0 3.4 0.0 2.0 0.3 0.0 0.5 1.7 0.8 0.2 1.6 1.4 0.0 1.3 7.0 1.3 1.4 1.8 0.6 1.3 0.8 0.0 0.0 0.2 1.1 0.2 0.7 0.5 3.2 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.5 0.6 2.7 0.1 0.1 1.0 0.3 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 338.6 33.0 0.0 0.0 0.1 0.0 0.1 390.3 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.1 0.0 0.1 0.0 8.5 0.0 0.0 112.4 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 2.4 1.7 0.0 0.3 0.0 0.0 0.0 TMEM191B ENSG00000278558 "Transmembrane protein 191B" P0C7N4 22 18527802-18530573 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "blood: 5.6;testis: 12.7" "Group enriched" "Detected in many" 14 "Early spermatids: 369.4;Late spermatids: 373.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.7;CACO-2: 3.5;U-266/70: 3.6;U-87 MG: 2.3" NA NA "unprognostic (1.70e-1)" "unprognostic (8.90e-2)" "unprognostic (3.18e-1)" "unprognostic (9.75e-2)" "unprognostic (1.60e-1)" "unprognostic (3.30e-1)" "unprognostic (1.25e-1)" "unprognostic (2.27e-1)" "unprognostic (1.98e-1)" "unprognostic (6.25e-2)" "unprognostic (4.90e-2)" "unprognostic (4.65e-2)" "unprognostic (4.44e-2)" "unprognostic (2.10e-2)" "unprognostic (3.54e-1)" "unprognostic (9.40e-2)" "unprognostic (9.22e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 12.7 0.0 0.0 0.0 1.6 2.8 4.2 5.6 0.5 3.1 3.3 1.3 0.0 1.0 0.0 0.0 0.0 4.7 0.3 0.0 0.1 0.0 3.5 0.8 1.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.2 0.3 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.3 1.1 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 1.1 0.9 0.0 3.6 0.6 1.2 2.3 0.0 0.7 4.2 2.7 1.4 1.5 5.6 0.7 0.8 2.4 1.5 2.8 1.6 1.8 3.1 2.0 0.5 4.7 2.4 1.4 3.3 0.0 0.3 1.4 3.8 0.0 2.6 0.8 5.1 0.0 0.0 8.7 0.0 24.6 3.3 6.8 369.4 0.6 25.7 0.0 7.0 8.6 1.3 5.2 0.0 3.6 7.1 1.6 10.5 1.3 5.6 373.7 2.3 2.6 0.0 9.0 16.9 2.3 21.8 0.0 2.1 5.8 2.7 0.0 2.5 9.5 4.3 0.0 9.2 5.0 13.3 2.8 TMEM191C ENSG00000206140 "Transmembrane protein 191C" A6NGB0 22 21466423-21471269 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 11 "blood: 6.1;testis: 4.1" "Group enriched" "Detected in many" 19 "Early spermatids: 745.3;Late spermatids: 836.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 4.2;HEK 293: 1.6;HeLa: 2.2;Hep G2: 1.7;MCF7: 1.9" NA NA "unprognostic (2.55e-1)" "unprognostic (2.18e-2)" "unprognostic (7.12e-3)" "unprognostic (2.83e-2)" "unprognostic (1.19e-1)" "unprognostic (1.86e-1)" "unprognostic (1.77e-2)" "unprognostic (5.97e-2)" "unprognostic (1.25e-1)" "unprognostic (2.40e-2)" "unprognostic (1.59e-3)" "unprognostic (2.09e-1)" "unprognostic (2.41e-1)" "unprognostic (1.78e-1)" "unprognostic (7.63e-2)" "unprognostic (1.36e-1)" "unprognostic (4.12e-3)" 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 1.9 0.4 3.6 6.1 0.6 3.0 1.3 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.6 0.1 2.2 1.7 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.9 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.2 0.5 0.0 0.0 3.6 1.4 0.0 0.2 4.6 1.3 0.6 0.5 1.4 0.4 1.9 3.0 0.7 0.7 0.6 6.1 0.3 0.4 1.3 0.0 2.9 0.5 1.5 4.4 3.6 0.6 5.1 2.7 0.0 5.2 2.0 42.0 0.0 2.5 745.3 1.0 21.0 0.0 0.2 19.4 3.0 1.4 6.9 1.7 8.8 12.7 9.8 1.8 9.4 836.6 4.9 7.1 3.3 3.6 7.1 1.0 3.1 7.4 3.9 3.8 2.4 0.0 2.7 11.5 6.3 5.9 15.9 5.0 6.5 0.7 TMEM196 MGC42090 ENSG00000173452 "Transmembrane protein 196" Q5HYL7 7 19719310-19773598 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 15.0;pituitary gland: 12.6" "Cell type enriched" "Detected in some" 10 "Bipolar cells: 51.1" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "ASC diff: 8.8;ASC TERT1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043163 Uncertain Uncertain "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA "Nucleoplasm, Golgi apparatus" "HPA043163: AB_10794772" "unprognostic (6.08e-3)" "unprognostic (1.88e-2)" "unprognostic (2.14e-2)" "unprognostic (9.30e-2)" "unprognostic (5.63e-2)" 0.7 3.7 8.0 0.6 8.6 0.4 0.4 0.3 15.0 1.2 0.6 0.3 0.0 0.4 3.8 1.5 0.5 1.2 0.4 0.4 3.6 10.1 0.6 0.4 0.4 0.4 2.9 7.4 0.4 3.0 0.7 12.6 0.4 5.0 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.4 1.0 1.4 0.4 2.6 0.5 2.8 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 8.8 8.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 8.6 0.3 7.3 3.6 10.1 2.9 7.4 5.0 2.8 0.0 0.0 0.0 0.0 0.0 51.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.8 0.4 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 20.6;Intestinal endocrine cells: 18.4;Muller glia cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 17.3;SH-SY5Y: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles NA NA Vesicles "HPA042385: AB_2677972, HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favorable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.0 9.4 14.4 3.1 10.3 0.9 2.3 14.2 22.0 3.3 2.6 4.1 1.4 16.1 4.0 2.5 2.7 2.5 3.9 3.4 16.5 5.2 3.0 2.6 2.4 1.8 4.1 11.9 10.9 20.0 5.2 13.0 2.6 6.2 4.0 1.8 3.0 7.0 4.3 3.5 2.2 6.4 3.5 7.5 1.8 4.7 5.0 4.9 0.0 4.0 0.5 1.9 3.8 1.2 0.2 2.6 0.1 0.0 0.8 0.4 0.4 0.5 0.1 4.8 8.2 1.0 0.9 4.3 2.5 1.3 2.0 1.7 10.5 1.4 2.1 2.4 1.5 5.0 2.9 1.7 1.2 0.4 7.1 2.0 1.7 2.1 8.6 1.5 0.6 4.0 2.1 0.7 0.9 2.3 2.2 0.0 1.5 6.2 7.0 1.2 1.0 0.1 0.5 6.2 0.8 0.7 0.2 2.9 2.4 1.2 1.1 17.3 15.0 0.6 1.7 4.1 0.9 0.2 3.3 0.1 2.2 0.9 2.0 1.0 6.7 1.9 2.2 2.0 0.1 3.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 2.6 0.0 0.4 14.4 10.3 14.2 22.0 16.5 5.2 4.1 11.9 6.2 4.9 0.0 1.4 0.0 1.1 0.1 8.1 1.6 0.0 0.0 0.0 0.0 2.0 0.8 1.7 2.7 0.7 0.0 1.0 0.0 7.0 0.6 2.2 0.8 0.0 1.5 0.2 20.6 18.4 0.0 0.3 1.3 2.6 0.0 1.7 1.0 0.9 9.8 1.8 0.8 4.6 1.6 6.5 0.0 2.8 9.2 3.1 0.1 2.4 0.5 0.1 0.3 TMEM2 ENSG00000135048 "Transmembrane protein 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.6" "Cell type enhanced" "Detected in many" 5 "Ito cells: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 36.6;BEWO: 34.0;OE19: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044889 Approved Supported "Vesicles,Plasma membrane" NA NA 130000 "Plasma membrane" Vesicles "HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 23.3 3.9 6.0 10.5 4.4 12.4 13.6 8.9 6.0 3.0 18.6 1.9 10.1 12.2 4.5 5.2 4.4 4.9 19.2 9.5 8.6 3.6 9.3 24.9 35.7 14.0 4.0 4.1 3.1 9.2 24.0 9.5 67.6 4.3 5.5 13.1 7.9 9.5 10.2 5.5 6.4 20.0 5.5 5.1 15.6 14.5 3.7 2.4 6.4 8.0 4.6 8.8 11.4 6.8 6.3 0.9 5.5 2.1 0.5 4.1 1.4 5.8 28.0 36.6 1.7 3.8 6.9 34.0 19.7 12.6 13.7 10.1 7.8 8.0 0.1 5.9 5.0 3.0 8.7 11.8 2.7 18.6 0.7 3.6 10.0 5.9 20.8 5.9 0.0 2.7 7.1 3.0 10.6 2.4 3.6 18.0 0.8 1.4 3.0 7.4 4.9 1.1 0.1 7.6 36.1 2.7 0.9 10.9 0.7 8.6 18.9 1.8 0.2 5.1 3.6 5.3 11.8 2.5 0.3 7.8 9.3 10.5 5.1 9.8 0.6 8.4 0.3 1.8 0.9 11.7 0.2 2.1 5.5 2.7 1.9 0.8 0.7 2.9 2.6 0.9 6.3 4.1 2.0 4.5 0.5 1.8 0.2 3.9 1.4 6.0 4.4 8.9 6.0 8.6 3.6 4.0 4.1 4.3 2.4 32.8 30.4 9.4 38.3 26.8 5.5 0.0 33.1 4.0 17.0 0.0 9.8 36.3 0.0 0.0 10.6 37.9 75.4 0.0 0.0 12.0 19.0 42.5 4.6 27.6 35.9 0.0 9.7 115.4 56.5 2.9 2.8 14.9 16.9 0.0 32.3 73.6 0.0 26.4 1.1 0.0 35.2 6.5 20.8 1.0 0.6 19.2 75.1 62.3 28.3 40.3 TMEM200A "KIAA1913, TTMC" ENSG00000164484 "Transmembrane protein 200A" Q86VY9 6 130365734-130443063 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 36.2" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 25.8;Erythroid cells: 23.3;Horizontal cells: 12.7;Intestinal endocrine cells: 23.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory CD4 T-cell: 1.8;NK-cell: 7.1" "Group enriched" "Detected in many" 8 "NK-cells: 7.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 20.8;hTEC/SVTERT24-B: 33.6;hTERT-RPE1: 16.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014396 Uncertain NA NA "HPA014396: AB_2204904" "unprognostic (1.07e-1)" "unprognostic (4.89e-2)" "unprognostic (2.33e-1)" "unprognostic (4.19e-2)" "unprognostic (7.62e-2)" "unprognostic (2.35e-1)" "unprognostic (3.28e-2)" "unprognostic (2.91e-1)" "unprognostic (7.25e-2)" "unprognostic (9.29e-2)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.27e-3)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (1.91e-3)" 6.0 17.0 4.6 7.6 2.7 0.0 5.6 0.6 6.2 12.1 7.1 1.5 0.0 4.7 36.2 8.1 1.9 10.6 4.2 4.3 3.1 2.2 14.4 1.2 7.0 3.9 1.1 2.5 26.0 3.9 0.4 11.6 2.1 1.4 4.3 15.1 6.8 2.0 0.8 2.6 2.3 5.3 13.5 0.9 1.2 3.9 7.8 0.2 7.4 3.6 0.3 2.1 8.7 4.0 0.5 0.0 0.0 0.0 7.1 1.8 0.4 0.0 0.0 0.1 0.0 6.0 7.6 0.0 5.2 6.4 5.6 9.9 8.1 0.0 0.0 0.0 10.9 1.2 1.2 0.5 0.0 20.8 7.4 0.0 0.0 0.0 0.3 2.7 0.1 0.0 8.5 0.0 33.6 6.7 16.9 0.2 0.1 0.0 0.7 2.6 0.0 0.0 0.0 4.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 6.5 6.4 2.0 0.5 0.9 4.1 0.0 0.0 3.8 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.0 0.5 1.8 1.0 0.0 0.1 0.3 0.1 0.0 7.1 0.0 0.0 0.0 0.4 4.6 2.7 0.6 6.2 3.1 2.2 1.1 2.5 1.4 0.2 0.0 0.3 0.0 0.0 1.8 25.8 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.2 6.4 23.3 0.0 1.3 4.1 0.0 0.0 0.0 0.2 12.7 23.6 0.0 0.0 1.3 5.5 0.0 1.7 0.0 1.4 0.5 0.2 7.2 9.9 9.2 1.9 0.0 2.3 0.5 1.5 1.3 0.5 1.5 3.3 0.0 TMEM200C TTMA ENSG00000206432 "Transmembrane protein 200C" A6NKL6 18 5882072-5895955 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 10.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 6.6;Cone photoreceptor cells: 5.9;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.8;NTERA-2: 4.5;PC-3: 20.8;SH-SY5Y: 3.3;U-2 OS: 10.6;U-251 MG: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA047253, HPA050490" Uncertain Approved Microtubules NA NA Microtubules "HPA047253: AB_2680001, HPA050490: AB_2681144" "unprognostic (6.57e-4)" "unprognostic (3.09e-1)" "unprognostic (1.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (3.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.12e-2)" "unprognostic (2.29e-2)" "unprognostic (6.31e-2)" "unprognostic (3.82e-4)" "unprognostic (2.48e-10)" "unprognostic (2.94e-2)" "unprognostic (6.38e-2)" "unprognostic (7.22e-2)" "unprognostic (2.38e-2)" 0.4 6.3 2.6 1.0 3.7 0.1 3.5 0.7 5.7 0.8 0.5 1.7 0.1 0.5 1.6 3.2 0.6 1.1 1.3 2.9 2.7 3.5 2.0 5.3 0.5 1.1 3.7 1.6 1.9 0.2 0.1 3.3 0.1 1.7 0.9 0.3 2.7 10.1 0.7 0.1 0.7 0.6 0.5 1.2 1.6 1.3 3.5 1.5 0.1 0.2 0.1 1.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 20.8 1.2 0.0 0.0 0.0 0.0 1.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.6 0.0 3.6 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.7 0.7 4.7 2.7 3.5 3.7 1.6 1.7 1.5 0.0 1.4 0.0 0.0 0.1 6.6 1.2 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 2.1 0.0 1.2 0.0 0.9 0.1 0.4 0.3 0.0 0.0 0.0 0.1 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588922-9614873 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.0" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favorable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavorable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 6.2 7.3 9.6 5.7 9.4 10.3 4.0 8.7 11.9 4.4 3.9 10.5 4.4 5.4 6.9 5.1 5.9 5.8 4.0 13.2 9.3 7.9 5.7 2.7 4.5 5.0 9.4 8.3 9.0 9.2 5.5 12.6 4.5 7.9 4.9 2.8 12.6 6.7 5.6 37.0 7.1 3.9 4.9 6.7 5.3 4.0 8.2 7.1 6.9 4.5 13.9 5.4 3.8 4.3 1.4 4.3 0.0 0.8 0.4 1.9 1.0 7.7 10.5 6.6 15.5 2.8 1.9 5.9 9.1 2.8 10.9 7.7 19.3 7.1 13.5 11.6 3.1 5.3 16.2 7.3 7.2 3.7 8.9 18.3 9.5 10.0 9.8 5.1 11.5 9.9 3.4 3.3 14.6 2.4 2.3 4.3 6.4 12.1 3.9 4.3 9.2 10.0 8.4 6.7 6.0 9.8 21.2 11.3 11.1 3.9 4.3 15.9 11.9 7.2 17.6 7.9 2.4 5.4 7.3 3.9 13.0 11.3 14.3 17.1 6.6 5.5 12.1 9.0 19.0 11.4 0.0 0.8 0.0 1.1 0.6 0.6 1.4 1.4 1.9 1.1 1.1 1.0 0.7 0.0 0.4 0.4 4.3 1.8 1.0 9.6 9.4 8.7 11.9 9.3 7.9 9.4 8.3 7.9 7.1 3.0 1.3 1.9 1.7 6.3 14.7 10.6 2.5 2.7 2.3 0.0 25.5 2.8 1.7 2.0 1.1 4.5 0.7 0.0 0.8 1.8 2.3 1.4 4.6 1.5 3.0 9.5 6.4 4.3 3.7 1.3 3.7 2.5 3.3 0.0 3.6 4.8 1.3 0.0 4.2 1.9 16.3 0.0 3.8 4.7 5.3 4.8 0.7 1.0 4.0 1.7 TMEM202 FLJ27523 ENSG00000187806 "Transmembrane protein 202" A6NGA9 15 72398273-72408029 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 219 "testis: 23.5" "Group enriched" "Detected in some" 44 "Early spermatids: 52.5;Late spermatids: 43.7;Spermatocytes: 18.0" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 18.0 0.9 0.0 0.0 0.0 0.0 0.0 TMEM206 "C1orf75, FLJ10874" ENSG00000065600 "Transmembrane protein 206" Q9H813 1 212363931-212414901 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.8" "Cell type enhanced" "Detected in many" 5 "monocytes: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008540 Uncertain NA NA "HPA008540: AB_10794083" "unprognostic (2.18e-1)" "unprognostic (2.22e-1)" "unprognostic (9.23e-2)" "unprognostic (1.02e-1)" "unprognostic (2.74e-2)" "unprognostic (3.09e-2)" "prognostic unfavorable (3.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "unprognostic (1.06e-3)" "unprognostic (6.33e-2)" "unprognostic (1.02e-1)" "unprognostic (9.10e-2)" "unprognostic (6.98e-2)" 3.7 3.7 10.7 5.5 11.7 7.1 3.5 3.8 22.5 2.3 2.6 35.3 2.2 2.9 4.2 3.0 3.8 2.1 4.2 3.3 15.4 11.8 14.3 2.1 4.3 9.9 21.8 7.1 2.0 3.9 3.4 3.1 5.9 19.7 4.4 3.3 1.4 2.8 2.5 2.0 2.9 3.1 4.2 50.8 6.1 2.2 7.7 17.8 7.8 2.7 1.3 7.2 6.5 3.0 7.7 17.7 11.6 10.1 6.2 6.4 5.2 7.5 5.8 8.9 14.6 5.2 2.9 8.8 4.4 3.5 7.4 6.6 4.9 5.6 9.0 3.6 2.1 7.2 6.8 8.4 4.0 7.4 6.7 9.1 8.5 4.2 6.0 7.5 13.5 13.3 2.5 4.3 6.8 4.9 7.4 8.3 13.2 7.6 5.3 5.1 2.9 14.9 13.9 11.7 3.5 7.8 12.3 9.9 8.6 3.7 3.8 13.8 21.4 5.1 7.6 19.4 9.1 11.4 16.7 7.2 4.9 5.5 11.5 11.4 6.9 11.1 12.5 6.5 12.5 13.4 11.6 7.7 4.3 4.9 10.1 6.4 7.7 3.8 5.7 12.5 7.3 5.6 6.0 0.6 6.2 8.7 17.7 5.3 5.2 10.7 11.7 3.8 12.8 15.4 11.8 21.8 7.1 19.7 17.8 3.0 0.0 12.3 2.6 11.2 3.1 3.2 0.0 1.4 1.2 5.2 0.0 11.4 1.7 6.1 1.5 5.2 0.7 0.0 3.6 5.8 5.0 4.2 12.7 0.8 25.2 0.0 4.6 2.5 12.4 0.4 2.3 13.9 6.8 31.5 0.5 26.1 5.7 2.9 1.8 18.7 4.9 6.5 3.3 11.6 25.1 11.2 6.9 5.1 1.9 3.9 TMEM207 ENSG00000198398 "Transmembrane protein 207" Q6UWW9 3 190428655-190449876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 75 "kidney: 21.1" "Cell type enriched" "Detected in some" 17 "Distal tubular cells: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "U-266/70: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA014332 Uncertain NA NA "HPA014332: AB_2204907" "unprognostic (4.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 58.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 TMEM210 ENSG00000185863 "Transmembrane protein 210" A6NLX4 9 137170858-137172409 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 18.7" "Group enriched" "Detected in some" 58 "Early spermatids: 718.1;Late spermatids: 1521.3" "Cancer enhanced" "Detected in single" "prostate cancer: 1.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.1" "Group enriched" "Detected in many" 4 "dendritic cells: 4.1;granulocytes: 1.4" "Cell line enriched" "Detected in some" 7 "RPMI-8226: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA066907 Enhanced NA NA "HPA066907: AB_2685747" "unprognostic (5.17e-2)" "unprognostic (5.04e-2)" "unprognostic (2.87e-5)" "unprognostic (4.18e-2)" "unprognostic (3.63e-2)" "unprognostic (3.14e-2)" "unprognostic (8.00e-2)" 0.1 0.0 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.1 4.0 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 18.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.6 4.1 1.4 0.3 0.5 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.7 0.1 15.8 0.0 0.0 0.1 0.1 0.0 2.1 0.1 0.1 1.5 0.0 0.0 0.1 0.1 0.6 0.0 0.3 0.2 0.0 0.3 0.2 0.0 1.4 0.3 0.1 0.2 0.2 0.3 0.1 0.2 0.2 0.2 0.6 0.3 0.3 1.2 0.5 0.2 4.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 718.1 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1521.3 11.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 6.0 0.0 0.0 19.4 0.1 8.8 3.5 0.1 0.0 0.0 0.0 0.2 TMEM211 bA9F11.1 ENSG00000206069 "Transmembrane protein 211" Q6ICI0 22 24934954-24946695 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "cervix, uterine: 5.3;salivary gland: 6.6;stomach 1: 5.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.8;endometrial cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.1;HEK 293: 1.1;OE19: 2.3" HPA066784 Uncertain NA NA "HPA066784: AB_2685722" "unprognostic (7.89e-3)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" "unprognostic (1.09e-2)" "unprognostic (5.97e-3)" "unprognostic (5.88e-2)" "unprognostic (1.31e-3)" "unprognostic (3.26e-2)" "unprognostic (2.06e-1)" "unprognostic (6.42e-2)" "unprognostic (2.65e-2)" "unprognostic (8.61e-3)" "unprognostic (3.59e-1)" "unprognostic (4.43e-2)" 0.0 0.0 0.0 0.4 0.4 0.0 0.8 0.4 0.1 5.3 0.4 0.0 1.2 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.1 6.6 0.0 0.0 1.4 0.1 0.0 0.0 0.0 5.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.2;lung: 10.0;ovary: 12.8" "Cell type enhanced" "Detected in some" 30 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: AB_2679436" "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 0.4 0.4 0.5 0.6 0.8 2.2 0.4 0.4 0.5 1.6 0.8 0.9 0.4 0.2 1.3 2.5 0.8 19.2 0.4 0.4 0.6 0.7 0.4 3.3 10.0 0.6 0.4 0.4 12.8 0.4 0.0 0.4 0.4 0.7 0.4 0.8 0.4 0.4 2.1 1.1 1.5 0.5 0.4 0.4 0.4 0.4 1.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 4.1 3.2 6.3 2.1 3.8 2.7 0.5 4.1 2.5 2.8 3.1 0.8 0.4 5.5 3.0 0.9 1.2 1.2 2.0 3.3 5.4 3.6 1.4 3.1 2.9 1.7 1.3 2.6 7.1 2.8 6.4 6.5 2.7 0.5 3.7 5.4 1.1 1.5 1.4 1.2 1.8 1.3 3.4 4.4 8.6 0.9 2.7 3.2 4.1 4.9 2.1 2.7 2.7 4.4 4.5 1.1 3.2 3.4 3.3 4.1 3.1 2.3 3.3 3.6 3.3 6.6 4.6 5.0 7.2 3.2 5.1 4.0 3.6 2.3 3.4 2.4 6.3 2.1 1.8 2.7 1.8 2.1 1.9 2.0 1.8 1.1 4.1 2.3 2.5 5.0 3.8 2.0 3.2 1.3 0.5 0.5 0.8 0.4 0.4 0.6 0.7 0.4 0.4 0.7 0.4 32.8 22.8 0.0 0.0 0.0 0.0 0.0 0.0 167.3 46.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.1 0.0 0.0 0.0 0.0 TMEM213 ENSG00000214128 "Transmembrane protein 213" A2RRL7 7 138797952-138838101 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "kidney: 48.1;salivary gland: 35.6" "Cell type enhanced" "Detected in some" 28 "Collecting duct cells: 50.6;Distal tubular cells: 122.7;Melanocytes: 25.3" "Cancer enriched" "Detected in some" 22 "renal cancer: 21.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 4.5" "Not detected" "Not detected" HPA054059 Enhanced NA NA "HPA054059: AB_2682361" "unprognostic (2.79e-2)" "unprognostic (2.56e-1)" "unprognostic (1.85e-2)" "unprognostic (1.19e-2)" "unprognostic (3.19e-2)" "unprognostic (6.84e-2)" "unprognostic (1.17e-2)" "unprognostic (2.10e-1)" "unprognostic (6.14e-2)" "unprognostic (6.08e-2)" "unprognostic (1.91e-2)" "prognostic favorable (5.54e-7)" "unprognostic (4.33e-1)" "unprognostic (9.99e-2)" "unprognostic (3.06e-1)" "unprognostic (1.05e-2)" 0.1 0.0 0.1 0.0 0.1 0.4 2.1 0.0 0.1 1.2 0.0 0.0 4.3 0.3 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 48.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 35.6 2.9 0.0 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.3 0.1 0.0 1.1 0.8 4.1 0.7 4.6 1.2 0.2 0.4 0.4 0.7 1.6 0.3 0.3 1.4 0.6 0.2 0.1 0.3 1.1 1.7 0.9 0.6 0.1 0.6 0.9 0.0 0.0 0.3 0.6 1.2 1.4 1.0 0.7 0.1 1.0 0.9 0.5 0.2 0.1 0.4 0.5 0.5 0.8 1.2 1.9 0.3 0.2 0.4 0.9 0.3 0.2 0.3 0.6 0.9 0.7 4.5 1.7 1.3 1.1 0.5 1.1 0.2 1.0 1.2 0.3 0.1 1.8 0.9 1.4 0.8 1.7 0.5 1.2 0.8 0.4 0.9 4.1 0.7 0.7 0.9 0.6 1.2 0.7 0.5 0.6 0.3 1.1 0.6 0.6 3.4 4.6 0.6 0.8 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 3.0 6.9 0.0 0.7 0.0 0.3 0.4 0.0 5.3 3.4 50.6 0.0 0.0 122.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.4 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 TMEM215 ENSG00000188133 "Transmembrane protein 215" Q68D42 9 32783499-32787399 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 8.0;retina: 6.5;testis: 17.9" "Cell type enhanced" "Detected in some" 32 "Bipolar cells: 564.3;Early spermatids: 108.6;Late spermatids: 188.4" "Cancer enriched" "Detected in single" 14 "thyroid cancer: 4.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 6.6;SH-SY5Y: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA052804, HPA063207" Supported "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA052804: AB_2681957, HPA063207: AB_2732697" "unprognostic (1.31e-2)" "unprognostic (4.57e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-2)" "unprognostic (5.85e-2)" "unprognostic (4.38e-3)" "unprognostic (2.17e-3)" "unprognostic (2.82e-1)" "unprognostic (2.72e-1)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" "unprognostic (2.32e-2)" 0.1 0.0 1.8 0.4 1.5 0.0 0.1 0.1 0.9 1.9 0.0 0.0 0.0 0.0 8.0 0.9 0.1 0.1 0.0 0.9 0.9 1.5 0.0 0.0 0.1 0.0 1.7 0.2 0.7 0.0 0.0 0.1 0.0 0.6 0.1 0.0 6.5 0.1 0.0 0.3 0.1 0.1 0.0 1.0 0.0 0.0 17.9 0.0 0.0 3.0 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.1 0.8 0.9 1.5 1.7 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 564.3 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 108.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 188.4 2.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.7 0.0 21.9 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212180-37258155 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 20.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 13.1;Exocrine glandular cells: 13.9;Pancreatic endocrine cells: 14.4;Spermatocytes: 19.2;Urothelial cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HEL: 4.8;hTEC/SVTERT24-B: 3.4;HUVEC TERT2: 5.0;TIME: 13.1" "Not detected" "Not detected" "HPA045432, HPA071187" Approved Nucleoli,Cytosol NA NA Nucleoli Cytosol "HPA045432: AB_2732519, HPA071187: AB_2732174" "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.3 2.7 0.4 0.4 1.4 1.3 0.3 0.4 1.1 0.3 0.3 1.6 0.0 0.4 0.2 1.1 1.4 0.4 0.7 0.4 0.3 0.4 0.9 0.5 0.5 0.1 0.9 1.0 1.1 3.1 0.6 2.3 0.2 1.0 0.4 0.3 1.1 1.5 0.1 1.0 0.5 0.4 0.5 1.6 0.2 0.2 20.1 0.9 0.0 0.5 0.0 0.3 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.2 1.3 0.0 0.4 2.8 1.0 3.7 0.7 0.5 0.1 0.2 0.0 1.5 0.5 0.3 0.3 1.1 0.1 0.2 4.8 0.0 0.1 0.3 0.0 2.8 0.5 0.7 3.4 0.2 1.2 5.0 0.4 1.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.2 0.6 0.0 0.1 13.1 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.1 0.4 1.4 0.4 1.1 0.3 0.4 0.9 1.0 1.0 0.9 0.0 1.1 0.0 8.5 2.3 0.4 0.2 0.0 2.7 2.3 1.8 0.0 0.7 3.3 13.1 12.1 2.1 1.2 0.0 13.9 0.4 2.4 6.4 5.7 0.0 0.8 3.2 1.7 0.0 0.0 11.8 0.6 1.4 1.7 0.0 0.2 6.0 14.4 0.0 0.0 1.0 0.5 0.0 0.8 19.2 0.8 2.6 0.9 0.0 0.4 14.2 TMEM220 ENSG00000187824 "Transmembrane protein 220" Q6QAJ8 17 10699015-10730316 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 58.2" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047680 Uncertain Nucleoplasm NA NA Nucleoplasm "HPA047680: " "unprognostic (1.71e-2)" "unprognostic (4.60e-2)" "unprognostic (6.31e-3)" "unprognostic (4.04e-3)" "unprognostic (1.05e-3)" "unprognostic (1.84e-4)" "prognostic favorable (2.23e-5)" "unprognostic (4.58e-2)" "unprognostic (4.96e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.97e-1)" "unprognostic (4.34e-3)" "unprognostic (2.25e-1)" "unprognostic (2.63e-2)" "unprognostic (7.80e-3)" "unprognostic (5.97e-2)" 6.5 7.4 4.5 2.4 4.6 3.3 7.8 1.3 2.8 4.7 6.1 3.8 14.3 8.1 4.9 11.1 3.3 3.9 10.1 6.3 3.8 2.4 6.4 58.2 4.6 3.1 2.9 1.2 4.8 6.0 2.4 2.4 1.7 4.9 12.0 2.8 6.6 3.5 18.5 4.1 3.7 15.4 5.4 2.5 4.7 7.1 17.2 3.5 0.6 9.4 2.6 2.4 4.1 3.4 11.6 2.9 2.3 2.5 4.5 9.0 1.9 0.5 3.5 1.3 8.3 5.2 5.2 1.0 6.9 7.3 4.7 6.8 0.0 0.3 1.2 0.5 4.3 0.4 0.4 3.4 0.6 3.5 0.4 1.5 0.5 0.2 2.9 7.6 0.9 0.8 3.4 0.4 1.5 0.3 1.0 2.2 3.0 0.4 0.3 3.0 0.4 1.1 1.5 5.0 0.4 0.0 4.8 0.2 0.6 11.1 0.2 0.5 6.0 0.3 0.1 0.7 1.9 0.4 1.8 4.8 0.4 1.3 2.6 0.4 0.8 0.3 0.3 4.9 1.4 0.6 1.4 2.5 2.3 0.9 1.8 1.1 4.2 2.2 1.3 2.9 11.6 9.0 6.1 2.1 4.5 0.8 2.3 0.4 1.9 4.5 4.6 1.3 2.8 3.8 2.4 2.9 1.2 4.9 3.5 3.0 8.3 5.6 13.2 8.5 1.5 8.8 56.0 8.1 11.4 17.4 7.9 10.1 18.3 13.7 72.2 7.9 60.8 23.3 20.8 20.6 12.0 37.1 39.3 146.5 20.4 0.0 2.9 10.4 11.8 12.5 16.7 5.4 23.6 6.4 15.2 44.1 14.9 28.8 9.2 20.3 22.1 19.4 9.6 52.0 7.5 6.9 3.8 2.5 10.0 21.1 TMEM221 ENSG00000188051 "Transmembrane protein 221" A6NGB7 19 17435509-17448567 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.4" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 13.7;Muller glia cells: 51.3;Rod photoreceptor cells: 22.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;PC-3: 11.3;REH: 6.3" "HPA041580, HPA062945" Supported Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700, HPA062945: " "unprognostic (3.60e-2)" "unprognostic (7.86e-2)" "unprognostic (4.51e-4)" "unprognostic (2.09e-2)" "unprognostic (2.61e-2)" "unprognostic (9.14e-3)" "unprognostic (3.19e-1)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (9.47e-4)" "unprognostic (2.37e-2)" "unprognostic (6.67e-2)" "unprognostic (2.76e-1)" "unprognostic (2.42e-2)" "unprognostic (1.23e-1)" 1.0 6.1 5.4 0.7 2.9 0.5 1.6 1.3 7.0 0.9 0.8 1.1 0.0 0.4 1.2 3.1 0.9 6.2 1.5 1.2 6.0 2.1 0.7 0.4 0.7 0.6 1.2 2.5 11.4 5.4 10.2 2.5 0.5 3.3 3.8 0.4 6.5 3.3 4.6 0.6 1.2 0.6 0.6 3.1 0.5 0.6 2.4 1.8 0.0 1.4 1.1 0.4 0.9 3.3 0.0 1.6 0.0 0.1 0.0 0.7 0.1 0.8 2.5 1.0 7.4 0.0 0.0 0.2 0.3 0.0 0.1 0.4 0.1 0.2 0.2 1.5 0.0 0.6 0.3 2.2 0.1 0.0 0.1 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 0.0 0.5 0.1 0.1 0.0 0.1 0.2 0.3 1.6 0.6 11.3 6.3 0.2 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.1 0.7 0.3 0.3 0.1 0.1 0.2 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.1 5.4 2.9 1.3 7.0 6.0 2.1 1.2 2.5 3.3 1.8 0.0 0.3 0.0 0.1 0.0 0.9 0.3 2.5 0.0 0.0 0.0 13.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 1.6 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 51.3 0.1 0.0 1.1 0.0 22.4 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 TMEM225 "PMP22CD, PPP1R154, SPATA47" ENSG00000204300 "Transmembrane protein 225" Q6GV28 11 123882926-123885642 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 79 "testis: 35.8" "Cell type enriched" "Detected in some" 4 "Early spermatids: 78.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.38e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 6.9 0.8 0.0 0.0 0.0 0.0 0.0 TMEM225B ENSG00000244219 "Transmembrane protein 225B" P0DP42 7 99598066-99610813 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 86.7" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 4.0;Club cells: 1.2;Exocrine glandular cells: 2.2;granulocytes: 1.1;Proximal tubular cells: 1.4;Syncytiotrophoblasts: 1.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 14.6;U-266/70: 8.2" "Low region specificity" "Detected in all" NA NA "unprognostic (1.91e-3)" "unprognostic (5.04e-3)" "unprognostic (1.04e-1)" "unprognostic (1.27e-2)" "unprognostic (2.00e-1)" "unprognostic (1.95e-1)" "unprognostic (6.27e-3)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (2.58e-2)" "unprognostic (1.25e-1)" "unprognostic (7.08e-2)" "unprognostic (1.62e-1)" "unprognostic (4.00e-1)" "unprognostic (6.86e-2)" "unprognostic (1.17e-1)" "unprognostic (2.50e-1)" 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.0 86.7 0.1 0.1 0.4 0.1 0.1 0.1 0.1 4.5 3.6 2.9 0.3 3.0 3.6 1.8 1.2 1.8 0.9 0.2 4.9 1.3 0.0 0.6 3.1 1.7 2.1 0.2 1.1 1.3 0.0 0.1 0.6 0.1 0.5 0.1 3.6 4.6 0.8 0.2 0.0 0.3 1.4 1.0 1.0 0.4 0.6 0.1 2.8 5.9 0.0 2.3 0.8 14.6 0.7 0.0 2.5 5.4 0.1 0.0 0.0 0.8 1.3 1.9 0.5 0.0 0.6 1.4 0.3 0.0 0.5 0.7 0.0 0.7 0.1 0.7 2.3 4.3 0.2 8.2 1.8 2.8 0.8 1.7 1.4 0.0 0.1 2.9 1.7 0.3 3.0 2.9 2.2 1.1 1.2 4.5 2.1 3.6 0.7 3.0 0.3 3.6 1.4 1.8 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 3.3;Cytotrophoblasts: 1.9;Muller glia cells: 1.3" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 0.0 0.0 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 TMEM229B "C14orf83, FLJ33387" ENSG00000198133 "Transmembrane protein 229B" Q8NBD8 14 67447084-67533739 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.8;ductus deferens: 27.5" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 13.7;Early spermatids: 11.9;Late spermatids: 16.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 9.3;MCF7: 9.7;SK-MEL-30: 8.2;U-937: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046562 Approved NA NA "HPA046562: AB_10960265" "prognostic favorable (5.38e-4)" "unprognostic (6.55e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.21e-5)" "unprognostic (7.37e-2)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (2.01e-1)" "unprognostic (2.01e-2)" "unprognostic (1.12e-1)" "unprognostic (2.76e-3)" "unprognostic (1.95e-2)" "unprognostic (5.18e-1)" "unprognostic (8.66e-2)" "unprognostic (1.22e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.79e-5)" 1.6 14.5 9.4 5.2 7.1 1.6 3.8 27.8 11.5 11.8 5.9 2.7 27.5 15.9 1.5 11.9 1.3 2.2 4.2 1.7 10.6 7.9 2.2 1.5 3.5 8.3 9.0 5.7 1.2 5.7 5.8 8.1 7.7 13.3 2.9 3.4 5.1 4.1 11.8 0.6 1.4 14.1 3.3 6.5 9.4 4.2 5.6 2.0 8.9 9.7 0.0 6.1 5.9 1.7 1.2 2.8 8.7 6.9 5.5 11.0 5.0 2.2 0.3 0.0 0.6 0.2 0.0 0.9 0.4 0.5 0.6 2.5 0.0 7.4 9.3 0.0 0.2 2.1 0.0 0.2 0.5 0.1 3.0 0.7 5.6 0.0 0.0 0.8 6.0 1.1 0.1 0.3 0.1 0.0 0.1 0.0 0.6 0.1 0.3 0.0 9.7 3.6 2.3 0.1 4.8 0.4 3.4 0.1 1.3 0.1 4.9 1.4 0.3 0.0 3.6 8.2 0.4 7.6 5.8 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.4 24.8 5.2 6.0 5.1 8.7 11.0 6.7 10.6 1.2 6.5 8.7 2.8 1.1 5.7 7.1 0.1 5.5 6.9 1.6 2.6 5.0 9.4 7.1 27.8 11.5 10.6 7.9 9.0 5.7 13.3 2.0 0.0 0.3 1.3 0.3 0.2 2.9 1.2 2.5 0.0 0.0 0.0 13.7 0.0 0.0 1.2 11.9 1.3 4.2 0.0 3.1 0.0 0.2 0.3 0.0 0.0 1.7 0.0 2.4 3.7 4.3 16.7 0.0 1.1 6.8 1.8 4.7 0.2 0.6 1.9 0.7 0.8 3.7 0.0 0.2 0.5 0.2 0.1 0.1 4.3 1.9 0.7 TMEM231 "ALYE870, FLJ22167, JBTS20, MKS11, PRO1886" ENSG00000205084 "Transmembrane protein 231" Q9H6L2 16 75536744-75556286 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 58.4" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 119.1;Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA042081 Enhanced Approved Vesicles NA NA Vesicles "HPA042081: AB_10795391" "unprognostic (4.29e-2)" "unprognostic (9.84e-2)" "unprognostic (8.07e-2)" "unprognostic (2.71e-3)" "unprognostic (1.03e-1)" "unprognostic (9.34e-2)" "unprognostic (2.90e-2)" "unprognostic (2.81e-1)" "unprognostic (2.92e-1)" "unprognostic (1.69e-2)" "unprognostic (3.34e-3)" "unprognostic (7.84e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (1.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 3.7 5.3 7.9 2.8 14.7 2.5 4.1 5.0 12.4 7.1 4.1 16.6 3.6 4.0 6.4 10.1 3.1 58.4 4.8 7.9 9.1 9.9 4.7 2.5 7.3 2.7 6.5 9.9 14.3 4.7 6.6 7.7 3.6 14.3 5.4 3.5 6.6 3.1 5.6 1.9 3.3 4.2 7.7 6.2 2.7 3.2 8.5 6.6 0.2 8.0 1.0 2.2 3.5 3.0 5.0 3.2 6.2 0.9 1.0 3.5 1.3 3.9 2.4 6.3 10.5 6.1 15.1 3.5 4.3 5.6 5.4 6.6 1.5 6.3 4.3 6.1 6.2 4.6 9.5 0.7 5.0 3.3 0.8 2.6 0.2 3.2 1.4 5.4 2.4 1.9 3.3 6.2 5.5 13.4 9.8 3.8 4.1 4.2 0.2 1.6 10.1 1.5 4.7 3.8 0.6 2.2 0.8 0.9 9.6 7.0 1.4 5.3 3.5 8.7 2.2 4.0 2.2 2.0 2.7 5.6 4.2 3.6 2.7 2.3 8.2 7.2 1.3 10.6 1.2 4.2 3.0 0.9 0.6 1.7 0.9 3.5 5.0 1.8 2.9 2.5 2.4 1.6 2.4 6.2 1.0 0.5 3.2 0.5 1.3 7.9 14.7 5.0 12.4 9.1 9.9 6.5 9.9 14.3 6.6 3.0 4.6 0.0 4.2 0.9 15.3 4.0 0.0 119.1 19.4 7.0 49.1 1.0 0.0 2.5 14.1 4.9 4.6 0.0 2.0 0.9 3.1 3.9 1.1 1.1 0.8 12.7 2.9 3.7 0.8 3.3 1.7 1.8 0.0 4.6 5.9 6.0 1.5 4.5 3.5 1.4 33.5 0.0 3.7 10.8 9.0 0.9 0.2 1.0 5.0 2.2 TMEM232 FLJ43080 ENSG00000186952 "Transmembrane protein 232" C9JQI7 5 110289233-110738956 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.8;pituitary gland: 19.8;testis: 23.7" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 115.1;Early spermatids: 85.8;Late spermatids: 50.0;Spermatocytes: 33.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-266/70: 6.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA049386 Uncertain NA NA "HPA049386: AB_2680739" "unprognostic (1.12e-2)" "unprognostic (1.43e-1)" "unprognostic (7.27e-2)" "unprognostic (1.47e-2)" "unprognostic (1.20e-1)" "unprognostic (4.40e-1)" "unprognostic (8.49e-2)" "unprognostic (9.88e-2)" "unprognostic (1.91e-1)" "unprognostic (1.22e-1)" "unprognostic (6.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.32e-5)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (3.14e-4)" "unprognostic (8.96e-2)" 1.2 2.3 4.6 0.7 5.9 0.5 2.0 3.0 6.8 2.1 1.0 3.7 4.9 1.2 1.7 4.8 1.2 21.8 2.8 1.4 4.7 4.5 6.1 1.4 2.9 0.9 2.9 4.8 3.4 1.3 3.6 19.8 1.1 9.2 1.6 0.9 3.1 1.3 1.6 0.7 1.0 0.9 1.0 3.1 0.8 1.7 23.7 4.4 0.5 6.1 0.0 0.8 1.3 0.9 1.1 0.0 0.8 0.1 0.3 0.6 0.1 0.9 0.3 2.6 0.8 2.3 3.8 0.5 0.0 0.0 0.5 0.5 0.4 0.4 1.1 0.7 0.1 3.9 0.8 0.4 1.9 0.5 2.4 0.3 0.4 0.0 0.0 1.9 0.6 0.5 1.1 0.3 0.5 0.9 3.5 0.4 2.8 0.6 0.7 1.5 0.3 1.3 0.7 0.3 0.3 0.0 0.5 0.2 0.4 2.7 0.0 2.5 2.6 0.3 0.0 2.1 4.1 0.9 0.2 0.0 2.4 0.3 0.1 0.1 6.2 2.1 0.9 2.0 0.7 0.4 0.0 0.1 0.8 0.0 0.0 0.5 1.1 0.0 0.1 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.0 0.1 4.6 5.9 3.0 6.8 4.7 4.5 2.9 4.8 9.2 4.4 0.0 4.8 0.0 0.8 0.3 5.3 1.2 2.5 115.1 14.8 7.0 25.5 0.2 8.3 0.6 85.8 0.1 0.2 0.0 0.4 0.1 0.2 0.9 0.0 0.8 0.1 3.2 1.2 0.0 1.0 50.0 1.1 0.6 0.0 0.0 0.6 5.0 0.1 0.0 0.7 4.2 15.9 0.0 0.3 33.8 3.8 0.4 0.2 0.0 0.0 0.6 TMEM233 IFITMD2 ENSG00000224982 "Transmembrane protein 233" B4DJY2 12 119593459-119643066 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 88.0" "Cell type enriched" "Detected in some" 4 "granulocytes: 76.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 12.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 11.5;hTERT-RPE1: 4.7;RH-30: 6.1;U-2197: 9.2;U-87 MG: 37.0" "Not detected" "Not detected" "HPA047506, HPA075435" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA047506: AB_10963068, HPA075435: " "unprognostic (1.46e-2)" "unprognostic (1.16e-2)" "unprognostic (1.39e-3)" "unprognostic (1.03e-2)" "unprognostic (1.99e-3)" "unprognostic (1.71e-2)" "unprognostic (5.86e-2)" "unprognostic (1.55e-2)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (1.63e-2)" "unprognostic (4.41e-2)" "unprognostic (6.06e-2)" "unprognostic (3.10e-3)" "unprognostic (2.94e-1)" "unprognostic (4.38e-2)" "unprognostic (3.66e-1)" 0.6 0.3 0.8 0.0 0.4 0.0 0.6 0.1 8.8 0.2 0.2 0.0 0.0 0.1 0.9 0.6 0.2 0.2 1.0 0.7 0.2 0.5 0.5 0.3 0.6 0.2 0.1 1.4 0.6 0.1 1.7 0.4 0.0 0.4 0.4 0.1 0.7 0.5 0.3 88.0 0.1 0.2 0.5 0.3 0.2 0.2 0.2 0.0 0.1 11.1 5.2 0.3 0.4 1.8 0.3 0.3 0.7 0.1 0.6 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.0 11.5 0.0 4.7 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.3 0.2 0.5 0.7 0.6 0.1 0.3 0.1 0.1 0.8 0.4 0.1 1.5 0.2 0.5 0.1 1.4 0.4 0.0 3.0 1.4 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 7.2 6.8 0.0 0.0 7.8 0.0 0.4 0.3 76.3 0.0 0.1 7.9 0.0 18.4 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 2.1 0.0 0.2 2.3 0.2 0.1 0.1 0.0 0.0 0.2 TMEM235 ENSG00000204278 "Transmembrane protein 235" A6NFC5 17 78231310-78240987 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 26 "brain: 33.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.0;HUVEC TERT2: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA053939 Uncertain NA NA "HPA053939: AB_2682316" "unprognostic (1.47e-1)" "unprognostic (6.91e-3)" "unprognostic (3.92e-2)" "unprognostic (1.71e-1)" 1.0 1.0 12.2 1.0 17.4 1.0 1.0 2.0 25.6 1.0 1.0 33.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 20.9 9.7 1.0 1.0 1.0 1.1 18.3 8.6 1.1 1.0 1.0 0.0 1.2 10.3 1.0 1.0 0.0 1.0 1.0 1.0 1.0 1.0 1.0 20.7 1.0 1.0 1.2 18.0 0.0 1.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 17.4 2.0 10.2 20.9 9.7 18.3 8.6 10.3 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM236 "bA162I21.2, bA16O1.2, FAM23A, FAM23B" ENSG00000148483 "Transmembrane protein 236" Q5W0B7 10 17752252-17800868 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 76.4" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 63.2;Intestinal endocrine cells: 22.5;Mucus-secreting cells: 22.8;Paneth cells: 49.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "MOLT-4: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA045096 Enhanced NA NA "HPA045096: AB_2732516" "unprognostic (4.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.88e-3)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (3.36e-2)" "unprognostic (2.52e-3)" "unprognostic (1.37e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.06e-3)" "unprognostic (1.75e-1)" "unprognostic (1.62e-2)" "unprognostic (1.72e-1)" "unprognostic (3.43e-2)" "unprognostic (3.16e-2)" "unprognostic (1.54e-2)" 0.5 0.3 0.3 4.9 0.3 0.0 0.3 0.3 0.3 0.4 32.0 0.1 0.1 13.7 0.5 0.1 0.4 0.2 0.1 0.3 0.3 0.3 0.5 0.4 0.6 0.1 0.3 0.1 0.3 0.7 0.0 0.3 0.6 0.1 0.3 9.1 0.1 0.3 0.1 0.5 0.3 76.4 0.3 0.3 0.3 0.3 0.5 0.1 0.1 0.3 0.1 0.1 0.3 0.3 1.3 0.9 2.6 0.6 1.0 0.6 0.1 0.3 0.2 0.4 0.5 0.1 0.1 0.6 0.3 0.0 0.1 0.3 0.5 0.5 0.3 0.2 0.2 0.2 0.3 0.2 0.2 0.8 0.2 0.5 0.6 0.5 0.5 0.1 0.5 1.6 0.2 0.4 0.2 0.3 0.2 0.4 0.7 0.2 0.4 0.2 0.3 15.3 0.3 0.3 0.1 0.1 0.6 0.4 0.3 0.1 0.3 0.4 0.2 0.2 0.1 0.5 0.6 0.2 0.0 0.7 0.5 0.6 0.2 0.3 0.3 0.2 0.3 0.2 0.2 0.2 2.6 0.6 0.9 0.6 0.4 0.4 0.7 0.5 0.4 0.4 1.3 0.5 0.6 2.2 1.0 0.4 0.9 0.4 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 63.2 0.0 0.8 0.1 0.0 0.3 1.1 0.0 5.4 0.0 22.5 1.8 4.0 0.4 0.0 4.9 0.0 0.0 22.8 0.2 0.8 49.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.7 0.4 TMEM238 ENSG00000233493 "Transmembrane protein 238" C9JI98 19 55379245-55384598 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 43.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 14.5;Intestinal endocrine cells: 13.3;Mucus-secreting cells: 19.6;Paneth cells: 14.2;Suprabasal keratinocytes: 22.7;Undifferentiated cells: 17.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 15.8;CAPAN-2: 10.0;HaCaT: 14.6;RPMI-8226: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.90e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-2)" "unprognostic (4.69e-2)" "unprognostic (1.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (7.35e-2)" "unprognostic (7.21e-2)" "unprognostic (2.25e-2)" "unprognostic (5.49e-2)" "unprognostic (5.33e-2)" "prognostic favorable (8.84e-6)" "unprognostic (1.78e-3)" "unprognostic (5.55e-2)" "unprognostic (7.91e-3)" "unprognostic (1.17e-3)" 1.6 1.4 0.6 13.1 0.7 1.8 3.6 0.9 1.0 3.8 29.5 0.0 11.8 14.6 1.2 4.5 15.8 2.2 19.1 0.7 0.5 0.5 10.3 27.0 12.4 12.2 0.6 0.0 2.7 43.8 2.0 3.7 0.7 0.7 6.4 2.5 1.3 25.2 11.9 1.6 7.0 36.5 0.7 0.5 3.5 17.1 1.0 0.0 9.3 23.3 13.5 14.8 4.4 3.3 1.5 0.6 0.3 0.2 0.5 3.0 0.4 15.8 1.5 0.0 1.1 0.1 0.0 1.0 0.6 0.1 0.0 0.0 1.2 10.0 7.5 2.9 0.0 0.0 14.6 0.4 0.3 0.0 2.3 1.0 0.3 1.2 0.0 0.0 2.1 0.6 0.0 2.0 0.1 0.3 0.1 0.0 2.2 1.0 6.7 0.0 3.2 2.7 0.8 0.6 4.4 4.9 3.8 0.4 9.8 0.6 5.0 5.6 1.8 0.7 8.0 1.1 0.2 6.2 0.9 0.0 0.3 1.7 0.1 0.2 4.4 2.6 1.9 0.1 1.3 0.2 0.0 0.2 0.3 1.3 0.0 2.4 1.5 2.4 1.7 0.1 1.2 1.9 1.5 0.0 0.5 0.0 0.6 3.0 0.4 0.6 0.7 0.9 0.6 0.5 0.5 0.6 0.0 0.7 0.0 0.0 3.7 0.0 1.7 7.6 0.1 0.8 5.1 0.0 0.0 7.0 0.0 0.0 1.7 1.7 0.0 0.1 14.5 0.0 3.7 0.1 0.8 1.7 0.0 9.2 0.3 3.2 13.3 1.3 0.3 0.0 0.0 0.0 1.7 1.0 19.6 4.2 3.2 14.2 0.0 1.1 1.2 0.0 0.4 0.0 0.0 22.7 0.0 1.3 17.4 2.3 TMEM238L LINC00675 ENSG00000263429 "Transmembrane protein 238 like" 17 10794913-10804099 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 19.9;intestine: 19.0;seminal vesicle: 14.6;stomach 1: 23.0" "Cell type enriched" "Detected in some" 15 "Collecting duct cells: 15.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "OE19: 11.0;RT4: 7.1" "Not detected" "Not detected" NA NA "unprognostic (7.23e-3)" "unprognostic (1.55e-1)" "unprognostic (3.49e-2)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (2.59e-2)" "unprognostic (2.99e-2)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "unprognostic (9.30e-3)" "unprognostic (6.09e-2)" "unprognostic (1.74e-1)" "unprognostic (1.27e-1)" "unprognostic (3.13e-1)" "unprognostic (3.11e-1)" "unprognostic (7.56e-2)" "unprognostic (1.19e-2)" 0.0 0.0 0.2 7.5 0.6 0.0 0.6 0.0 1.0 0.0 18.3 0.0 19.9 8.8 0.0 1.1 3.2 0.0 9.5 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 19.0 0.0 0.0 14.6 0.0 0.2 14.0 1.2 0.0 0.0 23.0 0.0 0.0 0.0 0.0 2.8 3.1 6.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.0 0.0 0.2 0.0 7.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM239 ENSG00000198326 "Transmembrane protein 239" Q8WW34 20 2816302-2820284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "testis: 42.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 109.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "HDLM-2: 13.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (5.12e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.7 0.5 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.2 0.3 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.2 0.2 1.7 0.3 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TMEM240 "C1orf70, SCA21" ENSG00000205090 "Transmembrane protein 240" Q5SV17 1 1535174-1540453 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.3" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 3.4;Peritubular cells: 2.1;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 9.5;HHSteC: 9.1;SCLC-21H: 10.8;SH-SY5Y: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066721 Supported NA NA "HPA066721: AB_2732750" "unprognostic (2.24e-1)" "unprognostic (1.87e-1)" "unprognostic (5.52e-5)" "unprognostic (2.31e-1)" "unprognostic (2.47e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" "unprognostic (3.85e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "prognostic favorable (2.52e-4)" "unprognostic (9.13e-2)" "unprognostic (7.96e-3)" "unprognostic (9.50e-4)" "unprognostic (2.64e-1)" "unprognostic (8.38e-2)" "unprognostic (1.93e-1)" 3.8 4.7 10.8 1.7 17.1 0.8 1.7 24.3 21.8 4.6 5.1 1.8 0.9 1.2 9.1 2.2 1.7 4.2 2.5 3.5 12.2 7.9 1.5 0.8 2.4 1.2 5.6 10.3 10.3 2.1 3.3 3.9 3.7 5.0 4.7 1.5 2.5 4.1 7.9 6.9 2.8 2.9 5.1 2.8 2.6 1.7 2.1 4.9 0.3 1.5 0.2 0.9 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 1.0 6.7 0.7 1.2 5.0 1.5 4.1 2.2 4.3 2.4 0.0 0.4 0.8 0.8 2.1 0.3 2.4 0.1 0.2 0.7 4.1 9.5 0.5 3.1 1.2 9.1 0.0 0.9 6.2 1.9 1.5 0.3 5.1 4.4 0.6 1.3 0.3 0.1 0.2 0.6 0.8 4.2 0.1 1.5 3.8 1.2 0.9 0.4 0.0 10.8 13.2 1.4 0.5 4.3 0.1 0.6 0.0 2.2 0.6 1.9 0.8 1.9 2.0 0.5 0.5 2.3 2.7 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 17.1 24.3 16.5 12.2 7.9 5.6 10.3 5.0 4.9 0.0 0.0 0.0 0.2 0.0 3.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 3.2 0.0 1.3 0.0 0.0 1.1 0.0 0.0 0.0 0.9 3.4 0.1 0.0 2.1 0.0 0.5 6.5 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.1 TMEM244 "bA174C7.4, C6orf191" ENSG00000203756 "Transmembrane protein 244" Q5VVB8 6 129831244-129861547 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "pituitary gland: 12.2;retina: 22.7" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 21.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 3.9;T-reg: 4.2" "Lineage enriched" "Detected in single" 8 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.3;LHCN-M2: 8.4;U-2 OS: 2.9;U-251 MG: 6.3;U-266/70: 6.1;WM-115: 4.1" "Not detected" "Not detected" NA NA "unprognostic (4.65e-1)" "unprognostic (3.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.54e-1)" "unprognostic (1.15e-1)" "unprognostic (2.15e-1)" "unprognostic (9.57e-2)" 0.3 0.2 2.7 0.4 2.7 0.4 0.4 0.2 5.2 0.4 0.5 1.5 0.0 0.0 0.2 1.6 0.3 0.4 0.3 0.7 2.5 0.7 0.7 0.2 0.6 2.3 4.8 3.3 0.2 0.2 0.0 12.2 0.2 0.9 1.1 0.6 22.7 1.2 0.2 1.0 0.4 0.3 0.0 1.9 0.7 1.1 0.4 2.0 0.0 0.3 0.0 2.5 0.8 0.4 0.5 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 8.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 1.0 6.3 6.1 0.0 0.0 1.7 0.0 4.1 0.0 0.0 0.0 2.5 0.0 0.0 0.5 3.9 1.1 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 4.2 0.4 2.7 2.7 0.2 2.7 2.5 0.7 4.8 3.3 0.9 2.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 TMEM247 ENSG00000284701 "Transmembrane protein 247" A6NEH6 2 46479565-46484425 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "testis: 21.8" "Group enriched" "Detected in some" 18 "Early spermatids: 326.4;Late spermatids: 284.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "U-266/84: 8.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079482 Enhanced NA NA "HPA079482: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 326.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 284.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 17.3 5.6 0.0 0.0 0.0 0.0 0.0 TMEM249 C8orfK29 ENSG00000261587 "Transmembrane protein 249" Q2WGJ8 8 144352219-144354914 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 35.1" "Group enriched" "Detected in some" 8 "Early spermatids: 25.7;Late spermatids: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;PC-3: 2.3;SK-MEL-30: 2.1" "Low region specificity" "Detected in all" HPA078901 Approved NA NA "HPA078901: " "unprognostic (2.23e-1)" "unprognostic (8.91e-3)" "unprognostic (1.72e-2)" "unprognostic (1.10e-1)" "unprognostic (4.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.03e-4)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.30e-1)" "unprognostic (8.44e-2)" "unprognostic (3.21e-1)" "unprognostic (1.13e-7)" "unprognostic (6.56e-3)" "unprognostic (1.62e-2)" "unprognostic (8.44e-3)" "unprognostic (3.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.3 0.0 0.6 0.2 0.2 2.5 0.8 0.0 0.3 0.2 0.0 0.7 1.6 0.0 0.3 0.0 0.2 0.0 0.1 0.0 1.5 0.4 0.4 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.3 0.0 0.8 0.0 2.3 1.7 0.7 0.0 0.0 1.2 1.3 1.7 0.0 0.3 2.1 0.0 0.9 1.0 0.0 0.5 2.0 0.8 0.2 0.6 0.4 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 24.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.2 0.0 TMEM252 "C9orf71, MGC34760" ENSG00000181778 "Transmembrane protein 252" Q8N6L7 9 68536580-68540867 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "intestine: 16.0;kidney: 64.2" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 15.1" "Cancer enriched" "Detected in many" 17 "renal cancer: 35.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 7.6" "Lineage enriched" "Detected in single" 37 "granulocytes: 7.6" "Group enriched" "Detected in some" 6 "EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.5;SK-BR-3: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA079457 Enhanced NA NA "HPA079457: " "unprognostic (2.64e-1)" "unprognostic (3.28e-3)" "unprognostic (3.72e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-2)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.64e-2)" "unprognostic (6.42e-2)" "prognostic favorable (1.75e-7)" "unprognostic (7.63e-2)" "unprognostic (6.15e-2)" "unprognostic (7.66e-2)" "unprognostic (2.50e-1)" 0.5 2.0 0.4 0.6 0.4 0.0 0.4 0.9 0.4 0.6 5.6 0.4 0.4 1.0 4.3 0.8 4.3 2.7 0.7 3.0 0.4 0.0 64.2 0.9 0.4 0.4 0.4 0.4 0.6 0.4 0.0 0.4 2.6 0.4 1.8 0.0 0.4 0.4 0.4 0.7 0.2 16.0 0.9 0.4 0.4 1.7 0.6 0.4 0.4 0.4 0.4 0.5 6.0 0.6 0.0 0.1 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.4 0.0 1.9 0.0 6.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.0 0.4 0.4 0.9 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM253 "C14orf176, C14orf95, NCRNA00220" ENSG00000232070 "Transmembrane protein 253" P0C7T8 14 21098937-21103724 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 31 "intestine: 110.5" "Cell type enriched" "Detected in some" 7 "Enterocytes: 67.8" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA052329, HPA065092" Enhanced NA NA "HPA052329: AB_2681791, HPA065092: AB_2685420" "unprognostic (7.48e-3)" "unprognostic (1.33e-2)" "unprognostic (7.19e-2)" "unprognostic (3.84e-2)" "unprognostic (1.41e-2)" "unprognostic (1.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.40e-1)" "unprognostic (1.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.93e-2)" "unprognostic (3.59e-1)" "unprognostic (1.80e-1)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" 0.4 1.5 0.4 2.2 0.4 0.0 0.3 0.5 0.5 0.5 32.6 0.4 2.0 41.8 0.4 0.8 0.9 0.2 3.1 0.9 0.3 0.4 0.4 0.5 0.4 0.2 0.5 0.4 0.4 0.7 0.4 0.3 0.5 0.4 0.5 5.7 0.4 2.8 0.7 0.3 0.6 110.5 0.6 0.3 0.4 0.2 0.4 0.2 0.2 3.6 0.8 0.7 0.3 0.5 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.4 0.9 2.7 2.6 4.0 1.0 4.4 1.0 2.0 0.5 0.9 2.3 2.1 3.2 0.6 0.2 0.2 4.1 0.9 5.0 0.6 1.9 0.2 1.6 3.0 2.7 0.6 0.0 0.1 1.9 4.3 2.1 3.3 1.8 0.3 1.3 1.1 0.2 1.3 0.8 0.1 0.3 3.5 4.6 0.1 0.7 1.3 1.7 2.3 2.0 0.7 1.4 1.1 0.8 2.4 2.6 0.8 0.0 0.0 0.0 1.4 0.5 0.3 0.8 0.4 0.0 0.2 1.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.5 0.5 0.3 0.4 0.5 0.4 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.4 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 67.8 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 3.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.1 5.8 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.5 0.8 0.0 10.0 0.7 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.4;ovary: 29.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Melanocytes: 5.0;monocytes: 5.4" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 10 "T-cells: 5.9" "Cell line enhanced" "Detected in some" "Karpas-707: 17.3;NTERA-2: 6.0;RPMI-8226: 11.1;SK-MEL-30: 18.1;U-2 OS: 7.8;U-87 MG: 19.8" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 3.9 5.5 6.8 3.4 14.4 1.5 5.4 6.8 7.8 11.2 3.5 12.4 1.7 1.9 3.2 2.9 4.4 6.3 2.1 2.4 5.3 25.4 2.4 1.5 4.8 5.0 30.4 4.4 29.6 1.1 0.6 6.6 0.8 18.4 3.8 3.9 7.1 1.3 3.3 2.4 4.0 2.8 2.0 13.0 2.8 2.1 0.9 7.8 6.4 0.9 1.8 5.7 1.6 8.0 0.5 0.3 0.0 0.6 0.0 5.9 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.3 0.1 0.0 0.1 0.2 0.0 1.8 0.0 1.1 0.4 0.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 17.3 0.3 0.0 0.0 0.1 6.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 3.5 0.2 0.3 0.0 18.1 0.2 0.0 0.2 0.0 0.0 7.8 0.0 2.8 0.0 3.3 2.4 19.8 0.0 0.0 0.0 0.6 0.0 5.9 0.2 3.3 0.5 0.4 2.2 0.3 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.9 6.8 14.4 6.8 3.9 5.3 25.4 30.4 4.4 18.4 7.8 3.0 0.0 0.0 0.0 0.3 0.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.6 1.1 0.6 0.7 5.0 5.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 1.1 0.1 0.0 0.0 0.0 TMEM26 "Em:AC068892.1, MGC35010" ENSG00000196932 "Transmembrane protein 26" Q6ZUK4 10 61406643-61453450 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 30.2" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 3.0;Ito cells: 7.4;Kupffer cells: 10.1;Late spermatids: 3.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.3;fHDF/TERT166: 2.2;HSkMC: 4.0;HUVEC TERT2: 2.9;MOLT-4: 4.3" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Low region specificity" "Detected in many" NA NA "unprognostic (1.21e-3)" "unprognostic (2.84e-1)" "unprognostic (7.34e-2)" "unprognostic (7.83e-2)" "unprognostic (1.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.69e-2)" "unprognostic (3.13e-1)" "unprognostic (9.41e-2)" "unprognostic (5.38e-2)" "unprognostic (5.24e-2)" "unprognostic (2.29e-5)" "unprognostic (2.55e-2)" "unprognostic (1.51e-2)" "unprognostic (8.53e-2)" "unprognostic (1.95e-1)" 1.3 1.2 3.7 1.0 2.1 0.0 7.4 0.3 2.0 3.2 1.1 0.9 1.1 1.8 5.6 0.9 0.6 0.8 1.2 0.6 0.9 1.0 3.6 4.5 1.8 5.8 1.5 1.3 2.1 0.4 5.6 0.7 1.8 1.1 3.5 1.1 3.6 0.5 3.2 0.7 0.3 1.9 2.5 0.9 30.2 0.5 4.4 1.2 6.2 0.7 0.2 0.1 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.7 0.2 0.0 9.3 1.0 1.2 0.0 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 4.0 0.0 1.0 0.0 1.1 2.9 1.1 0.0 0.0 0.3 0.0 4.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.1 0.3 2.0 0.9 1.0 1.5 1.3 1.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 7.4 10.1 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.4 0.4 0.1 0.1 0.0 0.0 0.0 0.0 TMEM260 "C14orf101, FLJ20392" ENSG00000070269 "Transmembrane protein 260" Q9NX78 14 56488354-56650606 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 61.0" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003502 Uncertain Approved "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Nucleoplasm, Cytosol" "Focal adhesion sites" "HPA003502: AB_1078314" "unprognostic (4.63e-2)" "unprognostic (2.41e-2)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (2.51e-1)" "unprognostic (3.58e-2)" "unprognostic (2.04e-1)" "prognostic favorable (7.11e-4)" "unprognostic (7.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.95e-3)" "unprognostic (3.22e-1)" "unprognostic (2.23e-3)" "unprognostic (5.81e-2)" "unprognostic (8.11e-2)" "unprognostic (1.32e-1)" "unprognostic (3.84e-2)" 7.8 7.4 7.3 11.0 10.6 3.8 9.1 13.3 9.9 61.0 8.8 13.7 11.6 8.1 11.8 12.1 6.7 11.4 10.3 6.0 8.9 8.6 10.7 8.7 8.4 8.8 10.8 7.5 14.8 13.6 12.4 17.2 8.7 9.7 8.7 9.1 8.7 7.4 13.0 5.2 8.6 10.7 8.9 12.2 9.2 8.4 10.1 8.3 17.6 12.6 4.6 8.8 10.1 9.7 2.0 4.6 2.9 2.8 6.3 3.5 2.0 7.4 5.2 4.0 8.6 14.4 11.9 7.9 7.9 8.8 5.2 6.3 2.4 5.5 6.0 7.8 5.9 5.9 8.6 9.3 5.8 8.3 7.5 4.7 3.9 2.4 3.3 10.1 5.4 9.4 14.5 10.4 2.9 10.1 9.6 6.8 4.7 4.8 6.5 6.8 4.9 2.8 2.0 3.7 12.2 8.3 4.0 6.4 2.0 8.8 11.0 8.5 4.2 8.9 6.5 5.2 7.9 8.2 8.4 9.5 10.6 4.1 7.9 3.9 3.9 3.1 3.5 6.7 4.0 5.2 0.0 2.8 2.9 3.5 1.9 2.4 1.8 2.4 1.8 2.2 2.0 3.2 2.3 1.4 6.3 1.7 4.6 2.9 2.0 7.3 10.6 13.3 9.9 8.9 8.6 10.8 7.5 9.7 8.3 17.9 12.1 4.2 7.4 4.7 14.2 2.9 0.0 17.4 5.7 21.0 3.9 7.9 1.7 6.8 69.7 4.7 6.3 0.0 3.3 6.5 6.7 8.2 11.5 7.5 5.5 6.4 17.2 8.6 13.9 25.8 14.1 7.8 1.7 5.4 10.8 5.6 5.0 7.0 10.3 3.7 17.1 0.0 4.2 7.9 8.5 4.8 9.3 5.7 10.8 6.8 TMEM262 ENSG00000187066 "Transmembrane protein 262" E9PQX1 11 65084979-65089375 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "testis: 18.1" "Cell type enriched" "Detected in some" 16 "Early spermatids: 137.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "memory B-cell: 1.5;neutrophil: 1.1" "Group enriched" "Detected in many" 5 "B-cells: 1.5;granulocytes: 1.1" "Cell line enhanced" "Detected in some" "JURKAT: 1.1;Karpas-707: 1.9;T-47d: 1.1" "Low region specificity" "Detected in single" NA NA "unprognostic (4.36e-2)" "unprognostic (2.77e-1)" "unprognostic (1.78e-3)" "unprognostic (1.62e-1)" "unprognostic (1.61e-1)" "unprognostic (1.71e-4)" "unprognostic (1.85e-5)" "unprognostic (3.28e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.19e-3)" "unprognostic (7.18e-3)" "unprognostic (7.13e-9)" "unprognostic (9.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 1.5 0.1 1.1 0.2 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 137.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.3 0.9 0.5 0.3 0.3 0.0 0.0 0.0 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.9 0.1 0.8 0.8 0.0 2.0 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.0 2.6 0.0 0.0 2.7 0.0 1.8 9.8 12.8 1.7 0.0 5.9 0.0 0.0 0.0 0.2 1.7 0.7 0.8 0.0 0.0 4.2 1.6 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.5 7.6 6.5 0.0 0.5 2.1 0.0 4.9 0.0 0.0 0.4 TMEM269 ENSG00000274386 "Transmembrane protein 269" A0A1B0GVZ9 1 42785007-42816619 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 3.4;skin 1: 2.1" "Cell type enriched" "Detected in single" 6 "granulocytes: 1.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (2.03e-1)" "unprognostic (1.30e-1)" "unprognostic (2.87e-2)" "unprognostic (1.26e-1)" "unprognostic (5.97e-2)" "unprognostic (8.28e-2)" "unprognostic (6.27e-2)" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (5.58e-2)" "unprognostic (8.51e-2)" "unprognostic (1.63e-1)" "unprognostic (4.01e-9)" "unprognostic (2.23e-1)" "unprognostic (2.85e-1)" "unprognostic (1.15e-1)" "unprognostic (4.77e-2)" 0.1 0.0 0.0 1.5 0.6 0.6 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.6 0.4 0.0 0.2 0.3 0.0 0.0 1.8 2.1 0.1 0.0 0.5 0.1 1.4 0.0 0.4 0.0 0.9 1.8 3.4 0.6 1.5 0.9 0.1 0.3 1.7 1.2 2.6 1.1 0.1 1.2 0.2 0.2 0.6 0.8 1.4 0.6 2.4 0.4 0.1 0.2 0.3 0.7 0.1 0.2 2.2 0.6 2.5 0.5 0.7 0.1 1.0 0.5 0.7 0.5 0.0 2.1 0.2 0.0 1.7 0.8 2.0 0.0 0.7 0.4 2.7 2.0 0.2 1.1 0.8 1.2 0.3 0.0 0.3 1.6 1.6 0.7 0.7 1.1 1.0 1.1 1.2 0.3 0.6 1.3 2.3 0.5 3.8 6.3 2.7 0.4 0.9 0.6 2.1 0.6 0.4 0.3 0.4 0.3 0.4 0.4 0.3 0.2 0.9 0.9 0.4 3.4 1.5 0.4 1.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 35.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "T-reg: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;GAMG: 1.5;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles NA NA Vesicles "HPA077196: AB_2732334" "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.4 1.5 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.0 0.3 1.8 0.0 0.0 1.4 0.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM272 "FLJ37307, LINC00282, NCRNA00282" ENSG00000281106 "Transmembrane protein 272" 13 51813347-51845175 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "blood: 24.5;brain: 35.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 54 "neutrophil: 24.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 24.5" "Cell line enhanced" "Detected in some" "BEWO: 2.4;HEL: 1.5;SK-MEL-30: 6.8" NA NA "unprognostic (2.27e-2)" "unprognostic (2.50e-1)" "unprognostic (5.12e-2)" "unprognostic (8.71e-7)" "unprognostic (4.52e-2)" "unprognostic (1.78e-4)" "unprognostic (6.16e-2)" "unprognostic (5.19e-2)" "unprognostic (8.88e-2)" "unprognostic (2.02e-1)" "unprognostic (3.73e-3)" "unprognostic (1.32e-5)" "unprognostic (2.12e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.58e-2)" 0.2 0.0 2.7 3.3 35.4 1.7 0.0 0.0 2.4 0.0 0.0 0.4 0.0 1.0 0.7 0.0 0.0 0.0 0.3 4.1 1.2 0.0 0.1 0.2 4.0 0.1 0.4 0.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.3 1.0 0.0 0.0 1.4 0.0 1.2 5.6 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 24.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.8 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.1 0.1 1.5 0.1 0.5 0.1 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.9 0.5 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 6.8 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM30B CDC50B ENSG00000182107 "Transmembrane protein 30B" Q3MIR4 14 61277370-61281840 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 50.3" "Cell type enhanced" "Detected in many" 5 "Basal glandular cells: 101.7;Urothelial cells: 117.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.8" "Lineage enriched" "Detected in single" 4 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "A-431: 25.0;CAPAN-2: 20.4;HaCaT: 11.9;HBEC3-KT: 14.4;hTCEpi: 11.0;MCF7: 16.1;RT4: 35.0;T-47d: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA043162 Uncertain NA NA "HPA043162: AB_10796688" "unprognostic (4.06e-2)" "unprognostic (2.46e-1)" "unprognostic (1.72e-1)" "unprognostic (3.47e-2)" "unprognostic (2.01e-1)" "unprognostic (6.20e-2)" "unprognostic (2.45e-3)" "unprognostic (3.43e-2)" "unprognostic (9.10e-2)" "unprognostic (2.20e-1)" "unprognostic (5.10e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.89e-5)" "unprognostic (2.21e-1)" "unprognostic (2.89e-1)" "unprognostic (2.60e-1)" "unprognostic (1.85e-1)" 3.7 1.2 0.8 1.6 1.3 0.0 4.7 0.7 1.0 5.4 11.5 0.5 18.0 14.1 3.9 14.6 8.1 4.8 10.6 1.5 0.8 0.8 6.7 5.5 6.4 0.4 0.8 0.7 4.8 23.3 20.3 27.3 11.6 3.4 9.1 8.4 1.0 18.9 14.4 1.6 3.9 19.5 2.0 1.7 0.9 13.3 6.3 0.2 2.3 50.3 6.2 4.7 9.6 5.7 0.0 0.0 0.0 0.0 0.7 2.8 0.5 25.0 0.0 0.0 0.0 2.9 0.7 0.0 0.0 0.0 0.0 0.0 4.3 20.4 0.0 0.0 0.0 0.0 11.9 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.2 10.3 0.5 0.0 0.5 0.0 0.0 35.0 4.2 0.0 0.3 9.7 0.0 0.7 11.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.6 0.0 1.2 0.6 0.0 0.0 2.8 1.8 0.0 0.7 0.0 0.0 0.0 0.5 0.8 1.3 0.7 1.0 0.8 0.8 0.8 0.7 3.4 0.2 26.8 29.3 0.0 101.7 57.7 0.0 1.1 40.8 10.7 19.4 38.4 0.0 24.7 11.6 21.2 0.9 2.9 81.5 0.0 32.4 9.3 8.9 91.9 2.3 11.5 1.7 0.0 22.4 3.7 1.3 1.0 8.1 1.0 5.0 1.0 67.9 2.7 28.3 56.1 74.3 0.5 0.2 12.9 2.1 4.3 1.5 55.7 30.0 3.2 55.7 117.4 TMEM31 MGC39655 ENSG00000179363 "Transmembrane protein 31" Q5JXX7 X 103710909-103714028 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 46.6" "Group enriched" "Detected in some" 63 "Early spermatids: 531.0;Late spermatids: 2031.4" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 3.0;BEWO: 7.3;MCF7: 10.4;NTERA-2: 3.2;U-937: 3.9" HPA052760 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA052760: " "unprognostic (9.42e-5)" "unprognostic (1.46e-2)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (7.75e-3)" "unprognostic (1.22e-2)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (1.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.39e-2)" "unprognostic (3.77e-1)" "unprognostic (5.91e-5)" "unprognostic (1.75e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (4.68e-2)" 0.2 0.0 0.3 0.2 0.6 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.4 1.4 0.2 0.4 0.2 0.2 0.5 0.8 0.2 0.2 0.2 0.2 0.6 0.2 0.8 0.2 0.4 0.2 0.6 0.2 0.3 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.7 0.2 0.0 46.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 2.0 1.8 0.0 0.9 0.0 0.8 0.1 0.0 0.0 3.0 0.1 0.3 0.0 7.3 0.1 0.1 0.4 0.5 0.0 0.3 0.1 0.2 0.0 0.5 0.0 1.2 0.0 0.4 0.0 2.7 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.3 10.4 0.3 2.0 3.2 0.5 0.0 1.2 0.0 0.1 0.0 0.0 0.9 0.6 0.7 0.1 0.3 1.5 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.8 0.0 3.9 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.9 0.2 0.0 1.4 2.0 0.8 0.4 0.0 0.0 0.9 1.8 0.0 0.1 0.3 0.6 0.2 0.2 0.5 0.8 0.6 0.2 0.2 0.2 0.0 0.0 0.0 0.6 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.2 531.0 0.0 0.0 0.0 0.6 7.0 0.5 0.3 0.0 0.0 0.3 0.0 0.0 1.3 0.0 2031.4 12.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.1 0.1 0.0 12.9 0.3 20.4 11.3 0.3 2.4 0.0 0.0 0.0 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.4 0.0 2.5 6.5 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 1.1 0.0 4.7 32.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM37 "PR, PR1" ENSG00000171227 "Transmembrane protein 37" Q8WXS4 2 119429901-119438520 "Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 110.5;kidney: 82.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 276.4;Hepatocytes: 166.8;Muller glia cells: 140.1;Proximal tubular cells: 167.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;naive CD4 T-cell: 3.3" "Group enriched" "Detected in many" 31 "monocytes: 2.8;T-cells: 3.3" "Group enriched" "Detected in some" 5 "EFO-21: 13.4;Hep G2: 35.1;RPTEC TERT1: 29.4" "Low region specificity" "Detected in many" HPA053794 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA053794: AB_2682265" "unprognostic (2.54e-2)" "unprognostic (3.10e-2)" "unprognostic (1.01e-1)" "unprognostic (4.59e-3)" "unprognostic (2.56e-1)" "unprognostic (9.60e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (1.36e-1)" "unprognostic (2.83e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-2)" "unprognostic (2.99e-1)" "unprognostic (2.61e-2)" 18.5 5.2 0.6 5.9 1.0 0.0 10.0 0.5 1.2 6.7 60.3 1.8 3.8 16.2 3.1 3.8 2.8 1.4 18.5 5.7 1.0 0.4 82.5 40.8 9.5 8.7 0.9 0.7 5.9 5.8 20.1 0.7 13.4 1.3 4.5 5.6 6.3 2.8 6.5 1.6 4.4 110.5 1.9 1.4 11.5 6.6 6.4 0.7 1.2 21.0 1.6 2.2 3.4 2.4 0.0 0.0 0.0 2.8 0.0 3.3 0.6 0.0 3.5 0.3 0.1 2.2 0.2 0.5 0.1 0.0 0.0 0.0 5.4 3.1 0.0 13.4 1.6 0.3 0.8 1.4 0.0 0.0 0.0 1.4 0.4 2.0 35.1 3.0 0.0 0.0 4.9 0.0 0.0 0.0 0.1 2.8 0.0 0.1 5.3 0.0 0.3 0.0 0.3 2.6 0.0 0.1 0.0 0.0 4.6 29.4 2.3 0.4 0.2 0.1 1.4 0.0 2.6 0.6 0.8 1.8 0.0 5.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.6 1.0 0.5 1.2 1.0 0.4 0.9 0.7 1.3 0.7 23.8 8.1 15.4 0.2 1.8 2.6 1.2 86.6 1.4 3.4 17.4 0.0 40.2 43.1 18.4 0.1 2.9 276.4 0.0 47.2 3.4 14.1 0.1 1.1 166.8 54.9 6.4 8.7 82.3 51.8 0.9 46.1 4.3 1.7 1.0 14.5 140.1 16.0 45.6 3.5 167.4 17.7 0.0 1.9 0.0 1.0 2.5 87.1 1.8 12.4 1.6 TMEM38A "MGC3169, TRIC-A" ENSG00000072954 "Transmembrane protein 38A" Q9H6F2 19 16661127-16690029 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 158.8" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 21.6;Cardiomyocytes: 22.4;Cone photoreceptor cells: 80.5;Peritubular cells: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 20.3" "Cell line enhanced" "Detected in many" "Daudi: 12.1;U-266/70: 12.2;U-698: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048100, HPA050463" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA048100: , HPA050463: AB_2681137" "unprognostic (1.56e-1)" "unprognostic (1.04e-2)" "unprognostic (3.39e-1)" "unprognostic (1.28e-3)" "unprognostic (3.87e-1)" "unprognostic (2.99e-1)" "unprognostic (3.49e-1)" "prognostic favorable (2.78e-5)" "unprognostic (2.94e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "prognostic favorable (2.99e-10)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (4.50e-3)" "unprognostic (1.96e-2)" 1.3 1.6 3.6 1.1 7.9 2.3 1.2 5.1 12.2 1.3 1.4 2.1 3.1 1.3 1.1 6.6 3.5 1.8 1.0 5.4 3.0 3.8 2.0 2.7 2.1 1.3 5.2 3.7 1.2 1.3 1.7 2.2 0.9 4.8 2.9 1.5 8.3 2.7 2.4 158.8 1.0 1.1 1.1 1.9 1.0 5.3 1.6 1.4 0.0 1.8 30.1 1.9 1.1 0.4 3.9 0.5 20.3 2.9 2.1 0.5 0.6 3.0 0.6 0.8 4.7 2.6 0.3 0.4 1.1 0.6 0.7 1.5 0.9 4.4 12.1 1.9 0.2 4.2 2.5 6.2 1.3 0.7 0.8 1.8 0.0 1.8 1.0 0.7 0.1 0.2 1.1 4.8 0.9 0.5 3.6 0.3 2.2 0.1 1.1 0.5 4.6 0.1 1.2 1.2 11.3 7.2 6.3 1.1 3.2 4.6 2.3 7.8 5.4 3.3 0.4 1.5 0.4 2.3 1.0 0.0 0.9 2.3 2.9 0.5 12.2 8.8 20.3 1.1 7.2 0.9 20.3 2.9 8.2 0.0 1.1 0.0 2.8 0.4 0.0 0.2 3.9 0.1 0.1 1.6 2.1 0.7 0.5 0.5 0.6 3.6 7.9 5.1 12.2 3.0 3.8 5.2 3.7 4.8 1.4 3.0 1.0 0.8 2.8 1.0 21.6 22.4 0.0 1.4 1.2 0.0 80.5 0.0 1.7 3.1 0.0 3.3 0.7 0.0 2.2 0.1 2.1 3.6 0.0 6.7 0.4 12.7 4.1 8.0 5.6 0.5 9.8 0.0 3.3 0.0 5.8 12.1 7.1 0.0 21.2 1.0 10.2 0.0 2.8 0.5 0.4 0.3 0.1 0.0 2.4 0.9 TMEM38B "bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B" ENSG00000095209 "Transmembrane protein 38B" Q9NVV0 9 105694544-105776612 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.9" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 220.6;Late spermatids: 366.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018465 Uncertain NA NA "HPA018465: AB_1858116" "unprognostic (3.34e-1)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (2.46e-2)" "unprognostic (2.68e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-2)" "unprognostic (3.11e-3)" "unprognostic (1.88e-2)" "unprognostic (3.54e-2)" "unprognostic (5.82e-3)" "unprognostic (5.80e-2)" "prognostic favorable (7.96e-4)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (3.89e-3)" "unprognostic (9.98e-2)" 8.8 10.0 6.0 4.0 7.4 10.4 17.4 4.1 5.7 6.8 7.4 10.4 2.8 4.0 5.5 11.0 4.8 4.5 4.2 28.3 6.6 6.1 18.6 11.7 5.7 8.1 12.5 3.4 11.7 4.1 5.3 16.6 2.9 7.9 5.1 7.3 9.2 4.2 4.4 43.9 4.0 6.4 5.2 10.4 3.6 4.3 21.1 9.0 3.3 17.9 15.6 3.0 7.5 8.2 26.3 24.2 24.5 13.3 12.0 20.2 11.3 5.9 9.3 7.2 11.4 42.1 9.3 15.4 8.8 5.6 8.4 8.8 14.4 8.2 13.8 4.4 3.0 13.6 4.3 10.4 4.9 9.2 10.4 14.1 5.6 6.5 8.8 5.9 17.0 12.2 8.7 4.4 5.7 8.3 2.6 3.3 9.7 29.6 12.4 5.1 16.5 11.7 5.1 5.6 17.4 10.2 7.9 22.8 6.6 3.8 5.0 12.7 3.1 8.8 14.5 6.3 5.1 18.1 12.0 1.7 7.7 7.7 29.3 8.8 15.2 37.6 6.8 14.3 18.8 15.3 5.8 9.7 24.5 6.7 13.3 8.7 26.3 9.2 7.9 10.8 24.7 20.2 12.5 1.4 12.0 11.5 24.2 7.8 11.3 6.0 7.4 4.1 5.7 6.6 6.1 12.5 3.4 7.9 9.0 0.0 2.4 10.3 19.8 27.0 12.2 48.5 17.8 4.0 2.3 24.4 27.5 8.2 56.3 6.4 220.6 8.2 11.8 0.0 5.9 14.5 10.8 30.3 15.1 23.1 29.9 11.1 30.6 2.5 7.3 366.7 78.9 26.7 30.4 25.2 11.2 27.6 7.3 14.0 42.1 31.4 11.8 116.4 51.3 129.7 51.9 28.5 17.7 10.0 19.9 10.7 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733525-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5" "Cell type enhanced" "Detected in many" 24 "Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 7000000 Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.2 1.4 1.8 0.0 0.0 11.7 0.0 0.0 0.4 0.0 0.9 0.6 62.9 1.6 0.1 1.6 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 53.6 0.1 2.3 0.0 0.0 6.6 1.4 0.4 24.0 0.0 0.7 0.0 1.1 0.0 0.4 0.0 0.4 0.0 40.5 41.8 10.6 18.6 0.0 0.5 4.5 0.6 0.0 0.3 21.1 7.4 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.3 0.4 0.2 1.1 0.0 0.0 0.0 0.2 2.1 0.0 73.7 1.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.4 10.3 0.0 0.0 0.0 9.2 0.0 1.4 0.8 0.2 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.0 0.0 0.5 0.0 21.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 71.9 57.1 0.0 3.3 0.0 22.7 6.8 1.8 0.0 120.6 0.0 0.5 0.6 0.4 0.0 0.0 0.0 12.6 4.3 9.6 0.0 0.6 9.6 0.0 0.0 0.0 0.3 1.6 0.3 0.2 10.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.9 176.4 549.0 0.0 0.0 120.1 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Cell type enhanced" "Detected in many" 4 "monocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.9 7.6 5.1 6.2 8.1 8.7 15.0 8.1 7.1 10.2 7.5 19.8 8.3 6.5 15.5 7.5 14.5 14.6 14.0 8.6 10.4 10.9 12.9 11.3 4.6 19.9 9.0 12.1 6.4 8.1 12.9 9.2 10.6 6.5 7.8 8.3 20.0 16.3 6.5 8.1 7.4 7.0 8.4 16.6 12.1 7.5 7.8 11.9 8.8 15.4 5.1 6.6 7.0 18.0 12.3 7.6 21.5 9.5 5.6 6.1 7.6 12.6 16.8 24.0 36.6 13.1 9.3 7.3 7.3 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 8.9 26.2 17.6 29.0 47.2 17.7 11.3 22.9 4.0 14.8 19.2 17.7 23.4 6.6 28.6 0.4 17.9 38.7 0.0 48.5 20.2 16.7 43.7 8.1 34.2 16.5 15.9 17.9 14.1 11.1 1.8 13.3 14.3 8.5 100.0 26.4 14.6 45.8 15.9 12.7 22.4 29.5 19.4 17.2 23.7 14.2 74.0 38.4 15.2 30.8 81.8 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 118.9" "Cell type enhanced" "Detected in many" 9 "Club cells: 118.3;Early spermatids: 138.9;Hepatocytes: 109.4;Suprabasal keratinocytes: 222.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3;myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 94.3;ASC TERT1: 27.6;HSkMC: 29.0" "Low region specificity" "Detected in all" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" NA NA "Endoplasmic reticulum" Vesicles "HPA062101: AB_2684682" "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 5.3 5.2 1.6 3.0 7.3 0.6 12.5 0.3 1.9 8.6 2.7 1.9 2.5 1.0 8.5 5.7 4.4 5.2 5.7 5.7 1.3 0.9 1.4 45.2 5.8 5.2 4.4 0.7 6.4 20.2 0.3 25.1 20.2 2.1 5.9 1.8 3.1 23.9 2.2 2.4 118.9 1.7 6.6 2.2 2.2 2.0 5.4 4.4 0.0 6.5 3.7 12.2 7.7 18.5 0.5 2.9 0.9 3.3 0.0 0.5 2.0 6.1 0.4 0.6 2.1 94.3 27.6 0.0 14.8 13.8 2.1 19.4 0.5 0.1 0.0 7.4 9.7 5.6 7.0 0.5 2.8 5.3 1.5 1.8 5.2 2.3 1.7 5.9 0.0 0.3 29.0 1.6 3.8 5.8 8.9 0.8 0.0 0.1 0.7 5.0 0.0 0.0 0.1 0.7 0.0 3.7 0.0 5.3 0.0 0.1 0.2 0.6 4.4 3.6 1.9 1.5 4.3 0.2 2.9 2.0 14.4 10.1 0.1 3.3 12.2 6.9 0.0 11.3 0.4 9.5 0.0 3.3 0.9 0.3 0.0 0.0 0.5 0.2 0.3 2.9 0.0 0.1 0.5 0.4 0.0 0.5 1.6 0.0 2.0 1.6 7.3 0.3 1.9 1.3 0.9 4.4 0.7 2.1 4.4 56.6 52.0 7.0 4.3 84.0 3.3 1.9 0.0 97.7 118.3 0.0 0.0 2.2 0.0 7.1 138.9 3.8 0.0 0.0 13.5 42.5 64.8 3.2 60.4 109.4 5.6 7.9 1.2 12.3 6.1 11.8 15.0 5.0 21.9 1.8 1.7 1.4 8.9 0.3 26.2 0.0 0.8 6.5 16.4 1.2 1.9 222.8 6.3 3.2 0.0 4.1 TMEM45B "BC016153, FLJ40787" ENSG00000151715 "Transmembrane protein 45B" Q96B21 11 129815819-129860003 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 106.6" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 253.0;Paneth cells: 150.7;Undifferentiated cells: 102.5;Urothelial cells: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1" "Group enriched" "Detected in many" 12 "granulocytes: 13.1;T-cells: 4.3" "Group enriched" "Detected in some" 5 "OE19: 82.8;RT4: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015474, HPA015878" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA015474: , HPA015878: AB_2205046" "unprognostic (4.92e-3)" "unprognostic (7.94e-2)" "unprognostic (5.98e-2)" "unprognostic (1.81e-1)" "unprognostic (5.44e-3)" "unprognostic (7.11e-2)" "unprognostic (1.17e-1)" "unprognostic (6.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.02e-3)" "unprognostic (1.33e-1)" "unprognostic (1.27e-1)" "unprognostic (1.04e-1)" "unprognostic (1.42e-2)" "unprognostic (2.24e-1)" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" 0.2 0.2 0.6 9.0 0.9 0.0 4.0 0.3 0.7 6.6 50.3 0.5 1.7 40.4 1.2 4.1 29.5 6.5 9.3 0.4 1.2 0.6 9.6 13.2 4.5 1.9 0.4 0.7 1.4 3.1 0.0 2.9 1.2 2.3 4.0 29.0 0.3 7.3 2.4 0.2 10.9 106.6 1.5 0.5 0.6 7.4 0.7 0.2 0.5 9.1 21.9 19.9 9.4 10.9 0.6 0.4 13.1 0.6 0.7 4.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 9.7 4.2 0.0 1.8 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.0 82.8 12.6 0.0 0.0 0.6 5.4 33.4 1.0 0.1 0.0 2.7 0.0 0.0 9.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.6 0.1 0.3 0.2 0.3 0.2 3.6 0.9 0.0 0.6 4.3 0.7 13.1 0.7 0.2 0.4 0.6 1.3 0.6 0.9 0.3 0.7 1.2 0.6 0.4 0.7 2.3 0.2 17.9 8.4 0.5 10.0 3.0 0.0 0.6 22.9 68.3 21.6 43.6 0.0 4.0 11.6 20.5 0.2 0.3 253.0 0.0 7.3 0.6 0.9 18.6 2.3 2.6 0.5 0.0 53.3 0.0 1.6 0.0 0.3 1.9 3.3 0.0 64.7 0.0 32.6 150.7 0.0 1.2 0.3 0.0 1.0 0.0 0.0 18.2 0.3 0.7 102.5 96.6 TMEM52 ENSG00000178821 "Transmembrane protein 52" Q8NDY8 1 1917590-1919273 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 19.1;Hepatocytes: 22.7;Spermatocytes: 23.3;Spermatogonia: 33.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 14.2;OE19: 12.8;RPMI-8226: 25.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (4.39e-2)" "unprognostic (2.60e-1)" "unprognostic (3.76e-2)" "unprognostic (7.35e-3)" "unprognostic (1.04e-5)" "unprognostic (1.46e-1)" "unprognostic (6.71e-3)" "unprognostic (3.68e-2)" "unprognostic (9.49e-2)" "unprognostic (1.69e-1)" "unprognostic (3.83e-3)" "unprognostic (5.80e-2)" "unprognostic (8.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" 1.7 12.5 0.5 0.2 0.5 0.1 1.3 1.5 0.4 0.3 0.9 0.4 0.1 1.0 0.3 1.5 2.0 0.8 0.4 0.4 0.4 0.5 0.6 3.3 1.0 0.1 0.2 0.5 0.5 67.1 0.9 0.3 0.2 0.4 0.5 0.4 0.5 13.8 0.1 77.9 0.8 1.7 0.2 0.3 0.7 1.2 7.9 0.2 0.2 0.9 38.9 2.5 0.3 0.4 0.2 2.3 0.0 0.4 0.0 0.6 0.0 2.3 0.2 0.6 1.3 0.2 0.1 5.5 0.3 0.1 1.6 1.0 3.9 1.6 0.6 1.6 2.5 0.6 0.8 3.9 1.1 0.3 0.2 2.9 0.0 0.6 14.2 0.8 0.0 0.9 0.0 2.3 0.5 0.2 0.1 0.1 2.8 3.5 1.4 0.0 4.5 0.3 1.1 2.1 12.8 7.7 1.0 0.0 25.8 0.8 0.1 2.7 1.8 0.0 2.2 0.3 1.0 1.5 0.3 0.0 0.0 1.1 0.7 0.0 1.8 0.6 0.7 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.5 1.5 0.4 0.4 0.5 0.2 0.5 0.4 0.2 0.0 0.0 1.5 2.5 3.9 0.2 0.6 5.1 4.0 3.4 0.0 0.0 0.9 1.7 1.8 3.4 0.2 9.1 0.0 19.1 5.3 1.7 4.9 0.0 22.7 0.6 0.0 0.0 1.3 0.3 4.5 13.8 0.7 8.5 1.0 7.3 1.2 10.4 2.9 9.2 8.2 1.0 0.0 0.7 23.3 33.4 2.5 3.1 0.0 7.0 2.7 TMEM52B "C12orf59, FLJ31166" ENSG00000165685 "Transmembrane protein 52B" Q4KMG9 12 10170542-10191801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 23 "kidney: 85.1" "Cell type enriched" "Detected in some" 16 "Distal tubular cells: 603.5" "Cancer enriched" "Detected in some" 5 "renal cancer: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 3.7" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "CACO-2: 46.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA058096 Enhanced Approved "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA058096: AB_2683603" "unprognostic (1.10e-2)" "unprognostic (7.61e-2)" "unprognostic (1.37e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (5.33e-3)" "unprognostic (1.37e-1)" "unprognostic (8.65e-2)" "unprognostic (7.14e-4)" "unprognostic (2.23e-1)" "unprognostic (6.36e-2)" "unprognostic (7.33e-2)" "unprognostic (3.24e-2)" "unprognostic (5.80e-2)" "unprognostic (5.51e-2)" "unprognostic (1.66e-1)" "unprognostic (3.18e-1)" 0.1 0.0 0.1 0.1 0.6 0.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 85.1 0.1 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.1 2.0 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 3.7 1.4 1.3 0.6 0.5 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 46.3 0.0 0.0 0.0 0.3 2.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 6.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 3.4 4.4 0.0 1.6 2.5 0.7 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 1.4 1.3 1.0 0.4 0.2 0.4 0.4 0.4 0.5 3.7 0.9 0.5 0.5 1.0 0.6 0.2 0.6 0.4 0.4 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 12.2 0.0 38.1 603.5 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.6 0.0 0.3 4.2 1.7 2.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.2 0.0 16.2 0.0 0.0 0.0 TMEM53 "FLJ22353, NET4" ENSG00000126106 "Transmembrane protein 53" Q6P2H8 1 44635238-44674555 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.7;liver: 44.7" "Cell type enriched" "Detected in all" 5 "Late spermatids: 845.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 38.7" "Lineage enriched" "Detected in all" 4 "dendritic cells: 38.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021134 Approved Approved "Golgi apparatus,Focal adhesion sites" NA NA "Golgi apparatus" "Focal adhesion sites" "HPA021134: AB_2205162" "unprognostic (5.28e-2)" "unprognostic (2.60e-1)" "unprognostic (5.37e-2)" "unprognostic (4.62e-2)" "unprognostic (3.93e-2)" "unprognostic (1.14e-1)" "unprognostic (2.82e-2)" "unprognostic (2.88e-2)" "unprognostic (2.19e-2)" "prognostic favorable (6.96e-4)" "unprognostic (3.00e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.02e-5)" "unprognostic (1.15e-3)" "unprognostic (1.84e-2)" "unprognostic (4.07e-2)" "unprognostic (2.29e-2)" 8.3 9.0 6.0 4.4 8.7 6.0 7.0 2.4 11.8 4.9 11.0 8.8 4.6 16.6 5.7 7.2 4.5 5.3 7.6 9.3 6.2 6.1 14.8 44.7 7.3 6.4 6.8 6.2 7.7 5.4 3.3 6.4 4.3 8.0 5.2 7.2 13.9 6.0 3.8 4.2 3.9 16.4 4.5 6.1 4.8 7.7 18.8 4.4 3.6 8.2 3.1 4.0 7.3 3.7 5.3 38.7 3.6 8.6 2.8 3.1 2.8 7.6 8.8 8.0 5.8 10.4 7.9 9.6 2.2 6.7 4.4 6.6 2.8 24.2 2.4 7.3 2.1 17.0 6.9 2.2 4.7 2.3 3.8 5.6 2.8 3.6 13.4 10.4 2.2 10.3 9.3 7.3 8.8 1.9 4.8 2.4 5.5 1.2 3.1 2.6 4.5 2.5 6.5 4.6 5.9 5.2 4.0 1.1 23.6 13.1 8.0 5.6 5.4 2.4 9.6 12.4 5.9 3.0 5.8 1.0 3.2 5.5 4.6 2.8 2.2 2.6 1.3 8.4 5.7 3.7 3.6 5.2 2.3 3.0 8.6 2.6 5.3 3.1 2.5 2.6 5.0 1.5 2.0 0.5 2.8 6.0 38.7 3.0 2.8 6.0 8.7 2.4 11.8 6.2 6.1 6.8 6.2 8.0 4.4 6.0 11.8 2.4 6.7 1.4 5.6 24.6 10.2 18.7 9.1 19.2 3.9 11.6 38.1 14.3 155.5 8.7 50.1 23.3 22.5 13.2 5.6 7.8 5.8 81.3 29.8 17.5 13.8 8.0 8.3 845.8 8.3 7.2 8.5 1.8 18.4 12.9 16.0 56.1 11.7 39.8 12.4 25.8 7.3 5.1 8.3 1.9 7.8 4.1 15.4 10.3 TMEM54 CAC-1 ENSG00000121900 "Transmembrane protein 54" Q969K7 1 32894594-32901438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.7" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 673.9;Mucus-secreting cells: 310.3;Paneth cells: 422.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.3;OE19: 57.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA061992 Approved Vesicles NA NA Vesicles "HPA061992: AB_2684652" "unprognostic (2.67e-1)" "unprognostic (2.57e-2)" "unprognostic (2.55e-1)" "unprognostic (4.98e-2)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.42e-2)" "unprognostic (3.48e-2)" "unprognostic (9.43e-2)" "unprognostic (6.82e-3)" "unprognostic (2.13e-2)" "unprognostic (9.06e-2)" "unprognostic (3.12e-2)" "unprognostic (3.40e-2)" 3.2 3.3 16.1 21.5 10.7 0.0 8.5 2.7 10.6 10.0 70.0 8.2 7.0 37.9 8.5 9.4 28.8 5.0 24.2 4.5 9.7 9.4 11.4 4.4 7.2 2.4 10.9 5.7 6.2 12.4 9.0 4.7 47.3 6.8 14.7 37.4 7.4 11.8 8.4 1.9 26.9 76.7 7.3 7.3 3.1 35.0 3.7 6.0 1.1 23.6 16.9 14.2 12.5 15.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 29.9 8.1 0.0 7.8 14.9 9.0 29.3 4.4 7.2 10.7 13.8 20.2 48.3 0.0 13.1 5.9 13.6 18.4 7.0 25.9 3.2 34.8 1.4 0.0 2.9 1.0 10.8 0.1 0.4 7.7 23.7 16.3 4.5 7.2 4.7 3.1 4.1 0.0 5.5 32.1 0.0 0.6 2.5 57.6 14.1 4.0 12.2 0.1 3.9 38.5 0.4 4.0 3.1 20.1 10.1 5.0 21.8 5.8 8.9 10.5 11.2 23.5 9.4 1.1 2.5 3.5 7.5 0.7 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 10.7 2.7 10.6 9.7 9.4 10.9 5.7 6.8 6.0 17.9 25.1 9.7 74.9 18.1 5.9 2.8 76.5 6.7 6.8 45.4 3.9 34.8 23.2 128.9 43.4 11.3 673.9 0.0 180.9 127.1 10.8 130.2 5.7 1.5 7.4 0.0 58.3 12.9 1.8 20.3 18.4 3.7 13.5 5.4 310.3 13.7 137.0 422.1 23.0 38.7 8.7 6.5 11.3 11.1 8.9 55.7 53.8 0.0 231.5 148.6 TMEM56 FLJ31842 ENSG00000152078 "Transmembrane protein 56" Q96MV1 1 95117338-95197607 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 74.2" "Group enriched" "Detected in many" 4 "Cardiomyocytes: 68.8;Erythroid cells: 186.9;Hepatocytes: 246.3" "Cancer enhanced" "Detected in many" "liver cancer: 13.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 3.3;naive B-cell: 1.6;neutrophil: 1.0" "Group enriched" "Detected in many" 6 "B-cells: 3.3;granulocytes: 1.0" "Cell line enhanced" "Detected in many" "A-431: 13.9;GAMG: 13.1;RH-30: 23.2" HPA046762 Approved "Nuclear speckles" No No "Nuclear speckles" "HPA046762: AB_2679792" "unprognostic (1.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.98e-3)" "unprognostic (2.79e-1)" "unprognostic (3.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.82e-3)" "unprognostic (3.63e-2)" "unprognostic (4.42e-3)" "unprognostic (2.69e-2)" "unprognostic (4.99e-2)" "unprognostic (4.40e-2)" "unprognostic (1.16e-3)" "unprognostic (1.10e-1)" "unprognostic (9.46e-2)" "unprognostic (1.59e-1)" "unprognostic (3.15e-2)" 3.3 6.6 6.1 1.6 6.5 10.4 2.0 10.9 10.6 2.0 8.2 3.8 2.8 3.6 2.5 2.1 1.9 2.2 4.5 15.1 4.2 3.2 3.9 74.2 2.6 0.7 3.5 5.7 1.5 6.5 5.4 6.8 3.1 4.7 3.8 6.6 28.1 4.8 2.7 7.2 1.7 6.6 8.1 4.1 1.0 3.9 3.2 3.2 0.0 4.8 1.7 0.8 4.8 3.1 3.3 0.1 1.0 0.1 0.0 0.3 0.1 13.9 8.0 1.1 1.7 0.5 0.0 1.9 0.5 0.3 1.8 4.3 5.8 6.7 0.0 7.0 0.2 13.1 0.1 4.7 0.7 3.2 9.7 2.6 0.3 6.8 1.2 0.5 0.2 0.4 0.8 0.2 1.4 0.0 2.9 0.0 0.8 12.2 0.7 0.4 1.1 0.8 0.0 1.1 0.4 4.4 0.0 23.2 0.3 7.8 9.1 2.9 2.3 9.9 7.0 4.1 1.2 7.6 0.2 0.1 0.2 6.0 0.7 4.9 2.5 4.8 0.0 1.0 0.0 1.4 0.3 0.1 0.1 0.1 0.0 0.0 3.3 0.2 0.2 0.0 1.6 0.3 0.1 1.0 0.0 0.0 0.1 0.1 0.1 6.1 6.5 10.9 10.6 4.2 3.2 3.5 5.7 4.7 3.2 6.0 22.6 10.7 4.2 1.0 3.2 68.8 25.5 4.0 3.4 14.0 0.0 6.6 1.7 13.6 13.9 1.0 39.2 186.9 21.0 1.3 5.1 21.2 0.0 246.3 0.5 0.0 15.6 17.2 5.0 36.7 2.6 0.0 1.7 0.0 18.7 37.5 10.3 13.6 2.1 12.4 1.0 6.5 4.2 3.3 6.0 0.4 3.8 1.0 13.3 4.2 TMEM56-RWDD3 ENSG00000271092 "TMEM56-RWDD3 readthrough" 1 95117923-95247225 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 42.6;retina: 25.5" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 2.7;granulocytes: 4.6;Intestinal endocrine cells: 1.7" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 15.1" NA NA "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.43e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.77e-3)" "unprognostic (4.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.70e-1)" "unprognostic (4.00e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.29e-2)" "unprognostic (3.42e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (1.42e-2)" 3.1 3.9 4.6 1.8 5.8 2.8 3.9 7.5 9.2 2.9 3.6 3.3 2.3 4.1 3.2 4.9 2.1 3.1 3.7 14.2 3.8 2.4 2.8 42.6 2.7 3.3 2.5 4.9 3.5 6.2 4.1 6.1 4.5 4.1 3.7 3.9 25.5 3.9 2.2 4.7 4.6 5.8 7.0 2.9 2.3 3.9 3.4 2.8 0.0 4.5 1.6 2.6 3.6 2.9 2.7 1.3 1.1 0.8 0.7 2.4 1.0 7.2 4.3 4.0 5.3 1.7 3.2 4.6 1.4 0.9 2.8 3.2 6.6 3.0 2.6 5.0 1.6 7.7 1.8 3.8 1.9 3.0 1.9 2.4 3.2 4.2 1.6 1.5 1.0 1.0 1.9 2.1 2.5 0.7 3.2 1.2 2.4 5.3 1.7 1.5 2.0 2.2 2.5 2.0 1.2 2.2 1.9 15.1 0.4 3.8 7.4 4.0 4.5 5.3 4.2 5.2 3.0 3.0 2.4 2.6 3.0 4.1 2.8 3.9 2.4 1.6 1.6 1.4 0.6 2.1 0.6 0.7 1.1 1.3 0.8 0.7 2.7 2.0 0.8 1.3 2.6 2.4 0.9 0.0 0.7 0.7 0.6 1.6 1.0 4.6 5.8 7.5 9.2 3.8 2.4 2.5 4.9 4.1 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 2.7 1.2 0.0 0.0 1.2 0.0 0.8 0.1 0.0 0.7 0.0 0.4 0.4 0.0 0.1 4.6 0.8 0.7 0.0 1.7 0.6 0.0 1.3 1.1 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 TMEM59L "BSMAP, C19orf4" ENSG00000105696 "Transmembrane protein 59 like" Q9UK28 19 18607430-18621039 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 148.3" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 92.0;Horizontal cells: 47.7;Muller glia cells: 72.1;Rod photoreceptor cells: 22.8" "Cancer enriched" "Detected in many" 8 "glioma: 44.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 20.4;ASC diff: 24.8;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;hTERT-RPE1: 13.4;SH-SY5Y: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010661 Approved NA NA "HPA010661: AB_1078338" "unprognostic (3.24e-2)" "unprognostic (5.53e-2)" "unprognostic (1.24e-4)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.70e-1)" "unprognostic (5.40e-3)" "unprognostic (3.53e-2)" "unprognostic (6.91e-2)" "unprognostic (1.10e-1)" "unprognostic (1.40e-3)" "prognostic favorable (8.80e-4)" "unprognostic (4.65e-2)" "unprognostic (9.17e-7)" "unprognostic (1.47e-3)" "unprognostic (2.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-5)" 2.6 12.8 36.9 2.5 39.4 1.7 1.9 41.9 148.3 2.2 2.9 7.5 0.0 2.0 2.5 2.0 2.5 2.1 2.9 3.5 39.9 49.6 1.9 1.8 1.9 1.8 17.7 32.8 1.8 2.8 4.9 13.2 2.3 24.1 2.2 2.2 1.9 2.3 2.6 2.5 1.8 3.0 3.1 7.3 1.7 2.0 2.4 5.2 0.0 1.8 0.0 1.7 2.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.2 20.4 24.8 1.2 0.0 2.1 0.4 0.8 0.4 0.0 1.0 0.1 14.6 1.3 2.0 0.3 6.0 0.0 0.7 0.1 0.9 0.0 0.3 14.8 3.8 0.0 0.3 9.1 0.0 0.2 0.7 13.4 0.0 0.8 0.0 0.1 0.5 0.9 0.1 0.0 1.8 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.3 12.1 1.4 0.0 0.0 0.2 0.2 0.0 0.2 0.4 4.9 0.1 1.3 3.0 1.1 0.1 0.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 36.9 39.4 41.9 70.3 39.9 49.6 17.7 32.8 24.1 5.2 0.0 0.0 0.0 0.2 0.0 92.0 0.4 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.2 47.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 1.0 0.0 72.1 0.3 0.0 0.0 0.0 22.8 0.0 2.7 2.6 0.9 0.1 0.1 0.0 0.0 0.0 TMEM61 ENSG00000143001 "Transmembrane protein 61" Q8N0U2 1 54980792-54992293 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1" "Group enriched" "Detected in many" 4 "Distal tubular cells: 41.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 52.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 5.2;pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 22.6" "Low region specificity" "Detected in many" HPA030614 Uncertain NA NA "HPA030614: AB_10603216" "unprognostic (7.62e-2)" "unprognostic (1.67e-3)" "prognostic favorable (1.07e-4)" "unprognostic (1.00e-1)" "unprognostic (6.63e-4)" "unprognostic (6.15e-2)" "unprognostic (2.67e-3)" "unprognostic (1.49e-1)" "unprognostic (3.05e-1)" "unprognostic (4.46e-2)" "unprognostic (1.91e-2)" "unprognostic (7.24e-2)" "prognostic favorable (1.78e-7)" "unprognostic (8.47e-2)" "unprognostic (2.20e-2)" "unprognostic (4.01e-2)" "unprognostic (4.62e-3)" 0.2 3.9 0.4 0.7 1.0 0.0 2.7 5.2 0.5 0.9 3.7 0.2 4.9 2.4 0.2 3.8 2.9 2.0 1.7 0.0 0.5 0.6 22.1 0.0 2.4 0.0 1.1 0.7 1.1 4.2 7.8 29.1 0.5 5.2 2.4 2.3 0.5 34.1 6.7 0.4 1.8 3.5 5.3 0.8 0.4 2.2 0.2 0.1 0.1 0.6 0.8 1.8 4.7 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.0 22.6 2.4 0.0 1.1 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.0 5.2 0.5 0.5 0.6 1.1 0.7 5.2 0.1 0.0 1.9 0.0 6.7 0.8 0.7 0.0 0.0 10.7 2.3 7.0 2.0 0.1 41.4 4.0 0.1 0.0 1.7 0.0 3.0 0.1 0.2 3.1 0.0 0.0 0.1 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 52.9 0.1 4.2 5.8 0.7 0.0 0.8 0.0 0.1 0.1 0.7 2.0 0.2 0.0 2.0 2.6 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882369 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Cell type enhanced" "Detected in many" 4 "Glandular cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 37.5;SK-BR-3: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" NA NA 96000 "Vesicles, Centriolar satellite" "HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057" "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favorable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 10.5 7.4 14.7 11.6 38.8 18.6 12.2 4.1 23.2 14.3 14.0 91.4 17.3 12.2 12.2 11.2 6.6 13.9 12.9 8.5 30.2 15.1 14.3 15.1 12.6 15.4 59.3 16.4 13.1 22.4 11.6 5.3 11.3 34.9 22.3 17.8 5.7 55.8 19.1 6.9 9.9 13.3 8.8 71.0 14.0 22.9 3.0 49.6 11.2 8.0 4.5 12.4 13.3 9.6 5.4 10.0 5.5 4.1 8.7 16.6 5.7 9.2 2.8 2.4 7.0 19.4 6.7 16.8 7.1 7.7 7.9 8.0 10.1 6.9 2.6 13.1 8.6 4.7 14.3 2.6 4.3 3.7 8.6 4.6 11.3 6.5 6.0 4.5 4.2 29.7 7.0 2.7 4.7 2.8 11.0 5.1 5.9 9.3 2.2 6.2 5.8 3.7 4.2 13.2 29.7 4.6 3.7 7.5 37.5 12.1 24.6 0.2 1.3 5.2 41.7 5.1 5.9 9.6 4.0 6.1 4.6 3.2 4.2 6.4 0.9 3.4 0.6 4.2 2.3 8.4 5.5 3.2 3.0 9.4 2.7 10.6 5.2 12.1 8.9 2.5 5.4 10.9 6.3 5.1 8.7 4.1 10.0 16.6 5.7 14.7 38.8 4.1 23.0 30.2 15.1 59.3 16.4 34.9 49.6 6.0 8.6 16.0 22.4 3.0 0.8 3.6 28.1 14.7 11.4 19.2 2.0 32.4 1.7 29.4 9.1 4.6 17.3 0.0 22.5 4.5 7.8 60.8 17.3 16.0 15.3 0.0 18.5 11.1 9.1 8.0 17.0 10.3 3.3 5.4 32.5 18.8 18.4 20.1 12.4 11.1 1.3 25.8 8.2 0.6 4.9 3.6 18.8 17.0 46.1 29.3 TMEM63C "C14orf171, CSC1, DKFZp434P0111, hsCSC1" ENSG00000165548 "Transmembrane protein 63C" Q9P1W3 14 77116568-77259495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 63.8;pituitary gland: 21.1" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 7.2;Intestinal endocrine cells: 18.4;Late spermatids: 4.8;Paneth cells: 6.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 11.8;Karpas-707: 15.9;RPMI-8226: 8.1;SCLC-21H: 21.7;SK-BR-3: 19.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030657 Uncertain Approved Centrosome NA NA Centrosome "HPA030657: AB_10601699" "unprognostic (2.74e-1)" "unprognostic (1.79e-2)" "unprognostic (2.30e-1)" "unprognostic (4.30e-8)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (2.68e-3)" "unprognostic (1.61e-3)" "unprognostic (2.51e-1)" "unprognostic (1.71e-1)" "unprognostic (1.21e-2)" "unprognostic (1.14e-1)" "unprognostic (2.90e-2)" "unprognostic (1.35e-3)" "unprognostic (3.72e-2)" "unprognostic (1.34e-7)" "unprognostic (5.90e-3)" 0.4 14.1 3.4 1.0 8.4 1.1 5.2 63.8 16.3 1.5 5.8 1.9 0.0 1.8 0.3 6.8 4.8 0.6 0.5 0.3 3.2 9.7 0.7 0.4 0.9 0.6 4.6 6.0 0.4 6.7 1.2 21.1 1.1 6.6 0.4 4.3 0.9 1.3 0.2 0.8 4.4 2.2 1.1 1.8 3.2 3.1 9.9 1.2 0.0 3.2 0.6 0.6 0.3 2.9 0.1 0.7 2.0 1.7 1.7 1.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 11.8 2.3 0.0 2.0 1.6 2.5 0.9 0.0 0.8 0.9 0.2 1.2 0.0 0.0 2.0 0.1 0.0 5.0 0.0 0.1 0.0 0.0 5.6 0.0 15.9 0.0 5.9 1.6 0.1 0.5 0.0 0.0 0.0 0.8 8.1 0.2 0.0 21.7 3.2 0.2 19.2 0.0 0.4 1.9 1.0 0.0 0.0 4.1 0.0 0.0 1.3 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.4 0.2 0.2 0.2 0.0 0.5 1.0 0.7 0.1 0.5 0.4 2.0 1.7 1.7 0.0 0.0 0.4 3.4 8.4 63.8 13.0 3.2 9.7 4.6 6.0 6.6 1.2 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.0 7.2 0.0 2.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 2.0 3.2 18.4 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.1 0.1 0.3 6.6 0.4 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 TMEM64 DKFZp762C1112 ENSG00000180694 "Transmembrane protein 64" Q6YI46 8 90621995-90791632 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "epididymis: 84.0" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 42.9;Leydig cells: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034221 Uncertain NA NA "CAB034221: AB_1567653" "unprognostic (3.61e-1)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (2.55e-3)" "unprognostic (4.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (3.30e-1)" "unprognostic (2.35e-1)" "unprognostic (2.59e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.97e-1)" 9.2 12.6 4.3 5.2 5.3 2.1 6.1 2.7 6.1 10.6 10.8 16.2 14.5 5.7 11.9 84.0 7.3 5.7 6.3 5.8 6.2 5.5 11.6 11.7 7.2 6.7 11.2 3.3 10.1 11.3 4.1 5.9 6.1 10.0 10.7 3.7 15.1 12.4 11.0 8.2 6.8 11.3 9.6 12.1 7.2 5.4 9.7 7.5 2.3 20.0 5.2 7.2 11.9 10.9 5.7 0.6 3.2 0.8 5.9 3.7 1.6 12.8 10.0 5.1 2.7 23.7 17.3 2.7 9.5 9.1 7.5 8.4 2.8 8.9 8.4 3.8 5.8 3.2 4.5 13.5 6.5 10.0 16.8 4.9 15.6 4.0 6.3 8.4 0.9 2.6 22.5 7.1 3.1 7.0 8.7 7.5 2.0 7.0 18.6 12.6 17.1 0.0 2.2 0.7 6.6 5.3 1.8 11.2 4.2 14.8 25.0 3.6 10.2 6.2 5.5 11.5 7.1 5.5 0.7 7.4 7.6 6.7 5.5 7.7 12.3 0.2 9.2 6.9 1.9 10.0 3.2 0.2 0.3 3.0 0.6 3.7 5.7 3.2 3.4 0.6 2.9 1.5 2.1 0.1 5.9 0.8 0.4 1.4 1.6 4.3 5.3 2.7 6.1 6.2 5.5 11.2 3.3 10.0 7.5 8.9 12.2 16.1 8.7 21.4 0.6 17.1 10.2 4.0 3.4 21.0 0.0 20.2 1.7 3.8 2.4 7.0 3.4 0.0 8.8 5.2 14.6 15.6 13.9 42.9 3.6 1.6 7.5 5.5 7.5 2.1 43.4 6.5 23.6 0.0 4.3 2.6 8.2 3.1 20.1 22.1 0.0 0.0 10.8 3.4 1.6 20.6 13.2 9.6 5.1 6.2 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Uncertain Supported Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 9.5 12.3 7.6 7.4 8.0 7.0 9.4 7.1 12.8 6.0 7.4 3.6 3.9 4.8 6.1 9.0 6.2 9.1 7.4 13.3 9.3 7.9 9.7 38.8 6.2 9.6 6.8 7.3 7.3 17.0 5.1 6.3 8.1 10.0 6.3 8.0 3.8 7.1 5.3 81.1 4.8 6.9 7.7 6.3 9.9 10.6 10.9 5.1 8.5 6.5 13.4 7.9 6.7 5.9 18.4 12.3 7.5 11.0 6.2 12.7 12.7 11.2 9.0 7.2 7.5 8.5 7.3 7.4 9.6 8.7 10.7 8.7 8.4 6.5 15.2 8.3 6.4 9.1 10.2 13.8 9.2 12.1 9.8 9.4 15.2 5.9 11.2 8.5 8.2 8.1 6.8 8.6 6.8 3.6 4.1 9.0 7.7 11.4 7.5 11.4 8.3 18.8 15.6 6.7 14.4 11.2 13.3 7.1 12.9 11.3 10.6 16.4 7.3 5.9 43.0 12.1 6.0 8.9 7.6 5.7 6.3 7.6 11.4 9.0 11.2 9.6 14.9 9.1 6.4 6.9 6.3 10.8 7.0 9.5 11.0 10.9 18.4 10.9 10.8 10.5 10.8 12.7 11.8 7.5 6.2 8.1 12.3 8.6 12.7 7.6 8.0 7.1 12.8 9.3 7.9 6.8 7.3 10.0 5.1 14.9 36.2 37.2 32.5 59.8 24.1 39.1 15.3 42.8 23.9 21.0 7.9 61.6 56.3 28.4 11.2 35.3 22.8 0.0 55.5 44.6 47.0 32.0 38.2 44.2 119.9 9.5 13.3 28.3 89.0 5.6 27.6 68.1 38.8 36.1 27.6 19.7 38.3 37.1 27.3 55.5 15.9 38.8 44.8 32.9 28.3 52.1 58.8 34.8 29.0 23.3 TMEM71 FLJ33069 ENSG00000165071 "Transmembrane protein 71" Q6P5X7 8 132685007-132760712 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 65.7;lymphoid tissue: 31.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 65.7" "Lineage enriched" "Detected in all" 4 "granulocytes: 65.7" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA058401, HPA070655" Uncertain Enhanced Mitochondria NA NA Mitochondria "HPA058401: AB_2683707, HPA070655: AB_2686292" "unprognostic (1.39e-3)" "unprognostic (7.27e-2)" "unprognostic (8.82e-2)" "unprognostic (3.10e-3)" "unprognostic (7.94e-2)" "unprognostic (3.91e-3)" "unprognostic (4.18e-2)" "unprognostic (5.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (1.63e-1)" "unprognostic (1.62e-1)" "unprognostic (8.83e-2)" "unprognostic (1.90e-2)" "unprognostic (6.29e-3)" "unprognostic (4.39e-2)" "unprognostic (2.73e-1)" 4.2 1.1 1.4 8.2 1.5 20.8 5.4 0.7 1.2 2.5 9.9 0.8 0.4 1.2 1.0 2.0 4.8 1.9 4.1 25.5 1.8 1.2 1.9 2.3 8.3 20.9 2.2 0.8 1.9 2.9 0.0 1.4 1.0 1.7 2.2 2.2 5.8 5.8 1.3 1.3 1.3 7.2 2.2 4.2 18.2 2.9 0.9 1.4 31.3 2.2 2.5 10.6 7.0 2.8 1.4 8.2 65.7 13.5 2.9 14.8 8.4 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.8 8.2 0.3 0.6 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.2 0.9 33.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 1.3 0.9 0.6 4.2 0.0 7.0 1.4 0.0 1.6 1.3 0.7 0.0 0.2 0.1 1.1 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.2 0.4 0.5 0.7 3.4 0.0 1.6 0.0 5.8 19.5 2.4 12.5 13.5 23.9 8.0 3.9 14.8 1.4 5.9 5.6 8.2 1.3 9.0 6.5 65.7 2.9 3.2 0.2 0.7 8.4 1.4 1.5 0.7 1.2 1.8 1.2 2.2 0.8 1.7 1.4 0.0 4.8 4.2 1.0 0.8 0.0 14.8 0.0 4.0 3.4 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 1.3 0.1 1.1 0.0 3.1 0.0 0.0 1.3 23.3 3.6 0.0 22.7 5.0 0.0 0.0 1.1 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.2 41.5 0.0 5.1 TMEM72 "bA285G1.3, C10orf127, KSP37" ENSG00000187783 "Transmembrane protein 72" A0PK05 10 44911200-44937002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 46.5;retina: 17.1" "Group enriched" "Detected in some" 4 "Collecting duct cells: 26.2;Distal tubular cells: 28.2;Late spermatids: 11.4;Paneth cells: 8.6" "Cancer enriched" "Detected in some" 8 "renal cancer: 8.7" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.2;pons and medulla: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 118 "RPMI-8226: 26.1;U-937: 16.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA039894, HPA062907" Enhanced NA NA "HPA039894: AB_10795261, HPA062907: AB_2684900" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (3.24e-2)" "unprognostic (8.58e-2)" "unprognostic (5.45e-2)" "prognostic favorable (1.01e-4)" "unprognostic (4.99e-3)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" 0.1 0.0 0.1 0.9 0.2 0.1 0.0 0.3 0.2 0.0 4.2 1.3 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 1.2 0.3 46.5 0.1 0.0 0.0 0.4 0.0 0.0 5.7 0.1 0.3 0.0 4.9 0.0 4.9 17.1 2.7 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.2 1.9 0.0 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 1.2 0.3 0.4 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 26.2 0.0 0.0 28.2 0.0 4.6 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.6 0.0 0.1 8.6 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.7 0.0 TMEM74 "FLJ30668, NET36" ENSG00000164841 "Transmembrane protein 74" Q96NL1 8 108606850-108787615 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 7.9;Spermatogonia: 5.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory B-cell: 1.4" "Lineage enriched" "Detected in single" 14 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "HEK 293: 5.2;NTERA-2: 6.5;SCLC-21H: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015672, HPA076461" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA015672: AB_1858132, HPA076461: " "unprognostic (8.99e-2)" "unprognostic (1.18e-1)" "unprognostic (4.25e-2)" "unprognostic (6.33e-2)" "unprognostic (2.05e-1)" "unprognostic (4.18e-1)" "unprognostic (1.95e-2)" "unprognostic (1.00e-1)" "unprognostic (2.54e-1)" "unprognostic (1.44e-2)" "unprognostic (2.01e-2)" "unprognostic (3.97e-2)" "unprognostic (3.75e-4)" "unprognostic (8.77e-2)" "unprognostic (6.36e-2)" "unprognostic (5.95e-2)" "unprognostic (1.46e-3)" 1.3 1.4 4.8 1.1 4.2 0.4 0.9 13.1 12.0 0.7 2.7 10.4 0.0 0.9 0.7 0.7 2.9 1.0 0.9 7.5 5.9 2.8 0.7 2.2 0.8 0.8 3.2 6.1 0.9 2.7 0.4 1.1 0.5 9.3 1.0 1.3 1.0 0.9 1.1 5.5 2.0 1.4 2.9 14.1 0.6 0.9 2.7 6.8 0.7 0.8 0.8 0.9 0.9 1.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.4 0.1 0.3 0.0 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.1 0.0 0.1 3.0 0.7 0.0 0.4 5.2 1.9 0.8 0.3 0.1 0.5 0.7 0.0 0.0 0.1 0.1 0.1 0.5 3.6 0.0 0.2 0.0 0.0 0.2 0.0 6.5 0.0 3.7 0.0 3.7 0.0 0.0 0.0 14.2 0.1 0.0 0.5 0.0 1.6 0.2 0.2 0.0 1.7 3.0 0.0 0.3 0.6 0.1 0.0 2.7 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.2 13.1 7.3 5.9 2.8 3.2 6.1 9.3 6.8 0.0 0.0 0.0 0.6 0.8 2.7 0.6 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.7 0.5 0.2 0.0 0.2 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 7.9 0.0 0.7 0.2 5.1 0.5 0.1 0.0 0.0 0.0 TMEM74B "C20orf46, FLJ11190" ENSG00000125895 "Transmembrane protein 74B" Q9NUR3 20 1180561-1185415 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;intestine: 16.0" "Cell type enhanced" "Detected in many" 10 "Bipolar cells: 10.3;Horizontal cells: 17.5;Intestinal endocrine cells: 15.0;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 7.9;Hep G2: 9.9;K-562: 16.8;Karpas-707: 7.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045213 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA045213: AB_10961999" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.05e-3)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (6.91e-3)" "unprognostic (1.97e-1)" "unprognostic (1.77e-4)" "unprognostic (9.58e-2)" "prognostic favorable (3.07e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.55e-7)" "unprognostic (1.20e-1)" "unprognostic (9.77e-2)" "unprognostic (8.37e-2)" "unprognostic (5.07e-3)" 2.3 0.3 4.3 0.3 13.9 0.0 1.1 2.3 7.3 0.1 0.7 12.5 0.6 0.3 0.7 3.9 2.5 3.9 2.3 6.9 0.6 1.0 9.4 0.9 2.3 0.0 0.6 0.2 3.5 12.2 0.5 0.9 3.3 11.3 2.9 4.6 16.0 1.1 1.1 0.6 2.7 0.9 1.6 0.4 0.7 0.0 1.6 0.1 0.0 0.1 0.0 0.5 0.3 0.0 5.0 2.8 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.7 0.1 1.0 0.0 2.9 0.3 3.7 0.5 0.1 0.0 4.7 1.1 0.0 9.9 0.0 0.0 1.4 0.0 1.1 0.0 0.2 0.2 0.1 0.7 16.8 7.6 0.0 0.1 0.1 0.1 3.4 1.2 0.4 0.0 0.2 0.0 0.8 0.7 0.7 2.1 0.1 0.0 0.1 1.2 0.0 0.1 2.0 0.0 3.3 0.1 0.2 3.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 0.0 0.0 0.4 0.2 10.3 1.6 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.5 0.8 3.6 2.0 0.0 0.2 1.0 0.2 0.7 0.0 0.6 0.0 17.5 15.0 3.1 0.8 0.4 0.0 0.0 1.7 1.8 2.7 0.2 1.4 1.7 0.0 0.3 2.7 19.4 5.7 0.2 0.2 0.6 1.1 0.0 0.8 0.4 TMEM78 FLJ40168 ENSG00000177800 "Transmembrane protein 78" Q5T7P6 1 229249636-229251810 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 5.3;bone marrow: 2.5" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA042351 Uncertain NA NA "HPA042351: AB_10961259" "unprognostic (2.45e-2)" "unprognostic (3.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.51e-1)" "unprognostic (3.33e-1)" "unprognostic (9.45e-2)" "unprognostic (5.59e-2)" "unprognostic (1.29e-1)" 0.1 0.4 0.5 0.2 0.5 2.5 0.4 0.7 0.7 0.1 0.1 0.1 0.5 0.6 0.1 0.3 0.2 0.1 0.4 0.3 0.1 0.6 0.0 0.7 0.3 0.2 0.7 0.5 0.2 0.0 0.4 0.3 0.7 0.0 1.8 1.2 0.2 0.0 0.3 0.6 0.1 0.7 0.3 0.2 0.1 0.1 1.3 2.6 5.3 0.5 1.3 0.9 0.1 0.4 1.3 0.8 2.1 0.2 0.0 0.6 0.4 0.0 0.1 0.1 0.2 1.9 0.5 0.5 0.4 0.2 1.0 0.0 0.0 0.3 0.6 0.6 0.8 1.8 0.3 0.0 0.6 0.5 0.2 0.0 0.1 0.0 0.5 0.1 0.5 0.3 0.7 0.0 0.3 0.6 1.5 0.6 0.4 0.6 0.4 0.4 0.2 0.3 1.1 0.4 0.5 0.5 0.2 0.0 1.1 0.5 0.1 0.0 0.6 0.5 0.5 0.3 0.9 0.6 0.8 0.5 0.6 0.8 5.3 0.5 0.7 0.7 0.3 0.5 0.8 0.6 0.5 0.1 1.3 0.9 0.8 2.6 1.3 0.5 2.6 0.4 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 TMEM79 "FLJ16057, FLJ32254, MATT, MGC13102" ENSG00000163472 "Transmembrane protein 79" Q9BSE2 1 156282935-156293185 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 47.5;skin 1: 35.7;tongue: 37.2" "Cell type enhanced" "Detected in many" 9 "Suprabasal keratinocytes: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 22.0;SK-BR-3: 18.1;T-47d: 19.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA055214 Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA055214: AB_2682741" "unprognostic (3.12e-1)" "unprognostic (2.96e-1)" "unprognostic (1.26e-1)" "unprognostic (8.17e-2)" "unprognostic (5.51e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (6.37e-2)" "unprognostic (2.44e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-3)" "prognostic unfavorable (4.31e-7)" "unprognostic (1.72e-1)" "unprognostic (1.96e-1)" "unprognostic (3.98e-2)" "unprognostic (2.37e-1)" 1.2 1.3 2.4 1.2 5.1 2.0 3.4 3.4 3.7 12.5 1.2 3.6 1.9 1.8 1.3 1.9 47.5 1.5 1.9 1.0 2.0 1.1 1.1 1.4 1.0 1.8 5.6 1.4 1.5 1.0 3.8 2.5 4.5 3.1 19.0 1.1 1.2 9.4 2.1 1.9 35.7 1.3 1.1 3.2 1.6 1.6 0.9 5.2 3.7 1.5 37.2 24.2 3.3 20.5 5.2 4.1 7.8 4.1 3.0 5.2 3.1 8.2 4.9 1.7 3.2 1.2 1.3 4.1 2.4 1.0 4.4 1.7 5.7 2.3 1.6 5.3 0.6 1.6 7.4 1.9 3.7 1.9 5.5 2.8 1.5 2.0 1.6 2.3 1.7 2.3 1.3 22.0 3.3 3.3 3.2 0.9 5.6 6.9 10.3 2.0 9.8 4.8 2.7 2.5 6.2 3.9 5.7 1.6 3.3 0.9 2.6 3.0 3.3 2.9 18.1 4.7 2.1 19.4 5.0 2.3 8.1 2.7 2.9 6.4 8.0 8.3 3.5 5.6 4.1 6.1 0.0 4.1 5.6 3.9 1.4 3.9 3.7 3.4 4.0 3.2 5.2 4.4 5.2 7.8 3.0 2.6 4.1 4.0 3.1 2.4 5.1 3.4 3.7 2.0 1.1 5.6 1.4 3.1 5.2 3.0 1.0 2.0 1.1 11.7 3.2 0.8 5.1 2.7 2.3 1.8 2.0 5.9 1.7 1.9 0.1 1.5 2.6 0.0 2.9 1.6 1.9 11.3 0.0 2.0 3.0 7.9 2.9 1.3 2.4 0.0 1.4 1.4 5.0 6.4 2.1 1.5 3.0 2.5 0.7 1.1 2.2 0.0 0.8 1.2 1.9 29.0 6.2 3.5 2.6 4.9 TMEM81 "HC3107, KVLA2788, MGC75217, UNQ2788" ENSG00000174529 "Transmembrane protein 81" Q6P7N7 1 205083129-205084460 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.2" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 3.5;Early spermatids: 7.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052515 Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA052515: AB_2681858" "unprognostic (9.19e-3)" "unprognostic (3.53e-1)" "unprognostic (1.91e-3)" "unprognostic (6.48e-2)" "unprognostic (2.44e-1)" "unprognostic (2.08e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (3.66e-2)" "unprognostic (2.68e-2)" "unprognostic (6.18e-2)" "unprognostic (5.86e-2)" "unprognostic (2.48e-2)" "prognostic unfavorable (6.65e-9)" "unprognostic (8.91e-2)" "unprognostic (6.24e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.67e-4)" 1.5 2.7 2.8 1.6 3.8 2.0 2.1 11.2 5.3 2.1 1.3 1.2 1.5 3.5 1.4 1.2 1.1 2.2 3.3 2.7 4.2 3.3 1.5 2.3 2.8 2.3 1.0 3.4 2.2 2.0 1.8 1.7 1.4 2.1 4.6 4.1 1.2 1.7 2.4 3.0 1.0 6.1 1.4 2.7 0.9 1.6 1.5 1.5 4.3 1.4 0.2 4.6 0.9 2.4 3.7 6.2 8.1 9.1 3.6 3.1 4.5 2.7 2.3 1.4 6.5 1.7 4.5 3.2 2.5 3.4 2.1 9.9 3.8 4.0 3.9 3.9 3.7 5.2 3.2 6.3 1.9 2.1 3.6 6.8 3.6 1.8 6.1 4.5 5.4 8.3 1.9 2.9 4.7 4.3 8.1 4.7 3.0 5.4 3.0 7.1 4.6 5.3 2.3 3.9 6.1 2.8 3.4 7.1 10.0 2.5 8.0 2.1 4.3 2.3 5.5 4.8 4.3 5.3 3.6 6.2 2.9 7.3 4.3 1.2 0.2 4.6 1.4 0.2 1.5 2.3 1.1 1.5 1.4 2.5 4.0 2.5 0.2 1.4 1.5 2.7 0.9 0.0 0.0 0.5 0.5 2.1 0.6 1.2 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.5 7.9 1.0 0.3 0.0 0.5 0.3 0.8 0.6 0.0 1.0 0.5 1.6 0.0 0.6 0.0 1.3 0.0 0.0 1.7 0.0 0.2 1.1 0.7 0.0 0.4 1.4 1.0 0.0 0.6 0.2 1.1 2.3 0.1 0.0 0.8 0.4 TMEM82 ENSG00000162460 "Transmembrane protein 82" A0PJX8 1 15742422-15747982 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 35.6;liver: 30.1" "Group enriched" "Detected in some" 9 "Enterocytes: 86.8;Hepatocytes: 38.2;Paneth cells: 57.5;Proximal tubular cells: 47.1" "Cancer enhanced" "Detected in some" "liver cancer: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "CACO-2: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060282 Uncertain Uncertain Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA060282: AB_2684241" "unprognostic (2.46e-2)" "unprognostic (7.96e-2)" "unprognostic (4.88e-2)" "unprognostic (1.40e-2)" "unprognostic (6.45e-2)" "unprognostic (6.90e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.80e-7)" "unprognostic (1.41e-1)" "unprognostic (5.80e-2)" "unprognostic (4.75e-2)" "unprognostic (1.09e-1)" 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 18.9 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 7.5 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.1 6.6 0.0 0.0 0.0 86.8 0.0 0.2 1.9 0.0 0.0 0.0 38.2 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.5 57.5 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 6.3 0.0 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 30.6;Hepatocytes: 28.9" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA057689 Uncertain Uncertain Midbody,Centrosome Yes No Centrosome Midbody "HPA057689: AB_2683504" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.5 0.7 1.3 1.8 6.3 2.2 4.8 1.2 1.1 1.3 1.7 0.9 1.0 0.6 0.9 11.2 8.8 2.5 5.9 1.2 4.0 3.7 0.8 1.7 2.1 1.3 1.8 0.5 9.2 6.0 3.5 0.8 2.4 6.4 10.0 0.9 1.9 2.4 6.0 2.8 12.6 1.1 5.1 2.1 3.9 1.8 0.8 4.9 1.3 2.2 8.4 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 6.0 2.4 0.8 0.4 3.0 7.6 0.5 30.6 0.0 1.2 0.0 2.0 0.4 0.0 0.9 2.0 1.7 5.2 0.0 0.2 0.3 1.1 1.1 0.0 28.9 0.9 9.5 10.3 0.0 6.2 3.6 0.9 1.7 3.3 1.8 1.9 1.1 0.8 0.0 0.4 0.8 3.6 0.0 0.5 1.6 1.1 1.9 0.2 4.6 1.9 1.7 TMEM88B ENSG00000205116 "Transmembrane protein 88B" A6NKF7 1 1426128-1427787 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 15 "brain: 36.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;Hep G2: 9.2;SCLC-21H: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065743 Enhanced NA NA "HPA065743: AB_2685552" "unprognostic (3.17e-2)" "unprognostic (1.42e-2)" "unprognostic (1.63e-4)" "unprognostic (1.11e-1)" "unprognostic (3.35e-2)" "unprognostic (2.67e-1)" "unprognostic (2.91e-2)" "unprognostic (5.30e-5)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (3.53e-2)" "unprognostic (7.19e-2)" "unprognostic (1.45e-1)" "unprognostic (7.95e-2)" 1.1 1.1 10.2 1.4 24.7 1.2 1.1 1.0 23.3 1.1 1.1 34.0 0.0 1.1 1.1 1.1 1.1 1.4 1.3 1.2 19.6 8.3 1.5 1.1 1.4 1.2 30.8 11.2 1.1 1.1 1.1 0.0 1.2 16.1 1.3 1.1 0.0 1.1 1.1 1.1 1.7 1.1 1.1 36.9 1.1 1.3 2.4 28.5 0.0 1.1 0.0 1.1 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 24.7 1.0 20.6 19.6 8.3 30.8 11.2 16.1 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM89 ENSG00000183396 "Transmembrane protein 89" A2RUT3 3 48620759-48621855 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 28.3" "Group enriched" "Detected in some" 79 "Early spermatids: 252.0;Late spermatids: 154.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.8;U-2197: 3.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053577 Uncertain NA NA "HPA053577: AB_2682196" "unprognostic (1.61e-1)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-3)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (2.02e-2)" "unprognostic (6.31e-3)" "unprognostic (5.90e-3)" "unprognostic (3.35e-2)" "unprognostic (3.83e-2)" "unprognostic (8.41e-2)" "unprognostic (2.71e-1)" "unprognostic (3.86e-2)" 0.1 0.0 0.1 0.1 0.1 2.8 0.1 0.1 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.5 0.1 0.1 0.1 0.7 28.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.7 0.4 1.1 0.3 1.1 0.7 0.0 0.2 0.0 1.1 1.8 0.2 0.4 0.0 0.0 0.3 0.0 0.5 0.8 0.6 0.5 0.0 1.5 0.0 1.4 1.9 0.6 0.2 0.0 0.8 0.0 0.0 0.0 0.8 0.0 2.8 0.6 0.4 0.0 0.7 0.5 0.0 0.7 1.2 0.1 0.9 0.0 0.7 0.4 0.5 0.8 0.0 0.0 1.4 1.5 3.1 1.6 0.5 0.8 0.5 1.8 0.7 2.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 154.1 2.6 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 74.7" "Cell type enhanced" "Detected in many" 15 "Pancreatic endocrine cells: 31.5;Urothelial cells: 92.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 21 "neutrophil: 5.5" "Lineage enriched" "Detected in single" 21 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 9.1;CACO-2: 15.5;CAPAN-2: 14.8;EFO-21: 30.9;OE19: 17.9;SuSa: 20.9" "Low region specificity" "Detected in all" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.1 0.3 1.9 0.3 0.4 0.3 0.3 0.3 3.3 27.9 0.3 0.1 23.3 1.2 0.3 1.0 0.7 11.7 0.1 0.8 0.3 0.4 10.2 6.1 0.1 0.3 0.2 2.4 1.2 0.0 0.1 0.3 0.9 1.2 1.8 1.1 4.3 1.2 0.1 0.2 74.7 0.4 0.4 0.3 17.9 0.5 0.3 0.1 0.1 0.4 1.6 2.2 3.7 0.1 0.2 5.5 0.1 0.0 0.0 0.0 0.9 9.1 0.2 0.0 0.0 0.4 2.0 0.2 0.3 0.0 0.0 15.5 14.8 0.0 30.9 0.6 3.5 0.0 0.2 1.7 0.0 2.4 0.1 0.0 0.9 1.5 0.1 0.1 0.1 0.1 1.7 0.1 0.5 1.4 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.2 3.4 17.9 4.0 0.2 0.0 3.8 3.3 0.0 0.0 0.0 0.0 0.1 0.0 20.9 1.9 0.5 0.0 0.1 2.1 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.3 0.8 0.3 0.3 0.2 0.9 0.3 3.0 17.1 0.0 6.4 0.5 0.0 0.1 22.9 2.7 1.2 7.0 0.0 0.0 0.0 6.2 0.0 0.0 8.0 0.0 17.8 1.2 1.0 16.8 0.0 11.3 0.4 0.0 5.2 1.8 0.3 0.0 0.0 0.0 0.0 1.8 20.4 0.0 31.5 16.4 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.9 0.0 0.0 14.9 92.2 TMEM95 "MGC129793, UNQ9390" ENSG00000182896 "Transmembrane protein 95" Q3KNT9 17 7355123-7357219 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 21 "testis: 19.3" "Group enriched" "Detected in some" 23 "Early spermatids: 20.4;Late spermatids: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.0;BJ: 1.0;hTERT-RPE1: 1.4" "Intracellular and membrane" NA NA "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.15e-1)" "unprognostic (5.15e-2)" "unprognostic (7.42e-2)" "unprognostic (7.44e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 TMEM97 MAC30 ENSG00000109084 "Transmembrane protein 97" Q5BJF2 17 28319095-28328685 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "pancreas: 228.7" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 94.3;Exocrine glandular cells: 170.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044795, HPA076689" Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA044795: AB_10959306, HPA076689: " "unprognostic (1.35e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (4.34e-2)" "unprognostic (3.20e-2)" "unprognostic (9.03e-2)" "unprognostic (1.04e-2)" "unprognostic (1.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.17e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.99e-1)" "unprognostic (4.01e-2)" 2.0 11.5 3.1 2.8 3.3 1.7 3.4 2.9 4.9 2.6 4.2 2.2 1.2 4.7 2.9 1.9 3.1 4.0 8.1 1.6 2.4 3.0 2.2 33.7 12.5 3.4 2.4 2.7 8.2 228.7 1.7 0.6 2.0 7.7 6.9 3.8 3.2 1.5 2.8 5.7 3.6 3.2 3.4 4.0 1.7 13.2 31.5 1.3 4.6 1.3 3.9 2.5 12.5 6.0 9.0 13.8 1.7 2.3 8.2 10.0 4.6 9.9 25.0 48.1 23.7 6.4 9.2 15.8 9.6 6.2 15.3 20.5 70.9 7.6 27.2 10.5 3.7 31.7 10.7 30.5 16.4 12.1 12.8 21.4 10.2 13.1 30.2 5.8 16.2 8.2 18.7 2.1 14.9 6.2 1.8 4.6 17.6 21.3 20.5 5.1 16.8 25.3 15.3 21.1 40.1 6.5 20.4 52.8 24.6 18.8 45.4 34.7 15.2 15.4 12.2 7.8 28.1 21.6 7.5 3.0 16.5 13.0 14.1 17.6 16.6 32.7 24.9 3.3 11.7 9.7 0.4 2.0 1.7 7.3 2.3 8.5 9.0 6.2 8.8 13.8 5.1 10.0 9.3 0.9 8.2 0.8 8.0 5.8 4.6 3.1 3.3 2.9 4.2 2.4 3.0 2.4 2.7 7.7 1.3 8.9 43.3 13.7 5.6 12.9 11.4 6.8 94.3 16.0 17.0 14.0 15.7 19.3 13.3 16.0 18.3 4.7 3.4 23.3 170.2 63.4 9.1 12.3 1.1 86.2 17.6 3.2 37.2 8.0 6.2 38.1 12.4 8.5 15.1 18.0 13.5 7.8 60.6 0.0 10.6 4.3 8.4 6.5 6.1 87.2 53.0 9.8 8.9 7.1 27.0 7.0 TMEM98 DKFZP564K1964 ENSG00000006042 "Transmembrane protein 98" Q9Y2Y6 17 32927910-32945106 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 96.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 7.9" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.9" "Cell line enhanced" "Detected in many" "CACO-2: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040473, HPA053385" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA040473: AB_10794876, HPA053385: AB_2682134" "unprognostic (1.55e-2)" "unprognostic (5.15e-2)" "unprognostic (4.36e-3)" "unprognostic (7.20e-2)" "unprognostic (1.19e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.14e-4)" "prognostic favorable (7.10e-4)" "unprognostic (6.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.41e-1)" "unprognostic (9.18e-3)" "prognostic favorable (3.85e-4)" "unprognostic (5.16e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-1)" 15.5 15.9 11.8 7.1 36.8 0.9 13.3 6.5 28.3 21.6 26.1 55.5 5.6 29.7 30.5 23.0 8.2 29.6 27.7 13.5 17.0 9.4 10.8 7.7 17.0 3.1 50.4 18.5 60.2 25.7 6.3 7.4 8.0 40.8 24.7 28.7 96.8 14.8 7.4 2.6 7.1 34.0 19.0 37.1 5.7 29.7 9.7 37.7 0.6 14.2 7.4 3.5 15.6 13.3 0.5 7.9 0.6 0.1 0.2 0.6 0.1 1.5 5.8 25.2 0.0 34.6 31.2 0.2 24.4 33.1 13.0 28.0 58.9 1.7 0.3 0.3 30.6 0.4 0.2 16.0 6.4 7.6 5.1 19.7 0.9 0.0 26.1 16.0 0.0 0.3 26.0 6.5 16.3 2.6 7.0 33.4 8.7 16.0 0.0 35.2 0.0 0.0 0.1 16.7 17.5 9.0 0.0 23.6 0.1 2.9 10.4 2.1 34.8 0.5 0.0 19.0 16.7 7.9 0.0 27.3 18.5 17.4 0.2 0.0 2.0 0.8 0.0 9.4 0.0 9.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.6 0.0 0.5 0.1 0.2 0.6 0.2 0.1 7.9 0.1 0.1 11.8 36.8 6.5 28.3 17.0 9.4 50.4 18.5 40.8 37.7 38.7 19.0 0.0 70.6 22.2 1.7 10.9 73.9 40.2 30.7 43.6 0.0 8.6 5.0 78.8 13.2 5.7 130.7 0.0 58.1 7.3 109.2 105.0 3.5 8.5 5.0 0.0 94.1 22.1 0.6 9.5 111.7 2.8 42.2 0.0 153.0 80.2 76.7 84.2 142.5 30.0 4.4 64.7 32.5 36.8 26.0 11.0 5.9 3.5 154.7 59.9 TMEM99 MGC21518 ENSG00000167920 "Transmembrane protein 99" Q8N816 17 40819106-40836274 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 63.4" "Cell type enhanced" "Detected in many" 11 "Spermatocytes: 234.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.14e-2)" "unprognostic (1.25e-1)" "unprognostic (1.58e-1)" "unprognostic (5.30e-3)" "unprognostic (8.83e-2)" "unprognostic (4.77e-3)" "unprognostic (1.14e-1)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.76e-1)" "unprognostic (9.44e-2)" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (4.73e-2)" "unprognostic (5.24e-2)" "unprognostic (8.68e-3)" "unprognostic (7.19e-2)" 4.5 6.1 4.5 2.6 4.5 0.4 11.8 4.1 4.3 7.1 3.7 4.6 15.8 3.5 4.9 21.5 7.0 8.8 8.3 6.8 3.7 3.4 8.5 11.3 7.1 3.1 4.2 3.3 7.5 22.8 7.8 9.1 4.9 5.5 8.2 3.8 4.8 29.1 9.9 5.2 27.6 4.1 3.8 3.0 4.8 6.1 63.4 3.8 4.9 13.3 6.0 4.0 5.5 8.3 9.5 5.9 7.8 2.4 10.8 14.1 4.0 10.4 13.5 6.8 7.9 16.1 20.4 6.6 9.8 5.4 12.4 14.8 10.2 6.8 4.4 14.9 11.3 15.7 20.4 9.9 15.3 18.0 3.7 21.5 6.6 9.8 22.4 14.8 10.0 9.2 10.3 27.5 19.4 19.6 8.7 4.2 13.3 24.0 6.5 16.4 3.9 8.2 5.7 11.1 11.1 7.7 10.4 13.5 8.4 13.6 6.8 15.1 0.6 4.9 25.1 17.9 16.9 19.2 10.6 2.6 10.6 7.5 17.6 11.4 0.1 3.3 8.0 11.8 5.6 6.1 7.8 1.6 4.6 10.1 2.2 12.8 7.8 8.5 12.7 4.0 9.5 14.1 11.7 0.1 10.8 2.4 5.9 5.2 4.0 4.5 4.5 4.1 4.3 3.7 3.4 4.2 3.3 5.5 3.8 6.0 1.6 11.1 23.3 13.1 5.7 7.9 40.8 10.7 12.5 14.0 0.0 35.5 41.4 21.3 65.9 8.0 8.5 0.0 13.6 35.7 12.5 14.4 5.7 46.6 8.5 4.8 2.9 8.6 8.6 42.9 28.7 5.9 10.1 2.8 10.8 14.6 9.4 8.6 28.0 28.3 7.3 25.8 6.4 234.1 41.7 20.3 21.7 8.7 14.6 28.2 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 11.7;brain: 11.4" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 3.5;Distal tubular cells: 1.7;Spermatogonia: 3.1" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.1" "Lineage enriched" "Detected in single" 17 "T-cells: 6.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;EFO-21: 3.8;JURKAT: 15.0;SH-SY5Y: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 1.2 11.7 6.7 0.7 2.9 0.0 0.5 2.7 7.0 0.8 0.9 2.3 0.4 0.6 0.8 1.2 2.2 1.0 0.4 1.0 5.9 11.4 1.4 0.9 1.8 1.2 5.8 4.8 2.8 0.4 0.0 8.1 0.7 3.8 0.9 0.6 1.1 0.8 1.8 5.8 1.3 0.6 0.7 5.2 1.2 0.3 1.6 1.0 0.4 0.8 1.7 1.3 0.8 0.4 0.0 0.3 0.0 0.1 0.0 6.1 1.2 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.3 0.0 3.8 0.0 0.7 0.2 0.2 0.3 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 2.6 0.0 1.7 0.0 0.7 15.0 0.0 0.4 0.0 0.2 0.1 0.0 0.3 1.0 0.2 1.6 0.0 0.3 0.1 0.1 0.4 3.3 0.4 0.5 0.0 0.2 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.0 1.8 1.0 0.3 0.0 6.1 0.9 0.0 0.0 0.0 0.0 1.0 1.2 6.7 2.9 2.7 7.0 5.9 11.4 5.8 4.8 3.8 1.0 0.0 0.0 0.0 0.1 0.7 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.2 0.2 0.0 0.0 0.4 0.1 0.5 0.2 0.0 0.0 0.5 0.0 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.0 1.3 0.7 0.0 0.4 0.0 0.4 0.0 1.4 1.4 3.1 0.6 0.1 0.0 0.0 0.1 TMIGD1 "TMIGD, UNQ9372" ENSG00000182271 "Transmembrane and immunoglobulin domain containing 1" Q6UXZ0 17 30316333-30334059 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 47.3" "Cell type enriched" "Detected in some" 14 "Enterocytes: 341.7" "Cancer enhanced" "Detected in single" "colorectal cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA021946 Approved Mitochondria NA NA Mitochondria "HPA021946: AB_1858140" "unprognostic (1.28e-1)" "unprognostic (1.30e-1)" "unprognostic (1.61e-1)" 0.2 0.0 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 26.8 0.2 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.0 1.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 33.9 0.2 0.2 0.2 0.2 0.0 47.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 341.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 24.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 TMIGD2 "CD28H, IGPR-1, MGC23244" ENSG00000167664 "Transmembrane and immunoglobulin domain containing 2" Q96BF3 19 4292232-4302431 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 34.0;lymphoid tissue: 43.8" "Cell type enriched" "Detected in some" 14 "T-cells: 26.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 34.0" "Group enriched" "Detected in many" 37 "dendritic cells: 30.8;NK-cells: 23.0;T-cells: 34.0" "Group enriched" "Detected in some" 4 "BEWO: 9.5;HEL: 21.9;MOLT-4: 19.6" "Low region specificity" "Detected in many" HPA011081 Approved NA NA "HPA011081: AB_1079372" "unprognostic (1.08e-3)" "unprognostic (6.55e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-4)" "unprognostic (4.31e-2)" "unprognostic (8.68e-3)" "unprognostic (7.78e-3)" "unprognostic (2.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.28e-1)" "unprognostic (2.12e-1)" "unprognostic (3.26e-1)" "unprognostic (7.10e-5)" "unprognostic (2.62e-2)" "unprognostic (4.54e-1)" "unprognostic (5.12e-4)" "unprognostic (8.89e-4)" 0.4 0.2 2.8 6.0 1.6 6.4 0.2 0.4 1.8 0.4 3.4 2.2 0.2 2.1 0.7 0.2 0.7 0.6 1.0 0.2 2.1 1.9 0.4 1.0 1.4 9.2 3.4 0.8 0.4 0.2 0.1 0.2 0.9 1.0 0.5 0.6 0.3 0.7 0.2 0.2 0.2 6.1 0.2 2.4 9.7 1.0 0.7 1.2 43.8 0.6 0.5 5.3 1.0 0.3 0.1 30.8 0.7 0.1 23.0 34.0 7.3 0.0 0.1 0.2 0.2 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 21.9 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 19.6 0.1 0.2 0.0 0.0 3.8 1.0 0.0 0.0 0.1 0.1 2.6 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.7 0.0 34.0 0.0 4.4 6.6 0.1 0.1 25.5 12.9 0.7 23.0 0.1 30.8 0.4 7.3 2.8 1.6 0.4 1.5 2.1 1.9 3.4 0.8 1.0 1.2 0.0 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.6 0.3 0.0 0.0 1.8 0.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 26.1 0.0 0.1 TMIGD3 AD026 ENSG00000121933 "Transmembrane and immunoglobulin domain containing 3" P0DMS9 1 111483348-111563962 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 28.2;brain: 16.4;testis: 50.4" "Group enriched" "Detected in many" 7 "Early spermatids: 216.3;Hofbauer cells: 179.2;Kupffer cells: 81.5;Late spermatids: 88.3" "Cancer enriched" "Detected in all" 5 "glioma: 16.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 39 "eosinophil: 28.2" "Lineage enriched" "Detected in single" 39 "granulocytes: 28.2" "Cell line enhanced" "Detected in some" "HDLM-2: 11.5;HMC-1: 3.1;Karpas-707: 2.2;NB-4: 6.3" NA NA "prognostic unfavorable (3.58e-4)" "unprognostic (7.64e-3)" "unprognostic (7.47e-3)" "unprognostic (2.11e-2)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (9.48e-2)" "unprognostic (5.70e-2)" "unprognostic (1.01e-1)" "unprognostic (2.07e-3)" "unprognostic (4.46e-2)" "unprognostic (9.50e-2)" "unprognostic (4.48e-2)" "unprognostic (5.69e-3)" "unprognostic (3.30e-1)" "unprognostic (1.44e-5)" "unprognostic (9.22e-2)" 5.4 4.1 8.4 1.9 14.4 2.4 1.4 1.2 8.1 1.5 1.5 12.6 0.0 0.9 1.3 0.6 1.4 1.4 1.4 1.4 7.3 1.5 1.3 3.0 2.8 2.9 15.0 3.3 1.3 1.3 0.8 1.3 5.1 8.4 1.4 1.2 0.9 1.3 2.0 1.3 1.3 2.1 1.3 16.4 2.0 1.4 50.4 13.5 0.0 1.4 0.0 1.0 1.4 1.3 0.0 0.3 28.2 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 28.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.2 0.0 0.2 8.4 14.4 1.2 8.1 7.3 1.5 15.0 3.3 8.4 13.5 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 216.3 0.5 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.2 179.2 0.0 0.0 6.2 81.5 88.3 3.4 3.6 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.3 0.3 12.9 0.0 19.1 1.5 0.0 2.4 2.5 0.0 0.0 TMOD1 "D9S57E, ETMOD, TMOD" ENSG00000136842 "Tropomodulin 1" P28289 9 97501180-97601748 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 71.7;skeletal muscle: 112.7" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 51.5;Erythroid cells: 140.2;Horizontal cells: 96.9" "Cancer enhanced" "Detected in many" "glioma: 21.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.4;HDLM-2: 48.0;K-562: 16.3;SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA051202 Enhanced NA NA 900000 "HPA051202: AB_2681387" "unprognostic (8.54e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-3)" "unprognostic (1.95e-1)" "unprognostic (1.08e-1)" "unprognostic (2.62e-3)" "unprognostic (2.82e-1)" "unprognostic (3.09e-1)" "unprognostic (2.09e-1)" "unprognostic (2.91e-1)" "unprognostic (1.40e-2)" "unprognostic (3.48e-1)" "unprognostic (1.72e-2)" "unprognostic (1.04e-2)" "unprognostic (1.42e-1)" "unprognostic (2.02e-1)" "unprognostic (4.88e-5)" 7.9 35.6 10.9 3.4 11.9 11.1 5.9 18.1 17.2 17.3 9.8 6.0 8.9 3.3 27.6 7.1 10.8 16.0 5.3 71.7 7.1 6.1 3.6 21.9 5.2 2.3 4.6 9.3 24.8 7.6 9.5 13.6 2.4 12.8 10.7 4.5 10.4 3.3 6.1 112.7 2.9 3.8 22.6 15.9 1.9 6.0 3.2 5.3 0.0 8.7 36.9 2.3 15.4 19.7 4.6 1.2 2.0 0.9 1.7 5.2 3.1 1.7 0.4 0.0 0.2 2.0 0.2 0.6 0.3 2.9 0.0 0.0 0.4 0.5 0.0 12.4 0.0 2.8 0.1 0.5 0.0 0.0 48.0 1.8 2.3 3.0 0.2 0.0 0.0 4.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 16.3 0.0 0.0 0.7 0.0 0.3 0.6 0.5 0.2 0.0 1.7 0.0 0.0 0.3 0.2 51.4 1.5 0.0 0.8 0.7 0.6 2.5 0.2 0.0 1.9 1.4 0.3 6.2 1.3 0.0 2.3 1.6 2.7 2.0 0.7 1.2 3.3 0.7 3.1 3.1 2.6 1.9 1.2 4.6 1.8 2.1 0.2 1.7 0.9 0.4 5.2 3.1 10.9 11.9 18.1 17.2 7.1 6.1 4.6 9.3 12.8 5.3 6.0 6.2 2.7 0.9 2.1 1.2 51.5 2.5 0.0 0.0 0.0 5.9 0.1 0.0 0.2 0.6 9.8 0.0 140.2 5.8 0.4 2.7 1.7 10.4 16.4 0.8 96.9 2.9 11.1 11.6 0.6 9.5 3.1 16.9 0.0 0.2 0.5 7.5 0.0 6.3 0.0 1.3 19.4 14.6 2.4 6.0 0.9 0.1 4.5 0.0 0.9 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751561-51816368 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 68.6" "Cell type enhanced" "Detected in many" 11 "Horizontal cells: 82.6" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 12.8" "Group enriched" "Detected in all" 4 "granulocytes: 12.8;monocytes: 8.8" "Cell line enhanced" "Detected in many" "SCLC-21H: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favorable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 5.9 6.3 25.4 6.1 29.6 1.6 5.1 22.0 68.6 7.0 6.1 9.1 4.6 3.1 6.0 4.4 4.9 6.0 5.2 4.9 21.6 18.1 3.5 2.2 4.5 4.9 16.9 22.6 6.5 3.1 6.7 4.4 3.0 29.5 3.7 5.1 2.9 3.8 9.6 2.7 4.6 4.7 6.7 11.4 4.5 3.7 3.1 9.6 1.2 4.3 0.2 4.7 4.7 4.6 2.5 1.6 12.8 8.8 1.3 2.2 1.1 0.8 0.5 1.7 4.0 8.2 8.9 0.3 4.5 1.5 3.5 3.7 0.0 0.4 3.6 0.1 3.5 3.6 2.4 7.2 4.0 1.1 0.0 3.5 0.0 0.7 0.0 1.4 1.4 0.2 5.1 5.5 0.5 1.0 4.6 0.7 9.6 0.0 0.1 4.3 0.6 2.9 0.5 1.1 0.0 0.8 2.3 1.0 0.1 0.5 1.2 26.5 6.5 4.2 0.0 1.2 2.3 1.0 0.2 1.6 9.4 0.7 5.9 3.2 0.0 0.0 0.0 2.9 9.8 4.3 0.1 5.9 7.8 2.2 2.3 1.0 2.5 1.3 1.0 1.6 1.8 1.7 0.7 12.8 1.3 8.8 1.2 0.4 1.1 25.4 29.6 22.0 38.3 21.6 18.1 16.9 22.6 29.5 9.6 0.0 5.5 3.0 2.9 4.2 24.2 5.4 0.0 4.0 2.3 10.4 21.6 0.1 6.6 3.4 20.6 11.4 0.3 0.0 1.5 0.0 2.8 1.7 0.0 0.2 4.2 82.6 22.4 13.5 7.8 15.1 10.3 5.7 1.7 27.9 0.3 11.6 2.1 0.0 5.3 1.0 19.7 6.5 4.2 6.3 4.7 6.6 0.2 4.4 0.4 1.8 TMOD4 Sk-Tmod ENSG00000163157 "Tropomodulin 4" Q9NZQ9 1 151169986-151176284 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 153.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 1.5;memory B-cell: 1.7;memory CD4 T-cell: 1.5;naive B-cell: 1.0;naive CD4 T-cell: 1.6;naive CD8 T-cell: 3.5;plasmacytoid DC: 1.0" "Group enriched" "Detected in many" 5 "B-cells: 1.7;dendritic cells: 1.0;T-cells: 3.5" "Cell line enhanced" "Detected in many" "HEK 293: 6.5;NB-4: 8.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA028203 Enhanced NA NA "HPA028203: AB_10600830" 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 4.0 1.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 1.6 0.1 153.5 0.2 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.3 35.0 1.6 0.4 0.1 1.7 1.0 0.4 0.3 0.0 3.5 0.6 0.5 0.4 0.9 0.1 0.7 0.2 1.6 0.1 0.6 0.4 0.1 0.0 0.6 1.4 0.7 1.7 0.5 0.5 1.4 0.3 0.5 2.7 6.5 2.6 2.2 0.0 1.1 1.5 3.2 0.0 0.4 1.3 3.0 1.6 0.8 3.4 1.6 2.3 0.2 2.3 0.7 8.1 1.4 0.1 2.7 2.5 0.3 0.1 0.5 1.6 1.8 1.1 0.7 0.0 0.1 0.7 0.8 5.0 1.0 0.2 1.1 2.3 0.7 3.0 5.6 1.2 0.8 4.5 0.6 0.0 0.3 0.4 1.5 0.0 0.4 1.7 1.5 0.2 0.1 1.0 1.6 3.5 0.2 0.0 0.3 1.0 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TMPO "LAP2, LEMD4, TP" ENSG00000120802 Thymopoietin "P42166, P42167" 12 98515512-98550379 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" DNA-binding Cardiomyopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 130.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008150, CAB009847, HPA070805" Enhanced Enhanced "Nuclear membrane" NA Yes "Nuclear membrane" "CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: " "unprognostic (2.36e-1)" "unprognostic (4.46e-3)" "unprognostic (5.90e-2)" "unprognostic (2.80e-2)" "unprognostic (1.35e-1)" "unprognostic (2.95e-2)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (1.74e-2)" "unprognostic (3.69e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-3)" "prognostic unfavorable (9.34e-4)" "unprognostic (6.01e-3)" "unprognostic (2.85e-1)" "unprognostic (5.26e-2)" "unprognostic (3.26e-2)" 10.8 9.5 8.1 25.0 9.5 36.8 12.7 19.1 11.0 16.9 22.9 10.7 8.7 15.9 18.4 17.1 23.0 15.4 10.3 9.6 8.5 8.3 15.8 20.5 13.8 34.0 9.0 11.2 34.7 21.6 9.9 9.9 13.6 7.6 15.6 17.6 12.5 14.0 9.7 9.4 11.7 22.6 10.7 9.4 29.1 16.8 11.4 10.3 130.9 13.2 12.2 35.4 13.0 17.9 14.1 10.9 18.1 33.1 9.7 15.6 13.3 30.8 20.4 50.3 25.5 4.2 5.6 29.8 25.4 13.5 34.5 25.1 22.2 15.5 53.9 15.6 14.7 12.6 19.8 42.1 19.1 31.7 37.7 26.1 46.1 18.6 14.6 3.8 53.2 30.8 3.1 6.3 20.3 10.9 12.0 19.6 33.6 38.9 20.9 21.4 19.4 86.8 42.0 30.2 28.6 19.1 72.9 33.3 37.3 12.2 28.8 39.8 23.8 43.5 27.3 13.7 20.6 30.8 25.6 10.5 20.0 17.5 13.6 25.9 22.8 38.8 60.3 5.7 30.9 26.5 18.1 14.4 6.1 9.5 25.0 10.2 10.9 11.1 10.8 10.9 14.1 15.6 11.7 1.1 9.7 33.1 6.1 13.3 13.3 8.1 9.5 19.1 11.0 8.5 8.3 9.0 11.2 7.6 10.3 29.8 18.0 45.4 21.4 24.6 20.8 7.1 25.5 36.1 48.9 29.6 11.8 16.5 26.6 16.3 26.8 36.0 27.6 70.0 27.6 75.5 19.0 17.7 27.8 45.0 32.2 9.5 27.5 32.5 64.7 21.9 26.4 40.1 16.9 34.3 51.4 24.2 21.6 31.5 38.2 27.8 47.9 19.4 15.6 38.6 53.5 20.5 9.8 33.1 42.9 16.3 TMPRSS11A ECRG1 ENSG00000187054 "Transmembrane serine protease 11A" Q6ZMR5 4 67909385-67964140 "Enzymes, Predicted membrane proteins" "Cell cycle" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6" "Group enriched" "Detected in some" 6 "Early spermatids: 4.6;Urothelial cells: 6.2" "Group enriched" "Detected in some" 9 "cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.1;OE19: 2.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA078316 Enhanced NA NA "HPA078316: " "unprognostic (1.63e-1)" "unprognostic (4.60e-2)" "unprognostic (1.76e-2)" "unprognostic (6.98e-2)" "unprognostic (1.98e-1)" "unprognostic (2.66e-1)" "unprognostic (4.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.36e-2)" "unprognostic (1.05e-1)" "unprognostic (3.50e-1)" "unprognostic (2.33e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 47.6 18.7 0.3 8.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 TMPRSS11B ENSG00000185873 "Transmembrane serine protease 11B" Q86T26 4 68226653-68245720 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0" "Group enriched" "Detected in some" 35 "Early spermatids: 8.5;Late spermatids: 11.5" "Group enriched" "Detected in some" 12 "cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.24e-2)" "prognostic favorable (6.91e-4)" "unprognostic (2.92e-1)" "unprognostic (3.96e-1)" 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 11.2 0.1 0.0 0.0 0.1 0.5 0.1 138.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 13.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.1 44.0 57.0 0.1 23.2 0.7 0.6 2.4 0.5 0.4 0.7 0.0 0.3 1.4 0.8 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.3 0.9 0.4 1.4 0.2 0.4 0.4 1.1 0.2 0.1 0.0 0.1 1.6 0.8 1.9 2.1 0.1 1.1 1.4 0.5 0.2 0.0 0.1 0.2 0.0 0.5 0.7 2.0 0.1 0.7 0.5 1.3 0.1 0.3 1.0 0.6 0.6 0.5 0.2 1.5 0.9 0.3 0.1 0.2 0.1 0.6 0.4 0.2 1.3 1.0 0.3 0.5 0.1 0.3 0.9 0.8 0.3 1.0 0.1 0.3 0.4 0.2 0.4 0.1 0.3 0.3 0.3 0.4 0.0 0.7 0.3 0.7 2.4 0.4 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 TMPRSS11D ENSG00000153802 "Transmembrane serine protease 11D" O60235 4 67820876-67884032 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1" "Cell type enriched" "Detected in single" 32 "Urothelial cells: 8.6" "Group enriched" "Detected in many" 5 "cervical cancer: 36.0;head and neck cancer: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA077704 Enhanced "Intracellular and membrane" NA NA "HPA077704: " "unprognostic (1.19e-1)" "unprognostic (6.83e-2)" "unprognostic (8.82e-2)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (1.12e-1)" "unprognostic (3.22e-1)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (4.79e-1)" "unprognostic (4.38e-3)" "unprognostic (1.96e-1)" "unprognostic (6.91e-2)" "unprognostic (4.48e-2)" "unprognostic (2.19e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.6 0.0 41.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 67.6 20.3 0.4 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447449-68497604 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6" "Group enriched" "Detected in some" 6 "Basal glandular cells: 12.6;Urothelial cells: 38.8" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.8" "Lineage enhanced" "Detected in single" "B-cells: 1.8" "Group enriched" "Detected in some" 6 "HaCaT: 5.0;HBEC3-KT: 1.9;OE19: 5.2;SuSa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA051062 Enhanced "Intracellular and membrane" NA NA "HPA051062: AB_2681329" "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 28.9 0.0 0.0 1.2 0.0 1.1 10.5 103.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.6 0.5 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 40.5 39.1 2.6 36.6 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 38.8 TMPRSS11F FLJ16046 ENSG00000198092 "Transmembrane serine protease 11F" Q6ZWK6 4 68053198-68129880 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1" "Cell type enhanced" "Detected in single" 19 "Cytotrophoblasts: 1.1" "Group enriched" "Detected in some" 7 "cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 2.5;K-562: 5.5;Karpas-707: 1.6;U-266/70: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA026911 Uncertain NA NA "HPA026911: AB_2205589" "unprognostic (9.46e-2)" "unprognostic (5.30e-1)" "unprognostic (7.16e-2)" "unprognostic (8.79e-3)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (1.22e-1)" "unprognostic (5.08e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.2 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.1 0.0 0.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 13.1 11.4 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.2 0.0 0.0 0.3 TMPRSS12 "CT151, MGC57341" ENSG00000186452 "Transmembrane serine protease 12" Q86WS5 12 50842920-50887884 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 52.7" "Group enriched" "Detected in some" 9 "Early spermatids: 21.7;Spermatocytes: 50.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.9;Karpas-707: 1.1;NTERA-2: 1.4;SK-BR-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.04e-1)" "unprognostic (9.09e-2)" "unprognostic (3.03e-2)" "unprognostic (7.25e-3)" "unprognostic (1.70e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-1)" "unprognostic (2.98e-2)" "unprognostic (2.60e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (5.65e-3)" "unprognostic (1.03e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 52.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.6 0.1 0.4 0.3 0.0 0.0 0.8 0.0 0.5 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 1.1 0.0 0.0 0.3 0.4 1.4 0.0 0.5 0.2 0.0 0.2 0.0 0.3 0.3 0.1 0.6 1.1 0.0 0.2 0.1 0.2 0.3 0.3 0.1 0.0 0.0 0.5 0.1 0.1 0.3 0.2 0.2 1.3 0.1 0.5 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.4 0.3 0.3 1.6 0.4 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.7 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 3.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 50.5 1.5 0.3 0.6 0.0 0.0 0.1 TMPRSS13 "MSPL, TMPRSS11" ENSG00000137747 "Transmembrane serine protease 13" Q9BYE2 11 117900643-117929459 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.1;salivary gland: 16.6;skin 1: 26.0" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 7.6;Cytotrophoblasts: 12.9;Extravillous trophoblasts: 12.2;Syncytiotrophoblasts: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.5;BEWO: 17.9;MCF7: 15.1;SK-BR-3: 25.9;T-47d: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.08e-3)" "unprognostic (5.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.06e-3)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (5.61e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-1)" "unprognostic (3.16e-6)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.08e-1)" "unprognostic (3.44e-1)" 0.2 0.3 0.2 0.6 0.2 0.3 6.2 0.2 0.2 5.8 0.2 0.2 0.2 0.2 0.9 0.7 14.8 0.1 0.2 0.2 0.4 0.0 0.7 0.2 4.0 0.7 0.2 0.2 0.3 5.7 0.0 0.5 22.1 0.2 0.9 0.2 0.6 16.6 0.2 0.2 26.0 0.5 0.2 0.2 1.0 0.1 0.3 0.2 0.4 9.5 13.7 10.6 0.3 5.6 1.0 2.6 1.0 0.7 1.9 1.2 0.8 7.5 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 5.7 0.1 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 2.1 0.2 0.0 0.0 25.9 0.3 0.9 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.6 0.0 0.9 0.7 0.0 1.0 0.1 1.2 1.8 0.5 0.4 0.1 0.0 1.9 0.5 2.6 0.7 0.8 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.0 2.9 0.0 3.7 1.4 0.0 1.4 7.6 0.0 2.3 0.0 0.0 12.9 0.0 6.2 0.3 0.0 0.4 0.0 1.0 12.2 0.5 5.3 0.0 0.0 2.5 0.0 0.0 0.0 1.2 0.6 0.0 0.7 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.9 16.2 0.0 0.4 6.9 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Cell type enriched" "Detected in single" 11 "Early spermatids: 4.2" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 20 "U-138 MG: 20.3;U-87 MG: 56.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214" "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.0 0.3 0.0 0.1 56.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464551-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.6;pancreas: 64.5;prostate: 68.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9" "Not detected" "Not detected" "HPA034493, HPA035787" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favorable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.2 0.1 0.2 15.5 0.4 0.0 6.1 0.2 0.5 1.3 38.7 0.4 24.4 17.5 0.5 0.9 10.7 2.2 17.3 0.2 0.3 0.1 19.4 18.4 20.7 0.2 0.2 0.2 0.7 64.5 0.0 1.3 1.0 0.4 68.2 18.5 0.3 52.3 35.7 0.2 2.1 75.6 0.9 0.2 0.3 36.7 0.8 0.3 0.5 19.9 3.9 10.2 5.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.5 1.2 20.6 0.0 0.0 0.0 1.3 0.5 33.9 0.0 0.4 0.0 6.9 0.1 0.2 5.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.5 0.3 0.1 0.2 0.2 0.4 0.3 47.6 88.6 0.0 31.0 0.2 0.0 0.6 25.5 14.7 38.7 45.4 0.0 0.5 19.9 30.0 19.4 0.0 190.3 0.0 52.6 0.1 0.6 290.4 6.9 28.7 0.1 0.0 17.3 0.0 0.8 3.5 0.0 1.5 10.1 1.0 79.6 0.0 53.4 127.7 0.0 3.7 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 73.2 115.9 TMPRSS3 "DFNB10, DFNB8" ENSG00000160183 "Transmembrane serine protease 3" P57727 21 42371837-42396846 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.7" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 11.9;Cholangiocytes: 28.1;Ciliated cells: 17.4;Ductal cells: 14.4;Exocrine glandular cells: 12.6;Muller glia cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "MAIT T-cell: 6.3" "Lineage enriched" "Detected in single" 7 "T-cells: 6.3" "Group enriched" "Detected in some" 5 "HEL: 18.8;U-266/84: 75.2" "Region enriched" "Detected in single" 7 "cerebellum: 0.9" "Not detected" "Not detected" NA NA "unprognostic (8.47e-3)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.64e-4)" "unprognostic (2.85e-1)" "unprognostic (2.45e-3)" "unprognostic (3.97e-2)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (9.62e-2)" "unprognostic (4.81e-2)" "unprognostic (2.65e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.66e-2)" "unprognostic (2.73e-1)" "unprognostic (8.00e-2)" "unprognostic (1.33e-1)" 1.8 0.7 8.6 0.3 7.7 0.3 9.4 0.3 7.1 6.8 0.4 0.0 0.0 1.7 0.9 0.4 0.4 24.7 8.6 0.2 1.8 1.6 3.5 3.5 3.7 0.6 3.7 2.0 2.8 7.4 0.2 5.8 5.7 3.3 0.8 0.4 2.4 12.3 0.6 0.3 0.6 1.3 0.2 0.2 0.6 15.9 0.2 0.8 0.0 9.8 0.2 0.6 1.9 0.0 0.0 0.1 0.7 0.8 0.0 6.3 1.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 18.8 7.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.1 0.0 0.4 1.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.4 0.0 0.0 9.8 0.4 0.0 0.0 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.2 75.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 6.3 0.0 3.5 3.6 0.1 0.0 0.7 1.8 0.7 0.0 0.8 0.0 1.6 1.0 8.6 7.7 0.3 7.1 1.8 1.6 3.7 2.0 3.3 0.8 11.9 3.0 0.0 1.9 0.2 0.1 0.6 28.1 17.4 3.4 7.0 0.0 0.0 5.0 14.4 1.3 0.0 1.3 0.0 12.6 0.1 0.1 1.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.3 0.1 0.0 0.0 0.7 23.8 7.9 0.6 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.0 1.3 0.4 3.9 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 37.9 0.0 1.4 0.0 0.0 16.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 64.5 0.0 0.0 0.0 0.0 26.6 33.2 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 1.7 0.0 21.5 1.0 0.0 0.6 0.0 17.4 36.4 10.4 0.0 0.1 0.0 0.1 2.6 0.0 108.9 0.0 6.6 1.6 0.2 6.8 5.7 0.0 0.2 0.0 4.1 0.0 0.0 1.3 0.0 1.0 0.0 0.0 49.1 0.0 30.7 61.7 0.0 1.4 0.0 0.0 0.7 0.0 0.1 5.5 0.2 0.0 54.6 226.3 TMPRSS5 "MGC141886, MGC148044" ENSG00000166682 "Transmembrane serine protease 5" Q9H3S3 11 113687546-113706373 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 24.0;salivary gland: 15.0;skeletal muscle: 6.0" "Cell type enhanced" "Detected in some" 14 "Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8;Muller glia cells: 3.4" "Cancer enhanced" "Detected in some" "glioma: 5.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.3;CAPAN-2: 7.1;WM-115: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010992 Approved Nucleoplasm NA NA Nucleoplasm "HPA010992: AB_1858152" "unprognostic (1.53e-2)" "unprognostic (3.81e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (2.99e-3)" "unprognostic (3.08e-1)" "unprognostic (5.19e-3)" "unprognostic (8.49e-2)" "unprognostic (8.13e-2)" "unprognostic (3.38e-2)" "unprognostic (1.96e-3)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.80e-1)" "unprognostic (4.04e-3)" 2.1 1.7 10.8 1.0 24.0 3.2 2.2 2.1 14.8 1.2 1.0 21.6 0.0 1.0 1.2 0.9 1.8 1.1 2.2 1.2 11.5 5.7 0.9 0.9 0.9 1.1 11.6 12.7 1.4 1.2 0.6 1.5 1.2 16.5 1.2 1.3 0.9 15.0 1.4 6.0 2.7 0.7 1.2 16.9 1.1 2.4 2.3 8.8 0.0 1.1 0.4 1.3 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.8 4.3 2.5 0.5 0.4 0.6 1.2 0.5 0.6 0.9 2.5 7.1 0.3 3.2 0.5 0.8 0.8 0.3 0.4 0.3 0.4 1.3 1.0 0.6 0.0 0.3 1.0 0.8 0.6 0.6 0.5 1.2 0.5 0.8 1.7 0.8 0.5 0.9 0.0 0.8 1.2 0.5 4.3 0.2 0.9 0.5 0.0 0.7 0.4 0.6 1.0 0.5 0.1 3.5 0.6 0.5 0.5 0.5 0.9 1.7 0.6 0.7 0.5 0.2 0.1 0.4 0.9 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 24.0 2.1 12.3 11.5 5.7 11.6 12.7 16.5 8.8 0.0 0.0 0.0 0.2 0.2 0.5 0.4 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.4 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.1 TMPRSS6 FLJ30744 ENSG00000187045 "Transmembrane serine protease 6" Q8IU80 22 37065436-37109563 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "liver: 59.3" "Group enriched" "Detected in some" 14 "Early spermatids: 60.9;Hepatocytes: 67.0;Late spermatids: 87.3" "Group enriched" "Detected in many" 14 "liver cancer: 51.3;thyroid cancer: 14.1" "Region enriched" "Detected in single" 10 "basal ganglia: 1.8" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Hep G2: 7.7;SCLC-21H: 13.2" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 2.2" NA NA "unprognostic (3.93e-1)" "unprognostic (3.28e-1)" "unprognostic (8.62e-2)" "unprognostic (6.29e-5)" "unprognostic (7.95e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.16e-6)" "unprognostic (2.44e-1)" "unprognostic (3.07e-1)" "unprognostic (2.41e-1)" "unprognostic (1.16e-2)" "unprognostic (3.58e-2)" "unprognostic (1.15e-7)" "unprognostic (2.38e-1)" "unprognostic (9.15e-2)" "unprognostic (2.39e-2)" "unprognostic (3.86e-5)" 0.1 0.0 0.1 0.1 1.8 0.0 0.8 0.1 0.1 0.1 0.3 0.1 0.1 1.1 0.1 0.4 0.1 0.2 0.4 0.1 0.1 0.0 0.1 59.3 1.9 0.1 0.1 0.1 0.5 0.9 0.0 5.3 0.6 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.6 0.1 0.1 0.1 2.3 2.6 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.1 0.0 1.3 0.0 0.2 0.8 0.2 0.4 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.9 2.3 0.3 0.1 7.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.1 0.6 0.0 1.3 0.0 0.0 0.3 0.2 0.1 0.5 0.2 0.3 0.0 0.0 13.2 0.4 0.2 1.0 0.0 0.2 0.1 0.0 0.6 0.5 1.6 0.1 0.0 1.6 0.4 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.5 0.2 1.3 0.1 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 60.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 67.0 0.1 0.0 5.1 2.5 2.9 87.3 0.3 0.0 0.0 0.0 1.0 0.0 0.3 1.5 0.4 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.2 0.0 0.6 0.0 TMPRSS7 ENSG00000176040 "Transmembrane serine protease 7" Q7RTY8 3 112034843-112081269 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.2;testis: 5.2" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.4;Ciliated cells: 10.7;Early spermatids: 3.3;Urothelial cells: 2.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 1.4;hTCEpi: 2.8;RT4: 1.3;U-266/70: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040630 Uncertain NA NA "HPA040630: AB_10796124" "unprognostic (4.02e-2)" "unprognostic (9.87e-2)" "unprognostic (9.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.24e-1)" "unprognostic (4.64e-3)" "unprognostic (6.63e-2)" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.94e-1)" "unprognostic (7.23e-2)" "unprognostic (2.96e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.2 0.1 0.1 0.0 0.5 0.8 0.0 0.0 0.0 1.0 5.2 0.3 0.0 0.2 0.0 0.8 0.5 2.2 0.3 0.5 0.7 0.1 0.3 0.0 0.7 0.2 0.4 0.1 0.9 0.6 0.7 0.2 0.5 0.6 0.2 0.0 0.0 0.0 0.8 1.4 0.0 0.9 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.1 0.9 0.4 0.0 0.8 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.7 0.2 0.2 0.1 0.6 0.3 0.2 0.0 0.8 0.7 0.2 1.7 0.5 0.2 0.5 0.2 0.1 0.0 0.0 0.0 3.4 0.5 0.0 0.3 0.0 10.7 2.3 0.0 0.0 0.3 0.0 0.2 3.3 0.0 1.4 0.0 0.2 0.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.7 0.0 0.1 2.6 TMPRSS9 ENSG00000178297 "Transmembrane serine protease 9" Q7Z410 19 2389771-2426239 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 6.3;lymphoid tissue: 4.6;testis: 5.9" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 19.9;Erythroid cells: 23.3;Late spermatids: 37.0;Spermatocytes: 8.6" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "eosinophil: 2.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.4" "Cell line enhanced" "Detected in some" "Karpas-707: 6.3;SK-BR-3: 3.2;U-266/70: 5.5" "Region enhanced" "Detected in single" "basal ganglia: 0.5" "Low region specificity" "Detected in all" HPA051483 Uncertain NA NA "HPA051483: AB_2681501" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (5.62e-3)" "unprognostic (1.86e-1)" "unprognostic (1.54e-2)" "unprognostic (1.87e-3)" "unprognostic (3.30e-1)" "unprognostic (6.44e-2)" "unprognostic (7.29e-2)" "unprognostic (2.07e-1)" "unprognostic (6.30e-2)" "unprognostic (9.20e-3)" "unprognostic (2.28e-3)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (3.07e-3)" "unprognostic (6.73e-2)" 0.1 1.1 0.9 0.4 0.2 2.0 1.3 0.0 0.2 0.0 0.4 0.3 0.4 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 6.3 0.0 0.1 0.0 0.2 1.2 0.0 0.2 0.1 0.1 0.0 0.5 0.0 1.5 1.8 0.4 0.0 0.0 4.6 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.9 2.4 0.0 0.0 0.0 0.1 1.7 0.3 0.2 0.6 0.0 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.6 0.4 0.6 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.8 0.2 2.2 2.3 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.6 1.0 6.3 0.0 1.2 0.2 0.4 0.5 0.1 0.8 1.1 0.0 0.9 0.0 0.3 0.1 0.2 0.2 3.2 0.1 0.3 0.4 1.6 0.4 1.1 0.8 1.1 0.7 5.5 1.3 1.5 0.2 0.9 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 23.3 0.0 0.1 0.3 0.0 0.0 2.4 0.2 0.0 0.0 1.3 0.0 37.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 2.7 0.0 0.5 0.0 0.0 0.0 TMSB10 TB10 ENSG00000034510 "Thymosin beta 10" P63313 2 84905625-84906675 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 764.0" "Cell type enhanced" "Detected in all" 7 "monocytes: 22456.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 4500000 "unprognostic (3.60e-1)" "unprognostic (4.52e-2)" "unprognostic (7.03e-2)" "unprognostic (6.19e-3)" "unprognostic (2.61e-2)" "unprognostic (4.73e-2)" "unprognostic (1.17e-3)" "unprognostic (3.26e-3)" "unprognostic (2.99e-2)" "unprognostic (2.76e-3)" "unprognostic (2.20e-3)" "unprognostic (7.24e-2)" "prognostic unfavorable (8.49e-7)" "unprognostic (1.28e-1)" "unprognostic (2.83e-1)" "prognostic favorable (4.97e-5)" "unprognostic (3.16e-2)" 159.1 50.6 179.7 148.7 112.1 122.4 142.6 20.5 128.4 129.3 199.6 30.9 44.9 71.1 86.5 244.1 128.4 62.6 120.8 78.5 110.3 87.6 115.8 49.1 166.0 197.1 78.4 135.1 203.5 76.5 8.8 45.6 129.1 66.1 67.0 183.0 53.2 97.0 44.0 68.3 68.2 131.5 114.6 68.3 170.4 79.5 104.5 51.1 154.3 69.9 101.7 163.8 111.4 116.9 320.3 387.6 206.4 346.8 142.7 452.9 764.0 110.6 128.5 119.5 66.7 156.9 324.0 62.6 167.3 232.6 185.8 223.8 101.9 171.8 56.3 122.7 336.8 116.0 42.7 33.6 385.6 200.0 192.2 32.0 25.6 88.1 84.1 98.5 24.1 24.1 282.7 191.8 227.6 122.7 207.6 281.3 30.0 9.4 97.0 306.4 85.8 84.9 100.8 42.3 295.4 132.6 64.7 184.6 46.0 276.9 20.9 63.7 58.3 112.4 98.0 138.9 114.6 29.5 42.9 273.7 150.9 108.0 137.6 169.6 19.4 31.1 50.8 253.0 103.5 118.8 169.1 346.8 206.4 191.8 299.9 118.1 294.6 291.0 201.6 387.6 320.3 304.3 256.5 50.2 142.7 252.7 231.6 452.9 764.0 179.7 112.1 20.5 128.4 110.3 87.6 78.4 135.1 66.1 51.1 1104.7 1440.1 3326.7 1298.5 1912.3 26.9 128.3 1342.7 701.3 970.2 1825.0 13.7 3340.7 858.8 6555.7 98.1 5207.7 2942.0 163.5 6380.5 9465.5 2896.2 1721.1 1333.8 234.9 5994.4 17.5 2211.5 3334.3 8121.6 239.0 1410.6 7405.3 3146.4 22456.7 5604.9 37.5 12141.3 11564.7 1117.0 1458.8 64.1 996.0 1340.3 33.0 237.0 1712.2 1304.5 3269.1 6723.4 2357.4 TMSB15A "TMSL8, TMSNB" ENSG00000158164 "Thymosin beta 15a" P0CG34 X 102513676-102516784 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 16.1;prostate: 17.3" "Cell type enhanced" "Detected in some" 17 "Glandular cells: 17.5;Sertoli cells: 6.5;Spermatogonia: 22.8" "Cancer enhanced" "Detected in many" "prostate cancer: 56.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 11 "NK-cell: 2.5;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 11 "dendritic cells: 1.1;NK-cells: 2.5" "Cell line enhanced" "Detected in many" "AF22: 101.2;NTERA-2: 26.1;RH-30: 46.0;SH-SY5Y: 26.3" NA NA "unprognostic (5.33e-3)" "unprognostic (3.09e-2)" "unprognostic (1.70e-2)" "unprognostic (5.82e-3)" "unprognostic (1.34e-1)" "unprognostic (4.03e-2)" "unprognostic (5.65e-2)" "unprognostic (1.34e-1)" "unprognostic (6.88e-2)" "unprognostic (1.59e-2)" "unprognostic (1.45e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-3)" "unprognostic (2.96e-4)" "unprognostic (2.14e-1)" "unprognostic (7.83e-2)" "unprognostic (2.07e-1)" 1.6 1.0 1.9 1.0 2.2 0.7 5.1 3.4 2.6 4.9 0.8 0.7 2.7 0.3 5.4 1.3 0.9 1.4 1.5 2.2 1.9 1.4 2.7 0.2 16.1 3.8 1.6 0.7 6.1 0.8 0.0 1.0 1.8 1.9 17.3 1.0 0.7 4.0 1.6 1.2 0.5 0.7 2.3 1.7 0.6 0.5 4.7 1.8 7.8 6.1 0.9 2.6 0.9 6.0 0.1 1.1 0.0 0.0 2.5 0.1 1.1 0.0 0.0 101.2 18.9 0.4 0.0 0.0 2.1 0.1 0.3 0.8 0.0 0.1 0.0 0.2 0.3 5.0 0.0 19.0 0.1 0.2 0.0 0.9 1.7 0.3 0.0 0.0 0.0 1.8 0.2 0.0 0.2 0.0 2.5 1.1 0.9 0.1 0.0 7.0 0.0 18.9 0.0 26.1 0.0 0.2 0.0 46.0 0.0 2.0 0.0 17.3 26.3 2.4 0.1 0.0 4.0 0.2 0.5 0.4 0.0 11.4 0.2 1.7 2.1 0.3 0.0 1.2 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 1.1 0.0 1.1 1.9 2.2 3.4 2.2 1.9 1.4 1.6 0.7 1.9 1.8 0.0 0.0 0.0 0.6 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.2 0.0 0.0 0.0 0.8 1.3 17.5 0.0 0.0 0.4 0.0 0.0 1.8 0.3 0.0 0.3 0.0 1.7 0.0 0.5 0.4 0.0 0.0 2.5 0.2 0.0 6.5 4.1 1.1 22.8 0.0 0.2 0.5 0.6 1.0 TMSB15B ENSG00000269226 "Thymosin beta 15B" X 104063871-104076212 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 4.2;ovary: 6.7" "Cell type enhanced" "Detected in some" 11 "Basal keratinocytes: 11.7;Melanocytes: 13.5;Suprabasal keratinocytes: 5.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 11.4;AN3-CA: 10.7;Karpas-707: 11.7" NA NA "unprognostic (5.95e-2)" "unprognostic (1.22e-1)" "unprognostic (6.14e-2)" "unprognostic (1.17e-3)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (1.04e-1)" "unprognostic (3.12e-1)" "unprognostic (6.46e-2)" "unprognostic (9.11e-3)" "unprognostic (2.61e-2)" "unprognostic (4.07e-4)" "unprognostic (1.93e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-1)" "unprognostic (9.07e-2)" 0.5 0.0 1.0 0.4 0.7 1.9 1.3 0.0 0.0 4.2 0.8 0.4 0.9 1.1 0.0 0.0 0.0 0.2 1.1 6.7 0.0 0.5 0.0 1.6 0.4 0.0 1.0 0.0 0.4 0.2 1.8 0.5 0.6 0.0 0.0 1.1 0.5 2.3 1.4 2.4 0.6 3.6 2.4 0.6 0.0 0.4 11.4 10.7 2.0 3.0 0.3 3.3 1.6 1.7 2.4 0.5 0.2 2.4 1.2 0.8 2.1 0.1 0.1 0.0 2.3 1.2 2.2 0.6 0.2 0.0 1.1 0.3 1.0 2.0 0.6 2.0 0.6 6.5 3.3 2.8 0.2 11.7 2.9 0.6 7.1 0.1 3.1 0.0 1.8 6.5 2.8 1.5 2.6 1.4 1.9 8.0 0.2 0.0 0.4 3.4 0.1 1.1 6.6 3.8 1.9 1.8 2.8 0.8 0.1 2.2 1.5 0.5 1.6 2.4 0.6 0.5 1.0 0.4 0.5 2.3 1.0 0.8 0.4 1.9 2.4 2.1 1.5 3.6 0.4 1.4 0.3 0.6 0.0 0.0 0.5 0.9 11.7 0.4 0.2 0.0 0.0 4.5 1.8 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 1.0 0.0 2.0 0.5 1.1 0.0 0.2 1.6 2.9 0.6 0.0 0.0 2.6 0.0 13.5 1.0 0.0 1.4 0.6 0.0 3.2 0.0 0.4 0.0 1.4 0.2 0.4 5.4 0.1 1.3 0.1 0.1 TMSB4X "TB4X, TMSB4" ENSG00000205542 "Thymosin beta 4, X-linked" P62328 X 12975108-12977227 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 1074.5" "Cell type enhanced" "Detected in all" 9 "Hofbauer cells: 27421.6;monocytes: 60748.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" CAB033806 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 400000000 "Nucleoplasm, Vesicles, Cytosol" "CAB033806: AB_2256019" "unprognostic (1.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.72e-2)" "unprognostic (3.27e-2)" "unprognostic (7.98e-3)" "unprognostic (1.71e-2)" "unprognostic (2.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (6.20e-4)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (3.77e-2)" "unprognostic (1.98e-1)" 122.3 97.5 79.8 105.4 76.4 169.0 87.1 33.2 74.8 92.3 93.3 62.0 59.7 38.5 83.7 67.2 62.7 53.0 92.5 54.9 90.8 67.8 69.6 50.8 134.4 205.2 111.4 84.0 61.9 51.0 4.4 23.4 53.4 74.3 46.6 86.6 31.2 42.3 100.4 28.9 39.6 71.5 75.1 195.6 205.7 98.9 26.4 63.8 96.8 34.4 48.6 154.5 112.2 62.1 296.5 495.3 775.0 554.0 272.7 521.9 1074.5 144.7 121.2 238.2 375.3 292.0 320.2 0.5 76.7 200.8 59.6 102.7 24.9 121.8 34.7 74.2 232.8 107.2 63.8 35.2 51.4 80.2 202.6 2.0 43.2 71.9 0.3 68.1 168.5 358.6 149.0 73.7 70.5 61.7 146.2 358.0 92.6 5.4 0.5 210.8 51.5 200.3 365.8 85.6 69.8 83.6 154.4 84.3 141.5 354.7 42.4 25.3 10.8 111.2 5.2 14.1 184.0 139.7 171.2 287.9 87.0 43.2 493.2 76.2 113.1 82.0 67.2 133.1 69.9 62.7 544.9 512.5 775.0 364.8 524.7 309.6 296.5 407.3 391.0 495.3 275.6 345.8 349.0 576.0 272.7 554.0 204.1 521.9 1074.5 79.8 76.4 33.2 74.8 90.8 67.8 111.4 84.0 74.3 63.8 4880.5 5161.6 6027.5 2141.8 7849.2 355.4 69.7 3189.8 1104.2 2643.4 6528.7 21.6 260.6 1848.6 14106.6 104.1 8207.2 4374.5 256.9 19960.8 448.9 5187.8 2457.6 4102.8 814.3 27421.6 58.8 1698.6 5862.6 15729.2 176.0 3640.8 24463.6 6022.8 60748.0 4889.5 45.5 20394.3 5909.2 5673.8 362.6 82.8 5639.7 7491.8 44.2 114.3 8329.0 380.3 13550.6 2818.5 7177.4 TMSB4Y TB4Y ENSG00000154620 "Thymosin beta 4, Y-linked" O14604 Y 13703567-13706024 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 13.2;HEL: 10.7;RPTEC TERT1: 16.7;RT4: 6.2;SCLC-21H: 4.9;U-698: 6.2" NA NA "unprognostic (7.27e-2)" "unprognostic (1.31e-1)" "unprognostic (5.79e-2)" "unprognostic (1.39e-5)" "unprognostic (1.46e-2)" "unprognostic (2.84e-1)" "unprognostic (3.39e-2)" "unprognostic (1.89e-1)" "unprognostic (3.30e-2)" "unprognostic (8.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.64e-3)" "unprognostic (1.84e-1)" "unprognostic (1.27e-1)" "unprognostic (1.09e-1)" 1.2 1.2 4.3 1.9 6.8 3.7 1.1 2.2 9.8 0.1 4.6 12.3 3.0 1.6 0.1 5.5 3.5 0.1 1.6 3.7 4.6 4.7 2.5 1.9 4.3 1.0 4.2 0.0 0.1 2.2 0.1 2.0 0.8 8.3 6.7 10.5 2.0 2.2 6.5 0.4 1.4 4.7 4.9 4.9 2.2 2.1 6.1 0.0 4.7 2.2 0.0 2.9 2.7 0.0 2.4 6.0 1.8 2.9 1.8 3.4 2.5 0.0 0.8 0.0 0.0 0.0 0.0 13.2 0.5 0.9 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 3.1 0.1 1.4 0.0 0.0 0.0 0.0 1.9 16.7 6.2 4.9 0.0 0.0 0.0 0.8 1.3 0.0 0.7 0.3 0.6 0.0 0.1 0.1 1.5 2.8 6.2 0.0 0.0 0.0 0.1 2.9 1.1 3.1 2.6 1.8 2.4 3.4 0.7 6.0 1.9 2.3 1.1 1.8 1.8 1.0 1.8 1.1 2.5 4.3 6.8 2.2 9.8 4.6 4.7 4.2 0.0 8.3 0.0 0.0 1.6 1.7 3.7 2.3 3.7 0.8 0.0 1.4 1.2 1.8 3.9 5.0 3.3 0.7 0.3 1.6 0.7 0.0 0.0 1.2 2.3 3.4 2.3 0.0 2.4 3.2 0.0 1.3 6.6 1.1 1.4 5.1 0.0 1.8 0.0 3.7 0.3 0.0 1.8 4.8 0.0 0.0 1.9 0.5 3.0 2.5 0.9 3.8 0.0 6.8 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane and tetratricopeptide repeat containing 4" Q5T4D3 13 100603927-100675093 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.7" "Cell type enhanced" "Detected in many" 6 "Ito cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016489, HPA057056" Approved Approved Vesicles NA NA Vesicles "HPA016489: AB_1858157, HPA057056: " "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 4.1 4.4 11.4 4.4 13.7 1.9 5.7 10.6 21.8 6.6 7.0 45.7 8.3 8.5 8.7 7.5 4.8 13.2 4.9 3.2 16.9 8.7 11.5 9.8 3.5 3.6 16.9 10.0 5.3 12.8 7.5 3.3 4.0 29.6 7.9 7.6 4.6 6.9 5.6 9.4 6.5 7.3 6.0 25.2 3.9 7.9 9.7 11.3 4.2 7.2 3.9 4.6 7.7 4.3 2.4 6.4 0.2 3.3 1.3 4.4 1.4 5.0 4.3 22.2 11.7 2.9 6.0 24.9 2.9 2.5 2.7 2.2 4.3 9.3 15.0 9.6 2.4 5.2 3.6 6.9 3.0 3.3 8.5 4.9 6.3 8.0 6.7 3.1 8.2 0.1 8.4 5.9 1.0 5.0 7.6 12.1 8.2 4.7 1.9 3.2 4.4 5.9 4.7 6.0 14.8 4.2 6.5 3.9 3.3 11.2 3.9 11.4 11.9 5.5 10.8 2.8 14.0 7.9 23.2 18.9 2.4 4.2 2.2 4.9 5.0 4.1 2.9 11.9 5.4 7.1 0.0 2.0 0.2 2.7 2.1 2.4 2.0 2.6 4.4 6.4 2.4 3.0 1.1 0.0 1.3 3.3 4.2 3.8 1.4 11.4 13.7 10.6 21.8 16.9 8.7 16.9 10.0 29.6 11.3 6.0 3.8 4.6 6.6 2.7 17.6 9.0 17.8 6.7 6.8 5.2 7.9 9.1 1.7 9.8 4.1 4.6 7.9 0.0 16.4 15.9 5.7 9.1 0.0 12.4 3.8 25.4 10.3 52.2 8.7 4.7 3.7 4.1 3.3 0.0 11.2 9.6 12.0 7.0 6.3 12.4 7.5 6.5 4.2 8.8 31.8 5.1 2.6 2.6 12.6 4.7 TNC "DFNA56, HXB, MGC167029, TN" ENSG00000041982 "Tenascin C" P24821 9 115019578-115118257 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 111.4" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 47.4;Basal glandular cells: 45.4;Smooth muscle cells: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 85.5;hTEC/SVTERT24-B: 69.9;U-138 MG: 58.8;U-251 MG: 51.6;U-87 MG: 78.4;WM-115: 134.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004592, HPA004823" Approved "Secreted to extracellular matrix" NA NA 560000000 760000000 "CAB004592: AB_628342, HPA004823: AB_1080243" "unprognostic (5.46e-2)" "unprognostic (3.76e-2)" "unprognostic (7.57e-2)" "unprognostic (1.69e-1)" "unprognostic (9.20e-2)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (7.86e-3)" "unprognostic (2.68e-3)" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (4.87e-3)" "unprognostic (1.79e-2)" "unprognostic (1.92e-2)" "unprognostic (7.60e-2)" "unprognostic (1.97e-3)" 20.6 2.5 1.4 50.9 11.4 0.5 12.6 0.4 6.4 19.4 63.6 18.6 24.1 5.3 42.4 23.9 18.5 12.0 16.9 13.6 3.4 2.8 16.4 2.6 21.0 66.3 4.3 3.3 10.6 1.8 0.6 3.3 3.2 14.7 13.0 9.3 0.0 8.5 10.8 10.8 10.3 21.2 111.4 5.7 26.9 31.3 5.4 6.8 4.7 5.5 15.4 16.1 20.4 6.6 0.3 0.3 1.9 0.3 0.2 0.3 0.1 2.5 0.6 0.7 0.1 4.2 1.1 0.0 22.0 85.5 46.6 23.0 0.5 6.0 0.0 3.4 31.0 0.7 9.2 0.0 1.3 28.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.4 0.6 0.1 69.9 32.5 4.8 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 7.2 0.1 9.4 0.0 49.4 0.0 42.4 0.0 0.0 0.6 9.2 0.0 2.2 16.9 0.0 0.1 0.0 58.8 9.7 10.1 51.6 1.6 0.0 0.0 78.4 0.0 134.1 0.1 0.3 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.1 0.2 1.9 0.2 0.0 0.2 0.0 0.1 1.4 11.4 0.4 3.9 3.4 2.8 4.3 3.3 14.7 6.8 11.9 47.4 0.0 45.4 10.8 0.0 1.1 0.0 1.4 14.8 1.8 0.0 0.7 0.0 19.5 15.8 5.4 0.0 0.0 4.1 0.2 24.2 6.4 2.3 0.0 1.0 0.0 0.0 3.7 0.6 12.7 3.1 2.6 5.0 0.0 0.0 0.5 3.4 0.0 0.4 0.1 0.2 0.0 91.7 0.4 0.2 4.0 0.8 0.7 0.0 5.1 TNF "DIF, TNF-alpha, TNFA, TNFSF2" ENSG00000232810 "Tumor necrosis factor" P01375 6 31575567-31578336 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.6;lymphoid tissue: 28.0" "Cell type enhanced" "Detected in many" 10 "Hofbauer cells: 32.8;Macrophages: 42.1;T-cells: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "non-classical monocyte: 10.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6" "Group enriched" "Detected in some" 5 "HDLM-2: 10.2;HMC-1: 9.8;NB-4: 29.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB078469 Supported "Secreted to blood" NA NA 10100 "CAB078469: AB_908070" "unprognostic (1.93e-1)" "unprognostic (1.07e-2)" "unprognostic (3.85e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-2)" "unprognostic (1.67e-1)" "unprognostic (3.46e-1)" "unprognostic (1.19e-2)" "unprognostic (1.94e-1)" "unprognostic (3.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-2)" "unprognostic (1.82e-1)" "unprognostic (9.85e-3)" "unprognostic (1.09e-1)" "unprognostic (2.04e-1)" 2.3 1.2 0.6 15.6 1.0 14.6 1.2 0.4 1.8 1.7 1.3 3.7 0.3 1.3 1.1 0.4 1.5 0.9 2.3 2.0 0.5 0.3 2.6 1.9 9.5 8.0 0.8 0.0 0.6 0.7 0.5 0.5 3.2 2.0 0.7 0.7 0.4 2.2 0.8 0.4 2.7 4.1 0.7 1.0 28.0 1.0 0.4 0.5 2.1 0.6 5.3 14.7 1.2 0.4 1.3 1.2 3.5 10.8 0.5 6.6 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 10.2 0.0 1.9 0.0 0.0 0.0 0.8 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.6 0.0 0.0 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 4.1 6.5 6.6 1.3 3.1 2.4 1.2 1.3 0.9 1.0 3.5 0.5 10.8 0.7 2.2 2.1 0.6 1.0 0.4 1.8 0.5 0.3 0.8 0.0 2.0 0.5 0.0 4.0 13.4 0.2 7.4 0.1 2.0 5.1 1.4 2.3 0.0 2.0 0.3 0.0 6.7 0.1 2.8 0.0 0.0 2.9 1.5 2.1 0.9 11.6 0.0 32.8 0.0 0.0 1.3 8.7 0.0 0.3 42.1 5.0 1.0 0.1 0.1 10.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 3.6 0.9 34.1 0.0 0.3 TNFAIP3 "A20, OTUD7C" ENSG00000118503 "TNF alpha induced protein 3" P21580 6 137867188-137883312 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Inflammatory response, Ubl conjugation pathway" "DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 112.4" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 688.4;Suprabasal keratinocytes: 651.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 31.8;Karpas-707: 48.1;REH: 41.8;U-266/84: 35.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002116 Approved Approved Centrosome,Cytosol NA NA "Centrosome, Cytosol" "HPA002116: AB_1858162" "unprognostic (5.50e-3)" "unprognostic (9.98e-3)" "unprognostic (3.06e-2)" "unprognostic (1.01e-2)" "unprognostic (4.01e-2)" "unprognostic (9.47e-2)" "unprognostic (5.01e-3)" "unprognostic (4.40e-2)" "unprognostic (2.92e-2)" "unprognostic (2.58e-1)" "unprognostic (1.72e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (6.06e-2)" "unprognostic (3.55e-3)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" 27.4 6.0 1.5 58.6 1.8 112.4 17.2 0.4 1.5 7.7 15.7 3.2 2.6 5.1 9.7 7.3 12.7 12.1 17.0 11.7 2.1 1.3 6.8 8.1 45.1 38.8 2.1 2.6 37.5 7.2 2.1 3.7 14.5 4.6 13.8 6.3 7.2 8.2 3.5 10.7 20.5 17.2 8.2 3.8 25.9 8.0 9.3 2.1 38.6 5.7 9.2 31.4 23.3 9.5 7.1 18.6 10.0 9.7 7.5 20.5 9.0 8.9 1.4 0.5 0.8 3.0 5.1 2.1 5.1 19.9 1.4 1.8 9.9 2.9 2.0 13.1 5.8 31.8 6.8 0.3 14.7 2.6 14.5 0.5 2.0 5.1 5.8 3.3 2.7 3.6 4.6 2.1 16.8 16.0 1.7 0.8 5.3 4.0 48.1 2.4 0.5 14.7 11.5 0.3 0.6 0.4 41.8 10.4 1.4 4.3 4.3 0.2 0.0 1.0 1.5 4.3 2.1 1.0 3.3 4.0 14.4 1.7 12.9 2.9 15.5 35.9 4.1 5.2 3.4 1.7 5.6 9.7 5.5 14.8 7.1 20.5 6.2 15.1 13.3 10.3 7.1 10.0 7.4 10.0 7.5 3.7 18.6 14.7 9.0 1.5 1.8 0.4 1.5 2.1 1.3 2.1 2.6 4.6 2.1 35.7 83.1 25.1 141.6 688.4 1.0 4.2 30.6 41.5 26.1 0.0 27.5 5.5 1.7 50.3 2.3 27.0 39.0 0.0 23.4 88.6 55.5 117.9 248.4 10.2 45.4 0.0 11.3 45.4 74.2 2.4 6.4 241.1 123.2 82.0 12.5 1.7 27.9 8.2 5.6 2.2 13.3 6.5 87.3 0.9 2.3 651.8 19.3 101.2 8.5 60.3 TNFAIP6 "TSG-6, TSG6" ENSG00000123610 "TNF alpha induced protein 6" P98066 2 151357592-151380048 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.9" "Cell type enriched" "Detected in many" 5 "Early spermatids: 341.4" "Cancer enhanced" "Detected in many" "renal cancer: 27.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 22 "neutrophil: 50.9" "Lineage enriched" "Detected in many" 22 "granulocytes: 50.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 31.1;HHSteC: 19.3;HSkMC: 9.3;hTEC/SVTERT24-B: 25.7;SH-SY5Y: 10.2;U-2197: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB032719, HPA050884" Approved "Secreted to blood" NA NA 15000 "CAB032719: AB_2204650, HPA050884: AB_2681261" "unprognostic (1.31e-1)" "prognostic unfavorable (8.18e-5)" "unprognostic (8.66e-2)" "unprognostic (2.51e-2)" "unprognostic (1.15e-3)" "unprognostic (3.26e-3)" "unprognostic (3.75e-4)" "unprognostic (4.49e-3)" "unprognostic (1.22e-1)" "unprognostic (1.90e-1)" "unprognostic (5.87e-3)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.59e-4)" "unprognostic (1.06e-2)" "unprognostic (1.25e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (9.16e-5)" 14.0 0.6 4.8 23.7 5.6 5.8 10.3 0.3 3.8 9.4 6.8 0.4 0.2 0.7 2.0 4.0 8.2 2.4 17.9 17.3 6.3 1.9 0.8 1.1 17.3 2.2 9.9 1.2 1.4 1.1 0.7 0.6 1.8 5.6 4.3 2.6 2.2 2.8 1.0 4.7 3.2 2.5 7.8 4.3 3.9 3.8 9.7 5.8 0.7 1.9 6.6 0.5 13.5 2.8 0.0 0.0 50.9 2.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.8 7.4 0.0 1.1 31.1 1.2 5.8 0.0 0.0 0.0 0.4 0.5 0.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 19.3 0.0 0.0 9.3 0.0 25.7 1.8 1.1 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.5 0.0 0.0 0.0 0.0 10.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 1.0 2.1 20.6 0.3 0.0 0.0 0.0 2.3 0.3 1.5 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.9 0.0 0.5 0.0 0.0 0.6 4.8 5.6 0.3 3.8 6.3 1.9 9.9 1.2 5.6 5.8 3.0 1.7 0.5 0.5 57.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 341.4 1.0 0.0 0.0 0.0 0.7 52.2 1.5 2.3 0.0 1.4 0.0 0.0 2.5 5.0 13.5 2.3 37.7 70.9 7.2 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 34.0 1.4 2.0 46.3 1.5 0.0 0.0 4.6 TNFAIP8 "GG2-1, MDC-3.13, SCC-S2" ENSG00000145779 "TNF alpha induced protein 8" O95379 5 119268692-119399688 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 73.4;lymphoid tissue: 83.1" "Cell type enhanced" "Detected in many" 6 "granulocytes: 208.8;monocytes: 266.9;Syncytiotrophoblasts: 244.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 44.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054434, HPA057089" Uncertain Enhanced Nucleoplasm No Yes 270000 Nucleoplasm "HPA054434: AB_2682487, HPA057089: AB_2683331" "prognostic favorable (2.45e-4)" "unprognostic (6.06e-2)" "unprognostic (9.81e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.86e-3)" "unprognostic (4.92e-1)" "unprognostic (1.55e-1)" "unprognostic (4.45e-2)" "unprognostic (5.81e-3)" "unprognostic (4.47e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.88e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-2)" 21.1 2.1 1.6 49.9 3.0 17.8 18.9 1.5 1.7 11.3 8.0 1.6 4.7 4.3 9.7 9.2 15.0 4.6 9.7 8.5 1.8 1.7 8.7 8.4 22.0 71.3 2.9 1.8 4.2 12.5 5.2 1.7 36.1 12.2 11.8 5.5 4.2 13.7 5.8 2.2 14.4 21.4 6.9 3.6 37.5 13.1 4.7 2.2 83.1 9.3 8.6 41.1 12.7 12.8 50.3 25.2 73.4 19.7 19.7 54.4 36.5 7.5 5.3 2.8 4.6 6.1 5.1 26.0 4.2 11.4 3.2 6.6 2.9 8.8 14.2 1.3 4.7 5.1 10.8 2.3 12.8 4.5 15.5 4.9 22.5 11.9 4.9 2.9 27.1 25.0 5.7 12.1 9.6 4.6 6.2 4.3 28.3 8.7 44.5 4.4 2.9 23.0 35.4 4.3 4.4 2.5 7.0 12.6 20.6 12.8 15.2 1.5 2.2 15.8 3.1 1.5 9.7 2.7 31.0 2.1 5.8 2.2 4.0 4.9 21.9 24.0 28.6 6.7 29.0 3.4 73.4 18.6 55.3 22.6 19.7 43.9 50.3 45.5 33.2 25.2 44.2 54.4 34.9 10.6 19.7 14.8 12.1 34.8 36.5 1.6 3.0 1.5 1.7 1.8 1.7 2.9 1.8 12.2 2.2 8.9 16.0 115.2 57.1 142.5 0.1 8.9 15.3 48.2 25.0 17.4 0.0 133.6 14.9 46.4 1.9 18.9 1.3 0.0 87.0 135.2 42.9 45.5 208.8 0.5 45.7 0.0 1.2 6.2 52.3 1.1 2.0 76.8 35.4 266.9 7.6 3.9 105.8 2.9 1.8 11.0 0.5 45.3 34.0 0.4 14.9 104.3 244.7 119.6 3.8 58.5 TNFAIP8L2 FLJ23467 ENSG00000163154 "TNF alpha induced protein 8 like 2" Q6P589 1 151156629-151159749 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 63.1;lymphoid tissue: 38.7" "Cell type enhanced" "Detected in some" 14 "Hofbauer cells: 59.6;Kupffer cells: 56.1;Macrophages: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 12.8;HL-60: 7.5;HMC-1: 19.9;NB-4: 10.8;THP-1: 41.5;U-937: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062742 Approved Vesicles NA NA Vesicles "HPA062742: " "unprognostic (3.19e-3)" "unprognostic (1.02e-2)" "unprognostic (6.63e-3)" "unprognostic (2.27e-2)" "unprognostic (1.29e-1)" "unprognostic (6.49e-3)" "unprognostic (1.05e-1)" "unprognostic (9.15e-3)" "prognostic favorable (3.64e-4)" "unprognostic (9.54e-2)" "unprognostic (3.32e-2)" "unprognostic (9.03e-2)" "prognostic unfavorable (3.53e-7)" "unprognostic (1.78e-1)" "unprognostic (3.91e-2)" "unprognostic (4.87e-2)" "unprognostic (2.23e-1)" 8.5 4.2 5.7 13.8 8.8 4.1 2.7 1.3 4.5 2.0 3.2 4.0 0.0 3.9 2.0 2.6 2.1 3.0 4.1 2.8 4.1 3.3 2.9 6.0 8.2 20.9 8.2 2.2 1.8 2.0 0.3 1.9 7.0 7.2 2.6 4.6 1.8 6.4 1.4 1.0 2.7 6.9 3.9 8.0 38.7 2.5 1.0 6.9 21.0 1.8 1.2 12.8 7.2 1.9 17.7 56.4 63.1 50.6 47.1 43.9 44.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 0.1 0.0 0.0 7.5 19.9 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.0 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 41.5 1.1 0.1 0.0 0.0 0.1 0.1 0.0 0.8 0.0 16.3 0.0 53.4 50.6 50.0 23.3 45.4 22.9 15.6 28.8 23.5 56.4 17.7 43.9 31.5 63.1 47.1 41.2 13.3 31.6 44.8 5.7 8.8 1.3 4.5 4.1 3.3 8.2 2.2 7.2 6.9 0.0 1.7 16.4 0.0 0.2 0.2 0.0 5.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.7 0.2 59.6 0.0 0.0 1.3 56.1 0.0 0.3 47.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.3 0.3 13.8 0.0 0.0 TNFAIP8L3 FLJ41287 ENSG00000183578 "TNF alpha induced protein 8 like 3" Q5GJ75 15 51056598-51105276 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.0;smooth muscle: 47.0" "Cell type enhanced" "Detected in many" 9 "Intestinal endocrine cells: 9.9;Leydig cells: 8.3;Smooth muscle cells: 9.2;Spermatocytes: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 12.9;ASC TERT1: 32.9;HSkMC: 12.1;HUVEC TERT2: 28.1;LHCN-M2: 26.4;TIME: 37.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077484 Approved Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA077484: AB_2732347" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.12e-3)" "unprognostic (6.63e-2)" "unprognostic (2.54e-1)" "unprognostic (1.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-2)" "unprognostic (4.21e-2)" "unprognostic (4.70e-3)" "unprognostic (6.54e-2)" "unprognostic (9.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (3.51e-4)" 4.6 2.4 11.8 4.1 3.8 0.8 10.5 0.6 5.8 9.8 4.1 1.8 2.8 1.2 47.0 9.9 11.5 20.9 3.7 5.5 11.4 3.1 1.9 1.5 6.6 5.4 1.9 5.6 17.5 1.6 0.6 1.8 1.4 3.3 6.6 5.0 0.6 1.9 3.5 2.1 10.7 3.2 47.0 1.5 14.7 2.9 3.4 1.1 0.0 2.5 4.7 2.4 12.3 18.8 1.4 1.0 3.7 1.5 1.7 0.8 0.3 0.0 0.1 0.0 0.0 12.9 32.9 0.1 0.1 0.0 0.3 0.5 0.0 0.3 0.0 0.6 1.8 4.1 0.0 0.4 0.3 0.1 0.0 0.3 0.0 0.9 2.1 3.4 0.1 0.7 12.1 2.6 2.4 9.5 2.2 28.1 0.0 0.0 0.0 26.4 0.3 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.4 0.1 0.2 37.7 2.9 0.2 9.7 0.7 0.1 0.0 0.0 6.1 0.0 0.0 2.8 1.5 0.7 0.5 0.7 0.6 0.8 0.6 0.5 0.3 1.4 0.6 0.8 3.7 1.7 1.0 1.0 0.4 0.3 11.8 3.8 0.6 5.8 11.4 3.1 1.9 5.6 3.3 1.1 0.0 0.3 0.0 0.6 3.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.3 0.0 3.7 0.4 0.0 0.0 2.7 0.0 9.9 2.5 2.5 0.4 8.3 2.8 1.7 1.0 2.8 0.0 0.1 1.1 4.9 0.0 0.2 6.5 9.2 16.8 0.4 7.3 0.0 0.0 2.6 0.4 TNFRSF10C "CD263, DcR1, LIT, TRAILR3, TRID" ENSG00000173535 "TNF receptor superfamily member 10c" O14798 8 23102590-23117437 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "blood: 173.4" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.3;Cholangiocytes: 5.1;granulocytes: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "neutrophil: 173.4" "Lineage enriched" "Detected in many" 113 "granulocytes: 173.4" "Group enriched" "Detected in some" 5 "BEWO: 37.9;HUVEC TERT2: 31.6" CAB025635 Enhanced NA NA 14600000 "CAB025635: " "unprognostic (2.63e-1)" "unprognostic (4.49e-3)" "unprognostic (7.21e-3)" "unprognostic (2.07e-2)" "unprognostic (3.55e-2)" "unprognostic (1.46e-1)" "unprognostic (1.81e-2)" "unprognostic (2.11e-3)" "unprognostic (5.56e-2)" "unprognostic (4.37e-2)" "unprognostic (8.98e-2)" "unprognostic (1.94e-3)" "unprognostic (2.74e-3)" "unprognostic (4.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.34e-3)" "unprognostic (6.54e-2)" 5.5 1.5 1.9 14.0 3.6 12.6 2.0 1.4 3.9 2.9 1.5 0.7 0.1 1.2 1.5 1.2 1.4 3.7 13.5 5.6 1.9 1.1 2.8 3.2 13.7 28.4 9.2 0.0 2.4 2.1 2.5 4.5 12.8 3.1 2.7 1.8 1.7 1.7 0.8 2.3 0.8 2.2 1.9 4.4 26.4 1.8 1.4 2.3 0.8 4.4 0.5 0.9 5.2 1.9 0.0 0.3 173.4 1.5 0.0 0.0 0.4 0.4 1.4 0.5 2.4 0.0 0.4 37.9 1.6 0.0 0.1 0.2 0.0 1.4 0.1 0.8 1.4 0.1 0.2 0.1 0.1 0.1 2.6 0.5 0.1 0.3 1.1 3.7 0.2 1.0 4.2 0.3 0.7 0.3 0.6 31.6 0.0 0.0 0.0 0.2 1.0 0.0 0.9 1.6 0.3 0.1 0.1 0.1 0.0 6.1 0.1 0.0 0.1 0.1 0.2 0.7 2.9 5.2 0.2 6.7 0.6 1.2 1.5 0.1 1.6 0.9 0.0 2.3 0.3 0.9 2.7 1.5 25.4 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 173.4 0.0 1.1 0.0 0.0 0.4 1.9 3.6 1.4 3.9 1.9 1.1 9.2 0.0 3.1 2.3 6.0 9.3 0.0 0.5 0.2 0.0 0.3 5.1 1.4 3.4 3.5 0.0 0.8 0.0 0.3 0.8 3.6 0.4 0.0 0.4 0.7 0.3 0.4 8.1 0.0 2.1 0.0 1.7 1.8 1.5 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.9 0.1 0.9 0.0 0.0 0.3 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391292 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 21.1;monocytes: 34.3;Mucus-secreting cells: 23.6;Paneth cells: 28.1;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "NK-cell: 8.9" "Lineage enriched" "Detected in many" 8 "NK-cells: 8.9" "Cell line enriched" "Detected in some" 6 "HDLM-2: 52.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: AB_2680227" "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 6.5 1.7 1.7 4.8 1.2 0.2 4.3 0.4 2.3 1.5 18.4 0.8 7.6 23.1 0.9 1.9 3.8 1.3 28.7 1.1 1.3 0.7 0.9 0.8 2.3 7.4 1.0 1.0 0.7 2.9 0.1 10.1 2.8 0.7 2.1 13.9 1.3 34.3 12.9 0.6 3.3 23.9 1.3 2.9 1.2 4.3 1.2 0.8 0.7 2.0 1.8 2.3 2.3 2.3 0.0 0.6 0.2 0.0 8.9 1.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 1.5 0.1 0.6 0.9 3.5 0.3 0.1 52.5 2.3 0.0 0.5 0.7 0.0 0.2 0.5 0.1 0.1 0.3 1.3 1.8 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.5 2.9 8.3 0.1 0.0 0.2 0.6 0.6 8.9 0.3 0.2 1.3 0.0 0.3 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 8.9 0.0 0.6 1.0 0.0 1.7 1.2 0.4 2.3 1.3 0.7 1.0 1.0 0.7 0.8 0.0 2.1 0.0 2.9 1.1 0.4 1.1 10.2 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.2 2.2 21.1 0.0 6.5 0.6 0.3 2.6 0.0 0.0 12.8 3.2 10.4 3.7 15.0 0.0 0.6 2.5 1.7 34.3 23.6 0.0 9.6 28.1 0.0 0.0 0.0 0.0 0.3 0.7 1.4 1.9 0.1 0.0 33.6 3.8 TNFRSF11B "OCIF, OPG, TR1" ENSG00000164761 "TNF receptor superfamily member 11b" O00300 8 118923557-118952200 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Apoptosis Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 18.6;thyroid gland: 52.8" "Group enriched" "Detected in many" 4 "Collecting duct cells: 69.8;Ductal cells: 23.2;Proximal tubular cells: 89.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 66 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in single" 66 "dendritic cells: 6.5" "Group enriched" "Detected in some" 4 "BJ: 50.9;BJ hTERT+: 189.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034939 Approved "Secreted in other tissues" NA NA "CAB034939: " "unprognostic (1.39e-2)" "prognostic unfavorable (6.22e-4)" "unprognostic (5.27e-2)" "unprognostic (2.33e-2)" "unprognostic (4.27e-3)" "unprognostic (1.10e-3)" "unprognostic (1.21e-3)" "unprognostic (5.50e-2)" "unprognostic (9.94e-2)" "unprognostic (6.32e-2)" "unprognostic (3.53e-2)" "unprognostic (2.43e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.32e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-3)" "prognostic unfavorable (3.88e-4)" 3.0 3.0 2.2 2.8 2.8 0.2 4.4 2.9 5.2 1.2 1.5 0.7 0.5 0.9 5.5 4.1 1.0 1.7 3.2 7.3 2.8 1.4 18.6 7.6 8.1 5.3 1.7 0.8 0.5 2.8 0.3 1.9 4.0 12.0 1.1 2.0 1.8 1.4 0.8 0.6 0.7 1.4 1.5 7.9 1.5 0.8 0.3 2.7 0.9 52.8 0.8 1.7 1.7 1.1 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 2.6 0.5 0.0 50.9 189.3 2.4 0.7 0.5 0.1 0.0 13.7 28.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.2 0.0 2.5 0.0 1.0 0.0 0.0 0.0 0.0 7.1 1.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.8 1.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.2 2.8 2.9 5.2 2.8 1.4 1.7 0.8 12.0 2.7 3.0 0.0 0.5 0.5 1.9 0.0 3.1 5.1 0.0 1.2 69.8 0.0 0.0 8.3 23.2 0.1 4.5 1.4 0.0 1.2 0.1 6.9 7.9 0.0 1.0 0.4 0.0 9.1 6.2 0.0 0.0 0.3 0.0 0.0 14.4 8.8 0.7 6.9 0.0 0.0 89.5 0.0 0.0 2.2 0.0 0.3 1.0 0.0 0.0 2.1 0.3 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.5 19.9 2.2 4.1 4.1 9.3 13.2 51.8 37.5 44.4 28.6 8.6 43.9 0.1 68.6 34.4 51.6 27.2 0.5 37.9 17.0 0.9 1.3 0.1 6.7 7.2 28.0 0.4 1.8 8.6 26.3 46.6 55.9 38.3 12.8 0.0 2.7 0.3 46.7 46.5 0.0 3.3 10.7 11.0 43.8 0.2 24.9 1.0 44.9 4.9 2.5 0.9 36.9 17.2 30.5 7.7 9.0 0.7 22.5 80.0 36.9 52.9 84.9 0.8 0.3 0.3 25.0 2.3 62.8 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 95.3 43.1 5.0 1094.9 544.0 0.9 57.7 163.1 50.9 130.8 172.7 2.0 112.5 54.7 954.3 0.6 22.7 41.3 0.0 607.7 131.7 179.4 600.3 58.8 15.3 38.1 0.0 26.1 28.8 4.6 0.4 5.8 29.4 106.3 16.2 4.6 20.6 874.5 25.8 6.3 93.5 5.1 6.5 212.1 7.7 4.1 314.4 158.1 8.6 12.4 560.0 TNFRSF13B "CD267, IGAD2, TACI" ENSG00000240505 "TNF receptor superfamily member 13B" O14836 17 16929816-16972118 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 45.1;lymphoid tissue: 44.6;skeletal muscle: 30.5" "Group enriched" "Detected in some" 31 "B-cells: 83.4;Melanocytes: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 42 "memory B-cell: 45.1;naive B-cell: 13.1" "Lineage enriched" "Detected in single" 65 "B-cells: 45.1" "Group enriched" "Detected in some" 8 "Karpas-707: 55.9;RPMI-8226: 35.1;U-266/70: 24.8" "Low region specificity" "Detected in all" HPA030453 Uncertain NA NA "HPA030453: AB_10601700" "unprognostic (3.94e-5)" "unprognostic (1.11e-3)" "unprognostic (4.88e-2)" "unprognostic (4.30e-3)" "unprognostic (1.23e-4)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-2)" "unprognostic (1.61e-4)" "unprognostic (2.22e-1)" "unprognostic (9.78e-2)" "unprognostic (1.59e-5)" "unprognostic (1.20e-1)" "unprognostic (4.49e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-1)" 0.5 0.3 0.4 17.6 0.3 0.2 0.5 0.2 0.3 0.7 3.0 0.1 0.0 1.9 0.3 0.0 2.7 0.5 0.5 2.5 0.3 0.3 0.6 0.5 1.2 12.5 0.3 0.2 0.3 0.3 0.0 0.3 0.0 0.1 0.9 1.2 0.6 9.0 1.1 30.5 0.3 14.8 0.0 0.4 44.6 2.4 0.3 0.1 0.9 0.6 0.9 37.8 2.3 0.4 45.1 0.0 0.1 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.4 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.1 0.1 0.0 0.0 83.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 TNFRSF13C "BAFFR, CD268" ENSG00000159958 "TNF receptor superfamily member 13C" Q96RJ3 22 41922023-41926818 "CD markers, Disease related genes, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;intestine: 18.9;lymphoid tissue: 69.1" "Cell type enriched" "Detected in some" 13 "B-cells: 100.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 51 "memory B-cell: 14.5;naive B-cell: 20.3" "Lineage enriched" "Detected in single" 59 "B-cells: 20.3" "Group enriched" "Detected in some" 6 "REH: 20.4;U-698: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA003246, CAB008380" Enhanced NA NA "CAB008380: AB_590602, HPA003246: AB_1078264" "unprognostic (3.43e-4)" "prognostic favorable (4.44e-7)" "unprognostic (6.52e-2)" "unprognostic (9.10e-2)" "unprognostic (7.64e-3)" "unprognostic (4.83e-3)" "unprognostic (2.89e-2)" "unprognostic (3.78e-3)" "unprognostic (1.95e-1)" "unprognostic (1.27e-1)" "unprognostic (2.51e-2)" "unprognostic (1.66e-1)" "unprognostic (4.79e-8)" "unprognostic (2.21e-1)" "unprognostic (1.89e-1)" "unprognostic (1.77e-1)" "unprognostic (9.44e-2)" 0.9 0.8 0.8 41.0 1.0 3.3 0.6 1.0 2.0 0.5 1.2 4.4 0.0 0.7 0.4 0.2 5.0 0.5 0.6 0.6 0.8 0.9 0.9 0.5 1.8 48.4 1.0 0.6 0.4 0.4 0.0 0.4 0.1 1.8 0.6 0.7 0.5 5.8 0.0 1.2 2.0 18.9 0.1 1.1 69.1 1.4 0.7 0.6 2.0 0.8 0.3 51.4 9.5 0.7 20.3 0.2 0.3 0.2 0.2 0.2 0.5 0.3 0.2 1.1 2.3 0.0 0.0 0.5 0.1 0.1 0.2 0.8 0.9 0.5 1.8 0.4 0.2 0.2 0.4 0.7 0.0 0.3 0.4 2.2 0.2 0.3 0.3 0.1 1.6 0.4 0.1 0.0 0.4 0.1 0.1 0.0 0.7 0.4 1.9 0.2 0.7 1.5 1.8 0.8 0.2 0.1 20.4 2.4 1.5 0.0 0.2 1.3 0.3 0.1 0.4 0.3 0.2 0.4 2.2 0.2 0.5 2.6 1.0 0.3 2.1 1.0 11.0 0.1 1.7 0.5 0.3 0.1 0.1 0.1 0.1 0.2 14.5 0.2 0.1 0.0 20.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.5 0.8 1.0 1.0 2.0 0.8 0.9 1.0 0.6 1.8 0.6 0.0 1.4 100.8 0.4 0.1 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 7.9 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.9 0.0 0.1 0.0 0.4 0.1 TNFRSF17 "BCM, BCMA, CD269, TNFRSF13A" ENSG00000048462 "TNF receptor superfamily member 17" Q02223 16 11965107-11968068 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 34.1;intestine: 17.8;lymphoid tissue: 28.8" "Group enriched" "Detected in some" 9 "B-cells: 29.3;Erythroid cells: 46.7;Melanocytes: 101.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 59 "memory B-cell: 34.1;naive B-cell: 26.9;plasmacytoid DC: 27.9" "Group enriched" "Detected in many" 62 "B-cells: 34.1;dendritic cells: 27.9" "Cell line enhanced" "Detected in some" "Karpas-707: 25.9;RPMI-8226: 40.8;U-266/70: 121.4;U-266/84: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA 2200000 "prognostic favorable (1.35e-5)" "unprognostic (3.41e-2)" "unprognostic (4.00e-3)" "unprognostic (1.41e-2)" "unprognostic (6.47e-2)" "prognostic favorable (1.58e-6)" "unprognostic (9.75e-3)" "unprognostic (5.93e-2)" "unprognostic (2.13e-2)" "unprognostic (7.96e-3)" "unprognostic (2.46e-1)" "unprognostic (2.58e-1)" "unprognostic (2.85e-6)" "unprognostic (2.06e-1)" "unprognostic (2.48e-1)" "unprognostic (3.54e-2)" "unprognostic (1.10e-1)" 0.6 0.4 0.4 24.0 0.9 0.3 5.4 0.5 0.4 1.5 17.8 0.2 0.2 12.3 0.5 0.2 3.7 1.1 4.9 0.7 0.4 0.4 1.3 0.8 3.0 22.4 0.4 0.2 0.9 3.1 0.0 0.5 0.3 0.2 1.0 9.4 0.6 14.2 0.2 0.4 0.4 11.7 0.2 0.4 22.2 9.4 2.2 0.3 3.1 1.1 1.4 28.8 7.6 0.7 34.1 27.9 0.5 0.1 0.2 0.1 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.4 60.3 9.4 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 34.1 0.0 0.0 0.0 26.9 0.0 0.0 0.5 0.2 0.0 27.9 0.0 3.7 0.4 0.9 0.5 0.4 0.4 0.4 0.4 0.2 0.2 0.3 0.0 0.0 29.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 46.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.6 0.0 0.0 101.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.5 0.4 0.5 0.0 0.0 0.0 0.0 TNFRSF18 "AITR, CD357, GITR" ENSG00000186891 "TNF receptor superfamily member 18" Q9Y5U5 1 1203508-1206691 "CD markers, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 46.6;skin 1: 28.9" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 167.9;granulocytes: 46.0;Melanocytes: 47.2;Suprabasal keratinocytes: 131.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 46.6" "Group enriched" "Detected in many" 11 "NK-cells: 46.6;T-cells: 19.0" "Group enriched" "Detected in some" 11 "RPMI-8226: 62.6;SCLC-21H: 45.0" HPA008025 Approved "Secreted to blood" NA NA "HPA008025: AB_1849696" "unprognostic (1.20e-3)" "unprognostic (4.61e-2)" "unprognostic (4.59e-2)" "prognostic favorable (7.72e-6)" "unprognostic (2.73e-4)" "prognostic favorable (4.12e-4)" "unprognostic (3.43e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.01e-1)" "unprognostic (1.00e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.40e-11)" "unprognostic (1.02e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-1)" "unprognostic (2.08e-1)" 1.4 0.5 1.0 8.9 1.0 1.9 4.2 4.9 2.5 14.3 8.3 0.3 0.1 5.7 2.1 1.1 4.7 1.0 3.7 0.2 0.5 0.3 1.1 1.7 3.0 9.1 0.4 2.4 0.3 2.7 9.4 3.8 1.3 1.7 1.9 1.2 0.5 9.0 2.6 1.0 28.9 5.0 0.2 0.3 6.7 3.8 0.8 0.1 4.4 0.9 2.7 8.2 1.5 2.2 2.9 0.0 0.2 0.0 46.6 19.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 4.7 0.0 0.0 62.6 0.1 0.0 45.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.6 1.3 8.5 1.2 0.0 2.9 0.3 0.4 0.2 46.6 0.0 0.0 19.0 2.1 1.0 1.0 4.9 2.5 0.5 0.3 0.4 2.4 1.7 0.1 0.0 2.2 7.5 10.8 167.9 0.0 2.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.5 0.9 11.2 7.3 46.0 0.0 0.8 0.0 3.4 1.3 0.8 0.0 0.0 1.8 47.2 21.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 131.6 0.0 20.8 0.0 3.3 TNFRSF19 "TAJ, TAJ-alpha, TRADE, TROY" ENSG00000127863 "TNF receptor superfamily member 19" Q9NS68 13 23570370-23676104 "Plasma proteins, Predicted membrane proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 60.5;skin 1: 47.9" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 55.3;Ciliated cells: 84.3;Suprabasal keratinocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "naive B-cell: 1.9;T-reg: 4.0" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 4.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.5;BJ hTERT+: 26.9;fHDF/TERT166: 20.4;Hep G2: 27.9;SK-MEL-30: 46.5;WM-115: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010135 Approved Nucleoplasm,Mitochondria No No Mitochondria Nucleoplasm "HPA010135: AB_1079797" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" "unprognostic (1.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.04e-1)" "unprognostic (1.86e-3)" "unprognostic (2.01e-2)" "prognostic favorable (3.87e-4)" "unprognostic (3.74e-1)" "unprognostic (5.47e-2)" "unprognostic (4.41e-2)" "unprognostic (6.56e-2)" "prognostic favorable (9.13e-7)" "unprognostic (3.44e-2)" "unprognostic (6.05e-2)" "unprognostic (3.25e-3)" "unprognostic (5.38e-3)" 1.3 1.3 1.0 0.4 1.4 0.6 4.6 0.8 2.0 3.4 1.5 3.0 17.1 0.7 5.3 7.3 5.1 14.3 2.3 14.7 1.5 1.5 7.1 0.5 7.9 0.6 3.0 1.3 3.4 2.2 0.1 8.0 3.8 2.8 12.7 0.8 11.4 60.5 13.0 1.2 47.9 0.9 4.1 1.9 2.5 2.4 2.7 1.1 0.8 5.7 8.0 3.7 2.7 4.0 1.9 0.7 0.7 0.0 0.6 4.0 0.2 0.0 1.0 1.2 0.0 1.6 16.5 1.2 1.2 26.9 0.6 0.9 7.8 0.0 0.0 0.0 20.4 0.1 0.0 1.1 0.9 1.2 0.0 0.9 0.2 0.8 27.9 0.7 0.0 0.3 7.8 0.2 7.8 0.1 0.5 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.7 9.6 1.7 0.0 4.5 0.0 2.8 0.1 10.7 1.8 0.0 0.0 46.5 1.3 0.0 0.1 0.0 3.9 0.2 0.0 1.1 0.0 0.0 0.0 1.5 0.0 28.9 0.0 0.0 0.7 0.0 0.0 0.4 0.7 0.4 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.0 0.7 4.0 0.2 1.0 1.4 0.8 2.0 1.5 1.5 3.0 1.3 2.8 1.1 0.0 17.3 0.0 3.6 55.3 0.6 19.1 2.5 84.3 14.8 8.7 7.9 0.2 0.0 9.9 1.1 2.9 0.0 0.0 0.9 0.0 9.8 18.5 1.1 0.6 0.1 0.0 0.0 0.0 0.0 0.8 10.6 0.2 13.5 0.0 0.0 3.0 7.4 0.0 13.1 18.8 2.5 0.0 5.7 0.9 2.1 70.1 0.0 0.5 0.0 0.5 TNFRSF1B "CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80" ENSG00000028137 "TNF receptor superfamily member 1B" P20333 1 12167003-12209228 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.1" "Cell type enhanced" "Detected in many" 10 "Kupffer cells: 168.8;Macrophages: 143.1;monocytes: 73.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 70.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.5;K-562: 21.4;THP-1: 25.1;U-87 MG: 17.2;U-937: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004796 Approved "Secreted to blood" NA NA 3230000 2500000 "HPA004796: AB_1078436" "unprognostic (4.45e-2)" "unprognostic (2.27e-3)" "unprognostic (7.62e-2)" "unprognostic (3.82e-3)" "unprognostic (6.30e-2)" "unprognostic (4.47e-3)" "unprognostic (5.28e-3)" "unprognostic (2.79e-1)" "unprognostic (1.69e-2)" "unprognostic (1.73e-2)" "unprognostic (7.26e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (8.35e-5)" "unprognostic (2.02e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (3.26e-2)" "unprognostic (1.10e-1)" 43.4 4.7 4.6 44.3 13.8 29.2 42.3 2.1 6.1 13.3 13.1 6.6 1.9 11.9 9.7 10.2 6.5 11.3 11.6 21.8 8.5 6.2 6.2 22.2 24.5 60.6 9.1 2.2 9.4 4.2 2.3 4.4 24.9 15.0 7.3 8.2 8.3 5.7 3.7 11.5 6.2 17.3 11.5 22.6 48.3 10.5 6.0 6.1 10.9 6.2 5.6 16.2 18.3 8.4 2.7 13.2 25.7 70.1 2.5 12.7 19.9 0.0 0.1 2.1 0.0 5.6 7.7 4.4 0.5 1.0 2.0 2.2 0.8 17.5 0.1 0.3 1.8 2.9 0.0 0.4 0.0 1.1 6.9 0.0 0.0 0.1 0.0 13.2 0.1 1.9 7.6 0.0 7.0 0.0 3.6 10.6 0.1 21.4 3.2 0.9 0.0 0.0 4.0 0.1 2.7 0.6 0.5 0.2 12.3 0.0 0.4 0.0 0.0 0.3 0.1 0.6 3.3 0.0 25.1 3.7 3.0 0.1 13.3 0.0 1.0 0.0 0.0 17.2 18.1 0.7 0.0 20.7 3.0 9.4 49.3 5.4 2.7 6.6 7.7 13.2 1.7 2.0 3.0 25.7 2.5 70.1 2.8 12.7 19.9 4.6 13.8 2.1 6.1 8.5 6.2 9.1 2.2 15.0 6.1 8.9 22.3 30.3 2.5 14.9 0.1 2.8 7.6 2.7 11.4 3.5 0.0 0.7 0.0 0.4 0.3 40.2 11.8 23.3 0.5 4.3 9.7 4.3 2.3 14.0 63.4 0.0 0.0 22.7 168.8 0.4 2.0 143.1 15.1 73.9 3.1 0.3 0.5 1.4 0.4 0.3 1.0 32.3 13.7 0.0 0.9 9.3 25.2 58.9 3.9 9.8 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.4" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 35 "plasmacytoid DC: 31.6" "Lineage enriched" "Detected in single" 309 "dendritic cells: 31.6" "Cell line enhanced" "Detected in many" "OE19: 39.2;RT4: 99.8;SuSa: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" NA NA 1300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favorable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 25.9 3.7 9.7 8.7 13.6 5.9 7.8 7.4 20.8 9.6 19.3 26.9 1.0 6.4 9.1 3.0 21.8 9.9 18.7 4.1 13.8 16.0 26.2 4.6 9.5 11.5 26.8 7.9 5.0 17.9 35.6 4.4 17.0 29.5 10.2 18.5 3.0 15.2 2.4 3.5 2.7 10.2 8.2 63.4 11.6 30.4 5.8 10.1 11.5 2.9 19.2 16.5 41.2 11.6 0.0 31.6 0.1 0.0 0.0 0.0 0.2 29.2 9.5 9.3 2.9 25.5 7.5 10.5 3.4 6.7 1.0 0.4 16.4 20.7 2.1 13.8 2.4 20.0 17.7 1.3 12.6 0.6 0.0 2.9 0.0 1.2 16.5 14.9 0.4 0.1 13.4 15.1 0.6 11.5 0.8 4.9 1.9 0.7 0.0 0.3 5.7 2.5 0.2 7.3 39.2 9.8 5.4 2.8 3.1 17.7 99.8 6.7 1.4 2.9 2.8 2.4 43.8 2.1 2.0 1.0 2.8 2.5 0.1 3.1 0.0 0.0 3.0 4.5 2.1 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.2 9.7 13.6 7.4 20.8 13.8 16.0 26.8 7.9 29.5 10.1 0.0 12.7 0.0 142.4 21.1 0.6 7.6 35.7 10.7 25.0 1.8 0.0 24.6 13.3 69.3 45.6 5.6 30.3 0.0 25.8 16.8 14.1 135.6 19.6 0.0 20.6 0.0 11.5 1.8 36.8 29.9 2.6 5.8 11.8 0.0 40.2 4.4 63.5 46.7 1.1 48.5 1.3 77.6 16.2 0.6 1.4 8.7 149.4 1.3 14.0 360.8 TNFRSF25 "APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR" ENSG00000215788 "TNF receptor superfamily member 25" Q93038 1 6461151-6466195 "Predicted membrane proteins, Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 11 "cerebellum: 19.2" "Cell type enhanced" "Detected in many" "T-reg: 9.5" "Lineage enriched" "Detected in single" 10 "T-cells: 9.5" "Cell line enhanced" "Detected in many" "HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7" "Group enriched" "Detected in some" 6 "amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3" "Not detected" "Not detected" HPA069834 Approved "Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites" "Secreted - unknown location" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" Nucleoplasm "HPA069834: " "unprognostic (8.09e-3)" "unprognostic (6.91e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (1.97e-1)" "unprognostic (9.63e-3)" "prognostic favorable (3.09e-4)" "unprognostic (2.16e-1)" "unprognostic (1.46e-1)" "unprognostic (2.04e-1)" "unprognostic (2.07e-1)" "unprognostic (6.01e-2)" "unprognostic (3.98e-2)" "prognostic unfavorable (1.65e-7)" "unprognostic (1.21e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (8.68e-3)" 2.2 1.6 1.2 20.3 1.6 0.4 1.4 19.2 1.8 1.4 13.4 0.7 0.6 2.8 1.2 0.6 4.1 2.4 2.1 2.3 1.8 0.9 1.4 2.3 6.3 13.9 1.1 0.6 1.1 0.6 1.4 14.0 4.1 1.3 1.9 1.3 1.1 10.5 2.3 0.8 24.1 11.2 0.6 0.6 18.9 0.8 1.0 0.8 11.7 1.1 3.2 26.0 3.2 1.5 0.0 0.4 0.0 0.9 0.6 9.5 1.3 1.4 0.3 0.8 1.6 0.0 0.4 0.8 0.6 0.4 0.2 0.0 1.3 2.2 0.0 3.0 0.0 1.0 3.2 0.4 3.7 0.0 20.2 1.5 0.8 1.1 0.0 0.6 0.0 0.0 0.0 2.4 1.2 3.2 1.9 3.2 0.9 0.0 0.0 0.0 1.6 0.0 8.0 1.0 1.1 5.5 0.6 0.2 19.7 0.8 0.5 3.9 5.4 0.0 1.9 0.1 0.3 1.7 2.2 1.7 1.0 1.5 0.0 1.5 0.0 3.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 1.7 0.3 8.0 0.0 6.9 3.2 0.4 0.0 6.4 1.1 0.0 0.6 0.9 0.0 9.5 1.3 1.2 1.6 19.2 1.8 1.8 0.9 1.1 0.6 1.3 0.8 3.0 5.3 0.5 1.8 21.9 0.8 0.8 2.5 2.7 2.3 1.8 2.0 0.4 0.0 0.1 0.3 5.5 16.9 0.0 0.4 1.6 3.2 1.1 6.9 1.1 3.2 4.8 6.4 9.8 1.6 0.0 2.6 2.1 6.8 1.0 17.6 11.2 0.9 11.5 8.9 0.3 9.3 0.0 0.8 0.5 1.1 25.0 0.1 36.2 28.4 6.7 TNFRSF4 "ACT35, CD134, OX40, TXGP1L" ENSG00000186827 "TNF receptor superfamily member 4" P43489 1 1211326-1214138 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 12.5;blood: 18.4;lymphoid tissue: 13.6" "Cell type enhanced" "Detected in some" 19 "Endothelial cells: 15.3;granulocytes: 67.9;monocytes: 30.7;T-cells: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 15.9;T-reg: 18.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "MOLT-4: 8.0;NB-4: 15.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" CAB016128 Enhanced NA NA "CAB016128: AB_626897" "unprognostic (2.24e-1)" "unprognostic (8.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-1)" "prognostic favorable (3.50e-6)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.30e-1)" "unprognostic (1.48e-2)" "unprognostic (7.04e-3)" "unprognostic (1.04e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (1.61e-1)" "unprognostic (5.46e-2)" "unprognostic (2.42e-1)" "unprognostic (5.91e-2)" 12.5 0.2 0.6 8.8 0.4 0.7 7.3 0.3 1.2 1.1 3.1 0.3 0.3 2.6 0.8 0.7 1.7 0.9 0.8 6.7 0.8 0.1 2.2 0.4 5.3 8.4 0.3 0.6 0.5 0.9 0.0 1.3 5.9 0.6 3.2 0.3 0.6 2.2 1.1 4.4 0.8 4.3 0.3 0.3 13.5 3.5 2.0 0.3 13.6 4.1 0.8 10.9 1.4 0.7 0.0 0.6 4.1 0.0 8.1 18.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.0 15.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.0 1.8 0.0 15.9 1.7 0.0 0.0 1.5 0.0 0.2 8.1 0.0 0.6 18.4 1.5 0.6 0.4 0.3 1.2 0.8 0.1 0.3 0.6 0.6 0.3 0.0 0.0 2.2 0.3 8.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.3 0.0 0.0 0.2 0.4 2.8 0.3 67.9 0.0 1.6 0.0 0.0 8.6 1.0 0.0 0.3 5.8 10.1 30.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.7 0.0 0.2 7.3 0.1 15.8 0.0 0.1 TNFRSF6B "DcR3, M68, TR6" ENSG00000243509 "TNF receptor superfamily member 6b" O95407 20 63696651-63698684 "Predicted secreted proteins" Apoptosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.4;lymphoid tissue: 56.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 17.4" "Lineage enriched" "Detected in single" 18 "dendritic cells: 17.4" "Group enriched" "Detected in some" 4 "HBEC3-KT: 11.7;RPTEC TERT1: 46.0;TIME: 28.5" "Not detected" "Not detected" HPA047154 Approved "Secreted to blood" NA NA 406000 "HPA047154: AB_2679959" 11.8 2.0 10.0 39.2 17.6 2.5 7.0 5.4 8.1 4.5 6.0 2.1 0.0 2.0 3.0 2.0 6.6 2.5 3.6 2.0 11.6 6.6 4.4 2.5 39.4 9.8 5.9 0.0 3.6 2.2 2.0 4.2 2.1 23.6 2.7 2.3 0.0 2.9 2.0 10.0 4.8 3.8 4.6 13.0 56.3 10.0 2.1 5.3 2.7 6.5 3.3 12.1 11.6 2.3 0.0 17.4 0.0 0.9 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.7 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 4.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 28.5 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.9 17.4 0.0 0.1 10.0 17.6 5.4 8.1 11.6 6.6 5.9 0.0 23.6 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNFRSF8 "CD30, D1S166E, KI-1" ENSG00000120949 "TNF receptor superfamily member 8" P28908 1 12063377-12144207 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.3" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 2.8;Kupffer cells: 6.0;Late spermatids: 7.2" "Cancer enriched" "Detected in some" 12 "testis cancer: 9.3" "Region enriched" "Detected in single" 14 "basal ganglia: 13.1" "Cell type enhanced" "Detected in some" "intermediate monocyte: 21.7;non-classical monocyte: 33.3" "Lineage enriched" "Detected in many" 5 "monocytes: 33.3" "Cell line enriched" "Detected in some" 21 "HDLM-2: 112.6" "Low region specificity" "Detected in many" "CAB000016, HPA014823, HPA032081, HPA032082" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142" "unprognostic (1.07e-2)" "unprognostic (2.06e-2)" "unprognostic (2.52e-2)" "unprognostic (5.98e-2)" "unprognostic (2.50e-1)" "unprognostic (1.46e-3)" "unprognostic (2.19e-1)" "unprognostic (3.93e-2)" "unprognostic (1.18e-1)" "unprognostic (9.18e-3)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-8)" "unprognostic (3.31e-1)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" 10.7 0.2 0.1 7.2 13.1 1.4 5.8 0.2 0.4 1.1 0.8 0.0 1.5 0.2 1.7 1.3 0.9 2.1 1.4 3.8 0.1 0.2 0.9 0.2 3.9 2.9 0.5 0.5 1.2 0.4 0.0 0.1 6.2 0.5 1.0 0.5 0.0 0.7 0.3 3.1 1.6 1.3 1.3 1.4 2.9 6.4 2.5 0.9 3.0 0.7 2.7 5.3 2.6 3.8 0.0 3.2 6.8 33.3 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 112.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 5.2 0.3 0.0 0.0 0.3 0.0 4.5 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 21.7 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.0 33.3 0.8 0.3 2.7 0.1 13.1 0.2 0.4 0.1 0.2 0.5 0.5 0.5 0.9 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 0.0 0.0 1.3 6.0 7.2 0.3 1.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.2 0.0 0.0 0.0 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Group enriched" "Detected in some" 4 "granulocytes: 62.3;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 47.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 0.4 0.1 0.4 0.0 0.8 0.2 0.0 0.2 0.5 47.0 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.7 0.0 0.2 0.2 0.2 1.6 0.1 0.2 0.1 0.1 0.1 5.8 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 0.0 1.7 0.0 0.4 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.0 0.0 0.4 0.3 62.3 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.8 5.0 53.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 12.9 0.0 0.3 TNFSF10 "Apo-2L, CD253, TL2, TRAIL" ENSG00000121858 "TNF superfamily member 10" P50591 3 172505508-172523507 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 115.1" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 542.5;Exocrine glandular cells: 368.6;Proximal tubular cells: 449.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3" "Group enriched" "Detected in all" 5 "granulocytes: 50.3;monocytes: 39.5" "Cell line enhanced" "Detected in many" "BEWO: 21.0;CAPAN-2: 14.9;HaCaT: 14.7;HMC-1: 69.1;RPTEC TERT1: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054938 Uncertain "Secreted to blood" NA NA 67400 "HPA054938: AB_2682643" "unprognostic (9.16e-2)" "unprognostic (2.79e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-3)" "unprognostic (2.52e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-1)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (1.32e-1)" "unprognostic (6.27e-2)" 30.9 22.1 3.4 14.6 4.7 2.0 23.3 3.0 5.4 31.4 25.8 4.4 17.1 20.6 13.0 10.3 33.3 9.6 10.7 9.9 3.8 3.2 115.1 44.4 91.5 23.5 5.5 3.4 13.5 11.6 10.9 6.7 100.8 6.7 37.6 19.5 12.0 50.6 12.9 13.9 13.0 54.0 7.9 5.6 35.8 9.5 6.0 4.6 8.3 28.2 17.7 16.1 22.4 24.0 3.4 9.5 50.3 39.5 9.3 7.0 11.9 3.4 0.1 0.0 0.0 2.4 1.8 21.0 0.0 0.1 1.0 1.6 0.0 14.9 2.1 10.1 0.0 0.9 14.7 0.0 1.8 0.2 5.3 0.0 0.0 0.4 0.3 0.1 3.9 69.1 2.4 2.4 0.4 0.0 0.0 7.6 0.4 0.0 2.5 0.0 0.0 0.5 5.2 0.0 0.1 0.1 0.8 0.0 0.9 34.8 1.3 0.1 0.1 7.7 0.3 0.1 0.1 4.2 2.2 0.3 0.0 0.0 0.0 0.2 2.6 0.3 2.6 0.2 2.2 0.0 42.4 25.6 2.7 2.3 39.5 3.1 3.2 6.4 3.5 9.5 3.4 4.7 1.8 50.3 9.3 38.3 0.6 7.0 11.9 3.4 4.7 3.0 5.4 3.8 3.2 5.5 3.4 6.7 4.6 65.5 119.9 15.2 153.0 19.6 0.1 4.5 63.7 99.0 113.7 62.8 0.0 1.1 38.1 542.5 3.9 163.8 223.5 23.3 368.6 166.3 27.9 96.6 248.5 58.7 22.3 1.6 46.3 140.0 77.7 2.8 17.0 51.4 6.8 16.2 96.5 21.7 249.5 190.0 4.6 449.0 0.8 0.0 10.3 0.0 0.2 22.3 9.2 43.6 68.5 109.1 TNFSF11 "CD254, ODF, OPGL, RANKL, TRANCE" ENSG00000120659 "TNF superfamily member 11" O14788 13 42562736-42608013 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Cytokine, Developmental protein, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 14.3;lymphoid tissue: 19.8" "Cell type enhanced" "Detected in some" 22 "Ductal cells: 3.3;Early spermatids: 5.8;Late spermatids: 14.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "NK-cell: 14.3" "Lineage enriched" "Detected in many" 8 "NK-cells: 14.3" "Cell line enhanced" "Detected in some" "Daudi: 1.8;HSkMC: 5.4;NTERA-2: 7.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB009193, HPA045142" Enhanced "Secreted to blood" NA NA 17200 "CAB009193: , HPA045142: AB_2679231" "unprognostic (3.97e-4)" "unprognostic (1.40e-1)" "unprognostic (9.01e-3)" "unprognostic (3.81e-3)" "unprognostic (1.12e-1)" "unprognostic (1.09e-1)" "unprognostic (7.09e-2)" "unprognostic (7.70e-2)" "unprognostic (2.29e-1)" "unprognostic (1.25e-3)" "unprognostic (1.00e-1)" "unprognostic (1.50e-1)" "unprognostic (3.94e-5)" "unprognostic (1.87e-1)" "unprognostic (9.67e-2)" "unprognostic (5.46e-2)" "unprognostic (7.74e-2)" 0.5 0.2 0.2 19.5 0.2 0.0 4.6 0.1 0.2 0.8 0.8 0.1 2.4 0.2 0.2 0.1 3.7 0.2 1.3 0.3 0.1 0.7 0.6 5.3 0.4 19.8 0.1 0.1 0.1 0.6 0.0 0.3 0.3 0.4 0.5 2.2 0.1 1.6 1.0 0.2 0.5 6.0 0.1 0.1 0.8 0.3 3.3 0.1 2.8 0.4 0.1 5.2 2.3 0.7 0.0 0.1 1.8 0.0 14.3 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.6 0.0 0.1 5.4 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.5 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.7 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 TNFSF13 "APRIL, CD256" ENSG00000161955 "TNF superfamily member 13" O75888 17 7558292-7561608 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Immunity Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 102.8" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 7.2;Ciliated cells: 2.7;Club cells: 3.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 63.5;eosinophil: 22.8;intermediate monocyte: 62.7;myeloid DC: 43.0;non-classical monocyte: 37.3;plasmacytoid DC: 19.8" "Group enriched" "Detected in many" 10 "dendritic cells: 43.0;granulocytes: 22.8;monocytes: 63.5" "Cell line enhanced" "Detected in many" "EFO-21: 18.8;RPTEC TERT1: 47.5;U-937: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA004863 Uncertain "Secreted to blood" NA NA 6770000 29000 "HPA004863: AB_1078187" "unprognostic (2.46e-2)" "unprognostic (2.20e-1)" "unprognostic (3.42e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (9.73e-4)" "unprognostic (3.57e-1)" "unprognostic (3.32e-2)" "unprognostic (3.70e-2)" "unprognostic (3.75e-1)" "unprognostic (1.15e-1)" "unprognostic (6.95e-2)" "unprognostic (2.65e-1)" "prognostic favorable (1.30e-9)" "unprognostic (4.69e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.38e-2)" 12.1 14.4 18.7 15.4 24.2 18.3 12.9 5.7 15.3 15.7 20.4 8.7 27.4 32.0 7.7 12.8 6.1 14.4 29.1 9.5 11.1 10.7 34.1 11.9 43.0 39.0 14.3 9.4 14.0 20.7 5.7 10.8 6.4 31.6 13.7 18.7 22.0 102.8 69.4 3.0 5.3 18.5 10.9 13.1 16.2 23.4 5.0 9.0 3.3 14.1 8.2 11.5 10.4 8.4 4.1 43.0 22.8 63.5 1.3 0.4 30.6 8.5 3.5 1.2 2.3 1.4 0.7 1.4 1.5 1.1 0.6 0.5 1.9 5.3 3.8 18.8 1.5 2.2 5.5 0.0 1.5 0.6 6.6 2.9 2.4 7.7 4.0 2.9 2.1 2.5 1.5 1.5 0.4 2.5 3.8 2.0 2.7 1.8 1.5 0.5 1.2 0.9 6.7 1.1 8.3 2.5 6.7 1.4 16.2 47.5 5.6 2.2 2.1 3.0 8.0 1.0 1.8 10.7 5.1 1.0 2.0 2.5 0.9 3.3 0.3 1.1 0.9 0.8 18.2 4.0 9.0 63.5 22.8 0.1 62.7 0.1 2.0 0.0 0.1 43.0 4.1 0.4 0.2 8.6 1.3 37.3 19.8 0.1 30.6 18.7 24.2 5.7 15.3 11.1 10.7 14.3 9.4 31.6 9.0 6.0 7.2 0.0 0.2 0.0 0.0 0.0 0.0 2.7 3.4 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.2 2.3 0.0 0.4 0.0 1.2 0.0 2.2 0.0 0.0 0.6 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 TNFSF13B "BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20" ENSG00000102524 "TNF superfamily member 13b" Q9Y275 13 108251240-108308484 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 76.5;lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 23 "Hofbauer cells: 88.9;Kupffer cells: 144.9;Macrophages: 141.3;monocytes: 457.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.5" "Group enriched" "Detected in many" 10 "dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7" "Cell line enriched" "Detected in some" 7 "U-937: 61.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009188, HPA030526" Enhanced Supported "Vesicles,Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 393000 530000 "Plasma membrane" "Vesicles, Focal adhesion sites" "CAB009188: , HPA030526: " "unprognostic (6.48e-2)" "unprognostic (3.05e-3)" "unprognostic (1.38e-1)" "unprognostic (1.90e-1)" "unprognostic (2.61e-2)" "unprognostic (7.99e-2)" "unprognostic (8.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.63e-1)" "unprognostic (1.02e-2)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.53e-11)" "unprognostic (1.23e-1)" "unprognostic (4.14e-2)" "unprognostic (1.88e-1)" "unprognostic (1.25e-1)" 7.2 8.2 3.0 18.5 8.2 13.2 3.4 1.4 5.2 1.6 4.2 2.1 1.0 7.8 1.2 6.5 3.5 2.9 9.4 9.4 5.7 2.9 3.1 5.0 13.2 39.6 7.2 2.6 2.9 2.7 0.5 2.1 6.4 5.7 3.7 6.4 2.6 5.4 1.8 1.6 1.6 6.8 3.5 11.6 23.5 3.4 1.0 4.9 7.2 5.1 1.7 12.7 8.5 3.8 1.0 31.0 76.5 53.7 0.6 5.3 20.8 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.2 0.8 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.3 0.1 0.0 0.1 3.6 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.1 0.0 0.0 0.1 0.1 0.0 8.1 0.0 0.1 0.0 0.0 0.1 3.8 0.1 0.0 3.9 61.0 0.6 1.2 53.7 14.4 0.8 39.8 5.3 0.6 3.5 0.7 31.0 1.0 1.7 0.5 76.5 0.6 31.7 11.5 2.8 20.8 3.0 8.2 1.4 5.2 5.7 2.9 7.2 2.6 5.7 4.9 14.9 17.5 3.7 0.7 6.4 0.3 0.5 12.7 2.7 5.7 5.2 0.0 0.5 1.7 2.0 1.0 1.3 0.5 0.0 29.2 0.9 13.3 1.6 4.7 1.5 88.9 0.0 1.2 4.9 144.9 0.2 4.9 141.3 8.5 457.1 0.2 0.4 1.9 0.0 1.8 1.0 0.0 6.5 5.0 0.1 0.1 4.1 0.9 6.2 1.2 1.3 TNFSF14 "CD258, HVEM-L, LIGHT, LTg" ENSG00000125735 "TNF superfamily member 14" O43557 19 6661253-6670588 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;liver: 50.6" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 22.9;granulocytes: 26.4;T-cells: 51.1" "Cancer enhanced" "Detected in many" "liver cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 50.8" "Group enriched" "Detected in many" 5 "granulocytes: 50.8;T-cells: 16.6" "Cell line enhanced" "Detected in some" "HDLM-2: 21.6;NB-4: 4.8;THP-1: 3.4;U-937: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA012700 Approved "Secreted to blood" NA NA 41000 "HPA012700: AB_1852870" "unprognostic (2.78e-3)" "unprognostic (2.11e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (3.82e-4)" "unprognostic (4.51e-2)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (1.05e-2)" "unprognostic (9.23e-2)" "unprognostic (9.22e-2)" "unprognostic (3.59e-1)" "prognostic unfavorable (6.07e-13)" "unprognostic (1.09e-1)" "unprognostic (9.56e-3)" "unprognostic (1.75e-1)" "unprognostic (3.62e-2)" 11.2 0.9 0.6 4.6 0.6 2.5 1.3 1.2 1.5 0.8 2.4 0.4 0.2 2.8 2.7 2.3 1.8 3.6 2.0 2.1 0.6 0.1 1.0 50.6 4.3 8.3 3.8 0.2 2.9 2.5 0.0 0.9 1.8 1.4 1.2 1.8 1.9 1.4 1.5 0.2 0.7 3.8 1.6 0.3 8.2 1.8 1.6 0.2 1.5 1.4 0.9 5.9 2.1 14.1 0.3 1.7 50.8 4.5 7.2 16.6 2.9 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.5 0.0 0.0 0.0 21.6 0.0 0.1 0.2 1.1 0.0 0.6 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 12.3 0.0 28.3 4.5 27.4 11.4 1.0 16.6 0.1 4.9 9.2 1.7 0.3 0.8 4.2 50.8 7.2 0.1 0.1 3.9 2.9 0.6 0.6 1.2 1.5 0.6 0.1 3.8 0.2 1.4 0.2 8.9 22.9 0.9 0.5 2.6 0.0 0.8 10.2 1.4 7.9 0.0 0.0 0.1 0.0 2.3 1.0 0.3 0.0 0.0 3.2 0.2 2.4 0.5 26.4 10.6 13.5 0.0 0.0 1.8 3.0 0.0 0.3 8.4 3.3 2.8 0.0 0.0 9.8 0.0 0.0 0.3 0.0 0.0 1.6 0.2 0.2 2.9 0.0 51.1 0.0 0.3 TNFSF15 "MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A" ENSG00000181634 "TNF superfamily member 15" O95150 9 114784635-114806126 "Predicted intracellular proteins, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.0;kidney: 16.2;salivary gland: 28.7" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 8.9;monocytes: 9.0;Proximal tubular cells: 9.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "myeloid DC: 2.8" "Group enriched" "Detected in many" 5 "dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;hTEC/SVTERT24-B: 7.3;HUVEC TERT2: 14.0;OE19: 13.1;RT4: 13.7;TIME: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012948, HPA046522" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted to blood" NA NA 1110000 "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA012948: AB_1858024, HPA046522: AB_2679683" "unprognostic (3.41e-1)" "unprognostic (2.06e-2)" "unprognostic (3.76e-1)" "unprognostic (1.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.67e-2)" "unprognostic (1.64e-1)" "unprognostic (2.29e-2)" "unprognostic (5.40e-2)" "unprognostic (1.38e-1)" "unprognostic (7.78e-2)" "unprognostic (2.09e-1)" "unprognostic (8.64e-5)" "unprognostic (1.97e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-3)" "unprognostic (4.46e-3)" 1.2 1.3 0.3 3.1 0.5 0.0 0.7 0.2 0.9 1.9 7.3 0.1 1.3 10.8 0.9 1.3 2.8 0.8 2.0 0.3 1.7 0.3 16.2 0.5 5.2 0.5 0.4 0.1 0.7 1.4 0.2 0.5 6.0 0.7 9.8 2.2 0.6 28.7 4.4 0.3 0.6 15.0 2.0 0.4 1.5 3.0 0.6 0.1 0.9 1.3 1.8 2.4 6.4 1.6 0.3 2.8 1.2 1.8 0.3 0.1 0.4 0.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.1 0.2 2.5 1.3 0.0 0.0 0.4 11.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 7.3 0.0 0.0 14.0 0.0 0.0 0.8 0.4 0.5 0.0 0.0 0.2 13.1 0.0 0.0 0.0 0.0 0.0 13.7 0.1 0.0 0.0 0.6 0.0 5.0 1.0 0.0 6.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 0.1 0.1 1.8 0.0 0.3 0.1 0.0 2.8 0.3 0.1 0.1 1.2 0.3 0.2 1.5 0.0 0.4 0.3 0.5 0.2 0.9 1.7 0.3 0.4 0.1 0.7 0.1 11.9 8.9 0.0 4.4 0.5 0.1 0.5 0.0 0.0 1.2 7.0 0.0 0.5 0.0 4.0 0.2 0.0 6.9 0.0 1.8 0.1 0.8 4.6 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 1.2 0.0 9.0 1.8 0.2 1.1 0.0 0.4 9.6 0.1 0.0 1.0 0.0 0.0 0.5 0.2 0.0 3.9 5.1 TNFSF18 "AITRL, hGITRL, TL6" ENSG00000120337 "TNF superfamily member 18" Q9UNG2 1 173039960-173050963 "Predicted membrane proteins" "Adaptive immunity, Immunity" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.3;tongue: 9.9" "Cell type enriched" "Detected in single" 8 "Hofbauer cells: 4.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "hippocampal formation: 7.3" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Group enriched" "Detected in some" 11 "EFO-21: 21.0;HUVEC TERT2: 31.6;TIME: 43.8" "Low region specificity" "Detected in many" NA NA "unprognostic (2.78e-1)" "unprognostic (7.40e-2)" "unprognostic (3.08e-3)" "unprognostic (1.32e-2)" "unprognostic (3.39e-2)" "unprognostic (5.72e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (2.22e-2)" "unprognostic (3.53e-2)" "unprognostic (1.13e-1)" "unprognostic (6.34e-2)" "unprognostic (2.71e-4)" "unprognostic (8.42e-3)" "unprognostic (6.21e-2)" "unprognostic (1.99e-1)" "unprognostic (8.74e-2)" 0.9 0.4 0.4 0.3 0.8 0.0 0.4 1.1 4.6 0.4 0.4 3.2 0.0 1.1 0.3 0.0 3.6 0.3 5.0 1.5 7.3 0.4 0.7 1.9 1.0 0.2 0.4 1.0 0.3 0.3 2.2 0.7 1.3 1.4 0.4 1.0 0.2 0.3 0.0 0.3 0.4 3.5 0.1 0.6 0.6 0.4 0.3 0.0 0.0 0.7 9.9 1.4 0.6 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.0 0.2 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 2.8 0.0 31.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.4 0.8 1.1 2.4 7.3 0.4 0.4 1.0 1.4 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 TNFSF4 "CD252, gp34, OX-40L, TXGP1" ENSG00000117586 "TNF superfamily member 4" P23510 1 173183734-173207313 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins" Cytokine "Cancer-related genes, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.5;testis: 14.4" "Group enriched" "Detected in some" 4 "Early spermatids: 4.3;monocytes: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 18.7;HHSteC: 8.1;HUVEC TERT2: 36.8;LHCN-M2: 30.6" HPA059579 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059579: AB_2684071" "unprognostic (1.88e-2)" "unprognostic (1.20e-1)" "unprognostic (4.58e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (1.74e-1)" "unprognostic (1.13e-3)" "unprognostic (2.13e-1)" "unprognostic (8.65e-2)" "unprognostic (5.17e-2)" "unprognostic (1.26e-2)" "unprognostic (1.18e-1)" "unprognostic (1.11e-7)" "unprognostic (3.73e-3)" "unprognostic (2.66e-1)" "unprognostic (9.49e-2)" "unprognostic (2.98e-2)" 2.1 4.0 1.7 8.2 2.3 0.9 3.7 4.5 3.4 1.7 1.8 1.0 0.8 0.3 1.5 1.5 1.6 1.4 2.1 2.1 3.0 2.0 1.5 1.6 2.5 11.5 1.9 0.8 2.7 2.1 1.0 3.3 1.2 1.2 2.8 2.5 1.0 0.8 1.0 0.8 0.3 2.5 1.6 1.9 9.7 1.4 14.4 1.2 9.3 0.8 0.8 3.7 1.6 1.6 1.3 2.6 1.7 0.2 3.4 1.2 6.5 0.0 0.0 0.2 0.5 1.3 6.7 0.0 1.8 0.4 0.1 0.1 0.0 0.0 0.0 0.3 18.7 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 8.1 0.1 0.0 2.9 0.1 0.9 0.1 0.6 36.8 0.7 0.0 0.2 30.6 0.0 0.3 0.1 0.1 0.0 0.3 0.9 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.1 0.3 0.6 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.4 0.6 0.1 0.1 3.4 2.0 0.0 0.2 0.3 1.1 0.1 0.8 1.1 0.7 0.9 0.8 1.3 1.2 1.1 1.7 3.4 0.1 2.6 0.9 6.5 1.7 2.3 4.5 3.4 3.0 2.0 1.9 0.8 1.2 1.2 0.0 0.3 0.0 0.4 0.7 0.0 1.2 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.0 4.3 0.7 0.0 0.0 0.0 0.1 1.2 0.5 0.0 0.9 0.4 0.0 0.0 0.0 0.8 0.9 0.3 0.2 1.7 12.6 0.0 1.0 0.2 0.0 1.8 0.0 0.3 0.0 1.9 0.2 0.2 0.5 0.0 1.5 0.0 0.1 TNFSF8 "CD153, CD30LG" ENSG00000106952 "TNF superfamily member 8" P32971 9 114893343-114930595 "Cancer-related genes, CD markers, Predicted membrane proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.6;lymphoid tissue: 48.1" "Group enriched" "Detected in some" 4 "B-cells: 4.4;Hofbauer cells: 3.2;Kupffer cells: 6.5;Macrophages: 4.4;T-cells: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Daudi: 34.1;SuSa: 16.1;U-698: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (8.82e-2)" "unprognostic (6.56e-3)" "unprognostic (7.79e-2)" "unprognostic (6.05e-2)" "unprognostic (2.67e-1)" "unprognostic (5.58e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.37e-1)" "unprognostic (1.24e-1)" "unprognostic (1.70e-1)" "unprognostic (2.02e-1)" "unprognostic (4.75e-2)" "unprognostic (3.01e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-2)" "unprognostic (1.82e-1)" 3.6 1.7 1.1 12.0 1.7 12.7 1.8 0.5 0.9 1.6 2.4 1.4 0.6 0.3 1.1 2.5 1.4 1.5 4.6 2.8 1.1 1.2 1.8 1.4 4.9 48.1 1.6 0.6 0.9 1.1 0.0 0.8 2.2 1.0 1.3 1.9 1.4 3.7 0.9 0.7 1.0 7.0 1.3 2.8 14.9 1.7 1.1 1.0 45.6 1.6 0.8 18.5 3.2 1.3 1.7 7.3 3.9 14.1 1.0 18.6 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 14.1 0.0 4.1 7.3 13.8 1.0 16.4 9.8 7.3 1.7 18.6 13.5 3.9 1.0 0.9 4.0 5.9 8.7 1.1 1.7 0.5 0.9 1.1 1.2 1.6 0.6 1.0 1.0 0.0 0.0 4.4 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.2 0.0 0.0 1.3 6.5 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 9.2 0.0 0.0 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171061339-171460408 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.9" "Cell type enhanced" "Detected in many" 7 "granulocytes: 79.9;Muller glia cells: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 23 "basophil: 4.4;eosinophil: 10.5;gdT-cell: 4.2;MAIT T-cell: 5.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.7;naive CD4 T-cell: 6.7;naive CD8 T-cell: 3.8;NK-cell: 2.7;T-reg: 5.3" "Group enriched" "Detected in many" 29 "granulocytes: 10.5;NK-cells: 2.7;T-cells: 6.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;HEL: 27.0;HMC-1: 30.8;WM-115: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol NA NA 9100 Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 2.2 5.4 29.0 7.4 30.9 4.9 3.6 21.1 26.1 1.9 10.9 12.2 4.1 25.8 4.3 2.1 5.6 4.3 7.1 11.2 30.9 14.8 5.6 4.6 11.3 7.9 11.4 18.3 2.6 5.2 0.7 9.0 3.1 13.6 5.6 9.5 3.5 2.9 7.3 23.2 1.6 25.6 6.0 14.5 5.8 9.2 10.7 21.1 3.7 7.1 2.2 6.9 6.4 2.6 0.2 0.0 10.5 0.1 2.7 6.7 1.1 0.3 0.5 19.9 2.1 0.3 0.0 4.7 4.1 1.2 3.3 2.2 17.8 7.4 0.0 1.5 3.8 3.0 6.1 2.8 1.1 3.6 0.1 4.4 27.0 1.5 0.0 9.5 5.3 30.8 2.9 3.0 1.9 0.4 7.7 19.8 4.5 9.7 0.0 0.5 0.4 1.7 6.8 8.2 14.2 7.7 0.0 5.1 7.1 6.4 0.0 0.9 1.0 2.5 0.2 4.4 2.2 9.0 1.3 0.2 0.0 3.5 9.0 3.0 0.0 0.0 0.0 0.9 6.0 23.0 4.4 0.1 10.5 4.2 0.0 5.2 0.0 5.0 3.7 0.0 0.2 6.7 3.8 0.1 2.7 0.1 0.0 5.3 1.1 29.0 30.9 21.1 22.2 30.9 14.8 11.4 18.3 13.6 21.1 6.0 37.9 0.5 1.4 2.3 9.3 25.7 25.5 2.7 12.5 8.7 13.7 4.7 5.0 9.2 29.5 1.6 26.2 0.0 6.8 1.8 4.4 0.6 79.9 6.8 2.5 0.0 12.7 1.3 5.6 33.0 2.3 3.3 1.7 0.0 9.4 79.4 4.8 16.5 6.0 14.9 27.7 0.0 7.6 2.8 1.0 1.4 2.1 31.2 15.3 2.4 TNIP3 "ABIN-3, FLJ21162, LIND" ENSG00000050730 "TNFAIP3 interacting protein 3" Q96KP6 4 121131408-121227466 "Predicted intracellular proteins" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 9.2;lung: 8.5;lymphoid tissue: 15.4" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 2: 23.7;Early spermatids: 11.2;Late spermatids: 32.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 9.2" "Lineage enriched" "Detected in single" 12 "T-cells: 9.2" "Cell line enhanced" "Detected in some" "HDLM-2: 5.7;hTEC/SVTERT24-B: 6.6;U-138 MG: 25.4;U-266/70: 7.2;U-266/84: 7.1;U-87 MG: 5.2" "Low region specificity" "Detected in many" HPA043063 Uncertain NA NA "HPA043063: AB_10793989" "unprognostic (2.89e-3)" "unprognostic (2.60e-1)" "unprognostic (5.23e-3)" "unprognostic (8.75e-5)" "unprognostic (9.62e-3)" "unprognostic (2.14e-2)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (2.80e-1)" "unprognostic (3.19e-2)" "unprognostic (2.55e-1)" "unprognostic (9.35e-2)" "unprognostic (2.84e-7)" "unprognostic (3.35e-2)" "unprognostic (6.51e-2)" "unprognostic (3.51e-1)" "unprognostic (8.78e-2)" 2.2 0.3 1.0 9.8 0.2 1.3 0.3 0.3 0.7 2.0 1.3 0.2 0.2 0.6 0.2 0.2 1.8 0.4 1.5 0.4 0.4 0.6 0.3 0.7 8.5 3.5 0.7 0.2 0.2 0.2 0.0 0.2 0.2 0.5 0.9 0.4 0.2 0.8 0.2 0.4 0.3 1.2 0.5 0.3 2.8 0.8 1.4 0.2 15.4 0.4 3.6 6.3 1.3 0.4 0.2 0.1 0.7 0.2 0.1 9.2 0.8 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.3 0.4 0.1 0.1 0.9 0.1 0.1 0.1 2.2 3.7 0.0 0.0 0.5 0.8 5.7 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 6.6 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.1 0.1 0.1 25.4 0.5 2.0 0.1 7.2 7.1 0.2 5.2 0.2 0.8 0.7 0.2 0.0 4.0 0.0 2.7 0.1 1.8 9.2 0.0 0.2 0.8 4.4 0.6 0.1 0.2 0.1 1.1 0.8 1.0 0.2 0.3 0.7 0.4 0.6 0.7 0.2 0.5 0.2 3.0 23.7 0.5 0.0 0.1 0.0 0.4 0.0 0.0 2.3 0.0 5.9 0.0 0.0 0.1 11.2 0.7 0.0 0.0 1.0 0.0 0.2 0.1 6.9 0.0 0.4 0.0 0.0 0.0 1.2 32.4 0.3 5.2 0.0 0.0 0.0 0.1 0.4 1.1 0.0 0.0 1.1 0.0 0.0 0.5 0.4 0.4 0.0 6.7 0.0 0.1 TNMD "BRICD4, ChM1L, myodulin, TEM, tendin" ENSG00000000005 Tenomodulin Q9H2S6 X 100584802-100599885 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 18.4;seminal vesicle: 25.0" "Cell type enhanced" "Detected in some" 23 "Basal keratinocytes: 1.8;Distal tubular cells: 3.3;Leydig cells: 8.6;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HAP1: 7.3;NTERA-2: 17.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA034961, HPA055634" Uncertain NA NA "HPA034961: AB_10670285, HPA055634: AB_2682868" "unprognostic (3.60e-2)" "unprognostic (9.84e-3)" "unprognostic (3.19e-2)" "unprognostic (7.77e-3)" "unprognostic (2.42e-1)" "unprognostic (2.15e-1)" "unprognostic (2.36e-2)" "unprognostic (1.37e-1)" "unprognostic (9.40e-2)" "unprognostic (9.60e-4)" "unprognostic (6.82e-2)" "unprognostic (5.67e-2)" "unprognostic (1.48e-1)" 18.4 0.1 0.1 0.4 0.0 0.0 10.9 0.0 0.1 0.4 0.6 0.0 11.1 0.0 0.2 8.9 0.4 0.2 0.3 0.7 0.9 0.1 0.7 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 1.9 0.6 1.1 0.4 4.7 1.3 25.0 5.9 2.9 0.5 0.5 0.0 0.1 0.1 0.2 0.0 0.2 0.1 2.6 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.1 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 8.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 TNN ENSG00000120332 "Tenascin N" Q9UQP3 1 175067858-175148066 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 15.2;gallbladder: 14.2" "Cell type enhanced" "Detected in some" 14 "Ito cells: 2.5;Smooth muscle cells: 2.7;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in some" "breast cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.6;NB-4: 4.7;THP-1: 14.4;U-266/70: 3.7;U-937: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB010907, HPA026726, HPA026764" Uncertain "Secreted to extracellular matrix" NA NA 11000000 "CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859" "unprognostic (1.16e-3)" "unprognostic (2.23e-2)" "unprognostic (1.35e-1)" "unprognostic (2.21e-2)" "unprognostic (1.34e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (3.55e-1)" "unprognostic (5.25e-3)" "unprognostic (1.01e-2)" "unprognostic (4.69e-1)" "unprognostic (5.07e-1)" "unprognostic (1.08e-3)" "unprognostic (1.76e-2)" "unprognostic (9.38e-3)" "unprognostic (1.89e-2)" "unprognostic (1.02e-2)" 15.2 0.2 0.1 1.5 0.2 0.0 7.9 0.4 0.8 0.3 0.8 0.1 0.1 1.0 0.1 0.5 0.3 0.0 14.2 0.6 0.1 0.0 0.4 1.8 1.8 0.1 0.1 0.9 0.1 0.3 1.8 3.7 0.1 0.6 0.1 0.1 4.8 6.4 0.1 0.1 5.3 1.0 0.8 0.7 0.6 0.5 0.1 0.3 0.3 2.6 7.5 0.3 0.1 0.2 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.3 0.0 14.4 0.0 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.7 0.1 0.0 0.1 0.9 0.6 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.7 1.6 0.1 0.0 0.0 0.0 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451102-52454070 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 431.6;skeletal muscle: 765.7" "Cell type enriched" "Detected in many" 8 "Cardiomyocytes: 2506.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Lineage enriched" "Detected in single" 7 "T-cells: 4.0" "Cell line enhanced" "Detected in some" "CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5" "Region enriched" "Detected in many" 4 "cerebral cortex: 88.3" "Not detected" "Not detected" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" NA NA 260000 "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 2.0 0.3 0.1 0.0 0.1 0.0 0.7 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 17.8 12.8 0.1 0.0 431.6 0.1 0.1 0.6 0.1 2.6 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.2 0.5 5.5 0.1 0.7 10.4 0.0 765.7 0.4 0.1 0.1 0.7 0.1 0.1 0.7 0.0 0.0 3.0 86.9 8.7 0.4 0.2 0.2 0.6 0.0 0.0 0.0 4.0 0.5 0.2 1.8 1.3 0.2 0.0 0.2 2.9 0.1 0.1 0.1 0.1 24.3 12.2 0.2 24.4 3.5 0.0 0.1 0.0 0.1 0.0 0.4 0.6 0.1 16.0 16.2 0.1 0.1 0.0 25.3 0.4 0.0 0.2 0.2 0.0 0.7 0.0 1.9 0.7 0.0 0.0 0.2 0.2 5.4 0.2 0.0 1.0 0.8 1.2 4.6 0.0 0.0 0.1 2.5 0.0 1.5 9.8 0.2 0.0 0.0 37.5 0.3 0.0 1.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 4.0 0.2 0.9 0.5 0.0 0.1 1.4 0.5 0.0 0.0 0.0 0.6 2.5 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.0 116.1 13.0 0.0 0.6 1.3 0.2 2506.5 0.0 0.0 7.9 3.5 2.0 44.2 23.2 6.6 0.6 0.0 0.7 0.0 11.8 4.0 14.0 0.6 0.0 0.6 4.1 0.0 318.5 0.6 0.0 3.6 20.8 1.0 5.0 0.0 0.3 1.5 4.4 0.0 166.9 0.5 0.0 0.0 15.5 1.2 0.4 0.6 26.0 0.8 1.5 4.1 TNNC2 ENSG00000101470 "Troponin C2, fast skeletal type" P02585 20 45823214-45833745 "FDA approved drug targets, Predicted intracellular proteins" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 851.6" "Group enriched" "Detected in many" 6 "Enterocytes: 242.7;Mucus-secreting cells: 94.6;Paneth cells: 103.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "memory B-cell: 6.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Hep G2: 9.9;HSkMC: 15.7;SCLC-21H: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043174, HPA058481" Enhanced Approved Nucleoplasm,Vesicles No NA 63000 Nucleoplasm Vesicles "HPA043174: AB_10806380, HPA058481: AB_2683729" "unprognostic (1.13e-1)" "unprognostic (7.25e-2)" "unprognostic (3.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-5)" "unprognostic (1.80e-2)" "unprognostic (5.72e-3)" "unprognostic (3.12e-3)" "unprognostic (2.19e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (1.05e-1)" "unprognostic (9.03e-3)" "unprognostic (7.15e-3)" "unprognostic (4.79e-1)" "unprognostic (5.23e-2)" "unprognostic (1.13e-1)" 12.0 0.2 0.1 0.1 0.4 0.1 0.3 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 2.7 4.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 1.4 0.1 0.0 7.8 0.1 851.6 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.6 169.1 6.6 0.1 0.1 6.0 0.8 2.4 1.1 0.3 4.1 11.9 0.1 0.0 0.3 0.5 1.7 1.2 1.8 0.2 0.4 0.0 0.1 0.2 1.2 0.4 1.2 1.0 0.4 0.4 0.0 0.4 0.0 0.0 0.3 0.0 1.0 9.9 0.4 0.3 0.2 15.7 0.2 0.1 0.8 0.4 0.0 1.2 0.1 0.5 0.2 1.2 0.7 0.1 0.0 0.4 0.6 0.3 0.6 0.2 0.3 0.1 11.8 0.6 1.7 0.1 0.4 0.5 1.4 0.4 0.5 0.3 0.4 0.9 0.2 1.6 0.4 0.3 1.6 0.1 0.2 0.0 0.7 1.4 0.2 1.1 0.7 6.0 1.5 0.2 0.3 3.8 0.0 0.3 2.4 0.3 0.8 0.8 4.1 11.9 0.1 0.4 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.1 4.2 0.5 0.7 1.3 0.4 2.5 0.0 4.5 3.5 0.0 2.1 3.3 1.3 2.9 0.1 242.7 0.0 4.7 0.2 2.6 0.7 0.0 0.8 0.2 0.0 22.0 0.0 0.0 26.3 1.1 0.5 0.0 0.0 94.6 1.4 2.5 103.7 2.8 0.7 1.7 0.0 3.6 2.3 5.8 7.3 0.1 0.0 25.8 0.5 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 559.6" "Cell type enriched" "Detected in some" 10 "Cardiomyocytes: 50.9" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 9 "RH-30: 106.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli NA NA 25000 Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 22.9 9.5 0.0 0.1 6.6 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 6.8 0.0 559.6 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.7 83.8 10.7 0.0 0.1 0.2 0.6 1.7 0.4 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 106.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.3 0.3 0.3 0.1 0.2 0.2 0.2 0.6 0.2 0.3 0.5 1.7 0.4 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 50.9 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 2.7 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838989-1841680 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skeletal muscle: 635.0;tongue: 527.7" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 241.7;Syncytiotrophoblasts: 72.9" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.4" "Group enriched" "Detected in many" 4 "dendritic cells: 46.4;granulocytes: 26.7" "Group enriched" "Detected in some" 6 "CAPAN-2: 23.2;hTCEpi: 66.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" NA NA 29000 "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: AB_2682976" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 13.9 0.1 0.1 0.1 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 16.5 11.6 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.3 0.0 1.2 0.1 0.0 15.7 0.4 635.0 4.8 0.2 0.1 0.2 0.4 0.1 0.1 0.0 0.0 3.0 527.7 11.5 2.1 0.1 2.3 46.4 26.7 8.6 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 23.2 0.6 0.1 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 5.6 66.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 2.0 0.0 0.0 0.8 1.5 0.0 0.6 0.0 0.6 0.0 0.4 0.0 0.0 8.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 6.1 3.1 26.7 0.0 6.5 0.0 1.9 0.0 0.0 4.3 2.3 0.0 0.0 21.1 0.2 8.6 46.4 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 4.1 7.2 0.5 22.2 0.0 4.9 20.4 10.7 3.4 0.0 0.0 31.7 0.0 1.2 0.0 0.7 0.0 0.0 0.5 241.7 2.3 0.0 10.4 0.0 38.5 0.0 0.0 0.0 18.2 0.0 0.3 18.6 0.0 3.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 5.6 72.9 0.9 0.0 0.5 TNNI3 "CMD2A, CMH7, TNNC1" ENSG00000129991 "Troponin I3, cardiac type" P19429 19 55151767-55157773 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 367 "heart muscle: 419.3" "Cell type enriched" "Detected in many" 56 "Cardiomyocytes: 9185.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 7.1;HMC-1: 11.9;K-562: 21.6;OE19: 30.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB009349, HPA046428" Enhanced Approved Vesicles,Cytosol NA NA 1700000 Cytosol Vesicles "CAB009349: AB_793465, HPA046428: AB_2679661" "unprognostic (2.12e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-2)" "unprognostic (1.36e-1)" "unprognostic (2.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.37e-3)" "unprognostic (2.13e-1)" "unprognostic (9.62e-3)" "unprognostic (9.40e-2)" "unprognostic (3.34e-2)" "unprognostic (2.17e-3)" "unprognostic (4.02e-3)" "unprognostic (8.89e-2)" "unprognostic (8.54e-2)" "unprognostic (1.05e-1)" "unprognostic (9.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 1.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.2 0.1 419.3 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.7 0.7 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.9 3.7 0.0 0.6 0.5 0.7 0.1 0.0 0.0 7.1 1.7 0.0 1.0 0.3 0.0 11.9 0.0 0.3 0.0 0.1 0.0 0.0 0.4 21.6 0.4 0.0 0.3 0.1 0.0 0.4 30.9 0.2 0.9 0.2 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.6 5.4 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 6.2 0.0 9185.5 10.2 6.7 2.3 5.2 0.0 0.9 0.0 0.6 46.9 0.1 0.0 0.0 0.2 0.4 3.1 0.0 0.0 0.0 1.9 1.6 1.7 0.0 0.0 164.8 0.3 0.2 1.7 0.0 0.2 1.8 1.1 0.0 1.8 0.0 0.2 0.0 0.0 4.2 10.3 2.5 2.1 0.0 0.4 0.0 TNNI3K CARK ENSG00000116783 "TNNI3 interacting kinase" Q59H18 1 74235401-74544428 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "heart muscle: 44.6" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 23.4;Early spermatids: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.3;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;HSkMC: 2.6;OE19: 2.8;RPTEC TERT1: 2.6" NA NA "unprognostic (1.04e-2)" "unprognostic (1.34e-2)" "unprognostic (3.83e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-1)" "unprognostic (3.40e-2)" "unprognostic (3.05e-1)" "unprognostic (2.48e-3)" "unprognostic (2.00e-1)" "unprognostic (9.66e-2)" "unprognostic (5.04e-2)" "unprognostic (1.80e-1)" "unprognostic (3.59e-3)" "unprognostic (4.88e-3)" "unprognostic (1.20e-1)" "unprognostic (8.80e-2)" "unprognostic (8.77e-2)" 0.7 0.6 1.1 0.5 1.5 0.0 1.0 6.0 1.7 0.5 0.5 0.5 0.5 0.2 0.5 1.7 0.5 0.7 0.5 44.6 1.1 1.3 2.2 0.5 0.5 0.5 0.6 0.5 0.7 0.5 0.3 0.6 0.5 0.9 0.5 0.3 0.5 0.5 1.2 0.5 0.9 0.5 0.6 0.5 0.5 0.1 1.8 0.5 0.5 0.6 0.5 0.5 0.5 0.5 0.3 1.9 0.0 2.3 0.0 1.0 0.1 0.0 0.6 0.7 0.0 0.5 1.5 0.0 0.0 1.3 0.3 1.0 0.0 3.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.5 2.6 1.5 0.2 0.0 0.0 0.5 0.3 0.0 0.8 1.1 0.0 0.2 0.2 1.1 2.8 0.0 0.2 0.0 0.0 2.6 0.0 0.3 0.9 0.0 0.0 0.0 0.1 0.0 0.8 1.3 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.1 2.3 0.0 0.1 0.3 1.0 0.1 0.3 0.2 0.4 0.0 0.0 0.2 1.9 0.0 0.1 1.1 1.5 6.0 1.7 1.1 1.3 0.6 0.5 0.9 0.5 0.0 0.0 0.0 0.1 0.8 1.2 23.4 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.1 20.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 1.6 0.0 0.0 0.0 5.4 0.9 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.7 3.3 0.2 0.0 1.7 0.4 1.1 0.3 0.1 0.0 0.0 0.1 TNNT1 "ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS" ENSG00000105048 "Troponin T1, slow skeletal type" P13805 19 55132794-55149354 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 1047.7" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 54.4;Cardiomyocytes: 49.6;Spermatogonia: 26.7;Suprabasal keratinocytes: 26.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "eosinophil: 53.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 53.3" "Cell line enhanced" "Detected in many" "HMC-1: 121.8;RH-30: 91.7" "Region enriched" "Detected in many" 5 "thalamus: 136.6" "Low region specificity" "Detected in some" "CAB015168, HPA058448" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Golgi apparatus, Cytosol" "CAB015168: AB_2206426, HPA058448: AB_2683720" "unprognostic (1.88e-1)" "unprognostic (7.23e-2)" "prognostic unfavorable (4.66e-4)" "prognostic unfavorable (4.66e-4)" "unprognostic (3.47e-3)" "unprognostic (3.92e-3)" "unprognostic (1.35e-3)" "unprognostic (1.03e-3)" "unprognostic (2.46e-1)" "unprognostic (1.95e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.23e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.91e-2)" "unprognostic (4.01e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-2)" 3.2 0.0 1.6 0.0 1.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.1 0.0 24.4 22.3 0.4 0.1 6.1 0.9 0.4 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 7.2 0.0 0.0 11.5 0.0 1047.7 1.8 0.0 0.0 0.1 0.1 0.1 0.5 0.0 0.0 9.2 124.4 17.8 0.3 0.1 0.1 9.9 53.3 11.6 0.1 0.1 2.6 24.8 14.6 0.1 3.2 0.0 0.2 4.8 1.1 4.3 1.6 4.8 5.3 16.6 0.3 9.7 0.4 13.0 12.7 3.4 10.8 1.3 1.6 27.6 4.7 1.5 0.9 0.5 0.3 121.8 5.4 17.6 0.5 18.7 18.5 0.0 5.0 23.6 23.1 1.5 23.7 0.4 0.0 3.1 6.3 29.0 15.9 91.7 2.9 3.8 0.8 0.9 7.2 1.5 0.2 8.0 1.3 15.1 14.5 0.5 24.1 35.9 0.9 1.8 0.1 0.9 1.2 25.4 3.7 7.3 0.5 11.6 53.3 0.0 5.9 0.1 0.0 0.1 0.0 9.9 0.1 0.1 0.1 0.5 0.1 2.6 0.2 0.0 2.6 1.6 1.0 0.1 1.0 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.4 1.5 49.6 0.0 6.7 0.0 0.0 0.0 1.3 0.0 1.8 1.3 0.0 0.0 0.0 0.0 14.0 8.0 0.0 0.0 0.0 13.2 0.0 2.4 1.8 12.0 6.0 0.3 4.2 3.3 0.0 0.2 0.8 0.4 0.0 0.0 0.0 0.6 0.0 0.9 2.8 26.7 26.6 3.0 0.0 0.3 0.1 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell type enriched" "Detected in many" 289 "Cardiomyocytes: 11884.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 189.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" No No 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 189.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 3.0 4.0 0.0 1.1 3.1 1.0 11884.8 0.0 0.0 1.2 1.8 0.0 2.3 0.0 0.5 9.4 0.0 1.6 0.0 0.3 0.9 41.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 4.6 0.5 0.0 0.7 0.8 1.1 0.8 0.5 0.0 0.4 0.0 0.2 6.4 3.5 0.0 2.8 1.4 TNNT3 "AMCD2B, DA2B, DKFZp779M2348, FSSV" ENSG00000130595 "Troponin T3, fast skeletal type" P45378 11 1919562-1938706 "Disease related genes, Predicted intracellular proteins" "Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 38 "skeletal muscle: 834.7;tongue: 355.7" "Cell type enhanced" "Detected in some" 16 "Ciliated cells: 29.4;Leydig cells: 102.6;Peritubular cells: 89.1" "Group enriched" "Detected in many" 9 "head and neck cancer: 28.8;urothelial cancer: 19.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "basophil: 9.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 9.5" "Cell line enriched" "Detected in some" 21 "HSkMC: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB002451, HPA037810, HPA056909" Enhanced NA NA "CAB002451: AB_564151, HPA037810: AB_10966217, HPA056909: AB_2683273" "unprognostic (1.01e-2)" "prognostic favorable (7.37e-4)" "unprognostic (2.17e-2)" "unprognostic (2.30e-3)" "unprognostic (1.23e-2)" "unprognostic (1.29e-2)" "unprognostic (4.53e-3)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (4.29e-3)" "unprognostic (3.53e-2)" "unprognostic (4.34e-1)" "unprognostic (1.42e-5)" "unprognostic (2.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.79e-2)" "unprognostic (2.90e-2)" 15.6 0.1 0.0 0.1 0.0 0.1 0.9 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.3 4.4 7.5 0.6 0.2 4.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 2.9 0.0 1.4 0.1 0.0 12.1 0.3 834.7 0.3 0.1 0.3 0.1 0.1 0.1 0.4 0.0 0.0 4.1 355.7 10.1 1.2 0.6 0.0 0.9 9.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 1.6 2.6 0.0 13.4 0.0 29.4 9.1 0.0 0.0 21.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 6.5 14.7 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.9 102.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 89.1 0.0 0.0 0.0 0.3 0.0 0.1 3.0 15.3 0.7 0.0 11.6 TNP1 ENSG00000118245 "Transition protein 1" P09430 2 216859458-216860064 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 103 "testis: 349.0" "Group enriched" "Detected in some" 154 "Early spermatids: 39992.5;Late spermatids: 95978.5" "Group enriched" "Detected in some" 58 "liver cancer: 6.0;testis cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.2;Hep G2: 6.9;NB-4: 2.6;U-2197: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA044387 Enhanced NA NA "HPA044387: AB_2678923" "unprognostic (1.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 349.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39992.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95978.5 379.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 232.0 0.0 0.0 245.8 0.0 441.5 152.2 0.0 0.0 0.0 0.0 0.0 TNP2 TP2 ENSG00000178279 "Transition protein 2" Q05952 16 11267748-11269533 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 166 "testis: 38.8" "Group enriched" "Detected in some" 124 "Early spermatids: 163.4;Late spermatids: 575.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HBEC3-KT: 1.9" "Not detected" "Not detected" NA NA "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 575.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.0 1.5 0.0 0.0 0.0 0.0 0.0 TNR ENSG00000116147 "Tenascin R" Q92752 1 175315194-175743770 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "brain: 56.4" "Cell type enriched" "Detected in some" 168 "Horizontal cells: 548.2" "Cancer enriched" "Detected in single" 46 "glioma: 9.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SH-SY5Y: 5.8;THP-1: 2.3;U-937: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022343, HPA027134, HPA027150, HPA029859" Enhanced "Secreted in brain" NA NA 230000 "CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916" "unprognostic (1.04e-1)" "unprognostic (7.43e-2)" "unprognostic (3.11e-2)" "unprognostic (1.12e-3)" "unprognostic (2.38e-1)" "unprognostic (1.51e-2)" "unprognostic (9.66e-2)" "unprognostic (2.57e-2)" "unprognostic (5.79e-2)" "unprognostic (5.06e-2)" "unprognostic (3.03e-3)" "unprognostic (7.26e-4)" "unprognostic (4.48e-4)" "unprognostic (3.26e-3)" "unprognostic (3.83e-1)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" 1.2 3.0 21.8 1.4 14.2 1.3 1.2 9.1 56.4 1.2 1.2 17.2 0.0 1.2 1.3 1.4 1.3 1.2 1.3 1.2 18.1 14.4 1.2 1.7 1.7 1.4 16.5 13.3 1.2 1.7 1.2 2.0 1.2 16.1 1.2 1.3 0.1 1.2 1.2 1.2 1.2 1.3 1.3 8.2 1.4 1.6 1.6 14.3 0.0 1.3 0.0 1.6 1.3 0.1 0.4 0.1 0.6 0.0 1.9 0.1 0.0 0.0 0.3 1.2 0.2 0.1 0.1 0.7 0.3 0.2 0.3 0.1 0.8 0.2 0.4 0.7 1.1 0.1 0.7 0.0 0.6 0.2 0.3 0.0 0.1 0.6 0.4 0.0 0.4 0.1 0.5 0.8 0.1 0.4 0.1 0.2 0.2 0.3 0.4 0.0 0.6 0.2 0.6 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.3 5.8 0.6 0.3 0.2 0.4 0.4 2.3 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.5 4.3 0.3 0.6 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.4 0.1 0.1 0.4 1.9 0.0 0.1 0.0 0.0 21.8 14.2 9.1 23.7 18.1 14.4 16.5 13.3 16.1 14.3 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 548.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TNRC6B KIAA1093 ENSG00000100354 "Trinucleotide repeat containing 6B" Q9UPQ9 22 40044817-40335808 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 86.1" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 432.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 86.1" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003180 Approved NA NA "HPA003180: AB_1079196" "unprognostic (1.45e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" "unprognostic (5.88e-2)" "unprognostic (1.92e-2)" "unprognostic (3.27e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-2)" "unprognostic (9.74e-2)" "unprognostic (4.93e-2)" "unprognostic (2.59e-1)" "unprognostic (8.42e-2)" "unprognostic (1.84e-3)" "unprognostic (8.85e-2)" "unprognostic (7.24e-2)" "unprognostic (7.00e-2)" "unprognostic (1.81e-1)" 8.0 8.0 16.7 15.3 13.8 32.6 8.3 27.8 19.4 9.0 8.2 11.1 8.0 6.8 10.3 12.3 7.4 7.7 9.2 9.2 15.1 8.3 8.5 11.3 9.8 15.7 13.4 10.4 9.5 8.1 13.3 14.3 7.5 11.5 7.9 7.7 10.1 8.5 9.7 11.4 10.2 10.4 9.5 10.3 11.8 8.6 27.2 15.1 20.8 10.4 3.5 13.9 8.9 9.6 25.7 18.0 86.1 6.0 5.6 9.8 1.8 5.7 8.7 8.9 9.3 6.0 4.2 4.9 4.0 7.3 6.2 7.6 3.9 4.1 10.8 7.1 4.7 7.3 4.0 11.0 8.0 6.5 11.8 8.8 8.2 8.2 4.9 3.0 9.2 12.0 4.6 3.8 9.7 4.9 3.0 8.4 6.2 6.6 10.2 5.7 6.1 5.6 3.0 11.6 4.4 6.3 7.0 8.5 5.5 5.9 9.8 10.9 2.6 9.5 3.4 5.0 8.5 4.8 3.4 9.6 5.4 20.2 5.5 3.6 8.1 7.4 7.1 3.5 4.7 6.4 31.0 6.0 10.7 8.8 3.3 7.8 16.9 9.2 7.9 2.7 25.7 9.8 9.8 86.1 5.6 4.7 18.0 4.9 1.8 16.7 13.8 27.8 19.4 15.1 8.3 13.4 10.4 11.5 15.1 35.7 40.0 163.9 56.7 66.4 230.6 133.6 109.5 62.9 43.3 66.3 432.0 31.1 59.7 45.4 60.5 95.1 69.1 140.2 51.2 17.5 70.1 67.0 64.6 92.3 34.4 322.6 135.4 108.1 95.1 61.3 103.6 58.0 62.4 55.9 77.0 148.7 49.0 75.0 120.2 44.5 360.3 51.8 78.3 77.0 88.4 71.8 6.3 107.1 75.5 51.5 TNS1 "DKFZp586K0617, MXRA6, PPP1R155, TNS" ENSG00000079308 "Tensin 1" Q9HBL0 2 217799588-218010421 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 153.0" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 299.8;Peritubular cells: 473.8;Sertoli cells: 362.2;Smooth muscle cells: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 46.9;ASC TERT1: 25.6;fHDF/TERT166: 22.2;REH: 24.4;TIME: 21.7" "Low region specificity" "Detected in all" "CAB018774, HPA036089, HPA036090" Approved Enhanced "Focal adhesion sites" NA NA "Focal adhesion sites" "CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.13e-2)" "unprognostic (5.46e-2)" "unprognostic (2.63e-2)" "unprognostic (1.20e-3)" "unprognostic (7.34e-2)" "unprognostic (2.55e-2)" "unprognostic (1.28e-3)" "unprognostic (5.57e-2)" "unprognostic (9.74e-2)" "unprognostic (4.71e-3)" "unprognostic (5.60e-3)" "unprognostic (2.88e-2)" "unprognostic (7.49e-2)" "prognostic unfavorable (5.19e-4)" 77.6 15.6 5.2 21.1 13.7 9.2 33.5 2.9 8.9 50.0 68.9 17.2 45.6 6.0 61.1 29.8 52.0 31.1 46.7 41.0 6.8 4.8 24.0 9.2 28.9 6.1 15.8 4.1 32.3 14.1 6.0 3.8 14.0 14.3 55.1 11.4 27.6 12.8 63.4 40.8 10.1 17.2 153.0 13.7 17.0 30.0 22.6 12.2 1.5 18.3 9.8 4.0 124.6 53.6 0.2 1.0 0.9 1.7 0.0 0.0 2.9 0.0 0.1 3.0 0.0 46.9 25.6 0.3 7.9 2.6 0.4 0.3 3.4 0.0 0.0 4.6 22.2 0.5 0.5 0.3 0.4 0.2 3.1 0.2 6.7 2.0 0.9 3.5 0.0 0.8 12.1 0.0 8.5 0.0 15.3 11.1 0.0 0.2 0.8 6.6 0.9 0.0 0.4 0.3 0.0 0.1 24.4 5.9 0.3 1.6 0.0 0.7 3.5 1.3 3.4 0.8 2.2 1.1 2.4 21.7 5.7 10.4 5.8 1.7 0.4 0.0 0.0 3.3 0.9 0.4 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.9 0.0 0.7 1.0 0.0 2.9 5.2 13.7 2.9 8.9 6.8 4.8 15.8 4.1 14.3 12.2 160.8 81.8 4.6 45.8 14.3 2.7 299.8 33.1 20.1 36.4 14.0 0.0 8.0 6.6 34.4 1.7 55.0 0.0 116.8 16.8 1.1 42.2 8.9 29.0 28.8 13.3 39.7 0.0 74.3 14.9 4.3 157.1 14.6 10.1 0.0 0.0 12.6 16.8 0.0 473.8 20.9 1.4 362.2 208.1 0.7 2.0 10.3 1.6 5.3 0.0 14.9 TNS4 CTEN ENSG00000131746 "Tensin 4" Q8IZW8 17 40475828-40501597 "Predicted intracellular proteins" Apoptosis Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 76.9;salivary gland: 58.8;skin 1: 60.1" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 73.7;Basal keratinocytes: 118.5;Suprabasal keratinocytes: 57.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 7 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "HaCaT: 23.7;HBEC3-KT: 105.4;hTCEpi: 78.5;hTERT-HME1: 24.6;OE19: 21.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (4.16e-2)" "unprognostic (9.83e-2)" "unprognostic (1.01e-1)" "unprognostic (3.40e-2)" "unprognostic (3.68e-4)" "unprognostic (7.88e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.89e-1)" "unprognostic (8.02e-3)" "unprognostic (2.01e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-2)" "unprognostic (3.72e-1)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (7.08e-2)" 0.4 0.2 0.2 0.5 0.2 0.0 10.4 0.2 0.2 12.5 1.7 0.0 18.2 0.3 1.2 10.8 35.3 0.6 2.4 0.2 0.2 0.2 2.6 0.2 1.3 0.0 0.2 0.0 0.2 0.2 0.0 1.0 76.9 0.0 17.5 3.5 0.0 58.8 38.2 0.2 60.1 0.4 2.1 0.2 0.2 0.9 1.2 0.0 0.0 8.1 28.4 27.6 7.4 23.1 0.0 0.0 0.0 0.0 0.2 1.4 0.1 1.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.6 0.0 0.0 23.7 0.0 105.4 0.0 0.0 0.0 0.0 9.4 1.5 0.0 0.0 0.0 0.0 78.5 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 12.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 13.6 2.5 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 73.7 118.5 0.0 0.6 0.0 6.7 15.9 0.0 0.0 3.5 1.7 0.2 0.0 0.6 4.9 0.0 0.2 0.4 1.9 13.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.0 1.0 1.7 0.0 14.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 57.2 3.7 0.7 0.9 25.7 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29061373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.7" "Lineage enriched" "Detected in single" 5 "T-cells: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 3.8;NB-4: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.3 2.3 3.0 1.7 8.4 2.6 0.4 3.4 1.7 0.6 0.6 7.1 0.0 0.8 1.1 14.4 0.7 15.7 0.5 2.6 3.3 3.9 0.3 0.5 14.2 1.1 2.1 2.0 4.5 0.8 0.1 6.1 0.6 15.3 0.5 0.4 0.1 0.5 0.1 1.7 0.6 0.7 0.8 2.5 2.2 1.5 3.2 6.1 0.0 0.3 0.3 1.3 0.4 0.3 0.3 0.3 0.6 0.3 0.6 3.7 1.0 0.2 0.2 0.3 0.2 0.3 0.0 0.7 0.1 2.3 0.7 2.2 0.4 0.3 0.3 0.3 0.0 0.3 0.9 0.4 0.0 0.7 0.4 1.4 0.2 2.0 0.5 0.9 2.0 3.8 0.2 0.3 0.0 0.0 0.8 0.3 2.7 0.3 1.0 0.8 0.2 0.8 3.6 2.7 1.2 0.7 0.1 0.7 1.5 1.1 0.3 2.6 1.8 0.1 0.1 0.1 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.5 0.5 0.2 1.7 1.3 0.1 0.5 0.3 0.3 3.7 0.1 2.0 0.2 0.6 2.9 0.1 0.3 0.4 1.0 0.6 0.6 0.2 0.3 1.5 1.0 3.0 8.4 3.4 1.2 3.3 3.9 2.1 2.0 15.3 6.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 56.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TOM1 ENSG00000100284 "Target of myb1 membrane trafficking protein" O60784 22 35299275-35347994 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.8" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 142.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000818, HPA001749" Approved Approved "Plasma membrane,Centriolar satellite,Cytosol" NA NA 14000 Cytosol "Plasma membrane, Centriolar satellite" "HPA000818: AB_2666101, HPA001749: AB_1080323" "unprognostic (3.75e-1)" "unprognostic (8.07e-2)" "unprognostic (5.18e-2)" "prognostic favorable (2.20e-5)" "unprognostic (1.11e-2)" "unprognostic (7.55e-2)" "unprognostic (4.07e-3)" "unprognostic (2.24e-1)" "unprognostic (9.92e-2)" "unprognostic (2.32e-1)" "unprognostic (3.71e-1)" "unprognostic (8.16e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.22e-1)" "unprognostic (1.30e-1)" "unprognostic (7.54e-3)" "unprognostic (3.31e-2)" 17.0 21.2 9.5 10.2 13.8 31.1 13.7 10.2 24.6 16.0 14.6 12.0 7.5 17.4 14.1 15.5 31.6 11.7 15.4 19.1 8.8 15.2 16.1 27.4 17.5 8.2 11.6 11.3 12.1 11.8 21.8 16.8 39.0 23.2 10.2 6.4 17.5 37.0 10.1 83.8 29.1 18.6 7.1 8.4 10.6 8.4 13.6 8.7 10.0 14.8 25.9 19.9 12.1 17.6 4.6 15.2 40.9 31.2 4.6 14.7 17.0 6.7 6.8 3.9 6.4 28.4 16.9 18.8 6.7 20.1 12.9 14.5 9.4 6.3 2.7 12.4 20.7 8.4 3.1 4.1 7.0 4.6 7.6 9.3 2.2 7.7 19.7 26.8 4.3 10.2 22.8 8.7 18.2 6.3 8.8 9.0 5.1 4.4 6.7 6.3 6.5 3.4 10.1 3.0 8.4 4.0 6.3 5.7 5.7 5.1 5.1 6.8 5.2 15.1 15.6 14.8 3.5 8.0 7.1 9.3 15.4 13.3 11.7 3.2 7.8 4.9 7.0 20.6 4.5 5.0 5.9 31.2 13.1 6.4 18.9 5.3 4.6 9.8 6.1 15.2 4.0 7.9 5.3 40.9 4.6 19.4 8.1 14.7 17.0 9.5 13.8 10.2 24.6 8.8 15.2 11.6 11.3 23.2 8.7 20.8 37.5 13.7 9.2 11.3 9.7 19.8 10.2 14.7 20.5 12.2 11.8 57.0 23.2 33.4 21.6 14.1 43.9 0.0 34.2 48.4 23.6 12.1 22.0 27.7 54.8 11.1 15.5 14.7 31.9 17.5 10.6 37.8 18.6 22.6 16.2 19.9 27.7 15.3 12.0 28.5 8.1 6.5 16.7 9.9 5.3 19.2 142.3 10.9 12.7 9.1 TOM1L2 ENSG00000175662 "Target of myb1 like 2 membrane trafficking protein" Q6ZVM7 17 17843511-17972422 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 81.5" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022541, HPA023304" Enhanced Approved "Golgi apparatus,Intermediate filaments" NA NA 66000 "Intermediate filaments" "Golgi apparatus" "HPA022541: AB_1858182, HPA023304: AB_1858183" "unprognostic (2.32e-1)" "unprognostic (7.54e-2)" "unprognostic (1.12e-1)" "unprognostic (2.57e-2)" "unprognostic (3.25e-2)" "prognostic favorable (1.24e-4)" "unprognostic (2.22e-1)" "unprognostic (1.08e-1)" "unprognostic (6.29e-2)" "prognostic unfavorable (2.58e-4)" "prognostic favorable (1.92e-4)" "unprognostic (3.19e-2)" "prognostic favorable (6.21e-9)" "unprognostic (7.11e-2)" "unprognostic (1.40e-1)" "unprognostic (4.18e-2)" "unprognostic (4.51e-2)" 11.8 14.8 24.7 7.3 27.4 3.5 10.4 23.2 38.2 10.5 12.8 32.3 8.7 8.8 12.8 8.2 35.9 12.7 8.8 81.5 25.9 21.8 13.1 4.4 14.4 4.8 24.4 23.8 15.7 12.2 28.7 14.4 6.3 42.3 21.1 9.7 19.5 9.7 19.3 32.0 29.0 10.5 16.0 16.4 7.7 10.9 14.7 20.9 4.3 24.8 13.7 10.5 12.0 11.0 2.7 2.2 14.6 3.9 1.4 5.3 1.8 11.1 13.3 3.6 2.8 8.9 9.0 5.6 19.2 9.1 10.9 9.0 12.2 8.1 2.0 25.1 18.8 5.7 46.6 2.9 11.2 6.5 3.1 5.2 3.3 12.0 2.3 5.5 0.7 2.3 10.5 7.8 9.9 7.4 9.6 10.8 3.2 1.2 2.9 13.7 11.7 1.4 1.8 0.6 15.8 8.2 1.8 8.7 5.0 14.1 21.7 4.1 3.8 8.5 11.2 6.8 28.1 5.7 1.5 13.8 10.1 2.7 20.2 7.0 2.6 2.1 0.8 11.6 1.0 24.0 7.1 3.9 5.1 3.5 1.2 2.5 2.0 3.2 2.8 1.8 2.7 5.3 3.9 14.6 1.4 3.4 2.2 1.5 1.8 24.7 27.4 23.2 38.2 25.9 21.8 24.4 23.8 42.3 20.9 29.8 13.4 12.3 11.9 9.6 69.6 59.0 20.4 14.7 11.4 10.4 149.2 6.4 5.0 10.3 25.9 9.5 25.8 0.0 7.7 16.0 10.4 37.1 2.3 11.3 8.1 90.6 19.7 12.9 7.3 46.0 24.5 6.5 11.8 10.0 17.1 32.4 12.4 31.7 24.1 7.9 76.8 19.4 13.2 14.6 10.7 15.1 26.9 8.7 13.3 45.0 TOMM20L UNQ9438 ENSG00000196860 "Translocase of outer mitochondrial membrane 20 like" Q6UXN7 14 58395916-58408701 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 28.3" "Cell type enriched" "Detected in some" 8 "Early spermatids: 116.6" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.0;T-cells: 1.9" "Cell line enhanced" "Detected in some" "SCLC-21H: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076397 Enhanced NA NA "HPA076397: " "unprognostic (1.72e-1)" "unprognostic (2.34e-4)" "unprognostic (8.13e-2)" "unprognostic (7.80e-3)" "unprognostic (5.08e-2)" "unprognostic (2.15e-1)" "unprognostic (1.35e-1)" "unprognostic (4.28e-2)" "unprognostic (4.93e-1)" "unprognostic (1.37e-3)" "unprognostic (3.06e-2)" "unprognostic (5.66e-3)" "unprognostic (4.57e-6)" "unprognostic (8.75e-2)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (7.66e-3)" 0.5 0.4 0.2 0.2 0.6 0.1 0.5 0.6 0.8 0.5 0.5 0.8 0.0 0.0 0.9 1.8 0.2 0.4 0.5 0.3 0.2 0.2 0.7 0.3 0.4 2.2 0.3 0.0 0.7 1.2 1.1 0.5 0.3 0.6 0.8 0.5 1.7 0.5 0.5 0.2 0.3 0.4 1.4 0.3 0.3 0.6 28.3 0.0 0.0 0.9 0.0 0.6 0.3 0.2 1.0 0.1 0.0 0.1 0.0 1.9 0.4 1.8 0.0 0.5 1.9 0.0 0.0 2.1 0.3 0.0 0.3 0.0 0.0 0.5 1.6 0.2 1.0 0.0 0.3 0.0 0.0 0.0 2.8 0.6 0.5 0.0 0.5 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.2 0.9 0.7 0.3 0.2 0.0 0.9 1.2 0.5 0.8 0.3 2.0 2.2 0.8 0.3 0.3 0.5 3.4 2.3 0.5 0.4 0.5 1.2 1.4 2.8 0.0 0.2 0.4 0.0 0.5 0.0 0.4 0.2 1.5 1.5 0.5 0.0 0.0 0.0 0.4 0.1 0.0 1.0 0.1 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.6 0.6 0.8 0.2 0.2 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 116.6 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.5 0.9 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.4 0.0 0.0 0.0 6.7 0.9 0.4 0.0 0.0 0.2 0.1 TOMM34 "HTOM34P, TOM34" ENSG00000025772 "Translocase of outer mitochondrial membrane 34" Q15785 20 44942130-44960486 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.2;testis: 53.2" "Cell type enhanced" "Detected in many" 12 "monocytes: 303.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018845, HPA056875" Enhanced Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "HPA018845: AB_1858184, HPA056875: AB_2683264" "unprognostic (4.96e-2)" "unprognostic (6.88e-2)" "unprognostic (5.05e-2)" "unprognostic (1.36e-3)" "unprognostic (4.91e-2)" "prognostic unfavorable (4.47e-5)" "prognostic unfavorable (8.71e-6)" "unprognostic (2.55e-1)" "unprognostic (5.04e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.11e-2)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.45e-4)" "unprognostic (5.79e-3)" 4.4 17.9 14.9 6.4 56.2 8.7 7.3 4.2 18.1 7.2 7.1 5.3 5.6 5.8 7.1 25.6 7.2 24.9 6.8 6.3 35.3 11.0 11.9 7.9 5.9 8.8 8.6 14.4 13.9 8.2 11.2 10.5 15.1 13.9 7.6 9.3 8.0 6.3 9.0 6.3 5.5 5.6 7.7 5.7 5.8 7.0 53.2 5.6 7.0 8.3 7.2 10.4 8.8 6.3 18.8 26.1 9.5 11.5 8.7 12.3 10.7 33.1 11.7 10.4 22.1 9.6 9.5 23.5 19.3 28.2 24.2 17.7 47.2 12.5 22.8 16.7 15.1 24.7 21.0 25.4 41.8 28.3 4.0 11.8 17.9 15.5 33.2 12.3 11.7 11.1 10.3 11.7 33.8 60.8 21.3 24.6 9.4 20.3 9.4 22.9 21.9 12.3 16.2 12.2 17.7 44.5 10.7 11.0 24.6 19.7 18.7 17.9 10.6 26.4 18.4 22.8 8.4 13.8 10.2 14.5 32.0 21.1 15.3 28.8 8.2 9.6 18.9 29.2 14.0 12.4 8.3 11.1 9.5 10.4 11.5 11.0 17.3 10.9 11.0 26.1 18.8 12.3 9.7 3.1 8.7 11.2 13.7 12.3 10.7 14.9 56.2 4.2 18.1 35.3 11.0 8.6 14.4 13.9 5.6 6.0 8.6 13.0 69.8 12.2 3.6 9.0 7.6 64.3 18.2 12.2 3.9 98.4 26.6 29.7 14.0 10.8 6.7 0.0 26.6 29.1 11.6 59.4 9.2 9.6 19.7 3.2 11.5 5.5 3.9 24.2 6.4 10.5 6.8 303.0 8.2 13.2 32.2 9.3 6.0 16.5 4.1 0.0 12.2 45.4 36.6 9.7 47.3 6.9 12.8 47.8 TOMM7 Tom7 ENSG00000196683 "Translocase of outer mitochondrial membrane 7" Q9P0U1 7 22812628-22822852 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 253.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.69e-2)" "unprognostic (1.93e-1)" "unprognostic (4.91e-2)" "unprognostic (2.25e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.30e-4)" "unprognostic (2.25e-2)" "unprognostic (7.63e-2)" "unprognostic (1.52e-1)" "unprognostic (6.36e-2)" "unprognostic (2.49e-3)" "unprognostic (1.36e-1)" "unprognostic (1.75e-1)" "unprognostic (3.69e-3)" "unprognostic (2.08e-1)" "unprognostic (3.86e-2)" "unprognostic (1.01e-2)" 63.5 76.7 66.0 36.7 63.2 48.5 70.1 41.3 58.1 42.7 46.2 19.8 41.4 51.3 41.8 36.0 41.1 40.1 39.1 61.6 50.2 42.6 42.1 43.7 37.0 70.0 58.4 42.5 106.7 96.4 23.0 43.4 22.7 44.0 41.7 30.1 39.5 62.4 42.1 253.0 37.5 41.7 71.5 52.0 45.4 43.6 24.4 47.4 21.1 36.6 81.9 44.2 49.1 70.8 117.8 81.0 47.7 51.3 49.5 151.7 130.5 57.3 17.4 19.4 40.9 48.4 51.6 23.4 49.3 37.1 18.7 15.1 12.2 33.7 35.2 51.8 37.7 101.8 40.0 31.9 27.0 17.3 23.4 36.5 19.3 45.2 17.1 45.2 54.3 27.0 74.7 54.0 31.5 45.6 121.1 26.8 37.3 53.4 38.1 30.7 24.3 25.6 59.0 74.7 88.1 44.1 23.6 23.5 55.6 15.8 18.1 16.8 34.7 32.6 73.2 107.1 68.6 52.6 88.5 37.0 21.3 42.5 43.5 46.5 98.2 83.0 64.1 32.1 49.1 80.4 20.4 51.3 47.7 65.5 44.0 81.2 117.8 112.6 79.2 51.8 102.3 151.7 106.3 17.8 49.5 44.2 81.0 84.2 130.5 66.0 63.2 41.3 58.1 50.2 42.6 58.4 42.5 44.0 47.4 241.2 277.9 735.1 671.2 787.2 247.2 1080.5 685.3 305.1 280.9 331.5 62.8 408.1 1125.7 384.0 287.0 426.3 659.7 420.4 808.5 601.1 500.9 701.8 487.8 1059.1 606.1 143.0 510.4 635.3 808.8 297.8 919.7 682.5 747.3 555.5 881.1 452.3 538.0 770.5 714.2 838.1 229.6 478.6 571.8 454.7 180.7 810.0 339.6 682.9 815.4 663.4 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388516-40417950 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 146.3;testis: 36.8" "Group enriched" "Detected in many" 4 "Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.7 2.0 0.4 20.0 0.5 14.6 4.1 0.4 0.5 3.0 6.9 0.5 0.5 7.0 2.0 3.4 18.2 0.7 2.4 2.3 0.6 0.5 1.4 1.9 5.5 15.4 0.6 0.4 1.2 1.1 0.0 0.4 10.7 0.6 1.2 8.0 0.6 3.2 0.3 0.6 5.9 9.2 2.6 1.8 7.3 4.5 36.8 0.3 146.3 0.9 11.8 16.7 3.2 5.7 1.3 0.3 0.3 0.3 3.2 5.7 1.1 34.3 45.6 58.1 26.6 2.9 5.9 12.9 47.1 25.4 43.4 38.5 21.4 26.3 55.4 24.0 15.9 26.0 54.7 44.6 18.8 58.3 29.5 29.8 36.6 29.2 35.6 0.2 51.2 39.0 1.3 1.5 30.5 31.1 9.4 22.8 36.1 39.5 38.0 46.8 11.9 59.3 34.4 24.1 24.9 18.2 50.4 90.2 23.0 10.4 22.0 34.3 24.7 38.0 47.5 15.0 35.3 39.8 23.6 14.9 28.6 40.4 33.0 45.2 21.8 24.6 48.3 16.1 35.3 47.7 0.3 0.0 0.0 0.6 0.0 0.0 1.3 0.9 0.9 0.3 0.4 0.2 0.1 0.3 3.2 0.3 0.0 5.7 1.1 0.4 0.5 0.4 0.5 0.6 0.5 0.6 0.4 0.6 0.3 0.0 1.3 28.7 1.4 10.4 0.0 1.1 2.5 0.0 6.8 0.0 0.0 8.4 0.0 0.9 12.5 0.7 2.1 280.4 0.0 81.4 9.7 1.2 0.0 3.9 64.5 0.0 0.0 27.6 30.0 15.2 4.4 13.1 1.7 2.8 5.9 0.0 0.2 3.6 1.8 0.0 0.0 71.1 1.4 527.8 241.9 5.4 7.4 7.7 24.2 2.6 TOPAZ1 "C3orf77, FLJ36157" ENSG00000173769 "Testis and ovary specific PAZ domain containing 1" Q8N9V7 3 44241886-44332098 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 49 "testis: 9.2" "Group enriched" "Detected in some" 17 "Sertoli cells: 19.4;Spermatocytes: 62.3;Spermatogonia: 44.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047431, HPA051034" Uncertain NA NA "HPA047431: AB_2680045, HPA051034: AB_2681318" "unprognostic (1.68e-1)" "unprognostic (8.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 19.4 0.0 62.3 44.4 0.0 0.0 0.0 0.0 0.0 TOX "KIAA0808, TOX1" ENSG00000198846 "Thymocyte selection associated high mobility group box" O94900 8 58805418-59119208 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 88.8" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 30.6;Intestinal endocrine cells: 44.1;Mucus-secreting cells: 25.4;T-cells: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 21.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 27.9;MOLT-4: 52.6;SH-SY5Y: 16.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018322, HPA073241" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA018322: AB_1858199, HPA073241: AB_2686584" "unprognostic (7.60e-4)" "unprognostic (6.16e-3)" "unprognostic (5.65e-2)" "unprognostic (2.27e-1)" "unprognostic (9.53e-2)" "unprognostic (4.52e-1)" "unprognostic (1.22e-1)" "prognostic favorable (5.20e-4)" "unprognostic (1.46e-1)" "unprognostic (3.46e-3)" "unprognostic (6.73e-3)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.90e-7)" "unprognostic (1.12e-1)" "unprognostic (1.75e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" 1.3 1.2 10.5 15.7 6.3 2.8 1.5 1.9 15.6 2.1 13.4 1.5 1.2 10.0 1.5 1.1 3.7 1.1 5.0 0.9 6.3 9.8 3.2 1.7 4.9 17.7 4.8 12.0 6.6 2.4 2.9 3.7 1.5 2.2 2.4 9.3 2.6 1.8 1.3 0.5 1.0 10.7 2.8 2.3 5.7 10.0 6.5 2.5 88.8 1.5 0.8 19.4 2.6 2.3 3.4 0.8 10.2 0.1 10.4 21.0 3.1 0.3 0.0 5.8 0.0 0.6 1.3 0.0 1.2 2.8 0.7 0.1 0.0 0.0 0.0 0.0 5.2 0.3 0.4 1.4 0.0 0.1 0.2 0.5 0.0 1.1 0.0 4.9 1.0 0.2 0.7 0.1 0.8 1.1 0.3 9.5 27.9 0.0 0.0 0.4 0.0 52.6 0.0 1.0 0.0 0.1 1.1 4.0 0.0 0.1 0.1 5.4 16.5 0.0 0.0 0.0 1.4 0.0 0.0 0.1 1.5 0.7 4.8 1.6 0.0 0.0 3.6 0.1 0.0 1.0 10.2 0.1 1.8 7.5 0.0 3.4 3.4 5.5 11.3 0.8 0.6 2.1 6.3 0.2 10.4 0.0 0.0 21.0 3.1 10.5 6.3 1.9 15.6 6.3 9.8 4.8 12.0 2.2 2.5 8.9 30.6 6.0 0.1 1.1 15.4 1.2 2.5 18.7 4.5 1.8 0.0 2.6 0.0 0.7 1.3 1.6 4.0 0.0 0.6 0.2 1.9 0.1 16.1 0.0 2.9 0.0 44.1 0.0 0.0 1.7 0.9 1.5 0.0 0.0 25.4 12.4 2.1 2.9 0.4 0.7 1.9 0.0 1.0 1.2 0.4 1.1 0.7 35.8 5.1 0.1 TOX2 "C20orf100, dJ1108D11.2, GCX-1" ENSG00000124191 "TOX high mobility group box family member 2" Q96NM4 20 43914864-44069616 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 77.2" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 21.1;Ito cells: 39.3;Late spermatids: 14.0;Smooth muscle cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 9.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 45.8;PC-3: 20.5;U-266/70: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049900, HPA058396" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA049900: AB_2680942, HPA058396: AB_2683704" "unprognostic (2.15e-2)" "unprognostic (1.82e-2)" "unprognostic (8.97e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.53e-3)" "unprognostic (6.29e-2)" "unprognostic (1.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (7.45e-8)" "unprognostic (1.60e-1)" "unprognostic (2.00e-1)" "unprognostic (7.60e-2)" "unprognostic (3.12e-1)" 7.0 4.4 8.0 9.9 5.2 2.4 4.8 0.8 14.5 6.7 4.8 2.6 3.5 2.3 3.6 3.5 12.2 3.0 4.7 2.0 7.8 20.6 2.4 4.1 20.1 19.2 13.7 7.0 1.8 2.7 17.3 14.9 4.6 7.3 9.9 4.2 3.0 2.4 5.3 0.8 2.9 5.3 12.0 4.5 7.1 5.7 17.6 2.0 77.2 4.8 2.4 11.8 9.7 6.5 0.1 3.7 9.7 0.3 1.9 2.0 0.2 4.5 5.7 1.8 0.3 2.0 5.8 0.0 5.7 2.4 3.6 4.5 0.0 1.8 0.0 8.3 6.5 16.3 2.3 1.4 0.1 3.3 7.3 1.5 0.0 0.4 0.0 45.8 0.0 8.7 15.7 6.8 12.7 0.6 11.6 4.4 4.2 0.0 5.4 2.2 4.8 1.7 1.6 1.4 0.1 20.5 0.0 4.4 7.5 0.0 0.5 2.0 15.5 1.0 0.0 7.3 0.2 0.0 3.9 5.4 0.0 3.6 0.1 0.0 29.6 6.4 3.9 7.5 0.0 12.1 0.0 0.3 9.7 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.1 0.2 0.1 1.0 1.9 0.0 3.7 2.0 0.2 8.0 5.2 0.8 14.5 7.8 20.6 13.7 7.0 7.3 2.0 0.0 1.1 4.5 0.7 0.9 0.4 0.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 8.7 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.8 1.1 3.2 0.0 39.3 4.3 14.0 1.7 0.0 1.7 0.0 0.0 4.3 0.1 0.0 0.7 0.0 0.0 0.0 12.6 1.1 1.4 1.1 0.2 3.2 0.6 0.3 TOX3 "CAGF9, TNRC9" ENSG00000103460 "TOX high mobility group box family member 3" O15405 16 52438005-52547802 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 18.7" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 40.8;Intestinal endocrine cells: 59.2;Muller glia cells: 158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 20.0;HAP1: 9.8;Hep G2: 8.7;OE19: 10.4;RT4: 38.0;SCLC-21H: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040240, HPA040376" Enhanced Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040240: , HPA040376: AB_10795522" "unprognostic (1.14e-2)" "unprognostic (9.75e-3)" "unprognostic (9.08e-3)" "unprognostic (3.32e-2)" "unprognostic (3.50e-1)" "unprognostic (2.31e-1)" "unprognostic (4.74e-3)" "unprognostic (1.28e-1)" "unprognostic (2.00e-1)" "unprognostic (2.94e-2)" "unprognostic (2.59e-1)" "unprognostic (4.60e-3)" "prognostic favorable (3.08e-12)" "unprognostic (1.19e-1)" "unprognostic (1.31e-1)" "prognostic favorable (3.95e-4)" 0.7 3.1 7.1 5.0 4.7 0.0 3.9 0.6 6.0 7.0 13.5 6.0 0.2 9.4 1.3 9.2 0.9 3.0 14.8 0.2 3.2 5.3 9.5 5.8 2.7 0.1 5.4 3.6 1.0 7.8 0.0 5.8 0.3 5.1 1.8 15.1 2.7 11.0 0.7 0.3 1.1 13.5 0.9 7.0 0.2 18.7 0.7 4.7 0.0 0.2 0.3 2.1 7.2 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.7 0.0 0.1 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 10.4 0.0 0.0 3.4 0.1 4.7 38.0 13.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 4.7 0.6 4.3 3.2 5.3 5.4 3.6 5.1 4.7 6.0 5.1 0.0 0.2 0.9 2.6 0.6 40.8 17.4 6.8 33.2 0.0 0.0 3.3 1.4 2.5 0.0 22.3 0.0 4.4 0.0 0.3 13.0 0.0 4.9 0.1 38.1 59.2 1.3 0.0 0.8 0.6 0.1 0.0 0.0 31.7 158.0 9.8 8.6 0.0 8.6 1.5 0.0 0.3 0.0 0.7 0.3 0.0 0.0 28.7 1.1 TP53 "LFS1, p53" ENSG00000141510 "Tumor protein p53" P04637 17 7661779-7687550 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 102.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876" Enhanced Enhanced Nucleoplasm Yes No Nucleoplasm "CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, HPA051244: AB_2681403, HPA063532: " "unprognostic (2.29e-2)" "unprognostic (8.83e-3)" "unprognostic (1.26e-2)" "prognostic favorable (1.35e-4)" "unprognostic (9.95e-2)" "unprognostic (4.00e-2)" "unprognostic (2.79e-3)" "unprognostic (4.99e-2)" "unprognostic (2.75e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.01e-4)" "unprognostic (1.86e-3)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (2.74e-1)" "unprognostic (1.08e-1)" 18.5 11.1 6.0 28.6 6.8 9.0 17.5 2.5 7.3 18.5 14.6 6.8 8.3 9.7 20.3 15.0 25.3 16.7 22.6 8.1 5.0 3.8 10.6 20.8 11.2 26.0 6.6 3.1 33.8 13.8 4.9 6.0 22.8 6.9 16.5 14.5 9.9 15.3 16.1 12.5 24.6 14.0 12.8 6.2 24.2 12.0 14.1 6.9 102.6 13.2 23.5 31.2 16.9 15.0 15.2 19.6 2.2 14.1 11.0 11.3 8.2 19.4 36.0 19.7 14.2 9.2 11.0 20.8 7.0 15.8 19.4 24.6 1.0 10.0 45.8 31.9 13.8 18.9 43.0 28.5 19.3 18.2 10.2 19.1 18.5 20.2 17.1 27.7 0.4 9.6 13.9 22.5 9.4 26.1 11.2 19.0 6.2 0.9 1.8 9.9 34.6 31.1 22.7 19.8 2.5 0.7 60.4 13.9 15.9 14.5 21.6 11.7 20.3 23.1 15.6 5.9 10.2 27.0 1.7 24.6 23.3 7.7 0.3 11.8 12.1 8.8 19.7 6.0 2.4 19.6 0.8 13.3 2.2 9.1 14.1 11.1 15.2 9.4 10.2 19.6 14.5 9.9 10.8 1.7 11.0 11.9 17.9 11.3 8.2 6.0 6.8 2.5 6.4 5.0 3.8 6.6 3.1 6.9 6.9 8.9 10.9 24.4 8.9 25.4 2.3 2.0 22.9 8.1 12.5 19.2 0.0 30.5 8.3 19.1 7.8 19.6 10.2 0.0 15.7 35.3 17.1 11.3 1.1 16.1 21.7 0.0 29.6 20.3 27.8 2.1 21.3 14.4 11.8 15.4 37.2 6.1 19.5 0.0 15.9 6.5 2.2 12.9 20.1 0.5 4.2 28.7 18.8 15.7 50.6 7.4 TP53AIP1 p53AIP1 ENSG00000120471 "Tumor protein p53 regulated apoptosis inducing protein 1" Q9HCN2 11 128934731-128943399 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5" "Cell type enhanced" "Detected in some" 18 "Basal glandular cells: 9.5;Basal keratinocytes: 40.4;Ciliated cells: 14.7;Suprabasal keratinocytes: 28.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;RT4: 3.4;SK-BR-3: 2.3" "HPA044300, HPA048797" Uncertain NA NA "HPA044300: AB_2678888, HPA048797: AB_2680524" "unprognostic (4.12e-7)" "unprognostic (3.00e-2)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-2)" "unprognostic (1.18e-1)" "unprognostic (4.66e-2)" "unprognostic (1.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.94e-1)" "unprognostic (6.57e-6)" "unprognostic (1.10e-2)" "unprognostic (3.71e-1)" "unprognostic (7.75e-2)" "unprognostic (1.78e-2)" 0.1 0.3 0.3 0.1 0.3 0.2 1.6 0.3 0.3 4.6 0.1 0.2 4.2 0.0 0.4 8.9 19.6 3.2 0.1 0.1 0.3 0.6 0.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 1.2 0.1 0.1 3.0 1.2 0.9 22.5 0.2 0.1 0.1 0.1 0.2 0.6 0.1 15.2 0.1 31.5 6.7 0.2 11.0 0.4 0.1 1.9 0.2 0.2 0.3 0.1 0.4 0.0 0.2 0.5 0.7 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.6 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.5 0.0 0.3 0.2 0.0 0.4 0.4 0.5 0.2 0.0 0.1 0.1 1.6 0.0 0.2 1.0 0.0 0.8 0.4 0.6 0.0 0.4 0.0 0.0 3.4 1.2 0.1 0.0 2.3 0.0 0.1 0.7 0.0 0.0 0.8 0.7 0.5 0.4 0.0 0.0 0.4 0.0 0.3 0.1 1.3 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.4 0.2 0.1 1.9 0.2 0.1 0.1 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.6 0.1 0.1 0.1 0.1 0.0 0.3 0.0 9.5 40.4 0.2 0.2 0.0 14.7 3.4 0.0 0.0 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.4 1.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 28.5 0.2 0.0 0.2 2.5 TP53I3 PIG3 ENSG00000115129 "Tumor protein p53 inducible protein 3" Q53FA7 2 24077433-24085861 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.0" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 190.0;Paneth cells: 164.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "T-47d: 115.8" "Low region specificity" "Detected in all" "CAB017479, HPA022012, HPA028742" Enhanced Supported Vesicles NA NA 200000 Vesicles "CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456" "unprognostic (3.66e-2)" "unprognostic (1.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-3)" "unprognostic (4.47e-1)" "unprognostic (1.09e-2)" "unprognostic (1.53e-3)" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-1)" "unprognostic (3.67e-2)" "unprognostic (8.57e-3)" 10.3 9.5 2.7 11.7 2.7 6.3 6.3 2.5 3.6 12.0 42.1 3.6 10.5 18.4 8.5 7.0 43.2 6.1 17.8 5.0 1.6 3.2 28.2 11.5 15.7 5.3 2.1 2.0 4.7 20.3 4.0 4.6 13.0 3.3 6.6 15.5 6.7 11.3 6.9 4.9 2.8 55.0 6.1 2.3 5.6 9.0 41.3 1.9 8.6 9.0 10.6 9.0 8.2 21.8 3.6 11.1 11.4 13.4 0.2 0.4 4.0 5.0 16.6 9.7 4.0 7.7 17.2 7.1 5.0 6.2 4.4 6.1 4.2 9.1 0.6 2.9 8.3 1.2 1.5 2.5 8.9 2.7 3.8 0.3 1.4 5.8 10.8 5.0 0.6 2.9 18.6 14.2 11.8 2.9 9.1 19.8 3.0 1.2 4.3 18.5 3.3 0.9 0.1 7.4 5.7 6.8 1.8 8.6 0.1 7.4 7.9 1.4 6.2 6.6 1.5 1.0 8.2 115.8 1.0 14.5 5.0 12.3 3.4 2.5 2.0 1.2 0.5 1.7 0.0 1.3 7.3 13.4 11.4 0.2 8.5 0.1 3.6 0.2 0.4 11.1 2.6 0.0 0.3 2.8 0.2 3.8 4.8 0.3 4.0 2.7 2.7 2.5 3.6 1.6 3.2 2.1 2.0 3.3 1.9 26.8 28.9 12.6 28.1 4.1 0.7 9.6 53.5 5.3 19.4 40.1 0.0 37.7 92.9 83.6 104.8 14.5 144.3 0.0 119.0 24.8 16.4 11.1 12.7 11.0 42.3 0.0 76.2 22.7 23.6 190.0 7.2 21.7 13.5 27.1 44.3 6.7 79.6 164.1 8.5 62.2 1.9 19.4 12.5 18.5 8.9 6.0 24.1 3.8 54.0 39.6 TP53INP2 "C20orf110, dJ1181N3.1, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, PINH" ENSG00000078804 "Tumor protein p53 inducible nuclear protein 2" Q8IXH6 20 34704290-34713439 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 142.8" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 182.2;Late spermatids: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 6.2" "Cell line enhanced" "Detected in many" "SK-BR-3: 70.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (3.33e-2)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (3.08e-2)" "unprognostic (2.07e-1)" "unprognostic (1.86e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-1)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (1.52e-2)" "unprognostic (2.57e-2)" "prognostic favorable (1.26e-8)" "unprognostic (8.03e-2)" "unprognostic (1.68e-1)" "unprognostic (1.93e-2)" "unprognostic (6.17e-2)" 9.3 13.2 57.8 5.1 82.9 38.9 3.1 10.1 43.7 5.9 19.3 131.9 3.7 9.5 11.1 8.1 31.9 5.9 11.8 36.6 70.5 51.2 13.4 22.3 7.1 2.5 107.3 19.4 3.8 8.3 22.8 5.0 5.1 65.3 16.8 18.9 8.0 5.9 16.1 22.7 2.9 9.9 17.1 142.8 2.6 6.7 9.0 65.3 0.0 10.6 11.8 8.0 9.2 5.0 0.1 0.4 6.2 0.2 0.0 0.1 0.0 0.7 0.9 3.1 4.1 7.3 6.0 1.3 3.1 9.9 4.1 3.5 5.4 0.4 2.4 2.1 6.2 8.3 0.6 6.7 1.5 4.6 0.7 0.8 4.4 2.5 5.2 9.5 0.7 3.5 17.9 2.3 3.3 0.4 5.2 6.5 2.3 1.7 8.0 4.6 1.0 0.4 1.5 0.4 0.6 2.3 2.3 2.1 3.8 5.2 2.8 7.0 7.8 2.7 70.8 4.8 3.9 5.1 3.2 4.8 11.5 4.0 1.5 1.2 3.2 3.9 1.9 7.3 9.9 4.0 1.2 0.2 1.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.4 0.0 0.0 57.8 82.9 10.1 43.7 70.5 51.2 107.3 19.4 65.3 65.3 3.0 11.7 4.7 14.0 3.3 18.0 64.6 17.8 5.3 5.7 3.5 49.1 1.7 5.0 16.3 182.2 8.0 72.0 0.0 21.2 0.7 6.1 20.0 6.9 26.0 4.7 30.2 50.3 12.9 3.8 271.2 6.9 5.5 5.0 4.6 42.6 10.3 19.4 78.6 12.4 7.7 55.1 19.4 31.8 3.5 1.9 2.6 23.8 2.9 13.6 18.2 TP53TG3 "P53TG3, TP53TG3A" ENSG00000183632 "TP53 target 3" Q9ULZ0 16 32673528-32676732 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.9;placenta: 1.4;testis: 4.3" "Cell type enhanced" "Detected in single" 34 "Early spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.4;HMC-1: 1.5;SK-MEL-30: 1.2;SuSa: 1.1;U-2 OS: 1.6" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3B ENSG00000261509 "TP53 target 3B" Q9ULZ0 16 33360274-33363478 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "epididymis: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HMC-1: 3.6;K-562: 2.1;SH-SY5Y: 2.0" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3C ENSG00000205457 "TP53 target 3C" Q9ULZ0 16 33193659-33196858 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 3.0;epididymis: 4.3;testis: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.4;REH: 1.1" "HPA047832, HPA060916" Uncertain "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.1 0.1 0.8 0.1 1.3 0.1 0.1 3.0 1.3 0.1 0.1 0.1 0.1 4.3 0.3 0.1 0.1 0.1 0.6 1.3 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.3 0.4 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 2.0 0.1 0.1 3.9 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3D ENSG00000205456 "TP53 target 3D" Q9ULZ0 16 32252719-32255922 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 8.7;testis: 5.1" "Group enriched" "Detected in some" 5 "Early spermatids: 53.8;Late spermatids: 17.1;Spermatocytes: 29.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.5;HEL: 3.2;HMC-1: 4.0;RH-30: 3.1;SCLC-21H: 3.4;U-2 OS: 3.6" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " "unprognostic (1.65e-2)" "unprognostic (1.92e-1)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (5.98e-3)" "unprognostic (1.47e-2)" "unprognostic (2.06e-2)" "unprognostic (1.48e-1)" "unprognostic (1.32e-1)" 0.1 2.0 0.9 0.2 1.5 0.0 0.1 3.3 1.8 0.0 0.1 0.1 0.4 8.7 0.8 0.3 0.1 0.6 0.6 1.8 0.0 0.0 0.1 0.2 1.0 0.2 0.0 0.0 0.6 1.0 0.7 0.0 0.2 0.0 0.0 0.8 0.0 0.0 1.7 0.5 0.1 5.1 0.2 0.0 0.0 0.4 0.8 0.0 0.7 0.4 0.0 0.6 1.5 0.6 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.5 0.2 0.0 0.0 0.1 3.1 0.3 0.0 0.0 3.4 1.0 0.0 0.0 0.9 0.6 0.8 0.0 0.0 0.3 3.6 0.6 0.0 1.7 0.8 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.5 0.1 0.7 0.0 0.2 0.0 0.3 1.5 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 1.1 0.0 5.0 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.0 6.5 0.0 29.4 5.0 0.1 0.0 0.0 0.0 0.0 TP53TG3E ENSG00000275034 "TP53 target 3 family member E" Q9ULZ0 16 33303739-33306935 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;placenta: 1.6;salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "A549: 1.5;AN3-CA: 3.2;SH-SY5Y: 1.3;U-266/70: 1.1" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 1.2 0.0 1.5 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3F ENSG00000278848 "TP53 target 3 family member F" Q9ULZ0 16 33459045-33462249 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 21 "epididymis: 11.6;testis: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.4;EFO-21: 1.8;HEL: 3.5;HMC-1: 2.1;K-562: 1.9;RPMI-8226: 1.6;U-2 OS: 2.6;U-266/84: 3.7" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.7 0.5 0.0 0.0 0.5 2.6 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG5 "C20orf10, CLG01, dJ453C12.5" ENSG00000124251 "TP53 target 5" Q9Y2B4 20 45372563-45407889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 35.4" "Group enriched" "Detected in some" 98 "Early spermatids: 648.4;Late spermatids: 205.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 5.3" "Low region specificity" "Detected in all" "HPA041979, HPA058510, HPA077455" Enhanced Supported "Nucleoli,Nucleoli rim,Mitotic chromosome" NA NA "Nucleoli, Nucleoli rim" "Mitotic chromosome" "HPA041979: AB_2677778, HPA058510: , HPA077455: " "unprognostic (2.86e-1)" "unprognostic (1.28e-1)" "unprognostic (2.18e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.29e-3)" "unprognostic (3.10e-3)" "unprognostic (9.26e-2)" "unprognostic (3.56e-2)" "unprognostic (1.72e-5)" "unprognostic (2.09e-2)" "unprognostic (7.46e-2)" "unprognostic (1.48e-1)" "unprognostic (1.46e-1)" "unprognostic (4.72e-4)" "unprognostic (1.41e-1)" 0.1 0.1 0.2 0.2 2.0 0.8 0.1 0.1 1.5 0.1 0.1 1.9 0.0 0.0 0.1 0.5 0.1 0.1 0.3 0.2 0.4 0.1 0.1 0.1 0.1 0.4 4.1 1.0 0.2 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 0.3 0.0 0.8 0.2 0.2 35.4 2.1 0.0 0.3 0.0 0.0 0.1 0.1 0.3 0.4 0.3 0.1 0.0 1.1 0.0 1.0 2.0 1.1 3.1 0.0 0.0 1.0 0.5 0.0 0.0 0.0 5.3 0.9 0.8 0.8 0.0 0.7 2.1 0.0 0.0 0.0 0.3 0.9 1.2 2.5 1.6 0.0 1.5 1.2 0.0 0.0 0.0 0.0 0.7 0.0 1.2 1.1 0.4 0.0 1.4 1.0 0.9 0.3 0.8 0.8 0.0 0.6 0.7 0.0 1.2 1.3 1.0 2.8 1.2 0.7 0.4 3.0 0.3 2.0 3.9 1.2 2.4 0.7 0.9 1.0 0.1 2.0 0.7 1.2 0.0 0.1 0.0 0.3 0.1 1.1 0.0 0.3 0.0 0.1 0.3 0.3 0.4 0.3 0.0 0.1 0.4 0.2 0.0 0.2 2.0 0.1 0.9 0.4 0.1 4.1 1.0 1.2 2.1 0.0 0.0 0.0 0.5 0.1 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 648.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 205.9 4.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 4.2 0.0 1.0 0.0 1.7 1.8 2.0 1.0 0.0 0.0 0.0 0.8 TP63 "EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L" ENSG00000073282 "Tumor protein p63" Q9H3D4 3 189631416-189897279 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 83.2;skin 1: 54.2" "Group enriched" "Detected in many" 12 "Basal keratinocytes: 244.6;Suprabasal keratinocytes: 247.4" "Group enriched" "Detected in many" 11 "cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HaCaT: 23.8;HBEC3-KT: 45.6;hTCEpi: 34.6;hTERT-HME1: 33.1;RT4: 50.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000083, HPA006288, HPA006289, HPA007009, HPA007010" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336" "prognostic favorable (1.07e-4)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "unprognostic (3.02e-1)" "unprognostic (4.38e-2)" "unprognostic (3.50e-1)" "unprognostic (1.29e-1)" "unprognostic (5.17e-2)" "unprognostic (2.78e-1)" "unprognostic (5.37e-2)" "unprognostic (2.09e-3)" "unprognostic (1.54e-1)" "unprognostic (1.87e-5)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (2.74e-3)" 2.9 0.1 0.2 0.7 0.1 0.0 7.2 0.1 0.2 9.5 0.1 0.1 5.7 0.0 0.3 8.0 33.7 0.3 0.0 0.2 0.1 0.1 0.4 0.1 1.2 0.2 0.1 0.2 0.1 0.1 0.0 0.3 7.8 0.8 9.6 0.0 0.3 9.0 7.8 83.2 54.2 0.1 2.7 0.6 0.1 0.1 1.2 0.0 9.0 0.4 36.7 26.1 9.6 19.2 3.7 1.3 3.0 0.9 1.2 1.2 0.2 0.6 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.1 0.0 0.0 23.8 0.0 45.6 0.0 0.3 0.0 0.5 0.3 0.1 0.0 0.0 0.1 0.0 34.6 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 50.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.3 0.1 0.0 0.2 2.0 0.4 1.1 0.9 0.5 0.7 3.7 1.2 1.0 0.4 1.7 0.8 0.7 3.0 1.2 0.9 1.3 0.8 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.8 0.0 0.0 4.0 0.0 20.4 244.6 0.0 0.6 0.0 1.4 5.7 0.0 0.0 18.7 0.0 0.2 0.7 0.3 0.0 0.0 0.2 1.8 1.0 2.6 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.5 1.0 0.0 0.0 1.2 0.0 1.1 0.0 0.0 0.0 0.5 0.3 2.6 247.4 7.4 0.0 0.0 10.1 TP73 P73 ENSG00000078900 "Tumor protein p73" O15350 1 3652520-3736201 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 17.4;Club cells: 7.9;Early spermatids: 18.5;Late spermatids: 10.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 25.7" "Cell type enhanced" "Detected in some" "eosinophil: 1.2;memory B-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 11.4;RH-30: 9.3;SCLC-21H: 14.6;U-698: 14.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002514, CAB003022, HPA027314, HPA044516" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA Yes Nucleoplasm "Golgi apparatus" "CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971" "unprognostic (5.71e-3)" "prognostic favorable (2.98e-4)" "unprognostic (2.71e-1)" "prognostic favorable (1.82e-4)" "unprognostic (5.58e-2)" "prognostic favorable (9.50e-4)" "unprognostic (5.25e-2)" "unprognostic (2.18e-1)" "unprognostic (4.27e-1)" "unprognostic (1.99e-1)" "unprognostic (5.33e-2)" "unprognostic (3.99e-1)" "unprognostic (1.26e-7)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (7.33e-2)" "unprognostic (1.65e-1)" 0.5 0.3 1.1 3.4 2.3 1.0 1.1 25.7 0.4 1.5 0.7 2.4 1.3 0.3 0.4 6.2 4.8 12.8 1.4 0.3 1.9 1.2 0.2 2.1 3.8 2.0 0.5 0.0 2.6 1.5 0.3 0.7 1.7 3.2 3.6 0.4 0.4 5.5 1.4 0.4 11.9 0.5 0.3 0.9 4.2 0.8 9.8 0.3 2.5 0.4 0.8 7.1 0.6 3.9 1.4 0.1 1.2 0.1 0.0 0.6 0.1 2.0 0.1 0.2 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 8.5 3.2 2.0 1.6 0.0 0.7 3.4 2.1 0.7 0.0 0.6 6.9 0.1 3.2 2.0 0.0 0.0 2.3 0.0 1.4 0.0 0.1 0.0 0.0 0.0 4.2 0.0 0.6 1.5 11.4 1.5 0.4 0.0 0.1 0.0 9.3 0.1 0.2 3.0 14.6 6.8 0.3 0.0 0.6 0.0 8.7 7.1 0.0 2.3 6.2 0.0 4.5 2.7 0.5 14.6 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 1.4 0.4 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.1 2.3 25.7 0.3 1.9 1.2 0.5 0.0 3.2 0.3 0.0 1.0 0.0 3.9 2.7 0.5 1.2 0.0 17.4 7.9 0.0 0.0 0.2 0.0 0.0 18.5 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 0.0 0.2 0.0 2.4 0.0 0.0 10.0 0.6 0.0 1.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.2 0.0 0.0 0.1 TPBGL ENSG00000261594 "Trophoblast glycoprotein like" P0DKB5 11 75240905-75243697 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.2;testis: 10.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 3.5;Horizontal cells: 1.6;Melanocytes: 3.3;Muller glia cells: 5.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 5.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;HMC-1: 5.1;OE19: 1.8;SCLC-21H: 5.1;SK-MEL-30: 2.2;WM-115: 2.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.55e-2)" "unprognostic (4.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.70e-3)" "unprognostic (1.93e-2)" "unprognostic (5.52e-2)" "unprognostic (1.50e-1)" "unprognostic (2.27e-2)" "unprognostic (1.02e-1)" "unprognostic (3.73e-2)" "unprognostic (3.12e-2)" "unprognostic (3.47e-2)" "unprognostic (1.49e-14)" "unprognostic (3.04e-2)" "unprognostic (1.66e-1)" "unprognostic (2.13e-1)" "unprognostic (4.62e-2)" 1.4 6.5 3.7 1.8 14.2 0.6 0.6 0.4 11.0 1.2 0.9 0.0 0.0 0.7 1.5 0.7 0.6 1.2 1.4 0.6 3.4 1.7 0.6 0.5 1.0 1.2 0.9 1.8 0.6 0.9 0.6 0.6 0.6 10.2 0.7 0.8 1.5 0.6 0.8 0.3 0.8 1.0 2.7 0.7 0.7 0.7 10.8 0.8 0.0 0.7 0.0 1.3 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.6 1.8 0.0 0.0 0.0 0.0 0.1 0.0 5.1 0.3 0.8 0.0 2.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 14.2 0.4 11.0 3.4 1.7 0.9 1.8 10.2 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 5.7 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 TPD52L1 "D53, hD53" ENSG00000111907 "Tumor protein D52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 95.2;salivary gland: 104.6" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 118.7;Distal tubular cells: 149.2;Exocrine glandular cells: 97.5;Extravillous trophoblasts: 106.8;Melanocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 52.5;hTCEpi: 46.2;MCF7: 68.6;RPTEC TERT1: 53.2;SK-BR-3: 37.1;T-47d: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (5.34e-4)" 10.3 95.2 31.5 4.3 47.5 1.0 25.7 2.6 32.9 10.5 8.5 9.2 31.0 4.3 6.2 27.6 43.3 13.9 10.8 26.0 21.4 9.5 11.7 22.0 4.7 2.9 15.4 12.8 9.0 18.0 10.3 8.7 4.0 16.1 16.6 5.8 13.0 104.6 32.7 34.4 11.8 4.6 27.1 5.5 1.4 10.3 2.6 18.2 0.0 23.5 20.1 11.0 18.1 14.6 1.1 0.9 5.9 1.2 5.3 1.7 1.0 7.0 8.0 0.0 52.5 0.4 0.1 12.5 1.2 1.1 0.0 0.1 12.8 9.0 0.0 27.0 5.9 1.7 16.2 1.6 11.2 0.0 0.1 11.2 0.1 11.3 0.1 1.1 0.0 0.0 1.4 46.2 0.0 6.1 16.4 0.0 0.0 5.6 0.1 0.9 68.6 0.0 0.1 0.8 6.9 4.4 0.0 0.0 0.0 53.2 1.8 1.7 0.0 13.5 37.1 0.8 2.0 31.6 0.1 0.0 0.3 1.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 2.7 1.2 0.8 0.8 0.6 0.8 0.8 1.3 0.6 0.5 1.1 1.7 1.2 5.9 5.3 0.3 0.9 0.4 1.0 31.5 47.5 2.6 32.9 21.4 9.5 15.4 12.8 16.1 18.2 0.0 21.2 0.5 40.2 17.4 1.7 40.6 17.8 13.4 13.6 118.7 3.9 27.1 149.2 28.9 5.4 30.1 4.6 0.0 97.5 106.8 3.1 35.2 2.3 56.3 9.5 0.0 15.5 4.3 1.9 3.4 16.1 4.1 124.9 1.0 9.1 3.2 37.3 0.0 34.3 26.2 1.3 0.0 15.6 2.8 5.3 32.5 12.0 2.9 9.7 17.9 TPD52L3 NYD-SP25 ENSG00000170777 "Tumor protein D52 like 3" Q96J77 9 6328375-6331900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 111 "testis: 107.6" "Group enriched" "Detected in some" 6 "Early spermatids: 503.6;Late spermatids: 841.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "BEWO: 5.4" NA NA "unprognostic (4.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 503.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 841.5 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 112.9 5.4 0.0 0.0 0.0 0.0 0.0 TPH1 "TPH, TPRH" ENSG00000129167 "Tryptophan hydroxylase 1" P17752 11 18017564-18042426 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3" "Cell type enriched" "Detected in many" 164 "Intestinal endocrine cells: 1412.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "cerebral cortex: 4.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 4.5" "Low region specificity" "Detected in some" "CAB010767, HPA022483" Approved Uncertain Cytosol NA NA Cytosol "CAB010767: AB_261587, HPA022483: AB_1858378" "unprognostic (2.14e-4)" "unprognostic (9.97e-2)" "unprognostic (6.92e-2)" "unprognostic (6.78e-2)" "unprognostic (1.55e-1)" "unprognostic (6.26e-5)" "unprognostic (1.73e-1)" "unprognostic (5.33e-2)" "unprognostic (1.60e-1)" "unprognostic (2.12e-2)" "unprognostic (1.19e-4)" "unprognostic (6.72e-2)" "unprognostic (5.40e-8)" "unprognostic (3.76e-2)" "unprognostic (7.42e-2)" "unprognostic (3.10e-1)" "unprognostic (2.46e-5)" 0.7 0.0 0.7 0.7 0.7 0.6 0.9 0.7 4.2 0.7 7.1 0.7 0.7 8.2 0.7 0.7 0.7 1.5 0.7 0.7 0.7 0.3 0.7 0.7 0.7 0.7 0.7 0.7 1.0 0.7 0.0 5.4 0.7 0.7 1.3 16.2 0.7 0.7 0.7 0.7 1.0 9.1 0.7 0.7 1.0 13.3 0.9 0.7 0.7 0.7 0.7 0.7 0.7 0.7 1.4 0.8 1.5 0.5 0.9 1.6 0.2 0.4 0.1 1.7 1.5 0.1 0.0 0.6 0.6 0.5 0.2 1.1 1.8 0.3 1.4 0.3 0.0 0.1 0.6 0.4 1.5 0.7 1.3 3.1 2.2 0.8 3.5 0.0 4.5 1.2 0.0 1.8 0.2 0.6 0.3 0.7 2.7 0.9 0.8 0.1 0.5 1.0 0.7 0.5 0.1 0.3 1.7 0.3 0.0 0.0 1.0 1.3 0.9 0.2 0.4 0.9 0.2 0.3 2.9 0.2 0.4 1.3 0.5 1.7 0.2 0.3 1.1 0.2 1.0 1.4 1.5 0.4 0.4 1.6 0.2 0.8 0.5 0.5 0.4 0.1 1.4 0.6 0.6 1.5 0.9 0.5 0.8 0.6 0.2 0.7 0.7 0.7 4.2 0.7 0.3 0.7 0.7 0.7 0.7 0.0 0.0 0.0 0.4 0.3 4.7 0.4 0.0 1.4 0.0 5.2 2.0 0.2 0.0 0.2 0.7 0.3 1.0 0.0 0.5 0.0 0.7 2.0 0.0 0.0 0.2 1.6 1412.4 0.0 0.0 0.4 0.9 0.9 0.0 0.0 2.8 1.5 0.4 8.6 1.1 0.2 6.0 6.5 1.0 2.7 3.4 1.3 0.0 0.5 1.7 0.0 TPH2 "FLJ37295, NTPH" ENSG00000139287 "Tryptophan hydroxylase 2" Q8IWU9 12 71938846-72186618 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Serotonin biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 46.2" "Group enriched" "Detected in some" 4 "Early spermatids: 5.6;Late spermatids: 4.5" "Not detected" "Not detected" "Region enriched" "Detected in many" 15 "pons and medulla: 46.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "EFO-21: 2.9;NTERA-2: 3.1;SCLC-21H: 1.5;SuSa: 1.0" "Group enriched" "Detected in some" 32 "midbrain: 127.6;pons and medulla: 36.3" "Group enriched" "Detected in some" 10 "midbrain: 95.6;pons and medulla: 91.5" CAB078198 Enhanced NA NA "CAB078198: AB_2665804" "unprognostic (1.19e-1)" "unprognostic (6.01e-1)" "unprognostic (3.46e-2)" "unprognostic (2.31e-1)" "unprognostic (5.91e-2)" "unprognostic (2.02e-1)" "unprognostic (5.01e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" 0.1 0.2 0.4 0.3 0.5 0.1 0.1 0.3 4.4 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 3.0 1.5 0.1 0.3 0.1 0.1 0.9 0.0 0.1 1.7 0.1 3.2 0.1 46.2 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.2 0.3 0.1 0.1 1.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.2 0.0 1.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.3 1.4 3.0 1.5 0.9 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.1 TPI1 ENSG00000111669 "Triosephosphate isomerase 1" P60174 12 6867119-6870948 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Gluconeogenesis, Glycolysis" "Isomerase, Lyase" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 234.8;skeletal muscle: 211.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050924, HPA053568" Uncertain Approved Nucleoplasm,Vesicles NA NA 270000000 Nucleoplasm Vesicles "HPA050924: AB_2681276, HPA053568: AB_2682193" "unprognostic (2.85e-1)" "unprognostic (5.58e-3)" "unprognostic (1.65e-1)" "unprognostic (1.62e-2)" "unprognostic (6.94e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (4.14e-3)" "unprognostic (7.49e-2)" "unprognostic (2.13e-2)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (6.54e-4)" "unprognostic (7.04e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" 20.2 41.2 41.2 24.3 46.9 27.4 83.4 93.2 196.1 27.1 39.1 12.8 18.6 40.1 17.2 22.6 51.0 22.1 33.3 94.9 36.7 33.1 43.1 40.8 48.8 140.2 34.0 34.6 19.9 87.0 32.1 16.8 27.1 70.7 19.0 43.5 21.1 26.0 28.7 211.0 25.8 37.8 29.4 20.8 20.1 21.6 15.7 19.4 14.2 20.2 38.4 38.0 23.0 28.0 55.4 170.3 145.5 148.2 81.2 67.1 234.8 115.0 103.1 54.7 84.5 53.6 56.6 96.6 83.3 92.0 157.5 191.0 106.5 63.3 67.6 16.8 82.2 81.5 57.3 130.0 139.2 174.7 89.1 96.8 87.5 75.6 70.2 39.9 99.6 71.9 61.4 58.1 121.4 104.7 221.1 95.7 34.4 45.2 26.0 120.8 84.7 52.3 84.2 134.8 98.1 65.8 30.7 90.0 69.3 98.6 82.2 38.9 64.8 72.7 75.6 40.3 119.8 17.3 74.9 59.1 84.5 72.3 54.6 122.1 50.8 20.8 100.9 169.5 62.0 60.6 87.7 146.1 145.5 56.1 148.2 57.0 55.4 56.5 54.5 170.3 44.3 39.9 49.3 61.1 81.2 127.8 30.7 67.1 234.8 41.2 46.9 93.2 196.1 36.7 33.1 34.0 34.6 70.7 19.4 125.0 186.6 268.1 429.8 608.3 247.2 505.0 410.2 145.9 159.3 369.9 104.1 935.0 1278.3 1116.4 147.7 369.6 973.7 70.0 686.0 1611.5 538.5 310.9 357.6 425.4 827.4 281.3 408.6 284.8 382.5 523.4 258.3 552.8 639.4 1545.5 419.4 603.3 953.1 852.2 247.5 1236.2 208.3 194.1 473.8 15.1 66.8 538.4 1279.9 363.9 717.3 571.4 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 544.2;skeletal muscle: 589.5" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 12627.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 23.8" "Group enriched" "Detected in all" 4 "dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 206.7;SuSa: 259.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" NA NA 280000000 "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (7.30e-4)" 17.9 5.7 5.5 32.4 5.2 1.2 15.2 5.6 5.1 48.1 119.7 2.4 84.2 14.6 72.4 38.3 121.6 36.2 75.3 544.2 4.1 2.6 14.5 4.4 10.5 3.3 3.3 7.0 27.0 29.3 1.9 3.2 17.7 4.1 72.5 28.0 19.1 12.9 81.3 589.5 6.5 39.5 245.2 2.7 6.5 51.7 9.6 2.3 0.4 7.7 121.7 5.9 193.8 38.7 2.7 8.4 23.8 11.6 1.2 3.4 9.9 33.8 22.3 27.0 1.3 9.4 5.9 88.9 95.4 35.1 58.7 43.6 15.7 6.7 0.1 43.8 95.3 39.4 18.8 22.9 15.3 39.1 0.8 3.2 5.0 24.1 7.6 26.5 0.2 1.1 8.3 8.8 48.2 12.8 206.7 15.3 0.8 0.5 1.2 44.8 17.5 1.5 0.4 32.1 8.0 3.8 0.5 9.5 0.9 83.8 18.7 6.4 4.4 11.4 18.1 4.0 259.0 13.2 0.9 70.7 77.6 38.1 11.5 67.6 0.3 0.2 0.4 21.9 1.3 53.7 23.8 6.1 2.9 2.5 11.6 2.0 2.7 2.4 2.7 8.4 2.6 2.6 2.3 6.7 1.2 7.9 1.7 3.4 9.9 5.5 5.2 5.6 5.1 4.1 2.6 3.3 7.0 4.1 2.3 53.6 87.9 11.7 166.6 63.8 52.3 12627.3 392.4 116.4 116.0 301.8 361.3 128.4 159.2 2265.1 4.5 128.8 537.1 0.0 1464.0 2646.2 335.9 214.6 50.8 122.9 165.5 49.3 257.1 251.7 29.3 13.2 189.8 54.2 77.6 57.7 811.2 43.7 1740.7 585.7 1062.5 207.5 461.5 1021.9 1520.7 21.6 75.4 44.2 86.2 21.9 280.4 186.5 TPM2 "AMCD1, DA1, NEM4" ENSG00000198467 "Tropomyosin 2" P07951 9 35681992-35690121 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Disease mutation, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 1091.5;tongue: 332.2" "Group enriched" "Detected in many" 4 "Peritubular cells: 1947.8;Sertoli cells: 2186.0;Smooth muscle cells: 3115.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 727 "plasmacytoid DC: 76.4" "Lineage enriched" "Detected in single" 727 "dendritic cells: 76.4" "Cell line enhanced" "Detected in many" "BJ: 196.4;fHDF/TERT166: 107.2;hTERT-RPE1: 123.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA047089, HPA053624" Approved NA NA 290000000 "HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (5.56e-2)" "unprognostic (5.37e-2)" "prognostic unfavorable (2.64e-4)" "unprognostic (3.34e-2)" "unprognostic (2.70e-1)" "unprognostic (1.75e-2)" "unprognostic (1.18e-3)" "unprognostic (6.56e-3)" "unprognostic (2.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.23e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (8.51e-10)" "unprognostic (1.43e-2)" "unprognostic (8.33e-2)" "unprognostic (5.52e-2)" "unprognostic (1.41e-2)" 14.5 8.2 1.8 24.5 1.6 0.7 9.1 3.7 1.7 47.5 101.0 1.4 76.0 8.4 86.6 51.1 166.5 26.8 100.3 34.6 1.9 1.4 9.5 1.1 10.0 5.3 1.5 3.1 29.2 2.2 1.1 2.6 8.6 3.4 72.2 9.6 15.0 21.0 81.0 1091.5 4.2 27.4 231.7 1.6 4.7 48.7 13.4 0.6 0.2 9.3 332.2 22.0 190.7 38.6 0.0 76.4 0.1 0.0 0.0 0.0 0.4 29.7 22.8 16.0 2.6 30.2 80.8 9.8 196.4 80.1 83.2 56.5 0.9 1.9 0.0 17.6 107.2 11.7 0.6 0.2 24.2 38.6 54.9 0.7 0.7 81.3 0.9 48.2 0.1 8.0 94.3 3.8 62.2 0.0 123.3 19.5 1.9 0.3 0.0 83.6 1.1 0.1 2.0 20.2 0.1 1.3 1.3 29.6 0.2 2.5 0.5 0.2 1.0 37.3 0.6 1.3 24.1 0.5 2.1 2.3 1.2 45.4 0.9 56.0 0.0 0.1 0.2 2.8 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 76.4 0.0 0.4 1.8 1.6 3.7 1.7 1.9 1.4 1.5 3.1 3.4 0.6 3.0 5.5 3.2 76.3 50.7 0.8 590.1 2.5 9.4 22.7 7.0 0.0 10.2 0.0 16.3 3.1 80.7 0.4 0.0 5.0 76.5 194.5 31.7 2.3 1.3 30.2 1.6 2.4 259.7 5.9 15.9 262.1 16.2 64.1 10.8 1.3 9.5 12.0 0.0 1947.8 0.3 0.8 2186.0 3115.2 2.3 25.4 37.4 12.2 3.5 1.6 26.2 TPM3 "NEM1, TRK" ENSG00000143549 "Tropomyosin 3" P06753 1 154155304-154194648 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 738.4;tongue: 203.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, HPA047089, HPA053624" Approved Approved "Actin filaments,Cytosol" NA NA 410000000 "Actin filaments" Cytosol "HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.64e-1)" "unprognostic (2.11e-2)" "unprognostic (3.01e-3)" "unprognostic (1.07e-1)" "unprognostic (2.39e-1)" "unprognostic (2.69e-3)" "prognostic unfavorable (6.73e-6)" "prognostic unfavorable (4.01e-4)" "unprognostic (2.80e-1)" "prognostic favorable (2.39e-5)" "prognostic unfavorable (3.65e-4)" "unprognostic (3.31e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.52e-2)" "unprognostic (1.67e-1)" "unprognostic (1.98e-2)" "unprognostic (1.00e-2)" 10.1 7.3 10.8 10.8 10.5 26.5 6.2 6.4 11.2 4.6 9.6 3.9 3.2 7.9 4.1 27.9 18.3 4.4 6.7 29.7 7.7 8.1 7.2 6.8 9.6 12.9 8.9 5.8 4.8 23.2 3.6 3.2 6.7 5.0 5.7 10.7 4.4 20.5 2.5 738.4 5.9 8.2 5.2 7.7 11.7 6.9 5.4 4.4 6.7 9.3 203.6 28.6 6.8 4.9 38.9 72.6 154.8 95.9 35.4 54.4 146.1 66.5 33.2 42.5 27.9 36.0 47.1 42.9 57.2 52.9 75.9 57.3 61.8 62.4 50.1 46.6 64.5 30.5 61.7 42.1 60.2 81.0 34.7 22.9 61.7 32.4 41.6 28.6 90.2 82.0 35.5 33.0 66.9 51.5 34.2 116.7 36.9 46.3 53.9 93.7 39.9 70.2 93.1 95.7 113.6 72.2 60.2 29.5 71.0 54.8 50.8 29.9 56.1 43.5 57.9 56.7 59.2 80.8 107.9 87.2 66.5 48.1 63.7 89.6 45.9 75.4 67.0 60.1 68.0 105.0 70.8 64.7 154.8 54.4 87.8 48.6 38.9 48.5 51.1 72.6 30.1 36.6 47.3 74.9 35.4 95.9 36.0 52.1 146.1 10.8 10.5 6.4 11.2 7.7 8.1 8.9 5.8 5.0 4.4 577.7 334.3 245.8 179.3 132.8 84.5 62.7 104.4 335.9 395.8 92.5 29.5 101.3 89.5 278.9 51.0 357.1 327.9 0.0 302.5 278.2 125.9 137.0 499.8 99.0 485.9 287.6 135.3 175.6 320.5 131.0 43.1 444.6 145.1 764.7 164.6 45.8 384.6 230.6 28.0 130.8 59.1 19.4 73.4 34.9 54.6 125.3 85.2 233.3 208.9 254.0 TPMT ENSG00000137364 "Thiopurine S-methyltransferase" P51580 6 18128311-18155074 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 48.2" "Cell type enhanced" "Detected in many" 8 "Proximal tubular cells: 230.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019851, HPA062364" Enhanced NA NA "HPA019851: AB_1858213, HPA062364: " "unprognostic (6.24e-2)" "unprognostic (3.16e-2)" "unprognostic (5.46e-3)" "prognostic unfavorable (8.45e-5)" "unprognostic (4.98e-2)" "unprognostic (2.25e-1)" "unprognostic (8.16e-2)" "unprognostic (4.36e-3)" "unprognostic (9.62e-2)" "prognostic favorable (1.41e-4)" "unprognostic (4.49e-2)" "unprognostic (3.40e-2)" "prognostic favorable (1.10e-4)" "unprognostic (7.56e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.39e-3)" 5.3 13.2 11.5 6.6 10.2 4.9 5.6 13.1 14.3 4.6 18.2 4.1 6.2 18.4 6.5 10.1 8.9 4.1 7.6 6.5 9.0 8.0 40.2 36.2 6.5 6.2 9.3 7.5 3.8 9.4 12.9 11.6 3.3 8.5 6.2 19.4 6.9 12.9 7.2 7.0 5.7 29.4 6.2 7.2 9.4 6.6 4.1 7.5 5.4 48.2 6.3 5.3 6.4 5.6 1.6 16.9 3.7 23.8 5.4 8.3 8.3 11.9 3.6 4.1 10.0 6.7 13.1 10.0 13.9 15.5 11.9 18.6 8.4 3.0 1.5 10.4 18.3 9.2 6.0 5.7 10.0 19.9 7.9 8.2 9.9 6.2 12.3 7.4 4.5 8.9 7.5 10.8 13.3 8.5 7.8 16.5 6.8 19.5 2.9 8.6 5.5 4.6 6.2 6.7 16.6 10.5 5.8 10.0 6.7 13.8 12.3 6.6 5.1 9.1 16.2 17.8 10.6 11.7 4.5 7.0 27.4 5.3 14.3 19.7 4.1 18.5 3.9 9.8 6.2 27.4 3.4 12.0 3.7 6.5 23.8 8.3 1.5 5.3 6.2 16.9 1.6 4.8 6.5 1.2 5.4 19.6 3.7 8.2 8.3 11.5 10.2 13.1 14.3 9.0 8.0 9.3 7.5 8.5 7.5 14.9 13.3 18.0 32.1 37.9 15.1 15.4 22.9 4.0 6.8 33.2 21.6 17.3 97.8 34.1 1.2 11.7 80.0 0.0 32.7 21.7 11.7 34.2 23.0 79.7 40.7 6.4 23.1 12.3 34.5 1.5 3.7 56.7 23.6 19.8 31.8 22.9 51.4 78.6 9.6 230.3 16.8 0.0 14.7 0.4 8.1 30.2 14.6 23.5 36.6 71.2 TPO TPX ENSG00000115705 "Thyroid peroxidase" P07202 2 1374223-1543711 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "thyroid gland: 411.3" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 2.2;Early spermatids: 3.0;Endothelial cells: 1.1;Late spermatids: 3.8;Peritubular cells: 3.5" "Cancer enriched" "Detected in some" 364 "thyroid cancer: 188.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "memory CD4 T-cell: 5.1;T-reg: 3.0" "Lineage enriched" "Detected in single" 21 "T-cells: 5.1" "Group enriched" "Detected in some" 5 "Karpas-707: 14.3;RPMI-8226: 6.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007987, CAB009587" Enhanced "Intracellular and membrane" NA NA "CAB009587: , HPA007987: AB_1080270" "unprognostic (1.55e-1)" "unprognostic (1.04e-1)" "unprognostic (2.88e-1)" "unprognostic (1.77e-2)" "unprognostic (3.56e-2)" "unprognostic (9.11e-2)" "unprognostic (2.24e-2)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-4)" "unprognostic (2.61e-2)" "unprognostic (3.29e-1)" "unprognostic (5.44e-4)" "unprognostic (1.21e-1)" "unprognostic (3.73e-2)" "unprognostic (4.98e-3)" "unprognostic (7.10e-3)" 1.1 0.0 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.5 0.0 0.2 0.1 0.1 7.1 0.2 0.1 0.1 0.1 411.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 5.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 3.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TPPP "p25, p25alpha, TPPP/p25, TPPP1" ENSG00000171368 "Tubulin polymerization promoting protein" O94811 5 659862-693395 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 77.5" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 35.7;Bipolar cells: 18.7;Horizontal cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.5;NK-cell: 1.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 8.6;AN3-CA: 6.4;SCLC-21H: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036575, HPA036576" Enhanced Supported Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" "HPA036575: AB_10673501, HPA036576: AB_2675200" "unprognostic (3.66e-2)" "unprognostic (3.70e-3)" "unprognostic (9.98e-3)" "unprognostic (7.82e-2)" "unprognostic (2.05e-2)" "unprognostic (3.20e-2)" "unprognostic (2.12e-1)" "unprognostic (3.80e-3)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-3)" "unprognostic (5.48e-2)" "prognostic favorable (5.40e-6)" "unprognostic (4.03e-2)" "unprognostic (2.30e-1)" "unprognostic (2.03e-2)" "unprognostic (3.31e-2)" 3.5 5.8 27.0 1.3 29.6 1.0 2.7 17.0 77.5 2.1 3.2 69.0 0.1 4.6 2.3 1.3 9.0 8.6 2.1 6.0 33.9 23.9 3.2 2.3 8.3 1.0 25.8 25.0 1.8 5.2 2.4 4.4 2.4 30.1 2.4 2.2 0.2 4.8 3.7 6.2 5.6 7.5 3.5 24.7 2.7 3.8 1.6 4.3 0.0 6.0 1.9 1.8 3.4 0.6 0.0 0.2 1.5 0.0 1.0 0.5 0.1 0.3 8.6 0.4 6.4 0.9 0.0 1.2 0.2 0.0 0.0 0.0 0.3 1.0 0.2 0.6 0.0 2.2 3.4 3.4 0.0 0.0 1.7 2.9 0.2 3.6 0.2 1.0 0.3 0.4 0.0 0.8 0.0 0.2 0.2 0.1 0.2 0.1 3.2 0.0 0.3 0.2 0.5 0.2 0.9 0.9 0.3 0.1 1.2 0.3 1.2 15.8 1.9 0.9 0.4 4.2 0.4 0.8 0.2 0.1 0.2 3.4 0.1 0.2 1.2 0.3 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.2 0.1 0.1 27.0 29.6 17.0 40.8 33.9 23.9 25.8 25.0 30.1 4.3 35.7 7.7 0.0 1.0 3.7 18.7 16.1 5.1 16.0 9.1 1.8 0.0 0.0 1.7 1.7 6.9 0.0 8.5 0.0 0.6 0.1 0.7 0.6 4.6 2.0 2.5 39.7 9.8 1.3 0.0 3.6 0.3 0.0 1.7 0.0 5.7 0.8 1.0 5.8 0.4 1.1 2.1 0.0 1.9 1.4 0.2 2.8 0.0 0.0 4.1 2.4 TPPP2 "C14orf8, CT152, p18, p25beta" ENSG00000179636 "Tubulin polymerization promoting protein family member 2" P59282 14 21024109-21036276 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 99.4" "Cell type enriched" "Detected in some" 4 "Late spermatids: 7275.7" "Cancer enhanced" "Detected in single" "liver cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;HAP1: 1.8;Hep G2: 1.3;RT4: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA004120 Enhanced NA NA "HPA004120: AB_2303582" "unprognostic (2.91e-2)" "unprognostic (2.49e-3)" "unprognostic (2.54e-1)" "unprognostic (1.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.57e-3)" "unprognostic (4.63e-4)" "unprognostic (3.83e-1)" "unprognostic (3.16e-1)" "unprognostic (1.09e-1)" "unprognostic (4.64e-4)" "unprognostic (2.51e-4)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (3.21e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 1.8 0.1 0.0 0.1 0.1 0.1 0.0 0.2 4.8 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.9 0.0 0.1 0.1 0.1 0.1 0.0 99.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 1716.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 7275.7 44.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 32.9 0.0 0.0 0.0 0.0 48.1 24.2 0.0 0.1 0.0 0.0 0.0 TPPP3 "CGI-38, p20, p25gamma" ENSG00000159713 "Tubulin polymerization promoting protein family member 3" Q9BW30 16 67389809-67393535 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 211.3" "Cell type enhanced" "Detected in many" 19 "Ciliated cells: 1619.4;Melanocytes: 475.8;Suprabasal keratinocytes: 432.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 26.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 29.0;OE19: 19.5;RH-30: 15.5;SCLC-21H: 23.9;SH-SY5Y: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047629, HPA061691" Enhanced Approved "Nucleoli fibrillar center" NA NA 29000 "Nucleoli fibrillar center" "HPA047629: AB_2680108, HPA061691: " "unprognostic (1.63e-1)" "unprognostic (6.62e-3)" "unprognostic (1.35e-1)" "unprognostic (7.28e-3)" "unprognostic (4.48e-3)" "unprognostic (1.59e-3)" "unprognostic (9.22e-2)" "unprognostic (3.23e-1)" "unprognostic (1.46e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.84e-4)" "unprognostic (3.51e-2)" "unprognostic (9.44e-2)" "unprognostic (9.46e-2)" "unprognostic (1.86e-3)" 9.6 7.6 30.5 2.9 20.7 1.0 21.9 3.7 25.0 12.8 11.9 70.3 2.0 6.4 7.2 15.1 24.8 211.3 6.0 11.3 36.4 41.9 6.1 1.9 36.3 1.7 26.4 22.1 14.1 6.5 2.2 5.8 70.6 24.5 3.4 4.3 2.2 5.2 4.2 14.4 28.1 9.8 10.0 40.6 3.8 11.3 2.6 24.4 0.1 3.5 37.6 6.1 7.4 5.5 0.0 14.1 5.2 26.2 0.0 0.1 3.6 0.2 29.0 0.3 0.2 0.2 4.8 0.1 0.8 0.2 0.2 0.4 1.8 5.8 0.0 0.4 0.4 0.1 5.5 4.5 0.0 0.0 0.0 1.7 0.0 0.8 0.8 0.0 0.0 0.0 1.2 0.1 1.8 0.0 0.9 0.3 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.9 19.5 0.0 0.0 15.5 0.1 0.0 0.0 23.9 10.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.4 0.0 10.9 5.2 0.0 15.4 0.1 0.0 0.0 0.0 14.1 0.0 0.0 0.0 2.6 0.0 26.2 0.1 0.0 3.6 30.5 20.7 3.7 23.8 36.4 41.9 26.4 22.1 24.5 24.4 14.9 90.7 0.0 8.9 269.9 1.4 4.0 15.3 1619.4 170.6 17.4 3.9 1.8 5.0 47.8 55.6 19.9 16.9 0.0 1.6 3.9 95.0 5.4 25.3 0.0 2.7 0.0 170.8 3.1 2.6 16.8 27.0 16.0 475.8 1.8 30.4 78.6 13.2 14.4 3.2 0.2 7.3 232.8 118.8 3.7 3.4 432.9 66.9 0.9 22.1 7.7 TPRG1 "FAM79B, FLJ41238, FLJ43694" ENSG00000188001 "Tumor protein p63 regulated 1" Q6ZUI0 3 188947214-189325304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.3;lymphoid tissue: 32.9" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 35.7;Early spermatids: 102.2" "Cancer enhanced" "Detected in many" "breast cancer: 7.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.8;Karpas-707: 4.5;OE19: 21.7;U-266/70: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044751, HPA060187" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044751: AB_2679073, HPA060187: AB_2684217" "prognostic favorable (5.43e-4)" "unprognostic (8.71e-3)" "unprognostic (2.10e-3)" "unprognostic (2.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.33e-3)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.66e-1)" "unprognostic (2.71e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-1)" "unprognostic (3.52e-8)" "unprognostic (8.50e-2)" "unprognostic (9.53e-2)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" 16.1 1.0 0.3 0.9 0.8 0.0 14.4 1.7 0.8 19.7 1.2 0.1 1.0 0.0 5.0 1.6 43.3 5.2 1.6 2.4 0.2 0.2 0.6 5.1 2.7 0.3 0.3 0.5 1.9 0.3 0.0 0.8 1.0 0.5 2.5 0.0 0.8 3.7 0.7 5.0 14.5 0.5 1.9 0.3 0.7 0.4 2.6 0.3 7.9 0.8 25.5 32.9 2.3 17.8 0.2 0.7 1.3 2.3 0.0 6.3 1.3 0.8 0.2 0.3 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.1 1.0 2.1 1.2 3.3 0.1 0.5 0.2 0.0 0.0 0.0 8.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.2 0.3 0.0 0.0 0.6 21.7 0.3 0.0 0.0 1.5 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.7 3.9 0.6 0.0 0.1 0.3 0.0 0.3 4.2 3.3 0.3 0.1 0.0 0.1 0.0 2.3 0.0 6.0 1.8 0.9 0.2 4.9 6.3 0.7 0.0 1.0 2.5 1.3 0.0 1.6 0.1 5.4 1.3 0.3 0.8 1.7 0.8 0.2 0.2 0.3 0.5 0.5 0.3 35.7 1.7 5.7 16.1 4.9 0.2 0.7 0.0 1.4 10.3 0.0 0.0 0.3 0.0 0.3 102.2 0.7 0.0 0.0 0.5 0.2 1.4 1.5 1.1 6.6 5.0 0.0 0.0 0.0 1.9 7.8 6.6 2.2 0.0 0.0 0.0 0.0 4.6 0.0 2.8 0.0 0.0 0.0 0.7 1.2 1.1 5.1 0.2 13.4 0.2 5.1 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.8;pancreas: 45.3" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 109.1;Mucus-secreting cells: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 27.8;T-47d: 26.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 40.9" "HPA020899, HPA076667" Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favorable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.2 3.8 8.5 5.0 16.8 3.2 3.3 26.1 17.9 3.4 18.5 32.8 2.3 23.6 2.8 1.8 8.2 4.2 4.8 3.6 11.2 7.0 12.1 10.0 5.8 3.0 25.3 7.1 4.7 45.3 2.8 2.7 4.3 11.0 4.4 8.1 13.1 8.7 4.8 5.0 8.0 29.0 2.4 11.9 3.7 10.8 4.7 21.7 0.2 2.5 2.3 3.5 3.8 2.7 1.2 2.3 0.2 2.9 2.9 2.2 0.6 4.5 5.2 1.7 7.9 2.5 2.6 14.1 3.2 2.0 3.3 1.8 17.4 5.6 8.4 4.8 1.6 4.3 14.0 3.6 1.8 0.4 5.3 5.1 3.9 7.8 11.4 3.7 6.0 5.1 2.2 3.5 2.9 2.0 2.1 2.0 3.8 7.1 3.0 0.9 27.8 3.9 13.0 6.3 25.0 6.8 11.8 4.2 12.7 7.3 9.6 11.5 4.2 4.9 23.2 5.7 1.4 26.9 9.5 2.3 6.0 2.8 9.4 6.8 2.5 4.8 4.3 4.3 5.4 3.3 0.0 2.9 0.2 1.3 2.6 0.4 1.1 1.3 1.8 2.1 1.2 0.6 1.2 0.0 2.9 1.5 2.3 2.2 0.6 8.5 16.8 26.1 17.9 11.2 7.0 25.3 7.1 11.0 21.7 17.9 5.6 2.7 1.1 1.5 15.5 7.3 12.7 1.4 1.2 15.7 5.9 4.7 6.6 7.1 2.3 1.9 109.1 23.3 38.5 1.1 1.6 2.8 1.1 14.4 3.1 11.1 8.6 4.3 3.2 3.8 3.1 2.1 5.0 1.8 43.9 10.9 16.4 23.2 4.2 16.6 5.9 6.5 1.7 1.0 5.5 2.5 1.6 0.0 21.2 1.7 TPRX1 FLJ40321 ENSG00000178928 "Tetrapeptide repeat homeobox 1" Q8N7U7 19 47801243-47819051 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 4.6" "Cell type enriched" "Detected in single" 7 "Rod photoreceptor cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA044922 Uncertain NA NA "HPA044922: AB_10962509" "unprognostic (8.56e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.6 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 TPSB2 ENSG00000197253 "Tryptase beta 2 (gene/pseudogene)" P20231 16 1227272-1230184 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.2" "Cell type enriched" "Detected in some" 18 "granulocytes: 8345.3" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 84 "basophil: 8.4" "Lineage enriched" "Detected in single" 84 "granulocytes: 8.4" "Cell line enriched" "Detected in some" 8 "HMC-1: 83.3" "HPA049153, HPA049554" Supported "Secreted to blood" NA NA 7500000 "HPA049153: AB_2680656, HPA049554: AB_2680815" "unprognostic (9.05e-2)" "unprognostic (8.46e-3)" "unprognostic (2.42e-3)" "unprognostic (2.27e-2)" "unprognostic (4.97e-3)" "unprognostic (1.02e-3)" "unprognostic (1.11e-1)" "unprognostic (8.55e-2)" "unprognostic (2.48e-1)" "unprognostic (2.24e-1)" "unprognostic (1.95e-1)" "unprognostic (8.30e-3)" "unprognostic (1.91e-2)" "unprognostic (5.76e-2)" "unprognostic (2.41e-2)" "unprognostic (4.65e-2)" "unprognostic (3.17e-2)" 1.8 0.0 0.9 1.9 0.9 0.0 4.1 0.9 0.9 8.8 5.3 0.9 0.9 4.9 2.9 0.9 7.7 0.1 16.2 0.9 0.9 0.9 0.9 12.3 2.4 0.9 0.9 0.9 1.3 0.0 0.9 0.9 0.9 2.7 2.3 0.9 6.2 1.2 0.9 3.4 9.7 4.4 0.9 0.9 13.6 0.9 0.9 0.9 0.9 0.9 0.9 4.2 0.9 0.0 0.0 8.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.1 83.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.7 468.0 0.0 1.9 0.0 0.0 1.3 0.0 6.7 30.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 3.9 8345.3 0.0 4.1 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 4.6 TPSG1 "PRSS31, TMT" ENSG00000116176 "Tryptase gamma 1" Q9NRR2 16 1221651-1225257 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 16.0" "Cell type enriched" "Detected in some" 6 "Mucus-secreting cells: 264.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HMC-1: 22.8;MCF7: 7.4" "Not detected" "Not detected" HPA060458 Enhanced NA NA "HPA060458: AB_2684283" "unprognostic (1.86e-1)" "unprognostic (3.46e-1)" "unprognostic (5.21e-3)" "unprognostic (1.27e-1)" "unprognostic (5.58e-2)" "unprognostic (1.18e-2)" "unprognostic (3.45e-2)" "unprognostic (4.60e-2)" "unprognostic (9.97e-2)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (6.39e-2)" "prognostic unfavorable (1.76e-8)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (8.65e-4)" "unprognostic (5.70e-2)" 1.3 0.6 0.4 4.5 0.4 0.0 3.1 0.4 0.4 0.6 14.4 0.4 0.4 14.0 1.2 0.4 0.7 0.5 1.0 0.4 0.4 0.0 0.4 0.4 0.6 0.4 0.4 0.4 2.0 0.4 0.0 3.2 0.4 0.4 1.1 8.8 0.4 0.4 0.4 0.4 1.1 16.0 1.2 0.4 0.4 1.0 1.3 0.4 0.4 0.4 1.1 0.4 1.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 0.0 1.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 264.6 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.6 0.0 TPST2 TANGO13B ENSG00000128294 "Tyrosylprotein sulfotransferase 2" O60704 22 26521983-26596717 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 71.0;pancreas: 192.5" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 157.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 57.1" "Low region specificity" "Detected in all" HPA021054 Enhanced "Intracellular and membrane" NA NA 33000 "HPA021054: AB_1858221" "unprognostic (2.24e-1)" "unprognostic (1.70e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.08e-5)" "unprognostic (8.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.19e-2)" "unprognostic (9.70e-2)" "unprognostic (3.18e-2)" "unprognostic (3.38e-1)" "unprognostic (2.70e-1)" "unprognostic (5.54e-2)" "prognostic unfavorable (2.34e-6)" "unprognostic (9.68e-2)" "unprognostic (9.21e-3)" "unprognostic (5.62e-2)" "unprognostic (2.01e-1)" 5.8 8.4 4.7 3.7 3.6 5.2 9.0 2.1 6.9 4.6 2.9 3.0 7.4 3.5 4.7 31.8 4.5 4.1 3.2 5.2 5.2 3.2 5.7 20.0 10.7 4.8 3.7 3.6 2.4 192.5 1.1 2.9 11.0 3.2 3.8 2.3 4.0 2.8 7.9 8.6 4.0 3.1 3.2 2.8 8.9 3.0 4.8 3.1 3.0 12.2 2.2 5.2 4.5 6.7 4.3 20.0 71.0 15.1 57.2 46.4 35.2 4.3 3.2 4.2 2.1 8.9 6.9 5.8 9.8 17.6 8.0 7.3 2.1 2.2 7.4 2.6 17.5 4.2 6.8 3.1 6.7 4.6 3.0 5.9 17.8 2.0 4.4 3.7 2.0 57.1 7.4 10.8 8.0 2.7 8.1 14.7 3.4 17.8 23.2 6.1 4.9 8.2 13.9 5.5 3.4 3.2 7.7 5.6 20.5 2.4 4.9 3.1 2.2 4.5 4.0 5.4 6.4 1.8 8.5 11.6 9.9 22.4 8.0 9.4 7.5 10.4 7.1 7.5 8.0 8.9 71.0 13.4 18.6 46.4 14.5 13.0 4.1 10.9 34.5 8.4 4.3 5.4 31.4 28.4 57.2 15.1 20.0 12.2 35.2 4.7 3.6 2.1 6.9 5.2 3.2 3.7 3.6 3.2 3.1 14.9 13.0 19.3 70.7 33.9 7.0 10.6 38.2 13.4 4.5 21.0 5.9 157.8 23.2 11.5 8.4 57.7 7.8 0.0 56.2 41.8 11.9 27.5 49.9 68.4 105.1 6.4 0.0 93.9 52.0 2.6 4.9 37.1 27.0 10.8 9.2 2.0 65.3 10.5 3.9 7.6 4.3 6.5 17.3 2.9 16.6 31.5 119.6 57.3 12.3 71.9 TPTE "CT44, PTEN2" ENSG00000274391 "Transmembrane phosphatase with tensin homology" P56180 21 10521553-10606140 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 69 "testis: 78.6" "Group enriched" "Detected in some" 14 "Spermatocytes: 282.4;Spermatogonia: 73.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;K-562: 8.6;Karpas-707: 7.0;MCF7: 5.1;PC-3: 5.2;RPMI-8226: 9.5;SuSa: 8.9;U-2 OS: 4.6;U-266/70: 8.5" "HPA049690, HPA068342" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA049690: AB_2680850, HPA068342: AB_2685976" "unprognostic (3.63e-2)" 0.1 0.0 0.0 0.7 0.2 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.8 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.4 0.0 0.9 0.0 78.6 0.0 0.4 0.1 0.4 0.8 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 7.0 0.0 5.1 0.0 0.0 1.2 0.0 5.2 0.0 0.0 9.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 8.9 0.0 0.0 0.0 2.0 4.6 2.4 0.0 8.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.6 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 12.9 0.0 282.4 73.0 0.0 0.9 0.0 0.0 0.0 TPTE2 TPIP ENSG00000132958 "Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2" Q6XPS3 13 19422877-19536762 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 12.3" "Cell type enhanced" "Detected in some" 23 "Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5" "Cancer enriched" "Detected in single" 6 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;Karpas-707: 2.9" HPA068342 Approved "Endoplasmic reticulum,Cytosol" NA NA Cytosol "Endoplasmic reticulum" "HPA068342: AB_2685976" "unprognostic (2.50e-1)" "unprognostic (2.10e-1)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (1.25e-2)" "unprognostic (5.33e-3)" "unprognostic (1.90e-1)" "unprognostic (1.24e-1)" "unprognostic (5.40e-2)" "unprognostic (3.67e-2)" "unprognostic (2.81e-1)" "unprognostic (1.05e-12)" "unprognostic (1.04e-1)" "unprognostic (1.47e-1)" "unprognostic (2.44e-1)" "unprognostic (5.00e-3)" 0.0 0.1 0.4 0.2 1.0 0.0 0.1 0.7 0.8 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.2 0.2 12.3 0.0 0.6 0.0 0.0 0.5 0.4 0.0 0.1 0.5 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 10.1 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 2.9 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.3 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 9.3 2.5 0.1 0.1 0.0 0.0 0.0 TPX2 "C20orf1, C20orf2, DIL-2, p100" ENSG00000088325 "TPX2, microtubule nucleation factor" Q9ULW0 20 31739271-31801805 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 92.7" "Group enriched" "Detected in many" 5 "Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 10.4" "Group enriched" "Detected in many" 5 "granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005487 Enhanced Supported "Nucleoplasm,Cytokinetic bridge,Mitotic spindle" Yes Yes Nucleoplasm "Cytokinetic bridge, Mitotic spindle" "HPA005487: AB_1858223" "unprognostic (2.18e-2)" "unprognostic (1.77e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.43e-6)" "unprognostic (2.99e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (8.07e-7)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.68e-5)" "unprognostic (5.99e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (4.56e-2)" "unprognostic (2.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.39e-1)" 1.8 1.7 1.0 13.4 2.0 21.7 1.2 2.2 1.7 2.2 5.7 0.5 0.3 4.6 1.2 2.3 13.3 0.5 1.9 1.5 0.8 0.7 1.2 2.7 2.6 12.9 0.7 1.1 0.8 0.5 0.0 0.7 6.6 0.9 0.7 7.4 0.5 2.3 0.5 2.2 5.9 4.7 3.2 0.9 5.9 3.2 22.0 0.6 92.7 0.7 11.0 16.2 2.2 3.8 1.0 1.4 4.0 0.1 4.8 10.4 1.3 70.8 23.8 28.8 22.5 2.3 4.2 27.8 29.8 16.9 43.3 32.7 50.5 30.7 33.4 17.6 16.6 32.4 37.5 32.8 27.0 49.5 14.4 12.7 65.4 22.8 34.4 0.7 25.1 16.8 1.4 1.5 27.1 19.8 6.2 23.3 25.3 48.3 30.5 33.9 29.1 41.9 19.5 32.1 27.4 25.8 23.9 77.8 20.2 11.6 11.6 20.9 14.1 45.6 17.3 13.5 20.7 30.0 15.3 15.7 48.6 29.9 22.2 45.7 12.2 21.1 29.9 15.2 89.5 31.6 4.0 0.0 0.5 0.6 0.0 0.3 1.0 1.9 2.3 0.6 0.4 0.4 0.7 0.4 4.8 0.1 1.4 10.4 1.3 1.0 2.0 2.2 1.7 0.8 0.7 0.7 1.1 0.9 0.6 0.0 6.2 16.2 0.8 6.2 0.8 0.8 7.6 0.0 5.7 0.0 0.0 4.4 0.0 1.0 6.4 0.3 0.6 70.0 0.4 57.2 2.9 0.6 0.0 2.5 15.9 1.6 1.2 9.8 5.3 10.6 0.9 5.1 0.0 3.6 2.6 0.3 1.2 0.6 0.0 0.0 0.3 0.0 2.1 121.8 68.8 5.4 3.9 6.9 7.3 1.4 TRABD2A "C2orf89, TIKI1" ENSG00000186854 "TraB domain containing 2A" Q86V40 2 84821650-84907008 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 450.4;Late spermatids: 221.7;Undifferentiated cells: 92.9" "Group enriched" "Detected in many" 9 "colorectal cancer: 14.4;stomach cancer: 3.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 29.3" "Lineage enriched" "Detected in many" 17 "T-cells: 29.3" "Cell line enhanced" "Detected in many" "BEWO: 24.7;HDLM-2: 18.6;HSkMC: 13.3;hTEC/SVTERT24-B: 10.9;SiHa: 10.6" HPA045817 Approved "Intracellular and membrane" NA NA "HPA045817: AB_2679460" "unprognostic (7.49e-3)" "unprognostic (3.35e-1)" "unprognostic (3.08e-1)" "unprognostic (3.29e-2)" "unprognostic (3.82e-5)" "unprognostic (2.46e-2)" "unprognostic (2.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.68e-2)" "unprognostic (1.66e-1)" "unprognostic (1.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.47e-4)" "unprognostic (4.29e-2)" "unprognostic (7.60e-2)" "unprognostic (1.41e-3)" "unprognostic (1.37e-1)" 1.8 0.5 0.7 24.7 1.6 2.1 6.3 0.6 3.7 0.5 23.2 0.9 0.0 2.4 0.5 0.4 0.5 1.3 0.2 0.7 0.9 0.8 0.9 0.9 3.0 11.3 0.9 3.1 23.7 0.4 0.4 0.6 2.0 0.2 0.5 26.6 1.2 3.3 0.0 0.3 1.2 9.3 1.8 0.9 3.1 0.6 0.6 0.0 6.4 0.7 0.0 6.3 0.7 0.7 1.7 0.6 0.5 0.1 1.3 29.3 5.3 0.7 0.6 0.2 0.1 7.3 7.9 24.7 1.2 1.9 3.6 6.5 0.3 2.8 0.0 0.3 3.8 6.6 0.0 1.7 0.3 5.3 18.6 0.4 0.0 5.2 0.0 0.9 0.0 0.0 13.3 0.0 10.9 4.8 0.8 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.6 1.2 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.1 0.2 0.0 0.1 0.2 3.5 0.5 0.0 1.2 2.2 0.0 0.0 3.1 2.0 0.0 0.0 0.1 0.0 3.3 0.1 4.0 0.3 13.1 5.0 0.6 1.7 29.3 18.2 0.5 1.3 0.0 0.6 8.5 5.3 0.7 1.6 0.6 3.7 0.9 0.8 0.9 3.1 0.2 0.0 3.0 11.2 8.2 0.7 0.9 1.2 59.0 0.0 1.4 1.2 0.0 0.0 8.6 0.0 0.0 450.4 4.5 20.6 0.0 0.8 36.4 2.4 0.5 2.3 0.0 2.5 0.0 12.2 1.8 0.6 221.7 4.6 3.6 3.3 18.0 53.4 0.0 0.5 56.1 2.5 1.1 0.0 6.5 1.0 3.2 4.3 0.5 3.7 8.7 92.9 0.3 TRABD2B TIKI2 ENSG00000269113 "TraB domain containing 2B" A6NFA1 1 47760528-47996895 "Predicted intracellular proteins" "Wnt signaling pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 34.3" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 7.4;Cholangiocytes: 10.2;Hepatocytes: 10.4;Proximal tubular cells: 20.3;Smooth muscle cells: 7.6" "Cancer enriched" "Detected in many" 7 "renal cancer: 12.8" "Region enhanced" "Detected in single" "cerebellum: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HeLa: 8.0;U-2197: 17.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045817 Approved "Intracellular and membrane" NA NA 22000 "HPA045817: AB_2679460" "unprognostic (2.38e-2)" "unprognostic (6.77e-2)" "unprognostic (1.19e-2)" "unprognostic (2.26e-2)" "unprognostic (5.65e-2)" "unprognostic (4.49e-2)" "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (2.74e-1)" "unprognostic (3.29e-3)" "unprognostic (1.84e-1)" "unprognostic (2.95e-1)" "unprognostic (1.41e-2)" "unprognostic (2.41e-2)" "unprognostic (4.77e-1)" "unprognostic (1.43e-2)" "unprognostic (1.67e-1)" 3.6 1.5 0.5 2.2 0.3 0.1 3.3 2.7 0.5 4.8 3.0 0.5 1.5 0.9 1.8 9.3 4.7 2.2 9.5 8.2 0.1 0.1 34.3 7.1 1.8 1.9 0.4 0.5 2.5 7.0 0.3 2.3 0.9 0.8 4.9 1.6 2.7 2.3 8.5 1.7 1.7 1.8 7.1 0.7 1.5 1.9 1.8 0.0 0.6 1.1 1.0 0.8 6.9 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.5 0.0 8.0 0.0 0.9 0.0 0.0 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.4 0.5 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.8 17.1 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.7 0.5 0.1 0.1 0.4 0.5 0.8 0.0 0.0 0.3 0.0 1.4 0.7 0.0 7.4 10.2 0.0 0.0 1.8 0.0 0.0 5.0 3.3 0.1 0.8 0.0 0.0 1.8 0.0 2.1 0.2 0.0 10.4 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.4 0.0 2.1 20.3 0.0 0.0 7.6 0.0 2.2 0.3 0.0 0.0 0.0 0.1 TRAF3IP3 T3JAM ENSG00000009790 "TRAF3 interacting protein 3" Q9Y228 1 209756032-209782320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 86.5;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 20 "B-cells: 61.1;granulocytes: 55.6;T-cells: 188.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 39.7;JURKAT: 22.7;Karpas-707: 16.5;MOLT-4: 20.5;NB-4: 23.6;THP-1: 22.3;U-266/70: 24.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040796 Enhanced Approved Vesicles NA NA Vesicles "HPA040796: AB_10794861" "prognostic favorable (4.11e-4)" "unprognostic (1.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.36e-4)" "unprognostic (2.67e-1)" "unprognostic (1.91e-5)" "unprognostic (3.83e-3)" "prognostic favorable (8.15e-4)" "unprognostic (5.30e-2)" "unprognostic (3.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.39e-1)" "unprognostic (1.38e-4)" "unprognostic (3.08e-1)" "unprognostic (2.93e-2)" "unprognostic (3.16e-2)" "unprognostic (4.21e-2)" 2.2 0.8 1.7 30.6 2.1 9.8 1.3 0.6 1.5 1.5 3.8 2.2 0.3 2.3 1.5 1.4 2.5 1.7 4.6 1.2 1.7 1.4 3.4 2.4 5.8 32.6 3.8 0.6 1.2 1.3 0.0 1.0 1.0 2.7 2.2 3.6 1.7 8.4 1.3 0.7 1.1 19.8 1.0 3.8 38.3 4.1 1.4 2.6 69.5 2.4 1.5 33.6 5.7 1.9 43.9 25.3 54.9 29.5 50.1 86.5 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 39.7 0.0 3.7 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 16.5 0.0 0.0 20.5 23.6 0.0 0.0 0.0 2.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 24.5 8.5 1.5 0.0 11.1 0.0 54.9 24.1 24.8 48.9 25.7 51.8 43.9 67.8 55.9 25.3 41.4 76.9 60.8 6.5 50.1 29.5 18.6 86.5 56.3 1.7 2.1 0.6 1.5 1.7 1.4 3.8 0.6 2.7 2.6 3.0 14.8 61.1 3.6 2.1 1.5 0.6 2.5 1.4 0.0 0.0 0.0 0.3 10.0 0.1 8.9 0.7 0.2 0.0 0.2 0.3 1.1 0.4 55.6 3.2 22.1 0.0 0.0 4.3 27.4 5.7 0.3 22.8 10.1 5.4 0.2 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.3 0.5 0.2 1.9 0.3 188.4 0.4 2.0 TRAIP "RNF206, TRIP" ENSG00000183763 "TRAF interacting protein" Q9BWF2 3 49828599-49856574 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.0" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 11.8;Spermatogonia: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036261, HPA036262" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036261: AB_10673348, HPA036262: AB_2675029" "unprognostic (5.30e-3)" "unprognostic (9.41e-2)" "unprognostic (1.48e-1)" "unprognostic (6.50e-3)" "unprognostic (1.88e-1)" "unprognostic (7.68e-3)" "prognostic unfavorable (8.77e-5)" "unprognostic (4.61e-2)" "unprognostic (1.52e-2)" "unprognostic (8.61e-2)" "unprognostic (1.24e-2)" "unprognostic (7.97e-2)" "unprognostic (9.01e-5)" "unprognostic (5.84e-2)" "unprognostic (4.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" 4.8 1.6 3.4 6.0 10.7 9.5 3.0 7.4 3.0 3.5 3.7 2.0 3.2 2.3 3.8 2.4 4.5 3.0 2.9 1.5 2.7 2.7 1.6 1.2 1.3 8.1 2.0 2.8 3.4 1.6 1.6 2.0 2.5 3.0 2.9 4.8 2.7 3.1 1.7 2.8 6.7 3.4 3.4 5.1 3.7 1.9 25.0 3.4 11.5 2.2 3.1 6.8 1.9 3.0 5.1 1.6 0.6 3.0 2.7 4.9 1.6 6.4 7.9 11.3 11.4 1.0 1.6 9.4 7.8 3.8 16.6 15.9 9.6 7.5 16.0 5.6 4.5 11.6 8.6 11.9 9.0 12.4 9.2 7.9 12.0 9.6 8.5 0.4 9.8 10.1 1.1 1.3 13.3 7.1 2.0 4.3 14.3 8.6 11.6 7.3 9.4 16.2 12.5 9.1 7.7 13.1 9.0 7.7 9.3 3.0 9.1 5.5 9.4 8.7 7.3 5.5 8.5 6.6 13.9 3.3 10.6 12.7 14.6 15.3 8.5 20.3 17.1 5.3 13.3 9.5 0.0 1.5 0.6 2.3 0.8 2.0 5.1 1.3 4.9 1.3 3.8 1.7 2.6 0.3 2.7 3.0 1.6 0.8 1.6 3.4 10.7 7.4 3.0 2.7 2.7 2.0 2.8 3.0 3.4 3.0 1.1 2.2 0.6 1.0 3.1 2.0 0.0 0.0 0.0 3.5 0.0 2.1 0.0 1.3 3.3 0.7 0.5 0.0 0.8 6.7 1.4 0.5 0.0 0.8 3.0 0.0 0.0 0.6 0.3 4.0 2.3 0.5 1.7 2.8 1.3 1.9 0.9 0.0 1.1 0.3 3.6 0.0 1.0 11.8 9.5 0.3 0.8 2.9 2.3 0.1 TRAK1 "KIAA1042, MILT1, OIP106" ENSG00000182606 "Trafficking kinesin protein 1" Q9UPV9 3 42013802-42225889 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 71.9;skeletal muscle: 101.1" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 240.0;Rod photoreceptor cells: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005853, HPA011367" Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoplasm "HPA005853: AB_1854778, HPA011367: AB_2668495" "unprognostic (5.55e-2)" "unprognostic (1.38e-2)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (1.95e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.56e-3)" "prognostic favorable (4.84e-8)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (1.00e-2)" "unprognostic (4.61e-3)" 11.3 5.9 14.7 8.3 15.7 7.6 8.6 20.5 20.1 7.1 23.5 15.4 4.2 15.5 6.1 8.0 14.9 9.6 21.9 71.9 15.1 12.4 9.5 7.7 11.0 9.8 14.3 15.6 4.1 6.5 16.8 11.0 9.7 16.2 7.8 11.9 23.8 22.9 7.7 101.1 21.6 23.7 7.9 11.7 12.2 26.9 7.0 10.6 4.9 14.4 31.9 14.2 19.1 10.5 7.1 4.8 1.6 4.3 1.7 1.8 1.1 7.5 6.6 13.1 5.6 9.2 9.0 17.2 10.2 11.5 6.7 7.3 4.3 10.7 14.8 5.4 25.3 7.3 3.6 9.1 23.5 7.3 13.4 6.5 10.2 6.7 12.1 4.6 11.6 8.1 7.7 10.1 14.8 13.6 9.7 13.4 4.0 5.2 11.9 8.5 3.1 1.2 6.1 5.7 20.6 5.1 5.4 4.9 12.4 9.2 57.0 8.5 9.9 3.9 5.7 5.4 11.4 5.1 9.8 13.7 5.8 6.9 34.8 5.9 8.9 7.5 13.4 6.4 10.2 5.6 1.6 2.5 1.0 1.2 4.3 1.1 5.0 1.8 1.5 2.8 7.1 0.8 1.8 1.1 1.7 2.4 4.8 0.8 1.1 14.7 15.7 20.5 20.1 15.1 12.4 14.3 15.6 16.2 10.6 29.8 26.7 25.6 13.5 33.8 21.5 240.0 28.1 84.3 35.2 14.0 94.2 20.3 1.7 9.5 1.0 20.2 61.3 0.0 10.9 15.7 10.1 17.2 10.4 8.5 13.4 31.8 21.9 4.3 13.9 2.7 1.7 23.7 23.6 4.6 35.6 32.5 17.2 36.5 2.5 7.9 131.7 32.3 18.4 0.7 3.6 37.8 13.2 5.3 28.1 23.2 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451579 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 96.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 130.8;Cone photoreceptor cells: 68.7;Horizontal cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: AB_2684702" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favorable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 16.9 13.4 20.4 9.9 23.9 28.0 14.5 11.8 19.4 11.3 14.1 31.5 5.4 7.8 9.1 9.4 10.6 8.9 11.5 42.7 25.6 21.8 15.8 9.2 12.9 9.8 43.1 12.2 6.7 9.0 17.2 11.8 15.0 31.0 8.4 15.5 9.6 14.0 10.2 8.4 5.9 9.4 13.1 96.9 10.8 8.0 4.7 23.2 5.6 22.1 7.1 8.6 10.1 18.8 14.6 3.9 4.6 6.4 10.3 11.3 5.3 3.9 5.7 3.8 13.9 25.9 37.4 4.1 14.4 12.7 10.6 12.4 8.3 3.7 2.5 5.9 20.0 10.6 3.9 8.0 4.5 18.3 7.3 4.3 5.7 10.4 6.2 14.3 4.4 6.9 20.0 4.4 11.1 9.0 11.7 15.4 3.9 4.5 11.0 22.5 5.7 3.5 2.7 4.2 4.4 11.5 4.4 9.3 4.0 9.1 5.6 7.0 9.2 7.8 6.3 24.4 6.0 4.5 4.6 18.0 17.1 6.4 11.7 8.9 6.1 10.5 3.1 14.5 7.0 8.8 1.8 4.7 4.6 7.6 6.4 6.9 8.0 9.6 6.5 3.9 14.6 6.5 7.0 2.6 10.3 5.4 2.2 11.3 5.3 20.4 23.9 11.8 19.4 25.6 21.8 43.1 12.2 31.0 23.2 14.9 24.3 7.1 3.4 7.3 34.1 130.8 30.6 17.4 15.9 8.7 68.7 8.1 6.6 12.5 1.5 13.7 23.4 0.0 12.6 3.8 11.8 6.3 18.5 11.4 9.4 73.1 28.4 17.8 11.4 2.4 7.5 9.4 25.3 10.0 20.9 3.7 9.9 10.5 12.0 8.2 21.7 12.9 16.9 7.1 14.4 3.6 4.7 10.2 20.4 5.4 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826820-36945098 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 42.3" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 14.9;Enterocytes: 15.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 42.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 42.3" "Cell line enhanced" "Detected in many" "Daudi: 38.8;HMC-1: 15.6" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 4.1 3.6 4.5 10.4 11.2 6.9 4.7 21.5 12.0 8.5 14.2 1.7 3.1 8.6 12.3 4.5 3.1 19.3 7.3 4.1 3.3 3.9 3.2 7.9 6.2 13.9 2.9 6.6 9.0 2.8 5.0 3.8 3.7 6.0 7.9 10.9 4.4 4.9 5.0 2.6 2.9 23.1 10.5 3.2 9.9 6.0 2.9 1.7 15.1 5.8 1.1 16.2 9.8 6.0 5.2 0.5 42.3 1.3 2.8 5.7 0.9 0.7 0.9 0.2 0.0 2.4 9.7 0.0 0.7 5.1 2.3 4.5 0.0 3.9 38.8 1.6 2.9 7.7 0.2 0.1 0.5 0.4 1.9 0.0 6.3 2.6 0.0 3.1 1.7 15.6 3.2 2.0 1.7 0.1 0.5 2.8 4.2 5.0 5.6 1.7 0.0 4.9 0.7 0.2 0.0 1.0 1.4 0.1 0.7 0.8 1.7 0.3 0.0 3.9 1.0 0.3 0.4 0.6 2.2 1.9 1.8 0.7 0.1 0.6 5.5 1.1 8.6 0.3 1.4 0.2 2.5 0.6 3.9 5.6 0.9 4.2 4.0 4.8 5.7 0.5 5.2 4.4 4.2 42.3 2.8 1.3 0.0 4.0 0.9 4.5 11.2 21.5 12.0 3.3 3.9 2.9 6.6 6.0 1.7 14.9 5.6 3.9 1.2 0.7 1.1 2.4 2.5 5.3 4.5 3.5 2.0 1.0 0.0 2.2 0.2 3.3 15.2 0.0 1.6 1.1 3.0 1.9 5.8 13.9 4.2 0.0 5.2 6.2 6.3 0.0 4.0 3.6 5.0 1.0 8.8 1.4 3.0 12.2 5.6 0.6 0.7 0.0 1.7 0.2 0.2 0.6 0.6 13.8 3.8 1.4 TRAPPC3L "bA259P20.2, BET3L, FLJ11180" ENSG00000173626 "Trafficking protein particle complex 3 like" Q5T215 6 116494989-116545610 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.9;placenta: 9.7" "Group enriched" "Detected in some" 6 "Ito cells: 6.2;Kupffer cells: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 12.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA060912 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA060912: " "unprognostic (1.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.93e-2)" "unprognostic (2.91e-1)" "unprognostic (5.25e-2)" "unprognostic (1.15e-2)" "unprognostic (8.98e-2)" "unprognostic (9.09e-4)" "unprognostic (8.41e-2)" "unprognostic (3.23e-2)" "unprognostic (1.96e-1)" "unprognostic (2.91e-3)" "unprognostic (2.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "unprognostic (8.11e-2)" "unprognostic (7.47e-3)" 1.1 0.9 0.8 0.5 0.9 4.3 1.0 0.6 1.3 0.7 0.8 0.7 0.4 0.7 1.1 2.2 0.9 0.8 1.3 2.6 1.5 1.6 1.3 5.2 3.4 5.0 1.4 0.4 1.1 0.5 1.5 0.8 9.7 0.8 1.8 0.1 3.4 1.1 0.5 1.8 2.6 1.9 1.6 2.3 10.9 0.9 1.9 0.4 0.4 2.1 0.4 0.4 0.9 0.7 0.4 0.7 2.1 0.5 0.4 0.6 7.0 1.6 0.9 2.2 3.2 0.7 2.3 2.2 1.2 1.0 0.8 1.1 1.0 1.4 2.7 1.4 0.5 1.6 1.9 0.7 1.4 1.2 1.5 1.1 2.6 3.3 1.2 1.2 1.8 1.5 1.4 0.9 0.7 1.0 3.1 1.5 2.1 1.6 12.6 0.8 2.8 1.6 2.1 2.1 0.7 1.1 1.7 1.5 4.0 1.5 2.6 2.1 1.6 1.6 1.0 1.2 2.7 1.6 1.6 2.3 2.4 2.0 2.6 1.2 2.5 1.5 1.7 1.8 1.8 1.5 1.1 0.4 0.6 0.5 0.4 0.3 0.3 0.4 0.4 0.3 0.4 0.6 0.4 2.1 0.4 0.5 0.7 0.3 7.0 0.8 0.9 0.6 1.3 1.5 1.6 1.4 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 6.2 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TRAT1 "HSPC062, TCRIM, TRIM" ENSG00000163519 "T cell receptor associated transmembrane adaptor 1" Q6PIZ9 3 108822698-108855005 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "blood: 57.9;lymphoid tissue: 128.9" "Cell type enriched" "Detected in some" 10 "T-cells: 74.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 57.9" "Group enriched" "Detected in many" 160 "granulocytes: 53.1;T-cells: 57.9" "Group enriched" "Detected in some" 23 "JURKAT: 16.4;MOLT-4: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002356, CAB026130, HPA072760" Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" NA NA "Plasma membrane" "Mitotic spindle, Centriolar satellite" "CAB026130: , HPA002356: AB_1080375, HPA072760: " "unprognostic (1.54e-4)" "unprognostic (1.41e-3)" "unprognostic (6.82e-2)" "unprognostic (4.95e-3)" "unprognostic (2.84e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (2.02e-2)" "unprognostic (7.21e-3)" "unprognostic (8.96e-3)" "unprognostic (8.03e-2)" "unprognostic (4.32e-1)" "unprognostic (2.86e-5)" "unprognostic (3.12e-1)" "unprognostic (3.01e-2)" "unprognostic (2.90e-4)" "unprognostic (4.36e-2)" 2.6 0.3 0.2 8.2 0.2 1.8 1.3 0.2 0.3 0.8 1.0 0.1 0.1 0.9 0.7 0.3 0.9 0.8 1.9 0.7 0.2 0.2 1.1 1.0 4.0 17.8 0.2 0.2 0.5 0.5 0.0 0.4 0.3 0.3 1.1 1.0 0.1 1.9 0.3 0.4 1.0 5.5 0.2 0.3 9.0 1.6 0.5 0.1 128.9 1.1 1.0 9.8 2.8 1.1 0.1 0.1 53.1 0.1 0.3 57.9 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 1.1 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.1 0.1 0.0 10.5 0.0 21.2 0.1 42.1 21.6 0.0 0.0 57.9 14.2 0.6 0.3 0.1 0.1 17.9 22.9 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.1 0.0 5.6 0.9 0.1 7.4 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 2.3 0.6 0.2 0.0 0.0 1.8 0.0 1.4 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 6.9 0.1 74.0 0.0 0.0 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 855.7;Muller glia cells: 805.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: AB_2683643" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.1 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 5.8 855.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.9 12.0 0.0 1.7 0.0 0.0 805.6 0.0 0.0 10.6 0.0 13.4 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 TREH "MGC129621, TRE, TREA" ENSG00000118094 Trehalase O43280 11 118657316-118679690 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 51.8" "Cell type enriched" "Detected in some" 6 "Late spermatids: 233.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.4;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;SK-MEL-30: 1.5;U-2 OS: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA039913, HPA042045" Enhanced "Intracellular and membrane" NA NA 12000000 "HPA039913: AB_10674988, HPA042045: AB_2677817" "unprognostic (1.29e-1)" "unprognostic (1.58e-1)" "unprognostic (1.01e-2)" "unprognostic (5.22e-4)" "unprognostic (2.52e-1)" "unprognostic (9.83e-2)" "prognostic favorable (3.76e-4)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (2.42e-1)" "unprognostic (1.04e-1)" "unprognostic (1.63e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.09e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.15e-1)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 24.1 0.0 0.0 28.9 0.1 3.3 0.6 0.1 3.7 0.1 0.1 0.1 6.1 2.6 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.1 0.2 0.4 0.0 0.2 0.0 0.1 0.1 51.8 0.0 0.1 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.3 5.4 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.2 0.9 1.8 0.3 1.5 0.1 0.7 0.0 0.8 0.1 2.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.1 37.2 0.0 2.9 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 2.9 0.0 0.0 233.7 2.0 0.0 0.0 0.0 0.9 0.0 0.6 5.8 1.8 16.5 0.0 0.0 0.1 1.8 0.8 0.0 0.0 0.0 1.2 0.0 TREM1 "CD354, TREM-1" ENSG00000124731 "Triggering receptor expressed on myeloid cells 1" Q9NP99 6 41267926-41286719 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 96.9;bone marrow: 38.5;lung: 34.2" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 31.6;Hofbauer cells: 25.6;Kupffer cells: 32.3;Macrophages: 79.4" "Cancer enhanced" "Detected in many" "lung cancer: 9.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 96.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 96.9" "Group enriched" "Detected in some" 5 "SuSa: 6.5;U-87 MG: 23.8" "HPA005563, HPA053612" Approved Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Golgi apparatus" "HPA005563: AB_1858259, HPA053612: " "unprognostic (6.41e-2)" "unprognostic (1.47e-3)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (6.07e-3)" "unprognostic (2.97e-2)" "unprognostic (5.73e-5)" "unprognostic (1.29e-1)" "unprognostic (1.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.24e-3)" "unprognostic (7.65e-2)" "unprognostic (3.18e-7)" "unprognostic (6.32e-3)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (7.26e-2)" 10.2 0.6 0.7 21.1 1.5 38.5 1.0 0.6 2.1 0.7 0.9 0.7 0.5 0.1 1.0 1.5 0.6 4.2 5.1 3.7 1.2 0.9 1.1 3.7 34.2 8.0 2.7 0.1 2.1 1.8 0.2 2.7 31.2 2.3 0.9 0.0 2.5 1.3 0.1 2.4 0.4 1.1 3.8 3.9 12.1 1.0 2.6 0.6 0.3 2.2 1.9 1.0 3.9 0.7 0.2 5.0 96.9 12.8 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 6.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 1.5 0.0 0.0 12.8 0.3 0.0 3.1 0.0 0.0 0.0 0.0 5.0 0.2 0.0 0.0 96.9 0.0 1.4 0.1 0.0 4.1 0.7 1.5 0.6 2.1 1.2 0.9 2.7 0.1 2.3 0.6 6.0 31.6 2.7 0.1 0.3 0.0 0.3 2.5 13.4 19.4 0.0 0.0 0.3 0.0 0.3 10.6 0.5 0.0 0.0 0.2 0.9 0.7 0.1 5.8 0.2 25.6 0.0 0.0 1.3 32.3 13.1 0.0 79.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 12.2 0.0 0.0 0.0 TREM2 "TREM-2, Trem2a, Trem2b, Trem2c" ENSG00000095970 "Triggering receptor expressed on myeloid cells 2" Q9NZC2 6 41158506-41163186 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 35.6;brain: 34.8;lung: 24.6" "Cell type enriched" "Detected in some" 12 "Hofbauer cells: 939.0" "Cancer enhanced" "Detected in all" "glioma: 93.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.9" "Group enriched" "Detected in many" 6 "dendritic cells: 4.9;monocytes: 1.3" "Group enriched" "Detected in some" 4 "hTCEpi: 37.4;THP-1: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010917, HPA012571" Approved "Intracellular and membrane" NA NA 19000 "HPA010917: AB_1080365, HPA012571: AB_1858260" "unprognostic (3.89e-1)" "unprognostic (4.44e-3)" "unprognostic (2.77e-2)" "unprognostic (1.80e-2)" "unprognostic (1.29e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (4.83e-2)" "unprognostic (1.07e-1)" "unprognostic (8.57e-3)" "unprognostic (1.33e-1)" "unprognostic (2.09e-1)" "unprognostic (3.58e-3)" "unprognostic (8.04e-2)" "unprognostic (1.04e-2)" "unprognostic (3.16e-3)" "unprognostic (1.85e-2)" 35.6 11.8 10.1 3.0 13.4 0.3 8.6 1.6 21.7 5.9 2.9 24.1 0.0 0.9 1.5 2.1 0.6 6.5 8.4 1.7 10.4 9.5 1.0 2.1 24.6 1.7 21.7 5.2 2.7 2.5 2.7 2.9 8.8 13.4 1.8 3.9 2.1 4.4 3.0 0.8 0.4 1.2 3.8 34.8 0.5 2.2 0.8 12.9 0.0 1.6 0.8 0.5 4.2 0.5 0.5 4.9 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.6 37.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.1 10.1 13.4 1.6 8.3 10.4 9.5 21.7 5.2 13.4 12.9 6.0 9.8 0.0 0.0 0.7 0.1 0.2 2.5 2.7 12.5 0.0 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.8 0.4 0.0 2.3 0.0 939.0 0.0 0.0 3.1 28.7 0.4 0.6 78.3 0.0 13.6 0.0 0.4 0.0 0.0 0.0 0.0 0.6 6.5 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 TREML1 "dJ238O23.3, TLT1" ENSG00000161911 "Triggering receptor expressed on myeloid cells like 1" Q86YW5 6 41149342-41154337 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7" "Cell type enriched" "Detected in some" 11 "monocytes: 44.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 19.2" "Lineage enriched" "Detected in single" 31 "granulocytes: 19.2" "Cell line enriched" "Detected in single" 167 "HEL: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016700, HPA017860" Enhanced Approved "Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol" NA NA 94000000 "Nuclear speckles, Cytosol" "Golgi apparatus, Plasma membrane" "HPA016700: AB_1858262, HPA017860: AB_1858261" "unprognostic (6.70e-2)" "unprognostic (3.50e-3)" "unprognostic (1.15e-3)" "unprognostic (1.62e-1)" "unprognostic (3.48e-2)" "unprognostic (4.53e-5)" "unprognostic (1.10e-2)" "unprognostic (2.55e-3)" "unprognostic (4.50e-1)" "unprognostic (2.12e-3)" "unprognostic (2.34e-2)" "unprognostic (7.04e-2)" "unprognostic (1.11e-4)" "unprognostic (1.36e-1)" "unprognostic (8.38e-2)" "unprognostic (7.51e-2)" "unprognostic (3.41e-2)" 1.2 1.2 2.1 3.7 1.2 10.5 0.6 0.5 1.3 0.4 0.3 0.3 0.3 0.0 0.3 0.6 0.3 0.6 1.3 10.0 2.1 1.6 0.3 0.3 2.9 7.7 3.3 0.3 1.9 0.5 0.2 0.6 1.7 1.2 0.3 1.3 0.6 1.3 0.3 0.8 0.3 0.4 0.3 4.3 26.7 0.2 0.8 0.3 1.4 0.6 0.3 7.1 1.1 0.3 0.1 0.3 19.2 0.6 0.0 0.2 37.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 38.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.6 0.8 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 3.9 0.0 0.1 0.3 0.0 37.9 2.1 1.2 0.5 0.7 2.1 1.6 3.3 0.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 1.0 0.0 0.0 1.7 0.0 44.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TREML2 "C6orf76, dJ238O23.1, FLJ13693, TLT2" ENSG00000112195 "Triggering receptor expressed on myeloid cells like 2" Q5T2D2 6 41190277-41201194 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.8;bone marrow: 13.6;placenta: 54.3" "Group enriched" "Detected in some" 12 "Early spermatids: 19.0;Late spermatids: 25.1;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 16.1;neutrophil: 20.8" "Group enriched" "Detected in many" 15 "B-cells: 16.1;dendritic cells: 5.5;granulocytes: 20.8" "Cell line enhanced" "Detected in some" "HEL: 24.6;HL-60: 5.7;JURKAT: 7.0;SuSa: 4.3;U-698: 7.0;U-937: 4.5" "Not detected" "Not detected" NA NA 2300000 "unprognostic (3.76e-3)" "unprognostic (2.39e-1)" "unprognostic (9.05e-3)" "unprognostic (1.30e-3)" "unprognostic (3.22e-3)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-1)" "unprognostic (7.46e-2)" "unprognostic (2.51e-1)" "unprognostic (2.40e-3)" "unprognostic (2.46e-1)" "unprognostic (2.02e-2)" "unprognostic (7.45e-2)" "unprognostic (1.54e-2)" "unprognostic (6.23e-2)" "unprognostic (6.71e-2)" 1.7 0.2 0.2 6.3 0.2 13.6 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.9 0.3 0.5 0.2 0.2 0.3 0.4 1.5 9.2 0.2 0.1 0.2 0.2 0.0 0.2 54.3 0.3 0.2 0.0 0.1 1.5 0.1 0.2 0.2 1.9 0.1 0.3 12.3 0.4 5.9 0.2 4.9 0.3 0.1 7.5 0.8 0.2 16.1 5.5 20.8 0.8 0.4 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.3 0.0 0.0 1.3 1.8 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 4.5 0.0 1.4 0.3 7.7 0.2 0.7 0.3 3.6 0.6 0.1 1.3 16.1 0.9 0.2 20.8 0.4 0.8 5.5 0.4 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.0 1.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 25.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.3 0.0 0.0 0.0 TREML4 TLT4 ENSG00000188056 "Triggering receptor expressed on myeloid cells like 4" Q6UXN2 6 41228324-41238882 "Predicted membrane proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 5.4;neutrophil: 10.3" "Lineage enriched" "Detected in many" 7 "granulocytes: 10.3" "Cell line enriched" "Detected in some" 4 "HEL: 4.6" HPA065044 Uncertain "Secreted - unknown location" NA NA "HPA065044: AB_2685411" "unprognostic (1.49e-1)" "unprognostic (1.51e-1)" "unprognostic (5.58e-2)" "unprognostic (2.07e-1)" "unprognostic (2.12e-1)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (9.50e-3)" "unprognostic (1.18e-4)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (5.26e-2)" "unprognostic (1.21e-2)" 0.3 0.1 0.1 1.2 0.3 3.1 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.6 0.3 0.2 0.1 0.2 0.1 0.2 3.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.4 9.5 0.1 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 1.3 0.9 10.3 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.5 1.3 0.0 0.0 10.3 0.0 0.4 0.9 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TREX2 ENSG00000183479 "Three prime repair exonuclease 2" Q9BQ50 X 153444720-153470587 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 39.6" "Cell type enhanced" "Detected in single" 21 "Suprabasal keratinocytes: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 3.9;eosinophil: 5.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "HEK 293: 7.6;U-698: 10.3;U-937: 9.6" "Not detected" "Not detected" HPA054060 Uncertain NA NA "HPA054060: AB_2682362" "unprognostic (2.32e-2)" "unprognostic (2.05e-3)" "unprognostic (1.13e-3)" "unprognostic (7.18e-4)" "unprognostic (6.05e-2)" "unprognostic (1.81e-2)" "unprognostic (8.40e-2)" "unprognostic (2.19e-1)" "unprognostic (2.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (1.52e-1)" "unprognostic (9.34e-2)" "unprognostic (2.15e-1)" "unprognostic (1.23e-2)" 3.2 1.5 2.1 3.4 3.0 1.9 2.1 1.1 3.6 4.3 2.6 1.9 15.5 1.4 2.5 2.2 4.5 2.6 2.2 3.5 1.6 1.2 2.8 4.6 2.4 3.1 2.4 2.4 2.1 2.2 1.5 1.7 2.6 2.7 2.5 1.4 1.4 4.5 7.4 2.0 39.6 2.3 1.9 1.2 4.3 1.7 2.1 1.9 5.8 3.3 6.2 4.7 2.2 5.2 0.4 0.3 5.7 0.1 0.2 0.4 0.2 2.8 3.6 0.3 1.3 0.5 0.7 0.3 0.9 0.8 0.7 2.0 1.0 0.7 0.3 1.9 0.8 0.2 3.1 1.2 2.0 0.0 3.2 7.6 0.3 0.7 0.4 0.3 0.8 2.0 0.8 1.9 0.9 0.7 0.4 0.3 0.6 0.4 3.5 0.2 3.3 2.0 2.3 1.2 0.6 2.4 4.9 1.0 2.3 0.3 1.0 0.8 0.4 0.3 0.3 1.1 0.1 0.6 0.9 0.0 1.3 2.4 2.8 1.1 4.0 2.7 10.3 0.3 9.6 1.5 3.9 0.0 5.7 0.3 0.0 0.2 0.4 0.1 0.3 0.3 0.3 0.4 0.1 0.0 0.2 0.1 0.0 0.1 0.2 2.1 3.0 1.1 3.6 1.6 1.2 2.4 2.4 2.7 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 TRH ENSG00000170893 "Thyrotropin releasing hormone" P20396 3 129974305-129977938 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5" "Cell type enriched" "Detected in some" 31 "Muller glia cells: 222.3" "Cancer enhanced" "Detected in some" "breast cancer: 13.3;endometrial cancer: 10.2" "Group enriched" "Detected in many" 14 "hypothalamus: 33.9;pons and medulla: 33.8" "Group enriched" "Detected in some" 11 "intermediate monocyte: 1.1;non-classical monocyte: 1.0" "Lineage enriched" "Detected in single" 12 "monocytes: 1.1" "Cell line enhanced" "Detected in some" "REH: 2.6;SuSa: 4.0;T-47d: 2.4" "Group enriched" "Detected in many" 5 "hypothalamus: 204.6;olfactory region: 182.2" "Low region specificity" "Detected in many" HPA035596 Enhanced "Secreted in other tissues" NA NA "HPA035596: AB_2674695" "unprognostic (1.22e-1)" "unprognostic (8.94e-2)" "unprognostic (5.82e-3)" "unprognostic (5.24e-2)" "unprognostic (2.82e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (4.44e-2)" "unprognostic (3.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" 0.3 0.1 0.4 0.2 2.4 2.8 0.9 0.3 1.7 23.6 0.1 0.1 0.6 0.2 17.5 0.1 0.1 2.3 0.1 0.5 2.0 33.9 0.1 0.1 0.6 0.1 0.4 0.8 3.2 0.1 0.1 0.1 0.3 33.8 0.1 0.1 6.3 1.0 0.2 0.2 0.5 0.1 0.4 3.6 0.1 0.1 0.8 0.0 0.8 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 4.0 2.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 2.4 0.3 1.7 2.0 33.9 0.4 0.8 33.8 0.0 0.0 0.0 0.0 0.5 0.7 6.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 222.3 0.0 0.0 0.0 0.0 7.1 0.0 0.4 0.4 0.4 0.1 0.1 0.0 0.0 0.5 TRHDE "PAP-II, PGPEP2, TRH-DE" ENSG00000072657 "Thyrotropin releasing hormone degrading enzyme" Q9UKU6 12 72087266-72670757 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;pancreas: 19.4" "Group enriched" "Detected in some" 4 "Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7" "Cancer enhanced" "Detected in some" "renal cancer: 1.9" "Region enhanced" "Detected in many" "cerebellum: 30.3" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 6200000 "unprognostic (3.56e-2)" "unprognostic (4.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.44e-6)" "unprognostic (1.77e-1)" "unprognostic (6.37e-2)" "unprognostic (7.79e-2)" "unprognostic (6.96e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (5.14e-4)" "unprognostic (2.40e-1)" "prognostic favorable (1.53e-7)" "unprognostic (2.55e-2)" "unprognostic (2.48e-1)" "unprognostic (8.91e-3)" "unprognostic (2.94e-2)" 6.2 2.2 2.9 1.0 4.7 1.0 7.6 30.3 12.3 10.2 2.4 0.1 2.5 4.8 2.7 1.7 0.9 2.5 2.5 2.2 7.3 2.8 9.9 1.5 3.0 0.6 1.2 5.5 6.5 19.4 0.4 1.6 0.7 1.5 5.5 1.5 1.0 2.4 5.8 0.7 0.8 4.2 1.2 0.9 4.8 1.1 1.7 0.5 0.0 0.5 0.4 1.0 2.8 7.6 0.2 0.0 1.0 0.3 0.3 0.0 0.0 2.4 0.0 0.4 0.0 1.1 0.0 6.7 20.8 20.2 2.0 1.4 0.0 0.0 0.0 10.9 3.0 2.1 0.2 3.8 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.6 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 6.9 4.6 2.0 0.0 0.0 0.0 0.0 0.4 0.0 4.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.1 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 2.9 4.7 30.3 12.3 7.3 2.8 1.2 5.5 1.5 0.5 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 1.4 0.0 1.8 0.0 0.0 3.3 0.0 30.7 0.0 6.9 0.0 2.2 0.3 0.5 0.2 0.0 1.3 0.2 0.0 0.0 0.0 0.0 47.8 27.3 0.3 0.0 0.0 1.5 0.3 2.1 2.9 12.7 7.4 0.6 0.0 0.4 0.1 0.7 0.0 0.1 0.0 0.7 0.1 TRHR ENSG00000174417 "Thyrotropin releasing hormone receptor" P34981 8 109086621-109119584 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 1.0;pituitary gland: 3.3;thyroid gland: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "PC-3: 1.6;SH-SY5Y: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055162 Approved NA NA "HPA055162: AB_2732592" "unprognostic (1.92e-2)" "unprognostic (8.58e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.3 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.2 0.3 0.6 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIB1 "C8FW, GIG2, TRB1" ENSG00000173334 "Tribbles pseudokinase 1" Q96RU8 8 125430321-125438405 "Enzymes, Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 84.2;thyroid gland: 90.7" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 192.3;Basal glandular cells: 267.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1" "Group enriched" "Detected in many" 11 "granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1" "Cell line enhanced" "Detected in many" "HEL: 55.1;U-266/70: 33.8;U-266/84: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063982 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA063982: AB_2685165" "unprognostic (1.90e-3)" "unprognostic (1.45e-1)" "unprognostic (8.80e-3)" "unprognostic (1.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.57e-2)" "unprognostic (4.12e-2)" "unprognostic (1.62e-2)" "unprognostic (6.81e-3)" "unprognostic (9.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.94e-1)" "unprognostic (1.04e-2)" "unprognostic (5.55e-2)" "unprognostic (2.08e-2)" 26.7 6.5 5.9 17.6 6.5 84.2 13.3 4.3 6.1 10.4 12.4 4.4 6.6 4.9 6.2 6.7 10.9 10.9 21.0 11.1 4.3 4.0 16.6 63.5 28.9 14.6 4.2 3.9 6.4 23.6 20.9 7.2 15.5 4.5 12.1 13.3 15.0 14.5 9.1 22.3 10.4 16.9 11.3 3.1 15.9 18.5 5.6 3.1 9.2 90.7 17.6 12.1 12.4 9.0 0.2 0.5 10.8 3.7 0.0 3.1 0.1 4.1 4.7 0.6 1.3 1.3 2.7 7.5 2.7 3.8 2.0 0.6 6.3 5.5 7.5 2.5 1.9 12.1 3.1 2.0 2.6 1.7 3.3 9.9 55.1 2.1 12.3 3.5 27.5 5.0 2.6 4.0 8.2 18.8 9.8 5.8 0.1 4.8 24.0 0.2 4.4 2.5 4.3 4.6 9.9 9.2 5.2 0.9 8.2 16.2 15.8 4.0 1.5 6.6 7.2 26.2 4.3 1.9 1.3 3.0 2.2 2.8 2.1 3.3 33.8 33.7 10.5 3.9 0.2 5.1 0.0 0.9 10.8 0.0 1.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 5.8 0.0 3.7 0.3 3.1 0.1 5.9 6.5 4.3 6.1 4.3 4.0 4.2 3.9 4.5 3.1 125.0 192.3 11.2 267.7 89.0 20.4 14.4 17.8 33.5 64.8 15.7 0.0 9.2 10.0 31.3 0.4 32.9 172.0 0.0 21.2 17.2 32.4 153.9 29.9 128.8 29.9 20.6 107.4 8.6 53.9 1.4 0.3 47.3 54.0 40.5 87.2 21.4 42.4 51.5 0.4 21.6 3.4 0.0 14.4 0.0 1.3 56.1 25.6 4.5 56.6 79.9 TRIB3 "C20orf97, dJ1103G7.3, TRB3" ENSG00000101255 "Tribbles pseudokinase 3" Q96RU7 20 362835-397559 "Enzymes, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.0;salivary gland: 47.5" "Cell type enhanced" "Detected in many" 8 "Ductal cells: 49.9;Hepatocytes: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 88.9;hTCEpi: 55.1;hTERT-HME1: 64.0;SK-MEL-30: 80.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA015272, HPA055442" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA015272: AB_1858269, HPA055442: AB_2682818" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.25e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (1.70e-4)" "prognostic unfavorable (6.75e-5)" "unprognostic (1.52e-3)" "unprognostic (1.76e-1)" "unprognostic (1.24e-1)" "unprognostic (7.95e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.07e-13)" "unprognostic (7.62e-2)" "unprognostic (2.79e-2)" "unprognostic (2.31e-1)" "unprognostic (4.05e-3)" 4.8 8.7 1.6 2.8 1.5 9.7 6.0 3.8 4.2 2.5 1.8 1.2 3.6 1.0 2.1 3.1 9.8 1.1 2.7 3.0 1.4 2.0 3.3 39.0 8.2 7.3 1.0 2.4 4.4 13.8 2.0 10.5 6.2 1.6 3.9 1.6 3.7 47.5 5.3 1.5 6.5 2.5 1.3 0.7 7.9 4.4 2.7 0.6 6.7 27.2 4.1 7.0 2.7 5.3 15.5 4.7 3.3 4.4 6.6 11.4 5.1 11.1 5.7 0.7 1.6 1.9 2.5 4.8 3.3 8.9 3.2 6.6 11.7 5.6 4.8 3.3 3.0 14.3 9.0 3.1 14.9 2.9 1.8 2.2 3.7 1.2 19.1 88.9 9.4 1.8 10.3 55.1 6.0 64.0 2.2 6.1 12.2 12.9 21.7 0.3 10.4 0.5 11.4 1.7 16.5 18.5 2.1 0.9 10.4 3.7 4.5 2.1 3.3 0.7 27.1 80.8 1.0 7.8 25.0 3.5 1.7 3.0 0.0 5.1 7.6 9.8 8.6 1.5 8.3 6.1 2.5 4.4 1.0 10.0 3.4 7.1 15.5 9.3 11.4 4.7 10.2 10.7 7.6 3.3 6.6 1.7 2.1 6.4 5.1 1.6 1.5 3.8 4.2 1.4 2.0 1.0 2.4 1.6 0.6 3.0 1.0 7.6 7.2 6.1 3.8 1.2 10.2 2.7 1.2 1.8 3.9 13.1 0.0 49.9 0.0 5.8 0.0 23.3 19.2 4.3 1.5 10.5 4.7 25.3 5.6 0.0 1.2 8.0 2.1 0.0 1.7 4.0 6.8 1.8 6.5 0.5 23.3 2.3 1.4 0.0 6.7 6.5 4.1 1.9 2.2 4.6 5.9 5.0 0.6 4.8 TRIL KIAA0644 ENSG00000255690 "TLR4 interactor with leucine rich repeats" Q7L0X0 7 28953358-28958292 "Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.7" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 11.9;Horizontal cells: 6.4;Muller glia cells: 13.7;Sertoli cells: 12.9" "Cancer enhanced" "Detected in many" "glioma: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 14.0;SH-SY5Y: 25.3;SK-BR-3: 22.4;T-47d: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.26e-3)" "unprognostic (3.29e-2)" "unprognostic (5.89e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-2)" "unprognostic (8.77e-2)" "prognostic unfavorable (8.52e-4)" "unprognostic (4.27e-3)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (2.07e-2)" 3.5 2.9 14.7 0.6 13.2 0.0 5.1 11.2 19.2 2.6 2.2 19.5 0.0 2.4 2.5 2.2 1.9 2.3 1.2 3.0 18.2 6.6 0.7 3.1 0.4 9.1 11.5 1.8 0.4 0.6 0.0 1.3 20.7 2.4 2.3 0.3 9.6 1.8 3.3 0.5 2.7 4.1 17.0 2.9 2.8 0.3 14.4 0.0 2.8 0.2 0.3 2.0 0.0 0.0 0.1 0.1 0.1 0.0 0.7 0.0 0.0 0.0 14.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 25.3 0.0 22.4 0.0 2.1 9.9 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 11.9 4.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 1.2 1.8 0.0 0.1 3.3 0.0 0.0 2.1 0.0 0.0 0.0 1.8 0.8 0.0 0.0 0.2 0.1 6.4 0.0 2.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 1.6 0.7 12.9 0.2 0.2 0.7 0.0 0.1 0.0 0.6 0.1 TRIM10 "HERF1, RFB30, RNF9" ENSG00000204613 "Tripartite motif containing 10" Q9UDY6 6 30151945-30160934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8" "Cell type enriched" "Detected in some" 12 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "EFO-21: 1.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "hippocampal formation: 4.0" HPA043325 Uncertain NA NA "HPA043325: AB_2678428" "unprognostic (2.98e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (2.13e-1)" "unprognostic (2.98e-1)" "unprognostic (9.53e-3)" "unprognostic (6.32e-2)" "unprognostic (2.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.74e-3)" "unprognostic (1.46e-2)" "unprognostic (4.37e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.0 3.0 0.0 0.0 1.4 0.1 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 70.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 5.8 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 TRIM15 "RNF93, ZNF178, ZNFB7" ENSG00000204610 "Tripartite motif containing 15" Q9C019 6 30163206-30172696 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 12.1;intestine: 29.3;liver: 14.1" "Cell type enhanced" "Detected in some" 18 "Enterocytes: 70.3;Mucus-secreting cells: 18.4;Paneth cells: 56.1;Proximal tubular cells: 18.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 14.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "HEL: 19.5" "Low region specificity" "Detected in all" HPA047527 Uncertain Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA047527: " "unprognostic (2.61e-1)" "unprognostic (1.54e-1)" "unprognostic (1.85e-1)" "unprognostic (1.71e-1)" "unprognostic (5.36e-2)" "unprognostic (1.92e-2)" "unprognostic (7.57e-4)" "unprognostic (5.27e-2)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (3.83e-1)" "unprognostic (1.63e-1)" "unprognostic (2.41e-1)" 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 8.6 0.0 0.2 0.2 0.0 12.1 0.0 0.0 0.0 4.3 14.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 29.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 1.7 0.7 0.0 0.0 70.3 0.0 1.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 5.7 56.1 0.0 18.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 10.6 0.0 TRIM16 EBBP ENSG00000221926 "Tripartite motif containing 16" O95361 17 15627960-15684311 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 52.9" "Cell type enhanced" "Detected in many" 8 "Pancreatic endocrine cells: 96.1;Suprabasal keratinocytes: 67.9;Urothelial cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "T-reg: 25.1" "Lineage enriched" "Detected in many" 11 "T-cells: 25.1" "Cell line enhanced" "Detected in many" "A549: 58.6;HaCaT: 47.3;HeLa: 42.7;OE19: 74.3" "HPA023623, HPA066431" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (9.61e-2)" "unprognostic (1.31e-2)" "unprognostic (6.19e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.94e-3)" "unprognostic (3.75e-2)" "unprognostic (4.65e-1)" "unprognostic (3.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.08e-1)" "unprognostic (8.48e-2)" "unprognostic (9.21e-3)" "prognostic unfavorable (6.71e-4)" 6.1 13.5 7.4 4.8 12.8 7.0 6.7 7.4 11.7 16.0 5.0 7.8 6.6 10.2 7.0 2.8 52.9 4.0 7.5 6.5 8.0 4.4 5.7 2.2 6.2 10.9 11.3 5.6 3.7 6.2 1.9 5.7 15.8 9.8 4.1 5.2 5.0 14.7 5.7 11.4 15.6 5.5 5.4 5.9 4.6 14.4 5.5 7.8 4.7 7.4 5.3 16.3 11.7 23.3 0.4 1.5 0.6 2.3 0.5 25.1 1.3 18.3 58.6 1.8 4.0 8.7 10.0 2.0 3.0 10.8 3.8 5.3 3.5 24.0 2.0 11.6 13.3 22.7 47.3 5.3 13.6 2.5 24.3 3.4 0.9 42.7 1.9 14.5 1.0 2.0 5.5 8.6 8.3 4.8 10.6 8.1 2.3 1.1 9.6 10.2 6.5 4.0 2.3 2.7 74.3 3.5 1.7 15.1 1.4 19.4 23.9 1.3 3.8 13.4 15.2 4.5 11.1 2.3 2.5 12.5 4.8 5.7 2.3 10.4 2.3 2.5 0.1 7.4 2.5 12.1 0.1 2.3 0.6 0.8 0.6 0.5 0.3 3.0 0.9 1.5 0.4 0.8 1.6 0.5 0.5 0.3 0.3 25.1 1.3 7.4 12.8 7.4 11.7 8.0 4.4 11.3 5.6 9.8 7.8 35.7 1.6 3.7 46.8 27.4 6.4 8.8 10.2 5.3 12.5 10.4 17.7 12.0 0.0 46.8 0.8 16.1 4.3 0.0 15.3 6.7 10.5 16.4 4.6 2.4 3.5 3.2 4.1 3.7 2.6 2.0 6.6 4.4 6.8 18.0 16.5 6.7 96.1 24.6 4.2 3.7 8.7 6.5 8.3 7.6 11.5 67.9 3.9 5.7 13.3 116.8 TRIM16L TRIM70 ENSG00000108448 "Tripartite motif containing 16 like" Q309B1 17 18697998-18736118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.5" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 44.3;HaCaT: 22.6;HeLa: 35.4;OE19: 51.5" HPA066431 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA066431: AB_2685668" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (2.00e-1)" "unprognostic (7.89e-3)" "unprognostic (5.66e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.08e-2)" "unprognostic (5.79e-2)" "unprognostic (6.28e-2)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" 2.8 4.4 2.0 1.0 3.1 0.5 7.1 1.0 3.0 2.2 3.6 1.3 1.0 2.0 1.4 3.2 10.5 3.3 8.1 16.8 2.0 2.5 3.5 2.8 2.4 1.0 4.7 1.0 1.3 1.3 0.1 1.0 1.8 3.1 3.6 1.0 2.1 2.6 3.7 22.5 0.8 1.1 6.5 4.7 1.0 3.0 2.9 1.4 1.0 4.5 12.7 3.4 6.7 11.8 1.5 0.8 0.4 1.4 2.7 2.1 1.8 4.7 44.3 0.2 1.9 5.4 2.2 3.5 0.4 3.7 1.6 3.3 0.8 19.1 0.5 3.5 12.7 8.8 22.6 0.5 1.0 0.8 0.1 0.6 0.3 35.4 0.4 13.3 0.0 0.4 2.3 1.3 2.4 0.9 7.0 0.5 0.4 0.0 0.0 4.3 4.7 0.1 0.5 0.4 51.5 0.9 0.5 2.3 0.0 3.2 2.8 0.1 1.0 5.0 1.0 2.7 0.3 2.3 0.3 9.9 1.1 5.7 1.8 6.3 0.5 0.5 0.0 3.7 0.4 8.4 0.1 0.7 0.4 0.7 1.4 1.0 1.5 1.0 0.6 0.8 1.1 1.6 1.5 0.3 2.7 0.5 0.2 2.1 1.8 2.0 3.1 1.0 1.9 2.0 2.5 4.7 1.0 3.1 1.4 6.0 3.2 0.8 8.5 3.4 2.7 5.5 10.2 8.1 1.2 1.8 7.9 2.0 3.3 9.0 0.5 2.6 0.9 0.0 5.3 3.7 2.5 3.8 3.5 2.5 1.4 3.2 2.4 2.5 3.4 0.7 3.4 2.1 0.0 15.4 3.2 3.5 21.6 0.0 1.8 6.8 2.4 0.0 2.8 3.2 5.6 5.6 0.9 1.3 3.4 6.3 TRIM17 "RBCC, RNF16, terf" ENSG00000162931 "Tripartite motif containing 17" Q9Y577 1 228407940-228416861 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;testis: 18.3" "Group enriched" "Detected in some" 56 "Early spermatids: 233.3;Late spermatids: 64.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 7.8;HEL: 3.5;NTERA-2: 3.3;SH-SY5Y: 4.1;T-47d: 9.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054908 Uncertain Approved Vesicles NA NA Vesicles "HPA054908: AB_2682638" "prognostic favorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (3.06e-2)" "unprognostic (5.45e-2)" "unprognostic (1.25e-1)" "unprognostic (7.74e-3)" "unprognostic (7.42e-3)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (8.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.04e-1)" "unprognostic (5.96e-4)" "unprognostic (3.88e-1)" "unprognostic (4.88e-2)" "unprognostic (6.33e-2)" "unprognostic (3.64e-1)" 1.3 0.8 14.4 1.5 19.1 1.1 1.9 25.8 11.8 1.5 0.9 0.6 1.7 1.4 3.6 1.7 1.3 3.9 1.7 1.5 8.9 3.4 1.2 0.6 1.7 2.0 0.7 9.2 2.2 1.1 0.8 1.0 1.3 2.7 2.0 0.8 1.9 5.9 3.8 0.8 3.5 1.6 1.1 0.9 5.3 1.4 18.3 4.7 0.0 2.9 0.1 1.2 2.5 1.3 1.7 0.6 0.7 0.3 0.0 1.0 0.1 0.3 0.7 0.5 0.4 0.0 0.0 7.8 0.5 0.0 0.0 0.1 1.7 0.9 0.1 1.9 0.0 0.2 1.7 0.0 0.0 0.1 0.3 0.8 3.5 1.0 0.2 1.6 0.1 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.5 0.2 0.5 0.1 0.1 0.3 0.0 3.3 0.1 0.2 0.1 0.1 0.0 0.0 0.8 0.5 4.1 0.0 0.4 0.0 0.8 9.6 0.2 0.0 0.4 1.7 0.3 0.1 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.3 0.7 0.9 0.1 1.0 0.6 0.2 1.0 0.0 1.7 1.0 0.8 0.2 0.0 0.2 0.6 0.0 0.1 14.4 19.1 25.8 11.8 8.9 3.4 0.7 9.2 2.7 4.7 0.0 0.3 0.0 1.1 0.2 1.1 0.6 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.7 233.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.0 1.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.4 0.0 0.0 0.0 0.0 1.2 1.6 0.3 0.7 0.5 0.0 0.6 TRIM2 "CMT2R, KIAA0517, RNF86" ENSG00000109654 "Tripartite motif containing 2" Q9C040 4 153152342-153339320 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 5.4" "Group enriched" "Detected in many" 4 "B-cells: 1.9;T-cells: 5.4" "Cell line enhanced" "Detected in many" "AF22: 28.6;NTERA-2: 23.5;RPTEC TERT1: 26.7;SK-MEL-30: 25.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035853, HPA035854" Enhanced Approved Centrosome NA NA Centrosome "HPA035853: AB_10669533, HPA035854: AB_10669659" "unprognostic (8.94e-2)" "unprognostic (7.89e-2)" "unprognostic (6.21e-3)" "unprognostic (7.51e-3)" "unprognostic (2.07e-2)" "unprognostic (2.32e-1)" "unprognostic (1.16e-2)" "unprognostic (2.30e-3)" "unprognostic (5.30e-2)" "unprognostic (6.77e-2)" "unprognostic (1.93e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.58e-14)" "unprognostic (5.89e-2)" "unprognostic (1.17e-2)" "unprognostic (4.19e-2)" "unprognostic (4.13e-2)" 4.2 9.9 28.4 4.4 35.7 0.6 12.2 28.9 56.9 19.6 17.8 67.0 5.9 13.5 9.7 15.1 8.5 12.9 10.3 6.2 38.9 25.3 22.1 6.4 5.9 2.3 39.4 34.6 10.9 8.2 1.0 10.9 2.5 45.3 11.5 19.2 4.6 30.1 11.8 1.8 3.8 14.4 6.6 44.2 8.8 23.5 1.9 44.7 0.0 38.9 0.6 4.3 7.6 5.5 1.9 0.8 0.3 0.6 0.3 5.4 0.7 4.8 0.2 28.6 12.5 10.8 12.4 0.5 6.4 8.7 1.8 2.7 2.8 0.3 0.2 4.1 11.1 5.5 4.3 13.3 2.4 1.9 0.1 5.0 0.2 2.9 0.6 12.6 0.2 0.1 8.0 1.4 3.6 2.3 7.0 1.7 0.3 0.2 0.1 2.2 0.4 1.4 0.0 23.5 14.3 5.7 0.8 5.2 0.0 26.7 6.3 9.2 18.1 3.0 11.6 25.6 4.3 1.2 0.2 2.4 8.0 2.3 6.2 3.0 0.1 0.0 0.1 11.9 0.1 9.8 0.3 0.6 0.1 0.1 0.0 0.0 1.6 5.4 0.1 0.8 1.9 1.6 1.0 0.2 0.3 0.0 0.1 2.6 0.7 28.4 35.7 28.9 41.1 38.9 25.3 39.4 34.6 45.3 44.7 6.0 22.3 3.2 14.9 6.3 65.3 26.2 12.7 81.7 61.4 55.8 27.5 1.4 86.2 8.4 2.7 14.0 51.1 0.0 23.1 0.4 18.1 22.3 1.1 10.9 1.1 104.9 59.8 18.4 1.5 2.1 27.3 2.6 60.8 4.6 59.2 78.7 19.0 31.6 30.8 12.2 20.8 25.8 9.9 0.4 0.9 3.4 0.6 1.0 74.3 26.7 TRIM21 "RNF81, Ro/SSA, RO52, SSA1" ENSG00000132109 "Tripartite motif containing 21" P19474 11 4384897-4393696 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "DNA-binding, Ribonucleoprotein, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 72.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004566, HPA005673" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "CAB004566: AB_628286, HPA005673: AB_1080090" "prognostic favorable (4.83e-5)" "unprognostic (4.55e-2)" "unprognostic (3.64e-2)" "unprognostic (3.01e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.20e-1)" "unprognostic (5.04e-2)" "unprognostic (1.27e-1)" "unprognostic (2.49e-2)" "unprognostic (3.31e-1)" "unprognostic (1.82e-2)" "unprognostic (6.27e-2)" "unprognostic (4.69e-2)" "prognostic favorable (2.26e-6)" "unprognostic (9.12e-3)" 18.2 12.1 4.9 13.7 6.5 15.0 9.8 2.5 6.4 15.0 11.7 6.4 6.0 12.5 11.6 10.3 14.6 10.4 10.8 8.5 5.0 5.3 12.9 14.9 14.6 21.4 6.8 4.0 17.4 10.7 4.3 9.9 19.9 8.6 18.0 12.0 8.5 11.9 8.6 4.5 6.9 21.8 12.0 4.7 28.3 13.5 6.0 4.7 21.5 19.1 6.8 17.0 11.6 13.5 10.9 22.0 72.4 27.5 14.5 19.5 28.6 5.7 6.8 3.4 3.2 7.1 10.7 4.8 7.4 14.0 29.4 32.6 3.1 16.8 8.8 3.4 10.9 30.4 8.3 6.0 11.3 9.1 14.8 6.7 13.6 3.9 2.8 15.8 16.0 13.6 10.4 6.8 5.9 4.1 10.7 17.9 7.7 4.2 9.7 9.7 5.1 8.4 11.8 2.9 6.6 3.5 5.9 4.5 4.9 11.6 5.4 0.0 1.5 6.1 6.8 8.2 5.8 2.3 11.0 16.1 7.2 5.6 3.7 2.7 5.1 4.0 5.6 6.5 12.7 5.1 18.8 26.9 60.1 19.3 27.5 16.8 10.5 16.6 17.1 22.0 10.9 14.9 15.7 72.4 14.5 24.4 7.4 19.5 28.6 4.9 6.5 2.5 6.4 5.0 5.3 6.8 4.0 8.6 4.7 8.9 4.6 4.7 4.4 1.8 0.5 2.5 5.1 10.7 11.4 5.2 0.0 5.5 6.6 10.3 0.0 6.2 6.7 0.0 7.4 7.2 2.8 3.4 11.6 7.6 8.6 1.6 2.4 9.8 11.0 0.4 4.0 7.2 1.7 10.0 6.9 1.4 9.9 5.8 6.7 3.1 0.0 12.9 4.2 0.3 0.4 1.5 7.6 8.3 4.8 2.8 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.4 0.0 0.8 0.0 0.1 54.2 0.0 12.4 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 72.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.5 0.2 0.9 40.5 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 97.6 241.7 0.0 1.1 2.5 33.5 13.6 0.0 0.0 37.9 0.0 1.3 21.4 0.4 2.1 0.0 3.9 5.0 5.4 34.5 1.1 0.0 4.4 0.0 2.4 0.0 0.0 78.0 0.6 1.7 21.9 0.0 2.3 0.0 33.2 0.8 0.0 0.2 0.0 0.0 7.2 0.6 1.4 402.6 20.7 0.0 1.4 144.0 TRIM3 "BERP, HAC1, RNF22, RNF97" ENSG00000110171 "Tripartite motif containing 3" O75382 11 6448613-6474459 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.0" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043396, HPA048233" Enhanced Approved Mitochondria NA NA Mitochondria "HPA043396: AB_2678460, HPA048233: AB_2680321" "unprognostic (1.24e-1)" "unprognostic (1.98e-1)" "unprognostic (2.31e-1)" "prognostic favorable (2.20e-4)" "unprognostic (4.01e-2)" "unprognostic (3.88e-2)" "unprognostic (1.61e-3)" "unprognostic (2.84e-1)" "unprognostic (2.24e-1)" "unprognostic (3.91e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.93e-1)" 6.9 5.4 9.0 5.8 8.8 1.6 6.2 34.0 17.1 6.3 8.1 9.4 3.4 22.6 8.7 2.6 3.7 5.9 5.3 6.1 6.8 7.0 3.9 3.8 6.2 3.0 8.1 9.6 5.8 5.3 2.8 3.8 5.3 14.3 7.7 6.5 6.1 9.2 7.7 9.3 7.1 19.5 8.9 7.3 4.9 8.6 3.0 7.0 0.7 4.2 2.5 2.1 6.6 5.8 0.5 3.9 1.8 3.0 2.0 1.9 1.5 4.3 7.5 3.0 5.1 5.1 4.9 4.1 6.2 3.7 4.8 5.4 4.5 3.0 2.4 2.2 4.7 5.6 3.0 3.1 4.6 1.8 2.8 4.6 0.7 7.5 3.0 3.1 0.2 2.5 4.2 2.2 3.7 2.0 2.0 4.8 1.7 1.0 2.9 4.6 9.0 0.2 0.6 2.2 8.9 6.5 1.4 2.6 2.9 1.1 2.2 3.1 4.9 3.4 33.9 4.0 1.6 12.8 0.8 8.1 12.7 6.0 9.2 4.1 3.4 2.0 0.5 6.9 1.0 4.7 0.0 3.0 1.8 1.7 2.9 1.3 0.4 1.4 1.4 3.9 0.5 0.5 1.9 0.0 2.0 0.8 0.8 1.5 1.5 9.0 8.8 34.0 17.1 6.8 7.0 8.1 9.6 14.3 7.0 6.0 0.0 2.0 2.6 4.2 8.5 1.7 2.5 2.7 0.0 0.0 9.8 1.6 0.0 2.8 3.1 4.7 17.1 0.0 2.9 2.0 6.1 4.0 1.1 1.9 4.1 7.9 4.6 4.3 1.0 3.9 5.5 2.8 6.8 3.6 10.7 1.7 2.6 5.7 4.9 2.4 8.7 12.9 10.2 1.9 4.9 4.6 0.7 0.7 5.2 1.6 TRIM31 "C6orf13, HCG1, HCGI, RNF" ENSG00000204616 "Tripartite motif containing 31" Q9BZY9 6 30102897-30113106 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 16.3;lymphoid tissue: 7.4;urinary bladder: 12.2" "Group enriched" "Detected in many" 4 "Enterocytes: 222.6;Urothelial cells: 174.9" "Group enriched" "Detected in many" 5 "cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 490 "RT4: 81.4" HPA074175 Enhanced NA NA "HPA074175: " "unprognostic (1.37e-1)" "unprognostic (7.78e-3)" "unprognostic (1.83e-1)" "unprognostic (7.05e-3)" "unprognostic (1.75e-1)" "unprognostic (9.37e-2)" "unprognostic (6.13e-2)" "unprognostic (1.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-2)" "unprognostic (1.97e-2)" "unprognostic (1.92e-1)" "unprognostic (1.43e-3)" "unprognostic (5.84e-3)" "unprognostic (6.20e-2)" "unprognostic (1.60e-1)" "unprognostic (2.50e-3)" 0.1 0.0 0.1 7.4 0.1 0.0 0.1 0.1 0.1 0.2 16.3 0.1 0.1 1.2 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.1 0.4 0.1 0.1 0.1 0.1 0.1 13.7 0.7 0.1 0.1 4.8 2.0 0.1 0.1 0.1 0.1 0.1 12.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.5 2.2 0.1 0.0 5.0 7.6 4.0 1.2 0.0 0.0 0.0 0.0 0.9 0.1 0.0 222.6 0.0 1.5 0.0 0.0 1.1 4.6 0.0 0.1 0.0 5.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 36.6 0.0 4.5 45.6 0.0 0.5 0.0 0.0 0.4 2.3 0.1 0.0 0.0 0.0 6.9 174.9 TRIM36 "HAPRIN, RBCC728, RNF98" ENSG00000152503 "Tripartite motif containing 36" Q9NQ86 5 115124762-115180546 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 88.8" "Group enriched" "Detected in many" 39 "Early spermatids: 1875.0;Late spermatids: 3810.8" "Cancer enhanced" "Detected in many" "prostate cancer: 9.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 7.5;non-classical monocyte: 7.7" "Group enriched" "Detected in many" 43 "dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7" "Cell line enhanced" "Detected in many" "RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA061321 Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA061321: AB_2684479" "unprognostic (6.36e-2)" "unprognostic (2.99e-1)" "unprognostic (4.54e-2)" "unprognostic (1.32e-1)" "unprognostic (1.55e-1)" "unprognostic (2.31e-2)" "unprognostic (5.33e-6)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (1.94e-1)" "unprognostic (1.84e-1)" "unprognostic (1.90e-1)" "unprognostic (2.82e-13)" "unprognostic (4.95e-2)" "unprognostic (1.38e-1)" "unprognostic (2.19e-1)" "unprognostic (6.80e-3)" 1.0 1.4 6.8 1.4 7.6 0.8 3.2 0.6 11.7 1.4 4.8 7.7 0.0 8.2 1.1 1.0 0.8 1.9 1.0 0.7 10.1 7.2 0.9 0.9 1.6 0.8 7.1 8.6 3.5 1.5 0.7 8.2 1.3 18.3 5.7 4.8 5.1 1.0 1.0 0.7 1.0 7.9 1.1 8.7 0.9 2.0 88.8 4.7 0.0 0.8 0.0 0.9 0.8 1.0 0.1 7.5 4.2 7.7 0.0 0.0 0.8 2.4 0.7 1.2 6.2 0.1 0.1 1.5 0.5 2.1 1.1 1.3 0.9 1.2 0.0 1.0 0.1 8.8 0.6 5.8 1.1 0.8 0.4 1.9 4.3 2.5 1.2 0.2 4.2 3.6 0.1 1.1 0.5 1.5 1.4 0.0 8.2 0.1 5.9 1.7 3.3 1.1 3.8 4.9 0.4 2.8 0.9 17.8 1.4 0.6 0.0 19.9 14.5 3.8 0.4 2.3 0.6 4.3 5.4 0.5 1.7 1.3 1.3 1.9 0.9 0.5 0.0 1.9 2.4 0.8 0.0 1.7 4.2 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.0 0.3 0.0 7.7 1.6 0.0 0.8 6.8 7.6 0.6 11.7 10.1 7.2 7.1 8.6 18.3 4.7 0.0 4.3 0.0 0.8 2.1 4.8 2.0 0.0 6.7 0.0 1.8 53.0 0.0 0.0 0.4 1875.0 0.7 21.6 0.0 1.6 0.4 0.6 8.8 1.1 0.0 2.5 4.8 3.4 0.6 1.6 3810.8 13.8 6.3 8.5 5.4 11.8 5.7 1.4 9.1 12.0 0.0 73.6 6.5 2.8 33.1 23.0 1.1 0.2 0.0 7.0 0.1 TRIM37 "KIAA0898, MUL, POB1, TEF3" ENSG00000108395 "Tripartite motif containing 37" O94972 17 58982638-59106921 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Repressor, Transferase" "Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.1" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 95.8;Spermatocytes: 106.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 20.0" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "MCF7: 77.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021911 Uncertain NA NA "HPA021911: AB_10964487" "unprognostic (4.07e-2)" "unprognostic (1.71e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-3)" "unprognostic (4.79e-2)" "unprognostic (2.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.46e-1)" "unprognostic (4.27e-2)" "unprognostic (3.04e-2)" 6.7 10.3 17.4 7.1 24.4 5.1 7.1 33.4 33.9 7.2 5.9 7.9 4.9 5.2 7.4 9.2 7.1 8.2 7.5 9.1 19.0 19.5 6.5 6.5 7.4 6.8 17.7 18.1 5.5 6.5 6.1 8.9 7.7 32.4 8.1 6.2 5.8 4.4 8.1 7.9 6.1 4.6 8.9 8.7 6.4 5.3 46.1 7.4 6.8 11.1 2.1 6.7 6.8 4.4 3.8 3.4 20.0 3.1 2.9 6.5 2.5 7.0 10.3 7.0 9.3 7.0 6.4 11.4 7.7 11.9 8.4 13.8 6.2 4.8 6.6 11.7 8.0 14.4 6.1 10.2 5.7 13.4 13.0 9.9 10.1 9.7 8.6 12.3 5.2 5.4 5.1 5.5 10.5 13.6 8.6 10.7 6.0 7.9 9.7 8.3 77.0 10.5 3.1 10.4 9.9 6.8 4.7 18.6 4.6 8.0 9.0 17.2 10.2 8.0 3.4 7.5 9.1 9.9 2.5 8.3 13.2 15.8 12.0 8.7 9.8 14.4 5.9 9.0 5.6 6.2 20.0 3.1 3.6 6.3 2.4 5.9 3.2 4.1 4.1 3.4 3.8 3.7 4.7 4.5 2.9 2.3 2.6 6.5 2.5 17.4 24.4 33.4 33.9 19.0 19.5 17.7 18.1 32.4 7.4 8.9 8.3 11.0 5.0 7.0 19.5 20.7 2.5 36.1 21.6 8.7 31.4 13.1 3.3 8.7 95.8 9.0 4.9 0.0 4.9 8.9 8.5 11.1 10.4 15.6 7.5 42.9 11.5 12.3 11.6 61.0 9.2 8.4 11.8 1.8 6.0 18.4 8.5 9.3 16.6 8.1 36.0 12.9 10.1 106.4 36.2 5.5 14.9 5.0 7.6 5.9 TRIM39-RPP21 ENSG00000248167 "TRIM39-RPP21 readthrough" 6 30328907-30346854 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 1.8;testis: 1.2" "Group enriched" "Detected in some" 10 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.3;Club cells: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 1.4;LHCN-M2: 2.2;MCF7: 1.8" HPA051120 Uncertain Approved Cytosol NA NA Cytosol "HPA051120: AB_2681348" "unprognostic (1.20e-1)" "unprognostic (7.35e-2)" "unprognostic (2.56e-1)" "unprognostic (1.60e-1)" "unprognostic (4.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.56e-1)" "unprognostic (5.84e-4)" "unprognostic (7.39e-2)" "unprognostic (1.50e-1)" "unprognostic (6.89e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TRIM40 RNF35 ENSG00000204614 "Tripartite motif containing 40" Q6P9F5 6 30136108-30148735 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 13.5;placenta: 39.4" "Group enriched" "Detected in some" 7 "Enterocytes: 3.6;Intestinal endocrine cells: 1.7;Paneth cells: 3.5;Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.7;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "HEL: 5.1" "Region enriched" "Detected in single" 19 "thalamus: 3.4" "Low region specificity" "Detected in all" HPA043818 Uncertain Approved Cytosol NA NA Cytosol "HPA043818: AB_10963090" "unprognostic (2.88e-1)" "unprognostic (5.20e-2)" "unprognostic (4.11e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (4.84e-2)" 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.3 2.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.2 0.0 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235809 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 39.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" NA NA "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (2.68e-2)" 10.0 8.3 25.5 9.4 24.3 9.3 5.4 7.3 17.0 6.9 6.5 19.8 8.8 11.2 6.1 8.3 7.3 8.4 7.0 9.8 26.9 20.4 10.7 7.6 6.9 6.0 37.3 12.5 5.9 12.3 18.8 7.6 7.3 17.0 7.0 4.0 7.8 8.3 8.4 30.0 9.0 9.0 5.3 43.7 7.5 9.5 19.1 18.3 10.6 11.3 7.2 7.2 5.8 5.2 2.2 2.4 3.9 2.3 1.9 4.3 1.4 4.6 12.3 4.6 7.6 5.4 5.4 10.8 6.9 3.7 5.1 4.8 10.3 7.1 7.9 11.3 4.7 9.5 8.9 4.7 16.5 2.8 39.0 15.1 9.0 12.1 5.8 5.2 6.6 6.2 4.7 8.5 6.3 2.3 4.9 2.9 12.3 11.2 9.9 2.8 16.8 9.9 7.4 4.3 3.5 5.9 9.4 7.0 10.3 2.9 7.5 7.1 6.7 6.3 7.5 9.6 2.1 15.0 7.5 6.0 7.0 4.7 4.1 5.2 21.7 13.7 11.2 7.3 7.8 5.8 0.9 1.4 2.2 2.4 1.1 3.6 1.9 2.5 4.3 1.6 2.2 2.6 3.1 3.9 1.9 2.3 2.4 3.2 1.4 25.5 24.3 7.3 17.0 26.9 20.4 37.3 12.5 17.0 18.3 3.0 14.3 11.3 9.2 7.1 18.9 11.3 7.6 20.1 10.3 10.4 17.7 12.2 10.0 7.4 5.5 9.2 10.7 0.0 10.6 7.8 6.2 7.5 2.3 19.5 7.7 27.0 12.2 11.6 12.3 2.6 4.9 6.7 8.5 8.2 12.0 14.5 8.9 10.1 11.0 6.7 27.6 0.0 7.5 32.2 19.0 9.8 10.9 12.7 10.6 5.8 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678039-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 85 "testis: 43.2" "Group enriched" "Detected in some" 113 "Early spermatids: 249.5;Late spermatids: 89.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria NA NA "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 249.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.0 0.0 0.0 TRIM43 TRIM43A ENSG00000144015 "Tripartite motif containing 43" Q96BQ3 2 95592018-95599778 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8;stomach 1: 1.5;testis: 2.8" "Cell type enriched" "Detected in single" 4 "Early spermatids: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.6" "HPA042223, HPA042772" Uncertain NA NA "HPA042223: AB_10962361, HPA042772: AB_10964436" "unprognostic (7.17e-3)" "unprognostic (1.42e-1)" "unprognostic (9.27e-2)" 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.9 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 TRIM43B ENSG00000144010 "Tripartite motif containing 43B" A6NCK2 2 95476967-95484731 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "testis: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-2 OS: 3.4" "HPA042223, HPA042772" Uncertain NA NA "HPA042223: AB_10962361, HPA042772: AB_10964436" "unprognostic (3.93e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM46 "FLJ23229, TRIFIC" ENSG00000163462 "Tripartite motif containing 46" Q7Z4K8 1 155173787-155184971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4;epididymis: 11.0" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 5.3;Early spermatids: 4.7;Late spermatids: 4.2;monocytes: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055583 Enhanced NA NA "HPA055583: AB_2732599" "unprognostic (1.06e-1)" "unprognostic (5.07e-2)" "unprognostic (2.86e-2)" "prognostic unfavorable (2.61e-7)" "unprognostic (1.75e-1)" "unprognostic (7.26e-2)" "unprognostic (1.59e-2)" "unprognostic (4.65e-2)" "unprognostic (4.09e-1)" "unprognostic (2.88e-2)" "unprognostic (2.18e-3)" "unprognostic (1.24e-1)" "unprognostic (2.29e-12)" "unprognostic (8.58e-2)" "unprognostic (2.45e-1)" "unprognostic (2.70e-1)" "unprognostic (1.72e-2)" 1.3 1.7 6.0 2.4 12.6 1.7 1.7 21.4 15.5 1.7 1.2 6.5 0.0 1.6 3.4 11.0 1.1 2.9 2.0 1.0 7.8 7.4 1.1 0.9 1.7 2.3 5.1 7.3 1.0 2.1 0.8 4.5 1.1 7.4 1.7 1.4 0.5 0.9 3.6 1.0 1.2 1.8 3.9 5.8 1.8 1.6 2.5 3.5 6.7 0.9 0.0 1.7 1.3 0.8 0.4 0.5 1.5 0.4 0.8 3.0 0.6 2.0 2.8 2.1 0.2 0.4 1.7 0.1 2.1 2.2 2.5 3.0 0.0 1.2 0.9 1.5 2.4 0.5 2.4 0.0 1.0 0.7 5.0 0.9 1.7 3.0 0.1 1.1 0.5 6.2 1.9 0.5 2.6 0.9 6.2 3.8 5.5 0.0 4.4 1.3 1.4 3.3 0.3 7.6 0.3 3.1 5.1 0.2 1.0 0.6 0.0 5.7 13.0 0.9 0.7 1.5 0.8 4.1 4.1 4.5 4.9 1.9 0.3 1.0 4.1 1.6 0.8 5.2 0.8 1.4 1.5 0.1 0.1 1.2 0.4 1.1 0.3 2.1 2.0 0.2 0.4 0.8 1.0 0.8 0.8 0.3 0.5 3.0 0.6 6.0 12.6 21.4 14.2 7.8 7.4 5.1 7.3 7.4 3.5 0.0 0.0 0.0 0.8 0.3 5.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.5 0.0 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.8 0.0 1.7 0.6 0.0 4.2 0.3 0.0 0.0 4.6 0.0 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.5 1.4 0.4 0.0 0.0 1.0 0.0 0.5 TRIM48 RNF101 ENSG00000150244 "Tripartite motif containing 48" Q8IWZ4 11 55262182-55271119 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.1;skin 1: 2.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 1.1" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.1" "Cell line enriched" "Detected in single" 5 "SK-MEL-30: 4.4" NA NA "unprognostic (8.04e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49 "RNF18, TRIM49A" ENSG00000168930 "Tripartite motif containing 49" P0CI25 11 89797655-89808575 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "basophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Cell line enhanced" "Detected in single" "U-2 OS: 2.0" NA NA "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49B ENSG00000182053 "Tripartite motif containing 49B" A6NDI0 11 49027501-49038451 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "U-2 OS: 3.4" NA NA "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49C TRIM49L2 ENSG00000204449 "Tripartite motif containing 49C" P0CI26 11 90031106-90042025 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "blood: 1.3;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "basophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Group enriched" "Detected in some" 19 "CACO-2: 3.2;U-2 OS: 3.7" NA NA "unprognostic (9.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D1 "TRIM49D, TRIM49D1P, TRIM49DP" ENSG00000223417 "Tripartite motif containing 49D1" C9J1S8 11 89911111-89921767 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "blood: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 199 "basophil: 19.8" "Lineage enriched" "Detected in single" 199 "granulocytes: 19.8" "Cell line enhanced" "Detected in single" "U-2 OS: 2.1" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM49D2 "TRIM49D2P, TRIM49L, TRIM49L1" ENSG00000233802 "Tripartite motif containing 49D2" C9J1S8 11 89924064-89933063 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "blood: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 160 "basophil: 15.9" "Lineage enriched" "Detected in single" 160 "granulocytes: 15.9" "Cell line enriched" "Detected in single" 6 "U-2 OS: 3.5" HPA072153 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA072153: " 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM50 "FLJ32804, TRIM50A" ENSG00000146755 "Tripartite motif containing 50" Q86XT4 7 73312539-73328082 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pancreas: 17.2;stomach 1: 22.8" "Cell type enhanced" "Detected in some" 14 "Distal tubular cells: 1.7;Early spermatids: 1.9;Spermatocytes: 4.4;Spermatogonia: 4.5" "Group enriched" "Detected in some" 8 "liver cancer: 2.9;renal cancer: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "Hep G2: 12.3" "HPA019862, HPA047843" Uncertain Approved Cytosol NA NA Cytosol "HPA019862: AB_1858305, HPA047843: AB_2680176" "unprognostic (1.93e-1)" "unprognostic (3.93e-1)" "unprognostic (1.07e-2)" "unprognostic (5.96e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-3)" "unprognostic (2.63e-2)" "unprognostic (2.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.36e-7)" "unprognostic (3.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.25e-1)" 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 17.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 1.0 0.0 0.0 0.1 22.8 4.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 12.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 4.4 4.5 0.0 0.1 0.0 0.0 0.0 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "blood: 11.0" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Cell type enriched" "Detected in single" 111 "basophil: 11.0" "Lineage enriched" "Detected in single" 111 "granulocytes: 11.0" "Group enriched" "Detected in some" 124 "SK-MEL-30: 36.0;WM-115: 9.2" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM54 "MURF, MURF-3, RNF30" ENSG00000138100 "Tripartite motif containing 54" Q9BYV2 2 27282392-27307439 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 187.1" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 75.1;Exocrine glandular cells: 36.7;Pancreatic endocrine cells: 31.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Cell type enriched" "Detected in single" 16 "NK-cell: 7.0" "Lineage enriched" "Detected in single" 16 "NK-cells: 7.0" "Group enriched" "Detected in some" 9 "HAP1: 8.4;NTERA-2: 18.0" "Region enhanced" "Detected in some" "amygdala: 3.2" "Not detected" "Not detected" HPA019690 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019690: AB_1858306" "unprognostic (6.98e-3)" "unprognostic (4.56e-3)" "unprognostic (3.22e-2)" "unprognostic (2.24e-2)" "unprognostic (1.58e-3)" "unprognostic (7.49e-2)" "unprognostic (1.25e-7)" "unprognostic (3.88e-3)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.41e-2)" "unprognostic (3.19e-1)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" 2.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.9 0.1 6.3 1.6 0.0 0.0 35.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 187.1 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.3 40.3 2.2 0.1 0.0 0.3 0.0 0.0 0.0 7.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 8.4 0.0 0.0 0.0 0.3 0.0 1.5 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 18.0 0.0 0.0 0.6 0.7 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.1 12.7 0.0 0.0 3.5 0.0 0.0 0.0 3.6 1.0 0.0 2.0 0.0 36.7 0.0 0.0 0.2 4.6 0.0 0.1 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 31.1 1.9 0.7 2.1 0.0 0.0 0.2 3.7 1.9 0.0 0.0 0.0 2.9 0.3 TRIM55 "MURF-2, RNF29" ENSG00000147573 "Tripartite motif containing 55" Q9BYV6 8 66126896-66175487 "Predicted intracellular proteins, Predicted membrane proteins" "Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4" "Cell type enhanced" "Detected in some" 26 "Cardiomyocytes: 96.0;Ciliated cells: 17.4;Hepatocytes: 28.0" "Group enriched" "Detected in some" 10 "liver cancer: 12.3;renal cancer: 5.8" "Region enriched" "Detected in single" 4 "cerebellum: 3.3" "Cell type enhanced" "Detected in single" "T-reg: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "LHCN-M2: 97.8" "Region enriched" "Detected in single" 8 "olfactory region: 0.5" "Not detected" "Not detected" "HPA038793, HPA053691" Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA038793: AB_10673289, HPA053691: AB_2682231" "unprognostic (5.44e-3)" "unprognostic (1.25e-2)" "unprognostic (5.93e-3)" "unprognostic (4.07e-2)" "unprognostic (6.83e-3)" "unprognostic (3.77e-3)" "unprognostic (8.31e-2)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.50e-1)" "unprognostic (5.18e-2)" "unprognostic (2.10e-2)" "unprognostic (9.51e-2)" "unprognostic (1.16e-2)" "unprognostic (1.77e-3)" 2.1 0.0 0.3 0.2 0.2 0.0 0.1 3.3 0.1 0.4 0.1 0.1 0.3 0.0 0.0 6.6 0.8 3.0 0.1 34.3 0.4 0.1 2.7 22.0 0.1 0.4 0.1 0.1 0.5 0.1 0.0 2.0 1.4 0.8 0.3 0.0 0.1 1.0 0.0 37.0 0.3 0.1 0.0 0.1 0.1 0.1 3.8 0.0 0.0 0.9 24.4 1.2 0.1 0.0 0.6 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 14.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 97.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 6.4 0.0 0.5 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.2 3.3 0.1 0.4 0.1 0.1 0.1 0.8 0.0 0.0 1.3 0.0 0.1 0.0 0.0 96.0 0.0 17.4 2.3 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.1 0.0 0.0 1.3 1.3 3.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.9 0.0 6.5 0.0 9.3 1.0 0.0 3.2 0.0 0.0 0.1 TRIM58 BIA2 ENSG00000162722 "Tripartite motif containing 58" Q8NG06 1 247857199-247878205 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2" "Cell type enriched" "Detected in many" 16 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 8.0;HEL: 21.4;K-562: 11.8;PC-3: 20.7;U-2 OS: 16.8;WM-115: 21.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023637 Uncertain NA NA 310000 "HPA023637: AB_1858309" "unprognostic (3.85e-1)" "unprognostic (5.24e-3)" "unprognostic (7.00e-2)" "unprognostic (6.52e-4)" "unprognostic (1.46e-1)" "unprognostic (3.47e-2)" "unprognostic (1.10e-1)" "unprognostic (4.14e-5)" "unprognostic (3.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (3.31e-1)" "unprognostic (1.08e-2)" "unprognostic (3.34e-1)" "unprognostic (1.00e-2)" "unprognostic (2.57e-2)" 0.7 0.8 1.3 1.0 4.4 24.8 0.7 0.3 3.7 0.6 1.3 0.2 0.0 0.3 0.5 0.4 0.5 1.4 0.5 0.8 1.5 3.2 0.5 0.6 3.4 0.4 2.4 1.2 1.1 0.4 0.3 0.7 22.4 6.9 1.7 1.0 1.1 0.5 0.4 0.5 1.2 0.6 0.8 1.3 5.8 0.7 4.9 0.1 0.0 15.2 0.0 0.4 1.9 0.7 3.1 0.6 3.7 0.7 1.7 0.3 1.9 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 1.0 8.0 0.0 0.0 0.0 0.8 21.4 0.0 0.0 0.0 2.8 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 11.8 0.1 0.0 0.0 0.0 0.1 1.4 0.0 20.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 2.1 0.0 0.0 16.8 0.0 0.0 3.6 0.0 0.0 0.0 6.1 21.8 2.8 0.7 1.8 0.3 0.5 0.2 3.1 0.2 0.2 0.6 1.0 0.3 0.2 3.7 1.7 0.6 0.6 0.2 1.9 1.3 4.4 0.3 3.7 1.5 3.2 2.4 1.2 6.9 0.1 3.0 4.0 1.7 0.6 0.9 2.3 0.4 0.0 6.7 10.3 1.8 11.8 2.4 0.0 0.1 3.1 0.8 0.0 186.9 0.0 3.3 1.5 2.9 8.1 0.0 2.0 0.0 1.2 1.8 2.6 0.5 0.9 1.6 1.7 0.0 0.4 1.5 0.2 0.0 0.7 0.0 3.5 0.0 0.8 2.8 10.9 0.6 4.1 1.3 0.8 0.9 TRIM59 "Mrf1, RNF104, TRIM57, TSBF1" ENSG00000213186 "Tripartite motif containing 59" Q8IWR1 3 160432445-160485773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6;lymphoid tissue: 24.6" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 23.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017750 Uncertain Approved "Rods & Rings" NA Yes "Rods & Rings" "HPA017750: AB_1858312" "unprognostic (3.74e-1)" "prognostic favorable (4.36e-4)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-1)" "unprognostic (8.00e-4)" "unprognostic (1.88e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (1.02e-3)" "unprognostic (2.44e-11)" "unprognostic (7.92e-2)" "unprognostic (2.42e-1)" "unprognostic (4.03e-2)" "unprognostic (5.91e-3)" 1.3 1.4 8.0 6.0 19.3 18.6 2.7 2.1 14.5 1.8 3.5 30.6 0.3 3.6 4.1 1.3 6.6 2.8 3.6 1.2 13.4 6.4 2.0 1.6 2.6 13.8 28.3 6.3 2.1 2.4 2.7 2.5 2.6 14.3 2.9 3.5 0.1 2.6 1.6 1.6 6.8 4.0 3.8 14.5 6.3 3.3 10.4 28.4 24.6 2.8 0.3 14.5 6.1 3.1 7.8 4.7 16.1 2.2 8.8 15.2 2.6 8.9 7.1 9.1 0.6 3.6 5.0 12.0 14.2 12.3 17.8 17.1 0.7 15.6 23.9 10.6 10.6 5.6 15.3 0.0 5.8 23.5 21.7 8.6 0.8 2.1 1.0 5.1 10.5 1.4 4.2 1.7 8.6 6.1 10.8 12.4 3.6 11.2 10.2 16.6 9.4 6.4 0.7 23.9 5.8 11.9 9.0 7.9 10.7 6.2 2.9 5.9 1.3 4.0 11.9 0.3 12.8 14.1 9.8 9.4 1.3 4.2 2.1 1.3 17.0 6.1 6.0 1.5 13.8 1.4 16.1 2.2 3.7 8.3 2.2 9.4 7.8 13.6 11.2 3.2 6.9 9.4 11.1 2.7 8.8 1.0 4.7 15.2 2.6 8.0 19.3 2.1 11.8 13.4 6.4 28.3 6.3 14.3 28.4 0.0 6.2 12.3 4.2 4.2 0.4 0.7 2.5 1.4 1.2 1.8 5.9 4.1 0.0 1.7 23.4 1.8 1.1 0.0 1.7 9.8 1.8 1.8 1.1 0.0 2.5 0.0 10.4 2.5 3.0 10.7 0.3 2.1 3.3 1.0 2.2 0.5 1.4 3.5 0.7 1.4 1.3 0.0 0.5 12.5 13.9 3.9 2.1 12.8 4.4 2.7 TRIM6 RNF89 ENSG00000121236 "Tripartite motif containing 6" Q9C030 11 5596109-5612958 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 42.7" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 11.1;Extravillous trophoblasts: 12.7;Proximal tubular cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 14.4;SuSa: 25.2;U-2 OS: 14.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA060514 Uncertain NA NA "HPA060514: AB_2684300" "unprognostic (9.00e-2)" "unprognostic (2.10e-3)" "unprognostic (9.16e-3)" "unprognostic (1.82e-1)" "unprognostic (3.25e-3)" "unprognostic (3.25e-3)" "unprognostic (2.35e-2)" "unprognostic (3.26e-3)" "unprognostic (8.59e-2)" "unprognostic (3.40e-2)" "unprognostic (8.61e-2)" "unprognostic (3.90e-1)" "unprognostic (5.68e-2)" "unprognostic (4.65e-4)" "unprognostic (4.77e-1)" "unprognostic (3.33e-2)" "unprognostic (4.36e-1)" 3.7 5.8 0.6 1.5 1.3 1.3 3.0 0.2 1.4 4.2 2.6 1.4 3.2 0.1 4.2 4.3 6.0 3.1 1.8 2.6 0.8 0.7 42.7 1.1 2.2 0.2 0.7 0.6 3.9 1.8 1.9 1.9 10.9 2.1 3.9 1.2 6.6 14.7 3.9 1.3 1.1 2.2 4.7 1.4 2.8 1.6 15.5 1.0 1.6 3.8 1.1 3.2 4.9 3.7 0.3 2.2 3.9 0.7 1.0 0.3 0.4 0.4 10.4 0.7 0.0 1.2 2.0 12.2 2.8 2.1 2.8 2.7 0.3 2.3 0.0 1.6 2.8 7.8 1.8 4.7 4.3 4.0 0.3 3.2 1.2 1.0 0.0 0.4 4.1 5.7 3.4 4.1 3.9 2.8 4.2 2.4 0.0 4.9 0.1 1.2 0.1 0.0 0.5 14.4 1.6 3.6 4.8 0.0 0.1 0.6 4.2 0.0 0.1 0.0 5.4 0.5 25.2 2.0 0.7 12.2 2.7 14.2 0.0 2.9 0.1 0.1 0.0 2.4 0.0 2.2 0.7 0.7 1.4 0.3 0.0 0.1 0.3 0.1 0.0 2.2 0.2 0.1 0.1 3.9 1.0 0.0 0.9 0.1 0.4 0.6 1.3 0.2 1.4 0.8 0.7 0.7 0.6 2.1 1.0 0.0 4.5 0.0 0.4 0.5 0.0 0.4 0.0 1.4 0.0 1.8 0.0 11.1 3.3 0.9 1.0 0.6 0.0 0.0 0.2 12.7 1.9 0.4 0.0 0.6 2.8 0.0 0.0 0.0 2.9 0.0 0.9 1.1 1.7 3.6 0.1 0.0 0.5 0.0 1.8 42.8 0.0 0.0 0.4 7.7 2.1 0.4 4.8 0.0 0.1 0.2 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "kidney: 30.3;salivary gland: 9.5;testis: 8.0" "Cell type enriched" "Detected in single" 9 "Ciliated cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "A549: 10.1" HPA077996 Uncertain Nucleoli,Centrosome NA NA Centrosome Nucleoli "HPA077996: AB_2686873" 0.9 0.7 0.4 0.6 0.4 0.1 0.9 0.4 0.4 1.4 0.4 0.0 0.7 0.8 1.5 1.6 1.9 0.7 0.2 1.4 0.4 0.3 30.3 0.4 0.7 0.1 0.3 0.0 1.7 2.7 1.1 0.4 1.4 0.3 1.5 0.2 2.2 9.5 1.9 0.4 0.4 0.6 1.9 0.4 1.1 0.4 8.0 0.0 0.0 1.7 0.0 1.5 1.1 0.5 0.5 1.5 1.3 0.8 0.9 0.2 0.2 0.0 10.1 0.0 0.0 0.2 0.8 1.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 1.1 0.0 0.0 0.7 0.6 0.6 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.2 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.2 0.2 0.1 0.4 0.0 0.1 1.5 0.5 0.1 0.1 1.3 0.9 0.4 0.3 0.0 0.2 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRIM61 RNF35 ENSG00000183439 "Tripartite motif containing 61" Q5EBN2 4 164954446-164977668 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 16.1;thyroid gland: 15.5" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 14.4;Late spermatids: 9.0;Spermatocytes: 18.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HHSteC: 9.7;HSkMC: 6.5;hTERT-RPE1: 5.2;SuSa: 6.9;U-266/70: 12.9;U-266/84: 6.5" HPA049109 Uncertain Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA049109: AB_2680636" "unprognostic (2.05e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (1.02e-2)" "unprognostic (8.24e-2)" "unprognostic (1.51e-2)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (7.81e-2)" "unprognostic (1.51e-1)" "unprognostic (3.67e-1)" "unprognostic (2.92e-1)" "unprognostic (9.77e-5)" "unprognostic (4.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.36e-1)" "unprognostic (4.32e-2)" 2.4 5.4 1.8 3.0 2.5 3.3 1.6 1.3 2.1 2.6 1.4 1.1 7.2 2.2 2.8 1.9 0.8 3.5 3.1 5.9 2.4 3.0 1.0 1.1 2.1 2.9 2.7 1.3 5.8 0.9 1.5 6.8 1.8 3.8 2.1 1.1 2.9 0.9 1.9 1.2 1.1 1.7 2.1 4.2 4.7 1.5 16.1 1.6 2.7 15.5 0.7 2.8 3.0 5.2 5.5 5.1 3.6 1.3 7.8 4.1 1.5 0.2 0.4 0.9 0.8 0.6 0.6 0.6 2.4 0.8 0.0 0.0 0.3 0.3 0.7 0.2 3.5 0.2 0.3 0.6 0.6 0.4 0.4 0.5 0.2 0.5 0.7 9.7 0.5 0.6 6.5 0.5 2.1 0.2 5.2 0.2 0.3 0.5 1.4 0.3 0.4 0.3 0.7 3.8 0.0 0.0 0.5 0.2 1.0 0.3 0.9 0.8 0.5 0.1 0.3 0.4 6.9 0.3 0.3 0.7 1.2 0.4 0.1 0.2 12.9 6.5 0.4 0.3 0.2 0.3 3.6 1.3 0.1 3.3 1.1 3.4 3.6 1.6 3.3 1.5 5.5 4.1 4.0 0.5 7.8 0.8 5.1 0.4 1.5 1.8 2.5 1.3 2.1 2.4 3.0 2.7 1.3 3.8 1.6 0.0 3.5 2.2 0.6 0.2 0.7 1.7 0.0 0.0 0.0 3.5 3.9 0.1 0.0 0.3 14.4 0.3 0.0 0.0 0.6 0.0 0.7 0.3 0.0 0.4 1.0 1.6 0.0 0.0 0.6 9.0 1.1 0.3 0.0 2.8 0.0 2.8 0.1 0.0 1.4 2.5 0.3 0.0 0.3 18.1 3.4 0.0 0.2 2.9 0.0 0.5 TRIM63 "IRF, MURF-1, RNF28, SMRZ" ENSG00000158022 "Tripartite motif containing 63" Q969Q1 1 26051304-26068436 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Muscle protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "skeletal muscle: 271.4" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 236.2" "Cancer enriched" "Detected in some" 10 "melanoma: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "ASC diff: 10.7;SK-MEL-30: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (1.10e-1)" "unprognostic (4.80e-4)" "unprognostic (1.45e-2)" "unprognostic (7.52e-3)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.71e-1)" "unprognostic (1.06e-1)" "unprognostic (3.17e-1)" "unprognostic (1.01e-1)" "unprognostic (2.16e-2)" "unprognostic (5.90e-2)" "unprognostic (1.33e-2)" "unprognostic (2.32e-1)" "unprognostic (5.58e-2)" 3.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 1.2 1.7 0.0 0.6 38.2 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.5 0.0 3.6 1.0 0.0 271.4 0.6 0.1 0.9 0.1 0.0 0.1 0.1 0.0 0.0 1.7 12.7 0.8 1.2 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.8 0.0 236.2 10.2 0.0 0.0 1.8 0.0 0.4 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 9.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.2 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 TRIM64 "C11orf28, TRIM64A" ENSG00000204450 "Tripartite motif containing 64" A6NGJ6 11 89968502-89975228 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 65 "blood: 8.6;placenta: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 86 "basophil: 8.6" "Lineage enriched" "Detected in single" 86 "granulocytes: 8.6" "Not detected" "Not detected" HPA045370 Approved NA NA "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64B ENSG00000189253 "Tripartite motif containing 64B" A6NI03 11 89869282-89876017 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 24 "blood: 22.3;placenta: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 223 "basophil: 22.3" "Lineage enriched" "Detected in single" 223 "granulocytes: 22.3" "Cell line enhanced" "Detected in single" "WM-115: 1.4" HPA045370 Approved NA NA "HPA045370: AB_2679298" "unprognostic (2.08e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.4 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64C ENSG00000214891 "Tripartite motif containing 64C" 11 49053714-49059112 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "blood: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "basophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Not detected" "Not detected" HPA045370 Uncertain NA NA "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM67 TNL ENSG00000119283 "Tripartite motif containing 67" Q6ZTA4 1 231162112-231221556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 14.4" "Cell type enriched" "Detected in some" 7 "Horizontal cells: 65.2" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 13.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.4;HMC-1: 1.6;HSkMC: 1.4;SCLC-21H: 7.2;SH-SY5Y: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034776 Uncertain NA NA "HPA034776: AB_10603997" "unprognostic (1.56e-3)" "unprognostic (1.54e-1)" "unprognostic (5.20e-2)" "unprognostic (5.39e-3)" "unprognostic (2.95e-1)" "unprognostic (3.82e-2)" "unprognostic (6.02e-2)" "unprognostic (4.63e-3)" "unprognostic (1.84e-2)" "unprognostic (1.74e-1)" "unprognostic (4.93e-10)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (4.25e-2)" "unprognostic (1.53e-1)" "unprognostic (2.30e-2)" "unprognostic (5.10e-3)" 0.3 0.7 1.3 0.2 1.3 0.1 0.1 13.3 14.4 0.2 0.2 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.3 1.2 1.9 0.2 0.1 0.1 0.2 1.5 0.0 0.2 0.2 0.1 1.9 0.4 1.9 0.1 0.2 1.7 0.2 0.1 0.1 0.4 0.3 0.2 0.9 0.2 0.2 0.5 0.2 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 1.6 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.1 0.0 0.0 7.2 1.9 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.3 13.3 1.9 1.2 1.9 1.5 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 9.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 TRIM69 "RNF36, Trif, TRIMLESS" ENSG00000185880 "Tripartite motif containing 69" Q86WT6 15 44728988-44767829 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 68.6" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "T-reg: 8.2" "Lineage enriched" "Detected in many" 7 "T-cells: 8.2" "Cell line enhanced" "Detected in some" "Karpas-707: 4.1;U-266/70: 13.8;U-266/84: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA028894 Enhanced NA NA "HPA028894: AB_10603136" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" "unprognostic (4.10e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-2)" "unprognostic (4.20e-1)" "unprognostic (9.27e-2)" "unprognostic (4.95e-2)" "unprognostic (6.49e-2)" "unprognostic (3.53e-3)" "unprognostic (1.38e-1)" "unprognostic (3.72e-2)" "prognostic favorable (2.26e-5)" "unprognostic (4.79e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-2)" "unprognostic (1.49e-2)" 4.6 3.9 9.0 4.0 10.8 3.0 3.9 7.2 9.1 3.5 4.4 5.1 1.7 3.6 3.4 3.7 4.7 3.4 4.1 11.0 7.9 7.9 4.7 3.8 3.8 4.9 7.5 5.4 3.8 2.8 3.4 4.9 3.1 5.3 5.9 4.2 3.7 3.7 3.2 14.0 4.1 4.0 5.3 5.7 6.7 3.9 68.6 4.7 3.9 5.3 5.2 5.5 4.1 8.1 1.2 0.0 0.1 0.3 0.0 8.2 0.3 0.2 0.0 0.4 0.7 0.5 1.2 0.0 0.1 0.5 0.9 2.5 0.0 0.3 0.2 0.2 0.0 0.2 0.0 0.3 0.0 0.6 2.6 0.0 0.3 0.1 0.0 0.9 0.0 0.2 1.5 0.9 0.2 0.2 2.1 0.2 1.0 0.0 4.1 0.4 0.0 0.0 0.1 0.1 0.6 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.8 0.3 13.8 3.4 2.1 0.4 0.4 0.1 0.0 0.0 0.0 0.6 0.2 1.2 1.2 1.9 1.8 0.0 0.0 0.3 1.2 0.1 0.0 0.3 0.0 8.2 0.3 9.0 10.8 7.2 9.1 7.9 7.9 7.5 5.4 5.3 4.7 6.0 6.1 20.6 18.3 18.9 9.8 54.6 10.2 9.4 14.8 8.7 3.9 4.6 34.9 28.3 172.6 14.8 12.1 0.0 14.0 3.5 9.3 13.2 13.9 4.7 32.0 22.3 4.1 11.1 18.8 66.2 8.6 18.5 11.8 73.9 6.5 11.7 18.3 14.4 11.0 17.2 2.6 6.5 21.7 6.7 1.5 36.0 1.3 22.0 5.3 41.5 TRIM7 "GNIP, RNF90" ENSG00000146054 "Tripartite motif containing 7" Q9C029 5 181193924-181205293 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 81.8;tongue: 34.0" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 15.9;Cardiomyocytes: 22.9;Sertoli cells: 12.9;Suprabasal keratinocytes: 24.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 16 "cerebellum: 21.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "monocytes: 4.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "HaCaT: 11.4;HDLM-2: 24.1;PC-3: 13.3;TIME: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039213 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA Vesicles "Nucleoplasm, Cytosol" "HPA039213: AB_10795173" "unprognostic (6.58e-2)" "unprognostic (1.17e-1)" "unprognostic (5.20e-2)" "unprognostic (1.10e-2)" "unprognostic (6.85e-2)" "unprognostic (1.80e-2)" "unprognostic (3.89e-4)" "unprognostic (3.45e-2)" "unprognostic (3.72e-1)" "unprognostic (1.64e-1)" "unprognostic (3.48e-2)" "unprognostic (1.97e-1)" "unprognostic (7.16e-3)" "unprognostic (1.26e-1)" "unprognostic (3.90e-2)" "unprognostic (6.17e-2)" "unprognostic (1.15e-2)" 1.3 0.9 0.1 0.9 0.5 0.5 3.4 21.7 1.3 2.5 0.8 0.3 1.1 0.5 1.0 6.4 13.0 0.6 1.7 2.2 0.1 0.8 2.2 0.5 0.9 0.6 0.2 0.2 0.6 4.2 1.6 1.9 0.5 0.5 2.0 0.6 0.6 5.9 1.1 81.8 9.5 0.6 0.9 0.3 0.8 1.4 0.9 0.2 0.1 3.3 34.0 13.5 1.6 2.9 0.7 0.8 0.1 4.9 0.5 2.2 1.1 6.1 3.0 0.0 0.3 0.5 0.5 0.2 1.4 0.0 0.5 1.2 0.3 8.1 0.4 4.3 1.7 2.6 11.4 3.3 9.3 0.1 24.1 1.3 0.5 7.9 0.1 1.6 0.0 1.4 0.1 7.2 0.2 4.6 1.8 2.6 1.1 0.3 1.3 0.2 0.8 0.3 0.2 0.0 9.7 13.3 0.3 4.2 0.9 3.3 0.0 0.3 0.7 2.9 0.2 4.1 0.1 0.7 0.2 11.0 0.1 2.4 0.4 4.3 1.9 0.2 0.7 0.3 0.4 1.0 0.0 4.9 0.1 1.4 1.9 2.2 0.4 1.2 1.4 0.8 0.7 2.2 1.8 0.1 0.5 1.4 0.6 2.2 1.1 0.1 0.5 21.7 1.3 0.1 0.8 0.2 0.2 0.5 0.2 0.0 1.4 0.0 3.9 15.9 5.7 22.9 0.0 0.0 0.0 3.5 0.0 0.0 5.0 0.4 0.6 1.4 2.4 0.0 2.0 0.4 0.8 1.8 0.0 0.2 1.1 0.0 0.0 1.8 9.4 0.0 0.9 1.6 1.7 0.0 3.1 0.5 3.2 8.5 1.4 1.1 2.7 12.9 9.0 0.9 0.4 24.8 0.0 0.0 2.2 2.4 TRIM71 "LIN-41, LIN41" ENSG00000206557 "Tripartite motif containing 71" Q2Q1W2 3 32818018-32897826 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Ubl conjugation pathway" "Developmental protein, RNA-binding, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 6.5;testis: 11.1" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 1: 8.9;Extravillous trophoblasts: 13.2;Spermatogonia: 12.6" "Cancer enriched" "Detected in some" 28 "testis cancer: 28.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.9;BEWO: 36.1;Hep G2: 23.3;NTERA-2: 31.9;SuSa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA038141, HPA038142" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Plasma membrane, Actin filaments, Focal adhesion sites" "HPA038141: AB_2675857, HPA038142: AB_10697240" "unprognostic (2.93e-2)" "unprognostic (4.29e-3)" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (2.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.25e-1)" "unprognostic (3.16e-2)" "unprognostic (3.04e-1)" "unprognostic (1.11e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-6)" "unprognostic (3.92e-2)" "unprognostic (9.27e-2)" "unprognostic (8.17e-2)" "unprognostic (4.65e-2)" 0.1 0.0 0.7 0.1 1.9 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.7 0.7 2.2 0.0 6.5 0.0 0.2 0.0 0.1 0.0 0.0 0.5 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 11.9 0.0 0.0 0.0 36.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.6 0.0 23.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.2 2.5 31.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 1.9 0.0 0.5 2.7 0.7 0.2 0.0 1.9 0.0 8.9 2.6 0.0 0.0 0.0 0.4 2.8 0.0 1.4 3.4 0.0 0.0 3.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 13.2 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.4 0.0 0.0 0.3 12.6 0.0 3.3 0.0 0.0 0.0 TRIM72 MG53 ENSG00000177238 "Tripartite motif containing 72" Q6ZMU5 16 31214021-31231537 "Predicted intracellular proteins, Transporters" "Exocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 71.6;tongue: 37.7" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Club cells: 4.5" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 12 "cerebellum: 3.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 4.8;LHCN-M2: 8.9;RH-30: 23.1;U-266/70: 14.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA054909 Enhanced Approved Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA054909: AB_2682639" "unprognostic (2.61e-1)" "unprognostic (3.21e-3)" "unprognostic (5.07e-2)" "unprognostic (9.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.13e-1)" "unprognostic (2.01e-3)" "unprognostic (2.80e-1)" "unprognostic (6.57e-2)" "unprognostic (4.90e-1)" "unprognostic (1.90e-1)" "unprognostic (2.49e-2)" "unprognostic (2.24e-10)" "unprognostic (7.70e-2)" "unprognostic (6.72e-2)" "unprognostic (4.15e-1)" "unprognostic (4.30e-4)" 2.3 0.1 0.1 0.1 0.2 0.3 0.1 3.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 5.5 1.8 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.8 0.0 0.0 1.0 0.0 71.6 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 1.2 37.7 1.9 0.0 0.0 2.0 1.9 4.9 1.3 2.1 1.3 0.4 0.1 0.2 0.2 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.2 0.4 0.2 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.7 0.3 0.2 4.8 0.2 1.0 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.5 8.9 0.2 0.1 0.4 0.2 0.1 0.3 0.3 23.1 3.0 0.0 0.3 1.9 0.2 0.2 0.3 0.1 0.3 0.2 2.0 0.1 0.2 0.3 0.2 0.1 14.4 1.2 0.2 0.2 0.4 0.2 4.5 1.3 1.5 1.1 1.2 1.0 1.3 1.0 0.9 0.8 2.0 1.3 1.3 4.9 2.1 1.2 1.9 0.8 0.4 0.1 0.2 3.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 6.7 0.0 2.0 0.1 0.8 2.6 0.0 0.0 4.5 0.0 2.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.2 1.4 1.1 0.0 0.2 0.0 0.0 0.6 1.9 0.0 0.0 0.6 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.5 1.6 TRIM73 TRIM50B ENSG00000178809 "Tripartite motif containing 73" Q86UV7 7 75395063-75410996 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 11.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 20.3;Cone photoreceptor cells: 17.7;Horizontal cells: 30.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.9;Hep G2: 13.3" "HPA047843, HPA051845" Uncertain Uncertain Cytosol NA NA Cytosol "HPA047843: AB_2680176, HPA051845: AB_2681635" "unprognostic (1.01e-2)" "unprognostic (9.85e-5)" "unprognostic (4.72e-3)" "unprognostic (9.44e-3)" "unprognostic (2.49e-1)" "unprognostic (1.48e-2)" "unprognostic (1.25e-3)" "unprognostic (9.17e-3)" "unprognostic (1.41e-1)" "unprognostic (2.80e-1)" "unprognostic (5.46e-3)" "unprognostic (6.79e-2)" "unprognostic (4.18e-2)" "unprognostic (9.67e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-2)" "unprognostic (2.73e-3)" 1.9 1.6 0.3 1.2 0.9 2.4 1.6 4.0 0.6 2.4 0.6 4.2 1.7 0.3 0.3 3.8 1.0 0.9 0.4 0.5 1.7 2.3 1.1 2.3 0.2 2.3 7.2 1.3 1.7 0.1 2.1 0.0 1.9 1.9 2.6 2.4 2.2 0.0 0.5 1.8 11.5 5.4 2.4 0.2 0.7 1.3 1.3 1.4 2.0 0.8 1.7 2.2 1.3 1.3 4.1 1.7 2.5 0.0 0.9 0.6 0.5 0.1 0.1 1.0 0.0 2.0 2.3 0.4 0.2 0.3 1.4 0.3 0.0 0.2 5.1 7.9 1.5 3.1 13.3 0.9 0.8 5.6 2.3 0.0 0.3 0.4 1.2 0.1 3.3 0.7 6.5 0.0 0.9 2.1 2.7 0.2 0.3 1.4 3.6 0.2 1.2 0.4 0.0 2.1 1.6 2.6 0.9 2.1 0.7 0.6 2.4 1.6 1.1 1.9 1.7 1.1 3.1 1.8 2.4 1.7 3.3 1.5 1.1 0.8 0.7 2.2 0.6 1.2 1.1 1.3 0.4 0.4 1.3 2.1 1.6 2.0 1.7 0.2 1.4 2.0 1.3 0.0 0.3 1.9 2.2 0.8 20.3 2.0 2.5 5.3 3.4 5.2 17.7 1.9 5.0 1.6 5.0 2.2 2.0 0.0 4.0 0.6 1.3 2.7 0.0 1.8 2.5 30.2 4.7 3.1 1.0 8.5 6.1 1.7 1.7 1.0 4.0 9.5 3.1 4.0 3.5 2.9 12.6 0.0 1.1 9.4 2.7 1.8 0.9 4.5 3.3 2.4 TRIM74 "MGC45440, TRIM50C" ENSG00000155428 "Tripartite motif containing 74" Q86UV6 7 72959485-72969466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 10.9" "Cell type enhanced" "Detected in single" 22 "Ciliated cells: 1.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 7.7;Hep G2: 5.4" HPA047843 Approved Cytosol NA NA Cytosol "HPA047843: AB_2680176" "unprognostic (8.78e-3)" "unprognostic (3.78e-4)" "unprognostic (5.84e-3)" "unprognostic (1.95e-2)" "unprognostic (1.03e-1)" "unprognostic (8.26e-2)" "unprognostic (3.58e-2)" "unprognostic (1.26e-3)" "unprognostic (1.65e-2)" "unprognostic (3.68e-1)" "unprognostic (8.13e-3)" "unprognostic (1.98e-2)" "unprognostic (7.78e-2)" "unprognostic (7.05e-2)" "unprognostic (1.67e-1)" "unprognostic (1.63e-1)" "unprognostic (1.12e-3)" 1.1 1.6 0.6 1.0 1.4 1.7 1.0 4.8 0.7 1.1 0.5 2.4 1.3 2.5 0.4 2.3 0.8 0.5 0.6 0.8 1.3 2.3 0.6 1.9 0.4 1.7 5.0 0.2 1.6 0.1 1.6 0.5 1.2 1.0 0.8 1.5 1.2 0.8 0.7 1.6 10.9 6.0 1.5 0.5 0.4 1.0 2.2 0.2 0.7 0.1 0.0 1.1 0.0 0.0 0.3 1.4 1.5 0.5 0.0 0.0 0.8 0.0 0.2 0.5 2.0 1.5 1.0 0.2 0.0 0.5 0.7 0.1 0.1 0.1 0.8 7.7 1.2 0.0 5.4 0.2 2.4 3.3 0.8 0.3 0.0 0.4 1.1 0.0 1.9 1.0 4.6 0.1 2.2 0.9 3.8 0.1 0.0 1.7 1.7 0.6 0.8 2.2 0.8 0.6 0.7 0.8 0.0 1.7 0.2 0.1 1.1 2.7 0.3 1.0 0.5 0.0 3.5 2.7 0.6 1.2 1.4 0.7 0.7 0.0 0.7 1.0 0.0 1.1 2.2 0.7 0.2 0.0 0.1 0.8 0.2 0.0 0.0 0.1 0.2 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 TRIM75P TRIM75 ENSG00000250374 "Tripartite motif containing 75, pseudogene" A6NK02 4 165059148-165060554 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "placenta: 1.8;testis: 1.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 8 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "BEWO: 7.0" NA NA "unprognostic (8.51e-2)" "unprognostic (2.81e-2)" "unprognostic (1.94e-3)" "unprognostic (3.29e-2)" "unprognostic (3.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM77 TRIM77P ENSG00000214414 "Tripartite motif containing 77" I1YAP6 11 89710299-89717872 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.1" HPA039896 Uncertain NA NA "HPA039896: AB_2676732" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM9 "RNF91, SPRING" ENSG00000100505 "Tripartite motif containing 9" Q9C026 14 50975262-51096061 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 61.5" "Group enriched" "Detected in some" 6 "Bipolar cells: 45.6;Cone photoreceptor cells: 31.4;Muller glia cells: 49.8;Rod photoreceptor cells: 26.4" "Cancer enriched" "Detected in some" 8 "glioma: 25.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 19.7;HAP1: 14.0;HDLM-2: 21.5;SCLC-21H: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.22e-1)" "unprognostic (6.37e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-3)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (2.24e-3)" "unprognostic (7.66e-2)" "unprognostic (1.88e-1)" "unprognostic (3.06e-2)" "unprognostic (2.38e-3)" "unprognostic (1.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.55e-1)" "unprognostic (9.00e-2)" "unprognostic (7.57e-6)" "unprognostic (1.85e-3)" 1.9 3.9 21.5 2.7 20.9 2.2 2.7 49.1 61.5 2.1 2.5 10.3 0.0 1.5 4.8 3.0 1.7 1.5 6.5 1.7 17.4 11.4 1.9 3.6 1.5 1.5 10.8 21.7 2.3 1.9 1.5 5.7 1.6 13.0 2.0 2.4 1.8 3.9 5.2 1.5 1.6 1.7 5.2 7.1 1.6 1.7 2.0 11.5 0.0 1.5 0.0 1.5 2.0 0.9 0.0 0.1 0.8 0.0 0.0 0.4 0.4 0.0 2.2 3.5 19.7 0.0 0.0 1.3 0.0 0.0 0.3 0.5 1.5 0.2 0.2 0.1 0.3 3.4 0.0 14.0 0.0 0.6 21.5 2.8 1.0 0.0 0.0 0.0 0.7 0.7 0.6 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.5 0.0 4.2 0.5 1.1 0.0 3.0 2.5 5.1 0.1 0.0 0.0 20.3 1.6 0.3 0.0 4.3 0.2 0.3 0.5 0.0 1.3 0.6 0.0 0.9 0.4 0.0 0.2 6.0 0.5 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.4 21.5 20.9 49.1 28.6 17.4 11.4 10.8 21.7 13.0 11.5 0.0 0.0 0.0 0.1 0.5 45.6 1.4 2.5 0.0 0.0 0.0 31.4 0.1 1.7 0.2 0.1 0.0 0.0 0.0 0.0 1.9 0.5 0.2 0.0 0.0 0.2 1.6 1.2 0.6 0.3 0.0 2.0 0.0 6.8 0.0 0.0 49.8 0.1 0.0 3.9 0.2 26.4 0.0 0.5 0.2 0.7 0.0 0.2 0.0 0.0 0.0 TRIML1 "FLJ36180, RNF209" ENSG00000184108 "Tripartite motif family like 1" Q8N9V2 4 188139419-188147743 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 14.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 94.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.99e-2)" "unprognostic (5.21e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 94.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.9 0.0 0.0 0.0 TRIML2 "FLJ25801, SPRYD6" ENSG00000179046 "Tripartite motif family like 2" Q8N7C3 4 188091273-188109603 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 9.8;testis: 6.2" "Cell type enhanced" "Detected in some" 17 "Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4" "Cancer enriched" "Detected in some" 33 "testis cancer: 24.4" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 58.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043838 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043838: AB_10963835" "unprognostic (3.32e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (9.82e-2)" "unprognostic (1.21e-5)" "unprognostic (3.06e-2)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.28e-3)" 0.1 0.1 0.2 0.1 1.4 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 9.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 12.6 0.0 0.0 0.0 0.0 7.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.3 2.4 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 58.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 5.5 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.5 0.0 7.4 0.0 0.0 0.3 TRIP10 "CIP4, HSTP, STOT, STP" ENSG00000125733 "Thyroid hormone receptor interactor 10" Q15642 19 6737925-6751526 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 103.7" "Cell type enhanced" "Detected in many" 10 "monocytes: 342.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 19.4" "Lineage enriched" "Detected in many" 12 "dendritic cells: 19.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041934, HPA072625, HPA073886" Approved Supported Nucleoplasm,Vesicles NA NA 15000 Vesicles Nucleoplasm "HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244" "unprognostic (5.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (3.61e-4)" "unprognostic (2.19e-2)" "unprognostic (6.57e-2)" "prognostic favorable (1.76e-4)" "unprognostic (6.73e-3)" "unprognostic (1.10e-3)" "unprognostic (1.51e-1)" "unprognostic (3.41e-1)" "unprognostic (7.87e-3)" "unprognostic (3.28e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.14e-2)" "unprognostic (1.42e-1)" "unprognostic (8.93e-2)" "unprognostic (8.83e-2)" 19.7 10.7 6.0 9.2 7.2 2.3 16.8 3.7 5.4 25.6 19.1 4.5 20.6 9.7 17.8 16.7 44.8 12.0 17.6 18.1 6.5 1.9 14.0 4.5 19.5 5.4 6.7 3.5 22.4 12.9 7.0 4.8 25.4 7.0 19.2 6.6 20.2 16.1 18.3 103.7 10.4 10.1 20.9 6.7 7.1 11.3 8.7 5.4 2.8 31.7 21.6 21.7 24.3 26.5 1.5 19.4 0.1 0.7 1.6 0.9 0.4 26.8 16.3 5.7 8.6 22.5 23.7 20.6 17.4 20.1 19.9 17.4 22.1 15.5 0.5 23.5 14.6 16.1 20.0 12.9 25.3 11.8 16.9 5.2 8.7 15.4 16.8 18.5 0.4 2.8 27.3 17.2 17.7 13.6 26.3 20.4 1.2 12.7 7.4 14.5 9.1 2.3 6.0 12.1 16.8 13.9 3.9 11.8 7.8 16.7 13.4 0.0 6.6 22.8 10.3 6.5 13.9 10.7 4.7 39.7 13.4 24.0 34.9 18.2 7.8 4.2 2.6 21.7 2.5 8.7 0.0 0.7 0.0 0.5 0.1 0.7 1.2 0.2 0.9 3.8 1.5 0.3 0.2 0.1 1.6 0.1 19.4 0.0 0.4 6.0 7.2 3.7 5.4 6.5 1.9 6.7 3.5 7.0 5.4 26.8 20.3 3.7 99.7 75.9 13.2 7.5 17.8 9.4 30.7 15.7 35.3 6.1 5.0 41.3 9.7 37.9 25.1 0.0 33.6 32.8 73.7 86.2 27.8 3.4 8.7 0.0 7.5 38.1 4.0 10.0 51.8 30.9 35.4 342.7 15.5 11.4 60.8 24.3 33.9 18.2 16.8 32.3 85.5 1.9 5.9 72.8 11.9 4.3 21.7 106.3 TRIP13 16E1BP ENSG00000071539 "Thyroid hormone receptor interactor 13" Q15645 5 892643-919357 "Disease related genes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.4;testis: 52.9" "Group enriched" "Detected in many" 5 "Ciliated cells: 109.7;Early spermatids: 114.7;Late spermatids: 165.0;Spermatocytes: 66.2;Spermatogonia: 77.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005727, HPA053093" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA005727: AB_10603220, HPA053093: AB_2682042" "unprognostic (1.65e-2)" "unprognostic (1.65e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.93e-4)" "unprognostic (2.34e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.30e-6)" "unprognostic (4.44e-3)" "unprognostic (1.73e-3)" "prognostic favorable (1.39e-4)" "unprognostic (4.25e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.04e-2)" "unprognostic (1.99e-1)" "unprognostic (1.31e-1)" "unprognostic (3.34e-1)" 1.5 0.9 1.7 8.6 1.2 3.4 1.7 0.6 1.6 1.6 2.7 0.4 1.4 2.4 1.6 1.9 5.3 4.9 2.4 1.2 1.4 1.7 1.3 0.8 1.5 4.7 0.6 0.6 2.1 1.0 0.0 1.9 2.8 1.0 1.0 4.5 0.4 1.3 1.0 0.6 1.4 2.5 2.5 0.7 3.8 1.4 52.9 0.3 16.4 0.5 8.8 6.3 1.1 1.8 2.7 2.3 0.0 0.3 3.3 4.8 0.9 19.5 22.6 14.7 20.8 1.3 3.3 15.4 20.6 10.3 32.8 30.8 21.2 13.5 17.6 14.8 12.1 28.5 14.3 31.1 14.7 41.0 26.3 24.2 12.3 42.5 15.4 0.3 19.9 7.3 1.4 1.0 27.3 11.9 3.4 16.0 14.2 18.0 15.6 22.3 13.3 19.3 16.5 16.1 11.5 19.7 11.6 27.3 32.8 8.7 10.5 14.6 15.0 31.3 11.3 6.0 13.3 21.8 9.3 8.1 17.5 21.7 14.2 22.9 9.2 20.0 19.1 10.3 22.8 19.0 0.0 0.1 0.0 1.0 0.1 0.5 2.7 1.4 1.9 0.3 2.1 0.6 0.2 0.0 3.3 0.3 2.3 4.8 0.9 1.7 1.2 0.6 1.6 1.4 1.7 0.6 0.6 1.0 0.3 0.0 1.4 3.7 3.5 3.1 0.6 0.2 0.0 109.7 4.5 0.0 0.0 3.6 0.0 3.1 114.7 1.4 0.8 0.0 1.6 20.1 1.9 2.1 5.7 0.2 6.2 3.2 4.1 3.1 1.5 165.0 2.0 3.2 0.0 1.8 2.4 0.8 1.8 1.5 2.1 1.0 0.7 6.5 0.3 66.2 77.5 1.3 2.9 4.3 2.8 2.0 TRMT9B "C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L" ENSG00000250305 "TRNA methyltransferase 9B (putative)" Q9P272 8 12945642-13031503 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 64.7;thyroid gland: 26.5" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 26.8;Club cells: 18.2;Collecting duct cells: 14.0;Distal tubular cells: 10.0" "Cancer enhanced" "Detected in some" "thyroid cancer: 3.2" "Group enriched" "Detected in all" 7 "cerebellum: 64.7;pons and medulla: 31.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 7.1;BJ: 10.2;fHDF/TERT166: 13.7;RPTEC TERT1: 4.8;SCLC-21H: 5.2;U-266/84: 4.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 77.4" HPA024673 Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA024673: AB_1845788" "unprognostic (9.85e-3)" "unprognostic (1.20e-1)" "unprognostic (5.54e-4)" "unprognostic (1.06e-2)" "unprognostic (4.08e-2)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (1.44e-1)" "unprognostic (1.93e-1)" "unprognostic (8.89e-2)" "unprognostic (1.96e-2)" "unprognostic (1.88e-1)" "prognostic favorable (2.77e-7)" "unprognostic (2.22e-1)" "unprognostic (4.63e-2)" "unprognostic (4.27e-3)" "unprognostic (3.34e-2)" 2.1 0.9 2.0 1.1 4.1 1.2 3.5 64.7 6.0 2.0 1.8 6.6 0.8 1.4 1.9 2.5 1.3 2.4 2.7 6.0 6.7 2.9 2.7 1.7 1.7 1.0 2.0 2.8 0.6 1.7 2.3 1.2 7.1 31.5 1.2 2.1 5.8 2.3 1.9 4.4 5.1 1.5 0.9 1.9 1.6 1.5 1.8 1.0 0.0 26.5 1.3 0.7 1.3 0.9 1.0 0.6 2.8 0.6 1.9 0.6 0.0 0.1 0.2 7.1 0.0 0.0 0.0 1.7 10.2 2.3 1.4 0.7 0.1 0.3 0.2 0.5 13.7 1.3 0.3 0.1 0.3 1.5 0.1 0.4 0.4 0.4 0.1 0.0 0.2 0.7 0.2 3.6 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.3 0.3 0.1 0.2 0.8 0.1 0.0 1.1 0.1 0.1 4.8 0.2 5.2 0.1 0.1 0.1 0.2 2.4 0.2 0.0 0.0 0.2 0.9 1.0 0.2 0.4 4.9 0.1 0.1 0.2 1.8 2.6 0.6 0.4 0.5 0.4 0.4 0.5 0.4 0.5 0.2 1.0 0.5 0.6 2.8 1.9 0.3 0.6 0.2 0.0 2.0 4.1 64.7 5.0 6.7 2.9 2.0 2.8 31.5 1.0 6.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 26.8 18.2 14.0 0.0 0.9 10.0 0.9 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRNP1 "C1orf225, LOC388610" ENSG00000253368 "TMF1-regulated nuclear protein 1" Q6NT89 1 26993707-27000898 "Predicted intracellular proteins" "Cell cycle, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "stomach 1: 81.1" "Cell type enriched" "Detected in many" 12 "Bipolar cells: 375.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.8;non-classical monocyte: 1.7" "Lineage enriched" "Detected in single" 12 "monocytes: 2.8" "Cell line enhanced" "Detected in many" "ASC TERT1: 46.9;BJ hTERT+: 44.5;EFO-21: 37.6;RPTEC TERT1: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.41e-1)" "unprognostic (7.15e-2)" "unprognostic (7.70e-2)" "unprognostic (1.15e-1)" "unprognostic (2.88e-3)" "unprognostic (6.23e-2)" "prognostic unfavorable (1.90e-6)" "unprognostic (3.53e-1)" "unprognostic (8.39e-3)" "unprognostic (1.64e-1)" "unprognostic (1.90e-1)" "unprognostic (9.71e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.55e-1)" "unprognostic (5.56e-2)" "unprognostic (1.88e-1)" "unprognostic (2.55e-2)" 4.1 4.3 11.3 2.0 11.7 0.9 8.5 12.3 22.0 6.3 5.3 1.8 0.5 3.7 6.8 3.7 32.0 7.9 20.9 11.6 9.7 10.2 9.3 2.6 5.1 2.3 10.1 9.2 3.6 13.2 12.9 5.3 5.8 18.4 5.9 2.6 9.6 6.0 8.1 1.6 4.2 3.7 7.8 2.8 3.0 81.1 2.1 1.7 0.1 2.8 2.4 16.2 9.1 9.3 0.0 0.2 0.0 2.8 0.0 0.0 0.0 6.3 18.7 4.6 2.9 36.2 46.9 0.0 32.7 44.5 3.0 1.4 2.5 3.1 0.0 37.6 30.4 1.2 6.6 2.4 13.2 3.7 0.1 1.9 0.0 0.4 13.0 26.2 0.0 0.0 26.8 28.1 1.5 28.9 2.9 2.9 0.2 0.4 0.0 7.2 0.9 0.0 0.4 6.0 28.7 31.0 1.8 0.0 0.5 37.5 1.9 7.7 0.5 6.3 1.3 14.9 3.0 0.6 0.1 15.3 1.0 7.5 16.0 1.4 0.0 0.1 0.1 1.0 0.1 1.8 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 11.3 11.7 12.3 22.0 9.7 10.2 10.1 9.2 18.4 1.7 17.9 1.1 0.0 10.1 6.5 375.7 21.9 30.6 2.7 3.4 8.7 7.9 0.1 26.6 6.9 0.4 1.0 0.0 0.0 27.2 0.1 1.4 4.0 0.0 0.2 0.2 7.9 11.5 1.8 1.9 0.0 8.9 0.8 3.3 1.8 0.5 27.5 20.3 0.0 2.8 0.0 31.8 25.8 13.3 1.4 0.5 7.8 0.0 0.0 0.2 9.5 TRO "KIAA1114, MAGE-D3, MAGED3" ENSG00000067445 Trophinin Q12816 X 54920462-54931431 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.1" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 4.0;Fibroblasts: 4.4;Horizontal cells: 7.9;Leydig cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 5.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 17.9;SH-SY5Y: 16.1;SuSa: 37.2" "Low region specificity" "Detected in all" HPA071449 Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA071449: " "unprognostic (6.18e-2)" "unprognostic (1.01e-1)" "unprognostic (2.24e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (9.09e-3)" "unprognostic (2.72e-1)" "unprognostic (5.66e-2)" "unprognostic (1.46e-1)" "unprognostic (4.67e-2)" "unprognostic (3.18e-1)" "prognostic favorable (1.93e-4)" "unprognostic (1.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.67e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (6.86e-2)" 4.5 4.2 21.7 2.1 15.5 1.6 3.7 11.3 23.8 8.0 2.5 7.9 1.4 1.7 16.3 8.6 2.4 7.1 5.6 2.9 17.9 15.6 5.3 13.2 2.5 2.3 10.5 13.2 21.7 5.7 7.6 20.2 5.5 22.3 7.4 3.2 5.0 1.5 6.9 32.1 1.5 1.8 10.9 8.9 1.4 2.0 3.6 14.2 4.2 9.2 0.1 2.4 3.6 5.0 0.7 2.6 0.0 0.2 5.2 1.2 0.4 0.0 0.1 17.9 0.0 3.5 4.8 0.0 0.9 6.1 0.9 0.3 0.0 0.0 0.0 2.5 6.4 1.4 0.1 0.1 0.3 0.5 0.0 11.0 8.2 0.0 0.6 1.3 0.0 0.0 11.2 0.0 5.7 0.0 5.7 0.4 4.3 0.0 0.1 6.6 0.0 0.1 0.0 9.1 0.0 0.0 5.2 7.8 0.0 1.7 0.1 12.0 16.1 0.0 0.2 1.5 37.2 0.0 1.0 0.0 7.5 7.8 0.1 1.0 2.8 0.4 0.0 1.1 0.0 6.5 0.0 0.0 0.0 1.2 0.0 0.7 0.7 0.1 0.4 0.0 0.5 0.3 0.7 0.0 5.2 0.2 2.6 0.0 0.4 21.7 15.5 11.3 23.8 17.9 15.6 10.5 13.2 22.3 14.2 0.0 0.0 0.0 1.1 0.3 4.0 1.6 0.0 0.0 3.4 3.5 0.0 0.6 0.0 1.4 0.3 0.7 0.0 0.0 0.2 0.5 4.4 0.4 1.1 0.0 0.4 7.9 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 2.9 0.3 0.0 3.5 0.3 1.0 0.0 0.4 1.0 1.0 0.1 0.6 0.5 0.0 0.3 TROAP TASTIN ENSG00000135451 "Trophinin associated protein" Q12815 12 49323236-49331731 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.3;lymphoid tissue: 45.6;testis: 29.1" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 58.4;Extravillous trophoblasts: 19.1;Late spermatids: 57.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.9" "Lineage enriched" "Detected in many" 5 "T-cells: 10.9" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA044102 Uncertain NA Yes "HPA044102: AB_10963691" "unprognostic (1.47e-1)" "unprognostic (2.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.92e-3)" "unprognostic (1.97e-1)" "unprognostic (4.29e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (3.43e-3)" "unprognostic (2.88e-2)" "unprognostic (2.65e-3)" "unprognostic (1.08e-3)" "unprognostic (3.51e-2)" "unprognostic (0.00e+0)" "unprognostic (1.80e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (5.17e-2)" 0.7 1.3 0.3 17.3 0.4 26.3 2.6 0.4 0.9 2.1 6.5 0.5 0.3 5.1 0.8 2.5 11.2 0.5 3.2 1.9 0.4 0.2 1.2 1.3 2.0 6.2 0.3 0.5 0.8 0.8 0.0 0.5 4.3 0.7 0.9 5.5 0.6 2.2 0.8 0.7 4.3 5.2 1.4 0.4 5.9 4.0 29.1 0.3 45.6 0.7 7.0 10.8 1.1 4.1 2.0 0.4 0.2 0.1 2.3 10.9 0.9 23.9 19.0 24.8 18.1 0.7 1.8 18.6 11.7 11.6 35.2 20.2 42.0 19.0 16.4 5.8 8.9 18.9 19.2 19.3 11.4 20.5 13.2 26.4 22.8 30.1 13.6 0.5 16.6 24.7 0.4 1.6 23.4 16.0 5.8 19.9 18.4 14.1 28.3 14.1 31.0 30.5 25.5 11.4 70.2 28.7 15.7 20.7 21.3 8.4 9.0 15.8 10.8 14.4 27.8 8.7 15.1 22.8 12.6 6.3 8.9 24.5 18.1 31.5 15.3 16.6 20.5 8.5 18.7 9.9 0.2 0.0 0.1 0.2 0.0 0.4 2.0 2.9 3.0 0.4 1.5 0.1 0.7 0.0 2.3 0.1 0.0 10.9 0.9 0.3 0.4 0.4 0.9 0.4 0.2 0.3 0.5 0.7 0.3 0.0 0.0 0.8 1.1 3.4 0.2 0.3 0.0 0.0 2.3 0.0 0.0 6.1 0.0 0.7 58.4 0.2 0.4 0.0 0.6 19.1 1.6 0.5 0.0 0.4 12.7 0.0 1.2 5.5 2.9 57.0 1.7 1.6 1.7 1.0 2.3 0.0 0.8 1.9 0.4 0.0 0.3 0.0 0.0 15.4 7.8 1.8 3.3 2.5 4.7 2.3 TRPA1 ANKTM1 ENSG00000104321 "Transient receptor potential cation channel subfamily A member 1" O75762 8 72019917-72075617 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 20.8;urinary bladder: 20.1;vagina: 12.1" "Group enriched" "Detected in some" 10 "Early spermatids: 6.4;Mucus-secreting cells: 5.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "HHSteC: 24.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (2.14e-2)" "unprognostic (2.50e-2)" "prognostic favorable (6.57e-4)" "unprognostic (1.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.37e-2)" "unprognostic (8.11e-3)" "unprognostic (4.22e-2)" "unprognostic (2.47e-1)" "unprognostic (2.78e-3)" "unprognostic (1.49e-1)" "unprognostic (2.16e-4)" "unprognostic (2.37e-1)" "unprognostic (9.67e-2)" "unprognostic (1.57e-1)" "unprognostic (2.90e-1)" 0.3 0.2 0.2 9.1 0.2 0.0 0.2 0.2 0.4 0.4 16.8 0.3 0.0 4.8 0.2 0.3 2.2 0.2 5.7 0.3 0.2 0.2 0.2 0.2 0.3 0.8 0.3 0.0 0.4 0.2 0.0 0.2 0.3 0.1 4.7 7.5 0.0 0.2 0.0 0.2 0.2 20.8 3.8 0.2 0.4 7.9 0.4 0.0 0.6 0.2 0.3 1.4 20.1 12.1 0.5 0.6 0.1 1.1 0.3 2.6 0.2 0.0 2.5 0.7 0.0 0.0 0.1 0.0 0.3 2.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.8 0.4 1.4 0.1 0.0 0.5 0.0 24.5 0.0 0.2 1.6 0.0 1.1 0.2 5.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 2.4 0.2 0.0 0.3 0.0 0.1 3.8 1.1 0.0 0.3 0.3 0.0 1.8 0.0 1.7 0.0 0.0 0.0 0.3 0.0 1.1 0.5 0.5 2.6 0.0 0.5 0.0 0.4 0.1 0.3 1.1 0.6 1.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 TRPC3 ENSG00000138741 "Transient receptor potential cation channel subfamily C member 3" Q13507 4 121879027-121951754 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "HEK 293: 3.7;HEL: 5.6;Karpas-707: 5.9;U-2 OS: 3.7;U-251 MG: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (2.39e-1)" "unprognostic (3.12e-2)" "unprognostic (5.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.12e-3)" "unprognostic (9.80e-2)" "unprognostic (4.80e-3)" "unprognostic (2.38e-1)" "unprognostic (3.26e-1)" "unprognostic (1.06e-1)" "unprognostic (4.33e-3)" "unprognostic (2.67e-3)" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (8.42e-3)" 1.4 0.4 1.8 0.7 9.3 0.3 0.5 5.8 7.4 3.3 0.8 1.7 0.8 0.8 1.6 1.2 0.6 1.1 7.3 0.5 1.8 2.3 0.7 0.5 2.9 0.5 2.3 1.9 0.8 0.2 0.6 12.0 4.2 7.3 1.1 0.8 0.3 0.8 2.5 0.6 0.5 1.2 9.4 1.1 1.0 0.9 1.6 3.6 0.0 0.6 0.0 0.4 3.6 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.3 1.0 1.5 0.6 0.0 0.0 0.0 0.0 1.0 0.7 0.0 0.9 0.0 0.1 0.0 3.7 5.6 0.1 0.0 0.2 1.5 0.5 0.6 0.0 0.1 0.0 2.5 0.0 0.2 0.0 5.9 1.3 0.0 1.6 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 3.7 0.0 3.3 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 9.3 5.8 7.4 1.8 2.3 2.3 1.9 7.3 3.6 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 28.1 0.0 0.6 0.1 0.7 0.0 0.0 0.0 0.0 0.0 TRPC4 "HTRP4, TRP4" ENSG00000133107 "Transient receptor potential cation channel subfamily C member 4" Q9UBN4 13 37636636-37870425 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.0;smooth muscle: 17.2" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.4;Smooth muscle cells: 1.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.2;BJ: 16.7;BJ hTERT+ SV40 Large T+: 7.2;fHDF/TERT166: 15.9;U-2197: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (4.52e-4)" "unprognostic (9.99e-2)" "unprognostic (5.42e-2)" "unprognostic (2.38e-1)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (3.28e-1)" "unprognostic (1.60e-1)" "unprognostic (5.10e-2)" "unprognostic (1.99e-1)" "unprognostic (1.47e-2)" "unprognostic (3.95e-2)" "unprognostic (1.07e-6)" "unprognostic (3.73e-3)" "unprognostic (1.93e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-2)" 1.3 0.8 4.6 1.2 4.0 0.2 0.6 2.1 4.0 5.5 4.1 0.6 6.9 0.8 31.0 2.1 0.4 1.9 4.5 1.9 4.8 2.1 3.0 0.5 4.2 0.3 2.5 0.4 3.8 1.8 0.7 0.5 4.6 3.9 9.5 1.1 0.1 0.5 12.6 0.4 0.5 1.6 17.2 2.5 0.5 3.6 0.8 2.5 0.0 1.1 0.0 0.3 3.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 1.1 2.4 0.0 16.7 2.3 7.2 3.8 0.0 0.2 0.0 0.0 15.9 2.4 0.0 0.1 0.0 3.6 0.0 0.1 0.0 0.3 0.0 2.8 0.0 0.0 1.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 7.6 1.5 4.0 1.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 4.0 2.1 4.0 4.8 2.1 2.5 0.4 3.9 2.5 0.0 0.0 0.0 0.4 0.0 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TRPC5 PPP1R159 ENSG00000072315 "Transient receptor potential cation channel subfamily C member 5" Q9UL62 X 111774315-112082776 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 5.3;liver: 3.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "testis cancer: 0.8;thyroid cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "NTERA-2: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (7.32e-2)" "unprognostic (2.60e-3)" "unprognostic (3.68e-2)" "unprognostic (5.69e-2)" "unprognostic (5.09e-2)" "unprognostic (2.78e-2)" 0.0 0.2 0.6 0.0 0.3 0.0 0.0 0.6 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.3 0.4 3.2 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPC5OS TRPC5-AS1 ENSG00000204025 "TRPC5 opposite strand" A6NMA1 X 111876051-111903990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 58 "testis: 34.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;REH: 1.1;THP-1: 4.6;U-937: 4.6" "Not detected" "Not detected" NA NA "unprognostic (1.77e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (2.99e-1)" "unprognostic (1.47e-2)" "unprognostic (9.90e-2)" "unprognostic (1.72e-1)" "unprognostic (1.40e-6)" "unprognostic (6.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.85e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.8 0.0 0.5 0.0 0.4 1.1 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 4.6 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 TRPC6 "FSGS2, TRP6" ENSG00000137672 "Transient receptor potential cation channel subfamily C member 6" Q9Y210 11 101451564-101872562 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.3;placenta: 20.6" "Cell type enhanced" "Detected in some" 16 "Club cells: 19.4;Leydig cells: 5.8;Smooth muscle cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 4.7;ASC diff: 8.8;BJ hTERT+: 4.7;HEL: 4.4;RPTEC TERT1: 21.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6" HPA045098 Approved NA NA 140000 "HPA045098: AB_10959600" "unprognostic (1.45e-1)" "unprognostic (4.21e-1)" "unprognostic (2.43e-1)" "unprognostic (8.71e-5)" "unprognostic (1.86e-1)" "unprognostic (1.36e-2)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (5.47e-4)" "unprognostic (1.99e-3)" "unprognostic (4.88e-2)" "unprognostic (7.16e-2)" "unprognostic (1.32e-2)" 6.0 0.5 1.5 0.6 2.4 0.1 9.7 0.8 2.0 7.6 3.9 1.1 7.5 1.1 6.6 7.0 10.8 5.3 3.2 1.1 2.0 1.5 1.6 0.4 35.3 0.9 2.2 3.4 2.2 1.0 1.0 0.6 20.6 2.9 2.3 1.6 0.3 3.3 7.2 0.8 3.0 1.9 3.9 0.7 2.0 1.5 1.0 0.1 0.1 9.6 2.7 1.1 1.6 3.8 0.0 1.0 5.5 0.5 0.0 0.0 0.3 0.0 4.7 0.2 0.0 8.8 2.2 0.0 3.0 4.7 0.7 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.3 1.5 2.4 0.8 2.0 2.0 1.5 2.2 3.4 2.9 0.1 0.0 1.6 0.0 1.7 2.1 0.8 0.4 0.0 1.4 19.4 3.5 0.0 0.9 0.0 0.0 0.6 0.8 0.0 0.0 0.2 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.8 2.6 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 9.8 0.0 0.0 3.0 0.3 0.0 0.0 1.0 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 705.2" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 113 "SK-MEL-30: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 3.8 705.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 30.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 2.4 0.0 0.0 150.1 0.0 0.0 10.0 0.0 0.0 0.0 0.6 18.1 0.0 0.0 7.9 3.8 0.9 0.8 0.0 0.0 0.0 TRPM2 "EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7" ENSG00000142185 "Transient receptor potential cation channel subfamily M member 2" O94759 21 44350163-44443081 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Sodium transport, Transport" "Calcium channel, Ion channel, Sodium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.9" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 7.0;Hofbauer cells: 15.8;Kupffer cells: 12.5;Macrophages: 9.0;Sertoli cells: 6.5;T-cells: 4.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.3;plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 8 "dendritic cells: 14.5;monocytes: 7.3" "Cell line enhanced" "Detected in some" "HL-60: 16.8;NB-4: 23.8;OE19: 16.9;THP-1: 29.4;U-937: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035260 Enhanced NA NA "HPA035260: AB_2674540" "unprognostic (3.61e-2)" "unprognostic (2.18e-1)" "unprognostic (7.55e-2)" "prognostic favorable (9.28e-4)" "unprognostic (6.49e-2)" "unprognostic (4.54e-2)" "unprognostic (5.17e-2)" "unprognostic (2.23e-1)" "unprognostic (8.13e-2)" "unprognostic (2.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.40e-1)" "unprognostic (3.31e-2)" "unprognostic (8.88e-3)" "prognostic favorable (7.59e-4)" 5.4 4.5 7.4 8.6 7.8 29.9 3.9 14.5 16.3 2.9 4.5 6.9 0.0 4.4 1.9 1.5 2.1 2.6 5.7 1.8 7.8 8.9 2.1 2.0 3.8 8.2 8.5 10.4 1.5 2.4 2.1 2.1 7.1 11.7 1.9 3.0 2.6 2.9 1.3 1.3 2.3 5.1 3.2 9.7 8.1 3.1 1.9 7.3 2.0 1.7 0.0 4.8 4.9 1.7 1.4 14.5 0.4 7.3 0.5 1.1 1.8 8.3 3.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.2 0.1 0.0 0.0 0.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 16.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.6 23.8 0.0 16.9 9.9 0.9 3.0 3.2 0.0 0.0 6.1 0.0 0.0 9.9 0.0 0.0 11.6 29.4 0.0 0.5 8.9 0.0 0.3 0.1 12.5 0.0 0.0 27.7 0.0 0.0 7.3 0.0 1.0 2.6 0.6 0.3 0.3 0.4 2.5 1.4 0.3 0.4 0.4 0.5 2.0 14.5 1.1 1.8 7.4 7.8 14.5 16.3 7.8 8.9 8.5 10.4 11.7 7.3 0.0 0.3 0.0 0.0 0.3 0.5 1.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.0 1.0 0.0 0.0 0.2 7.0 0.2 0.0 1.1 0.0 15.8 0.0 0.0 0.6 12.5 1.2 0.6 9.0 0.0 1.0 0.1 0.5 0.8 0.0 0.0 0.1 0.4 6.5 0.0 0.5 0.0 0.3 1.1 4.8 0.0 0.0 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 278.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Cell line enriched" "Detected in some" 4 "HAP1: 19.4" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles NA NA Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.1 0.1 1.3 3.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.4 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.2 0.0 0.0 1.2 4.5 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 1.0 0.0 1.3 0.0 0.2 0.0 0.4 0.2 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 3.0 4.0 0.0 0.9 0.3 9.5 4.8 2.5 1.4 4.5 15.7 62.8 0.0 5.0 0.0 3.9 1.3 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.0 0.2 1.6 14.8 0.6 0.0 1.7 5.2 1.1 0.0 0.0 0.0 278.6 0.1 0.0 8.5 25.8 4.7 0.0 1.0 1.5 0.4 0.6 0.2 0.8 0.0 0.3 TRPM5 "LTRPC5, MTR1" ENSG00000070985 "Transient receptor potential cation channel subfamily M member 5" Q9NZQ8 11 2404515-2423045 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0" "Cell type enhanced" "Detected in single" 14 "Undifferentiated cells: 1.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 2.6;OE19: 3.6;RPMI-8226: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (6.47e-5)" "unprognostic (6.81e-4)" "unprognostic (7.90e-3)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (2.24e-2)" "unprognostic (4.75e-1)" "unprognostic (1.53e-1)" "unprognostic (2.36e-1)" "unprognostic (3.19e-1)" "unprognostic (5.07e-3)" "unprognostic (2.40e-1)" "unprognostic (5.21e-1)" "unprognostic (5.72e-2)" "unprognostic (4.91e-2)" 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.1 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.5 0.0 0.2 0.5 0.0 4.0 0.0 0.0 6.3 0.0 0.0 0.0 0.5 0.9 3.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 3.6 0.1 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 TRPM6 "CHAK2, FLJ22628, HOMG, HSH" ENSG00000119121 "Transient receptor potential cation channel subfamily M member 6" Q9BX84 9 74722495-74888094 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.1;intestine: 19.5" "Group enriched" "Detected in many" 4 "Enterocytes: 28.8;Paneth cells: 10.5" "Cancer enhanced" "Detected in some" "testis cancer: 1.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 16.1;neutrophil: 6.6" "Lineage enriched" "Detected in single" 30 "granulocytes: 16.1" "Cell line enhanced" "Detected in some" "BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "unprognostic (3.95e-2)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "unprognostic (7.80e-2)" "unprognostic (9.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.82e-1)" "unprognostic (1.84e-1)" "unprognostic (5.72e-4)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (8.10e-2)" "unprognostic (7.54e-2)" "unprognostic (1.89e-2)" "unprognostic (2.11e-2)" 2.9 0.0 1.3 0.5 1.2 2.5 1.1 1.3 1.2 0.8 13.3 0.2 1.0 7.2 0.4 0.2 0.6 0.4 1.0 0.5 1.9 1.2 3.1 0.2 1.5 0.2 2.6 0.0 0.4 0.2 3.8 4.9 0.2 1.6 1.7 17.5 0.4 1.1 0.0 1.6 0.8 19.5 0.7 5.0 3.9 0.2 1.7 0.5 1.6 0.3 1.1 2.1 0.5 0.6 0.3 0.3 16.1 0.1 0.5 0.1 0.0 0.1 1.7 0.2 0.2 0.0 0.0 7.7 0.1 0.0 0.0 0.1 2.1 0.2 0.6 0.0 0.1 0.3 0.3 0.5 0.5 0.0 0.1 0.2 0.2 4.5 0.3 0.1 0.1 0.2 0.3 0.2 0.0 0.0 0.1 0.2 0.3 0.0 2.6 0.1 0.9 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.3 0.0 7.4 0.3 0.0 0.0 0.1 0.1 0.4 0.3 0.0 0.0 0.2 1.1 0.2 0.0 2.8 0.0 0.2 0.1 0.1 0.3 16.1 0.1 1.9 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 6.6 0.5 0.1 0.3 0.0 0.0 1.3 1.2 1.3 1.2 1.9 1.2 2.6 0.0 1.6 0.5 0.0 1.7 0.0 1.7 0.1 0.2 0.6 0.0 1.4 2.3 3.5 0.0 0.2 0.0 0.0 2.5 0.7 28.8 0.0 0.0 0.1 0.3 1.1 0.0 0.0 0.0 0.0 3.5 4.9 0.3 0.4 0.0 0.2 0.0 0.0 3.3 0.1 0.0 10.5 0.4 0.0 2.3 0.0 0.3 1.5 2.3 0.9 0.1 0.0 2.6 0.9 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686815 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 91.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 50.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: AB_2681749" "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 13.3 10.8 6.6 14.7 9.0 12.8 12.1 19.5 9.3 11.8 11.7 8.1 9.7 9.9 16.5 10.7 9.4 11.0 8.2 19.1 5.5 4.9 16.0 20.0 10.8 10.6 12.4 5.2 16.6 11.6 91.8 14.6 14.3 10.2 9.7 10.3 28.6 11.5 13.5 10.8 11.7 12.8 12.8 9.8 11.1 10.3 6.9 10.0 14.5 12.6 6.9 12.6 12.9 12.3 7.0 4.7 4.4 3.4 5.7 7.6 2.0 8.5 8.5 7.1 7.9 20.6 15.5 8.7 10.8 15.0 6.9 9.1 11.7 4.7 18.6 5.3 12.4 17.8 14.4 9.5 7.9 9.9 10.3 5.7 14.8 13.1 6.1 18.8 15.3 11.5 14.4 9.4 7.8 14.7 10.1 5.5 11.8 16.7 14.3 12.5 13.4 9.8 7.5 5.4 11.8 5.3 10.8 9.9 9.1 9.6 20.2 5.9 7.5 7.4 11.9 14.5 13.1 7.4 16.7 8.4 11.0 5.2 50.9 12.4 9.7 21.5 17.9 11.9 31.3 10.2 3.8 3.4 3.9 6.6 3.2 7.6 5.6 4.8 4.4 3.7 7.0 4.4 5.2 4.4 5.7 3.2 4.7 4.8 2.0 6.6 9.0 19.5 9.3 5.5 4.9 12.4 5.2 10.2 10.0 17.9 25.3 18.2 14.9 28.0 22.9 21.4 28.1 24.1 7.9 12.2 11.8 18.5 3.3 9.7 25.2 18.5 16.9 23.3 11.1 8.0 17.0 21.2 16.3 35.0 12.7 20.6 17.7 15.4 18.6 17.9 24.5 17.0 18.6 14.4 17.3 9.1 12.8 12.9 19.1 9.6 21.5 12.9 13.7 13.6 19.4 21.1 13.6 17.5 16.3 9.0 TRPM8 ENSG00000144481 "Transient receptor potential cation channel subfamily M member 8" Q7Z2W7 2 233917398-234019522 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "liver: 16.7;prostate: 44.1" "Group enriched" "Detected in some" 7 "Glandular cells: 24.4;Hepatocytes: 42.4" "Cancer enriched" "Detected in some" 27 "prostate cancer: 72.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 3.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 4.4;Karpas-707: 7.1;RPTEC TERT1: 10.7;SK-MEL-30: 10.7;WM-115: 6.5" "Region enhanced" "Detected in single" "cerebellum: 0.8" "Low region specificity" "Detected in many" NA NA "unprognostic (4.41e-3)" "unprognostic (7.91e-2)" "unprognostic (1.11e-1)" "unprognostic (5.49e-3)" "unprognostic (1.05e-1)" "unprognostic (4.60e-3)" "prognostic favorable (7.15e-4)" "unprognostic (3.28e-2)" "unprognostic (3.71e-1)" "unprognostic (9.88e-3)" "unprognostic (7.10e-3)" "unprognostic (4.69e-2)" "unprognostic (3.36e-5)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (1.18e-1)" "unprognostic (5.53e-2)" 3.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 44.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.9 0.2 3.0 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 7.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.6 0.7 10.7 0.0 0.7 0.4 0.0 0.1 10.7 0.0 0.4 0.7 0.0 0.0 0.1 0.3 0.1 1.6 2.5 0.0 0.9 0.0 6.5 0.5 0.2 0.1 0.3 0.1 0.2 0.2 0.3 0.2 0.0 0.4 0.3 0.3 0.9 3.0 0.1 0.2 0.1 0.0 0.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.7 0.9 0.0 0.0 0.0 5.0 0.3 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 1.6 0.0 0.0 24.4 0.0 42.4 0.2 0.0 0.0 1.3 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 1.1 0.4 0.1 0.0 0.0 0.0 2.5 TRPS1 "GC79, LGCR" ENSG00000104447 "Transcriptional repressor GATA binding 1" Q9UHF7 8 115408496-115809673 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 65.9" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 77.5;Late spermatids: 117.5" "Cancer enriched" "Detected in many" 8 "breast cancer: 49.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 8.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 13.7;SK-BR-3: 23.4;T-47d: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060380, HPA071767" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA060380: AB_2684270, HPA071767: AB_2732185" "unprognostic (4.34e-2)" "unprognostic (4.65e-2)" "unprognostic (1.73e-2)" "unprognostic (2.57e-1)" "unprognostic (1.87e-1)" "prognostic favorable (9.42e-4)" "unprognostic (2.23e-3)" "unprognostic (2.08e-1)" "unprognostic (9.31e-2)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (3.02e-1)" "unprognostic (2.17e-2)" "unprognostic (1.93e-2)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (3.07e-3)" 6.7 4.5 11.4 6.8 12.0 8.2 65.9 7.0 8.9 16.8 7.7 7.5 9.2 2.0 11.7 6.8 16.3 7.2 11.7 5.9 14.0 4.3 9.8 3.3 6.5 5.9 8.7 8.1 6.8 2.4 9.1 9.7 4.0 10.8 11.7 4.1 4.1 16.0 10.6 4.1 13.5 3.6 12.6 20.6 5.2 4.7 13.2 8.6 1.8 7.2 14.8 9.2 9.6 17.6 1.8 3.1 1.6 8.5 1.8 2.1 1.3 0.8 0.1 1.7 0.0 1.6 6.2 0.1 1.4 3.3 0.9 1.6 0.1 1.4 0.7 0.0 3.7 0.8 0.0 6.8 1.2 1.1 0.0 2.0 0.0 2.8 0.0 2.2 0.0 0.0 2.9 1.3 2.6 4.8 2.7 0.8 0.1 0.3 11.3 1.8 13.7 0.0 0.0 0.3 0.3 1.4 0.0 0.0 8.6 1.5 0.0 1.5 1.2 0.7 23.4 0.9 0.9 73.3 0.6 0.0 4.1 2.1 1.2 2.8 3.0 0.0 1.3 4.4 0.0 2.7 0.0 8.5 0.0 1.7 3.5 2.0 1.0 2.1 2.0 3.1 1.8 1.9 1.8 1.6 1.8 2.5 1.1 0.8 1.3 11.4 12.0 7.0 8.9 14.0 4.3 8.7 8.1 10.8 8.6 6.0 4.0 11.5 20.1 8.4 6.6 3.5 5.1 0.0 3.4 17.4 41.2 0.1 10.0 2.3 77.5 4.5 0.0 0.0 2.5 0.1 11.8 17.3 12.7 0.9 14.3 0.0 0.0 3.1 46.8 117.5 23.3 45.2 20.3 2.8 0.0 10.0 1.9 0.0 26.5 20.3 36.6 6.5 24.5 1.7 9.4 10.9 0.2 11.5 0.0 8.9 TRPV1 VR1 ENSG00000196689 "Transient receptor potential cation channel subfamily V member 1" Q8NER1 17 3565444-3609411 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.7" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 25.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (3.96e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-2)" "unprognostic (6.83e-2)" "unprognostic (3.21e-4)" "unprognostic (9.90e-2)" "unprognostic (2.95e-1)" "unprognostic (2.03e-1)" "unprognostic (2.56e-2)" "unprognostic (3.43e-3)" "unprognostic (6.17e-3)" "unprognostic (6.97e-4)" "unprognostic (4.25e-1)" "unprognostic (4.78e-1)" "unprognostic (3.81e-2)" "unprognostic (5.12e-3)" 1.4 1.2 3.5 0.7 2.9 0.3 1.7 2.7 2.1 2.1 1.4 6.5 2.3 1.5 0.8 2.8 1.1 1.9 3.2 3.6 2.5 11.7 0.7 1.3 4.7 5.1 2.5 1.0 2.0 1.2 1.5 1.7 2.1 1.0 2.8 4.7 5.1 0.9 2.3 1.2 2.2 1.2 1.3 0.8 1.2 1.1 1.1 1.4 1.5 0.8 0.5 2.2 0.3 3.0 5.6 4.5 5.0 4.9 4.7 4.1 1.7 2.4 2.6 2.4 1.4 1.7 1.2 2.3 1.8 1.8 13.2 2.8 0.9 1.9 7.3 6.7 0.7 2.9 5.6 2.2 0.4 5.7 5.6 3.0 3.8 1.5 2.5 0.5 2.9 0.3 2.2 1.5 3.8 2.1 1.0 3.0 0.6 2.7 6.2 2.9 0.9 2.2 2.7 1.9 4.2 2.3 4.4 2.2 3.5 8.3 2.3 1.7 1.1 2.7 4.5 2.2 1.9 1.3 0.5 1.9 2.4 2.4 0.9 0.8 1.5 0.7 0.2 0.9 0.4 0.6 0.2 0.1 1.1 0.8 2.2 1.5 0.5 0.3 1.4 0.2 0.3 0.0 1.6 0.0 0.4 0.0 8.6 0.2 2.5 4.0 2.3 5.2 15.7 1.0 0.0 0.4 1.8 0.0 2.6 0.0 0.6 0.3 0.4 0.6 0.0 6.4 0.7 6.4 1.2 2.5 0.6 0.2 4.4 1.2 0.0 0.0 1.5 2.8 0.4 0.0 3.5 1.4 25.1 0.0 0.1 0.7 0.7 0.0 0.7 0.0 2.2 0.3 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane" "Centrosome, Cytosol" "HPA069550: AB_2686149" "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.6 0.0 0.5 0.1 0.3 0.6 5.4 0.2 0.0 0.0 0.0 4.3 1.0 0.2 1.1 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.3 0.5 0.1 13.3 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 5.6 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.8 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 0.0 4.5 1.4 4.0 16.7 0.8 2.4 2.5 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.2 1.6 10.8 0.0 0.0 0.7 4.3 2.9 0.0 0.4 0.2 4.8 0.0 0.0 0.0 0.0 2.8 2.2 6.8 0.0 0.7 2.0 0.8 0.8 3.2 0.8 0.9 0.0 0.9 0.0 1.1 21.5 0.5 2.1 0.6 2.2 TRPV4 "CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC" ENSG00000111199 "Transient receptor potential cation channel subfamily V member 4" Q9HBA0 12 109783085-109833401 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 32.6" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 15.3;Cytotrophoblasts: 16.0;Syncytiotrophoblasts: 17.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 11 "pons and medulla: 15.0" "Cell type enriched" "Detected in single" 7 "classical monocyte: 3.0" "Lineage enriched" "Detected in single" 7 "monocytes: 3.0" "Cell line enhanced" "Detected in many" "BEWO: 9.0;BJ hTERT+: 9.3;EFO-21: 8.2;HaCaT: 14.8;HUVEC TERT2: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA007150 Uncertain NA NA "HPA007150: AB_1080393" "unprognostic (2.98e-2)" "unprognostic (1.12e-2)" "unprognostic (2.33e-2)" "unprognostic (4.20e-3)" "unprognostic (6.25e-3)" "unprognostic (1.09e-2)" "unprognostic (7.95e-2)" "unprognostic (2.03e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "prognostic favorable (4.12e-5)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" 1.3 0.9 0.3 0.9 0.4 0.1 3.3 0.2 0.6 2.3 0.4 3.2 0.0 0.6 0.8 3.7 9.5 5.6 5.2 1.6 1.3 0.2 11.6 7.8 2.6 1.8 0.2 0.0 0.6 7.1 0.1 4.3 11.1 15.0 6.2 0.3 12.6 32.6 1.4 0.2 6.5 0.3 0.9 0.3 3.5 0.9 0.7 0.1 0.2 0.9 2.6 8.7 2.6 1.7 0.0 0.4 0.0 3.0 0.0 0.0 0.4 2.6 0.1 0.0 0.0 1.9 1.9 9.0 4.3 9.3 1.3 0.5 0.0 6.4 0.0 8.2 5.5 0.0 14.8 1.1 0.0 0.3 0.0 2.1 0.0 0.0 3.6 0.7 0.0 0.0 3.3 2.0 3.3 0.0 0.5 8.4 0.0 0.8 0.0 0.4 5.4 0.0 0.0 1.7 0.0 0.3 0.0 0.5 0.0 0.0 5.2 0.0 0.0 0.3 0.6 2.6 4.1 1.2 0.4 5.1 0.0 3.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.2 0.6 1.3 0.2 0.2 0.0 15.0 0.1 0.0 0.0 1.3 8.2 3.0 0.0 1.1 15.3 5.3 6.8 10.4 0.0 16.0 3.3 2.2 0.2 0.5 0.0 0.0 8.4 4.3 0.7 3.7 0.0 6.4 3.6 0.0 0.0 0.6 10.7 0.0 0.9 1.6 6.8 1.0 0.0 0.0 1.5 0.0 0.0 11.1 0.0 0.0 0.8 0.2 1.3 3.3 17.6 0.0 0.0 2.0 TRPV5 "CaT2, ECAC1" ENSG00000127412 "Transient receptor potential cation channel subfamily V member 5" Q9NQA5 7 142908101-142933808 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 26.0" "Cell type enriched" "Detected in single" 8 "Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA063175 Uncertain NA NA "HPA063175: AB_2684954" "unprognostic (7.44e-2)" "unprognostic (3.93e-2)" "unprognostic (1.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.78e-2)" "unprognostic (1.07e-1)" "unprognostic (7.95e-2)" "unprognostic (7.73e-4)" "unprognostic (4.87e-2)" "unprognostic (3.41e-1)" "unprognostic (4.58e-1)" "unprognostic (7.76e-3)" 0.1 0.0 0.8 0.4 0.7 0.5 0.5 0.1 0.8 0.1 0.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 1.1 0.7 26.0 0.1 0.1 0.2 1.6 0.4 0.1 0.3 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.1 0.2 0.1 0.1 0.1 3.5 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.5 1.1 0.7 1.6 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPV6 "CaT1, ECAC2" ENSG00000165125 "Transient receptor potential cation channel subfamily V member 6" Q9H1D0 7 142871203-142885762 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 26.1;placenta: 65.1;salivary gland: 34.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 25.5;Collecting duct cells: 26.2;Ductal cells: 63.7;Early spermatids: 26.4;Late spermatids: 28.8" "Cancer enriched" "Detected in many" 5 "prostate cancer: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.7;HaCaT: 10.5;RT4: 18.7;SK-BR-3: 13.8;T-47d: 30.8" "Low region specificity" "Detected in some" HPA062864 Approved NA NA "HPA062864: AB_2684885" "unprognostic (9.85e-2)" "unprognostic (1.60e-2)" "unprognostic (6.29e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (5.43e-2)" "unprognostic (3.50e-1)" "unprognostic (4.56e-2)" "unprognostic (3.89e-2)" "unprognostic (3.27e-2)" "unprognostic (8.49e-2)" "unprognostic (9.39e-3)" "unprognostic (1.69e-1)" "unprognostic (7.17e-3)" "unprognostic (3.53e-2)" 0.3 0.0 0.3 0.3 0.3 0.0 2.1 0.3 0.3 0.4 1.2 0.3 0.3 4.1 0.3 0.4 1.7 0.1 4.1 0.3 0.3 0.2 2.5 0.6 0.8 0.3 0.8 0.3 0.3 26.1 0.0 0.4 65.1 0.4 12.6 0.0 0.4 34.2 0.7 0.3 3.7 1.0 0.5 2.0 0.3 2.4 0.7 0.3 0.3 0.7 0.6 1.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 1.1 0.0 0.0 13.8 0.3 0.6 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.8 0.3 0.4 0.3 3.0 0.0 0.0 0.9 0.5 0.4 1.6 25.5 1.4 2.3 26.2 0.0 13.3 0.0 63.7 26.4 0.0 0.0 0.0 2.8 0.6 0.4 14.3 0.0 0.0 1.4 3.2 0.0 0.0 0.0 28.8 0.9 0.0 0.0 3.6 0.0 0.8 13.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.6 5.0 0.0 0.0 3.1 TSACC "C1orf182, SIP, SSTK-IP" ENSG00000163467 "TSSK6 activating cochaperone" Q96A04 1 156337314-156346995 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 262.0" "Group enriched" "Detected in many" 10 "Early spermatids: 5429.3;Late spermatids: 13574.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 5 "basophil: 12.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029897 Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA029897: AB_2756315" "unprognostic (3.95e-1)" "unprognostic (5.82e-3)" "unprognostic (8.24e-2)" "unprognostic (9.34e-2)" "unprognostic (1.04e-1)" "unprognostic (8.36e-3)" "unprognostic (1.18e-2)" "unprognostic (5.95e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (3.53e-2)" "unprognostic (4.85e-2)" "unprognostic (2.63e-6)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (3.28e-2)" 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.0 1.6 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 262.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.0 2.1 12.0 0.6 2.3 2.1 0.4 3.3 4.5 2.0 2.2 1.5 2.7 3.7 1.6 0.9 2.2 2.4 4.1 2.4 4.8 2.6 0.9 2.4 3.8 3.8 0.5 2.1 2.8 8.3 3.3 6.6 4.4 1.0 3.0 2.9 1.0 6.4 2.2 2.9 1.2 0.7 4.8 9.0 3.1 0.4 5.7 2.9 1.8 6.2 8.1 5.5 3.4 0.8 4.7 5.7 2.0 3.1 1.7 2.3 6.3 2.5 9.1 3.4 3.2 1.6 1.4 2.3 1.2 2.2 5.7 9.1 7.3 0.9 1.7 1.2 12.0 0.5 0.1 1.5 0.3 0.7 1.7 1.1 1.3 0.3 2.0 2.1 1.8 0.2 2.3 0.6 2.1 1.2 0.4 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.8 0.2 0.2 0.2 0.6 0.0 4.0 2.3 3.5 0.0 4.6 1.7 1.0 5429.3 0.0 0.0 0.0 0.6 1.1 0.3 0.4 0.0 3.0 0.9 0.0 0.0 0.0 0.3 13574.2 103.3 0.0 0.0 0.0 0.4 0.3 1.3 0.0 80.6 3.7 0.9 51.8 0.1 941.5 81.3 0.4 2.3 0.0 0.4 0.6 TSC22D4 "THG-1, TILZ2" ENSG00000166925 "TSC22 domain family member 4" Q9Y3Q8 7 100463359-100479279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 97.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 493.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006757 Uncertain Approved Cytosol NA NA Cytosol "HPA006757: AB_1080403" "unprognostic (2.34e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (2.66e-4)" "unprognostic (5.77e-2)" "unprognostic (1.69e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (9.45e-4)" "unprognostic (9.96e-2)" "unprognostic (1.27e-1)" "unprognostic (1.62e-2)" "unprognostic (2.31e-2)" "unprognostic (3.36e-1)" "unprognostic (1.09e-1)" "unprognostic (1.54e-2)" "unprognostic (3.84e-2)" "unprognostic (7.36e-2)" "unprognostic (3.81e-3)" 11.2 11.9 77.8 16.4 83.5 32.4 7.7 17.8 92.4 9.7 9.9 96.1 3.4 12.4 9.1 6.2 10.3 9.9 8.0 10.2 69.5 53.8 8.9 5.1 10.2 18.7 97.2 40.6 11.7 9.7 8.8 7.1 12.2 60.5 11.5 6.2 11.8 49.2 13.0 7.8 17.2 12.5 8.0 89.8 24.0 11.7 8.0 62.3 6.7 5.8 1.7 12.2 8.6 5.7 6.9 7.5 32.2 11.4 10.2 13.8 8.8 12.3 9.3 3.2 10.6 11.3 13.5 6.0 9.4 15.9 9.1 8.4 4.9 7.6 11.2 11.2 7.6 20.8 9.6 3.8 8.5 3.2 19.2 7.7 10.0 9.8 4.2 18.1 13.2 26.8 15.2 7.7 10.5 10.5 10.8 18.7 9.0 22.1 20.7 7.3 22.5 16.5 60.8 4.3 10.9 13.3 27.3 2.5 15.5 7.5 6.8 2.7 7.5 13.0 25.0 19.6 5.5 7.0 19.6 15.5 12.4 12.6 30.2 6.9 13.0 12.3 7.9 11.4 20.4 14.9 5.0 10.9 15.6 11.7 11.4 9.1 6.9 10.0 10.8 7.2 6.6 9.6 10.0 32.2 10.2 10.8 7.5 13.8 8.8 77.8 83.5 17.8 65.4 69.5 53.8 97.2 40.6 60.5 62.3 11.9 6.2 54.1 32.3 29.1 13.9 11.6 45.9 4.0 4.5 38.4 5.9 27.8 116.0 50.9 1.4 25.1 57.3 0.0 29.7 30.6 33.2 48.6 16.1 9.5 68.0 17.5 32.2 43.6 53.1 3.1 42.3 43.7 52.3 86.6 28.4 493.0 47.4 43.5 37.4 15.9 11.6 45.3 36.0 0.9 3.6 29.5 66.1 90.8 30.2 50.5 TSGA10 "CEP4L, CT79" ENSG00000135951 "Testis specific 10" Q9BZW7 2 98997261-99154964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 55.7" "Group enriched" "Detected in many" 6 "Ciliated cells: 127.2;Early spermatids: 359.6;Late spermatids: 192.4;Spermatocytes: 112.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036879 Approved Cytosol NA NA Cytosol "HPA036879: AB_10671715" "unprognostic (1.71e-3)" "unprognostic (6.68e-2)" "unprognostic (2.97e-1)" "unprognostic (1.12e-1)" "unprognostic (4.95e-2)" "unprognostic (3.69e-2)" "unprognostic (1.04e-2)" "unprognostic (2.52e-2)" "unprognostic (1.98e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-5)" "unprognostic (2.32e-1)" "unprognostic (2.82e-6)" "unprognostic (1.06e-2)" "unprognostic (9.91e-3)" "unprognostic (9.79e-2)" "unprognostic (8.37e-4)" 2.2 2.2 4.9 1.7 7.1 1.7 2.6 9.5 6.4 2.5 2.0 6.1 2.7 2.1 2.3 3.6 1.7 15.1 2.2 1.3 4.7 3.4 3.3 1.6 2.9 2.1 5.9 4.5 1.7 3.2 2.9 12.2 1.5 4.7 2.2 2.5 1.0 2.3 1.8 1.1 3.1 1.7 1.3 4.2 1.9 2.5 55.7 6.6 1.8 4.5 0.7 1.9 2.3 2.3 2.5 1.2 0.6 0.7 2.3 3.5 0.9 1.4 0.5 2.5 0.9 1.5 1.5 1.9 0.0 0.1 0.4 0.5 0.3 1.8 1.4 0.6 0.0 1.0 0.4 0.5 0.2 0.7 1.7 1.5 0.1 0.0 0.5 0.2 1.0 3.6 1.8 2.1 0.2 0.3 1.5 0.0 1.6 0.0 0.1 1.6 0.3 0.5 0.5 0.4 0.6 0.4 0.6 0.3 0.4 9.0 1.4 3.5 0.4 1.7 1.5 0.2 3.0 0.4 0.5 0.8 0.4 0.9 0.1 0.3 1.2 0.3 0.3 0.8 2.2 0.9 0.3 0.7 0.6 1.9 0.1 2.1 2.1 2.2 2.6 0.1 2.5 3.5 2.1 0.0 2.3 0.0 1.2 2.2 0.9 4.9 7.1 9.5 6.4 4.7 3.4 5.9 4.5 4.7 6.6 3.0 8.6 9.1 8.8 3.2 17.9 6.2 15.3 127.2 18.2 22.7 27.5 5.7 21.6 6.4 359.6 3.4 5.1 0.0 9.3 3.7 3.6 8.1 4.7 6.6 3.9 19.1 14.9 2.5 2.4 192.4 10.3 2.9 1.7 4.6 7.3 15.4 5.1 11.4 9.2 11.0 34.3 6.5 2.7 112.7 30.1 3.9 7.8 5.9 8.3 8.4 TSGA10IP "FAM161C, FLJ32880" ENSG00000175513 "Testis specific 10 interacting protein" Q3SY00 11 65945445-65959963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "blood: 2.2;testis: 8.5" "Group enriched" "Detected in some" 5 "Early spermatids: 42.4;Late spermatids: 50.8" "Group enriched" "Detected in some" 7 "testis cancer: 1.5;thyroid cancer: 1.0" "Cell type enhanced" "Detected in some" "eosinophil: 1.4;myeloid DC: 2.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 16 "AF22: 2.4;NTERA-2: 6.9" "Not detected" "Not detected" NA NA "unprognostic (1.69e-1)" "unprognostic (8.39e-3)" "unprognostic (3.84e-1)" "unprognostic (6.76e-2)" "unprognostic (2.31e-1)" "unprognostic (3.57e-4)" "unprognostic (8.66e-2)" "unprognostic (8.53e-3)" "unprognostic (1.69e-1)" "unprognostic (1.11e-1)" "unprognostic (5.47e-2)" "unprognostic (5.61e-1)" "unprognostic (1.62e-4)" "unprognostic (8.96e-2)" "unprognostic (2.31e-1)" "unprognostic (7.35e-2)" "unprognostic (6.66e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.3 0.0 0.0 0.0 2.2 1.4 0.7 0.0 0.0 0.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 1.4 0.0 0.5 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 50.8 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.5 0.0 0.0 0.0 0.0 0.0 TSGA13 ENSG00000213265 "Testis specific 13" Q96PP4 7 130668648-130687432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "testis: 16.5" "Group enriched" "Detected in some" 9 "Early spermatids: 62.7;Late spermatids: 126.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 1.0;THP-1: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA022968 Uncertain Approved "Vesicles,Plasma membrane,Cytosol" NA NA Vesicles "Plasma membrane, Cytosol" "HPA022968: AB_2671013" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "unprognostic (1.86e-1)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.2 0.6 0.8 0.5 0.3 0.1 0.5 0.0 0.0 0.9 0.7 0.2 0.4 0.0 0.2 1.0 0.0 0.6 0.2 0.1 0.0 0.1 0.1 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 0.9 0.1 0.3 0.4 0.1 0.2 1.1 0.6 0.2 0.5 0.2 0.3 0.2 0.2 0.1 0.2 0.6 0.5 0.4 1.2 0.8 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 4.6 0.5 0.1 1.4 1.4 0.0 0.0 10.7 3.4 0.0 7.9 0.1 0.0 0.0 62.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 126.7 0.6 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.1 0.0 0.1 1.2 0.6 0.4 0.6 0.0 0.0 0.0 TSHB ENSG00000134200 "Thyroid stimulating hormone beta" P01222 1 115029824-115034309 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 77 "pituitary gland: 192.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "NK-cell: 2.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.0" "Cell line enhanced" "Detected in some" "JURKAT: 1.2;SH-SY5Y: 1.0;U-937: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB022202, HPA042681" Enhanced "Secreted to blood" NA NA "CAB022202: , HPA042681: AB_2732500" "unprognostic (2.14e-4)" "unprognostic (1.37e-1)" "unprognostic (1.73e-1)" 0.1 0.0 0.1 0.9 0.1 2.4 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 1.4 0.1 1.4 0.0 1.8 0.1 0.1 0.0 0.3 0.1 1.4 0.1 0.1 0.1 0.1 1.6 0.0 192.4 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.6 0.1 0.1 0.1 0.4 1.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.2 0.1 2.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TSHR LGR3 ENSG00000165409 "Thyroid stimulating hormone receptor" P16473 14 80954989-81146302 "Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "thyroid gland: 158.0" "Cell type enhanced" "Detected in some" 15 "Club cells: 2.3;Intestinal endocrine cells: 1.7" "Cancer enriched" "Detected in some" 116 "thyroid cancer: 100.4" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 9.9" "Lineage enriched" "Detected in many" 5 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "JURKAT: 34.0;MOLT-4: 13.3;SCLC-21H: 13.7;U-266/70: 6.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" CAB000473 Approved "Intracellular and membrane" NA NA "CAB000473: AB_2303782" "unprognostic (3.36e-3)" "unprognostic (1.31e-3)" "unprognostic (1.02e-2)" "unprognostic (4.17e-6)" "unprognostic (3.01e-3)" "unprognostic (1.85e-3)" "unprognostic (1.83e-1)" "unprognostic (2.66e-2)" "unprognostic (3.39e-2)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" "unprognostic (7.11e-3)" "unprognostic (5.08e-7)" "unprognostic (1.32e-1)" "unprognostic (7.40e-2)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" 0.1 0.2 0.1 0.2 0.4 0.3 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.3 0.3 0.5 0.1 0.0 0.8 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.2 0.1 0.1 0.1 27.3 158.0 0.2 0.4 0.1 0.1 1.8 0.8 1.3 0.3 0.1 9.9 0.1 0.2 0.1 0.4 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.2 0.3 0.4 0.1 0.1 0.2 0.1 0.5 0.0 0.1 0.2 0.1 0.2 0.4 0.2 0.0 0.1 0.2 0.2 0.0 0.1 0.2 0.1 0.0 34.0 0.2 0.4 0.1 0.3 13.3 0.3 0.3 0.1 0.1 0.5 0.1 0.5 0.0 0.3 13.7 0.2 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.4 0.3 0.3 0.2 6.7 3.5 0.3 0.2 0.1 0.2 0.6 0.2 0.2 0.2 0.1 0.2 1.0 0.8 0.5 0.1 1.8 0.3 0.2 1.3 0.1 0.3 0.8 9.9 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TSKS "PPP1R161, TSSKS" ENSG00000126467 "Testis specific serine kinase substrate" Q9UJT2 19 49739753-49763330 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 54.3" "Group enriched" "Detected in some" 54 "Early spermatids: 789.1;Late spermatids: 761.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "classical monocyte: 1.4;intermediate monocyte: 1.3;memory CD4 T-cell: 2.5;myeloid DC: 2.5;naive CD4 T-cell: 1.2;non-classical monocyte: 3.0;plasmacytoid DC: 2.1;T-reg: 1.8" "Group enriched" "Detected in many" 27 "dendritic cells: 2.5;monocytes: 3.0;T-cells: 2.5" "Cell line enriched" "Detected in some" 5 "NB-4: 15.8" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 6 "basal ganglia: 4.9" HPA045729 Enhanced NA NA "HPA045729: AB_10963430" "unprognostic (3.56e-1)" "unprognostic (3.75e-3)" "unprognostic (8.33e-2)" "unprognostic (1.67e-1)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (1.93e-1)" "unprognostic (3.55e-1)" "unprognostic (1.54e-1)" "unprognostic (3.04e-2)" "unprognostic (2.44e-1)" "unprognostic (1.51e-8)" "unprognostic (7.89e-3)" "unprognostic (1.37e-1)" "unprognostic (2.79e-2)" "unprognostic (3.52e-2)" 0.5 0.0 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.7 0.1 0.2 0.2 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.0 54.3 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.0 2.5 0.0 3.0 0.0 2.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.1 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 15.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.0 0.0 2.5 0.0 2.5 0.0 1.2 0.2 0.0 0.0 3.0 2.1 1.8 0.6 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.4 0.3 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 789.1 0.0 0.0 0.0 0.0 7.0 1.3 0.0 0.0 0.0 2.1 0.0 0.0 0.6 0.6 761.8 8.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 7.1 0.0 0.0 12.9 0.2 14.4 7.0 1.3 5.6 0.0 0.0 0.1 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798154 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.8" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 427.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 41.4;ASC diff: 70.9;OE19: 44.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted - unknown location" NA NA 2100000 Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (2.87e-4)" "prognostic favorable (1.66e-4)" "prognostic unfavorable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 33.1 2.8 1.0 3.6 1.4 0.6 26.9 1.5 2.0 38.8 16.1 1.8 6.4 11.5 13.2 25.5 17.8 15.3 8.6 9.3 1.2 0.3 31.8 86.8 5.1 3.7 1.7 1.3 27.8 12.2 2.6 4.3 43.0 3.4 15.7 4.5 48.5 9.3 10.8 7.0 15.0 21.4 13.0 0.8 3.0 8.7 9.0 0.8 1.5 12.2 16.0 12.4 18.2 27.9 1.8 0.7 2.1 0.4 0.7 1.3 0.2 0.8 41.4 4.6 4.5 70.9 9.1 8.5 1.4 7.8 3.1 3.0 5.3 11.4 0.1 8.1 5.1 13.2 16.6 2.6 10.2 0.9 8.5 1.4 2.0 10.7 14.8 13.4 0.7 3.1 9.3 11.2 5.5 4.5 5.9 3.8 1.5 4.5 0.3 2.8 19.1 0.1 1.5 6.1 44.7 1.8 1.3 4.4 6.5 7.3 7.2 4.2 6.9 7.9 6.2 3.8 4.1 8.3 0.6 1.1 8.7 6.9 21.1 3.3 0.3 0.1 0.3 4.1 2.1 1.5 1.8 0.4 0.5 0.9 0.2 0.4 1.8 0.8 0.7 0.4 1.8 0.9 1.3 2.1 0.7 0.4 0.7 0.8 0.2 1.0 1.4 1.5 2.0 1.2 0.3 1.7 1.3 3.4 0.8 0.0 0.3 0.0 13.0 15.3 3.2 3.9 15.3 2.7 5.7 1.8 0.0 42.8 0.0 5.8 0.2 3.6 20.6 23.3 19.6 58.8 39.7 6.5 1.1 427.8 8.4 0.0 7.5 8.6 9.5 1.2 34.5 1.6 5.0 2.8 14.2 10.4 17.7 20.1 42.5 21.9 0.5 0.0 13.4 0.4 2.3 19.7 36.6 4.4 11.3 17.0 TSNAXIP1 TXI1 ENSG00000102904 "Translin associated factor X interacting protein 1" Q2TAA8 16 67806765-67832148 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.2;testis: 40.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 46.8;Early spermatids: 85.4;Late spermatids: 137.1;Spermatocytes: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 7.1;SiHa: 4.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA053516 Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA053516: AB_2682175" "unprognostic (9.78e-3)" "unprognostic (2.05e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.22e-4)" "unprognostic (1.92e-1)" "unprognostic (2.82e-3)" "unprognostic (2.73e-1)" "unprognostic (7.09e-2)" "unprognostic (2.93e-1)" "unprognostic (6.66e-2)" "unprognostic (1.81e-3)" "unprognostic (1.94e-1)" "unprognostic (4.74e-3)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (9.49e-3)" "unprognostic (1.59e-3)" 0.9 1.9 4.8 1.1 9.2 0.6 0.9 2.0 3.9 1.3 0.9 3.3 1.9 0.5 1.8 3.6 0.7 14.2 1.2 0.7 3.8 3.3 1.6 0.8 2.1 0.7 1.2 3.7 2.5 2.2 2.9 6.9 0.7 6.3 1.0 0.7 1.0 1.0 2.0 0.5 0.8 0.6 1.2 0.9 0.8 1.2 40.6 2.5 0.0 1.1 0.0 0.7 0.9 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.4 1.1 0.4 2.5 7.1 3.5 0.9 0.9 0.0 1.6 0.5 2.4 0.7 0.8 1.1 1.1 0.2 0.8 1.4 1.0 1.1 1.5 0.4 0.9 0.0 0.8 0.1 1.1 1.7 0.2 0.9 0.9 3.6 0.5 0.5 0.0 1.4 0.5 0.3 0.0 0.0 0.3 0.6 0.7 0.2 0.4 1.7 0.7 0.1 3.6 0.7 2.0 2.1 4.5 0.1 0.4 0.9 1.8 0.1 0.9 0.4 0.1 0.3 0.2 1.3 2.1 0.2 0.3 0.2 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 4.8 9.2 2.0 3.9 3.8 3.3 1.2 3.7 6.3 2.5 0.0 2.4 0.0 0.4 0.1 3.1 8.1 0.0 46.8 5.7 5.2 3.9 0.4 0.0 0.6 85.4 0.6 0.0 0.0 0.0 0.2 0.5 0.3 0.0 0.8 0.2 3.2 0.0 0.6 0.0 137.1 2.6 0.5 0.0 0.0 0.0 3.5 0.1 0.0 1.8 2.1 10.0 6.5 0.3 56.4 11.2 0.3 0.5 0.0 0.0 0.1 TSPAN1 "NET-1, TSPAN-1" ENSG00000117472 "Tetraspanin 1" O60635 1 46175073-46185958 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.0;testis: 119.0" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 1113.5;Collecting duct cells: 549.6;Enterocytes: 573.6;Late spermatids: 654.5;Paneth cells: 587.5" "Cancer enhanced" "Detected in all" "prostate cancer: 455.6" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 90 "plasmacytoid DC: 8.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 8.9" "Cell line enhanced" "Detected in some" "A-431: 21.3;CAPAN-2: 36.8;HaCaT: 25.7;hTCEpi: 29.8;OE19: 42.8;RPTEC TERT1: 107.8;RT4: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA011909 Approved Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA011909: AB_2668565" "unprognostic (1.21e-1)" "unprognostic (3.11e-1)" "unprognostic (3.67e-2)" "unprognostic (4.12e-1)" "unprognostic (2.69e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "unprognostic (1.44e-1)" "unprognostic (1.88e-3)" "unprognostic (8.73e-2)" "prognostic favorable (9.28e-6)" "unprognostic (5.90e-2)" "unprognostic (2.61e-1)" "unprognostic (4.90e-2)" "unprognostic (4.30e-2)" 1.7 0.6 1.7 4.8 2.4 0.0 1.5 11.4 3.5 9.0 59.9 1.8 1.5 2.2 1.8 4.6 1.9 13.9 2.6 2.6 2.2 0.0 46.0 1.9 5.7 2.1 2.4 1.7 1.5 1.5 15.4 3.3 1.5 2.1 22.7 70.0 3.3 16.1 7.8 1.5 0.1 18.3 1.9 1.8 1.6 24.6 119.0 1.9 1.6 13.9 1.8 1.9 21.0 1.5 0.0 8.9 0.0 0.0 0.0 0.0 0.0 21.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 36.8 0.0 6.9 0.0 0.0 25.7 0.0 18.8 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 29.8 0.1 10.6 0.6 0.0 0.2 0.0 0.0 0.2 0.8 0.0 0.0 0.0 42.8 1.3 0.0 0.0 0.2 107.8 51.7 0.3 0.0 0.0 2.2 0.1 0.1 1.5 0.0 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 1.7 2.4 11.4 3.5 2.2 0.0 2.4 1.7 2.1 1.9 23.8 19.0 15.7 180.5 0.9 0.0 0.6 15.3 1113.5 208.1 549.6 0.0 0.1 39.7 40.8 130.9 1.2 573.6 0.0 480.2 0.1 1.0 212.2 11.5 2.6 0.2 0.0 193.7 2.5 0.3 654.5 4.6 4.0 5.0 2.8 525.2 0.0 292.8 587.5 1.8 400.8 0.0 0.0 0.3 4.2 1.9 1.1 0.0 0.8 136.2 439.3 TSPAN10 OCSP ENSG00000182612 "Tetraspanin 10" 17 81637171-81648749 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 29 "retina: 117.4" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 12.2;Horizontal cells: 12.7" "Cancer enriched" "Detected in many" 15 "melanoma: 32.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 6.2;SK-MEL-30: 17.9;U-138 MG: 6.5;U-87 MG: 8.2" "Region enriched" "Detected in single" 12 "olfactory region: 1.6" "Low region specificity" "Detected in all" NA NA "unprognostic (1.81e-2)" "unprognostic (3.67e-1)" "unprognostic (2.17e-3)" "unprognostic (1.08e-3)" "unprognostic (3.74e-1)" "unprognostic (3.48e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-1)" "unprognostic (2.33e-1)" "unprognostic (1.95e-1)" "unprognostic (5.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.31e-2)" "unprognostic (2.81e-1)" "unprognostic (1.58e-1)" 1.0 0.1 0.1 1.3 0.1 0.0 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.9 1.1 0.5 0.3 0.7 0.1 0.1 0.1 0.2 0.5 2.2 0.1 0.1 0.2 0.9 0.0 0.1 1.4 0.2 1.1 0.0 117.4 0.3 1.0 0.1 4.0 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.4 0.1 0.5 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.8 1.9 0.2 0.2 0.6 0.7 0.2 1.9 6.0 2.9 1.7 0.6 3.2 0.8 0.7 1.8 1.6 0.1 0.1 0.4 0.3 0.6 3.6 0.0 0.4 0.4 0.4 0.0 1.1 0.7 0.8 3.4 0.1 6.2 0.0 0.7 0.0 0.2 2.8 0.2 0.1 0.4 0.2 0.0 2.9 1.3 0.0 0.0 0.2 0.5 0.0 1.3 3.3 0.4 17.9 1.7 3.6 0.4 0.1 6.5 2.0 0.5 1.7 0.0 0.0 0.0 8.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 8.2 0.5 2.3 0.0 1.7 1.4 5.1 6.7 4.5 12.2 3.9 1.6 8.3 2.4 0.6 1.0 1.3 0.0 2.0 4.6 1.4 1.9 7.0 1.0 7.5 12.7 0.0 3.7 1.3 1.8 1.4 0.9 0.0 0.0 0.8 5.2 1.0 0.0 1.1 2.2 4.9 0.0 0.5 2.6 6.4 0.0 1.1 0.0 0.9 0.9 TSPAN11 ENSG00000110900 "Tetraspanin 11" A1L157 12 30926428-30996599 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 25.6" "Cell type enhanced" "Detected in some" 10 "Ito cells: 7.4;Late spermatids: 8.4;Leydig cells: 4.4;Muller glia cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.6;HSkMC: 18.4;NTERA-2: 14.8;SCLC-21H: 7.1;SH-SY5Y: 14.2;SuSa: 9.1" "Low region specificity" "Detected in many" HPA066789 Approved Vesicles NA NA Vesicles "HPA066789: AB_2685723" "unprognostic (4.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.38e-3)" "unprognostic (1.18e-2)" "unprognostic (4.51e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.28e-2)" "prognostic favorable (3.43e-4)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (1.51e-2)" "unprognostic (3.03e-2)" "unprognostic (5.77e-3)" "unprognostic (2.04e-2)" "unprognostic (5.81e-2)" "unprognostic (2.90e-3)" "unprognostic (1.79e-1)" 3.1 2.5 6.4 16.0 3.8 0.0 2.5 15.2 12.7 9.0 25.6 9.0 3.0 4.4 6.4 7.8 8.8 2.4 12.2 8.8 5.0 4.7 1.6 1.0 8.5 2.6 4.1 3.8 1.9 1.4 0.3 1.5 0.8 3.8 5.4 11.0 12.2 3.8 6.8 0.8 6.5 10.9 8.3 2.6 2.6 4.5 1.6 3.7 0.0 4.0 12.3 8.9 6.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.5 0.0 1.1 1.6 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.1 14.2 0.1 0.0 0.0 9.1 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 3.8 15.2 4.3 5.0 4.7 4.1 3.8 3.8 3.7 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 7.4 0.0 8.4 4.4 1.1 1.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 0.2 1.0 0.0 0.0 0.0 0.0 TSPAN16 "TM-8, TM4-B, TM4SF16" ENSG00000130167 "Tetraspanin 16" Q9UKR8 19 11296139-11326996 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "blood: 21.8;testis: 46.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 4024.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "basophil: 6.9;eosinophil: 10.8;neutrophil: 21.8" "Lineage enriched" "Detected in many" 16 "granulocytes: 21.8" "Cell line enhanced" "Detected in some" "MCF7: 3.0;THP-1: 1.1;U-937: 3.0" "Not detected" "Not detected" HPA076551 Enhanced NA NA "HPA076551: " "unprognostic (1.06e-1)" "unprognostic (2.82e-2)" "unprognostic (1.73e-2)" "unprognostic (4.74e-3)" "unprognostic (1.53e-1)" "unprognostic (2.06e-3)" "unprognostic (1.37e-1)" "unprognostic (2.21e-1)" "unprognostic (7.68e-2)" "unprognostic (1.90e-1)" "unprognostic (8.69e-4)" "unprognostic (8.81e-8)" "unprognostic (1.98e-1)" "unprognostic (1.12e-1)" "unprognostic (1.95e-3)" "unprognostic (2.67e-1)" 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 21.8 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.7 0.0 3.0 0.0 0.9 0.3 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.6 1.1 0.0 0.2 0.0 0.2 0.1 0.0 0.2 0.0 0.0 3.0 0.0 6.9 1.3 10.8 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 21.8 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 855.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4024.1 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 6.5 0.0 18.6 10.1 0.0 0.0 0.0 0.0 0.0 TSPAN19 ENSG00000231738 "Tetraspanin 19" P0C672 12 85014311-85036277 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lung: 9.7;pituitary gland: 20.0" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 360.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 6.4;SK-BR-3: 4.3" "Low region specificity" "Detected in all" HPA057066 Uncertain NA NA "HPA057066: AB_2683325" "unprognostic (1.94e-1)" "unprognostic (9.81e-4)" "unprognostic (8.57e-2)" "unprognostic (8.37e-2)" "unprognostic (2.33e-1)" "unprognostic (6.57e-2)" "unprognostic (2.26e-3)" "unprognostic (9.52e-2)" "unprognostic (5.09e-3)" "unprognostic (2.22e-1)" "unprognostic (3.78e-2)" 0.4 0.8 1.5 0.5 1.9 2.3 0.2 1.0 2.6 0.5 0.4 1.4 0.0 1.1 0.5 2.5 0.8 1.8 0.8 0.4 3.2 4.4 0.7 0.1 9.7 0.5 2.3 4.4 0.4 1.6 0.4 20.0 0.5 4.9 1.0 0.2 2.4 0.8 0.0 1.6 4.5 0.6 0.0 1.6 0.5 0.5 8.4 1.4 0.0 4.1 1.3 0.2 0.5 0.2 1.8 0.9 5.4 1.0 0.8 1.1 0.0 0.9 0.0 1.6 0.5 0.9 1.4 1.8 0.9 0.1 0.0 0.5 0.8 0.0 1.0 0.1 0.0 1.1 0.3 0.2 0.3 0.0 0.8 1.6 0.0 0.5 0.7 2.1 1.5 1.7 1.0 1.1 0.9 0.6 3.2 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 1.4 0.2 0.0 0.0 0.3 6.4 2.7 0.0 4.3 0.9 0.7 1.0 0.3 1.2 3.0 0.9 1.3 0.8 3.8 0.0 0.5 3.3 0.0 1.4 1.1 1.0 1.1 1.0 0.7 0.7 0.9 0.8 0.5 0.1 1.8 1.1 1.0 5.4 0.8 0.4 0.9 0.3 0.0 1.5 1.9 1.0 2.6 3.2 4.4 2.3 4.4 4.9 1.4 3.0 1.3 0.0 0.0 0.1 2.4 0.8 0.0 360.0 34.2 0.0 7.9 0.0 0.0 0.0 46.9 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.4 0.0 7.9 6.5 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 44.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "pons and medulla: 11.9" "Cell type enhanced" "Detected in many" "neutrophil: 35.0" "Group enriched" "Detected in many" 4 "granulocytes: 35.0;NK-cells: 25.9" "Cell line enhanced" "Detected in many" "EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 3.7 0.6 1.1 4.7 2.5 9.6 3.2 0.9 2.0 20.1 31.0 1.5 8.9 2.5 30.6 6.9 12.3 14.2 10.6 6.1 1.1 2.6 4.0 0.6 3.0 1.5 1.9 1.9 6.5 2.0 6.4 2.0 1.5 11.9 15.2 6.2 1.9 2.2 15.7 2.0 1.6 7.0 44.6 1.6 2.2 10.0 4.4 0.8 2.6 4.0 4.9 0.9 25.4 7.0 0.2 1.2 35.0 2.9 25.9 7.4 3.8 8.5 0.1 0.7 0.0 0.0 0.1 0.0 1.4 0.5 1.4 2.2 1.7 5.2 0.0 35.1 1.9 1.9 1.2 1.1 0.0 1.5 1.7 0.7 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.8 0.0 6.9 0.0 0.5 0.0 0.4 4.6 0.7 8.0 1.7 0.9 0.0 0.5 0.0 0.2 3.2 1.8 2.9 2.1 0.9 0.1 4.9 0.1 0.3 0.1 0.1 3.4 0.2 8.0 7.3 0.2 0.0 0.0 15.4 3.8 27.8 2.9 16.6 5.9 0.0 1.9 0.2 7.0 7.4 1.2 0.1 1.2 6.0 35.0 25.9 0.0 1.2 0.9 3.8 1.1 2.5 0.9 2.0 1.1 2.6 1.9 1.9 11.9 0.8 0.0 1.1 0.0 22.5 7.1 0.2 9.2 0.0 10.7 2.3 10.4 0.0 0.1 0.0 16.3 10.8 15.0 0.0 0.0 2.2 3.1 3.1 10.9 0.0 0.0 0.6 0.0 37.7 5.5 0.8 2.7 0.6 0.9 3.3 0.0 0.8 0.0 7.7 0.0 2.8 1.0 0.4 6.5 20.2 0.1 0.9 2.4 0.2 5.0 1.0 9.2 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318200 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Cardiomyocytes: 13.4;granulocytes: 29.0;Macrophages: 13.0;T-cells: 23.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 8 "HEL: 15.8;HL-60: 6.9;NB-4: 5.7;THP-1: 6.1;U-937: 9.6" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA 37000 Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 1.2 0.4 0.3 6.3 0.5 17.5 0.5 0.4 1.0 1.3 1.3 2.1 0.0 0.2 1.6 1.6 0.9 0.6 1.4 11.9 0.3 0.4 0.9 0.8 3.1 5.1 0.5 0.3 0.8 0.4 0.0 0.4 0.9 0.5 1.2 0.1 1.7 5.6 0.9 0.3 0.5 1.1 1.8 0.8 5.8 1.4 0.4 1.1 7.4 0.5 2.1 11.5 1.0 0.8 1.1 14.9 17.9 19.3 25.3 13.2 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 15.8 0.0 0.1 0.7 6.9 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 9.6 0.0 17.9 15.2 2.0 13.0 17.9 8.1 1.1 4.7 11.1 14.9 0.6 3.7 13.2 8.4 25.3 19.3 0.7 5.8 9.5 0.3 0.5 0.4 1.0 0.3 0.4 0.5 0.3 0.5 1.1 0.0 10.7 2.7 0.0 0.8 0.0 13.4 0.0 2.7 1.2 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.9 0.0 29.0 0.0 4.4 0.0 0.0 0.0 6.6 3.5 0.9 13.0 1.7 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.5 0.0 23.5 0.0 0.0 TSPAN33 "MGC50844, Penumbra" ENSG00000158457 "Tetraspanin 33" Q86UF1 7 129144892-129169697 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 56.8" "Cell type enhanced" "Detected in many" 11 "Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 5.3;naive B-cell: 6.4" "Group enriched" "Detected in many" 5 "B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2" "Cell line enhanced" "Detected in many" "AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020357 Enhanced Approved Microtubules NA NA Microtubules "HPA020357: AB_1858410" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (4.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-2)" "unprognostic (5.62e-2)" "unprognostic (2.29e-2)" "unprognostic (2.29e-1)" "unprognostic (3.57e-1)" "unprognostic (2.66e-1)" "prognostic favorable (8.88e-4)" "unprognostic (1.67e-1)" "prognostic favorable (8.74e-5)" "unprognostic (2.50e-2)" "unprognostic (2.73e-1)" "unprognostic (1.55e-2)" "unprognostic (1.16e-2)" 2.8 3.5 7.4 13.4 7.7 3.8 3.5 7.5 10.0 1.9 4.3 9.9 8.7 3.8 1.5 15.9 3.4 2.6 3.8 5.4 7.2 12.4 56.8 17.2 3.2 15.9 12.1 6.5 1.8 13.0 9.4 13.0 4.6 7.9 8.0 4.8 5.5 20.5 9.5 7.1 4.5 7.1 2.8 8.0 13.7 4.3 6.8 6.0 10.4 8.5 2.9 19.6 6.2 2.4 6.4 2.8 0.2 3.2 0.4 0.9 2.1 1.2 2.7 0.8 20.9 0.0 0.0 1.0 0.0 0.2 0.5 0.2 0.4 1.9 15.8 1.6 0.5 12.2 1.4 10.8 3.3 0.8 13.4 8.3 32.6 0.8 5.9 0.8 4.5 0.6 0.6 3.3 0.1 1.1 0.0 0.5 9.4 0.3 2.0 0.0 3.6 9.5 0.1 6.0 0.9 2.9 2.9 0.4 0.4 1.7 3.9 4.9 5.9 2.0 0.6 11.0 6.2 4.5 1.9 0.0 0.0 1.5 1.7 0.5 38.6 4.5 6.8 0.3 14.5 2.0 0.0 1.1 0.0 0.1 3.2 0.0 5.3 0.1 0.0 2.8 6.4 0.9 0.1 0.2 0.4 0.2 1.1 0.0 2.1 7.4 7.7 7.5 10.0 7.2 12.4 12.1 6.5 7.9 6.0 0.0 1.1 24.2 0.8 2.3 3.8 5.6 0.0 2.7 0.0 5.2 3.9 0.1 11.6 2.0 2.0 0.4 0.8 0.0 7.4 0.2 1.1 2.5 0.0 12.5 7.1 0.0 3.4 0.6 17.8 3.3 2.6 25.0 1.7 64.9 0.3 4.8 3.0 0.0 30.8 50.8 1.4 0.0 0.0 0.5 0.7 2.6 0.1 1.5 0.2 1.0 TSPAN5 "NET-4, TM4SF9, Tspan-5" ENSG00000168785 "Tetraspanin 5" P62079 4 98470367-98658629 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.5;ovary: 38.2" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 104.9;Intestinal endocrine cells: 77.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 30 "B-cells: 2.5;NK-cells: 4.5;T-cells: 6.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.7;BJ hTERT+: 35.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.17e-1)" "unprognostic (2.00e-3)" "unprognostic (2.65e-1)" "unprognostic (2.44e-3)" "unprognostic (1.41e-2)" "unprognostic (1.54e-2)" "unprognostic (9.27e-2)" "unprognostic (1.79e-1)" "unprognostic (3.30e-3)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.83e-5)" "prognostic unfavorable (8.56e-4)" "unprognostic (2.15e-1)" "unprognostic (3.23e-3)" "unprognostic (1.23e-1)" 1.9 1.5 14.1 3.1 17.1 7.0 12.7 47.5 37.5 11.8 3.8 20.9 2.1 1.6 13.4 23.4 10.4 4.9 4.3 2.9 15.5 10.1 4.4 0.9 3.7 7.4 13.7 13.8 38.2 1.0 0.9 5.7 6.3 17.3 4.7 3.5 8.6 7.9 7.5 2.6 15.3 2.4 13.2 16.7 7.5 7.2 9.7 13.9 5.7 14.8 2.9 7.2 4.9 5.9 2.5 0.1 0.1 0.0 4.5 6.9 1.2 7.7 3.1 3.2 0.2 12.3 36.7 1.1 32.2 35.1 11.6 14.3 2.7 4.2 0.0 0.3 11.4 6.3 2.0 2.7 15.0 26.1 9.6 1.5 4.7 0.4 0.1 12.7 2.6 0.2 20.9 0.4 21.3 26.4 17.9 18.7 3.2 1.8 8.4 27.7 0.2 7.9 0.0 2.1 6.6 14.3 2.4 3.0 1.1 1.0 2.3 22.8 4.3 0.5 10.2 0.0 1.1 0.3 0.4 19.1 24.4 11.0 8.7 11.2 5.9 8.7 0.0 9.5 6.3 8.3 0.0 0.0 0.0 4.6 0.0 5.0 1.3 6.4 6.4 0.1 2.5 3.2 2.2 0.1 4.5 0.0 0.0 6.9 1.2 14.1 17.1 47.5 24.9 15.5 10.1 13.7 13.8 17.3 13.9 20.8 7.8 5.0 13.2 19.6 43.8 1.7 0.0 0.0 6.8 27.9 25.5 1.1 5.0 2.5 64.2 10.1 0.5 46.7 6.5 0.8 16.0 33.6 2.3 1.0 1.9 104.9 77.7 6.7 2.7 68.0 42.6 2.8 27.0 0.0 4.4 20.5 15.7 0.0 15.9 0.3 39.0 6.5 15.9 3.7 6.3 50.4 2.4 20.8 2.5 44.4 TSPAN6 "T245, TM4SF6, TSPAN-6" ENSG00000000003 "Tetraspanin 6" O43657 X 100627109-100639991 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 88.4" "Group enriched" "Detected in many" 6 "Early spermatids: 313.3;Late spermatids: 1149.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "pons and medulla: 34.2" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.6" "Lineage enriched" "Detected in single" 8 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "NTERA-2: 43.2;RT4: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004109 Approved Approved "Nucleoli fibrillar center,Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "Nucleoli fibrillar center" "HPA004109: AB_1080301" "unprognostic (7.71e-2)" "unprognostic (8.97e-2)" "unprognostic (3.56e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-3)" "unprognostic (5.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.80e-3)" "unprognostic (2.04e-3)" "unprognostic (8.76e-2)" "unprognostic (3.83e-3)" "unprognostic (4.28e-2)" "unprognostic (1.14e-1)" "unprognostic (2.24e-1)" "unprognostic (9.54e-3)" 27.0 9.8 7.0 4.4 6.6 0.1 33.0 2.9 4.9 15.9 17.8 12.6 6.4 9.7 11.1 10.4 27.1 24.2 10.0 5.7 7.4 7.3 26.7 68.2 8.3 3.6 6.9 4.1 27.6 25.1 19.6 17.7 23.6 34.2 15.5 20.3 16.7 88.4 6.7 3.5 4.7 11.6 4.7 10.4 8.6 8.0 17.5 6.6 2.9 24.6 11.0 19.8 17.2 11.5 0.3 0.2 0.8 0.2 0.3 6.6 1.4 7.9 10.6 28.7 14.5 12.6 6.8 11.6 4.5 7.1 9.0 21.1 23.8 13.9 0.0 19.1 4.6 6.2 6.5 0.1 8.6 10.6 0.0 15.4 1.4 6.9 26.5 7.0 0.0 1.1 13.3 4.2 7.9 3.1 13.1 19.1 0.0 0.0 0.0 9.2 8.2 0.0 0.1 43.2 12.0 8.0 0.0 13.6 0.0 14.1 65.2 1.8 7.8 4.5 3.9 6.0 24.1 5.7 1.0 5.3 5.6 8.6 9.2 2.9 0.0 0.0 0.0 5.0 0.0 4.0 0.5 0.1 0.2 1.0 0.1 3.5 0.3 2.4 0.8 0.0 0.2 6.6 3.8 0.8 0.3 0.2 0.2 0.1 1.4 7.0 6.6 2.9 4.9 7.4 7.3 6.9 4.1 34.2 6.6 3.0 8.5 7.8 36.0 6.4 0.7 7.3 61.1 115.1 21.6 89.0 0.0 26.5 19.9 64.9 313.3 22.2 51.9 0.0 11.1 33.5 17.7 46.5 0.0 94.2 3.8 0.0 32.3 58.9 11.8 1149.4 30.5 2.9 10.1 1.8 42.7 38.6 20.9 46.0 33.6 37.7 1.5 19.4 7.5 19.0 32.2 4.6 11.3 3.5 78.3 78.2 TSPAN7 "A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2" ENSG00000156298 "Tetraspanin 7" P41732 X 38561370-38688920 "CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 131.1" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 113.7;Ito cells: 372.0" "Cancer enhanced" "Detected in all" "glioma: 71.5" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 68.6;MOLT-4: 45.1;SCLC-21H: 25.2;U-266/70: 16.7" "HPA003140, CAB062566, CAB068245" Enhanced NA NA "CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454" "unprognostic (1.12e-2)" "unprognostic (1.42e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.40e-4)" "unprognostic (5.06e-2)" "unprognostic (3.90e-3)" "unprognostic (3.88e-3)" "unprognostic (1.37e-2)" "unprognostic (1.14e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.54e-1)" "prognostic favorable (5.48e-7)" "unprognostic (5.65e-3)" "unprognostic (9.53e-2)" "unprognostic (1.48e-1)" "unprognostic (1.03e-3)" 15.2 28.7 39.6 3.5 83.0 0.8 7.3 83.8 131.1 12.4 18.5 11.5 2.3 7.9 11.6 9.2 7.9 10.5 5.8 17.1 34.5 30.7 15.8 12.0 16.2 8.8 19.4 37.7 5.2 4.4 4.1 11.4 6.6 23.8 5.6 17.3 8.1 3.3 7.4 17.9 4.9 7.8 14.5 11.9 21.3 4.6 1.7 9.5 0.0 11.8 5.4 8.2 8.2 4.2 0.9 0.5 0.3 0.2 0.3 2.9 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.3 0.0 10.9 2.0 0.0 0.0 8.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 68.6 0.0 0.0 0.2 0.1 45.1 0.0 2.3 0.0 0.0 2.2 0.9 0.0 1.1 0.2 25.2 2.6 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.2 16.7 4.7 0.0 1.0 0.1 0.3 0.2 0.1 0.0 0.6 0.2 0.7 0.4 1.1 2.9 0.1 0.9 2.1 1.8 0.3 0.3 0.0 0.5 0.0 0.1 39.6 83.0 83.8 86.3 34.5 30.7 19.4 37.7 23.8 9.5 11.9 18.4 0.5 2.3 9.4 87.2 35.4 2.5 1.4 4.5 10.4 41.2 0.3 19.9 0.4 0.0 113.7 34.6 0.0 0.5 0.4 6.8 2.4 9.3 2.9 33.9 92.2 18.0 372.0 20.5 1.1 0.6 1.5 13.5 0.0 25.1 94.7 1.4 17.3 2.8 8.3 66.4 58.2 4.4 0.6 3.2 5.6 0.7 4.3 31.0 0.9 TSPAN8 "CO-029, TM4SF3" ENSG00000127324 "Tetraspanin 8" P19075 12 71125085-71441898 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 235.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 1761.5;Mucus-secreting cells: 790.5;Paneth cells: 2064.2;Undifferentiated cells: 1231.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 283.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 211.9" "Low region specificity" "Detected in many" "HPA022273, CAB026009, HPA044337" Enhanced Approved Vesicles NA NA Vesicles "CAB026009: , HPA022273: , HPA044337: AB_2678899" "unprognostic (1.64e-1)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "unprognostic (6.40e-2)" "unprognostic (6.81e-2)" "unprognostic (7.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.01e-3)" "unprognostic (2.93e-1)" "prognostic unfavorable (9.66e-5)" "unprognostic (1.88e-2)" "unprognostic (1.00e-1)" "unprognostic (2.97e-2)" "prognostic favorable (7.36e-5)" 1.9 0.8 0.7 24.1 2.3 0.0 1.1 0.6 1.3 2.0 139.5 2.8 1.5 83.2 1.2 1.5 1.1 1.3 30.8 1.0 0.7 0.7 7.6 3.7 5.1 1.0 4.7 1.0 6.9 9.9 0.0 0.8 0.7 3.5 14.2 79.5 2.6 11.7 1.0 12.5 2.4 235.3 3.4 9.7 0.6 55.5 1.6 2.7 0.6 1.8 3.1 5.0 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 211.9 17.7 0.0 0.0 0.4 3.4 4.1 0.4 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.6 1.3 0.7 0.7 4.7 1.0 3.5 2.7 0.0 2.1 2.7 36.6 18.4 0.2 0.4 346.5 45.5 54.6 41.8 0.0 0.8 107.8 562.4 25.2 2.2 1761.5 0.0 594.9 0.6 38.2 601.4 4.6 21.3 0.2 0.0 167.5 1.8 2.1 10.6 40.9 3.5 60.8 13.6 790.5 7.2 214.1 2064.2 30.1 2.1 0.4 0.0 20.6 0.5 0.9 11.8 0.9 1.5 1231.3 12.4 TSPAN9 NET-5 ENSG00000011105 "Tetraspanin 9" O75954 12 3077355-3286564 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;heart muscle: 58.5" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 58.2" "Cell type enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RH-30: 63.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 125.3" HPA014002 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 1900000 "Nucleoplasm, Golgi apparatus" Cytosol "HPA014002: AB_2304038" "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-2)" "unprognostic (3.53e-2)" "unprognostic (3.11e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" "unprognostic (1.26e-2)" "unprognostic (1.89e-1)" "unprognostic (6.70e-2)" "unprognostic (1.57e-1)" "unprognostic (2.68e-2)" "unprognostic (1.04e-2)" 12.7 5.3 2.6 4.0 5.9 0.3 16.2 58.2 11.5 17.6 6.6 3.0 16.1 3.6 20.9 11.2 6.8 8.8 13.8 58.5 2.9 2.7 21.3 25.3 13.6 3.9 2.8 3.3 15.3 6.5 17.4 3.8 27.7 4.5 10.7 2.7 21.8 8.4 17.7 7.1 13.3 5.4 9.5 2.6 8.4 5.6 5.7 2.3 6.0 9.4 9.4 4.3 8.1 13.6 0.0 0.0 0.6 0.1 0.0 1.1 3.6 0.4 3.5 6.0 5.1 4.9 4.7 14.1 6.8 20.6 4.4 5.8 8.2 3.2 0.2 6.8 3.9 4.2 0.9 2.4 2.5 2.6 1.1 2.7 9.3 2.7 5.8 13.5 0.0 0.7 6.0 2.2 9.1 4.2 14.8 15.0 0.3 0.2 0.2 3.8 5.3 0.0 0.2 8.4 2.1 1.9 2.7 63.6 0.8 18.4 1.6 10.7 7.2 4.5 11.5 4.4 12.9 4.0 0.0 8.8 2.4 7.3 3.9 6.4 0.0 0.0 0.0 6.1 0.1 2.6 0.0 0.1 0.0 1.1 0.1 0.3 0.0 0.2 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.0 3.6 2.6 5.9 58.2 11.5 2.9 2.7 2.8 3.3 4.5 2.3 0.0 2.6 0.9 10.8 17.1 66.4 45.8 10.2 1.4 3.4 12.2 2.0 49.9 5.0 16.1 1.4 32.2 2.4 0.0 7.8 79.2 21.2 16.1 0.0 33.3 5.4 31.8 5.8 38.1 3.3 2.4 16.1 0.9 11.8 1.0 2.6 3.3 9.1 0.0 16.3 18.2 4.2 19.4 19.5 1.4 3.4 10.5 67.5 0.0 1.9 9.7 TSPEAR "C21orf29, DFNB98, MGC11251, TSP-EAR" ENSG00000175894 "Thrombospondin type laminin G domain and EAR repeats" Q8WU66 21 44497892-44711580 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 14.9" "Cell type enriched" "Detected in single" 4 "Early spermatids: 3.4" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in some" "basal ganglia: 2.5" "Cell type enriched" "Detected in single" 10 "neutrophil: 1.4" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 2.7;Hep G2: 2.6;HMC-1: 2.6;SH-SY5Y: 5.1;U-2 OS: 3.6" "Region enhanced" "Detected in single" "basal ganglia: 0.5" "Region enhanced" "Detected in some" "olfactory region: 2.0" "CAB034203, CAB034204, HPA052995" Uncertain "Secreted in other tissues" NA NA "CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008" "unprognostic (8.61e-3)" "unprognostic (2.45e-1)" "unprognostic (1.86e-4)" "unprognostic (7.87e-3)" "unprognostic (4.08e-2)" "unprognostic (1.00e-3)" "unprognostic (7.92e-3)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.15e-2)" "unprognostic (3.86e-4)" "unprognostic (2.13e-2)" "unprognostic (4.80e-7)" "unprognostic (2.08e-1)" "unprognostic (1.69e-1)" "unprognostic (1.88e-2)" "unprognostic (2.98e-2)" 0.3 0.1 0.2 0.3 2.5 0.0 0.5 0.2 0.9 0.2 0.2 0.2 0.2 0.7 0.2 0.4 0.2 1.1 0.2 2.7 0.2 0.1 0.5 1.4 1.4 0.8 0.2 0.2 0.2 0.2 2.6 14.9 0.2 1.0 0.2 0.0 0.2 0.2 0.2 0.2 3.9 0.5 0.2 0.2 0.6 0.3 4.6 0.2 0.5 2.8 0.2 0.4 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.2 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 1.1 0.0 0.0 1.1 5.1 0.0 0.1 0.0 0.4 0.1 0.3 1.4 0.0 3.6 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.2 0.9 0.2 0.1 0.2 0.2 1.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.6 23.6 1.6 22.4 9.0 29.9 1.8 35.6 17.4 17.9 19.1 4.6 36.5 0.0 24.7 27.6 8.8 39.5 4.5 27.6 2.3 7.9 18.6 4.8 25.9 1.6 32.7 10.8 24.4 23.2 45.5 10.6 9.5 21.1 42.4 0.0 3.9 9.0 18.3 39.9 0.1 30.2 1.9 24.6 59.0 10.7 0.0 81.4 22.9 28.8 2.3 11.0 16.9 33.8 41.5 0.0 12.7 42.0 43.7 22.3 16.7 22.7 14.9 3.6 0.6 0.4 28.9 35.1 28.5 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 148.9 135.1 105.0 344.2 325.8 2.2 79.7 336.3 127.2 167.2 195.4 2.0 9.0 313.4 570.0 2.1 215.5 499.4 46.7 512.5 126.3 307.4 297.1 261.1 99.0 745.0 3.2 187.3 163.2 688.0 6.1 76.5 573.3 686.7 477.9 485.1 116.9 963.2 644.9 148.2 97.5 17.1 103.5 217.3 1.1 4.9 468.6 16.7 155.6 529.3 666.0 TSPO2 "BZRPL1, dJ34B21.2" ENSG00000112212 "Translocator protein 2" Q5TGU0 6 41042554-41044337 "Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 32.4" "Cell type enriched" "Detected in some" 84 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "OE19: 15.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060691, HPA066996" Approved "Plasma membrane" NA NA "Plasma membrane" "HPA060691: , HPA066996: AB_2685761" "unprognostic (1.89e-3)" "unprognostic (8.35e-3)" "unprognostic (2.57e-3)" "unprognostic (2.29e-2)" "unprognostic (1.63e-1)" "unprognostic (2.66e-2)" "unprognostic (6.61e-3)" "unprognostic (2.29e-1)" "unprognostic (3.37e-1)" "unprognostic (2.89e-1)" "unprognostic (2.71e-1)" "unprognostic (4.92e-2)" "unprognostic (1.86e-2)" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (5.37e-2)" "unprognostic (1.76e-2)" 0.1 0.0 0.1 0.1 0.1 32.4 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.0 1.3 2.5 0.4 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 1.3 0.1 3.3 4.5 1.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.3 0.2 0.5 0.0 15.8 0.0 0.4 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.4 0.2 0.8 0.2 0.2 0.0 0.4 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.3 210.2 0.8 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TSPOAP1 "BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1" ENSG00000005379 "TSPO associated protein 1" O95153 17 58301228-58328760 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 7.0;Ciliated cells: 14.7;Club cells: 7.9;Collecting duct cells: 7.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 5.4" "Group enriched" "Detected in many" 8 "NK-cells: 2.7;T-cells: 5.4" "Cell line enhanced" "Detected in some" "HDLM-2: 54.1;HL-60: 19.6;NB-4: 20.0;REH: 39.9;THP-1: 13.9;U-266/70: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024662, HPA025244" Enhanced NA NA "HPA024662: AB_2066340, HPA025244: AB_1845509" "unprognostic (2.03e-2)" "unprognostic (5.32e-2)" "unprognostic (4.60e-2)" "unprognostic (2.23e-1)" "unprognostic (2.24e-1)" "unprognostic (8.23e-4)" "unprognostic (1.24e-1)" "unprognostic (3.03e-3)" "unprognostic (1.03e-1)" "unprognostic (1.05e-1)" "prognostic favorable (9.15e-7)" "unprognostic (1.62e-1)" "unprognostic (7.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-1)" "unprognostic (3.82e-2)" "unprognostic (1.22e-2)" 2.3 9.7 76.9 5.2 59.1 26.1 6.4 46.5 83.7 8.0 6.7 10.2 0.7 3.4 16.0 6.2 5.2 21.6 5.7 6.1 65.3 13.0 5.9 2.8 8.2 8.1 12.0 47.9 22.0 11.1 13.9 15.9 1.5 18.6 13.5 3.3 1.5 17.9 16.6 7.1 5.0 4.4 6.9 14.3 8.5 7.4 1.1 23.2 10.3 10.0 0.6 4.2 4.8 4.8 0.0 0.0 0.5 0.0 2.7 5.4 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 1.2 1.3 0.3 0.0 0.1 0.0 0.0 0.0 54.1 0.4 0.2 0.5 0.0 0.0 19.6 2.1 0.0 0.2 0.0 0.0 6.7 0.0 7.3 0.6 3.6 0.0 0.0 6.6 20.0 0.3 0.0 0.0 39.9 0.0 5.6 0.2 0.0 3.0 2.1 0.0 0.0 0.0 0.0 0.1 13.9 0.0 0.0 0.5 0.0 0.0 14.1 2.6 3.5 0.0 0.6 0.0 0.5 0.0 0.1 5.4 0.0 2.2 0.0 0.5 1.2 0.0 0.0 0.5 1.2 0.0 2.7 0.0 0.0 0.1 1.0 76.9 59.1 46.5 83.7 65.3 13.0 12.0 47.9 18.6 23.2 8.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 7.9 7.0 0.0 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TSPY1 "CT78, TSPY" ENSG00000258992 "Testis specific protein, Y-linked 1" Q01534 Y 9466955-9469748 "Disease related genes, Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 105 "testis: 10.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 361 "U-266/70: 64.9;U-266/84: 60.7" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.9 60.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 TSPY10 ENSG00000236424 "Testis specific protein, Y-linked 10" Y 9527880-9530682 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 6.3" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 8.6" "Cancer enriched" "Detected in single" 13 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/84: 36.6" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (5.36e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.3 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 8.6 0.0 0.0 0.0 0.0 0.0 TSPY2 TSPYQ1 ENSG00000168757 "Testis specific protein, Y-linked 2" A6NKD2 Y 6246223-6249019 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 104 "testis: 13.5" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 26.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 426 "U-266/70: 41.9;U-266/84: 43.2" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (3.69e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 43.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 26.0 0.0 0.0 0.0 0.0 0.0 TSPY3 CT78 ENSG00000228927 "Testis specific protein, Y-linked 3" P0CV98 Y 9398421-9401223 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 4 "testis: 7.6" "Cell type enriched" "Detected in single" 25 "Spermatogonia: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 75 "U-266/70: 50.9;U-266/84: 46.1" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " "unprognostic (4.19e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 50.9 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.1 0.0 0.0 0.0 0.0 0.0 TSPY4 ENSG00000233803 "Testis specific protein, Y-linked 4" "P0CV99, P0CW01" Y 9337464-9340284 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 222 "testis: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 604 "U-266/70: 178.3;U-266/84: 187.8" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 178.3 187.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 TSPY8 ENSG00000229549 "Testis specific protein, Y-linked 8" P0CW00 Y 9357797-9360599 "Predicted intracellular proteins" "Differentiation, Gonadal differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 10 "testis: 4.1" "Cell type enriched" "Detected in single" 12 "Spermatogonia: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 230 "U-266/84: 77.1" "HPA049384, HPA067289" Supported Approved Cytosol NA NA Cytosol "HPA049384: AB_2680738, HPA067289: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 77.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.9 0.0 0.0 0.0 0.0 0.0 TSPYL2 "CDA1, CINAP, CTCL, DENTT, HRIHFB2216, SE20-4, TSPX" ENSG00000184205 "TSPY like 2" Q9H2G4 X 53082367-53088540 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 91.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 47.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044133 Approved NA NA "HPA044133: AB_10965838" "unprognostic (3.29e-2)" "unprognostic (2.68e-3)" "prognostic unfavorable (3.23e-4)" "unprognostic (3.87e-3)" "unprognostic (1.06e-1)" "unprognostic (9.58e-2)" "unprognostic (1.36e-1)" "unprognostic (5.99e-3)" "unprognostic (3.18e-2)" "unprognostic (1.59e-1)" "prognostic favorable (6.74e-8)" "unprognostic (1.29e-1)" "prognostic unfavorable (8.16e-7)" "unprognostic (6.50e-2)" "unprognostic (9.93e-2)" "unprognostic (2.31e-1)" "unprognostic (3.10e-2)" 15.2 34.9 27.9 12.6 91.4 31.8 11.2 49.3 46.6 16.3 14.5 9.6 18.4 5.5 32.5 34.5 12.2 16.5 17.7 14.0 26.2 27.7 7.3 7.6 11.3 17.3 14.1 33.4 68.0 11.7 10.8 46.5 6.3 23.8 24.4 7.1 12.6 8.0 32.9 13.4 10.2 11.0 17.9 8.3 15.9 12.7 40.7 18.2 4.8 17.7 3.7 12.2 15.2 12.4 7.0 12.5 2.8 1.0 6.1 12.7 4.8 1.6 5.5 5.7 23.6 4.4 5.4 8.2 12.0 12.8 7.9 7.8 8.1 3.8 12.7 2.3 6.3 6.1 5.0 4.7 4.8 7.3 3.2 10.2 3.2 21.7 10.5 13.0 5.2 4.1 10.4 8.8 10.8 18.4 4.8 5.7 4.5 2.4 11.9 4.3 7.6 7.3 6.2 8.6 2.5 10.4 5.8 7.2 9.3 1.4 9.5 7.0 4.2 9.5 3.5 6.2 27.6 5.3 1.6 8.2 3.7 6.2 47.0 2.2 12.9 8.0 12.0 6.2 8.6 7.5 2.8 0.1 1.7 6.6 0.6 8.1 5.3 9.2 5.2 0.1 7.0 12.7 9.0 1.0 6.1 1.0 12.5 6.6 4.8 27.9 91.4 49.3 46.6 26.2 27.7 14.1 33.4 23.8 18.2 8.9 41.6 31.5 92.2 36.2 98.0 28.8 10.2 25.4 37.5 17.4 43.2 5.0 1.7 8.0 10.1 26.3 3.9 0.0 5.2 10.5 43.7 44.0 62.4 5.7 5.3 28.6 69.7 20.9 8.9 7.6 36.2 28.3 42.2 7.2 4.6 34.0 4.4 5.8 48.8 1.1 29.9 58.2 76.2 19.0 48.5 31.9 13.7 93.7 5.0 25.5 TSPYL4 "dJ486I3.2, KIAA0721" ENSG00000187189 "TSPY like 4" Q9UJ04 6 116249961-116254140 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 51.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044863 Approved NA NA "HPA044863: AB_10962578" "unprognostic (5.10e-2)" "unprognostic (2.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.65e-3)" "unprognostic (1.67e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (1.80e-2)" "unprognostic (3.34e-1)" "unprognostic (7.41e-3)" "prognostic favorable (8.46e-5)" "unprognostic (1.30e-1)" "prognostic favorable (5.13e-7)" "unprognostic (3.34e-3)" "unprognostic (2.57e-1)" "unprognostic (3.61e-1)" "unprognostic (5.38e-2)" 5.3 24.5 24.2 4.8 43.6 6.0 9.6 42.2 51.2 10.3 4.9 12.0 5.4 4.0 14.5 12.6 6.9 14.5 7.2 13.5 23.6 35.5 10.4 4.9 6.9 6.3 18.3 28.7 17.7 8.2 25.6 16.9 7.2 29.2 15.6 5.7 6.3 5.0 13.2 3.0 6.9 4.3 10.7 13.3 7.0 9.4 9.5 14.0 5.8 9.8 1.5 6.0 5.7 8.1 6.5 5.7 5.4 4.9 6.9 8.4 5.8 2.9 1.6 23.6 19.5 9.7 8.4 4.4 11.8 8.0 15.2 9.1 4.6 2.9 2.4 4.5 18.1 8.0 6.6 10.1 10.5 23.0 9.8 3.4 4.8 8.2 10.8 7.7 9.0 3.2 8.1 4.9 11.8 6.0 11.9 10.3 13.7 7.3 8.1 12.6 9.1 17.2 5.5 5.7 1.0 3.9 9.9 1.3 2.3 4.6 4.3 27.8 18.8 10.5 4.4 2.0 8.8 8.0 5.0 11.8 12.7 10.7 7.2 6.7 3.2 3.8 0.4 5.9 6.0 7.9 0.9 3.6 4.3 6.3 3.5 7.5 4.7 7.6 6.3 3.4 6.5 8.4 5.9 5.4 6.9 4.9 5.7 6.6 5.8 24.2 43.6 42.2 48.7 23.6 35.5 18.3 28.7 29.2 14.0 3.0 4.8 7.3 8.9 4.2 19.9 31.9 7.6 37.5 10.3 10.4 19.6 2.7 16.6 4.0 15.8 8.2 0.9 0.0 6.5 1.5 8.0 9.4 10.5 3.0 3.0 38.1 30.4 12.9 4.0 5.3 9.5 4.3 5.0 2.8 5.5 19.7 5.3 2.9 10.3 4.5 27.1 0.0 9.2 15.4 2.9 4.5 2.9 7.0 3.7 8.1 TSPYL5 KIAA1750 ENSG00000180543 "TSPY like 5" Q86VY4 8 97273474-97277964 "Predicted intracellular proteins" "Growth regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.4" "Group enriched" "Detected in many" 8 "Early spermatids: 165.5;Late spermatids: 304.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 16.4;K-562: 13.7;SCLC-21H: 29.2;SH-SY5Y: 22.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031347 Enhanced Approved "Golgi apparatus,Cytosol" No No Cytosol "Golgi apparatus" "HPA031347: AB_10601454" "prognostic favorable (1.21e-4)" "unprognostic (5.13e-2)" "unprognostic (4.90e-2)" "unprognostic (1.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.06e-1)" "unprognostic (1.01e-1)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "unprognostic (3.46e-2)" "unprognostic (1.25e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.40e-5)" "unprognostic (3.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.31e-2)" "unprognostic (3.13e-1)" 5.5 8.3 9.0 4.0 19.7 1.3 11.3 8.4 24.0 11.5 8.0 9.3 20.1 1.9 14.2 14.9 4.5 11.9 6.3 11.1 9.1 15.0 8.5 1.9 6.6 5.5 8.6 9.1 23.9 8.0 5.5 12.8 4.1 17.4 14.6 3.4 7.1 8.7 17.7 10.5 3.8 3.7 13.3 7.1 6.4 7.4 46.4 5.2 6.3 7.9 4.4 6.6 9.8 4.6 1.5 2.3 0.7 0.5 1.0 1.3 0.4 0.0 7.4 0.0 0.0 0.2 0.2 0.0 5.8 0.0 5.8 3.8 0.0 0.2 0.0 8.1 6.9 0.0 2.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 9.4 0.0 8.2 0.0 0.0 0.0 16.4 13.7 0.0 0.2 10.7 0.0 0.0 0.0 0.0 0.1 10.6 0.0 0.0 4.9 0.0 29.2 22.6 0.0 1.9 0.0 4.1 0.0 0.9 0.0 0.0 12.8 0.0 0.0 6.9 10.3 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.5 0.0 0.7 0.5 0.1 2.3 1.5 1.3 0.5 0.0 1.0 0.2 2.2 1.1 0.4 9.0 19.7 8.4 24.0 9.1 15.0 8.6 9.1 17.4 5.2 6.0 2.6 0.0 4.2 2.1 10.9 10.6 2.5 5.3 3.4 8.7 19.6 0.1 5.0 5.6 165.5 9.0 0.0 0.0 2.9 0.1 7.3 6.3 0.0 0.8 5.1 7.9 2.4 4.9 3.9 304.7 22.7 2.6 6.8 2.8 0.0 11.4 4.2 0.0 19.8 0.9 11.5 6.5 5.6 28.1 26.0 1.4 0.1 0.0 0.2 3.1 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Group enriched" "Detected in some" 9 "Spermatocytes: 27.4;Spermatogonia: 22.4" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 66 "K-562: 13.4" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoplasm "Nucleoli, Cytosol" "HPA034699: AB_2674288, HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 27.4 22.4 0.0 0.0 0.0 0.0 0.0 TSSK1B "FKSG81, SPOGA4, STK22D, TSSK1" ENSG00000212122 "Testis specific serine kinase 1B" Q9BXA7 5 113432554-113435031 "Enzymes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 50 "testis: 59.9" "Group enriched" "Detected in some" 101 "Early spermatids: 408.3;Late spermatids: 766.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.3;EFO-21: 2.1;RT4: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA027827 Enhanced NA NA "HPA027827: AB_10603138" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.6 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.2 0.0 1.3 0.2 2.1 0.0 0.4 0.4 0.2 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.6 0.7 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.6 0.1 0.0 0.1 0.1 0.3 0.0 0.4 0.0 0.5 0.2 0.2 0.3 0.1 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 408.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 766.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 5.8 3.2 0.0 0.0 0.0 0.0 0.0 TSSK2 "FLJ38613, SPOGA2, STK22B" ENSG00000206203 "Testis specific serine kinase 2" Q96PF2 22 19130808-19132623 "Enzymes, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 57 "testis: 95.7" "Group enriched" "Detected in some" 70 "Early spermatids: 1437.9;Late spermatids: 2322.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;HL-60: 1.8;SCLC-21H: 3.5;THP-1: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 1.0 0.0 1.6 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.8 0.0 0.6 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.8 1.4 0.5 0.0 0.2 0.1 0.9 0.3 0.0 0.3 1.2 0.0 0.0 1.0 0.4 0.0 0.0 0.5 0.1 0.8 0.3 0.7 0.2 0.5 0.2 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1437.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2322.2 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 6.5 0.0 26.9 11.5 0.0 0.0 0.0 0.0 0.0 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Group enriched" "Detected in some" 52 "Early spermatids: 242.3;Late spermatids: 839.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: AB_2675517" "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.5 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 1.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 6.3 0.0 4.6 3.1 5.8 0.0 0.6 1.4 1.5 1.5 0.4 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 4.4 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 0.0 0.3 0.0 0.4 0.1 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.2 242.3 0.0 0.0 0.0 0.6 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 839.4 8.6 0.0 0.0 0.0 0.3 0.9 0.2 0.0 8.9 0.6 1.4 6.5 0.0 10.3 3.8 0.0 0.2 0.0 0.2 0.2 TSSK4 "C14orf20, STK22E" ENSG00000139908 "Testis specific serine kinase 4" Q6SA08 14 24205697-24208362 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 46.1" "Cell type enriched" "Detected in some" 15 "Early spermatids: 178.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA060660, HPA077103" Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA060660: AB_2684339, HPA077103: AB_2732332" "unprognostic (1.95e-1)" "unprognostic (4.30e-2)" "unprognostic (1.52e-1)" "unprognostic (5.69e-2)" "unprognostic (2.36e-1)" "unprognostic (3.38e-5)" "unprognostic (1.06e-1)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (3.39e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-3)" "unprognostic (3.42e-1)" "unprognostic (4.30e-2)" "unprognostic (6.28e-2)" "unprognostic (8.98e-2)" "unprognostic (7.26e-2)" 0.6 0.9 0.6 1.7 0.6 3.1 0.6 1.5 1.8 0.6 0.6 0.6 0.6 1.5 0.8 0.9 1.4 0.8 1.7 0.6 0.6 0.4 0.6 0.6 0.8 2.8 0.6 0.6 0.8 0.9 0.0 0.6 0.6 0.6 0.6 0.0 0.6 1.4 0.6 1.0 4.7 1.6 0.6 0.6 1.5 0.6 46.1 0.6 0.6 1.4 0.6 0.6 1.0 0.6 2.1 1.7 2.0 1.0 1.8 2.0 0.7 1.0 4.1 4.0 1.5 0.1 0.0 4.3 1.6 0.1 0.0 0.0 2.1 3.7 3.1 0.9 0.1 0.8 3.8 0.0 0.1 0.0 1.6 3.1 3.5 4.8 3.0 0.0 1.5 3.8 0.0 0.0 0.0 0.6 3.6 0.1 3.7 1.3 2.0 0.0 3.8 3.6 1.7 0.7 0.9 3.2 3.0 1.6 2.7 0.0 5.3 2.2 2.1 2.7 2.5 0.8 1.8 1.6 1.8 1.4 2.9 1.8 3.8 1.3 4.3 4.8 4.8 1.0 2.8 0.9 0.0 1.0 2.0 2.0 1.0 0.7 2.0 1.6 1.6 0.6 2.1 1.6 1.7 2.0 1.8 0.9 1.7 0.7 0.7 0.6 0.6 1.5 0.6 0.6 0.4 0.6 0.6 0.6 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 178.8 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.1 0.0 0.0 0.0 TSSK6 "CT72, FLJ24002, SSTK" ENSG00000178093 "Testis specific serine kinase 6" Q9BXA6 19 19512418-19515685 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "testis: 50.8" "Cell type enriched" "Detected in some" 5 "Late spermatids: 5597.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.12e-1)" "unprognostic (7.89e-2)" "unprognostic (7.26e-2)" "unprognostic (6.64e-2)" "unprognostic (3.39e-1)" "unprognostic (7.20e-5)" "unprognostic (3.38e-1)" "unprognostic (5.51e-3)" "unprognostic (5.17e-2)" "unprognostic (1.46e-1)" "unprognostic (3.98e-4)" "unprognostic (2.28e-2)" "unprognostic (5.34e-3)" "unprognostic (2.74e-3)" "unprognostic (2.78e-2)" "unprognostic (1.52e-3)" "unprognostic (9.89e-2)" 0.9 1.2 1.0 1.2 1.5 1.3 1.0 0.9 1.9 0.9 1.1 2.2 1.6 2.1 0.9 3.7 1.1 1.1 1.0 0.7 1.2 0.8 1.8 2.2 0.7 1.2 2.5 1.0 0.9 3.3 1.1 1.0 0.6 1.3 1.4 0.6 0.9 1.3 1.0 1.0 2.7 1.9 1.2 1.9 2.1 1.7 50.8 1.7 3.1 2.0 0.1 1.7 1.1 1.0 3.1 1.0 2.2 0.7 0.4 3.8 0.8 1.6 2.7 0.1 1.1 0.4 1.0 8.0 1.1 0.5 0.6 0.3 4.2 1.3 1.4 2.0 0.0 0.5 1.4 0.5 1.1 0.2 1.0 1.9 0.7 1.7 0.9 1.2 0.9 3.2 0.6 1.0 0.6 1.9 0.6 0.3 5.4 1.9 0.8 0.0 0.5 3.4 2.0 3.7 0.8 4.4 2.7 0.7 1.2 0.1 0.5 0.6 2.9 1.6 0.4 1.4 0.4 2.6 0.7 0.3 2.0 0.6 3.9 1.7 3.5 1.4 0.8 2.2 1.2 1.9 0.0 0.6 2.2 0.8 0.2 1.1 3.1 1.7 2.0 0.3 1.9 3.8 2.1 1.1 0.4 0.7 1.0 1.0 0.8 1.0 1.5 0.9 1.9 1.2 0.8 2.5 1.0 1.3 1.7 0.0 0.0 0.0 0.2 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1053.4 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.3 0.6 5597.9 44.3 0.0 1.7 0.0 0.0 0.0 0.1 0.0 53.7 0.1 0.0 19.4 0.6 51.3 21.7 0.1 0.1 0.0 0.0 0.0 TST RDS ENSG00000128311 "Thiosulfate sulfurtransferase" Q16762 22 37010859-37020183 "Enzymes, Predicted intracellular proteins" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.1" "Cell type enhanced" "Detected in many" 8 "Cholangiocytes: 203.8;Enterocytes: 300.1;Hepatocytes: 350.5;Paneth cells: 284.5;Proximal tubular cells: 229.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 16.0" "Group enriched" "Detected in all" 6 "dendritic cells: 16.0;granulocytes: 14.3;monocytes: 11.5" "Cell line enhanced" "Detected in many" "OE19: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003044, HPA003643, CAB009546" Enhanced Supported Mitochondria NA NA 2800000 Mitochondria "CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411" "unprognostic (3.09e-2)" "unprognostic (2.70e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-2)" "unprognostic (2.38e-2)" "unprognostic (2.32e-1)" "unprognostic (7.96e-3)" "unprognostic (4.38e-2)" "unprognostic (1.78e-1)" "prognostic favorable (7.59e-6)" "unprognostic (6.08e-3)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "prognostic favorable (1.04e-4)" 8.5 29.7 6.0 13.5 7.6 5.7 6.1 5.0 10.5 9.5 38.4 12.9 10.9 37.4 5.9 4.0 16.6 6.8 38.4 14.1 5.1 4.9 19.7 102.1 6.2 3.2 8.2 7.0 7.2 23.9 1.8 2.3 5.0 5.9 8.1 21.6 6.2 13.6 6.9 8.3 5.4 39.5 3.8 4.7 3.5 22.8 3.3 6.7 1.8 8.5 12.8 10.5 7.2 9.2 1.6 16.0 14.3 11.5 2.2 1.2 5.2 11.1 24.9 3.1 10.6 7.7 3.0 5.9 6.2 5.3 3.6 5.4 7.2 7.3 3.0 5.2 4.9 3.5 9.6 2.3 6.2 0.8 8.7 13.9 3.1 4.7 14.0 19.2 4.3 7.4 5.9 7.0 2.7 2.3 5.1 8.8 1.6 3.6 5.2 1.7 25.6 0.1 13.9 5.4 73.6 10.9 10.0 3.4 5.2 10.2 10.5 1.8 4.8 6.5 11.8 8.4 3.2 12.2 10.9 6.6 4.1 7.7 6.8 1.9 3.9 3.9 0.9 1.5 12.4 2.4 5.3 11.5 4.9 0.6 3.0 1.1 1.6 0.5 0.4 16.0 0.8 0.3 0.2 14.3 2.2 0.8 1.1 1.2 5.2 6.0 7.6 5.0 10.5 5.1 4.9 8.2 7.0 5.9 6.7 26.8 66.9 14.5 10.5 1.1 0.8 32.5 203.8 21.4 19.4 19.2 0.0 9.5 39.7 35.3 1.4 5.0 300.1 0.0 38.8 6.0 15.5 9.3 13.9 350.5 13.2 1.6 33.0 36.2 24.7 2.7 12.0 8.3 1.7 17.2 154.8 25.4 33.8 284.5 7.4 229.1 0.6 0.0 3.6 0.7 0.1 2.0 9.5 10.9 155.4 15.2 TTBK1 KIAA1855 ENSG00000146216 "Tau tubulin kinase 1" Q5TCY1 6 43243680-43288259 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9" "Cell type enhanced" "Detected in some" 17 "Bipolar cells: 6.7;Horizontal cells: 4.8;Proximal tubular cells: 1.9" "Cancer enhanced" "Detected in some" "glioma: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "SCLC-21H: 21.3;SH-SY5Y: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031735, HPA031736" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA031735: AB_2674019, HPA031736: AB_10670294" "unprognostic (1.68e-1)" "unprognostic (7.88e-3)" "unprognostic (7.01e-2)" "unprognostic (1.62e-3)" "unprognostic (2.18e-1)" "unprognostic (2.24e-4)" "unprognostic (2.46e-3)" "unprognostic (3.01e-2)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.01e-2)" "unprognostic (2.12e-4)" "unprognostic (7.42e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (2.64e-3)" "unprognostic (3.04e-4)" 1.1 3.9 12.4 1.3 12.9 0.9 1.0 14.9 28.9 1.0 1.4 8.2 0.0 4.6 1.0 1.0 1.0 1.1 1.4 1.3 10.3 7.5 1.7 3.5 1.1 1.2 7.1 12.5 1.0 1.4 1.6 7.7 1.0 9.0 1.3 1.3 0.7 1.0 1.2 1.0 1.0 6.8 1.1 6.2 1.2 1.3 2.3 8.3 0.0 1.0 0.0 1.3 1.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.0 0.3 0.0 0.0 0.7 0.0 0.2 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 21.3 8.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.4 12.9 14.9 21.7 10.3 7.5 7.1 12.5 9.0 8.3 0.0 0.0 0.0 0.0 0.0 6.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 4.8 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.9 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 TTBK2 "KIAA0847, SCA11" ENSG00000128881 "Tau tubulin kinase 2" Q6IQ55 15 42738734-42920809 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 41.8" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 69.2;Late spermatids: 113.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018113, HPA049866" Approved Uncertain "Intermediate filaments" NA NA "Intermediate filaments" "HPA018113: AB_1858421, HPA049866: AB_2680923" "unprognostic (2.15e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (7.73e-2)" "unprognostic (4.26e-1)" "unprognostic (6.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.78e-2)" "unprognostic (8.62e-2)" "unprognostic (3.46e-2)" "unprognostic (7.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" 6.7 7.3 8.7 5.1 14.0 8.0 6.0 17.8 22.0 7.0 7.2 10.9 3.8 3.3 8.5 6.2 4.2 7.8 6.2 10.7 9.4 11.5 6.1 4.3 6.1 5.5 11.1 14.8 11.5 3.3 9.0 13.9 8.8 24.7 8.2 5.6 7.6 4.8 6.5 11.6 6.3 4.6 8.4 10.9 7.1 4.9 41.8 10.8 3.6 6.7 1.9 5.4 6.8 8.7 2.5 1.4 1.3 3.0 2.1 3.1 0.7 6.2 3.4 9.3 4.9 6.4 6.6 1.9 5.1 7.3 4.4 6.6 4.6 1.5 4.0 6.5 4.9 8.9 4.2 8.1 6.0 6.8 13.0 5.7 5.0 7.7 1.9 5.0 7.1 8.6 5.2 6.2 4.0 21.0 9.6 5.5 5.4 7.5 6.5 4.2 0.8 4.7 5.0 2.6 1.5 3.8 7.9 8.8 2.0 5.6 3.8 6.9 7.8 12.5 0.9 2.6 6.7 3.2 8.8 6.7 5.7 5.7 7.1 7.1 7.6 10.1 6.0 4.2 5.5 3.6 0.4 3.0 1.2 1.7 1.4 3.1 1.5 1.6 1.3 0.8 2.5 2.1 1.5 1.3 2.1 1.5 1.4 0.5 0.7 8.7 14.0 17.8 22.0 9.4 11.5 11.1 14.8 24.7 10.8 6.0 10.2 7.4 11.8 9.5 31.0 14.2 15.3 33.5 9.1 8.7 35.3 3.5 0.0 4.9 69.2 12.8 3.6 23.3 3.7 2.6 13.1 11.0 18.5 6.8 6.4 42.9 13.7 12.9 13.9 113.0 15.5 15.4 11.8 9.0 4.9 15.0 6.5 2.9 19.1 4.5 38.8 12.9 18.9 39.4 7.1 8.2 2.6 8.7 5.2 5.5 TTC12 "FLJ13859, FLJ20535, TPARM" ENSG00000149292 "Tetratricopeptide repeat domain 12" Q9H892 11 113314529-113383544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.8" "Group enriched" "Detected in many" 6 "Ciliated cells: 78.9;Early spermatids: 130.7;Late spermatids: 140.2;Spermatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038542, HPA038543, HPA061364" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA038542: AB_2676072, HPA038543: AB_10674686, HPA061364: AB_2684492" "unprognostic (2.32e-1)" "unprognostic (1.17e-1)" "prognostic favorable (3.14e-4)" "prognostic favorable (2.48e-5)" "unprognostic (2.11e-2)" "unprognostic (3.27e-1)" "unprognostic (1.13e-3)" "unprognostic (3.33e-3)" "unprognostic (7.67e-2)" "unprognostic (1.57e-1)" "unprognostic (6.03e-2)" "unprognostic (5.46e-2)" "prognostic favorable (5.95e-5)" "unprognostic (3.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.26e-1)" "unprognostic (1.35e-2)" 3.1 6.1 3.8 8.8 5.2 1.3 8.1 3.1 4.4 9.0 4.7 7.3 16.3 2.8 10.8 14.9 4.3 13.1 6.8 5.4 3.5 4.5 7.2 4.4 4.9 9.8 3.9 2.1 6.9 5.1 17.5 25.7 3.4 5.7 9.8 5.1 10.0 9.5 13.1 3.5 4.7 4.2 11.5 4.0 4.2 4.6 44.8 4.7 2.5 12.1 5.9 8.4 7.2 4.6 6.4 4.0 3.1 1.8 2.9 5.7 2.2 3.8 2.4 5.9 6.2 4.3 5.4 3.5 3.5 6.7 4.8 4.6 2.9 10.6 2.0 5.2 0.1 3.9 8.3 0.0 17.0 7.1 2.2 2.7 0.8 7.7 4.3 8.7 0.0 1.4 5.9 6.7 0.0 10.4 9.1 3.4 0.0 3.5 1.4 8.5 4.8 0.0 0.7 3.8 13.3 4.5 0.0 1.0 3.6 8.7 2.8 5.2 7.0 18.2 6.6 3.5 8.4 11.6 2.4 1.2 0.8 4.2 3.6 6.1 1.2 2.0 0.1 4.0 0.4 0.0 0.0 1.8 3.0 3.5 1.8 5.4 4.5 4.7 3.8 4.0 6.4 5.7 5.0 3.1 2.9 1.8 3.3 1.8 2.2 3.8 5.2 3.1 4.4 3.5 4.5 3.9 2.1 5.7 4.7 0.0 4.8 0.5 3.5 1.1 6.7 5.4 7.6 78.9 18.2 5.2 2.0 6.2 5.0 4.9 130.7 1.6 2.6 0.0 4.2 1.5 2.9 2.5 2.3 2.0 2.3 1.6 4.6 0.6 0.6 140.2 3.1 1.2 1.7 1.0 3.2 5.6 4.3 2.6 3.5 7.2 8.7 6.5 1.7 51.6 5.1 1.5 2.3 0.5 3.6 1.8 TTC16 FLJ32780 ENSG00000167094 "Tetratricopeptide repeat domain 16" Q8NEE8 9 127716066-127731600 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "fallopian tube: 10.4;testis: 30.8" "Group enriched" "Detected in some" 5 "Ciliated cells: 54.9;Early spermatids: 91.4;Late spermatids: 218.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "gdT-cell: 3.9;MAIT T-cell: 2.4;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 3.6" "Lineage enriched" "Detected in single" 40 "T-cells: 3.9" "Cell line enhanced" "Detected in some" "JURKAT: 3.1;MOLT-4: 1.7;REH: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (3.10e-3)" "unprognostic (1.63e-3)" "unprognostic (3.86e-3)" "unprognostic (2.02e-4)" "unprognostic (4.08e-3)" "unprognostic (2.25e-3)" "unprognostic (8.87e-4)" "unprognostic (2.91e-2)" "unprognostic (2.25e-2)" "unprognostic (2.36e-1)" "unprognostic (1.96e-3)" "unprognostic (7.32e-2)" "unprognostic (9.14e-3)" "unprognostic (6.35e-3)" "unprognostic (5.29e-2)" "unprognostic (1.17e-1)" "unprognostic (5.54e-3)" 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.6 0.4 0.0 0.4 0.0 0.0 0.2 1.3 0.0 10.4 0.1 0.0 0.3 0.3 0.2 0.0 2.1 0.4 0.0 0.2 1.3 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 30.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 2.4 0.0 1.3 2.8 0.0 0.0 0.6 3.6 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.5 0.0 0.6 0.3 0.3 0.0 0.2 0.6 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.8 0.0 54.9 9.1 0.0 0.0 0.0 0.0 0.0 91.4 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 218.9 1.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 3.5 0.2 0.4 0.0 0.0 23.2 1.5 0.0 0.0 0.5 0.0 0.0 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 51.9" "Group enriched" "Detected in many" 4 "Ciliated cells: 41.5;Early spermatids: 60.9;Late spermatids: 68.3;Spermatocytes: 73.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0;naive B-cell: 2.7" "Group enriched" "Detected in many" 6 "B-cells: 2.7;monocytes: 1.7" "Cell line enhanced" "Detected in some" "Karpas-707: 3.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.9 0.8 2.5 2.2 4.1 0.7 0.8 1.0 2.9 0.9 0.9 2.2 1.9 0.9 1.8 3.0 0.9 2.0 0.7 0.9 2.4 0.8 0.9 0.9 1.0 1.0 0.9 3.6 1.0 2.1 0.9 7.0 0.7 2.9 0.9 0.7 1.4 1.0 0.8 1.0 0.9 0.8 0.6 0.9 0.8 0.9 51.9 1.9 0.0 0.9 0.0 1.6 0.8 0.9 2.7 0.3 0.3 1.7 0.0 0.0 0.1 0.6 1.1 0.3 0.7 0.0 0.7 0.9 1.2 0.9 0.9 0.5 0.0 0.6 2.6 0.0 0.4 0.2 0.5 0.4 1.7 0.2 1.1 0.5 0.1 1.1 0.0 1.3 1.0 0.8 0.9 0.9 0.0 1.3 1.1 0.0 0.7 0.0 3.8 0.0 1.2 0.1 0.4 0.1 0.0 0.0 0.2 0.2 0.4 0.0 1.1 1.3 0.5 1.2 3.0 1.3 0.3 2.9 0.1 0.6 0.3 0.5 2.5 0.5 2.7 0.3 0.2 1.0 0.0 0.6 0.0 0.5 0.0 0.0 1.7 0.0 2.0 0.0 0.0 0.3 2.7 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 2.5 4.1 1.0 2.9 2.4 0.8 0.9 3.6 2.9 1.9 0.0 4.0 3.2 3.9 0.6 3.8 5.6 2.5 41.5 5.7 1.8 7.9 1.2 0.0 1.3 60.9 1.8 2.0 0.0 1.6 1.5 1.7 1.9 1.1 1.0 1.3 4.8 4.1 3.7 1.8 68.3 6.6 2.1 3.3 1.0 2.2 3.1 1.4 2.5 5.6 0.8 13.9 6.5 2.3 73.9 3.4 0.5 3.1 1.3 1.9 2.1 TTC22 FLJ20619 ENSG00000006555 "Tetratricopeptide repeat domain 22" Q5TAA0 1 54779712-54801267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 46.8" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 45.7;Mucus-secreting cells: 19.6;Paneth cells: 38.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.4;CAPAN-2: 10.4;HaCaT: 11.9;hTCEpi: 6.8;OE19: 14.0;RPMI-8226: 7.6" "Low region specificity" "Detected in single" HPA035072 Uncertain NA NA "HPA035072: AB_10602252" "prognostic favorable (2.06e-4)" "unprognostic (8.52e-2)" "unprognostic (4.84e-2)" "unprognostic (4.98e-2)" "unprognostic (1.01e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.02e-1)" "unprognostic (2.60e-1)" "unprognostic (3.07e-2)" "unprognostic (4.57e-2)" "unprognostic (7.27e-2)" "unprognostic (1.51e-3)" "unprognostic (5.08e-3)" "unprognostic (1.00e-1)" "unprognostic (3.16e-2)" "unprognostic (2.21e-1)" 0.3 0.4 1.0 4.2 3.5 0.6 1.5 0.2 0.4 12.1 11.8 0.2 5.1 10.1 1.6 2.4 46.8 2.1 7.7 0.2 1.1 0.6 6.6 6.4 5.0 1.5 0.3 0.5 0.6 5.7 8.2 5.7 0.5 0.6 3.6 7.3 1.0 9.5 3.9 0.1 12.2 27.7 0.3 0.3 1.1 8.7 0.5 0.7 3.0 5.3 18.4 21.0 1.8 18.8 1.2 0.1 4.0 0.1 2.9 6.5 0.7 8.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 10.4 0.1 0.4 0.0 0.0 11.9 0.0 3.5 0.0 3.7 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.1 0.1 14.0 1.1 0.1 0.0 7.6 0.4 2.1 0.3 0.2 0.7 0.1 0.0 0.2 0.3 0.2 0.1 0.2 0.0 0.2 0.1 0.8 2.0 0.1 0.1 0.1 0.0 1.4 0.1 4.0 6.0 0.0 3.6 1.2 2.9 6.5 0.1 0.9 2.5 3.1 2.3 2.9 0.1 0.1 3.9 0.7 1.0 3.5 0.2 0.4 1.1 0.6 0.3 0.5 0.6 0.7 0.0 1.9 0.0 5.9 1.1 0.0 1.8 12.7 2.7 2.3 3.5 0.0 0.2 6.6 4.5 3.0 0.0 45.7 0.0 7.9 0.4 0.2 5.1 0.0 1.8 0.0 0.0 2.4 0.0 0.0 0.4 0.3 0.0 1.7 0.0 19.6 0.0 7.9 38.5 0.0 7.4 0.0 0.0 0.0 0.2 0.6 4.0 0.0 3.5 11.9 11.7 TTC23L FLJ25439 ENSG00000205838 "Tetratricopeptide repeat domain 23 like" Q6PF05 5 34838833-34899456 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 13.5;testis: 25.9" "Group enriched" "Detected in some" 6 "Early spermatids: 308.7;Late spermatids: 177.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 2.5;NTERA-2: 1.9;T-47d: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037807 Enhanced NA NA "HPA037807: AB_10672466" "unprognostic (7.87e-2)" "unprognostic (6.80e-3)" "unprognostic (1.36e-1)" "unprognostic (1.78e-3)" "unprognostic (8.92e-3)" "unprognostic (9.89e-3)" "unprognostic (3.48e-2)" "unprognostic (9.93e-4)" "unprognostic (1.36e-1)" "unprognostic (2.20e-2)" "unprognostic (2.30e-3)" "unprognostic (1.30e-1)" "unprognostic (3.06e-3)" "unprognostic (4.16e-1)" "unprognostic (9.90e-2)" "unprognostic (2.53e-3)" "unprognostic (4.69e-4)" 0.4 1.0 1.8 0.4 5.3 0.2 1.1 0.4 1.7 0.9 0.4 1.6 13.5 0.2 0.7 3.1 0.4 4.9 0.5 0.4 3.3 1.0 0.6 0.5 0.6 0.5 0.6 1.6 0.5 1.2 2.1 8.6 0.3 3.0 0.5 0.3 1.0 1.0 10.0 0.4 1.0 0.4 0.3 1.1 0.4 0.5 25.9 1.2 0.0 1.0 0.0 0.4 0.6 0.4 1.4 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.4 0.6 0.6 0.0 0.0 1.4 0.1 0.0 0.4 0.1 0.0 1.7 0.2 0.3 0.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.5 0.8 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.8 1.1 0.0 0.0 0.5 0.4 0.1 1.9 0.0 0.3 0.4 0.3 0.0 0.2 0.2 1.8 0.4 0.6 1.1 0.8 1.0 2.2 0.0 0.0 0.3 1.6 0.4 0.1 1.8 0.8 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.2 0.0 1.4 0.5 0.7 0.0 0.2 0.0 0.0 0.0 0.2 1.8 5.3 0.4 1.7 3.3 1.0 0.6 1.6 3.0 1.2 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.0 37.5 4.5 0.0 9.8 0.2 0.0 0.0 308.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 177.9 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.8 0.0 0.3 0.0 0.0 3.6 2.0 0.0 0.3 0.0 0.0 0.1 TTC24 ENSG00000187862 "Tetratricopeptide repeat domain 24" A2A3L6 1 156579727-156586770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 13.3;lymphoid tissue: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 13.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 12.4;MOLT-4: 3.7;REH: 13.9;U-698: 2.7" HPA029799 Approved Nucleoplasm NA NA Nucleoplasm "HPA029799: AB_10601684" "unprognostic (2.43e-3)" "unprognostic (5.61e-5)" "unprognostic (5.86e-2)" "unprognostic (1.39e-1)" "unprognostic (2.62e-1)" "unprognostic (4.48e-6)" "unprognostic (6.26e-2)" "unprognostic (1.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.20e-1)" "unprognostic (4.42e-1)" "unprognostic (7.96e-2)" "unprognostic (4.87e-9)" "unprognostic (1.07e-2)" "unprognostic (5.19e-2)" "unprognostic (2.22e-2)" "unprognostic (9.76e-4)" 0.2 0.0 0.2 2.7 0.3 2.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 8.4 0.2 0.2 0.2 0.2 0.0 3.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.6 0.0 2.6 0.2 0.2 5.1 0.4 0.2 0.2 1.4 0.2 0.2 7.5 0.2 0.2 2.2 13.3 0.3 0.0 3.8 1.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 1.1 0.1 2.2 0.2 1.9 0.3 3.8 0.0 13.3 0.0 0.6 0.2 0.3 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 TTC25 DKFZP434H0115 ENSG00000204815 "Tetratricopeptide repeat domain 25" Q96NG3 17 41930635-41965651 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 7.7;fallopian tube: 24.6;pituitary gland: 10.6;testis: 29.6" "Group enriched" "Detected in many" 4 "Ciliated cells: 145.9;Early spermatids: 173.2;Spermatocytes: 46.4" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 7.1;U-87 MG: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023908 Enhanced NA NA "HPA023908: AB_2241243" "unprognostic (3.08e-3)" "unprognostic (4.51e-2)" "unprognostic (6.96e-2)" "unprognostic (1.23e-3)" "unprognostic (1.93e-1)" "unprognostic (4.57e-2)" "unprognostic (4.11e-2)" "unprognostic (1.41e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-4)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (2.10e-2)" "unprognostic (9.21e-3)" "unprognostic (3.76e-1)" "unprognostic (2.71e-1)" 0.3 0.8 2.0 0.1 5.3 2.3 0.7 0.5 4.0 1.5 0.3 3.8 1.5 0.3 2.1 4.1 0.3 24.6 0.7 0.5 2.0 1.5 0.3 2.8 0.6 0.6 2.5 2.9 0.8 4.0 10.6 2.2 7.7 0.7 0.3 2.8 0.3 0.8 0.9 0.3 0.2 0.9 0.6 0.2 0.5 29.6 1.7 0.0 1.8 0.0 0.2 0.4 0.0 0.5 1.8 0.0 0.5 0.0 1.0 0.3 0.1 2.8 3.6 4.7 0.7 0.8 0.5 0.1 1.9 0.8 1.5 0.4 3.2 0.3 1.6 0.7 1.3 0.6 0.6 0.4 0.8 0.7 0.6 1.3 0.8 0.1 1.0 0.0 2.1 0.6 0.6 2.5 0.2 2.2 0.1 1.9 0.1 2.7 0.5 1.8 1.8 0.5 0.8 0.1 0.3 0.0 0.1 1.8 4.6 0.3 7.1 5.5 0.0 0.9 3.5 1.4 1.9 0.7 0.0 0.2 2.0 1.6 0.9 2.6 2.6 0.2 8.4 0.1 1.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 1.0 0.0 1.1 0.5 1.0 0.2 0.0 0.0 0.0 1.8 0.0 0.3 3.0 4.5 0.0 0.5 0.0 2.6 1.2 0.0 145.9 27.3 3.5 7.9 0.4 1.7 1.8 173.2 0.0 0.0 0.0 0.7 0.5 0.4 0.2 3.5 0.0 0.4 3.2 0.0 1.3 0.0 23.7 3.1 0.0 0.0 0.0 0.1 3.2 0.4 0.0 1.8 3.3 5.3 12.9 0.0 46.4 3.2 0.0 0.1 0.0 0.0 0.2 TTC29 NYD-SP14 ENSG00000137473 "Tetratricopeptide repeat domain 29" Q8NA56 4 146706638-146945882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 55.9" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 136.5;Early spermatids: 509.6;Late spermatids: 355.5" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.9" "Group enriched" "Detected in many" 5 "basal ganglia: 4.3;pons and medulla: 12.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.1;hTERT-HME1: 3.2;Karpas-707: 2.3;U-266/70: 4.2;U-87 MG: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA037006, HPA061473" Uncertain NA NA "HPA037006: AB_10670379, HPA061473: AB_2684534" "unprognostic (1.28e-3)" "unprognostic (1.52e-2)" "unprognostic (8.21e-2)" "unprognostic (1.70e-1)" "unprognostic (6.70e-2)" "unprognostic (1.35e-1)" "unprognostic (6.94e-3)" "unprognostic (1.32e-1)" "unprognostic (5.67e-4)" "unprognostic (9.81e-4)" "unprognostic (7.30e-2)" "unprognostic (6.88e-4)" 0.2 0.1 0.9 0.1 4.3 0.1 0.1 0.1 1.2 0.8 0.1 1.7 0.5 0.1 0.3 10.7 0.1 13.3 0.1 0.1 1.5 1.3 0.2 0.1 7.0 0.1 0.3 0.7 2.6 0.1 0.8 0.2 0.1 12.7 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.4 0.1 0.1 55.9 0.6 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 10.1 0.0 0.0 0.8 0.3 0.1 0.0 0.5 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.1 0.9 3.2 0.3 0.3 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.2 0.0 0.0 4.2 0.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 0.1 1.2 1.5 1.3 0.3 0.7 12.7 0.6 0.0 2.6 0.0 0.0 0.0 0.0 0.4 0.0 136.5 15.9 0.0 0.0 0.0 0.0 0.0 509.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 355.5 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 85.1 7.3 0.0 0.0 0.0 0.0 0.0 TTC30A "FLJ13946, IFT70A" ENSG00000197557 "Tetratricopeptide repeat domain 30A" Q86WT1 2 177612992-177618966 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.5" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 29.4;Early spermatids: 31.2;Spermatocytes: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA051714, HPA052100, HPA052487" Supported Approved Nucleoplasm,Centrosome NA NA "Nucleoplasm, Centrosome" "HPA051714: AB_2681583, HPA052100: AB_2681726, HPA052487: AB_2681848" "unprognostic (7.75e-2)" "unprognostic (3.83e-3)" "unprognostic (2.16e-1)" "unprognostic (3.00e-2)" "unprognostic (1.17e-3)" "unprognostic (1.36e-2)" "unprognostic (1.24e-1)" "unprognostic (3.79e-1)" "unprognostic (4.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (1.78e-2)" "unprognostic (1.85e-1)" "unprognostic (5.84e-3)" "unprognostic (1.41e-1)" "unprognostic (4.67e-3)" "unprognostic (6.07e-2)" 2.7 4.1 3.8 1.5 7.1 0.4 5.6 2.2 7.1 4.2 3.4 5.9 7.8 2.2 5.0 10.9 2.4 8.4 4.8 4.4 3.7 4.2 6.9 4.6 3.7 1.4 3.6 6.6 5.5 4.4 11.6 8.1 1.9 4.8 3.9 3.3 5.0 8.1 4.0 3.5 1.9 2.5 3.6 3.0 1.7 3.6 24.5 2.1 2.6 9.6 4.6 1.7 3.1 1.7 0.5 1.6 1.9 1.6 0.2 2.7 1.0 5.7 3.3 3.3 0.0 6.7 5.6 2.4 2.8 8.1 5.0 5.3 1.0 4.2 1.3 5.4 4.8 6.8 4.8 2.2 6.1 5.5 0.4 1.8 1.1 1.6 1.4 2.7 1.4 1.3 3.4 4.0 2.8 1.1 4.8 2.3 2.9 0.8 0.5 3.5 2.9 4.4 2.6 1.8 2.0 1.2 2.9 8.8 0.6 6.3 1.5 10.8 7.2 2.5 4.9 3.0 8.1 2.8 1.4 2.1 3.1 1.9 3.4 2.3 2.2 2.1 0.4 7.7 0.1 3.0 0.0 1.3 1.9 0.4 1.6 0.1 0.4 0.1 0.4 1.6 0.5 2.7 1.2 0.7 0.2 1.3 0.6 1.0 1.0 3.8 7.1 2.2 7.1 3.7 4.2 3.6 6.6 4.8 2.1 8.9 1.9 0.0 1.1 0.7 2.2 3.1 2.5 29.4 4.5 7.0 2.0 0.8 1.7 4.1 31.2 1.4 1.7 0.0 3.5 0.7 1.5 1.0 0.0 2.9 0.7 15.9 6.9 4.3 0.3 6.8 2.0 0.2 1.7 0.0 2.5 10.6 2.4 0.0 2.1 3.8 11.3 0.0 0.9 33.6 4.6 0.4 0.2 0.0 2.3 0.3 TTC34 ENSG00000215912 "Tetratricopeptide repeat domain 34" A8MYJ7 1 2635976-2801717 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "fallopian tube: 3.5;testis: 4.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 16.9;Late spermatids: 19.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;JURKAT: 1.7;Karpas-707: 1.9" "Low region specificity" "Detected in many" HPA066832 Uncertain NA NA "HPA066832: AB_2685731" "unprognostic (1.45e-4)" "unprognostic (5.00e-2)" "unprognostic (7.09e-2)" "unprognostic (3.25e-2)" "unprognostic (3.55e-2)" "unprognostic (3.52e-2)" "unprognostic (1.70e-1)" "unprognostic (3.93e-2)" "unprognostic (1.98e-3)" "unprognostic (1.71e-1)" "unprognostic (3.69e-3)" "unprognostic (9.93e-2)" "unprognostic (1.95e-1)" "unprognostic (9.16e-3)" "unprognostic (2.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.68e-4)" 0.1 0.2 0.6 0.3 1.2 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.5 0.6 0.0 3.5 0.0 0.0 0.9 0.7 0.0 0.0 0.4 0.1 0.1 0.6 0.0 0.2 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.1 0.5 0.3 4.6 1.5 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.9 0.0 0.1 0.6 0.1 0.7 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.7 0.2 0.0 0.0 0.4 0.8 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.3 0.2 0.0 0.7 0.5 0.2 0.0 0.0 0.2 0.0 1.7 0.0 1.9 0.0 0.7 0.1 0.2 0.4 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.3 0.4 0.1 0.3 0.0 0.6 0.1 0.0 0.2 0.7 0.7 0.1 0.0 0.6 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 6.0 0.0 0.0 0.4 0.0 3.6 5.3 2.5 4.0 1.2 0.0 0.0 0.1 0.0 0.5 16.9 0.3 0.0 0.0 0.5 0.0 0.2 0.3 4.6 0.0 0.2 0.0 0.0 0.0 0.3 19.7 0.6 0.0 1.7 0.0 0.2 3.4 0.4 0.0 0.0 0.3 4.1 0.0 0.1 1.8 0.7 0.1 0.0 0.0 0.4 0.0 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 53.9" "Group enriched" "Detected in some" 12 "Hepatocytes: 410.0;Proximal tubular cells: 138.6" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 12.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038731 Enhanced Uncertain Nucleoplasm NA NA 20000 Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 2.9 0.4 0.2 0.4 0.3 0.0 3.7 0.6 0.2 0.1 5.5 0.1 0.1 3.4 0.3 8.3 0.1 0.1 0.6 0.7 0.1 0.2 3.2 53.9 0.2 0.1 0.1 0.1 0.1 0.3 0.0 0.5 0.1 0.1 0.2 0.0 0.1 1.0 0.6 0.4 0.1 2.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.8 2.4 0.0 0.0 0.7 0.5 0.0 0.2 0.2 0.2 0.8 0.0 0.0 2.7 0.4 0.0 0.0 0.0 0.2 0.5 0.3 1.7 0.0 0.0 0.8 0.1 0.0 0.0 1.5 2.0 0.1 0.1 0.5 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.0 2.7 0.6 0.5 1.3 0.0 0.0 0.7 1.7 0.6 12.4 0.0 0.1 2.2 0.0 0.3 0.0 0.9 0.0 0.2 1.1 1.4 1.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.8 0.2 0.3 0.2 0.1 0.5 0.0 0.0 0.7 0.0 2.4 0.0 0.0 0.2 0.3 0.6 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 4.3 0.6 0.2 0.0 0.3 7.6 0.0 0.0 12.2 0.0 0.8 14.9 0.3 0.0 0.0 1.7 23.3 0.4 0.2 0.0 3.0 0.0 410.0 0.1 0.0 2.4 10.4 11.0 0.0 0.3 0.0 0.0 1.0 2.6 0.5 0.3 0.2 0.0 138.6 0.7 0.0 0.1 0.2 0.0 0.1 1.7 0.0 1.0 1.0 TTC38 FLJ20699 ENSG00000075234 "Tetratricopeptide repeat domain 38" Q5R3I4 22 46267961-46294008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 59.8;liver: 92.8" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 78.3;Hepatocytes: 110.0;Proximal tubular cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 36.0" "Group enriched" "Detected in many" 5 "granulocytes: 10.1;NK-cells: 13.5;T-cells: 36.0" "Cell line enhanced" "Detected in many" "Hep G2: 35.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029302, HPA075893" Approved Approved Cytosol NA NA 19000 Cytosol "HPA029302: AB_10601704, HPA075893: " "unprognostic (7.78e-2)" "unprognostic (5.85e-2)" "unprognostic (4.92e-3)" "prognostic favorable (3.21e-6)" "unprognostic (8.34e-2)" "unprognostic (6.38e-2)" "unprognostic (8.72e-2)" "unprognostic (3.62e-2)" "unprognostic (9.45e-2)" "unprognostic (7.22e-2)" "unprognostic (1.12e-1)" "unprognostic (5.66e-2)" "unprognostic (7.34e-3)" "unprognostic (9.02e-2)" "unprognostic (4.12e-1)" "unprognostic (4.97e-1)" "unprognostic (8.33e-2)" 10.5 8.1 3.8 8.8 5.0 16.1 14.0 3.9 4.4 5.5 31.6 5.5 6.2 31.2 6.6 5.0 6.7 5.9 15.0 10.9 3.8 3.3 47.2 92.8 5.3 5.0 6.0 2.2 10.0 19.8 3.0 5.9 3.1 5.3 8.7 12.9 7.5 10.4 6.9 8.6 3.9 59.8 5.2 3.9 8.4 9.1 2.5 5.5 1.0 8.2 4.7 4.2 5.3 5.8 0.9 4.0 10.1 4.3 13.5 36.0 13.4 5.6 6.3 8.0 16.7 7.5 6.5 8.1 8.4 5.5 9.1 7.2 10.3 4.2 0.0 5.4 8.5 3.6 5.2 8.0 6.7 3.3 12.7 18.0 7.5 14.1 35.4 10.5 4.1 29.5 11.2 3.5 4.1 4.8 6.3 7.6 0.1 5.5 9.4 5.8 5.6 0.1 13.1 6.1 10.6 6.3 0.0 3.9 3.8 6.2 6.6 1.4 11.3 11.5 7.9 6.2 3.8 12.7 8.4 8.9 6.5 7.2 5.0 5.2 7.3 4.3 0.8 4.3 6.5 6.6 10.1 4.3 8.0 36.0 4.1 3.9 0.9 3.5 16.0 4.0 0.7 1.5 15.4 2.9 13.5 3.0 1.6 1.6 13.4 3.8 5.0 3.9 4.4 3.8 3.3 6.0 2.2 5.3 5.5 0.0 6.9 6.0 4.9 3.0 2.5 8.7 30.6 4.0 3.4 8.7 5.9 8.8 19.9 8.8 0.1 7.2 78.3 0.0 8.9 7.4 5.2 8.0 17.3 110.0 11.4 4.8 20.1 8.0 11.1 0.7 6.9 8.7 5.0 16.2 36.7 9.0 10.3 45.8 13.1 122.9 4.9 6.5 5.2 1.7 4.3 7.2 5.4 35.9 47.2 4.2 TTC39B "C9orf52, FLJ33868" ENSG00000155158 "Tetratricopeptide repeat domain 39B" Q5VTQ0 9 15163622-15307360 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 2.0;gdT-cell: 4.1;MAIT T-cell: 5.4;memory CD4 T-cell: 5.6;memory CD8 T-cell: 6.3;naive CD4 T-cell: 6.7;naive CD8 T-cell: 4.1;NK-cell: 7.6;T-reg: 4.9" "Group enriched" "Detected in many" 5 "granulocytes: 2.0;NK-cells: 7.6;T-cells: 6.7" "Cell line enhanced" "Detected in many" "HEL: 27.2;RT4: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063162 Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA063162: AB_2684952" "unprognostic (1.64e-1)" "unprognostic (9.32e-3)" "unprognostic (1.47e-2)" "unprognostic (7.89e-2)" "unprognostic (7.47e-2)" "unprognostic (1.06e-1)" "unprognostic (4.12e-2)" "prognostic favorable (9.64e-6)" "unprognostic (5.99e-2)" "unprognostic (4.77e-2)" "unprognostic (1.59e-1)" "unprognostic (6.89e-2)" "prognostic favorable (4.08e-7)" "unprognostic (3.31e-3)" "unprognostic (2.12e-2)" "unprognostic (5.19e-2)" "unprognostic (1.48e-1)" 7.3 4.9 3.6 7.2 7.9 2.3 7.7 35.9 12.9 8.2 10.5 1.7 1.8 9.0 10.0 4.4 14.2 6.1 11.2 3.0 3.6 5.6 14.6 8.5 8.6 8.9 5.3 6.4 6.6 6.3 3.7 13.5 2.2 20.8 4.6 9.3 3.8 6.3 3.4 3.7 15.1 15.2 6.9 5.9 6.8 8.8 8.5 2.9 1.3 4.7 4.7 9.3 6.2 8.1 1.0 0.6 2.0 0.9 7.6 6.7 3.4 2.6 0.5 0.8 3.9 3.8 7.0 0.8 3.4 6.2 2.7 6.5 0.5 1.1 0.0 0.4 4.2 3.2 2.3 0.6 4.2 2.3 2.9 0.5 27.2 1.2 4.9 6.2 0.0 0.6 6.8 3.3 5.6 6.3 1.9 3.8 2.3 0.1 6.2 6.8 0.8 1.4 0.1 1.0 8.2 0.8 0.3 2.1 1.2 5.8 15.5 2.0 0.4 0.8 2.0 0.6 1.3 8.7 1.7 2.8 1.5 1.3 2.1 0.9 0.1 0.0 0.0 1.4 0.3 0.7 2.0 0.9 1.2 4.1 0.7 5.4 0.3 5.6 6.3 0.6 1.0 6.7 4.1 0.7 7.6 0.9 0.1 4.9 3.4 3.6 7.9 35.9 12.9 3.6 5.6 5.3 6.4 20.8 2.9 11.9 17.5 2.7 6.0 15.3 23.4 2.7 7.6 16.0 9.1 7.0 0.0 2.7 14.9 5.3 30.6 6.3 28.8 0.0 19.0 0.9 8.9 7.4 27.8 10.4 4.2 12.7 12.2 6.2 3.7 25.3 6.6 5.6 6.8 2.8 14.3 16.0 10.1 44.2 12.0 32.1 3.9 0.0 10.3 2.3 1.9 18.7 3.4 20.1 12.6 13.2 TTC39C "C18orf17, FLJ33761, HsT2697" ENSG00000168234 "Tetratricopeptide repeat domain 39C" Q8N584 18 23992773-24135610 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 92.2" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 120.1;Hepatocytes: 148.6;Late spermatids: 236.0;Rod photoreceptor cells: 233.7" "Cancer enhanced" "Detected in all" "liver cancer: 19.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 35.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065705, HPA065713" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA065705: AB_2685538, HPA065713: AB_2685542" "prognostic favorable (1.48e-4)" "unprognostic (6.37e-2)" "unprognostic (3.66e-1)" "unprognostic (9.97e-2)" "unprognostic (4.37e-2)" "unprognostic (2.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.30e-3)" "unprognostic (2.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.60e-5)" "unprognostic (2.32e-1)" "unprognostic (3.51e-1)" "unprognostic (8.94e-3)" "unprognostic (4.48e-3)" 9.0 14.2 6.2 12.0 4.9 17.7 10.9 5.1 12.2 8.7 6.3 2.4 1.5 5.1 9.8 6.5 9.4 9.0 17.2 3.9 5.3 2.7 3.3 92.2 7.1 14.1 2.2 6.7 5.9 9.8 1.3 13.4 1.5 6.2 9.7 4.6 20.8 11.8 3.9 4.7 24.2 6.2 5.3 2.2 6.7 6.1 14.3 1.0 12.0 3.7 5.7 20.9 8.3 9.3 5.2 8.8 0.5 1.9 5.7 35.5 4.2 6.6 4.9 3.3 2.2 21.1 22.3 12.1 9.5 21.8 7.6 7.8 0.6 3.7 10.9 9.4 16.6 5.7 8.3 6.5 8.3 6.1 16.3 6.7 3.2 23.9 12.3 4.1 17.1 8.5 18.0 11.3 4.3 6.1 14.1 0.5 7.9 0.1 0.1 4.8 5.1 2.8 5.2 8.2 2.9 12.7 15.7 5.0 4.2 7.9 10.1 8.8 7.0 18.4 6.1 5.8 3.6 4.8 6.3 4.2 6.7 5.0 5.1 4.8 0.2 0.0 15.9 9.0 17.9 4.5 0.5 1.9 0.0 11.2 1.9 28.8 5.2 24.9 14.0 2.5 3.3 10.7 9.0 0.5 5.7 1.5 8.8 35.5 4.2 6.2 4.9 5.1 12.2 5.3 2.7 2.2 6.7 6.2 1.0 0.0 4.3 22.3 15.8 40.9 14.4 3.1 53.5 12.0 2.3 7.0 43.2 0.5 0.0 9.7 120.1 3.0 2.2 0.0 10.1 12.5 12.4 19.8 2.3 148.6 11.3 12.7 4.1 4.9 24.7 236.0 10.3 20.8 13.5 1.8 9.0 20.5 8.2 0.0 7.4 1.1 233.7 0.0 8.3 23.8 1.7 75.3 0.5 59.9 4.6 16.7 TTC6 "C14orf25, NCRNA00291" ENSG00000139865 "Tetratricopeptide repeat domain 6" Q86TZ1 14 37595847-38041442 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 9.7;prostate: 20.5" "Cell type enhanced" "Detected in some" 14 "Club cells: 18.2;Early spermatids: 30.4;Late spermatids: 14.0" "Group enriched" "Detected in some" 7 "breast cancer: 2.2;prostate cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 7.3;MCF7: 10.7;RT4: 7.5;T-47d: 20.7" HPA069293 Approved Centrosome NA NA Centrosome "HPA069293: AB_2686110" "unprognostic (7.92e-2)" "unprognostic (6.95e-2)" "unprognostic (9.22e-2)" "unprognostic (1.98e-1)" "unprognostic (7.06e-2)" "unprognostic (1.22e-2)" "unprognostic (1.68e-1)" "unprognostic (3.60e-4)" "unprognostic (6.75e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-4)" "unprognostic (5.60e-2)" "unprognostic (8.91e-8)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-1)" "unprognostic (6.07e-3)" 0.0 0.0 0.3 1.3 0.6 0.0 9.7 0.3 0.6 0.2 2.2 0.2 0.0 0.6 0.0 1.3 0.6 0.4 1.0 0.0 0.8 0.9 0.0 7.9 5.6 0.0 0.7 0.4 0.4 0.0 0.0 1.1 0.3 0.1 20.5 0.5 0.0 3.0 1.1 0.0 0.8 1.2 2.5 0.6 0.0 3.8 6.0 0.0 0.0 0.0 0.6 2.3 2.2 4.6 0.6 0.2 0.4 0.0 0.0 0.1 0.0 0.6 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.4 0.0 0.0 2.2 1.2 0.2 0.0 0.0 3.1 0.0 0.9 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 10.7 0.0 0.0 0.0 1.5 4.0 0.0 0.0 0.0 1.0 7.5 2.2 0.0 0.0 4.1 0.0 0.0 20.7 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.6 0.3 0.6 0.8 0.9 0.7 0.4 0.1 0.0 0.0 6.7 0.0 2.6 0.0 0.0 0.6 2.5 8.1 18.2 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 2.5 0.0 0.0 7.5 0.0 0.0 14.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 4.4 0.4 0.0 0.0 0.0 0.8 2.7 TTC7A "KIAA1140, TTC7" ENSG00000068724 "Tetratricopeptide repeat domain 7A" Q9ULT0 2 46916157-47076137 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 56.0" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 47.0;Late spermatids: 143.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "REH: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036781, HPA036782" Enhanced NA NA "HPA036781: AB_10673665, HPA036782: AB_10671711" "unprognostic (2.51e-1)" "unprognostic (1.43e-1)" "unprognostic (8.56e-2)" "unprognostic (1.67e-2)" "unprognostic (4.01e-2)" "unprognostic (1.03e-3)" "unprognostic (1.51e-3)" "unprognostic (3.60e-1)" "unprognostic (4.36e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (3.19e-3)" "unprognostic (1.15e-1)" "unprognostic (5.06e-3)" "unprognostic (1.30e-1)" "unprognostic (9.62e-2)" "unprognostic (1.52e-1)" "unprognostic (5.15e-2)" 8.9 18.2 7.1 10.6 18.1 18.7 7.1 2.1 10.4 7.4 14.7 16.0 4.0 14.2 5.0 5.8 14.2 6.0 7.3 4.3 8.1 4.2 7.3 6.4 13.8 10.8 17.0 4.2 5.2 17.2 7.0 5.3 12.6 10.6 5.4 6.9 8.6 13.6 5.9 2.2 12.4 22.5 4.3 12.3 11.6 11.6 36.7 16.2 56.0 11.3 6.0 16.2 6.1 8.9 3.8 5.3 1.4 5.0 0.5 2.5 1.4 16.7 6.1 2.1 0.5 3.2 3.8 8.5 4.6 6.2 3.0 2.8 9.5 9.9 11.3 4.5 8.4 3.5 7.0 2.8 5.8 2.5 21.8 2.3 1.1 4.5 10.3 1.2 4.5 4.6 1.5 7.1 3.8 4.8 3.6 2.4 4.4 4.3 7.5 1.6 6.1 22.5 5.9 2.2 18.1 1.6 37.8 3.4 19.5 2.9 4.3 2.7 2.4 8.5 16.9 1.5 4.0 3.2 9.8 6.1 3.3 2.7 2.4 3.8 4.8 1.8 6.1 2.5 5.5 1.9 0.1 5.0 0.0 0.8 2.5 1.2 3.8 2.5 0.9 3.4 3.5 1.8 0.7 1.4 0.5 0.8 5.3 1.1 1.4 7.1 18.1 2.1 10.4 8.1 4.2 17.0 4.2 10.6 16.2 20.8 14.3 15.2 4.1 5.8 1.3 3.5 15.3 8.1 4.5 7.0 0.0 5.4 3.3 4.8 47.0 3.6 24.1 0.0 6.4 9.0 5.8 3.2 8.1 7.5 15.6 0.0 6.4 2.5 27.4 143.1 4.4 16.5 5.0 2.8 7.9 23.0 16.2 10.5 6.3 3.4 3.3 0.0 4.8 5.6 6.8 4.8 3.3 5.0 4.7 4.3 TTC9 "KIAA0227, TTC9A" ENSG00000133985 "Tetratricopeptide repeat domain 9" Q92623 14 70641787-70675360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.0" "Cell type enhanced" "Detected in many" 10 "Pancreatic endocrine cells: 24.0;Urothelial cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.7;Daudi: 10.3;RH-30: 14.4;SK-BR-3: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.37e-2)" "unprognostic (6.01e-2)" "unprognostic (9.29e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.81e-2)" "unprognostic (2.38e-2)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.18e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.10e-8)" "unprognostic (1.22e-2)" "unprognostic (1.01e-1)" "unprognostic (3.16e-2)" "unprognostic (9.38e-2)" 1.3 1.7 7.6 4.2 11.0 1.3 4.3 6.3 9.7 4.0 1.3 1.5 2.2 1.3 1.8 2.0 42.0 10.8 3.9 2.4 7.5 6.5 2.3 1.5 4.8 8.9 4.6 10.3 0.6 1.4 2.1 3.2 5.8 9.8 3.1 1.4 1.5 9.8 2.2 6.5 5.4 2.0 1.4 2.9 5.8 4.4 1.0 1.5 1.2 4.6 7.2 18.6 3.2 9.0 3.4 0.2 2.3 3.5 0.0 3.4 0.7 11.7 1.4 4.5 0.2 0.0 0.0 4.8 0.2 0.1 0.3 1.5 0.2 5.9 10.3 1.6 0.1 1.0 4.3 3.3 0.4 0.2 0.3 1.2 1.4 0.4 3.3 0.0 0.0 3.0 0.4 0.8 0.0 0.1 0.2 0.0 2.3 0.0 0.9 4.8 5.8 0.2 0.1 2.5 8.5 1.5 2.4 14.4 0.1 7.4 2.7 2.8 1.3 1.3 24.4 0.0 2.8 8.5 0.4 0.0 0.0 2.2 0.0 0.2 0.0 0.1 3.2 0.0 0.2 0.1 0.0 0.0 1.5 1.1 0.7 2.5 1.8 2.0 1.5 0.2 3.4 3.4 1.9 2.3 0.0 3.5 0.0 1.0 0.7 7.6 11.0 6.3 9.7 7.5 6.5 4.6 10.3 9.8 1.5 3.0 7.4 5.2 3.4 0.9 2.8 1.6 15.3 10.7 3.4 8.7 5.9 18.7 1.7 18.9 0.2 3.3 0.0 0.0 4.9 1.2 1.0 10.4 1.1 1.6 2.2 0.0 1.2 0.0 6.4 0.6 0.0 0.0 6.8 0.0 0.3 16.0 24.0 0.0 0.0 0.0 5.1 0.0 0.5 0.0 1.3 1.5 6.2 2.5 0.6 48.2 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell type enhanced" "Detected in some" 26 "Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Secreted in brain" NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 25.1 1.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 0.0 0.0 0.0 0.0 0.0 37.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 17.5 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.7 0.0 7.3 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.2 0.1 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.3;testis: 31.7" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol NA Yes "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 1.1 1.4 0.3 3.2 0.4 13.9 1.0 0.3 0.4 1.0 2.7 0.2 0.2 2.2 0.5 1.0 6.5 0.3 0.4 1.5 0.4 0.3 0.9 0.6 1.2 4.6 0.4 0.2 0.4 0.5 0.0 0.3 3.0 0.6 0.6 3.6 0.3 1.2 0.6 0.3 2.0 2.8 0.7 0.8 2.1 1.8 31.7 0.2 58.3 0.5 2.6 5.4 0.8 1.8 1.7 0.0 1.1 0.0 1.1 4.0 0.8 13.3 8.0 24.0 19.6 1.1 3.5 13.6 15.5 9.5 22.7 27.8 10.9 10.2 19.8 12.1 6.6 23.8 17.3 21.1 9.5 31.6 18.0 17.0 18.3 10.6 8.9 0.0 21.5 11.9 0.4 1.0 15.8 10.1 3.3 12.8 27.9 19.9 20.4 19.2 9.9 12.2 15.5 14.1 12.0 9.7 11.0 43.8 8.2 5.7 8.6 16.5 9.7 9.1 9.9 5.6 13.5 9.3 16.3 5.3 10.2 10.2 6.6 24.7 4.6 15.5 11.0 3.6 20.0 8.7 0.0 0.0 1.1 0.6 0.0 0.6 0.9 1.0 1.6 0.0 1.7 0.3 0.5 0.3 1.1 0.0 0.0 4.0 0.8 0.3 0.4 0.3 0.4 0.4 0.3 0.4 0.2 0.6 0.2 3.0 0.6 0.0 0.5 1.1 0.0 0.7 0.0 4.0 3.4 0.0 2.0 4.1 3.3 0.4 19.9 0.1 0.2 23.3 0.2 13.1 0.8 0.2 1.1 0.0 5.2 0.0 1.7 0.0 2.4 12.8 0.9 1.2 0.0 9.0 1.0 0.3 0.4 0.0 0.7 0.0 1.2 6.5 0.2 63.4 28.5 0.3 3.1 0.0 1.2 0.7 TTLL10 "FLJ36119, TTLL5" ENSG00000162571 "Tubulin tyrosine ligase like 10" Q6ZVT0 1 1173884-1197935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 48.2" "Group enriched" "Detected in many" 8 "Early spermatids: 234.3;Late spermatids: 619.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "pons and medulla: 2.2" "Cell type enriched" "Detected in single" 29 "NK-cell: 2.9" "Lineage enriched" "Detected in single" 29 "NK-cells: 2.9" "Cell line enriched" "Detected in single" 24 "SCLC-21H: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA042712 Uncertain NA NA "HPA042712: AB_10797019" "unprognostic (1.74e-1)" "unprognostic (7.95e-2)" "unprognostic (2.66e-3)" "prognostic favorable (1.61e-5)" "unprognostic (5.33e-2)" "unprognostic (2.68e-3)" "unprognostic (4.93e-3)" "unprognostic (2.14e-3)" "unprognostic (4.50e-1)" "unprognostic (3.69e-2)" "unprognostic (1.28e-2)" "unprognostic (6.63e-2)" "unprognostic (6.00e-4)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (1.12e-1)" "unprognostic (4.39e-2)" 1.2 0.0 0.1 0.1 0.5 0.0 0.6 0.1 0.2 1.7 0.1 1.0 0.1 0.0 0.2 1.1 0.1 10.9 0.1 0.1 0.3 0.3 0.1 0.1 3.1 0.1 0.1 0.3 0.7 0.1 0.0 1.3 1.5 2.2 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.5 48.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.2 0.3 0.3 0.1 0.3 2.2 0.3 0.0 0.3 0.0 0.5 1.5 0.0 0.6 2.5 54.9 2.3 0.0 2.0 0.0 0.0 0.2 234.3 0.5 0.0 0.0 1.2 0.7 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 619.5 4.9 0.0 0.0 0.0 3.1 0.2 0.9 0.0 4.2 0.0 0.0 6.5 0.0 2.8 2.1 1.8 0.1 0.0 4.1 1.0 TTLL11 "bA244O19.1, C9orf20" ENSG00000175764 "Tubulin tyrosine ligase like 11" Q8NHH1 9 121821928-122093606 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.5" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 21.0;Late spermatids: 19.2;Spermatocytes: 10.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021828 Approved "Intracellular and membrane" NA NA "HPA021828: AB_2670841" "unprognostic (2.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (5.56e-3)" "unprognostic (7.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.59e-3)" "unprognostic (2.30e-1)" "unprognostic (1.10e-1)" "unprognostic (3.71e-2)" "unprognostic (5.27e-3)" "unprognostic (3.88e-2)" "unprognostic (3.61e-6)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "unprognostic (5.62e-2)" "unprognostic (3.53e-2)" 4.9 5.8 8.5 3.3 14.4 1.6 4.6 15.7 17.2 5.3 8.3 35.5 4.1 3.4 6.2 4.0 9.0 6.5 4.4 6.4 10.9 6.8 3.8 6.7 4.8 2.9 15.6 10.5 5.7 6.2 7.7 5.2 5.5 17.3 5.9 5.3 2.7 6.0 7.0 26.6 5.0 3.6 11.7 19.9 3.8 4.6 13.4 16.1 1.3 4.5 3.7 3.2 6.4 4.2 2.0 1.5 0.0 1.0 1.7 0.5 0.2 2.7 1.4 4.6 6.2 6.5 7.9 1.8 5.2 6.4 9.1 5.2 4.2 1.6 6.1 1.6 10.7 3.0 6.7 7.9 6.2 5.6 4.2 6.5 3.0 6.1 4.2 7.5 5.2 3.5 5.6 9.0 3.6 5.8 3.4 3.2 5.4 9.0 6.2 3.2 4.2 3.7 4.2 2.4 9.3 9.7 3.8 8.0 9.5 4.7 2.2 9.7 4.0 3.1 5.9 3.8 2.6 4.7 4.6 3.6 4.3 0.8 7.7 6.9 6.9 8.6 2.6 4.0 5.9 1.2 0.0 1.0 0.0 0.0 0.5 0.1 2.0 0.2 0.0 0.4 0.4 0.2 0.5 0.0 1.7 0.7 1.5 0.1 0.2 8.5 14.4 15.7 17.2 10.9 6.8 15.6 10.5 17.3 16.1 0.0 1.0 2.2 0.8 2.3 2.6 1.5 2.5 2.7 0.0 1.8 9.8 1.2 1.7 1.8 21.0 0.6 0.5 0.0 1.6 0.6 1.4 0.8 1.1 1.7 1.4 6.4 1.2 0.0 0.3 19.2 3.4 0.0 3.3 0.0 1.3 1.5 1.7 0.0 2.8 1.3 2.6 0.0 3.3 10.7 2.3 3.6 0.8 1.0 0.9 0.8 TTLL13P "FLJ46079, MGC33417, TTLL13" ENSG00000213471 "Tubulin tyrosine ligase like 13, pseudogene" A6NNM8 15 90249530-90265482 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 50 "testis: 34.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CACO-2: 1.3;HEL: 1.2;JURKAT: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA041305 Enhanced NA NA "HPA041305: AB_2732492" "unprognostic (6.23e-3)" "unprognostic (2.19e-2)" "unprognostic (6.49e-4)" "unprognostic (6.09e-4)" "unprognostic (2.46e-1)" "unprognostic (1.43e-1)" "unprognostic (8.58e-2)" "unprognostic (5.17e-3)" "unprognostic (3.61e-3)" "unprognostic (9.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.79e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-2)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.88e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.6 0.1 0.0 0.4 0.0 0.0 0.9 0.0 1.1 0.2 0.0 0.5 0.2 1.3 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 1.2 0.9 0.4 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.3 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325086-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "testis: 54.1" "Group enriched" "Detected in some" 167 "Early spermatids: 407.9;Late spermatids: 161.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "CACO-2: 6.3" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" NA NA "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 54.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.8 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 407.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 TTLL4 KIAA0173 ENSG00000135912 "Tubulin tyrosine ligase like 4" Q14679 2 218710845-218755416 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 39.1" "Cell type enhanced" "Detected in many" 13 "Muller glia cells: 91.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027091, HPA050252" Approved Approved Mitochondria NA NA Mitochondria "HPA027091: AB_10601828, HPA050252: AB_2681064" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.64e-1)" "unprognostic (1.49e-2)" "unprognostic (2.09e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (3.83e-3)" "unprognostic (2.96e-2)" "unprognostic (1.21e-1)" "unprognostic (7.52e-2)" "unprognostic (2.42e-2)" "prognostic unfavorable (6.63e-12)" "unprognostic (9.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" "unprognostic (5.29e-3)" 6.1 9.0 10.6 11.1 15.1 7.1 9.0 11.2 12.7 5.9 7.7 17.7 5.9 7.9 8.5 5.5 9.2 10.5 7.0 5.9 10.9 6.8 6.3 7.7 8.7 8.0 16.6 6.3 6.9 9.1 8.8 14.5 11.0 13.1 8.4 9.3 11.2 8.9 5.8 7.0 10.8 8.0 7.6 16.7 7.6 12.6 39.1 14.1 8.6 5.3 5.3 11.9 6.1 7.7 4.0 6.8 13.5 11.3 1.8 3.2 3.9 9.0 6.1 16.3 8.2 4.2 3.3 23.0 6.3 4.9 10.0 8.6 25.7 10.7 7.1 5.4 4.6 9.7 10.1 17.1 8.3 11.8 8.5 15.6 9.2 9.2 24.4 6.0 11.3 6.8 5.4 5.1 9.0 10.2 4.3 9.5 8.0 26.0 11.2 5.5 5.2 6.2 7.7 18.7 6.5 4.3 14.9 7.4 9.3 10.0 7.1 6.7 6.5 4.6 6.9 11.9 26.1 5.5 5.8 4.0 9.0 9.4 6.2 5.9 5.9 4.9 16.1 4.7 7.1 11.6 0.1 11.3 0.7 3.2 5.7 2.9 4.0 2.3 2.2 6.8 3.2 1.5 1.4 13.5 1.8 7.4 4.0 1.4 3.9 10.6 15.1 11.2 12.7 10.9 6.8 16.6 6.3 13.1 14.1 3.0 4.3 2.9 9.9 4.0 5.9 1.4 2.5 1.4 4.5 7.0 25.5 5.5 0.0 4.7 28.9 2.3 2.6 0.0 3.3 6.9 3.7 11.6 1.1 1.7 7.0 3.2 5.2 2.5 3.2 13.2 2.8 5.4 3.3 7.2 4.4 91.9 5.0 2.9 1.4 1.4 12.6 0.0 3.1 14.4 12.1 3.6 4.8 2.5 4.4 10.3 TTLL5 KIAA0998 ENSG00000119685 "Tubulin tyrosine ligase like 5" Q6EMB2 14 75633625-75955078 "Disease related genes, Predicted intracellular proteins" Transcription Ligase "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 119.8;Early spermatids: 86.9;Late spermatids: 71.0;Rod photoreceptor cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032128 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA032128: AB_10600835" "unprognostic (7.35e-2)" "unprognostic (7.29e-2)" "unprognostic (7.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (5.96e-2)" "unprognostic (7.21e-5)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (7.93e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-1)" "unprognostic (5.67e-3)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (8.97e-2)" "unprognostic (2.15e-2)" 5.9 6.5 7.6 5.9 11.1 10.1 7.4 12.0 10.4 8.0 6.5 18.0 6.4 4.9 11.8 7.7 8.1 11.8 6.7 6.8 7.9 7.1 6.6 4.4 6.6 5.0 10.1 6.9 8.1 5.8 13.2 9.5 7.6 13.9 7.4 7.6 8.2 7.7 7.5 5.2 7.2 4.8 8.9 15.8 4.2 6.0 51.1 10.5 10.1 8.1 5.5 7.3 7.1 7.1 3.8 5.7 12.4 3.8 3.4 5.1 2.3 14.3 10.5 9.3 9.5 7.3 11.4 8.5 8.5 10.3 10.2 13.1 6.5 13.5 4.0 4.7 8.9 7.5 13.7 7.9 14.0 19.4 4.8 4.8 7.9 11.0 7.1 6.2 5.7 7.7 8.7 7.0 12.8 14.3 11.1 21.9 11.4 4.5 6.9 10.1 20.1 9.7 7.9 6.6 11.3 10.8 6.0 13.0 5.5 9.8 14.2 12.2 7.8 17.9 13.1 4.4 7.5 18.0 6.3 24.7 13.6 12.1 12.0 7.8 5.8 8.3 9.4 13.8 6.6 9.0 12.4 3.5 2.7 4.6 3.3 4.0 3.8 4.2 4.5 5.1 3.5 5.1 4.7 3.8 3.4 3.8 5.7 3.4 2.3 7.6 11.1 12.0 10.4 7.9 7.1 10.1 6.9 13.9 10.5 3.0 8.5 2.4 5.1 4.4 8.9 7.6 20.4 34.8 13.6 10.4 119.8 6.8 3.3 6.0 86.9 9.0 6.3 0.0 4.6 11.2 7.8 7.7 11.6 5.8 5.0 0.0 7.5 24.5 7.0 71.0 11.5 6.4 5.0 9.0 6.1 8.1 4.3 9.9 11.0 1.4 81.7 12.9 4.4 28.7 15.8 5.5 5.0 6.9 6.8 4.1 TTLL6 FLJ35808 ENSG00000170703 "Tubulin tyrosine ligase like 6" Q8N841 17 48762235-48817214 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.8;intestine: 5.0;testis: 17.6" "Group enriched" "Detected in many" 11 "Ciliated cells: 40.2;Early spermatids: 40.1;Late spermatids: 142.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HDLM-2: 9.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA052397 Enhanced Approved Vesicles,Microtubules NA NA Microtubules Vesicles "HPA052397: AB_2681812" "unprognostic (5.74e-2)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-1)" "unprognostic (8.04e-2)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.35e-1)" "unprognostic (2.21e-5)" "unprognostic (1.10e-2)" "unprognostic (6.01e-5)" "unprognostic (1.17e-1)" "unprognostic (3.28e-1)" "unprognostic (6.68e-2)" "unprognostic (2.09e-3)" 0.1 0.0 0.5 3.3 0.5 0.0 0.1 0.1 1.1 0.2 3.6 0.1 1.3 1.6 0.8 0.1 0.1 4.8 1.4 0.1 0.8 0.4 1.8 0.1 1.1 0.1 0.2 1.1 0.8 0.6 0.0 0.3 0.1 0.9 0.1 5.0 0.3 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.1 0.1 17.6 0.1 0.1 0.1 0.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 9.9 0.1 0.3 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 1.1 0.8 0.4 0.2 1.1 0.9 0.1 3.0 1.6 0.0 0.0 0.0 0.1 0.4 0.0 40.2 6.8 1.8 0.0 0.0 1.7 0.1 40.1 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 4.1 1.8 0.0 142.0 1.1 0.0 0.0 0.0 3.1 0.3 0.0 2.6 0.0 2.1 0.4 0.0 0.0 5.6 0.3 0.0 0.0 0.0 3.3 0.1 TTLL7 FLJ23033 ENSG00000137941 "Tubulin tyrosine ligase like 7" Q6ZT98 1 83865028-83999150 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Ligase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.8" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 124.4;Early spermatids: 135.0;Rod photoreceptor cells: 112.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 3.3" "Lineage enriched" "Detected in single" 32 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "HDLM-2: 20.7;RH-30: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052249 Uncertain NA NA "HPA052249: AB_2681773" "unprognostic (9.68e-2)" "unprognostic (3.78e-1)" "unprognostic (3.15e-1)" "unprognostic (2.82e-2)" "unprognostic (6.56e-2)" "unprognostic (1.30e-1)" "unprognostic (1.25e-3)" "unprognostic (1.95e-1)" "unprognostic (3.06e-1)" "unprognostic (3.63e-2)" "unprognostic (7.93e-4)" "unprognostic (4.34e-1)" "unprognostic (1.84e-3)" "unprognostic (3.32e-1)" "unprognostic (2.67e-2)" "unprognostic (3.77e-3)" "unprognostic (1.04e-3)" 7.4 3.7 20.6 3.1 33.6 1.4 2.8 12.4 47.8 4.1 4.3 24.7 0.7 3.9 7.0 3.6 6.4 8.0 7.6 5.2 19.4 11.7 2.5 3.1 6.0 1.5 33.1 17.2 2.7 4.9 7.8 11.3 1.4 24.2 10.2 4.9 2.8 5.1 5.8 4.0 1.7 3.9 12.9 24.9 2.0 4.9 8.7 41.3 0.0 3.8 0.5 1.6 6.9 3.1 0.0 0.0 3.3 0.0 0.0 0.1 0.0 2.4 0.1 1.9 3.4 1.7 3.9 0.0 5.3 2.1 1.9 3.6 0.0 0.4 0.0 1.6 4.9 7.8 0.0 3.7 1.9 2.9 20.7 2.7 3.0 3.9 0.1 0.9 0.1 0.4 1.2 0.1 3.0 0.1 5.7 2.1 0.1 0.0 7.8 7.8 0.0 0.0 0.0 1.5 0.0 2.6 0.0 16.8 0.0 0.3 1.3 10.7 6.8 2.8 1.6 1.7 3.7 2.3 0.1 0.2 2.9 1.2 0.4 5.6 2.7 4.7 0.1 4.0 0.0 4.2 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 33.6 12.4 26.8 19.4 11.7 33.1 17.2 24.2 41.3 62.5 9.8 1.9 17.3 2.9 124.4 15.1 15.3 37.5 12.5 7.0 68.7 0.5 1.7 14.6 135.0 5.5 0.7 0.0 6.4 0.2 6.5 31.5 24.3 2.6 0.5 90.6 26.5 4.9 0.0 21.5 10.0 2.5 16.9 0.0 3.0 17.1 6.9 3.5 79.5 5.8 112.3 19.4 54.6 75.3 33.1 1.8 0.6 1.9 0.8 22.5 TTLL8 ENSG00000138892 "Tubulin tyrosine ligase like 8" A6PVC2 22 50015123-50056935 "Predicted intracellular proteins" Ligase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 36 "testis: 8.4" "Group enriched" "Detected in some" 38 "Cardiomyocytes: 1.7;Early spermatids: 4.6;Late spermatids: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "U-266/70: 4.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA016882 Uncertain NA NA "HPA016882: AB_10603223" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (8.18e-2)" "unprognostic (1.21e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.1 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TTLL9 "C20orf125, dJ310O13.1" ENSG00000131044 "Tubulin tyrosine ligase like 9" Q3SXZ7 20 31870702-31944963 "Cancer-related genes, Predicted intracellular proteins" Ligase "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 30.5;Ciliated cells: 65.6;Early spermatids: 31.2;Late spermatids: 53.4" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.8;REH: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041772, HPA055676" Uncertain Uncertain Nucleoplasm,Microtubules NA NA "Nucleoplasm, Microtubules" "HPA041772: AB_10959904, HPA055676: AB_2682881" "unprognostic (8.77e-2)" "unprognostic (8.19e-3)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (4.63e-1)" "unprognostic (1.53e-3)" "unprognostic (1.80e-1)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.59e-1)" "unprognostic (9.05e-3)" "unprognostic (6.17e-2)" "unprognostic (8.35e-3)" "unprognostic (1.84e-1)" "unprognostic (1.70e-1)" "unprognostic (1.25e-3)" "unprognostic (2.23e-2)" 0.4 0.6 3.4 0.5 8.9 0.4 1.3 1.0 2.8 0.6 0.5 10.9 1.8 0.6 1.1 8.9 0.6 9.2 0.8 0.5 4.8 3.7 0.8 0.5 1.7 0.7 5.2 0.6 1.8 0.4 2.8 2.8 0.7 16.0 0.6 0.5 0.0 0.5 1.8 0.4 0.6 0.4 0.6 4.5 0.5 0.6 11.0 4.0 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 1.8 0.0 0.9 0.0 0.8 0.0 0.4 0.0 0.0 0.0 1.9 0.0 0.0 0.3 0.0 0.4 0.7 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.3 0.5 0.3 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 8.9 1.0 2.7 4.8 3.7 5.2 0.6 16.0 4.0 11.9 30.5 0.0 0.9 0.1 1.7 0.8 0.0 65.6 13.6 0.0 3.9 0.1 0.0 0.1 31.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 7.0 0.0 0.0 4.8 0.0 0.6 0.0 53.4 1.4 0.8 0.0 1.0 0.0 0.3 0.2 0.0 1.1 0.0 0.5 0.0 0.0 9.7 1.1 0.1 0.0 0.0 0.0 0.3 TTN "CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD" ENSG00000155657 Titin Q8WZ42 2 178525989-178830802 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0" "Cell type enriched" "Detected in many" 134 "Cardiomyocytes: 19161.7" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 4.9" "Not detected" "Not detected" "HPA007042, CAB022682, HPA030048" Enhanced NA NA 25000000 "CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451" "unprognostic (1.00e-2)" "unprognostic (3.92e-1)" "unprognostic (1.77e-1)" "unprognostic (7.11e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (6.62e-2)" "unprognostic (1.84e-1)" "unprognostic (2.49e-2)" "unprognostic (1.86e-1)" "unprognostic (2.79e-1)" "unprognostic (2.65e-1)" "unprognostic (3.49e-4)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (1.34e-2)" 23.7 0.3 0.2 0.3 0.3 0.9 0.3 0.2 0.4 0.2 0.2 0.0 0.0 0.2 0.2 21.3 8.3 0.2 0.3 136.5 0.2 0.2 0.2 0.2 0.4 0.4 0.2 0.0 0.3 0.4 0.2 0.3 0.3 0.0 0.7 0.2 0.0 11.6 0.2 713.8 0.3 0.2 0.2 0.3 0.3 0.2 0.4 0.0 0.0 5.6 227.0 15.8 0.3 0.2 7.0 0.3 1.9 0.3 5.0 7.3 0.1 0.7 0.3 1.9 1.0 0.0 0.0 3.4 0.6 0.0 0.0 0.0 1.8 0.3 2.4 0.6 0.0 1.8 1.8 0.0 0.0 0.0 2.4 2.0 3.7 2.7 1.1 0.0 0.3 0.8 2.4 0.0 0.0 0.0 1.7 1.4 1.8 2.2 1.2 0.4 0.4 1.6 2.5 0.4 0.2 1.8 1.3 4.9 1.3 0.0 0.6 1.1 1.7 0.4 1.3 0.0 1.7 0.8 2.4 1.6 0.0 0.0 0.9 0.4 3.6 0.4 3.5 0.1 1.1 0.9 1.9 0.3 0.7 0.5 0.2 0.2 6.9 1.2 0.9 0.2 7.0 2.7 3.5 1.3 5.0 0.2 0.3 7.3 0.1 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 14.9 142.6 2.2 0.2 0.8 28.9 19161.7 17.8 5.3 11.4 0.0 19.6 0.4 1.7 7.7 35.3 0.7 0.0 0.0 23.6 0.2 0.5 0.1 9.3 0.5 0.2 15.9 4.1 2.5 0.0 4.3 1.1 0.4 0.0 0.0 0.0 10.3 0.9 0.0 4.2 0.0 26.3 0.0 1.4 5.7 0.2 0.1 0.3 4.9 0.0 0.0 TTPA AVED ENSG00000137561 "Alpha tocopherol transfer protein" P49638 8 63048553-63086053 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "liver: 74.1" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 67.2" "Cancer enriched" "Detected in some" 9 "liver cancer: 21.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 3.6;SK-BR-3: 10.3;T-47d: 3.8;U-2 OS: 5.4;U-2197: 6.4" "Low region specificity" "Detected in all" NA NA "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (7.82e-3)" "unprognostic (1.30e-7)" "unprognostic (1.78e-1)" "unprognostic (8.44e-2)" "unprognostic (1.25e-2)" "unprognostic (7.84e-2)" "unprognostic (4.04e-2)" "unprognostic (3.50e-1)" "unprognostic (5.40e-2)" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (1.49e-2)" "unprognostic (3.57e-2)" "unprognostic (5.46e-3)" "unprognostic (6.16e-3)" 0.9 0.4 2.4 0.4 3.3 0.3 2.5 3.5 2.0 0.3 1.6 2.1 0.0 0.4 0.3 0.3 0.3 0.3 0.4 0.3 3.9 1.1 1.4 74.1 0.6 0.3 2.4 1.8 0.3 0.8 0.4 0.3 1.0 3.8 0.3 2.3 0.0 0.3 0.3 0.3 0.4 0.4 0.4 3.1 0.3 0.4 0.4 2.4 0.0 0.3 0.0 0.3 0.3 0.2 0.9 0.3 2.0 0.5 0.3 0.4 0.0 0.1 1.5 1.0 0.2 0.5 0.0 0.0 0.1 0.0 0.4 0.1 0.2 2.4 0.0 0.1 0.0 3.6 0.0 2.7 0.2 0.5 0.0 0.1 0.1 0.2 0.6 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.3 0.0 0.1 0.1 0.2 0.4 1.2 0.1 0.2 1.0 0.1 0.7 0.1 0.0 0.0 0.0 0.7 0.4 0.1 1.0 10.3 1.0 0.1 3.8 0.4 0.3 0.1 5.4 6.4 1.1 0.4 0.0 0.1 2.3 0.1 2.0 2.0 0.5 0.3 0.4 0.1 0.3 0.4 0.3 0.2 0.2 0.9 0.3 0.3 1.6 0.3 0.2 0.3 0.2 0.0 2.4 3.3 3.5 2.0 3.9 1.1 2.4 1.8 3.8 2.4 3.0 0.6 0.0 0.0 0.0 0.0 0.1 5.1 0.0 2.3 0.0 0.0 8.1 1.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 67.2 0.6 0.0 2.4 2.5 1.0 0.0 0.0 0.0 0.0 0.0 1.7 10.6 0.1 0.0 0.0 4.4 0.2 0.0 0.1 0.0 0.1 0.1 8.2 0.0 6.6 0.1 TTR "CTS, CTS1, HsT2651, PALB" ENSG00000118271 Transthyretin P02766 18 31591726-31599021 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Transport "Hormone, Thyroid hormone" "Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "brain: 1008.0;liver: 680.8;retina: 332.4" "Cell type enriched" "Detected in many" 24 "Hepatocytes: 22945.1" "Group enriched" "Detected in many" 28 "liver cancer: 928.2;pancreatic cancer: 666.0" "Region enriched" "Detected in many" 9 "pons and medulla: 1008.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 31.4;EFO-21: 11.1;Hep G2: 48.2;U-2 OS: 14.5" "Group enriched" "Detected in many" 5 "basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9" "Region enhanced" "Detected in many" "pons and medulla: 1006.9" "CAB002517, HPA002550, CAB062567, CAB073406" Supported Approved "Golgi apparatus" "Secreted to blood" NA NA 345000000000 180000000000 "Golgi apparatus" "CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419" "unprognostic (6.79e-3)" "unprognostic (3.38e-2)" "unprognostic (4.10e-1)" "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (8.15e-2)" "unprognostic (3.74e-2)" "unprognostic (9.66e-3)" "unprognostic (8.72e-2)" "unprognostic (1.23e-2)" "unprognostic (8.35e-3)" "unprognostic (5.26e-1)" "unprognostic (3.52e-2)" 0.5 0.4 3.6 0.4 3.0 0.6 0.4 5.8 60.8 0.4 0.6 361.3 0.0 0.9 0.4 0.4 0.4 0.4 3.3 0.4 115.6 4.4 1.0 680.8 0.4 0.4 7.1 0.0 0.4 62.3 1.6 0.5 0.4 1008.0 0.4 0.5 332.4 0.4 0.4 0.4 1.0 0.6 0.4 4.9 0.5 2.0 0.4 0.6 0.0 0.4 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.6 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 48.2 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 14.5 0.0 1.1 0.0 0.6 4.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.0 5.8 60.8 115.6 4.4 7.1 0.0 1008.0 0.6 0.0 0.0 32.7 0.0 0.5 25.4 1.4 973.2 0.0 0.0 5.2 153.2 0.2 5.0 2.7 5.4 0.1 1.1 163.5 1.6 0.6 0.6 0.2 0.0 22945.1 2.3 25.4 342.4 228.9 289.5 6.6 0.3 0.0 0.0 0.0 1.5 13.2 212.8 2.9 0.0 1.1 45.2 0.0 0.4 3.4 0.6 0.1 3.3 0.5 1.6 0.0 TTYH1 ENSG00000167614 "Tweety family member 1" Q9H313 19 54415219-54436900 "Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 66.9" "Group enriched" "Detected in many" 4 "Muller glia cells: 594.3;Rod photoreceptor cells: 149.3" "Cancer enriched" "Detected in many" 15 "glioma: 63.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 6.3;AN3-CA: 19.6;U-2 OS: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023617, HPA050655" Approved NA NA "HPA023617: AB_10600836, HPA050655: AB_2681204" "prognostic favorable (3.64e-4)" "unprognostic (1.71e-1)" "unprognostic (1.24e-2)" "unprognostic (1.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.50e-3)" "unprognostic (8.93e-2)" "unprognostic (1.51e-2)" "unprognostic (5.94e-3)" "unprognostic (1.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.60e-1)" "unprognostic (0.00e+0)" "unprognostic (2.09e-1)" "unprognostic (1.41e-1)" "unprognostic (4.45e-2)" "unprognostic (1.69e-1)" 2.2 2.7 49.5 2.1 55.4 2.1 2.3 17.9 66.9 2.4 2.3 33.9 0.0 2.4 2.6 2.1 2.2 4.4 2.3 2.3 31.0 23.4 2.1 2.1 2.1 2.1 39.3 24.4 2.2 10.4 2.1 1.9 2.1 19.7 2.5 2.1 1.9 2.8 2.4 3.0 2.2 2.1 2.2 29.7 2.4 2.2 7.4 18.0 0.0 2.1 0.0 2.1 2.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.3 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 49.5 55.4 17.9 42.9 31.0 23.4 39.3 24.4 19.7 18.0 3.0 1.1 0.0 1.0 0.7 84.6 1.1 0.0 1.4 1.2 0.0 19.6 0.4 0.0 25.4 3.1 0.6 0.0 0.0 0.5 0.6 0.5 2.1 0.0 0.0 0.2 9.5 1.2 1.3 0.0 4.0 1.7 0.0 21.9 0.0 0.0 594.3 2.2 0.0 0.7 0.6 149.3 6.5 1.4 2.1 4.4 0.6 3.5 0.0 0.2 1.0 TTYH2 C17orf29 ENSG00000141540 "Tweety family member 2" Q9BSA4 17 74213514-74262020 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 84.1" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 58.7;granulocytes: 21.8;Melanocytes: 21.9" "Group enriched" "Detected in all" 6 "glioma: 16.7;melanoma: 20.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 16.6" "Group enriched" "Detected in many" 5 "dendritic cells: 11.5;monocytes: 16.6" "Cell line enhanced" "Detected in many" "HSkMC: 11.8;SK-MEL-30: 41.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.19e-1)" "unprognostic (5.08e-1)" "unprognostic (1.58e-3)" "unprognostic (3.51e-4)" "unprognostic (1.59e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-2)" "unprognostic (5.90e-2)" "unprognostic (8.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.81e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (9.74e-5)" "unprognostic (8.98e-3)" "unprognostic (5.70e-3)" "unprognostic (2.50e-3)" "unprognostic (3.51e-3)" 4.6 4.4 20.7 5.8 32.1 2.8 2.9 4.6 63.5 3.8 3.1 84.1 0.0 2.6 4.4 3.4 3.1 4.8 4.5 12.8 31.6 15.9 1.8 1.9 4.3 5.9 59.3 19.0 12.9 4.9 5.4 3.1 8.2 28.7 2.8 2.6 8.5 5.4 3.9 10.5 4.5 3.2 3.6 48.6 8.8 2.3 9.2 45.6 0.7 8.5 2.1 4.8 3.0 2.1 0.2 11.5 0.8 16.6 0.1 3.1 3.8 0.1 1.0 4.7 4.4 0.5 0.6 0.1 0.2 0.0 0.3 0.0 3.0 0.0 2.6 0.7 0.1 0.5 7.4 4.6 0.1 0.1 6.2 2.6 2.8 0.1 0.2 3.3 0.3 1.9 11.8 2.4 0.1 0.8 0.3 0.1 1.9 0.5 1.3 0.1 0.5 1.3 0.2 0.9 4.3 8.1 4.4 8.4 5.0 0.1 0.3 1.6 5.7 0.0 2.8 41.1 2.5 1.5 0.6 0.1 0.0 2.3 0.0 0.1 0.2 0.1 0.0 0.1 0.8 2.5 0.6 8.0 0.7 1.6 13.9 0.2 0.2 3.1 2.6 9.0 0.2 0.5 1.1 0.8 0.1 16.6 11.5 2.7 3.8 20.7 32.1 4.6 29.8 31.6 15.9 59.3 19.0 28.7 45.6 0.0 5.5 2.2 0.7 2.1 58.7 1.4 2.5 0.0 0.0 0.0 5.9 0.3 0.0 0.1 20.0 2.1 0.0 0.0 0.2 0.4 3.1 0.5 21.8 0.4 4.2 3.2 1.7 0.6 13.0 8.7 8.9 10.1 21.9 15.4 0.0 15.3 0.2 0.0 2.5 0.1 9.1 19.4 3.8 1.5 1.6 2.3 0.2 1.3 0.0 0.3 TUB rd5 ENSG00000166402 "Tubby bipartite transcription factor" P50607 11 8019244-8106112 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 39.3;Horizontal cells: 28.6;Rod photoreceptor cells: 51.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 13.3;HEK 293: 18.2;HeLa: 24.3;SCLC-21H: 27.6;SH-SY5Y: 20.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017997, HPA049019" Enhanced Approved "Nucleoli,Centriolar satellite" "Intracellular and membrane" NA NA "Centriolar satellite" Nucleoli "HPA017997: AB_1858449, HPA049019: AB_2680601" "unprognostic (2.53e-1)" "unprognostic (7.23e-2)" "unprognostic (1.80e-2)" "unprognostic (4.06e-2)" "unprognostic (9.62e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (9.71e-2)" "unprognostic (5.08e-2)" "prognostic favorable (2.85e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.35e-5)" "unprognostic (8.37e-3)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (1.39e-2)" 5.0 18.3 18.9 2.8 16.1 0.7 4.5 12.4 36.4 18.2 4.2 6.3 2.8 2.5 24.3 10.7 3.6 20.8 5.5 10.2 20.5 17.9 11.7 1.0 3.4 2.2 25.1 22.6 17.9 5.1 11.0 18.4 4.6 17.7 8.7 2.9 11.3 5.6 9.0 3.1 6.5 2.4 12.0 9.2 2.1 2.4 5.1 9.1 0.5 10.5 2.9 1.3 5.2 8.7 0.7 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.9 7.1 8.8 6.7 2.3 0.0 4.8 1.2 5.2 6.8 0.0 0.0 0.0 0.4 6.4 2.4 0.0 13.3 1.0 4.5 0.0 18.2 0.0 24.3 2.9 1.1 0.0 0.2 3.5 1.2 2.3 0.0 0.4 0.4 8.2 0.0 0.0 2.4 0.6 0.0 0.0 4.9 0.0 0.0 6.6 0.1 0.0 0.0 0.2 27.6 20.6 3.4 0.0 1.3 3.2 0.8 0.1 0.0 2.9 6.9 0.4 2.0 0.0 0.0 0.0 2.5 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.2 1.2 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.9 16.1 12.4 36.4 20.5 17.9 25.1 22.6 17.7 9.1 0.0 0.0 0.0 1.7 0.7 14.6 2.2 0.0 6.7 1.2 0.0 39.3 0.1 5.0 0.1 3.3 0.5 0.0 0.0 0.0 0.3 6.2 0.7 1.1 0.0 0.2 28.6 1.7 1.8 0.0 3.7 13.6 0.0 1.7 0.0 0.0 11.7 0.0 0.0 13.8 6.3 51.9 0.0 1.3 1.5 1.1 0.6 0.0 0.0 0.0 0.1 TUBA1A "B-ALPHA-1, FLJ25113, TUBA3" ENSG00000167552 "Tubulin alpha 1a" Q71U36 12 49184796-49189324 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 270.7;smooth muscle: 166.4" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 819.1;Ductal cells: 1030.6;monocytes: 926.1" "Cancer enriched" "Detected in all" 9 "glioma: 942.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 151.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 226.7;SCLC-21H: 152.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008686, HPA039247, HPA043684, HPA063394" Enhanced Enhanced Microtubules NA NA Microtubules "CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (3.11e-1)" "unprognostic (1.61e-1)" "unprognostic (3.77e-1)" "unprognostic (1.14e-1)" "unprognostic (4.73e-1)" "unprognostic (1.15e-2)" "unprognostic (2.56e-2)" "unprognostic (2.12e-1)" "unprognostic (3.49e-2)" "unprognostic (3.80e-1)" "unprognostic (1.11e-3)" "unprognostic (9.79e-2)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.07e-2)" "unprognostic (4.27e-2)" "unprognostic (1.12e-2)" "unprognostic (1.27e-3)" 27.8 25.5 82.1 29.4 81.3 24.7 35.4 63.2 163.0 40.6 48.8 210.9 6.9 9.9 71.7 34.8 27.7 65.3 37.9 26.3 99.3 118.3 10.3 4.2 39.8 13.4 131.0 50.2 35.7 9.9 16.0 20.6 23.1 165.2 35.1 26.7 16.7 13.6 53.4 5.9 20.0 14.5 166.4 270.7 11.6 18.3 15.7 50.4 19.4 7.4 7.3 10.6 35.1 14.5 14.8 28.9 151.2 69.2 7.5 15.7 38.4 0.2 10.2 226.7 32.2 20.6 49.9 0.8 19.1 24.5 12.6 29.3 0.6 4.1 8.1 23.8 61.7 23.2 0.4 26.9 6.9 9.8 6.7 9.2 2.7 2.1 2.3 4.0 4.8 0.2 28.1 2.7 24.7 2.5 47.4 74.4 17.7 3.1 9.2 67.2 4.5 20.5 3.9 23.9 0.3 7.6 16.5 16.2 1.0 56.1 0.9 152.7 83.6 5.3 0.4 7.2 37.0 16.1 6.5 63.3 13.5 8.5 1.6 5.5 3.1 8.9 16.2 7.3 7.9 13.4 38.8 23.0 73.1 15.7 48.9 11.5 14.8 13.9 14.3 28.9 14.6 13.6 12.5 151.2 7.5 69.2 9.3 15.2 38.4 82.1 81.3 63.2 126.2 99.3 118.3 131.0 50.2 165.2 50.4 214.4 242.9 85.9 170.9 77.4 225.2 156.6 25.5 819.1 121.7 61.1 72.6 8.0 21.6 1030.6 8.3 170.4 2.2 0.0 13.8 13.6 257.4 39.2 532.6 1.0 383.6 235.2 754.8 152.9 63.0 14.2 179.2 227.9 173.7 926.1 14.3 698.4 320.1 4.2 134.0 28.1 331.3 161.7 313.6 10.0 11.3 86.8 13.3 132.0 9.6 82.6 TUBA3C "bA408E5.3, TUBA2" ENSG00000198033 "Tubulin alpha 3c" Q13748 13 19173770-19181852 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 415 "testis: 161.0" "Cell type enhanced" "Detected in some" 22 "Early spermatids: 509.9;Late spermatids: 171.1;Spermatocytes: 798.7;Spermatogonia: 313.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 50 "HDLM-2: 28.0;U-2 OS: 71.3;U-266/70: 23.1;U-266/84: 28.0" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA Yes Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (3.76e-3)" "unprognostic (1.33e-1)" "unprognostic (3.00e-1)" "unprognostic (1.04e-1)" "unprognostic (1.26e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 161.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 71.3 0.0 0.0 23.1 28.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 509.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 171.1 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 12.9 0.0 798.7 313.9 0.3 0.0 0.0 0.0 0.0 TUBA3D H2-ALPHA ENSG00000075886 "Tubulin alpha 3d" Q13748 2 131476093-131482934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 104.2" "Group enriched" "Detected in some" 5 "Early spermatids: 255.8;Spermatocytes: 568.1;Spermatogonia: 326.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "CAB004972, HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA NA Microtubules "CAB004972: AB_425727, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "prognostic favorable (4.65e-4)" "unprognostic (6.66e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-3)" "unprognostic (1.82e-1)" "unprognostic (1.50e-3)" "unprognostic (2.17e-1)" "unprognostic (2.06e-2)" "unprognostic (1.39e-1)" "unprognostic (2.89e-1)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (4.75e-9)" "unprognostic (4.60e-2)" "unprognostic (2.28e-1)" "unprognostic (9.96e-4)" "unprognostic (2.28e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.7 0.2 0.2 0.2 0.0 1.2 2.9 0.2 1.6 0.2 20.4 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 2.9 0.0 0.2 0.6 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 104.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 1.1 0.0 0.0 0.3 0.0 0.8 0.4 1.7 0.8 0.6 3.0 0.0 0.0 2.0 0.7 0.0 0.0 0.0 2.6 1.2 1.1 0.3 0.0 0.1 2.1 0.0 0.0 0.0 1.5 2.3 0.4 0.9 1.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.2 0.0 1.1 2.1 1.0 0.1 1.9 1.4 3.3 2.4 0.2 1.2 1.2 0.1 0.7 0.0 0.8 1.9 0.3 0.5 0.3 0.0 0.8 0.4 0.0 0.9 1.1 1.7 1.5 1.2 0.6 0.6 0.7 0.8 1.1 0.5 0.0 0.2 0.0 0.3 0.0 0.2 0.8 0.6 0.4 0.0 1.1 0.7 0.8 0.0 0.0 0.3 0.0 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 255.8 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 82.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 51.8 0.0 568.1 326.9 0.0 0.0 0.0 0.0 0.0 TUBA3E ENSG00000152086 "Tubulin alpha 3e" Q6PEY2 2 130191743-130198461 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 27 "heart muscle: 14.2;testis: 51.0" "Group enriched" "Detected in some" 5 "Early spermatids: 166.5;Late spermatids: 88.5;Spermatocytes: 322.3;Spermatogonia: 183.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 9.0;U-2 OS: 5.8" "HPA039247, HPA043684, HPA063394" Uncertain Supported Microtubules NA NA Microtubules "HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.02e-3)" "unprognostic (2.79e-1)" "unprognostic (3.73e-2)" "unprognostic (1.51e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (6.81e-3)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (7.89e-2)" "unprognostic (2.65e-7)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (2.02e-3)" "unprognostic (8.94e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 1.1 0.4 0.1 0.7 0.1 14.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 51.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.0 0.5 0.1 0.9 0.1 0.1 0.0 0.0 0.2 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.4 0.4 0.0 0.9 0.5 0.4 0.3 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 166.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 88.5 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 38.8 0.0 322.3 183.3 0.0 0.0 0.0 0.0 0.0 TUBA4A "FLJ30169, H2-ALPHA, TUBA1" ENSG00000127824 "Tubulin alpha 4a" P68366 2 219249711-219278170 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 124.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 416.2;Late spermatids: 672.1;Pancreatic endocrine cells: 390.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 79.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004621, CAB005887, HPA039247, HPA043684, HPA063394" Approved Enhanced Microtubules NA NA 500000000 Microtubules "CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (8.08e-2)" "unprognostic (2.31e-1)" "unprognostic (4.03e-2)" "unprognostic (2.56e-2)" "unprognostic (5.18e-3)" "unprognostic (3.99e-2)" "prognostic unfavorable (4.54e-6)" "unprognostic (1.52e-3)" "unprognostic (4.47e-1)" "unprognostic (8.85e-2)" "unprognostic (1.49e-2)" "unprognostic (5.27e-2)" "unprognostic (1.94e-1)" "unprognostic (2.70e-1)" "unprognostic (2.36e-1)" "unprognostic (7.38e-3)" "unprognostic (9.32e-2)" 5.0 9.4 22.4 13.4 30.5 37.7 7.5 23.2 63.3 7.4 13.8 4.5 5.2 8.1 3.4 5.2 27.1 6.1 6.1 23.5 24.9 23.6 13.2 10.5 7.2 20.9 20.4 21.9 6.1 8.0 18.1 6.5 2.9 43.1 7.9 12.4 5.7 15.6 10.7 124.1 63.5 9.5 6.2 6.2 15.7 10.1 8.2 3.3 6.2 3.7 34.8 25.0 9.1 13.9 25.8 4.2 66.8 13.0 14.8 32.0 49.2 19.2 16.1 0.0 0.0 1.7 1.3 0.0 2.9 9.4 0.5 0.3 3.6 20.2 25.4 33.0 2.0 31.9 48.8 9.0 79.7 0.7 14.7 0.1 31.8 30.0 2.6 1.4 10.6 11.5 1.2 29.6 4.3 9.4 5.1 3.3 0.4 3.6 17.4 19.1 0.7 0.0 19.1 6.2 15.1 19.2 1.1 26.2 15.5 24.5 1.4 16.3 0.2 37.9 3.3 0.1 0.3 1.4 9.0 2.2 9.6 5.1 11.1 10.3 7.1 8.6 30.6 35.2 20.2 0.4 22.1 12.5 32.4 22.5 8.6 23.2 25.8 32.0 30.2 4.2 17.7 30.4 29.5 66.8 14.8 13.0 0.7 27.5 49.2 22.4 30.5 23.2 63.3 24.9 23.6 20.4 21.9 43.1 3.3 41.7 43.9 91.6 169.1 161.5 104.5 57.4 17.8 0.0 31.8 47.1 72.6 0.4 119.3 200.8 416.2 26.3 83.1 93.5 178.3 0.4 11.2 32.6 15.1 28.8 6.2 63.5 103.5 29.4 16.6 672.1 15.5 24.6 74.2 4.6 89.4 31.3 390.1 46.0 7.1 67.0 61.4 0.0 21.7 4.5 4.5 213.7 2.1 167.5 43.8 126.3 TUBA4B "FLJ13940, TUBA4" ENSG00000243910 "Tubulin alpha 4b" Q9H853 2 219253243-219272188 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "fallopian tube: 29.7" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 152.6" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 8.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Hep G2: 3.1;SCLC-21H: 3.6" NA NA "unprognostic (3.20e-5)" "unprognostic (1.47e-4)" "unprognostic (1.85e-1)" "unprognostic (3.70e-3)" "unprognostic (9.63e-2)" "unprognostic (8.97e-2)" "unprognostic (2.18e-3)" "unprognostic (7.32e-2)" "unprognostic (9.50e-2)" "unprognostic (6.56e-2)" "unprognostic (2.50e-1)" "unprognostic (2.12e-1)" "unprognostic (2.41e-3)" "unprognostic (3.78e-2)" "unprognostic (9.57e-2)" "unprognostic (3.91e-2)" "unprognostic (4.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 29.7 0.0 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 2.4 0.6 0.6 1.5 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.5 0.7 0.0 0.3 0.7 0.0 0.7 0.0 0.4 0.2 0.2 0.6 3.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 3.6 0.1 0.9 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.1 0.4 0.0 0.6 0.8 0.5 0.0 0.7 0.4 1.4 0.7 0.4 0.8 1.0 1.5 1.2 0.2 0.8 1.2 1.4 2.4 0.6 0.6 0.1 1.3 4.0 0.0 2.7 0.0 0.3 0.0 0.0 0.8 0.0 152.6 7.9 1.8 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 TUBA8 TUBAL2 ENSG00000183785 "Tubulin alpha 8" Q9NY65 22 18110331-18146554 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 50.3;skeletal muscle: 125.4" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 16.2;Late spermatids: 15.1;Sertoli cells: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2;NK-cell: 5.8" "Group enriched" "Detected in many" 14 "granulocytes: 4.2;NK-cells: 5.8" "Group enriched" "Detected in many" 6 "NB-4: 20.9;SCLC-21H: 10.3;TIME: 26.0" "Group enriched" "Detected in many" 4 "cerebellum: 61.3;olfactory region: 66.2" "Low region specificity" "Detected in all" "HPA043684, CAB046031, HPA063394" Approved Supported Microtubules NA NA 260000000 Microtubules "CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003" "unprognostic (1.07e-1)" "unprognostic (1.34e-2)" "unprognostic (2.79e-3)" "unprognostic (1.52e-2)" "unprognostic (2.74e-1)" "unprognostic (8.92e-2)" "unprognostic (6.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" "unprognostic (2.64e-2)" "unprognostic (1.92e-2)" "unprognostic (3.36e-1)" "unprognostic (2.90e-5)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (4.08e-2)" "unprognostic (5.61e-4)" 3.2 1.2 5.3 1.2 10.5 2.4 2.5 20.5 23.4 1.4 1.2 1.5 0.2 1.5 1.2 4.3 2.6 1.6 1.3 50.3 7.5 5.6 1.2 2.0 1.2 2.2 3.9 9.2 1.3 2.2 1.8 4.3 1.0 2.5 1.7 1.1 0.4 2.1 1.2 125.4 1.4 1.4 1.2 1.1 1.6 1.7 19.2 1.0 0.0 3.5 13.3 1.3 1.1 0.3 0.0 0.2 4.2 0.1 5.8 0.3 15.7 0.4 0.9 0.7 0.8 1.3 0.8 0.3 0.7 0.7 1.2 1.2 0.3 0.9 0.7 3.3 0.6 0.5 0.3 2.1 0.1 0.3 2.0 2.0 2.3 0.4 0.3 0.7 1.4 1.3 0.7 0.7 0.8 0.1 0.4 1.9 0.8 1.0 0.8 0.4 2.7 1.7 20.9 0.9 0.4 1.0 1.7 0.0 0.2 0.5 0.3 10.3 1.1 0.4 0.5 1.3 0.2 0.5 3.4 26.0 0.1 0.2 0.7 0.5 2.4 1.1 0.7 0.9 1.0 0.2 1.2 0.1 2.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.3 0.1 4.2 5.8 0.1 0.2 0.0 15.7 5.3 10.5 20.5 23.4 7.5 5.6 3.9 9.2 2.5 1.0 0.0 1.7 0.0 0.0 0.0 0.6 2.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 16.2 0.1 0.2 0.0 1.0 0.0 0.0 0.0 2.3 0.0 0.1 3.2 0.0 0.6 0.0 15.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.2 6.5 0.0 0.1 0.2 0.3 0.1 0.0 0.0 0.0 TUBAL3 FLJ21665 ENSG00000178462 "Tubulin alpha like 3" A6NHL2 10 5393098-5404830 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 41.5" "Cell type enhanced" "Detected in some" 31 "Enterocytes: 15.4;Paneth cells: 2.9;Proximal tubular cells: 4.4" "Cancer enhanced" "Detected in some" "colorectal cancer: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEL: 15.8;JURKAT: 9.2;K-562: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA045900, HPA063394" Uncertain NA NA "HPA045900: AB_10961130, HPA063394: AB_2685003" "unprognostic (2.63e-1)" "unprognostic (1.69e-2)" "unprognostic (5.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.59e-2)" "unprognostic (2.13e-2)" "unprognostic (3.02e-2)" "unprognostic (4.02e-1)" "unprognostic (1.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-1)" "unprognostic (3.44e-1)" "unprognostic (4.52e-2)" "unprognostic (2.75e-1)" "unprognostic (1.35e-4)" "unprognostic (7.93e-4)" 0.2 0.0 0.3 0.7 0.4 0.0 0.2 0.1 0.9 0.1 16.1 0.1 0.1 18.0 0.4 0.1 0.3 0.1 0.3 0.5 0.2 0.2 4.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.2 8.1 0.1 0.8 0.1 0.1 0.4 41.5 0.1 0.4 0.1 0.1 1.2 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.9 0.0 1.6 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 15.8 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 9.2 5.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.1 0.9 0.2 0.2 0.2 0.1 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 15.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 2.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.0 TUBB "M40, MGC16435, OK/SW-cl.56, Tubb5" ENSG00000196230 "Tubulin beta class I" P07437 6 30720201-30725426 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 198.7" "Cell type enhanced" "Detected in all" 6 "Extravillous trophoblasts: 1893.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005417, CAB012406, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes 510000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (1.01e-1)" "unprognostic (2.33e-1)" "unprognostic (2.17e-3)" "unprognostic (1.92e-2)" "unprognostic (1.56e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (2.57e-2)" "unprognostic (2.52e-1)" "unprognostic (2.18e-3)" "unprognostic (1.27e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.62e-8)" "unprognostic (8.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" 51.6 27.7 30.0 31.8 33.2 78.8 30.0 30.9 57.2 43.3 37.0 24.3 18.7 10.8 58.5 39.7 39.9 41.0 29.6 33.1 23.7 48.2 31.4 74.1 32.7 62.1 27.8 24.0 81.5 27.0 15.3 16.3 41.1 39.9 32.2 34.2 30.6 27.9 24.3 29.6 37.6 24.3 37.6 27.4 47.7 29.1 19.7 14.4 198.7 26.9 36.8 91.5 39.7 34.3 15.4 17.5 8.6 15.4 12.3 18.2 19.8 42.4 15.7 61.3 26.6 17.4 30.0 0.5 0.0 0.0 0.0 0.0 29.9 16.2 21.2 26.3 19.6 16.4 14.7 49.5 44.5 0.0 11.9 31.3 0.5 0.0 17.2 8.3 57.8 28.5 22.3 10.4 0.0 0.5 13.5 21.6 46.9 16.7 0.0 27.0 30.7 41.8 0.2 0.0 13.5 18.5 0.0 0.6 12.5 35.8 24.2 10.7 35.9 23.1 10.2 0.4 39.9 26.7 5.3 13.3 64.5 28.7 0.0 0.2 19.8 38.1 49.2 12.7 57.5 81.6 4.9 7.7 8.6 15.5 12.2 18.2 15.4 12.1 17.6 6.2 10.0 12.3 12.2 4.3 12.3 15.4 17.5 14.2 19.8 30.0 33.2 30.9 57.2 23.7 48.2 27.8 24.0 39.9 14.4 122.1 48.4 184.6 261.7 511.8 64.2 96.8 186.0 50.9 100.1 162.3 37.3 493.5 263.6 1083.5 6.9 247.2 97.2 700.8 929.9 1893.7 657.3 117.4 203.1 240.5 829.2 103.3 156.9 268.2 310.8 15.4 372.8 361.3 305.4 1224.5 123.1 172.7 843.8 91.2 223.1 178.3 51.0 116.4 444.0 46.2 42.8 376.4 184.3 200.5 178.2 168.9 TUBB1 dJ543J19.4 ENSG00000101162 "Tubulin beta 1 class VI" Q9H4B7 20 59019254-59026654 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 58.6;lymphoid tissue: 28.2" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 11.5;Erythroid cells: 23.3;Late spermatids: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "basophil: 8.7;neutrophil: 6.5" "Lineage enriched" "Detected in single" 14 "granulocytes: 8.7" "Cell line enriched" "Detected in some" 19 "HEL: 25.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004286, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA 480000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (3.76e-1)" "unprognostic (2.69e-1)" "unprognostic (6.10e-4)" "unprognostic (1.02e-1)" "unprognostic (5.00e-2)" "unprognostic (2.02e-1)" "unprognostic (5.86e-2)" "unprognostic (7.51e-4)" "unprognostic (1.90e-2)" "unprognostic (2.63e-1)" "unprognostic (6.80e-5)" "unprognostic (3.46e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-1)" "unprognostic (2.31e-1)" "unprognostic (1.00e-1)" 0.6 0.3 0.2 0.4 0.6 12.2 0.2 0.7 0.7 0.2 0.2 0.1 0.0 0.2 0.2 0.9 0.2 0.5 0.6 10.8 0.2 0.2 0.2 1.0 8.3 0.4 0.2 0.4 0.8 0.4 0.0 0.7 3.2 0.6 0.3 0.0 0.5 0.2 0.6 0.6 0.2 0.5 0.0 0.6 28.2 0.3 1.8 0.0 0.0 0.5 0.3 0.2 0.4 1.8 0.1 0.6 8.7 0.5 0.0 0.1 58.6 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.1 0.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 25.0 0.6 1.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.2 0.0 0.3 0.3 0.2 0.1 0.5 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.3 8.7 0.5 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.0 6.5 0.0 0.0 0.6 0.1 58.6 0.2 0.6 0.7 0.7 0.2 0.2 0.2 0.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.2 0.0 3.9 0.0 0.0 0.0 11.5 0.0 0.0 23.3 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.6 0.0 4.9 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 TUBB2A "dJ40E16.7, TUBB, TUBB2" ENSG00000137267 "Tubulin beta 2A class IIa" Q13885 6 3153669-3157526 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 158.3" "Cell type enhanced" "Detected in all" 7 "Horizontal cells: 487.8;Suprabasal keratinocytes: 322.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 6.0;monocytes: 2.6;T-cells: 5.5" "Cell line enhanced" "Detected in many" "AF22: 49.5;CACO-2: 50.0;SuSa: 77.3;WM-115: 55.3" "Low region specificity" "Detected in all" "CAB015339, HPA043640, HPA046280" Supported Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.57e-1)" "unprognostic (9.86e-3)" "unprognostic (5.90e-3)" "unprognostic (7.98e-3)" "unprognostic (4.02e-3)" "unprognostic (1.67e-1)" "unprognostic (1.82e-3)" "unprognostic (7.53e-2)" "unprognostic (1.48e-3)" "unprognostic (9.99e-2)" "unprognostic (1.24e-2)" "unprognostic (1.42e-2)" "prognostic favorable (4.65e-4)" "unprognostic (2.39e-2)" "unprognostic (1.79e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (1.61e-4)" 19.6 9.1 59.4 8.7 46.9 26.8 7.9 46.5 158.3 5.4 8.7 9.1 1.2 11.1 6.7 13.5 17.2 4.8 10.9 6.1 56.5 76.0 7.7 16.9 4.1 5.4 58.4 43.3 2.6 14.3 1.6 6.9 11.0 78.6 6.1 4.5 4.6 5.8 8.0 7.3 24.7 13.8 17.7 24.3 2.3 17.6 2.9 5.4 0.1 1.9 10.4 4.7 5.4 5.8 6.0 0.9 0.7 2.6 0.6 5.5 1.8 10.6 9.0 49.5 11.1 6.3 7.0 2.9 23.7 8.9 16.2 23.6 50.0 3.6 5.3 14.6 22.4 16.1 5.1 17.5 5.3 5.6 25.6 11.6 1.8 2.6 15.1 6.5 0.2 1.8 7.3 6.3 17.0 1.1 5.9 7.5 2.2 6.3 1.8 14.5 4.7 2.8 0.5 42.4 3.1 11.6 2.4 4.6 4.0 5.5 5.4 12.4 11.3 5.9 1.8 33.9 77.3 3.8 0.3 14.9 11.0 12.0 23.7 12.7 0.7 0.8 3.6 4.0 1.4 55.3 0.0 1.9 0.0 4.0 2.6 4.4 6.0 3.9 5.5 0.9 1.2 2.1 3.7 0.7 0.6 2.0 0.3 5.3 1.8 59.4 46.9 46.5 89.2 56.5 76.0 58.4 43.3 78.6 5.4 14.9 16.2 11.3 50.6 276.6 98.5 16.7 48.4 24.1 15.9 12.2 15.7 2.1 184.1 43.1 50.4 30.8 111.0 70.0 155.6 48.0 118.0 26.1 34.6 48.9 44.2 487.8 70.0 11.1 6.5 18.3 19.2 38.9 123.2 125.4 69.8 243.3 112.9 105.2 14.5 26.4 58.8 6.5 107.2 21.2 12.6 322.2 5.1 10.7 23.3 53.3 TUBB2B "bA506K6.1, DKFZp566F223, MGC8685" ENSG00000137285 "Tubulin beta 2B class IIb" Q9BVA1 6 3224261-3231730 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 125.4" "Group enriched" "Detected in many" 6 "Distal tubular cells: 351.5;Horizontal cells: 406.8;Muller glia cells: 726.9" "Cancer enriched" "Detected in many" 9 "glioma: 216.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 21 "memory B-cell: 2.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.0" "Cell line enhanced" "Detected in some" "AF22: 73.9;CACO-2: 54.3;NTERA-2: 36.2;RPMI-8226: 37.2;SCLC-21H: 110.9;SH-SY5Y: 53.8;SuSa: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Supported Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.66e-2)" "unprognostic (3.41e-1)" "unprognostic (5.92e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (6.81e-2)" "unprognostic (3.26e-2)" "unprognostic (9.03e-3)" "unprognostic (8.33e-2)" "unprognostic (1.08e-1)" "unprognostic (2.02e-1)" "unprognostic (3.78e-3)" "unprognostic (3.34e-2)" "unprognostic (2.03e-2)" "unprognostic (6.24e-3)" "unprognostic (6.04e-2)" "unprognostic (3.58e-4)" "unprognostic (2.30e-3)" 3.8 5.9 53.6 5.9 63.1 1.5 4.4 23.2 125.4 4.7 4.6 22.6 0.0 2.8 4.0 29.7 2.5 2.0 3.6 2.1 34.3 48.6 6.6 1.4 1.6 6.0 56.7 18.6 1.5 2.9 1.4 4.8 3.9 36.1 2.1 3.1 2.3 3.6 4.3 4.5 3.0 4.7 5.5 80.5 1.8 3.3 1.7 16.2 0.0 1.6 0.0 4.6 2.1 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 73.9 22.3 0.0 0.0 0.0 0.4 0.9 2.7 6.0 54.3 0.2 0.0 0.7 0.5 0.0 0.0 28.9 0.0 1.6 0.0 13.2 0.0 0.0 4.2 0.2 0.0 0.8 0.4 0.0 0.3 0.0 0.9 0.0 0.0 0.8 0.1 0.7 0.0 0.1 0.0 36.2 0.0 2.3 0.0 3.5 37.2 0.3 0.0 110.9 53.8 0.0 0.2 0.3 35.3 0.4 0.0 0.0 0.0 12.6 0.6 0.0 7.3 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 53.6 63.1 23.2 39.2 34.3 48.6 56.7 18.6 36.1 16.2 0.0 0.0 1.5 2.5 7.7 30.9 33.1 10.2 0.0 0.0 7.0 15.7 0.1 351.5 10.8 3.0 6.0 0.2 0.0 3.0 0.4 24.0 2.8 0.0 0.8 2.5 406.8 64.0 1.3 0.0 4.1 0.3 0.0 87.7 6.4 0.5 726.9 19.6 0.0 0.0 1.4 34.7 0.0 27.8 1.2 6.8 2.4 0.7 0.0 0.4 0.7 TUBB3 "beta-4, CFEOM3, CFEOM3A, FEOM3" ENSG00000258947 "Tubulin beta 3 class III" Q13509 16 89921392-89938761 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 85.1" "Cell type enhanced" "Detected in some" 20 "Ductal cells: 22.7;Exocrine glandular cells: 18.4;Late spermatids: 9.5;Pancreatic endocrine cells: 44.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "naive B-cell: 5.2" "Lineage enriched" "Detected in single" 7 "B-cells: 5.2" "Cell line enhanced" "Detected in many" "A549: 66.2;SCLC-21H: 67.5;SH-SY5Y: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA 250000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (7.08e-2)" "unprognostic (3.37e-4)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (8.01e-2)" "unprognostic (3.12e-2)" "unprognostic (4.04e-3)" "unprognostic (1.12e-3)" "unprognostic (1.22e-2)" "unprognostic (6.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-2)" "unprognostic (7.57e-2)" "unprognostic (1.27e-3)" "unprognostic (3.70e-2)" "unprognostic (3.05e-1)" "unprognostic (1.91e-2)" 5.1 19.4 23.9 8.9 23.3 3.2 1.2 24.1 85.1 2.4 4.1 7.8 0.0 3.6 7.9 1.1 2.2 1.0 7.3 1.8 25.0 66.5 1.1 1.1 1.6 5.7 44.5 15.9 1.1 2.5 1.0 9.9 2.2 60.9 1.6 2.8 5.5 1.9 1.3 1.0 4.1 4.8 9.3 12.9 1.1 2.5 11.2 3.3 0.0 1.0 1.7 4.4 5.3 0.6 5.2 0.7 0.2 0.3 0.0 0.2 0.2 4.6 66.2 24.7 28.1 2.9 28.5 1.0 28.4 4.8 17.1 7.8 9.0 8.6 14.0 14.8 21.4 12.0 17.5 23.8 4.2 4.3 3.4 2.3 0.1 5.6 58.7 0.9 0.0 11.0 16.3 1.2 26.2 2.3 22.3 14.1 0.9 1.4 0.5 19.5 44.1 0.1 4.7 43.3 1.7 36.4 0.0 8.7 1.5 21.3 1.3 67.5 68.2 39.9 0.7 19.4 4.7 2.2 0.2 17.6 23.5 25.3 31.4 28.7 0.2 2.8 5.3 24.3 1.8 41.5 0.2 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.2 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.2 23.9 23.3 24.1 51.0 25.0 66.5 44.5 15.9 60.9 3.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 22.7 5.3 0.0 0.0 0.0 18.4 0.3 0.0 0.0 0.0 0.0 0.2 4.8 4.7 0.0 0.0 9.5 0.3 0.0 0.0 0.0 0.0 0.2 44.3 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 TUBB4A "beta-5, DYT4, TUBB4" ENSG00000104833 "Tubulin beta 4A class IVa" P04350 19 6494319-6502848 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Dystonia, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 62.6;brain: 197.8" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 9.5;Melanocytes: 13.5;Muller glia cells: 31.5" "Group enriched" "Detected in many" 9 "glioma: 50.1;melanoma: 83.2;testis cancer: 49.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 12 "B-cells: 5.3;T-cells: 6.5" "Cell line enhanced" "Detected in many" "AN3-CA: 36.3;HAP1: 20.8;HEL: 30.5;PC-3: 15.1;REH: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010768, HPA043640, HPA046280" Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA 360000000 Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.72e-1)" "prognostic unfavorable (8.42e-7)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (8.08e-2)" "unprognostic (6.69e-2)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (1.12e-3)" "unprognostic (1.36e-2)" "unprognostic (1.58e-1)" "unprognostic (2.06e-1)" "unprognostic (2.30e-1)" 2.3 62.6 41.3 2.9 52.4 2.2 2.3 115.3 197.8 2.2 2.9 115.2 0.0 2.7 2.3 2.3 2.5 2.3 2.4 2.3 56.8 36.9 2.8 2.2 2.3 2.6 73.7 34.5 2.6 2.8 2.1 0.2 2.5 72.0 2.2 2.5 2.7 2.7 2.3 3.9 4.6 3.2 2.5 73.2 4.8 2.2 31.3 43.0 0.0 2.1 0.0 2.4 2.3 0.1 5.3 0.1 0.2 0.0 0.4 6.5 1.6 0.0 10.7 0.0 36.3 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.1 0.0 10.6 0.0 1.3 0.3 20.8 0.0 0.2 0.0 3.4 30.5 0.7 0.3 0.0 0.0 2.0 0.0 0.0 0.8 0.0 0.3 0.0 6.0 2.9 0.2 0.0 1.0 6.1 1.3 2.7 0.0 15.1 15.0 0.0 7.1 3.9 0.0 0.1 12.1 0.1 0.1 10.6 1.0 0.3 0.7 0.0 0.0 4.5 0.0 0.1 0.8 0.5 4.1 0.4 0.0 0.2 0.0 0.0 0.0 6.3 0.0 4.6 5.3 1.0 6.5 0.0 1.6 2.2 4.7 0.2 0.4 0.0 0.1 0.0 1.6 41.3 52.4 115.3 79.7 56.8 36.9 73.7 34.5 72.0 43.0 0.0 0.0 0.5 0.5 1.6 2.6 8.1 0.0 0.0 0.0 0.0 0.0 0.1 5.0 1.6 2.5 0.6 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.3 9.5 0.0 0.6 0.0 5.6 4.9 0.0 13.5 0.0 0.0 31.5 0.2 0.0 0.4 1.6 1.7 6.5 1.7 1.4 1.1 1.4 0.1 0.0 0.0 0.1 TUBB4B "Beta2, TUBB2C" ENSG00000188229 "Tubulin beta 4B class IVb" P68371 9 137241213-137243707 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 207.7" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 1754.5;Late spermatids: 2132.3;Spermatocytes: 1761.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010880, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA Yes Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.24e-1)" "unprognostic (1.77e-3)" "unprognostic (1.50e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.98e-4)" "unprognostic (9.92e-3)" "unprognostic (2.90e-1)" "unprognostic (3.63e-1)" "unprognostic (2.34e-1)" "unprognostic (4.09e-2)" "unprognostic (2.47e-3)" "unprognostic (6.37e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.36e-6)" "unprognostic (1.69e-1)" 31.1 22.1 33.0 22.1 32.7 87.5 24.4 22.3 67.2 23.0 44.0 35.9 25.2 33.4 22.7 52.7 65.7 122.5 32.1 66.4 35.2 55.5 46.6 49.7 28.4 21.0 33.8 46.6 33.7 33.0 13.4 25.3 31.9 48.4 29.8 27.3 40.9 41.8 31.8 37.1 55.9 38.9 28.4 21.5 21.0 30.5 207.7 12.2 61.1 40.1 56.7 40.1 21.8 25.7 17.2 18.3 37.0 14.6 11.2 21.7 14.4 59.3 89.0 38.1 27.4 19.2 20.3 53.1 55.8 47.0 77.2 53.4 94.0 73.1 36.4 42.7 54.1 75.3 113.0 47.1 89.8 29.4 25.9 39.8 26.4 70.9 73.8 12.1 31.0 29.4 13.0 25.5 58.9 16.2 19.2 55.1 26.1 36.8 21.0 63.6 163.2 28.1 42.3 40.2 105.3 155.3 35.8 72.7 33.7 58.0 55.6 26.7 28.7 73.9 42.6 14.8 22.6 61.3 33.8 42.7 55.2 61.5 62.5 73.3 8.1 22.5 40.2 45.0 24.3 47.8 37.0 14.1 20.5 21.4 14.6 20.6 17.2 16.7 18.2 17.5 14.1 10.7 14.3 28.6 11.2 14.6 18.3 21.7 14.4 33.0 32.7 22.3 67.2 35.2 55.5 33.8 46.6 48.4 12.2 205.4 139.7 150.7 842.9 289.7 457.2 82.3 132.5 1026.5 175.1 136.1 282.7 235.6 187.3 348.8 1754.5 152.3 547.1 490.6 391.5 458.3 161.8 365.4 188.9 114.3 228.8 230.4 375.8 129.5 67.2 2132.3 235.3 111.2 131.6 359.7 292.5 271.2 343.5 375.2 143.9 259.6 647.3 109.9 245.2 1761.9 564.6 260.1 268.5 97.8 359.3 575.4 TUBB8 bA631M21.2 ENSG00000261456 "Tubulin beta 8 class VIII" Q3ZCM7 10 46892-74163 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.2;parathyroid gland: 2.3;testis: 2.5" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 9.6;Spermatocytes: 13.5;Spermatogonia: 8.7" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Cell type enhanced" "Detected in some" "eosinophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;MCF7: 5.4;NTERA-2: 1.9" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.75e-2)" "unprognostic (6.02e-2)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-1)" "unprognostic (1.80e-1)" "unprognostic (7.74e-2)" "unprognostic (8.33e-3)" "unprognostic (1.50e-1)" "unprognostic (4.15e-3)" "unprognostic (7.17e-2)" "unprognostic (3.30e-2)" "unprognostic (1.33e-3)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.19e-2)" "unprognostic (6.86e-3)" 0.0 0.0 0.5 0.0 1.1 0.1 0.0 0.0 0.0 0.4 0.1 0.0 1.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.5 0.3 0.1 0.5 1.0 0.1 2.2 0.3 0.2 0.5 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 5.4 0.1 0.0 1.9 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.2 0.7 0.2 0.4 1.0 0.4 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.2 0.1 2.2 0.5 0.2 0.2 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 13.5 8.7 0.0 0.0 0.0 0.0 0.7 TUBB8P12 ENSG00000173213 "Tubulin beta 8 pseudogene 12" A6NNZ2 18 47390-49557 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 7.4" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "testis cancer: 1.7" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;neutrophil: 1.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.3;Hep G2: 2.2;MCF7: 1.7;T-47d: 2.3;U-266/70: 1.8;U-266/84: 1.9" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.34e-1)" "unprognostic (3.15e-2)" "unprognostic (1.29e-1)" "unprognostic (6.73e-2)" "unprognostic (1.76e-1)" "unprognostic (6.91e-2)" "unprognostic (1.92e-1)" "unprognostic (4.36e-2)" "unprognostic (1.29e-1)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (7.42e-4)" "unprognostic (3.96e-2)" "unprognostic (5.98e-2)" "unprognostic (4.88e-2)" "unprognostic (3.21e-2)" "unprognostic (1.78e-1)" 0.1 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.5 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.2 0.0 1.3 0.1 0.3 0.5 0.8 0.3 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.3 7.4 0.1 0.1 0.6 0.1 0.4 0.0 1.1 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 2.2 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 1.2 0.0 0.0 0.0 0.7 0.2 0.5 2.3 0.0 0.0 0.0 0.0 0.6 0.0 1.8 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUBG1 "TUBG, TUBGCP1" ENSG00000131462 "Tubulin gamma 1" P23258 17 42609676-42615234 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Disease mutation, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 102.4" "Cell type enhanced" "Detected in all" 12 "Early spermatids: 583.2;Late spermatids: 391.6;Spermatocytes: 311.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004608 Enhanced NA Yes "CAB004608: AB_628417" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (1.79e-2)" "prognostic favorable (8.99e-4)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.08e-8)" "unprognostic (2.62e-3)" "unprognostic (5.67e-2)" "unprognostic (1.83e-1)" "unprognostic (3.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.48e-5)" "unprognostic (2.64e-1)" "unprognostic (3.52e-1)" "unprognostic (2.61e-3)" "unprognostic (1.97e-2)" 11.7 14.1 8.8 10.7 11.2 23.9 13.0 12.4 19.3 7.5 9.8 6.9 7.8 9.6 9.7 7.8 15.4 7.7 10.4 18.3 13.2 12.6 16.2 20.5 8.6 9.2 8.7 12.0 8.8 30.1 13.1 9.5 14.2 12.2 9.6 8.6 8.3 9.2 11.1 24.3 15.9 7.7 14.1 6.8 10.3 12.8 102.4 5.2 14.6 9.7 11.8 10.8 10.8 9.5 9.7 26.2 1.8 15.4 6.8 8.3 6.3 23.6 62.6 24.3 26.5 15.8 10.9 21.9 27.2 18.8 44.6 34.7 37.9 16.5 17.0 20.1 22.3 38.4 38.0 26.1 38.1 32.5 44.7 33.4 13.7 41.6 62.9 7.7 14.9 19.5 8.5 11.9 54.8 16.6 11.1 28.1 26.1 25.0 17.3 32.9 69.6 36.5 15.8 12.6 36.0 31.3 17.6 36.0 27.2 19.2 29.3 34.7 16.8 17.0 16.1 13.2 25.6 50.2 14.6 17.9 44.7 28.7 36.6 42.2 25.2 30.9 25.4 23.5 14.8 31.1 1.3 8.4 1.8 7.3 15.4 7.6 9.7 6.7 7.5 9.7 8.3 7.1 7.3 0.4 6.8 15.2 26.2 8.3 6.3 8.8 11.2 12.4 19.3 13.2 12.6 8.7 12.0 12.2 5.2 14.9 3.4 8.9 12.1 15.7 12.2 15.7 10.2 13.4 6.8 7.0 3.9 32.5 33.2 32.7 583.2 15.0 10.5 140.2 48.1 68.4 11.3 12.1 2.3 13.0 34.6 19.1 9.2 14.7 7.0 391.6 21.0 9.9 16.9 43.3 10.6 15.2 33.2 8.0 20.5 45.9 10.6 58.2 13.0 311.8 108.4 25.0 16.8 4.9 9.8 11.9 TUBG2 ENSG00000037042 "Tubulin gamma 2" Q9NRH3 17 42659305-42667006 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011495 Approved Supported "Centriolar satellite" NA NA "Centriolar satellite" "CAB011495: AB_443396" "unprognostic (2.60e-1)" "unprognostic (5.85e-3)" "unprognostic (6.21e-3)" "unprognostic (5.79e-2)" "unprognostic (1.33e-3)" "unprognostic (5.11e-2)" "prognostic unfavorable (4.68e-5)" "unprognostic (3.53e-2)" "unprognostic (2.20e-2)" "unprognostic (7.88e-3)" "unprognostic (1.82e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.31e-2)" "unprognostic (3.59e-2)" "unprognostic (3.73e-1)" "unprognostic (7.61e-3)" 15.4 17.7 32.9 5.8 34.5 2.8 10.3 21.7 55.7 13.3 9.6 24.2 5.5 5.8 13.9 14.2 9.9 14.4 10.2 17.2 34.5 24.3 12.6 5.2 10.9 6.6 25.7 29.2 20.7 29.9 17.6 14.2 8.7 30.4 13.5 5.4 11.7 15.7 22.5 6.6 11.2 5.3 13.5 19.4 9.1 9.5 8.3 20.8 1.0 13.0 3.1 5.2 12.2 9.7 2.1 7.1 0.5 1.4 1.4 5.9 2.7 5.1 10.7 5.2 7.9 20.6 11.4 3.4 9.2 10.3 7.4 7.4 6.0 3.8 2.5 5.5 13.1 7.8 19.3 0.2 8.3 6.0 5.0 6.2 1.9 13.6 11.7 8.9 0.2 6.9 12.5 8.8 8.5 9.2 12.7 5.3 6.0 0.5 5.7 14.1 10.7 4.9 4.4 1.9 5.0 2.8 3.8 3.2 5.7 7.8 5.3 6.0 4.2 5.8 9.4 6.1 9.8 18.0 2.4 6.0 23.7 1.7 5.9 5.2 30.0 5.3 0.8 8.3 0.2 13.7 0.0 1.4 0.3 5.0 0.9 2.3 2.1 5.4 1.9 1.5 0.9 5.9 3.9 0.5 1.4 0.3 7.1 2.4 2.7 32.9 34.5 21.7 55.7 34.5 24.3 25.7 29.2 30.4 20.8 3.0 3.4 1.4 17.2 4.8 16.2 10.8 2.5 9.4 5.7 3.5 3.9 4.4 14.9 4.4 6.1 6.0 0.0 0.0 8.2 3.6 10.2 4.5 11.5 3.4 3.0 19.1 1.2 7.4 1.3 9.0 16.1 3.2 15.1 4.6 1.0 7.3 4.3 0.0 20.1 11.2 4.5 12.9 9.6 5.1 3.5 3.4 2.1 4.1 0.4 3.1 TUFT1 ENSG00000143367 "Tuftelin 1" Q9NNX1 1 151540305-151583583 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 54.9" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 61.5;Suprabasal keratinocytes: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 72.2" "HPA028112, HPA054301" Approved Approved Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA028112: AB_10603224, HPA054301: AB_2682442" "unprognostic (6.16e-2)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.83e-4)" "unprognostic (4.49e-3)" "unprognostic (1.12e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-2)" "unprognostic (8.29e-3)" "unprognostic (9.06e-2)" "unprognostic (6.70e-3)" "unprognostic (7.88e-2)" "unprognostic (2.58e-3)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-3)" "unprognostic (4.53e-2)" 3.4 4.0 2.7 3.3 2.5 3.8 11.6 8.5 4.5 13.3 8.1 1.1 6.7 4.6 5.9 6.9 23.4 3.1 9.7 3.0 2.0 4.0 9.4 3.9 5.3 2.2 1.9 3.9 5.4 9.3 7.8 5.7 33.1 3.3 7.5 8.3 3.3 18.8 9.4 1.7 54.9 9.8 9.6 1.8 1.1 7.4 5.0 1.5 0.5 3.6 12.0 14.4 11.9 12.2 1.2 1.6 6.5 1.1 0.2 6.0 0.9 14.6 5.0 3.7 4.3 0.8 0.7 23.9 3.9 3.5 15.7 15.1 15.9 11.7 1.3 24.6 4.6 7.4 17.2 6.5 6.0 11.5 9.7 3.2 0.8 8.5 2.4 12.5 0.3 1.8 2.5 7.1 12.3 27.4 9.3 1.2 1.8 1.3 10.1 4.8 6.0 0.7 0.2 4.4 10.8 4.3 0.0 10.6 5.0 13.0 22.7 7.4 3.0 25.2 17.2 3.0 11.7 13.7 0.7 3.2 2.8 19.8 17.4 26.1 2.5 4.8 0.1 2.4 0.3 1.7 6.5 1.1 1.1 0.7 0.3 1.4 1.2 1.9 1.0 1.6 0.6 1.7 0.6 4.5 0.2 0.6 0.2 6.0 0.9 2.7 2.5 8.5 4.5 2.0 4.0 1.9 3.9 3.3 1.5 23.8 1.3 0.0 41.3 61.5 1.8 8.9 7.6 1.4 9.1 14.0 0.0 22.2 11.6 15.0 2.1 0.7 37.6 0.0 13.3 12.0 7.4 24.8 4.6 9.3 3.5 0.0 30.9 1.8 0.0 1.9 2.3 2.6 8.5 2.8 21.4 2.0 31.3 21.6 4.9 9.1 0.5 6.5 5.6 0.7 3.4 58.2 47.5 3.2 17.0 26.9 TULP1 "LCA15, RP14, TUBL1" ENSG00000112041 "Tubby like protein 1" O00294 6 35497874-35512938 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "retina: 56.1" "Group enriched" "Detected in some" 7 "Cone photoreceptor cells: 251.3;Rod photoreceptor cells: 308.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 4 "hippocampal formation: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.4;CACO-2: 1.4;MCF7: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Intracellular and membrane" NA NA "unprognostic (7.98e-2)" "unprognostic (2.33e-2)" "unprognostic (4.38e-2)" "unprognostic (4.60e-5)" "unprognostic (2.28e-2)" "unprognostic (3.12e-3)" "unprognostic (3.30e-1)" "unprognostic (5.49e-3)" "unprognostic (1.85e-1)" "unprognostic (2.66e-2)" "unprognostic (7.42e-2)" "unprognostic (1.66e-6)" "unprognostic (1.72e-1)" "unprognostic (1.30e-1)" "unprognostic (5.42e-2)" "unprognostic (4.11e-2)" 0.3 0.2 0.3 0.6 0.5 0.0 0.3 0.3 0.3 1.0 0.3 0.3 0.3 0.0 1.2 2.3 0.7 1.4 0.3 0.3 2.4 0.0 0.3 0.3 0.3 0.3 0.3 0.3 1.3 0.3 0.0 0.6 0.8 0.4 2.7 0.0 56.1 1.1 1.9 0.3 2.5 0.3 0.3 0.3 0.3 0.2 0.9 0.3 0.3 0.3 0.3 0.3 0.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 7.4 0.1 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 4.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.5 0.1 0.2 0.0 0.1 1.1 0.0 0.0 0.4 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.3 0.3 2.4 0.0 0.3 0.3 0.4 0.3 0.0 0.0 0.0 0.6 0.0 27.7 0.6 0.0 0.0 0.0 0.0 251.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.0 0.0 308.3 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 0.2 TULP2 "CT65, TUBL2" ENSG00000104804 "Tubby like protein 2" O00295 19 48880965-48898733 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.6;testis: 25.5" "Group enriched" "Detected in some" 43 "Early spermatids: 174.6;Late spermatids: 168.8" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 10 "dendritic cells: 6.6" "Cell line enhanced" "Detected in some" "BEWO: 5.5;U-266/70: 6.4;U-266/84: 6.9" "Not detected" "Not detected" HPA075828 Approved Cytosol "Secreted in male reproductive system" NA NA Cytosol "HPA075828: " "unprognostic (9.97e-2)" "unprognostic (5.55e-3)" "unprognostic (1.15e-1)" "unprognostic (9.39e-2)" "unprognostic (1.69e-4)" "unprognostic (6.79e-4)" "unprognostic (1.07e-2)" "unprognostic (2.57e-1)" "unprognostic (5.94e-3)" "unprognostic (1.08e-2)" "unprognostic (9.82e-2)" "unprognostic (1.33e-1)" "unprognostic (4.59e-4)" "unprognostic (6.37e-2)" "unprognostic (1.63e-1)" "unprognostic (1.08e-1)" "unprognostic (1.97e-1)" 0.2 0.3 0.2 0.2 0.2 4.3 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.8 0.8 0.5 0.6 0.5 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 1.3 0.2 0.0 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.0 0.2 25.5 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 6.6 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.6 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 1.1 1.9 0.9 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.9 0.9 1.8 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.7 0.0 0.9 0.0 1.1 0.0 0.0 0.0 0.1 0.0 6.4 6.9 0.3 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 6.6 0.0 0.0 0.2 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 174.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.8 168.8 4.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.1 1.4 0.4 0.0 0.0 0.0 0.0 TUNAR "HI-LNC78, LINC00617, TUNA" ENSG00000250366 "TCL1 upstream neural differentiation-associated RNA" 14 95876392-95925571 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "brain: 28.7" "Group enriched" "Detected in some" 8 "Bipolar cells: 2.4;Cone photoreceptor cells: 2.0;Early spermatids: 2.1;Rod photoreceptor cells: 1.7;Spermatogonia: 4.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;EFO-21: 2.8;NTERA-2: 10.2;SCLC-21H: 10.3" "Low region specificity" "Detected in all" NA NA "unprognostic (1.28e-3)" "unprognostic (3.94e-1)" "unprognostic (4.10e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.55e-4)" "unprognostic (5.33e-2)" "unprognostic (2.92e-2)" "unprognostic (1.18e-1)" 0.2 0.2 0.9 0.2 18.6 0.5 0.4 1.2 8.8 0.4 0.3 1.3 0.0 0.5 3.7 0.2 0.2 5.1 0.5 0.3 6.0 0.3 0.2 0.2 0.4 0.0 3.7 0.2 6.1 0.2 0.0 0.3 28.7 0.2 0.4 0.7 0.2 3.4 0.2 0.7 0.2 0.3 1.3 0.2 0.3 1.1 6.8 0.0 0.9 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 10.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 10.3 1.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 TUSC3 "MGC13453, MRT7, N33, OST3A" ENSG00000104723 "Tumor suppressor candidate 3" Q13454 8 15417215-15766649 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 127.8" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 406.6;Extravillous trophoblasts: 249.7;Syncytiotrophoblasts: 655.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049851, HPA049974" Approved NA NA "HPA049851: AB_2680913, HPA049974: AB_2680976" "unprognostic (3.31e-2)" "unprognostic (7.17e-2)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (4.46e-1)" "unprognostic (2.34e-1)" "unprognostic (7.15e-3)" "unprognostic (5.02e-2)" "unprognostic (7.39e-2)" "unprognostic (4.79e-2)" "unprognostic (1.59e-3)" "unprognostic (4.81e-1)" "unprognostic (1.60e-3)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" "prognostic favorable (7.86e-4)" "unprognostic (1.55e-1)" 10.5 35.3 10.5 4.0 23.0 0.1 19.7 21.5 19.8 12.1 6.2 5.4 5.1 4.5 16.0 50.5 6.1 27.0 8.1 16.1 10.4 21.4 11.6 3.2 8.5 3.3 6.0 15.6 35.5 15.8 24.8 50.6 127.8 13.4 23.9 7.1 11.6 5.7 14.1 2.8 3.8 4.1 14.4 4.3 3.6 5.2 10.2 3.3 2.9 4.7 3.6 2.4 15.0 9.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 13.2 9.6 26.5 24.7 30.9 35.8 0.0 18.8 40.4 20.8 34.9 0.0 0.0 0.1 6.6 25.0 23.0 10.1 9.2 18.0 30.3 0.0 12.6 0.0 7.8 1.5 13.4 0.0 1.3 28.4 5.7 29.1 10.9 29.9 1.7 3.9 17.5 4.0 31.6 9.5 4.8 0.1 13.2 0.0 8.3 5.9 22.0 0.1 28.8 33.0 10.5 20.3 0.0 10.7 14.6 20.2 12.6 0.0 8.1 19.2 19.0 8.0 9.3 0.0 2.3 0.0 0.3 0.0 26.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 23.0 21.5 19.8 10.4 21.4 6.0 15.6 13.4 3.3 0.0 9.3 0.0 50.9 8.9 49.5 42.5 20.4 75.0 29.6 75.0 7.9 406.6 14.9 137.4 9.6 16.8 0.2 0.0 10.2 249.7 45.2 77.9 1.1 0.0 36.4 30.2 92.1 10.4 0.0 5.7 32.2 2.2 23.6 2.8 20.2 33.8 32.0 0.0 21.5 18.8 20.0 38.8 18.3 50.1 42.8 3.6 655.5 0.5 8.3 40.9 TUSC5 "BEC-1, IFITMD3, LOST1" ENSG00000184811 "Tumor suppressor candidate 5" Q8IXB3 17 1279663-1300987 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "adipose tissue: 79.1;breast: 63.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "breast cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 268 "ASC diff: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA050825 Approved NA NA "HPA050825: AB_2681252" "unprognostic (5.84e-2)" "unprognostic (7.21e-2)" "unprognostic (1.15e-1)" "unprognostic (3.00e-1)" "unprognostic (2.01e-1)" "unprognostic (2.91e-2)" "unprognostic (1.09e-2)" "unprognostic (1.01e-1)" "unprognostic (2.73e-1)" "unprognostic (1.83e-2)" "unprognostic (2.66e-1)" "unprognostic (5.79e-2)" "unprognostic (1.90e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (5.10e-1)" 79.1 0.9 0.0 2.1 0.0 0.1 63.0 0.0 0.1 0.2 4.1 0.0 0.0 0.1 0.1 0.9 0.2 0.2 3.4 5.2 0.0 0.0 0.4 0.1 0.1 2.2 0.0 0.0 0.2 0.5 0.1 0.0 0.1 0.0 0.1 0.2 0.0 2.5 1.4 4.4 0.8 1.1 0.2 0.0 0.1 0.2 0.2 0.0 0.0 0.6 2.7 0.1 0.8 2.5 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.3" "Cell type enriched" "Detected in many" 8 "monocytes: 50.5" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.6;SH-SY5Y: 6.1;U-266/70: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles NA NA Vesicles "HPA060582: AB_2684326" "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.9 4.3 10.1 3.3 11.0 5.5 1.1 5.6 13.3 1.7 1.4 2.3 1.6 2.4 2.4 2.3 1.2 2.3 3.2 2.5 9.4 8.0 1.3 1.5 2.3 6.1 6.6 11.8 8.7 2.0 0.5 3.6 0.8 5.7 4.6 1.4 3.1 2.1 3.7 1.9 2.5 2.6 2.8 2.9 3.2 2.1 2.8 3.1 1.3 1.5 0.0 2.6 2.4 1.4 1.6 3.8 0.8 0.8 0.5 0.8 0.4 0.4 0.8 0.9 1.0 0.0 0.3 0.8 0.2 0.0 0.0 0.1 0.2 0.8 1.3 0.5 0.2 0.7 1.2 0.0 0.0 0.0 2.8 0.6 0.4 1.7 1.2 0.0 0.3 1.6 0.4 0.0 0.4 0.0 0.6 0.0 0.7 0.4 1.2 0.0 0.8 0.8 1.1 3.6 0.3 0.1 2.0 0.3 0.3 0.1 1.3 0.6 6.1 0.2 0.6 0.1 0.7 0.6 0.5 0.9 1.0 0.8 1.2 0.5 3.2 0.5 0.9 0.9 1.1 0.5 0.6 0.8 0.2 0.6 0.6 0.4 0.9 0.8 0.2 3.8 1.6 0.4 0.4 0.8 0.5 0.6 0.8 0.2 0.4 10.1 11.0 5.6 13.3 9.4 8.0 6.6 11.8 5.7 3.1 0.0 2.6 0.0 0.0 1.0 6.4 0.5 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.6 0.6 0.0 0.0 0.5 0.2 1.5 0.0 0.0 0.0 0.8 1.6 0.0 0.0 1.3 0.0 2.6 5.0 1.7 50.5 0.0 4.8 0.2 0.0 1.4 1.0 0.9 0.0 0.8 1.4 2.7 0.9 1.1 0.0 0.0 0.1 TWF2 "A6r, A6RP, PTK9L" ENSG00000247596 "Twinfilin actin binding protein 2" Q6IBS0 3 52228610-52239260 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.7" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 187.1;monocytes: 272.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053874 Uncertain Uncertain "Plasma membrane" NA NA 14000000 "Plasma membrane" "HPA053874: AB_2682287" "unprognostic (4.24e-2)" "unprognostic (8.61e-2)" "unprognostic (2.18e-1)" "unprognostic (2.62e-2)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (5.46e-3)" "unprognostic (2.76e-1)" "unprognostic (6.56e-2)" "unprognostic (1.97e-1)" "unprognostic (2.58e-2)" "unprognostic (5.07e-2)" "unprognostic (4.31e-3)" "unprognostic (4.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.07e-2)" 25.0 13.0 10.4 21.0 10.9 17.0 22.3 17.5 21.1 13.8 15.2 7.7 10.4 12.1 14.3 13.1 17.2 11.4 18.7 38.8 13.2 9.4 13.9 11.7 16.5 39.4 9.2 13.2 14.4 10.9 5.4 7.5 11.0 9.1 13.4 7.1 10.4 18.2 13.5 81.7 11.9 13.5 13.5 8.4 23.3 13.4 7.9 7.3 34.5 9.4 15.4 19.5 18.7 14.3 32.3 46.8 72.5 50.1 26.9 40.9 38.7 6.6 17.1 6.0 10.4 19.6 24.0 10.7 15.7 25.4 18.8 16.9 8.9 18.3 23.9 10.4 18.4 17.2 11.8 7.5 22.0 4.2 15.1 9.9 24.6 12.8 21.5 16.9 14.8 41.3 22.2 10.6 22.3 7.6 12.8 28.6 15.2 5.7 12.5 14.0 5.8 20.4 34.0 9.3 8.7 48.6 7.9 6.2 25.0 14.8 10.8 4.7 17.9 5.6 23.7 31.1 3.8 5.4 16.1 29.4 18.5 20.1 14.3 13.5 11.2 9.9 11.6 36.4 42.0 22.2 26.8 50.1 39.6 33.7 48.9 30.6 32.3 35.9 35.8 46.8 25.4 28.9 35.6 72.5 26.9 49.5 42.3 40.9 38.7 10.4 10.9 17.5 21.1 13.2 9.4 9.2 13.2 9.1 7.3 6.0 8.5 43.9 25.9 15.2 12.0 25.8 30.6 5.3 4.5 12.2 0.0 35.9 31.5 70.3 2.8 31.5 60.1 0.0 89.7 67.2 36.1 19.7 40.3 8.9 187.1 6.4 21.2 23.4 112.2 2.4 32.5 86.2 32.1 272.3 18.1 14.9 81.2 38.6 31.8 14.6 4.5 51.8 24.5 0.9 23.6 13.4 18.9 73.4 21.1 23.7 TWIST1 "ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST" ENSG00000122691 "Twist family bHLH transcription factor 1" Q15672 7 19020991-19117672 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 50.0;placenta: 45.6" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 11.1;Fibroblasts: 17.6;Melanocytes: 11.8;Smooth muscle cells: 9.8;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "SH-SY5Y: 75.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.62e-1)" "unprognostic (1.29e-2)" "unprognostic (9.80e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-2)" "unprognostic (8.51e-3)" "unprognostic (5.91e-2)" "unprognostic (8.99e-3)" "unprognostic (3.69e-1)" "unprognostic (1.29e-9)" "unprognostic (8.55e-3)" "unprognostic (1.54e-1)" "unprognostic (6.83e-3)" "unprognostic (1.97e-2)" 19.9 5.1 0.6 2.6 0.6 0.1 50.0 0.4 1.2 4.6 3.3 0.5 1.4 0.2 19.6 4.0 7.0 2.2 7.5 3.3 0.6 0.4 0.7 0.3 0.4 2.8 0.7 1.1 6.2 0.4 0.2 5.3 45.6 1.6 7.6 0.6 2.2 6.4 1.0 3.5 12.0 0.4 11.3 1.0 0.1 4.5 3.6 0.5 0.0 2.8 8.6 5.3 12.6 11.4 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.4 0.5 2.5 0.0 13.1 5.4 0.0 10.7 5.0 8.2 10.9 0.0 0.0 0.0 1.1 8.8 2.0 0.0 1.0 0.8 5.5 2.3 2.8 0.0 1.1 0.0 7.8 2.7 0.0 13.0 2.8 1.7 4.5 2.5 0.0 0.1 0.0 0.0 8.7 0.0 0.0 0.1 1.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 4.5 75.7 1.7 0.0 2.1 1.7 0.2 3.4 0.0 10.2 0.0 8.0 1.8 0.0 0.0 0.0 5.6 0.0 12.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 0.4 1.2 0.6 0.4 0.7 1.1 1.6 0.5 0.0 0.0 0.0 0.2 11.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.1 0.8 0.0 0.0 0.0 0.1 17.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 1.2 11.8 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 0.0 9.8 0.5 0.9 7.4 1.1 0.0 0.0 0.3 TWIST2 "bHLHa39, Dermo-1, DERMO1" ENSG00000233608 "Twist family bHLH transcription factor 2" Q8WVJ9 2 238848032-238910543 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 34.6" "Group enriched" "Detected in many" 6 "Basal glandular cells: 14.2;Fibroblasts: 25.5;Leydig cells: 44.5;Peritubular cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 21 "eosinophil: 11.2" "Lineage enriched" "Detected in single" 52 "granulocytes: 11.2" "Cell line enhanced" "Detected in many" "ASC diff: 33.5;ASC TERT1: 21.3;BJ: 27.2;BJ hTERT+: 85.8;fHDF/TERT166: 38.9;U-2197: 33.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062870 Supported Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA062870: AB_2684888" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.83e-2)" "unprognostic (4.06e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-2)" "unprognostic (2.33e-1)" "unprognostic (2.24e-1)" "unprognostic (1.17e-1)" "unprognostic (2.40e-9)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.98e-2)" "unprognostic (4.48e-2)" 25.8 1.3 0.2 4.7 0.6 0.6 21.7 0.1 0.4 34.6 8.4 0.4 4.3 0.6 14.3 6.2 9.1 7.4 5.8 4.3 0.6 0.2 0.7 0.3 4.2 0.9 1.1 0.0 15.6 0.7 0.0 2.1 9.1 0.4 13.1 1.9 3.9 2.2 7.1 4.3 9.7 2.3 12.4 1.7 1.2 3.3 4.6 0.5 0.0 4.0 6.4 3.4 15.9 18.6 0.2 0.0 11.2 0.1 0.0 0.0 0.0 0.0 1.8 0.1 0.0 33.5 21.3 0.0 27.2 85.8 12.7 19.2 0.0 0.0 0.0 0.8 38.9 1.0 0.2 0.3 2.2 9.3 0.0 2.9 0.0 1.6 0.1 5.7 0.0 0.6 4.9 1.2 6.1 5.1 1.5 1.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.3 4.7 0.5 0.9 33.2 0.3 0.0 0.0 0.0 0.1 0.8 1.7 0.0 0.1 11.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.3 0.6 0.2 1.1 0.0 0.4 0.5 0.0 1.6 0.0 14.2 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.7 25.5 2.5 1.1 0.0 2.0 0.0 0.0 4.3 0.0 0.2 44.5 0.0 1.7 0.0 0.0 0.0 0.1 0.0 36.7 0.0 0.0 0.0 5.1 0.5 1.7 1.5 1.4 0.0 0.0 3.0 TXK "BTKL, PSCTK5, PTK4, RLK, TKL" ENSG00000074966 "TXK tyrosine kinase" P42681 4 48066393-48134256 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4" "Cell type enriched" "Detected in some" 9 "T-cells: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 43.5" "Group enriched" "Detected in many" 26 "NK-cells: 43.5;T-cells: 17.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062482 Approved Vesicles NA NA Vesicles "HPA062482: AB_2684778" "unprognostic (1.04e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (9.24e-3)" "unprognostic (1.09e-2)" "unprognostic (2.58e-4)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (1.50e-1)" "unprognostic (6.39e-3)" "unprognostic (8.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (2.59e-1)" "unprognostic (2.04e-2)" 1.8 1.5 0.3 15.3 0.4 3.9 1.5 0.2 0.6 0.8 2.1 0.3 0.2 1.3 1.3 11.6 2.4 2.6 1.7 0.7 0.2 0.4 2.1 2.8 4.0 49.1 0.5 0.5 0.5 1.0 0.4 1.3 28.4 0.6 0.9 1.0 1.0 6.1 0.2 0.5 1.7 7.9 0.4 0.4 17.8 1.0 1.7 0.2 14.0 1.9 0.2 19.3 2.4 1.4 0.0 0.1 1.1 0.0 43.5 17.5 10.6 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.8 0.0 1.4 0.0 0.2 0.2 0.0 0.0 0.4 0.2 0.1 2.4 0.0 0.0 0.0 0.3 11.3 0.0 0.0 0.1 0.0 0.8 0.1 0.4 0.2 0.0 0.7 0.0 0.0 2.1 0.0 0.6 0.8 0.3 0.0 0.0 1.4 1.3 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.1 5.5 6.8 0.4 0.0 0.4 25.4 1.1 0.0 0.3 13.2 0.0 17.4 0.0 6.8 6.4 0.0 0.0 17.5 11.9 0.8 43.5 0.0 0.1 5.1 10.6 0.3 0.4 0.2 0.6 0.2 0.4 0.5 0.5 0.6 0.2 0.0 2.6 0.8 0.5 0.3 0.0 0.2 2.5 0.0 0.0 0.0 3.9 0.2 1.7 1.3 4.3 0.1 0.0 0.0 0.0 0.1 0.5 0.4 1.1 1.0 1.2 0.0 0.0 4.3 5.1 1.3 0.3 0.5 1.7 0.0 0.0 2.3 0.2 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.2 1.0 0.5 43.1 0.2 0.6 TXLNB "C6orf198, dJ522B19.2, DKFZp451A175, MDP77" ENSG00000164440 "Taxilin beta" Q8N3L3 6 139240061-139292139 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "heart muscle: 37.9;skeletal muscle: 131.5;tongue: 49.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 228.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 5.3" "Group enriched" "Detected in many" 4 "B-cells: 5.3;granulocytes: 2.1" "Cell line enhanced" "Detected in some" "Daudi: 7.3;HSkMC: 4.7;REH: 3.9;RPMI-8226: 5.4;U-698: 10.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA030401, HPA030402, HPA030403" Enhanced NA NA "HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461" "unprognostic (1.54e-1)" "unprognostic (7.01e-3)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (5.75e-3)" "unprognostic (2.94e-1)" "unprognostic (1.09e-2)" "unprognostic (6.00e-2)" "unprognostic (2.06e-1)" "unprognostic (8.10e-3)" "unprognostic (4.79e-1)" "unprognostic (5.15e-2)" "unprognostic (2.16e-4)" "unprognostic (2.19e-2)" "unprognostic (2.21e-1)" "unprognostic (2.65e-1)" "unprognostic (8.05e-4)" 4.5 0.9 0.4 1.1 0.6 0.1 0.7 0.2 0.5 1.0 0.7 0.6 0.0 0.2 1.3 5.1 3.4 0.6 0.7 37.9 0.5 0.5 0.3 0.3 0.6 0.9 0.5 0.4 3.8 0.2 2.3 0.7 0.2 0.8 0.9 0.3 0.1 2.1 0.1 131.5 0.3 0.8 1.1 1.5 1.0 0.4 1.2 0.1 3.4 0.9 49.7 2.7 1.0 0.5 5.3 0.3 2.1 0.3 0.3 0.8 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 7.3 0.0 0.1 0.4 0.0 0.3 0.0 0.0 0.1 0.8 1.0 0.1 0.0 0.0 2.0 0.3 4.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.2 0.4 0.3 0.7 0.8 0.2 0.0 0.5 3.9 1.7 5.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 0.9 2.2 1.4 0.1 0.1 0.0 0.1 1.2 2.1 10.2 0.3 2.0 0.0 0.0 0.2 0.0 0.4 0.2 0.6 5.3 0.4 0.8 0.1 1.9 0.4 0.2 2.1 0.3 0.3 0.3 0.3 0.3 0.4 0.6 0.2 0.5 0.5 0.5 0.5 0.4 0.8 0.1 0.0 0.0 5.2 0.1 0.5 0.0 228.7 0.0 21.4 2.3 1.8 0.0 0.1 0.0 0.0 30.5 3.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 1.3 5.8 49.6 0.6 2.2 5.0 0.0 0.0 7.5 0.0 0.0 2.1 0.0 0.0 0.0 0.4 4.7 0.5 0.4 0.0 1.3 0.0 0.0 TXN TRX ENSG00000136810 Thioredoxin P10599 9 110243811-110256640 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transcription, Transcription regulation, Transport" Activator Allergen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 447.3" "Cell type enriched" "Detected in all" 10 "monocytes: 27271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 127.1;granulocytes: 104.5" "Cell line enhanced" "Detected in all" "OE19: 265.0" "Low region specificity" "Detected in all" "CAB008678, HPA047478, HPA055752" Enhanced Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" NA NA 25000000 "Nucleoplasm, Cytosol" "CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907" "unprognostic (2.12e-2)" "unprognostic (1.27e-1)" "unprognostic (9.77e-2)" "prognostic favorable (3.40e-6)" "unprognostic (1.80e-2)" "unprognostic (2.13e-2)" "unprognostic (5.52e-3)" "unprognostic (1.37e-2)" "unprognostic (1.75e-1)" "unprognostic (3.36e-2)" "unprognostic (5.93e-3)" "unprognostic (1.66e-1)" "unprognostic (4.96e-3)" "unprognostic (7.80e-2)" "unprognostic (8.55e-2)" "unprognostic (2.99e-2)" "unprognostic (8.51e-2)" 23.6 16.7 26.6 18.2 16.9 35.8 25.9 10.8 19.7 30.8 57.9 7.7 17.5 40.7 15.5 20.4 162.3 27.5 22.2 11.7 20.9 19.0 65.8 69.4 39.0 19.4 21.3 14.1 18.2 22.0 5.3 8.0 41.2 28.7 15.5 50.6 8.0 50.2 16.3 16.0 26.3 58.9 21.9 17.6 19.8 26.3 9.2 7.0 40.0 18.9 447.3 82.0 31.3 27.1 12.8 127.1 104.5 25.1 14.2 26.0 18.8 45.9 63.1 17.1 18.8 43.2 56.3 25.2 55.9 52.2 39.0 29.7 40.9 55.4 40.9 24.0 51.6 85.4 103.8 24.3 74.5 38.3 60.7 54.1 20.5 59.2 70.8 49.4 50.9 62.7 39.9 49.1 57.0 43.2 36.3 34.2 26.1 34.5 39.4 53.3 37.2 42.3 76.4 36.4 265.0 77.0 17.8 58.0 47.6 49.8 32.6 37.2 13.3 60.3 49.0 37.9 34.4 47.0 35.2 41.0 40.2 26.0 75.4 69.2 20.0 56.4 34.8 58.3 44.4 55.8 32.2 25.1 104.5 14.5 15.1 13.9 12.8 20.5 17.4 37.1 5.6 7.7 11.5 99.7 14.2 9.6 127.1 26.0 18.8 26.6 16.9 10.8 19.7 20.9 19.0 21.3 14.1 28.7 7.0 363.3 237.5 189.1 832.3 1158.8 34.8 96.1 504.4 436.3 374.2 249.5 19.6 560.0 824.0 1017.1 20.9 327.5 1162.8 233.6 1150.3 840.4 409.8 774.5 261.1 685.2 516.6 27.0 534.8 206.2 278.9 11.1 373.3 793.2 723.7 27271.2 934.3 40.9 1608.6 1292.8 268.3 2636.4 24.8 142.3 563.4 10.6 70.3 1303.3 391.5 213.2 1478.0 1356.2 TXNDC2 SPTRX1 ENSG00000168454 "Thioredoxin domain containing 2" Q86VQ3 18 9885726-9889275 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 73.0" "Group enriched" "Detected in some" 85 "Early spermatids: 257.8;Late spermatids: 100.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 4.5;U-2 OS: 3.8" "CAB016414, HPA018817" Enhanced NA NA "CAB016414: , HPA018817: AB_2241329" "unprognostic (1.21e-2)" "unprognostic (3.55e-3)" "unprognostic (6.31e-2)" "unprognostic (5.25e-2)" "unprognostic (1.33e-1)" "unprognostic (1.25e-1)" "unprognostic (6.13e-1)" "unprognostic (1.21e-1)" "unprognostic (3.17e-2)" "unprognostic (8.95e-3)" "unprognostic (3.75e-2)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (2.18e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.9 2.9 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.7 0.3 0.8 0.0 1.1 0.4 0.8 0.0 0.2 0.0 0.3 0.4 2.1 0.1 0.4 0.0 0.9 0.2 0.6 1.7 1.1 0.0 2.2 0.2 2.4 0.1 0.1 1.1 0.0 0.8 0.5 0.0 4.5 0.0 0.3 0.3 0.0 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.7 0.0 0.3 0.0 0.8 1.2 0.9 3.8 1.7 1.2 0.1 0.3 0.0 1.4 0.0 0.7 0.0 0.6 0.9 0.0 2.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 257.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 100.2 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 1.4 1.0 0.0 0.1 0.0 0.0 0.0 TXNDC8 "bA427L11.2, SPTRX-3, TRX6" ENSG00000204193 "Thioredoxin domain containing 8" Q6A555 9 110303521-110337884 "Cancer-related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 23.9" "Group enriched" "Detected in some" 151 "Early spermatids: 310.1;Late spermatids: 448.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "Daudi: 1.3;HeLa: 1.5;NTERA-2: 1.0;SK-BR-3: 1.4;THP-1: 5.8" "Not detected" "Not detected" NA NA "unprognostic (1.50e-1)" "unprognostic (1.13e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 310.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 448.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 TXNRD3 "TGR, TR2, TRXR3" ENSG00000197763 "Thioredoxin reductase 3" Q86VQ6 3 126607052-126655155 "Enzymes, Predicted intracellular proteins" "Differentiation, Electron transport, Spermatogenesis, Transport" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 27.8" "Cell type enhanced" "Detected in many" 13 "Spermatocytes: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.0" "Lineage enriched" "Detected in single" 4 "T-cells: 4.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020802, HPA036109" Uncertain Enhanced Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB020802: , HPA036109: AB_2674945" "unprognostic (1.41e-1)" "unprognostic (1.55e-2)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (3.90e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (3.39e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (3.14e-1)" "prognostic favorable (2.72e-4)" "unprognostic (5.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" 5.4 5.9 4.9 2.4 4.7 0.9 7.2 5.5 5.7 7.3 4.2 4.6 5.5 1.6 8.3 7.1 6.4 4.7 5.2 4.9 4.0 2.9 6.7 10.0 7.0 5.2 4.6 3.5 8.8 7.1 12.3 8.5 3.3 7.0 5.2 3.6 6.4 5.7 5.1 7.3 4.8 2.6 8.1 5.1 3.3 4.9 27.8 5.8 5.0 7.4 3.6 2.1 6.6 5.3 0.3 0.7 0.5 0.9 0.9 4.0 0.3 14.0 3.6 4.6 7.2 8.5 13.0 2.3 6.2 5.6 5.1 7.2 6.4 7.9 0.0 7.9 8.5 3.1 5.6 5.7 6.4 6.5 0.0 4.2 1.6 3.3 4.9 7.4 5.7 0.5 11.9 5.6 1.7 11.8 7.0 3.7 4.6 3.4 0.0 8.2 10.1 1.2 3.1 6.5 3.8 2.7 0.4 4.0 2.3 5.4 7.0 8.0 4.9 17.8 5.2 9.0 3.7 7.2 2.2 6.1 6.3 1.5 8.5 2.9 3.7 1.6 0.0 3.4 2.0 5.3 0.0 0.9 0.5 0.5 0.8 0.1 0.0 0.2 0.6 0.7 0.3 4.0 1.3 0.0 0.9 0.2 0.0 0.0 0.3 4.9 4.7 5.5 5.7 4.0 2.9 4.6 3.5 7.0 5.8 3.0 7.4 0.0 4.8 0.9 1.9 3.6 5.1 2.7 3.4 3.5 2.0 7.5 3.3 4.3 15.1 1.5 0.0 0.0 3.4 4.6 3.7 2.1 5.7 7.3 2.6 0.0 4.1 1.3 0.3 2.9 4.4 0.3 0.0 0.0 2.3 2.3 3.9 0.0 8.1 2.8 0.5 0.0 2.7 54.7 15.3 0.5 6.1 0.0 1.5 2.5 TXNRD3NB "TR2IT1, TXNRD3IT1, TXNRD3NT1" ENSG00000206483 "Thioredoxin reductase 3 neighbor" Q6F5E7 3 126571789-126572636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "ovary: 1.4;testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;HL-60: 2.2;NTERA-2: 1.5;PC-3: 1.0;U-937: 1.1" HPA058257 Uncertain NA NA "HPA058257: AB_2683655" 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.6 0.1 0.4 0.0 0.0 0.3 0.7 0.8 0.8 0.1 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.8 2.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 1.0 0.2 0.0 0.8 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TXNRD3NB "TR2IT1, TXNRD3IT1, TXNRD3NT1" ENSG00000283374 "Thioredoxin reductase 3 neighbor" Q6F5E7 3 126571779-126608555 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "parathyroid gland: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.8;PC-3: 1.4" HPA058257 Uncertain NA NA "HPA058257: AB_2683655" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.7 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530056 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 57.8" "Cell type enriched" "Detected in many" 5 "monocytes: 2738.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9" "Group enriched" "Detected in many" 18 "dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 16.2;HHSteC: 40.2;Karpas-707: 38.8;U-266/70: 18.6" "Low region specificity" "Detected in some" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 16000000 "Nuclear bodies, Golgi apparatus" Cytosol "CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favorable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 25.2 7.9 2.8 41.6 8.4 12.1 19.0 1.5 4.4 10.7 10.7 3.8 2.3 10.4 4.4 15.7 22.0 13.7 9.6 15.0 7.0 2.6 18.6 38.1 28.8 57.8 6.5 0.4 7.5 5.8 1.7 3.9 11.5 9.1 7.9 4.9 5.4 16.5 3.8 10.0 8.8 13.9 7.3 15.2 43.9 12.4 3.0 5.0 13.3 12.5 25.5 28.8 12.4 9.4 0.9 12.2 18.2 23.0 0.8 0.9 2.6 6.7 0.8 0.0 0.1 1.0 1.3 0.6 1.2 0.1 2.4 5.4 0.0 16.2 0.5 0.8 2.7 0.8 5.9 0.2 0.3 0.0 2.8 1.4 0.3 1.1 0.4 40.2 0.1 7.7 2.5 2.4 3.2 0.0 0.1 0.0 0.0 0.2 38.8 0.2 0.1 0.0 1.0 0.0 0.9 2.1 0.2 0.0 7.8 0.0 0.0 0.0 1.4 6.2 8.5 0.6 0.0 0.7 4.9 1.5 0.0 0.6 0.1 0.2 18.6 3.8 0.4 0.2 0.1 0.2 2.5 23.0 18.2 0.3 22.4 0.2 0.8 0.3 0.2 12.2 0.9 0.2 0.1 6.7 0.8 15.9 1.1 0.9 2.6 2.8 8.4 1.5 4.4 7.0 2.6 6.5 0.4 9.1 5.0 11.9 35.6 80.8 45.0 52.0 2.9 2.0 40.8 21.4 19.4 31.4 3.9 11.5 24.9 326.6 1.8 45.0 161.9 0.0 563.3 281.5 67.3 63.5 54.1 80.8 472.8 0.0 16.1 38.1 417.7 8.6 4.6 429.6 108.0 2738.6 29.6 2.0 289.0 94.7 1.8 76.1 5.4 25.8 44.2 1.4 8.3 49.4 28.0 34.5 27.7 63.3 TYMS "HsT422, TMS, TS, Tsase" ENSG00000176890 "Thymidylate synthetase" P04818 18 657604-673578 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Methyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.9;lymphoid tissue: 75.5" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 109.0;Spermatocytes: 197.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 13.8" "Group enriched" "Detected in many" 6 "NK-cells: 6.8;T-cells: 13.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebellum: 6.7;olfactory region: 8.8" "CAB002784, HPA074922" Enhanced NA Yes "CAB002784: , HPA074922: " "unprognostic (7.58e-2)" "unprognostic (2.06e-3)" "unprognostic (9.31e-2)" "unprognostic (2.34e-2)" "unprognostic (7.35e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.10e-6)" "unprognostic (1.62e-3)" "unprognostic (1.68e-2)" "unprognostic (9.82e-2)" "unprognostic (1.07e-3)" "unprognostic (3.28e-2)" "unprognostic (1.23e-2)" "unprognostic (6.34e-2)" "unprognostic (1.66e-1)" "unprognostic (5.65e-3)" "unprognostic (2.47e-1)" 3.0 2.6 4.6 15.5 5.8 34.9 2.8 1.2 6.3 3.4 10.1 10.2 1.5 4.8 2.5 3.6 12.3 2.4 4.6 2.0 5.8 2.9 4.8 5.1 4.2 15.4 3.4 4.5 2.0 3.1 1.1 1.3 14.3 3.4 3.0 12.9 1.1 3.4 0.8 0.7 3.6 6.9 5.5 4.6 8.9 4.2 21.5 5.3 75.5 1.7 10.9 19.3 4.8 4.3 1.2 1.8 1.0 0.1 6.8 13.8 2.5 13.9 21.5 44.9 21.7 5.0 8.4 22.8 32.9 19.7 35.6 42.7 18.1 11.2 21.7 12.9 17.7 20.2 6.3 31.3 12.4 30.8 20.4 34.8 36.8 20.2 31.1 1.1 75.6 40.4 7.4 2.9 22.4 7.0 6.8 29.7 46.2 29.5 34.9 44.8 16.0 91.0 41.9 16.2 17.0 16.1 60.2 40.4 26.1 13.3 12.4 15.3 24.9 27.8 12.9 8.3 29.1 8.8 34.5 11.7 41.2 81.4 37.7 64.2 43.3 53.3 49.6 10.9 32.7 47.0 0.0 0.0 1.0 1.1 0.1 0.0 1.2 2.9 2.2 1.8 0.0 0.0 0.7 0.6 6.8 0.1 0.3 13.8 2.5 4.6 5.8 1.2 6.3 5.8 2.9 3.4 4.5 3.4 5.3 0.0 2.9 3.0 11.2 12.8 0.4 2.1 5.1 0.0 7.9 0.0 0.0 36.1 1.7 2.4 18.3 1.5 8.4 23.3 0.7 109.0 7.2 4.0 6.9 1.7 57.9 0.0 1.2 6.2 15.9 22.3 5.8 9.2 10.1 6.4 13.0 42.9 1.4 3.5 3.5 19.4 1.9 12.9 4.1 197.1 30.9 6.4 22.5 7.5 39.0 3.5 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177452-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 70 "retina: 82.0;skin 1: 25.2" "Cell type enriched" "Detected in some" 8 "Melanocytes: 175.5" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 864 "SK-MEL-30: 86.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles NA NA Vesicles "CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 82.0 0.7 0.0 0.0 25.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 175.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.0 TYRO3 "Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif" ENSG00000092445 "TYRO3 protein tyrosine kinase" Q06418 15 41557675-41583586 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.2;ovary: 48.2" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 41.1;Peritubular cells: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.0" "Cell line enhanced" "Detected in many" "BEWO: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071245 Approved NA NA 6400000 "HPA071245: AB_2686371" "unprognostic (1.26e-1)" "unprognostic (6.34e-2)" "unprognostic (1.47e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.56e-3)" "unprognostic (5.41e-2)" "unprognostic (3.72e-1)" "unprognostic (3.21e-1)" "unprognostic (2.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.92e-10)" "unprognostic (7.59e-2)" "unprognostic (5.22e-1)" "unprognostic (4.04e-3)" "unprognostic (1.84e-2)" 18.3 4.1 18.7 2.1 16.6 1.5 7.7 27.3 39.2 2.3 1.8 25.6 1.2 2.3 5.0 4.2 12.7 11.7 3.1 2.5 15.1 7.8 6.4 1.6 3.2 1.9 19.6 18.2 48.2 9.5 1.3 0.8 5.9 14.0 3.3 1.7 1.7 2.4 6.7 1.4 13.0 2.9 4.8 23.1 5.4 3.6 17.9 16.6 0.0 1.8 2.2 4.1 2.9 2.8 1.2 1.0 5.0 0.9 1.0 0.8 0.2 4.8 3.2 10.1 11.0 9.5 6.4 33.9 7.0 4.5 7.0 6.5 17.8 1.6 0.1 9.0 5.6 9.8 11.4 11.2 1.7 3.2 2.7 7.5 1.4 10.1 8.5 6.6 2.4 0.2 2.0 3.6 5.3 1.8 2.8 5.1 4.7 8.8 2.1 3.8 4.6 1.1 0.4 23.2 7.5 3.2 14.9 9.1 1.8 0.6 9.3 12.1 3.4 6.5 10.5 7.8 15.3 8.6 2.8 4.0 13.9 6.1 10.2 10.5 0.8 1.6 1.4 8.4 16.0 8.3 2.6 0.9 0.8 0.6 0.5 0.6 0.7 0.6 0.8 0.3 1.2 0.7 0.7 5.0 1.0 0.5 1.0 0.5 0.2 18.7 16.6 27.3 32.7 15.1 7.8 19.6 18.2 14.0 16.6 3.0 1.4 0.9 6.2 6.1 1.2 3.7 2.5 0.0 0.0 3.5 5.9 2.4 0.0 3.4 2.7 4.9 0.9 0.0 3.1 8.9 5.6 4.8 0.0 0.2 1.0 0.0 1.7 12.3 0.6 4.0 41.1 1.1 8.5 0.0 0.1 6.5 3.7 0.0 44.2 1.5 3.9 0.0 2.8 2.4 5.4 9.5 15.8 0.0 1.6 4.7 TYROBP "DAP12, KARAP, PLO-SL, PLOSL" ENSG00000011600 "TYRO protein tyrosine kinase binding protein" O43914 19 35904401-35908295 "Disease related genes, Predicted membrane proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6" "Group enriched" "Detected in many" 4 "Hofbauer cells: 3494.1;Kupffer cells: 3415.8;Macrophages: 2767.6;monocytes: 2409.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 267.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HMC-1: 118.8;THP-1: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009493, HPA041899" Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "CAB009493: AB_638987, HPA041899: AB_10795266" "unprognostic (7.09e-2)" "unprognostic (8.38e-3)" "unprognostic (7.87e-2)" "unprognostic (4.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.39e-1)" "unprognostic (5.27e-2)" "unprognostic (8.04e-2)" "unprognostic (2.07e-2)" "unprognostic (2.47e-1)" "unprognostic (2.91e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (4.47e-2)" "unprognostic (1.72e-2)" "unprognostic (4.27e-2)" "unprognostic (4.39e-2)" 76.0 21.4 13.3 54.9 20.7 125.7 16.4 2.8 11.3 11.9 14.3 24.0 2.3 17.1 8.1 19.3 7.2 14.0 25.7 17.5 12.9 14.2 17.6 29.8 75.3 80.0 20.8 5.6 11.7 8.7 1.8 9.0 32.0 17.2 14.9 12.3 15.0 12.4 7.2 7.3 6.7 18.9 16.0 36.3 123.6 10.4 7.3 18.6 8.5 6.7 6.6 10.3 22.3 8.4 0.7 79.3 267.2 190.6 62.8 20.3 162.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.1 5.4 118.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 65.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 0.0 32.8 190.6 100.9 20.3 134.4 10.6 0.7 0.4 2.8 79.3 0.3 0.5 2.3 267.2 62.8 130.3 68.5 0.3 162.3 13.3 20.7 2.8 11.3 12.9 14.2 20.8 5.6 17.2 18.6 53.6 239.1 119.8 2.3 49.0 0.0 5.3 56.0 37.5 79.6 19.2 0.0 18.6 1.7 0.8 2.5 35.9 0.7 0.0 4.8 19.4 38.6 1.2 723.1 19.1 3494.1 0.0 0.0 89.6 3415.8 4.7 8.6 2767.6 54.0 2409.4 0.0 0.5 1.2 0.2 1.1 6.8 1.1 77.6 17.2 0.7 2.8 39.0 32.5 348.1 0.1 1.0 TYRP1 "b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP" ENSG00000107165 "Tyrosinase related protein 1" P17643 9 12685439-12710290 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 277.3" "Cell type enriched" "Detected in some" 19 "Melanocytes: 2358.5" "Cancer enriched" "Detected in some" 262 "melanoma: 313.2" "Region enriched" "Detected in some" 5 "pons and medulla: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 52 "SK-MEL-30: 177.7" "Group enriched" "Detected in some" 5 "olfactory region: 5.6;thalamus: 2.0" "Low region specificity" "Detected in all" "HPA000937, CAB002520" Enhanced Approved Vesicles NA NA 16000 Vesicles "CAB002520: AB_564153, HPA000937: AB_1080437" "unprognostic (7.48e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-1)" "unprognostic (3.16e-3)" "unprognostic (8.10e-2)" "unprognostic (3.82e-3)" "unprognostic (1.53e-1)" "unprognostic (2.25e-3)" "unprognostic (4.46e-1)" "unprognostic (8.71e-2)" "unprognostic (6.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.68e-6)" "unprognostic (1.27e-1)" "unprognostic (5.99e-2)" "unprognostic (1.95e-2)" 0.2 0.0 0.2 0.2 0.3 0.0 1.7 0.2 1.0 0.2 0.5 1.3 0.2 1.6 0.2 0.3 3.6 0.2 1.4 21.5 0.9 0.1 5.7 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 5.0 0.2 1.8 277.3 1.1 0.2 1.3 51.1 1.4 0.4 1.1 0.2 0.6 0.5 0.2 0.2 0.2 0.9 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 177.7 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.0 0.9 0.1 0.2 0.3 5.0 0.2 0.0 0.0 0.0 0.0 82.0 0.6 39.7 0.0 0.0 0.0 3.5 2.0 0.0 122.7 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.3 0.3 0.0 2358.5 0.0 0.0 15.4 0.0 0.0 0.0 0.8 1.3 0.0 3.1 0.5 0.7 14.6 0.0 0.0 0.0 0.1 TYSND1 "MGC34695, NET41" ENSG00000156521 "Trypsin domain containing 1" Q2T9J0 10 70137981-70146676 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 90.7;Late spermatids: 154.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 18.0;PC-3: 27.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030304 Approved Uncertain Nucleoplasm,Centrosome,Cytosol NA NA "Nucleoplasm, Centrosome" Cytosol "HPA030304: AB_10670560" "unprognostic (4.75e-3)" "unprognostic (4.30e-2)" "unprognostic (2.44e-2)" "unprognostic (7.69e-2)" "unprognostic (1.84e-1)" "unprognostic (4.53e-2)" "unprognostic (2.02e-2)" "unprognostic (1.55e-1)" "unprognostic (1.33e-1)" "unprognostic (1.10e-1)" "unprognostic (1.59e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-1)" "unprognostic (9.26e-3)" "unprognostic (1.91e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" 15.2 8.2 4.7 7.0 6.8 3.0 8.0 6.7 7.3 6.0 6.7 5.9 6.9 10.1 5.3 8.4 13.9 5.4 5.2 3.5 3.7 2.8 7.4 7.4 3.5 7.2 3.7 3.6 5.6 9.0 3.3 4.5 4.7 3.5 6.9 2.7 6.9 8.0 5.7 5.3 12.5 8.5 4.8 4.7 9.0 8.2 40.7 3.4 6.2 8.5 6.6 10.1 6.5 7.6 6.1 1.4 1.2 1.6 2.9 6.3 2.3 9.5 6.9 0.5 4.1 0.8 0.6 2.5 1.2 0.9 1.4 1.3 4.3 6.1 8.6 4.0 0.3 0.3 18.0 0.7 2.7 0.3 5.4 6.2 0.5 1.9 2.1 1.7 0.7 0.0 1.3 5.2 1.2 2.2 0.8 1.0 3.1 0.0 2.6 0.6 4.2 3.2 3.5 2.2 2.3 27.7 5.7 1.6 3.8 0.6 1.6 5.0 2.6 4.2 9.4 3.6 0.2 6.1 0.7 1.7 1.6 1.1 3.0 5.4 9.8 5.9 4.2 1.9 3.6 1.2 0.0 1.3 1.2 6.3 1.6 4.1 5.1 3.7 4.9 1.4 6.1 5.3 4.4 0.4 2.9 1.1 1.0 4.0 2.3 4.7 6.8 6.7 7.3 3.7 2.8 3.7 3.6 3.5 3.4 8.9 4.0 13.7 13.8 12.7 6.8 4.3 25.5 1.4 5.7 10.4 0.0 30.0 14.9 6.8 90.7 6.7 14.8 0.0 8.3 6.8 6.3 10.9 13.8 14.3 10.7 0.0 13.7 6.7 9.5 154.7 8.6 8.0 11.8 2.8 10.6 6.2 5.1 10.5 7.4 12.4 4.5 6.5 4.7 41.1 11.1 16.2 14.0 11.8 20.3 5.2 U2AF1L5 ENSG00000275895 "U2 small nuclear RNA auxiliary factor 1 like 5" P0DN76 21 6484623-6499261 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 74.4" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 20.7;Ciliated cells: 18.7;Club cells: 26.1;granulocytes: 27.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044833, HPA052083" Supported Uncertain Nucleoplasm NA NA Nucleoplasm "HPA044833: AB_10960990, HPA052083: AB_2681720" "unprognostic (6.54e-2)" "unprognostic (2.42e-1)" "unprognostic (2.75e-2)" "unprognostic (8.31e-3)" "unprognostic (2.80e-1)" "unprognostic (5.99e-2)" "unprognostic (2.02e-1)" "unprognostic (4.54e-2)" "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (1.70e-1)" "unprognostic (3.42e-2)" "unprognostic (5.39e-3)" "unprognostic (3.14e-1)" "unprognostic (2.79e-2)" "unprognostic (5.98e-2)" "unprognostic (8.20e-2)" 4.7 5.3 0.5 5.3 6.4 7.0 6.2 6.2 21.0 4.7 6.0 7.3 6.8 3.7 9.5 8.6 8.9 4.5 8.5 8.2 3.0 7.4 5.8 6.6 6.0 0.5 12.0 11.9 8.5 3.9 0.5 14.9 6.4 4.0 6.5 8.1 12.8 5.3 4.3 4.2 3.5 11.0 4.6 5.0 3.2 11.2 0.8 10.6 14.2 0.5 11.4 4.2 7.7 40.6 63.8 74.4 41.8 33.3 47.6 47.0 25.6 10.6 55.2 24.0 15.4 14.1 24.6 15.3 18.2 29.6 20.5 39.0 17.3 57.8 13.2 21.2 32.7 17.9 44.6 22.0 42.8 11.4 4.2 74.1 24.9 48.4 25.4 80.5 25.8 10.7 13.7 19.8 21.3 15.0 27.1 27.3 58.3 33.7 30.1 24.7 56.1 51.0 57.5 41.5 3.4 88.1 30.3 33.2 33.6 39.1 29.0 19.3 27.0 27.3 27.3 13.9 19.2 45.1 24.0 21.5 28.9 11.4 33.8 41.1 34.6 67.0 19.4 49.1 29.3 35.8 41.8 36.9 29.9 34.6 36.4 37.9 38.7 35.2 43.5 40.6 43.8 37.0 74.4 33.3 26.1 63.8 47.6 47.0 11.9 20.7 0.5 1.5 0.0 0.1 0.0 2.5 18.7 26.1 0.0 0.0 1.3 1.7 4.2 0.6 0.0 0.2 0.0 6.1 1.5 0.8 2.9 27.9 0.8 0.9 0.0 2.4 1.8 0.6 0.0 0.3 1.3 0.0 4.6 1.9 0.4 5.4 2.3 1.1 1.3 0.4 0.0 0.0 1.7 1.9 0.0 1.7 0.0 1.7 1.1 UACA "FLJ10128, KIAA1561" ENSG00000137831 "Uveal autoantigen with coiled-coil domains and ankyrin repeats" Q9BZF9 15 70654554-70763593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.0" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 148.5;Leydig cells: 115.9;Peritubular cells: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9" "Group enriched" "Detected in many" 11 "B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3" "Cell line enhanced" "Detected in many" "BJ: 62.0;BJ hTERT+: 37.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041412, HPA043503, HPA056006" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: " "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (7.01e-5)" "unprognostic (4.95e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (1.03e-4)" 21.7 8.9 4.7 8.6 8.1 0.4 25.9 2.9 5.8 15.4 14.1 8.4 22.8 10.6 17.2 22.3 15.6 10.5 15.7 18.0 6.1 4.2 16.4 8.2 23.7 7.5 9.0 4.6 17.5 8.6 8.2 6.5 13.7 9.6 15.5 7.6 26.7 18.8 26.9 68.0 10.1 16.9 11.4 14.9 15.7 8.4 10.1 7.1 1.0 18.6 32.4 5.3 9.9 13.5 3.4 2.0 0.2 4.3 0.1 0.3 0.7 10.5 8.7 3.9 5.1 7.9 34.2 0.0 62.0 37.9 16.2 14.1 14.6 15.6 7.2 17.1 15.4 4.7 12.2 8.8 4.9 20.5 0.0 3.9 4.0 6.8 3.0 10.3 0.1 1.5 16.1 2.8 9.6 7.3 26.9 17.2 1.7 1.0 0.0 20.1 3.4 0.0 0.6 3.2 4.8 4.6 0.0 28.3 0.0 7.8 3.6 1.0 2.0 11.7 1.8 12.5 8.2 3.4 1.2 33.0 0.9 6.5 5.3 9.8 0.6 2.1 0.0 8.2 1.1 7.0 0.2 2.2 0.0 0.0 4.3 0.0 1.2 0.1 0.0 2.0 3.4 0.3 0.1 0.2 0.1 2.9 0.1 0.0 0.7 4.7 8.1 2.9 5.8 6.1 4.2 9.0 4.6 9.6 7.1 6.0 8.3 4.7 14.2 10.1 7.0 148.5 12.7 87.0 22.7 47.1 3.9 0.8 3.3 42.5 15.2 80.4 36.5 0.0 42.6 1.0 25.7 13.4 15.0 14.8 8.6 23.8 8.7 43.6 19.1 8.1 115.9 9.6 28.7 11.8 23.3 55.9 56.3 28.5 132.6 3.0 3.4 51.8 46.4 38.5 29.6 11.4 0.8 3.2 20.0 9.6 UBAC1 "GBDR1, KPC2, UBADC1" ENSG00000130560 "UBA domain containing 1" Q9BSL1 9 135932969-135961380 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 113.2" "Cell type enhanced" "Detected in all" 6 "Erythroid cells: 233.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 60.5;K-562: 76.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005651 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA 54000 "Plasma membrane, Cytosol" "Golgi apparatus" "HPA005651: AB_1858489" "unprognostic (8.41e-2)" "prognostic favorable (4.34e-6)" "unprognostic (2.10e-1)" "unprognostic (9.15e-2)" "unprognostic (4.11e-1)" "unprognostic (3.85e-2)" "unprognostic (7.68e-3)" "unprognostic (2.85e-1)" "unprognostic (4.37e-2)" "unprognostic (3.23e-1)" "unprognostic (3.92e-3)" "unprognostic (1.20e-1)" "prognostic favorable (3.58e-7)" "unprognostic (1.95e-3)" "unprognostic (9.46e-2)" "unprognostic (3.16e-2)" "unprognostic (5.78e-2)" 7.6 5.7 12.4 5.8 13.4 27.1 6.2 10.9 12.7 6.1 11.0 8.0 6.8 9.9 6.2 10.3 10.0 9.4 5.1 22.2 11.0 8.6 8.8 7.6 6.4 5.8 11.6 7.4 7.8 6.7 6.9 6.6 9.3 8.7 7.4 7.8 7.7 9.2 9.2 113.2 15.7 9.6 9.3 10.1 5.7 6.1 10.9 7.8 3.9 6.1 21.9 9.0 7.6 8.3 3.2 9.7 5.1 18.8 2.2 3.6 4.0 9.1 10.7 7.6 11.0 5.8 6.7 14.3 8.0 6.9 10.0 8.1 14.8 11.7 11.1 7.8 6.6 11.9 31.3 10.6 9.3 4.5 60.5 10.0 9.2 19.2 8.3 6.0 12.0 8.8 6.3 12.2 6.3 6.2 6.7 8.3 10.5 76.7 9.0 7.9 18.9 9.7 12.3 18.0 21.6 18.2 11.1 14.3 14.6 7.1 5.9 11.8 13.0 11.6 10.5 8.1 7.1 8.9 13.0 6.7 5.7 8.6 6.8 9.9 5.3 9.8 13.2 10.5 10.9 7.7 3.4 11.3 5.1 3.1 17.2 3.3 3.2 3.6 2.1 9.7 2.0 1.9 2.2 2.5 2.2 18.8 1.0 2.7 4.0 12.4 13.4 10.9 12.7 11.0 8.6 11.6 7.4 8.7 7.8 14.9 7.7 13.7 32.8 36.1 36.5 74.9 12.7 91.0 14.8 26.2 29.5 121.1 79.6 15.6 80.0 25.3 39.3 233.6 20.0 20.6 17.0 18.9 6.9 26.7 64.5 12.7 16.1 16.0 27.7 144.8 18.1 30.0 33.7 43.3 32.5 43.1 17.5 46.5 21.2 21.9 35.3 19.4 19.8 43.5 52.7 56.7 50.6 10.1 47.7 37.6 UBALD2 "FAM100B, MGC29814" ENSG00000185262 "UBA like domain containing 2" Q8IYN6 17 76265202-76271299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 108.9" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 20.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 20.3" "Cell line enhanced" "Detected in all" "HDLM-2: 63.0;Karpas-707: 82.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023046 Uncertain NA NA "HPA023046: AB_1848359" "unprognostic (1.33e-1)" "unprognostic (2.04e-3)" "unprognostic (3.14e-1)" "unprognostic (3.06e-1)" "unprognostic (9.21e-2)" "unprognostic (1.74e-1)" "unprognostic (3.22e-3)" "unprognostic (5.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.01e-1)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (4.80e-2)" "unprognostic (3.78e-2)" "unprognostic (9.24e-2)" "unprognostic (3.45e-3)" "unprognostic (1.45e-3)" 21.0 10.1 10.7 29.6 16.4 108.9 45.6 8.6 13.2 11.2 33.1 12.3 11.4 45.9 10.4 10.4 35.0 11.6 17.3 19.9 12.3 11.4 14.4 13.4 26.6 40.0 13.1 7.2 7.9 26.5 7.8 9.0 23.1 22.6 13.7 10.3 10.5 25.9 14.3 72.1 22.1 45.7 9.1 23.5 30.0 28.5 8.0 11.1 28.7 21.4 11.3 28.5 17.8 21.8 1.7 2.7 20.3 1.3 0.9 3.3 0.5 23.0 5.2 4.8 3.8 5.4 5.3 11.4 8.5 6.4 3.3 3.8 6.1 25.8 6.1 9.1 2.2 3.8 8.7 2.2 4.8 2.6 63.0 5.7 6.9 5.8 5.6 3.7 7.9 33.5 4.6 5.8 3.5 9.3 3.9 11.2 20.1 10.6 82.0 4.1 11.9 37.5 18.4 4.4 12.7 9.2 18.3 9.9 16.9 6.1 13.1 12.3 11.8 6.0 8.4 42.2 5.0 6.0 20.9 8.2 7.4 10.8 12.3 13.6 36.5 27.8 12.4 8.5 6.6 20.2 3.7 1.3 2.2 1.6 1.0 1.3 1.7 2.8 1.7 0.5 1.3 3.3 2.6 20.3 0.9 0.7 2.7 1.8 0.5 10.7 16.4 8.6 13.2 12.3 11.4 13.1 7.2 22.6 11.1 20.8 18.3 50.3 79.6 63.8 12.8 16.9 68.8 20.1 13.6 22.7 13.7 7.4 13.3 26.9 20.1 33.7 106.3 0.0 26.4 16.4 14.6 81.9 21.9 30.7 25.2 11.1 34.9 25.2 49.5 5.0 18.4 53.8 47.2 13.6 53.5 24.3 33.8 59.6 19.1 14.0 18.4 19.4 16.5 1.6 3.6 93.0 23.3 66.0 57.2 174.3 UBAP1L ENSG00000246922 "Ubiquitin associated protein 1 like" F5GYI3 15 65092770-65115197 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "retina: 91.1" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 149.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-MEL-30: 6.9;U-266/70: 3.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 10 "cerebellum: 49.0;pons and medulla: 8.6" HPA065334 Uncertain "Nuclear bodies" NA NA "Nuclear bodies" "HPA065334: AB_2685472" "unprognostic (6.89e-3)" "unprognostic (2.62e-1)" "unprognostic (2.66e-3)" "unprognostic (2.73e-2)" "unprognostic (1.64e-1)" "unprognostic (2.98e-3)" "unprognostic (6.59e-2)" "unprognostic (7.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.56e-1)" "unprognostic (5.62e-5)" "unprognostic (6.40e-3)" "unprognostic (3.11e-6)" "unprognostic (5.03e-2)" "unprognostic (1.39e-1)" "unprognostic (3.70e-1)" "unprognostic (6.11e-3)" 1.4 1.5 2.4 0.9 2.4 1.1 1.3 11.5 3.6 1.5 0.9 0.9 0.9 0.4 2.7 1.1 1.2 1.5 0.9 0.9 2.8 3.2 0.9 1.1 1.0 1.1 2.6 0.9 3.2 1.0 0.5 0.9 0.9 3.6 1.1 0.2 91.1 2.0 1.8 6.2 1.5 1.1 1.2 3.1 2.0 0.9 1.5 0.9 0.9 1.2 0.9 2.2 0.9 0.9 0.1 1.3 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.8 2.0 0.6 0.2 1.8 1.3 0.1 0.6 0.6 1.2 0.3 0.9 1.6 0.2 0.3 1.4 1.1 0.1 0.0 1.7 1.1 0.1 1.1 0.2 0.8 1.0 0.9 0.6 0.9 0.3 0.4 1.7 0.2 0.8 0.5 0.8 0.2 0.2 0.3 1.3 0.7 0.2 0.7 1.5 0.5 1.1 0.0 0.4 1.1 0.7 0.6 0.2 6.9 1.0 0.4 1.0 0.0 0.6 0.3 0.7 0.6 3.6 0.6 0.4 0.4 0.7 0.5 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.0 1.3 0.0 0.0 2.4 2.4 11.5 3.1 2.8 3.2 2.6 0.9 3.6 0.9 0.0 1.4 0.0 1.1 0.6 26.4 5.2 0.0 0.0 1.2 3.5 227.8 0.6 1.7 0.5 0.4 1.4 0.4 0.0 0.7 0.2 0.9 1.1 0.0 2.1 0.3 3.2 1.2 1.8 0.6 0.9 3.1 0.4 1.7 0.0 1.2 16.6 0.9 0.0 3.2 2.2 149.2 6.5 1.4 1.8 3.6 0.6 0.6 3.2 0.7 0.6 UBASH3A "CLIP4, STS-2, TULA" ENSG00000160185 "Ubiquitin associated and SH3 domain containing A" P57075 21 42403447-42447681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 17.6;lymphoid tissue: 62.3" "Cell type enriched" "Detected in some" 14 "T-cells: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "gdT-cell: 6.9;MAIT T-cell: 12.1;memory CD4 T-cell: 15.1;memory CD8 T-cell: 13.1;naive CD4 T-cell: 17.6;naive CD8 T-cell: 12.8;T-reg: 13.6" "Lineage enriched" "Detected in many" 15 "T-cells: 17.6" "Group enriched" "Detected in some" 6 "HEL: 13.4;JURKAT: 23.5;MOLT-4: 27.5" "Region enriched" "Detected in single" 13 "hippocampal formation: 0.5" "Low region specificity" "Detected in all" HPA035367 Supported "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA035367: AB_2732466" "unprognostic (5.14e-4)" "unprognostic (3.91e-4)" "unprognostic (1.57e-2)" "unprognostic (4.10e-5)" "unprognostic (4.33e-2)" "unprognostic (1.85e-6)" "unprognostic (5.54e-4)" "unprognostic (1.46e-3)" "unprognostic (6.17e-4)" "unprognostic (2.47e-3)" "unprognostic (1.94e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-6)" "unprognostic (1.65e-1)" "unprognostic (7.96e-2)" "unprognostic (3.24e-2)" "unprognostic (4.17e-2)" 1.1 0.7 0.3 19.7 0.3 2.6 0.8 0.3 0.3 0.9 2.8 0.1 0.0 1.9 0.8 0.8 1.2 1.3 3.2 1.1 0.3 0.4 1.4 1.1 6.0 23.1 0.4 0.0 0.7 0.6 0.0 0.6 0.4 0.3 1.2 1.0 1.1 5.0 0.2 0.3 0.5 5.9 0.6 0.7 10.8 2.2 0.4 0.0 62.3 1.4 1.1 14.1 2.6 1.1 0.0 0.0 0.3 0.0 1.1 17.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 13.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 23.5 2.5 0.0 0.0 0.0 27.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 12.1 0.0 15.1 13.1 0.0 0.0 17.6 12.8 0.3 1.1 0.0 0.0 13.6 5.1 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 16.2 0.0 0.0 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655675-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5;lymphoid tissue: 27.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 29.2;Extravillous trophoblasts: 45.7;Hofbauer cells: 34.3;Kupffer cells: 31.7;Syncytiotrophoblasts: 39.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 32.5;pons and medulla: 21.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 42.6;HMC-1: 32.5;hTEC/SVTERT24-B: 26.5;REH: 25.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038607" Approved Approved "Plasma membrane" NA NA 2200000 "Plasma membrane" "HPA038605: AB_10669648, HPA038607: AB_2676112" "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 4.3 1.3 2.8 5.5 4.0 7.2 1.5 32.5 4.9 4.0 1.5 0.7 0.0 1.7 1.3 0.3 1.8 1.1 2.4 1.3 3.4 3.5 1.5 1.7 5.5 10.9 5.1 1.9 0.8 1.2 0.6 0.9 16.8 21.2 1.3 1.8 0.9 1.3 0.9 1.8 4.1 2.4 2.3 2.1 27.7 1.7 2.1 0.2 23.9 2.9 1.7 3.8 3.4 1.3 1.0 1.7 9.8 11.0 6.5 4.9 1.8 4.5 11.1 2.0 2.7 0.9 1.6 10.6 16.2 9.0 6.6 5.1 4.4 2.4 1.8 1.3 8.6 6.3 2.2 0.0 5.8 10.5 0.0 0.3 42.6 0.3 3.7 2.5 5.1 32.5 1.4 0.3 26.5 9.8 7.2 4.4 1.9 0.0 0.0 6.4 0.1 6.3 3.3 0.9 4.6 2.6 25.4 1.2 0.2 10.4 3.8 4.6 0.1 4.3 0.3 3.6 4.4 0.0 1.4 11.4 8.6 4.6 5.0 6.7 0.4 0.0 5.4 4.5 7.3 15.5 0.0 1.3 9.8 2.0 6.5 2.2 0.3 2.6 1.8 1.7 1.0 3.0 1.6 2.8 6.5 11.0 0.2 4.9 1.8 2.8 4.0 32.5 4.9 3.4 3.5 5.1 1.9 21.2 0.2 0.0 6.6 0.0 3.5 6.4 0.6 1.2 0.0 0.0 1.2 3.5 0.0 29.2 0.0 9.2 1.9 4.2 0.4 0.0 8.3 45.7 4.2 2.9 12.7 0.0 34.3 11.1 0.0 4.9 31.7 2.8 0.0 19.6 1.7 0.0 0.0 0.5 16.9 0.0 0.4 0.0 1.1 0.0 4.2 0.0 0.5 5.3 39.8 7.2 0.3 2.7 UBD FAT10 ENSG00000213886 "Ubiquitin D" O15205 6 29555515-29559925 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 53.2" "Group enriched" "Detected in some" 16 "Ductal cells: 316.2;Exocrine glandular cells: 231.1;monocytes: 265.1;Pancreatic endocrine cells: 685.5" "Cancer enhanced" "Detected in all" "liver cancer: 75.1" "Region enriched" "Detected in single" 5 "pons and medulla: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "RT4: 13.8" "Not detected" "Not detected" HPA043710 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA Nucleoplasm "Nucleoli fibrillar center" "HPA043710: AB_2756303" "unprognostic (2.99e-3)" "unprognostic (4.16e-2)" "unprognostic (6.37e-2)" "unprognostic (2.61e-2)" "unprognostic (3.93e-2)" "unprognostic (3.53e-3)" "unprognostic (1.60e-1)" "unprognostic (9.47e-2)" "unprognostic (1.44e-2)" "prognostic favorable (7.35e-4)" "unprognostic (1.28e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (4.04e-2)" "unprognostic (6.02e-2)" "unprognostic (8.40e-2)" "unprognostic (1.21e-2)" 3.4 0.4 0.0 53.2 0.0 0.4 1.8 0.0 0.4 0.7 1.8 0.0 0.0 1.5 0.6 1.6 4.2 1.2 2.9 1.8 0.0 0.0 13.4 16.3 5.1 26.3 0.0 0.0 0.5 14.6 0.4 0.7 0.4 1.0 5.6 3.0 1.0 11.3 0.7 3.1 0.6 15.5 0.7 0.2 18.6 3.5 0.4 0.0 26.3 2.7 4.5 50.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 3.0 1.9 0.0 0.0 0.1 0.0 0.0 22.9 16.0 15.9 0.0 0.0 0.0 1.7 316.2 0.0 0.0 3.3 0.0 231.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 265.1 3.1 0.0 685.5 6.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 UBE2B "HHR6B, RAD6B, UBC2" ENSG00000119048 "Ubiquitin conjugating enzyme E2 B" P63146 5 134371179-134391992 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 83.3" "Lineage enriched" "Detected in all" 6 "granulocytes: 83.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003875, HPA051765, HPA065898" Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Plasma membrane" "Vesicles, Cytosol" "HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (7.39e-2)" "unprognostic (6.66e-2)" "unprognostic (1.44e-1)" "unprognostic (1.48e-2)" "unprognostic (2.56e-1)" "unprognostic (1.27e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-1)" "unprognostic (2.49e-1)" "unprognostic (8.39e-2)" "unprognostic (1.64e-3)" "unprognostic (6.30e-3)" "unprognostic (3.42e-2)" "unprognostic (2.04e-1)" "unprognostic (5.52e-2)" 17.7 27.7 20.4 17.0 16.6 25.9 22.8 16.2 28.3 13.8 18.0 7.9 11.6 14.4 19.4 17.0 25.6 13.6 18.3 59.2 20.3 16.4 17.8 19.8 21.8 18.7 13.8 18.7 16.7 26.4 7.8 16.2 27.8 17.6 15.4 15.1 10.2 16.1 18.5 106.5 15.9 16.2 21.6 15.1 16.6 14.1 21.7 12.7 13.2 18.2 34.0 16.3 19.2 22.8 9.6 8.8 83.3 14.1 9.6 14.6 10.5 35.5 9.3 19.6 18.6 17.1 18.5 31.6 26.7 14.1 17.2 20.5 28.3 23.9 19.4 32.3 17.0 47.0 14.2 14.8 19.7 18.8 30.7 16.0 10.6 25.9 30.3 20.0 12.6 21.9 15.9 27.0 15.6 13.2 23.2 14.7 16.2 19.5 35.3 15.5 20.7 20.0 33.4 8.4 10.6 8.9 20.2 21.6 27.0 15.4 27.5 26.5 20.6 21.0 9.9 46.4 22.2 21.3 34.8 29.1 20.0 14.0 26.9 29.2 29.5 40.3 27.4 22.6 23.9 19.9 34.7 11.5 31.2 9.4 12.5 8.6 9.6 12.0 9.5 7.9 9.6 14.6 12.3 83.3 9.6 14.1 8.8 14.1 10.5 20.4 16.6 16.2 28.3 20.3 16.4 13.8 18.7 17.6 12.7 68.5 53.6 80.6 311.1 324.0 73.3 287.9 109.5 50.9 37.5 71.5 76.6 127.7 145.9 138.0 194.0 119.9 104.0 210.2 148.2 103.0 162.4 304.2 116.3 90.1 106.8 82.6 126.4 82.3 121.3 244.2 143.5 139.6 215.9 189.4 109.5 124.2 180.7 129.8 106.4 130.7 89.5 148.8 178.2 201.6 171.6 323.2 605.1 89.5 82.7 405.3 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Group enriched" "Detected in many" 5 "Erythroid cells: 397.1;Extravillous trophoblasts: 368.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" Yes Yes "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658" "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.3 28.9 52.2 25.0 1.4 3.2 30.0 31.3 15.9 51.6 37.1 94.9 45.6 41.8 30.7 14.9 64.3 38.9 0.2 33.5 52.7 17.8 27.5 12.9 22.2 24.9 0.4 18.4 32.3 1.0 3.6 34.9 34.2 7.8 25.1 26.7 0.2 35.6 42.4 64.9 30.3 5.2 31.3 44.8 69.3 32.2 47.3 0.2 17.4 13.7 30.1 25.1 49.3 36.1 19.8 27.4 36.5 27.1 9.1 46.3 40.5 31.4 60.5 11.3 0.3 46.5 28.1 13.1 43.8 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 0.0 5.9 29.5 3.6 15.3 0.0 0.0 2.5 0.0 7.9 0.0 0.0 15.5 0.0 0.8 5.8 0.2 5.5 397.1 0.4 368.9 5.1 2.7 5.7 3.9 75.1 0.0 1.2 22.7 19.9 5.4 0.9 9.3 0.0 1.8 12.8 0.0 1.0 6.2 0.0 0.0 0.0 0.0 1.9 6.1 18.0 10.2 26.1 10.1 15.1 8.2 UBE2D1 "E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A" ENSG00000072401 "Ubiquitin conjugating enzyme E2 D1" P51668 10 58334975-58370753 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.9" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (4.23e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.04e-6)" "unprognostic (9.71e-3)" "unprognostic (4.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.66e-2)" 8.2 10.6 8.1 10.0 7.9 17.1 7.5 7.7 9.0 6.3 7.3 5.5 4.8 4.7 8.5 5.5 8.2 5.5 6.4 25.6 7.6 7.2 5.5 5.4 7.0 13.7 8.1 6.7 5.9 4.8 5.3 7.4 6.8 7.4 6.5 7.9 3.5 6.4 5.0 74.9 4.6 5.8 8.8 8.4 11.0 5.6 3.2 8.4 5.5 6.0 25.1 7.1 9.5 10.0 3.7 7.2 41.0 13.7 2.8 3.5 7.1 10.7 5.8 10.9 14.0 22.4 18.1 7.1 7.1 12.1 8.1 12.0 11.8 9.3 0.0 11.2 10.6 6.0 9.8 21.1 10.3 11.5 11.1 12.4 2.8 2.1 6.7 14.7 8.5 6.9 20.9 11.6 8.5 15.8 11.0 16.2 7.5 5.5 4.5 11.0 3.4 9.1 9.5 13.4 6.5 9.2 7.7 9.9 5.9 12.2 6.3 8.3 11.1 13.9 23.5 11.3 17.5 8.6 5.7 13.1 3.1 10.9 10.6 7.8 11.6 9.0 9.5 9.9 17.7 3.5 2.8 13.7 6.2 2.4 9.5 2.8 3.3 2.9 3.0 7.2 3.7 3.0 2.3 41.0 2.8 7.9 3.0 3.5 7.1 8.1 7.9 7.7 9.0 7.6 7.2 8.1 6.7 7.4 8.4 11.9 9.1 36.6 70.2 172.6 16.8 82.7 20.4 12.0 15.9 26.2 17.7 26.7 64.6 55.7 3.4 26.3 20.4 0.0 37.1 42.2 48.3 73.3 23.0 12.3 68.9 15.9 39.9 20.3 88.9 2.2 30.8 81.6 50.6 49.5 35.6 15.8 57.2 16.4 30.4 41.3 13.7 6.5 58.7 28.6 16.0 166.2 124.6 28.7 24.7 105.6 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926438-43956136 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 25.3" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.86e-4)" "prognostic favorable (5.77e-4)" "prognostic favorable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 10.1 13.1 14.7 5.0 13.3 4.5 9.1 13.8 17.4 8.8 7.6 11.4 7.9 5.3 7.5 11.2 8.0 9.0 7.2 23.8 14.2 10.0 12.7 15.3 8.4 5.3 12.1 9.4 7.9 17.4 8.7 6.9 5.9 11.9 8.7 6.2 8.1 10.6 9.1 48.6 9.4 5.3 10.3 12.8 7.3 6.5 5.1 6.1 2.7 9.6 16.1 5.7 7.7 6.5 10.7 11.8 12.9 20.5 7.7 14.0 6.7 3.8 3.2 2.0 9.1 9.4 3.8 1.5 1.9 4.7 2.4 3.2 1.7 4.6 3.7 5.3 5.0 6.8 4.4 2.5 2.1 3.7 8.3 4.2 4.0 5.0 4.4 3.5 8.7 8.2 2.9 4.4 2.7 4.2 3.5 3.0 4.6 4.4 7.8 3.3 2.5 5.1 5.0 4.4 4.7 4.2 3.2 2.8 5.8 5.1 4.7 7.4 25.3 4.0 8.1 3.0 3.8 4.0 2.6 2.6 1.6 5.1 3.4 5.5 11.2 8.4 1.8 4.8 11.4 8.9 6.3 11.7 12.9 9.3 18.4 9.5 10.3 11.6 10.5 11.8 10.7 14.0 11.5 1.1 7.7 20.5 10.2 9.4 6.7 14.7 13.3 13.8 17.4 14.2 10.0 12.1 9.4 11.9 6.1 0.0 6.2 8.8 8.1 5.6 8.3 21.8 5.1 2.7 6.8 15.7 2.0 9.7 46.4 15.9 5.0 11.9 8.4 0.0 24.7 17.3 10.8 9.8 4.6 22.2 24.7 11.1 18.0 9.2 7.3 8.0 11.2 12.9 15.1 24.4 7.1 9.1 14.6 5.8 20.5 38.0 10.4 6.5 12.0 15.1 8.3 9.8 6.4 6.9 7.9 9.3 UBE2G1 "UBC7, UBE2G" ENSG00000132388 "Ubiquitin conjugating enzyme E2 G1" P62253 17 4269259-4366628 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 95.6" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 254.1;Suprabasal keratinocytes: 209.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045681, HPA050551" Approved Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045681: AB_2679417, HPA050551: AB_2681171" "unprognostic (1.57e-3)" "unprognostic (1.94e-1)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "unprognostic (5.16e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (5.13e-2)" "unprognostic (1.86e-1)" "unprognostic (2.80e-1)" "unprognostic (1.67e-2)" "unprognostic (9.99e-2)" "unprognostic (2.16e-1)" "unprognostic (4.58e-2)" "unprognostic (3.97e-2)" "unprognostic (6.50e-2)" 10.8 11.1 12.6 17.8 13.5 14.3 11.2 11.6 15.3 13.0 19.4 17.8 8.9 11.9 13.3 8.5 27.4 9.2 9.7 26.9 13.5 11.2 14.6 17.7 8.9 18.7 15.2 9.7 9.1 17.1 12.0 6.0 11.4 14.5 14.0 13.3 8.8 11.9 12.0 95.6 14.1 16.6 14.6 19.4 15.0 11.9 11.8 13.6 21.3 12.5 20.7 23.3 17.7 16.5 23.7 13.1 24.4 11.5 20.5 20.6 13.1 21.2 23.1 21.6 15.8 17.7 18.7 30.8 20.8 16.7 19.8 17.5 15.9 10.9 33.4 21.8 20.4 16.2 23.1 26.8 19.3 32.0 17.5 21.8 12.5 12.3 18.1 17.4 18.1 23.7 15.9 28.9 18.8 27.4 14.0 26.5 22.5 21.8 36.2 16.3 9.5 23.0 16.6 23.8 15.8 12.0 29.9 11.4 30.5 23.1 14.0 9.3 17.4 19.6 17.1 16.1 33.3 16.7 11.9 19.8 19.9 15.2 23.3 23.2 14.1 16.5 47.2 15.3 17.0 15.3 8.1 10.3 24.4 15.4 10.8 20.6 23.7 20.1 20.1 13.1 15.5 20.2 20.5 18.6 20.5 11.5 9.6 18.3 13.1 12.6 13.5 11.6 15.3 13.5 11.2 15.2 9.7 14.5 13.6 20.8 11.8 63.6 34.1 254.1 16.5 62.6 30.6 13.4 13.6 24.4 5.9 36.7 69.6 27.6 105.5 28.7 35.4 0.0 23.2 45.9 34.4 47.3 20.7 52.9 41.3 14.3 36.9 32.5 36.1 173.0 18.1 34.1 64.1 33.3 32.7 23.0 32.9 27.5 19.8 61.3 13.9 6.5 47.9 63.9 47.7 209.5 55.8 43.3 26.8 53.3 UBE2L5 UBE2L5P ENSG00000236444 "Ubiquitin conjugating enzyme E2 L5" 13 30422488-30428616 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 31.5" "Cell type enriched" "Detected in single" 4 "Ciliated cells: 1.4" "Low cancer specificity" "Detected in single" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA045609, HPA062415" Approved Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA045609: AB_10961322, HPA062415: AB_2684756" "unprognostic (2.09e-1)" "unprognostic (1.18e-2)" "unprognostic (8.01e-3)" "unprognostic (6.41e-4)" "unprognostic (1.78e-1)" "unprognostic (7.13e-2)" "unprognostic (2.20e-1)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (6.49e-3)" "unprognostic (1.78e-1)" "unprognostic (8.00e-2)" "unprognostic (3.50e-2)" "unprognostic (9.37e-2)" "unprognostic (2.60e-1)" "unprognostic (2.44e-2)" "unprognostic (8.75e-2)" 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.2 0.2 0.1 0.2 0.5 0.3 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 31.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 1.9 2.7 3.6 1.9 2.0 2.8 0.7 0.3 1.3 1.6 0.6 0.7 0.7 1.2 0.6 0.4 0.2 0.0 3.1 1.4 0.6 1.3 1.3 0.6 0.8 0.4 1.1 2.5 0.6 0.4 0.8 0.2 0.2 0.7 1.5 0.2 0.3 0.6 0.2 1.4 0.9 0.9 0.8 1.3 0.3 0.0 1.6 2.6 1.4 0.2 0.2 0.4 0.6 0.4 0.9 1.5 1.2 0.3 0.4 0.1 1.8 0.9 0.6 2.4 0.0 0.7 0.5 0.7 1.1 1.5 0.3 1.6 1.0 0.9 0.4 1.8 1.1 1.9 1.4 3.6 1.2 3.2 1.5 1.6 1.5 1.7 1.4 2.0 2.7 1.9 1.6 1.9 2.0 2.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBE2Q2L ENSG00000259511 "Ubiquitin conjugating enzyme E2 Q2 like" H0YL09 15 84172490-84182234 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 6.5;testis: 8.1" "Group enriched" "Detected in many" 4 "Early spermatids: 15.0;Spermatocytes: 14.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.9;K-562: 5.8;Karpas-707: 4.8;RPMI-8226: 1.7;RPTEC TERT1: 1.6;U-266/70: 3.4" NA NA "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (9.10e-3)" "unprognostic (2.66e-1)" "unprognostic (3.41e-3)" "unprognostic (2.00e-1)" "unprognostic (8.12e-2)" "unprognostic (7.96e-3)" "unprognostic (1.03e-1)" "unprognostic (5.05e-2)" "unprognostic (3.16e-2)" 0.8 1.8 0.3 1.0 0.2 0.7 0.8 0.0 2.3 1.2 1.2 0.0 1.3 0.0 0.3 0.8 1.3 2.4 0.4 0.5 0.1 0.0 0.2 0.0 0.3 6.5 3.0 2.2 0.9 0.0 0.7 0.0 0.1 1.7 0.0 0.5 0.2 0.0 0.5 0.0 0.7 8.1 0.1 0.2 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 5.8 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.4 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 0.0 2.0 0.5 0.0 0.3 0.0 0.0 2.3 3.5 2.0 0.0 1.7 0.5 15.0 0.3 0.0 0.0 0.3 0.0 1.3 0.5 1.1 0.0 0.1 1.6 0.0 0.0 0.0 2.3 1.1 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 0.7 0.0 0.0 1.4 14.9 2.5 1.0 0.1 0.0 0.0 0.6 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448623-6494909 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 23.6;Cardiomyocytes: 25.0;Horizontal cells: 42.9;Rod photoreceptor cells: 49.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "Karpas-707: 18.2;PC-3: 15.2;SCLC-21H: 14.2;U-266/70: 34.1;U-266/84: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favorable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 0.6 2.3 8.6 0.8 4.2 0.3 0.9 20.7 28.1 1.0 1.8 1.0 0.5 0.7 1.4 1.8 1.0 0.5 0.8 11.3 12.6 8.2 2.6 1.1 0.4 0.7 5.2 4.6 3.6 0.8 0.3 1.3 0.3 8.7 3.1 0.8 8.2 1.0 8.6 21.3 2.4 1.0 1.3 1.4 0.4 2.2 0.9 0.0 0.0 1.9 2.0 0.5 0.5 0.9 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.0 3.1 0.0 0.0 0.2 0.0 15.2 0.1 0.0 6.7 0.0 0.0 14.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.1 30.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 4.2 20.7 19.4 12.6 8.2 5.2 4.6 8.7 0.0 0.0 0.0 0.0 0.6 1.1 23.6 25.0 0.0 0.0 0.0 0.0 5.9 0.0 5.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.8 0.1 42.9 5.2 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 8.4 0.2 0.0 6.3 0.0 49.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407777 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 226.9;Spermatocytes: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" NA Yes "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: AB_2683351" "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 10.2 9.2 18.0 19.5 15.9 68.0 4.7 11.4 21.6 6.1 12.0 9.1 4.5 8.4 7.1 7.2 17.1 6.0 9.7 18.0 18.7 18.1 5.9 5.6 6.3 22.9 13.7 14.4 6.4 6.0 3.7 12.9 9.8 12.9 7.0 7.1 6.2 4.9 5.3 7.3 6.2 7.3 10.7 15.3 11.0 10.6 69.4 8.2 60.2 5.9 14.3 21.1 10.0 7.1 4.5 3.1 6.0 1.9 0.6 2.6 0.3 60.3 32.7 28.8 22.9 1.8 2.6 5.1 49.2 14.9 30.4 27.7 22.1 21.6 58.8 20.4 12.3 36.6 17.8 28.8 12.8 13.5 46.0 95.7 35.1 18.8 7.1 5.5 42.0 34.2 2.9 3.6 22.3 21.6 6.6 11.9 32.1 34.9 41.2 19.0 16.0 56.8 21.8 72.2 16.9 55.5 50.1 22.2 21.1 8.1 12.9 73.1 39.6 62.7 15.6 27.9 9.1 11.1 22.8 18.2 18.3 52.1 15.6 116.9 33.2 79.7 69.0 19.2 29.7 66.3 1.1 1.9 2.9 1.8 1.5 1.2 4.5 2.6 2.6 1.5 1.6 2.5 1.5 6.0 0.6 0.9 3.1 1.0 0.3 18.0 15.9 11.4 21.6 18.7 18.1 13.7 14.4 12.9 8.2 0.0 4.3 37.3 136.4 144.5 56.5 2.4 7.6 0.0 0.0 19.2 51.1 34.3 13.3 44.4 86.7 31.2 25.8 70.0 26.4 226.9 94.9 63.2 18.4 9.6 55.5 30.2 88.9 22.7 24.7 27.7 16.1 39.9 70.9 55.1 28.4 76.7 57.6 28.1 11.7 14.8 59.0 12.9 96.6 216.2 140.8 101.4 50.0 44.7 30.4 121.0 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 46.8" "Cell type enhanced" "Detected in many" 12 "Erythroid cells: 186.9;Extravillous trophoblasts: 82.9;Spermatocytes: 115.5;Spermatogonia: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 1.9 4.2 9.6 8.5 12.2 20.8 3.9 4.4 13.5 3.5 11.2 0.7 17.2 7.5 4.3 4.1 10.3 2.9 3.0 8.8 8.8 11.2 4.5 2.8 3.1 15.2 8.7 8.2 1.3 0.9 2.4 3.1 8.7 8.2 2.2 13.9 1.9 2.8 7.0 13.1 4.5 6.9 8.1 3.4 6.7 4.0 16.0 1.8 46.8 2.6 12.8 15.3 6.3 4.5 9.0 3.6 1.7 8.6 1.1 11.1 2.9 30.4 29.1 43.3 20.4 4.0 7.4 24.8 33.3 18.6 38.1 26.9 20.7 37.4 35.5 13.2 12.1 28.4 24.9 40.0 19.5 34.4 32.2 22.9 21.7 15.8 23.6 1.8 25.9 26.4 2.6 4.7 29.9 12.5 9.1 22.1 40.1 27.3 29.3 29.8 28.3 46.4 33.1 16.8 31.7 14.8 36.0 46.1 30.8 14.6 14.6 34.1 34.8 23.3 28.7 11.1 13.5 30.2 16.4 10.8 17.2 27.5 30.0 39.5 14.9 29.1 45.2 17.0 27.0 35.6 0.0 0.8 1.7 3.7 2.4 2.8 9.0 5.0 3.9 1.7 6.3 7.3 8.0 0.0 1.1 8.6 3.6 11.1 2.9 9.6 12.2 4.4 13.5 8.8 11.2 8.7 8.2 8.2 1.8 0.0 2.1 10.4 11.0 12.7 5.2 12.2 0.0 6.7 7.9 5.2 0.0 33.9 5.0 11.2 13.0 1.9 2.7 186.9 6.6 82.9 4.8 2.2 8.1 1.7 23.5 9.5 1.2 4.3 1.8 6.6 2.8 5.2 3.3 3.6 9.0 1.3 7.8 0.0 3.9 7.9 0.9 6.5 1.9 115.5 96.9 9.5 18.8 9.5 19.6 4.1 UBE2U MGC35130 ENSG00000177414 "Ubiquitin conjugating enzyme E2 U (putative)" Q5VVX9 1 64203627-64267368 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "testis: 31.8" "Group enriched" "Detected in some" 12 "Early spermatids: 118.4;Late spermatids: 169.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;U-266/84: 1.3" "Region enhanced" "Detected in many" "midbrain: 19.5" NA NA "unprognostic (9.44e-4)" "unprognostic (5.52e-2)" "unprognostic (1.81e-1)" "unprognostic (2.37e-1)" "unprognostic (4.01e-2)" "unprognostic (3.63e-1)" "unprognostic (7.69e-2)" 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 118.4 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 169.4 1.7 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 11.9 1.8 0.0 0.2 0.0 0.0 0.0 UBL4B FLJ25690 ENSG00000186150 "Ubiquitin like 4B" Q8N7F7 1 110112468-110113945 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 79 "testis: 65.3" "Cell type enriched" "Detected in some" 4 "Late spermatids: 5150.4" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 21.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA031364 Enhanced NA NA "HPA031364: AB_10604000" "unprognostic (2.92e-1)" "unprognostic (3.48e-2)" "unprognostic (3.53e-1)" "unprognostic (9.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-2)" "unprognostic (3.43e-2)" "unprognostic (6.87e-3)" "unprognostic (4.46e-1)" "unprognostic (2.20e-9)" "unprognostic (3.29e-2)" "unprognostic (7.39e-2)" "unprognostic (1.59e-4)" "unprognostic (3.90e-2)" 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 65.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1273.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5150.4 27.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 20.8 0.0 0.0 12.9 0.0 37.9 15.1 0.0 0.0 0.0 0.0 0.0 UBQLN3 TUP-1 ENSG00000175520 "Ubiquilin 3" Q9H347 11 5507300-5509985 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "testis: 86.9" "Group enriched" "Detected in some" 72 "Early spermatids: 596.2;Late spermatids: 1514.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2197: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020547, HPA062018" Enhanced NA NA "HPA020547: AB_1858577, HPA062018: AB_2684661" "unprognostic (3.79e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 596.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1514.2 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 6.5 0.0 14.6 4.8 0.0 0.0 0.0 0.0 0.0 UBQLNL "MGC20470, MGC26958" ENSG00000175518 "Ubiquilin like" Q8IYU4 11 5514393-5516705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 31.9" "Group enriched" "Detected in some" 69 "Early spermatids: 172.7;Late spermatids: 509.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "hTCEpi: 2.4;hTERT-RPE1: 3.4;SK-BR-3: 2.4" NA NA "unprognostic (2.86e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-4)" "unprognostic (1.43e-1)" "unprognostic (6.17e-2)" "unprognostic (7.60e-2)" "unprognostic (7.69e-2)" "unprognostic (2.22e-2)" "unprognostic (3.64e-1)" "unprognostic (1.17e-3)" "unprognostic (1.73e-1)" "unprognostic (1.54e-1)" "unprognostic (1.52e-8)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (1.17e-1)" "unprognostic (9.69e-5)" 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.6 0.6 0.3 0.2 0.2 0.1 0.5 1.2 0.2 0.4 0.2 0.2 0.2 0.0 0.5 0.4 0.3 0.2 0.2 0.2 1.6 0.3 0.1 0.2 0.2 0.2 0.8 0.1 0.2 0.3 0.2 0.2 0.5 0.3 0.3 0.2 0.8 0.1 31.9 0.2 0.2 0.6 0.2 0.2 0.2 0.4 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 1.0 0.7 0.5 0.2 0.4 0.3 0.4 0.0 0.5 0.0 0.2 0.5 0.6 0.2 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.4 0.3 1.6 2.4 0.0 0.1 3.4 0.0 0.7 0.1 0.0 0.4 0.1 0.0 1.0 0.0 0.2 0.6 1.6 0.0 0.0 0.4 0.1 0.0 0.0 0.0 2.4 0.3 0.4 0.0 0.0 0.3 0.1 1.0 0.0 0.0 1.6 0.4 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 172.7 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 1.8 0.0 509.3 4.9 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 3.4 2.5 0.1 0.2 0.0 0.1 0.0 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3 (putative)" Q6ZT12 2 169827458-170084131 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.3" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 97.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 11.9 15.5 10.9 6.1 18.3 5.4 9.6 15.5 18.9 9.9 10.0 9.8 9.1 6.7 11.5 7.1 10.7 8.1 7.8 23.1 10.3 7.2 12.9 16.9 9.2 5.6 11.9 14.0 8.9 9.8 20.9 14.9 7.2 14.7 11.2 7.3 8.0 11.1 9.2 76.3 11.5 8.4 9.6 10.2 6.9 9.2 7.9 11.4 6.3 14.9 10.9 6.0 12.8 8.7 2.0 2.8 1.9 2.1 2.4 4.3 1.2 8.9 7.6 8.1 10.7 16.2 12.9 6.8 16.2 9.4 9.4 7.6 11.7 5.7 10.2 14.1 12.6 7.6 11.9 9.7 8.2 11.7 10.5 8.3 37.1 8.1 12.3 8.1 12.2 12.0 7.7 7.7 12.3 8.2 7.5 9.2 5.1 19.3 11.1 16.0 8.4 7.9 6.0 6.3 9.1 6.4 7.6 13.3 10.8 6.8 12.7 16.0 8.7 11.4 10.5 6.5 6.8 6.9 6.9 11.7 14.2 5.7 11.1 10.2 9.0 7.0 9.4 11.7 7.2 7.8 0.0 2.1 1.7 3.2 1.8 4.2 2.0 1.9 2.7 2.8 1.2 3.3 4.3 1.9 2.4 1.6 2.4 3.1 1.2 10.9 18.3 15.5 18.6 10.3 7.2 11.9 14.0 14.7 11.4 41.7 21.1 7.5 11.4 23.0 40.4 97.6 15.3 9.4 19.4 12.2 76.6 14.8 3.3 8.0 6.6 23.7 13.4 23.3 9.5 6.8 18.3 22.3 16.1 32.7 8.9 60.4 16.0 31.9 21.5 7.4 23.9 16.8 15.1 4.6 12.5 63.3 9.4 14.0 18.0 10.2 53.7 25.8 26.4 13.0 7.6 25.3 19.2 13.1 9.9 12.3 UBTFL1 C11orf27 ENSG00000255009 "Upstream binding transcription factor, RNA polymerase I-like 1" P0CB47 11 90085950-90087131 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "blood: 2.5" "Cell type enriched" "Detected in single" 17 "Distal tubular cells: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 2.5" "Lineage enriched" "Detected in single" 25 "dendritic cells: 2.5" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBXN10 "FLJ25429, UBXD3" ENSG00000162543 "UBX domain protein 10" Q96LJ8 1 20186085-20196048 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 44.3;testis: 30.4" "Group enriched" "Detected in many" 7 "Ciliated cells: 120.5;Early spermatids: 95.0;Late spermatids: 125.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 6.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 3.8;HMC-1: 9.9;K-562: 11.0;SCLC-21H: 7.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028555, HPA028564" Uncertain NA NA "HPA028555: AB_10600417, HPA028564: AB_10601897" "unprognostic (3.00e-3)" "unprognostic (3.30e-2)" "unprognostic (4.31e-2)" "prognostic favorable (2.02e-4)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.43e-1)" "unprognostic (3.43e-2)" "unprognostic (2.37e-1)" "unprognostic (6.76e-2)" "unprognostic (4.60e-1)" "unprognostic (8.79e-2)" "unprognostic (5.78e-2)" "unprognostic (1.65e-3)" "unprognostic (7.11e-2)" "unprognostic (4.47e-2)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" 0.9 1.7 2.4 0.8 4.3 1.8 3.1 2.6 8.5 6.8 10.3 6.8 5.3 1.1 6.0 8.4 4.0 44.3 2.1 3.3 3.5 4.2 2.9 6.0 7.6 0.6 2.8 2.7 7.1 1.7 2.8 8.8 1.2 9.0 2.6 4.7 1.7 1.3 2.9 0.5 0.9 2.5 3.4 2.1 0.4 3.8 30.4 1.9 0.0 11.3 0.1 0.8 3.0 0.7 0.8 1.5 0.8 0.9 6.6 4.9 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 1.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 2.5 11.0 0.0 0.0 0.0 0.4 0.4 1.1 0.3 0.0 0.0 0.0 0.0 0.8 0.5 7.8 0.0 0.0 0.2 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 4.8 0.1 4.9 0.8 1.4 1.7 1.5 0.2 1.1 1.6 0.8 6.6 0.0 0.0 0.6 0.8 2.4 4.3 2.6 8.5 3.5 4.2 2.8 2.7 9.0 1.9 0.0 6.7 0.0 0.0 0.1 0.0 4.5 2.5 120.5 15.9 3.5 0.0 0.1 5.0 2.2 95.0 0.3 1.1 0.0 1.6 0.4 0.8 0.2 12.8 3.9 0.8 0.0 1.2 1.3 1.9 125.2 2.6 0.0 0.0 1.0 9.2 1.2 1.1 0.0 1.1 2.2 2.9 0.0 0.4 17.3 1.9 0.0 0.2 0.0 2.9 0.1 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Group enriched" "Detected in many" 4 "Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: AB_2686844" "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favorable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.3 13.7 8.0 7.5 9.2 12.2 2.8 12.2 11.3 11.1 12.4 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.7 7.8 19.4 9.6 7.9 12.0 5.9 6.4 6.5 5.6 33.5 9.2 16.5 7.2 7.9 6.0 10.8 22.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 7.0 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 3.0 8.0 3.0 4.1 0.0 1.9 3.2 15.3 1.4 5.7 14.0 19.6 20.6 6.6 7.1 162.1 6.2 6.3 0.0 4.5 16.0 9.4 4.1 13.9 56.2 19.0 11.1 8.2 27.0 14.2 132.0 13.3 6.9 0.0 10.0 6.4 6.6 3.9 3.5 9.2 22.0 1.8 6.5 3.9 14.1 20.4 0.0 12.7 7.2 10.0 2.4 UCHL1 "PARK5, PGP9.5, Uch-L1" ENSG00000154277 "Ubiquitin C-terminal hydrolase L1" P09936 4 41256413-41268455 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 225.8" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 109.9;Distal tubular cells: 218.8;Horizontal cells: 138.2;Spermatogonia: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 3.6" "Lineage enriched" "Detected in single" 37 "B-cells: 3.6" "Cell line enhanced" "Detected in many" "EFO-21: 99.0;SCLC-21H: 98.8;U-251 MG: 90.4;U-266/84: 87.2;U-87 MG: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002580, HPA005993, CAB079024" Enhanced Supported Supported Nucleoplasm,Cytosol NA NA 440000 Cytosol Nucleoplasm "CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560" "unprognostic (1.54e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.08e-5)" "unprognostic (2.34e-1)" "unprognostic (1.98e-1)" "unprognostic (6.28e-3)" "unprognostic (1.09e-2)" "unprognostic (4.31e-2)" "unprognostic (8.77e-3)" "unprognostic (3.56e-3)" "unprognostic (3.70e-2)" "unprognostic (1.82e-3)" "unprognostic (1.24e-2)" "unprognostic (7.12e-3)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.93e-4)" 8.2 40.2 52.4 8.9 65.1 2.0 3.1 17.5 225.8 4.5 6.3 11.5 0.0 5.5 6.0 1.8 2.7 5.7 6.5 5.4 53.4 97.4 14.0 2.0 2.7 6.5 62.0 57.1 15.4 6.3 1.8 30.5 2.7 100.6 5.3 4.7 6.0 3.0 4.4 7.5 2.7 8.6 5.2 38.6 2.3 2.8 8.0 8.3 0.0 3.9 0.0 4.5 5.6 2.8 3.6 0.0 0.0 0.0 0.0 0.0 0.6 0.2 56.1 11.6 0.0 1.5 1.9 0.0 58.7 30.3 20.8 21.0 11.3 0.0 0.0 99.0 29.9 31.4 0.1 21.4 0.0 8.5 0.1 8.7 0.0 0.3 0.0 44.9 0.0 0.0 10.8 0.2 16.7 0.0 34.7 0.1 0.0 0.0 0.2 11.0 0.0 0.0 0.9 33.6 0.0 63.4 0.0 24.8 0.0 31.4 0.0 98.8 62.0 0.3 0.2 0.2 13.9 0.0 0.5 0.3 1.3 0.4 0.0 90.4 46.4 87.2 0.2 96.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 52.4 65.1 17.5 92.6 53.4 97.4 62.0 57.1 100.6 8.3 0.0 1.9 0.8 0.8 1.4 19.7 2.5 0.0 12.0 5.7 109.9 7.9 2.5 218.8 3.6 2.0 2.1 0.0 0.0 0.7 0.8 15.8 2.8 2.3 0.4 4.7 138.2 4.1 11.1 0.3 4.4 34.2 1.7 3.3 1.0 0.0 22.6 4.0 0.0 16.3 7.9 39.1 0.0 7.3 6.6 90.2 1.4 1.3 0.0 0.0 0.6 UCK2 UMPK ENSG00000143179 "Uridine-cytidine kinase 2" Q9BZX2 1 165827531-165911618 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.8" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057128 Approved Nucleoplasm NA NA Nucleoplasm "HPA057128: AB_2683346" "unprognostic (5.37e-2)" "unprognostic (1.75e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" "unprognostic (4.54e-2)" "unprognostic (6.83e-3)" "prognostic unfavorable (9.22e-8)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (6.70e-4)" "unprognostic (3.04e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.12e-13)" "unprognostic (2.49e-3)" "unprognostic (1.14e-1)" "unprognostic (2.01e-3)" "unprognostic (1.83e-1)" 12.5 7.1 6.5 11.1 8.6 11.6 17.5 16.9 9.6 9.3 18.4 8.9 11.0 15.3 10.1 15.3 20.5 8.8 9.0 9.6 6.4 6.6 6.6 14.6 11.1 10.3 10.5 6.6 7.5 17.6 7.9 9.4 65.8 11.2 8.1 19.9 5.0 16.1 9.9 20.9 15.0 24.8 10.0 8.2 7.7 13.2 7.2 7.9 13.1 6.4 12.4 12.3 9.0 11.1 3.4 14.7 0.8 5.6 3.4 3.9 2.0 25.2 26.3 14.2 12.7 7.3 12.2 23.1 27.9 20.6 29.8 34.0 24.9 27.8 12.5 19.9 17.3 12.1 20.8 26.6 32.8 26.7 22.9 22.4 14.5 22.6 25.6 18.2 28.3 11.1 11.5 16.9 56.2 35.0 7.2 19.6 24.1 38.3 18.0 26.7 18.3 25.1 18.2 38.9 35.2 25.5 11.5 15.6 42.5 13.8 16.5 21.4 25.3 19.9 39.4 19.3 28.3 24.3 27.0 20.4 16.7 23.3 18.9 29.5 24.2 36.0 46.3 14.4 18.8 12.7 0.8 5.6 0.1 1.8 3.7 3.9 3.4 1.7 2.4 14.7 3.4 0.0 1.4 0.2 3.4 3.2 14.0 2.2 2.0 6.5 8.6 16.9 9.6 6.4 6.6 10.5 6.6 11.2 7.9 0.0 1.4 3.0 24.7 20.4 4.3 4.1 12.7 1.4 4.5 8.7 0.0 1.2 6.6 15.0 94.9 15.3 22.2 0.0 19.1 46.9 11.0 10.1 0.0 4.9 11.9 0.0 6.4 4.9 3.5 31.3 6.1 7.1 10.1 17.2 13.7 4.0 38.8 14.4 3.2 5.8 4.2 0.0 9.0 5.2 11.5 26.0 22.1 4.8 18.3 20.9 UCMA C10orf49 ENSG00000165623 "Upper zone of growth plate and cartilage matrix associated" Q8WVF2 10 13221767-13234334 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Group enriched" "Detected in some" 6 "amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;THP-1: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046718 Uncertain "Secreted to extracellular matrix" NA NA "HPA046718: AB_2679771" "unprognostic (4.25e-1)" 0.0 0.0 6.2 0.2 3.7 0.0 0.0 0.2 6.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 3.2 0.7 0.2 0.0 0.1 0.5 0.0 0.1 0.9 5.4 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.7 0.2 6.1 0.7 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 UCN "UI, UROC" ENSG00000163794 Urocortin P55089 2 27307400-27308445 "Predicted secreted proteins" Hearing Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 8.5" "Cell type enhanced" "Detected in some" 5 "Exocrine glandular cells: 3.2;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "U-266/70: 20.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" CAB010911 Approved Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 133000 "Endoplasmic reticulum" "CAB010911: AB_261834" "unprognostic (7.35e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.42e-2)" "unprognostic (5.08e-2)" "unprognostic (7.72e-2)" "unprognostic (5.69e-3)" "unprognostic (2.66e-1)" "unprognostic (2.48e-1)" "unprognostic (1.15e-1)" "unprognostic (3.80e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.84e-7)" "unprognostic (4.84e-2)" "unprognostic (3.87e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" 1.1 2.8 4.6 1.3 5.5 2.4 1.0 3.1 4.5 0.9 0.7 0.8 1.9 1.4 0.6 1.9 2.0 4.2 4.7 3.8 0.7 3.2 1.6 1.6 3.1 2.3 1.8 0.0 2.2 2.4 1.2 0.0 1.3 0.9 8.5 0.8 1.2 1.0 2.8 3.0 0.5 1.5 1.5 0.4 0.5 0.4 0.0 0.0 0.0 0.7 2.9 0.9 0.2 1.2 2.7 0.4 0.8 1.2 1.1 5.3 0.4 1.1 0.4 0.4 0.2 2.1 1.0 0.6 0.4 1.2 0.4 0.5 0.3 0.0 3.3 4.5 2.4 1.7 2.1 3.1 0.2 2.7 1.6 2.1 0.2 2.5 2.7 0.0 2.0 2.3 1.9 0.1 2.0 1.3 7.1 4.5 0.1 2.9 3.4 2.4 1.5 0.1 0.5 0.8 2.3 1.1 0.1 5.8 0.3 1.1 3.2 0.2 0.9 5.0 1.5 1.9 20.1 2.1 0.7 3.9 5.7 1.4 0.0 0.7 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 2.9 0.4 0.0 0.6 0.2 0.0 0.3 0.0 0.2 0.5 2.7 0.4 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.5 0.1 0.5 0.0 3.2 0.6 0.5 0.7 0.0 0.8 0.7 1.6 0.0 1.3 1.9 0.0 1.4 1.3 0.0 0.0 0.2 2.0 0.9 0.0 0.7 0.3 3.3 0.0 0.1 0.9 0.6 0.0 0.7 1.0 0.6 0.1 UCN2 "SRP, UCN-II, UCNI, URP" ENSG00000145040 "Urocortin 2" Q96RP3 3 48561727-48563773 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 18.6;vagina: 6.3" "Cell type enriched" "Detected in single" 5 "Basal keratinocytes: 2.6" "Cancer enhanced" "Detected in many" "melanoma: 18.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 15.7;hTEC/SVTERT24-B: 12.4;SiHa: 10.8;U-251 MG: 11.4;WM-115: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA066841 Uncertain Approved Vesicles "Secreted to blood" NA NA 98600 Vesicles "HPA066841: AB_2685735" "unprognostic (7.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (1.96e-2)" "unprognostic (2.39e-2)" "unprognostic (4.26e-2)" "unprognostic (1.92e-3)" "unprognostic (2.02e-3)" "unprognostic (1.62e-1)" "unprognostic (2.93e-3)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (3.34e-14)" "unprognostic (4.39e-2)" "unprognostic (2.75e-1)" "unprognostic (1.36e-1)" "unprognostic (2.88e-2)" 1.7 0.0 0.3 0.5 0.9 0.1 0.6 0.3 0.3 2.0 0.3 0.3 0.3 0.1 1.8 1.1 3.7 0.1 0.6 0.3 0.3 0.5 0.9 0.3 0.3 0.3 1.6 0.3 0.3 0.3 0.0 0.3 0.3 0.9 3.3 0.1 0.3 1.6 0.7 0.3 18.6 0.3 0.4 0.3 0.5 0.1 1.1 0.3 0.3 0.3 0.3 0.3 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 1.0 0.6 1.5 5.4 6.8 3.4 2.5 0.0 0.0 0.0 0.2 1.3 4.1 1.0 0.0 6.5 1.8 5.0 0.1 0.1 8.9 0.8 1.1 0.0 0.3 0.7 15.7 12.4 2.5 2.4 0.0 0.1 0.0 0.1 0.5 0.0 0.0 1.0 0.4 0.0 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.0 10.8 0.0 8.1 1.0 0.1 0.2 0.0 1.5 1.0 0.1 11.4 0.0 0.1 0.0 5.1 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.3 0.3 0.3 0.5 1.6 0.3 0.9 0.3 0.0 0.0 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UCN3 "SPC, UCNIII" ENSG00000178473 "Urocortin 3" Q969E3 10 5365009-5374692 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6" "Cell type enriched" "Detected in some" 89 "Intestinal endocrine cells: 233.1" "Group enriched" "Detected in many" 5 "lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 5.5" "Region enhanced" "Detected in some" "hypothalamus: 5.9" "Region enriched" "Detected in single" 7 "hypothalamus: 4.7" HPA038281 Uncertain "Secreted to blood" NA NA "HPA038281: AB_10672408" "unprognostic (2.00e-2)" "unprognostic (2.31e-1)" "unprognostic (1.60e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-3)" "unprognostic (8.42e-2)" "unprognostic (3.55e-2)" "unprognostic (2.91e-2)" 0.1 0.9 0.1 0.1 0.4 0.0 0.1 0.4 0.4 0.1 14.4 0.1 0.1 11.6 0.1 0.1 0.1 1.2 1.2 0.1 0.1 1.7 0.8 0.1 1.3 0.1 0.1 0.5 0.1 10.6 0.0 5.6 0.1 1.6 0.2 3.1 0.3 0.1 0.1 0.1 0.0 14.9 0.1 0.5 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 5.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.4 0.1 1.7 0.1 0.5 1.6 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 233.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.6 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 UCP1 "SLC25A7, UCP" ENSG00000109424 "Uncoupling protein 1" P25874 4 140559434-140568805 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Diabetes mellitus, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1" "Cell type enhanced" "Detected in single" 24 "Syncytiotrophoblasts: 1.9" "Cancer enhanced" "Detected in single" "breast cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 9.8;HAP1: 7.1;JURKAT: 2.5" "Not detected" "Not detected" NA NA "unprognostic (5.08e-3)" "unprognostic (4.44e-1)" "unprognostic (2.65e-2)" "unprognostic (2.30e-1)" "unprognostic (7.17e-2)" "unprognostic (6.08e-2)" "unprognostic (3.98e-2)" "unprognostic (1.85e-1)" "unprognostic (5.75e-2)" "unprognostic (1.38e-1)" "unprognostic (4.45e-2)" "unprognostic (2.29e-1)" "unprognostic (1.40e-1)" "unprognostic (4.58e-2)" 2.4 8.4 0.1 0.1 0.1 0.0 2.2 0.1 0.1 0.1 0.7 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 7.1 0.1 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.6 0.2 0.0 0.1 0.8 0.1 0.1 0.0 0.1 1.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 9.8 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974667-73983307 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 219.1;lymphoid tissue: 144.8" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 420.4;Hofbauer cells: 378.7;Intestinal endocrine cells: 285.5;monocytes: 710.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 68.0;SK-BR-3: 87.6;U-698: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria NA NA Mitochondria "CAB025583: , HPA075202: AB_2732284" "unprognostic (1.13e-1)" "prognostic favorable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 19.8 9.8 5.3 40.4 9.5 24.5 15.9 1.1 4.9 8.1 7.7 10.2 20.3 11.4 4.2 12.0 4.5 37.9 13.1 11.5 4.4 5.5 12.8 10.6 20.2 85.6 7.8 2.4 7.2 4.7 1.2 6.2 8.7 6.5 6.5 8.9 14.2 17.4 17.2 45.3 4.3 24.7 6.4 9.0 91.1 12.3 5.5 5.9 144.8 17.9 19.3 55.7 19.4 2.9 141.6 219.1 101.8 135.3 119.8 180.2 172.1 0.1 14.3 3.3 9.8 1.9 0.0 2.5 2.4 1.6 9.8 2.8 25.1 12.2 68.0 34.0 3.7 0.8 0.6 2.3 0.0 4.6 17.2 0.8 39.7 6.0 5.2 5.9 20.8 16.7 2.2 0.0 9.3 0.0 1.9 1.3 26.2 18.2 27.8 1.9 24.5 21.5 11.2 2.6 1.5 2.9 19.9 22.7 38.5 27.4 40.6 5.0 6.1 12.8 87.6 4.8 9.9 25.8 18.6 1.8 0.0 12.6 2.9 4.7 9.5 4.5 56.6 1.7 8.3 0.1 45.7 81.5 101.8 112.6 135.3 69.9 141.6 92.3 95.0 88.4 134.2 86.9 91.1 11.4 119.8 111.3 219.1 180.2 172.1 5.3 9.5 1.1 4.9 4.4 5.5 7.8 2.4 6.5 5.9 3.0 35.4 250.6 2.3 3.1 0.9 3.6 2.5 93.7 23.9 87.2 7.9 6.6 6.6 1.2 16.1 5.0 4.2 420.4 6.5 10.3 6.7 15.6 84.3 0.6 378.7 0.0 285.5 11.6 244.1 37.5 0.9 160.3 25.3 710.6 23.4 2.9 2.5 37.6 0.4 1.9 6.3 6.5 5.3 14.4 13.4 4.0 9.4 172.7 24.7 21.6 UCP3 SLC25A9 ENSG00000175564 "Uncoupling protein 3" P55916 11 74000281-74009435 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "skeletal muscle: 99.6" "Group enriched" "Detected in some" 5 "Early spermatids: 14.7;Late spermatids: 10.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 4 "HDLM-2: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010771, HPA072225" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Nucleoplasm, Cytosol" "Plasma membrane" "CAB010771: AB_261839, HPA072225: AB_2686498" "unprognostic (3.76e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-1)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-2)" "unprognostic (3.95e-3)" "unprognostic (6.61e-2)" "unprognostic (1.25e-1)" "unprognostic (8.58e-2)" "unprognostic (2.13e-4)" "unprognostic (1.61e-2)" "unprognostic (3.25e-6)" "unprognostic (2.68e-1)" "unprognostic (1.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.50e-4)" 0.9 0.2 0.2 0.3 0.2 0.6 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.5 0.9 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 1.0 0.2 99.6 0.3 0.2 0.2 0.2 0.5 0.1 0.6 0.2 0.2 0.6 6.4 0.8 0.2 0.2 0.8 0.1 0.7 0.3 0.2 2.1 0.4 0.2 2.1 2.1 1.8 0.8 0.4 0.4 0.5 0.5 0.5 0.3 0.5 0.4 1.1 0.3 0.4 0.3 2.2 0.8 0.4 0.8 18.3 0.7 0.4 2.4 0.2 0.6 1.2 1.7 0.5 1.4 1.3 0.1 0.4 0.7 1.0 0.5 1.4 0.7 1.2 0.8 1.6 1.0 1.6 1.4 1.6 4.3 0.6 1.1 0.6 1.2 1.3 0.5 0.9 0.7 0.4 0.2 1.1 0.4 0.3 1.4 0.7 1.3 1.6 1.7 0.8 0.3 1.1 0.7 0.0 0.3 0.7 2.1 0.1 0.9 0.0 1.5 1.8 0.0 0.8 0.6 1.2 0.1 0.2 0.0 0.1 0.4 0.4 0.2 0.2 1.1 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.5 0.1 0.1 2.2 0.5 0.0 2.7 1.2 0.0 0.0 0.3 0.0 0.3 14.7 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.6 0.8 10.7 0.0 0.0 0.0 0.0 0.6 0.7 0.3 0.0 0.7 0.0 1.6 0.0 0.1 1.2 0.7 0.3 0.2 2.2 0.6 0.0 UGDH ENSG00000109814 "UDP-glucose 6-dehydrogenase" O60701 4 39498755-39528311 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 125.8" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 293.1;Hepatocytes: 215.1;Pancreatic endocrine cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 85.7;Hep G2: 99.2;U-2197: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034444, HPA036656, HPA036657" Enhanced Supported Nucleoplasm Yes No 42000 Nucleoplasm "CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360" "unprognostic (1.22e-2)" "unprognostic (1.62e-1)" "unprognostic (2.73e-2)" "unprognostic (3.96e-2)" "unprognostic (5.54e-2)" "unprognostic (1.63e-1)" "unprognostic (8.78e-3)" "unprognostic (6.07e-2)" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (9.81e-3)" "unprognostic (6.86e-2)" "prognostic unfavorable (5.51e-10)" "unprognostic (2.48e-1)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" 25.9 11.3 4.4 24.7 3.2 0.2 12.7 4.0 3.1 13.0 29.3 3.8 10.2 13.7 11.5 9.7 22.9 9.9 12.9 10.1 3.6 3.5 28.2 125.8 13.5 4.7 4.0 2.2 20.6 24.9 5.1 4.7 26.8 5.3 13.2 23.3 7.5 8.2 7.3 7.5 5.5 24.2 17.7 3.7 3.3 14.1 5.0 3.8 1.7 16.7 12.7 7.1 30.2 24.1 12.0 12.3 17.1 12.0 21.8 22.4 10.2 4.9 85.7 9.4 12.3 30.9 34.4 7.9 16.3 19.4 16.1 14.8 12.0 18.5 3.1 10.2 22.6 14.8 5.1 9.8 4.6 16.9 4.0 1.7 3.5 11.1 99.2 12.2 4.3 3.5 11.5 2.5 27.6 8.7 13.0 10.3 2.5 4.6 2.6 11.1 14.6 4.2 4.7 7.6 32.4 6.3 7.2 14.6 3.1 8.9 19.7 4.8 7.1 10.0 5.9 6.8 7.2 3.3 3.6 12.0 16.6 7.7 61.6 7.8 6.0 4.3 3.1 14.0 3.6 8.6 17.1 12.0 10.9 14.3 10.6 22.4 10.9 11.4 14.8 10.7 12.0 9.8 12.0 2.3 21.8 6.1 12.3 7.3 10.2 4.4 3.2 4.0 3.0 3.6 3.5 4.0 2.2 5.3 3.8 23.8 22.2 19.5 56.0 103.1 7.7 7.3 22.9 72.3 30.7 19.2 13.7 18.5 59.7 44.3 0.9 20.2 111.9 0.0 293.1 59.3 101.2 100.0 35.7 215.1 16.1 9.5 108.6 23.4 18.5 0.9 30.8 17.2 28.7 26.2 69.3 5.2 205.5 85.2 27.3 54.9 8.6 32.3 92.4 2.4 4.0 35.0 24.3 11.5 88.0 69.0 UGP2 "UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840940-63891562 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 185.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 93.6;T-reg: 29.9" "Group enriched" "Detected in all" 5 "granulocytes: 93.6;T-cells: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria NA NA 12000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 58.2 14.7 23.3 13.6 22.5 7.8 25.2 12.4 30.4 13.3 38.2 6.7 7.4 12.3 15.5 12.5 19.8 12.7 12.2 46.3 18.8 13.2 33.0 185.5 12.7 15.2 17.3 18.3 12.0 13.4 17.1 22.9 31.0 19.3 11.0 33.1 5.7 18.5 12.9 104.1 11.0 17.2 16.8 8.6 9.9 13.0 8.1 10.5 31.0 17.4 75.5 12.7 19.7 19.5 6.4 5.9 93.6 7.8 12.7 29.9 11.0 27.5 14.5 13.9 9.3 47.4 61.5 58.3 35.6 29.1 19.2 22.9 37.1 23.4 28.9 10.7 38.2 17.5 12.1 16.8 22.3 31.2 19.3 7.1 18.3 10.3 25.3 22.7 16.1 16.1 40.3 40.9 18.0 18.6 25.9 26.6 9.8 9.1 11.7 80.1 10.8 21.8 15.2 33.3 45.0 10.2 17.9 27.6 16.6 34.0 16.0 7.3 6.0 28.4 36.6 13.5 44.1 10.4 11.5 36.3 20.1 31.7 29.9 18.7 21.0 9.4 36.6 24.1 25.3 61.3 93.6 7.0 9.7 9.9 7.8 10.3 6.4 11.4 10.3 5.9 6.2 12.6 11.2 9.0 12.7 7.6 5.5 29.9 11.0 23.3 22.5 12.4 30.4 18.8 13.2 17.3 18.3 19.3 10.5 26.8 52.5 51.7 74.0 67.3 48.5 238.8 89.2 73.6 69.4 45.4 60.9 359.1 205.6 116.3 61.0 61.3 412.6 0.0 90.6 369.3 148.4 77.6 65.8 448.9 107.3 82.6 42.9 66.3 100.6 64.7 73.4 90.8 91.1 173.1 112.3 37.4 81.0 167.8 72.9 209.2 49.4 71.1 124.3 71.2 57.5 50.6 395.3 112.8 144.5 90.3 UGT1A1 "GNT1, UGT1, UGT1A" ENSG00000241635 "UDP glucuronosyltransferase family 1 member A1" P22309 2 233760248-233773299 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 48.6;liver: 120.3" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 83.9" "Cancer enriched" "Detected in some" 19 "liver cancer: 16.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 8.1;OE19: 35.4;RT4: 19.3" "Not detected" "Not detected" NA NA "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (3.60e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-3)" "unprognostic (6.31e-3)" "unprognostic (1.94e-5)" "unprognostic (2.78e-3)" "unprognostic (2.99e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.2 35.6 0.1 0.1 48.6 0.1 0.1 4.3 0.0 0.3 0.1 0.1 0.0 4.5 120.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.4 0.1 0.7 0.1 0.1 0.9 48.2 0.5 0.1 0.1 1.3 0.2 0.1 0.1 0.2 0.1 0.1 5.2 0.8 1.0 0.4 4.7 0.4 1.1 0.5 0.2 0.2 0.6 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.1 0.2 0.1 1.4 0.0 0.0 8.1 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.3 35.4 3.6 0.0 0.1 0.3 0.0 19.3 0.1 0.2 1.4 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.4 0.2 0.1 2.1 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.3 0.1 1.0 0.4 0.5 4.7 1.1 0.4 0.4 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.7 6.8 1.8 0.0 0.0 0.0 0.2 2.8 0.0 3.5 0.0 0.0 0.0 0.0 0.9 0.0 83.9 0.0 0.0 0.0 1.3 3.3 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 6.2 UGT1A10 UGT1J ENSG00000242515 "UDP glucuronosyltransferase family 1 member A10" Q9HAW8 2 233636454-233773305 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4" "Cell type enhanced" "Detected in some" 22 "Club cells: 1.2;Enterocytes: 2.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 142 "RT4: 109.0" "Intracellular and membrane" NA NA "unprognostic (9.33e-2)" "unprognostic (7.64e-2)" "unprognostic (2.45e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.49e-10)" "unprognostic (2.90e-1)" "unprognostic (1.50e-1)" "unprognostic (3.59e-3)" 0.3 0.0 0.3 2.6 0.3 0.0 0.3 0.3 0.3 0.3 19.2 0.3 0.3 31.1 0.3 0.3 9.4 0.1 8.4 0.3 0.3 0.0 0.3 1.4 0.6 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 14.3 0.3 0.9 0.3 0.3 0.3 20.2 0.5 0.3 0.3 12.4 1.0 0.3 0.3 0.3 0.3 1.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 UGT1A3 UGT1C ENSG00000243135 "UDP glucuronosyltransferase family 1 member A3" P35503 2 233729108-233773299 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 40.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "liver cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 16.7" NA NA "unprognostic (5.15e-2)" "unprognostic (9.93e-2)" "unprognostic (2.97e-1)" "unprognostic (4.59e-2)" "unprognostic (1.04e-4)" "unprognostic (8.22e-2)" "unprognostic (2.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A4 "HUG-BR2, UGT1D" ENSG00000244474 "UDP glucuronosyltransferase family 1 member A4" P22310 2 233718778-233773299 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "liver: 99.4" "Group enriched" "Detected in some" 8 "Club cells: 4.5;Hepatocytes: 10.5" "Cancer enriched" "Detected in single" 487 "liver cancer: 24.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2" NA NA "unprognostic (9.89e-3)" "unprognostic (6.77e-5)" "unprognostic (2.59e-1)" "unprognostic (3.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A5 UGT1E ENSG00000240224 "UDP glucuronosyltransferase family 1 member A5" P35504 2 233712992-233773299 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 3.7;intestine: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;RT4: 1.6" NA NA "unprognostic (2.18e-3)" "unprognostic (1.36e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 11.2 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 111.7;liver: 50.1;urinary bladder: 32.7" "Group enriched" "Detected in some" 5 "Early spermatids: 37.7;Late spermatids: 19.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 40.4;OE19: 160.5" "CAB009819, HPA054065" Enhanced NA NA "CAB009819: AB_2241481, HPA054065: AB_2682367" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 0.5 0.2 0.5 2.0 0.3 0.9 13.0 0.0 1.1 0.1 0.1 0.0 111.7 50.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.3 0.1 3.3 0.4 0.1 1.3 1.2 0.1 3.8 1.2 2.3 0.1 0.1 8.1 0.2 0.1 0.5 0.2 5.6 8.7 32.7 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.2 0.0 11.3 0.0 0.1 40.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 160.5 0.0 0.0 0.0 0.0 0.4 20.4 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.3 0.0 0.0 4.5 1.8 0.0 0.0 0.0 0.0 37.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.6 0.0 19.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 2.1 UGT1A7 UGT1G ENSG00000244122 "UDP glucuronosyltransferase family 1 member A7" Q9HAW7 2 233681938-233773299 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6" "Cell type enriched" "Detected in some" 5 "Urothelial cells: 8.4" "Group enriched" "Detected in some" 10 "cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 14 "SiHa: 50.6" NA NA "unprognostic (6.27e-2)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.09e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-7)" "unprognostic (2.14e-1)" "unprognostic (4.57e-2)" 0.1 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 40.2 0.2 2.8 0.2 0.1 1.6 0.2 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 50.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 8.4 UGT1A8 UGT1H ENSG00000242366 "UDP glucuronosyltransferase family 1 member A8" Q9HAW9 2 233617645-233773310 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;urinary bladder: 15.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 58 "RT4: 52.5" NA NA "unprognostic (1.27e-2)" "unprognostic (1.35e-1)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (4.78e-1)" "unprognostic (9.71e-12)" "unprognostic (9.26e-2)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 7.3 0.0 0.0 0.0 0.0 0.0 3.3 5.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 UGT1A9 "HLUGP4, LUGP4, UGT1AI" ENSG00000241119 "UDP glucuronosyltransferase family 1 member A9" O60656 2 233671853-233773300 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 169.8" "Cell type enhanced" "Detected in some" 29 "Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3" "Group enriched" "Detected in some" 157 "liver cancer: 16.1;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "A549: 4.9;RT4: 4.0" NA NA "unprognostic (2.46e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (5.04e-5)" "unprognostic (4.26e-2)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 39.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A1 ENSG00000173610 "UDP glucuronosyltransferase family 2 member A1 complex locus" Q9Y4X1 4 69588417-69653249 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 10.6;liver: 14.5;pituitary gland: 21.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 32.3" "Cancer enhanced" "Detected in some" "liver cancer: 0.7" "Region enriched" "Detected in single" 17 "pons and medulla: 1.7" "Cell type enhanced" "Detected in some" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6" "HPA017261, HPA045108" Uncertain NA NA "HPA017261: AB_10963582, HPA045108: AB_2679218" "unprognostic (3.93e-3)" "unprognostic (5.62e-1)" "unprognostic (1.28e-4)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 14.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 2.0 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 1.7 0.5 0.4 0.2 0.2 0.1 0.1 0.4 0.2 0.1 0.3 0.2 0.1 2.0 0.9 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A2 ENSG00000271271 "UDP glucuronosyltransferase family 2 member A2" Q9Y4X1 4 69589309-69639642 "Enzymes, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "cervix, uterine: 1.6;kidney: 2.6;liver: 5.4;pituitary gland: 3.8;skin 1: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 2.6" "Not detected" "Not detected" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 5.4 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A3 FLJ21934 ENSG00000135220 "UDP glucuronosyltransferase family 2 member A3" Q6UWM9 4 68928463-68951791 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 150.5;kidney: 43.2" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7" "Cancer enriched" "Detected in many" 5 "renal cancer: 46.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 53 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 9 "Hep G2: 21.0" HPA045108 Supported NA NA "HPA045108: AB_2679218" "prognostic favorable (3.31e-4)" "unprognostic (3.97e-3)" "unprognostic (8.87e-3)" "prognostic favorable (6.07e-7)" "unprognostic (2.10e-2)" 0.1 0.1 0.1 4.3 0.1 0.0 0.7 0.1 0.1 0.1 63.8 0.1 0.1 31.9 0.1 1.7 0.1 0.1 14.6 0.3 0.1 0.1 43.2 9.6 0.1 0.1 0.1 0.1 0.1 12.0 0.0 0.1 0.1 0.1 0.1 8.6 0.1 0.1 0.1 0.1 0.1 150.5 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 94.3 0.0 0.0 3.5 0.0 0.0 10.0 21.3 0.0 0.0 115.5 0.0 2.3 0.0 0.0 0.0 0.0 49.3 0.0 0.0 11.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 28.2 0.0 6.0 52.6 0.0 125.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 UGT2B10 ENSG00000109181 "UDP glucuronosyltransferase family 2 member B10" P36537 4 68815993-68831196 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 277 "liver: 120.4" "Cell type enriched" "Detected in some" 15 "Hepatocytes: 221.7" "Cancer enriched" "Detected in single" 296 "liver cancer: 93.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "Hep G2: 16.1" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (3.50e-3)" "unprognostic (1.92e-3)" "unprognostic (4.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 120.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 221.7 0.0 0.0 0.0 1.3 4.7 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 UGT2B11 ENSG00000213759 "UDP glucuronosyltransferase family 2 member B11" O75310 4 69199951-69214731 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "breast: 77.4" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 12.7" "Group enriched" "Detected in some" 17 "breast cancer: 17.4;liver cancer: 13.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "basophil: 6.8;eosinophil: 5.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 6.8" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.49e-1)" "unprognostic (6.53e-2)" "unprognostic (2.26e-2)" "unprognostic (1.65e-1)" "unprognostic (7.84e-3)" "unprognostic (5.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.51e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 77.4 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 3.3 0.1 0.1 0.0 1.2 7.3 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.1 0.0 3.7 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.6 0.0 0.0 6.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B15 UGT2B8 ENSG00000196620 "UDP glucuronosyltransferase family 2 member B15" P54855 4 68646630-68670628 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 22.4;intestine: 50.7;liver: 65.4" "Group enriched" "Detected in some" 6 "Cholangiocytes: 168.2;Hepatocytes: 134.4" "Cancer enriched" "Detected in many" 10 "liver cancer: 120.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.7" "Lineage enhanced" "Detected in single" "B-cells: 2.7" "Cell line enhanced" "Detected in some" "A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1" HPA045108 Approved NA NA "HPA045108: AB_2679218" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (2.22e-2)" "unprognostic (3.86e-1)" "unprognostic (1.94e-1)" "prognostic favorable (9.82e-4)" "unprognostic (6.73e-2)" "unprognostic (3.49e-2)" "unprognostic (7.84e-2)" "unprognostic (5.81e-3)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "prognostic favorable (4.50e-4)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 48.0 0.1 0.1 5.4 0.1 0.1 0.2 0.0 22.4 0.1 0.1 0.0 0.1 65.4 0.1 0.1 0.1 0.1 0.1 5.3 0.0 0.1 0.1 0.1 0.2 1.6 0.1 0.1 0.1 0.1 0.0 50.7 0.1 0.1 0.1 5.7 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 1.2 1.1 0.0 0.2 0.1 0.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.4 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 168.2 0.0 0.0 0.0 0.0 0.0 0.0 14.9 1.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 134.4 0.0 0.0 0.0 1.8 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.5 UGT2B17 ENSG00000197888 "UDP glucuronosyltransferase family 2 member B17" O75795 4 68537184-68568527 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 68.1;liver: 21.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.3;liver cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 3.3;naive B-cell: 11.9" "Lineage enriched" "Detected in single" 59 "B-cells: 11.9" "Group enriched" "Detected in some" 7 "BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1" HPA045108 Supported NA NA "HPA045108: AB_2679218" "unprognostic (1.66e-1)" "unprognostic (2.97e-2)" "unprognostic (2.96e-2)" "unprognostic (2.41e-1)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.36e-1)" "unprognostic (8.44e-3)" "unprognostic (9.67e-2)" "unprognostic (4.80e-3)" "unprognostic (8.52e-2)" "unprognostic (2.45e-1)" "unprognostic (6.44e-2)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" 0.4 0.1 0.4 4.7 0.4 0.0 0.4 0.4 0.4 0.4 55.6 0.4 0.4 54.1 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.1 0.4 21.6 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 0.1 68.1 1.1 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 11.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 5.2 0.2 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 UGT2B28 ENSG00000135226 "UDP glucuronosyltransferase family 2 member B28" Q9BY64 4 69280499-69295050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 71.7;salivary gland: 25.6" "Cell type enriched" "Detected in single" 178 "Cholangiocytes: 17.8" "Cancer enriched" "Detected in single" 8 "breast cancer: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 2.5;eosinophil: 4.0" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.0" "Group enriched" "Detected in some" 10 "Daudi: 7.1;NB-4: 6.5" HPA045108 Uncertain "Intracellular and membrane" NA NA "HPA045108: AB_2679218" "unprognostic (1.81e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-3)" "unprognostic (1.51e-2)" "unprognostic (4.37e-5)" "unprognostic (9.79e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.2 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B4 UGT2B11 ENSG00000156096 "UDP glucuronosyltransferase family 2 member B4" P06133 4 69480165-69526014 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "liver: 175.1" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 831.9" "Cancer enriched" "Detected in some" 96 "liver cancer: 351.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 10.4" "CAB033260, HPA045108" Enhanced "Intracellular and membrane" NA NA "CAB033260: AB_2241496, HPA045108: AB_2679218" "unprognostic (7.46e-2)" "unprognostic (1.50e-1)" "unprognostic (9.37e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-2)" "unprognostic (1.47e-1)" "unprognostic (9.43e-3)" "unprognostic (3.52e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 175.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 10.4 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 34.2 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 831.9 0.1 0.0 0.0 14.7 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B7 UGT2B9 ENSG00000171234 "UDP glucuronosyltransferase family 2 member B7" P16662 4 69051363-69112987 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 125.4;liver: 156.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 539.4;Proximal tubular cells: 775.7" "Group enriched" "Detected in many" 7 "liver cancer: 116.4;renal cancer: 101.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 21.0;RPTEC TERT1: 83.6" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic favorable (7.65e-5)" "unprognostic (1.11e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-2)" "unprognostic (5.41e-3)" "unprognostic (1.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.17e-3)" "unprognostic (1.98e-1)" "prognostic favorable (3.79e-4)" "unprognostic (1.08e-2)" "unprognostic (2.55e-1)" "unprognostic (6.23e-3)" "prognostic favorable (5.38e-4)" 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 3.1 7.9 0.1 2.5 6.4 0.6 4.7 0.1 4.7 1.5 0.1 0.1 0.1 125.4 156.0 0.2 0.1 0.1 0.1 0.6 14.7 0.0 0.1 0.2 0.1 0.3 0.4 0.2 1.0 2.7 0.3 0.2 27.7 0.1 0.1 0.2 0.1 0.6 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 83.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 3.9 0.6 0.1 0.0 0.0 58.6 0.0 0.0 118.7 0.0 0.0 82.9 5.6 0.2 0.0 6.7 0.0 9.1 0.0 0.0 0.4 0.0 539.4 0.1 0.0 3.4 6.2 10.7 0.0 1.7 0.0 3.3 0.0 20.1 0.0 11.8 11.9 0.0 775.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 2.0 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Group enriched" "Detected in some" 5 "Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 25.3" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 47.1 0.0 0.0 3.3 0.0 91.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.1 0.0 0.0 2.5 2.2 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 58.6 0.3 6.5 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 UGT8 CGT ENSG00000174607 "UDP glycosyltransferase 8" Q16880 4 114598455-114678224 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 96.6" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 24.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 25.7;Spermatogonia: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 7.3;naive B-cell: 10.6" "Lineage enriched" "Detected in single" 12 "B-cells: 10.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.5;OE19: 41.1;RPTEC TERT1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014405, HPA065785" Enhanced Approved Mitochondria No No Mitochondria "HPA014405: AB_1858606, HPA065785: AB_2685559" "unprognostic (7.38e-3)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (2.38e-1)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (1.16e-2)" "unprognostic (2.38e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-3)" "unprognostic (4.49e-2)" "unprognostic (2.76e-1)" "prognostic favorable (8.55e-5)" "unprognostic (2.80e-1)" "unprognostic (1.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.49e-1)" 0.9 0.8 13.2 2.8 30.0 1.0 3.1 2.7 44.8 4.9 15.5 66.6 0.0 18.4 2.7 0.6 1.2 3.0 7.1 0.9 24.2 12.4 20.1 0.8 1.0 3.2 53.9 15.9 0.8 4.8 0.3 0.9 0.5 38.3 0.9 17.3 0.0 4.5 0.8 0.8 1.8 16.1 1.5 96.6 1.3 10.0 3.3 42.6 0.0 8.5 0.0 3.4 0.8 1.0 10.6 0.0 0.9 0.0 0.0 0.6 0.3 0.2 0.1 1.7 0.3 0.1 0.0 0.3 0.1 0.0 0.0 1.2 5.8 21.5 6.4 0.5 0.1 5.1 9.1 0.0 0.0 0.0 0.1 4.5 0.1 9.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.1 5.4 1.3 0.0 0.1 0.1 0.7 2.5 41.1 3.2 0.6 10.3 0.1 21.3 0.2 12.1 1.8 0.0 1.9 0.3 0.4 0.3 2.1 0.4 0.5 7.3 0.3 6.8 2.1 0.3 0.2 10.6 0.3 6.6 0.2 0.0 0.9 0.0 0.0 0.6 7.3 0.1 0.0 0.0 10.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.3 13.2 30.0 2.7 24.4 24.2 12.4 53.9 15.9 38.3 42.6 6.0 1.0 8.1 1.2 0.0 0.0 0.4 7.6 2.7 6.8 24.4 0.0 0.0 8.3 1.8 5.5 0.1 20.6 0.0 11.4 0.0 0.2 0.5 0.0 0.0 0.0 0.0 46.4 0.0 0.0 1.7 1.1 0.7 1.7 0.0 25.7 0.0 9.1 17.5 0.0 1.3 0.0 0.0 0.2 10.6 36.2 0.1 0.0 0.0 21.1 0.9 UHRF1 "FLJ21925, ICBP90, Np95, RNF106, TDRD22" ENSG00000276043 "Ubiquitin like with PHD and ring finger domains 1" Q96T88 19 4903080-4962154 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, DNA-binding, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 75.6" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Group enriched" "Detected in many" 4 "dendritic cells: 8.2;T-cells: 4.2" "Cell line enhanced" "Detected in many" "MOLT-4: 63.9;REH: 145.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA049408, HPA055446" Enhanced Supported Nucleoplasm No Yes Nucleoplasm "HPA049408: AB_2756317, HPA055446: AB_2732597" "unprognostic (3.83e-2)" "unprognostic (6.83e-3)" "unprognostic (5.13e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (7.21e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (4.30e-2)" "prognostic unfavorable (6.81e-4)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.52e-5)" "unprognostic (2.33e-3)" "unprognostic (0.00e+0)" "unprognostic (3.75e-3)" "unprognostic (2.45e-1)" "unprognostic (2.01e-1)" "unprognostic (2.02e-1)" 0.7 0.0 0.7 8.2 3.7 16.5 0.7 0.3 4.2 0.3 1.5 1.6 0.0 2.1 0.3 0.2 2.0 0.0 1.0 0.9 1.2 0.1 0.1 0.3 10.0 4.3 0.7 0.3 0.6 0.0 0.0 1.0 1.4 0.0 1.4 0.0 0.0 0.0 0.3 1.9 2.2 0.8 0.7 2.2 1.9 3.1 4.0 75.6 0.0 4.0 6.6 1.1 0.0 0.4 8.2 1.5 0.4 0.9 4.2 0.9 15.9 11.6 17.5 12.4 0.5 2.0 2.8 13.0 6.2 13.6 13.2 13.8 8.1 9.1 3.2 5.7 4.9 8.0 12.0 7.0 9.6 14.7 13.7 7.8 10.8 14.7 0.2 19.3 11.9 1.0 0.5 7.3 1.9 2.1 4.0 14.4 11.2 10.5 8.1 12.5 63.9 11.8 7.8 5.8 12.5 145.0 39.1 6.6 3.7 11.7 13.0 10.3 10.2 5.6 1.8 2.9 10.1 18.4 5.0 14.4 11.7 18.6 15.7 4.5 4.6 26.8 8.3 18.8 18.3 0.6 0.4 0.2 1.1 0.1 0.1 0.3 1.5 1.9 2.2 0.4 0.4 1.5 1.5 0.9 0.3 8.2 4.2 0.9 0.0 0.0 1.5 0.6 0.0 2.6 1.6 2.5 1.4 1.2 0.0 0.0 1.7 0.0 1.7 2.5 0.0 0.9 0.0 0.3 5.8 0.5 0.5 0.0 0.6 7.5 3.2 0.0 0.0 2.1 0.9 0.6 0.7 0.0 2.8 1.5 0.5 2.6 1.9 0.4 0.0 0.8 0.0 1.5 4.2 6.9 0.0 1.1 0.0 4.7 0.7 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 23.1;JURKAT: 17.8" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: AB_2686332" "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.6 1.4 2.6 7.7 2.7 3.6 1.1 1.6 2.8 1.8 3.1 2.7 2.9 12.4 6.6 2.6 23.1 4.5 4.3 12.0 3.8 0.2 0.9 0.0 13.6 0.1 1.0 8.4 5.6 11.4 3.0 1.3 2.3 17.8 2.2 0.0 4.0 3.2 2.8 0.0 0.9 1.7 4.2 1.2 2.4 0.3 4.9 2.0 0.9 0.3 5.3 3.3 0.8 1.6 2.6 5.3 1.9 1.3 2.3 5.1 3.2 0.4 0.4 2.5 7.9 4.0 3.3 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 6.0 2.1 0.0 0.4 0.1 0.0 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.5 0.0 0.0 0.0 0.1 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942000-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.8" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 7 "T-cells: 5.5" "Cell line enhanced" "Detected in many" "SiHa: 32.0;U-2197: 23.1" CAB018974 Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB018974: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 3.3 1.7 4.5 1.9 2.3 4.3 5.9 5.3 6.5 1.6 0.6 0.0 0.0 0.9 0.6 0.5 10.8 0.5 1.6 4.1 4.4 1.0 1.9 1.7 6.2 1.1 1.0 2.1 0.2 1.6 0.3 1.1 4.4 3.9 0.6 0.7 0.3 1.5 0.4 0.6 1.0 0.4 2.0 0.6 0.5 0.7 3.6 0.1 0.5 3.5 4.6 2.4 4.1 5.2 0.0 0.0 0.0 0.0 0.8 5.5 0.9 9.2 0.8 0.2 2.9 0.5 2.8 1.6 9.6 5.6 10.1 8.3 3.5 5.3 0.0 14.7 10.9 14.5 6.6 3.6 8.8 5.8 4.2 1.9 0.5 1.4 0.0 3.6 0.0 0.7 1.3 6.8 8.9 3.9 8.2 5.7 8.0 1.1 0.0 7.4 6.4 0.8 0.0 0.0 1.7 4.9 1.4 2.2 0.0 14.3 2.7 0.3 0.0 32.0 0.7 0.9 1.6 0.9 4.0 8.9 6.6 8.3 23.1 11.0 0.0 0.0 0.4 9.5 5.1 4.7 0.0 0.0 0.0 5.5 0.0 0.6 0.0 1.8 3.2 0.0 0.0 0.6 3.9 0.0 0.8 0.0 0.0 3.0 0.9 4.5 2.3 5.3 6.5 4.4 1.0 1.0 2.1 3.9 0.1 0.0 2.2 0.0 5.4 3.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.9 6.3 3.8 0.0 0.0 7.4 0.2 0.9 0.9 0.0 0.0 1.8 0.0 0.0 9.2 1.2 6.4 0.0 1.7 1.7 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 1.0 2.3 3.2 2.5 0.0 2.9 0.0 3.2 ULBP3 RAET1N ENSG00000131019 "UL16 binding protein 3" Q9BZM4 6 150063150-150069095 "Predicted intracellular proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 2.7" "Lineage enriched" "Detected in single" 7 "T-cells: 2.7" "Low cell line specificity" "Detected in many" "HPA056541, HPA063007" Approved Uncertain "Vesicles,Centriolar satellite" "Intracellular and membrane" NA NA Vesicles "Centriolar satellite" "HPA056541: , HPA063007: AB_2684920" "unprognostic (4.87e-2)" "unprognostic (4.49e-2)" "unprognostic (3.14e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (2.99e-2)" "unprognostic (8.47e-2)" "unprognostic (1.96e-1)" "unprognostic (5.87e-2)" "unprognostic (8.71e-2)" "unprognostic (1.66e-2)" "unprognostic (3.54e-2)" "unprognostic (6.26e-2)" "unprognostic (3.43e-1)" "unprognostic (2.12e-1)" "unprognostic (5.45e-2)" "unprognostic (5.16e-2)" 8.0 3.6 1.0 0.4 1.2 0.2 8.2 0.3 2.0 1.9 2.8 0.4 1.1 1.4 1.1 2.1 3.6 3.6 4.4 1.2 1.3 2.3 5.5 2.6 3.1 0.3 0.7 0.6 2.0 1.1 1.9 0.7 1.4 0.8 1.3 1.1 1.7 1.2 0.4 0.7 1.0 1.0 0.8 0.5 0.5 2.9 24.3 0.3 0.3 8.2 5.3 2.1 1.8 3.1 0.3 0.0 0.0 0.0 0.0 2.7 0.5 3.9 1.6 4.6 5.1 1.5 8.8 1.4 4.2 1.9 5.4 6.0 8.4 3.7 0.0 9.4 6.9 8.4 6.5 13.8 15.2 5.4 3.4 7.0 0.1 2.4 0.4 2.1 0.0 0.6 7.8 2.9 11.5 6.0 5.0 7.0 0.0 0.2 0.0 4.8 5.7 0.0 0.0 2.1 1.7 12.4 4.4 4.7 0.2 10.7 9.0 0.8 0.1 9.8 6.1 2.1 2.2 1.8 1.0 3.8 0.9 7.1 14.0 9.8 0.0 0.0 2.8 7.5 2.0 3.8 0.0 0.0 0.0 1.5 0.0 2.0 0.3 2.0 1.1 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 2.7 0.5 1.0 1.2 0.3 2.0 1.3 2.3 0.7 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UMOD ENSG00000169344 Uromodulin P07911 16 20333052-20356301 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Ciliopathy, Disease mutation, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 417 "kidney: 237.4" "Group enriched" "Detected in some" 383 "Collecting duct cells: 235.5;Distal tubular cells: 805.7" "Cancer enriched" "Detected in single" 39 "renal cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "EFO-21: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009446, HPA043420, HPA054721" Enhanced "Secreted in other tissues" NA NA 55000000 83000000 "CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (6.45e-2)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "unprognostic (1.43e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 237.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 235.5 0.0 0.0 805.7 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UMODL1 ENSG00000177398 "Uromodulin like 1" Q5DID0 21 42062959-42143453 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "lymphoid tissue: 22.7" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 1.2;Early spermatids: 3.1;Late spermatids: 1.7;Spermatocytes: 2.3" "Group enriched" "Detected in some" 7 "lung cancer: 0.6;testis cancer: 2.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "SCLC-21H: 3.7;U-266/70: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA067245 Uncertain NA NA "HPA067245: AB_2685810" "unprognostic (4.70e-3)" "unprognostic (3.75e-5)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (4.92e-2)" "unprognostic (1.32e-2)" "unprognostic (2.72e-7)" "unprognostic (2.38e-1)" "unprognostic (9.47e-2)" "unprognostic (2.63e-2)" "unprognostic (3.82e-1)" "unprognostic (9.24e-3)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (4.02e-4)" "unprognostic (2.68e-1)" 0.6 0.1 0.4 3.6 0.1 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 4.9 0.0 0.2 0.2 0.3 0.4 0.4 0.6 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.1 0.8 0.2 3.8 0.0 22.7 0.1 0.0 2.0 0.1 0.0 0.5 0.1 0.3 0.5 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.5 0.5 0.0 0.1 0.3 0.7 0.6 0.0 0.0 0.5 0.0 1.0 0.2 0.4 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 UNC119 "HRG4, POC7, POC7A" ENSG00000109103 "Unc-119 lipid binding chaperone" Q13432 17 28546707-28552668 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 197.8" "Group enriched" "Detected in many" 6 "Bipolar cells: 683.7;Cone photoreceptor cells: 807.0;Rod photoreceptor cells: 1668.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041912 Enhanced NA NA "HPA041912: AB_10795267" "unprognostic (8.93e-2)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (4.95e-3)" "unprognostic (2.10e-1)" "unprognostic (1.44e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.76e-3)" "prognostic favorable (8.09e-5)" "unprognostic (2.65e-1)" "unprognostic (8.08e-3)" "unprognostic (5.51e-3)" "unprognostic (1.87e-1)" "prognostic unfavorable (9.82e-4)" "unprognostic (1.71e-3)" 10.0 12.3 15.0 15.1 16.1 34.8 10.3 16.3 21.6 10.1 8.2 6.8 9.1 8.1 9.3 12.9 11.5 9.5 10.2 9.8 15.4 19.8 14.3 20.7 9.0 18.1 13.3 10.1 10.6 13.5 10.5 12.5 8.3 13.3 12.1 7.6 197.8 17.3 15.0 4.4 15.3 10.2 9.5 6.5 23.7 7.7 22.9 6.4 11.4 12.1 5.7 19.7 11.4 10.3 9.1 22.4 32.3 47.9 4.3 4.9 7.4 12.2 15.5 15.6 21.6 16.4 16.1 7.7 10.2 14.0 18.5 17.5 21.5 4.1 10.1 11.1 15.5 12.7 20.4 13.1 15.1 9.9 18.7 24.5 7.0 7.5 6.5 11.3 10.3 22.0 14.7 20.9 13.3 6.7 17.5 14.8 11.0 7.1 8.4 11.3 19.3 10.1 10.4 15.1 10.4 11.3 16.3 25.5 4.4 14.0 13.7 6.1 21.4 14.6 23.9 15.2 18.9 18.8 17.8 11.1 10.7 20.4 17.2 9.8 9.6 9.9 2.2 17.6 16.7 9.7 5.2 11.5 28.2 2.2 27.9 2.3 6.8 4.3 3.5 20.0 9.1 4.9 3.4 32.3 4.3 47.9 22.4 3.7 7.4 15.0 16.1 16.3 21.6 15.4 19.8 13.3 10.1 13.3 6.4 0.0 4.8 13.7 16.5 11.8 683.7 10.9 12.7 2.7 2.3 12.2 807.0 21.7 28.2 17.0 2.0 14.3 16.5 0.0 16.2 7.5 14.3 18.3 12.7 10.4 31.4 138.2 24.3 10.4 32.2 4.0 13.6 47.2 18.6 55.1 13.5 174.9 15.8 13.9 20.1 16.1 1668.5 45.3 15.3 1.7 11.3 12.5 16.7 18.8 11.4 16.9 UNC13A "KIAA1032, Munc13-1" ENSG00000130477 "Unc-13 homolog A" Q9UPW8 19 17601328-17688365 "Predicted intracellular proteins" "Differentiation, Exocytosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 48.4;pituitary gland: 16.7" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 41.3;Cone photoreceptor cells: 51.1;Horizontal cells: 112.8;Rod photoreceptor cells: 22.2" "Cancer enhanced" "Detected in some" "glioma: 2.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HMC-1: 11.3;NTERA-2: 16.4;SCLC-21H: 27.1;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.50e-1)" "unprognostic (2.61e-1)" "unprognostic (1.02e-1)" "unprognostic (4.96e-3)" "unprognostic (1.69e-1)" "unprognostic (3.98e-3)" "unprognostic (2.13e-3)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.89e-1)" "unprognostic (4.33e-3)" "unprognostic (1.40e-2)" "unprognostic (8.19e-3)" "unprognostic (1.94e-1)" "unprognostic (4.83e-2)" "unprognostic (2.14e-2)" "unprognostic (2.00e-1)" 1.3 4.9 15.8 1.7 25.3 1.2 1.2 24.6 48.4 1.3 1.4 1.9 0.0 1.5 1.3 1.3 1.2 1.3 1.3 1.1 16.8 7.5 1.3 1.1 1.3 1.5 4.1 16.3 1.3 2.5 1.3 16.7 1.4 8.2 1.2 1.5 1.2 1.2 1.3 1.1 1.2 1.4 1.4 1.9 3.8 2.4 2.1 1.6 0.0 1.2 0.0 1.6 1.2 0.1 0.4 0.3 1.1 0.2 0.2 0.3 0.0 0.0 1.6 1.4 0.3 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.7 0.4 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 11.3 0.0 0.0 0.0 1.0 0.3 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 16.4 0.1 0.4 0.4 0.0 0.2 0.0 0.0 27.1 6.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.4 0.2 0.3 1.1 0.2 0.1 0.3 0.0 0.0 15.8 25.3 24.6 35.4 16.8 7.5 4.1 16.3 8.2 1.6 0.0 0.0 0.0 0.2 0.2 41.3 1.8 0.0 0.0 0.0 0.0 51.1 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.2 112.8 8.1 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.7 0.9 0.0 1.4 0.0 22.2 0.0 0.4 0.3 2.1 0.0 0.0 0.0 0.0 0.3 UNC13C "DKFZp547H074, Munc13-3" ENSG00000137766 "Unc-13 homolog C" Q8NB66 15 54012904-54633414 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.7;testis: 11.6" "Group enriched" "Detected in some" 13 "Bipolar cells: 67.9;Early spermatids: 140.5;Late spermatids: 51.5;Rod photoreceptor cells: 35.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Karpas-707: 32.1;U-266/70: 42.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 419.8" NA NA "unprognostic (4.85e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.90e-3)" "unprognostic (1.58e-2)" "unprognostic (9.69e-2)" "unprognostic (2.42e-2)" "unprognostic (1.26e-1)" 0.2 0.4 13.3 0.3 2.6 0.5 0.3 19.7 16.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.1 0.7 0.4 3.5 2.6 1.1 0.2 0.2 0.5 8.3 0.9 1.4 0.2 0.1 0.2 0.2 1.5 0.2 0.2 0.5 0.3 0.2 1.5 0.3 0.2 0.2 1.4 0.2 0.3 11.6 1.1 0.2 1.0 0.2 0.6 0.2 0.2 2.2 0.4 1.4 0.4 0.6 0.4 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.8 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.3 0.3 0.1 0.2 2.2 0.3 0.3 0.0 0.6 0.3 0.4 1.2 0.6 0.2 0.4 0.2 0.3 13.3 2.6 19.7 11.1 3.5 2.6 8.3 0.9 1.5 1.1 0.0 0.0 0.0 0.5 0.3 67.9 0.6 2.5 0.0 0.0 3.5 5.9 0.8 0.0 0.0 140.5 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 51.5 2.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.4 0.3 35.7 0.0 0.5 1.4 0.5 0.1 0.2 0.0 0.0 0.5 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844717 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 70.2;granulocytes: 43.9;Hofbauer cells: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 56.1;HMC-1: 58.2;SK-BR-3: 39.8" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" "Not detected" "Not detected" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol NA NA 14000000 Cytosol Vesicles "HPA067117: AB_2685784, HPA073525: AB_2686615" "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 4.5 3.3 2.9 17.1 5.2 31.3 4.5 4.1 3.1 5.2 5.2 2.8 1.4 4.5 3.8 1.8 11.5 5.2 8.7 13.0 1.8 1.6 2.6 4.9 30.1 24.9 4.5 1.6 8.7 5.5 0.3 5.3 67.1 3.2 3.1 2.6 2.6 8.0 3.9 3.2 3.0 7.6 2.8 3.7 33.8 7.2 2.2 3.3 23.6 2.4 9.3 24.7 7.0 8.2 4.0 6.9 24.8 13.6 8.2 11.5 7.9 8.4 3.2 0.1 0.0 0.1 0.2 10.7 0.0 0.0 0.0 0.0 8.2 19.1 0.7 10.2 0.0 1.4 2.9 0.0 0.5 0.0 0.1 0.1 56.1 24.9 5.2 0.9 21.4 58.2 0.1 0.4 0.1 0.5 0.5 3.8 9.8 19.4 0.2 0.0 14.4 22.6 10.7 0.2 15.0 0.4 7.2 0.2 0.3 0.3 3.4 0.0 15.6 3.6 39.8 0.2 0.1 10.7 12.1 10.6 0.1 15.1 0.1 0.0 0.3 1.3 0.9 0.1 6.8 0.0 24.8 8.0 16.4 11.5 9.4 10.4 4.0 6.7 8.1 6.9 2.2 5.3 6.9 22.4 8.2 13.6 4.0 6.0 7.9 2.9 5.2 4.1 3.1 1.8 1.6 4.5 1.6 3.2 3.3 41.7 11.7 22.2 1.7 1.0 11.3 70.2 10.2 0.0 5.7 3.5 19.6 2.8 0.0 6.2 3.9 5.7 20.0 0.0 5.3 8.4 2.3 1.1 43.9 0.8 46.9 4.8 5.8 4.3 22.7 0.0 2.6 18.4 1.7 13.6 2.3 5.8 27.8 10.5 1.4 0.6 15.5 0.0 1.4 1.4 0.9 1.3 21.6 30.5 2.2 2.0 UNC45B "CMYA4, UNC45" ENSG00000141161 "Unc-45 myosin chaperone B" Q8IWX7 17 35147817-35189345 "Disease related genes, Predicted intracellular proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 181.6" "Group enriched" "Detected in some" 5 "head and neck cancer: 0.9;testis cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "gdT-cell: 3.5" "Lineage enriched" "Detected in single" 10 "T-cells: 3.5" "Group enriched" "Detected in some" 11 "BEWO: 4.7;HSkMC: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017861 Approved Cytosol NA NA Cytosol "HPA017861: AB_1847012" "unprognostic (7.17e-2)" "unprognostic (6.47e-3)" "unprognostic (9.36e-3)" "unprognostic (2.93e-1)" "unprognostic (1.49e-3)" "unprognostic (5.30e-2)" "unprognostic (3.07e-1)" "unprognostic (1.09e-2)" "unprognostic (5.46e-2)" "unprognostic (2.40e-2)" "unprognostic (8.46e-2)" "unprognostic (6.73e-2)" "unprognostic (1.13e-6)" "unprognostic (6.77e-2)" "unprognostic (5.05e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.9 0.0 0.3 48.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.2 62.5 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.2 23.2 1.0 0.0 0.0 0.0 0.0 0.2 0.3 0.3 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 0.2 2.9 0.0 0.7 1.8 0.0 0.0 0.4 2.0 0.2 0.3 0.3 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 181.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.0 0.0 0.0 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell type enhanced" "Detected in some" 24 "Horizontal cells: 4.8;Late spermatids: 1.9;Muller glia cells: 10.3;Rod photoreceptor cells: 2.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 44.3" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA071450: AB_2686397" "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 1.7 0.0 0.0 0.0 1.2 5.1 0.0 44.3 1.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 UNC5B "p53RDL1, UNC5H2" ENSG00000107731 "Unc-5 netrin receptor B" Q8IZJ1 10 71212570-71302864 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 43.7" "Cell type enhanced" "Detected in many" 14 "Horizontal cells: 106.5;Muller glia cells: 63.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.5" "Lineage enriched" "Detected in single" 6 "monocytes: 1.5" "Cell line enhanced" "Detected in many" "HHSteC: 47.1;hTCEpi: 41.5;SH-SY5Y: 38.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076687 Approved NA NA "HPA076687: " "unprognostic (3.98e-2)" "unprognostic (3.14e-2)" "unprognostic (9.28e-2)" "unprognostic (2.71e-1)" "unprognostic (5.64e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.01e-5)" "unprognostic (8.82e-3)" "unprognostic (6.79e-3)" "prognostic unfavorable (3.80e-5)" "unprognostic (7.70e-3)" "unprognostic (6.67e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.17e-2)" "unprognostic (4.62e-2)" "unprognostic (9.89e-3)" "unprognostic (2.25e-1)" 3.8 12.4 9.1 4.6 19.8 0.5 2.3 23.1 12.5 5.7 8.3 29.5 33.6 3.2 5.4 7.5 14.2 9.1 10.5 13.8 12.2 6.8 6.6 2.1 9.3 3.9 27.1 9.7 4.5 5.2 1.5 5.3 6.0 15.0 10.1 6.0 7.1 4.5 43.7 3.0 5.9 4.5 5.5 17.5 8.5 9.9 6.0 20.4 2.2 4.6 5.2 3.6 9.6 8.9 0.0 0.2 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.2 1.2 3.7 6.1 0.1 2.0 6.0 0.0 0.1 1.1 5.5 0.0 2.1 12.7 0.1 14.3 0.4 0.8 0.0 0.0 1.3 3.2 0.2 0.0 47.1 0.0 0.3 5.2 41.5 0.5 2.6 0.5 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 3.2 2.9 0.1 0.0 1.4 0.0 0.0 6.2 6.4 38.9 0.4 0.5 0.3 6.0 0.6 0.2 2.4 0.4 1.9 0.8 0.8 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 9.1 19.8 23.1 12.5 12.2 6.8 27.1 9.7 15.0 20.4 0.0 3.5 0.0 15.5 2.7 1.5 7.3 0.0 6.7 3.4 5.2 0.0 0.3 0.0 3.6 0.4 9.5 13.4 0.0 1.4 0.3 10.6 9.4 23.0 0.0 1.2 106.5 2.9 8.0 4.5 0.8 0.6 3.6 1.7 1.0 7.0 63.8 7.4 20.1 0.7 0.1 3.7 0.0 3.6 0.5 4.4 3.8 0.2 0.0 1.5 29.5 UNC5C ENSG00000182168 "Unc-5 netrin receptor C" O95185 4 95162504-95549206 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3" "Group enriched" "Detected in some" 7 "Leydig cells: 19.5;Paneth cells: 11.5;Peritubular cells: 11.0;Rod photoreceptor cells: 10.3;Sertoli cells: 6.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 6.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 230000 "unprognostic (1.55e-1)" "unprognostic (2.72e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (3.03e-1)" "unprognostic (3.20e-1)" "unprognostic (3.48e-1)" "unprognostic (3.40e-1)" "unprognostic (3.12e-1)" "unprognostic (1.11e-3)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (2.70e-5)" "unprognostic (1.25e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (3.62e-4)" 3.2 17.4 13.5 2.4 16.2 0.7 3.2 4.7 14.2 4.2 5.9 31.3 1.8 3.0 5.1 4.1 1.9 4.3 4.4 5.8 10.7 7.3 2.9 2.6 5.0 1.5 13.7 10.8 6.2 1.3 1.0 2.6 3.8 19.6 7.2 7.0 6.4 11.4 8.3 0.8 1.0 4.0 5.1 13.1 7.9 4.4 5.3 19.9 0.0 22.7 0.0 1.3 4.7 7.9 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 2.1 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 42.0 0.0 0.0 0.1 2.7 0.1 6.3 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 4.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 13.5 16.2 4.7 14.2 10.7 7.3 13.7 10.8 19.6 19.9 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.1 1.5 0.2 0.0 0.0 1.4 0.0 1.2 0.6 0.0 0.2 19.5 0.0 1.7 0.0 0.2 1.4 0.0 11.5 11.0 0.0 10.3 6.5 1.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 UNC5CL "MGC34763, ZUD" ENSG00000124602 "Unc-5 family C-terminal like" Q8IV45 6 41026911-41039217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 52.2;kidney: 60.9;liver: 29.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 40.8;Collecting duct cells: 21.0;Exocrine glandular cells: 59.0;Hepatocytes: 25.2;Pancreatic endocrine cells: 25.3;Proximal tubular cells: 29.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "OE19: 31.1;RPTEC TERT1: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015725 Enhanced Approved Centrosome NA NA Centrosome "HPA015725: AB_2669283" "unprognostic (1.10e-2)" "unprognostic (3.59e-2)" "unprognostic (1.60e-1)" "unprognostic (2.57e-1)" "unprognostic (7.87e-2)" "unprognostic (1.46e-1)" "unprognostic (1.16e-1)" "unprognostic (8.55e-3)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" "unprognostic (9.30e-2)" "unprognostic (2.35e-1)" "unprognostic (2.31e-1)" "unprognostic (1.19e-1)" "unprognostic (5.60e-6)" 0.4 0.2 0.4 0.6 0.4 0.3 0.5 0.4 0.4 0.4 9.9 0.5 0.4 23.7 0.8 0.8 0.5 0.7 10.2 0.4 0.4 0.1 60.9 29.9 0.9 0.4 0.4 0.4 0.5 17.7 0.1 0.6 0.8 0.4 0.5 0.7 0.4 0.5 0.4 0.4 0.6 52.2 0.4 0.4 1.2 15.9 0.6 0.4 0.4 0.7 0.4 0.4 0.4 0.4 0.3 1.0 0.7 0.3 0.0 2.4 0.2 0.3 0.1 0.4 0.6 0.1 0.1 0.4 0.0 0.0 0.0 0.0 4.9 0.1 0.0 1.8 0.0 0.0 0.1 0.1 0.2 0.0 0.7 0.9 0.4 0.0 2.6 0.1 0.2 0.1 0.1 0.4 0.0 0.3 0.0 0.0 2.0 0.3 0.3 0.0 0.1 0.6 1.5 0.2 31.1 0.1 0.6 0.0 0.3 9.5 0.0 0.4 0.4 0.0 0.0 0.9 0.5 0.1 0.1 0.1 0.0 0.3 0.2 0.0 3.1 1.5 0.4 0.0 1.0 0.0 0.0 0.0 0.7 1.3 0.0 0.1 0.2 0.7 0.2 0.1 0.3 0.4 0.0 0.0 0.0 0.3 1.0 2.4 0.2 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 3.0 1.4 0.9 0.6 0.7 0.2 0.6 40.8 0.0 0.0 21.0 3.9 0.4 3.3 14.5 1.7 0.2 5.9 0.0 59.0 0.7 0.4 0.5 0.0 25.2 0.3 1.6 1.2 1.3 0.6 0.0 0.3 1.0 1.7 1.0 2.7 0.3 25.3 1.5 0.7 29.6 0.3 0.0 0.3 0.4 0.7 0.1 0.7 0.5 4.1 0.3 UNC5D "KIAA1777, Unc5h4" ENSG00000156687 "Unc-5 netrin receptor D" Q6UXZ4 8 35235457-35796550 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6" "Group enriched" "Detected in some" 7 "Bipolar cells: 12.4;Early spermatids: 21.6;Horizontal cells: 38.1" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.6;SH-SY5Y: 4.8;SuSa: 4.4;U-251 MG: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042940 Uncertain NA NA "HPA042940: AB_10959525" "unprognostic (7.88e-2)" "unprognostic (1.28e-1)" "unprognostic (1.41e-2)" "unprognostic (2.29e-1)" "unprognostic (7.60e-2)" "unprognostic (1.87e-1)" "unprognostic (8.47e-2)" "unprognostic (3.82e-2)" "unprognostic (2.04e-1)" "unprognostic (4.13e-2)" "unprognostic (1.99e-1)" "unprognostic (4.48e-8)" "unprognostic (1.34e-1)" "unprognostic (9.15e-2)" "unprognostic (4.28e-1)" 0.3 3.9 8.4 0.4 13.5 0.3 0.4 2.8 15.4 5.0 0.9 0.5 0.1 11.7 3.8 0.5 0.4 0.6 0.3 0.3 3.6 9.4 5.0 0.3 0.5 0.3 1.3 8.1 0.3 0.6 0.4 14.2 0.3 4.7 10.6 1.5 3.3 0.4 0.8 0.3 0.4 3.9 2.4 0.8 0.4 0.6 1.6 0.8 0.0 2.1 0.0 0.3 0.3 0.4 0.0 0.0 0.8 0.2 0.3 0.1 0.0 0.0 1.4 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.6 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.1 0.9 0.3 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 8.4 13.5 2.8 15.4 3.6 9.4 1.3 8.1 4.7 0.8 0.0 0.0 0.0 0.0 0.0 12.4 0.6 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 38.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 2.7 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 42.7;Early spermatids: 28.8;Horizontal cells: 38.1;Late spermatids: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 8.5;SCLC-21H: 6.3;SH-SY5Y: 4.0;U-937: 3.0" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071881: AB_2732189" "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.1 0.0 0.0 8.5 0.0 0.0 0.2 0.2 6.3 4.0 0.1 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 0.0 0.0 0.0 0.2 0.2 42.7 2.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.3 28.8 0.3 0.4 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 38.1 0.0 0.0 0.6 12.6 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.4 1.4 4.7 0.0 1.0 3.3 1.6 0.3 0.6 0.0 0.1 0.3 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771993-209999300 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 10.0;brain: 27.2;pituitary gland: 20.1;testis: 6.9" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 111.2;Cone photoreceptor cells: 62.8;Horizontal cells: 49.3;Muller glia cells: 36.9;Rod photoreceptor cells: 74.9" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 5.2;SCLC-21H: 8.5;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" NA NA "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.9 10.0 10.2 0.9 19.3 0.9 0.9 27.2 23.4 1.0 1.0 2.1 0.0 1.0 1.3 1.8 0.9 1.7 3.6 1.0 8.0 7.4 1.0 0.9 1.1 0.8 5.4 13.5 2.1 3.2 1.4 20.1 0.9 14.5 3.2 1.1 3.0 0.9 1.5 0.8 1.2 1.1 1.3 2.2 1.1 1.9 6.9 4.9 0.0 1.5 0.0 0.8 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 8.5 4.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 19.3 27.2 20.2 8.0 7.4 5.4 13.5 14.5 4.9 0.0 0.6 0.0 0.2 0.7 111.2 1.7 0.0 1.4 1.2 0.0 62.8 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.1 0.0 0.1 49.3 0.0 0.0 0.0 7.6 0.9 0.0 0.0 0.0 0.0 36.9 0.2 0.0 1.8 0.0 74.9 0.0 0.0 2.1 2.9 0.1 0.0 0.0 0.0 0.3 UNC93A "dJ366N23.1, dJ366N23.2" ENSG00000112494 "Unc-93 homolog A" Q86WB7 6 167271169-167316019 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.8;liver: 17.4;skin 1: 18.8" "Cell type enhanced" "Detected in some" 25 "Collecting duct cells: 10.4;Hepatocytes: 4.9;Mucus-secreting cells: 2.4;Undifferentiated cells: 1.7" "Cancer enhanced" "Detected in many" "liver cancer: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "CACO-2: 10.4;Hep G2: 4.3;OE19: 10.6;SCLC-21H: 4.6" "Not detected" "Not detected" HPA035729 Uncertain NA NA "HPA035729: AB_10696508" "unprognostic (2.49e-1)" "unprognostic (2.67e-1)" "unprognostic (2.32e-1)" "unprognostic (1.28e-1)" "unprognostic (2.28e-1)" "unprognostic (2.26e-1)" "unprognostic (2.32e-1)" "unprognostic (2.10e-1)" "unprognostic (3.32e-3)" "unprognostic (2.99e-2)" "unprognostic (5.97e-3)" "unprognostic (1.85e-1)" "unprognostic (4.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.6 0.1 0.1 0.5 1.4 0.1 0.1 9.2 0.1 0.5 5.9 1.0 1.6 0.1 0.1 0.0 2.5 17.4 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.5 0.1 0.1 18.8 9.8 0.1 0.1 0.1 0.1 0.1 0.1 1.6 0.1 3.9 2.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 UNC93B1 UNC93 ENSG00000110057 "Unc-93 homolog B1, TLR signaling regulator" Q9H1C4 11 67991104-68004982 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 28.6" "Cell type enhanced" "Detected in many" 6 "Hofbauer cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "CAPAN-2: 31.3;RPMI-8226: 87.0;SK-BR-3: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038716, HPA038717, HPA042803" Approved Approved Nucleoplasm No No Nucleoplasm "HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176" "unprognostic (3.32e-2)" "unprognostic (1.75e-1)" "unprognostic (3.32e-2)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (7.66e-2)" "unprognostic (1.29e-2)" "unprognostic (9.36e-2)" "unprognostic (5.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.76e-2)" "prognostic unfavorable (7.38e-4)" "unprognostic (1.73e-2)" "unprognostic (1.85e-2)" "unprognostic (7.05e-3)" "unprognostic (5.23e-3)" 8.0 2.7 5.7 9.7 7.4 9.2 5.0 6.2 7.0 4.7 11.9 5.3 6.9 11.8 2.3 5.7 5.5 4.1 13.9 4.6 8.7 6.0 5.9 7.1 13.4 20.8 3.6 0.4 3.0 5.2 0.8 3.3 6.7 2.7 5.3 1.2 5.0 12.3 9.0 6.1 3.7 16.9 2.7 3.5 28.6 10.7 4.1 2.2 2.6 5.3 2.4 13.3 5.9 2.8 2.5 13.6 5.7 6.6 1.8 0.2 0.9 4.5 8.2 0.6 3.3 1.8 0.6 7.1 2.0 1.8 3.2 2.9 0.6 31.3 10.0 7.8 0.9 2.7 10.9 0.2 1.7 0.1 3.5 2.3 1.0 2.6 1.5 2.8 7.1 5.7 1.5 1.8 0.9 0.3 1.2 0.6 1.5 0.7 4.7 0.5 4.3 0.0 5.6 1.5 11.0 4.4 5.9 0.0 87.0 2.8 2.5 0.9 1.4 3.4 23.4 4.5 0.2 8.7 9.3 2.2 2.1 3.1 3.1 0.2 3.3 4.4 1.6 4.0 7.3 2.5 0.1 3.6 5.7 0.1 6.6 0.2 2.4 0.2 0.2 4.7 2.5 0.0 0.0 3.1 1.8 6.6 13.6 0.0 0.9 5.7 7.4 6.2 7.0 8.7 6.0 3.6 0.4 2.7 2.2 8.9 7.8 29.4 21.8 3.5 0.0 1.6 35.7 36.1 6.8 15.7 0.0 9.0 1.7 33.6 0.6 5.8 24.2 0.0 20.5 41.1 8.3 14.1 6.9 4.0 87.3 4.8 4.1 5.5 53.9 0.0 4.0 51.3 21.9 53.3 14.2 4.8 34.0 21.0 3.9 5.7 0.3 0.0 4.2 0.0 0.9 5.6 6.1 9.6 18.7 30.4 UNCX Uncx4.1 ENSG00000164853 "UNC homeobox" A6NJT0 7 1232907-1237318 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 20 "cerebellum: 44.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "NB-4: 47.2" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Region enriched" "Detected in many" 8 "cerebellum: 19.3" HPA063294 Approved Nucleoplasm NA NA Nucleoplasm "HPA063294: AB_2684977" "unprognostic (1.15e-1)" "unprognostic (9.71e-2)" 0.1 0.1 0.0 0.2 0.0 0.1 0.1 44.8 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 3.5 0.1 0.1 0.1 0.9 0.0 0.1 0.1 0.1 0.3 0.1 2.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 0.0 0.0 1.1 0.9 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPB1 BUP1 ENSG00000100024 "Beta-ureidopropionase 1" Q9UBR1 22 24494107-24528390 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 85.7" "Group enriched" "Detected in many" 7 "Hepatocytes: 119.4;monocytes: 36.9;Proximal tubular cells: 58.6" "Cancer enriched" "Detected in some" 8 "liver cancer: 25.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 27 "basophil: 11.4;neutrophil: 3.0" "Lineage enriched" "Detected in single" 43 "granulocytes: 11.4" "Group enriched" "Detected in some" 5 "CACO-2: 11.2;NB-4: 4.6;THP-1: 6.1;U-937: 6.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA000728, HPA076321" Enhanced NA NA 790000 "HPA000728: AB_1080471, HPA076321: " "unprognostic (7.27e-2)" "unprognostic (4.57e-3)" "unprognostic (2.27e-1)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (1.09e-4)" "prognostic favorable (2.30e-7)" "unprognostic (8.41e-2)" "unprognostic (1.06e-1)" "unprognostic (2.93e-1)" "unprognostic (4.89e-6)" "unprognostic (3.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (1.99e-1)" "unprognostic (4.63e-3)" 0.1 0.0 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.6 0.1 0.5 0.1 0.0 0.1 0.5 0.1 0.0 13.5 85.7 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.2 0.2 1.5 0.1 0.1 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 11.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.0 11.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 1.2 0.0 0.3 1.2 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.1 0.4 0.3 0.1 0.0 0.2 1.1 1.3 0.4 0.0 0.0 0.0 6.1 0.5 0.1 0.1 0.0 0.0 1.2 0.1 1.3 1.4 6.9 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 3.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.3 0.0 1.2 0.6 3.0 1.8 0.0 0.0 0.0 1.8 9.8 0.1 10.0 0.1 0.8 2.3 0.0 0.0 0.3 0.1 1.0 1.0 0.0 119.4 0.1 0.0 2.4 4.9 3.7 0.9 0.3 0.0 0.0 36.9 0.0 0.3 0.0 0.0 0.0 58.6 2.0 0.0 2.1 3.4 6.4 1.0 0.2 0.0 0.0 0.7 UPK1A TSPAN21 ENSG00000105668 "Uroplakin 1A" O00322 19 35666516-35678483 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 20.3;urinary bladder: 80.6" "Cell type enriched" "Detected in some" 4 "Urothelial cells: 28.0" "Cancer enriched" "Detected in many" 41 "urothelial cancer: 148.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "RT4: 29.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049879 Enhanced NA NA "HPA049879: AB_2680929" "unprognostic (3.29e-1)" "unprognostic (1.78e-1)" "unprognostic (1.19e-3)" "unprognostic (3.40e-4)" "unprognostic (4.05e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-2)" "unprognostic (3.11e-3)" "unprognostic (2.30e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (2.34e-1)" "unprognostic (2.48e-9)" "unprognostic (1.48e-1)" "unprognostic (4.14e-2)" "unprognostic (2.45e-2)" "unprognostic (1.72e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 6.0 0.1 0.1 0.1 0.0 0.4 0.1 12.8 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 20.3 0.0 0.1 0.9 0.1 0.1 6.7 0.1 4.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 1.1 1.0 80.6 8.6 1.7 0.5 1.8 0.5 1.6 2.0 0.8 0.2 0.9 0.1 0.2 0.3 0.1 0.3 0.2 0.0 0.1 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 2.8 0.7 0.0 0.3 0.2 0.1 0.1 0.4 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.4 6.1 0.2 0.0 0.1 0.0 0.0 29.6 0.1 0.3 0.4 0.3 0.5 0.2 0.2 0.3 0.9 0.0 1.2 0.1 0.2 0.1 0.4 0.0 0.1 0.1 0.2 1.1 0.5 0.2 0.3 0.4 0.5 0.6 2.0 0.6 0.2 1.7 0.1 0.6 1.8 1.6 0.1 0.5 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.4 0.1 0.0 0.0 28.0 UPK1B "TSPAN20, UPK1" ENSG00000114638 "Uroplakin 1B" O75841 3 119173517-119205153 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.4;urinary bladder: 41.9" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 35.7;Club cells: 9.1;Ductal cells: 10.8;Proximal tubular cells: 11.2;Urothelial cells: 19.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 147.3" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CACO-2: 15.4;RPTEC TERT1: 14.4;RT4: 55.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA031799, HPA031800" Enhanced NA NA "HPA031799: AB_10671579, HPA031800: AB_10671580" "unprognostic (1.20e-2)" "unprognostic (7.18e-2)" "prognostic favorable (3.87e-5)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (8.77e-3)" "unprognostic (3.67e-1)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.68e-1)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" 6.1 0.2 0.2 0.2 1.2 0.0 0.2 0.2 0.3 3.6 0.7 0.0 0.0 0.0 1.5 0.3 2.4 5.1 12.9 1.8 0.2 0.2 6.6 0.6 1.4 0.0 0.2 0.1 0.8 11.6 0.0 0.4 56.4 1.1 15.4 0.0 0.0 0.4 0.0 0.2 0.6 0.2 4.3 1.8 0.2 22.9 0.7 0.0 1.4 0.2 1.4 12.9 41.9 1.1 0.7 1.1 2.5 0.5 0.6 1.9 0.5 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.4 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.4 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.5 0.3 0.3 0.2 0.4 0.2 0.3 0.5 0.7 1.9 0.3 1.8 0.6 0.4 1.1 0.2 0.5 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.1 1.1 0.0 0.0 1.0 0.0 0.3 0.2 0.4 0.1 35.7 0.0 9.1 0.0 0.0 1.0 0.0 10.8 3.0 0.1 0.0 0.0 0.6 7.7 0.2 0.8 2.3 0.0 0.5 1.6 0.0 0.0 0.0 1.0 0.0 1.4 1.7 1.8 0.0 0.2 0.6 0.0 0.0 11.2 0.6 0.0 0.2 0.2 0.2 0.0 1.3 0.0 0.0 19.0 UPK2 "MGC138598, UP2, UPII" ENSG00000110375 "Uroplakin 2" O00526 11 118925164-118958559 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "prostate: 39.0;urinary bladder: 52.4;vagina: 25.9" "Group enriched" "Detected in some" 6 "Club cells: 3.4;Cytotrophoblasts: 5.1;Syncytiotrophoblasts: 8.0;Urothelial cells: 6.9" "Cancer enriched" "Detected in many" 72 "urothelial cancer: 339.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.0;T-reg: 1.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "MCF7: 47.0;RT4: 53.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043312, HPA061106" Enhanced NA NA "HPA043312: AB_2678420, HPA061106: AB_2684429" "unprognostic (6.04e-3)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "unprognostic (3.97e-2)" "unprognostic (1.21e-1)" "unprognostic (4.12e-4)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (3.13e-3)" "unprognostic (1.37e-1)" "unprognostic (1.05e-3)" "unprognostic (6.35e-3)" "prognostic unfavorable (7.30e-7)" "unprognostic (6.69e-2)" "unprognostic (7.45e-2)" "unprognostic (2.98e-1)" "unprognostic (1.00e-1)" 1.0 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.1 0.0 0.0 0.2 0.2 0.8 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.0 3.8 0.0 39.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 6.8 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.2 1.3 52.4 25.9 0.7 0.6 0.0 0.1 2.0 1.9 0.2 1.2 0.1 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.4 0.0 2.0 0.0 0.6 1.9 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.4 0.0 0.0 5.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.4 0.2 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 8.0 0.0 0.0 6.9 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284982-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5" "Cell type enhanced" "Detected in some" 20 "Basal glandular cells: 20.5;Glandular cells: 61.9;monocytes: 13.6;Urothelial cells: 21.4" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Group enriched" "Detected in many" 11 "classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0" "Group enriched" "Detected in many" 16 "dendritic cells: 33.7;monocytes: 11.3" "Group enriched" "Detected in some" 5 "Hep G2: 18.7;RT4: 31.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" NA NA "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.3 1.6 0.4 0.9 0.3 0.2 0.5 0.4 0.7 0.0 0.0 0.0 0.2 2.3 0.2 0.2 0.6 0.2 0.3 0.3 0.2 0.2 0.2 1.0 0.4 0.1 0.2 0.2 6.4 0.5 0.0 0.7 17.9 0.5 0.6 12.9 1.8 24.5 0.2 1.8 13.0 0.3 0.7 0.2 0.2 0.0 1.3 4.6 1.7 0.6 45.5 2.7 0.3 33.7 1.4 11.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 2.9 0.0 0.0 0.0 0.1 0.0 31.3 0.1 0.0 0.1 0.5 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 9.6 0.0 0.3 0.0 0.0 33.7 0.2 0.0 0.0 1.4 0.1 11.3 13.0 0.0 2.8 0.3 0.4 0.2 0.5 0.3 0.3 0.4 0.1 0.7 0.0 0.0 0.0 0.5 20.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 61.9 0.0 0.0 1.6 0.0 0.0 0.0 6.4 0.9 0.3 6.3 0.0 13.6 3.1 0.7 0.0 7.0 0.0 0.0 0.0 0.0 0.9 0.0 0.3 0.4 0.1 0.0 2.8 21.4 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510428-76516521 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 1: 113.2" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Region enriched" "Detected in single" 58 "pons and medulla: 5.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2" HPA010506 Approved NA NA "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 28.5 0.3 0.0 7.1 0.0 0.4 0.3 0.0 0.3 1.5 6.9 0.1 0.0 0.3 0.8 7.9 40.2 2.8 3.0 9.4 0.0 0.0 0.3 0.4 34.1 0.4 0.0 0.0 13.2 0.3 0.3 0.1 0.3 5.8 1.4 0.3 0.8 1.4 0.3 0.4 1.1 0.5 1.5 0.2 0.4 0.6 6.1 0.0 0.2 0.3 6.1 25.0 20.5 2.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.6 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.5 0.0 0.2 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.2 2.3 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 113.2 3.5 0.0 0.2 1.4 0.0 0.3 2.5 4.0 9.1 3.5 3.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 1.6 0.0 0.6 0.0 0.0 11.2 0.9 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 2.5 0.1 0.0 0.1 2.5 UPK3BL1 "UPK3BL, UPLP" ENSG00000267368 "Uroplakin 3B like 1" "B0FP48, E5RIL1" 7 102637025-102642791 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.1;lymphoid tissue: 34.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.7;Ciliated cells: 9.4;Club cells: 5.7;granulocytes: 7.0;monocytes: 3.6;Pancreatic endocrine cells: 2.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 48.8" HPA011403 Supported NA NA "HPA011403: AB_2668503" "unprognostic (4.63e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (6.19e-3)" "unprognostic (3.35e-1)" "unprognostic (2.88e-1)" "unprognostic (9.39e-3)" "unprognostic (4.00e-1)" "unprognostic (8.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.93e-2)" 3.0 2.2 2.1 3.3 2.7 7.9 3.0 4.5 2.1 6.5 2.9 3.6 3.4 1.7 45.1 3.7 1.0 2.2 3.0 1.9 4.6 4.0 3.4 7.1 2.1 3.7 3.8 3.4 4.3 1.7 5.9 1.5 7.7 23.7 6.5 5.1 4.6 0.9 2.0 8.8 3.0 1.3 13.1 34.6 11.8 15.1 5.3 6.8 13.6 5.9 7.1 9.6 4.7 7.4 5.9 3.8 1.6 1.6 0.2 5.2 0.0 0.8 0.9 2.2 0.9 4.0 1.1 1.4 0.9 1.2 48.8 1.1 5.4 0.6 6.6 8.6 1.1 2.4 1.7 0.5 1.9 2.0 3.2 7.1 0.0 1.3 6.7 6.9 0.2 2.8 4.1 2.5 16.9 3.0 16.2 1.7 6.4 1.8 3.0 2.1 6.1 7.0 5.9 2.6 6.0 10.1 2.6 2.4 3.2 0.8 3.0 2.3 14.5 6.2 5.1 2.8 4.3 2.0 0.7 3.1 4.5 2.4 13.6 5.9 8.5 9.6 5.2 4.4 5.3 5.0 4.7 6.8 4.9 6.3 4.8 7.1 7.1 1.7 6.8 7.9 4.7 8.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.7 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.6 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 UPK3BL2 ENSG00000284981 "Uroplakin 3B like 2" E5RIL1 7 102538417-102543849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.2;lymphoid tissue: 12.8" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA011403 Approved NA NA "HPA011403: AB_2668503" 0.8 0.0 1.5 6.5 1.0 0.3 0.0 0.6 1.0 0.7 0.4 12.2 0.9 0.6 0.0 0.0 0.1 0.8 3.4 0.4 0.7 0.2 0.3 1.2 0.8 1.5 3.6 2.7 2.8 0.9 0.1 3.2 0.4 0.0 4.5 12.8 2.5 5.0 8.4 6.1 3.7 1.0 7.9 1.3 5.8 9.0 3.9 6.8 1.9 0.6 13.4 10.7 13.4 13.5 16.7 3.1 9.8 6.6 5.3 4.0 1.4 18.9 0.4 5.0 3.7 7.3 11.0 2.3 14.8 5.3 7.8 5.7 7.3 6.5 7.4 3.9 3.6 3.1 6.1 8.6 6.1 15.3 4.9 23.9 6.4 9.6 1.5 2.8 1.8 5.0 2.1 9.6 7.6 22.9 5.0 5.5 6.0 2.9 5.4 7.0 3.1 5.4 2.7 7.2 3.2 4.6 4.3 15.3 4.8 4.1 2.0 10.3 5.2 0.2 3.7 2.6 7.9 1.9 2.9 4.7 3.1 2.5 1.5 5.0 5.6 2.8 6.1 1.0 2.0 8.4 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Group enriched" "Detected in some" 4 "Distal tubular cells: 11.6;Proximal tubular cells: 23.3" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.9 0.0 0.7 0.8 0.9 0.0 0.0 0.0 0.1 1.1 0.6 1.2 1.4 0.3 0.0 0.3 0.6 0.6 0.4 0.4 0.5 0.0 0.4 0.8 0.1 0.0 0.2 0.2 0.0 0.0 1.2 0.1 0.4 0.3 1.2 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412141 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.2" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 51.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 12.6 19.2 13.7 10.6 24.5 2.5 10.1 19.6 23.9 10.9 13.3 15.7 12.1 13.0 14.2 14.2 10.5 11.7 8.4 34.3 13.5 15.9 20.0 17.2 8.7 10.9 16.6 18.2 11.9 10.8 19.8 17.0 10.1 20.1 11.9 17.5 15.8 12.1 12.9 70.2 9.2 11.3 15.5 15.5 11.2 12.2 13.2 13.4 8.9 14.2 17.1 13.8 11.0 9.9 13.5 13.5 16.3 11.9 19.7 15.2 9.6 6.9 10.1 11.4 10.5 11.6 12.7 1.6 13.2 14.4 23.7 16.5 32.7 13.8 22.3 25.1 8.3 20.1 18.5 20.1 22.9 18.1 6.6 7.9 29.9 13.5 26.2 7.4 17.9 8.9 12.5 23.5 12.7 15.9 17.6 8.0 18.1 12.8 7.4 16.5 9.1 20.4 6.4 9.6 13.8 20.8 11.2 17.9 12.2 21.9 7.9 16.1 10.8 11.3 54.1 11.7 10.1 8.0 11.4 7.5 16.2 10.3 8.5 12.0 11.4 12.3 9.2 29.0 10.4 13.0 16.3 7.7 11.0 12.7 11.9 15.2 10.3 12.1 12.5 13.5 13.5 14.6 13.2 0.3 19.7 7.7 11.5 11.2 9.6 13.7 24.5 19.6 23.9 13.5 15.9 16.6 18.2 20.1 13.4 0.0 5.6 3.7 8.0 5.7 19.3 39.9 7.6 13.4 5.7 15.7 7.9 18.9 51.4 16.0 8.7 7.0 10.5 0.0 11.2 11.9 8.0 6.7 8.1 12.5 10.1 17.5 11.5 4.3 5.9 7.9 9.8 7.0 13.5 17.2 8.9 14.0 16.8 3.5 11.3 14.0 21.4 6.5 8.2 18.4 16.4 4.5 14.5 7.0 12.8 8.8 UQCR10 "HSPC051, QCR9, UCCR7.2, UCRC" ENSG00000184076 "Ubiquinol-cytochrome c reductase, complex III subunit X" Q9UDW1 22 29767369-29770413 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 144.4;skeletal muscle: 144.7" "Cell type enhanced" "Detected in all" 9 "Cardiomyocytes: 4128.5;Distal tubular cells: 1946.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (1.09e-1)" "unprognostic (2.96e-3)" "unprognostic (1.56e-1)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (2.73e-2)" "unprognostic (1.25e-1)" "unprognostic (1.75e-3)" "unprognostic (3.05e-2)" "unprognostic (9.24e-3)" "unprognostic (2.94e-1)" "unprognostic (1.12e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.34e-1)" "unprognostic (2.00e-1)" "unprognostic (1.73e-1)" "unprognostic (1.80e-3)" 23.0 37.0 42.5 18.2 42.9 20.1 23.8 25.2 48.5 17.2 35.5 14.7 24.3 35.9 12.6 24.9 23.7 23.7 19.9 97.9 38.3 30.2 38.3 43.6 22.6 25.2 39.8 25.8 16.1 39.4 19.3 22.5 17.5 25.4 22.2 29.1 21.6 25.2 25.6 144.7 14.7 33.1 17.6 24.2 19.8 29.9 28.5 20.6 20.9 23.6 62.9 20.8 22.8 15.0 132.9 126.0 141.5 118.4 73.9 123.2 144.4 30.9 32.5 31.4 24.4 29.5 19.5 17.5 17.2 21.6 30.9 32.4 41.9 17.9 23.4 18.8 27.3 22.7 31.0 37.2 40.4 19.3 29.2 78.3 29.2 39.5 91.6 21.2 37.5 32.0 32.5 24.8 32.2 21.8 26.0 22.9 25.3 19.9 31.7 30.3 78.1 28.1 44.1 18.0 74.7 43.1 30.7 25.2 42.4 53.2 59.2 34.7 17.5 20.1 43.1 27.1 20.8 30.6 36.0 18.0 32.0 38.7 19.6 25.4 23.9 24.1 31.1 28.8 29.1 20.1 112.9 118.4 141.5 71.0 115.5 77.6 132.9 98.0 90.9 123.1 107.0 106.8 91.6 82.2 73.9 102.8 126.0 123.2 144.4 42.5 42.9 25.2 48.5 38.3 30.2 39.8 25.8 25.4 20.6 229.3 250.2 242.5 180.2 161.5 158.1 4128.5 537.6 353.3 215.0 594.9 72.6 608.3 1946.4 397.6 222.6 157.6 904.3 373.8 481.7 445.1 188.1 297.9 145.6 1099.7 633.2 108.1 365.2 164.5 360.2 448.1 217.1 268.7 295.3 421.2 634.0 208.4 426.1 624.3 194.1 1057.8 204.8 207.0 152.7 328.9 185.1 246.2 486.6 198.4 623.5 323.4 UQCR11 "QCR10, UQCR" ENSG00000127540 "Ubiquinol-cytochrome c reductase, complex III subunit XI" O14957 19 1597172-1605490 "Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 125.4;skeletal muscle: 149.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.90e-1)" "unprognostic (6.67e-3)" "unprognostic (1.78e-1)" "prognostic favorable (1.23e-4)" "unprognostic (5.62e-2)" "unprognostic (1.32e-1)" "unprognostic (2.06e-1)" "unprognostic (5.42e-3)" "unprognostic (9.10e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.86e-4)" "unprognostic (1.03e-1)" "prognostic favorable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (1.43e-1)" "unprognostic (2.22e-2)" "unprognostic (1.06e-2)" 24.9 23.6 35.1 15.8 29.5 20.3 18.5 13.2 25.1 12.5 28.5 13.1 20.3 34.4 12.4 18.2 22.9 14.1 21.7 106.4 26.9 21.1 24.4 46.1 11.9 17.2 31.0 19.2 9.8 30.0 8.8 16.7 15.4 18.5 18.3 13.3 14.5 29.6 23.6 149.2 11.5 27.5 16.8 21.5 18.3 27.6 8.8 15.1 10.9 22.0 47.1 12.9 15.8 14.1 63.8 78.6 88.2 75.6 43.8 67.9 125.4 22.5 21.2 10.5 23.8 17.5 12.0 25.5 16.3 12.8 16.0 14.3 34.2 15.2 13.3 16.9 11.5 4.1 14.4 15.4 17.3 7.5 21.8 47.1 11.7 26.2 32.1 18.2 19.3 18.3 18.5 17.9 10.1 11.8 8.3 14.5 19.5 25.8 24.2 10.1 31.0 19.2 23.4 27.4 18.2 51.0 11.6 11.0 44.4 20.9 45.5 20.8 22.3 11.2 27.1 28.7 8.2 19.2 23.1 20.2 15.6 10.1 41.1 18.9 34.2 28.1 16.3 27.4 20.2 21.1 83.7 75.6 87.0 52.6 61.8 52.9 63.8 64.3 58.2 63.1 54.1 61.7 59.3 88.2 43.8 57.4 78.6 67.9 125.4 35.1 29.5 13.2 25.1 26.9 21.1 31.0 19.2 18.5 15.1 250.1 365.3 312.4 147.9 0.0 116.7 1545.7 580.9 491.2 293.5 601.9 37.3 421.8 1518.6 593.8 133.9 281.1 1267.5 350.4 708.1 511.1 324.6 312.1 183.7 1781.4 835.4 84.2 436.5 444.4 741.4 307.4 234.1 456.9 0.0 926.1 940.5 193.7 712.8 958.2 244.0 853.5 119.2 219.9 179.7 157.0 128.1 0.0 428.8 332.1 797.4 248.2 UQCRB "QCR7, QP-C, UQBP, UQCR6" ENSG00000156467 "Ubiquinol-cytochrome c reductase binding protein" P14927 8 96225920-96235634 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 234.1" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 4932.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA043060 Approved NA NA 380000 "HPA043060: AB_10806376" "unprognostic (5.48e-2)" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (9.47e-3)" "unprognostic (2.15e-1)" "unprognostic (8.41e-2)" "unprognostic (2.79e-1)" "unprognostic (9.20e-2)" "unprognostic (3.98e-1)" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.92e-1)" "prognostic favorable (2.90e-4)" "unprognostic (1.01e-1)" "unprognostic (7.54e-2)" "unprognostic (1.07e-1)" "unprognostic (5.66e-3)" 37.8 51.7 52.1 27.8 54.3 31.3 27.9 25.5 44.0 31.1 37.7 17.9 28.5 35.2 30.7 41.3 38.6 25.5 27.9 156.1 42.3 39.6 57.3 45.1 22.0 28.1 52.2 35.6 48.7 35.2 25.5 45.5 20.3 41.9 35.6 33.8 19.4 42.0 31.7 234.1 16.8 31.7 57.8 44.3 26.9 30.6 15.5 30.8 22.9 33.0 90.0 31.9 51.2 33.8 50.3 38.5 31.9 65.4 30.3 64.4 46.4 52.7 25.3 32.8 20.9 47.5 48.6 21.4 42.7 32.6 23.7 25.5 22.9 25.5 23.0 64.9 34.2 24.6 26.0 29.9 39.8 31.8 34.6 23.8 75.7 48.6 37.9 34.9 41.9 32.4 56.7 35.7 26.7 42.6 77.4 34.3 38.8 39.8 40.1 36.3 34.2 66.6 64.2 19.3 109.5 38.9 29.9 21.7 42.5 46.4 42.4 30.2 30.1 25.8 9.9 64.7 45.8 40.8 70.3 41.7 15.6 23.7 27.3 45.5 34.7 26.0 53.3 25.6 56.6 16.9 26.6 34.8 31.9 32.2 56.4 39.5 50.3 52.0 40.2 38.5 38.7 64.4 58.8 24.7 30.3 65.4 33.7 56.8 46.4 52.1 54.3 25.5 44.0 42.3 39.6 52.2 35.6 41.9 30.8 413.9 522.6 695.6 387.7 268.5 266.1 4932.0 861.1 515.3 513.0 315.8 110.0 494.8 2105.5 666.2 870.6 469.6 871.3 210.2 806.3 418.8 464.2 366.1 567.6 867.4 984.6 119.2 702.2 585.0 1469.2 177.7 799.9 759.0 777.7 959.4 915.4 233.9 819.0 855.1 677.5 1659.4 303.1 530.3 608.7 264.6 241.0 254.4 500.5 684.9 974.2 501.5 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 172.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 576.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria NA NA 1300000 Mitochondria "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favorable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 18.1 13.7 11.1 9.8 12.5 9.4 11.8 12.5 20.5 11.0 33.7 6.9 10.4 20.0 9.1 9.7 15.8 12.4 10.8 66.7 10.8 11.2 23.0 30.5 7.7 9.3 13.3 13.5 6.3 14.4 20.4 7.8 11.5 13.3 12.5 12.3 7.8 19.5 21.9 172.7 14.0 20.9 12.0 8.7 8.4 23.0 18.4 7.4 9.4 9.1 39.9 9.8 10.3 9.1 23.3 52.7 28.1 57.8 15.1 22.0 74.3 10.1 16.5 6.0 3.6 8.8 8.1 27.1 18.8 15.2 15.6 14.2 25.6 3.0 26.3 11.9 8.4 18.3 9.8 7.5 21.8 2.9 15.6 35.9 27.0 14.3 27.7 17.5 16.9 11.7 11.1 24.8 10.6 17.5 7.4 15.5 17.4 14.5 1.8 9.4 17.7 12.2 19.3 15.0 15.0 65.5 8.3 16.0 21.5 16.1 11.1 6.4 11.4 25.4 3.1 15.0 1.7 6.5 2.7 15.5 4.3 16.5 13.6 19.3 16.0 14.1 15.2 9.6 19.5 13.9 17.6 57.8 28.1 18.9 56.9 17.9 23.3 18.9 19.0 52.7 18.6 17.1 16.4 14.1 15.1 48.5 21.0 22.0 74.3 11.1 12.5 12.5 20.5 10.8 11.2 13.3 13.5 13.3 7.4 53.6 50.3 63.6 133.4 104.5 38.0 576.9 142.7 78.9 46.6 115.1 27.5 292.1 310.0 150.4 116.4 44.8 496.0 46.7 145.4 266.4 68.1 72.4 80.8 173.2 214.8 38.1 138.8 44.2 110.4 218.8 54.1 87.6 113.1 113.6 228.6 55.4 138.8 252.6 66.4 309.3 39.8 58.2 92.9 102.7 76.4 92.1 281.6 56.5 307.7 117.4 UQCRFS1 "RIP1, RIS1, RISP, UQCR5" ENSG00000169021 "Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1" P47985 19 29205321-29213541 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.3" "Cell type enhanced" "Detected in all" 6 "Cardiomyocytes: 1206.2;Distal tubular cells: 877.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041863, HPA050339" Enhanced Approved Mitochondria NA NA Mitochondria "HPA041863: AB_10794638, HPA050339: AB_2681095" "unprognostic (4.00e-2)" "unprognostic (2.23e-3)" "prognostic favorable (3.29e-4)" "unprognostic (7.91e-3)" "unprognostic (3.93e-2)" "unprognostic (8.68e-2)" "unprognostic (1.84e-1)" "unprognostic (7.53e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.73e-2)" "unprognostic (1.66e-1)" "prognostic favorable (3.92e-9)" "unprognostic (6.11e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (1.92e-2)" 15.2 27.1 20.1 10.8 18.3 25.4 28.2 18.3 33.4 11.9 27.3 9.1 9.8 24.3 10.5 14.3 16.9 11.9 14.2 95.3 19.4 14.8 34.9 33.8 12.0 21.2 18.3 13.1 9.1 26.4 15.9 10.6 10.8 17.6 11.8 30.3 11.5 17.0 13.9 112.3 12.9 27.0 19.6 11.5 11.3 18.8 16.6 6.5 17.7 12.9 55.0 14.5 13.7 10.0 18.5 35.6 14.9 29.9 15.0 22.1 45.1 21.8 37.0 13.8 12.4 22.6 17.3 15.3 17.1 17.9 23.7 26.3 22.4 13.6 19.9 18.1 19.3 19.4 23.3 30.1 20.4 28.7 13.5 30.1 28.2 14.6 20.3 19.2 26.8 24.8 20.8 22.1 16.2 24.7 14.0 18.9 24.9 20.0 12.5 25.4 20.2 18.7 20.1 14.4 46.7 14.4 17.1 18.4 15.1 29.5 26.4 16.8 8.2 15.6 30.9 19.6 16.1 14.4 22.4 11.9 16.1 24.5 11.0 17.7 6.0 11.3 18.4 14.2 23.3 11.4 14.9 29.9 14.0 17.9 29.3 17.8 18.5 19.2 18.3 35.6 15.7 20.4 19.4 9.1 15.0 24.3 19.7 22.1 45.1 20.1 18.3 18.3 33.4 19.4 14.8 18.3 13.1 17.6 6.5 50.6 43.5 83.4 229.0 131.1 67.3 1206.2 170.7 48.2 45.5 108.2 15.7 255.3 877.0 208.2 176.6 94.4 303.4 70.0 204.7 204.0 122.3 162.8 88.9 250.4 234.4 49.3 153.7 93.9 135.6 102.8 85.4 113.1 156.9 178.5 238.4 96.8 186.1 196.4 76.7 532.4 58.7 97.0 163.6 296.9 77.1 140.0 319.3 108.3 325.0 307.9 UQCRHL ENSG00000233954 "Ubiquinol-cytochrome c reductase hinge protein like" A0A096LP55 1 15807169-15809348 "Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 418.0" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042574 Approved NA NA "HPA042574: AB_10960998" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (3.70e-2)" "unprognostic (3.19e-2)" "unprognostic (7.10e-2)" "unprognostic (4.01e-3)" "unprognostic (4.83e-1)" "unprognostic (6.76e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-1)" "unprognostic (9.67e-3)" "unprognostic (9.76e-3)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (9.70e-3)" "unprognostic (1.02e-1)" 0.0 0.1 0.2 2.2 0.4 0.4 0.0 0.0 0.2 0.4 1.6 0.1 0.4 0.4 0.1 0.0 0.4 0.2 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.5 0.0 4.4 2.1 0.4 0.1 0.6 0.0 0.5 0.2 0.0 0.0 1.5 1.2 5.5 1.0 1.3 1.0 0.5 0.7 0.5 3.2 3.3 0.8 0.9 1.2 0.6 0.3 0.1 0.3 0.7 2.5 1.2 0.9 0.5 0.9 1.3 0.6 0.5 0.7 2.2 0.4 1.1 1.9 0.5 0.7 0.9 1.5 0.6 1.0 0.4 0.3 1.2 0.0 1.6 1.1 2.4 0.2 1.9 0.4 1.5 1.6 0.4 1.3 1.1 0.7 1.1 0.0 1.7 2.7 1.8 1.0 2.1 0.8 0.7 0.9 2.7 0.5 2.0 1.1 1.2 0.8 2.3 0.9 1.3 1.0 2.1 0.9 3.6 1.0 0.9 0.8 0.7 0.6 1.1 0.6 0.8 0.6 1.5 1.0 1.0 5.5 1.3 0.7 1.2 0.5 0.5 0.0 0.6 37.2 21.8 0.0 3.8 418.0 28.1 0.0 1.2 8.7 5.9 20.5 19.9 1.0 2.4 12.3 7.7 0.0 0.6 18.0 10.8 25.1 2.3 21.7 18.5 1.6 7.0 17.8 58.5 2.7 10.3 0.8 0.0 0.0 14.1 3.0 0.7 0.0 11.7 6.1 7.3 6.5 1.0 3.2 14.6 0.0 19.7 4.5 17.7 24.4 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866560-132868031 "Disease related genes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 174.9" "Cell type enhanced" "Detected in all" 7 "Cardiomyocytes: 3256.1;Hepatocytes: 4283.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria NA NA Mitochondria "HPA046693: AB_10968453, HPA053323: AB_2682112" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 26.4 38.4 43.2 24.5 34.2 20.9 30.9 18.0 37.5 22.5 49.7 13.8 44.0 42.5 15.4 41.8 32.1 15.3 42.7 111.1 33.2 31.7 48.8 112.5 18.8 21.5 42.0 30.4 12.3 64.6 14.0 23.1 17.0 30.5 32.0 44.8 19.7 44.6 39.6 174.9 16.4 40.5 21.2 25.4 15.2 37.4 16.1 20.8 14.3 24.6 71.5 16.8 22.6 20.5 56.6 95.8 67.9 99.9 53.8 56.7 106.3 45.5 63.7 37.6 91.0 56.4 45.9 32.6 33.1 46.7 53.0 66.1 89.7 53.3 18.7 70.0 43.3 67.4 46.2 34.3 80.6 45.6 34.2 72.0 24.8 100.5 70.5 49.0 28.1 42.8 48.9 56.2 37.8 52.2 35.5 41.3 40.4 31.7 60.4 55.5 86.2 64.6 64.9 26.7 85.4 57.6 42.4 41.7 80.5 68.5 89.0 63.1 52.5 40.9 46.2 70.6 27.0 68.8 64.9 25.7 48.6 61.4 39.8 66.8 66.8 88.7 33.5 64.6 52.5 48.3 67.9 99.9 61.1 47.0 76.6 48.3 56.6 54.9 53.5 87.4 46.0 53.6 51.5 47.4 53.8 70.2 95.8 56.7 106.3 43.2 34.2 18.0 37.5 33.2 31.7 42.0 30.4 30.5 20.8 232.3 318.2 275.9 309.6 309.4 83.7 3256.1 1189.8 321.2 221.8 746.8 113.9 633.7 1536.9 621.2 357.1 305.7 1715.1 233.6 826.7 362.7 374.6 615.6 285.5 4283.6 668.1 68.3 527.7 324.1 428.0 786.4 261.5 374.1 678.2 396.8 861.3 232.4 704.3 1273.0 271.5 1804.0 170.0 181.1 456.8 296.8 123.0 449.3 470.6 222.6 1052.4 401.6 URAD PRHOXNB ENSG00000183463 "Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase" A6NGE7 13 27977714-27988654 "Enzymes, Predicted intracellular proteins" "Purine metabolism" "Decarboxylase, Lyase" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "breast: 8.8;intestine: 16.7" "Group enriched" "Detected in some" 5 "Enterocytes: 112.1;Mucus-secreting cells: 56.3;Paneth cells: 57.5" "Cancer enriched" "Detected in some" 15 "colorectal cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "BEWO: 6.9;CACO-2: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA038972 Uncertain NA NA "HPA038972: AB_10671869" "unprognostic (2.00e-1)" "unprognostic (1.05e-1)" "unprognostic (5.21e-2)" 2.8 0.0 0.1 1.5 0.1 0.0 8.8 0.6 0.1 0.1 16.7 0.1 0.1 8.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 16.0 0.2 0.1 0.1 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.3 0.0 112.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 56.3 0.0 0.0 57.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 UROC1 "FLJ31300, HMFN0320" ENSG00000159650 "Urocanate hydratase 1" Q96N76 3 126481281-126517773 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 50.7" "Cell type enriched" "Detected in some" 17 "Hepatocytes: 31.8" "Cancer enriched" "Detected in single" 100 "liver cancer: 12.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Lineage enhanced" "Detected in single" "granulocytes: 1.5" "Cell line enriched" "Detected in some" 8 "NB-4: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069863 Enhanced NA NA 510000 "HPA069863: AB_2732143" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-2)" "unprognostic (6.43e-2)" "unprognostic (1.43e-1)" "unprognostic (2.23e-3)" "unprognostic (2.95e-1)" "unprognostic (2.57e-2)" "unprognostic (7.71e-2)" "unprognostic (9.97e-2)" "unprognostic (3.04e-1)" "unprognostic (3.65e-5)" "unprognostic (3.97e-2)" "unprognostic (2.66e-1)" "unprognostic (5.52e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 31.8 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USH1C "AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C" ENSG00000006611 "USH1 protein network component harmonin" Q9Y6N9 11 17493895-17544416 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Hearing" "Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 26.0;intestine: 57.0;kidney: 22.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 240.3;Muller glia cells: 140.5;Paneth cells: 192.9;Proximal tubular cells: 119.4;Undifferentiated cells: 94.1" "Group enriched" "Detected in many" 7 "colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 31.4;HeLa: 11.2;OE19: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013690, HPA027398, HPA027492, HPA028033" Enhanced Enhanced Cytosol No NA Cytosol "CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782" "unprognostic (3.60e-2)" "unprognostic (6.19e-2)" "unprognostic (2.36e-1)" "unprognostic (3.83e-2)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (2.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.51e-2)" "unprognostic (9.65e-2)" "prognostic favorable (9.41e-4)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (1.62e-1)" "unprognostic (2.61e-1)" 0.1 0.1 1.6 4.3 7.1 0.0 0.0 0.8 3.3 0.1 23.8 6.2 0.0 40.5 0.0 6.3 0.0 1.3 26.0 0.3 5.0 2.3 22.1 0.4 0.0 0.0 4.8 1.9 0.3 2.1 0.0 5.2 0.0 3.5 0.1 20.7 1.8 0.0 0.1 0.0 0.0 57.0 0.9 10.2 0.0 11.5 0.2 3.6 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 31.4 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 7.1 0.8 2.3 5.0 2.3 4.8 1.9 3.5 3.6 0.0 0.0 0.8 0.0 0.0 0.7 0.6 48.4 0.0 1.2 5.2 2.0 0.0 18.3 18.8 1.0 0.0 240.3 0.0 25.0 0.0 0.0 0.0 4.6 0.0 0.0 1.6 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.4 140.5 34.3 192.9 0.0 119.4 3.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 94.1 0.0 USH1G "ANKS4A, FLJ33924, Sans" ENSG00000182040 "USH1 protein network component sans" Q495M9 17 74916084-74923256 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;epididymis: 11.4;esophagus: 11.8" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 7.8;Late spermatids: 12.2;Muller glia cells: 11.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.6" "Region enriched" "Detected in single" 20 "cerebellum: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 4.5;hTCEpi: 4.2;K-562: 3.1;MCF7: 4.8;OE19: 4.6;U-2 OS: 2.6" "Region enriched" "Detected in single" 12 "olfactory region: 12.1" "Low region specificity" "Detected in some" HPA024360 Uncertain NA NA "HPA024360: AB_1858660" "unprognostic (2.95e-1)" "unprognostic (6.17e-2)" "unprognostic (6.34e-4)" "unprognostic (2.92e-2)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (5.59e-4)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (8.64e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (3.10e-4)" "unprognostic (1.57e-1)" "unprognostic (8.48e-2)" "unprognostic (2.25e-1)" "unprognostic (3.35e-2)" 0.0 1.4 0.0 0.0 0.4 0.3 0.0 13.9 0.2 1.4 0.0 0.0 1.1 0.3 1.9 11.4 11.8 0.2 0.0 0.1 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.5 0.1 0.0 1.3 0.9 0.1 0.0 4.2 0.7 1.5 0.0 0.0 0.0 2.6 0.0 0.5 0.0 1.2 0.8 0.5 1.7 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.0 4.5 0.9 0.2 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.1 4.2 0.0 0.0 0.0 0.1 0.0 3.1 0.3 0.0 4.8 0.0 0.1 0.1 4.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.5 0.0 0.2 0.7 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 13.9 0.2 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.3 0.0 0.0 0.0 0.0 11.4 0.0 2.9 0.4 0.1 0.2 0.0 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 USH2A "RP39, USH2" ENSG00000042781 Usherin O75445 1 215622894-216423396 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "liver: 13.7;retina: 36.6" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 190.5;Rod photoreceptor cells: 174.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 1.6;SCLC-21H: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.97e-2)" "unprognostic (5.38e-2)" "unprognostic (9.19e-2)" "unprognostic (2.04e-1)" "unprognostic (6.62e-4)" "unprognostic (1.00e-1)" "unprognostic (3.68e-1)" "unprognostic (2.06e-1)" "unprognostic (6.07e-3)" "unprognostic (3.15e-2)" "unprognostic (3.28e-11)" "unprognostic (2.02e-2)" "unprognostic (1.91e-1)" "unprognostic (3.35e-2)" "unprognostic (9.09e-4)" 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.4 0.1 0.2 0.3 13.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 5.1 0.1 0.5 0.0 0.0 36.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.7 0.1 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.7 3.6 2.5 0.0 0.0 0.0 190.5 0.0 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.7 0.0 3.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.4 0.0 174.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 USO1 "p115, TAP, VDP" ENSG00000138768 "USO1 vesicle transport factor" O60763 4 75724593-75814286 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 94.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010108, HPA038282, HPA038283" Supported Supported "Nucleoli fibrillar center,Golgi apparatus" NA NA 43000 "Golgi apparatus" "Nucleoli fibrillar center" "CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929" "unprognostic (9.45e-3)" "unprognostic (3.12e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-3)" "unprognostic (6.29e-2)" "unprognostic (2.11e-1)" "unprognostic (2.03e-1)" "unprognostic (3.24e-2)" "unprognostic (9.18e-2)" "unprognostic (7.95e-3)" "unprognostic (4.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-2)" 18.1 22.1 9.9 14.9 11.5 4.1 14.6 13.8 13.2 18.1 16.5 9.1 24.9 13.0 18.6 25.3 20.1 15.8 12.1 35.4 10.9 10.4 18.7 38.8 13.6 10.8 11.5 11.7 23.2 23.6 16.8 32.1 23.1 16.1 19.4 14.0 11.4 20.8 22.2 94.4 13.2 17.3 19.1 14.7 13.5 14.8 15.3 10.6 15.0 20.7 27.0 14.1 23.8 18.8 10.1 14.6 16.8 21.2 19.1 20.7 11.2 14.2 11.3 16.0 21.3 39.2 52.0 14.6 33.6 41.3 18.5 22.6 11.2 22.2 18.8 20.8 30.8 16.0 16.6 23.8 20.9 28.0 20.7 9.3 13.0 10.1 23.6 30.8 17.1 15.0 29.4 25.8 19.3 37.9 36.0 27.7 13.2 22.4 21.7 27.4 9.4 16.8 9.0 21.8 30.3 6.8 11.2 15.2 15.1 27.7 16.6 12.8 12.4 12.3 26.2 21.2 24.9 19.2 14.0 21.2 17.0 10.6 30.8 12.6 20.5 11.0 9.2 25.3 10.3 20.1 16.8 11.4 10.1 15.2 16.5 20.7 9.3 12.9 14.5 14.6 10.1 13.6 13.1 7.0 19.1 21.2 11.8 12.9 11.2 9.9 11.5 13.8 13.2 10.9 10.4 11.5 11.7 16.1 10.6 56.6 72.1 28.3 45.2 33.8 31.7 119.3 33.1 77.6 72.8 24.4 41.2 41.6 29.9 33.3 7.0 31.7 32.6 0.0 42.1 41.2 49.4 55.7 47.4 50.5 38.8 25.4 38.5 33.2 29.4 7.8 72.8 35.6 27.0 52.3 62.2 30.7 47.4 31.6 64.3 39.6 50.3 38.8 44.0 44.7 71.1 35.3 75.7 29.2 38.5 52.8 USP1 ENSG00000162607 "Ubiquitin specific peptidase 1" O94782 1 62436297-62451804 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 70.6" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 281.4;Spermatogonia: 214.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028387, HPA028440" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA028387: AB_2672578, HPA028440: AB_10603000" "unprognostic (1.22e-1)" "unprognostic (5.36e-2)" "unprognostic (1.78e-3)" "unprognostic (4.05e-3)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (6.72e-2)" "unprognostic (1.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.33e-3)" "unprognostic (3.99e-2)" "unprognostic (2.76e-2)" "unprognostic (9.61e-3)" "unprognostic (5.70e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" 11.6 9.0 11.3 17.2 10.7 29.3 15.9 20.6 14.2 19.2 13.3 7.8 8.0 10.8 15.1 12.0 15.6 13.8 8.9 9.0 11.5 9.6 11.8 9.3 11.7 19.2 14.2 9.6 26.7 12.7 14.8 18.4 13.6 10.9 14.8 13.9 7.6 12.7 13.5 11.7 12.3 13.3 15.8 15.5 18.1 11.6 31.6 11.8 70.6 15.0 13.3 20.1 16.5 16.5 14.7 11.8 23.4 12.4 15.5 16.3 9.2 22.3 6.6 27.8 15.0 6.2 7.5 15.4 21.5 14.7 26.8 29.3 11.1 10.9 40.4 15.6 12.0 24.0 13.0 22.7 14.8 37.5 20.2 16.4 33.2 22.9 11.6 6.8 35.5 16.8 4.0 9.7 24.2 18.3 7.3 12.6 27.5 24.0 35.3 18.8 10.0 36.3 13.7 24.4 13.4 13.7 34.5 47.1 25.0 10.0 16.7 28.7 16.1 24.3 19.9 23.5 19.4 11.4 21.7 8.7 20.7 22.5 30.2 30.1 14.0 19.5 46.4 14.0 28.4 18.5 17.4 9.5 23.4 12.6 9.6 16.3 14.7 15.0 12.7 11.4 10.7 14.3 11.9 16.9 15.5 12.4 11.8 13.6 9.2 11.3 10.7 20.6 14.2 11.5 9.6 14.2 9.6 10.9 11.8 44.7 25.6 45.4 30.6 55.3 44.0 29.7 20.4 56.2 43.3 15.7 21.6 30.6 16.6 26.4 117.0 37.9 12.9 0.0 29.7 56.2 38.1 45.1 26.6 15.8 26.9 33.4 8.1 23.4 28.2 52.6 46.3 31.1 25.3 53.3 29.2 47.5 22.4 7.0 38.5 13.5 78.0 51.8 47.7 281.4 214.8 56.2 27.6 46.5 30.4 28.8 USP10 "KIAA0190, UBPO" ENSG00000103194 "Ubiquitin specific peptidase 10" Q14694 16 84699978-84779922 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 105.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 105.5" "Lineage enriched" "Detected in all" 6 "granulocytes: 105.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006731, HPA006749" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA006731: AB_1080495, HPA006749: AB_1080492" "unprognostic (4.14e-2)" "unprognostic (2.28e-1)" "unprognostic (2.36e-2)" "unprognostic (4.85e-2)" "unprognostic (6.93e-2)" "unprognostic (1.77e-3)" "unprognostic (1.03e-3)" "unprognostic (2.91e-3)" "unprognostic (1.75e-1)" "unprognostic (3.84e-2)" "unprognostic (2.56e-2)" "unprognostic (1.82e-3)" "prognostic favorable (1.00e-4)" "unprognostic (5.91e-2)" "unprognostic (4.57e-2)" "unprognostic (8.57e-2)" "unprognostic (1.38e-1)" 13.9 18.8 16.0 24.2 19.0 13.4 14.4 24.4 20.4 15.9 18.1 15.6 8.4 16.1 20.2 10.4 19.7 18.2 12.0 16.4 19.3 15.1 16.4 20.7 13.7 18.8 19.7 17.4 18.5 17.1 35.8 15.0 23.5 16.2 15.0 15.6 17.9 15.3 17.8 47.0 17.0 17.5 20.2 16.3 16.0 15.0 15.5 16.2 20.4 17.6 15.7 20.9 19.7 15.8 7.2 10.4 105.5 8.6 7.7 17.3 10.0 13.9 19.3 18.8 23.3 6.9 11.8 25.4 13.8 14.6 23.4 12.9 27.2 12.2 24.2 16.0 14.4 11.7 16.0 26.1 21.9 31.2 9.8 13.7 13.9 9.1 18.0 9.2 20.6 8.4 7.4 17.0 24.4 28.3 13.9 17.9 16.2 37.9 5.3 16.2 29.2 21.3 10.0 22.6 15.6 13.1 27.8 10.3 11.5 14.7 11.4 17.6 10.4 33.0 10.7 9.3 17.2 24.7 13.2 13.1 16.3 13.0 8.2 13.1 8.9 12.3 61.4 10.5 13.3 16.6 2.5 8.6 1.6 5.7 7.0 6.8 7.2 17.3 6.3 10.4 6.7 9.9 6.0 105.5 7.7 6.3 3.5 6.1 10.0 16.0 19.0 24.4 20.4 19.3 15.1 19.7 17.4 16.2 16.2 50.6 41.3 27.5 36.9 45.7 24.1 56.0 25.5 124.5 62.6 26.2 27.5 85.2 26.6 26.4 61.2 28.2 27.5 23.3 21.5 65.0 33.0 35.8 53.5 33.4 27.3 19.1 27.7 27.0 34.9 79.4 21.9 31.0 23.6 27.9 26.5 20.1 22.1 17.5 21.2 35.6 48.5 25.8 38.2 32.5 29.0 43.3 50.9 25.4 33.2 36.5 USP11 UHX1 ENSG00000102226 "Ubiquitin specific peptidase 11" P51784 X 47232690-47248328 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 74.0" "Cell type enhanced" "Detected in all" 6 "Bipolar cells: 178.6;Horizontal cells: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003103, HPA037536" Enhanced Supported Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA Nucleoplasm Cytosol "HPA003103: AB_10671088, HPA037536: AB_10672904" "unprognostic (1.60e-1)" "unprognostic (2.77e-3)" "unprognostic (5.84e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.08e-2)" "unprognostic (2.02e-1)" "unprognostic (6.11e-3)" "unprognostic (9.21e-2)" "unprognostic (3.18e-2)" "unprognostic (3.52e-1)" "unprognostic (3.29e-3)" "unprognostic (3.74e-2)" "prognostic favorable (4.13e-5)" "unprognostic (3.14e-2)" "unprognostic (9.23e-2)" "unprognostic (9.51e-2)" "unprognostic (7.11e-2)" 11.5 17.3 32.9 11.5 55.0 4.9 9.4 35.7 74.0 17.5 9.1 19.9 5.8 6.0 22.6 12.7 9.7 26.6 12.8 20.6 27.0 44.0 13.6 6.7 12.5 13.8 23.1 47.4 38.2 13.8 28.4 32.3 12.6 27.8 15.7 7.6 17.9 9.3 21.3 13.7 7.8 7.3 19.1 17.0 13.5 9.1 19.2 14.6 19.0 27.2 4.3 14.3 11.0 9.8 21.0 20.6 22.8 8.7 19.8 31.7 16.4 14.4 22.8 39.3 26.7 14.9 10.0 10.9 11.1 17.5 22.1 24.7 21.7 11.9 9.6 8.8 20.0 23.6 17.3 31.8 7.8 19.7 14.8 24.1 11.2 18.1 19.2 17.3 12.6 23.4 14.3 3.3 23.3 10.0 12.4 8.8 22.5 8.3 1.3 17.2 22.0 24.3 13.4 29.2 7.9 20.3 27.4 38.5 8.0 10.8 20.0 22.3 38.1 20.3 4.1 12.0 26.2 8.6 7.2 9.2 18.6 19.7 26.2 12.6 17.8 11.2 16.7 11.6 15.7 16.6 22.8 3.5 7.4 22.6 7.4 19.9 20.1 10.2 22.1 4.6 21.0 15.4 31.7 2.2 19.8 8.7 20.6 12.7 16.4 32.9 55.0 35.7 74.0 27.0 44.0 23.1 47.4 27.8 14.6 20.8 15.3 34.1 35.1 12.0 178.6 20.7 12.7 41.5 29.6 31.4 53.0 16.9 43.1 13.8 20.4 19.6 7.8 23.3 9.0 11.2 33.9 14.4 45.0 6.6 12.0 131.9 34.0 23.4 8.8 28.3 27.3 12.9 27.0 26.2 7.9 89.6 11.0 7.0 39.6 12.5 53.1 25.8 33.0 11.7 38.3 5.6 13.6 30.6 8.0 25.7 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179652755-179789401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 34.8;skeletal muscle: 90.3" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 182.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "MAIT T-cell: 15.4" "Lineage enriched" "Detected in many" 8 "T-cells: 15.4" "Cell line enhanced" "Detected in many" "HDLM-2: 36.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.06e-4)" 6.4 7.5 2.0 2.3 2.8 0.8 3.5 2.9 4.1 2.7 2.1 4.6 1.5 0.7 3.2 3.8 2.6 2.5 2.5 34.8 2.0 2.3 2.3 3.4 6.0 2.5 2.1 2.1 7.2 3.0 3.3 9.8 1.9 3.0 3.0 1.8 3.1 3.3 2.1 90.3 1.8 1.7 3.7 2.5 1.6 1.6 5.6 1.3 1.7 5.5 17.1 3.2 2.6 1.9 2.0 1.9 0.0 0.4 0.0 15.4 0.7 12.5 5.4 10.2 7.8 4.6 6.4 4.9 7.4 8.5 10.9 9.2 7.9 4.4 15.5 8.3 8.9 12.3 0.9 11.4 4.5 13.0 36.6 4.9 4.1 8.1 7.4 3.3 11.4 0.0 6.9 1.6 8.5 10.8 5.3 8.7 6.1 2.0 20.0 9.0 8.2 6.9 2.1 7.9 1.1 4.9 11.9 10.1 12.7 7.4 3.5 5.8 7.5 7.1 9.5 4.3 3.0 16.4 8.2 9.4 13.2 10.5 11.3 28.4 9.7 8.1 31.7 6.1 7.7 12.2 0.0 0.2 0.0 1.3 0.4 15.4 2.0 1.3 2.9 1.5 0.6 1.0 1.0 0.0 0.0 0.4 1.9 0.6 0.7 2.0 2.8 2.9 4.1 2.0 2.3 2.1 2.1 3.0 1.3 8.9 31.0 4.3 1.7 2.3 12.7 182.3 5.1 2.7 9.1 1.8 5.9 8.7 13.3 1.0 2.1 9.7 0.3 0.0 3.7 1.6 7.1 3.4 2.3 6.8 3.7 15.9 9.2 27.6 3.1 2.0 8.6 4.7 13.5 0.0 1.6 6.3 1.6 5.8 8.9 2.7 9.7 12.9 5.3 5.1 2.1 1.4 4.2 3.2 3.8 1.6 USP15 "KIAA0529, UNPH4" ENSG00000135655 "Ubiquitin specific peptidase 15" Q9Y4E8 12 62260338-62417431 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 68.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 68.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006237, HPA006428, HPA071014" Approved Supported "Plasma membrane,Cytosol" NA NA 280000 Cytosol "Plasma membrane" "HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333" "unprognostic (8.18e-2)" "unprognostic (3.22e-1)" "unprognostic (9.63e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (6.59e-2)" "unprognostic (7.70e-3)" "unprognostic (2.19e-1)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (9.28e-2)" "unprognostic (5.81e-3)" "unprognostic (1.11e-2)" "unprognostic (1.26e-1)" 23.1 16.8 11.5 22.5 11.9 88.9 17.8 21.1 15.7 14.5 14.5 5.2 11.9 11.4 12.7 12.4 16.1 14.1 11.2 15.2 9.6 6.2 13.8 20.4 23.8 26.2 11.6 9.4 22.5 15.8 18.9 22.5 31.0 14.9 12.4 13.8 7.6 16.2 10.7 28.5 23.0 19.7 16.3 16.2 35.6 14.3 20.0 11.0 33.1 14.1 15.4 18.9 18.4 17.9 5.7 6.0 68.5 14.2 3.3 12.1 4.8 9.4 8.9 8.9 7.8 14.1 16.5 16.0 15.4 13.7 13.6 12.2 8.9 9.5 10.1 8.8 13.2 5.8 10.4 11.9 13.4 16.0 11.2 7.3 13.9 7.6 6.8 13.6 22.0 33.8 12.0 14.0 16.1 14.3 12.8 16.2 10.3 45.0 19.6 12.6 10.5 13.1 11.1 13.0 8.6 13.2 8.4 9.4 16.3 12.7 10.9 11.3 5.4 17.8 11.3 8.7 9.7 15.0 13.2 19.3 10.6 10.6 16.5 9.5 9.3 10.4 11.6 12.2 17.9 12.0 27.2 14.2 13.8 3.4 7.3 3.5 5.7 4.6 3.2 4.9 4.7 5.9 3.5 68.5 3.3 5.8 6.0 12.1 4.8 11.5 11.9 21.1 15.7 9.6 6.2 11.6 9.4 14.9 11.0 35.7 31.3 91.0 32.3 52.2 54.5 62.7 17.8 42.8 59.1 22.7 104.1 25.1 10.0 31.3 139.8 44.6 32.3 93.5 36.2 36.1 49.5 31.6 85.6 42.0 41.1 39.7 40.4 22.1 108.1 130.5 57.2 94.6 50.6 36.1 22.9 24.4 41.2 45.6 27.6 19.4 146.4 38.8 56.5 62.9 41.8 67.2 55.0 65.0 23.3 54.9 USP17L1 USP17L1P ENSG00000230549 "Ubiquitin specific peptidase 17-like family member 1" Q7RTZ2 8 7332387-7333979 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "brain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.0;JURKAT: 1.4" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L11 ENSG00000233136 "Ubiquitin specific peptidase 17-like family member 11" C9JVI0 4 9215405-9217356 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.0;fallopian tube: 1.2;thyroid gland: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 1.0" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.5;JURKAT: 1.4;NTERA-2: 1.6" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L15 ENSG00000223569 "Ubiquitin specific peptidase 17-like family member 15" C9J2P7 4 9234385-9236334 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "brain: 1.0;epididymis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-87 MG: 1.2" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.2 1.0 0.0 0.3 0.0 0.1 0.3 0.4 0.0 0.4 0.2 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L17 ENSG00000249104 "Ubiquitin specific peptidase 17-like family member 17" D6RBQ6 4 9243879-9245830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "thyroid gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 1.2;NTERA-2: 1.4" HPA045642 Uncertain NA NA "HPA045642: AB_2679403" 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP17L23 ENSG00000250913 "Ubiquitin specific peptidase 17-like family member 23" D6RBM5 4 9272364-9272914 "Enzymes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "gallbladder: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HMC-1: 1.4" NA NA 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381726 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 79.9" "Group enriched" "Detected in many" 5 "Early spermatids: 399.1;Late spermatids: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enriched" "Detected in many" 4 "U-266/70: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favorable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 3.1 4.8 6.9 1.4 12.2 1.5 1.6 12.6 16.1 2.5 5.9 10.0 0.0 7.9 2.6 6.4 5.9 7.0 2.2 26.8 5.7 3.1 29.7 10.6 2.2 0.7 5.7 6.2 2.9 10.1 18.4 7.6 1.3 6.7 2.3 3.9 19.1 3.2 2.4 79.9 4.6 11.7 4.2 3.8 0.8 2.7 36.1 8.8 0.0 2.2 25.2 1.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 3.5 0.3 0.5 2.0 0.1 0.1 0.8 0.4 0.2 0.0 0.4 3.6 0.5 6.1 1.1 0.6 0.9 0.6 4.8 1.8 0.1 4.2 0.6 1.7 2.6 7.5 1.7 0.0 1.7 0.6 0.3 0.4 1.2 0.8 0.3 4.6 8.4 0.5 1.0 2.4 0.0 0.4 0.9 1.2 0.8 0.0 1.3 0.9 2.8 0.2 7.4 2.2 2.1 1.6 0.4 1.1 5.4 3.7 0.0 0.0 0.9 0.5 0.6 35.2 7.7 0.1 0.0 1.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.3 0.3 6.9 12.2 12.6 16.1 5.7 3.1 5.7 6.2 6.7 8.8 3.0 2.4 0.0 4.5 2.2 73.3 74.6 5.1 42.8 9.1 5.2 90.3 0.3 96.2 2.6 399.1 2.2 31.5 0.0 1.4 0.5 4.6 1.0 0.0 19.8 13.2 9.5 0.0 1.3 1.5 802.9 6.1 1.3 0.0 0.0 1.6 37.9 1.5 10.5 6.7 24.9 128.7 19.4 18.6 19.9 14.9 3.4 1.1 1.5 2.2 2.0 USP24 KIAA1057 ENSG00000162402 "Ubiquitin specific peptidase 24" Q9UPU5 1 55066359-55215113 "Enzymes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 46.0" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 68.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026723, HPA028428, HPA067124" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785" "unprognostic (2.28e-1)" "unprognostic (9.81e-3)" "unprognostic (4.70e-3)" "unprognostic (4.86e-3)" "unprognostic (9.31e-3)" "unprognostic (4.84e-3)" "prognostic unfavorable (1.34e-7)" "unprognostic (2.04e-1)" "unprognostic (6.93e-2)" "unprognostic (2.98e-1)" "unprognostic (5.08e-2)" "unprognostic (1.86e-1)" "unprognostic (8.12e-2)" "unprognostic (1.79e-1)" "unprognostic (6.42e-2)" "unprognostic (4.12e-2)" "unprognostic (1.64e-1)" 12.3 7.6 7.5 12.1 8.8 30.1 10.6 20.1 8.5 7.8 10.2 6.8 10.6 5.0 10.1 7.0 7.7 6.9 7.0 14.7 7.9 6.4 10.4 9.3 7.6 12.7 8.0 5.6 10.9 7.3 15.5 16.9 5.8 6.9 7.6 8.5 5.1 9.7 10.7 46.0 8.9 8.7 7.3 6.2 10.9 7.8 4.9 8.7 16.4 7.4 11.5 12.7 9.7 13.7 6.0 10.5 5.9 2.2 3.8 4.5 1.1 17.7 9.8 12.3 6.6 16.0 14.1 14.2 7.9 9.9 11.4 11.9 13.9 6.3 14.3 8.7 14.6 23.4 14.4 16.3 13.3 17.9 14.9 9.8 28.6 21.4 16.3 9.5 19.7 22.2 12.3 11.8 17.2 19.6 11.0 10.3 14.6 26.3 6.0 15.1 4.2 11.8 10.5 18.0 8.6 11.9 12.3 15.7 6.2 19.8 12.0 10.8 7.6 13.4 9.6 11.7 19.5 6.7 9.8 13.9 10.4 10.1 12.5 12.5 7.6 5.6 18.8 9.9 16.4 9.3 5.9 2.0 2.5 4.5 1.8 2.8 4.8 3.5 3.5 1.8 6.0 3.2 4.2 2.3 3.8 2.2 10.5 1.9 1.1 7.5 8.8 20.1 8.5 7.9 6.4 8.0 5.6 6.9 8.7 14.9 18.3 14.2 7.0 13.3 12.9 28.1 10.2 8.1 15.9 12.2 68.7 3.6 0.0 8.8 0.4 13.1 6.8 0.0 8.7 6.5 9.6 9.6 12.7 10.9 8.4 36.5 16.6 10.4 17.5 1.3 10.9 12.2 10.1 12.6 16.4 7.1 9.9 11.5 7.4 4.5 16.7 6.5 10.5 8.6 5.8 15.1 1.3 17.1 14.9 8.6 USP26 ENSG00000134588 "Ubiquitin specific peptidase 26" Q9BXU7 X 133024631-133097109 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 3.8" "Cell type enriched" "Detected in single" 14 "Spermatogonia: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "HPA000424, HPA027310" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA000424: , HPA027310: " "unprognostic (7.92e-4)" "unprognostic (3.59e-2)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.4 0.1 0.1 0.1 0.1 0.1 3.8 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.3 0.0 0.0 0.5 0.4 0.5 0.4 0.1 0.1 0.2 0.2 0.7 0.1 0.2 0.1 0.7 0.1 0.1 0.0 0.1 0.7 0.1 0.2 0.3 1.0 0.3 1.0 0.3 0.1 0.1 0.0 1.5 0.6 0.4 0.1 0.3 0.1 0.4 0.4 0.4 0.2 0.2 0.1 0.8 0.4 0.2 0.3 0.4 0.1 0.0 0.9 0.5 0.5 0.2 0.1 0.1 0.2 1.0 0.1 0.7 0.3 0.9 0.1 0.3 0.4 0.9 0.3 0.1 0.2 0.4 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.0 0.0 0.0 USP28 KIAA1515 ENSG00000048028 "Ubiquitin specific peptidase 28" Q96RU2 11 113797874-113875570 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 40.1;skeletal muscle: 50.2" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006778, HPA006779" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA Nucleoplasm "Nuclear bodies" "HPA006778: AB_1080520, HPA006779: AB_1080517" "unprognostic (2.54e-1)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" "unprognostic (3.72e-2)" "unprognostic (5.51e-2)" "unprognostic (2.30e-1)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.04e-3)" "unprognostic (1.82e-3)" "unprognostic (3.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.11e-2)" "unprognostic (2.06e-2)" "unprognostic (9.03e-2)" "unprognostic (1.35e-3)" "unprognostic (5.03e-2)" 3.9 3.4 4.8 8.6 5.7 2.4 5.7 26.4 8.6 11.6 5.1 4.9 14.0 4.7 6.0 6.0 5.7 5.0 4.0 40.1 5.0 4.8 5.1 5.6 5.1 7.2 6.8 4.5 7.5 4.1 10.6 9.7 3.9 4.8 8.9 6.0 5.7 5.7 12.2 50.2 3.5 5.1 11.6 6.4 6.9 4.4 5.5 3.8 3.6 5.1 10.1 7.7 7.1 4.6 10.3 4.1 2.1 3.7 17.9 16.2 6.0 8.6 9.7 13.1 17.3 10.8 10.7 9.3 6.4 8.8 8.6 14.8 14.4 12.5 11.5 14.6 8.6 19.9 17.0 18.5 12.0 12.0 12.8 8.4 6.1 6.8 7.7 6.6 7.8 6.1 6.4 9.1 10.0 11.9 12.6 15.5 5.7 10.5 7.5 9.0 4.4 5.9 12.8 15.7 16.0 7.0 14.7 18.3 13.9 9.5 8.5 5.7 6.2 15.2 5.2 4.9 42.9 12.6 2.7 8.2 9.6 14.4 8.7 6.5 5.1 7.3 9.7 0.9 15.3 6.2 0.1 3.2 2.1 16.2 2.4 8.4 10.3 4.1 11.4 4.1 8.4 2.7 9.4 0.9 17.9 3.7 1.2 5.6 6.0 4.8 5.7 26.4 8.6 5.0 4.8 6.8 4.5 4.8 3.8 8.9 9.1 10.0 6.9 1.4 16.1 130.6 5.1 14.7 10.3 5.2 17.7 3.5 5.0 5.7 1.4 4.3 5.1 0.0 3.4 3.7 4.7 6.2 1.1 6.7 3.9 4.8 4.7 6.2 4.1 1.4 6.4 6.5 1.7 5.4 10.3 10.1 4.4 3.5 13.1 6.3 20.2 6.5 5.2 10.8 10.0 1.8 0.9 24.5 9.2 4.9 USP29 ENSG00000131864 "Ubiquitin specific peptidase 29" Q9HBJ7 19 57119138-57131926 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4" "Group enriched" "Detected in some" 9 "Collecting duct cells: 1.8;Early spermatids: 1.7;Spermatocytes: 4.8;Spermatogonia: 1.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.3;HEK 293: 3.2" "Not detected" "Not detected" HPA076515 Enhanced NA NA "HPA076515: " "unprognostic (1.32e-1)" 0.1 0.1 0.2 0.0 0.2 2.7 0.1 0.1 0.4 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.3 0.2 0.1 0.1 0.1 0.3 0.1 0.2 2.1 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.2 2.3 0.1 0.0 0.1 0.1 0.4 8.4 0.4 0.0 0.7 0.1 1.1 1.9 4.1 1.1 1.2 0.8 0.6 0.1 0.7 0.8 0.3 0.0 0.0 3.3 0.0 0.0 0.1 0.1 1.7 0.0 0.9 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 3.2 0.8 0.0 0.0 1.1 0.0 2.0 0.9 1.0 1.4 0.0 0.0 0.0 1.0 0.3 0.9 0.0 0.7 0.0 1.2 0.0 0.5 1.0 0.9 0.0 1.0 0.0 2.1 2.1 0.7 0.6 0.4 0.3 1.2 0.8 1.3 1.5 1.3 0.5 0.0 0.0 1.6 0.5 1.5 0.5 0.8 0.0 3.1 1.1 1.1 0.8 0.7 0.6 0.5 0.7 0.3 0.3 1.1 0.7 0.7 4.1 1.2 0.4 1.9 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 1.5 0.0 0.0 0.0 0.0 0.1 USP32 "NY-REN-60, USP10" ENSG00000170832 "Ubiquitin specific peptidase 32" Q8NFA0 17 60179094-60422470 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.4" "Cell type enhanced" "Detected in all" 11 "Cone photoreceptor cells: 227.8;Rod photoreceptor cells: 128.6;Spermatocytes: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 28.4" "Group enriched" "Detected in many" 10 "dendritic cells: 28.4;granulocytes: 13.5" "Cell line enhanced" "Detected in all" "MCF7: 61.6" HPA044365 Approved Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus" Cytosol "HPA044365: AB_2678914" "unprognostic (4.10e-2)" "unprognostic (3.38e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.90e-3)" "unprognostic (2.33e-2)" "unprognostic (2.24e-1)" "unprognostic (3.93e-1)" "unprognostic (6.49e-2)" "unprognostic (2.78e-1)" "unprognostic (2.82e-1)" "unprognostic (1.97e-1)" "unprognostic (7.23e-2)" "unprognostic (8.35e-2)" "unprognostic (4.16e-2)" 9.5 13.9 17.3 10.8 19.5 20.6 10.9 14.6 20.3 8.0 8.5 18.9 7.9 7.2 8.2 5.4 13.1 7.4 9.1 11.1 14.7 12.2 15.5 19.7 12.5 8.6 18.8 14.3 7.4 8.5 17.3 11.4 9.8 19.2 8.7 8.9 11.6 8.2 9.0 23.0 12.2 7.2 9.8 16.5 12.1 8.1 58.4 18.1 7.3 15.6 7.9 8.5 8.8 8.5 1.4 28.4 13.5 2.1 0.6 1.1 0.9 11.1 12.7 6.8 10.8 17.2 16.2 6.4 9.1 13.8 12.0 15.4 6.6 7.3 6.9 7.7 16.8 19.3 5.9 11.5 12.6 21.2 5.2 5.1 13.8 10.1 7.2 17.1 10.9 12.6 15.1 9.3 16.1 14.9 12.4 13.1 8.3 13.9 5.7 14.8 61.6 11.0 7.7 7.9 10.7 6.1 5.3 17.9 4.1 12.6 8.1 4.8 7.2 7.6 2.2 11.7 12.3 9.4 15.2 11.0 18.2 19.0 11.4 8.5 5.9 11.2 6.5 9.1 8.6 11.8 4.3 2.1 7.2 1.0 1.8 0.7 1.4 0.7 0.8 4.1 1.1 0.5 1.0 13.5 0.6 2.0 28.4 1.1 0.9 17.3 19.5 14.6 20.3 14.7 12.2 18.8 14.3 19.2 18.1 6.0 13.1 7.7 11.6 23.9 16.9 7.6 5.1 6.7 13.6 5.2 227.8 4.3 3.3 9.0 69.1 8.4 6.8 23.3 6.3 5.3 10.4 9.3 11.5 10.6 16.5 12.7 7.9 9.2 33.2 25.6 12.0 27.7 5.0 14.4 4.2 10.3 8.4 9.1 5.3 3.7 128.6 25.8 9.5 100.3 9.1 19.2 4.1 12.9 4.4 7.1 USP35 KIAA1372 ENSG00000118369 "Ubiquitin specific peptidase 35" Q9P2H5 11 78188812-78214711 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 32.4" "Group enriched" "Detected in many" 4 "Early spermatids: 20.7;Late spermatids: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "eosinophil: 3.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055213, HPA058592" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" Nucleoplasm "HPA055213: AB_2682740, HPA058592: AB_2683766" "unprognostic (6.69e-2)" "unprognostic (1.17e-2)" "unprognostic (1.69e-1)" "unprognostic (6.87e-3)" "unprognostic (3.38e-2)" "unprognostic (1.08e-2)" "unprognostic (2.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.57e-2)" "unprognostic (3.84e-3)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (1.29e-3)" "unprognostic (2.93e-1)" "unprognostic (1.31e-1)" "unprognostic (4.38e-2)" "unprognostic (1.49e-2)" 4.9 17.1 5.1 5.4 9.3 3.8 5.2 10.4 15.0 6.4 5.8 8.0 6.3 5.5 6.8 5.4 5.6 5.4 5.6 8.7 6.1 6.7 5.0 13.8 5.6 4.8 6.7 8.8 6.6 6.4 32.4 12.0 7.1 15.0 5.0 3.4 7.7 4.0 5.6 5.6 3.2 5.3 7.8 4.5 4.6 3.9 5.3 4.0 1.9 7.7 2.9 4.1 5.2 6.6 0.0 0.1 3.4 0.6 0.1 0.3 0.2 2.1 3.3 5.7 6.0 9.7 9.0 3.9 4.9 5.8 5.8 4.1 8.3 4.6 1.7 5.1 9.2 6.2 5.7 3.8 7.6 3.4 12.2 2.0 2.8 8.6 4.8 7.6 1.8 8.3 7.6 5.1 12.1 3.5 11.5 7.1 6.2 3.9 4.2 4.5 1.9 4.6 7.2 1.7 6.0 5.3 2.8 5.3 2.0 4.6 3.9 2.8 5.4 3.8 5.0 1.8 8.5 4.2 1.5 8.6 10.7 6.1 12.6 2.6 5.7 1.8 2.6 3.2 1.9 6.2 0.0 0.2 3.4 0.1 0.6 0.0 0.0 0.2 0.2 0.1 0.0 0.3 0.0 0.2 0.1 0.1 0.1 0.1 0.2 5.1 9.3 10.4 15.0 6.1 6.7 6.7 8.8 15.0 4.0 0.0 2.6 0.0 0.1 0.7 0.7 1.8 0.0 0.0 0.0 0.0 5.9 0.6 0.0 0.8 20.7 1.5 0.8 0.0 1.7 1.3 2.0 0.2 0.0 3.0 1.3 0.0 0.0 2.5 0.8 31.6 1.4 0.9 1.7 3.6 0.6 0.5 1.8 0.0 2.8 0.8 0.5 6.5 0.9 0.9 1.6 0.9 0.2 3.9 0.7 0.1 USP38 "HP43.8KD, KIAA1891" ENSG00000170185 "Ubiquitin specific peptidase 38" Q8NB14 4 143184917-143223830 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 35.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036990, HPA047948" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA036990: AB_2675419, HPA047948: AB_2680220" "unprognostic (5.01e-2)" "unprognostic (2.45e-1)" "unprognostic (2.04e-3)" "unprognostic (2.99e-2)" "unprognostic (1.87e-1)" "unprognostic (2.61e-2)" "unprognostic (1.67e-1)" "unprognostic (7.49e-2)" "unprognostic (3.66e-2)" "unprognostic (3.97e-2)" "unprognostic (8.03e-2)" "unprognostic (7.72e-3)" "prognostic favorable (1.20e-4)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.29e-1)" "unprognostic (1.02e-1)" 7.7 7.8 6.6 6.6 6.5 19.1 8.3 7.4 7.8 7.9 12.1 8.6 8.8 8.8 8.3 7.1 8.6 7.1 7.6 12.5 6.6 5.3 9.3 15.2 12.7 11.1 10.3 5.1 6.3 8.8 10.0 6.2 11.4 5.9 6.6 6.6 7.1 7.2 7.0 45.3 8.9 13.2 6.5 10.8 10.6 7.4 7.5 8.2 22.6 8.6 10.2 8.4 7.8 8.8 6.3 8.1 12.5 5.7 12.3 9.9 5.0 4.8 4.5 4.0 6.9 5.3 5.3 3.0 7.7 7.5 7.2 6.1 13.1 7.2 6.0 5.5 6.5 4.6 3.8 9.5 7.7 5.9 14.6 6.1 5.5 5.4 2.8 7.3 11.1 5.5 6.4 7.1 7.3 5.9 5.1 7.1 6.9 11.9 18.9 4.7 7.7 14.5 2.1 3.6 9.8 8.9 9.5 6.0 5.7 4.6 5.6 8.2 7.4 6.0 10.5 6.7 3.1 6.4 4.2 8.4 6.6 5.4 5.7 8.0 21.1 35.7 10.9 6.7 8.5 5.5 12.5 5.4 11.7 7.5 5.7 9.6 6.3 6.6 6.5 8.1 5.7 6.7 5.7 5.4 12.3 5.7 3.5 9.9 5.0 6.6 6.5 7.4 7.7 6.6 5.3 10.3 5.1 5.9 8.2 20.8 13.7 10.5 16.5 47.6 7.5 15.1 7.6 13.4 14.8 0.0 11.8 10.9 1.7 7.5 27.8 12.0 18.4 0.0 6.6 5.8 9.7 16.1 3.5 32.7 9.2 7.9 29.4 17.8 14.5 15.4 6.4 12.2 11.8 1.8 19.9 13.6 8.5 11.5 8.9 14.2 8.2 12.9 15.1 9.5 5.1 51.7 22.3 13.4 14.5 38.1 USP43 FLJ30626 ENSG00000154914 "Ubiquitin specific peptidase 43" Q70EL4 17 9644698-9729691 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.6" "Cell type enhanced" "Detected in many" 11 "Syncytiotrophoblasts: 61.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 12.4;SK-BR-3: 8.6;T-47d: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA023389, HPA027762" Uncertain NA NA "HPA023389: AB_1858691, HPA027762: AB_10603001" "unprognostic (1.39e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-3)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (2.04e-1)" "unprognostic (6.40e-3)" "unprognostic (2.26e-1)" "unprognostic (3.05e-3)" "unprognostic (2.41e-2)" "unprognostic (7.49e-2)" "unprognostic (5.95e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.24e-1)" "unprognostic (2.06e-1)" "unprognostic (3.28e-1)" 0.2 0.2 4.2 1.2 3.4 0.9 3.0 0.7 6.0 4.9 10.0 0.6 15.7 6.2 2.9 1.7 6.7 6.3 5.1 0.2 4.1 3.8 3.7 8.7 3.4 0.2 1.7 3.1 1.0 7.7 1.7 3.7 61.6 0.7 10.8 5.0 0.3 11.3 12.4 0.2 2.4 12.5 0.3 1.0 0.2 2.6 2.9 0.2 0.4 1.7 4.2 2.7 1.3 2.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 5.7 1.5 0.0 0.6 0.0 0.0 12.4 0.1 0.2 0.7 1.7 2.8 4.7 0.0 1.9 0.2 2.7 7.0 0.6 5.5 0.7 3.6 1.9 0.3 3.0 1.0 0.1 0.5 0.0 0.0 7.2 0.3 3.0 0.3 0.0 0.8 0.0 0.0 0.0 2.7 0.9 4.7 0.7 4.9 0.3 3.7 0.0 0.8 4.4 3.1 0.8 0.0 2.5 8.6 1.0 4.1 10.4 1.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 4.2 3.4 0.7 6.0 4.1 3.8 1.7 3.1 0.7 0.2 3.0 1.9 0.0 7.2 4.1 0.0 0.5 7.6 21.4 7.9 10.4 5.9 16.6 1.7 3.9 1.1 0.0 9.0 0.0 4.0 19.6 0.6 9.5 0.0 12.4 2.4 0.0 2.4 0.0 1.6 0.8 0.0 0.0 5.0 0.0 7.8 8.1 8.5 2.9 0.0 1.3 1.3 0.0 0.3 1.1 0.2 2.9 61.2 0.0 9.0 10.0 USP44 FLJ14528 ENSG00000136014 "Ubiquitin specific peptidase 44" Q9H0E7 12 95516560-95551490 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.8" "Cell type enriched" "Detected in many" 4 "Early spermatids: 343.6" "Cancer enhanced" "Detected in some" "testis cancer: 3.0" "Region enriched" "Detected in many" 5 "cerebellum: 10.9" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.6" "Group enriched" "Detected in many" 39 "B-cells: 5.6;T-cells: 8.6" "Cell line enhanced" "Detected in some" "HEL: 10.0;JURKAT: 22.6;NTERA-2: 54.2" "Low region specificity" "Detected in some" HPA026543 Approved "Nucleoli fibrillar center,Microtubules" NA NA "Nucleoli fibrillar center, Microtubules" "HPA026543: AB_1858692" "unprognostic (2.12e-2)" "unprognostic (1.14e-1)" "unprognostic (4.68e-2)" "unprognostic (1.01e-3)" "unprognostic (1.83e-4)" "unprognostic (7.18e-4)" "unprognostic (5.55e-2)" "unprognostic (1.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.73e-2)" "unprognostic (6.88e-2)" "unprognostic (2.97e-2)" "unprognostic (8.12e-2)" "unprognostic (1.41e-2)" "unprognostic (1.08e-1)" "unprognostic (7.41e-2)" "unprognostic (7.07e-2)" 1.3 1.0 0.7 1.2 1.3 0.5 1.4 10.9 2.1 1.7 1.7 1.7 1.4 0.5 3.0 1.0 0.9 1.6 1.1 1.0 0.7 0.6 1.9 0.2 4.7 1.9 1.3 1.2 1.6 3.6 4.8 4.0 0.3 1.8 1.7 0.6 2.3 1.8 2.6 0.4 0.6 1.3 1.2 0.6 1.9 1.0 26.8 1.2 0.8 1.7 0.0 1.6 1.1 2.3 5.6 0.1 0.1 0.0 0.1 8.6 1.3 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.4 1.3 0.5 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 2.2 10.0 0.0 0.0 2.3 4.0 0.2 0.0 0.0 0.3 0.0 0.2 0.2 22.6 1.5 0.0 0.0 0.0 5.1 0.0 54.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 3.5 2.3 0.0 0.0 0.0 5.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.3 0.1 0.0 0.0 0.0 1.5 0.0 3.4 5.6 2.3 2.0 0.0 4.4 8.6 5.5 0.1 0.1 0.0 0.1 0.3 1.3 0.7 1.3 10.9 2.1 0.7 0.6 1.3 1.2 1.8 1.2 11.9 19.9 0.0 2.9 0.9 6.2 1.2 0.0 0.0 6.8 7.0 5.9 2.1 0.0 3.9 343.6 2.3 0.0 0.0 2.7 0.3 1.0 2.7 0.0 0.0 0.1 0.0 0.0 1.3 0.3 78.5 5.2 0.4 3.3 1.0 0.0 3.4 1.3 0.0 3.2 1.1 8.6 6.5 3.1 10.0 5.2 0.6 0.9 1.7 0.0 1.6 USP50 ENSG00000170236 "Ubiquitin specific peptidase 50" Q70EL3 15 50500562-50546708 "Enzymes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "testis: 20.2" "Group enriched" "Detected in some" 87 "Early spermatids: 76.1;Late spermatids: 42.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 1.2;HaCaT: 1.2;HEL: 1.1;OE19: 1.3;RH-30: 1.0;SK-BR-3: 1.6;SK-MEL-30: 2.8;U-698: 1.0" "Region enriched" "Detected in single" 9 "hippocampal formation: 0.4" "Not detected" "Not detected" HPA039470 Uncertain NA NA "HPA039470: AB_10672964" "unprognostic (7.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.01e-2)" "unprognostic (4.04e-3)" "unprognostic (3.37e-1)" "unprognostic (2.53e-2)" "unprognostic (3.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.81e-2)" "unprognostic (4.65e-2)" "unprognostic (2.47e-1)" "unprognostic (7.49e-4)" "unprognostic (3.03e-1)" 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.2 1.6 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.6 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 42.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 USP51 ENSG00000247746 "Ubiquitin specific peptidase 51" Q70EK9 X 55484616-55489202 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 34.1" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 24.4;Ciliated cells: 17.4;Muller glia cells: 29.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 2.4;naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001942 Uncertain Approved "Nucleoli fibrillar center,Cytosol" NA NA Cytosol "Nucleoli fibrillar center" "HPA001942: AB_1080536" "unprognostic (1.19e-2)" "unprognostic (4.65e-2)" "unprognostic (3.67e-2)" "unprognostic (1.02e-3)" "unprognostic (8.08e-2)" "unprognostic (3.26e-1)" "unprognostic (3.17e-3)" "unprognostic (2.07e-3)" "unprognostic (5.69e-2)" "prognostic favorable (5.70e-4)" "unprognostic (1.01e-3)" "unprognostic (1.27e-1)" "prognostic favorable (2.63e-5)" "unprognostic (2.81e-3)" "unprognostic (5.92e-2)" "unprognostic (5.85e-2)" "unprognostic (1.63e-1)" 0.6 2.7 2.0 0.3 2.9 0.1 0.9 2.3 1.8 1.4 0.6 0.0 1.8 34.1 0.2 3.4 0.3 1.0 1.8 3.7 2.2 0.5 0.7 0.4 1.6 4.1 0.8 3.6 1.8 1.3 1.3 0.3 0.3 1.5 0.0 0.5 0.5 1.1 1.4 0.9 0.3 1.3 3.2 0.5 0.7 0.5 0.9 0.0 2.4 0.0 0.6 2.4 0.1 0.0 0.8 5.4 1.6 2.7 1.4 0.0 0.9 0.4 1.0 1.3 1.7 0.7 0.0 6.4 1.2 1.1 0.3 1.4 0.6 1.6 1.7 0.1 1.4 0.3 0.0 1.1 3.3 0.3 5.5 0.1 0.6 0.0 0.4 0.3 4.1 4.1 4.1 0.9 3.5 3.2 1.7 6.7 0.0 0.3 4.6 1.0 2.1 1.3 0.2 0.0 1.1 1.5 0.2 5.0 10.2 1.3 1.7 0.2 2.1 2.9 0.5 0.1 6.5 2.6 1.3 1.4 1.8 1.4 0.0 0.0 2.4 0.3 0.0 0.0 0.6 0.6 0.0 0.0 0.9 2.4 0.2 0.0 0.6 0.0 0.0 0.0 0.1 3.0 5.6 0.0 1.7 0.8 24.4 5.0 0.0 17.4 3.4 3.5 5.9 3.4 8.3 1.0 0.3 5.8 0.0 0.0 0.0 2.1 4.3 1.1 1.1 0.8 6.1 6.4 3.5 4.9 3.9 0.8 3.7 2.5 5.0 0.0 0.3 29.9 0.3 0.0 7.8 12.2 15.2 0.0 3.9 3.6 6.7 0.4 2.3 1.7 0.2 0.4 USP54 "bA137L10.3, bA137L10.4, C10orf29, FLJ37318" ENSG00000166348 "Ubiquitin specific peptidase 54" Q70EL1 10 73497538-73625953 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Glandular cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047663, HPA063665" Approved Approved Mitochondria NA NA Mitochondria "HPA047663: AB_2680116, HPA063665: " "unprognostic (2.46e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-2)" "unprognostic (1.89e-2)" "unprognostic (2.48e-2)" "unprognostic (4.89e-3)" "unprognostic (6.63e-4)" "prognostic favorable (7.00e-4)" "unprognostic (6.24e-2)" "unprognostic (4.35e-2)" "unprognostic (8.91e-3)" "unprognostic (3.49e-1)" "unprognostic (1.95e-3)" "unprognostic (8.18e-2)" "unprognostic (6.88e-2)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" 2.9 1.7 12.3 2.5 33.8 0.5 7.7 7.9 21.3 7.9 7.8 43.8 1.8 2.5 4.2 4.5 10.2 7.7 3.1 4.0 14.1 6.8 2.7 1.6 9.0 0.6 49.5 14.2 4.0 6.3 7.1 3.4 1.2 28.6 5.8 11.1 3.4 8.8 3.6 12.0 6.1 2.9 4.0 25.4 1.5 11.3 4.7 42.8 0.4 24.3 1.2 3.6 5.6 4.0 2.4 2.2 1.3 2.4 1.5 3.2 2.3 6.3 6.6 10.2 9.6 2.7 3.2 3.2 3.4 6.7 5.7 6.6 5.5 10.5 4.8 4.0 3.5 4.4 8.8 6.5 2.4 7.6 2.3 6.1 3.0 4.8 3.7 2.2 3.3 1.2 2.5 2.3 6.6 6.6 11.6 2.6 3.5 4.7 0.7 3.9 3.2 3.2 2.1 4.7 17.8 24.0 4.8 9.1 1.8 4.1 6.2 3.3 3.2 6.5 8.0 7.7 6.3 10.4 3.0 3.5 2.2 6.7 4.3 4.3 1.7 3.1 3.4 5.4 3.1 2.0 0.8 2.3 1.3 1.6 1.9 3.1 2.4 2.7 2.5 1.9 1.0 3.2 1.9 0.1 1.5 2.4 2.2 3.0 2.3 12.3 33.8 7.9 21.3 14.1 6.8 49.5 14.2 28.6 42.8 44.7 23.5 0.0 4.6 2.4 7.1 5.6 5.1 17.4 15.9 12.2 15.7 0.6 0.0 4.1 1.6 4.5 11.4 0.0 7.1 0.8 2.9 59.6 3.5 1.7 1.2 4.8 9.9 3.1 0.6 1.7 3.1 1.4 8.5 1.0 20.7 13.0 8.8 7.0 10.3 1.1 11.1 6.5 3.8 8.0 6.6 3.4 1.1 1.3 10.5 10.5 USP6 "HRP1, Tre-2, TRE17, Tre2, TRESMCR" ENSG00000129204 "Ubiquitin specific peptidase 6" P35125 17 5116438-5175034 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Calmodulin-binding, Hydrolase, Protease, Thiol protease" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 18.2;testis: 29.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 19.3;Erythroid cells: 23.3;Spermatocytes: 19.2" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " "unprognostic (3.89e-2)" "unprognostic (3.79e-3)" "unprognostic (2.50e-1)" "unprognostic (1.85e-1)" "unprognostic (9.32e-2)" "unprognostic (3.50e-3)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (3.45e-2)" "unprognostic (2.46e-2)" "unprognostic (7.91e-4)" "unprognostic (6.28e-3)" "unprognostic (3.24e-4)" "unprognostic (3.75e-2)" "unprognostic (3.13e-1)" "unprognostic (2.71e-1)" "unprognostic (7.09e-4)" 0.3 0.3 0.3 0.3 0.6 0.2 0.4 0.5 0.5 0.3 0.5 0.3 1.2 0.0 0.6 0.6 0.3 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 2.6 0.3 0.0 0.4 0.4 0.3 0.4 0.1 0.3 0.3 0.3 18.2 0.6 0.7 0.9 0.3 0.3 0.0 29.0 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.9 1.2 1.9 1.0 0.2 0.4 0.1 2.2 0.9 2.2 1.6 0.4 0.2 2.3 1.9 0.1 0.6 0.4 0.8 1.0 2.2 1.6 1.2 1.9 1.0 0.7 0.8 0.5 1.5 1.3 1.7 1.3 0.9 1.2 0.5 2.8 1.1 0.5 0.1 0.2 2.5 0.3 1.8 0.5 0.3 0.5 2.5 1.8 0.7 1.5 0.7 0.1 1.4 1.9 0.2 0.5 0.7 0.9 2.1 1.0 0.1 3.3 3.7 2.1 2.2 1.2 0.9 3.2 2.0 1.4 2.0 1.6 1.5 0.0 0.1 2.6 0.1 0.4 0.9 0.4 0.3 0.2 0.6 0.3 0.3 0.3 0.9 0.3 0.4 1.9 0.2 1.0 1.2 0.1 0.1 0.3 0.6 0.5 0.3 0.3 0.1 0.3 0.3 0.3 0.3 6.0 9.6 0.5 0.9 9.6 7.9 1.6 7.6 5.3 5.7 3.5 11.8 0.5 3.3 0.0 19.3 2.9 0.0 23.3 0.0 0.8 1.5 2.4 0.0 2.6 2.3 1.6 0.0 4.9 4.9 9.4 1.7 5.7 3.3 0.0 0.0 4.7 0.1 0.0 2.5 2.8 9.8 6.5 0.6 19.2 5.5 9.2 0.6 0.7 0.0 0.9 UTF1 ENSG00000171794 "Undifferentiated embryonic cell transcription factor 1" Q5T230 10 133230274-133231558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "ovary: 22.9;testis: 23.4" "Group enriched" "Detected in some" 7 "Kupffer cells: 2.4;Macrophages: 6.9;Spermatogonia: 8.7" "Cancer enriched" "Detected in single" 243 "testis cancer: 49.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.1;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 18 "NTERA-2: 11.2;RPMI-8226: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" CAB022384 Enhanced NA NA "CAB022384: " "unprognostic (9.19e-2)" "unprognostic (1.95e-1)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (2.99e-3)" "unprognostic (2.88e-1)" "unprognostic (3.82e-1)" 0.2 0.3 0.4 0.1 0.2 0.5 0.1 0.3 0.3 0.1 0.1 0.0 0.0 0.1 0.3 0.8 0.1 0.7 0.1 0.9 0.2 0.2 0.1 0.2 0.6 1.6 0.1 0.0 22.9 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.2 0.1 0.3 0.1 0.1 0.4 3.1 0.2 23.4 0.0 1.1 0.1 0.1 0.5 0.1 0.0 0.5 0.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.2 0.3 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.9 0.3 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.7 0.9 0.1 0.0 0.0 0.0 UTP11 "CGI-94, UTP11L" ENSG00000183520 "UTP11, small subunit processome component" Q9Y3A2 1 38009258-38024824 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.7" "Cell type enhanced" "Detected in many" 5 "Ductal cells: 54.9;Exocrine glandular cells: 58.5;Pancreatic endocrine cells: 60.3;Syncytiotrophoblasts: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045830 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA045830: AB_10969917" "unprognostic (1.95e-1)" "unprognostic (2.23e-1)" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (7.29e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.44e-8)" "unprognostic (3.51e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-3)" "unprognostic (1.40e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (1.42e-8)" "unprognostic (1.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" 11.3 12.4 9.1 9.6 8.4 9.3 9.7 7.5 11.3 10.6 12.1 6.0 6.9 7.3 11.4 9.1 13.8 9.8 8.6 11.5 12.9 9.5 9.1 13.1 7.4 8.6 9.3 8.7 10.7 11.5 6.6 10.2 11.4 11.2 12.9 8.7 6.7 10.0 8.8 74.7 9.4 7.6 19.7 10.9 10.2 10.4 9.3 5.7 10.5 8.1 26.1 10.6 22.6 10.9 12.9 18.7 9.6 22.5 21.9 17.7 12.3 15.0 9.1 16.0 15.6 12.0 16.4 14.6 17.1 16.3 23.2 21.4 13.4 18.9 25.2 16.1 13.8 11.4 13.2 18.1 15.0 29.1 18.9 16.6 29.3 12.3 11.7 16.2 29.2 19.3 15.1 9.7 25.6 22.4 14.5 18.5 19.3 33.5 13.7 26.2 10.7 22.6 30.2 38.9 16.9 12.2 20.1 34.2 23.4 15.2 14.7 21.2 17.6 15.0 13.0 27.5 17.6 11.8 18.0 13.6 15.9 19.2 17.3 32.5 13.1 25.6 21.3 21.3 32.1 19.5 8.4 18.9 9.6 16.9 20.5 17.7 10.5 13.5 14.0 18.7 12.9 12.4 15.0 5.7 21.9 22.5 18.0 15.6 12.3 9.1 8.4 7.5 11.3 12.9 9.5 9.3 8.7 11.2 5.7 32.8 35.8 0.0 0.0 0.0 0.0 0.0 0.0 46.8 38.7 24.4 0.0 47.4 33.2 54.9 0.0 0.0 0.0 0.0 58.5 41.6 0.0 0.0 23.3 0.0 47.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 33.3 0.0 0.0 60.3 0.0 0.0 36.3 0.0 0.0 0.0 0.0 0.0 0.0 65.1 0.0 0.0 0.0 UTS2 "PRO1068, U-II, UCN2, UII" ENSG00000049247 "Urotensin 2" O95399 1 7843083-7853512 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 25.4;brain: 19.8" "Cell type enriched" "Detected in some" 5 "granulocytes: 40.4" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 19 "hypothalamus: 5.2;pons and medulla: 19.8" "Cell type enriched" "Detected in many" 6 "T-reg: 25.4" "Lineage enriched" "Detected in many" 6 "T-cells: 25.4" "Cell line enhanced" "Detected in some" "CACO-2: 16.8;HEL: 5.9;HMC-1: 5.0;THP-1: 21.5" HPA017000 Uncertain "Secreted to blood" NA NA 2590000 "HPA017000: AB_1858656" "unprognostic (2.10e-3)" "unprognostic (1.35e-1)" "unprognostic (3.89e-3)" "unprognostic (1.33e-3)" "unprognostic (2.32e-5)" "unprognostic (1.09e-4)" "unprognostic (4.95e-2)" "unprognostic (6.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.65e-2)" "unprognostic (1.28e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-5)" "unprognostic (1.75e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (3.30e-3)" 1.0 6.3 0.3 0.6 0.3 5.2 0.3 0.3 0.3 0.5 1.2 0.4 1.2 1.1 0.3 0.3 0.3 0.6 0.9 0.3 0.6 5.2 0.3 0.3 0.6 2.9 0.3 0.3 0.4 0.3 0.0 0.3 0.3 19.8 2.0 2.4 0.3 0.3 0.3 0.3 0.5 1.0 2.3 12.7 2.1 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.9 0.3 0.0 0.4 4.1 0.0 3.2 25.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.0 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.1 0.0 0.3 3.0 0.0 4.0 0.0 2.7 2.8 0.4 0.0 0.2 0.8 0.0 3.2 0.0 0.0 25.4 0.9 0.3 0.3 0.3 0.3 0.6 5.2 0.3 0.3 19.8 0.3 0.0 3.4 0.8 0.0 1.3 1.8 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 40.4 0.0 0.1 4.8 1.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.5 0.8 0.1 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.4 0.1 6.9 8.4 0.0 UTS2B "U2B, URP, UTS2D" ENSG00000188958 "Urotensin 2B" Q765I0 3 191267168-191330536 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 19.0" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Early spermatids: 5.1;Late spermatids: 1.3" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "amygdala: 19.0" "Cell type enhanced" "Detected in some" "memory B-cell: 6.2;naive B-cell: 3.0" "Lineage enriched" "Detected in many" 5 "B-cells: 6.2" "Cell line enhanced" "Detected in many" "PC-3: 7.2" HPA026992 Uncertain "Secreted - unknown location" NA NA "HPA026992: AB_1858703" "unprognostic (1.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.17e-2)" "unprognostic (2.77e-2)" "unprognostic (2.14e-2)" "unprognostic (3.09e-1)" "unprognostic (2.63e-2)" "unprognostic (3.39e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (7.58e-2)" "unprognostic (2.08e-1)" "unprognostic (1.29e-1)" "unprognostic (3.10e-2)" 1.1 1.5 19.0 0.7 0.8 0.2 1.6 0.5 2.5 0.6 0.6 0.8 0.5 7.7 1.5 0.5 0.6 1.0 3.0 0.9 1.5 1.2 0.5 4.8 0.6 0.9 0.8 0.5 1.7 4.1 0.0 0.5 0.5 1.0 0.5 0.1 0.5 0.5 0.5 0.5 1.3 4.2 0.5 1.1 1.1 1.9 2.9 0.5 0.5 0.5 0.5 0.8 0.9 0.7 6.2 1.2 0.1 0.1 0.0 0.1 0.1 0.9 2.1 2.9 1.4 0.8 3.7 0.9 2.1 1.2 0.8 0.4 1.5 1.1 1.4 1.1 1.0 5.8 1.1 0.9 0.0 3.5 1.4 1.0 1.3 2.8 6.1 0.7 1.6 0.8 1.5 0.4 0.5 0.6 1.9 0.8 1.2 0.9 1.4 1.1 1.2 0.4 1.2 1.6 2.7 7.2 1.8 3.4 0.5 0.4 3.6 1.6 1.0 1.3 1.5 0.8 1.3 1.2 1.0 3.0 1.6 0.9 2.8 0.8 2.3 1.3 1.4 1.9 1.1 1.0 0.0 0.0 0.1 0.1 0.0 0.0 6.2 0.1 0.0 0.0 3.0 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 19.0 0.8 0.5 2.5 1.5 1.2 0.8 0.5 1.0 0.5 3.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.7 0.9 0.3 0.2 0.0 0.0 0.0 UTS2R GPR14 ENSG00000181408 "Urotensin 2 receptor" Q9UKP6 17 82374230-82375586 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 6.2;thyroid gland: 3.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "stomach cancer: 0.7;testis cancer: 2.2;thyroid cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Karpas-707: 7.8;U-266/70: 19.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "unprognostic (1.55e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.92e-1)" "unprognostic (1.46e-2)" "unprognostic (8.26e-2)" "unprognostic (2.30e-2)" "unprognostic (3.98e-1)" "unprognostic (6.38e-2)" "unprognostic (4.44e-2)" "unprognostic (8.73e-2)" "unprognostic (1.81e-1)" "unprognostic (1.32e-1)" "unprognostic (7.84e-2)" 0.0 0.0 0.1 0.5 0.0 0.4 0.2 0.4 1.7 0.0 0.7 1.5 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.1 0.7 0.0 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.1 0.0 0.7 0.0 0.0 0.7 0.7 6.2 3.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.2 0.0 2.2 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 19.2 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.9;U-266/84: 11.4;U-698: 14.9" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 5.3 5.1 3.0 15.4 10.3 9.0 5.1 6.1 11.0 0.4 8.4 18.0 18.4 4.3 0.4 16.5 7.2 0.4 6.5 4.7 3.5 3.4 5.0 6.9 11.9 19.0 3.3 0.0 0.5 15.1 0.4 6.3 5.9 13.0 14.0 10.6 16.8 10.9 16.1 9.3 7.4 10.1 18.6 4.8 17.4 5.7 6.7 0.0 37.7 6.3 10.3 22.0 7.2 0.0 6.1 4.8 6.6 3.8 9.9 6.7 1.3 0.0 1.8 0.0 0.0 0.0 0.0 6.6 3.3 5.7 3.7 5.7 0.0 0.0 9.0 0.0 3.8 0.0 0.0 0.0 0.0 5.3 4.9 0.0 14.9 0.1 0.0 4.9 0.0 0.0 6.0 5.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 4.1 0.0 5.1 0.1 0.0 0.0 0.0 0.0 2.4 4.0 4.1 6.1 3.7 0.0 0.0 0.0 10.7 6.8 0.0 3.2 4.3 6.6 0.0 0.0 2.3 10.2 11.4 14.9 0.6 0.0 0.0 1.8 2.8 5.8 4.7 3.4 6.7 5.0 4.6 3.6 3.0 6.1 6.5 4.7 6.6 9.9 3.8 4.8 5.3 1.3 3.0 10.3 6.1 11.0 3.5 3.4 3.3 0.0 13.0 0.0 14.9 22.3 25.2 17.2 10.1 30.4 5.2 2.5 10.7 13.6 17.4 60.9 8.5 0.0 2.9 0.3 7.7 1.0 0.0 0.0 2.7 7.6 12.2 15.1 0.0 2.4 35.0 1.7 8.6 13.3 0.9 10.0 15.3 8.5 10.8 0.0 18.3 2.5 0.0 11.0 1.3 38.6 0.0 6.2 1.8 5.9 13.4 11.1 21.3 0.0 16.0 VAMP1 "SYB1, VAMP-1" ENSG00000139190 "Vesicle associated membrane protein 1" P23763 12 6462237-6470987 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 38.7;brain: 85.2" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "U-698: 67.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002779, CAB016119, CAB079000" Approved Supported NA NA "CAB002779: , CAB016119: AB_628309, CAB079000: " "unprognostic (2.33e-1)" "unprognostic (6.72e-3)" "prognostic unfavorable (6.37e-5)" "unprognostic (8.09e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.22e-2)" "unprognostic (6.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.40e-3)" "unprognostic (3.48e-2)" "prognostic unfavorable (1.04e-11)" "unprognostic (1.47e-2)" "unprognostic (5.99e-2)" "unprognostic (1.62e-1)" "unprognostic (3.65e-2)" 3.4 6.8 10.2 13.7 12.8 38.7 4.2 9.8 53.1 5.7 8.0 11.1 1.6 4.7 8.7 5.4 3.9 5.1 5.2 4.0 14.1 25.4 3.2 4.3 5.3 24.3 33.5 10.0 3.8 2.4 1.1 3.1 2.4 85.2 8.6 8.8 4.8 6.3 7.6 4.0 4.2 7.9 7.7 31.3 12.4 5.4 3.7 8.3 3.7 7.9 0.8 23.0 5.0 4.7 5.5 2.5 13.4 1.0 2.1 7.0 2.5 0.9 3.5 1.9 2.6 5.7 6.6 2.2 1.8 3.5 1.9 5.5 1.1 3.2 9.9 0.4 4.4 1.9 3.0 2.3 1.0 2.8 7.8 5.5 1.5 10.4 1.2 2.7 3.8 3.8 4.8 0.4 2.5 1.4 6.5 1.7 4.4 0.5 2.9 4.3 1.0 5.0 4.4 9.4 0.4 1.5 5.5 3.1 1.8 1.2 1.3 0.4 0.8 3.8 2.0 1.4 10.8 0.6 1.5 2.1 0.9 3.0 2.0 1.2 2.6 1.0 67.8 3.6 8.0 0.7 6.9 1.0 13.4 6.7 0.4 5.3 5.5 5.5 6.2 1.1 1.3 5.8 4.8 5.5 2.1 0.5 2.5 7.0 2.5 10.2 12.8 9.8 53.1 14.1 25.4 33.5 10.0 85.2 8.3 6.0 1.3 8.2 2.7 1.0 16.3 1.4 2.5 4.0 2.3 0.0 5.9 0.3 1.7 0.2 0.3 2.2 1.7 0.0 0.4 0.7 2.6 2.4 10.4 3.2 1.4 1.6 4.6 2.5 1.8 0.4 3.4 2.4 0.0 4.6 1.2 6.1 0.5 0.9 4.6 0.3 6.8 6.5 3.6 2.3 2.6 0.6 0.1 9.2 1.5 0.8 VAMP2 "SYB2, VAMP-2" ENSG00000220205 "Vesicle associated membrane protein 2" P63027 17 8159149-8163546 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 168.0" "Cell type enhanced" "Detected in all" 7 "Bipolar cells: 1189.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB078785 Supported NA NA "CAB078785: " "unprognostic (8.25e-2)" "unprognostic (4.41e-2)" "unprognostic (1.58e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (7.28e-2)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "prognostic favorable (3.83e-6)" "unprognostic (8.27e-2)" "prognostic favorable (9.76e-8)" "unprognostic (1.21e-2)" "unprognostic (7.00e-2)" "unprognostic (1.54e-1)" "unprognostic (1.08e-1)" 22.0 38.3 65.1 16.2 111.7 57.4 20.2 72.2 168.0 20.1 16.3 51.6 11.6 15.7 27.4 24.1 11.6 26.8 14.4 22.1 61.7 56.5 23.5 11.4 21.0 23.1 52.7 71.1 48.4 22.6 52.2 40.6 15.4 88.4 25.1 19.3 37.5 19.5 27.0 33.6 25.0 17.9 25.2 30.7 27.2 17.4 15.1 35.1 9.2 22.0 8.8 22.8 11.7 16.0 25.1 15.4 37.8 8.8 25.1 33.4 9.3 13.8 10.4 25.8 13.8 22.7 17.8 11.6 13.0 16.5 13.3 18.3 4.1 9.5 15.8 9.3 20.8 12.5 16.9 16.9 14.0 15.4 18.3 18.5 11.0 26.7 5.6 20.4 7.3 17.1 19.6 21.1 15.3 23.0 27.5 12.9 27.7 8.5 18.4 22.5 7.3 19.1 10.1 5.9 9.3 7.7 24.4 11.8 12.4 17.2 9.3 12.0 19.2 10.2 5.7 12.7 11.8 13.0 9.5 19.7 8.1 11.2 14.8 12.0 20.3 11.5 11.4 20.6 12.8 18.3 13.7 7.4 24.5 28.4 6.9 24.4 25.1 28.2 30.0 5.7 22.1 33.4 30.8 37.8 25.1 8.8 15.4 20.1 9.3 65.1 111.7 72.2 168.0 61.7 56.5 52.7 71.1 88.4 35.1 38.7 21.2 219.6 147.9 101.1 1189.4 24.3 147.7 17.4 34.2 219.8 233.7 157.6 334.9 66.7 5.4 128.8 97.5 23.3 73.0 75.1 142.8 110.4 150.8 68.4 95.0 440.2 310.2 154.7 94.0 5.9 242.4 101.2 183.9 129.8 134.5 437.1 85.1 111.2 202.6 152.5 445.5 291.1 199.4 106.5 119.6 131.7 267.6 252.2 82.9 115.3 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 172.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 210000 "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 16.5 8.2 7.1 20.7 11.2 27.6 24.2 1.9 6.2 16.3 49.4 5.7 43.5 24.1 6.0 25.5 65.4 17.1 28.8 13.0 4.7 3.8 67.7 46.5 53.1 48.0 10.5 3.2 7.1 58.0 15.4 8.3 108.1 11.9 22.1 31.9 7.7 90.7 40.4 9.0 43.3 87.1 6.8 10.4 53.5 28.7 5.5 8.4 24.5 47.5 35.4 34.9 20.6 30.4 39.2 172.5 37.7 69.7 41.4 51.3 100.9 23.9 3.1 0.2 0.2 0.2 0.1 23.9 0.0 0.0 0.0 0.0 17.8 22.0 5.3 17.4 0.1 1.8 17.0 0.2 42.9 0.0 21.8 16.6 27.6 10.6 20.2 0.3 82.0 28.6 0.2 30.5 0.0 7.1 0.1 5.5 0.1 19.7 1.1 9.8 33.6 0.0 128.2 0.3 30.0 2.5 0.5 0.9 36.0 49.7 36.0 0.8 0.3 11.7 62.1 1.9 13.0 22.8 63.7 11.0 0.0 1.5 0.3 0.2 0.3 13.5 31.4 0.3 85.1 0.1 37.7 69.7 25.2 40.4 57.7 38.8 39.2 46.8 39.5 63.5 37.8 37.3 39.1 4.5 41.4 34.3 172.5 51.3 100.9 7.1 11.2 1.9 6.2 4.7 3.8 10.5 3.2 11.9 8.4 345.4 256.8 171.2 244.0 230.2 1.1 5.5 331.2 341.3 271.8 347.2 0.0 869.6 648.2 536.4 20.3 29.2 900.3 0.0 637.4 386.9 34.1 294.8 263.2 244.8 1050.6 0.0 124.1 155.3 836.3 34.0 8.6 660.7 334.0 762.0 322.8 2.4 674.2 501.5 7.1 797.0 1.6 45.3 25.8 28.4 6.4 288.3 734.1 248.2 230.6 528.7 VANGL2 "KIAA1215, LPP1, LTAP, MGC119403, MGC119404, STB1, STBM, STBM1" ENSG00000162738 "VANGL planar cell polarity protein 2" Q9ULK5 1 160400586-160428678 "Disease related genes, Predicted membrane proteins" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 39.5" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 31.4;Intestinal endocrine cells: 16.1;Mucus-secreting cells: 15.6;Suprabasal keratinocytes: 14.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 45.8;AN3-CA: 11.3;NTERA-2: 18.5;SH-SY5Y: 12.5;SuSa: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027043 Uncertain NA NA "HPA027043: AB_10601709" "unprognostic (4.32e-3)" "unprognostic (1.86e-1)" "unprognostic (1.59e-2)" "unprognostic (1.07e-3)" "unprognostic (3.05e-1)" "unprognostic (2.55e-1)" "unprognostic (1.72e-1)" "unprognostic (2.13e-1)" "unprognostic (1.84e-3)" "unprognostic (9.83e-2)" "unprognostic (3.84e-1)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (6.58e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.18e-2)" 1.4 2.1 7.5 2.9 6.9 0.6 6.6 18.4 12.6 10.6 6.0 13.5 9.9 5.9 8.1 7.5 11.2 7.1 3.8 4.5 11.7 8.8 3.7 0.7 4.9 5.0 9.5 4.3 10.9 5.6 6.8 4.3 6.8 10.9 10.0 6.4 13.0 11.3 9.8 2.2 39.5 6.8 4.6 11.9 2.5 4.6 2.8 11.8 5.3 9.6 5.4 7.6 7.8 11.6 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.5 0.6 45.8 11.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.2 0.0 5.8 0.0 0.0 2.6 7.5 0.4 0.0 0.0 0.5 2.2 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.1 0.0 1.7 3.4 0.0 0.3 0.0 2.9 0.1 18.5 0.2 0.0 6.0 2.4 0.0 0.0 0.0 4.2 12.5 0.0 0.0 4.0 16.6 0.0 0.6 0.0 0.0 7.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.5 6.9 18.4 7.5 11.7 8.8 9.5 4.3 10.9 11.8 0.0 0.3 0.0 2.2 14.1 3.1 2.4 2.5 2.7 1.2 0.0 31.4 0.0 0.0 4.2 1.0 2.0 1.1 0.0 1.4 0.0 2.3 6.4 0.0 0.0 0.1 9.5 16.1 0.6 0.0 0.7 3.4 0.0 6.8 0.0 15.6 4.5 3.3 0.0 6.7 0.4 0.0 0.0 3.8 0.5 3.4 14.9 0.0 0.0 6.4 4.5 VASH2 FLJ12505 ENSG00000143494 "Vasohibin 2" Q86V25 1 212950520-212992037 "Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.2" "Group enriched" "Detected in some" 12 "Early spermatids: 75.2;Late spermatids: 59.3" "Cancer enhanced" "Detected in many" "testis cancer: 3.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "AF22: 9.6;AN3-CA: 11.7;NTERA-2: 18.4;RH-30: 54.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045820 Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA045820: " "unprognostic (2.22e-1)" "unprognostic (1.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.29e-2)" "unprognostic (1.28e-1)" "unprognostic (1.57e-2)" "unprognostic (1.25e-2)" "unprognostic (4.04e-2)" "unprognostic (2.59e-3)" "unprognostic (3.50e-2)" "unprognostic (2.45e-1)" "unprognostic (6.58e-2)" "unprognostic (1.84e-5)" "unprognostic (1.95e-3)" "unprognostic (2.74e-1)" "unprognostic (6.85e-2)" "unprognostic (6.81e-4)" 3.1 0.7 2.6 5.8 6.0 1.4 3.7 1.1 4.8 3.3 1.4 0.1 1.0 1.3 4.2 3.8 7.8 1.5 4.9 2.8 1.5 1.8 1.1 0.8 2.2 3.8 1.2 1.7 1.8 0.8 1.8 7.7 1.4 3.6 7.7 1.2 5.7 1.6 1.6 1.6 1.2 2.0 3.5 1.1 2.1 1.3 23.2 1.1 9.7 1.2 3.1 3.7 2.9 6.3 0.2 3.2 0.0 0.0 0.0 0.4 0.0 0.1 0.6 9.6 11.7 0.1 0.0 1.5 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.1 0.0 0.2 0.0 3.9 0.0 0.4 7.7 1.4 0.7 0.5 0.5 0.0 0.0 0.1 1.5 0.0 0.5 0.0 0.2 0.1 4.4 0.0 2.3 0.8 0.1 4.9 0.6 18.4 0.0 1.4 2.9 54.2 0.5 0.0 0.7 2.2 3.4 1.2 0.1 0.1 5.2 1.8 0.3 0.0 0.4 1.1 0.2 0.5 1.3 2.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 3.2 0.4 0.0 2.6 6.0 1.1 4.8 1.5 1.8 1.2 1.7 3.6 1.1 0.0 0.6 0.0 0.7 1.3 1.9 0.8 0.0 1.4 0.0 0.0 2.0 0.1 0.0 0.5 75.2 0.3 0.0 0.0 0.2 0.2 5.8 1.4 0.0 0.0 0.2 1.6 1.2 0.0 0.3 59.3 0.3 1.3 0.0 1.0 0.0 0.8 0.1 0.0 0.7 0.3 2.1 0.0 1.7 1.0 1.0 1.4 0.0 0.0 0.0 0.4 VAT1L KIAA1576 ENSG00000171724 "Vesicle amine transport 1 like" Q9HCJ6 16 77788530-77980107 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 57.3;brain: 47.1;retina: 32.1" "Group enriched" "Detected in some" 15 "Horizontal cells: 281.3;Muller glia cells: 83.1" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+: 27.7;fHDF/TERT166: 15.1;NTERA-2: 32.6;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044061, CAB046032, HPA061138" Enhanced Approved Cytosol NA NA Cytosol "CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: " "unprognostic (1.49e-2)" "unprognostic (8.74e-3)" "unprognostic (8.80e-3)" "unprognostic (3.39e-2)" "unprognostic (3.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (8.57e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.01e-6)" "unprognostic (2.50e-2)" "unprognostic (6.53e-2)" "unprognostic (1.19e-1)" "unprognostic (5.96e-2)" 1.1 57.3 7.9 3.0 41.3 1.2 1.0 28.4 20.1 1.3 3.4 5.7 0.0 2.4 1.8 6.3 2.0 1.4 3.8 12.7 3.8 47.1 5.3 1.4 0.9 1.0 8.4 12.7 0.9 2.1 0.6 1.5 2.0 27.2 0.8 5.2 32.1 0.9 1.0 0.6 0.6 3.1 2.6 15.4 0.7 1.7 2.1 5.8 0.0 2.0 0.0 2.4 1.4 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 3.2 0.0 0.0 1.1 27.7 0.3 0.3 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 32.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.4 0.0 6.0 0.0 7.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 41.3 28.4 9.1 3.8 47.1 8.4 12.7 27.2 5.8 0.0 0.0 0.0 0.0 0.0 7.2 8.7 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 281.3 2.9 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 83.1 0.1 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 VAV1 VAV ENSG00000141968 "Vav guanine nucleotide exchange factor 1" P15498 19 6772714-6857366 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1" "Group enriched" "Detected in many" 5 "B-cells: 26.9;granulocytes: 34.6;Hofbauer cells: 42.9;Kupffer cells: 22.9;Macrophages: 27.7;T-cells: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 31.3;Karpas-707: 35.7;MOLT-4: 33.9;REH: 22.5;THP-1: 26.3;U-266/70: 21.4;U-266/84: 25.9;U-937: 28.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001864, HPA005925" Enhanced Approved Cytosol NA NA 30000 Cytosol "HPA001864: AB_1858722, HPA005925: " "unprognostic (2.93e-1)" "unprognostic (1.96e-1)" "unprognostic (1.80e-1)" "unprognostic (1.01e-1)" "unprognostic (6.82e-2)" "unprognostic (1.13e-2)" "unprognostic (5.62e-1)" "unprognostic (1.97e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-2)" "unprognostic (3.56e-2)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (9.55e-2)" "unprognostic (1.78e-1)" "unprognostic (6.57e-2)" "unprognostic (3.28e-1)" 5.1 3.0 3.1 19.0 5.6 25.7 2.3 0.7 2.2 1.7 3.5 4.0 0.3 2.8 1.9 2.6 2.6 2.6 3.1 3.3 2.5 3.0 2.7 2.6 8.5 25.1 5.3 1.2 2.0 1.5 5.2 1.8 4.4 3.5 3.2 3.7 2.3 5.8 1.1 0.8 1.4 10.7 2.6 8.7 37.1 2.5 1.5 4.8 43.1 2.0 1.2 20.0 6.1 2.4 9.3 10.5 25.7 22.8 11.5 14.7 10.5 0.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.9 15.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.5 18.6 0.0 0.0 0.0 18.0 31.3 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.7 35.7 0.0 2.6 33.9 10.3 0.0 0.0 0.0 22.5 0.0 12.1 0.6 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.2 26.3 0.0 0.0 0.4 0.0 0.0 21.4 25.9 17.5 0.0 28.4 0.0 0.9 11.5 11.9 14.7 18.8 10.5 9.3 10.7 12.7 10.5 9.2 11.8 10.6 25.7 11.5 22.8 9.0 8.5 10.5 3.1 5.6 0.7 2.2 2.5 3.0 5.3 1.2 3.5 4.8 3.0 4.8 26.9 0.5 1.1 0.2 0.7 0.0 5.3 1.2 0.0 0.0 0.4 0.0 5.1 3.2 1.1 0.0 0.0 0.3 0.6 1.2 0.2 34.6 0.0 42.9 0.0 1.2 1.3 22.9 1.3 0.0 27.7 1.7 1.8 0.9 0.0 5.9 5.8 0.0 0.0 0.0 0.0 0.3 1.2 0.9 0.6 1.1 25.5 2.1 0.6 VAV3 ENSG00000134215 "Vav guanine nucleotide exchange factor 3" Q9UKW4 1 107571160-107965144 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.5;placenta: 54.4" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 99.5;Syncytiotrophoblasts: 205.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 19.1;RH-30: 23.5;RPTEC TERT1: 33.0;T-47d: 40.3" "Low region specificity" "Detected in all" CAB002012 Uncertain NA NA "CAB002012: " "unprognostic (4.80e-3)" "unprognostic (7.99e-3)" "unprognostic (5.31e-3)" "unprognostic (3.78e-3)" "unprognostic (1.15e-1)" "unprognostic (1.67e-3)" "unprognostic (6.84e-2)" "unprognostic (2.34e-2)" "unprognostic (3.39e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.60e-8)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-2)" "unprognostic (1.23e-2)" 2.3 1.2 1.8 12.2 2.4 7.1 15.2 2.7 3.0 11.4 17.5 0.8 6.4 3.8 3.3 4.8 32.6 1.6 1.7 2.0 1.2 1.9 47.5 1.1 7.1 8.6 3.8 0.8 1.0 7.3 0.5 2.0 54.4 3.1 6.2 22.2 6.9 6.3 5.3 0.8 27.1 7.6 2.1 1.0 13.1 3.7 2.5 0.4 8.9 4.2 17.6 17.6 7.3 11.5 4.4 4.8 6.8 1.1 3.8 4.6 1.1 0.0 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 6.3 0.2 0.0 0.0 0.0 1.7 6.4 2.3 3.7 0.0 5.9 2.5 0.0 13.9 0.0 0.4 0.0 0.0 3.2 0.0 5.0 0.0 2.0 12.2 1.5 1.9 0.0 0.4 19.1 23.5 0.1 33.0 10.9 1.1 1.0 6.1 2.7 0.1 0.6 40.3 10.9 0.4 0.2 0.0 0.0 0.2 3.0 1.1 0.2 5.0 9.6 0.4 6.8 1.1 1.4 4.1 1.0 2.3 2.9 1.2 2.0 4.8 4.4 0.3 2.9 3.3 3.8 0.4 3.1 4.6 1.1 1.8 2.4 2.7 3.0 1.2 1.9 3.8 0.8 3.1 0.4 0.0 1.7 22.9 10.8 10.4 14.6 1.7 2.5 13.4 19.4 48.8 2.0 73.5 99.5 3.9 44.5 6.3 29.0 0.0 0.0 24.7 2.6 1.9 7.0 0.0 20.4 0.0 20.3 12.9 16.3 31.8 0.3 12.8 3.3 0.0 25.9 1.8 0.1 43.2 0.4 39.3 28.4 6.5 1.0 0.6 0.5 18.3 205.7 14.1 47.7 1.3 VAX1 ENSG00000148704 "Ventral anterior homeobox 1" Q5SQQ9 10 117128521-117138301 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "brain: 21.8" "Cell type enhanced" "Detected in single" 27 "Cardiomyocytes: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 7.7;WM-115: 5.8" "Group enriched" "Detected in some" 6 "basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8" "Low region specificity" "Detected in many" HPA028946 Uncertain Approved "Nucleoplasm,Nucleoli rim" Yes NA "Nucleoli rim" Nucleoplasm "HPA028946: AB_10602679" "unprognostic (1.08e-2)" "unprognostic (1.92e-2)" "unprognostic (1.46e-1)" "unprognostic (2.96e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (5.72e-2)" "unprognostic (2.09e-1)" "unprognostic (2.99e-1)" 0.4 0.4 1.4 0.4 21.8 0.4 0.4 0.0 7.0 0.5 0.5 9.5 0.0 0.4 0.4 0.4 0.5 0.4 0.5 0.4 1.5 5.2 0.4 0.4 0.4 0.4 0.7 4.3 0.4 0.4 0.7 0.5 0.4 1.2 0.4 0.5 0.0 0.4 0.5 0.7 0.4 0.5 0.4 1.3 0.4 0.4 2.1 2.9 0.0 0.4 0.0 0.4 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.7 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 21.8 0.0 7.0 1.5 5.2 0.7 4.3 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 VAX2 DRES93 ENSG00000116035 "Ventral anterior homeobox 2" Q9UIW0 2 70900590-70965373 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4;retina: 21.2" "Group enriched" "Detected in some" 7 "Bipolar cells: 8.7;Cone photoreceptor cells: 15.7;Horizontal cells: 11.1;monocytes: 7.2;Muller glia cells: 7.2;Rod photoreceptor cells: 17.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 16.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 6.6;MCF7: 7.5;RH-30: 6.5;SCLC-21H: 6.6;SH-SY5Y: 7.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "basal ganglia: 2.1;hypothalamus: 4.7" HPA009708 Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA009708: AB_2668261" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.96e-2)" "unprognostic (3.16e-2)" "unprognostic (1.63e-2)" "unprognostic (2.17e-1)" "unprognostic (3.52e-2)" "unprognostic (7.23e-3)" "unprognostic (2.42e-1)" "unprognostic (1.98e-1)" "unprognostic (3.81e-1)" "unprognostic (2.16e-1)" "unprognostic (7.74e-3)" "unprognostic (6.63e-3)" "unprognostic (4.65e-1)" "unprognostic (6.67e-3)" "unprognostic (2.18e-2)" 2.7 2.6 4.4 1.4 1.9 0.4 2.1 16.4 7.9 1.9 0.8 1.1 0.0 0.5 3.6 0.8 1.8 1.1 0.6 1.5 2.5 4.1 0.6 0.3 0.9 0.6 1.4 1.1 2.3 6.9 0.9 2.2 1.2 0.8 2.3 0.6 21.2 4.5 0.6 2.0 1.5 0.5 1.9 1.6 0.4 0.4 0.8 1.0 0.0 0.7 1.2 0.4 1.1 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 5.0 1.2 6.6 1.8 1.0 3.7 1.2 0.5 0.1 0.0 0.1 0.0 0.0 0.0 2.9 2.2 0.3 2.5 0.0 0.2 0.0 4.1 0.0 0.1 2.8 0.8 0.0 0.0 1.8 0.0 0.3 0.0 1.9 0.6 0.3 0.0 0.0 2.4 7.5 0.0 0.1 2.9 0.0 0.1 0.0 6.5 0.0 2.0 1.6 6.6 7.9 5.1 0.0 2.7 0.2 2.9 0.2 1.2 3.1 0.7 1.5 1.3 0.0 0.0 0.0 1.5 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.9 16.4 2.7 2.5 4.1 1.4 1.1 0.8 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 15.7 0.1 1.7 1.4 0.0 0.4 0.0 0.0 0.6 0.2 0.8 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.2 0.0 7.2 0.6 0.0 0.0 0.0 17.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 VCAM1 CD106 ENSG00000162692 "Vascular cell adhesion molecule 1" P19320 1 100719742-100739045 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "kidney: 69.6;lymphoid tissue: 129.2" "Cell type enhanced" "Detected in many" 21 "Ductal cells: 130.8;Ito cells: 82.3;Kupffer cells: 410.3;Proximal tubular cells: 200.7" "Cancer enriched" "Detected in all" 8 "renal cancer: 89.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 17 "T-cells: 2.9" "Group enriched" "Detected in some" 5 "HHSteC: 58.3;HSkMC: 38.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000154, HPA034796, HPA069867" Enhanced Supported "Cell Junctions" NA NA 624000000 960000000 "Cell Junctions" "CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215" "unprognostic (2.96e-1)" "prognostic favorable (3.82e-4)" "unprognostic (1.31e-1)" "unprognostic (7.49e-3)" "unprognostic (1.04e-1)" "prognostic favorable (7.19e-5)" "unprognostic (1.60e-2)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (1.20e-1)" "unprognostic (3.95e-2)" "unprognostic (8.23e-2)" "unprognostic (1.80e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.55e-2)" 10.9 18.1 1.5 20.2 3.2 1.3 5.2 0.9 1.1 3.7 5.0 3.3 1.4 3.3 4.9 4.5 5.3 4.9 6.8 7.2 1.7 2.3 69.6 11.8 9.8 26.8 2.8 1.7 11.1 6.6 10.6 3.5 10.9 4.2 8.3 5.5 15.3 4.9 1.1 4.7 1.8 6.3 4.2 3.7 129.2 3.0 2.5 1.6 13.3 3.5 2.8 20.9 8.2 2.8 0.0 0.1 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.3 0.1 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 8.4 0.0 0.0 0.0 0.0 58.3 0.0 0.0 38.9 0.0 10.2 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 2.9 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 3.2 0.9 1.1 1.7 2.3 2.8 1.7 4.2 1.6 0.0 6.4 2.4 0.1 8.9 0.0 2.0 0.0 2.7 0.0 3.5 0.0 0.9 8.3 130.8 0.1 16.1 0.0 0.0 2.7 0.8 67.5 0.6 1.1 2.5 3.0 0.0 0.0 82.3 410.3 0.0 15.8 1.9 1.7 0.0 0.0 3.0 2.6 0.0 7.1 200.7 0.0 0.0 14.0 0.0 0.0 6.5 2.3 1.5 0.0 0.0 VCX "VCX-10r, VCX-B1, VCX1, VCX10R" ENSG00000182583 "Variable charge, X-linked" Q9H320 X 7842262-7844143 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 51 "testis: 22.7" "Group enriched" "Detected in some" 8 "Spermatocytes: 368.4;Spermatogonia: 931.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.6;NB-4: 3.8;RPMI-8226: 3.0;THP-1: 3.5;U-138 MG: 3.3;U-266/70: 6.7" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.65e-1)" "unprognostic (3.39e-1)" "unprognostic (1.17e-3)" "unprognostic (1.71e-1)" "unprognostic (1.50e-1)" "unprognostic (2.73e-1)" "unprognostic (7.89e-2)" "unprognostic (6.44e-2)" "unprognostic (1.20e-1)" "unprognostic (7.18e-3)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.8 0.0 3.8 1.8 0.9 0.4 0.5 0.0 3.0 0.0 1.5 0.1 0.2 0.0 0.0 0.0 0.9 1.5 3.5 0.0 3.3 0.8 2.3 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 58.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 72.2 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 84.1 0.0 368.4 931.5 0.0 0.1 0.0 0.0 0.0 VCX2 VCX-2r ENSG00000177504 "Variable charge, X-linked 2" Q9H322 X 8169944-8171267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 106 "testis: 21.5" "Group enriched" "Detected in some" 5 "Spermatocytes: 168.0;Spermatogonia: 388.8" "Cancer enhanced" "Detected in some" "stomach cancer: 0.8;testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "T-47d: 1.8;U-266/70: 2.4" "HPA044642, HPA044996, HPA049357" Enhanced NA NA "HPA044642: AB_2679033, HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 58.2 0.0 168.0 388.8 0.0 0.0 0.0 0.0 0.0 VCX3A "VCX-8r, VCX-A, VCX3" ENSG00000169059 "Variable charge, X-linked 3A" Q9NNX9 X 6533618-6535118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 195 "testis: 28.8" "Group enriched" "Detected in some" 4 "Spermatocytes: 209.9;Spermatogonia: 564.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 7.4;PC-3: 3.7;U-138 MG: 11.2;U-2197: 2.8;U-266/70: 7.0" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (2.43e-1)" "unprognostic (3.29e-2)" "unprognostic (1.64e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 3.7 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 0.0 11.2 0.0 2.8 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.9 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 90.5 0.0 209.9 564.1 0.0 0.2 0.0 0.0 0.0 VCX3B VCX-C ENSG00000205642 "Variable charge, X-linked 3B" Q9H321 X 8464830-8466510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 61 "testis: 21.7" "Group enriched" "Detected in some" 5 "Spermatocytes: 324.1;Spermatogonia: 857.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 19 "U-138 MG: 20.9" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" "unprognostic (1.60e-1)" "unprognostic (1.25e-1)" "unprognostic (1.67e-1)" "unprognostic (7.51e-2)" "unprognostic (2.07e-1)" "unprognostic (4.19e-3)" "unprognostic (4.41e-2)" "unprognostic (3.06e-2)" "unprognostic (1.99e-1)" "unprognostic (3.58e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 20.9 0.0 0.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 41.3 7.5 0.0 1.7 0.0 0.0 0.3 0.1 0.0 1.8 0.0 0.0 109.9 0.0 324.1 857.5 0.3 0.1 0.0 0.0 0.0 VCY "BPY1, VCY1, VCY1A" ENSG00000129864 "Variable charge, Y-linked" O14598 Y 13985772-13986513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 122 "testis: 31.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-266/70: 5.6" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.6 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VCY1B BPY1B ENSG00000129862 "Variable charge, Y-linked 1B" O14598 Y 14056217-14056958 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 113 "testis: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-266/70: 5.6" "HPA044996, HPA049357" Supported NA NA "HPA044996: AB_2679174, HPA049357: AB_2680727" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 5.6 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VDAC1 "MGC111064, PORIN" ENSG00000213585 "Voltage dependent anion channel 1" P21796 5 133971915-134005133 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 189.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005885, HPA030780, CAB072343" Supported Uncertain Vesicles NA NA 4800000 Vesicles "CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608" "prognostic unfavorable (5.30e-4)" "unprognostic (7.63e-3)" "unprognostic (3.07e-3)" "unprognostic (2.01e-1)" "unprognostic (5.11e-3)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (8.49e-4)" "prognostic unfavorable (2.87e-5)" "unprognostic (1.81e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (2.64e-1)" "unprognostic (3.19e-2)" "unprognostic (8.98e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" 22.4 27.0 32.2 18.9 36.6 9.8 22.6 24.4 46.4 13.8 31.3 15.6 20.4 54.0 12.1 42.8 35.2 13.3 25.8 79.0 31.0 32.3 44.9 52.5 16.3 17.3 30.6 29.5 14.6 27.5 31.6 14.1 22.8 41.8 17.9 35.3 23.3 26.6 17.9 189.4 21.9 39.9 18.9 20.7 18.3 32.5 8.3 14.7 16.3 17.3 66.6 25.5 18.9 21.3 18.9 44.7 9.2 36.5 26.5 23.3 20.0 55.6 49.5 45.4 47.0 45.6 63.9 64.1 62.7 46.4 62.4 64.3 101.2 44.8 77.0 47.2 65.3 83.3 43.9 64.0 110.4 78.3 45.4 52.7 44.3 53.0 80.9 46.6 40.6 44.1 58.1 59.3 48.4 54.1 62.5 60.4 39.2 39.4 31.6 81.4 62.1 49.4 40.5 31.7 86.1 42.0 45.6 45.4 73.1 96.9 70.5 50.8 28.7 39.9 48.8 62.5 65.2 23.4 39.9 48.9 58.8 39.2 53.8 81.9 42.4 41.8 48.3 87.3 54.6 66.7 6.4 26.2 9.2 18.5 36.5 20.4 18.9 19.1 19.3 44.7 13.4 13.7 15.1 2.2 26.5 31.2 13.1 23.3 20.0 32.2 36.6 24.4 46.4 31.0 32.3 30.6 29.5 41.8 14.7 98.3 53.8 114.9 202.6 182.0 420.0 257.9 188.5 124.5 83.0 120.4 76.6 339.7 618.4 271.3 51.9 101.8 313.3 0.0 265.3 390.2 136.0 191.2 120.0 170.9 298.9 491.0 99.9 56.4 90.4 40.4 88.6 191.3 236.2 427.4 159.8 195.2 250.0 193.2 105.4 471.4 182.7 84.1 306.0 8.8 29.6 203.5 272.3 89.7 280.1 214.3 VDAC3 HD-VDAC3 ENSG00000078668 "Voltage dependent anion channel 3" Q9Y277 8 42391624-42405897 "Plasma proteins, Predicted intracellular proteins" "Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 187.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026864 Uncertain Supported Mitochondria NA NA 9300000 Mitochondria "HPA026864: AB_1858733" "unprognostic (2.55e-2)" "unprognostic (1.96e-2)" "unprognostic (9.88e-3)" "unprognostic (4.40e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-1)" "unprognostic (4.98e-2)" "unprognostic (2.25e-2)" "unprognostic (1.40e-2)" "unprognostic (5.76e-2)" "unprognostic (3.74e-1)" "unprognostic (1.19e-2)" "unprognostic (6.16e-3)" "unprognostic (2.96e-2)" "unprognostic (1.76e-1)" "unprognostic (8.78e-3)" "unprognostic (6.94e-3)" 19.9 18.8 26.0 13.7 29.8 18.6 17.3 38.3 39.1 16.0 23.7 14.5 12.3 19.1 19.1 17.7 26.8 21.5 13.9 85.8 28.2 35.3 27.9 22.1 12.5 14.6 32.5 24.6 18.1 15.0 17.5 16.5 15.4 44.3 17.6 26.2 16.0 22.2 20.8 187.5 13.0 22.7 22.1 19.6 17.3 16.6 27.4 13.0 20.5 21.6 39.7 18.4 23.1 13.3 34.4 59.4 47.5 44.4 31.4 52.4 81.9 48.6 49.1 38.6 41.1 32.6 28.4 19.2 39.0 33.3 50.2 46.0 37.8 41.7 50.0 37.5 33.0 45.3 31.2 52.1 41.8 55.3 25.4 43.0 76.1 32.8 53.8 23.3 36.6 42.5 22.1 31.8 38.0 17.7 33.5 60.9 44.5 59.6 35.0 51.0 27.0 78.2 42.1 45.9 62.4 32.0 41.4 71.1 35.4 53.9 43.4 34.1 29.3 24.7 29.3 24.5 29.8 61.9 28.0 32.5 19.5 34.1 48.6 37.7 32.6 54.2 57.1 26.2 51.8 32.9 31.1 44.4 47.5 42.1 43.8 42.4 34.4 45.1 41.7 59.4 24.2 45.1 43.3 22.0 31.4 38.5 43.8 52.4 81.9 26.0 29.8 38.3 39.1 28.2 35.3 32.5 24.6 44.3 13.0 41.7 19.5 49.6 71.1 57.4 83.7 294.5 58.6 89.7 33.0 62.8 33.4 118.8 260.2 101.6 108.7 64.1 58.2 46.7 78.4 84.2 75.7 46.5 54.3 48.2 122.7 130.3 45.9 60.2 53.6 110.3 64.2 66.6 69.2 161.5 75.4 54.5 76.5 66.6 91.6 145.2 76.0 64.7 82.1 279.8 154.0 61.9 48.7 63.7 98.4 64.8 VDR "NR1I1, PPP1R163" ENSG00000111424 "Vitamin D receptor" P11473 12 47841537-47943048 "Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 57.1;parathyroid gland: 45.8" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 101.9;Paneth cells: 43.0;Undifferentiated cells: 54.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9" "Group enriched" "Detected in many" 8 "dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 23.0;HDLM-2: 32.4;U-937: 31.8" "Region enhanced" "Detected in single" "olfactory region: 2.5" "Not detected" "Not detected" "CAB004617, HPA047740, HPA072102" Supported "Nucleoplasm,Intermediate filaments,Cytosol" NA NA Nucleoplasm "Intermediate filaments, Cytosol" "CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: " "unprognostic (1.11e-2)" "unprognostic (5.49e-2)" "unprognostic (1.01e-1)" "unprognostic (7.59e-3)" "unprognostic (3.33e-3)" "unprognostic (2.74e-2)" "unprognostic (4.78e-2)" "unprognostic (1.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (6.72e-2)" "prognostic favorable (4.89e-6)" "unprognostic (1.46e-1)" "unprognostic (8.76e-2)" "unprognostic (3.28e-1)" "unprognostic (3.82e-2)" 3.0 9.2 0.2 10.0 0.3 2.5 7.8 0.3 0.6 3.5 40.9 0.4 4.1 21.2 1.2 7.7 10.2 1.1 10.7 1.5 0.5 0.3 13.0 0.6 8.3 3.8 0.5 0.1 1.3 6.5 45.8 11.7 4.4 0.6 2.1 12.6 0.4 4.9 2.8 5.3 15.2 57.1 1.2 1.5 3.1 2.6 1.5 0.2 2.0 1.9 9.4 8.2 4.0 5.2 0.7 5.7 7.5 7.0 0.2 0.8 1.2 5.5 0.9 0.0 0.0 4.8 7.0 0.1 6.8 3.5 5.8 5.0 4.0 4.7 1.4 7.4 4.6 4.1 10.4 0.2 23.0 2.7 32.4 1.7 2.4 1.3 0.3 3.5 4.9 7.8 9.4 10.8 6.4 10.5 9.2 0.4 0.5 0.7 1.5 2.6 3.7 0.1 2.4 0.0 13.8 7.5 0.1 0.0 3.5 5.2 5.5 2.6 0.1 5.8 16.7 2.1 0.0 18.8 2.7 0.4 11.1 2.9 3.2 3.8 0.9 0.0 1.2 3.4 31.8 2.8 0.2 3.7 2.1 0.0 7.0 0.1 0.7 0.3 0.0 5.7 0.1 0.1 0.0 7.5 0.2 6.9 0.6 0.8 1.2 0.2 0.3 0.3 0.6 0.5 0.3 0.5 0.1 0.6 0.2 11.9 15.3 1.9 8.2 32.1 0.4 1.2 0.0 9.4 11.4 7.0 0.0 0.1 6.6 3.7 0.1 0.8 101.9 0.0 9.4 0.1 7.8 3.9 6.9 0.4 3.6 0.0 20.8 0.0 6.6 0.0 0.0 18.7 8.5 6.4 30.0 0.2 14.7 43.0 0.4 17.5 0.2 0.0 2.8 0.7 0.3 35.5 0.2 3.2 54.4 8.4 VEGFC VRP ENSG00000150630 "Vascular endothelial growth factor C" P49767 4 176683538-176792727 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 20.1" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 10.5;Fibroblasts: 7.4;Ito cells: 5.5;Leydig cells: 12.7" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.2" "Cell line enhanced" "Detected in many" "BJ: 41.6;HBF TERT88: 33.9;hTEC/SVTERT24-B: 34.0;LHCN-M2: 37.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 383000 50000 "unprognostic (4.18e-1)" "unprognostic (4.07e-2)" "unprognostic (4.84e-3)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (3.05e-3)" "unprognostic (1.57e-1)" "prognostic unfavorable (7.88e-5)" "unprognostic (4.53e-1)" "unprognostic (2.80e-2)" "unprognostic (2.23e-1)" "unprognostic (1.23e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (1.89e-3)" "unprognostic (4.41e-2)" "unprognostic (2.54e-1)" "unprognostic (1.22e-1)" 8.9 2.0 0.5 1.9 2.0 0.0 20.1 1.5 1.9 4.8 4.5 0.7 2.9 0.8 6.2 1.5 5.5 5.1 7.7 5.9 0.8 1.5 1.7 16.0 3.5 0.0 0.1 3.9 0.5 0.6 0.0 11.6 1.6 4.8 1.6 3.4 4.3 2.7 6.2 0.2 1.6 3.8 1.7 2.6 0.4 2.4 0.4 0.3 17.7 3.4 2.3 6.8 9.2 0.0 0.0 1.2 0.0 0.0 0.0 0.1 1.6 0.8 0.5 0.0 7.6 7.6 0.0 41.6 25.1 23.2 18.5 0.0 0.2 0.0 0.0 23.5 9.7 1.2 0.3 15.7 33.9 0.0 0.8 0.0 1.1 0.0 4.1 0.0 0.0 8.0 0.7 34.0 23.8 23.3 14.3 0.0 0.0 0.0 37.6 0.6 0.0 0.0 0.3 0.0 13.6 0.0 2.4 0.0 0.0 0.9 0.0 0.0 0.6 0.9 0.0 0.2 0.2 0.0 6.9 24.7 2.6 6.0 11.7 0.0 0.0 0.0 10.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 1.2 2.2 0.6 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 2.6 10.5 0.0 0.0 0.0 0.0 7.4 1.9 0.0 0.0 0.3 1.6 0.0 5.5 0.0 1.0 12.7 0.9 3.3 0.0 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 1.7 0.0 1.7 1.8 0.0 0.0 0.0 2.2 VEGFD "FIGF, VEGF-D" ENSG00000165197 "Vascular endothelial growth factor D" O43915 X 15345591-15384376 "Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 39.0" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.2;Club cells: 1.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 6.0;EFO-21: 2.7;HSkMC: 6.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA027342 Uncertain "Secreted to blood" NA NA 592000 340000 "HPA027342: AB_1848597" "unprognostic (5.90e-2)" "unprognostic (9.79e-3)" "unprognostic (1.02e-1)" "unprognostic (1.06e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-1)" "unprognostic (6.06e-3)" "unprognostic (5.57e-2)" "unprognostic (2.24e-3)" "unprognostic (2.65e-2)" "unprognostic (1.59e-5)" "unprognostic (3.08e-2)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (1.75e-2)" 9.5 7.4 0.6 1.8 1.0 0.1 19.5 1.1 0.7 10.5 7.6 0.2 4.1 1.1 10.1 12.9 15.4 2.7 3.5 27.8 0.6 1.1 1.0 1.3 39.0 0.7 0.8 0.2 7.3 2.6 0.2 4.4 0.2 0.8 22.2 1.9 0.2 1.5 1.8 12.0 0.5 4.3 9.8 0.6 2.3 3.4 14.9 0.1 0.0 2.0 17.5 1.2 12.3 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.1 1.8 7.3 6.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 2.7 0.0 0.8 0.5 0.5 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.4 0.0 0.8 6.1 0.7 0.0 0.0 0.1 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.5 0.6 0.4 0.3 0.1 0.6 1.4 0.0 0.7 0.3 0.0 0.1 0.3 0.3 0.4 1.2 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 1.1 0.7 0.6 1.1 0.8 0.2 0.8 0.1 3.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.3 0.0 2.5 9.4 0.0 11.0 24.5 3.3 4.8 0.3 1.7 0.0 4.3 11.8 0.5 0.0 0.1 0.2 18.3 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 14.0 2.8 26.3 65.1 0.0 0.6 0.0 8.9 0.2 0.0 0.0 1.7 0.5 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 0.0 18.9 0.0 38.7 13.1 0.4 4.5 15.1 0.0 0.0 0.0 10.5 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 247.1 124.4 0.0 0.2 1.5 0.0 0.3 12.7 14.7 26.1 29.6 2.0 1.6 39.7 5.5 67.1 0.0 0.0 0.0 8.7 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 63.8 1.4 0.4 27.0 1.0 0.2 0.8 2.0 2.8 0.4 24.1 0.3 0.0 0.0 0.3 0.6 0.4 0.0 0.0 0.6 0.1 VGF "SCG7, SgVII" ENSG00000128564 "VGF nerve growth factor inducible" O15240 7 101162509-101165593 "Plasma proteins, Predicted secreted proteins" "Antibiotic, Antimicrobial, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 59.4;pituitary gland: 30.4" "Group enriched" "Detected in many" 7 "Horizontal cells: 212.9;Intestinal endocrine cells: 123.0" "Cancer enriched" "Detected in many" 6 "melanoma: 236.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 36.7;SK-MEL-30: 99.1;U-2 OS: 18.0;WM-115: 29.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA055177, HPA072505" Enhanced Enhanced "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 1270000 2800000 "Golgi apparatus, Vesicles" "HPA055177: AB_2682728, HPA072505: AB_2686528" "unprognostic (3.04e-2)" "unprognostic (3.45e-1)" "unprognostic (3.19e-3)" "prognostic unfavorable (4.25e-4)" "prognostic unfavorable (3.31e-4)" "unprognostic (1.51e-2)" "unprognostic (2.86e-2)" "unprognostic (1.66e-3)" "unprognostic (2.25e-2)" "unprognostic (8.77e-2)" "unprognostic (3.84e-3)" "unprognostic (3.70e-3)" "unprognostic (9.82e-3)" "unprognostic (3.79e-1)" "unprognostic (7.23e-2)" "unprognostic (4.36e-3)" "unprognostic (2.21e-1)" 3.8 3.1 10.9 2.3 25.2 1.3 1.1 1.3 59.4 1.1 1.5 1.3 0.0 1.3 2.2 1.1 1.1 1.1 1.2 1.2 12.2 51.0 1.4 1.1 1.1 1.1 3.9 22.8 1.1 6.2 1.1 30.4 1.2 41.2 1.2 1.2 0.5 1.1 1.1 1.1 1.4 1.3 1.5 6.6 1.2 3.6 1.4 0.5 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 2.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.5 0.1 0.0 0.6 0.0 0.3 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.4 0.0 4.7 0.0 0.4 3.7 0.2 0.4 0.1 0.0 0.0 0.0 0.0 3.0 36.7 0.0 0.1 99.1 0.2 0.1 0.0 0.0 0.0 18.0 0.0 0.4 0.0 0.1 0.9 2.9 0.0 29.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 25.2 1.3 59.4 12.2 51.0 3.9 22.8 41.2 0.5 0.0 0.0 0.0 1.0 1.3 8.5 2.4 0.0 0.0 0.0 0.0 0.0 1.3 24.9 0.3 0.0 0.3 1.3 0.0 0.0 6.3 0.2 2.8 0.0 0.0 0.5 212.9 123.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.1 1.4 9.5 2.9 0.0 1.0 4.5 0.0 0.2 0.2 4.2 1.9 1.1 0.0 0.9 0.5 VGLL1 "TDU, TONDU" ENSG00000102243 "Vestigial like family member 1" Q99990 X 136532152-136556807 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 124.6" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 1053.7;Extravillous trophoblasts: 494.4;Syncytiotrophoblasts: 1495.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 25.3;BEWO: 39.0;CAPAN-2: 14.2;RT4: 67.0;SK-BR-3: 65.8" "Low region specificity" "Detected in all" "HPA042403, HPA064616" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042403: AB_2677980, HPA064616: AB_2685300" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (5.16e-2)" "unprognostic (1.80e-1)" "unprognostic (4.28e-1)" "unprognostic (6.14e-3)" "unprognostic (1.92e-3)" "unprognostic (1.37e-2)" "unprognostic (5.53e-2)" "unprognostic (3.05e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.6 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.7 1.4 0.4 0.3 0.1 0.1 0.0 3.7 0.1 0.9 0.1 0.1 0.1 0.2 0.6 0.0 1.3 124.6 0.1 2.8 0.0 0.1 5.0 2.3 0.1 0.1 0.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 19.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 3.8 14.2 0.0 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 65.8 0.0 2.8 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 20.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.0 4.5 34.9 0.0 1053.7 0.0 1.3 0.0 0.0 0.0 0.0 0.2 494.4 0.0 2.2 1.1 0.0 93.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1495.8 0.0 0.0 9.8 VGLL2 ENSG00000170162 "Vestigial like family member 2" Q8N8G2 6 117265558-117273565 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 75.9" "Cell type enhanced" "Detected in some" 27 "Cardiomyocytes: 1.7;Hofbauer cells: 1.1" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RH-30: 17.4;U-2 OS: 6.1" "Region enhanced" "Detected in single" "hypothalamus: 0.4" "Not detected" "Not detected" NA NA "unprognostic (3.02e-2)" "unprognostic (3.09e-2)" "unprognostic (1.75e-1)" "unprognostic (4.92e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 9.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 1.7 0.3 75.9 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 1.0 7.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 2.1 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991119 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 195.7" "Group enriched" "Detected in many" 4 "Early spermatids: 105.6;Extravillous trophoblasts: 167.0;Late spermatids: 52.5;Leydig cells: 122.6;Peritubular cells: 140.4;Syncytiotrophoblasts: 67.5" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "U-2197: 106.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054983 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA054983: AB_2682663" "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 22.5 1.0 0.5 3.4 0.5 0.2 8.6 0.2 0.3 6.3 6.2 0.4 3.3 0.6 8.2 7.8 6.1 5.2 6.8 4.3 1.0 0.7 1.8 0.6 16.1 3.6 0.6 0.3 10.6 2.7 0.7 0.4 195.7 0.8 8.0 1.6 2.8 1.9 3.1 7.5 4.0 2.1 11.9 0.8 2.4 2.9 8.0 0.3 0.1 3.4 1.9 1.0 12.2 9.2 1.1 0.6 2.3 0.5 0.8 0.7 0.1 1.5 2.6 14.2 0.0 19.0 23.8 0.2 9.8 6.9 8.4 10.5 3.0 0.6 0.0 0.0 15.3 0.9 1.3 0.9 0.9 11.6 5.5 0.0 0.7 0.9 0.0 8.7 0.1 0.0 18.1 1.5 12.3 5.5 4.5 1.2 0.0 0.0 0.0 10.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 18.9 0.1 0.0 1.6 0.0 0.0 4.2 0.1 0.0 0.5 0.0 0.0 0.5 18.7 2.7 106.2 0.3 0.0 0.0 0.0 3.4 0.0 0.7 2.3 0.5 0.7 0.4 0.3 0.4 0.5 0.5 0.3 0.2 1.1 0.6 0.7 2.0 0.8 0.4 0.6 0.5 0.1 0.5 0.5 0.2 0.3 1.0 0.7 0.6 0.3 0.8 0.3 3.0 2.1 0.0 7.4 7.1 0.0 0.7 0.0 5.3 4.5 10.4 0.0 20.7 0.0 10.3 105.6 1.5 0.0 0.0 2.1 167.0 26.2 18.3 0.0 0.0 6.7 0.0 0.0 4.3 0.0 52.5 122.6 2.4 3.3 0.0 0.0 15.8 8.4 0.0 140.4 0.0 0.3 12.9 17.8 1.4 1.0 4.5 67.5 0.0 0.0 3.7 VHLL "VHLP, VLP" ENSG00000189030 "VHL like" Q6RSH7 1 156298624-156299299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.6;pancreas: 1.6;skeletal muscle: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.0;Daudi: 2.5;hTCEpi: 3.0" NA NA "unprognostic (1.61e-1)" "unprognostic (2.45e-1)" 0.1 0.1 0.1 0.0 0.3 0.0 0.0 2.6 0.2 0.0 0.1 0.0 0.3 0.0 1.2 0.1 0.8 0.1 0.2 0.2 0.0 0.4 0.1 0.1 0.0 0.2 1.6 0.0 0.1 0.1 0.2 0.1 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.2 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.5 0.7 0.0 3.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VIL1 "D2S1471, VIL" ENSG00000127831 "Villin 1" P09327 2 218419092-218453295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Actin capping, Actin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 129.3" "Group enriched" "Detected in many" 5 "Enterocytes: 321.8;Intestinal endocrine cells: 109.0;Mucus-secreting cells: 120.3;Paneth cells: 175.6;Undifferentiated cells: 122.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Group enriched" "Detected in some" 91 "CACO-2: 121.2;Hep G2: 56.9;OE19: 50.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB002452, HPA006884, HPA006885" Enhanced Enhanced "Plasma membrane" NA NA 41000000 "Plasma membrane" "CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.36e-1)" "unprognostic (3.03e-1)" "unprognostic (5.90e-2)" "unprognostic (2.44e-2)" "unprognostic (7.06e-2)" "unprognostic (4.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-3)" "unprognostic (3.90e-1)" "unprognostic (2.58e-1)" "unprognostic (4.79e-2)" "unprognostic (4.65e-2)" 0.3 0.2 0.6 5.7 0.8 0.0 0.3 0.7 0.4 0.3 36.6 0.3 0.3 68.9 0.3 1.2 0.3 0.2 22.6 0.3 0.5 0.5 4.6 6.1 0.3 0.3 0.5 0.3 0.3 7.2 0.0 0.4 0.3 0.3 0.3 32.6 0.3 0.5 0.3 0.3 0.3 129.3 1.2 0.5 0.4 0.9 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 2.5 0.1 0.1 0.1 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 121.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 50.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.1 0.0 0.4 0.0 7.8 0.6 0.8 0.7 0.4 0.5 0.5 0.5 0.3 0.3 0.3 0.0 0.0 0.0 0.2 0.7 2.2 0.4 17.8 0.0 0.0 0.0 2.0 0.2 3.3 6.7 1.5 0.0 321.8 0.0 37.7 0.1 0.6 0.3 9.2 28.8 0.1 1.6 109.0 1.3 2.6 0.0 0.0 1.0 0.0 0.0 120.3 0.8 15.1 175.6 0.0 26.6 1.2 0.0 0.8 0.7 0.9 0.6 0.2 1.0 122.8 0.4 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.3;stomach 1: 52.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 130.9;Paneth cells: 94.7" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.2;OE19: 40.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 2.7 2.1 7.1 12.3 7.2 6.3 3.4 4.7 5.3 5.3 28.0 1.7 3.9 33.2 6.2 3.2 3.8 4.1 21.8 3.3 5.3 4.1 2.8 0.6 7.0 7.3 2.9 4.6 3.9 2.2 0.6 3.4 3.6 2.9 8.5 14.8 4.5 3.8 4.8 1.0 5.1 46.3 3.8 3.4 6.3 52.5 3.5 3.5 12.1 4.5 3.1 9.6 15.0 3.8 5.4 4.6 0.1 3.9 4.0 9.2 4.8 4.2 0.0 0.1 0.2 1.5 1.2 0.4 1.2 1.0 1.2 1.2 3.2 13.2 2.0 1.9 0.8 0.0 1.0 0.9 0.1 0.2 0.4 0.0 3.7 0.0 0.3 1.9 3.9 5.1 1.8 1.2 1.2 0.0 0.0 2.4 8.5 3.7 1.2 1.4 0.0 6.2 4.4 0.1 40.5 0.0 2.4 0.0 1.0 0.4 5.1 0.0 0.1 0.0 0.3 0.9 0.0 0.3 6.4 1.4 0.5 0.2 1.6 0.0 0.7 1.5 0.6 0.3 5.6 2.6 0.0 3.9 0.0 8.7 2.4 9.2 4.4 5.8 4.9 2.6 5.4 7.4 5.4 0.1 4.0 1.6 4.6 6.8 4.8 7.1 7.2 4.7 5.3 5.3 4.1 2.9 4.6 2.9 3.5 8.9 9.0 0.5 5.1 2.1 0.8 1.5 10.2 12.0 14.8 0.0 0.0 2.4 0.0 2.1 4.9 3.7 130.9 0.0 15.4 2.8 3.7 5.4 8.1 0.0 2.0 1.6 9.2 3.1 1.0 14.5 3.4 2.7 1.7 1.8 40.6 26.2 22.9 94.7 2.5 1.4 0.4 0.0 3.8 4.5 2.4 1.3 0.8 10.0 38.0 23.8 VIP ENSG00000146469 "Vasoactive intestinal peptide" P01282 6 152750798-152759765 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 32.5;lymphoid tissue: 64.7" "Group enriched" "Detected in some" 4 "Early spermatids: 7.7;Melanocytes: 27.0" "Group enriched" "Detected in some" 6 "colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 2.2;SH-SY5Y: 7.0;TIME: 4.9;U-2 OS: 2.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA017324, CAB018649, HPA072701, CAB079780" Supported Supported Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 122000 "Endoplasmic reticulum" "CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550" "unprognostic (9.58e-2)" "unprognostic (2.29e-2)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (3.33e-2)" "unprognostic (2.48e-2)" "unprognostic (7.21e-2)" "unprognostic (2.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (3.62e-1)" "unprognostic (2.92e-3)" "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (1.30e-1)" "unprognostic (5.90e-2)" 1.2 5.7 9.7 64.7 8.3 0.3 0.9 1.5 20.1 0.6 31.5 0.5 0.3 7.5 0.7 0.4 13.1 0.5 4.2 1.1 12.4 7.7 0.9 0.6 1.7 0.4 2.7 8.3 0.4 3.8 0.5 0.4 0.5 1.6 6.3 28.3 3.2 0.4 6.9 0.8 0.4 32.5 18.0 0.4 5.2 13.2 0.5 0.1 0.0 1.3 0.5 0.4 9.1 4.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.4 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 7.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 2.0 0.2 0.2 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 9.7 8.3 1.5 20.1 12.4 7.7 2.7 8.3 1.6 0.1 0.0 0.0 0.0 0.0 0.3 0.5 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 7.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 4.2 0.0 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 VIPR1 "HVR1, RDC1, VPAC1, VPAC1R" ENSG00000114812 "Vasoactive intestinal peptide receptor 1" P32241 3 42489299-42537573 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 83.1" "Cell type enhanced" "Detected in many" 14 "Enterocytes: 40.7;Mucus-secreting cells: 38.5;Paneth cells: 92.0;Sertoli cells: 32.3" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.2;intermediate monocyte: 2.6;MAIT T-cell: 1.9;memory CD4 T-cell: 4.8;memory CD8 T-cell: 1.9;myeloid DC: 3.9;naive CD4 T-cell: 5.5;naive CD8 T-cell: 1.7;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 32 "dendritic cells: 3.9;monocytes: 3.2;T-cells: 5.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 27.3;OE19: 15.9;RT4: 19.5;SK-BR-3: 11.1;WM-115: 35.4" "Group enriched" "Detected in many" 5 "amygdala: 6.5;basal ganglia: 4.1;cerebral cortex: 9.2;hippocampal formation: 8.5" "Low region specificity" "Detected in all" HPA026777 Approved NA NA "HPA026777: AB_10604003" "unprognostic (9.02e-2)" "unprognostic (9.34e-3)" "unprognostic (3.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.28e-1)" "unprognostic (1.47e-2)" "unprognostic (8.89e-4)" "unprognostic (4.00e-3)" "unprognostic (1.03e-1)" "unprognostic (2.95e-2)" "unprognostic (1.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-3)" "unprognostic (7.70e-2)" "unprognostic (1.69e-1)" "unprognostic (1.03e-2)" "unprognostic (1.05e-2)" 8.1 1.8 5.6 6.4 11.8 1.3 7.4 10.2 13.8 2.0 17.7 0.6 27.8 22.0 0.9 4.6 2.7 1.0 10.6 3.1 2.9 1.2 1.4 15.4 83.1 5.1 1.3 8.4 0.5 1.4 2.9 1.2 1.9 1.9 13.0 18.1 2.2 9.7 29.0 0.8 12.2 25.9 1.3 0.9 2.7 3.7 0.9 1.3 0.0 7.2 3.2 3.1 6.0 2.4 0.1 3.9 0.1 3.2 0.0 5.5 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.9 27.3 0.1 1.3 0.0 0.0 1.1 0.0 0.7 0.0 0.0 2.1 1.6 0.8 0.0 0.1 0.0 0.2 0.0 1.7 0.1 0.5 0.0 0.3 0.2 0.0 0.0 0.0 2.2 0.0 0.1 1.7 15.9 0.1 0.2 0.0 1.2 0.0 19.5 0.6 0.0 0.0 11.1 0.0 3.3 6.8 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.4 0.0 3.2 0.0 0.4 2.6 1.9 0.1 4.8 1.9 3.9 0.0 5.5 1.7 0.1 0.0 2.3 0.0 0.7 1.3 5.6 11.8 10.2 13.8 2.9 1.2 1.3 8.4 1.9 1.3 3.0 5.9 2.0 4.2 6.8 0.1 1.2 5.1 1.4 2.3 1.8 7.9 0.0 0.0 0.4 0.7 1.4 40.7 0.0 0.8 0.3 0.4 9.6 0.0 0.0 0.6 0.0 4.6 14.7 8.9 0.4 0.0 2.4 0.0 0.0 38.5 1.2 0.8 92.0 0.0 0.0 5.1 32.3 2.2 0.0 0.0 6.8 0.2 1.3 22.9 3.2 VKORC1 VKCFD2 ENSG00000167397 "Vitamin K epoxide reductase complex subunit 1" Q9BQB6 16 31090842-31095980 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 173.3" "Cell type enhanced" "Detected in all" 8 "Hepatocytes: 682.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 98.9" "Low region specificity" "Detected in all" HPA042720 Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Endoplasmic reticulum" "HPA042720: AB_10961864" "unprognostic (5.99e-2)" "unprognostic (2.98e-1)" "unprognostic (7.11e-3)" "unprognostic (7.68e-3)" "unprognostic (5.49e-2)" "unprognostic (3.23e-3)" "unprognostic (3.02e-2)" "unprognostic (2.32e-2)" "unprognostic (2.42e-1)" "unprognostic (2.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.09e-10)" "unprognostic (1.11e-2)" "unprognostic (6.65e-2)" "unprognostic (3.12e-2)" "unprognostic (9.66e-2)" 21.3 23.0 9.3 11.5 11.0 12.9 28.1 9.4 14.5 24.3 19.3 17.1 16.5 12.6 24.0 27.4 18.5 17.8 22.6 20.1 9.8 10.2 29.9 173.3 16.4 17.5 13.7 9.1 25.5 55.5 14.0 25.0 22.5 13.3 22.3 12.6 20.8 34.8 21.4 11.4 15.9 26.8 27.7 12.5 15.4 17.5 18.2 10.6 15.8 25.6 13.8 14.6 28.4 18.7 32.3 49.9 59.6 40.6 24.7 43.7 33.6 10.5 27.1 8.9 25.5 98.9 58.9 9.9 39.1 34.0 19.3 32.8 11.2 12.1 8.3 21.2 48.9 13.6 9.8 12.3 15.3 22.0 11.7 29.9 7.5 37.5 53.9 15.6 14.6 11.3 34.0 8.2 26.6 22.9 52.3 20.8 11.8 9.8 19.8 37.6 38.2 10.7 30.0 16.1 14.6 26.1 19.4 23.7 41.2 19.0 9.2 18.2 22.1 17.1 12.5 19.0 15.0 20.6 17.8 18.1 25.9 9.3 23.7 14.7 12.0 11.1 7.3 67.4 25.3 13.3 21.5 40.6 59.6 40.3 28.1 39.7 29.9 40.5 40.7 39.6 32.3 36.4 35.4 34.2 24.7 28.3 49.9 43.7 33.6 9.3 11.0 9.4 14.5 9.8 10.2 13.7 9.1 13.3 10.6 53.6 38.2 37.9 58.4 75.2 11.2 20.0 119.8 32.1 40.9 102.9 7.9 64.0 53.0 183.3 4.8 87.9 36.0 46.7 112.2 211.1 138.5 58.9 55.3 682.4 166.1 9.5 64.4 119.7 79.0 8.3 146.4 85.1 109.6 129.8 41.2 64.7 107.2 24.6 161.9 160.1 16.9 58.2 95.7 23.7 24.7 97.9 33.1 47.3 51.3 46.5 VLDLR "CARMQ1, CHRMQ1, VLDLRCH" ENSG00000147852 "Very low density lipoprotein receptor" P98155 9 2621834-2660053 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Receptor "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 50.5" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 72.2;Cone photoreceptor cells: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 14.1" "Lineage enriched" "Detected in many" 12 "granulocytes: 14.1" "Cell line enhanced" "Detected in many" "BEWO: 27.2;JURKAT: 21.2;THP-1: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032462, HPA051312" Uncertain Uncertain "Vesicles,Cytokinetic bridge,Centriolar satellite" NA NA 180000 Vesicles "Cytokinetic bridge, Centriolar satellite" "CAB032462: AB_2216805, HPA051312: " "unprognostic (5.31e-2)" "unprognostic (2.65e-1)" "unprognostic (6.92e-2)" "prognostic favorable (5.95e-4)" "unprognostic (1.15e-1)" "unprognostic (2.67e-2)" "unprognostic (2.48e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-2)" "unprognostic (3.79e-2)" "unprognostic (2.33e-1)" "unprognostic (6.75e-2)" "unprognostic (1.48e-2)" "unprognostic (1.93e-1)" "unprognostic (1.80e-2)" "unprognostic (4.34e-2)" 11.3 13.7 7.2 3.7 9.6 1.3 11.2 8.7 7.3 6.9 3.9 12.8 6.5 1.2 12.1 4.3 11.6 15.1 5.5 38.0 7.6 4.5 8.8 2.5 6.9 0.9 13.2 5.3 50.5 20.8 43.6 5.9 9.4 7.7 5.7 2.9 12.3 7.5 4.4 21.2 3.4 1.6 15.7 10.1 5.5 5.8 5.6 10.3 0.0 8.8 12.5 3.9 11.9 6.1 0.1 0.8 14.1 0.1 0.1 1.1 0.0 0.0 2.9 18.8 0.8 2.8 0.2 27.2 8.5 2.8 2.2 6.5 4.7 0.3 0.0 9.2 5.2 1.4 0.2 5.2 5.7 7.3 9.9 1.9 0.1 2.5 2.2 3.0 11.8 2.1 1.2 4.2 0.8 0.4 9.7 1.1 21.2 0.0 16.7 1.3 0.8 2.1 1.6 9.5 1.5 1.1 0.2 0.6 0.0 10.9 1.1 4.2 3.0 0.6 0.9 11.8 14.2 0.4 28.0 0.3 3.1 5.8 0.0 5.6 12.7 5.1 3.0 20.2 9.9 1.1 0.1 0.1 14.1 0.2 0.0 1.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 2.0 0.1 0.0 0.8 0.0 0.0 7.2 9.6 8.7 7.3 7.6 4.5 13.2 5.3 7.7 10.3 14.9 9.1 0.0 1.0 2.4 17.9 72.2 2.5 8.1 2.3 5.2 98.2 11.4 1.7 10.1 4.5 2.7 0.9 0.0 8.9 18.7 14.0 5.0 0.0 1.3 2.1 11.1 10.5 1.3 0.3 1.9 7.2 0.6 10.1 1.8 0.3 2.7 11.2 2.6 10.3 4.4 30.4 0.0 10.3 1.5 7.0 1.8 2.9 1.8 0.6 3.0 VMO1 ENSG00000182853 "Vitelline membrane outer layer 1 homolog" Q7Z5L0 17 4785285-4786433 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9" "Cell type enriched" "Detected in many" 14 "monocytes: 1494.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "non-classical monocyte: 37.9" "Lineage enriched" "Detected in many" 9 "monocytes: 37.9" "Cell line enhanced" "Detected in many" "A549: 6.1;MCF7: 7.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA023038 Uncertain "Secreted to blood" NA NA 1200000 "HPA023038: AB_10964632" "unprognostic (1.30e-1)" "unprognostic (5.71e-2)" "unprognostic (1.65e-3)" "unprognostic (9.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (5.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (7.41e-2)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (2.69e-1)" 3.8 1.3 1.6 5.9 1.4 1.5 1.9 1.2 2.8 2.6 1.4 1.7 0.4 4.4 1.1 1.9 1.1 0.5 2.8 7.1 1.8 2.1 2.1 9.2 7.4 4.9 1.9 1.4 1.1 2.3 21.2 19.9 1.9 3.6 1.7 0.5 13.1 2.9 1.4 8.8 1.3 4.6 1.0 3.3 21.1 0.8 0.9 1.9 1.4 0.7 2.8 1.2 3.5 1.8 0.0 4.4 0.0 37.9 0.1 0.0 1.1 0.5 6.1 0.6 3.6 0.8 1.6 0.7 1.1 2.2 0.3 0.7 1.9 2.3 0.2 0.1 0.3 0.5 1.0 0.0 0.9 0.4 4.4 0.9 0.2 1.1 1.5 1.3 0.0 2.8 1.0 0.9 0.2 0.9 1.3 0.0 0.9 0.6 1.0 1.2 7.9 0.0 1.8 1.6 1.3 2.4 1.3 2.8 0.6 0.0 1.4 0.6 0.9 0.5 0.5 0.6 0.6 2.3 0.2 0.6 2.7 0.2 0.7 0.4 0.1 0.5 0.1 1.0 1.3 1.7 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 37.9 0.0 0.0 1.1 1.6 1.4 1.2 2.8 1.8 2.1 1.9 1.4 3.6 1.9 3.0 10.6 6.9 8.3 7.6 6.1 0.8 2.5 17.4 42.1 0.0 0.0 0.3 1.7 0.8 3.5 1.6 1.7 0.0 1.3 0.2 1.5 9.1 13.9 3.2 17.0 0.0 1.2 104.3 52.6 25.1 0.3 82.9 5.0 1494.2 1.0 0.8 1.1 0.0 1.1 1.4 2.5 12.9 3.4 0.5 1.0 6.4 0.2 0.7 1.0 9.2 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "blood: 193.2" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 872.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "neutrophil: 193.2" "Lineage enriched" "Detected in all" 5 "granulocytes: 193.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: AB_2685348" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 22.0 37.8 20.4 21.9 24.9 13.0 18.6 20.0 28.7 18.2 32.0 27.8 16.7 40.5 18.3 15.4 22.9 14.4 25.2 19.6 21.7 22.3 22.9 43.0 22.4 20.1 23.1 15.6 16.5 22.9 19.0 20.1 27.9 29.8 17.3 29.3 20.0 17.8 13.9 19.8 19.2 39.7 14.3 26.4 36.6 19.0 17.6 16.2 14.4 18.1 12.5 16.8 19.5 17.6 3.3 10.9 193.2 39.9 3.8 4.1 24.7 20.3 41.0 13.3 20.5 28.5 17.5 21.4 32.4 23.1 20.2 27.2 26.8 29.3 11.7 48.4 21.9 22.1 25.3 15.4 18.6 25.2 30.0 19.3 15.0 23.5 28.2 27.8 17.0 18.4 26.8 15.9 26.0 22.1 16.2 21.4 10.0 19.6 20.7 20.9 56.0 15.8 8.9 15.0 42.3 21.1 8.7 23.4 24.1 25.0 23.8 9.6 21.7 18.5 15.7 21.5 19.1 32.5 14.6 30.2 27.2 26.0 21.6 26.7 32.2 36.9 16.3 30.0 10.4 27.4 7.0 35.1 4.4 3.8 24.4 4.0 3.3 3.7 4.0 10.9 2.8 3.5 3.8 193.2 3.8 39.9 3.6 4.1 24.7 20.4 24.9 20.0 28.7 21.7 22.3 23.1 15.6 29.8 16.2 83.4 125.2 71.3 872.7 143.1 32.8 26.9 112.1 278.4 247.9 261.7 55.0 83.1 19.9 167.6 5.2 128.4 394.9 0.0 118.5 105.1 178.7 606.4 129.6 93.2 107.6 27.0 298.1 52.2 269.6 8.8 33.1 306.0 123.2 55.9 173.1 46.7 132.9 326.1 33.2 57.2 44.2 90.5 178.6 63.8 38.3 113.3 147.0 90.6 149.1 526.3 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 4.8;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 6.2;U-266/70: 5.6;U-266/84: 6.7" HPA062209 Uncertain Nucleoplasm,Vesicles NA NA Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.5 0.7 0.4 1.9 0.0 0.2 0.2 0.9 0.2 0.3 0.0 0.4 0.2 0.7 0.0 6.2 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.7 0.1 0.4 1.0 0.2 0.6 0.3 0.9 0.9 0.3 0.4 2.1 0.5 0.1 0.6 0.4 1.2 0.9 0.6 1.1 3.4 1.4 0.0 0.5 0.1 1.0 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.6 6.7 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 0.0 0.6 0.5 0.0 0.0 4.8 0.2 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.7 0.0 3.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 VN1R2 V1RL2 ENSG00000196131 "Vomeronasal 1 receptor 2" Q8NFZ6 19 53258292-53261837 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 5.0;testis: 3.2" "Group enriched" "Detected in some" 10 "Early spermatids: 16.0;Late spermatids: 7.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" HPA044551 Uncertain NA NA "HPA044551: AB_2678982" "unprognostic (9.54e-2)" "unprognostic (3.17e-1)" "unprognostic (1.06e-1)" 0.2 0.2 0.4 0.8 0.4 0.5 0.3 0.6 0.8 0.2 0.3 0.2 0.5 1.6 0.3 0.2 0.0 5.0 0.4 0.4 0.3 0.3 0.2 1.7 0.3 0.6 0.2 0.3 0.2 0.0 0.3 0.0 0.4 0.0 0.4 0.9 0.6 0.0 0.3 0.3 0.2 3.2 0.5 0.0 0.3 0.3 0.8 0.5 1.3 0.5 0.6 1.1 0.2 0.8 0.8 0.8 1.3 0.0 0.0 0.3 1.1 0.0 0.0 0.3 0.0 2.2 2.0 0.5 0.5 0.7 0.6 0.0 0.0 0.0 0.8 0.8 1.2 2.7 1.6 0.0 0.2 1.7 0.6 0.4 0.2 0.0 0.6 0.0 0.7 0.8 0.7 0.4 0.9 0.4 1.1 0.5 0.3 0.7 1.1 2.1 0.0 0.5 2.3 1.3 1.3 0.2 0.8 0.3 0.4 1.4 0.1 1.7 1.0 0.8 1.3 0.4 1.7 0.6 0.8 1.2 0.5 0.8 0.4 0.5 0.5 1.1 0.3 0.4 0.2 0.4 0.2 0.2 0.8 0.3 1.0 1.3 0.6 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 VN1R4 V1RL4 ENSG00000228567 "Vomeronasal 1 receptor 4" Q7Z5H5 19 53266676-53267723 "G-protein coupled receptors, Predicted membrane proteins" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.3" HPA027018 Uncertain NA NA "HPA027018: AB_10603142" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 VNN1 Tiff66 ENSG00000112299 "Vanin 1" O95497 6 132681590-132714049 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 131.9;liver: 112.2" "Group enriched" "Detected in many" 5 "Cholangiocytes: 71.4;Ductal cells: 179.6;Hepatocytes: 68.4;Pancreatic endocrine cells: 77.2" "Cancer enhanced" "Detected in many" "liver cancer: 41.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "classical monocyte: 13.4" "Group enriched" "Detected in many" 71 "dendritic cells: 4.9;granulocytes: 8.0;monocytes: 13.4" "Cell line enhanced" "Detected in some" "A-431: 4.1;CAPAN-2: 4.3;EFO-21: 15.1;HBEC3-KT: 4.0;LHCN-M2: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA064145 Uncertain "Intracellular and membrane" NA NA 1100000000 "HPA064145: AB_2685197" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (9.95e-2)" "unprognostic (1.35e-3)" "unprognostic (6.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.20e-1)" "unprognostic (4.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (4.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (2.26e-2)" "unprognostic (4.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.34e-1)" 1.8 0.4 0.3 0.6 0.3 2.4 0.7 0.2 0.3 0.4 128.6 0.1 0.0 40.6 2.5 0.2 0.6 1.7 27.0 1.1 0.3 0.3 6.5 112.2 7.9 2.4 0.4 0.1 0.4 0.9 0.0 0.3 1.0 0.5 0.4 0.3 0.2 1.5 0.1 0.4 0.5 131.9 0.0 0.5 5.6 0.8 0.5 0.1 0.2 0.4 0.0 0.4 0.4 0.9 0.1 4.9 8.0 13.4 0.0 0.0 3.6 4.1 0.0 0.5 0.1 0.1 1.3 0.9 0.3 0.3 0.0 0.0 0.1 4.3 0.2 15.1 0.0 0.8 0.1 0.0 4.0 1.1 0.1 0.0 0.2 0.2 2.3 2.3 0.3 0.1 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 4.3 0.2 0.0 0.6 0.1 0.1 0.2 0.1 0.2 1.8 0.9 0.3 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.7 1.0 0.1 0.5 0.2 0.4 0.0 0.1 0.5 0.1 0.6 2.3 13.4 0.0 0.0 7.4 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 8.0 0.0 10.2 0.2 0.0 3.6 0.3 0.3 0.2 0.3 0.3 0.3 0.4 0.1 0.5 0.1 0.0 4.8 0.0 0.0 1.1 0.0 0.3 71.4 1.4 1.2 1.8 0.0 0.0 0.0 179.6 0.0 0.0 13.2 0.0 17.0 0.1 0.2 3.1 0.0 68.4 13.9 0.0 0.0 0.6 13.9 0.0 0.0 10.6 0.0 5.4 4.3 0.0 77.2 0.9 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 9.9 VNN2 "FOAP-4, GPI-80" ENSG00000112303 "Vanin 2" O95498 6 132743870-132763459 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 85.2;lung: 36.4;lymphoid tissue: 43.6" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 17.4;Ductal cells: 36.1;Kupffer cells: 27.8;Macrophages: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 8 "neutrophil: 85.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 85.2" "Cell line enriched" "Detected in some" 8 "Daudi: 35.7" "Not detected" "Not detected" NA NA 270000 "unprognostic (2.13e-1)" "unprognostic (1.15e-1)" "unprognostic (9.60e-3)" "unprognostic (5.71e-2)" "unprognostic (2.14e-1)" "unprognostic (5.61e-3)" "unprognostic (1.98e-3)" "unprognostic (4.38e-1)" "unprognostic (3.07e-1)" "unprognostic (3.46e-1)" "unprognostic (2.84e-1)" "unprognostic (8.30e-2)" "prognostic unfavorable (2.72e-7)" "unprognostic (1.62e-1)" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (5.45e-2)" 10.1 1.4 1.1 9.5 1.1 10.8 1.4 1.4 1.4 1.8 1.9 0.8 0.0 0.7 0.9 3.1 2.1 4.3 10.2 10.5 1.1 1.1 2.8 5.6 36.4 39.8 3.8 0.3 2.1 2.4 0.0 1.2 8.6 1.5 2.4 0.9 1.8 1.3 0.2 1.0 0.7 3.6 2.4 2.2 43.6 2.8 3.6 0.6 3.4 1.4 0.7 17.7 7.3 10.9 6.4 2.2 85.2 10.9 5.8 6.7 5.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.7 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.9 0.0 0.0 1.5 10.9 0.0 4.2 2.4 1.7 6.4 1.4 4.9 2.2 5.5 4.5 6.7 85.2 5.8 1.5 0.4 0.9 5.7 1.1 1.1 1.4 1.4 1.1 1.1 3.8 0.3 1.5 0.6 0.0 10.7 0.0 0.0 0.0 0.0 1.2 2.5 17.4 3.4 0.0 0.0 0.6 0.0 36.1 0.0 0.0 0.0 0.0 0.3 0.1 0.5 5.6 4.7 0.0 11.3 0.0 0.0 4.3 27.8 0.0 0.0 17.1 0.0 1.8 0.0 0.0 4.0 0.0 0.0 0.3 0.0 6.5 0.5 0.0 0.0 0.0 1.1 6.1 0.0 8.4 VNN3 HSA238982 ENSG00000093134 "Vanin 3" Q9NY84 6 132722787-132734765 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 39.5;bone marrow: 29.8;liver: 29.4" "Group enriched" "Detected in some" 5 "Ciliated cells: 69.6;Club cells: 19.4" "Cancer enhanced" "Detected in some" "liver cancer: 3.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "neutrophil: 39.5" "Lineage enriched" "Detected in single" 40 "granulocytes: 39.5" "Cell line enhanced" "Detected in some" "Daudi: 2.5;EFO-21: 3.7;GAMG: 1.6;hTCEpi: 2.3" "Secreted to blood" NA NA 150000000 "unprognostic (3.20e-2)" "unprognostic (2.70e-1)" "unprognostic (7.92e-3)" "unprognostic (1.71e-2)" "unprognostic (3.05e-3)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.01e-1)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "unprognostic (5.84e-8)" "unprognostic (1.25e-2)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.56e-1)" 1.1 0.1 0.4 3.3 0.4 29.8 0.2 0.2 0.6 2.4 1.2 0.2 0.2 0.0 0.2 0.8 0.9 2.4 1.3 1.0 0.4 0.0 0.3 29.4 6.1 1.2 0.4 0.2 1.2 0.2 0.0 0.2 5.8 0.3 0.5 0.0 0.4 1.1 0.2 0.2 0.1 0.2 0.2 0.2 7.6 0.4 0.3 0.2 0.2 0.3 2.4 0.7 0.6 0.3 0.0 0.0 39.5 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 2.5 3.7 0.0 1.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 6.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.5 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.2 0.6 0.4 0.0 0.4 0.2 0.3 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.0 69.6 19.4 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 9.7 0.1 0.0 0.0 0.6 9.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 VPREB1 "CD179A, VpreB" ENSG00000169575 "V-set pre-B cell surrogate light chain 1" P12018 22 22244675-22245515 "CD markers, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 8.1;bone marrow: 23.8;lymphoid tissue: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory B-cell: 5.8;naive B-cell: 8.1" "Lineage enriched" "Detected in many" 5 "B-cells: 8.1" "Group enriched" "Detected in some" 11 "Daudi: 8.6;MOLT-4: 18.3;RPMI-8226: 4.9" "Not detected" "Not detected" HPA055886 Uncertain "Intracellular and membrane" NA NA "HPA055886: AB_2682956" 0.0 0.0 0.0 2.2 0.0 23.8 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 1.3 0.0 4.8 0.0 0.0 1.2 0.0 0.0 8.1 1.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 VPREB3 8HS20 ENSG00000128218 "V-set pre-B cell surrogate light chain 3" Q9UKI3 22 23752743-23754468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9" "Cell type enriched" "Detected in some" 41 "B-cells: 216.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 730 "memory B-cell: 79.9;naive B-cell: 90.4" "Lineage enriched" "Detected in single" 775 "B-cells: 90.4" "Group enriched" "Detected in some" 45 "Daudi: 58.3;REH: 68.9;U-698: 18.2" "Not detected" "Not detected" HPA003041 Supported "Intracellular and membrane" NA NA "HPA003041: AB_1080577" "unprognostic (2.06e-3)" "unprognostic (4.75e-3)" "unprognostic (2.35e-1)" "unprognostic (2.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.75e-2)" "unprognostic (4.79e-2)" "unprognostic (6.63e-3)" "unprognostic (9.15e-2)" "unprognostic (1.38e-2)" "unprognostic (4.93e-2)" "unprognostic (4.84e-2)" "unprognostic (8.44e-2)" "unprognostic (4.19e-2)" "unprognostic (1.18e-1)" "unprognostic (2.87e-1)" "unprognostic (4.12e-1)" 0.5 9.2 0.7 62.6 0.9 7.5 0.3 0.7 0.8 0.3 1.3 0.3 0.2 0.2 0.3 27.9 2.3 0.1 0.7 0.4 0.6 0.7 1.1 0.9 1.2 77.9 0.8 0.2 0.3 0.3 0.1 1.4 0.3 0.2 0.6 0.9 0.4 4.8 0.2 0.8 0.4 32.7 0.2 0.5 31.6 1.4 1.4 0.2 1.6 0.8 1.0 36.0 3.1 0.2 90.4 0.0 0.1 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 58.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.3 68.9 0.1 1.0 0.0 0.0 0.1 0.2 0.0 0.1 0.8 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.3 0.0 18.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.9 0.0 0.0 0.0 90.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.7 0.9 0.7 0.8 0.6 0.7 0.8 0.2 0.2 0.2 0.0 0.3 216.6 0.6 0.3 4.6 0.4 2.5 0.0 1.2 0.0 2.0 0.0 1.7 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.2 0.0 5.2 0.0 0.3 0.0 0.0 0.0 5.0 0.0 0.6 0.7 0.1 0.0 0.0 1.4 1.7 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.6 0.4 VRK1 ENSG00000100749 "Vaccinia related kinase 1" Q99986 14 96797304-96931722 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.0" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 93.5;Spermatocytes: 141.1;Spermatogonia: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000660, HPA017929" Enhanced Supported Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA000660: AB_1080579, HPA017929: AB_1858770" "unprognostic (1.03e-1)" "unprognostic (1.17e-2)" "unprognostic (1.84e-2)" "unprognostic (2.24e-3)" "unprognostic (5.42e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.20e-2)" "unprognostic (2.11e-2)" "unprognostic (5.47e-2)" "unprognostic (5.14e-2)" "unprognostic (1.60e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (4.56e-2)" "unprognostic (3.36e-2)" "unprognostic (1.58e-1)" 6.0 4.4 7.1 9.8 17.1 39.0 8.7 8.6 10.2 6.1 7.8 4.4 4.1 5.2 5.9 5.7 9.4 6.9 3.3 6.0 7.4 6.5 6.2 4.3 4.5 18.3 6.9 6.1 5.9 3.7 3.8 5.1 7.1 6.7 5.3 9.1 4.1 4.8 4.1 4.3 6.4 6.9 5.4 6.1 15.7 6.7 33.3 6.9 33.0 4.9 6.1 18.4 5.9 5.7 20.8 13.5 20.1 9.5 28.5 22.3 12.5 15.8 9.1 22.7 10.1 2.7 5.0 14.1 12.0 9.3 19.2 19.2 10.9 15.8 40.4 8.1 7.1 11.8 17.6 21.2 15.7 26.5 23.0 11.3 25.1 6.0 11.1 3.0 48.4 15.8 2.7 2.8 14.5 10.6 3.9 13.3 31.0 21.4 25.6 16.5 18.1 38.4 20.8 14.5 12.1 17.5 36.0 39.7 13.7 8.8 16.4 16.0 9.1 10.6 10.8 8.1 11.9 12.4 19.2 7.1 8.8 7.8 15.1 12.0 13.4 15.8 39.1 13.7 21.2 10.4 20.1 7.6 14.5 15.1 9.3 18.4 20.3 17.6 18.5 9.9 20.8 19.1 19.3 4.5 28.5 9.5 13.5 22.3 12.5 7.1 17.1 8.6 10.2 7.4 6.5 6.9 6.1 6.7 6.9 3.0 2.9 30.5 11.8 14.9 12.3 10.6 15.3 42.8 13.6 14.0 7.9 19.7 10.0 9.8 13.3 11.3 2.4 93.5 16.8 39.6 10.4 5.3 27.7 2.4 16.3 9.5 2.9 6.2 9.7 10.8 5.2 11.5 11.8 12.6 8.0 5.2 7.6 0.0 9.2 8.4 6.6 19.4 11.3 141.1 122.1 12.2 12.6 26.7 11.2 8.4 VRK3 ENSG00000105053 "Vaccinia related kinase 3" Q8IV63 19 49976467-50025946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 77.2" "Group enriched" "Detected in all" 6 "Early spermatids: 469.4;Late spermatids: 1260.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056489 Approved Supported Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA056489: AB_2683150" "unprognostic (2.09e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-1)" "unprognostic (4.94e-3)" "unprognostic (1.23e-1)" "unprognostic (2.22e-3)" "unprognostic (9.78e-2)" "unprognostic (3.47e-1)" "unprognostic (8.79e-2)" "unprognostic (2.48e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-1)" "prognostic favorable (1.83e-4)" "unprognostic (9.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.06e-1)" "prognostic favorable (5.66e-4)" 9.7 11.9 9.2 9.4 12.7 10.7 8.3 12.0 14.1 8.9 13.4 11.9 9.3 13.4 15.7 10.8 8.4 18.0 12.2 7.4 9.3 11.1 16.7 16.2 8.5 13.4 10.4 9.9 11.2 11.5 7.1 11.8 10.7 9.8 9.4 11.7 14.2 14.3 8.5 11.8 7.7 17.3 7.5 11.0 12.8 10.9 77.2 9.1 24.7 14.1 6.0 12.9 9.9 8.0 24.5 19.7 47.3 20.9 33.5 30.1 18.1 16.0 16.7 12.3 13.2 16.3 15.1 12.8 11.6 13.9 17.3 19.1 8.9 18.0 19.4 8.3 11.2 12.1 12.0 11.4 9.9 14.0 16.9 23.4 15.1 10.1 15.4 12.3 18.8 26.6 13.5 14.9 10.0 10.6 15.5 14.2 21.3 18.3 29.0 12.4 6.8 25.4 12.7 6.6 28.6 14.4 20.5 12.9 24.8 14.7 17.0 13.8 6.7 11.4 14.0 12.6 11.4 12.9 20.1 10.7 17.7 10.3 7.1 9.0 18.8 23.9 10.2 14.2 11.7 12.1 37.0 17.8 32.4 23.8 18.8 19.1 24.5 21.7 22.7 19.7 21.9 22.1 20.4 47.3 33.5 20.9 18.8 30.1 18.1 9.2 12.7 12.0 14.1 9.3 11.1 10.4 9.9 9.8 9.1 6.0 29.4 27.3 13.1 6.0 34.9 7.1 20.4 56.2 26.1 14.0 135.5 38.6 26.6 25.3 469.4 15.8 62.6 23.3 28.7 31.8 13.8 24.2 17.4 37.6 29.7 30.2 21.4 25.2 25.0 1260.7 20.4 23.9 13.5 47.7 27.2 28.4 29.0 71.9 24.4 60.6 112.4 12.9 10.5 91.2 49.8 9.5 47.9 33.7 27.6 26.7 VRTN "C14orf115, FLJ10811, vertnin" ENSG00000133980 "Vertebrae development associated" Q9H8Y1 14 74303069-74360008 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;lymphoid tissue: 4.5;testis: 5.8" "Cell type enhanced" "Detected in single" 25 "Spermatocytes: 1.9" "Cancer enriched" "Detected in single" 40 "testis cancer: 15.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "NTERA-2: 33.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA001460 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA001460: AB_1078318" "unprognostic (1.20e-1)" "unprognostic (4.31e-2)" "unprognostic (1.37e-1)" "unprognostic (5.98e-2)" "unprognostic (1.35e-1)" "unprognostic (3.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.77e-1)" 0.1 0.1 0.1 2.2 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.6 0.0 4.9 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.5 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 0.2 0.2 5.8 0.0 0.0 0.1 0.0 1.9 0.1 0.1 0.8 1.2 1.4 0.5 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.4 0.5 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.8 0.3 0.4 1.4 0.8 0.5 1.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 VSIG1 MGC44287 ENSG00000101842 "V-set and immunoglobulin domain containing 1" Q86XK7 X 108044970-108079184 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 29.5;stomach 1: 66.6;testis: 87.4" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 23.8;Alveolar cells type 2: 14.1;Late spermatids: 8.0;Pancreatic endocrine cells: 19.7" "Group enriched" "Detected in many" 17 "lung cancer: 8.7;pancreatic cancer: 17.7;stomach cancer: 31.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 11.7;T-reg: 11.2" "Lineage enriched" "Detected in many" 4 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HBEC3-KT: 5.8;HUVEC TERT2: 11.9;PC-3: 4.0;TIME: 3.0" "Not detected" "Not detected" "HPA001445, HPA036310, HPA036311" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA001445: AB_10669749, HPA036310: AB_10670795, HPA036311: AB_10673350" "unprognostic (4.33e-3)" "unprognostic (4.60e-2)" "unprognostic (3.22e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-1)" "unprognostic (4.80e-2)" "unprognostic (3.25e-2)" "unprognostic (9.79e-2)" "unprognostic (4.58e-1)" "unprognostic (2.35e-2)" "unprognostic (2.11e-2)" "unprognostic (1.25e-1)" "unprognostic (6.31e-7)" "unprognostic (1.48e-1)" "unprognostic (1.07e-1)" "unprognostic (2.19e-2)" "unprognostic (2.23e-3)" 0.1 0.0 0.1 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.3 0.8 0.1 0.3 0.1 0.2 0.2 0.0 29.5 0.1 0.1 0.1 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.0 1.3 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 66.6 87.4 0.1 0.1 0.1 0.1 0.4 1.5 0.1 2.6 0.1 0.6 0.1 0.2 11.7 2.5 0.2 1.0 0.0 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.5 0.0 5.8 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.3 0.4 1.0 0.1 1.9 0.1 11.9 0.1 0.1 0.3 0.0 0.4 0.4 0.3 0.4 1.1 4.0 0.4 0.0 0.0 0.7 1.1 0.2 0.1 0.2 0.2 0.6 0.0 0.1 0.0 3.0 0.3 0.9 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 1.0 0.0 3.7 2.6 7.7 3.3 0.0 1.0 11.7 5.4 0.4 0.2 0.1 0.1 11.2 2.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 23.8 14.1 0.0 0.6 0.6 0.8 0.4 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 4.1 0.0 0.2 0.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 8.0 0.6 0.2 0.0 0.0 0.0 0.1 19.7 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.5 0.0 0.1 0.5 0.0 0.9 VSIG10 ENSG00000176834 "V-set and immunoglobulin domain containing 10" Q8N0Z9 12 118063593-118136026 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 60.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 22.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062022 Enhanced Approved "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA062022: AB_2732675" "unprognostic (1.32e-1)" "unprognostic (7.76e-2)" "unprognostic (2.05e-1)" "unprognostic (4.62e-3)" "unprognostic (1.09e-1)" "unprognostic (6.42e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (2.49e-1)" "unprognostic (1.75e-1)" "unprognostic (2.85e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.48e-2)" 8.1 10.2 2.6 9.8 3.1 0.4 18.0 2.9 2.6 8.2 31.6 2.7 5.2 11.7 4.5 4.5 8.9 4.0 7.6 3.6 2.4 2.2 6.2 11.9 11.6 3.8 3.2 1.4 5.9 10.9 8.9 4.0 12.2 3.4 8.4 13.9 4.0 6.3 6.4 12.9 4.6 60.9 3.8 2.5 3.3 5.5 3.9 2.5 1.7 26.3 6.1 4.9 6.1 8.6 0.7 2.4 3.5 2.0 0.4 0.6 0.4 4.9 7.3 3.1 10.5 13.1 5.9 7.9 8.5 5.5 4.2 3.5 2.1 11.8 0.7 3.4 6.3 7.9 12.1 22.0 2.2 5.0 2.4 3.3 1.1 6.9 3.2 2.6 0.6 1.8 2.7 6.4 3.2 2.0 12.3 9.2 2.4 1.4 0.1 3.9 5.2 0.0 0.7 9.7 14.5 4.6 1.8 8.6 0.0 6.2 16.1 2.7 3.4 8.3 3.5 2.2 7.0 7.7 3.3 10.7 4.9 3.1 6.0 4.3 0.1 0.1 0.0 7.1 3.5 9.7 0.6 2.0 2.3 0.4 0.6 0.6 0.0 0.4 0.2 2.4 0.7 0.4 0.6 3.5 0.4 0.2 0.7 0.6 0.4 2.6 3.1 2.9 2.2 2.4 2.2 3.2 1.4 3.4 2.5 17.9 22.9 0.8 12.2 2.2 9.7 9.2 20.4 4.0 6.8 27.9 11.8 33.6 16.6 22.4 5.1 15.5 75.3 0.0 17.6 31.6 6.0 13.2 2.3 24.2 9.5 4.8 48.5 16.5 4.3 6.5 16.7 7.2 3.3 10.8 45.7 23.2 20.5 45.6 13.8 9.9 8.0 0.0 5.6 3.9 6.5 2.8 11.7 2.9 51.9 14.0 VSIG10L ENSG00000186806 "V-set and immunoglobulin domain containing 10 like" Q86VR7 19 51331536-51342124 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Melanocytes: 5.0;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 5.9;OE19: 13.7;T-47d: 10.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA060453, HPA066745" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA060453: AB_2684280, HPA066745: AB_2685712" "unprognostic (1.70e-2)" "unprognostic (1.95e-2)" "unprognostic (1.30e-2)" "unprognostic (2.98e-3)" "unprognostic (1.08e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (8.75e-4)" "unprognostic (2.40e-3)" "unprognostic (2.78e-1)" "unprognostic (9.87e-2)" "unprognostic (2.62e-2)" "unprognostic (1.87e-1)" "unprognostic (2.90e-4)" "unprognostic (1.42e-2)" "unprognostic (8.51e-2)" "unprognostic (7.74e-2)" "unprognostic (5.19e-3)" 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.1 9.8 0.1 0.0 2.0 0.1 0.6 0.0 70.9 0.0 0.9 0.1 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 72.9 2.6 0.2 4.9 0.2 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 37.6 52.2 0.1 10.8 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.1 1.2 0.1 0.5 0.5 0.1 0.2 0.1 0.1 0.0 0.1 0.4 0.9 0.7 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.7 0.1 0.2 5.9 0.0 0.0 1.0 0.0 0.7 0.2 0.0 0.0 0.0 0.3 0.5 1.7 0.0 0.5 0.0 0.1 0.8 13.7 0.6 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 10.8 0.0 0.1 0.0 0.2 0.9 0.0 1.4 0.9 0.1 0.7 0.2 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.8 1.1 0.6 1.7 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.1 0.4 0.7 0.0 0.0 0.7 1.4 0.9 1.1 1.0 4.0 9.5 1.2 1.3 3.2 0.0 2.0 1.8 5.0 1.8 0.6 1.2 0.4 0.2 3.9 0.8 0.4 6.5 1.0 0.5 2.2 0.4 0.5 0.0 0.4 0.3 VSIG10L2 ENSG00000283703 "V-set and immunoglobulin domain containing 10 like 2" P0DP72 11 125946056-125958647 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.6;skin 1: 20.4" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 4.0;Club cells: 3.4;Ductal cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;AN3-CA: 1.1;SH-SY5Y: 2.7;SK-BR-3: 1.4" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 2.3 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 2.8 0.0 0.0 20.4 0.2 0.6 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 3.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VSIG2 "CTH, CTXL" ENSG00000019102 "V-set and immunoglobulin domain containing 2" Q96IQ7 11 124747472-124752238 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.2;stomach 1: 105.5" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 296.5;Mucus-secreting cells: 283.0;Paneth cells: 482.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "OE19: 98.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA035919, HPA050147" Enhanced Approved Nucleoplasm NA NA 81000 Nucleoplasm "HPA035919: AB_10669981, HPA050147: AB_2681032" "unprognostic (1.64e-3)" "unprognostic (1.21e-1)" "unprognostic (1.10e-2)" "unprognostic (1.90e-1)" "unprognostic (2.00e-1)" "unprognostic (2.18e-3)" "unprognostic (2.16e-1)" "unprognostic (2.22e-2)" "unprognostic (3.47e-3)" "unprognostic (2.02e-1)" "unprognostic (6.01e-2)" "unprognostic (2.78e-2)" "unprognostic (2.99e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (1.87e-1)" "unprognostic (1.36e-2)" 1.3 0.1 0.3 11.2 0.4 0.2 3.3 0.3 0.5 5.2 23.5 0.7 0.3 0.7 1.0 0.8 8.6 2.9 38.2 0.6 0.3 0.2 1.6 0.7 25.3 0.3 0.3 0.3 2.2 0.4 0.0 0.3 0.7 0.5 18.5 24.3 0.4 12.4 0.8 0.3 0.3 2.0 3.5 0.3 0.3 105.5 1.2 0.3 0.3 28.9 3.1 5.3 26.0 14.7 0.3 1.4 0.6 3.8 0.8 2.1 2.7 0.0 0.0 1.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 1.7 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 98.4 0.8 0.0 0.8 0.0 0.0 16.0 0.0 0.2 0.0 1.0 0.0 0.1 0.1 0.5 0.9 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.0 3.8 0.0 0.0 0.6 1.6 0.0 1.8 0.3 1.4 0.3 2.0 1.6 0.6 0.8 0.5 0.0 2.1 2.7 0.3 0.4 0.3 0.5 0.3 0.2 0.3 0.3 0.5 0.3 116.1 39.3 0.0 14.5 0.7 0.6 0.4 76.5 17.4 43.3 3.5 0.0 0.0 1.7 4.7 0.0 4.5 296.5 0.0 82.7 0.0 0.5 69.3 1.1 0.0 0.1 0.0 64.2 4.3 0.3 0.0 1.4 2.3 3.3 0.0 283.0 0.0 152.0 482.9 0.0 0.0 0.0 0.0 4.4 0.3 0.4 0.4 0.0 0.0 145.8 135.8 VSIG8 ENSG00000243284 "V-set and immunoglobulin domain containing 8" P0DPA2 1 159854316-159862657 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "tongue: 83.5" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 10.0;Collecting duct cells: 5.2;Intestinal endocrine cells: 3.5;Suprabasal keratinocytes: 4.0" "Group enriched" "Detected in some" 6 "cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0" "Region enriched" "Detected in single" 13 "cerebellum: 4.2" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.4;U-87 MG: 2.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA023219 Uncertain NA NA "HPA023219: AB_1845635" "unprognostic (8.66e-3)" "unprognostic (2.17e-1)" "unprognostic (2.74e-1)" "unprognostic (9.13e-3)" "unprognostic (4.50e-3)" "unprognostic (1.15e-2)" "unprognostic (9.26e-2)" "unprognostic (6.28e-2)" "unprognostic (1.68e-2)" "unprognostic (2.79e-1)" "unprognostic (2.93e-3)" "unprognostic (9.32e-2)" "unprognostic (7.94e-7)" "unprognostic (1.72e-2)" "unprognostic (4.25e-1)" "unprognostic (1.81e-3)" "unprognostic (1.99e-1)" 0.4 0.1 0.2 0.2 0.3 0.0 0.2 4.2 0.2 2.2 0.2 0.2 0.2 0.2 0.2 0.2 2.5 1.0 0.2 0.2 0.2 0.2 2.7 0.2 0.2 0.2 0.2 0.2 1.2 0.2 0.0 0.2 0.3 0.2 0.2 0.0 0.2 4.3 0.2 0.2 18.9 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.8 0.4 83.5 9.2 0.2 2.0 0.6 0.0 0.1 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.1 0.2 0.2 0.4 1.0 1.1 0.2 0.0 1.4 0.0 0.0 2.1 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.5 0.6 0.3 0.5 0.0 0.0 0.7 0.5 0.1 0.7 0.0 0.0 0.3 0.0 0.2 0.3 4.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.5 10.0 2.6 0.0 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.3 0.1 1.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.2 0.0 3.5 0.6 0.0 0.0 0.6 0.0 0.0 0.0 1.7 1.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 4.0 0.1 0.5 1.1 0.6 VSIR "B7-H5, B7H5, C10orf54, GI24, PD-1H, SISP1, VISTA" ENSG00000107738 "V-set immunoregulatory receptor" Q9H7M9 10 71747559-71773498 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 111.3" "Cell type enhanced" "Detected in many" 19 "Cytotrophoblasts: 279.2;Extravillous trophoblasts: 255.7;monocytes: 118.2;Syncytiotrophoblasts: 566.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 111.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 26.5;HaCaT: 20.2;HMC-1: 33.8;U-937: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007968 Approved Nucleoplasm NA NA 360000 Nucleoplasm "HPA007968: AB_1845518" "unprognostic (1.19e-1)" "unprognostic (1.76e-3)" "unprognostic (1.64e-1)" "unprognostic (6.67e-2)" "unprognostic (9.29e-2)" "unprognostic (2.05e-2)" "unprognostic (1.88e-1)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (1.02e-2)" "unprognostic (6.82e-2)" "unprognostic (8.70e-2)" "unprognostic (2.57e-3)" "unprognostic (2.72e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.37e-3)" "unprognostic (3.29e-1)" 20.8 5.7 13.3 23.4 14.8 55.3 30.4 3.4 10.2 10.7 12.9 10.5 5.4 16.6 14.7 8.8 13.7 15.0 10.8 13.6 13.0 9.8 5.8 4.1 20.1 60.0 12.4 7.2 17.5 4.4 2.4 3.8 48.2 11.8 11.0 7.1 8.1 8.6 8.7 4.7 9.1 16.3 12.7 11.1 55.1 10.2 6.4 11.8 4.6 7.7 10.1 17.6 14.1 24.8 1.9 24.4 111.3 44.9 5.8 11.7 40.1 3.3 6.5 0.0 0.1 3.5 2.9 3.1 1.2 7.9 1.5 2.6 2.6 26.5 0.2 1.7 11.2 0.0 20.2 0.0 0.7 0.4 0.1 0.0 4.4 1.4 0.2 4.9 0.7 33.8 2.4 0.8 0.2 0.1 2.3 0.5 0.6 0.1 2.5 0.9 0.1 0.7 5.5 0.0 5.0 1.3 0.0 0.3 1.5 0.0 1.5 0.0 0.1 1.7 1.3 1.2 0.4 0.1 9.5 1.7 0.0 0.0 5.4 0.0 1.8 0.9 0.0 0.1 29.5 0.1 22.0 42.3 81.0 8.9 40.5 11.7 1.8 8.9 8.4 24.4 1.9 8.3 8.3 111.3 5.8 44.9 6.4 8.8 40.1 13.3 14.8 3.4 10.2 13.0 9.8 12.4 7.2 11.8 11.8 26.8 11.6 0.0 0.0 0.0 0.0 0.0 0.0 6.7 11.4 10.4 0.0 279.2 0.0 37.3 0.0 0.0 0.0 0.0 9.6 255.7 0.0 0.0 29.1 0.0 66.9 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 118.2 0.0 0.0 36.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 566.7 0.0 0.0 0.0 VSNL1 "HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1" ENSG00000163032 "Visinin like 1" P62760 2 17539126-17657018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 165.7" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 23.4;Cardiomyocytes: 27.7;Club cells: 29.6;Hepatocytes: 16.8;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 44.2;Hep G2: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053808 Approved Cytosol NA NA Cytosol "HPA053808: AB_2682270" "unprognostic (1.04e-1)" "unprognostic (7.90e-2)" "unprognostic (3.44e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (4.90e-2)" "unprognostic (5.48e-2)" "unprognostic (2.81e-2)" "unprognostic (4.66e-2)" "unprognostic (2.99e-1)" "unprognostic (1.65e-1)" "unprognostic (2.18e-1)" "unprognostic (5.14e-4)" "unprognostic (3.26e-2)" "unprognostic (1.23e-1)" "unprognostic (6.19e-3)" "unprognostic (1.51e-2)" 1.4 13.6 36.5 1.7 48.8 1.2 3.9 91.6 165.7 1.8 3.0 3.3 0.0 1.3 1.7 1.2 18.0 1.9 1.3 17.5 34.8 27.9 2.0 10.5 2.4 1.2 19.9 66.1 2.8 1.7 1.2 0.2 3.4 64.0 3.0 3.6 0.1 3.2 1.5 1.7 5.2 1.3 1.6 7.1 1.3 1.7 1.5 1.4 0.0 1.5 3.1 4.1 2.3 3.4 0.1 0.7 0.2 0.1 0.1 0.5 0.1 0.2 0.0 0.5 8.0 0.9 1.3 0.0 0.0 0.0 0.0 0.2 0.1 4.8 0.0 0.0 0.0 0.0 44.2 0.3 1.5 0.0 0.0 0.2 0.0 0.0 44.7 0.0 0.0 0.1 0.3 2.3 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 8.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 3.6 3.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.6 0.0 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.1 0.7 0.0 0.1 36.5 48.8 91.6 138.6 34.8 27.9 19.9 66.1 64.0 1.4 0.0 0.3 0.0 23.4 16.3 6.9 27.7 2.5 0.0 29.6 0.0 0.0 0.3 1.7 0.0 3.9 0.7 0.0 0.0 0.2 0.1 5.8 4.9 0.0 16.8 0.5 3.2 1.2 0.0 0.3 4.7 0.6 0.0 3.3 1.0 4.0 3.2 0.3 0.0 0.0 1.4 10.5 0.0 1.4 1.8 0.6 17.7 0.3 0.7 4.1 8.8 VSTM1 UNQ3033 ENSG00000189068 "V-set and transmembrane domain containing 1" Q6UX27 19 54040825-54063953 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 53.5;bone marrow: 39.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 15.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 15 "eosinophil: 53.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 53.5" "Group enriched" "Detected in some" 7 "EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6" HPA059365 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA059365: " "unprognostic (5.13e-2)" "unprognostic (5.31e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (9.47e-2)" "unprognostic (1.31e-5)" "unprognostic (3.73e-1)" "unprognostic (1.14e-1)" "unprognostic (9.74e-2)" "unprognostic (4.67e-2)" 0.9 0.2 0.7 0.1 0.2 39.4 0.1 0.0 0.5 0.2 0.1 1.3 0.0 0.1 0.3 0.1 0.1 0.6 0.1 4.2 0.7 0.2 0.5 1.2 4.0 7.2 0.6 0.0 0.2 1.1 0.1 8.7 2.0 0.2 0.1 0.1 0.2 0.1 0.1 2.1 0.1 0.8 0.3 0.1 7.9 0.1 0.5 0.3 3.0 0.4 0.0 0.1 0.8 0.0 0.0 0.0 53.5 3.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.0 53.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 2.1 0.7 0.2 0.0 0.5 0.7 0.2 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 2.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 VSTM2A "MGC33530, VSTM2" ENSG00000170419 "V-set and transmembrane domain containing 2A" Q8TAG5 7 54542325-54571080 "Plasma proteins, Predicted secreted proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 13.7;brain: 51.7;prostate: 13.7" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 38.3" "Cancer enhanced" "Detected in some" "breast cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Karpas-707: 3.4;SCLC-21H: 10.5;SH-SY5Y: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (4.66e-1)" "prognostic favorable (5.34e-4)" "unprognostic (4.34e-2)" "unprognostic (6.79e-2)" "unprognostic (7.15e-2)" 0.7 13.7 18.4 0.7 22.7 0.7 1.1 0.5 51.7 0.7 6.0 1.4 0.0 2.4 0.7 0.7 0.7 0.7 0.9 0.7 9.4 15.5 0.8 0.7 0.8 0.7 4.4 13.6 0.7 1.8 0.7 0.4 0.7 6.7 13.7 5.8 1.1 0.7 0.7 0.8 0.7 1.1 0.8 3.2 0.7 7.2 1.2 3.0 0.0 0.7 0.0 0.7 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.5 7.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.4 22.7 0.5 51.7 9.4 15.5 4.4 13.6 6.7 3.0 0.0 0.0 0.0 0.0 0.0 38.3 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 VSTM2B ENSG00000187135 "V-set and transmembrane domain containing 2B" A6NLU5 19 29526499-29564479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 40.8" "Group enriched" "Detected in some" 7 "Bipolar cells: 32.2;Horizontal cells: 14.3" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.74e-1)" "unprognostic (1.87e-3)" "unprognostic (6.64e-2)" "unprognostic (1.08e-2)" "unprognostic (5.35e-2)" 1.0 1.2 16.2 1.0 17.0 0.9 1.0 13.4 40.8 3.1 1.0 8.6 0.0 1.0 1.0 1.6 0.9 1.0 1.0 1.0 14.2 9.4 1.0 0.9 0.9 1.1 12.5 9.2 1.0 0.9 0.9 0.0 0.9 4.5 0.9 1.0 0.3 0.9 1.0 0.9 1.0 1.0 1.3 11.7 1.0 1.0 1.0 2.2 0.0 0.9 0.0 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 13.4 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 17.0 13.4 16.6 14.2 9.4 12.5 9.2 4.5 2.2 0.0 0.0 0.0 0.0 0.0 32.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 VSTM2L "C20orf102, dJ1118M15.2" ENSG00000132821 "V-set and transmembrane domain containing 2 like" Q96N03 20 37903104-37945350 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.8" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 26.6;Cholangiocytes: 66.2;Ciliated cells: 34.8" "Group enriched" "Detected in all" 5 "lung cancer: 23.6;pancreatic cancer: 34.4;prostate cancer: 72.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 26.9;HDLM-2: 36.8;hTCEpi: 9.5;SH-SY5Y: 8.9;SK-BR-3: 32.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043832 Uncertain "Secreted - unknown location" NA NA "HPA043832: AB_10968449" "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (1.63e-5)" "unprognostic (4.96e-3)" "unprognostic (1.56e-1)" "unprognostic (1.83e-2)" "unprognostic (1.39e-1)" "unprognostic (1.52e-1)" "unprognostic (2.34e-3)" "unprognostic (9.86e-2)" "unprognostic (2.00e-1)" "unprognostic (1.85e-3)" "unprognostic (1.29e-3)" "unprognostic (1.68e-1)" "unprognostic (9.66e-2)" "prognostic unfavorable (8.14e-4)" 1.6 7.5 29.3 1.6 22.7 0.8 1.4 7.0 44.8 14.0 1.8 1.8 21.4 2.0 1.6 11.5 1.6 17.5 18.9 25.6 34.9 23.5 1.1 2.5 4.5 1.2 10.7 17.6 0.9 3.5 0.9 6.9 1.6 9.7 6.0 1.3 3.6 3.8 19.8 1.0 1.0 1.4 1.7 6.2 18.6 8.9 2.5 1.5 0.0 1.3 0.0 1.8 1.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.1 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 26.9 0.0 0.1 0.2 0.1 0.1 0.0 1.2 0.0 36.8 0.6 0.0 0.0 0.0 1.5 0.0 1.0 1.3 9.5 0.0 0.3 1.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 0.9 7.9 0.0 0.0 0.1 0.0 0.0 1.0 8.9 1.1 32.9 0.3 0.0 0.1 0.0 1.7 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 22.7 7.0 44.8 34.9 23.5 10.7 17.6 9.7 1.5 6.0 2.6 0.0 1.5 0.3 7.5 26.6 66.2 34.8 10.3 0.0 7.9 0.2 0.0 3.8 0.3 0.5 0.0 0.0 0.2 0.1 0.4 8.4 0.0 0.8 0.0 12.7 17.9 0.0 0.3 0.4 4.9 0.2 0.0 0.0 0.9 0.8 4.7 0.2 15.2 0.4 3.1 0.0 1.0 0.2 0.4 0.5 0.1 0.0 0.0 0.6 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850531 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.9;placenta: 10.7" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 16.9;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.3;OE19: 6.8;PC-3: 10.0;SH-SY5Y: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: AB_2732704" "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.5 0.6 3.1 0.4 2.9 0.1 1.1 2.2 8.2 2.8 3.0 0.4 0.6 0.5 0.9 3.2 0.5 0.5 1.5 0.8 3.2 9.9 2.1 0.1 0.3 0.2 4.7 3.5 0.3 1.3 0.1 1.2 10.7 4.9 1.6 4.4 0.3 1.4 1.3 0.2 0.3 1.3 1.9 1.3 0.1 4.9 0.4 0.0 0.0 0.4 0.0 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.9 0.2 1.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 10.0 0.0 0.0 0.3 0.0 0.3 0.2 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 2.2 8.2 3.2 9.9 4.7 3.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.3 0.0 0.0 0.5 0.0 2.7 0.3 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.8 2.5 0.4 1.0 0.3 0.0 0.0 0.0 0.0 0.1 4.9 0.0 1.6 0.0 VSX1 "PPCD, PPCD1, PPD" ENSG00000100987 "Visual system homeobox 1" Q9NZR4 20 25070885-25082365 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Developmental protein, DNA-binding" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 17.0;retina: 20.7" "Cell type enriched" "Detected in some" 20 "Bipolar cells: 345.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "cerebellum: 17.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "Karpas-707: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.93e-1)" "unprognostic (6.63e-2)" "unprognostic (9.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.27e-1)" "unprognostic (1.97e-1)" "unprognostic (4.01e-1)" "unprognostic (8.64e-3)" "unprognostic (2.70e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-9)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "unprognostic (3.07e-4)" "unprognostic (2.38e-1)" 0.4 3.0 2.3 0.4 1.6 1.6 0.4 17.0 2.8 0.4 0.4 0.4 0.4 0.1 1.0 0.4 0.4 0.4 0.4 0.5 1.9 2.1 0.4 0.4 0.4 0.4 2.1 0.4 4.6 1.2 1.1 2.7 0.4 0.5 0.5 0.1 20.7 0.4 1.0 1.0 0.6 0.5 0.4 1.5 0.4 0.3 0.7 0.4 0.4 0.7 0.4 0.4 0.4 0.4 1.0 1.5 2.4 0.3 1.3 0.6 0.1 0.1 1.5 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 1.8 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.4 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.0 9.9 0.0 0.2 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.3 0.0 0.2 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.3 0.0 0.3 1.0 0.1 0.1 2.4 0.3 0.3 0.6 0.3 0.5 0.7 0.4 0.3 0.0 1.0 0.4 0.5 2.1 1.3 0.2 1.5 0.1 0.1 2.3 1.6 17.0 1.4 1.9 2.1 2.1 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 345.7 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.1 0.0 0.0 0.0 16.9 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 VSX2 "CHX10, HOX10, RET1" ENSG00000119614 "Visual system homeobox 2" P58304 14 74239472-74262738 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Repressor" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 29.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 128.4;Muller glia cells: 90.5" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;HAP1: 1.0;SK-BR-3: 1.2;U-698: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "pons and medulla: 2.3" HPA003436 Enhanced NA NA "HPA003436: AB_1078523" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-1)" "unprognostic (3.21e-4)" "unprognostic (7.77e-2)" "unprognostic (8.39e-4)" "unprognostic (3.13e-1)" 0.3 0.1 0.3 0.4 1.0 0.2 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 1.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 29.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.2 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.3 0.2 0.5 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 128.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 90.5 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 VTCN1 "B7-H4, B7H4, B7S1, B7X, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 74.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" No NA "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: AB_2682415" "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 46.4 0.1 0.1 6.7 0.1 0.1 7.0 0.0 2.6 29.9 0.4 14.2 1.9 0.2 0.1 0.1 27.0 0.9 0.3 0.1 0.1 0.1 4.5 35.9 0.0 1.4 3.0 0.1 1.5 0.0 0.1 17.5 3.6 0.2 2.2 0.1 0.8 0.1 0.1 1.5 2.5 0.1 0.2 0.1 0.5 1.5 2.1 0.7 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.3 0.0 0.0 74.4 0.0 9.6 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 2.4 0.0 0.0 1.2 0.0 4.0 10.3 52.4 0.0 1.7 0.0 73.6 1.6 0.0 0.0 0.0 31.1 1.1 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.9 VTN VN ENSG00000109072 Vitronectin P04004 17 28367276-28373091 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "liver: 321.7" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 4765.6" "Cancer enriched" "Detected in many" 85 "liver cancer: 2216.6" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 11 "CACO-2: 168.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB016695, CAB016765, HPA060933, HPA068011" Supported Supported "Endoplasmic reticulum,Vesicles" "Secreted to blood" NA NA 606000000000 32000000000 "Endoplasmic reticulum, Vesicles" "CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: " "unprognostic (1.19e-1)" "unprognostic (2.12e-1)" "unprognostic (2.29e-2)" "unprognostic (6.13e-2)" "unprognostic (9.74e-2)" "unprognostic (8.42e-2)" "prognostic favorable (3.74e-4)" "unprognostic (6.20e-2)" "unprognostic (3.97e-1)" "unprognostic (8.95e-2)" "unprognostic (3.24e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (4.10e-11)" "unprognostic (8.82e-3)" "unprognostic (2.27e-1)" "unprognostic (4.86e-3)" "unprognostic (7.09e-2)" 0.2 7.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.2 0.0 0.0 0.0 321.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.2 0.7 2.1 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.1 168.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 8.7 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 15.5 0.9 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 1.0 0.0 0.9 0.0 0.9 0.9 0.1 0.3 0.6 2.1 0.6 0.7 0.0 0.2 0.0 0.1 0.0 0.6 55.9 0.0 0.0 10.7 14.7 1151.5 0.0 0.0 0.0 72.6 2.6 3.3 14.8 0.0 0.7 0.0 233.6 17.1 1.6 7.6 0.0 0.0 4765.6 4.3 36.5 0.0 116.0 117.8 0.0 0.0 0.0 0.0 35.1 0.0 4.8 38.2 0.0 1.4 2.2 24.6 0.0 2.0 0.3 0.4 0.0 8.0 0.7 0.0 0.0 VWA1 "FLJ22215, VWA-1, WARP" ENSG00000179403 "Von Willebrand factor A domain containing 1" Q6PCB0 1 1434861-1442882 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 125.2" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 241.9;Syncytiotrophoblasts: 242.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 16.0;CACO-2: 16.2;CAPAN-2: 48.0;EFO-21: 15.4;Hep G2: 28.6;SCLC-21H: 17.0;T-47d: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA 190000 "unprognostic (2.78e-1)" "unprognostic (4.85e-2)" "unprognostic (5.91e-3)" "unprognostic (2.75e-1)" "unprognostic (2.67e-3)" "unprognostic (6.73e-2)" "unprognostic (9.52e-3)" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (1.61e-1)" "unprognostic (3.47e-1)" "unprognostic (2.79e-2)" "unprognostic (3.13e-2)" "unprognostic (1.15e-1)" "unprognostic (1.69e-2)" "unprognostic (3.08e-2)" "unprognostic (6.71e-2)" 13.9 6.4 13.1 17.5 16.2 1.3 9.4 2.7 19.6 12.4 26.3 46.1 34.8 9.4 18.1 13.9 15.7 13.2 15.6 8.9 17.5 9.5 14.0 71.3 13.6 9.0 22.4 12.1 13.9 23.2 5.0 5.1 23.9 15.7 47.0 4.2 11.4 23.9 125.2 6.0 8.6 8.9 34.7 29.8 4.7 17.8 11.8 21.5 0.4 16.6 3.9 4.9 30.7 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 5.4 0.7 5.5 0.1 0.5 8.7 1.0 0.0 0.8 0.0 16.2 48.0 0.0 15.4 0.4 1.8 4.2 5.6 2.8 0.1 1.0 3.9 0.5 0.0 28.6 1.3 0.0 1.9 1.0 0.1 0.3 0.0 0.1 0.2 0.0 0.5 0.0 0.0 4.0 0.0 0.3 2.1 5.6 1.5 0.2 0.3 0.7 0.9 2.7 17.0 2.6 0.0 14.8 1.9 1.4 21.6 0.2 0.5 0.0 0.2 0.1 5.2 0.1 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 16.2 2.7 19.6 17.5 9.5 22.4 12.1 15.7 21.5 17.9 29.7 1.4 20.2 5.8 5.1 3.4 17.8 12.0 15.9 50.6 3.9 241.9 6.6 64.8 0.4 55.0 8.6 0.0 57.3 79.4 13.4 33.7 1.1 43.2 19.6 14.3 12.0 7.4 0.6 1.5 31.7 1.4 23.6 4.6 7.2 53.6 40.5 9.0 55.5 5.0 3.9 6.5 13.2 0.5 1.9 7.4 242.8 0.0 6.7 15.4 VWA2 "AMACO, CCSP-2, FLJ16213, FLJ45857, NET42" ENSG00000165816 "Von Willebrand factor A domain containing 2" Q5GFL6 10 114239330-114291513 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 16.3" "Group enriched" "Detected in some" 5 "Basal glandular cells: 3.7;Early spermatids: 9.8;Late spermatids: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 11.6;HaCaT: 5.5;SCLC-21H: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037847 Uncertain "Secreted to extracellular matrix" NA NA "HPA037847: AB_10670961" "unprognostic (6.03e-2)" "unprognostic (8.29e-2)" "unprognostic (3.27e-2)" "unprognostic (7.33e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (3.02e-2)" "unprognostic (9.33e-3)" "unprognostic (2.44e-1)" "unprognostic (3.70e-1)" "unprognostic (1.37e-3)" "unprognostic (3.14e-1)" "unprognostic (7.27e-3)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "unprognostic (9.30e-2)" "unprognostic (1.22e-1)" 0.7 0.2 1.5 2.2 1.8 0.4 3.9 1.0 3.2 5.3 2.0 2.1 3.6 2.5 1.4 14.3 5.5 10.8 2.6 0.3 2.2 1.6 1.0 0.3 8.4 0.4 4.1 1.7 2.3 6.0 0.1 4.1 0.6 2.4 7.4 1.1 0.1 16.3 1.6 0.4 6.7 2.1 0.1 2.3 1.6 12.4 2.3 2.2 1.2 0.8 1.3 1.5 2.1 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 11.6 0.0 0.4 0.0 0.0 5.5 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 1.8 1.0 3.2 2.2 1.6 4.1 1.7 2.4 2.2 0.0 0.0 0.0 3.7 0.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 1.2 0.0 1.6 9.8 0.0 0.0 0.0 1.4 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.0 0.3 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.6 0.0 0.1 1.1 VWA3A "FLJ40941, FLJ46765" ENSG00000175267 "Von Willebrand factor A domain containing 3A" A6NCI4 16 22092538-22156966 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 26.8;fallopian tube: 27.0" "Group enriched" "Detected in some" 5 "Ciliated cells: 101.7;Club cells: 27.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 3.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 1.5;U-266/70: 1.2;U-266/84: 2.5;WM-115: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA041696, HPA042044" Uncertain "Secreted - unknown location" NA NA "HPA041696: AB_10964202, HPA042044: AB_10968997" "unprognostic (2.69e-2)" "unprognostic (1.54e-1)" "unprognostic (9.75e-4)" "prognostic favorable (8.15e-4)" "unprognostic (2.70e-1)" "unprognostic (4.46e-2)" "unprognostic (1.65e-2)" "unprognostic (6.79e-3)" "unprognostic (5.55e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (1.40e-1)" "unprognostic (2.16e-5)" "unprognostic (1.08e-1)" "unprognostic (2.97e-1)" "unprognostic (6.24e-2)" "unprognostic (3.06e-4)" 1.0 1.1 3.6 0.7 8.3 1.1 0.9 0.3 12.2 8.1 0.8 13.2 0.0 0.8 2.3 9.6 0.8 27.0 0.7 0.9 4.8 5.8 0.9 0.7 5.5 0.8 0.7 6.7 3.0 1.0 0.9 10.0 0.8 26.8 0.9 0.8 0.0 0.8 0.8 0.8 2.3 1.1 0.7 3.8 1.0 0.9 5.0 3.6 0.0 0.9 0.0 0.9 0.9 0.1 0.2 0.1 0.0 0.5 0.0 0.4 0.0 0.1 1.1 0.6 0.7 0.3 0.1 0.0 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.7 0.0 0.1 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.5 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 1.2 2.5 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 3.6 8.3 0.3 12.2 4.8 5.8 0.7 6.7 26.8 3.6 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 101.7 27.3 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 VWA3B "DKFZp686F2227, MGC26733" ENSG00000168658 "Von Willebrand factor A domain containing 3B" Q502W6 2 98087116-98313299 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "fallopian tube: 24.4;testis: 51.9" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 178.0;Early spermatids: 410.6;Late spermatids: 741.4" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.0" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.0;U-138 MG: 1.7" "Low region specificity" "Detected in many" "HPA036700, HPA036701" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA036700: AB_2675261, HPA036701: AB_10673505" "unprognostic (2.36e-2)" "unprognostic (4.27e-2)" "unprognostic (1.23e-1)" "unprognostic (1.01e-3)" "unprognostic (5.16e-2)" "unprognostic (3.27e-1)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (1.44e-2)" "unprognostic (4.53e-2)" "unprognostic (6.41e-2)" "unprognostic (2.63e-7)" "unprognostic (2.57e-1)" "unprognostic (5.04e-2)" "unprognostic (2.27e-1)" "unprognostic (4.96e-2)" 0.0 0.0 1.0 0.2 1.7 0.0 0.0 0.0 0.2 1.1 0.2 2.0 0.0 0.0 0.5 4.3 0.0 24.4 0.5 0.4 1.7 1.6 0.0 0.0 4.0 0.0 0.1 0.1 2.3 0.0 0.0 1.1 0.1 3.2 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 51.9 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.0 0.1 1.7 1.6 0.1 0.1 3.2 0.3 0.0 0.6 0.0 1.1 0.2 0.6 0.8 0.0 178.0 19.4 1.8 29.5 0.0 0.0 0.0 410.6 0.0 0.2 0.0 0.4 0.1 0.4 0.3 0.0 0.0 0.2 0.0 1.7 1.8 0.0 741.4 4.4 0.9 0.0 1.0 1.3 0.3 0.1 1.5 5.3 0.0 0.5 0.0 0.3 16.1 5.4 0.4 0.0 0.0 0.8 0.5 VWA5B1 FLJ32784 ENSG00000158816 "Von Willebrand factor A domain containing 5B1" Q5TIE3 1 20290919-20354894 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;epididymis: 6.4;testis: 6.9" "Group enriched" "Detected in some" 12 "Early spermatids: 7.7;Late spermatids: 6.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027496, HPA028405, HPA064829" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Secreted in male reproductive system" NA NA Mitochondria "Plasma membrane, Cytosol" "HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363" "unprognostic (2.34e-1)" "unprognostic (2.91e-1)" "unprognostic (7.78e-2)" "unprognostic (1.16e-2)" "unprognostic (4.73e-2)" "unprognostic (1.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.86e-2)" "unprognostic (4.39e-2)" "unprognostic (1.73e-1)" "unprognostic (5.41e-4)" "unprognostic (7.43e-4)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" 0.0 1.2 0.7 0.2 3.3 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 0.0 6.4 0.1 0.7 0.5 0.1 2.8 3.3 2.0 0.0 0.1 0.2 0.2 0.4 0.0 0.1 2.2 5.6 0.2 17.6 0.2 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.5 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.5 2.8 3.3 0.2 0.4 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 35.9;brain: 10.1;pancreas: 11.0" "Cell type enriched" "Detected in some" 34 "Intestinal endocrine cells: 107.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 27.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507" "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.4 35.9 9.2 0.4 4.8 0.2 0.4 9.8 10.1 0.5 2.5 0.4 0.4 1.7 0.4 0.4 0.4 1.2 0.4 0.4 9.5 3.3 0.4 0.4 2.4 0.4 1.9 0.4 3.7 11.0 1.6 3.4 0.4 0.4 0.9 0.4 0.4 0.5 2.4 0.4 0.1 2.4 0.4 0.4 0.4 2.8 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.0 0.0 27.1 1.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.7 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 4.8 9.8 10.1 9.5 3.3 1.9 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 3.2 107.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777294 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.6;pituitary gland: 20.5" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5" "Group enriched" "Detected in some" 5 "cerebellum: 7.8;pons and medulla: 4.1" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA "Plasma membrane, Cytosol" "HPA046954: AB_2679875, HPA054262: AB_2682430" "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favorable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 1.1 1.6 3.1 1.4 9.5 1.1 1.2 5.6 10.5 1.1 1.9 0.0 3.9 2.6 4.6 3.0 1.1 19.6 2.0 3.9 1.6 5.5 5.6 1.5 2.5 1.2 1.7 5.4 1.4 2.5 5.1 20.5 1.0 9.7 1.3 1.7 0.8 1.7 2.0 5.3 1.7 3.3 2.3 2.3 1.3 5.8 1.3 2.3 0.0 1.8 0.6 1.3 1.3 0.8 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.5 1.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 2.2 0.5 0.7 0.3 0.1 0.9 0.7 0.2 0.0 0.0 0.0 0.1 3.4 0.5 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.2 0.0 0.6 0.2 3.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.3 0.0 2.1 2.2 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.1 4.5 1.3 0.1 0.0 0.6 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 3.1 9.5 5.6 10.5 1.6 5.5 1.7 5.4 9.7 2.3 0.0 0.6 0.0 0.5 0.1 0.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.4 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 VWC2 "PSST739, UNQ739" ENSG00000188730 "Von Willebrand factor C domain containing 2" Q2TAL6 7 49773661-49921950 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 17.0;heart muscle: 12.8;ovary: 12.5" "Cell type enhanced" "Detected in some" 23 "Bipolar cells: 26.4;Cardiomyocytes: 44.9;Paneth cells: 9.7;Rod photoreceptor cells: 12.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 1.4;U-266/70: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055243 Approved "Secreted to extracellular matrix" NA NA "HPA055243: AB_2682755" "unprognostic (3.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.90e-4)" "unprognostic (8.97e-2)" "unprognostic (8.77e-2)" "unprognostic (1.56e-3)" "unprognostic (3.41e-2)" "unprognostic (4.11e-1)" "unprognostic (6.65e-2)" "unprognostic (1.69e-4)" "unprognostic (1.60e-2)" "unprognostic (2.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.94e-1)" "unprognostic (9.70e-3)" 0.5 0.3 3.6 0.4 3.9 0.4 0.5 17.0 6.9 0.6 0.5 1.4 0.0 0.5 1.9 0.4 0.5 0.8 0.5 12.8 1.7 2.8 0.4 0.3 0.6 0.4 2.1 1.8 12.5 0.3 0.3 0.2 0.3 3.8 0.4 0.5 0.6 0.4 0.5 0.4 1.2 0.7 1.5 0.8 0.6 0.4 0.5 0.8 0.0 0.4 0.0 0.3 0.4 0.2 0.1 0.0 0.9 0.4 1.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.9 1.0 0.2 0.0 0.0 0.0 3.6 3.9 17.0 6.9 1.7 2.8 2.1 1.8 3.8 0.8 0.0 0.0 0.0 0.0 0.5 26.4 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 9.7 0.0 0.0 12.3 0.0 0.3 0.0 0.4 1.8 0.0 0.0 0.2 0.1 VWC2L ENSG00000174453 "Von Willebrand factor C domain containing protein 2 like" B2RUY7 2 214411065-214578959 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 8.9;pituitary gland: 2.3" "Cell type enriched" "Detected in single" 9 "Bipolar cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA044815, HPA059414" Uncertain "Secreted - unknown location" NA NA "HPA044815: AB_10962359, HPA059414: AB_2684007" "unprognostic (8.77e-2)" "unprognostic (2.83e-3)" "unprognostic (2.05e-2)" "unprognostic (8.49e-2)" "unprognostic (1.51e-3)" "unprognostic (4.36e-1)" "unprognostic (2.56e-2)" "unprognostic (2.05e-1)" "unprognostic (3.89e-1)" 0.3 0.3 1.9 0.3 3.2 0.3 0.3 0.2 8.9 0.3 0.3 0.0 0.0 0.3 0.3 0.5 0.3 0.4 0.3 0.3 2.4 6.6 0.3 0.3 0.5 0.3 3.9 2.9 0.3 0.3 0.3 2.3 0.3 6.6 0.4 0.3 0.1 0.3 0.4 0.5 0.4 0.3 0.3 1.0 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.2 0.2 8.5 2.4 6.6 3.9 2.9 6.6 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VWCE "FLJ32009, URG11, VWC1" ENSG00000167992 "Von Willebrand factor C and EGF domains" Q96DN2 11 61258286-61295424 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 19.8;ovary: 10.7" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA040401, HPA043921" Uncertain Supported Nucleoplasm,Vesicles,Cytosol "Secreted - unknown location" NA NA 1300000 Nucleoplasm "Vesicles, Cytosol" "HPA040401: AB_2676963, HPA043921: AB_2678731" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (1.15e-1)" "unprognostic (3.96e-3)" "unprognostic (9.27e-4)" "unprognostic (1.21e-2)" "unprognostic (4.01e-4)" "unprognostic (3.04e-2)" "unprognostic (3.42e-2)" "unprognostic (6.58e-4)" "unprognostic (7.20e-2)" "unprognostic (3.01e-1)" "unprognostic (1.25e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-1)" "unprognostic (2.30e-1)" 2.9 1.1 0.9 0.6 1.3 2.3 3.1 0.7 1.3 2.8 1.0 1.4 3.4 0.5 1.4 2.9 1.5 5.7 1.4 1.0 1.3 1.2 0.6 19.8 0.8 0.3 0.4 1.1 10.7 0.1 0.5 0.5 9.1 0.3 1.8 0.6 1.3 1.7 1.0 1.9 0.9 1.1 1.2 0.2 0.9 0.3 1.8 0.5 6.5 0.8 1.0 1.0 1.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.2 1.1 0.4 0.2 1.8 0.0 0.3 5.7 0.0 0.3 0.0 0.4 0.1 0.0 2.0 0.0 0.1 0.4 0.0 0.5 0.0 19.3 1.1 0.0 0.1 11.4 0.5 0.5 0.0 0.1 1.8 2.6 0.2 0.3 0.3 0.1 4.2 0.0 1.6 0.0 0.0 10.9 0.1 0.0 0.1 0.1 0.4 0.9 0.0 0.1 0.6 2.0 0.7 0.0 0.5 0.2 0.3 0.5 0.1 0.2 0.4 0.9 0.8 0.2 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.7 1.3 1.3 1.2 0.4 1.1 0.3 0.5 3.0 1.7 0.0 1.5 1.5 3.2 0.7 0.0 5.3 2.3 0.0 27.5 0.9 0.0 0.1 0.4 2.2 0.0 0.0 0.4 2.2 1.4 0.4 3.5 14.0 1.1 0.0 1.7 3.1 4.0 0.0 6.4 2.2 1.7 1.8 0.0 3.2 0.0 0.0 1.8 0.3 17.1 0.0 0.5 0.9 3.0 1.9 3.7 0.5 0.1 0.7 VWDE FLJ14712 ENSG00000146530 "Von Willebrand factor D and EGF domains" Q8N2E2 7 12330885-12403941 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "pituitary gland: 29.5" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 1.7;Cardiomyocytes: 4.7;Ciliated cells: 1.4;Glandular cells: 2.2;Urothelial cells: 1.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 10.8;NTERA-2: 5.4;SCLC-21H: 8.7" "Low region specificity" "Detected in many" "HPA026619, HPA036044" Uncertain Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA Cytosol Nucleoplasm "HPA026619: AB_2671920, HPA036044: AB_2674916" "unprognostic (6.39e-2)" "unprognostic (1.65e-3)" "unprognostic (5.36e-3)" "unprognostic (1.78e-4)" "unprognostic (1.39e-2)" "unprognostic (4.19e-3)" "unprognostic (2.38e-1)" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (6.25e-2)" "unprognostic (1.68e-1)" "unprognostic (6.72e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-3)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.73e-1)" 0.4 0.5 1.6 0.3 2.7 2.3 2.3 0.4 2.3 0.8 0.9 0.0 0.9 0.2 0.7 4.9 0.8 1.5 0.7 4.1 0.8 0.5 0.7 0.5 0.7 0.2 0.4 0.5 0.5 0.9 0.0 29.5 0.3 0.5 1.5 0.3 0.1 5.7 5.5 0.4 0.6 0.6 0.2 0.4 0.5 2.0 0.6 0.0 0.1 6.2 0.0 1.3 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.6 0.0 0.5 0.0 0.3 1.8 0.0 2.1 0.7 0.8 0.4 3.0 0.2 0.0 0.0 0.7 0.4 2.1 2.0 0.6 4.0 2.2 3.5 4.8 0.0 0.0 1.1 2.4 0.1 0.3 0.0 1.2 2.7 0.8 1.2 10.8 0.0 0.0 1.2 0.0 0.0 5.4 0.0 0.6 0.0 0.0 1.6 0.0 1.3 8.7 1.4 0.0 1.7 0.0 1.4 0.0 1.1 0.1 0.0 1.0 0.0 0.9 3.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.9 0.1 1.6 2.7 0.4 2.3 0.8 0.5 0.4 0.5 0.5 0.0 0.0 1.0 0.0 1.7 0.2 0.0 4.7 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.2 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.0 0.4 1.6 VWF F8VWF ENSG00000110799 "Von Willebrand factor" P04275 12 5948874-6124770 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Cancer-related genes, Disease mutation, FDA approved drug targets, von Willebrand disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 91.7" "Cell type enhanced" "Detected in many" 24 "Cardiomyocytes: 99.1;Endothelial cells: 414.7;Ito cells: 229.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enhanced" "Detected in single" "granulocytes: 1.3" "Cell line enriched" "Detected in some" 57 "HUVEC TERT2: 113.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001694, HPA001815, HPA002082, CAB072874, CAB072875" Supported "Secreted to blood" NA NA 28300000000 6400000000 "CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (2.91e-3)" "unprognostic (7.09e-2)" "unprognostic (4.63e-1)" "unprognostic (5.63e-2)" "unprognostic (3.92e-2)" "unprognostic (4.69e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.55e-1)" "unprognostic (3.12e-1)" "unprognostic (2.73e-3)" 91.7 3.1 6.1 9.7 8.1 0.8 41.5 3.7 8.6 19.7 13.9 7.3 6.8 6.6 21.5 16.7 14.4 15.1 15.3 38.7 7.4 5.0 4.6 1.5 41.2 9.9 9.4 7.1 13.6 5.8 17.7 2.6 36.4 10.2 18.7 5.1 26.3 7.2 10.5 28.9 8.1 11.8 22.1 7.4 19.0 9.6 12.7 5.9 1.8 18.6 13.2 6.5 18.9 35.0 0.0 0.0 1.3 0.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 113.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.8 6.1 8.1 3.7 8.6 7.4 5.0 9.4 7.1 10.2 5.9 11.9 41.6 0.0 0.4 6.0 0.0 99.1 2.5 1.4 2.3 10.4 0.0 0.8 0.0 0.3 5.0 414.7 0.0 0.0 0.0 0.7 3.3 0.7 5.7 1.5 0.4 0.0 0.0 229.6 2.1 10.0 5.5 0.8 5.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.8 0.0 3.3 1.8 3.4 3.8 0.8 2.2 0.0 1.6 WARS "IFI53, IFP53" ENSG00000140105 "Tryptophanyl-tRNA synthetase" P23381 14 100333788-100376805 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.8;thyroid gland: 157.0" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "intermediate monocyte: 131.2;non-classical monocyte: 142.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 118.8;SK-MEL-30: 143.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005573, HPA018944" Enhanced Enhanced Cytosol No No 53000000 Cytosol "HPA005573: AB_2667366, HPA018944: AB_2669986" "unprognostic (5.36e-2)" "unprognostic (5.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.54e-1)" "unprognostic (2.30e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.14e-2)" "unprognostic (4.26e-2)" "prognostic favorable (1.94e-4)" "unprognostic (4.84e-2)" "unprognostic (3.21e-1)" "unprognostic (3.53e-3)" "unprognostic (1.37e-1)" "unprognostic (9.45e-2)" "unprognostic (1.62e-1)" "unprognostic (5.92e-3)" 42.5 23.3 14.5 53.9 20.1 17.0 20.6 10.7 25.4 11.1 19.1 13.3 7.1 12.7 16.5 20.5 17.8 14.5 13.7 32.0 17.8 18.7 24.6 17.9 68.5 35.3 16.9 14.8 12.1 15.6 9.4 23.5 89.6 28.2 16.4 21.0 23.5 15.7 11.7 22.3 9.3 19.8 21.0 15.7 51.6 19.8 23.7 9.4 20.9 157.0 19.2 22.7 24.0 13.8 5.6 27.7 51.8 142.8 3.3 3.4 46.4 11.1 10.6 7.0 40.7 10.1 14.4 11.2 14.4 27.9 31.0 39.2 6.9 10.0 12.1 13.5 34.3 7.6 19.0 20.2 16.4 20.0 19.2 5.8 7.8 8.1 8.5 118.8 22.2 12.8 16.3 23.6 18.0 37.5 9.4 27.8 8.2 24.4 32.1 13.2 21.3 7.6 10.4 7.0 11.4 19.3 6.4 11.0 7.7 15.1 9.8 18.7 10.9 8.6 7.5 143.4 9.4 19.1 28.2 18.4 3.3 7.5 33.9 7.5 62.6 31.8 22.5 37.4 17.3 30.2 6.1 39.5 51.8 3.4 131.2 3.1 5.6 2.8 3.1 27.7 4.1 2.0 2.4 14.1 3.3 142.8 4.2 3.3 46.4 14.5 20.1 10.7 25.4 17.8 18.7 16.9 14.8 28.2 9.4 23.8 39.7 41.6 6.7 12.9 9.0 12.1 7.6 30.8 29.6 21.0 19.6 14.6 13.3 29.0 112.5 76.4 8.5 0.0 56.4 9.8 20.5 12.1 29.0 14.9 40.6 7.9 14.3 87.8 44.2 82.6 10.6 72.8 8.5 71.3 14.1 9.3 34.3 7.2 12.7 15.3 15.8 19.4 21.7 69.3 20.9 10.7 13.8 10.2 10.1 11.4 WAS "IMD2, THC, WASP, WASPA" ENSG00000015285 "Wiskott-Aldrich syndrome" P42768 X 48676596-48691427 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 55.9" "Cell type enhanced" "Detected in many" 8 "B-cells: 72.2;Hofbauer cells: 95.2;Kupffer cells: 94.9;Macrophages: 70.0;T-cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 20.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 21.7;HEL: 19.1;HMC-1: 46.5;MOLT-4: 19.7;NB-4: 21.5;RPMI-8226: 26.5;THP-1: 19.5;U-266/70: 24.6;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002022, CAB004290" Enhanced Approved "Plasma membrane,Cytosol" NA NA 320000 "Plasma membrane" Cytosol "CAB004290: AB_628445, HPA002022: AB_1080581" "unprognostic (1.43e-3)" "unprognostic (2.09e-3)" "unprognostic (2.36e-2)" "prognostic favorable (4.95e-4)" "unprognostic (9.89e-2)" "prognostic favorable (3.78e-4)" "unprognostic (5.12e-3)" "unprognostic (7.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (7.40e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (2.24e-1)" "unprognostic (2.37e-2)" "unprognostic (3.55e-2)" "unprognostic (1.71e-1)" 7.6 4.0 4.9 28.9 7.8 30.7 3.3 2.0 5.1 2.7 4.4 5.9 0.5 4.8 2.4 5.6 3.7 4.5 4.4 3.0 4.6 4.1 4.1 5.0 12.6 29.9 7.6 1.3 2.6 2.2 0.7 2.6 5.4 6.0 3.2 3.2 3.5 5.4 1.9 1.4 2.2 14.3 3.7 12.8 55.9 4.1 1.7 7.3 53.2 2.8 1.4 33.2 5.8 2.5 2.1 3.5 20.3 5.3 2.1 3.2 2.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 21.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 12.5 0.1 19.1 0.2 0.0 0.2 9.8 46.5 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.2 13.4 0.0 2.2 19.7 21.5 0.1 0.3 0.1 17.3 0.0 26.5 0.0 0.0 0.1 0.2 0.3 0.2 0.2 0.1 0.1 19.5 0.1 0.0 0.1 0.3 0.0 24.6 12.0 15.2 0.1 24.8 0.0 1.8 4.6 20.3 3.0 5.0 2.2 1.8 2.3 2.5 3.5 2.1 2.1 2.3 18.1 2.1 5.3 1.8 3.2 2.0 4.9 7.8 2.0 5.1 4.6 4.1 7.6 1.3 6.0 7.3 3.0 21.3 72.2 0.1 2.2 0.0 0.8 0.0 2.7 0.0 0.0 0.0 0.8 1.7 0.1 0.5 0.5 0.0 23.3 0.3 0.9 1.5 0.2 46.2 0.9 95.2 0.0 1.2 5.5 94.9 0.8 0.0 70.0 3.3 45.9 0.0 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.6 1.4 1.1 1.3 1.1 87.0 0.0 0.1 WASF1 "KIAA0269, SCAR1, WAVE, WAVE1" ENSG00000112290 "WAS protein family member 1" Q92558 6 110099819-110180004 "Predicted intracellular proteins" Actin-binding "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 63.3;ovary: 17.7;testis: 55.4" "Cell type enhanced" "Detected in many" 23 "Early spermatids: 160.4;Late spermatids: 354.5;Spermatocytes: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "memory B-cell: 3.9;naive B-cell: 5.9;plasmacytoid DC: 10.7" "Group enriched" "Detected in many" 10 "B-cells: 5.9;dendritic cells: 10.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 42.3" "Low region specificity" "Detected in all" "HPA004105, CAB022161" Approved Supported NA NA "CAB022161: , HPA004105: AB_1080583" "unprognostic (8.22e-2)" "unprognostic (1.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.30e-3)" "unprognostic (5.50e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (2.82e-8)" "unprognostic (9.20e-2)" "unprognostic (5.06e-2)" "unprognostic (2.52e-1)" "unprognostic (3.33e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.95e-2)" "unprognostic (3.09e-2)" "unprognostic (9.03e-2)" "unprognostic (3.38e-1)" 5.4 7.6 19.8 3.4 44.3 7.1 5.5 18.0 63.3 5.4 3.9 10.9 0.5 2.3 9.9 5.1 6.1 4.9 6.6 1.8 43.8 10.3 6.5 4.6 2.6 3.3 10.6 26.7 17.7 4.6 4.1 5.8 2.8 17.0 4.3 3.5 0.9 3.3 4.3 1.3 4.3 2.7 10.5 12.8 2.4 3.0 55.4 9.3 1.0 2.3 0.6 3.4 4.6 2.8 5.9 10.7 0.1 0.8 0.6 0.3 0.5 3.4 3.9 20.4 16.6 8.8 11.5 2.2 7.2 8.3 6.2 10.8 6.6 3.3 19.6 4.7 11.3 9.2 3.9 31.8 9.9 10.8 0.3 15.0 38.3 7.5 6.0 15.9 2.2 5.9 9.0 14.0 8.6 42.3 9.0 9.4 9.7 14.4 4.6 7.1 2.8 20.1 0.6 18.4 2.5 5.0 18.5 7.5 0.7 9.9 3.9 16.5 25.6 5.1 3.8 4.7 22.2 4.8 9.8 6.9 5.7 5.9 16.6 9.6 0.1 3.0 17.2 6.4 16.5 4.2 0.0 0.7 0.0 0.1 0.2 0.3 3.9 0.3 0.0 0.8 5.9 0.1 0.1 0.1 0.6 0.8 10.7 0.0 0.5 19.8 44.3 18.0 48.9 43.8 10.3 10.6 26.7 17.0 9.3 0.0 0.0 0.0 1.9 13.2 11.4 0.9 0.0 0.0 1.2 0.0 5.9 3.3 1.7 4.4 160.4 1.8 0.0 23.3 0.8 2.7 5.6 2.3 0.0 5.6 0.9 9.5 12.1 6.7 3.0 354.5 16.7 1.6 3.3 0.0 2.0 4.6 1.7 0.9 8.9 9.5 6.2 6.5 3.7 66.2 20.5 7.8 1.5 0.0 0.5 1.8 WASF3 "KIAA0900, SCAR3, WAVE3" ENSG00000132970 "WAS protein family member 3" Q9UPY6 13 26557703-26688948 "Cancer-related genes, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 83.6;Horizontal cells: 77.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037086, HPA066228" Enhanced NA NA "CAB037086: AB_1080585, HPA066228: " "unprognostic (1.42e-1)" "unprognostic (3.65e-2)" "unprognostic (2.25e-1)" "unprognostic (7.57e-2)" "unprognostic (8.23e-2)" "unprognostic (3.34e-1)" "unprognostic (6.19e-2)" "unprognostic (8.37e-2)" "unprognostic (8.98e-2)" "unprognostic (2.99e-1)" "prognostic favorable (2.21e-4)" "unprognostic (8.86e-3)" "unprognostic (2.93e-3)" "unprognostic (6.35e-2)" "unprognostic (2.12e-2)" "unprognostic (2.69e-3)" "unprognostic (9.18e-2)" 18.7 17.3 27.3 3.4 33.2 1.1 11.8 30.9 55.1 7.1 3.4 18.6 2.0 1.9 8.7 6.0 4.8 7.1 4.6 7.3 22.7 19.7 8.0 7.6 7.9 3.0 22.1 22.5 22.4 6.0 6.8 4.5 1.3 18.4 10.1 4.1 8.9 6.6 10.8 7.4 3.7 2.5 8.4 17.1 5.5 5.3 12.9 14.1 0.0 17.7 0.7 2.4 4.3 5.0 0.2 0.0 1.3 0.0 0.0 0.0 0.8 0.0 0.1 17.9 0.0 39.5 7.7 1.7 6.8 10.4 10.2 5.3 0.0 1.6 6.7 0.9 15.7 4.4 1.5 5.0 5.1 8.9 0.0 4.2 0.3 0.0 6.8 5.9 2.3 5.1 16.1 5.0 2.6 8.1 2.4 15.9 2.1 0.1 0.0 3.8 1.4 0.0 0.1 4.9 0.3 1.7 0.0 10.1 0.0 1.3 2.9 4.2 8.3 3.5 3.3 5.2 3.8 0.0 0.2 7.9 8.0 3.3 3.9 3.6 0.0 0.0 6.5 4.1 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 27.3 33.2 30.9 30.7 22.7 19.7 22.1 22.5 18.4 14.1 23.8 1.3 0.0 2.6 1.9 28.6 9.0 2.5 1.4 2.3 8.7 31.4 0.1 10.0 2.2 83.6 10.5 0.0 0.0 2.3 0.3 9.9 4.2 14.9 6.7 0.2 77.9 19.7 10.4 1.6 23.6 13.6 0.3 5.0 1.0 1.3 43.9 1.6 0.0 27.3 2.3 39.7 6.5 4.7 8.1 19.3 1.3 0.0 0.0 0.3 1.7 WBP1L "C10orf26, FLJ20154, OPAL1" ENSG00000166272 "WW domain binding protein 1 like" Q9NX94 10 102743970-102816267 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 77.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037635, HPA038371" Uncertain Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA037635: AB_10672462, HPA038371: AB_2675980" "unprognostic (3.28e-2)" "unprognostic (6.46e-2)" "unprognostic (1.14e-2)" "prognostic favorable (4.03e-4)" "unprognostic (5.35e-3)" "unprognostic (2.73e-2)" "unprognostic (3.33e-2)" "unprognostic (1.25e-1)" "unprognostic (1.69e-1)" "unprognostic (2.43e-3)" "unprognostic (2.55e-1)" "unprognostic (1.34e-1)" "prognostic favorable (1.56e-6)" "unprognostic (2.34e-2)" "unprognostic (1.57e-1)" "unprognostic (4.88e-2)" "unprognostic (1.53e-1)" 23.8 23.0 11.5 12.9 13.7 2.3 14.2 9.5 14.2 19.0 14.5 12.2 13.3 9.0 18.9 14.9 13.1 18.9 15.3 23.6 11.9 8.9 11.6 21.3 13.3 11.5 14.9 8.0 23.6 9.3 12.5 13.5 14.1 17.5 15.2 9.2 20.2 21.8 14.9 77.3 20.1 12.3 16.3 15.0 12.5 15.0 11.0 10.1 23.2 26.1 35.5 11.1 17.6 11.4 6.1 8.2 14.7 16.7 12.4 8.7 8.9 10.1 13.2 7.3 12.3 24.3 19.8 14.9 10.4 28.3 10.4 13.1 9.0 15.9 8.8 14.1 16.0 8.4 11.3 5.3 9.0 7.9 8.8 5.6 17.8 6.0 6.4 15.8 8.5 21.2 21.3 16.2 13.3 10.3 23.9 20.2 10.7 8.6 11.1 17.7 13.3 10.3 9.5 5.5 7.8 6.5 20.7 19.2 5.6 9.2 10.1 1.7 7.0 5.7 5.8 11.7 13.7 23.7 9.5 15.0 10.0 10.4 11.3 9.2 20.6 10.8 6.5 14.2 16.5 4.4 6.6 11.8 14.7 8.7 13.7 6.9 6.1 7.4 8.4 8.2 6.0 6.8 7.2 14.4 12.4 16.7 5.2 7.5 8.9 11.5 13.7 9.5 14.2 11.9 8.9 14.9 8.0 17.5 10.1 20.8 21.3 12.6 8.9 7.2 5.5 12.1 15.3 20.1 17.0 12.2 0.0 27.0 1.7 13.1 1.9 18.4 17.0 0.0 22.1 12.1 18.9 19.8 38.0 44.0 23.3 12.7 8.7 23.9 39.9 1.0 12.0 16.5 10.1 18.0 15.7 8.3 18.1 11.5 18.4 9.2 3.7 19.4 19.6 5.0 6.1 10.3 33.4 8.7 10.9 8.9 WBP2NL "FLJ26145, GRAMD7, MGC26816, PAWP" ENSG00000183066 "WBP2 N-terminal like" Q6ICG8 22 41998725-42058456 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 24.8" "Group enriched" "Detected in many" 16 "Early spermatids: 223.5;Late spermatids: 587.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.3;HDLM-2: 1.0;HHSteC: 1.1;HSkMC: 1.1;THP-1: 1.6" HPA048557 Enhanced Approved Cytosol NA NA Cytosol "HPA048557: AB_2680440" "unprognostic (1.90e-2)" "unprognostic (2.25e-4)" "unprognostic (2.77e-3)" "unprognostic (6.12e-2)" "unprognostic (6.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (1.04e-2)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (9.84e-4)" "unprognostic (3.31e-2)" "unprognostic (4.19e-2)" "unprognostic (1.79e-1)" "unprognostic (2.06e-1)" "unprognostic (2.85e-3)" "unprognostic (9.36e-5)" 1.1 0.9 3.0 1.2 2.9 0.6 2.4 3.6 4.6 0.9 0.9 3.2 1.8 0.8 1.4 4.1 0.8 2.0 1.1 0.8 2.3 1.2 1.2 0.9 1.3 1.1 2.0 2.4 2.4 2.8 2.6 2.4 0.8 2.8 1.3 1.0 2.0 1.9 1.5 0.8 1.6 1.0 0.9 3.7 1.0 1.1 24.8 3.3 0.0 2.3 0.0 1.1 0.9 1.7 1.1 1.5 0.0 0.6 0.4 1.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 4.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.5 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.1 1.6 0.0 0.0 0.2 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.6 0.0 1.1 0.0 0.0 0.9 0.4 0.0 1.5 1.1 0.3 0.3 0.0 0.4 0.2 0.6 1.4 0.2 3.0 2.9 3.6 4.6 2.3 1.2 2.0 2.4 2.8 3.3 0.0 3.2 2.0 1.2 0.3 16.2 0.7 2.5 0.0 5.7 0.0 19.6 1.8 3.3 0.9 223.5 0.7 2.0 0.0 1.2 0.9 0.3 0.9 0.0 1.5 1.2 9.5 4.6 2.5 4.6 587.8 6.1 2.1 1.7 0.0 1.9 2.8 0.9 3.7 5.3 1.5 20.6 0.0 0.8 25.5 15.6 0.6 1.6 2.5 1.7 0.9 WBP4 "FBP21, MGC117310" ENSG00000120688 "WW domain binding protein 4" O75554 13 41061274-41084006 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038965, HPA058738" Approved Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA Nucleoplasm "Vesicles, Plasma membrane" "HPA038965: AB_10672836, HPA058738: AB_2683803" "unprognostic (2.56e-1)" "unprognostic (3.69e-3)" "unprognostic (1.75e-1)" "unprognostic (1.99e-2)" "unprognostic (9.30e-2)" "unprognostic (1.76e-3)" "unprognostic (1.54e-2)" "unprognostic (2.13e-2)" "unprognostic (1.34e-2)" "unprognostic (2.05e-2)" "unprognostic (3.71e-3)" "unprognostic (2.97e-1)" "unprognostic (2.66e-2)" "unprognostic (8.52e-2)" "unprognostic (7.65e-3)" "prognostic favorable (2.89e-4)" "unprognostic (2.52e-1)" 14.0 14.2 17.2 7.9 22.1 11.4 11.5 15.8 17.2 12.0 10.7 8.6 8.9 9.6 16.6 14.1 10.9 10.1 8.0 18.8 14.7 15.8 10.5 13.4 8.7 9.0 14.7 19.0 11.8 7.5 8.8 11.3 15.9 15.9 12.5 8.0 4.8 7.2 13.2 76.2 9.4 9.6 14.7 15.0 7.9 8.1 10.0 12.8 12.7 9.6 12.6 9.3 13.3 11.1 10.9 15.2 22.7 16.2 9.7 12.9 5.0 8.9 5.9 16.5 10.6 10.9 16.6 10.1 20.3 14.3 16.0 12.3 9.3 9.6 12.8 8.2 14.2 19.6 12.6 6.2 10.1 20.6 13.2 8.8 18.0 5.8 9.4 16.7 11.2 11.8 13.6 15.5 11.6 16.5 13.3 13.4 12.4 9.6 5.7 16.7 7.5 16.0 12.3 10.0 13.9 4.9 15.1 10.2 5.0 14.5 8.8 3.8 9.2 6.4 7.0 9.5 14.0 5.7 17.6 11.8 10.1 9.2 13.8 11.6 3.8 4.1 8.9 12.4 8.2 13.6 13.0 11.0 9.7 9.3 9.6 8.5 10.9 11.8 9.9 8.9 10.6 12.9 12.6 22.7 9.7 16.2 15.2 11.3 5.0 17.2 22.1 15.8 17.2 14.7 15.8 14.7 19.0 15.9 12.8 47.6 24.8 31.2 52.4 48.3 47.0 92.8 28.1 20.1 28.4 24.4 31.4 49.2 64.6 45.6 4.7 45.0 27.6 116.8 36.7 51.6 45.6 38.5 45.0 61.4 36.2 42.9 36.4 33.7 22.5 5.0 44.3 37.8 30.4 80.2 20.9 62.1 40.8 34.5 49.5 46.9 43.4 25.8 50.5 63.7 97.3 39.3 41.8 21.3 24.9 37.1 WDFY4 "C10orf64, Em:AC060234.3, FLJ45748, KIAA1607" ENSG00000128815 "WDFY family member 4" Q6ZS81 10 48684876-48982956 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.7;lymphoid tissue: 31.2" "Cell type enhanced" "Detected in some" 10 "B-cells: 20.5;Early spermatids: 25.8;Hofbauer cells: 11.8;Kupffer cells: 11.7;Late spermatids: 11.6;Macrophages: 21.6;monocytes: 17.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7" "Group enriched" "Detected in many" 7 "B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2" "Cell line enhanced" "Detected in some" "Daudi: 30.0;HDLM-2: 27.5;HL-60: 10.5;THP-1: 9.3;U-698: 12.8;U-937: 12.4" "Low region specificity" "Detected in many" HPA040634 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040634: AB_10795491" "unprognostic (6.20e-2)" "unprognostic (6.60e-3)" "unprognostic (1.87e-1)" "unprognostic (3.31e-2)" "unprognostic (1.87e-1)" "unprognostic (9.38e-4)" "unprognostic (9.41e-2)" "unprognostic (3.89e-3)" "unprognostic (2.15e-2)" "unprognostic (3.74e-1)" "unprognostic (3.49e-2)" "unprognostic (9.64e-2)" "unprognostic (3.21e-1)" "unprognostic (1.34e-1)" "unprognostic (1.35e-2)" "unprognostic (1.97e-1)" "unprognostic (3.76e-2)" 2.7 1.5 3.6 31.2 5.4 8.6 1.5 0.9 2.7 1.2 1.6 5.2 0.0 1.1 1.2 1.5 1.5 1.5 2.6 1.4 3.1 1.9 1.7 1.2 9.4 20.8 5.3 0.6 1.1 1.1 0.2 1.1 0.8 3.7 1.2 1.5 1.2 5.7 0.4 0.9 2.0 10.2 1.3 7.3 19.1 1.6 1.5 4.4 4.1 1.6 0.9 26.6 3.0 1.2 12.5 19.7 6.2 1.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 3.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.0 12.4 0.0 0.0 1.7 0.0 0.0 1.6 0.0 8.9 0.0 0.1 6.7 12.5 0.0 0.0 6.2 0.0 0.8 19.7 0.0 0.6 3.6 5.4 0.9 2.7 3.1 1.9 5.3 0.6 3.7 4.4 0.0 0.6 20.5 0.0 0.3 0.0 1.1 0.0 0.0 1.2 1.8 0.0 0.1 1.7 0.0 25.8 0.3 0.0 0.0 0.0 0.1 0.9 0.0 5.7 0.0 11.8 0.0 0.0 0.0 11.7 11.6 0.3 21.6 1.7 17.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.6 0.6 0.3 0.2 0.0 0.0 0.0 WDHD1 "AND-1, CHTF4, CTF4" ENSG00000198554 "WD repeat and HMG-box DNA binding protein 1" O75717 14 54938950-55027105 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.1" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 10.6;Spermatogonia: 20.5" "Cancer enhanced" "Detected in all" "testis cancer: 23.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000632, HPA001122" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000632: , HPA001122: AB_1080589" "unprognostic (1.88e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-2)" "unprognostic (2.25e-3)" "unprognostic (1.20e-1)" "unprognostic (6.85e-3)" "unprognostic (2.33e-4)" "unprognostic (5.52e-3)" "unprognostic (7.28e-3)" "unprognostic (8.05e-3)" "prognostic unfavorable (9.24e-4)" "unprognostic (5.11e-2)" "unprognostic (2.67e-4)" "unprognostic (8.31e-3)" "unprognostic (1.50e-1)" "unprognostic (3.49e-2)" "unprognostic (2.36e-2)" 5.0 2.8 6.3 6.6 7.5 10.8 3.8 7.2 4.6 3.7 4.9 2.7 0.6 3.2 4.2 2.9 7.0 4.0 2.3 2.3 3.2 2.3 2.8 2.1 2.9 8.9 3.3 2.5 4.1 2.0 3.0 1.9 6.0 4.4 2.1 7.3 2.6 3.0 2.2 2.0 4.5 3.6 4.6 2.8 4.6 2.8 8.8 3.5 21.1 2.1 6.4 11.2 3.6 4.3 4.8 1.8 4.3 0.9 4.3 4.6 1.6 16.0 10.4 20.6 9.0 2.0 4.9 12.0 15.6 6.7 12.6 15.5 6.9 10.8 18.4 8.0 4.4 9.1 13.7 30.6 9.0 26.6 12.3 5.3 12.1 10.1 6.6 0.8 22.8 9.3 2.5 1.6 15.6 6.1 3.0 8.2 12.0 15.1 9.3 12.1 8.9 21.4 4.5 16.3 8.6 10.8 20.1 29.6 7.1 3.6 10.8 12.0 8.4 16.6 4.2 5.4 15.7 11.3 4.6 5.3 16.1 19.1 11.7 13.2 2.8 5.7 24.6 7.3 11.3 12.6 4.3 0.8 1.4 2.3 0.6 3.2 3.0 2.7 3.3 1.4 4.8 3.3 4.6 1.2 4.3 0.9 1.8 3.9 1.6 6.3 7.5 7.2 4.6 3.2 2.3 3.3 2.5 4.4 3.5 0.0 1.3 2.9 1.5 3.4 2.1 1.5 0.0 4.0 5.7 3.5 0.0 5.8 0.0 1.8 0.5 1.0 0.5 0.0 0.9 8.0 3.1 0.5 0.0 0.8 3.4 3.2 0.0 1.3 1.6 0.8 0.0 2.0 1.7 1.8 2.5 1.5 1.0 0.0 2.8 1.9 3.3 0.0 3.3 10.6 20.5 2.0 2.2 0.0 3.1 0.9 WDR17 ENSG00000150627 "WD repeat domain 17" Q8IZU2 4 176065834-176182818 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9;parathyroid gland: 19.0;pituitary gland: 22.5" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 15.7;Cone photoreceptor cells: 60.9;Horizontal cells: 20.6;Rod photoreceptor cells: 35.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.9;SCLC-21H: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042766, HPA054501" Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA042766: AB_10806372, HPA054501: AB_2732586" "unprognostic (3.41e-4)" "unprognostic (1.72e-1)" "unprognostic (1.20e-1)" "unprognostic (6.43e-7)" "unprognostic (3.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.07e-1)" "unprognostic (1.91e-1)" "unprognostic (8.62e-2)" "unprognostic (1.42e-1)" "unprognostic (1.39e-3)" "unprognostic (6.04e-4)" "unprognostic (3.66e-4)" "unprognostic (9.25e-3)" "unprognostic (4.63e-2)" "unprognostic (7.32e-3)" "unprognostic (8.24e-3)" 2.1 5.8 12.4 2.2 22.1 1.5 3.3 12.2 23.9 2.0 2.9 3.4 0.0 1.6 4.5 6.2 1.9 3.5 3.0 1.3 9.7 7.1 6.2 1.0 3.6 1.8 4.4 16.3 4.0 3.0 19.0 22.5 0.7 7.9 2.3 3.1 6.0 1.7 2.2 0.7 1.2 1.8 2.8 4.0 2.9 3.1 4.1 6.9 0.1 10.2 0.0 1.6 1.9 1.5 1.1 0.7 2.6 1.6 1.3 0.8 0.2 0.0 3.7 8.9 0.1 0.2 0.6 0.3 0.2 0.0 0.8 3.1 0.2 0.1 6.1 0.0 0.1 4.8 0.1 3.9 2.0 0.8 0.0 3.1 0.0 0.7 0.0 0.3 3.3 4.8 1.4 1.2 0.1 0.5 1.3 0.0 7.1 0.0 0.3 0.6 1.6 3.4 0.1 2.0 0.0 1.9 0.0 3.8 0.0 0.5 0.0 10.2 7.4 0.0 2.4 6.2 1.4 0.4 0.0 0.0 1.2 1.7 0.1 5.7 4.4 2.9 3.5 7.0 0.0 2.4 2.6 0.6 0.3 0.6 1.6 0.3 1.1 0.6 0.4 0.2 0.8 0.7 0.8 1.7 1.3 0.3 0.7 0.3 0.2 12.4 22.1 12.2 21.8 9.7 7.1 4.4 16.3 7.9 6.9 0.0 4.3 0.0 0.4 0.1 15.7 0.8 2.5 12.0 2.3 0.0 60.9 0.0 1.7 0.3 1.2 0.5 0.0 0.0 0.5 0.0 0.5 0.2 3.5 0.0 0.2 20.6 4.6 1.8 0.3 0.8 0.9 0.2 1.7 0.0 0.0 9.5 0.3 0.0 1.4 4.4 35.8 0.0 1.0 2.6 4.5 0.0 0.0 0.0 0.0 0.3 WDR19 "DYF-2, FLJ23127, IFT144, KIAA1638, NPHP13, ORF26, Oseg6, Pwdmp" ENSG00000157796 "WD repeat domain 19" Q8NEZ3 4 39182404-39285810 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Ectodermal dysplasia, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 41.1" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 41.5;Spermatocytes: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.4;ASC TERT1: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039616, HPA058847" Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA039616: AB_10796331, HPA058847: AB_2683834" "unprognostic (1.80e-1)" "unprognostic (9.32e-2)" "unprognostic (6.40e-2)" "unprognostic (5.69e-2)" "unprognostic (1.37e-1)" "unprognostic (1.26e-3)" "prognostic unfavorable (4.43e-4)" "unprognostic (1.06e-1)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "prognostic favorable (2.70e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (5.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.56e-2)" 8.5 7.6 8.1 4.8 12.9 3.4 9.2 21.0 14.5 13.2 7.8 5.7 7.8 1.9 15.5 11.2 5.4 20.9 8.6 5.1 11.7 4.1 8.6 7.0 8.6 4.4 6.0 11.0 19.0 6.6 10.1 41.1 6.3 14.6 8.1 4.3 6.9 7.6 8.2 3.1 6.0 5.7 9.5 9.7 4.3 8.0 12.7 7.3 6.8 17.1 3.8 5.0 9.9 8.9 3.9 1.1 1.5 2.0 2.3 2.4 0.8 3.2 2.3 5.5 6.6 25.4 28.5 2.5 4.3 9.7 4.5 6.0 1.4 3.7 5.3 2.1 4.1 9.7 1.9 5.4 2.8 5.0 0.3 3.9 1.0 4.4 2.7 7.9 5.2 1.4 17.3 6.1 6.0 3.8 12.5 5.4 5.4 4.7 5.3 5.4 1.1 3.5 3.6 1.8 1.9 2.6 4.3 5.6 2.4 3.7 1.3 6.1 5.6 4.2 1.4 2.8 6.9 2.8 1.9 3.9 4.4 3.0 9.7 4.2 3.9 3.6 3.7 6.6 1.5 2.0 0.7 1.2 0.9 1.7 2.0 1.3 3.4 2.1 2.4 1.1 3.9 2.1 2.1 1.5 2.3 1.7 0.7 1.4 0.8 8.1 12.9 21.0 14.5 11.7 4.1 6.0 11.0 14.6 7.3 11.9 5.7 3.2 4.9 4.2 7.6 3.8 2.5 41.5 12.5 17.4 9.8 1.0 0.0 4.5 3.0 4.5 0.0 0.0 3.1 2.0 5.6 3.1 2.3 10.6 2.7 23.8 2.4 4.3 1.9 2.6 15.3 2.9 1.7 1.0 2.2 7.3 2.9 0.0 17.7 3.4 22.5 0.0 3.8 30.3 10.2 4.1 1.1 1.0 1.0 1.8 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385143-224437033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.9" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028538, HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427" "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 8.2 7.2 6.7 6.7 6.7 18.5 7.2 8.2 7.3 7.8 7.0 6.7 6.7 4.0 6.8 9.3 13.0 5.9 7.0 7.5 6.7 5.0 6.7 9.3 9.0 7.2 6.7 6.7 7.0 6.9 9.2 6.7 8.7 6.7 7.0 6.7 6.7 7.2 6.7 15.2 9.9 6.7 7.1 6.7 10.2 6.3 63.9 6.7 6.7 7.0 6.7 7.4 6.7 8.3 1.5 2.1 8.3 3.9 2.7 2.7 1.3 11.9 6.2 19.3 8.9 25.8 29.4 13.9 17.6 28.8 16.1 15.2 9.8 13.6 14.2 17.7 28.3 6.2 10.9 11.3 15.1 26.5 11.1 12.9 9.8 8.1 9.2 28.1 10.2 17.2 27.3 21.9 17.0 16.1 26.7 26.8 8.7 12.9 14.7 21.1 6.6 10.5 9.9 18.6 12.4 7.2 9.7 20.2 11.2 19.6 12.1 7.0 17.9 20.0 27.1 21.5 21.1 31.1 16.8 28.1 13.8 6.3 12.9 21.1 15.7 7.5 9.7 15.7 7.3 17.0 4.1 1.9 3.3 2.7 2.4 1.5 1.5 1.9 2.1 1.8 1.4 1.4 2.1 8.3 2.7 3.9 2.1 1.6 1.3 6.7 6.7 8.2 6.7 6.7 5.0 6.7 6.7 6.7 6.7 98.3 43.8 19.4 25.3 99.0 23.8 42.4 45.9 41.5 50.0 33.2 29.5 23.4 5.0 19.2 178.7 37.6 21.6 0.0 20.3 11.8 51.5 39.3 46.2 31.0 44.5 36.5 34.0 44.2 119.9 79.7 34.2 49.8 43.9 12.6 40.3 16.9 26.6 25.9 26.5 17.0 22.9 19.4 41.9 36.4 24.6 107.0 57.1 31.6 23.8 59.3 WDR38 ENSG00000136918 "WD repeat domain 38" Q5JTN6 9 124853417-124857890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "fallopian tube: 51.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 83.0;Early spermatids: 23.2;Late spermatids: 80.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 12.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.5;HDLM-2: 3.0;HeLa: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA056607 Approved Vesicles NA NA Vesicles "HPA056607: AB_2683188" "unprognostic (5.66e-3)" "unprognostic (2.15e-3)" "unprognostic (1.51e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.14e-1)" "unprognostic (2.17e-3)" "unprognostic (4.29e-3)" "unprognostic (7.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.82e-1)" "unprognostic (1.38e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-5)" "unprognostic (1.01e-1)" "unprognostic (3.25e-2)" "unprognostic (6.36e-2)" "unprognostic (4.42e-2)" 0.2 0.2 2.0 0.2 3.1 0.2 0.2 0.2 0.5 2.9 0.2 10.6 0.0 0.2 0.7 11.9 0.2 51.4 0.2 0.3 2.8 3.3 0.2 0.2 10.8 0.2 0.3 0.4 6.0 0.2 0.2 1.0 0.2 8.8 0.2 0.2 0.0 0.2 0.3 0.3 0.3 0.2 0.3 0.7 0.2 0.2 7.0 1.3 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.3 0.5 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.1 0.4 2.5 0.1 0.1 0.3 1.1 0.1 0.2 0.0 0.0 3.0 0.3 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.7 0.1 0.3 0.6 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.7 0.0 0.2 1.3 0.0 0.0 0.0 0.5 0.5 0.2 0.4 0.5 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 0.2 0.5 2.8 3.3 0.3 0.4 8.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 83.0 9.1 0.0 0.0 0.0 0.0 0.2 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 80.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 WDR45 "JM5, NBIA5, WDRX1, WIPI4" ENSG00000196998 "WD repeat domain 45" Q9Y484 X 49071470-49101170 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 124.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027562 Uncertain Uncertain "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA027562: AB_10610565" "unprognostic (1.39e-1)" "prognostic favorable (1.21e-4)" "unprognostic (1.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.32e-1)" "prognostic favorable (1.61e-4)" "unprognostic (4.30e-2)" "unprognostic (6.66e-3)" "unprognostic (7.12e-2)" "unprognostic (3.57e-1)" "unprognostic (3.22e-2)" "unprognostic (1.77e-1)" "unprognostic (5.06e-3)" "unprognostic (2.85e-1)" "unprognostic (5.27e-1)" "unprognostic (3.60e-2)" "unprognostic (1.11e-3)" 21.2 30.3 16.7 13.5 22.6 21.4 20.3 16.1 29.8 19.4 20.7 16.6 30.6 16.2 21.1 124.8 16.5 18.1 21.9 28.6 16.4 15.1 24.6 34.4 17.1 18.4 19.1 12.7 20.7 23.7 26.3 17.6 28.4 17.0 18.6 12.3 20.0 28.2 26.6 40.7 17.9 16.8 15.1 12.2 18.2 21.5 7.6 13.6 18.8 32.4 24.5 17.1 20.5 16.4 19.8 27.1 44.0 36.0 32.4 25.5 26.4 12.6 14.8 8.5 8.6 18.7 24.2 16.5 13.9 28.9 11.0 15.5 7.7 18.6 8.8 8.0 27.7 14.1 11.1 12.9 11.3 8.0 9.9 21.8 5.4 27.1 11.7 42.8 4.2 12.7 21.4 20.0 18.1 19.4 17.7 11.0 8.5 11.4 16.0 14.4 14.1 8.8 10.7 8.6 5.6 12.9 7.2 12.5 29.3 19.5 11.6 11.3 16.7 17.9 13.7 42.2 11.7 8.7 15.6 15.1 12.0 10.9 23.9 5.8 24.5 16.5 6.3 22.3 6.9 8.7 44.0 36.0 31.5 23.1 32.1 22.8 19.8 17.6 21.8 26.7 18.6 14.0 15.9 36.5 32.4 35.4 27.1 25.5 26.4 16.7 22.6 16.1 29.8 16.4 15.1 19.1 12.7 17.0 13.6 29.8 38.3 23.8 41.6 41.3 15.9 30.3 35.7 13.4 34.2 33.2 11.8 27.4 48.0 57.6 0.8 29.2 33.3 23.3 86.2 44.8 53.1 51.2 26.5 44.8 37.4 25.4 27.6 31.3 37.3 1.5 37.4 39.7 33.7 92.0 30.1 29.0 88.8 30.2 30.4 90.2 20.8 19.4 45.3 1.8 2.5 41.4 51.9 42.6 24.2 58.5 WDR47 KIAA0893 ENSG00000085433 "WD repeat domain 47" O94967 1 108970214-109042113 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.6" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 83.1;Suprabasal keratinocytes: 91.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027287, HPA027289" Approved Approved "Nucleoplasm,Actin filaments" NA NA "Actin filaments" Nucleoplasm "HPA027287: AB_10599416, HPA027289: AB_10601862" "unprognostic (8.55e-2)" "unprognostic (3.36e-2)" "unprognostic (7.51e-2)" "unprognostic (2.44e-1)" "unprognostic (4.90e-1)" "prognostic favorable (9.86e-4)" "unprognostic (4.05e-3)" "unprognostic (2.83e-2)" "unprognostic (2.87e-1)" "unprognostic (3.67e-2)" "unprognostic (2.71e-2)" "unprognostic (1.93e-1)" "unprognostic (8.39e-3)" "unprognostic (7.90e-3)" "unprognostic (9.23e-2)" "unprognostic (2.73e-2)" "unprognostic (8.09e-2)" 7.1 7.2 17.7 5.1 24.0 10.1 6.4 19.9 42.6 8.0 5.6 9.5 3.4 3.7 9.4 5.8 13.7 8.4 7.1 7.5 20.1 20.6 7.5 3.6 6.7 5.0 14.8 21.0 7.6 5.6 10.4 4.4 6.3 24.8 7.3 5.4 5.8 4.7 7.2 14.2 20.3 4.1 9.8 12.7 5.3 5.6 19.9 11.3 5.5 6.1 4.8 7.0 6.8 6.3 3.5 5.6 18.8 5.0 2.2 4.6 2.0 10.8 3.3 6.3 8.0 12.6 11.1 3.4 12.4 7.6 8.3 9.3 3.2 1.6 4.9 6.7 11.8 6.1 12.2 9.0 5.4 10.9 9.0 5.0 4.1 7.3 3.6 7.2 6.3 6.1 6.8 9.1 12.9 6.3 10.1 9.8 5.8 2.4 6.9 14.1 6.4 6.1 5.0 2.7 3.5 6.6 8.7 16.2 2.7 13.8 9.4 11.3 10.2 10.8 5.8 8.6 7.1 2.7 6.5 16.7 11.1 5.1 19.3 10.1 4.4 3.6 4.0 12.9 6.3 16.4 11.4 4.7 5.8 3.2 5.0 2.8 2.0 2.9 3.4 5.1 3.5 2.6 2.2 18.8 2.2 4.5 5.6 4.6 2.0 17.7 24.0 19.9 32.4 20.1 20.6 14.8 21.0 24.8 11.3 11.9 9.2 1.9 4.3 83.1 15.1 17.6 12.7 18.7 10.3 7.0 43.2 2.1 5.0 2.7 24.9 11.7 2.4 0.0 0.8 1.6 6.1 2.2 2.3 1.7 3.9 11.1 2.9 4.9 5.6 30.9 7.8 8.6 23.6 5.4 1.0 12.6 3.3 0.0 14.2 4.8 31.5 6.5 17.6 25.7 26.2 91.2 4.1 4.3 1.7 3.3 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 21.6;fallopian tube: 20.7" "Group enriched" "Detected in some" 5 "Ciliated cells: 50.9;Club cells: 18.2" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 5.6;myeloid DC: 4.1;plasmacytoid DC: 5.2" "Group enriched" "Detected in many" 24 "dendritic cells: 5.2;monocytes: 5.6" "Cell line enhanced" "Detected in some" "AF22: 3.4;NTERA-2: 3.8;THP-1: 17.1;U-937: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.5 0.7 6.5 1.1 6.8 3.6 0.6 12.6 5.0 1.2 0.9 8.5 0.0 3.9 1.2 4.4 2.1 20.7 0.7 4.7 12.3 5.4 1.0 0.4 4.0 0.9 7.6 2.8 3.2 0.9 0.4 1.7 0.4 21.6 0.7 0.6 0.0 0.7 0.4 0.4 0.5 8.0 0.7 17.6 1.1 0.8 1.5 14.2 0.0 0.5 0.0 1.0 0.8 0.6 0.2 5.2 0.0 5.6 0.0 0.0 0.7 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.1 0.0 0.0 5.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 6.5 6.8 12.6 3.7 12.3 5.4 7.6 2.8 21.6 14.2 0.0 1.1 0.0 0.8 0.0 0.0 1.0 0.0 50.9 18.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.0" "Group enriched" "Detected in many" 6 "Early spermatids: 232.6;Late spermatids: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 4.3 4.3 5.9 6.8 6.9 7.2 5.2 6.4 5.9 4.0 4.2 4.5 7.1 2.1 4.9 6.6 5.1 3.9 3.5 4.0 4.8 3.8 4.0 5.4 3.8 5.5 5.9 4.3 4.3 3.3 7.5 11.9 4.4 6.1 4.1 4.1 4.8 4.0 4.5 6.8 6.7 4.5 4.1 5.0 6.2 4.0 48.0 4.6 7.4 4.2 3.2 6.5 3.9 4.2 7.5 5.9 13.9 6.7 6.5 14.9 4.9 19.1 4.1 7.4 6.6 7.6 6.6 11.9 10.1 7.9 11.5 10.9 11.2 10.2 9.1 34.1 6.1 10.6 11.2 9.3 8.7 14.4 14.3 8.1 9.2 10.1 7.3 9.5 12.9 7.6 5.4 12.8 10.2 11.2 5.7 8.9 11.6 8.9 17.6 8.7 17.8 10.9 13.2 10.1 12.2 12.0 13.1 12.7 19.4 6.3 6.7 7.3 8.0 7.0 10.5 14.8 10.4 27.0 12.1 8.3 9.8 9.2 10.9 19.7 15.0 30.0 27.2 6.5 16.6 9.8 9.6 5.1 13.9 8.6 4.4 14.0 7.5 12.3 8.7 4.1 7.1 10.3 6.2 4.4 6.5 6.7 5.9 14.9 4.9 5.9 6.9 6.4 5.9 4.8 3.8 5.9 4.3 6.1 4.6 0.0 3.2 0.8 2.8 3.8 3.1 2.7 2.5 1.4 4.5 3.5 0.0 4.7 5.0 4.2 232.6 5.2 1.0 0.0 3.7 5.5 2.8 2.3 9.2 2.4 3.9 3.2 0.0 3.1 4.5 86.7 4.6 5.0 5.0 8.2 1.5 3.6 2.6 1.9 3.2 3.5 2.3 19.4 6.2 27.9 13.1 4.1 3.9 5.7 2.3 2.3 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 56.8" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 297.1;Spermatocytes: 180.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 4.8 6.3 9.4 5.4 17.0 5.0 4.8 8.4 15.4 7.0 3.9 6.0 10.5 3.0 7.0 7.8 3.1 56.8 7.2 3.4 9.9 11.6 7.9 1.4 8.1 8.6 4.8 13.0 8.4 5.4 21.3 16.0 5.4 7.8 5.0 3.7 10.5 3.9 9.0 1.5 3.5 3.9 6.8 3.5 7.7 5.7 27.6 3.7 20.6 5.8 2.5 8.9 6.2 4.0 12.6 23.1 2.3 5.3 13.2 18.7 10.0 15.8 29.5 14.5 12.6 5.2 9.8 4.5 8.1 16.8 21.4 19.9 2.4 12.6 14.2 8.5 9.1 13.1 13.7 10.2 36.4 18.8 10.6 6.2 6.9 16.3 1.6 5.4 10.9 5.7 4.4 10.3 21.7 11.3 25.2 11.1 22.5 2.8 16.8 11.7 24.7 17.1 11.5 11.1 3.8 11.2 14.8 16.3 29.6 18.8 8.0 25.3 19.6 6.4 5.8 9.4 4.4 9.4 5.2 5.5 11.0 19.3 11.8 18.1 18.3 9.2 3.6 32.4 6.6 7.9 2.3 4.2 0.3 16.2 5.3 16.3 12.6 18.7 17.4 14.1 11.1 13.2 12.8 0.3 13.2 4.5 23.1 17.5 10.0 9.4 17.0 8.4 15.4 9.9 11.6 4.8 13.0 7.8 3.7 3.0 13.8 25.3 15.6 6.3 45.6 1.3 20.4 297.1 38.7 22.7 78.5 8.0 16.6 23.9 56.6 23.3 0.5 0.0 5.4 8.0 13.4 11.9 12.7 0.8 7.7 30.2 27.7 27.0 8.6 82.2 15.8 7.8 11.8 44.1 4.5 45.6 11.0 1.7 20.8 19.6 99.9 0.0 18.9 180.1 17.7 4.3 2.4 29.9 4.0 9.5 WDR62 "C19orf14, DKFZP434J046, FLJ33298, MCPH2" ENSG00000075702 "WD repeat domain 62" O43379 19 36054881-36105106 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 25.6;testis: 88.4" "Cell type enhanced" "Detected in many" 10 "Cardiomyocytes: 42.0;Cone photoreceptor cells: 80.5;Late spermatids: 32.8;Rod photoreceptor cells: 46.1;Spermatocytes: 70.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "non-classical monocyte: 3.7" "Lineage enriched" "Detected in single" 9 "monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA043255, HPA043639" Enhanced Enhanced "Centriolar satellite,Cytosol" NA NA Cytosol "Centriolar satellite" "HPA043255: AB_2678393, HPA043639: AB_2678593" "unprognostic (1.77e-1)" "unprognostic (2.79e-3)" "unprognostic (3.16e-2)" "unprognostic (4.88e-2)" "unprognostic (1.77e-1)" "unprognostic (4.22e-3)" "unprognostic (1.78e-4)" "unprognostic (2.00e-1)" "unprognostic (4.00e-2)" "unprognostic (5.82e-3)" "unprognostic (4.72e-2)" "unprognostic (4.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.73e-3)" "unprognostic (2.72e-1)" "unprognostic (1.50e-1)" "unprognostic (2.67e-1)" 0.5 0.2 0.2 3.3 0.4 4.3 0.6 0.4 0.5 0.4 0.5 0.4 0.4 0.4 0.4 0.8 1.0 0.2 0.5 5.5 0.5 0.2 0.5 0.3 0.5 1.4 0.2 0.2 0.4 0.2 0.0 0.3 0.7 0.4 0.3 0.3 0.3 0.6 0.2 25.6 1.4 0.7 0.4 0.5 1.1 0.3 88.4 0.3 10.3 0.2 1.3 3.0 0.3 0.7 0.1 0.1 0.0 3.7 0.0 0.3 0.2 10.8 21.8 8.5 7.8 0.5 0.7 4.3 9.4 4.5 13.1 11.9 11.4 4.3 14.1 6.4 4.9 5.9 3.8 7.9 3.0 7.8 8.9 5.6 9.6 12.4 7.3 0.1 10.4 14.5 0.2 0.2 9.9 4.0 1.2 3.2 11.4 12.3 19.4 6.5 13.6 18.2 6.3 4.6 8.9 4.5 15.3 7.9 5.7 1.9 5.0 9.5 4.8 7.7 8.8 1.5 4.3 6.0 7.6 2.6 13.2 12.9 9.9 15.5 9.4 11.8 16.8 5.3 10.0 14.2 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.3 0.2 0.2 0.4 0.4 0.5 0.5 0.2 0.2 0.2 0.4 0.3 0.0 8.5 2.2 1.1 1.9 1.5 42.0 0.0 0.0 1.2 0.0 80.5 0.9 1.7 0.3 29.4 0.6 0.2 23.3 0.8 1.6 1.3 0.6 0.0 0.0 1.9 3.2 0.0 1.3 1.5 32.8 1.1 1.1 1.7 1.0 1.3 2.0 0.4 0.0 0.4 0.0 46.1 6.5 1.0 70.1 17.0 3.1 0.2 0.7 1.7 0.7 WDR63 "DIC3, FLJ30067, NYD-SP29" ENSG00000162643 "WD repeat domain 63" Q8IWG1 1 84999147-85133138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 21.3;brain: 39.7;testis: 31.0" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 167.3" "Cancer enhanced" "Detected in some" "melanoma: 2.9" "Region enriched" "Detected in many" 9 "pons and medulla: 39.7" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2" "Lineage enriched" "Detected in single" 4 "T-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.9;HBEC3-KT: 5.4;HSkMC: 7.2;hTCEpi: 8.7;LHCN-M2: 7.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038526 Enhanced NA NA "HPA038526: AB_2676063" "unprognostic (3.12e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-1)" "unprognostic (1.61e-2)" "unprognostic (1.09e-4)" "unprognostic (1.10e-3)" "unprognostic (2.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.56e-1)" "unprognostic (2.53e-1)" "unprognostic (1.82e-3)" "unprognostic (2.31e-1)" "unprognostic (1.14e-5)" "unprognostic (8.57e-3)" "unprognostic (2.60e-1)" "unprognostic (2.35e-2)" "unprognostic (1.82e-1)" 0.3 21.3 2.0 0.4 4.6 0.1 0.9 0.1 0.9 1.3 0.6 4.2 1.0 0.3 0.7 11.7 0.6 14.0 0.4 0.9 3.0 2.9 2.5 0.1 3.7 0.3 0.4 0.9 4.9 0.5 3.9 14.6 0.5 39.7 0.3 0.6 0.3 1.8 0.3 0.3 1.9 0.2 0.4 0.9 0.2 0.2 31.0 1.9 0.0 1.1 1.0 0.2 0.7 0.3 0.0 0.5 0.0 0.0 0.0 2.2 0.4 0.2 0.5 0.1 0.4 3.9 10.9 2.0 2.1 4.3 0.7 1.1 0.0 0.6 0.5 0.0 0.4 2.6 0.0 0.4 5.4 0.9 0.1 0.4 0.3 0.0 0.0 0.6 0.0 0.0 7.2 8.7 3.6 0.2 0.4 0.1 0.6 0.0 0.0 7.8 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.8 0.2 0.2 0.0 0.0 0.2 1.3 2.2 0.0 3.4 0.0 0.6 0.3 0.0 0.5 0.0 0.0 0.4 4.2 0.2 1.4 0.0 0.0 0.0 2.2 0.0 1.3 0.0 1.2 0.9 0.1 0.0 0.8 1.9 0.0 0.0 0.0 0.5 0.0 0.4 2.0 4.6 0.1 0.9 3.0 2.9 0.4 0.9 39.7 1.9 0.0 1.7 0.0 0.4 0.9 0.0 0.7 0.0 167.3 18.2 0.0 3.9 0.1 3.3 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 5.1 0.0 0.0 3.6 1.7 0.0 18.6 4.6 0.0 0.5 0.0 0.0 0.0 0.7 0.4 0.0 0.0 36.6 2.9 0.1 0.1 0.0 0.0 0.1 WDR64 FLJ32978 ENSG00000162843 "WD repeat domain 64" B1ANS9 1 241652278-241802133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 17.8" "Group enriched" "Detected in some" 78 "Early spermatids: 168.8;Late spermatids: 96.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 3.1;JURKAT: 1.0;U-266/84: 1.3" "Not detected" "Not detected" HPA046186 Uncertain NA NA "HPA046186: AB_10960064" "unprognostic (6.44e-2)" "unprognostic (1.13e-1)" "unprognostic (2.34e-1)" "unprognostic (2.78e-1)" "unprognostic (1.87e-3)" "unprognostic (1.52e-1)" "unprognostic (9.26e-2)" "unprognostic (2.35e-1)" "unprognostic (1.40e-2)" "unprognostic (2.43e-2)" "unprognostic (2.03e-1)" "unprognostic (4.49e-2)" "unprognostic (4.56e-4)" "unprognostic (2.43e-1)" "unprognostic (1.93e-1)" "unprognostic (7.28e-3)" "unprognostic (2.21e-1)" 0.1 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.2 0.5 0.1 0.1 0.2 0.1 1.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.0 0.3 0.1 0.1 0.2 0.2 17.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.1 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.0 1.7 0.3 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 168.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 96.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.7 0.0 0.0 0.0 WDR66 "CaM-IP4, MGC33630" ENSG00000158023 "WD repeat domain 66" Q8TBY9 12 121917862-122003927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 228.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favorable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.3 1.2 6.3 1.0 13.2 0.4 1.7 0.4 4.0 4.4 0.5 4.5 1.5 0.4 2.5 11.3 0.5 24.6 2.0 1.5 6.4 3.7 3.2 1.8 6.4 0.9 0.7 3.2 3.9 2.1 4.7 28.4 1.3 18.0 0.8 0.4 1.3 1.3 2.2 0.5 1.8 0.5 1.0 0.9 2.0 0.8 35.0 2.4 0.0 6.7 0.0 1.2 0.8 1.7 0.2 4.9 0.4 0.0 0.1 0.3 0.0 1.8 0.2 0.3 0.1 0.3 0.3 0.3 0.2 1.7 0.8 2.1 0.2 0.9 0.1 2.5 0.1 0.5 0.6 0.2 21.9 3.1 0.1 0.3 0.1 0.4 0.2 2.6 0.0 6.0 1.2 20.7 1.7 14.0 0.4 0.9 0.3 5.0 0.0 1.3 0.6 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.0 3.8 0.3 1.7 0.1 0.2 0.0 0.1 0.6 0.5 0.1 0.7 1.8 2.7 0.3 0.3 0.3 0.1 2.6 2.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.4 0.1 0.0 4.9 0.3 0.0 6.3 13.2 0.4 4.0 6.4 3.7 0.7 3.2 18.0 2.4 6.0 10.0 1.5 5.9 5.5 5.0 2.2 5.1 228.8 36.4 10.4 29.5 0.2 3.3 3.1 38.6 1.3 0.0 0.0 0.4 0.1 1.9 1.9 8.1 0.8 0.5 7.9 1.7 28.3 2.2 49.3 6.9 1.8 1.7 1.0 0.0 1.8 0.7 0.0 7.1 1.1 16.8 6.5 1.0 34.9 14.4 3.1 0.5 0.8 0.0 2.2 WDR72 FLJ38736 ENSG00000166415 "WD repeat domain 72" Q3MJ13 15 53513741-53762878 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 64.1;thyroid gland: 36.3" "Group enriched" "Detected in some" 5 "Collecting duct cells: 21.0;Hepatocytes: 38.9;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.1;OE19: 14.9;RPMI-8226: 13.9;RPTEC TERT1: 9.1;SuSa: 13.6;U-266/70: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048212, HPA057410, HPA059819" Uncertain Approved Vesicles NA NA Vesicles "HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133" "unprognostic (6.39e-4)" "unprognostic (1.41e-1)" "unprognostic (3.19e-2)" "unprognostic (1.79e-2)" "unprognostic (2.63e-2)" "unprognostic (3.37e-2)" "unprognostic (5.54e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.26e-1)" "unprognostic (2.78e-2)" "unprognostic (1.09e-2)" "prognostic favorable (3.33e-16)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (7.67e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.7 0.2 0.1 3.0 0.8 0.6 4.9 0.3 0.8 4.6 0.2 0.1 0.1 64.1 13.1 0.8 0.1 0.1 0.1 0.5 1.3 1.5 0.9 0.8 0.1 0.2 0.1 0.3 11.2 0.4 0.1 1.1 0.6 0.1 0.1 0.1 0.2 1.1 0.1 0.1 36.3 0.4 0.5 0.6 0.1 0.2 0.0 0.1 0.0 0.2 0.8 0.1 0.0 8.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 2.6 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 14.9 0.1 0.0 0.1 13.9 9.1 2.9 1.6 0.0 0.0 0.1 0.0 13.6 2.0 0.0 0.1 0.3 0.4 0.0 0.1 6.4 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.3 0.5 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.0 5.1 0.0 0.8 0.1 0.4 0.4 7.6 0.0 0.0 21.0 0.0 0.3 8.3 1.0 0.9 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.0 38.9 0.1 3.2 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 75.4 0.0 0.0 0.0 1.1 0.9 0.4 0.1 0.0 0.3 4.9 WDR74 FLJ10439 ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.4" "Group enriched" "Detected in many" 4 "Club cells: 168.4;Early spermatids: 612.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 14.2 13.2 12.6 19.7 13.8 77.4 14.2 14.6 21.5 12.5 12.5 10.9 8.7 10.8 14.1 10.2 16.1 15.1 12.8 12.6 12.2 11.9 15.5 19.7 10.0 18.1 15.4 16.5 17.4 20.6 9.4 8.0 11.9 13.6 12.5 11.2 8.0 16.5 9.8 42.1 19.8 10.6 11.5 9.5 18.0 13.4 23.5 16.6 16.0 20.0 19.1 16.0 12.4 14.0 39.1 44.8 15.9 34.8 26.8 16.7 11.9 16.4 19.8 7.7 12.8 6.4 8.8 24.0 9.2 10.0 20.1 13.4 28.9 20.2 28.9 26.3 7.6 16.2 22.0 23.7 18.4 15.8 18.4 17.5 14.6 21.8 25.0 18.8 28.9 9.6 8.5 20.7 12.8 42.6 6.6 9.8 21.1 31.8 8.6 9.1 31.6 27.6 46.0 31.5 18.9 26.3 28.2 13.3 50.4 14.2 9.4 17.2 19.4 10.7 22.0 29.7 7.8 15.5 22.4 7.0 11.8 14.2 26.3 23.1 21.4 29.7 35.1 13.0 17.7 15.3 8.7 34.8 3.2 11.7 16.9 14.7 18.6 12.1 11.0 29.2 39.1 16.7 14.8 15.9 26.8 11.3 44.8 13.7 11.9 12.6 13.8 14.6 21.5 12.2 11.9 15.4 16.5 13.6 16.6 35.7 64.8 46.3 33.6 92.8 13.9 1.4 33.1 44.2 168.4 15.7 15.7 47.5 36.5 39.1 612.8 32.3 22.2 0.0 34.8 40.2 35.6 20.1 41.7 28.4 34.0 3.2 39.4 17.8 30.3 74.1 30.5 38.9 28.7 18.0 28.7 13.4 36.2 26.6 20.1 37.0 11.0 19.4 37.3 14.7 27.4 95.5 29.1 57.9 38.1 31.5 WDR76 FLJ12973 ENSG00000092470 "WD repeat domain 76" Q9H967 15 43826963-43868419 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 37.2" "Cell type enhanced" "Detected in many" 10 "Spermatogonia: 44.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039804, HPA040626" Uncertain Approved "Nucleoli fibrillar center,Nuclear bodies" NA Yes "Nuclear bodies" "Nucleoli fibrillar center" "HPA039804: AB_10795297, HPA040626: AB_10795527" "unprognostic (2.26e-1)" "unprognostic (7.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.85e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (6.98e-4)" "prognostic unfavorable (8.02e-5)" "unprognostic (4.24e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.91e-2)" "prognostic unfavorable (1.35e-8)" "unprognostic (7.71e-2)" "unprognostic (9.42e-2)" "unprognostic (4.02e-2)" "unprognostic (3.28e-2)" 5.4 1.8 2.4 21.9 3.0 17.5 4.8 12.9 6.0 5.3 6.3 1.5 1.6 3.6 4.9 3.6 8.2 3.3 2.1 2.5 2.4 2.0 2.8 2.5 5.1 19.8 2.4 2.1 4.2 4.8 3.9 3.3 4.3 3.3 4.2 6.8 4.5 4.6 2.4 1.4 6.3 5.8 7.0 3.9 6.5 4.8 6.7 2.1 37.2 2.9 7.1 21.9 5.3 5.5 3.2 1.6 0.4 0.8 5.7 8.3 2.6 11.1 5.7 13.6 10.4 1.5 3.7 3.7 18.8 11.2 20.6 26.0 7.2 5.9 16.5 8.3 8.7 10.4 16.2 14.0 6.7 18.0 25.6 8.3 20.3 18.2 2.3 0.8 20.6 9.1 1.1 1.1 11.3 2.6 3.0 6.5 17.9 15.3 28.9 14.1 3.9 19.9 4.8 4.8 3.5 5.9 21.4 23.4 10.4 3.8 11.6 10.5 10.4 11.8 7.5 2.3 4.4 11.6 10.0 2.9 19.0 9.0 21.2 19.0 14.3 35.6 42.1 13.6 18.3 10.4 0.0 0.8 0.4 5.1 0.5 5.4 2.5 6.4 4.4 1.3 3.2 5.2 4.1 0.0 5.7 0.2 1.6 8.3 2.6 2.4 3.0 12.9 6.0 2.4 2.0 2.4 2.1 3.3 2.1 3.0 2.2 6.0 3.1 6.5 2.0 1.2 0.0 0.0 3.4 1.8 9.8 5.5 1.7 2.0 1.5 3.5 0.8 0.0 3.5 11.4 2.5 1.6 5.7 0.4 7.5 1.6 0.0 3.1 3.3 0.6 1.7 3.1 3.3 3.6 2.2 7.3 0.9 1.5 2.1 0.6 15.7 6.5 5.3 8.7 44.7 5.1 3.0 10.9 5.6 1.3 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 68.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favorable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 11.2 16.5 10.0 17.3 16.2 5.9 9.7 8.5 18.1 9.8 10.9 14.3 5.7 9.5 13.9 15.7 19.0 68.6 15.7 16.6 9.9 10.8 13.6 19.2 9.9 16.8 12.1 9.6 14.6 14.0 15.1 11.7 12.1 15.8 12.6 16.6 10.3 16.4 13.4 27.2 8.9 11.1 13.0 7.9 16.5 14.5 12.9 9.3 19.3 9.9 23.2 22.7 19.1 11.0 24.9 25.7 6.2 17.7 26.7 16.1 11.9 20.7 18.2 17.4 14.3 10.5 6.1 24.2 15.7 8.4 24.1 15.9 26.7 7.8 35.4 15.4 13.3 15.6 15.1 31.4 30.1 29.2 14.0 24.6 21.1 21.3 38.4 11.8 21.6 36.1 7.5 21.6 23.6 15.2 6.4 16.0 15.8 28.1 9.4 23.2 26.2 27.7 11.3 34.2 19.5 30.5 27.7 27.4 13.5 21.4 36.8 14.4 10.5 13.8 17.4 12.5 23.3 14.0 14.9 11.6 13.4 26.9 25.9 33.3 7.8 9.8 31.8 16.9 24.3 39.1 6.2 11.6 2.9 13.9 17.7 15.5 24.9 15.1 15.5 25.7 21.6 16.1 15.0 1.7 26.7 15.5 16.1 12.5 11.9 10.0 16.2 8.5 18.1 9.9 10.8 12.1 9.6 15.8 9.3 11.9 10.7 30.3 21.0 18.4 11.9 21.5 12.7 37.5 9.1 17.4 23.6 49.7 21.6 29.8 2.7 9.8 7.4 0.0 11.8 45.7 9.9 13.5 15.1 13.4 41.0 7.9 15.1 8.0 19.6 2.7 6.9 17.8 5.0 10.8 16.5 8.4 20.0 7.0 8.5 24.4 9.2 12.9 13.1 12.3 22.6 16.2 38.1 17.5 21.3 22.3 WDR78 "DIC4, FLJ23129" ENSG00000152763 "WD repeat domain 78" Q5VTH9 1 66812885-66924887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 25.7;testis: 29.8" "Group enriched" "Detected in many" 5 "Ciliated cells: 310.5;Early spermatids: 118.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 7.6" "Lineage enriched" "Detected in many" 5 "NK-cells: 7.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 8.8;RPTEC TERT1: 13.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (4.26e-2)" "unprognostic (4.04e-1)" "unprognostic (1.58e-3)" "unprognostic (2.19e-2)" "unprognostic (1.85e-1)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (8.19e-2)" "unprognostic (4.00e-1)" "unprognostic (1.68e-3)" "unprognostic (2.08e-2)" "prognostic favorable (9.60e-5)" "unprognostic (1.98e-1)" "unprognostic (5.79e-2)" "unprognostic (5.03e-2)" "unprognostic (1.69e-1)" 1.6 2.0 3.1 2.7 7.5 0.3 3.0 0.9 3.9 4.2 5.1 4.0 4.0 0.9 3.1 16.0 0.9 25.7 2.5 1.7 4.2 4.1 6.8 1.3 5.6 1.0 2.0 4.0 7.6 2.0 6.3 7.0 2.1 16.8 2.4 4.0 2.4 2.1 5.8 0.9 1.3 1.2 1.5 2.4 1.2 1.2 29.8 3.3 1.6 6.2 1.1 0.9 1.7 1.5 1.6 0.0 0.2 0.0 7.6 1.0 0.2 3.3 1.4 1.8 2.5 5.8 8.8 0.6 1.5 2.6 2.0 2.0 0.3 2.9 1.7 0.3 1.5 5.9 0.3 1.4 0.3 3.0 0.2 0.4 0.5 0.7 0.3 2.0 0.1 0.1 4.0 4.2 7.2 1.5 6.9 0.7 1.8 0.5 0.1 3.2 1.2 0.7 0.5 2.4 1.1 0.7 0.8 0.0 0.0 13.6 0.0 2.3 1.1 1.5 0.6 1.2 2.0 0.6 1.2 0.3 0.8 0.0 5.5 0.7 0.5 0.0 3.8 1.6 0.4 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.7 0.6 0.3 0.0 1.6 1.0 0.4 0.2 7.6 0.0 0.0 0.1 0.2 3.1 7.5 0.9 3.9 4.2 4.1 2.0 4.0 16.8 3.3 6.0 4.6 0.0 1.7 1.1 3.1 6.5 0.0 310.5 40.9 15.7 17.7 1.4 13.3 2.7 118.7 1.4 2.1 0.0 1.4 0.4 1.8 0.8 3.5 1.0 0.6 1.6 4.1 3.1 0.3 19.1 9.8 0.1 0.0 1.8 3.8 3.8 1.8 5.1 9.2 8.4 11.9 0.0 3.3 21.7 1.3 0.6 0.6 0.0 2.6 0.9 WDR86 ENSG00000187260 "WD repeat domain 86" Q86TI4 7 151375909-151410727 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "thyroid gland: 33.8" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 2.7;Fibroblasts: 3.8;Muller glia cells: 9.1;Peritubular cells: 2.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 14.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HSkMC: 16.8;NTERA-2: 3.1;SCLC-21H: 7.1;SH-SY5Y: 5.1;SuSa: 4.8" "Group enriched" "Detected in many" 4 "basal ganglia: 1.5;cerebellum: 1.4;hippocampal formation: 4.4;pons and medulla: 3.6;thalamus: 2.7" "Low region specificity" "Detected in all" NA NA "unprognostic (8.93e-3)" "unprognostic (1.83e-2)" "unprognostic (3.13e-4)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.34e-2)" "unprognostic (6.02e-2)" "unprognostic (1.14e-2)" "unprognostic (6.32e-3)" "unprognostic (2.20e-1)" "unprognostic (1.84e-6)" "unprognostic (7.22e-2)" "unprognostic (1.96e-1)" "unprognostic (2.35e-2)" "unprognostic (1.04e-1)" 7.4 1.7 6.8 0.9 4.2 0.7 5.0 0.6 4.7 11.1 5.6 1.5 15.7 1.8 7.7 8.8 0.9 8.2 2.1 1.1 5.5 1.0 2.3 0.8 1.0 2.1 2.4 2.4 4.5 0.7 21.7 5.0 5.6 3.2 2.9 0.7 14.7 1.9 11.3 1.2 0.7 1.7 1.9 1.3 15.6 2.6 1.9 0.3 0.8 33.8 0.4 0.8 2.3 4.5 0.0 0.0 0.0 0.7 0.7 1.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 5.1 0.0 0.0 0.0 4.8 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 6.8 4.2 0.6 4.7 5.5 1.0 2.4 2.4 3.2 0.3 0.0 0.3 0.0 0.2 0.0 0.2 1.0 0.0 2.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 3.8 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.8 0.0 9.1 0.0 0.0 2.8 0.0 0.6 0.0 2.0 0.0 0.1 0.3 0.7 0.7 0.0 0.1 WDR87 NYD-SP11 ENSG00000171804 "WD repeat domain 87" Q6ZQQ6 19 37884823-37906677 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 94 "testis: 48.4" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 104.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "U-266/70: 2.0;U-266/84: 1.1" NA NA "unprognostic (6.37e-3)" "unprognostic (1.26e-2)" "unprognostic (5.59e-2)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (1.89e-2)" "unprognostic (2.60e-1)" "unprognostic (4.22e-1)" "unprognostic (5.43e-2)" "unprognostic (2.58e-2)" "unprognostic (1.78e-8)" "unprognostic (1.19e-1)" "unprognostic (2.42e-1)" "unprognostic (5.48e-2)" "unprognostic (4.12e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 48.4 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 104.6 4.4 0.0 0.0 0.0 0.0 0.0 WDR88 PQWD ENSG00000166359 "WD repeat domain 88" Q6ZMY6 19 33132090-33175795 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 25.2" "Group enriched" "Detected in some" 15 "Early spermatids: 24.8;Late spermatids: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "JURKAT: 6.4" "Not detected" "Not detected" "HPA041916, HPA050336" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA041916: AB_10804121, HPA050336: AB_2681093" "unprognostic (1.02e-1)" "unprognostic (9.40e-2)" "unprognostic (3.12e-1)" "unprognostic (1.33e-4)" "unprognostic (5.14e-2)" "unprognostic (7.98e-2)" "unprognostic (8.44e-2)" "unprognostic (2.01e-1)" "unprognostic (6.62e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-4)" "unprognostic (3.40e-1)" "unprognostic (1.87e-2)" "unprognostic (2.28e-1)" "unprognostic (1.63e-1)" "unprognostic (2.43e-2)" "unprognostic (6.67e-2)" 0.3 0.5 0.4 1.1 0.6 1.0 0.3 0.7 1.4 0.3 0.3 0.3 0.3 0.7 0.3 0.3 0.7 0.2 0.6 1.2 0.4 0.4 0.3 0.3 0.3 1.6 0.3 0.3 1.0 1.0 0.0 0.5 0.3 0.3 0.3 0.0 0.3 1.1 0.3 0.3 0.9 0.9 0.3 0.3 0.6 0.3 25.2 0.3 0.3 1.4 0.3 0.3 0.3 0.3 1.2 0.6 0.6 1.3 2.9 1.4 0.3 1.0 2.2 1.5 2.7 0.8 0.0 2.0 0.8 0.0 0.2 0.0 1.1 2.2 2.7 1.4 0.0 1.6 0.8 0.0 0.3 0.0 5.5 0.8 2.5 1.7 0.5 0.0 1.9 2.2 0.0 0.0 0.0 0.0 0.6 0.0 6.4 1.7 2.8 0.0 3.2 1.1 1.2 1.1 0.9 0.9 2.1 0.8 0.5 0.0 1.3 3.9 3.9 2.7 1.2 0.6 1.9 3.4 2.0 1.5 0.7 2.1 1.2 0.4 2.6 1.8 1.5 0.4 4.2 1.1 0.0 0.4 0.4 1.4 1.3 1.3 0.0 1.2 1.0 0.3 1.2 0.8 0.7 0.6 2.9 0.6 0.6 0.2 0.3 0.4 0.6 0.7 0.8 0.4 0.4 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.0 0.0 WDR93 ENSG00000140527 "WD repeat domain 93" Q6P2C0 15 89690797-89743638 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.0;testis: 28.6" "Cell type enhanced" "Detected in many" 13 "Ciliated cells: 58.9;Cone photoreceptor cells: 19.6;Early spermatids: 41.0;Late spermatids: 27.2;Spermatocytes: 24.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA046196, HPA048112" Uncertain Uncertain "Actin filaments" NA NA "Actin filaments" "HPA046196: AB_2679582, HPA048112: AB_2680267" "unprognostic (2.56e-3)" "unprognostic (3.21e-3)" "unprognostic (7.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.90e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-2)" "unprognostic (2.08e-2)" "unprognostic (1.22e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.40e-2)" "unprognostic (4.73e-2)" "unprognostic (9.84e-2)" "unprognostic (4.44e-2)" 0.5 0.3 1.2 0.7 2.3 0.8 1.1 1.1 1.4 1.2 0.2 3.7 0.0 0.0 0.6 8.0 0.1 12.0 0.3 1.6 1.6 1.6 2.5 0.2 1.3 0.3 0.3 0.4 1.7 0.8 0.4 3.0 0.2 6.2 0.9 0.2 2.5 1.1 1.9 0.3 0.4 0.2 0.0 0.5 0.3 0.2 28.6 1.2 0.1 3.3 0.0 0.2 0.2 0.1 0.5 1.1 2.2 0.3 1.3 0.6 0.2 1.1 1.0 0.1 0.5 1.3 1.0 1.5 1.0 0.5 1.2 0.7 0.5 2.8 0.6 1.1 0.7 0.4 0.7 0.1 0.8 1.9 1.3 0.8 0.8 1.3 0.6 1.8 1.1 0.2 1.6 2.0 0.4 0.1 0.5 0.3 1.1 0.1 0.9 0.9 1.0 1.0 0.5 1.5 0.4 0.6 0.4 0.4 0.4 2.7 0.6 3.4 0.8 2.8 0.8 3.7 0.9 0.5 1.8 0.0 1.0 0.8 1.6 0.6 0.5 0.9 0.9 1.2 0.4 0.7 1.2 0.3 0.4 0.5 0.3 0.2 0.2 0.3 0.2 0.3 0.5 0.3 0.6 2.2 1.3 0.2 1.1 0.2 0.2 1.2 2.3 1.1 1.4 1.6 1.6 0.3 0.4 6.2 1.2 3.0 0.3 0.0 0.5 0.2 3.0 0.3 0.0 58.9 5.7 8.7 19.6 0.3 3.3 0.7 41.0 0.0 0.0 0.0 0.2 0.2 0.2 0.7 0.0 0.0 0.2 3.2 0.0 0.6 0.8 27.2 1.4 0.7 1.7 1.0 0.0 0.6 0.2 0.0 0.7 1.3 14.9 0.0 0.1 24.5 5.9 0.1 0.2 0.7 0.0 0.2 WDR97 KIAA1875 ENSG00000179698 "WD repeat domain 97" A6NE52 8 144107726-144118315 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 4.1;testis: 7.8" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 6.5;Cone photoreceptor cells: 5.9;Horizontal cells: 4.8;Muller glia cells: 5.4;Rod photoreceptor cells: 9.1" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 7 "pons and medulla: 4.1" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.2;NB-4: 1.1;PC-3: 2.8;U-2 OS: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA059409 Uncertain NA NA "HPA059409: AB_2684005" "unprognostic (3.95e-2)" "unprognostic (1.31e-2)" "unprognostic (3.58e-3)" "unprognostic (1.70e-1)" "unprognostic (2.70e-1)" "unprognostic (3.01e-4)" "unprognostic (3.10e-2)" "unprognostic (2.40e-1)" "unprognostic (6.20e-2)" "unprognostic (1.40e-1)" "unprognostic (2.97e-3)" "unprognostic (6.92e-2)" "unprognostic (6.11e-6)" "unprognostic (2.79e-3)" "unprognostic (4.95e-2)" "unprognostic (2.51e-1)" "unprognostic (3.73e-4)" 0.1 0.5 0.2 0.2 0.1 0.6 0.0 0.2 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.5 0.0 0.2 0.0 0.1 0.6 0.0 0.1 0.0 4.1 0.1 0.2 0.0 0.0 0.0 0.5 0.4 0.1 0.0 0.1 0.1 0.2 7.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.6 0.9 0.3 1.3 0.8 0.1 0.2 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.5 0.4 0.0 0.1 0.0 0.3 0.2 0.1 0.0 0.0 0.3 0.3 1.2 0.1 0.2 0.1 0.4 0.5 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.1 2.8 0.2 0.4 0.2 0.0 0.6 0.4 0.4 0.1 0.0 0.0 0.3 0.3 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.6 0.3 0.2 0.4 0.1 0.7 0.3 0.4 0.2 0.0 0.7 0.8 0.4 0.9 1.3 0.2 0.6 0.1 0.1 0.2 0.1 0.2 0.6 0.2 0.1 0.2 0.0 4.1 0.0 0.0 1.7 0.0 0.2 0.0 6.5 0.0 0.0 1.4 0.0 0.0 5.9 0.1 1.7 0.5 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.7 0.2 4.8 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.5 5.4 0.5 0.3 0.0 0.0 9.1 0.0 0.0 3.4 1.7 0.0 0.0 0.0 0.4 0.1 WFDC1 PS20 ENSG00000103175 "WAP four-disulfide core domain 1" Q9HC57 16 84294646-84329851 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 64.5" "Group enriched" "Detected in many" 5 "Bipolar cells: 68.7;Peritubular cells: 241.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 19.1;BJ: 13.0;HEL: 10.9;HeLa: 17.4;THP-1: 6.3;U-937: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031411 Uncertain "Secreted to extracellular matrix" NA NA "HPA031411: AB_10600921" "unprognostic (6.53e-2)" "unprognostic (1.27e-1)" "unprognostic (1.61e-2)" "unprognostic (8.66e-4)" "unprognostic (1.41e-2)" "unprognostic (1.50e-3)" "unprognostic (1.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.12e-1)" "unprognostic (3.78e-2)" "unprognostic (5.49e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (3.04e-1)" 3.9 12.0 6.3 4.2 5.5 0.9 1.9 7.0 5.9 15.8 28.8 2.2 12.0 3.9 11.4 8.3 10.6 3.4 64.5 2.8 5.5 5.0 8.7 1.9 16.0 2.5 3.7 4.3 3.3 0.6 0.3 2.2 40.7 1.9 29.9 7.5 43.8 4.2 50.6 1.2 1.1 6.6 47.5 1.7 1.9 8.9 9.4 0.7 0.0 2.0 4.6 2.2 30.3 5.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.9 19.1 0.0 0.1 0.1 13.0 1.6 0.0 0.0 0.0 0.0 0.0 3.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 17.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.2 0.0 0.0 1.4 0.0 0.0 3.6 0.1 0.0 0.3 2.1 0.0 0.1 6.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.3 5.5 7.0 5.9 5.5 5.0 3.7 4.3 1.9 0.7 3.0 0.3 0.0 0.9 1.5 68.7 1.1 0.0 1.4 0.0 1.8 0.0 1.8 10.0 0.0 23.3 2.0 0.2 0.0 0.0 1.7 14.3 1.2 0.0 0.0 5.5 4.8 4.1 19.0 0.0 20.9 14.7 0.0 0.0 0.0 4.2 1.2 0.1 0.0 241.9 1.0 3.9 0.0 30.9 0.7 0.9 0.4 3.2 0.0 3.3 0.8 WFDC10A "C20orf146, dJ688G8.3, WAP10" ENSG00000180305 "WAP four-disulfide core domain 10A" Q9H1F0 20 45629526-45631196 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "epididymis: 62.4" "Group enriched" "Detected in some" 4 "granulocytes: 4.6;Late spermatids: 2.1" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebral cortex: 1.6" "Cell type enriched" "Detected in single" 7 "naive CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 8 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 1.2;CACO-2: 2.5" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.5 0.0 0.1 62.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.1 0.0 1.2 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFDC10B WAP12 ENSG00000182931 "WAP four-disulfide core domain 10B" Q8IUB3 20 45684653-45705019 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 27.3;testis: 5.9;urinary bladder: 8.0" "Group enriched" "Detected in some" 5 "Early spermatids: 4.4;Late spermatids: 7.3;Rod photoreceptor cells: 8.7;Spermatocytes: 3.2" "Cancer enhanced" "Detected in some" "lung cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;Daudi: 2.7;HHSteC: 2.3;hTEC/SVTERT24-B: 1.8;PC-3: 5.7;U-87 MG: 2.6" "Secreted in male reproductive system" NA NA "unprognostic (1.14e-1)" "unprognostic (2.31e-1)" "unprognostic (1.37e-4)" "unprognostic (1.60e-1)" "unprognostic (2.69e-1)" "unprognostic (4.81e-2)" "unprognostic (4.30e-3)" "unprognostic (5.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.36e-1)" "unprognostic (0.00e+0)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" "unprognostic (2.21e-2)" "unprognostic (3.17e-1)" 0.2 0.0 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.2 0.0 0.3 27.3 0.2 0.3 0.2 0.2 0.2 0.1 0.2 0.2 0.9 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 1.0 0.5 0.2 0.2 0.2 0.2 1.5 0.2 0.3 0.2 0.2 0.4 5.9 0.2 0.2 0.2 0.2 0.2 8.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 2.0 2.7 0.1 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 1.8 0.0 1.7 0.0 0.1 0.0 0.0 0.7 0.7 0.0 0.0 0.8 1.8 5.7 0.0 0.3 0.0 0.6 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 8.7 0.0 0.0 3.2 0.2 0.0 0.1 0.0 0.0 0.3 WFDC11 WAP11 ENSG00000180083 "WAP four-disulfide core domain 11" Q8NEX6 20 45648563-45670270 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "epididymis: 46.2" "Cell type enriched" "Detected in some" 25 "Early spermatids: 50.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 4.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HeLa: 13.0;RPMI-8226: 7.9" "Secreted in male reproductive system" NA NA 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 46.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.4 0.0 0.8 0.7 4.7 0.4 1.3 0.8 0.1 0.2 1.1 0.1 0.2 0.6 0.8 1.2 1.1 0.1 0.0 0.0 0.7 0.3 0.7 0.4 0.0 0.1 0.6 0.0 0.2 0.0 0.0 0.8 1.1 13.0 0.8 0.0 0.6 0.8 0.3 0.0 0.0 0.2 0.2 0.0 0.4 0.6 0.2 0.0 0.2 0.5 1.1 1.1 0.4 0.6 0.2 0.5 7.9 0.0 0.4 0.1 0.0 0.0 0.4 0.0 1.0 0.1 1.1 0.0 0.2 0.7 0.3 0.1 0.5 0.5 0.0 0.1 2.2 0.3 4.7 0.4 0.2 0.4 0.2 0.4 0.3 0.3 0.3 0.1 0.8 0.4 0.8 1.2 1.3 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 WFDC12 "C20orf122, dJ211D12.4, WAP2" ENSG00000168703 "WAP four-disulfide core domain 12" Q8WWY7 20 45123425-45124465 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 26.9;skin 1: 30.5" "Cell type enhanced" "Detected in some" 33 "Alveolar cells type 2: 1.6;Collecting duct cells: 5.2" "Group enriched" "Detected in many" 7 "head and neck cancer: 18.9;melanoma: 14.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Secreted - unknown location" NA NA 20000 "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "unprognostic (1.18e-2)" "unprognostic (5.42e-2)" "unprognostic (2.25e-1)" "unprognostic (2.86e-1)" "unprognostic (3.40e-3)" "unprognostic (1.72e-2)" "unprognostic (8.70e-3)" "prognostic unfavorable (5.65e-4)" "unprognostic (4.49e-2)" "unprognostic (3.91e-1)" "unprognostic (5.50e-3)" 0.1 0.0 0.1 0.1 0.1 0.5 1.9 0.1 0.1 1.5 0.1 0.1 26.9 0.2 0.1 1.2 6.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 3.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.1 1.3 0.0 0.1 1.8 4.1 0.2 30.5 0.1 0.1 0.1 0.1 0.0 1.0 0.1 2.2 0.1 6.4 0.9 0.1 10.0 0.8 0.3 0.9 0.4 0.0 1.1 0.0 0.9 0.6 0.3 0.6 3.5 0.4 1.3 0.3 1.8 0.2 1.6 0.6 0.4 0.9 0.3 0.4 0.7 0.6 0.3 0.9 2.3 1.5 0.0 0.0 1.1 1.3 1.4 0.0 1.3 0.0 0.3 1.4 0.9 1.5 1.1 0.6 0.9 1.2 1.1 0.4 0.4 1.3 1.7 1.5 0.4 0.3 2.0 0.4 2.1 0.6 0.0 0.2 0.0 1.0 0.0 1.0 0.6 2.6 0.0 0.2 0.4 1.2 1.2 1.4 1.3 1.3 0.9 3.2 0.6 0.1 0.4 0.9 0.1 0.4 1.1 0.3 0.1 0.2 0.1 0.8 0.4 0.3 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 WFDC13 "C20orf138, dJ601O1.3, WAP13" ENSG00000168634 "WAP four-disulfide core domain 13" Q8IUB5 20 45702016-45708817 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 11 "epididymis: 92.8" "Group enriched" "Detected in some" 17 "Cone photoreceptor cells: 2.0;Rod photoreceptor cells: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "naive CD4 T-cell: 3.1" "Lineage enriched" "Detected in single" 7 "T-cells: 3.1" "Cell line enhanced" "Detected in some" "Daudi: 1.9;RT4: 3.4;U-87 MG: 2.7" "Secreted in male reproductive system" NA NA "unprognostic (2.53e-1)" "unprognostic (1.30e-2)" "unprognostic (7.84e-3)" "unprognostic (7.96e-3)" "unprognostic (2.04e-1)" "unprognostic (1.02e-11)" "unprognostic (1.17e-1)" "unprognostic (1.44e-2)" "unprognostic (2.22e-2)" 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 8.3 0.0 0.1 92.8 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.4 0.0 3.1 1.3 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.3 0.0 3.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.3 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFDC2 "dJ461P17.6, EDDM4, HE4, WAP5" ENSG00000101443 "WAP four-disulfide core domain 2" Q14508 20 45469706-45481532 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 1206.7;Ciliated cells: 1080.1;Club cells: 1101.0;Collecting duct cells: 1886.1;Mucus-secreting cells: 1147.4;Urothelial cells: 3035.7" "Cancer enhanced" "Detected in all" "endometrial cancer: 1815.6" "Region enriched" "Detected in single" 5 "basal ganglia: 3.0" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Group enriched" "Detected in some" 9 "A-431: 26.9;CAPAN-2: 50.2;EFO-21: 42.0;HaCaT: 36.6;RPTEC TERT1: 38.9" "Low region specificity" "Detected in some" HPA042302 Enhanced "Secreted in other tissues" NA NA 1300000 "HPA042302: AB_2677939" "unprognostic (5.75e-2)" "unprognostic (2.23e-1)" "unprognostic (4.37e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (7.19e-3)" "unprognostic (1.94e-1)" "unprognostic (5.49e-3)" "unprognostic (3.71e-1)" "unprognostic (2.01e-1)" "unprognostic (1.42e-1)" "unprognostic (1.40e-1)" "prognostic favorable (4.44e-5)" "unprognostic (1.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.00e-1)" "unprognostic (3.20e-2)" 1.2 0.1 0.3 1.5 3.0 0.0 10.6 0.2 0.6 352.3 11.0 0.4 143.4 0.7 19.4 385.4 4.5 44.6 10.4 0.4 0.3 0.3 135.1 9.9 31.6 0.2 0.3 0.3 20.4 5.0 5.0 14.9 1.3 0.5 27.2 14.7 2.2 343.7 60.9 0.2 2.8 5.0 10.9 0.2 0.1 3.8 15.6 0.5 0.7 45.5 15.3 29.1 21.9 6.9 0.0 1.2 0.0 0.0 0.0 0.0 0.1 26.9 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.1 50.2 0.0 42.0 0.0 0.1 36.6 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.6 4.4 0.1 0.0 0.0 0.0 0.0 38.9 0.3 1.2 0.2 2.5 0.0 0.2 0.5 0.7 0.1 0.0 0.0 0.7 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 3.0 0.2 0.6 0.3 0.3 0.3 0.3 0.5 0.5 157.8 201.9 2.7 1206.7 7.9 23.5 1.2 107.0 1080.1 1101.0 1886.1 21.6 0.7 187.3 214.0 0.9 0.6 87.9 0.0 117.6 0.6 4.1 847.7 9.3 1.1 1.6 0.0 406.4 3.1 1.2 2.7 33.4 5.6 10.1 10.0 1147.4 14.8 130.4 454.8 0.0 77.8 4.2 6.5 11.9 11.6 11.0 12.3 0.6 1.3 278.2 3035.7 WFDC3 "dJ447F3.3, WAP14" ENSG00000124116 "WAP four-disulfide core domain 3" Q8IUB2 20 45747944-45791932 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 16 "skin 1: 14.9;testis: 45.2" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 81.6;Late spermatids: 127.9;Spermatocytes: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Lineage enhanced" "Detected in single" "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HUVEC TERT2: 1.0;PC-3: 5.0" "Secreted in male reproductive system" NA NA "unprognostic (7.47e-2)" "unprognostic (1.94e-1)" "unprognostic (2.64e-1)" "unprognostic (2.39e-2)" "unprognostic (1.06e-1)" "unprognostic (5.75e-2)" "unprognostic (9.30e-4)" "unprognostic (6.63e-3)" "unprognostic (4.02e-2)" "unprognostic (1.47e-1)" "unprognostic (1.69e-3)" "unprognostic (1.79e-1)" "unprognostic (1.36e-8)" "unprognostic (8.53e-2)" "unprognostic (2.45e-1)" "unprognostic (5.27e-3)" "unprognostic (3.03e-2)" 0.4 0.1 0.2 0.3 1.1 0.0 1.8 0.2 1.0 0.1 0.2 1.4 1.3 0.5 0.2 1.1 0.1 0.9 0.1 0.3 0.5 0.2 0.1 0.1 0.2 0.0 0.5 0.4 0.1 0.2 0.0 1.1 0.1 0.6 0.2 0.2 0.0 0.0 0.6 0.1 14.9 0.1 1.2 0.5 0.1 0.1 45.2 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.5 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 5.0 0.2 0.5 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.2 1.0 0.5 0.2 0.5 0.4 0.6 0.4 0.0 1.6 0.0 4.4 1.0 1.0 0.8 0.0 5.3 11.4 3.5 5.9 0.3 10.0 1.3 81.6 0.1 2.9 0.0 8.9 0.6 2.2 4.2 1.1 0.4 1.0 0.0 3.5 3.1 1.2 127.9 1.4 0.0 0.0 0.0 6.8 1.4 7.6 2.5 2.5 3.0 30.4 0.0 1.4 67.1 2.5 2.8 0.0 0.0 0.9 11.2 WFDC5 "dJ211D12.5, WAP1" ENSG00000175121 "WAP four-disulfide core domain 5" Q8TCV5 20 45109452-45115172 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skin 1: 99.0" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 49.6;Early spermatids: 17.0;Suprabasal keratinocytes: 37.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 17.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HBEC3-KT: 2.4;Karpas-707: 3.8;RT4: 3.5" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (1.32e-1)" "unprognostic (3.22e-2)" "unprognostic (3.05e-1)" "unprognostic (1.54e-1)" "unprognostic (1.28e-4)" "unprognostic (6.59e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (2.32e-5)" "unprognostic (4.12e-2)" "unprognostic (2.17e-1)" "unprognostic (5.96e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.4 0.7 0.2 99.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 1.8 0.0 22.6 11.4 0.2 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.7 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.3 0.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.4 49.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 37.8 0.0 0.0 0.0 0.3 WFDC6 "C20orf171, dJ461P17.11, WAP6" ENSG00000243543 "WAP four-disulfide core domain 6" Q9BQY6 20 45534196-45539495 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "epididymis: 79.9;testis: 25.5" "Cell type enriched" "Detected in some" 16 "Ciliated cells: 56.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-87 MG: 7.8" "Secreted in male reproductive system" NA NA "unprognostic (3.68e-3)" "unprognostic (2.21e-3)" "unprognostic (1.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.91e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 7.6 0.0 0.2 79.9 0.1 2.8 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.4 0.1 0.3 0.1 0.1 0.1 0.1 0.0 25.5 0.1 0.1 0.3 0.1 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.2 3.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.1 WFDC8 "C20orf170, dJ461P17.1, WAP8" ENSG00000158901 "WAP four-disulfide core domain 8" Q8IUA0 20 45551153-45579326 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "epididymis: 103.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "U-87 MG: 7.8" "Not detected" "Not detected" "HPA042710, HPA071119" Enhanced "Secreted in male reproductive system" NA NA "HPA042710: AB_2732501, HPA071119: AB_2732172" "unprognostic (5.63e-3)" "unprognostic (1.09e-2)" "unprognostic (2.34e-1)" "unprognostic (9.96e-2)" "unprognostic (1.07e-2)" 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 5.6 0.0 1.0 103.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.0 0.1 0.1 1.0 0.6 1.0 0.9 0.7 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 7.8 0.0 0.1 0.6 0.9 0.2 0.3 0.3 0.2 0.2 0.2 0.1 0.1 1.0 0.4 0.4 1.0 0.7 0.4 0.6 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFDC9 "dJ688G8.2, WAP9" ENSG00000180205 "WAP four-disulfide core domain 9" Q8NEX5 20 45607939-45631268 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "epididymis: 162.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;NB-4: 4.8;SH-SY5Y: 2.1" "Group enriched" "Detected in some" 6 "basal ganglia: 0.5;thalamus: 0.9" "Not detected" "Not detected" "Secreted in male reproductive system" NA NA 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.1 0.5 0.1 0.1 0.0 10.1 0.0 0.1 162.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.1 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WFIKKN1 "C16orf12, RJD2, WFDC20A, WFIKKN" ENSG00000127578 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1" Q96NZ8 16 629239-634116 "Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.8;lymphoid tissue: 5.1" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 3.0;Horizontal cells: 9.5;Melanocytes: 3.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.9;Hep G2: 2.1;NTERA-2: 2.9;SuSa: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (3.12e-1)" "unprognostic (2.57e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-2)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (3.36e-2)" "unprognostic (4.45e-2)" "unprognostic (8.53e-2)" "unprognostic (2.43e-1)" "unprognostic (3.78e-3)" "unprognostic (1.19e-1)" "unprognostic (5.56e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (2.50e-3)" "unprognostic (4.70e-5)" 0.7 0.2 1.3 0.3 2.4 0.4 0.3 5.8 1.9 0.7 1.4 0.3 0.3 0.2 1.3 0.3 0.3 0.2 0.3 0.3 1.0 0.2 1.3 0.6 1.3 0.3 0.4 2.3 0.5 1.2 0.2 1.5 0.5 0.3 0.6 0.2 0.3 0.5 0.3 1.0 0.7 0.4 0.3 0.3 1.6 1.2 1.0 0.3 5.1 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.6 0.7 0.0 0.0 0.4 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.7 2.9 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.4 0.1 0.3 0.0 0.1 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 1.3 2.4 5.8 1.9 1.0 0.2 0.4 2.3 0.3 0.3 0.0 0.3 0.0 0.2 0.8 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.2 0.1 0.4 0.6 1.1 0.5 0.1 9.5 1.2 1.3 0.8 0.0 0.0 0.0 3.3 0.0 1.3 1.0 0.5 2.9 0.7 0.2 0.0 0.0 0.0 1.0 0.6 1.4 0.2 0.0 0.9 0.4 WFIKKN2 "WFDC20B, WFIKKNRP" ENSG00000173714 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2" Q8TEU8 17 50834650-50842348 "Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 89.1;ovary: 56.4" "Group enriched" "Detected in some" 7 "Leydig cells: 8.3;Peritubular cells: 22.6" "Group enriched" "Detected in some" 5 "glioma: 0.7;testis cancer: 2.2" "Region enriched" "Detected in some" 10 "pons and medulla: 89.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.6;T-47d: 3.8;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "midbrain: 6.0;pons and medulla: 13.1;thalamus: 6.8" "Secreted in other tissues" NA NA 1700000 "unprognostic (7.31e-2)" "unprognostic (7.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.80e-2)" "unprognostic (3.46e-2)" "unprognostic (5.72e-2)" "unprognostic (5.42e-3)" "unprognostic (2.54e-3)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (1.42e-3)" "unprognostic (2.17e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-1)" 0.1 0.5 0.2 0.1 0.3 0.0 0.0 0.8 0.5 0.2 0.3 6.8 0.0 0.1 0.7 0.4 0.2 0.6 0.2 0.3 9.1 0.2 0.1 0.0 1.0 0.0 0.4 0.0 56.4 0.3 0.1 0.8 0.0 89.1 0.3 0.1 4.5 0.1 0.5 1.3 0.6 0.1 0.2 0.3 0.1 0.1 1.6 0.5 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.5 9.1 0.2 0.4 0.0 89.1 0.5 0.0 0.0 0.0 0.0 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 2.3 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 WHAMM "KIAA1971, WHAMM1, WHDC1" ENSG00000156232 "WAS protein homolog associated with actin, golgi membranes and microtubules" Q8TF30 15 82809628-82836108 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039690, HPA040231" Supported Supported Cytosol NA NA Cytosol "HPA039690: AB_10795405, HPA040231: AB_10795361" "unprognostic (7.98e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (8.56e-2)" "unprognostic (6.68e-2)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.37e-2)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.20e-2)" 10.6 6.6 7.9 9.8 11.7 44.5 10.1 14.0 9.5 8.7 8.8 11.2 7.7 8.8 8.5 6.7 10.2 7.3 6.6 7.4 10.1 5.3 9.5 11.4 10.7 9.6 10.7 8.0 10.9 9.3 16.7 7.9 8.9 13.9 10.1 8.2 7.6 9.3 7.5 23.3 12.0 10.6 12.0 12.3 11.9 8.3 5.5 14.3 8.3 9.6 6.6 11.0 11.1 13.1 3.2 2.4 5.0 1.6 5.8 3.2 0.9 4.1 4.2 2.6 4.0 8.6 6.0 4.5 5.8 5.8 6.4 6.4 2.8 7.6 9.0 7.2 5.3 6.1 9.2 8.1 4.7 4.2 2.9 4.6 5.1 4.8 4.0 8.8 3.7 6.1 5.9 6.4 3.0 6.3 6.5 4.5 4.3 4.6 11.9 6.3 3.1 3.0 5.3 1.1 5.1 2.6 4.5 5.7 2.5 11.0 16.8 2.6 2.1 8.9 5.9 5.9 5.7 4.0 7.9 7.1 8.5 3.0 5.7 6.5 12.9 7.2 4.4 6.0 5.1 5.3 5.0 1.6 1.3 3.2 1.1 2.9 2.6 3.1 2.4 1.0 3.2 2.9 2.9 3.6 5.8 1.1 2.4 2.4 0.9 7.9 11.7 14.0 9.5 10.1 5.3 10.7 8.0 13.9 14.3 14.9 12.9 35.0 39.1 23.6 15.2 13.6 7.6 5.3 7.9 19.2 13.7 12.0 5.0 7.7 5.5 16.4 14.8 0.0 8.9 13.6 13.1 41.0 10.4 11.5 16.5 22.3 6.4 16.5 10.2 2.4 16.1 17.9 18.6 9.0 16.6 17.7 11.0 14.1 22.3 8.6 17.7 32.3 15.6 22.8 30.6 22.0 21.3 26.3 12.3 64.2 WHRN "CIP98, DFNB31, PDZD7B, USH2D" ENSG00000095397 Whirlin Q9P202 9 114402080-114505450 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hearing "Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 58.2" "Cell type enriched" "Detected in some" 4 "Ciliated cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.0;memory CD8 T-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 16.3;Karpas-707: 47.6;U-266/70: 29.9;U-266/84: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (6.06e-3)" "unprognostic (1.02e-1)" "unprognostic (9.96e-2)" "unprognostic (4.27e-3)" "unprognostic (4.59e-1)" "unprognostic (7.07e-2)" "unprognostic (3.66e-2)" "unprognostic (7.25e-2)" "unprognostic (6.13e-3)" "unprognostic (3.43e-2)" "prognostic favorable (2.28e-4)" "unprognostic (1.03e-1)" "unprognostic (1.71e-3)" "unprognostic (3.21e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-2)" "unprognostic (3.44e-1)" 3.3 58.2 11.7 4.1 24.5 3.2 4.9 7.6 18.1 8.3 5.4 31.7 2.9 8.3 17.8 8.4 4.7 9.5 4.1 3.6 12.0 9.1 4.0 2.2 3.7 4.5 26.0 7.6 12.6 9.8 10.2 19.3 3.2 20.0 7.8 2.9 13.0 10.9 6.9 1.3 7.3 8.0 9.5 14.4 17.8 6.5 23.6 29.8 11.0 5.7 1.5 2.4 4.0 7.2 0.3 0.0 0.2 0.0 0.7 2.0 0.1 0.6 1.0 1.6 6.0 0.6 0.2 3.2 0.4 0.9 0.6 0.4 0.1 0.3 0.0 1.2 0.4 7.9 3.6 0.3 0.6 0.1 16.3 2.7 0.0 11.5 1.3 0.2 0.0 0.4 0.5 1.9 2.2 0.2 4.4 0.0 0.8 3.3 47.6 0.6 6.0 0.0 0.2 2.1 0.0 9.9 0.8 0.0 12.5 1.6 0.3 7.4 0.5 3.5 4.2 12.5 1.9 4.0 0.1 1.0 2.1 1.2 2.3 2.9 29.9 30.7 0.2 0.8 0.0 1.2 0.0 0.0 0.0 0.3 0.0 2.0 0.1 0.5 2.0 0.0 0.3 0.0 0.6 0.2 0.7 0.0 0.0 1.0 0.1 11.7 24.5 7.6 18.1 12.0 9.1 26.0 7.6 20.0 29.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 14.7 2.3 0.0 0.0 2.5 0.0 1.6 0.0 0.0 0.0 0.0 1.8 1.9 0.0 0.0 2.3 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 WIF1 ENSG00000156076 "WNT inhibitory factor 1" Q9Y5W5 12 65050626-65121566 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.2;lung: 67.7;retina: 29.6" "Cell type enriched" "Detected in many" 15 "Muller glia cells: 2337.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 16.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 5.4;LHCN-M2: 2.5;NTERA-2: 7.0;SCLC-21H: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Secreted to extracellular matrix" NA NA "unprognostic (5.96e-3)" "unprognostic (2.00e-1)" "unprognostic (4.29e-3)" "unprognostic (3.26e-3)" "unprognostic (9.66e-2)" "unprognostic (1.91e-1)" "unprognostic (1.26e-2)" "unprognostic (7.94e-2)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (3.17e-1)" "unprognostic (2.30e-5)" "unprognostic (3.02e-1)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (7.24e-3)" 0.9 2.4 23.3 0.8 35.2 0.6 14.2 1.6 20.6 1.6 0.8 1.0 1.9 0.6 5.5 14.5 3.4 1.5 0.6 0.7 10.4 3.9 1.0 0.6 67.7 0.7 1.4 8.2 0.8 0.8 0.6 21.4 0.6 0.4 9.5 0.8 29.6 24.8 2.3 0.6 4.2 1.8 1.2 0.7 0.7 0.9 1.0 3.5 0.0 0.6 3.6 0.6 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.5 0.1 0.0 0.9 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 35.2 1.6 20.6 10.4 3.9 1.4 8.2 0.4 3.5 32.8 159.2 0.0 31.4 11.2 20.4 1.1 0.0 62.9 48.9 1.8 7.9 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 1.9 16.0 7.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 3.1 21.9 0.0 0.0 2337.6 0.0 0.0 0.4 0.8 66.4 0.0 3.6 0.5 0.2 9.3 0.0 0.0 0.0 0.5 WIPF3 "CR16, FLJ36931" ENSG00000122574 "WAS/WASL interacting protein family member 3" A6NGB9 7 29806486-29917066 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;ovary: 44.7" "Group enriched" "Detected in many" 8 "Leydig cells: 46.9;Peritubular cells: 94.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 18.5;HEK 293: 4.1;K-562: 6.3;NTERA-2: 5.2;RPMI-8226: 11.1;SK-MEL-30: 4.5" "Region enhanced" "Detected in many" "hippocampal formation: 234.6" "HPA041145, HPA041211" Uncertain Uncertain Mitochondria NA NA Mitochondria "HPA041145: AB_10795001, HPA041211: AB_10795003" "prognostic favorable (7.93e-4)" "unprognostic (1.35e-1)" "unprognostic (1.37e-3)" "unprognostic (2.12e-3)" "unprognostic (3.65e-3)" "unprognostic (1.53e-1)" "unprognostic (8.95e-3)" "unprognostic (4.53e-2)" "unprognostic (3.49e-1)" "unprognostic (1.19e-2)" "unprognostic (1.08e-2)" "unprognostic (7.49e-2)" "unprognostic (1.61e-2)" "unprognostic (1.35e-1)" "unprognostic (2.27e-2)" "unprognostic (3.33e-2)" "unprognostic (1.41e-1)" 1.8 6.6 13.4 1.6 40.6 1.1 1.9 5.5 15.1 1.2 1.4 3.8 1.0 3.6 4.2 21.8 2.1 9.9 3.5 4.6 30.0 5.1 3.3 1.3 1.3 1.4 4.0 12.1 44.7 2.4 1.6 5.6 1.0 1.5 5.5 1.3 0.8 4.5 5.9 23.0 1.7 3.5 5.2 1.7 1.7 6.3 27.6 7.8 0.0 2.8 2.9 2.3 3.2 0.8 0.8 2.1 2.6 1.2 0.9 1.3 0.2 0.3 1.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 18.5 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.1 0.0 0.1 0.0 0.1 5.2 0.0 3.6 0.0 0.0 11.1 0.0 0.0 1.8 1.6 0.1 0.1 4.5 2.6 0.4 0.0 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.6 0.5 0.9 0.3 0.7 0.6 0.7 0.9 0.3 0.3 0.8 1.3 0.8 1.2 0.9 1.2 2.1 0.5 0.2 13.4 40.6 5.5 15.1 30.0 5.1 4.0 12.1 1.5 7.8 0.0 0.0 0.0 1.3 1.9 4.9 8.9 0.0 8.1 2.3 3.5 2.0 0.0 3.3 3.7 1.3 1.1 1.3 0.0 3.1 0.1 0.9 1.1 0.0 0.4 4.7 4.8 1.7 0.6 0.0 3.0 46.9 0.0 5.0 0.0 0.5 5.4 2.3 0.8 94.4 3.5 2.7 6.5 2.1 0.5 3.0 0.4 0.0 0.0 1.9 0.3 WISP2 "CCN5, CT58, CTGF-L" ENSG00000064205 "WNT1 inducible signaling pathway protein 2" O76076 20 44714844-44728509 "Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 109.7" "Cell type enriched" "Detected in many" 12 "Leydig cells: 367.7" "Cancer enhanced" "Detected in many" "melanoma: 8.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 10.0;ASC TERT1: 26.9;HeLa: 15.0;HSkMC: 10.9;U-2197: 85.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB019273 Approved "Secreted to extracellular matrix" NA NA 400000 "CAB019273: " "unprognostic (1.87e-1)" "unprognostic (2.64e-1)" "unprognostic (3.01e-2)" "unprognostic (1.12e-1)" "unprognostic (1.70e-1)" "unprognostic (2.83e-1)" "unprognostic (1.83e-1)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (9.42e-2)" "unprognostic (2.81e-1)" "unprognostic (7.95e-3)" "unprognostic (1.76e-10)" "unprognostic (1.55e-3)" "unprognostic (7.21e-2)" "unprognostic (4.84e-2)" "unprognostic (1.28e-1)" 57.0 6.5 0.2 2.0 2.2 0.4 32.7 0.1 0.5 109.7 4.7 0.6 8.6 0.6 7.0 12.4 47.1 5.5 8.4 29.7 0.3 0.0 0.5 0.9 25.6 0.9 0.1 1.4 48.4 1.8 0.7 0.0 0.9 0.2 20.1 0.9 0.5 4.3 8.9 18.0 30.6 1.4 22.0 0.2 0.5 1.4 37.7 0.4 0.0 2.5 3.7 0.6 18.2 18.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 10.0 26.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.2 0.1 0.5 0.3 0.0 0.1 1.4 0.2 0.4 0.0 2.2 0.0 1.3 28.4 0.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.0 0.0 0.0 0.0 14.4 1.3 0.0 0.0 0.1 0.0 0.0 25.8 0.8 4.0 367.7 1.5 23.6 0.0 0.0 2.0 0.2 0.0 30.1 0.0 0.0 12.9 24.7 1.7 0.8 19.6 0.0 0.0 0.0 2.0 WISP3 CCN6 ENSG00000112761 "WNT1 inducible signaling pathway protein 3" O95389 6 112054072-112070969 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.5" "Cell type enriched" "Detected in some" 9 "Early spermatids: 82.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "basal ganglia: 2.3;cerebellum: 5.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 11.2;THP-1: 3.6;U-2197: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA064196 Supported Mitochondria "Secreted to extracellular matrix" NA NA Mitochondria "HPA064196: AB_2685209" "unprognostic (2.13e-2)" "unprognostic (7.90e-3)" "unprognostic (5.00e-2)" "unprognostic (2.22e-2)" "unprognostic (3.76e-1)" "unprognostic (6.52e-2)" "unprognostic (1.98e-3)" "unprognostic (4.07e-3)" "unprognostic (1.82e-1)" "unprognostic (3.90e-1)" "unprognostic (1.02e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-2)" "unprognostic (1.50e-2)" "unprognostic (3.11e-1)" "unprognostic (4.91e-2)" "unprognostic (2.93e-2)" 0.4 0.5 0.3 0.4 2.3 0.8 4.2 5.9 0.5 1.9 0.3 0.3 0.3 0.1 0.6 9.5 0.9 3.2 1.4 0.4 0.3 0.5 5.3 0.8 0.4 0.5 0.4 0.3 1.6 0.3 0.0 0.3 0.4 0.3 1.1 0.0 0.3 0.6 0.3 0.6 4.8 0.3 0.3 0.4 0.4 0.4 5.8 0.9 0.3 0.3 2.8 2.2 0.3 1.5 1.1 0.6 2.0 0.5 1.7 1.2 0.2 0.1 0.0 0.3 1.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.9 0.2 0.3 0.3 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.7 0.3 0.1 0.0 0.2 0.9 0.4 0.1 0.2 0.3 0.1 0.3 0.0 11.2 0.5 0.6 0.1 0.2 0.9 0.4 0.2 3.6 0.2 0.2 0.2 2.6 0.3 0.3 0.0 0.3 0.4 1.1 0.2 1.4 0.4 0.6 0.5 0.3 0.6 0.8 0.9 0.9 0.3 1.1 1.2 1.1 2.0 1.7 0.5 0.6 0.6 0.2 0.3 2.3 5.9 0.5 0.3 0.5 0.4 0.3 0.3 0.9 0.0 0.0 0.0 2.7 0.7 0.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 82.4 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.2 6.5 0.0 0.6 0.7 0.6 0.1 0.0 0.0 2.1 WNK2 "KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43" ENSG00000165238 "WNK lysine deficient protein kinase 2" Q9Y3S1 9 93184916-93320572 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 101.2" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.9" "Cell line enhanced" "Detected in many" "Daudi: 11.5;Hep G2: 18.8;SCLC-21H: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015555, HPA016519, CAB017813" Enhanced Approved Cytosol NA NA Cytosol "CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380" "unprognostic (5.02e-2)" "unprognostic (1.32e-2)" "unprognostic (2.61e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.04e-1)" "unprognostic (1.79e-3)" "unprognostic (1.94e-1)" "unprognostic (2.81e-2)" "unprognostic (1.31e-3)" "unprognostic (2.23e-1)" "unprognostic (4.48e-3)" "unprognostic (6.51e-2)" "unprognostic (1.44e-1)" "unprognostic (4.38e-4)" "unprognostic (1.62e-1)" 0.0 0.7 3.9 0.9 3.8 0.0 1.2 9.5 7.2 0.7 7.5 7.4 1.3 1.5 2.1 6.6 0.1 21.9 4.0 4.2 0.0 0.0 0.0 0.0 2.6 0.0 18.3 0.8 7.5 0.9 4.9 4.8 19.5 5.5 23.7 3.0 6.2 1.6 1.1 0.5 3.0 1.5 0.0 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 0.3 0.0 4.4 4.0 2.9 8.2 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.6 0.1 11.5 1.5 0.0 0.8 0.2 6.5 0.0 0.0 0.0 7.5 0.0 3.5 18.8 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.3 0.0 0.0 6.0 0.1 0.1 7.3 4.4 0.2 0.0 0.0 9.3 0.0 0.7 23.9 9.4 1.5 6.5 0.6 0.8 0.8 1.3 0.1 0.0 3.1 0.1 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 8.1 1.1 57.3 56.7 30.6 5.3 9.1 0.0 151.2 11.9 0.0 11.7 0.9 0.5 34.4 0.0 8.0 5.6 1.1 12.9 0.0 0.0 2.9 1.6 31.2 0.6 1.0 1.9 0.9 0.0 1.7 1.0 57.9 60.6 3.3 42.1 5.6 0.7 101.2 12.9 4.4 0.4 6.6 4.8 13.0 0.0 51.8 6.4 WNK3 PRKWNK3 ENSG00000196632 "WNK lysine deficient protein kinase 3" Q9BYP7 X 54192823-54358642 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 31.6;testis: 26.7" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 178.0;Spermatogonia: 48.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.1;T-cells: 1.9" "Cell line enhanced" "Detected in some" "AF22: 5.9;AN3-CA: 4.5;HAP1: 6.8;NTERA-2: 11.9;SiHa: 5.8;SuSa: 5.3;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077678 Approved Approved Vesicles NA NA Vesicles "HPA077678: AB_2686850" "unprognostic (1.86e-1)" "unprognostic (1.68e-3)" "unprognostic (2.44e-1)" "unprognostic (7.87e-5)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (1.85e-2)" "unprognostic (3.32e-2)" "unprognostic (3.38e-1)" "unprognostic (3.03e-2)" "unprognostic (5.78e-4)" "unprognostic (2.22e-1)" "unprognostic (2.64e-2)" "unprognostic (5.61e-2)" "unprognostic (9.99e-2)" "unprognostic (7.63e-2)" "unprognostic (8.74e-2)" 0.9 5.0 3.9 0.9 4.3 0.8 1.7 3.0 3.6 1.5 0.7 1.7 13.9 1.0 1.3 31.6 1.1 1.8 1.1 1.5 3.9 3.4 2.8 8.7 0.9 1.0 2.3 3.0 5.7 0.9 2.2 14.0 1.2 3.9 2.2 0.7 1.3 1.2 4.8 0.7 0.9 0.7 1.5 3.3 1.0 1.2 26.7 3.5 0.0 1.7 0.0 0.8 1.3 1.9 1.1 0.0 0.1 0.0 0.1 1.9 0.1 0.0 0.0 5.9 4.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 6.8 0.1 0.2 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.2 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 2.8 0.8 0.0 1.2 0.2 1.9 1.8 5.8 0.0 0.7 5.3 0.5 0.0 0.3 0.0 5.2 0.0 1.2 0.0 4.0 0.0 1.6 0.0 2.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 1.1 1.9 0.4 0.1 0.1 0.0 0.0 0.0 0.1 3.9 4.3 3.0 3.6 3.9 3.4 2.3 3.0 3.9 3.5 0.0 2.9 0.8 4.6 3.3 24.5 178.0 2.5 0.0 5.7 7.0 13.7 0.2 5.0 1.4 4.2 3.1 0.0 0.0 0.0 0.3 3.1 4.8 5.8 41.5 0.1 33.4 0.0 17.8 0.6 14.6 14.7 0.5 0.0 0.0 0.0 20.7 0.3 0.0 41.1 3.1 40.9 6.5 3.3 30.2 48.2 1.0 0.1 0.0 0.0 1.1 WNK4 PRKWNK4 ENSG00000126562 "WNK lysine deficient protein kinase 4" Q96J92 17 42780678-42796936 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.1;ovary: 14.6" "Group enriched" "Detected in some" 7 "Distal tubular cells: 135.9;Mucus-secreting cells: 39.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 19.9;K-562: 22.2;TIME: 21.4;WM-115: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016500 Approved NA NA "HPA016500: AB_10962984" "unprognostic (6.34e-3)" "unprognostic (1.35e-1)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (1.78e-2)" "unprognostic (1.96e-1)" "unprognostic (2.48e-1)" "unprognostic (1.69e-1)" "unprognostic (5.84e-2)" "unprognostic (3.94e-1)" "unprognostic (2.08e-3)" "unprognostic (4.33e-3)" "unprognostic (7.70e-3)" "unprognostic (1.62e-1)" "unprognostic (6.11e-2)" "unprognostic (1.43e-1)" "unprognostic (7.99e-2)" 1.1 0.0 0.8 5.8 0.2 0.0 2.6 0.6 0.3 0.7 12.9 0.4 0.4 2.1 0.2 2.8 8.7 0.5 1.0 0.2 2.6 0.0 28.1 0.2 0.4 0.1 0.1 0.3 14.6 1.0 0.0 2.4 0.0 1.7 11.1 11.7 12.2 1.4 1.2 0.0 0.5 3.3 0.4 0.8 0.1 2.6 0.4 0.2 0.0 0.0 0.2 2.0 0.3 0.4 0.4 0.0 0.0 0.3 0.0 1.0 0.0 1.2 0.6 0.2 0.0 0.2 0.1 2.9 7.4 2.9 2.8 0.9 0.4 0.5 0.2 4.4 19.9 0.7 0.0 0.1 0.2 4.8 0.4 1.0 0.0 0.0 2.9 4.7 0.0 0.4 2.5 0.4 4.0 1.2 1.4 0.2 0.2 22.2 0.7 0.0 0.6 0.0 0.5 0.2 1.2 5.1 0.3 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.1 1.0 2.7 1.4 1.6 21.4 0.2 1.9 0.2 0.1 3.6 3.1 0.7 0.0 1.2 14.5 0.0 0.3 0.0 0.0 0.0 0.7 0.4 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.6 0.3 2.6 0.0 0.1 0.3 1.7 0.2 0.0 1.1 0.0 0.1 0.0 0.2 0.7 2.5 5.3 1.2 7.0 0.0 0.0 135.9 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 6.5 4.6 0.0 0.0 0.0 12.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 39.6 0.0 0.1 2.9 0.4 0.5 0.3 0.0 0.3 0.7 0.8 0.4 0.0 0.0 13.3 0.1 WNT1 INT1 ENSG00000125084 "Wnt family member 1" P04628 12 48978453-48981676 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;brain: 6.5;placenta: 17.5" "Cell type enriched" "Detected in single" 36 "Cardiomyocytes: 3.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basal ganglia: 6.5;cerebral cortex: 1.8" "Group enriched" "Detected in some" 8 "gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 24 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;JURKAT: 2.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1" "Secreted to extracellular matrix" NA NA "unprognostic (2.02e-2)" "unprognostic (5.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-3)" "unprognostic (5.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.63e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-2)" "unprognostic (4.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-1)" "unprognostic (7.35e-3)" "unprognostic (2.76e-2)" 0.3 0.1 0.4 1.5 6.5 2.3 0.3 0.3 2.9 0.3 0.3 0.3 0.3 1.5 0.3 0.3 0.5 0.1 0.7 0.3 0.6 0.5 0.3 0.3 0.7 2.9 0.3 0.3 0.3 0.3 0.0 0.3 17.5 0.3 0.3 0.0 0.3 1.2 0.3 0.3 0.0 1.8 0.3 0.3 1.9 1.2 1.4 0.3 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.0 7.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 7.7 0.3 3.0 4.8 0.0 0.0 0.5 3.2 0.0 0.0 0.0 0.0 0.4 0.8 0.4 6.5 0.3 1.8 0.6 0.5 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WNT10A ENSG00000135925 "Wnt family member 10A" Q9GZT5 2 218880363-218899581 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation, Ectodermal dysplasia, Hypotrichosis, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 24.8" "Cell type enhanced" "Detected in some" 9 "B-cells: 11.1;Basal glandular cells: 7.2;Basal keratinocytes: 15.1;Bipolar cells: 15.4;Collecting duct cells: 8.7;Melanocytes: 6.8" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.9" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in many" 6 "dendritic cells: 8.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.4;HaCaT: 47.3;HDLM-2: 19.5;RPTEC TERT1: 9.1;U-266/70: 24.8" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.2" HPA013898 Uncertain "Secreted to extracellular matrix" NA NA "HPA013898: AB_1858847" "unprognostic (2.99e-4)" "unprognostic (4.31e-2)" "unprognostic (8.55e-2)" "unprognostic (1.17e-3)" "unprognostic (2.87e-2)" "unprognostic (2.59e-1)" "unprognostic (1.62e-1)" "unprognostic (2.56e-2)" "unprognostic (1.04e-1)" "unprognostic (6.34e-2)" "unprognostic (2.23e-3)" "unprognostic (9.52e-2)" "unprognostic (6.64e-9)" "unprognostic (1.22e-1)" "unprognostic (1.72e-1)" "unprognostic (4.89e-3)" "unprognostic (1.82e-1)" 0.9 0.4 0.5 10.6 2.5 0.6 0.8 0.1 1.7 2.0 4.2 0.3 2.3 5.5 0.3 1.7 10.5 1.8 0.9 0.6 1.5 0.9 3.6 0.3 1.9 3.3 0.3 0.0 1.0 0.1 0.0 6.0 5.0 0.1 2.2 1.5 3.4 8.0 7.5 0.9 12.4 3.0 1.1 0.1 4.2 3.7 0.6 0.6 2.1 0.3 24.8 10.2 8.0 3.7 1.1 8.4 0.0 0.0 0.0 1.4 0.1 5.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.4 0.9 3.7 0.0 1.2 47.3 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 9.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 24.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 1.1 0.4 0.1 0.0 0.0 0.0 8.4 1.4 0.1 0.5 2.5 0.1 1.7 1.5 0.9 0.3 0.0 0.1 0.6 0.0 0.0 11.1 7.2 15.1 15.4 1.2 0.0 0.0 0.0 8.7 2.0 0.2 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.4 2.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.8 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.5 0.5 0.6 4.1 0.1 1.9 0.0 1.3 WNT10B "SHFM6, WNT-12" ENSG00000169884 "Wnt family member 10B" O00744 12 48965340-48971763 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell type enriched" "Detected in some" 11 "Extravillous trophoblasts: 12.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.6" "Lineage enriched" "Detected in single" 17 "T-cells: 1.6" "Cell line enhanced" "Detected in many" "K-562: 8.1;T-47d: 9.7;U-266/84: 8.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA055048, HPA062539" Enhanced Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA "Golgi apparatus" "HPA055048: AB_2682683, HPA062539: AB_2684793" "unprognostic (1.13e-1)" "unprognostic (2.14e-2)" "unprognostic (5.73e-4)" "unprognostic (2.27e-2)" "unprognostic (3.09e-2)" "unprognostic (3.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.38e-1)" "unprognostic (2.12e-1)" "unprognostic (1.14e-1)" "unprognostic (4.99e-3)" "unprognostic (3.05e-2)" "unprognostic (5.39e-6)" "unprognostic (4.29e-2)" "unprognostic (3.74e-2)" "unprognostic (4.50e-1)" "unprognostic (1.25e-1)" 2.3 0.6 10.9 2.6 23.4 2.1 1.8 0.0 14.3 0.5 1.7 0.5 3.0 2.8 0.4 3.2 1.5 0.6 1.1 1.2 7.3 4.9 0.2 0.3 1.3 3.0 3.0 7.2 1.2 0.0 0.1 1.1 7.0 4.1 1.0 1.6 0.7 1.7 1.4 1.6 5.0 3.3 2.0 0.8 2.9 2.0 1.7 0.3 0.2 0.5 1.2 2.9 1.8 1.6 0.0 0.0 0.0 0.0 0.0 1.6 0.2 2.1 1.4 0.0 2.0 0.0 0.0 5.4 1.5 2.8 0.6 0.2 4.2 4.7 0.0 0.4 0.3 1.8 2.6 5.6 0.4 0.2 1.2 7.4 2.4 1.8 0.1 0.0 0.8 3.5 0.0 0.4 0.1 2.5 4.9 0.0 1.8 8.1 0.3 0.8 2.8 0.1 2.8 0.0 1.5 3.0 0.0 0.7 2.6 0.0 0.5 0.1 0.0 0.3 0.2 0.7 2.8 9.7 3.1 0.0 3.1 6.0 0.4 0.7 3.1 8.7 0.0 1.2 6.2 0.2 0.0 0.0 0.0 1.6 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.0 0.0 0.2 10.9 23.4 0.0 13.9 7.3 4.9 3.0 7.2 4.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.8 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 1.1 0.9 0.0 0.0 WNT11 ENSG00000085741 "Wnt family member 11" O96014 11 76186325-76210736 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 25.9;breast: 24.1" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 4.9;Extravillous trophoblasts: 2.7;Fibroblasts: 5.2;Paneth cells: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 6 "NK-cell: 6.6" "Lineage enriched" "Detected in many" 6 "NK-cells: 6.6" "Cell line enhanced" "Detected in some" "BEWO: 20.8;CACO-2: 6.7;CAPAN-2: 10.0;EFO-21: 33.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA050101 Uncertain "Secreted to extracellular matrix" NA NA "HPA050101: AB_2681015" "prognostic favorable (5.97e-4)" "unprognostic (9.27e-2)" "unprognostic (2.01e-2)" "unprognostic (2.52e-1)" "unprognostic (1.87e-2)" "unprognostic (8.43e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (2.88e-2)" "unprognostic (4.36e-2)" "unprognostic (3.10e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (3.16e-3)" "unprognostic (1.09e-3)" 25.9 14.1 0.8 1.6 1.0 0.9 24.1 1.8 0.9 3.4 7.6 1.4 0.7 2.6 1.9 6.0 4.7 3.1 3.4 7.2 0.4 0.4 1.2 8.5 4.8 2.3 0.5 0.1 4.3 7.8 0.5 2.3 6.3 2.2 4.0 1.2 1.0 3.4 1.3 11.1 4.5 7.9 3.1 0.3 3.5 0.7 3.7 0.5 0.3 10.8 5.4 0.7 4.6 10.2 0.0 0.0 0.8 0.1 6.6 1.1 0.4 0.0 0.0 0.0 0.0 1.7 0.1 20.8 0.0 0.0 0.0 0.1 6.7 10.0 0.0 33.0 0.0 0.1 3.1 0.6 0.0 0.0 3.0 1.2 1.6 0.7 1.2 0.0 0.0 0.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.8 0.1 0.0 0.2 0.5 0.0 1.6 0.2 0.0 1.2 0.1 0.0 1.5 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.4 0.8 1.0 1.8 0.9 0.4 0.4 0.5 0.1 2.2 0.5 0.0 0.0 0.0 0.2 1.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.2 2.7 5.2 0.0 0.0 2.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 3.5 0.7 0.0 0.0 0.0 1.8 0.3 0.1 0.6 1.1 0.0 1.4 0.0 WNT16 ENSG00000002745 "Wnt family member 16" Q9UBV4 7 121325367-121341104 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 13.1;cervix, uterine: 19.7;ductus deferens: 11.7;skin 1: 24.4" "Group enriched" "Detected in some" 49 "Basal keratinocytes: 9.0;Suprabasal keratinocytes: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 125 "memory B-cell: 13.1;naive B-cell: 11.8" "Lineage enriched" "Detected in single" 132 "B-cells: 13.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.2;HEK 293: 10.0;hTEC/SVTERT24-B: 3.0;U-2197: 4.9;U-266/70: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to extracellular matrix" NA NA "unprognostic (6.53e-2)" "unprognostic (3.63e-2)" "unprognostic (7.24e-2)" "unprognostic (1.90e-2)" "unprognostic (2.94e-3)" "unprognostic (5.23e-2)" "unprognostic (1.77e-2)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (1.94e-1)" "unprognostic (3.77e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-10)" "unprognostic (5.89e-3)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (1.66e-1)" 0.3 0.5 0.8 0.7 1.0 0.2 2.0 0.9 2.2 19.7 1.0 0.2 11.7 0.2 2.1 7.9 0.3 0.4 0.3 0.2 0.8 0.4 0.2 0.4 0.4 1.3 0.8 0.9 0.1 0.2 0.1 0.6 0.8 1.6 1.0 0.3 0.0 0.5 4.0 0.3 24.4 0.7 0.3 2.3 1.2 0.3 0.6 0.8 0.0 0.2 0.0 0.6 0.5 5.5 13.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.1 0.2 0.3 4.2 0.3 0.0 0.9 0.2 1.0 0.0 0.0 0.1 0.0 10.0 0.0 0.4 0.1 0.0 0.0 0.0 1.9 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 4.9 0.5 3.0 0.1 0.0 0.6 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.0 0.9 2.2 0.8 0.4 0.8 0.9 1.6 0.8 0.0 0.0 0.0 0.0 9.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.0 0.0 0.0 0.0 0.0 WNT2 "INT1L1, IRP" ENSG00000105989 "Wnt family member 2" P09544 7 117276631-117323289 "Cancer-related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 10.4;lung: 10.9;placenta: 40.9" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 21.6" "Region enhanced" "Detected in many" "basal ganglia: 12.6" "Low region specificity" "Detected in all" HPA020920 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA020920: AB_1858850" "unprognostic (1.90e-1)" "unprognostic (6.97e-2)" "unprognostic (2.88e-2)" "unprognostic (4.11e-3)" "unprognostic (9.14e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-2)" "unprognostic (2.75e-1)" "unprognostic (2.74e-1)" "unprognostic (5.70e-2)" "unprognostic (1.36e-2)" "unprognostic (1.41e-1)" "unprognostic (3.43e-1)" "unprognostic (4.05e-2)" "unprognostic (2.50e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-1)" 1.8 0.0 0.2 0.1 1.1 0.0 1.4 0.3 2.3 3.0 0.2 0.4 0.4 0.0 10.4 2.7 0.4 1.0 0.2 0.7 0.9 0.9 0.3 0.8 10.9 0.0 0.1 0.5 0.8 0.1 0.0 0.2 40.9 0.5 7.6 0.0 0.9 0.1 0.5 0.0 1.1 0.2 1.2 0.2 1.5 0.1 0.7 0.0 0.0 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 2.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.3 2.3 0.9 0.9 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.0 24.8 0.4 0.0 0.0 0.0 2.9 9.4 0.2 0.0 0.0 6.8 0.0 0.0 11.1 1.0 7.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 1.6 0.1 2.4 7.6 0.0 0.0 0.1 WNT2B "WNT13, XWNT2" ENSG00000134245 "Wnt family member 2B" Q93097 1 112466541-112530165 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 66.7" "Group enriched" "Detected in many" 4 "Leydig cells: 74.2;Peritubular cells: 185.6" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 6.8;HSkMC: 13.0;SuSa: 5.3;TIME: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047274, HPA066368" Approved Nucleoplasm,Vesicles "Secreted to extracellular matrix" NA NA Vesicles Nucleoplasm "HPA047274: AB_2732539, HPA066368: AB_2685664" "unprognostic (2.08e-3)" "unprognostic (2.06e-3)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (1.77e-1)" "unprognostic (1.49e-1)" "unprognostic (9.42e-2)" "unprognostic (4.90e-3)" "unprognostic (1.15e-1)" "unprognostic (2.37e-1)" "unprognostic (5.94e-2)" "unprognostic (1.13e-1)" "unprognostic (5.65e-4)" "unprognostic (5.41e-2)" "unprognostic (7.64e-2)" "unprognostic (4.80e-2)" "unprognostic (2.49e-2)" 3.4 1.9 1.7 3.4 4.6 0.2 2.1 2.6 2.9 9.2 12.0 0.8 3.7 3.9 7.5 5.4 7.6 4.4 8.0 3.6 1.6 1.7 1.8 0.5 5.2 0.9 2.0 2.4 28.7 2.0 1.2 1.9 6.0 1.5 7.3 6.8 66.7 1.7 18.3 1.3 13.4 9.1 12.9 3.0 1.2 4.4 16.2 0.8 0.5 1.4 5.6 1.9 10.3 8.5 2.3 1.2 1.7 0.7 0.8 1.2 0.1 0.7 0.4 3.4 0.8 3.4 6.8 0.6 1.4 1.5 0.4 0.6 0.3 0.7 1.8 0.3 1.6 0.4 2.1 1.1 0.5 0.3 0.1 0.7 0.2 1.1 0.5 2.9 0.2 0.8 13.0 1.2 0.6 0.2 1.9 1.7 0.5 0.2 0.3 0.4 0.5 0.1 0.2 0.6 0.1 0.5 0.1 0.5 0.0 2.4 0.4 0.5 0.5 1.3 0.2 1.1 5.3 0.1 0.4 5.2 0.5 2.0 1.3 0.4 0.2 0.1 0.0 1.4 0.2 1.3 0.9 0.7 1.0 0.9 0.3 0.8 1.4 1.2 1.0 0.3 2.3 0.4 0.7 1.7 0.8 0.5 1.2 0.4 0.1 1.7 4.6 2.6 2.9 1.6 1.7 2.0 2.4 1.5 0.8 11.9 3.5 0.5 1.6 9.0 13.0 3.9 2.5 4.0 2.3 1.8 25.5 1.6 0.0 0.7 3.5 8.4 2.3 0.0 1.2 0.7 7.8 1.5 2.3 0.0 1.0 4.8 8.1 4.9 1.6 2.8 74.2 5.7 3.3 1.8 1.7 8.2 1.6 4.2 185.6 0.6 30.4 0.0 2.8 4.2 4.2 12.2 1.6 1.9 1.5 2.0 WNT3 "INT4, MGC131950, MGC138321, MGC138323" ENSG00000108379 "Wnt family member 3" P56703 17 46762506-46833154 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 7.8;skin 1: 17.2" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 39.5;Early spermatids: 27.0;Late spermatids: 45.9;Suprabasal keratinocytes: 15.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 13.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.3;U-698: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066281 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA066281: AB_2685647" "unprognostic (1.84e-1)" "unprognostic (2.90e-2)" "unprognostic (2.35e-1)" "unprognostic (6.41e-4)" "unprognostic (4.73e-2)" "unprognostic (5.26e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (4.97e-2)" "unprognostic (2.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "unprognostic (1.10e-8)" "unprognostic (1.77e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.38e-1)" 0.5 0.6 1.0 0.6 3.9 0.4 0.4 1.4 4.7 0.2 0.2 3.8 0.1 4.7 0.3 0.4 0.6 0.4 0.4 0.6 1.4 2.9 0.6 7.8 0.3 2.9 2.1 3.5 0.6 0.3 6.0 0.9 0.7 4.1 0.8 0.6 0.1 1.2 0.3 0.5 17.2 1.4 0.5 1.6 0.5 0.4 2.4 2.3 0.1 0.6 1.4 0.5 0.2 0.3 1.0 1.4 0.2 0.3 0.0 1.2 0.1 2.6 0.0 10.3 0.0 0.0 0.0 0.9 0.8 0.6 1.8 0.0 2.6 2.0 1.9 1.1 0.4 2.0 1.2 0.4 0.0 2.3 0.0 0.2 0.0 0.5 2.3 0.0 0.0 0.3 0.0 1.4 0.3 0.6 1.7 0.5 0.2 1.6 0.0 0.3 0.4 0.0 1.6 0.1 1.0 1.2 1.1 1.9 0.1 0.1 0.0 0.2 0.7 1.4 0.0 0.5 0.8 0.0 2.5 0.0 3.2 1.4 0.5 0.7 0.3 0.2 11.3 0.5 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.3 1.4 1.2 0.1 1.0 3.9 1.4 4.7 1.4 2.9 2.1 3.5 4.1 2.3 0.0 1.0 0.0 0.5 39.5 1.1 0.9 0.0 0.0 0.0 0.0 0.0 1.8 1.7 0.7 27.0 0.1 1.0 0.0 2.1 0.1 0.9 1.1 0.0 3.9 0.2 7.9 0.0 0.0 0.0 45.9 0.3 0.0 1.7 1.0 0.5 0.2 1.9 0.6 0.4 0.3 0.6 0.0 0.6 0.4 1.1 15.4 0.2 0.0 0.6 0.3 WNT3A ENSG00000154342 "Wnt family member 3A" P56704 1 228007051-228061260 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lung: 7.4;placenta: 19.9" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 11.9;Basal glandular cells: 2.4;Basal keratinocytes: 3.1;Syncytiotrophoblasts: 2.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HEK 293: 2.8;U-2 OS: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA066281 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA066281: AB_2685647" "unprognostic (9.84e-3)" "prognostic favorable (6.11e-5)" "unprognostic (2.40e-1)" "unprognostic (3.37e-1)" "unprognostic (7.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.96e-1)" "unprognostic (4.22e-2)" "unprognostic (4.12e-2)" "unprognostic (2.16e-1)" "unprognostic (4.80e-3)" "unprognostic (1.99e-1)" "unprognostic (7.26e-2)" "unprognostic (5.43e-3)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.2 0.1 0.1 0.1 0.0 0.2 0.1 7.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 19.9 0.1 2.4 0.0 0.1 1.7 0.1 0.1 3.0 0.1 0.1 0.6 0.1 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 11.9 0.0 0.0 2.4 3.1 0.0 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 2.4 0.0 0.0 0.5 WNT4 WNT-4 ENSG00000162552 "Wnt family member 4" P56705 1 22117305-22143969 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 34.3;skin 1: 28.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2" "Low region specificity" "Detected in many" HPA011397 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA011397: AB_1858854" "unprognostic (1.85e-1)" "unprognostic (9.08e-2)" "unprognostic (6.67e-3)" "unprognostic (1.75e-2)" "unprognostic (7.17e-2)" "unprognostic (4.30e-3)" "unprognostic (2.77e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.34e-4)" "unprognostic (2.14e-2)" "prognostic favorable (4.90e-4)" "unprognostic (1.01e-1)" "unprognostic (2.95e-2)" "unprognostic (4.21e-1)" "unprognostic (2.32e-1)" "unprognostic (4.74e-2)" "unprognostic (9.49e-2)" 0.5 6.5 1.0 0.3 1.0 0.0 1.4 0.6 1.7 4.3 1.7 1.1 1.0 2.0 3.1 6.6 6.9 6.4 6.4 0.6 1.5 3.1 1.1 1.2 1.4 0.3 1.0 1.7 34.3 1.9 0.0 3.7 11.8 1.7 7.7 1.0 1.7 3.0 1.8 2.7 28.6 4.1 1.2 1.5 0.3 2.8 0.9 0.8 1.4 2.2 5.4 2.8 2.0 3.5 0.0 0.0 2.8 0.0 0.0 0.4 0.0 1.5 0.1 3.1 0.1 0.1 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.1 0.3 10.2 0.0 0.8 0.0 0.3 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 1.4 0.2 0.4 0.0 0.0 0.0 1.9 12.5 0.0 0.1 10.6 0.7 0.8 4.2 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.6 1.7 1.5 3.1 1.0 1.7 1.7 0.8 3.0 7.5 0.0 3.4 14.8 0.0 0.6 0.0 2.7 6.8 0.0 0.0 0.6 0.0 2.2 0.0 0.0 0.3 0.0 0.5 0.1 0.9 3.8 0.0 0.4 0.1 0.0 28.3 1.3 0.0 0.0 0.0 0.0 5.0 0.0 10.2 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 9.2 0.2 0.0 0.5 2.6 WNT5A hWNT5A ENSG00000114251 "Wnt family member 5A" P41221 3 55465715-55490539 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Wnt signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 26.8" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 47.6;Club cells: 47.8;Peritubular cells: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 43.0;BJ hTERT+: 59.3;HeLa: 45.3;SiHa: 67.1;U-87 MG: 48.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (2.34e-3)" "unprognostic (1.35e-1)" "prognostic favorable (2.94e-5)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-2)" "unprognostic (3.91e-2)" "unprognostic (5.89e-2)" "unprognostic (9.58e-2)" "unprognostic (8.34e-3)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (9.70e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-3)" "unprognostic (3.63e-2)" 2.1 0.8 3.4 3.8 2.0 0.0 3.4 2.5 3.8 6.1 2.3 1.6 6.8 2.2 19.6 2.8 15.8 4.8 5.0 2.3 2.6 2.0 2.7 1.6 3.6 4.6 2.3 1.3 8.2 5.3 0.1 1.9 25.6 2.0 5.0 2.1 1.0 26.8 18.2 1.1 2.3 2.5 4.2 4.8 2.5 2.2 1.6 2.5 1.9 2.7 13.1 6.8 21.0 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 3.0 7.3 0.0 43.0 59.3 8.8 15.5 0.2 0.0 1.2 0.1 24.4 3.7 0.0 1.8 0.0 9.2 0.0 1.2 1.2 45.3 0.0 6.8 0.0 0.0 4.8 1.1 26.6 1.4 4.3 0.0 0.0 0.0 21.0 21.3 0.0 0.0 0.0 2.1 0.1 2.6 0.0 2.7 0.1 1.1 1.4 0.0 0.2 67.1 8.2 0.0 3.6 0.0 0.0 0.0 14.9 2.6 13.5 3.4 5.0 0.0 0.4 48.3 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 2.0 2.5 3.8 2.6 2.0 2.3 1.3 2.0 2.5 47.6 18.0 0.0 1.7 1.3 6.9 3.2 0.0 1.4 47.8 12.2 0.0 2.4 0.0 0.2 16.8 1.7 0.3 0.0 0.2 0.4 8.6 0.8 2.3 2.5 1.2 0.0 0.0 1.8 2.2 3.6 18.1 1.1 0.0 7.2 0.0 1.5 0.4 0.0 28.3 0.8 1.3 0.0 0.3 0.0 0.9 1.4 1.3 0.0 0.9 6.7 WNT6 ENSG00000115596 "Wnt family member 6" Q9Y6F9 2 218859821-218874233 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell type enriched" "Detected in some" 9 "Sertoli cells: 90.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 8.7" "Group enriched" "Detected in many" 7 "basal ganglia: 23.4;thalamus: 7.4" "Cell type enhanced" "Detected in some" "myeloid DC: 1.1;NK-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 7 "BEWO: 28.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070759 Approved "Secreted to extracellular matrix" NA NA "HPA070759: AB_2732164" "unprognostic (1.86e-2)" "unprognostic (6.03e-2)" "unprognostic (5.14e-2)" "unprognostic (2.06e-1)" "unprognostic (5.32e-2)" "unprognostic (7.34e-2)" "unprognostic (8.08e-3)" "unprognostic (4.73e-2)" "unprognostic (1.27e-2)" "unprognostic (1.19e-1)" "unprognostic (1.21e-2)" "unprognostic (2.66e-1)" "unprognostic (1.24e-3)" "unprognostic (5.26e-2)" "unprognostic (4.82e-2)" "unprognostic (1.55e-1)" "unprognostic (2.07e-1)" 2.5 3.5 0.8 1.4 23.4 0.6 15.0 0.9 2.1 4.0 5.7 0.2 1.1 1.3 2.3 2.0 3.1 2.3 2.1 4.8 0.9 0.3 1.6 0.7 0.7 1.3 2.1 0.1 2.9 1.7 0.6 1.7 9.8 1.4 4.0 0.9 4.3 1.9 2.1 2.4 2.3 2.3 2.0 2.4 6.4 2.3 3.7 7.4 0.0 0.7 0.8 1.2 1.5 11.1 0.7 1.1 0.0 0.6 1.5 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 28.1 0.0 0.0 0.0 0.0 2.6 0.4 0.0 3.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 4.1 1.3 0.0 0.0 3.2 0.1 3.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.0 1.5 0.0 0.7 0.0 0.0 0.8 23.4 0.9 0.9 0.9 0.3 2.1 0.1 1.4 7.4 0.0 0.0 0.5 10.5 0.5 0.8 0.4 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 1.6 0.0 0.0 0.0 0.0 1.5 0.8 3.2 0.0 0.0 0.7 1.6 0.0 3.1 0.0 3.4 0.0 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 1.8 90.5 3.3 2.1 0.3 0.1 0.6 0.0 0.0 0.9 WNT7A ENSG00000154764 "Wnt family member 7A" O00755 3 13816258-13880121 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.5;gallbladder: 8.7;placenta: 19.4" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 48.0;Extravillous trophoblasts: 129.2;Pancreatic endocrine cells: 57.6;Syncytiotrophoblasts: 155.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Cell line enhanced" "Detected in some" "BEWO: 25.3;EFO-21: 23.8;PC-3: 8.3;RPTEC TERT1: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015719, CAB025894" Approved "Secreted to extracellular matrix" NA NA "CAB025894: , HPA015719: AB_1858856" "unprognostic (1.26e-2)" "unprognostic (4.60e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (3.02e-1)" "unprognostic (1.14e-3)" "unprognostic (2.49e-1)" "unprognostic (3.32e-4)" "unprognostic (2.20e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (7.89e-2)" "unprognostic (3.78e-2)" "unprognostic (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (3.74e-1)" "unprognostic (8.88e-3)" 0.4 0.4 7.8 0.6 6.1 0.7 0.4 1.2 11.5 1.1 0.4 2.1 0.0 0.4 3.4 1.0 1.6 0.7 8.7 0.4 3.3 2.8 0.7 0.5 5.7 1.4 3.1 3.2 0.4 0.8 0.4 0.2 19.4 3.9 0.5 0.4 0.0 0.5 1.4 0.4 2.8 0.4 0.5 4.4 3.1 0.4 2.3 2.3 0.0 0.4 0.0 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 4.4 0.5 3.4 0.0 0.3 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 3.1 0.0 23.8 0.0 0.0 4.6 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.6 42.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.6 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 7.8 6.1 1.2 7.2 3.3 2.8 3.1 3.2 3.9 2.3 11.9 0.0 0.0 2.3 5.3 0.0 0.6 0.0 0.0 1.2 0.0 0.0 48.0 0.0 13.3 14.3 0.0 0.0 0.0 8.2 129.2 0.5 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 57.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 1.1 155.3 0.5 0.0 4.7 WNT7B ENSG00000188064 "Wnt family member 7B" P56706 22 45920362-45977129 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 25.9" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 29.9;Club cells: 23.9;Pancreatic endocrine cells: 25.3;Urothelial cells: 38.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 40.7;HeLa: 36.2;RPTEC TERT1: 14.4;SK-BR-3: 17.8;U-87 MG: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "unprognostic (2.02e-3)" "unprognostic (7.83e-3)" "unprognostic (8.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-2)" "unprognostic (1.31e-1)" "unprognostic (1.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-1)" "unprognostic (4.05e-2)" "unprognostic (3.85e-3)" "unprognostic (1.69e-2)" "unprognostic (8.58e-4)" "unprognostic (1.90e-1)" "unprognostic (6.73e-2)" "unprognostic (1.36e-1)" "unprognostic (1.22e-2)" 0.5 0.4 9.6 0.5 4.7 0.5 2.3 2.4 7.6 4.2 0.4 1.2 0.7 0.5 0.6 2.0 10.8 2.2 10.9 0.4 6.4 5.4 2.4 0.6 4.9 0.4 2.0 2.2 0.5 2.1 0.4 0.3 1.1 1.3 4.4 0.4 0.0 2.0 3.5 0.5 25.9 0.4 0.7 0.7 0.4 0.5 0.9 1.4 0.1 0.8 4.9 5.3 10.0 10.0 1.4 0.8 1.3 0.4 0.2 0.5 0.0 7.7 40.7 0.1 0.0 0.0 0.0 5.3 0.1 0.4 0.0 0.0 0.1 5.3 0.0 1.3 0.0 0.4 8.8 0.3 5.2 0.0 0.0 0.3 0.0 36.2 0.2 0.0 0.0 0.0 0.0 3.6 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 3.2 7.7 0.0 0.0 0.4 14.4 11.5 1.5 0.0 3.5 17.8 0.0 0.0 2.9 4.6 0.0 0.7 0.6 0.0 0.3 0.0 0.0 0.0 33.0 0.0 0.0 0.6 0.4 0.3 0.4 0.3 0.5 0.7 0.5 0.3 0.2 1.4 0.5 0.5 1.3 0.2 0.2 0.8 0.3 0.0 9.6 4.7 2.4 7.6 6.4 5.4 2.0 2.2 1.3 1.4 6.0 17.0 0.0 18.3 29.9 0.3 1.2 10.2 13.4 23.9 12.2 3.9 2.7 0.0 5.2 0.2 0.3 0.0 0.0 0.4 0.2 1.7 12.4 2.3 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.6 0.0 1.8 0.0 0.0 25.3 0.0 0.4 0.0 1.1 0.0 2.5 0.0 1.6 17.9 0.6 0.0 0.0 38.3 WNT8A WNT8D ENSG00000061492 "Wnt family member 8A" Q9H1J5 5 138083892-138092365 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.5;testis: 3.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Region enhanced" "Detected in single" "basal ganglia: 2.5" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.1" "Group enriched" "Detected in some" 5 "Hep G2: 1.4;SuSa: 5.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038539 Uncertain "Secreted to extracellular matrix" NA NA "HPA038539: AB_10669646" "unprognostic (1.11e-5)" "unprognostic (4.11e-2)" "unprognostic (4.11e-2)" "unprognostic (5.32e-2)" 0.1 0.0 0.2 0.1 2.5 0.1 0.4 0.7 0.8 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.6 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 3.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 2.5 0.7 0.8 0.3 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 WNT8B ENSG00000075290 "Wnt family member 8B" Q93098 10 100463041-100483744 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 3.3;parathyroid gland: 3.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 5.6;JURKAT: 7.3;RPMI-8226: 2.2;SCLC-21H: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036570 Uncertain "Secreted to extracellular matrix" NA NA "HPA036570: AB_10670113" "unprognostic (6.92e-2)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (6.67e-2)" "unprognostic (3.88e-1)" "unprognostic (1.90e-1)" "unprognostic (2.64e-1)" "unprognostic (9.16e-4)" "unprognostic (1.95e-2)" "unprognostic (1.02e-1)" "unprognostic (1.53e-1)" "unprognostic (7.83e-2)" "unprognostic (2.42e-3)" "unprognostic (5.02e-2)" "unprognostic (1.63e-1)" "unprognostic (2.68e-2)" "unprognostic (1.24e-2)" 0.2 3.3 0.2 0.2 0.5 0.0 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.4 2.3 0.2 0.2 0.2 0.2 0.2 0.3 1.6 3.8 0.5 0.2 0.2 0.7 0.0 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.1 2.6 0.2 2.2 0.2 0.2 0.2 1.6 0.2 0.0 0.3 0.7 0.0 0.0 1.3 0.3 0.0 0.0 5.6 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.8 0.2 0.0 0.0 0.5 1.1 0.0 0.0 0.2 0.0 1.5 0.2 0.0 0.1 0.0 0.0 0.3 0.0 7.3 0.0 0.6 0.0 1.5 1.9 0.0 0.0 0.1 0.3 0.6 0.0 2.2 0.0 1.6 2.6 0.7 0.0 0.0 0.1 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.7 0.0 0.0 0.3 0.0 0.3 0.2 0.5 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WNT9B "WNT14B, WNT15" ENSG00000158955 "Wnt family member 9B" O14905 17 46833201-46886730 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 1.1;Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "AF22: 1.9;SuSa: 5.7" "Region enriched" "Detected in single" 7 "thalamus: 6.4" "Low region specificity" "Detected in all" "HPA058361, HPA059572" Approved "Secreted to extracellular matrix" NA NA "HPA058361: AB_2683691, HPA059572: AB_2684067" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-2)" "unprognostic (3.18e-2)" "unprognostic (7.48e-3)" "unprognostic (3.37e-3)" "unprognostic (1.78e-1)" "unprognostic (8.11e-2)" "unprognostic (1.59e-2)" "unprognostic (3.66e-2)" "unprognostic (6.19e-4)" "unprognostic (1.13e-1)" "unprognostic (3.69e-2)" "unprognostic (7.52e-4)" "unprognostic (1.27e-1)" "unprognostic (2.70e-1)" "unprognostic (1.37e-1)" 1.0 0.4 0.3 0.2 0.4 0.3 0.8 1.4 1.6 0.4 0.5 0.1 31.6 1.5 0.8 13.0 0.2 0.6 0.2 2.1 1.1 1.0 7.4 2.4 2.4 0.5 1.0 0.0 0.3 0.3 4.2 0.1 0.5 2.0 0.5 0.2 6.7 0.2 19.1 0.6 2.5 4.5 0.4 0.7 1.8 0.2 0.9 0.0 0.0 0.3 0.0 0.1 0.8 0.3 0.6 0.5 2.0 0.5 0.3 0.4 0.0 0.0 0.3 1.9 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 5.7 0.3 0.0 0.0 0.2 0.0 0.4 0.1 0.4 0.0 0.6 0.1 0.1 0.0 2.0 0.3 0.3 0.3 0.1 0.2 0.3 0.2 0.2 0.1 0.6 0.4 0.4 1.8 0.3 0.5 0.5 0.2 0.0 0.3 0.4 1.4 1.6 1.1 1.0 1.0 0.0 2.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WSCD1 KIAA0523 ENSG00000179314 "WSC domain containing 1" Q658N2 17 6057807-6124427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.7;lymphoid tissue: 16.7" "Group enriched" "Detected in many" 6 "Early spermatids: 70.9;Enterocytes: 18.3;Late spermatids: 67.5" "Group enriched" "Detected in many" 7 "glioma: 18.8;renal cancer: 4.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 21.9;HUVEC TERT2: 13.4;OE19: 13.9;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015919 Uncertain Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA Nucleoplasm "Golgi apparatus" "HPA015919: AB_2216211" "unprognostic (1.50e-1)" "unprognostic (7.10e-2)" "unprognostic (5.32e-2)" "unprognostic (1.15e-2)" "unprognostic (2.61e-1)" "unprognostic (4.18e-2)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (3.59e-2)" "unprognostic (1.69e-1)" "unprognostic (3.46e-4)" "unprognostic (2.08e-1)" "unprognostic (1.18e-2)" "unprognostic (4.13e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" 3.9 2.6 11.2 1.6 7.3 0.4 1.3 17.1 24.7 1.5 8.7 11.2 0.0 4.7 1.5 1.4 1.2 1.7 1.6 3.8 10.5 9.7 6.2 1.1 1.8 1.9 11.9 5.3 0.8 2.4 2.3 2.7 6.5 8.5 1.2 5.4 1.1 1.8 1.3 13.3 2.0 5.7 2.1 12.2 16.7 1.4 12.9 10.5 0.6 1.3 0.0 1.6 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 3.1 21.9 1.7 0.1 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.4 0.1 0.0 0.0 7.4 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 13.4 0.0 0.0 0.5 0.6 0.4 0.0 0.0 7.3 13.9 13.5 0.0 27.7 0.8 4.6 1.1 8.5 0.0 0.1 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.2 7.3 17.1 7.3 10.5 9.7 11.9 5.3 8.5 10.5 0.0 0.0 0.0 0.0 0.3 5.6 2.8 0.0 0.0 0.0 1.8 0.0 0.7 1.7 0.3 70.9 3.0 18.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.9 1.6 0.0 8.0 0.3 67.5 0.6 0.0 1.7 0.0 2.8 9.1 0.3 5.7 0.0 1.2 2.8 0.0 1.4 0.5 2.8 0.5 0.0 0.0 5.6 0.1 WSCD2 KIAA0789 ENSG00000075035 "WSC domain containing 2" Q2TBF2 12 108129471-108250537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8" "Group enriched" "Detected in some" 10 "Bipolar cells: 35.7;Horizontal cells: 20.6" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.6" "Region enhanced" "Detected in all" "cerebellum: 44.0" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enhanced" "Detected in single" "T-cells: 2.5" "Cell line enriched" "Detected in some" 21 "RT4: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013346, HPA048133" Approved Uncertain Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA013346: AB_1858865, HPA048133: AB_2797236" "unprognostic (1.50e-1)" "unprognostic (1.64e-3)" "unprognostic (1.50e-2)" "unprognostic (4.27e-3)" "unprognostic (1.68e-1)" "unprognostic (3.43e-1)" "unprognostic (1.80e-2)" "unprognostic (3.43e-3)" "unprognostic (3.03e-2)" "unprognostic (3.05e-1)" "unprognostic (3.15e-1)" "unprognostic (7.43e-2)" "unprognostic (5.99e-2)" "unprognostic (3.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.32e-3)" "unprognostic (7.62e-3)" 1.4 1.2 6.5 0.5 12.5 0.4 1.0 44.0 15.2 5.4 1.7 1.6 0.0 0.7 6.9 3.0 3.8 2.0 0.5 0.5 10.0 3.0 1.3 0.4 0.8 0.5 1.3 6.0 0.6 2.1 0.4 0.9 0.6 1.9 6.0 0.7 9.9 0.5 18.2 0.5 0.6 0.9 9.2 1.5 0.5 2.0 0.6 2.0 0.0 21.8 0.2 0.5 3.0 0.9 0.8 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.4 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.5 0.0 6.5 12.5 44.0 15.2 10.0 3.0 1.3 6.0 1.9 2.0 0.0 0.0 0.5 0.0 0.1 35.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.6 0.0 1.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.9 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 WT1 "AWT1, GUD, NPHS4, WAGR, WIT-2" ENSG00000184937 "Wilms tumor 1" P19544 11 32387775-32435630 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 19.2;Late spermatids: 5.9;Leydig cells: 7.8;Sertoli cells: 6.5" "Cancer enriched" "Detected in many" 14 "ovarian cancer: 55.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 13.5;HMC-1: 17.4;K-562: 12.2;NB-4: 32.6;THP-1: 15.6" "Region enhanced" "Detected in single" "pons and medulla: 0.5" "Not detected" "Not detected" "CAB000327, HPA035717, HPA053848" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279" "unprognostic (3.09e-3)" "unprognostic (9.97e-4)" "unprognostic (3.32e-1)" "unprognostic (8.24e-3)" "unprognostic (5.20e-2)" "unprognostic (1.98e-3)" "unprognostic (2.94e-2)" "unprognostic (1.59e-2)" "unprognostic (1.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-10)" "unprognostic (2.65e-3)" "unprognostic (1.87e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-2)" 10.3 0.0 0.2 1.8 0.6 0.0 0.2 0.2 0.5 20.3 1.5 0.2 3.7 0.0 69.0 9.3 0.4 34.5 0.8 2.1 0.9 0.0 5.3 0.2 0.8 0.5 0.2 0.2 53.4 0.2 0.0 0.2 6.9 0.3 0.9 0.0 0.2 0.2 4.2 0.2 0.0 0.4 23.7 0.2 14.6 0.0 24.5 0.2 0.2 0.3 0.2 0.2 1.3 4.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 4.7 13.5 0.0 1.2 3.8 9.0 17.4 0.0 0.0 2.8 0.0 0.0 0.0 2.8 12.2 0.1 2.7 0.0 7.9 32.6 0.7 0.0 3.8 1.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.8 15.6 0.1 0.0 2.4 0.0 0.3 0.0 0.0 0.0 0.1 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.6 0.2 0.5 0.9 0.0 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 19.2 0.0 0.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.3 0.0 0.0 2.5 0.0 5.9 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 0.0 6.5 0.0 1.9 0.9 0.0 0.7 0.0 0.0 0.1 WWC1 "KIAA0869, KIBRA, PPP1R168" ENSG00000113645 "WW and C2 domain containing 1" Q8IX03 5 168291651-168472303 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 78.7" "Cell type enhanced" "Detected in many" 6 "Club cells: 63.7;Cone photoreceptor cells: 86.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 30.4;RPTEC TERT1: 67.9;SK-BR-3: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038016, HPA038017" Approved Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA038016: AB_10697091, HPA038017: AB_10669513" "unprognostic (3.60e-1)" "unprognostic (2.24e-2)" "unprognostic (1.08e-1)" "unprognostic (9.92e-2)" "unprognostic (1.51e-1)" "unprognostic (6.77e-3)" "unprognostic (2.89e-1)" "unprognostic (3.50e-2)" "unprognostic (1.47e-1)" "unprognostic (1.34e-1)" "unprognostic (3.31e-2)" "unprognostic (7.38e-2)" "prognostic favorable (1.95e-8)" "unprognostic (2.81e-3)" "unprognostic (1.80e-1)" "unprognostic (2.77e-1)" "unprognostic (1.50e-1)" 2.9 0.9 17.6 2.2 23.5 0.7 13.1 4.8 14.2 4.3 6.8 11.4 10.2 14.3 2.3 4.7 10.1 10.7 8.9 0.9 15.2 12.9 27.1 16.5 11.8 2.1 16.0 9.2 1.4 15.5 9.8 3.8 15.8 12.2 10.2 4.2 10.0 78.7 13.3 0.6 9.3 15.0 1.3 9.9 1.0 12.5 1.4 10.4 0.0 17.9 3.8 6.2 4.1 3.9 0.4 0.2 1.2 0.3 0.3 0.3 1.5 12.6 14.4 2.4 0.1 0.0 0.0 25.4 0.9 0.2 4.5 4.0 30.4 19.0 0.0 15.5 0.3 12.5 9.0 4.9 11.8 5.3 0.0 4.8 0.0 7.3 7.5 0.2 1.1 0.0 1.6 3.6 8.4 7.5 3.5 0.0 0.7 0.0 1.8 0.3 14.1 0.0 0.0 3.4 15.3 2.1 0.0 0.1 7.3 67.9 17.5 8.0 3.0 17.0 35.5 4.4 3.2 17.6 1.1 0.0 0.8 9.0 0.1 9.3 0.2 0.0 0.0 0.9 0.0 2.2 1.2 0.3 0.2 0.3 0.1 0.2 0.3 0.3 0.1 0.0 0.4 0.2 0.2 0.9 0.3 0.1 0.2 0.3 1.5 17.6 23.5 4.8 14.2 15.2 12.9 16.0 9.2 12.2 10.4 59.6 59.5 1.4 10.5 10.5 1.3 1.7 28.1 38.8 63.7 55.8 86.4 10.0 11.6 41.8 0.4 0.5 15.3 0.0 34.7 1.7 2.6 23.7 1.1 14.7 1.2 0.0 7.5 1.8 0.8 0.0 1.1 0.8 10.1 1.8 7.5 16.4 53.6 7.8 0.7 41.8 7.8 0.0 1.4 0.3 3.0 12.2 15.2 0.5 11.5 15.7 WWC3 "BM042, KIAA1280" ENSG00000047644 "WWC family member 3" Q9ULE0 X 10015562-10144478 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 56.9" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 58.6;Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 54.2" "Low region specificity" "Detected in all" HPA039814 Uncertain Approved "Actin filaments,Cytosol" NA NA Cytosol "Actin filaments" "HPA039814: AB_10674987" "unprognostic (2.53e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (9.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.80e-1)" "unprognostic (3.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.58e-2)" "unprognostic (4.91e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.90e-2)" "unprognostic (2.09e-1)" "unprognostic (5.03e-2)" "unprognostic (4.50e-2)" 10.2 13.2 8.9 9.8 12.6 5.3 10.3 13.7 10.1 10.0 13.1 18.2 56.9 4.5 11.6 22.0 12.4 8.9 10.8 15.4 10.0 7.2 7.2 3.9 21.0 12.5 13.1 6.4 18.7 9.4 9.9 6.7 25.7 10.6 11.3 5.6 12.6 9.0 44.4 7.6 12.3 10.8 13.2 9.4 11.8 11.2 6.9 11.8 6.2 12.2 8.1 10.2 10.2 18.1 6.6 0.7 12.3 1.0 2.7 6.9 2.1 6.8 7.7 9.4 3.1 4.0 5.6 8.9 3.8 6.8 2.3 2.6 1.0 7.1 0.7 0.0 5.1 9.2 3.6 2.2 4.0 1.9 5.0 0.7 1.5 5.1 0.7 8.6 0.0 2.4 3.6 8.5 5.8 6.2 12.6 10.9 1.3 0.1 9.2 5.6 14.0 1.6 0.4 8.8 3.6 2.7 4.9 0.4 2.9 2.3 3.5 1.0 2.7 4.7 6.1 4.1 18.3 54.2 0.5 14.6 6.9 0.1 10.1 4.2 7.5 5.1 2.5 4.2 2.5 10.1 4.1 1.0 0.2 6.9 0.8 6.0 2.4 3.4 5.1 0.5 6.6 3.2 3.8 12.3 2.7 0.8 0.7 1.6 2.1 8.9 12.6 13.7 10.1 10.0 7.2 13.1 6.4 10.6 11.8 20.8 58.6 4.2 12.1 4.9 6.3 17.9 7.6 6.7 13.6 5.2 5.9 11.9 0.0 5.6 0.6 20.4 5.1 46.7 8.2 5.3 11.6 11.0 3.5 5.5 9.2 3.2 15.4 31.3 21.9 0.4 11.8 7.4 15.1 0.0 3.0 3.2 7.9 5.8 23.3 2.1 2.1 19.4 16.5 0.7 1.1 11.4 6.6 7.9 3.3 7.6 XAGE1A "CT12.1a, GAGED2, XAGE-1, XAGE1" ENSG00000204379 "X antigen family member 1A" Q9HD64 X 52495676-52500812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 28.7" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 9.3;Spermatogonia: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 74.6;NB-4: 72.7;THP-1: 74.6;U-2 OS: 54.5;U-266/70: 35.5;U-266/84: 96.5;U-937: 59.9" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 72.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.5 0.0 0.1 0.2 0.0 5.1 74.6 0.0 0.0 54.5 0.0 10.4 35.5 96.5 0.1 0.0 59.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 XAGE1B CT12.1b ENSG00000204382 "X antigen family member 1B" Q9HD64 X 52512077-52520803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 28.8" "Cell type enhanced" "Detected in single" 28 "Spermatogonia: 1.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "plasmacytoid DC: 4.7" "Lineage enriched" "Detected in single" 19 "dendritic cells: 4.7" "Cell line enhanced" "Detected in some" "HMC-1: 78.4;NB-4: 76.2;THP-1: 74.1;U-2 OS: 56.8;U-266/70: 35.7;U-266/84: 97.4;U-937: 60.9" HPA046363 Approved Nucleoplasm NA NA Nucleoplasm "HPA046363: " 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 28.8 0.0 0.3 0.0 0.0 0.0 4.7 0.0 0.2 0.0 0.0 0.0 0.3 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 78.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.1 76.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.6 0.0 0.2 0.3 0.0 5.3 74.1 0.0 0.0 56.8 0.0 10.5 35.7 97.4 0.1 0.0 60.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.0 0.0 0.0 XAGE2 "CT12.2, GAGED3, XAGE-2, XAGE2B" ENSG00000155622 "X antigen family member 2" Q96GT9 X 52369030-52375680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "placenta: 106.9" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 760.4;Extravillous trophoblasts: 1534.6;Syncytiotrophoblasts: 1143.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 46.2;SK-BR-3: 10.8;SuSa: 14.0;T-47d: 9.5" "HPA052507, HPA060900" Supported NA NA "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (1.21e-1)" "unprognostic (9.67e-2)" "unprognostic (1.49e-1)" "unprognostic (4.47e-2)" 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 106.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.8 0.5 14.0 9.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 35.7 10.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.3 0.0 0.0 760.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1534.6 0.0 0.0 0.0 0.0 93.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1143.7 0.0 0.0 0.0 XAGE3 "CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3" ENSG00000171402 "X antigen family member 3" Q8WTP9 X 52862525-52868068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "placenta: 98.5" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 1947.3;Extravillous trophoblasts: 1021.2;Syncytiotrophoblasts: 2239.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 10 "B-cells: 1.7" "Cell line enhanced" "Detected in some" "BEWO: 3.3;U-266/70: 5.8;U-266/84: 5.3" "HPA052507, HPA060900" Supported NA NA "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (6.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.92e-1)" 1.0 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 1.2 0.5 0.7 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.8 5.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1947.3 0.0 0.1 0.1 0.0 0.0 0.0 0.3 1021.2 0.0 0.0 0.0 3.4 166.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 5.5 6.4 0.0 2239.5 0.0 0.0 0.0 XAGE5 "CT12.5, GAGED5, XAGE-5" ENSG00000171405 "X antigen family member 5" Q8WWM1 X 52812204-52818301 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in single" 6 "testis: 5.1" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 9.6" "Cancer enhanced" "Detected in single" "liver cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 34 "U-2 OS: 22.7" "HPA052507, HPA055941" Uncertain Approved Nucleoplasm,Vesicles No No "Nucleoplasm, Vesicles" "HPA052507: AB_2681855, HPA055941: AB_2682978" "unprognostic (1.89e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 9.6 0.0 1.6 0.0 0.0 0.0 XBP1 XBP2 ENSG00000100219 "X-box binding protein 1" P17861 22 28794555-28800597 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Angiogenesis, Apoptosis, Autophagy, Differentiation, Lipid biosynthesis, Lipid metabolism, Myogenesis, Protein transport, Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 321.9;salivary gland: 176.0" "Low cell type specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 108.7;SK-BR-3: 102.2;T-47d: 118.9" "Low region specificity" "Detected in all" NA NA 15.6 14.3 5.4 20.5 7.2 20.6 75.2 4.2 5.9 39.3 21.9 4.2 73.1 15.6 14.7 26.4 16.9 17.6 22.1 22.9 4.8 5.3 23.1 104.0 23.7 37.3 7.4 3.6 19.0 321.9 10.9 27.4 31.3 8.7 29.3 19.6 8.7 176.0 72.2 15.5 12.6 27.8 10.1 7.3 37.2 39.7 7.4 6.7 30.5 42.7 12.1 47.5 29.2 24.9 10.0 22.1 44.2 7.6 25.0 29.9 9.6 8.6 5.8 8.4 13.0 16.0 17.6 21.4 15.1 26.0 15.2 20.2 9.4 12.1 33.1 7.5 14.0 8.9 12.1 15.6 7.4 13.2 14.6 9.9 10.0 5.3 40.3 34.7 18.6 9.6 10.9 44.7 10.0 43.5 13.8 12.1 4.0 8.8 41.7 9.1 108.7 2.5 17.7 5.8 67.8 9.2 19.1 9.2 44.9 13.9 12.1 11.2 10.7 9.1 102.2 39.5 11.7 118.9 21.5 6.9 8.7 8.4 9.2 5.4 71.1 50.2 19.8 11.7 24.0 13.1 44.2 7.6 6.1 22.9 4.0 29.9 10.0 16.5 23.6 6.9 8.2 16.4 13.7 0.6 25.0 2.8 22.1 5.5 9.6 5.4 7.2 4.2 5.9 4.8 5.3 7.4 3.6 8.7 6.7 80.4 195.2 80.5 377.5 187.1 23.3 38.9 165.6 89.7 109.2 130.9 123.7 90.3 68.0 199.7 26.3 68.0 196.4 140.2 546.5 297.7 209.0 362.6 100.2 559.6 219.1 14.3 181.9 91.4 113.4 16.2 88.6 130.1 337.4 82.0 436.3 17.3 441.9 140.3 60.8 58.9 49.0 12.9 203.2 21.1 24.9 176.7 292.5 159.8 142.8 289.4 XCL1 "ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1" ENSG00000143184 "X-C motif chemokine ligand 1" P47992 1 168576473-168582077 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 33.8;lymphoid tissue: 29.6" "Group enriched" "Detected in some" 9 "Melanocytes: 37.1;T-cells: 113.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 10 "NK-cell: 33.8" "Lineage enriched" "Detected in many" 10 "NK-cells: 33.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.4;Hep G2: 5.5;SCLC-21H: 5.3;SuSa: 9.7;U-266/70: 7.5;U-266/84: 2.7" HPA057725 Approved "Secreted to blood" NA NA "HPA057725: AB_2683511" "unprognostic (5.38e-3)" "unprognostic (5.72e-2)" "unprognostic (8.23e-3)" "unprognostic (4.19e-3)" "unprognostic (1.43e-1)" "unprognostic (6.10e-2)" "unprognostic (2.96e-1)" "unprognostic (4.27e-2)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (4.61e-1)" "unprognostic (8.85e-2)" "unprognostic (5.34e-10)" "unprognostic (1.96e-1)" "unprognostic (1.32e-1)" "unprognostic (5.47e-2)" "unprognostic (2.15e-2)" 1.7 0.4 0.6 8.8 0.6 5.0 1.3 0.7 0.5 1.5 1.1 0.2 0.0 1.4 4.8 2.8 1.4 1.8 1.6 2.6 0.6 0.9 1.8 3.9 4.1 10.7 0.8 0.0 1.0 2.4 0.0 0.7 3.7 0.3 1.6 1.5 1.6 3.7 0.6 0.4 0.6 2.6 1.0 1.1 10.6 1.7 0.5 0.1 29.6 1.3 2.2 5.9 2.9 1.3 0.0 0.0 0.8 0.0 33.8 3.3 0.7 1.4 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 5.3 0.0 0.4 0.0 0.0 9.7 0.0 0.0 0.0 0.0 1.6 0.1 0.0 7.5 2.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.2 0.0 0.1 0.0 0.5 3.3 0.0 0.0 0.1 2.5 0.1 33.8 0.0 0.0 0.0 0.7 0.6 0.6 0.7 0.5 0.6 0.9 0.8 0.0 0.3 0.1 3.0 8.5 0.0 0.0 3.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.4 0.2 0.0 0.2 0.8 4.3 0.1 2.3 0.4 0.3 0.0 0.0 1.3 1.2 0.0 0.0 0.8 37.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 3.8 0.7 113.6 0.3 0.0 XCL2 "SCM-1b, SCYC2" ENSG00000143185 "X-C motif chemokine ligand 2" Q9UBD3 1 168540765-168543997 "Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 73.4" "Group enriched" "Detected in some" 23 "Melanocytes: 32.1;T-cells: 124.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 8 "NK-cell: 73.4" "Lineage enriched" "Detected in many" 8 "NK-cells: 73.4" "Cell line enhanced" "Detected in some" "BEWO: 1.3;CACO-2: 7.2;HSkMC: 1.3;RT4: 3.0;SuSa: 1.6" HPA057725 Approved "Secreted to blood" NA NA "HPA057725: AB_2683511" "unprognostic (9.88e-3)" "unprognostic (7.89e-3)" "unprognostic (4.77e-2)" "unprognostic (9.32e-3)" "unprognostic (8.21e-2)" "unprognostic (6.79e-4)" "unprognostic (9.33e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.58e-3)" "unprognostic (6.26e-2)" "unprognostic (2.02e-1)" "unprognostic (3.12e-1)" "prognostic unfavorable (8.36e-9)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "unprognostic (3.02e-2)" "unprognostic (1.06e-1)" 1.9 0.6 0.5 10.0 0.5 11.8 3.0 0.4 0.4 1.2 1.4 0.2 0.9 2.6 5.4 2.8 0.9 1.4 4.7 2.0 0.5 0.5 1.2 4.6 6.7 4.4 0.6 0.4 0.6 1.9 0.0 0.7 7.0 0.3 2.2 1.1 2.4 4.8 0.9 0.4 0.6 3.9 1.0 1.1 19.3 2.3 0.4 0.0 10.6 1.3 1.4 3.9 2.3 1.2 0.0 0.0 0.3 0.0 73.4 9.5 2.9 0.4 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 1.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.5 0.0 0.5 0.0 0.7 9.4 0.0 0.0 0.4 7.6 0.3 73.4 0.0 0.0 0.0 2.9 0.5 0.5 0.4 0.4 0.5 0.5 0.6 0.4 0.3 0.0 0.0 1.4 0.8 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.6 0.3 0.0 0.0 1.3 3.4 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 124.6 0.0 0.0 XCR1 "CCXCR1, GPR5" ENSG00000173578 "X-C motif chemokine receptor 1" P46094 3 46017024-46027742 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.5" "Cell type enhanced" "Detected in some" 16 "Late spermatids: 1.3;Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "myeloid DC: 7.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 7.2" "Cell line enhanced" "Detected in many" "Karpas-707: 5.6;RT4: 4.4;U-266/84: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013169 Uncertain NA NA "HPA013169: AB_1846211" "unprognostic (3.49e-3)" "unprognostic (4.23e-3)" "unprognostic (1.15e-2)" "unprognostic (5.91e-3)" "unprognostic (7.91e-2)" "unprognostic (8.53e-6)" "unprognostic (3.89e-6)" "unprognostic (9.27e-3)" "unprognostic (4.41e-3)" "unprognostic (3.40e-3)" "unprognostic (2.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.87e-1)" "unprognostic (5.98e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.80e-1)" 0.7 0.5 0.4 4.0 0.5 2.5 0.7 0.4 0.5 1.1 2.5 0.1 0.1 1.1 0.6 4.9 2.5 0.7 3.3 0.9 0.4 0.4 0.8 0.7 1.8 9.8 0.4 0.1 0.9 0.6 0.0 0.5 9.4 0.2 0.5 0.8 1.7 2.1 0.2 0.6 7.6 3.3 1.1 0.5 6.8 0.8 0.7 0.1 27.5 0.8 6.3 5.1 1.0 1.2 0.1 7.2 0.9 0.3 0.3 0.7 0.6 0.1 1.9 0.9 0.0 0.0 0.0 1.6 0.8 1.9 0.0 0.0 1.6 0.0 1.6 0.1 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.4 3.1 0.0 0.9 0.0 0.0 1.0 0.6 1.1 5.6 0.0 1.8 0.9 0.0 0.0 1.0 0.0 1.1 0.0 0.6 0.8 4.4 0.4 0.0 0.0 0.5 0.1 1.7 0.5 0.1 0.0 1.0 2.2 0.4 0.2 2.7 4.6 1.5 3.2 0.0 0.4 0.9 0.1 0.3 0.7 0.1 0.1 0.0 0.1 0.6 7.2 0.1 0.1 0.4 0.7 0.3 0.3 0.2 0.1 0.6 0.4 0.5 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 XDH "XO, XOR" ENSG00000158125 "Xanthine dehydrogenase" P47989 2 31334321-31414715 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.6;liver: 32.5" "Group enriched" "Detected in many" 5 "Enterocytes: 95.3;Hepatocytes: 35.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA062641, HPA069323" Supported Uncertain Nucleoplasm,Nucleoli "Intracellular and membrane" No No Nucleoplasm Nucleoli "HPA062641: AB_2684816, HPA069323: AB_2686121" "unprognostic (8.58e-2)" "unprognostic (4.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-2)" "unprognostic (7.06e-2)" "unprognostic (4.38e-3)" "unprognostic (7.48e-3)" "unprognostic (3.55e-1)" "unprognostic (3.60e-2)" "unprognostic (3.95e-3)" "unprognostic (3.51e-2)" "unprognostic (1.24e-6)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.54e-1)" "prognostic favorable (8.73e-6)" 0.2 0.2 0.2 2.4 0.2 0.0 17.8 0.2 0.2 2.6 17.9 0.1 0.0 20.1 0.3 6.3 9.3 0.2 1.8 0.2 0.1 0.2 0.4 32.5 0.2 0.0 0.2 0.0 0.2 0.4 0.0 1.5 3.7 0.1 1.2 4.2 0.1 20.9 0.0 0.7 1.0 78.6 0.1 0.2 0.2 1.3 0.2 0.0 0.2 0.3 2.4 6.1 1.8 1.1 0.7 0.3 1.0 0.6 0.7 0.5 0.0 1.5 0.3 0.0 0.0 0.0 0.1 0.1 6.2 3.6 0.7 1.1 0.2 1.7 0.0 1.2 0.2 0.6 3.2 0.0 15.3 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.4 0.9 24.5 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.9 0.1 0.0 1.1 3.3 4.5 3.9 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 3.0 1.9 0.1 6.7 2.0 0.1 0.0 0.2 0.0 0.0 0.5 0.6 0.2 0.2 0.2 0.4 0.1 0.3 0.3 0.0 0.7 0.2 0.5 1.0 0.7 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.0 0.1 0.0 0.0 3.7 0.0 2.6 0.5 0.3 0.3 2.5 0.0 2.3 0.0 0.0 0.1 0.0 2.4 0.2 0.0 95.3 0.0 7.2 0.5 0.0 0.5 0.0 35.8 0.0 0.0 11.3 1.8 1.6 0.0 0.0 0.0 0.0 0.0 5.2 0.1 8.8 7.0 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.1 0.3 0.0 12.8 14.2 XG PBDX ENSG00000124343 "Xg blood group" P55808 X 2752048-2816500 "Blood group antigen proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8" "Group enriched" "Detected in some" 8 "Basal keratinocytes: 12.8;Melanocytes: 10.1;Suprabasal keratinocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 2.1;naive B-cell: 1.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.1" "Group enriched" "Detected in some" 6 "ASC diff: 34.4;ASC TERT1: 25.6;fHDF/TERT166: 16.1;hTCEpi: 23.9;T-47d: 12.9" "Low region specificity" "Detected in all" NA NA "prognostic unfavorable (4.25e-4)" "unprognostic (1.69e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" "unprognostic (8.62e-2)" "unprognostic (7.21e-2)" "unprognostic (2.30e-1)" "unprognostic (8.10e-6)" "unprognostic (3.96e-3)" "unprognostic (7.98e-2)" "unprognostic (5.83e-3)" "unprognostic (6.77e-3)" 8.9 0.0 0.3 0.3 0.6 0.8 9.1 0.5 0.6 22.8 0.3 0.3 0.3 0.0 2.6 0.3 7.1 0.6 3.0 1.2 1.4 0.0 1.3 0.3 0.3 0.3 0.6 0.3 1.1 0.3 0.0 0.3 18.4 1.9 0.5 0.0 0.3 4.1 0.4 1.4 25.8 0.3 0.3 4.2 0.3 0.1 0.3 0.3 0.3 0.9 0.3 2.4 1.2 7.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 25.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 23.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 1.7 0.0 12.9 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.6 1.4 0.0 0.6 0.3 1.9 0.3 0.0 0.0 0.0 0.6 12.8 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.5 19.2 0.5 0.0 0.0 0.1 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "heart muscle: 95.0;skeletal muscle: 219.0" "Cell type enriched" "Detected in single" 1478 "Cardiomyocytes: 827.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 1.7 1.9 0.0 0.4 95.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.2 0.3 1.1 0.0 0.0 1.3 0.0 219.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 4.9 18.2 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 1.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 827.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888487-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 292.8" "Cell type enriched" "Detected in some" 66 "Cardiomyocytes: 1858.5" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.0 292.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 51.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1858.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria No No Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.4 0.1 0.0 0.4 1.6 8.9 0.0 0.0 0.0 2.4 25.2 1.4 0.0 0.0 13.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.2 6.4 0.1 0.9 0.1 11.9 3.2 0.4 3.2 0.0 0.0 11.4 0.0 0.6 2.4 0.0 0.4 0.8 0.0 0.5 1.2 3.2 0.0 0.0 0.4 0.0 1.4 5.5 9.1 0.0 0.1 6.9 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 0.0 0.6 0.0 0.2 0.3 0.5 5.9 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 0.9 0.0 21.1 23.3 2.6 0.1 0.0 1.1 0.0 0.8 0.1 3.2 5.8 0.0 0.0 0.2 0.0 0.0 1.7 0.0 12.1 0.0 1.2 8.6 0.7 0.0 0.9 0.0 1.7 4.6 4.3 1.0 0.0 0.0 10.8 0.4 XKR3 "MGC57211, XTES" ENSG00000172967 "XK related 3" Q5GH77 22 16783412-16821699 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 44 "blood: 4.7;testis: 13.5" "Cell type enriched" "Detected in some" 15 "Early spermatids: 93.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basophil: 1.5;neutrophil: 4.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 4.7" "Cell line enriched" "Detected in some" 16 "Karpas-707: 73.1" "HPA003379, HPA035081" Uncertain NA NA "HPA003379: AB_10602682, HPA035081: AB_2674451" "unprognostic (4.57e-1)" "unprognostic (3.37e-1)" "unprognostic (3.11e-2)" "unprognostic (3.13e-2)" "unprognostic (5.77e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.5 73.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 1.5 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 6.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.1 0.0 0.0 0.0 XKR4 KIAA1889 ENSG00000206579 "XK related 4" Q5GH76 8 55102389-55542054 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 25.5;Club cells: 17.0;Cone photoreceptor cells: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "REH: 3.7;RPTEC TERT1: 15.0" "Low region specificity" "Detected in all" "HPA025072, HPA028083" Uncertain Approved Vesicles NA NA Vesicles "HPA025072: AB_1858886, HPA028083: AB_10601025" "unprognostic (7.15e-4)" "unprognostic (1.28e-3)" "unprognostic (6.98e-2)" "unprognostic (5.63e-3)" "unprognostic (7.39e-2)" "unprognostic (5.68e-3)" "unprognostic (6.33e-2)" "unprognostic (5.14e-2)" "unprognostic (1.88e-1)" "unprognostic (2.63e-1)" "unprognostic (2.38e-3)" "unprognostic (6.63e-2)" "unprognostic (3.46e-4)" "unprognostic (2.08e-2)" "unprognostic (2.39e-2)" "unprognostic (7.36e-2)" "unprognostic (4.96e-2)" 1.2 1.4 18.7 4.3 5.6 0.8 0.7 4.4 12.1 2.1 5.1 0.6 0.3 1.5 1.0 1.4 2.5 1.1 1.4 2.6 8.6 4.5 0.9 0.7 0.7 2.0 2.0 8.8 0.9 1.1 0.5 5.3 0.6 2.0 1.2 2.2 2.5 2.0 2.9 0.8 1.4 2.0 3.5 1.2 0.9 1.5 0.9 3.4 0.6 0.7 0.6 2.3 1.0 1.6 0.8 0.3 2.2 0.2 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.7 0.0 0.0 15.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.2 0.3 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.8 0.2 0.3 1.2 0.7 0.1 0.3 0.1 0.1 18.7 5.6 4.4 11.5 8.6 4.5 2.0 8.8 2.0 3.4 8.9 25.5 0.0 0.5 0.3 6.5 1.4 0.0 9.4 17.0 3.5 33.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.1 0.7 0.5 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 1.1 8.5 2.8 0.0 0.6 0.7 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.7 XKR5 ENSG00000275591 "XK related 5" 8 6808517-6835644 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 6.0;NTERA-2: 4.0;SCLC-21H: 3.3;SH-SY5Y: 5.9;U-2 OS: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "unprognostic (8.95e-2)" "unprognostic (1.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.46e-2)" "unprognostic (1.78e-1)" "unprognostic (6.73e-2)" "unprognostic (9.91e-2)" "unprognostic (2.16e-3)" "unprognostic (1.30e-1)" "unprognostic (7.91e-3)" "unprognostic (3.13e-2)" "unprognostic (9.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-2)" "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.9 0.0 2.0 0.0 0.3 0.6 2.7 0.0 0.2 0.0 0.0 1.3 0.6 0.4 0.6 0.7 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.5 0.0 0.0 1.8 0.0 9.5 0.0 0.0 0.5 0.0 0.0 0.2 1.2 0.4 0.1 0.1 0.1 0.0 0.0 0.0 6.0 1.1 0.0 0.0 0.0 2.1 1.0 1.1 1.7 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.6 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 3.3 5.9 0.4 0.0 0.0 0.5 0.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 XKR6 "C8orf21, C8orf5, C8orf7" ENSG00000171044 "XK related 6" Q5GH73 8 10896045-11201366 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Group enriched" "Detected in many" 4 "Bipolar cells: 39.8;Cone photoreceptor cells: 13.7;Horizontal cells: 25.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 6.2;U-266/84: 10.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA024828, HPA064769" Uncertain Approved "Actin filaments" NA NA "Actin filaments" "HPA024828: AB_2215165, HPA064769: AB_2732720" "unprognostic (8.63e-3)" "unprognostic (8.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.92e-6)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (1.18e-1)" "unprognostic (8.75e-3)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" "unprognostic (2.87e-1)" "unprognostic (1.31e-1)" "unprognostic (3.78e-2)" "unprognostic (3.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.29e-3)" 2.0 2.9 3.0 4.8 13.1 4.1 2.5 21.4 6.3 1.9 2.7 1.4 1.9 1.7 2.4 1.3 3.8 2.2 2.0 1.5 3.4 1.6 2.3 1.0 2.7 3.9 1.3 4.4 0.9 5.1 3.3 8.8 1.2 5.3 3.2 2.1 1.1 5.2 5.0 0.8 3.9 3.3 1.6 1.4 3.8 3.3 7.5 2.4 0.1 3.0 0.2 3.6 3.0 2.3 1.3 0.6 0.0 0.0 1.2 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.6 0.6 1.8 0.0 0.5 5.0 0.0 1.0 3.0 0.2 2.2 2.7 0.9 0.1 0.6 1.6 0.2 0.0 0.9 0.0 4.3 0.5 1.8 0.0 2.2 2.2 1.1 0.0 0.1 6.2 0.8 0.5 0.0 0.0 3.3 0.3 1.2 0.0 0.0 1.2 2.4 1.8 3.3 1.9 1.0 0.1 0.0 2.7 0.0 0.8 0.0 2.6 1.3 0.0 0.9 1.8 10.2 4.6 1.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 1.2 0.0 0.6 0.2 0.1 3.0 13.1 21.4 6.3 3.4 1.6 1.3 4.4 5.3 2.4 6.0 0.3 6.4 3.7 1.5 39.8 1.5 5.1 0.0 1.2 3.5 13.7 0.0 1.7 2.0 6.5 1.0 1.0 0.0 4.5 0.0 0.4 3.2 0.0 0.0 0.4 25.4 4.1 4.3 1.0 1.4 0.0 0.0 1.7 0.0 0.7 6.6 3.1 0.9 0.0 0.8 6.0 0.0 1.0 3.5 4.5 1.1 0.0 1.5 1.2 3.1 XKR7 "C20orf159, dJ310O13.4" ENSG00000260903 "XK related 7" Q5GH72 20 31968002-32003387 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 28.0;pituitary gland: 12.3" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Early spermatids: 1.3;Horizontal cells: 1.6;Rod photoreceptor cells: 2.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 28.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 21.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 25.6" HPA040854 Uncertain NA NA "HPA040854: AB_10795481" "unprognostic (2.74e-2)" "unprognostic (5.60e-3)" "unprognostic (8.03e-2)" "unprognostic (3.74e-7)" "unprognostic (4.29e-2)" "unprognostic (9.34e-2)" "unprognostic (1.45e-1)" "unprognostic (2.69e-2)" "unprognostic (4.47e-2)" "unprognostic (2.68e-3)" "unprognostic (2.12e-1)" "unprognostic (1.26e-3)" "unprognostic (3.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.82e-5)" "unprognostic (1.99e-1)" 0.5 1.5 2.9 0.6 4.4 0.5 0.4 28.0 10.0 0.4 0.5 0.0 0.0 0.6 0.4 0.5 0.4 0.5 0.5 0.4 1.2 1.5 0.5 0.4 0.5 0.4 0.8 4.6 0.4 1.8 0.4 12.3 0.4 3.5 0.4 0.6 2.0 0.4 0.5 0.4 0.5 0.5 0.4 0.6 0.5 1.7 1.2 0.0 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 21.7 4.9 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.9 4.4 28.0 8.7 1.2 1.5 0.8 4.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.8 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 XKR8 FLJ10307 ENSG00000158156 "XK related 8" Q9H6D3 1 27959462-27968096 "Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "blood: 47.1" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 47.7;monocytes: 27.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 10 "eosinophil: 47.1;neutrophil: 24.3" "Lineage enriched" "Detected in all" 15 "granulocytes: 47.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049984, HPA053529" Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA049984: AB_2680982, HPA053529: AB_2682179" "prognostic favorable (8.63e-4)" "unprognostic (2.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-3)" "unprognostic (1.97e-2)" "unprognostic (1.38e-2)" "unprognostic (6.25e-3)" "unprognostic (1.64e-1)" "unprognostic (7.87e-2)" "unprognostic (8.41e-2)" "unprognostic (1.83e-3)" "unprognostic (6.29e-2)" "unprognostic (8.55e-2)" "unprognostic (2.93e-2)" "unprognostic (1.02e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-2)" 2.6 2.3 2.8 4.2 3.8 10.3 1.8 8.3 1.8 2.3 2.5 4.1 3.3 2.9 2.4 3.2 2.9 3.2 2.8 1.9 3.3 8.6 3.1 3.0 3.0 3.6 8.7 3.5 2.4 7.8 3.5 2.4 5.6 3.7 2.9 2.0 3.1 3.5 4.9 5.6 4.7 1.6 3.5 2.4 2.8 2.4 1.3 2.6 47.1 2.5 2.8 3.0 1.9 4.6 2.5 3.0 2.9 3.3 6.2 7.6 6.9 7.5 8.8 9.0 6.6 3.7 0.0 5.7 7.6 1.9 2.6 5.5 3.3 3.1 7.5 10.0 6.1 2.0 4.5 5.4 0.0 0.0 6.5 5.5 9.5 2.7 9.4 8.6 4.6 0.0 1.8 5.0 2.2 3.3 2.2 13.9 4.4 5.7 5.4 0.0 3.3 5.7 2.4 2.1 0.0 2.0 2.8 0.1 6.6 2.0 4.7 3.6 7.0 0.2 13.1 2.2 7.3 7.0 0.8 17.3 0.0 0.3 3.5 2.5 47.1 3.0 2.4 2.9 1.3 3.0 2.6 2.6 1.3 2.6 2.6 24.3 2.8 1.7 1.2 2.9 1.9 3.0 0.6 8.8 3.3 1.6 3.9 2.4 2.5 0.0 4.5 3.5 0.0 47.7 3.3 6.8 0.4 5.2 4.5 0.0 9.9 12.2 4.8 4.7 1.1 4.3 12.1 3.2 1.7 6.2 6.6 0.5 3.1 5.4 1.7 27.9 5.2 15.4 6.3 0.0 3.5 3.6 0.9 6.5 2.5 0.6 5.9 2.6 18.8 8.7 4.5 3.4 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669365-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 17.1" "Cell type enriched" "Detected in many" 11 "Spermatocytes: 89.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;hTCEpi: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA044430 Enhanced Approved Mitochondria NA NA Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.9 3.4 1.9 0.8 4.3 0.9 1.1 0.6 6.4 0.9 1.7 1.9 0.0 4.9 0.7 2.5 1.1 0.7 4.1 1.0 2.3 1.5 1.0 7.5 2.1 1.0 1.3 7.3 1.0 1.3 0.3 2.1 0.8 7.4 1.4 1.0 2.6 2.0 0.2 0.9 1.7 9.6 3.5 1.7 1.0 3.6 17.1 0.7 0.0 1.0 0.0 1.0 2.5 1.2 1.2 0.3 0.9 0.2 0.6 3.1 0.2 3.9 0.3 0.8 0.4 0.0 1.0 0.6 1.6 0.8 0.5 1.7 5.4 0.4 0.5 2.7 0.1 1.9 0.1 0.1 0.9 2.0 0.8 0.5 0.4 0.3 0.6 0.1 1.2 2.2 1.1 11.1 0.3 0.0 0.5 0.0 2.6 0.2 3.9 0.3 0.5 0.7 0.6 2.2 0.1 0.5 0.5 1.1 0.2 0.3 2.9 2.4 0.4 0.9 1.6 0.5 0.3 0.5 0.2 0.4 0.5 1.1 0.8 0.6 3.4 0.9 2.5 0.2 0.5 0.3 0.9 0.1 0.3 0.9 0.1 1.7 0.9 1.7 0.8 0.1 1.2 2.6 1.7 0.6 0.6 0.2 0.3 3.1 0.2 1.9 4.3 0.6 6.4 2.3 1.5 1.3 7.3 7.4 0.7 6.0 2.1 0.0 3.1 2.4 2.3 0.4 2.5 4.0 4.5 0.0 7.9 0.8 0.0 1.0 4.0 0.1 1.2 0.0 3.9 0.3 0.7 1.1 0.0 0.5 0.3 1.6 0.0 0.0 0.0 2.9 0.9 0.2 0.0 0.0 1.0 1.5 5.3 0.2 0.4 0.3 5.4 0.0 0.3 89.2 5.1 0.6 0.8 0.0 0.1 1.8 XKRX "XKR2, XPLAC" ENSG00000182489 "XK related, X-linked" Q6PP77 X 100913445-100929433 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0" "Cell type enhanced" "Detected in some" 17 "Melanocytes: 1.7;Syncytiotrophoblasts: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 44 "B-cells: 5.0;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "CACO-2: 13.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (3.35e-1)" "unprognostic (2.38e-2)" "unprognostic (4.51e-3)" "unprognostic (1.87e-1)" "unprognostic (8.53e-2)" "unprognostic (2.67e-2)" "unprognostic (2.96e-2)" "unprognostic (5.18e-2)" "unprognostic (3.69e-2)" "unprognostic (7.37e-2)" "unprognostic (5.70e-2)" "unprognostic (1.58e-2)" "unprognostic (5.60e-6)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.18e-1)" 0.1 1.0 0.2 2.1 0.3 0.1 1.1 0.1 0.1 1.2 7.2 0.2 8.3 0.4 0.2 1.9 3.5 1.1 0.5 0.1 0.2 0.4 0.3 0.1 3.3 2.4 0.2 0.0 0.3 0.2 0.0 12.0 12.2 0.2 0.5 1.3 0.0 1.0 1.8 0.2 12.9 6.8 0.0 0.2 0.6 0.5 0.4 0.0 0.8 11.0 1.9 5.4 0.5 2.4 5.0 0.0 0.0 0.0 0.0 3.7 0.6 0.3 1.0 0.1 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 13.2 1.6 1.0 0.1 0.0 1.1 0.2 0.0 0.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.3 2.5 1.0 0.0 0.1 0.1 0.6 0.1 0.0 0.4 2.5 0.0 0.0 0.0 2.5 0.1 2.1 0.3 1.1 0.2 1.1 0.0 0.3 0.4 0.0 2.3 0.0 0.3 0.0 0.0 2.0 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.0 5.0 3.7 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 2.2 0.0 0.1 0.3 XPNPEP2 ENSG00000122121 "X-prolyl aminopeptidase 2" O43895 X 129738974-129769538 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 145.6;kidney: 49.7" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2" "Group enriched" "Detected in many" 7 "monocytes: 4.4;T-cells: 7.3" "Cell line enhanced" "Detected in some" "ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000339, CAB025136, CAB025269, HPA064568" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 8900000 "Plasma membrane, Cytosol" "CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: " "unprognostic (7.95e-2)" "unprognostic (5.73e-2)" "unprognostic (2.56e-1)" "unprognostic (6.21e-3)" "unprognostic (3.54e-2)" "unprognostic (1.54e-1)" "unprognostic (4.04e-1)" "unprognostic (3.26e-1)" "unprognostic (3.01e-1)" "unprognostic (2.41e-2)" "unprognostic (3.07e-1)" "unprognostic (9.28e-3)" "unprognostic (2.77e-2)" "unprognostic (6.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-3)" 4.7 0.5 0.0 1.1 0.1 0.0 3.2 0.0 0.1 1.7 57.4 0.1 0.8 37.0 1.2 1.7 4.2 3.4 1.3 2.6 0.0 0.0 49.7 8.0 1.0 1.2 0.0 0.0 3.5 0.9 0.0 0.0 0.6 0.1 3.6 2.0 0.7 0.7 0.3 1.6 2.1 145.6 2.5 0.1 0.2 1.7 1.2 0.0 0.1 0.9 1.4 0.3 4.0 10.7 0.4 0.8 0.2 4.4 0.0 7.3 1.3 0.0 0.0 0.5 0.0 6.3 33.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.3 2.1 2.2 0.0 2.4 4.8 0.3 0.4 0.7 3.6 0.2 0.0 4.4 0.8 2.2 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 5.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 4.4 0.0 0.0 11.6 0.7 0.0 1.2 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 5.8 0.0 49.7 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.0 0.2 0.0 XPO4 "FLJ13046, KIAA1721" ENSG00000132953 "Exportin 4" Q9C0E2 13 20777329-20903048 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 60.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053768 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA053768: AB_2682254" "unprognostic (2.24e-1)" "unprognostic (1.20e-2)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.67e-1)" "unprognostic (7.24e-3)" "unprognostic (9.50e-3)" "unprognostic (2.99e-1)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-2)" "unprognostic (2.42e-1)" 8.9 6.6 4.9 6.9 9.6 10.9 7.9 13.6 11.1 7.5 6.7 11.6 7.9 5.0 11.4 5.9 7.5 7.3 4.9 12.8 6.1 5.3 6.9 6.1 7.7 8.6 8.0 5.3 9.0 7.8 8.1 12.9 6.8 10.2 7.3 7.6 10.7 7.4 7.4 47.3 8.2 7.2 8.2 8.3 8.6 6.7 7.9 8.0 14.3 8.4 6.3 12.3 7.8 7.3 3.1 2.7 3.1 6.0 3.1 4.0 1.2 6.7 5.1 8.4 8.0 4.1 7.2 8.7 7.7 5.7 9.1 7.6 10.4 8.5 14.9 4.2 7.4 6.9 11.1 19.4 10.4 17.1 10.1 5.5 23.6 6.4 6.9 6.2 20.6 7.7 7.0 6.6 9.2 17.6 5.3 11.0 8.6 11.1 4.9 8.6 5.5 9.8 9.1 9.5 14.3 4.8 11.0 13.9 6.2 6.3 8.2 9.6 6.6 6.6 9.7 7.9 8.9 5.7 11.3 9.0 6.5 5.1 7.9 10.9 3.3 4.8 12.4 3.2 13.3 9.6 3.1 2.0 2.1 3.4 2.3 4.0 3.1 2.9 2.9 2.7 2.6 3.6 3.5 0.0 3.1 6.0 2.0 2.7 1.2 4.9 9.6 13.6 11.1 6.1 5.3 8.0 5.3 10.2 8.0 11.9 15.1 10.4 7.2 7.3 14.3 19.9 10.2 2.7 0.0 8.7 60.9 6.9 0.0 4.9 8.1 7.1 3.5 0.0 3.6 6.4 7.7 6.1 15.0 9.6 9.1 9.5 1.2 13.5 7.9 6.1 16.1 8.0 11.8 6.4 6.8 6.4 4.3 3.5 7.8 3.4 21.0 32.3 9.3 10.9 17.2 9.8 10.8 11.5 8.5 8.7 XRCC2 FANCU ENSG00000196584 "X-ray repair cross complementing 2" O43543 7 152644779-152676165 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.7;testis: 11.7" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 19.4;Spermatocytes: 22.4;Spermatogonia: 24.3;Syncytiotrophoblasts: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065153 Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA065153: AB_2685422" "unprognostic (9.31e-3)" "unprognostic (8.25e-2)" "unprognostic (1.62e-1)" "unprognostic (5.53e-3)" "unprognostic (9.10e-2)" "unprognostic (2.52e-2)" "unprognostic (3.36e-5)" "unprognostic (9.98e-3)" "unprognostic (5.82e-3)" "unprognostic (4.04e-3)" "unprognostic (1.06e-3)" "unprognostic (2.43e-2)" "unprognostic (1.55e-15)" "unprognostic (4.52e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-1)" "unprognostic (1.73e-2)" 1.3 1.3 3.4 4.5 2.0 5.4 2.4 4.4 2.6 1.6 1.5 2.5 0.6 1.1 1.9 2.2 2.6 1.3 0.6 2.5 3.3 1.1 1.1 1.3 1.4 3.0 1.9 1.9 2.0 1.2 0.4 1.3 7.2 2.7 1.5 2.9 0.6 1.5 1.3 1.1 1.6 1.9 1.3 1.8 1.8 1.5 11.7 2.2 12.7 1.2 1.1 3.6 1.3 1.6 1.8 1.0 3.1 1.1 1.1 1.6 0.6 7.5 4.5 6.7 7.3 0.8 0.7 7.7 5.4 2.0 4.7 4.7 5.7 6.6 10.7 4.2 2.1 7.4 5.5 5.4 4.4 8.7 5.1 5.6 7.7 6.1 3.1 0.3 11.5 3.8 0.5 0.4 7.7 2.0 1.0 1.6 6.4 15.9 9.2 2.7 5.2 10.6 2.7 8.8 4.5 4.1 8.5 9.0 6.0 1.4 5.0 6.4 6.1 6.1 2.7 1.1 4.5 2.2 2.5 3.2 6.3 2.8 5.9 10.0 3.3 6.5 9.4 3.3 6.2 8.2 2.0 0.9 1.5 1.6 0.6 1.1 1.3 1.3 1.1 0.3 1.8 1.6 0.8 3.1 1.1 1.1 1.0 1.5 0.6 3.4 2.0 4.4 2.6 3.3 1.1 1.9 1.9 2.7 2.2 0.0 1.4 1.5 0.9 1.1 4.8 0.6 0.0 0.0 2.3 1.8 0.0 7.1 0.0 0.6 6.1 0.6 0.0 0.0 0.2 19.4 1.9 0.5 0.0 0.0 2.1 0.0 0.0 1.8 1.2 3.6 0.9 0.4 0.0 1.0 1.4 2.0 0.3 0.0 1.1 0.1 2.0 0.0 0.5 22.4 24.3 1.3 10.5 0.5 1.5 0.8 XRCC3 ENSG00000126215 "X-ray repair cross complementing 3" O43542 14 103697609-103715504 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 30.3" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062422, HPA068953" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA062422: AB_2684757, HPA068953: AB_2686062" "unprognostic (2.52e-2)" "unprognostic (1.81e-3)" "unprognostic (6.75e-2)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.53e-4)" "unprognostic (2.93e-2)" "unprognostic (4.67e-2)" "unprognostic (1.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.53e-2)" "unprognostic (3.52e-7)" "unprognostic (1.27e-1)" "unprognostic (1.57e-1)" "unprognostic (8.84e-2)" "unprognostic (3.72e-2)" 5.4 3.3 8.1 15.1 7.3 22.0 5.4 11.3 8.0 5.5 5.8 6.5 4.6 5.4 6.4 5.1 8.5 6.1 5.3 4.4 6.9 2.6 4.1 3.8 6.0 11.1 7.3 5.4 7.0 7.8 2.1 4.4 5.6 6.8 7.7 6.2 5.3 11.1 2.9 8.9 30.3 7.0 2.3 5.3 13.5 6.8 10.1 5.0 17.6 5.6 6.7 14.2 5.3 9.0 4.5 2.0 3.0 3.3 2.5 3.9 3.6 12.7 23.3 12.8 15.9 1.1 3.3 23.3 14.1 4.7 20.0 21.6 12.9 20.5 20.3 12.2 2.9 15.9 20.4 14.0 21.0 12.3 12.5 14.5 19.8 11.4 11.9 2.0 17.7 12.9 2.5 2.1 17.6 11.2 4.2 8.1 20.7 12.2 12.5 10.3 27.8 30.7 14.0 11.0 18.7 16.6 25.0 18.5 8.0 4.4 17.6 12.7 10.5 16.6 9.0 5.8 7.4 14.2 13.9 7.0 10.4 12.2 33.0 15.4 10.7 9.7 25.2 6.5 14.7 15.9 2.6 1.6 3.0 3.8 3.3 3.9 4.5 3.3 3.2 2.0 4.0 3.3 2.2 1.2 2.5 2.5 1.4 2.5 3.6 8.1 7.3 11.3 8.0 6.9 2.6 7.3 5.4 6.8 5.0 0.0 0.0 1.9 2.1 1.3 1.5 0.2 2.5 1.4 3.4 0.0 2.0 6.8 1.7 1.4 0.4 0.9 2.0 0.0 1.6 4.5 0.4 1.4 0.0 0.4 3.8 3.2 1.2 0.0 0.0 1.5 0.3 1.5 0.0 1.8 5.0 1.3 1.4 3.5 1.1 0.0 2.1 0.0 0.9 3.4 5.7 1.1 2.6 0.0 5.0 0.7 XYLB "FLJ10343, FLJ12539" ENSG00000093217 Xylulokinase O75191 3 38346760-38421348 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Xylose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 34.0" "Group enriched" "Detected in many" 5 "Hepatocytes: 42.9;Proximal tubular cells: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 3.6;T-cells: 3.9" "Cell line enhanced" "Detected in many" "Hep G2: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037863, HPA038415" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA037863: AB_10672729, HPA038415: AB_10672592" "unprognostic (2.48e-1)" "unprognostic (9.72e-2)" "unprognostic (3.42e-2)" "unprognostic (6.25e-2)" "unprognostic (7.52e-2)" "unprognostic (5.19e-2)" "unprognostic (5.82e-2)" "unprognostic (1.26e-3)" "unprognostic (6.55e-2)" "unprognostic (2.22e-1)" "unprognostic (6.91e-3)" "unprognostic (4.63e-2)" "prognostic favorable (8.57e-4)" "unprognostic (3.26e-1)" "unprognostic (2.06e-1)" "unprognostic (5.78e-2)" "unprognostic (3.37e-2)" 2.3 3.2 2.7 1.9 3.4 2.5 3.0 10.3 4.7 2.7 5.9 2.3 1.6 5.8 3.7 3.6 3.1 1.9 2.5 1.5 1.8 1.8 11.3 34.0 1.8 1.3 1.9 3.3 2.8 6.1 1.2 3.1 1.4 4.1 2.1 5.1 3.0 7.1 1.8 1.3 1.9 9.8 3.6 2.0 1.6 3.7 2.1 1.6 2.3 1.5 1.8 1.3 2.7 2.9 0.4 6.4 1.1 3.6 0.9 3.9 1.1 3.0 5.8 2.1 4.7 2.9 3.3 5.2 4.3 1.6 3.9 3.8 7.8 3.3 2.7 1.1 5.5 5.0 2.1 6.3 2.6 4.3 3.8 4.9 5.3 4.5 21.3 1.8 7.6 5.8 2.1 4.4 5.3 2.1 1.2 3.5 7.2 14.6 5.3 3.7 1.6 6.5 1.0 3.1 6.4 7.0 3.2 4.2 3.9 0.4 4.8 2.6 2.5 2.5 11.6 9.4 1.9 5.6 4.4 1.4 7.4 5.8 11.2 1.9 2.8 4.6 7.4 4.0 6.3 5.4 0.5 2.2 0.7 1.5 3.6 1.0 0.3 1.2 0.8 6.4 0.4 1.5 1.5 1.1 0.9 2.9 1.3 3.9 1.1 2.7 3.4 10.3 4.7 1.8 1.8 1.9 3.3 4.1 1.6 0.0 2.2 0.0 1.6 0.8 3.1 0.8 0.0 1.4 2.3 0.0 0.0 3.2 1.7 0.9 0.2 1.0 4.9 0.0 2.6 3.0 1.3 0.9 0.0 42.9 3.4 0.0 0.0 1.8 1.2 0.0 1.4 2.3 0.0 1.0 4.7 0.4 1.3 6.6 1.8 19.9 5.0 0.0 0.9 0.3 2.7 0.6 1.1 0.5 4.5 1.8 XYLT1 "PXYLT1, XT-I" ENSG00000103489 "Xylosyltransferase 1" Q86Y38 16 17101769-17470881 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 92.3;Peritubular cells: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007478, HPA007966" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA 30000 "Plasma membrane" "Endoplasmic reticulum" "HPA007478: AB_1080616, HPA007966: AB_1080618" "unprognostic (1.82e-1)" "unprognostic (7.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (9.12e-2)" "unprognostic (8.13e-2)" "unprognostic (9.40e-2)" "unprognostic (2.41e-3)" "unprognostic (2.82e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" 5.7 5.9 6.3 21.6 3.1 5.9 7.0 3.8 6.7 8.0 7.4 1.4 0.9 3.9 7.4 3.0 4.9 3.2 4.4 3.8 6.3 4.2 1.9 0.9 2.9 7.5 4.3 2.2 5.5 2.6 0.2 1.8 5.4 2.6 4.4 4.9 3.4 2.6 4.3 1.3 4.1 4.7 5.1 3.9 6.3 3.2 3.0 2.1 4.6 2.7 6.7 6.6 4.7 4.2 1.2 0.8 1.2 3.6 0.9 0.7 0.5 0.0 0.1 2.7 0.0 19.2 11.9 3.3 8.5 4.3 1.0 0.4 0.2 0.2 2.1 0.0 10.3 0.3 0.2 0.0 1.7 1.5 4.1 0.2 2.6 0.0 0.0 0.2 3.7 3.5 4.4 0.2 5.5 0.8 1.6 0.0 0.2 0.3 8.0 1.0 0.3 0.0 4.0 2.9 1.4 0.0 1.2 0.0 0.4 0.0 3.9 0.7 5.2 0.6 2.6 0.5 2.1 0.7 2.3 0.0 9.0 1.0 19.7 0.0 9.0 0.5 3.9 10.0 4.2 7.6 0.6 0.6 1.2 0.6 2.5 0.7 1.2 0.5 0.3 0.8 1.2 0.5 0.4 0.3 0.9 3.6 0.2 0.7 0.5 6.3 3.1 3.8 5.3 6.3 4.2 4.3 2.2 2.6 2.1 3.0 4.5 7.5 1.5 7.0 13.3 2.7 0.0 0.0 1.2 0.0 92.3 9.8 0.0 1.2 0.4 2.2 5.1 0.0 1.4 16.8 16.2 3.4 2.3 0.0 3.3 0.0 12.1 2.5 8.5 0.4 11.8 8.0 3.3 2.8 3.8 1.3 2.6 7.0 47.0 0.2 4.1 6.5 5.7 0.2 2.5 16.2 11.0 4.4 6.5 4.2 XYLT2 "PXYLT2, XT-II" ENSG00000015532 "Xylosyltransferase 2" Q9H1B5 17 50346092-50363138 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 53.4" "Group enriched" "Detected in many" 7 "Early spermatids: 305.8;Late spermatids: 85.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 990000 "unprognostic (1.52e-1)" "unprognostic (2.84e-1)" "unprognostic (1.65e-1)" "unprognostic (8.07e-2)" "unprognostic (1.90e-3)" "unprognostic (1.90e-1)" "unprognostic (7.29e-3)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (2.30e-1)" "unprognostic (1.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.63e-2)" "unprognostic (5.15e-2)" "unprognostic (7.38e-2)" "unprognostic (1.52e-2)" "unprognostic (2.68e-2)" 6.9 8.5 5.8 11.3 10.6 4.1 7.4 10.3 10.9 10.7 9.2 5.4 15.8 10.0 9.6 12.2 8.5 10.4 14.9 9.4 5.3 4.8 9.2 6.1 6.1 10.2 4.7 8.8 11.8 13.5 9.1 5.8 9.0 5.4 12.1 3.9 13.1 12.7 11.7 7.9 15.6 6.9 17.0 3.8 8.4 53.4 5.8 3.7 10.2 9.5 6.7 10.4 11.7 9.0 5.3 4.9 6.6 4.0 7.8 7.8 4.3 9.9 12.7 3.5 2.9 4.9 4.8 9.1 9.3 8.6 8.4 9.5 13.5 7.5 5.2 23.7 8.3 7.4 7.7 1.1 13.1 1.7 25.7 9.1 11.7 3.9 5.8 6.7 3.6 6.3 6.5 8.1 6.7 3.1 8.4 7.1 4.6 2.0 4.3 5.5 13.0 6.7 5.0 3.1 6.6 9.0 3.4 10.2 4.3 4.7 5.2 1.9 4.4 6.2 5.9 9.8 4.1 28.2 3.5 8.4 19.2 9.8 10.4 8.3 23.9 10.9 1.8 20.3 5.9 5.2 6.6 4.0 3.2 5.9 2.8 6.3 2.9 5.9 7.8 4.9 5.3 6.0 5.3 4.7 7.8 2.5 3.4 5.2 4.3 5.8 10.6 10.3 10.9 5.3 4.8 4.7 8.8 5.4 3.7 8.9 6.7 4.2 4.0 5.0 8.2 6.4 15.3 0.0 2.3 1.8 27.5 6.0 0.0 6.2 305.8 7.4 4.2 0.0 5.5 4.7 9.1 1.4 1.1 7.2 3.4 6.4 10.4 8.6 4.1 85.8 11.5 3.8 6.8 1.8 9.9 5.7 5.8 0.0 16.3 2.1 5.6 25.8 7.2 1.4 4.5 2.8 1.3 3.1 11.8 0.6 YBEY C21orf57 ENSG00000182362 "YbeY metallopeptidase (putative)" P58557 21 46286337-46297751 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.3" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 253.1;Late spermatids: 197.2;Spermatocytes: 177.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016593, HPA018162" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016593: AB_1845698, HPA018162: AB_1845699" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (7.24e-3)" "unprognostic (4.81e-1)" "unprognostic (2.78e-2)" "unprognostic (7.99e-2)" "unprognostic (1.95e-1)" "unprognostic (1.72e-1)" "unprognostic (8.87e-2)" "unprognostic (1.66e-3)" "unprognostic (2.95e-1)" "unprognostic (1.51e-2)" "unprognostic (7.50e-2)" "unprognostic (7.48e-2)" "unprognostic (1.94e-1)" "unprognostic (3.64e-3)" 7.0 8.3 9.5 8.9 10.3 4.1 10.9 8.9 12.1 7.6 11.1 11.6 10.1 8.9 6.6 12.0 5.9 8.2 6.8 8.1 9.0 9.1 8.8 11.0 10.1 10.9 11.4 10.5 8.2 11.3 10.1 10.0 4.7 9.2 10.4 9.7 7.3 10.5 9.6 11.5 9.4 12.4 6.3 13.6 7.0 6.8 58.3 8.5 6.8 7.5 12.7 10.6 6.3 6.4 21.8 16.0 14.8 7.8 12.7 16.8 6.8 10.1 8.9 7.6 9.2 5.8 22.4 7.4 6.9 10.4 6.9 8.4 4.7 1.7 12.9 6.1 7.1 3.6 3.3 3.2 3.2 6.3 12.2 12.8 3.7 5.8 1.8 16.8 4.1 0.4 15.4 13.9 5.4 11.3 9.0 4.4 6.4 8.8 15.5 8.0 8.6 8.1 5.4 22.3 3.8 9.3 17.2 3.6 24.7 14.0 4.7 5.6 9.9 9.4 4.3 18.6 2.6 2.2 3.7 5.4 6.6 2.4 5.3 4.5 19.4 34.3 22.2 12.0 4.6 4.0 14.8 6.1 4.6 9.6 6.8 9.3 21.8 11.6 11.7 6.9 15.5 11.4 13.0 2.1 12.7 7.8 16.0 16.8 6.8 9.5 10.3 8.9 12.1 9.0 9.1 11.4 10.5 9.2 8.5 3.0 6.1 22.7 30.1 41.1 13.0 19.0 15.3 10.7 13.6 17.4 7.9 14.0 54.7 31.5 253.1 18.0 46.6 0.0 67.1 20.6 27.3 31.8 11.5 43.2 21.8 15.9 30.8 22.1 27.5 197.2 37.7 32.3 37.1 17.2 53.4 14.0 43.0 49.1 23.0 56.4 21.1 6.5 27.0 177.3 30.9 52.9 8.0 22.4 53.3 31.2 YBX1 "BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1" ENSG00000065978 "Y-box binding protein 1" P67809 1 42682427-42702349 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen, Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 128.1;testis: 426.5" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 6931.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005875, HPA040304, HPA057159" Supported Enhanced Vesicles,Cytosol "Intracellular and membrane" NA NA 870000 Cytosol Vesicles "CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355" "unprognostic (8.59e-2)" "unprognostic (5.16e-2)" "unprognostic (9.27e-3)" "unprognostic (2.68e-3)" "unprognostic (7.76e-2)" "unprognostic (8.03e-3)" "prognostic unfavorable (9.87e-10)" "unprognostic (2.80e-2)" "unprognostic (2.31e-2)" "unprognostic (2.79e-3)" "unprognostic (7.51e-2)" "unprognostic (5.52e-2)" "prognostic unfavorable (3.59e-7)" "unprognostic (3.66e-2)" "unprognostic (2.44e-1)" "unprognostic (1.94e-2)" "unprognostic (3.25e-1)" 47.5 20.6 15.6 36.4 18.4 57.6 35.2 13.7 14.4 27.9 44.5 21.2 20.1 25.6 35.1 36.4 40.0 25.6 32.5 57.8 15.2 12.3 33.1 38.1 35.3 49.8 17.6 13.2 30.2 36.7 9.4 12.2 26.1 15.5 32.0 33.1 31.1 26.6 23.0 128.1 22.5 27.1 50.0 21.0 47.9 33.2 426.5 15.9 53.2 31.4 64.1 37.2 39.4 41.0 23.5 26.9 21.8 40.5 11.6 23.0 10.6 92.5 54.6 87.4 87.6 85.2 77.1 77.9 68.3 63.6 95.0 74.6 74.7 86.5 117.5 71.7 68.6 40.6 56.0 98.4 103.6 94.4 62.7 91.3 119.8 108.4 95.9 68.7 160.8 89.8 70.9 89.3 94.8 117.4 52.1 78.5 98.4 124.6 51.2 88.4 58.3 181.7 156.6 197.1 59.5 73.8 110.0 157.1 126.9 94.0 68.5 120.9 85.2 67.0 90.7 127.6 97.4 30.2 320.5 61.2 67.5 115.2 91.4 138.9 75.1 94.1 133.7 63.9 120.6 71.6 4.3 18.1 21.8 16.3 37.8 19.9 23.5 19.5 15.8 26.9 20.1 16.8 17.2 3.3 11.6 40.5 20.9 23.0 10.6 15.6 18.4 13.7 14.4 15.2 12.3 17.6 13.2 15.5 15.9 160.8 193.6 710.2 1008.1 1241.5 227.0 1010.1 351.6 187.4 286.6 308.8 141.4 639.1 1235.1 944.3 6931.7 600.7 713.3 817.7 771.6 1697.6 856.8 736.8 377.2 465.4 1556.8 114.4 564.5 393.5 1134.6 2234.4 695.5 1494.6 858.7 964.0 841.6 220.6 737.9 799.5 757.7 816.8 432.4 459.2 1265.4 2608.0 287.2 1138.5 402.6 588.8 1140.5 1354.3 YBX2 "Contrin, CSDA3, MSY2" ENSG00000006047 "Y-box binding protein 2" Q9Y2T7 17 7288252-7294615 "Predicted intracellular proteins, Transcription factors" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "testis: 97.3" "Group enriched" "Detected in some" 22 "Early spermatids: 260.3;Late spermatids: 369.1;Spermatocytes: 266.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.3;MCF7: 14.4;SH-SY5Y: 5.6;SK-BR-3: 7.4;T-47d: 22.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB012332, HPA053904, HPA056744" Enhanced NA NA "CAB012332: AB_776541, HPA053904: AB_2682302, HPA056744: AB_2683223" "unprognostic (1.76e-2)" "unprognostic (4.62e-3)" "unprognostic (3.99e-2)" "prognostic unfavorable (6.50e-5)" "unprognostic (9.80e-4)" "unprognostic (4.68e-2)" "unprognostic (2.23e-1)" "unprognostic (3.44e-1)" "unprognostic (1.41e-1)" "unprognostic (1.20e-1)" "unprognostic (2.20e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-4)" "unprognostic (1.78e-2)" "unprognostic (2.15e-1)" "unprognostic (5.31e-1)" "unprognostic (2.35e-2)" 1.8 0.0 0.5 1.2 0.2 0.1 0.5 0.0 0.6 0.5 1.6 0.0 0.6 0.8 0.5 1.4 0.7 0.5 0.0 0.2 0.5 0.0 0.2 0.3 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.4 0.7 1.4 0.2 2.0 0.4 0.1 0.0 0.2 97.3 0.1 0.1 0.2 0.3 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 8.3 4.0 0.0 4.0 0.0 0.1 0.7 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 14.4 0.5 0.6 2.5 0.3 0.0 0.1 0.1 0.1 0.3 0.0 0.1 5.6 2.3 7.4 0.4 3.6 22.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.6 0.5 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.6 0.0 3.9 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 260.3 0.1 10.7 0.0 0.2 0.2 0.0 0.3 0.0 1.1 0.1 0.0 4.6 0.0 0.0 369.1 6.4 0.0 3.3 0.0 2.4 0.8 0.0 3.5 6.3 0.3 0.4 0.0 0.4 266.9 11.5 0.6 0.1 0.0 13.4 0.9 YBX3 "CSDA, CSDA1, dbpA, ZONAB" ENSG00000060138 "Y-box binding protein 3" P16989 12 10699089-10723312 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "skeletal muscle: 612.6" "Cell type enhanced" "Detected in all" 5 "Basal glandular cells: 961.9;Early spermatids: 1123.4;Urothelial cells: 1185.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 9.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034838 Approved Supported Cytosol NA NA 56000 Cytosol "HPA034838: AB_10670980" "unprognostic (1.93e-2)" "unprognostic (6.20e-2)" "unprognostic (3.56e-1)" "unprognostic (3.61e-2)" "unprognostic (4.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.10e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-1)" "unprognostic (2.41e-1)" "unprognostic (3.23e-3)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.17e-13)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (4.25e-2)" "unprognostic (2.44e-1)" 23.8 5.0 3.0 6.4 6.0 11.2 15.9 2.1 4.6 12.4 14.3 2.0 3.7 3.2 8.5 14.7 25.0 8.4 6.7 91.6 3.2 1.7 7.6 6.5 17.2 6.8 5.5 0.8 17.2 20.6 1.3 8.1 9.5 6.2 12.4 5.3 6.2 12.9 6.8 612.6 29.9 5.0 14.9 5.8 8.6 9.5 30.2 4.1 4.5 18.5 54.2 12.0 27.2 24.6 9.5 4.5 1.0 5.7 0.9 2.3 1.4 18.0 15.8 7.1 23.1 29.7 55.0 51.9 28.2 24.1 24.2 22.8 27.7 43.8 17.7 9.5 22.5 17.3 34.7 30.4 58.7 21.0 0.1 54.6 14.6 22.3 16.9 37.1 26.2 1.6 63.4 76.3 22.4 73.8 26.1 55.5 26.6 19.7 0.0 25.9 19.2 21.6 22.6 71.6 17.2 13.0 12.2 32.5 20.0 32.7 23.9 8.8 0.0 21.4 21.3 26.2 51.6 6.1 20.7 36.3 16.6 46.6 17.7 31.7 0.1 5.8 2.0 22.8 0.0 17.7 0.0 5.7 0.0 0.7 5.4 0.0 1.6 0.0 2.1 4.5 9.5 0.1 2.3 1.0 0.9 3.0 0.2 0.1 1.4 3.0 6.0 2.1 4.6 3.2 1.7 5.5 0.8 6.2 4.1 140.0 176.5 92.6 961.9 679.4 30.6 444.3 50.9 175.3 168.4 137.9 84.4 126.8 112.7 102.4 1123.4 256.4 56.1 654.1 122.3 76.8 207.6 567.0 61.2 16.3 93.4 15.9 64.9 106.2 162.4 213.4 245.1 187.6 246.3 24.4 118.1 52.5 144.1 38.6 210.4 172.9 294.1 122.9 393.5 248.3 90.5 918.2 105.2 24.0 146.4 1185.0 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289170 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 138.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014840, HPA076194" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA014840: AB_2217189, HPA076194: " "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (8.70e-4)" 16.0 19.7 11.3 12.4 11.7 6.4 18.9 8.0 16.5 17.3 21.4 19.3 18.5 26.1 19.4 24.8 18.5 16.4 24.6 20.1 9.8 9.2 26.2 138.8 16.5 16.0 12.8 9.4 21.2 55.2 18.9 26.8 24.7 12.3 16.8 17.9 16.5 24.4 19.2 32.3 14.3 32.1 19.1 15.2 12.8 19.4 16.9 10.7 16.4 28.2 26.4 17.7 18.2 13.7 27.4 40.4 5.5 38.9 13.3 23.6 26.1 20.8 34.6 10.8 19.6 36.5 39.4 19.8 30.7 33.0 26.3 26.0 32.7 25.7 17.8 30.2 43.1 29.8 31.8 16.4 28.9 21.0 20.2 18.9 11.0 26.9 40.5 40.8 15.4 16.8 27.1 39.3 27.1 44.1 21.3 24.5 17.9 20.5 31.3 22.8 50.6 18.5 16.4 10.9 39.0 36.1 14.3 16.5 53.0 22.2 19.0 15.8 15.6 16.6 28.8 27.2 14.3 42.3 11.5 21.6 22.2 18.8 44.7 14.2 21.0 21.7 15.9 34.8 14.7 24.4 4.9 28.0 5.5 21.8 38.9 23.6 27.4 18.8 20.3 33.2 22.6 15.1 17.2 2.8 13.3 37.2 40.4 15.2 26.1 11.3 11.7 8.0 16.5 9.8 9.2 12.8 9.4 12.3 10.7 35.7 49.5 40.9 73.7 32.1 25.8 28.6 66.2 69.6 35.2 43.6 21.6 105.1 54.7 124.9 21.6 45.3 78.6 0.0 130.4 213.7 96.8 110.9 29.9 155.3 96.6 25.4 84.0 49.7 32.3 35.0 69.9 39.6 69.2 37.9 97.4 73.4 109.8 89.6 77.4 112.8 27.8 38.8 58.4 32.7 49.9 40.5 129.1 42.6 93.3 84.8 YIPF7 "FinGER9, FLJ39576" ENSG00000177752 "Yip1 domain family member 7" Q8N8F6 4 44622065-44678556 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 45.3;tongue: 14.8" "Cell type enhanced" "Detected in single" 32 "Cardiomyocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 1.5;fHDF/TERT166: 1.3;GAMG: 1.8;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6" "Region enriched" "Detected in single" 6 "cerebellum: 0.7" "Region enriched" "Detected in single" 29 "cerebellum: 14.8" HPA030642 Uncertain NA NA "HPA030642: AB_10601027" "unprognostic (9.41e-4)" "unprognostic (2.27e-1)" "unprognostic (2.90e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.46e-2)" "unprognostic (9.81e-2)" "unprognostic (2.32e-2)" "unprognostic (3.05e-2)" "unprognostic (1.52e-2)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.98e-2)" 1.5 0.0 0.3 0.0 0.5 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.6 0.1 45.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 14.8 0.7 0.0 0.0 2.3 3.3 0.3 1.0 0.3 0.9 0.3 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.8 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.0 0.0 0.3 0.3 0.0 0.7 0.0 0.6 0.3 0.0 0.3 0.5 1.1 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.5 0.7 0.4 2.3 0.9 0.7 0.6 0.6 0.3 0.4 0.3 0.3 0.2 3.3 0.1 0.3 0.3 0.5 0.8 0.3 0.3 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 YJEFN3 "FLJ44968, hYjeF_N3-19p13.11" ENSG00000250067 "YjeF N-terminal domain containing 3" A6XGL0 19 19528861-19537581 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.8" "Group enriched" "Detected in many" 16 "Early spermatids: 137.6;Late spermatids: 456.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 11.4;HEK 293: 13.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060789 Enhanced Approved Mitochondria NA NA Mitochondria "HPA060789: AB_2684366" "unprognostic (2.59e-2)" "unprognostic (2.50e-1)" "unprognostic (5.99e-6)" "unprognostic (1.65e-1)" "unprognostic (3.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.37e-4)" "unprognostic (2.38e-1)" "unprognostic (1.04e-2)" "unprognostic (1.06e-1)" "prognostic favorable (7.25e-4)" "unprognostic (2.11e-2)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.17e-2)" "unprognostic (8.26e-2)" "unprognostic (2.48e-1)" "unprognostic (9.49e-3)" 1.2 0.9 24.2 1.4 47.8 0.8 1.0 0.8 26.5 1.1 1.3 1.1 0.0 1.0 1.3 6.6 1.0 1.6 0.9 0.8 29.5 8.3 1.0 0.8 1.4 1.4 7.7 10.2 1.1 1.0 1.7 0.8 1.3 3.6 2.0 1.6 4.1 0.9 1.5 1.6 3.0 1.6 1.2 1.0 1.1 1.4 7.1 5.1 0.0 1.7 0.0 1.3 1.5 0.0 0.5 0.5 0.3 1.1 0.0 2.2 0.3 0.3 0.8 1.9 0.8 0.3 0.5 11.4 0.5 0.1 0.5 0.7 0.9 0.6 0.4 1.5 0.1 0.2 1.1 0.3 0.2 0.0 0.1 13.4 0.0 1.6 0.0 0.1 0.3 0.6 0.1 0.6 0.3 0.4 0.1 0.0 0.9 0.9 0.6 0.0 1.0 0.0 0.1 3.6 0.0 2.6 2.1 0.4 0.4 0.0 0.1 0.3 3.2 0.2 0.0 0.2 0.6 1.3 1.6 0.7 0.3 0.7 3.5 0.8 3.2 2.2 0.6 0.2 1.7 0.4 0.0 0.7 0.0 0.7 1.1 0.8 0.3 1.2 0.6 0.5 0.5 0.7 1.1 0.3 0.0 0.7 0.0 2.2 0.3 24.2 47.8 0.8 26.5 29.5 8.3 7.7 10.2 3.6 5.1 8.9 0.3 1.3 2.5 1.8 18.1 1.6 2.5 2.7 6.8 0.0 9.8 1.3 1.7 1.7 137.6 1.6 4.7 0.0 0.5 1.0 2.7 2.1 1.1 1.0 1.0 9.5 5.2 1.8 0.3 456.0 3.4 1.5 1.7 0.0 6.3 7.2 0.5 3.5 1.8 0.3 14.9 6.5 3.9 14.0 9.6 3.6 1.5 2.9 5.0 0.9 YOD1 "DKFZp451J1719, DUBA8, OTUD2" ENSG00000180667 "YOD1 deubiquitinase" Q5VVQ6 1 207043849-207052980 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway, Unfolded protein response" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 44.7" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 69.8;Urothelial cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 40.3;K-562: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028400, HPA028439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 40000 "Nucleoplasm, Plasma membrane, Cytosol" "HPA028400: AB_10599854, HPA028439: AB_10600994" "unprognostic (3.69e-2)" "unprognostic (8.72e-2)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.03e-2)" "unprognostic (3.28e-2)" "unprognostic (9.87e-3)" "unprognostic (9.38e-2)" "unprognostic (2.31e-3)" "unprognostic (8.96e-2)" "unprognostic (1.47e-3)" "unprognostic (1.03e-2)" "unprognostic (6.07e-2)" "unprognostic (6.86e-2)" "unprognostic (2.83e-1)" "unprognostic (1.79e-2)" "unprognostic (3.62e-1)" 4.5 4.6 4.0 4.0 5.3 44.7 6.6 4.8 7.5 6.1 3.9 7.6 2.6 4.1 4.0 3.1 24.5 3.7 3.5 5.0 4.0 2.2 4.5 5.2 9.4 4.2 7.1 4.4 3.5 3.6 2.5 5.1 6.3 5.1 3.4 4.0 3.4 9.7 3.0 6.5 14.9 4.8 2.7 8.5 5.2 8.4 5.6 6.9 14.3 5.8 10.0 8.2 5.8 12.3 0.5 1.3 3.9 1.5 1.2 1.8 0.9 5.4 2.9 4.6 2.7 1.6 2.1 9.0 3.6 2.8 2.7 2.8 5.5 5.6 2.8 1.5 2.2 1.3 6.0 0.0 4.4 3.1 2.3 4.9 40.3 11.9 2.6 1.5 5.2 14.2 1.5 3.4 2.2 8.6 3.2 2.4 5.9 28.0 0.0 2.3 0.0 4.6 2.9 4.4 2.2 6.5 2.3 0.2 2.1 2.7 6.1 2.4 5.3 5.9 6.9 7.7 4.2 2.4 3.7 1.1 2.4 6.2 1.9 4.7 4.6 0.2 4.2 2.8 0.0 1.6 3.9 1.2 2.0 1.1 1.5 1.5 0.4 1.7 0.9 1.3 0.5 1.4 1.8 2.9 1.2 1.0 0.7 0.8 0.9 4.0 5.3 4.8 7.5 4.0 2.2 7.1 4.4 5.1 6.9 38.7 9.8 0.8 21.4 28.0 7.8 5.3 5.1 13.4 5.7 1.8 3.9 2.3 1.7 3.8 28.6 3.5 9.8 46.7 9.3 2.7 5.7 29.8 8.1 5.4 2.4 11.1 8.5 3.7 8.5 69.8 1.4 6.4 13.5 1.8 3.5 4.2 15.5 4.9 2.1 5.4 16.2 6.5 3.1 8.8 4.1 35.1 1.5 7.5 5.4 62.9 YPEL1 ENSG00000100027 "Yippee like 1" O60688 22 21697544-21735834 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.8;testis: 44.2" "Group enriched" "Detected in many" 32 "Early spermatids: 569.5;Late spermatids: 1037.8;Spermatocytes: 261.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.6;JURKAT: 15.6;MOLT-4: 11.4;REH: 10.3;SCLC-21H: 10.2;U-266/70: 8.9" "Group enriched" "Detected in many" 6 "amygdala: 35.6;basal ganglia: 12.9;cerebral cortex: 29.3;hippocampal formation: 33.9;olfactory region: 12.4" "Low region specificity" "Detected in all" "HPA030501, HPA045621" Uncertain NA NA "HPA030501: AB_10602683, HPA045621: " "unprognostic (1.36e-1)" "unprognostic (2.47e-3)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.82e-3)" "unprognostic (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (1.10e-2)" "unprognostic (2.38e-1)" "unprognostic (1.61e-1)" "unprognostic (4.68e-3)" "unprognostic (2.06e-1)" "unprognostic (1.27e-1)" "unprognostic (6.03e-2)" "unprognostic (1.55e-1)" "unprognostic (2.51e-2)" "unprognostic (5.16e-3)" 2.6 1.8 9.7 2.2 23.8 3.6 3.5 10.5 12.8 1.9 2.2 3.0 0.1 1.2 4.9 2.3 1.8 2.9 2.4 6.1 7.7 4.7 2.0 2.1 4.7 3.9 2.6 6.7 7.6 2.3 1.8 2.5 1.1 3.1 2.7 2.3 2.6 2.2 1.6 10.1 1.9 1.7 2.6 2.9 7.6 2.4 44.2 4.9 7.9 2.3 2.2 3.8 2.1 1.0 1.6 3.0 2.3 0.4 4.5 2.8 0.7 0.8 0.0 8.6 4.8 0.7 0.5 0.4 0.4 0.1 0.8 0.9 0.0 0.5 1.3 1.2 0.3 1.2 0.1 0.6 0.2 0.7 4.4 1.6 0.1 0.1 0.5 0.5 0.4 1.5 0.8 0.1 0.2 0.0 2.0 1.3 15.6 0.3 4.6 0.4 0.3 11.4 2.1 0.3 0.1 0.5 10.3 2.1 0.5 0.2 0.0 10.2 7.1 0.8 0.8 1.0 2.2 0.5 0.9 1.4 0.2 2.0 0.2 0.2 8.9 3.4 3.5 0.6 1.1 1.1 0.4 0.3 0.3 2.8 0.4 2.7 0.4 0.8 2.7 0.3 1.6 0.3 1.5 2.3 4.5 0.3 3.0 1.1 0.7 9.7 23.8 10.5 10.0 7.7 4.7 2.6 6.7 3.1 4.9 3.0 3.7 7.7 2.2 1.5 6.4 2.8 5.1 1.4 3.4 3.5 5.9 0.4 0.0 5.0 569.5 3.0 0.0 0.0 3.1 0.4 2.1 4.6 0.0 5.5 1.3 6.4 12.6 8.0 2.1 1037.8 10.6 2.8 0.0 1.8 1.3 4.5 4.8 0.0 10.3 3.0 5.7 12.9 1.7 261.5 11.8 1.6 1.1 19.7 2.2 2.6 YPEL4 FLJ30213 ENSG00000166793 "Yippee like 4" Q96NS1 11 57645087-57649944 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 27.4" "Group enriched" "Detected in many" 5 "Bipolar cells: 32.5;Early spermatids: 30.9;Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "AF22: 6.2;ASC diff: 3.8;SK-MEL-30: 7.3;SuSa: 3.6;U-87 MG: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045621 Uncertain NA NA "HPA045621: " "unprognostic (6.91e-3)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (8.62e-3)" "unprognostic (2.40e-1)" "unprognostic (7.50e-2)" "unprognostic (2.11e-2)" "unprognostic (2.47e-1)" "unprognostic (4.28e-2)" "unprognostic (1.04e-1)" "unprognostic (2.14e-1)" "unprognostic (4.18e-1)" "unprognostic (1.34e-6)" "unprognostic (1.50e-4)" "unprognostic (9.56e-2)" "unprognostic (1.86e-3)" "unprognostic (2.92e-1)" 2.1 7.5 17.8 1.5 13.5 12.3 2.4 27.4 26.3 5.0 1.7 6.0 0.0 1.9 5.1 1.3 1.9 1.8 3.1 1.9 9.8 10.6 1.1 1.1 1.9 1.3 8.0 17.7 8.7 1.6 1.0 3.5 2.2 8.5 1.3 1.4 0.2 1.4 2.0 1.0 1.6 1.9 3.5 5.3 1.8 1.3 2.5 8.9 0.0 1.1 0.0 1.2 1.6 1.9 0.0 0.0 0.0 0.3 0.0 1.6 0.1 0.7 0.1 6.2 0.3 3.8 3.5 0.7 0.2 2.8 0.0 0.0 0.4 0.1 0.1 0.4 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.1 0.0 3.3 1.5 0.0 0.4 0.0 2.9 0.0 1.2 0.0 0.2 0.0 0.0 0.9 0.4 2.5 0.2 0.0 2.4 0.7 0.4 0.1 0.0 0.0 1.6 0.3 0.6 7.3 3.6 0.5 0.0 0.0 0.4 1.6 0.0 0.0 2.7 0.0 0.0 3.6 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.1 17.8 13.5 27.4 23.1 9.8 10.6 8.0 17.7 8.5 8.9 0.0 0.0 0.8 0.6 1.0 32.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 30.9 1.3 0.0 70.0 0.0 0.2 1.2 0.3 3.5 0.0 0.9 7.9 0.0 0.6 1.5 9.6 1.1 4.2 5.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 2.4 0.0 2.1 0.3 0.0 1.1 2.7 0.0 0.0 0.1 YPEL5 CGI-127 ENSG00000119801 "Yippee like 5" P62699 2 30146941-30160533 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 164.9" "Cell type enhanced" "Detected in all" 4 "monocytes: 480.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042809 Approved Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA042809: AB_2678179" "unprognostic (7.22e-3)" "unprognostic (6.50e-3)" "unprognostic (9.16e-2)" "unprognostic (5.47e-2)" "unprognostic (4.88e-2)" "unprognostic (1.83e-2)" "unprognostic (3.60e-2)" "unprognostic (3.39e-2)" "unprognostic (1.95e-1)" "unprognostic (5.73e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-3)" "unprognostic (1.16e-2)" "unprognostic (7.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.67e-3)" 29.6 32.5 39.0 20.1 38.2 164.9 32.9 34.2 52.9 31.2 34.6 20.7 38.2 19.4 28.7 40.9 35.1 25.6 30.8 26.1 38.1 39.5 40.5 29.8 31.9 30.5 35.3 32.5 30.0 23.4 24.6 26.0 48.1 36.4 33.8 22.2 33.1 28.7 47.6 27.7 26.1 29.1 36.8 30.6 29.6 27.2 31.4 18.3 34.2 39.0 20.6 28.2 40.1 25.2 21.3 35.0 72.4 31.9 12.5 21.6 30.9 9.9 5.5 12.0 5.9 34.1 33.1 10.2 14.1 43.7 8.2 12.7 4.5 10.3 5.9 9.6 28.4 19.0 5.4 2.7 14.4 11.6 26.1 5.4 3.1 2.5 7.2 29.1 1.0 7.2 34.1 29.4 15.5 20.0 35.6 15.5 3.9 4.3 10.5 22.1 5.2 3.2 7.2 6.7 11.5 6.5 1.9 16.3 5.6 27.5 19.4 4.8 14.9 7.2 6.9 17.5 23.0 7.7 5.8 20.3 22.3 8.6 6.1 3.9 25.1 9.8 7.9 15.9 2.8 9.0 41.7 19.6 43.1 13.6 21.8 13.5 21.3 16.6 15.9 18.2 17.4 16.0 14.1 72.4 12.5 31.9 35.0 21.6 30.9 39.0 38.2 34.2 52.9 38.1 39.5 35.3 32.5 36.4 18.3 77.4 75.1 107.8 142.4 118.9 71.0 67.4 35.7 57.6 64.8 96.0 45.2 147.4 117.7 76.8 214.0 63.9 69.5 116.8 69.5 110.5 88.3 121.7 81.7 36.8 91.0 60.4 200.3 49.1 87.4 400.6 53.5 101.5 161.9 480.7 69.6 83.5 86.2 73.7 77.8 97.1 49.3 51.8 103.9 99.6 72.4 124.6 341.2 117.6 43.7 247.9 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Cell type enhanced" "Detected in all" 5 "Basal keratinocytes: 363.1;Suprabasal keratinocytes: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported "Nucleoplasm,Nucleoli rim,Cytosol" NA NA 160000000 Cytosol "Nucleoplasm, Nucleoli rim" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavorable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavorable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.4 47.2 41.7 53.0 42.8 24.7 18.9 43.6 21.6 27.1 29.4 29.6 40.4 52.9 15.0 38.7 45.1 35.1 52.3 48.1 38.1 35.8 22.8 50.1 32.3 32.8 39.1 61.1 49.0 27.1 46.2 31.6 65.5 28.8 42.9 28.8 68.7 59.9 40.3 35.3 43.6 45.2 46.3 30.3 33.1 51.1 42.3 58.4 42.4 25.6 22.4 62.3 48.3 62.0 30.8 56.2 43.1 37.0 45.3 52.9 30.7 46.9 58.2 19.9 37.2 81.5 47.5 57.8 56.3 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 29.8 23.7 44.7 105.7 363.1 100.2 200.1 43.3 22.7 45.5 36.6 11.8 29.7 31.5 43.8 87.4 64.2 34.1 46.7 32.8 61.5 84.6 106.7 66.8 81.5 75.7 117.6 81.9 48.5 90.6 18.9 42.8 83.5 89.4 41.5 31.5 23.8 60.8 28.8 40.7 41.0 26.9 32.3 122.6 10.3 16.7 371.9 56.2 18.7 33.8 146.6 YWHAH YWHA1 ENSG00000128245 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta" Q04917 22 31944461-31957603 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 154.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025918, HPA061603" Uncertain Approved "Nucleoli rim,Cytosol" NA NA 130000000 Cytosol "Nucleoli rim" "CAB025918: , HPA061603: " "unprognostic (3.77e-1)" "unprognostic (6.13e-2)" "unprognostic (1.67e-2)" "unprognostic (1.86e-2)" "unprognostic (1.13e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (1.59e-5)" "unprognostic (8.62e-2)" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (3.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.40e-1)" "unprognostic (1.59e-1)" "unprognostic (5.60e-2)" "unprognostic (7.00e-2)" "unprognostic (6.81e-2)" 21.5 18.6 87.9 20.6 47.4 16.3 19.3 41.9 154.3 13.7 24.4 10.0 4.3 17.2 13.1 14.1 14.0 16.4 18.6 15.2 78.8 59.1 11.7 11.5 25.0 13.5 35.5 101.6 10.0 16.7 5.2 10.4 22.4 49.5 12.3 20.1 6.8 9.9 15.6 13.9 9.9 17.4 25.9 19.4 12.8 26.9 3.7 9.1 6.3 10.5 5.5 15.1 18.5 10.6 8.1 16.6 14.9 14.4 17.7 12.8 9.6 68.7 27.5 30.8 17.9 18.7 17.3 19.5 66.8 33.0 38.6 44.0 29.1 23.9 40.6 16.3 61.3 19.6 33.3 36.8 36.7 36.4 35.9 32.0 23.9 21.6 26.0 18.9 77.1 26.8 15.7 19.6 32.4 23.2 24.5 31.5 14.6 33.0 29.7 29.3 27.7 23.4 35.5 36.6 29.8 30.1 33.6 42.3 21.5 24.3 29.7 66.1 21.7 38.0 26.6 23.8 41.9 15.2 19.1 50.3 38.9 38.9 28.5 42.4 16.5 25.5 50.8 28.2 31.1 34.1 7.8 14.4 14.9 5.7 11.8 8.1 8.1 7.0 8.1 16.6 7.6 2.8 3.6 8.7 17.7 12.2 4.5 12.8 9.6 87.9 47.4 41.9 126.3 78.8 59.1 35.5 101.6 49.5 9.1 47.6 23.7 81.8 190.9 296.7 53.4 42.8 104.4 28.1 20.5 120.4 21.6 126.3 197.3 124.3 2.1 136.1 126.2 116.8 139.6 127.7 124.6 221.7 40.3 62.5 235.5 50.9 72.4 94.5 125.5 9.1 56.7 261.3 285.1 89.2 93.7 65.8 158.8 99.3 76.0 76.7 58.1 155.2 217.9 21.2 37.4 297.2 29.1 84.7 98.9 163.9 YY2 ZNF631 ENSG00000230797 "YY2 transcription factor" O15391 X 21855987-21858727 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.5" "Cell type enriched" "Detected in many" 8 "Spermatogonia: 52.4" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001119, HPA030335" Enhanced Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA001119: AB_1858930, HPA030335: AB_2673434" "unprognostic (1.90e-2)" "unprognostic (3.34e-2)" "unprognostic (2.75e-2)" "unprognostic (8.39e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-2)" "unprognostic (4.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (2.21e-2)" "unprognostic (2.03e-1)" "unprognostic (8.78e-4)" "unprognostic (4.04e-1)" "unprognostic (9.38e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" 1.6 1.8 0.7 1.4 0.9 0.3 1.4 1.8 0.8 1.6 1.2 0.3 2.8 1.9 1.3 1.6 1.2 1.2 0.5 0.6 1.0 2.5 1.4 0.7 0.8 3.3 1.4 1.5 2.5 2.2 1.8 0.9 1.3 1.6 1.2 1.8 0.8 2.0 1.1 0.9 0.9 9.5 1.6 0.6 1.1 1.5 1.5 1.2 0.0 0.6 1.4 2.7 0.5 3.6 3.3 2.3 7.3 2.9 1.2 0.3 4.0 2.3 4.7 5.3 2.7 6.1 4.2 2.4 5.2 6.0 2.0 5.0 5.5 8.2 3.0 4.8 1.1 8.9 2.2 5.0 4.5 2.2 2.4 4.1 3.5 5.8 3.6 2.9 1.6 4.2 5.0 8.2 2.5 2.4 4.6 4.3 1.8 4.4 2.3 3.9 6.4 2.5 1.6 1.3 3.3 2.3 2.0 6.6 6.3 3.5 1.5 3.1 8.6 1.7 14.9 4.7 3.4 3.9 2.6 5.6 2.2 6.8 0.0 0.6 0.0 0.8 0.1 0.6 1.5 1.3 0.8 0.6 1.1 2.7 0.6 0.0 1.4 0.4 1.2 1.2 0.5 0.0 1.6 0.0 0.7 0.8 2.3 0.8 0.0 0.0 0.0 1.8 3.9 2.5 0.0 0.8 0.4 1.8 0.4 0.0 0.6 1.1 1.9 1.2 1.1 2.1 1.9 6.4 1.2 1.8 2.2 1.0 5.8 1.8 0.0 3.6 0.3 1.3 1.3 0.0 3.5 0.3 3.4 0.0 0.5 6.9 52.4 1.3 1.7 0.0 0.6 1.1 Z82190.2 ENSG00000285404 22 31754899-31956243 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.9;brain: 1.3;liver: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "non-classical monocyte: 1.9" "Group enriched" "Detected in many" 6 "granulocytes: 1.1;monocytes: 1.9" "Cell line enhanced" "Detected in some" "HDLM-2: 1.0;REH: 1.1;U-2197: 2.5;U-251 MG: 1.4;U-698: 1.1" "HPA054969, HPA055619" Uncertain NA NA "HPA054969: AB_2682655, HPA055619: AB_2682864" 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 1.4 0.0 0.2 1.1 0.0 0.0 0.0 0.3 0.2 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.6 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Z82206.1 ENSG00000225528 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3" "Group enriched" "Detected in some" 5 "Distal tubular cells: 6.6;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 4.0;JURKAT: 3.2;K-562: 16.1;MOLT-4: 2.7" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes NA "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.0 0.0 0.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.3 3.6 3.0 5.7 2.2 2.2 8.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 16.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.8 4.4 5.2 2.2 4.5 3.6 6.5 5.7 2.7 3.2 6.7 8.1 4.3 2.2 1.9 3.0 4.2 7.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Z83844.3 ENSG00000285304 22 37639693-37666932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA000757 Approved Approved Cytosol NA NA Cytosol "HPA000757: AB_1079951" 2.4 0.1 1.8 12.3 2.7 8.5 1.0 2.4 3.5 3.7 7.5 2.0 0.9 8.4 1.3 2.0 11.6 1.9 2.4 1.0 1.5 0.3 1.0 3.7 8.2 1.7 1.5 2.5 0.9 2.8 0.0 6.0 1.8 3.5 5.7 1.4 4.4 2.8 0.0 2.2 12.5 2.6 2.5 13.4 1.6 0.9 2.4 10.5 0.3 10.4 16.3 4.6 2.0 1.6 3.6 0.1 2.7 1.7 2.6 1.5 9.2 1.6 5.3 3.3 1.5 4.6 5.9 2.7 8.5 10.1 10.6 7.4 2.3 6.7 1.1 3.0 3.3 8.0 5.7 13.9 3.2 6.9 5.1 14.0 0.2 7.4 3.0 21.4 19.3 5.4 6.6 11.8 1.1 4.8 0.6 4.3 4.0 5.0 0.4 11.2 0.9 2.0 5.4 16.0 1.3 8.7 3.6 5.5 1.1 3.3 3.0 5.5 0.7 3.5 6.1 3.9 4.6 10.7 1.2 1.5 5.5 0.7 0.0 9.1 3.4 6.1 3.6 14.8 10.1 0.0 2.7 0.1 2.2 1.3 1.8 1.6 1.4 2.1 3.6 0.9 2.6 1.6 0.0 1.7 2.7 2.2 2.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Z84488.2 ENSG00000285446 6 116399395-116463696 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.5;lymphoid tissue: 3.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "basophil: 3.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "BJ: 3.4;GAMG: 2.9;HDLM-2: 3.6;hTEC/SVTERT24-B: 2.8;Karpas-707: 4.3;RPMI-8226: 3.2" NA NA 0.5 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.8 1.5 0.0 0.0 0.4 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.4 0.0 3.0 1.1 0.0 0.0 0.5 0.0 0.5 0.1 3.5 0.3 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.9 0.0 1.2 0.0 0.0 0.0 0.8 0.0 2.9 1.4 0.2 1.8 0.9 3.6 0.0 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.8 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.3 0.0 3.2 0.0 0.6 0.0 0.0 2.4 0.2 0.7 1.7 0.0 0.0 0.0 0.2 0.1 0.0 1.9 0.5 0.0 0.1 0.2 0.8 0.0 3.5 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.2 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZACN "L2, LGICZ, LGICZ1, ZAC, ZAC1" ENSG00000186919 "Zinc activated ion channel" Q401N2 17 76071961-76083666 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "intestine: 2.1" "Cell type enhanced" "Detected in single" 15 "Ciliated cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SiHa: 2.1" "Low region specificity" "Detected in many" NA NA "unprognostic (8.27e-2)" "unprognostic (2.89e-2)" "unprognostic (8.92e-2)" "unprognostic (7.43e-2)" "unprognostic (5.46e-2)" "unprognostic (1.13e-2)" "unprognostic (5.10e-3)" "unprognostic (5.17e-2)" "unprognostic (4.49e-2)" "unprognostic (7.42e-2)" "unprognostic (3.16e-5)" "unprognostic (2.70e-2)" "unprognostic (5.19e-7)" "unprognostic (6.27e-2)" "unprognostic (3.59e-1)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.1 2.1 1.2 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.7 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.4 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.6 0.3 0.2 0.2 0.0 0.4 0.2 0.3 0.5 0.1 0.2 0.3 0.1 0.4 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 ZAN ENSG00000146839 "Zonadhesin (gene/pseudogene)" 7 100733626-100797797 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 14.3" "Group enriched" "Detected in some" 8 "Early spermatids: 8.0;Late spermatids: 9.6" "Cancer enriched" "Detected in single" 8 "testis cancer: 1.3" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.6" "Group enriched" "Detected in some" 6 "REH: 1.1;SK-BR-3: 1.4" "Not detected" "Not detected" NA NA "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (3.69e-1)" "unprognostic (4.60e-2)" "unprognostic (5.83e-6)" "unprognostic (9.44e-2)" "unprognostic (4.56e-2)" "unprognostic (2.08e-1)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (5.70e-2)" "unprognostic (4.10e-9)" "unprognostic (5.70e-2)" "unprognostic (2.58e-1)" "unprognostic (8.43e-2)" "unprognostic (3.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 ZAP70 "SRK, STD, ZAP-70" ENSG00000115085 "Zeta chain of T cell receptor associated protein kinase 70" P43403 2 97713560-97739862 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Disease mutation, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 37.4;lymphoid tissue: 107.1" "Cell type enriched" "Detected in many" 4 "T-cells: 96.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 41 "gdT-cell: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9" "Group enriched" "Detected in many" 53 "NK-cells: 26.4;T-cells: 37.4" "Group enriched" "Detected in some" 11 "JURKAT: 39.8;MOLT-4: 57.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB002625, HPA003134" Enhanced NA NA "CAB002625: , HPA003134: AB_1080629" "unprognostic (4.11e-3)" "prognostic favorable (6.89e-5)" "unprognostic (3.82e-3)" "prognostic favorable (9.66e-8)" "unprognostic (5.78e-2)" "prognostic favorable (3.93e-6)" "unprognostic (2.30e-3)" "unprognostic (1.09e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-2)" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.02e-8)" "unprognostic (1.29e-1)" "unprognostic (1.65e-1)" "unprognostic (6.40e-2)" "unprognostic (5.83e-3)" 2.2 0.5 0.3 18.1 0.6 11.2 1.5 0.7 0.6 1.2 3.7 0.7 0.3 2.9 1.2 1.1 1.7 1.5 2.8 0.9 0.4 0.8 2.2 2.3 5.8 28.1 0.8 0.6 0.9 1.3 0.0 0.7 0.9 0.6 2.1 0.6 1.0 5.5 1.0 0.7 1.0 12.3 0.7 0.7 24.8 3.2 1.4 0.6 107.1 2.5 1.1 20.8 3.0 1.7 0.4 0.2 0.5 0.2 26.4 37.4 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.8 0.0 0.2 0.0 0.0 57.4 0.1 0.0 0.0 0.0 2.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 37.4 0.1 25.4 0.0 19.6 29.2 0.0 0.4 14.3 21.9 0.5 26.4 0.2 0.2 19.9 14.3 0.3 0.6 0.7 0.6 0.4 0.8 0.8 0.6 0.6 0.6 8.9 22.3 1.4 0.0 1.3 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.4 0.1 2.3 0.6 1.7 0.0 0.0 3.1 0.8 0.7 0.0 1.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 1.4 1.7 1.3 0.0 96.4 0.0 0.1 ZAR1 Z3CXXC6 ENSG00000182223 "Zygote arrest 1" Q86SH2 4 48490252-48494389 "Plasma proteins, Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 2.0;brain: 2.7;salivary gland: 1.3;testis: 4.2" "Group enriched" "Detected in some" 13 "Early spermatids: 3.4;Late spermatids: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.3;HeLa: 1.5;K-562: 1.2;SCLC-21H: 2.4;SH-SY5Y: 3.2" "Low region specificity" "Detected in some" NA NA "unprognostic (9.71e-2)" "unprognostic (2.58e-1)" "unprognostic (4.59e-3)" "unprognostic (2.47e-2)" "unprognostic (6.83e-2)" "unprognostic (2.41e-1)" "unprognostic (3.54e-1)" "unprognostic (1.08e-1)" "unprognostic (6.35e-2)" "unprognostic (6.32e-5)" "unprognostic (4.51e-1)" 0.0 0.0 0.0 0.0 0.8 2.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.7 0.4 0.0 0.0 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 3.2 0.9 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 ZAR1L Z3CXXC7 ENSG00000189167 "Zygote arrest 1 like" A6NP61 13 32303700-32315344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.2;gallbladder: 2.7;testis: 3.5" "Cell type enhanced" "Detected in single" 27 "Spermatocytes: 2.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "cerebral cortex: 2.2;thalamus: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;MCF7: 2.2;U-698: 2.4" "Group enriched" "Detected in many" 5 "amygdala: 1.0;basal ganglia: 1.8;cerebral cortex: 2.8;hippocampal formation: 2.2" "Low region specificity" "Detected in many" HPA041319 Uncertain NA NA "HPA041319: AB_10794407" "unprognostic (4.03e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.26e-1)" "unprognostic (2.25e-1)" "unprognostic (8.33e-3)" "unprognostic (6.08e-2)" "unprognostic (1.47e-2)" "unprognostic (1.66e-1)" "unprognostic (8.34e-2)" "unprognostic (3.73e-1)" "unprognostic (7.51e-2)" 0.2 0.1 0.1 0.1 0.1 0.8 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 2.7 0.0 0.1 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.2 0.0 3.5 1.3 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.8 0.5 0.3 0.2 0.0 0.1 0.0 0.1 0.4 0.3 0.0 0.2 0.2 0.0 0.6 0.5 3.0 0.3 1.3 0.4 0.0 0.3 0.3 1.3 0.2 0.4 0.6 0.0 0.3 0.5 0.3 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.6 0.5 0.4 0.2 2.2 0.3 0.6 1.1 0.4 0.7 1.2 1.0 0.3 0.0 0.3 0.1 0.2 0.0 0.4 0.2 0.1 0.1 1.0 0.0 0.4 0.0 0.9 0.0 0.8 0.5 2.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.1 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.1 0.0 0.0 0.0 0.0 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167240287-167381346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3" "Group enriched" "Detected in some" 7 "Ciliated cells: 290.4;Early spermatids: 339.8;Late spermatids: 178.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.4;CAPAN-2: 1.7;SCLC-21H: 1.5;SuSa: 5.2;U-87 MG: 1.8" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.3 0.6 2.5 0.3 12.9 0.3 0.3 0.0 3.3 1.3 0.4 4.5 0.0 0.3 1.1 14.2 0.3 23.4 0.3 0.3 4.7 3.9 0.5 0.3 7.2 0.4 0.4 2.6 6.9 0.3 0.8 5.3 0.4 22.0 0.4 0.3 0.0 0.3 0.4 0.4 0.3 0.3 0.4 0.5 0.3 0.4 33.3 3.4 0.0 0.4 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.2 0.4 0.0 0.0 1.1 0.6 0.0 0.1 0.6 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 12.9 0.0 3.3 4.7 3.9 0.4 2.6 22.0 3.4 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 290.4 40.9 1.8 0.0 0.0 0.0 0.0 339.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 178.7 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 21.8 10.0 0.0 0.0 0.0 0.0 0.0 ZBED1 "ALTE, DREF, hDREF, KIAA0785, TRAMP" ENSG00000214717 "Zinc finger BED-type containing 1" O96006 X 2486414-2500967 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.3" "Low region specificity" "Detected in all" HPA077591 Approved Approved "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Nucleoplasm, Centrosome" "Nuclear membrane" "HPA077591: AB_2686847" "unprognostic (7.66e-3)" "unprognostic (3.79e-2)" "unprognostic (2.39e-2)" "unprognostic (4.92e-3)" "unprognostic (4.86e-2)" "unprognostic (1.50e-2)" "unprognostic (1.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.21e-1)" "unprognostic (1.22e-2)" "unprognostic (1.53e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (3.27e-1)" 8.5 10.5 24.8 6.0 30.7 3.1 63.7 24.8 29.0 36.8 8.1 1.7 1.7 10.6 28.9 2.8 6.1 6.4 7.1 43.4 27.3 7.2 39.6 13.6 5.9 6.0 25.1 19.6 28.7 10.4 6.8 27.8 37.5 32.5 6.8 6.4 1.7 7.7 6.3 29.5 9.5 11.2 5.1 30.4 7.9 6.6 3.4 27.1 1.7 5.4 1.7 4.8 5.8 31.4 12.7 13.7 13.0 12.4 5.4 11.5 10.2 5.2 13.1 9.6 10.5 6.1 6.5 43.3 7.4 8.2 4.4 5.1 16.7 4.6 10.4 8.6 9.9 12.1 2.5 9.1 7.7 3.3 12.2 12.2 7.7 11.2 14.2 8.0 4.7 16.2 9.6 6.1 4.6 3.5 6.6 10.4 7.1 9.8 3.4 8.5 3.7 7.9 3.8 23.5 3.4 7.8 6.4 9.4 4.9 7.4 10.2 11.4 11.2 6.3 17.1 11.8 11.2 4.7 10.2 14.2 9.5 5.0 5.2 8.1 4.2 0.0 17.2 3.8 6.8 5.3 1.8 11.6 9.7 11.5 12.4 10.3 9.4 6.8 6.5 13.7 12.7 6.6 5.4 13.0 5.4 9.3 10.1 6.6 10.2 24.8 30.7 24.8 29.0 27.3 7.2 25.1 19.6 32.5 27.1 11.9 9.4 11.5 14.3 13.5 56.5 22.9 48.4 14.7 7.9 24.4 13.7 13.2 10.0 21.0 0.2 17.9 19.8 0.0 20.2 15.4 16.9 18.3 14.9 33.1 15.5 9.5 14.9 13.5 11.8 0.8 18.4 17.7 8.5 19.0 19.5 19.9 20.8 17.3 21.5 15.8 22.4 6.5 14.4 0.0 3.2 9.8 31.8 12.5 21.9 11.5 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595443 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 21.0;thyroid gland: 74.5" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 41.7" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Region enriched" "Detected in single" 6 "basal ganglia: 1.4" "Cell type enhanced" "Detected in many" "naive B-cell: 4.0" "Group enriched" "Detected in many" 6 "B-cells: 4.0;T-cells: 2.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" No No "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.1 0.0 0.1 0.9 1.4 0.0 0.1 0.1 0.1 3.7 0.1 0.1 0.1 0.0 0.2 0.2 8.1 11.1 0.2 0.1 0.1 0.0 0.3 0.1 5.6 3.4 0.1 0.1 1.2 0.1 0.0 0.4 4.0 0.1 0.1 0.0 0.1 1.7 0.1 0.1 1.3 0.3 0.1 0.1 0.1 0.1 0.2 0.2 21.0 74.5 7.5 7.4 0.2 6.2 4.0 0.0 0.1 0.0 0.5 2.5 0.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.1 14.0 0.0 0.0 19.4 0.0 43.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 3.6 0.6 0.3 0.0 4.0 1.9 2.5 0.1 0.5 0.0 0.0 1.1 0.3 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 41.7 1.4 0.0 0.2 3.9 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.7 0.0 0.1 ZBED6CL C7orf29 ENSG00000188707 "ZBED6 C-terminal like" Q96FA7 7 150329789-150332721 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.4;parathyroid gland: 11.3" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 7.9;Exocrine glandular cells: 11.0;Pancreatic endocrine cells: 19.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 40.8;K-562: 17.5" "HPA019724, HPA055805" Approved Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane" Vesicles "HPA019724: AB_1845756, HPA055805: AB_2682929" "prognostic favorable (9.48e-5)" "unprognostic (6.77e-2)" "unprognostic (2.06e-2)" "unprognostic (7.41e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (3.35e-2)" "unprognostic (2.49e-3)" "unprognostic (2.78e-2)" "unprognostic (3.12e-2)" "unprognostic (3.44e-1)" "prognostic favorable (2.44e-5)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.86e-2)" "unprognostic (7.82e-2)" "unprognostic (8.52e-3)" "unprognostic (1.50e-3)" 0.4 37.4 0.4 2.6 0.4 1.7 0.8 0.3 0.2 1.1 1.4 1.6 2.0 0.2 1.2 1.9 0.4 0.4 0.3 0.6 1.8 5.6 1.5 3.9 0.3 3.1 3.2 11.3 2.5 0.0 1.5 1.5 1.1 0.9 0.1 2.2 2.1 0.6 0.1 2.3 1.7 0.3 1.8 3.7 1.3 0.8 3.6 1.0 2.8 1.0 2.8 3.5 2.4 4.5 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 6.3 4.7 2.6 2.3 0.0 0.0 1.8 0.0 0.0 0.3 40.8 3.3 3.1 6.7 10.7 1.3 0.0 4.8 0.9 2.4 0.0 0.0 0.1 0.2 9.1 17.5 6.8 0.0 2.0 7.7 1.9 3.0 1.8 0.0 0.0 0.3 5.7 2.1 9.0 8.6 5.0 6.9 1.9 0.3 1.4 0.6 2.1 0.1 0.0 0.0 0.0 0.0 5.5 1.5 0.0 0.0 0.0 0.0 0.0 1.0 1.0 2.7 0.7 3.2 2.2 2.4 3.4 0.7 3.6 3.5 2.9 2.8 2.8 0.2 1.0 2.2 2.4 0.0 1.0 0.0 0.3 0.2 1.0 0.6 5.1 0.0 2.3 1.8 7.9 1.3 5.0 2.1 0.0 0.0 0.9 0.0 11.0 0.7 0.6 0.3 1.1 2.6 0.5 0.0 4.6 0.0 1.6 0.0 2.6 0.0 0.0 3.6 2.0 1.4 19.3 0.0 1.1 0.7 0.5 0.0 0.2 0.5 0.9 0.1 1.6 0.0 2.3 0.5 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Group enriched" "Detected in many" 4 "Early spermatids: 17.9;Spermatocytes: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 7.8;hTCEpi: 7.1;K-562: 12.5;U-266/84: 6.0" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" NA NA Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.9 0.0 0.0 0.0 2.3 0.4 0.0 0.4 1.2 0.0 1.2 0.0 7.8 0.1 3.8 1.0 0.0 2.1 0.4 0.0 5.2 0.5 1.2 1.8 1.3 0.0 0.0 1.1 7.1 0.1 3.5 1.1 0.0 0.0 12.5 0.0 0.1 1.4 0.0 0.1 1.8 0.0 0.9 0.7 0.8 0.1 2.0 2.2 2.0 4.9 0.0 2.0 0.0 2.8 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 6.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 0.0 2.7 0.0 0.8 0.0 1.6 1.6 5.1 1.4 1.2 0.0 2.0 2.0 1.7 1.7 17.9 0.0 0.4 0.0 1.2 1.1 0.4 1.1 0.0 1.6 0.3 0.0 1.2 0.0 0.0 3.2 2.3 0.0 0.0 0.0 1.4 1.1 0.6 0.0 0.0 0.7 1.1 0.0 0.0 27.7 2.9 0.0 0.8 0.0 0.9 0.6 ZBP1 "C20orf183, DAI, dJ718J7.3, DLM-1, DLM1" ENSG00000124256 "Z-DNA binding protein 1" Q9H171 20 57603846-57620576 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Necrosis" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 23.2;lymphoid tissue: 29.6" "Group enriched" "Detected in some" 6 "B-cells: 20.4;Melanocytes: 13.5;T-cells: 27.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 25.0;U-266/70: 12.3;U-266/84: 15.8" "Low region specificity" "Detected in many" HPA041256 Enhanced NA NA "HPA041256: AB_2677380" "unprognostic (5.78e-3)" "unprognostic (9.86e-2)" "unprognostic (6.14e-2)" "unprognostic (6.20e-2)" "unprognostic (6.65e-2)" "unprognostic (1.05e-4)" "unprognostic (1.37e-2)" "unprognostic (1.31e-1)" "unprognostic (1.19e-3)" "unprognostic (1.38e-3)" "unprognostic (7.19e-2)" "unprognostic (2.58e-1)" "unprognostic (1.58e-8)" "unprognostic (8.29e-2)" "unprognostic (1.73e-1)" "unprognostic (4.65e-2)" "unprognostic (9.79e-2)" 3.3 0.8 0.8 20.8 0.9 12.6 1.5 0.7 1.1 1.6 4.6 1.4 0.9 6.1 1.3 2.6 5.1 1.4 4.7 1.0 1.1 1.0 2.6 1.9 5.2 12.1 1.2 1.0 1.2 0.8 0.0 1.1 1.5 1.8 1.6 5.3 2.0 12.0 1.5 1.1 1.7 7.5 0.3 2.5 24.5 3.6 0.9 1.0 3.1 2.1 2.7 29.6 7.0 1.4 10.1 2.6 23.2 2.2 11.4 12.0 3.8 0.5 0.4 1.5 2.6 0.4 0.4 0.8 0.4 0.5 0.2 0.7 2.2 1.6 6.7 0.5 0.0 0.9 1.1 0.0 0.8 0.0 0.6 1.4 2.3 3.5 1.0 0.4 2.7 1.6 0.0 0.3 0.8 0.7 1.3 0.3 1.1 0.9 25.0 1.0 3.3 1.0 3.4 1.6 0.4 3.0 1.1 0.1 7.0 0.0 3.4 1.4 1.5 0.2 1.2 1.0 1.0 0.9 1.0 1.8 3.2 1.1 2.2 1.1 12.3 15.8 2.9 1.2 2.0 0.7 0.9 2.2 9.8 12.0 2.2 8.0 10.1 8.1 7.0 2.6 6.9 3.7 5.2 23.2 11.4 1.3 0.1 10.5 3.8 0.8 0.9 0.7 1.1 1.1 1.0 1.2 1.0 1.8 1.0 0.0 1.1 20.4 1.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.0 0.4 0.9 3.5 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 1.3 13.5 0.0 0.6 0.6 0.7 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.0 27.3 0.6 0.9 ZBTB18 "C2H2-171, RP58, TAZ-1, ZNF238" ENSG00000179456 "Zinc finger and BTB domain containing 18" Q99592 1 244048939-244057476 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 114.4;skeletal muscle: 40.3" "Cell type enhanced" "Detected in many" 5 "Muller glia cells: 48.1" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 114.4" "Cell type enhanced" "Detected in many" "neutrophil: 5.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024656, HPA074019" Enhanced Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA024656: , HPA074019: " "unprognostic (3.48e-3)" "unprognostic (9.17e-3)" "unprognostic (3.69e-3)" "prognostic favorable (1.34e-4)" "unprognostic (6.83e-2)" "unprognostic (4.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.15e-2)" "unprognostic (1.15e-2)" "unprognostic (8.43e-2)" "unprognostic (1.01e-2)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.54e-3)" "prognostic favorable (6.78e-6)" 4.1 3.4 20.1 7.3 14.7 13.4 4.7 114.4 26.0 4.1 4.7 5.4 8.1 6.9 3.5 10.3 3.0 4.6 3.8 7.4 24.8 6.3 6.4 10.0 5.1 8.8 7.1 19.1 4.0 13.0 3.1 2.7 4.9 11.7 5.5 5.8 4.6 5.2 6.7 40.3 4.1 6.2 5.9 7.5 10.0 5.8 11.4 4.6 16.4 4.4 2.8 8.1 6.5 9.3 2.4 2.2 5.8 1.5 0.3 1.4 0.2 11.7 4.2 16.2 0.6 2.1 2.2 11.3 6.6 4.9 10.7 6.5 3.2 9.5 8.9 0.6 12.7 3.4 1.2 10.3 3.3 13.4 3.1 9.1 1.5 1.4 1.5 3.3 1.8 4.7 1.8 2.8 6.4 4.0 12.9 11.5 9.9 1.1 3.8 12.6 0.1 15.3 7.5 8.3 3.6 1.9 4.5 11.0 2.5 6.7 4.1 23.9 23.3 2.7 0.1 7.3 7.1 0.2 13.6 17.1 5.5 6.7 3.4 13.9 1.6 0.2 3.5 5.5 5.8 11.1 0.2 0.7 2.9 0.3 0.7 0.4 1.6 0.7 0.5 0.9 2.4 1.4 0.9 5.8 0.3 1.5 2.2 0.5 0.2 20.1 14.7 114.4 24.1 24.8 6.3 7.1 19.1 11.7 4.6 8.9 21.0 6.4 3.0 10.0 5.1 19.9 12.7 10.7 11.4 17.4 11.8 1.2 0.0 4.0 2.6 13.2 6.2 0.0 4.5 1.7 2.8 5.0 5.8 37.6 5.2 6.4 18.6 13.5 24.1 2.2 2.0 13.3 3.3 2.8 18.3 48.1 7.3 7.0 4.6 10.1 24.2 12.9 8.1 10.0 6.6 17.2 0.8 3.2 12.8 3.1 ZBTB20 "DKFZp566F123, DPZF, ODA-8S, ZNF288" ENSG00000181722 "Zinc finger and BTB domain containing 20" Q9HC78 3 114314501-115147271 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.6" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 279.2;Early spermatids: 317.2" "Cancer enhanced" "Detected in some" "stomach cancer: 1.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015551, HPA016815" Approved Enhanced "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA015551: AB_2669217, HPA016815: AB_1858947" "unprognostic (1.79e-1)" "unprognostic (1.50e-2)" "unprognostic (5.51e-2)" "unprognostic (2.33e-3)" "unprognostic (5.72e-3)" "unprognostic (3.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-3)" "unprognostic (6.94e-2)" "unprognostic (1.41e-1)" "unprognostic (7.83e-3)" "unprognostic (1.81e-1)" 10.7 7.3 6.3 2.9 12.3 4.0 6.2 17.3 9.3 7.2 4.2 10.8 5.3 1.7 6.6 17.4 3.5 4.9 4.3 6.1 9.7 5.2 9.8 9.8 4.4 3.3 14.9 3.7 12.7 5.9 5.3 26.1 2.2 11.5 10.0 2.7 7.9 5.4 9.2 12.1 4.4 4.0 7.5 19.2 4.4 3.9 44.6 14.2 2.1 9.1 8.1 3.3 5.2 5.0 18.2 4.3 7.8 3.6 4.1 7.7 2.7 2.3 4.4 1.7 4.2 6.3 2.8 0.0 1.8 3.9 1.1 0.9 2.5 0.8 0.6 6.1 4.6 1.5 0.1 6.1 1.0 1.1 0.5 0.1 0.6 2.1 1.9 1.5 0.3 0.0 2.7 0.3 2.5 0.8 3.9 1.3 0.5 0.1 1.0 6.4 0.0 0.3 0.2 0.4 0.0 0.2 0.2 5.1 0.0 4.3 0.0 0.4 1.0 0.8 0.0 1.3 0.2 0.0 0.5 7.2 1.6 5.5 0.3 2.7 1.6 0.0 0.3 2.6 0.4 2.0 7.8 1.4 5.1 6.1 2.0 4.2 18.2 6.0 5.6 1.6 10.7 7.7 6.6 3.1 4.1 3.6 4.3 2.8 2.7 6.3 12.3 17.3 9.3 9.7 5.2 14.9 3.7 11.5 14.2 148.9 92.8 51.6 33.4 22.9 70.0 42.8 101.9 45.5 35.2 279.2 56.9 0.2 41.4 165.4 317.2 68.7 13.9 0.0 71.6 0.5 90.0 35.5 79.6 95.2 3.8 76.3 30.5 49.7 16.5 71.3 97.8 22.0 30.4 34.3 15.3 183.7 101.7 11.4 113.5 147.9 113.2 84.1 55.2 6.6 4.3 16.2 0.5 36.3 16.6 21.7 ZBTB32 "FAXF, FAZF, Rog, TZFP, ZNF538" ENSG00000011590 "Zinc finger and BTB domain containing 32" Q9Y2Y4 19 35704527-35717038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 81.0" "Group enriched" "Detected in some" 13 "B-cells: 19.1;Early spermatids: 28.4;granulocytes: 17.3;Late spermatids: 55.0;Spermatocytes: 58.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 12.6" "Lineage enriched" "Detected in many" 5 "B-cells: 12.6" "Cell line enhanced" "Detected in some" "HDLM-2: 9.0;hTEC/SVTERT24-B: 4.4;U-266/70: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA076730 Enhanced NA NA "HPA076730: AB_2732320" "unprognostic (2.11e-3)" "unprognostic (1.08e-4)" "unprognostic (3.87e-2)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.04e-5)" "unprognostic (2.59e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (1.63e-3)" "unprognostic (1.01e-2)" "unprognostic (3.78e-1)" "unprognostic (1.02e-8)" "unprognostic (2.44e-3)" "unprognostic (2.25e-1)" "unprognostic (6.26e-5)" "unprognostic (1.94e-3)" 0.1 0.1 0.0 2.3 0.0 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.4 0.1 0.0 0.0 0.1 0.1 0.5 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.7 0.0 0.0 0.0 1.2 0.2 0.0 2.0 0.4 81.0 0.0 0.1 0.1 0.0 3.6 0.5 0.1 12.6 0.0 0.0 0.1 0.0 2.5 0.6 1.5 1.4 0.3 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.0 0.3 0.0 1.7 0.0 0.0 0.0 1.6 0.0 0.0 4.4 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.4 0.1 0.2 0.0 0.0 0.7 1.5 0.0 0.0 0.0 0.1 0.3 0.3 0.9 0.9 0.0 0.3 0.6 0.0 0.0 0.9 0.3 0.8 0.1 2.6 2.1 0.6 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.0 12.6 0.7 0.7 0.0 3.4 0.2 0.3 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.2 19.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 55.0 1.1 0.0 1.7 2.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 58.1 0.7 0.0 0.0 1.9 0.0 0.0 ZBTB42 ZNF925 ENSG00000179627 "Zinc finger and BTB domain containing 42" B2RXF5 14 104800596-104804712 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.8" "Cell type enhanced" "Detected in many" 4 "Club cells: 11.4;Exocrine glandular cells: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 8.4" "Lineage enriched" "Detected in single" 8 "granulocytes: 8.4" "Cell line enhanced" "Detected in many" "HDLM-2: 13.5;MCF7: 22.8;T-47d: 18.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA066961 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA066961: AB_2685756" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (8.68e-2)" "unprognostic (1.59e-1)" "unprognostic (6.99e-2)" "unprognostic (6.67e-2)" "unprognostic (6.17e-3)" "unprognostic (2.56e-1)" "unprognostic (4.35e-1)" "unprognostic (2.70e-2)" "unprognostic (1.63e-1)" "unprognostic (3.42e-1)" "prognostic favorable (2.30e-9)" "unprognostic (1.34e-1)" "unprognostic (2.75e-1)" "unprognostic (1.58e-3)" "unprognostic (5.45e-2)" 4.8 4.1 1.1 2.4 1.3 0.1 3.8 0.7 1.2 4.5 4.7 0.9 7.7 3.9 2.6 6.2 5.4 5.6 10.1 4.1 0.8 0.6 4.8 9.9 9.0 4.6 1.2 0.6 5.1 25.8 2.0 1.7 2.4 1.7 7.5 2.1 3.2 10.6 7.3 6.9 2.8 5.2 1.5 1.3 2.9 6.6 2.4 0.3 3.7 6.7 4.5 4.8 3.1 2.3 0.8 0.7 8.4 0.3 0.2 0.9 0.3 0.9 3.0 0.9 3.7 0.7 0.8 3.9 1.3 1.4 2.4 2.2 1.9 3.6 0.3 2.7 1.3 1.6 4.1 0.8 1.3 0.4 13.5 0.9 1.2 1.6 2.2 1.2 0.3 7.4 1.5 1.5 0.9 0.5 1.7 1.0 2.7 2.0 2.0 0.4 22.8 2.4 1.9 0.6 6.1 2.9 3.5 0.2 1.8 1.8 5.9 4.2 1.8 1.0 5.6 2.4 0.9 18.9 1.4 1.7 0.9 2.2 0.2 0.4 2.3 1.2 0.2 3.1 1.3 2.0 0.0 0.3 8.4 0.5 0.1 0.9 0.8 0.7 0.1 0.1 0.6 0.5 0.8 0.1 0.2 0.1 0.7 0.6 0.3 1.1 1.3 0.7 1.2 0.8 0.6 1.2 0.6 1.7 0.3 3.0 9.4 0.0 4.0 0.3 0.4 3.8 10.2 1.4 11.4 0.0 0.0 0.9 3.3 3.6 1.9 1.6 3.1 0.0 11.3 1.4 0.6 5.6 0.0 6.4 0.9 0.0 5.2 1.8 3.7 0.0 0.6 1.0 1.7 0.0 7.3 2.6 7.2 2.9 0.4 3.5 0.3 0.0 1.4 0.6 3.6 0.1 0.7 0.0 3.3 4.0 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 51.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favorable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 6.6 6.2 7.8 4.9 12.1 51.7 6.6 10.6 13.6 5.8 5.6 9.5 3.0 5.6 6.6 5.2 10.3 5.3 5.9 9.5 7.9 5.7 5.1 9.0 9.3 6.0 8.6 7.1 7.1 5.9 9.6 9.3 8.2 8.1 5.1 6.6 7.5 7.4 4.4 34.7 14.6 6.7 6.0 8.5 5.7 7.4 15.7 9.3 5.3 6.2 7.1 10.1 5.5 7.0 6.1 5.2 10.6 6.3 9.0 10.7 4.3 4.6 3.6 6.5 6.0 5.6 7.9 6.8 6.6 6.1 4.9 4.4 8.7 3.2 6.5 3.1 6.2 9.9 13.5 5.8 6.1 6.1 6.1 3.8 4.5 10.6 3.7 7.5 6.2 8.5 9.6 15.5 7.9 19.9 4.7 3.7 5.4 7.7 15.1 7.2 5.0 5.4 4.0 5.9 5.0 6.2 4.7 21.1 5.2 5.4 5.4 5.8 5.4 6.7 6.4 5.8 6.2 5.9 4.0 3.5 5.9 5.7 6.6 5.3 16.2 11.5 2.5 7.4 5.3 4.8 10.6 6.3 5.3 10.7 6.3 10.2 6.1 5.8 6.2 5.2 5.1 6.4 7.3 3.5 9.0 4.8 2.8 8.2 4.3 7.8 12.1 10.6 13.6 7.9 5.7 8.6 7.1 8.1 9.3 32.8 40.1 29.9 62.2 75.4 37.7 33.5 22.9 20.1 46.6 26.2 102.1 15.5 1.7 27.3 73.1 17.3 40.0 0.0 16.1 10.4 25.7 47.1 30.1 22.9 13.6 25.4 10.9 17.2 14.6 30.4 16.4 26.4 23.6 11.8 16.6 33.0 31.3 14.2 13.4 5.8 56.4 12.9 25.9 42.1 61.8 102.6 43.5 20.1 18.1 123.4 ZBTB47 "DKFZp434N0615, KIAA1190, ZNF651" ENSG00000114853 "Zinc finger and BTB domain containing 47" Q9UFB7 3 42653684-42665854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.1;skeletal muscle: 33.1" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 7.9;Early spermatids: 9.9;Melanocytes: 8.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 33.9;fHDF/TERT166: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074057 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA074057: AB_2686657" "unprognostic (1.03e-1)" "unprognostic (1.15e-2)" "unprognostic (8.23e-2)" "unprognostic (3.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" "unprognostic (2.74e-1)" "unprognostic (2.00e-2)" "unprognostic (4.86e-2)" "unprognostic (8.99e-2)" "prognostic favorable (7.96e-5)" "unprognostic (5.77e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (7.10e-2)" 5.8 3.3 11.4 3.1 18.0 0.5 2.8 3.3 11.3 4.8 4.4 15.7 0.7 1.1 5.4 1.5 4.4 3.1 4.4 28.1 16.1 4.7 1.2 2.0 2.6 2.1 8.6 9.1 5.0 4.5 2.7 3.0 2.1 6.3 4.8 1.0 2.9 7.6 6.2 33.1 2.8 1.4 5.8 12.8 1.7 3.0 3.1 16.7 0.7 5.2 4.2 1.6 3.7 3.3 0.0 0.9 2.8 1.6 0.3 0.3 0.4 3.6 3.3 2.0 1.3 33.9 13.2 0.7 8.8 7.6 3.9 2.8 0.7 1.5 0.0 3.6 18.0 1.4 0.9 0.5 3.4 0.8 0.0 4.4 2.2 9.5 0.8 10.4 0.0 3.0 14.1 6.2 4.9 4.3 10.0 4.2 0.0 2.0 2.6 7.7 0.9 0.1 0.3 1.1 0.1 2.2 2.7 3.9 1.0 2.1 0.8 2.3 3.8 4.1 0.7 3.3 0.9 4.6 4.8 9.5 8.1 4.7 7.8 3.5 0.1 0.0 0.0 7.4 2.6 2.4 0.0 1.6 0.1 0.3 1.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 2.8 0.3 0.9 0.0 0.0 0.4 11.4 18.0 3.3 9.3 16.1 4.7 8.6 9.1 6.3 16.7 0.0 0.6 0.0 1.2 3.5 4.8 7.9 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.6 9.9 1.5 0.0 0.0 1.1 0.1 3.0 1.1 4.6 0.5 1.2 0.0 0.0 1.8 1.8 1.4 3.1 1.3 8.5 1.0 0.0 6.6 0.7 0.2 2.8 0.6 1.7 0.0 5.6 0.0 0.2 2.8 0.1 0.0 0.0 1.0 ZBTB7B "c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B" ENSG00000160685 "Zinc finger and BTB domain containing 7B" O15156 1 155002630-155018522 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.0" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 141.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006811, HPA025820" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA006811: AB_1859046, HPA025820: AB_1859045" "unprognostic (5.13e-2)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (4.36e-2)" "unprognostic (2.43e-1)" "unprognostic (4.95e-3)" "unprognostic (9.55e-2)" "unprognostic (1.41e-1)" "unprognostic (3.72e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-2)" "unprognostic (1.46e-2)" "unprognostic (5.35e-2)" "unprognostic (1.11e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" "unprognostic (1.53e-2)" 9.4 11.1 3.0 8.8 4.7 11.6 11.1 4.0 4.9 9.5 33.7 11.3 22.3 27.3 5.4 4.5 29.1 5.9 13.2 6.4 4.3 2.1 9.3 19.1 10.5 6.3 8.0 4.3 6.2 18.2 5.1 6.4 11.3 5.9 9.9 8.1 9.6 19.1 18.6 11.8 33.3 54.0 5.4 5.6 10.3 11.2 3.8 7.3 1.8 14.3 11.2 16.0 8.6 12.4 2.0 2.3 5.7 3.4 1.5 2.5 4.3 7.5 13.5 1.2 4.1 6.2 3.5 16.6 5.2 6.2 5.5 6.4 9.0 11.0 3.3 9.4 5.8 4.3 11.5 3.8 7.3 1.1 18.0 4.3 5.5 22.5 6.0 9.1 4.2 15.2 4.6 26.2 7.5 9.3 7.4 4.3 0.5 7.8 15.3 3.1 14.3 0.1 9.4 4.1 12.1 11.2 3.1 0.9 20.7 8.2 7.9 7.7 7.9 10.0 26.8 4.2 5.3 16.7 14.1 3.6 3.6 6.3 7.0 4.3 18.2 11.1 3.5 8.3 14.0 4.0 0.9 3.2 2.9 1.5 3.4 0.5 1.6 2.0 0.9 2.3 2.0 1.7 0.5 5.7 1.5 2.9 0.2 2.5 4.3 3.0 4.7 4.0 4.9 4.3 2.1 8.0 4.3 5.9 7.3 8.9 0.0 4.7 8.4 31.3 14.0 1.4 20.4 0.0 1.2 5.2 2.0 9.2 10.0 11.9 2.2 4.1 141.0 0.0 13.0 12.8 5.6 21.8 5.7 23.7 12.7 15.9 6.4 4.9 30.8 5.6 8.3 16.2 15.1 6.4 27.3 5.1 14.5 48.0 6.7 8.9 9.8 0.0 6.3 0.4 1.2 46.9 23.0 7.4 33.0 16.9 ZBTB7C "ZBTB36, ZNF857C" ENSG00000184828 "Zinc finger and BTB domain containing 7C" A1YPR0 18 48026673-48410752 "Predicted intracellular proteins, Transcription factors" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 19.7;Mucus-secreting cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "RT4: 30.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.83e-3)" "unprognostic (6.60e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.58e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" "unprognostic (2.71e-1)" "unprognostic (5.52e-3)" "unprognostic (3.85e-3)" "unprognostic (2.89e-2)" 3.3 6.8 1.7 4.9 1.8 0.1 4.5 0.8 4.9 10.4 10.2 1.9 7.3 1.2 3.0 13.5 38.6 10.3 18.2 3.0 1.8 2.7 1.6 1.3 5.8 0.2 2.9 2.1 10.8 1.1 6.1 2.8 3.5 3.8 3.6 9.6 5.9 12.8 5.7 1.6 19.2 2.7 3.0 4.9 8.7 9.9 6.5 1.5 0.0 15.7 22.9 20.8 6.7 14.9 1.5 1.1 3.2 2.2 0.7 1.3 0.2 0.0 0.0 1.0 0.8 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.0 1.2 2.0 0.1 0.3 0.1 0.2 0.9 0.1 2.4 0.0 0.0 0.1 0.4 0.1 0.5 0.1 0.3 0.0 0.0 0.9 0.1 0.0 0.4 0.5 1.3 0.3 0.4 6.1 0.1 0.1 0.0 6.8 1.0 30.5 4.1 5.0 0.4 0.2 0.0 1.2 0.7 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.3 0.1 2.0 0.1 0.2 3.2 0.8 0.7 1.3 0.9 0.6 0.3 0.6 1.1 0.0 1.5 0.5 0.9 1.1 0.7 2.2 1.1 0.3 0.2 1.7 1.8 0.8 4.9 1.8 2.7 2.9 2.1 3.8 1.5 6.0 1.0 0.0 4.9 5.5 0.6 2.4 15.3 8.1 5.7 1.8 0.0 10.8 0.0 0.7 8.7 2.7 19.7 0.0 3.6 0.4 1.9 5.0 0.0 0.6 1.3 1.6 4.6 0.0 1.3 2.6 3.4 0.0 3.3 0.0 27.8 0.3 0.9 7.0 11.3 0.0 2.3 12.9 11.4 0.7 0.4 7.8 10.5 0.0 17.2 9.7 ZBTB8B "DKFZp547H154, RP1-27O5.1, ZNF916B" ENSG00000273274 "Zinc finger and BTB domain containing 8B" Q8NAP8 1 32465069-32496686 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 10.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 5.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RT4: 3.6;SCLC-21H: 3.6" HPA055553 Enhanced NA NA "HPA055553: AB_2682848" "unprognostic (8.32e-4)" "unprognostic (1.23e-1)" "unprognostic (3.83e-1)" "unprognostic (3.83e-5)" "unprognostic (1.86e-2)" "unprognostic (5.65e-2)" "unprognostic (1.67e-4)" "unprognostic (1.57e-2)" "unprognostic (5.94e-2)" "unprognostic (3.43e-3)" "unprognostic (9.08e-3)" "unprognostic (1.35e-1)" "unprognostic (2.93e-2)" "unprognostic (3.44e-2)" "unprognostic (6.11e-2)" "unprognostic (3.26e-3)" "unprognostic (5.88e-3)" 0.4 1.3 5.1 0.6 2.8 2.5 0.6 2.2 5.0 0.4 0.3 1.3 0.7 0.5 1.2 1.3 0.7 0.7 0.6 0.4 3.3 4.7 0.6 0.6 0.5 0.9 2.6 2.7 1.0 0.8 1.0 10.8 0.7 4.1 0.8 0.4 0.2 1.7 0.5 3.4 1.7 0.5 0.5 1.6 0.8 0.5 3.1 1.6 0.0 0.8 0.0 0.6 1.0 0.4 1.4 1.2 3.2 0.8 1.3 0.7 0.2 0.2 0.1 2.0 1.5 0.2 0.5 0.6 0.2 0.1 0.7 0.6 0.2 0.5 0.4 0.7 0.1 1.1 0.7 2.3 0.2 0.5 0.7 2.4 0.3 0.7 0.4 0.0 0.3 0.4 0.2 0.2 0.5 0.0 0.4 0.2 0.2 0.2 0.9 0.1 0.3 0.3 0.6 2.1 0.1 0.9 0.3 0.2 0.3 0.4 3.6 3.6 2.1 1.3 0.5 0.2 2.9 0.4 0.3 0.9 0.5 0.4 0.6 0.3 0.7 0.7 0.4 0.5 0.4 0.4 3.2 0.8 1.0 0.6 0.5 0.6 0.8 0.6 0.5 0.3 1.4 0.7 0.7 2.9 1.3 0.7 1.2 0.5 0.2 5.1 2.8 2.2 5.0 3.3 4.7 2.6 2.7 4.1 1.6 0.0 2.6 0.0 0.8 1.4 2.9 0.6 0.0 2.7 1.2 0.0 5.9 1.5 0.0 0.0 1.5 0.7 0.0 0.0 0.0 1.0 0.8 0.7 3.5 0.2 0.3 3.2 0.0 1.3 0.3 1.0 0.6 1.5 1.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.7 0.0 0.3 1.9 1.2 0.5 0.2 1.0 0.0 0.7 ZC2HC1B "C6orf94, dJ468K18.5, FAM164B" ENSG00000118491 "Zinc finger C2HC-type containing 1B" Q5TFG8 6 143864436-143938356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 36 "testis: 29.1" "Cell type enhanced" "Detected in some" 30 "Early spermatids: 8.8;Late spermatids: 3.6;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 3.3;U-266/70: 1.1;U-266/84: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.4 1.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 ZC2HC1C "C14orf140, FAM164C" ENSG00000119703 "Zinc finger C2HC-type containing 1C" Q53FD0 14 75064170-75079987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 75.7" "Group enriched" "Detected in many" 8 "Ciliated cells: 48.2;Early spermatids: 103.8;Late spermatids: 150.0;Spermatocytes: 54.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA050928, HPA065062" Enhanced Approved "Nuclear speckles,Mitochondria" No No "Nuclear speckles" Mitochondria "HPA050928: AB_2681277, HPA065062: AB_2732728" "unprognostic (8.01e-2)" "unprognostic (2.01e-2)" "unprognostic (9.61e-2)" "unprognostic (8.01e-2)" "unprognostic (1.97e-3)" "unprognostic (6.00e-2)" "unprognostic (8.94e-2)" "unprognostic (1.20e-2)" "unprognostic (3.71e-3)" "unprognostic (3.22e-2)" "unprognostic (1.09e-3)" "unprognostic (2.26e-1)" "prognostic favorable (4.63e-13)" "unprognostic (4.69e-3)" "unprognostic (7.37e-2)" "unprognostic (3.12e-1)" "unprognostic (1.81e-1)" 0.7 2.1 2.3 0.5 5.3 0.2 1.3 1.8 3.4 1.5 2.0 2.3 4.6 2.5 1.0 18.2 1.3 8.2 1.5 2.9 3.0 3.0 4.3 6.8 2.2 0.1 2.3 2.3 0.8 3.6 5.2 10.9 3.3 4.7 1.0 1.8 1.2 2.3 5.7 3.0 1.1 1.9 1.0 1.9 0.6 1.2 75.7 2.3 0.6 5.9 0.5 0.4 1.2 0.4 1.6 0.6 0.8 0.3 3.8 3.8 0.8 6.0 4.7 1.0 5.3 0.3 0.3 2.8 0.5 2.1 2.7 1.2 7.7 11.1 5.6 4.3 0.5 3.7 2.4 0.0 0.1 1.9 5.9 0.6 1.4 1.6 2.7 3.7 0.1 3.7 1.1 0.6 3.4 0.1 3.1 1.6 0.4 8.0 2.5 1.3 1.3 0.6 0.7 1.7 3.5 3.3 0.1 0.3 2.7 6.0 0.4 9.7 2.3 3.5 3.1 2.8 1.0 4.4 1.8 0.8 1.7 1.9 2.9 1.1 5.6 8.3 2.9 2.4 1.0 0.9 0.8 0.3 0.8 1.9 0.0 0.5 1.6 1.6 0.5 0.3 0.8 0.7 0.8 0.4 3.8 0.2 0.6 3.8 0.8 2.3 5.3 1.8 3.4 3.0 3.0 2.3 2.3 4.7 2.3 6.0 8.9 0.9 1.5 1.5 4.4 5.6 5.1 48.2 10.3 10.4 9.8 1.9 3.3 3.2 103.8 1.7 2.6 0.0 1.2 1.0 1.3 2.0 1.1 3.9 1.4 11.1 5.1 1.8 1.0 150.0 2.8 0.9 3.3 1.0 3.1 3.1 1.5 0.0 2.5 5.7 8.4 6.5 0.5 54.1 5.3 0.6 4.2 0.0 3.3 0.8 ZC3H11B ZC3HDC11B ENSG00000215817 "Zinc finger CCCH-type containing 11B" 1 219608347-219613145 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 8.9" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.4;Collecting duct cells: 1.8;monocytes: 1.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "HPA026439, HPA028490, HPA028526" Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533" "unprognostic (1.75e-1)" "unprognostic (5.54e-2)" "unprognostic (2.21e-1)" "unprognostic (2.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.92e-1)" "unprognostic (5.07e-1)" "unprognostic (1.15e-1)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.30e-1)" "unprognostic (8.19e-2)" "unprognostic (2.28e-2)" "unprognostic (7.87e-2)" "unprognostic (9.15e-2)" "unprognostic (2.56e-2)" "unprognostic (1.87e-2)" 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.8 0.1 0.0 0.1 0.0 8.9 0.0 0.0 0.0 0.5 0.7 2.1 0.9 0.6 0.9 0.6 1.0 0.8 2.2 1.3 0.4 0.3 1.9 1.9 0.3 0.3 0.4 0.9 0.9 0.7 0.5 0.3 1.0 1.5 0.2 0.2 0.3 3.1 0.8 0.5 1.1 0.8 0.1 0.8 1.8 0.2 0.1 0.4 0.5 0.8 0.0 1.9 2.2 2.3 0.2 0.4 1.6 1.1 1.2 0.2 0.6 0.7 1.5 0.7 0.2 0.9 0.9 1.4 1.1 1.7 1.3 1.0 1.4 3.2 1.1 1.0 1.3 1.0 2.0 1.4 1.2 1.1 2.3 1.4 2.0 1.0 0.9 0.7 0.7 0.4 0.8 0.5 0.6 0.7 0.7 0.5 0.7 0.6 2.1 0.6 0.3 0.3 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZC3H12A "FLJ23231, MCPIP1" ENSG00000163874 "Zinc finger CCCH-type containing 12A" Q5D1E8 1 37474552-37484379 "Disease related genes, Predicted intracellular proteins" "Angiogenesis, Antiviral defense, Apoptosis, Differentiation, DNA damage, Host-virus interaction, Immunity, Inflammatory response, Neurogenesis, Stress response, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.7;tongue: 56.9" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 174.0;Suprabasal keratinocytes: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.3;RT4: 30.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA032052, HPA032053" Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" No No "Cytoplasmic bodies" Nucleoplasm "HPA032052: AB_10603241, HPA032053: AB_2674128" "unprognostic (2.35e-2)" "unprognostic (6.09e-3)" "unprognostic (1.51e-2)" "prognostic favorable (9.67e-4)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (9.03e-2)" "unprognostic (4.66e-3)" "unprognostic (1.05e-1)" "unprognostic (9.69e-3)" "unprognostic (9.01e-2)" "unprognostic (1.82e-2)" "prognostic unfavorable (5.95e-5)" "unprognostic (5.17e-2)" "unprognostic (4.69e-2)" "unprognostic (1.68e-1)" "unprognostic (3.77e-2)" 11.7 8.4 0.8 15.0 2.9 58.7 8.2 1.3 1.3 6.4 13.3 2.9 5.6 7.0 5.0 6.9 25.2 8.1 22.6 6.3 2.1 0.7 6.7 10.7 21.0 11.3 1.8 0.7 7.1 6.8 1.0 4.6 8.1 3.8 16.1 4.2 3.0 10.9 6.3 11.8 23.1 14.1 8.5 2.6 10.9 11.0 3.4 1.1 8.3 4.0 56.9 34.8 17.0 22.2 6.1 2.6 8.9 2.1 5.5 5.5 2.3 3.7 2.7 0.3 1.7 1.4 2.0 3.1 2.7 24.3 1.7 2.3 3.0 8.5 4.2 11.6 2.6 19.2 8.2 1.1 17.5 1.0 8.5 1.6 1.1 8.9 4.7 2.0 2.2 1.8 4.4 9.0 15.2 2.7 4.0 1.9 2.2 2.1 7.0 1.6 4.5 1.7 3.9 2.1 5.0 2.4 2.5 1.1 2.5 4.4 30.1 0.8 0.5 5.4 8.6 0.6 2.8 3.0 2.5 2.0 5.2 2.9 3.8 4.1 5.6 2.0 3.1 11.9 4.6 1.0 1.8 2.1 5.8 5.4 2.1 5.5 5.2 2.2 3.3 2.6 6.1 1.3 2.5 8.9 5.5 1.9 2.5 2.8 2.3 0.8 2.9 1.3 1.3 2.1 0.7 1.8 0.7 3.8 1.1 14.9 39.3 19.1 112.5 174.0 0.0 3.9 38.2 8.1 21.6 10.4 0.0 3.1 0.0 64.4 17.4 11.7 60.6 0.0 65.3 7.5 22.6 104.0 42.6 11.6 9.3 0.0 61.3 1.8 10.8 2.4 0.9 50.4 45.5 20.8 50.6 0.8 44.4 38.4 1.1 0.3 4.3 6.5 45.7 1.4 0.9 196.9 9.8 17.3 33.3 73.7 ZC3H12B "CXorf32, MCPIP2" ENSG00000102053 "Zinc finger CCCH-type containing 12B" Q5HYM0 X 65366638-65507887 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 6.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 6.0;Bipolar cells: 3.8;Intestinal endocrine cells: 4.1;Peritubular cells: 3.9" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA000836 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Endoplasmic reticulum" "Golgi apparatus, Vesicles" "HPA000836: AB_2217374" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (1.38e-1)" "unprognostic (1.71e-2)" "unprognostic (1.64e-1)" "unprognostic (7.44e-3)" "unprognostic (7.86e-3)" "unprognostic (5.46e-2)" "unprognostic (3.32e-1)" "unprognostic (5.76e-2)" "unprognostic (1.12e-3)" "unprognostic (1.28e-1)" "unprognostic (2.61e-1)" "unprognostic (1.11e-2)" "unprognostic (5.08e-2)" "unprognostic (1.45e-2)" "unprognostic (1.71e-2)" 0.3 0.9 2.6 0.5 3.9 0.1 0.5 2.8 6.1 1.9 1.1 0.9 2.6 0.8 0.4 2.0 1.1 0.5 2.8 2.5 1.2 0.5 0.6 0.7 1.7 3.3 0.1 2.7 2.7 0.0 1.8 1.1 0.3 2.4 0.0 0.3 0.9 1.8 1.5 0.4 1.3 0.0 1.5 0.2 1.0 0.7 1.3 0.8 0.7 0.4 0.8 1.8 0.2 0.3 0.4 5.1 0.7 0.0 0.0 0.6 1.2 2.7 0.0 0.8 0.7 0.5 0.8 0.3 1.4 0.0 0.8 1.3 0.0 0.1 0.7 3.7 1.7 2.3 0.7 0.1 1.5 0.4 0.2 0.0 0.1 0.0 1.1 0.0 4.1 0.9 4.1 0.1 0.0 2.1 0.6 2.1 2.8 1.0 2.4 0.2 1.0 0.1 0.2 0.2 2.4 0.0 0.1 0.2 3.0 0.1 1.2 0.0 0.1 1.0 1.7 0.5 0.9 1.0 1.7 3.2 2.2 0.0 0.6 0.4 0.1 0.6 0.2 0.5 0.9 0.8 0.8 0.2 1.3 1.8 0.8 0.7 0.8 0.2 0.8 0.4 0.2 6.0 0.3 1.5 0.2 0.0 3.8 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.2 0.1 0.4 0.0 0.2 0.1 0.4 0.3 0.0 0.4 0.1 1.6 4.1 0.6 0.0 0.0 2.3 0.0 0.0 0.0 1.3 0.8 0.2 0.0 3.9 0.3 1.4 0.0 1.4 0.0 0.0 0.4 0.0 0.0 0.9 0.1 ZC3H12D "C6orf95, dJ281H8.1, MCPIP4" ENSG00000178199 "Zinc finger CCCH-type containing 12D" A2A288 6 149446795-149485061 "Disease related genes, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 38.1" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 5.4;Kupffer cells: 10.8;T-cells: 5.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "HDLM-2: 27.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA036897 Uncertain Supported "Nucleoplasm,Cytoplasmic bodies" NA NA "Nucleoplasm, Cytoplasmic bodies" "HPA036897: AB_10672104" "unprognostic (2.89e-2)" "unprognostic (3.91e-4)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.47e-6)" "unprognostic (2.20e-2)" "unprognostic (2.50e-3)" "unprognostic (1.34e-1)" "unprognostic (3.30e-2)" "unprognostic (2.33e-2)" "unprognostic (1.86e-1)" "unprognostic (1.28e-4)" "unprognostic (1.21e-2)" "unprognostic (9.24e-3)" "unprognostic (6.99e-2)" "unprognostic (5.52e-2)" 3.3 0.8 0.5 33.4 1.0 3.4 1.2 0.7 0.6 0.8 3.0 0.1 1.0 3.0 0.6 1.2 0.8 0.8 0.9 0.6 0.5 0.7 1.3 0.8 2.0 10.6 0.5 0.0 0.4 0.7 0.0 0.6 0.8 0.5 0.7 1.5 0.9 2.0 0.2 0.4 1.1 7.7 0.4 0.7 9.5 0.7 0.7 0.4 4.8 0.9 1.6 38.1 1.7 0.6 3.2 1.7 1.3 2.7 0.7 7.2 1.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 6.4 0.1 0.0 0.2 0.2 0.0 0.0 0.1 27.0 0.2 0.2 0.8 2.2 0.0 2.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 2.0 0.0 0.0 0.0 5.6 0.0 0.7 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 3.6 0.0 0.2 0.1 0.1 0.1 0.1 0.2 2.3 0.3 2.1 0.1 1.3 1.8 0.4 0.3 1.0 0.5 3.1 3.2 1.5 1.7 3.2 2.0 0.5 1.3 0.7 2.7 1.0 7.2 1.5 0.5 1.0 0.7 0.6 0.5 0.7 0.5 0.0 0.5 0.4 3.0 3.8 3.2 0.5 0.3 0.6 1.1 2.5 0.0 1.2 0.0 3.9 0.0 1.7 0.0 0.3 1.1 5.4 0.0 0.3 0.0 0.6 0.3 0.0 0.0 3.2 0.0 0.0 2.5 10.8 0.2 0.0 3.6 1.7 0.0 1.5 0.8 0.2 0.0 0.0 1.4 0.6 0.0 0.3 0.1 0.4 1.3 0.0 5.7 2.1 0.3 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562909-88627596 "Disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.1" "Group enriched" "Detected in many" 5 "Early spermatids: 961.1;Late spermatids: 410.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Nuclear speckles" "Nucleoli, Nucleoli rim" "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 13.5 12.6 16.2 10.8 16.4 9.7 13.3 23.4 19.6 14.0 15.3 14.3 17.5 10.6 17.2 15.5 12.4 15.8 10.4 12.3 14.8 8.4 15.2 24.9 13.9 9.1 16.1 16.3 17.1 19.4 19.3 24.1 14.8 16.0 14.9 16.6 11.3 18.0 16.3 15.4 13.6 15.2 14.8 11.2 9.4 12.7 73.1 14.1 9.3 19.4 8.2 11.4 16.2 12.8 13.3 17.4 21.7 21.1 18.5 17.7 13.3 16.4 31.8 29.2 23.1 23.2 22.5 29.6 25.3 23.0 36.0 31.8 22.6 26.0 23.0 18.3 25.7 19.8 20.3 20.6 23.6 49.1 19.4 15.5 11.2 22.7 18.4 23.3 24.6 14.7 18.0 27.8 28.1 28.2 24.6 23.4 21.1 21.9 10.6 32.5 35.1 22.2 13.6 18.6 25.9 28.1 19.4 37.3 10.0 24.3 29.7 21.9 19.6 31.6 36.2 17.7 25.2 33.0 16.1 17.2 43.8 26.8 18.4 25.1 13.6 11.8 25.7 21.5 12.0 20.0 12.9 16.0 21.7 15.9 20.0 17.7 13.3 15.5 17.5 17.4 12.0 14.7 14.7 2.9 18.5 21.1 9.5 13.2 13.3 16.2 16.4 23.4 19.6 14.8 8.4 16.1 16.3 16.0 14.1 113.2 41.2 16.2 22.0 20.1 59.3 19.0 25.5 75.0 46.6 19.2 72.6 40.8 29.9 22.1 961.1 18.2 22.3 0.0 19.9 23.4 21.3 22.4 43.9 29.7 17.6 62.0 30.5 23.4 10.4 410.4 36.5 14.0 5.0 13.6 27.9 35.0 19.9 14.0 44.6 24.5 76.1 12.9 27.6 125.8 76.6 17.2 34.0 17.5 29.2 13.6 ZCCHC12 "FLJ16123, PNMA7A, SIZN, SIZN1" ENSG00000174460 "Zinc finger CCHC-type containing 12" Q6PEW1 X 118823790-118826968 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 51.3;endometrium 1: 53.4;fallopian tube: 60.7;smooth muscle: 72.5" "Cell type enhanced" "Detected in some" 13 "Intestinal endocrine cells: 1.2;Muller glia cells: 1.6" "Cancer enriched" "Detected in many" 76 "thyroid cancer: 256.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "naive CD8 T-cell: 4.1" "Lineage enriched" "Detected in single" 6 "T-cells: 4.1" "Cell line enhanced" "Detected in some" "HAP1: 5.5;HEK 293: 14.1;NTERA-2: 4.5;SH-SY5Y: 3.6;SuSa: 3.0" "HPA031016, HPA034940" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA031016: AB_2673698, HPA034940: AB_10671098" "unprognostic (1.29e-1)" "unprognostic (7.48e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.66e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (3.44e-1)" "unprognostic (8.36e-3)" "unprognostic (5.34e-4)" "unprognostic (9.18e-13)" "unprognostic (4.14e-3)" "unprognostic (1.63e-1)" "prognostic favorable (3.42e-5)" "unprognostic (1.18e-1)" 0.9 4.8 30.5 1.2 20.2 0.8 1.0 20.3 17.3 9.7 1.1 1.6 0.9 1.0 53.4 11.6 0.8 60.7 1.0 0.8 28.7 51.3 0.8 0.8 0.9 1.1 4.4 11.6 6.7 0.8 0.8 7.9 0.8 14.7 1.0 1.0 1.1 0.8 1.1 0.8 0.8 1.1 72.5 4.5 0.9 0.8 1.0 0.8 0.0 2.9 0.0 1.1 0.8 1.7 0.6 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.8 0.0 0.0 0.4 0.0 0.3 0.0 5.5 0.0 0.2 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.2 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 3.6 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.2 30.5 20.2 20.3 17.3 28.7 51.3 4.4 11.6 14.7 0.8 0.0 0.0 0.0 0.1 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.0 ZCCHC13 "4930513O09RIK, Cnbp2, ZNF9L" ENSG00000187969 "Zinc finger CCHC-type containing 13" Q8WW36 X 74304190-74305031 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 88 "testis: 27.3" "Group enriched" "Detected in some" 61 "Early spermatids: 206.5;Late spermatids: 380.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA003382 Enhanced NA NA "HPA003382: AB_10967182" "unprognostic (1.61e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 206.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 380.2 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 4.8 1.2 0.0 0.0 0.0 0.0 0.0 ZCCHC18 "PNMA7B, SIZN2" ENSG00000166707 "Zinc finger CCHC-type containing 18" P0CG32 X 104112131-104115846 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.6;ovary: 9.4" "Cell type enhanced" "Detected in some" 8 "Intestinal endocrine cells: 4.1;Muller glia cells: 3.2;Sertoli cells: 6.5;T-cells: 6.1" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 19 "B-cells: 3.0;T-cells: 2.2" "Cell line enhanced" "Detected in some" "Daudi: 4.6;Karpas-707: 8.6;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "HPA034940, HPA078516" Uncertain Approved Vesicles NA NA Vesicles "HPA034940: AB_10671098, HPA078516: " "unprognostic (7.20e-2)" "unprognostic (7.71e-4)" "unprognostic (8.29e-2)" "unprognostic (4.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-3)" "unprognostic (2.20e-2)" "unprognostic (3.22e-2)" "unprognostic (7.59e-2)" "unprognostic (3.34e-1)" "unprognostic (4.44e-6)" "unprognostic (4.05e-2)" "unprognostic (1.02e-6)" "unprognostic (3.82e-2)" "unprognostic (4.02e-1)" "unprognostic (3.91e-2)" "unprognostic (4.14e-3)" 0.9 2.3 3.4 3.3 9.4 1.1 2.6 9.6 9.2 1.7 0.9 1.2 0.5 1.1 3.6 1.1 1.0 1.6 1.4 1.2 3.1 7.7 0.5 0.3 1.0 4.9 3.8 4.9 9.4 2.6 0.3 2.3 0.7 4.7 1.5 1.1 1.2 0.5 1.8 1.0 0.5 2.6 1.9 2.5 3.4 1.4 2.2 2.2 0.0 0.4 0.2 5.1 2.0 1.1 3.0 0.0 0.0 0.0 0.1 2.2 0.3 0.0 0.2 3.5 2.5 0.3 0.0 0.2 0.7 0.1 0.6 0.6 0.1 0.0 4.6 0.1 0.2 0.8 0.0 2.1 0.0 0.3 1.3 1.7 0.8 0.2 0.0 0.4 2.6 0.8 0.2 0.0 0.4 0.0 2.1 0.7 0.3 0.0 8.6 0.2 0.0 0.0 0.1 2.0 0.0 0.6 3.1 0.9 0.0 0.5 0.3 2.5 5.8 0.2 0.0 0.0 0.4 0.0 0.3 1.6 0.2 1.1 0.2 1.0 0.2 0.0 2.2 0.1 2.5 0.7 0.0 0.0 0.0 1.4 0.0 2.2 2.5 1.1 1.7 0.0 3.0 1.2 1.6 0.0 0.1 0.0 0.0 0.8 0.3 3.4 9.4 9.6 7.2 3.1 7.7 3.8 4.9 4.7 2.2 0.0 1.1 0.0 0.1 0.1 0.6 0.6 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 1.6 4.1 0.0 0.3 0.0 1.4 0.0 1.7 0.0 0.0 3.2 0.0 0.0 1.1 0.1 0.8 6.5 2.1 0.0 0.2 0.0 0.0 6.1 0.0 0.0 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 114.5;Late spermatids: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 6.0 5.2 4.5 8.9 13.8 5.9 8.6 3.4 5.2 8.3 8.3 2.8 3.7 17.0 4.6 5.7 6.8 10.2 14.5 7.6 3.4 11.7 6.8 4.4 12.1 19.0 4.7 8.5 6.5 5.8 9.9 5.2 9.8 6.0 15.5 7.7 4.7 5.7 2.7 4.9 5.5 3.6 2.9 4.4 5.2 7.4 4.8 0.1 5.7 6.1 5.7 3.5 5.8 13.1 5.1 8.5 4.6 6.8 6.6 8.1 5.6 3.2 4.9 2.2 4.3 7.3 6.1 3.6 3.0 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 23.8 19.7 4.2 13.1 23.7 27.6 18.8 15.3 9.4 14.8 15.7 51.1 6.3 3.3 5.4 114.5 20.9 7.7 0.0 5.3 10.1 7.6 13.8 2.3 28.0 12.5 41.3 12.1 17.8 39.8 110.8 7.5 21.1 6.8 4.6 13.2 9.2 4.8 10.5 7.4 4.3 19.1 6.5 15.3 11.5 6.6 16.2 5.7 7.5 10.3 10.5 ZCCHC24 "C10orf56, FLJ90798, Z3CXXC8" ENSG00000165424 "Zinc finger CCHC-type containing 24" Q8N2G6 10 79382325-79445627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 40.7;Hepatocytes: 44.7;Ito cells: 57.1;Leydig cells: 63.6;Peritubular cells: 61.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 43.5;ASC TERT1: 37.4;BJ hTERT+: 28.5;HSkMC: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038348 Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA038348: AB_10669538" "unprognostic (3.47e-3)" "unprognostic (8.70e-3)" "unprognostic (3.35e-1)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (7.28e-2)" "unprognostic (2.17e-2)" "unprognostic (2.25e-2)" "unprognostic (2.62e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (4.77e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (5.35e-6)" "unprognostic (1.84e-2)" "unprognostic (5.52e-2)" "unprognostic (2.85e-2)" "unprognostic (2.95e-3)" 27.9 9.0 30.9 9.5 54.4 1.8 9.8 11.1 36.0 22.9 19.8 56.8 4.2 4.6 18.0 6.9 10.3 15.5 16.8 19.1 30.6 19.7 3.5 13.5 10.2 4.8 56.7 23.5 20.1 4.0 3.9 3.0 11.4 36.2 14.5 6.8 4.5 6.2 20.7 34.8 5.0 5.4 25.6 36.8 7.0 9.0 6.6 51.9 0.0 6.0 2.5 3.2 14.9 7.3 0.0 3.4 0.6 2.4 0.7 0.9 0.5 0.9 0.9 3.2 2.8 43.5 37.4 0.8 7.5 28.5 4.5 5.2 0.8 0.0 0.0 4.1 15.1 1.5 0.0 0.5 0.1 3.8 1.8 2.0 0.4 2.3 0.9 11.3 1.1 0.6 38.8 0.4 4.0 1.1 13.3 0.9 0.2 1.4 1.6 3.8 0.3 0.0 4.4 0.7 0.2 9.3 0.2 3.8 0.6 0.5 1.2 0.1 4.0 2.3 0.3 9.4 3.2 1.1 2.1 0.6 4.3 4.0 11.7 2.5 2.9 1.9 0.0 8.8 1.4 15.3 0.0 2.4 0.6 0.9 1.1 0.2 0.0 0.0 0.3 1.6 0.0 0.0 0.2 0.6 0.7 0.1 3.4 0.4 0.5 30.9 54.4 11.1 36.0 30.6 19.7 56.7 23.5 36.2 51.9 0.0 1.6 0.0 1.5 6.8 0.0 16.5 7.6 1.4 1.2 0.0 0.0 0.6 0.0 0.8 1.7 17.0 0.0 0.0 0.7 0.8 40.7 3.6 1.1 44.7 8.5 0.0 0.0 57.1 15.9 3.7 63.6 6.8 15.1 1.0 0.4 16.4 0.7 0.0 61.5 1.4 0.7 12.9 21.2 0.7 1.0 4.0 1.3 4.3 0.0 1.1 ZCWPW1 "DKFZp434N0510, FLJ10057, ZCW1" ENSG00000078487 "Zinc finger CW-type and PWWP domain containing 1" Q9H0M4 7 100400826-100428992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 42.2" "Group enriched" "Detected in many" 6 "Spermatocytes: 370.4;Spermatogonia: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 14.8;hTERT-HME1: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020911 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA020911: AB_1858990" "unprognostic (1.86e-2)" "prognostic favorable (1.99e-4)" "unprognostic (1.92e-3)" "unprognostic (6.74e-2)" "unprognostic (2.58e-2)" "unprognostic (8.46e-3)" "unprognostic (1.99e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.66e-1)" "unprognostic (1.73e-1)" "prognostic favorable (1.93e-4)" "unprognostic (2.43e-3)" "unprognostic (1.72e-2)" "unprognostic (2.84e-1)" "unprognostic (1.22e-1)" "unprognostic (1.19e-2)" "prognostic favorable (5.26e-4)" 3.5 2.7 3.8 2.5 8.2 2.4 4.1 3.5 4.8 2.5 3.0 7.9 2.5 1.1 3.7 4.3 2.3 4.7 2.7 3.5 3.8 3.1 3.3 5.3 2.6 3.3 8.9 3.1 5.9 2.3 4.9 2.3 1.7 5.7 3.0 1.8 2.1 1.9 3.7 3.3 4.0 2.5 3.3 6.6 3.5 2.2 42.2 6.8 1.8 4.8 1.5 3.3 3.7 3.2 11.4 3.2 13.5 7.4 2.7 4.5 1.8 5.5 2.5 1.2 2.1 7.2 5.8 0.8 2.8 3.3 2.4 3.1 0.9 1.8 14.8 11.4 2.1 5.5 1.5 1.3 0.9 3.8 1.1 1.1 4.5 0.6 0.7 2.3 1.8 2.8 3.2 6.0 1.9 13.8 1.1 0.2 3.0 3.2 4.5 2.2 5.1 1.5 4.1 0.5 2.8 0.7 3.4 1.0 0.9 2.0 1.2 4.2 1.8 7.2 2.0 4.4 1.2 3.0 3.0 0.3 6.3 2.5 5.4 1.0 1.6 1.9 6.7 2.4 5.0 5.4 3.2 1.4 13.5 2.1 2.9 3.3 11.4 2.6 2.8 1.6 11.4 4.5 3.1 5.0 2.7 7.4 3.2 1.5 1.8 3.8 8.2 3.5 4.8 3.8 3.1 8.9 3.1 5.7 6.8 0.0 9.0 5.1 8.8 7.1 11.2 4.8 0.0 28.1 11.4 5.2 2.0 1.0 10.0 4.7 24.3 5.3 3.0 0.0 3.1 0.5 6.9 5.5 20.7 9.6 3.1 4.8 2.4 4.3 7.3 43.2 15.3 5.5 1.7 2.8 2.3 11.3 4.0 2.9 7.4 7.2 4.9 45.3 3.4 370.4 163.3 4.0 1.1 7.0 3.5 6.0 ZDBF2 "FLJ45338, KIAA1571, Slx9" ENSG00000204186 "Zinc finger DBF-type containing 2" Q9HCK1 2 206274663-206314428 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 26.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SuSa: 13.4" "Low region specificity" "Detected in many" "HPA039121, HPA050311" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA039121: AB_2676357, HPA050311: AB_2681081" "unprognostic (8.32e-2)" "unprognostic (1.66e-1)" "unprognostic (2.75e-2)" "unprognostic (2.86e-2)" "unprognostic (3.27e-2)" "unprognostic (4.52e-2)" "unprognostic (2.01e-1)" "unprognostic (2.98e-1)" "unprognostic (7.73e-3)" "unprognostic (7.59e-2)" "unprognostic (4.41e-2)" "unprognostic (3.80e-2)" "unprognostic (2.01e-1)" "unprognostic (9.59e-2)" "unprognostic (3.08e-1)" "unprognostic (3.09e-1)" "unprognostic (1.40e-1)" 4.4 12.0 8.6 3.5 26.9 2.2 4.2 14.7 12.7 5.4 3.7 2.1 5.1 2.0 7.2 6.1 3.1 5.1 4.4 4.5 8.9 8.3 4.9 3.6 3.2 3.8 3.7 10.8 14.8 8.3 5.6 20.9 7.5 9.0 4.7 2.6 3.8 3.7 5.3 5.4 3.9 3.0 5.1 4.0 4.2 3.4 5.4 3.1 2.5 6.5 2.9 3.3 3.7 3.5 0.7 0.5 0.3 0.0 0.3 1.4 0.2 1.7 0.3 6.0 1.1 2.0 1.8 8.4 1.7 2.0 0.8 1.2 0.9 1.4 0.0 0.8 2.1 3.5 0.4 3.8 1.3 1.6 2.1 3.6 0.0 3.4 0.2 2.6 1.8 3.8 1.8 2.1 1.5 3.6 6.1 2.2 1.4 0.3 2.3 2.6 0.3 0.4 0.0 8.1 0.1 1.7 0.0 6.2 0.0 1.0 0.9 3.1 7.5 3.0 0.0 2.4 13.4 0.2 0.0 3.3 0.7 2.9 0.7 1.3 5.4 1.3 0.3 4.2 0.0 2.0 0.3 0.0 0.0 0.3 0.0 0.9 0.5 1.0 0.6 0.0 0.7 1.1 0.7 0.0 0.3 0.0 0.5 1.4 0.2 8.6 26.9 14.7 12.7 8.9 8.3 3.7 10.8 9.0 3.1 3.0 3.8 0.5 1.6 3.5 24.3 7.6 2.5 13.4 5.7 10.4 13.7 3.9 0.0 2.3 2.8 3.6 0.7 0.0 1.9 5.9 4.8 3.0 12.7 2.0 0.4 7.9 7.5 3.7 0.3 4.2 4.0 0.0 1.7 0.0 1.1 9.7 1.7 0.0 4.9 1.7 16.8 0.0 13.7 4.7 8.0 2.9 7.6 1.3 0.4 0.9 ZDHHC11 "FLJ13153, ZNF399" ENSG00000188818 "Zinc finger DHHC-type containing 11" Q9H8X9 5 795606-850986 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.2" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 17.9;Ciliated cells: 42.8;Club cells: 23.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 11.5" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.67e-1)" "unprognostic (9.76e-3)" "unprognostic (4.47e-5)" "unprognostic (5.43e-2)" "unprognostic (7.46e-2)" "unprognostic (4.68e-2)" "unprognostic (3.71e-2)" "unprognostic (1.49e-2)" "unprognostic (1.01e-2)" "unprognostic (2.32e-1)" "unprognostic (2.28e-2)" "unprognostic (2.65e-1)" "unprognostic (5.23e-5)" "unprognostic (4.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.86e-2)" "unprognostic (3.51e-2)" 1.8 1.4 3.4 1.0 4.2 0.7 2.7 11.0 3.8 1.6 1.5 6.3 1.0 9.5 1.7 2.9 3.2 10.3 1.2 6.4 4.2 3.8 2.0 2.6 7.5 1.0 15.2 1.9 1.5 1.9 1.8 7.8 1.2 10.9 2.7 1.2 1.0 1.4 3.4 2.1 2.7 1.7 1.0 5.0 2.4 5.9 6.3 6.1 1.0 1.1 2.3 1.8 1.0 1.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.3 7.4 4.1 0.8 1.3 0.3 5.5 0.3 0.1 0.2 0.1 1.0 0.3 3.0 0.8 0.1 0.9 6.9 2.2 0.0 0.1 9.0 4.8 0.3 2.6 3.7 0.3 4.3 0.3 0.4 0.3 0.9 1.0 0.3 0.0 1.2 0.7 1.7 0.2 3.3 0.4 2.6 7.3 0.0 2.9 4.5 2.8 4.1 0.2 1.5 4.1 0.7 0.2 0.1 3.1 8.4 11.5 0.7 0.4 0.2 6.9 3.9 0.1 5.5 7.7 0.9 0.3 8.9 0.2 0.0 0.0 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.2 11.0 3.8 4.2 3.8 15.2 1.9 10.9 6.1 17.9 9.6 0.0 0.3 1.6 2.0 6.7 0.0 42.8 23.9 0.0 0.0 0.2 0.0 0.4 6.6 0.8 1.7 0.0 0.0 0.1 1.7 0.4 3.5 1.7 0.3 6.4 1.7 1.3 0.0 6.8 0.6 0.0 0.0 0.0 2.0 0.3 0.2 1.1 0.0 0.8 1.7 6.5 1.0 9.3 3.8 1.4 0.2 0.0 1.1 0.3 ZDHHC11B ENSG00000206077 "Zinc finger DHHC-type containing 11B" P0C7U3 5 710360-766952 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 11.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 16.5;Ciliated cells: 36.1" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "T-reg: 1.5" "Lineage enriched" "Detected in single" 15 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "HAP1: 5.1;RPMI-8226: 4.5;SCLC-21H: 6.6;THP-1: 7.2" "HPA057886, HPA069008" Uncertain Approved Mitochondria NA NA Mitochondria "HPA057886: AB_2683548, HPA069008: AB_2686068" "unprognostic (2.81e-1)" "unprognostic (8.38e-3)" "unprognostic (3.79e-2)" "unprognostic (5.11e-3)" "unprognostic (7.18e-2)" "unprognostic (4.02e-3)" "unprognostic (1.19e-1)" "prognostic favorable (3.98e-4)" "unprognostic (4.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.45e-4)" "unprognostic (6.94e-2)" "unprognostic (1.43e-2)" "unprognostic (9.21e-2)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (2.31e-1)" 0.3 1.8 2.9 0.0 3.7 0.0 0.6 11.7 5.3 0.0 1.1 3.8 0.5 0.4 2.8 3.4 0.5 3.8 3.9 2.9 0.4 0.6 5.3 0.0 2.8 0.8 2.4 1.5 3.7 0.1 0.6 1.9 1.0 0.4 3.3 4.8 5.9 0.0 2.5 3.3 3.8 0.8 0.7 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.9 0.8 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.2 1.0 0.3 0.0 0.8 2.4 5.1 0.2 0.0 3.1 2.3 0.1 1.9 0.9 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.1 0.3 0.0 0.0 4.5 0.1 1.5 6.6 1.9 0.1 0.0 0.6 0.6 0.1 7.2 0.1 0.0 2.6 0.0 0.0 2.5 0.8 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 17.9 16.5 0.0 1.0 2.4 6.1 7.3 2.5 36.1 10.3 3.5 0.0 0.0 0.0 0.6 1.1 1.1 2.4 0.0 0.7 0.0 1.1 0.4 1.1 1.6 1.3 9.5 2.9 0.6 0.0 0.0 0.9 0.0 0.0 0.0 2.3 0.5 0.1 0.6 0.0 0.3 0.2 6.5 2.1 1.0 0.8 2.8 0.0 0.0 1.7 0.8 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type containing 12" Q96GR4 9 128720869-128724127 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 77.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 54.8" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 7.3 10.9 3.9 15.3 4.5 21.8 11.2 2.5 6.5 7.5 21.2 6.8 19.3 16.2 5.9 8.3 27.2 6.9 21.5 9.2 3.5 3.1 20.6 23.6 14.2 28.0 3.8 3.8 5.0 40.5 4.3 5.0 24.7 4.8 11.1 8.4 7.7 26.3 13.3 7.5 16.8 33.0 5.4 5.8 14.9 18.7 9.2 2.7 23.6 10.3 16.4 24.4 10.1 11.7 22.2 50.6 77.4 28.7 17.4 26.1 18.8 14.2 39.0 1.6 8.4 5.1 3.5 16.4 9.2 8.2 10.1 6.8 31.9 16.5 9.9 8.6 6.9 17.6 37.7 3.5 18.2 1.0 18.2 9.4 5.2 29.7 14.0 10.4 8.7 24.2 5.6 12.6 8.2 3.1 4.8 7.4 18.8 5.2 25.3 1.9 54.8 11.9 17.5 7.2 31.7 32.3 5.4 5.9 28.5 7.7 13.4 11.6 8.4 12.5 17.3 4.9 2.7 26.7 9.3 7.4 0.0 10.5 7.1 12.3 16.4 28.9 4.4 16.8 10.1 11.1 39.2 26.5 77.4 23.5 24.7 20.3 20.3 21.8 22.5 21.0 22.2 22.7 20.6 56.8 17.4 28.7 50.6 26.1 18.8 3.9 4.5 2.5 6.5 3.5 3.1 3.8 3.8 4.8 2.7 14.9 8.1 54.1 42.0 14.3 0.9 9.6 79.0 4.0 11.4 43.6 0.0 147.4 11.6 94.7 58.6 14.7 157.1 70.0 176.4 191.0 11.1 49.6 18.4 48.9 121.4 0.0 49.2 28.3 52.9 22.4 8.9 39.8 40.5 159.7 93.7 14.5 109.4 171.9 6.7 32.7 1.7 6.5 9.5 23.1 17.5 24.6 112.1 48.4 94.2 52.6 ZDHHC18 DKFZp667O2416 ENSG00000204160 "Zinc finger DHHC-type containing 18" Q9NUE0 1 26826710-26857602 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 86.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 27.0" "Lineage enriched" "Detected in many" 20 "granulocytes: 27.0" "Cell line enhanced" "Detected in all" "HDLM-2: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040234 Approved Approved Microtubules NA NA Microtubules "HPA040234: AB_10805709" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (2.35e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.01e-1)" "prognostic unfavorable (7.42e-7)" "unprognostic (1.53e-1)" "unprognostic (2.90e-2)" "unprognostic (2.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (1.36e-10)" "unprognostic (3.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 20.5 8.2 13.3 22.7 18.9 86.2 39.0 21.4 18.4 10.2 13.0 11.9 7.5 11.7 12.4 6.4 19.3 9.9 13.5 9.8 13.5 20.0 7.8 14.5 16.2 23.5 16.3 12.8 9.6 10.8 7.1 10.5 20.3 15.2 10.7 13.9 11.2 14.1 9.8 8.7 16.3 12.2 16.6 10.4 27.1 10.8 7.0 9.5 11.7 14.6 10.1 23.3 16.5 24.7 0.2 0.4 27.0 0.6 0.5 1.3 0.2 18.5 8.3 13.5 9.3 11.3 7.9 13.3 11.2 13.3 19.7 14.7 7.6 11.9 8.6 7.2 14.8 10.3 13.1 14.3 6.7 17.0 54.3 12.2 8.3 6.1 10.5 9.7 7.3 7.3 6.8 9.1 18.1 12.0 7.1 11.0 13.3 8.6 17.9 7.8 9.0 13.9 5.9 12.9 11.6 8.0 11.6 11.6 9.1 8.3 4.7 6.3 7.6 7.5 5.7 8.1 10.8 5.1 7.3 9.3 13.7 10.5 22.3 12.8 21.3 15.3 7.4 7.7 13.4 9.3 0.0 0.2 5.1 0.9 0.6 0.7 0.2 0.6 0.6 0.4 0.1 0.4 0.4 27.0 0.5 0.4 0.2 1.3 0.2 13.3 18.9 21.4 18.4 13.5 20.0 16.3 12.8 15.2 9.5 8.9 9.3 9.8 7.5 22.8 39.0 4.8 12.7 0.0 6.8 1.8 25.5 8.9 0.0 3.2 2.9 8.0 12.3 23.3 2.5 6.3 7.1 12.5 1.1 10.4 6.6 17.5 2.9 6.7 6.9 1.4 5.8 8.9 10.1 36.9 4.3 4.8 6.7 9.5 3.5 2.2 33.0 0.0 5.5 2.2 11.1 31.7 5.1 8.7 5.2 13.2 ZDHHC19 MGC33345 ENSG00000163958 "Zinc finger DHHC-type containing 19" Q8WVZ1 3 196197449-196211437 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 53.4" "Group enriched" "Detected in some" 15 "Early spermatids: 298.7;Late spermatids: 632.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 21 "eosinophil: 2.4;memory B-cell: 3.9;naive B-cell: 5.2;neutrophil: 3.4" "Group enriched" "Detected in many" 24 "B-cells: 5.2;granulocytes: 3.4" "Cell line enhanced" "Detected in some" "HMC-1: 1.7;K-562: 1.2;NTERA-2: 1.1;SH-SY5Y: 1.9;THP-1: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.15e-1)" "unprognostic (7.50e-4)" "unprognostic (2.87e-3)" "unprognostic (6.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (3.66e-3)" "unprognostic (4.63e-2)" "unprognostic (6.52e-2)" "unprognostic (2.86e-2)" "unprognostic (3.46e-7)" "unprognostic (8.05e-4)" "unprognostic (4.71e-1)" "unprognostic (7.08e-3)" "unprognostic (4.28e-2)" 0.0 0.6 0.0 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 298.7 0.7 0.0 0.0 0.0 0.4 0.3 0.1 0.0 3.4 1.3 0.0 0.0 0.0 1.5 632.3 15.3 1.4 0.0 0.0 0.0 0.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 4.9 3.0 0.0 2.1 0.0 0.0 0.0 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type containing 20" Q5W0Z9 13 21372573-21459370 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.4" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 77.2;Kupffer cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 7.5 7.0 8.3 9.4 33.6 14.9 11.3 6.4 15.3 10.3 10.9 21.0 7.6 10.8 9.3 5.6 18.4 7.1 10.0 5.4 12.7 11.8 3.8 7.6 10.6 12.3 47.4 4.9 6.5 6.1 4.0 5.3 10.8 26.1 9.2 9.6 3.1 10.4 9.9 5.5 12.2 15.4 8.9 45.0 8.6 23.1 22.0 35.8 10.4 10.0 5.1 10.9 16.2 9.6 4.6 7.8 8.8 15.2 10.1 10.2 11.1 13.2 7.7 11.2 7.1 10.5 11.1 27.5 14.6 14.7 9.8 8.7 13.9 40.9 14.2 7.9 17.8 10.3 21.7 12.9 11.2 18.5 15.4 8.2 24.9 4.8 7.7 5.9 16.8 10.8 10.0 7.9 9.6 6.8 12.4 15.1 18.4 6.9 6.0 14.4 11.2 23.5 6.4 9.1 35.2 7.6 18.9 20.2 4.9 11.6 24.9 10.7 4.9 19.1 12.0 7.8 12.0 11.0 8.6 26.2 10.3 9.9 17.3 10.8 6.2 7.6 14.7 7.4 9.7 29.1 8.8 15.2 3.4 10.2 14.2 9.4 4.6 8.8 8.7 7.8 3.7 8.3 8.5 2.7 10.1 12.0 3.9 9.3 11.1 8.3 33.6 6.4 15.3 12.7 11.8 47.4 4.9 26.1 35.8 47.6 26.9 15.8 6.9 0.9 8.3 6.4 17.8 20.1 36.4 10.4 7.9 18.2 0.0 8.6 77.2 15.0 29.0 0.0 10.5 16.6 10.3 19.1 13.9 17.4 19.9 17.5 23.1 19.6 86.8 67.8 14.4 35.8 1.7 7.2 29.0 4.4 18.7 23.0 10.3 6.2 9.6 19.4 6.9 9.7 12.3 1.4 37.3 20.8 23.4 16.9 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type containing 22" Q8N966 14 77131270-77142734 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 52.3" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 9.9;Cone photoreceptor cells: 3.9;Late spermatids: 3.3" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 5.3;NTERA-2: 5.6;RH-30: 9.4;SCLC-21H: 10.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" NA NA "Plasma membrane" "HPA049471: AB_2732553, HPA072213: AB_2686496" "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 1.1 1.5 11.2 1.1 12.6 1.1 1.1 8.4 52.3 1.1 1.2 6.7 0.0 1.1 1.1 1.4 1.3 1.2 1.1 1.2 14.5 18.4 1.1 1.1 1.1 1.1 10.7 19.5 1.1 1.1 1.1 3.1 1.1 9.2 1.1 1.3 0.5 1.1 1.1 1.3 1.1 1.1 1.2 3.6 1.1 1.3 1.4 5.1 0.0 1.3 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.6 0.0 0.7 0.0 9.4 0.0 0.0 0.0 10.4 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 11.2 12.6 8.4 29.5 14.5 18.4 10.7 19.5 9.2 5.1 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type containing 23" Q8IYP9 3 113947901-113965401 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.8" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.4;Late spermatids: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.7;naive B-cell: 1.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favorable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.90e-4)" "unprognostic (3.29e-3)" 1.0 0.8 6.3 2.1 5.9 0.4 1.9 2.7 10.4 1.4 7.7 0.9 2.2 6.0 1.5 1.6 1.7 2.1 1.8 1.3 8.9 1.9 4.7 3.2 2.4 2.7 0.9 4.7 1.1 4.4 8.2 3.5 0.4 1.4 1.8 9.9 1.2 4.9 1.4 1.2 2.9 5.4 0.7 0.9 1.9 5.0 25.8 0.6 0.8 5.5 0.9 2.8 1.7 1.5 2.7 1.1 0.5 0.0 0.0 0.5 0.1 13.1 3.3 0.4 7.8 1.2 0.2 11.5 5.2 1.6 1.0 1.6 5.4 8.9 6.1 4.6 3.0 8.6 8.7 10.0 1.4 1.7 3.6 4.6 5.6 4.8 3.3 0.4 6.2 5.2 0.2 1.7 0.2 0.6 1.2 0.8 6.5 0.0 3.6 0.1 7.6 5.1 0.4 2.4 13.6 3.7 0.9 4.5 5.0 5.6 6.5 13.7 3.5 4.0 13.5 2.6 3.2 8.1 2.1 0.2 3.8 7.6 0.8 2.3 4.0 5.2 9.8 3.2 4.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 0.1 0.0 1.7 0.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 6.3 5.9 2.7 10.4 8.9 1.9 0.9 4.7 1.4 0.6 0.0 1.0 5.9 1.6 2.7 1.8 1.2 10.2 5.3 2.3 15.7 7.9 0.6 0.0 2.1 20.4 1.4 15.7 0.0 1.6 1.2 0.6 3.5 0.0 5.4 0.4 0.0 13.3 1.8 0.3 26.8 1.1 1.2 3.3 1.0 12.2 3.8 0.7 9.5 0.0 3.4 0.7 0.0 0.3 11.6 1.9 2.4 0.2 0.0 11.4 1.7 ZDHHC9 "CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type containing 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavorable (9.77e-5)" "prognostic unfavorable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 18.2 7.3 16.7 6.7 24.7 3.2 14.2 7.8 33.9 14.1 14.7 78.3 5.1 21.1 8.4 8.4 9.8 7.9 10.4 7.4 24.1 15.2 25.4 27.0 15.6 3.0 24.9 13.9 8.0 17.4 19.6 7.1 11.5 28.4 13.4 17.3 3.8 13.2 8.3 7.4 19.7 22.2 10.4 32.7 2.4 12.8 2.8 25.3 1.2 9.6 5.7 4.3 10.8 9.4 4.6 7.8 2.6 6.8 3.4 7.6 3.3 15.0 7.9 11.4 23.0 39.4 31.1 9.3 14.9 17.1 7.2 9.0 12.5 19.7 0.5 25.5 15.9 18.6 10.2 12.8 15.0 10.4 0.8 8.0 3.0 8.3 16.4 15.6 2.0 5.4 33.7 24.4 11.7 17.4 12.6 13.5 5.0 3.2 6.1 11.5 13.1 2.8 3.7 6.1 33.8 13.7 2.7 7.3 8.8 10.4 8.4 9.0 7.6 4.2 22.1 6.9 14.0 9.4 3.3 10.9 7.3 2.5 17.1 12.0 5.7 4.0 1.8 13.1 8.3 3.6 0.0 3.3 2.6 4.8 2.9 6.1 4.6 5.8 4.7 3.7 2.7 7.6 4.3 0.0 3.4 6.8 7.8 2.5 3.3 16.7 24.7 7.8 33.9 24.1 15.2 24.9 13.9 28.4 25.3 20.8 28.7 3.0 9.8 16.6 9.1 3.5 28.1 5.3 17.0 43.6 2.0 5.0 3.3 16.9 1.1 10.3 26.8 0.0 17.0 17.3 20.5 23.0 2.3 41.5 4.4 1.6 17.3 6.7 2.1 1.3 11.2 4.6 10.1 0.0 24.9 1.2 26.6 10.5 7.1 24.6 2.4 0.0 13.7 6.1 6.0 16.8 8.6 2.5 25.5 13.6 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell type enhanced" "Detected in many" 10 "Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 39.1;THP-1: 46.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.5 0.0 26.9 13.7 0.0 9.2 9.4 10.4 10.1 0.0 0.2 1.7 0.0 10.0 2.8 0.1 3.8 0.0 13.0 9.6 2.6 39.1 1.6 0.0 6.1 6.7 31.1 11.2 0.2 12.9 6.2 8.8 7.8 0.0 10.9 1.1 12.2 0.0 0.0 20.5 3.2 0.0 0.5 11.5 15.5 0.0 0.1 0.2 0.2 5.9 1.1 0.0 24.3 7.5 0.0 46.5 12.1 12.0 0.2 23.3 2.9 12.7 0.0 1.9 17.9 20.2 32.2 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 6.0 25.8 45.8 1.2 22.0 178.1 50.1 2.5 6.7 18.2 5.2 3.9 1.3 1.7 0.6 2.0 23.8 0.0 23.3 0.7 1.6 146.0 1.5 150.5 2.1 126.8 626.1 0.0 81.0 357.2 4.0 111.7 271.2 97.8 46.9 0.0 84.2 0.2 0.0 62.6 7.3 8.6 181.1 167.0 2.3 7.0 17.1 3.9 99.2 0.0 2.0 ZFAND4 "ANUBL1, FLJ40185" ENSG00000172671 "Zinc finger AN1-type containing 4" Q86XD8 10 45615501-45672780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "testis: 49.1" "Group enriched" "Detected in many" 9 "Early spermatids: 369.5;Late spermatids: 511.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "Daudi: 31.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057543, HPA074103" Enhanced Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA057543: AB_2683461, HPA074103: " "unprognostic (1.57e-1)" "unprognostic (1.53e-2)" "unprognostic (6.90e-2)" "unprognostic (3.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.46e-3)" "unprognostic (2.55e-1)" "unprognostic (3.16e-1)" "unprognostic (8.85e-5)" "unprognostic (3.23e-1)" "unprognostic (9.15e-3)" "unprognostic (1.18e-1)" "unprognostic (6.19e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-3)" 2.7 4.1 3.0 7.3 5.2 2.6 4.5 14.7 3.6 3.5 2.9 6.8 4.2 2.9 5.0 2.5 2.5 4.1 2.9 3.3 3.2 4.4 3.2 4.4 3.3 6.1 5.0 1.7 3.3 3.7 3.1 9.7 2.0 5.5 3.9 3.5 4.8 2.9 3.9 2.7 4.0 2.6 3.0 5.1 3.6 2.4 49.1 5.8 9.7 4.8 2.1 6.2 2.9 2.8 1.9 0.8 2.0 1.6 3.2 2.4 0.4 0.9 0.8 1.4 1.9 3.1 2.5 0.0 1.2 2.4 1.3 1.4 0.0 0.9 31.3 1.4 0.8 1.9 0.2 1.1 0.7 1.7 4.6 1.3 0.9 1.1 0.9 2.2 0.0 6.5 2.3 1.5 0.4 1.3 1.1 1.5 4.4 0.8 5.5 1.3 0.1 3.0 0.6 1.3 1.1 0.7 0.4 1.1 0.0 1.2 0.9 2.6 1.8 0.9 1.2 1.0 1.7 2.7 1.7 1.0 0.5 2.3 2.1 1.6 3.8 6.7 0.0 1.1 3.0 0.5 2.0 0.8 0.0 1.9 0.6 2.4 1.9 1.9 1.6 0.7 1.4 1.5 2.2 0.1 3.2 1.6 0.8 1.2 0.4 3.0 5.2 14.7 3.6 3.2 4.4 5.0 1.7 5.5 5.8 6.0 1.9 4.7 2.9 0.7 6.9 3.1 2.5 10.7 0.0 1.8 25.5 0.2 1.7 1.1 369.5 2.0 2.0 0.0 1.5 0.2 1.1 3.5 2.3 4.5 1.9 3.2 1.7 1.8 1.8 511.2 6.1 1.1 3.3 1.8 2.1 4.0 1.4 0.0 2.8 3.1 7.3 6.5 0.6 51.6 13.9 1.9 0.1 3.2 1.9 1.4 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351425-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 207.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018129, HPA077824" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA018129: AB_1859012, HPA077824: " "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 82.5 57.6 26.9 15.5 35.2 36.6 57.1 31.7 34.3 28.6 23.1 20.3 31.4 10.8 25.7 35.5 29.0 27.4 28.7 33.0 24.3 22.6 32.6 56.5 31.6 23.6 24.3 21.1 59.3 20.9 17.0 45.4 22.4 25.1 24.0 15.1 22.4 17.2 52.7 207.5 17.6 15.8 28.4 25.9 24.1 23.2 26.7 21.7 14.6 23.1 29.5 16.5 39.2 29.3 7.0 13.6 15.4 32.1 8.6 6.8 7.8 22.2 22.8 26.9 11.9 34.8 16.6 20.3 26.3 36.7 14.2 11.1 2.8 21.0 12.4 16.0 41.2 20.1 24.9 62.0 10.3 21.3 83.9 9.6 9.8 13.1 13.9 25.7 14.0 14.6 21.7 19.1 14.8 16.6 33.1 25.1 12.0 9.4 16.4 16.6 5.9 18.3 8.0 34.7 20.9 15.9 14.3 14.0 13.1 46.2 21.6 19.7 17.6 16.6 18.3 21.5 29.2 8.1 12.3 19.1 11.8 14.6 20.8 18.0 23.7 20.6 6.5 15.9 9.6 29.2 15.1 13.6 15.4 5.2 21.6 5.7 7.0 6.8 6.6 13.6 6.2 6.3 5.6 12.2 8.6 32.1 2.9 4.8 7.8 26.9 35.2 31.7 34.3 24.3 22.6 24.3 21.1 25.1 21.7 163.8 158.6 37.3 496.3 301.3 88.2 288.5 91.7 88.3 127.4 125.6 70.7 117.4 126.0 118.6 62.4 115.1 102.1 46.7 122.4 145.8 149.1 300.6 109.4 271.5 176.8 38.1 131.1 95.2 243.2 35.2 109.6 177.8 197.4 297.6 71.5 51.7 193.5 79.3 87.7 95.7 65.3 84.1 204.0 123.7 99.9 254.7 189.3 64.8 81.2 398.4 ZFAT "KIAA1485, ZFAT1, ZNF406" ENSG00000066827 "Zinc finger and AT-hook domain containing" Q9P243 8 134477788-134713049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 68.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 57.3;Early spermatids: 44.4;Late spermatids: 36.0;Syncytiotrophoblasts: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in single" 25 "dendritic cells: 22.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020989, HPA063592" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA020989: AB_2670552, HPA063592: AB_2685051" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (4.62e-3)" "unprognostic (5.91e-3)" "unprognostic (2.45e-1)" "unprognostic (5.12e-2)" "unprognostic (1.31e-4)" "unprognostic (6.27e-2)" "unprognostic (2.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.90e-2)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (1.33e-1)" 4.5 2.9 4.2 3.5 4.2 1.7 5.0 6.8 4.5 3.0 7.8 2.6 2.8 3.2 5.0 3.1 4.2 3.3 2.4 3.8 3.0 1.7 12.4 2.8 4.1 4.5 2.5 2.8 3.3 3.3 3.7 4.6 68.8 2.9 3.9 2.6 4.3 3.7 4.2 8.5 3.4 3.8 3.9 2.0 4.4 3.6 3.5 3.0 4.8 3.3 2.8 4.0 6.0 5.3 0.6 22.1 0.8 0.5 0.0 0.5 0.5 5.7 9.0 3.3 4.1 6.4 6.4 2.8 6.2 5.5 5.8 5.8 6.2 7.2 6.4 5.5 6.4 3.4 4.4 6.6 7.8 7.4 5.4 8.8 12.0 9.2 4.6 5.0 6.7 5.9 5.4 4.0 6.4 8.2 5.2 7.0 2.4 4.5 12.0 4.8 7.4 6.9 0.8 4.6 5.8 5.9 4.3 4.3 2.7 5.4 8.6 3.7 3.1 6.4 4.9 5.2 3.9 4.1 6.4 7.6 3.4 5.0 4.8 7.0 4.4 5.8 6.4 4.3 5.0 6.4 0.7 0.3 0.8 0.3 0.5 0.3 0.6 0.2 0.5 0.3 0.6 0.4 0.2 0.7 0.0 0.3 22.1 0.1 0.5 4.2 4.2 6.8 4.5 3.0 1.7 2.5 2.8 2.9 3.0 3.0 3.5 6.0 1.2 1.3 3.6 1.6 0.0 0.0 3.4 1.8 3.9 57.3 0.0 2.0 44.4 1.1 1.1 0.0 1.3 13.9 2.4 1.2 2.3 1.0 7.1 1.6 0.0 0.6 2.4 36.0 3.1 2.0 8.5 3.6 1.3 2.6 2.9 0.0 2.5 9.2 5.9 0.0 1.6 2.9 5.5 1.5 106.0 1.3 1.1 1.1 ZFHX2 "KIAA1056, KIAA1762, ZFH-5, ZNF409" ENSG00000136367 "Zinc finger homeobox 2" Q9C0A1 14 23520855-23556192 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 17.9" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 30.6;Late spermatids: 13.8;Spermatocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 8.1;SuSa: 6.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000720, HPA005146" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" Yes No "Nucleoli fibrillar center" Nucleoplasm "HPA000720: AB_10603462, HPA005146: AB_1859250" "unprognostic (7.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (6.12e-3)" "unprognostic (1.40e-1)" "unprognostic (5.40e-2)" "unprognostic (3.94e-2)" "unprognostic (3.71e-2)" "unprognostic (5.08e-4)" "unprognostic (2.39e-1)" "unprognostic (5.33e-3)" "unprognostic (3.75e-1)" "unprognostic (7.35e-2)" "unprognostic (1.76e-1)" "unprognostic (1.90e-2)" 1.7 2.6 5.1 1.9 5.8 0.9 1.7 15.5 12.4 1.7 1.6 3.9 1.2 1.1 1.9 2.0 1.2 6.6 1.9 1.2 6.8 4.9 3.0 1.1 2.1 1.5 4.5 6.3 2.0 1.9 7.4 8.1 1.2 5.4 2.0 1.2 1.6 1.8 4.0 2.3 2.1 1.2 2.4 3.2 1.1 1.8 17.9 6.1 0.0 2.1 0.0 1.4 1.8 0.7 0.3 0.5 2.3 0.4 0.0 0.9 0.0 0.2 5.1 4.1 8.1 2.8 0.4 0.3 1.1 0.4 0.6 2.1 0.5 0.4 0.3 0.5 0.1 0.5 0.1 2.1 0.3 0.9 3.6 1.3 4.1 0.0 1.0 0.4 0.7 3.0 0.6 0.1 0.8 0.3 2.2 0.5 3.6 0.6 0.7 0.1 1.4 0.5 0.5 5.0 0.6 1.2 2.2 0.1 0.0 2.2 1.9 4.5 2.9 0.7 1.1 0.3 6.6 1.7 1.0 0.1 0.0 2.1 1.3 0.5 0.5 1.6 0.2 0.1 0.3 0.2 0.0 0.4 0.0 0.1 0.3 0.9 0.0 0.0 0.2 0.5 0.3 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 5.8 15.5 12.4 6.8 4.9 4.5 6.3 5.4 6.1 0.0 0.6 0.0 0.4 0.1 9.0 2.0 0.0 6.7 3.4 1.8 0.0 0.2 1.7 2.8 30.6 0.6 0.0 0.0 2.1 0.0 0.8 1.2 0.0 0.0 0.8 7.9 6.4 0.6 0.6 13.8 0.6 0.7 0.0 1.8 0.7 3.9 1.3 0.0 0.4 1.0 3.2 0.0 0.2 19.2 1.1 0.0 0.2 0.0 0.6 0.1 ZFHX4 "FLJ20980, ZFH4" ENSG00000091656 "Zinc finger homeobox 4" Q86UP3 8 76681219-76867285 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 29.1" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 75.7;Cholangiocytes: 48.4;Early spermatids: 49.4;Hepatocytes: 24.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 13.1;TIME: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023837 Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Nucleoplasm, Nucleoli fibrillar center" "HPA023837: AB_1859013" "unprognostic (2.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.63e-3)" "unprognostic (6.14e-8)" "unprognostic (3.81e-1)" "unprognostic (1.17e-1)" "unprognostic (7.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.79e-2)" "unprognostic (9.15e-4)" "unprognostic (3.18e-2)" "unprognostic (1.17e-3)" "unprognostic (6.20e-7)" "unprognostic (3.50e-3)" "unprognostic (2.51e-1)" "unprognostic (4.50e-4)" "unprognostic (5.89e-4)" 4.9 8.8 6.2 2.1 10.7 0.8 5.8 1.4 8.5 6.3 5.1 7.7 14.1 1.0 2.2 8.9 1.7 2.0 2.9 1.5 7.2 4.3 1.6 7.3 1.1 1.5 8.3 4.3 5.5 1.5 1.2 13.7 1.1 5.9 3.2 2.0 8.0 1.6 29.1 6.5 1.4 1.3 11.8 11.6 1.2 2.0 15.6 9.8 0.0 1.2 2.4 1.0 7.8 5.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 2.5 0.0 4.9 6.4 0.0 2.1 3.0 2.4 2.6 0.0 0.0 0.0 4.0 3.5 1.2 0.2 4.9 0.6 4.5 0.0 7.2 0.1 0.0 0.0 1.3 0.0 0.3 13.1 0.2 6.4 2.6 4.5 0.4 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.4 0.2 4.2 0.0 4.4 0.0 3.9 0.0 0.0 4.6 0.0 0.5 0.0 0.0 0.6 0.0 28.6 2.5 3.8 7.2 4.8 7.4 0.7 0.0 1.1 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 10.7 1.4 8.5 7.2 4.3 8.3 4.3 5.9 9.8 0.0 1.0 0.0 0.0 0.5 75.7 3.2 48.4 0.0 0.0 5.2 2.0 0.0 0.0 0.0 49.4 0.9 0.0 0.0 0.0 0.0 4.7 0.2 0.0 24.6 0.3 4.8 0.0 1.8 0.3 17.6 12.7 1.1 0.0 0.0 0.0 19.8 0.0 0.0 20.1 0.0 5.3 0.0 1.6 8.6 1.5 1.0 0.0 0.0 0.0 0.6 ZFP42 "REX1, ZNF754" ENSG00000179059 "ZFP42 zinc finger protein" Q96MM3 4 187995771-188005050 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.7;placenta: 6.6;testis: 7.1" "Group enriched" "Detected in some" 5 "Early spermatids: 41.4;Extravillous trophoblasts: 49.9" "Cancer enriched" "Detected in some" 41 "testis cancer: 40.5" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 13 "BEWO: 47.2;SuSa: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB025557 Uncertain NA NA "CAB025557: " "unprognostic (2.30e-1)" "unprognostic (1.07e-4)" "unprognostic (4.88e-3)" "unprognostic (3.75e-1)" "unprognostic (1.77e-1)" "unprognostic (3.86e-1)" "unprognostic (2.27e-1)" "unprognostic (4.66e-3)" 0.5 0.2 0.2 0.3 0.2 1.3 0.2 0.2 0.3 0.3 0.9 0.2 0.2 0.6 0.2 0.5 0.2 0.5 0.2 0.2 0.2 0.3 0.4 0.2 1.1 0.8 0.3 0.2 0.2 0.2 0.0 0.2 6.6 1.3 0.2 0.3 0.2 0.4 0.2 1.9 1.8 0.2 0.2 0.2 1.1 0.5 7.1 0.2 0.2 0.2 0.2 0.4 0.2 0.2 1.9 1.2 4.7 1.0 2.3 2.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 47.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 33.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 4.3 1.0 1.2 2.0 0.8 1.5 1.7 1.6 1.3 0.4 1.9 1.7 1.7 4.7 2.3 0.9 1.2 1.5 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.2 1.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 41.4 0.0 0.0 0.0 0.0 49.9 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 7.9 0.0 0.0 0.1 ZFP57 "bA145L22, bA145L22.2, C6orf40, ZNF698" ENSG00000204644 "ZFP57 zinc finger protein" Q9NU63 6 29672392-29681110 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.7;heart muscle: 14.4" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 4.2;Extravillous trophoblasts: 3.1;granulocytes: 2.3;Late spermatids: 3.6;Pancreatic endocrine cells: 2.7" "Cancer enriched" "Detected in many" 10 "testis cancer: 18.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "basophil: 3.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.8" "Group enriched" "Detected in some" 14 "BEWO: 12.0;SuSa: 3.4" "Low region specificity" "Detected in all" HPA047172 Uncertain NA NA "HPA047172: AB_10960886" "unprognostic (1.35e-1)" "unprognostic (1.74e-1)" "unprognostic (5.02e-2)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.72e-3)" "unprognostic (4.65e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-4)" "prognostic favorable (1.95e-4)" "unprognostic (1.33e-1)" "unprognostic (1.32e-1)" "unprognostic (2.29e-2)" "unprognostic (8.56e-2)" "unprognostic (7.45e-2)" "unprognostic (6.11e-2)" 0.9 0.6 3.8 0.3 4.1 1.1 4.2 0.1 2.3 0.5 0.4 0.4 2.4 0.3 0.5 0.5 0.9 0.3 1.9 14.4 5.5 3.2 0.5 0.3 0.9 6.1 7.6 0.1 0.7 5.2 0.3 0.1 1.5 0.5 0.7 0.6 0.2 2.3 2.1 0.4 0.7 1.2 1.5 12.7 0.8 0.3 1.4 0.1 1.2 0.3 0.7 1.1 1.5 5.5 0.3 0.7 3.8 0.5 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.8 0.5 0.0 0.6 0.3 0.3 0.3 0.4 0.5 0.7 0.0 0.2 0.4 0.0 0.3 0.2 0.0 0.6 0.3 3.8 4.1 0.1 1.4 5.5 3.2 7.6 0.1 0.5 0.1 0.0 1.1 0.0 0.2 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.9 3.1 0.4 0.0 2.3 0.0 1.1 0.0 0.0 0.0 0.0 3.6 0.0 1.1 0.0 1.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.3 0.7 1.5 0.1 0.2 0.0 0.0 0.0 ZFP69B "FLJ34293, ZKSCAN23B, ZNF643, ZSCAN54B" ENSG00000187801 "ZFP69 zinc finger protein B" Q9UJL9 1 40450102-40463718 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.8" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 2.9;Spermatogonia: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044289 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA044289: AB_10962717" "unprognostic (2.01e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-2)" "unprognostic (1.73e-2)" "unprognostic (1.58e-1)" "unprognostic (1.36e-2)" "unprognostic (6.44e-9)" "unprognostic (2.05e-1)" "unprognostic (7.10e-2)" "unprognostic (1.02e-2)" "unprognostic (6.85e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-5)" "unprognostic (1.64e-1)" "unprognostic (8.05e-2)" "unprognostic (7.88e-2)" "unprognostic (1.89e-1)" 1.6 1.7 7.8 4.6 11.1 1.1 2.8 8.2 12.8 3.1 2.5 1.8 0.1 2.6 4.3 2.4 2.2 1.6 3.3 1.8 6.3 4.9 1.6 2.4 1.6 3.7 3.6 5.8 2.0 3.5 3.2 3.6 1.1 4.7 2.0 3.1 1.2 1.9 1.8 1.2 1.4 1.8 3.0 3.2 2.3 2.5 4.0 3.8 5.0 2.7 0.9 5.5 3.8 1.7 2.1 1.2 0.9 2.1 1.3 4.1 1.0 3.3 1.3 5.7 14.0 2.1 5.7 1.6 3.2 3.1 1.5 2.8 1.6 2.2 6.3 3.2 2.8 2.9 1.2 2.9 2.8 3.3 5.5 1.2 2.6 3.2 4.8 1.5 0.4 4.2 1.3 4.7 5.2 6.9 1.5 2.0 8.5 6.8 6.4 4.4 2.3 8.5 0.6 7.7 1.2 1.4 4.8 5.6 3.0 2.9 3.3 7.7 8.0 5.1 4.4 2.2 3.4 2.3 7.4 4.3 4.8 10.1 4.4 4.6 9.8 9.3 13.8 6.3 0.9 4.9 0.0 0.3 0.9 2.6 2.1 3.5 2.0 1.8 1.4 1.2 2.1 3.4 3.0 0.2 1.3 0.7 0.5 4.1 1.0 7.8 11.1 8.2 12.8 6.3 4.9 3.6 5.8 4.7 3.8 0.0 0.0 0.0 0.6 0.2 2.9 0.4 0.0 0.0 0.0 1.8 0.0 0.4 0.0 1.0 0.0 0.3 0.0 0.0 0.2 1.3 0.4 0.2 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.8 0.9 0.0 0.4 0.0 1.7 0.0 0.3 1.5 5.9 0.1 0.0 0.8 0.1 0.3 ZFP92 ZNF897 ENSG00000189420 "ZFP92 zinc finger protein" A6NM28 X 153418322-153426481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 6.7" "Cell type enriched" "Detected in some" 6 "Sertoli cells: 19.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.2" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 6.1;HMC-1: 5.9;THP-1: 3.9;U-937: 10.1" "Region enhanced" "Detected in many" "hypothalamus: 10.3" "Low region specificity" "Detected in all" HPA003030 Uncertain NA NA "HPA003030: AB_2666758" "unprognostic (6.94e-2)" "unprognostic (2.54e-2)" "unprognostic (7.85e-2)" "unprognostic (2.57e-4)" "unprognostic (1.01e-2)" "unprognostic (3.84e-2)" "unprognostic (1.21e-1)" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.62e-2)" "unprognostic (6.51e-3)" "unprognostic (6.71e-2)" "unprognostic (1.84e-1)" "unprognostic (8.49e-4)" "unprognostic (1.81e-1)" "unprognostic (2.71e-2)" "unprognostic (6.66e-3)" 2.0 2.8 1.1 0.4 1.5 4.0 0.8 3.6 2.5 1.1 0.5 0.1 1.8 4.3 0.0 5.4 0.4 0.7 0.9 1.9 0.8 0.2 2.3 0.3 0.9 6.7 0.8 1.3 1.8 0.8 0.5 0.0 0.0 2.5 0.0 0.0 0.6 1.5 0.2 0.6 0.4 0.7 0.4 0.4 0.0 0.0 0.4 0.0 0.1 1.8 0.0 0.9 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.8 1.5 1.4 1.3 0.7 0.1 0.0 0.8 0.9 0.4 0.7 0.6 0.7 1.1 6.1 0.0 2.3 0.0 0.0 2.5 0.7 5.9 0.4 0.9 0.0 0.1 0.0 2.4 1.5 1.8 0.0 0.0 0.0 1.5 0.5 0.3 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.6 1.5 0.0 0.0 1.6 0.0 0.1 3.9 0.0 0.0 3.0 0.0 0.0 1.4 0.0 1.6 0.0 10.1 0.6 0.0 0.7 0.0 0.9 1.8 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.8 0.0 2.3 0.5 0.0 0.0 0.0 0.2 0.3 0.0 3.2 0.2 0.2 19.4 0.8 0.1 0.6 0.0 0.0 0.0 0.0 0.0 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453317-88537016 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 30.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 19.6;Cone photoreceptor cells: 27.5;Horizontal cells: 33.4;Muller glia cells: 36.6" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 14.5;K-562: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA046603: AB_2679718" "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favorable (4.24e-4)" 4.3 3.7 3.7 7.9 2.9 12.0 2.2 6.8 3.3 2.9 11.2 1.6 4.7 18.5 3.8 4.5 2.8 3.7 30.4 4.7 3.9 3.0 2.7 15.2 5.4 5.5 2.7 1.9 7.3 24.5 1.5 5.6 1.8 2.1 7.0 1.7 7.7 6.9 7.3 2.2 3.8 15.4 1.5 2.1 12.7 21.5 12.7 0.8 15.7 3.8 1.4 9.4 4.8 2.2 0.3 0.6 1.5 0.3 0.6 1.3 0.3 1.1 2.9 2.2 4.5 0.4 0.1 9.3 3.1 0.4 1.0 0.3 9.2 1.1 4.5 2.4 0.4 1.1 7.2 0.1 2.5 0.2 3.4 1.9 14.5 5.7 8.0 1.7 0.8 4.9 1.0 1.7 1.1 0.4 1.1 1.0 1.2 21.5 0.3 0.8 5.5 5.1 5.2 1.5 7.0 2.5 1.5 1.0 2.1 1.0 3.6 6.0 10.1 3.8 0.2 3.0 1.2 2.4 2.4 3.6 3.9 2.5 1.7 0.6 1.1 0.7 0.4 1.1 1.7 3.7 0.0 0.1 1.5 0.9 0.2 0.2 0.1 0.4 1.3 0.2 0.3 0.3 0.5 0.9 0.6 0.3 0.6 0.1 0.3 3.7 2.9 6.8 3.3 3.9 3.0 2.7 1.9 2.1 0.8 3.0 2.1 0.5 4.4 0.8 19.6 11.8 7.6 0.0 0.0 1.8 27.5 0.3 1.7 1.2 0.5 1.9 5.1 0.0 4.3 0.1 2.1 2.3 0.0 5.9 0.8 33.4 5.8 4.9 4.8 0.7 0.9 0.9 1.7 0.0 6.7 36.6 2.9 4.5 1.4 1.1 17.4 0.0 1.9 0.3 0.4 1.3 0.2 0.0 4.1 1.8 ZFPM2 "FOG2, hFOG-2, ZC2HC11B, ZNF89B" ENSG00000169946 "Zinc finger protein, FOG family member 2" Q8WW38 8 104590733-105804532 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Gonadal differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.0;ovary: 37.8" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 18.3;Early spermatids: 43.3;Late spermatids: 22.7;Leydig cells: 22.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 67.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.4;ASC diff: 5.6;BJ hTERT+: 13.9;HHSteC: 10.1;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.6;K-562: 5.7;TIME: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004094 Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA004094: AB_1859058" "unprognostic (4.48e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-3)" "unprognostic (1.36e-2)" "unprognostic (3.51e-1)" "unprognostic (1.53e-1)" "unprognostic (8.37e-2)" "unprognostic (8.35e-3)" "unprognostic (1.97e-2)" "unprognostic (1.04e-1)" "unprognostic (1.97e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-6)" "unprognostic (4.10e-3)" "unprognostic (5.41e-2)" "unprognostic (1.63e-4)" "unprognostic (2.61e-2)" 10.7 3.8 7.9 3.9 2.7 0.6 15.4 67.0 8.2 8.4 4.2 0.7 2.0 1.1 16.6 7.3 5.5 14.2 6.8 11.2 14.8 3.5 1.8 3.5 5.6 8.2 3.4 4.9 37.8 1.4 1.2 2.5 5.0 9.3 3.3 2.9 0.9 1.5 2.9 23.3 2.0 2.3 19.8 3.5 3.5 3.5 4.9 2.0 0.0 8.0 6.5 2.1 7.6 9.9 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.4 0.0 5.6 1.8 0.0 0.5 13.9 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 5.0 1.6 0.0 0.0 10.1 0.0 0.0 0.6 0.0 5.7 0.0 1.9 10.6 0.0 5.7 0.0 1.4 0.0 1.4 0.0 0.2 0.1 1.5 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.5 4.4 0.0 6.4 0.3 0.9 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 2.7 67.0 8.2 14.8 3.5 3.4 4.9 9.3 2.0 0.0 1.1 0.0 0.2 3.2 0.6 18.3 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 43.3 6.2 0.0 0.0 0.0 0.1 8.7 0.4 0.0 0.0 0.3 7.9 0.0 8.6 0.0 22.7 22.2 0.0 1.7 1.0 0.0 0.0 0.1 0.0 12.7 0.0 0.6 6.5 3.1 0.7 1.4 2.5 0.3 0.0 0.0 0.3 ZFR2 KIAA1086 ENSG00000105278 "Zinc finger RNA binding protein 2" Q9UPR6 19 3804024-3869032 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0;pituitary gland: 19.8;testis: 20.3" "Cell type enhanced" "Detected in some" 9 "Bipolar cells: 29.9;Cone photoreceptor cells: 25.5;Early spermatids: 21.1;Horizontal cells: 30.2;Rod photoreceptor cells: 35.3;Spermatocytes: 26.9" "Cancer enhanced" "Detected in some" "cervical cancer: 2.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 12 "HMC-1: 17.8;NTERA-2: 30.6;SiHa: 9.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043275, HPA055678" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA043275: , HPA055678: AB_2682883" "unprognostic (1.74e-3)" "unprognostic (2.32e-3)" "unprognostic (4.05e-3)" "unprognostic (1.51e-2)" "unprognostic (6.60e-3)" "unprognostic (5.47e-4)" "unprognostic (9.12e-2)" "unprognostic (3.87e-2)" "unprognostic (1.18e-2)" "unprognostic (4.92e-2)" "unprognostic (1.97e-3)" "unprognostic (4.29e-2)" "unprognostic (3.58e-1)" "unprognostic (3.58e-1)" "unprognostic (5.81e-2)" "unprognostic (9.20e-2)" "unprognostic (2.18e-2)" 1.0 6.8 13.0 1.2 17.0 1.3 1.3 2.2 16.9 1.5 0.9 1.9 0.0 0.9 0.9 0.8 0.8 2.4 1.2 1.1 7.6 12.2 0.9 0.9 1.4 1.1 4.9 10.9 1.0 1.7 0.8 19.8 0.8 7.4 1.3 1.0 5.7 1.2 1.1 0.9 1.2 1.4 0.8 3.9 1.3 1.3 20.3 2.3 0.0 1.2 0.0 1.4 0.8 0.2 0.9 0.2 1.5 0.2 1.7 4.5 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 30.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.1 0.6 9.0 0.0 0.5 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.5 0.2 0.2 3.4 0.0 4.5 0.2 2.6 1.9 0.0 0.9 3.9 3.4 0.5 1.7 0.0 0.2 0.8 1.4 13.0 17.0 2.2 15.0 7.6 12.2 4.9 10.9 7.4 2.3 0.0 0.6 0.0 0.5 0.9 29.9 1.1 0.0 2.7 0.0 0.0 25.5 0.0 0.0 0.3 21.1 0.5 0.0 0.0 0.2 0.1 0.2 0.4 1.1 0.0 0.1 30.2 0.0 0.0 0.0 7.5 0.9 0.0 1.7 0.0 0.0 4.0 0.3 0.0 0.0 0.2 35.3 0.0 0.3 26.9 14.1 0.1 0.0 2.2 0.0 0.4 ZFYVE28 KIAA1643 ENSG00000159733 "Zinc finger FYVE-type containing 28" Q9HCC9 4 2269582-2418663 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "brain: 63.6" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 28.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 63.6" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038175, HPA057587" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" Nucleoplasm "HPA038175: AB_10697244, HPA057587: AB_2683477" "unprognostic (1.59e-1)" "unprognostic (4.60e-2)" "unprognostic (7.68e-2)" "unprognostic (3.08e-3)" "unprognostic (9.89e-3)" "unprognostic (3.79e-2)" "unprognostic (3.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-3)" "unprognostic (2.56e-2)" "unprognostic (3.64e-2)" "prognostic favorable (1.35e-6)" "unprognostic (6.05e-2)" "unprognostic (5.27e-2)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" 4.5 8.6 7.7 5.1 15.8 3.1 3.7 63.6 15.1 3.7 7.4 4.6 1.8 10.4 4.1 3.1 3.4 4.3 5.9 2.4 7.1 5.5 5.7 4.2 4.4 6.1 7.9 8.0 3.4 7.3 7.9 7.5 1.8 9.9 2.9 5.1 5.8 9.5 5.4 4.3 5.7 11.9 2.8 9.4 7.0 7.5 7.9 6.7 1.2 5.3 3.1 4.0 4.5 3.2 3.1 0.7 0.9 0.4 0.3 4.4 1.3 0.8 1.0 0.2 3.7 2.2 0.7 0.1 1.8 3.1 1.0 0.3 0.1 6.7 0.0 1.9 3.2 2.6 3.8 1.2 0.3 0.6 9.7 1.3 0.2 4.3 0.3 4.4 0.7 11.2 3.0 0.6 1.1 0.1 7.0 3.1 1.0 1.8 8.2 0.9 2.2 0.1 12.1 0.1 2.0 8.2 0.0 0.0 3.9 1.5 0.5 5.8 0.4 1.8 0.1 1.0 0.1 2.5 0.3 0.5 1.8 0.0 5.5 0.1 12.8 9.3 0.2 5.4 2.3 1.8 0.9 0.4 0.1 4.4 0.0 1.9 0.9 2.3 3.2 0.7 3.1 3.2 3.2 0.1 0.3 0.3 0.2 4.0 1.3 7.7 15.8 63.6 15.1 7.1 5.5 7.9 8.0 9.9 6.7 0.0 1.7 0.0 3.2 5.3 10.7 3.3 5.1 1.4 3.4 10.4 17.7 0.3 6.6 2.7 28.4 4.5 16.9 0.0 2.0 0.2 1.9 1.5 9.2 4.9 1.8 7.9 2.4 5.5 1.9 5.8 1.4 7.1 6.8 4.6 5.9 1.4 2.1 9.0 2.1 3.1 16.3 0.0 2.8 2.1 9.0 4.3 0.2 21.0 5.2 4.1 ZG16 "hZG16, JCLN, JCLN1, ZG16A" ENSG00000174992 "Zymogen granule protein 16" O60844 16 29778240-29782973 "Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 84.6" "Cell type enriched" "Detected in some" 11 "Mucus-secreting cells: 6838.5" "Cancer enriched" "Detected in some" 6 "colorectal cancer: 21.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 1.9;SK-BR-3: 7.0" "Not detected" "Not detected" "HPA052066, HPA052512" Enhanced "Secreted to digestive system" NA NA 250000 "HPA052066: AB_2681716, HPA052512: AB_2681857" "unprognostic (1.64e-2)" "unprognostic (2.05e-1)" "unprognostic (2.60e-3)" "unprognostic (8.20e-2)" "unprognostic (3.50e-2)" "unprognostic (1.93e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-1)" "unprognostic (7.77e-2)" "unprognostic (3.27e-1)" "unprognostic (2.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" 0.2 0.0 0.2 13.3 0.2 0.0 0.2 0.2 0.2 0.2 67.8 0.2 0.2 9.9 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.2 3.6 0.2 0.2 0.2 0.2 0.2 8.9 0.0 0.2 0.2 0.2 0.2 84.6 0.2 0.2 0.2 0.2 0.0 51.6 2.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.7 0.2 0.4 0.7 1.1 1.0 0.1 0.8 0.2 0.1 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 1.3 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.3 0.2 0.4 0.0 7.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.5 0.3 0.6 0.3 0.6 0.5 0.0 0.7 0.9 1.0 0.4 1.1 0.3 0.2 0.5 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 1.4 0.2 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 602.0 0.0 10.5 0.0 0.0 0.2 41.3 24.1 0.0 0.0 139.9 0.6 0.6 0.0 0.0 0.0 0.0 0.0 6838.5 0.0 0.5 331.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 287.1 0.1 ZG16B "HRPE773, JCLN2, PRO1567" ENSG00000162078 "Zymogen granule protein 16B" Q96DA0 16 2830169-2839585 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "salivary gland: 1069.4" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 160.9;Glandular cells: 457.9;Mucus-secreting cells: 224.9;Urothelial cells: 223.9" "Cancer enhanced" "Detected in many" "prostate cancer: 47.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3" "Lineage enriched" "Detected in many" 7 "monocytes: 11.4" "Cell line enhanced" "Detected in some" "MCF7: 15.2;OE19: 32.4;SK-BR-3: 14.0;T-47d: 12.8" "HPA041125, HPA053549" Enhanced Approved Nucleoplasm,Vesicles "Secreted to digestive system" NA NA 1200000 Vesicles Nucleoplasm "HPA041125: AB_10794264, HPA053549: AB_2682184" "unprognostic (5.29e-2)" "unprognostic (2.71e-1)" "unprognostic (4.37e-2)" "prognostic favorable (3.48e-6)" "unprognostic (1.39e-3)" "unprognostic (1.94e-2)" "unprognostic (2.34e-3)" "unprognostic (4.13e-2)" "unprognostic (1.01e-1)" "unprognostic (3.45e-3)" "unprognostic (1.37e-1)" "unprognostic (1.47e-2)" "unprognostic (1.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.17e-1)" "unprognostic (1.04e-1)" "unprognostic (8.33e-2)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.7 0.2 0.0 0.2 0.1 0.1 0.1 0.5 0.0 1.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.6 0.0 0.0 0.0 1.6 0.3 0.0 1069.4 0.2 0.1 0.8 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 78.5 3.7 0.2 0.2 0.0 1.1 1.7 11.4 1.1 0.4 1.7 0.0 0.6 0.0 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.1 1.2 0.0 2.5 0.0 0.0 0.0 5.0 1.4 1.3 1.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.1 2.1 0.1 15.2 0.0 0.2 0.1 32.4 2.9 0.0 0.0 4.8 0.1 3.6 0.0 0.0 0.0 14.0 0.0 0.1 12.8 0.0 1.8 0.0 0.3 1.1 0.0 0.0 0.2 0.2 0.2 3.7 0.1 1.7 6.7 0.0 0.0 11.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 1.1 7.3 0.0 0.4 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.9 8.0 0.0 0.0 89.2 1.4 5.7 1.8 0.0 0.0 0.0 3.6 5.3 0.1 36.1 0.0 25.2 2.7 0.8 457.9 5.7 0.0 13.1 0.0 55.9 0.6 2.9 3.1 0.0 2.6 79.2 1.8 224.9 0.0 30.0 80.9 0.0 0.0 0.0 0.0 0.3 1.0 0.1 21.0 0.2 0.0 68.0 223.9 ZGPAT "dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP" ENSG00000197114 "Zinc finger CCCH-type and G-patch domain containing" Q8N5A5 20 63707465-63736142 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 56.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.3;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056705 Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056705: AB_2683213" "unprognostic (4.50e-2)" "unprognostic (2.74e-1)" "unprognostic (5.30e-2)" "unprognostic (4.42e-2)" "unprognostic (8.58e-2)" "prognostic favorable (6.17e-5)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.54e-1)" "unprognostic (9.31e-3)" "unprognostic (1.60e-2)" "unprognostic (3.43e-3)" "unprognostic (1.37e-1)" "unprognostic (4.11e-2)" "unprognostic (1.24e-1)" "unprognostic (9.86e-3)" 9.3 9.8 9.6 13.6 14.5 14.5 8.0 20.2 13.2 7.6 8.9 12.0 10.8 11.1 12.9 6.1 9.1 8.1 11.2 8.8 10.3 7.1 11.7 56.1 7.2 11.0 16.9 10.7 7.3 12.6 8.3 10.8 9.0 14.2 8.3 3.9 8.0 14.0 8.8 9.2 10.5 10.8 9.4 8.5 11.7 10.3 14.9 15.0 11.3 8.0 5.8 13.5 8.3 9.2 15.6 21.7 19.2 16.4 20.2 23.8 13.0 8.6 11.1 4.4 7.0 3.6 2.5 10.1 9.0 6.0 14.3 6.0 23.8 11.9 9.0 17.2 5.0 13.8 15.8 2.9 10.6 1.8 6.0 7.7 8.4 9.7 24.3 7.1 5.2 14.9 6.4 9.0 5.8 2.3 3.8 7.7 10.9 9.2 8.5 4.7 8.6 12.9 12.5 7.1 12.8 14.0 13.6 3.3 9.1 7.9 8.0 8.3 10.4 12.8 14.5 8.0 2.3 9.9 14.8 8.7 22.3 7.9 8.4 11.4 8.4 13.2 12.3 14.0 5.2 9.9 6.6 16.0 19.2 23.8 16.4 23.1 15.6 20.4 21.5 15.1 14.5 20.3 20.5 17.0 20.2 13.2 21.7 19.8 13.0 9.6 14.5 20.2 13.2 10.3 7.1 16.9 10.7 14.2 15.0 3.0 4.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.2 0.2 0.0 2.3 1.6 0.2 0.0 1.7 0.6 1.8 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.3 0.0 0.0 0.4 1.0 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.0 0.1 ZGRF1 "C4orf21, FLJ11331" ENSG00000138658 "Zinc finger GRF-type containing 1" Q86YA3 4 112539333-112636995 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.0" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 19.0;Spermatocytes: 17.1;Spermatogonia: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA030704, HPA030706" Uncertain Approved Cytosol NA NA Cytosol "HPA030704: AB_2673577, HPA030706: AB_10601784" "unprognostic (8.48e-2)" "unprognostic (6.17e-2)" "unprognostic (9.51e-2)" "unprognostic (1.53e-1)" "unprognostic (1.10e-1)" "unprognostic (1.84e-3)" "unprognostic (5.83e-3)" "unprognostic (1.45e-1)" "unprognostic (5.89e-4)" "unprognostic (4.74e-2)" "unprognostic (4.30e-2)" "unprognostic (3.72e-3)" "unprognostic (7.60e-10)" "unprognostic (3.45e-2)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (2.02e-4)" 2.5 1.8 3.3 4.9 4.8 13.8 2.8 13.8 6.5 2.5 2.4 0.5 0.1 2.6 2.6 1.5 3.0 2.1 1.3 1.5 3.1 1.0 1.6 1.6 2.7 5.0 2.5 3.3 3.2 2.2 0.9 4.5 3.5 3.5 2.1 3.1 1.1 2.7 2.3 2.9 3.0 3.2 2.1 4.2 3.8 2.6 7.3 4.1 17.0 2.7 2.2 5.8 2.1 2.5 2.5 2.8 1.3 2.9 1.1 1.6 0.4 3.7 2.7 9.4 6.6 0.7 1.3 3.6 6.7 2.8 6.8 6.1 5.2 5.6 9.8 2.0 2.0 2.8 3.0 9.7 3.5 7.8 5.3 2.5 6.1 4.3 1.6 0.3 13.7 4.1 0.6 0.4 8.5 2.3 0.9 2.7 10.5 8.7 11.1 4.6 6.1 18.3 5.0 4.9 3.9 3.3 10.3 14.0 3.3 1.2 3.3 4.4 7.4 3.0 4.1 1.2 7.2 1.9 4.0 3.2 8.6 8.4 4.5 5.3 4.2 7.3 13.1 3.9 4.7 4.8 0.0 0.6 1.3 1.0 2.9 0.6 1.3 0.5 0.2 0.1 2.5 1.6 1.6 0.9 1.1 0.7 2.8 1.0 0.4 3.3 4.8 13.8 6.5 3.1 1.0 2.5 3.3 3.5 4.1 0.0 2.2 6.4 1.2 0.0 9.0 2.0 0.0 1.4 6.8 1.8 7.9 1.9 0.0 0.8 2.3 0.7 0.7 0.0 0.4 2.7 1.4 1.0 2.3 0.4 1.5 4.8 1.2 0.0 1.0 1.4 0.6 2.6 0.0 0.0 1.1 2.0 0.5 0.9 2.1 0.3 19.0 0.0 0.8 17.1 11.5 0.0 0.7 2.2 1.2 0.4 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "brain: 124.7" "Cell type enhanced" "Detected in some" 14 "Hepatocytes: 4.4;Leydig cells: 1.4;Muller glia cells: 4.2;Peritubular cells: 1.4;Rod photoreceptor cells: 1.5" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 8 "cerebellum: 124.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "AF22: 62.2" "Region enhanced" "Detected in many" "cerebellum: 232.6" "Region enriched" "Detected in many" 9 "cerebellum: 491.0" HPA004098 Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 0.7 0.6 1.5 0.5 8.6 0.5 0.8 124.7 25.5 0.5 0.7 12.3 0.0 0.9 0.6 3.8 1.0 0.5 0.8 0.5 6.2 5.2 0.5 7.3 0.7 0.7 5.2 8.0 0.9 0.5 0.6 0.6 0.5 15.3 0.5 0.7 3.0 0.5 0.6 7.4 4.1 1.9 0.5 10.0 0.5 0.5 1.0 4.5 0.0 0.5 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.2 0.0 6.5 7.2 3.5 4.0 4.8 4.3 3.6 0.0 0.0 0.0 3.2 0.3 3.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.0 0.2 0.0 0.0 1.0 0.0 3.8 15.0 0.0 0.0 0.1 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.6 0.0 0.0 0.0 0.0 6.5 0.0 10.1 3.8 0.0 0.0 0.0 4.8 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 8.6 124.7 5.2 6.2 5.2 5.2 8.0 15.3 4.5 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 1.4 0.0 1.5 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ZIC2 HPE5 ENSG00000043355 "Zic family member 2" O95409 13 99981772-99986773 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease mutation, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 63.0" "Cell type enhanced" "Detected in some" 20 "Collecting duct cells: 1.8;Cone photoreceptor cells: 5.9;Muller glia cells: 8.4;Rod photoreceptor cells: 3.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 63.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 27.7;HDLM-2: 13.3;HEK 293: 21.0;NTERA-2: 25.8;SCLC-21H: 58.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 214.5" HPA055031 Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA055031: AB_2682676" "unprognostic (6.43e-6)" "prognostic favorable (2.64e-4)" "unprognostic (5.73e-2)" "unprognostic (1.99e-2)" "unprognostic (4.39e-1)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (4.66e-2)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (9.36e-3)" "unprognostic (7.42e-2)" "unprognostic (0.00e+0)" "unprognostic (3.26e-1)" "unprognostic (2.11e-1)" "unprognostic (5.36e-3)" 0.6 0.5 3.9 0.5 2.9 0.5 0.7 63.0 14.7 0.5 0.8 7.7 0.0 0.6 0.8 0.5 0.8 0.5 0.5 0.5 6.1 2.1 0.6 0.5 0.7 0.6 1.7 7.4 0.5 0.6 0.5 0.5 0.5 13.4 0.6 0.6 3.8 0.5 0.5 0.5 0.8 0.5 0.6 2.2 0.5 0.6 2.5 1.0 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.5 27.7 1.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 1.8 0.0 2.3 0.0 1.4 0.0 1.2 0.0 0.0 13.3 21.0 1.9 1.2 1.3 0.0 0.0 1.3 0.0 2.0 0.0 1.2 0.1 0.0 0.6 2.0 0.0 0.0 0.9 0.1 10.5 25.8 0.0 0.6 6.0 1.0 0.0 0.1 0.7 58.0 0.0 0.8 0.1 0.0 1.1 1.3 10.3 0.0 6.5 0.0 1.1 1.7 0.2 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 2.9 63.0 7.1 6.1 2.1 1.7 7.4 13.4 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.8 5.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.9 0.5 0.1 0.0 0.0 0.0 0.0 ZIC3 "HTX, HTX1, ZNF203" ENSG00000156925 "Zic family member 3" O60481 X 137566142-137577691 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 50.6" "Cell type enhanced" "Detected in some" 27 "Muller glia cells: 7.1;Rod photoreceptor cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 2.7" "Cancer enriched" "Detected in single" 14 "testis cancer: 5.0" "Region enriched" "Detected in all" 8 "cerebellum: 50.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 35 "AF22: 24.0;NTERA-2: 26.7;SuSa: 16.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052936, HPA069523" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA052936: AB_2681993, HPA069523: AB_2732136" "unprognostic (3.55e-5)" "unprognostic (3.82e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" 0.3 0.2 1.4 0.4 2.5 1.1 0.4 50.6 5.8 0.3 0.4 2.7 0.0 0.5 0.5 0.2 0.3 0.3 0.4 0.3 1.9 2.2 0.3 0.3 0.4 0.4 2.4 1.2 0.4 0.5 0.4 1.1 0.4 6.1 0.5 0.3 3.9 0.7 0.3 0.5 0.8 0.5 0.2 1.9 0.5 0.4 3.9 2.2 0.0 0.5 0.0 0.4 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 26.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 16.2 0.3 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 2.5 50.6 2.6 1.9 2.2 2.4 1.2 6.1 2.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.4 2.7 0.0 0.0 0.0 0.0 0.0 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406860 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 52.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 18 "cerebellum: 52.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 118.4" HPA030194 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030194: AB_2673367" "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.2 0.0 0.2 0.0 0.4 0.0 0.0 52.2 7.9 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.8 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 3.7 3.5 0.5 0.0 1.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 18.7 0.0 5.3 2.2 4.0 1.9 0.4 0.2 0.5 0.0 0.0 0.0 2.4 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 2.3 0.0 0.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.4 0.0 4.4 2.0 0.0 0.0 0.0 1.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 52.2 0.4 0.3 0.8 0.3 0.4 2.9 0.3 0.0 0.0 0.0 0.0 0.1 0.6 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ZIC5 ENSG00000139800 "Zic family member 5" Q96T25 13 99962964-99971909 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 48.9" "Cell type enhanced" "Detected in some" 29 "Muller glia cells: 1.7;Rod photoreceptor cells: 1.3;Spermatocytes: 5.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 24 "cerebellum: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 11.2;HEK 293: 6.4;NTERA-2: 7.6;SCLC-21H: 43.8" "Group enriched" "Detected in many" 5 "basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7" "Region enriched" "Detected in all" 6 "cerebellum: 53.2" HPA074045 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA074045: " "unprognostic (2.78e-5)" "unprognostic (1.71e-2)" "unprognostic (2.44e-2)" "unprognostic (2.29e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.38e-4)" "unprognostic (2.13e-2)" "unprognostic (1.02e-1)" "unprognostic (5.01e-2)" "unprognostic (1.06e-2)" "unprognostic (3.87e-2)" "unprognostic (1.13e-1)" "unprognostic (3.12e-2)" "unprognostic (4.94e-2)" 0.1 0.0 1.2 0.0 0.5 0.0 0.1 48.9 4.2 0.0 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.5 0.1 0.1 0.1 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 2.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.1 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 11.2 0.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.5 1.0 0.0 1.6 0.0 0.5 0.0 2.2 0.0 0.0 1.9 6.4 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 1.5 0.0 0.0 0.8 0.0 0.8 7.6 0.0 0.1 0.9 0.4 0.0 0.0 0.0 43.8 0.0 1.2 1.0 0.0 0.8 0.0 1.4 0.0 0.6 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.5 48.9 1.3 1.5 0.5 0.4 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 5.7 0.4 0.0 0.0 0.0 0.0 0.0 ZIM2 ZNF656 ENSG00000269699 "Zinc finger imprinted 2" Q9NZV7 19 56774552-56840729 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;ovary: 35.4" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 24.1;Horizontal cells: 9.5;Late spermatids: 24.5;Spermatogonia: 18.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.4;Hep G2: 9.8;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.1;U-266/84: 2.0" HPA071856 Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA071856: AB_2686460" "unprognostic (9.01e-4)" "unprognostic (8.77e-2)" "unprognostic (5.09e-2)" "unprognostic (4.60e-2)" "unprognostic (2.45e-2)" "unprognostic (3.01e-1)" "unprognostic (2.33e-1)" "unprognostic (8.68e-3)" "unprognostic (4.12e-1)" "unprognostic (1.00e-1)" 1.6 13.1 8.5 1.6 44.0 1.4 2.5 8.2 19.1 2.2 1.7 4.8 0.0 1.6 3.2 1.2 1.7 2.8 1.4 2.6 8.1 6.5 2.0 1.7 1.4 1.5 3.0 13.7 35.4 1.5 1.8 21.1 18.3 18.2 2.0 1.5 0.1 3.7 2.0 1.3 1.4 1.8 2.2 3.9 1.7 1.5 11.4 6.1 0.0 2.2 0.0 2.0 1.9 1.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.9 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 44.0 8.2 19.1 8.1 6.5 3.0 13.7 18.2 6.1 0.0 0.0 0.0 0.0 0.1 3.8 0.8 0.0 0.0 0.0 0.0 0.0 4.6 1.7 0.0 24.1 0.0 0.0 0.0 0.0 0.9 0.4 0.1 0.0 0.0 0.5 9.5 0.0 0.0 0.0 24.5 1.7 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.4 0.0 2.4 0.0 0.0 7.5 18.3 0.1 8.2 0.0 0.0 0.0 ZIM3 ZNF657 ENSG00000141946 "Zinc finger imprinted 3" Q96PE6 19 57134096-57145202 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 3.5;testis: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" HPA034575 Uncertain NA NA "HPA034575: AB_10603463" "unprognostic (9.06e-2)" "unprognostic (1.46e-1)" 0.1 0.1 0.1 0.3 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 1.4 1.6 0.1 0.0 0.1 0.5 0.1 2.8 0.2 0.1 0.1 0.1 1.4 0.7 3.5 0.5 0.7 1.0 0.3 0.6 0.9 0.1 1.1 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.5 0.4 0.1 0.0 0.0 0.2 0.2 0.6 0.9 0.9 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.8 0.0 0.5 0.2 1.1 0.0 0.3 0.7 0.5 0.3 0.3 0.0 0.4 0.1 0.2 0.0 0.8 0.5 0.3 0.0 0.8 0.0 0.7 0.8 0.1 0.0 0.4 0.6 0.3 0.2 1.2 0.4 0.2 0.6 0.8 0.1 3.5 0.4 0.5 0.5 0.3 0.5 0.7 0.7 0.5 0.1 1.4 0.6 1.0 2.1 0.7 0.5 0.7 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 ZMAT1 KIAA1789 ENSG00000166432 "Zinc finger matrin-type 1" Q5H9K5 X 101882288-101932031 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 38.7" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 54.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 12.6;U-266/70: 6.3" "Low region specificity" "Detected in all" HPA012827 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA012827: AB_1859070" "unprognostic (9.30e-2)" "unprognostic (4.13e-2)" "unprognostic (2.51e-2)" "unprognostic (2.80e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-5)" "unprognostic (1.20e-3)" "unprognostic (2.22e-2)" "unprognostic (3.70e-2)" "unprognostic (6.09e-2)" "prognostic favorable (1.72e-5)" "unprognostic (6.33e-3)" "unprognostic (1.72e-2)" "unprognostic (3.05e-1)" "unprognostic (5.28e-2)" "unprognostic (2.21e-1)" "unprognostic (1.38e-2)" 6.1 13.0 11.4 9.9 12.4 10.0 9.9 7.1 12.8 5.0 4.9 16.5 7.0 4.0 7.4 38.7 3.0 7.3 7.2 7.6 11.1 9.6 9.6 6.5 10.8 10.9 10.2 11.4 11.9 7.3 14.5 31.4 2.3 9.2 9.3 3.4 13.6 7.9 14.2 5.1 4.3 5.4 8.3 12.0 10.7 4.1 5.9 11.3 7.0 18.8 3.2 7.5 3.3 3.7 3.7 3.2 2.6 1.1 0.6 1.6 0.6 0.4 0.0 1.5 1.5 0.0 0.0 0.2 0.6 0.1 0.0 0.7 0.0 1.8 2.7 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.8 0.0 0.0 0.0 0.3 0.3 1.1 2.8 0.0 12.6 1.0 0.0 0.1 0.2 1.9 0.0 0.2 2.1 0.0 0.1 3.4 0.0 0.6 1.7 1.0 0.0 0.1 1.7 2.2 3.1 3.1 0.9 0.0 0.0 0.1 6.3 0.4 0.0 0.6 3.0 0.9 2.6 1.1 1.7 0.9 0.4 1.6 2.0 1.3 1.4 0.2 3.7 1.6 1.4 0.8 0.6 0.7 3.2 0.6 0.6 11.4 12.4 7.1 12.8 11.1 9.6 10.2 11.4 9.2 11.3 14.9 34.0 4.5 5.8 3.7 34.3 22.7 5.1 22.7 26.1 14.0 41.2 0.0 3.3 3.2 8.5 10.8 1.1 23.3 2.5 0.0 5.4 9.2 15.1 9.0 3.1 15.9 9.9 12.3 6.1 7.5 1.7 9.3 6.8 8.2 2.9 38.4 1.6 1.4 1.1 3.7 54.5 0.0 8.6 10.3 9.7 2.5 0.1 8.7 2.1 4.1 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 11.5;brain: 21.6;thyroid gland: 29.1" "Group enriched" "Detected in some" 5 "Early spermatids: 18.2;Late spermatids: 39.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "NK-cell: 11.5" "Lineage enriched" "Detected in single" 115 "NK-cells: 11.5" "Group enriched" "Detected in some" 5 "AF22: 21.1;U-2197: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli No NA "Nucleoplasm, Nucleoli" "HPA069813: AB_2686206, HPA071585: AB_2686423" "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.79e-3)" 0.8 2.0 4.4 0.9 15.3 0.8 0.9 0.6 20.4 3.3 1.0 0.9 0.0 0.7 1.4 1.0 0.7 0.9 1.0 1.5 6.1 4.0 1.2 0.7 0.8 0.9 3.3 7.8 1.6 0.7 0.7 5.3 1.0 21.6 1.6 1.2 1.4 0.8 1.5 0.7 0.7 0.8 0.8 1.0 1.3 1.0 2.9 3.9 0.0 29.1 0.0 0.9 0.8 0.2 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 1.2 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.2 0.0 0.0 0.2 0.0 0.0 1.2 0.3 0.0 0.0 0.0 1.8 3.4 0.0 0.0 0.0 0.6 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.1 4.4 15.3 0.6 20.4 6.1 4.0 3.3 7.8 21.6 3.9 0.0 0.0 0.0 0.2 0.0 6.0 0.4 2.5 0.0 0.0 0.0 5.9 0.0 1.7 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 39.7 2.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.1 0.0 1.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 ZMYND10 "BLU, CILD22" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50346852 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 55.7;testis: 99.4" "Group enriched" "Detected in many" 10 "Ciliated cells: 293.1;Early spermatids: 194.4;Late spermatids: 324.6;Spermatocytes: 352.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 10.6;U-87 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035255 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favorable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.1 0.1 1.9 0.2 4.8 0.3 0.6 0.3 0.8 1.6 0.1 5.5 0.2 0.2 0.9 4.6 0.2 55.7 0.3 0.1 2.6 3.1 0.5 0.2 4.7 0.2 0.2 0.3 4.2 0.2 1.4 1.6 0.1 10.2 0.1 0.1 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.5 0.2 0.1 99.4 1.2 0.1 0.8 0.1 0.1 0.1 0.0 0.4 1.1 0.8 0.7 3.8 2.5 0.5 2.7 1.0 0.4 0.8 1.0 1.6 0.8 0.4 1.8 3.0 0.9 0.2 1.4 1.0 1.1 1.7 0.3 0.6 2.4 0.1 0.3 1.1 1.1 2.5 3.6 0.1 0.1 0.7 1.2 0.1 0.3 3.8 0.2 2.7 0.2 2.2 0.6 0.6 0.5 1.4 0.5 3.4 0.0 0.4 1.1 1.1 0.1 0.8 3.7 0.1 2.9 1.2 0.3 0.8 0.2 0.1 10.6 0.9 0.0 0.8 0.8 1.8 0.2 1.4 0.6 0.3 7.4 3.4 0.2 0.3 0.4 0.3 2.5 0.4 1.0 0.1 0.2 0.4 1.1 0.4 0.1 0.5 0.8 3.8 0.7 0.4 0.1 0.5 1.9 4.8 0.3 0.8 2.6 3.1 0.2 0.3 10.2 1.2 3.0 6.1 0.0 0.3 0.5 1.2 0.8 0.0 293.1 29.6 1.8 3.9 0.1 0.0 0.7 194.4 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.5 0.5 0.0 0.0 1.3 0.0 324.6 8.3 0.2 1.7 0.0 0.4 1.0 0.1 0.0 5.3 0.7 5.7 0.0 0.4 352.7 8.5 0.4 0.1 0.7 0.2 0.1 ZMYND12 DKFZp434N2435 ENSG00000066185 "Zinc finger MYND-type containing 12" Q9H0C1 1 42430329-42456267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 51.8" "Group enriched" "Detected in many" 4 "Ciliated cells: 30.8;Early spermatids: 110.7;Late spermatids: 52.1;Spermatocytes: 31.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HSkMC: 6.0;SK-MEL-30: 5.0;WM-115: 3.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA "unprognostic (4.54e-2)" "unprognostic (1.57e-1)" "unprognostic (2.20e-1)" "unprognostic (6.43e-3)" "unprognostic (2.53e-3)" "unprognostic (8.13e-2)" "unprognostic (4.89e-2)" "unprognostic (2.79e-3)" "unprognostic (7.23e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "unprognostic (1.87e-2)" "prognostic favorable (1.11e-5)" "unprognostic (1.76e-1)" "unprognostic (2.27e-2)" "unprognostic (1.52e-1)" "unprognostic (1.45e-1)" 1.0 2.6 3.4 0.3 4.7 0.4 2.2 1.1 3.3 1.9 1.0 4.7 3.3 0.9 1.3 7.8 0.5 15.3 1.8 2.1 3.3 4.8 6.9 5.4 2.1 0.5 2.7 4.0 2.0 3.0 3.0 6.1 0.5 9.7 2.2 1.0 2.7 1.3 3.1 1.8 0.7 0.6 1.0 2.8 0.8 1.5 51.8 2.5 0.2 4.9 0.2 0.4 1.2 0.7 0.6 2.0 0.1 1.6 3.0 0.8 1.0 0.0 0.0 0.4 1.6 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 1.2 0.0 0.0 6.0 0.4 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.9 0.1 1.5 0.0 0.8 0.0 0.0 0.4 0.0 1.5 0.9 0.0 0.8 5.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 2.0 1.8 0.0 0.0 0.7 3.6 0.0 1.6 0.1 0.1 1.2 0.7 0.2 0.8 0.0 2.0 0.6 0.7 0.4 0.1 3.0 1.1 0.7 0.0 1.0 3.4 4.7 1.1 3.3 3.3 4.8 2.7 4.0 9.7 2.5 3.0 2.4 0.0 0.6 0.0 0.4 3.5 7.6 30.8 4.5 7.0 0.0 1.0 13.3 0.4 110.7 0.1 0.7 0.0 0.4 1.0 0.8 0.9 0.0 3.4 2.2 0.0 0.0 0.6 2.2 52.1 2.3 0.0 3.3 1.0 1.7 3.1 0.1 0.0 2.1 11.1 2.9 0.0 0.2 31.6 3.4 0.3 0.6 0.0 0.6 0.7 ZMYND15 DKFZp434N127 ENSG00000141497 "Zinc finger MYND-type containing 15" Q9H091 17 4740015-4746119 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 25.6" "Group enriched" "Detected in many" 6 "Early spermatids: 141.0;monocytes: 36.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.1;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;monocytes: 1.5" "Cell line enhanced" "Detected in some" "A-431: 5.1;CAPAN-2: 4.8;HaCaT: 3.9;T-47d: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA023286 Uncertain "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA023286: AB_1859076" "unprognostic (2.30e-3)" "unprognostic (1.63e-2)" "unprognostic (1.61e-2)" "unprognostic (7.49e-3)" "unprognostic (3.62e-2)" "unprognostic (7.86e-2)" "unprognostic (4.97e-2)" "unprognostic (1.59e-2)" "unprognostic (1.33e-2)" "unprognostic (3.49e-1)" "unprognostic (6.72e-3)" "unprognostic (4.02e-1)" "unprognostic (5.47e-2)" "unprognostic (4.62e-2)" "unprognostic (9.24e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" 3.6 1.6 2.3 2.9 2.0 0.9 2.0 0.7 2.7 1.3 1.0 5.1 1.4 5.2 1.8 4.5 1.2 1.5 3.8 3.8 3.6 1.8 2.4 3.5 6.1 4.9 3.7 1.7 0.9 4.7 12.5 1.8 1.5 3.4 1.9 1.0 4.2 3.8 2.7 0.4 1.8 3.9 1.2 4.8 6.2 2.4 25.6 2.9 0.7 1.4 0.7 0.8 1.6 0.9 0.0 0.1 1.1 1.5 0.0 0.0 0.2 5.1 0.9 0.0 2.5 0.1 0.2 0.4 0.1 1.4 1.3 3.1 2.3 4.8 0.0 0.2 0.0 0.6 3.9 0.9 0.4 0.1 0.5 1.7 0.0 0.5 1.3 0.8 0.1 1.4 0.2 0.6 0.2 0.2 0.7 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.7 0.6 0.6 0.0 0.1 1.4 1.6 2.3 0.0 3.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 1.5 0.0 0.0 0.2 2.3 2.0 0.7 2.7 3.6 1.8 3.7 1.7 3.4 2.9 0.0 1.3 0.0 5.2 0.8 0.1 0.6 0.0 0.0 1.2 1.8 0.0 0.0 0.0 1.4 141.0 0.3 4.0 0.0 3.5 0.0 0.3 5.3 0.0 0.2 5.0 0.0 1.2 3.7 7.6 15.1 0.6 10.7 1.7 36.9 2.6 1.4 2.6 0.6 2.1 0.7 0.2 0.0 0.5 0.7 1.2 0.6 0.0 0.0 0.6 7.4 ZNF10 KOX1 ENSG00000256223 "Zinc finger protein 10" P21506 12 133130575-133159465 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003204 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" Nucleoplasm "HPA003204: AB_1080663" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (6.48e-2)" "unprognostic (2.67e-3)" "unprognostic (1.87e-1)" "unprognostic (6.39e-3)" "unprognostic (4.02e-3)" "unprognostic (2.13e-1)" "unprognostic (3.35e-3)" "unprognostic (2.50e-2)" "unprognostic (3.94e-2)" "unprognostic (3.41e-1)" "unprognostic (1.52e-1)" "unprognostic (4.36e-2)" "unprognostic (5.13e-3)" 4.8 12.7 5.7 4.9 11.5 6.3 10.5 13.0 9.9 9.3 7.9 7.8 14.4 3.0 12.7 20.7 5.1 10.2 9.9 6.7 5.0 5.6 7.3 7.6 6.4 4.4 8.5 6.4 18.2 10.3 22.6 57.6 4.2 8.3 12.2 5.4 8.8 6.2 16.4 5.1 7.2 5.6 12.3 8.8 5.0 8.2 12.1 7.9 6.8 17.3 5.1 5.6 8.1 7.2 4.4 4.4 1.8 0.7 8.6 8.8 2.4 3.1 2.0 10.0 0.0 11.3 4.7 6.1 4.1 3.7 5.1 3.5 3.6 2.2 0.0 5.7 4.1 2.8 1.6 6.4 3.4 3.7 0.0 5.9 7.4 9.4 3.7 3.4 4.5 2.5 4.9 3.2 5.5 6.1 7.6 4.1 5.8 5.3 0.0 6.0 1.1 10.8 9.5 10.3 2.0 4.1 8.9 6.4 5.0 3.9 7.3 10.2 6.4 8.1 1.1 3.4 4.8 6.3 4.4 4.0 3.7 3.4 3.5 3.4 0.2 0.0 11.8 1.2 1.6 3.4 1.1 0.6 1.8 4.0 0.7 4.5 4.2 4.6 5.5 1.7 4.4 8.8 4.4 0.7 8.6 0.5 4.4 1.2 2.4 5.7 11.5 13.0 9.9 5.0 5.6 8.5 6.4 8.3 7.9 0.0 7.0 3.7 4.2 3.4 16.5 6.7 2.5 1.4 9.1 0.0 29.5 3.5 1.7 1.7 11.6 2.3 1.7 0.0 1.2 1.7 3.1 4.1 10.4 3.8 2.1 4.8 12.1 1.3 3.1 4.7 2.6 2.8 3.3 1.8 3.0 6.1 0.9 2.3 6.3 1.7 16.3 0.0 11.3 13.7 13.8 3.3 3.2 4.4 3.0 1.4 ZNF101 "DKFZp570I0164, HZF12" ENSG00000181896 "Zinc finger protein 101" Q8IZC7 19 19668796-19683509 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 27.4;lymphoid tissue: 37.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Lineage enriched" "Detected in all" 4 "T-cells: 27.4" "Cell line enhanced" "Detected in all" "U-698: 41.1" "HPA023449, HPA055486" Uncertain NA NA "HPA023449: AB_2671211, HPA055486: AB_2682831" "unprognostic (5.05e-2)" "prognostic favorable (5.76e-5)" "unprognostic (1.68e-2)" "unprognostic (2.81e-1)" "unprognostic (1.11e-1)" "prognostic favorable (2.15e-4)" "unprognostic (2.43e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.62e-2)" "prognostic favorable (2.26e-4)" "unprognostic (9.34e-3)" "unprognostic (1.63e-2)" "unprognostic (8.84e-3)" "prognostic favorable (1.11e-4)" "unprognostic (3.15e-2)" "unprognostic (7.02e-2)" "prognostic favorable (4.37e-4)" 4.0 2.5 2.8 21.6 2.7 9.7 5.6 2.7 2.9 2.7 3.7 2.2 2.3 2.5 3.2 2.3 8.1 2.0 4.4 2.2 3.2 2.4 4.0 3.0 4.0 36.0 2.8 1.9 2.7 3.6 1.5 2.5 4.2 2.2 2.5 3.8 3.9 7.0 3.1 1.5 4.2 8.1 1.6 3.1 11.0 3.5 11.3 2.1 37.9 4.5 4.3 22.1 5.4 3.1 6.8 4.8 5.4 3.3 4.8 27.4 7.7 3.0 2.8 3.5 4.2 1.4 2.4 6.3 3.6 2.0 2.8 4.9 3.5 3.8 17.5 3.9 1.9 3.0 2.8 6.1 3.7 5.7 2.5 3.2 5.6 2.7 5.7 1.1 10.1 9.5 1.8 2.1 5.1 3.8 1.7 3.4 13.3 3.9 9.9 3.3 3.6 12.8 3.3 9.3 3.0 4.3 5.1 4.6 7.4 2.9 5.1 1.8 2.0 3.3 2.8 1.2 4.8 3.7 6.0 2.5 4.0 1.6 6.0 3.5 4.6 9.1 41.1 2.3 5.5 3.7 5.4 2.0 3.4 6.5 2.7 11.5 6.8 15.5 10.2 3.0 6.4 22.2 16.1 3.0 4.8 3.3 4.8 27.4 7.7 2.8 2.7 2.7 2.9 3.2 2.4 2.8 1.9 2.2 2.1 11.9 5.0 16.1 1.9 2.3 6.4 2.4 2.5 6.7 4.5 8.7 5.9 4.9 3.3 3.6 9.5 6.8 3.6 0.0 5.6 4.2 2.3 2.5 5.8 2.4 5.9 1.6 2.9 4.9 7.3 7.1 2.6 6.1 3.3 5.4 2.3 2.5 4.6 3.5 1.4 2.4 10.7 0.0 1.9 8.6 9.8 1.9 1.7 17.5 2.6 3.1 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1626.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.4 8.4 14.7 16.2 37.2 32.8 9.0 11.8 11.2 10.3 11.0 19.7 4.2 9.7 10.5 14.4 11.8 16.6 15.2 12.0 15.8 15.7 7.3 18.6 19.6 7.0 10.7 22.2 11.1 24.7 8.1 15.7 17.5 9.2 16.5 12.2 22.0 1.3 16.7 5.7 8.5 5.4 6.2 11.4 8.6 8.1 26.7 5.3 5.4 16.3 9.4 5.0 23.8 11.2 13.2 12.0 10.3 14.5 24.9 11.1 17.1 14.7 17.2 8.1 15.6 36.4 9.9 17.8 19.2 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 125.0 90.2 37.8 49.6 34.2 58.0 1626.8 56.0 188.7 61.4 27.9 90.3 31.5 34.9 37.0 133.3 49.8 30.9 23.3 36.8 30.7 62.9 79.6 42.8 32.7 46.8 33.4 38.7 57.1 104.1 80.0 34.8 64.4 62.4 28.9 28.5 43.3 51.2 23.0 87.0 34.8 75.4 45.3 46.4 55.4 37.4 26.1 25.6 29.4 33.7 64.4 ZNF107 "smap-7, ZFD25, ZNF588" ENSG00000196247 "Zinc finger protein 107" Q9UII5 7 64666083-64711582 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 37.4" "Cell type enhanced" "Detected in many" 5 "B-cells: 18.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 23.3;REH: 24.8;U-698: 26.2" NA NA "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.50e-2)" "unprognostic (4.98e-2)" "unprognostic (1.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.67e-2)" "unprognostic (2.51e-2)" "unprognostic (4.13e-3)" "unprognostic (1.62e-2)" "unprognostic (2.34e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (3.32e-1)" "unprognostic (1.66e-1)" "unprognostic (5.49e-2)" "unprognostic (7.15e-3)" 5.6 8.6 3.7 16.2 6.6 9.6 19.3 8.6 5.0 9.5 3.6 5.8 2.7 3.5 4.1 3.4 5.9 4.2 3.9 3.2 4.2 3.2 4.0 3.0 4.7 19.7 7.8 3.2 6.3 4.0 2.9 9.3 4.5 5.8 6.0 4.8 2.4 10.3 6.1 2.2 9.6 14.6 3.3 8.2 17.8 4.8 4.2 7.7 37.4 7.0 4.2 18.9 8.4 7.2 10.1 2.7 13.5 1.6 2.5 6.2 1.6 3.4 2.0 6.0 10.3 1.4 1.5 4.4 2.6 1.7 3.9 5.2 3.2 3.3 20.1 4.8 1.7 5.3 2.7 6.6 2.6 5.9 4.8 4.5 3.9 3.1 1.8 0.7 7.3 7.0 2.5 1.8 3.3 1.9 2.0 1.9 18.6 6.8 10.5 3.5 2.8 23.3 8.0 11.5 2.1 2.3 24.8 5.0 4.4 2.1 6.8 6.7 5.4 4.0 4.2 2.6 8.7 6.6 5.1 1.6 6.6 2.6 2.6 3.7 5.0 4.4 26.2 1.5 5.1 4.3 8.6 0.7 1.4 3.5 1.6 3.7 8.4 4.7 4.7 1.0 10.1 6.2 5.7 13.5 2.5 1.1 2.7 3.9 1.6 3.7 6.6 8.6 5.0 4.2 3.2 7.8 3.2 5.8 7.7 11.9 6.2 18.2 2.8 1.9 5.7 2.8 5.1 2.7 5.7 7.0 2.0 2.5 1.7 2.4 5.8 3.8 1.2 0.0 2.7 2.0 2.7 3.9 0.0 0.5 1.5 3.2 6.3 2.5 2.5 5.7 4.0 3.4 0.0 1.0 3.3 3.5 3.2 2.9 3.2 1.7 5.7 6.5 1.7 2.9 5.1 3.6 2.1 7.5 3.3 2.7 ZNF114 MGC17986 ENSG00000178150 "Zinc finger protein 114" Q8NC26 19 48270102-48287608 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 11.5" "Cell type enhanced" "Detected in many" 12 "Club cells: 4.5;Syncytiotrophoblasts: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 17.0;Hep G2: 19.9;NTERA-2: 10.3;REH: 10.5" "HPA025019, HPA029553" Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA025019: AB_1859080, HPA029553: AB_10603005" "unprognostic (1.82e-1)" "unprognostic (1.88e-1)" "unprognostic (5.41e-2)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (2.67e-1)" "unprognostic (3.35e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (4.56e-3)" "unprognostic (5.21e-2)" "unprognostic (1.13e-7)" "unprognostic (9.74e-2)" "unprognostic (2.78e-1)" "unprognostic (9.15e-2)" "unprognostic (1.63e-1)" 1.5 1.0 3.7 2.2 2.7 2.1 1.2 1.2 3.3 2.3 0.6 2.1 1.0 0.9 2.4 2.4 1.3 1.9 1.5 1.7 3.7 4.6 1.6 0.5 1.4 1.9 2.6 0.8 1.2 5.3 4.2 1.6 7.5 2.1 3.1 0.4 2.5 3.7 1.3 3.7 3.7 0.7 1.4 3.5 1.6 0.7 1.6 1.7 1.0 11.5 0.5 1.1 1.3 5.7 2.6 3.5 5.4 0.7 2.0 0.6 0.4 2.7 4.3 5.2 0.5 0.3 0.0 17.0 0.5 0.0 1.6 2.1 1.5 4.3 0.1 5.0 0.3 1.9 5.6 7.1 0.3 1.8 0.1 0.4 0.6 1.3 19.9 1.6 2.7 0.5 0.3 0.5 0.8 0.1 0.5 0.3 0.7 0.7 0.4 0.3 8.1 0.2 8.4 10.3 7.4 0.9 10.5 0.0 0.3 0.2 2.3 2.1 2.4 2.8 0.0 3.0 3.3 1.1 5.0 0.7 0.8 1.8 1.5 0.5 0.4 0.1 0.1 0.2 1.5 0.8 3.3 0.7 0.9 0.5 0.6 0.3 0.9 0.6 0.4 1.7 2.6 0.5 0.4 5.4 2.0 0.7 3.5 0.2 0.4 3.7 2.7 1.2 3.3 3.7 4.6 2.6 0.8 2.1 1.7 3.0 2.6 0.0 0.8 0.3 1.2 0.4 0.0 1.4 4.5 0.0 0.0 1.9 1.7 0.1 2.1 1.1 0.0 0.0 0.5 2.1 0.8 0.7 0.0 0.4 1.4 0.0 0.0 1.8 0.8 0.0 1.1 1.1 0.0 0.0 0.0 1.3 0.4 0.0 0.7 0.0 0.6 0.0 0.8 0.5 2.7 0.1 12.8 0.0 0.0 1.0 ZNF124 "HZF-16, HZF16" ENSG00000196418 "Zinc finger protein 124" Q15973 1 247121975-247172016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.7;salivary gland: 23.4" "Group enriched" "Detected in many" 31 "Early spermatids: 319.1;Late spermatids: 835.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA031127 Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nucleoplasm, Nuclear membrane" "HPA031127: AB_10602685" "unprognostic (3.97e-1)" "unprognostic (3.50e-1)" "unprognostic (2.14e-1)" "unprognostic (2.43e-1)" "unprognostic (2.01e-2)" "unprognostic (2.23e-2)" "unprognostic (4.54e-3)" "unprognostic (1.42e-3)" "unprognostic (1.66e-3)" "unprognostic (8.23e-2)" "unprognostic (8.08e-2)" "unprognostic (3.35e-2)" "unprognostic (5.40e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (2.41e-1)" "prognostic favorable (1.03e-4)" 1.9 1.1 1.2 1.9 1.0 2.8 2.1 1.9 1.4 1.6 3.9 3.5 4.1 2.3 1.7 1.7 1.8 1.5 1.5 1.7 3.4 1.9 2.8 3.0 1.8 3.1 3.9 0.5 0.8 2.2 2.3 4.0 23.4 1.2 1.1 2.2 4.2 1.8 2.1 5.2 2.6 2.8 2.4 3.4 3.1 1.8 10.6 12.6 10.0 14.7 9.9 12.3 6.3 3.6 2.8 7.9 10.4 3.0 1.9 19.9 3.8 2.3 4.0 4.1 4.2 3.3 7.4 4.5 3.0 2.7 4.0 9.4 3.0 5.7 0.4 2.6 6.5 3.3 8.9 2.9 11.6 7.5 2.3 2.4 3.9 3.8 1.9 5.7 8.7 9.1 5.2 5.0 3.2 11.9 7.5 20.5 7.1 6.5 12.6 6.4 5.2 3.8 11.0 12.4 12.6 5.6 4.4 3.8 9.9 3.2 18.6 6.5 3.0 4.5 3.3 6.8 4.5 5.5 10.9 1.2 11.9 6.3 6.2 8.8 10.0 7.0 9.9 10.1 10.6 9.1 8.5 12.6 6.7 12.3 11.8 2.0 9.9 14.7 9.9 6.7 6.3 14.9 9.9 3.7 3.6 3.2 3.3 4.4 5.1 4.0 7.9 3.5 3.9 3.1 1.7 4.3 319.1 8.8 6.6 0.0 4.3 5.7 2.7 4.0 10.5 0.8 7.2 0.0 7.5 2.5 18.7 835.8 11.2 14.2 6.8 5.4 5.6 2.1 3.7 10.7 11.3 4.9 5.2 6.5 3.3 7.4 12.8 1.4 1.1 4.3 8.0 5.7 ZNF138 pHZ-32 ENSG00000197008 "Zinc finger protein 138" P52744 7 64794388-64833681 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "unprognostic (1.12e-2)" "unprognostic (3.25e-1)" "unprognostic (1.10e-2)" "unprognostic (3.12e-3)" "unprognostic (2.12e-1)" "unprognostic (1.60e-1)" "unprognostic (5.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.81e-3)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (1.23e-3)" "unprognostic (5.04e-2)" 6.2 10.3 15.3 6.5 24.7 5.7 15.0 41.5 18.7 7.6 6.0 5.9 1.5 5.5 4.5 8.2 7.7 4.3 5.5 5.7 14.2 9.7 8.3 8.9 5.0 11.0 16.2 12.6 5.9 4.3 3.1 10.5 5.1 16.3 7.2 8.0 3.5 7.8 5.4 7.0 15.2 5.5 5.4 16.6 6.2 7.9 9.5 17.1 10.0 7.4 5.6 11.2 5.5 6.4 9.6 6.9 11.2 3.9 4.0 8.9 3.3 3.9 2.9 5.8 11.0 4.0 4.8 6.1 2.5 2.5 3.5 5.9 5.2 6.4 15.7 6.2 1.6 8.3 2.5 9.2 2.7 6.4 6.1 5.9 4.7 4.1 3.6 1.9 9.4 4.7 2.7 2.8 6.0 4.9 4.6 3.1 11.1 12.1 5.9 4.1 7.0 9.1 5.9 13.2 4.3 6.2 7.0 6.5 5.4 4.7 8.8 9.6 9.8 4.3 7.3 5.8 16.3 11.4 8.9 1.7 4.0 4.5 3.5 6.2 8.9 10.4 19.0 2.6 6.3 3.0 11.2 2.2 4.0 5.3 3.9 5.9 9.5 8.3 8.4 2.7 9.6 8.9 8.3 3.4 4.0 3.6 6.9 7.6 3.3 15.3 24.7 41.5 18.7 14.2 9.7 16.2 12.6 16.3 17.1 0.0 3.2 4.2 6.2 8.1 20.2 12.1 0.0 0.0 4.5 5.2 5.9 8.8 6.6 6.3 8.5 8.0 3.8 0.0 12.2 8.3 6.6 3.6 13.9 5.9 6.5 22.3 4.1 4.3 7.0 8.0 6.4 9.3 1.7 7.2 7.0 10.3 7.6 7.0 4.6 5.4 12.4 0.0 4.7 17.6 13.9 9.3 4.7 10.8 7.6 5.9 ZNF157 HZF22 ENSG00000147117 "Zinc finger protein 157" P51786 X 47370583-47414305 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;epididymis: 4.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 3.5;U-266/84: 6.0" "Low region specificity" "Detected in all" HPA003319 Uncertain NA NA "HPA003319: AB_1080677" "unprognostic (1.85e-1)" "unprognostic (3.99e-1)" "unprognostic (7.24e-4)" "unprognostic (1.17e-2)" "unprognostic (1.02e-2)" "unprognostic (7.38e-4)" "unprognostic (2.99e-1)" "unprognostic (2.32e-1)" "unprognostic (4.59e-4)" "unprognostic (5.36e-2)" "unprognostic (6.51e-2)" "unprognostic (1.80e-2)" "unprognostic (3.51e-2)" "unprognostic (7.15e-2)" "unprognostic (4.92e-2)" 0.1 0.3 0.8 0.2 1.0 0.4 0.3 4.4 1.6 0.6 0.1 0.2 0.7 4.4 0.2 3.8 0.1 0.1 0.8 1.0 0.6 0.0 0.1 1.4 0.8 1.0 0.1 2.3 3.0 0.0 0.5 0.1 0.2 0.7 0.1 0.3 0.2 0.5 0.9 0.4 0.1 0.8 1.4 0.8 0.3 0.3 1.4 0.7 1.3 0.3 0.7 2.8 0.9 0.0 0.3 1.0 0.1 0.3 0.3 0.2 0.0 0.0 0.2 0.5 0.1 0.3 1.4 0.7 0.3 0.9 0.0 2.5 1.3 0.2 0.1 1.1 0.5 0.4 0.0 0.0 0.0 0.5 0.3 0.0 1.4 0.1 0.0 0.0 2.4 0.1 3.5 0.4 0.0 1.0 0.3 2.1 0.2 0.1 0.3 0.0 0.0 0.5 0.2 2.6 2.9 0.0 0.3 0.2 2.5 1.6 0.3 0.0 1.1 1.1 0.1 0.1 1.9 6.0 1.7 0.3 0.1 0.0 0.7 0.3 0.4 0.4 0.3 0.2 1.4 0.5 2.2 0.1 1.2 2.8 1.8 1.3 0.7 0.3 0.7 0.8 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.1 ZNF165 "CT53, ZSCAN7" ENSG00000197279 "Zinc finger protein 165" P49910 6 28080975-28089563 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.9" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 113.2;Intestinal endocrine cells: 51.6;Syncytiotrophoblasts: 66.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 8.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.7;GAMG: 14.0" "Low region specificity" "Detected in all" HPA007247 Approved "Nuclear speckles,Microtubules" NA NA "Nuclear speckles, Microtubules" "HPA007247: AB_2797217" "unprognostic (1.85e-1)" "unprognostic (2.01e-3)" "unprognostic (1.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.45e-1)" "unprognostic (4.32e-3)" "unprognostic (3.42e-1)" "unprognostic (2.09e-1)" "unprognostic (1.93e-2)" "prognostic favorable (2.10e-4)" "unprognostic (1.18e-3)" "unprognostic (1.29e-2)" "prognostic favorable (1.19e-5)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (2.18e-1)" "prognostic favorable (9.82e-5)" 0.4 0.8 1.2 2.1 1.7 0.7 2.2 1.3 2.4 1.5 2.6 0.9 7.9 2.0 1.1 6.3 2.5 1.8 0.6 0.8 1.7 1.1 3.5 2.7 2.6 0.9 0.8 0.3 0.7 5.4 3.1 7.7 6.2 4.0 1.2 3.6 0.6 2.5 1.3 0.4 1.0 3.4 0.4 0.5 1.0 2.2 23.9 0.5 1.2 3.1 1.4 2.5 1.2 1.2 8.6 4.2 1.6 0.6 0.2 1.7 0.5 10.5 0.7 0.7 0.5 0.3 0.5 18.7 0.4 0.5 0.8 0.7 7.3 7.9 1.0 3.1 0.2 14.0 4.1 1.7 5.2 0.6 0.2 2.9 0.3 1.2 7.9 0.3 1.8 1.4 0.3 2.9 0.6 7.8 0.5 0.2 0.6 1.8 0.3 0.5 3.0 0.3 2.0 1.5 9.6 0.9 1.3 0.6 6.1 4.3 5.2 7.8 0.6 0.8 9.3 0.7 2.1 4.3 0.3 0.1 0.5 0.8 0.3 0.7 2.6 7.0 2.7 0.3 2.0 0.3 0.0 0.3 1.6 0.7 0.6 1.5 6.0 0.9 0.5 1.2 8.6 1.7 1.3 1.1 0.2 0.2 4.2 0.4 0.5 1.2 1.7 1.3 2.4 1.7 1.1 0.8 0.3 4.0 0.5 6.0 9.5 11.5 12.9 7.6 0.8 0.5 2.5 17.4 6.8 3.5 0.0 6.9 3.3 13.6 113.2 0.9 23.8 0.0 10.7 7.5 0.6 4.0 0.0 0.0 1.3 0.0 51.6 0.0 0.6 7.2 0.9 1.5 5.0 2.8 4.7 1.2 17.1 10.5 2.1 1.4 2.4 0.0 1.3 12.3 2.7 10.3 66.6 1.3 5.6 36.9 ZNF177 ENSG00000188629 "Zinc finger protein 177" Q13360 19 9363020-9382617 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 29.4" "Group enriched" "Detected in some" 11 "Early spermatids: 9.1;Late spermatids: 5.3;Spermatocytes: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 13.1" HPA003141 Uncertain NA NA "HPA003141: AB_1859102" "unprognostic (1.66e-1)" "unprognostic (2.88e-1)" "unprognostic (8.86e-3)" "unprognostic (1.74e-1)" "unprognostic (1.75e-2)" "unprognostic (2.71e-2)" "unprognostic (2.32e-3)" "unprognostic (5.11e-2)" "unprognostic (3.80e-2)" "unprognostic (3.38e-1)" "unprognostic (1.71e-1)" "unprognostic (4.04e-2)" "unprognostic (1.97e-2)" 2.2 2.7 8.1 1.4 6.9 0.4 3.2 8.1 8.5 3.4 2.7 2.3 1.4 0.8 5.8 13.3 1.8 4.7 2.2 3.4 5.1 4.7 3.4 2.3 3.0 1.9 4.5 3.4 9.9 2.0 5.4 5.4 2.8 5.4 3.9 2.3 7.3 2.5 4.2 1.6 2.9 1.4 3.5 4.8 2.3 1.3 29.4 2.7 8.5 4.3 1.4 1.4 1.8 2.2 1.1 1.8 2.4 0.4 3.1 2.1 0.8 0.5 1.3 7.1 4.7 3.4 4.4 2.5 1.5 1.1 3.4 2.8 0.4 0.2 0.5 4.5 0.9 2.9 0.3 2.1 2.0 4.0 1.4 10.1 2.2 0.6 1.3 2.9 3.4 5.5 1.9 3.4 1.6 4.1 6.1 0.9 5.9 0.4 7.3 3.0 0.0 5.4 13.1 2.0 0.1 3.7 2.5 2.4 0.8 1.7 4.5 5.7 1.4 2.0 0.1 1.0 6.1 1.6 4.6 0.8 2.6 1.6 5.2 2.4 0.3 0.0 2.7 0.8 1.9 2.2 2.4 0.1 1.6 1.7 0.4 1.1 1.1 0.2 1.9 1.8 0.2 2.1 1.2 1.6 3.1 0.2 1.1 0.5 0.8 8.1 6.9 8.1 8.5 5.1 4.7 4.5 3.4 5.4 2.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.6 0.5 0.0 0.0 0.0 0.0 0.0 ZNF185 SCELL ENSG00000147394 "Zinc finger protein 185 with LIM domain" O15231 X 152914442-152973480 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 93.5;esophagus: 67.6" "Cell type enhanced" "Detected in many" 10 "Pancreatic endocrine cells: 42.4;Suprabasal keratinocytes: 18.4;Urothelial cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.6" "Group enriched" "Detected in many" 5 "granulocytes: 21.6;monocytes: 13.9" "Cell line enhanced" "Detected in many" "A-431: 31.7;EFO-21: 37.7;HBEC3-KT: 26.2;PC-3: 23.2;TIME: 61.8" "Low region specificity" "Detected in all" "HPA000400, HPA016438" Enhanced Supported "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" NA NA 5400 "Plasma membrane, Cytosol" "Actin filaments, Focal adhesion sites" "HPA000400: AB_1080685, HPA016438: AB_1859109" "unprognostic (1.34e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" "unprognostic (9.75e-3)" "unprognostic (2.69e-1)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (7.94e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.30e-5)" "unprognostic (5.18e-2)" "unprognostic (8.12e-2)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" 3.9 1.7 1.8 2.0 3.2 0.8 1.8 2.7 2.0 14.3 1.8 1.4 10.7 0.0 3.8 93.5 67.6 3.1 2.0 1.9 1.7 0.8 2.0 1.1 3.3 3.1 2.1 1.1 1.2 0.9 0.1 2.3 4.0 1.7 4.2 0.3 1.3 10.1 28.1 1.5 9.9 1.2 1.4 1.2 3.7 0.8 1.9 2.0 1.2 3.9 1.4 6.6 2.1 22.8 0.4 3.8 21.6 13.9 0.2 0.6 10.2 31.7 6.7 0.6 0.4 0.8 1.1 1.5 1.5 0.1 3.9 0.5 0.2 9.6 0.4 37.7 2.3 0.4 4.5 0.9 26.2 16.3 0.3 0.6 2.0 2.7 1.0 1.9 0.1 0.1 0.8 18.8 0.4 15.4 3.9 20.2 0.4 0.1 0.3 0.1 7.5 0.1 0.1 0.5 8.1 23.2 0.1 0.1 0.2 2.0 3.0 0.2 2.2 0.0 6.0 0.9 6.5 6.2 0.7 61.8 0.2 13.7 0.8 1.1 0.3 0.2 0.2 0.4 2.3 0.4 21.6 13.9 5.7 0.5 12.9 0.3 0.4 0.4 0.6 3.8 0.3 0.6 0.3 9.5 0.2 10.2 2.5 0.5 10.2 1.8 3.2 2.7 2.0 1.7 0.8 2.1 1.1 1.7 2.0 11.9 1.6 0.5 4.9 8.1 0.5 1.0 2.5 2.7 4.5 8.7 2.0 3.2 0.0 8.6 0.2 0.5 0.0 0.0 2.6 4.3 2.8 5.1 1.1 0.0 8.6 0.0 0.0 0.6 8.8 0.0 1.1 4.6 3.3 4.6 2.1 3.0 42.4 0.0 1.1 0.9 0.0 0.0 0.5 2.3 5.3 18.4 0.6 0.0 3.3 17.6 ZNF189 ENSG00000136870 "Zinc finger protein 189" O75820 9 101398873-101410660 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 61.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034814 Uncertain Approved "Intermediate filaments" NA NA "Intermediate filaments" "HPA034814: AB_10601030" "unprognostic (3.87e-2)" "unprognostic (3.47e-1)" "unprognostic (5.30e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (1.42e-1)" "unprognostic (1.26e-2)" "unprognostic (3.59e-3)" "unprognostic (1.70e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "prognostic favorable (5.32e-4)" "unprognostic (3.31e-1)" "unprognostic (4.58e-1)" "unprognostic (1.86e-2)" "unprognostic (6.57e-2)" 15.6 15.8 15.1 6.3 28.2 2.8 11.6 13.9 15.9 9.5 9.0 16.8 9.0 8.6 10.0 61.6 5.5 7.8 16.3 10.9 18.7 9.3 10.6 12.5 6.8 6.8 15.4 11.4 11.8 23.0 11.2 23.6 6.3 14.1 10.3 7.5 5.0 6.7 9.4 11.6 4.4 9.7 9.7 25.1 9.9 8.7 9.3 16.1 8.5 9.6 3.7 10.2 6.1 8.0 3.6 2.2 4.1 3.0 3.6 4.7 1.9 5.5 4.6 15.0 10.9 13.5 9.5 7.2 8.0 12.3 9.4 8.2 9.7 4.4 7.5 5.4 9.6 9.9 10.9 7.5 7.6 8.4 9.9 5.2 8.2 7.2 20.6 10.1 8.5 7.2 11.5 10.5 8.3 13.0 12.9 11.6 9.2 9.7 10.9 13.8 3.1 10.2 3.7 10.8 12.3 5.2 7.3 21.5 5.7 8.9 6.5 15.6 9.8 8.6 6.0 8.6 10.3 4.9 10.9 9.7 9.2 6.7 7.6 6.1 10.4 16.0 3.6 8.0 3.4 9.3 1.3 2.5 4.1 2.3 3.0 2.4 2.8 4.0 4.7 2.2 3.6 4.7 4.1 1.4 3.6 2.3 1.7 2.0 1.9 15.1 28.2 13.9 15.9 18.7 9.3 15.4 11.4 14.1 16.1 8.9 5.4 2.4 7.4 8.8 7.9 20.2 22.9 8.1 12.5 1.8 3.9 3.6 8.3 5.3 1.9 9.0 4.9 0.0 15.9 1.7 8.0 5.2 9.2 7.8 4.7 7.9 5.2 8.0 14.0 1.5 10.3 6.6 6.8 1.8 5.3 6.7 8.4 4.9 10.3 11.4 3.3 12.9 9.2 6.2 3.4 5.6 1.6 5.4 3.6 3.5 ZNF19 "KOX12, MGC51021" ENSG00000157429 "Zinc finger protein 19" P17023 16 71464555-71565089 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 32.0" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 13.4;Rod photoreceptor cells: 24.7;Spermatocytes: 14.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063685 Approved Approved Mitochondria NA NA Mitochondria "HPA063685: AB_2685090" "unprognostic (5.59e-4)" "unprognostic (1.38e-1)" "unprognostic (1.39e-1)" "unprognostic (2.05e-4)" "unprognostic (6.02e-3)" "unprognostic (4.92e-2)" "unprognostic (3.34e-2)" "unprognostic (6.97e-3)" "unprognostic (2.23e-1)" "unprognostic (4.84e-2)" "unprognostic (8.90e-4)" "unprognostic (1.31e-1)" "unprognostic (3.04e-6)" "unprognostic (3.38e-1)" "unprognostic (1.03e-1)" "unprognostic (2.83e-2)" "unprognostic (4.87e-2)" 4.7 3.3 4.8 4.1 6.8 2.5 6.3 4.3 5.2 3.8 2.6 7.1 2.9 3.3 5.6 14.4 4.6 9.1 6.9 4.7 4.9 4.1 5.6 3.4 4.5 3.4 3.0 4.4 4.8 6.4 3.9 32.0 1.7 6.8 3.6 2.2 5.2 4.9 3.2 9.0 6.9 3.4 2.6 4.5 3.1 3.0 18.7 5.5 3.0 8.9 2.0 2.6 2.8 1.9 6.1 3.5 4.4 2.5 2.5 4.3 1.7 2.5 1.7 5.7 6.2 2.8 3.8 3.7 3.0 1.4 2.4 3.0 3.8 6.3 4.5 4.1 1.6 3.8 2.4 3.0 2.9 1.1 2.7 3.3 4.6 4.1 4.9 0.9 4.9 4.1 5.0 3.8 2.8 5.3 4.8 2.3 6.2 2.9 4.2 1.8 3.5 3.3 3.6 2.9 1.1 4.5 2.1 4.7 1.8 2.9 5.5 9.1 5.8 6.1 1.8 5.0 4.2 4.5 3.7 2.7 6.2 3.1 4.3 3.5 4.0 3.3 1.7 5.6 3.0 3.4 4.4 2.4 2.1 3.1 2.2 1.3 5.4 3.4 3.0 1.9 6.1 4.3 3.9 4.3 2.5 2.5 3.5 1.4 1.7 4.8 6.8 4.3 4.8 4.9 4.1 3.0 4.4 6.8 5.5 0.0 2.7 0.5 2.0 0.2 3.2 1.1 0.0 13.4 2.3 1.8 9.8 1.1 5.0 3.4 2.4 1.1 1.7 0.0 1.2 0.7 1.0 1.6 0.0 2.9 1.2 9.5 1.2 2.5 0.6 3.6 0.6 0.6 0.0 1.0 1.5 3.8 2.2 1.4 1.8 2.1 24.7 6.5 1.0 14.6 7.0 0.5 0.5 0.9 1.2 0.7 ZNF200 ENSG00000010539 "Zinc finger protein 200" P98182 16 3222325-3236221 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 27.3" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 31.6;Spermatocytes: 38.8;Spermatogonia: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018981, HPA059310" Uncertain Approved Mitochondria No No Mitochondria "HPA018981: AB_1859021, HPA059310: AB_2683974" "unprognostic (1.74e-1)" "unprognostic (5.74e-2)" "unprognostic (3.21e-2)" "unprognostic (8.78e-2)" "unprognostic (9.72e-2)" "unprognostic (3.71e-2)" "unprognostic (1.31e-1)" "unprognostic (2.20e-1)" "unprognostic (7.55e-2)" "unprognostic (2.16e-1)" "unprognostic (3.80e-2)" "unprognostic (2.98e-2)" "unprognostic (2.68e-1)" "unprognostic (1.12e-2)" "unprognostic (1.89e-1)" "unprognostic (1.11e-1)" "unprognostic (5.23e-3)" 5.4 5.5 4.4 7.5 5.4 3.0 5.7 8.6 7.0 5.1 4.9 6.0 4.7 5.5 6.0 6.8 5.1 5.9 4.7 5.2 4.0 4.3 4.8 6.4 5.2 9.5 4.6 3.3 6.2 3.9 7.3 7.1 8.2 5.6 5.3 5.0 4.2 5.1 4.7 4.0 4.1 5.4 5.3 3.8 10.4 4.7 27.3 5.0 9.6 6.8 2.9 8.3 5.8 4.9 5.8 5.0 19.3 5.1 8.7 10.1 5.4 4.9 5.2 11.7 8.3 4.3 4.6 14.1 6.4 8.0 8.9 8.2 7.8 4.2 9.7 5.0 5.2 5.2 3.7 9.1 7.0 10.6 9.0 8.4 8.0 6.9 6.4 5.8 13.6 19.1 4.6 5.8 6.5 5.9 5.1 7.6 6.9 8.8 7.4 7.7 4.5 9.7 7.1 18.4 6.1 5.0 11.8 16.1 11.3 5.5 2.8 6.7 9.9 6.1 4.7 5.3 8.3 6.7 15.3 5.2 9.1 8.5 3.1 5.6 19.0 18.6 8.3 2.2 8.5 7.0 19.3 3.9 13.6 8.5 5.1 8.2 5.8 7.8 10.1 5.0 5.6 8.0 8.9 16.9 8.7 4.7 3.1 9.0 5.4 4.4 5.4 8.6 7.0 4.0 4.3 4.6 3.3 5.6 5.0 3.0 3.0 0.5 4.1 2.9 5.3 3.4 7.6 2.7 5.7 3.5 11.8 5.9 3.3 3.9 31.6 7.0 2.6 23.3 3.4 5.3 5.1 3.4 4.7 3.8 6.0 0.0 6.4 6.7 7.1 17.1 5.2 6.9 6.8 3.6 4.0 5.7 2.9 4.0 2.8 1.9 6.1 6.5 5.7 38.8 31.2 2.8 4.9 6.5 3.3 4.2 ZNF215 "ZKSCAN11, ZSCAN43" ENSG00000149054 "Zinc finger protein 215" Q9UL58 11 6926404-7001004 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.6" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 7.0;Cone photoreceptor cells: 5.9;Spermatogonia: 7.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 18.1" "Low region specificity" "Detected in all" "HPA047243, HPA051010" Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA047243: , HPA051010: AB_2681308" "unprognostic (2.18e-2)" "unprognostic (1.52e-1)" "unprognostic (2.29e-2)" "unprognostic (1.08e-1)" "unprognostic (8.18e-2)" "unprognostic (4.76e-2)" "unprognostic (1.01e-4)" "unprognostic (2.02e-1)" "unprognostic (1.50e-2)" "unprognostic (1.05e-1)" "unprognostic (3.44e-1)" "unprognostic (1.45e-2)" "unprognostic (9.01e-3)" "unprognostic (4.29e-3)" "unprognostic (7.89e-2)" "unprognostic (1.21e-1)" "unprognostic (1.90e-1)" 1.2 1.4 1.5 9.0 1.8 1.4 2.7 0.7 4.0 1.9 4.2 0.3 0.9 4.6 2.3 5.2 2.8 1.4 1.1 1.4 1.2 2.2 2.9 1.6 1.5 6.7 0.7 1.4 1.9 10.4 0.0 0.8 0.7 1.9 2.7 5.5 1.2 4.2 2.0 0.9 1.6 5.5 0.9 1.1 4.8 1.6 6.1 0.0 6.5 2.7 2.1 11.6 3.3 2.2 2.5 2.9 4.0 1.8 1.5 1.4 0.8 2.6 1.2 1.8 0.6 1.3 1.6 5.8 6.2 5.3 3.2 6.4 0.2 0.1 8.7 2.0 3.3 4.1 3.1 5.1 6.1 6.1 0.0 7.0 0.1 0.8 0.1 1.3 5.3 0.4 2.8 2.9 0.1 6.7 1.6 5.1 0.1 10.2 3.0 1.3 0.1 0.2 0.2 8.5 0.0 1.7 0.2 0.1 1.0 0.2 4.8 0.1 0.2 0.0 2.2 0.2 4.5 0.2 2.2 2.4 2.0 5.8 2.4 0.1 0.4 0.1 18.1 4.6 0.3 1.8 4.0 1.8 0.6 0.8 1.0 0.3 2.5 0.6 1.4 1.7 2.5 1.4 0.8 2.7 1.5 0.5 2.9 0.7 0.8 1.5 1.8 0.7 4.0 1.2 2.2 0.7 1.4 1.9 0.0 0.0 0.0 2.2 1.3 0.3 0.5 0.2 0.0 0.0 1.2 7.0 5.9 0.3 1.7 0.1 0.2 0.0 1.3 0.0 1.5 2.2 0.5 0.4 1.1 1.0 0.4 3.2 1.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.6 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.9 1.5 7.5 0.3 0.0 0.0 2.5 0.6 ZNF217 ZABC1 ENSG00000171940 "Zinc finger protein 217" O75362 20 53567065-53609907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 114.7;Suprabasal keratinocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 50.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051857 Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA051857: AB_2681641" "unprognostic (4.17e-2)" "unprognostic (4.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (2.49e-3)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.13e-3)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.67e-1)" "unprognostic (2.52e-2)" 9.9 3.0 3.6 9.3 2.9 10.9 15.0 2.2 3.1 7.6 6.7 3.1 6.1 4.5 6.2 2.9 10.0 5.7 5.7 5.4 3.4 1.6 6.3 10.3 8.8 20.9 3.0 2.3 6.1 7.1 8.3 3.9 65.5 4.8 7.1 6.8 5.7 11.0 8.6 5.2 11.9 8.9 6.6 3.4 16.8 6.7 9.9 2.4 16.7 6.9 4.9 9.5 10.6 8.6 4.3 4.1 19.4 11.5 5.8 3.6 2.2 9.2 11.0 9.3 13.5 8.7 10.0 20.4 10.4 10.7 11.8 5.9 7.1 10.4 9.0 11.2 12.6 15.3 9.1 7.4 10.9 13.7 6.4 2.1 2.9 4.8 12.3 6.8 4.6 12.5 5.4 10.6 6.3 17.6 9.3 6.7 9.4 6.3 42.8 8.8 36.9 16.0 10.3 9.8 5.3 11.0 12.6 7.8 10.4 6.8 20.7 0.9 2.6 9.6 50.0 10.1 12.3 14.9 19.8 4.7 23.9 8.9 12.2 12.7 17.8 19.7 7.6 8.7 5.3 7.6 5.9 4.9 8.4 2.8 6.3 3.6 4.3 3.0 3.5 3.9 3.9 3.4 3.3 19.4 5.8 11.5 4.1 2.9 2.2 3.6 2.9 2.2 3.1 3.4 1.6 3.0 2.3 4.8 2.4 0.0 10.1 12.3 36.1 114.7 0.6 7.5 15.3 22.7 14.8 17.4 0.0 11.9 8.3 23.0 36.2 14.6 32.6 23.3 14.3 14.2 18.3 61.3 11.5 24.3 13.3 0.0 5.8 16.0 38.2 20.0 6.4 34.4 20.3 6.4 27.1 2.0 19.8 28.1 4.9 9.6 0.5 0.0 8.6 5.4 24.0 93.3 37.8 20.8 21.0 72.7 ZNF221 ENSG00000159905 "Zinc finger protein 221" 19 43951223-43967709 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 22.4" "Cell type enhanced" "Detected in some" 7 "Bipolar cells: 2.6;Cone photoreceptor cells: 2.0;Melanocytes: 1.7;Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA059435 Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA059435: AB_2684016" "unprognostic (2.06e-1)" "unprognostic (8.35e-2)" "unprognostic (2.65e-2)" "unprognostic (1.63e-1)" "unprognostic (3.17e-3)" "unprognostic (2.11e-1)" "unprognostic (1.81e-2)" "unprognostic (3.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.17e-2)" "unprognostic (5.02e-2)" "unprognostic (1.91e-1)" "unprognostic (1.84e-2)" "unprognostic (3.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" 3.8 5.4 7.9 2.0 7.5 2.0 4.3 22.4 9.5 4.2 3.2 4.2 1.9 1.7 4.5 3.2 2.9 4.6 2.3 3.8 7.9 3.9 4.0 3.5 3.5 2.2 7.3 6.0 7.1 3.0 10.4 10.1 4.5 7.0 5.4 2.7 2.5 3.4 4.3 2.1 3.7 2.6 4.8 7.8 3.4 3.4 3.5 11.3 1.2 6.0 1.2 2.4 4.9 3.3 1.6 1.9 1.6 1.2 3.5 1.7 0.9 2.1 1.8 5.8 4.4 2.1 3.9 1.4 2.2 3.3 1.8 3.3 2.4 0.9 0.0 1.2 2.3 1.6 0.9 2.3 1.5 3.8 0.0 4.1 5.8 7.4 0.9 1.6 0.6 2.7 4.6 1.2 3.4 1.3 3.6 3.7 0.0 0.2 0.0 2.6 0.1 0.0 1.0 5.1 0.7 1.8 0.1 6.5 0.7 1.4 6.9 4.8 3.9 4.3 0.4 0.5 3.4 1.6 4.9 6.0 2.5 5.7 1.3 1.9 3.0 3.8 0.0 0.8 2.4 2.7 1.5 0.8 1.2 1.1 1.2 1.5 0.6 1.7 1.7 1.9 1.6 1.1 0.7 1.6 3.5 0.9 1.8 0.7 0.9 7.9 7.5 22.4 9.5 7.9 3.9 7.3 6.0 7.0 11.3 0.0 1.3 0.0 0.0 0.0 2.6 0.6 0.0 0.0 0.0 0.0 2.0 0.3 0.0 0.5 0.3 0.0 0.0 0.0 0.4 0.1 0.3 0.1 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.7 0.0 0.0 1.4 0.3 0.0 0.4 0.1 2.2 0.0 0.2 1.1 0.2 0.1 0.2 0.0 0.0 0.3 ZNF233 FLJ38032 ENSG00000159915 "Zinc finger protein 233" A6NK53 19 44259880-44275317 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 25.2" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 23.3;Spermatocytes: 8.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 10.7;U-266/84: 10.0" HPA020975 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA020975: AB_1859145" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-1)" "unprognostic (1.60e-1)" "unprognostic (3.72e-2)" "unprognostic (7.37e-3)" "unprognostic (2.77e-2)" "unprognostic (9.07e-3)" "unprognostic (1.48e-1)" "unprognostic (4.20e-3)" "unprognostic (1.65e-1)" "unprognostic (6.28e-3)" "unprognostic (6.88e-2)" "unprognostic (3.47e-2)" "unprognostic (2.71e-4)" "unprognostic (1.55e-1)" 0.6 2.3 4.4 2.1 6.3 3.9 2.5 10.9 8.5 1.3 4.3 0.8 0.2 1.9 0.9 2.8 1.4 2.2 1.8 4.8 4.1 5.0 2.1 0.8 1.2 2.3 3.3 6.1 1.2 1.6 3.1 11.2 2.2 6.2 4.8 2.2 2.1 1.6 2.3 2.5 3.8 1.8 1.6 3.4 2.2 2.1 25.2 2.4 3.3 3.5 2.7 1.0 1.6 0.8 4.7 3.9 3.3 1.2 3.4 2.2 0.5 0.7 2.7 3.1 3.1 3.2 0.6 1.3 1.2 0.8 1.0 1.8 2.8 3.3 1.2 2.9 0.8 1.5 1.3 0.1 0.7 1.1 0.6 3.8 1.9 3.5 2.9 2.2 1.3 1.3 0.7 0.5 0.7 1.9 4.3 1.3 1.4 1.3 5.9 0.2 1.6 1.0 1.0 3.2 0.6 0.8 2.0 0.4 2.4 0.7 2.4 4.3 6.4 1.2 0.8 2.1 5.7 5.1 1.5 0.8 1.3 0.8 0.9 0.8 10.7 10.0 2.2 4.4 1.3 1.4 3.3 1.0 0.9 1.6 1.1 1.5 2.7 1.4 1.1 0.5 4.7 2.0 2.2 2.4 3.4 1.2 3.9 2.1 0.5 4.4 6.3 10.9 8.5 4.1 5.0 3.3 6.1 6.2 2.4 0.0 0.3 0.0 0.1 0.0 3.7 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 23.3 0.0 0.4 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.5 0.0 1.2 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 4.2 0.0 0.1 8.7 1.9 0.0 0.0 0.0 0.3 0.0 ZNF275 ENSG00000063587 "Zinc finger protein 275" Q9NSD4 X 153334155-153360110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.6" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 25.5;Peritubular cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 36.2;U-698: 20.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000566 Approved Approved Nucleoli NA NA Nucleoli "HPA000566: AB_1080700" "unprognostic (6.96e-2)" "unprognostic (8.97e-2)" "unprognostic (3.10e-2)" "unprognostic (1.11e-3)" "unprognostic (5.25e-2)" "unprognostic (1.45e-1)" "unprognostic (9.59e-2)" "unprognostic (9.37e-2)" "unprognostic (2.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (4.33e-2)" "unprognostic (2.69e-1)" "unprognostic (1.95e-1)" "unprognostic (3.74e-2)" "unprognostic (1.14e-2)" 6.5 38.6 5.9 3.4 5.9 2.2 11.5 5.9 6.9 5.8 3.5 7.0 20.4 2.8 5.9 12.6 2.5 5.4 4.9 3.0 6.8 6.9 3.8 8.5 3.3 7.0 8.8 5.3 30.3 8.5 5.8 6.9 2.1 6.2 5.1 3.2 3.8 6.3 27.9 3.1 2.5 4.5 5.6 10.7 6.8 4.1 10.5 6.5 3.9 4.7 1.7 5.3 4.0 2.6 4.5 2.7 0.7 1.7 2.8 5.0 2.0 6.0 2.7 5.3 3.7 6.1 6.0 2.6 4.2 7.0 2.7 4.1 2.8 1.4 10.4 8.7 7.9 4.0 1.0 6.0 3.8 4.0 2.4 4.8 3.3 2.6 3.9 8.2 4.2 3.1 7.1 2.7 2.3 4.3 4.4 3.3 5.7 5.1 0.0 4.8 4.4 4.9 3.5 2.4 5.9 4.3 6.0 5.6 3.6 2.0 4.0 2.7 3.7 2.1 0.2 5.1 3.4 1.0 7.5 3.5 4.1 4.9 6.8 5.4 36.2 9.6 20.7 3.7 8.5 2.8 0.7 1.7 0.2 3.7 1.5 4.4 4.5 3.4 3.3 1.6 4.4 5.0 4.2 0.1 2.8 1.4 2.7 4.6 2.0 5.9 5.9 5.9 6.5 6.8 6.9 8.8 5.3 6.2 6.5 0.0 5.8 5.2 3.4 3.0 6.6 4.7 10.2 1.4 2.3 8.7 11.8 1.3 6.6 2.6 1.2 4.1 1.6 0.0 4.4 3.4 7.2 4.9 2.3 25.5 2.2 0.0 0.0 8.0 5.3 2.0 13.3 3.1 3.3 1.0 6.2 6.3 4.4 2.9 37.1 6.5 2.2 12.9 11.4 3.3 3.4 1.9 0.7 3.8 5.0 1.7 ZNF28 "DKFZp781D0275, KOX24" ENSG00000198538 "Zinc finger protein 28" P17035 19 52797409-52857600 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 64.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "prognostic unfavorable (9.29e-4)" "unprognostic (2.11e-1)" "unprognostic (7.05e-2)" "unprognostic (3.40e-2)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-2)" "unprognostic (6.91e-3)" "unprognostic (5.38e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (6.57e-2)" "unprognostic (1.06e-2)" "unprognostic (7.09e-2)" "unprognostic (1.11e-2)" "unprognostic (2.22e-1)" "unprognostic (5.68e-2)" 7.3 7.8 7.5 4.8 6.4 1.0 7.6 10.2 5.7 6.8 7.5 4.5 11.6 6.8 5.7 5.9 7.3 8.1 8.1 4.6 5.7 3.9 8.9 3.9 5.2 9.0 5.0 3.1 5.9 8.3 7.2 7.0 64.1 5.9 7.3 9.3 3.2 6.5 5.8 2.2 4.7 11.0 6.0 4.7 6.1 6.8 6.1 5.7 12.7 11.7 2.8 6.9 8.8 6.5 5.4 6.1 15.4 4.7 19.4 8.0 5.5 7.5 0.8 4.5 8.4 7.2 5.8 15.9 6.7 5.2 6.7 9.3 6.3 7.3 12.9 7.9 5.1 6.8 5.8 7.3 4.3 9.3 0.1 7.7 10.2 4.4 1.8 7.4 0.1 10.4 4.8 6.8 8.8 8.7 5.1 6.6 7.2 11.8 0.1 7.8 2.3 10.2 4.2 5.6 8.2 6.5 6.7 11.4 7.4 7.1 26.0 7.4 5.6 14.4 6.8 5.2 12.5 10.0 9.5 5.6 3.4 6.9 3.0 6.8 2.7 11.3 14.0 0.2 1.6 13.3 15.4 4.7 7.3 8.0 3.5 6.9 5.0 5.6 6.6 6.1 5.4 6.5 7.6 2.5 19.4 3.8 3.2 4.4 5.5 7.5 6.4 10.2 5.7 5.7 3.9 5.0 3.1 5.9 5.7 3.0 6.6 1.5 3.2 2.9 1.4 4.7 12.7 9.4 13.6 10.4 2.0 5.9 6.6 6.7 0.8 4.0 10.9 0.0 4.4 7.3 2.8 6.1 8.1 4.2 8.3 4.8 13.9 8.0 10.2 0.9 2.3 3.7 3.3 3.6 11.6 1.5 6.5 12.9 1.8 4.4 1.6 0.0 2.3 1.8 4.7 1.9 5.8 6.4 10.0 8.7 ZNF280A "3'OY11.1, SUHW1, ZNF280, ZNF636" ENSG00000169548 "Zinc finger protein 280A" P59817 22 22513736-22520270 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.6;epididymis: 5.6;retina: 2.2" "Cell type enhanced" "Detected in some" 30 "Melanocytes: 1.7;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in some" "melanoma: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;EFO-21: 1.9;K-562: 13.0;SK-MEL-30: 3.5" "Not detected" "Not detected" HPA044475 Approved Nucleoplasm NA NA Nucleoplasm "HPA044475: AB_10960420" "unprognostic (7.53e-2)" "unprognostic (3.76e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-2)" "unprognostic (3.29e-1)" "unprognostic (4.65e-3)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" 0.0 5.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.4 0.0 0.0 0.1 5.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.5 0.0 1.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 1.0 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 13.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.5 0.3 0.5 0.2 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.2 0.0 0.0 0.0 ZNF280B "5'OY11.1, SUHW2, ZNF279, ZNF632" ENSG00000275004 "Zinc finger protein 280B" Q86YH2 22 22484421-22509154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 12.4;testis: 19.2" "Group enriched" "Detected in many" 14 "Early spermatids: 147.7;Late spermatids: 74.6;Spermatocytes: 65.0;Spermatogonia: 149.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 13.1;U-2 OS: 6.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059519 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059519: AB_2684050" "unprognostic (7.32e-2)" "unprognostic (2.99e-2)" "unprognostic (1.12e-1)" "unprognostic (2.00e-1)" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (2.65e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-2)" "unprognostic (2.85e-3)" "unprognostic (1.10e-1)" "unprognostic (5.42e-2)" "unprognostic (3.34e-2)" "unprognostic (4.80e-1)" "unprognostic (2.44e-2)" "unprognostic (5.34e-2)" 0.3 2.1 4.3 0.9 5.5 0.6 0.5 3.9 6.8 0.7 0.5 1.6 0.0 0.4 1.5 1.3 0.5 1.2 0.6 0.8 1.8 0.5 0.3 0.5 1.2 1.7 3.2 2.5 0.7 2.0 5.6 0.5 6.6 1.3 0.7 3.5 0.5 1.4 0.8 0.6 0.6 1.1 2.2 1.1 0.6 19.2 1.2 0.0 2.3 0.0 1.2 0.6 0.0 3.3 3.1 12.4 6.4 6.8 5.4 2.0 0.0 1.9 2.2 0.0 0.0 0.0 2.9 0.4 0.0 0.0 0.0 1.1 0.8 2.0 2.1 0.0 1.8 0.0 1.8 0.3 0.0 0.0 3.5 2.3 0.4 2.7 1.6 1.6 3.0 0.9 0.0 1.8 0.0 0.3 1.9 2.2 13.1 0.8 0.7 0.0 2.0 1.1 1.6 0.9 0.4 1.7 0.0 0.2 0.6 0.0 1.2 1.6 0.0 0.0 0.7 2.0 0.0 1.4 0.8 3.3 6.9 0.7 0.0 1.2 1.2 1.2 2.0 1.5 0.1 12.4 2.3 3.8 2.9 3.3 5.4 3.1 3.6 3.1 2.0 3.3 4.5 4.9 5.9 6.8 6.4 3.1 3.5 2.0 0.0 1.1 2.7 0.5 0.1 6.6 1.2 5.1 0.0 1.2 0.0 3.9 0.1 0.0 1.9 147.7 0.3 0.0 0.0 3.0 0.2 0.5 0.6 0.0 0.0 2.4 4.8 2.9 2.5 0.6 74.6 2.3 0.4 5.0 2.8 0.9 6.0 2.1 0.0 6.7 2.9 7.9 6.5 0.3 65.0 149.7 0.0 0.2 0.5 1.2 0.0 ZNF296 ZNF342 ENSG00000170684 "Zinc finger protein 296" Q8WUU4 19 45071500-45076588 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 29.8;lymphoid tissue: 26.2" "Cell type enhanced" "Detected in many" 7 "monocytes: 36.9;Paneth cells: 28.6;Undifferentiated cells: 23.5" "Cancer enhanced" "Detected in all" "testis cancer: 19.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 16.6;SK-BR-3: 11.2;U-698: 19.4" "Low region specificity" "Detected in many" "HPA046940, HPA049576" Uncertain Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA046940: AB_2679871, HPA049576: AB_2680821" "unprognostic (1.32e-1)" "unprognostic (5.37e-3)" "unprognostic (1.18e-1)" "unprognostic (7.71e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.24e-4)" "unprognostic (3.83e-3)" "unprognostic (1.67e-2)" "unprognostic (9.70e-2)" "unprognostic (9.55e-2)" "unprognostic (3.20e-3)" "unprognostic (1.12e-1)" "unprognostic (2.67e-5)" "unprognostic (7.14e-3)" "unprognostic (1.52e-1)" "unprognostic (1.74e-1)" "unprognostic (1.39e-3)" 1.4 0.8 2.4 22.8 3.4 10.5 7.3 6.6 1.4 3.0 7.1 0.4 3.2 6.4 1.0 1.2 11.3 1.4 4.0 1.4 2.0 1.7 1.4 1.0 3.4 15.9 1.1 0.1 0.6 2.7 0.3 3.5 0.7 0.8 2.4 1.0 0.8 13.8 3.4 0.8 6.2 10.1 0.6 1.3 16.9 5.5 2.6 0.6 4.3 1.7 9.5 26.2 2.0 2.7 29.8 26.7 14.7 6.2 14.7 3.5 2.6 3.0 2.1 0.0 0.4 0.0 0.2 1.8 0.5 0.0 0.2 0.2 3.5 1.2 16.6 1.9 0.1 0.0 5.8 0.8 1.3 0.0 3.5 4.4 4.8 0.9 3.4 0.9 2.7 5.1 0.7 0.6 0.7 0.0 0.1 0.5 0.3 3.5 5.9 0.0 4.6 0.2 4.6 1.9 2.0 4.4 9.3 0.0 10.0 0.4 1.1 3.1 0.3 2.1 11.2 0.1 0.3 2.4 5.5 1.1 0.0 1.7 0.1 0.0 6.1 6.1 19.4 0.1 3.5 0.1 14.7 3.6 5.7 3.0 6.2 3.5 29.8 1.6 3.3 8.8 22.4 0.7 1.7 1.8 14.7 5.8 26.7 1.4 2.6 2.4 3.4 6.6 1.4 2.0 1.7 1.1 0.1 0.8 0.6 0.0 1.1 18.6 12.1 10.8 0.9 0.9 0.0 2.7 1.2 3.5 3.9 0.3 0.0 1.9 0.4 0.0 13.3 0.0 0.8 1.9 1.7 2.8 9.2 0.0 3.0 0.0 5.1 1.3 3.0 0.0 0.0 4.1 3.3 36.9 19.9 0.5 1.0 28.6 1.1 0.3 1.6 0.0 2.0 0.9 10.9 8.8 0.7 10.2 23.5 5.7 ZNF30 "DKFZp686N19164, FLJ20562, KOX28" ENSG00000168661 "Zinc finger protein 30" P17039 19 34926903-34945170 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 12.7;Rod photoreceptor cells: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA030400 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA030400: AB_10603245" "unprognostic (3.04e-1)" "unprognostic (9.77e-2)" "unprognostic (9.69e-2)" "unprognostic (3.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.49e-2)" "unprognostic (5.10e-3)" "unprognostic (4.97e-2)" "unprognostic (1.58e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.16e-4)" "unprognostic (5.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-2)" 3.4 5.2 11.1 2.6 10.9 0.7 5.9 21.4 11.6 5.3 3.9 5.0 2.9 4.2 4.5 3.4 3.4 7.0 2.6 5.0 7.0 5.4 4.6 6.5 6.0 5.1 10.0 6.5 5.6 6.9 6.4 7.7 3.3 6.6 5.8 4.5 5.8 4.6 5.2 5.3 5.6 3.9 5.1 7.2 5.4 4.8 3.9 8.3 2.4 4.4 2.0 5.1 3.8 4.0 3.4 1.3 2.8 0.4 6.9 7.2 1.8 3.6 8.2 3.5 8.8 6.3 4.0 0.1 3.6 2.6 3.3 3.7 5.8 1.2 0.0 4.8 2.3 1.2 2.3 10.1 5.1 4.2 0.0 4.8 2.7 4.4 4.4 3.2 3.6 2.5 3.5 4.6 3.3 4.4 1.4 5.2 7.2 8.7 0.0 5.3 2.7 2.6 1.6 4.9 8.9 4.3 3.4 2.7 0.9 2.5 3.2 4.6 6.6 0.0 0.1 3.4 3.8 3.3 1.0 3.7 7.0 3.7 2.5 4.8 2.4 11.5 1.0 1.4 0.0 4.0 2.8 0.1 0.1 4.8 0.4 4.7 3.4 3.8 2.2 1.3 2.1 7.2 7.2 0.0 6.9 0.0 1.2 3.4 1.8 11.1 10.9 21.4 11.6 7.0 5.4 10.0 6.5 6.6 8.3 0.0 0.6 0.0 0.2 0.3 5.3 2.8 0.0 4.0 0.0 1.8 5.9 0.1 3.3 0.9 0.2 3.5 0.0 0.0 1.2 0.5 0.6 0.3 5.7 1.0 0.7 12.7 1.2 5.5 1.8 0.4 2.0 0.1 1.7 0.0 1.4 3.5 1.0 0.0 2.1 1.3 10.0 0.0 1.0 2.6 2.4 0.1 0.0 1.7 1.3 0.3 ZNF330 "HSA6591, NOA36" ENSG00000109445 "Zinc finger protein 330" Q9Y3S2 4 141220887-141234697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 80.7" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 163.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015705, HPA056325" Uncertain Supported Nucleoli NA NA Nucleoli "HPA015705: AB_1859199, HPA056325: AB_2683101" "unprognostic (1.90e-1)" "unprognostic (4.65e-2)" "unprognostic (3.66e-1)" "unprognostic (1.35e-2)" "unprognostic (4.12e-1)" "unprognostic (5.93e-2)" "unprognostic (2.37e-1)" "unprognostic (2.32e-3)" "unprognostic (4.49e-3)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.66e-6)" "prognostic favorable (7.27e-6)" "unprognostic (3.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.02e-2)" "unprognostic (1.30e-2)" 21.7 15.9 8.9 12.2 13.7 16.2 13.8 17.5 11.2 14.9 17.4 9.8 14.2 9.5 19.0 15.6 13.6 14.0 10.5 80.7 9.0 9.5 14.9 26.7 15.2 13.4 13.7 8.6 14.9 16.5 13.2 15.1 10.4 12.7 12.2 12.3 22.3 44.9 11.4 34.7 10.9 12.6 18.9 14.1 16.0 14.2 14.2 13.3 14.3 23.5 15.4 13.5 18.7 16.0 16.3 21.9 12.2 20.8 14.6 19.3 11.8 7.7 9.6 11.6 9.2 20.9 18.9 16.4 21.0 12.1 13.5 12.8 12.9 15.0 33.4 12.9 13.2 7.6 6.3 20.5 13.6 20.8 15.4 13.4 15.5 14.8 18.1 22.4 38.9 12.5 18.9 16.0 12.7 18.6 16.5 14.1 20.7 31.4 22.8 17.2 17.6 30.1 18.3 10.3 24.1 18.3 24.6 16.7 21.1 14.5 8.7 20.3 9.4 7.3 16.9 20.6 13.7 8.4 10.7 15.0 17.3 11.7 10.4 14.9 38.2 27.4 31.7 14.5 24.4 12.3 9.7 20.8 12.2 12.9 17.5 17.8 16.3 16.4 16.6 21.9 13.4 18.0 16.2 3.2 14.6 13.5 15.0 19.3 11.8 8.9 13.7 17.5 11.2 9.0 9.5 13.7 8.6 12.7 13.3 50.6 29.6 27.4 41.1 43.7 64.5 140.4 22.9 20.1 23.9 8.7 13.7 30.9 49.7 27.5 163.4 28.7 21.1 23.3 44.0 30.7 29.8 28.9 23.0 63.5 61.1 15.9 16.1 33.7 48.2 40.5 36.2 41.2 43.9 17.2 22.7 29.8 35.0 24.6 26.9 67.2 23.1 12.9 36.8 47.3 16.1 45.0 28.7 24.9 26.0 54.1 ZNF331 "RITA, ZNF361, ZNF463" ENSG00000130844 "Zinc finger protein 331" Q9NQX6 19 53520981-53580269 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 66.4;ovary: 86.4" "Cell type enhanced" "Detected in many" 7 "granulocytes: 234.6;Smooth muscle cells: 196.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 36.4;RT4: 27.8" "Low region specificity" "Detected in all" HPA063157 Approved Nucleoplasm NA NA Nucleoplasm "HPA063157: AB_2684951" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (5.18e-2)" "unprognostic (1.55e-2)" "unprognostic (4.24e-1)" "unprognostic (8.16e-2)" "unprognostic (7.62e-3)" "unprognostic (3.25e-2)" "unprognostic (1.84e-2)" "unprognostic (4.40e-2)" "unprognostic (5.68e-3)" "unprognostic (2.69e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" 19.1 66.4 6.8 9.0 8.2 18.6 10.5 11.4 9.5 9.4 5.3 8.4 8.9 2.1 9.5 11.6 4.9 19.5 23.8 15.5 5.1 7.7 6.6 6.1 15.6 4.0 6.8 5.5 86.4 9.9 11.3 29.0 23.3 7.2 10.2 4.2 9.9 4.7 31.5 6.3 5.2 4.8 8.5 9.1 4.5 6.3 8.1 6.0 3.8 7.8 4.4 4.8 25.7 9.2 8.1 4.1 6.5 7.4 4.6 14.7 5.2 0.1 5.1 10.3 11.8 8.0 5.9 17.2 7.3 6.5 5.6 10.2 5.5 2.6 4.1 1.9 4.3 2.6 3.0 7.4 5.5 10.0 0.0 36.4 5.1 8.7 3.3 5.8 3.2 7.2 5.9 3.6 6.2 3.0 3.1 2.5 6.4 0.2 1.6 5.5 3.6 7.2 6.8 4.6 0.1 7.6 8.9 6.5 4.2 3.3 27.8 7.3 7.4 3.4 9.7 2.4 21.4 1.7 2.9 2.6 7.9 7.0 4.6 4.8 20.3 13.2 7.7 0.1 0.4 6.1 0.5 4.9 6.5 8.7 3.8 13.4 8.1 9.4 8.8 3.6 8.1 14.7 9.7 0.7 4.6 7.4 4.1 9.4 5.2 6.8 8.2 11.4 9.5 5.1 7.7 6.8 5.5 7.2 6.0 17.9 70.7 15.9 15.3 39.8 52.9 16.5 7.6 17.4 20.5 73.3 27.5 32.9 8.3 2.9 128.2 19.9 2.1 0.0 3.6 30.4 36.8 11.9 234.6 3.9 60.1 28.6 22.5 14.7 33.7 61.5 22.5 79.8 43.9 3.6 5.1 25.1 2.3 3.5 18.4 3.7 35.8 0.0 196.7 34.4 19.8 44.3 37.2 74.7 3.2 9.4 ZNF365 "KIAA0844, UAN" ENSG00000138311 "Zinc finger protein 365" "Q70YC4, Q70YC5" 10 62374192-62672011 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 12.6;Horizontal cells: 17.5;Rod photoreceptor cells: 4.9;Urothelial cells: 6.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 3.4;memory CD4 T-cell: 3.1;memory CD8 T-cell: 3.5;naive CD8 T-cell: 3.7;NK-cell: 7.4;T-reg: 7.5" "Group enriched" "Detected in many" 51 "NK-cells: 7.4;T-cells: 7.5" "Cell line enhanced" "Detected in many" "HaCaT: 17.3;PC-3: 11.2;U-251 MG: 14.4;U-87 MG: 10.3" "Group enriched" "Detected in all" 4 "amygdala: 328.0;basal ganglia: 309.9;cerebral cortex: 424.1;hippocampal formation: 348.1;thalamus: 127.9" "Low region specificity" "Detected in all" HPA052446 Enhanced Supported "Vesicles,Centriolar satellite" NA NA "Vesicles, Centriolar satellite" "HPA052446: AB_2681836" "unprognostic (7.46e-2)" "unprognostic (1.42e-1)" "unprognostic (1.36e-1)" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (4.05e-3)" "unprognostic (1.73e-1)" "unprognostic (7.67e-2)" "unprognostic (2.15e-2)" "unprognostic (3.11e-3)" "unprognostic (3.06e-2)" "unprognostic (7.90e-2)" "unprognostic (1.12e-6)" "unprognostic (2.49e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-4)" "unprognostic (2.89e-2)" 0.9 2.5 11.8 1.0 19.4 1.0 1.3 8.4 41.3 2.0 0.9 13.1 0.0 1.1 1.2 1.5 11.7 1.0 4.0 2.0 9.6 7.4 1.1 1.2 3.1 1.1 7.5 16.0 1.0 1.3 9.0 1.8 1.2 6.9 3.0 1.1 1.0 1.2 3.3 1.0 2.6 0.9 0.9 10.5 1.3 1.0 1.6 9.1 0.0 1.6 0.0 2.2 1.9 1.2 0.1 0.0 0.1 0.1 7.4 7.5 1.0 5.7 0.8 0.5 0.7 0.6 0.3 0.3 4.3 4.5 2.2 1.9 0.6 1.4 0.4 0.7 2.6 7.4 17.3 0.5 0.3 3.0 0.2 0.4 0.3 1.5 0.4 0.2 0.3 1.4 0.3 0.3 5.9 0.8 6.2 0.7 0.3 0.4 0.6 4.3 2.1 0.7 0.5 0.9 0.3 11.2 0.4 0.5 0.4 0.5 2.6 0.2 0.9 1.1 0.9 0.4 0.6 0.1 0.3 3.1 1.2 5.6 0.6 14.4 0.2 0.5 0.3 10.3 0.6 1.9 0.0 0.0 0.0 3.4 0.1 0.0 0.0 3.1 3.5 0.0 0.1 0.6 3.7 0.1 7.4 0.1 0.0 7.5 1.0 11.8 19.4 8.4 32.3 9.6 7.4 7.5 16.0 6.9 9.1 0.0 0.0 0.0 3.3 0.5 12.6 2.4 0.0 0.0 0.0 3.5 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.1 17.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.6 0.0 0.0 0.6 4.9 0.0 1.2 0.0 0.4 0.4 0.0 0.0 0.0 6.7 ZNF366 FLJ39796 ENSG00000178175 "Zinc finger protein 366" Q8N895 5 72442652-72507727 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 24.3" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 29.5;Endothelial cells: 11.6;Ito cells: 8.6;monocytes: 23.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "myeloid DC: 14.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 14.5" "Cell line enhanced" "Detected in some" "A549: 2.5;HUVEC TERT2: 4.2;RH-30: 2.0;TIME: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023128, HPA023526" Uncertain NA NA "HPA023128: AB_1859223, HPA023526: AB_1859224" "unprognostic (3.49e-1)" "unprognostic (8.44e-2)" "unprognostic (2.44e-1)" "unprognostic (2.27e-1)" "unprognostic (6.17e-2)" "unprognostic (1.95e-3)" "unprognostic (9.25e-2)" "unprognostic (6.67e-2)" "unprognostic (1.43e-1)" "unprognostic (2.47e-1)" "unprognostic (1.34e-1)" "unprognostic (1.27e-1)" "unprognostic (1.88e-3)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (6.29e-2)" 24.3 2.4 4.6 6.1 8.1 0.7 9.3 2.5 6.6 8.4 3.1 2.4 2.9 2.7 6.3 2.9 3.7 5.0 4.4 7.2 4.9 3.4 5.8 3.0 8.0 7.1 4.5 2.2 2.7 2.5 2.0 2.2 14.7 5.0 4.2 2.7 5.1 3.2 2.9 8.7 3.6 3.8 7.2 4.3 10.5 2.9 1.5 5.2 4.2 5.9 6.5 6.2 4.4 10.8 0.1 14.5 0.4 1.5 0.1 0.1 0.6 0.1 2.5 0.3 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.2 1.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 4.2 0.1 0.0 0.5 0.7 0.0 0.1 0.3 0.2 0.0 0.1 0.7 2.0 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.6 0.2 0.1 4.7 0.9 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.0 1.5 0.0 0.0 0.7 0.0 0.1 0.0 0.1 14.5 0.0 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.6 4.6 8.1 2.5 6.6 4.9 3.4 4.5 2.2 5.0 5.2 0.0 1.1 0.0 0.2 0.5 0.2 1.2 0.0 0.0 1.2 0.0 29.5 0.0 0.0 0.0 0.2 11.6 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 8.6 4.0 0.0 0.3 2.5 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 ZNF367 FLJ33970 ENSG00000165244 "Zinc finger protein 367" Q7RTV3 9 96385941-96418329 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.8;lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 8.9;Sertoli cells: 6.5;Spermatocytes: 7.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Lineage enriched" "Detected in single" 7 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015319, HPA015785" Uncertain Supported Nucleoplasm NA Yes Nucleoplasm "HPA015319: AB_2669185, HPA015785: AB_2217750" "unprognostic (5.91e-2)" "unprognostic (2.78e-3)" "unprognostic (2.17e-2)" "unprognostic (1.11e-2)" "unprognostic (2.36e-1)" "unprognostic (4.57e-3)" "unprognostic (7.76e-3)" "unprognostic (1.60e-3)" "unprognostic (4.35e-2)" "unprognostic (3.01e-1)" "unprognostic (3.78e-3)" "unprognostic (2.71e-2)" "unprognostic (4.88e-3)" "unprognostic (3.23e-3)" "unprognostic (1.72e-1)" "prognostic favorable (2.34e-4)" "unprognostic (2.28e-1)" 2.7 1.2 2.1 8.9 4.6 23.8 4.4 2.9 3.9 2.2 4.9 2.9 1.7 3.2 1.3 2.1 4.5 1.3 3.0 4.6 2.5 2.1 3.3 12.0 2.6 4.7 4.4 2.0 2.2 1.8 3.9 0.6 3.7 3.8 1.4 3.8 2.1 3.2 0.6 3.9 3.9 3.2 2.6 4.3 3.4 2.4 9.6 4.3 21.5 1.3 6.5 5.0 2.1 2.5 0.1 0.2 0.1 0.2 0.1 1.8 0.7 13.3 5.5 5.4 4.9 2.1 3.0 7.4 18.7 11.1 9.3 11.2 3.4 9.5 10.2 8.0 8.9 7.0 16.5 6.3 6.8 11.1 11.1 5.5 7.4 10.6 2.8 0.0 10.3 9.1 0.5 0.4 7.5 3.8 2.0 3.4 7.2 6.7 24.9 11.9 8.9 15.8 8.5 3.7 14.8 9.1 8.0 27.6 6.2 2.7 9.0 9.6 6.7 8.2 9.9 5.7 4.6 5.2 9.2 3.0 15.4 8.8 14.1 14.1 9.7 16.4 4.2 9.3 9.1 12.9 0.0 0.0 0.1 1.2 0.0 0.8 0.0 0.8 1.2 0.2 0.1 1.1 1.3 0.0 0.1 0.2 0.1 1.8 0.7 2.1 4.6 2.9 3.9 2.5 2.1 4.4 2.0 3.8 4.3 0.0 0.0 2.2 1.0 8.9 0.6 2.2 0.0 0.0 1.2 0.0 0.0 1.6 0.0 0.4 0.6 0.6 0.6 0.0 1.0 3.5 1.7 0.4 0.0 3.9 1.7 0.0 0.0 1.3 2.5 0.6 0.6 1.5 3.3 0.0 1.9 0.5 0.5 0.0 0.7 2.2 1.5 6.5 2.5 7.2 1.4 5.6 0.7 2.5 2.5 0.1 ZNF382 "FLJ14686, KS1" ENSG00000161298 "Zinc finger protein 382" Q96SR6 19 36604817-36634113 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 27.6" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 22.7;Early spermatids: 21.4;Horizontal cells: 47.7;Late spermatids: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049259 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA049259: AB_2680694" "unprognostic (5.43e-3)" "unprognostic (5.16e-2)" "unprognostic (1.17e-1)" "unprognostic (2.68e-3)" "unprognostic (6.13e-2)" "unprognostic (1.85e-3)" "unprognostic (5.63e-2)" "unprognostic (6.64e-2)" "unprognostic (1.12e-2)" "unprognostic (5.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.07e-3)" "unprognostic (1.76e-5)" "unprognostic (8.71e-2)" "unprognostic (2.06e-2)" "unprognostic (2.53e-1)" "unprognostic (6.22e-2)" 3.3 5.9 6.7 3.5 10.5 1.9 3.3 27.6 13.8 4.2 3.9 4.9 2.3 1.3 4.8 4.2 3.1 5.8 3.0 7.5 6.2 6.2 3.8 1.5 2.7 5.1 5.6 11.2 4.7 2.6 4.8 11.0 4.6 9.4 3.6 1.9 4.4 3.3 3.1 1.7 1.4 2.8 4.3 5.5 5.5 2.2 6.7 5.3 3.6 5.7 2.0 6.3 4.0 2.0 9.0 2.4 3.5 0.7 4.5 9.0 2.7 0.2 0.1 4.5 6.4 1.9 2.6 1.5 2.0 0.6 5.9 6.1 0.1 0.4 3.9 4.3 2.4 2.6 0.1 5.8 0.1 3.8 10.9 2.6 6.3 0.3 1.6 5.2 0.9 7.6 3.5 0.2 3.3 0.2 6.0 0.7 7.7 0.1 0.2 3.8 0.6 8.8 2.1 3.0 0.0 2.2 0.4 1.9 1.7 1.6 0.2 0.6 8.7 0.3 0.3 3.5 6.8 2.7 0.7 0.2 1.4 0.3 0.3 5.7 10.0 0.7 0.4 0.1 0.1 3.5 2.1 0.6 3.5 5.6 0.7 9.0 9.0 8.8 6.2 2.3 6.6 7.6 8.4 1.2 4.5 0.7 2.4 5.0 2.7 6.7 10.5 27.6 13.8 6.2 6.2 5.6 11.2 9.4 5.3 3.0 0.0 0.0 0.6 0.1 22.7 9.8 0.0 2.7 1.2 3.5 9.8 1.8 5.0 2.4 21.4 2.1 0.0 0.0 0.4 0.8 2.0 0.4 0.0 0.4 2.4 47.7 0.0 1.3 0.6 15.0 0.6 1.1 1.7 1.0 0.1 4.0 0.2 0.0 1.1 1.3 12.7 0.0 1.2 4.4 2.8 0.0 0.1 2.1 0.0 0.4 ZNF385A "DKFZp586G1122, Hzf, ZFP385, ZNF385" ENSG00000161642 "Zinc finger protein 385A" Q96PM9 12 54369133-54391298 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation, Translation regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 81.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 219.7;Cone photoreceptor cells: 161.0;Horizontal cells: 136.7;Rod photoreceptor cells: 153.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 15.3;intermediate monocyte: 16.8;myeloid DC: 16.6;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 10 "dendritic cells: 16.6;monocytes: 16.8" "Cell line enhanced" "Detected in many" "HaCaT: 29.4;HBEC3-KT: 28.0;HEL: 35.2;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039799 Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA039799: AB_10795117" "unprognostic (8.56e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (6.70e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-3)" "unprognostic (2.30e-2)" "unprognostic (1.21e-1)" "unprognostic (2.75e-1)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (9.75e-5)" "unprognostic (1.00e-1)" "unprognostic (3.68e-2)" "unprognostic (2.43e-1)" "unprognostic (6.07e-3)" 23.7 4.3 23.6 16.3 27.3 16.8 7.9 13.2 32.5 7.9 5.7 12.8 2.3 4.8 3.2 10.7 28.1 6.2 8.9 4.3 18.4 22.6 2.3 3.8 11.6 8.9 31.8 15.4 2.0 2.0 13.8 8.5 12.6 19.4 10.3 5.4 35.5 8.9 10.1 5.9 81.6 5.7 8.7 16.4 13.9 4.4 2.1 16.1 5.5 18.1 21.9 21.9 25.8 14.9 0.8 16.6 1.6 16.8 0.0 0.2 6.6 0.8 3.4 5.3 6.6 6.1 4.1 14.6 0.6 2.6 2.8 2.4 7.0 2.6 1.9 2.4 1.4 2.2 29.4 2.0 28.0 0.9 1.8 2.8 35.2 2.3 1.3 2.7 0.5 24.7 3.6 31.6 3.1 7.9 6.8 1.7 4.9 16.9 0.1 1.2 15.6 1.7 5.0 3.0 3.3 2.7 6.2 0.4 6.9 2.1 23.0 2.3 10.6 0.2 19.9 1.4 6.4 23.5 14.7 1.7 1.5 3.5 1.7 1.7 0.5 0.1 1.6 6.3 1.6 3.8 1.6 15.3 0.0 0.0 16.8 0.0 0.6 0.0 0.0 16.6 0.8 0.0 0.2 1.2 0.0 11.9 1.6 0.0 6.6 23.6 27.3 13.2 32.5 18.4 22.6 31.8 15.4 19.4 16.1 0.0 0.0 5.0 20.2 32.2 219.7 3.1 2.5 2.7 2.3 8.7 161.0 56.0 8.3 3.5 0.4 2.9 0.0 0.0 0.5 5.3 14.9 11.9 1.1 1.0 53.9 136.7 4.6 2.5 63.8 0.0 13.8 52.2 8.5 19.0 0.0 74.9 2.2 0.0 8.5 2.1 153.5 0.0 4.7 2.2 2.5 57.7 91.1 1.3 0.0 27.3 ZNF385B "FLJ25270, ZNF533" ENSG00000144331 "Zinc finger protein 385B" Q569K4 2 179441982-179861505 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 2: 81.3;Bipolar cells: 179.5;Distal tubular cells: 69.6;Rod photoreceptor cells: 128.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 8.2;HAP1: 16.3;U-698: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046086 Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA046086: AB_2679532" "prognostic favorable (4.86e-8)" "unprognostic (8.05e-3)" "unprognostic (1.14e-1)" "unprognostic (3.91e-2)" "unprognostic (3.49e-1)" "unprognostic (1.51e-2)" "unprognostic (3.49e-3)" "unprognostic (1.14e-1)" "unprognostic (8.99e-3)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "unprognostic (2.69e-1)" "prognostic favorable (1.04e-9)" "unprognostic (7.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.20e-3)" 1.7 4.2 3.2 1.1 14.4 0.9 8.3 33.0 23.2 2.4 1.8 0.9 1.1 1.0 2.1 5.2 1.6 1.2 1.2 23.1 4.2 2.1 9.5 21.3 20.1 2.1 2.7 9.5 18.4 0.8 0.5 0.8 2.9 15.6 14.4 1.3 10.1 1.4 1.1 11.2 1.9 1.2 1.0 1.3 1.0 8.5 10.6 6.1 0.0 1.0 2.9 1.1 1.4 2.9 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 3.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 8.2 0.0 0.0 3.1 0.0 16.3 0.0 0.2 0.0 2.0 0.0 0.4 0.5 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.6 0.0 0.9 0.0 0.6 0.6 0.8 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 1.2 0.1 0.6 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.2 14.4 33.0 23.2 4.2 2.1 2.7 9.5 15.6 6.1 26.8 81.3 0.0 0.6 3.1 179.5 26.0 7.6 2.7 2.3 0.0 51.1 0.0 69.6 0.0 50.4 0.3 0.0 0.0 0.0 0.0 3.3 8.2 1.1 12.1 0.2 1.6 1.7 1.3 0.0 21.9 0.6 0.4 1.7 0.0 0.0 5.8 0.1 0.0 0.4 10.6 128.3 0.0 1.4 2.6 0.7 0.6 0.1 0.0 0.0 0.9 ZNF385C ENSG00000187595 "Zinc finger protein 385C" 17 42025576-42098479 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 19.0;testis: 21.9" "Cell type enriched" "Detected in some" 9 "Early spermatids: 27.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "cerebellum: 19.0" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;JURKAT: 3.7;MOLT-4: 6.7;SCLC-21H: 5.5" "Region enriched" "Detected in single" 12 "cerebellum: 31.8" "Region enriched" "Detected in all" 7 "cerebellum: 44.2" NA NA "unprognostic (1.58e-3)" "unprognostic (3.38e-2)" "unprognostic (2.02e-3)" "unprognostic (3.95e-2)" "unprognostic (3.95e-2)" "unprognostic (2.61e-1)" "unprognostic (3.07e-1)" "unprognostic (2.64e-1)" "unprognostic (2.48e-1)" "unprognostic (8.67e-3)" "unprognostic (1.10e-1)" "unprognostic (8.90e-2)" "unprognostic (2.59e-1)" "unprognostic (8.71e-2)" "unprognostic (1.50e-1)" "unprognostic (6.22e-2)" "unprognostic (6.05e-2)" 0.4 0.0 0.7 1.6 0.7 0.5 1.6 19.0 0.8 0.5 0.4 0.4 0.4 0.1 1.0 0.5 0.4 2.0 0.4 0.4 0.5 0.4 0.6 0.4 0.8 0.4 2.0 0.4 3.4 3.1 0.6 2.1 0.4 1.4 1.4 0.2 0.4 2.3 0.5 2.9 0.7 0.4 0.4 0.9 0.6 0.5 21.9 0.4 0.9 0.4 0.9 1.5 0.4 0.5 0.4 3.2 0.0 0.0 0.0 0.2 0.0 0.3 0.3 0.5 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.5 2.4 0.0 1.2 0.0 0.1 0.8 0.3 0.0 0.0 3.9 2.4 0.0 0.0 0.8 0.1 0.0 1.0 0.0 2.9 0.0 1.4 0.1 0.0 3.7 0.2 0.0 0.0 0.5 6.7 0.1 0.5 1.2 0.0 0.5 0.0 1.1 0.1 0.4 5.5 0.6 0.2 0.5 0.3 0.7 3.1 1.2 0.0 0.0 0.4 0.0 0.0 2.6 0.5 0.4 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.7 0.7 19.0 0.8 0.5 0.4 2.0 0.4 1.4 0.4 0.0 0.3 0.0 1.6 0.3 2.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.4 27.8 0.0 0.4 0.0 0.4 0.1 0.6 2.3 0.0 0.0 0.6 1.6 0.0 0.0 0.0 3.1 1.4 0.0 0.0 0.0 0.5 2.9 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.9 1.9 0.5 0.0 0.0 0.4 0.8 ZNF385D "FLJ22419, ZNF659" ENSG00000151789 "Zinc finger protein 385D" Q9H6B1 3 21412222-22373321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 17.7;brain: 59.5;testis: 18.5" "Group enriched" "Detected in many" 5 "Early spermatids: 137.4;Horizontal cells: 305.1;Late spermatids: 198.0;Muller glia cells: 119.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 7 "cerebellum: 59.5" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.9;hTERT-RPE1: 4.2;RPTEC TERT1: 6.7;U-87 MG: 12.6" "Low region specificity" "Detected in all" HPA036190 Uncertain NA NA "HPA036190: AB_10602355" "unprognostic (4.07e-2)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (3.23e-2)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (8.20e-2)" "unprognostic (6.60e-2)" "unprognostic (7.84e-2)" "unprognostic (3.73e-1)" "unprognostic (2.35e-1)" "unprognostic (9.01e-2)" "unprognostic (3.49e-7)" "unprognostic (8.70e-3)" "unprognostic (5.38e-2)" "unprognostic (7.76e-3)" "unprognostic (2.15e-5)" 17.7 1.1 4.0 2.2 5.9 1.1 5.3 59.5 9.1 4.3 2.2 0.1 1.2 1.2 2.3 3.9 4.0 2.3 4.7 3.9 3.9 3.6 3.2 0.9 1.9 2.0 7.4 4.0 1.7 2.5 1.3 0.5 0.7 4.1 3.0 1.8 4.1 1.9 3.2 2.8 2.4 1.3 3.5 1.9 1.3 1.3 18.5 1.7 0.1 1.5 5.2 2.0 4.0 5.7 0.7 0.3 2.0 0.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.5 4.9 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 4.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.3 0.0 1.4 0.0 0.0 0.0 6.7 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.4 0.2 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.7 0.0 0.1 2.0 0.1 0.0 0.3 0.0 0.2 4.0 5.9 59.5 9.1 3.9 3.6 7.4 4.0 4.1 1.7 11.9 14.9 0.5 0.6 8.7 41.0 2.8 0.0 8.1 35.2 1.8 7.9 0.2 23.2 0.4 137.4 35.0 1.1 0.0 0.6 0.1 13.6 1.3 4.7 5.9 0.4 305.1 0.0 3.7 0.0 198.0 15.5 5.6 11.8 0.0 0.5 119.7 1.1 0.0 12.7 6.2 28.4 12.9 14.4 9.1 1.3 6.8 0.1 0.0 0.4 0.1 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99486519-99500324 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 77.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Uncertain Enhanced Nucleoplasm,Cytosol Yes No Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 11.3 8.3 10.0 11.5 11.8 77.5 12.2 16.4 13.2 10.8 10.9 11.7 8.8 10.7 11.0 7.7 12.2 11.2 9.3 10.4 7.9 6.2 9.4 9.5 12.6 12.2 11.2 6.6 14.3 12.0 7.9 16.2 8.4 9.7 13.0 9.1 10.1 10.1 9.0 14.8 13.6 13.5 9.1 9.1 19.1 10.9 9.5 11.0 15.6 11.4 8.8 17.5 11.9 11.6 17.6 22.3 31.6 17.0 24.3 29.3 17.0 7.8 7.8 5.3 11.1 8.2 5.6 10.5 6.7 8.9 7.8 7.6 8.2 8.7 9.4 9.7 6.9 11.0 7.6 7.1 8.5 7.7 6.8 9.4 9.2 9.3 9.0 6.6 13.1 16.1 7.4 7.4 7.6 8.1 5.8 8.9 8.4 13.2 18.7 7.1 14.7 13.5 21.5 11.8 9.8 9.4 7.7 5.8 16.3 8.4 11.2 6.3 13.1 7.8 19.0 12.6 13.5 4.9 16.3 9.3 9.5 9.5 13.6 8.3 15.4 16.1 15.2 6.7 13.3 9.9 31.6 14.3 24.1 23.1 17.0 24.2 17.6 23.6 25.0 15.6 17.2 29.3 23.1 26.3 24.3 16.7 22.3 25.2 17.0 10.0 11.8 16.4 13.2 7.9 6.2 11.2 6.6 9.7 11.0 14.9 22.4 32.0 29.5 31.6 8.1 7.0 2.5 20.1 11.4 10.4 11.8 13.3 14.9 13.3 5.6 16.9 25.5 0.0 12.4 14.8 17.4 23.7 57.7 10.5 16.3 14.3 20.0 12.9 22.1 1.1 14.4 20.8 27.0 15.4 14.7 12.4 14.1 18.6 12.7 9.5 10.6 12.9 17.0 42.5 30.3 31.0 24.8 44.5 15.8 52.9 ZNF454 FLJ37444 ENSG00000178187 "Zinc finger protein 454" Q8N9F8 5 178941191-178966433 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.6" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 21.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 12.3;Spermatocytes: 14.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.5;EFO-21: 4.9;HHSteC: 3.7;HSkMC: 4.5;NTERA-2: 3.6;SH-SY5Y: 2.4;SuSa: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024556 Uncertain NA NA "HPA024556: AB_1859283" "unprognostic (1.27e-1)" "unprognostic (9.10e-2)" "unprognostic (1.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (4.21e-2)" "unprognostic (1.41e-1)" "unprognostic (8.35e-2)" "unprognostic (3.72e-2)" "unprognostic (2.34e-2)" "unprognostic (9.52e-3)" "unprognostic (1.52e-1)" "unprognostic (3.95e-2)" "unprognostic (9.58e-2)" "unprognostic (3.68e-2)" "unprognostic (8.43e-3)" "unprognostic (2.78e-1)" 3.4 2.6 7.5 1.5 7.5 0.6 4.6 20.6 8.7 5.9 3.3 3.6 1.7 1.6 6.2 3.1 2.2 7.1 4.7 3.6 6.5 4.6 3.4 1.2 3.1 1.0 5.7 5.2 8.3 3.5 1.0 18.1 3.5 6.7 6.3 2.8 3.9 3.5 5.7 1.0 2.3 2.1 6.1 2.5 2.2 3.1 7.7 7.2 0.0 5.4 0.0 1.5 3.8 3.3 0.2 0.0 0.7 0.0 0.3 0.3 0.0 0.0 0.0 2.5 0.5 0.0 0.0 0.0 0.6 0.0 1.6 0.4 0.0 0.0 0.0 4.9 1.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 4.5 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 2.4 0.0 0.0 0.0 4.3 0.1 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.3 0.6 0.3 0.0 0.0 0.1 0.0 7.5 7.5 20.6 8.7 6.5 4.6 5.7 5.2 6.7 7.2 3.0 8.3 0.0 1.3 0.1 21.8 1.0 0.0 5.3 9.1 0.0 15.7 0.9 1.7 1.6 2.0 3.6 0.0 0.0 0.4 1.1 1.7 1.6 1.1 0.0 0.3 4.8 0.0 0.6 0.0 1.0 3.7 0.2 0.0 0.0 0.0 5.2 0.7 0.0 2.5 0.3 12.3 0.0 0.9 14.3 1.4 0.4 0.7 0.0 0.1 0.9 ZNF468 ENSG00000204604 "Zinc finger protein 468" "A2RRD8, Q5VIY5" 19 52838008-52890375 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 46.9" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "prognostic unfavorable (6.87e-4)" "unprognostic (2.16e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-2)" "unprognostic (9.93e-2)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (2.09e-1)" "unprognostic (1.25e-2)" "prognostic favorable (3.94e-7)" "unprognostic (1.04e-1)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (5.59e-2)" 6.6 7.6 6.6 3.5 5.1 5.2 6.9 8.4 5.1 6.2 6.2 4.3 11.0 3.2 4.7 6.4 6.3 6.3 8.0 4.6 4.2 2.9 8.2 3.4 4.9 9.8 4.2 2.8 4.8 10.0 8.8 5.5 65.5 5.2 7.9 7.2 3.1 7.0 5.8 3.7 4.6 10.8 6.2 3.9 5.1 7.1 3.4 3.3 12.0 10.4 1.9 5.5 8.0 5.4 8.8 7.0 11.5 10.3 19.1 12.5 8.6 6.2 0.8 5.7 10.0 6.1 4.5 16.7 5.0 6.3 6.5 9.7 6.2 3.9 9.6 5.1 5.3 7.7 3.3 3.9 5.1 8.6 0.0 5.8 7.3 6.4 2.6 12.4 0.4 9.4 7.2 6.1 8.0 6.6 3.6 5.4 5.3 7.2 0.4 5.7 1.4 9.1 5.9 7.0 4.5 6.1 5.5 8.2 6.4 8.8 46.9 5.9 8.7 6.3 5.7 1.5 12.6 7.5 5.7 4.4 2.2 5.7 3.0 7.3 3.9 13.9 8.6 0.5 0.8 8.0 8.3 6.1 11.5 12.3 10.3 12.5 8.1 8.0 9.8 7.0 8.8 10.0 9.2 6.3 19.1 8.0 5.3 9.3 8.6 6.6 5.1 8.4 5.1 4.2 2.9 4.2 2.8 5.2 3.3 3.0 3.7 4.5 4.7 3.0 1.0 3.3 7.6 0.0 5.7 8.7 0.0 6.4 14.9 6.1 2.4 3.1 5.3 0.0 8.3 10.7 2.5 8.9 17.3 2.6 5.4 0.0 8.2 3.1 10.0 0.4 0.9 3.5 1.7 3.6 12.2 0.8 7.5 7.0 2.5 5.4 0.2 0.0 2.7 0.5 4.0 4.6 20.1 6.9 6.9 9.7 ZNF473 "DKFZP434N043, HZFP100, KIAA1141" ENSG00000142528 "Zinc finger protein 473" Q8WTR7 19 50025714-50053414 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 38.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 63.5;Spermatocytes: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA004191, HPA073309" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004191: AB_2667168, HPA073309: AB_2686594" "unprognostic (7.47e-3)" "unprognostic (3.57e-2)" "unprognostic (2.47e-1)" "unprognostic (3.40e-1)" "unprognostic (4.27e-1)" "unprognostic (8.00e-3)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.31e-3)" "unprognostic (6.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.70e-2)" "unprognostic (3.22e-3)" "unprognostic (8.49e-2)" "unprognostic (1.60e-1)" "unprognostic (3.93e-2)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" 3.8 3.7 4.4 3.8 6.5 3.8 4.8 9.7 5.8 4.1 3.7 4.6 3.7 2.9 5.9 4.4 3.8 10.1 3.4 3.0 5.1 4.3 3.8 4.1 4.0 3.7 5.9 3.2 4.8 4.8 4.0 7.7 3.1 7.3 5.1 3.3 2.7 3.4 5.6 4.9 3.8 3.0 5.1 5.0 6.4 3.3 38.6 7.7 2.6 5.2 3.3 4.5 3.7 18.6 12.4 5.6 5.0 7.9 2.4 11.6 4.6 9.4 6.4 10.1 8.4 3.8 4.7 5.7 8.9 5.2 12.7 11.9 12.3 6.3 14.4 3.4 5.1 4.7 7.1 12.7 5.9 16.3 10.3 12.0 14.8 5.6 5.7 4.7 10.6 8.8 4.8 11.0 13.3 17.6 5.2 4.2 8.7 20.9 13.2 6.4 4.1 8.1 5.0 7.1 14.7 9.9 10.4 14.0 6.3 4.2 10.4 8.3 9.4 12.6 6.9 6.2 7.0 6.2 9.8 2.0 17.7 9.0 3.4 8.9 6.1 14.4 12.3 4.2 8.4 14.3 2.2 5.5 2.9 7.2 7.9 7.3 12.4 7.2 8.8 5.4 10.2 9.2 11.6 5.0 2.4 3.5 5.6 3.9 4.6 4.4 6.5 9.7 5.8 5.1 4.3 5.9 3.2 7.3 7.7 0.0 1.7 2.7 2.3 4.0 0.7 2.1 0.0 13.4 1.2 0.0 0.0 2.0 3.3 2.1 63.5 2.8 1.7 0.0 2.8 2.5 2.4 2.8 0.0 1.0 1.9 0.0 1.7 8.6 2.1 16.0 3.4 1.6 1.7 2.8 2.7 1.7 3.2 2.0 3.5 1.5 3.7 12.9 2.9 38.6 20.2 4.1 1.6 3.2 1.8 1.4 ZNF474 "4933409D10Rik, FLJ32921" ENSG00000164185 "Zinc finger protein 474" Q6S9Z5 5 122129513-122153571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 11.4;fallopian tube: 21.4;testis: 22.9" "Cell type enhanced" "Detected in some" 26 "Ciliated cells: 30.8;Club cells: 6.8;Early spermatids: 13.5;Late spermatids: 8.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "pons and medulla: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 3.3;CAPAN-2: 3.2;GAMG: 4.3;TIME: 3.8" "Low region specificity" "Detected in some" NA NA "unprognostic (9.98e-2)" "unprognostic (2.13e-1)" "unprognostic (7.42e-2)" "unprognostic (5.90e-3)" "unprognostic (7.82e-2)" "unprognostic (2.49e-2)" "unprognostic (3.94e-2)" "unprognostic (7.61e-2)" "unprognostic (3.14e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-1)" "unprognostic (1.06e-2)" "unprognostic (1.51e-3)" "unprognostic (1.12e-3)" "unprognostic (9.74e-2)" "unprognostic (2.20e-1)" "unprognostic (4.09e-4)" 0.3 0.1 1.4 0.3 1.5 0.1 0.3 0.2 0.2 1.2 0.5 6.3 0.6 0.2 1.1 4.9 0.5 21.4 0.7 0.1 1.5 1.1 0.1 0.1 7.9 0.1 0.4 0.2 7.1 0.1 0.2 0.7 0.6 11.4 0.3 0.2 0.0 0.1 0.2 0.0 0.3 0.3 0.3 0.4 0.1 0.2 22.9 0.9 0.0 1.3 0.0 0.2 0.4 0.2 0.2 0.9 0.0 0.0 0.0 0.6 0.0 0.1 1.3 0.5 0.2 0.8 0.4 0.1 3.3 0.8 0.4 0.1 0.1 3.2 0.0 0.2 2.1 4.3 0.6 0.2 0.0 1.3 0.3 0.3 1.1 0.7 0.0 0.7 1.1 0.1 0.4 1.4 0.8 0.4 0.6 0.1 0.6 0.0 0.1 0.1 2.0 0.8 0.4 0.0 0.2 0.0 0.9 0.1 0.9 0.4 0.1 0.7 0.2 1.0 0.1 0.3 0.4 0.5 0.5 3.8 1.1 0.7 2.2 0.8 0.3 0.6 0.4 2.6 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.3 0.6 0.0 0.0 0.0 0.9 0.0 0.0 1.4 1.5 0.2 0.2 1.5 1.1 0.4 0.2 11.4 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.8 6.8 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF479 KR19 ENSG00000185177 "Zinc finger protein 479" Q96JC4 7 57119614-57139864 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 7.4" "Group enriched" "Detected in some" 7 "Early spermatids: 62.7;Late spermatids: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (1.54e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 0.2 1.2 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.5 0.2 0.3 0.4 0.3 0.3 0.2 0.5 0.8 0.8 0.2 1.2 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 6.0 0.0 0.0 0.0 0.0 0.1 ZNF483 "KIAA1962, ZKSCAN16, ZSCAN48" ENSG00000173258 "Zinc finger protein 483" Q8TF39 9 111525159-111577844 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.3;pituitary gland: 40.4" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 44.0;Horizontal cells: 33.4;Muller glia cells: 21.7;Rod photoreceptor cells: 22.6" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055041 Approved Nucleoli NA NA Nucleoli "HPA055041: AB_2682681" "unprognostic (4.33e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (2.34e-1)" "unprognostic (4.11e-2)" "unprognostic (5.95e-3)" "unprognostic (9.18e-5)" "unprognostic (2.02e-1)" "unprognostic (9.50e-2)" "unprognostic (4.44e-3)" "unprognostic (5.49e-2)" "unprognostic (5.19e-4)" "unprognostic (7.19e-3)" "unprognostic (1.74e-1)" "unprognostic (4.30e-2)" "unprognostic (6.17e-2)" 3.2 10.1 13.9 2.1 30.5 7.7 5.6 35.9 36.3 6.1 4.0 8.6 2.9 2.0 10.0 11.9 2.4 7.0 4.9 4.7 18.1 7.3 5.1 2.5 3.9 3.4 9.5 23.0 12.6 4.3 13.6 40.4 1.8 24.4 7.2 2.4 5.9 3.2 7.7 2.3 3.5 2.9 5.5 9.8 4.8 3.9 11.8 10.3 0.0 12.5 0.0 3.1 4.7 4.8 2.5 1.0 4.6 1.0 2.1 6.5 1.5 0.3 3.2 3.2 4.8 0.4 0.6 1.0 0.4 1.6 3.2 3.0 0.4 1.5 0.5 0.5 1.3 2.4 0.9 1.5 1.7 1.9 0.2 1.9 1.7 4.5 2.6 0.9 0.6 0.4 1.2 0.6 1.7 0.9 2.4 2.9 2.1 1.3 0.9 0.7 3.0 0.2 0.8 11.8 1.5 1.1 0.3 4.9 0.4 1.2 1.3 6.9 3.3 1.2 0.6 0.8 3.0 1.9 0.4 0.5 1.0 1.6 1.5 2.2 0.7 1.9 0.4 1.1 0.5 0.7 4.6 1.0 0.6 4.8 0.5 2.7 1.5 3.3 2.3 0.3 2.5 5.9 6.5 3.4 2.1 0.7 1.0 1.6 1.5 13.9 30.5 35.9 36.3 18.1 7.3 9.5 23.0 24.4 10.3 0.0 7.5 0.0 4.4 0.7 44.0 2.9 0.0 1.4 6.8 7.0 19.6 0.9 5.0 0.8 17.5 1.8 0.2 0.0 1.8 0.5 3.1 3.3 0.0 2.1 0.3 33.4 2.9 0.6 0.0 6.7 4.4 1.0 1.7 0.0 0.0 21.7 0.9 0.0 9.6 0.0 22.6 6.5 2.3 7.5 2.7 1.3 0.6 0.0 0.1 3.0 ZNF484 "BA526D8.4, FLJ33884" ENSG00000127081 "Zinc finger protein 484" Q5JVG2 9 92845031-92878038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.0" "Cell type enhanced" "Detected in some" 7 "Ciliated cells: 6.7;Club cells: 7.9;Horizontal cells: 4.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA028973 Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA Nucleoplasm "Nuclear membrane, Cytosol" "HPA028973: AB_10610703" "unprognostic (5.52e-2)" "unprognostic (3.05e-2)" "unprognostic (1.72e-1)" "unprognostic (6.05e-2)" "unprognostic (5.69e-2)" "unprognostic (3.86e-1)" "unprognostic (6.45e-2)" "unprognostic (1.91e-1)" "unprognostic (6.04e-2)" "unprognostic (9.84e-2)" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (4.03e-2)" "unprognostic (3.74e-1)" "unprognostic (4.77e-1)" "unprognostic (6.49e-2)" "unprognostic (1.51e-1)" 6.5 6.6 9.9 5.4 14.6 10.1 6.5 33.0 13.9 7.7 4.8 7.8 4.7 3.7 7.0 5.3 4.2 6.2 4.7 4.9 11.7 7.0 7.3 5.2 5.8 6.6 12.5 7.1 9.1 4.5 12.1 14.0 7.9 12.6 7.0 5.2 4.6 5.0 6.3 3.7 4.2 5.0 6.2 17.1 7.7 6.0 4.8 13.5 2.8 9.0 1.9 7.9 7.3 5.8 5.6 2.5 5.3 3.5 4.5 7.4 3.0 4.1 5.1 6.7 4.3 3.5 4.3 0.0 3.4 5.5 6.1 6.7 1.6 3.2 3.6 3.0 2.7 4.3 6.8 4.9 5.1 6.5 5.8 2.1 3.1 4.1 3.3 5.4 2.5 5.6 4.8 3.9 6.7 7.1 4.5 5.3 4.0 3.3 14.6 6.5 4.2 3.7 1.2 5.6 4.7 2.5 3.1 8.2 2.6 3.2 4.8 4.7 4.2 6.0 1.7 3.4 5.3 0.4 2.0 5.7 5.5 5.3 2.8 2.4 5.5 2.7 2.1 3.6 2.1 4.3 1.4 2.5 5.3 5.3 3.5 6.5 3.7 5.4 4.4 2.2 5.6 7.4 6.7 1.4 4.5 3.1 2.5 4.4 3.0 9.9 14.6 33.0 13.9 11.7 7.0 12.5 7.1 12.6 13.5 0.0 1.0 0.0 0.5 0.1 4.2 1.7 0.0 6.7 7.9 1.8 0.0 0.9 1.7 1.1 0.5 0.9 0.8 0.0 0.4 0.9 0.7 0.4 2.3 0.2 0.7 4.8 0.0 0.0 0.8 0.0 0.6 0.2 0.0 0.0 0.9 3.1 0.7 0.9 1.4 1.3 3.5 0.0 1.0 0.5 0.8 0.1 0.6 1.3 0.5 0.5 ZNF486 "KRBO2, MGC2396" ENSG00000256229 "Zinc finger protein 486" Q96H40 19 20167228-20200490 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 59.2" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 16.6;HBF TERT88: 16.5;SuSa: 15.8" NA NA "unprognostic (9.94e-3)" "unprognostic (1.29e-1)" "unprognostic (6.89e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-3)" "unprognostic (4.14e-2)" "unprognostic (4.83e-2)" "unprognostic (2.42e-2)" "unprognostic (1.51e-2)" "unprognostic (3.25e-2)" "unprognostic (2.64e-1)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (1.66e-1)" "unprognostic (1.01e-1)" "unprognostic (4.65e-2)" "unprognostic (2.43e-2)" 5.1 2.6 3.5 5.3 4.3 2.2 7.2 9.0 4.1 7.7 2.6 1.6 15.4 0.9 6.2 6.1 3.4 5.1 4.1 2.8 2.7 2.2 9.5 1.4 3.8 6.3 5.2 1.8 7.0 5.6 7.7 3.4 10.2 3.4 7.9 2.5 2.5 3.0 10.1 1.4 4.0 3.2 2.6 4.7 6.0 3.6 2.4 5.3 7.0 59.2 2.1 5.4 13.5 7.0 3.6 1.3 13.9 1.7 1.5 3.2 0.9 0.0 0.0 4.4 0.3 3.3 3.9 0.4 6.3 4.7 11.6 11.4 0.5 2.7 5.9 16.6 5.4 8.0 2.6 0.0 0.5 16.5 0.1 2.4 0.0 0.1 1.5 4.1 0.0 0.0 6.4 1.8 7.2 0.6 4.5 0.9 0.2 2.4 0.0 2.6 0.1 1.1 4.5 7.6 0.0 1.6 3.7 6.4 2.1 13.5 4.4 2.7 7.3 0.0 7.3 1.0 15.8 3.0 0.1 1.8 1.1 0.4 7.7 5.1 0.6 7.2 5.0 0.1 0.1 2.2 3.1 0.9 1.2 1.4 1.7 1.6 2.6 1.9 2.0 1.2 3.6 2.4 3.2 13.9 1.5 1.2 1.3 2.1 0.9 3.5 4.3 9.0 4.1 2.7 2.2 5.2 1.8 3.4 5.3 6.0 4.1 2.2 1.7 0.1 1.0 2.0 0.0 18.7 6.8 3.5 0.0 3.6 3.3 5.9 0.4 2.7 0.0 0.0 6.3 10.0 1.8 0.9 4.7 0.0 1.8 0.0 1.2 1.3 1.6 0.2 4.0 1.9 0.0 1.8 1.3 2.3 2.4 0.0 2.5 0.8 0.4 6.5 1.6 2.8 1.3 1.0 1.3 0.9 2.5 2.4 ZNF487 "KRBO1, ZNF487P" ENSG00000243660 "Zinc finger protein 487" B1APH4 10 43436841-43483179 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.1" "Group enriched" "Detected in many" 7 "Ciliated cells: 78.9;Early spermatids: 155.2;Late spermatids: 196.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA037820 Approved "Nucleoplasm,Nuclear membrane,Cytosol" Yes No "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA037820: AB_10697083" "unprognostic (1.97e-1)" "unprognostic (1.69e-3)" "unprognostic (1.49e-1)" "unprognostic (3.42e-3)" "unprognostic (7.40e-2)" "unprognostic (1.42e-2)" "unprognostic (7.10e-2)" "unprognostic (4.84e-1)" "unprognostic (4.00e-2)" "unprognostic (1.05e-2)" "unprognostic (6.97e-4)" "unprognostic (5.85e-2)" "unprognostic (3.97e-4)" "unprognostic (2.91e-1)" "unprognostic (4.42e-2)" "unprognostic (2.52e-2)" "unprognostic (5.92e-2)" 4.1 2.7 4.8 2.7 5.3 5.1 3.9 11.1 9.1 4.6 3.5 3.3 2.2 3.3 5.1 3.1 2.8 7.9 4.9 3.2 6.6 5.0 3.3 3.1 4.0 2.9 5.6 7.4 6.1 2.3 3.7 6.9 2.6 11.2 3.3 2.7 4.0 2.5 4.0 1.7 3.3 3.5 4.2 8.1 3.1 3.0 32.1 6.4 4.3 4.4 2.0 2.9 4.3 3.4 3.2 5.1 13.9 3.9 3.5 4.7 2.6 2.4 2.3 2.8 3.0 3.6 7.2 0.7 4.0 6.9 3.7 4.0 3.6 6.6 6.1 0.7 4.7 3.7 3.9 0.9 1.5 4.6 0.6 1.5 1.9 0.5 2.0 4.4 1.9 2.8 7.1 3.3 6.0 4.5 7.5 1.3 1.3 1.0 1.2 2.7 4.1 3.9 1.6 0.8 1.3 2.5 2.0 1.0 2.4 8.2 2.6 2.8 1.9 3.4 2.0 2.2 1.8 3.1 2.3 2.0 3.4 2.4 1.9 1.1 0.5 1.6 6.7 8.2 2.7 1.3 2.5 3.9 5.8 4.7 2.8 4.0 2.8 3.5 4.3 5.1 3.2 3.0 3.6 13.9 3.5 1.5 3.9 1.8 2.6 4.8 5.3 11.1 9.1 6.6 5.0 5.6 7.4 11.2 6.4 20.8 3.7 7.2 5.4 1.5 4.9 3.1 5.1 78.9 9.1 5.2 7.9 1.4 10.0 3.7 155.2 4.9 5.2 0.0 1.8 3.3 4.0 5.1 0.0 2.4 3.0 6.4 7.5 3.7 5.7 196.9 4.4 5.6 1.7 2.8 4.6 8.0 1.7 3.7 6.3 9.1 17.1 0.0 3.6 6.7 7.6 2.5 1.4 5.0 3.0 5.5 ZNF488 FLJ32104 ENSG00000265763 "Zinc finger protein 488" Q96MN9 10 47365496-47384273 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 29.7;intestine: 25.8" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035957, HPA035958" Supported Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Nucleoplasm, Cytosol" "HPA035957: AB_10672234, HPA035958: AB_2674887" "unprognostic (3.29e-2)" "unprognostic (1.05e-2)" "unprognostic (7.87e-2)" "unprognostic (1.49e-4)" "unprognostic (1.16e-1)" "unprognostic (8.85e-2)" "unprognostic (1.60e-3)" "unprognostic (2.13e-2)" "unprognostic (3.11e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (3.60e-1)" "unprognostic (6.62e-5)" "unprognostic (2.76e-1)" "unprognostic (4.47e-1)" "unprognostic (8.10e-2)" "unprognostic (3.18e-2)" 0.4 0.4 5.7 0.4 18.5 0.3 1.2 2.9 14.2 0.5 3.2 17.0 0.0 25.8 0.5 2.3 0.9 0.5 0.6 0.4 15.1 1.1 0.3 0.5 0.3 19.8 6.0 0.7 0.3 0.3 0.0 4.1 21.4 0.6 1.1 0.0 0.6 0.4 0.3 2.2 12.5 0.4 29.7 0.3 0.6 1.2 12.8 0.0 0.3 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.4 6.8 1.2 0.3 0.0 0.0 0.1 0.2 0.3 0.4 0.4 2.7 6.4 0.1 0.4 0.0 2.7 23.7 0.6 2.6 0.3 34.3 0.7 0.1 0.7 0.2 0.0 0.0 0.3 0.0 6.2 0.2 0.6 0.1 0.0 1.3 0.0 0.0 0.0 0.1 0.2 0.1 1.8 5.1 0.6 0.0 3.0 0.0 0.1 19.1 5.7 1.0 1.6 0.2 0.0 2.7 0.5 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 5.6 5.0 0.3 0.0 0.0 1.0 0.0 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.1 30.2 0.0 0.8 0.3 ZNF492 "KIAA1473, ZNF115" ENSG00000229676 "Zinc finger protein 492" Q9P255 19 22634324-22667670 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.1" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 2: 6.7;Spermatocytes: 8.1;Spermatogonia: 8.5" "Group enriched" "Detected in some" 6 "ovarian cancer: 0.6;testis cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 8.5;HAP1: 4.8;NB-4: 6.3;NTERA-2: 6.1;U-2197: 6.0" NA NA "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (3.14e-1)" "unprognostic (1.24e-3)" "unprognostic (7.94e-2)" "unprognostic (2.42e-2)" "unprognostic (1.47e-2)" "unprognostic (6.75e-2)" "unprognostic (1.08e-3)" "unprognostic (5.63e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.91e-2)" "unprognostic (2.65e-1)" "unprognostic (8.93e-2)" "unprognostic (6.04e-2)" 2.1 0.7 2.0 1.0 3.1 7.4 2.6 7.6 3.8 2.0 1.0 0.1 0.0 0.3 1.2 0.7 1.9 1.2 0.4 1.6 1.9 0.9 1.2 0.6 1.4 1.8 3.1 0.9 2.5 0.9 1.2 0.6 2.1 1.1 0.8 1.4 0.7 0.9 0.6 0.6 1.4 0.9 1.0 0.9 1.8 0.7 8.0 2.3 11.1 1.3 0.0 1.3 0.9 1.3 2.4 0.5 1.4 0.3 0.9 1.0 0.4 0.0 0.0 2.1 0.1 0.0 0.0 8.5 1.3 0.0 0.7 0.7 0.0 0.1 0.0 3.0 1.1 3.7 0.1 4.8 0.0 1.6 0.0 1.5 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 1.7 0.0 0.0 0.0 3.3 1.2 0.2 0.0 0.8 0.0 6.3 6.1 0.0 0.1 0.0 0.0 0.9 0.8 1.5 0.1 3.5 0.0 0.0 0.5 1.5 2.5 2.2 0.0 0.1 3.2 6.0 0.2 0.1 0.0 3.9 0.0 0.0 0.0 0.7 0.3 0.2 0.3 0.2 0.9 0.6 0.6 0.2 0.1 2.4 1.0 0.5 1.4 0.9 0.2 0.5 0.8 0.4 2.0 3.1 7.6 3.8 1.9 0.9 3.1 0.9 1.1 2.3 0.0 6.7 0.0 1.3 0.5 1.5 0.9 0.0 2.7 1.2 0.0 0.0 0.6 0.0 0.4 0.6 0.7 0.0 0.0 0.2 2.0 0.7 0.8 1.1 0.0 0.1 3.2 0.0 1.8 0.8 0.0 0.9 0.0 0.0 0.0 0.2 1.4 0.2 0.0 0.4 0.0 1.7 0.0 0.6 8.1 8.5 0.5 0.5 0.0 0.0 0.7 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 31.6;liver: 23.8" "Cell type enriched" "Detected in single" 12 "Club cells: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 16.1;OE19: 11.5" "HPA035360, HPA038713, HPA052451" Supported Uncertain "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839" 2.1 1.6 1.1 5.0 1.7 1.2 6.2 3.0 2.7 3.1 11.9 1.9 4.9 31.6 3.9 3.5 3.5 1.3 3.0 4.8 1.8 13.7 23.8 2.1 4.7 2.2 1.9 4.9 9.7 0.9 2.1 1.5 1.7 5.1 7.6 2.9 5.0 3.0 5.8 1.3 28.1 4.4 0.8 3.0 3.4 6.5 2.7 3.2 4.6 7.1 3.0 2.0 4.8 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.2 3.1 5.0 0.0 0.0 6.7 0.0 1.4 0.0 0.0 6.7 2.1 0.0 3.2 1.7 0.2 0.1 0.8 0.0 2.1 0.3 0.0 0.9 0.0 16.1 0.0 1.2 1.8 0.0 0.0 1.5 4.8 0.0 0.0 0.6 0.3 6.1 0.0 0.0 3.2 5.2 0.3 11.5 0.0 0.9 1.2 2.9 0.2 0.3 0.5 5.4 0.3 2.7 2.3 3.3 0.0 0.5 0.0 0.0 3.0 2.5 0.1 1.5 0.0 0.8 0.3 1.1 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF519 "FLJ36809, HsT2362" ENSG00000175322 "Zinc finger protein 519" Q8TB69 18 14057457-14132490 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 14.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA028982 Uncertain Approved Nucleoli NA NA Nucleoli "HPA028982: AB_10610705" "unprognostic (1.85e-2)" "unprognostic (4.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.90e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.18e-1)" "unprognostic (6.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-5)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (2.38e-1)" "unprognostic (3.65e-4)" 1.8 1.4 2.8 1.9 7.6 1.4 2.8 13.7 14.4 5.7 4.6 0.7 0.8 1.2 7.0 2.6 3.4 4.5 1.8 1.9 3.4 1.6 0.8 1.0 2.7 6.6 1.7 4.0 8.7 1.2 1.1 1.5 1.2 3.0 2.6 2.6 2.0 1.6 2.7 1.0 2.0 2.1 6.0 2.1 2.2 1.4 3.0 2.5 1.1 2.0 0.9 1.9 4.3 3.8 1.7 0.1 0.0 0.6 0.5 3.5 0.7 1.3 0.3 6.0 6.3 0.8 1.2 1.6 1.6 0.9 3.5 3.2 2.7 1.2 3.1 1.7 1.2 1.6 1.0 4.9 1.2 4.1 1.9 3.3 5.5 1.8 1.1 0.2 11.3 2.4 0.6 1.6 2.9 1.2 1.0 0.6 4.7 2.7 4.7 2.0 1.8 6.9 4.4 2.7 3.5 1.4 7.4 5.8 3.9 0.9 1.9 9.3 2.5 2.3 0.8 1.8 4.0 0.7 3.1 0.4 5.7 7.6 2.5 1.8 1.8 1.2 4.5 1.8 4.4 4.7 0.0 0.3 0.0 1.1 0.6 1.8 1.7 1.4 1.5 0.1 0.8 3.5 2.2 0.0 0.5 0.5 0.1 2.0 0.7 2.8 7.6 13.7 14.4 3.4 1.6 1.7 4.0 3.0 2.5 6.0 7.4 4.2 2.4 1.8 14.4 4.4 2.5 2.7 1.2 0.0 2.0 2.3 1.7 2.0 0.7 2.1 0.1 0.0 1.7 3.5 3.9 1.2 3.5 0.8 1.5 3.2 1.2 3.7 2.4 1.1 6.1 1.8 1.7 1.0 1.3 5.0 0.8 0.0 8.5 0.6 6.8 0.0 2.2 6.9 11.5 1.1 0.7 4.4 2.5 1.4 ZNF521 "EHZF, Evi3" ENSG00000198795 "Zinc finger protein 521" Q96K83 18 25061926-25352190 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.1" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 27.9;Endothelial cells: 22.4;Horizontal cells: 14.3;Ito cells: 14.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 69.1" "Group enriched" "Detected in some" 5 "basophil: 8.8;plasmacytoid DC: 9.8" "Group enriched" "Detected in many" 5 "dendritic cells: 9.8;granulocytes: 8.8" "Cell line enhanced" "Detected in many" "AF22: 32.0;fHDF/TERT166: 15.0;HUVEC TERT2: 21.9;THP-1: 17.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 105.4" "HPA023056, HPA023849" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA023056: AB_1859315, HPA023849: AB_1859316" "unprognostic (8.80e-3)" "unprognostic (9.68e-2)" "unprognostic (2.05e-1)" "unprognostic (3.40e-2)" "unprognostic (5.43e-2)" "unprognostic (3.73e-3)" "unprognostic (1.52e-3)" "unprognostic (6.17e-2)" "unprognostic (1.72e-1)" "unprognostic (1.57e-1)" "unprognostic (8.18e-2)" "unprognostic (1.83e-1)" "unprognostic (1.19e-3)" "unprognostic (1.16e-3)" "unprognostic (2.43e-1)" "unprognostic (2.52e-3)" "unprognostic (7.82e-4)" 9.2 11.3 5.2 2.8 7.0 1.9 9.1 69.1 11.5 11.0 3.4 9.1 4.7 1.7 19.8 5.9 3.8 9.0 10.0 7.0 5.8 5.1 3.1 1.2 6.4 4.0 8.4 2.8 20.5 1.4 1.4 16.8 8.0 12.2 4.4 3.5 6.7 8.7 3.0 3.8 4.6 3.2 13.3 12.2 18.5 2.4 3.4 8.9 0.5 5.3 6.9 2.6 7.4 5.4 0.0 9.8 8.8 0.1 1.7 0.0 0.1 0.0 0.0 32.0 0.0 5.1 9.0 0.1 4.6 6.7 1.6 1.0 0.0 0.0 0.0 0.0 15.0 0.0 0.1 0.0 0.0 1.3 0.0 1.9 6.3 0.3 0.2 0.9 0.0 9.6 11.1 0.0 0.1 0.0 0.0 21.9 7.6 0.1 0.0 2.8 0.0 4.1 0.0 2.2 0.0 0.0 0.0 7.2 0.5 0.0 0.0 4.1 2.6 0.4 0.0 0.0 3.0 0.0 17.8 12.4 12.7 1.0 3.7 0.7 0.0 0.0 0.1 4.8 0.0 10.4 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 9.8 0.0 0.1 5.2 7.0 69.1 4.3 5.8 5.1 8.4 2.8 12.2 8.9 0.0 4.8 0.0 0.1 3.3 27.9 9.1 0.0 2.7 1.2 0.0 2.0 0.0 0.0 0.0 1.6 22.4 0.0 0.0 0.0 0.0 7.2 0.2 12.7 0.0 0.1 14.3 1.2 14.1 1.6 3.6 9.2 0.9 13.5 0.0 0.0 0.7 0.0 0.0 7.4 3.1 2.7 0.0 3.3 0.1 1.5 3.9 0.1 0.0 0.0 0.1 ZNF534 "FLJ25344, KRBO3" ENSG00000198633 "Zinc finger protein 534" Q76KX8 19 52429187-52452315 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.8;testis: 8.9" "Group enriched" "Detected in some" 4 "Spermatocytes: 3.8;Spermatogonia: 12.0" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "K-562: 1.3;SuSa: 5.2" NA NA "unprognostic (2.66e-1)" "unprognostic (3.35e-1)" "unprognostic (2.35e-1)" "unprognostic (2.35e-1)" "unprognostic (7.65e-4)" "unprognostic (7.25e-2)" "unprognostic (9.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.36e-2)" "unprognostic (1.33e-1)" "unprognostic (1.02e-1)" "unprognostic (2.22e-1)" "unprognostic (9.57e-4)" "unprognostic (3.04e-2)" "unprognostic (4.51e-2)" "unprognostic (1.59e-1)" "unprognostic (5.80e-2)" 0.3 0.6 1.5 0.3 3.8 0.0 1.2 3.7 2.5 0.3 0.3 0.3 0.3 0.0 0.3 0.7 0.7 0.9 0.3 0.8 1.6 1.6 0.3 0.3 0.5 0.3 0.8 0.3 1.0 0.3 0.0 0.3 0.8 0.3 1.0 0.1 0.3 0.3 0.8 1.4 0.2 0.3 0.3 1.1 0.3 0.1 8.9 0.3 0.3 1.9 2.0 0.3 0.3 0.3 0.2 0.0 1.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.2 0.4 0.0 0.5 0.4 0.1 0.0 0.0 0.0 5.2 0.0 0.6 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 1.2 0.2 0.0 0.0 0.1 0.0 1.5 3.8 3.7 1.6 1.6 1.6 0.8 0.3 0.3 0.3 0.0 0.0 0.0 0.7 0.3 0.8 1.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.6 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.5 0.0 0.4 3.8 12.0 0.4 0.0 0.0 0.0 0.1 ZNF536 KIAA0390 ENSG00000198597 "Zinc finger protein 536" O15090 19 30228290-30713538 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 44.5" "Group enriched" "Detected in some" 5 "Bipolar cells: 29.2;Horizontal cells: 66.7;Muller glia cells: 58.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.0;HAP1: 8.9;SH-SY5Y: 24.4;U-937: 5.9;WM-115: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077341 Approved "Nucleoplasm,Cell Junctions" NA NA "Nucleoplasm, Cell Junctions" "HPA077341: AB_2732340" "unprognostic (1.98e-1)" "unprognostic (4.11e-1)" "unprognostic (1.92e-2)" "unprognostic (1.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.03e-1)" "unprognostic (4.70e-2)" "unprognostic (4.68e-1)" "unprognostic (5.50e-2)" "unprognostic (1.74e-2)" "unprognostic (1.25e-2)" "unprognostic (4.46e-4)" "unprognostic (1.58e-1)" "unprognostic (2.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.45e-1)" 1.1 6.0 9.9 2.0 21.0 0.6 0.8 14.3 24.1 4.2 4.0 44.5 0.0 2.7 1.7 1.3 6.9 1.0 1.3 2.9 13.3 7.7 0.8 0.7 1.0 0.7 20.9 9.6 0.9 0.9 0.7 3.4 0.7 18.3 3.7 4.1 4.8 1.6 2.4 1.4 1.2 4.2 1.2 23.1 1.5 2.1 5.0 18.4 0.0 6.9 0.0 0.7 2.9 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 8.9 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 24.4 0.0 0.0 1.6 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 5.9 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.9 21.0 14.3 15.1 13.3 7.7 20.9 9.6 18.3 18.4 0.0 0.0 0.0 0.1 0.3 29.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.5 66.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.0 0.0 0.0 9.5 0.0 1.9 0.3 0.4 0.3 0.0 0.0 0.0 0.1 ZNF540 DKFZp547B0714 ENSG00000171817 "Zinc finger protein 540" Q8NDQ6 19 37551406-37614097 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 30.7" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 23.5;Early spermatids: 14.0;Horizontal cells: 17.5;Rod photoreceptor cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 6.8" HPA003444 Supported Supported Nucleoplasm,Vesicles,Cytosol NA NA Nucleoplasm "Vesicles, Cytosol" "HPA003444: AB_1080732" "unprognostic (2.51e-2)" "unprognostic (2.30e-4)" "unprognostic (4.92e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-4)" "unprognostic (4.24e-4)" "unprognostic (3.44e-3)" "unprognostic (8.88e-4)" "unprognostic (2.65e-1)" "unprognostic (3.17e-1)" "unprognostic (3.38e-5)" "unprognostic (1.50e-1)" "unprognostic (1.09e-6)" "unprognostic (2.74e-1)" "unprognostic (4.75e-2)" "unprognostic (8.08e-2)" "unprognostic (8.33e-5)" 2.8 9.3 8.6 3.9 29.9 1.2 6.0 23.7 16.7 5.8 4.4 5.0 5.3 3.9 6.0 9.4 3.0 4.2 3.6 9.1 8.6 12.1 6.3 2.6 5.0 6.3 9.0 9.1 13.8 3.8 13.3 30.7 2.3 11.0 7.1 3.6 9.0 6.1 8.9 2.9 6.0 4.5 3.8 7.9 6.3 4.6 11.5 9.5 2.7 14.4 3.1 6.0 3.4 4.0 3.1 0.3 1.2 0.1 3.0 7.1 1.8 0.4 0.0 2.6 2.6 6.8 4.1 0.2 0.9 0.9 1.1 2.1 0.2 0.0 1.2 0.3 2.4 0.6 1.0 1.8 0.9 0.9 3.7 2.6 0.9 1.2 0.0 1.8 1.2 2.0 1.8 2.4 0.7 0.0 0.5 0.1 5.1 0.4 0.0 1.6 0.1 1.7 0.7 0.9 0.3 0.5 1.4 1.6 0.8 0.6 0.4 2.7 3.0 1.0 0.3 0.3 1.9 1.3 0.7 0.0 1.0 3.1 1.2 0.9 3.6 2.0 2.5 0.0 0.4 0.6 0.0 0.0 1.2 3.9 0.1 3.9 2.9 4.1 4.4 0.1 3.1 6.8 7.1 0.2 3.0 0.0 0.3 4.2 1.8 8.6 29.9 23.7 16.7 8.6 12.1 9.0 9.1 11.0 9.5 3.0 1.6 0.8 1.1 1.4 23.5 8.7 0.0 0.0 2.3 1.8 5.9 0.2 6.6 0.1 14.0 0.9 0.4 0.0 0.4 0.3 0.9 0.4 3.5 0.8 0.7 17.5 0.0 2.5 0.3 4.3 2.3 0.9 3.3 0.0 0.0 5.2 0.3 0.0 5.3 2.1 19.7 6.5 3.3 4.4 2.7 1.1 0.1 3.5 0.2 0.0 ZNF541 DKFZp434I1930 ENSG00000118156 "Zinc finger protein 541" Q9H0D2 19 47520685-47555856 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 17.7" "Group enriched" "Detected in some" 8 "Early spermatids: 18.8;Late spermatids: 8.5;Proximal tubular cells: 10.3;Spermatocytes: 28.8;Spermatogonia: 9.8" "Cancer enhanced" "Detected in some" "cervical cancer: 2.7" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Group enriched" "Detected in some" 5 "HEL: 3.1;SiHa: 10.2;U-87 MG: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA058541, HPA076453" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA058541: AB_2683748, HPA076453: AB_2732310" "unprognostic (4.49e-2)" "prognostic favorable (2.94e-4)" "unprognostic (8.33e-2)" "unprognostic (3.09e-1)" "unprognostic (2.74e-1)" "unprognostic (5.92e-5)" "unprognostic (7.98e-2)" "unprognostic (5.19e-3)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-2)" "unprognostic (7.52e-2)" "unprognostic (3.09e-2)" "unprognostic (5.20e-2)" "unprognostic (2.14e-1)" "unprognostic (1.01e-1)" "unprognostic (1.59e-2)" 1.2 2.6 0.1 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.9 0.0 0.1 0.1 0.0 2.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.5 0.0 17.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 1.0 0.3 0.0 0.2 0.2 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.5 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.0 18.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 8.5 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.3 0.8 0.0 0.0 28.8 9.8 0.1 0.0 0.0 0.0 0.0 ZNF556 FLJ11637 ENSG00000172000 "Zinc finger protein 556" Q9HAH1 19 2867335-2883445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.6;brain: 22.3;ovary: 11.3" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 12.2;Ciliated cells: 8.1;Club cells: 9.1;granulocytes: 7.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 22.3" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 14.6" "Lineage enriched" "Detected in many" 11 "dendritic cells: 14.6" "Cell line enhanced" "Detected in some" "CACO-2: 7.2;HBEC3-KT: 7.7;Hep G2: 12.1;RH-30: 18.0;THP-1: 6.5" HPA060593 Approved Nucleoplasm NA NA Nucleoplasm "HPA060593: AB_2684328" "unprognostic (1.36e-1)" "unprognostic (9.07e-2)" "unprognostic (2.70e-3)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "unprognostic (1.98e-2)" "unprognostic (3.12e-3)" "unprognostic (3.23e-1)" "unprognostic (4.81e-1)" "unprognostic (2.17e-1)" "unprognostic (6.14e-4)" "unprognostic (2.85e-1)" "unprognostic (2.61e-2)" "unprognostic (1.51e-1)" "unprognostic (1.51e-1)" "unprognostic (5.26e-3)" "unprognostic (5.54e-3)" 0.3 0.2 0.5 0.3 0.5 1.0 0.5 22.3 0.5 0.7 0.3 0.0 1.7 0.1 1.6 0.7 3.1 4.2 0.8 0.2 0.4 0.3 2.6 0.1 0.4 0.3 0.4 0.1 11.3 2.6 0.4 1.6 0.8 1.3 0.4 0.1 0.1 1.0 0.1 4.5 0.7 0.2 0.3 0.5 0.3 0.3 3.5 0.0 0.6 0.2 8.7 0.9 0.2 0.2 0.4 14.6 1.2 0.2 0.6 0.2 0.1 1.9 0.3 0.0 3.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 7.2 0.1 2.4 1.2 0.1 0.0 0.1 0.0 7.7 0.0 0.1 0.0 0.1 3.2 12.1 0.1 0.2 3.8 0.6 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 2.3 0.0 0.0 0.2 0.0 0.1 0.1 0.0 18.0 1.5 0.0 0.3 0.1 2.9 0.0 0.3 0.0 0.1 3.7 6.5 0.0 0.1 0.1 4.7 0.1 2.1 3.9 0.1 0.2 0.1 0.1 1.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.6 0.1 14.6 0.1 0.1 0.5 0.5 22.3 0.5 0.4 0.3 0.4 0.1 1.3 0.0 3.0 12.2 0.0 2.3 0.3 2.2 0.4 0.0 8.1 9.1 3.5 2.0 0.4 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.2 0.5 1.5 7.0 0.0 0.2 3.2 0.0 1.3 1.2 0.0 0.6 1.4 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.6 4.6 0.0 0.5 5.6 4.7 0.1 0.2 0.8 0.0 1.6 ZNF560 FLJ31986 ENSG00000198028 "Zinc finger protein 560" Q96MR9 19 9466507-9498607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "testis: 21.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 48.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8" "HPA045439, HPA074438" Enhanced "Nucleoplasm,Nuclear speckles" NA NA Nucleoplasm "Nuclear speckles" "HPA045439: AB_2732520, HPA074438: " "unprognostic (4.43e-3)" "unprognostic (8.91e-2)" "unprognostic (9.85e-3)" "unprognostic (2.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.29e-1)" "unprognostic (1.04e-1)" "unprognostic (1.39e-1)" "unprognostic (6.57e-3)" "unprognostic (6.33e-5)" "unprognostic (5.60e-2)" "unprognostic (2.32e-1)" "unprognostic (9.15e-3)" "unprognostic (1.65e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 21.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.8 2.4 0.0 1.4 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 1.0 17.9 0.0 0.0 1.3 0.0 4.4 2.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 11.3 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.0 8.3 0.0 0.0 0.0 0.0 0.0 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Cell type enhanced" "Detected in many" 4 "granulocytes: 15.0;Rod photoreceptor cells: 16.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.8 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 4.6 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.3 6.3 5.8 4.7 1.3 8.7 2.4 0.8 5.3 1.7 9.6 2.1 15.8 2.9 3.5 4.8 3.0 5.1 9.1 11.6 13.6 9.5 6.4 2.1 3.2 13.2 9.7 1.3 0.8 3.0 3.9 3.3 6.9 7.7 15.8 13.2 0.5 0.8 6.6 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 0.0 1.3 4.5 1.1 1.5 9.3 1.1 2.5 4.0 5.7 5.2 9.8 1.8 3.3 1.7 10.5 2.5 0.8 0.0 1.4 1.3 2.3 1.7 15.0 0.8 1.4 12.7 1.2 2.5 1.3 2.5 4.0 1.3 5.0 0.0 2.1 4.5 0.8 0.0 2.5 2.6 16.6 12.9 1.7 7.2 5.7 2.3 1.0 6.2 1.3 0.5 ZNF578 FLJ31384 ENSG00000258405 "Zinc finger protein 578" Q96N58 19 52453576-52512154 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.3" "Cell type enhanced" "Detected in some" 7 "Early spermatids: 4.5;Horizontal cells: 6.4;Rod photoreceptor cells: 7.4" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 5.8;SuSa: 8.2;U-266/84: 12.6" NA NA "unprognostic (6.57e-3)" "unprognostic (1.43e-2)" "unprognostic (1.56e-2)" "unprognostic (3.77e-2)" "unprognostic (1.60e-3)" "unprognostic (2.96e-3)" "unprognostic (5.42e-2)" "unprognostic (5.69e-2)" "unprognostic (2.55e-2)" "unprognostic (8.14e-2)" "unprognostic (9.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.81e-1)" "unprognostic (2.64e-1)" "unprognostic (1.82e-1)" "unprognostic (3.96e-2)" "unprognostic (2.42e-1)" 1.9 1.2 1.9 2.5 5.6 1.0 1.9 4.4 2.5 2.4 1.5 1.5 0.7 2.0 4.9 0.8 0.9 2.1 1.2 1.9 1.7 2.0 1.6 0.8 1.6 1.5 1.6 1.6 3.3 1.7 2.1 5.2 5.1 2.6 2.9 1.1 4.6 2.0 1.8 1.0 1.4 1.6 2.5 2.0 3.3 1.6 15.3 2.3 0.7 3.8 2.1 1.4 1.6 2.7 2.0 0.9 0.8 0.9 10.2 5.3 1.6 1.1 0.0 2.3 2.3 0.5 1.1 2.2 2.5 0.7 0.1 0.8 0.1 0.8 0.5 0.4 2.7 3.9 1.9 0.0 0.4 0.2 0.1 1.4 0.4 0.7 0.3 0.9 0.0 3.3 2.3 0.1 0.9 0.1 0.9 1.0 0.0 0.4 0.0 3.8 0.3 0.0 0.4 5.8 0.3 0.7 0.0 0.0 0.3 0.2 3.9 0.4 3.3 0.9 0.4 0.1 8.2 2.4 0.8 1.0 0.1 0.4 0.8 0.6 0.5 12.6 1.7 0.1 0.0 2.3 0.8 0.6 0.8 5.3 0.3 2.7 2.0 1.4 2.4 0.9 1.8 1.9 2.6 0.1 10.2 0.9 0.2 0.8 1.6 1.9 5.6 4.4 2.3 1.7 2.0 1.6 1.6 2.6 2.3 0.0 0.0 0.8 1.1 0.8 4.0 3.0 0.0 0.0 0.0 0.0 3.9 0.6 0.0 0.1 4.5 0.7 0.0 0.0 0.2 0.6 0.4 0.5 1.1 0.0 0.2 6.4 0.0 0.6 0.0 3.9 0.6 0.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 7.4 0.0 0.0 0.0 2.3 0.4 0.7 1.5 0.0 1.4 ZNF593 ZT86 ENSG00000142684 "Zinc finger protein 593" O00488 1 26169871-26170873 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054363, HPA059387" Supported Enhanced Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA054363: AB_2682462, HPA059387: AB_2684001" "unprognostic (1.23e-2)" "unprognostic (8.97e-2)" "unprognostic (7.13e-2)" "unprognostic (7.42e-2)" "unprognostic (9.37e-2)" "unprognostic (5.92e-2)" "unprognostic (1.63e-2)" "unprognostic (8.96e-2)" "unprognostic (5.06e-1)" "unprognostic (1.76e-2)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.46e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (4.79e-2)" 11.7 11.5 9.4 10.7 9.4 15.7 18.3 7.2 12.1 9.0 11.7 7.0 12.1 11.4 8.7 9.0 10.9 8.4 11.3 14.5 8.9 10.0 13.5 30.8 7.7 16.8 10.0 7.0 11.6 36.2 9.7 9.3 12.7 10.9 10.4 5.8 5.9 15.9 12.0 59.3 9.8 11.0 6.5 7.3 13.0 15.2 9.3 8.3 5.4 15.1 17.2 9.2 10.6 10.1 23.5 26.8 0.7 25.0 16.1 21.7 14.1 20.1 11.1 3.8 13.4 3.7 4.9 20.2 9.0 4.6 10.5 10.1 17.0 12.2 23.6 16.6 5.6 8.4 13.2 12.9 11.7 3.8 14.1 41.4 16.0 9.1 25.7 16.1 22.1 14.1 8.8 11.5 11.6 12.2 4.4 8.8 5.8 24.0 9.1 6.2 15.4 9.0 41.1 15.1 19.5 39.5 11.3 6.7 23.8 7.5 8.9 10.1 11.0 10.9 27.4 34.2 3.3 11.3 12.5 9.1 10.1 11.9 21.1 16.8 18.0 18.2 25.5 11.8 45.9 12.9 0.1 15.7 0.2 14.2 25.0 13.3 23.5 20.1 14.0 21.7 22.7 15.0 14.3 0.7 16.1 25.0 26.8 21.7 14.1 9.4 9.4 7.2 12.1 8.9 10.0 10.0 7.0 10.9 8.3 11.9 63.0 48.3 137.4 152.1 16.6 5.9 58.6 21.4 40.9 57.6 2.0 93.3 87.9 89.4 5.0 36.0 55.3 23.3 126.2 135.2 54.6 99.4 51.7 184.5 69.6 3.2 105.3 38.6 55.7 10.0 30.0 42.5 47.2 47.7 71.1 18.5 122.6 60.4 21.9 148.8 11.7 12.9 55.6 33.0 56.3 147.0 186.2 28.8 68.1 152.9 ZNF595 FLJ31740 ENSG00000272602 "Zinc finger protein 595" 4 53285-88211 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "placenta: 35.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 28.1;K-562: 64.4;SH-SY5Y: 44.1" NA NA "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" "unprognostic (6.33e-2)" "unprognostic (2.95e-1)" "unprognostic (6.98e-2)" "unprognostic (1.03e-2)" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-1)" "unprognostic (6.63e-3)" "unprognostic (2.52e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (4.56e-3)" "unprognostic (2.31e-1)" "unprognostic (2.68e-1)" "unprognostic (6.46e-2)" 5.4 5.0 3.5 3.8 5.3 4.5 5.8 15.9 5.7 6.7 3.6 3.7 3.0 2.3 6.0 3.5 2.5 4.4 2.8 2.5 3.9 3.1 3.5 4.0 5.3 4.5 4.2 10.1 4.2 3.5 10.3 35.9 7.0 4.6 3.5 3.1 2.9 2.5 5.1 3.9 1.8 6.4 5.5 5.1 2.7 4.7 4.7 9.5 7.4 1.9 5.7 4.2 3.2 12.5 11.6 11.0 2.4 16.7 6.7 3.4 1.0 3.6 2.4 2.2 14.1 17.5 18.8 1.3 1.2 1.4 1.9 1.7 1.5 28.1 2.2 1.0 2.4 0.8 13.6 1.2 2.1 2.2 1.9 0.1 0.0 0.0 0.9 0.0 7.4 1.9 1.6 1.4 1.5 1.6 1.1 12.9 64.4 0.3 1.1 8.0 0.0 7.8 4.2 0.0 1.6 0.0 0.5 0.0 2.0 1.1 2.0 44.1 1.6 1.9 0.7 10.1 13.7 4.5 7.9 1.5 10.9 0.8 1.6 0.1 13.6 3.3 0.0 0.0 4.8 3.4 2.1 11.0 6.7 2.4 3.1 12.5 3.6 4.3 3.1 12.4 5.0 5.0 3.7 16.7 2.2 11.6 2.7 3.4 6.0 9.4 10.5 8.7 4.0 8.2 4.9 7.6 2.7 19.4 3.5 2.0 8.7 13.3 6.6 3.9 8.2 1.6 0.0 3.8 7.3 4.8 4.8 7.0 3.4 3.3 3.2 0.0 9.2 3.5 4.9 10.3 2.6 5.0 1.0 2.7 9.8 3.3 2.9 8.5 4.2 6.2 0.0 4.7 12.2 12.7 4.0 7.1 8.6 3.3 5.2 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 25.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favorable (1.92e-6)" 4.7 5.3 7.1 3.9 7.4 1.6 9.5 14.2 7.4 5.3 6.5 5.2 1.9 2.8 5.5 5.3 4.7 4.3 3.7 4.3 9.7 4.7 8.7 4.0 4.9 6.3 7.2 4.9 6.5 3.4 7.4 7.0 8.2 8.8 25.4 6.7 5.4 4.5 5.6 3.9 4.5 4.9 5.8 7.5 6.7 4.2 3.5 7.0 9.0 7.3 2.6 5.2 5.8 4.1 10.1 9.6 14.1 11.3 9.5 14.3 7.0 3.1 4.1 6.8 6.8 5.9 6.8 1.7 5.2 8.4 7.0 9.1 1.3 3.7 2.6 2.8 6.5 6.2 3.5 6.6 6.5 7.6 0.1 8.6 5.5 2.9 3.9 6.1 0.3 7.8 5.0 7.5 6.6 5.4 8.6 7.5 6.5 2.5 0.0 7.0 0.5 9.1 4.0 4.9 1.3 5.9 5.0 7.3 2.8 6.8 10.7 4.6 4.5 8.5 6.2 5.0 11.2 6.5 6.7 4.8 3.1 5.8 2.3 5.6 6.0 0.0 5.1 0.2 0.0 9.2 7.7 7.4 14.1 10.4 7.5 9.3 7.6 11.1 12.1 9.6 10.1 11.2 14.3 7.6 9.5 11.3 4.8 10.0 7.0 7.1 7.4 14.2 7.4 9.7 4.7 7.2 4.9 8.8 7.0 3.0 1.6 0.0 0.5 0.5 2.1 3.1 2.5 0.0 3.4 3.5 0.0 4.9 3.3 2.1 2.0 2.4 1.0 0.0 1.9 1.5 0.9 1.1 1.1 1.5 2.6 0.0 1.2 1.8 1.8 0.4 1.1 1.1 0.0 3.6 2.9 2.2 1.7 2.8 1.4 1.4 4.2 0.0 0.5 1.6 1.1 0.5 5.9 0.9 1.7 0.5 ZNF648 FLJ46813 ENSG00000179930 "Zinc finger protein 648" Q5T619 1 182054570-182061712 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;liver: 1.7;ovary: 3.0;testis: 2.2" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.8;Melanocytes: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 80 "HMC-1: 29.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053897 Uncertain NA NA "HPA053897: AB_2682297" "unprognostic (3.52e-4)" "unprognostic (1.44e-1)" "unprognostic (7.96e-2)" "unprognostic (1.69e-3)" "unprognostic (2.30e-1)" "unprognostic (4.33e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-2)" "unprognostic (2.95e-2)" "unprognostic (2.24e-1)" "unprognostic (1.38e-2)" "unprognostic (8.16e-6)" "unprognostic (4.96e-2)" "unprognostic (3.25e-1)" "unprognostic (2.42e-1)" "unprognostic (2.83e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.8 0.0 0.3 0.2 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 3.0 0.4 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 ZNF658 "DKFZp572C163, FLJ32813, MGC35232" ENSG00000274349 "Zinc finger protein 658" Q5TYW1 9 66856426-66932141 "Predicted intracellular proteins, Transcription factors" "Ribosome biogenesis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 20.9" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 12.0;Distal tubular cells: 13.3;Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in some" 11 "neutrophil: 20.9" "Lineage enriched" "Detected in many" 11 "granulocytes: 20.9" "Low cell line specificity" "Detected in many" "HPA047730, HPA048668" Uncertain Approved Nucleoplasm No No Nucleoplasm "HPA047730: AB_2680136, HPA048668: AB_2680487" "unprognostic (9.54e-2)" "unprognostic (1.60e-1)" "unprognostic (9.06e-3)" "unprognostic (1.97e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-2)" "unprognostic (1.45e-1)" "unprognostic (1.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (2.75e-3)" "unprognostic (8.04e-2)" "unprognostic (1.18e-4)" "unprognostic (2.68e-2)" "unprognostic (6.99e-2)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" 0.5 0.8 0.1 0.0 2.8 1.4 1.6 0.6 0.3 1.5 0.8 1.4 1.8 0.1 1.8 1.5 0.5 0.9 0.5 3.5 1.1 2.4 0.1 1.8 0.7 1.6 1.4 1.9 4.5 0.0 0.9 1.1 0.6 1.2 2.1 0.9 0.9 1.3 0.4 20.9 0.5 1.8 1.4 0.1 2.8 4.8 4.7 8.8 4.8 5.8 3.6 2.2 4.1 3.1 3.4 0.4 2.2 6.4 2.5 2.1 3.3 7.6 3.7 4.4 3.3 0.2 2.3 1.0 4.0 1.0 5.3 4.0 2.4 4.5 9.8 3.0 4.4 6.4 6.0 4.3 1.3 1.3 3.9 1.6 3.2 2.0 4.0 2.0 8.2 0.3 7.5 2.3 3.3 7.3 6.8 4.1 3.5 1.9 3.4 5.1 2.7 10.3 1.3 4.0 5.1 3.5 2.7 0.8 3.7 1.6 1.8 1.4 4.2 0.5 0.5 1.5 0.6 0.4 0.1 0.6 0.9 0.8 0.2 1.3 1.4 0.7 20.9 1.8 0.4 0.4 0.5 0.1 3.0 2.7 0.5 1.0 0.8 6.4 3.2 0.0 12.0 3.4 0.0 0.0 2.3 13.3 0.9 0.6 0.7 0.9 0.0 0.6 0.7 0.9 0.7 1.1 2.4 1.6 9.5 0.0 0.6 1.3 0.9 2.8 0.1 0.0 0.0 1.8 4.9 0.8 0.0 4.9 4.8 3.9 0.0 0.5 2.6 2.0 1.8 0.8 0.0 1.2 0.9 ZNF676 ENSG00000196109 "Zinc finger protein 676" Q8N7Q3 19 22179091-22196951 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 6.5" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 16.6;Early spermatids: 17.1;Spermatocytes: 17.7" "Cancer enriched" "Detected in some" 7 "testis cancer: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "NTERA-2: 12.6" NA NA "unprognostic (7.77e-2)" "unprognostic (2.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.64e-2)" "unprognostic (3.22e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (8.33e-2)" "unprognostic (1.36e-2)" "unprognostic (1.64e-1)" "unprognostic (5.45e-1)" "unprognostic (6.76e-3)" "unprognostic (9.98e-3)" "unprognostic (5.14e-2)" "unprognostic (1.16e-1)" "unprognostic (3.70e-3)" 1.4 0.1 0.0 0.2 0.1 0.0 1.6 0.0 1.3 1.2 1.3 0.0 2.4 1.1 0.1 2.3 0.5 2.1 0.1 0.2 1.4 0.0 0.1 0.1 0.4 2.4 1.6 6.5 1.9 0.0 0.6 0.2 0.2 0.5 0.0 0.4 0.2 1.8 0.8 0.8 0.1 4.6 4.3 0.0 0.3 0.8 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.2 3.3 0.0 0.0 0.0 5.2 0.0 0.9 16.6 6.1 17.1 2.9 0.0 0.0 2.3 0.5 0.5 0.2 0.0 0.0 0.2 1.6 0.0 2.5 0.0 3.6 0.9 0.0 0.0 0.0 0.0 1.2 1.6 0.0 0.4 1.0 0.0 6.5 0.9 17.7 7.5 0.3 0.7 0.0 0.0 0.3 ZNF677 MGC48625 ENSG00000197928 "Zinc finger protein 677" Q86XU0 19 53235381-53254898 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 40.5" "Group enriched" "Detected in many" 11 "Early spermatids: 557.4;Late spermatids: 339.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 19.6;SuSa: 17.4" HPA023106 Approved Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA023106: AB_1859409" "unprognostic (2.06e-2)" "unprognostic (1.52e-1)" "unprognostic (2.88e-2)" "unprognostic (1.32e-1)" "unprognostic (2.34e-2)" "unprognostic (2.02e-3)" "unprognostic (7.73e-2)" "unprognostic (4.07e-3)" "unprognostic (7.87e-3)" "unprognostic (8.16e-2)" "unprognostic (2.52e-1)" "unprognostic (3.12e-2)" "unprognostic (8.70e-8)" "unprognostic (6.57e-3)" "unprognostic (7.85e-2)" "unprognostic (1.76e-1)" "unprognostic (3.17e-2)" 9.1 7.3 5.9 4.3 8.3 4.2 9.3 13.0 7.3 7.4 7.0 13.9 1.3 2.9 12.3 5.7 4.6 9.7 6.2 9.4 5.3 4.3 6.3 2.3 6.8 7.3 9.9 4.8 14.3 4.4 9.1 9.9 7.5 6.6 8.9 3.4 7.6 7.4 6.2 3.9 7.5 3.9 8.1 10.5 7.0 5.7 40.5 8.7 6.7 10.1 5.2 5.0 8.2 6.6 17.4 14.5 10.1 2.8 10.3 15.4 4.1 0.2 0.2 11.4 0.4 3.9 6.0 2.0 7.4 5.6 7.7 7.0 0.0 0.4 0.1 5.6 6.4 9.7 0.7 0.0 5.8 2.3 0.2 4.1 0.3 0.5 0.2 9.6 0.1 7.6 10.3 0.0 7.4 0.1 0.2 3.4 0.1 0.1 0.5 5.2 0.2 6.2 0.2 19.6 0.1 2.6 0.1 0.0 0.2 2.2 3.0 0.2 10.8 0.2 2.8 0.1 17.4 0.4 0.3 2.1 12.1 0.2 0.2 4.9 0.3 0.1 0.2 0.2 0.3 0.1 10.1 2.2 6.4 5.1 2.8 7.3 9.6 7.2 5.6 6.1 17.4 15.4 10.0 2.6 10.3 1.8 14.5 4.5 4.1 5.9 8.3 13.0 7.0 5.3 4.3 9.9 4.8 6.6 8.7 23.8 3.2 10.7 23.0 10.2 23.9 15.9 15.3 9.4 17.0 19.2 13.7 10.7 29.9 13.8 557.4 22.4 0.7 23.3 6.0 17.2 15.5 23.9 13.9 0.4 6.7 27.0 0.0 22.7 4.0 339.6 25.3 10.3 13.5 9.0 2.4 20.1 6.5 0.0 16.3 2.2 19.1 19.4 17.6 39.3 35.1 12.8 9.8 10.4 1.9 22.1 ZNF679 MGC42415 ENSG00000197123 "Zinc finger protein 679" Q8IYX0 7 64228474-64266931 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 4.6" "Group enriched" "Detected in some" 14 "Early spermatids: 4.5;Late spermatids: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SH-SY5Y: 2.2;T-47d: 1.5" NA NA "unprognostic (1.27e-1)" "unprognostic (8.09e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.2 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 ZNF680 FLJ90430 ENSG00000173041 "Zinc finger protein 680" Q8NEM1 7 64519884-64563106 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA003173 Approved Nucleoplasm NA NA Nucleoplasm "HPA003173: AB_1080744" "unprognostic (1.65e-1)" "unprognostic (3.21e-2)" "unprognostic (6.88e-2)" "unprognostic (7.41e-2)" "unprognostic (1.52e-3)" "unprognostic (3.62e-2)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (1.07e-2)" "unprognostic (1.20e-1)" "unprognostic (2.46e-1)" "unprognostic (5.72e-2)" "unprognostic (1.35e-1)" "unprognostic (8.66e-2)" "unprognostic (2.21e-1)" "unprognostic (2.26e-1)" "unprognostic (8.05e-3)" 6.4 15.8 18.7 4.2 24.4 2.6 15.4 37.0 23.7 7.7 4.4 7.1 3.3 3.4 5.9 7.0 4.4 6.2 6.2 12.1 20.0 10.8 9.8 21.6 5.7 6.9 23.4 14.6 13.1 5.8 4.0 10.0 5.3 19.9 12.0 6.2 3.9 5.4 6.8 11.6 6.6 3.9 7.1 25.9 7.3 7.0 4.7 24.4 5.4 28.5 6.6 6.0 6.8 5.2 4.3 1.7 4.2 1.3 8.3 4.4 1.7 3.7 2.2 8.8 10.6 4.4 5.0 5.6 3.1 2.5 5.6 7.0 3.0 7.3 7.1 7.6 2.9 6.3 2.6 7.2 3.3 9.1 1.3 5.1 5.4 4.3 2.7 1.9 7.1 4.9 3.3 4.0 4.9 5.5 7.0 5.2 10.1 9.7 0.0 7.6 2.9 11.0 11.5 10.4 3.3 2.7 8.7 9.0 21.4 7.7 12.2 7.2 9.7 9.2 8.7 3.2 17.4 8.8 3.1 2.8 6.8 3.4 3.2 5.2 6.3 8.1 20.2 0.3 6.6 5.9 4.2 1.0 1.1 3.0 1.3 2.5 4.3 4.1 3.5 1.7 3.4 4.4 4.0 0.5 8.3 1.1 1.4 1.2 1.7 18.7 24.4 37.0 23.7 20.0 10.8 23.4 14.6 19.9 24.4 11.9 3.2 9.9 9.2 3.8 11.2 11.6 20.4 2.7 12.5 24.4 3.9 10.0 8.3 7.5 0.8 8.7 2.2 0.0 8.0 8.8 9.1 11.1 6.9 17.4 4.4 1.6 0.0 26.4 12.4 1.3 25.6 5.6 6.8 8.2 4.3 22.8 5.2 3.5 20.8 5.6 9.0 19.4 6.9 11.1 15.1 4.5 5.9 10.2 4.5 8.1 ZNF681 FLJ31526 ENSG00000196172 "Zinc finger protein 681" Q96N22 19 23739195-23758891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.7" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 11.6;Spermatogonia: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 14.7" NA NA "unprognostic (1.48e-1)" "unprognostic (4.49e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (6.22e-2)" "unprognostic (1.01e-1)" "unprognostic (2.45e-3)" "unprognostic (8.55e-2)" "unprognostic (1.61e-2)" "unprognostic (5.24e-2)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (7.98e-2)" "unprognostic (2.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.55e-2)" 3.3 3.6 6.4 5.9 4.9 1.7 5.1 15.8 9.5 4.0 4.0 1.0 2.2 2.6 2.9 4.4 5.1 3.6 1.9 2.0 5.7 5.5 2.2 1.2 2.4 6.7 4.1 6.8 5.6 4.9 1.9 5.4 3.1 8.3 3.1 5.1 1.1 3.0 2.1 1.1 5.8 3.2 2.3 4.7 7.2 2.8 6.1 4.6 17.7 5.0 0.6 5.7 6.6 3.9 3.7 1.5 0.6 0.6 1.8 7.0 1.8 0.7 0.0 4.7 9.2 0.3 0.0 2.6 0.6 0.1 1.4 1.6 1.2 2.4 1.2 4.3 0.8 2.1 2.2 4.3 0.2 2.4 14.7 1.6 2.3 0.0 0.0 0.7 0.0 0.4 1.1 0.8 0.6 0.6 0.3 0.0 3.3 6.2 0.0 2.4 2.0 7.9 2.2 6.8 0.1 2.1 6.2 3.4 9.6 1.2 4.5 0.4 4.9 0.0 0.0 0.8 6.9 4.9 0.4 0.0 0.9 0.1 3.0 3.3 0.1 8.4 7.2 0.0 0.0 0.0 0.3 0.6 0.1 2.0 0.4 3.2 2.4 3.4 2.8 1.0 3.7 7.0 5.8 0.6 1.8 0.4 1.5 3.4 1.8 6.4 4.9 15.8 9.5 5.7 5.5 4.1 6.8 8.3 4.6 3.0 0.0 3.7 1.0 1.0 2.7 0.9 2.5 9.4 5.7 1.8 0.0 3.1 1.7 1.6 7.2 2.2 2.7 0.0 2.1 3.7 1.9 1.1 0.0 0.0 1.9 1.6 2.4 2.5 2.7 4.0 0.6 0.9 1.7 1.0 2.6 1.8 1.0 1.9 2.8 1.4 1.1 0.0 1.0 11.6 13.0 1.1 3.1 3.8 1.7 0.9 ZNF683 "Hobit, MGC33414" ENSG00000176083 "Zinc finger protein 683" Q8IZ20 1 26361634-26374522 "Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 47.7;testis: 39.4" "Group enriched" "Detected in some" 134 "Early spermatids: 495.3;Late spermatids: 367.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "gdT-cell: 47.7;memory CD8 T-cell: 30.6" "Lineage enriched" "Detected in many" 18 "T-cells: 47.7" "Group enriched" "Detected in some" 8 "NB-4: 4.5;OE19: 10.0" "Not detected" "Not detected" HPA023865 Uncertain NA NA "HPA023865: AB_2671333" "unprognostic (3.95e-3)" "unprognostic (5.58e-3)" "unprognostic (5.83e-2)" "prognostic favorable (2.90e-5)" "unprognostic (9.17e-2)" "unprognostic (8.98e-4)" "unprognostic (7.90e-2)" "unprognostic (5.05e-3)" "unprognostic (5.81e-3)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.30e-2)" "unprognostic (3.54e-8)" "unprognostic (5.90e-3)" "unprognostic (1.63e-1)" "unprognostic (1.14e-2)" "prognostic favorable (3.45e-5)" 0.3 0.2 0.3 0.2 0.3 1.0 0.5 0.2 0.5 1.7 0.3 0.3 0.0 0.0 2.0 1.0 1.2 1.0 1.0 0.6 0.3 0.3 0.4 0.4 4.8 1.0 0.4 0.6 1.2 1.1 0.0 0.4 0.7 0.6 1.2 0.2 0.9 8.2 1.6 0.2 0.4 0.4 1.3 1.2 1.2 2.1 39.4 0.2 7.1 0.8 1.1 1.4 0.6 0.6 0.0 0.1 0.3 0.8 2.7 47.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.5 0.3 10.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 47.7 0.0 0.1 0.0 10.3 30.6 0.0 0.0 4.0 18.1 0.3 2.7 0.8 0.1 0.2 4.9 0.3 0.3 0.2 0.5 0.3 0.3 0.4 0.6 0.6 0.2 3.0 1.1 0.0 0.0 0.5 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 495.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 367.1 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.2 2.0 0.0 0.0 3.2 0.0 0.0 ZNF695 SBZF3 ENSG00000197472 "Zinc finger protein 695" Q8IW36 1 246945547-247008093 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 8.3;testis: 8.3" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 2.0;Extravillous trophoblasts: 3.7;Mucus-secreting cells: 2.0;Spermatocytes: 3.1;Spermatogonia: 2.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 5.1" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.2" "Low cell line specificity" "Detected in many" HPA024743 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA024743: AB_1859419" "unprognostic (8.46e-3)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (2.57e-4)" "unprognostic (4.51e-2)" "unprognostic (1.72e-1)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (5.71e-5)" "unprognostic (7.42e-4)" "unprognostic (2.81e-3)" "unprognostic (2.21e-2)" "unprognostic (1.05e-9)" "unprognostic (2.22e-1)" "unprognostic (2.07e-1)" "unprognostic (2.72e-1)" "unprognostic (3.87e-1)" 0.3 0.3 0.6 3.2 2.1 3.3 1.5 1.6 1.0 0.6 1.0 0.0 0.0 0.4 0.6 0.0 1.3 0.3 0.2 0.3 5.1 0.4 0.7 0.2 0.9 1.1 0.5 0.9 0.6 1.7 0.0 0.6 2.5 0.3 0.4 1.5 0.1 1.1 0.1 0.2 0.5 2.3 1.4 0.7 0.4 0.6 8.3 0.0 8.3 0.3 0.0 2.2 0.4 0.7 0.1 0.1 3.2 0.2 0.2 0.2 0.0 6.6 0.8 4.1 10.3 0.1 0.1 10.8 2.2 0.1 3.1 4.3 6.9 0.4 5.5 4.4 1.2 3.8 2.0 11.6 0.6 3.6 0.0 4.0 3.5 1.5 4.2 0.0 0.0 1.4 0.2 0.0 3.6 2.9 0.9 1.2 7.0 4.7 0.0 3.3 2.6 7.4 3.9 7.7 6.7 4.3 4.1 9.5 0.0 0.7 3.7 3.7 6.3 3.4 2.7 1.2 4.2 2.9 4.9 0.5 0.5 6.0 3.1 0.0 0.7 1.8 0.1 0.0 0.0 2.2 0.7 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 3.2 0.2 0.1 0.1 0.0 0.0 0.6 2.1 1.6 1.0 5.1 0.4 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.6 0.1 0.0 0.0 0.0 3.7 0.4 0.1 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.1 2.7 0.1 0.9 0.0 1.4 0.1 ZNF703 "FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1" ENSG00000183779 "Zinc finger protein 703" Q9H7S9 8 37695751-37700021 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 64.6" "Cell type enriched" "Detected in many" 4 "Syncytiotrophoblasts: 363.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "intermediate monocyte: 5.5;non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 12 "monocytes: 6.7" "Cell line enhanced" "Detected in many" "HEK 293: 55.7;OE19: 21.1;SK-MEL-30: 20.1;T-47d: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023930, CAB068249" Supported NA NA "CAB068249: AB_2665667, HPA023930: AB_1859425" "unprognostic (4.64e-2)" "unprognostic (3.15e-2)" "unprognostic (7.01e-3)" "unprognostic (1.71e-3)" "unprognostic (2.54e-1)" "unprognostic (1.42e-1)" "unprognostic (6.93e-2)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (2.70e-7)" "unprognostic (5.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-1)" "unprognostic (2.23e-1)" 12.7 6.7 9.3 8.2 8.4 2.4 15.4 7.2 10.1 25.1 20.0 4.6 31.3 14.0 13.8 19.5 15.3 18.4 12.1 8.0 8.5 3.6 3.5 2.1 4.9 4.0 5.4 4.7 15.0 4.3 2.0 3.1 54.9 7.8 15.1 12.3 12.0 13.7 17.7 64.6 24.6 15.4 14.9 3.4 13.4 12.6 4.9 5.5 1.9 5.3 24.0 7.2 20.4 13.8 0.0 0.5 0.1 6.7 0.0 0.1 0.2 1.1 2.3 0.3 1.8 5.5 2.9 1.8 10.2 4.8 3.1 2.7 9.4 12.7 0.0 2.6 6.4 1.4 6.0 1.0 1.5 2.4 0.3 55.7 0.0 3.3 6.0 5.5 0.0 1.1 9.8 2.9 3.3 1.3 6.8 2.7 0.1 0.1 0.0 5.0 9.4 0.0 0.3 0.9 21.1 4.1 0.9 1.7 1.2 0.9 4.9 1.0 0.1 1.9 1.6 20.1 2.3 18.7 1.0 8.1 3.7 8.7 5.7 4.2 0.7 0.0 0.0 3.3 1.1 2.4 0.0 0.7 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 6.7 0.0 0.0 0.2 9.3 8.4 7.2 10.1 8.5 3.6 5.4 4.7 7.8 5.5 6.0 0.0 6.2 10.8 42.7 3.5 7.6 2.5 2.7 2.3 5.2 0.0 33.0 3.3 7.7 0.3 5.0 32.1 0.0 2.2 34.7 27.2 9.5 0.0 1.7 29.3 0.0 76.4 3.7 9.1 0.0 29.1 11.7 32.1 0.0 83.3 8.3 2.6 52.6 14.9 2.1 0.8 51.8 81.2 0.0 0.6 65.2 363.1 0.7 82.3 9.5 ZNF705A FLJ16353 ENSG00000196946 "Zinc finger protein 705A" Q6ZN79 12 8157034-8188537 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.2" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 3.6;Late spermatids: 1.5;Sertoli cells: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 2.2" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Cell line enhanced" "Detected in many" "AN3-CA: 7.5;ASC TERT1: 5.8;BJ hTERT+: 8.8;HDLM-2: 7.2;HSkMC: 6.9;NTERA-2: 8.3" NA NA "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (8.16e-2)" "unprognostic (4.16e-3)" "unprognostic (8.80e-2)" "unprognostic (2.52e-3)" "unprognostic (4.31e-6)" "unprognostic (2.61e-1)" "unprognostic (1.80e-1)" "unprognostic (1.41e-2)" 0.6 0.5 0.6 0.6 0.6 0.0 0.8 0.6 4.9 2.6 0.6 0.6 0.6 0.0 1.8 4.7 0.6 2.5 0.8 0.6 0.6 0.6 0.6 0.6 0.8 0.6 0.6 0.6 4.1 1.4 2.3 0.6 1.1 0.6 1.6 0.0 0.6 0.6 2.1 0.6 0.5 0.6 1.5 0.6 0.6 0.5 7.2 0.6 0.6 3.6 0.6 0.6 0.6 0.6 0.4 0.1 0.0 0.3 0.2 2.2 0.1 0.0 2.8 0.6 7.5 2.7 5.8 0.3 1.2 8.8 0.9 4.0 0.0 1.1 0.2 0.0 2.0 4.2 0.0 1.4 0.7 2.3 7.2 2.8 0.0 0.0 0.0 2.0 0.0 0.2 6.9 0.6 0.5 1.5 2.0 0.0 2.0 0.0 0.3 0.9 4.1 0.5 0.0 8.3 0.1 0.0 1.4 0.9 0.0 1.9 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.2 0.1 0.4 0.6 0.1 1.1 0.4 1.1 0.0 0.0 0.0 0.5 0.1 0.4 0.2 0.3 1.2 0.1 0.4 0.7 2.2 0.0 0.2 0.3 0.0 0.0 0.1 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 ZNF705B ENSG00000215356 "Zinc finger protein 705B" P0CI00 8 7926337-7952413 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 16 "testis: 4.9" "Group enriched" "Detected in some" 27 "Early spermatids: 3.3;Late spermatids: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.1" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705D ENSG00000215343 "Zinc finger protein 705D" P0CH99 8 12104389-12115516 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "epididymis: 9.7" "Group enriched" "Detected in some" 31 "Early spermatids: 4.2;Late spermatids: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" NA NA "unprognostic (2.04e-1)" 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705E ENSG00000214534 "Zinc finger protein 705E" 11 71814045-71821548 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "epididymis: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA "unprognostic (3.65e-2)" "unprognostic (1.34e-2)" "unprognostic (5.02e-2)" "unprognostic (3.80e-1)" "unprognostic (7.34e-3)" "unprognostic (8.00e-5)" "unprognostic (6.79e-2)" "unprognostic (1.37e-2)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" "unprognostic (5.94e-2)" "unprognostic (2.70e-1)" "unprognostic (5.13e-4)" "unprognostic (9.18e-3)" "unprognostic (1.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.34e-2)" 0.0 0.0 0.1 0.5 0.6 0.0 0.0 0.0 0.6 0.1 3.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.8 0.7 0.0 0.3 0.0 0.2 0.0 0.8 1.0 0.3 0.9 1.1 0.4 0.1 0.1 0.7 0.9 0.1 0.7 0.8 0.1 0.1 0.5 1.0 0.1 1.2 0.4 0.1 0.1 0.1 0.2 0.6 0.1 2.1 0.1 1.3 0.1 0.8 0.8 1.7 0.1 1.1 0.3 0.4 1.6 0.0 0.4 0.0 0.6 1.1 0.7 0.1 0.4 0.4 0.3 0.4 0.5 0.0 0.8 0.2 0.1 1.1 0.5 0.4 0.5 1.2 0.5 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF705G ENSG00000215372 "Zinc finger protein 705G" A8MUZ8 8 7355517-7385558 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 28 "epididymis: 1.3;testis: 4.3" "Group enriched" "Detected in some" 15 "Early spermatids: 29.2;Late spermatids: 22.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 20 "LHCN-M2: 3.2" NA NA "unprognostic (1.71e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ZNF708 "KOX8, ZNF15, ZNF15L1" ENSG00000182141 "Zinc finger protein 708" P17019 19 21291160-21329425 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.0" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 29.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (4.18e-2)" "unprognostic (3.67e-1)" "unprognostic (1.96e-2)" "unprognostic (3.98e-2)" "prognostic favorable (7.16e-4)" "unprognostic (2.96e-3)" "unprognostic (1.11e-2)" "unprognostic (1.67e-3)" "unprognostic (2.05e-2)" "prognostic favorable (3.53e-4)" "unprognostic (4.00e-3)" "unprognostic (1.22e-2)" "unprognostic (5.39e-2)" "unprognostic (2.94e-2)" "unprognostic (9.30e-2)" "unprognostic (8.21e-2)" "unprognostic (1.22e-3)" 4.4 6.5 11.2 9.2 44.3 7.5 10.0 14.2 24.0 9.2 5.4 14.5 3.0 5.9 6.6 6.9 4.3 6.6 5.5 6.2 11.5 8.9 4.9 3.5 6.5 12.1 46.0 9.8 18.4 8.3 5.5 9.3 5.3 25.7 9.0 5.6 4.8 7.8 5.7 3.7 4.6 6.1 3.7 32.1 7.4 8.3 6.3 35.7 8.6 10.8 2.9 9.5 5.9 5.2 6.3 3.1 11.2 2.7 6.1 8.4 3.3 1.7 1.2 10.9 6.0 3.2 2.9 9.7 3.2 1.4 2.0 3.7 3.2 2.6 0.1 4.7 2.3 2.0 1.7 3.7 2.1 3.4 1.4 5.9 8.7 4.2 2.3 1.4 7.7 2.4 2.4 2.3 1.3 2.1 3.2 2.9 4.5 6.0 0.6 3.6 2.3 6.5 6.0 15.1 0.4 3.6 8.1 5.5 4.2 1.3 11.3 8.6 5.1 2.9 0.1 2.6 6.4 4.1 5.4 4.4 2.9 1.8 3.9 3.4 5.3 4.7 11.0 0.2 3.1 2.2 10.8 2.7 5.7 5.3 2.6 7.7 5.4 6.9 7.9 3.1 6.3 8.4 7.6 11.2 6.1 2.3 2.9 4.6 3.3 11.2 44.3 14.2 24.0 11.5 8.9 46.0 9.8 25.7 35.7 29.8 6.7 9.8 5.4 1.1 11.7 2.8 2.5 8.1 3.4 8.7 9.8 2.7 5.0 6.6 0.7 4.5 2.1 0.0 4.6 2.1 3.7 4.0 11.5 1.5 2.3 15.9 6.9 6.7 1.6 0.8 7.8 5.9 3.3 1.0 2.9 12.0 4.8 0.0 6.3 1.6 15.4 6.5 4.2 6.2 4.1 0.5 2.9 14.9 2.3 2.8 ZNF709 FLJ38281 ENSG00000242852 "Zinc finger protein 709" Q8N972 19 12461184-12513854 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 26.6" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 31.1;Late spermatids: 26.0;Spermatocytes: 7.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA045573, HPA053153" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA045573: AB_2679370, HPA053153: AB_2682060" "unprognostic (2.27e-1)" "unprognostic (7.40e-4)" "unprognostic (3.53e-2)" "unprognostic (3.01e-2)" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (4.19e-3)" "unprognostic (2.58e-4)" "unprognostic (6.76e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-3)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" "unprognostic (1.71e-1)" "unprognostic (3.19e-2)" "unprognostic (2.13e-1)" "unprognostic (8.53e-5)" 3.4 3.0 7.8 4.8 8.4 2.0 5.1 12.7 7.3 5.0 2.7 3.2 5.6 0.7 5.5 5.3 2.4 6.6 2.4 3.6 6.2 5.4 5.4 2.0 3.0 2.7 3.8 4.6 8.4 4.1 6.2 8.0 3.5 4.9 5.7 2.1 3.3 3.4 4.5 2.5 2.8 2.7 5.1 5.5 4.0 2.6 26.6 5.0 7.2 8.5 0.0 4.0 4.1 4.5 2.0 1.3 3.5 1.1 5.5 4.4 1.0 1.9 0.0 6.3 7.7 1.2 1.8 1.0 1.9 2.2 2.1 2.3 1.7 0.2 1.8 1.3 2.0 0.6 1.3 3.4 1.3 2.4 0.3 0.9 1.6 1.1 1.2 2.5 0.4 2.7 1.0 0.6 1.2 0.0 3.0 1.4 2.4 1.0 0.2 2.7 3.5 4.0 2.2 2.1 0.7 2.0 2.2 6.1 5.7 2.2 3.0 2.9 4.0 0.0 0.3 0.8 2.9 1.5 1.0 0.0 3.3 0.7 1.4 1.3 3.4 4.8 2.6 0.0 0.0 1.5 3.5 0.4 0.1 2.0 0.1 3.1 1.7 3.3 2.1 0.9 2.0 4.4 3.1 0.1 5.5 1.1 1.3 1.8 1.0 7.8 8.4 12.7 7.3 6.2 5.4 3.8 4.6 4.9 5.0 0.0 0.3 0.0 0.1 0.3 0.5 0.3 0.0 0.0 1.2 1.8 0.0 0.4 0.0 0.4 31.1 0.1 0.0 0.0 0.3 0.2 0.4 0.4 0.0 0.0 0.4 0.0 0.0 1.3 1.0 26.0 0.9 0.2 0.0 0.0 0.6 1.5 0.2 0.0 0.7 0.7 2.1 6.5 0.3 7.2 1.7 0.5 0.2 0.0 0.0 0.1 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001392-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "pancreas: 79.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.9" "Group enriched" "Detected in many" 5 "dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 2.6 2.1 5.6 8.7 6.7 4.3 3.2 2.9 5.0 3.1 4.3 6.6 1.7 5.3 3.3 4.1 9.5 2.9 4.8 5.9 3.9 3.5 2.7 3.4 6.4 7.9 4.0 4.1 3.4 79.6 1.5 2.5 3.2 5.0 4.2 4.0 3.5 5.2 2.6 18.3 6.7 4.5 4.3 6.3 8.6 5.9 2.4 4.1 11.7 3.5 5.2 7.0 4.4 4.9 0.3 2.3 3.0 7.9 0.4 0.8 0.9 5.8 6.9 13.3 5.0 1.8 2.7 7.0 6.1 5.7 4.5 5.8 4.9 5.4 6.0 2.9 5.9 4.2 4.0 3.4 8.7 2.5 3.8 6.3 10.9 2.8 8.2 3.7 3.1 17.0 4.4 4.8 9.6 5.3 2.1 7.7 6.6 3.6 4.1 1.7 15.1 7.0 8.8 10.4 7.2 4.5 8.6 3.0 6.5 1.8 7.3 12.2 8.3 8.2 29.5 4.2 3.6 6.4 10.9 11.0 9.3 4.6 2.8 4.7 3.3 1.7 5.8 7.1 9.4 4.8 0.0 2.6 1.8 0.4 5.7 0.3 0.2 0.2 0.3 1.9 0.3 0.8 0.8 3.0 0.4 7.9 2.3 0.7 0.9 5.6 6.7 2.9 4.3 3.9 3.5 4.0 4.1 5.0 4.1 3.0 8.0 1.5 3.9 4.7 1.8 7.6 7.6 1.4 6.8 10.4 2.0 2.0 0.0 2.9 0.6 2.9 3.5 0.0 5.3 2.6 2.7 5.9 1.1 1.0 10.4 3.2 4.6 8.0 13.9 2.9 2.3 12.8 1.7 9.0 8.1 0.9 8.0 10.5 2.8 0.7 0.8 6.5 2.3 0.2 1.9 6.6 1.9 2.9 5.8 12.9 ZNF711 "CMPX1, dJ75N13.1, MRX97, Zfp711, ZNF4, ZNF5, ZNF6" ENSG00000147180 "Zinc finger protein 711" Q9Y462 X 85244032-85273362 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 38.6" "Cell type enhanced" "Detected in many" 8 "Intestinal endocrine cells: 17.7;Spermatogonia: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.6;naive B-cell: 3.6" "Group enriched" "Detected in many" 7 "B-cells: 3.6;T-cells: 1.3" "Cell line enhanced" "Detected in many" "AF22: 16.8;AN3-CA: 13.1;HAP1: 24.2;HEK 293: 22.3;Karpas-707: 14.9;RH-30: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030654 Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA030654: AB_10670561" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.07e-2)" "unprognostic (5.51e-3)" "unprognostic (1.75e-2)" "unprognostic (9.11e-3)" "unprognostic (7.40e-3)" "unprognostic (1.37e-2)" "unprognostic (2.96e-1)" "unprognostic (2.50e-3)" "unprognostic (3.25e-3)" "unprognostic (1.53e-1)" "unprognostic (1.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.28e-1)" "unprognostic (5.72e-2)" "unprognostic (6.62e-3)" 1.4 13.6 11.6 2.1 11.9 5.8 5.4 10.8 19.2 5.9 2.4 4.4 0.0 3.0 8.9 2.9 2.1 4.7 4.0 3.8 11.1 8.3 5.1 0.7 1.9 2.2 6.5 8.1 9.3 4.3 1.5 16.0 7.1 12.6 4.1 1.9 3.3 4.0 2.8 1.6 11.2 4.2 3.4 9.8 4.5 2.8 38.6 9.5 14.4 4.2 1.6 2.5 3.0 2.5 3.6 0.2 0.0 0.0 0.3 1.3 0.3 0.0 1.5 16.8 13.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 3.5 1.4 0.0 0.6 0.2 2.7 0.3 24.2 0.0 0.0 0.0 22.3 7.7 0.4 0.9 0.6 0.0 0.2 1.6 0.2 0.0 3.1 0.0 0.1 7.5 2.3 14.9 2.9 0.8 13.0 0.0 8.2 1.4 0.3 0.0 20.4 0.0 0.0 1.2 4.9 12.7 0.0 0.4 0.0 10.3 2.2 2.1 0.0 0.0 5.5 0.0 0.0 5.6 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.6 0.1 0.4 0.1 3.6 1.3 0.8 0.0 0.3 0.0 0.2 0.0 0.3 11.6 11.9 10.8 15.1 11.1 8.3 6.5 8.1 12.6 9.5 3.0 0.6 1.5 6.8 10.6 8.7 2.4 2.5 1.4 2.3 1.8 0.0 0.3 5.0 1.6 2.0 2.3 0.5 0.0 0.4 0.2 5.2 2.5 0.0 0.0 0.3 3.2 17.7 3.7 1.2 4.0 2.8 0.7 5.0 0.0 1.0 10.0 0.7 1.7 3.5 1.9 1.3 0.0 6.2 5.2 25.4 8.0 0.2 0.0 1.1 2.5 ZNF716 FLJ46189 ENSG00000182111 "Zinc finger protein 716" A6NP11 7 57450177-57473546 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "blood: 2.9;testis: 6.9" "Group enriched" "Detected in some" 7 "Early spermatids: 3.2;Late spermatids: 2.5;Spermatocytes: 1.5;Spermatogonia: 4.3" "Cancer enriched" "Detected in single" 23 "testis cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RPMI-8226: 4.8;SuSa: 1.2;T-47d: 3.1" NA NA "unprognostic (1.57e-1)" "unprognostic (1.95e-2)" "unprognostic (1.21e-1)" 0.1 0.2 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.7 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.4 0.1 0.1 0.1 0.1 0.1 0.2 0.7 0.2 0.1 0.1 0.1 0.1 6.9 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.9 0.6 2.9 0.6 1.1 0.9 0.2 0.1 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 1.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.1 0.1 4.8 0.0 0.2 0.2 0.1 0.1 0.1 0.0 1.2 3.1 0.0 0.0 0.2 0.8 0.2 0.1 0.2 0.0 0.0 0.0 0.2 0.0 2.4 0.6 0.7 0.6 0.4 0.3 0.6 0.6 0.4 0.2 0.9 0.9 0.8 2.9 1.1 0.3 0.6 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.5 4.3 0.0 0.0 0.0 0.0 0.3 ZNF723 ZNF723P ENSG00000268696 "Zinc finger protein 723" 19 22832321-22858667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "testis: 14.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 25 "testis cancer: 3.6" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 1.7;SuSa: 4.0;U-2197: 1.9" NA NA "unprognostic (4.37e-2)" "unprognostic (5.02e-2)" "unprognostic (7.20e-2)" 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.5 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 14.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.4 3.5 0.3 0.5 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.4 0.4 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 4.0 0.4 0.1 0.0 0.1 0.1 1.9 0.0 0.0 0.0 0.3 0.1 0.0 0.0 3.5 0.2 1.3 0.3 0.2 0.5 0.5 0.4 0.4 0.2 1.0 0.7 0.5 2.2 0.5 0.3 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF724 ZNF724P ENSG00000196081 "Zinc finger protein 724" A8MTY0 19 23221599-23250390 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.5" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 1.4;Cytotrophoblasts: 1.5;Extravillous trophoblasts: 4.3;granulocytes: 2.3;Syncytiotrophoblasts: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 14.3" NA NA "unprognostic (2.02e-1)" "unprognostic (1.65e-1)" "unprognostic (1.78e-2)" "unprognostic (3.80e-2)" "unprognostic (2.27e-2)" "unprognostic (2.33e-1)" "unprognostic (1.94e-2)" "unprognostic (1.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (5.34e-2)" "unprognostic (3.07e-2)" "unprognostic (2.73e-2)" "unprognostic (3.20e-1)" "unprognostic (3.76e-1)" "unprognostic (3.30e-2)" 2.6 1.8 3.0 7.5 4.0 8.1 2.2 5.3 4.4 2.1 1.9 0.8 0.5 1.2 2.0 2.2 8.7 1.3 1.5 2.7 1.8 2.4 2.4 1.7 2.2 5.5 2.5 2.6 2.0 1.7 1.5 1.3 2.4 3.4 2.8 2.5 0.5 2.4 1.8 2.1 2.6 2.1 1.7 5.7 7.1 6.5 6.1 3.7 16.5 2.1 0.9 3.3 2.1 2.5 5.1 3.2 5.9 1.6 4.6 2.6 0.4 3.5 2.3 6.0 7.4 0.5 0.8 7.1 1.8 1.6 4.6 5.4 3.6 1.2 3.7 4.3 1.8 1.8 2.3 6.5 2.8 8.2 0.5 7.1 3.7 1.3 1.5 0.3 0.1 3.6 0.4 0.4 5.4 3.7 0.6 0.2 5.2 5.5 0.3 2.8 5.3 9.0 2.1 14.3 0.1 4.8 5.0 8.0 2.7 0.6 4.4 3.6 3.5 0.0 0.1 0.8 5.3 2.1 2.1 0.1 1.7 0.2 5.3 4.8 0.0 1.5 7.9 0.0 1.0 1.4 4.0 1.6 0.7 2.5 1.4 1.3 3.9 1.7 1.9 1.2 5.1 2.1 2.6 5.9 4.6 1.1 3.2 1.0 0.4 3.0 4.0 5.3 4.4 1.8 2.4 2.5 2.6 3.4 3.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 0.0 0.0 1.5 0.0 0.7 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 2.3 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 ZNF727 ZNF727P ENSG00000214652 "Zinc finger protein 727" A8MUV8 7 64045443-64078549 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 13.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 1.9;Distal tubular cells: 3.3;Early spermatids: 1.8;Horizontal cells: 1.6;Late spermatids: 1.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "T-47d: 13.1" "HPA051027, HPA061215" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA051027: , HPA061215: AB_2684452" "unprognostic (5.87e-2)" "unprognostic (3.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.75e-3)" "unprognostic (1.36e-2)" "unprognostic (1.80e-1)" "unprognostic (3.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (2.54e-1)" "unprognostic (4.04e-2)" "unprognostic (5.73e-4)" "unprognostic (8.70e-2)" "unprognostic (6.36e-2)" "unprognostic (8.61e-2)" 2.6 1.6 2.7 0.9 10.6 0.3 5.4 3.9 7.4 5.2 1.7 5.8 0.0 0.6 5.9 3.1 2.0 4.7 1.6 2.2 4.7 3.1 0.5 1.9 1.2 5.3 2.5 9.1 2.0 1.1 13.7 0.3 7.2 4.9 2.0 3.1 2.2 3.3 1.2 2.0 1.0 3.7 4.2 1.6 2.0 5.5 6.1 0.0 8.7 0.0 0.9 2.6 3.9 1.1 0.4 0.0 0.4 0.4 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.0 13.1 0.0 0.0 0.0 1.6 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.4 1.1 1.0 0.7 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 ZNF728 ENSG00000269067 "Zinc finger protein 728" P0DKX0 19 22975468-23003176 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 18.6" "Cell type enhanced" "Detected in some" 15 "Distal tubular cells: 3.3;Horizontal cells: 7.9;Spermatocytes: 4.2;Spermatogonia: 2.3" "Cancer enriched" "Detected in single" 8 "testis cancer: 3.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "GAMG: 4.4;SuSa: 4.8;U-266/84: 6.9" NA NA "unprognostic (4.12e-2)" "unprognostic (4.25e-2)" "unprognostic (5.00e-2)" "unprognostic (1.78e-2)" "unprognostic (3.56e-1)" "unprognostic (4.03e-1)" "unprognostic (1.13e-2)" "unprognostic (5.45e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-2)" 2.3 1.0 2.7 1.0 6.5 0.4 2.0 1.9 2.9 3.2 1.9 1.3 0.7 0.7 2.8 1.8 1.6 3.4 2.1 3.4 3.8 1.4 2.4 0.7 1.1 0.4 3.2 1.9 5.8 1.0 3.1 5.9 0.8 4.2 2.6 0.9 1.7 1.1 2.6 0.8 0.8 1.1 4.0 3.7 1.3 1.2 18.6 3.6 0.0 4.6 0.1 0.4 3.3 1.4 0.5 0.1 0.1 0.2 1.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.2 0.8 0.0 0.0 0.0 0.1 0.0 4.4 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 1.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 4.8 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.2 0.1 0.1 0.5 0.7 0.1 0.1 1.3 0.0 0.0 0.0 0.0 2.7 6.5 1.9 2.9 3.8 1.4 3.2 1.9 4.2 3.6 0.0 0.0 0.0 0.0 0.0 1.7 2.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 4.2 2.3 0.0 0.1 0.0 0.0 0.0 ZNF729 ENSG00000196350 "Zinc finger protein 729" A6NN14 19 22286408-22317176 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 3.6;testis: 9.7" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Spermatocytes: 4.1;Spermatogonia: 4.4" "Cancer enriched" "Detected in single" 41 "testis cancer: 5.3" "Group enriched" "Detected in many" 5 "amygdala: 1.2;cerebral cortex: 1.1;hippocampal formation: 3.6;olfactory region: 1.5;pons and medulla: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.2;NTERA-2: 7.2;SuSa: 4.0;T-47d: 1.8" NA NA "unprognostic (1.84e-1)" "unprognostic (2.14e-3)" "unprognostic (3.05e-4)" "unprognostic (1.30e-1)" "unprognostic (1.74e-1)" 0.2 0.1 1.2 0.1 0.3 0.0 0.5 0.1 1.1 0.1 0.1 0.0 1.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 3.6 0.1 0.7 0.1 0.1 0.0 0.1 1.5 0.2 0.1 0.4 0.1 0.8 1.5 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 1.5 0.1 0.1 9.7 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 7.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 1.8 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.3 0.1 1.1 3.6 0.1 0.1 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.4 0.0 0.2 0.0 0.0 0.0 ZNF730 ENSG00000183850 "Zinc finger protein 730" Q6ZMV8 19 23075210-23147219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.2" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 18.6;Late spermatids: 11.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 12.0;NTERA-2: 15.8;REH: 13.9;U-698: 12.6" NA NA "unprognostic (6.75e-3)" "unprognostic (2.49e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-3)" "unprognostic (3.33e-2)" "unprognostic (1.78e-2)" "unprognostic (4.24e-4)" "unprognostic (9.34e-2)" "unprognostic (1.01e-1)" "unprognostic (4.92e-2)" "unprognostic (3.10e-2)" "unprognostic (5.98e-2)" "unprognostic (1.37e-3)" "unprognostic (5.53e-2)" "unprognostic (1.90e-1)" "unprognostic (6.67e-2)" "unprognostic (1.43e-2)" 0.9 0.7 3.4 3.6 3.0 2.5 2.0 2.5 3.6 1.2 0.9 1.9 1.1 0.1 2.5 2.7 1.2 1.9 1.5 1.1 2.2 3.1 0.9 0.7 1.3 3.2 2.2 3.5 5.1 0.8 2.3 1.8 6.3 7.2 3.2 1.4 3.5 0.8 0.8 0.7 0.9 0.8 1.9 4.1 0.9 0.8 9.9 1.0 25.2 2.0 0.2 3.7 1.1 1.3 0.9 1.5 0.3 0.4 0.2 0.5 0.3 0.0 0.0 11.6 8.4 0.5 0.9 2.5 3.4 0.0 7.1 12.0 0.0 0.0 0.0 4.3 2.1 3.4 0.0 1.2 0.4 10.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.6 1.4 0.0 3.2 1.0 0.8 0.0 9.2 4.0 0.0 6.3 1.6 10.4 3.2 15.8 0.0 2.0 13.9 7.0 0.7 0.9 7.7 0.0 6.7 0.0 0.0 0.0 8.5 5.5 3.7 0.1 0.1 0.6 2.3 3.4 0.0 2.4 12.6 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.4 0.0 0.6 0.3 0.3 0.6 0.9 0.0 0.1 0.0 0.2 0.0 1.5 0.0 0.3 3.4 3.0 2.5 2.3 2.2 3.1 2.2 3.5 7.2 1.0 0.0 2.6 0.0 0.2 0.0 3.8 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 18.6 0.4 0.0 0.0 0.2 1.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.4 0.0 0.0 0.0 0.3 1.9 3.2 0.0 1.1 0.0 0.0 0.1 ZNF732 FLJ59067 ENSG00000186777 "Zinc finger protein 732" B4DXR9 4 270675-305321 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 19.5" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 8.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NTERA-2: 12.3" NA NA "unprognostic (7.83e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.54e-2)" "unprognostic (8.99e-4)" "unprognostic (7.60e-3)" "unprognostic (8.13e-2)" "unprognostic (3.83e-2)" "unprognostic (4.89e-3)" "unprognostic (1.44e-3)" "unprognostic (3.60e-3)" "unprognostic (5.45e-3)" "unprognostic (8.40e-4)" "unprognostic (3.85e-1)" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (2.53e-1)" 0.7 0.6 1.1 3.8 5.9 0.6 1.9 4.6 1.8 1.3 1.0 0.1 0.8 0.4 1.6 0.2 2.3 1.1 0.6 0.9 1.1 1.1 0.5 0.3 0.6 2.3 0.8 0.3 2.3 0.7 0.7 2.2 2.3 1.5 1.3 0.3 0.2 0.8 0.3 0.2 3.3 0.4 1.0 0.9 1.0 0.4 19.5 0.4 0.3 1.6 2.4 2.8 2.0 1.2 0.5 0.1 0.1 0.0 0.9 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 2.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 12.3 0.0 2.4 0.0 0.0 0.0 1.0 1.5 0.0 2.8 0.0 0.0 0.0 3.0 2.7 0.0 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.2 0.1 0.0 0.9 0.0 0.1 0.1 0.0 1.1 5.9 4.6 1.8 1.1 1.1 0.8 0.3 1.5 0.4 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 8.3 0.3 0.0 0.0 0.0 0.0 ZNF735 ZNF735P ENSG00000223614 "Zinc finger protein 735" P0CB33 7 64207090-64220508 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 ZNF750 "FLJ13841, Zfp750" ENSG00000141579 "Zinc finger protein 750" Q32MQ0 17 82829435-82840578 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.3;lymphoid tissue: 54.2;skeletal muscle: 84.2" "Cell type enhanced" "Detected in some" 14 "Cytotrophoblasts: 18.3;Suprabasal keratinocytes: 35.9;Syncytiotrophoblasts: 57.0;Urothelial cells: 46.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 17.4;hTCEpi: 6.4;MCF7: 4.6;SK-BR-3: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021573, HPA023012" Enhanced NA NA "HPA021573: AB_1859438, HPA023012: AB_1859439" "unprognostic (3.46e-3)" "unprognostic (1.94e-2)" "unprognostic (7.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.45e-1)" "unprognostic (9.73e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-3)" "unprognostic (1.34e-1)" "unprognostic (4.33e-2)" "unprognostic (6.30e-3)" "unprognostic (1.23e-2)" "unprognostic (5.30e-3)" "unprognostic (3.04e-2)" "unprognostic (5.94e-2)" "unprognostic (2.04e-1)" "unprognostic (4.25e-2)" 0.4 0.1 0.1 0.1 0.1 0.1 3.0 0.1 0.1 14.0 0.1 0.0 9.0 0.2 0.9 3.8 59.3 0.4 0.2 0.2 0.1 0.1 0.2 0.1 2.3 0.1 0.1 0.0 0.1 0.1 0.6 2.2 19.5 0.0 3.2 0.1 0.0 38.3 13.2 84.2 46.2 0.1 0.4 0.1 0.1 0.1 0.2 0.0 3.4 6.7 44.1 54.2 3.2 16.8 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 1.1 1.0 0.0 13.0 0.0 1.5 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 5.1 0.0 13.2 4.6 0.0 0.4 0.0 6.7 10.3 0.0 0.0 18.3 0.0 0.0 1.4 0.6 0.0 0.0 0.0 1.0 0.3 6.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 57.0 0.0 0.0 46.4 ZNF761 "FLJ16231, FLJ35333, KIAA2033" ENSG00000160336 "Zinc finger protein 761" 19 53431993-53458261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "prostate: 33.9" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 37.9" "Cancer enhanced" "Detected in all" "prostate cancer: 31.9" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "unprognostic (8.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.89e-2)" "unprognostic (1.39e-1)" "unprognostic (7.03e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (4.68e-2)" "unprognostic (3.74e-3)" "unprognostic (1.12e-1)" "unprognostic (2.19e-3)" "unprognostic (1.59e-1)" "unprognostic (2.33e-3)" "unprognostic (1.19e-1)" "unprognostic (4.13e-1)" "unprognostic (8.71e-2)" "unprognostic (1.38e-3)" 3.5 3.3 2.9 5.1 4.8 4.2 6.0 3.5 4.3 3.0 3.0 4.4 3.0 2.6 4.1 5.9 2.2 3.7 4.4 1.9 3.3 3.6 1.9 2.9 7.0 4.2 2.4 4.8 7.0 4.7 6.0 12.6 4.2 33.9 3.7 2.3 4.6 5.7 1.8 5.1 3.4 3.1 4.5 4.5 4.1 2.8 5.0 5.2 4.0 2.4 5.3 6.3 10.2 7.8 6.3 6.6 5.4 16.3 9.7 5.1 10.2 5.7 3.9 8.4 11.8 10.0 16.3 6.7 5.6 4.9 7.5 7.8 4.1 9.5 3.9 6.1 6.7 7.3 10.5 6.9 7.5 1.4 16.5 9.3 7.8 8.0 6.8 0.5 10.8 9.6 7.3 5.6 10.0 6.8 5.1 8.1 9.3 5.8 8.1 5.9 10.7 8.7 8.0 10.0 8.2 8.3 9.0 10.2 4.4 29.0 5.5 4.5 8.7 10.2 4.2 14.5 5.5 8.6 4.7 6.8 5.8 1.2 7.1 7.8 15.7 16.1 0.3 5.0 6.0 6.6 5.4 6.6 6.6 5.4 8.1 7.6 7.4 8.0 5.5 7.8 8.2 8.9 5.0 16.3 5.1 6.3 9.7 5.1 3.0 5.3 5.1 10.5 0.0 1.4 5.2 15.3 4.0 7.9 3.5 0.0 14.1 19.9 4.1 0.4 4.9 4.1 0.0 2.5 11.2 5.6 20.9 9.2 8.9 7.5 4.8 2.4 11.1 7.9 1.5 11.5 5.5 0.0 1.0 10.6 1.5 4.7 5.8 7.4 9.8 0.9 19.4 4.9 1.4 5.4 0.0 37.9 4.4 6.0 9.6 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461123 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 65.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 5.0 4.3 5.5 4.1 8.8 6.9 4.9 7.1 9.3 5.2 5.2 5.4 3.5 4.5 7.3 3.5 4.1 6.5 3.5 4.7 5.3 5.1 3.8 4.4 4.4 4.7 4.3 5.3 9.1 6.6 6.6 5.9 65.7 6.6 5.8 3.3 5.0 7.3 5.8 10.6 7.3 4.4 5.4 6.2 6.0 4.9 4.2 3.5 3.5 5.2 4.8 3.9 6.2 5.0 0.4 0.2 0.6 0.3 0.1 1.5 0.1 10.2 12.7 8.6 12.4 6.4 5.2 11.0 6.6 7.0 9.0 7.8 7.9 6.6 6.5 13.4 7.5 5.6 6.8 8.3 10.1 5.0 10.5 12.7 6.4 3.6 7.8 10.9 9.0 9.3 6.1 11.6 7.3 10.7 4.8 4.8 8.9 20.5 0.0 5.1 13.2 18.9 12.3 10.4 4.6 7.5 15.7 4.4 13.6 5.6 8.0 9.3 13.1 11.4 11.8 11.0 3.3 5.5 15.1 7.5 7.6 3.0 14.9 10.8 6.2 5.4 3.0 5.7 6.2 9.7 0.0 0.3 0.0 0.5 0.3 0.1 0.3 0.4 0.4 0.0 0.4 0.1 1.5 0.6 0.1 0.1 0.2 0.0 0.1 5.5 8.8 7.1 9.3 5.3 5.1 4.3 5.3 6.6 3.5 0.0 1.7 1.5 1.4 1.0 6.9 2.3 2.5 1.4 0.0 1.8 5.9 1.8 0.0 0.7 2.1 1.6 1.5 0.0 0.9 2.8 1.1 2.0 0.0 5.0 1.3 1.6 1.7 2.5 2.8 2.5 2.6 1.1 0.0 0.0 3.1 4.9 1.0 2.9 3.2 1.4 5.4 0.0 1.4 0.6 4.7 1.6 3.2 2.2 2.6 0.9 ZNF784 MGC75238 ENSG00000179922 "Zinc finger protein 784" Q8NCA9 19 55620742-55624601 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 39.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059676 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA059676: AB_2684102" "unprognostic (4.67e-2)" "unprognostic (8.13e-2)" "unprognostic (4.03e-1)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-1)" "unprognostic (9.44e-2)" "unprognostic (4.74e-1)" "unprognostic (1.26e-1)" "unprognostic (9.11e-3)" "unprognostic (4.86e-2)" "unprognostic (3.48e-3)" "unprognostic (3.87e-1)" "unprognostic (7.93e-2)" "unprognostic (5.10e-2)" "prognostic favorable (1.02e-4)" 5.9 5.6 2.9 7.4 3.2 5.7 4.9 5.2 5.0 7.5 9.3 3.3 4.1 8.6 7.9 8.0 4.9 6.7 7.0 9.1 2.8 2.3 5.8 7.3 10.4 3.5 2.7 3.2 9.7 15.0 6.0 5.5 4.9 3.9 7.9 3.8 5.8 5.9 5.8 39.1 4.9 11.2 10.4 2.6 6.5 5.8 3.6 2.6 3.2 7.3 16.1 6.1 6.7 4.5 1.4 1.6 2.9 2.0 1.4 1.3 0.6 4.5 6.4 6.1 3.2 2.3 3.2 5.7 4.8 3.0 2.8 3.7 3.3 5.1 5.5 4.2 3.4 2.1 2.5 1.7 4.2 2.0 3.0 17.1 5.2 5.0 4.0 4.7 4.2 5.5 4.3 4.6 2.3 3.0 4.4 1.8 7.9 6.0 5.7 4.2 4.4 3.2 4.8 5.9 3.5 14.2 6.1 4.1 6.1 5.0 11.7 6.8 9.1 7.9 3.7 2.1 4.2 4.0 7.5 5.5 3.2 3.0 1.9 3.9 6.6 2.7 3.2 4.9 3.2 2.7 0.0 2.0 2.9 0.8 1.8 0.6 1.0 0.8 0.8 1.6 1.4 0.8 1.3 1.1 1.4 1.5 1.2 0.1 0.6 2.9 3.2 5.2 5.0 2.8 2.3 2.7 3.2 3.9 2.6 0.0 9.0 3.2 3.6 0.8 5.4 11.3 5.1 2.7 2.3 0.0 2.0 4.3 3.3 3.2 1.9 2.0 9.3 0.0 3.6 2.3 1.0 2.0 2.3 5.4 3.0 7.9 5.2 1.8 1.9 0.0 3.7 1.3 0.0 4.6 5.1 4.1 4.0 7.0 2.5 4.3 9.5 12.9 2.0 0.7 1.9 1.1 8.5 2.1 5.2 3.4 ZNF80 pT17 ENSG00000174255 "Zinc finger protein 80" P51504 3 114234631-114237578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.4;breast: 17.4" "Cell type enhanced" "Detected in some" 23 "granulocytes: 1.1;Ito cells: 1.3;T-cells: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 2.8;T-cells: 4.4" "Cell line enhanced" "Detected in some" "MCF7: 6.5;SK-BR-3: 3.6" HPA065484 Uncertain NA NA "HPA065484: AB_2685496" "unprognostic (6.27e-3)" "unprognostic (3.00e-2)" "unprognostic (4.42e-2)" "unprognostic (1.26e-1)" "unprognostic (4.52e-2)" "unprognostic (9.68e-5)" "unprognostic (5.36e-1)" "unprognostic (6.52e-3)" "unprognostic (2.80e-2)" "unprognostic (1.27e-2)" "unprognostic (6.25e-2)" "unprognostic (1.49e-1)" "unprognostic (6.69e-12)" "unprognostic (1.85e-1)" "unprognostic (3.10e-1)" "unprognostic (1.16e-1)" "unprognostic (1.34e-2)" 0.4 0.0 0.0 1.1 0.0 0.2 17.4 0.0 0.0 0.4 0.7 0.0 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.3 0.3 1.0 2.1 0.0 0.1 0.2 0.0 0.2 0.0 0.3 1.1 0.2 0.0 0.0 0.1 2.3 0.0 0.2 3.6 0.2 1.2 0.6 0.2 0.6 0.4 0.8 0.1 2.8 0.2 0.5 4.4 0.8 0.3 0.4 0.7 0.7 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.6 0.9 1.0 0.1 0.1 0.7 0.3 0.0 0.0 0.0 2.7 0.3 0.2 1.2 0.8 0.0 0.0 0.5 0.4 1.1 0.1 0.0 0.1 0.0 1.1 0.6 1.5 0.7 6.5 0.2 0.4 2.3 0.8 0.1 0.2 1.3 0.2 0.1 0.8 0.7 0.3 0.4 3.6 0.5 0.4 2.1 0.8 0.7 0.3 2.8 0.3 0.3 1.8 0.5 1.5 1.5 0.4 0.3 2.8 0.2 1.3 2.1 0.1 0.6 0.7 1.7 4.2 0.0 0.8 0.9 0.9 0.4 0.5 0.0 0.1 4.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.4 0.0 3.3 0.0 0.0 ZNF804A C2orf10 ENSG00000170396 "Zinc finger protein 804A" Q7Z570 2 184598366-184939492 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "brain: 31.6;lymphoid tissue: 9.6" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 31.9" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Region enriched" "Detected in many" 4 "cerebellum: 31.6" "Cell type enhanced" "Detected in some" "memory B-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029195 Uncertain Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029195: AB_10603011" "unprognostic (1.10e-1)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.08e-2)" "unprognostic (1.26e-2)" "unprognostic (1.50e-1)" "unprognostic (2.41e-1)" "unprognostic (4.45e-1)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (5.20e-2)" "unprognostic (4.98e-4)" "unprognostic (6.21e-2)" "unprognostic (4.04e-1)" "unprognostic (8.45e-2)" "unprognostic (4.93e-2)" 0.4 1.0 4.3 9.6 7.2 1.8 0.4 31.6 10.7 0.6 0.8 0.1 0.8 1.5 0.4 0.3 0.6 0.4 4.8 0.3 5.2 7.3 1.8 0.6 1.2 2.7 2.2 3.0 0.8 0.3 0.2 0.4 0.5 5.4 4.1 1.1 2.4 1.1 4.4 0.3 0.3 3.3 0.5 1.5 1.8 1.2 0.9 0.4 0.0 4.4 0.0 2.9 1.8 2.1 2.0 1.2 1.0 1.7 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 4.9 1.6 1.5 0.0 0.0 20.8 0.0 0.0 2.1 0.0 0.3 0.0 3.7 0.1 0.0 5.5 0.8 0.1 8.2 5.2 0.0 2.5 0.0 0.0 1.3 2.5 3.9 0.0 0.0 0.9 0.0 0.0 0.0 4.9 0.0 0.0 3.3 0.0 14.3 0.8 0.0 0.0 0.3 2.4 0.0 0.0 0.0 0.1 0.0 10.5 0.0 5.3 0.1 0.2 2.1 2.2 0.0 15.5 6.1 1.5 1.7 0.0 1.1 0.0 0.0 1.7 0.0 2.0 0.0 0.0 1.2 0.3 0.0 0.0 1.0 0.0 0.6 0.0 0.0 0.3 4.3 7.2 31.6 7.5 5.2 7.3 2.2 3.0 5.4 0.4 0.0 1.1 3.4 0.0 0.0 31.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.2 0.0 0.0 2.7 0.4 0.3 3.2 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 2.6 6.5 0.2 0.5 1.4 0.0 0.0 0.0 0.0 0.0 ZNF804B FLJ32110 ENSG00000182348 "Zinc finger protein 804B" A4D1E1 7 88759368-89337057 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "thyroid gland: 31.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 11.9;Proximal tubular cells: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "AF22: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA026702 Uncertain NA NA "HPA026702: AB_1859459" "unprognostic (1.10e-1)" "unprognostic (5.00e-2)" "unprognostic (1.29e-1)" "unprognostic (1.99e-1)" 0.2 0.2 0.6 0.7 1.3 0.1 0.4 0.2 2.0 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.2 0.4 2.5 0.2 0.2 3.3 0.2 0.5 0.5 1.3 0.1 0.4 0.6 1.6 0.6 0.1 1.3 1.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.3 0.0 0.0 31.4 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.3 0.2 2.0 0.2 0.4 0.2 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 ZNF821 ENSG00000102984 "Zinc finger protein 821" O75541 16 71859680-71895336 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9;testis: 23.7" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 9.3;naive B-cell: 11.5" "Group enriched" "Detected in many" 8 "B-cells: 11.5;T-cells: 5.1" "Cell line enhanced" "Detected in many" "AF22: 14.0;SCLC-21H: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036372, HPA042742" Enhanced Supported "Nucleoplasm,Nuclear speckles" NA NA "Nucleoplasm, Nuclear speckles" "HPA036372: AB_10669790, HPA042742: AB_2678140" "unprognostic (3.16e-1)" "unprognostic (1.77e-1)" "unprognostic (6.50e-2)" "unprognostic (1.12e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.69e-2)" "unprognostic (2.28e-2)" "unprognostic (7.72e-2)" "unprognostic (5.25e-2)" "unprognostic (3.04e-2)" "prognostic favorable (4.27e-5)" "unprognostic (2.83e-2)" "prognostic favorable (6.32e-10)" "unprognostic (1.82e-2)" "unprognostic (1.79e-1)" "unprognostic (7.97e-2)" "unprognostic (1.02e-1)" 2.0 4.2 6.3 3.7 7.5 3.1 4.8 26.9 13.4 4.3 3.8 5.1 2.3 2.1 5.8 11.1 2.5 3.5 3.9 2.9 5.7 7.6 5.9 2.6 3.4 6.0 5.2 6.0 7.3 2.4 5.6 9.2 2.5 7.1 4.4 5.0 5.2 5.2 5.1 4.0 6.0 4.3 3.0 4.8 3.7 3.3 23.7 3.4 2.2 6.1 0.7 7.3 2.4 4.0 11.5 0.9 0.4 0.5 1.0 5.1 0.7 1.1 0.9 14.0 6.7 2.8 3.6 2.4 1.4 3.1 3.1 4.9 1.9 0.9 2.6 2.4 2.7 3.4 2.0 4.6 2.1 3.8 3.9 5.2 0.5 1.0 0.8 1.7 0.9 3.0 3.1 3.5 2.1 1.3 5.3 2.4 0.6 1.6 2.0 3.4 3.3 1.5 0.9 5.5 4.0 0.6 6.1 3.0 4.5 3.5 0.4 14.1 6.7 1.8 1.2 1.5 6.3 4.7 3.0 4.6 3.3 3.5 1.2 0.9 4.7 2.4 10.6 1.1 2.6 3.2 0.0 0.5 0.4 2.2 0.0 1.9 9.3 2.3 1.6 0.9 11.5 1.4 0.5 0.4 1.0 0.5 0.0 5.1 0.7 6.3 7.5 26.9 13.4 5.7 7.6 5.2 6.0 7.1 3.4 0.0 3.4 20.5 6.0 7.1 41.7 1.1 12.7 2.7 1.2 15.7 43.2 5.2 18.3 8.1 108.2 5.8 26.4 0.0 4.1 4.3 8.5 6.0 9.2 1.7 6.8 30.2 22.5 12.9 4.0 40.3 11.5 9.3 3.3 2.8 9.2 20.9 5.9 14.4 11.7 8.6 47.4 12.9 4.7 50.4 18.3 6.6 5.1 17.5 6.4 3.4 ZNF829 DKFZp779O175 ENSG00000185869 "Zinc finger protein 829" Q3KNS6 19 36888124-36916291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 20.1" "Cell type enriched" "Detected in many" 8 "Early spermatids: 241.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 15.0" HPA073073 Approved "Nucleoplasm,Nuclear bodies" No No Nucleoplasm "Nuclear bodies" "HPA073073: AB_2686567" "unprognostic (4.55e-2)" "unprognostic (2.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-4)" "unprognostic (1.32e-1)" "unprognostic (6.46e-2)" "unprognostic (8.20e-2)" "unprognostic (1.33e-2)" "unprognostic (9.35e-4)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (3.39e-2)" "unprognostic (3.48e-4)" "unprognostic (5.47e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (8.92e-4)" 2.6 2.8 4.9 2.4 5.9 1.9 4.3 8.0 4.8 2.9 2.6 2.3 5.0 1.7 3.6 2.0 2.2 3.1 1.8 2.4 3.3 2.5 2.6 1.8 2.2 2.8 6.4 2.9 5.3 2.1 3.8 3.4 3.6 3.3 3.6 1.6 1.6 2.6 3.0 1.9 3.5 2.1 4.8 4.4 2.8 2.3 20.1 5.1 3.4 5.2 1.0 2.9 3.1 4.7 3.3 1.4 4.2 0.8 2.1 4.9 1.0 0.0 1.2 3.3 0.1 1.8 2.8 1.4 3.7 2.2 4.6 7.1 0.1 0.6 0.1 4.4 2.3 4.3 0.7 0.0 2.7 5.4 0.0 5.3 1.9 0.1 0.1 1.8 0.0 5.2 2.8 2.6 5.1 0.0 1.5 0.5 1.4 0.0 0.1 5.0 0.8 0.7 0.8 5.5 0.0 0.0 0.0 4.5 1.7 1.3 5.5 3.8 5.6 0.1 0.0 3.1 4.9 3.5 0.3 1.4 3.0 3.9 3.8 4.0 9.8 15.0 6.3 0.0 0.1 6.9 4.2 0.6 2.9 3.2 0.7 4.2 2.2 3.2 4.9 1.0 3.3 4.1 4.2 1.3 2.1 0.8 1.4 3.2 1.0 4.9 5.9 8.0 4.8 3.3 2.5 6.4 2.9 3.3 5.1 0.0 4.3 1.3 1.8 1.3 5.8 4.6 5.1 1.4 5.7 3.5 3.9 3.2 0.0 2.3 241.5 3.9 0.0 0.0 0.9 2.1 2.8 1.6 1.1 0.0 1.4 11.1 0.0 1.3 0.3 29.7 5.5 2.5 3.3 1.8 0.9 2.4 0.8 0.0 6.7 1.1 11.3 0.0 2.3 9.5 10.0 2.4 3.5 2.9 0.4 0.7 ZNF831 "C20orf174, dJ492J12.1" ENSG00000124203 "Zinc finger protein 831" Q5JPB2 20 59123381-59259113 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.8;pituitary gland: 6.6" "Cell type enriched" "Detected in some" 5 "T-cells: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 4.1;MAIT T-cell: 3.3;memory CD4 T-cell: 2.3;memory CD8 T-cell: 3.3;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.4;NK-cell: 2.3;T-reg: 4.2" "Group enriched" "Detected in many" 6 "NK-cells: 2.3;T-cells: 4.2" "Group enriched" "Detected in some" 6 "Daudi: 9.3;HMC-1: 2.6" "Group enriched" "Detected in many" 4 "amygdala: 5.3;basal ganglia: 4.3;cerebral cortex: 5.1;hippocampal formation: 6.0;olfactory region: 4.7" "Group enriched" "Detected in many" 26 "amygdala: 6.5;basal ganglia: 5.1;cerebral cortex: 4.5;hippocampal formation: 7.1;olfactory region: 11.1" HPA016839 Uncertain NA NA "HPA016839: AB_1859466" "unprognostic (2.90e-3)" "unprognostic (7.70e-6)" "unprognostic (9.71e-4)" "unprognostic (1.31e-3)" "unprognostic (7.00e-2)" "unprognostic (3.00e-5)" "unprognostic (3.08e-3)" "unprognostic (2.23e-2)" "unprognostic (2.89e-3)" "unprognostic (2.21e-3)" "unprognostic (2.80e-3)" "unprognostic (4.31e-1)" "unprognostic (3.40e-3)" "unprognostic (2.39e-1)" "unprognostic (3.42e-2)" "unprognostic (2.21e-1)" "unprognostic (1.93e-2)" 0.6 0.1 1.7 9.1 3.6 1.3 0.4 0.2 1.2 0.2 0.4 0.2 0.2 0.3 0.2 0.4 0.8 0.4 0.8 0.2 1.5 0.6 0.3 0.3 1.3 10.0 0.2 0.2 0.2 0.3 0.0 6.6 0.2 0.2 0.2 0.5 0.2 0.5 0.2 0.2 0.1 4.2 0.2 0.2 9.3 0.9 0.4 0.2 0.4 0.7 0.9 13.8 3.1 0.2 0.4 0.0 0.5 0.0 2.3 4.2 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 4.1 0.0 3.3 0.4 2.3 3.3 0.0 0.4 1.9 2.4 0.2 2.3 0.0 0.0 4.2 0.8 1.7 3.6 0.2 1.2 1.5 0.6 0.2 0.2 0.2 0.2 0.0 1.1 2.7 0.0 0.2 0.0 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 13.8 0.0 0.0 ZNF850 ZNF850P ENSG00000267041 "Zinc finger protein 850" A8MQ14 19 36714383-36772825 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 17.9" "Cell type enhanced" "Detected in many" 5 "Ito cells: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.7" HPA029299 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029299: AB_2672987" "unprognostic (1.35e-2)" "unprognostic (5.54e-2)" "unprognostic (3.85e-2)" "unprognostic (1.38e-3)" "unprognostic (7.78e-2)" "unprognostic (6.63e-2)" "unprognostic (1.65e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-2)" "unprognostic (1.25e-1)" "unprognostic (3.00e-2)" "unprognostic (5.56e-2)" "unprognostic (4.11e-3)" "unprognostic (1.77e-1)" "unprognostic (7.49e-2)" "unprognostic (4.49e-2)" "unprognostic (7.37e-3)" 4.0 3.4 2.6 3.0 4.2 11.5 3.3 8.7 3.1 5.1 2.4 3.4 1.6 1.9 5.6 2.6 2.8 2.9 3.2 4.6 2.5 1.7 2.0 2.8 3.0 4.0 5.9 0.7 5.9 4.1 3.2 6.4 17.9 3.2 3.4 2.9 3.0 2.3 2.2 1.9 3.2 2.9 2.3 3.5 3.6 2.7 6.7 3.8 7.0 2.6 1.0 2.9 5.0 4.4 6.8 3.5 6.0 3.8 3.8 6.0 5.1 0.3 1.7 3.7 5.8 0.8 0.3 7.2 2.4 1.3 1.4 2.1 1.3 0.4 1.2 5.1 0.4 7.8 0.8 2.6 0.5 2.7 0.6 2.1 14.7 0.2 1.1 1.0 1.8 8.4 1.1 0.1 2.4 0.0 0.5 1.4 1.8 3.8 0.8 3.7 0.8 2.6 1.8 10.8 0.6 1.0 1.6 7.3 0.9 0.6 7.4 2.5 4.0 3.8 0.2 0.6 5.4 1.5 3.3 3.0 3.7 5.8 2.1 3.6 1.5 2.6 3.2 0.0 0.8 5.7 4.2 3.4 2.4 3.9 3.6 5.0 6.8 4.8 3.2 3.2 5.4 5.7 6.0 6.0 3.8 3.8 3.5 3.2 5.1 2.6 4.2 8.7 3.1 2.5 1.7 5.9 0.7 3.2 3.8 0.0 0.0 0.9 1.1 1.9 1.1 2.4 2.5 0.0 0.0 3.5 0.0 3.0 0.0 1.1 6.1 2.1 0.0 0.0 0.6 3.8 2.6 0.5 0.0 1.8 1.1 4.8 0.0 8.6 2.7 3.6 1.1 1.1 3.3 0.0 2.9 1.3 0.5 0.0 0.4 0.4 0.0 0.0 1.4 2.6 2.5 3.0 2.4 0.9 0.6 0.9 ZNF853 DKFZp434J1015 ENSG00000236609 "Zinc finger protein 853" P0CG23 7 6615617-6624290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 28.9" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 13.0;Muller glia cells: 10.9;Rod photoreceptor cells: 9.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5" "Cell line enhanced" "Detected in many" "AN3-CA: 14.8;SH-SY5Y: 22.1;U-2 OS: 14.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067690 Approved Approved Nucleoli NA NA Nucleoli "HPA067690: AB_2685888" "unprognostic (1.35e-3)" "unprognostic (2.63e-1)" "unprognostic (7.17e-2)" "unprognostic (8.77e-2)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" "unprognostic (1.17e-1)" "unprognostic (3.54e-1)" "unprognostic (2.26e-2)" "unprognostic (5.06e-2)" "unprognostic (1.87e-3)" "unprognostic (9.28e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.41e-3)" "unprognostic (4.95e-2)" "unprognostic (2.30e-3)" "unprognostic (4.01e-2)" 3.7 3.9 16.6 2.9 14.4 1.0 4.6 4.5 13.5 7.8 7.7 10.4 2.8 1.8 9.4 5.9 5.6 11.8 5.8 12.3 16.1 15.5 3.3 0.9 4.5 4.3 14.8 9.1 15.6 10.6 7.3 4.5 3.7 11.9 7.6 2.5 6.0 6.7 11.5 28.9 2.4 2.7 8.5 10.1 4.3 3.6 3.0 9.9 2.6 9.9 2.7 2.7 6.5 11.7 0.3 0.4 3.1 0.0 1.1 1.5 0.3 0.0 1.2 3.5 14.8 0.1 0.0 0.1 0.3 0.0 1.6 0.3 2.6 0.6 0.0 5.8 0.0 0.5 0.0 5.3 0.1 1.5 0.0 1.9 0.4 0.0 2.7 2.1 0.0 0.1 0.5 0.5 0.2 0.0 1.5 0.0 1.2 2.2 0.0 0.9 0.1 0.3 1.9 5.5 0.0 0.0 1.6 5.8 0.1 1.1 5.5 4.7 22.1 0.0 0.2 0.9 3.0 0.8 3.1 0.0 1.1 14.8 0.0 1.3 0.3 0.1 0.0 0.0 0.0 5.7 0.0 0.0 3.1 1.2 0.0 1.5 0.3 0.8 1.4 0.0 0.3 0.2 1.4 0.0 1.1 0.0 0.4 0.0 0.3 16.6 14.4 4.5 12.4 16.1 15.5 14.8 9.1 11.9 9.9 0.0 0.0 0.0 1.5 0.5 13.0 8.5 0.0 4.0 1.2 7.0 5.9 0.0 0.0 0.5 1.5 1.5 0.0 0.0 0.6 0.0 2.3 1.1 0.0 0.0 0.1 4.8 1.7 1.8 0.0 1.7 4.9 0.0 3.3 0.0 0.0 10.9 0.4 0.0 8.1 0.2 9.1 12.9 1.4 0.5 0.7 0.3 0.2 0.8 0.0 0.7 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981771-31991628 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.2" "Cell type enhanced" "Detected in some" 9 "B-cells: 3.4;Ciliated cells: 6.7;Club cells: 4.5;Intestinal endocrine cells: 3.4;Syncytiotrophoblasts: 3.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 61 "memory B-cell: 9.1;naive B-cell: 6.4" "Lineage enriched" "Detected in single" 71 "B-cells: 9.1" "Cell line enriched" "Detected in many" 4 "BEWO: 31.9" HPA063386 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063386: AB_2684999" "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 2.0 1.0 0.7 11.2 1.0 0.1 2.8 0.8 1.5 4.3 1.1 0.0 1.7 0.3 4.1 4.9 6.2 1.9 3.6 1.3 0.6 1.6 7.2 0.4 3.7 8.3 1.6 0.6 1.8 0.6 0.1 5.5 8.1 1.1 6.0 1.6 1.6 5.6 2.6 0.4 2.3 3.7 6.7 0.5 9.6 1.1 2.2 0.0 0.5 1.8 4.2 20.2 6.4 3.6 9.1 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.7 0.0 1.6 0.0 0.0 31.9 0.2 0.1 0.2 0.2 2.1 2.5 2.3 2.3 0.0 1.0 1.9 0.7 3.1 0.2 0.0 0.3 0.0 3.2 1.0 0.0 0.0 0.0 0.1 1.4 0.2 6.1 0.2 0.6 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.8 5.6 3.4 0.0 0.0 0.1 7.2 0.9 0.2 0.0 0.5 3.8 0.0 1.6 2.9 0.0 1.2 0.2 2.6 0.0 0.2 0.0 0.0 3.6 0.3 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 1.0 0.8 1.5 0.6 1.6 1.6 0.6 1.1 0.0 0.0 0.0 3.4 0.4 0.8 0.2 0.6 0.0 6.7 4.5 0.0 0.0 1.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 3.0 0.5 0.9 0.0 0.0 0.3 0.0 3.4 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.9 0.2 0.0 0.4 1.1 0.0 0.0 0.3 0.1 0.1 0.3 3.5 0.0 0.3 0.6 ZNF865 ENSG00000261221 "Zinc finger protein 865" P0CJ78 19 55605405-55617269 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.2" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 18.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068079 Approved Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA068079: AB_2685947" "unprognostic (3.98e-3)" "unprognostic (2.46e-1)" "unprognostic (4.72e-3)" "unprognostic (8.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (8.85e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "unprognostic (9.41e-3)" 12.1 7.5 8.3 11.0 10.5 11.1 8.2 12.3 15.1 8.0 10.0 9.7 6.6 11.0 11.5 6.8 6.2 8.7 7.0 12.2 7.3 5.8 8.3 6.7 8.7 13.3 7.4 8.5 10.3 11.2 9.9 9.5 6.1 7.4 9.9 4.8 8.1 12.1 7.7 56.2 11.1 10.4 7.4 7.3 16.0 12.2 4.7 7.9 14.0 9.5 8.0 9.1 9.3 9.9 1.2 0.5 1.4 0.1 0.1 0.6 0.1 6.4 5.3 2.3 3.7 2.5 1.9 6.3 4.6 2.6 2.5 2.4 1.7 4.2 7.5 5.4 3.4 1.3 5.4 1.4 2.8 1.0 7.4 17.6 4.3 3.2 2.2 4.0 4.9 8.4 2.9 4.5 3.1 1.9 2.3 1.7 4.7 8.2 5.1 1.6 3.0 7.7 5.3 5.2 3.7 9.2 12.0 3.6 4.7 2.9 4.4 5.5 8.9 6.4 3.9 3.9 1.2 3.1 7.7 5.0 3.9 9.3 3.5 5.8 10.8 9.3 3.9 4.8 3.8 6.2 0.0 0.0 1.4 0.3 0.1 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.6 0.8 0.1 0.1 0.5 0.0 0.1 8.3 10.5 12.3 15.1 7.3 5.8 7.4 8.5 7.4 7.9 0.0 0.0 1.9 1.0 3.7 3.7 18.6 2.5 0.0 0.0 14.0 0.0 2.1 5.0 3.1 1.9 5.2 5.2 0.0 3.8 2.7 3.8 1.2 0.0 5.4 4.0 9.5 5.8 6.7 5.4 3.2 4.9 4.2 5.0 1.8 6.3 3.9 4.7 0.0 9.6 3.6 3.2 6.5 4.1 1.2 1.4 3.8 2.2 4.8 5.7 0.9 ZNF90 HTF9 ENSG00000213988 "Zinc finger protein 90" Q03938 19 20077994-20127076 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.3;seminal vesicle: 36.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 192.8;Suprabasal keratinocytes: 245.0" "Cancer enhanced" "Detected in many" "testis cancer: 10.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AN3-CA: 9.4;NTERA-2: 16.0;SuSa: 11.7;U-2197: 6.7" HPA003227 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA003227: AB_1859471" "unprognostic (4.52e-2)" "unprognostic (2.64e-3)" "unprognostic (3.93e-1)" "unprognostic (2.45e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-2)" "unprognostic (7.34e-3)" "unprognostic (4.95e-1)" "unprognostic (4.44e-3)" "unprognostic (2.28e-1)" "unprognostic (1.09e-1)" "unprognostic (1.18e-4)" "unprognostic (2.79e-2)" "unprognostic (1.13e-1)" "unprognostic (9.10e-2)" "unprognostic (2.60e-2)" 1.5 1.0 1.1 3.6 2.5 1.6 1.8 6.9 1.1 3.0 1.7 1.2 20.3 0.5 3.3 2.7 2.1 2.8 1.0 1.4 0.8 0.6 1.7 0.7 2.4 3.0 2.1 0.3 4.7 3.4 12.7 1.4 3.8 1.7 4.1 2.1 3.2 1.2 36.4 1.2 2.8 2.3 3.3 1.6 2.3 2.7 1.6 2.2 4.1 10.3 0.7 2.9 4.9 2.9 0.5 0.4 1.8 0.2 0.3 0.9 0.2 0.0 0.0 3.8 9.4 0.0 0.0 0.0 1.0 0.4 3.6 4.3 3.2 2.2 1.4 1.7 0.6 2.5 0.9 0.0 0.5 6.3 0.0 0.9 0.0 0.0 0.6 0.3 0.0 0.0 0.2 0.0 3.5 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.9 5.4 16.0 0.0 0.0 0.0 3.4 0.2 2.0 3.3 0.0 3.4 0.0 1.1 0.1 11.7 1.9 0.0 0.0 0.9 0.0 6.7 3.6 0.0 1.5 0.0 0.0 0.0 1.4 0.8 0.2 0.3 0.1 0.0 0.9 0.2 0.2 0.4 0.4 0.5 0.3 0.1 1.8 0.3 0.0 0.2 0.7 0.2 1.1 2.5 6.9 1.1 0.8 0.6 2.1 0.3 1.7 2.2 6.0 5.9 72.1 60.7 192.8 0.6 1.7 56.0 0.0 7.9 7.0 2.0 81.3 14.9 2.0 5.9 31.2 3.3 70.0 1.8 83.3 43.9 74.9 1.1 52.0 41.8 0.0 8.2 48.5 105.1 17.6 56.4 28.6 118.1 1.0 14.4 1.4 1.0 10.5 32.5 4.6 2.1 19.4 51.2 8.2 14.3 245.0 68.2 76.2 20.2 56.5 ZNF98 "F7175, ZNF739" ENSG00000197360 "Zinc finger protein 98" A6NK75 19 22391019-22532485 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 36.9" "Group enriched" "Detected in some" 5 "Distal tubular cells: 13.3;Early spermatids: 10.7;Spermatocytes: 8.8;Spermatogonia: 23.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory B-cell: 1.0;naive B-cell: 1.5;plasmacytoid DC: 1.9" "Group enriched" "Detected in many" 5 "B-cells: 1.5;dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "BEWO: 3.0;GAMG: 8.8;NB-4: 7.4;RPMI-8226: 3.1;SuSa: 3.5;T-47d: 5.5;U-2197: 5.8" NA NA "unprognostic (1.11e-1)" "unprognostic (1.31e-2)" "unprognostic (6.95e-3)" "unprognostic (1.36e-3)" "unprognostic (3.07e-3)" "unprognostic (1.56e-1)" "unprognostic (7.20e-2)" "unprognostic (1.63e-1)" "unprognostic (1.81e-1)" "unprognostic (3.81e-2)" "unprognostic (1.99e-2)" "unprognostic (2.14e-1)" "unprognostic (2.66e-1)" "unprognostic (7.56e-2)" 1.3 1.0 3.2 0.6 9.2 0.6 4.2 0.9 13.2 3.9 0.8 2.1 2.1 0.5 1.8 6.3 0.6 2.7 0.8 1.5 4.2 1.6 3.7 0.5 0.6 0.7 2.6 7.2 12.6 36.9 4.5 1.1 0.9 3.8 1.3 0.5 0.4 1.1 1.2 0.5 0.6 0.6 1.7 1.4 0.6 0.7 10.2 3.1 0.0 5.1 0.0 0.4 1.2 0.8 1.5 1.9 0.2 0.1 0.2 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 3.0 0.2 0.0 0.4 0.2 0.0 0.0 0.0 1.3 0.0 8.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.3 0.2 7.4 1.6 0.0 0.3 0.5 0.0 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.5 5.5 1.8 0.0 0.0 0.6 5.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.0 1.0 0.3 0.0 0.0 1.5 0.3 0.2 0.0 0.2 0.1 1.9 0.1 0.0 3.2 9.2 0.9 13.2 4.2 1.6 2.6 7.2 3.8 3.1 0.0 0.0 0.0 0.4 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.9 13.3 2.0 10.7 0.0 0.0 0.0 1.2 0.3 0.0 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 2.9 1.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 1.8 0.6 0.0 0.0 0.3 8.8 23.7 0.0 0.3 0.0 0.0 0.1 ZNF99 "C19orf9, MGC24986" ENSG00000213973 "Zinc finger protein 99" A8MXY4 19 22752183-22784107 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "kidney: 5.5;testis: 11.2" "Group enriched" "Detected in some" 6 "Sertoli cells: 19.4;Spermatocytes: 11.2" "Cancer enriched" "Detected in single" 9 "testis cancer: 1.5" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 2.7;NTERA-2: 3.5;SuSa: 2.5" NA NA "unprognostic (8.31e-2)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (4.78e-2)" "unprognostic (1.96e-2)" "unprognostic (2.28e-1)" "unprognostic (9.83e-2)" "unprognostic (4.22e-2)" "unprognostic (2.65e-1)" "unprognostic (1.92e-3)" "unprognostic (2.61e-1)" "unprognostic (8.92e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (3.49e-1)" "unprognostic (4.05e-3)" "unprognostic (8.55e-2)" 0.7 0.5 1.6 0.4 2.9 1.0 1.1 1.1 2.8 0.8 0.5 0.3 0.0 0.4 1.5 1.3 0.5 0.7 0.4 0.8 1.6 0.6 5.5 0.5 0.5 1.5 0.6 1.4 0.8 0.5 0.3 0.5 0.5 2.4 0.5 0.3 0.3 0.5 0.4 0.7 0.9 0.5 0.7 0.6 0.7 0.5 11.2 0.7 0.4 0.8 0.0 0.3 0.6 0.7 1.1 1.2 2.9 0.6 0.8 0.8 0.2 0.1 0.4 0.2 0.3 0.1 0.0 2.7 0.0 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.4 0.3 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.7 0.0 0.2 0.1 0.4 3.5 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.4 0.6 0.0 0.3 0.1 2.5 0.8 0.1 0.3 0.2 0.1 1.2 0.2 0.3 0.3 0.2 0.1 0.2 0.0 1.7 0.5 0.5 0.5 0.5 0.4 0.7 0.5 0.3 0.2 1.1 0.8 0.7 2.9 0.8 0.6 1.2 0.4 0.2 1.6 2.9 1.1 2.8 1.6 0.6 0.6 1.4 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.0 0.0 0.0 0.0 0.0 0.7 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 19.4 0.0 11.2 2.5 0.0 0.2 0.0 0.0 0.1 ZNRF1 "DKFZp434E229, FLJ14846, nin283" ENSG00000186187 "Zinc and ring finger 1" Q8ND25 16 74999030-75110994 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.1" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.5;T-reg: 5.2" "Group enriched" "Detected in many" 4 "granulocytes: 4.5;monocytes: 1.4;T-cells: 5.2" "Cell line enhanced" "Detected in many" "HMC-1: 54.8;MOLT-4: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027470 Approved NA NA "HPA027470: AB_10603108" "unprognostic (2.78e-2)" "prognostic favorable (9.90e-4)" "unprognostic (4.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.34e-2)" "unprognostic (1.18e-2)" "unprognostic (2.51e-1)" "unprognostic (2.07e-1)" "unprognostic (1.12e-2)" "unprognostic (5.38e-2)" "unprognostic (3.69e-1)" "unprognostic (2.28e-1)" "unprognostic (1.46e-1)" "unprognostic (4.89e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-2)" "unprognostic (1.44e-2)" 10.0 9.5 13.4 8.1 13.7 5.2 16.6 6.3 16.5 13.2 12.5 8.1 6.7 8.3 10.7 9.1 28.2 10.0 11.3 9.1 11.6 14.6 5.6 12.8 12.8 8.7 9.1 9.4 10.1 6.1 12.2 6.2 9.7 7.8 9.1 10.8 7.2 7.5 7.5 58.6 14.5 11.2 10.1 8.8 2.8 11.8 21.6 4.9 80.1 21.4 16.9 13.3 14.0 15.5 0.2 0.8 4.5 1.4 0.0 5.2 0.3 3.2 4.7 8.1 8.4 8.7 6.8 28.1 3.9 5.5 5.4 5.3 7.6 10.0 0.8 3.0 8.5 5.2 7.7 3.9 5.4 4.3 7.8 2.2 16.8 1.5 13.8 6.9 8.0 54.8 6.1 4.5 5.6 4.6 9.6 8.8 20.7 8.0 2.6 4.1 30.8 39.2 29.6 11.3 9.3 5.1 17.4 3.0 5.1 7.6 9.1 10.9 11.7 6.2 8.3 2.2 7.0 21.9 7.7 6.0 3.7 6.5 6.6 2.3 15.6 15.8 9.3 4.9 9.0 3.8 4.5 1.4 0.9 0.2 1.1 1.3 0.2 1.5 0.2 0.8 0.0 0.0 0.2 1.2 0.0 1.1 0.0 5.2 0.3 13.4 13.7 6.3 16.5 11.6 14.6 9.1 9.4 7.8 4.9 8.9 11.8 0.8 13.7 14.2 10.6 15.7 15.3 14.7 12.5 3.5 49.1 5.5 0.0 6.8 17.8 23.3 12.9 0.0 10.9 9.4 10.4 10.2 35.8 11.6 8.3 3.2 19.0 9.2 5.9 10.1 6.4 4.0 13.5 7.2 14.4 11.9 14.8 11.5 3.9 5.1 5.5 0.0 7.6 11.3 16.1 17.1 3.8 6.4 9.8 25.7 ZNRF4 "RNF204, spzn, Ssrzf1" ENSG00000105428 "Zinc and ring finger 4" Q8WWF5 19 5455431-5456856 "Enzymes, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 90.2" "Group enriched" "Detected in some" 94 "Early spermatids: 525.4;Late spermatids: 405.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 525.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 405.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 4.7 3.1 0.0 0.0 0.0 0.0 0.0 ZP1 ENSG00000149506 "Zona pellucida glycoprotein 1" P60852 11 60867562-60875693 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 6.5;epididymis: 2.2;pituitary gland: 3.3" "Group enriched" "Detected in some" 7 "Early spermatids: 25.5;Late spermatids: 62.7" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 66 "plasmacytoid DC: 6.5" "Lineage enriched" "Detected in single" 66 "dendritic cells: 6.5" "Group enriched" "Detected in some" 36 "RPMI-8226: 16.2;SK-BR-3: 4.6" "Region enriched" "Detected in single" 7 "basal ganglia: 0.7" "Secreted in female reproductive system" NA NA "unprognostic (6.40e-3)" "unprognostic (2.18e-4)" "unprognostic (1.63e-1)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (7.02e-2)" "unprognostic (8.27e-2)" "unprognostic (9.95e-2)" "unprognostic (1.94e-2)" "unprognostic (8.15e-3)" "unprognostic (2.52e-1)" "unprognostic (9.25e-4)" "unprognostic (5.31e-13)" "unprognostic (4.13e-2)" "unprognostic (2.38e-1)" "unprognostic (6.27e-2)" "unprognostic (5.61e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.3 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 2.2 0.0 0.0 0.1 1.4 0.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 25.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 62.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 6.5 2.0 0.5 0.0 0.1 0.2 0.0 0.0 0.0 ZP2 ZPA ENSG00000103310 "Zona pellucida glycoprotein 2" Q05996 16 21197450-21214510 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 22 "cerebellum: 35.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 35 "HDLM-2: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA011296 Enhanced "Secreted in female reproductive system" NA NA "HPA011296: AB_1859485" "unprognostic (2.35e-2)" "unprognostic (3.12e-2)" "unprognostic (6.60e-2)" "unprognostic (9.83e-2)" "unprognostic (3.44e-3)" "unprognostic (3.12e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" 0.0 0.1 0.0 0.0 0.0 0.0 1.1 35.2 0.1 0.8 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.9 1.6 0.0 0.1 0.0 3.1 0.0 0.0 0.1 1.5 0.1 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZP4 ZPB ENSG00000116996 "Zona pellucida glycoprotein 4" Q12836 1 237877864-237890922 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 8.5" "Not detected" "Not detected" HPA008547 Supported "Secreted in female reproductive system" NA NA "HPA008547: AB_1080766" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.59e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZPBP "SP38, ZPBP1" ENSG00000042813 "Zona pellucida binding protein" Q9BS86 7 49850421-50121329 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 95 "testis: 90.4" "Group enriched" "Detected in some" 16 "Early spermatids: 705.4;Spermatocytes: 420.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.4;NTERA-2: 1.2;SCLC-21H: 1.7;U-698: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058673 Enhanced "Secreted in male reproductive system" NA NA "HPA058673: AB_2683794" "unprognostic (1.16e-1)" "unprognostic (6.46e-2)" "unprognostic (7.80e-2)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.15e-7)" "unprognostic (9.49e-2)" "unprognostic (2.34e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.4 0.1 0.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 9.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 705.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 35.4 10.3 0.0 0.0 0.0 0.0 2.0 0.2 0.0 7.4 0.3 19.4 6.5 0.0 420.4 8.1 0.3 0.0 0.0 0.0 0.1 ZPBP2 "MGC41930, ZPBPL" ENSG00000186075 "Zona pellucida binding protein 2" Q6X784 17 39868164-39877896 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 85.7" "Group enriched" "Detected in some" 4 "Early spermatids: 159.4;Spermatocytes: 377.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive B-cell: 2.6" "Group enriched" "Detected in many" 8 "B-cells: 2.6;T-cells: 1.0" "Cell line enhanced" "Detected in some" "Daudi: 2.9;U-698: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA027997, HPA053070" Enhanced "Secreted in male reproductive system" NA NA "HPA027997: AB_1859488, HPA053070: AB_2682033" "unprognostic (2.14e-2)" "unprognostic (3.38e-1)" "unprognostic (1.62e-1)" "unprognostic (2.87e-1)" "unprognostic (5.39e-1)" "unprognostic (2.54e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 85.7 0.0 0.0 0.1 0.0 0.3 0.0 0.0 2.6 0.1 0.1 0.2 0.0 1.0 0.2 0.1 0.1 1.0 0.4 0.3 0.6 0.1 0.3 0.2 0.2 0.5 0.4 0.2 2.9 0.2 0.4 0.2 0.1 0.6 0.2 0.5 0.6 1.3 0.4 0.4 0.0 0.3 0.4 0.2 0.2 0.7 0.1 0.2 0.4 0.3 0.3 0.3 0.9 0.0 0.1 0.1 0.6 1.0 0.7 0.7 0.4 0.9 2.2 0.3 0.3 1.0 0.3 0.1 0.6 0.3 1.3 0.3 0.0 0.4 0.3 0.3 0.6 0.1 1.0 0.2 10.4 0.3 0.4 0.5 0.0 0.0 0.1 0.4 0.0 0.1 0.8 0.4 1.0 0.0 2.6 1.0 0.5 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 159.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.2 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 377.5 8.5 0.0 0.0 0.0 0.0 0.0 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.0;gallbladder: 6.7;kidney: 2.6" "Cell type enhanced" "Detected in some" 18 "Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 8 "non-classical monocyte: 3.0" "Lineage enriched" "Detected in single" 11 "monocytes: 3.0" "Cell line enriched" "Detected in some" 8 "RPTEC TERT1: 12.4" "Region enriched" "Detected in single" 7 "olfactory region: 3.4" "Low region specificity" "Detected in all" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 2.5 1.0 0.0 0.0 0.2 6.7 0.3 0.0 0.6 2.6 0.3 0.0 0.0 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 1.3 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 12.4 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 ZSCAN1 "FLJ33779, ZNF915" ENSG00000152467 "Zinc finger and SCAN domain containing 1" Q8NBB4 19 58034032-58054631 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;epididymis: 16.4;pituitary gland: 15.8" "Group enriched" "Detected in some" 4 "Distal tubular cells: 10.0;Early spermatids: 20.0;Late spermatids: 14.4;Muller glia cells: 5.8;Spermatocytes: 17.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;HMC-1: 4.4;NTERA-2: 4.5;T-47d: 6.5" HPA007938 Uncertain Approved Nucleoli NA NA Nucleoli "HPA007938: AB_1080768" "unprognostic (1.60e-3)" "unprognostic (2.44e-1)" "unprognostic (2.21e-1)" "unprognostic (3.58e-1)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (1.97e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-1)" "prognostic favorable (7.36e-4)" "unprognostic (1.41e-2)" "unprognostic (3.81e-2)" "unprognostic (1.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.32e-1)" "unprognostic (2.47e-2)" "unprognostic (3.60e-1)" 0.9 2.2 7.0 0.7 9.5 0.9 3.2 4.0 13.7 2.2 0.8 6.5 1.0 0.8 1.7 16.4 0.8 4.3 1.3 1.6 6.3 9.7 2.8 0.7 1.4 0.8 6.0 6.7 0.9 2.1 7.3 15.8 1.3 8.2 3.7 0.7 3.4 1.6 3.0 0.8 0.8 1.0 1.1 3.7 0.9 1.0 13.3 2.4 0.9 8.1 0.0 0.7 1.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 6.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.3 0.0 0.0 0.0 0.9 6.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 9.5 4.0 13.7 6.3 9.7 6.0 6.7 8.2 2.4 0.0 0.0 0.0 0.3 0.0 2.8 0.6 0.0 0.0 0.0 1.8 2.0 0.0 10.0 0.8 20.0 0.4 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 14.4 0.9 0.0 1.7 0.0 0.0 5.8 0.4 0.0 0.0 0.0 2.1 0.0 0.3 17.0 3.1 0.0 0.0 0.0 0.0 0.4 ZSCAN10 ZNF206 ENSG00000130182 "Zinc finger and SCAN domain containing 10" Q96SZ4 16 3088890-3099317 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 2.8;testis: 3.9" "Cell type enhanced" "Detected in single" 25 "Cytotrophoblasts: 1.5" "Cancer enriched" "Detected in single" 207 "testis cancer: 19.5" "Region enriched" "Detected in single" 7 "cerebellum: 2.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 9 "NTERA-2: 36.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA076826 Approved Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA076826: " "unprognostic (4.37e-2)" "unprognostic (5.13e-2)" "unprognostic (9.15e-2)" "unprognostic (6.65e-3)" "unprognostic (6.24e-2)" "unprognostic (7.60e-2)" "unprognostic (3.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.72e-1)" "unprognostic (1.85e-11)" "unprognostic (5.98e-2)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" 0.2 0.2 0.3 0.2 0.2 1.3 0.2 2.7 1.4 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.5 0.2 1.3 0.9 0.3 0.2 0.2 0.1 0.2 0.2 0.2 1.1 2.8 0.3 0.2 0.2 0.6 1.2 3.9 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.8 0.7 2.4 0.8 0.6 1.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 36.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 2.4 0.8 0.8 0.4 0.6 1.1 0.8 0.2 1.0 0.4 0.8 0.5 0.6 1.3 0.6 0.7 0.7 0.1 0.2 0.3 0.2 2.7 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 36.9" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favorable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favorable (4.16e-5)" 9.8 7.6 5.2 7.2 7.4 9.7 15.0 5.9 6.3 7.3 6.2 5.8 9.0 4.1 9.5 8.4 3.4 5.3 8.2 8.2 4.8 4.7 9.1 10.1 4.5 8.0 6.2 5.0 10.2 36.9 6.9 6.3 2.8 5.1 7.1 4.3 6.7 12.4 5.1 9.5 3.4 5.5 9.0 5.1 8.1 8.5 12.0 6.0 24.4 6.3 3.9 6.9 6.5 9.7 7.1 10.5 10.0 12.2 9.0 12.1 6.4 1.6 9.5 7.5 12.3 4.4 3.0 6.5 1.8 5.2 3.9 5.3 7.3 3.9 3.5 5.3 2.9 7.2 4.1 6.3 3.6 3.5 7.2 9.7 4.5 5.5 15.4 3.8 2.8 3.6 4.4 4.3 5.1 4.9 5.4 11.8 18.7 5.9 2.8 4.8 4.7 13.0 6.7 13.7 3.3 5.7 13.6 4.2 6.6 4.2 12.1 10.5 18.5 5.7 3.2 8.8 11.7 6.6 8.0 7.7 4.9 9.4 2.3 2.3 4.9 6.4 11.8 3.2 6.6 3.0 10.0 9.6 8.3 10.9 10.5 5.4 7.1 9.2 8.2 10.5 7.1 7.6 8.2 5.4 9.0 12.2 10.2 12.1 6.4 5.2 7.4 5.9 6.3 4.8 4.7 6.2 5.0 5.1 6.0 0.0 1.3 2.2 1.1 0.8 3.5 2.2 7.6 2.7 0.0 7.0 2.0 1.4 5.0 5.4 11.3 1.9 1.1 0.0 7.3 3.9 2.2 2.8 1.1 7.8 3.1 0.0 2.9 0.6 3.2 9.5 0.9 3.1 1.7 7.2 2.9 2.4 10.1 3.5 1.4 14.3 2.9 6.5 1.4 3.4 8.1 0.4 1.1 3.2 2.4 1.3 ZSCAN4 "FLJ35105, ZNF494" ENSG00000180532 "Zinc finger and SCAN domain containing 4" Q8NAM6 19 57668935-57679152 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 7.0" "Group enriched" "Detected in some" 4 "Collecting duct cells: 1.8;Syncytiotrophoblasts: 1.4" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RT4: 3.8;SuSa: 2.0" "Low region specificity" "Detected in all" HPA006491 Uncertain NA NA "HPA006491: AB_10603385" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (1.44e-1)" "unprognostic (2.75e-1)" "unprognostic (4.04e-2)" "unprognostic (2.59e-2)" "unprognostic (2.85e-3)" "unprognostic (1.06e-2)" "unprognostic (7.26e-2)" "unprognostic (1.45e-2)" "unprognostic (3.33e-1)" "unprognostic (1.45e-1)" "unprognostic (4.69e-5)" "unprognostic (1.73e-1)" 0.4 0.1 0.0 0.0 0.0 0.5 0.2 0.6 0.0 2.4 0.1 0.1 0.1 1.2 0.1 1.1 0.2 0.5 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.6 2.1 1.5 0.3 1.2 1.7 0.3 2.1 0.2 0.0 0.0 0.5 7.0 1.0 0.8 0.0 3.9 0.4 0.7 0.7 1.2 0.7 0.4 0.7 0.0 0.1 0.2 0.1 1.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.6 0.4 0.1 0.0 0.1 0.6 0.0 1.5 0.0 0.2 0.3 1.3 0.4 1.4 0.1 0.0 0.7 0.0 1.2 0.3 0.4 0.1 0.2 0.2 0.4 0.8 0.0 0.5 0.4 0.7 0.7 0.0 0.2 0.2 0.0 0.5 0.0 3.8 0.4 0.2 0.1 0.3 0.3 2.0 0.4 0.1 0.0 0.5 0.8 0.3 0.2 0.8 0.1 0.1 0.2 0.2 0.1 1.0 0.3 0.4 0.5 0.2 0.4 0.3 0.3 0.4 0.2 0.7 0.5 0.7 1.2 0.4 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 ZSCAN5A "MGC4161, ZNF495, ZSCAN5" ENSG00000131848 "Zinc finger and SCAN domain containing 5A" Q9BUG6 19 56219670-56368383 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 29.9" "Group enriched" "Detected in many" 6 "Early spermatids: 101.0;Late spermatids: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (1.72e-1)" "unprognostic (3.19e-3)" "unprognostic (8.22e-4)" "unprognostic (1.65e-2)" "unprognostic (2.05e-3)" "unprognostic (6.99e-2)" "unprognostic (1.39e-3)" "unprognostic (3.10e-3)" "unprognostic (1.17e-1)" "unprognostic (2.42e-1)" "unprognostic (8.67e-4)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.10e-2)" "unprognostic (4.70e-2)" "unprognostic (6.15e-3)" "unprognostic (3.99e-3)" 4.0 4.9 5.2 5.4 9.9 3.8 4.3 5.9 8.0 6.0 6.0 6.5 4.9 6.1 6.6 5.0 4.7 11.3 4.3 8.1 5.2 4.8 5.6 5.8 5.0 4.3 4.9 3.9 6.3 5.9 6.4 14.3 4.9 6.9 4.6 7.4 9.9 5.7 7.8 5.9 6.1 5.6 6.3 3.4 4.6 4.1 29.9 5.5 7.6 5.4 5.9 5.3 4.6 4.7 4.2 10.8 4.7 8.9 1.4 8.0 4.1 4.8 4.2 6.1 7.4 5.0 3.2 8.9 2.9 6.2 8.8 5.3 8.4 2.9 8.7 2.3 5.0 5.3 6.0 7.8 6.2 8.0 2.5 16.5 10.7 2.8 8.3 4.0 11.8 12.1 2.5 9.4 8.7 4.0 1.7 6.3 6.9 4.2 4.0 2.7 5.9 2.8 6.7 10.9 4.3 11.1 4.5 9.2 5.1 3.6 9.1 5.9 6.0 7.6 5.9 3.1 3.6 2.6 10.9 3.4 7.7 7.7 4.1 9.4 6.6 16.7 6.1 10.0 11.8 2.9 4.4 7.7 4.7 5.3 8.9 8.0 4.2 5.5 4.0 8.7 2.5 7.2 3.8 0.6 1.4 5.0 10.8 1.4 4.1 5.2 9.9 5.9 8.0 5.2 4.8 4.9 3.9 6.9 5.5 0.0 3.4 5.4 4.3 4.2 3.9 14.8 0.0 12.0 4.5 0.0 7.9 2.7 10.0 4.2 101.0 4.6 3.2 0.0 4.5 3.0 3.1 4.0 2.3 5.9 5.9 3.2 7.5 4.9 6.3 64.2 2.3 4.3 0.0 1.0 3.6 4.8 4.0 0.0 2.5 4.5 9.6 0.0 3.9 11.9 13.8 3.1 5.8 2.5 4.9 2.7 ZSCAN5B "ZNF371, ZNF495B" ENSG00000197213 "Zinc finger and SCAN domain containing 5B" A6NJL1 19 56189570-56197920 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 1.5;testis: 6.1" "Cell type enriched" "Detected in single" 11 "Spermatogonia: 5.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "myeloid DC: 1.5;plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEK 293: 1.7;hTCEpi: 1.3" "HPA043123, HPA046836, HPA059494, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: " "unprognostic (4.73e-2)" "unprognostic (9.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (5.79e-2)" "unprognostic (2.88e-2)" "unprognostic (2.44e-1)" "unprognostic (5.15e-1)" "unprognostic (1.98e-1)" "unprognostic (7.01e-2)" "unprognostic (2.90e-1)" "unprognostic (2.55e-1)" "unprognostic (3.52e-2)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.83e-2)" 0.0 0.0 0.7 0.0 1.2 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.8 0.3 0.4 0.3 0.2 0.5 0.5 0.0 0.6 0.0 0.0 1.0 0.1 0.9 0.1 0.1 0.2 0.0 0.0 0.0 1.7 0.9 0.0 0.3 0.0 0.6 0.3 0.4 1.3 0.0 0.0 0.1 0.2 0.5 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.9 0.0 0.3 0.0 0.4 0.0 1.0 0.0 0.4 0.0 0.3 0.0 0.6 0.8 0.3 0.0 0.6 0.0 0.1 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.7 0.0 0.0 0.0 0.0 0.0 ZSCAN5C "ZNF495C, ZSCAN5CP" ENSG00000204532 "Zinc finger and SCAN domain containing 5C" A6NGD5 19 56202301-56209452 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.7" "HPA041263, HPA043123, HPA046836, HPA060667" Uncertain Uncertain "Nuclear speckles" NA NA "Nuclear speckles" "HPA041263: AB_2677382, HPA043123: AB_2678328, HPA046836: AB_2679832, HPA060667: " "unprognostic (3.74e-1)" "unprognostic (1.54e-1)" "unprognostic (3.29e-2)" "unprognostic (2.56e-2)" "unprognostic (9.17e-3)" "unprognostic (1.53e-1)" "unprognostic (1.47e-1)" "unprognostic (3.68e-2)" "unprognostic (4.01e-2)" "unprognostic (2.13e-2)" "unprognostic (7.45e-2)" "unprognostic (1.35e-1)" "unprognostic (8.51e-2)" "unprognostic (1.55e-1)" "unprognostic (7.89e-2)" "unprognostic (2.53e-1)" "unprognostic (9.53e-3)" 0.4 0.0 0.1 0.4 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 1.0 0.3 0.0 0.7 0.0 0.9 0.3 0.0 0.3 0.0 0.7 0.2 0.2 0.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.9 0.0 0.4 0.7 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.4 0.9 0.2 1.7 0.2 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.8 0.0 0.0 0.2 0.4 0.7 0.7 0.3 0.0 0.3 0.4 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.6 0.3 0.7 0.7 0.7 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZSWIM2 "MEX, MGC33890, ZZZ2" ENSG00000163012 "Zinc finger SWIM-type containing 2" Q8NEG5 2 186827835-186849208 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 17.4" "Group enriched" "Detected in some" 5 "Early spermatids: 41.7;Late spermatids: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 1.1;U-138 MG: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.00e-1)" 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.3 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.1 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.6 0.0 0.2 0.0 0.0 0.0 ZWILCH "FLJ10036, KNTC1AP" ENSG00000174442 "Zwilch kinetochore protein" Q9H900 15 66504959-66550128 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.5" "Cell type enhanced" "Detected in many" 15 "Early spermatids: 80.0;Late spermatids: 61.6;Spermatocytes: 202.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.10e-1)" "unprognostic (9.99e-2)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-1)" "unprognostic (4.83e-3)" "unprognostic (3.32e-2)" "unprognostic (1.31e-2)" "unprognostic (2.17e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (7.34e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.81e-2)" "unprognostic (4.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-1)" 4.1 2.6 4.8 6.8 6.3 6.0 4.5 4.8 7.3 4.6 5.7 2.4 2.2 3.5 4.3 4.4 7.7 3.3 3.9 2.5 4.5 3.3 4.6 4.2 3.5 7.1 2.4 6.2 5.4 3.8 2.4 2.8 6.5 5.4 3.2 6.8 2.3 4.0 2.6 3.5 5.2 4.0 4.2 3.6 8.1 3.6 34.5 1.5 17.8 2.9 6.6 9.2 3.7 4.5 8.0 4.2 7.4 8.9 8.5 8.7 4.4 12.1 15.6 19.4 17.0 4.6 8.2 10.3 19.0 11.7 23.1 25.6 12.6 10.5 26.3 9.0 12.4 19.3 30.2 51.1 13.7 28.1 13.3 10.3 18.8 21.6 10.0 1.6 13.0 10.6 3.3 3.5 23.6 17.4 7.1 14.6 11.2 18.1 14.3 17.9 12.0 11.4 7.9 36.7 24.1 10.1 13.2 23.7 19.0 8.2 13.8 11.4 12.4 10.4 13.6 16.2 23.1 10.9 8.7 9.6 21.3 23.0 12.4 27.8 7.2 28.3 26.9 14.3 30.1 17.6 7.4 3.8 6.3 8.4 7.8 7.3 8.0 8.7 7.9 3.8 7.0 5.8 8.0 5.1 8.5 8.9 4.2 8.4 4.4 4.8 6.3 4.8 7.3 4.5 3.3 2.4 6.2 5.4 1.5 3.0 5.8 5.2 4.7 9.8 4.8 0.9 5.1 4.0 10.3 1.8 0.0 10.2 3.3 6.4 80.0 6.2 1.8 23.3 5.7 20.9 6.5 3.9 14.0 4.3 10.9 0.0 4.6 3.7 4.9 61.6 6.9 8.8 5.0 9.0 7.6 1.3 6.8 0.0 4.9 1.6 3.8 25.8 5.2 202.6 41.9 7.4 10.8 8.4 8.1 5.0 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357228-56361275 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.6;testis: 37.1" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 87.4;Late spermatids: 149.1;Spermatocytes: 124.1;Spermatogonia: 125.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 15.2" "Lineage enriched" "Detected in many" 5 "T-cells: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 1.7 3.5 3.4 14.6 3.1 18.4 3.0 0.9 2.8 3.3 9.4 1.3 2.1 6.8 2.0 4.5 14.1 1.1 6.3 1.6 2.7 1.8 4.6 2.9 2.6 12.8 2.4 3.4 1.7 2.8 2.8 1.9 7.3 1.9 1.8 11.8 1.5 4.2 1.4 0.9 5.2 8.8 3.1 2.5 9.0 6.2 37.1 0.7 35.6 1.9 12.7 17.2 3.1 4.6 1.6 1.3 0.6 2.6 2.9 15.2 3.0 39.9 31.8 22.7 25.2 1.6 2.3 18.5 29.5 22.3 35.7 32.5 56.2 24.0 20.6 11.3 10.1 16.7 20.6 31.8 22.2 33.3 52.3 16.6 20.5 25.6 26.0 0.1 33.8 27.6 1.1 1.4 33.2 13.7 4.4 17.9 27.7 27.7 25.3 31.3 32.3 29.8 21.4 16.1 27.5 39.3 30.5 44.1 11.0 11.1 17.9 21.1 12.9 27.9 63.5 7.4 13.7 41.1 33.1 9.7 15.6 40.3 16.1 45.1 22.3 10.7 35.8 22.1 42.6 19.6 0.0 0.7 0.6 2.2 2.6 0.3 1.6 5.3 3.6 1.3 0.3 6.4 3.6 0.0 2.9 2.0 1.0 15.2 3.0 3.4 3.1 0.9 2.8 2.7 1.8 2.4 3.4 1.9 0.7 3.0 1.7 4.5 4.8 16.4 1.3 0.8 5.1 1.4 3.4 5.2 0.0 36.2 0.0 9.4 58.5 2.3 7.0 46.7 11.7 87.4 2.8 1.3 0.0 3.4 41.1 0.0 0.0 9.8 8.3 149.1 4.6 7.4 6.8 2.8 11.6 1.2 6.7 11.8 2.5 4.6 1.1 0.0 0.9 124.1 125.8 7.2 19.3 7.9 22.7 2.0 ZYG11A ZYG11 ENSG00000203995 "Zyg-11 family member A, cell cycle regulator" Q6WRX3 1 52842511-52894998 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.2;thyroid gland: 8.1" "Cell type enhanced" "Detected in some" 18 "Glandular cells: 1.7;Spermatocytes: 3.4;Spermatogonia: 6.9" "Cancer enriched" "Detected in many" 7 "testis cancer: 11.1" "Region enhanced" "Detected in single" "pons and medulla: 2.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 10.6;hTEC/SVTERT24-B: 10.3;K-562: 9.9;SiHa: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030378, HPA030379" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA030378: AB_10604159, HPA030379: AB_2673451" "unprognostic (7.94e-2)" "unprognostic (6.71e-3)" "unprognostic (1.04e-2)" "unprognostic (4.06e-3)" "unprognostic (1.59e-2)" "unprognostic (1.00e-4)" "unprognostic (1.87e-1)" "unprognostic (2.34e-1)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "unprognostic (4.01e-2)" "unprognostic (1.01e-1)" "unprognostic (6.15e-3)" "unprognostic (2.95e-1)" "unprognostic (1.21e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" 0.3 0.1 0.2 3.0 0.2 0.4 1.4 0.7 0.1 0.6 0.2 0.1 0.8 0.4 0.1 3.0 1.7 0.1 0.4 0.9 0.1 0.3 6.4 3.1 0.1 1.0 0.1 0.0 0.6 0.3 0.6 0.5 1.0 2.2 1.7 0.2 1.0 0.5 0.0 0.3 0.6 0.3 0.5 1.3 0.3 0.1 21.2 0.0 0.9 8.1 1.3 5.6 0.5 1.1 1.0 0.8 3.1 0.6 0.9 0.7 0.2 0.0 1.9 0.3 0.0 0.0 0.0 4.4 1.2 1.3 5.7 4.6 0.1 0.1 0.0 3.0 1.7 0.0 0.1 3.8 0.1 6.8 0.3 7.3 0.0 10.6 0.0 2.8 0.0 0.9 0.0 0.3 10.3 0.1 0.3 1.3 0.1 9.9 5.5 0.2 5.3 0.0 5.3 1.4 0.0 1.0 0.0 1.3 4.7 3.6 0.2 1.5 2.2 10.3 0.5 0.0 4.6 5.8 2.9 0.1 0.0 0.1 0.0 0.0 2.8 4.5 0.1 0.0 0.1 0.8 1.8 0.6 0.8 0.5 0.3 0.3 0.7 0.5 0.5 0.1 1.0 0.6 0.7 3.1 0.9 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.1 0.1 0.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 1.7 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 1.3 0.0 0.0 3.4 6.9 0.1 0.2 0.0 0.0 0.3 ZYG11B "FLJ13456, ZYG11" ENSG00000162378 "Zyg-11 family member B, cell cycle regulator" Q9C0D3 1 52726467-52827342 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.9" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 97.3;Horizontal cells: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028156 Uncertain Approved "Golgi apparatus,Intermediate filaments" NA NA "Golgi apparatus, Intermediate filaments" "HPA028156: AB_10602360" "unprognostic (2.54e-1)" "unprognostic (2.02e-1)" "prognostic favorable (5.42e-6)" "unprognostic (1.58e-2)" "unprognostic (4.44e-2)" "unprognostic (3.04e-3)" "unprognostic (7.15e-2)" "unprognostic (1.85e-1)" "unprognostic (4.84e-3)" "unprognostic (5.06e-2)" "unprognostic (2.76e-1)" "unprognostic (6.08e-2)" "prognostic favorable (9.80e-7)" "unprognostic (2.22e-1)" "unprognostic (3.37e-1)" "unprognostic (1.13e-1)" "unprognostic (9.57e-2)" 8.9 9.1 10.8 5.6 15.6 7.1 7.7 22.3 21.7 9.9 10.4 9.1 5.6 4.7 11.0 6.5 9.7 7.3 6.8 15.9 10.7 15.4 12.9 17.7 7.7 5.0 10.1 11.6 11.3 6.5 12.7 9.1 7.2 16.4 9.8 7.9 10.1 6.1 9.2 63.9 6.5 5.8 12.3 8.4 5.7 6.3 8.4 7.7 6.9 12.7 11.4 5.7 9.2 7.0 2.2 2.2 5.7 2.4 2.1 3.8 1.0 8.1 7.4 9.4 11.7 17.3 15.1 8.2 9.2 11.8 7.3 6.8 6.3 2.7 7.8 9.3 17.8 9.9 4.2 10.7 8.0 11.7 6.5 7.0 10.0 8.5 3.9 9.2 7.5 6.2 10.7 8.8 10.5 7.4 10.3 12.7 1.8 8.9 1.6 13.2 3.4 2.9 4.7 9.7 4.0 7.7 5.0 17.8 7.1 7.5 12.9 4.3 8.7 16.0 10.0 8.5 12.5 6.0 5.8 14.5 11.4 6.7 11.2 5.7 6.8 8.2 6.0 7.8 5.1 7.3 1.0 2.4 2.7 2.1 1.3 2.3 2.2 2.6 1.6 2.2 2.1 3.8 2.7 5.7 2.1 2.0 1.7 3.0 1.0 10.8 15.6 22.3 21.7 10.7 15.4 10.1 11.6 16.4 7.7 23.8 24.5 6.9 9.4 10.1 48.7 78.7 17.8 6.7 12.5 14.0 19.6 20.1 6.6 10.4 4.6 18.0 13.5 0.0 9.5 9.4 18.4 19.6 8.1 97.3 18.3 92.2 9.8 35.6 30.1 6.4 22.7 14.5 20.3 4.6 10.9 21.7 13.8 15.6 29.0 25.4 23.0 25.8 19.4 9.4 26.9 12.8 29.1 5.7 13.6 13.9